diff --git "a/BioMedGraphica-Conn/Entity/Drug/BioMedGraphica_Conn_Drug_LLM_Name_ID_Combined.csv" "b/BioMedGraphica-Conn/Entity/Drug/BioMedGraphica_Conn_Drug_LLM_Name_ID_Combined.csv"
new file mode 100644--- /dev/null
+++ "b/BioMedGraphica-Conn/Entity/Drug/BioMedGraphica_Conn_Drug_LLM_Name_ID_Combined.csv"
@@ -0,0 +1,20919 @@
+BioMedGraphica_Conn_ID,BioMedGraphica_ID,Names_and_IDs
+BMGC_DG00001,BMG_DG000018,"(1R,2S,12S,15S)-1,2-dihydroxy-7-methoxy-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione | PubChem CID:10001648 | CAS RN:111427-99-7 | 12,13-Dihydroxyfumitremorgin C"
+BMGC_DG00002,BMG_DG000025,2-AMINO-4-SEC-BUTYLPHENOL | PubChem SID:474493534 | UNII:TN5YFF4JQQ | CAS RN:3280-71-5 | PubChem CID:100028
+BMGC_DG00003,BMG_DG000029,AMG-3 | PubChem CID:10002952 | UNII:U90K6D923K | PubChem SID:198966102 | CAS RN:179044-94-1
+BMGC_DG00004,BMG_DG000037,CAS RN:693823-79-9 | AMG-076 FREE BASE | PubChem SID:198937626 | PubChem CID:10004545 | UNII:HX4T7JEV3D
+BMGC_DG00005,BMG_DG000045,UNII:I6208298TA | HYDANTOIN | PubChem SID:198983861 | CAS RN:461-72-3 | PubChem CID:10006
+BMGC_DG00006,BMG_DG000050,DrugBank ID:DB01556 | CAS RN:461-78-9 | PubChem SID:198968656 | Chlorphentermine | 1-(4-chlorophenyl)-2-methylpropan-2-amine | PubChem CID:10007 | CHLORPHENTERMINE | UNII:NHW07912O7
+BMGC_DG00007,BMG_DG000053,PubChem CID:10007341 | UNII:909F424Q1Y | PubChem SID:198985659 | FR-226928 FREE BASE | CAS RN:765261-46-9
+BMGC_DG00008,BMG_DG000065,CAS RN:462-08-8 | UNII:69JE8P2L84 | PubChem SID:198975488 | M-AMINOPYRIDINE | PubChem CID:10009
+BMGC_DG00009,BMG_DG000067,PubChem SID:198979276 | Oglufanide | UNII:4RHY598T5U | PubChem CID:100094 | DrugBank ID:DB05779 | CAS RN:122933-59-9 | CAS RN:38101-59-6 | OGLUFANIDE | (4S)-4-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid
+BMGC_DG00010,BMG_DG000070,PHENETHYLAMINE | PubChem SID:175266206 | DrugBank ID:DB04325 | Phenethylamine | CAS RN:64-04-0 | UNII:327C7L2BXQ | PubChem CID:1001 | 2-phenylethanamine
+BMGC_DG00011,BMG_DG000086,PubChem SID:348480833 | CAS RN:44604-90-2 | S-(2-FLUOROETHYL)ISOTHIOUREA | UNII:13W6WJX09R | PubChem CID:10011896
+BMGC_DG00012,BMG_DG000097,"PubChem SID:198969528 | NGX-267 | (2S)-2-Ethyl-8-methyl-1-thia-4,8-diazaspiro[4,5]decan-3-one | DrugBank ID:DB05152 | UNII:8D3PZX7G73 | CAS RN:503431-81-0 | PubChem CID:10013505 | (2S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro[4.5]decan-3-one"
+BMGC_DG00013,BMG_DG000109,PubChem CID:10014835 | NE-10790 | PubChem SID:459275282 | CAS RN:152831-36-2 | UNII:NR6E47E4WN
+BMGC_DG00014,BMG_DG000115,"5-[(2S)-2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol | DrugBank ID:DB05284 | PubChem CID:100154 | CA4P"
+BMGC_DG00015,BMG_DG000116,"UNII:Q7K6GJQ4O4 | PubChem CID:10016012 | CAS RN:1123760-88-2 | PubChem SID:317229433 | 8-Quinolinol, 5,7-dichloro-2-((dimethylamino)methyl)- | CAS RN:747408-78-2 | 5,7-dichloro-2-[(dimethylamino)methyl]quinolin-8-ol | PBT-1033 | DrugBank ID:DB05565"
+BMGC_DG00016,BMG_DG000121,"CAS RN:86680-33-3 | Citrusinine II | 1,3,5-trihydroxy-4-methoxy-10-methylacridin-9-one | PubChem CID:10016895"
+BMGC_DG00017,BMG_DG000127,UNII:7FBG8DMS2E | 3C-B-FLY | PubChem SID:441331153 | PubChem CID:10017554 | CAS RN:219986-75-1
+BMGC_DG00018,BMG_DG000131,"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid | DrugBank ID:DB07283 | PubChem CID:10017976"
+BMGC_DG00019,BMG_DG000139,6-NITROSACCHARIN | CAS RN:22952-24-5 | UNII:8E9B47A8XW | PubChem CID:100187 | PubChem SID:318164746
+BMGC_DG00020,BMG_DG000153,N-DESETHYL-BRINZOLAMIDE | PubChem SID:441659523 | CAS RN:404034-55-5 | PubChem CID:10021113 | UNII:88WG3B2PNK
+BMGC_DG00021,BMG_DG000164,"UNII:G9FWZ369GX | DrugBank ID:DB15167 | 5-(3-fluoropropyl)-2,3-dimethoxy-N-[[(2S)-1-prop-2-enylpyrrolidin-2-yl]methyl]benzamide | PubChem SID:198954677 | CAS RN:166173-78-0 | Fallypride | PubChem CID:10021692 | FALLYPRIDE"
+BMGC_DG00022,BMG_DG000165,PubChem SID:443624146 | PubChem CID:10021712 | UNII:CZR4Q39QWU | CAS RN:477844-47-6 | LY-33169
+BMGC_DG00023,BMG_DG000166,PubChem CID:10021742 | CAS RN:147395-95-7 | UNII:JA69V91QCF | LEUCETTAMINE A | PubChem SID:445498922
+BMGC_DG00024,BMG_DG000169,CAS RN:132998-84-6 | UNII:6TIJ704AEZ | XANTHOANGELOL E | PubChem CID:10022050 | PubChem SID:405055457
+BMGC_DG00025,BMG_DG000171,PubChem SID:198952097 | CAS RN:710334-99-9 | UNII:I7AFS7640N | CT-32521 | PubChem CID:10022582
+BMGC_DG00026,BMG_DG000187,"DrugBank ID:DB07271 | 4-[(3R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(2,2,2-trifluoroethyl)-1,4-diazepan-2-one | PubChem CID:10024590"
+BMGC_DG00027,BMG_DG000197,"PubChem SID:198973457 | UNII:XY02042OD4 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | 1Alpha-Hydroxyvitamin D5 | DrugBank ID:DB13097 | 1.ALPHA.-HYDROXYVITAMIN D5 | CAS RN:187935-17-7 | 1alpha-Hydroxyvitamin D5 | PubChem CID:10025615"
+BMGC_DG00028,BMG_DG000201,PENTYL NITRITE | Pentyl nitrite | CAS RN:463-04-7 | PubChem SID:312524767 | DrugBank ID:DB01612 | Amyl Nitrite | pentyl nitrite | PubChem CID:10026 | UNII:H2HUX79FYK
+BMGC_DG00029,BMG_DG000202,"propan-2-yl 3-(3,4-difluorobenzoyl)-1,1-dimethyl-2,6-dihydroazepino[4,5-b]indole-5-carboxylate | TUROFEXORATE ISOPROPYL | Turofexorate isopropyl | UNII:S6KDM312I5 | DrugBank ID:DB12719 | PubChem SID:198989171 | PubChem CID:10026128 | CAS RN:629664-81-9"
+BMGC_DG00030,BMG_DG000217,UNII:EX3O2Q61UV | PubChem SID:198945474 | PDK1 inhibitor AR-12 | CAS RN:742112-33-0 | PubChem CID:10027278 | AR-12 | 2-amino-N-[4-[5-phenanthren-2-yl-3-(trifluoromethyl)pyrazol-1-yl]phenyl]acetamide
+BMGC_DG00031,BMG_DG000218,"(5Z,8Z,11Z,14Z)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]icosa-5,8,11,14-tetraenamide | Arachidonoyl Serotonin | CAS RN:187947-37-1 | PubChem CID:10027372"
+BMGC_DG00032,BMG_DG000224,NH-3 | UNII:54KY638G8W | PubChem SID:441331645 | PubChem CID:10027822 | CAS RN:447415-26-1
+BMGC_DG00033,BMG_DG000239,"PubChem SID:198947338 | CAS RN:603288-22-8 | PubChem CID:10029385 | DrugBank ID:DB11913 | LY-2090314 | UNII:822M3GYM67 | Ly-2090314 | 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione"
+BMGC_DG00034,BMG_DG000243,"CAS RN:41941-56-4 | Tocladesine | TOCLADESINE | PubChem SID:198954668 | (4aR,6R,7R,7aS)-6-(6-amino-8-chloropurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol | DrugBank ID:DB13046 | UNII:BQ94Z7E5OR | PubChem CID:100299"
+BMGC_DG00035,BMG_DG000245,dihydrogen phosphate | Dihydrogenphosphate | PubChem CID:1003 | DrugBank ID:DB02831 | CAS RN:14066-20-7
+BMGC_DG00036,BMG_DG000254,"Malabaricone C | PubChem CID:100313 | CAS RN:63335-25-1 | PubChem SID:474492478 | MALABARICONE C | UNII:C9K53R3PRN | 1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one"
+BMGC_DG00037,BMG_DG000274,UNII:CT7C6AR5DD | Coumarin 30 | PubChem SID:474491957 | 7-(diethylamino)-3-(1-methylbenzimidazol-2-yl)chromen-2-one | COUMARIN 30 | CAS RN:41044-12-6 | PubChem CID:100335
+BMGC_DG00038,BMG_DG000281,"FIDAXOMICIN | Fidaxomicin | DrugBank ID:DB08874 | [(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate | NDC:52015-700 | CAS RN:873857-62-6 | NDC:52015-080 | CAS RN:56645-60-4 | PubChem SID:175268138 | PubChem CID:10034073 | UNII:Z5N076G8YQ"
+BMGC_DG00039,BMG_DG000295,PubChem CID:10036413 | CAS RN:113866-42-5 | Brassitin | S-methyl N-(1H-indol-3-ylmethyl)carbamothioate
+BMGC_DG00040,BMG_DG000309,"LOXOPROFEN TRANS-ALCOHOL, (2S,1'R,2'S)- | CAS RN:83648-76-4 | PubChem CID:10037656 | UNII:926CB5J9Z0 | PubChem SID:198976205"
+BMGC_DG00041,BMG_DG000329,"PubChem SID:472422324 | PubChem CID:10039361 | 2-MORPHOLIN-4-YLPYRIMIDO(2,1-A)ISOQUINOLIN-4-ONE | CAS RN:168425-64-7 | UNII:TN9PWB4UM5"
+BMGC_DG00042,BMG_DG000330,3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide | DrugBank ID:DB08030 | PubChem CID:10039403
+BMGC_DG00043,BMG_DG000334,"PubChem SID:346537773 | PubChem CID:10039774 | 18-methyl-19-nortestosterone | 17.BETA.-HYDROXY-13.BETA.-ETHYL-4-GONEN-3-ONE, (±)- | 17.BETA.-HYDROXY-13.BETA.-ETHYL-4-GONEN-3-ONE, (+/-)- | DrugBank ID:DB01543 | CAS RN:793-55-5 | CAS RN:793-54-4 | UNII:2B802ECT5B | PubChem SID:198981727 | 18-METHYL-19-NORTESTOSTERONE | UNII:6AL6ML53DZ"
+BMGC_DG00044,BMG_DG000336,DrugBank ID:DB09394 | phosphoric acid | Phosphoric Acid | Phosphoric acid | PubChem SID:175266944 | CAS RN:62046-92-8 | UNII:E4GA8884NN | CAS RN:7664-38-2 | PubChem CID:1004 | PHOSPHORIC ACID
+BMGC_DG00045,BMG_DG000348,"DrugBank ID:DB11372 | UNII:2U0X0JA2NB | (8S,13S,14S,17R)-17-hydroxy-13-methyl-17-prop-2-enyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | ALTRENOGEST | CAS RN:850-52-2 | PubChem CID:10041070 | PubChem SID:175266549 | Altrenogest"
+BMGC_DG00046,BMG_DG000367,CAS RN:31645-39-3 | DrugBank ID:DB05668 | UNII:6A4U6NN813 | PubChem CID:100427 | PALIFOSFAMIDE | Palifosfamide | bis(2-chloroethylamino)phosphinic acid | PubChem SID:198980540
+BMGC_DG00047,BMG_DG000368,"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | PubChem CID:10042950 | DrugBank ID:DB08539"
+BMGC_DG00048,BMG_DG000386,BENZOYLBENZYL FENTANYL | UNII:Q3VQA4M52L | PubChem CID:10044685 | CAS RN:95869-86-6 | PubChem SID:404859482
+BMGC_DG00049,BMG_DG000396,[1-(2-morpholin-4-ylethyl)indol-3-yl]-naphthalen-1-ylmethanone | JWH-200 | PubChem CID:10045570 | PubChem SID:198942467 | CAS RN:103610-04-4 | Jwh-200 | UNII:9HN5J913P3
+BMGC_DG00050,BMG_DG000410,CAS RN:51484-40-3 | PubChem SID:198948415 | UNII:Q6U5F6E1QL | DrugBank ID:DB13371 | PubChem CID:100472 | Difenpiramide | 2-(4-phenylphenyl)-N-pyridin-2-ylacetamide | DIFENPIRAMIDE
+BMGC_DG00051,BMG_DG000411,4-(1-(4-(Aminosulfonyl)phenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)benzoic acid | PubChem SID:198953744 | UNII:EQJ1364UKF | CAS RN:170571-01-4 | PubChem CID:10047220 | 4-[2-(4-sulfamoylphenyl)-5-(trifluoromethyl)pyrazol-3-yl]benzoic acid | 4-(1-(4-(AMINOSULFONYL)PHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-YL)BENZOIC ACID
+BMGC_DG00052,BMG_DG000418,PubChem CID:10048077 | PubChem SID:198989739 | CAS RN:643094-49-9 | UNII:780SH2YCYY | FASOBEGRON
+BMGC_DG00053,BMG_DG000425,"5-NITRO-2-(PYRIDIN-2-YL)-1H-1,3-BENZODIAZOLE | UNII:VY9H3X5NR2 | CAS RN:51759-60-5 | PubChem CID:100489 | PubChem SID:475550084 | 5-nitro-2-(pyridin-2-yl)-1H-1,3-benzodiazole"
+BMGC_DG00054,BMG_DG000427,"UNII:W4PN5LDP26 | PubChem SID:376231041 | CAS RN:22055-22-7 | PubChem CID:100492 | Diphyllin | 9-(1,3-BENZODIOXOL-5-YL)-4-HYDROXY-6,7-DIMETHOXYNAPHTHO(2,3-C)FURAN-1(3H)-ONE | 9-(1,3-benzodioxol-5-yl)-4-hydroxy-6,7-dimethoxy-3H-benzo[f][2]benzofuran-1-one"
+BMGC_DG00055,BMG_DG000433,DrugBank ID:DB01819 | PHOSPHOENOLPYRUVIC ACID | PubChem CID:1005 | UNII:545YL308OW | 2-phosphonooxyprop-2-enoic acid | PubChem SID:198979417 | CAS RN:138-08-9 | Phosphoenolpyruvate
+BMGC_DG00056,BMG_DG000437,DrugBank ID:DB01940 | PubChem CID:10050566 | Balanol Analog 2
+BMGC_DG00057,BMG_DG000441,CAS RN:675122-44-8 | BMS-639623 | PubChem CID:10050884 | PubChem SID:198937275 | UNII:PON9OFP69G
+BMGC_DG00058,BMG_DG000451,PubChem SID:472412375 | UNII:57T55636JD | PubChem CID:100520 | 4-[(5-Nitro-2-thiazolyl)thio]pyrimidine | CAS RN:75464-90-3 | 4-((5-NITRO-2-THIAZOLYL)THIO)PYRIMIDINE
+BMGC_DG00059,BMG_DG000452,OTENABANT | PubChem SID:198965251 | UNII:J8211Y53EF | PubChem CID:10052040 | Otenabant | DrugBank ID:DB11745 | CAS RN:686344-29-6 | 1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)purin-6-yl]-4-(ethylamino)piperidine-4-carboxamide
+BMGC_DG00060,BMG_DG000459,PubChem SID:198985333 | ARCTIIN | UNII:TM5RQ949K7 | PubChem CID:100528 | CAS RN:20362-31-6
+BMGC_DG00061,BMG_DG000482,Caproctamine | 6-[(2-methoxyphenyl)methyl-methylamino]-N-[8-[6-[(2-methoxyphenyl)methyl-methylamino]hexanoyl-methylamino]octyl]-N-methylhexanamide | PubChem CID:10055202
+BMGC_DG00062,BMG_DG000489,"(3S)-3-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[(2-amino-2-oxoethyl)amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | CAS RN:122752-15-2 | PubChem CID:10055958 | deltorphin I, Ala(2)-"
+BMGC_DG00063,BMG_DG000520,"2,6-DIISOPROPYL-4-CHLOROPHENOL | PubChem SID:485663609 | UNII:SU8QCP8MR6 | PubChem CID:10059055 | 2,6-Diisopropyl-4-chlorophenol | CAS RN:91561-75-0"
+BMGC_DG00064,BMG_DG000529,"4-Methoxy-2-nitronaphtho[2,1-b]furan | PubChem SID:474491772 | CAS RN:75965-72-9 | UNII:GPQ8ZN3SWG | PubChem CID:100603 | 4-METHOXY-2-NITRONAPHTHO(2,1-B)FURAN"
+BMGC_DG00065,BMG_DG000532,HEPSULFAM | PubChem SID:322058715 | 7-sulfamoyloxyheptyl sulfamate | PubChem CID:100606 | Hepsulfam | CAS RN:96892-57-8 | UNII:971DU2GQ51
+BMGC_DG00066,BMG_DG000534,"UNII:5WDJ8G2R9N | 2,6-DIHYDROXY-3-CYANOPYRIDINE | CAS RN:35441-10-2 | PubChem SID:474491798 | PubChem CID:100608"
+BMGC_DG00067,BMG_DG000559,"PubChem CID:10062702 | DrugBank ID:DB07489 | 4-Amino-2-[(3-chlorophenyl)amino]-5-(4-fluorobenzoyl)-1,3-thiazol-3-ium"
+BMGC_DG00068,BMG_DG000560,PubChem CID:10062713 | (2R)-3-Methyl-1-phenyl-2-butanyl [(2S)-1-oxo-2-hexanyl]carbamate | DrugBank ID:DB07592
+BMGC_DG00069,BMG_DG000561,1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE | DrugBank ID:DB07593 | PubChem CID:10062714
+BMGC_DG00070,BMG_DG000562,"PubChem SID:445498894 | 5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE | DrugBank ID:DB07730 | CAS RN:850314-30-6 | PubChem CID:10062718 | UNII:832C81WLO3"
+BMGC_DG00071,BMG_DG000563,UNII:QM00M3504A | PubChem SID:316916278 | CAS RN:2440-59-7 | N(6)-(pyridoxal phosphate)-L-lysine | PubChem CID:10062732 | N6-(PYRIDOXAL PHOSPHATE)LYSINE | DrugBank ID:DB04083
+BMGC_DG00072,BMG_DG000564,DrugBank ID:DB02235 | L-methionine (R)-S-oxide | CAS RN:3226-66-2 | L-Methionine (R)-S-oxide | (2S)-2-amino-4-[(R)-methylsulfinyl]butanoic acid | PubChem CID:10062737
+BMGC_DG00073,BMG_DG000568,CAS RN:521-88-0 | KARANJIN | PubChem SID:198954489 | UNII:WV7IM0I02M | PubChem CID:100633
+BMGC_DG00074,BMG_DG000569,2-Undecyl-4(1H)-quinolinone | 2-Undecyl-4(1H)-quinolone | UNII:Z2S75NSY7P | PubChem SID:482554695 | 2-UNDECYL-4(1H)-QUINOLONE | CAS RN:56183-46-1 | 2-undecyl-1H-quinolin-4-one | PubChem CID:10063343
+BMGC_DG00075,BMG_DG000586,PubChem CID:10065 | UNII:0083BRI2A7 | CAS RN:465-69-0 | PubChem SID:317229538 | OXOFLUOXYMESTERONE
+BMGC_DG00076,BMG_DG000592,UNII:SH52PPU72X | PubChem SID:375579647 | CAS RN:573-40-0 | RAPANONE | PubChem CID:100659
+BMGC_DG00077,BMG_DG000621,PubChem CID:100684 | DrugBank ID:DB04356 | 9-Deazaguanine
+BMGC_DG00078,BMG_DG000632,PubChem SID:472408725 | CAS RN:170570-09-9 | 2-METHYL CELECOXIB | PubChem CID:10069246 | UNII:FU7XND9V2J
+BMGC_DG00079,BMG_DG000641,"Lofentanil | methyl (3R,4S)-3-methyl-1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate | PubChem CID:10070040 | DrugBank ID:DB09174"
+BMGC_DG00080,BMG_DG000655,Pimavanserin | CAS RN:706779-91-1 | DrugBank ID:DB05316 | 1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea | PubChem SID:198956315 | PIMAVANSERIN | PubChem CID:10071196 | UNII:JZ963P0DIK
+BMGC_DG00081,BMG_DG000658,DrugBank ID:DB02289 | PubChem CID:100714 | 2-Aminopropanedioic Acid
+BMGC_DG00082,BMG_DG000662,PubChem CID:10071695 | CANNFLAVIN A | UNII:GP8SR738HV | PubChem SID:441331179 | CAS RN:76735-57-4
+BMGC_DG00083,BMG_DG000672,"PubChem CID:10072851 | 5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE | DrugBank ID:DB07117"
+BMGC_DG00084,BMG_DG000677,UNII:I655N5I88O | PubChem CID:10073306 | RO-4597014 | PubChem SID:329589260 | CAS RN:710321-76-9
+BMGC_DG00085,BMG_DG000682,Masupirdine | PubChem CID:10073773 | 1-(2-bromophenyl)sulfonyl-5-methoxy-3-[(4-methylpiperazin-1-yl)methyl]indole | MASUPIRDINE | UNII:8XZ281AO3G | CAS RN:701205-60-9 | PubChem SID:333495778 | DrugBank ID:DB06140
+BMGC_DG00086,BMG_DG000688,PubChem SID:198986059 | JNJ-10258859 | CAS RN:374927-03-4 | PubChem CID:10074226 | UNII:4NPX9224XR
+BMGC_DG00087,BMG_DG000690,"4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide | PubChem SID:198959514 | PubChem CID:10074640 | MASITINIB | Masitinib | UNII:M59NC4E26P | DrugBank ID:DB11526 | CAS RN:790299-79-5"
+BMGC_DG00088,BMG_DG000712,"VORAPAXAR SULFATE | Vorapaxar Sulfate | UNII:IN66038E6C | PubChem CID:10077129 | PubChem SID:198945705 | ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate;sulfuric acid | CAS RN:705260-08-8"
+BMGC_DG00089,BMG_DG000713,"PubChem SID:198944426 | UNII:ZCE93644N2 | CAS RN:618385-01-6 | ethyl N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(E)-2-[5-(3-fluorophenyl)pyridin-2-yl]ethenyl]-1-methyl-3-oxo-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-1H-benzo[f][2]benzofuran-6-yl]carbamate | VORAPAXAR | PubChem CID:10077130 | DrugBank ID:DB09030 | Vorapaxar"
+BMGC_DG00090,BMG_DG000714,DrugBank ID:DB11688 | 2-chloroethyl-3-sarcosinamide-1-nitrosourea | UNII:BHB013S3MO | 2-CHLOROETHYL-3-SARCOSINAMIDE-1-NITROSOUREA | PubChem SID:198982791 | PubChem CID:100773 | CAS RN:81965-43-7 | Sarmustine | 2-[[2-chloroethyl(nitroso)carbamoyl]-methylamino]acetamide
+BMGC_DG00091,BMG_DG000727,"CAS RN:53518-16-4 | PubChem CID:100790 | UNII:NBQ7XX6HZB | PubChem SID:472411837 | 6,7,8,9-TETRAHYDRO-4-(TRIFLUOROMETHYL)-2H-PYRANO(3,2-G)QUINOLIN-2-ONE"
+BMGC_DG00092,BMG_DG000735,"CAS RN:1403-17-4 | DrugBank ID:DB01152 | CAS RN:39372-30-0 | PubChem CID:10079874 | Candeptin | (23E,25E,27E,29E,31E,33E,35E)-22-[(3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-38-[7-(4-aminophenyl)-5-hydroxy-4-methyl-7-oxoheptan-2-yl]-10,12,14,18,20-pentahydroxy-37-methyl-2,4,8,16-tetraoxo-1-oxacyclooctatriaconta-23,25,27,29,31,33,35-heptaene-19-carboxylic acid"
+BMGC_DG00093,BMG_DG000739,"2,7-PHENANTHRENEDIOL, 5-ETHENYL-9,10-DIHYDRO-1-METHYL- | UNII:S436Y000RU | CAS RN:73166-28-6 | PubChem SID:375579488 | PubChem CID:100801"
+BMGC_DG00094,BMG_DG000758,4-(HYDROXYMETHYL)BENZENESULFONAMIDE | PubChem SID:482554104 | UNII:7TZ9W97FYX | PubChem CID:10081162 | 4-(Hydroxymethyl)benzenesulfonamide | CAS RN:67472-44-0
+BMGC_DG00095,BMG_DG000759,"CAS RN:77779-50-1 | 2-(4-METHOXYPHENYL)-2H-PYRAZOLO(4,3-C)QUINOLIN-3-OL | UNII:VEN7HT4FPL | PubChem CID:100812 | PubChem SID:474489528 | 2-(4-Methoxyphenyl)-2H-pyrazolo[4,3-c]quinolin-3-ol"
+BMGC_DG00096,BMG_DG000764,PubChem CID:10081842 | UNII:0868W4SS6C | 3-METHOXY-5-(2-PYRIDINYLETHYNYL)PYRIDINE | PubChem SID:438788738 | CAS RN:524924-76-3
+BMGC_DG00097,BMG_DG000772,"PubChem SID:461432285 | BIOTINOL, D- | UNII:N2GT586J33 | PubChem CID:10082587 | CAS RN:53906-36-8"
+BMGC_DG00098,BMG_DG000773,UNII:HD9DMM9M4N | PubChem SID:474492251 | CAS RN:39890-42-1 | N-ISOPROPYL-2-(PIPERAZIN-1-YL)ACETAMIDE | PubChem CID:100826 | N-Isopropyl-2-(piperazin-1-yl)acetamide
+BMGC_DG00099,BMG_DG000777,Pipradrol | diphenyl(piperidin-2-yl)methanol | UNII:S6I030E0DA | CAS RN:467-60-7 | PubChem CID:10083 | PubChem SID:198935075 | PIPRADROL | DrugBank ID:DB11584
+BMGC_DG00100,BMG_DG000801,"UNII:JT2J433TRR | CAS RN:288862-83-9 | 1-Oxazolo[4,5-b]pyridin-2-yl-6-phenyl-1-hexanone | PubChem SID:485663574 | 1-OXAZOLO(4,5-B)PYRIDIN-2-YL-6-PHENYL-1-HEXANONE | PubChem CID:10085812"
+BMGC_DG00101,BMG_DG000802,PubChem SID:363908668 | UNII:B3B8503HM8 | CAS RN:467-68-5 | N-ETHYL-3-PIPERIDYL PHENYLCYCLOPENTYLGLYCOLATE | PubChem CID:10086
+BMGC_DG00102,BMG_DG000805,CAS RN:3984-73-4 | PubChem CID:10086155 | PubChem SID:472422956 | METHYLLINDERONE | UNII:YYE85YM58K
+BMGC_DG00103,BMG_DG000809,DrugBank ID:DB02869 | PubChem CID:10086234 | 3-amino-5-phenylpentane
+BMGC_DG00104,BMG_DG000813,PubChem CID:10086952 | CAS RN:741693-76-5 | 5-[(1S)-3-(methylamino)-1-thiophen-2-ylpropoxy]naphthalen-2-ol | 5-((S)-3-Methylamino-1-thiophen-2-yl-propoxy)-naphthalen-2-ol
+BMGC_DG00105,BMG_DG000825,"5-ETHYL-4-(4-METHANESULFONYLPHENYL)-5-METHYL-3-(PROPAN-2-YLOXY)-2,5-DIHYDROFURAN-2-ONE, (5R)- | CAS RN:189954-90-3 | PubChem CID:10088506 | UNII:MQ2PE7JMC5 | PubChem SID:445499741"
+BMGC_DG00106,BMG_DG000830,"PubChem CID:10089048 | DrugBank ID:DB07811 | N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide"
+BMGC_DG00107,BMG_DG000832,A-277249 | UNII:MB7S05DTHO | PubChem SID:198980016 | CAS RN:251994-26-0 | PubChem CID:10089338
+BMGC_DG00108,BMG_DG000839,"PubChem CID:10090 | NORMETHADONE | Normethadone | UNII:KR2L2A68XL | 6-(dimethylamino)-4,4-diphenylhexan-3-one | CAS RN:467-85-6 | PubChem SID:198987567 | DrugBank ID:DB11609"
+BMGC_DG00109,BMG_DG000843,"Galunisertib | UNII:3OKH1W5LZE | PubChem CID:10090485 | 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide | PubChem SID:198946153 | DrugBank ID:DB11911 | GALUNISERTIB | CAS RN:700874-72-2"
+BMGC_DG00110,BMG_DG000845,UNII:46AF8680RC | ENDOXIFEN | CAS RN:112093-28-4 | PubChem SID:198982937 | 4-[(Z)-1-[4-[2-(methylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol | PubChem CID:10090750 | Endoxifen | CAS RN:110025-28-0
+BMGC_DG00111,BMG_DG000854,"Unii-1U7V49ntqg | PubChem CID:10091392 | ORG-28611 | [1-(cyclohexylmethyl)-7-methoxyindol-3-yl]-[(3S)-3,4-dimethylpiperazin-1-yl]methanone | PubChem SID:198935674 | UNII:1U7V49NTQG | CAS RN:639068-99-8"
+BMGC_DG00112,BMG_DG000886,"CID 10093379 | PubChem CID:10093379 | CAS RN:32222-06-3 | (1R,3S,5Z)-5-[(2E)-2-[(1S,3aR,7aS)-1-[(2S)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol"
+BMGC_DG00113,BMG_DG000888,CAS RN:256938-53-1 | PubChem CID:10093682 | PubChem SID:485663380 | 4-(4-Bromophenyl)-1-(diphenylmethyl)piperidin-4-ol | UNII:NB7YMY8XUM | 4-(4-BROMOPHENYL)-1-(DIPHENYLMETHYL)PIPERIDIN-4-OL
+BMGC_DG00114,BMG_DG000894,"PubChem CID:10094631 | CAS RN:167427-23-8 | (1S,2S,5S,7S,9R,10R,11R,14S)-7-(2-hydroxypropan-2-yl)-1,2,10-trimethyl-6-oxa-23-azahexacyclo[12.10.0.02,11.05,10.016,24.017,22]tetracosa-16(24),17,19,21-tetraen-9-ol | Terpendole E"
+BMGC_DG00115,BMG_DG000907,PubChem SID:198987345 | UNII:RZF1QN1Z8R | PubChem CID:10095180 | CAS RN:16290-07-6 | KAEMPFEROL 7-O-GLUCOSIDE
+BMGC_DG00116,BMG_DG000924,DrugBank ID:DB07211 | (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE | PubChem CID:10095865
+BMGC_DG00117,BMG_DG000926,"4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL | PubChem CID:10095904 | DrugBank ID:DB06957"
+BMGC_DG00118,BMG_DG000928,UNII:9BBR605NUE | PubChem SID:198945386 | CAS RN:618068-98-7 | OSU-02067 | PubChem CID:10096122
+BMGC_DG00119,BMG_DG000931,"NDC:0597-0275 | DrugBank ID:DB08882 | Linagliptin | 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione | CAS RN:668270-12-0 | LINAGLIPTIN | NDC:0597-0147 | NDC:50090-4383 | NDC:0597-0140 | UNII:3X29ZEJ4R2 | CAS RN:1233245-11-8 | PubChem SID:175267212 | NDC:0597-0146 | NDC:0597-0270 | PubChem CID:10096344 | NDC:0597-0148 | NDC:55154-0410"
+BMGC_DG00120,BMG_DG000960,"UNII:19V3ECX465 | JERVINE | PubChem SID:198986889 | Jervine | CAS RN:469-59-0 | (3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3-hydroxy-3',6',10,11b-tetramethylspiro[1,2,3,4,6,6a,6b,7,8,11a-decahydrobenzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-11-one | PubChem CID:10098"
+BMGC_DG00121,BMG_DG000991,"methyl 1-[3-[[5-carbamoyl-4-(3,4-difluorophenyl)-6-ethyl-2-oxo-1,4-dihydropyrimidine-3-carbonyl]amino]propyl]-4-phenylpiperidine-4-carboxylate | CAS RN:252201-38-0 | 1-(3-{[5-Carbamoyl-6-(3,4-difluoro-phenyl)-4-ethyl-2-oxo-3,6-dihydro-2H-pyrimidine-1-carbonyl]-amino}-propyl)-4-phenyl-piperidine-4-carboxylic acid methyl ester | PubChem CID:10099811"
+BMGC_DG00122,BMG_DG000996,"PROPOXYPHENE | PubChem CID:10100 | PubChem SID:198954439 | PROPOXYPHENE, (+/-)- | DrugBank ID:DB00647 | PubChem SID:175267938 | CAS RN:2621-61-6 | Propoxyphene | [(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate | UNII:S2F83W92TK | CAS RN:469-62-5 | UNII:II2G62OV6F | PROPOXYPHENE, (±)- | Dextropropoxyphene"
+BMGC_DG00123,BMG_DG000999,(2S)-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-(diaminomethylideneamino)pentanamide | PubChem CID:10100083 | CAS RN:64190-70-1 | Fmrfamide | PubChem SID:198978514 | UNII:8953X1KZFL | NEUROPEPTIDE C (MACROCALLISTA NIMBOSA CARDIOEXCITATORY) | CAS RN:152165-14-5
+BMGC_DG00124,BMG_DG001017,"PubChem CID:101009379 | N-acetyl-Asp-Glu-Val-Asp-CHO | (4S)-4-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]-5-[[(2S)-1-[[(2S)-1-carboxy-3,4-dioxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid"
+BMGC_DG00125,BMG_DG001018,UNII:PQS1L514CF | 1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]propan-1-one | PubChem CID:10101 | Ketobemidone | KETOBEMIDONE | CAS RN:469-79-4 | PubChem SID:198971890 | DrugBank ID:DB06738
+BMGC_DG00126,BMG_DG001021,"PubChem SID:198988991 | Bismuth Subcitrate | CAS RN:57644-54-9 | bismuth;tripotassium;2-hydroxypropane-1,2,3-tricarboxylate | BISMUTH SUBCITRATE | PubChem CID:10101269 | UNII:HS813P8QPX"
+BMGC_DG00127,BMG_DG001031,"4-O-[3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 1-O-[3-[(1R,2S)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate | DrugBank ID:DB05710 | PubChem CID:10102486 | GANTACURIUM | CAS RN:758669-50-0 | Gantacurium | UNII:N9VK9ZO25E | PubChem SID:198954042"
+BMGC_DG00128,BMG_DG001044,"(2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one;(2R)-2-[(1S)-1,2-dihydroxyethyl]-5-oxo-2H-furan-3,4-diolate;iron(2+) | DrugBank ID:DB14490 | PubChem CID:101033550 | (+)-Iron(II) L-ascorbate"
+BMGC_DG00129,BMG_DG001079,3-HYDROXYTACRINE | PubChem SID:441659597 | UNII:R32E49V3H2 | PubChem CID:10104685 | CAS RN:178450-86-7
+BMGC_DG00130,BMG_DG001087,"PubChem SID:316911695 | UNII:Y49P7H49WX | BENZO(A)PYRENE-9,10-EPOXIDE | PubChem CID:101053797 | CAS RN:36504-66-2"
+BMGC_DG00131,BMG_DG001121,PubChem CID:101072 | UNII:74M0104F2J | PubChem SID:198969487 | IBUPROFENAMIDE | CAS RN:59512-17-3
+BMGC_DG00132,BMG_DG001122,PubChem SID:405218101 | UNII:U4Y54D5P9L | CAS RN:508202-22-0 | PubChem CID:10107234 | PHA-709829
+BMGC_DG00133,BMG_DG001125,PubChem CID:10107360 | PubChem SID:375084581 | CAS RN:424829-90-3 | FP-TZTP | UNII:C2LNI0YP8Z
+BMGC_DG00134,BMG_DG001127,"FLUTEMETAMOL | Flutemetamol | PubChem CID:10107393 | CAS RN:637003-10-2 | PubChem SID:198941783 | UNII:0F3M7032P5 | DrugBank ID:DB15058 | 2-[3-fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol"
+BMGC_DG00135,BMG_DG001132,N-DESMETHYLDULOXETINE | CAS RN:178273-35-3 | PubChem SID:433968582 | UNII:6B3S58SVQ2 | PubChem CID:10107888
+BMGC_DG00136,BMG_DG001159,UNII:Y9A2N9O85G | CAS RN:345987-15-7 | PubChem CID:10109823 | AS-601245 | PubChem SID:198952864
+BMGC_DG00137,BMG_DG001197,NDC:69842-280 | NDC:41250-270 | NDC:11673-007 | NDC:69842-398 | NDC:79903-221 | NDC:36800-082 | NDC:0135-0540 | NDC:51316-050 | NDC:69626-0008 | NDC:0363-1082 | NDC:50804-127 | NDC:11673-755 | NDC:68016-679 | NDC:0135-0076 | NDC:11673-624 | NDC:21130-201 | NDC:69842-015 | NDC:41250-691 | NDC:66715-6422 | NDC:11822-0312 | NDC:69842-363 | NDC:63981-171 | NDC:68016-700 | NDC:51376-127 | NDC:66715-9822 | NDC:76162-131 | NDC:55910-273 | NDC:41167-1004 | NDC:49035-048 | NDC:0363-0511 | NDC:30142-200 | NDC:79903-103 | NDC:0135-0154 | NDC:63941-624 | NDC:70000-0460 | NDC:11673-480 | NDC:79481-1150 | NDC:67296-1256 | NDC:53041-171 | NDC:51316-053 | NDC:83324-128 | NDC:67751-227 | NDC:59088-156 | NDC:51316-405 | NDC:71481-001 | NDC:68016-652 | NDC:62372-552 | NDC:0924-0086 | NDC:55319-925 | NDC:83324-318 | NDC:69396-142 | NDC:69842-902 | NDC:50804-176 | NDC:49035-321 | NDC:68016-678 | NDC:0135-0611 | NDC:11822-1037 | NDC:68016-249 | NDC:11822-1029 | NDC:37808-936 | NDC:41250-427 | NDC:71481-003 | NDC:0363-9953 | NDC:63941-021 | NDC:70000-0416 | NDC:36800-595 | NDC:50804-151 | NDC:66715-6355 | NDC:41167-1043 | NDC:49035-778 | NDC:50804-027 | NDC:70000-0592 | NDC:83324-314 | NDC:0280-0002 | NDC:0363-1093 | NDC:11822-1039 | NDC:55301-203 | NDC:69842-173 | NDC:0135-0155 | NDC:41250-395 | NDC:42681-0028 | NDC:30142-204 | NDC:37808-493 | NDC:11822-1166 | NDC:59779-738 | NDC:41250-669 | NDC:0135-0140 | NDC:55301-202 | NDC:41250-203 | NDC:50804-171 | NDC:67751-202 | NDC:11822-0223 | NDC:41250-415 | NDC:68210-5027 | NDC:0135-0138 | CAS RN:13397-26-7 | NDC:79903-200 | NDC:0135-0623 | NDC:67091-365 | NDC:69842-171 | NDC:46122-007 | NDC:63868-701 | NDC:11673-010 | NDC:68998-101 | NDC:68016-668 | NDC:70000-0459 | NDC:53943-108 | NDC:0135-0178 | NDC:11673-548 | NDC:37808-465 | NDC:53041-102 | NDC:11673-813 | NDC:24385-485 | NDC:69790-820 | NDC:37835-126 | NDC:84540-323 | NDC:62372-796 | NDC:37808-212 | NDC:72288-234 | NDC:62372-541 | NDC:71141-143 | NDC:0135-0118 | NDC:71481-002 | NDC:79481-0041 | NDC:37835-115 | NDC:57896-624 | NDC:83324-129 | NDC:55319-018 | NDC:16837-246 | NDC:63941-071 | NDC:0135-0630 | NDC:57896-663 | NDC:0135-0633 | NDC:0135-0235 | NDC:41520-905 | NDC:70000-0683 | NDC:0135-0456 | NDC:11673-060 | NDC:11822-0500 | NDC:63868-155 | NDC:27854-120 | NDC:41163-131 | NDC:68071-2258 | NDC:83324-124 | NDC:0924-0287 | NDC:30142-040 | NDC:71481-008 | NDC:62011-0482 | NDC:0395-0431 | NDC:41163-101 | NDC:73598-1144 | NDC:37808-464 | NDC:84269-2516 | NDC:41250-566 | NDC:55319-624 | NDC:83876-010 | NDC:0280-0059 | NDC:42681-0004 | NDC:62372-501 | NDC:49035-810 | NDC:69842-368 | NDC:50804-175 | NDC:73598-1392 | NDC:46122-345 | NDC:83324-316 | NDC:21130-207 | NDC:0363-2103 | NDC:48951-8201 | NDC:51316-102 | NDC:59779-748 | NDC:21130-209 | NDC:0135-1001 | NDC:50090-2440 | NDC:51316-301 | NDC:68703-382 | CALCIUM CARBONATE | NDC:62372-551 | NDC:0121-0766 | NDC:0135-0569 | NDC:37808-406 | NDC:21130-501 | NDC:53041-098 | NDC:41167-1040 | NDC:62372-510 | NDC:84126-324 | NDC:11673-156 | NDC:37808-058 | NDC:41250-420 | NDC:51316-031 | NDC:69423-826 | NDC:0135-1328 | NDC:84540-422 | NDC:69423-825 | NDC:76162-127 | NDC:54738-030 | NDC:0113-6023 | NDC:68391-102 | NDC:24385-595 | NDC:41250-978 | NDC:63941-101 | NDC:69842-360 | NDC:48951-8006 | NDC:0363-1083 | NDC:11673-625 | NDC:30142-207 | NDC:41415-111 | NDC:82431-101 | NDC:76162-405 | NDC:29485-8120 | NDC:0280-0221 | NDC:83324-126 | NDC:55910-590 | NDC:53943-107 | calcium;carbonate | NDC:51316-103 | NDC:0135-0181 | NDC:0363-3103 | NDC:41250-284 | NDC:69618-020 | NDC:83324-263 | NDC:41250-965 | NDC:82431-106 | NDC:49035-815 | NDC:0135-0624 | NDC:21130-302 | NDC:41520-031 | DrugBank ID:DB06724 | NDC:47682-920 | NDC:71481-007 | NDC:69842-440 | NDC:70000-0681 | NDC:30142-300 | NDC:0280-0058 | NDC:30142-162 | NDC:55910-605 | NDC:0135-0184 | NDC:0280-0224 | NDC:76162-404 | NDC:0067-0119 | NDC:11822-1156 | NDC:0135-0180 | NDC:37808-494 | NDC:68163-011 | NDC:41415-296 | NDC:73057-377 | NDC:79481-0095 | NDC:69842-436 | NDC:11673-902 | NDC:0135-0074 | NDC:68998-103 | NDC:70000-0431 | NDC:46122-225 | NDC:0363-6701 | NDC:0363-2730 | NDC:29485-6522 | NDC:0135-0183 | NDC:66715-8553 | NDC:11822-3016 | NDC:82501-1586 | NDC:55319-151 | NDC:83324-317 | NDC:11673-786 | NDC:36800-485 | NDC:41250-298 | NDC:70677-1076 | NDC:49035-058 | NDC:67091-356 | NDC:63941-115 | NDC:36800-478 | NDC:36800-616 | NDC:53041-130 | NDC:63868-130 | NDC:37808-063 | NDC:21130-203 | NDC:36800-203 | NDC:83698-360 | NDC:66715-7822 | NDC:79903-102 | NDC:41167-1002 | NDC:30142-039 | NDC:0135-0071 | NDC:41250-109 | NDC:49035-046 | NDC:71481-010 | NDC:11822-0048 | NDC:16837-891 | NDC:41250-454 | NDC:68163-101 | NDC:36800-830 | NDC:69842-060 | NDC:49035-803 | NDC:49035-167 | NDC:49314-1013 | NDC:41250-392 | NDC:0135-1000 | NDC:76162-128 | NDC:69842-397 | NDC:47682-820 | NDC:71141-144 | NDC:37808-503 | NDC:41520-409 | NDC:68163-100 | NDC:70677-1100 | NDC:82442-321 | NDC:81522-360 | NDC:36800-615 | NDC:69168-229 | NDC:0135-0243 | NDC:70000-0582 | NDC:83422-000 | NDC:68998-102 | NDC:0135-0642 | NDC:41520-035 | NDC:69842-371 | NDC:11673-052 | NDC:70000-0593 | NDC:55319-919 | NDC:37808-121 | NDC:0363-5960 | NDC:83324-313 | NDC:55319-127 | NDC:0067-0118 | NDC:0135-0631 | NDC:0280-0245 | NDC:17714-041 | NDC:51316-021 | NDC:51316-115 | NDC:68016-669 | NDC:72427-6020 | NDC:83698-002 | NDC:11673-547 | NDC:55319-927 | NDC:70000-0436 | PubChem CID:10112 | NDC:41250-409 | NDC:48951-8203 | NDC:68163-102 | NDC:63868-048 | NDC:79903-201 | NDC:11673-040 | NDC:50804-012 | NDC:41250-232 | NDC:51316-003 | NDC:53041-184 | NDC:62011-0229 | NDC:0135-0185 | NDC:49035-889 | NDC:69423-828 | NDC:36800-828 | NDC:66715-8151 | NDC:46122-151 | Calcium Carbonate | NDC:69842-396 | NDC:0536-1206 | NDC:11673-933 | NDC:70000-0682 | NDC:73065-0011 | NDC:63941-022 | NDC:66715-6522 | NDC:0135-0618 | NDC:0363-0184 | NDC:0113-0032 | NDC:0536-1007 | NDC:48433-106 | NDC:68210-5033 | NDC:50332-0151 | NDC:36800-962 | NDC:49631-178 | NDC:41163-129 | NDC:69842-271 | NDC:0363-9201 | NDC:37835-171 | NDC:55910-115 | NDC:37808-203 | NDC:47682-850 | NDC:0132-0507 | NDC:11822-0216 | NDC:17714-025 | NDC:41167-1003 | NDC:0280-0042 | NDC:11822-0040 | NDC:37808-341 | NDC:50269-016 | NDC:41163-125 | NDC:0536-1050 | NDC:83324-127 | NDC:41250-135 | NDC:83324-123 | NDC:0135-1326 | NDC:63941-107 | NDC:49035-902 | UNII:H0G9379FGK | NDC:82431-105 | NDC:36800-692 | NDC:21130-310 | NDC:68599-1411 | NDC:0135-0560 | NDC:37808-638 | NDC:0135-0606 | NDC:69842-716 | NDC:0363-0713 | NDC:41520-617 | NDC:11822-2019 | NDC:55910-315 | NDC:70264-034 | NDC:0904-6412 | PubChem SID:175267024 | NDC:51316-052 | NDC:0536-1225 | NDC:0135-0553 | NDC:69423-829 | NDC:11673-699 | NDC:37835-127 | NDC:70000-0034 | NDC:30142-307 | NDC:84126-343 | NDC:41250-553 | NDC:70000-0430 | NDC:36800-489 | NDC:83324-221 | NDC:82431-104 | NDC:21130-516 | NDC:63868-700 | NDC:53041-717 | NDC:52642-034 | NDC:37808-111 | NDC:84540-523 | NDC:30142-038 | NDC:47682-285 | CAS RN:72608-12-9 | NDC:67091-360 | NDC:55319-171 | NDC:68016-666 | NDC:24385-106 | NDC:11673-715 | NDC:49035-546 | NDC:0135-0227 | NDC:79481-0093 | NDC:0135-0070 | NDC:42681-0029 | NDC:72476-022 | NDC:62372-520 | NDC:41167-1001 | NDC:55301-102 | NDC:0363-9952 | NDC:63868-703 | NDC:0363-0317 | NDC:76162-130 | NDC:68016-665 | NDC:72288-321 | NDC:82442-173 | NDC:73598-1142 | NDC:72476-026 | NDC:41415-201 | CAS RN:471-34-1 | NDC:41163-184 | NDC:30142-267 | NDC:41250-363 | NDC:51316-300 | NDC:73408-921 | NDC:55910-692 | NDC:68196-103 | NDC:11673-333 | NDC:55910-210 | NDC:0135-0521 | NDC:69423-827 | NDC:69168-219 | NDC:59779-862 | NDC:59779-596 | NDC:41167-1031 | NDC:46122-346 | NDC:0135-0246 | NDC:21130-087 | NDC:49035-101 | NDC:59779-675 | NDC:30142-115 | NDC:71610-301 | NDC:36800-881 | NDC:0363-3390 | NDC:0363-3113 | NDC:41163-132 | NDC:11673-776 | NDC:0135-0561 | NDC:11822-0596 | NDC:52642-035 | NDC:55910-510 | NDC:71481-009 | NDC:0536-1229 | NDC:76162-129 | NDC:63941-010 | NDC:84126-322 | NDC:0363-0107 | NDC:11673-051 | NDC:0280-0001 | NDC:71481-004 | NDC:21130-515 | NDC:41415-101 | NDC:70264-046 | NDC:63868-702 | NDC:50804-129 | NDC:84540-322 | NDC:30142-993 | NDC:47682-201 | NDC:30142-036 | NDC:37835-184 | NDC:68016-675 | NDC:0121-4766 | NDC:0280-0225 | NDC:83324-315 | NDC:0536-1048 | NDC:43353-958 | NDC:0363-1224 | Calcium carbonate | NDC:21130-472 | NDC:70677-1081 | NDC:67091-357 | NDC:41415-102 | NDC:59779-636 | NDC:83455-173 | NDC:55319-921 | NDC:63868-047 | NDC:48951-8007 | NDC:21130-546 | NDC:63868-057 | NDC:69842-184 | NDC:70677-1079 | NDC:11673-479 | NDC:50804-112 | NDC:62372-400 | NDC:21130-031 | NDC:82442-010 | NDC:70677-1075 | NDC:67091-358 | NDC:36800-468 | NDC:84732-049 | NDC:72427-6010 | NDC:79481-0042 | NDC:0135-1002 | NDC:37808-103 | NDC:0135-0228 | NDC:0536-1049 | NDC:16837-298 | NDC:55910-077 | NDC:67751-235 | NDC:41250-108 | NDC:37808-938 | NDC:11822-1512 | NDC:51013-323 | NDC:0135-0641 | NDC:37808-132 | NDC:41167-1041 | NDC:63941-031 | NDC:0363-1081 | NDC:41163-171 | NDC:30142-213 | NDC:82431-102 | NDC:56062-263 | NDC:55319-920 | NDC:55910-070 | NDC:72288-235 | NDC:71481-006 | NDC:71481-005 | NDC:41163-102 | NDC:58933-446 | NDC:37835-471 | NDC:37808-101 | NDC:41250-690 | NDC:63868-049 | NDC:51316-657 | NDC:41250-723 | NDC:55319-049 | NDC:68084-988 | NDC:37808-136 | NDC:84126-325 | NDC:37808-137 | NDC:68163-115 | NDC:0135-0245 | NDC:69842-362 | NDC:57896-763 | NDC:41163-321 | NDC:82431-103 | NDC:67091-359 | NDC:62372-410 | NDC:11673-726 | NDC:42961-208 | NDC:0363-3355 | NDC:41415-103 | NDC:83698-263 | NDC:0280-0051 | NDC:84540-522 | NDC:69423-824 | NDC:24385-478 | NDC:51316-051 | NDC:50804-113 | NDC:17714-043 | NDC:30142-108 | NDC:51316-201 | NDC:49035-596
+BMGC_DG00138,BMG_DG001200,"Zapnometinib | PubChem CID:10112191 | PubChem SID:443623942 | ZAPNOMETINIB | CAS RN:303175-44-2 | UNII:4RZD8LK83V | 2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic acid"
+BMGC_DG00139,BMG_DG001201,PubChem CID:101122 | CAS RN:627-76-9 | 2-Aminoheptanedioic acid | PubChem SID:317229757 | 2-aminoheptanedioic acid | UNII:V76629V970 | CAS RN:3721-85-5 | 2-AMINOPIMELIC ACID
+BMGC_DG00140,BMG_DG001202,"1-BENZYL-4-(5,6-DIMETHOXY-1-OXO-INDAN-2-YLMETHYL)-PYRIDINIUM | 4-((2,3-DIHYDRO-5,6-DIMETHOXY-1-OXO-1H-INDEN-2-YL)METHYL)-1-(PHENYLMETHYL)PYRIDINIUM | PubChem CID:10112210 | PubChem SID:443623445 | UNII:AS2QT83Y3Z | CAS RN:757173-38-9"
+BMGC_DG00141,BMG_DG001237,"CAS RN:444731-52-6 | UNII:7RN5DR86CK | NDC:60505-4779 | NDC:51407-872 | DrugBank ID:DB06589 | PAZOPANIB | 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide | PubChem SID:175268752 | PubChem CID:10113978 | Pazopanib | CAS RN:790713-33-6"
+BMGC_DG00142,BMG_DG001238,"CAS RN:107420-91-7 | DrugBank ID:DB13089 | ENOXOLONE | (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid | UNII:P540XA09DR | PubChem SID:175266413 | PubChem CID:10114 | CAS RN:1449-05-4 | CAS RN:471-53-4 | CAS RN:15301-63-0 | Enoxolone"
+BMGC_DG00143,BMG_DG001243,"PubChem CID:10114365 | N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide | DrugBank ID:DB07946"
+BMGC_DG00144,BMG_DG001246,"PubChem CID:10114519 | DEHYDROARIPIPRAZOLE | UNII:2S514OZH3B | 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-1H-quinolin-2-one | Dehydroaripiprazole | CAS RN:129722-25-4 | PubChem SID:198979532"
+BMGC_DG00145,BMG_DG001272,"DrugBank ID:DB12540 | Lecozotan | PubChem SID:198975736 | CAS RN:434283-16-6 | LECOZOTAN | 4-cyano-N-[(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]propyl]-N-pyridin-2-ylbenzamide | UNII:48854OTZ5E | PubChem CID:10116877"
+BMGC_DG00146,BMG_DG001282,"CAS RN:377727-87-2 | 4-(furan-2-yl)-10-[2-[4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl]ethyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine | PubChem CID:10117987 | Preladenant | PRELADENANT | UNII:950O97NUPO | DrugBank ID:DB11864 | PubChem SID:198945905"
+BMGC_DG00147,BMG_DG001301,"PubChem CID:10120218 | (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[6-(dimethylamino)-1-methyl-2,4-dioxoquinazolin-3-yl]phenyl]propanoic acid | CAROTEGRAST | CAS RN:401904-75-4 | Carotegrast | PubChem SID:198945212 | UNII:Y1HYC6SO3F"
+BMGC_DG00148,BMG_DG001381,"UNII:0N1X9UW73U | PubChem SID:313183463 | CAS RN:80300-10-3 | 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, (-)- | PubChem CID:10125797"
+BMGC_DG00149,BMG_DG001383,"PubChem CID:10125830 | DrugBank ID:DB07078 | (3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE"
+BMGC_DG00150,BMG_DG001393,PubChem CID:101263 | TAURINAMIDE | CAS RN:4378-70-5 | PubChem SID:198986542 | UNII:NTG0L34CGG
+BMGC_DG00151,BMG_DG001411,NDC:0310-0625 | CAS RN:606143-52-6 | 6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide | Selumetinib | PubChem CID:10127622 | PubChem SID:198960497 | NDC:0310-0610 | UNII:6UH91I579U | SELUMETINIB | DrugBank ID:DB11689
+BMGC_DG00152,BMG_DG001497,1H-PYRROLE-3-PROPANAMIDE | UNII:XFJ75AUL2Y | CAS RN:152509-75-6 | PubChem CID:10129992 | 1H-Pyrrole-3-propanamide | PubChem SID:475550291
+BMGC_DG00153,BMG_DG001498,DICENTRINE | PubChem SID:198951319 | UNII:J2ZGT5M0N7 | CAS RN:517-66-8 | PubChem CID:101300
+BMGC_DG00154,BMG_DG001511,S-ACETYLCYSTEINE | UNII:SSR768695G | PubChem CID:10130120 | CAS RN:15312-11-5 | S-Acetyl-Cysteine | PubChem SID:461433754 | DrugBank ID:DB02039
+BMGC_DG00155,BMG_DG001522,Solriamfetol | UNII:939U7C91AI | DrugBank ID:DB14754 | CAS RN:178429-62-4 | SOLRIAMFETOL | [(2R)-2-amino-3-phenylpropyl] carbamate | PubChem CID:10130337 | PubChem SID:319892470
+BMGC_DG00156,BMG_DG001528,UNII:NF9LS47A5E | CAS RN:700834-58-8 | TC-1698 | PubChem SID:474492672 | PubChem CID:10130417
+BMGC_DG00157,BMG_DG001538,"PubChem SID:198975639 | PubChem CID:10130510 | FE-999011 | CAS RN:171092-64-1 | 2-Pyrrolidinecarbonitrile, 1-((2S)-2-amino-3,3-dimethyl-1-oxobutyl)-, (2S)- | UNII:I17T1J33X6 | (2S)-1-[(2S)-2-amino-3,3-dimethylbutanoyl]pyrrolidine-2-carbonitrile"
+BMGC_DG00158,BMG_DG001541,"UNII:WT3F2K5PF2 | PubChem CID:10130527 | PubChem SID:472423301 | CAS RN:115970-17-7 | DESNITRO-IMIDACLOPRID | 1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-amine | (2z)-1-[(6-Chloropyridin-3-Yl)methyl]imidazolidin-2-Imine"
+BMGC_DG00159,BMG_DG001547,"UNII:MN9LW8268N | Way-163909 | PubChem CID:10130594 | WAY-163909 | CAS RN:428868-32-0 | (11R,15R)-7,10-diazatetracyclo[8.5.1.05,16.011,15]hexadeca-1,3,5(16)-triene | PubChem SID:441097460"
+BMGC_DG00160,BMG_DG001568,CAS RN:173039-10-6 | UNII:XH88WJG9LJ | PubChem SID:474494030 | PubChem CID:10130754 | 2-PMPA
+BMGC_DG00161,BMG_DG001575,"UNII:DZ02S3A31N | DrugBank ID:DB05650 | PubChem CID:10131000 | Ot-551 | PubChem SID:198958754 | OT-551 | (1-hydroxy-2,2,6,6-tetramethylpiperidin-4-yl) cyclopropanecarboxylate | CAS RN:627085-11-4"
+BMGC_DG00162,BMG_DG001576,"CAS RN:209682-64-4 | 1H-INDOLE, 5-ETHYL-3-(((2R)-1-METHYL-2-PYRROLIDINYL)METHYL)- | UNII:68TX8Z5QGM | PubChem SID:441583363 | PubChem CID:10131024"
+BMGC_DG00163,BMG_DG001578,"UNII:SQC232V4YY | PubChem SID:198974095 | CAS RN:799279-80-4 | (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane | SOFINICLINE | PubChem CID:10131048 | Sofinicline | DrugBank ID:DB12527"
+BMGC_DG00164,BMG_DG001580,PubChem CID:10131112 | CAS RN:54635-62-0 | PubChem SID:474492849 | UNII:URZ93Y3D9J | EMD-386088
+BMGC_DG00165,BMG_DG001619,PubChem CID:101319 | PubChem SID:474494793 | UNII:PM9XR2Z6YD | 2-[(2-Nitrophenyl)amino]benzoic acid | 2-((2-NITROPHENYL)AMINO)BENZOIC ACID | CAS RN:5933-35-7
+BMGC_DG00166,BMG_DG001620,2-oxopropanedioic acid | Mesoxalic acid | PubChem SID:198939751 | MESOXALIC ACID | DrugBank ID:DB03589 | PubChem CID:10132 | CAS RN:473-90-5 | UNII:62R514HE48
+BMGC_DG00167,BMG_DG001626,CP-642931 | PubChem CID:10132209 | UNII:4Q45INJ6TQ | PubChem SID:255509289 | CAS RN:300551-49-9
+BMGC_DG00168,BMG_DG001658,"UNII:0GEI24LG0J | DrugBank ID:DB06777 | (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | CHENODIOL | PubChem SID:175267399 | PubChem CID:10133 | Chenodiol | CAS RN:24404-86-2 | NDC:68974-876 | Chenodeoxycholic acid | CAS RN:474-25-9"
+BMGC_DG00169,BMG_DG001676,PubChem CID:10134160 | DrugBank ID:DB07010 | N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE
+BMGC_DG00170,BMG_DG001681,"PubChem CID:10134493 | N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide | DrugBank ID:DB06940"
+BMGC_DG00171,BMG_DG001693,"(24R)-24-Hydroxycholesterol | UNII:T2AI20QQ7C | PubChem CID:10135759 | 24-EPICEREBROSTEROL | PubChem SID:381132532 | CAS RN:27460-26-0 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"
+BMGC_DG00172,BMG_DG001695,"DrugBank ID:DB08232 | PubChem CID:10135836 | [5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid"
+BMGC_DG00173,BMG_DG001707,(2R)-2-[[6-[(4-phenylphenyl)methylamino]-9-propan-2-ylpurin-2-yl]amino]butan-1-ol | PubChem CID:10137573 | (2~{R})-2-[[6-[(4-phenylphenyl)methylamino]-9-propan-2-yl-purin-2-yl]amino]butan-1-ol
+BMGC_DG00174,BMG_DG001711,PubChem SID:198989389 | HEMATEIN | UNII:88Q1SYD10B | PubChem CID:10138 | CAS RN:475-25-2
+BMGC_DG00175,BMG_DG001712,UNII:AT74LY8RUQ | PubChem SID:441332080 | PubChem CID:10138058 | BROMADOL HYDROCHLORIDE | CAS RN:70895-01-1
+BMGC_DG00176,BMG_DG001715,"CAS RN:627908-92-3 | PubChem CID:10138259 | PubChem SID:198974479 | 1H-Pyrrole-3-carboxamide, 5-((5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-N-((2S)-2-hydroxy-3-(4-morpholinyl)propyl)-2,4-dimethyl- | UNII:ZZ6VH5MZ17 | SU-14813 | 5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-morpholin-4-ylpropyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide | CAS RN:452105-23-6"
+BMGC_DG00177,BMG_DG001723,"PubChem CID:10138993 | N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE | DrugBank ID:DB07220"
+BMGC_DG00178,BMG_DG001736,2-formamidobenzoic acid | PubChem SID:198935162 | 2-(Formylamino)benzoic acid | CAS RN:3342-77-6 | UNII:6670418F9K | N-FORMYLANTHRANILIC ACID | PubChem CID:101399
+BMGC_DG00179,BMG_DG001738,"PubChem CID:1014 | N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium | DrugBank ID:DB03945 | Phosphocholine | CAS RN:3616-04-4 | trimethyl(2-phosphonooxyethyl)azanium"
+BMGC_DG00180,BMG_DG001739,"CAS RN:475-31-0 | GLYCOCHOLIC ACID | PubChem SID:175265919 | PubChem CID:10140 | UNII:G59NX3I3RT | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid | Glycocholic Acid"
+BMGC_DG00181,BMG_DG001745,CAS RN:27693-70-5 | PubChem CID:101403 | 2-(3-NITROANILINO)BENZOIC ACID | UNII:3VAU2E4P9K | PubChem SID:472411319
+BMGC_DG00182,BMG_DG001764,"5,8-Dihydroxy-1,4-naphthoquinone | PubChem CID:10141 | UNII:S9IX5I5C0K | 5,8-dihydroxynaphthalene-1,4-dione | NAPHTHAZARIN | PubChem SID:376072586 | CAS RN:475-38-7"
+BMGC_DG00183,BMG_DG001813,CAS RN:444912-48-5 | PubChem SID:198986530 | PubChem CID:10141893 | UNII:DLM851L3RD | AM-1241
+BMGC_DG00184,BMG_DG001819,"PubChem SID:376231496 | 1,3-DIETHYLXANTHINE | UNII:4550Q64O79 | PubChem CID:101420 | CAS RN:5169-95-9"
+BMGC_DG00185,BMG_DG001824,"7-PROPARGYL 1,3-DIMETHYLXANTHINE | UNII:NV128EH6B5 | CAS RN:14114-45-5 | PubChem SID:376073181 | PubChem CID:101422"
+BMGC_DG00186,BMG_DG001841,"CAS RN:475-67-2 | PubChem SID:198971737 | PubChem CID:10143 | Isocorydine | (6aS)-1,2,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-11-ol | UNII:3B5E87JEOX | ISOCORYDINE"
+BMGC_DG00187,BMG_DG001855,LIRIODENINE | PubChem CID:10144 | CAS RN:475-75-2 | PubChem SID:319892408 | UNII:E134R7X4O9
+BMGC_DG00188,BMG_DG001862,PubChem CID:101446 | 7-ALLYLTHEOPHYLLINE | CAS RN:61444-26-6 | UNII:NC789Z71XR | PubChem SID:198965266
+BMGC_DG00189,BMG_DG001866,PubChem SID:376072323 | UNII:09ZBE12LSD | PubChem CID:101450 | BENZYL SELENOCYANATE | CAS RN:4671-93-6
+BMGC_DG00190,BMG_DG001869,CAS RN:261947-38-0 | PubChem CID:10145345 | CP-532623 | PubChem SID:255509546 | UNII:5KK52HG8DY
+BMGC_DG00191,BMG_DG001877,NUCIFERINE | CAS RN:475-83-2 | PubChem CID:10146 | UNII:W26UEB90B7 | PubChem SID:198954511
+BMGC_DG00192,BMG_DG001883,PubChem CID:101464 | N-PHENOTHIAZINECARBOXAMIDE | PubChem SID:387065403 | UNII:4O0H2D8MVD | CAS RN:4412-24-2
+BMGC_DG00193,BMG_DG001886,CAS RN:518062-14-1 | JNJ-10311795 | UNII:W3IL23KVI4 | PubChem SID:198957468 | PubChem CID:10146470
+BMGC_DG00194,BMG_DG001920,CAS RN:582323-16-8 | PubChem CID:10149311 | UNII:NCO5DC74G8 | ICA-069673 | PubChem SID:363909747
+BMGC_DG00195,BMG_DG001933,PHOSPHORYLCOLAMINE | Phosphorylcolamine | 2-aminoethyl dihydrogen phosphate | PubChem CID:1015 | 2-Aminoethyl dihydrogen phosphate | UNII:78A2BX7AEU | PubChem SID:198958213 | DrugBank ID:DB01738 | CAS RN:1071-23-4
+BMGC_DG00196,BMG_DG001935,"DrugBank ID:DB08208 | PubChem CID:10150081 | 2-(4-ethynyl-2-fluoroanilino)-3,4-difluoro-N-(2-hydroxyethoxy)benzamide | 2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE | 2-[(4-Ethynyl-2-Fluorophenyl)amino]-3,4-Difluoro-N-(2-Hydroxyethoxy)benzamide"
+BMGC_DG00197,BMG_DG001936,"PubChem CID:10150441 | 2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid | DrugBank ID:DB08449"
+BMGC_DG00198,BMG_DG001938,PubChem SID:198958378 | 1-(4'-FLUOROPHENYL)-1-(3-DIMETHYLAMINOPROPYL)-5-BROMOPHTHALANE | UNII:63L06KXW8L | PubChem CID:10150457 | CAS RN:64169-39-7
+BMGC_DG00199,BMG_DG001939,PubChem SID:198986553 | CAS RN:554403-49-5 | WAY-181187 | PubChem CID:10150497 | UNII:WXE3H7W295
+BMGC_DG00200,BMG_DG001948,N-Desmethyl sorafenib | CAS RN:284461-74-1 | 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]pyridine-2-carboxamide | PubChem CID:10151557 | BAY-439007 | UNII:N4T1W2J64C | PubChem SID:312525140
+BMGC_DG00201,BMG_DG001958,"PubChem SID:198975750 | Becatecarin | PubChem CID:101524 | CAS RN:119673-08-4 | UNII:A60X6MBU6G | BECATECARIN | DrugBank ID:DB06362 | 5,21-dichloro-13-[2-(diethylamino)ethyl]-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione"
+BMGC_DG00202,BMG_DG001960,"PubChem SID:175268709 | NDC:70518-3738 | NDC:55111-112 | NDC:66298-8507 | NDC:50090-4058 | NDC:68180-421 | NDC:63629-8357 | NDC:0093-7387 | NDC:72789-038 | NDC:0832-1410 | NDC:50090-6248 | NDC:68083-210 | Moxifloxacin Hydrochloride | NDC:71335-2329 | PubChem CID:101526 | NDC:57237-156 | NDC:46708-505 | NDC:63323-850 | NDC:31722-845 | NDC:82804-055 | UNII:C53598599T | NDC:70069-081 | 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride | NDC:82667-700 | MOXIFLOXACIN HYDROCHLORIDE | NDC:50090-7244 | CAS RN:186826-86-8 | CAS RN:1346603-25-5 | NDC:67296-1764 | NDC:0904-7407 | NDC:68084-722 | NDC:67457-323 | NDC:72789-233 | NDC:65862-603 | NDC:65862-840 | NDC:16714-643 | NDC:50090-6357 | NDC:51991-943 | NDC:72789-350 | NDC:72266-158 | NDC:62332-505 | NDC:50090-4100 | NDC:50090-4781 | NDC:0781-7135 | NDC:50268-576 | NDC:72189-334 | NDC:72789-037 | NDC:50090-6609"
+BMGC_DG00203,BMG_DG001961,"UNII:N673F6W2VH | PubChem SID:198938642 | ODANACATIB | Odanacatib | CAS RN:603139-19-1 | PubChem CID:10152654 | (2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide | DrugBank ID:DB06670"
+BMGC_DG00204,BMG_DG001965,CAS RN:476-69-7 | UNII:1O1D15OP5R | PubChem CID:10153 | PubChem SID:198935543 | CORYDINE
+BMGC_DG00205,BMG_DG001979,"Odevixibat | NDC:15054-3302 | PubChem SID:333495898 | NDC:15054-3303 | NDC:74528-040 | ODEVIXIBAT | NDC:15054-3304 | NDC:74528-120 | PubChem CID:10153627 | NDC:74528-060 | NDC:15054-3301 | NDC:74528-020 | CAS RN:501692-44-0 | UNII:2W150K0UUC | (2S)-2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1lambda6,2,5-benzothiadiazepin-8-yl)oxy]acetyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]butanoic acid"
+BMGC_DG00206,BMG_DG001982,"UNII:8I91GE2769 | Boldine | PubChem SID:198946360 | (6aS)-1,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol | PubChem CID:10154 | BOLDINE | CAS RN:476-70-0"
+BMGC_DG00207,BMG_DG002004,"PubChem CID:101543 | 3'-Uridinemonophosphate | CAS RN:84-53-7 | PubChem SID:313390130 | DrugBank ID:DB02714 | 3'-Uridylic acid | UNII:ZI74VYB8VZ | 3'-URIDINEMONOPHOSPHATE | [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate"
+BMGC_DG00208,BMG_DG002010,UNII:FS4RUH9JTY | PubChem SID:485663569 | PubChem CID:10154392 | CAS RN:412049-71-9 | 1-(Phenylsulfonyl)-4-(1-piperazinyl)-1H-indole | 1-(PHENYLSULFONYL)-4-(1-PIPERAZINYL)-1H-INDOLE
+BMGC_DG00209,BMG_DG002011,2'-CYTIDYLIC ACID | 2'-cytidylic acid | PubChem SID:198989383 | CAS RN:85-94-9 | UNII:KBN4598ZJQ | DrugBank ID:DB03765 | PubChem CID:101544
+BMGC_DG00210,BMG_DG002032,"PubChem CID:10156 | DrugBank ID:DB15534 | 7-Acetamido-10-hydroxy-1,2,3-trimethoxy-6,7-dihydrobenzo[a]heptalen-9(5H)-one | N-(10-hydroxy-1,2,3-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide"
+BMGC_DG00211,BMG_DG002039,"PubChem CID:101565497 | 2H,4H-Benzo(a)pyrano(3,4-j)xanthene-4,11(7aH)-dione, 1,8,9,9a,10,13a,13b,14-octahydro-1,5,8-trihydroxy-2,7a,10,10,13a-pentamethyl-, (1R,2R,7aR,8S,9aR,13aS,13bS)- | CAS RN:132196-53-3 | (1S,5R,6R,14R,15S,17R,22S)-5,10,15-trihydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.03,12.04,9.017,22]docosa-3(12),4(9),10,20-tetraene-8,19-dione"
+BMGC_DG00212,BMG_DG002041,CAS RN:170569-99-0 | PubChem CID:10156660 | 4-DESMETHYL-2-METHYL CELECOXIB | UNII:R33DD74FP2 | PubChem SID:472408727
+BMGC_DG00213,BMG_DG002045,PubChem CID:10156987 | DrugBank ID:DB07025 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE
+BMGC_DG00214,BMG_DG002047,"PubChem CID:10157080 | DrugBank ID:DB07029 | 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE"
+BMGC_DG00215,BMG_DG002049,"PubChem CID:10157141 | (3R)-3-AMINO-4-(3,4-DIFLUOROPHENYL)-1-(5,6-DIHYDRO-3-(TRIFLUOROMETHYL)-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)-1-BUTANONE | CAS RN:486459-88-5 | UNII:QHD8RD5DCQ"
+BMGC_DG00216,BMG_DG002152,"PubChem SID:198980380 | PubChem SID:198972617 | CAS RN:133-05-1 | 5-[(3R,3aR,6S,6aR)-3-(1,3-benzodioxol-5-yl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]-1,3-benzodioxole | Asarinin | ASARININ, (+)- | ASARININ, (+/-)- | CAS RN:133-03-9 | PubChem CID:101612 | UNII:C3RVX72NMG | UNII:F6PWY73ZGT | ASARININ, (±)-"
+BMGC_DG00217,BMG_DG002155,AZD-9056 | PubChem CID:10161381 | Azd9056 | PubChem SID:198952266 | DrugBank ID:DB12594 | UNII:F13K378W4L | CAS RN:345304-65-6 | CAS RN:847254-30-2 | N-(1-adamantylmethyl)-2-chloro-5-[3-(3-hydroxypropylamino)propyl]benzamide
+BMGC_DG00218,BMG_DG002162,"Lobeline | 2-[(2R,6S)-6-[(2S)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanone | UNII:D0P25S3P81 | LOBELINE | PubChem SID:198942142 | PubChem CID:101616 | DrugBank ID:DB05137 | CAS RN:90-69-7"
+BMGC_DG00219,BMG_DG002197,"AFATINIB, (R)- | PubChem SID:496141844 | UNII:4L4QT28LW3 | Afatinib, (R)- | CAS RN:945553-91-3 | PubChem CID:10163178"
+BMGC_DG00220,BMG_DG002225,PubChem CID:101644397 | CAS RN:2173322-11-5 | UNII:F6LFT9F3UZ | ACETYLSTAUROSPORINE | PubChem SID:445500560
+BMGC_DG00221,BMG_DG002315,"4,5-dihydroxy-9,10-dioxoanthracene-2-carboxylic acid | RHEIN | PubChem SID:198975977 | Rhein | DrugBank ID:DB13174 | CAS RN:478-43-3 | PubChem CID:10168 | UNII:YM64C2P6UX"
+BMGC_DG00222,BMG_DG002326,PubChem CID:10168449 | JNJ-10329670 | CAS RN:400797-24-2 | UNII:2HVJ5O3FV3 | PubChem SID:198953803
+BMGC_DG00223,BMG_DG002363,Phthalic Acid | PHTHALIC ACID | CAS RN:254110-94-6 | PubChem CID:1017 | phthalic acid | Phthalic acid | CAS RN:88-99-3 | DrugBank ID:DB02746 | PubChem SID:198981079 | UNII:6O7F7IX66E
+BMGC_DG00224,BMG_DG002381,PubChem SID:198966517 | BROMOLYSERGIDE | PubChem CID:10171 | CAS RN:478-84-2 | UNII:JUA77QEU32
+BMGC_DG00225,BMG_DG002398,"CAS RN:63877-76-9 | UNII:4DC9L42B37 | 3,4'-DIHYDROXYSTILBENE | PubChem SID:472422934 | PubChem CID:10171348 | 3,4′-Dihydroxystilbene"
+BMGC_DG00226,BMG_DG002403,"2-(4'-METHYLAMINOPHENYL)-6-HYDROXYBENZOTHIAZOLE | CAS RN:566169-93-5 | 2-(4-(Methylamino)phenyl)benzo[d]thiazol-6-ol | UNII:K6396E6G8G | PubChem CID:10171487 | PubChem SID:252823917 | 2-[4-(methylamino)phenyl]-1,3-benzothiazol-6-ol"
+BMGC_DG00227,BMG_DG002413,PubChem CID:10171904 | N-CAFFEOYLDOPAMINE | UNII:HEM1G2VY70 | CAS RN:103188-49-4 | PubChem SID:438788544
+BMGC_DG00228,BMG_DG002428,"UNII:CZP9GB25HO | E-6201 | DrugBank ID:DB11687 | PubChem CID:10172827 | PubChem SID:198988608 | (4S,5R,6Z,9S,10S,12E)-16-(ethylamino)-9,10,18-trihydroxy-4,5-dimethyl-3-oxabicyclo[12.4.0]octadeca-1(14),6,12,15,17-pentaene-2,8-dione | CAS RN:603987-35-5"
+BMGC_DG00229,BMG_DG002429,UNII:44X4BU4PFM | PubChem CID:10172878 | ER-36009 | PubChem SID:198971559 | CAS RN:187400-31-3
+BMGC_DG00230,BMG_DG002432,UNII:Q4UG565ZYH | A-443654 | DrugBank ID:DB08073 | (2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE | PubChem SID:482555255 | PubChem CID:10172943 | CAS RN:552325-16-3
+BMGC_DG00231,BMG_DG002437,APILIMOD | N-[(E)-(3-methylphenyl)methylideneamino]-6-morpholin-4-yl-2-(2-pyridin-2-ylethoxy)pyrimidin-4-amine | DrugBank ID:DB05611 | CAS RN:541550-19-0 | PubChem SID:198972105 | Apilimod | UNII:GFW2K84S4L | PubChem CID:10173277
+BMGC_DG00232,BMG_DG002438,PALOSURAN | PubChem SID:198951279 | CAS RN:540769-28-6 | PubChem CID:10173280 | UNII:ULD9ZKE457
+BMGC_DG00233,BMG_DG002443,"CAS RN:573981-31-4 | PubChem CID:10174045 | CANNABINOR | Cannabinor | DrugBank ID:DB05048 | (E)-4-[2-[(1S,2S,5S)-6,6-dimethyl-4-oxo-2-bicyclo[3.1.1]heptanyl]-3-hydroxy-5-(2-methyloctan-2-yl)phenoxy]-4-oxobut-2-enoic acid | UNII:O8E148Q90M | PubChem SID:252319937"
+BMGC_DG00234,BMG_DG002444,(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide | PubChem CID:10174090 | DrugBank ID:DB07422
+BMGC_DG00235,BMG_DG002475,Aluminum hydroxide | CAS RN:8064-00-4 | PubChem CID:10176082 | Aluminum Hydroxide | ALUMINUM HYDROXIDE | UNII:5QB0T2IUN0 | CAS RN:21645-51-2 | CAS RN:8012-63-3 | PubChem SID:175265870 | aluminum;trihydroxide | DrugBank ID:DB06723
+BMGC_DG00236,BMG_DG002479,"Erythrodiol | PubChem CID:101761 | UNII:3VWF903FSS | (3S,4aR,6aR,6bS,8aS,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol | CAS RN:545-48-2 | ERYTHRODIOL | PubChem SID:252319702 | CAS RN:118204-21-0"
+BMGC_DG00237,BMG_DG002507,UNII:Q2L6T24QLT | CAS RN:91556-75-1 | PubChem CID:10176454 | PubChem SID:474492655 | RJR-2429
+BMGC_DG00238,BMG_DG002513,"PubChem SID:441331261 | 7-pyridin-3-yl-1,7-diazaspiro[4.4]nonane | TC-2216 | PubChem CID:10176607 | CAS RN:646055-67-6 | UNII:J2T94PE2HD | Tc-2216"
+BMGC_DG00239,BMG_DG002519,"2-(4,6-DIFLUOROINDAN-1-YLIDENE)-ACETAMIDE, (E)- | PubChem SID:346536881 | UNII:UDZM0RWW7I | PubChem CID:10176672 | CAS RN:162548-01-8"
+BMGC_DG00240,BMG_DG002525,"DrugBank ID:DB12125 | Dianicline | PubChem CID:10176764 | UNII:Y0SNM34C6O | CAS RN:292634-27-6 | PubChem SID:198980806 | DIANICLINE | (1R,10S)-9-oxa-4,13-diazatetracyclo[11.2.1.01,10.03,8]hexadeca-3(8),4,6-triene"
+BMGC_DG00241,BMG_DG002530,Indirubin | PubChem SID:377308256 | UNII:1LXW6D3W2Z | CAS RN:479-41-4 | CAS RN:397242-72-7 | CAS RN:906748-38-7 | INDIRUBIN | DrugBank ID:DB12379 | ISOINDIRUBIN | PubChem SID:198990797 | PubChem CID:10177 | UNII:V86L8P74GI | 2-(2-hydroxy-1H-indol-3-yl)indol-3-one
+BMGC_DG00242,BMG_DG002531,"ZYMOSTENOL | PubChem CID:101770 | PubChem SID:198952783 | (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | CAS RN:566-97-2 | Zymostenol | UNII:L3GY707BLC"
+BMGC_DG00243,BMG_DG002533,"3alpha,21-Dihydroxy-5alpha-pregnan-20-one | PubChem CID:101771 | CAS RN:567-02-2 | 2-hydroxy-1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone"
+BMGC_DG00244,BMG_DG002536,CAS RN:360775-96-8 | UNII:AR34521QFL | SERGLIFLOZIN | PubChem SID:198961504 | PubChem CID:10177526
+BMGC_DG00245,BMG_DG002549,NDC:24208-446 | PubChem SID:175265578 | BESIFLOXACIN | 7-[(3R)-3-aminoazepan-1-yl]-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid | NDC:50090-1241 | CAS RN:141388-76-3 | DrugBank ID:DB06771 | Besifloxacin | PubChem CID:10178705 | UNII:BFE2NBZ7NX
+BMGC_DG00246,BMG_DG002550,"PubChem CID:101788 | CAS RN:600-57-7 | 11Beta-Hydroxyprogesterone | (8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG00247,BMG_DG002560,DrugBank ID:DB01979 | PubChem CID:101798 | Methyl alpha-D-mannoside
+BMGC_DG00248,BMG_DG002563,PubChem SID:198970506 | PICOLINIC ACID | Picolinic acid | pyridine-2-carboxylic acid | CAS RN:32075-31-3 | UNII:QZV2W997JQ | CAS RN:98-98-6 | CAS RN:88161-53-9 | PubChem CID:1018
+BMGC_DG00249,BMG_DG002564,UNII:FC6D57000M | PubChem SID:198952423 | 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one | Lucanthone | DrugBank ID:DB04967 | CAS RN:479-50-5 | LUCANTHONE | PubChem CID:10180
+BMGC_DG00250,BMG_DG002566,DrugBank ID:DB07205 | N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE | PubChem CID:10180201
+BMGC_DG00251,BMG_DG002571,UNII:493YC8TX2Q | PubChem CID:10181075 | PubChem SID:496141897 | CAS RN:404844-11-7 | 4-(Chloromethyl)-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide | 4-(CHLOROMETHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINO)PHENYL)BENZAMIDE
+BMGC_DG00252,BMG_DG002602,"UNII:3Z9Y7UWC1J | PubChem SID:175266926 | NDC:55154-0613 | APIXABAN | NDC:67296-1673 | PubChem CID:10182969 | NDC:82804-085 | NDC:63629-8432 | NDC:50090-1436 | NDC:50090-1437 | NDC:0003-0894 | 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide | NDC:63629-7747 | NDC:14445-150 | NDC:71610-662 | CAS RN:503612-47-3 | Apixaban | NDC:50090-6454 | NDC:50090-6451 | NDC:70518-1861 | NDC:0003-0893 | NDC:55154-0612 | NDC:82982-054 | NDC:71610-811 | NDC:14445-149 | DrugBank ID:DB06605"
+BMGC_DG00253,BMG_DG002611,PubChem SID:441659575 | IODOXYBENZENE | PubChem CID:101840 | CAS RN:696-33-3 | UNII:K5D68AG7XA
+BMGC_DG00254,BMG_DG002616,UNII:41UD74L59M | CAS RN:439081-18-2 | (E)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide | PubChem SID:175267335 | CAS RN:850140-72-6 | Afatinib | NDC:0597-0137 | NDC:0597-0138 | DrugBank ID:DB08916 | NDC:0597-0141 | AFATINIB | PubChem CID:10184653
+BMGC_DG00255,BMG_DG002617,"PubChem SID:175268108 | 4-[(1R)-2-[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol | PubChem CID:10184665 | VILANTEROL | DrugBank ID:DB09082 | CAS RN:503068-34-6 | Vilanterol | UNII:028LZY775B"
+BMGC_DG00256,BMG_DG002636,"1,8,9-Trihydroxyanthracene | PubChem CID:10187 | CAS RN:480-22-8 | anthracene-1,8,9-triol"
+BMGC_DG00257,BMG_DG002643,"CAS RN:480-30-8 | Dichloralphenazone | 1,5-dimethyl-2-phenylpyrazol-3-one;2,2,2-trichloroethane-1,1-diol | DICHLORALPHENAZONE | DrugBank ID:DB01495 | PubChem CID:10188 | PubChem SID:175265664 | UNII:YYX637R279"
+BMGC_DG00258,BMG_DG002644,PubChem SID:478838716 | UNII:2X6NHN9RRN | CAS RN:1633666-49-5 | PubChem CID:101882900 | Nizubaglustat | NIZUBAGLUSTAT
+BMGC_DG00259,BMG_DG002653,BAR-501 | UNII:AVN65GUL86 | CAS RN:1632118-69-4 | PubChem CID:101886302
+BMGC_DG00260,BMG_DG002655,"PubChem CID:101886309 | (3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-[(2R)-4-hydroxybutan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | CAS RN:1612191-86-2 | CID 101886309"
+BMGC_DG00261,BMG_DG002658,PubChem SID:472388017 | Eugenin | 5-hydroxy-7-methoxy-2-methylchromen-4-one | EUGENIN | UNII:E8D279U89S | PubChem CID:10189 | CAS RN:480-34-2
+BMGC_DG00262,BMG_DG002707,"PubChem SID:198985653 | Indantadol | INDANTADOL | CAS RN:202844-10-8 | PubChem CID:10192617 | DrugBank ID:DB12664 | 2-(2,3-dihydro-1H-inden-2-ylamino)acetamide | UNII:Z3867B9SQP"
+BMGC_DG00263,BMG_DG002711,5.ALPHA.-ANDROST-2-ENE-17-ONE | PubChem CID:101928 | PubChem SID:346541284 | CAS RN:963-75-7 | UNII:AHC8P4E4ZL
+BMGC_DG00264,BMG_DG002766,"PubChem SID:198980304 | 2-(1,3-benzothiazol-2-yl)-2-[2-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]pyrimidin-4-yl]acetonitrile | UNII:TT3L4B4U0N | BENTAMAPIMOD | CAS RN:541507-14-6 | PubChem CID:10195250 | Bentamapimod | CAS RN:848344-36-5"
+BMGC_DG00265,BMG_DG002767,PubChem CID:10195332 | UNII:XVK9W4THB6 | CAS RN:548797-97-3 | N-[2-[(2S)-3-[[1-[(4-chlorophenyl)methyl]piperidin-4-yl]amino]-2-hydroxy-2-methylpropoxy]-4-hydroxyphenyl]acetamide | N-(2-(((2S)-3-((1-(4-CHLOROBENZYL)-4-PIPERIDINYL)AMINO)-2-HYDROXY-2-METHYLPROPYL)OXY)-4-HYDROXYPHENYL)ACETAMIDE
+BMGC_DG00266,BMG_DG002777,CVT-5440 | UNII:29S2U9DRGS | PubChem CID:10196114 | PubChem SID:198960969 | CAS RN:531506-64-6
+BMGC_DG00267,BMG_DG002783,"CAS RN:1097-51-4 | UNII:F2DR02G069 | PubChem CID:101966 | 16.ALPHA.,17-EPOXYPROGESTERONE | PubChem SID:198936218"
+BMGC_DG00268,BMG_DG002786,CAS RN:20988-30-1 | UNII:C7PLL5BF8H | PubChem SID:472425648 | VARIEGATIC ACID | Variegatic acid | PubChem CID:101967051
+BMGC_DG00269,BMG_DG002815,CAS RN:29126-50-9 | PubChem SID:198953043 | Lithium succinate | DrugBank ID:DB14508 | UNII:MD64P82Y28 | PubChem CID:10197702 | dilithium;butanedioate | CAS RN:16090-09-8 | DILITHIUM SUCCINATE
+BMGC_DG00270,BMG_DG002834,PubChem CID:10197984 | CAS RN:191471-52-0 | UNII:S96JF4J697 | PubChem SID:472405939 | LY-379268
+BMGC_DG00271,BMG_DG002839,8-Isopropoxyquinolin-2-amine | 8-ISOPROPOXYQUINOLIN-2-AMINE | PubChem CID:10198125 | CAS RN:635755-26-9 | PubChem SID:478838335 | UNII:WYR9P3LV8A
+BMGC_DG00272,BMG_DG002842,PubChem SID:472409387 | 2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID | PubChem CID:10198171 | UNII:TV8F3S5KLG | CAS RN:254737-29-6
+BMGC_DG00273,BMG_DG002843,DrugBank ID:DB07482 | (2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE | PubChem CID:10198228
+BMGC_DG00274,BMG_DG002846,"PubChem SID:445498814 | PubChem CID:10198248 | UNII:5K3E87REH7 | N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-6-QUINOXALINAMINE | CAS RN:91147-43-2"
+BMGC_DG00275,BMG_DG002853,CAS RN:74772-78-4 | PubChem CID:10198397 | UNII:M8U25244KP | U-90441 | PubChem SID:198939940
+BMGC_DG00276,BMG_DG002857,PubChem CID:10198481 | PubChem SID:474492853 | UNII:86G23YCN73 | PHA-57378 FREE BASE | CAS RN:303799-62-4 | PHA-57378 Free Base
+BMGC_DG00277,BMG_DG002858,PubChem CID:10198541 | PubChem SID:198975689 | 5-[(Z)-6-cyclohexylhex-3-enyl]-1H-imidazole | UNII:1P032TC0JJ | GT-2227 | CAS RN:186096-20-8
+BMGC_DG00278,BMG_DG002869,"(3R,5S,8R,9S,10S,13R,14S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | Androstenol | DrugBank ID:DB01889 | PubChem CID:101989 | CAS RN:1153-51-1 | ANDROSTENOL | 16,17-Androstene-3-Ol | UNII:48K9VAM062 | PubChem SID:198980400"
+BMGC_DG00279,BMG_DG002872,PubChem SID:316913852 | HMR-279 | CAS RN:185915-32-6 | UNII:2785QG4477 | PubChem CID:10198927
+BMGC_DG00280,BMG_DG002906,UNII:1RBK3FD79Y | CAS RN:170570-01-1 | PubChem CID:10199832 | PubChem SID:461433183 | 4-(5-(3-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)BENZENESULFONAMIDE
+BMGC_DG00281,BMG_DG002920,PubChem SID:198966295 | UNII:61G8S0H9KX | CAS RN:732983-37-8 | BAY-61-3606 FREE BASE | PubChem CID:10200390
+BMGC_DG00282,BMG_DG002921,"2-chloro-4-[4-[[5-(2-hydroxypropan-2-yl)pyridin-2-yl]amino]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]benzonitrile | Gumelutamide | PubChem SID:478837074 | UNII:B7CL5GXS2R | PubChem CID:102004291 | GUMELUTAMIDE | CAS RN:1831085-48-3"
+BMGC_DG00283,BMG_DG002940,"CAS RN:131-48-6 | (2R,5R)-5-acetamido-2,4-dihydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid | PubChem CID:102004932"
+BMGC_DG00284,BMG_DG002947,"DrugBank ID:DB07833 | N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide | PubChem CID:10200651"
+BMGC_DG00285,BMG_DG002950,6-KETOCHOLESTANOL | PubChem CID:102008 | PubChem SID:198960481 | CAS RN:1175-06-0 | UNII:2V12D4A742
+BMGC_DG00286,BMG_DG002951,"DrugBank ID:DB12260 | UNII:5XGC17ZKUF | 2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide | PubChem SID:198954324 | RADIPRODIL | CAS RN:496054-87-6 | Radiprodil | PubChem CID:10200813"
+BMGC_DG00287,BMG_DG002965,BALICATIB | Balicatib | PubChem CID:10201696 | PubChem SID:198959058 | N-[1-(cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide | CAS RN:354813-19-7 | DrugBank ID:DB12239 | UNII:E00MVC7O57
+BMGC_DG00288,BMG_DG002981,CAS RN:528859-04-3 | E-6801 | UNII:W4Q1543X33 | PubChem CID:10202564 | PubChem SID:198954261
+BMGC_DG00289,BMG_DG002982,CAS RN:452342-67-5 | PubChem SID:198940356 | GW-788388 | UNII:N14114957J | PubChem CID:10202642
+BMGC_DG00290,BMG_DG002985,"PubChem CID:102030 | 16alpha-Hydroxydehydroepiandrosterone | PubChem SID:440793583 | (3S,8R,9S,10R,13S,14S,16R)-3,16-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one | CAS RN:1232-73-1 | UNII:WU2DU6GA72 | 16ALPHA-HYDROXYDEHYDROEPIANDROSTERONE"
+BMGC_DG00291,BMG_DG002994,"PubChem SID:198938207 | CAS RN:481-30-1 | UNII:48L726977Z | Epitestosterone | DrugBank ID:DB07768 | (8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | PubChem CID:10204 | EPITESTOSTERONE"
+BMGC_DG00292,BMG_DG003001,"CAS RN:481-42-5 | UNII:YAS4TBQ4OQ | 5-hydroxy-2-methylnaphthalene-1,4-dione | Plumbagin | PubChem CID:10205 | PubChem SID:198975013 | PLUMBAGIN"
+BMGC_DG00293,BMG_DG003014,"Cepharanthine | PubChem SID:198984407 | CEPHARANTHINE | PubChem CID:10206 | UNII:7592YJ0J6T | CAS RN:481-49-2 | (14S,27R)-22,33-dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.216,19.13,10.121,25.04,8.031,35.014,39]nonatriaconta-1(33),3(39),4(8),9,16(38),17,19(37),21,23,25(36),31,34-dodecaene"
+BMGC_DG00294,BMG_DG003035,"PubChem CID:10207 | Aloe emodin | CAS RN:481-72-1 | ALOE EMODIN | 1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione | UNII:C8IYT9CR7C | PubChem SID:198985515"
+BMGC_DG00295,BMG_DG003042,"CHRYSOPHANIC ACID | Chrysophanic acid | PubChem CID:10208 | UNII:N1ST8V8RR2 | PubChem SID:198985135 | CAS RN:481-74-3 | 1,8-dihydroxy-3-methylanthracene-9,10-dione"
+BMGC_DG00296,BMG_DG003047,"UNII:VQ093653DO | 2-methylnaphthalene-1,4-diol | CAS RN:1142409-65-1 | Menadiol | CAS RN:481-85-6 | MENADIOL | PubChem CID:10209 | PubChem SID:198985736"
+BMGC_DG00297,BMG_DG003061,PubChem SID:198960684 | 3-[5-(aminomethyl)-4-(carboxymethyl)-1H-pyrrol-3-yl]propanoic acid | CAS RN:487-90-1 | Porphobilinogen | DrugBank ID:DB02272 | UNII:74KHC72QXK | PORPHOBILINOGEN | PubChem CID:1021
+BMGC_DG00298,BMG_DG003071,UNII:LE80Z850I1 | BYAKANGELICIN | CAS RN:482-25-7 | PubChem CID:10211 | PubChem SID:317229804
+BMGC_DG00299,BMG_DG003090,"Pentosalen | PubChem CID:10212 | PubChem SID:198941707 | 9-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one | CAS RN:482-44-0 | UNII:K713N25C78 | PENTOSALEN"
+BMGC_DG00300,BMG_DG003115,"UNII:5TH3ERG159 | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methyl sulfo hydrogen phosphate | 3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE | PubChem SID:317228893 | DrugBank ID:DB02902 | PubChem CID:10214 | CAS RN:482-67-7 | 3'-phospho-5'-adenylyl sulfate | Phosphoadenosine Phosphosulfate"
+BMGC_DG00301,BMG_DG003141,"CAS RN:1605-89-6 | DrugBank ID:DB01471 | (7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13,17-tetramethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | PubChem CID:102146 | PubChem SID:198955400 | BOLASTERONE | Bolasterone | UNII:T7ZM08F7FU"
+BMGC_DG00302,BMG_DG003172,"CAS RN:1867-73-8 | N6-Methyladenosine | PubChem CID:102175 | (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(methylamino)purin-9-yl]oxolane-3,4-diol | UNII:CLE6G00625 | PubChem SID:198963412 | N-METHYLADENOSINE"
+BMGC_DG00303,BMG_DG003192,"Emetine | DrugBank ID:DB13393 | (2S,3R,11bS)-2-[[(1R)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine | PubChem SID:198975813 | EMETINE | PubChem CID:10219 | CAS RN:483-18-1 | UNII:X8D5EPO80M"
+BMGC_DG00304,BMG_DG003207,"PubChem CID:102194063 | Chrodrimanin H | (1S,6R,14R,15S,17R,22S)-10,15-dihydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.03,12.04,9.017,22]docosa-3(12),4(9),10-triene-8,19-dione"
+BMGC_DG00305,BMG_DG003230,"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one | PubChem CID:10219702 | DrugBank ID:DB07677"
+BMGC_DG00306,BMG_DG003237,"CAS RN:38618-23-4 | UNII:KCP993E27T | 2-[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl]oxyethanol | PubChem SID:316909210 | 2-(l-Menthoxy)ethanol | CAS RN:75443-64-0 | 2-(L-MENTHOXY)ETHANOL | PubChem CID:10219851 | 2-(MENTHOXY)ETHANOL | UNII:5ZWW23169H | DrugBank ID:DB11174 | PubChem SID:175268191"
+BMGC_DG00307,BMG_DG003246,"UNII:JH46EUC2D9 | PubChem CID:10219934 | CAS RN:102284-72-0 | 3-ISOPROPYL-1-METHYL-3,7-DIHYDRO-PURINE-2,6-DIONE"
+BMGC_DG00308,BMG_DG003248,LY-339624 | PubChem CID:10219992 | UNII:H2U26QEW5Q | CAS RN:213778-21-3 | PubChem SID:459056398
+BMGC_DG00309,BMG_DG003249,"ISOCORYPALMINE, (±)- | ISOCORYPALMINE, (+/-)- | UNII:YHT108XMMM | CAS RN:6487-33-8 | PubChem CID:10220 | PubChem SID:198952292"
+BMGC_DG00310,BMG_DG003268,"CAS RN:143200-94-6 | PubChem CID:10220327 | Zileuton, (S)- | ZILEUTON, (S)- | 1-[(1S)-1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea | UNII:0CG9649AC6 | PubChem SID:329589044"
+BMGC_DG00311,BMG_DG003276,"NDC:43068-304 | N-[[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl]propanamide | NDC:0480-4490 | Tasimelteon | PubChem CID:10220503 | PubChem SID:198968673 | UNII:SHS4PU80D9 | NDC:43068-220 | TASIMELTEON | NDC:60505-4665 | CAS RN:609799-22-6 | NDC:69238-2548 | DrugBank ID:DB09071"
+BMGC_DG00312,BMG_DG003280,"PubChem CID:10220590 | N4-(3-Methylphenyl)-4,6-quinazolinediamine | UNII:6G9S589MJE | N4-(3-METHYLPHENYL)-4,6-QUINAZOLINEDIAMINE | CAS RN:153436-70-5 | PubChem SID:485663570"
+BMGC_DG00313,BMG_DG003291,"Gestonorone | GESTONORONE | CAS RN:2137-18-0 | PubChem CID:102210 | (8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | UNII:H4G605B7VP | PubChem SID:198936411 | DrugBank ID:DB13230 | CAS RN:16895-64-0"
+BMGC_DG00314,BMG_DG003306,PubChem CID:102213 | PubChem SID:198983362 | CAS RN:2140-79-6 | 2'-O-METHYLADENOSINE | UNII:02YX82IHZ5
+BMGC_DG00315,BMG_DG003307,N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE | PubChem CID:10221335 | DrugBank ID:DB07389
+BMGC_DG00316,BMG_DG003332,PubChem SID:198944797 | ESTRIOL TRIPROPIONATE | PubChem CID:102232 | Estriol tripropionate | CAS RN:2236-31-9 | UNII:S2A0P1AFQ9 | DrugBank ID:DB14641
+BMGC_DG00317,BMG_DG003346,"UNII:C4K5AF576C | 4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID | DrugBank ID:DB07827 | CAS RN:451471-51-5 | 4-((1,4-DIHYDRO-1-METHYL-2,4-DIOXO-6-(3-PHENYL-1-PROPYN-1-YL)-3(2H)-QUINAZOLINYL)METHYL)BENZOIC ACID | PubChem CID:10224181"
+BMGC_DG00318,BMG_DG003351,ALEPLASININ | UNII:LL56J87F3X | PubChem CID:10224267 | 2-[1-[(4-tert-butylphenyl)methyl]-5-(3-methylphenyl)indol-3-yl]-2-oxoacetic acid | Aleplasinin | CAS RN:481629-87-2 | DrugBank ID:DB12635 | PubChem SID:198978724
+BMGC_DG00319,BMG_DG003356,(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol | DrugBank ID:DB08463 | PubChem CID:10224714
+BMGC_DG00320,BMG_DG003361,PubChem CID:10225083 | 3-[1-[3-(5-methoxy-2-methylphenoxy)-4-methylpentyl]piperidin-4-yl]-1H-benzimidazol-2-one | 1-(1-(3-(5-methoxy-2-methylphenoxy)-4-methylpentyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one
+BMGC_DG00321,BMG_DG003394,CAS RN:484-12-8 | Osthol | PubChem SID:198966612 | OSTHOL | CAS RN:1440642-68-1 | PubChem CID:10228 | UNII:XH1TI1759C | 7-methoxy-8-(3-methylbut-2-enyl)chromen-2-one
+BMGC_DG00322,BMG_DG003413,"2,4-dichloro-N-(3,5-dichloro-4-quinolin-3-yloxyphenyl)benzenesulfonamide | PubChem CID:10229498 | PubChem SID:198947192 | DrugBank ID:DB05490 | IBRIGAMPAR | UNII:E7ILQ6U50J | CAS RN:315224-26-1 | Benzenesulfonamide, 2,4-dichloro-N-(3,5-dichloro-4-(3-quinolinyloxy)phenyl)-"
+BMGC_DG00323,BMG_DG003418,PubChem SID:175267003 | PYROPHOSPHORIC ACID | CAS RN:33943-49-6 | DrugBank ID:DB04160 | CAS RN:2466-09-3 | UNII:4E862E7GRQ | Pyrophosphoric acid | phosphono dihydrogen phosphate | PubChem CID:1023
+BMGC_DG00324,BMG_DG003419,UNII:PCU411F5L6 | Dihydralazine | (4-hydrazinylphthalazin-1-yl)hydrazine | PubChem CID:10230 | PubChem SID:198937040 | CAS RN:484-23-1 | DIHYDRALAZINE | DrugBank ID:DB12945
+BMGC_DG00325,BMG_DG003427,"DILLAPIOLE | CAS RN:8025-95-4 | UNII:438CJQ562D | Dillapiol | PubChem SID:198958051 | CAS RN:484-31-1 | PubChem CID:10231 | 4,5-dimethoxy-6-prop-2-enyl-1,3-benzodioxole"
+BMGC_DG00326,BMG_DG003429,CAS RN:401903-53-5 | CT-53608 | PubChem CID:10231458 | PubChem SID:313184431 | UNII:0VM9M42OBH
+BMGC_DG00327,BMG_DG003439,PubChem SID:198979103 | UNII:Q6K46G80ZD | LOPHINE | CAS RN:484-47-9 | PubChem CID:10232
+BMGC_DG00328,BMG_DG003472,"UNII:53S5U404NU | CAS RN:115051-74-6 | DrugBank ID:DB09028 | CYTISINICLINE | Cytisine | CAS RN:485-35-8 | Cytisinicline | PubChem SID:198964121 | PubChem CID:10235 | (1R,9S)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one"
+BMGC_DG00329,BMG_DG003473,"7-Hydroxy-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4(9),5,7,15,17,19-octaen-14-one | 7-hydroxy-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4(9),5,7,15,17,19-octaen-14-one | PubChem CID:102351043"
+BMGC_DG00330,BMG_DG003478,"Ninhydrin | PubChem SID:198951991 | PubChem CID:10236 | 2,2-dihydroxyindene-1,3-dione | UNII:HCL6S9K23A | NINHYDRIN | CAS RN:485-47-2"
+BMGC_DG00331,BMG_DG003481,"IMAGABALIN | (3S,5R)-3-amino-5-methyloctanoic acid | UNII:NDG6931B7H | PubChem CID:10236037 | DrugBank ID:DB12105 | CAS RN:610300-07-7 | PubChem SID:198964873 | Imagabalin"
+BMGC_DG00332,BMG_DG003495,PubChem CID:10236758 | PubChem SID:474492706 | UNII:9ZH28BM589 | 77-LH-28-1 | CAS RN:560085-11-2
+BMGC_DG00333,BMG_DG003496,"UNII:Y37615DVKC | Bicuculline | PubChem SID:198944075 | PubChem CID:10237 | CAS RN:485-49-4 | DrugBank ID:DB11562 | (6R)-6-[(5S)-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-6H-furo[3,4-g][1,3]benzodioxol-8-one | BICUCULLINE"
+BMGC_DG00334,BMG_DG003497,"CAS RN:155239-87-5 | 4-[(E)-4-(3,5-dimethoxy-4-oxocyclohexa-2,5-dien-1-ylidene)but-2-enylidene]-2,6-dimethoxycyclohexa-2,5-dien-1-one | Kinobeon A | PubChem CID:10237057"
+BMGC_DG00335,BMG_DG003505,"CAS RN:485-84-7 | DrugBank ID:DB03708 | PubChem CID:10238 | Adenosine 5'-phosphosulfate | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl sulfo hydrogen phosphate | Adenosine-5'-phosphosulfate"
+BMGC_DG00336,BMG_DG003506,UNII:4PK52982QT | PubChem CID:10238338 | GW-848687X | PubChem SID:459055714 | CAS RN:612831-24-0
+BMGC_DG00337,BMG_DG003514,UNII:UK6392GD5W | PubChem CID:10239 | CAS RN:485-89-2 | Oxycinchophen | DrugBank ID:DB13596 | 3-hydroxy-2-phenylquinoline-4-carboxylic acid | OXYCINCHOPHEN | PubChem SID:198977206
+BMGC_DG00338,BMG_DG003523,"DrugBank ID:DB03205 | UNII:47819QGH5L | 4,5-dioxo-1H-pyrrolo[2,3-f]quinoline-2,7,9-tricarboxylic acid | Pyrroloquinoline Quinone | Pyrroloquinoline quinone | CAS RN:72909-34-3 | PubChem CID:1024 | PYRROLOQUINOLINEDIONE TRICARBOXYLIC ACID | PubChem SID:252319712"
+BMGC_DG00339,BMG_DG003524,"CAPTODIAME | DrugBank ID:DB09014 | UNII:H93K9455DD | 2-[(4-butylsulfanylphenyl)-phenylmethyl]sulfanyl-N,N-dimethylethanamine | PubChem SID:198954403 | PubChem CID:10240 | CAS RN:486-17-9 | Captodiame"
+BMGC_DG00340,BMG_DG003535,CAS RN:486-25-9 | 9-FLUORENONE | UNII:AZ9T83S2AQ | fluoren-9-one | 9-Fluorenone | PubChem CID:10241 | PubChem SID:198946786
+BMGC_DG00341,BMG_DG003550,CAS RN:56421-85-3 | PubChem CID:10242258 | PubChem SID:485663600 | 3-(3-Thienyl)quinoline | UNII:AC55L3QQ99 | 3-(3-THIENYL)QUINOLINE
+BMGC_DG00342,BMG_DG003567,CAS RN:3650-73-5 | HOMOCARNOSINE | (2S)-2-(4-aminobutanoylamino)-3-(1H-imidazol-5-yl)propanoic acid | PubChem CID:10243361 | Homocarnosine | PubChem SID:404859360 | UNII:M8L4BH36SC
+BMGC_DG00343,BMG_DG003579,Benzylsulfinylsulfanylmethylbenzene | CAS RN:16302-98-0 | benzylsulfinylsulfanylmethylbenzene | PubChem CID:10244468
+BMGC_DG00344,BMG_DG003586,PubChem CID:10244543 | PubChem SID:445500066 | UNII:K67KML53HD | N-(3-PHENOXYPYRIDIN-4-YL)METHANESULFONAMIDE | CAS RN:180194-78-9
+BMGC_DG00345,BMG_DG003591,"PIPERETTINE | PubChem CID:10244953 | CAS RN:583-34-6 | Piperettine | PubChem SID:482554092 | (2E,4E,6E)-7-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylhepta-2,4,6-trien-1-one | UNII:5LSU6EU5C7"
+BMGC_DG00346,BMG_DG003594,4-methyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide | 4-methyl-N-(2-phenylpyrazol-3-yl)benzenesulfonamide | PubChem CID:10245060 | CAS RN:4365-68-8
+BMGC_DG00347,BMG_DG003602,"[(2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate | CAS RN:29584-22-3 | PubChem SID:198934627 | PubChem CID:10245972 | UNII:2K3YP54BYU | Zuretinol acetate | ZURETINOL ACETATE | DrugBank ID:DB12112 | Zuretinol Acetate"
+BMGC_DG00348,BMG_DG003610,PubChem CID:10246505 | PubChem SID:241179239 | CAS RN:72357-31-4 | LICOFLAVONE C | UNII:0DQ85982ZY
+BMGC_DG00349,BMG_DG003611,UNII:1CJ4ADI36E | 3-(BENZENESULFONYL)-1-PIPERIDIN-4-YLINDOLE | PubChem SID:443624296 | PubChem CID:10246639 | CAS RN:651335-50-1
+BMGC_DG00350,BMG_DG003623,4-methoxy-N-(3-(pyridin-2-yl)isoquinolin-1-yl)benzamide | 4-methoxy-N-(3-pyridin-2-ylisoquinolin-1-yl)benzamide | PubChem CID:10247610
+BMGC_DG00351,BMG_DG003630,"PubChem SID:474492395 | 6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-(1-methyl-1-phenylethyl)-6H-dibenzo[b,d]pyran-1-ol, (6aR,10aR)-rel- | PubChem CID:10248110 | KM-233 | UNII:YMV7S3C3B7 | CAS RN:628263-22-9 | CAS RN:797793-15-8 | PubChem SID:474494676 | UNII:BAJ4486BWX | 6A,7,10,10A-TETRAHYDRO-6,6,9-TRIMETHYL-3-(1-METHYL-1-PHENYLETHYL)-6H-DIBENZO(B,D)PYRAN-1-OL, (6AR,10AR)-REL-"
+BMGC_DG00352,BMG_DG003635,"Methyl (1S,17R)-17-(2-methoxyethyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate | PubChem CID:10248465 | CAS RN:308123-60-6 | methyl (1S,17R)-17-(2-methoxyethyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate"
+BMGC_DG00353,BMG_DG003638,PubChem CID:10248747 | CAS RN:333455-11-1 | BIRA-0596 | UNII:0U6QL95YQD | PubChem SID:198970524
+BMGC_DG00354,BMG_DG003640,NICOTYRINE | PubChem CID:10249 | PubChem SID:198983170 | UNII:XN4R1LH79Y | CAS RN:487-19-4
+BMGC_DG00355,BMG_DG003641,CAS RN:816-19-3 | PubChem SID:316916745 | METHYL 2-ETHYLHEXANOATE | PubChem CID:102491 | UNII:3100891M19
+BMGC_DG00356,BMG_DG003643,"PubChem CID:10249180 | 3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DrugBank ID:DB08535"
+BMGC_DG00357,BMG_DG003644,"PubChem CID:10249182 | DrugBank ID:DB08537 | 3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine"
+BMGC_DG00358,BMG_DG003662,JWH-193 | UNII:WB1TIJ1IO9 | PubChem CID:10250276 | PubChem SID:312524856 | CAS RN:133438-58-1
+BMGC_DG00359,BMG_DG003666,DrugBank ID:DB08173 | 5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE | PubChem CID:10250490
+BMGC_DG00360,BMG_DG003669,"PENAMECILLIN | DrugBank ID:DB13739 | Penamecillin | PubChem SID:198960840 | CAS RN:983-85-7 | UNII:H0P1YE5581 | acetyloxymethyl (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | PubChem CID:10250769"
+BMGC_DG00361,BMG_DG003670,FLAVANONE | PubChem CID:10251 | PubChem SID:198950662 | UNII:WX22P730FB | CAS RN:487-26-3
+BMGC_DG00362,BMG_DG003846,"2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine | UNII:547KGL06IP | 25I-NBOME | PubChem CID:10251906 | CAS RN:919797-19-6 | PubChem SID:198958551 | 25I-NBOMe"
+BMGC_DG00363,BMG_DG003847,SALACETAMIDE | CAS RN:487-48-9 | PubChem CID:10252 | UNII:7G29CRR596 | PubChem SID:198990587
+BMGC_DG00364,BMG_DG003849,PubChem CID:10252009 | UNII:TR9YQ07ELN | CAS RN:615539-20-3 | EZEPROGIND | PubChem SID:375083331 | Ezeprogind | N-[3-[4-[3-[bis(2-methylpropyl)amino]propyl]piperazin-1-yl]propyl]-1H-benzimidazol-2-amine
+BMGC_DG00365,BMG_DG003858,"DrugBank ID:DB12542 | PubChem SID:198962460 | GSK-356278 | UNII:1QTA9P992C | CAS RN:720704-34-7 | 5-[5-[(2,4-dimethyl-1,3-thiazol-5-yl)methyl]-1,3,4-oxadiazol-2-yl]-1-ethyl-N-(oxan-4-yl)pyrazolo[3,4-b]pyridin-4-amine | Gsk-356278 | PubChem CID:10252640"
+BMGC_DG00366,BMG_DG003859,2-[(2-hydroxybenzoyl)amino]acetic acid | N-SALICYLOYLGLYCINE | PubChem SID:198976355 | Salicyluric acid | UNII:5BR3P7J05U | PubChem CID:10253 | CAS RN:487-54-7
+BMGC_DG00367,BMG_DG003861,"PubChem SID:198965216 | GW842166 | 2-(2,4-dichloroanilino)-N-(oxan-4-ylmethyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide | DrugBank ID:DB11903 | UNII:VL1I6P2DZ8 | PubChem CID:10253143 | CAS RN:666260-75-9 | 2-((2,4-dichlorophenyl)amino)-N-((tetrahydro-2H-pyran-4-yl)methyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide"
+BMGC_DG00368,BMG_DG003873,"KAINIC ACID | Kainic acid | PubChem CID:10255 | (2S,3S,4S)-3-(carboxymethyl)-4-prop-1-en-2-ylpyrrolidine-2-carboxylic acid | UNII:SIV03811UC | PubChem SID:198989339 | CAS RN:487-79-6 | CAS RN:4071-38-9"
+BMGC_DG00369,BMG_DG003877,"PubChem SID:175267970 | 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracene-2-carboxylic acid | PubChem CID:10255083 | UNII:CID8Z8N95N | CAS RN:1260-17-9 | CARMINIC ACID | CAS RN:1390-65-4 | Carminic acid"
+BMGC_DG00370,BMG_DG003879,"UNII:97H5S09M4T | PubChem SID:198970933 | CAS RN:857401-00-4 | ETANAUTINE | PubChem CID:10255142 | 2-benzhydryloxy-N,N-dimethylethanamine;2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid | Etanautine | DrugBank ID:DB13636"
+BMGC_DG00371,BMG_DG003880,UNII:O90RQ1XQ79 | PubChem CID:10255153 | CAS RN:685885-75-0 | E-2508 FREE BASE | PubChem SID:313183251
+BMGC_DG00372,BMG_DG003887,"PubChem CID:10255482 | CAS RN:3828-96-4 | 5-Fluorouridine 5'-triphosphate | [[(2R,3S,4R,5R)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate"
+BMGC_DG00373,BMG_DG003891,CAS RN:487-89-8 | PubChem CID:10256 | UNII:7FN04C32UO | CAS RN:1228547-52-1 | PubChem SID:198972883 | INDOLE-3-CARBOXALDEHYDE | 1H-indole-3-carbaldehyde | CAS RN:4877-89-8 | Indole-3-Carboxaldehyde
+BMGC_DG00374,BMG_DG003902,Bufotenin | PubChem CID:10257 | DrugBank ID:DB01445 | Bufotenine | PubChem SID:198955790 | CAS RN:487-93-4 | BUFOTENINE | 3-[2-(dimethylamino)ethyl]-1H-indol-5-ol | UNII:0A31347TZK
+BMGC_DG00375,BMG_DG003937,PubChem CID:10257218 | N-[1-[acetyl-[(2-methoxyphenyl)methyl]amino]-3-(1H-indol-3-yl)propan-2-yl]-2-(4-piperidin-1-ylpiperidin-1-yl)acetamide | LY303870;LY-303870;LY 303870
+BMGC_DG00376,BMG_DG003942,"NDC:68974-400 | Sparsentan | 2-[4-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-2-(ethoxymethyl)phenyl]-N-(4,5-dimethyl-1,2-oxazol-3-yl)benzenesulfonamide | PubChem CID:10257882 | PubChem SID:198948890 | UNII:9242RO5URM | DrugBank ID:DB12548 | SPARSENTAN | NDC:68974-200 | CAS RN:254740-64-2"
+BMGC_DG00377,BMG_DG003945,DrugBank ID:DB07992 | UNII:KT0QA88913 | PubChem SID:198951582 | PubChem CID:10258 | 1H-indol-3-yl hydrogen sulfate | Indoxyl sulfate | CAS RN:487-94-5 | INDOXYL SULFATE
+BMGC_DG00378,BMG_DG003965,"CAS RN:163706-36-3 | PubChem CID:10260031 | CANGRELOR TETRASODIUM | UNII:2144G00Y7W | PubChem SID:198987559 | Cangrelor tetrasodium | tetrasodium;[dichloro(phosphonato)methyl]-[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-oxidophosphoryl]oxyphosphinate"
+BMGC_DG00379,BMG_DG003982,"Bastadin 14 | PubChem CID:10260430 | (12E,25E,28E)-5,16,21,32,33-pentabromo-4,20-dihydroxy-12,25-bis(hydroxyimino)-2,18-dioxa-10,27-diazapentacyclo[28.2.2.214,17.13,7.119,23]octatriaconta-1(32),3,5,7(38),14,16,19,21,23(35),28,30,33,36-tridecaene-11,26-dione"
+BMGC_DG00380,BMG_DG004015,PubChem CID:10264211 | AZD-5904 | CAS RN:618913-30-7 | PubChem SID:322058790 | UNII:62A9CG81VN
+BMGC_DG00381,BMG_DG004025,PubChem SID:472422653 | CAS RN:599191-49-8 | N-(6-(TRIFLUOROMETHYL)-1H-INDAZOL-3-YL)BUTANAMIDE | UNII:LX7PMD7RLW | PubChem CID:10265187
+BMGC_DG00382,BMG_DG004038,"PHENGLUTARIMIDE | PubChem SID:198977034 | Phenglutarimide | 3-[2-(diethylamino)ethyl]-3-phenylpiperidine-2,6-dione | UNII:679RC9H8TG | DrugBank ID:DB13413 | CAS RN:1156-05-4 | PubChem CID:102669"
+BMGC_DG00383,BMG_DG004039,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate | PubChem CID:10267 | CAS RN:34378-77-3 | CAS RN:488-69-7 | beta-D-fructofuranose 1,6-bisphosphate | CAS RN:132418-66-7 | PubChem SID:375579371 | CAS RN:34693-15-7 | DrugBank ID:DB04551 | .BETA.-D-FOSFRUCTOFURANOSE | 1,6-di-O-phosphono-beta-D-fructofuranose | UNII:WCH874XLB1"
+BMGC_DG00384,BMG_DG004045,DrugBank ID:DB07267 | 2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine | PubChem CID:10267580
+BMGC_DG00385,BMG_DG004056,"CAS RN:489-01-0 | PubChem CID:10269 | 2,6-DI-TERT-BUTYL-4-METHOXYPHENOL | UNII:616072TMXY | PubChem SID:198990220"
+BMGC_DG00386,BMG_DG004067,"PubChem SID:440090071 | PubChem CID:102710 | FENETHYLLINE HYDROCHLORIDE, (-)- | PubChem SID:198986698 | CAS RN:1892-80-4 | 1,3-dimethyl-7-[2-(1-phenylpropan-2-ylamino)ethyl]purine-2,6-dione;hydrochloride | Fenethylline | DrugBank ID:DB01482 | FENETHYLLINE HYDROCHLORIDE, (+)- | UNII:V3Z39LK3EV | UNII:YA7K8ADZ2V | FENETHYLLINE HYDROCHLORIDE | UNII:HK6XYT4SE5 | PubChem SID:440089265 | CAS RN:22256-64-0 | CAS RN:22256-65-1 | Fenethylline hydrochloride"
+BMGC_DG00387,BMG_DG004076,PubChem SID:198968818 | CAS RN:490-11-9 | PubChem CID:10273 | UNII:7389UZW5DY | CINCHOMERONIC ACID
+BMGC_DG00388,BMG_DG004080,PF-00277343 | PubChem CID:10274474 | PubChem SID:198941071 | CAS RN:332926-04-2 | UNII:9XZ07VI986
+BMGC_DG00389,BMG_DG004082,"PubChem SID:198964037 | ALEGLITAZAR | Aleglitazar | (2S)-2-methoxy-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl]propanoic acid | UNII:41T4OAG59U | CAS RN:475479-34-6 | PubChem CID:10274777 | DrugBank ID:DB08915"
+BMGC_DG00390,BMG_DG004086,UNII:A3X38AF5BQ | PubChem SID:459055286 | CEP-5214 | CAS RN:402857-39-0 | PubChem CID:10275001
+BMGC_DG00391,BMG_DG004089,"UNII:74RWP7W0J9 | PubChem CID:10275777 | DrugBank ID:DB12364 | BETRIXABAN | N-(5-chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide | PubChem SID:198980128 | Betrixaban | CAS RN:330942-05-7"
+BMGC_DG00392,BMG_DG004090,UNII:9058I8S63D | CAS RN:945619-31-8 | PubChem SID:198986891 | PubChem CID:10275789 | PIK-75
+BMGC_DG00393,BMG_DG004094,"PubChem CID:10276451 | CAS RN:474432-66-1 | N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)benzo[b]thiophene-2-carboxamide | N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide"
+BMGC_DG00394,BMG_DG004101,CAS RN:470689-87-3 | UNII:LV99ZTJ3GS | NIBR-1282 | PubChem CID:10278617 | PubChem SID:443624842
+BMGC_DG00395,BMG_DG004111,"CAS RN:126-49-8 | CAS RN:87664-40-2 | UNII:Z66B98Z97I | PubChem SID:198979711 | DrugBank ID:DB08427 | PREPHENIC ACID | PubChem CID:1028 | 1-(2-carboxy-2-oxoethyl)-4-hydroxycyclohexa-2,5-diene-1-carboxylic acid | Prephenic acid"
+BMGC_DG00396,BMG_DG004114,"PubChem SID:198981897 | PubChem CID:10280735 | DrugBank ID:DB09075 | N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide | EDOXABAN | CAS RN:912273-65-5 | Edoxaban | CAS RN:480449-70-5 | UNII:NDU3J18APO"
+BMGC_DG00397,BMG_DG004115,"THYMOQUINONE | PubChem CID:10281 | UNII:O60IE26NUF | Thymoquinone | CAS RN:490-91-5 | 2-methyl-5-propan-2-ylcyclohexa-2,5-diene-1,4-dione | PubChem SID:375085760"
+BMGC_DG00398,BMG_DG004131,1-Hydroxyisoquinoline | CAS RN:491-30-5 | 2H-isoquinolin-1-one | CAS RN:87602-67-3 | PubChem CID:10284 | CAS RN:489453-23-8 | UNII:95EG3HGG1P | ISOCARBOSTYRIL | PubChem SID:375579338
+BMGC_DG00399,BMG_DG004149,PubChem CID:10286 | CHROMONE | PubChem SID:198955199 | UNII:20C556MJ76 | Chromone | chromen-4-one | CAS RN:491-38-3
+BMGC_DG00400,BMG_DG004150,PubChem CID:10286059 | PubChem SID:198976586 | CAS RN:477603-18-2 | UNII:YLE5P531SS | BN-82685
+BMGC_DG00401,BMG_DG004153,"PubChem SID:198978623 | DrugBank ID:DB07933 | UNII:2ZUL6758TZ | (3aS,4R,9bR)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol | ERTEBEREL | CAS RN:533884-09-2 | Erteberel | PubChem CID:10286159"
+BMGC_DG00402,BMG_DG004156,3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE | DrugBank ID:DB07230 | PubChem CID:10286462
+BMGC_DG00403,BMG_DG004157,PubChem SID:198964425 | UNII:372AB76LQL | Azd-3043 | AZD-3043 | DrugBank ID:DB12576 | PubChem CID:10286834 | propyl 2-[4-[2-(diethylamino)-2-oxoethoxy]-3-ethoxyphenyl]acetate | CAS RN:579494-66-9
+BMGC_DG00404,BMG_DG004165,PubChem CID:10288191 | UNII:181R97MR71 | CAS RN:606143-89-9 | DrugBank ID:DB11967 | 6-(4-bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide | PubChem SID:198988096 | Binimetinib | CAS RN:1073666-70-2 | BINIMETINIB
+BMGC_DG00405,BMG_DG004207,"N-[2-(ethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide | PubChem CID:10292573 | N-Desethyl Sunitinib | UNII:42LJ35612R | CAS RN:356068-97-8 | N-DESETHYLSUNITINIB | PubChem SID:198974797"
+BMGC_DG00406,BMG_DG004208,"CAS RN:355387-25-6 | UNII:6Z77FY8ZWZ | PubChem SID:363908720 | PubChem CID:10292707 | 2-((5,7-DIPROPYL-3-(TRIFLUOROMETHYL)-1,2-BENZISOXAZOL-6-YL)OXY)-2-METHYLPROPANOIC ACID"
+BMGC_DG00407,BMG_DG004216,"Palovarotene | DrugBank ID:DB12320 | UNII:28K6I5M16G | PubChem SID:198990432 | 4-[(E)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic acid | PubChem CID:10295295 | CAS RN:410528-02-8 | PALOVAROTENE"
+BMGC_DG00408,BMG_DG004219,UNII:Y6TH2I6W99 | CAS RN:401907-26-4 | JYL-1421 | PubChem CID:10295883 | PubChem SID:198985095
+BMGC_DG00409,BMG_DG004223,"PubChem SID:472409613 | SB-649,915 | CAS RN:420785-70-2 | PubChem CID:10296414 | UNII:HD3UV2MFJ8"
+BMGC_DG00410,BMG_DG004224,UNII:S8X36868E6 | N-(2-((3-(4-(AMINOMETHYL)PHENYL)PROPYL)AMINO)ETHYL)-1-CHLORONAPHTHALENE-2-SULFONAMIDE | PubChem SID:445499123 | CAS RN:779320-96-6 | PubChem CID:10296435
+BMGC_DG00411,BMG_DG004229,"UNII:7I279E1NZ8 | CAS RN:949935-06-2 | PubChem CID:10296883 | DrugBank ID:DB12369 | PubChem SID:198968798 | CAS RN:425637-18-9 | CAS RN:1058706-31-2 | SOTRASTAURIN | 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione | Sotrastaurin"
+BMGC_DG00412,BMG_DG004230,"CAS RN:492-41-1 | UNII:33RU150WUN | PHENYLPROPANOLAMINE | UNII:57B9YG5Y1E | (1R,2S)-2-amino-1-phenylpropan-1-ol | CAS RN:14838-15-4 | PubChem CID:10297 | PubChem SID:175271864 | DrugBank ID:DB00397 | PHENYLPROPANOLAMINE, (-)- | PubChem SID:252823746 | Phenylpropanolamine"
+BMGC_DG00413,BMG_DG004231,"DrugBank ID:DB12558 | CAS RN:497839-62-0 | PubChem CID:10297043 | UNII:F9JLR95I3I | (R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | PubChem SID:198966206 | 6-[4-[(4-ethylpiperazin-1-yl)methyl]phenyl]-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | AEE-788"
+BMGC_DG00414,BMG_DG004234,"DILMAPIMOD | UNII:Q3238VQW0N | 8-(2,6-difluorophenyl)-2-(1,3-dihydroxypropan-2-ylamino)-4-(4-fluoro-2-methylphenyl)pyrido[2,3-d]pyrimidin-7-one | PubChem SID:198986669 | CAS RN:444606-18-2 | PubChem CID:10297982 | DrugBank ID:DB12140 | Dilmapimod"
+BMGC_DG00415,BMG_DG004237,"CAS RN:347887-36-9 | PubChem SID:198942558 | (2S)-2-N,2-N-dimethyl-1-N-[[2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl]methyl]pyrrolidine-1,2-dicarboxamide | DrugBank ID:DB11734 | Fedovapagon | PubChem CID:10298385 | UNII:VX2GBO4I0V | FEDOVAPAGON"
+BMGC_DG00416,BMG_DG004240,"2,3,6,8-tetrahydroxy-1,4,7-tris(3-methylbut-2-enyl)xanthen-9-one | PubChem CID:10298511 | CAS RN:112649-21-5 | GARCINONE E | PubChem SID:441332066 | UNII:83JJA5L4ZG | Garcinone E"
+BMGC_DG00417,BMG_DG004244,"UNII:958AQ7B6R1 | CAS RN:355129-15-6 | EPROTIROME | PubChem SID:198936338 | PubChem CID:10299876 | DrugBank ID:DB05035 | Eprotirome | 3-[3,5-dibromo-4-(4-hydroxy-3-propan-2-ylphenoxy)anilino]-3-oxopropanoic acid"
+BMGC_DG00418,BMG_DG004245,"CAS RN:123120-98-9 | NDC:69842-446 | DrugBank ID:DB01839 | NDC:84422-103 | NDC:0065-1509 | NDC:79903-259 | NDC:37808-650 | propane-1,2-diol | NDC:0363-1474 | NDC:0065-1530 | NDC:70000-0013 | NDC:11673-155 | CAS RN:63625-56-9 | NDC:0065-1433 | PROPYLENE GLYCOL | PubChem CID:1030 | NDC:83324-028 | NDC:70000-0706 | NDC:84186-002 | NDC:66051-236 | CAS RN:57-55-6 | NDC:49035-243 | NDC:79539-002 | PubChem SID:175271676 | NDC:11822-3728 | NDC:84186-008 | Propylene Glycol | Propylene glycol | UNII:6DC9Q167V3 | NDC:79539-401 | NDC:0065-0481"
+BMGC_DG00419,BMG_DG004252,"PubChem SID:375579708 | PubChem CID:10301 | CAS RN:493-09-4 | 1,4-BENZODIOXAN | UNII:ZC5YP57PSW"
+BMGC_DG00420,BMG_DG004258,"PubChem SID:198975945 | SARACATINIB | N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine | CAS RN:379231-04-6 | PubChem CID:10302451 | DrugBank ID:DB11805 | Saracatinib | UNII:9KD24QGH76"
+BMGC_DG00421,BMG_DG004259,PubChem CID:10303 | PubChem SID:198940174 | UNII:69083AX1ZX | 2-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid | CAS RN:493-52-7 | CAS RN:74886-84-3 | METHYL RED | DrugBank ID:DB08209 | Methyl red
+BMGC_DG00422,BMG_DG004272,PubChem CID:10304095 | UNII:H6SN9DF6JS | PubChem SID:459056153 | CAS RN:363151-21-7 | SSR-182289
+BMGC_DG00423,BMG_DG004279,PubChem CID:10305301 | DrugBank ID:DB04088 | 2-[{4-[(2S)-2-{[(Allyloxy)carbonyl]amino}-3-({4-[3-hydroxy-2-(methoxycarbonyl)phenoxy]butyl}amino)-3-oxopropyl]phenyl}(carboxycarbonyl)amino]benzoic acid
+BMGC_DG00424,BMG_DG004289,PubChem CID:10307884 | UNII:CJ4E5VXN2Z | CAS RN:19170-74-2 | PubChem SID:459275612 | 2-(1H-IMIDAZOL-4-YL)PHENOL
+BMGC_DG00425,BMG_DG004293,PubChem CID:10308106 | (2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID | DrugBank ID:DB08492
+BMGC_DG00426,BMG_DG004301,UNII:C6KYU23R4U | PubChem SID:461433776 | CAS RN:124027-56-1 | N-(E)-CAFFEOYL-L-TYROSINE | PubChem CID:10308838
+BMGC_DG00427,BMG_DG004302,PubChem SID:443623817 | HZ-166 | CAS RN:612527-56-7 | PubChem CID:10309028 | UNII:MUR6UE5SL3
+BMGC_DG00428,BMG_DG004303,"N-[4-(4-amino-2-ethylimidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide | UNII:6PJC3KPK6S | PubChem CID:10309114 | DrugBank ID:DB12476 | CAS RN:532959-63-0 | Cpg-52852 | CPG-52852 | PubChem SID:198955159"
+BMGC_DG00429,BMG_DG004307,R-306465 | PubChem CID:10309899 | N-hydroxy-2-(4-naphthalen-2-ylsulfonylpiperazin-1-yl)pyrimidine-5-carboxamide | CAS RN:604769-01-9 | PubChem SID:198972739 | UNII:5WD7KK1IIQ | DrugBank ID:DB12382
+BMGC_DG00430,BMG_DG004308,CAS RN:71-23-8 | CAS RN:89603-83-8 | 1-Propanol | propan-1-ol | DrugBank ID:DB03175 | Propyl alcohol | CAS RN:62309-51-7 | PubChem SID:175266148 | CAS RN:188894-71-5 | PubChem CID:1031 | PROPYL ALCOHOL | CAS RN:70907-80-1 | CAS RN:142583-61-7 | UNII:96F264O9SV
+BMGC_DG00431,BMG_DG004310,"GS-9411 FREE BASE | CAS RN:587879-32-1 | 552-02 Free base | PubChem CID:10310524 | UNII:2WWN8F640E | PubChem SID:198971742 | 3,5-diamino-6-chloro-N-[N'-[4-[4-(2,3-dihydroxypropoxy)phenyl]butyl]carbamimidoyl]pyrazine-2-carboxamide"
+BMGC_DG00432,BMG_DG004312,"MELARSOPROL | [2-[4-[(4,6-diamino-1,3,5-triazin-2-yl)amino]phenyl]-1,3,2-dithiarsolan-4-yl]methanol | Melarsoprol | CAS RN:494-79-1 | PubChem SID:472423316 | DrugBank ID:DB12864 | UNII:ZF3786Q2E8 | PubChem CID:10311"
+BMGC_DG00433,BMG_DG004315,"UNII:NLE429IZUC | PubChem SID:198955660 | PubChem CID:10311306 | DrugBank ID:DB09291 | CAS RN:552292-08-7 | Rolapitant | (5S,8S)-8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one | ROLAPITANT"
+BMGC_DG00434,BMG_DG004322,UNII:K8YW73872D | CAS RN:495-18-1 | Benzhydroxamic Acid | BENZOHYDROXAMIC ACID | PubChem SID:198968166 | PubChem CID:10313 | DrugBank ID:DB01924
+BMGC_DG00435,BMG_DG004337,UNII:6YB4901Y90 | CAS RN:7773-01-5 | PubChem CID:10313134 | MANGANESE CHLORIDE ANHYDROUS | PubChem SID:198985738
+BMGC_DG00436,BMG_DG004346,D-4-epi-Fagomine | CAS RN:158236-23-8 | PubChem CID:10313212 | UNII:5J2CV36N4X | PubChem SID:474494572 | D-4-EPI-FAGOMINE
+BMGC_DG00437,BMG_DG004378,AGN-190205 | UNII:VSDTYDJDJJ | PubChem CID:10314719 | CAS RN:104561-41-3 | PubChem SID:346537749
+BMGC_DG00438,BMG_DG004380,UNII:99T4HMN9HV | PubChem SID:474492769 | CAS RN:122718-49-4 | PubChem CID:10314993 | WY-46824
+BMGC_DG00439,BMG_DG004398,UNII:NSC8QP4B6Z | CAS RN:459133-38-1 | PubChem CID:10316203 | 2-[(tert-butylamino)methyl]-5-[(7-chloroquinolin-4-yl)amino]phenol | Gsk-369796 | GSK-369796 | PubChem SID:441331601
+BMGC_DG00440,BMG_DG004411,"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine | PubChem CID:10317619 | DrugBank ID:DB08536"
+BMGC_DG00441,BMG_DG004414,CAS RN:145508-87-8 | UNII:RY1AR8DY6G | CP-126998 | PubChem SID:363907851 | PubChem CID:10318177
+BMGC_DG00442,BMG_DG004429,PubChem CID:10319620 | PubChem SID:313183394 | CAS RN:166599-76-4 | UNII:J53IGM38PB | JWH-198
+BMGC_DG00443,BMG_DG004430,"CAS RN:64907-23-9 | (3beta)-3,25-Dihydroxycholest-5-en-7-one | (3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,3,4,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-7-one | PubChem CID:10319758"
+BMGC_DG00444,BMG_DG004432,DrugBank ID:DB03766 | PROPIONIC ACID | PubChem SID:175267506 | Propionic Acid | UNII:JHU490RVYR | propanoic acid | Propanoic acid | Propionic acid | PubChem CID:1032 | CAS RN:79-09-4 | CAS RN:90990-11-7
+BMGC_DG00445,BMG_DG004434,"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM | DrugBank ID:DB08504 | PubChem CID:10320144"
+BMGC_DG00446,BMG_DG004437,PubChem CID:10320994 | 6-HYDROXYBENZBROMARONE | PubChem SID:472426232 | 6-Hydroxybenzbromarone | CAS RN:152831-00-0 | UNII:4M7NUR5V9E
+BMGC_DG00447,BMG_DG004454,4-{[(3S)-3-{[(7-methoxynaphthalen-2-yl)sulfonyl](methyl)amino}-2-oxopyrrolidin-1-yl]methyl}thiophene-2-carboximidamide | 4-[[(3S)-3-[(7-methoxynaphthalen-2-yl)sulfonyl-methylamino]-2-oxopyrrolidin-1-yl]methyl]thiophene-2-carboximidamide | PubChem CID:10322586
+BMGC_DG00448,BMG_DG004455,"PubChem CID:10322880 | 1-Cyclopentyl-5-(4-hydroxy-1,10,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-13-yl)pentan-3-one | 1-cyclopentyl-5-(4-hydroxy-1,10,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-13-yl)pentan-3-one"
+BMGC_DG00449,BMG_DG004465,PubChem CID:10324083 | PubChem SID:198951924 | UNII:OW44B6FA0Y | CAS RN:683746-68-1 | JNJ-5207787
+BMGC_DG00450,BMG_DG004466,"BOCEPREVIR | Boceprevir | UNII:89BT58KELH | PubChem CID:10324367 | (1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-(tert-butylcarbamoylamino)-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | PubChem SID:175271658 | CAS RN:394730-60-0 | DrugBank ID:DB08873"
+BMGC_DG00451,BMG_DG004474,CAS RN:95152-75-3 | UNII:4422E9639H | FONSECINONE A | PubChem SID:318691463 | PubChem CID:10325700
+BMGC_DG00452,BMG_DG004475,"INDAN | UNII:H9SCX043IG | PubChem CID:10326 | CAS RN:496-11-7 | 2,3-dihydro-1H-indene | Indan | CAS RN:56573-11-6 | PubChem SID:198943385"
+BMGC_DG00453,BMG_DG004490,CAS RN:87213-50-1 | PubChem SID:441096697 | UNII:2AVB9ZZ4ZS | PubChem CID:1032830 | PHENAZOLAM
+BMGC_DG00454,BMG_DG004492,"UNII:OKY3285J18 | Eledoisin | ELEDOISIN | PubChem SID:375085763 | CAS RN:69-25-0 | PubChem CID:10328936 | (3S)-3-[[(2S)-6-amino-2-[[(2S)-3-hydroxy-2-[[(2S)-1-[(2S)-5-oxopyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid"
+BMGC_DG00455,BMG_DG004493,CAS RN:496-16-2 | UNII:99E861415L | COUMARAN | PubChem CID:10329 | PubChem SID:198936349
+BMGC_DG00456,BMG_DG004500,"2,4-DIISOBUTYLPHENOL | CAS RN:65152-07-0 | PubChem SID:198971149 | PubChem CID:103295 | UNII:P3052JKW75"
+BMGC_DG00457,BMG_DG004508,PubChem CID:10330240 | UNII:WR5V5TB2TR | VUF-5681 | CAS RN:768358-61-8 | PubChem SID:482554214
+BMGC_DG00458,BMG_DG004514,COUMARILIC ACID | PubChem SID:198937034 | UNII:7Z6NMG947L | PubChem CID:10331 | CAS RN:496-41-3
+BMGC_DG00459,BMG_DG004520,PubChem SID:445500591 | CAS RN:362603-40-5 | UNII:KT54N4CC67 | AL-37350A | PubChem CID:10331436
+BMGC_DG00460,BMG_DG004521,"NAPABUCASIN | UNII:Z1HHM49K7O | Napabucasin | 2-acetylbenzo[f][1]benzofuran-4,9-dione | PubChem SID:198943961 | DrugBank ID:DB12155 | CAS RN:83280-65-3 | PubChem CID:10331844"
+BMGC_DG00461,BMG_DG004522,"Raseglurant | RASEGLURANT | PubChem CID:10331863 | CAS RN:757950-09-7 | PubChem SID:198959267 | UNII:66UCJ8Z8L1 | 2-[2-(3-fluorophenyl)ethynyl]-4,6-dimethylpyridin-3-amine"
+BMGC_DG00462,BMG_DG004536,"CAS RN:116539-60-7 | PubChem SID:198938027 | PubChem CID:10334821 | UNII:TK9VOT90JQ | DULOXETINE, (R)-"
+BMGC_DG00463,BMG_DG004542,"CAS RN:752243-39-3 | UNII:267WB8R4TI | PubChem SID:198956314 | PubChem CID:10335364 | Orteronel, (R)- | 6-[(7R)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide | ORTERONEL, (R)-"
+BMGC_DG00464,BMG_DG004551,PubChem CID:10336538 | PubChem SID:198984440 | UNII:G8F040299R | CAS RN:337972-47-1 | FAUC-213
+BMGC_DG00465,BMG_DG004555,PubChem SID:377308638 | BAVACHININ | PubChem CID:10337211 | UNII:VL3EV483SZ | CAS RN:19879-30-2
+BMGC_DG00466,BMG_DG004559,CAS RN:629645-40-5 | PubChem SID:198970234 | UNII:36G59HLT1Z | AZ-11665362 | PubChem CID:10337564
+BMGC_DG00467,BMG_DG004560,CAS RN:633304-27-5 | WAY-208466 | UNII:0AXW9ALG9W | PubChem SID:317229771 | PubChem CID:10337743
+BMGC_DG00468,BMG_DG004563,"CAS RN:189299-05-6 | PubChem CID:10338075 | (E)-1-(5-hydroxy-7-methoxy-2,2-dimethylchromen-6-yl)-3-(4-hydroxyphenyl)prop-2-en-1-one | Xanthohumol C"
+BMGC_DG00469,BMG_DG004574,"PubChem CID:10339710 | DrugBank ID:DB07210 | 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine"
+BMGC_DG00470,BMG_DG004577,NDC:0220-3577 | PubChem CID:10340 | SODIUM CARBONATE | NDC:0220-3531 | PubChem SID:175265897 | NDC:37662-1875 | CAS RN:7542-12-3 | NDC:37662-1876 | Sodium carbonate | NDC:37662-1871 | NDC:68703-219 | UNII:45P3261C7T | NDC:37662-1877 | CAS RN:1332-57-6 | NDC:0220-3532 | Sodium Carbonate | NDC:0220-3534 | NDC:0220-3535 | CAS RN:497-19-8 | NDC:0220-3536 | DrugBank ID:DB09460 | NDC:37662-1873 | NDC:0220-3538 | NDC:37662-1874 | NDC:0220-3533 | disodium;carbonate | NDC:37662-1870 | NDC:37662-1872 | NDC:0220-3537
+BMGC_DG00471,BMG_DG004585,PubChem CID:10340781 | AS-1517499 | PubChem SID:198981225 | CAS RN:919486-40-1 | UNII:2H31HOT08T
+BMGC_DG00472,BMG_DG004587,CAS RN:497-23-4 | PubChem CID:10341 | 2(5H)-Furanone | 2(5H)-FURANONE | UNII:8KXK25H388 | PubChem SID:198983328 | 2H-furan-5-one
+BMGC_DG00473,BMG_DG004589,"CAS RN:479543-46-9 | PubChem CID:10341154 | UNII:527E7SK68P | Vx-702 | VX-702 | DrugBank ID:DB05470 | PubChem SID:313183686 | CAS RN:745833-23-2 | 6-(N-carbamoyl-2,6-difluoroanilino)-2-(2,4-difluorophenyl)pyridine-3-carboxamide"
+BMGC_DG00474,BMG_DG004590,UNII:D379MU4RV2 | CAS RN:866484-00-6 | LY-2121260 | PubChem CID:10341191 | PubChem SID:459275848
+BMGC_DG00475,BMG_DG004592,UNII:19KW9LD704 | PubChem SID:198961364 | KCL-1999000269 | PubChem CID:10341445 | CAS RN:311769-66-1
+BMGC_DG00476,BMG_DG004603,"CAS RN:68401-05-8 | PubChem CID:10342292 | 2-[5-[(2E)-3,7-dimethylocta-2,6-dienyl]-2,4-dihydroxyphenyl]-5,7-dihydroxy-2,3-dihydrochromen-4-one | Kuwanon E"
+BMGC_DG00477,BMG_DG004606,"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID | PubChem CID:10342449 | 2-({[3,5-Difluoro-3'-(Trifluoromethoxy)biphenyl-4-Yl]amino}carbonyl)cyclopent-1-Ene-1-Carboxylic Acid | 2-[[2,6-difluoro-4-[3-(trifluoromethoxy)phenyl]phenyl]carbamoyl]cyclopentene-1-carboxylic acid | DrugBank ID:DB07975"
+BMGC_DG00478,BMG_DG004611,CAS RN:698394-73-9 | Vercirnon | CAS RN:1197003-10-3 | VERCIRNON | PubChem CID:10343454 | UNII:MWI54OUA12 | DrugBank ID:DB15250 | 4-tert-butyl-N-[4-chloro-2-(1-oxidopyridin-1-ium-4-carbonyl)phenyl]benzenesulfonamide | PubChem SID:198938393
+BMGC_DG00479,BMG_DG004612,"TARAZEPIDE | CAS RN:141374-81-4 | PubChem CID:10343641 | N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraene-2-carboxamide | UNII:RK2972YZ2U | Tarazepide | PubChem SID:198987706 | DrugBank ID:DB06435"
+BMGC_DG00480,BMG_DG004613,2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE | PubChem CID:10343728 | DrugBank ID:DB07277
+BMGC_DG00481,BMG_DG004615,"PubChem SID:333495780 | UNII:1E03US327G | PubChem CID:10343847 | FRESELESTAT, (S)- | CAS RN:208847-91-0"
+BMGC_DG00482,BMG_DG004621,"CAS RN:575484-78-5 | PubChem CID:10344820 | 2-[3-[[4-[(2,2-difluoro-3-oxo-4H-1,4-benzoxazin-6-yl)amino]-5-fluoropyrimidin-2-yl]amino]phenoxy]-N-methylacetamide | PubChem SID:461432830 | UNII:Y4069R7J86 | R-343"
+BMGC_DG00483,BMG_DG004627,"UNII:DIH95YP7J3 | PubChem CID:10345214 | RONACALERET | CAS RN:753449-67-1 | DrugBank ID:DB05255 | 3-[3-[(2R)-3-[[1-(2,3-dihydro-1H-inden-2-yl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]-4,5-difluorophenyl]propanoic acid | Ronacaleret | PubChem SID:198987907"
+BMGC_DG00484,BMG_DG004638,BMS-363131 | UNII:82AT6RBC74 | PubChem SID:198935746 | CAS RN:384829-65-6 | PubChem CID:10347259
+BMGC_DG00485,BMG_DG004655,"NDC:72974-120 | 1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea | UNII:P76B05O5V6 | PubChem SID:198967092 | DrugBank ID:DB11853 | Relugolix | PubChem CID:10348973 | CAS RN:737789-87-6 | RELUGOLIX"
+BMGC_DG00486,BMG_DG004656,CAS RN:498-21-5 | PubChem CID:10349 | UNII:H1547KG7UZ | PubChem SID:251965972 | METHYLSUCCINIC ACID
+BMGC_DG00487,BMG_DG004670,"PubChem CID:10351092 | UNII:7WAL1X78KV | Angiotensin Amide | ANGIOTENSIN AMIDE | (2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid | CAS RN:53-73-6 | PubChem SID:375085521 | DrugBank ID:DB13517"
+BMGC_DG00488,BMG_DG004688,NDC:37662-3506 | NDC:37662-3508 | ALUMINUM CARBONATE | PubChem CID:10353966 | NDC:37662-3507 | NDC:37662-3510 | UNII:1GA689N629 | dialuminum;tricarbonate | NDC:37662-3509 | Aluminum Carbonate | CAS RN:14455-29-9 | NDC:37662-3505 | PubChem SID:198936198 | NDC:37662-3504 | NDC:37662-3511 | CAS RN:53547-27-6
+BMGC_DG00489,BMG_DG004690,PROPAZOLAMIDE | PubChem CID:10354098 | PubChem SID:198985453 | CAS RN:98-75-9 | UNII:5E2PXL9FZF
+BMGC_DG00490,BMG_DG004706,"3,5-DIMETHYLBENZOIC ACID | CAS RN:499-06-9 | UNII:ED8AV34N0Y | PubChem CID:10356 | PubChem SID:198961238"
+BMGC_DG00491,BMG_DG004712,"CAS RN:499-40-1 | (2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol | 6-O-.ALPHA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSE | 6-O-α-D-Glucopyranosyl-β-D-glucopyranose | PubChem CID:10357 | beta-Isomaltose | UNII:U7W8T8R4YZ | PubChem SID:485665857 | CAS RN:37169-69-0"
+BMGC_DG00492,BMG_DG004715,CAS RN:1597-68-8 | PubChem CID:10357822 | UNII:O9R6BZK55Y | 6.ALPHA.-FLUOROTESTOSTERONE | PubChem SID:241180090
+BMGC_DG00493,BMG_DG004724,"Stepharanine | CAS RN:17369-30-1 | 3,9-dimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-2,10-diol | PubChem CID:10358881"
+BMGC_DG00494,BMG_DG004730,"PubChem CID:10359522 | 1-benzyl-3-propylpurino[7,8-a]pyridine-2,4-dione | 1-Benzyl-3-propyl-1h,3h-pyrido[2,1-f]purine-2,4-dione"
+BMGC_DG00495,BMG_DG004731,UNII:NGJ1K8EOK1 | FAUC-312 | PubChem SID:198955545 | CAS RN:562104-72-7 | PubChem CID:10359539
+BMGC_DG00496,BMG_DG004732,"CAS RN:613679-11-1 | UNII:W918223VQ6 | PubChem SID:198968571 | Bpr-0L075 | PubChem CID:10359957 | BPR-0L075 | (6-methoxy-1H-indol-3-yl)-(3,4,5-trimethoxyphenyl)methanone"
+BMGC_DG00497,BMG_DG004738,PubChem CID:10360860 | PubChem SID:272993909 | CAS RN:155471-10-6 | JWH-007 | UNII:5IQ75333OM
+BMGC_DG00498,BMG_DG004742,"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine | DrugBank ID:DB08708 | PubChem CID:10361208"
+BMGC_DG00499,BMG_DG004744,UNII:9SY76D3YUK | CAS RN:510-22-5 | PubChem SID:461434415 | VOACANGINE | PubChem CID:10361692
+BMGC_DG00500,BMG_DG004752,PubChem SID:198964477 | PubChem CID:10364 | Carvacrol | CARVACROL | 2-methyl-5-propan-2-ylphenol | CAS RN:499-75-2 | UNII:9B1J4V995Q
+BMGC_DG00501,BMG_DG004755,"DrugBank ID:DB07006 | 9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | PubChem CID:10364585"
+BMGC_DG00502,BMG_DG004758,"N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE | PubChem CID:10364826 | DrugBank ID:DB08025"
+BMGC_DG00503,BMG_DG004760,LUTIDINIC ACID | PubChem CID:10365 | UNII:AFI29F0TVL | CAS RN:499-80-9 | PubChem SID:375579027
+BMGC_DG00504,BMG_DG004766,PubChem CID:10366 | PubChem SID:472410656 | UNII:N5NMH4PZ3D | DINICOTINIC ACID | CAS RN:499-81-0
+BMGC_DG00505,BMG_DG004767,DrugBank ID:DB11832 | CRENOLANIB | PubChem CID:10366136 | PubChem SID:198943954 | UNII:LQF7I567TQ | 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine | Crenolanib | CAS RN:670220-88-9
+BMGC_DG00506,BMG_DG004768,"3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one | CAS RN:105114-22-5 | 13-(6-deoxy-alpha-L-mannopyranosyl)-6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one | PubChem CID:10366843"
+BMGC_DG00507,BMG_DG004770,"Dipicolinic Acid | PubChem CID:10367 | Dipicolinic acid | DrugBank ID:DB04267 | PubChem SID:198939936 | 2,6-PYRIDINEDICARBOXYLIC ACID | pyridine-2,6-dicarboxylic acid | UNII:UE81S5CQ0G | CAS RN:499-83-2"
+BMGC_DG00508,BMG_DG004775,"CAS RN:758722-49-5 | DrugBank ID:DB11671 | Azd-4877 | N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide | PubChem SID:198951307 | CAS RN:1176760-49-8 | AZD-4877 | UNII:19ORU63E06 | PubChem CID:10368812"
+BMGC_DG00509,BMG_DG004779,Amauromine | UNII:ZB3XU39EJD | CAS RN:88360-87-6 | PubChem SID:482553033 | PubChem CID:10369017 | AMAUROMINE
+BMGC_DG00510,BMG_DG004787,"PubChem CID:10370341 | UNII:BP826B3J9M | (2S)-6-amino-2-[[(2S)-2-[[(2R)-2-amino-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-N-(4-nitrophenyl)hexanamide | CAS RN:63589-93-5 | L-Lysinamide, D-valyl-L-leucyl-N-(4-nitrophenyl)- | D-VALYL-L-LEUCYL-L-LYSINE 4-NITROANILIDE | PubChem SID:443624915"
+BMGC_DG00511,BMG_DG004803,UNII:1IAT42T80T | [1-[3-[2-chloro-4-[[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]methyl]-5-methoxyanilino]-3-oxopropyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate | CAS RN:743461-65-6 | Batefenterol | BATEFENTEROL | DrugBank ID:DB12526 | PubChem SID:198936727 | PubChem CID:10372836
+BMGC_DG00512,BMG_DG004811,UNII:48SN4K3W0E | CHLORAZANIL | PubChem SID:198973133 | PubChem CID:10374 | CAS RN:500-42-5
+BMGC_DG00513,BMG_DG004820,CAS RN:829-71-0 | PubChem SID:472421935 | PubChem CID:10375558 | 4-(2-HYDROXYETHYL)BENZENESULFONAMIDE | UNII:VT87HL547L
+BMGC_DG00514,BMG_DG004824,"CAS RN:78950-82-0 | PubChem CID:10375676 | 1-Naphthalenol, 5,6,7,8-tetrahydro-6-(propylamino)- | 6-(propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol"
+BMGC_DG00515,BMG_DG004834,"UNII:65OP0NEZ1P | Olivetol | PubChem SID:198981182 | CAS RN:500-66-3 | PubChem CID:10377 | 5-pentylbenzene-1,3-diol | OLIVETOL"
+BMGC_DG00516,BMG_DG004842,UNII:136B46378D | PubChem SID:198954510 | PubChem CID:10378 | OXANILIC ACID | CAS RN:500-72-1
+BMGC_DG00517,BMG_DG004858,DrugBank ID:DB07350 | PubChem CID:10379137 | (2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide
+BMGC_DG00518,BMG_DG004889,UNII:G391998J57 | Jwh-018 | PubChem CID:10382701 | naphthalen-1-yl-(1-pentylindol-3-yl)methanone | JWH-018 | PubChem SID:198978164 | CAS RN:209414-07-3
+BMGC_DG00519,BMG_DG004904,4-SULFAMOYL-N-(2-(4-SULFAMOYLPHENYL)ETHYL)BENZAMIDE | CAS RN:361438-75-7 | UNII:W5GSE2PV4D | PubChem CID:10385283 | PubChem SID:472422211
+BMGC_DG00520,BMG_DG004919,GGTI-2154 | PubChem SID:445500537 | UNII:33BP5968EC | CAS RN:251577-10-3 | PubChem CID:10387426
+BMGC_DG00521,BMG_DG004920,"ETHASELEN | Ethaselen | 2-[2-(3-oxo-1,2-benzoselenazol-2-yl)ethyl]-1,2-benzoselenazol-3-one | PubChem CID:10387485 | PubChem SID:381132594 | DrugBank ID:DB15051 | CAS RN:217798-39-5 | UNII:4Q2EZS1IWG"
+BMGC_DG00522,BMG_DG004928,CAS RN:98383-40-5 | PubChem CID:10388920 | PubChem SID:381132330 | CI-936 | UNII:EJ0E2OG5J5
+BMGC_DG00523,BMG_DG004930,CAS RN:360551-59-3 | PubChem CID:10389213 | UNII:5P909HKP24 | A-317920 | PubChem SID:198940008 | N-[(2R)-1-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]-1-oxopropan-2-yl]furan-2-carboxamide
+BMGC_DG00524,BMG_DG004931,"PubChem CID:10389239 | 2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE | DrugBank ID:DB08358"
+BMGC_DG00525,BMG_DG004934,PubChem CID:10389383 | UNII:97TO44634I | PubChem SID:198968410 | PD-0210293 | CAS RN:239095-01-3
+BMGC_DG00526,BMG_DG004939,PubChem SID:241180517 | CAS RN:501-65-5 | UNII:Y70JA8HB75 | PubChem CID:10390 | TOLAN
+BMGC_DG00527,BMG_DG004940,ALUMINUM CLOFIBRATE | aluminum;2-(4-chlorophenoxy)-2-methylpropanoate;hydroxide | UNII:56203T2K2X | PubChem SID:198952680 | PubChem CID:10390009 | DrugBank ID:DB13780 | CAS RN:24818-79-9 | Aluminum clofibrate
+BMGC_DG00528,BMG_DG004947,UNII:F5N0ALI65V | N-benzyl-3-chloropropanamide | PubChem SID:198969148 | BECLAMIDE | PubChem CID:10391 | Beclamide | DrugBank ID:DB09011 | CAS RN:501-68-8
+BMGC_DG00529,BMG_DG004951,CAS RN:708258-16-6 | BMS-354326 | PubChem CID:10391699 | PubChem SID:198975236 | UNII:T12M854Z97
+BMGC_DG00530,BMG_DG004954,UNII:U5Y9CKP3XR | FYK-1388 FREE BASE | PubChem SID:459055886 | PubChem CID:10392082 | CAS RN:184947-93-1
+BMGC_DG00531,BMG_DG004958,DrugBank ID:DB13103 | PubChem CID:10392558 | Camsirubicin
+BMGC_DG00532,BMG_DG004960,PubChem SID:384647882 | UNII:809U4O7OQO | CAS RN:334998-36-6 | PubChem CID:10392802 | CUR-61414
+BMGC_DG00533,BMG_DG004961,TYROSOL | PubChem CID:10393 | CAS RN:501-94-0 | PubChem SID:198976548 | UNII:1AK4MU3SNX | Tyrosol | 4-(2-hydroxyethyl)phenol
+BMGC_DG00534,BMG_DG004965,PubChem CID:10394 | CAS RN:501-97-3 | Phloretic acid | DrugBank ID:DB03897 | 3-(4-Hydroxyphenyl)propionic acid | PubChem SID:198944929 | 3-(4-hydroxyphenyl)propanoic acid | 3-(4-HYDROXYPHENYL)PROPIONIC ACID | UNII:6QNC6P18SR
+BMGC_DG00535,BMG_DG004994,"PubChem CID:10397869 | DrugBank ID:DB07281 | N~3~-BENZYLPYRIDINE-2,3-DIAMINE"
+BMGC_DG00536,BMG_DG004999,PubChem SID:472422259 | AMDA | UNII:JG5GX32FDE | PubChem CID:10398175 | CAS RN:22136-76-1
+BMGC_DG00537,BMG_DG005007,PubChem SID:461432373 | PubChem CID:10399068 | 6-CHLOROTACRINE | CAS RN:5778-84-7 | UNII:C5T9A4VHZ8
+BMGC_DG00538,BMG_DG005011,"CAS RN:51863-60-6 | 1-(3,5-dihydroxyphenyl)ethanone | PubChem CID:103993 | UNII:KP7R433NNR | PubChem SID:198989484 | 3',5'-DIHYDROXYACETOPHENONE | 3',5'-Dihydroxyacetophenone"
+BMGC_DG00539,BMG_DG005020,"2,5-Dimethoxy-4-trifluoromethylamphetamine | PubChem CID:10400521 | 2,5-DIMETHOXY-4-TRIFLUOROMETHYLAMPHETAMINE | CAS RN:159277-07-3 | UNII:NLH3FWZ9T4 | PubChem SID:474492892"
+BMGC_DG00540,BMG_DG005023,oxepan-2-one | PubChem SID:198972827 | CAPROLACTONE | PubChem CID:10401 | CAS RN:502-44-3 | Caprolactone | CAS RN:1219802-08-0 | CAS RN:25248-42-4 | UNII:56RE988L1R
+BMGC_DG00541,BMG_DG005029,N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE | PubChem CID:10401956 | DrugBank ID:DB08462
+BMGC_DG00542,BMG_DG005052,"4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol | DrugBank ID:DB07502 | PubChem CID:10403821"
+BMGC_DG00543,BMG_DG005055,"Fauc 113 | CAS RN:221470-50-4 | 3-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]pyrazolo[1,5-a]pyridine | PubChem CID:10404144"
+BMGC_DG00544,BMG_DG005057,MACELIGNAN | PubChem SID:175266272 | UNII:8PP3614Z43 | CAS RN:107534-93-0 | PubChem CID:10404245
+BMGC_DG00545,BMG_DG005060,"2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-3H-benzimidazol-5-ol | PubChem CID:10404448 | PubChem SID:433968744 | UNII:QH71GLR6GT | CAS RN:151602-49-2 | 5-O-Desmethyl Omeprazole | 5-O-DESMETHYLOMEPRAZOLE"
+BMGC_DG00546,BMG_DG005064,PubChem SID:441097556 | UNII:CJD4EF9EME | DESMETHOXYFALLYPRIDE | PubChem CID:10404663 | CAS RN:166173-81-5
+BMGC_DG00547,BMG_DG005070,"PubChem CID:10405091 | 3,6,8-trihydroxy-2-methoxy-1-(3-methylbut-2-enyl)xanthen-9-one | Dulxanthone D"
+BMGC_DG00548,BMG_DG005082,"5,7-dihydroxy-8-[2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]-2-phenylchromen-4-one | 5,7-Dihydroxy-8-[2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]-2-phenylchromen-4-one | PubChem CID:10406644"
+BMGC_DG00549,BMG_DG005087,UNII:3SI12BK34I | PubChem CID:10406874 | CAS RN:710335-06-1 | CT-32615 | PubChem SID:198943619
+BMGC_DG00550,BMG_DG005088,"PubChem CID:104070 | 1H,3H-NAPHTHO(1,8-CD)PYRAN-6-SULFONIC ACID, 1,3-DIOXO- | UNII:D99D4PPK7H | 1H,3H-Naphtho[1,8-cd]pyran-6-sulfonic acid, 1,3-dioxo- | CAS RN:52083-12-2 | PubChem SID:485661663"
+BMGC_DG00551,BMG_DG005095,"CAS RN:77263-06-0 | 6A,11A-DIHYDRO-2,10-BIS(3-METHYL-2-BUTEN-1-YL)-6H-BENZOFURO(3,2-C)(1)BENZOPYRAN-3,9-DIOL, (6AR,11AR)- | UNII:JLW4FP5CVK | PubChem CID:10408212"
+BMGC_DG00552,BMG_DG005098,TCS-OX2-29 | PubChem SID:474492675 | CAS RN:372523-75-6 | UNII:KH2US47J8R | PubChem CID:10408514
+BMGC_DG00553,BMG_DG005103,"BMS-582949 | 4-[5-(cyclopropylcarbamoyl)-2-methylanilino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide | PubChem SID:198972880 | Bms-582949 | UNII:CR743OME9E | DrugBank ID:DB12696 | CAS RN:623152-17-0 | PubChem CID:10409068"
+BMGC_DG00554,BMG_DG005104,XANTHOANGELOL B | UNII:PA91X8J87C | PubChem CID:10409180 | CAS RN:132998-81-3 | PubChem SID:405055571
+BMGC_DG00555,BMG_DG005110,CAS RN:157075-58-6 | PubChem CID:10409484 | UNII:6KQ3QJ08FF | SPIROQUINAZOLINE | PubChem SID:406588657
+BMGC_DG00556,BMG_DG005131,"PubChem CID:10411846 | DrugBank ID:DB07359 | 3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide"
+BMGC_DG00557,BMG_DG005139,DrugBank ID:DB01440 | UNII:30IW36W5B2 | OXYBATE | 4-hydroxybutanoic acid | PubChem CID:10413 | PubChem SID:175268868 | CAS RN:52352-27-9 | 4-Hydroxybutanoic acid | CAS RN:591-81-1
+BMGC_DG00558,BMG_DG005151,"CAS RN:101140-06-1 | PubChem CID:10414856 | 3,8'-Biapigenin | 3-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one"
+BMGC_DG00559,BMG_DG005157,CAS RN:58822-25-6 | PubChem CID:10415290 | 2-[2-(2-{2-[2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-acetylamino}-acetylamino)-3-phenyl-propionylamino]-4-methyl-pentanoic acid | (2R)-2-[[(2R)-2-[[2-[[2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid
+BMGC_DG00560,BMG_DG005169,"CAS RN:52348-51-3 | PubChem CID:104165 | PubChem SID:198947495 | 2,6-DIISOBUTYLPHENOL | UNII:32VIS902J4"
+BMGC_DG00561,BMG_DG005175,UNII:BKU7CX6USX | PubChem SID:472390521 | PubChem CID:10417379 | CAS RN:1403-36-7 | CHAETOMIN
+BMGC_DG00562,BMG_DG005176,SB-435495 | CAS RN:304694-39-1 | UNII:0ORT6ZXL2X | PubChem CID:10417440 | PubChem SID:363908966
+BMGC_DG00563,BMG_DG005216,PubChem CID:10422105 | PubChem SID:472423044 | UNII:KWW2264QDT | CAS RN:148180-61-4 | WRIGHTIADIONE
+BMGC_DG00564,BMG_DG005219,PubChem SID:485661856 | UNII:49F5H9E5Y4 | PubChem CID:104223 | 3-Trifluoromethylphenethylamine | 3-(Trifluoromethyl)phenethylamine | 2-[3-(trifluoromethyl)phenyl]ethanamine | 3-TRIFLUOROMETHYLPHENETHYLAMINE | CAS RN:52516-30-0
+BMGC_DG00565,BMG_DG005223,PubChem SID:443625148 | UNII:B6V3UR69XC | 4-BROMOPROPOFOL | CAS RN:2432-03-3 | PubChem CID:10422572
+BMGC_DG00566,BMG_DG005241,"9-HYDROXY-4-ANDROSTENE-3,17-DIONE | (8S,9R,10S,13S,14S)-9-hydroxy-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione | PubChem CID:10425017 | UNII:VL5PS7G5VP | CAS RN:560-62-3 | 9-Hydroxy-4-androstene-3,17-dione"
+BMGC_DG00567,BMG_DG005243,4-HYDROXYCARBAZOLE | UNII:3D95E7727V | PubChem SID:198939885 | CAS RN:52602-39-8 | PubChem CID:104251
+BMGC_DG00568,BMG_DG005246,UNII:RWL9H93ARB | A-412997 | PubChem CID:10425450 | CAS RN:630116-49-3 | PubChem SID:198986120
+BMGC_DG00569,BMG_DG005248,"(4,5-dihydroxy-9,10-dioxoanthracen-2-yl)methyl acetate | Aloe emodin w-acetate | CAS RN:65615-58-9 | PubChem CID:10425624"
+BMGC_DG00570,BMG_DG005254,"PubChem CID:10426659 | CAS RN:132206-99-6 | PubChem SID:198938487 | UNII:04L43UOA5T | 2-cyclopentyl-N-phenyl-3H-imidazo[4,5-c]quinolin-4-amine | DU-124183"
+BMGC_DG00571,BMG_DG005257,PubChem SID:461433944 | CAS RN:681135-77-3 | UNII:NC2J8K4ARH | PubChem CID:10427006 | OL-135
+BMGC_DG00572,BMG_DG005267,"UNII:7ACH1U1E2M | CAS RN:677297-51-7 | TG-100115 | 3-[2,4-diamino-7-(3-hydroxyphenyl)pteridin-6-yl]phenol | Tg100-115 | PubChem SID:198958964 | DrugBank ID:DB05552 | PubChem CID:10427712"
+BMGC_DG00573,BMG_DG005280,"2-[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]amino]-3-(1H-indol-3-yl)propanoic acid | CAS RN:109163-69-1 | N-Caffeoyltryptophan | PubChem CID:10428959"
+BMGC_DG00574,BMG_DG005286,PubChem SID:381608542 | UNII:N5P71K0GE3 | PubChem CID:10429214 | DIOXINODEHYDROECKOL | CAS RN:639514-05-9
+BMGC_DG00575,BMG_DG005290,"MITOGLITAZONE | CAS RN:146062-49-9 | PubChem CID:10429242 | 5-[[4-[2-(5-ethylpyridin-2-yl)-2-oxoethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | PubChem SID:316912150 | UNII:29I7RP18RG | DrugBank ID:DB11721 | Mitoglitazone"
+BMGC_DG00576,BMG_DG005296,"PubChem SID:198941626 | PubChem CID:10429706 | 5-amino-6-chloro-2-methyl-N-[[1-(2-methylpropyl)piperidin-4-yl]methyl]imidazo[1,2-a]pyridine-8-carboxamide | CJ-033466 | CAS RN:519148-48-2 | UNII:9KUW8W70PJ | Imidazo(1,2-a)pyridine-8-carboxamide, 5-amino-6-chloro-2-methyl-N-((1-(2-methylpropyl)-4-piperidinyl)methyl)-"
+BMGC_DG00577,BMG_DG005299,PubChem CID:10430 | 3-methylbutanoic acid | ISOVALERIC ACID | CAS RN:503-74-2 | UNII:1BR7X184L5 | Isovaleric acid | CAS RN:35915-22-1 | Isovaleric Acid | DrugBank ID:DB03750 | PubChem SID:198935025 | CAS RN:92634-50-9
+BMGC_DG00578,BMG_DG005301,"CAS RN:149709-44-4 | DrugBank ID:DB14127 | PubChem SID:198956000 | Sacubitrilat | SACUBITRILAT | UNII:SPI5PBF81S | PubChem CID:10430040 | (2R,4S)-4-(3-carboxypropanoylamino)-2-methyl-5-(4-phenylphenyl)pentanoic acid"
+BMGC_DG00579,BMG_DG005305,"CAS RN:862832-38-0 | PubChem CID:10430360 | CAS RN:395104-30-0 | CC-401 | Cc-401 | UNII:NOE38VQA1W | DrugBank ID:DB12432 | PubChem SID:198962317 | 3-[3-(2-piperidin-1-ylethoxy)phenyl]-5-(1H-1,2,4-triazol-5-yl)-1H-indazole"
+BMGC_DG00580,BMG_DG005306,"PubChem SID:346538790 | PubChem CID:10430623 | 3-naphthalen-1-ylsulfonyl-5-piperazin-1-yl-2H-indazole | CAS RN:744218-85-7 | 1H-Indazole, 3-(1-naphthalenylsulfonyl)-5-(1-piperazinyl)- | UNII:AF9MF92XFM | WAY-255315"
+BMGC_DG00581,BMG_DG005308,DAA-1106 | UNII:3A8IVT5Q3P | CAS RN:220551-92-8 | PubChem SID:402404430 | PubChem CID:10430788
+BMGC_DG00582,BMG_DG005310,PubChem CID:10430935 | N-[2-[bis(4-fluorophenyl)methylsulfanyl]ethyl]-3-phenylpropan-1-amine | N-(2-((bis(4-fluorophenyl)methyl)thio)ethyl)-3-phenylpropan-1-amine | CAS RN:140890-64-8
+BMGC_DG00583,BMG_DG005322,PubChem SID:440088335 | CAS RN:409064-57-9 | PubChem CID:10432257 | PANEPOPHENANTHRIN | UNII:791VPS8I0J
+BMGC_DG00584,BMG_DG005325,Piragliatin | CAS RN:625114-41-2 | UNII:BM1HR7IP1L | PIRAGLIATIN | (2R)-2-(3-chloro-4-methylsulfonylphenyl)-3-[(1R)-3-oxocyclopentyl]-N-pyrazin-2-ylpropanamide | PubChem SID:198955902 | PubChem CID:10432339
+BMGC_DG00585,BMG_DG005326,"PubChem SID:459276036 | 5-Fluorouridine diphosphate | 5-FLUOROURIDINE DIPHOSPHATE | CAS RN:803-98-5 | [(2R,3S,4R,5R)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate | UNII:M4MRY7EA2Y | PubChem CID:10432343"
+BMGC_DG00586,BMG_DG005331,"PubChem CID:10432609 | Methanone, (2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl-, (S)- | [(11S)-2-methyl-11-(morpholin-4-ylmethyl)-9-oxa-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraen-3-yl]-naphthalen-1-ylmethanone | CAS RN:131543-24-3"
+BMGC_DG00587,BMG_DG005336,PubChem SID:198942623 | CAS RN:702681-67-2 | CP-868388 | PubChem CID:10433320 | UNII:999KY5ZIGB
+BMGC_DG00588,BMG_DG005340,XL-999 | PubChem CID:10433653 | UNII:6I7PLF6N8L | Tyrosine kinase-IN-1 | CAS RN:705946-27-6 | CAS RN:921206-68-0 | PubChem SID:346540926 | (3Z)-5-[(1-ethylpiperidin-4-yl)amino]-3-[(3-fluorophenyl)-(5-methyl-1H-imidazol-2-yl)methylidene]-1H-indol-2-one
+BMGC_DG00589,BMG_DG005342,"CAS RN:504-02-9 | UNII:6UK3D2BXJT | 1,3-Cyclohexanedione | PubChem SID:198945802 | DIHYDRORESORCINOL | cyclohexane-1,3-dione | PubChem CID:10434"
+BMGC_DG00590,BMG_DG005358,JTT-553 | CAS RN:701232-94-2 | UNII:G3MY6FGE1J | PubChem SID:381132340 | PubChem CID:10435589
+BMGC_DG00591,BMG_DG005359,CAS RN:494844-07-4 | PubChem SID:312524743 | NESS-0327 | UNII:X1BQI2J97I | PubChem CID:10435654
+BMGC_DG00592,BMG_DG005361,"CAS RN:952516-02-8 | 5-methylbenzene-1,3-diol | PubChem SID:198943595 | UNII:534PMB3438 | CAS RN:504-15-4 | PubChem CID:10436 | ORCINOL | Orcinol"
+BMGC_DG00593,BMG_DG005368,"PubChem SID:198946482 | DrugBank ID:DB12318 | [(3S)-morpholin-3-yl]methyl N-[4-[[1-[(3-fluorophenyl)methyl]indazol-5-yl]amino]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]carbamate | BMS-599626 | PubChem CID:10437018 | CAS RN:714971-09-2 | UNII:2252724U5N | Bms-599626"
+BMGC_DG00594,BMG_DG005373,PubChem CID:10437614 | L-749372 | CAS RN:159183-70-7 | PubChem SID:198968699 | UNII:163N8LK4P3
+BMGC_DG00595,BMG_DG005382,CAS RN:26445-05-6 | pyridin-2-amine | 2-Aminopyridine | UNII:WSX981HEWU | PubChem SID:198964097 | CAS RN:24843-39-8 | CAS RN:504-29-0 | PubChem CID:10439 | 2-AMINOPYRIDINE
+BMGC_DG00596,BMG_DG005383,PubChem CID:10439034 | UNII:749Y52DBP2 | CAS RN:149859-17-6 | PubChem SID:198979049 | MDL-101146
+BMGC_DG00597,BMG_DG005396,Ethyl Oxo(Piperidin-1-Yl)Acetate | PubChem CID:104406 | DrugBank ID:DB02419 | CAS RN:53074-96-7 | UNII:D7IIF4X1TU | ETHYL OXO(PIPERIDIN-1-YL)ACETATE | PubChem SID:438788173
+BMGC_DG00598,BMG_DG005407,"PubChem CID:10442 | NDC:84507-021 | PROPANEDIOL | 1,3-Propanediol | UNII:5965N8W85T | CAS RN:345260-48-2 | propane-1,3-diol | CAS RN:504-63-2 | PubChem SID:175265679 | CAS RN:31714-45-1 | DrugBank ID:DB02774 | NDC:84507-007"
+BMGC_DG00599,BMG_DG005411,"CAS RN:43111-36-0 | PubChem CID:10442227 | 2-(Phenoxymethyl)-4,5-dihydro-1H-imidazole | UNII:UW48FCK8YJ | 2-(PHENOXYMETHYL)-4,5-DIHYDRO-1H-IMIDAZOLE | PubChem SID:478838442"
+BMGC_DG00600,BMG_DG005412,"(S)-Isosclerone | CAS RN:62332-73-4 | PubChem CID:10442251 | 4,8-dihydroxy-3,4-dihydro-2H-naphthalen-1-one | UNII:AU5N5H7K3C | ISOSCLERONE, (±)- | ISOSCLERONE, (+/-)- | PubChem SID:459276149"
+BMGC_DG00601,BMG_DG005429,"Thiazolidines | CAS RN:504-78-9 | UNII:I320806BKW | THIAZOLIDINE | 1,3-thiazolidine | PubChem SID:198954669 | PubChem CID:10444"
+BMGC_DG00602,BMG_DG005437,PubChem SID:198968380 | PubChem CID:104452 | UNII:56DW142LLX | CAS RN:53242-88-9 | 4-(4-CHLOROBENZYL)PHTHALAZIN-1(2H)-ONE
+BMGC_DG00603,BMG_DG005443,"(3,5-diethoxypyridin-4-yl)methanamine | PubChem CID:10445774 | 4-Pyridinemethanamine, 3,5-diethoxy-"
+BMGC_DG00604,BMG_DG005446,PubChem SID:317229265 | ISOELEUTHERIN | PubChem CID:10445924 | UNII:VAL9X3HM57 | CAS RN:478-37-5
+BMGC_DG00605,BMG_DG005451,CAS RN:73903-17-0 | JNJ-10191584 | PubChem CID:10446295 | PubChem SID:198986994 | UNII:7EE5T3WL8P
+BMGC_DG00606,BMG_DG005452,UNII:PP549Z0645 | PubChem CID:10446567 | PubChem SID:198938632 | CAS RN:627490-01-1 | DASB
+BMGC_DG00607,BMG_DG005468,"(6-hydroxy-1H-indol-3-yl)-(3,4,5-trimethoxyphenyl)methanone | PubChem CID:10449104"
+BMGC_DG00608,BMG_DG005474,"PubChem SID:198969853 | butane-1,4-diamine | DrugBank ID:DB01917 | Putrescine | PUTRESCINE | PubChem CID:1045 | UNII:V10TVZ52E4 | CAS RN:110-60-1"
+BMGC_DG00609,BMG_DG005478,"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE | PubChem CID:10450114 | DrugBank ID:DB07154"
+BMGC_DG00610,BMG_DG005482,"DrugBank ID:DB15288 | Etamicastat | ETAMICASTAT | CAS RN:760173-05-5 | PubChem SID:198963176 | PubChem CID:10450387 | 4-(2-aminoethyl)-3-[(3R)-6,8-difluoro-3,4-dihydro-2H-chromen-3-yl]-1H-imidazole-2-thione | UNII:9X96V6DBU4"
+BMGC_DG00611,BMG_DG005483,"PubChem CID:10450624 | {3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID | DrugBank ID:DB07093"
+BMGC_DG00612,BMG_DG005485,"CAS RN:102448-00-0 | alpha,beta-Dihydroxanthohumol | PubChem CID:10450920 | 1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)propan-1-one"
+BMGC_DG00613,BMG_DG005492,LL-Z1272.EPISILON. | UNII:AQD59552Y1 | PubChem SID:319892556 | PubChem CID:10451939 | CAS RN:22562-68-1
+BMGC_DG00614,BMG_DG005493,"PubChem CID:10451940 | 4-[2-(1,3-benzothiazol-2-yl)vinyl]-N,N-diethylbenzenesulfonamide | 4-[(E)-2-(1,3-benzothiazol-2-yl)ethenyl]-N,N-diethylbenzenesulfonamide"
+BMGC_DG00615,BMG_DG005513,"PubChem SID:198989894 | DrugBank ID:DB11698 | CAS RN:761423-87-4 | IPRAGLIFLOZIN | UNII:3N2N8OOR7X | Ipragliflozin | PubChem CID:10453870 | (2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol"
+BMGC_DG00616,BMG_DG005516,PubChem CID:10454092 | GW-833972A FREE BASE | UNII:TV127I2X7M | CAS RN:667905-37-5 | PubChem SID:198943017
+BMGC_DG00617,BMG_DG005531,PubChem SID:472424076 | CAS RN:167498-29-5 | UNII:U433S6RM7M | PubChem CID:10456222 | N-(BENZYLOXYCARBONYL)-L-PHENYLALANYL-L-TYROSINAL
+BMGC_DG00618,BMG_DG005537,"5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide | DrugBank ID:DB06961 | PubChem CID:10456828"
+BMGC_DG00619,BMG_DG005543,6-[2-fluoro-4-[[2-(oxan-4-yl)ethylamino]methyl]phenoxy]pyridine-3-carboxamide | PubChem SID:198987355 | CAS RN:676501-25-0 | UNII:4VZT670SD9 | DrugBank ID:DB12585 | Ondelopran | PubChem CID:10457387 | ONDELOPRAN
+BMGC_DG00620,BMG_DG005547,"DrugBank ID:DB07530 | (1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol | PubChem CID:10457944"
+BMGC_DG00621,BMG_DG005552,"Tesevatinib | PubChem CID:10458325 | CAS RN:1000599-06-3 | CAS RN:781613-23-8 | 7-[[(3aR,6aS)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine | UNII:F6XM2TN5A1 | TESEVATINIB | DrugBank ID:DB11973 | PubChem SID:198983317"
+BMGC_DG00622,BMG_DG005555,"1-(3-tert-butyl-4-methoxy-5-morpholin-4-ylphenyl)-2-(5,6-diethoxy-4-fluoro-3-imino-1H-isoindol-2-yl)ethanone | DrugBank ID:DB12046 | PubChem CID:10459564 | Atopaxar | UNII:HTI275SD2D | CAS RN:751475-53-3 | PubChem SID:198956310 | ATOPAXAR"
+BMGC_DG00623,BMG_DG005560,CAS RN:98-96-4 | NDC:33342-447 | NDC:0054-0812 | NDC:10135-735 | PubChem SID:175267402 | DrugBank ID:DB00339 | PubChem CID:1046 | NDC:60687-789 | NDC:70954-484 | PYRAZINAMIDE | NDC:61748-012 | pyrazine-2-carboxamide | Pyrazinamide | UNII:2KNI5N06TI
+BMGC_DG00624,BMG_DG005563,PubChem CID:10460379 | CAS RN:660847-06-3 | (2S)-6-acetamido-2-[[2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]acetyl]amino]-N-(4-methyl-2-oxochromen-7-yl)hexanamide | (S)-6-acetamido-2-(2-((S)-2-acetamido-4-methylpentanamido)acetamido)-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide
+BMGC_DG00625,BMG_DG005576,SCOLYMOSIDE | PubChem SID:472408048 | CAS RN:20633-84-5 | PubChem CID:10461109 | UNII:LDM9NL7QUS
+BMGC_DG00626,BMG_DG005581,Volasertib | VOLASERTIB | CAS RN:755038-65-4 | CAS RN:755038-54-1 | N-[4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl]-4-[[(7R)-7-ethyl-5-methyl-6-oxo-8-propan-2-yl-7H-pteridin-2-yl]amino]-3-methoxybenzamide | UNII:6EM57086EA | DrugBank ID:DB12062 | PubChem CID:10461508 | PubChem SID:198980559
+BMGC_DG00627,BMG_DG005583,PubChem SID:198988542 | UNII:0VXU5T5R3J | CAS RN:477575-56-7 | PubChem CID:10461815 | PHA-665752
+BMGC_DG00628,BMG_DG005589,gamma-carboxy-L-glutamic acid | PubChem SID:198974326 | UNII:16FQV4RZKL | CAS RN:53861-57-7 | .GAMMA.-CARBOXYGLUTAMIC ACID | PubChem CID:104625 | DrugBank ID:DB03847
+BMGC_DG00629,BMG_DG005610,butanedioate;iron(2+) | CAS RN:10030-90-7 | UNII:818ZYK7N91 | Ferrous succinate | PubChem CID:10464762 | PubChem SID:198984150 | FERROUS SUCCINATE | DrugBank ID:DB14489
+BMGC_DG00630,BMG_DG005613,PubChem SID:198955997 | PubChem CID:10465 | heptadecanoic acid | MARGARIC ACID | UNII:V987Y9OZ8L | CAS RN:506-12-7 | CAS RN:63399-94-0 | Heptadecanoic acid
+BMGC_DG00631,BMG_DG005634,batatasin III | UNII:89H85UDY3J | CAS RN:56684-87-8 | 3-[2-(3-hydroxyphenyl)ethyl]-5-methoxyphenol | PubChem CID:10466989 | BATATASIN III
+BMGC_DG00632,BMG_DG005635,Arachidic Acid | UNII:PQB8MJD4RB | CAS RN:506-30-9 | PubChem CID:10467 | icosanoic acid | ARACHIDIC ACID | PubChem SID:198960941
+BMGC_DG00633,BMG_DG005641,BW-19 | CAS RN:221651-26-9 | PubChem CID:10467502 | UNII:Y7Y41ZW429 | PubChem SID:198955004
+BMGC_DG00634,BMG_DG005649,PubChem SID:198948274 | CAS RN:75755-10-1 | DEOXY RISEDRONIC ACID | UNII:KU59Z0XVL4 | PubChem CID:10468166
+BMGC_DG00635,BMG_DG005665,"PubChem CID:10469827 | 3-(4-hydroxyphenyl)-7-propan-2-yloxychromen-4-one | CAS RN:97846-18-9 | 4H-1-Benzopyran-4-one, 3-(4-hydroxyphenyl)-7-(1-methylethoxy)-"
+BMGC_DG00636,BMG_DG005667,UNII:2WB23298SP | CAS RN:98-97-5 | pyrazine-2-carboxylic acid | PubChem CID:1047 | PubChem SID:198956488 | Pyrazinoic Acid | PYRAZINOIC ACID
+BMGC_DG00637,BMG_DG005670,UNII:MW88KT29DZ | PubChem CID:10470802 | PubChem SID:443623558 | PNU-142796 | CAS RN:205037-64-5
+BMGC_DG00638,BMG_DG005678,PubChem SID:198951631 | CAS RN:749269-77-0 | CHF-5022 | UNII:JO8EVV007Q | PubChem CID:10471478
+BMGC_DG00639,BMG_DG005682,UNII:BBX3BP2772 | PubChem CID:10471670 | (1-butylindol-3-yl)-naphthalen-1-ylmethanone | CAS RN:208987-48-8 | 1-Butyl-3-(1-naphthoyl)indole | PubChem SID:252319730 | JWH-073
+BMGC_DG00640,BMG_DG005695,"BEMPEDOIC ACID | PubChem SID:198942788 | Bempedoic acid | DrugBank ID:DB11936 | CAS RN:738606-46-7 | PubChem CID:10472693 | 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid | NDC:72426-118 | UNII:1EJ6Z6Q368 | Bempedoic Acid | NDC:72426-818"
+BMGC_DG00641,BMG_DG005696,PubChem SID:175267619 | Aluminum Cation | CAS RN:22537-23-1 | PubChem CID:104727 | aluminum(3+) | ALUMINUM CATION | DrugBank ID:DB14519 | UNII:3XHB1D032B
+BMGC_DG00642,BMG_DG005704,"Resolvin E1 | UNII:GND3JH08JA | RESOLVIN E1 | CAS RN:1309610-43-2 | PubChem CID:10473088 | CAS RN:552830-51-0 | DrugBank ID:DB13105 | (5S,6Z,8E,10E,12R,14Z,16E,18R)-5,12,18-trihydroxyicosa-6,8,10,14,16-pentaenoic acid | PubChem SID:313182477"
+BMGC_DG00643,BMG_DG005707,GSK-207040 | UNII:3SW22QPG5V | PubChem SID:443624641 | CAS RN:720690-77-7 | PubChem CID:10473209
+BMGC_DG00644,BMG_DG005708,UNII:S6HE0BU457 | PubChem CID:10473280 | 1-(DIPHENYLMETHYL)-3-ISOQUINOLIN-5-YL-UREA | CAS RN:581810-91-5 | PubChem SID:443625076
+BMGC_DG00645,BMG_DG005719,"NDC:55150-394 | NDC:16729-436 | NDC:68001-484 | NDC:63323-715 | NDC:0143-9022 | DrugBank ID:DB00947 | PubChem SID:251965828 | NDC:25021-471 | UNII:22X328QOC4 | NDC:0310-0720 | NDC:71288-555 | Fulvestrant | NDC:43598-262 | NDC:70771-1626 | NDC:83634-203 | PubChem CID:104741 | CAS RN:1807900-80-6 | CAS RN:1316849-17-8 | NDC:70860-211 | CAS RN:129453-61-8 | NDC:16714-070 | NDC:70710-1688 | NDC:68001-626 | FULVESTRANT | NDC:62332-650 | (7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol | NDC:70121-1463 | NDC:0781-9055 | NDC:0781-3532 | NDC:71731-6121 | NDC:68001-522 | NDC:70700-284"
+BMGC_DG00646,BMG_DG005722,PubChem SID:472424796 | CAS RN:172906-90-0 | PB-28 | PubChem CID:10474335 | UNII:XTX7Z22467
+BMGC_DG00647,BMG_DG005725,PubChem CID:104745 | UNII:AKW5EM890C | PubChem SID:375085992 | Propionate ion | PROPIONATE ION | propanoate | CAS RN:72-03-7
+BMGC_DG00648,BMG_DG005728,"DrugBank ID:DB09327 | Tegafur-uracil | Tegafur-Uracil | CAS RN:74578-38-4 | PubChem CID:104747 | 5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione;1H-pyrimidine-2,4-dione"
+BMGC_DG00649,BMG_DG005729,PubChem CID:104748 | UNII:OJ9787WBLU | Hydrogen sulfite | CAS RN:15181-46-1 | BISULFITE ION | PubChem SID:198987770 | hydrogen sulfite
+BMGC_DG00650,BMG_DG005730,"CID 10474948 | PubChem CID:10474948 | 10-[(3S)-3-aminopyrrolidin-1-yl]-11-fluoro-14-oxo-8-oxa-1-azatetracyclo[7.7.1.02,7.013,17]heptadeca-2,4,6,9(17),10,12,15-heptaene-15-carboxylic acid"
+BMGC_DG00651,BMG_DG005736,"CAS RN:42583-46-0 | 2,3-Epoxyaflatoxin B1 | PubChem CID:104756 | (3R,4R,6S,8S)-12-methoxy-5,7,9,20-tetraoxahexacyclo[11.7.0.02,10.03,8.04,6.014,18]icosa-1,10,12,14(18)-tetraene-17,19-dione"
+BMGC_DG00652,BMG_DG005737,ARTEROLANE | PubChem SID:198979011 | PubChem CID:10475633 | Arterolane | CAS RN:664338-39-0 | UNII:3N1TN351VB
+BMGC_DG00653,BMG_DG005738,"(3S,7R,14S)-14-hydroxy-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione | Aflatoxin Q1 | PubChem CID:104757 | CAS RN:52819-96-2"
+BMGC_DG00654,BMG_DG005739,Raltitrexed | PubChem CID:104758 | DrugBank ID:DB00293
+BMGC_DG00655,BMG_DG005745,VID-400 | UNII:A53Q3K00XS | CAS RN:174262-10-3 | PubChem SID:198956167 | PubChem CID:10476195
+BMGC_DG00656,BMG_DG005746,"MIZORIBINE | CAS RN:50524-49-7 | PubChem CID:104762 | DrugBank ID:DB12617 | CAS RN:50924-49-7 | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxyimidazole-4-carboxamide | PubChem SID:198987472 | Mizoribine | UNII:4JR41A10VP"
+BMGC_DG00657,BMG_DG005754,"CAS RN:111900-32-4 | CAS RN:27-84-9 | CAS RN:67684-64-4 | (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid | PubChem CID:104766 | CAS RN:39026-63-6"
+BMGC_DG00658,BMG_DG005759,chlorate | Chlorate ion | PubChem SID:175265751 | UNII:08Z8093742 | CAS RN:14866-68-3 | CHLORATE ION | PubChem CID:104770
+BMGC_DG00659,BMG_DG005762,"CAS RN:98007-99-9 | N-n-Butyl-N-methyl-11-(3,17beta-dihydroxyestra-1,3,5(10)-trien-7alpha-yl)undecanamide | ICI-164384 | DrugBank ID:DB03860 | PubChem CID:104772 | N-butyl-11-[(7R,8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-7-yl]-N-methylundecanamide | PubChem SID:198960504 | UNII:84LT43726C"
+BMGC_DG00660,BMG_DG005765,Butanoate | PubChem CID:104775 | butanoate | CAS RN:461-55-2
+BMGC_DG00661,BMG_DG005768,"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE | PubChem CID:10477723 | DrugBank ID:DB07831"
+BMGC_DG00662,BMG_DG005770,"UNII:7VYX4ELWQM | Perfluorohexyloctane | PubChem CID:10477896 | CAS RN:133331-77-8 | PubChem SID:346538391 | 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane | PERFLUOROHEXYLOCTANE"
+BMGC_DG00663,BMG_DG005779,"PubChem CID:104787 | Enkephalin, D-Penicillamine (2,5)- | DPDPE | (4S,7S,13S)-13-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-7-benzyl-3,3,14,14-tetramethyl-6,9,12-trioxo-1,2-dithia-5,8,11-triazacyclotetradecane-4-carboxylic acid | UNII:HB4QD9GL6F | PubChem SID:374388154 | CAS RN:88373-73-3 | DrugBank ID:DB08861"
+BMGC_DG00664,BMG_DG005784,BAY-59-3074 | PubChem CID:10479060 | UNII:5FO5Z101GU | CAS RN:406205-74-1 | PubChem SID:198976497
+BMGC_DG00665,BMG_DG005786,"PubChem CID:104794 | 1-[6-[[(8R,9S,13S,14S,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]amino]hexyl]pyrrole-2,5-dione | CAS RN:112648-68-7 | 1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione"
+BMGC_DG00666,BMG_DG005789,ELUBRIXIN | UNII:MW2AIJ8USP | PubChem SID:198944793 | DrugBank ID:DB12135 | Elubrixin | CAS RN:688763-64-6 | 1-(2-chloro-3-fluorophenyl)-3-(4-chloro-2-hydroxy-3-piperazin-1-ylsulfonylphenyl)urea | PubChem CID:10479502
+BMGC_DG00667,BMG_DG005791,CAS RN:22537-39-9 | Strontium cation | STRONTIUM CATION | PubChem CID:104798 | UNII:37077S2C93 | PubChem SID:175268081 | strontium(2+)
+BMGC_DG00668,BMG_DG005792,"CAS RN:191220-84-5 | PubChem SID:198991218 | FOTEMUSTINE, (-)- | UNII:GQ7JL9P5I2 | Fotemustine | FOTEMUSTINE | CAS RN:92118-27-9 | PubChem CID:104799 | FOTEMUSTINE, (+)- | 1-(2-chloroethyl)-3-(1-diethoxyphosphorylethyl)-1-nitrosourea | UNII:UPB2NN83AR | PubChem SID:440793728 | UNII:QY93P3GN94 | PubChem SID:440794142 | CAS RN:191219-77-9"
+BMGC_DG00669,BMG_DG005794,Pyrazole | 1H-pyrazole | PubChem CID:1048 | UNII:3QD5KJZ7ZJ | DrugBank ID:DB02757 | PYRAZOLE | PubChem SID:198970679 | CAS RN:105809-46-9 | CAS RN:288-13-1
+BMGC_DG00670,BMG_DG005799,CAS RN:99896-85-2 | CAS RN:119865-10-0 | PubChem CID:104802 | CAS RN:124123-27-9 | (2S)-2-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]butanedioic acid | PubChem SID:198936357 | UNII:78VO7F77PN | ARGINYL-GLYCYL-ASPARTIC ACID | Arginyl-glycyl-aspartic acid
+BMGC_DG00671,BMG_DG005800,AUY922 | DrugBank ID:DB11881 | PubChem CID:10480258
+BMGC_DG00672,BMG_DG005803,PubChem CID:104805 | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | CAS RN:7789-77-7 | UNII:O7TSZ97GEP | PubChem SID:175266707 | calcium;hydrogen phosphate;dihydrate | CAS RN:14567-92-1 | Dibasic Calcium Phosphate Dihydrate | DrugBank ID:DB14481
+BMGC_DG00673,BMG_DG005804,Peroxynitrite ion | oxido nitrite | PEROXYNITRITE ION | PubChem SID:474489540 | Oxido nitrite | PubChem CID:104806 | CAS RN:19059-14-4 | UNII:UR67NH4U77
+BMGC_DG00674,BMG_DG005807,7-PHLOROECKOL | UNII:97GCC12YF0 | PubChem CID:10480940 | CAS RN:662165-35-7 | PubChem SID:381608524
+BMGC_DG00675,BMG_DG005809,CAS RN:22541-12-4 | PubChem CID:104810 | Barium Cation | barium(2+) | BARIUM CATION | PubChem SID:175265523 | UNII:V645272HLN
+BMGC_DG00676,BMG_DG005813,CAS RN:17493-86-6 | copper(1+) | CAS RN:139076-62-3 | PubChem CID:104815 | Cuprous ion
+BMGC_DG00677,BMG_DG005819,"DrugBank ID:DB08909 | GLYCEROL PHENYLBUTYRATE | Glycerol phenylbutyrate | PubChem SID:175267661 | PubChem CID:10482134 | 2,3-bis(4-phenylbutanoyloxy)propyl 4-phenylbutanoate | UNII:ZH6F1VCV7B | NDC:75987-050 | CAS RN:611168-24-2 | Glycerol Phenylbutyrate"
+BMGC_DG00678,BMG_DG005825,Resiniferatoxin | DrugBank ID:DB06515 | PubChem CID:104826
+BMGC_DG00679,BMG_DG005830,PubChem CID:10483360 | AMG-009 | UNII:83262TRK3S | PubChem SID:198974799 | CAS RN:1027847-67-1
+BMGC_DG00680,BMG_DG005834,"PubChem CID:104838 | IMIPENEM ANHYDROUS | DrugBank ID:DB01598 | (5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid | Imipenem | UNII:Q20IM7HE75 | PubChem SID:175266490 | CAS RN:64221-86-9"
+BMGC_DG00681,BMG_DG005839,"CAS RN:86639-52-3 | 7-ETHYL-10-HYDROXYCAMPTOTHECIN | PubChem CID:104842 | 7-Ethyl-10-hydroxycamptothecin | PubChem SID:198938117 | UNII:0H43101T0J | CAS RN:113015-38-6 | CAS RN:110714-48-2 | (19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione | SN-38 | DrugBank ID:DB05482"
+BMGC_DG00682,BMG_DG005842,"ALFAXALONE | PubChem SID:198934736 | CAS RN:23930-19-0 | Alfaxalone | DrugBank ID:DB11371 | (3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one | UNII:BD07M97B2A | PubChem CID:104845"
+BMGC_DG00683,BMG_DG005848,"UNII:HL0V2LQZ09 | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide;hydrochloride | PubChem CID:104849 | RIMONABANT HYDROCHLORIDE | PubChem SID:198975683 | CAS RN:158681-13-1 | Rimonabant Hydrochloride"
+BMGC_DG00684,BMG_DG005850,"CAS RN:168273-06-1 | UNII:RML78EN3XE | DrugBank ID:DB06155 | PubChem SID:175268647 | RIMONABANT | PubChem CID:104850 | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide | Rimonabant"
+BMGC_DG00685,BMG_DG005855,CAS RN:76014-81-8 | 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol | PubChem CID:104856 | 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL | PubChem SID:316915611 | UNII:EN7PIX794W | N-(4-hydroxy-4-pyridin-3-ylbutyl)-N-methylnitrous amide
+BMGC_DG00686,BMG_DG005860,4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide | NDC:65162-874 | CAS RN:1174918-31-0 | PubChem SID:175267004 | BOSENTAN ANHYDROUS | PubChem CID:104865 | Bosentan | DrugBank ID:DB00559 | UNII:XUL93R30K2 | CAS RN:174227-18-0 | CAS RN:147536-97-8 | NDC:65162-873
+BMGC_DG00687,BMG_DG005866,"PubChem SID:198989831 | UNII:217A6T1V8N | Androsta-1,4,6-triene-3,17-dione | CAS RN:633-35-2 | (8R,9S,10R,13S,14S)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthrene-3,17-dione | ANDROSTA-1,4,6-TRIENE-3,17-DIONE | PubChem CID:104880"
+BMGC_DG00688,BMG_DG005878,"CP-55940 | 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol | CP-55940, (+/-)- | UNII:8YX8JK1BQG | CAS RN:83003-12-7 | CP-55940, (±)- | CAS RN:83002-04-4 | PubChem SID:374388670 | 2-[(1r,2r,5r)-5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol | PubChem CID:104895 | UNII:KFY70972J5 | PubChem SID:252823772"
+BMGC_DG00689,BMG_DG005880,PubChem SID:175267821 | lanthanum(3+) | DrugBank ID:DB14579 | UNII:O7FU5X12W5 | Lanthanum cation (3+) | PubChem CID:104897 | LANTHANUM CATION (3+) | CAS RN:16096-89-2
+BMGC_DG00690,BMG_DG005882,PubChem SID:198984141 | CAS RN:29761-81-7 | Pyridine | UNII:NH9L3PP67S | PYRIDINE | CAS RN:110-86-1 | PubChem CID:1049 | pyridine
+BMGC_DG00691,BMG_DG005885,"(8S,10S,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one | UNII:YD064E883I | DrugBank ID:DB13050 | CAS RN:110101-66-1 | PubChem CID:104903 | Tirilazad | TIRILAZAD | PubChem SID:198950356"
+BMGC_DG00692,BMG_DG005886,"Ecgonine methyl ester | DrugBank ID:DB04688 | methyl (1R,2R,3S,5S)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | Methylecgonine | CAS RN:7143-09-1 | UNII:Y35FJB3QBJ | PubChem CID:104904 | ECGONINE METHYL ESTER | PubChem SID:198949479"
+BMGC_DG00693,BMG_DG005892,"PubChem CID:104916 | CGS-8216 | UNII:YXH2C8E92N | 2-phenyl-1H-pyrazolo[4,3-c]quinolin-3-one | CAS RN:77779-60-3 | 2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one | PubChem SID:474489588"
+BMGC_DG00694,BMG_DG005897,"Cyfluthrin | PubChem CID:104926 | CAS RN:68359-37-5 | DrugBank ID:DB13828 | [cyano-(4-fluoro-3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate | UNII:SCM2QLZ6S0 | PubChem SID:198937505 | CYFLUTHRIN"
+BMGC_DG00695,BMG_DG005906,"PubChem CID:10494 | PubChem SID:175267875 | OLEANOLIC ACID | UNII:6SMK8R7TGJ | (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid | Oleanolic Acid | CAS RN:508-02-1"
+BMGC_DG00696,BMG_DG005908,"1,2,3-tribromo-5-(3,4,5-tribromophenyl)benzene | PubChem SID:241177950 | UNII:O0S2JKE526 | 3,3',4,4',5,5'-HEXABROMOBIPHENYL | CAS RN:60044-26-0 | 3,3',4,4',5,5'-Hexabromobiphenyl | PubChem CID:104942"
+BMGC_DG00697,BMG_DG005909,"CAS RN:132746-60-2 | CP-96345 | CAS RN:129912-34-1 | 2-(Diphenylmethyl)-N-((2-methoxyphenyl)methyl)-1-azabicyclo(2.2.2)octan-3-amine | PubChem CID:104943 | UNII:W22ILA2I52 | (2S,3S)-2-benzhydryl-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine | PubChem SID:198953175"
+BMGC_DG00698,BMG_DG005915,"UNII:JC2M95KK23 | N-(1-methyl-6-phenylimidazo[4,5-b]pyridin-2-yl)hydroxylamine | PubChem SID:475549739 | PubChem CID:104954 | N-hydroxy-PhIP | CAS RN:124489-20-9 | 2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | N-HYDROXY-PHIP"
+BMGC_DG00699,BMG_DG005918,SKF-96365 FREE BASE | PubChem SID:316914603 | PubChem CID:104956 | 1-[2-(4-methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl]imidazole | SKF-96365 free base | UNII:I61V87164A | CAS RN:162849-90-3
+BMGC_DG00700,BMG_DG005926,"2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethylamino]-2-propan-2-ylpentanenitrile | Norverapamil | NORVERAPAMIL | PubChem SID:198971436 | UNII:957Z3K3R56 | PubChem CID:104972 | CAS RN:67018-85-3"
+BMGC_DG00701,BMG_DG005928,"PubChem CID:104974 | SAREDUTANT | N-[(2S)-4-(4-acetamido-4-phenylpiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl]-N-methylbenzamide | CAS RN:142001-63-6 | PubChem SID:198987047 | DrugBank ID:DB06660 | UNII:720U2QK8I5 | Saredutant"
+BMGC_DG00702,BMG_DG005934,"PROPIDIUM IODIDE | CAS RN:25535-16-4 | UNII:TP416O228T | PubChem CID:104981 | PubChem SID:198971238 | Propidium Iodide | 3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium;diiodide"
+BMGC_DG00703,BMG_DG005945,"UNII:SIN7411HG7 | 1H-imidazo[2,1-f]purine | CAS RN:13875-63-3 | DrugBank ID:DB01952 | 1,N6-Ethenoadenine | PubChem SID:443625142 | PubChem CID:104994 | N6-ETHENOADENINE"
+BMGC_DG00704,BMG_DG005948,"PubChem CID:104999 | METHYL 6,7-DIMETHOXY-4-ETHYL-.BETA.-CARBOLINE-3-CARBOXYLATE | CAS RN:82499-00-1 | methyl 4-ethyl-6,7-dimethoxy-9H-pyrido[3,4-b]indole-3-carboxylate | PubChem SID:198980730 | UNII:1309288N1J | Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate"
+BMGC_DG00705,BMG_DG005949,Phosphohydroxypyruvic acid | CAS RN:114887-36-4 | 2-oxo-3-phosphonooxypropanoic acid | PubChem CID:105 | PHOSPHOHYDROXYPYRUVIC ACID | CAS RN:3913-50-6 | PubChem SID:445498781 | UNII:ZX4PWG857L
+BMGC_DG00706,BMG_DG005950,PubChem SID:198978054 | CAS RN:66-72-8 | 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde | UNII:3THM379K8A | PubChem CID:1050 | DrugBank ID:DB00147 | PYRIDOXAL | Pyridoxal
+BMGC_DG00707,BMG_DG005951,"PubChem SID:198938075 | PubChem CID:105000 | CAS RN:90365-57-4 | INDOLACTAM V | (10S,13S)-13-(hydroxymethyl)-9-methyl-10-propan-2-yl-3,9,12-triazatricyclo[6.6.1.04,15]pentadeca-1,4(15),5,7-tetraen-11-one | Indolactam V | CAS RN:132341-58-3 | UNII:8CIY9O1323"
+BMGC_DG00708,BMG_DG005955,UNII:8Q3M8GL2XV | FPL-55712 FREE BASE | 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-4-oxo-8-propylchromene-2-carboxylic acid | PubChem SID:363908023 | FPL-55712 free base | PubChem CID:105007 | CAS RN:40785-97-5
+BMGC_DG00709,BMG_DG005956,"CAS RN:57186-25-1 | CAS RN:1233509-81-3 | (1S,2R,5S,7R,11S,14S)-11-hydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.02,11.05,10.016,24.017,22]tetracosa-9,16(24),17,19,21-pentaen-8-one | PubChem CID:105008 | PubChem SID:198950074 | PAXILLINE | Paxilline | UNII:3T9U9Z96L7"
+BMGC_DG00710,BMG_DG005957,CAS RN:135467-92-4 | PubChem CID:105009 | (2S)-pyrrolidine-2-carbodithioic acid
+BMGC_DG00711,BMG_DG005966,UNII:964MRK2PEL | DrugBank ID:DB11142 | CAS RN:3211-76-5 | Selenomethionine | L-selenomethionine | PubChem CID:105024 | PubChem SID:175267624 | (2S)-2-amino-4-methylselanylbutanoic acid | SELENOMETHIONINE
+BMGC_DG00712,BMG_DG005970,UNII:YML51WA0FW | isocyanate | PubChem CID:105034 | CAS RN:661-20-1 | CAS RN:71000-82-3 | CYANATE ION | PubChem SID:198959278 | Isocyanate
+BMGC_DG00713,BMG_DG005974,"MDE | Methylenedioxyethamphetamine | DrugBank ID:DB01566 | 3,4-Methylenedioxy-N-ethylamphetamine | 1-(1,3-benzodioxol-5-yl)-N-ethylpropan-2-amine | CAS RN:82801-81-8 | UNII:ML1I4KK67B | CAS RN:14089-52-2 | PubChem SID:198939297 | PubChem CID:105039"
+BMGC_DG00714,BMG_DG005979,UNII:99U9GL8GBL | PubChem SID:445499335 | CAS RN:118415-57-9 | MK-866 | PubChem CID:105049
+BMGC_DG00715,BMG_DG005983,"UNII:8ZT6KJ947T | CAS RN:357924-75-5 | WIN-35428 | methyl (1R,2S,3S,5S)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | PubChem SID:333495843 | CAS RN:50370-56-4 | PubChem CID:105056"
+BMGC_DG00716,BMG_DG005993,"Pregnenolone sulfate | UNII:04Y4D91RG0 | PREGNENOLONE SULFATE | PubChem SID:198969336 | CAS RN:1247-64-9 | [(3S,8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate | PubChem CID:105074"
+BMGC_DG00717,BMG_DG005995,ETHYL .BETA.-CARBOLINE-3-CARBOXYLATE | PubChem CID:105078 | PubChem SID:198978867 | CAS RN:74214-62-3 | UNII:HYW8K5N21Y
+BMGC_DG00718,BMG_DG006008,PYRIDOXAL PHOSPHATE ANHYDROUS | PubChem SID:175266412 | CAS RN:54-47-7 | CAS RN:853645-22-4 | PubChem CID:1051 | DrugBank ID:DB00114 | UNII:F06SGE49M6 | (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate | Pyridoxal phosphate
+BMGC_DG00719,BMG_DG006014,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide | PubChem CID:105104 | N-methyl-2-phenyl-N-[(5R,7S,8S)-7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl]acetamide | U-69593 | CAS RN:96744-75-1 | PubChem SID:198966748 | UNII:J5S4K6TKTG"
+BMGC_DG00720,BMG_DG006029,BROMOACETALDEHYDE | PubChem SID:472386342 | Bromoacetaldehyde | CAS RN:17157-48-1 | 2-bromoacetaldehyde | UNII:TGB3VXQ7JV | PubChem CID:105131
+BMGC_DG00721,BMG_DG006035,CAS RN:22537-33-3 | PubChem SID:175267070 | GALLIUM CATION | UNII:F7K5MP217W | PubChem CID:105145
+BMGC_DG00722,BMG_DG006044,"Methadyl acetate | UNII:L59OC40KWJ | Methadyl Acetate | CAS RN:509-74-0 | PubChem SID:198970365 | PubChem CID:10517 | DrugBank ID:DB01433 | [6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate | METHADYL ACETATE"
+BMGC_DG00723,BMG_DG006050,"PubChem SID:198938489 | Heptabarbital | DrugBank ID:DB01354 | 5-(cyclohepten-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione | HEPTABARBITAL | UNII:V10R70ML23 | CAS RN:509-86-4 | PubChem CID:10518"
+BMGC_DG00724,BMG_DG006056,PubChem CID:1052 | UNII:6466NM3W93 | PubChem SID:198971612 | DrugBank ID:DB11673 | Pyridoxamine | 4-(aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol | CAS RN:85-87-0 | PYRIDOXAMINE
+BMGC_DG00725,BMG_DG006085,DrugBank ID:DB02142 | PubChem SID:198936102 | Pyridoxamine phosphate | [4-(aminomethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl dihydrogen phosphate | PubChem CID:1053 | CAS RN:529-96-4 | CAS RN:16774-56-4 | UNII:Q05R77UO7P | Pyridoxamine-5'-Phosphate | PYRIDOXAMINE PHOSPHATE ANHYDROUS
+BMGC_DG00726,BMG_DG006087,"DrugBank ID:DB00320 | DIHYDROERGOTAMINE | UNII:436O5HM03C | (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | Dihydroergotamine | CAS RN:511-12-6 | PubChem CID:10531 | PubChem SID:175268884"
+BMGC_DG00727,BMG_DG006113,PubChem CID:10536901 | UNII:F5A5K9V9TP | CAS RN:168897-19-6 | PubChem SID:472422238 | 1-(2-(4-NITROPHENYL)ETHYL)PYRROLIDINE
+BMGC_DG00728,BMG_DG006120,"DrugBank ID:DB00165 | 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol | CAS RN:65-23-6 | CAS RN:12001-77-3 | UNII:KV2JZ1BI6Z | PYRIDOXINE | PubChem CID:1054 | Pyridoxine | PubChem SID:175265773"
+BMGC_DG00729,BMG_DG006132,"(3R,4S,5R,6R)-2-[[(2R,3S,4S,5R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | CAS RN:6227-50-5 | PubChem CID:10542"
+BMGC_DG00730,BMG_DG006137,"GLABROCOUMARONE A | UNII:362X110XMT | Glabrocoumarone A | 8-(6-hydroxy-1-benzofuran-2-yl)-2,2-dimethylchromen-5-ol | PubChem CID:10542808 | PubChem SID:198977679 | CAS RN:178330-48-8"
+BMGC_DG00731,BMG_DG006141,"2,5-DIMETHOXY-4-NITROAMPHETAMINE | 2,5-Dimethoxy-4-nitroamphetamine | PubChem SID:316913791 | UNII:3FIV60666J | PubChem CID:105432 | CAS RN:67460-68-8"
+BMGC_DG00732,BMG_DG006163,UNII:BA9QH3P00T | Echothiophate Iodide | CAS RN:513-10-0 | PubChem SID:175265540 | ECHOTHIOPHATE IODIDE | 2-diethoxyphosphorylsulfanylethyl(trimethyl)azanium;iodide | PubChem CID:10547
+BMGC_DG00733,BMG_DG006166,JWH-081 | CAS RN:210179-46-7 | UNII:77E58024IT | Jwh-081 | PubChem CID:10547208 | (4-methoxynaphthalen-1-yl)-(1-pentylindol-3-yl)methanone | PubChem SID:252319243
+BMGC_DG00734,BMG_DG006169,CAS RN:6736-03-4 | ECHOTHIOPHATE | UNII:0F350BVT6S | PubChem CID:10548 | PubChem SID:175265459 | Echothiophate | 2-diethoxyphosphorylsulfanylethyl(trimethyl)azanium | DrugBank ID:DB01057
+BMGC_DG00735,BMG_DG006179,CAS RN:203395-81-7 | PubChem CID:10549689 | PubChem SID:445499952 | DESCHLORO ARIPIPRAZOLE | UNII:353J3NU2S8
+BMGC_DG00736,BMG_DG006182,DrugBank ID:DB02209 | UNII:RG20W8WYLS | PubChem CID:1055 | PubChem SID:198948385 | PYRIDOXINE PHOSPHATE | Pyridoxine 5'-phosphate | Pyridoxine phosphate | CAS RN:447-05-2 | [5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl dihydrogen phosphate
+BMGC_DG00737,BMG_DG006224,UNII:Q29YLG74LW | PubChem SID:482554595 | PubChem CID:10559162 | CAS RN:184046-85-3 | CALYSTEGINE B4 | Calystegine B4
+BMGC_DG00738,BMG_DG006255,"PubChem CID:10566365 | 4-hydroxy-N-(3-phenyl-1,2,4-thiadiazol-5-yl)cyclohexane-1-carboxamide"
+BMGC_DG00739,BMG_DG006269,"CAS RN:87-66-1 | PYROGALLOL | PubChem SID:198970003 | Pyrogallol | PubChem CID:1057 | CAS RN:30813-84-4 | UNII:01Y4A2QXY0 | benzene-1,2,3-triol"
+BMGC_DG00740,BMG_DG006273,"CAS RN:209807-53-4 | PubChem SID:445500153 | N,N-DIETHYL-4-((3-FLUOROPHENYL)(PIPERIDIN-4-YLIDENE)METHYL)BENZAMIDE | UNII:F4DV6P2L7G | PubChem CID:10570940"
+BMGC_DG00741,BMG_DG006296,ESTRIOL SUCCINATE | CAS RN:514-68-1 | PubChem SID:198938771 | UNII:AS13K2DY03 | PubChem CID:10577
+BMGC_DG00742,BMG_DG006378,UNII:8558G7RUTR | Pyruvic Acid | CAS RN:127-17-3 | 2-oxopropanoic acid | Pyruvic acid | PubChem SID:175266481 | PYRUVIC ACID | PubChem CID:1060 | DrugBank ID:DB00119
+BMGC_DG00743,BMG_DG006390,"CAS RN:17647-60-8 | PubChem CID:10603 | CAS RN:1412-19-7 | CAS RN:1621-46-1 | 7,11b-Dihydroindeno[2,1-c]chromene-3,4,6a,9,10(6H)-pentol | 7,11b-dihydro-6H-indeno[2,1-c]chromene-3,4,6a,9,10-pentol"
+BMGC_DG00744,BMG_DG006409,"PODOFILOX | NDC:0574-0621 | (5R,5aR,8aR,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one | PubChem SID:175266532 | Podofilox | NDC:0023-6118 | NDC:0574-0611 | NDC:63629-8832 | CAS RN:518-28-5 | DrugBank ID:DB01179 | CAS RN:11016-28-7 | PubChem CID:10607 | UNII:L36H50F353"
+BMGC_DG00745,BMG_DG006412,3-(FURAN-3-YL)INDOLE | UNII:7WR23735KY | PubChem SID:459275493 | PubChem CID:10607518 | CAS RN:155440-58-7
+BMGC_DG00746,BMG_DG006424,Phosphate Ion | PHOSPHATE ION | UNII:NK08V8K8HR | DrugBank ID:DB14523 | phosphate | CAS RN:14265-44-2 | PubChem SID:175268694 | PubChem CID:1061
+BMGC_DG00747,BMG_DG006438,"3-(3-piperazin-1-ylpropyl)-5-(1,2,4-triazol-4-yl)-1H-indole | CAS RN:174609-58-6 | 3-(3-Piperazin-1-yl-propyl)-5-[1,2,4]triazol-4-yl-1H-indole | PubChem CID:10614907"
+BMGC_DG00748,BMG_DG006456,MEPIPERPHENIDOL | CAS RN:13004-75-6 | PubChem SID:198957188 | PubChem CID:10620 | UNII:8I07J24F45
+BMGC_DG00749,BMG_DG006460,"PubChem SID:175267900 | DrugBank ID:DB04703 | Hesperidin | UNII:E750O06Y6O | (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one | HESPERIDIN | PubChem CID:10621 | CAS RN:520-26-3"
+BMGC_DG00750,BMG_DG006461,"PNU-109291, (R)- | PubChem SID:459056039 | UNII:VY762J4L4K | CAS RN:187665-61-8 | PubChem CID:10621491"
+BMGC_DG00751,BMG_DG006468,PSILOCYBIN | Psilocybin | [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate | DrugBank ID:DB11664 | CAS RN:520-52-5 | PubChem SID:198988355 | UNII:2RV7212BP0 | PubChem CID:10624
+BMGC_DG00752,BMG_DG006481,"CAS RN:162652-95-1 | DrugBank ID:DB11641 | PubChem SID:198966918 | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-4-[(12S,14S,16R)-16-(1,1-difluoroethyl)-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-12-ethyl-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | UNII:5BF646324K | Vinflunine | PubChem CID:10629256 | VINFLUNINE"
+BMGC_DG00753,BMG_DG006485,"3-ethyl-5,5-dimethyl-1,3-oxazolidine-2,4-dione | Ethadione | PubChem CID:10630 | DrugBank ID:DB13799 | UNII:I0F8O700BB | PubChem SID:198989513 | CAS RN:520-77-4 | ETHADIONE"
+BMGC_DG00754,BMG_DG006492,"(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | UNII:HSU1C9YRES | PubChem CID:10631 | MEDROXYPROGESTERONE | CAS RN:520-85-4 | PubChem SID:175266663 | Medroxyprogesterone"
+BMGC_DG00755,BMG_DG006499,PubChem SID:459275708 | CAS RN:183500-37-0 | PubChem CID:10632289 | UNII:63M9BY29L9 | 4-((5-FORMYL-1H-IMIDAZOL-1-YL)METHYL)BENZONITRILE
+BMGC_DG00756,BMG_DG006503,"PubChem CID:10633 | PubChem SID:198990773 | UNII:S712YZ168E | MESTANOLONE | Mestanolone | (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-one | CAS RN:521-11-9"
+BMGC_DG00757,BMG_DG006507,"ANDROSTENEDIOL | UNII:95PS51EMXY | PubChem SID:198966861 | PubChem CID:10634 | (3S,8R,9S,10R,13S,14S,17S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol | Androstenediol | DrugBank ID:DB01524 | CAS RN:521-17-5"
+BMGC_DG00758,BMG_DG006511,"(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | UNII:08J2K08A3Y | PubChem CID:10635 | PubChem SID:198934802 | Stanolone | ANDROSTANOLONE | DrugBank ID:DB02901 | Androstanolone | CAS RN:521-18-6"
+BMGC_DG00759,BMG_DG006523,"PHYSCIONE | Physcione | UNII:H6PT94IV61 | 1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione | CAS RN:521-61-9 | PubChem CID:10639 | PubChem SID:198961614"
+BMGC_DG00760,BMG_DG006526,"CAS RN:521-73-3 | PubChem SID:375579794 | PubChem CID:10640 | 1,3,4-(2H)ISOQUINOLINETRIONE | UNII:BM68CV5X6Q"
+BMGC_DG00761,BMG_DG006545,PubChem SID:198952110 | UNII:2305SQ56Z2 | CAS RN:84-08-2 | PARATHIAZINE | PubChem CID:10646
+BMGC_DG00762,BMG_DG006597,"NDC:0574-2430 | NDC:0574-2410 | METHYLPHENIDATE, L-THREO- | NDC:68968-5554 | methyl (2S)-2-phenyl-2-[(2S)-piperidin-2-yl]acetate | NDC:68968-5553 | NDC:70165-300 | PubChem CID:10657292 | L-Threo-methylphenidate | NDC:43602-178 | NDC:0574-2415 | NDC:0378-8261 | NDC:70165-200 | NDC:0378-8260 | NDC:43602-177 | NDC:68968-5555 | NDC:0378-8263 | UNII:207ZZ9QZ49 | METHYLPHENIDATE | CAS RN:20748-11-2 | CAS RN:40431-62-7 | NDC:70165-100 | PubChem SID:461432956 | NDC:0574-2420 | NDC:0378-8262 | UNII:IS6UTS8ES9 | PubChem SID:175271967 | NDC:68968-5552"
+BMGC_DG00763,BMG_DG006598,"furo[2,3-h]chromen-2-one | Angelicin | UNII:CZZ080D7BD | PubChem SID:198954101 | PubChem CID:10658 | ANGELICIN | CAS RN:523-50-2"
+BMGC_DG00764,BMG_DG006603,"PubChem CID:1066 | Quinolinic Acid | DrugBank ID:DB01796 | QUINOLINIC ACID | CAS RN:89-00-9 | UNII:F6F0HK1URN | pyridine-2,3-dicarboxylic acid | CAS RN:28605-84-7 | PubChem SID:198959532 | CAS RN:339155-13-4"
+BMGC_DG00765,BMG_DG006604,"PubChem SID:175267021 | NDC:0363-0198 | NDC:11673-198 | UNII:JB937PER5C | NDC:67091-118 | NDC:49035-981 | NDC:10237-942 | NDC:66715-9809 | NDC:63323-366 | NDC:70677-0022 | NDC:0904-6772 | NDC:0363-1980 | NDC:10237-943 | NDC:83324-032 | NDC:11822-0198 | CAS RN:523-87-5 | NDC:0904-2051 | NDC:10237-940 | NDC:70677-1087 | NDC:69842-206 | NDC:66715-6409 | NDC:49873-802 | NDC:63029-910 | 2-benzhydryloxy-N,N-dimethylethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione | NDC:29485-8048 | NDC:63029-902 | NDC:63868-034 | NDC:50844-199 | NDC:36800-930 | NDC:70000-0404 | PubChem CID:10660 | NDC:63941-198 | NDC:10237-941 | NDC:69168-408 | DIMENHYDRINATE | Dimenhydrinate | NDC:10237-944 | DrugBank ID:DB00985 | NDC:50804-198 | NDC:63029-901 | NDC:46122-536"
+BMGC_DG00766,BMG_DG006609,"8-chloro-1,3-dimethyl-7H-purine-2,6-dione | 8-Chlorotheophylline | DrugBank ID:DB14132 | CAS RN:85-18-7 | 8-CHLOROTHEOPHYLLINE | PubChem CID:10661 | PubChem SID:175266983 | UNII:GE2UA340FM"
+BMGC_DG00767,BMG_DG006611,UNII:Z2V3FF4B7F | CAS RN:523-88-6 | DIBROMOSALICIL | PubChem CID:10662 | PubChem SID:198936015
+BMGC_DG00768,BMG_DG006627,"PubChem CID:10667 | naphthalene-1,2-dione | CAS RN:524-42-5 | NDC:44911-0439 | NDC:44911-0646 | 1,2-NAPHTHOQUINONE | UNII:804K62F61Q | 1,2-Naphthoquinone | PubChem SID:198957906"
+BMGC_DG00769,BMG_DG006631,"Dimethylthiambutene | DrugBank ID:DB01444 | PubChem CID:10668 | PubChem SID:198987882 | N,N-dimethyl-4,4-dithiophen-2-ylbut-3-en-2-amine | DIMETHYLTHIAMBUTENE | UNII:915D88LM9O | CAS RN:524-84-5"
+BMGC_DG00770,BMG_DG006632,"UNII:ZMC4G1W59S | PubChem CID:10668061 | SCH-442416 | 2-(Furan-2-yl)-7-(3-(4-methoxyphenyl)propyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine | CAS RN:316173-57-6 | PubChem SID:249492309 | 4-(furan-2-yl)-10-[3-(4-methoxyphenyl)propyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine"
+BMGC_DG00771,BMG_DG006644,PubChem CID:10671412 | N-DESMETHYL RUBOXISTAURIN | PubChem SID:441658850 | UNII:M2BQ56K56V | CAS RN:191848-32-5
+BMGC_DG00772,BMG_DG006647,"(1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | Lunacalcipol | UNII:XN4TL6M50Z | LUNACALCIPOL | PubChem SID:198966300 | CAS RN:250384-82-8 | PubChem CID:10672195"
+BMGC_DG00773,BMG_DG006688,UNII:S2V45N7G3B | CAS RN:11091-19-3 | CAS RN:525-82-6 | PubChem SID:198954539 | PubChem CID:10680 | Flavone | FLAVONE | 2-phenylchromen-4-one | DrugBank ID:DB07776
+BMGC_DG00774,BMG_DG006691,"ZILEUTON, (R)- | UNII:8POY3UMU73 | CAS RN:142606-21-1 | PubChem SID:329589216 | PubChem CID:10681296"
+BMGC_DG00775,BMG_DG006705,CAS RN:152460-09-8 | N-(2-METHYL-5-NITROPHENYL)-4-(3-PYRIDINYL)-2-PYRIMIDINAMINE | PubChem CID:10686149 | UNII:48PDW22YGS
+BMGC_DG00776,BMG_DG006711,CAS RN:1508-62-9 | PubChem CID:10687366 | PubChem SID:316917900 | UNII:V186SR50A8 | CYCLOHEXIMIDE ACETATE
+BMGC_DG00777,BMG_DG006716,"UNII:R4R8J0Q44B | DrugBank ID:DB13180 | PubChem SID:175266242 | (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid | PubChem CID:10690 | CAS RN:133-42-6 | GLUCONIC ACID | CAS RN:19222-41-4 | CAS RN:526-95-4 | Gluconic Acid | CAS RN:124423-64-9"
+BMGC_DG00778,BMG_DG006720,5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID | DrugBank ID:DB07309 | PubChem SID:475550289 | UNII:WU438K8EAL | 5-Bromo-2-[[(4-chlorophenyl)sulfonyl]amino]benzoic acid | CAS RN:107143-69-1 | PubChem CID:1069140 | 5-BROMO-2-(((4-CHLOROPHENYL)SULFONYL)AMINO)BENZOIC ACID
+BMGC_DG00779,BMG_DG006734,"sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | CEFOTAXIME SODIUM | NDC:0143-9933 | NDC:21586-012 | NDC:21586-011 | Cefotaxime Sodium | NDC:0143-9930 | NDC:0143-9931 | UNII:258J72S7TZ | NDC:0143-9935 | PubChem SID:175268949 | CAS RN:64485-93-4 | PubChem CID:10695961"
+BMGC_DG00780,BMG_DG006746,3-PHENYL PROPIONIC ACID | 3-phenylpropanoic acid | 3-phenylpropionic acid | CAS RN:501-52-0 | PubChem CID:107 | DrugBank ID:DB02024 | CAS RN:35845-62-6 | PubChem SID:198978049 | 3-Phenylpropionic acid | UNII:5Q445IN5CU
+BMGC_DG00781,BMG_DG006748,PubChem SID:198950684 | 2-THIOPHENECARBOXYLIC ACID | UNII:3FD00JX53J | CAS RN:527-72-0 | 2-Thiophenecarboxylic acid | thiophene-2-carboxylic acid | PubChem CID:10700
+BMGC_DG00782,BMG_DG006769,"DrugBank ID:DB07714 | 6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID | PubChem CID:10708341"
+BMGC_DG00783,BMG_DG006774,2-oxalobenzoic acid | PubChem CID:10710 | CAS RN:528-46-1 | Phthalonic acid
+BMGC_DG00784,BMG_DG006776,PubChem CID:10710332 | N-[2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethyl]propan-1-amine | [2-(4-Methoxy-3-phenethyloxy-phenyl)-ethyl]-propyl-amine; hydrochloride
+BMGC_DG00785,BMG_DG006791,PubChem SID:434370122 | PD-155144 | PubChem CID:10713620 | UNII:4264O4MLU9 | CAS RN:216884-47-8
+BMGC_DG00786,BMG_DG006799,CAS RN:528-92-7 | PubChem SID:198950946 | PubChem CID:10715 | APRONALIDE | N-carbamoyl-2-propan-2-ylpent-4-enamide | DrugBank ID:DB13221 | Apronal | UNII:V18J24E25E
+BMGC_DG00787,BMG_DG006807,AM-087 | CAS RN:152674-96-9 | UNII:B4C266FTR4 | PubChem SID:440089647 | PubChem CID:10717065
+BMGC_DG00788,BMG_DG006813,PubChem CID:10718956 | DrugBank ID:DB12149 | CAS RN:203640-27-1 | PubChem SID:198978411 | UNII:BK459F050X | (2R)-3-(1H-indol-3-yl)-2-[[5-[2-(4-methylphenyl)ethynyl]thiophen-2-yl]sulfonylamino]propanoic acid | S-3304
+BMGC_DG00789,BMG_DG006818,"PubChem SID:443623646 | CAS RN:209176-12-5 | UNII:ZSY62NL4GP | N-(9,10-DIOXO-7-(3-(PYRROLIDIN-1-YL)PROPANAMIDO)-9,10-DIHYDROANTHRACEN-2-YL)-3-(PYRROLIDIN-1-YL)PROPANAMIDE | PubChem CID:10719801"
+BMGC_DG00790,BMG_DG006840,"1-Tetralone | UNII:6VT52A15HY | PubChem SID:198970358 | 3,4-dihydro-2H-naphthalen-1-one | PubChem CID:10724 | 1-TETRALONE | CAS RN:529-34-0 | CAS RN:29059-07-2"
+BMGC_DG00791,BMG_DG006910,PubChem SID:384158440 | PE-2I | UNII:CVO3TI9K02 | CAS RN:188680-71-9 | PubChem CID:10741033
+BMGC_DG00792,BMG_DG006918,"PubChem SID:198962464 | 4-hydroxy-3,5-dimethoxybenzoic acid | Syringic acid | PubChem CID:10742 | UNII:E390O181H5 | SYRINGIC ACID | CAS RN:530-57-4"
+BMGC_DG00793,BMG_DG006924,"PubChem CID:10743 | 3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid | Sinapic acid"
+BMGC_DG00794,BMG_DG006928,2-(2-acetyloxybenzoyl)oxybenzoic acid | PubChem CID:10745 | PubChem SID:198956413 | Acetylsalicylsalicylic acid | UNII:VBE72MCP5L | ACETYLSALICYLSALICYLIC ACID | CAS RN:530-75-6
+BMGC_DG00795,BMG_DG006935,PubChem CID:107475 | CAS RN:3918-94-3 | (2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoic acid | CAS RN:3918-93-2 | Val-Val
+BMGC_DG00796,BMG_DG006938,CAS RN:531-59-9 | UNII:DGK72G008A | 7-methoxychromen-2-one | PubChem CID:10748 | 7-Methoxycoumarin | 7-METHOXYCOUMARIN | PubChem SID:198965860
+BMGC_DG00797,BMG_DG006944,PubChem SID:472424769 | PubChem CID:1074953 | CAS RN:415713-60-9 | UNII:S8WG8ZRQ99 | RI-1
+BMGC_DG00798,BMG_DG006959,UNII:V85UOV8788 | PubChem SID:198991165 | COUMARIN-3-CARBOXYLIC ACID | PubChem CID:10752 | CAS RN:531-81-7
+BMGC_DG00799,BMG_DG006961,"PubChem SID:175266018 | NDC:84660-034 | ANHYDROUS DEXTROSE | CAS RN:8027-56-3 | CAS RN:19030-38-7 | CAS RN:50-99-7 | CAS RN:815-92-9 | D-glucose | NDC:55792-007 | CAS RN:58367-01-4 | (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal | PubChem CID:107526 | UNII:5SL0G7R0OK | CAS RN:28823-03-2 | DrugBank ID:DB01914"
+BMGC_DG00800,BMG_DG006974,"3,3'-Diiodo-L-thyronine | PubChem SID:198953709 | PubChem CID:107564 | (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3-iodophenyl]propanoic acid | CAS RN:4604-41-5 | UNII:3L9U2Z4602 | 3,3'-DIIODOTHYRONINE, L-"
+BMGC_DG00801,BMG_DG006975,PubChem CID:10757 | 2-chloro-1-phenylethanone | PubChem SID:198952554 | 2-Chloroacetophenone | UNII:88B5039IQG | CHLOROACETOPHENONE | CAS RN:532-27-4
+BMGC_DG00802,BMG_DG006992,"PubChem CID:10762160 | PubChem SID:198952194 | 2-((1-BENZYLPIPERIDIN-4-YL)METHYLENE)-5,6-DIMETHOXYINDAN-1-ONE, (E)- | CAS RN:145546-80-1 | UNII:1D3K90DIY3"
+BMGC_DG00803,BMG_DG006999,Indobufen | 2-[4-(3-oxo-1H-isoindol-2-yl)phenyl]butanoic acid | UNII:6T9949G4LZ | CAS RN:63610-08-2 | PubChem SID:198939857 | INDOBUFEN | DrugBank ID:DB12545 | PubChem CID:107641
+BMGC_DG00804,BMG_DG007013,UNII:QRW683O56T | CAS RN:644-26-8 | Amylocaine | AMYLOCAINE | PubChem CID:10767 | PubChem SID:198956051 | DrugBank ID:DB09088 | [1-(dimethylamino)-2-methylbutan-2-yl] benzoate
+BMGC_DG00805,BMG_DG007021,"CAS RN:92203-21-9 | 3-(N-n-Octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolinium ethyl phosphate | PubChem CID:107681 | CAS RN:85703-73-7 | [2-methoxy-3-(octadecylcarbamoyloxy)propyl] 2-(1,3-thiazol-3-ium-3-yl)ethyl phosphate"
+BMGC_DG00806,BMG_DG007023,"UNII:49U9M41BGY | (3aR,7aR)-2-[2-(2-methoxyphenyl)ethanimidoyl]-7,7-diphenyl-1,3,3a,5,6,7a-hexahydroisoindol-4-one | PubChem SID:198990164 | PubChem CID:107686 | RP-67580 | 4H-Isoindol-4-one, octahydro-2-(1-imino-2-(2-methoxyphenyl)ethyl)-7,7-diphenyl-, (3aR,7aR)- | CAS RN:135911-02-3"
+BMGC_DG00807,BMG_DG007024,"NDC:0220-4477 | CAS RN:79-33-4 | NDC:0220-4475 | PubChem SID:175268111 | DrugBank ID:DB14475 | Lactic Acid, L- | (2S)-2-hydroxypropanoic acid | PubChem CID:107689 | NDC:0220-4474 | NDC:0220-4476 | NDC:0220-4478 | CAS RN:26811-96-1 | NDC:58345-105 | LACTIC ACID, L- | UNII:F9S9FFU82N"
+BMGC_DG00808,BMG_DG007026,"(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[bis(prop-2-enyl)amino]-3-(4-hydroxyphenyl)propanoyl]amino]-2-methylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid | N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine | PubChem CID:107691"
+BMGC_DG00809,BMG_DG007028,"Cyproterone acetate, ethinyl estradiol drug combination | CAS RN:60528-19-0 | PubChem CID:107694 | [(1S,2S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol"
+BMGC_DG00810,BMG_DG007034,1-(cyclohexylamino)propan-2-yl benzoate | PubChem SID:198941877 | UNII:511IU0826Z | CAS RN:532-77-4 | Hexylcaine | DrugBank ID:DB00473 | HEXYLCAINE | PubChem CID:10770
+BMGC_DG00811,BMG_DG007038,"CAS RN:69954-48-9 | methyl 9H-pyrido[3,4-b]indole-3-carboxylate | PubChem SID:198940241 | .BETA.-CARBOLINE-3-CARBOXYLIC ACID METHYL ESTER | beta-Carboline-3-carboxylic acid methyl ester | PubChem CID:107704 | UNII:I2A008F6YL"
+BMGC_DG00812,BMG_DG007040,"UNII:DWI62G0P59 | 2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid | CAS RN:127373-66-4 | PubChem CID:107706 | DrugBank ID:DB12863 | PubChem SID:198973808 | Sivelestat | SIVELESTAT | CAS RN:331731-18-1"
+BMGC_DG00813,BMG_DG007050,"DrugBank ID:DB13345 | DIHYDROERGOCRISTINE | PubChem SID:175267054 | CAS RN:17479-19-5 | Dihydroergocristine | (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | UNII:05D48LUM4Z | PubChem CID:107715"
+BMGC_DG00814,BMG_DG007055,"PubChem SID:198954318 | (3S,7S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | UNII:95D0I22I0V | 7.ALPHA.-HYDROXYCHOLESTEROL | 7alpha-Hydroxycholesterol | PubChem CID:107722 | CAS RN:566-26-7"
+BMGC_DG00815,BMG_DG007057,"UNII:LEY8QK99UR | PubChem SID:198953795 | DrugBank ID:DB05710 | GANTACURIUM CHLORIDE | 4-O-[3-[(1S,2R)-6,7-dimethoxy-2-methyl-1-(3,4,5-trimethoxyphenyl)-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 1-O-[3-[(1R,2S)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (Z)-2-chlorobut-2-enedioate;dichloride | CAS RN:213998-46-0 | Gantacurium | Gantacurium chloride | PubChem CID:10772467"
+BMGC_DG00816,BMG_DG007065,PubChem CID:107735 | Pyruvate | CAS RN:57-60-3 | 2-oxopropanoate | PYRUVATE ION | UNII:HO43T60JMG | PubChem SID:375083848
+BMGC_DG00817,BMG_DG007069,N'-Phenylbenzohydrazide | PubChem SID:478837854 | UNII:K25CT2CYZ7 | PubChem CID:10774 | N'-PHENYLBENZOHYDRAZIDE | CAS RN:532-96-7
+BMGC_DG00818,BMG_DG007071,3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropanal | Aldophosphamide | ALDOPHOSPHAMIDE | PubChem SID:316910170 | CAS RN:35144-64-0 | PubChem CID:107744 | UNII:7AM2ILM9FI
+BMGC_DG00819,BMG_DG007077,RACECADOTRIL | benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate | Racecadotril | DrugBank ID:DB11696 | UNII:76K53XP4TO | PubChem SID:175271347 | PubChem CID:107751 | CAS RN:81110-73-8
+BMGC_DG00820,BMG_DG007082,"Inositol 1,3,4,5-tetraphosphate | PubChem CID:107758 | Inositol 1,3,4,5-tetrakisphosphate | CAS RN:102850-29-3 | PubChem SID:478838493 | [(1S,2S,4S,5R)-2,4-dihydroxy-3,5,6-triphosphonooxycyclohexyl] dihydrogen phosphate | DrugBank ID:DB01863 | UNII:XK67P86535 | Inositol 1,3,4,5-Tetrakisphosphate | INOSITOL 1,3,4,5-TETRAPHOSPHATE"
+BMGC_DG00821,BMG_DG007088,"PubChem SID:198954273 | Dihydroetorphine | PubChem CID:107765 | (1S,2S,6R,14R,15R,16R)-16-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol | DrugBank ID:DB01450 | UNII:QQX8S479YV | CAS RN:14357-76-7 | DIHYDROETORPHINE"
+BMGC_DG00822,BMG_DG007093,"PubChem SID:175265429 | UNII:TD3P7Q3SG6 | CAS RN:74847-35-1 | 4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol | PubChem CID:107771 | PYRONARIDINE | DrugBank ID:DB12975 | Pyronaridine"
+BMGC_DG00823,BMG_DG007095,PubChem CID:107775 | CAS RN:91037-65-9 | Arginyl-glycyl-aspartyl-serine | PubChem SID:198969281 | FIBRONECTIN TETRAPEPTIDE | UNII:AC6UDA2MFC | (3S)-3-[[2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid
+BMGC_DG00824,BMG_DG007098,"DrugBank ID:DB06444 | UNII:R6VT8U5372 | (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | Dexanabinol | PubChem CID:107778 | PubChem SID:198988688 | CAS RN:112924-45-5 | DEXANABINOL"
+BMGC_DG00825,BMG_DG007100,"CAS RN:1049739-35-6 | 2'-Methyl-4'-(5-methyl-(1,2,4)-oxadiazol-3-yl)biphenyl-4-carboxylic acid (4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)amide | PubChem SID:198985096 | GR-127935 | UNII:2LLH6CEB40 | CAS RN:148672-13-3 | PubChem CID:107780 | N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-4-[2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]benzamide"
+BMGC_DG00826,BMG_DG007102,"Betamethasone phosphate | PubChem CID:107782 | CAS RN:360-63-4 | BETAMETHASONE PHOSPHATE | DrugBank ID:DB14669 | [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate | PubChem SID:198974656 | UNII:YJO1F9W10R"
+BMGC_DG00827,BMG_DG007103,"CATHINONE, (±)- | PubChem SID:461435044 | CATHINONE, (+/-) | 2-amino-1-phenylpropan-1-one | PubChem CID:107786 | 2-Aminopropiophenone | UNII:CX1Z9618HE | CAS RN:5265-18-9"
+BMGC_DG00828,BMG_DG007106,"CAS RN:21373-30-8 | PubChem CID:107794 | UNII:9HBL9XYQ8O | PubChem SID:198963833 | 6-HYDROXYDOPA, DL-"
+BMGC_DG00829,BMG_DG007113,UNII:0N3V8R4E13 | CAS RN:89459-25-6 | PubChem CID:107805 | Acridine Carboxamide | XR-5000 | PubChem SID:198945208 | N-[2-(dimethylamino)ethyl]acridine-4-carboxamide | DrugBank ID:DB11880
+BMGC_DG00830,BMG_DG007115,"PERINDOPRIL | UNII:Y5GMK36KGY | (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid | PubChem CID:107807 | CAS RN:82834-16-0 | DrugBank ID:DB00790 | PubChem SID:175265414 | Perindopril"
+BMGC_DG00831,BMG_DG007117,PubChem SID:198960174 | Hypotaurine | HYPOTAURINE | PubChem CID:107812 | 2-aminoethanesulfinic acid | UNII:5L08GE4332 | CAS RN:300-84-5
+BMGC_DG00832,BMG_DG007129,"PubChem SID:198942084 | PubChem CID:10783 | CAS RN:533-45-9 | 5-(2-chloroethyl)-4-methyl-1,3-thiazole | UNII:0C5DBZ19HV | Chlormethiazole | DrugBank ID:DB06470 | CLOMETHIAZOLE | Clomethiazole"
+BMGC_DG00833,BMG_DG007132,"PubChem CID:107838 | UNII:65027TMI0H | Tryptoline | TRYPTOLINE | PubChem SID:198977353 | CAS RN:16502-01-5 | 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole"
+BMGC_DG00834,BMG_DG007135,ethyl N-[10-[3-(diethylamino)propanoyl]phenothiazin-2-yl]carbamate | CAS RN:4596-66-1 | PubChem CID:107841 | Ethacizine | UNII:FE5SPV1Z6G | ETHACIZINE | PubChem SID:198972643 | DrugBank ID:DB13645 | CAS RN:33414-33-4
+BMGC_DG00835,BMG_DG007137,"PubChem CID:107847 | CAS RN:75644-90-5 | (2S,3R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoic acid | Dslet"
+BMGC_DG00836,BMG_DG007138,UNII:145295QLXY | PubChem CID:107848 | PubChem SID:198975407 | CAS RN:24512-63-8 | GENIPOSIDE
+BMGC_DG00837,BMG_DG007150,"UNII:SX2WTG9R3Z | 11-[2-[2-(diethylaminomethyl)piperidin-1-yl]acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one | PubChem SID:329589336 | CAS RN:100158-38-1 | OTENZEPAD | UNII:OM7J0XAL0S | PubChem CID:107867 | UNII:WW6A9TFL2C | CAS RN:121029-35-4 | CAS RN:102394-31-0 | CAS RN:122467-13-4 | PubChem SID:198968204 | PubChem SID:329589032 | OTENZEPAD, (-)- | OTENZEPAD, (+)- | Otenzepad"
+BMGC_DG00838,BMG_DG007157,CAS RN:15092-81-6 | PubChem SID:198984537 | PERSULFATE ION | UNII:1SQ1481FEQ | PubChem CID:107879
+BMGC_DG00839,BMG_DG007163,PubChem SID:441583643 | UNII:MQ4LMC2HN5 | CAS RN:52497-36-6 | PubChem CID:107883 | DIHYDROKAINIC ACID
+BMGC_DG00840,BMG_DG007167,"TROPOLONE | CAS RN:533-75-5 | Tropolone | 2-hydroxycyclohepta-2,4,6-trien-1-one | UNII:7L6DL16P1T | PubChem CID:10789 | PubChem SID:175267276"
+BMGC_DG00841,BMG_DG007170,4-[6-imino-3-(4-methoxyphenyl)pyridazin-1-yl]butanoic acid | UNII:L45297DIU1 | PubChem SID:249817723 | Gabazine free base | CAS RN:105538-73-6 | PubChem CID:107896 | GABAZINE FREE BASE
+BMGC_DG00842,BMG_DG007172,CAS RN:252351-95-4 | LUCIDADIOL | PubChem CID:10789991 | UNII:ANY54A9QKX | PubChem SID:472423606
+BMGC_DG00843,BMG_DG007176,"UNII:92587OVD8Z | PubChem SID:198942895 | [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | CAS RN:1257-08-5 | EPICATECHIN GALLATE | (-)-Epicatechin gallate | PubChem CID:107905"
+BMGC_DG00844,BMG_DG007182,"CAS RN:59468-90-5 | PubChem SID:198947832 | PubChem CID:107917 | [8-chloro-6-(2-fluorophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepin-1-yl]methanol | UNII:E5142BN92Z | 1-Hydroxymidazolam | 1'--HYDROXYMIDAZOLAM | 1′--HYDROXYMIDAZOLAM"
+BMGC_DG00845,BMG_DG007189,"ASULACRINE | 9-[4-(methanesulfonamido)-2-methoxyanilino]-N,5-dimethylacridine-4-carboxamide | PubChem CID:107924 | CAS RN:80841-47-0 | Asulacrine | PubChem SID:198978864 | UNII:S8P50T62B6"
+BMGC_DG00846,BMG_DG007190,"tert-butyl (7S)-14-bromo-12-oxo-2,4,11-triazatetracyclo[11.4.0.02,6.07,11]heptadeca-1(17),3,5,13,15-pentaene-5-carboxylate | PubChem CID:107926 | UNII:OSZ0E9DGOJ | CAS RN:84379-13-5 | BRETAZENIL | Bretazenil | PubChem SID:198982997"
+BMGC_DG00847,BMG_DG007191,UNII:7AC8BF38NP | PubChem SID:316914840 | 1-[5-hydroxy-2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one | 5-HYDROXYPROPAFENONE | PubChem CID:107927 | CAS RN:86384-10-3 | 5-Hydroxypropafenone
+BMGC_DG00848,BMG_DG007195,"(6aS,13bR)-11-chloro-7-methyl-5,6,6a,8,9,13b-hexahydronaphtho[1,2-a][3]benzazepin-12-ol | PubChem CID:107930 | Ecopipam | ECOPIPAM | DrugBank ID:DB12273 | CAS RN:112108-01-7 | UNII:0X748O646K | PubChem SID:198936426"
+BMGC_DG00849,BMG_DG007198,"(1S,14S)-17,18-dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.03,12.04,9.015,20]docosa-3(12),4(9),5,10,15,17,19-heptaen-13-one | CAS RN:522-17-8 | UNII:K5Z93K66IE | PubChem CID:107935 | DEGUELIN | PubChem SID:198983133 | Deguelin"
+BMGC_DG00850,BMG_DG007206,"3-Methyl-6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine | UNII:O7GR5XL5B5 | 3-methyl-6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine | PubChem SID:404859806 | PubChem CID:107950 | CAS RN:66548-69-4 | CL-218872"
+BMGC_DG00851,BMG_DG007212,"(4S,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | H-DPhe-cyclo[DPen-Tyr-DTrp-Lys-Val-Cys]-Thr-NH2 | CAS RN:108736-35-2 | PubChem CID:10796238"
+BMGC_DG00852,BMG_DG007219,PubChem SID:198940481 | PubChem CID:107968 | CAS RN:156719-41-4 | S-METHYLTHIOCITRULLINE | UNII:M790X706JV | (2S)-2-amino-5-[[amino(methylsulfanyl)methylidene]amino]pentanoic acid | S-Methyl-L-thiocitrulline | CAS RN:156719-39-0
+BMGC_DG00853,BMG_DG007221,"NDC:68462-166 | NDC:0078-0607 | NDC:42291-048 | NDC:70377-019 | FINGOLIMOD HYDROCHLORIDE | NDC:31722-889 | CAS RN:162359-56-0 | NDC:82009-143 | NDC:67877-476 | Fingolimod Hydrochloride | NDC:65862-952 | NDC:0078-0965 | NDC:43598-285 | NDC:16729-342 | NDC:72865-257 | NDC:70771-1603 | PubChem CID:107969 | NDC:0480-7820 | PubChem SID:175268571 | NDC:73086-300 | NDC:0378-4525 | NDC:68382-912 | UNII:G926EC510T | 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol;hydrochloride | NDC:64980-449 | NDC:62756-064 | NDC:60505-4332"
+BMGC_DG00854,BMG_DG007224,"CAS RN:162359-55-9 | DrugBank ID:DB08868 | 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol | NDC:43547-003 | PubChem CID:107970 | Fingolimod | FINGOLIMOD | PubChem SID:175268765 | DrugBank ID:DB05286 | UNII:3QN8BYN5QF"
+BMGC_DG00855,BMG_DG007226,"3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | DAIDZIN | PubChem SID:198961741 | CAS RN:552-66-9 | DrugBank ID:DB02115 | Daidzin | UNII:4R2X91A5M5 | PubChem CID:107971"
+BMGC_DG00856,BMG_DG007239,CAS RN:36889-13-1 | N(G)-Iminoethylornithine | PubChem CID:107984 | DrugBank ID:DB03305 | PubChem SID:472390411 | UNII:XQ6P9GL3YT | n5-Iminoethyl-l-ornithine | N5-(1-Iminoethyl)-L-ornithine | (2S)-2-amino-5-(1-aminoethylideneamino)pentanoic acid | N5-(1-IMINOETHYL)-L-ORNITHINE
+BMGC_DG00857,BMG_DG007241,"TRIPTOLIDE | UNII:19ALD1S53J | PubChem CID:107985 | (1S,2S,4S,5S,7R,8R,9S,11S,13S)-8-hydroxy-1-methyl-7-propan-2-yl-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-17-one | DrugBank ID:DB12025 | PubChem SID:198962795 | CAS RN:38748-32-2 | Triptolide"
+BMGC_DG00858,BMG_DG007246,MK-212 | PubChem SID:198982088 | UNII:62C3N7238U | CAS RN:64022-27-1 | PubChem CID:107992 | DrugBank ID:DB12111 | 2-Chloro-6-(1-piperazinyl)pyrazine | 2-chloro-6-piperazin-1-ylpyrazine
+BMGC_DG00859,BMG_DG007247,"UNII:34SSX5LDE5 | (3S)-2-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid | PubChem CID:107994 | PubChem SID:175267480 | Quinaprilat | QUINAPRILAT | CAS RN:85441-60-7 | DrugBank ID:DB14217 | CAS RN:82768-85-2"
+BMGC_DG00860,BMG_DG007248,UNII:9J5D4ZN1JK | PubChem CID:107995 | N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-3-iodo-6-methoxybenzamide | IOLOPRIDE | Iolopride | CAS RN:84226-06-2 | PubChem SID:249492058
+BMGC_DG00861,BMG_DG007253,CAS RN:501-81-5 | 2-pyridin-3-ylacetic acid | UNII:7UFO07435N | PubChem SID:198961609 | 3-PYRIDINEACETIC ACID | PubChem CID:108 | 3-Pyridineacetic acid
+BMGC_DG00862,BMG_DG007256,"(1-methylindol-3-yl)-[(5R)-4,5,6,7-tetrahydro-3H-benzimidazol-5-yl]methanone | CAS RN:132036-88-5 | Ramosetron | PubChem CID:108000 | DrugBank ID:DB09290 | PubChem SID:198983023 | UNII:7ZRO0SC54Y | RAMOSETRON"
+BMGC_DG00863,BMG_DG007259,CAS RN:157659-79-5 | PubChem CID:108002 | SKB-209670 | PubChem SID:198936705 | UNII:0I32BCL40Z
+BMGC_DG00864,BMG_DG007261,UNII:133DU2F2VS | PubChem SID:198968398 | CAS RN:5975-78-0 | PubChem CID:108003 | ZEARALANONE
+BMGC_DG00865,BMG_DG007277,"PubChem SID:316913599 | UNII:2ISE72RACC | CAS RN:66611-26-5 | RU-24969 | CAS RN:74163-68-1 | 5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole | PubChem CID:108029"
+BMGC_DG00866,BMG_DG007279,CAS RN:77779-36-3 | PubChem CID:108030 | CGS-9896 | UNII:86PWQ4PVN0 | PubChem SID:198982499
+BMGC_DG00867,BMG_DG007284,"Sepimostat | UNII:5ZFR16F4QQ | SEPIMOSTAT | PubChem CID:108041 | CAS RN:103926-64-3 | (6-carbamimidoylnaphthalen-2-yl) 4-(4,5-dihydro-1H-imidazol-2-ylamino)benzoate | PubChem SID:198942624"
+BMGC_DG00868,BMG_DG007287,PubChem CID:108046 | Bmy-14802 | CAS RN:105565-56-8 | PubChem SID:318691788 | 1-(4-fluorophenyl)-4-[4-(5-fluoropyrimidin-2-yl)piperazin-1-yl]butan-1-ol | UNII:A5NB5G07JO | BMY-14802
+BMGC_DG00869,BMG_DG007297,NIMBIN | PubChem CID:108058 | PubChem SID:241180533 | CAS RN:5945-86-8 | UNII:N4CTG7K9IU
+BMGC_DG00870,BMG_DG007298,"UNII:9AMX4Q13CC | PubChem SID:198963909 | DrugBank ID:DB14583 | [(8R,9S,10R,13S,14S,17R)-17-acetyl-13-methyl-16-methylidene-3-oxo-2,6,7,8,9,10,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate | PubChem CID:108059 | CAS RN:7759-35-5 | SEGESTERONE ACETATE | Segesterone Acetate"
+BMGC_DG00871,BMG_DG007305,"PubChem CID:108068 | CID 108068 | (1S,2S,4R,11S)-4,8-dimethyl-12-methylidene-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one | CAS RN:20554-84-1"
+BMGC_DG00872,BMG_DG007325,"UNII:I43T3ID6G2 | 2-(4-benzylphenoxy)-N,N-diethylethanamine | PubChem SID:198960558 | DrugBank ID:DB04905 | CAS RN:98774-23-3 | TESMILIFENE | Tesmilifene | PubChem CID:108092"
+BMGC_DG00873,BMG_DG007340,CAS RN:2898-76-2 | PubChem CID:108107 | BENZAMIL | PubChem SID:198980634 | UNII:04659UUJ94
+BMGC_DG00874,BMG_DG007345,"PubChem CID:108112 | UNII:9YY9X4HSE2 | 3,5-DIMETHYL-3'-ISOPROPYL-L-THYRONINE | CAS RN:26384-44-1 | PubChem SID:384647865"
+BMGC_DG00875,BMG_DG007351,"PubChem CID:108121 | 3-bromo-7-oxabicyclo[4.1.0]hepta-2,4-diene | CAS RN:51981-75-0 | Bromobenzene-3,4-oxide"
+BMGC_DG00876,BMG_DG007354,"PubChem CID:108130 | CAS RN:61281-37-6 | Schisandrin B | 3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene"
+BMGC_DG00877,BMG_DG007356,"CAS RN:208848-13-9 | FRESELESTAT, (R)- | PubChem SID:333495650 | PubChem CID:10813515 | UNII:2021Q1V2MF"
+BMGC_DG00878,BMG_DG007357,"UNII:00427X161I | Sch 28080 | PubChem CID:108137 | 2-(2-methyl-8-phenylmethoxyimidazo[1,2-a]pyridin-3-yl)acetonitrile | PubChem SID:241178743 | CAS RN:76081-98-6 | SCH-28080"
+BMGC_DG00879,BMG_DG007361,"4-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)carbamoyl]benzoic acid | PubChem CID:108143 | CAS RN:94497-51-5 | TAMIBAROTENE | DrugBank ID:DB04942 | Tamibarotene | PubChem SID:198988962 | UNII:08V52GZ3H9"
+BMGC_DG00880,BMG_DG007362,"Carboxyamidotriazole | PubChem SID:198972622 | CARBOXYAMIDOTRIAZOLE | CAS RN:99519-84-3 | UNII:6ST3ZF52WB | PubChem CID:108144 | 5-amino-1-[[3,5-dichloro-4-(4-chlorobenzoyl)phenyl]methyl]triazole-4-carboxamide | DrugBank ID:DB11960"
+BMGC_DG00881,BMG_DG007364,PubChem CID:108147 | CAS RN:106128-89-6 | (3S)-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]-methylamino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(3-carboxypropanoylamino)-4-oxobutanoic acid | Senktide | CAS RN:189261-10-7
+BMGC_DG00882,BMG_DG007365,CAS RN:536-25-4 | UNII:JK16YI13QK | ORTHOCAINE | PubChem CID:10815 | PubChem SID:198981337
+BMGC_DG00883,BMG_DG007366,"TRABECTEDIN | PubChem SID:198978374 | NDC:59676-610 | Trabectedin | CAS RN:114899-77-3 | DrugBank ID:DB05109 | PubChem CID:108150 | [(1R,2R,3R,11S,12S,14R,26R)-5,6',12-trihydroxy-6,7'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-3,4-dihydro-2H-isoquinoline]-22-yl] acetate | UNII:ID0YZQ2TCP"
+BMGC_DG00884,BMG_DG007369,CAS RN:74389-68-7 | PLATELET-ACTIVATING FACTOR | PubChem CID:108156 | DrugBank ID:DB02261 | [(2R)-2-acetyloxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate | PubChem SID:322058959 | Platelet Activating Factor | Platelet activating factor | UNII:42EWD89I80
+BMGC_DG00885,BMG_DG007372,"1-[(3S)-3-(3,4-dichlorophenyl)-3-[2-(4-phenyl-1-azoniabicyclo[2.2.2]octan-1-yl)ethyl]piperidin-1-yl]-2-(3-propan-2-yloxyphenyl)ethanone | PubChem SID:198942482 | PubChem CID:108167 | Nolpitantium | CAS RN:155418-05-6 | NOLPITANTIUM | UNII:NR72W2V70N"
+BMGC_DG00886,BMG_DG007373,PubChem SID:198983267 | ARISTOLOCHIC ACID II | UNII:BB72D5PU2Y | PubChem CID:108168 | CAS RN:475-80-9
+BMGC_DG00887,BMG_DG007382,ZACOPRIDE | 4-amino-N-(1-azabicyclo[2.2.2]octan-3-yl)-5-chloro-2-methoxybenzamide | CAS RN:90182-92-6 | PubChem SID:198936632 | PubChem CID:108182 | Zacopride | UNII:9GN3OT4156
+BMGC_DG00888,BMG_DG007384,PubChem CID:108185 | CAS RN:124750-92-1 | UNII:GD76OCH73X | 2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid | Losartan carboxylic acid | EXP-3174 | PubChem SID:316912063
+BMGC_DG00889,BMG_DG007386,PubChem CID:108187 | CI-988 | UNII:2637PDX9SI | 4-[[(1R)-2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid | CAS RN:130332-27-3 | PubChem SID:322058714 | Ci-988
+BMGC_DG00890,BMG_DG007387,DrugBank ID:DB12912 | PubChem CID:108189 | Nolatrexed
+BMGC_DG00891,BMG_DG007389,PERILLYL ALCOHOL | CAS RN:536-59-4 | PubChem CID:10819 | Perillyl alcohol | UNII:319R5C7293 | (4-prop-1-en-2-ylcyclohexen-1-yl)methanol | PubChem SID:198988059
+BMGC_DG00892,BMG_DG007390,"(2S,3S,4S,5R,6R)-6-[[(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | CAS RN:1180-25-2 | Testosterone glucuronide | CAS RN:16996-33-1 | PubChem CID:108192"
+BMGC_DG00893,BMG_DG007393,PubChem CID:1082 | 2-amino-5-[[1-(carboxymethylamino)-3-(hydroxymethylsulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | DrugBank ID:DB05446 | H-DL-gGlu-DL-Cys(MeOH)-Gly-OH | LJP 1082
+BMGC_DG00894,BMG_DG007406,"PubChem SID:472410265 | 5-ACETYLAMINO-6-FORMYLAMINO-3-METHYLURACIL | CAS RN:85438-96-6 | UNII:LQW8YAU3VF | PubChem CID:108214 | N-(6-formamido-3-methyl-2,4-dioxo-1H-pyrimidin-5-yl)acetamide | 5-Acetylamino-6-formylamino-3-methyluracil"
+BMGC_DG00895,BMG_DG007409,"methyl (1R,2S,3S,5S)-3-(4-iodophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | Iometopane | PubChem SID:198935558 | CAS RN:133647-95-7 | CAS RN:135416-43-2 | IOMETOPANE | PubChem CID:108220 | UNII:4H1Z7121WS"
+BMGC_DG00896,BMG_DG007411,"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL | DrugBank ID:DB07906 | PubChem CID:10822243"
+BMGC_DG00897,BMG_DG007412,"UNII:9G2MP84A8W | 2-DEOXYGLUCOSE | 2-deoxyglucose | (3R,4S,5R)-3,4,5,6-tetrahydroxyhexanal | 2-deoxy-D-glucose | DrugBank ID:DB08831 | CAS RN:154-17-6 | PubChem SID:175265418 | PubChem CID:108223"
+BMGC_DG00898,BMG_DG007415,"7-(1,2,4-Triazol-4-ylmethyl)chromen-4-one | UNII:C26E93G3F8 | PubChem SID:485663551 | PubChem CID:10823163 | 7-(1,2,4-TRIAZOL-4-YLMETHYL)CHROMEN-4-ONE | CAS RN:331684-17-4"
+BMGC_DG00899,BMG_DG007431,PubChem SID:440793517 | PubChem CID:1082702 | CAS RN:73570-11-3 | UNII:24B88BKX5U | DrugBank ID:DB06851 | N-(PYRIDIN-3-YLMETHYL)ANILINE | N-(pyridin-3-ylmethyl)aniline
+BMGC_DG00900,BMG_DG007432,"CAS RN:39642-87-0 | PubChem SID:441659562 | PubChem CID:1082704 | N,N'-DI-4-PYRIDINYLUREA | UNII:K6T4QXS7EN"
+BMGC_DG00901,BMG_DG007445,PubChem SID:198955706 | AMANOZINE | PubChem CID:10832 | UNII:X43W7JDA8L | CAS RN:537-17-7
+BMGC_DG00902,BMG_DG007448,PubChem CID:10832101 | 4-methoxy-N-(2-pyridin-2-ylquinazolin-4-yl)benzamide
+BMGC_DG00903,BMG_DG007453,"PubChem CID:10833710 | CAS RN:177795-59-4 | PubChem SID:316917423 | RABEPRAZOLE, (S)- | UNII:Q9Z21M00M9"
+BMGC_DG00904,BMG_DG007454,UNII:77GNH26GH3 | O-774 | PubChem SID:459055580 | PubChem CID:10833730 | CAS RN:336104-74-6
+BMGC_DG00905,BMG_DG007458,PubChem CID:10836 | DrugBank ID:DB01577 | CAS RN:537-46-2 | PubChem SID:175268005 | Metamfetamine | METHAMPHETAMINE | UNII:44RAL3456C | Methamphetamine | (2S)-N-methyl-1-phenylpropan-2-amine
+BMGC_DG00906,BMG_DG007468,PubChem CID:10839 | UNII:15E9I74NZ8 | CAS RN:139-62-8 | CYCLOMETHYCAINE | PubChem SID:198974944
+BMGC_DG00907,BMG_DG007471,PubChem SID:175268933 | THIOSULFATE ION | UNII:LLT6XV39PY | dioxido-oxo-sulfanylidene-lambda6-sulfane | PubChem CID:1084 | CAS RN:14383-50-7 | Thiosulfate ion
+BMGC_DG00908,BMG_DG007506,"2,3-di(octanoyloxy)propyl octanoate | PubChem SID:175265901 | DrugBank ID:DB12176 | PubChem CID:10850 | TRICAPRILIN | CAS RN:352431-24-4 | UNII:6P92858988 | Tricaprylin | CAS RN:538-23-8"
+BMGC_DG00909,BMG_DG007510,"UNII:FT3V3J5647 | 3-(3-CHLOROPHENYL)-5,7-DIHYDROXY-4H-1-BENZOPYRAN-4-ONE | PubChem CID:10850934 | PubChem SID:482553826 | 3-(3-Chlorophenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one | CAS RN:62845-10-7"
+BMGC_DG00910,BMG_DG007513,UNII:V4UZ8R6BCK | PubChem SID:474492818 | CAS RN:201654-12-8 | PubChem CID:10851308 | LG-120907
+BMGC_DG00911,BMG_DG007521,UNII:0K14I09J76 | CAS RN:538-32-9 | BENZYLUREA | PubChem SID:198948391 | PubChem CID:10853
+BMGC_DG00912,BMG_DG007568,PubChem CID:10862355 | 4-[5-(4-fluorophenyl)-2-methylsulfanyl-1H-imidazol-4-yl]-N-[(1R)-1-phenylethyl]pyridin-2-amine | {4-[5-(4-Fluoro-phenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine
+BMGC_DG00913,BMG_DG007589,UNII:NY2FPS5DTU | 3-CHLORO-4-MORPHOLINOANILINE | PubChem SID:459276053 | CAS RN:55048-24-3 | PubChem CID:108661
+BMGC_DG00914,BMG_DG007608,CAS RN:538-75-0 | PubChem CID:10868 | UNII:0T1427205E | Dicyclohexylcarbodiimide | PubChem SID:198937151 | DICYCLOHEXYLCARBODIIMIDE
+BMGC_DG00915,BMG_DG007619,PubChem CID:10869340 | CRA_1802 | DrugBank ID:DB02875
+BMGC_DG00916,BMG_DG007624,"(8R,9S,13S,14S,16R,17R)-16-(18F)fluoranyl-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol | Fluoroestradiol F-18 | PubChem CID:10869981 | CAS RN:94153-53-4 | NDC:72874-001 | FLUOROESTRADIOL F-18 | PubChem SID:198937796 | UNII:T32277KB09"
+BMGC_DG00917,BMG_DG007633,"9-Methyluric acid | 9-Methyl Uric Acid | UNII:S4TO803W5P | 9-methyl-3,7-dihydropurine-2,6,8-trione | PubChem SID:438788389 | PubChem CID:108714 | DrugBank ID:DB03293 | 9-METHYLURIC ACID | CAS RN:55441-71-9"
+BMGC_DG00918,BMG_DG007642,"(1R,3S,5Z)-5-[(2Z)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | PubChem CID:10873438 | CAS RN:32222-06-3"
+BMGC_DG00919,BMG_DG007664,PubChem SID:472424463 | PubChem CID:108770 | CAS RN:55804-65-4 | UNII:7GE3Q7LWR9 | COUMARIN 343
+BMGC_DG00920,BMG_DG007691,3-Benzyl-5-methyl-3H-benzooxazol-2-one | PubChem SID:482554056 | UNII:WUT8D5MHW8 | PubChem CID:1087842 | CAS RN:107235-17-6 | 3-BENZYL-5-METHYL-3H-BENZOOXAZOL-2-ONE
+BMGC_DG00921,BMG_DG007698,UNII:A2RZ9UPC7D | PubChem CID:10879621 | PubChem SID:459055914 | FUB-594 | CAS RN:457074-02-1
+BMGC_DG00922,BMG_DG007701,PubChem CID:1088 | 2-(methylamino)acetic acid | DrugBank ID:DB12519 | UNII:Z711V88R5F | SARCOSINE | Sarcosine | PubChem SID:175267032 | CAS RN:107-97-1 | CAS RN:25951-24-0
+BMGC_DG00923,BMG_DG007750,"Cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide | CAS RN:68-19-9 | PubChem CID:10887743 | cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl phosphate;cyanide"
+BMGC_DG00924,BMG_DG007778,DrugBank ID:DB11068 | SELENIC ACID | Selenic acid | PubChem SID:198971028 | UNII:HV0Y51NC4J | CAS RN:7783-08-6 | PubChem CID:1089 | selenic acid
+BMGC_DG00925,BMG_DG007815,p-Iodophenol | CAS RN:540-38-5 | 4-Iodophenol | DrugBank ID:DB03002 | UNII:BH194BAK0B | 4-iodophenol | PubChem SID:198936088 | P-IODOPHENOL | PubChem CID:10894
+BMGC_DG00926,BMG_DG007842,PubChem CID:108985 | 1-L-ALANYL-D-PROLINE | CAS RN:60643-20-1 | PubChem SID:318164360 | UNII:1B9JC6P4Q5
+BMGC_DG00927,BMG_DG007843,"carbanide;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl phosphate | PubChem CID:10898559 | CAS RN:13422-55-4 | Methyl vitamin B12"
+BMGC_DG00928,BMG_DG007855,PubChem CID:10899191 | UNII:YUV63OTC0P | PubChem SID:313182622 | 5-METHOXYCOUMARIN | CAS RN:51559-36-5
+BMGC_DG00929,BMG_DG007869,"UNII:UZY4HYK4ZX | CAS RN:2381-08-0 | CYSTEINESULFINIC ACID, (±)- | PubChem CID:109 | CYSTEINESULFINIC ACID, (+/-)- | PubChem SID:333495567 | 3-Sulfinoalanine | 2-amino-3-sulfinopropanoic acid"
+BMGC_DG00930,BMG_DG007876,UNII:9S9ZA8EV55 | N-MERCAPTOACETYL-L-HISTIDINE | PubChem SID:336286837 | PubChem CID:10900407 | CAS RN:62404-82-4
+BMGC_DG00931,BMG_DG007897,DrugBank ID:DB02288 | CRA-9334 | PubChem CID:10904076
+BMGC_DG00932,BMG_DG007925,"DrugBank ID:DB00626 | (4R)-4-[[(2S)-2-[[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[(2S,3S)-1-[[(3S,6R,9S,12R,15S,18R,21S)-3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | CAS RN:85800-09-5 | PubChem SID:175266973 | CAS RN:22601-59-8 | UNII:DDA3RRX0P7 | BACITRACIN A | Bacitracin | Bacitracin A | PubChem CID:10909430"
+BMGC_DG00933,BMG_DG007930,5-SULFANYLPENTANOIC ACID | UNII:VPX7SE7TKE | CAS RN:30247-98-4 | PubChem CID:10909614 | PubChem SID:459275333
+BMGC_DG00934,BMG_DG007937,PubChem CID:10909908 | CAS RN:23631-84-7 | L-methionine (S)-S-oxide | DrugBank ID:DB02467 | (2S)-2-amino-4-[(S)-methylsulfinyl]butanoic acid | L-Methionine (S)-S-oxide
+BMGC_DG00935,BMG_DG007938,Selenious Acid | selenous acid | DrugBank ID:DB11127 | UNII:F6A27P4Q4R | PubChem CID:1091 | CAS RN:7783-00-8 | Selenious acid | PubChem SID:198977015 | SELENIOUS ACID
+BMGC_DG00936,BMG_DG007940,"PubChem CID:10910111 | 1-AMINO-2-PHENYLCYCLOPROPANECARBOXYLIC ACID, (1S-CIS)- | UNII:61O01AHZ0M | PubChem SID:316915784 | PubChem SID:313184251 | CAS RN:129101-43-5 | UNII:D4NJ2ZUL47 | 1-AMINO-2-PHENYLCYCLOPROPANECARBOXYLIC ACID, CIS- | CAS RN:3200-80-4"
+BMGC_DG00937,BMG_DG007967,1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea | PubChem CID:10915062 | DrugBank ID:DB06883
+BMGC_DG00938,BMG_DG007978,PubChem CID:10917 | NDC:0517-1045 | (3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate | NDC:54482-145 | LEVOCARNITINE | Levocarnitine | NDC:0517-1075 | PubChem SID:175267623 | NDC:54482-147 | NDC:71656-016 | NDC:16571-762 | NDC:70954-492 | NDC:52817-830 | CAS RN:44985-71-9 | NDC:70954-139 | NDC:64980-503 | UNII:0G389FZZ9M | NDC:54482-144 | NDC:70954-140 | NDC:54482-148 | DrugBank ID:DB00583 | NDC:0143-9852 | CAS RN:541-15-1
+BMGC_DG00939,BMG_DG007980,(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium | CAS RN:44984-08-9 | DrugBank ID:DB02648 | PubChem CID:10918 | (3-Carboxy-2-(R)-hydroxy-propyl)-trimethyl-ammonium | [(2R)-3-carboxy-2-hydroxypropyl]-trimethylazanium
+BMGC_DG00940,BMG_DG008013,PubChem SID:478838455 | CAS RN:329203-01-2 | 2-Methyl-4-(2-phenylethynyl)thiazole | 2-METHYL-4-(2-PHENYLETHYNYL)THIAZOLE | PubChem CID:10921526 | UNII:A58TEG4UBJ
+BMGC_DG00941,BMG_DG008048,BUTANAMIDE | PubChem SID:198959971 | Butyramide | DrugBank ID:DB02121 | CAS RN:541-35-5 | PubChem CID:10927 | butanamide | UNII:9J6OR937VR
+BMGC_DG00942,BMG_DG008050,9-O-DEMETHYLMITRAGYNINE | PubChem SID:461434878 | UNII:RNE3SSW79R | CAS RN:425623-55-8 | PubChem CID:10927114
+BMGC_DG00943,BMG_DG008065,"PubChem SID:198938562 | CAS RN:121263-19-2 | UNII:I271P23G24 | Calphostin C | PubChem CID:10930781 | [(2R)-1-[3,10-dihydroxy-12-[(2R)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate | CALPHOSTIN C"
+BMGC_DG00944,BMG_DG008076,CAS RN:140-92-1 | PROXAN POTASSIUM | PubChem CID:10931938 | PubChem SID:198984445 | UNII:CF12586ULS
+BMGC_DG00945,BMG_DG008155,CAS RN:71911-90-5 | UNII:8795XG0M1T | PubChem CID:109374149 | TERRETONIN | PubChem SID:287446121
+BMGC_DG00946,BMG_DG008192,UNII:AIQ630U6XO | Furtrethonium | CAS RN:7618-86-2 | PubChem SID:198973060 | furan-2-ylmethyl(trimethyl)azanium | FURTRETHONIUM | PubChem CID:10938
+BMGC_DG00947,BMG_DG008260,"(19S)-10-[(E)-2-aminoethoxyiminomethyl]-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione | PubChem CID:10950142 | Namitecan | PubChem SID:198990139 | CAS RN:372105-27-6 | DrugBank ID:DB12124 | CAS RN:292621-05-7 | UNII:X34Z8N66T3 | NAMITECAN"
+BMGC_DG00948,BMG_DG008272,delta-Valerolactone | PubChem SID:198938910 | oxan-2-one | UNII:14V1X9149L | PubChem CID:10953 | DELTA-VALEROLACTONE | CAS RN:26354-94-9 | CAS RN:542-28-9
+BMGC_DG00949,BMG_DG008305,OVALICIN | Ovalicin | PubChem SID:474492451 | PubChem CID:10957430 | CAS RN:19683-98-8 | UNII:XBF6GMZ9TW
+BMGC_DG00950,BMG_DG008347,Malonaldehyde | DrugBank ID:DB03057 | PubChem CID:10964 | propanedial | CAS RN:542-78-9 | Malondialdehyde | PubChem SID:198973102 | UNII:4Y8F71G49Q | MALONDIALDEHYDE
+BMGC_DG00951,BMG_DG008370,"4-Piperazin-1-ylthieno[3,2-c]pyridine | PubChem CID:10966027 | 4-PIPERAZIN-1-YLTHIENO(3,2-C)PYRIDINE | PubChem SID:478838417 | CAS RN:106261-27-2 | UNII:SJ2ZNT5VA2"
+BMGC_DG00952,BMG_DG008374,PubChem CID:1096735 | CAS RN:736945-96-3 | GSK-417651A | UNII:WV82DEG4YA | PubChem SID:441096950
+BMGC_DG00953,BMG_DG008398,PubChem SID:198954531 | 2-acetamidoacetic acid | DrugBank ID:DB02713 | N-Acetylglycine | Acetylamino-Acetic Acid | UNII:U2UT4677KR | PubChem CID:10972 | ACETURIC ACID | CAS RN:543-24-8
+BMGC_DG00954,BMG_DG008402,"CAS RN:76706-55-3 | PubChem SID:363909263 | MYXOTHIAZOL | (2E,4R,5S,6E)-3,5-dimethoxy-4-methyl-7-[2-[2-[(2S,3E,5E)-7-methylocta-3,5-dien-2-yl]-1,3-thiazol-4-yl]-1,3-thiazol-4-yl]hepta-2,6-dienamide | PubChem CID:10972974 | DrugBank ID:DB04741 | UNII:6VY98BQ7NB | Myxothiazol"
+BMGC_DG00955,BMG_DG008422,CAS RN:79307-47-4 | UNII:3GV9J2GPP2 | PubChem CID:10975947 | PubChem SID:459055995 | 10-DEOXYEUCOMMIOL
+BMGC_DG00956,BMG_DG008427,Phosphonothreonine | PubChem CID:10976469 | DrugBank ID:DB02482
+BMGC_DG00957,BMG_DG008442,PubChem CID:10979337 | PubChem SID:312524720 | CAS RN:565460-15-3 | UNII:B8371SFA9K | URB-602
+BMGC_DG00958,BMG_DG008445,CAS RN:356068-93-4 | PubChem CID:10979489 | SUNITINIB ACID | PubChem SID:443624337 | UNII:3TA57TDQ6K
+BMGC_DG00959,BMG_DG008453,PubChem SID:175271746 | OCTODRINE | PubChem CID:10982 | UNII:3GQ9E911BI | CAS RN:543-82-8
+BMGC_DG00960,BMG_DG008531,"DrugBank ID:DB09207 | 5-bromo-N-[(6R)-1-ethyl-4-methyl-1,4-diazepan-6-yl]-2-methoxy-4-(methylamino)benzamide | PubChem CID:10993014 | AS-8112"
+BMGC_DG00961,BMG_DG008586,"1,2-dichloroethane | DrugBank ID:DB03733 | CAS RN:107-06-2 | ETHYLENE DICHLORIDE | PubChem CID:11 | CAS RN:52399-93-6 | Ethylene Dichloride | PubChem SID:198949617 | UNII:55163IJI47 | 1,2-Dichloroethane"
+BMGC_DG00962,BMG_DG008594,"UNII:8FG9H9D31J | DrugBank ID:DB11644 | Tafamidis | NDC:0069-8730 | 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid | TAFAMIDIS | CAS RN:137464-18-7 | PubChem SID:175268578 | PubChem CID:11001318 | CAS RN:594839-88-0"
+BMGC_DG00963,BMG_DG008611,MYRISTIC ACID | CAS RN:62217-70-3 | CAS RN:544-63-8 | UNII:0I3V7S25AW | PubChem CID:11005 | tetradecanoic acid | Myristic Acid | DrugBank ID:DB08231 | CAS RN:32112-52-0 | Myristic acid | PubChem SID:175267930
+BMGC_DG00964,BMG_DG008637,UNII:J24U57ALH7 | 2-(4-CHLOROBENZYLIDENE)CYCLOPENTANONE | PubChem SID:475550302 | CAS RN:134791-44-9 | 2-(4-Chlorobenzylidene)cyclopentanone | PubChem CID:11009103
+BMGC_DG00965,BMG_DG008677,PubChem CID:11016019 | CAS RN:20126-59-4 | UNII:X641V68UOZ | PubChem SID:333495757 | DIOSMETIN 7-O-GLUCOSIDE
+BMGC_DG00966,BMG_DG008683,"PubChem SID:198971267 | POLDINE | CAS RN:596-50-9 | UNII:8R92106W2F | Poldine | PubChem CID:11018 | (1,1-dimethylpyrrolidin-1-ium-2-yl)methyl 2-hydroxy-2,2-diphenylacetate | DrugBank ID:DB13507"
+BMGC_DG00967,BMG_DG008702,"PubChem SID:198952029 | PubChem CID:1102 | N'-(3-aminopropyl)butane-1,4-diamine | CAS RN:133483-05-3 | CAS RN:1122077-27-3 | CAS RN:124-20-9 | SPERMIDINE | UNII:U87FK77H25 | CAS RN:133483-10-0 | DrugBank ID:DB03566 | Spermidine"
+BMGC_DG00968,BMG_DG008728,"ZINC CITRATE | PubChem SID:175265739 | Zinc citrate | CAS RN:546-46-3 | PubChem CID:11023 | UNII:K72I3DEX9B | DrugBank ID:DB11154 | CAS RN:5590-32-9 | trizinc;2-hydroxypropane-1,2,3-tricarboxylate | Zinc Citrate"
+BMGC_DG00969,BMG_DG008756,Deoxynojirimycin tetrabenzyl ether | PubChem SID:496143330 | DEOXYNOJIRIMYCIN TETRABENZYL ETHER | UNII:CXN5WZQ882 | PubChem CID:11027759 | CAS RN:69567-11-9
+BMGC_DG00970,BMG_DG008760,"PubChem SID:336286866 | PubChem CID:1102887 | 4-(3-METHYL-5-OXO-1-PHENYL-4,5-DIHYDRO-1H-PYRAZOL-4-YLAZO)-BENZENESULFONAMIDE | CAS RN:32039-48-8 | UNII:F64D20266I"
+BMGC_DG00971,BMG_DG008762,Magnesium Carbonate | PubChem CID:11029 | Magnesium carbonate | UNII:0IHC698356 | CAS RN:53678-75-4 | MAGNESITE | magnesium;carbonate | CAS RN:13717-00-5 | CAS RN:7757-69-9 | PubChem SID:175267914 | CAS RN:546-93-0 | DrugBank ID:DB09481 | CAS RN:695808-81-2
+BMGC_DG00972,BMG_DG008772,"SPERMINE | Spermine | CAS RN:71052-31-8 | DrugBank ID:DB00127 | N,N'-bis(3-aminopropyl)butane-1,4-diamine | UNII:2FZ7Y3VOQX | CAS RN:71-44-3 | PubChem CID:1103 | PubChem SID:198942683"
+BMGC_DG00973,BMG_DG008781,"CAS RN:473251-79-5 | 2-PMPA, (2R)- | UNII:SE262M2WRR | PubChem SID:474493605 | PubChem CID:11031538"
+BMGC_DG00974,BMG_DG008782,CAS RN:72490-14-3 | 2-(4-phenoxyphenoxy)ethanamine | 2-(4-Phenoxyphenoxy)ethanamine | PubChem CID:11031651
+BMGC_DG00975,BMG_DG008816,PubChem SID:198946324 | CAS RN:362718-73-8 | PubChem CID:11039077 | UNII:2I921E370K | L-869298
+BMGC_DG00976,BMG_DG008836,5-BENZYL-1H-PYRAZOLE-3-CARBOXYLIC ACID | CAS RN:595610-51-8 | PubChem SID:485663419 | 5-Benzyl-1H-pyrazole-3-carboxylic acid | UNII:M57JYJ77FR | PubChem CID:11041813
+BMGC_DG00977,BMG_DG008876,"CAS RN:125399-78-2 | ACID RED 87 | CAS RN:17372-87-1 | PubChem SID:198935305 | disodium;2-(2,4,5,7-tetrabromo-3-oxido-6-oxoxanthen-9-yl)benzoate | Eosin | UNII:TDQ283MPCW | DrugBank ID:DB13706 | CAS RN:548-26-5 | PubChem CID:11048"
+BMGC_DG00978,BMG_DG008943,"UNII:J4Z741D6O5 | [4-[bis[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium;chloride | NDC:55758-373 | PubChem CID:11057 | GENTIAN VIOLET | NDC:24286-1531 | NDC:82645-917 | NDC:69469-010 | NDC:54633-014 | NDC:73386-152 | Gentian Violet | NDC:0395-1005 | NDC:24385-003 | NDC:73635-1219 | CAS RN:548-62-9 | NDC:0395-1003 | PubChem SID:175266116"
+BMGC_DG00979,BMG_DG008985,PubChem CID:110634 | Vardenafil | DrugBank ID:DB00862
+BMGC_DG00980,BMG_DG008986,"NDC:47335-012 | NDC:51655-487 | NDC:60219-1347 | NDC:76420-546 | (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione | NDC:60219-1346 | NDC:13668-565 | NDC:71335-1255 | NDC:82804-040 | NDC:68071-3781 | NDC:72865-106 | NDC:50090-7314 | NDC:70518-3931 | NDC:13668-566 | NDC:71610-567 | NDC:31722-646 | NDC:43598-575 | NDC:16714-077 | NDC:69097-374 | NDC:82804-042 | NDC:50090-7152 | NDC:31722-645 | NDC:46708-180 | NDC:68071-3777 | NDC:46708-178 | NDC:35561-256 | NDC:0002-4462 | CAS RN:1242099-07-5 | NDC:0002-4463 | NDC:72789-430 | NDC:63629-8409 | NDC:29300-286 | NDC:70771-1475 | NDC:0002-4464 | NDC:50090-7391 | NDC:71335-1620 | NDC:70771-1478 | NDC:71205-268 | NDC:65862-880 | NDC:71821-008 | NDC:72789-344 | NDC:72789-407 | NDC:75834-248 | NDC:50090-7390 | NDC:68382-898 | NDC:82804-112 | NDC:24979-730 | NDC:62332-177 | NDC:0480-9277 | NDC:31722-643 | NDC:24979-729 | NDC:70771-1477 | NDC:47335-011 | NDC:42291-864 | NDC:62332-178 | NDC:13668-581 | NDC:71205-400 | NDC:50268-738 | PubChem SID:175268234 | NDC:71205-502 | NDC:35561-255 | NDC:35573-462 | NDC:27241-123 | NDC:68071-3601 | NDC:50090-7315 | NDC:0480-2309 | NDC:67184-0525 | NDC:50090-6150 | NDC:43547-047 | NDC:42291-866 | NDC:43598-578 | NDC:43547-051 | NDC:46287-045 | NDC:69238-1347 | NDC:72865-104 | NDC:68071-3598 | NDC:0480-2310 | NDC:65862-852 | NDC:69238-1349 | NDC:75834-250 | NDC:68180-914 | NDC:50090-4660 | NDC:82968-005 | NDC:68788-8465 | NDC:16729-372 | NDC:33342-266 | NDC:16729-370 | NDC:76420-544 | NDC:75834-247 | NDC:68071-5186 | NDC:63629-8157 | CAS RN:171596-29-5 | NDC:35573-463 | NDC:33342-267 | NDC:13668-567 | NDC:68788-8664 | NDC:82968-002 | DrugBank ID:DB00820 | CAS RN:171488-03-2 | NDC:71335-2467 | NDC:71610-603 | NDC:43547-050 | NDC:71610-214 | NDC:0480-2308 | NDC:70954-434 | NDC:33342-278 | NDC:29300-288 | NDC:70518-3697 | NDC:71335-2363 | NDC:76420-542 | NDC:51655-473 | NDC:71205-418 | NDC:82009-080 | NDC:16729-371 | NDC:62332-179 | NDC:43547-049 | NDC:0093-3016 | NDC:68382-896 | NDC:51655-063 | NDC:46708-177 | NDC:47335-010 | NDC:68382-899 | PubChem CID:110635 | NDC:50090-6945 | Tadalafil | NDC:33342-265 | NDC:35561-254 | CAS RN:171596-27-3 | NDC:35561-257 | NDC:42291-865 | NDC:50268-739 | NDC:71821-006 | NDC:82868-028 | NDC:67046-1371 | NDC:71610-581 | NDC:46708-179 | NDC:68071-3586 | NDC:72789-324 | NDC:43063-969 | NDC:71335-1587 | NDC:67184-0526 | NDC:82968-001 | NDC:70518-3864 | NDC:13668-568 | TADALAFIL | NDC:31722-647 | NDC:43598-576 | NDC:69238-1346 | NDC:43598-574 | NDC:82968-003 | NDC:65862-850 | NDC:65862-853 | NDC:70771-1476 | NDC:75834-249 | NDC:71205-269 | NDC:71205-754 | NDC:16714-075 | NDC:24979-728 | NDC:69097-376 | NDC:66302-467 | NDC:71821-007 | NDC:0093-3019 | NDC:68071-5202 | NDC:70954-433 | NDC:31722-644 | NDC:0002-4465 | NDC:68071-3545 | NDC:65862-851 | NDC:35573-461 | NDC:69097-526 | NDC:72865-108 | NDC:76420-642 | NDC:47335-009 | NDC:0093-3018 | NDC:60219-1349 | NDC:62332-180 | NDC:67184-0523 | NDC:0093-3334 | NDC:42291-804 | NDC:43598-573 | NDC:71821-009 | NDC:71205-720 | NDC:71610-213 | NDC:72865-107 | NDC:68382-897 | NDC:16714-074 | NDC:68071-3753 | NDC:16714-076 | NDC:71335-1884 | NDC:76420-541 | UNII:742SXX0ICT | NDC:72789-408 | NDC:24979-727 | NDC:35573-460 | NDC:69097-375 | NDC:0480-2311 | NDC:67184-0524 | NDC:82804-041 | NDC:69238-1348 | NDC:0093-3017 | NDC:68071-3758 | NDC:69097-373 | NDC:16729-369 | NDC:43547-990 | NDC:33342-268 | NDC:76420-126 | NDC:29300-287 | NDC:29300-289 | NDC:60219-1348 | NDC:70954-435 | NDC:42291-867 | NDC:68788-8153 | NDC:76420-543 | NDC:80425-0443"
+BMGC_DG00981,BMG_DG009001,UNII:4A04YKB3FT | CAS RN:549-21-3 | PubChem CID:11066 | 8-OXYBERBERINE | PubChem SID:198965631
+BMGC_DG00982,BMG_DG009032,"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE | PubChem CID:11069133 | DrugBank ID:DB06891"
+BMGC_DG00983,BMG_DG009036,METHYL CHENODEOXYCHOLATE | PubChem CID:11069533 | CAS RN:3057-04-3 | PubChem SID:318164138 | UNII:48O35JP4YI
+BMGC_DG00984,BMG_DG009062,"DrugBank ID:DB02172 | PubChem CID:11073745 | 2,5-Dideoxy-2,5-Imino-D-Glucitol"
+BMGC_DG00985,BMG_DG009075,PubChem SID:485666783 | UNII:A42VTD2TBN | 4-Methoxy-1-naphthylamine | CAS RN:16430-99-2 | 4-METHOXY-1-NAPHTHYLAMINE | PubChem CID:11074644
+BMGC_DG00986,BMG_DG009091,"PubChem CID:11077541 | CAS RN:274901-16-5 | (2S)-1-[2-[[(5S,7R)-3-hydroxy-1-adamantyl]amino]acetyl]pyrrolidine-2-carbonitrile | (S)-1-[2-((5S,7S)-3-hydroxy-adamantan-1-ylamino)-acetyl]-pyrrolidine-2-carbonitrile"
+BMGC_DG00987,BMG_DG009103,CAS RN:551-06-4 | PubChem SID:198975586 | PubChem CID:11080 | 1-NAPHTHYL ISOTHIOCYANATE | UNII:HG44814A3V
+BMGC_DG00988,BMG_DG009107,[[(2-Ethylhexyl)imino]bis(methylene)]bisphosphonic acid | (((2-ETHYLHEXYL)IMINO)BIS(METHYLENE))BISPHOSPHONIC ACID | CAS RN:6204-28-0 | UNII:PNC85SZ934 | PubChem SID:485663794 | PubChem CID:110803
+BMGC_DG00989,BMG_DG009111,"CAS RN:551-16-6 | UNII:QR0C4R7XVN | PubChem CID:11082 | PubChem SID:175268562 | 6-AMINOPENICILLANIC ACID | (2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | 6-Aminopenicillanic acid"
+BMGC_DG00990,BMG_DG009140,"2-PMPA, (2S)- | CAS RN:473251-81-9 | PubChem SID:474493604 | PubChem CID:11085481 | UNII:KYW3RS2DJY"
+BMGC_DG00991,BMG_DG009199,"UNII:CQT975GLYF | PubChem CID:11095 | ERIODICTYOL, (±)- | ERIODICTYOL, (+/-)- | CAS RN:4049-38-1 | PubChem SID:316914700"
+BMGC_DG00992,BMG_DG009206,"PubChem CID:11095381 | 6-CHLORO-5-PROPYL-2,4(1H,3H)-PYRIMIDINEDIONE | 6-Chloro-5-propyl-2,4(1H,3H)-pyrimidinedione | CAS RN:19030-76-3 | PubChem SID:482553887 | UNII:X2N4EP6EJW"
+BMGC_DG00993,BMG_DG009234,"CAS RN:202815-28-9 | PubChem CID:11099375 | (E)-1-(2,4-dihydroxyphenyl)-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one | Licoagrochalcone A"
+BMGC_DG00994,BMG_DG009240,PubChem CID:111 | PubChem SID:472411817 | CAS RN:462-88-4 | 3-UREIDOPROPIONIC ACID | 3-Ureidopropionic acid | 3-(carbamoylamino)propanoic acid | UNII:C24QL9BQ36
+BMGC_DG00995,BMG_DG009241,PubChem SID:175265552 | butanedioic acid | CAS RN:110-15-6 | DrugBank ID:DB00139 | SUCCINIC ACID | Succinic acid | PubChem CID:1110 | UNII:AB6MNQ6J6L | CAS RN:26776-24-9 | Succinic Acid
+BMGC_DG00996,BMG_DG009242,PubChem CID:11100 | FUROIN | PubChem SID:198979676 | CAS RN:552-86-3 | UNII:FP41RNB020
+BMGC_DG00997,BMG_DG009251,"PubChem CID:11101442 | (8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | CAS RN:19897-08-6 | 25-Hydroxycholest-4-en-3-one"
+BMGC_DG00998,BMG_DG009258,"UNII:HBT6M5H379 | Hematoporphyrin | CAS RN:136752-88-0 | PubChem SID:198950079 | CAS RN:14459-29-1 | PubChem CID:11103 | 3-[18-(2-carboxyethyl)-8,13-bis(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid | HEMATOPORPHYRIN"
+BMGC_DG00999,BMG_DG009268,"ANHYDROVINBLASTINE | PubChem SID:249492192 | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R)-17-ethyl-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9,16-pentaen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | DrugBank ID:DB12586 | Anhydrovinblastine | PubChem CID:11104750 | CAS RN:38390-45-3 | UNII:5B622U08B3"
+BMGC_DG01000,BMG_DG009283,L-DEOXYALTRONOJIRIMYCIN | PubChem CID:11105683 | CAS RN:188779-13-7 | UNII:MC3UKB9VNH | L-Deoxyaltronojirimycin | PubChem SID:472425816
+BMGC_DG01001,BMG_DG009288,PubChem SID:198939742 | UNII:I64IQB89JB | CAS RN:366-13-2 | NEUTRAL RED BASE | PubChem CID:11106
+BMGC_DG01002,BMG_DG009315,"(1S,3R,4E,8E,12S,13E)-1,5,9-trimethyl-12-propan-2-ylcyclotetradeca-4,8,13-triene-1,3-diol | PubChem CID:11109567 | Cembra-2,7,11-triene-4,6-diol"
+BMGC_DG01003,BMG_DG009337,"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid | DrugBank ID:DB02316 | PubChem CID:11113761"
+BMGC_DG01004,BMG_DG009341,PubChem CID:11115 | CAS RN:4439-25-2 | Metabutethamine | METABUTETHAMINE | DrugBank ID:DB13578 | UNII:PSJ9VIF3RV | 2-(2-methylpropylamino)ethyl 3-aminobenzoate | PubChem SID:198990624
+BMGC_DG01005,BMG_DG009371,PubChem SID:443625149 | OCTYL SULFAMATE | UNII:LB3L4HVA9J | CAS RN:282725-75-1 | PubChem CID:11117301
+BMGC_DG01006,BMG_DG009386,PubChem SID:198956205 | Succinic semialdehyde | 4-oxobutanoic acid | CAS RN:692-29-5 | UNII:M73BX3CPMU | PubChem CID:1112 | SUCCINIC SEMIALDEHYDE
+BMGC_DG01007,BMG_DG009389,"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE | DrugBank ID:DB07903 | PubChem CID:11120251"
+BMGC_DG01008,BMG_DG009396,"UNII:VF06HB6AZN | 2-METHYL-1,4-BENZOQUINONE | PubChem SID:198962244 | CAS RN:553-97-9 | p-Toluquinone | 2-methylcyclohexa-2,5-diene-1,4-dione | PubChem CID:11122"
+BMGC_DG01009,BMG_DG009403,NDC:0054-8526 | NDC:46708-303 | dilithium;carbonate | NDC:62332-013 | NDC:46708-304 | NDC:68462-222 | NDC:70518-1481 | NDC:0378-1450 | NDC:0054-2527 | NDC:62559-280 | NDC:67046-1004 | NDC:70518-2312 | NDC:37662-0936 | NDC:68462-223 | NDC:0220-3128 | NDC:72789-173 | NDC:62332-014 | NDC:71610-557 | NDC:63187-304 | NDC:70518-3565 | NDC:37662-0941 | NDC:43063-901 | NDC:31722-544 | NDC:37662-0938 | NDC:72789-174 | PubChem CID:11125 | NDC:43857-0020 | NDC:71335-0120 | NDC:0220-3131 | NDC:72789-171 | NDC:51079-180 | NDC:0054-0021 | NDC:70518-2699 | NDC:37662-0937 | NDC:62332-148 | NDC:68084-655 | NDC:63629-1917 | NDC:23155-763 | NDC:68462-221 | NDC:37662-0935 | NDC:0054-4527 | NDC:42291-496 | NDC:0054-2526 | NDC:68462-220 | Lithium Carbonate | DrugBank ID:DB14509 | NDC:0054-0020 | NDC:0615-8480 | NDC:71205-238 | NDC:46708-148 | NDC:60687-806 | NDC:70518-0608 | NDC:50090-6052 | NDC:70518-2086 | NDC:62756-430 | NDC:70518-0668 | LITHIUM CARBONATE | CAS RN:554-13-2 | NDC:0054-8527 | NDC:44911-0147 | NDC:31722-546 | NDC:71335-1006 | NDC:70518-4115 | NDC:31722-545 | NDC:68462-224 | UNII:2BMD2GNA4V | NDC:64980-205 | NDC:64980-278 | NDC:48951-6091 | NDC:0054-8528 | NDC:37662-0940 | NDC:0054-2531 | NDC:50090-1470 | NDC:72789-172 | NDC:70518-2345 | NDC:62332-015 | NDC:68084-640 | NDC:0378-1300 | NDC:55154-4920 | NDC:46708-305 | NDC:37662-0939 | NDC:70518-1434 | PubChem SID:175266606
+BMGC_DG01010,BMG_DG009433,"Linamarin | CAS RN:554-35-8 | 2-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropanenitrile | PubChem SID:198951228 | LINAMARIN | UNII:H3V9RP3WLO | PubChem CID:11128"
+BMGC_DG01011,BMG_DG009441,"CAS RN:741657-02-3 | UNII:S2TY6482KP | PubChem CID:11129932 | 1-(2-(TRICYCLO(3.3.1.13,7)DEC-1-YLAMINO)ACETYL)-2-PYRROLIDINECARBONITRILE, (2S)-"
+BMGC_DG01012,BMG_DG009455,"Anecortave acetate | UNII:Y0PC411K4T | PubChem CID:111332 | ANECORTAVE ACETATE | DrugBank ID:DB05288 | [2-[(8S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | PubChem SID:198990172 | CAS RN:7753-60-8"
+BMGC_DG01013,BMG_DG009459,CAS RN:7801-18-5 | PubChem CID:111337 | PubChem SID:319892352 | KURCHININ | UNII:3EYK2B885X
+BMGC_DG01014,BMG_DG009485,"UNII:OU36OO5MTN | DrugBank ID:DB08632 | PubChem CID:11138 | Trimesic acid | CAS RN:554-95-0 | 1,3,5-BENZENETRICARBOXYLIC ACID | PubChem SID:198941699"
+BMGC_DG01015,BMG_DG009501,PubChem SID:198964774 | CAS RN:87392-12-9 | S-Metolachlor | UNII:1O4NMK7I6H | S-METOLACHLOR | PubChem CID:11140605 | 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide
+BMGC_DG01016,BMG_DG009506,PubChem CID:11141268 | 1-(4-Nitrophenyl)-2-(phenylsulfonyl)ethanone | UNII:WJ46RZ52VH | PubChem SID:485663627 | 1-(4-NITROPHENYL)-2-(PHENYLSULFONYL)ETHANONE | CAS RN:38488-17-4
+BMGC_DG01017,BMG_DG009516,"PubChem CID:11143173 | DrugBank ID:DB06837 | (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide"
+BMGC_DG01018,BMG_DG009547,1-phenyl-2-pyrrolidin-1-ylpentan-1-one | CAS RN:14530-33-7 | alpha-Pyrrolidinovalerophenone | PubChem SID:251965667 | .ALPHA.-PYRROLIDINOPENTIOPHENONE | PubChem CID:11148955 | UNII:767K3AWA4R
+BMGC_DG01019,BMG_DG009553,3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL | PubChem CID:11149479 | DrugBank ID:DB07712
+BMGC_DG01020,BMG_DG009556,PubChem CID:11149707 | DrugBank ID:DB07388 | ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
+BMGC_DG01021,BMG_DG009557,DrugBank ID:DB07842 | PubChem CID:11149906 | (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid
+BMGC_DG01022,BMG_DG009559,N-(3-PHENOXY-4-PYRIDINYL)ETHANESULFONAMIDE | PubChem SID:459275725 | PubChem CID:11150126 | UNII:4GST782ZVG | CAS RN:833455-54-2
+BMGC_DG01023,BMG_DG009563,4-HYDROXY-2-BUTANONE | PubChem CID:111509 | 4-Hydroxy-2-Butanone | CAS RN:590-90-9 | DrugBank ID:DB04094 | 4-hydroxybutan-2-one | UNII:TCM0BJ44MF | PubChem SID:198948858
+BMGC_DG01024,BMG_DG009566,UNII:3NQ2FNM62E | 2-((2-METHOXYPHENOXY)METHYL)-4-(PHENYLMETHYL)MORPHOLINE | PubChem CID:11151135 | CAS RN:203861-88-5
+BMGC_DG01025,BMG_DG009568,ABT-107 FREE BASE | PubChem SID:461433702 | PubChem CID:11151363 | UNII:SXS38HR98H | CAS RN:855291-54-2
+BMGC_DG01026,BMG_DG009572,"JNJ-18038683 FREE BASE | JNJ-18038683 free base | PubChem CID:11151899 | CAS RN:851373-91-6 | PubChem SID:252164112 | 1-benzyl-3-(4-chlorophenyl)-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine | UNII:28PGH5X4OQ"
+BMGC_DG01027,BMG_DG009575,(S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide | CAS RN:860352-01-8 | PubChem CID:11152667 | PubChem SID:198971572 | UNII:5D822Y3L1H | CAS RN:1019773-80-8 | AZD-7762 | 3-(carbamoylamino)-5-(3-fluorophenyl)-N-[(3S)-piperidin-3-yl]thiophene-2-carboxamide | DrugBank ID:DB12242
+BMGC_DG01028,BMG_DG009577,"N-(2-CHLORO-6-METHYLPHENYL)-2-((2,6-DIMETHYL-4-PYRIMIDINYL)AMINO)-5-THIAZOLECARBOXAMIDE | UNII:N9PH4O199D | CAS RN:302961-18-8 | PubChem SID:319892546 | PubChem CID:11153014"
+BMGC_DG01029,BMG_DG009584,"PubChem SID:198939878 | CARIPRAZINE | Cariprazine | NDC:61874-145 | NDC:61874-115 | PubChem CID:11154555 | CAS RN:839712-12-8 | 3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea | DrugBank ID:DB06016 | NDC:61874-130 | UNII:F6RJL8B278 | CAS RN:1480744-38-4 | NDC:61874-160"
+BMGC_DG01030,BMG_DG009585,"BRIVANIB ALANINATE | DrugBank ID:DB11865 | [(2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-yl] (2S)-2-aminopropanoate | PubChem SID:198987707 | PubChem CID:11154925 | Brivanib alaninate | UNII:U2Y5OFN795 | CAS RN:649735-63-7"
+BMGC_DG01031,BMG_DG009593,"DrugBank ID:DB11660 | 4-nitrooxybutyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate | LATANOPROSTENE BUNOD | Latanoprostene bunod | PubChem CID:11156438 | Latanoprostene Bunod | PubChem SID:198934872 | NDC:24208-504 | CAS RN:860005-21-6 | UNII:I6393O0922"
+BMGC_DG01032,BMG_DG009605,RO-4491533 | CAS RN:579482-31-8 | PubChem SID:472423122 | PubChem CID:11158623 | UNII:HF59BT62UG
+BMGC_DG01033,BMG_DG009616,"DrugBank ID:DB05939 | CAS RN:1934699-08-7 | MK-0354 | UNII:4U62D8JYIQ | PubChem SID:313184082 | PubChem CID:11159621 | 3-(2H-tetrazol-5-yl)-1,4,5,6-tetrahydrocyclopenta[c]pyrazole | CAS RN:851776-28-8"
+BMGC_DG01034,BMG_DG009624,"PubChem CID:11160307 | 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol | DrugBank ID:DB08443"
+BMGC_DG01035,BMG_DG009631,PubChem CID:11161 | Glycyl-glycyl-glycine | PubChem SID:198984596 | TRIGLYCINE | UNII:CVK73ZDQ8B | 2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetic acid | CAS RN:556-33-2
+BMGC_DG01036,BMG_DG009639,BX-517 | PubChem CID:11161844 | UNII:SYV8VN8W5K | PubChem SID:198983953 | CAS RN:946843-63-6
+BMGC_DG01037,BMG_DG009641,PubChem CID:11162285 | RU-56279 | CAS RN:143782-20-1 | PubChem SID:445500227 | UNII:6PAG4TC385
+BMGC_DG01038,BMG_DG009647,DIGLYCINE | CAS RN:556-50-3 | PubChem CID:11163 | PubChem SID:175265918 | UNII:10525P22U0
+BMGC_DG01039,BMG_DG009670,PubChem SID:198985826 | UNII:PGR0H531I4 | PubChem CID:11167112 | AMG-548 | CAS RN:864249-60-5
+BMGC_DG01040,BMG_DG009671,4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide | DrugBank ID:DB06938 | PubChem CID:11167118
+BMGC_DG01041,BMG_DG009672,DrugBank ID:DB08896 | REGORAFENIB ANHYDROUS | PubChem CID:11167602 | PubChem SID:175267155 | Regorafenib | CAS RN:755037-03-7 | CAS RN:835621-08-4 | 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide | UNII:24T2A1DOYB
+BMGC_DG01042,BMG_DG009673,PubChem SID:198981309 | UNII:3FWQ4MD98O | NBI-42902 | CAS RN:352290-60-9 | PubChem CID:11167850
+BMGC_DG01043,BMG_DG009675,PubChem CID:11168182 | PubChem SID:474492599 | UNII:3FN59X9DPR | CAS RN:791789-61-2 | SB-699551
+BMGC_DG01044,BMG_DG009676,PubChem CID:11168203 | 3-ACETYL-11-KETO-.BETA.-BOSWELLIC ACID | CAS RN:67416-61-9 | UNII:BS16QT99Q1 | PubChem SID:198981150
+BMGC_DG01045,BMG_DG009681,"benzyl (2S)-2-[[[(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate | Osgemcitabine palabenamide | PubChem CID:11169170 | UNII:XCL1K2T28K | CAS RN:840506-29-8 | PubChem SID:346539254 | FOSGEMCITABINE PALABENAMIDE, P(RS)- | DrugBank ID:DB15057"
+BMGC_DG01046,BMG_DG009687,sulfate | PubChem SID:175265300 | Sulfate Ion | PubChem CID:1117 | DrugBank ID:DB14546 | UNII:7IS9N8KPMG | CAS RN:14808-79-8 | CAS RN:18785-72-3 | SULFATE ION
+BMGC_DG01047,BMG_DG009690,"CAS RN:66758-35-8 | TREHALOSE 6,6'-DIBEHENATE | Trehalose 6,6′-dibehenate | PubChem SID:478838410 | PubChem CID:11170611 | UNII:672NB7JH7R"
+BMGC_DG01048,BMG_DG009691,"Dotatate | UNII:MRL3739G66 | (2S,3R)-2-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-[[(2R)-3-phenyl-2-[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propanoyl]amino]-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]amino]-3-hydroxybutanoic acid | CAS RN:177943-88-3 | PubChem SID:198967548 | DrugBank ID:DB14554 | OXODOTREOTIDE | PubChem CID:11170867"
+BMGC_DG01049,BMG_DG009697,"DrugBank ID:DB07609 | N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE | PubChem CID:11171679"
+BMGC_DG01050,BMG_DG009698,PubChem CID:11171903 | CAS RN:85-27-8 | UNII:G37UFG162O | PubChem SID:175272107 | PHENYLETHYL RESORCINOL
+BMGC_DG01051,BMG_DG009709,"CAS RN:112111-47-4 | UNII:152JRG3T0U | PubChem CID:11173366 | MODAFINIL, (S)- | PubChem SID:252165374"
+BMGC_DG01052,BMG_DG009715,"Tetrodotoxin | UNII:3KUM2721U9 | TETRODOTOXIN | CAS RN:4368-28-9 | PubChem CID:11174599 | (1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol | PubChem SID:241179998"
+BMGC_DG01053,BMG_DG009719,AT-7867 | 4-(4-chlorophenyl)-4-[4-(1H-pyrazol-4-yl)phenyl]piperidine | DrugBank ID:DB07859 | UNII:ERF7YL2CE2 | 4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE | PubChem CID:11175137 | CAS RN:857531-00-1 | PubChem SID:441097184
+BMGC_DG01054,BMG_DG009727,UNII:70097M6I30 | DrugBank ID:DB14077 | CAS RN:557-04-0 | Magnesium stearate | MAGNESIUM STEARATE | PubChem CID:11177 | magnesium;octadecanoate | Magnesium Stearate | PubChem SID:175265911
+BMGC_DG01055,BMG_DG009732,BARETTIN | PubChem CID:11177588 | PubChem SID:474492524 | CAS RN:104311-70-8 | UNII:LAM9W2P97T | Barettin
+BMGC_DG01056,BMG_DG009735,"PubChem CID:11178236 | Sepantronium bromide | PubChem SID:198972028 | CAS RN:781661-94-7 | SEPANTRONIUM BROMIDE | UNII:7H5Q4J1CM5 | 1-(2-methoxyethyl)-2-methyl-3-(pyrazin-2-ylmethyl)benzo[f]benzimidazol-3-ium-4,9-dione;bromide"
+BMGC_DG01057,BMG_DG009737,"(1S,5S,6R,9S,15E,20R)-5-hydroxy-20-methyl-6-propan-2-yl-2-oxa-11,12-dithia-7,19,22-triazabicyclo[7.7.6]docos-15-ene-3,8,18,21-tetrone | DrugBank ID:DB12279 | PubChem SID:251966068 | Obp-801 | OBP-801 | PubChem CID:11178958 | UNII:30Q3VS5HZ4 | CAS RN:328548-11-4"
+BMGC_DG01058,BMG_DG009743,CAS RN:110942-02-4 | Sulfuric acid | CAS RN:7664-93-9 | Sulfuric Acid | CAS RN:12772-98-4 | DrugBank ID:DB11309 | PubChem CID:1118 | UNII:O40UQP6WCF | SULFURIC ACID | sulfuric acid | PubChem SID:175267916
+BMGC_DG01059,BMG_DG009747,"3-[4-[2-butyl-1-[4-(4-chlorophenoxy)phenyl]imidazol-4-yl]phenoxy]-N,N-diethylpropan-1-amine | CAS RN:603148-36-3 | CAS RN:1421852-66-5 | AZELIRAGON | UNII:LPU25F15UQ | DrugBank ID:DB12689 | PubChem CID:11180124 | PubChem SID:198947448 | Azeliragon"
+BMGC_DG01060,BMG_DG009759,"UNII:8UUN42B3QT | PubChem CID:11181988 | CAS RN:142706-18-1 | Pantoprazole, (R)- | PubChem SID:440089095 | 6-(difluoromethoxy)-2-[(R)-(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole | PANTOPRAZOLE, (R)-"
+BMGC_DG01061,BMG_DG009774,PubChem SID:198954262 | CAS RN:439608-12-5 | CP-810123 | UNII:E6G4550EC4 | PubChem CID:11184481
+BMGC_DG01062,BMG_DG009782,"PubChem CID:11185362 | N-(2,6-Diphenyl-4-pyrimidinyl)acetamide | N-(2,6-DIPHENYL-4-PYRIMIDINYL)ACETAMIDE | CAS RN:820961-40-8 | UNII:8UT769LEP5 | PubChem SID:482553888"
+BMGC_DG01063,BMG_DG009790,Edivoxetine | PubChem SID:198951347 | CAS RN:1194508-25-2 | PubChem CID:11186829 | UNII:3W9N3F4JOO | (1R)-2-(5-fluoro-2-methoxyphenyl)-1-[(2S)-morpholin-2-yl]-1-(oxan-4-yl)ethanol | DrugBank ID:DB09184 | CAS RN:852237-54-8 | EDIVOXETINE
+BMGC_DG01064,BMG_DG009791,PubChem CID:11186895 | CAS RN:6018-40-2 | CORYPALMINE | PubChem SID:198969027 | UNII:28R31624GX
+BMGC_DG01065,BMG_DG009796,"UNII:WA33E149SW | GALETERONE | (3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol | PubChem CID:11188409 | CAS RN:851983-85-2 | Galeterone | PubChem SID:198990861 | DrugBank ID:DB12415"
+BMGC_DG01066,BMG_DG009800,"DrugBank ID:DB07596 | PubChem CID:11188898 | (17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate"
+BMGC_DG01067,BMG_DG009815,NDC:10237-467 | NDC:10237-468 | CAS RN:557-34-6 | Zinc Acetate | zinc;diacetate | NDC:10237-466 | UNII:H2ZEY72PME | PubChem CID:11192 | NDC:10237-459 | PubChem SID:175267993 | NDC:10237-476 | NDC:10237-478 | DrugBank ID:DB14487 | NDC:10237-473 | NDC:10237-460 | NDC:10237-470 | CAS RN:82279-57-0 | ZINC ACETATE ANHYDROUS
+BMGC_DG01068,BMG_DG009818,N-[2-[(3S)-3-[[4-hydroxy-4-(5-pyrimidin-2-ylpyridin-2-yl)cyclohexyl]amino]pyrrolidin-1-yl]-2-oxoethyl]-3-(trifluoromethyl)benzamide | PubChem SID:441097559 | CAS RN:1372407-07-2 | UNII:3M2595V4KT | CAS RN:1341224-83-6 | CAS RN:857679-55-1 | PF-4136309 | PubChem CID:11192346
+BMGC_DG01069,BMG_DG009851,"DrugBank ID:DB07638 | PubChem CID:11197931 | (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL"
+BMGC_DG01070,BMG_DG009854,PubChem CID:11198569 | PubChem SID:459055538 | CAS RN:796874-99-2 | UNII:8J78D7C2FJ | KYP-2047
+BMGC_DG01071,BMG_DG009857,"UNII:6M6L09OU0A | BENZENESULFONAMIDE, N-HYDROXY-4-(5-METHYL-3-PHENYL-4-ISOXAZOLYL)- | PubChem CID:11198846 | CAS RN:501093-49-8 | PubChem SID:198968707"
+BMGC_DG01072,BMG_DG009859,"PubChem CID:11198924 | UNII:OPL214POJ1 | CAS RN:840486-93-3 | DrugBank ID:DB06579 | PubChem SID:198961665 | ADIPIPLON | 7-[[2-(3-fluoropyridin-2-yl)imidazol-1-yl]methyl]-2-methyl-8-propyl-[1,2,4]triazolo[1,5-c]pyrimidine | Adipiplon"
+BMGC_DG01073,BMG_DG009872,CAS RN:88191-84-8 | benzyl N-[(2s)-3-methyl-1-oxo-1-[(1-oxo-3-phenylpropan-2-yl)amino]butan-2-yl]carbamate | PubChem CID:11199915 | benzyl N-[(2S)-3-methyl-1-oxo-1-[(1-oxo-3-phenylpropan-2-yl)amino]butan-2-yl]carbamate
+BMGC_DG01074,BMG_DG009875,"ADL-5747 free base | N,N-diethyl-3-hydroxy-4-spiro[chromene-2,4'-piperidine]-4-ylbenzamide | PubChem SID:198939789 | UNII:BRJ718SA03 | CAS RN:850176-30-6 | ADL-5747 FREE BASE | PubChem CID:11200189"
+BMGC_DG01075,BMG_DG009878,UNII:6AY300X9G3 | CAS RN:839712-25-3 | DIDESMETHYL CARIPRAZINE | PubChem SID:252823880 | PubChem CID:11200383
+BMGC_DG01076,BMG_DG009879,PubChem CID:11200445 | UNII:UB4R7U7T78 | MALEIMIDE ANALOG | PubChem SID:459276034 | CAS RN:863886-38-8
+BMGC_DG01077,BMG_DG009922,METHANESULFONYL FLUORIDE | methanesulfonyl fluoride | PubChem SID:198952158 | UNII:9H250YYY0R | CAS RN:558-25-8 | DrugBank ID:DB13058 | Methanesulfonyl Fluoride | PubChem CID:11207
+BMGC_DG01078,BMG_DG009923,UNII:HDQ4N37UGV | CAS RN:584-85-0 | PubChem CID:112072 | PubChem SID:198938815 | (2S)-2-(3-aminopropanoylamino)-3-(3-methylimidazol-4-yl)propanoic acid | ANSERINE | Anserine
+BMGC_DG01079,BMG_DG009938,"PubChem CID:11209919 | 4-benzyl-7-methyl-2-propyl-6H-purino[7,8-a]imidazole-1,3-dione | 1-Benzyl-7-methyl-3-propyl-1H,8H-imidazo[2,1-f]purine-2,4-dione"
+BMGC_DG01080,BMG_DG009943,CAS RN:857064-38-1 | WP-1066 | PubChem SID:198969184 | Wp 1066 | UNII:63V8AIE65T | (E)-3-(6-bromopyridin-2-yl)-2-cyano-N-[(1S)-1-phenylethyl]prop-2-enamide | PubChem CID:11210478 | DrugBank ID:DB12679
+BMGC_DG01081,BMG_DG009953,"CAS RN:7755-01-3 | (3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol | PubChem CID:11213350 | 20-EPIPROTOPANAXADIOL | PubChem SID:381608429 | (20S)-Protopanaxadiol | UNII:MR8AEF5T1N | CAS RN:30636-90-9 | CAS RN:6892-79-1"
+BMGC_DG01082,BMG_DG009954,UNII:RC3A285J2G | Tamatinib | TAMATINIB | PubChem CID:11213558 | DrugBank ID:DB07159 | CAS RN:841290-80-0 | PubChem SID:317229193
+BMGC_DG01083,BMG_DG009957,PubChem CID:11214940 | ERASTIN | PubChem SID:474492585 | CAS RN:571203-78-6 | UNII:ZJA3NS42T9
+BMGC_DG01084,BMG_DG009959,"SLV-334 | CAS RN:182821-33-6 | PubChem SID:317229394 | (2R)-2-[[1-[[(3S)-1-(carboxymethyl)-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]carbamoyl]cyclopentyl]methyl]-4-naphthalen-1-ylbutanoic acid | PubChem CID:11215055 | Slv-334 | DrugBank ID:DB15356 | UNII:3613ZP748K"
+BMGC_DG01085,BMG_DG009968,"PubChem CID:11217464 | CAS RN:46118-02-9 | 4-(3-hydroxypropyl)benzene-1,2-diol | 4-(3-Hydroxypropyl)benzene-1,2-diol"
+BMGC_DG01086,BMG_DG009987,"DrugBank ID:DB05016 | ATALUREN | PubChem CID:11219835 | Ataluren | PubChem SID:175268844 | 3-[5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid | CAS RN:775304-57-9 | UNII:K16AME9I3V"
+BMGC_DG01087,BMG_DG009989,Tartronate semialdehyde | CAS RN:2480-77-5 | 2-hydroxy-3-oxopropanoic acid | PubChem CID:1122
+BMGC_DG01088,BMG_DG009991,UNII:W27ZP6H9WL | PubChem CID:11220599 | CAS RN:850352-59-9 | PubChem SID:363908693 | 4'-BROMO-.ALPHA.-PYRROLIDINOPENTIOPHENONE
+BMGC_DG01089,BMG_DG009996,DrugBank ID:DB07202 | PubChem CID:11221386 | 6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE
+BMGC_DG01090,BMG_DG009999,"(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | UNII:4U5T0O9SI3 | PubChem SID:198942983 | 18-HYDROXYCORTICOSTERONE | PubChem CID:11222 | 18-Hydroxycorticosterone | CAS RN:561-65-9"
+BMGC_DG01091,BMG_DG010006,"CAS RN:69002-85-3 | UNII:8489I2R79K | 2-[2-(2,6-dichloro-3-hydroxyanilino)phenyl]acetic acid | PubChem CID:112230 | 3'-HYDROXYDICLOFENAC | 3'-Hydroxydiclofenac | PubChem SID:316914325"
+BMGC_DG01092,BMG_DG010010,"PubChem SID:198940010 | PubChem CID:11223423 | DrugBank ID:DB12910 | EMICERFONT | UNII:OJ8EG4264P | CAS RN:786701-13-1 | 1-[1-[1-(4-methoxy-2-methylphenyl)-6-methyl-2,3-dihydropyrrolo[2,3-b]pyridin-4-yl]pyrazol-3-yl]imidazolidin-2-one | Emicerfont"
+BMGC_DG01093,BMG_DG010017,"UNII:53PC6LO35W | CAS RN:869884-78-6 | PubChem CID:11224409 | DrugBank ID:DB12339 | PubChem SID:198986092 | RADEZOLID | N-[[(5S)-3-[3-fluoro-4-[4-[(2H-triazol-4-ylmethylamino)methyl]phenyl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide | Radezolid"
+BMGC_DG01094,BMG_DG010018,"6-[4-(2-methylsulfanylphenyl)piperazin-1-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)hexanamide | PubChem CID:11224758"
+BMGC_DG01095,BMG_DG010024,PHENOPERIDINE | PubChem SID:472422780 | DrugBank ID:DB13605 | CAS RN:562-26-5 | ethyl 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylate | PubChem CID:11226 | Phenoperidine | UNII:G9BH09J4JW
+BMGC_DG01096,BMG_DG010025,"UNII:X9U622S114 | PubChem SID:198978240 | TARANABANT | PubChem CID:11226090 | Taranabant | CAS RN:701977-09-5 | DrugBank ID:DB06624 | N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl]-2-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]oxypropanamide | CAS RN:701977-00-6 | CAS RN:1204240-86-7"
+BMGC_DG01097,BMG_DG010028,"PubChem CID:1122655 | N-(3-chlorophenyl)-2-[(4-phenyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]acetamide | Neurokinin-1 Receptor Antagonists | CAS RN:337505-63-2"
+BMGC_DG01098,BMG_DG010033,"DrugBank ID:DB08383 | PubChem CID:1122713 | 4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole"
+BMGC_DG01099,BMG_DG010038,PubChem CID:11227406 | UNII:YEB4K6A2JC | PubChem SID:443625090 | DPC-168 | CAS RN:275810-55-4
+BMGC_DG01100,BMG_DG010040,Abt-737 | PubChem SID:198934891 | CAS RN:852808-04-9 | 4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide | UNII:Z5NFR173NV | ABT-737 | PubChem CID:11228183
+BMGC_DG01101,BMG_DG010053,PubChem SID:482553828 | UNII:9H3XGZ5L94 | PubChem CID:11229234 | DrugBank ID:DB07617 | N-Methyl[5-(pyridin-3-yl)furan-2-yl]methanamine | N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE | CAS RN:837376-50-8
+BMGC_DG01102,BMG_DG010065,CAS RN:107-35-7 | UNII:1EQV5MLY3D | NDC:43857-0229 | Taurine | PubChem SID:175268867 | TAURINE | 2-aminoethanesulfonic acid | PubChem CID:1123 | NDC:43742-0658 | DrugBank ID:DB01956
+BMGC_DG01103,BMG_DG010066,"4-TERPINEOL, (+/-)- | PubChem CID:11230 | UNII:L65MV77ZG6 | 4-TERPINEOL, (±)- | 4-Terpineol, (+/-)- | CAS RN:562-74-3 | 4-methyl-1-propan-2-ylcyclohex-3-en-1-ol | DrugBank ID:DB12816 | Terpinen-4-ol | PubChem SID:175272005"
+BMGC_DG01104,BMG_DG010083,"PubChem SID:443624046 | 1-(9-PHENYLFLUOREN-9-YL)-1,2,4-TRIAZOLE | CAS RN:828265-51-6 | UNII:V00V2XR06M | PubChem CID:11232117"
+BMGC_DG01105,BMG_DG010094,"TEDIZOLID | DrugBank ID:DB14569 | CAS RN:856866-72-3 | (5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one | PubChem CID:11234049 | Tedizolid | PubChem SID:198955202 | UNII:97HLQ82NGL"
+BMGC_DG01106,BMG_DG010095,"PubChem SID:198948130 | CAS RN:649735-46-6 | (2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-ol | Brivanib | DrugBank ID:DB11958 | BRIVANIB | UNII:DDU33B674I | PubChem CID:11234052"
+BMGC_DG01107,BMG_DG010098,"UNII:T23U22X160 | 4-[(2S)-2-amino-2-carboxyethyl]-N,N-bis(2-chloroethyl)benzeneamine oxide;dihydrochloride | PubChem SID:198946266 | PX-478 | PubChem CID:11234794 | DrugBank ID:DB06082 | CAS RN:685898-44-6 | Px-478"
+BMGC_DG01108,BMG_DG010104,"(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile | (1S,3S,5S)-2-[(2S)-2-amino-2-[(1r,3R,5R,7S)-3-hydroxyadamantan-1-yl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile | CAS RN:361442-04-8 | (1S,3S,5S)-2-[(2S)-2-amino-2-[(5S,7R)-3-hydroxy-1-adamantyl]acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile | PubChem CID:11235729 | DrugBank ID:DB07465"
+BMGC_DG01109,BMG_DG010107,PubChem CID:11236126 | CAS RN:851528-79-5 | Seladelpar | 2-[4-[(2R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methylphenoxy]acetic acid | PubChem SID:316908816 | SELADELPAR | DrugBank ID:DB12390 | UNII:7C00L34NB9
+BMGC_DG01110,BMG_DG010114,"PF-184563 | UNII:UQ326LKZ43 | PubChem SID:474492586 | 8-chloro-5-methyl-1-(1-pyridin-2-ylpiperidin-4-yl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-5,6-dihydro-5-methyl-1-[1-(2-pyridinyl)-4-piperidinyl]- | CAS RN:748806-39-5 | PubChem CID:11237434"
+BMGC_DG01111,BMG_DG010120,"Naronapride | CAS RN:860174-12-5 | PubChem SID:198990155 | [(3R)-1-azabicyclo[2.2.2]octan-3-yl] 6-[(3S,4R)-4-[(4-amino-5-chloro-2-methoxybenzoyl)amino]-3-methoxypiperidin-1-yl]hexanoate | PubChem CID:11237985 | UNII:058896B00B | DrugBank ID:DB05542 | NARONAPRIDE"
+BMGC_DG01112,BMG_DG010121,UNII:Y778RDH3Y6 | PubChem CID:11238212 | ATC-0065 FREE BASE | PubChem SID:198979881 | CAS RN:509145-82-8
+BMGC_DG01113,BMG_DG010123,CAS RN:848133-17-5 | DrugBank ID:DB13002 | PubChem CID:11238512 | (E)-N-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide | PubChem SID:198959485 | Hki-357 | HKI-357 | UNII:39R3638KZ6
+BMGC_DG01114,BMG_DG010126,Azilsartan medoxomil | DrugBank ID:DB08822 | PubChem CID:11238823
+BMGC_DG01115,BMG_DG010133,PubChem CID:11239949 | 1-[[4-[4-[[4-(4-chloro-N-methylanilino)quinolin-1-ium-1-yl]methyl]phenyl]phenyl]methyl]-N-(4-chlorophenyl)-N-methylquinolin-1-ium-4-amine | RSM-932A CATION | RSM-932A cation | PubChem SID:377308957 | CAS RN:850993-73-6 | UNII:PM765BVW4Z
+BMGC_DG01116,BMG_DG010139,PubChem CID:11240776 | 6-Methoxycoumarin | 6-methoxychromen-2-one | CAS RN:17372-53-1
+BMGC_DG01117,BMG_DG010145,"Uk-396,082 | CAS RN:400044-47-5 | (2S)-5-amino-2-[(1-propylimidazol-4-yl)methyl]pentanoic acid | PubChem SID:198964882 | DrugBank ID:DB12099 | PubChem CID:11241908 | UK-396,082 | UNII:2Q5861SUIG"
+BMGC_DG01118,BMG_DG010152,NAPHYRONE | CAS RN:850352-53-3 | UNII:96ON64182B | PubChem CID:11243002 | PubChem SID:316910474 | 1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one | 1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one
+BMGC_DG01119,BMG_DG010159,"DrugBank ID:DB06335 | CAS RN:1073057-20-1 | Saxagliptin | CAS RN:361442-04-8 | SAXAGLIPTIN ANHYDROUS | PubChem SID:175267813 | PubChem CID:11243969 | UNII:8I7IO46IVQ | (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile"
+BMGC_DG01120,BMG_DG010170,CAS RN:781652-57-1 | PubChem SID:474492423 | CDPPB | UNII:Y4F3R8YW3G | PubChem CID:11245456
+BMGC_DG01121,BMG_DG010173,PubChem SID:198979736 | JNJ-26993135 | CAS RN:841202-16-2 | PubChem CID:11245596 | UNII:7W7511NPF8
+BMGC_DG01122,BMG_DG010174,"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate | PubChem CID:11245700 | DrugBank ID:DB06954"
+BMGC_DG01123,BMG_DG010184,CAS RN:573678-04-3 | UNII:K3S4K8ACHE | PubChem SID:313183999 | PubChem CID:11247522 | NGD-8243 | Ngd-8243 | N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)pyridin-2-yl]quinazolin-4-amine
+BMGC_DG01124,BMG_DG010190,PubChem SID:198984113 | FERROUS CARBONATE | PubChem CID:11248 | Ferrous Carbonate | CAS RN:14476-16-5 | CAS RN:563-71-3 | DrugBank ID:DB13698 | CAS RN:1335-56-4 | iron(2+);carbonate | NDC:53645-1750 | UNII:MZ3Q72U52O
+BMGC_DG01125,BMG_DG010192,"CAS RN:865783-99-9 | [2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]phenyl] dihydrogen phosphate | BRICICLIB | UNII:WG93X96336 | DrugBank ID:DB12004 | Briciclib | PubChem SID:198987128 | PubChem CID:11248490"
+BMGC_DG01126,BMG_DG010195,PubChem SID:459055744 | PubChem CID:11249084 | CAS RN:398493-79-3 | UNII:65W8KZU2A4 | PHA-680632
+BMGC_DG01127,BMG_DG010201,"DrugBank ID:DB15317 | [(3aS,8bR)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-phenylcarbamate | CAS RN:116839-68-0 | PubChem SID:376230883 | UNII:Z0O4TJ588O | Buntanetap | PubChem CID:11249342 | BUNTANETAP"
+BMGC_DG01128,BMG_DG010211,"PubChem CID:11250029 | ELUXADOLINE | NDC:61874-100 | UNII:45TPJ4MBQ1 | Eluxadoline | NDC:61874-075 | CAS RN:864821-90-9 | PubChem SID:198959793 | DrugBank ID:DB09272 | 5-[[[(2S)-2-amino-3-(4-carbamoyl-2,6-dimethylphenyl)propanoyl]-[(1S)-1-(5-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid"
+BMGC_DG01129,BMG_DG010310,"ELAGOLIX | PubChem CID:11250647 | CAS RN:834153-87-6 | PubChem SID:198990581 | Elagolix | 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid | DrugBank ID:DB11979 | UNII:5B2546MB5Z | CAS RN:832720-36-2"
+BMGC_DG01130,BMG_DG010312,"PubChem CID:11251471 | CAS RN:341973-06-6 | N-[[(2S,4R)-1-[2-(2,4-difluorobenzoyl)benzoyl]-4-tritylsulfanylpyrrolidin-2-yl]methyl]-4-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzamide | N-(((2S,4R)-1-(2-(2,4-difluorobenzoyl)benzoyl)-4-(tritylthio)pyrrolidin-2-yl)methyl)-4-((Z)-(2,4-dioxothiazolidin-5-ylidene)methyl)benzamide"
+BMGC_DG01131,BMG_DG010323,Dutogliptin | UNII:38EAO245ZX | CAS RN:852329-66-9 | PubChem SID:198942663 | DUTOGLIPTIN | PubChem CID:11253490 | [(2R)-1-[2-[[(3R)-pyrrolidin-3-yl]amino]acetyl]pyrrolidin-2-yl]boronic acid | DrugBank ID:DB11723
+BMGC_DG01132,BMG_DG010338,"ABT-102 | Abt 102 | UNII:J0YBN3USJN | CAS RN:808756-71-0 | PubChem CID:11256560 | PubChem SID:333495853 | 1-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-3-(1H-indazol-4-yl)urea"
+BMGC_DG01133,BMG_DG010339,"N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine | UNII:0G9LGB5O2W | CAS RN:690656-53-2 | MAVORIXAFOR | CAS RN:558447-26-0 | DrugBank ID:DB05501 | PubChem CID:11256587 | Mavorixafor | PubChem SID:198950476"
+BMGC_DG01134,BMG_DG010340,Roxadustat | DrugBank ID:DB04847 | UNII:X3O30D9YMX | PubChem CID:11256664 | PubChem SID:198987636 | CAS RN:808118-40-3 | ROXADUSTAT | 2-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid
+BMGC_DG01135,BMG_DG010341,INTEPIRDINE | CAS RN:607742-69-8 | PubChem CID:11256720 | DrugBank ID:DB12680 | PubChem SID:198952878 | UNII:2IOB2M82HY | Intepirdine | 3-(benzenesulfonyl)-8-piperazin-1-ylquinoline
+BMGC_DG01136,BMG_DG010343,PubChem SID:198971999 | N-[4-(4-aminophenyl)sulfonylphenyl]acetamide | PubChem CID:11257 | MONOACETYLDAPSONE | Monoacetyldapsone | CAS RN:565-20-8 | UNII:A4YKS8ULCN
+BMGC_DG01137,BMG_DG010345,"PubChem SID:319891864 | 5-chloro-2,4-dihydroxy-6-methyl-3-[(2E,4E)-3-methyl-5-[(1R,2R,6R)-1,2,6-trimethyl-3-oxocyclohexyl]penta-2,4-dienyl]benzaldehyde | UNII:PEZ8F05ODV | CAS RN:26166-39-2 | PubChem CID:11258227 | Ascochlorin | ASCOCHLORIN"
+BMGC_DG01138,BMG_DG010349,Metahexamide | METAHEXAMIDE | PubChem SID:198959625 | PubChem CID:11259 | UNII:T3U6F5D722 | DrugBank ID:DB13675 | CAS RN:565-33-3 | 1-(3-amino-4-methylphenyl)sulfonyl-3-cyclohexylurea
+BMGC_DG01139,BMG_DG010351,CAS RN:820240-77-5 | PubChem CID:11259583 | 3-[[2-[4-phenyl-3-(trifluoromethyl)phenyl]-1-benzothiophen-5-yl]methylamino]propanoic acid | Auy954
+BMGC_DG01140,BMG_DG010406,"PubChem CID:11267278 | CAS RN:827036-76-0 | 4-(dimethylamino)-N-[5-[(2-sulfanylacetyl)amino]pentyl]benzamide | Benzamide, 4-(dimethylamino)-N-[5-[(mercaptoacetyl)amino]pentyl]-"
+BMGC_DG01141,BMG_DG010415,"(4R,6S,8R,9Z,11E)-16-chloro-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.06,8]nonadeca-1(15),9,11,16,18-pentaene-2,13-dione | PubChem CID:11268547 | CID 11268547"
+BMGC_DG01142,BMG_DG010416,PubChem SID:348480763 | UNII:R0GPP0WDF9 | AM-1710 | PubChem CID:11268660 | CAS RN:335371-36-3
+BMGC_DG01143,BMG_DG010417,PubChem SID:441331685 | PubChem CID:11268746 | CAS RN:824960-76-1 | JWH-267 | UNII:C2Z4BXW5TJ
+BMGC_DG01144,BMG_DG010420,"PubChem SID:198990814 | DrugBank ID:DB12263 | 5-chloro-N-[(2S)-4,4,4-trifluoro-1-hydroxy-3-(trifluoromethyl)butan-2-yl]thiophene-2-sulfonamide | CAS RN:769169-27-9 | BEGACESTAT | Begacestat | PubChem CID:11269353 | UNII:3666C56BBU"
+BMGC_DG01145,BMG_DG010423,"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z) | PubChem CID:11269429 | DrugBank ID:DB08742"
+BMGC_DG01146,BMG_DG010424,CAS RN:182136-94-3 | PubChem CID:11269661 | UNII:JV53JWY86D | PubChem SID:198964762 | DYSIDIOLIDE
+BMGC_DG01147,BMG_DG010430,PubChem CID:11270500 | DrugBank ID:DB07982 | 2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol
+BMGC_DG01148,BMG_DG010431,"CVT-6883 | UNII:67CKV7X08G | DrugBank ID:DB05936 | PubChem SID:198957650 | CAS RN:1215343-16-0 | PubChem CID:11270783 | 3-ethyl-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]pyrazol-4-yl]-7H-purine-2,6-dione | Cvt-6883 | CAS RN:752222-83-6"
+BMGC_DG01149,BMG_DG010442,"DrugBank ID:DB08905 | (8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | PubChem SID:198969121 | FORMESTANE | CAS RN:566-48-3 | UNII:PUB9T8T355 | PubChem CID:11273 | Formestane"
+BMGC_DG01150,BMG_DG010444,"PubChem CID:11273179 | DrugBank ID:DB05553 | UNII:Q6C8TY6SW1 | REGRELOR | PubChem SID:175267651 | CAS RN:787548-03-2 | [(2S,3aR,4R,6R,6aR)-4-[6-(ethylcarbamoylamino)purin-9-yl]-2-[(E)-2-phenylethenyl]-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methyl dihydrogen phosphate | Regrelor"
+BMGC_DG01151,BMG_DG010455,UNII:114L0XB8FM | CAS RN:854758-17-1 | PubChem SID:198962142 | PubChem CID:11274374 | A-792611
+BMGC_DG01152,BMG_DG010480,"PubChem SID:384648020 | 2-((6-((3R)-3-AMINO-1-PIPERIDINYL)-3,4-DIHYDRO-2,4-DIOXO-1(2H)-PYRIMIDINYL)METHYL)BENZONITRILE | CAS RN:865758-98-1 | PubChem CID:11278798 | UNII:625UXD6CJI"
+BMGC_DG01153,BMG_DG010491,JWH-048 | PubChem CID:11280135 | UNII:ZLS6Q88UQ8 | PubChem SID:474492277 | CAS RN:316189-66-9
+BMGC_DG01154,BMG_DG010495,ARBACLOFEN PLACARBIL | UNII:W89H91R7VX | CAS RN:847353-30-4 | Arbaclofen placarbil | DrugBank ID:DB08892 | (3R)-3-(4-chlorophenyl)-4-[[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino]butanoic acid | PubChem SID:198948941 | Arbaclofen Placarbil | PubChem CID:11281011
+BMGC_DG01155,BMG_DG010502,CAS RN:865244-30-0 | PubChem CID:11281589 | UNII:SWZ19ET35C | PubChem SID:438788634 | 6.ALPHA.-ETHYLURSODEOXYCHOLIC ACID
+BMGC_DG01156,BMG_DG010506,"Amuvatinib | CAS RN:850879-09-3 | PubChem SID:198969243 | AMUVATINIB | DrugBank ID:DB12742 | UNII:SO9S6QZB4R | N-(1,3-benzodioxol-5-ylmethyl)-4-([1]benzofuro[3,2-d]pyrimidin-4-yl)piperazine-1-carbothioamide | PubChem CID:11282283"
+BMGC_DG01157,BMG_DG010519,"SAGOPILONE | UNII:KY72JU32FO | CAS RN:305841-29-6 | PubChem SID:198970184 | DrugBank ID:DB12391 | PubChem CID:11284169 | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methyl-1,3-benzothiazol-5-yl)-10-prop-2-enyl-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | Sagopilone"
+BMGC_DG01158,BMG_DG010526,PubChem SID:485660823 | CAS RN:568-75-2 | PubChem CID:11285 | (12-methylbenzo[a]anthracen-7-yl)methanol | 7-Hydroxymethyl-12-methylbenz[a]anthracene | UNII:L6MWC2VTY9 | 7-HYDROXYMETHYL-12-METHYLBENZ(A)ANTHRACENE
+BMGC_DG01159,BMG_DG010528,"RGB-286638 FREE BASE | PubChem CID:11285002 | RGB-286638 free base | PubChem SID:198971803 | CAS RN:784210-88-4 | 1-[3-[4-[[4-(2-methoxyethyl)piperazin-1-yl]methyl]phenyl]-4-oxo-1H-indeno[1,2-c]pyrazol-5-yl]-3-morpholin-4-ylurea | UNII:1GAJ98SC2X"
+BMGC_DG01160,BMG_DG010532,"UNII:911Z9PCQ5F | DANOPREVIR | PubChem SID:198980821 | [(1S,4R,6S,7Z,14S,18R)-4-(cyclopropylsulfonylcarbamoyl)-14-[(2-methylpropan-2-yl)oxycarbonylamino]-2,15-dioxo-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-en-18-yl] 4-fluoro-1,3-dihydroisoindole-2-carboxylate | Danoprevir | CAS RN:850876-88-9 | DrugBank ID:DB11779 | PubChem CID:11285588"
+BMGC_DG01161,BMG_DG010535,"UNII:15C116UA4Y | CAS RN:497223-25-3 | PubChem CID:11285792 | Cenicriviroc | DrugBank ID:DB11758 | (5E)-8-[4-(2-butoxyethoxy)phenyl]-1-(2-methylpropyl)-N-[4-[(S)-(3-propylimidazol-4-yl)methylsulfinyl]phenyl]-3,4-dihydro-2H-1-benzazocine-5-carboxamide | CENICRIVIROC | PubChem SID:198946193"
+BMGC_DG01162,BMG_DG010550,PubChem CID:11287480 | CAS RN:776281-37-9 | 3-CHLORO-4-HYDRAZINYLBENZENESULFONAMIDE | 3-Chloro-4-hydrazinylbenzenesulfonamide | PubChem SID:482553933 | UNII:RZ667JG7AP
+BMGC_DG01163,BMG_DG010553,"DrugBank ID:DB12143 | REZATOMIDINE | PubChem CID:11287722 | UNII:W5LMZ0RC8I | 4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1,3-dihydroimidazole-2-thione | PubChem SID:198977787 | CAS RN:847829-38-3 | Rezatomidine"
+BMGC_DG01164,BMG_DG010558,"DrugBank ID:DB00269 | PubChem SID:198938716 | PubChem CID:11289 | Chlorotrianisene | CAS RN:569-57-3 | UNII:6V5034L121 | CHLOROTRIANISENE | 1-[1-chloro-2,2-bis(4-methoxyphenyl)ethenyl]-4-methoxybenzene"
+BMGC_DG01165,BMG_DG010568,"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide | PubChem CID:11290116 | DrugBank ID:DB06930"
+BMGC_DG01166,BMG_DG010569,"PubChem SID:485663606 | N-(4,6-Diphenyl-2-pyrimidinyl)-2-ethylbutanamide | N-(4,6-DIPHENYL-2-PYRIMIDINYL)-2-ETHYLBUTANAMIDE | UNII:KAL4L7UCR8 | PubChem CID:11290921 | CAS RN:820961-71-5"
+BMGC_DG01167,BMG_DG010570,"2-methyl-9-phenyl-1,3,4,9-tetrahydroindeno[2,1-c]pyridine | PubChem CID:11291 | DrugBank ID:DB01619 | PHENINDAMINE | UNII:772BQ8KSST | CAS RN:82-88-2 | Phenindamine | PubChem SID:198949029"
+BMGC_DG01168,BMG_DG010573,"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one | UNII:NP74Y62UYL | DrugBank ID:DB08058 | PubChem SID:485663659 | 4-[[3-(1,4-diazepane-1-carbonyl)-4-fluorophenyl]methyl]-2H-phthalazin-1-one | PubChem CID:11291932 | 4-(3-(1,4-DIAZEPAN-1-YLCARBONYL)-4-FLUOROBENZYL)PHTHALAZIN-1(2H)-ONE | CAS RN:763111-49-5"
+BMGC_DG01169,BMG_DG010576,CAS RN:802904-66-1 | AZD-1981 | DrugBank ID:DB11946 | Azd1981 | 2-[4-acetamido-3-(4-chlorophenyl)sulfanyl-2-methylindol-1-yl]acetic acid | PubChem CID:11292191 | PubChem SID:198939074 | UNII:2AD53WQ2CX
+BMGC_DG01170,BMG_DG010581,GSK-163090 | PubChem SID:198987459 | 1-[3-[2-[4-(2-methylquinolin-5-yl)piperazin-1-yl]ethyl]phenyl]imidazolidin-2-one | 1-(3-(2-(4-(2-Methyl-5-quinolinyl)-1-piperazinyl)ethyl)phenyl)-2-imidazolidinone | CAS RN:844903-58-8 | PubChem CID:11292933 | UNII:7XI927X82B
+BMGC_DG01171,BMG_DG010588,"PubChem CID:11293572 | 3-{cyclobutyl[3-(5-fluoro-1H-indol-3-yl)propyl]amino}-8-fluorochromane-5-carboxamide | 3-[cyclobutyl-[3-(5-fluoro-1H-indol-3-yl)propyl]amino]-8-fluoro-3,4-dihydro-2H-chromene-5-carboxamide"
+BMGC_DG01172,BMG_DG010598,DG-041 | UNII:1844425CLP | PubChem SID:198937728 | PubChem CID:11296282 | CAS RN:861238-35-9
+BMGC_DG01173,BMG_DG010599,"UNII:D58G680W0G | CAS RN:72496-41-4 | PubChem SID:198958032 | PIRARUBICIN | (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione | Pirarubicin | DrugBank ID:DB11616 | PubChem CID:11296583"
+BMGC_DG01174,BMG_DG010602,PubChem CID:11297 | CAS RN:570-14-9 | 4-HYDROXYTRYPTAMINE | PubChem SID:198941838 | UNII:DP0D1701D1
+BMGC_DG01175,BMG_DG010619,PubChem SID:478838468 | CAS RN:217091-19-5 | PubChem CID:11298778 | UNII:6NMG4K6VRB | 6-Phenoxy-1-hexanethiol | 6-PHENOXY-1-HEXANETHIOL
+BMGC_DG01176,BMG_DG010632,UNII:UM9572UF9L | CAS RN:14979-97-6 | PubChem CID:11299968 | 4-METHOXY-.ALPHA.-PYRROLIDINOVALEROPHENONE | PubChem SID:316909106
+BMGC_DG01177,BMG_DG010633,"PubChem SID:175268573 | CAS RN:70-16-6 | DrugBank ID:DB00152 | Thiamine | UNII:4ABT0J945J | THIAMINE ION | 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol | PubChem CID:1130"
+BMGC_DG01178,BMG_DG010652,"CAS RN:571-22-2 | 5beta-dihydrotestosterone | 5beta-Dihydrotestosterone | (5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | DrugBank ID:DB07447 | UNII:SVX1G0C5VD | PubChem SID:405218090 | PubChem CID:11302 | 5.BETA.-DIHYDROTESTOSTERONE"
+BMGC_DG01179,BMG_DG010655,PubChem CID:11302540 | PubChem SID:198963237 | CAS RN:870653-45-5 | UNII:A62C114Q0Q | PAP-1
+BMGC_DG01180,BMG_DG010656,CAS RN:132998-83-5 | UNII:D71R0C2HOV | PubChem CID:11302670 | PubChem SID:405055228 | XANTHOANGELOL D
+BMGC_DG01181,BMG_DG010663,"PubChem CID:11304 | PubChem SID:198986337 | 1,4-DIMETHYLNAPHTHALENE | UNII:BQH3S1I0SO | CAS RN:571-58-4"
+BMGC_DG01182,BMG_DG010667,"DrugBank ID:DB07179 | PubChem CID:11304412 | 3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide"
+BMGC_DG01183,BMG_DG010669,"NDC:50419-252 | PubChem CID:11304743 | NDC:50419-253 | NDC:50419-250 | RIOCIGUAT | PubChem SID:198980755 | CAS RN:1304478-72-5 | CAS RN:625115-55-1 | DrugBank ID:DB08931 | UNII:RU3FE2Y4XI | Riociguat | NDC:50419-251 | NDC:50419-254 | methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate"
+BMGC_DG01184,BMG_DG010670,3-Hydroxypropyl 3-[(7-carbamimidoyl-1-naphthyl)carbamoyl]benzenesulfonate | DrugBank ID:DB07022 | PubChem CID:11304895
+BMGC_DG01185,BMG_DG010671,"naphthalene-1,4-diol | CAS RN:571-60-8 | 1,4-Dihydroxynaphthalene | PubChem SID:287445881 | PubChem CID:11305 | CAS RN:35199-33-8 | UNII:AML1P6T42C | 1,4-NAPHTHALENEDIOL"
+BMGC_DG01186,BMG_DG010677,"UNII:60CM3233U9 | PubChem SID:198969631 | CAS RN:571-61-9 | 1,5-DIMETHYLNAPHTHALENE | PubChem CID:11306"
+BMGC_DG01187,BMG_DG010681,"UNII:X9M873A9NG | RAC-SITAGLIPTIN | CAS RN:790712-60-6 | CAS RN:823817-56-7 | rac-Sitagliptin | PubChem CID:11306691 | 3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one"
+BMGC_DG01188,BMG_DG010704,9-FORMYL-8-JULOLIDINOL | PubChem SID:438788273 | UNII:A26Y1H0WB5 | CAS RN:63149-33-7 | PubChem CID:113099
+BMGC_DG01189,BMG_DG010709,"UNII:KR47E7VT2X | CAS RN:848952-62-5 | PubChem CID:11310264 | PubChem SID:472408833 | 2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID, (2R)-"
+BMGC_DG01190,BMG_DG010714,CAS RN:468715-83-5 | UNII:WR55VTJ7AL | PubChem SID:198981329 | PubChem CID:11310988 | BMS-505130 FREE BASE
+BMGC_DG01191,BMG_DG010716,UNII:DRY2E23E56 | PubChem SID:459055856 | PubChem CID:11311147 | CAS RN:850352-54-4 | 2-METHYL-.ALPHA.-PYRROLIDINOPENTIOPHENONE
+BMGC_DG01192,BMG_DG010717,UNII:C6U044JFN5 | PubChem SID:443623875 | PubChem CID:11311402 | CAS RN:828265-57-2 | 4-(2-IMIDAZOL-1-YLETHOXY)CHROMEN-2-ONE
+BMGC_DG01193,BMG_DG010718,RO-2433 | PubChem CID:11311503 | (2'R)-2'-DEOXY-2'-FLUORO-2'-METHYLURIDINE | CAS RN:863329-66-2 | PubChem SID:316909117 | UNII:44V7045CXS
+BMGC_DG01194,BMG_DG010726,"PubChem CID:11313151 | CAS RN:820961-44-2 | UNII:88G2HAE2AF | N-(2,6-DIPHENYLPYRIMIDIN-4-YL)ISOBUTYRAMIDE | N-(2,6-diphenylpyrimidin-4-yl)isobutyramide | PubChem SID:485663706"
+BMGC_DG01195,BMG_DG010729,"PubChem CID:11313622 | DrugBank ID:DB12129 | 4-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione | CAS RN:945421-01-2 | TIDEGLUSIB | CAS RN:1353564-66-5 | PubChem SID:198979629 | Tideglusib | UNII:Q747Y6TT42 | CAS RN:865854-05-3"
+BMGC_DG01196,BMG_DG010731,METHIMEPIP | UNII:259YSH2WL6 | PubChem SID:472422919 | CAS RN:151070-80-3 | PubChem CID:11313837
+BMGC_DG01197,BMG_DG010739,A-674563 | PubChem CID:11314340 | UNII:3W2X0WGW6C | PubChem SID:322058919 | CAS RN:552325-73-2 | DrugBank ID:DB08568
+BMGC_DG01198,BMG_DG010745,RIVOCERANIB | PubChem SID:198954456 | N-(4-(1-Cyanocyclopentyl)phenyl)-2-((pyridin-4-ylmethyl)amino)nicotinamide | UNII:5S371K6132 | CAS RN:811803-05-1 | N-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide | DrugBank ID:DB14765 | PubChem CID:11315474
+BMGC_DG01199,BMG_DG010751,1-BROMO-2-NAPHTHOL | CAS RN:573-97-7 | UNII:VKE7L55PP9 | PubChem CID:11316 | PubChem SID:198990071
+BMGC_DG01200,BMG_DG010756,PF-514273 | PubChem SID:459276088 | CAS RN:851728-60-4 | UNII:45FRJ4YGM2 | PubChem CID:11316919
+BMGC_DG01201,BMG_DG010757,"PubChem CID:11317 | 1,2-DIMETHYLNAPHTHALENE | CAS RN:573-98-8 | UNII:23T7O135BD | PubChem SID:198966255"
+BMGC_DG01202,BMG_DG010760,KI-8751 | PubChem CID:11317348 | PubChem SID:445498661 | UNII:RP6UGT29FF | CAS RN:228559-41-9
+BMGC_DG01203,BMG_DG010761,"TEMSAVIR | PubChem CID:11317439 | CAS RN:701213-36-7 | PubChem SID:198960749 | UNII:4B6J53W8N3 | 1-(4-benzoylpiperazin-1-yl)-2-[4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]ethane-1,2-dione | Temsavir | DrugBank ID:DB14675"
+BMGC_DG01204,BMG_DG010766,"1,2-NAPHTHALENEDIOL | UNII:2R5017T335 | CAS RN:574-00-5 | 1,2-Dihydroxynaphthalene | PubChem SID:287446351 | Naphthalene-1,2-Diol | PubChem CID:11318 | naphthalene-1,2-diol | DrugBank ID:DB07610"
+BMGC_DG01205,BMG_DG010771,(2S)-2-[[(2S)-1-(2-aminoacetyl)-2-methylpyrrolidine-2-carbonyl]amino]pentanedioic acid | TROFINETIDE | NDC:63090-660 | UNII:Z2ME8F52QL | DrugBank ID:DB06045 | PubChem SID:249492631 | PubChem CID:11318905 | CAS RN:853400-76-7 | Trofinetide
+BMGC_DG01206,BMG_DG010773,"CAS RN:781649-09-0 | DrugBank ID:DB12228 | Telcagepant | TELCAGEPANT | PubChem SID:198956378 | N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide | UNII:D42O649ALL | PubChem CID:11319053"
+BMGC_DG01207,BMG_DG010775,"PubChem CID:11319217 | CAS RN:864953-29-7 | UNII:97IQ273H4L | Fostemsavir | FOSTEMSAVIR | DrugBank ID:DB11796 | [3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate | PubChem SID:198989146"
+BMGC_DG01208,BMG_DG010786,"CAS RN:574-17-4 | 1-ACETYLISATIN | 1-acetylindole-2,3-dione | UNII:V5O1T1H718 | PubChem CID:11321 | 1-Acetylisatin | PubChem SID:375579641"
+BMGC_DG01209,BMG_DG010794,PubChem SID:482553889 | CAS RN:828265-61-8 | PubChem CID:11322098 | 6-(IMIDAZOL-1-YLMETHYL)CHROMEN-2-ONE | UNII:4948AJR2JU | 6-(Imidazol-1-ylmethyl)chromen-2-one
+BMGC_DG01210,BMG_DG010796,CAS RN:850352-62-4 | UNII:2417D71166 | PubChem CID:11322641 | 4'-FLUORO-.ALPHA.-PYRROLIDINOPENTIOPHENONE | PubChem SID:316916539
+BMGC_DG01211,BMG_DG010821,"CAS RN:575-37-1 | UNII:TRF323Y1QW | PubChem SID:198971135 | PubChem CID:11326 | 1,7-Dimethylnaphthalene | 1,7-DIMETHYLNAPHTHALENE | 1,7-dimethylnaphthalene"
+BMGC_DG01212,BMG_DG010827,CAS RN:841205-47-8 | UNII:O3571H3R8N | PubChem SID:198956621 | (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide | DrugBank ID:DB12078 | PubChem CID:11326715 | Enobosarm | CAS RN:1202044-20-9 | ENOBOSARM
+BMGC_DG01213,BMG_DG010829,"1,3-DIMETHYLNAPHTHALENE | PubChem CID:11327 | PubChem SID:363908154 | UNII:3RY1AV3CER | CAS RN:575-41-7"
+BMGC_DG01214,BMG_DG010831,UNII:XF6ZJD5WGU | PubChem CID:11327430 | PubChem SID:443625065 | CAS RN:503468-95-9 | NU-7441
+BMGC_DG01215,BMG_DG010833,"PubChem CID:11327981 | CJ-17493 | (2S,3S)-N-[[(1R)-6-methoxy-1-methyl-1-(trifluoromethyl)-3,4-dihydroisochromen-7-yl]methyl]-2-phenylpiperidin-3-amine | CAS RN:875322-24-0 | UNII:N44B36Q2DK | CAS RN:225655-10-7 | 3-Piperidinamine, N-(((1R)-3,4-dihydro-6-methoxy-1-methyl-1-(trifluoromethyl)-1H-2-benzopyran-7-yl)methyl)-2-phenyl-, (2S,3S)- | PubChem SID:363909315"
+BMGC_DG01216,BMG_DG010835,"1,6-Dimethylnaphthalene | PubChem SID:198959992 | 1,6-dimethylnaphthalene | 1,6-DIMETHYLNAPHTHALENE | UNII:DXN13WI5EY | CAS RN:575-43-9 | PubChem CID:11328"
+BMGC_DG01217,BMG_DG010838,"DrugBank ID:DB12517 | PubChem SID:198940278 | CAS RN:862281-92-3 | PubChem CID:11328898 | UNII:63P236Z73I | Methanone, ((3S,4R)-4-(2,4-difluorophenyl)-1-(1,1-dimethylethyl)-3-pyrrolidinyl)((3R,5S)-4-hydroxy-3,5-dimethyl-4-phenyl-1-piperidinyl)- | [(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]-[(3S,5R)-4-hydroxy-3,5-dimethyl-4-phenylpiperidin-1-yl]methanone | PF-00446687"
+BMGC_DG01218,BMG_DG010848,PubChem CID:1133083 | UNII:2T4Z77A4C2 | N-(2-AMINOPHENYL)NICOTINAMIDE | CAS RN:436089-31-5
+BMGC_DG01219,BMG_DG010851,"CAS RN:575-90-6 | PubChem CID:11332 | 2,6-DICHLOROPHENOXYACETIC ACID | UNII:LG89KT4A2B | PubChem SID:461434176"
+BMGC_DG01220,BMG_DG010857,(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE | CAS RN:837376-48-4 | 5-(3-PYRIDINYL)-2-FURANMETHANAMINE | 5-(3-Pyridinyl)-2-furanmethanamine | PubChem SID:478838456 | DrugBank ID:DB07621 | PubChem CID:11332763 | UNII:7S869EMF45
+BMGC_DG01221,BMG_DG010860,".ALPHA.-LACTULOSE | Lactulose | CAS RN:58166-24-8 | DrugBank ID:DB00581 | (2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | UNII:9XH2P2N8EP | PubChem CID:11333 | CAS RN:58166-25-9 | PubChem SID:198936501"
+BMGC_DG01222,BMG_DG010867,UNII:FXK4KLK3G8 | PubChem SID:485663727 | PubChem CID:11333903 | 2-Methyl-6-[3-(phenylthio)-1-propyn-1-yl]pyridine | 2-METHYL-6-(3-(PHENYLTHIO)-1-PROPYN-1-YL)PYRIDINE | CAS RN:851855-84-0
+BMGC_DG01223,BMG_DG010874,"2,6-XYLENOL | PubChem SID:198973727 | PubChem CID:11335 | UNII:I8N0RO87OV | CAS RN:576-26-1 | 2,6-dimethylphenol | 2,6-Dimethylphenol"
+BMGC_DG01224,BMG_DG010891,"UNII:X1BF92PW9T | CAS RN:844442-38-2 | 4-[(2,6-dichlorobenzoyl)amino]-N-piperidin-4-yl-1H-pyrazole-5-carboxamide | DrugBank ID:DB08142 | 4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide | PubChem CID:11338033 | AT-7519 | PubChem SID:198975169"
+BMGC_DG01225,BMG_DG010899,CAS RN:519187-97-4 | PubChem CID:11338749 | 1-[3-[2-(1-benzothiophen-5-yl)ethoxy]propyl]azetidin-3-ol;(Z)-but-2-enedioic acid | T-817 MALEATE | PubChem SID:313183104 | T-817 maleate | UNII:0LB9F7I5P3
+BMGC_DG01226,BMG_DG010901,PubChem CID:11338928 | CAS RN:839712-15-1 | DESMETHYL CARIPRAZINE | UNII:286RCD7025 | PubChem SID:252823761
+BMGC_DG01227,BMG_DG010902,"UNII:M7P27195AG | DOCUSATE | PubChem SID:175272007 | PubChem CID:11339 | 1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonic acid | CAS RN:10041-19-7 | DrugBank ID:DB11089 | CAS RN:21954-86-9 | Docusate"
+BMGC_DG01228,BMG_DG010903,PubChem CID:11339118 | PubChem SID:198947543 | UNII:71JE0C439X | CAS RN:821768-06-3 | JNJ-17203212
+BMGC_DG01229,BMG_DG010909,"UNII:TJ5VED6U7A | PubChem SID:405055581 | PubChem CID:11339853 | 4(3H)-QUINAZOLINONE, 3-AMINO-5,6,7,8-TETRAHYDRO-6-HYDROXY-2-(4-(4-(2-QUINOLINYL)-1-PIPERAZINYL)BUTYL)- | CAS RN:864386-63-0"
+BMGC_DG01230,BMG_DG010914,CAS RN:851884-87-2 | PubChem SID:459055549 | GKA-50 | UNII:L9S2U67JS6 | PubChem CID:11340230
+BMGC_DG01231,BMG_DG010917,"DrugBank ID:DB11818 | Retosiban | CAS RN:820957-38-8 | (3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl]piperazine-2,5-dione | RETOSIBAN | PubChem CID:11340891 | PubChem SID:198952542 | UNII:GIE06H28OX"
+BMGC_DG01232,BMG_DG010941,UNII:Q5Y9SZ78W4 | 7-Mercapto-N-3-pyridinylheptanamide | 7-MERCAPTO-N-3-PYRIDINYLHEPTANAMIDE | PubChem SID:472421926 | CAS RN:728890-50-4 | PubChem CID:11345433
+BMGC_DG01233,BMG_DG010953,4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone | 4-(4-((5S)-5-(AMINOMETHYL)-2-OXO-3-OXAZOLIDINYL)PHENYL)-3-MORPHOLINONE | UNII:JZ8PKP6CTZ | CAS RN:446292-10-0 | PubChem CID:11346837 | PubChem SID:441659758
+BMGC_DG01234,BMG_DG010959,"CAS RN:437742-34-2 | PubChem CID:11347535 | UNII:703P9YDP7F | MARIZOMIB | DrugBank ID:DB11762 | Marizomib | (1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-[(1S)-cyclohex-2-en-1-yl]-hydroxymethyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione | PubChem SID:198989908"
+BMGC_DG01235,BMG_DG010965,"PubChem CID:11348631 | DrugBank ID:DB07311 | 18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE"
+BMGC_DG01236,BMG_DG010967,PubChem CID:11349 | UNII:ZTG9LSS5QH | 3-Hydroxyflavone | 3-hydroxy-2-phenylchromen-4-one | PubChem SID:198942952 | CAS RN:577-85-5 | FLAVONOL
+BMGC_DG01237,BMG_DG010969,"BMS-690514 | DrugBank ID:DB11665 | (3R,4R)-4-amino-1-[[4-(3-methoxyanilino)pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol | PubChem SID:198989201 | (3R,4R)-4-Amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methyl]piperidin-3-ol | UNII:VKU5X213Q7 | PubChem CID:11349170 | CAS RN:859853-30-8"
+BMGC_DG01238,BMG_DG010970,"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE | PubChem CID:11349402 | DrugBank ID:DB07798"
+BMGC_DG01239,BMG_DG010972,UNII:Q2CW3V5WGF | PubChem SID:472422965 | A-423579 | CAS RN:461045-17-0 | PubChem CID:11349657
+BMGC_DG01240,BMG_DG010976,"CAS RN:65-71-4 | CAS RN:123430-67-1 | CAS RN:691841-57-3 | THYMINE | Thymine | CAS RN:153445-43-3 | CAS RN:3059-73-2 | CAS RN:2792-47-4 | DrugBank ID:DB03462 | CAS RN:69497-78-5 | 5-methyl-1H-pyrimidine-2,4-dione | UNII:QR26YLT7LT | PubChem CID:1135 | PubChem SID:175268008"
+BMGC_DG01241,BMG_DG010982,2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate;2-hydroxyethyl(trimethyl)azanium | PubChem CID:11350701 | NDC:68180-128 | NDC:33342-295 | NDC:33342-294 | UNII:4BMH7IZT98 | CAS RN:856676-23-8 | Choline Fenofibrate | NDC:68180-129 | PubChem SID:175266985 | CHOLINE FENOFIBRATE
+BMGC_DG01242,BMG_DG011002,"UNII:LR24G6354G | DrugBank ID:DB08871 | ERIBULIN | Eribulin | CAS RN:253128-41-5 | PubChem CID:11354606 | PubChem SID:175268313 | (1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-20-[(2S)-3-amino-2-hydroxypropyl]-21-methoxy-14-methyl-8,15-dimethylidene-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-24-one"
+BMGC_DG01243,BMG_DG011023,4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME | DrugBank ID:DB07150 | PubChem CID:11357504
+BMGC_DG01244,BMG_DG011036,"GSI-136 | PubChem CID:11358855 | 5-chloro-N-[(2S)-3-ethyl-1-hydroxypentan-2-yl]thiophene-2-sulfonamide | PubChem SID:198981233 | DrugBank ID:DB12819 | 2-Thiophenesulfonamide, 5-chloro-N-((1S)-2-ethyl-1-(hydroxymethyl)butyl)- | UNII:51JV4753AD | CAS RN:443989-01-3"
+BMGC_DG01245,BMG_DG011038,PubChem SID:198967608 | 8-AMINOQUINOLINE | CAS RN:578-66-5 | UNII:U34EAV21TG | PubChem CID:11359
+BMGC_DG01246,BMG_DG011041,"CAS RN:860175-16-2 | 4-METHYL-5-THIAZOLEETHANOL | CAS RN:137-00-8 | UNII:3XYV4I47I8 | 4-Methyl-5-thiazoleethanol | 5-(2-hydroxyethyl)-4-methylthiazole | DrugBank ID:DB02969 | PubChem CID:1136 | PubChem SID:198936083 | 2-(4-methyl-1,3-thiazol-5-yl)ethanol"
+BMGC_DG01247,BMG_DG011051,"1-PHENYL-1,2-PROPANEDIONE | UNII:ZB5XA3GD0I | PubChem CID:11363 | 1-Phenyl-1,2-propanedione | PubChem SID:198975151 | 1-phenylpropane-1,2-dione | CAS RN:579-07-7"
+BMGC_DG01248,BMG_DG011053,"PONESIMOD | PubChem SID:198945887 | DrugBank ID:DB12016 | PubChem CID:11363176 | UNII:5G7AKV2MKP | NDC:43068-620 | Ponesimod | CAS RN:854107-55-4 | (5Z)-5-[[3-chloro-4-[(2R)-2,3-dihydroxypropoxy]phenyl]methylidene]-3-(2-methylphenyl)-2-propylimino-1,3-thiazolidin-4-one | NDC:50458-720"
+BMGC_DG01249,BMG_DG011056,"4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide | UNII:4LJG22T9C6 | CAS RN:755038-02-9 | 4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide | PubChem CID:11364421 | PubChem SID:198984127 | BI-2536"
+BMGC_DG01250,BMG_DG011075,PubChem CID:11367905 | 4-[3-(Trifluoromethyl)-3H-diazirin-3-yl]benzyl alcohol | CAS RN:87736-88-7 | UNII:BVF7RFE6SA | 4-(3-(TRIFLUOROMETHYL)-3H-DIAZIRIN-3-YL)BENZYL ALCOHOL | PubChem SID:482553988
+BMGC_DG01251,BMG_DG011078,PubChem CID:11368987 | DrugBank ID:DB07708 | 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL
+BMGC_DG01252,BMG_DG011079,KR-32568 | PubChem SID:443625274 | CAS RN:852146-73-7 | PubChem CID:11368995 | UNII:QJ7D8A9YGY
+BMGC_DG01253,BMG_DG011086,"PubChem CID:11369918 | PubChem SID:287446150 | NORQUETIAPINE | 6-piperazin-1-ylbenzo[b][1,4]benzothiazepine | Norquetiapine | UNII:V3H1ZVV9S6 | CAS RN:5747-48-8"
+BMGC_DG01254,BMG_DG011089,"PubChem CID:1137 | 4-Methyl-5-hydroxyethylthiazole phosphate | CAS RN:3269-79-2 | 4-Methyl-5-Hydroxyethylthiazole Phosphate | 2-(4-methyl-1,3-thiazol-5-yl)ethyl dihydrogen phosphate | DrugBank ID:DB03145"
+BMGC_DG01255,BMG_DG011094,"UNII:BLH9UKX9V1 | DrugBank ID:DB06156 | (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(ethoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane | CAS RN:195875-84-4 | Tesofensine | PubChem SID:198958606 | PubChem CID:11370864 | TESOFENSINE"
+BMGC_DG01256,BMG_DG011097,"UNII:439411S4TB | DIPHENYLAMINE-2,2'-DICARBOXYLIC ACID | PubChem SID:198936635 | PubChem CID:11371 | CAS RN:579-92-0"
+BMGC_DG01257,BMG_DG011100,UNII:SYU33I753N | CAS RN:580-13-2 | 2-BROMONAPHTHALENE | PubChem SID:198950036 | PubChem CID:11372
+BMGC_DG01258,BMG_DG011101,PubChem CID:11372171 | UNII:BUN2P7889F | CAS RN:824961-41-3 | PubChem SID:441332091 | JWH-166
+BMGC_DG01259,BMG_DG011102,PubChem CID:11372270 | Ladarixin | CAS RN:849776-05-2 | UNII:DEH7Q6472O | [4-[(2R)-1-(methanesulfonamido)-1-oxopropan-2-yl]phenyl] trifluoromethanesulfonate | PubChem SID:198960956 | LADARIXIN
+BMGC_DG01260,BMG_DG011103,6-AMINOQUINOLINE | PubChem CID:11373 | 6-Aminoquinoline | PubChem SID:474489862 | CAS RN:580-15-4 | UNII:XN7T264NL4
+BMGC_DG01261,BMG_DG011104,"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE | DrugBank ID:DB08464 | PubChem CID:11373270"
+BMGC_DG01262,BMG_DG011105,CAS RN:851845-37-9 | PubChem CID:11373432 | AZD6703 | UNII:8QS8G2Y8E0 | PubChem SID:383470524 | AZD-6703
+BMGC_DG01263,BMG_DG011108,PubChem SID:496141717 | UNII:8Q99A974BL | SHA-68 | CAS RN:847553-89-3 | PubChem CID:11374217
+BMGC_DG01264,BMG_DG011109,GSK-183390 | PubChem CID:11374679 | CAS RN:852814-21-2 | UNII:TYR4ZI4S0Z | PubChem SID:377308221
+BMGC_DG01265,BMG_DG011118,"Azd3409 | PubChem CID:11377266 | UNII:F99W9H5WUE | PubChem SID:383470689 | propan-2-yl (2S)-2-[[2-[2-(4-fluorophenyl)ethyl]-5-[[(2S,4S)-4-(pyridine-3-carbonylsulfanyl)pyrrolidin-2-yl]methylamino]benzoyl]amino]-4-methylsulfanylbutanoate | AZD-3409 | CAS RN:345915-10-8"
+BMGC_DG01266,BMG_DG011131,CAS RN:139265-95-5 | PubChem SID:375083577 | PubChem CID:11379 | CAS RN:101772-05-8 | CAS RN:580-22-3 | CAS RN:31135-62-3 | 2-AMINOQUINOLINE | 2-Aminoquinoline | quinolin-2-amine | UNII:GR9M8HW75Z
+BMGC_DG01267,BMG_DG011134,"2-(Phenylethynyl)-7,8-dihydroquinolin-5(6H)-one | UNII:DXL4CVS8KQ | CAS RN:864224-08-8 | PubChem SID:485663579 | PubChem CID:11379626 | 2-(PHENYLETHYNYL)-7,8-DIHYDROQUINOLIN-5(6H)-ONE"
+BMGC_DG01268,BMG_DG011145,4-(4-CHLOROPHENYLTHIO)-2-(PYRIDIN-2-YL)PYRIMIDINE | PubChem SID:459275895 | UNII:YGA4A82T8D | PubChem CID:11381029 | CAS RN:863581-72-0
+BMGC_DG01269,BMG_DG011146,"PubChem CID:11381543 | UNII:DFL2XAU6XJ | CAS RN:820961-68-0 | N-(4,6-DIPHENYL-2-PYRIMIDINYL)-2-METHYLPROPANAMIDE | PubChem SID:461432498"
+BMGC_DG01270,BMG_DG011152,UNII:4C4P7L0W63 | ADX-47273 | PubChem CID:11383075 | PubChem SID:198977704 | CAS RN:851881-60-2
+BMGC_DG01271,BMG_DG011158,PubChem SID:198968066 | PubChem CID:11385 | 3-AMINOACRIDINE | CAS RN:581-29-3 | UNII:5T83GY5877
+BMGC_DG01272,BMG_DG011161,3-ACETYL-.BETA.-BOSWELLIC ACID | PubChem SID:198979246 | PubChem CID:11386458 | UNII:5M3483EOU5 | CAS RN:5968-70-7
+BMGC_DG01273,BMG_DG011164,"CAS RN:581-42-0 | PubChem SID:251965959 | UNII:76U29QW3FM | CAS RN:96789-56-9 | 2,6-Dimethylnaphthalene | 2,6-DIMETHYLNAPHTHALENE | PubChem CID:11387 | 2,6-dimethylnaphthalene"
+BMGC_DG01274,BMG_DG011168,"CAS RN:778576-62-8 | DrugBank ID:DB12375 | OGLEMILAST | Oglemilast | PubChem CID:11387409 | UNII:67GXQ6WCC6 | N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)-8-(methanesulfonamido)dibenzofuran-1-carboxamide | PubChem SID:198973602"
+BMGC_DG01275,BMG_DG011170,PubChem CID:11387605 | DrugBank ID:DB11851 | 4-[[(3S)-3-(dimethylamino)pyrrolidin-1-yl]methyl]-N-[4-methyl-3-[(4-pyrimidin-5-ylpyrimidin-2-yl)amino]phenyl]-3-(trifluoromethyl)benzamide | UNII:NVW4Z03I9B | BAFETINIB | Bafetinib | CAS RN:859212-16-1 | PubChem SID:198990636
+BMGC_DG01276,BMG_DG011172,"PubChem CID:11388 | UNII:5PP654XB7D | CAS RN:581-49-7 | PubChem SID:198942833 | Anatabine | ANATABINE | 3-[(2S)-1,2,3,6-tetrahydropyridin-2-yl]pyridine"
+BMGC_DG01277,BMG_DG011177,"PubChem CID:11389 | CAS RN:581-50-0 | 2,3'-BIPYRIDINE | UNII:WG6152JUQT | PubChem SID:249493198"
+BMGC_DG01278,BMG_DG011192,N-(DIAMINOMETHYLIDENE)-5-(5-FLUORO-2-METHOXYPHENYL)FURAN-2-CARBOXAMIDE | PubChem CID:11391762 | UNII:3PK8S2Z6AT | CAS RN:852146-74-8 | PubChem SID:459055657
+BMGC_DG01279,BMG_DG011194,"UNII:BTT4WXT3J9 | 3-(3,4-DIHYDROXYPHENYL)-N-PHENETHYLPROPENAMIDE, (E)- | PubChem CID:11391937 | CAS RN:103188-47-2 | PubChem SID:461434818"
+BMGC_DG01280,BMG_DG011199,PubChem SID:252165496 | UNII:U35ZNO9DJH | 17-DIHYDROEXEMESTANE | PubChem CID:11392371 | CAS RN:140461-66-1
+BMGC_DG01281,BMG_DG011203,PubChem SID:198960795 | PF-184298 | PubChem CID:11392888 | UNII:PZR8DT7L3O | CAS RN:813447-40-4
+BMGC_DG01282,BMG_DG011204,"PubChem CID:11392960 | N-(4,6-diphenylpyrimidin-2-yl)butanamide | CAS RN:820961-65-7"
+BMGC_DG01283,BMG_DG011205,UNII:202H99Z0CE | CAS RN:581-96-4 | PubChem CID:11393 | 2-NAPHTHALENEACETIC ACID | PubChem SID:198989391
+BMGC_DG01284,BMG_DG011207,UNII:I7Q196L4AU | PubChem CID:11393311 | PubChem SID:198969701 | HU-331 | CAS RN:137252-25-6
+BMGC_DG01285,BMG_DG011212,"Rislenemdaz | PubChem SID:241177923 | RISLENEMDAZ | RISLENEMDAZ, (+/-)- | DrugBank ID:DB12063 | (4-methylphenyl)methyl (3S,4R)-3-fluoro-4-[(pyrimidin-2-ylamino)methyl]piperidine-1-carboxylate | PubChem SID:241179898 | CERC-301 | RISLENEMDAZ, (±)- | UNII:1DY7M91WQ1 | CAS RN:1221592-28-4 | CAS RN:808733-05-3 | PubChem CID:11394238 | UNII:5HAM167S5T | CAS RN:808732-98-1"
+BMGC_DG01286,BMG_DG011215,Indeglitazar | UNII:JMC809G4ZH | PubChem SID:198951715 | DrugBank ID:DB07724 | PubChem CID:11395145 | CAS RN:835619-41-5 | 3-[5-methoxy-1-(4-methoxyphenyl)sulfonylindol-3-yl]propanoic acid | INDEGLITAZAR
+BMGC_DG01287,BMG_DG011216,"PubChem SID:198938460 | 2,7-DIMETHYLNAPHTHALENE | UNII:ON63XH5BQ4 | CAS RN:582-16-1 | PubChem CID:11396"
+BMGC_DG01288,BMG_DG011217,"UNII:2WDS5F2V6Q | PubChem SID:198987163 | ELOCALCITOL | DrugBank ID:DB06194 | (1R,3Z,5S)-3-[(2E)-2-[(3aS,7aS)-1-[(E,2S)-6-ethyl-6-hydroxyoct-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-5-fluoro-4-methylidenecyclohexan-1-ol | CAS RN:199798-84-0 | PubChem CID:11396600 | Elocalcitol"
+BMGC_DG01289,BMG_DG011222,"N-(2,6-dimethylphenyl)-N-[2-[4-(1,2,4-oxadiazol-3-yl)anilino]-2-oxoethyl]-1,1-dioxothiane-4-carboxamide | AMENAMEVIR | Amenamevir | DrugBank ID:DB11701 | UNII:94X46KW4AE | PubChem CID:11397521 | CAS RN:841301-32-4 | PubChem SID:198962754"
+BMGC_DG01290,BMG_DG011227,"PubChem CID:11399764 | Encequidar | ENCEQUIDAR | PubChem SID:316918825 | UNII:K4I4I996O4 | N-[2-[2-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]tetrazol-5-yl]-4,5-dimethoxyphenyl]-4-oxochromene-2-carboxamide | CAS RN:849675-66-7 | DrugBank ID:DB14070"
+BMGC_DG01291,BMG_DG011229,UNII:3FPU23BG52 | CAS RN:25013-04-1 | DrugBank ID:DB11558 | PubChem SID:175265654 | toluene | CAS RN:108-88-3 | TOLUENE | Toluene | PubChem CID:1140
+BMGC_DG01292,BMG_DG011230,TRICAINE | ethyl 3-aminobenzoate | PubChem CID:11400 | Tricaine | CAS RN:582-33-2 | PubChem SID:175267451 | DrugBank ID:DB11552 | UNII:02591PHL19
+BMGC_DG01293,BMG_DG011242,PubChem CID:11403628 | KR-32570 | PubChem SID:198940359 | CAS RN:852146-75-9 | UNII:31SF23L56C
+BMGC_DG01294,BMG_DG011244,KR-60436 FREE BASE | CAS RN:761414-79-3 | UNII:YA2BZ14G7C | PubChem SID:316915740 | PubChem CID:11403745
+BMGC_DG01295,BMG_DG011246,"PubChem SID:198960139 | CAS RN:803712-67-6 | OBATOCLAX | PubChem CID:11404337 | DrugBank ID:DB12191 | UNII:QN4128B52A | (2Z)-2-[(5Z)-5-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole | Obatoclax"
+BMGC_DG01296,BMG_DG011247,"UNII:D8E31JM2U4 | N-(2,6-DIPHENYLPYRIMIDIN-4-YL)PENTANAMIDE | CAS RN:820961-43-1 | PubChem CID:11404772 | PubChem SID:459056404"
+BMGC_DG01297,BMG_DG011253,"6-(2,4-difluorophenoxy)-8-methyl-2-(oxan-4-ylamino)pyrido[2,3-d]pyrimidin-7-one | CAS RN:449811-92-1 | DrugBank ID:DB06518 | PubChem SID:346540681 | PubChem CID:11406590 | UNII:IO0DCY55NQ | R-1487"
+BMGC_DG01298,BMG_DG011265,CAS RN:630124-46-8 | UNII:W34UO2M4T6 | PubChem SID:198941880 | AST-487 | PubChem CID:11409972
+BMGC_DG01299,BMG_DG011281,1-(3-METHOXYNAPHTHALEN-2-YL)IMIDAZOLE | CAS RN:674309-81-0 | PubChem CID:11413434 | UNII:WG9PEF479N | PubChem SID:472421917
+BMGC_DG01300,BMG_DG011287,"PubChem CID:11413953 | PubChem SID:316917906 | UNII:89G464XVIL | DODECATETRAENOIC ACID ISOBUTYLAMIDE, (2E,2E,8Z,10Z)- | CAS RN:77448-63-6"
+BMGC_DG01301,BMG_DG011293,"PubChem SID:198959432 | Verubulin | DrugBank ID:DB05585 | VERUBULIN | PubChem CID:11414799 | UNII:X97O9FTB92 | CAS RN:827031-83-4 | N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine"
+BMGC_DG01302,BMG_DG011305,"Carmegliptin | CAS RN:813452-18-5 | UNII:9Z723VGH7J | CARMEGLIPTIN | (4S)-1-[(2S,3S,11bS)-2-amino-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-3-yl]-4-(fluoromethyl)pyrrolidin-2-one | PubChem SID:198991183 | DrugBank ID:DB12268 | PubChem CID:11417567"
+BMGC_DG01303,BMG_DG011308,"UNII:FA554TW3UP | Benzamide, N,N-diethyl-4-(5-hydroxyspiro(2H-1-benzopyran-2,4'-piperidin)-4-yl)- | PubChem SID:198989741 | CAS RN:850305-06-5 | PubChem CID:11417954 | ADL-5859 | N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide"
+BMGC_DG01304,BMG_DG011310,"PubChem CID:11418570 | UNII:TH52F4317B | CAS RN:17140-79-3 | PubChem SID:198982715 | Magnesium gluconate | MAGNESIUM GLUCONATE ANHYDROUS | CAS RN:3632-91-5 | magnesium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate"
+BMGC_DG01305,BMG_DG011312,CAS RN:583-60-8 | 2-Methylcyclohexanone | UNII:56E8224ZFJ | 2-methylcyclohexan-1-one | PubChem CID:11419 | PubChem SID:198979966 | 2-METHYLCYCLOHEXANONE
+BMGC_DG01306,BMG_DG011316,"2-[(4,6-dimethoxypyrimidin-2-yl)carbamoylsulfamoyl]-4-formamido-N,N-dimethylbenzamide | CAS RN:173159-57-4 | UNII:4XJD212JQB | PubChem CID:11419598 | PubChem SID:198990864 | FORAMSULFURON | Foramsulfuron"
+BMGC_DG01307,BMG_DG011320,UNII:LB160J37HD | PubChem SID:198951153 | PubChem CID:11420211 | CAS RN:824982-41-4 | A-784168
+BMGC_DG01308,BMG_DG011325,"PubChem CID:11421412 | PubChem SID:472426393 | 3-((R)-2-AMINO-2-PHENYLETHYL)-5-(2-FLUORO-3-METHOXYPHENYL)-1-(2-FLUORO-6-TRIFLUOROMETHYLBENZYL)-6-METHYL-1H-PYRIMIDINE-2,4-DIONE | UNII:296CMR9U5E | CAS RN:830346-50-4 | (R)-3-(2-Amino-2-phenylethyl)-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione"
+BMGC_DG01309,BMG_DG011345,PubChem CID:11424684 | CAS RN:856171-18-1 | 2-(FURAN-2-YL)-6-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE | UNII:P16V6A93I1 | PubChem SID:443625092
+BMGC_DG01310,BMG_DG011351,PubChem SID:252319496 | CAS RN:87205-99-0 | UNII:562G9360V6 | PubChem CID:11425923 | DIHYDROTANSHINONE I
+BMGC_DG01311,BMG_DG011360,"CAS RN:728890-52-6 | UNII:0QHA1X95MF | PubChem CID:11427204 | N-(4-PHENYL-1,3-THIAZOL-2-YL)-7-SULFANYL-HEPTANAMIDE | PubChem SID:445500062"
+BMGC_DG01312,BMG_DG011361,UNII:2D9N67F58G | CAS RN:841258-76-2 | Kw-2449 | PubChem CID:11427553 | KW-2449 | [4-[(E)-2-(1H-indazol-3-yl)ethenyl]phenyl]-piperazin-1-ylmethanone | CAS RN:841259-17-4 | CAS RN:1000669-72-6 | PubChem SID:319892536
+BMGC_DG01313,BMG_DG011363,"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide | DrugBank ID:DB06991 | PubChem CID:11427975"
+BMGC_DG01314,BMG_DG011366,"PubChem CID:11428356 | 2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile | DrugBank ID:DB08088"
+BMGC_DG01315,BMG_DG011369,NDC:0220-2815 | NDC:0220-2810 | NDC:37662-1479 | NDC:37662-1474 | NDC:48951-6093 | NDC:37662-1480 | POTASSIUM CARBONATE | NDC:48951-6067 | NDC:37662-1478 | NDC:0220-2811 | NDC:0220-2812 | dipotassium;carbonate | NDC:37662-1475 | NDC:0220-2814 | NDC:37662-1481 | DrugBank ID:DB13977 | PubChem CID:11430 | NDC:15631-0249 | NDC:37662-1476 | Potassium Carbonate | CAS RN:584-08-7 | NDC:0220-2813 | NDC:15631-2800 | PubChem SID:175268668 | UNII:BQN1B9B9HA | NDC:37662-1477 | NDC:0220-2863 | NDC:0220-2809 | NDC:0220-2816
+BMGC_DG01316,BMG_DG011373,"UNII:ORR805EVE6 | PubChem SID:405055659 | TZB-30878 | CAS RN:864385-95-5 | 3-amino-2-[4-(4-quinolin-2-ylpiperazin-1-yl)butyl]-5,6,7,8-tetrahydroquinazolin-4-one | PubChem CID:11430418 | 3-Amino-2-[4-(4-quinolin-2-ylpiperazin-1-yl)butyl]-5,6,7,8-tetrahydroquinazolin-4-one"
+BMGC_DG01317,BMG_DG011377,N-[3-[4-[4-(cyclohexylmethylsulfonylamino)butyl]piperazin-1-yl]phenyl]acetamide | DrugBank ID:DB05562 | NALUZOTAN | CAS RN:740873-06-7 | Naluzotan | UNII:LQ54E5B4EW | PubChem SID:198977761 | PubChem CID:11430856
+BMGC_DG01318,BMG_DG011379,"2-[[2-(3-bromo-2,4,6-trimethylanilino)-2-oxoethyl]-(carboxymethyl)amino]acetic acid;technetium-99 | PubChem CID:11431716 | TECHNETIUM TC-99M MEBROFENIN | Technetium Tc 99m mebrofenin | CAS RN:1415247-71-0 | UNII:F2NQ468L52 | DrugBank ID:DB09137 | PubChem SID:346541234 | Technetium Tc-99m mebrofenin"
+BMGC_DG01319,BMG_DG011381,UNII:5XN29VGR24 | CAS RN:862073-77-6 | PubChem SID:441331985 | PubChem CID:11431898 | HERKINORIN
+BMGC_DG01320,BMG_DG011390,REBEMADLIN | NUTLIN-3 | PubChem SID:198961530 | PubChem SID:198945090 | CAS RN:675576-98-4 | PubChem CID:11433190 | UNII:53IA0V845C | UNII:L7C92IOE65 | CAS RN:548472-68-0
+BMGC_DG01321,BMG_DG011393,PubChem CID:11433918 | PubChem SID:316908891 | CAS RN:865110-07-2 | UNII:S441P37178 | MK-0668
+BMGC_DG01322,BMG_DG011398,"[(3R)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate | UNII:K17VY42F6C | Aclidinium | DrugBank ID:DB08897 | CAS RN:727649-81-2 | ACLIDINIUM | PubChem SID:198975237 | PubChem CID:11434515"
+BMGC_DG01323,BMG_DG011414,N-HYDROXY-2-(2-NAPHTHALENYLTHIO)ACETAMIDE | CAS RN:834918-57-9 | PubChem CID:11436221 | UNII:XQX2P3L256 | PubChem SID:482554026 | N-Hydroxy-2-(2-naphthalenylthio)acetamide
+BMGC_DG01324,BMG_DG011424,N-PHENYL-6-(2-SULFANYLETHANOYLAMINO)HEXANAMIDE | UNII:AC74GBC7QX | CAS RN:824970-14-1 | PubChem CID:11437457 | PubChem SID:472422232
+BMGC_DG01325,BMG_DG011425,2-MORPHOLIN-4-YLBENZO(G)CHROMEN-4-ONE | PubChem CID:11437483 | 2-Morpholin-4-ylbenzo[g]chromen-4-one | CAS RN:503467-97-8 | PubChem SID:485663641 | UNII:HR42SG72VQ
+BMGC_DG01326,BMG_DG011426,"PubChem SID:485663442 | CAS RN:223707-22-0 | 1,2-BIS(3,5-DIFLUOROPHENYL)-1,2-ETHANEDIONE | 1,2-Bis(3,5-difluorophenyl)-1,2-ethanedione | UNII:PE9A4DX2VX | PubChem CID:11437501"
+BMGC_DG01327,BMG_DG011431,"PubChem CID:11438771 | PubChem SID:198978800 | 2-chloro-4-[2-[1-(4-fluorophenyl)-2,5-dimethylimidazol-4-yl]ethynyl]pyridine | BASIMGLURANT | CAS RN:802906-73-6 | Basimglurant | UNII:3110E3AO8S | DrugBank ID:DB11833 | CAS RN:1034442-21-1"
+BMGC_DG01328,BMG_DG011432,"PubChem CID:11439 | CAS RN:584-43-0 | PubChem SID:198955759 | SUCCINIMIDE | UNII:10X90O3503 | pyrrolidine-2,5-dione | DrugBank ID:DB13376 | CAS RN:123-56-8 | Succinimide"
+BMGC_DG01329,BMG_DG011437,UNII:6HNB6FRT7X | PubChem CID:11440685 | PubChem SID:441331221 | CAS RN:92545-30-7 | SALVINORIN B
+BMGC_DG01330,BMG_DG011441,"PubChem CID:11441375 | N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide | DrugBank ID:DB07274"
+BMGC_DG01331,BMG_DG011447,"DANUSERTIB | N-[5-[(2R)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide | PubChem CID:11442891 | DrugBank ID:DB11778 | PubChem SID:198940281 | Danusertib | CAS RN:827318-97-8 | UNII:M3X659D0FY"
+BMGC_DG01332,BMG_DG011451,O-DESETHYL-BELNACASAN | UNII:Q257O24H4J | PubChem CID:11443029 | CAS RN:244133-31-1 | PubChem SID:198980719
+BMGC_DG01333,BMG_DG011483,PubChem CID:11448366 | UNII:F8GXN7H2LY | PubChem SID:472422257 | 7-METHOXY-2-MORPHOLIN-4-YLCHROMEN-4-ONE | CAS RN:130735-66-9
+BMGC_DG01334,BMG_DG011488,PubChem SID:198951176 | EX-2 | CAS RN:851365-34-9 | PubChem CID:11449246 | UNII:2OJV8MB11B
+BMGC_DG01335,BMG_DG011498,"DrugBank ID:DB06203 | CAS RN:850649-61-5 | CAS RN:1246610-75-2 | UNII:JHC049LO86 | Alogliptin | PubChem CID:11450633 | PubChem SID:175265639 | ALOGLIPTIN | CAS RN:1347001-80-2 | 2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile"
+BMGC_DG01336,BMG_DG011505,"FINGOLIMOD PHOSPHATE ESTER, (S)- | CAS RN:402616-26-6 | PubChem CID:11452022 | PubChem SID:318691816 | UNII:92YDM6122J"
+BMGC_DG01337,BMG_DG011512,"CAS RN:287405-51-0 | DrugBank ID:DB13020 | UNII:C6BZ5263BJ | PubChem CID:11452716 | APRATASTAT | Apratastat | (3S)-N-hydroxy-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulfonyl-2,2-dimethylthiomorpholine-3-carboxamide | PubChem SID:198962024"
+BMGC_DG01338,BMG_DG011524,PubChem SID:438787800 | PubChem CID:11455910 | CAS RN:877877-35-5 | UNII:FQ8NY4LUO5 | TW-37
+BMGC_DG01339,BMG_DG011525,"2-[N-(2-bromoethyl)-2,4-dinitro-6-(2-phosphonooxyethylcarbamoyl)anilino]ethyl methanesulfonate | PubChem CID:11455973 | CAS RN:851627-62-8 | DrugBank ID:DB05968 | PR-104 | UNII:V16D2ZT7DT | 2-((2-Bromoethyl)(2,4-dinitro-6-((2-(phosphonooxy)ethyl)carbamoyl)phenyl)amino)ethyl methanesulfonate | PubChem SID:198955259"
+BMGC_DG01340,BMG_DG011549,PubChem CID:11460087 | (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid | DrugBank ID:DB08760
+BMGC_DG01341,BMG_DG011556,PubChem CID:11460771 | 4-[(3-Chlorophenyl)thio]-2-(2-pyridinyl)pyrimidine | UNII:H4N4C876MV | PubChem SID:478838495 | 4-((3-CHLOROPHENYL)THIO)-2-(2-PYRIDINYL)PYRIMIDINE | CAS RN:863581-71-9
+BMGC_DG01342,BMG_DG011558,"PubChem SID:433968578 | (E)-3',4-DIHYDROXY-3,4',5-TRIMETHOXY-STILBENE | PubChem CID:11460836 | CAS RN:859511-60-7 | UNII:PB4S7WD65N"
+BMGC_DG01343,BMG_DG011559,3-Methoxybenzoic Acid | PubChem SID:198974212 | CAS RN:586-38-9 | 3-METHOXYBENZOIC ACID | PubChem CID:11461 | 3-methoxybenzoic acid | UNII:E2I36FH6QZ
+BMGC_DG01344,BMG_DG011560,PubChem SID:346540597 | PubChem CID:11461586 | UNII:J6M7L6J6PN | CAS RN:824955-98-8 | JWH-120
+BMGC_DG01345,BMG_DG011561,PubChem SID:346541218 | PubChem CID:114619 | 3-PHENYL-N-(3-PHENYL-N-((PHENYLMETHOXY)CARBONYL)-L-ALANYL)-L-ALANINE | UNII:Q3HUG35MZD | CAS RN:13122-91-3
+BMGC_DG01346,BMG_DG011563,UNII:04XB9TB8OL | CAS RN:851723-84-7 | Timapiprant | PubChem CID:11462174 | OC-459 | TIMAPIPRANT | 2-[5-fluoro-2-methyl-3-(quinolin-2-ylmethyl)indol-1-yl]acetic acid | CAS RN:227609-25-8 | PubChem SID:198970355 | DrugBank ID:DB11900
+BMGC_DG01347,BMG_DG011577,DrugBank ID:DB07967 | 9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE | PubChem CID:11464526
+BMGC_DG01348,BMG_DG011578,PubChem CID:11464846 | PubChem SID:249817379 | UNII:37F97S18KQ | CAS RN:610323-32-5 | MT-7716 FREE BASE
+BMGC_DG01349,BMG_DG011579,PubChem SID:198941392 | CAS RN:314267-57-7 | UNII:95RGX89OQD | PubChem CID:11464906 | JNJ-17029259
+BMGC_DG01350,BMG_DG011584,"ZICRONAPINE | UNII:QZV11V7G6A | PubChem SID:198975150 | CAS RN:170381-16-5 | 4-[(1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl]-1,2,2-trimethylpiperazine | PubChem CID:11465618 | DrugBank ID:DB12188 | Zicronapine"
+BMGC_DG01351,BMG_DG011585,"PubChem CID:11465695 | CAS RN:853003-48-2 | PubChem SID:198990122 | CAS RN:1198359-14-6 | 1-(2-ethoxyethyl)-5-[ethyl(methyl)amino]-7-[(4-methylpyridin-2-yl)amino]-N-methylsulfonylpyrazolo[4,3-d]pyrimidine-3-carboxamide | UNII:2S27T3DSZ3 | Pf-00489791 | PF-00489791 | DrugBank ID:DB11736"
+BMGC_DG01352,BMG_DG011597,BMS-509744 | PubChem CID:11467730 | CAS RN:439575-02-7 | PubChem SID:198952259 | UNII:5V7VG25953
+BMGC_DG01353,BMG_DG011603,"CAS RN:25656-67-1 | PubChem CID:114683 | PubChem SID:198984289 | UNII:Z3OC8499KG | 3h-Indole-5,6-Diol | DIHYDROXYINDOLE | DrugBank ID:DB01811 | 5,6-Dihydroxyindole | 1H-indole-5,6-diol | CAS RN:3131-52-0"
+BMGC_DG01354,BMG_DG011621,"UNII:XFX1A5KJ3V | LICARBAZEPINE | CAS RN:29331-92-8 | PubChem CID:114709 | 5-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide | Licarbazepine | PubChem SID:198977351"
+BMGC_DG01355,BMG_DG011635,PubChem SID:443625040 | 2-(3-FLUOROPHENYL)BENZO(H)CHROMEN-4-ONE | CAS RN:652138-30-2 | UNII:WI1RND3FG4 | PubChem CID:11471812
+BMGC_DG01356,BMG_DG011645,UNII:366KH3B6RR | PubChem SID:461433979 | CAS RN:863581-73-1 | 4-(3-BROMOPHENYL)SULFANYL-2-PYRIDIN-2-YL-PYRIMIDINE | PubChem CID:11473392
+BMGC_DG01357,BMG_DG011646,"CAS RN:70407-20-4 | Territrem B | (1S,2S,7R,10R)-1,7-dihydroxy-2,6,6,10-tetramethyl-14-(3,4,5-trimethoxyphenyl)-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-4,12(17),13-triene-3,16-dione | PubChem CID:114734"
+BMGC_DG01358,BMG_DG011654,PubChem CID:114743 | DESMETHYLSERTRALINE | PubChem SID:198962737 | UNII:CJJ71O9BE8 | CAS RN:87857-41-8
+BMGC_DG01359,BMG_DG011655,PubChem SID:472422970 | CAS RN:96316-00-6 | UNII:NFS3HJC8WD | METAPHIT | PubChem CID:114745
+BMGC_DG01360,BMG_DG011656,CAS RN:652978-45-5 | UNII:YP3P4N7NQQ | PubChem SID:474492592 | RTI-371 FREE BASE | PubChem CID:11474847
+BMGC_DG01361,BMG_DG011658,"TALTIRELIN | UNII:DOZ62MV6A5 | PubChem SID:198943553 | CAS RN:103300-74-9 | PubChem CID:114750 | Taltirelin | (4S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide"
+BMGC_DG01362,BMG_DG011662,PubChem SID:472387924 | 6-PHENYLHEXYL ISOTHIOCYANATE | UNII:PCB7WLT5ZX | 6-Phenylhexyl isothiocyanate | CAS RN:133920-06-6 | PubChem CID:114757
+BMGC_DG01363,BMG_DG011667,UNII:97QB5037VR | PubChem CID:11476171 | PubChem SID:198954966 | AEW-541 | CAS RN:475488-34-7
+BMGC_DG01364,BMG_DG011669,PubChem CID:11476297 | MBX-8025 (Seladelpar) | 2-[4-[2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methylphenoxy]acetic acid
+BMGC_DG01365,BMG_DG011670,"TEDIZOLID PHOSPHATE | Tedizolid phosphate | DrugBank ID:DB09042 | NDC:67919-041 | UNII:O7DRJ6R4DW | NDC:72000-320 | NDC:67919-040 | PubChem SID:198936003 | [(5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl dihydrogen phosphate | CAS RN:856867-55-5 | PubChem CID:11476460 | NDC:72000-310 | Tedizolid Phosphate"
+BMGC_DG01366,BMG_DG011676,UNII:8EJD945ABL | CAS RN:790658-27-4 | PubChem CID:11477180 | PubChem SID:445499080 | PG-01037
+BMGC_DG01367,BMG_DG011682,"PubChem CID:114776 | UNII:A37342TIX1 | PubChem SID:198989341 | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one | ISOORIENTIN | CAS RN:4261-42-1 | Isoorientin"
+BMGC_DG01368,BMG_DG011683,"PubChem CID:114777 | CAS RN:4670-05-7 | PubChem SID:198966012 | THEAFLAVIN | UNII:1IA46M0D13 | 3,4,6-trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-5-one | 3,4,5-trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-6-one"
+BMGC_DG01369,BMG_DG011688,CAS RN:10023-74-2 | PubChem CID:114781 | Pentanoate | pentanoate
+BMGC_DG01370,BMG_DG011692,"N-[4-methyl-3-[1-methyl-7-[(6-methylpyridin-3-yl)amino]-2-oxo-4H-pyrimido[4,5-d]pyrimidin-3-yl]phenyl]-3-(trifluoromethyl)benzamide | Benzamide, N-[3-[1,4-dihydro-1-methyl-7-[(6-methyl-3-pyridinyl)amino]-2-oxopyrimido[4,5-D]pyrimidin-3(2H)-YL]-4-methylphenyl]-3-(trifluoromethyl)- | PubChem CID:11478363 | CAS RN:839706-07-9"
+BMGC_DG01371,BMG_DG011718,"PubChem CID:114811 | Florfenicol | DrugBank ID:DB11413 | CAS RN:76639-94-6 | 2,2-dichloro-N-[(1R,2S)-3-fluoro-1-hydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide | UNII:9J97307Y1H | FLORFENICOL | PubChem SID:175268154 | CAS RN:73231-34-2"
+BMGC_DG01372,BMG_DG011719,(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol | DrugBank ID:DB04472 | PubChem CID:11481186
+BMGC_DG01373,BMG_DG011726,CAS RN:851854-41-6 | UNII:UUL6887MPD | PubChem SID:478838503 | 2-Methyl-6-(3-p-tolyloxy-prop-1-ynyl)pyridine | 2-METHYL-6-(3-P-TOLYLOXY-PROP-1-YNYL)PYRIDINE | PubChem CID:11481793
+BMGC_DG01374,BMG_DG011727,(E)-N-methoxy-3-[2-(6-methylpyridin-2-yl)ethynyl]cyclohex-2-en-1-imine | CAS RN:1224977-89-2 | CAS RN:924298-51-1 | (E)-3-(2-(6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone O-methyl oxime | PubChem CID:11481862
+BMGC_DG01375,BMG_DG011737,"UNII:T194LKP9W6 | Liquiritigenin | PubChem CID:114829 | DrugBank ID:DB03601 | CAS RN:578-86-9 | PubChem SID:198979837 | (2S)-7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | 5-deoxyflavanone | LIQUIRITIGENIN"
+BMGC_DG01376,BMG_DG011741,"Androsterone glucuronide | ANDROSTERONE GLUCURONIDE | (2S,3S,4S,5R,6R)-6-[[(3R,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | PubChem CID:114833 | PubChem SID:381608372 | CAS RN:1852-43-3 | UNII:IMD4XD0W3U"
+BMGC_DG01377,BMG_DG011744,"DrugBank ID:DB05959 | PubChem CID:11483754 | UNII:760O4GJB9O | ENMD-1198 | PubChem SID:198965670 | CAS RN:864668-87-1 | Enmd-1198 | (8S,9S,13R,14S)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-3-carboxamide"
+BMGC_DG01378,BMG_DG011746,(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid | PubChem CID:11483970 | DrugBank ID:DB08121
+BMGC_DG01379,BMG_DG011747,"UNII:TBV5O16GAP | CAS RN:5843-65-2 | HIGENAMINE | DrugBank ID:DB12779 | PubChem SID:198969565 | Higenamine | 1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol | PubChem CID:114840"
+BMGC_DG01380,BMG_DG011757,"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE | PubChem CID:11485425 | DrugBank ID:DB07739"
+BMGC_DG01381,BMG_DG011759,LINIFANIB | 1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea | PubChem SID:198985906 | CAS RN:796967-16-3 | PubChem CID:11485656 | UNII:CO93X137CW | Linifanib
+BMGC_DG01382,BMG_DG011763,"Dechloroethylcyclophosphamide | 3-DECHLOROETHYLIFOSFAMIDE | UNII:C6Q3UC3WP5 | CAS RN:36761-83-8 | N-(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine | PubChem SID:252164032 | PubChem CID:114861"
+BMGC_DG01383,BMG_DG011766,"PubChem CID:114864 | (R)-(-)-Ibuprofen | (2R)-2-[4-(2-methylpropyl)phenyl]propanoic acid | IBUPROFEN, (-)- | UNII:99W8H60N62 | PubChem SID:251965566 | CAS RN:51146-57-7"
+BMGC_DG01384,BMG_DG011776,3-(2-(Phenethyl(Propyl)Amino)Ethyl)Phenol | PubChem CID:114876 | 3-[2-[2-phenylethyl(propyl)amino]ethyl]phenol
+BMGC_DG01385,BMG_DG011784,DrugBank ID:DB12183 | Sapitinib | PubChem CID:11488320 | 2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide | SAPITINIB | PubChem SID:198989379 | CAS RN:848942-61-0 | UNII:3499328002
+BMGC_DG01386,BMG_DG011787,MK-9470 | CAS RN:947371-30-4 | PubChem SID:198977081 | UNII:3XCL8256SA | PubChem CID:11488705
+BMGC_DG01387,BMG_DG011789,CAS RN:78756-33-9 | UNII:ZRD5QFZ6DV | CHLOROFLUMAZENIL | PubChem SID:461433610 | PubChem CID:114888
+BMGC_DG01388,BMG_DG011797,"1,3,8-trichloro-6-methyldibenzofuran | CAS RN:115039-00-4 | CAS RN:118174-38-2 | 6-METHYL-1,3,8-TRICHLORODIBENZOFURAN | PubChem SID:440089406 | PubChem CID:114900 | 6-Methyl-1,3,8-trichlorodibenzofuran | UNII:1FU4HF6ELF"
+BMGC_DG01389,BMG_DG011801,"LANDIOLOL | UNII:62NWQ924LH | Landiolol | CAS RN:133242-30-5 | PubChem CID:114905 | DrugBank ID:DB12212 | [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate | PubChem SID:198982236"
+BMGC_DG01390,BMG_DG011804,"PubChem SID:198954241 | CAS RN:76-80-2 | PubChem CID:114909 | Tephrosin | TEPHROSIN | UNII:9C081V83CC | (1R,14R)-14-hydroxy-17,18-dimethoxy-7,7-dimethyl-2,8,21-trioxapentacyclo[12.8.0.03,12.04,9.015,20]docosa-3(12),4(9),5,10,15,17,19-heptaen-13-one"
+BMGC_DG01391,BMG_DG011809,"CAS RN:4431-41-8 | Dihydrowogonin | PubChem CID:11491431 | 5,7-dihydroxy-8-methoxy-2-phenyl-2,3-dihydrochromen-4-one"
+BMGC_DG01392,BMG_DG011811,"CAS RN:54693-68-4 | PubChem CID:114917 | PubChem SID:198945269 | TANSHINONE I | CAS RN:568-73-0 | 1,6-dimethylnaphtho[1,2-g][1]benzofuran-10,11-dione | UNII:03UUH3J385 | Tanshinone I"
+BMGC_DG01393,BMG_DG011812,"UNII:2XYB6EX2PG | PubChem SID:459055664 | 2-amino-3-oxophenoxazine-1,9-dicarboxylic acid | PubChem CID:114918 | CINNABARINIC ACID | Cinnabarinic acid | CAS RN:606-59-7"
+BMGC_DG01394,BMG_DG011817,3-(2-aminoethyl)phenol | M-TYRAMINE | CAS RN:588-05-6 | UNII:K1OA38R0EZ | m-Tyramine | PubChem CID:11492 | PubChem SID:198985326
+BMGC_DG01395,BMG_DG011818,"PubChem CID:114920 | CAS RN:1816-85-9 | 11.BETA.-HYDROXYTESTOSTERONE | (8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | UNII:BEF7K94MWQ | 11beta-Hydroxytestosterone | PubChem SID:445500345"
+BMGC_DG01396,BMG_DG011820,"UNII:A2FA8F63VS | 4-FLUORO-N,N-DIMETHYL-1H-INDOLE-3-ETHANAMINE | PubChem CID:11492162 | CAS RN:1644-64-0 | PubChem SID:478838321 | 4-Fluoro-N,N-dimethyl-1H-indole-3-ethanamine"
+BMGC_DG01397,BMG_DG011821,PubChem CID:11492186 | DrugBank ID:DB07161 | 5-phenyl-1H-indazol-3-amine
+BMGC_DG01398,BMG_DG011831,"UNII:CG1P9V70LE | CAS RN:850442-84-1 | PubChem CID:11493035 | 3',4'-DIMETHOXY-.ALPHA.-PYRROLIDINOPENTIOPHENONE | PubChem SID:363908019"
+BMGC_DG01399,BMG_DG011837,Coproporphyrin III | PubChem CID:114935 | COPROPORPHYRIN III | CAS RN:14643-66-4 | PubChem SID:482553071 | UNII:ETX4TFE9GJ
+BMGC_DG01400,BMG_DG011839,"DrugBank ID:DB07794 | PubChem CID:11493598 | UNII:4C7X7GV82C | FR-180204 | 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE | PubChem SID:445500369 | CAS RN:865362-74-9"
+BMGC_DG01401,BMG_DG011843,"CAS RN:889673-61-4 | 2,6-BIS(4-METHOXYPHENYL)PURINE | PubChem CID:11493677 | UNII:BUV3TDZ93K | PubChem SID:434369826"
+BMGC_DG01402,BMG_DG011844,UNII:DQF20NHW2M | CAS RN:864445-45-4 | PubChem SID:375085327 | JWH-302 | PubChem CID:11493740
+BMGC_DG01403,BMG_DG011845,"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide | PubChem CID:11493841 | DrugBank ID:DB08361"
+BMGC_DG01404,BMG_DG011849,"UNII:PJ4H73IL17 | (3R,4R)-3-(1-azatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraen-3-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione | CAS RN:905854-02-6 | CAS RN:905853-99-8 | CAS RN:1000873-98-2 | TIVANTINIB | PubChem SID:198981526 | DrugBank ID:DB12200 | Tivantinib | PubChem CID:11494412"
+BMGC_DG01405,BMG_DG011852,PubChem CID:114947 | UNII:R67LEH4X5Q | CAS RN:23219-33-2 | PubChem SID:440089999 | DrugBank ID:DB04598 | 2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID
+BMGC_DG01406,BMG_DG011853,"DIHYDRO-.ALPHA.-ERGOCRYPTINE | DrugBank ID:DB11274 | PubChem CID:114948 | Dihydroergocryptine | PubChem SID:175265280 | UNII:202229IR8Y | CAS RN:25447-66-9 | (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide"
+BMGC_DG01407,BMG_DG011854,"PubChem CID:11494891 | {4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID | DrugBank ID:DB07999"
+BMGC_DG01408,BMG_DG011862,"DrugBank ID:DB07135 | PubChem CID:11495704 | (2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE"
+BMGC_DG01409,BMG_DG011864,"PubChem CID:114959 | Listerine | CAS RN:51273-66-6 | 5-methyl-2-propan-2-ylcyclohexan-1-ol;5-methyl-2-propan-2-ylphenol;1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane"
+BMGC_DG01410,BMG_DG011868,PubChem CID:11496610 | PubChem SID:485663418 | CAS RN:872002-72-7 | UNII:D68C48FA7B | 6-[[4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl]methyl]quinoxaline | 6-((4-(2-(4-TERT-BUTYLPHENYL)-1H-BENZIMIDAZOL-4-YL)PIPERAZIN-1-YL)METHYL)QUINOXALINE
+BMGC_DG01411,BMG_DG011879,2-[ethyl-[3-[4-[[5-[2-(3-fluoroanilino)-2-oxoethyl]-1H-pyrazol-3-yl]amino]quinazolin-7-yl]oxypropyl]amino]ethyl dihydrogen phosphate | UNII:16XC2U7W8N | PubChem CID:11497983 | Barasertib | CAS RN:722543-31-9 | DrugBank ID:DB11747 | PubChem SID:198959212 | BARASERTIB
+BMGC_DG01412,BMG_DG011883,"PubChem CID:11498153 | DrugBank ID:DB12244 | (1S,8R)-4-(trifluoromethyl)-10-azatricyclo[6.3.1.02,7]dodeca-2(7),3,5-triene | Cp-601927 | UNII:VI5LR1EU47 | CAS RN:1448551-01-6 | CP-601927 | PubChem SID:198954744 | CAS RN:357425-02-6"
+BMGC_DG01413,BMG_DG011886,"UNII:8O74K609HN | 4-[2-[[3,5-bis(trifluoromethyl)phenyl]methyl-[(2R,4S)-1-ethoxycarbonyl-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinolin-4-yl]amino]pyrimidin-5-yl]oxybutanoic acid | DrugBank ID:DB14890 | CAS RN:866399-87-3 | CAS RN:1454689-48-5 | OBICETRAPIB | Obicetrapib | PubChem SID:346539051 | PubChem CID:11498596"
+BMGC_DG01414,BMG_DG011890,"FASITIBANT | CAS RN:869939-83-3 | UNII:0WL827Z7AE | PubChem CID:11498853 | PubChem SID:198953925 | [(4S)-4-amino-5-[4-[4-[[2,4-dichloro-3-[(2,4-dimethylquinolin-8-yl)oxymethyl]phenyl]sulfonylamino]oxane-4-carbonyl]piperazin-1-yl]-5-oxopentyl]-trimethylazanium | Fasitibant"
+BMGC_DG01415,BMG_DG011893,TROLNITRATE | PubChem SID:198990433 | PubChem CID:11499 | CAS RN:7077-34-1 | 2-[bis(2-nitrooxyethyl)amino]ethyl nitrate | Trolnitrate | UNII:B9M85U075P | DrugBank ID:DB13719
+BMGC_DG01416,BMG_DG011896,"CAS RN:174671-46-6 | Tavaborole | TAVABOROLE | PubChem SID:175267658 | NDC:69097-686 | NDC:72578-102 | DrugBank ID:DB09041 | NDC:0574-0157 | NDC:62332-467 | NDC:70771-1826 | NDC:21922-020 | PubChem CID:11499245 | UNII:K124A4EUQ3 | NDC:62135-663 | NDC:51862-690 | NDC:69238-1657 | 5-fluoro-1-hydroxy-3H-2,1-benzoxaborole | NDC:51672-1397"
+BMGC_DG01417,BMG_DG011903,"UNII:EVH7O0422T | CAS RN:120072-59-5 | PubChem SID:198981124 | BioMed 101 | 7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-8-propyl-3,4-dihydro-2H-chromene-2-carboxylic acid | PubChem CID:114999 | SC-41930"
+BMGC_DG01418,BMG_DG011905,CAS RN:61-54-1 | DrugBank ID:DB08653 | TRYPTAMINE | 2-(1H-indol-3-yl)ethanamine | Tryptamine | PubChem SID:198990710 | PubChem CID:1150 | UNII:422ZU9N5TV
+BMGC_DG01419,BMG_DG011912,"DrugBank ID:DB06914 | 1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE | PubChem CID:11500273"
+BMGC_DG01420,BMG_DG011913,"N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE | DrugBank ID:DB07303 | PubChem CID:11500493"
+BMGC_DG01421,BMG_DG011915,UNII:7WT415DLW0 | PubChem CID:11500603 | PubChem SID:443624312 | CAS RN:869093-66-3 | 2-(4-BROMO-2-CYCLOHEXYLPHENOXY)ACETIC ACID
+BMGC_DG01422,BMG_DG011916,"Neorautenol, (-)- | PubChem CID:11500744 | NEORAUTENOL, (-)- | UNII:NF6JUS6BNH | CAS RN:53766-52-2 | PubChem SID:478838494"
+BMGC_DG01423,BMG_DG011923,FLORBETABEN F-18 | NDC:54828-001 | DrugBank ID:DB09148 | PubChem CID:11501341 | CAS RN:902143-01-5 | Florbetaben F-18 | 4-[(E)-2-[4-[2-[2-(2-(18F)fluoranylethoxy)ethoxy]ethoxy]phenyl]ethenyl]-N-methylaniline | UNII:TLA7312TOI | PubChem SID:198981135
+BMGC_DG01424,BMG_DG011924,S-sulphocysteine | PubChem CID:115015 | DrugBank ID:DB04370 | S-SULFOCYSTEINE | PubChem SID:313182405 | CAS RN:1637-71-4 | S-Sulfocysteine | (2R)-2-amino-3-sulfosulfanylpropanoic acid | UNII:885F2S42LL
+BMGC_DG01425,BMG_DG011925,PubChem SID:198979139 | GSK-554418A | CAS RN:871819-90-8 | PubChem CID:11501580 | UNII:9132NB1UJR
+BMGC_DG01426,BMG_DG011931,"CAS RN:866206-54-4 | PRX-08066 free base | PubChem SID:198942161 | UNII:82SK298EBU | PRX-08066 FREE BASE | 5-[[4-[(6-chlorothieno[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]methyl]-2-fluorobenzonitrile | PubChem CID:11502243"
+BMGC_DG01427,BMG_DG011934,PubChem CID:11502647 | CHIR-124 | DrugBank ID:DB06852
+BMGC_DG01428,BMG_DG011937,"UNII:BZ2O8A84A4 | CAS RN:891859-12-4 | 1-[[6-[(2-methoxy-4-propylphenyl)methoxy]-1-methyl-3,4-dihydronaphthalen-2-yl]methyl]azetidine-3-carboxylic acid | Ceralifimod | PubChem SID:198947332 | CERALIFIMOD | PubChem CID:11502996"
+BMGC_DG01429,BMG_DG011938,UNII:02N4V81704 | N-METHYLPHENETHYLAMINE | PubChem SID:287445956 | CAS RN:589-08-2 | PubChem CID:11503
+BMGC_DG01430,BMG_DG011946,"MICONAZOLE, (R)- | UNII:C90U92KSVX | PubChem CID:1150344 | 1-[(2R)-2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole | (R)-Miconazole | PubChem SID:255509099 | CAS RN:47447-53-0"
+BMGC_DG01431,BMG_DG011947,tellurite | PubChem CID:115037 | Tellurite | CAS RN:15852-22-9
+BMGC_DG01432,BMG_DG011951,"Olodaterol | PubChem CID:11504295 | CAS RN:868049-49-4 | 6-hydroxy-8-[(1R)-1-hydroxy-2-[[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino]ethyl]-4H-1,4-benzoxazin-3-one | PubChem SID:198980824 | UNII:VD2YSN1AFD | OLODATEROL | DrugBank ID:DB09080"
+BMGC_DG01433,BMG_DG011957,PubChem SID:459055399 | UNII:55GY047QB0 | CAS RN:133410-84-1 | DrugBank ID:DB04653 | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1S)-3-fluoro-1-(4-hydroxybenzyl)-2-oxopropyl]-L-leucinamide | PubChem CID:11505008 | CALPAIN INHIBITOR IV
+BMGC_DG01434,BMG_DG011961,"PubChem CID:11505444 | DrugBank ID:DB11871 | UNII:ZH5SMU97AJ | PF-00610355 | 2-[3-[2-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(methanesulfonamido)phenyl]ethyl]amino]-2-methylpropyl]phenyl]-N-[[3-(4-hydroxyphenyl)phenyl]methyl]acetamide | Benzeneacetamide, N-((4'-hydroxy(1,1'-biphenyl)-3-yl)methyl)-3-(2-(((2R)-2-hydroxy-2-(4-hydroxy-3-((methylsulfonyl)amino)phenyl)ethyl)amino)-2-methylpropyl)- | CAS RN:862541-45-5 | PubChem SID:198946895"
+BMGC_DG01435,BMG_DG011962,"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE | DrugBank ID:DB07393 | PubChem CID:11505541"
+BMGC_DG01436,BMG_DG011964,"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE | DrugBank ID:DB07701 | PubChem CID:1150567"
+BMGC_DG01437,BMG_DG011972,PubChem SID:198945313 | PubChem CID:115067 | CAS RN:62499-27-8 | GASTRODIN | UNII:5YS9U2W3RQ
+BMGC_DG01438,BMG_DG011976,"PubChem CID:115069 | 4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL | UNII:RX2C8QLH24 | 4,4'-BIS(METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL | PubChem SID:438788577 | DrugBank ID:DB08373 | CAS RN:66640-68-4"
+BMGC_DG01439,BMG_DG011978,"(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL | PubChem CID:11507040 | DrugBank ID:DB08255"
+BMGC_DG01440,BMG_DG011988,UNII:2WBU91OKM7 | CAS RN:874902-19-9 | LY-2183240 | PubChem SID:319892025 | PubChem CID:11507802
+BMGC_DG01441,BMG_DG011991,"N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE | PubChem CID:11507920 | DrugBank ID:DB07993"
+BMGC_DG01442,BMG_DG012002,"CAS RN:872365-16-7 | PubChem CID:11508736 | Nvp-qav-680 | UNII:0E3D72URPD | PubChem SID:198980299 | QAV-680 | 2-[2-methyl-1-[(4-methylsulfonylphenyl)methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid | DrugBank ID:DB11658"
+BMGC_DG01443,BMG_DG012005,CAS RN:349085-38-7 | PubChem SID:443624396 | PubChem CID:1150897 | UNII:MU78VFH9C7 | HC-030031
+BMGC_DG01444,BMG_DG012013,"1,2,3,4,5,6,7,8-octahydroacridin-9-amine | UNII:2YM9179F4V | PubChem CID:115097 | CAS RN:13415-07-1 | Octahydroaminoacridine | PubChem SID:198973880 | OCTAHYDROAMINOACRIDINE"
+BMGC_DG01445,BMG_DG012014,"CAS RN:96304-42-6 | PubChem CID:115098 | Trypanothione disulfide | (2S)-2-amino-5-[[(4R,23R)-4-[[(4S)-4-amino-4-carboxybutanoyl]amino]-5,8,19,22-tetraoxo-1,2-dithia-6,9,13,18,21-pentazacyclotetracos-23-yl]amino]-5-oxopentanoic acid"
+BMGC_DG01446,BMG_DG012018,CAS RN:913692-28-1 | PubChem CID:115100 | N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-7-yl]-4-(4-phenylbutoxy)benzamide
+BMGC_DG01447,BMG_DG012022,"PubChem CID:115104 | N-hydroxy-MeIQx | CAS RN:115044-41-2 | UNII:JK23F1137Z | PubChem SID:346538708 | N-(3,8-dimethylimidazo[4,5-f]quinoxalin-2-yl)hydroxylamine | N-HYDROXY-MEIQX"
+BMGC_DG01448,BMG_DG012024,"PubChem CID:115107 | (4aS,10bS)-4-propyl-3,4a,5,10b-tetrahydro-2H-chromeno[4,3-b][1,4]oxazin-9-ol | CAS RN:123594-64-9"
+BMGC_DG01449,BMG_DG012029,PubChem CID:11511120 | UNII:2XJX250C20 | CAS RN:1110813-31-4 | (E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide | PubChem SID:198956821 | DACOMITINIB ANHYDROUS | DrugBank ID:DB11963 | Dacomitinib
+BMGC_DG01450,BMG_DG012032,"16alpha-Hydroxyestrone | (8R,9S,13S,14S,16R)-3,16-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one | CAS RN:566-76-7 | PubChem SID:252165154 | PubChem CID:115116 | UNII:JY611949JU | 16.ALPHA.-HYDROXYESTRONE"
+BMGC_DG01451,BMG_DG012034,PubChem CID:115121 | CAS RN:5230-87-5 | ANISATIN | UNII:W9K8802FZL | PubChem SID:198955063
+BMGC_DG01452,BMG_DG012044,"(3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-25,30-diethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,27,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21,24-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | ALISPORIVIR | UNII:VBP9099AA6 | DrugBank ID:DB12139 | PubChem SID:198945554 | PubChem CID:11513676 | Alisporivir | CAS RN:254435-95-5"
+BMGC_DG01453,BMG_DG012059,"CAS RN:21416-68-2 | 4-[3-(3,5-dioxopiperazin-1-yl)butan-2-yl]piperazine-2,6-dione | 4,4'-(1,2-Dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione | PubChem CID:115150"
+BMGC_DG01454,BMG_DG012064,PubChem CID:11515395 | CAS RN:895155-95-0 | UR-144 N-5-HYDROXYPENTYL | PubChem SID:252319871 | UNII:4MC625LVID
+BMGC_DG01455,BMG_DG012067,N-(4-cyano-benzo(b)thiophene-2-carbonyl)guanidine | KR-33028 | PubChem SID:459055386 | CAS RN:861218-37-3 | 4-cyano-N-(diaminomethylidene)-1-benzothiophene-2-carboxamide | PubChem CID:11515637 | UNII:FX7EF8AXC3
+BMGC_DG01456,BMG_DG012072,"Pyrrolidine, 1,5-dimethyl-3,3-diphenyl-2-ethylidene- | PubChem CID:115159 | CAS RN:30223-73-5 | 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine"
+BMGC_DG01457,BMG_DG012076,"Gosogliptin | GOSOGLIPTIN | CAS RN:869490-23-3 | CAS RN:869490-47-1 | PubChem SID:198938880 | UNII:GI718UO477 | PubChem CID:11516136 | DrugBank ID:DB08382 | (3,3-difluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone"
+BMGC_DG01458,BMG_DG012078,"DrugBank ID:DB01605 | PubChem SID:198990067 | 2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | Pivmecillinam | UNII:1WAM1OQ30B | AMDINOCILLIN PIVOXIL | CAS RN:32886-97-8 | Amdinocillin Pivoxil | PubChem CID:115163"
+BMGC_DG01459,BMG_DG012088,PubChem SID:443623774 | PubChem CID:11517307 | 2-(4-(HYDROXY(DIPHENYL)METHYL)-1-AZONIABICYCLO(2.2.2)OCTAN-1-YL)ETHANOL | UNII:NTT66YHP9Y | CAS RN:869184-56-5
+BMGC_DG01460,BMG_DG012095,PubChem CID:11517980 | CAS RN:883986-34-3 | AZD-2932 | PubChem SID:377307920 | UNII:SJ9PP5S9IM
+BMGC_DG01461,BMG_DG012097,UNII:26YW2T2JUC | PubChem SID:496142985 | CAS RN:865479-76-1 | 5-Chloro-N-methyl-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide | 5-CHLORO-N-METHYL-N-(((5S)-2-OXO-3-(4-(3-OXO-4-MORPHOLINYL)PHENYL)-5-OXAZOLIDINYL)METHYL)-2-THIOPHENECARBOXAMIDE | PubChem CID:11518043
+BMGC_DG01462,BMG_DG012100,PubChem SID:198936619 | Trifarotene | UNII:0J8RN2W0HK | DrugBank ID:DB12808 | 4-[3-(3-tert-butyl-4-pyrrolidin-1-ylphenyl)-4-(2-hydroxyethoxy)phenyl]benzoic acid | CAS RN:895542-09-3 | TRIFAROTENE | PubChem CID:11518241 | NDC:0299-5935
+BMGC_DG01463,BMG_DG012108,diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol;bromide | UNII:7AN603V4JV | PubChem CID:11519069 | UMECLIDINIUM BROMIDE | NDC:0173-0869 | CAS RN:869113-09-7 | NDC:0173-0873 | Umeclidinium Bromide | PubChem SID:198936820
+BMGC_DG01464,BMG_DG012109,DrugBank ID:DB09076 | UNII:GE2T1418SV | UMECLIDINIUM | diphenyl-[1-(2-phenylmethoxyethyl)-1-azoniabicyclo[2.2.2]octan-4-yl]methanol | Umeclidinium | PubChem CID:11519070 | CAS RN:869185-19-3 | PubChem SID:198977602
+BMGC_DG01465,BMG_DG012115,"NDC:70515-001 | NDC:70515-002 | CAS RN:320345-99-1 | PubChem SID:175268353 | NDC:0310-0900 | UNII:UQW7UF9N91 | PubChem CID:11519741 | ACLIDINIUM BROMIDE | [(3R)-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octan-3-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate;bromide | Aclidinium Bromide"
+BMGC_DG01466,BMG_DG012124,"BzATP | 3'-O-(4-BENZOYL)BENZOYLADENOSINE 5'-TRIPHOSPHATE | PubChem SID:198945631 | UNII:4P5DXU1F8Q | PubChem CID:115205 | CAS RN:81790-82-1 | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy(phosphonooxy)phosphoryl]oxyphosphoryl]oxymethyl]oxolan-3-yl] 4-benzoylbenzoate"
+BMGC_DG01467,BMG_DG012126,"UNII:64N10FV9M3 | 1,7,8-TRICHLORODIBENZO-P-DIOXIN | CAS RN:82306-65-8 | 1,7,8-trichlorodibenzo-p-dioxin | 1,7,8-Trichlorodibenzo-p-dioxin | PubChem SID:198982775 | PubChem CID:115206"
+BMGC_DG01468,BMG_DG012128,"PubChem CID:115208 | CAS RN:81656-30-6 | N-[[5-(2-fluorophenyl)-1-methyl-2,3-dihydro-1,4-benzodiazepin-2-yl]methyl]thiophene-3-carboxamide | UNII:TF8X866L0I | TIFLUADOM | Tifluadom | CAS RN:83386-35-0 | PubChem SID:198955565"
+BMGC_DG01469,BMG_DG012130,"UNII:48Z35KB15K | RIDAFOROLIMUS | DrugBank ID:DB06233 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-dimethylphosphoryloxy-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone | CAS RN:572924-54-0 | PubChem SID:198958143 | Ridaforolimus | PubChem CID:11520894"
+BMGC_DG01470,BMG_DG012133,"ethyl 4-methyl-5-propan-2-yloxy-9H-pyrido[3,4-b]indole-3-carboxylate | Ethyl 4-methyl-5-(1-methylethoxy)-9H-pyrido(3,4-b)indole-3-carboxylate | PubChem SID:474489527 | PubChem CID:115210 | ZK-93426 | UNII:S8EEB2VSB3 | CAS RN:89592-45-0"
+BMGC_DG01471,BMG_DG012141,"CAS RN:92689-49-1 | UNII:SNU299M83Q | PubChem CID:115212 | PubChem SID:198972676 | Annamycin | (7S,9S)-7-[(2R,3R,4R,5R,6S)-4,5-dihydroxy-3-iodo-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione | DrugBank ID:DB06420 | Naxtarubicin | NAXTARUBICIN"
+BMGC_DG01472,BMG_DG012145,"CAS RN:620948-93-8 | CAS RN:887258-95-9 | (12R,16S)-7,10-diazatetracyclo[8.6.1.05,17.012,16]heptadeca-1,3,5(17)-triene | Vabicaserin | UNII:WD9550HPNL | DrugBank ID:DB12071 | PubChem CID:11521822 | PubChem SID:198949440 | VABICASERIN"
+BMGC_DG01473,BMG_DG012147,CAS RN:104448-53-5 | (1-((2-Methoxy-4-(((phenylsulfonyl)amino)carbonyl)phenyl)methyl)-1H-indazol-6-yl)carbamic acid cyclopentyl ester | PubChem SID:482554065 | PubChem CID:115219 | (1-((2-METHOXY-4-(((PHENYLSULFONYL)AMINO)CARBONYL)PHENYL)METHYL)-1H-INDAZOL-6-YL)CARBAMIC ACID CYCLOPENTYL ESTER | UNII:E9XYB5543A
+BMGC_DG01474,BMG_DG012157,"DrugBank ID:DB08620 | THIACLOPRID | CAS RN:1119449-18-1 | UNII:DSV3A944A4 | [3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene]cyanamide | Thiacloprid | CAS RN:111988-49-9 | PubChem CID:115224 | PubChem SID:198943076"
+BMGC_DG01475,BMG_DG012158,"PubChem CID:11522441 | DrugBank ID:DB08035 | 1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE"
+BMGC_DG01476,BMG_DG012168,"CAS RN:144598-75-4 | NDC:42291-916 | NDC:16714-869 | NDC:47335-766 | NDC:62332-805 | NDC:65162-282 | NDC:68180-525 | NDC:31722-318 | NDC:43975-352 | NDC:68180-526 | NDC:60687-459 | NDC:47335-765 | NDC:27241-276 | NDC:43602-294 | NDC:27241-278 | NDC:46708-803 | NDC:50458-554 | NDC:27241-279 | NDC:68180-523 | NDC:27241-277 | NDC:50458-550 | NDC:16714-867 | NDC:72819-158 | DrugBank ID:DB01267 | NDC:43602-297 | NDC:65162-280 | NDC:43602-296 | NDC:42291-917 | NDC:16714-866 | NDC:46708-804 | NDC:72819-157 | UNII:838F01T721 | NDC:31722-320 | NDC:46708-805 | NDC:42291-915 | NDC:62332-806 | NDC:68180-524 | NDC:46708-806 | NDC:16714-868 | NDC:31722-319 | NDC:62332-804 | NDC:65162-281 | PALIPERIDONE | NDC:27808-224 | NDC:27808-223 | NDC:43602-295 | NDC:0904-6935 | NDC:43975-351 | NDC:72819-159 | NDC:43975-349 | NDC:27808-225 | NDC:62332-803 | NDC:72819-160 | 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one | NDC:42291-918 | NDC:43975-350 | NDC:50458-552 | NDC:60687-470 | NDC:27808-222 | NDC:0904-6937 | NDC:47335-744 | NDC:31722-317 | NDC:0904-6936 | NDC:50458-551 | NDC:47335-767 | Paliperidone | NDC:65162-283 | PubChem SID:472386150 | PubChem CID:115237"
+BMGC_DG01477,BMG_DG012170,UNII:SVT5HFY7J5 | PubChem SID:441096845 | PubChem CID:115239 | 5-(4-fluorophenyl)-1-(4-methylsulfonylphenyl)-3-(trifluoromethyl)pyrazole | 1-((4-Methylsulfonyl)phenyl)-3-trifluoromethyl-5-(4-fluorophenyl)pyrazole | CAS RN:162054-19-5 | 1-((4-METHYLSULFONYL)PHENYL)-3-TRIFLUOROMETHYL-5-(4-FLUOROPHENYL)PYRAZOLE
+BMGC_DG01478,BMG_DG012172,"CAS RN:895169-20-7 | ONO-2952 | PubChem SID:329904279 | DrugBank ID:DB14802 | UNII:ZH8CPX4YNB | Ono-2952 | PubChem CID:11524127 | 1-[(1S)-1-(4-chloro-2-methoxyphenyl)-5-fluorospiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,1'-cyclopropane]-2-yl]ethanone"
+BMGC_DG01479,BMG_DG012173,"DrugBank ID:DB08597 | Dorsomorphin | DORSOMORPHIN | UNII:10K52CIC1Z | CAS RN:866405-64-3 | PubChem SID:322058684 | 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine | PubChem CID:11524144"
+BMGC_DG01480,BMG_DG012176,"L-proline betaine | CAS RN:471-87-4 | PubChem CID:115244 | PubChem SID:198941396 | UNII:S1L688345C | (2S)-1,1-dimethylpyrrolidin-1-ium-2-carboxylate | DrugBank ID:DB04284 | Stachydrine | STACHYDRINE"
+BMGC_DG01481,BMG_DG012177,CAS RN:847728-01-2 | UNII:CN7Z4P7QXS | PubChem SID:485663679 | CJ-042794 | PubChem CID:11524454
+BMGC_DG01482,BMG_DG012178,"PubChem SID:317229854 | PubChem CID:115245 | Glycolithocholic acid | 2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid | CAS RN:474-74-8 | GLYCOLITHOCHOLIC ACID | UNII:Q53GV75CJG"
+BMGC_DG01483,BMG_DG012184,"PubChem CID:11524901 | CAS RN:865479-71-6 | RIVAROXABAN, (R)- | PubChem SID:441658884 | UNII:RJP4GEG36M"
+BMGC_DG01484,BMG_DG012191,"4'-PHOSPHOPANTETHEINE | [(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] dihydrogen phosphate | PubChem CID:115254 | DrugBank ID:DB03912 | UNII:NM39WU8OFM | 4'-Phosphopantetheine | PubChem SID:198953424 | D-pantetheine 4'-phosphate | CAS RN:2226-71-3"
+BMGC_DG01485,BMG_DG012192,"Estrone glucuronide | PubChem CID:115255 | UNII:933Q277TO2 | PubChem SID:198974626 | ESTRONE GLUCURONIDE | CAS RN:2479-90-5 | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-2-carboxylic acid"
+BMGC_DG01486,BMG_DG012197,DrugBank ID:DB04701 | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-methylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | PubChem CID:115260 | PubChem SID:198960136 | UNII:OOW3025SR1 | S-Methyl glutathione | CAS RN:2922-56-7 | S-Methylglutathione | S-METHYLGLUTATHIONE
+BMGC_DG01487,BMG_DG012198,"PEMAFIBRATE | DrugBank ID:DB15212 | UNII:17VGG92R23 | PubChem CID:11526038 | Pemafibrate | PubChem SID:198987966 | CAS RN:848259-27-8 | (2R)-2-[3-[[1,3-benzoxazol-2-yl-[3-(4-methoxyphenoxy)propyl]amino]methyl]phenoxy]butanoic acid"
+BMGC_DG01488,BMG_DG012202,"ULIMORELIN | PubChem SID:198971919 | Ulimorelin | CAS RN:842131-33-3 | UNII:LGI67MCW2S | (3R,6S,9R,12R)-6-cyclopropyl-12-[(4-fluorophenyl)methyl]-3,8,9-trimethyl-2-oxa-5,8,11,14-tetrazabicyclo[16.4.0]docosa-1(22),18,20-triene-7,10,13-trione | DrugBank ID:DB12128 | PubChem CID:11526696"
+BMGC_DG01489,BMG_DG012214,IBODUTANT | 6-methyl-N-[1-[[(2R)-1-[[1-(oxan-4-ylmethyl)piperidin-4-yl]methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]cyclopentyl]-1-benzothiophene-2-carboxamide | CAS RN:522664-63-7 | UNII:1H7RSQ28BJ | Ibodutant | DrugBank ID:DB12042 | PubChem CID:11527495 | PubChem SID:198986261
+BMGC_DG01490,BMG_DG012216,N-[2-[[(3R)-1-[4-hydroxy-4-(6-methoxypyridin-3-yl)cyclohexyl]pyrrolidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | CAS RN:887401-92-5 | Unii-0W6K09gaqb | INCB-3284 | UNII:0W6K09GAQB | PubChem CID:11527661 | PubChem SID:252319157
+BMGC_DG01491,BMG_DG012230,"1-(2-propan-2-yloxyethyl)-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one | Verdiperstat | UNII:TT3345YXVR | VERDIPERSTAT | CAS RN:890655-80-8 | PubChem SID:255509496 | PubChem CID:11528958 | DrugBank ID:DB12440"
+BMGC_DG01492,BMG_DG012247,CAS RN:870773-76-5 | AC-261066 | PubChem SID:198945043 | PubChem CID:11530459 | UNII:LGF3F89BZP
+BMGC_DG01493,BMG_DG012250,"DrugBank ID:DB07932 | PubChem CID:11531308 | dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate"
+BMGC_DG01494,BMG_DG012254,PubChem SID:441097071 | PubChem CID:11531745 | CAS RN:868359-05-1 | WAY-213613 | UNII:8QTE6AZR4F
+BMGC_DG01495,BMG_DG012258,PRX-07034 FREE BASE | PubChem CID:11532574 | UNII:YJ5TMF911R | CAS RN:903580-16-5 | PubChem SID:316912254
+BMGC_DG01496,BMG_DG012259,"KRP-105, (R)- | UNII:Y7KKH4TH37 | PubChem CID:11532616 | CAS RN:876145-68-5 | PubChem SID:459055889"
+BMGC_DG01497,BMG_DG012270,DrugBank ID:DB08190 | UNII:2Q5TZ5754A | PubChem CID:115348 | 2-Iodomelatonin | 2-IODOMELATONIN | N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide | PubChem SID:472408848 | CAS RN:93515-00-5
+BMGC_DG01498,BMG_DG012279,"NDC:70505-210 | DrugBank ID:DB00348 | NDC:70709-000 | UNII:K5BN214699 | PubChem SID:175268251 | NDC:0254-3022 | NITISINONE | Nitisinone | NDC:70505-205 | NDC:63629-2233 | NDC:70709-005 | NDC:71863-119 | NDC:0254-3020 | NDC:71863-121 | NDC:71863-122 | PubChem CID:115355 | NDC:63629-2234 | NDC:66658-204 | 2-[2-nitro-4-(trifluoromethyl)benzoyl]cyclohexane-1,3-dione | NDC:0254-3021 | NDC:63629-2235 | NDC:66658-120 | CAS RN:104206-65-7 | NDC:70505-202 | NDC:70709-002 | NDC:71863-120 | NDC:66658-110 | NDC:66658-102 | NDC:70505-220 | NDC:66658-105"
+BMGC_DG01499,BMG_DG012282,PubChem SID:472421927 | PubChem CID:11535796 | 2-METHYL-4-(2-(2-THIENYL)ETHYNYL)THIAZOLE | UNII:VC2XK69RWS | CAS RN:878018-56-5
+BMGC_DG01500,BMG_DG012283,"DrugBank ID:DB06608 | CAS RN:106635-80-7 | PubChem CID:115358 | PubChem SID:198977802 | 4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine | NDC:71475-257 | TAFENOQUINE | UNII:262P8GS9L9 | Tafenoquine"
+BMGC_DG01501,BMG_DG012285,CAS RN:878018-41-8 | PubChem CID:11535913 | 3-[2-(2-Methyl-4-thiazolyl)ethynyl]benzonitrile | 3-(2-(2-METHYL-4-THIAZOLYL)ETHYNYL)BENZONITRILE | PubChem SID:485663482 | UNII:6QGB2S2KZ2
+BMGC_DG01502,BMG_DG012294,"2-BROMANYL-4-(2-(3-FLUOROPHENYL)ETHYNYL)-1,3-THIAZOLE | UNII:VSS4MBV59P | PubChem CID:11536470 | CAS RN:878018-74-7 | PubChem SID:472421918"
+BMGC_DG01503,BMG_DG012298,"PubChem SID:198937425 | (3aS,7aR)-2-[4-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]butyl]-3a,4,5,6,7,7a-hexahydroisoindole-1,3-dione | CAS RN:150915-41-6 | Perospirone | PubChem CID:115368 | DrugBank ID:DB08922 | CAS RN:129273-38-7 | UNII:N303OK87DT | PEROSPIRONE"
+BMGC_DG01504,BMG_DG012307,UNII:TPY5M47AYQ | PubChem CID:11537652 | PubChem SID:441331817 | AB-005 | CAS RN:895155-25-6
+BMGC_DG01505,BMG_DG012310,Quisinostat | CAS RN:875320-29-9 | QUISINOSTAT | N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide | UNII:9BJ85K1J8S | PubChem CID:11538455 | DrugBank ID:DB12985 | PubChem SID:198951338
+BMGC_DG01506,BMG_DG012312,"PubChem CID:11538992 | DrugBank ID:DB07072 | (1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE"
+BMGC_DG01507,BMG_DG012316,PubChem SID:198971169 | GGTI-2418 | CAS RN:501010-06-6 | UNII:M67G28K74K | Ggti-2418 | PubChem CID:11539477 | (2S)-2-[[(2S)-2-benzyl-4-[(5-methyl-1H-imidazol-4-yl)methyl]-3-oxopiperazine-1-carbonyl]amino]-4-methylpentanoic acid
+BMGC_DG01508,BMG_DG012317,"UNII:742ZNN7NYE | 3-(6-((4-(2-HYDROXYETHYL)PIPERAZIN-1-YL)METHYL)-4-(MORPHOLIN-4-YL)THIENO(3,2-D)PYRIMIDIN-2-YL)PHENOL | PubChem CID:11539769 | PubChem SID:459055287 | CAS RN:885617-20-9"
+BMGC_DG01509,BMG_DG012322,"Oleandrin | CAS RN:465-16-7 | [(3S,5R,8R,9S,10S,13R,14S,16S,17R)-14-hydroxy-3-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] acetate | PubChem SID:198965326 | DrugBank ID:DB12843 | PubChem CID:11541511 | UNII:II95UDU7I4 | CAS RN:1315607-79-4 | OLEANDRIN"
+BMGC_DG01510,BMG_DG012338,"PubChem CID:11544170 | DrugBank ID:DB08191 | 4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid"
+BMGC_DG01511,BMG_DG012339,CAS RN:895155-57-4 | PubChem CID:11544639 | A-834735 | PubChem SID:252319574 | UNII:XE27L67C93
+BMGC_DG01512,BMG_DG012343,"DrugBank ID:DB07056 | 2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide | PubChem CID:11545694"
+BMGC_DG01513,BMG_DG012354,"PubChem SID:198956430 | DrugBank ID:DB11838 | Revamilast | PubChem CID:11546664 | REVAMILAST | UNII:30LE65637T | N-(3,5-dichloro-1-hydroxypyridin-4-ylidene)-6-(difluoromethoxy)-[1]benzofuro[3,2-c]pyridine-9-carboxamide | CAS RN:893555-90-3"
+BMGC_DG01514,BMG_DG012358,"DrugBank ID:DB12113 | 2-chloro-N-[(1-hydroxycycloheptyl)methyl]-5-[4-[(2R)-2-hydroxy-3-methoxypropyl]-3,5-dioxo-1,2,4-triazin-2-yl]benzamide | CAS RN:1391953-24-4 | PubChem CID:11547499 | UNII:T8B02RAU3C | Ce-224535 | PubChem SID:198989366 | CAS RN:724424-43-5 | CE-224535"
+BMGC_DG01515,BMG_DG012363,"PubChem SID:198969342 | DrugBank ID:DB12933 | 3,4-difluoro-2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-5-[(3-oxooxazinan-2-yl)methyl]benzamide | RO-4987655 | 3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)amino]-N-(2-Hydroxyethoxy)-5-[(3-Oxo-1,2-Oxazinan-2-Yl)methyl]benzamide | CAS RN:874101-00-5 | UNII:I3733P75ML | PubChem CID:11548630"
+BMGC_DG01516,BMG_DG012365,PubChem CID:11548933 | AZD-2207 | UNII:9ZI8H1XB9X | PubChem SID:363908973 | CAS RN:866598-45-0
+BMGC_DG01517,BMG_DG012376,PubChem CID:11550377 | CAS RN:878018-80-5 | UNII:TT94CE7L9Q | PubChem SID:485663464 | 2-ETHYNYL-4-(2-(3-FLUOROPHENYL)ETHYNYL)THIAZOLE | 2-Ethynyl-4-[2-(3-fluorophenyl)ethynyl]thiazole
+BMGC_DG01518,BMG_DG012395,"Losmapimod | PubChem SID:198938694 | CAS RN:585543-15-3 | 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide | PubChem CID:11552706 | LOSMAPIMOD | UNII:F2DQF16BXE | DrugBank ID:DB12270"
+BMGC_DG01519,BMG_DG012398,"DrugBank ID:DB07146 | PubChem CID:11553058 | 2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE"
+BMGC_DG01520,BMG_DG012400,"CAS RN:256934-39-1 | ONTERNABEZ | [(1S,4S,5S)-4-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methanol | PubChem SID:198973998 | [(1S,4S,5S)-4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methanol | PubChem CID:11553430 | UNII:8I5L034D55"
+BMGC_DG01521,BMG_DG012401,"DrugBank ID:DB07092 | PubChem CID:11554165 | (2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE"
+BMGC_DG01522,BMG_DG012409,"PubChem SID:198963790 | (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one | PubChem CID:11556427 | UNII:P7T269PR6S | ANACETRAPIB | Anacetrapib | CAS RN:875446-37-0 | DrugBank ID:DB06630"
+BMGC_DG01523,BMG_DG012411,CAS RN:868540-17-4 | UNII:72X6E3J5AR | Carfilzomib | PubChem SID:175266683 | NDC:76075-103 | DrugBank ID:DB08889 | NDC:76075-102 | CARFILZOMIB | PubChem CID:11556711 | (2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide | NDC:76075-101
+BMGC_DG01524,BMG_DG012431,PubChem CID:11559235 | UNII:U8C5C9D65S | A-841720 | PubChem SID:198962182 | CAS RN:869802-58-4
+BMGC_DG01525,BMG_DG012433,PubChem SID:441097537 | XLR-12 | CAS RN:895155-78-9 | UNII:EG79K9XQF5 | PubChem CID:11559386
+BMGC_DG01526,BMG_DG012436,UNII:E6999JX933 | PubChem CID:11559627 | PubChem SID:478839569 | PRLX-93936 | CAS RN:903499-49-0
+BMGC_DG01527,BMG_DG012439,"6-[bis(2,2,2-trifluoroethyl)amino]-4-(trifluoromethyl)-1H-quinolin-2-one | UNII:RI376RM5MT | PubChem SID:198988085 | 6-(Bis-(2,2,2-trifluoroethyl)amino)-4-trifluoromethyl-1H-quinolin-2-one | DrugBank ID:DB08089 | PubChem CID:11560224 | LGD-2226 | CAS RN:328947-93-9"
+BMGC_DG01528,BMG_DG012440,PubChem SID:459276013 | PubChem CID:11560249 | PSNCBAM-1 | UNII:P34SC5V6W2 | CAS RN:877202-74-9
+BMGC_DG01529,BMG_DG012442,DrugBank ID:DB05171 | PubChem SID:313182577 | PubChem CID:11560787 | CAS RN:870843-42-8 | E-2012 | UNII:3LSD4Y5F0F | (E)-1-[(1S)-1-(4-Fluorophenyl)ethyl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-YL)benzylidene]piperidin-2-one | (3E)-1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]piperidin-2-one
+BMGC_DG01530,BMG_DG012444,"DrugBank ID:DB06997 | PubChem CID:11560856 | 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide"
+BMGC_DG01531,BMG_DG012448,PubChem CID:11561383 | 5-cyclopropyl-2-(4-fluorophenyl)-6-[2-hydroxyethyl(methylsulfonyl)amino]-N-methyl-1-benzofuran-3-carboxamide | PubChem SID:198942728 | Nesbuvir | DrugBank ID:DB07238 | CAS RN:691852-58-1 | NESBUVIR | UNII:EYK815W3Z8
+BMGC_DG01532,BMG_DG012449,"UNII:7BZQ418Z0J | PubChem SID:198985146 | N-(1-OXOPENTYL)-N-((2'-(2H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-L-VALINE METHYL ESTER | PubChem CID:11561462 | CAS RN:137863-17-3"
+BMGC_DG01533,BMG_DG012450,"PubChem CID:11561674 | PubChem SID:198938842 | DrugBank ID:DB05676 | CAS RN:608141-41-9 | NDC:55513-497 | UNII:UP7QBP99PN | N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide | NDC:55513-137 | APREMILAST | Apremilast"
+BMGC_DG01534,BMG_DG012454,PubChem SID:198965015 | UNII:6VG04XOV89 | CORTISTATIN A | CAS RN:882976-95-6 | PubChem CID:11561907
+BMGC_DG01535,BMG_DG012456,PubChem CID:11562302 | PubChem SID:438788852 | UNII:3MAE0MXI6K | CAS RN:867330-68-5 | TG-100435
+BMGC_DG01536,BMG_DG012460,CAS RN:591-20-8 | 3-Bromophenol | PubChem CID:11563 | M-BROMOPHENOL | PubChem SID:198968463 | 3-bromophenol | UNII:VMU0X6956Y
+BMGC_DG01537,BMG_DG012471,CAS RN:329205-54-1 | UNII:67WK8KAK5K | PubChem CID:11564671 | 4-(3-PYRIDYLETHYNYL)-2-THIAZOLYLAMINE | PubChem SID:459275778
+BMGC_DG01538,BMG_DG012482,HDS-029 | PubChem SID:319891810 | PubChem CID:11566580 | CAS RN:881001-19-0 | UNII:ZN0X0Q76F1
+BMGC_DG01539,BMG_DG012487,"UNII:63J9EQ81YC | 1-Piperazinepropanoic acid, 4-dibenz(b,f)(1,4)oxazepin-11-yl-alpha,alpha-dimethyl- | DrugBank ID:DB15092 | PubChem SID:333495856 | 3-(4-benzo[b][1,4]benzoxazepin-6-ylpiperazin-1-yl)-2,2-dimethylpropanoic acid | CAS RN:879409-35-5 | LY-2624803 | PubChem CID:11567064"
+BMGC_DG01540,BMG_DG012490,"UNII:D26OSN9Q4R | PubChem CID:11567473 | DrugBank ID:DB09047 | FINAFLOXACIN | Finafloxacin | CAS RN:209342-40-5 | PubChem SID:198977962 | 7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid"
+BMGC_DG01541,BMG_DG012491,PubChem CID:11567474 | 5-fluoro-2-[[(1S)-1-(4-fluorophenyl)ethyl]amino]-6-[(3-propan-2-yloxy-1H-pyrazol-5-yl)amino]pyridine-3-carbonitrile | (S)-5-Fluoro-2-(1-(4-fluorophenyl)ethylamino)-6-(5-isopropoxy-1H-pyrazol-3-ylamino)nicotinonitrile | CAS RN:905585-60-6
+BMGC_DG01542,BMG_DG012493,"PALIRODEN | 1-[2-(4-phenylphenyl)ethyl]-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2H-pyridine | Paliroden | CAS RN:188396-77-2 | UNII:17VJ76L90T | DrugBank ID:DB05454 | PubChem CID:11567682 | PubChem SID:198956889"
+BMGC_DG01543,BMG_DG012495,UNII:L3WTS6QT82 | PubChem CID:11568 | M-AMINOPHENOL | PubChem SID:198937252 | 3-Aminophenol | CAS RN:591-27-5 | 3-aminophenol
+BMGC_DG01544,BMG_DG012498,"L-733061, (-)- | PubChem CID:11568372 | PubChem SID:474494781 | CAS RN:148700-91-8 | Jdh4VT5tsv | (2R,3R)-3-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine | UNII:JDH4VT5TSV"
+BMGC_DG01545,BMG_DG012506,"PubChem CID:11569967 | Cenisertib | CENISERTIB | (1S,2S,3R,4R)-3-[[5-fluoro-2-[3-methyl-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide | UNII:5277GPA358 | PubChem SID:198990125 | DrugBank ID:DB06347 | CAS RN:871357-89-0"
+BMGC_DG01546,BMG_DG012510,"3-[[4-[(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]benzoyl]amino]propanoic acid | CAS RN:870823-12-4 | UNII:CCP2U6LWTP | MK-0893 | PubChem SID:198948957 | DrugBank ID:DB12044 | Mk-0893 | PubChem CID:11570626"
+BMGC_DG01547,BMG_DG012511,PubChem SID:440088944 | CAS RN:1173659-25-0 | PubChem CID:11570708 | UNII:6H8FDD5016 | AS-1410
+BMGC_DG01548,BMG_DG012527,"PubChem CID:11572592 | PubChem SID:443624062 | UNII:M7XGQ4XKP6 | CAS RN:889673-58-9 | 2,6-DIPHENYL-7H-PURINE"
+BMGC_DG01549,BMG_DG012533,DrugBank ID:DB07239 | PubChem CID:11572962 | 7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile
+BMGC_DG01550,BMG_DG012542,"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE | PubChem CID:11574606 | DrugBank ID:DB07688"
+BMGC_DG01551,BMG_DG012543,CAS RN:51209-48-4 | UNII:9HK5L7YBBR | Iodobenzene | CAS RN:591-50-4 | PubChem SID:198943548 | iodobenzene | DrugBank ID:DB02252 | IODOBENZENE | PubChem CID:11575
+BMGC_DG01552,BMG_DG012550,"CAS RN:677772-84-8 | PubChem CID:11577204 | N-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide"
+BMGC_DG01553,BMG_DG012555,CALCIUM LEVULINATE ANHYDROUS | PubChem CID:11578 | PubChem SID:198978513 | DrugBank ID:DB13800 | calcium;4-oxopentanoate | CAS RN:591-64-0 | Calcium levulinate | UNII:LLQ966USIL
+BMGC_DG01554,BMG_DG012556,UNII:DYO3SU8O2M | PubChem CID:11578126 | PubChem SID:255509548 | CAS RN:903579-36-2 | MK-8141
+BMGC_DG01555,BMG_DG012564,Laevulinic Acid | UNII:RYX5QG61EI | DrugBank ID:DB02239 | CAS RN:123-76-2 | PubChem SID:175266778 | 4-oxopentanoic acid | LEVULINIC ACID | Levulinic Acid | PubChem CID:11579
+BMGC_DG01556,BMG_DG012577,CAS RN:873693-47-1 | NBI-75043 | PubChem SID:461434802 | PubChem CID:11580427 | UNII:EJG9C09D7R
+BMGC_DG01557,BMG_DG012585,DrugBank ID:DB08387 | CAS RN:898562-94-2 | PubChem SID:198943249 | 2-[[4-(1-methyl-4-pyridin-4-ylpyrazol-3-yl)phenoxy]methyl]quinoline | Mardepodect | CAS RN:1292799-56-4 | PubChem CID:11581936 | MARDEPODECT | UNII:R9Y8EY0G42
+BMGC_DG01558,BMG_DG012597,"CDP-choline | [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl [hydroxy-[2-(trimethylazaniumyl)ethoxy]phosphoryl] phosphate | PubChem CID:11583971 | CAS RN:987-78-0"
+BMGC_DG01559,BMG_DG012600,CAS RN:895155-26-7 | PubChem CID:11584525 | PubChem SID:198967842 | UNII:5N69DXA53Z | A-796260
+BMGC_DG01560,BMG_DG012611,UNII:K7KY60XF2T | DrugBank ID:DB07206 | PubChem SID:443625032 | CAS RN:892873-16-4 | 6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE | 6-(2-(1H-INDOL-6-YL)ETHYL)PYRIDIN-2-AMINE | PubChem CID:11586735
+BMGC_DG01561,BMG_DG012612,"PubChem CID:11586785 | CAS RN:878018-63-4 | PubChem SID:443624335 | 3-(2-(2-METHYL-1,3-THIAZOL-4-YL)ETHYNYL)BENZAMIDE | UNII:L01T8YRR69"
+BMGC_DG01562,BMG_DG012613,DrugBank ID:DB14514 | magnesium;4-oxopentanoate | UNII:DU3I0H5Z4H | PubChem CID:11586912 | Magnesium levulinate | CAS RN:58505-81-0 | PubChem SID:241179240 | MAGNESIUM LEVULINATE
+BMGC_DG01563,BMG_DG012620,PubChem CID:11588811 | Vpc23019 | [(2R)-2-amino-3-(3-octylanilino)-3-oxopropyl] dihydrogen phosphate | CAS RN:449173-19-7
+BMGC_DG01564,BMG_DG012625,PubChem CID:11589975 | CAS RN:302556-51-0 | PubChem SID:445498770 | FMS-586 FREE BASE | UNII:P89BJJ8QAR
+BMGC_DG01565,BMG_DG012631,PubChem SID:198944371 | UNII:0TA0YE45QE | CAS RN:904302-98-3 | VIQUIDACIN | PubChem CID:11591505
+BMGC_DG01566,BMG_DG012634,PubChem SID:319892489 | PubChem CID:11592228 | CAS RN:1310826-85-7 | CAS RN:866269-28-5 | AZD-8848 | Azd-8848 | methyl 2-[3-[[3-(6-amino-2-butoxy-8-oxo-7H-purin-9-yl)propyl-(3-morpholin-4-ylpropyl)amino]methyl]phenyl]acetate | DrugBank ID:DB14868 | UNII:322ZMR6920
+BMGC_DG01567,BMG_DG012643,"CAS RN:66309-83-9 | UNII:UJE9TV6NUB | PubChem CID:11593477 | PubChem SID:377308268 | 2,6-DIMETHYL-2,3-DIHYDRO-1H-INDEN-1-ONE"
+BMGC_DG01568,BMG_DG012646,"PubChem CID:11593706 | Sevelamer Carbonate, Technical Grade | CAS RN:845273-93-0 | carbonic acid;2-(chloromethyl)oxirane;prop-2-en-1-amine"
+BMGC_DG01569,BMG_DG012653,CAS RN:885101-89-3 | PubChem CID:11595431 | GW-9508 | UNII:4T77GYP2CS | PubChem SID:198946013
+BMGC_DG01570,BMG_DG012654,PubChem SID:312524795 | CAS RN:386297-97-8 | UNII:PQF723MLIV | DPA-713 | PubChem CID:11595759
+BMGC_DG01571,BMG_DG012656,PubChem CID:11596309 | PubChem SID:241177911 | UNII:E4XEY076JN | CAS RN:59870-65-4 | GLABROL
+BMGC_DG01572,BMG_DG012657,"CAS RN:885220-61-1 | 3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]pyrazolo[1,5-a]pyrimidin-7-amine | VERUCERFONT | Verucerfont | PubChem CID:11596613 | PubChem SID:198987595 | UNII:X60608B091 | DrugBank ID:DB12512"
+BMGC_DG01573,BMG_DG012662,"TANZISERTIB | CAS RN:899805-25-5 | PubChem SID:175268478 | DrugBank ID:DB11798 | 4-[[9-[(3S)-oxolan-3-yl]-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol | PubChem CID:11597537 | CAS RN:1629774-47-5 | UNII:M5O06306UO | Tanzisertib"
+BMGC_DG01574,BMG_DG012663,"3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine | PubChem CID:11597571 | UNII:SGP54RX3KH | Crizotinib, (R,S)- | CRIZOTINIB, (R,S)- | 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine | CAS RN:877400-66-3 | PubChem SID:496142552"
+BMGC_DG01575,BMG_DG012664,"PubChem SID:175267860 | NDC:64850-552 | NDC:43547-603 | NDC:72205-135 | NDC:70010-218 | NDC:0527-4667 | NDC:0527-4662 | NDC:60505-4745 | NDC:60505-4743 | (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide;methanesulfonic acid | NDC:42858-162 | NDC:59417-102 | NDC:31722-350 | NDC:31722-356 | NDC:65162-027 | NDC:59417-120 | NDC:43602-312 | NDC:60505-4741 | NDC:0480-9739 | NDC:31722-321 | NDC:43602-553 | NDC:70010-219 | NDC:59417-106 | NDC:0406-5129 | NDC:0527-4664 | NDC:0054-0372 | NDC:0480-3569 | NDC:0480-9737 | NDC:0378-6855 | NDC:47781-565 | NDC:60505-4744 | NDC:59417-104 | NDC:72205-132 | NDC:0480-9738 | NDC:47781-564 | NDC:0480-3566 | NDC:42858-167 | NDC:31722-352 | NDC:0378-6858 | NDC:31722-323 | NDC:59417-103 | NDC:0480-3564 | NDC:57664-050 | NDC:0406-5124 | NDC:47781-567 | NDC:0480-9744 | Lisdexamfetamine Dimesylate | NDC:57664-049 | NDC:0527-4666 | NDC:59417-118 | NDC:0480-9742 | NDC:43602-551 | NDC:64850-555 | NDC:65162-023 | NDC:47781-568 | NDC:43547-606 | NDC:60505-4740 | NDC:59417-117 | NDC:43602-554 | NDC:0378-6857 | NDC:72205-137 | NDC:43547-605 | NDC:70010-214 | NDC:64850-550 | NDC:0378-6859 | NDC:0378-6854 | NDC:59417-107 | NDC:0406-5112 | NDC:31722-324 | NDC:0406-5113 | NDC:31722-351 | NDC:0480-3567 | NDC:64850-554 | CAS RN:608137-33-3 | NDC:43547-607 | NDC:57664-087 | NDC:47781-562 | NDC:42858-164 | NDC:43602-311 | NDC:0406-5116 | NDC:65162-028 | NDC:60505-4742 | NDC:0406-5111 | NDC:57664-084 | NDC:57664-051 | NDC:43602-556 | NDC:0406-5127 | NDC:64850-551 | NDC:72205-133 | NDC:0406-5125 | NDC:0480-3565 | NDC:0480-3568 | NDC:65162-024 | NDC:64850-553 | NDC:0406-5126 | NDC:0054-0370 | NDC:64850-556 | NDC:65162-025 | NDC:0406-5114 | NDC:31722-325 | NDC:31722-322 | NDC:47781-566 | NDC:0378-6860 | NDC:57664-052 | NDC:43602-307 | NDC:70010-217 | NDC:43602-309 | NDC:0406-5128 | NDC:72205-136 | NDC:70010-215 | NDC:0406-5115 | NDC:42858-165 | NDC:59417-116 | NDC:43547-604 | NDC:57664-086 | NDC:70010-216 | NDC:57664-088 | NDC:43602-310 | NDC:31722-353 | NDC:43547-602 | NDC:43547-608 | NDC:43602-552 | NDC:42858-166 | UNII:SJT761GEGS | NDC:0054-0373 | NDC:42858-161 | NDC:31722-354 | NDC:0527-4663 | NDC:60505-4739 | NDC:72162-2216 | PubChem CID:11597697 | NDC:59417-105 | NDC:72205-134 | NDC:57664-083 | NDC:43602-306 | NDC:0527-4665 | NDC:0054-0375 | NDC:42858-163 | NDC:57664-047 | NDC:0480-3570 | NDC:57664-046 | NDC:59417-115 | NDC:59417-101 | NDC:0378-6856 | NDC:43602-555 | LISDEXAMFETAMINE DIMESYLATE | NDC:57664-085 | NDC:65162-026 | NDC:0406-5117 | NDC:43602-308 | NDC:0527-4661 | NDC:0480-9741 | NDC:31722-326 | NDC:0054-0374 | NDC:0054-0371 | NDC:31722-355 | NDC:47781-563 | NDC:59417-119 | NDC:57664-048"
+BMGC_DG01576,BMG_DG012665,"Lisdexamfetamine | PubChem SID:175265708 | PubChem CID:11597698 | DrugBank ID:DB01255 | CAS RN:608137-32-2 | (2S)-2,6-diamino-N-[(2S)-1-phenylpropan-2-yl]hexanamide | LISDEXAMFETAMINE | UNII:H645GUL8KJ"
+BMGC_DG01577,BMG_DG012676,5-CHLOROTHIABENDAZOLE | UNII:4S25553RBI | PubChem CID:11601120 | CAS RN:142383-75-3 | PubChem SID:317229492
+BMGC_DG01578,BMG_DG012682,"Cannabidivarin | 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-propylbenzene-1,3-diol | CAS RN:24274-48-4 | PubChem SID:336286683 | DrugBank ID:DB14050 | CANNABIDIVARIN | PubChem CID:11601669 | UNII:I198VBV98I"
+BMGC_DG01579,BMG_DG012684,CAS RN:896138-40-2 | FLT-3 INHIBITOR II | PubChem CID:11601743 | UNII:A36VAB7JH6
+BMGC_DG01580,BMG_DG012686,PubChem SID:475550257 | UNII:FHR74J733U | CAS RN:503468-86-8 | 2-Morpholin-4-yl-8-thiophen-2-ylchromen-4-one | PubChem CID:11602076 | 2-MORPHOLIN-4-YL-8-THIOPHEN-2-YLCHROMEN-4-ONE
+BMGC_DG01581,BMG_DG012689,"UNII:G8DW2Y2JBT | CAS RN:124649-78-1 | PubChem SID:313184140 | DIHYDROGUAIARETIC ACID, (-)- | PubChem CID:11602375"
+BMGC_DG01582,BMG_DG012690,PubChem CID:11602780 | UNII:H55RRH6H7K | CAS RN:575467-47-9 | NNC-0038-0000-1202 | PubChem SID:445498924
+BMGC_DG01583,BMG_DG012691,CAS RN:2416-95-7 | DIPROPOFO | UNII:H9GE6HX42A | PubChem SID:198972994 | PubChem CID:11602828
+BMGC_DG01584,BMG_DG012692,"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione | PubChem CID:11602832 | DrugBank ID:DB07257"
+BMGC_DG01585,BMG_DG012702,"TEMANOGREL | PubChem CID:11604525 | CAS RN:887936-68-7 | UNII:F42Z27575A | Benzamide, 3-methoxy-N-[3-(1-methyl-1H-pyrazol-5-yl)-4-[2-(4-morpholinyl)ethoxy]phenyl]- | PubChem SID:198983333 | 3-methoxy-N-[3-(2-methylpyrazol-3-yl)-4-(2-morpholin-4-ylethoxy)phenyl]benzamide"
+BMGC_DG01586,BMG_DG012712,UNII:PSZ2YGB0DK | PubChem SID:198967009 | PubChem CID:11607299 | diethyl 2-[[2-[3-(dimethylcarbamoyl)-4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]phenyl]acetyl]oxymethyl]-2-phenylpropanedioate | CAS RN:916683-32-4 | DrugBank ID:DB12934 | GRANOTAPIDE | Granotapide | CAS RN:594842-13-4
+BMGC_DG01587,BMG_DG012723,UNII:8SN2Q5RGH8 | PubChem SID:461432796 | 5-MERCAPTO-N-PHENYLPENTANAMIDE | PubChem CID:11608171 | CAS RN:670233-81-5
+BMGC_DG01588,BMG_DG012725,PubChem CID:11608401 | N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE | DrugBank ID:DB07854
+BMGC_DG01589,BMG_DG012728,PubChem CID:11608719 | CAS RN:202136-43-4 | UNII:6SX4K72X7W | PubChem SID:482554018 | 8-Bromo-9-butyl-9H-purin-6-amine | 8-BROMO-9-BUTYL-9H-PURIN-6-AMINE
+BMGC_DG01590,BMG_DG012734,"PubChem CID:11609586 | CAS RN:881202-45-5 | PubChem SID:198947717 | Serdemetan | DrugBank ID:DB12027 | SERDEMETAN | 1-N-[2-(1H-indol-3-yl)ethyl]-4-N-pyridin-4-ylbenzene-1,4-diamine | UNII:ID6YB4W3V8"
+BMGC_DG01591,BMG_DG012738,PubChem SID:198977137 | CAS RN:864814-88-0 | DrugBank ID:DB12392 | PubChem CID:11609955 | RESMINOSTAT | UNII:1578EUB98L | (E)-3-[1-[4-[(dimethylamino)methyl]phenyl]sulfonylpyrrol-3-yl]-N-hydroxyprop-2-enamide | Resminostat
+BMGC_DG01592,BMG_DG012742,"NDC:0002-4491 | CAS RN:439239-90-4 | PubChem SID:198939474 | DrugBank ID:DB11732 | 2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)pyridin-2-yl]benzamide | NDC:0002-4312 | LASMIDITAN | PubChem CID:11610526 | UNII:760I9WM792 | Lasmiditan"
+BMGC_DG01593,BMG_DG012743,DrugBank ID:DB08386 | PubChem CID:11610553 | 2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline
+BMGC_DG01594,BMG_DG012744,"PubChem SID:198978439 | TRABODENOSON | UNII:1T237110W4 | Trabodenoson | PubChem CID:11610599 | DrugBank ID:DB13122 | CAS RN:871108-05-3 | [(2R,3S,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methyl nitrate"
+BMGC_DG01595,BMG_DG012746,DrugBank ID:DB13016 | 3-[(S)-[4-[(4-acetyl-3-hydroxy-2-propylphenoxy)methyl]phenyl]-hydroxymethyl]benzoic acid | PubChem SID:312524772 | PubChem CID:11611800 | Ly-2300559 | CAS RN:889116-06-7 | LY-2300559 | UNII:Z572ZBT8XL
+BMGC_DG01596,BMG_DG012759,"CID 11614352 | PubChem CID:11614352 | N-[1-[(3R)-3-(3,5-difluorophenyl)-3-(1-methylsulfonylpiperidin-4-yl)propyl]piperidin-4-yl]-N-ethyl-2-(4-methylsulfonylphenyl)acetamide"
+BMGC_DG01597,BMG_DG012775,"Jnj-26489112 | UNII:G1TI012DLT | PubChem CID:11616111 | CAS RN:871824-55-4 | (2S)-6-chloro-2-[(sulfamoylamino)methyl]-2,3-dihydro-1,4-benzodioxine | PubChem SID:346540986 | DrugBank ID:DB15203 | JNJ-26489112"
+BMGC_DG01598,BMG_DG012778,PubChem CID:11616723 | PubChem SID:272993785 | UNII:55H9NDH32M | CAS RN:864445-39-6 | JWH-251
+BMGC_DG01599,BMG_DG012779,PubChem CID:11616886 | NW-1772 FREE BASE | 7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE | DrugBank ID:DB07513 | CAS RN:911290-20-5 | UNII:XT4DJB88UB | PubChem SID:445500455
+BMGC_DG01600,BMG_DG012780,3-prop-2-enylsulfanylprop-1-ene | PubChem CID:11617 | PubChem SID:198961889 | UNII:60G7CF7CWZ | CAS RN:592-88-1 | DIALLYL SULFIDE | Diallyl sulfide
+BMGC_DG01601,BMG_DG012781,"8-cyclopentyl-2,6-diphenyl-7H-purine | PubChem CID:11617054"
+BMGC_DG01602,BMG_DG012783,PubChem SID:198950783 | CAS RN:870483-87-7 | UNII:SRV0JCF9LI | GW-2580 | PubChem CID:11617559
+BMGC_DG01603,BMG_DG012786,PubChem SID:198935635 | PubChem CID:11618268 | 6-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)ethyl]quinazolin-4-one | DrugBank ID:DB15407 | ACALISIB | Acalisib | UNII:OVW60IDW1D | CAS RN:870281-34-8
+BMGC_DG01604,BMG_DG012787,"PubChem SID:198983564 | Tozadenant | DrugBank ID:DB12203 | 4-hydroxy-N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methylpiperidine-1-carboxamide | UNII:D9K857J81I | CAS RN:870070-55-6 | TOZADENANT | PubChem CID:11618368"
+BMGC_DG01605,BMG_DG012794,CAS RN:876145-69-6 | PubChem CID:11619439 | UNII:CB5UF7PNN7 | PubChem SID:459055212 | KRP-105
+BMGC_DG01606,BMG_DG012796,"N-Acetylmuramyl-L-alanyl-D-isoglutamine | CAS RN:53678-77-6 | (4R)-4-[[(2S)-2-[[(2R)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoic acid | PubChem CID:11620162"
+BMGC_DG01607,BMG_DG012800,"PubChem SID:198935983 | N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methylbutanamide | CAS RN:871026-44-7 | TAK-285 | UNII:70CCB438L6 | Tak-285 | PubChem CID:11620908"
+BMGC_DG01608,BMG_DG012807,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[(2-acetamidoacetyl)amino]propanoyl]amino]-5-amino-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-6-aminohexanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]propanoyl]amino]-6-aminohexanoic acid | CAS RN:901117-03-1 | PubChem SID:348481469 | UNII:609AWV0US2 | PubChem CID:11622197 | DrugBank ID:DB14886 | Bio-11006 | BIO-11006"
+BMGC_DG01609,BMG_DG012809,"CAS RN:96847-55-1 | 2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide | PubChem CID:11622909 | DrugBank ID:DB04896 | CAS RN:136090-84-1"
+BMGC_DG01610,BMG_DG012813,UNII:AE66S9MZ8U | 2-MORPHOLIN-4-YL-8-THIOPHEN-3-YL-CHROMEN-4-ONE | PubChem SID:485663589 | CAS RN:503468-85-7 | PubChem CID:11623802 | 2-Morpholin-4-yl-8-thiophen-3-yl-chromen-4-one
+BMGC_DG01611,BMG_DG012820,PubChem SID:459275522 | CAS RN:883093-10-5 | UNII:ZK5NA2M82J | PubChem CID:11624499 | RO-4938581
+BMGC_DG01612,BMG_DG012822,2-(3-Chloro-4-Hydroxyphenyl)-N-[2-(4-Sulfamoylphenyl)ethyl]acetamide | 2-(3-chloro-4-hydroxyphenyl)-N-[2-(4-sulfamoylphenyl)ethyl]acetamide | PubChem CID:11624852
+BMGC_DG01613,BMG_DG012828,INCB-3619 | PubChem SID:198979173 | CAS RN:791826-72-7 | UNII:Q56UE7E40Y | PubChem CID:11625778
+BMGC_DG01614,BMG_DG012829,CAS RN:1453810-72-4 | 5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one | Idelalisib | PubChem SID:198954688 | DrugBank ID:DB09054 | UNII:YG57I8T5M0 | PubChem CID:11625818 | CAS RN:870281-82-6 | IDELALISIB
+BMGC_DG01615,BMG_DG012830,AKP-001 | PubChem SID:363908354 | PubChem CID:11626055 | UNII:M4VHS5O48Z | CAS RN:897644-83-6
+BMGC_DG01616,BMG_DG012833,"CAS RN:152520-56-4 | (R,S,S,S)-nebivolol hydrochloride | CAS RN:920299-33-8 | PubChem CID:11626384 | (1S)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-[[(2S)-2-[(2R)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl]amino]ethanol;hydrochloride"
+BMGC_DG01617,BMG_DG012834,"3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine | CRIZOTINIB | PubChem CID:11626560 | UNII:53AH36668S | CAS RN:877399-52-5 | DrugBank ID:DB08865 | Crizotinib | PubChem SID:175265614"
+BMGC_DG01618,BMG_DG012837,"Evodenoson | EVODENOSON | PubChem CID:11627443 | UNII:HZ03U10J2Z | DrugBank ID:DB12295 | PubChem SID:198955296 | CAS RN:844873-47-8 | methyl 4-[3-[6-amino-9-[(2R,3R,4S,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]prop-2-ynyl]piperidine-1-carboxylate"
+BMGC_DG01619,BMG_DG012848,PubChem SID:461433434 | UNII:8KH9796NLC | 4-(2-(3-FLUOROPHENYL)ETHYNYL)-2-THIAZOLAMINE | PubChem CID:11629906 | CAS RN:878018-65-6
+BMGC_DG01620,BMG_DG012853,PubChem CID:11630793 | CAS RN:103188-46-1 | UNII:HBC0Y4WZ56 | PubChem SID:440088851 | N-COUMAROYLDOPAMINE
+BMGC_DG01621,BMG_DG012855,PubChem CID:11630874 | PubChem SID:198971938 | CAS RN:900515-16-4 | AS-252424 | UNII:63D4RUV1GN
+BMGC_DG01622,BMG_DG012862,PubChem SID:198952865 | CH-4933468 | UNII:626ZE9ZBKU | CAS RN:875055-92-8 | PubChem CID:11632731
+BMGC_DG01623,BMG_DG012864,"Nivocasan | (5R)-N-[(2S,3S)-2-(fluoromethyl)-2-hydroxy-5-oxooxolan-3-yl]-3-isoquinolin-1-yl-5-propan-2-yl-4H-1,2-oxazole-5-carboxamide | CAS RN:908253-63-4 | NIVOCASAN | PubChem SID:198934812 | UNII:9554OW6MVU | PubChem CID:11633038 | DrugBank ID:DB12720"
+BMGC_DG01624,BMG_DG012865,"DrugBank ID:DB07994 | PubChem CID:11633167 | N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE"
+BMGC_DG01625,BMG_DG012867,PubChem CID:11633816 | UNII:8BGQ397Y39 | KKHA-761 | CAS RN:457660-81-0 | PubChem SID:459276173
+BMGC_DG01626,BMG_DG012871,"PubChem SID:198953461 | (2R,4R)-1-N-(4-chlorophenyl)-2-N-[2-fluoro-4-(2-oxopyridin-1-yl)phenyl]-4-methoxypyrrolidine-1,2-dicarboxamide | Eribaxaban | CAS RN:536748-46-6 | DrugBank ID:DB06920 | PubChem CID:11634458 | ERIBAXABAN | UNII:5FCH6YDY7Z"
+BMGC_DG01627,BMG_DG012872,"DrugBank ID:DB11934 | Epelsiban | CAS RN:872599-83-2 | UNII:T2EZ19HX73 | EPELSIBAN | (3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethylpyridin-3-yl)-2-morpholin-4-yl-2-oxoethyl]piperazine-2,5-dione | PubChem CID:11634973 | PubChem SID:198956691"
+BMGC_DG01628,BMG_DG012874,PubChem SID:333495828 | UNII:5V7E4UQL93 | CAS RN:509083-77-6 | PubChem CID:11635371 | BMS-587101
+BMGC_DG01629,BMG_DG012875,"QUARFLOXIN | 15-fluoro-N-[2-[(2S)-1-methylpyrrolidin-2-yl]ethyl]-18-oxo-14-(3-pyrazin-2-ylpyrrolidin-1-yl)-12-oxa-1-azapentacyclo[11.7.1.02,11.04,9.017,21]henicosa-2,4,6,8,10,13(21),14,16,19-nonaene-19-carboxamide | PubChem SID:198943813 | CAS RN:865311-47-3 | PubChem CID:11635763 | UNII:8M31J5031Q | Quarfloxin | DrugBank ID:DB06638"
+BMGC_DG01630,BMG_DG012888,"CAS RN:341998-55-8 | 4-(1H-Pyrrolo[2,3-b]pyridin-3-yl)-2-pyrimidinamine | 4-(1H-PYRROLO(2,3-B)PYRIDIN-3-YL)-2-PYRIMIDINAMINE | PubChem CID:11637090 | UNII:3775FF3L37 | PubChem SID:485663703"
+BMGC_DG01631,BMG_DG012889,CAS RN:410074-75-8 | UNII:NS8NWQ6NF4 | PubChem SID:376072832 | PubChem CID:11637190 | DOV-102677
+BMGC_DG01632,BMG_DG012891,N-Hydroxy-6-(phenylthio)hexanamide | CAS RN:875737-01-2 | PubChem CID:11637291 | PubChem SID:482553812 | N-HYDROXY-6-(PHENYLTHIO)HEXANAMIDE | UNII:LXD3CW995T
+BMGC_DG01633,BMG_DG012901,PubChem CID:11639342 | CBS-3595 | PubChem SID:438788725 | UNII:MOC9KI2UHA | CAS RN:908380-97-2
+BMGC_DG01634,BMG_DG012907,"CAS RN:867160-71-2 | PubChem CID:11640390 | PubChem SID:198945656 | UNII:15A52GPT8T | DrugBank ID:DB06075 | LINSITINIB | CAS RN:1356958-77-4 | Linsitinib | 3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol | CAS RN:867160-72-3"
+BMGC_DG01635,BMG_DG012911,"PubChem SID:198965169 | 1-[1-[(2S)-3-(6-chloronaphthalen-2-yl)sulfonyl-2-hydroxypropanoyl]piperidin-4-yl]-1,3-diazinan-2-one | UNII:Y3WB03966W | LETAXABAN | CAS RN:870262-90-1 | PubChem CID:11641515 | Letaxaban | DrugBank ID:DB11984"
+BMGC_DG01636,BMG_DG012912,CAS RN:905272-07-3 | PubChem CID:11641798 | PubChem SID:377309139 | UNII:B0ZRP80SWM | RO-5013853
+BMGC_DG01637,BMG_DG012921,"PubChem SID:198975989 | PubChem CID:11643449 | Desacetylvinblastine amide | UNII:RSA8KO39WH | VINDESINE | DrugBank ID:DB00309 | CAS RN:53643-48-4 | methyl (13S,15R,17S)-13-[(1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate"
+BMGC_DG01638,BMG_DG012940,DrugBank ID:DB04337 | Isocyanomethane | METHYL ISOCYANIDE | PubChem SID:363909845 | CAS RN:593-75-9 | PubChem CID:11646 | isocyanomethane | UNII:B5B6DXM7GG
+BMGC_DG01639,BMG_DG012942,"N-(1,3-benzodioxol-5-ylmethyl)-N'-(3-imidazol-1-yl-1,2,4-thiadiazol-5-yl)-N'-methylpropane-1,3-diamine | PubChem CID:11646432 | Kd7040"
+BMGC_DG01640,BMG_DG012943,PubChem CID:11646648 | 1-((5-methoxy-1H-indol-3-yl)methyl)-4-(4-(methylthio)phenyl)piperidin-4-ol | 1-[(5-methoxy-1H-indol-3-yl)methyl]-4-(4-methylsulfanylphenyl)piperidin-4-ol | CAS RN:873445-73-9
+BMGC_DG01641,BMG_DG012945,"PubChem CID:11646777 | CAS RN:892128-60-8 | Ly-2334737 | N-[1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]-2-propylpentanamide | PubChem SID:198966650 | LY-2334737 | UNII:YLR364XYSA | DrugBank ID:DB12906"
+BMGC_DG01642,BMG_DG012946,PubChem CID:11646823 | CAS RN:871362-31-1 | PubChem SID:472421804 | CTEP | UNII:E3BWG5775S
+BMGC_DG01643,BMG_DG012949,"4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine | DrugBank ID:DB12904 | PubChem CID:11647372 | UNII:K0068GK39A | PubChem SID:198979207 | 4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine | ZSTK-474 | CAS RN:475110-96-4"
+BMGC_DG01644,BMG_DG012952,DIMETHYLSELENIDE | UNII:YK0R6JKT6H | PubChem SID:198975392 | PubChem CID:11648 | Dimethyl selenide | CAS RN:593-79-3 | methylselanylmethane
+BMGC_DG01645,BMG_DG012956,"CAS RN:898563-00-3 | 2-{4-[4-Pyridin-4-YL-1-(2,2,2-trifluoro-ethyl)-1H-pyrazol-3-YL]-phenoxymethyl}-quinoline | 2-[[4-[4-pyridin-4-yl-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline | PubChem CID:11648276"
+BMGC_DG01646,BMG_DG012971,DrugBank ID:DB07535 | 2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one | PubChem CID:11651760
+BMGC_DG01647,BMG_DG012972,PubChem SID:485661450 | PubChem CID:116521 | CAS RN:30433-91-1 | UNII:7UZ2FP9KDC | Thiophene-2-ethylamine | THIOPHENE-2-ETHYLAMINE
+BMGC_DG01648,BMG_DG012974,UNII:AC7QO6038O | OLEOCANTHAL | PubChem CID:11652416 | PubChem SID:198981181 | CAS RN:289030-99-5
+BMGC_DG01649,BMG_DG012986,"PubChem CID:11653652 | (1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime | DrugBank ID:DB08553"
+BMGC_DG01650,BMG_DG012991,"UNII:NJF5O599EF | 2-[2-(2,6-dichloro-4-hydroxyanilino)phenyl]acetic acid | 4'-Hydroxydiclofenac | PubChem CID:116545 | CAS RN:64118-84-9 | 4'-HYDROXYDICLOFENAC | PubChem SID:316909418"
+BMGC_DG01651,BMG_DG012996,PubChem CID:11655119 | CAS RN:700874-71-1 | LY-2109761 | PubChem SID:459275262 | UNII:DV3HD37UBK
+BMGC_DG01652,BMG_DG012997,"MK-0731 | CAS RN:845256-65-7 | PubChem CID:11655511 | (5S)-3-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-5-(hydroxymethyl)-N-methyl-5-phenyl-2H-pyrrole-1-carboxamide | PubChem SID:317229264 | UNII:8HIJ5G3O02 | DrugBank ID:DB08037"
+BMGC_DG01653,BMG_DG012999,PubChem CID:11655728 | GSK-588045 | PubChem SID:459275761 | CAS RN:876922-98-4 | UNII:8HG5QW7P7Z
+BMGC_DG01654,BMG_DG013004,PubChem CID:11656518 | PubChem SID:333495888 | 1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine | RAF-265 | CAS RN:927880-90-8 | UNII:8O434L3768 | DrugBank ID:DB05984 | Raf-265
+BMGC_DG01655,BMG_DG013010,PubChem CID:11657687 | CHAETOCIN A | PubChem SID:441659486 | CAS RN:28097-03-2 | UNII:DF939M63W4
+BMGC_DG01656,BMG_DG013017,"PubChem SID:198972110 | UNII:0T7H9YA5WZ | PubChem CID:11658617 | N-[(2E)-3,7-dimethylocta-2,6-dienyl]cyclopropanecarboxamide | CAS RN:1462392-75-1 | Cyclopropanecarboxamide, N-((2E)-3,7-dimethyl-2,6-octadien-1-yl)- | N-3,7-DIMETHYL-2,6-OCTADIENYL CYCLOPROPYLCARBOXAMIDE, (2E)- | CAS RN:744251-93-2"
+BMGC_DG01657,BMG_DG013018,"UNII:5W2YA6F455 | DOV-216303 | PubChem SID:198962154 | CAS RN:66504-40-3 | PubChem CID:11658655 | PubChem SID:198946106 | UNII:GE0J375F8F | CAS RN:410074-73-6 | (1R,5S)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane | AMITIFADINE | DrugBank ID:DB05964 | Amitifadine"
+BMGC_DG01658,BMG_DG013019,"(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride hydrate | PubChem CID:11658859 | (5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;hydrate;hydrochloride | CAS RN:856681-05-5"
+BMGC_DG01659,BMG_DG013020,"Lorcaserin | CAS RN:616202-92-7 | LORCASERIN | PubChem CID:11658860 | DrugBank ID:DB04871 | PubChem SID:175268181 | UNII:637E494O0Z | (5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine"
+BMGC_DG01660,BMG_DG013025,6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE | DrugBank ID:DB07245 | PubChem CID:11659487
+BMGC_DG01661,BMG_DG013030,"PubChem CID:11660035 | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | DrugBank ID:DB08000"
+BMGC_DG01662,BMG_DG013033,"PubChem CID:11660296 | Benzopyrano(4,3,2-de)phthalazin-3(2H)-one, 10-((4-hydroxy-1-piperidinyl)methyl)- | CAS RN:902128-92-1 | CAS RN:1005412-29-2 | 4-[(4-hydroxypiperidin-1-yl)methyl]-8-oxa-15,16-diazatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2(7),3,5,9,11,13(17)-heptaen-14-one | PubChem SID:198985709 | UNII:M8926C7ILX | E-7016"
+BMGC_DG01663,BMG_DG013043,PubChem CID:11661758 | methyl N-[6-[4-[[(2S)-2-aminopropanoyl]amino]phenyl]sulfanyl-1H-benzimidazol-2-yl]carbamate | DENIBULIN | Denibulin | CAS RN:284019-34-7 | PubChem SID:198970862 | UNII:K7037M241U | DrugBank ID:DB05932
+BMGC_DG01664,BMG_DG013063,PubChem SID:461434444 | PubChem CID:11665793 | UNII:U2CXD22CWU | 4-(2-(2-METHOXYPHENYL)ETHYNYL)-2-METHYLTHIAZOLE | CAS RN:878018-34-9
+BMGC_DG01665,BMG_DG013073,"(1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide | UNII:7W2581Z5L8 | CAS RN:852626-89-2 | SAMIDORPHAN | PubChem SID:198959187 | Samidorphan | PubChem CID:11667832 | DrugBank ID:DB12543"
+BMGC_DG01666,BMG_DG013074,"MOTESANIB | PubChem CID:11667893 | PubChem SID:198946291 | DrugBank ID:DB05575 | N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide | UNII:U1JK633AYI | Motesanib | CAS RN:453562-69-1"
+BMGC_DG01667,BMG_DG013076,PubChem CID:11668 | DrugBank ID:DB03635 | CAS RN:594-45-6 | Ethanesulfonic acid | PubChem SID:198968823 | UNII:599310E3U2 | ETHANESULFONIC ACID
+BMGC_DG01668,BMG_DG013078,8-DIBENZOFURAN-4-YL-2-MORPHOLIN-4-YLCHROMEN-4-ONE | 8-Dibenzofuran-4-yl-2-morpholin-4-ylchromen-4-one | PubChem CID:11668417 | PubChem SID:475550288 | CAS RN:503468-92-6 | UNII:3NY6DEE6Y3
+BMGC_DG01669,BMG_DG013085,"DrugBank ID:DB08322 | CAS RN:868065-90-1 | FR-258900 | UNII:66G69TD43K | 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID | PubChem CID:11669698 | PubChem SID:459055150"
+BMGC_DG01670,BMG_DG013088,"[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate | CAS RN:528-04-1 | PubChem CID:1167 | CAS RN:26575-17-7 | Uridine diphosphate-N-acetylgalactosamine"
+BMGC_DG01671,BMG_DG013092,PubChem SID:313184038 | UNII:R5TH77F919 | 4-[[2-methyl-2-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]propanoyl]amino]adamantane-1-carboxamide | PubChem CID:11670435 | 4-[[2-Methyl-2-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]propanoyl]amino]adamantane-1-carboxamide | DrugBank ID:DB12501 | CAS RN:868623-40-9 | ABT-384
+BMGC_DG01672,BMG_DG013096,"PubChem CID:11671467 | FOSTAMATINIB | DrugBank ID:DB12010 | NDC:71332-001 | UNII:SQ8A3S5101 | Fostamatinib | CAS RN:901119-35-5 | [6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate | NDC:71332-002 | PubChem SID:198973453"
+BMGC_DG01673,BMG_DG013102,"Gadofosveset Trisodium | GADOFOSVESET TRISODIUM ANHYDROUS | PubChem SID:198941354 | trisodium;2-[[(2R)-2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexyl)oxy-oxidophosphoryl]oxypropyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+) | CAS RN:211570-55-7 | UNII:9430ZR8ZAN | PubChem CID:11672461 | CAS RN:193901-90-5"
+BMGC_DG01674,BMG_DG013106,"[(2R)-3-[2-[[(2S)-2-[[(4R)-4-[[(2S)-2-[[(2R)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoyl]amino]propanoyl]amino]ethoxy-hydroxyphosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate | PubChem CID:11672602"
+BMGC_DG01675,BMG_DG013112,CAS RN:864074-51-1 | UNII:SJ9858KS5M | PubChem SID:443624045 | PubChem CID:11673176 | PT-630
+BMGC_DG01676,BMG_DG013124,"PubChem CID:11674979 | (E)-[4-(3,5-Difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol | DrugBank ID:DB07840"
+BMGC_DG01677,BMG_DG013127,"PubChem CID:11675645 | DrugBank ID:DB08239 | (2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE"
+BMGC_DG01678,BMG_DG013128,"PubChem CID:11675994 | CAS RN:881413-29-2 | PubChem SID:198935099 | Ethanesulfonamide, N-(1-((4,4-difluorocyclohexyl)methyl)-2-(1,1-dimethylethyl)-1H-benzimidazol-5-yl)- | ART-2713 | UNII:0J0035E9FT | N-[2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]benzimidazol-5-yl]ethanesulfonamide"
+BMGC_DG01679,BMG_DG013130,UNII:KW4O83PQ97 | PubChem CID:11676119 | IN-1130 | PubChem SID:198958932 | CAS RN:868612-83-3
+BMGC_DG01680,BMG_DG013131,BM-613 | UNII:PB9LJH9R4Y | CAS RN:284465-11-8 | PubChem SID:198938429 | PubChem CID:11676121
+BMGC_DG01681,BMG_DG013132,CAS RN:840523-39-9 | CS-0777-P | PubChem CID:11676168 | PubChem SID:272993885 | UNII:30YQ86DS4E
+BMGC_DG01682,BMG_DG013134,PubChem CID:11676786 | CAS RN:878739-06-1 | PubChem SID:198949888 | AZ-628 | UNII:560S6B5D79
+BMGC_DG01683,BMG_DG013136,PubChem CID:11676971 | PubChem SID:198961520 | UNII:YKQ241VJ92 | CAS RN:885692-52-4 | JNJ-28312141 FREE BASE
+BMGC_DG01684,BMG_DG013141,"DrugBank ID:DB12836 | PubChem SID:198958560 | UNII:J9F5ZPH7NB | Grapiprant | PubChem CID:11677589 | 1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylurea | CAS RN:415903-37-6 | GRAPIPRANT"
+BMGC_DG01685,BMG_DG013145,(2R)-2-[3-[3-(4-methoxybenzoyl)-2-methyl-6-(trifluoromethoxy)indol-1-yl]phenoxy]butanoic acid | CAS RN:668455-28-5 | UNII:J17152066B | PubChem CID:11678534 | Mk-0533 | DrugBank ID:DB15242 | PubChem SID:333495646 | MK-0533
+BMGC_DG01686,BMG_DG013169,PF-670462 free base | PubChem SID:198952645 | PubChem CID:11681588 | PF-670462 FREE BASE | UNII:I4PNN9897I | 4-[3-cyclohexyl-5-(4-fluorophenyl)imidazol-4-yl]pyrimidin-2-amine | CAS RN:950980-98-0
+BMGC_DG01687,BMG_DG013172,4-(4-methylphenyl)-3-(4-methylsulfonylphenyl)-1-propyl-2H-pyrrol-5-one | UNII:SGW6W5758V | Imrecoxib | PubChem CID:11682175 | DrugBank ID:DB12354 | PubChem SID:287446530 | IMRECOXIB | CAS RN:395683-14-4
+BMGC_DG01688,BMG_DG013178,"NDC:0121-0945 | NDC:64380-158 | PubChem CID:11683 | NDC:64380-160 | CAS RN:51154-23-5 | NDC:17856-0907 | NDC:24979-041 | Megestrol Acetate | DrugBank ID:DB00351 | NDC:66689-020 | NDC:68788-8714 | NDC:0555-0607 | NDC:69339-160 | Megestrol acetate | NDC:71335-2544 | [(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate | NDC:68094-063 | NDC:71335-2181 | PubChem SID:175265649 | UNII:TJ2M0FR8ES | NDC:64380-159 | NDC:70954-896 | NDC:71205-943 | NDC:0555-0606 | NDC:63739-549 | NDC:51407-910 | NDC:68094-174 | NDC:17856-0060 | CAS RN:595-33-5 | NDC:0904-7236 | MEGESTROL ACETATE"
+BMGC_DG01689,BMG_DG013179,UNII:9XX54M675G | PubChem CID:11683005 | DrugBank ID:DB06179 | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-dimethylarsanylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | CAS RN:69819-86-9 | DARINAPARSIN | Darinaparsin | PubChem SID:198986190
+BMGC_DG01690,BMG_DG013181,UNII:D361S17AIF | CLIGOSIBAN | CAS RN:900510-03-4 | PubChem SID:363908948 | PubChem CID:11683187
+BMGC_DG01691,BMG_DG013182,"UNII:4ZA73QEW2P | Nelotanserin | DrugBank ID:DB12555 | 1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea | CAS RN:839713-36-9 | PubChem SID:198958520 | NELOTANSERIN | PubChem CID:11683556"
+BMGC_DG01692,BMG_DG013184,"CAS RN:1219804-04-2 | Dimebutic Acid | PubChem SID:198960284 | 2,2-dimethylbutanoic acid | CAS RN:595-37-9 | 2,2-Dimethylbutyric acid | PubChem CID:11684 | DIMEBUTIC ACID | UNII:AY606CN05O"
+BMGC_DG01693,BMG_DG013191,CAS RN:480462-62-2 | JTK-109 | UNII:BJA28665XS | PubChem CID:11686018 | PubChem SID:459055884
+BMGC_DG01694,BMG_DG013206,PubChem CID:11687376 | UNII:QFG58Y96EP | CAS RN:877316-38-6 | JNJ-26990990 | PubChem SID:252823962
+BMGC_DG01695,BMG_DG013210,PubChem SID:198939448 | UNII:69D634Q702 | N-[[4-[(pyrimidin-2-ylamino)methyl]phenyl]methyl]pyrimidin-2-amine | Msx-122 | MSX-122 | DrugBank ID:DB12715 | CAS RN:897657-95-3 | PubChem CID:11687907
+BMGC_DG01696,BMG_DG013212,TERT-BUTYLBENZAMIDO HYDROXYLBENZAMIDE | PubChem SID:198954323 | CAS RN:847249-57-4 | UNII:8ZGC21O8KI | PubChem CID:11688197
+BMGC_DG01697,BMG_DG013215,"BISEGLIPTIN | PubChem SID:198979436 | ethyl 4-[[2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl]amino]bicyclo[2.2.2]octane-1-carboxylate | UNII:9U5KQ79OK6 | PubChem CID:11688894 | DrugBank ID:DB06127 | CAS RN:862501-61-9 | Bisegliptin"
+BMGC_DG01698,BMG_DG013217,CAS RN:788155-53-3 | PubChem SID:459275302 | R-1485 | PubChem CID:11689373 | UNII:B254UB9ZBA
+BMGC_DG01699,BMG_DG013220,CAS RN:873697-71-3 | UNII:2M19539ERK | Omecamtiv Mecarbil | DrugBank ID:DB11816 | PubChem CID:11689883 | OMECAMTIV MECARBIL | Omecamtiv mecarbil | PubChem SID:198937236 | methyl 4-[[2-fluoro-3-[(6-methylpyridin-3-yl)carbamoylamino]phenyl]methyl]piperazine-1-carboxylate
+BMGC_DG01700,BMG_DG013229,1-[1-[(2-aminopyridin-4-yl)methyl]indol-4-yl]-3-(5-bromo-2-methoxyphenyl)urea | PubChem SID:198980287 | PubChem CID:11691242 | DrugBank ID:DB12744 | UNII:980M4N37DH | JI-101 | CGI-1842 | Ji-101 | CAS RN:900573-88-8
+BMGC_DG01701,BMG_DG013231,"PubChem CID:11691442 | 8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide | DrugBank ID:DB08365"
+BMGC_DG01702,BMG_DG013232,CAS RN:897732-93-3 | UNII:345354O7AT | propan-2-yl 4-[5-methoxy-6-[(2-methyl-6-methylsulfonylpyridin-3-yl)amino]pyrimidin-4-yl]oxypiperidine-1-carboxylate | PubChem CID:11691484 | DrugBank ID:DB12084 | PubChem SID:198956289 | ADP-597 | Isopropyl 4-((5-methoxy-6-((2-methyl-6-(methylsulfonyl)pyridin-3-yl)amino)pyrimidin-4-yl)oxy)piperidine-1-carboxylate
+BMGC_DG01703,BMG_DG013234,PubChem CID:11691531 | CAS RN:905269-86-5 | RO-4993850 | UNII:JXS24PN594
+BMGC_DG01704,BMG_DG013237,UNII:I0J230BJOO | CAS RN:893409-49-9 | PubChem SID:198965832 | BAY-60-5521 | PubChem CID:11691871
+BMGC_DG01705,BMG_DG013238,BROMOTRIPHENYLMETHANE | PubChem SID:441097254 | PubChem CID:11692 | CAS RN:596-43-0 | UNII:EWY6H8D4L5
+BMGC_DG01706,BMG_DG013241,"(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide | Glycopyrrolate | CAS RN:596-51-0 | PubChem CID:11693"
+BMGC_DG01707,BMG_DG013259,"UNII:WA4499B7GU | PubChem SID:482554997 | 1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine | CAS RN:885499-63-8 | 4-((4-CHLOROPHENYL)METHYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-4-PIPERIDINEMETHANAMINE | 4-[(4-Chlorophenyl)methyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinemethanamine | PubChem CID:11696113 | DrugBank ID:DB08149"
+BMGC_DG01708,BMG_DG013263,"PF-00217830 | PubChem CID:11697676 | DrugBank ID:DB12998 | 7-[4-(4-naphthalen-1-ylpiperazin-1-yl)butoxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one | CAS RN:846032-02-8 | UNII:8BC08N1MS5 | Pf-00217830 | PubChem SID:310825952"
+BMGC_DG01709,BMG_DG013264,Mk-0249 | CAS RN:862309-06-6 | UNII:KF50235Q04 | MK-0249 | CAS RN:1167574-41-5 | PubChem CID:11697697 | DrugBank ID:DB11910 | 2-methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one | PubChem SID:198937202
+BMGC_DG01710,BMG_DG013273,BMS-688521 | PubChem CID:11699447 | CAS RN:893397-44-9 | UNII:N4LDS4H73C | PubChem SID:198948567
+BMGC_DG01711,BMG_DG013280,CAS RN:451493-31-5 | PubChem CID:11700696 | N-[4-(3-chloro-4-fluoroanilino)-7-[3-methyl-3-(4-methylpiperazin-1-yl)but-1-ynyl]quinazolin-6-yl]prop-2-enamide;4-methylbenzenesulfonic acid | UNII:Z541VW0W40 | AV-412 | DrugBank ID:DB06021 | PubChem SID:198935027
+BMGC_DG01712,BMG_DG013285,CAS RN:223796-90-5 | UNII:4TXR4R74JA | PubChem SID:445499044 | PubChem CID:11701287 | NS-3956 FREE BASE
+BMGC_DG01713,BMG_DG013290,"PubChem CID:11701820 | N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE | DrugBank ID:DB07284"
+BMGC_DG01714,BMG_DG013294,PubChem SID:433968081 | UNII:42FZN61Y9L | PubChem CID:11702115 | NBI-2 (NON-LABELED) | CAS RN:867036-65-5
+BMGC_DG01715,BMG_DG013300,CAS RN:1613638-27-9 | PubChem CID:11703255 | PubChem SID:198965236 | ethyl (6R)-6-[(2-chloro-4-fluorophenyl)sulfamoyl]cyclohexene-1-carboxylate | RESATORVID | UNII:H2MZ648C31 | CAS RN:243984-11-4 | DrugBank ID:DB05943 | Resatorvid
+BMGC_DG01716,BMG_DG013302,"(S)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-ol | (2S)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-ol | CAS RN:649735-47-7 | PubChem CID:11703421"
+BMGC_DG01717,BMG_DG013314,"PubChem CID:11705608 | CAS RN:832714-46-2 | Apd668 | PubChem SID:445498892 | UNII:JC77BCH2AP | propan-2-yl 4-[1-(2-fluoro-4-methylsulfonylphenyl)pyrazolo[3,4-d]pyrimidin-4-yl]oxypiperidine-1-carboxylate | APD-668"
+BMGC_DG01718,BMG_DG013318,DrugBank ID:DB07136 | BX-528 | PubChem CID:11705956 | CAS RN:607837-17-2 | UNII:60045PL22T | PubChem SID:241179555
+BMGC_DG01719,BMG_DG013354,"UNII:33E86K87QN | CAS RN:871700-17-3 | PubChem CID:11707110 | Trametinib | DrugBank ID:DB08911 | PubChem SID:175265958 | TRAMETINIB | N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide"
+BMGC_DG01720,BMG_DG013366,CAS RN:99185-68-9 | 5-AMINO-2-PHENYL-4-OXAZOLECARBOXAMIDE | UNII:W8WHN8NBZ9 | PubChem CID:11708263
+BMGC_DG01721,BMG_DG013382,"DrugBank ID:DB07193 | (2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine | PubChem CID:11710963"
+BMGC_DG01722,BMG_DG013389,"PubChem CID:11711522 | 6-hydroxy-8-[(1R)-1-hydroxy-2-[[1-(4-methoxyphenyl)-2-methylpropan-2-yl]amino]ethyl]-4H-1,4-benzoxazin-3-one;hydrochloride | PubChem SID:198962907 | NDC:0597-0155 | Olodaterol Hydrochloride | OLODATEROL HYDROCHLORIDE | UNII:65R445W3V9 | CAS RN:869477-96-3 | NDC:0597-0192"
+BMGC_DG01723,BMG_DG013390,(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid | PubChem CID:11711595 | DrugBank ID:DB07070
+BMGC_DG01724,BMG_DG013395,"DrugBank ID:DB07486 | PubChem CID:11712628 | 3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline"
+BMGC_DG01725,BMG_DG013396,"4-[[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid | UNII:BX854EHD63 | 4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid | MLN8054 | PubChem SID:198945325 | PubChem CID:11712649 | CAS RN:1203588-98-0 | CAS RN:869363-13-3 | DrugBank ID:DB13061"
+BMGC_DG01726,BMG_DG013399,NBI-35965 FREE BASE | UNII:SFQ6J6N9F3 | PubChem CID:11713007 | CAS RN:268546-19-6 | PubChem SID:459056406
+BMGC_DG01727,BMG_DG013400,PubChem CID:11713159 | PubChem SID:348480985 | CAS RN:717907-75-0 | UNII:K5BX8ZA7UF | PF-562271
+BMGC_DG01728,BMG_DG013407,"1-[5-tert-butyl-2-(3-chloro-4-hydroxyphenyl)pyrazol-3-yl]-3-[[2-[[3-[2-(2-hydroxyethylsulfanyl)phenyl]-[1,2,4]triazolo[4,3-a]pyridin-6-yl]sulfanyl]phenyl]methyl]urea | PF-03715455 | PubChem CID:11714580 | Pf-03715455 | DrugBank ID:DB12138 | CAS RN:1056164-52-3 | UNII:0TJ631J0KP | PubChem SID:198949581"
+BMGC_DG01729,BMG_DG013420,CAS RN:845714-00-3 | UNII:5M2GUN688C | PubChem SID:459275900 | PubChem CID:11715767 | PHA-767491
+BMGC_DG01730,BMG_DG013427,PubChem SID:198942020 | LAS-38096 | PubChem CID:11716665 | CAS RN:1015481-75-0 | 4-(furan-2-yl)-N-pyridin-3-yl-5-pyrimidin-4-ylpyrimidin-2-amine | CAS RN:851371-22-7 | UNII:168SF9F04E | Unii-168SF9F04E
+BMGC_DG01731,BMG_DG013428,"CAS RN:877660-90-7 | UNII:K2X8KX5UDK | PubChem CID:11716677 | PubChem SID:474492662 | 8,9-DIHYDROCANNABIDIOL"
+BMGC_DG01732,BMG_DG013431,PubChem SID:443624220 | PubChem CID:11717001 | UNII:E488J6BA6E | CAS RN:2230954-03-5 | GDC-0879
+BMGC_DG01733,BMG_DG013432,"ORG-25935 | 2-[[(1R,2S)-6-methoxy-1-phenyl-1,2,3,4-tetrahydronaphthalen-2-yl]methyl-methylamino]acetic acid | ORG-25935 free base | DrugBank ID:DB12220 | PubChem SID:198988009 | UNII:55L20667O4 | PubChem CID:11717074 | CAS RN:1147011-84-4"
+BMGC_DG01734,BMG_DG013435,"CAS RN:910487-58-0 | 2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide | PubChem CID:11717831 | BAY-60-6583 | PubChem SID:461434345 | 2-[6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl]sulfanylacetamide | UNII:UAT5472LHH"
+BMGC_DG01735,BMG_DG013438,UNII:966F77521M | PubChem CID:11718722 | PubChem SID:198971603 | CAS RN:878197-98-9 | GSK-812397
+BMGC_DG01736,BMG_DG013441,DrugBank ID:DB13930 | ULIXERTINIB | UNII:16ZDH50O1U | Ulixertinib | PubChem CID:11719003 | PubChem SID:198956409 | N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide | CAS RN:869886-67-9
+BMGC_DG01737,BMG_DG013444,UNII:9KNB4W7WNH | CAS RN:505031-78-7 | SLV-330 | PubChem SID:459055523 | PubChem CID:11719546
+BMGC_DG01738,BMG_DG013456,PubChem CID:11722357 | CAS RN:2241-94-3 | UNII:47329QA2F6 | PubChem SID:310825832 | 6.ALPHA.-METHYLANDROSTENEDIONE
+BMGC_DG01739,BMG_DG013469,CAS RN:105624-86-0 | PubChem CID:11723708 | 5HPP-33 | UNII:5SZ69PBV5B | PubChem SID:461433413
+BMGC_DG01740,BMG_DG013481,UNII:5S4363I4ED | CAS RN:82419-52-1 | PubChem SID:198988358 | N-DESMETHYL OFLOXACIN | PubChem CID:11725233
+BMGC_DG01741,BMG_DG013486,FAUC-327 | UNII:22MG80B8B8 | CAS RN:444056-97-7 | PubChem SID:198974399 | PubChem CID:11725531
+BMGC_DG01742,BMG_DG013490,UNII:WFX1F20RS9 | 3-((4-NONYLPHENYL)METHYLAMINO)PROPYLPHOSPHONIC ACID | PubChem CID:11725751 | PubChem SID:445499521 | CAS RN:569684-50-0
+BMGC_DG01743,BMG_DG013515,"UNII:U32USC3QC2 | Trachyspic acid, (±)- | PubChem SID:472422993 | UNII:VJA25444QX | CAS RN:149718-37-6 | PubChem SID:472426378 | TRACHYSPIC ACID | CAS RN:512808-12-7 | TRACHYSPIC ACID, (+/-)- | PubChem CID:11729317"
+BMGC_DG01744,BMG_DG013547,"PubChem CID:11735892 | CAS RN:848952-63-6 | PubChem SID:472409388 | UNII:VD7R92E9CG | 2-(3-MERCAPTOPROPYL)PENTANEDIOIC ACID, (2S)-"
+BMGC_DG01745,BMG_DG013558,"CAS RN:786640-83-3 | PubChem SID:459056004 | PubChem CID:11738768 | UNII:PEM4GH3C8D | 5-BUTYL-7-CHLORO-6-HYDROXY-11LAMBDA5-PYRIDO(1,2-A)QUINOLIN-11-YLIUM"
+BMGC_DG01746,BMG_DG013561,PubChem SID:485663524 | CAS RN:841200-46-2 | 2-(4-(2-(1-PIPERIDINYL)ETHOXY)PHENOXY)BENZOXAZOLE | UNII:F3R7Q55CD5 | PubChem CID:11739248 | 2-[4-[2-(1-Piperidinyl)ethoxy]phenoxy]benzoxazole
+BMGC_DG01747,BMG_DG013564,"PubChem CID:1174 | CAS RN:66-22-8 | Uracil | CAS RN:51953-14-1 | CAS RN:66255-05-8 | UNII:56HH86ZVCT | DrugBank ID:DB03419 | CAS RN:24897-51-6 | CAS RN:144104-68-7 | CAS RN:66224-60-0 | CAS RN:51953-19-6 | 1H-pyrimidine-2,4-dione | URACIL | PubChem SID:175267171"
+BMGC_DG01748,BMG_DG013565,"N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane | DrugBank ID:DB02979 | PubChem CID:11740154"
+BMGC_DG01749,BMG_DG013570,"DrugBank ID:DB07011 | PubChem CID:11740318 | (3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE"
+BMGC_DG01750,BMG_DG013579,"PubChem CID:11741361 | UNII:83481Y1YCX | 4-Piperidinemethanamine, 1-(3-chloro-4-fluorobenzoyl)-4-fluoro-N-((5-methyl-2-pyrimidinyl)methyl)- | CAS RN:635323-95-4 | PubChem SID:198942007 | F-15599 | (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[(5-methylpyrimidin-2-yl)methylamino]methyl]piperidin-1-yl]methanone"
+BMGC_DG01751,BMG_DG013588,PubChem CID:11742 | P-CUMYLPHENOL | UNII:2RLA3OL3QT | DrugBank ID:DB06902 | PubChem SID:198936308 | CAS RN:599-64-4 | p-Cumylphenol
+BMGC_DG01752,BMG_DG013601,PubChem CID:11743533 | PubChem SID:459055563 | L-750034 | CAS RN:163209-37-8 | UNII:M7UBK3FJ4N
+BMGC_DG01753,BMG_DG013604,PubChem CID:117443 | CUBEBIN | PubChem SID:198982235 | UNII:J237078S8A | CAS RN:18423-69-3
+BMGC_DG01754,BMG_DG013632,"UNII:K4WBE45SCM | CAS RN:600-14-6 | pentane-2,3-dione | 2,3-PENTANEDIONE | PubChem CID:11747 | 2,3-Pentanedione | PubChem SID:198934867"
+BMGC_DG01755,BMG_DG013635,PubChem SID:472415671 | PubChem CID:117475 | CAS RN:25412-75-3 | 4-NITROBENZAMIDINE | UNII:YE6GJ3QK3X
+BMGC_DG01756,BMG_DG013639,PubChem SID:287445812 | PubChem CID:11747706 | CAS RN:6218-29-7 | UNII:ZX4VV1AKUF | 9(10)-DEHYDRONANDROLONE
+BMGC_DG01757,BMG_DG013653,CAS RN:783355-60-2 | 3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide | ABEXINOSTAT | PubChem SID:198941643 | UNII:IYO470654U | DrugBank ID:DB12565 | PubChem CID:11749858 | Abexinostat
+BMGC_DG01758,BMG_DG013654,"Uric acid | CAS RN:69-93-2 | PubChem SID:175267695 | URIC ACID | 7,9-dihydro-3H-purine-2,6,8-trione | DrugBank ID:DB08844 | UNII:268B43MJ25 | PubChem CID:1175 | Uric Acid"
+BMGC_DG01759,BMG_DG013656,"DrugBank ID:DB12499 | NDC:47335-994 | CLASCOTERONE | PubChem CID:11750009 | Clascoterone | PubChem SID:198965402 | CAS RN:19608-29-8 | [(8R,9S,10R,13S,14S,17R)-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate | UNII:XN7MM8XG2M"
+BMGC_DG01760,BMG_DG013661,"19-methyl-3-(2-methylpropyl)-7-(pyrimidin-2-ylamino)-3,13,19,20-tetrazahexacyclo[14.7.0.02,10.04,9.011,15.017,21]tricosa-1(16),2(10),4(9),5,7,11(15),17,20-octaen-14-one | Cep-11981 | UNII:J8AY0Z4CBP | CAS RN:856691-93-5 | CEP-11981 | PubChem CID:11751922 | PubChem SID:198953371"
+BMGC_DG01761,BMG_DG013667,"Azd-3778 | UNII:9BC2MUG4A8 | PubChem SID:472426066 | PubChem CID:11753159 | CAS RN:485391-80-8 | AZD-3778 | CAS RN:1032129-23-9 | 4-[4-(3,4-dichlorophenoxy)piperidin-1-yl]-N-(4-methylphenyl)sulfonylpiperidine-1-carboxamide"
+BMGC_DG01762,BMG_DG013669,CAS RN:864750-70-9 | PubChem SID:310825435 | PubChem CID:11753673 | Revefenacin | REVEFENACIN | [1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate | CAS RN:1211931-83-7 | UNII:G2AE2VE07O | DrugBank ID:DB11855 | NDC:49502-806
+BMGC_DG01763,BMG_DG013674,PubChem SID:472425950 | PubChem CID:11754511 | BX-912 | UNII:Y7RG737FY6 | CAS RN:702674-56-4
+BMGC_DG01764,BMG_DG013681,"(1R,2R)-2-[4-[3-[3-(cyclopropylcarbamoyl)-4-oxo-1,8-naphthyridin-1-yl]phenyl]-2-fluorophenyl]cyclopropane-1-carboxylic acid | PubChem SID:252164354 | MK-0952 | UNII:N48GH1UIR0 | PubChem CID:11755033 | CAS RN:934995-87-6"
+BMGC_DG01765,BMG_DG013706,"PubChem SID:433968455 | N-((1R)-1-(3,4-DIHYDRO-3-(4-HYDROXYPHENYL)-4-OXOPYRIDO(2,3-D)PYRIMIDIN-2-YL)ETHYL)-N-(3-PYRIDINYLMETHYL)-4-(TRIFLUOROMETHOXY)BENZENEACETAMIDE | N-[(1R)-1-[3-(4-hydroxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethoxy)phenyl]acetamide | UNII:4V0EBS1I32 | PubChem CID:11757854 | CAS RN:752244-91-0 | AMG-487 metabolite M2"
+BMGC_DG01766,BMG_DG013778,UNII:8W8T17847W | NDC:72162-2203 | CAS RN:57-13-6 | NDC:54295-312 | NDC:59088-698 | NDC:84844-009 | NDC:24470-938 | NDC:24470-939 | UREA | NDC:42291-849 | NDC:52187-549 | DrugBank ID:DB03904 | CAS RN:3138-51-0 | NDC:0904-7167 | urea | NDC:82429-308 | NDC:63629-2036 | Urea | NDC:42808-202 | NDC:58657-487 | NDC:63629-2040 | NDC:81542-201 | NDC:16477-340 | NDC:54295-311 | NDC:58657-489 | NDC:63629-9267 | PubChem CID:1176 | NDC:71399-8455 | NDC:44523-617 | NDC:71399-8456 | NDC:59088-489 | CAS RN:37955-36-5 | NDC:84844-010 | NDC:50268-872 | NDC:84186-009 | NDC:16477-341 | NDC:42808-204 | CAS RN:4744-36-9 | NDC:44523-618 | NDC:44523-801 | NDC:73076-139 | NDC:84117-018 | NDC:54295-308 | PubChem SID:175266080 | NDC:72162-1668 | NDC:50268-820
+BMGC_DG01767,BMG_DG013782,"CAS RN:1629229-37-3 | NDC:0469-2460 | PubChem SID:313368882 | UNII:83VNE45KXX | NDC:0469-2760 | PubChem CID:117604931 | (4-fluorophenyl)-[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone | Fezolinetant | FEZOLINETANT | NDC:0469-2660"
+BMGC_DG01768,BMG_DG013783,"PubChem CID:117607904 | Zetomipzomib | ZETOMIPZOMIB | UNII:O4BT6C02M2 | CAS RN:1629677-75-3 | Kzr-616 | (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide | PubChem SID:381608598"
+BMGC_DG01769,BMG_DG013825,PubChem SID:441331509 | CAS RN:1400742-18-8 | PubChem CID:117650397 | 5-FLUORO-CUMYL-PICA | UNII:7BN4RS63UV
+BMGC_DG01770,BMG_DG013833,"alpha-Acetyldigoxin | DrugBank ID:DB13691 | CAS RN:5511-98-8 | .ALPHA.-ACETYLDIGOXIN | PubChem SID:198936783 | [(2R,3R,4S,6S)-6-[(2R,3S,4S,6S)-6-[(2R,3S,4S,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-3-hydroxy-2-methyloxan-4-yl] acetate | UNII:Q28IFH7A50 | PubChem CID:11765960"
+BMGC_DG01771,BMG_DG013847,PubChem SID:198935209 | PubChem CID:11768 | UNII:845J3299E1 | ANTHRAGALLOL | CAS RN:602-64-2
+BMGC_DG01772,BMG_DG013896,"Adcetris | [4-[[(2S)-5-(carbamoylamino)-2-[[(2S)-2-[6-(2,5-dioxo-3-sulfanylpyrrolidin-1-yl)hexanoylamino]-3-methylbutanoyl]amino]pentanoyl]amino]phenyl]methyl N-[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylcarbamate | PubChem CID:117723179"
+BMGC_DG01773,BMG_DG013913,"PubChem CID:117752163 | CAS RN:2414285-40-6 | Sivopixant | UNII:S0N1VEG94I | PubChem SID:433968593 | (2S)-3-[3-[(4-chlorophenyl)methyl]-2,6-dioxo-4-(4-pyridin-2-yloxyanilino)-1,3,5-triazin-1-yl]-2-methylpropanoic acid | SIVOPIXANT | CAS RN:1640808-39-4"
+BMGC_DG01774,BMG_DG013917,"PubChem SID:346537587 | CAS RN:1642288-47-8 | NDC:73625-114 | PubChem CID:117761397 | Mavacamten | NDC:73625-111 | 6-[[(1S)-1-phenylethyl]amino]-3-propan-2-yl-1H-pyrimidine-2,4-dione | DrugBank ID:DB14921 | NDC:73625-112 | NDC:73625-113 | UNII:QX45B99R3J | MAVACAMTEN"
+BMGC_DG01775,BMG_DG013919,5-[(3-Chlorophenyl)methyl]-1H-pyrazole-3-carboxylic acid | 5-((3-CHLOROPHENYL)METHYL)-1H-PYRAZOLE-3-CARBOXYLIC ACID | PubChem SID:485663370 | CAS RN:595610-55-2 | PubChem CID:11776293 | UNII:G3X43GW2KL
+BMGC_DG01776,BMG_DG013922,Beta-D-Glucopyranose Spirohydantoin | DrugBank ID:DB01823 | PubChem CID:11776755
+BMGC_DG01777,BMG_DG013927,4-[(3S)-1-prop-2-enoylpiperidin-3-yl]-1H-indole-7-carboxamide | UNII:1487U1Q3IQ | PubChem CID:117773770 | ELSUBRUTINIB | Elsubrutinib | CAS RN:1643570-24-4 | PubChem SID:387065439
+BMGC_DG01778,BMG_DG013931,"PubChem SID:333495865 | UNII:9T56TV18X7 | Padnarsertib | CAS RN:2226508-53-6 | (E)-3-(6-aminopyridin-3-yl)-N-[[5-[4-(4,4-difluoropiperidine-1-carbonyl)phenyl]-7-(4-fluorophenyl)-1-benzofuran-2-yl]methyl]prop-2-enamide | CAS RN:1643913-93-2 | PADNARSERTIB | PubChem CID:117779453"
+BMGC_DG01779,BMG_DG013944,O-2172 | PubChem SID:441097287 | PubChem CID:11778793 | UNII:SPK6RB6JMK | CAS RN:521062-92-0
+BMGC_DG01780,BMG_DG013945,"3-(3,4-dihydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one | PubChem CID:11778945 | CAS RN:57765-66-9 | 3-(3,4-Dihydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one"
+BMGC_DG01781,BMG_DG013951,"Isoxsuprine | DrugBank ID:DB08941 | UNII:R15UI3245N | 4-[(1S,2R)-1-hydroxy-2-[[(2R)-1-phenoxypropan-2-yl]amino]propyl]phenol | CAS RN:395-28-8 | CAS RN:395-29-9 | CAS RN:256493-97-7 | PubChem SID:175271909 | ISOXSUPRINE | PubChem CID:11779629"
+BMGC_DG01782,BMG_DG013954,"PubChem SID:475549820 | DrugBank ID:DB08179 | PubChem CID:11779786 | Methyl Gerfelin | UNII:JWQ46YJR3Q | METHYL GERFELIN | CAS RN:700870-56-0 | methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate"
+BMGC_DG01783,BMG_DG013967,CAS RN:603-76-9 | 1-METHYLINDOLE | PubChem SID:198937135 | PubChem CID:11781 | UNII:8H698ROJ5F
+BMGC_DG01784,BMG_DG013975,"Vorasidenib | NDC:72694-879 | CAS RN:1644545-52-7 | PubChem CID:117817422 | 6-(6-chloropyridin-2-yl)-2-N,4-N-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine | PubChem SID:346537594 | VORASIDENIB | UNII:789Q85GA8P | NDC:72694-728"
+BMGC_DG01785,BMG_DG014005,"5-(5-((3-((1S,5R)-1-(2-Fluoro-4-(trifluoromethyl)phenyl)-5-methyl-3-azabicyclo(3.1.0)hexan-3-yl)propyl)thio)-4-methyl-4H-1,2,4-triazol-3-yl)-4-methyloxazole | 5-[5-[3-[(1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexan-3-yl]propylsulfanyl]-4-methyl-1,2,4-triazol-3-yl]-4-methyl-1,3-oxazole | CAS RN:863680-46-0 | PubChem SID:198952616 | UNII:Y5OZ63HC3V | PubChem CID:11784937 | GSK-598809"
+BMGC_DG01786,BMG_DG014018,"UNII:MM4S7BD3DF | PubChem CID:117857370 | CAS RN:1654725-02-6 | GLPG-1837 | PubChem SID:472424486 | N-(3-carbamoyl-5,5,7,7-tetramethyl-4H-thieno[2,3-c]pyran-2-yl)-1H-pyrazole-5-carboxamide | Glpg-1837"
+BMGC_DG01787,BMG_DG014022,N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide | PubChem CID:11786594 | CAS RN:848144-15-0 | PubChem SID:198959231 | ITX-5061 FREE BASE | ITX-5061 free base | UNII:RDD1D7O9YX
+BMGC_DG01788,BMG_DG014025,PubChem SID:472422068 | UNII:KK3Y3KN5BV | PubChem CID:11787114 | CAS RN:697235-38-4 | SILVESTROL
+BMGC_DG01789,BMG_DG014028,"CAS RN:1399849-02-5 | PubChem CID:117877477 | Sph3127 | UNII:C2M78A9V6Z | methyl N-[3-[3-[(1R)-1-[cyclopropyl-[(2R)-morpholine-2-carbonyl]amino]ethyl]-6-methylpyrazolo[3,4-b]pyridin-1-yl]propyl]carbamate | Sitokiren | SITOKIREN | PubChem SID:440089538"
+BMGC_DG01790,BMG_DG014062,"3-[7,12,18-tris(2-carboxyethyl)-3,8,13,17-tetrakis(carboxymethyl)-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoic acid | Uroporphyrinogen III | CAS RN:1976-85-8 | PubChem CID:1179"
+BMGC_DG01791,BMG_DG014063,"PubChem SID:376231551 | PubChem CID:11790 | CAS RN:604-59-1 | alpha-Naphthoflavone | 7,8-BENZOFLAVONE | DrugBank ID:DB07453 | UNII:FML65D8PY5"
+BMGC_DG01792,BMG_DG014068,"CAS RN:2089-89-6 | PubChem CID:11790598 | 2,7-NAPHTHALENEDICARBOXYLIC ACID | UNII:D5IW7R9WZY | PubChem SID:346537528"
+BMGC_DG01793,BMG_DG014074,"PubChem CID:117909640 | PubChem SID:346539058 | Olafertinib | N-[3-[2-[2,3-difluoro-4-[4-(2-hydroxyethyl)piperazin-1-yl]anilino]quinazolin-8-yl]phenyl]prop-2-enamide | CAS RN:145379-14-2 | UNII:708TLB8J3Y | OLAFERTINIB | CAS RN:1660963-42-7"
+BMGC_DG01794,BMG_DG014084,"CAS RN:1661854-97-2 | PubChem SID:461433474 | PubChem CID:117918742 | N-[(8S)-4-amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide | Zipalertinib | UNII:T4YMU8TW9H | ZIPALERTINIB"
+BMGC_DG01795,BMG_DG014099,"UNII:7K28NB895L | 3-[[(1S,2S,3R)-2,3-difluoro-1-hydroxy-7-methylsulfonyl-2,3-dihydro-1H-inden-4-yl]oxy]-5-fluorobenzonitrile | PubChem SID:404859532 | Belzutifan | BELZUTIFAN | CAS RN:1672668-24-4 | NDC:0006-5331 | PubChem CID:117947097"
+BMGC_DG01796,BMG_DG014100,"Fluprednidene | UNII:FA517NS3N7 | PubChem CID:11794741 | CAS RN:2193-87-5 | PubChem SID:198937022 | DrugBank ID:DB08970 | (8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-16-methylidene-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-3-one | FLUPREDNIDENE"
+BMGC_DG01797,BMG_DG014101,"PubChem CID:117947705 | CAS RN:1673568-73-4 | Rodatristat | RODATRISTAT | (3S)-8-[2-amino-6-[(1R)-1-(4-chloro-2-phenylphenyl)-2,2,2-trifluoroethoxy]pyrimidin-4-yl]-2,8-diazaspiro[4.5]decane-3-carboxylic acid | PubChem SID:377308477 | UNII:91D8378G2V"
+BMGC_DG01798,BMG_DG014107,UNII:KDA2HUE7KP | PubChem CID:117951478 | CAS RN:1675203-84-5 | PubChem SID:475550322 | BMS-202
+BMGC_DG01799,BMG_DG014115,"BUPIVACAINE, (R)- | UNII:16O5OYF58E | PubChem SID:322058899 | CAS RN:27262-45-9 | PubChem CID:117963"
+BMGC_DG01800,BMG_DG014131,"CAS RN:1693734-80-3 | N-[5-(2,3-dihydro-1,4-benzodioxine-6-carbonylamino)-2-fluorophenyl]-2-[(4-ethylpiperazin-1-yl)methyl]quinoline-6-carboxamide | PubChem CID:117996795 | CID 117996795"
+BMGC_DG01801,BMG_DG014143,"NDC:72064-150 | PubChem SID:346536770 | PubChem CID:118023034 | Avapritinib | AVAPRITINIB | DrugBank ID:DB15233 | CAS RN:1703793-34-3 | NDC:72064-130 | NDC:72064-125 | NDC:72064-110 | NDC:72064-120 | UNII:513P80B4YJ | (1S)-1-(4-fluorophenyl)-1-[2-[4-[6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-4-yl]piperazin-1-yl]pyrimidin-5-yl]ethanamine"
+BMGC_DG01802,BMG_DG014149,"UNII:4HTE364XIK | CAS RN:1702259-66-2 | PubChem SID:346540121 | DrugBank ID:DB15169 | H3B-6527 | N-[2-[[6-[(2,6-dichloro-3,5-dimethoxyphenyl)carbamoyl-methylamino]pyrimidin-4-yl]amino]-5-(4-ethylpiperazin-1-yl)phenyl]prop-2-enamide | PubChem CID:118029202"
+BMGC_DG01803,BMG_DG014155,"UNII:M64JF6WMSA | N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide | ROBLITINIB | Roblitinib | CAS RN:1708971-55-4 | PubChem SID:363909836 | PubChem CID:118036971"
+BMGC_DG01804,BMG_DG014157,"RINETERKIB | Rineterkib | CAS RN:1715025-32-3 | 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide | UNII:15KFN616FK | PubChem SID:433968673 | PubChem CID:118045847"
+BMGC_DG01805,BMG_DG014170,"NDC:0363-0795 | NDC:35916-1654 | PubChem SID:175266963 | PAMABROM | Pamabrom | PubChem CID:11806 | DrugBank ID:DB11106 | 2-amino-2-methylpropan-1-ol;8-bromo-1,3-dimethyl-7H-purine-2,6-dione | NDC:52389-249 | UNII:UA8U0KJM72 | CAS RN:606-04-2 | NDC:0280-0070 | NDC:52389-325"
+BMGC_DG01806,BMG_DG014174,"PubChem SID:472421757 | PubChem CID:11806279 | UNII:EJ699JF2AV | CAS RN:951-88-2 | 1,2-DICYCLOHEXYLETHANE-1,2-DIONE"
+BMGC_DG01807,BMG_DG014175,"UNII:CJ1PL0TE6J | PubChem CID:118063735 | 4-[[benzyl-(8-chloro-1-methyl-4H-chromeno[4,3-c]pyrazole-3-carbonyl)amino]methyl]benzoic acid | Nidufexor | CAS RN:1773489-72-7 | PubChem SID:363908629 | NIDUFEXOR"
+BMGC_DG01808,BMG_DG014189,"ANDROST-3-EN-17-ONE, (5.ALPHA.)- | PubChem CID:11807837 | 5a-Androst-3-en-17-one | UNII:QR7BMS5XDS | PubChem SID:482554020 | Androst-3-en-17-one, (5α)- | CAS RN:14935-81-0 | (5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,2,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one"
+BMGC_DG01809,BMG_DG014190,"Bromotheophylline | DrugBank ID:DB14018 | BROMOTHEOPHYLLINE | UNII:FZG87K1MQ6 | CAS RN:10381-75-6 | PubChem SID:175265764 | PubChem CID:11808 | 8-bromo-1,3-dimethyl-7H-purine-2,6-dione"
+BMGC_DG01810,BMG_DG014192,"N-cyclopropyl-4-[7-[(3-hydroxy-3-methylcyclobutyl)methylamino]-5-pyridin-3-yloxypyrazolo[1,5-a]pyrimidin-3-yl]-2-methylbenzamide | UNII:HE97PTK3Q6 | PubChem SID:459276020 | CAS RN:1610759-22-2 | Luvixasertib | LUVIXASERTIB | PubChem CID:118086034"
+BMGC_DG01811,BMG_DG014203,"PubChem CID:11809364 | TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE | DrugBank ID:DB07902"
+BMGC_DG01812,BMG_DG014204,CAS RN:1782070-22-7 | PubChem CID:118094189 | UNII:53T7TDA5QJ | PAT-505 | PubChem SID:443623979
+BMGC_DG01813,BMG_DG014209,PubChem SID:387065197 | UNII:I7MVZ8HDNU | Remibrutinib | PubChem CID:118107483 | N-[3-[6-amino-5-[2-[methyl(prop-2-enoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoro-2-methylphenyl]-4-cyclopropyl-2-fluorobenzamide | CAS RN:1787294-07-8 | REMIBRUTINIB
+BMGC_DG01814,BMG_DG014211,"CAS RN:606-14-4 | 3-hydroxy-L-kynurenine | PubChem SID:472411555 | (2S)-2-amino-4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid | PubChem CID:11811 | UNII:F459WK6M6B | 3-HYDROXYKYNURENINE, (S)-"
+BMGC_DG01815,BMG_DG014213,"5-cyclopropyl-4-[[1-[(1S)-1-(3,5-dichlorophenyl)ethyl]piperidin-4-yl]methoxy]-2-fluoro-N-methylsulfonylbenzamide | GDC-0310 | UNII:72GO7NL642 | Gdc-0310 | PubChem SID:461434268 | PubChem CID:118110531 | CAS RN:1788063-52-4"
+BMGC_DG01816,BMG_DG014217,"DrugBank ID:DB14924 | PubChem SID:333495601 | RITLECITINIB | Ritlecitinib | UNII:2OYE00PC25 | PubChem CID:118115473 | CAS RN:1792180-81-4 | 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one"
+BMGC_DG01817,BMG_DG014224,CAS RN:1793080-72-4 | (4-(2-(4-fluoro-2-methylphenoxy)-4-(trifluoromethyl)benzamido)-2-oxopyridin-1(2H)-yl)methyl dihydrogen phosphate | PubChem CID:118126601 | [4-[[2-(4-fluoro-2-methylphenoxy)-4-(trifluoromethyl)benzoyl]amino]-2-oxopyridin-1-yl]methyl dihydrogen phosphate
+BMGC_DG01818,BMG_DG014236,"LJ-529 | UNII:Q768R9SQ5Y | PubChem SID:445500611 | (2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methylthiolane-2-carboxamide | Q768R9SQ5Y | PubChem CID:11813713 | CAS RN:596103-01-4"
+BMGC_DG01819,BMG_DG014238,PubChem SID:461434840 | BIIB-068 | UNII:M6RN4LQ25S | N-[[2-methyl-4-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]phenyl]methyl]-3-propan-2-yloxyazetidine-1-carboxamide | CAS RN:1798787-27-5 | PubChem CID:118139356 | Biib-068
+BMGC_DG01820,BMG_DG014244,"UNII:04ISX24T1B | PubChem SID:198944147 | Zaragozic Acid C | CAS RN:146389-62-0 | CAS RN:137681-56-2 | ZARAGOZIC ACID C | (1S,3S,4S,5R,6R,7R)-1-[(4R,5R)-4-acetyloxy-5-methyl-6-phenylhexyl]-4,7-dihydroxy-6-[(E,6R)-6-methyl-9-phenylnon-4-enoyl]oxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid | PubChem CID:11814656"
+BMGC_DG01821,BMG_DG014255,"CAS RN:1799831-02-9 | (2~{R})-2-[5-[3-chloranyl-2-methyl-4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy-3-[2-[[2-(2-methoxyphenyl)pyrimidin-4-yl]methoxy]phenyl]propanoic acid | PubChem CID:118157243 | CAS RN:1799631-75-6 | (2R)-2-[5-[3-chloro-2-methyl-4-[2-(4-methylpiperazin-1-yl)ethoxy]phenyl]-6-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxy-3-[2-[[2-(2-methoxyphenyl)pyrimidin-4-yl]methoxy]phenyl]propanoic acid"
+BMGC_DG01822,BMG_DG014260,"LANRAPLENIB | PubChem SID:363908208 | Lanraplenib | 6-(6-aminopyrazin-2-yl)-N-[4-[4-(oxetan-3-yl)piperazin-1-yl]phenyl]imidazo[1,2-a]pyrazin-8-amine | CAS RN:1800046-95-0 | DrugBank ID:DB14770 | PubChem CID:118161062 | UNII:A6U64OU57E"
+BMGC_DG01823,BMG_DG014261,"CC-90005 | Cc-90005 | UNII:GEZ43HM6NW | 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile | PubChem CID:118162109 | PubChem SID:461434497 | CAS RN:1799574-70-1"
+BMGC_DG01824,BMG_DG014262,"UNII:OIK6I0DA01 | LXE-408 | PubChem SID:461434729 | N-[4-fluoro-3-[6-(3-methylpyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]phenyl]-2,4-dimethyl-1,3-oxazole-5-carboxamide | CAS RN:1799330-15-6 | Lxe408 | PubChem CID:118162630"
+BMGC_DG01825,BMG_DG014265,PubChem CID:118166560 | LYS-006 | CAS RN:1799681-85-8 | (3S)-3-amino-4-[5-[4-(5-chloro-3-fluoropyridin-2-yl)oxyphenyl]tetrazol-2-yl]butanoic acid | UNII:59CF90960T | PubChem SID:461434093 | Lys006
+BMGC_DG01826,BMG_DG014266,"Astx-660 | TOLINAPANT | CAS RN:1799328-86-1 | PubChem SID:387065308 | 1-[6-[(4-fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-2H-pyrrolo[3,2-b]pyridin-1-yl]-2-[(2R,5R)-5-methyl-2-[[(3R)-3-methylmorpholin-4-yl]methyl]piperazin-1-yl]ethanone | PubChem CID:118169620 | UNII:2LHZ9ZC3YO"
+BMGC_DG01827,BMG_DG014288,"PubChem SID:375085325 | PubChem CID:118196485 | Bms-986158 | EZOBRESIB | DrugBank ID:DB15435 | Ezobresib | CAS RN:1800340-40-2 | UNII:X8BW0MQ5PI | 2-[3-(3,5-dimethyltriazol-4-yl)-5-[(S)-oxan-4-yl(phenyl)methyl]pyrido[3,2-b]indol-7-yl]propan-2-ol"
+BMGC_DG01828,BMG_DG014291,UNII:UQ470VV48X | 1-Methyl-2-quinolone | PubChem CID:11820 | DrugBank ID:DB04580 | CAS RN:606-43-9 | PubChem SID:375579144 | 1-METHYL-2-QUINOLONE
+BMGC_DG01829,BMG_DG014293,"PubChem CID:11820174 | CAS RN:1080-95-1 | 2,N,N-TRIMETHYLTRYPTAMINE | PubChem SID:313182658 | UNII:P15UO6J3FK"
+BMGC_DG01830,BMG_DG014300,"PubChem SID:472419545 | UNII:1KKS7U3X86 | CAS RN:1801333-55-0 | 4-[[2-(5-chloro-2-fluorophenyl)-5-propan-2-ylpyridin-4-yl]amino]-N-(1,3-dihydroxypropan-2-yl)pyridine-3-carboxamide | 1Kks7U3X86 | PubChem CID:118211239 | PF-06952229"
+BMGC_DG01831,BMG_DG014311,"CAS RN:1801344-14-8 | PubChem CID:118224491 | N-[5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-morpholin-4-yl-[1,3]oxazolo[4,5-b]pyridin-6-yl]-2-(2-methylpyridin-4-yl)-1,3-oxazole-4-carboxamide | EMAVUSERTIB | UNII:MH5DMF9JKY | Emavusertib | PubChem SID:461432898"
+BMGC_DG01832,BMG_DG014323,"UNII:FPJWORQEGI | (3S,4S)-8-[6-amino-5-(2-amino-3-chloropyridin-4-yl)sulfanylpyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine | CAS RN:1801765-04-7 | Batoprotafib | BATOPROTAFIB | PubChem CID:118238370 | PubChem SID:441097125"
+BMGC_DG01833,BMG_DG014324,"CAS RN:606-58-6 | UNII:L7995C4D7F | Toyocamycin | DrugBank ID:DB13916 | 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carbonitrile | TOYOCAMYCIN | PubChem CID:11824 | PubChem SID:198964893"
+BMGC_DG01834,BMG_DG014338,"BRENSOCATIB | CAS RN:1802148-05-5 | PubChem CID:118253852 | UNII:25CG88L0BB | (2S)-N-[(1S)-1-cyano-2-[4-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide | PubChem SID:329589083 | Brensocatib"
+BMGC_DG01835,BMG_DG014346,PubChem CID:118261815 | RG-7834 | UNII:56JM4WYS8E | CAS RN:2072057-17-9 | PubChem SID:474493837
+BMGC_DG01836,BMG_DG014353,PubChem SID:198963913 | CAS RN:195131-60-3 | UNII:5ZBV2H2P2M | PubChem CID:11826628 | GW-9820
+BMGC_DG01837,BMG_DG014361,"Sigma-2 receptor antagonist 1 | CAS RN:1802632-22-9 | PubChem SID:440089108 | CT-1812 | CAS RN:2243184-39-4 | PubChem CID:118278088 | 4-[3-methyl-3-(5-methylsulfonyl-1,3-dihydroisoindol-2-yl)butyl]-2-[(2-methylpropan-2-yl)oxy]phenol | UNII:0661V34NTV"
+BMGC_DG01838,BMG_DG014365,PubChem CID:11828024 | PubChem SID:496143071 | CAS RN:147444-03-9 | PYRIPYROPENE A | Pyripyropene A | UNII:EKX655RQH9
+BMGC_DG01839,BMG_DG014375,PubChem CID:11829 | UNII:XHP5J23AZ5 | 5-NITROQUINOLINE | CAS RN:607-34-1 | PubChem SID:472387755
+BMGC_DG01840,BMG_DG014376,"Incb-059872 | PubChem CID:118290753 | CAS RN:1802909-49-4 | UNII:12XU6D9FLM | 1-[[4-(methoxymethyl)-4-[[[(1R,2S)-2-phenylcyclopropyl]amino]methyl]piperidin-1-yl]methyl]cyclobutane-1-carboxylic acid | INCB-059872 | PubChem SID:472408697"
+BMGC_DG01841,BMG_DG014385,"N-(5-hydroxy-1,3-benzothiazol-2-yl)acetamide | N-(5-Oxidanyl-1,3-Benzothiazol-2-Yl)ethanamide | PubChem CID:118295558"
+BMGC_DG01842,BMG_DG014387,"PRN-1371 | CAS RN:1802929-43-6 | PubChem SID:346540635 | Prn1371 | PubChem CID:118295624 | UNII:S3OPE9IA3Q | 6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)-8-[3-(4-prop-2-enoylpiperazin-1-yl)propyl]pyrido[2,3-d]pyrimidin-7-one"
+BMGC_DG01843,BMG_DG014391,CAS RN:121-33-5 | UNII:CHI530446X | Vanillin | VANILLIN | 4-hydroxy-3-methoxybenzaldehyde | PubChem CID:1183 | PubChem SID:175267110
+BMGC_DG01844,BMG_DG014392,CAS RN:607-35-2 | PubChem CID:11830 | PubChem SID:198939172 | UNII:YWO6S88V4V | 8-NITROQUINOLINE
+BMGC_DG01845,BMG_DG014405,"PubChem CID:118308154 | CAS RN:1803557-42-7 | CVN-766 | N-[(1S,2S)-2-[[3-ethyl-5-(trifluoromethyl)pyrazin-2-yl]amino]cyclopentyl]-3-(triazol-2-yl)pyridine-2-carboxamide | N-[(1S,2S)-2-{[3-Ethyl-5-(trifluoromethyl)pyrazin-2-yl]amino}cyclopentyl]-3-(2H-1,2,3-triazol-2-yl)pyridine-2-carboxamide | UNII:PF6B68X8JN"
+BMGC_DG01846,BMG_DG014408,"CAS RN:1803274-65-8 | PubChem CID:118310260 | Bay1436032 | 3-[2-[4-(trifluoromethoxy)anilino]-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid"
+BMGC_DG01847,BMG_DG014410,5-AMINO-3-(1-METHYLPIPERIDIN-4-YL)-1H-INDOLE | PubChem CID:11831220 | UNII:R6G8JA3YT8 | CAS RN:182564-38-1 | PubChem SID:474492399 | 5-Amino-3-(1-methylpiperidin-4-yl)-1H-indole
+BMGC_DG01848,BMG_DG014419,"Danicopan | UNII:JM8C1SFX0U | DANICOPAN | DrugBank ID:DB15401 | PubChem SID:363909456 | PubChem CID:118323590 | (2S,4R)-1-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide | CAS RN:1903768-17-1"
+BMGC_DG01849,BMG_DG014426,CAS RN:607-71-6 | 4-METHYLCOUMARIN | 4-Methylcoumarin | DrugBank ID:DB08785 | PubChem SID:287445960 | PubChem CID:11833 | UNII:2YZ8R79U9H
+BMGC_DG01850,BMG_DG014438,"LINVENCORVIR | Linvencorvir | 3-[(8aS)-7-[[(4S)-5-ethoxycarbonyl-4-(3-fluoro-2-methylphenyl)-2-(1,3-thiazol-2-yl)-1,4-dihydropyrimidin-6-yl]methyl]-3-oxo-5,6,8,8a-tetrahydro-1H-imidazo[1,5-a]pyrazin-2-yl]-2,2-dimethylpropanoic acid | PubChem SID:461435004 | PubChem CID:118354396 | UNII:74UDO8415O | CAS RN:1808248-05-6"
+BMGC_DG01851,BMG_DG014439,(+)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)(cyclopropyl-methylamino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide | 2-[3-(aminomethyl)phenyl]-N-[5-[(3-cyanophenyl)-(cyclopropylmethylamino)methyl]-2-fluorophenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide | PubChem CID:118355809
+BMGC_DG01852,BMG_DG014443,3-CHLOROIMINODIBENZYL | PubChem CID:118364 | UNII:0514QW7D2I | CAS RN:32943-25-2 | PubChem SID:198957819
+BMGC_DG01853,BMG_DG014445,PubChem CID:11837140 | PubChem SID:474492698 | HALICIN | CAS RN:40045-50-9 | Halicin | UNII:Y4KQC5P9B2
+BMGC_DG01854,BMG_DG014450,"PubChem CID:118374999 | CAS RN:1268244-88-7 | PubChem SID:377308579 | 4-(2-(2-Chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid | PubChem SID:317229522 | UNII:378SU5NO8S | 4-[(1S,2S)-2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid | CAS RN:2020096-17-5 | CAS RN:1268244-85-4 | UNII:6TU6SUZ3BY | PX-20606 | DrugBank ID:DB15416 | PX-102"
+BMGC_DG01855,BMG_DG014466,PubChem SID:375579321 | CAS RN:608-05-9 | UNII:AK8XAB7PS8 | PubChem CID:11840 | 5-METHYLISATIN
+BMGC_DG01856,BMG_DG014471,"DrugBank ID:DB06880 | (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE | PubChem CID:11840904"
+BMGC_DG01857,BMG_DG014472,PubChem CID:11840906 | DrugBank ID:DB06959 | (2S)-1-(3H-Indol-3-yl)-3-{[5-(6-isoquinolinyl)-3-pyridinyl]oxy}-2-propanamine
+BMGC_DG01858,BMG_DG014473,"DrugBank ID:DB07180 | 5-[(Z)-(5-Chloro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-N,2,4-trimethyl-1H-pyrrole-3-carboxamide | PubChem CID:11840911"
+BMGC_DG01859,BMG_DG014474,"DrugBank ID:DB07328 | PubChem CID:11840913 | METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE"
+BMGC_DG01860,BMG_DG014475,"DrugBank ID:DB07356 | (1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE | PubChem CID:11840917"
+BMGC_DG01861,BMG_DG014476,DrugBank ID:DB04629 | Aplyronine A | PubChem CID:11840920
+BMGC_DG01862,BMG_DG014477,"PubChem CID:11840927 | DrugBank ID:DB07497 | 5-(hexahydro-2-oxo-1H-thieno[3,4-D]imidazol-6-yl)pentanal"
+BMGC_DG01863,BMG_DG014478,4-PIPERIDIN-4-YLBUTANAL | PubChem CID:11840929 | DrugBank ID:DB04654
+BMGC_DG01864,BMG_DG014479,"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE | PubChem CID:11840930 | DrugBank ID:DB07520"
+BMGC_DG01865,BMG_DG014481,"PubChem CID:11840933 | N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE | DrugBank ID:DB07587"
+BMGC_DG01866,BMG_DG014482,"DrugBank ID:DB07589 | PubChem CID:11840934 | N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE"
+BMGC_DG01867,BMG_DG014483,"PubChem CID:11840955 | DrugBank ID:DB07949 | ({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid"
+BMGC_DG01868,BMG_DG014484,"4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine | DrugBank ID:DB08219 | PubChem CID:11840966"
+BMGC_DG01869,BMG_DG014485,"PubChem CID:11840968 | (2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE | DrugBank ID:DB08246"
+BMGC_DG01870,BMG_DG014486,"(1R,2R)-N-(2-Aminoethyl)-2-{[(4-methoxyphenyl)sulfonyl]methyl}cyclohexanecarboxamide | PubChem CID:11840970 | DrugBank ID:DB08287"
+BMGC_DG01871,BMG_DG014487,"PubChem CID:11840979 | DrugBank ID:DB08465 | 2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE"
+BMGC_DG01872,BMG_DG014488,"DrugBank ID:DB08515 | PubChem CID:11840981 | (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE"
+BMGC_DG01873,BMG_DG014493,UNII:3AF7Z8794Q | Indoxyl acetate | INDOXYL ACETATE | PubChem SID:474489627 | PubChem CID:11841 | CAS RN:608-08-2
+BMGC_DG01874,BMG_DG014495,"PubChem CID:118414016 | PubChem SID:376072892 | DrugBank ID:DB15143 | CAS RN:1817626-54-2 | 1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy]-7-methoxyisoquinoline-6-carboxamide | ZIMLOVISERTIB | UNII:S3F315JJXI | Zimlovisertib"
+BMGC_DG01875,BMG_DG014497,UNII:G24JS5Y1KL | X-165 | PubChem CID:118417573 | PubChem SID:482553790
+BMGC_DG01876,BMG_DG014499,"CAS RN:1815613-42-3 | UNII:9G4RLM5X6Z | PubChem CID:118419773 | PubChem SID:472423639 | Pilavapadin | (2S)-1-[2-(difluoromethyl)-6-[2-(difluoromethyl)pyridin-4-yl]pyridin-3-yl]oxy-2,4-dimethylpentan-2-amine | PILAVAPADIN | Aak1-IN-1"
+BMGC_DG01877,BMG_DG014503,CAS RN:33252-32-3 | PubChem SID:478837201 | UNII:5WXK5F5SZY | 4-Ethyl-2-pyridinamine | 4-ETHYL-2-PYRIDINAMINE | PubChem CID:118425
+BMGC_DG01878,BMG_DG014506,"PubChem SID:387065503 | CAS RN:1816989-16-8 | MEVOCICLIB | UNII:704LW082GI | PubChem CID:118426108 | Mevociclib | N-[(1S,3R)-3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-1-methylcyclohexyl]-5-[[(E)-4-(dimethylamino)but-2-enoyl]amino]pyridine-2-carboxamide"
+BMGC_DG01879,BMG_DG014509,"VELUSETRAG | Velusetrag | N-[(1S,5R)-8-[(2R)-2-hydroxy-3-[methyl(methylsulfonyl)amino]propyl]-8-azabicyclo[3.2.1]octan-3-yl]-2-oxo-1-propan-2-ylquinoline-3-carboxamide | CAS RN:866933-46-2 | PubChem SID:198960766 | DrugBank ID:DB12702 | PubChem CID:11842633 | UNII:J4VNV64ARB"
+BMGC_DG01880,BMG_DG014516,CAS RN:1818252-52-6 | UNII:N9N6RK0CBN | PubChem SID:375085193 | PubChem CID:118432652 | TAK-418 FREE BASE
+BMGC_DG01881,BMG_DG014520,"CAS RN:1818339-66-0 | PubChem CID:118435360 | PubChem SID:461434238 | UNII:1Y0Y126GUG | N-[2-[(4aR,6S,8aR)-2-amino-6-methyl-4a,5,6,8-tetrahydro-4H-pyrano[3,4-d][1,3]thiazin-8a-yl]-1,3-thiazol-4-yl]-5-(difluoromethoxy)pyridine-2-carboxamide | Pf-06751979 | PF-06751979 | DrugBank ID:DB15105"
+BMGC_DG01882,BMG_DG014521,"Fipravirimat | PubChem CID:118435805 | (1R)-4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethylamino]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]-1-(fluoromethyl)cyclohex-3-ene-1-carboxylic acid | PubChem SID:461432616 | UNII:M5FP5REG5Q | FIPRAVIRIMAT | CAS RN:1818867-24-1"
+BMGC_DG01883,BMG_DG014526,PubChem SID:443624291 | PubChem CID:118440466 | CAS RN:1817773-66-2 | UNII:1874HVK11I | BEVUROGANT
+BMGC_DG01884,BMG_DG014532,PubChem SID:440089953 | UNII:CVL0CMW8XR | 2-AMINO-6-CHLOROPYRAZINE | DrugBank ID:DB02297 | CAS RN:33332-28-4 | PubChem CID:118458 | 2-Amino-6-Chloropyrazine
+BMGC_DG01885,BMG_DG014542,"UNII:KTJCIKNF3F | Etrinabdione | CAS RN:1818428-24-8 | 5-(benzylamino)-4-hydroxy-3-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-6-pentylcyclohexa-3,5-diene-1,2-dione | PubChem SID:387065367 | PubChem CID:118465221 | ETRINABDIONE"
+BMGC_DG01886,BMG_DG014545,"PubChem SID:329904237 | PubChem CID:11846746 | (S)-Venlafaxine | VENLAFAXINE, (S)- | UNII:5FIM3PQD9S | CAS RN:93413-44-6 | 1-[(1S)-2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol"
+BMGC_DG01887,BMG_DG014549,"UNII:27MIP05EAV | 2,6-dibromophenol | 2,6-DIBROMOPHENOL | PubChem SID:198943048 | 2,6-Dibromophenol | CAS RN:59779-25-8 | PubChem CID:11847 | CAS RN:608-33-3"
+BMGC_DG01888,BMG_DG014559,"1-[3-fluoro-4-[7-(5-methyl-1H-imidazol-2-yl)-1-oxo-2,3-dihydroisoindol-4-yl]phenyl]-3-(2,4,6-trifluorophenyl)urea | UNII:TQ6PBX1JU0 | PubChem CID:118480924 | CAS RN:1616428-23-9 | LUXEPTINIB | PubChem SID:384436264 | Luxeptinib"
+BMGC_DG01889,BMG_DG014562,"CEBRANOPADOL | 6-fluoro-N,N-dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine | PubChem SID:198982507 | UNII:7GDW9S3GN3 | PubChem CID:11848225 | DrugBank ID:DB12830 | CAS RN:863513-93-3 | Cebranopadol | CAS RN:863513-91-1"
+BMGC_DG01890,BMG_DG014564,4-[2-(4-aminopiperidin-1-yl)-5-(3-fluoro-4-methoxyphenyl)-1-methyl-6-oxopyrimidin-4-yl]-2-fluorobenzonitrile | PULRODEMSTAT | PubChem CID:118483201 | CAS RN:1821307-10-1 | Pulrodemstat | PubChem SID:440793726 | UNII:W6F4FRQ5QC
+BMGC_DG01891,BMG_DG014571,PubChem SID:485663381 | PubChem CID:11849871 | CAS RN:908355-66-8 | UNII:KC94H8R32U | 8-Bromo-9-propyl-9H-purin-6-amine | 8-BROMO-9-PROPYL-9H-PURIN-6-AMINE
+BMGC_DG01892,BMG_DG014572,"CAS RN:2234851-14-8 | PubChem CID:11850 | CAS RN:608-66-2 | GALACTITOL | (2R,3S,4R,5S)-hexane-1,2,3,4,5,6-hexol | Galactitol | PubChem SID:198958127 | UNII:113ZQ1Y7DD"
+BMGC_DG01893,BMG_DG014573,UNII:TRX7HA5YYG | PubChem CID:118500 | CAS RN:33543-62-3 | M-METHOXY-N-METHYLPHENETHYLAMINE | PubChem SID:440089585
+BMGC_DG01894,BMG_DG014575,"Azd0156 | UNII:P5T0XWC07Z | CAS RN:1821428-35-6 | AZD-0156 | PubChem SID:376073035 | PubChem CID:118502708 | 8-[6-[3-(dimethylamino)propoxy]pyridin-3-yl]-3-methyl-1-(oxan-4-yl)imidazo[4,5-c]quinolin-2-one"
+BMGC_DG01895,BMG_DG014586,"NDC:50242-175 | PubChem SID:363908746 | DrugBank ID:DB15305 | RISDIPLAM | Risdiplam | 7-(4,7-diazaspiro[2.5]octan-7-yl)-2-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)pyrido[1,2-a]pyrimidin-4-one | UNII:76RS4S2ET1 | CAS RN:1825352-65-5 | PubChem CID:118513932"
+BMGC_DG01896,BMG_DG014587,PubChem SID:461433493 | PubChem CID:11851424 | CAS RN:912345-32-5 | N-PROP-2-YNYL-4-SULFAMOYLBENZAMIDE | UNII:66N56UQP3M
+BMGC_DG01897,BMG_DG014592,UNII:V5QX2RCH3C | CAS RN:1831144-46-7 | PubChem CID:118522534 | GDC-0214
+BMGC_DG01898,BMG_DG014601,PubChem SID:312525252 | 25D-NBOME | CAS RN:1354632-02-2 | PubChem CID:118536027 | UNII:7RET11HE13
+BMGC_DG01899,BMG_DG014605,"PF-06456384 trihydrochloride, >=98% (HPLC) | 3-cyano-4-[2-[2-[(2-piperidin-4-ylethylamino)methyl]pyridin-4-yl]-4-[3-(trifluoromethyl)phenyl]phenoxy]-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide | CAS RN:1834610-73-9 | PubChem CID:118540795"
+BMGC_DG01900,BMG_DG014608,A-859261 | UNII:AH35111NF4 | PubChem CID:11854292 | PubChem SID:198967731 | CAS RN:851523-11-0
+BMGC_DG01901,BMG_DG014627,"CAS RN:1622849-43-7 | PubChem SID:461432891 | 5-benzyl-N-[(3S)-7,9-difluoro-2-oxo-1,3,4,5-tetrahydro-1-benzazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide | GSK-3145095 | Gsk-3145095 | UNII:B4D3WPS7JY | PubChem CID:118557502"
+BMGC_DG01902,BMG_DG014630,N-[1-[(5-cyanopyridin-2-yl)methyl]pyrazol-3-yl]-2-[4-[1-(trifluoromethyl)cyclopropyl]phenyl]acetamide | UNII:3Z7U1U8Z9E | Apinocaltamide | Act-709478 | APINOCALTAMIDE | CAS RN:1838651-58-3 | PubChem CID:118560618 | PubChem SID:377307946
+BMGC_DG01903,BMG_DG014632,CAS RN:1838622-25-5 | PubChem CID:118561036 | EST-73502 | PubChem SID:496142509 | UNII:2L6QPL2USH
+BMGC_DG01904,BMG_DG014634,"UNII:0U2750935P | Setileuton | CAS RN:910656-27-8 | 4-(4-fluorophenyl)-7-[[[5-[(2S)-1,1,1-trifluoro-2-hydroxybutan-2-yl]-1,3,4-oxadiazol-2-yl]amino]methyl]chromen-2-one | SETILEUTON | PubChem SID:198937290 | PubChem CID:11856170"
+BMGC_DG01905,BMG_DG014642,"UNII:S4L4MM20B6 | Pf-06821497 | DrugBank ID:DB14799 | CAS RN:1844849-10-0 | Mevrometostat | 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1-one | PubChem CID:118572065 | MEVROMETOSTAT | PubChem SID:363909039"
+BMGC_DG01906,BMG_DG014650,"(E)-3-[4-[[2-[2-(1,1-difluoroethyl)-4-fluorophenyl]-6-hydroxy-1-benzothiophen-3-yl]oxy]phenyl]prop-2-enoic acid | CAS RN:2135600-76-7 | UNII:0Y175XGX4P | DrugBank ID:DB15362 | Lsz-102 | LSZ-102 | PubChem CID:118574930 | PubChem SID:461434680"
+BMGC_DG01907,BMG_DG014652,"MK-6240 | FLORQUINITAU | PubChem SID:317229880 | UNII:800U03334F | CAS RN:1841078-87-2 | PubChem CID:118577045 | 6-fluoro-3-pyrrolo[2,3-c]pyridin-1-ylisoquinolin-5-amine"
+BMGC_DG01908,BMG_DG014662,"PubChem SID:198985110 | 3,4,5-Trichlorophenol | 3,4,5-trichlorophenol | UNII:2JF54EGE7O | CAS RN:609-19-8 | PubChem CID:11859 | 3,4,5-TRICHLOROPHENOL"
+BMGC_DG01909,BMG_DG014664,"N-methyl-3-[2-[(3S)-3-methylmorpholin-4-yl]-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)pyrido[2,3-d]pyrimidin-7-yl]benzamide | UNII:RM15YYQ1CI | Mti-31 | PubChem SID:405055690 | PubChem CID:118591386 | MTI-31 | CAS RN:1567915-38-1"
+BMGC_DG01910,BMG_DG014670,"Adafosbuvir | DrugBank ID:DB14906 | UNII:S83770Y75R | ADAFOSBUVIR | CAS RN:1613589-09-5 | PubChem SID:348481704 | propan-2-yl (2S)-2-[[[(2S,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-fluoro-3,4-dihydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate | PubChem CID:118596336"
+BMGC_DG01911,BMG_DG014672,"TOMIVOSERTIB | DrugBank ID:DB15219 | 6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione | PubChem CID:118598754 | CAS RN:1849590-01-7 | PubChem SID:363907720 | UNII:U2H19X4WBV | Tomivosertib"
+BMGC_DG01912,BMG_DG014675,"UNII:6C9UKZ0CYE | DrugBank ID:DB15418 | 2-[(3S)-7-fluoro-4-(3-oxo-4H-1,4-benzoxazine-6-carbonyl)-2,3-dihydro-1,4-benzoxazin-3-yl]-N-methylacetamide | CAS RN:1850385-64-6 | PubChem SID:381132305 | Azd9977 | PubChem CID:118599727 | BALCINRENONE"
+BMGC_DG01913,BMG_DG014684,propan-2-yl 2-[4-[2-(dimethylamino)ethyl-methylamino]-2-methoxy-5-(prop-2-enoylamino)anilino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate | PubChem CID:118607832 | CAS RN:1847461-43-1 | Mobocertinib | UNII:39HBQ4A67L | MOBOCERTINIB | PubChem SID:387065449
+BMGC_DG01914,BMG_DG014692,Cofrogliptin | PubChem SID:474494106 | UNII:LH4G6K6NKP | PubChem CID:118613788 | COFROGLIPTIN | CAS RN:1844874-26-5
+BMGC_DG01915,BMG_DG014698,"(1R,2S)-2-Phenylcyclopropanaminium | DrugBank ID:DB02665 | PubChem CID:11861988"
+BMGC_DG01916,BMG_DG014707,"CAS RN:1853164-83-6 | IPN-60090 | PubChem SID:461432407 | 1-[(2R)-4-[6-[[2-[4-(3,3-difluorocyclobutyl)oxy-6-methylpyridin-2-yl]acetyl]amino]pyridazin-3-yl]-2-fluorobutyl]-N-methyltriazole-4-carboxamide | UNII:O6ZT4D087I | PubChem CID:118627280"
+BMGC_DG01917,BMG_DG014708,"CAS RN:1858276-04-6 | [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate | Subasumstat | SUBASUMSTAT | PubChem SID:438787770 | UNII:XQ43H3V6M1 | PubChem CID:118628567"
+BMGC_DG01918,BMG_DG014712,"PubChem CID:118639856 | PubChem SID:461434574 | IRUPLINALKIB | Iruplinalkib | UNII:Z5F65W1YAZ | 5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-(9-methyl-3,9-diazaspiro[5.5]undecan-3-yl)phenyl]pyrimidine-2,4-diamine | CAS RN:1854943-32-0"
+BMGC_DG01919,BMG_DG014716,"UNII:R76M2Z6366 | ERAGIDOMIDE | CAS RN:1860875-51-9 | Cc-90009 | PubChem SID:443623649 | 2-(4-chlorophenyl)-N-[[2-(2,6-dioxopiperidin-3-yl)-1-oxo-3H-isoindol-5-yl]methyl]-2,2-difluoroacetamide | PubChem CID:118647211"
+BMGC_DG01920,BMG_DG014733,"PubChem CID:118665163 | UNII:DFS6CB44VG | N-((6-AMINO-2,4-DIMETHYL-3-PYRIDINYL)METHYL)-2-((3-CHLORO-6-QUINOLINYL)METHYL)-4-PYRIDINECARBOXAMIDE | CAS RN:1801253-04-2"
+BMGC_DG01921,BMG_DG014759,"PubChem CID:118693659 | PubChem SID:346540589 | Azd-5153 | AZD-5153 | CAS RN:1869912-39-9 | (3R)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]-1,3-dimethylpiperazin-2-one | UNII:C7C7U6YEAO"
+BMGC_DG01922,BMG_DG014763,"CAS RN:25499-90-5 | PubChem CID:11869658 | 3-Epioleanolic acid | (4aS,6aR,6aS,6bR,8aR,10R,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid"
+BMGC_DG01923,BMG_DG014783,"NDC:68083-562 | NDC:70756-636 | NDC:0143-9619 | NDC:76420-075 | NDC:72603-650 | NDC:0517-0032 | NDC:25021-502 | NDC:76420-618 | NDC:67457-400 | NDC:69680-112 | Erythrotin | NDC:69680-121 | NDC:51662-1440 | PubChem SID:346541296 | NDC:71288-302 | NDC:71288-303 | NDC:70771-1688 | NDC:68001-542 | cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide | CAS RN:68-19-9 | NDC:70069-172 | NDC:71288-300 | CYANOCOBALAMIN | NDC:55150-364 | NDC:49884-270 | NDC:0517-0130 | NDC:0404-9995 | UNII:P6YC3EG204 | NDC:51662-1394 | NDC:0404-9840 | NDC:63323-044 | NDC:70771-1690 | NDC:71288-301 | NDC:84341-002 | NDC:70710-1663 | NDC:76420-111 | NDC:50090-6229 | NDC:70512-840 | NDC:0143-9621 | NDC:70710-1665 | NDC:68083-449 | NDC:0143-9620 | NDC:0517-0031 | NDC:43386-237 | NDC:67457-399 | NDC:69680-113 | NDC:70710-1664 | NDC:45802-491 | NDC:51662-1647 | PubChem CID:118701720 | NDC:70069-005 | NDC:68083-561 | NDC:70771-1689 | NDC:70069-171 | NDC:70756-635"
+BMGC_DG01924,BMG_DG015080,"PubChem CID:118705500 | Amphotericitin B | (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid"
+BMGC_DG01925,BMG_DG015085,5-(1-(4-(TERT-BUTYL)BENZYL)-1H-PYRAZOL-3-YL)-NHYDROXYPENTANAMIDE | PubChem SID:346539390 | CAS RN:1436462-48-4 | PubChem CID:118714372 | UNII:B9Z4XRMPYK
+BMGC_DG01926,BMG_DG015086,PubChem SID:346537783 | CAS RN:1436462-52-0 | PubChem CID:118714374 | N-HYDROXY-5-(1-(4-(TRIFLUOROMETHYL)BENZYL)-1H-PYRAZOL-3-YL)PENTANAMIDE | UNII:OHN35K8IAK
+BMGC_DG01927,BMG_DG015102,"UNII:9C6CFL5ECY | CAS RN:159354-61-7 | EPOXY EXEMESTANE, 1,2-.ALPHA.- | Epoxy Exemestane, 1,2-α- | PubChem SID:485664509 | PubChem CID:118730170"
+BMGC_DG01928,BMG_DG015107,"UNII:AD1ID2JF5O | PubChem CID:11874 | PubChem SID:198976079 | 2,3,4-TRIHYDROXYBENZOIC ACID | CAS RN:610-02-6"
+BMGC_DG01929,BMG_DG015109,PubChem SID:313183852 | UNII:K3141VKX05 | RO-7-9957 | PubChem CID:118749 | CAS RN:34932-78-0
+BMGC_DG01930,BMG_DG015143,"PubChem CID:118753026 | (E)-3-[4-[[(3aS,8bR)-8b-hydroxy-3a-methyl-2,4-dihydro-1H-pyrrolo[2,3-b]indol-3-yl]methyl]phenyl]-N-hydroxyprop-2-enamide"
+BMGC_DG01931,BMG_DG015144,"PubChem CID:118753027 | (E)-3-[4-[[(3aS,8bR)-8b-hydroxy-3a-methyl-2,4-dihydro-1H-pyrrolo[2,3-b]indol-3-yl]methyl]phenyl]prop-2-enamide"
+BMGC_DG01932,BMG_DG015160,"UNII:HU7MC66574 | 4-fluoro-5-[6-[(2R)-2-hydroxypropoxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-yl]oxy-1H-indole-2-carboxylic acid | PubChem SID:440088847 | 4-Fluoro-5-(6-((2R)-2-hydroxypropoxy)-5-methyl-pyrrolo(2,1-F)(1,2,4)triazin-4-YL)oxy-1H-indole-2-carboxylic acid | PubChem CID:118753064 | 4-FLUORO-5-(6-((2R)-2-HYDROXYPROPOXY)-5-METHYL-PYRROLO(2,1-F)(1,2,4)TRIAZIN-4-YL)OXY-1H-INDOLE-2-CARBOXYLIC ACID"
+BMGC_DG01933,BMG_DG015234,PubChem CID:118753189 | (E)-3-[4-[[2-(6-hydroxy-2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide
+BMGC_DG01934,BMG_DG015481,"[2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate | Desoxycorticosterone Pivalate | DESOXYCORTICOSTERONE PIVALATE | CAS RN:808-48-0 | UNII:16665T4A2X | Desoxycorticosterone pivalate | PubChem SID:175266301 | DrugBank ID:DB01134 | PubChem CID:11876263"
+BMGC_DG01935,BMG_DG015502,N-PROPYLIMIDAZOLE | UNII:PR14NYU5X2 | PubChem CID:118785 | PubChem SID:438787642 | CAS RN:35203-44-2
+BMGC_DG01936,BMG_DG015620,"CAS RN:1262670-81-4 | PubChem SID:175267435 | 3,7-dihydropurine-2,6-dione | XANTHINE | UNII:1AVZ07U9S7 | DrugBank ID:DB02134 | CAS RN:69-89-6 | Xanthine | PubChem CID:1188"
+BMGC_DG01937,BMG_DG015640,1-AMINOANTHRACENE | Aminoanthracene | CAS RN:610-49-1 | PubChem SID:198952024 | DrugBank ID:DB01976 | UNII:8H6056DWN2 | PubChem CID:11885
+BMGC_DG01938,BMG_DG015653,"LEPIRUDIN | (2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[(1R,6R,9S,12S,15S,18S,24S,27S,33S,36S,39R,44R,47S,53S,56S,59S,67S,73S,76S)-15,76-bis(4-aminobutyl)-44-[[(2S)-2-[[(4R,7S,10S,13S,19S,22S,25S,28R)-28-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-carboxypropanoyl]amino]-10-(2-amino-2-oxoethyl)-13-(3-amino-3-oxopropyl)-22-(2-carboxyethyl)-25-[(1R)-1-hydroxyethyl]-19-(hydroxymethyl)-7-(2-methylpropyl)-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carbonyl]amino]-4-methylpentanoyl]amino]-12,56,73-tris(2-amino-2-oxoethyl)-9,67-bis(3-amino-3-oxopropyl)-36-[(2S)-butan-2-yl]-18,47-bis(2-carboxyethyl)-24-(carboxymethyl)-27,53-bis(hydroxymethyl)-33-(2-methylpropyl)-8,11,14,17,20,23,26,29,32,35,38,45,48,51,54,57,60,62,65,68,71,74,77-tricosaoxo-59-propan-2-yl-3,4,41,42-tetrathia-7,10,13,16,19,22,25,28,31,34,37,46,49,52,55,58,61,63,66,69,72,75,78-tricosazabicyclo[37.22.17]octaheptacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoic acid | CAS RN:138068-37-8 | Lepirudin | PubChem SID:375085231 | UNII:Y43GF64R34 | PubChem CID:118856773"
+BMGC_DG01939,BMG_DG015656,"PROPANAMIDE, N-(5-(2-(2-METHOXY-3-PYRIDINYL)-7-METHYLIMIDAZO(1,2-A)PYRIDIN-3-YL)-6-(2-(1-METHYL-6-ISOQUINOLINYL)ETHYNYL)-2-PYRIDINYL)-2-(METHYLAMINO)-, (2S)- | UNII:XE77D7FKW4 | PubChem SID:472419178 | CAS RN:1875100-07-4 | PubChem CID:118863018"
+BMGC_DG01940,BMG_DG015662,"UNII:2P6T8SD99L | 5-(benzhydrylsulfinylmethyl)-1,3-thiazole | CE-123 | PubChem SID:441096745 | CAS RN:1879038-73-9 | PubChem CID:118871455"
+BMGC_DG01941,BMG_DG015663,PubChem SID:404859566 | Darovasertib | CAS RN:1874276-76-2 | DAROVASERTIB | PubChem CID:118873253 | UNII:E0YF0M8O09 | 3-amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide
+BMGC_DG01942,BMG_DG015665,PubChem CID:118877433 | BMS-986166 PHOSPHATE | PubChem SID:440090168 | UNII:7D9OME8BVV | CAS RN:1883345-27-4
+BMGC_DG01943,BMG_DG015666,"PubChem CID:118877516 | CAS RN:1883345-06-9 | [(1R,3S)-1-amino-3-[(6S)-6-[2-(2-methoxyphenyl)ethyl]-5,6,7,8-tetrahydronaphthalen-2-yl]cyclopentyl]methanol | Udifitimod | PubChem SID:440088428 | UNII:283FTA936D | Bms-986166 | UDIFITIMOD"
+BMGC_DG01944,BMG_DG015667,"DrugBank ID:DB15003 | PubChem SID:381132240 | BREPOCITINIB | UNII:3X8387Q25N | [(1S)-2,2-difluorocyclopropyl]-[(1R,5S)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone | PubChem CID:118878093 | CAS RN:1883299-62-4 | Brepocitinib"
+BMGC_DG01945,BMG_DG015675,"CAS RN:1876450-69-9 | Marbostat-100 | PubChem CID:118884610 | N-hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide"
+BMGC_DG01946,BMG_DG015681,"N-[6-(2,6-dichloro-3,5-dimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-4-(3,3-dimethylpiperazin-1-yl)benzamide | PubChem CID:118893637 | Segigratinib | UNII:G0Z5E4YTB4 | CAS RN:1882873-93-9 | PubChem SID:474492351 | SEGIGRATINIB"
+BMGC_DG01947,BMG_DG015690,UNII:E9QIS63WUM | ASN-90 | PubChem CID:118903008 | PubChem SID:472422625
+BMGC_DG01948,BMG_DG015698,"(3'R,4S,6'R,7'S,8'E,11'S,12'R)-7-chloro-7'-methoxy-11',12'-dimethyl-13',13'-dioxospiro[2,3-dihydro-1H-naphthalene-4,22'-20-oxa-13lambda6-thia-1,14-diazatetracyclo[14.7.2.03,6.019,24]pentacosa-8,16(25),17,19(24)-tetraene]-15'-one | PubChem CID:118910268 | Tapotoclax | CAS RN:1883727-34-1 | PubChem SID:381132617 | UNII:97W7N9T08G | TAPOTOCLAX"
+BMGC_DG01949,BMG_DG015720,"(15R)-5-[2-chloro-5-(ethoxymethyl)pyrimidin-4-yl]oxy-15-methyl-11-thia-6,14,17-triazatetracyclo[8.8.0.02,7.012,18]octadeca-1(10),2(7),3,5,8,12(18)-hexaen-13-one | PubChem SID:478838480 | Gamcemetinib | CAS RN:1887069-10-4 | UNII:OS2IR8TV1O | GAMCEMETINIB | PubChem CID:118936948"
+BMGC_DG01950,BMG_DG015731,PubChem CID:118955396 | Olutasidenib | UNII:0T4IMT8S5Z | CAS RN:1887014-12-1 | NDC:71332-005 | OLUTASIDENIB | PubChem SID:376073110 | 5-[[(1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile
+BMGC_DG01951,BMG_DG015741,CAS RN:1888318-68-0 | PubChem CID:118973614 | N-[3-[[5-chloro-2-[4-fluoro-3-[methyl(prop-2-enoyl)amino]anilino]pyrimidin-4-yl]amino]propyl]-4-cyanobenzamide
+BMGC_DG01952,BMG_DG015748,"PubChem SID:461434621 | CAS RN:1892581-29-1 | ONFASPRODIL | 6-[(1S)-2-[(3aR,6aS)-5-(2-fluorophenoxy)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl]-1-hydroxyethyl]pyridin-3-ol | Onfasprodil | UNII:C6I8M5AWKP | PubChem CID:118981713"
+BMGC_DG01953,BMG_DG015749,"Amdizalisib | UNII:F3YMY7783P | 4-amino-6-[[(1S)-1-(3-chloro-6-phenylimidazo[1,2-b]pyridazin-7-yl)ethyl]amino]pyrimidine-5-carbonitrile | CAS RN:1894229-03-8 | PubChem CID:118981804 | AMDIZALISIB | PubChem SID:443623912 | CAS RN:1894229-05-0"
+BMGC_DG01954,BMG_DG015755,"PubChem CID:118984355 | azane;2-hydroxypropane-1,2,3-tricarboxylic acid;iron(3+) | FERRIC AMMONIUM CITRATE | UNII:UVP74NG1C5 | CAS RN:1185-57-5 | DrugBank ID:DB09501 | Ferric Ammonium Citrate | PubChem SID:472385903"
+BMGC_DG01955,BMG_DG015770,"Humulin N | NDC:0002-8803 | NDC:47918-878 | NDC:47918-891 | NDC:50090-6565 | PubChem SID:375083274 | (4S)-4-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74R,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-47-[[(1S)-3-amino-1-carboxy-3-oxopropyl]carbamoyl]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2S)-butan-2-yl]-24,56-bis(2-carboxyethyl)-83-[(1R)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-4-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[(2S)-2-[[(2S)-6-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | INSULIN HUMAN | NDC:0169-3007 | PubChem CID:118984375 | NDC:0002-8715 | NDC:0002-8805 | NDC:0002-8501 | NDC:0169-1837 | NDC:0002-8215 | NDC:50090-0403 | NDC:50090-0353 | NDC:0002-0213 | NDC:0169-1833 | NDC:0002-8824 | NDC:0338-0126 | NDC:0169-3003 | NDC:47918-874 | NDC:0002-8315 | CAS RN:11061-68-0 | UNII:1Y17CTI5SR | NDC:0169-3004 | NDC:0169-1834"
+BMGC_DG01956,BMG_DG015795,"Tachmalcor | UNII:BG60K165ZS | (1R,9R,10S,13S,14R,15R,16S,17R,18R)-15-[3-(diethylamino)-2-hydroxypropyl]-13-ethyl-8-methyl-8-aza-15-azoniahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol | CAS RN:47719-70-0 | PubChem CID:118984402 | DETAJMIUM | PubChem SID:249492869"
+BMGC_DG01957,BMG_DG015797,"UNII:81I73K1HKN | Decamethoxin | PubChem CID:118984404 | 10-[dimethyl-[2-[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl]oxy-2-oxoethyl]azaniumyl]decyl-dimethyl-[2-[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl]oxy-2-oxoethyl]azanium;dichloride | CAS RN:38146-42-8 | DrugBank ID:DB13705 | DECAMETHOXIN | PubChem SID:316911713"
+BMGC_DG01958,BMG_DG015803,CAS RN:41342-54-5 | PubChem CID:118984410 | CARBALDRATE | UNII:6931E8LH07 | PubChem SID:322058597
+BMGC_DG01959,BMG_DG015804,"MAZATICOL | UNII:I6X824OGWZ | DrugBank ID:DB13448 | [(1R,3R,5S)-6,6,9-trimethyl-9-azabicyclo[3.3.1]nonan-3-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate | PubChem CID:118984411 | PubChem SID:316917895 | CAS RN:42024-98-6 | Mazaticol"
+BMGC_DG01960,BMG_DG015838,"NDC:83257-011 | INSULIN GLARGINE | NDC:50090-6178 | NDC:50090-6184 | NDC:50090-2193 | NDC:50090-6439 | NDC:0024-5761 | NDC:49502-251 | NDC:0955-1728 | NDC:0002-7715 | NDC:49502-393 | PubChem SID:375085994 | NDC:0955-2900 | NDC:83257-012 | NDC:0088-5020 | Basaglar | NDC:0955-1729 | NDC:50090-4068 | NDC:49502-250 | NDC:83257-015 | NDC:50090-4177 | (4S)-4-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74R,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2S)-butan-2-yl]-24,56-bis(2-carboxyethyl)-47-(carboxymethylcarbamoyl)-83-[(1R)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-4-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[(2S)-2-[[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | UNII:2ZM8CX04RZ | NDC:0024-5871 | NDC:50090-0876 | NDC:49502-394 | NDC:0024-5869 | PubChem CID:118984454 | NDC:0088-2219 | CAS RN:160337-95-1 | NDC:0088-2220 | NDC:50090-1398 | NDC:0002-8980 | NDC:0088-5021 | NDC:83257-014 | NDC:0955-3900 | NDC:0002-8214"
+BMGC_DG01961,BMG_DG015842,"NDC:47783-101 | PubChem SID:375085132 | UNII:5Q6TZN2HNM | PubChem CID:118984459 | (2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(1R,2aS,4S,5aS,8aS,11aR,13S,14aS,16S,17aS,19S,20aS,22S,23aS,25S,26aS,28S,29aS,31R,32aS,35aS,36R,38aS,39S,41aS,42S,44aS,45S,48R,50aS,51S,53aS,54S,56aS,57S,59aS,60S,63S,66S,69S,72S,75S,78S,84S,87R,96S,99S)-22,42,45-tris(4-aminobutyl)-31-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-29a,72,78-tris(2-amino-2-oxoethyl)-14a,75-bis(3-amino-3-oxopropyl)-2a,23a,25,32a,35a,66-hexabenzyl-26a,99-bis[(2S)-butan-2-yl]-17a,41a,59a,69-tetrakis(3-carbamimidamidopropyl)-5a,8a,51,54,63,84-hexakis(2-carboxyethyl)-13,16-bis(carboxymethyl)-20a-[(1R)-1-hydroxyethyl]-60-(hydroxymethyl)-96-[(4-hydroxyphenyl)methyl]-50a-(1H-imidazol-5-ylmethyl)-38a-(1H-indol-3-ylmethyl)-19,28,53a,56a-tetramethyl-57-(2-methylpropyl)-39-(2-methylsulfanylethyl)-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,21,22a,24,25a,27,28a,30,31a,34a,37a,38,40a,41,43a,44,47,49a,50,52a,53,55a,56,58a,59,61a,62,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-33,34,63a,64a,67a,68a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,20,21a,23,24a,26,27a,29,30a,33a,36a,37,39a,40,42a,43,46,48a,49,51a,52,54a,55,57a,58,60a,61,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazapentacyclo[85.74.4.448,111.04,8.0144,148]nonahexacontahectane-36-carbonyl]amino]-3-hydroxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]butanedioic acid | Plasma kallikrein | ECALLANTIDE | CAS RN:460738-38-9"
+BMGC_DG01962,BMG_DG015844,"NDC:73070-403 | CID 118984462 | UNII:54Q18076QB | NDC:0169-2660 | NDC:50090-7175 | NDC:0169-2911 | NDC:73070-503 | NDC:50090-3491 | PubChem SID:375084087 | NDC:0169-2550 | NDC:50090-7077 | 16-[[(1S)-4-[[(5S)-5-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74R,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-47-[[(1S)-3-amino-1-carboxy-3-oxopropyl]carbamoyl]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2S)-butan-2-yl]-24,56-bis(2-carboxyethyl)-83-[(1R)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-4-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-carboxypentyl]amino]-1-carboxy-4-oxobutyl]amino]-16-oxohexadecanoic acid | NDC:50090-7094 | CAS RN:844439-96-9 | PubChem CID:118984462 | INSULIN DEGLUDEC | NDC:0169-2662 | NDC:73070-400 | NDC:50090-7176"
+BMGC_DG01963,BMG_DG015847,"PubChem CID:118984465 | DrugBank ID:DB06290 | (1R,4R,7Z,15R,17R)-N-cyclopropylsulfonyl-17-[7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-13-methyl-2,14-dioxo-3,13-diazatricyclo[13.3.0.04,6]octadec-7-ene-4-carboxamide | CAS RN:923604-59-5"
+BMGC_DG01964,BMG_DG015855,"3,4-Dichlorobenzyl mercaptan | PubChem CID:118986 | CAS RN:36480-40-7 | PubChem SID:485662954 | UNII:T5L72N5A3X | 3,4-DICHLOROBENZYL MERCAPTAN"
+BMGC_DG01965,BMG_DG015858,Bismuth subcitrate potassium | PubChem CID:118987133 | DrugBank ID:DB09275
+BMGC_DG01966,BMG_DG015910,UNII:2ACZ6IPC6I | PubChem SID:175265385 | NDC:44911-0558 | NDC:44911-0002 | CAS RN:56-12-2 | NDC:43742-1277 | NDC:44911-0672 | NDC:44911-0584 | NDC:43742-2051 | NDC:71742-0001 | 4-aminobutanoic acid | NDC:63479-1142 | NDC:43742-1591 | NDC:43742-1486 | NDC:43857-0149 | NDC:83027-0032 | NDC:60564-0003 | NDC:44911-0649 | NDC:43742-1589 | .GAMMA.-AMINOBUTYRIC ACID | Gamma-Aminobutyric Acid | CAS RN:20-79-1 | NDC:50181-0041 | gamma-Aminobutyric acid | DrugBank ID:DB02530 | NDC:43742-2201 | NDC:43742-1372 | NDC:43857-0123 | NDC:62185-0051 | NDC:43742-1423 | NDC:43742-1449 | NDC:44911-0527 | NDC:44911-0710 | NDC:43853-0032 | PubChem CID:119
+BMGC_DG01967,BMG_DG016157,"BW-373U86, (±)- | PubChem SID:472406414 | BW-373U86, (+/-)- | CAS RN:150428-54-9 | PubChem CID:119029 | UNII:RR2QFN29K7"
+BMGC_DG01968,BMG_DG016162,"UNII:D5EQV23TDS | PubChem CID:119031 | PubChem SID:198945327 | DrugBank ID:DB00786 | MARIMASTAT | (2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide | Marimastat | CAS RN:154039-60-8"
+BMGC_DG01969,BMG_DG016164,[3-(nitrooxymethyl)phenyl] 2-acetyloxybenzoate | Nitroaspirin | DrugBank ID:DB12445 | UNII:EH04H13L6B | NCX-4016 | PubChem SID:255509337 | PubChem CID:119032 | CAS RN:175033-36-0
+BMGC_DG01970,BMG_DG016165,"PRUNASIN | CAS RN:99-18-3 | UNII:14W4BPM5FB | PubChem CID:119033 | (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyacetonitrile | PubChem SID:198946195 | Prunasin"
+BMGC_DG01971,BMG_DG016166,"UNII:9PA5A687X5 | PubChem SID:198945856 | PubChem CID:119034 | (1S,2R,4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid | ASIATIC ACID | Asiatic Acid | DrugBank ID:DB14054 | CAS RN:464-92-6"
+BMGC_DG01972,BMG_DG016174,TAURINE HYODEOXYCHOLATE | PubChem SID:316909923 | UNII:D6V086EMME | PubChem CID:119046 | CAS RN:2958-04-5
+BMGC_DG01973,BMG_DG016178,CAS RN:5778-80-3 | PubChem CID:119053 | 7-MEOTA | UNII:H6LUF2H8W4 | PubChem SID:445499641
+BMGC_DG01974,BMG_DG016179,"UNII:NHM754Q310 | (1R,2R,3S,4S,5R,6S)-7-oxabicyclo[4.1.0]heptane-2,3,4,5-tetrol | CAS RN:6090-95-5 | CONDURITOL B EPOXIDE | Conduritol b epoxide | PubChem CID:119054 | CAS RN:133319-97-8 | PubChem SID:198954720"
+BMGC_DG01975,BMG_DG016180,"PubChem CID:119055 | DrugBank ID:DB04400 | L-erythro-7,8-dihydrobiopterin"
+BMGC_DG01976,BMG_DG016191,"PubChem CID:119057475 | (1r)-1-[(4-{[(6,7-Dihydro[1,4]dioxino[2,3-C]pyridazin-3-Yl)methyl]amino}piperidin-1-Yl)methyl]-9-Fluoro-1,2-Dihydro-4h-Pyrrolo[3,2,1-Ij]quinolin-4-One | GSK-945237 | PubChem SID:377308114 | DrugBank ID:DB15345 | CAS RN:944406-54-6 | UNII:U9T63BZ3AS | (3R)-3-[[4-(6,7-dihydro-[1,4]dioxino[2,3-c]pyridazin-3-ylmethylamino)piperidin-1-yl]methyl]-5-fluoro-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12),9-tetraen-11-one"
+BMGC_DG01977,BMG_DG016276,"Voxzogo | UNII:7SE5582Q2P | PubChem SID:375085962 | VOSORITIDE | CAS RN:1480724-61-5 | PubChem CID:119058036 | (4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,43S,49S,52R)-52-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-5-amino-5-oxo-2-[[2-[[(2S)-pyrrolidine-2-carbonyl]amino]acetyl]amino]pentanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]hexanoyl]amino]acetyl]amino]propanoyl]amino]-4-oxobutanoyl]amino]hexanoyl]amino]hexanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]acetyl]amino]-40-(4-aminobutyl)-49-benzyl-28-[(2S)-butan-2-yl]-31-(3-carbamimidamidopropyl)-34-(carboxymethyl)-16,22-bis(hydroxymethyl)-10,37,43-tris(2-methylpropyl)-19-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carboxylic acid"
+BMGC_DG01978,BMG_DG016346,"DrugBank ID:DB08032 | N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE | PubChem CID:1190625"
+BMGC_DG01979,BMG_DG016352,CAS RN:15447-05-9 | UNII:9C67W47A7M | VIOXANTHIN | PubChem SID:252164363 | PubChem CID:119072
+BMGC_DG01980,BMG_DG016357,RUTHENIUM TETROXIDE | PubChem CID:119079 | UNII:97E960G9RP | CAS RN:20427-56-9 | PubChem SID:198964433
+BMGC_DG01981,BMG_DG016402,Thiodigalactoside | DrugBank ID:DB04396 | PubChem CID:119138
+BMGC_DG01982,BMG_DG016403,"(R)-Mandelic acid | UNII:PPL7YW1M9W | DrugBank ID:DB02280 | CAS RN:611-71-2 | PubChem SID:198935146 | PubChem CID:11914 | MANDELIC ACID, (R)-"
+BMGC_DG01983,BMG_DG016405,"UNII:5U54JM2T8G | PubChem CID:119146 | 8-[4-(4-fluorophenyl)-4-oxobutyl]-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | CAS RN:87539-19-3 | 3-N-Methylspiperone | MESPIPERONE | PubChem SID:363908475"
+BMGC_DG01984,BMG_DG016406,PHENYLGLYOXYLIC ACID | PubChem CID:11915 | PubChem SID:198990613 | Benzoylformic Acid | CAS RN:611-73-4 | DrugBank ID:DB02279 | UNII:2PZL5A0W0M
+BMGC_DG01985,BMG_DG016415,"DrugBank ID:DB09235 | UNII:40ZTP2T37Q | PubChem SID:198942378 | 2-(N-benzylanilino)ethyl 5-(5,5-dimethyl-2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate | PubChem CID:119171 | CAS RN:111011-63-3 | EFONIDIPINE | Efonidipine"
+BMGC_DG01986,BMG_DG016420,"NDC:68083-386 | DrugBank ID:DB00631 | CAS RN:123318-82-1 | NDC:0955-1746 | NDC:43598-309 | NDC:49315-003 | PubChem CID:119182 | CLOFARABINE | Clofarabine | (2R,3R,4S,5R)-5-(6-amino-2-chloropurin-9-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-ol | NDC:70121-1236 | PubChem SID:175265795 | NDC:63323-572 | NDC:60505-6166 | UNII:762RDY0Y2H | NDC:55150-326 | NDC:67457-546 | NDC:0024-5860 | NDC:71288-128 | NDC:72266-108"
+BMGC_DG01987,BMG_DG016425,"UNII:5JBP4SI96H | PubChem SID:198956518 | CAS RN:146362-70-1 | PubChem CID:119192 | CAS RN:113158-35-3 | DrugBank ID:DB06455 | 2-[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid | MECLINERTANT | Meclinertant"
+BMGC_DG01988,BMG_DG016426,"DrugBank ID:DB12162 | HX-1171 | 1-O-Hexyl-2,3,5-trimethylhydroquinone | 4-hexoxy-2,3,6-trimethylphenol | CAS RN:148081-72-5 | PubChem SID:198962338 | UNII:70BK60I8RP | PubChem CID:119193"
+BMGC_DG01989,BMG_DG016429,"PubChem SID:317229439 | PubChem CID:119198 | (3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-ol | ESEROLINE | CAS RN:469-22-7 | Eseroline | UNII:Q22H41O18D"
+BMGC_DG01990,BMG_DG016432,PubChem SID:198965474 | DrugBank ID:DB08619 | TESTOSTERONE SUCCINATE | CAS RN:521-15-3 | UNII:4114I54YIH | PubChem CID:119202 | Testosterone succinate
+BMGC_DG01991,BMG_DG016434,"Matairesinol | DrugBank ID:DB04200 | PubChem SID:381608366 | UNII:XLW63P8WUA | (3R,4R)-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one | PubChem CID:119205 | MATAIRESINOL | CAS RN:580-72-3"
+BMGC_DG01992,BMG_DG016439,"3,4-Dihydroxyphenylacetaldehyde | PubChem SID:474493907 | PubChem CID:119219 | DOPAL | CAS RN:5707-55-1 | Dopal | 2-(3,4-dihydroxyphenyl)acetaldehyde | UNII:F2E9Q24TSL"
+BMGC_DG01993,BMG_DG016441,CAS RN:5725-89-3 | 7-Methoxyresorufin | PubChem CID:119220 | 7-methoxyphenoxazin-3-one
+BMGC_DG01994,BMG_DG016448,"PubChem CID:11923097 | (1S,2R,3S,4R)-3-(4-methylpiperazine-1-carbonyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid"
+BMGC_DG01995,BMG_DG016461,CAS RN:612-58-8 | PubChem SID:198966499 | 3-Methylquinoline | 3-methylquinoline | UNII:1YC9RBW2G0 | PubChem CID:11926 | 3-METHYLQUINOLINE
+BMGC_DG01996,BMG_DG016464,CAS RN:136271-60-8 | 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-hydroxybutyl]piperidin-4-ol | Reduced haloperidol | PubChem SID:472404621 | CAS RN:34104-67-1 | DIHYDROHALOPERIDOL | UNII:D9M1Q7KW8U | PubChem CID:119265
+BMGC_DG01997,BMG_DG016465,"CAS RN:37831-70-2 | (6aR,11aR)-10-(3-methylbut-2-enyl)-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromene-3,9-diol | Phaseollidin | PubChem CID:119268"
+BMGC_DG01998,BMG_DG016478,PubChem CID:119303 | UNII:97TZA8ANPC | CAS RN:74135-04-9 | Morphiceptin | PubChem SID:198983265 | (2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide | MORPHICEPTIN
+BMGC_DG01999,BMG_DG016492,"PubChem SID:461433879 | UNII:5UDJ46528K | CAS RN:103782-08-7 | N-[(2S,3R,4S,5S,6R)-2-[(2R,3S,4S,5R,6R)-6-[[(3aR,4R,5R,6S,6aS)-2-(dimethylamino)-4-hydroxy-6-(hydroxymethyl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d][1,3]oxazol-5-yl]oxy]-5-acetamido-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | DrugBank ID:DB04628 | PubChem CID:119339 | Allosamidin | ALLOSAMIDIN"
+BMGC_DG02000,BMG_DG016494,"(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid | Npc-567 | PubChem SID:198974654 | UNII:DV64B0PLEH | NPC-567 | CAS RN:109333-26-8 | PubChem CID:119343"
+BMGC_DG02001,BMG_DG016502,"UNII:KFR8EX22KX | PubChem SID:485665592 | AF-DX-384 | CAS RN:118290-26-9 | N-[2-[2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxo-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide | CAS RN:118290-27-0 | PubChem CID:119357"
+BMGC_DG02002,BMG_DG016509,"PubChem SID:485660907 | UNII:QUJ5KNX7DW | 1-CYCLOPROPYL-6,8-DIFLUORO-1,4-DIHYDRO-7-(4-HYDROXYPHENYL)-4-OXO-3-QUINOLINECARBOXYLIC ACID | CAS RN:136440-70-5 | 1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-(4-hydroxyphenyl)-4-oxo-3-quinolinecarboxylic acid | PubChem CID:119367"
+BMGC_DG02003,BMG_DG016511,"CAS RN:137975-06-5 | MOZAVAPTAN | Mozavaptan | N-[4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]phenyl]-2-methylbenzamide | PubChem SID:198950536 | UNII:17OJ42922Y | PubChem CID:119369"
+BMGC_DG02004,BMG_DG016513,"DrugBank ID:DB04881 | CAS RN:143664-11-3 | N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10H-acridine-4-carboxamide | PubChem CID:119373 | ELACRIDAR | PubChem SID:198951619 | UNII:N488540F94 | Elacridar"
+BMGC_DG02005,BMG_DG016516,"PubChem CID:119376 | 1H-Indole-3-carboxylic acid, 1-methyl-, (1-(2-((methylsulfonyl)amino)ethyl)-4-piperidinyl)methyl ester | UNII:ZT350OYT3I | PubChem SID:198975756 | GR-113808 | CAS RN:144625-51-4 | [1-[2-(methanesulfonamido)ethyl]piperidin-4-yl]methyl 1-methylindole-3-carboxylate"
+BMGC_DG02006,BMG_DG016519,"UNII:B9I6MZL7BW | ABT-418 | PubChem CID:119380 | CAS RN:147402-53-7 | PubChem SID:272993923 | 3-methyl-5-[(2S)-1-methylpyrrolidin-2-yl]-1,2-oxazole | 3-Methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole"
+BMGC_DG02007,BMG_DG016524,Octanoate | octanoate | PubChem CID:119389 | CAS RN:74-81-7
+BMGC_DG02008,BMG_DG016527,"(2R)-2-amino-3-(1,3-benzothiazol-2-ylsulfanyl)propanoic acid | S-(2-benzothiazolyl)cysteine | CAS RN:399-82-6 | PubChem CID:119392"
+BMGC_DG02009,BMG_DG016530,"UNII:0YQK3WBH32 | DrugBank ID:DB13175 | PubChem CID:119396 | RHEIN-9-ANTHRONE | PubChem SID:376072059 | Rheinanthrone | CAS RN:480-09-1 | Rhein-9-anthrone | 4,5-dihydroxy-10-oxo-9H-anthracene-2-carboxylic acid"
+BMGC_DG02010,BMG_DG016537,"5,6-DIHYDROXY-1H-INDOLE-2-CARBOXYLIC ACID | PubChem CID:119405 | 5,6-Dihydroxyindole-2-Carboxylic Acid | CAS RN:4790-08-3 | 5,6-dihydroxy-1H-indole-2-carboxylic acid | PubChem SID:472408886 | UNII:S6M6LZR326"
+BMGC_DG02011,BMG_DG016540,UNII:22OAC2MO2S | CAS RN:5961-85-3 | TRIS(2-CARBOXYETHYL)PHOSPHINE | Tris(2-carboxyethyl)phosphine | PubChem CID:119411 | CAS RN:115290-70-5 | PubChem SID:198943600 | 3-[bis(2-carboxyethyl)phosphanyl]propanoic acid
+BMGC_DG02012,BMG_DG016559,9-oxo-6-propan-2-yloxyxanthene-2-carboxylic acid | UNII:NU957VN2AW | 6-ISOPROPOXY-9-OXOXANTHENE-2-CARBOXYLIC ACID | 6-Isopropoxy-9-oxoxanthene-2-carboxylic acid | PubChem CID:119461 | CAS RN:33458-93-4 | PubChem SID:485660880
+BMGC_DG02013,BMG_DG016578,METHYL ECGONIDINE | CAS RN:43021-26-7 | PubChem CID:119478 | PubChem SID:198980820 | UNII:58C337KP3E
+BMGC_DG02014,BMG_DG016583,"CAS RN:136199-02-5 | PubChem SID:198942140 | 1H-Purine-2,6-dione, 8-(hexahydro-2,5-methanopentalen-3a(1H)-yl)-3,7-dihydro-1,3-dipropyl- | DrugBank ID:DB12670 | 1,3-dipropyl-8-[(1R,5S)-3-tricyclo[3.3.1.03,7]nonanyl]-7H-purine-2,6-dione | ROLOFYLLINE | PubChem CID:11948288 | Rolofylline | UNII:7805S5HIHX"
+BMGC_DG02015,BMG_DG016604,"PubChem SID:198945623 | DrugBank ID:DB09038 | CAS RN:864070-44-0 | UNII:HDC1R2M35U | EMPAGLIFLOZIN | (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | PubChem CID:11949646 | Empagliflozin"
+BMGC_DG02016,BMG_DG016605,"PubChem SID:198988098 | Teneligliptin | CAS RN:760937-92-6 | PubChem CID:11949652 | CAS RN:906093-29-6 | [(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone | DrugBank ID:DB11950 | UNII:28ZHI4CF9C | TENELIGLIPTIN"
+BMGC_DG02017,BMG_DG016611,DrugBank ID:DB04714 | CAS RN:358-71-4 | ISOPENTENYL PYROPHOSPHATE | Isopentenyl pyrophosphate | PubChem CID:1195 | 3-methylbut-3-enyl phosphono hydrogen phosphate | PubChem SID:474490021 | UNII:LSC8849M7B
+BMGC_DG02018,BMG_DG016613,BELUMOSUDIL | Belumosudil | CAS RN:911417-87-3 | PubChem SID:198961955 | UNII:834YJF89WO | 2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-propan-2-ylacetamide | PubChem CID:11950170
+BMGC_DG02019,BMG_DG016618,"PubChem CID:119507 | 5-ethyl-5-(4-hydroxyphenyl)-3-methylimidazolidine-2,4-dione | CAS RN:61837-65-8 | 5-Ethyl-5-(4-hydroxyphenyl)-3-methylimidazolidine-2,4-dione"
+BMGC_DG02020,BMG_DG016619,"(1S,3aS,3bS,5aR,9aS,9bS,11aS)-8-fluoro-N-(1H-imidazo[4,5-b]pyridin-2-ylmethyl)-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,9b,10,11-decahydro-1H-indeno[5,4-f]quinoline-1-carboxamide | CAS RN:606101-58-0 | PubChem CID:11950726 | UNII:5730VNW22X | PubChem SID:198971998 | MK-0773"
+BMGC_DG02021,BMG_DG016622,2-Aminoacetophenone | CAS RN:613-89-8 | PHENACYLAMINE | PubChem CID:11952 | 2-amino-1-phenylethanone | UNII:4M571C83H7 | PubChem SID:198956155
+BMGC_DG02022,BMG_DG016623,"2,2-dichlorooxirane | PubChem SID:461434912 | PubChem CID:119521 | UNII:7L2MY8DN4Q | CAS RN:68226-83-5 | 2,2-DICHLOROOXIRANE | 1,1-Dichloroethylene epoxide"
+BMGC_DG02023,BMG_DG016626,"5-bromo-18-methoxy-10-methyl-16-oxa-2,10,21,23-tetrazatetracyclo[15.6.2.03,8.020,24]pentacosa-1(23),3(8),4,6,17,19,21,24-octaene | JNJ-26483327 | UNII:16720VER1H | PubChem CID:11952856 | PubChem SID:383470541 | Jnj-26483327 | CAS RN:807640-87-5"
+BMGC_DG02024,BMG_DG016627,"PubChem CID:11952901 | PubChem SID:443624303 | CAS RN:35162-01-7 | 3,4,5-TRIBROMO-2-(2,4-DIBROMOPHENOXY)PHENOL | UNII:B1LB95ZSV8"
+BMGC_DG02025,BMG_DG016628,"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid | PubChem CID:11952989 | DrugBank ID:DB07837"
+BMGC_DG02026,BMG_DG016630,"CAS RN:911637-19-9 | 1-[(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-7-yl]-4-oxobutyl]-5,5-difluoropiperidin-2-one | UNII:5DHU18M5D6 | Gemigliptin | PubChem SID:198989555 | DrugBank ID:DB12412 | PubChem CID:11953153 | GEMIGLIPTIN"
+BMGC_DG02027,BMG_DG016633,"CAS RN:286936-40-1 | Otx-008 | UNII:8JI63CFH5V | PubChem CID:11953346 | PubChem SID:312525062 | OTX-008 | DrugBank ID:DB13123 | N-[2-(dimethylamino)ethyl]-2-[[26,27,28-tris[2-[2-(dimethylamino)ethylamino]-2-oxoethoxy]-25-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaenyl]oxy]acetamide"
+BMGC_DG02028,BMG_DG016637,PubChem CID:119537 | 3-Aminonorharman | 3-AMINONORHARMAN | UNII:89GRX55RRD | CAS RN:73834-77-2 | PubChem SID:478836805
+BMGC_DG02029,BMG_DG016646,"PubChem CID:11953816 | PubChem SID:198944042 | PALMITOYL CARNITINE, (-)- | UNII:1G38O5K038 | L-Palmitoylcarnitine | (3R)-3-hexadecanoyloxy-4-(trimethylazaniumyl)butanoate | CAS RN:2364-67-2"
+BMGC_DG02030,BMG_DG016657,"DrugBank ID:DB00646 | Nystatin | PubChem CID:11953884 | (21E,23E,25E,27E,31E,33E)-20-[(3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-4,6,8,11,12,16,18,36-octahydroxy-35,37,38-trimethyl-2,14-dioxo-1-oxacyclooctatriaconta-21,23,25,27,31,33-hexaene-17-carboxylic acid"
+BMGC_DG02031,BMG_DG016662,"CID 11953898 | CAS RN:13422-51-0 | cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate | PubChem CID:11953898"
+BMGC_DG02032,BMG_DG016666,"methyl (1S,15S,17S,18S)-17-ethyl-6-[(1R,12R,14R,15E)-15-ethylidene-18-methoxycarbonyl-17-methyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate | DrugBank ID:DB04877 | CAS RN:3371-85-5 | Voacamine | PubChem CID:11953931"
+BMGC_DG02033,BMG_DG016683,UNII:WXG88DST4R | PubChem SID:198947090 | .BETA.-DIHYDROEQUILIN | PubChem CID:11954027 | CAS RN:3563-27-7
+BMGC_DG02034,BMG_DG016686,"(8S,9S,11S,13S,14S,17R)-17-ethynyl-11-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol | UNII:6923NT44OW | CAS RN:34816-55-2 | PubChem CID:11954041 | Moxestrol | MOXESTROL | PubChem SID:198973763 | DrugBank ID:DB13418"
+BMGC_DG02035,BMG_DG016728,CAS RN:3066-12-4 | PubChem CID:11954152 | UNII:LFI38P8752 | PubChem SID:318164000 | 11.ALPHA.-HYDROXYTESTOSTERONE
+BMGC_DG02036,BMG_DG016729,PubChem CID:11954153 | CAS RN:31084-38-5 | UNII:CRW83OBW6B | PubChem SID:198969435 | 1-DEHYDRO-7.ALPHA.-METHYLTESTOSTERONE
+BMGC_DG02037,BMG_DG016752,"(3S,7S,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | CAS RN:64907-22-8 | PubChem CID:11954197 | 7alpha,25-Dihydroxycholesterol"
+BMGC_DG02038,BMG_DG016789,"PubChem CID:11954293 | DrugBank ID:DB06216 | Asenapine | 5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole maleate | (Z)-but-2-enedioic acid;9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene | CAS RN:1449581-64-9"
+BMGC_DG02039,BMG_DG016798,"UNII:ZS6D2ITA30 | PubChem CID:11954310 | BOLDENONE UNDECYLENATE | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] undec-10-enoate | CAS RN:13103-34-9 | Boldenone Undecylenate | PubChem SID:198963429 | DrugBank ID:DB14639"
+BMGC_DG02040,BMG_DG016828,"PubChem CID:11954353 | PubChem SID:198976475 | CAS RN:4258-85-9 | CLOCORTOLONE ACETATE | DrugBank ID:DB14652 | Clocortolone acetate | [2-[(6S,8S,9R,10S,11S,13S,14S,16R,17S)-9-chloro-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | UNII:85061HTR8T"
+BMGC_DG02041,BMG_DG016840,"CAS RN:2607-06-9 | PubChem SID:198959401 | Difluocortolone | UNII:K253365DXI | DrugBank ID:DB09095 | (6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one | DIFLUCORTOLONE | Diflucortolone | PubChem CID:11954369"
+BMGC_DG02042,BMG_DG016847,DrugBank ID:DB06159 | Rubitecan | PubChem CID:11954380
+BMGC_DG02043,BMG_DG016861,CAS RN:87627-28-9 | 3-Methyl-2-(3-pyridyl)-1-indoleoctanoic acid | PubChem CID:119553 | UNII:GDV947F7UO | CGS-12970 | 8-(3-methyl-2-pyridin-3-ylindol-1-yl)octanoic acid | PubChem SID:348481804
+BMGC_DG02044,BMG_DG016864,PubChem CID:11955614 | PQ-10 | UNII:63643I762J | PubChem SID:198980121 | DrugBank ID:DB08391 | CAS RN:927691-21-2
+BMGC_DG02045,BMG_DG016866,"UNII:Q7Y33N57ZZ | Onalespib | DrugBank ID:DB06306 | ONALESPIB | CAS RN:912999-49-6 | PubChem CID:11955716 | PubChem SID:198982137 | (2,4-dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone"
+BMGC_DG02046,BMG_DG016867,RABUSERTIB | DrugBank ID:DB11662 | PubChem SID:198976853 | PubChem CID:11955855 | CAS RN:911222-45-2 | 1-[5-bromo-4-methyl-2-[[(2S)-morpholin-2-yl]methoxy]phenyl]-3-(5-methylpyrazin-2-yl)urea | UNII:3S9L1NU6U7 | Rabusertib
+BMGC_DG02047,BMG_DG016880,"PubChem SID:198988224 | (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine;dihydrochloride | Pramipexole Dihydrochloride | CAS RN:104632-25-9 | UNII:4R2HD0M28N | PRAMIPEXOLE DIHYDROCHLORIDE ANHYDROUS | PubChem CID:119569"
+BMGC_DG02048,BMG_DG016882,"(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine | CAS RN:556801-24-2 | PubChem SID:175266401 | PubChem CID:119570 | Pramipexole | PRAMIPEXOLE | CAS RN:104632-26-0 | DrugBank ID:DB00413 | UNII:83619PEU5T"
+BMGC_DG02049,BMG_DG016884,2-[2-(4-Chloro-Phenylsulfanyl)-Acetylamino]-3-(4-Guanidino-Phenyl)-Propionamide | PubChem CID:11957380 | DrugBank ID:DB07105
+BMGC_DG02050,BMG_DG016885,"DrugBank ID:DB07248 | 7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE | PubChem CID:11957393"
+BMGC_DG02051,BMG_DG016888,"DrugBank ID:DB07471 | PubChem CID:11957417 | 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE"
+BMGC_DG02052,BMG_DG016902,"5-(methylamino)-2-[[(2S,3R,5R,6S,8R,9R)-3,5,9-trimethyl-2-[(2S)-1-oxo-1-(1H-pyrrol-2-yl)propan-2-yl]-1,7-dioxaspiro[5.5]undecan-8-yl]methyl]-1,3-benzoxazole-4-carboxylic acid | UNII:37H9VM9WZL | PubChem SID:198974685 | CALCIMYCIN | CAS RN:52665-69-7 | Calcimycin | CAS RN:79646-37-0 | PubChem CID:11957499"
+BMGC_DG02053,BMG_DG016922,UNII:L6WNM6ZP7X | PubChem CID:11957573 | CAS RN:32385-58-3 | IMETIT DIHYDROBROMIDE
+BMGC_DG02054,BMG_DG016965,"PubChem SID:438787727 | (3R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO(1,2,4)TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)BUTAN-1-ONE | CAS RN:945261-48-3 | 5-DESFLUORO SITAGLIPTIN | PubChem CID:11957945 | UNII:IP5PMS7GWY"
+BMGC_DG02055,BMG_DG016970,PubChem SID:474489457 | PubChem CID:119582 | JORO SPIDER TOXIN | UNII:MPT5X293RB | CAS RN:112163-33-4 | Joro Spider Toxin
+BMGC_DG02056,BMG_DG016973,PubChem CID:119584 | UNII:I8MFJ1C0BY | DrugBank ID:DB11675 | PubChem SID:198983789 | Mosapride | 4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide | MOSAPRIDE | CAS RN:112885-41-3
+BMGC_DG02057,BMG_DG016977,"CAS RN:120444-71-5 | PubChem SID:198935447 | PubChem CID:119590 | DERAMCICLANE | Deramciclane | N,N-dimethyl-2-[[(1R,2S,4R)-1,7,7-trimethyl-2-phenyl-2-bicyclo[2.2.1]heptanyl]oxy]ethanamine | DrugBank ID:DB06512 | UNII:O5KFK61E74"
+BMGC_DG02058,BMG_DG016990,CAS RN:912444-00-9 | DrugBank ID:DB07232 | VELIPARIB | 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide | Veliparib | PubChem SID:198953538 | PubChem CID:11960529 | UNII:01O4K0631N
+BMGC_DG02059,BMG_DG016991,"PubChem CID:119607 | Valdecoxib | VALDECOXIB | PubChem SID:175268083 | UNII:2919279Q3W | CAS RN:181695-72-7 | 4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide | DrugBank ID:DB00580"
+BMGC_DG02060,BMG_DG016994,DrugBank ID:DB12725 | PubChem CID:11961293 | Felcisetrag | UNII:35F0Y2W16Q | CAS RN:916075-84-8 | methyl 4-[[4-[[(2-propan-2-yl-1H-benzimidazole-4-carbonyl)amino]methyl]piperidin-1-yl]methyl]piperidine-1-carboxylate | FELCISETRAG | PubChem SID:312524889
+BMGC_DG02061,BMG_DG017014,NDC:71699-025 | NDC:71699-150 | DrugBank ID:DB06119 | [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate | NDC:71699-050 | NDC:71699-200 | NDC:71699-100 | Cenobamate | CENOBAMATE | PubChem CID:11962412 | UNII:P85X70RZWS | PubChem SID:252165509 | CAS RN:913088-80-9
+BMGC_DG02062,BMG_DG017017,"DrugBank ID:DB12100 | UNII:QXA167CM6F | ABEDITEROL | Abediterol | 5-[(1R)-2-[6-(2,2-difluoro-2-phenylethoxy)hexylamino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one | PubChem SID:198947200 | PubChem CID:11962616 | CAS RN:915133-65-2"
+BMGC_DG02063,BMG_DG017028,DrugBank ID:DB08635 | PubChem CID:11963512 | N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID
+BMGC_DG02064,BMG_DG017029,"PubChem CID:11963546 | DrugBank ID:DB08099 | 6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine"
+BMGC_DG02065,BMG_DG017030,"PubChem CID:11963551 | DrugBank ID:DB08292 | (5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE"
+BMGC_DG02066,BMG_DG017031,"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE | PubChem CID:11963552 | DrugBank ID:DB08293"
+BMGC_DG02067,BMG_DG017032,"PubChem CID:11963557 | 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE | DrugBank ID:DB07186"
+BMGC_DG02068,BMG_DG017037,Nitroprusside | PubChem CID:11963622 | Pentacyano(nitroso)iron(2-) | CAS RN:15078-28-1 | iron(4+);nitroxyl anion;pentacyanide | DrugBank ID:DB00325
+BMGC_DG02069,BMG_DG017042,Dimethyl Propionate Ester Heme | DrugBank ID:DB04009 | PubChem CID:11963944
+BMGC_DG02070,BMG_DG017047,PubChem CID:11964036 | CAS RN:881375-00-4 | PubChem SID:443623454 | UNII:LM6DZS6PYA | KU-0060648
+BMGC_DG02071,BMG_DG017056,"DrugBank ID:DB11611 | LIFITEGRAST | Lifitegrast | CAS RN:1025967-78-5 | PubChem SID:198983601 | (2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid | UNII:038E5L962W | PubChem CID:11965427"
+BMGC_DG02072,BMG_DG017058,"PubChem CID:11965767 | UNII:S9Y83SS7PQ | 1-Pentanol, 2-[[2-aMino-5-[[(1S)-1-phenylethyl]thio]thiazolo[4,5-d]pyriMidin-7-yl]aMino]-4-Methyl-, (2R)- | CAS RN:911715-90-7 | (2R)-2-[[2-amino-5-[(1S)-1-phenylethyl]sulfanyl-[1,3]thiazolo[4,5-d]pyrimidin-7-yl]amino]-4-methylpentan-1-ol | AZD-8797"
+BMGC_DG02073,BMG_DG017073,"PubChem CID:11966124 | Tetradecanoyl-coa | DrugBank ID:DB02180 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] tetradecanethioate | Myristoyl-Coa | CAS RN:3130-72-1"
+BMGC_DG02074,BMG_DG017137,"DrugBank ID:DB08396 | 4-{[(Z)-(5-oxo-2-phenyl-1,3-oxazol-4(5H)-ylidene)methyl]amino}butanoic acid | PubChem CID:11967789"
+BMGC_DG02075,BMG_DG017138,"1,2-Benzoxazol-3-ylmethanesulfonimidic acid | 1,2-benzoxazol-3-ylmethanesulfonimidic acid | PubChem CID:11967800"
+BMGC_DG02076,BMG_DG017139,"Cardiogreen | CAS RN:3599-32-4 | sodium;4-[(2E)-2-[(2E,4E,6E)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-3-ium-2-yl]hepta-2,4,6-trienylidene]-1,1-dimethylbenzo[e]indol-3-yl]butane-1-sulfonate | Indocyanine green acid form | DrugBank ID:DB09374 | PubChem CID:11967809"
+BMGC_DG02077,BMG_DG017140,Protoporphyrin Ix Containing Co | PubChem CID:11967905 | DrugBank ID:DB02110
+BMGC_DG02078,BMG_DG017143,"PubChem CID:11968014 | Scopolamine | [(1R,2S,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate | CAS RN:51-34-3"
+BMGC_DG02079,BMG_DG017146,"CAS RN:139891-98-8 | PubChem CID:11968389 | PubChem SID:383470450 | 3',6-DISINAPOYLSUCROSE | UNII:XNG7ST1C16"
+BMGC_DG02080,BMG_DG017171,CAS RN:614-75-5 | UNII:UK3R9Q59AV | PubChem SID:198941762 | 2-HYDROXYPHENYLACETIC ACID | PubChem CID:11970 | 2-Hydroxyphenylacetic acid | 2-(2-hydroxyphenyl)acetic acid
+BMGC_DG02081,BMG_DG017245,"PubChem SID:472407956 | UNII:FYA63XE34E | 6-(3-CHLORO-2-NAPHTHALENYL)-1,3,5-TRIAZINE-2,4-DIAMINE | PubChem CID:11971100 | CAS RN:92616-27-8"
+BMGC_DG02082,BMG_DG017281,Brulidine | PubChem CID:11973 | 3-bromo-4-[3-(2-bromo-4-carbamimidoylphenoxy)propoxy]benzenecarboximidamide;2-hydroxyethanesulfonic acid
+BMGC_DG02083,BMG_DG017285,"PubChem CID:11973736 | CAS RN:867331-82-6 | PubChem SID:198962314 | [4-chloro-3-[5-methyl-3-[4-(2-pyrrolidin-1-ylethoxy)anilino]-1,2,4-benzotriazin-7-yl]phenyl] benzoate | DrugBank ID:DB05075 | UNII:1VZO7A0J9S | 4-Chloro-3-(5-methyl-3-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)benzo[e][1,2,4]triazin-7-yl)phenyl benzoate | TG-100801"
+BMGC_DG02084,BMG_DG017286,PubChem SID:346537593 | CAS RN:862310-66-5 | PubChem CID:11973780 | UNII:D8A4Z52D1J | MK-3134 | 3-[4-(1-cyclobutylpiperidin-4-yl)oxyphenyl]-2-methyl-5-(trifluoromethyl)quinazolin-4-one
+BMGC_DG02085,BMG_DG017287,PubChem CID:11974 | PubChem SID:198969771 | 3-bromo-4-[3-(2-bromo-4-carbamimidoylphenoxy)propoxy]benzenecarboximidamide | CAS RN:496-00-4 | Dibrompropamidine | UNII:269M3QL74S | DrugBank ID:DB13548 | DIBROMPROPAMIDINE
+BMGC_DG02086,BMG_DG017289,PROP-2-YNYL 4-SULFAMOYLBENZOATE | Prop-2-ynyl 4-sulfamoylbenzoate | UNII:H2722SU8TH | PubChem CID:11974340 | PubChem SID:478838329 | CAS RN:915694-58-5
+BMGC_DG02087,BMG_DG017291,"PubChem CID:11974440 | Abt-341 | [(4R,5S)-5-amino-4-(2,4,5-trifluorophenyl)cyclohexen-1-yl]-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone | CAS RN:927206-35-7 | DrugBank ID:DB08044 | ABT-341 | CAS RN:913623-69-5"
+BMGC_DG02088,BMG_DG017309,"DACTOLISIB | PubChem CID:11977753 | Dactolisib | CAS RN:915019-65-7 | PubChem SID:198950726 | CAS RN:1028385-31-0 | UNII:RUJ6Z9Y0DT | 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile | DrugBank ID:DB11651"
+BMGC_DG02089,BMG_DG017311,"PubChem CID:11977989 | CAS RN:913978-37-7 | UNII:GH23A7L3EL | AMG-222 | DrugBank ID:DB06011 | Amg-222 | 2-[(2S)-2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]propyl]-6-N,6-N,13-N,13-N-tetramethyl-2-(2H-tetrazol-5-yl)tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene-6,13-dicarboxamide | PubChem SID:252319441"
+BMGC_DG02090,BMG_DG017313,PubChem CID:11978018 | UNII:0C9IQ6NHUX | PubChem SID:198941721 | CAS RN:915124-86-6 | TELMISARTAN AMIDE
+BMGC_DG02091,BMG_DG017320,"CAS RN:80246-24-8 | PubChem CID:11978695 | 2,3,4-TRIBROMO-6-(2,4-DIBROMOPHENOXY)PHENOL | PubChem SID:459055255 | UNII:75A72MZ8WK"
+BMGC_DG02092,BMG_DG017321,"BGT-226 FREE BASE | PubChem CID:11978790 | CAS RN:915020-55-2 | BGT-226 free base | 8-(6-methoxypyridin-3-yl)-3-methyl-1-[4-piperazin-1-yl-3-(trifluoromethyl)phenyl]imidazo[4,5-c]quinolin-2-one | UNII:ZXE7F2GMJJ | PubChem SID:198955571"
+BMGC_DG02093,BMG_DG017323,NDC:27241-204 | NDC:60219-1649 | NDC:60219-1651 | NDC:75929-273 | Brexpiprazole | 7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one | NDC:59148-036 | NDC:59148-038 | NDC:59148-040 | PubChem CID:11978813 | NDC:27241-207 | CAS RN:1427049-19-1 | NDC:60219-1650 | NDC:27241-205 | NDC:60219-1653 | UNII:2J3YBM1K8C | CAS RN:913611-97-9 | NDC:59148-039 | NDC:59148-037 | PubChem SID:198965857 | NDC:59148-035 | NDC:27241-209 | NDC:27241-208 | NDC:60219-1652 | BREXPIPRAZOLE | NDC:60219-1654 | DrugBank ID:DB09128 | NDC:27241-206
+BMGC_DG02094,BMG_DG017324,5-Methylbenzimidazole | DrugBank ID:DB03177 | PubChem SID:377307969 | 5-methylbenzimidazole | PubChem CID:11979 | 6-methyl-1H-benzimidazole | CAS RN:614-97-1 | 5-METHYLBENZIMIDAZOLE | UNII:R56855UC8Y
+BMGC_DG02095,BMG_DG017326,"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide | PubChem CID:11979006 | DrugBank ID:DB07875"
+BMGC_DG02096,BMG_DG017328,"Pituitrin | DrugBank ID:DB00067 | PubChem CID:11979316 | N-[6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide;1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide"
+BMGC_DG02097,BMG_DG017350,"PubChem SID:363908251 | UNII:9RW6G5D4MQ | Isocitric acid | PubChem CID:1198 | CAS RN:320-77-4 | ISOCITRIC ACID | 1-hydroxypropane-1,2,3-tricarboxylic acid"
+BMGC_DG02098,BMG_DG017363,"PubChem CID:119812 | UNII:WL47LGK6P8 | PubChem SID:445499688 | CAS RN:28075-29-8 | N-METHYL-3,3-DIPHENYLPROPYLAMINE"
+BMGC_DG02099,BMG_DG017375,"UNII:9TUW81Y3CE | PARECOXIB | PubChem CID:119828 | CAS RN:198470-84-7 | Parecoxib | PubChem SID:198980232 | N-[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonylpropanamide | DrugBank ID:DB08439"
+BMGC_DG02100,BMG_DG017379,"PubChem CID:11983 | 2H-INDEN-2-ONE, 1,3-DIHYDRO- | PubChem SID:198955382 | CAS RN:615-13-4 | 2-Indanone | 1,3-dihydroinden-2-one | UNII:0I79N673DE"
+BMGC_DG02101,BMG_DG017385,SB-699551DIHYDROCHLORIDE | UNII:XDC9VEX4CH | PubChem CID:11983346 | PubChem SID:474493998 | CAS RN:864741-95-7 | SB-699551dihydrochloride
+BMGC_DG02102,BMG_DG017394,BENZODROCORTISONE | PubChem CID:119845 | CAS RN:28956-89-0 | UNII:BCV386QGUZ | PubChem SID:329589322
+BMGC_DG02103,BMG_DG017404,"1,3-dihydrobenzimidazol-2-one | PubChem CID:11985 | CAS RN:102976-62-5 | 2-Hydroxybenzimidazole | 2-BENZIMIDAZOLINONE | CAS RN:615-16-7 | UNII:CV8118UZEW | PubChem SID:198984769"
+BMGC_DG02104,BMG_DG017414,"PubChem CID:11987556 | HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM | DrugBank ID:DB08218"
+BMGC_DG02105,BMG_DG017422,"DrugBank ID:DB07700 | PubChem CID:11987804 | 3-carboxamido-1,3,5(10)-estratrien-17(R)-spiro-2'(5',5'-dimethyl-6'oxo)tetrahydropyran"
+BMGC_DG02106,BMG_DG017426,"PubChem CID:11987846 | DrugBank ID:DB07757 | (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one"
+BMGC_DG02107,BMG_DG017427,"DrugBank ID:DB07026 | (1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE | PubChem CID:11987860"
+BMGC_DG02108,BMG_DG017428,"PubChem CID:11987861 | DrugBank ID:DB06990 | 4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID"
+BMGC_DG02109,BMG_DG017429,PubChem CID:11987868 | DrugBank ID:DB07280 | 5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE
+BMGC_DG02110,BMG_DG017430,"PubChem CID:11987874 | DrugBank ID:DB07792 | (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE"
+BMGC_DG02111,BMG_DG017431,"DrugBank ID:DB08153 | (5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE | PubChem CID:11987878"
+BMGC_DG02112,BMG_DG017432,"(2-((3-NITROPHENYL)CARBONYLAMINO)-1-(3-OXIDANYLPROPYL)BENZIMIDAZOL-5-YL) 2,2-DIMETHYLPROPANOATE | PubChem CID:11987888 | PubChem SID:459056358 | DrugBank ID:DB08590 | 1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE | UNII:QOL8WS9UXV | CAS RN:509093-60-1"
+BMGC_DG02113,BMG_DG017434,PubChem CID:11988 | CAS RN:615-21-4 | UNII:JS4DO3CU7W | PubChem SID:377308272 | HYDRAZINOBENZOTHIAZOLE
+BMGC_DG02114,BMG_DG017456,"(2S,3R,4R,5S,6R)-2-[5-[(4-ethoxyphenyl)methyl]-2-methoxy-4-methylphenyl]-6-(hydroxymethyl)thiane-3,4,5-triol | CAS RN:898537-18-3 | PubChem SID:198974793 | DrugBank ID:DB12214 | Luseogliflozin | PubChem CID:11988953 | UNII:C596HWF74Z | LUSEOGLIFLOZIN"
+BMGC_DG02115,BMG_DG017479,"DrugBank ID:DB07728 | 2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE | PubChem CID:11992146"
+BMGC_DG02116,BMG_DG017489,"SETMELANOTIDE | (4R,7S,10S,13R,16S,19R,22R)-22-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carboxamide | Setmelanotide | CAS RN:1504602-49-6 | DrugBank ID:DB11700 | PubChem CID:11993702 | UNII:N7T15V1FUY | PubChem SID:198939692 | CAS RN:920014-72-8"
+BMGC_DG02117,BMG_DG017490,"DrugBank ID:DB06600 | PubChem SID:198948945 | NEMONOXACIN | Nemonoxacin | CAS RN:378746-64-6 | PubChem CID:11993740 | 7-[(3S,5S)-3-amino-5-methylpiperidin-1-yl]-1-cyclopropyl-8-methoxy-4-oxoquinoline-3-carboxylic acid | UNII:P94L0PVO94"
+BMGC_DG02118,BMG_DG017493,CAS RN:859239-19-3 | UNII:Q6K7NSL6B4 | 5-(3-PYRIDINYL)-2-FURANMETHANETHIOL | PubChem CID:11993866 | PubChem SID:441659442
+BMGC_DG02119,BMG_DG017494,(5-Phenylfuran-2-yl)methanamine | PubChem SID:482553896 | PubChem CID:11993871 | UNII:R3VMP2ZB9L | CAS RN:39170-18-8 | (5-PHENYLFURAN-2-YL)METHANAMINE
+BMGC_DG02120,BMG_DG017495,"3-phenacyl-UDP | PubChem CID:11994011 | [(2R,3S,4R,5R)-5-(2,4-dioxo-3-phenacylpyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate"
+BMGC_DG02121,BMG_DG017500,"UNII:7DE9P17E1J | CAS RN:947696-17-5 | PubChem SID:381132194 | JHU-75528 | 4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-N-piperidin-1-ylpyrazole-3-carboxamide | PubChem CID:11995515 | Jhu-75528"
+BMGC_DG02122,BMG_DG017502,N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide | DrugBank ID:DB07089 | PubChem CID:11995761
+BMGC_DG02123,BMG_DG017513,PubChem CID:11996845 | UNII:6TEM3HH2EG | CAS RN:907609-33-0 | TAK-100 | PubChem SID:461434651
+BMGC_DG02124,BMG_DG017514,PubChem SID:405054968 | UNII:FRH0WC636A | ISOSCUTELLARIN | PubChem CID:11996857 | CAS RN:62023-92-1
+BMGC_DG02125,BMG_DG017522,DrugBank ID:DB12812 | PubChem CID:11998575 | CAS RN:914913-88-5 | Palomid 529 | PALOMID 529 | UNII:XV9409EWG4 | 8-(1-hydroxyethyl)-2-methoxy-3-[(4-methoxyphenyl)methoxy]benzo[c]chromen-6-one | PubChem SID:198949539
+BMGC_DG02126,BMG_DG017523,"(4S)-4-(3-chlorophenyl)-2-[(3,5-dimethyl-4-(4-hydroxy-3-isopropylbenzyl)phenoxy)methyl]-2-oxido-[1,3,2]-dioxaphosphonane | PubChem CID:11998611 | 4-[[4-[[(4S)-4-(3-chlorophenyl)-2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl]methoxy]-2,6-dimethylphenyl]methyl]-2-propan-2-ylphenol"
+BMGC_DG02127,BMG_DG017534,"PubChem CID:12000240 | DrugBank ID:DB05408 | PubChem SID:198971688 | UNII:P0GMS9N47Q | EMRICASAN | (3S)-3-[[(2S)-2-[[2-(2-tert-butylanilino)-2-oxoacetyl]amino]propanoyl]amino]-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid | CAS RN:254750-02-2 | Emricasan"
+BMGC_DG02128,BMG_DG017540,UNII:4HA03Q8EZ9 | CAS RN:913548-29-5 | AR-9281 | DrugBank ID:DB06345 | 1-(1-acetylpiperidin-4-yl)-3-(1-adamantyl)urea | PubChem SID:287446349 | PubChem CID:12000797
+BMGC_DG02129,BMG_DG017544,DrugBank ID:DB11792 | Mirodenafil | PubChem CID:12001014
+BMGC_DG02130,BMG_DG017546,"CAS RN:921765-80-2 | PubChem SID:445498762 | UNII:V7P59U95XA | PubChem CID:12001280 | (2R,4S)-4-(4-ACETYL-3-HYDROXY-1-PIPERAZINYL)-N-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHYL)-2-(4-FLUORO-2-METHYLPHENYL)-N-METHYL-1-PIPERIDINECARBOXAMIDE"
+BMGC_DG02131,BMG_DG017548,PubChem CID:12001785 | ACT-178882 | CAS RN:1007392-69-9 | UNII:TA1ATU85YC | PubChem SID:363909657
+BMGC_DG02132,BMG_DG017559,PubChem CID:120031 | 10-METHOXYCARBAMAZEPINE | PubChem SID:198986137 | UNII:Q13NU3QR2X | CAS RN:28721-09-7
+BMGC_DG02133,BMG_DG017564,"PubChem CID:120035 | 1,4,5,6-Tetrahydro-3-phenylcyclopentapyrazole | CAS RN:28749-00-0 | 1,4,5,6-TETRAHYDRO-3-PHENYLCYCLOPENTAPYRAZOLE | UNII:2EQK5UQA7W | PubChem SID:485662462"
+BMGC_DG02134,BMG_DG017572,"PubChem SID:198970257 | DrugBank ID:DB12211 | Psi-697 | 2-[(4-chlorophenyl)methyl]-3-hydroxy-7,8,9,10-tetrahydrobenzo[h]quinoline-4-carboxylic acid | UNII:LH1XC916ME | PubChem CID:12004316 | PSI-697 | CAS RN:851546-61-7"
+BMGC_DG02135,BMG_DG017577,"PubChem SID:198981903 | 2,4-DIBROMOPHENOL | 2,4-Dibromophenol | UNII:IA75T5C9TG | PubChem CID:12005 | CAS RN:615-58-7 | 2,4-dibromophenol"
+BMGC_DG02136,BMG_DG017584,PubChem CID:120065 | 5-METHYL-2-PHENYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID | UNII:A6Z9R25LRY | CAS RN:28824-94-4
+BMGC_DG02137,BMG_DG017647,UNII:7O50LKL2G8 | RHODANINE | PubChem CID:1201546 | PubChem SID:198949170 | CAS RN:141-84-4
+BMGC_DG02138,BMG_DG017648,"PubChem CID:1201549 | Benzatropine | Benztropine | DrugBank ID:DB00245 | (1S,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane | PubChem SID:175266154 | CAS RN:802597-90-6 | BENZTROPINE | CAS RN:86-13-5 | UNII:1NHL2J4X8K"
+BMGC_DG02139,BMG_DG017658,UNII:X4NBI2F334 | O-METHYLPSILOCIN | PubChem CID:12017578 | CAS RN:3965-97-7 | PubChem SID:312524749
+BMGC_DG02140,BMG_DG017675,"PubChem SID:198983768 | CAS RN:300656-38-6 | 2-((2'-(1-ETHYL-4,5-DIPHENYL-1H-IMIDAZOL-2-YL)(1,1'-BIPHENYL)-3-YL)OXY)-ACETIC ACID | PubChem CID:12020821 | UNII:O4V054O83V"
+BMGC_DG02141,BMG_DG017682,UNII:UWB1PR3UR6 | 4-FLOUROBENZENESULFONAMIDE | 4-Flourobenzenesulfonamide | CAS RN:402-46-0 | PubChem SID:438788225 | DrugBank ID:DB01784 | PubChem CID:120231
+BMGC_DG02142,BMG_DG017683,5-Fluoro-3-pyridinecarboxylic acid | UNII:9C94XTS5CX | PubChem SID:472426694 | PubChem CID:120232 | CAS RN:402-66-4 | 5-FLUORONICOTINIC ACID | 5-Fluoronicotinic acid | 5-fluoropyridine-3-carboxylic acid
+BMGC_DG02143,BMG_DG017685,P-FLUORO-N-METHYLPHENETHYLAMINE | CAS RN:459-28-9 | UNII:H3YJB6ELXE | PubChem CID:120234 | PubChem SID:287446418
+BMGC_DG02144,BMG_DG017688,PubChem SID:485661444 | 2-CHLORO-4'-FLUOROACETOPHENONE | PubChem CID:120248 | CAS RN:456-04-2 | 2-Chloro-4'-fluoroacetophenone | UNII:AW8FP5M4P2
+BMGC_DG02145,BMG_DG017692,PubChem SID:387065282 | UNII:X88Z903YTF | THIAMINE THIAZOLONE | PubChem CID:120267 | CAS RN:490-82-4
+BMGC_DG02146,BMG_DG017714,NDC:25021-812 | NDC:14445-412 | NDC:0517-7510 | Acetylcysteine | (2R)-2-acetamido-3-sulfanylpropanoic acid | NDC:0409-3307 | NDC:0574-0805 | NDC:84420-4855 | NDC:0409-3308 | NDC:70710-1015 | NDC:59088-795 | NDC:0517-7610 | ACETYLCYSTEINE | NDC:63323-694 | NDC:66220-207 | NDC:83270-001 | NDC:17089-067 | NDC:70069-788 | NDC:63323-691 | NDC:0517-7504 | NDC:63323-963 | UNII:WYQ7N0BPYC | NDC:63323-690 | CAS RN:616-91-1 | NDC:55154-5731 | DrugBank ID:DB06151 | NDC:68462-946 | NDC:63323-695 | NDC:70771-1412 | NDC:0517-7604 | PubChem CID:12035 | NDC:63323-692 | PubChem SID:175267087 | NDC:63323-693 | NDC:55154-5730 | NDC:72611-860 | NDC:70594-111 | NDC:55150-259
+BMGC_DG02147,BMG_DG017717,ETHYL VANILLATE | CAS RN:617-05-0 | PubChem SID:198960604 | PubChem CID:12038 | UNII:V38JK4Z93O
+BMGC_DG02148,BMG_DG017720,2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane | PubChem CID:1204 | Epibatidine | CAS RN:148152-66-3 | CAS RN:152378-30-8
+BMGC_DG02149,BMG_DG017725,PubChem SID:198969053 | Ethyl pyruvate | DrugBank ID:DB05869 | UNII:03O98E01OB | ethyl 2-oxopropanoate | ETHYL PYRUVATE | PubChem CID:12041 | CAS RN:617-35-6
+BMGC_DG02150,BMG_DG017748,PubChem CID:1204893 | CAY-10505 | PubChem SID:461434352 | UNII:S8TQU87RAT | CAS RN:1218777-13-9
+BMGC_DG02151,BMG_DG017761,UNII:3PRA9BL2CC | DIETHYLCYANAMIDE | Diethylcyanamide | CAS RN:617-83-4 | PubChem CID:12050 | PubChem SID:482553465
+BMGC_DG02152,BMG_DG017784,Benzenesulfinic acid | CAS RN:618-41-7 | PubChem SID:316914233 | BENZENESULFINIC ACID | UNII:G9560D97PI | PubChem CID:12057 | DrugBank ID:DB03848
+BMGC_DG02153,BMG_DG017791,"CAS RN:4846-07-5 | METHAMPHETAMINE, DL- | PubChem CID:1206 | CAS RN:7632-10-2 | N-methyl-1-phenylpropan-2-amine | UNII:13ZT6YG5SD | PubChem SID:175271546 | DL-Methamphetamine"
+BMGC_DG02154,BMG_DG017798,PubChem CID:12063257 | CAS RN:732244-33-6 | PubChem SID:198936053 | 2C-T-19 | UNII:H190WE556H
+BMGC_DG02155,BMG_DG017820,"Licoagroaurone | CAS RN:325144-70-5 | (2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-6-hydroxy-7-(3-methylbut-2-enyl)-1-benzofuran-3-one | PubChem CID:12069327"
+BMGC_DG02156,BMG_DG017859,"AZD-8309 | CAS RN:333742-48-6 | (R)-5-((2,3-difluorobenzyl)thio)-7-((1-hydroxypropan-2-yl)amino)thiazolo[4,5-d]pyrimidin-2(3H)-one | UNII:8PD78CVU5V | PubChem CID:12073810 | 5-[(2,3-difluorophenyl)methylsulfanyl]-7-[[(2R)-1-hydroxypropan-2-yl]amino]-3H-[1,3]thiazolo[4,5-d]pyrimidin-2-one | PubChem SID:475550432"
+BMGC_DG02157,BMG_DG017880,PubChem SID:478838801 | PubChem CID:12082255 | UNII:EWR4G9V8JG | CAS RN:23953-39-1 | Arhalofenic Acid | ARHALOFENIC ACID
+BMGC_DG02158,BMG_DG017881,"PubChem CID:12082256 | UNII:UU4GVG5BXW | CAS RN:23953-40-4 | 2-(4-CHLOROPHENYL)-2-(3-(TRIFLUOROMETHYL)PHENOXY)ACETIC ACID, (2S)-"
+BMGC_DG02159,BMG_DG017882,UNII:1P01UJR9X1 | CAS RN:24136-23-0 | DrugBank ID:DB11811 | PubChem SID:198952211 | PubChem CID:12082259 | ARHALOFENATE | 2-acetamidoethyl (2R)-2-(4-chlorophenyl)-2-[3-(trifluoromethyl)phenoxy]acetate | Arhalofenate
+BMGC_DG02160,BMG_DG017883,"4-[(E,6R)-6,7-dihydroxy-3,7-dimethyloct-2-enoxy]furo[3,2-g]chromen-7-one | CAS RN:264234-05-1 | UNII:S2O194AWTV | PubChem SID:198946176 | DIHYDROXYBERGAMOTTIN | PubChem CID:12082365 | Dihydroxybergamottin"
+BMGC_DG02161,BMG_DG017893,"PubChem CID:12085802 | CHLOROPHYLL A | UNII:YF5Q9EJC8Y | PubChem SID:198935833 | CAS RN:479-61-8 | Chlorophyll A | CAS RN:42617-16-3 | magnesium;methyl (3R,21S,22S)-16-ethenyl-11-ethyl-12,17,21,26-tetramethyl-4-oxo-22-[3-oxo-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enoxy]propyl]-23,25-diaza-7,24-diazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13(25),14,16,18,20(23)-decaene-3-carboxylate | DrugBank ID:DB02133"
+BMGC_DG02162,BMG_DG017910,UNII:D1MA908EV0 | PubChem SID:198983254 | 4-(DIMETHYLAMINO)BENZOIC ACID | 4-(Dimethylamino)benzoic acid | CAS RN:619-84-1 | DrugBank ID:DB08748 | PubChem CID:12092
+BMGC_DG02163,BMG_DG017948,PubChem CID:121026 | DrugBank ID:DB08790 | 1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID
+BMGC_DG02164,BMG_DG017962,CAS RN:216504-75-5 | 4-[3-(4-Fluorophenyl)-1h-Pyrazol-4-Yl]pyridine | DrugBank ID:DB07829 | PubChem CID:12106168 | 4-[5-(4-fluorophenyl)-1H-pyrazol-4-yl]pyridine | 4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE
+BMGC_DG02165,BMG_DG017977,"CAS RN:620-92-8 | PubChem SID:198977142 | PubChem CID:12111 | 4,4'-Methylenediphenol | BISPHENOL F | 4-[(4-hydroxyphenyl)methyl]phenol | UNII:QD2C19044Z"
+BMGC_DG02166,BMG_DG017987,CAS RN:49793-39-7 | PubChem SID:198940851 | DrugBank ID:DB14479 | CAS RN:128645-11-4 | zinc;(2R)-2-acetamido-3-sulfanylpropanoate | Acetylcysteine Zinc | UNII:LP811J9FA1 | ACETYLCYSTEINE ZINC | PubChem CID:12114682
+BMGC_DG02167,BMG_DG017993,UNII:554PDF1275 | BENZYL SULFOXIDE | benzylsulfinylmethylbenzene | PubChem SID:251965923 | PubChem CID:12116 | Benzyl sulfoxide | CAS RN:621-08-9
+BMGC_DG02168,BMG_DG017996,PubChem SID:482553815 | PubChem CID:12117342 | 3-TERT-BUTYLCARBAZOLE | UNII:AVF2AGH99B | 3-tert-Butylcarbazole | CAS RN:22401-74-7
+BMGC_DG02169,BMG_DG017999,7-(2-(DIMETHYLAMINO)ETHOXY)-2-PHENYL-4H-1-BENZOPYRAN-4-ONE | CAS RN:10400-01-8 | PubChem CID:121180 | UNII:YA83XD65FJ
+BMGC_DG02170,BMG_DG018009,"MENER, (S,S)- | PubChem SID:251965863 | PubChem CID:12122109 | UNII:4XWI258BOT | CAS RN:105018-14-2"
+BMGC_DG02171,BMG_DG018115,"CAS RN:1914078-41-3 | PubChem CID:121231408 | tert-butyl N-[4-[4-amino-1-[2-[4-(dimethylamino)piperidin-1-yl]ethyl]pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl]carbamate | eCF506"
+BMGC_DG02172,BMG_DG018146,CAS RN:621-42-1 | PubChem SID:198940257 | PubChem CID:12124 | METACETAMOL | UNII:V942ZCN81H | Metacetamol | N-(3-hydroxyphenyl)acetamide
+BMGC_DG02173,BMG_DG018147,"PubChem SID:461434204 | UNII:GGK40O1O85 | Mizacorat | Azd9567 | MIZACORAT | PubChem CID:121248172 | CAS RN:1893415-00-3 | 2,2-difluoro-N-[(1R,2S)-3-methyl-1-[1-(1-methyl-6-oxopyridin-3-yl)indazol-5-yl]oxy-1-phenylbutan-2-yl]propanamide"
+BMGC_DG02174,BMG_DG018160,N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide | LAZERTINIB | UNII:4A2Y23XK11 | Lazertinib | CAS RN:1903008-80-9 | NDC:57894-080 | NDC:57894-240 | PubChem SID:348481227 | PubChem CID:121269225
+BMGC_DG02175,BMG_DG018161,CAS RN:621-59-0 | 3-hydroxy-4-methoxybenzaldehyde | Isovanillin | PubChem CID:12127 | UNII:4A9N90H9X6 | PubChem SID:198969035 | ISOVANILLIN
+BMGC_DG02176,BMG_DG018167,PubChem SID:459275518 | PubChem CID:121280087 | UNII:T4RS462G19 | AUMOLERTINIB | CAS RN:1899921-05-1 | Aumolertinib | N-[5-[[4-(1-cyclopropylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
+BMGC_DG02177,BMG_DG018174,Foscarbidopa | CAS RN:1907685-81-7 | NDC:0074-0501 | PubChem CID:121288738 | FOSCARBIDOPA | (2S)-2-hydrazinyl-3-(3-hydroxy-4-phosphonooxyphenyl)-2-methylpropanoic acid | PubChem SID:346540854 | UNII:5NT8HCA4OO
+BMGC_DG02178,BMG_DG018177,"UNII:7LBRZUYSHU | CAS RN:1912445-55-6 | DrugBank ID:DB15347 | 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide | PubChem CID:121293929 | PubChem SID:381132290 | Branebrutinib | BRANEBRUTINIB"
+BMGC_DG02179,BMG_DG018185,"CAS RN:1918143-53-9 | PubChem SID:375579808 | 4-[(2R,4R)-4-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic acid | GALICAFTOR | Galicaftor | PubChem CID:121301049 | UNII:J0IIT8QSQS | DrugBank ID:DB14894"
+BMGC_DG02180,BMG_DG018187,"PubChem CID:121303394 | 5-[2,3-dichloro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-N-(2-hydroxy-2-methylpropyl)-4-[(2R)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide | US10150762, Example 2/16 | CAS RN:1917306-14-9"
+BMGC_DG02181,BMG_DG018188,"2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate | UNII:3QKI37EEHE | REMDESIVIR | CAS RN:1809249-37-3 | PubChem CID:121304016 | PubChem SID:319892613 | NDC:61958-2902 | NDC:61958-2901 | Remdesivir | DrugBank ID:DB14761"
+BMGC_DG02182,BMG_DG018203,4-chloro-N-[(1R)-1-[4-(6-fluoroquinolin-4-yl)cyclohexyl]ethyl]benzamide | PubChem CID:121318866 | CAS RN:1923844-48-7 | 4-Chloro-N-[(1R)-1-[4-(6-fluoroquinolin-4-yl)cyclohexyl]ethyl]benzamide
+BMGC_DG02183,BMG_DG018204,PubChem SID:198957159 | BENDAZOL | 2-benzyl-1H-benzimidazole | PubChem CID:12132 | UNII:26601THN1D | Bendazol | CAS RN:621-72-7
+BMGC_DG02184,BMG_DG018205,PubChem CID:121322333 | GLYCO-OBETICHOLIC ACID | PubChem SID:346540454 | CAS RN:863239-60-5 | UNII:O2MZK6V9LQ
+BMGC_DG02185,BMG_DG018207,Linrodostat | UNII:0A7729F42K | CAS RN:1923833-60-6 | PubChem CID:121328278 | PubChem SID:375579090 | (2R)-N-(4-chlorophenyl)-2-[4-(6-fluoroquinolin-4-yl)cyclohexyl]propanamide | DrugBank ID:DB14986 | LINRODOSTAT
+BMGC_DG02186,BMG_DG018217,"PubChem CID:121333423 | PubChem SID:461434174 | (2R,4R)-1-[(3-chloro-2-fluorophenyl)methyl]-4-[[3-fluoro-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyridin-2-yl]methyl]-2-methylpiperidine-4-carboxylic acid | CAS RN:1919888-06-4 | Ak-01 | AK-01 | UNII:1WX8O5XV4R"
+BMGC_DG02187,BMG_DG018221,"PubChem CID:121334520 | 5-[4,6-bis(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine | Pqr620"
+BMGC_DG02188,BMG_DG018238,"Mitiperstat | PubChem CID:121362450 | PubChem SID:461434272 | CAS RN:1933460-19-5 | 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one | UNII:S6GYK3X4QQ | MITIPERSTAT"
+BMGC_DG02189,BMG_DG018240,CAS RN:1931994-81-8 | N-[6-(2-hydroxypropan-2-yl)-2-(2-methylsulfonylethyl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide | Zabedosertib | PubChem SID:440794126 | UNII:N1GRK350ZM | PubChem CID:121364961 | ZABEDOSERTIB
+BMGC_DG02190,BMG_DG018241,CAS RN:1931994-80-7 | N-[2-(3-hydroxy-3-methylbutyl)-6-(2-hydroxypropan-2-yl)indazol-5-yl]-6-(trifluoromethyl)pyridine-2-carboxamide | Irak4-IN-20 | PubChem CID:121364971
+BMGC_DG02191,BMG_DG018242,UNII:O5ZD2TU2B7 | CAS RN:1933514-13-6 | PubChem SID:443623459 | Sebetralstat | N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-[[4-[(2-oxopyridin-1-yl)methyl]phenyl]methyl]pyrazole-4-carboxamide | PubChem CID:121365142 | SEBETRALSTAT
+BMGC_DG02192,BMG_DG018244,CAS RN:1616493-44-7 | Tucidinostat | TUCIDINOSTAT | UNII:87CIC980Y0 | N-(2-amino-4-fluorophenyl)-4-[[[(E)-3-pyridin-3-ylprop-2-enoyl]amino]methyl]benzamide | PubChem SID:198983837 | DrugBank ID:DB06334 | CAS RN:743438-44-0 | PubChem CID:12136798
+BMGC_DG02193,BMG_DG018263,Carglumic acid | DrugBank ID:DB06775 | UNII:5L0HB4V1EW | NDC:35573-459 | CARGLUMIC ACID | PubChem SID:175268265 | NDC:68475-006 | NDC:71863-114 | PubChem CID:121396 | Carglumic Acid | NDC:52276-312 | (2S)-2-(carbamoylamino)pentanedioic acid | CAS RN:1188-38-1
+BMGC_DG02194,BMG_DG018264,"CAS RN:1948229-21-7 | ELIAPIXANT | PubChem SID:404859778 | PubChem CID:121397587 | 3-(5-methyl-1,3-thiazol-2-yl)-5-[(3R)-oxolan-3-yl]oxy-N-[(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl]benzamide | UNII:9GH7E6347B | Eliapixant"
+BMGC_DG02195,BMG_DG018265,"PubChem CID:121397607 | 3-[[(2R)-4-methylmorpholin-2-yl]methoxy]-5-(5-methyl-1,3-thiazol-2-yl)-N-[(1R)-1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl]benzamide | CAS RN:1948232-63-0 | Filapixant | FILAPIXANT | PubChem SID:404859975 | UNII:B35HB63WZF"
+BMGC_DG02196,BMG_DG018268,"TEMUTERKIB | 6,6-dimethyl-2-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5-(2-morpholin-4-ylethyl)thieno[2,3-c]pyrrol-4-one | UNII:V0Q46LFE6F | Temuterkib | CAS RN:1951483-29-6 | PubChem CID:121408882 | PubChem SID:441583597"
+BMGC_DG02197,BMG_DG018271,"PubChem SID:404859669 | PubChem CID:121410806 | Giredestrant | UNII:28P3DU6DB3 | 3-[(1R,3R)-1-[2,6-difluoro-4-[[1-(3-fluoropropyl)azetidin-3-yl]amino]phenyl]-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-2-yl]-2,2-difluoropropan-1-ol | CAS RN:1953133-47-5 | GIREDESTRANT"
+BMGC_DG02198,BMG_DG018272,"Mak-683 | UNII:4K446Z8N51 | PubChem CID:121412508 | CAS RN:1951408-58-4 | PubChem SID:441097535 | MAK-683 | N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine"
+BMGC_DG02199,BMG_DG018273,"CAS RN:1952316-43-6 | ACALABRUTINIB, (R)- | UNII:6J82PAQ862 | PubChem CID:121413436 | Acalabrutinib, (R)- | PubChem SID:474492959"
+BMGC_DG02200,BMG_DG018274,PubChem SID:441097562 | PubChem CID:121414283 | CAS RN:1952276-71-9 | UNII:N8LRS5GBB6 | KCL-286
+BMGC_DG02201,BMG_DG018275,"3-[5-Chloranyl-6-[(1~{r})-1-Pyridin-2-Ylethoxy]-1,2-Benzoxazol-3-Yl]propanoic Acid | 3-[5-chloro-6-[(1R)-1-pyridin-2-ylethoxy]-1,2-benzoxazol-3-yl]propanoic acid | CAS RN:1953156-61-0 | GSK-065 | PubChem SID:496143945 | PubChem CID:121415134 | UNII:WVX3449E6S"
+BMGC_DG02202,BMG_DG018277,"2-[(1R,5S)-3-[[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]methoxy]-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid | TROPIFEXOR | Ljn452 | CAS RN:1383816-29-2 | UNII:NMZ08KM76Z | PubChem CID:121418176 | PubChem SID:329904019"
+BMGC_DG02203,BMG_DG018281,UNII:WV3E0S3IQB | PubChem CID:121425461 | CAS RN:1648737-78-3 | VELUFENACIN | PubChem SID:404859794
+BMGC_DG02204,BMG_DG018283,"(3R)-3-[3-amino-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]-3-cyclopentylpropanenitrile | UNII:A4V35P6KWS | PubChem CID:121427554 | Rovadicitinib | ROVADICITINIB | PubChem SID:478839068 | CAS RN:1948242-59-8"
+BMGC_DG02205,BMG_DG018288,"CAS RN:1933507-63-1 | 1-(4-tert-butylphenyl)sulfonyl-3-[(3R)-3-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butyl]urea | PubChem CID:121428882"
+BMGC_DG02206,BMG_DG018299,"N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[[4-(prop-2-enoylamino)benzoyl]amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide | CAS RN:1957203-01-8 | PubChem CID:121443990 | Ykl-5-124"
+BMGC_DG02207,BMG_DG018302,"Aldumastat | ALDUMASTAT | PubChem SID:433968518 | UNII:EI4HZ6P03E | PubChem CID:121448788 | (5S)-5-cyclopropyl-5-[3-[(3S)-4-(3,5-difluorophenyl)-3-methylpiperazin-1-yl]-3-oxopropyl]imidazolidine-2,4-dione | CAS RN:1957278-93-1"
+BMGC_DG02208,BMG_DG018304,PubChem SID:474492792 | CAS RN:1663564-42-8 | UNII:JA6FTF7C5A | PubChem CID:121453184 | GAT100
+BMGC_DG02209,BMG_DG018319,"UNII:VJ3OXN6K2H | EP4 receptor antagonist 2 | BMS-986310 | PubChem SID:482553788 | CAS RN:1965316-82-8 | PubChem CID:121481566 | 4-[4-cyano-2-[[(1'R,4S)-6-(propan-2-ylcarbamoyl)spiro[2,3-dihydrochromene-4,2'-cyclopropane]-1'-carbonyl]amino]phenyl]butanoic acid"
+BMGC_DG02210,BMG_DG018327,"UNII:B5B6YF7GWT | 1-[(2R)-2-(2-hydroxyethyl)-4-[2-(trifluoromethyl)-4-[2-(trifluoromethyl)pyrimidin-5-yl]-1,3-thiazol-5-yl]piperazin-1-yl]-2-(3-methyl-1,2,4-triazol-1-yl)ethanone | PubChem CID:121485701 | CAS RN:1967811-46-6 | PubChem SID:485665873 | ACT-777991"
+BMGC_DG02211,BMG_DG018328,UNII:6O70DED99N | CAS RN:648917-13-9 | AVE-2865 | PubChem SID:318691515 | DrugBank ID:DB07396 | PubChem CID:12148754
+BMGC_DG02212,BMG_DG018362,"Atuveciclib | CAS RN:1414943-94-4 | PubChem SID:316917795 | 4-(4-fluoro-2-methoxyphenyl)-N-[3-[(methylsulfonimidoyl)methyl]phenyl]-1,3,5-triazin-2-amine | PubChem CID:121488167 | CAS RN:2923012-24-0 | ATUVECICLIB | UNII:63Q7F59W0V"
+BMGC_DG02213,BMG_DG018365,PubChem SID:472420815 | CAS RN:1644392-61-9 | UNII:8M7V7Q6537 | (2S)-2-amino-6-[[4-[2-[2-[[4-[[(5S)-5-amino-5-carboxypentyl]amino]-4-oxobutanoyl]amino]ethoxy]ethylamino]-4-oxobutanoyl]amino]hexanoic acid | Pegunigalsidase Alfa | PubChem CID:121488171 | PEGUNIGALSIDASE ALFA | Pegunigalsidase-alfa
+BMGC_DG02214,BMG_DG018369,PubChem SID:472410608 | NDC:10122-502 | (2S)-2-amino-6-(2-methoxyethoxycarbonylamino)hexanoic acid | ELAPEGADEMASE | UNII:9R3D3Y0UHS | CAS RN:1709806-75-6 | PubChem CID:121488177 | Revcovi
+BMGC_DG02215,BMG_DG018420,"PubChem SID:384436261 | CAS RN:75377-45-6 | (1R,2R)-1-(3-methoxyphenyl)-2-(methylaminomethyl)cyclohexan-1-ol | UNII:8M7YSN2KII | N-DESMETHYLTRAMADOL | rac N-Desmethyl Tramadol | CAS RN:147762-57-0 | PubChem CID:12149038"
+BMGC_DG02216,BMG_DG018476,"nonadecasodium;1-[(2R,4S,5R)-4-[[(2R,3S,5R)-3-[[(2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-hydroxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-5-(6-aminopurin-9-yl)-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxyoxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-oxidophosphinothioyl]oxy-5-[[[(2R,3S,5R)-2-[[[(2R,3S,5R)-2-[[[(2R,3R,4R,5R)-2-[[[(2R,3R,4R,5R)-2-[[[(2R,3R,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2-[[[(2R,3R,4R,5R)-2-(hydroxymethyl)-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-oxidophosphinothioyl]oxymethyl]-4-(2-methoxyethoxy)oxolan-3-yl]oxy-sulfidophosphoryl]oxymethyl]-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-oxidophosphinothioyl]oxymethyl]-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-oxidophosphinothioyl]oxymethyl]-5-(2-amino-6-oxo-1H-purin-9-yl)-4-(2-methoxyethoxy)oxolan-3-yl]oxy-oxidophosphinothioyl]oxymethyl]-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-3-yl]oxy-oxidophosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-oxidophosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione | PubChem CID:121493436 | NDC:72126-007 | INOTERSEN SODIUM | CAS RN:1432726-13-0 | PubChem SID:316918496 | UNII:950736UC77 | CID 121493436"
+BMGC_DG02217,BMG_DG018507,NDC:0904-7269 | NDC:82182-106 | NDC:51655-031 | NDC:0378-9205 | NDC:0904-7470 | DrugBank ID:DB00364 | NDC:69339-209 | NDC:0254-1011 | NDC:72162-2264 | NDC:51407-881 | NDC:63629-9153 | NDC:70518-3987 | NDC:80425-0213 | NDC:50742-386 | NDC:67296-2090 | NDC:55154-4379 | NDC:71610-541 | NDC:63739-193 | NDC:42291-781 | UNII:XX73205DH5 | NDC:60687-738 | NDC:0093-2210 | NDC:60687-695 | NDC:0615-4517 | NDC:82804-102 | NDC:68094-043 | NDC:82804-063 | NDC:68071-1749 | NDC:58914-171 | NDC:63629-9152 | NDC:50090-0582 | PubChem CID:121494085 | NDC:65162-062 | NDC:68788-8316 | NDC:68788-8946 | NDC:70771-1833 | NDC:71335-2114 | NDC:71610-017 | Sucralfate | NDC:17856-1011 | SUCRALFATE | NDC:42291-936 | NDC:60219-1656 | NDC:66689-305 | NDC:68788-8779 | NDC:68071-3478 | NDC:29033-003 | NDC:0713-0791 | NDC:72189-234 | NDC:72578-081 | NDC:71335-2461 | NDC:80425-0188 | CAS RN:54182-58-0 | NDC:62135-436 | NDC:70518-3959 | NDC:70518-0775 | NDC:0121-0974 | NDC:51655-475 | NDC:55154-5790 | NDC:55154-4348 | NDC:64380-149 | NDC:80425-0377 | NDC:80425-0091 | NDC:50090-6455 | NDC:72189-429 | PubChem SID:472422750 | NDC:63629-1307 | NDC:69238-1656 | NDC:50268-745 | NDC:51079-753 | NDC:50090-5287 | NDC:52817-840 | NDC:58914-170 | NDC:59762-0401
+BMGC_DG02218,BMG_DG018539,"CID 121494123 | 1-[(2R,4S,5R)-4-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-[hydroxy-[[(2R,3R,4R,5R)-3-hydroxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-[[[(2R,3S,5R)-2-[[[(2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2-[[[(2R,3R,4R,5R)-2-[[[(2R,3R,4R,5R)-2-[[[(2R,3R,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2-[[[(2R,3R,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-(2-methoxyethoxy)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-(2-methoxyethoxy)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphinothioyl]oxymethyl]oxolan-2-yl]-5-methylpyrimidine-2,4-dione | CAS RN:915430-78-3 | PubChem CID:121494123"
+BMGC_DG02219,BMG_DG018555,"CAS RN:522-66-7 | UNII:31J3Q51T6L | Hydroquinine | (R)-[(2S,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol | PubChem SID:198941801 | HYDROQUININE | CAS RN:23495-98-9 | PubChem CID:121515 | DrugBank ID:DB13718"
+BMGC_DG02220,BMG_DG018556,PubChem CID:12152 | BENZYL AZIDE | PubChem SID:198962723 | UNII:HFD57Z7J9J | CAS RN:622-79-7
+BMGC_DG02221,BMG_DG018572,PubChem CID:121591 | N-TRIS((HYDROXYMETHYL)METHYL)-3-AMINOPROPANESULFONIC ACID | CAS RN:29915-38-6 | UNII:Y5DC3IN066 | PubChem SID:198984020
+BMGC_DG02222,BMG_DG018654,"PubChem CID:121596688 | PubChem SID:317229981 | DrugBank ID:DB15366 | SOR-C13 | Sor-c13 | UNII:C79B5A73C4 | CAS RN:1187852-48-7 | (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-4-(diaminomethylideneamino)butyl]carbamoyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-[[(2S)-2,6-diaminohexanoyl]amino]-5-oxopentanoic acid"
+BMGC_DG02223,BMG_DG018656,"DrugBank ID:DB14917 | CAS RN:1352226-88-0 | PubChem SID:317230024 | Ceralasertib | CERALASERTIB | imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-c]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane | UNII:85RE35306Z | PubChem CID:121596701"
+BMGC_DG02224,BMG_DG018657,PZM21 | CAS RN:1997387-43-5 | UNII:M8GB23F27E | PubChem CID:121596705 | PubChem SID:474492442
+BMGC_DG02225,BMG_DG018659,"PubChem CID:121596782 | CID 121596782 | CAS RN:1936529-65-5 | 3-(2-chloro-6-methylphenyl)-7-[2-methoxy-4-(1-methylpiperidin-4-yl)anilino]-1-(5-methoxypyridin-2-yl)-4H-pyrimido[4,5-d]pyrimidin-2-one"
+BMGC_DG02226,BMG_DG018686,PubChem SID:443624733 | P-ANISYL-P-BENZOQUINONE | UNII:WO53B5R5JN | CAS RN:30100-35-7 | PubChem CID:121637
+BMGC_DG02227,BMG_DG018730,"CAS RN:30711-93-4 | UNII:2F68ANQ65T | PubChem CID:121749 | Brl 6231 | 6,6-DIMETHYL-1-(3-(2,4,5-TRICHLOROPHENOXY)PROPOXY)-1,3,5-TRIAZINE-2,4-DIAMINE HYDROCHLORIDE | 6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,3,5-triazine-2,4-diamine;hydrochloride"
+BMGC_DG02228,BMG_DG018731,"CAS RN:47326-86-3 | DrugBank ID:DB08734 | 6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE | PubChem CID:121750 | UNII:BYE8DTK2TG | 6,6-DIMETHYL-1-(3-(2,4,5-TRICHLOROPHENOXY)PROPOXY)-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE | 6,6-Dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine | 6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,3,5-triazine-2,4-diamine"
+BMGC_DG02229,BMG_DG018744,"CAS RN:71636-61-8 | PubChem SID:316913452 | PubChem CID:1218 | 9-chloro-5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol | Skf-81297 | SKF-81297 | UNII:9GBP09E08K"
+BMGC_DG02230,BMG_DG018761,"PubChem CID:121829 | 5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide | CAS RN:94666-07-6 | Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-"
+BMGC_DG02231,BMG_DG018763,CAS RN:98063-21-9 | (3R)-3-amino-4-(trimethylazaniumyl)butanoate | Emeriamine | PubChem CID:121830
+BMGC_DG02232,BMG_DG018772,"CAS RN:163163-24-4 | Chromanol 293B | PubChem CID:121846 | CAS RN:163163-23-3 | N-[(3R,4S)-6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-N-methylethanesulfonamide"
+BMGC_DG02233,BMG_DG018774,"CAS RN:89331-66-8 | UNII:M9TTW3YXU5 | FLUOREN-9-ONE O-(3-TERT-BUTYLAMINO-2-HYDROXYPROPYL)OXIME, (RS)- | PubChem CID:121848"
+BMGC_DG02234,BMG_DG018779,PubChem SID:198935006 | SUAM-312 | (2S)-2-acetamido-4-methyl-N-[(2S)-4-methyl-1-[[(2S)-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]pentanamide | UNII:1D8SBU367Z | PubChem CID:121855 | CAS RN:110115-07-6 | N-acetylleucyl-leucyl-methioninal
+BMGC_DG02235,BMG_DG018794,PubChem SID:348481734 | UNII:6GM6ZN5S1Y | CAS RN:145455-23-8 | L-692429 | PubChem CID:121879
+BMGC_DG02236,BMG_DG018796,"(1-butylpiperidin-4-yl)methyl 5-amino-6-chloro-2,3-dihydro-1,4-benzodioxine-8-carboxylate | SB 204070 hydrochloride | PubChem CID:121881 | CAS RN:148702-58-3"
+BMGC_DG02237,BMG_DG018798,"ethyl 2-[[(7S)-7-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]acetate;hydrochloride | CAS RN:121524-09-2 | AMIBEGRON HYDROCHLORIDE | UNII:N910CJ679E | Amibegron Hydrochloride | PubChem CID:121888 | PubChem SID:198977255"
+BMGC_DG02238,BMG_DG018799,"MITIGLINIDE | (2S)-4-[(3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoic acid | Mitiglinide | UNII:D86I0XLB13 | PubChem SID:198946246 | DrugBank ID:DB01252 | CAS RN:145375-43-5 | PubChem CID:121891"
+BMGC_DG02239,BMG_DG018800,EZOGABINE | PubChem SID:175267478 | Ezogabine | CAS RN:150812-12-7 | PubChem CID:121892 | UNII:12G01I6BBU | DrugBank ID:DB04953 | ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
+BMGC_DG02240,BMG_DG018801,"CAS RN:7412-77-3 | PubChem CID:121893 | 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoic acid | Protoporphyrinogen IX"
+BMGC_DG02241,BMG_DG018804,"CAS RN:74938-11-7 | 7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol | UNII:RR7D75YDF4 | 7-(Dipropylamino)-5,6,7,8-tetrahydronaphthalen-2-ol | PubChem SID:316918881 | 7-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN | PubChem CID:1219"
+BMGC_DG02242,BMG_DG018808,"CAS RN:15797-36-1 | 6-Deoxyerythronolide B | 6-deoxyerythronolide B | DrugBank ID:DB04070 | (3R,4S,5R,6S,7S,9R,11R,12S,13R,14R)-14-ethyl-4,6,12-trihydroxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione | PubChem CID:121904"
+BMGC_DG02243,BMG_DG018813,"[(1S,2R,3S,4S,5R,6R)-2,3-dihydroxy-4,5,6-triphosphonooxycyclohexyl] dihydrogen phosphate | CAS RN:112791-61-4 | CAS RN:121010-58-0 | D-myo-Inositol 3,4,5,6-tetrakisphosphate | CAS RN:109837-24-3 | PubChem CID:121920"
+BMGC_DG02244,BMG_DG018814,Alpha-Amino-2-Indanacetic Acid | PubChem CID:12192007 | DrugBank ID:DB04061
+BMGC_DG02245,BMG_DG018818,"ZK-93423 | ethyl 4-(methoxymethyl)-6-phenylmethoxy-9H-pyrido[3,4-b]indole-3-carboxylate | CAS RN:83910-44-5 | UNII:B6PWX5B47Q | PubChem CID:121926 | 6-Benzyloxy-4-methoxymethyl-beta-carboline-3-carboxylic acid ethyl ester | PubChem SID:472426551"
+BMGC_DG02246,BMG_DG018823,UNII:30060WAL99 | PubChem CID:121935 | PubChem SID:198970288 | 20.ALPHA.-HYDROXYCHOLESTEROL | CAS RN:516-72-3
+BMGC_DG02247,BMG_DG018824,"(2S,4aS,6aR,6aS,6bR,10S,12aS,14bS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid | CAS RN:1449-05-4 | PubChem CID:12193680 | 18alpha-Glycyrrhetic acid"
+BMGC_DG02248,BMG_DG018825,"8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine | 8,9-DICHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO(C)AZEPINE | DrugBank ID:DB04273 | PubChem CID:121938 | UNII:2K2UE2I8AY | CAS RN:71274-97-0 | PubChem SID:438788032"
+BMGC_DG02249,BMG_DG018829,PubChem CID:121942 | DrugBank ID:DB04681 | UNII:868YEO5270 | BETA-METHYLLACTOSIDE | PubChem SID:438788048 | CAS RN:7216-69-5
+BMGC_DG02250,BMG_DG018830,CAS RN:1101-84-4 | PubChem CID:121945 | UNII:EFF64524YR | .EPSILON.-DANSYLLYSINE | DrugBank ID:DB04676 | PubChem SID:249492467 | Dansyllysine
+BMGC_DG02251,BMG_DG018831,"Shikimate-3-phosphate | (3R,4S,5R)-4,5-dihydroxy-3-phosphonooxycyclohexene-1-carboxylic acid | CAS RN:63959-45-5 | DrugBank ID:DB04328 | PubChem CID:121947 | Shikimate-3-Phosphate"
+BMGC_DG02252,BMG_DG018832,"UNII:47IMW63S3F | PubChem SID:198964314 | CAS RN:474-73-7 | PubChem CID:121948 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 24(S)-hydroxycholesterol | 24-HYDROXYCHOLESTEROL"
+BMGC_DG02253,BMG_DG018842,DrugBank ID:DB03958 | 7-methyl-guanosine-5'-triphosphate-5'-guanosine | PubChem CID:121959
+BMGC_DG02254,BMG_DG018846,"(2S)-1-[(6R,7S)-3-(acetyloxymethyl)-7-methoxy-5,5,8-trioxo-5lambda6-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carbonyl]pyrrolidine-2-carboxylic acid | PubChem CID:121963 | PubChem SID:348481139 | UNII:YMN4MD1ZGQ | CAS RN:116507-04-1 | L 658758 | L-658,758"
+BMGC_DG02255,BMG_DG018848,"DrugBank ID:DB03723 | [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl] hydrogen phosphate | PubChem CID:121966 | 2'-Deoxy-thymidine-beta-L-rhamnose | CAS RN:2147-59-3"
+BMGC_DG02256,BMG_DG018850,CAS RN:135135-80-7 | DUP-734 FREE BASE | PubChem SID:198948616 | PubChem CID:121968 | UNII:T033730RWW
+BMGC_DG02257,BMG_DG018851,"(1s,3r,4r,6s)-1,3,4,6-Tetrapkisphosphate | PubChem CID:121969 | DrugBank ID:DB04300"
+BMGC_DG02258,BMG_DG018864,"[(2R,3S,4R,5R)-5-amino-2,3,4-trihydroxy-6-oxohexyl] dihydrogen phosphate | D-GLUCOSAMINE 6-PHOSPHATE | PubChem SID:440089852 | PubChem CID:121988 | D-glucosamine-6-phosphate | CAS RN:3616-42-0 | UNII:Y5ANY8MJ8J"
+BMGC_DG02259,BMG_DG018870,"5-Fluorodihydrouracil | UNII:CLP4LM9HXK | PubChem CID:121997 | PubChem SID:445498849 | 5-FLUORO-5,6-DIHYDROURACIL | CAS RN:696-06-0 | 5-fluoro-1,3-diazinane-2,4-dione"
+BMGC_DG02260,BMG_DG018871,UNII:V1PIQ8ZW62 | CAS RN:75106-70-6 | PubChem CID:121999 | PubChem SID:363909746 | DYNORPHIN A 1-6
+BMGC_DG02261,BMG_DG018872,"UNII:IWS1724PX6 | CAS RN:78950-78-4 | 7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol | PubChem CID:1220 | 8-OH-DPAT | PubChem SID:316917507 | 8-Hydroxy-2-(di-n-propylamino)tetralin | CAS RN:105558-30-3"
+BMGC_DG02262,BMG_DG018892,1-[5-ethyl-2-hydroxy-4-[6-methyl-6-(2H-tetrazol-5-yl)heptoxy]phenyl]ethanone | LY 255283 | PubChem CID:122023 | CAS RN:117690-79-6 | PubChem SID:198978319 | LY-255283 | UNII:H037W1I5AL
+BMGC_DG02263,BMG_DG018902,"UNII:DS09NL006S | PubChem SID:198989547 | CAS RN:76877-33-3 | D-346 | PubChem CID:122042 | 1-[4-[7-(diethylamino)-4-methyl-2-oxochromen-3-yl]phenyl]pyrrole-2,5-dione | N-(4-(7-Diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide"
+BMGC_DG02264,BMG_DG018903,PubChem CID:122044 | UNII:96R6F9J2AV | CAS RN:150725-87-4 | RO-46-2005 | Ro 46-2005 | 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)pyrimidin-4-yl]benzenesulfonamide
+BMGC_DG02265,BMG_DG018905,HOMOMAZINDOL | UNII:ZM6V5Z8UXP | PubChem CID:12204576 | CAS RN:36951-86-7 | PubChem SID:445499036
+BMGC_DG02266,BMG_DG018908,"CAS RN:63795-61-9 | (3S,6R,8S,9S,13R,14S,17R)-13-methyl-6-(methyl(75Se)selanylmethyl)-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol | PubChem CID:122051 | PubChem SID:249492390 | UNII:XWR21TJ99H | SELENIUM SE-75 NORCHOLESTEROL | DrugBank ID:DB13622 | Scintadren"
+BMGC_DG02267,BMG_DG018921,PubChem SID:441659529 | 4-[(7-chloroquinolin-4-yl)amino]-2-(ethylaminomethyl)phenol | Desethylamodiaquine | UNII:BY36SG7NP9 | DESETHYLAMODIAQUINE | PubChem CID:122068 | CAS RN:79352-78-6
+BMGC_DG02268,BMG_DG018930,"PubChem SID:198988061 | CAS RN:136381-85-6 | Lintitript | PubChem CID:122077 | DrugBank ID:DB04867 | UNII:3YFV00531K | 2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]acetic acid | LINTITRIPT"
+BMGC_DG02269,BMG_DG018942,"PubChem CID:1221 | PubChem SID:198949080 | CAS RN:77521-29-0 | UNII:J090588E6X | CAS RN:110592-37-5 | 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid | AMPA | alpha-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID | CAS RN:74341-63-2"
+BMGC_DG02270,BMG_DG018961,"Phytosphingosine | UNII:GIN46U9Q2Q | (2S,3S,4R)-2-aminooctadecane-1,3,4-triol | CAS RN:388566-94-7 | PHYTOSPHINGOSINE | PubChem CID:122121 | CAS RN:554-62-1 | PubChem SID:175266635 | DrugBank ID:DB14119"
+BMGC_DG02271,BMG_DG018972,PubChem SID:433968915 | DX-9065 | PubChem CID:122129 | (2s)-3-(7-Carbamimidoylnaphthalen-2-Yl)-2-[4-({(3r)-1-[(1z)-Ethanimidoyl]pyrrolidin-3-Yl}oxy)phenyl]propanoic Acid | (2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-[4-[(3S)-1-ethanimidoylpyrrolidin-3-yl]oxyphenyl]propanoic acid | UNII:RF60GS0DRO | CAS RN:150612-55-8
+BMGC_DG02272,BMG_DG019001,"PubChem CID:122147 | 4-(2-methylpropylamino)-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide | CAS RN:123291-07-6"
+BMGC_DG02273,BMG_DG019004,PubChem CID:122150 | UNII:LRZ36BCQ1Y | 3-amino-2-(4-chlorophenyl)propane-1-sulfonic acid | SACLOFEN | CAS RN:125464-42-8 | Saclofen | PubChem SID:198977634
+BMGC_DG02274,BMG_DG019010,"PubChem CID:122159 | CAS RN:95851-37-9 | KADSURENONE, (+)- | PubChem SID:472407194 | UNII:DZY9CV5VH7 | Kadsurenone, (+)-"
+BMGC_DG02275,BMG_DG019015,UNII:B31Y10A9UR | LUZINDOLE | PubChem CID:122162 | PubChem SID:434369927 | CAS RN:117946-91-5
+BMGC_DG02276,BMG_DG019055,PubChem CID:122173811 | DrugBank ID:DB05168 | Vintafolide
+BMGC_DG02277,BMG_DG019095,CAS RN:1235995-16-0 | UNII:N9WN9W54QJ | PubChem CID:122179477 | MK-1421 | PubChem SID:459056141
+BMGC_DG02278,BMG_DG019103,"PubChem CID:122184713 | (1S,6R,14S,17R,22S)-10-hydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.03,12.04,9.017,22]docosa-3(12),4(9),10,20-tetraene-8,19-dione | Verruculide A"
+BMGC_DG02279,BMG_DG019106,"PubChem CID:122187 | UNII:1G916IMD7L | 5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin | (7S)-7-(dipropylamino)-4-fluoro-5,6,7,8-tetrahydronaphthalen-1-ol | UH-301 FREE BASE, (S)- | PubChem SID:198976244 | CAS RN:127126-21-0"
+BMGC_DG02280,BMG_DG019107,"CAS RN:130656-51-8 | NIFEKALANT HYDROCHLORIDE | UNII:TPP5R0MDQS | Nifekalant hydrochloride | PubChem SID:198943973 | 6-[2-[2-hydroxyethyl-[3-(4-nitrophenyl)propyl]amino]ethylamino]-1,3-dimethylpyrimidine-2,4-dione;hydrochloride | PubChem CID:122188"
+BMGC_DG02281,BMG_DG019112,UNII:AE3IIW7JBO | N-METHYLETHYLAMINE | CAS RN:624-78-2 | PubChem SID:438787647 | PubChem CID:12219 | DrugBank ID:DB02396 | Methylethylamine
+BMGC_DG02282,BMG_DG019119,"PubChem CID:122195 | DrugBank ID:DB03956 | Inositol 2,4,5-trisphosphate"
+BMGC_DG02283,BMG_DG019209,"PubChem CID:122199235 | PubChem SID:496143977 | IOA-289 | CAMBRITAXESTAT | UNII:LYY3P2KA27 | CAS RN:1979939-16-6 | N-[(1S)-1-(4-chlorophenyl)ethyl]-3-[3-[[4-(trifluoromethoxy)phenyl]methyl]imidazo[4,5-b]pyridin-2-yl]propanamide"
+BMGC_DG02284,BMG_DG019210,"(2S,4R)-1-[(2S)-2-[(1-cyanocyclopropanecarbonyl)amino]-3,3-dimethylbutanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide | VH298 | PubChem CID:122199236 | CAS RN:2097381-85-4"
+BMGC_DG02285,BMG_DG019211,".ALPHA.-METHYL-4-CARBOXYPHENYLGLYCINE, (+/-)- | PubChem CID:1222 | .ALPHA.-METHYL-4-CARBOXYPHENYLGLYCINE, (±)- | PubChem SID:316916018 | CAS RN:146669-29-6 | Alpha-methyl-4-carboxyphenylglycine, (+/-)- | 4-(1-amino-1-carboxyethyl)benzoic acid | UNII:7HJ67IIE31"
+BMGC_DG02286,BMG_DG019247,PubChem SID:318691673 | PubChem CID:122201312 | TAURO-OBETICHOLIC ACID | UNII:T5IG4XE90K | CAS RN:863239-61-6
+BMGC_DG02287,BMG_DG019308,Dalda | (2S)-6-amino-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-phenylpropanoyl]amino]hexanamide | PubChem CID:122222 | CAS RN:118476-85-0
+BMGC_DG02288,BMG_DG019323,"TRETOQUINOL, (+)- | UNII:R3W0Z48O6V | PubChem CID:12224034 | CAS RN:36478-07-6 | PubChem SID:198944292"
+BMGC_DG02289,BMG_DG019330,CAS RN:116817-13-1 | N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine | CAS RN:116539-58-3 | N-Methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine | PubChem CID:122252
+BMGC_DG02290,BMG_DG019333,7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline | DrugBank ID:DB13941 | Piperaquine | CAS RN:1261394-71-1 | PIPERAQUINE | PubChem SID:198972196 | UNII:A0HV2Q956Y | PubChem CID:122262 | CAS RN:4085-31-8
+BMGC_DG02291,BMG_DG019334,"PubChem SID:348481816 | UNII:4CT4CS5BA7 | 2-((2-(Dimethylamino)ethyl)thio)-3-phenylquinoline | PubChem CID:122265 | CAS RN:85273-95-6 | N,N-dimethyl-2-(3-phenylquinolin-2-yl)sulfanylethanamine | ICI-169369 FREE BASE"
+BMGC_DG02292,BMG_DG019337,EFEGATRAN | CAS RN:105806-65-3 | PubChem SID:198955271 | Efegatran | PubChem CID:122267 | UNII:VT0VK2474K | (2S)-N-[(2S)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide
+BMGC_DG02293,BMG_DG019341,"PubChem CID:122272 | 5-(dimethylamino)-N-(3,4-dimethyl-1,2-oxazol-5-yl)naphthalene-1-sulfonamide | 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide | CAS RN:153042-42-3"
+BMGC_DG02294,BMG_DG019349,METHYL ISOCYANATE | Methyl isocyanate | PubChem CID:12228 | UNII:C588JJ4BV9 | CAS RN:624-83-9 | Methyl Isocyanate | PubChem SID:198979419 | DrugBank ID:DB12765 | methylimino(oxo)methane
+BMGC_DG02295,BMG_DG019350,"PubChem CID:122281 | CAS RN:1852-50-2 | 16-Glucuronide-estriol | (2S,3S,4S,5R,6R)-6-[[(8R,9S,13S,14S,16R,17R)-3,17-dihydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid"
+BMGC_DG02296,BMG_DG019351,"CAS RN:10095-06-4 | Mebicar | UNII:55FE6NPG89 | CAS RN:106780-29-4 | DrugBank ID:DB13522 | 1,3,4,6-tetramethyl-3a,6a-dihydroimidazo[4,5-d]imidazole-2,5-dione | PubChem SID:198949769 | PubChem CID:122282 | TEMGICOLURIL"
+BMGC_DG02297,BMG_DG019357,CAS RN:56643-68-6 | 1-(3-Chlorobenzyl)imidazole | PubChem CID:12229386 | PubChem SID:485663651 | UNII:3RAW2D7YTD | 1-(3-CHLOROBENZYL)IMIDAZOLE
+BMGC_DG02298,BMG_DG019358,PubChem CID:12229388 | PubChem SID:472422252 | 1-((4-FLUOROPHENYL)METHYL)IMIDAZOLE | UNII:7J8LU26YRA | CAS RN:56643-73-3
+BMGC_DG02299,BMG_DG019359,PubChem CID:12229396 | DrugBank ID:DB08369 | 1-(biphenyl-4-ylmethyl)-1H-imidazole
+BMGC_DG02300,BMG_DG019360,"PubChem CID:122295 | SK&F 104078 | PubChem SID:198945817 | UNII:22XBK6DY1E | 6-chloro-3-methyl-9-(3-methylbut-2-enoxy)-1,2,4,5-tetrahydro-3-benzazepine | CAS RN:110857-22-2 | SKF-104078"
+BMGC_DG02301,BMG_DG019362,CAS RN:130982-43-3 | [(1R)-1-[[(2S)-1-[(2R)-2-acetamido-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-4-(diaminomethylideneamino)butyl]boronic acid | PubChem CID:122296 | Acetylphenylalanyl-prolyl-boroarginine
+BMGC_DG02302,BMG_DG019372,"PubChem CID:122312 | 3Alpha,7Alpha,12Alpha-trihydroxy-5Beta-cholestan-26-oic acid | (6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid | CAS RN:547-98-8"
+BMGC_DG02303,BMG_DG019380,"2,2-Dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide | 2,2-dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide | PubChem SID:348481339 | PubChem CID:122327 | PD-128042 | CAS RN:114289-47-3 | UNII:8653IQ20EA"
+BMGC_DG02304,BMG_DG019385,"PubChem CID:122334 | 5-Methoxy-1-methyl-2-(n-propylamino)tetralin | (1S,2R)-5-methoxy-1-methyl-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine | CAS RN:85379-09-5"
+BMGC_DG02305,BMG_DG019386,"Efaproxiral | PubChem SID:198983237 | EFAPROXIRAL | CAS RN:131179-95-8 | UNII:J81E81G364 | PubChem CID:122335 | DrugBank ID:DB08486 | 2-[4-[2-(3,5-dimethylanilino)-2-oxoethyl]phenoxy]-2-methylpropanoic acid"
+BMGC_DG02306,BMG_DG019387,"Trehalose-6-phosphate | Trehalose-6-Phosphate | DrugBank ID:DB02430 | CAS RN:4484-88-2 | [(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl dihydrogen phosphate | PubChem CID:122336"
+BMGC_DG02307,BMG_DG019396,"PubChem SID:441659203 | CAS RN:1518-89-4 | PubChem CID:12234986 | 4-[(2R)-2-aminopropyl]phenol | UNII:F4LK5VKU9B | HYDROXYAMPHETAMINE, (R)- | Hydroxyamphetamine, (R)-"
+BMGC_DG02308,BMG_DG019405,N-(4-aminobutyl)acetamide | N-ACETYLPUTRESCINE | PubChem SID:461432489 | N-Acetylputrescine | CAS RN:5699-41-2 | UNII:8FTM5ZL5A6 | PubChem CID:122356
+BMGC_DG02309,BMG_DG019406,"CAS RN:585-18-2 | D-Erythrose 4-phosphate | UNII:2156QF7O8M | [(2R,3R)-2,3-dihydroxy-4-oxobutyl] dihydrogen phosphate | DrugBank ID:DB03937 | PubChem CID:122357 | D-erythrose 4-phosphate | ERYTHROSE 4-PHOSPHATE, D- | PubChem SID:198963191"
+BMGC_DG02310,BMG_DG019500,"PubChem CID:1224 | 6-tert-butyl-3-azapentacyclo[11.8.1.03,8.09,22.016,21]docosa-9,11,13(22),16,18,20-hexaen-6-ol | 3-Tert-butyl-2,3,4,4a,8,9,13b,14-octahydro-1h-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol"
+BMGC_DG02311,BMG_DG019532,"CAS RN:1973494-16-4 | PubChem CID:122428084 | UNII:Y983WLP5LE | BA-1049, (R)- | PubChem SID:474494598"
+BMGC_DG02312,BMG_DG019533,"PubChem SID:496143477 | UNII:58W44AA6DK | PubChem CID:122429808 | Gsk3186899 | GSK-3186899 | CAS RN:1972617-87-0 | 3,3,3-trifluoro-N-[4-[[3-[(2S)-2-methylmorpholin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl]amino]cyclohexyl]propane-1-sulfonamide"
+BMGC_DG02313,BMG_DG019538,"(2R,3R,4S,5R,6R)-2-(5-bromopyridin-3-yl)sulfanyl-6-(hydroxymethyl)-4-[4-(3,4,5-trifluorophenyl)triazol-1-yl]oxane-3,5-diol | SELVIGALTIN | CAS RN:1978336-95-6 | PubChem SID:474492466 | PubChem CID:122443488 | UNII:94EN2E6BLW | Selvigaltin"
+BMGC_DG02314,BMG_DG019554,"BOMEDEMSTAT | Bomedemstat | CAS RN:1990504-34-1 | DrugBank ID:DB15126 | PubChem SID:376072975 | UNII:Y2T4ALDEAT | N-[(2S)-5-[[(1R,2S)-2-(4-fluorophenyl)cyclopropyl]amino]-1-(4-methylpiperazin-1-yl)-1-oxopentan-2-yl]-4-(triazol-1-yl)benzamide | PubChem CID:122460381"
+BMGC_DG02315,BMG_DG019581,"CAS RN:80751-65-1 | PubChem SID:316909972 | PubChem CID:1225 | SK&F 82958 | SKF-82958 | UNII:7W60FE897Q | 9-chloro-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol"
+BMGC_DG02316,BMG_DG019588,BMS-986260 | PubChem SID:459275498 | PubChem CID:122510453 | CAS RN:2001559-19-7 | UNII:3ERE9QW3XH
+BMGC_DG02317,BMG_DG019590,"(1R,2R,6S,7R)-4,10-dioxatricyclo[5.2.1.02,6]decane-3,5-dione | Demethylcantharidin | PubChem CID:12251907"
+BMGC_DG02318,BMG_DG019605,"LENUMLOSTAT | [3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]-[(3R,4R)-3-fluoro-4-hydroxypyrrolidin-1-yl]methanone | PubChem SID:434369764 | Lenumlostat | UNII:Y3HMF6G24B | CAS RN:2098884-52-5 | CAS RN:2007885-39-2 | PubChem CID:122536283 | Pat-1251"
+BMGC_DG02319,BMG_DG019640,"Bms-986235 | BMS-986235 | CAS RN:2253947-47-4 | 1-[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-3-phenylurea | PubChem CID:122583088 | PubChem SID:459275370 | UNII:F8S5G34WY1"
+BMGC_DG02320,BMG_DG019641,"(2R)-2-[(2-amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino]-2-methylhexan-1-ol | CID 122585078 | PubChem CID:122585078 | CAS RN:2004677-13-6"
+BMGC_DG02321,BMG_DG019655,"UNII:A2G9VU2P2J | CAS RN:7361-76-4 | PubChem SID:198963523 | PENTAZOCINE, (+)- | PubChem CID:12259685"
+BMGC_DG02322,BMG_DG019656,"LARTESERTIB | M-4076 | Lartesertib | UNII:KL7B6D38VC | 8-(1,3-dimethylpyrazol-4-yl)-1-(3-fluoro-5-methoxypyridin-4-yl)-7-methoxy-3-methylimidazo[4,5-c]quinolin-2-one | CAS RN:2495096-26-7 | CAS RN:2020089-41-0 | PubChem SID:445499378 | PubChem CID:122599280"
+BMGC_DG02323,BMG_DG019670,Z-Pro-Prolinal | PubChem SID:438788309 | CAS RN:88795-32-8 | PubChem CID:122623 | UNII:4YM8D0GKX6 | DrugBank ID:DB03535 | Z-PRO-PROLINAL
+BMGC_DG02324,BMG_DG019676,PubChem SID:316913856 | DOAM | CAS RN:63779-90-8 | PubChem CID:12262512 | UNII:N80EWL36CB
+BMGC_DG02325,BMG_DG019680,"PubChem CID:122632882 | CAS RN:1817791-73-3 | N-(2,6-diethylphenyl)-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]-5,6-dihydropyrimido[4,5-e]indolizine-7-carboxamide"
+BMGC_DG02326,BMG_DG019681,"PubChem CID:122633900 | 4-(methylamino)-2-[4-methyl-3-(prop-2-enoylamino)anilino]-N-[2-methyl-5-[(3,4,5-trimethoxybenzoyl)amino]phenyl]pyrimidine-5-carboxamide | Chmfl-bmx-078 | CAS RN:1808288-51-8"
+BMGC_DG02327,BMG_DG019682,"PubChem CID:122635 | EMODIN-9-ANTHRONE | 1,3,8-trihydroxy-6-methyl-10H-anthracen-9-one | PubChem SID:198960793 | CAS RN:491-60-1 | UNII:77C500W1A2 | Emodin anthrone"
+BMGC_DG02328,BMG_DG019690,PubChem CID:122644519 | 5-hydroxy-2-(4-hydroxyphenyl)-N-methyl-4-(piperidin-1-ylmethyl)-1-benzofuran-3-carboxamide | 2-(4-Hydroxyphenyl)-~{n}-Methyl-5-Oxidanyl-4-(Piperidin-1-Ylmethyl)-1-Benzofuran-3-Carboxamide
+BMGC_DG02329,BMG_DG019692,PURINOSTAT | CAS RN:1929583-17-4 | PubChem SID:440088821 | UNII:FTV8V4AYQ8 | PubChem CID:122648367
+BMGC_DG02330,BMG_DG019694,"Risvodetinib | RISVODETINIB | CAS RN:2031185-00-7 | N-[4-methyl-3-[[4-[5-(4-methyl-1,2-oxazol-5-yl)pyridin-3-yl]pyrimidin-2-yl]amino]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide | UNII:2QG2B2XW2I | PubChem CID:122650693 | PubChem SID:478838313"
+BMGC_DG02331,BMG_DG019708,"UNII:F9736DF7CF | ETHYLBENZOPRIM | Ethylbenzoprim | CAS RN:118344-72-2 | PubChem CID:122668 | 5-[4-[benzyl(ethyl)amino]-3-nitrophenyl]-6-ethylpyrimidine-2,4-diamine | PubChem SID:461433009"
+BMGC_DG02332,BMG_DG019711,"PubChem CID:122670110 | (1S,2S)-2-[5-(5-chloro-2,4-difluoro-N-(2-fluoro-2-methylpropyl)anilino)-3-methoxypyrazine-2-carbonyl]cyclopropane-1-carboxylic acid | PubChem SID:496142919 | CAS RN:2042347-69-1 | (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic acid | UNII:CH43TDX2PU | AZD-9898"
+BMGC_DG02333,BMG_DG019712,DrugBank ID:DB02796 | PubChem CID:122671 | 9-deazainosine
+BMGC_DG02334,BMG_DG019721,"(1R,2R)-2-[4-(5-methyl-1H-pyrazol-3-yl)benzoyl]-N-(4-oxo-6,7-dihydro-5H-pyrazolo[1,5-a]pyrazin-3-yl)cyclohexane-1-carboxamide | UNII:NV6352Y6TV | PubChem CID:122678117 | PubChem SID:443624836 | CAS RN:2041075-86-7 | Atuliflapon | ATULIFLAPON"
+BMGC_DG02335,BMG_DG019734,"AZELAPRAG | Azelaprag | (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide | PubChem SID:375579612 | PubChem CID:122702529 | UNII:4B8REJ8ZGY | CAS RN:2049980-18-7"
+BMGC_DG02336,BMG_DG019939,MAGALDRATE | DrugBank ID:DB08938 | PubChem SID:319892020 | pentaaluminum;decamagnesium;hentriacontahydroxide;disulfate;hydrate | UNII:6V88E24N5T | Magaldrate | CAS RN:74978-16-8 | PubChem CID:122706784
+BMGC_DG02337,BMG_DG019940,"PubChem SID:319892026 | PSMA-617 Lu-177 | 2-[4-[2-[[4-[[(2S)-1-[[(5S)-5-carboxy-5-[[(1S)-1,3-dicarboxypropyl]carbamoylamino]pentyl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]carbamoyl]cyclohexyl]methylamino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;lutetium-177(3+) | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN | CAS RN:1703749-62-5 | NDC:69488-010 | UNII:G6UF363ECX | PubChem CID:122706785"
+BMGC_DG02338,BMG_DG019941,"(2S)-2-[[(1S)-1-carboxy-5-[[(2S)-3-naphthalen-2-yl-2-[[4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]methyl]cyclohexanecarbonyl]amino]propanoyl]amino]pentyl]carbamoylamino]pentanedioic acid | VIPIVOTIDE TETRAXETAN | PubChem CID:122706786 | CAS RN:1702967-37-0 | Vipivotide tetraxetan | UNII:4YM1W0EGQ5 | PubChem SID:376231198"
+BMGC_DG02339,BMG_DG019991,"PubChem CID:122724 | CELASTROL | (2R,4aS,6aR,6aS,14aS,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6,13,14,14b-octahydropicene-2-carboxylic acid | Celastrol | CAS RN:34157-83-0 | UNII:L8GG98663L | PubChem SID:198979715"
+BMGC_DG02340,BMG_DG020025,PubChem SID:198941754 | PubChem CID:122796 | UNII:OPH24O2PWB | PD-117596 | CAS RN:99734-98-2
+BMGC_DG02341,BMG_DG020032,"PubChem CID:122805 | 9-(3,4-DIMETHOXY-PHENYL)-8-H-FURO(3',4':6,7)NAPHTHO(2,3-D)(1,3)DIOXOL-6-ONE | UNII:FPB7483LCY | CAS RN:5707-96-0 | PubChem SID:377307989"
+BMGC_DG02342,BMG_DG020045,PubChem CID:122826 | PubChem SID:198953678 | UNII:FGW9D01COE | AAPTAMINE | CAS RN:85547-22-4
+BMGC_DG02343,BMG_DG020047,"UNII:5O052W0G6I | PubChem SID:198976265 | 6-Methyluracil | CAS RN:626-48-2 | PubChem CID:12283 | 6-methyl-1H-pyrimidine-2,4-dione | 6-METHYLURACIL"
+BMGC_DG02344,BMG_DG020050,"CAS RN:97743-96-9 | PubChem CID:122838 | UNII:V44PLT6RWZ | XESTOQUINONE, (+)- | PubChem SID:472424663"
+BMGC_DG02345,BMG_DG020058,PubChem SID:384647709 | BETULONIC ACID | PubChem CID:122844 | UNII:7C1UV6ITF5 | CAS RN:4481-62-3
+BMGC_DG02346,BMG_DG020061,"PubChem CID:122850 | Aromadendrin | UNII:7YA4640575 | CAS RN:480-20-6 | CAS RN:104486-98-8 | PubChem SID:198939337 | (2R,3R)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | AROMADENDRIN"
+BMGC_DG02347,BMG_DG020077,UNII:J6NE4PR3ER | PubChem SID:485666645 | CAS RN:446269-58-5 | 6-Chloro-N-[2-(4-morpholinyl)ethyl]-3-pyridinecarboxamide | PubChem CID:1228702 | 6-CHLORO-N-(2-(4-MORPHOLINYL)ETHYL)-3-PYRIDINECARBOXAMIDE
+BMGC_DG02348,BMG_DG020079,PubChem SID:348481122 | CYCLIC HPMPC | PubChem CID:122873 | UNII:BO8PRP86RH | CAS RN:127757-45-3
+BMGC_DG02349,BMG_DG020089,"PubChem CID:1229 | DOI | PubChem SID:316910948 | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine | 4-Iodo-2,5-dimethoxyphenylisopropylamine | CAS RN:82830-53-3 | UNII:OOM10GW9UE | CAS RN:64584-34-5"
+BMGC_DG02350,BMG_DG020095,CAS RN:32596-43-3 | PubChem CID:122912 | UNII:VFD8T994MW | 5-Chloro-2-hydroxyisophthalaldehyde | PubChem SID:472414704 | 5-CHLORO-2-HYDROXYISOPHTHALALDEHYDE
+BMGC_DG02351,BMG_DG020118,CAS RN:2879-14-3 | PubChem SID:287445916 | UNII:0S2BVG6C31 | 8-PHENYLXANTHINE | PubChem CID:12295530
+BMGC_DG02352,BMG_DG020119,PubChem SID:381132234 | UNII:3IGY251T33 | PubChem CID:12295531 | 8-PHENYLCAFFEINE | CAS RN:6439-88-9
+BMGC_DG02353,BMG_DG020139,PubChem CID:12298033 | .BETA.-HYDROXY-CARFENTANIL | UNII:79P5284592 | PubChem SID:478839459 | β-hydroxy-Carfentanil
+BMGC_DG02354,BMG_DG020156,PubChem CID:123 | UNII:FZN0LJN8CC | TIFORMIN | Tiformin | PubChem SID:198964095 | 4-(diaminomethylideneamino)butanamide | CAS RN:4210-97-3
+BMGC_DG02355,BMG_DG020218,SCUTELLARIC ACID | UNII:GKB52TAX5N | PubChem SID:198950175 | PubChem CID:12302571 | CAS RN:102919-76-6
+BMGC_DG02356,BMG_DG020219,"CAS RN:69-79-4 | L-Glc(a1-4)a-L-Glc | (2S,3R,4R,5S,6S)-2-(hydroxymethyl)-6-[(2S,3R,4S,5S,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol | PubChem CID:12302673"
+BMGC_DG02357,BMG_DG020340,"(2S,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-2-carboxylic acid | PubChem CID:12305517 | CAS RN:564-16-9 | 11-Deoxoglycyrrhetinic acid"
+BMGC_DG02358,BMG_DG020380,"2-phenyl-2-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}acetonitrile | 2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | PubChem CID:12306131 | CAS RN:29883-15-6"
+BMGC_DG02359,BMG_DG020381,PubChem CID:12306155 | UNII:XLL7MH4OJO | .ALPHA.-AMYRENONE | CAS RN:638-96-0 | PubChem SID:198961616
+BMGC_DG02360,BMG_DG020406,BENZYL 2-NAPHTHYL ETHER | UNII:TT5AWE5U2C | Benzyl 2-naphthyl ether | CAS RN:613-62-7 | PubChem CID:123080 | PubChem SID:478837166
+BMGC_DG02361,BMG_DG020432,LUTEOLIN 3'-GLUCOSIDE | UNII:NE54EDY436 | PubChem CID:12309350 | CAS RN:5154-41-6 | PubChem SID:252320408
+BMGC_DG02362,BMG_DG020462,"PubChem CID:12309904 | UNII:2X3E5GQF9F | 3',4',7,8-TETRAHYDROXYFLAVANONE, (+/-)- | CAS RN:489-73-6"
+BMGC_DG02363,BMG_DG020482,"CAS RN:14226-18-7 | (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2-(hydroxymethyl)-2,4a,6a,6b,9,9,12a-heptamethyl-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picen-13-one | 30-Hydroxy-11-oxo-beta-amyrin | PubChem CID:12310283"
+BMGC_DG02364,BMG_DG020483,"Glycoursodeoxycholic acid | CAS RN:64480-66-6 | UNII:PF1G5J2X2A | PubChem CID:12310288 | URSODEOXYCHOLYLGLYCINE | PubChem SID:198977798 | 2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid"
+BMGC_DG02365,BMG_DG020565,"CAS RN:572-76-9 | UNII:7T6VF792DB | NANDININE | PubChem SID:198941568 | (1S)-17-methoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaen-16-ol | Nandinine | PubChem CID:12313091"
+BMGC_DG02366,BMG_DG020621,"5,7-Dihydroxy-2-(4-Hydroxyphenyl)-3-(3,4,5-Trihydroxy-6-((3,4,5-Trihydroxy-6-Methyloxan-2-Yl)Oxymethyl)Oxan-2-Yl)Oxychromen-4-One | PubChem CID:12313332 | 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-4-one"
+BMGC_DG02367,BMG_DG020667,"PubChem CID:123133557 | sodium;2-[[(2S)-2-[[(4R)-4-[[(2S)-2-[[(2R)-2-[(2R,3R,4R,5R)-2-acetamido-4,5,6-trihydroxy-1-oxohexan-3-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoyl]amino]propanoyl]amino]ethyl [(2R)-2,3-di(hexadecanoyloxy)propyl] phosphate;hydrate | CAS RN:838853-48-8 | DrugBank ID:DB13615 | PubChem SID:322058943 | UNII:1LM890Q4FY | Mifamurtide | MIFAMURTIDE"
+BMGC_DG02368,BMG_DG020685,"PubChem CID:123134034 | CAS RN:68-19-9 | carbanide;cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate | CAS RN:13422-55-4"
+BMGC_DG02369,BMG_DG020716,UNII:JV79HC9A5B | CAS RN:17990-42-0 | PubChem CID:12313704 | OLEANONIC ACID
+BMGC_DG02370,BMG_DG020739,"UNII:CT36KGC6A6 | CAS RN:1182-87-2 | PubChem CID:12314120 | (3S,5R,8R,9S,10R,13R,14S,17R)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde | DrugBank ID:DB13756 | PERUVOSIDE | Peruvoside | PubChem SID:241180202"
+BMGC_DG02371,BMG_DG020841,4-Methoxybenzyl isothiocyanate | UNII:2PA7V3TJK2 | PubChem CID:123197 | 4-METHOXYBENZYL ISOTHIOCYANATE | 1-(isothiocyanatomethyl)-4-methoxybenzene | PubChem SID:445499370 | CAS RN:3694-57-3
+BMGC_DG02372,BMG_DG020887,"PubChem CID:12329382 | UNII:B6E8U4IPLT | CAS RN:33817-12-8 | ETILAMFETAMINE, (R)- | PubChem SID:329904142"
+BMGC_DG02373,BMG_DG020889,"UNII:44AS82FRSI | PubChem CID:1233 | PubChem SID:241177841 | 2-amino-2-(3-oxo-1,2-oxazol-5-yl)acetic acid | IBOTENIC ACID | CAS RN:2552-55-8 | Ibotenic acid"
+BMGC_DG02374,BMG_DG020913,PubChem SID:198960757 | 4-HYDROXYPHENYL METHYL SULFONE | CAS RN:14763-60-1 | UNII:F7BIF7ZQJ9 | PubChem CID:123350
+BMGC_DG02375,BMG_DG020914,perchlorate | Perchlorate | PubChem CID:123351 | PubChem SID:198963898 | DrugBank ID:DB03138 | PERCHLORATE ION | CAS RN:14797-73-0 | UNII:VLA4NZX2P4
+BMGC_DG02376,BMG_DG020916,"CAS RN:16214-27-0 | UNII:7LZB7QNE77 | PubChem CID:123358 | 1,2-Indandione | 1,2-INDANDIONE | PubChem SID:474492534"
+BMGC_DG02377,BMG_DG020944,"5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile | DrugBank ID:DB12923 | PubChem CID:1234 | CAS RN:16662-47-8 | PubChem SID:198959802 | GALLOPAMIL | UNII:39WPC8JHR8 | Gallopamil"
+BMGC_DG02378,BMG_DG020968,BROMOSELENOBENZENE | PubChem SID:485662894 | Bromoselenobenzene | UNII:SSC5P7WU8V | PubChem CID:123446 | CAS RN:34837-55-3
+BMGC_DG02379,BMG_DG020994,CAS RN:39627-84-4 | PubChem SID:478839326 | 2-Naphthoylhydrazide | UNII:QUU59P67B5 | 2-NAPHTHOYLHYDRAZIDE | PubChem CID:123485
+BMGC_DG02380,BMG_DG021003,"CAS RN:7619-35-4 | 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-allyl-6,11-dimethyl- | CAS RN:825594-24-9 | 1,13-dimethyl-10-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | PubChem CID:1235"
+BMGC_DG02381,BMG_DG021014,"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE | PubChem CID:1235170 | DrugBank ID:DB08705"
+BMGC_DG02382,BMG_DG021059,"2,6-Difluorophenylacetic acid | CAS RN:85068-28-6 | UNII:Y45QQ4KF4U | PubChem SID:485662239 | PubChem CID:123585 | 2,6-DIFLUOROPHENYLACETIC ACID"
+BMGC_DG02383,BMG_DG021088,"UNII:6EE945D3OK | CAS RN:6147-18-8 | PubChem SID:175272138 | DEXMECAMYLAMINE | PubChem CID:12358972 | PubChem SID:198937590 | Dexmecamylamine | UNII:5Y1141YI4U | DrugBank ID:DB11807 | CAS RN:107538-05-6 | (1R,2S,4S)-N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine | MECAMYLAMINE"
+BMGC_DG02384,BMG_DG021107,"Niguldipine | NIGULDIPINE, (+/-)- | 5-O-[3-(4,4-diphenylpiperidin-1-yl)propyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | PubChem CID:1236 | NIGULDIPINE, (±)- | PubChem SID:316915988 | CAS RN:102993-22-6 | UNII:6Q39TPF0GL"
+BMGC_DG02385,BMG_DG021108,Levalbuterol | LEVALBUTEROL | Levosalbutamol | PubChem SID:175267044 | CAS RN:324000-04-6 | CAS RN:34391-04-3 | NDC:43598-409 | NDC:43598-412 | NDC:43598-410 | PubChem CID:123600 | DrugBank ID:DB13139 | UNII:EDN2NBH5SS | 4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol
+BMGC_DG02386,BMG_DG021113,"PubChem SID:175268547 | N,N-dimethyl-2-[5-(pyrrolidin-1-ylsulfonylmethyl)-1H-indol-3-yl]ethanamine | ALMOTRIPTAN | DrugBank ID:DB00918 | CAS RN:154323-57-6 | UNII:1O4XL5SN61 | PubChem CID:123606 | Almotriptan"
+BMGC_DG02387,BMG_DG021118,"Integrilin | 2-[20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid | CAS RN:148031-34-9 | PubChem CID:123610"
+BMGC_DG02388,BMG_DG021121,CAS RN:75970-99-9 | DrugBank ID:DB06457 | UNII:W5DCO14M05 | Tecastemizole | 1-[(4-fluorophenyl)methyl]-N-piperidin-4-ylbenzimidazol-2-amine | TECASTEMIZOLE | PubChem SID:198989887 | PubChem CID:123618
+BMGC_DG02389,BMG_DG021122,UNII:WRX4NFY03R | 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine | DrugBank ID:DB01628 | PubChem CID:123619 | ETORICOXIB | CAS RN:202409-33-4 | Etoricoxib | PubChem SID:175266728
+BMGC_DG02390,BMG_DG021131,"UNII:SE10G96M8W | PubChem SID:175267759 | DrugBank ID:DB01606 | TAZOBACTAM | (2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | CAS RN:1246733-29-8 | CAS RN:89786-04-9 | Tazobactam | PubChem CID:123630"
+BMGC_DG02391,BMG_DG021132,PubChem SID:175266245 | NDC:50742-366 | NDC:60505-4512 | NDC:67184-0531 | PubChem CID:123631 | CAS RN:184475-35-2 | NDC:0310-0482 | NDC:69339-168 | DrugBank ID:DB00317 | GEFITINIB | Gefitinib | N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine | UNII:S65743JHBS | NDC:0480-4053
+BMGC_DG02392,BMG_DG021134,"[(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate;(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol;(8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol | CAS RN:66100-41-2 | PubChem CID:123634 | Trisekvens"
+BMGC_DG02393,BMG_DG021140,PubChem CID:1236449 | UNII:MAT6XRA834 | PubChem SID:461432648 | CAS RN:112809-54-8 | 4-(IMIDAZOL-1-YLMETHYL)BENZONITRILE
+BMGC_DG02394,BMG_DG021142,2-NITRO-5-THIOBENZOIC ACID | 5-Mercapto-2-Nitro-Benzoic Acid | PubChem SID:241180715 | UNII:OWT399B07G | DrugBank ID:DB02763 | CAS RN:15139-21-6 | PubChem CID:123648
+BMGC_DG02395,BMG_DG021149,"Propyl beta-carboline-3-carboxylate | CAS RN:76808-18-9 | PubChem CID:123662 | propyl 9H-pyrido[3,4-b]indole-3-carboxylate"
+BMGC_DG02396,BMG_DG021168,"PubChem SID:198971672 | PubChem CID:123683 | UNII:30679UMI0N | (2S,3S,4R,5R)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]-N-methyloxolane-2-carboxamide | CAS RN:152918-18-8 | PICLIDENOSON | Piclidenoson | IB-Meca | DrugBank ID:DB05511"
+BMGC_DG02397,BMG_DG021170,PubChem SID:316917497 | 1-[2-[[3-(2-Cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea | CAS RN:53671-71-9 | PubChem CID:123686 | 1-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-3-phenylurea | ICI-89406 | UNII:C027IY98WE
+BMGC_DG02398,BMG_DG021175,1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine | CAS RN:112726-66-6 | PubChem CID:123692 | PubChem SID:363909726 | UNII:Q1WR6UP7MW | 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine | BENOCYCLIDINE
+BMGC_DG02399,BMG_DG021191,PubChem CID:123715 | PubChem SID:381608590 | UNII:DS6B3J0V03 | L-TYROSYLGLYCYLGLYCINE | CAS RN:21778-69-8
+BMGC_DG02400,BMG_DG021198,(2R)-2-cyclopentyl-2-[4-(quinolin-2-ylmethoxy)phenyl]acetic acid | CAS RN:128253-31-6 | PubChem CID:123723 | PubChem SID:198972657 | VELIFLAPON | Veliflapon | UNII:JXH6X663L0
+BMGC_DG02401,BMG_DG021202,"[2-aminoethoxy(hydroxy)phosphoryl] [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate | CDP-Ethanolamine | PubChem CID:123727 | CAS RN:3036-18-8"
+BMGC_DG02402,BMG_DG021206,"CAS RN:629-11-8 | DrugBank ID:DB02210 | CAS RN:27236-13-1 | Hexane-1,6-diol | PubChem CID:12374 | PubChem SID:175267534 | UNII:ZIA319275I | HEXANEDIOL | hexane-1,6-diol | Hexane-1,6-Diol"
+BMGC_DG02403,BMG_DG021209,3-[(2-benzyl-3-sulfanylpropanoyl)amino]propanoic acid | CAS RN:100845-83-8 | PubChem CID:123742 | SQ 28603
+BMGC_DG02404,BMG_DG021210,"7alpha-Hydroxy-4-cholesten-3-one | PubChem CID:123743 | (7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | CAS RN:3862-25-7"
+BMGC_DG02405,BMG_DG021245,UNII:E65W20MU7A | PubChem SID:198986015 | CAS RN:13448-22-1 | CLOROTEPINE | PubChem CID:1238
+BMGC_DG02406,BMG_DG021248,DrugBank ID:DB09139 | TECHNETIUM TC-99M OXIDRONATE | PubChem CID:123801 | PubChem SID:346539087 | UNII:MG4KI49HHJ | CAS RN:72945-61-0 | [hydroxy(phosphono)methyl]phosphonic acid;technetium-99 | Technetium Tc-99m oxidronate | Technetium Tc 99m oxidronate
+BMGC_DG02407,BMG_DG021251,"PubChem SID:375085318 | Angiotensin 1-7 | ANGIOTENSIN 1-7 | (2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid | CAS RN:39386-80-6 | UNII:IJ3FUK8MOF | PubChem CID:123805 | Angiotensin (1-7) | DrugBank ID:DB11720 | TALFIRASTIDE | CAS RN:51833-78-4"
+BMGC_DG02408,BMG_DG021252,UNII:JX2F2W6WSP | 2-CHLORO-N6-CYCLOPENTYLADENOSINE | 2-Chloro-N6-cyclopentyladenosine | PubChem CID:123807 | CAS RN:37739-05-2 | PubChem SID:474492511
+BMGC_DG02409,BMG_DG021254,"(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid;2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide | PubChem CID:123809 | CAS RN:37270-69-2 | Modopar"
+BMGC_DG02410,BMG_DG021256,(3S)-3-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid | CAS RN:96426-21-0 | Glycyl-arginyl-glycyl-aspartyl-serine | PubChem CID:123811
+BMGC_DG02411,BMG_DG021259,"CAS RN:23025-68-5 | CAS RN:12676-15-2 | Angiotensin IV | PubChem CID:123814 | (2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid"
+BMGC_DG02412,BMG_DG021273,"CAS RN:1313730-20-9 | CAS RN:65005-57-4 | N,N-dimethylarginine | CAS RN:30315-93-6 | PubChem SID:316911187 | (2S)-2-amino-5-[[amino(dimethylamino)methylidene]amino]pentanoic acid | N,N-DIMETHYLARGININE | UNII:63CV1GEK3Y | DrugBank ID:DB01686 | PubChem CID:123831 | N,N-Dimethylarginine"
+BMGC_DG02413,BMG_DG021275,"CAS RN:862377-31-9 | CAS RN:171598-74-6 | CAS RN:3466-75-9 | 9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol | Dihydrotetrabenazine | CAS RN:862377-29-5 | PubChem CID:123836"
+BMGC_DG02414,BMG_DG021281,"CYCLIC ADP-RIBOSE | PubChem CID:123847 | PubChem SID:317229221 | (2R,3R,4S,5R,13R,14S,15R,16R)-8,10-dihydroxy-24-imino-8,10-dioxo-7,9,11,25,26-pentaoxa-1,17,19,22-tetraza-8lambda5,10lambda5-diphosphapentacyclo[18.3.1.12,5.113,16.017,21]hexacosa-18,20,22-triene-3,4,14,15-tetrol | UNII:Q780BR06V8 | CAS RN:119340-53-3 | Cyclic ADP-Ribose"
+BMGC_DG02415,BMG_DG021295,"DrugBank ID:DB04263 | PubChem CID:123865 | CAS RN:49863-47-0 | UNII:A08F5XTI6G | Geneticin | PubChem SID:198948062 | GENETICIN | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-[(1R)-1-hydroxyethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol"
+BMGC_DG02416,BMG_DG021299,DrugBank ID:DB13723 | PubChem SID:198969815 | CAS RN:802032-35-5 | 3-[(trimethylazaniumyl)amino]propanoate | CAS RN:76144-81-5 | PubChem CID:123868 | MELDONIUM | Meldonium | UNII:73H7UDN6EC
+BMGC_DG02417,BMG_DG021304,"L-TOPAQUINONE | PubChem SID:318164361 | UNII:PAG3GKA51Y | (2S)-2-amino-3-(6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl)propanoic acid | DrugBank ID:DB04334 | PubChem CID:123871 | CAS RN:135791-48-9 | CAS RN:64192-68-3 | 6-hydroxydopa quinone | L-Topaquinone"
+BMGC_DG02418,BMG_DG021308,"UNII:P1ALI72U6C | PubChem CID:123879 | PubChem SID:198937833 | DrugBank ID:DB13036 | Ramatroban | RAMATROBAN | 3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid | CAS RN:116649-85-5"
+BMGC_DG02419,BMG_DG021314,PubChem CID:123883 | CAS RN:150210-46-1 | TAK-044 free acid | TAK-044 FREE ACID | UNII:GV4UZC9M2H | PubChem SID:485666279
+BMGC_DG02420,BMG_DG021322,CAS RN:53054-07-2 | DrugBank ID:DB03144 | UNII:J2FGL272NZ | N(5)-[(hydroxyamino)(imino)methyl]-L-ornithine | (2S)-2-amino-5-[[amino-(hydroxyamino)methylidene]amino]pentanoic acid | N-omega-Hydroxy-L-arginine | PubChem CID:123895 | PubChem SID:472424036 | N-OMEGA-HYDROXY-L-ARGININE
+BMGC_DG02421,BMG_DG021331,".ALPHA.-D-GALACTOSE 1-PHOSPHATE | Alpha-D-Galactose-1-Phosphate | CAS RN:2255-14-3 | UNII:4Z9Z6N3GH4 | alpha-D-Galactose 1-phosphate | PubChem SID:472423963 | DrugBank ID:DB02317 | [(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate | PubChem CID:123912"
+BMGC_DG02422,BMG_DG021332,UNII:H7125Z98HT | PubChem SID:198969993 | PubChem CID:123913 | CAS RN:13115-71-4 | GLYCYL-GLUTAMINE
+BMGC_DG02423,BMG_DG021336,"CAS RN:76543-15-2 | 3,4-bis[(3-hydroxyphenyl)methyl]oxolan-2-one | 3,4-Bis[(3-hydroxyphenyl)methyl]oxolan-2-one | CAS RN:918502-72-4 | PubChem CID:123917"
+BMGC_DG02424,BMG_DG021340,"PubChem SID:241178484 | 7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE | 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline | PubChem CID:123920 | CAS RN:61563-24-4 | 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline | UNII:A0EP5O913J | DrugBank ID:DB08550"
+BMGC_DG02425,BMG_DG021342,SNC-80 | UNII:L842QB22SW | CAS RN:156727-74-1 | PubChem SID:440793835 | PubChem CID:123924
+BMGC_DG02426,BMG_DG021351,DrugBank ID:DB11876 | UNII:U5JDO2770Z | l-Alanyl-l-glutamine | PubChem SID:175267234 | Alanyl glutamine | ALANYL GLUTAMINE | CAS RN:210541-56-3 | CAS RN:39537-23-0 | (2S)-5-amino-2-[[(2S)-2-aminopropanoyl]amino]-5-oxopentanoic acid | PubChem CID:123935
+BMGC_DG02427,BMG_DG021353,CAS RN:636-58-8 | (2S)-2-amino-5-[[(1R)-1-carboxy-2-sulfanylethyl]amino]-5-oxopentanoic acid | gamma-Glutamylcysteine | UNII:M984VJS48P | .GAMMA.-GLUTAMYLCYSTEINE | DrugBank ID:DB03408 | PubChem CID:123938 | PubChem SID:198936226
+BMGC_DG02428,BMG_DG021356,SENAZODAN | PubChem CID:123942 | CAS RN:98326-32-0 | UNII:427L2I2KIM | PubChem SID:198982717
+BMGC_DG02429,BMG_DG021357,PubChem CID:12394434 | UNII:5U9H5QRX4C | 2-oxo-2H-thiochromene-3-carboxylic acid | PubChem SID:475550256 | 2-OXO-2H-THIOCHROMENE-3-CARBOXYLIC ACID | CAS RN:66253-08-5
+BMGC_DG02430,BMG_DG021367,"Vadimezan | CAS RN:117570-53-3 | VADIMEZAN | PubChem CID:123964 | 2-(5,6-dimethyl-9-oxoxanthen-4-yl)acetic acid | UNII:0829J8133H | PubChem SID:198969117 | DrugBank ID:DB06235"
+BMGC_DG02431,BMG_DG021368,"PubChem CID:123966 | alpha-1,4-Tetraglucose | CAS RN:34612-38-9 | PubChem SID:249817492 | DrugBank ID:DB02237 | UNII:BO88JLT87R | MALTOTETRAOSE | Maltotetraose | (2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanal"
+BMGC_DG02432,BMG_DG021373,Satraplatin | PubChem CID:123974 | DrugBank ID:DB04996
+BMGC_DG02433,BMG_DG021374,"(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | PubChem SID:198985423 | CHOLEST-5-ENE-3.BETA.,26-DIOL, (25R)- | UNII:6T2NA6P5SQ | 27-Hydroxycholesterol | PubChem CID:123976 | CAS RN:20380-11-4"
+BMGC_DG02434,BMG_DG021377,PubChem SID:440089868 | 3-Carboxy-4-methyl-5-propyl-2-furanpropionic acid | 3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC | 2-(2-CARBOXYETHYL)-4-METHYL-5-PROPYLFURAN-3-CARBOXYLICACID | DrugBank ID:DB07517 | 2-(2-carboxyethyl)-4-methyl-5-propylfuran-3-carboxylic acid | PubChem CID:123979 | CAS RN:86879-39-2 | UNII:JTU41879GF
+BMGC_DG02435,BMG_DG021380,"PubChem SID:198948294 | 6-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepine | Benalfocin | UNII:YCN2U5UGIQ | PubChem CID:123981 | CAS RN:73943-10-9 | BENALFOCIN"
+BMGC_DG02436,BMG_DG021381,UNII:46BBW2U5D6 | KELATORPHAN | Kelatorphan | CAS RN:92175-57-0 | PubChem SID:198963430 | (2S)-2-[[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]amino]propanoic acid | PubChem CID:123982 | DrugBank ID:DB08040
+BMGC_DG02437,BMG_DG021384,"PubChem CID:123985 | e-64 | PubChem SID:198959984 | E-64 | CAS RN:66701-25-5 | CAS RN:80408-29-3 | (2S,3S)-3-[[(2S)-1-[4-(diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid | UNII:R76F7856MV"
+BMGC_DG02438,BMG_DG021388,PubChem CID:123990 | trimethyl-[2-[8-oxo-8-[2-(trimethylazaniumyl)ethoxy]octanoyl]oxyethyl]azanium | Trimethyl-[2-[8-oxo-8-[2-(trimethylazaniumyl)ethoxy]octanoyl]oxyethyl]azanium
+BMGC_DG02439,BMG_DG021389,"PubChem CID:123991 | 2,3-Didehydroalanine | Dehydroalanine | 2-aminoprop-2-enoic acid | DEHYDROALANINE | PubChem SID:198971476 | DrugBank ID:DB02688 | CAS RN:1948-56-7 | UNII:98RA387EKY"
+BMGC_DG02440,BMG_DG021399,"2-(N-Phenethyl-N-propyl)amino-5-hydroxytetralin | 6-[2-phenylethyl(propyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol | CAS RN:87857-27-0 | PubChem CID:1240"
+BMGC_DG02441,BMG_DG021401,"CAS RN:127792-75-0 | CP-93129 | UNII:Y4BW369LGS | PubChem CID:124007 | PubChem SID:472388626 | CAS RN:879089-64-2 | 3-(1,2,3,6-tetrahydropyridin-4-yl)-1,4-dihydropyrrolo[3,2-b]pyridin-5-one | 3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one"
+BMGC_DG02442,BMG_DG021407,"PubChem CID:124016 | CAS RN:79907-44-1 | CAS RN:212066-01-8 | [(2R,3R)-2-(3,4-dihydroxyphenyl)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3,4,5-trihydroxybenzoyl)oxy-3,4-dihydro-2H-chromen-4-yl]-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | 3,3'-Digalloylprocyanidin B2"
+BMGC_DG02443,BMG_DG021411,".BETA.-GLUCOGALLIN | PubChem CID:124021 | [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] 3,4,5-trihydroxybenzoate | UNII:4X7JGS9BFY | CAS RN:13405-60-2 | PubChem SID:241180844 | beta-Glucogallin | CAS RN:554-37-0"
+BMGC_DG02444,BMG_DG021438,"(2S)-5-acetamido-2,4-dihydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid | CAS RN:131-48-6 | PubChem CID:124040735"
+BMGC_DG02445,BMG_DG021447,"UNII:HOC5567T41 | Glabridin | PubChem SID:198984749 | 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol | GLABRIDIN | PubChem CID:124052 | CAS RN:59870-68-7"
+BMGC_DG02446,BMG_DG021456,"PubChem CID:124072 | Tetrahydrocurcumin | TETRAHYDRODIFERULOYLMETHANE | UNII:00U0645U03 | CAS RN:36062-04-1 | 1,7-bis(4-hydroxy-3-methoxyphenyl)heptane-3,5-dione | PubChem SID:175265498"
+BMGC_DG02447,BMG_DG021458,"UNII:1X2A1U6BH3 | CAS RN:477-89-4 | 6-methoxy-9-methyl-[1,3]dioxolo[4,5-h]quinolin-8-one | CASIMIROIN | PubChem CID:124075 | Casimiroin | PubChem SID:241179144 | DrugBank ID:DB08744"
+BMGC_DG02448,BMG_DG021472,PubChem CID:124080445 | DUCLAUXIN | CAS RN:1732-37-2 | PubChem SID:474489815 | UNII:Y76N2QE4RZ | Duclauxin
+BMGC_DG02449,BMG_DG021521,"BALOXAVIR MARBOXIL | NDC:50242-583 | DrugBank ID:DB13997 | PubChem SID:329589357 | CAS RN:1830312-72-5 | UNII:505CXM6OHG | NDC:50242-860 | PubChem CID:124081896 | [(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-9,12-dioxo-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-yl]oxymethyl methyl carbonate | NDC:50242-877 | CAS RN:1985606-14-1 | Baloxavir Marboxil"
+BMGC_DG02450,BMG_DG021524,"[2-(2-chlorophenyl)-5-hydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-4-oxochromen-7-yl] dihydrogen phosphate | TP-1287 | Tp-1287 | UNII:7MPP85IIJ3 | PubChem SID:402404575 | PubChem CID:124083048 | CAS RN:2044686-42-0"
+BMGC_DG02451,BMG_DG021527,"DrugBank ID:DB00967 | UNII:FVF865388R | DESLORATADINE | Desloratadine | CAS RN:100643-71-8 | PubChem SID:175268022 | 13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene | PubChem CID:124087"
+BMGC_DG02452,BMG_DG021536,"GARENOXACIN | UNII:V72H9867WB | DrugBank ID:DB06160 | 1-cyclopropyl-8-(difluoromethoxy)-7-[(1R)-1-methyl-2,3-dihydro-1H-isoindol-5-yl]-4-oxoquinoline-3-carboxylic acid | PubChem SID:198974823 | CAS RN:194804-75-6 | PubChem CID:124093 | Garenoxacin"
+BMGC_DG02453,BMG_DG021545,"UNII:XA99M7XZR5 | 5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol | SKF-77434 | PubChem SID:316913291 | SK&F 77434 | CAS RN:104422-04-0 | PubChem CID:1241"
+BMGC_DG02454,BMG_DG021550,Glpg-2451 | CAS RN:2055015-61-5 | 3-amino-N-[(2S)-2-hydroxypropyl]-5-[4-(trifluoromethoxy)phenyl]sulfonylpyridine-2-carboxamide | GLPG-2451 | PubChem SID:404859701 | UNII:W94ID4MZ81 | PubChem CID:124106089
+BMGC_DG02455,BMG_DG021555,"TOLEBRUTINIB | Tolebrutinib | CAS RN:1971920-73-6 | 4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]imidazo[4,5-c]pyridin-2-one | UNII:8CZ82ZYY9X | PubChem CID:124111565 | PubChem SID:404859501"
+BMGC_DG02456,BMG_DG021560,"CAS RN:1848959-10-3 | 7-[5-[(aminosulfonyl)amino]-5-deoxy-beta-D-ribofuranosyl]-5-[2-(2-ethoxy-6-fluorophenyl)ethynyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | PubChem CID:124121703 | 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(sulfamoylamino)methyl]oxolan-2-yl]-5-[2-(2-ethoxy-6-fluorophenyl)ethynyl]pyrrolo[2,3-d]pyrimidine"
+BMGC_DG02457,BMG_DG021562,CAS RN:2055597-12-9 | N-[(1S)-2-amino-1-(3-chloro-5-fluorophenyl)ethyl]-1-[5-methyl-2-(oxan-4-ylamino)pyrimidin-4-yl]imidazole-4-carboxamide | Asn007 | PubChem CID:124122366
+BMGC_DG02458,BMG_DG021565,3-pyridin-4-yl-1H-indazole | PubChem CID:12412578 | DrugBank ID:DB08113
+BMGC_DG02459,BMG_DG021566,"Cintirorgon | UNII:LPN433P0EA | CAS RN:2055536-64-4 | PubChem SID:375579127 | 3-[(2S)-6-[3-(difluoromethoxy)-5-fluorophenyl]-4-[3-(trifluoromethyl)phenyl]sulfonyl-2,3-dihydro-1,4-benzoxazin-2-yl]-2,2-dimethylpropanoic acid | PubChem CID:124126348 | CINTIRORGON"
+BMGC_DG02460,BMG_DG021578,UNII:QBK5MBZ22Q | PubChem SID:478838982 | JMS-053 | PubChem CID:124141953 | CAS RN:1954650-11-3
+BMGC_DG02461,BMG_DG021587,"Azd-4573 | (1S,3R)-3-acetamido-N-[5-chloro-4-(5,5-dimethyl-4,6-dihydropyrrolo[1,2-b]pyrazol-3-yl)pyridin-2-yl]cyclohexane-1-carboxamide | PubChem SID:440089905 | PubChem CID:124155204 | Zemirciclib | ZEMIRCICLIB | CAS RN:2057509-72-3 | UNII:E5XSP3X68B"
+BMGC_DG02462,BMG_DG021592,PubChem CID:1241606 | 5-(P-METHOXYBENZYLIDENE)RHODANINE | UNII:LT2BR5U5UG | CAS RN:5462-97-5
+BMGC_DG02463,BMG_DG021600,"Inavolisib | INAVOLISIB | UNII:L4C1UY2NYH | NDC:50242-084 | (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide | PubChem SID:377308960 | CAS RN:2060571-02-8 | NDC:50242-079 | PubChem CID:124173720 | DrugBank ID:DB15275"
+BMGC_DG02464,BMG_DG021608,PubChem CID:124193915 | PF-06843195 | PubChem SID:459275952 | UNII:75658JDG29 | CAS RN:2067281-51-8
+BMGC_DG02465,BMG_DG021611,"PubChem CID:1242 | SKF-38393 | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | UNII:R7TF327S2C | CAS RN:67287-49-4 | PubChem SID:363909864 | 5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol"
+BMGC_DG02466,BMG_DG021680,PubChem SID:461432904 | UNII:BV62EAN2VM | SKULLCAPFLAVONE II | CAS RN:55084-08-7 | PubChem CID:124211
+BMGC_DG02467,BMG_DG021734,"TOVINONTRINE | 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-(oxan-4-yl)-7H-imidazo[1,5-a]pyrazin-8-one | Tovinontrine | PubChem CID:124220601 | PubChem SID:329904159 | CAS RN:2062661-53-2 | UNII:W248Y1AKOR"
+BMGC_DG02468,BMG_DG021744,"2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-10-(carboxylatomethyl)-7-(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;copper-64(2+) | CAS RN:1426155-87-4 | UNII:N3858377KC | PubChem SID:329904405 | PubChem CID:124220636 | Copper Oxodotreotide Cu-64 | NDC:69945-064 | COPPER OXODOTREOTIDE CU-64"
+BMGC_DG02469,BMG_DG021763,"6-fluoro-1-methyl-4-oxo-7-piperazin-1-yl-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid | CAS RN:112984-60-8 | Ulifloxacin | UNII:C38638H76Y | PubChem CID:124225 | PubChem SID:198988626 | ULIFLOXACIN"
+BMGC_DG02470,BMG_DG021773,UNII:4IHY34Y2NV | N-[7-(methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide | PubChem CID:124246 | PubChem SID:198980187 | Iguratimod | DrugBank ID:DB12233 | IGURATIMOD | CAS RN:123663-49-0
+BMGC_DG02471,BMG_DG021787,"SKF-83566 | CAS RN:99295-33-7 | PubChem SID:198962781 | 8-Bromo-3-methyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-ol | PubChem CID:1243 | 8-bromo-3-methyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol | UNII:D203LR7XUS"
+BMGC_DG02472,BMG_DG021850,BULBOCAPNINE | UNII:O0TGI865QO | PubChem SID:198977713 | PubChem CID:12441 | CAS RN:298-45-3
+BMGC_DG02473,BMG_DG021892,CAS RN:127414-85-1 | UNII:7LZN33KW88 | PubChem SID:482553973 | Calystegine B2 | DrugBank ID:DB04658 | PubChem CID:124434 | CALYSTEGINE B2
+BMGC_DG02474,BMG_DG021948,"Brilliant green | NDC:66689-710 | [4-[[4-(diethylamino)phenyl]-phenylmethylidene]cyclohexa-2,5-dien-1-ylidene]-diethylazanium;hydrogen sulfate | Brilliant green cation | PubChem SID:175267288 | PubChem CID:12449 | DrugBank ID:DB11279 | BRILLIANT GREEN | UNII:G0L543D370 | CAS RN:633-03-4"
+BMGC_DG02475,BMG_DG021953,PubChem SID:198972199 | VANILLYLMANDELIC ACID | 2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)acetic acid | PubChem CID:1245 | CAS RN:53587-34-1 | UNII:0DQI268449 | Vanillylmandelic acid | 3-Methoxy-4-hydroxymandelate | CAS RN:55-10-7 | CAS RN:2394-20-9
+BMGC_DG02476,BMG_DG021980,PubChem CID:12452 | 6-DEHYDROANDROSTENEDIONE | PubChem SID:287445776 | CAS RN:633-34-1 | UNII:7RS0NIL39S
+BMGC_DG02477,BMG_DG021998,"16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene;chloride | PubChem CID:12456 | UNII:UOT4O1BYV8 | CAS RN:633-65-8 | PubChem SID:175267164 | Berberine Chloride | BERBERINE CHLORIDE"
+BMGC_DG02478,BMG_DG022025,CAS RN:1142-15-0 | PubChem SID:198988610 | UNII:5EL148B7HG | 1-METHOXY-4-(2-PHENYLETHENYL)-BENZENE | PubChem CID:1245920
+BMGC_DG02479,BMG_DG022026,"3,4-dimethyl-2-phenylmorpholine | CAS RN:21784-30-5 | Bontril | PubChem CID:12460"
+BMGC_DG02480,BMG_DG022055,"PubChem CID:124653 | PubChem SID:249817690 | Methylprednisone | UNII:621XR2W6OP | 6alpha-Methylprednisone | (6S,8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione | DrugBank ID:DB12952 | 6.ALPHA.-METHYLPREDNISONE | CAS RN:91523-05-6"
+BMGC_DG02481,BMG_DG022082,UNII:G15V730JCM | PubChem SID:404859222 | PubChem CID:124704 | PYRAZINOYLGUANIDINE | CAS RN:60398-24-5
+BMGC_DG02482,BMG_DG022091,PubChem SID:472411117 | CAS RN:634-97-9 | 1H-pyrrole-2-carboxylic acid | Pyrrole-2-carboxylic acid | DrugBank ID:DB02543 | 2-PYRROLECARBOXYLIC ACID | PubChem CID:12473 | UNII:2NNB85QQT9 | Pyrrole-2-Carboxylate
+BMGC_DG02483,BMG_DG022109,PubChem SID:198971418 | 2-AMINO-5-CHLOROBENZOIC ACID | PubChem CID:12476 | CAS RN:635-21-2 | UNII:Z2Y66JMI31
+BMGC_DG02484,BMG_DG022117,UNII:17XEB07K1M | CATECHOL DIACETATE | PubChem CID:12479 | CAS RN:635-67-6 | PubChem SID:198990271
+BMGC_DG02485,BMG_DG022118,CAS RN:635-90-5 | PubChem SID:198965491 | PubChem CID:12480 | UNII:3OD6N6545H | 1-PHENYLPYRROLE
+BMGC_DG02486,BMG_DG022124,5-CHLOROSALICYLALDEHYDE | CAS RN:635-93-8 | UNII:4GCC8ZKM3O | PubChem CID:12481 | PubChem SID:198983541
+BMGC_DG02487,BMG_DG022128,DrugBank ID:DB04195 | Heptulose-2-Phosphate | HEPTULOSE-2-PHOSPHATE | CAS RN:92642-58-5 | UNII:CVS7X5XC4L | PubChem CID:124823
+BMGC_DG02488,BMG_DG022153,4-isothiocyanatobutylbenzene | PubChem CID:124881 | CAS RN:61499-10-3 | CAS RN:61449-10-3 | 4-Phenylbutyl isothiocyanate
+BMGC_DG02489,BMG_DG022155,CAS RN:106272-20-2 | CAS RN:70-18-8 | GLUTATHIONE | CAS RN:95687-20-0 | PubChem SID:175266859 | Glutathione | UNII:GAN16C9B8O | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid | DrugBank ID:DB00143 | PubChem CID:124886
+BMGC_DG02490,BMG_DG022169,"DrugBank ID:DB13792 | PubChem CID:12492 | 4-chloro-N-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-3-sulfamoylbenzamide | CAS RN:636-54-4 | PubChem SID:198944602 | CLOPAMIDE | Clopamide | UNII:17S83WON0I | CAS RN:3563-77-7"
+BMGC_DG02491,BMG_DG022195,"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE) | PubChem CID:124969 | DrugBank ID:DB07380"
+BMGC_DG02492,BMG_DG022209,N-(Phosphonoacetyl)-L-Ornithine | DrugBank ID:DB02011 | PubChem CID:124992
+BMGC_DG02493,BMG_DG022210,PubChem CID:125 | UNII:1A3AH1FP1B | 4-HYDROXYBENZYL ALCOHOL | PubChem SID:198982349 | 4-Hydroxybenzyl alcohol | 4-(hydroxymethyl)phenol | CAS RN:623-05-2
+BMGC_DG02494,BMG_DG022212,CAS RN:93413-62-8 | NDC:70771-1312 | Desvenlafaxine | NDC:46708-152 | NDC:70771-1661 | NDC:46708-153 | 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol | NDC:68382-105 | PubChem SID:175271698 | UNII:NG99554ANW | PubChem CID:125017 | DrugBank ID:DB06700 | NDC:63304-191 | DESVENLAFAXINE | NDC:68382-741 | NDC:68382-469 | NDC:70771-1311 | NDC:63304-192
+BMGC_DG02495,BMG_DG022227,CAS RN:119515-38-7 | Icaridin | butan-2-yl 2-(2-hydroxyethyl)piperidine-1-carboxylate | CAS RN:658051-75-3 | PubChem CID:125098 | DrugBank ID:DB14074 | UNII:N51GQX0837 | PubChem SID:198981130 | ICARIDIN
+BMGC_DG02496,BMG_DG022229,"6-Hydroxydihydrodaidzein | 6,7-dihydroxy-3-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | PubChem CID:125100"
+BMGC_DG02497,BMG_DG022243,"PubChem SID:440089783 | DrugBank ID:DB02676 | 1,3-BIS(TRIS(HYDROXYMETHYL)METHYLAMINO)PROPANE | PubChem CID:125132 | 2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol | CAS RN:64431-96-5 | UNII:N5YD0CS4DO"
+BMGC_DG02498,BMG_DG022351,UNII:19936LIY2V | tridecanoic acid | TRIDECANOIC ACID | PubChem CID:12530 | PubChem SID:198970323 | CAS RN:638-53-9 | Tridecanoic acid | DrugBank ID:DB02448 | N-Tridecanoic Acid
+BMGC_DG02499,BMG_DG022372,PubChem CID:125328 | UNII:NVE9K68QA3 | L-687384 | PubChem SID:384647869 | CAS RN:95417-67-7
+BMGC_DG02500,BMG_DG022437,CAS RN:1490-04-6 | Menthol | 5-methyl-2-propan-2-ylcyclohexan-1-ol | CAS RN:15356-70-4 | CAS RN:89-78-1 | CAS RN:491-01-0 | PubChem CID:1254 | CAS RN:491-02-1
+BMGC_DG02501,BMG_DG022454,"CAS RN:16564-43-5 | PubChem SID:198958496 | GLYCOCHENODEOXYCHOLIC ACID | CAS RN:640-79-9 | Glycochenodeoxycholic Acid | UNII:451ZNJ667Y | PubChem CID:12544 | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid | DrugBank ID:DB02123"
+BMGC_DG02502,BMG_DG022461,"ethyl (1R,2S)-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate | UNII:1I0Q98V2I5 | TILIDINE, (-)- | CAS RN:38690-93-6 | Tilidine | PubChem CID:12546498 | PubChem SID:198935263"
+BMGC_DG02503,BMG_DG022485,Miridesap | DrugBank ID:DB13087 | CAS RN:224624-80-0 | MIRIDESAP | PubChem CID:125516 | (2R)-1-[6-[(2R)-2-carboxypyrrolidin-1-yl]-6-oxohexanoyl]pyrrolidine-2-carboxylic acid | PubChem SID:198964792 | UNII:WO97N24A47
+BMGC_DG02504,BMG_DG022496,"BENZYDAMINE | Benzydamine | 3-(1-benzylindazol-3-yl)oxy-N,N-dimethylpropan-1-amine | PubChem CID:12555 | DrugBank ID:DB09084 | CAS RN:642-72-8 | PubChem SID:198937676 | UNII:4O21U048EF"
+BMGC_DG02505,BMG_DG022500,"UNII:AQ316B4F8C | 2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine | PubChem SID:198982671 | CAS RN:132810-10-7 | PubChem CID:125564 | DrugBank ID:DB09223 | BLONANSERIN | Blonanserin"
+BMGC_DG02506,BMG_DG022504,"ERYTHROMYCIN STEARATE | PubChem SID:175265949 | PubChem CID:12559 | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;octadecanoic acid | CAS RN:643-22-1 | Erythromycin Stearate | UNII:LXW024X05M"
+BMGC_DG02507,BMG_DG022507,"CAS RN:7540-22-9 | PubChem SID:175267068 | PubChem CID:12560 | Erythromycin | CAS RN:82343-12-2 | CAS RN:114-07-8 | UNII:63937KV33D | CAS RN:215031-94-0 | ERYTHROMYCIN | DrugBank ID:DB00199 | CAS RN:643-22-1 | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione | CAS RN:7704-67-8"
+BMGC_DG02508,BMG_DG022510,"CAS RN:39834-38-3 | 7,12-DIMETHYLBENZ(A)ANTHRACENE 5,6-OXIDE | PubChem SID:316910236 | PubChem CID:12560658 | UNII:285J8GSL0Z"
+BMGC_DG02509,BMG_DG022518,"UNII:8LH16383PK | PubChem CID:12562545 | CAS RN:39243-02-2 | Pyrazolam | PYRAZOLAM | 8-bromo-1-methyl-6-pyridin-2-yl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | PubChem SID:316916328 | DrugBank ID:DB14718"
+BMGC_DG02510,BMG_DG022519,PubChem CID:12562546 | PubChem SID:404859298 | BROMAZOLAM | UNII:YMC9OT97Z1 | CAS RN:71368-80-4
+BMGC_DG02511,BMG_DG022590,ALTERPERYLENOL | UNII:GRK18WHV7F | CAS RN:88899-62-1 | PubChem CID:125848 | PubChem SID:198937533
+BMGC_DG02512,BMG_DG022594,4-methylpentanoic acid | PubChem CID:12587 | ISOCAPROIC ACID | PubChem SID:198939369 | Isocaproic acid | DrugBank ID:DB03993 | 4-Methylpentanoic acid | UNII:4G4U8JA28T | CAS RN:646-07-1
+BMGC_DG02513,BMG_DG022602,PubChem SID:348481423 | CL-277082 | CAS RN:96224-26-9 | UNII:KOF50RA8PQ | PubChem CID:125893
+BMGC_DG02514,BMG_DG022613,"PubChem SID:198976518 | Prasterone sulfate | DrugBank ID:DB05804 | PRASTERONE SULFATE | [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] hydrogen sulfate | UNII:57B09Q7FJR | Dehydroepiandrosterone sulfate | CAS RN:1099-87-2 | CAS RN:651-48-9 | PubChem CID:12594"
+BMGC_DG02515,BMG_DG022623,"(3S,3aR,6R,6aR)-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-3,6-diol | ISOSORBIDE | Isosorbide | CAS RN:652-67-5 | DrugBank ID:DB09401 | CAS RN:28980-83-8 | PubChem SID:175268087 | PubChem CID:12597 | UNII:WXR179L51S"
+BMGC_DG02516,BMG_DG022626,BUTAPERAZINE | 1-[10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazin-2-yl]butan-1-one | CAS RN:653-03-2 | DrugBank ID:DB13213 | CAS RN:80463-18-9 | Butaperazine | UNII:TXP4T9106S | PubChem SID:198974622 | PubChem CID:12598
+BMGC_DG02517,BMG_DG022652,"(S)-Indapamide | PubChem SID:312525023 | CAS RN:77083-53-5 | INDAPAMIDE, (S)- | DrugBank ID:DB07467 | PubChem CID:12598931 | UNII:GDV888123I"
+BMGC_DG02518,BMG_DG022653,"[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate | PubChem CID:12599 | PubChem SID:198970112 | DEOXYADENOSINE 5'-MONOPHOSPHATE | CAS RN:653-63-4 | UNII:VFR8I97ORM | 2'-Deoxyadenosine-5'-monophosphate | CAS RN:54509-79-4"
+BMGC_DG02519,BMG_DG022654,4-HYDROXYBENZALDEHYDE | CAS RN:123-08-0 | DrugBank ID:DB03560 | 4-hydroxybenzaldehyde | PubChem CID:126 | UNII:O1738X3Y38 | P-Hydroxybenzaldehyde | 4-Hydroxybenzaldehyde | PubChem SID:198970689
+BMGC_DG02520,BMG_DG022669,UNII:R0C9NIE5JJ | CAS RN:804-10-4 | DrugBank ID:DB13279 | PubChem CID:12604 | PubChem SID:198989788 | CHROMONAR | ethyl 2-[3-[2-(diethylamino)ethyl]-4-methyl-2-oxochromen-7-yl]oxyacetate | Chromonar
+BMGC_DG02521,BMG_DG022670,"PubChem SID:175267096 | Ectoine | UNII:7GXZ3858RY | CAS RN:96702-03-3 | PubChem CID:126041 | ECTOINE | (6S)-2-methyl-1,4,5,6-tetrahydropyrimidine-6-carboxylic acid"
+BMGC_DG02522,BMG_DG022676,"PubChem CID:12606920 | N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE | DrugBank ID:DB08631"
+BMGC_DG02523,BMG_DG022688,"IFENPRODIL, THREO- | CAS RN:74991-34-7 | PubChem CID:12613159 | PubChem SID:472423504 | UNII:6Q1H0KS8B9"
+BMGC_DG02524,BMG_DG022689,CAS RN:16543-55-8 | N'-Nitrosonornicotine | 3-[(2S)-1-nitrosopyrrolidin-2-yl]pyridine | N-NITROSONORNICOTINE | PubChem CID:12613538 | PubChem SID:198937145 | UNII:X656TZ86DX
+BMGC_DG02525,BMG_DG022694,"CAS RN:3705-27-9 | (S)-Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | Cyclo(prolylglycyl) | UNII:W7O69J5F2B | (8aS)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | CAS RN:97011-16-0 | DrugBank ID:DB04541 | PubChem CID:126154 | PubChem SID:384436226 | CYCLO(PROLYLGLYCYL)"
+BMGC_DG02526,BMG_DG022711,NDC:76162-818 | NDC:81522-922 | NDC:0363-8980 | NDC:0135-0300 | NDC:37808-765 | NDC:59726-924 | NDC:82791-362 | NDC:21130-823 | NDC:62332-682 | NDC:41250-867 | NDC:72476-922 | NDC:0363-8877 | NDC:41163-722 | NDC:30142-286 | NDC:82442-112 | NDC:79903-248 | NDC:46122-624 | NDC:59726-112 | NDC:41250-932 | NDC:37808-661 | NDC:51672-1406 | NDC:59726-877 | NDC:55910-963 | NDC:11673-846 | UNII:9G1OE216XY | NDC:55301-877 | NDC:21130-770 | PubChem CID:12620 | NDC:59726-922 | NDC:30142-869 | NDC:11822-3977 | NDC:68016-345 | NDC:72476-965 | NDC:21922-023 | NDC:49035-259 | NDC:0536-1427 | NDC:81522-112 | NDC:46122-800 | NDC:70000-0672 | NDC:46122-681 | docosan-1-ol | NDC:76162-900 | NDC:37808-223 | NDC:70677-1046 | NDC:0713-0353 | NDC:79903-118 | NDC:0135-0200 | DrugBank ID:DB00632 | NDC:81522-923 | NDC:30142-981 | NDC:30142-322 | NDC:79481-0065 | NDC:21130-605 | NDC:68016-344 | Docosanol | CAS RN:661-19-8 | NDC:0363-6510 | NDC:61269-981 | NDC:0363-9222 | NDC:63941-212 | NDC:37808-229 | NDC:72476-492 | NDC:11673-769 | NDC:63941-922 | NDC:55910-550 | DOCOSANOL | NDC:58602-019 | NDC:55319-113 | NDC:70000-0517 | NDC:79481-0112 | PubChem SID:175267910 | NDC:51316-763 | NDC:61269-989 | NDC:70677-1255 | NDC:21130-422 | NDC:11822-6500 | NDC:55910-859 | NDC:0536-1379 | NDC:11822-3450 | NDC:55319-922 | CAS RN:30303-65-2 | NDC:55301-112 | NDC:11822-3951 | NDC:62011-0433 | NDC:0363-9220 | NDC:79903-011 | NDC:11822-3451 | NDC:55910-722 | NDC:41163-724 | NDC:79481-9220
+BMGC_DG02527,BMG_DG022739,"PubChem CID:12626561 | BROLAMFETAMINE, (R)- | CAS RN:43061-15-0 | UNII:C918IS60W6 | PubChem SID:255509345"
+BMGC_DG02528,BMG_DG022746,PubChem CID:126280 | PubChem SID:198961325 | INDATRALINE | CAS RN:86939-10-8 | UNII:4U40Y96J1Z
+BMGC_DG02529,BMG_DG022782,CAS RN:138356-08-8 | PubChem SID:474492604 | PubChem CID:126388 | BD-1008 | UNII:JCY43QE7FQ
+BMGC_DG02530,BMG_DG022786,CAS RN:138847-85-5 | PubChem SID:474492526 | PubChem CID:126402 | UNII:74BW8WG2MQ | PRE-084
+BMGC_DG02531,BMG_DG022793,UNII:08GH1YF0RA | 4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide | CAS RN:73819-26-8 | PubChem CID:126437 | CAS RN:55368-40-6 | Furamidine | PubChem SID:434369594 | FURAMIDINE
+BMGC_DG02532,BMG_DG022868,CAS RN:672-15-1 | DrugBank ID:DB04193 | (2S)-2-amino-4-hydroxybutanoic acid | HOMOSERINE | L-Homoserine | L-homoserine | UNII:6KA95X0IVO | PubChem CID:12647 | PubChem SID:198985274 | CAS RN:119736-88-8
+BMGC_DG02533,BMG_DG022902,"PubChem CID:126480325 | CAS RN:1639324-58-5 | UNII:CQQ59545BV | Cemdisiran, terminal sugar modification- | CAS RN:1436858-07-9 | PubChem SID:333495890 | [(2S,4R)-1-[12-[[1,3-bis[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]-2-[[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]methyl]propan-2-yl]amino]-12-oxododecanoyl]-4-hydroxypyrrolidin-2-yl]methyl dihydrogen phosphate | CEMDISIRAN, TERMINAL SUGAR MODIFICATION-"
+BMGC_DG02534,BMG_DG022905,"PubChem SID:363908296 | (2R)-7-chloro-2-[4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide | Valemetostat | UNII:60RD0234VE | VALEMETOSTAT | PubChem CID:126481870 | CAS RN:1809336-39-7"
+BMGC_DG02535,BMG_DG022912,UNII:CA2K6LJ2BV | CAS RN:672-76-4 | PubChem CID:12649 | PubChem SID:472390426 | γ-Thujaplicin | .GAMMA.-THUJAPLICIN
+BMGC_DG02536,BMG_DG022914,"CAS RN:2071265-08-0 | PubChem CID:126494519 | PubChem SID:381132239 | UNII:B4RS1V5YSP | methyl N-[[(5S)-3-[3-fluoro-4-(2-oxa-6-azaspiro[3.3]heptan-6-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]carbamate | Tbi-223 | TBI-223"
+BMGC_DG02537,BMG_DG022937,UNII:9BTW3ZDT8P | PubChem SID:459275619 | 4-(1-IMIDAZOLYLMETHYL)ANILINE | PubChem CID:1265319 | CAS RN:56643-85-7
+BMGC_DG02538,BMG_DG022938,"CAS RN:2075750-05-7 | N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine | UNII:W49YFX3FPQ | PubChem SID:474493602 | Ulecaciclib | PubChem CID:126535127 | ULECACICLIB"
+BMGC_DG02539,BMG_DG022943,"PubChem SID:482553205 | UNII:L46P54NB4V | PubChem CID:126558497 | BTX-A51 | CAS RN:2079068-74-7 | Casein Kinase inhibitor A51 | 4-N-[5-chloro-4-[5-(cyclopropylmethyl)-1-methylpyrazol-4-yl]pyrimidin-2-yl]cyclohexane-1,4-diamine"
+BMGC_DG02540,BMG_DG022945,"CAS RN:111358-88-4 | PubChem SID:198961101 | Lestaurtinib | (15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaen-3-one | LESTAURTINIB | PubChem CID:126565 | UNII:DO989GC5D1 | DrugBank ID:DB06469"
+BMGC_DG02541,BMG_DG022947,"DrugBank ID:DB02966 | Fluoro-Willardiine | 5-Fluorowillardiine, (S)- | PubChem SID:472407157 | UNII:7CTR2LWV5M | 5-FLUOROWILLARDIINE, (S)- | CAS RN:140187-23-1 | PubChem CID:126569"
+BMGC_DG02542,BMG_DG022950,"PubChem SID:472424520 | N-[4-fluoro-3-(3-morpholin-4-ylimidazo[1,2-a]pyrimidin-7-yl)phenyl]pyrrolidine-1-carboxamide | GSK-3494245 | UNII:T7XAE9Y6B9 | CAS RN:2080410-41-7 | PubChem CID:126571915 | Gsk-3494245"
+BMGC_DG02543,BMG_DG022951,"PubChem CID:126573394 | PubChem SID:381132555 | Aclimostat | CAS RN:2082752-83-6 | UNII:X150A3JK8R | ACLIMOSTAT | [(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] 3-(2-morpholin-4-ylethyl)azetidine-1-carboxylate"
+BMGC_DG02544,BMG_DG022954,"PubChem CID:126582741 | 1,3-Dimethyl-5-[2-(oxan-4-yl)-3-[2-(trifluoromethyloxy)ethyl]benzimidazol-5-yl]pyridin-2-one | CAS RN:2081072-29-7 | 1,3-dimethyl-5-[2-(oxan-4-yl)-3-[2-(trifluoromethoxy)ethyl]benzimidazol-5-yl]pyridin-2-one"
+BMGC_DG02545,BMG_DG022970,N-[(2S)-1-(benzylamino)-4-imidazol-1-yl-1-oxobutan-2-yl]-1-methylpyrrole-2-carboxamide | CAS RN:2082765-42-0 | Lucid-21-302 | PubChem CID:126615756
+BMGC_DG02546,BMG_DG022975,UNII:G2MA4KIQ1B | PubChem CID:12662 | CAS RN:675-09-2 | PubChem SID:377307803 | MESITENE LACTONE
+BMGC_DG02547,BMG_DG022985,"5-(4-((2S,5S)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1H-1,2,4-TRIAZOL-3-AMINE | X4D0G881CN | 3-[4-[(2S,5S)-5-[(4-chlorophenyl)methyl]-2-methylmorpholin-4-yl]piperidin-1-yl]-1H-1,2,4-triazol-5-amine | PubChem CID:126642132 | UNII:X4D0G881CN | CAS RN:2088453-21-6 | PubChem SID:434369902"
+BMGC_DG02548,BMG_DG022987,2-PIPERIDONE | PubChem CID:12665 | PubChem SID:198939722 | CAS RN:675-20-7 | UNII:WLN0GQQ6EK
+BMGC_DG02549,BMG_DG023000,UNII:N4ZJ2D98HM | AMTHAMINE | CAS RN:142437-67-0 | PubChem SID:443624699 | PubChem CID:126688
+BMGC_DG02550,BMG_DG023001,"AZD-1390 | PubChem CID:126689157 | Azd1390 | 7-fluoro-3-methyl-8-[6-(3-piperidin-1-ylpropoxy)pyridin-3-yl]-1-propan-2-ylimidazo[4,5-c]quinolin-2-one | UNII:CI43QFE22O | CAS RN:2089288-03-7 | PubChem SID:404859522"
+BMGC_DG02551,BMG_DG023011,CAS RN:2091134-68-6 | GOLIDOCITINIB | Golidocitinib | UNII:3BY9Z3M34G | PubChem SID:377308507 | (2R)-N-[3-[2-[(3-methoxy-1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propanamide | PubChem CID:126715380
+BMGC_DG02552,BMG_DG023024,"1,1,1,2,2,3,3,4,4,5,5,5-dodecafluoropentane | PubChem SID:198982389 | PERFLENAPENT | CAS RN:678-26-2 | UNII:483AU1Y5CZ | Dodecafluoropentane | PubChem CID:12675 | DrugBank ID:DB11625"
+BMGC_DG02553,BMG_DG023027,"LY-300168 | CAS RN:143692-18-6 | PubChem CID:126758 | PubChem SID:316918878 | UNII:X46FC5N190 | 5-(4-aminophenyl)-N,8-dimethyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide"
+BMGC_DG02554,BMG_DG023030,CAS RN:2093928-28-8 | KT-II-115 | UNII:V3796LJK8G | PubChem CID:126764043 | PubChem SID:474494249
+BMGC_DG02555,BMG_DG023033,PubChem CID:126769 | PubChem SID:474492750 | SB-200646 | CAS RN:143797-63-1 | UNII:RT8F72CL8L
+BMGC_DG02556,BMG_DG023035,PubChem CID:126778 | CAS RN:97581-70-9 | LY-163443 FREE BASE | UNII:2KF2DCU28W | PubChem SID:363909692
+BMGC_DG02557,BMG_DG023059,"Penicillic acid | PubChem CID:1268111 | (2Z)-3-methoxy-5-methyl-4-oxohexa-2,5-dienoic acid | CAS RN:90-65-3"
+BMGC_DG02558,BMG_DG023082,DrugBank ID:DB12051 | Setrobuvir | PubChem CID:126843190
+BMGC_DG02559,BMG_DG023143,"NDC:16729-277 | NDC:54436-020 | UNII:YL5FZ2Y5U1 | NDC:54436-015 | NDC:82497-015 | NDC:54436-010 | NDC:82497-012 | NDC:0904-7141 | NDC:70771-1058 | NDC:52652-2001 | NDC:81927-204 | NDC:0143-9830 | NDC:54436-022 | PubChem SID:175267160 | NDC:82497-022 | DrugBank ID:DB00563 | NDC:82497-020 | CAS RN:59-05-2 | (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid | NDC:0143-9517 | NDC:82497-010 | NDC:0143-9519 | NDC:68382-775 | NDC:54436-025 | NDC:82497-017 | NDC:0143-9518 | NDC:0143-9516 | NDC:82497-025 | NDC:54436-017 | PubChem CID:126941 | METHOTREXATE | CAS RN:102613-64-9 | CAS RN:133073-73-1 | NDC:0143-9367 | NDC:54436-012 | Methotrexate"
+BMGC_DG02560,BMG_DG023249,"UNII:AD4J2O47FQ | NDC:80644-0013 | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-2-methylpropanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-carboxy-1-[[(2S)-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-5-oxopentanoic acid | Dasiglucagon [WHO-DD] | PubChem SID:375085280 | NDC:0169-1912 | CAS RN:1544300-84-6 | NDC:0169-1913 | DASIGLUCAGON | PubChem CID:126961379 | NDC:80644-0012"
+BMGC_DG02561,BMG_DG023279,S-63845 | UNII:TVF3XUQ4PG | CAS RN:1799633-27-4 | PubChem SID:383470466 | PubChem CID:126970642
+BMGC_DG02562,BMG_DG023283,PubChem CID:126970666 | UNII:CDI2Y58ICE | PubChem SID:459275774 | BPR-1K871
+BMGC_DG02563,BMG_DG023289,UNII:59X161SCYL | THIOURACIL | CAS RN:124700-71-6 | CAS RN:80275-68-9 | 2-sulfanylidene-1H-pyrimidin-4-one | Thiouracil | CAS RN:126160-72-3 | PubChem SID:198944682 | CAS RN:141-90-2 | CAS RN:125220-28-2 | CAS RN:156-82-1 | CAS RN:124700-72-7 | PubChem CID:1269845
+BMGC_DG02564,BMG_DG023293,PubChem CID:127 | 2-(4-hydroxyphenyl)acetic acid | UNII:3J9SHG0RCN | 4-Hydroxyphenylacetic acid | CAS RN:156-38-7 | PubChem SID:319891904 | P-HYDROXYPHENYLACETIC ACID
+BMGC_DG02565,BMG_DG023306,"CAS RN:1639422-97-1 | JH-VIII-157-02 | PubChem CID:127037084 | 2-[4-(3-cyano-9-ethyl-6,6-dimethyl-11-oxo-5H-benzo[b]carbazol-8-yl)pyrazol-1-yl]-N,N-dimethylacetamide"
+BMGC_DG02566,BMG_DG023307,"PubChem CID:12704 | UNII:HXX5LM4J4E | PubChem SID:405218143 | methyl N,N-diethylcarbamodithioate | METHYL DIETHYLDITHIOCARBAMATE | CAS RN:686-07-7 | Methyl diethyldithiocarbamate"
+BMGC_DG02567,BMG_DG023308,CAS RN:1039342-24-9 | (2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]propanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]hexanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]propanoic acid | MMI-0100 | Mmi-0100 | UNII:6VP6PBL1ZH | PubChem SID:387065213 | PubChem CID:127043567
+BMGC_DG02568,BMG_DG023344,PubChem SID:482554029 | CAS RN:76472-28-1 | UNII:LRX3G8M882 | 4-(Aminosulfonyl)phenyl 4-[(aminoiminomethyl)amino]benzoate | PubChem CID:127139 | 4-(AMINOSULFONYL)PHENYL 4-((AMINOIMINOMETHYL)AMINO)BENZOATE
+BMGC_DG02569,BMG_DG023353,Reboxetine | CAS RN:105017-38-7 | UNII:947S0YZ36I | PubChem SID:198950510 | (2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine | DrugBank ID:DB00234 | REBOXETINE | CAS RN:71620-89-8 | PubChem CID:127151
+BMGC_DG02570,BMG_DG023357,PubChem CID:12717 | DrugBank ID:DB02109 | CAS RN:689-13-4 | 2-[formyl(hydroxy)amino]acetic acid | HADACIDIN | Hadacidin | PubChem SID:198956052 | UNII:BFO5P1010A
+BMGC_DG02571,BMG_DG023368,KUSHENOL E | PubChem SID:461433399 | UNII:U5JUH7PH28 | CAS RN:99119-72-9 | PubChem CID:127234
+BMGC_DG02572,BMG_DG023409,CAS RN:834-24-2 | UNII:DI9WQ08BLU | PubChem SID:363909110 | 4-AMINOSTILBENE | PubChem CID:1272788
+BMGC_DG02573,BMG_DG023423,CAS RN:3806-42-6 | UNII:HL967B8SHG | 5-Benzylidenerhodanine | 5-BENZYLIDENERHODANINE | PubChem CID:1273210 | PubChem SID:475550109
+BMGC_DG02574,BMG_DG023440,PubChem CID:127370 | N2-Succinyl-L-ornithine | CAS RN:99590-80-4 | (2S)-5-amino-2-(3-carboxypropanoylamino)pentanoic acid | N~2~-Succinylornithine | DrugBank ID:DB03582
+BMGC_DG02575,BMG_DG023446,PubChem CID:1274030 | CAS RN:503-87-7 | UNII:CP2PH1A61R | PubChem SID:377309163 | THIOHYDANTOIN
+BMGC_DG02576,BMG_DG023448,CAS RN:693-54-9 | 2-Decanone | UNII:GX543OLT0R | decan-2-one | 2-DECANONE | PubChem CID:12741 | PubChem SID:198988053
+BMGC_DG02577,BMG_DG023455,UNII:7RJS5S67YH | PubChem SID:474492057 | PubChem CID:1274334 | 2-Anilino-5-benzylidenethiazol-4(5H)-one | CAS RN:851429-54-4 | 2-ANILINO-5-BENZYLIDENETHIAZOL-4(5H)-ONE
+BMGC_DG02578,BMG_DG023470,PubChem SID:198951406 | UNII:T0049Z45LZ | 2-methyl-1H-imidazole | 2-METHYLIMIDAZOLE | 2-Methylimidazole | CAS RN:693-98-1 | PubChem CID:12749
+BMGC_DG02579,BMG_DG023476,ISOFLUPREDONE | PubChem SID:175266259 | UNII:HYS0B45Z2S | CAS RN:338-95-4 | PubChem CID:127516
+BMGC_DG02580,BMG_DG023480,PubChem SID:198949552 | PubChem CID:12752253 | 4-DESMETHOXY-4-ETHOXY TRIMETHOPRIM | CAS RN:78025-68-0 | UNII:29X0GX73RM
+BMGC_DG02581,BMG_DG023482,"PubChem SID:198968743 | DrugBank ID:DB13638 | CAS RN:76610-84-9 | (6R,7S)-7-[[(2R,3S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-3-hydroxybutanoyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | UNII:T0785J3X40 | PubChem CID:127527 | CEFBUPERAZONE | Cefbuperazone"
+BMGC_DG02582,BMG_DG023498,PubChem SID:198956884 | UNII:J16NAT1G41 | CAS RN:695-06-7 | .GAMMA.-HEXALACTONE | PubChem CID:12756
+BMGC_DG02583,BMG_DG023501,"CAS RN:100480-81-7 | PubChem CID:127577 | 2-(3-hydroxypropyl)-4,6,7-trimethyl-1,3-benzoxathiol-5-ol | 3-(5-Hydroxy-4,6,7-trimethyl-1,3-benzoxathiazol-2-yl)propanol"
+BMGC_DG02584,BMG_DG023508,UNII:PP61C9NWB0 | DESFLUORO FLUMAZENIL | CAS RN:78756-03-3 | PubChem SID:461432852 | PubChem CID:127597
+BMGC_DG02585,BMG_DG023526,"UNII:8P1M2O1XHP | N,N'-DICYCLOHEXYLSULFAMIDE | CAS RN:14041-87-3 | PubChem SID:313182896 | PubChem CID:12765315"
+BMGC_DG02586,BMG_DG023529,"PubChem CID:12765746 | PubChem SID:329904482 | UNII:48981H0IVO | CAS RN:41932-49-4 | CLOROTEPINE, (S)-"
+BMGC_DG02587,BMG_DG023535,"[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] sulfamate | Emate | CAS RN:148672-09-7 | PubChem CID:127676"
+BMGC_DG02588,BMG_DG023544,UNII:Z5XDS9Z25L | PubChem CID:127698 | CI-1007 | CAS RN:150013-70-0 | PubChem SID:363909295
+BMGC_DG02589,BMG_DG023553,"DrugBank ID:DB03411 | PubChem SID:440089370 | PubChem CID:127716 | (2S,3S,4S)-2-(HYDROXYMETHYL)PYRROLIDINE-3,4-DIOL | UNII:Z330X18GMD | CAS RN:100937-53-9 | 2-Hydroxymethyl-Pyrrolidine-3,4-Diol"
+BMGC_DG02590,BMG_DG023559,"CAS RN:150869-74-2 | LY-295501 | 1-(3,4-dichlorophenyl)-3-(2,3-dihydro-1-benzofuran-5-ylsulfonyl)urea | Ly-295501 | UNII:240Y4YO0TN | DrugBank ID:DB12574 | PubChem SID:252163728 | PubChem CID:127737"
+BMGC_DG02591,BMG_DG023561,"ECONAZOLE, (S)- | PubChem CID:12773795 | (S)-econazole | DrugBank ID:DB07705 | PubChem SID:329903612 | CAS RN:73094-37-8 | UNII:E3VE9L071S"
+BMGC_DG02592,BMG_DG023569,UNII:37NQZ0J76I | PubChem CID:127766 | Levodopa-4'-monophosphate | FOSLEVODOPA | PubChem SID:333495569 | (2S)-2-amino-3-(3-hydroxy-4-phosphonooxyphenyl)propanoic acid | CAS RN:97321-87-4 | CAS RN:101141-95-1
+BMGC_DG02593,BMG_DG023573,PubChem CID:127779 | BW-A 78U | CAS RN:101155-02-6 | PubChem SID:363908297 | UNII:DX8S5Q0N0S
+BMGC_DG02594,BMG_DG023576,2-AMINO-1-PYRROLINE | PubChem SID:485663608 | PubChem CID:12778904 | CAS RN:872-34-4 | 2-Amino-1-pyrroline | UNII:K9AJ4V6RZH
+BMGC_DG02595,BMG_DG023609,"PubChem SID:198985362 | TEZAMPANEL ANHYDROUS | (3S,4aR,6R,8aR)-6-[2-(2H-tetrazol-5-yl)ethyl]-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid | DrugBank ID:DB06354 | CAS RN:154652-83-2 | PubChem CID:127894 | UNII:GA36S2O9C2 | Tezampanel | CAS RN:150131-78-5"
+BMGC_DG02596,BMG_DG023617,CAS RN:155289-31-9 | UNII:LLE3Y7VC87 | PubChem CID:127912 | 1192U90 FREE BASE | PubChem SID:346540252
+BMGC_DG02597,BMG_DG023621,PubChem CID:127928 | PubChem SID:434369740 | CAS RN:162542-90-7 | CDP-840 | UNII:OK8OFX8K7F
+BMGC_DG02598,BMG_DG023622,CAS RN:701-64-4 | PubChem SID:198950554 | DrugBank ID:DB03298 | phenyl dihydrogen phosphate | PubChem CID:12793 | UNII:75M88J863E | Phenyl dihydrogen phosphate | Phenylphosphate | MONOPHENYL PHOSPHATE
+BMGC_DG02599,BMG_DG023625,"(2S,3S)-N-[[2-methoxy-5-(tetrazol-1-yl)phenyl]methyl]-2-phenylpiperidin-3-amine | PubChem CID:127944"
+BMGC_DG02600,BMG_DG023649,"UNII:75E39HK2X2 | 1,6-DIHYDRO-2-METHYL-6-OXO(3,4'-BIPYRIDINE)-5-CARBOXAMIDE | CAS RN:80047-24-1 | PubChem CID:12799331 | PubChem SID:404859507"
+BMGC_DG02601,BMG_DG023660,CAS RN:172854-55-6 | 3-(3-(Dimethylamino)propyl)-4-hydroxy-N-(4-(4-pyridinyl)phenyl)benzamide | UNII:QPY74DMU5M | 3-[3-(dimethylamino)propyl]-4-hydroxy-N-[4-(pyridin-4-yl)phenyl]benzamide | CAS RN:159533-26-3 | PubChem SID:482554046 | 3-(3-(DIMETHYLAMINO)PROPYL)-4-HYDROXY-N-(4-(PYRIDIN-4-YL)PHENYL)BENZAMIDE | 3-[3-(dimethylamino)propyl]-4-hydroxy-N-(4-pyridin-4-ylphenyl)benzamide | PubChem CID:128018
+BMGC_DG02602,BMG_DG023666,PubChem SID:459055840 | CAS RN:180847-28-3 | 4-((1-(3-(FLUORO)PROPYL)-4-PIPERIDINYL)METHOXY)BENZONITRILE | PubChem CID:128032 | UNII:DVG774J9LJ
+BMGC_DG02603,BMG_DG023670,PubChem SID:485663308 | UNII:GP8G6WR6H9 | 10-Imidazolyldecanoic acid | PubChem CID:12803316 | 10-IMIDAZOLYLDECANOIC ACID | CAS RN:68887-70-7
+BMGC_DG02604,BMG_DG023678,PubChem CID:128069 | CAS RN:102251-91-2 | PubChem SID:348480864 | SC-42867 | UNII:A4J4Z9P6VZ
+BMGC_DG02605,BMG_DG023698,5-hexyloxolan-2-one | .GAMMA.-DECALACTONE | Gamma-Decalactone | PubChem CID:12813 | CAS RN:706-14-9 | UNII:7HLS05KP9O | PubChem SID:175272103 | CAS RN:2825-92-5
+BMGC_DG02606,BMG_DG023719,"1,2-Dioctanoyl-sn-glycero-3-phosphate | CAS RN:102731-57-7 | PubChem CID:128167 | UNII:637NLP8R7J | DIOCTANOYLPHOSPHATIDIC ACID | [(2R)-2-octanoyloxy-3-phosphonooxypropyl] octanoate | PubChem SID:461434489"
+BMGC_DG02607,BMG_DG023726,"PubChem CID:12818200 | DrugBank ID:DB08962 | 1-[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-3-(4-methylphenyl)sulfonylurea | PubChem SID:198941633 | GLIBORNURIDE | Glibornuride | UNII:VP83E7434R | CAS RN:26944-48-9"
+BMGC_DG02608,BMG_DG023728,PubChem CID:12819 | CAS RN:708-06-5 | UNII:PP9CFN7QNL | PubChem SID:363908689 | 1-FORMYL-2-NAPHTHOL
+BMGC_DG02609,BMG_DG023731,DrugBank ID:DB01767 | Hemi-Babim | PubChem CID:1282
+BMGC_DG02610,BMG_DG023742,CAS RN:103213-32-7 | PubChem CID:128239 | FMOC-L-CYS(TRT)-OH | UNII:7VS47T4LL8
+BMGC_DG02611,BMG_DG023762,"PubChem SID:252319326 | .DELTA.9-CIS-TETRAHYDROCANNABINOL, (-)- | PubChem CID:12831993 | UNII:7JN0PAV0CJ | CAS RN:43009-38-7"
+BMGC_DG02612,BMG_DG023769,PubChem SID:445500548 | CAS RN:712-08-3 | 5-FLUORO-AMT | UNII:P46235ZAP7 | PubChem CID:12834
+BMGC_DG02613,BMG_DG023771,2-(5-methoxy-1H-indol-3-yl)ethanol | CAS RN:712-09-4 | 5-Methoxytryptophol | PubChem CID:12835
+BMGC_DG02614,BMG_DG023793,"CAS RN:103597-56-4 | [(1R,2S,4R,5S)-2,3,4,6-tetrahydroxy-5-phosphonooxycyclohexyl] dihydrogen phosphate | DrugBank ID:DB02942 | Inositol 1,3-bisphosphate | PubChem CID:128419 | Inositol 1,3-Bisphosphate"
+BMGC_DG02615,BMG_DG023807,"UNII:GH878F6QQL | PubChem CID:128480 | 4-(5-Methoxy-3-methyl-1H-indol-2-yl)-2,6-dimethylphenol | CAS RN:104007-80-9 | 4-(5-METHOXY-3-METHYL-1H-INDOL-2-YL)-2,6-DIMETHYLPHENOL | PubChem SID:485663657"
+BMGC_DG02616,BMG_DG023833,9-CYCLOPENTYLADENINE | CAS RN:715-91-3 | 9-Cyclopentyladenine | PubChem CID:12852 | PubChem SID:474492117 | UNII:Y9QMS8JX87
+BMGC_DG02617,BMG_DG023836,PubChem SID:472422671 | UNII:PLW2TN7B39 | CAS RN:104261-69-0 | PubChem CID:128523 | NE-58051
+BMGC_DG02618,BMG_DG023845,3-PHENYLBENZOIC ACID | UNII:W48UX3L48Z | PubChem CID:12854 | CAS RN:716-76-7 | 3-Phenylbenzoic acid | PubChem SID:474492231
+BMGC_DG02619,BMG_DG023848,"CAS RN:142128-58-3 | KETOCONAZOLE, (2R,4R)- | KETOCONAZOLE, TRANS- | Ketoconazole, (2R,4R)- | UNII:2EWW9YYR6A | CAS RN:83374-59-8 | UNII:3INP7D7XI3 | PubChem CID:12854713 | PubChem SID:198945321 | PubChem SID:485666315"
+BMGC_DG02620,BMG_DG023851,CAS RN:716-79-0 | PubChem SID:198942829 | UNII:CB9ZJ140SB | 2-PHENYLBENZIMIDAZOLE | PubChem CID:12855
+BMGC_DG02621,BMG_DG023860,"Salvinorin A | PubChem SID:198941395 | DrugBank ID:DB12327 | methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate | CAS RN:83729-01-5 | SALVINORIN A | UNII:T56W91NG6J | PubChem CID:128563"
+BMGC_DG02622,BMG_DG023861,N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE | (2R)-N'-hydroxy-N-[(2S)-3-(4-methoxyphenyl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide | PubChem CID:128564 | n-[3-(n'-Hydroxycarboxamido)-2-(2-methylpropyl)-propanoyl]-o-tyrosine-n-methylamide | DrugBank ID:DB07926 | CAS RN:104408-38-0
+BMGC_DG02623,BMG_DG023887,"UNII:T7F4GCF4F9 | PubChem SID:459275346 | CAS RN:85233-29-0 | PubChem CID:128646 | 3,7-DIHYDROXYTROPOLONE"
+BMGC_DG02624,BMG_DG023954,PubChem CID:128814 | UNII:Q5ELR5A7Y5 | RAGAGLITAZAR | CAS RN:222834-30-2 | Ragaglitazar | PubChem SID:198982917 | (2R)-2-ethoxy-3-[4-(2-phenoxazin-10-ylethoxy)phenyl]propanoic acid | DrugBank ID:DB06533
+BMGC_DG02625,BMG_DG023955,PubChem CID:12881464 | DrugBank ID:DB09081 | Idebenone
+BMGC_DG02626,BMG_DG023957,N-Depropylpropafenone | CAS RN:86383-21-3 | N-DEPROPYLPROPAFENONE | 1-[2-(3-amino-2-hydroxypropoxy)phenyl]-3-phenylpropan-1-one | UNII:KN087PHW5T | PubChem SID:249817519 | PubChem CID:128820
+BMGC_DG02627,BMG_DG023970,PubChem CID:128837 | UNII:96TER1JROC | LYSYLLYSINE | PubChem SID:346541001 | CAS RN:13184-13-9
+BMGC_DG02628,BMG_DG023976,"CAS RN:89664-20-0 | UNII:37W6H6V7ST | NOMIFENSINE, (R)- | PubChem SID:472407954 | PubChem CID:12884652"
+BMGC_DG02629,BMG_DG023979,"2-(3,4,5-trihydroxyphenyl)chromenylium-3,5,7-triol | CAS RN:13270-61-6 | UNII:031A4BN94T | DELPHINIDIN CATION | PubChem CID:128853 | PubChem SID:241180626 | Flavylium, 3,3',4',5,5',7-hexahydroxy-"
+BMGC_DG02630,BMG_DG023981,"PubChem SID:198946232 | CAS RN:13306-05-3 | UNII:7732ZHU564 | 2-(3,4-dihydroxyphenyl)chromenylium-3,5,7-triol | PubChem CID:128861 | Cyanidin | CYANIDIN CATION"
+BMGC_DG02631,BMG_DG023987,PubChem CID:128882 | 3'-Phosphate-Adenosine-5'-Diphosphate | DrugBank ID:DB01842
+BMGC_DG02632,BMG_DG024006,"PubChem SID:198975707 | PubChem CID:128919 | XALIPRODEN | UNII:V8QL94KNQO | Xaliproden | 1-(2-naphthalen-2-ylethyl)-4-[3-(trifluoromethyl)phenyl]-3,6-dihydro-2H-pyridine | CAS RN:135354-02-8 | DrugBank ID:DB06393"
+BMGC_DG02633,BMG_DG024007,UNII:72G763P0UO | PubChem SID:198956353 | PubChem CID:12892 | CAS RN:729-46-4 | DIMORPHOLINETHIURAM DISULFIDE
+BMGC_DG02634,BMG_DG024008,"PubChem CID:128924 | CAS RN:67805-97-4 | 5'-Thioadenosine | (2R,3R,4S,5S)-2-(6-aminopurin-9-yl)-5-(sulfanylmethyl)oxolane-3,4-diol"
+BMGC_DG02635,BMG_DG024014,"PubChem CID:12894 | PubChem SID:198982385 | SULFAMOXOLE | UNII:HGG82XE020 | DrugBank ID:DB08798 | 4-amino-N-(4,5-dimethyl-1,3-oxazol-2-yl)benzenesulfonamide | Sulfamoxole | CAS RN:729-99-7"
+BMGC_DG02636,BMG_DG024020,"PubChem CID:12895728 | UNII:ODG984O60W | CAS RN:37577-22-3 | PubChem SID:313184269 | NORFENFLURAMINE, (R)-"
+BMGC_DG02637,BMG_DG024045,4-methylpentanal | PubChem CID:129 | 4-METHYLVALERALDEHYDE | UNII:T0AO9E93RH | PubChem SID:376072379 | 4-Methylpentanal | CAS RN:1119-16-0
+BMGC_DG02638,BMG_DG024064,"CAS RN:732-11-6 | Phosmet | PubChem CID:12901 | PHOSMET | PubChem SID:198949136 | CAS RN:5104-30-3 | DrugBank ID:DB11448 | UNII:VN04LI540Y | 2-(dimethoxyphosphinothioylsulfanylmethyl)isoindole-1,3-dione"
+BMGC_DG02639,BMG_DG024172,"CAS RN:133514-43-9 | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-5-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-5-oxopentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | UNII:5313W10MYT | PubChem CID:129012199 | AVEXITIDE | PubChem SID:316917751 | DrugBank ID:DB14806 | Avexitide"
+BMGC_DG02640,BMG_DG024176,UNII:EDZ8BK9GK2 | PubChem CID:129027150 | CAS RN:1842340-93-5 | 2-[[5-[3-(4-chlorophenoxy)prop-1-ynyl]-3-hydroxypyridine-2-carbonyl]amino]acetic acid | Ddo-3055 | PubChem SID:461433886 | DDO-3055
+BMGC_DG02641,BMG_DG024183,"Nemtabrutinib | NEMTABRUTINIB | (2-chloro-4-phenoxyphenyl)-[4-[[(3R,6S)-6-(hydroxymethyl)oxan-3-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]methanone | CAS RN:2095393-15-8 | PubChem CID:129045720 | UNII:JTZ51LIXN4 | PubChem SID:346540206"
+BMGC_DG02642,BMG_DG024191,UNII:14FDK6ISC9 | PubChem CID:129053037 | Astx029 | PubChem SID:461433535 | BEROTERKIB ANHYDROUS | (2R)-2-[5-[5-chloro-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxo-1H-isoindol-2-yl]-N-[(1S)-1-(3-fluoro-5-methoxyphenyl)-2-hydroxyethyl]propanamide | Beroterkib anhydrous | CAS RN:2095719-92-7
+BMGC_DG02643,BMG_DG024206,UNII:1WPE73O1WV | N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide | PRALSETINIB | PubChem CID:129073603 | Pralsetinib | CAS RN:2097132-94-8 | CAS RN:2097132-93-7 | PubChem SID:381608584
+BMGC_DG02644,BMG_DG024214,2-[5-[5-chloro-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxo-1H-isoindol-2-yl]-N-(2-phenylpropan-2-yl)acetamide | 2-[5-[5-chloranyl-2-(oxan-4-ylamino)pyrimidin-4-yl]-3-oxidanylidene-1~{H}-isoindol-2-yl]-~{N}-(2-phenylpropan-2-yl)ethanamide | PubChem CID:129077798
+BMGC_DG02645,BMG_DG024223,2-(Pyridin-3-ylmethyl)-1H-indazol-3-one | 2-(PYRIDIN-3-YLMETHYL)-1H-INDAZOL-3-ONE | PubChem SID:478838344 | UNII:C6F3674CUN | CAS RN:120273-58-7 | PubChem CID:129095
+BMGC_DG02646,BMG_DG024226,"CAS RN:2097002-61-2 | PubChem CID:129103609 | (6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexazapentacyclo[16.5.2.02,6.07,12.021,25]pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one | Selitrectinib | DrugBank ID:DB14896 | SELITRECTINIB | UNII:0J45910S3X | PubChem SID:346537759"
+BMGC_DG02647,BMG_DG024236,PubChem CID:129111 | PubChem SID:474492465 | CLITOCINE | CAS RN:105798-74-1 | Clitocine | UNII:9Z4QXQ98QW
+BMGC_DG02648,BMG_DG024238,"UNII:VO9KX45QIQ | (6R)-7-[(3,4-difluorophenyl)methyl]-6-(methoxymethyl)-2-[5-methyl-2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]-5,6-dihydroimidazo[1,2-a]pyrazin-8-one | TIZATERKIB | CAS RN:2097416-76-5 | Tizaterkib | PubChem CID:129116690 | PubChem SID:461434650"
+BMGC_DG02649,BMG_DG024247,UNII:8I28LF0B2D | CAS RN:105823-04-9 | PubChem SID:375085961 | JWH-057 | PubChem CID:129128
+BMGC_DG02650,BMG_DG024253,"PubChem SID:381608325 | Zotatifin | CAS RN:2098191-54-7 | 4-[(2S,3R,4S,5S,6R)-4-[(dimethylamino)methyl]-2,3-dihydroxy-10,12-dimethoxy-5-phenyl-7-oxa-11-azatricyclo[6.4.0.02,6]dodeca-1(12),8,10-trien-6-yl]benzonitrile | UNII:2EWN8Z05CN | ZOTATIFIN | CAS RN:2098191-53-6 | PubChem CID:129138801"
+BMGC_DG02651,BMG_DG024262,1-O-Octyl-2-heptylphosphonyl-SN-glycero-3-phosphoethanolamine | 1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine | CAS RN:120411-63-4 | [(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octoxypropan-2-yl]oxy-heptylphosphinic acid | DrugBank ID:DB03565 | PubChem CID:129148
+BMGC_DG02652,BMG_DG024268,CAS RN:2098545-89-0 | PubChem CID:129165016 | 4-(2-chloroanilino)-6-[(6-methylpyridin-2-yl)amino]pyridine-3-carboxamide | Nvp-cee321
+BMGC_DG02653,BMG_DG024284,PubChem CID:1292 | Mandelic Acid | CAS RN:90-64-2 | CAS RN:611-72-3 | CAS RN:81432-25-9 | 2-hydroxy-2-phenylacetic acid | DrugBank ID:DB13218 | MANDELIC ACID | CAS RN:32518-00-6 | PubChem SID:175272044 | UNII:NH496X0UJX
+BMGC_DG02654,BMG_DG024285,"UNII:5Y2Z8AH65E | CAS RN:2099128-41-1 | PubChem CID:129202507 | Crozbaciclib | PubChem SID:474492367 | 5-fluoro-4-(7'-fluoro-2'-methylspiro[cyclopentane-1,3'-indole]-5'-yl)-N-[5-(1-methylpiperidin-4-yl)pyridin-2-yl]pyrimidin-2-amine | CROZBACICLIB"
+BMGC_DG02655,BMG_DG024286,"Azd-0284 | (1R)-2-acetyl-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-5-methylsulfonyl-1,3-dihydroisoindole-1-carboxamide | AZD-0284 | PubChem CID:129205086 | PubChem SID:445498796 | CAS RN:2101291-07-8 | UNII:5G4XF6VU2Y"
+BMGC_DG02656,BMG_DG024291,TAMSULOSIN | PubChem SID:175268106 | DrugBank ID:DB00706 | Tamsulosin | UNII:G3P28OML5I | 5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide | CAS RN:106133-20-4 | PubChem CID:129211
+BMGC_DG02657,BMG_DG024296,"NDC:31722-599 | NDC:42571-392 | NDC:59651-616 | NDC:68462-713 | RUFINAMIDE | NDC:68180-803 | NDC:72603-261 | Rufinamide | NDC:59651-563 | NDC:31722-598 | PubChem SID:175266026 | NDC:0378-2330 | NDC:68180-797 | NDC:59651-617 | CAS RN:170939-95-4 | NDC:42571-391 | NDC:0378-2331 | NDC:62856-583 | UNII:WFW942PR79 | NDC:68180-804 | NDC:67877-673 | NDC:0054-0426 | NDC:75929-098 | NDC:0054-0528 | PubChem CID:129228 | NDC:62856-584 | CAS RN:106308-44-5 | NDC:69452-223 | 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxamide | NDC:0054-0425 | NDC:31722-688 | NDC:68462-714 | NDC:62856-582 | DrugBank ID:DB06201"
+BMGC_DG02658,BMG_DG024301,CAS RN:120615-25-0 | PubChem SID:438788628 | N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide | DrugBank ID:DB03693 | PubChem CID:129236 | N-(2-AMINOETHYL)-5-CHLOROISOQUINOLINE-8-SULFONAMIDE | UNII:3IE84W82O5
+BMGC_DG02659,BMG_DG024309,"PubChem SID:461432474 | CAS RN:2101700-15-4 | Pirtobrutinib | NDC:0002-7026 | 5-amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(2S)-1,1,1-trifluoropropan-2-yl]pyrazole-4-carboxamide | PIRTOBRUTINIB | PubChem CID:129269915 | UNII:JNA39I7ZVB | NDC:0002-6902"
+BMGC_DG02660,BMG_DG024310,"CAS RN:68011-66-5 | 3-hydroxybenzo[b][1]benzazepine-11-carboxamide | HYDROXYCARBAMAZEPINE, 2- | PubChem SID:438788155 | 2-Hydroxycarbamazepine | PubChem CID:129274 | UNII:1UT0PR32AJ"
+BMGC_DG02661,BMG_DG024315,"2-[(1R,5S)-3-[2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl]-3-azabicyclo[3.1.0]hexan-6-yl]acetic acid | PF-06835919 | PubChem CID:129278694 | PubChem SID:482553782 | CAS RN:2102501-84-6 | Ketohexokinase inhibitor 1 | UNII:EC2P9H3A8S"
+BMGC_DG02662,BMG_DG024550,"24,25 Dihydroxyvitamin D3 | PubChem CID:129446563 | (3S,6S)-6-[(1S,3aR,4E,7aS)-4-[(2Z)-2-[(5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol | CAS RN:55721-11-4"
+BMGC_DG02663,BMG_DG024557,NDC:76420-850 | NDC:50090-6629 | NDC:50090-7306 | NDC:83980-001 | NDC:50090-6280 | NDC:16729-563 | NDC:82009-045 | NDC:68788-7747 | NDC:0615-8459 | NDC:62135-752 | NDC:71335-1771 | NDC:16571-112 | NDC:71610-473 | NDC:42385-927 | NDC:55154-2074 | CAS RN:14480-75-2 | Hydroxychloroquine Sulfate | NDC:50268-412 | PubChem SID:175271802 | NDC:69238-1544 | NDC:71610-701 | NDC:16729-485 | NDC:68382-096 | NDC:71205-448 | NDC:76420-643 | NDC:63739-777 | NDC:57664-761 | NDC:63629-4465 | NDC:50090-4659 | NDC:70954-804 | NDC:43598-133 | UNII:8Q2869CNVH | NDC:43598-131 | 2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol;sulfuric acid | NDC:16729-562 | NDC:16729-561 | HYDROXYCHLOROQUINE SULFATE | NDC:60219-1544 | NDC:0093-2401 | NDC:43353-051 | NDC:43598-721 | NDC:55154-3567 | NDC:71610-506 | NDC:65841-633 | CAS RN:747-36-4 | NDC:16571-687 | NDC:70954-805 | NDC:71335-1523 | NDC:71335-0897 | NDC:43598-132 | NDC:16714-110 | NDC:50090-7307 | NDC:68084-269 | NDC:59212-562 | NDC:71335-1949 | NDC:0904-7046 | PubChem CID:12947 | NDC:42385-971
+BMGC_DG02664,BMG_DG024558,UNII:GKX573279U | FLUBROMAZEPAM | PubChem CID:12947024 | PubChem SID:312524979 | CAS RN:2647-50-9
+BMGC_DG02665,BMG_DG024589,"PubChem SID:440089242 | PubChem CID:129532613 | 5F-Cumyl-p7aica | 5F-CUMYL-P7AICA | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)pyrrolo[2,3-b]pyridine-3-carboxamide | UNII:V3J3TQ3UPP | CAS RN:2171492-36-5"
+BMGC_DG02666,BMG_DG024624,"UNII:CY7817W711 | PubChem SID:316911868 | 2-[2-(2,6-dichloro-3-hydroxy-4-methoxyanilino)phenyl]acetic acid | PubChem CID:129615 | 3'-HYDROXY-4'-METHOXYDICLOFENAC | 3'-Hydroxy-4'-methoxydiclofenac | CAS RN:106610-60-0"
+BMGC_DG02667,BMG_DG024756,"cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,7S,12S,13S,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide | CAS RN:68-19-9 | PubChem CID:129627537"
+BMGC_DG02668,BMG_DG024815,"PubChem SID:329904253 | DIMETINDENE, (R)- | CAS RN:135821-89-5 | UNII:C9Z23T6963 | PubChem CID:12963076"
+BMGC_DG02669,BMG_DG024907,UNII:8L4C2S5DL6 | Fmoc-D-Tyr(tBu)-OH | CAS RN:118488-18-9 | FMOC-D-TYR(TBU)-OH | PubChem CID:12968135 | PubChem SID:496142506
+BMGC_DG02670,BMG_DG024930,"4-[amino(carboxy)methyl]-2-hydroxybenzoic acid | UNII:M725GQ103A | CAS RN:134052-66-7 | (RS)-4-Carboxy-3-hydroxyphenylglycine | PubChem CID:1297 | 4-CARBOXY-3-HYDROXYPHENYLGLYCINE, (±)- | 4-CARBOXY-3-HYDROXYPHENYLGLYCINE, (+/-)- | PubChem SID:316914356"
+BMGC_DG02671,BMG_DG024935,PubChem SID:198943049 | FG-8205 | PubChem CID:129710 | UNII:7V0I080855 | CAS RN:122384-14-9
+BMGC_DG02672,BMG_DG025004,PubChem SID:485664250 | UNII:C8QT2QBL7Y | Y-590 | PubChem CID:129826 | CAS RN:70386-06-0
+BMGC_DG02673,BMG_DG025060,6-KETOESTRONE | PubChem SID:482554998 | PubChem CID:12985714 | UNII:WJN9234S5H | CAS RN:1476-34-2 | 6-Ketoestrone
+BMGC_DG02674,BMG_DG025079,"DrugBank ID:DB05513 | 3-(8,8-dipropyl-2-azaspiro[4.5]decan-2-yl)-N,N-diethylpropan-1-amine | PubChem CID:129869 | UNII:MG7D3QD743 | ATIPRIMOD | CAS RN:123018-47-3 | PubChem SID:198984930 | Atiprimod"
+BMGC_DG02675,BMG_DG025092,6-HYDROXY-6-METHYL-HEPTAN-3-ONE | PubChem SID:438787812 | CAS RN:123065-56-5 | DrugBank ID:DB03711 | 6-Hydroxy-6-Methyl-Heptan-3-One | UNII:G2CVU7ZB99 | PubChem CID:129891
+BMGC_DG02676,BMG_DG025104,Somapacitan [WHO-DD] | PubChem CID:129894493 | (2S)-5-[2-[2-[2-[[(2S)-1-amino-6-[[2-[(2R)-2-amino-2-carboxyethyl]sulfanylacetyl]amino]-1-oxohexan-2-yl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-[[(4S)-4-carboxy-4-[[2-[2-[2-[4-[16-(2H-tetrazol-5-yl)hexadecanoylsulfamoyl]butanoylamino]ethoxy]ethoxy]acetyl]amino]butanoyl]amino]-5-oxopentanoic acid | CAS RN:1338578-34-9
+BMGC_DG02677,BMG_DG025151,DrugBank ID:DB04918 | PubChem CID:12993649 | Ceftobiprole
+BMGC_DG02678,BMG_DG025158,CAS RN:107813-63-8 | UNII:K4UOE2TWW7 | PubChem SID:348481518 | PubChem CID:129968 | RG-7152
+BMGC_DG02679,BMG_DG025186,CAS RN:145537-81-1 | PubChem CID:130021 | DrugBank ID:DB05010 | (3-Aminopropyl)(n-butyl)phosphinic acid | UNII:GBZ5UC0RME | 3-aminopropyl(butyl)phosphinic acid | CAS RN:123690-78-8 | SGS-742 | PubChem SID:272993930
+BMGC_DG02680,BMG_DG025192,"2-METHYL-1,3-CYCLOPENTANEDIONE | PubChem SID:318691707 | CAS RN:765-69-5 | UNII:C9LG5VP01C | PubChem CID:13005"
+BMGC_DG02681,BMG_DG025206,"CAS RN:123942-05-2 | 1-cyclopropyl-7-(2,6-dimethylpyridin-4-yl)-6,8-difluoro-4-oxoquinoline-3-carboxylic acid | PubChem CID:130078 | 1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxyic acid"
+BMGC_DG02682,BMG_DG025236,"PubChem SID:198982503 | PubChem CID:130165 | ALT-2074 | 4,4-Dimethyl-3,4-dihydro-2H-1,2-benzoselenazine | DrugBank ID:DB05631 | 4,4-dimethyl-2,3-dihydro-1,2-benzoselenazine | UNII:634U7OUR4R | CAS RN:173026-17-0"
+BMGC_DG02683,BMG_DG025237,PubChem SID:348481191 | Cyclohexylformamide | PubChem CID:13017 | UNII:X2CFE4SDT6 | DrugBank ID:DB03559 | CYCLOHEXYLFORMAMIDE | N-cyclohexylformamide | CAS RN:766-93-8 | N-Cyclohexylformamide
+BMGC_DG02684,BMG_DG025247,PubChem CID:13019 | 4-CYANOPHENOL | CAS RN:767-00-0 | UNII:1S13529YJU | PubChem SID:198944427
+BMGC_DG02685,BMG_DG025249,"UNII:484EDA7KEM | PubChem CID:130196740 | N-(4-(1-CYCLOPROPYL-4-FLUORO-2-METHYL-1H-BENZO(D)IMIDAZOL-6-YL)-5-FLUOROPYRIMIDIN-2-YL)-6-(2-(DIMETHYLAMINO)ETHYL)-5,6,7,8-TETRAHYDRO-L,6-NAPHTHYRIDIN-2-AMINE | PubChem SID:482554288 | CAS RN:2102887-41-0"
+BMGC_DG02686,BMG_DG025250,"PubChem CID:130196825 | 1,6-Naphthyridine-6(5H)-ethanamine, 2-[[5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinyl]amino]-7,8-dihydro-N,N-dimethyl- | CAS RN:2102887-51-2 | 1,6-NAPHTHYRIDINE-6(5H)-ETHANAMINE, 2-((5-FLUORO-4-(4-FLUORO-2-METHYL-1-(1-METHYLETHYL)-1H-BENZIMIDAZOL-6-YL)-2-PYRIMIDINYL)AMINO)-7,8-DIHYDRO-N,N-DIMETHYL- | UNII:85RT63WT83 | PubChem SID:482554868"
+BMGC_DG02687,BMG_DG025256,"UNII:T5ADC7PXJ9 | PubChem CID:1302 | CAS RN:23981-80-8 | NAPROXEN, (+/-)-"
+BMGC_DG02688,BMG_DG025265,"PubChem SID:440793820 | [[(2R,3S,4R,5R)-5-[6-chloro-4-[[(1S)-1-(2-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid | UNII:J6K8WSV73A | CAS RN:2105904-82-1 | QUEMLICLUSTAT | PubChem CID:130205852 | Quemliclustat"
+BMGC_DG02689,BMG_DG025268,"PubChem SID:316912517 | 2-AMINO-4,6-DIMETHYLPYRIMIDINE | 4,6-dimethylpyrimidin-2-amine | PubChem CID:13021 | UNII:4S48MI253M | CAS RN:767-15-7 | 2-Amino-4,6-dimethylpyrimidine"
+BMGC_DG02690,BMG_DG025277,"5-[8-oxo-5-(6-piperidin-4-yloxypyridin-3-yl)-6-sulfanylidene-5,7-diazaspiro[3.4]octan-7-yl]-3-(trifluoromethyl)pyridine-2-carbonitrile | UNII:GNG9GQ9Y27 | CAS RN:2110426-27-0 | Jnj-63576253 | TRC-253 | PubChem SID:472425691 | PubChem CID:130229812"
+BMGC_DG02691,BMG_DG025279,"Amcenestrant | PubChem SID:404859774 | UNII:TBF1NHY02O | 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid | AMCENESTRANT | PubChem CID:130232326 | CAS RN:2114339-57-8"
+BMGC_DG02692,BMG_DG025281,"CAS RN:78859-33-3 | CARAZOLOL, (S)- | DrugBank ID:DB07543 | PubChem SID:252164904 | PubChem CID:13023332 | UNII:6Q9080LN3O | (S)-carazolol"
+BMGC_DG02693,BMG_DG025313,"methyl (2R,3S)-3-(methanesulfonamido)-2-[(4-phenylcyclohexyl)oxymethyl]piperidine-1-carboxylate | PubChem SID:433968529 | Tak-925 | DANAVOREXTON | PubChem CID:130310079 | UNII:1QMD83K4YN | CAS RN:2114324-48-8"
+BMGC_DG02694,BMG_DG025316,"PubChem CID:130313 | PubChem SID:175268670 | UNII:S4TF6I2330 | SULBACTAM | DrugBank ID:DB09324 | Sulbactam | CAS RN:68373-14-8 | (2S,5R)-3,3-dimethyl-4,4,7-trioxo-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"
+BMGC_DG02695,BMG_DG025326,"UNII:HY5SOV7O0Q | 3-(cyanomethyl)-3-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]pyrazol-1-yl]cyclobutane-1-carbonitrile | PubChem SID:441331818 | CAS RN:2127109-85-5 | ROPSACITINIB | Pf-06826647 | PubChem CID:130339268 | CAS RN:2127109-84-4"
+BMGC_DG02696,BMG_DG025330,"CAS RN:2126744-35-0 | PubChem CID:130345472 | PubChem SID:472423638 | SW-100 | UNII:43U5GL7ZCP | 4-[(6-chloro-3,4-dihydro-2H-quinolin-1-yl)methyl]-N-hydroxybenzamide"
+BMGC_DG02697,BMG_DG025348,"PubChem CID:130375753 | N-[4-[4-amino-3-(2-amino-1,3-benzoxazol-5-yl)pyrazolo[3,4-d]pyrimidin-1-yl]butyl]-3-[2-[2-[2-[2-[2-[2-[2-[2-[4-[2-[(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl]oxyethoxymethyl]triazol-1-yl]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanamide"
+BMGC_DG02698,BMG_DG025357,UNII:487JA5G388 | PubChem CID:130395 | FOY-251 | CAS RN:71079-08-8 | PubChem SID:485664243
+BMGC_DG02699,BMG_DG025384,PubChem CID:130431318 | CAS RN:1982347-43-2 | N-[4-[4-(3-chloro-5-ethyl-2-methoxyphenyl)piperazin-1-yl]-3-hydroxybutyl]-1H-indole-2-carboxamide
+BMGC_DG02700,BMG_DG025385,(R)-N-(4-(4-(3-Chloro-5-ethyl-2-methoxyphenyl)piperazin-1-yl)-3-hydroxybutyl)-1H-indole-2-carboxamide | N-[(3R)-4-[4-(3-chloro-5-ethyl-2-methoxyphenyl)piperazin-1-yl]-3-hydroxybutyl]-1H-indole-2-carboxamide | PubChem CID:130431329
+BMGC_DG02701,BMG_DG025386,PubChem CID:130431397 | PubChem SID:472424547 | UNII:2M8P7UAW4W | CAS RN:2134602-45-0 | SR-17018
+BMGC_DG02702,BMG_DG025405,"DrugBank ID:DB14911 | Luminate | RISUTEGANIB | PubChem SID:363908201 | UNII:123DNA66IA | PubChem CID:130476723 | (2S)-1-[(2S,3R)-2-[[(2R)-2-[[2-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-3-sulfopropanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid | CAS RN:1307293-62-4"
+BMGC_DG02703,BMG_DG025460,CAS RN:109628-27-5 | N-(6-methoxy-8-quinolyl)-4-toluenesulfonamide | PubChem CID:130606 | N-(6-methoxyquinolin-8-yl)-4-methylbenzenesulfonamide | UNII:7SWW052N6R | N-(6-METHOXY-8-QUINOLYL)-4-TOLUENESULFONAMIDE | PubChem SID:198937211
+BMGC_DG02704,BMG_DG025464,"KIFUNENSINE | CAS RN:109944-15-2 | Kifunensine | (5R,6R,7S,8R,8aS)-6,7,8-trihydroxy-5-(hydroxymethyl)-1,5,6,7,8,8a-hexahydroimidazo[1,2-a]pyridine-2,3-dione | UNII:0NI8960271 | DrugBank ID:DB02742 | PubChem SID:241179639 | PubChem CID:130611"
+BMGC_DG02705,BMG_DG025470,CAS RN:778-22-3 | DIMETHYLDIPHENYLMETHANE | UNII:OV5R1AZU4N | PubChem SID:198973853 | PubChem CID:13065
+BMGC_DG02706,BMG_DG025506,"Talotrexin | CAS RN:113857-87-7 | UNII:A8E516A20K | PubChem CID:130731 | PubChem SID:198969278 | 2-[[(4S)-4-carboxy-4-[[4-[(2,4-diaminopteridin-6-yl)methylamino]benzoyl]amino]butyl]carbamoyl]benzoic acid | DrugBank ID:DB06178 | TALOTREXIN"
+BMGC_DG02707,BMG_DG025513,PubChem SID:472425680 | UNII:YL48YW74QQ | PubChem CID:13074411 | CAS RN:83947-94-8 | PYR1
+BMGC_DG02708,BMG_DG025551,.GAMMA.-CARBOLINE | PubChem SID:198961908 | UNII:89407EP2HE | PubChem CID:130802 | CAS RN:244-69-9
+BMGC_DG02709,BMG_DG025554,DrugBank ID:DB08453 | PubChem CID:130804 | 2-Nonyl-4-quinolinol 1-oxide
+BMGC_DG02710,BMG_DG025555,"[(2R,3S,4R,5R)-5-[(2-formamidoacetyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | CAS RN:349-34-8 | PubChem CID:130805 | UNII:X3J3LQ4ML8 | FORMYLGLYCINAMIDE RIBOTIDE | 5'-phosphoribosyl-N-formylglycinamide | Formylglycinamide ribotide | PubChem SID:474492494"
+BMGC_DG02711,BMG_DG025584,"NDC:33342-180 | NDC:50090-6686 | NDC:70756-809 | NDC:42571-203 | NDC:65162-080 | NDC:0527-2425 | NDC:50090-6632 | NDC:27808-276 | NDC:70518-2127 | NDC:0527-2427 | NDC:51407-199 | NDC:0527-2426 | NDC:71335-2362 | NDC:59746-465 | NDC:68462-437 | NDC:82009-073 | NDC:63629-9426 | NDC:71205-174 | NDC:72189-548 | NDC:62332-133 | NDC:50090-3487 | NDC:63629-8525 | NDC:71205-172 | NDC:68382-644 | NDC:72189-373 | NDC:71335-2376 | NDC:72189-549 | NDC:71205-459 | NDC:50090-6606 | NDC:27808-277 | NDC:82009-075 | NDC:46708-133 | NDC:49252-067 | NDC:72205-167 | NDC:70518-4040 | NDC:50228-340 | NDC:71335-0775 | PubChem CID:130881 | NDC:42571-201 | NDC:65162-081 | NDC:72205-165 | NDC:71335-1920 | NDC:71335-0817 | NDC:72189-558 | NDC:82009-074 | NDC:51407-198 | NDC:0713-0862 | NDC:65862-743 | NDC:70771-1059 | NDC:72205-166 | NDC:67877-447 | NDC:64980-601 | NDC:65862-741 | NDC:27808-275 | NDC:43547-299 | NDC:72189-138 | NDC:67877-446 | NDC:51407-197 | NDC:50090-6633 | NDC:43547-300 | NDC:70756-808 | NDC:70756-810 | NDC:64980-602 | NDC:62332-132 | NDC:68382-645 | NDC:68462-436 | NDC:46708-132 | Olmesartan Medoxomil | NDC:59746-466 | NDC:62135-881 | NDC:43547-301 | NDC:62332-131 | OLMESARTAN MEDOXOMIL | NDC:50090-3471 | NDC:70518-2347 | NDC:50090-3655 | NDC:67877-445 | NDC:65162-079 | NDC:59746-463 | NDC:70518-1343 | NDC:50090-7087 | NDC:62135-882 | NDC:33342-179 | NDC:50228-341 | NDC:71335-2380 | NDC:71205-458 | NDC:0713-0860 | NDC:70771-1060 | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate | UNII:6M97XTV3HD | NDC:63629-8522 | NDC:16729-321 | NDC:70771-1061 | NDC:70518-4053 | CAS RN:144689-63-4 | NDC:71335-2448 | NDC:16729-320 | NDC:64980-665 | NDC:49252-066 | NDC:68382-643 | NDC:72189-137 | NDC:50228-339 | NDC:64980-603 | NDC:68462-438 | NDC:46708-131 | NDC:63629-8524 | NDC:16729-322 | NDC:42571-202 | NDC:49252-065 | NDC:63629-8523 | NDC:0713-0861 | NDC:50090-3656 | NDC:65862-742 | NDC:71335-2399 | PubChem SID:175265389 | NDC:62135-880 | NDC:33342-178"
+BMGC_DG02712,BMG_DG025622,"PubChem CID:130956 | PubChem SID:198979870 | CAS RN:180064-38-4 | DrugBank ID:DB06548 | MINODRONIC ACID | UNII:40SGR63TGL | CAS RN:127657-42-5 | Minodronic acid | (1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid"
+BMGC_DG02713,BMG_DG025634,"Dimethyl [1,1'-biphenyl]-4,4'-dicarboxylate | Biphenyl dimethyl dicarboxylate | PubChem CID:13099 | CAS RN:792-74-5 | PubChem SID:198952683 | methyl 4-(4-methoxycarbonylphenyl)benzoate | BIPHENYL DIMETHYL DICARBOXYLATE | UNII:K61BXA0U9C | DrugBank ID:DB12475"
+BMGC_DG02714,BMG_DG025668,"NDC:0536-1142 | NDC:71205-120 | NDC:58602-892 | NDC:50419-424 | NDC:82791-538 | NDC:0536-1433 | NDC:51660-723 | NDC:59556-286 | NDC:72288-324 | NDC:62756-720 | LEVONORGESTREL | NDC:71205-361 | NDC:50419-423 | NDC:58602-841 | NDC:69953-628 | NDC:70000-0600 | NDC:70700-164 | NDC:79929-016 | NDC:69536-200 | PubChem SID:175265457 | NDC:58602-712 | NDC:0023-5858 | NDC:16714-809 | NDC:69536-146 | NDC:69953-517 | DrugBank ID:DB00367 | NDC:69536-162 | NDC:59726-138 | NDC:72657-108 | NDC:50742-352 | NDC:43386-622 | NDC:50102-211 | NDC:69536-133 | NDC:72288-111 | NDC:73436-2859 | NDC:71713-098 | Norgestrel | NDC:70000-0675 | NDC:69953-515 | NDC:51660-999 | PubChem CID:13109 | UNII:5W7SIA7YZW | NDC:68071-4294 | NDC:0113-2003 | NDC:62756-718 | NDC:82791-532 | NDC:58602-721 | NDC:59556-282 | NDC:68180-852 | CAS RN:797-63-7 | NDC:69536-103 | Levonorgestrel | NDC:58602-891 | NDC:80584-100 | NDC:0113-8101 | (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | NDC:73358-241 | NDC:50090-5978 | NDC:40032-622 | NDC:72657-123 | PubChem SID:249493407 | NDC:73358-911 | CAS RN:6533-00-2 | UNII:3J8Q1747Z2 | NDC:62756-723 | NDC:69953-618 | NDC:50419-422 | NDC:69953-516 | NORGESTREL | NDC:69953-617"
+BMGC_DG02715,BMG_DG025686,UNII:TZ913SWN6M | PubChem SID:198958877 | CHLORACYZINE | CAS RN:800-22-6 | PubChem CID:13113
+BMGC_DG02716,BMG_DG025692,5-Fluorolevulinic Acid | PubChem CID:131153 | UNII:U7AG97N7XY | 5-FLUOROLEVULINIC ACID | PubChem SID:438788002 | DrugBank ID:DB02828 | CAS RN:76385-49-4
+BMGC_DG02717,BMG_DG025694,"PubChem SID:198943451 | DrugBank ID:DB06478 | PubChem CID:13116 | UNII:H1WK901OA6 | CAS RN:801-52-5 | Porfiromycin | [(4S,6S,7R,8S)-11-amino-7-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate | PORFIROMYCIN"
+BMGC_DG02718,BMG_DG025709,"PubChem CID:131204 | DEXPANTHENOL | NDC:83472-521 | NDC:83472-311 | NDC:73519-001 | Dexpanthenol | DrugBank ID:DB09357 | NDC:67457-146 | NDC:83472-411 | NDC:83472-522 | CAS RN:81-13-0 | PubChem SID:175268189 | NDC:83472-412 | UNII:1O6C93RI7Z | (2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide | NDC:83472-511"
+BMGC_DG02719,BMG_DG025737,"CAS RN:29759-38-4 | PubChem CID:13129 | CAS RN:811-97-2 | DrugBank ID:DB13116 | Norflurane | PubChem SID:175267570 | 1,1,1,2-tetrafluoroethane | NORFLURANE | 1,1,1,2-Tetrafluoroethane | UNII:DH9E53K1Y8"
+BMGC_DG02720,BMG_DG025761,"PubChem CID:13136 | CALCIUM CITRATE ANHYDROUS | PubChem SID:198935729 | Calcium citrate | UNII:86117BWO7P | CAS RN:813-94-5 | tricalcium;2-hydroxypropane-1,2,3-tricarboxylate | DrugBank ID:DB11093 | CAS RN:7693-13-2"
+BMGC_DG02721,BMG_DG025785,DrugBank ID:DB13609 | PubChem SID:198957419 | CAS RN:131707-25-0 | CAS RN:5674-91-9 | ethyl 6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-(phenylsulfanylmethyl)indole-3-carboxylate | UMIFENOVIR | PubChem CID:131411 | UNII:93M09WW4RU | Arbidol
+BMGC_DG02722,BMG_DG025789,"2-(2-Phenylethoxy)adenosine | CAS RN:131865-79-7 | PubChem CID:131432 | UNII:73QD7Q797X | (2R,3R,4S,5R)-2-[6-amino-2-(2-phenylethoxy)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol | PubChem SID:461433059 | 2-(2-PHENYLETHOXY)ADENOSINE"
+BMGC_DG02723,BMG_DG025790,Calcium lactate | DrugBank ID:DB13231 | CAS RN:63690-56-2 | PubChem CID:13144 | CALCIUM LACTATE ANHYDROUS | CAS RN:814-80-2 | PubChem SID:175271794 | CAS RN:28305-25-1 | CAS RN:5743-48-6 | UNII:2URQ2N32W3 | calcium;2-hydroxypropanoate
+BMGC_DG02724,BMG_DG025805,PubChem CID:13148394 | CIS-HYDROXY LOXOPROFEN | UNII:K53ZT7U8TM | CAS RN:371753-20-7
+BMGC_DG02725,BMG_DG025811,PubChem CID:131505 | PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER | DrugBank ID:DB07657
+BMGC_DG02726,BMG_DG025818,PubChem SID:198985761 | PubChem CID:131534 | UNII:6H13T09362 | FLUPERAMIDE | CAS RN:53179-10-5
+BMGC_DG02727,BMG_DG025819,"FOSAMPRENAVIR CALCIUM | PubChem SID:175267207 | CAS RN:226700-81-8 | PubChem CID:131535 | NDC:49702-207 | UNII:ID1GU2627N | Fosamprenavir Calcium | NDC:0378-3520 | calcium;[(2R,3S)-1-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-[[(3S)-oxolan-3-yl]oxycarbonylamino]-4-phenylbutan-2-yl] phosphate | NDC:63304-583"
+BMGC_DG02728,BMG_DG025820,"CAS RN:1257693-05-2 | PubChem SID:175267520 | Fosamprenavir | [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate | UNII:WOU1621EEG | DrugBank ID:DB01319 | FOSAMPRENAVIR | PubChem CID:131536 | CAS RN:226700-79-4"
+BMGC_DG02729,BMG_DG025825,"7-METHYL-2-PROPYL-1,8-NAPHTHYRIDIN-4-OL | PubChem CID:13155595 | 7-Methyl-2-propyl-1,8-naphthyridin-4-ol | PubChem SID:485663691 | CAS RN:718624-73-8 | UNII:7KPH4G367X"
+BMGC_DG02730,BMG_DG025843,"PubChem CID:131584 | CAS RN:133058-72-7 | 8-(3-oxocyclopentyl)-1,3-dipropyl-7H-purine-2,6-dione | Kfm 19 | CAS RN:154601-67-9"
+BMGC_DG02731,BMG_DG025846,PubChem CID:131590 | CAS RN:133085-33-3 | PubChem SID:440089327 | BIBS-39 | UNII:NV95PEF62M
+BMGC_DG02732,BMG_DG025848,"PubChem SID:198952510 | PubChem CID:1316 | 1,1-dimethyl-4-phenylpiperazin-1-ium | CAS RN:114-28-3 | UNII:2FLS86GK2A | Dimethylphenylpiperazinium | DIMETHYLPHENYLPIPERAZINIUM"
+BMGC_DG02733,BMG_DG025854,"PubChem CID:131624 | Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester | DrugBank ID:DB01737"
+BMGC_DG02734,BMG_DG025868,"2H-1-Benzopyran-4-carboxylic acid, 6-chloro-7-(4-(((2-(4-chloro-2-methoxyphenyl)ethyl)amino)carbonyl)phenoxy)-3,4-dihydro-, (4S)- | ARRY-502 | UNII:5LO1ZK1LCW | PubChem SID:346536741 | (4S)-6-chloro-7-[4-[2-(4-chloro-2-methoxyphenyl)ethylcarbamoyl]phenoxy]-3,4-dihydro-2H-chromene-4-carboxylic acid | PubChem CID:131633366 | CAS RN:1202891-16-4"
+BMGC_DG02735,BMG_DG025954,"DrugBank ID:DB14792 | UNII:E3T5XXY9HX | 17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentazaheptacyclo[27.7.1.14,7.011,15.016,21.020,24.030,35]octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30,32,34-tridecaene-23-carboxylic acid | Unii-E3T5xxy9HX | AZD-5991 | CAS RN:2143061-81-6 | PubChem CID:131634760 | CAS RN:2143061-82-7 | CAS RN:2143010-83-5 | PubChem SID:346539451"
+BMGC_DG02736,BMG_DG025987,"PubChem CID:131635025 | CAS RN:13870-90-1 | COBAMAMIDE | (2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | UNII:F0R1QK73KB | 5'-Deoxyadenosylcobalamin | PubChem SID:198939962"
+BMGC_DG02737,BMG_DG026035,"PAGOCLONE | PubChem CID:131664 | 2-(7-chloro-1,8-naphthyridin-2-yl)-3-(5-methyl-2-oxohexyl)-3H-isoindol-1-one | Pagoclone | PubChem SID:198976646 | CAS RN:1515959-69-9 | DrugBank ID:DB04903 | CAS RN:133737-32-3 | CAS RN:133737-48-1 | UNII:38VAG2SA33"
+BMGC_DG02738,BMG_DG026122,Etheno-NAD | DrugBank ID:DB02483 | PubChem CID:131675359
+BMGC_DG02739,BMG_DG026133,"NEVANIMIBE | Nevanimibe | UNII:VK9OS8R205 | PubChem SID:198965083 | 1-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-3-[2,6-di(propan-2-yl)phenyl]urea | CAS RN:133825-80-6 | PubChem CID:131679"
+BMGC_DG02740,BMG_DG026134,PubChem SID:198984441 | PubChem CID:131682 | CAS RN:133865-89-1 | DrugBank ID:DB06654 | UNII:90ENL74SIG | (2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide | SAFINAMIDE | Safinamide
+BMGC_DG02741,BMG_DG026153,PubChem CID:131704172 | DrugBank ID:DB00743 | 2-[2-[bis(carboxylatomethyl)amino]ethyl-[2-[carboxymethyl-(1-carboxy-2-phenylmethoxyethyl)amino]ethyl]amino]acetate;gadolinium(3+) | Gadobenic acid | 2-[2-[Bis(carboxylatomethyl)amino]ethyl-[2-[carboxymethyl-(1-carboxy-2-phenylmethoxyethyl)amino]ethyl]amino]acetate;gadolinium(3+)
+BMGC_DG02742,BMG_DG026154,Colistin | DrugBank ID:DB00803 | PubChem CID:131704173
+BMGC_DG02743,BMG_DG026155,PubChem CID:131704176 | DrugBank ID:DB01705 | Bis(5-Amidino-Benzimidazolyl)Methane
+BMGC_DG02744,BMG_DG026156,DrugBank ID:DB01710 | PubChem CID:131704177 | Porphyrin Fe(III)
+BMGC_DG02745,BMG_DG026157,PubChem CID:131704180 | 7-thionicotinamide-adenine-dinucleotide phosphate | DrugBank ID:DB01763
+BMGC_DG02746,BMG_DG026161,"DrugBank ID:DB01978 | PubChem CID:131704185 | 7,9-Dimethylguanine"
+BMGC_DG02747,BMG_DG026163,CRA_16847 | PubChem CID:131704187 | DrugBank ID:DB02063
+BMGC_DG02748,BMG_DG026164,CRA_17312 | DrugBank ID:DB02084 | PubChem CID:131704188
+BMGC_DG02749,BMG_DG026166,"PubChem CID:131704191 | DrugBank ID:DB02158 | (2S,3S,4R,5S)-2-(4-Amino-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)-5-[(methylsulfanyl)methyl]-3,4-pyrrolidinediol"
+BMGC_DG02750,BMG_DG026173,2-deoxy-2-fluoro-alpha-D-mannosyl fluoride | PubChem CID:131704200 | DrugBank ID:DB02318
+BMGC_DG02751,BMG_DG026176,12-Phenylheme | DrugBank ID:DB02468 | PubChem CID:131704203
+BMGC_DG02752,BMG_DG026177,Ghavamiol | PubChem CID:131704205 | DrugBank ID:DB02492
+BMGC_DG02753,BMG_DG026186,PubChem CID:131704218 | 2-Amino-3-Oxo-4-Sulfo-Butyric Acid | DrugBank ID:DB02735
+BMGC_DG02754,BMG_DG026188,"DrugBank ID:DB02820 | PubChem CID:131704220 | 1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct"
+BMGC_DG02755,BMG_DG026191,Penicillin G Acyl-Serine | PubChem CID:131704224 | DrugBank ID:DB02968
+BMGC_DG02756,BMG_DG026192,5-fluoro-beta-L-gulosyl fluoride | DrugBank ID:DB03008 | PubChem CID:131704225
+BMGC_DG02757,BMG_DG026194,PubChem CID:131704227 | DrugBank ID:DB03021 | Ulapualide A
+BMGC_DG02758,BMG_DG026198,(S)-Hmg-Coa | DrugBank ID:DB03169 | PubChem CID:131704231
+BMGC_DG02759,BMG_DG026199,DrugBank ID:DB03179 | PubChem CID:131704232 | Sinapoyl coenzyme A
+BMGC_DG02760,BMG_DG026200,DrugBank ID:DB03189 | PubChem CID:131704233 | Cu-Cyclam
+BMGC_DG02761,BMG_DG026201,Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone | DrugBank ID:DB03213 | PubChem CID:131704234
+BMGC_DG02762,BMG_DG026204,PubChem CID:131704237 | DrugBank ID:DB03286 | C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide
+BMGC_DG02763,BMG_DG026206,"DrugBank ID:DB03319 | (2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate | PubChem CID:131704239"
+BMGC_DG02764,BMG_DG026209,DrugBank ID:DB03373 | ZK-806711 | PubChem CID:131704242
+BMGC_DG02765,BMG_DG026211,"PubChem CID:131704245 | DrugBank ID:DB03425 | 2s,4r-4-Methylglutamate"
+BMGC_DG02766,BMG_DG026212,bis(5-amidino-benzimidazolyl)methanone zinc | DrugBank ID:DB03443 | PubChem CID:131704246
+BMGC_DG02767,BMG_DG026214,DrugBank ID:DB03531 | PubChem CID:131704249 | Flavin-adenine dinucleotide-N5-isobutyl ketone
+BMGC_DG02768,BMG_DG026215,PubChem CID:131704251 | DrugBank ID:DB03536 | Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate
+BMGC_DG02769,BMG_DG026216,"DrugBank ID:DB03546 | N-({4-[(1R)-4-[(2R,4S,5S)-2,4-diamino-6-oxohexahydropyrimidin-5-yl]-1-(2,2,2-trifluoro-1,1-dihydroxyethyl)butyl]phenyl}carbonyl)-L-glutamic acid | PubChem CID:131704252"
+BMGC_DG02770,BMG_DG026217,"(3R,4R)-3-Hydroxy-4-(hydroxymethyl)-1-[(4-oxo-4,4a,5,7a-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]pyrrolidinium | DrugBank ID:DB03551 | PubChem CID:131704253"
+BMGC_DG02771,BMG_DG026218,DrugBank ID:DB03557 | PubChem CID:131704254 | 4-[[(2S)-1-[[6-[(1-Amino-1-oxo-3-sulfanylpropan-2-yl)amino]-6-oxohexyl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[[2-[4-[difluoro(phosphono)methyl]phenyl]acetyl]amino]-4-oxobutanoic acid
+BMGC_DG02772,BMG_DG026220,[(1S)-4-(1-Aminobutylideneamino)-1-carboxybutyl]azanium | DrugBank ID:DB03710 | PubChem CID:131704256
+BMGC_DG02773,BMG_DG026224,DrugBank ID:DB03845 | PubChem CID:131704260 | P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate
+BMGC_DG02774,BMG_DG026225,"(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium | PubChem CID:131704261 | DrugBank ID:DB03881"
+BMGC_DG02775,BMG_DG026226,PubChem CID:131704262 | DrugBank ID:DB03893 | Thionicotinamide-Adenine-Dinucleotide
+BMGC_DG02776,BMG_DG026227,PubChem CID:131704263 | DrugBank ID:DB03962 | Nicotinamide 8-bromo-adenine dinucleotide phosphate
+BMGC_DG02777,BMG_DG026230,Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium | DrugBank ID:DB04008 | PubChem CID:131704266
+BMGC_DG02778,BMG_DG026232,PubChem CID:131704268 | Hexatantalum Dodecabromide | DrugBank ID:DB04119
+BMGC_DG02779,BMG_DG026237,Zinc Substituted Heme C | PubChem CID:131704274 | DrugBank ID:DB04249
+BMGC_DG02780,BMG_DG026238,PubChem CID:131704276 | Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate | DrugBank ID:DB04301
+BMGC_DG02781,BMG_DG026239,PubChem CID:131704277 | DrugBank ID:DB04363 | Mesobiliverdin IV alpha
+BMGC_DG02782,BMG_DG026249,Verdoheme | PubChem CID:131704289 | DrugBank ID:DB04803
+BMGC_DG02783,BMG_DG026253,DrugBank ID:DB05045 | Obinepitide | PubChem CID:131704295
+BMGC_DG02784,BMG_DG026255,PubChem CID:131704297 | Mipomersen | DrugBank ID:DB05528
+BMGC_DG02785,BMG_DG026256,PubChem CID:131704298 | Apatorsen | DrugBank ID:DB06094
+BMGC_DG02786,BMG_DG026257,Mangafodipir | PubChem CID:131704299 | DrugBank ID:DB06796
+BMGC_DG02787,BMG_DG026258,"PubChem CID:131704300 | DrugBank ID:DB06841 | [(2R)-1-[(2S)-2-[[(2S,3S)-1-Chloro-6-(diaminomethylideneamino)-2-hydroxyhexan-3-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium"
+BMGC_DG02788,BMG_DG026261,"DrugBank ID:DB07515 | 1-(2-{[(6-amino-2-methylpyridin-3-yl)methyl]amino}ethyl)-6-chloro-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-1,4-dihydropyrazin-2-ol | PubChem CID:131704304"
+BMGC_DG02789,BMG_DG026262,"DrugBank ID:DB07521 | PubChem CID:131704305 | (3Z,6S)-6-Chloro-1-(2-{[(5-chloro-1-benzothiophen-3-yl)methyl]amino}ethyl)-3-({2-[(2R)-2-piperidinyl]ethyl}imino)-2-piperazinol"
+BMGC_DG02790,BMG_DG026263,"DrugBank ID:DB07740 | (7R,12R,13R)-13-formyl-12,14-dihydroxy-3,5,7-trimethyltetradeca-2,4-dienoic acid | PubChem CID:131704306"
+BMGC_DG02791,BMG_DG026270,"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE | DrugBank ID:DB08676 | PubChem CID:131704313"
+BMGC_DG02792,BMG_DG026271,2-[2-[bis(carboxylatomethyl)amino]ethyl-[(2S)-2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]amino]acetate;gadolinium(3+) | PubChem CID:131704314 | Gadoxetic acid | Gadoxetate | DrugBank ID:DB08884
+BMGC_DG02793,BMG_DG026274,DrugBank ID:DB09265 | PubChem CID:131704317 | Lixisenatide
+BMGC_DG02794,BMG_DG026278,Mirvetuximab soravtansine | PubChem CID:131704323 | DrugBank ID:DB12489
+BMGC_DG02795,BMG_DG026280,PubChem CID:131704325 | DrugBank ID:DB13142 | Calcium glubionate anhydrous
+BMGC_DG02796,BMG_DG026281,Inosine pranobex | DrugBank ID:DB13156 | PubChem CID:131704326
+BMGC_DG02797,BMG_DG026283,"PubChem CID:131704328 | Sazio | DrugBank ID:DB13518 | 3-(6-carboxy-3,4-dihydroxy-5-phosphanyloxan-2-yl)oxy-4,5-dihydroxy-6-phosphanyloxyoxane-2-carboxylic acid | Alginic acid"
+BMGC_DG02798,BMG_DG026284,PubChem CID:131704329 | Megalac | dialuminum;magnesium;disilicate;hydrate | DrugBank ID:DB13595 | CAS RN:71205-22-6 | Almasilate | ALMASILATE | UNII:OZQ8O62H53 | PubChem SID:472421767
+BMGC_DG02799,BMG_DG026325,UNII:30VA6WH2E7 | PubChem CID:131717 | PubChem SID:348480824 | CAS RN:134235-78-2 | CGS-22652
+BMGC_DG02800,BMG_DG026327,"CAS RN:13422-55-4 | PubChem CID:131724228 | carbanide;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(1R,2R,3R,7S,12S,13S,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate"
+BMGC_DG02801,BMG_DG026350,"CAS RN:9002-05-5 | Blood-coagulation factor Xa | (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid | PubChem CID:131750177"
+BMGC_DG02802,BMG_DG028568,"3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5-hydroxy-7-methoxy-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one | Kanzonol G | PubChem CID:131752866"
+BMGC_DG02803,BMG_DG074150,"PubChem SID:198951471 | O-PHENANTHROLINE | PubChem CID:1318 | DrugBank ID:DB02365 | 1,10-phenanthroline | UNII:W4X6ZO7939 | CAS RN:66-71-7 | 1,10-Phenanthroline"
+BMGC_DG02804,BMG_DG074225,"UNII:IFD73D535A | DrugBank ID:DB15286 | PubChem CID:131801114 | NUMIDARGISTAT | PubChem SID:433968379 | CAS RN:2095732-06-0 | Numidargistat | (3R,4S)-3-amino-1-[(2S)-2-aminopropanoyl]-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid"
+BMGC_DG02805,BMG_DG074253,"CAS RN:1258984-36-9 | Spinraza | PubChem CID:131801471 | 1-[(2R,3R,4R,5R)-4-[[(2R,3R,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4R,5R)-3-[[(2R,3R,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[(2R,3R,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(6-aminopurin-9-yl)-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(6-aminopurin-9-yl)-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(6-aminopurin-9-yl)-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(6-aminopurin-9-yl)-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-hydroxyphosphinothioyl]oxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]-5-methylpyrimidine-2,4-dione"
+BMGC_DG02806,BMG_DG075028,"CAS RN:1186-47-6 | 1,1-Dihydroxypropan-2-one | 1,1-dihydroxypropan-2-one | PubChem CID:13180982"
+BMGC_DG02807,BMG_DG075031,"PubChem SID:198988314 | 3,4,5-TRIPHENYL-1H-PYRAZOLE-1-NONANOIC ACID | UNII:91L70Q8BIT | CAS RN:134701-70-5 | PubChem CID:131814"
+BMGC_DG02808,BMG_DG075357,CGS-23885 | PubChem SID:363909911 | PubChem CID:131820 | CAS RN:134822-78-9 | UNII:U0A841DNQ7
+BMGC_DG02809,BMG_DG078775,UNII:V86FZ29QXL | CH-7057288 | PubChem SID:485666297 | PubChem CID:131839646 | CAS RN:2095616-82-1
+BMGC_DG02810,BMG_DG078883,PubChem SID:348481546 | UNII:783V5Z8EJM | PubChem CID:131842331 | ALPELISIB ACID
+BMGC_DG02811,BMG_DG079078,"PubChem SID:363909132 | CAS RN:135947-75-0 | PubChem CID:131925 | L-680573, (S,S)- | UNII:FEE1BH3VXV"
+BMGC_DG02812,BMG_DG079087,UNII:Q64GF9FV4I | CAS RN:928113-28-4 | PubChem CID:13195 | 5-methyl-1H-imidazole | DrugBank ID:DB03385 | 4-Methylimidazole | PubChem SID:198936926 | 4-METHYLIMIDAZOLE | CAS RN:822-36-6
+BMGC_DG02813,BMG_DG079111,"CAS RN:32222-06-3 | (1R,3S,5Z)-5-[2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | Calcitriol (Rocaltrol) | PubChem CID:131954609"
+BMGC_DG02814,BMG_DG079133,PubChem SID:461432248 | CAS RN:2138498-18-5 | UNII:L7DUG75C36 | DIABZI STING AGONIST-1 | PubChem CID:131986624
+BMGC_DG02815,BMG_DG079135,"UNII:9V1XHG6QRM | CAS RN:62749-26-2 | 6-OXO-1,6-DIHYDRO-(3,4'-BIPYRIDINE)-5-CARBONITRILE | PubChem SID:434370080 | PubChem CID:131989"
+BMGC_DG02816,BMG_DG079144,"CAS RN:2138861-99-9 | PubChem CID:132010322 | ABBV-744 | PubChem SID:381608532 | N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide | UNII:9MX546E2SF"
+BMGC_DG02817,BMG_DG079162,"CAS RN:823-40-5 | PubChem SID:198953406 | UNII:H838Q10551 | 2-methylbenzene-1,3-diamine | PubChem CID:13205 | 2,6-Diaminotoluene | TOLUENE-2,6-DIAMINE"
+BMGC_DG02818,BMG_DG079166,PubChem CID:132056570 | CIRTUVIVINT | CAS RN:2143917-62-6 | 2-(4-methylpiperazin-1-yl)-N-[6-(1-methylpyrazol-4-yl)isoquinolin-3-yl]pyridine-4-carboxamide | PubChem SID:433968383 | Cirtuvivint | UNII:7T1PY32ZPH
+BMGC_DG02819,BMG_DG079167,"PubChem CID:132059 | PubChem SID:474492476 | CAS RN:137403-12-4 | L-694,247 | UNII:PZ5DP5EN56"
+BMGC_DG02820,BMG_DG079191,"PubChem SID:433968091 | PubChem CID:132123624 | BMS-986251 | Bms-986251 | UNII:2WQX2MS3MQ | CAS RN:2041841-30-7 | CAS RN:2460133-35-9 | (1R,3S,4R)-4-[(3aR,9bR)-9b-(4-fluorophenyl)sulfonyl-7-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-2,3a,4,5-tetrahydro-1H-benzo[e]indole-3-carbonyl]-3-methylcyclohexane-1-carboxylic acid"
+BMGC_DG02821,BMG_DG079192,"10-[2-(diethylamino)ethylamino]-5-hydroxy-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2(7),3,5,9,11,13(16),14-heptaen-8-one | UNII:MZ4Y5H4OAB | PubChem CID:132127 | CAS RN:138154-39-9 | C-1311 | C 1311 | PubChem SID:198988388"
+BMGC_DG02822,BMG_DG079193,UNII:3S0283Z6W9 | PubChem CID:132128 | PubChem SID:316916033 | CAS RN:138154-40-2 | C-1310
+BMGC_DG02823,BMG_DG079201,"ZANDATRIGINE | PubChem CID:132141687 | UNII:SV2WPA4R4J | Nbi-921352 | 4-[[(3S)-1-benzylpyrrolidin-3-yl]-methylamino]-2-fluoro-5-methyl-N-(1,3-thiazol-4-yl)benzenesulfonamide | CAS RN:2154406-04-7 | Zandatrigine | PubChem SID:438788011"
+BMGC_DG02824,BMG_DG079204,LL-340001 | PubChem CID:132145547 | UNII:YNY8RD8MYN | CAS RN:2046137-49-7 | PubChem SID:461434491
+BMGC_DG02825,BMG_DG079211,PubChem SID:496142877 | MPT0G-211 | CAS RN:2151853-97-1 | UNII:NF3LL97ZD3 | PubChem CID:132157820
+BMGC_DG02826,BMG_DG079234,"PubChem CID:132200405 | PF-06939999 | UNII:JY9FEZ3ZDX | CAS RN:2159123-14-3 | PubChem SID:472419697 | (1S,2S,3S,5R)-3-[[6-(difluoromethyl)-5-fluoro-1,2,3,4-tetrahydroisoquinolin-8-yl]oxy]-5-(4-methylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol"
+BMGC_DG02827,BMG_DG079241,"UNII:BCB1002X86 | CAS RN:2166023-31-8 | CID 132203319 | TAS-1553 | PubChem CID:132203319 | 5-chloro-2-[[(1S,2R)-2-(6-fluoro-2,3-dimethylphenyl)-1-(2-oxo-3H-1,3,4-oxadiazol-5-yl)propyl]sulfamoyl]benzamide"
+BMGC_DG02828,BMG_DG079245,"4-fluoro-N-[(1R)-1-[1-(oxane-4-carbonyl)-2,3-dihydroindol-5-yl]ethyl]benzamide | CAS RN:2166616-75-5 | PubChem CID:132209614 | PubChem SID:475550338 | UNII:10T9596ILQ | LY-3381916 | Ido1-IN-5"
+BMGC_DG02829,BMG_DG079260,PubChem SID:478838309 | 1-ethyl-3-[[(3R)-3-[[(2S)-2-hydroxy-3-(3-methylsulfonylphenoxy)propyl]amino]-1-oxa-8-azaspiro[4.5]decan-8-yl]sulfonyl]quinolin-4-one | PubChem CID:132225057 | VEMTOBERANT | Vemtoberant | UNII:4IJ6WR3BW8 | CAS RN:2169905-68-2
+BMGC_DG02830,BMG_DG079261,PubChem SID:461433110 | RIMINKEFON | CAS RN:2168572-99-2 | UNII:RL873BGZ2M | PubChem CID:132225736
+BMGC_DG02831,BMG_DG079262,PubChem SID:198980063 | PubChem CID:132228 | CAS RN:139314-01-5 | UNII:2L1YNO4SQJ | QUILOSTIGMINE
+BMGC_DG02832,BMG_DG079265,"PubChem SID:461433450 | Bms-986278 | ADMILPARANT | Admilparant | CAS RN:2170126-74-4 | PubChem CID:132232205 | (1S,3S)-3-[2-methyl-6-[1-methyl-5-[[methyl(propyl)carbamoyl]oxymethyl]triazol-4-yl]pyridin-3-yl]oxycyclohexane-1-carboxylic acid | UNII:4UN9AOU6G8"
+BMGC_DG02833,BMG_DG079266,"N2-(3-(2-(2H-1,2,3-triazol-2-yl)propan-2-yl)-1-cyclopropyl-1H-pyrazol-5-yl)N4-ethyi-5-(trifluoromethyl)pyrimidine-2,4-diamine | N2-(3-(2-(2H-1,2,3-TRIAZOL-2-YL)PROPAN-2-YL)-1-CYCLOPROPYL-1H-PYRAZOL-5-YL)N4-ETHYI-5-(TRIFLUOROMETHYL)PYRIMIDINE-2,4-DIAMINE | PubChem CID:132232498 | 2-N-[2-cyclopropyl-5-[2-(triazol-2-yl)propan-2-yl]pyrazol-3-yl]-4-N-ethyl-5-(trifluoromethyl)pyrimidine-2,4-diamine | CAS RN:2170179-24-3 | N2-(3-(2-(2H-1,2,3-Triazol-2-yl)propan-2-yl)-1-cyclopropyl-1H-pyrazol-5-yl)-N4-ethyl-5-(trifluoromethyl)pyrimidine-2,4-diamine | PubChem SID:475550292 | UNII:JB92FP7XER"
+BMGC_DG02834,BMG_DG079268,PubChem SID:198942714 | UNII:7W631H5302 | 2-METHYL-8-HYDROXYQUINOLINE | CAS RN:826-81-3 | PubChem CID:13224
+BMGC_DG02835,BMG_DG079275,Lenumlostat hydrochloride | LENUMLOSTAT HYDROCHLORIDE | PubChem CID:132253084 | CAS RN:2098884-53-6 | UNII:4JZ3PGD8T8 | PubChem SID:434369864
+BMGC_DG02836,BMG_DG079284,"CAS RN:210542-51-1 | Cyclazosin | PubChem SID:482553137 | UNII:2FH26454WF | [(4aR,8aS)-4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-2,3,4a,5,6,7,8,8a-octahydroquinoxalin-1-yl]-(furan-2-yl)methanone | CYCLAZOSIN, (+)- | CAS RN:139953-73-4 | Cyclazosin, (+)- | PubChem CID:132266"
+BMGC_DG02837,BMG_DG079288,"UNII:LXP7MZL0VF | AFIMETORAN | CAS RN:2171019-55-7 | Afimetoran | PubChem SID:434369657 | PubChem CID:132271862 | 2-[4-[2-(7,8-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)-3-propan-2-yl-1H-indol-5-yl]piperidin-1-yl]acetamide"
+BMGC_DG02838,BMG_DG079311,"CAS RN:2059148-82-0 | UNII:ZT62NQ6YEV | Imp-1088 | 1-[5-[3,4-difluoro-2-[2-(1,3,5-trimethylpyrazol-4-yl)ethoxy]phenyl]-1-methylindazol-3-yl]-N,N-dimethylmethanamine | IMP-1088 | PubChem CID:132274735 | PubChem SID:474492942"
+BMGC_DG02839,BMG_DG079319,PubChem CID:132281917 | PubChem SID:472426454 | CAS RN:2216763-38-9 | HY-124798 | UNII:N6P39EU2QU
+BMGC_DG02840,BMG_DG079334,"CAS RN:2254483-95-7 | Malacidin A | PubChem CID:132282518 | DrugBank ID:DB14051 | (3S)-4-[[(3S,6R,12S,15S,18S,21R,24S,28S,30R)-18-(4-aminobutyl)-6-(1-carboxyethyl)-15-[carboxy(hydroxy)methyl]-12-(carboxymethyl)-25,30-dimethyl-2,5,8,11,14,17,20,23,27-nonaoxo-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,26-nonazabicyclo[26.3.0]hentriacontan-24-yl]amino]-2-methyl-3-[[(2E,4Z)-8-methylnona-2,4-dienoyl]amino]-4-oxobutanoic acid"
+BMGC_DG02841,BMG_DG079335,"(3S)-4-[[(3S,6R,12S,15S,18S,21R,24S,28S,30R)-18-(4-aminobutyl)-6-(1-carboxyethyl)-15-[carboxy(hydroxy)methyl]-12-(carboxymethyl)-25,30-dimethyl-2,5,8,11,14,17,20,23,27-nonaoxo-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,26-nonazabicyclo[26.3.0]hentriacontan-24-yl]amino]-2-methyl-3-[[(2E,4Z)-8-methyldeca-2,4-dienoyl]amino]-4-oxobutanoic acid | Malacidin B | PubChem CID:132282519 | DrugBank ID:DB14052 | CAS RN:2254483-96-8"
+BMGC_DG02842,BMG_DG079370,"CAS RN:140687-51-0 | Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine | 4-(2-(HYDROXYMETHYL)PYRIMIDIN-4-YL)-N,N-DIMETHYLPIPERAZINE-1-SULFONAMIDE | DrugBank ID:DB04478 | PubChem SID:438787598 | UNII:ZI4EMQ9WYE | PubChem CID:132302"
+BMGC_DG02843,BMG_DG079372,CAS RN:140841-32-3 | PubChem SID:363909859 | ZD-2138 | PubChem CID:132306 | UNII:B6G6OX1ZH5
+BMGC_DG02844,BMG_DG079415,"2,2-Dimethyl-7-(3-(3-phenylpropyl)-2-thienyl)heptanoic acid | 2,2-DIMETHYL-7-(3-(3-PHENYLPROPYL)-2-THIENYL)HEPTANOIC ACID | PubChem SID:485663714 | CAS RN:142422-79-5 | PubChem CID:132425 | UNII:8F8A563YWD"
+BMGC_DG02845,BMG_DG079479,"CAS RN:831-61-8 | UNII:235I6UDD3L | ethyl 3,4,5-trihydroxybenzoate | PubChem CID:13250 | Ethyl gallate | PubChem SID:198949988 | ETHYL GALLATE"
+BMGC_DG02846,BMG_DG079487,Ilomastat | PubChem CID:132519 | PubChem SID:175266701 | UNII:I0403ML141 | DrugBank ID:DB02255 | CAS RN:142880-36-2 | ILOMASTAT
+BMGC_DG02847,BMG_DG079512,PubChem CID:132552 | PubChem SID:472405831 | CP-122288 | UNII:59E9WCT6EM | CAS RN:143321-74-8
+BMGC_DG02848,BMG_DG079518,PubChem SID:346538994 | UNII:23B5RBZGBD | ZD-8731 FREE BASE | PubChem CID:132562 | CAS RN:143494-72-8
+BMGC_DG02849,BMG_DG079519,"CP-132,484 | PubChem SID:474492861 | PubChem CID:132564 | UNII:F7483B89JC | CAS RN:143508-76-3"
+BMGC_DG02850,BMG_DG079526,PubChem SID:474492525 | RU-56187 | UNII:L6RT6E57LS | CAS RN:143782-25-6 | PubChem CID:132581
+BMGC_DG02851,BMG_DG079542,"CAS RN:1975982-94-5 | 2-PROPENAMIDE, N-(2-((2-(DIMETHYLOXIDOAMINO)ETHYL)METHYLAMINO)-4-METHOXY-5-((4-(1-METHYL-1H-INDOL-3-YL)-2-PYRIMIDINYL)AMINO)PHENYL)- | PubChem CID:132609257 | UNII:9DD4NXS7RD | PubChem SID:441658948"
+BMGC_DG02852,BMG_DG079551,GP-515 | PubChem SID:445498961 | PubChem CID:132663 | UNII:12DPV3L6JD | CAS RN:144928-48-3
+BMGC_DG02853,BMG_DG079552,PubChem SID:474492790 | UNII:3X9N8P9ZST | CAS RN:76778-28-4 | 1-(2-(BIS(4-FLUOROPHENYL)METHOXY)ETHYL)-4-(3-(4-FLUOROPHENYL)PROPYL)PIPERAZINE | 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-[3-(4-fluorophenyl)propyl]piperazine | PubChem CID:132673
+BMGC_DG02854,BMG_DG079554,"2-Hydroxyestradiol-3-methyl ether | (8R,9S,13S,14S,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-2,17-diol | CAS RN:5976-65-8 | PubChem CID:13267935"
+BMGC_DG02855,BMG_DG079567,"DrugBank ID:DB01342 | UNII:065F7WPT0B | PubChem SID:198958407 | FORASARTAN | CAS RN:145216-43-9 | Forasartan | 5-[(3,5-dibutyl-1,2,4-triazol-1-yl)methyl]-2-[2-(2H-tetrazol-5-yl)phenyl]pyridine | PubChem CID:132706"
+BMGC_DG02856,BMG_DG079581,"PubChem CID:132779642 | (2R)-2-phenyl-2-[(2R,3R,4R,5S)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | CAS RN:29883-15-6"
+BMGC_DG02857,BMG_DG079590,"1,3-DIETHYL-8-PHENYLXANTHINE | UNII:2KCV39GKGL | PubChem SID:198935029 | CAS RN:75922-48-4 | PubChem CID:1328"
+BMGC_DG02858,BMG_DG079592,AK-7 | CAS RN:420831-40-9 | UNII:308B6B695N | PubChem CID:1328033 | PubChem SID:198943500
+BMGC_DG02859,BMG_DG079601,PubChem SID:198955525 | PubChem CID:132832 | SCH-48461 | UNII:T0H910M40A | CAS RN:148260-92-8
+BMGC_DG02860,BMG_DG079607,CAS RN:148504-51-2 | PubChem SID:198970824 | UNII:7LQ7OQP653 | PubChem CID:132840 | RIPISARTAN
+BMGC_DG02861,BMG_DG079610,"L-733060, (+/-)- | PubChem SID:474493770 | PubChem CID:132846 | (2S,3S)-3-[[3,5-bis(trifluoromethyl)phenyl]methoxy]-2-phenylpiperidine | UNII:PK8CG2B44U | L-733060, (±)- | PubChem SID:474492866 | CAS RN:148700-85-0 | UNII:62GFZ49F3X | CAS RN:155764-99-1 | L-733060, (+)-"
+BMGC_DG02862,BMG_DG079619,Tilarginine | PubChem CID:132862 | CAS RN:17035-90-4 | UNII:27JT06E6GR | (2S)-2-amino-5-[(N'-methylcarbamimidoyl)amino]pentanoic acid | DrugBank ID:DB11815 | PubChem SID:198967182 | TILARGININE
+BMGC_DG02863,BMG_DG079624,"PubChem SID:198972207 | DrugBank ID:DB12946 | DPCPX | 8-cyclopentyl-1,3-dipropyl-7H-purine-2,6-dione | UNII:9PTP4FOI9E | 8-CYCLOPENTYL-1,3-DIPROPYLXANTHINE | PubChem CID:1329 | 8-Cyclopentyl-1,3-dipropylxanthine | CAS RN:102146-07-6"
+BMGC_DG02864,BMG_DG079628,UNII:PNU369SWT5 | PubChem CID:132907 | 9-HYDROXY-.ALPHA.-NAPHTHOFLAVONE | 9-Hydroxy-α-naphthoflavone | CAS RN:78729-83-6 | PubChem SID:485661470
+BMGC_DG02865,BMG_DG079630,UNII:10TO0RP68C | PubChem CID:132916 | PRANAZEPIDE | CAS RN:150408-73-4 | PubChem SID:198935329
+BMGC_DG02866,BMG_DG079656,CAS RN:152886-85-6 | UNII:K5FQ4JYU8H | PubChem CID:132955 | PubChem SID:474492709 | PNU-91356A
+BMGC_DG02867,BMG_DG079660,CAS RN:153438-49-4 | DAPITANT | UNII:NRD5XF638P | PubChem CID:132961 | PubChem SID:198948881
+BMGC_DG02868,BMG_DG079669,"ABIRATERONE | PubChem CID:132971 | CAS RN:154229-19-3 | (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol | UNII:G819A456D0 | DrugBank ID:DB05812 | Abiraterone | PubChem SID:175268637"
+BMGC_DG02869,BMG_DG079670,PubChem SID:198973960 | PubChem CID:132974 | CAS RN:154541-72-7 | ALINASTINE | UNII:FDP9A2F6YL
+BMGC_DG02870,BMG_DG079676,PubChem SID:443624120 | L-740093 | PubChem CID:132980 | UNII:QQM82D8YUP | CAS RN:154967-59-6
+BMGC_DG02871,BMG_DG079678,"cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,7S,12S,13S,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide | CAS RN:68-19-9 | PubChem CID:132980806"
+BMGC_DG02872,BMG_DG079680,RU-58841 | UNII:0D8FJQ0ADW | CAS RN:154992-24-2 | PubChem SID:346540329 | PubChem CID:132981
+BMGC_DG02873,BMG_DG079747,"Fce 28260 | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-9a,11a-dimethyl-7-oxo-N-(1,1,1-trifluoro-2-phenylpropan-2-yl)-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide | CAS RN:155651-56-2 | PubChem CID:132992 | UNII:HP9C5LM7NX | PubChem SID:474492708 | FCE-28260"
+BMGC_DG02874,BMG_DG079748,PubChem SID:485660856 | PubChem CID:132998 | 1-ETHYL-6-((3-FLUORO-5-(TETRAHYDRO-4-METHOXY-2H-PYRAN-4-YL)PHENOXY)METHYL)-2(1H)-QUINOLINONE | 1-Ethyl-6-[[3-fluoro-5-(tetrahydro-4-methoxy-2H-pyran-4-yl)phenoxy]methyl]-2(1H)-quinolinone | UNII:W3YP2PF3E9 | CAS RN:155944-23-3
+BMGC_DG02875,BMG_DG079749,"PubChem SID:175267572 | CAS RN:155974-00-8 | Ivabradine | UNII:3H48L0LPZQ | DrugBank ID:DB09083 | 3-[3-[[(7S)-3,4-dimethoxy-7-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one | IVABRADINE | PubChem CID:132999"
+BMGC_DG02876,BMG_DG079751,"4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)benzenesulfonic acid | 1,3-Dipropyl-8-(4-sulfophenyl)xanthine | CAS RN:89073-57-4 | PubChem CID:1330"
+BMGC_DG02877,BMG_DG079754,DrugBank ID:DB05403 | PubChem CID:133005 | CEP-1347
+BMGC_DG02878,BMG_DG079755,PubChem CID:133008 | UNII:C5B89UM05U | L-741742 | PubChem SID:318691480 | CAS RN:156337-32-5
+BMGC_DG02879,BMG_DG079758,"DrugBank ID:DB11614 | RUPATADINE | UNII:2AE8M83G3E | 13-chloro-2-[1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene]-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene | PubChem SID:198953434 | CAS RN:158876-82-5 | Rupatadine | PubChem CID:133017"
+BMGC_DG02880,BMG_DG079764,"UNII:P5T6BYS22Y | LICOFELONE | PubChem CID:133021 | Licofelone | DrugBank ID:DB04725 | 2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic acid | CAS RN:156897-06-2 | PubChem SID:198972330"
+BMGC_DG02881,BMG_DG079804,"Teicoplanin | PubChem CID:133065662 | (1S,2R,19R,22R,34S,37R,40R,52S)-2-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-amino-5,15-dichloro-64-[(2S,3R,4R,5S,6R)-3-(decanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid | CAS RN:61036-62-2"
+BMGC_DG02882,BMG_DG079814,CAS RN:170858-33-0 | PubChem CID:133079 | UNII:O609V24217 | SONEPIPRAZOLE | PubChem SID:198973210
+BMGC_DG02883,BMG_DG079816,"Boldenone | PubChem SID:198953076 | DrugBank ID:DB01541 | (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one | BOLDENONE | PubChem CID:13308 | UNII:5H7I2IP58X | CAS RN:846-48-0"
+BMGC_DG02884,BMG_DG079949,"LENACAPAVIR | PubChem CID:133082658 | PubChem SID:363908926 | Lenacapavir | N-[(1S)-1-[3-[4-chloro-3-(methanesulfonamido)-1-(2,2,2-trifluoroethyl)indazol-7-yl]-6-(3-methyl-3-methylsulfonylbut-1-ynyl)pyridin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-[(2S,4R)-5,5-difluoro-9-(trifluoromethyl)-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]acetamide | CAS RN:2189684-44-2 | UNII:A9A0O6FB4H"
+BMGC_DG02885,BMG_DG080050,DrugBank ID:DB06429 | Talnetant | PubChem CID:133090
+BMGC_DG02886,BMG_DG080060,"DrugBank ID:DB03910 | PubChem CID:1331 | S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea"
+BMGC_DG02887,BMG_DG080095,"UNII:89386PYU9O | NORGESTRIENONE | DrugBank ID:DB13563 | CAS RN:848-21-5 | PubChem SID:198943541 | (8S,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | PubChem CID:13313 | Norgestrienone"
+BMGC_DG02888,BMG_DG080098,"PubChem CID:13314 | UNII:GU56C842ZA | CAS RN:848-75-9 | DrugBank ID:DB13872 | PubChem SID:198963744 | LORMETAZEPAM | Lormetazepam | 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1-methyl-3H-1,4-benzodiazepin-2-one"
+BMGC_DG02889,BMG_DG080099,CAS RN:78954-23-1 | UNII:2X58Y9JC7L | PubChem CID:133145 | PubChem SID:384647993 | YAKUCHINONE A
+BMGC_DG02890,BMG_DG080115,"PubChem CID:133246 | DrugBank ID:DB02562 | Quinonoid 7,8-Tetrahydrobiopterin"
+BMGC_DG02891,BMG_DG080146,"UNII:X188638Y2V | PubChem CID:13331 | DrugBank ID:DB01491 | DIPIPANONE | Dipipanone | PubChem SID:198971670 | 4,4-diphenyl-6-piperidin-1-ylheptan-3-one | CAS RN:467-83-4"
+BMGC_DG02892,BMG_DG080178,"UNII:5V9KLZ54CY | PubChem SID:175268513 | DrugBank ID:DB00570 | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | Vinblastine | CAS RN:132142-72-4 | PubChem CID:13342 | CAS RN:865-21-4 | VINBLASTINE"
+BMGC_DG02893,BMG_DG080187,"PubChem SID:175268119 | Potassium Citrate | DrugBank ID:DB09125 | CAS RN:7778-49-6 | Potassium citrate | PubChem CID:13344 | tripotassium;2-hydroxypropane-1,2,3-tricarboxylate | CAS RN:866-84-2 | UNII:86R1NVR0HW | POTASSIUM CITRATE ANHYDROUS"
+BMGC_DG02894,BMG_DG080212,.ALPHA.-FLUORO-.BETA.-ALANINE | alpha-Fluoro-beta-alanine | PubChem CID:13351 | 3-amino-2-fluoropropanoic acid | CAS RN:3821-81-6 | PubChem SID:251965535 | UNII:1461S5575Q
+BMGC_DG02895,BMG_DG080269,"L-Glc(a1-6)b-L-Glc | CAS RN:499-40-1 | PubChem CID:133612057 | (2S,3S,4R,5R,6S)-6-[[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol"
+BMGC_DG02896,BMG_DG080270,"PubChem CID:133612069 | Hydroxocobalamin; Vitamin B12b | CAS RN:13422-51-0 | cobalt(2+);[(2S,3R,4S,5R)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(1S,2S,3S,5Z,7R,10Z,12R,13R,15Z,17R,18R,19S)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate"
+BMGC_DG02897,BMG_DG080289,"CAS RN:81226-60-0 | PubChem CID:133633 | 3-(4-(4-Chlorophenyl-4-hydroxypiperidino)methyl)indole | UNII:WTW4A6SW92 | PubChem SID:472408654 | 4-(4-chlorophenyl)-1-(1H-indol-3-ylmethyl)piperidin-4-ol | L-741,626"
+BMGC_DG02898,BMG_DG080327,"PubChem CID:13369486 | PubChem SID:459276089 | CAS RN:54712-38-8 | ISOSCLERONE, (S)- | UNII:YF5MZ96X5K"
+BMGC_DG02899,BMG_DG080329,"DrugBank ID:DB02141 | PubChem CID:1337 | S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea"
+BMGC_DG02900,BMG_DG080342,"3-AMINOPYRROLIDINE-2,5-DIONE, (S)- | (S)-Aspartimide | PubChem CID:13373305 | UNII:LNT846Q6U9 | CAS RN:73537-92-5 | DrugBank ID:DB03487"
+BMGC_DG02901,BMG_DG080344,"PubChem CID:13373715 | 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE | DrugBank ID:DB07319"
+BMGC_DG02902,BMG_DG080352,CAS RN:871-71-6 | PubChem SID:316912477 | PubChem CID:13376 | UNII:S17P62W6IH | N-BUTYLFORMAMIDE
+BMGC_DG02903,BMG_DG080375,METHYLPYRROLIDONE | CAS RN:30207-69-3 | PubChem CID:13387 | DrugBank ID:DB12521 | CAS RN:26138-58-9 | CAS RN:872-50-4 | PubChem SID:175266110 | 1-methylpyrrolidin-2-one | Methyl pyrrolidone | UNII:JR9CE63FPM | CAS RN:2687-44-7 | CAS RN:51013-18-4 | CAS RN:26876-92-6 | Methylpyrrolidone
+BMGC_DG02904,BMG_DG080404,"PubChem CID:133967 | CAS RN:156680-74-9 | DrugBank ID:DB06250 | CAS RN:112859-71-9 | (8R,9S,10R,13S,14S,16R)-16-fluoro-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one | UNII:R7M5UGD04G | FLUASTERONE | Fluasterone | PubChem SID:198939276"
+BMGC_DG02905,BMG_DG080406,UNII:GF8BS53B6V | 4-CHLOROBENZYL ALCOHOL | PubChem CID:13397 | PubChem SID:198948937 | CAS RN:873-76-7
+BMGC_DG02906,BMG_DG080413,UNII:XV7XP64JR5 | CAS RN:874-24-8 | PubChem CID:13401 | 3-HYDROXYPICOLINIC ACID | PubChem SID:459055319
+BMGC_DG02907,BMG_DG080417,"NDC:72578-137 | NDC:27808-206 | NDC:67877-669 | NDC:43547-295 | NDC:46708-191 | NDC:43547-296 | DrugBank ID:DB04854 | NDC:68071-3760 | NDC:71610-411 | NDC:55111-797 | NDC:64764-677 | NDC:62332-190 | NDC:72205-029 | NDC:68071-3761 | NDC:0904-7396 | NDC:0527-2244 | NDC:64764-918 | NDC:0904-7485 | NDC:68071-5271 | NDC:27808-207 | NDC:0054-0414 | Febuxostat | NDC:16714-059 | NDC:59651-114 | NDC:55111-796 | NDC:0904-7484 | NDC:33342-275 | NDC:51407-294 | NDC:62332-191 | NDC:16714-060 | NDC:71610-450 | NDC:0054-0413 | 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid | NDC:70771-1552 | FEBUXOSTAT | PubChem CID:134018 | NDC:70771-1553 | NDC:72205-028 | NDC:59651-113 | NDC:47335-722 | NDC:47335-721 | NDC:51407-293 | PubChem SID:175267123 | NDC:0527-2248 | UNII:101V0R1N2E | NDC:46708-190 | NDC:0904-7395 | NDC:69539-035 | CAS RN:144060-53-7 | NDC:33342-274 | NDC:72578-136 | NDC:67877-668 | NDC:60687-538 | NDC:69539-036"
+BMGC_DG02908,BMG_DG080418,"PIXANTRONE | 6,9-bis(2-aminoethylamino)benzo[g]isoquinoline-5,10-dione | CAS RN:144510-96-3 | PubChem SID:198945891 | DrugBank ID:DB06193 | PubChem CID:134019 | Pixantrone | UNII:F5SXN2KNMR"
+BMGC_DG02909,BMG_DG080429,UNII:P6629XE33T | CAS RN:75659-07-3 | DILEVALOL | CAS RN:72487-32-2 | PubChem CID:134044 | Dilevalol | PubChem SID:198982866 | 2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-4-phenylbutan-2-yl]amino]ethyl]benzamide
+BMGC_DG02910,BMG_DG080437,"CAS RN:32222-06-3 | (1R,3S)-5-[2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | PubChem CID:134070 | (1R,3S)-5-[2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylenecyclohexane-1,3-diol"
+BMGC_DG02911,BMG_DG080474,UNII:4MVW7F3BCT | PubChem CID:134128281 | CAS RN:2309668-15-1 | AR-13503 | PubChem SID:375085272
+BMGC_DG02912,BMG_DG080499,"PubChem CID:13414 | 2,6-DIMETHYLQUINOLINE | UNII:KST0M1T4MB | PubChem SID:252165302 | CAS RN:877-43-0"
+BMGC_DG02913,BMG_DG080633,"SMW-139 C-11 | PubChem CID:134160121 | PubChem SID:374388650 | UNII:POV7O5DM8F | 2-chloro-5-(111C)methoxy-N-[(3,5,7-trifluoro-1-adamantyl)methyl]benzamide | Smw-139 C-11"
+BMGC_DG02914,BMG_DG080657,"VEPAFESTINIB | CAS RN:2129515-96-2 | PubChem CID:134164132 | 4-amino-N-[4-(methoxymethyl)phenyl]-7-(1-methylcyclopropyl)-6-(3-morpholin-4-ylprop-1-ynyl)pyrrolo[2,3-d]pyrimidine-5-carboxamide | PubChem SID:443624987 | UNII:LF333FK2V5 | Vepafestinib"
+BMGC_DG02915,BMG_DG080661,PubChem SID:383470509 | PubChem CID:134183206 | RMC-4550 | UNII:2Q6NVG4EXB | CAS RN:2172651-73-7
+BMGC_DG02916,BMG_DG080664,CAS RN:57536-86-4 | PubChem SID:472407065 | 1-(1-Naphthalenyl)piperazine | UNII:FJ7MR37A24 | 1-(1-NAPHTHALENYL)PIPERAZINE | PubChem CID:1342
+BMGC_DG02917,BMG_DG080681,"PubChem CID:134247638 | CAS RN:2185857-97-8 | Ebvaciclib | PubChem SID:438787994 | 6-(difluoromethyl)-8-[(1R,2R)-2-hydroxy-2-methylcyclopentyl]-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrido[2,3-d]pyrimidin-7-one | EBVACICLIB | UNII:3B512HJD65"
+BMGC_DG02918,BMG_DG080691,ERVOGASTAT | 2-[5-(3-ethoxypyridin-2-yl)oxypyridin-3-yl]-N-[(3S)-oxolan-3-yl]pyrimidine-5-carboxamide | PubChem CID:134262752 | PubChem SID:461434297 | CAS RN:2186700-33-2 | Ervogastat | UNII:BSOIY5AKQW
+BMGC_DG02919,BMG_DG080702,"AG-270 | 3-(cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(pyridin-2-ylamino)-1H-pyrazolo[1,5-a]pyrimidin-7-one | UNII:E1P2TDU69L | PubChem CID:134307820 | CAS RN:2201056-66-6 | E1P2Tdu69L | PubChem SID:461433453"
+BMGC_DG02920,BMG_DG080714,"PubChem CID:134330557 | MHV-370 | (3S)-N-[4-[[5-(1,6-dimethylpyrazolo[3,4-b]pyridin-4-yl)-3-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-1-yl]methyl]-1-bicyclo[2.2.2]octanyl]morpholine-3-carboxamide | Tlr7/8-IN-1 | PubChem SID:485665381 | UNII:WGB3V7X9VT | CAS RN:2205095-75-4"
+BMGC_DG02921,BMG_DG080722,"PubChem CID:134347893 | PubChem SID:440793422 | UNII:DGN7ROZ8EN | Atuzaginstat | CAS RN:2211981-76-7 | ATUZAGINSTAT | N-[(3S)-7-amino-2-oxo-1-(2,3,6-trifluorophenoxy)heptan-3-yl]cyclopentanecarboxamide"
+BMGC_DG02922,BMG_DG080723,PubChem SID:482554045 | UNII:XTR8M295WN | 1-(4-AMIDINOBENZYL)INDOLE | 1-(4-Amidinobenzyl)indole | PubChem CID:134348 | CAS RN:83783-25-9
+BMGC_DG02923,BMG_DG080727,UNII:7P54H519IJ | (phenyldisulfanyl)benzene | PubChem SID:198943139 | CAS RN:882-33-7 | Diphenyl disulfide | PubChem CID:13436 | DIPHENYL DISULFIDE | CAS RN:93345-44-9
+BMGC_DG02924,BMG_DG080738,"UNII:EP0P7SHM0U | CAS RN:2216753-97-6 | 2-[6-(6,7-dimethoxyquinolin-3-yl)pyridin-3-yl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide | Zeteletinib | ZETELETINIB | PubChem SID:440793592 | PubChem CID:134391533"
+BMGC_DG02925,BMG_DG080755,"PubChem SID:472419819 | UNII:H6NYM0V650 | Bavdegalutamide | BAVDEGALUTAMIDE | PubChem CID:134414307 | N-[4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[4-[[4-[2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-dioxoisoindol-5-yl]piperazin-1-yl]methyl]piperidin-1-yl]pyridazine-3-carboxamide | CAS RN:2222112-77-6"
+BMGC_DG02926,BMG_DG080757,"PubChem SID:461434837 | (8R,9S,10R,11S,13S,14S,17S)-17-(3,3-dimethylbut-1-ynyl)-17-hydroxy-13-methyl-11-[4-[methyl(propan-2-yl)amino]phenyl]-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | PubChem CID:134415769 | CAS RN:2222344-98-9 | UNII:VI6E2D3CYP | Oric-101 | ORIC-101"
+BMGC_DG02927,BMG_DG080762,"CAS RN:65841-03-4 | PubChem CID:13443185 | 2-HYDROXY-4,6-DINITROBENZOIC ACID | 2-Hydroxy-4,6-dinitrobenzoic acid | PubChem SID:485663707 | UNII:JY8RE5VHT4"
+BMGC_DG02928,BMG_DG080766,"CAS RN:2152628-33-4 | UNII:CEGM9YBNGD | 6-(2-hydroxy-2-methylpropoxy)-4-[6-[6-[(6-methoxypyridin-3-yl)methyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]pyridin-3-yl]pyrazolo[1,5-a]pyridine-3-carbonitrile | PubChem SID:381608431 | PubChem CID:134436906 | SELPERCATINIB | Selpercatinib"
+BMGC_DG02929,BMG_DG080767,"CAS RN:2222755-14-6 | PubChem SID:381608492 | UNII:SM0SJ89UOO | PubChem CID:134437053 | 4-(5-(6-((6-METHOXYPYRIDIN-3-YL)METHYL)-3,6-DIAZABICYCLO(3.1.1)HEPTAN-3-YL)PYRAZIN-2-YL)-6-(((R)-MORPHOLIN-2-YL)METHOXY)PYRAZOLO(1,5-A)PYRIDINE-3-CARBONITRILE"
+BMGC_DG02930,BMG_DG080772,ENRUPATINIB | UNII:9L35RVQ9J6 | PubChem CID:134442338 | CAS RN:2222689-47-4
+BMGC_DG02931,BMG_DG080780,"(6S)-1-(3,4-difluorophenyl)-6-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(4-methoxycyclohexyl)benzimidazol-2-yl]piperidin-2-one | PubChem CID:134457551 | Inobrodib | CAS RN:2222941-37-7 | PubChem SID:443625152 | UNII:BW5QA5GEW7 | INOBRODIB"
+BMGC_DG02932,BMG_DG080781,UNII:CW51396YVP | 3-Hydroxyvalproic acid | CAS RN:58888-84-9 | 3-hydroxy-2-propylpentanoic acid | 3-HYDROXY-VALPROIC ACID | PubChem CID:134459 | PubChem SID:377309164
+BMGC_DG02933,BMG_DG080787,"PubChem CID:134470179 | Orludodstat | PubChem SID:440793910 | N-(2-chloro-6-fluorophenyl)-4-[4-ethyl-3-(hydroxymethyl)-5-oxo-1,2,4-triazol-1-yl]-5-fluoro-2-[(2S)-1,1,1-trifluoropropan-2-yl]oxybenzamide | UNII:X8GF945GMK | CAS RN:2225819-06-5 | ORLUDODSTAT"
+BMGC_DG02934,BMG_DG080793,"2-amino-5-[(2R,4S)-2-(2,5-difluorophenyl)-4-fluoropyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidine-3-carboxamide | EMZELTRECTINIB | UNII:436Z4BZ8HF | Emzeltrectinib | CAS RN:2223678-97-3 | PubChem CID:134480550 | PubChem SID:478839103"
+BMGC_DG02935,BMG_DG080796,"DrugBank ID:DB03817 | UNII:61HPH2F0W7 | L-2,4-diaminobutyric acid | CAS RN:1758-80-1 | PubChem SID:198941911 | (2S)-2,4-diaminobutanoic acid | 2,4-DIAMINOBUTYRIC ACID, L- | PubChem CID:134490"
+BMGC_DG02936,BMG_DG080797,"UNII:D8A379RX68 | 5beta-Androstane-3alpha,17beta-diol | ETIOCHOLANEDIOL | PubChem CID:134494 | (3R,5R,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol | PubChem SID:287446219 | CAS RN:1851-23-6"
+BMGC_DG02937,BMG_DG080802,4-Iodo-L-phenylalanine | PubChem SID:198958847 | DrugBank ID:DB03660 | 4-IODOPHENYLALANINE | CAS RN:24250-85-9 | UNII:J882Z73MPL | PubChem CID:134497
+BMGC_DG02938,BMG_DG080803,PubChem CID:1345 | CAS RN:85340-56-3 | UNII:YNF83VN1RL | N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide | PK-11195 | PubChem SID:198980466 | CAS RN:205934-46-9 | CAS RN:85532-75-8 | PK 11195
+BMGC_DG02939,BMG_DG080804,"PubChem CID:13450 | UNII:ZXL474TLFP | PubChem SID:198935149 | DrugBank ID:DB08215 | CAS RN:886-50-0 | Terbutryn | 2-N-tert-butyl-4-N-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine | TERBUTRYN"
+BMGC_DG02940,BMG_DG080807,(3S)-3-aminothiolan-2-one | PubChem CID:134505 | CAS RN:2338-04-7 | Homocysteine thiolactone
+BMGC_DG02941,BMG_DG080811,UNII:WGK69BVU4F | PubChem CID:13451 | CAS RN:886-59-9 | N-CYCLOHEXYL-N'-PHENYLUREA | PubChem SID:441658781
+BMGC_DG02942,BMG_DG080812,"N-[5-[4-methoxy-2-methyl-5-[(3R)-3-methyl-4-prop-2-enoyl-1,4-diazepane-1-carbonyl]phenyl]sulfanyl-1,3-thiazol-2-yl]cyclopropanecarboxamide | PubChem SID:485663343 | SOQUELITINIB | CAS RN:2226636-04-8 | Soquelitinib | PubChem CID:134517711 | UNII:6I5H17AN3I"
+BMGC_DG02943,BMG_DG080815,PubChem SID:482554830 | CVN-636 | PubChem CID:134521670 | UNII:EY764XW2YM | CAS RN:2226732-62-1
+BMGC_DG02944,BMG_DG080819,"UNII:8U90X70OCF | CAS RN:3275-44-3 | 5-(4-CHLOROPHENYL)-6-METHYLPYRIMIDINE-2,4-DIAMINE | PubChem CID:134531 | PubChem SID:381132296"
+BMGC_DG02945,BMG_DG080830,UNII:N81WKW91XF | PubChem CID:134542980 | PubChem SID:377308443 | CAS RN:2227154-23-4 | Lb-102 | LB-102 | N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxy-4-(methylamino)benzamide
+BMGC_DG02946,BMG_DG080836,"alpha-Ergocryptine | UNII:6WFB60157B | PubChem SID:198986633 | .ALPHA.-ERGOCRYPTINE | α-Ergocryptine | CAS RN:511-09-1 | (6aR,9R)-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | PubChem CID:134551"
+BMGC_DG02947,BMG_DG080842,"PubChem CID:134558471 | CAS RN:2227211-00-7 | 2-[3-[2-amino-6-[1-(oxetan-3-yl)-3,6-dihydro-2H-pyridin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2-(hydroxymethyl)phenyl]-6-cyclopropyl-8-fluoroisoquinolin-1-one | Docirbrutinib | DOCIRBRUTINIB | Milrebrutinib | PubChem SID:478838687 | UNII:4E4EWP9DJQ"
+BMGC_DG02948,BMG_DG080844,"5-(((4-AMINOPHENYL)SULFONYL)AMINO)-1,3,4-THIADIAZOLE-2-SULFONAMIDE | UNII:M36B7U9TKT | CAS RN:3523-95-3 | PubChem CID:134560"
+BMGC_DG02949,BMG_DG080867,CAS RN:2230187-60-5 | 2-((1-(2-(1-AZETIDINYL)PHENYL)-5-(3-(CYCLOBUTYLOXY)PHENYL)-1H-PYRAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID | UNII:5XE5F8EZ7S | PubChem CID:134587161
+BMGC_DG02950,BMG_DG080868,"CAS RN:2216712-66-0 | PubChem SID:433968167 | PubChem CID:134587348 | UNII:RRN67GMB0V | Elexacaftor | DrugBank ID:DB15444 | N-(1,3-dimethylpyrazol-4-yl)sulfonyl-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide | ELEXACAFTOR | CAS RN:2229860-93-7"
+BMGC_DG02951,BMG_DG080869,"PubChem CID:134588268 | Alogabat | ALOGABAT | PubChem SID:443624852 | 6-[[5-methyl-3-(6-methylpyridin-3-yl)-1,2-oxazol-4-yl]methoxy]-N-(oxan-4-yl)pyridazine-3-carboxamide | CAS RN:2230009-48-8 | UNII:0HPA4GK3UH"
+BMGC_DG02952,BMG_DG080873,PubChem SID:312524950 | N-(2-METHOXYPHENYL)PIPERAZINE | 1-(2-methoxyphenyl)piperazine | PubChem CID:1346 | 1-(2-Methoxyphenyl)piperazine | CAS RN:35386-24-4 | UNII:81NJO1330A
+BMGC_DG02953,BMG_DG080875,DrugBank ID:DB00168 | CAS RN:53906-69-7 | UNII:Z0H242BBR1 | CAS RN:7421-84-3 | PubChem SID:175266887 | (3S)-3-amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid | ASPARTAME | PubChem CID:134601 | CAS RN:22839-47-0 | Aspartame
+BMGC_DG02954,BMG_DG080880,PubChem CID:134611040 | PubChem SID:384158425 | 2-[[4-[6-[(4-cyano-2-fluorophenyl)methoxy]pyridin-2-yl]piperidin-1-yl]methyl]-3-[[(2S)-oxetan-2-yl]methyl]benzimidazole-5-carboxylic acid | DANUGLIPRON | Danuglipron | CAS RN:2230198-02-2 | UNII:DN9IUI24GP
+BMGC_DG02955,BMG_DG080881,"Lorpucitinib | PubChem CID:134611548 | 2-[3-[4-(cyanomethyl)cyclohexyl]-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,4,6,8,11-pentaen-4-yl]-N-(2-hydroxy-2-methylpropyl)acetamide | UNII:OE1QTY7C25 | PubChem SID:404859384 | CAS RN:2230282-02-5 | LORPUCITINIB"
+BMGC_DG02956,BMG_DG080898,"PubChem CID:134664 | 1H-1,2-benzodiazepine | UNII:M0Q7802G2B | DrugBank ID:DB12537 | 1,2-Benzodiazepine | PubChem SID:198947534 | 1H-1,2-BENZODIAZEPINE | CAS RN:12794-10-4 | Benzodiazepines | CAS RN:264-60-8"
+BMGC_DG02957,BMG_DG080918,PubChem SID:375083568 | SMW-139 | CAS RN:2133010-38-3 | UNII:L22UF6D1CU | PubChem CID:134687118
+BMGC_DG02958,BMG_DG081033,"CAS RN:131-48-6 | (2R,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid | PubChem CID:134689626"
+BMGC_DG02959,BMG_DG081043,"UNII:P83HS633ZK | CAS RN:2131798-13-3 | GSK656 HCl | Ganfeborole hydrochloride | 2-[[(3S)-3-(aminomethyl)-4-chloro-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]ethanol;hydrochloride | PubChem SID:377308605 | PubChem CID:134691736 | GANFEBOROLE HYDROCHLORIDE"
+BMGC_DG02960,BMG_DG081107,"(2R)-2-phenyl-2-[(4S,5S)-3,4,5-trihydroxy-6-[[(3R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | PubChem CID:134694146 | CAS RN:29883-15-6"
+BMGC_DG02961,BMG_DG081119,"Cotadutide | PubChem SID:375579269 | UNII:QL6A9B13HW | DrugBank ID:DB15194 | COTADUTIDE | (2S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-carboxy-1-[[(2S)-1-[[2-(carboxymethylamino)-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-6-oxohexyl]amino]-2-(hexadecanoylamino)-5-oxopentanoic acid | PubChem CID:134694273 | CAS RN:1686108-82-6"
+BMGC_DG02962,BMG_DG081138,CAS RN:2088113-98-6 | PubChem CID:134694318 | PubChem SID:375579761 | AZ-31 | UNII:GXC30M65XM
+BMGC_DG02963,BMG_DG081159,"PubChem CID:134694664 | (1R,5Z)-5-[2-[(3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | CAS RN:32222-06-3"
+BMGC_DG02964,BMG_DG081162,"CAS RN:19356-17-3 | 3-[2-[(1R,3aS,7aR)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol | PubChem CID:134694705"
+BMGC_DG02965,BMG_DG081166,"CAS RN:9050-36-6 | Dextrin10 | (2R,5R,6R)-2-(hydroxymethyl)-6-[(2R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol | PubChem CID:134694829"
+BMGC_DG02966,BMG_DG081221,PubChem SID:175267518 | magnesium;diacetate;tetrahydrate | NDC:37662-2802 | UNII:I01G0EJC3B | Magnesium Acetate Tetrahydrate | NDC:37662-2798 | NDC:37662-2801 | NDC:37662-2803 | DrugBank ID:DB09409 | NDC:37662-2804 | Magnesium acetate tetrahydrate | NDC:37662-2800 | CAS RN:16674-78-5 | NDC:37662-2799 | MAGNESIUM ACETATE TETRAHYDRATE | PubChem CID:134717 | NDC:37662-2805
+BMGC_DG02967,BMG_DG081224,"Androsta-1,4-diene-3,17-dione | (8R,9S,10R,13S,14S)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione | DrugBank ID:DB07373 | UNII:2166Q8568W | PubChem SID:198956710 | CAS RN:897-06-3 | Boldione | PubChem CID:13472 | BOLDIONE"
+BMGC_DG02968,BMG_DG081271,PubChem SID:241178177 | Didesmethylsibutramine | CAS RN:84467-54-9 | 1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutan-1-amine | PubChem CID:134772 | DIDESMETHYLSIBUTRAMINE | UNII:987R943R3P
+BMGC_DG02969,BMG_DG081277,"NDC:59572-501 | PubChem CID:134780 | CAS RN:443919-33-3 | Pomalidomide | PubChem SID:175271747 | UNII:D2UX06XLB5 | 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione | POMALIDOMIDE | CAS RN:19171-19-8 | DrugBank ID:DB08910 | NDC:59572-502 | NDC:59572-503 | NDC:59572-504"
+BMGC_DG02970,BMG_DG081290,MY-5445 | PubChem SID:198962719 | PubChem CID:1348 | UNII:F8CSS73B6A | CAS RN:78351-75-4
+BMGC_DG02971,BMG_DG081325,"PubChem CID:134812633 | UNII:WJY2WD3C7A | CAS RN:2120282-75-7 | Fanotaprim | PubChem SID:433968886 | FANOTAPRIM | 5-[4-[3-(2-methoxypyrimidin-5-yl)phenyl]piperazin-1-yl]pyrimidine-2,4-diamine"
+BMGC_DG02972,BMG_DG081326,Bavarostat | PubChem CID:134812690 | CAS RN:2134109-20-7 | 4-[[1-adamantylmethyl(methyl)amino]methyl]-3-fluoro-N-hydroxybenzamide
+BMGC_DG02973,BMG_DG081330,PubChem SID:441097042 | UNII:9ZGC48P3RV | PubChem CID:134814269 | NB-003 FREE BASE | CAS RN:2248003-60-1
+BMGC_DG02974,BMG_DG081455,"6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide | NDC:0003-0895 | DEUCRAVACITINIB | PubChem CID:134821691 | Deucravacitinib | PubChem SID:433968676 | UNII:N0A21N6RAU | CAS RN:1609392-27-9"
+BMGC_DG02975,BMG_DG081456,"(2R)-2-amino-N-(4-oxo-6,7-dihydro-5H-1,3-benzothiazol-2-yl)propanamide | (2~{R})-2-azanyl-~{N}-(4-oxidanylidene-6,7-dihydro-5~{H}-1,3-benzothiazol-2-yl)propanamide | PubChem CID:134822012"
+BMGC_DG02976,BMG_DG081487,Serdexmethylphenidate | PubChem CID:134823895 | PubChem SID:376231471 | (2S)-3-hydroxy-2-[[1-[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]piperidine-1-carbonyl]oxymethyl]pyridin-1-ium-3-carbonyl]amino]propanoate | CAS RN:1996626-29-9 | UNII:0H8KZ470DW | SERDEXMETHYLPHENIDATE
+BMGC_DG02977,BMG_DG081560,CAS RN:25893-06-5 | UNII:8EL2WZ4FZM | 5-AMINOTHIABENDAZOLE | PubChem SID:440088380 | PubChem CID:134912
+BMGC_DG02978,BMG_DG081569,"CAS RN:911-65-9 | Etonitazene | DrugBank ID:DB01462 | PubChem SID:198964317 | UNII:9U3GT3353T | 2-[2-[(4-ethoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine | PubChem CID:13493 | ETONITAZENE"
+BMGC_DG02979,BMG_DG081599,NDC:62135-205 | NDC:63629-9251 | NDC:72162-1803 | NDC:64980-265 | DrugBank ID:DB00763 | PubChem CID:1349907 | NDC:68788-8227 | NDC:60429-381 | NDC:64380-212 | NDC:72603-316 | NDC:23155-070 | NDC:0832-6072 | NDC:63629-9250 | NDC:67046-1366 | NDC:72162-1802 | METHIMAZOLE | NDC:64380-213 | NDC:71335-0883 | NDC:72603-315 | NDC:23155-071 | NDC:70518-1475 | NDC:62135-206 | PubChem SID:175265937 | 3-methyl-1H-imidazole-2-thione | NDC:33342-336 | CAS RN:85916-84-3 | NDC:0832-6073 | NDC:63629-8347 | UNII:554Z48XN5E | NDC:68788-8768 | CAS RN:223768-14-7 | Methimazole | NDC:69452-329 | NDC:71335-2349 | NDC:63629-9249 | NDC:69452-328 | NDC:60429-380 | NDC:33342-335 | CAS RN:60-56-0 | NDC:60687-680 | NDC:64980-264 | NDC:68788-8226 | NDC:71335-2218 | NDC:70518-1506 | NDC:50090-6536 | NDC:60687-669
+BMGC_DG02980,BMG_DG081603,4-HYDROXYBENZOIC ACID | CAS RN:99-96-7 | 4-Hydroxybenzoic acid | PubChem SID:198957055 | DrugBank ID:DB04242 | UNII:JG8Z55Y12H | CAS RN:30729-36-3 | 4-hydroxybenzoic acid | PubChem CID:135
+BMGC_DG02981,BMG_DG081634,"ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate | DrugBank ID:DB01081 | Diphenoxylate | PubChem CID:13505 | DIPHENOXYLATE | UNII:73312P173G | CAS RN:915-30-0 | PubChem SID:175267295"
+BMGC_DG02982,BMG_DG081645,UNII:N9Q32YUR4E | METIPAMIDE | PubChem CID:135086 | CAS RN:85683-41-6 | PubChem SID:438788871
+BMGC_DG02983,BMG_DG081663,PubChem SID:461434514 | PubChem CID:135138184 | UNII:C238YE66P2 | CAS RN:2169273-59-8 | ATINVICITINIB
+BMGC_DG02984,BMG_DG081674,PubChem SID:363908105 | UNII:8V3S9M26DE | BMY-25368 | CAS RN:86134-80-7 | PubChem CID:135156
+BMGC_DG02985,BMG_DG081679,PubChem CID:135177281 | UNII:L08E1MGN85 | CAS RN:2230757-47-6 | ACP-5862
+BMGC_DG02986,BMG_DG081690,1-(5-Isoquinolinylsulfonyl)-3-methylpiperazine | 5-(3-methylpiperazin-1-yl)sulfonylisoquinoline | PubChem CID:1352 | CAS RN:84477-73-6
+BMGC_DG02987,BMG_DG081691,"Lithium Citrate | DrugBank ID:DB14507 | PubChem SID:198936915 | UNII:3655633623 | PubChem CID:13520 | CAS RN:919-16-4 | CAS RN:6680-58-6 | LITHIUM CITRATE ANHYDROUS | CAS RN:1313437-84-1 | trilithium;2-hydroxypropane-1,2,3-tricarboxylate"
+BMGC_DG02988,BMG_DG081698,CAS RN:2064121-65-7 | 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide | PubChem CID:135206011 | PubChem SID:433968323 | ASUNDEXIAN | UNII:LA585UM8DE | Asundexian
+BMGC_DG02989,BMG_DG081709,CAS RN:2241039-81-4 | Azd-4604 | PubChem CID:135240395 | (2R)-N-[3-[5-fluoro-2-(2-fluoro-3-methylsulfonylanilino)pyrimidin-4-yl]-1H-indol-7-yl]-3-methoxy-2-(4-methylpiperazin-1-yl)propanamide | PubChem SID:445499110 | LONDAMOCITINIB | UNII:JAC34RRR7S | Londamocitinib
+BMGC_DG02990,BMG_DG081710,PubChem CID:135240787 | PubChem SID:496143957 | CAS RN:2238819-65-1 | UNII:43K4X7JG75 | JT-001
+BMGC_DG02991,BMG_DG081712,3-[2-amino-6-[1-[[6-(2-hydroxypropan-2-yl)pyridin-2-yl]methyl]triazol-4-yl]pyrimidin-4-yl]-2-methylbenzonitrile | ETRUMADENANT | PubChem SID:461434210 | CAS RN:2239273-34-6 | PubChem CID:135242184 | UNII:W0ZE0NT8IF | Etrumadenant
+BMGC_DG02992,BMG_DG081719,demeton-S-methyl | DEMETON-S-METHYL | 1-dimethoxyphosphorylsulfanyl-2-ethylsulfanylethane | CAS RN:919-86-8 | PubChem CID:13526 | PubChem SID:198942475 | UNII:HU8BO5S9WK
+BMGC_DG02993,BMG_DG081720,"UNII:Y4G2SI35XZ | Noracymethadol, (-)- | PubChem CID:135260 | [(3S,6S)-6-(methylamino)-4,4-diphenylheptan-3-yl] acetate | CAS RN:43033-71-2 | PubChem SID:198962895 | NORACYMETHADOL, (-)-"
+BMGC_DG02994,BMG_DG081725,"PubChem CID:135281127 | UNII:8A64419SNL | PubChem SID:443623837 | N-((1R)-1-PHENYLETHYL)-6-(1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-YL)QUINAZOLIN-2-AMINE | CAS RN:2093318-43-3"
+BMGC_DG02995,BMG_DG081728,3-Hydroxycarbamazepine | UNII:PDG5O25MKO | 3-HYDROXYCARBAMAZEPINE | PubChem SID:402404574 | 2-hydroxybenzo[b][1]benzazepine-11-carboxamide | CAS RN:68011-67-6 | PubChem CID:135290
+BMGC_DG02996,BMG_DG081736,CAS RN:2241676-74-2 | 15-Pgdh-IN-1 | 2-methyl-6-[7-(piperidine-1-carbonyl)quinoxalin-2-yl]isoquinolin-1-one | PubChem CID:135300446
+BMGC_DG02997,BMG_DG081739,CAS RN:2242593-26-4 | PubChem SID:459275948 | PubChem CID:135303972 | UNII:SVJ8KG89JE | TAMINADENANT HYDROXY METABOLITE
+BMGC_DG02998,BMG_DG081759,PubChem CID:135326 | IOBENGUANE I-123 | UNII:P2TH1XYZ84 | PubChem SID:175268662 | Iobenguane I-123 | 2-[(3-(123I)iodanylphenyl)methyl]guanidine | CAS RN:76924-93-1 | NDC:17156-235
+BMGC_DG02999,BMG_DG081763,PubChem SID:474492336 | Omesdafexor | PubChem CID:135329968 | CAS RN:2244440-85-3 | OMESDAFEXOR | UNII:E05WEZ4XLE
+BMGC_DG03000,BMG_DG081778,"INUPADENANT, (+/-)- | PubChem SID:433968636 | PubChem CID:135346979 | CAS RN:2246607-06-5 | INUPADENANT, (±)- | UNII:L9RDR3F7GU"
+BMGC_DG03001,BMG_DG081779,PubChem CID:135348858 | AVS-100 | CAS RN:2245942-72-5 | UNII:9EYT5CWH6E | PubChem SID:474493696
+BMGC_DG03002,BMG_DG081783,"PubChem CID:135351887 | CAS RN:2092925-89-6 | PALAZESTRANT | PubChem SID:478838419 | UNII:VU35KM56Q4 | Palazestrant | (1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1-[4-(1-propylazetidin-3-yl)oxyphenyl]-1,3,4,9-tetrahydropyrido[3,4-b]indole"
+BMGC_DG03003,BMG_DG081787,"PubChem SID:472419957 | 1-tert-butyl-N-[(5R)-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-2-(oxetan-3-yl)-1,3,4,5-tetrahydro-2-benzazepin-5-yl]triazole-4-carboxamide | UNII:MJ0LWX26KB | CAS RN:2247614-80-6 | BIIB-091 | Biib091 | PubChem CID:135355941"
+BMGC_DG03004,BMG_DG081801,"CAS RN:2107353-05-7 | PubChem CID:135365200 | (3S)-3-(4-aminobutyl)-1-[[4-fluoro-2-(3-methylimidazol-4-yl)phenyl]methyl]-4-hydroxy-4-oxo-1,4lambda5-azaphosphinane-3-carboxylic acid"
+BMGC_DG03005,BMG_DG081815,PubChem CID:135378781 | CAS RN:2252277-73-7 | GDC-4379 | UNII:C2J2F95UM8 | PubChem SID:472424521
+BMGC_DG03006,BMG_DG081817,CAS RN:923-01-3 | PubChem CID:13538 | PubChem SID:440793982 | UNII:NGZ6PU7PK7 | 3-CYANOALANINE
+BMGC_DG03007,BMG_DG081835,"PubChem CID:135390719 | PubChem SID:377307852 | (2S)-4-[2-methoxyethyl-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-(quinazolin-4-ylamino)butanoic acid | BEXOTEGRAST | Bexotegrast | CAS RN:2376257-44-0 | UNII:QCV154PFT4"
+BMGC_DG03008,BMG_DG081925,PubChem SID:377308852 | UNII:9ARF19M2H4 | PubChem CID:135391000 | PUQUITINIB MESYLATE DIHYDRATE
+BMGC_DG03009,BMG_DG081931,"PubChem SID:377308908 | PubChem CID:135391013 | UNII:70JCV6CT08 | (4-(4-(1-(2-(2-(2-(2-(2-(2-(2-(4-GUANIDINOMETHYL-PHENOXY)-ETHOXY)-ETHOXY)-ETHOXY)-ETHOXY)-ETHOXY)-ETHOXY)-ETHYL)-1H-(1,2,3)TRIAZOL-4-YLMETHOXY)-3,5-DIIODO-PHENOXY)-3,5-DIIODO-PHENYL)-ACETIC ACID"
+BMGC_DG03010,BMG_DG082030,PubChem CID:135398492 | BIX-02188 | CAS RN:1094614-84-2 | UNII:4Y3VYY2X83 | PubChem SID:198946898
+BMGC_DG03011,BMG_DG082031,PubChem CID:135398495 | 1-cyclopropyl-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea | UNII:XAV9KYN9WL | CAS RN:896466-04-9 | 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea | PubChem SID:198947373 | AT-9283
+BMGC_DG03012,BMG_DG082035,"UNII:NNU2O4609D | DrugBank ID:DB00442 | 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1H-purin-6-one | NDC:43547-437 | CAS RN:142217-69-4 | PubChem SID:175266384 | NDC:43547-436 | PubChem CID:135398508 | NDC:31722-834 | Entecavir | CAS RN:1333204-94-6 | ENTECAVIR ANHYDROUS | NDC:31722-833"
+BMGC_DG03013,BMG_DG082036,Dovitinib | DOVITINIB | DrugBank ID:DB05928 | PubChem SID:198975799 | UNII:I35H55G906 | CAS RN:1027263-12-2 | 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one | CAS RN:804551-71-1 | PubChem CID:135398510 | CAS RN:405169-16-6
+BMGC_DG03014,BMG_DG082038,NDC:68071-2526 | NDC:82804-012 | NDC:72162-1724 | NDC:72578-082 | NDC:68071-3573 | NDC:62135-803 | NDC:67046-1206 | NDC:65162-835 | NDC:81288-039 | NDC:68084-107 | NDC:71335-2261 | NDC:50268-061 | NDC:71335-0470 | NDC:31722-778 | NDC:0187-0994 | NDC:0378-8700 | NDC:62332-423 | NDC:63629-2328 | PubChem SID:175266287 | NDC:0904-5789 | NDC:63187-154 | NDC:63187-182 | NDC:71205-472 | DrugBank ID:DB00787 | CAS RN:59277-89-3 | NDC:50268-062 | NDC:54348-624 | NDC:50090-6844 | NDC:68071-2287 | NDC:71335-0695 | NDC:0472-0082 | NDC:70518-2085 | NDC:63629-2009 | NDC:71205-053 | NDC:0187-5104 | NDC:61442-114 | NDC:72241-028 | NDC:23155-229 | NDC:50090-7216 | NDC:68071-2279 | NDC:68788-7923 | NDC:71205-578 | NDC:60505-5307 | NDC:43063-589 | NDC:71335-1645 | NDC:72241-026 | NDC:76420-050 | NDC:67296-1458 | NDC:72578-002 | NDC:13668-515 | NDC:72162-1960 | NDC:61442-113 | NDC:50090-0644 | NDC:70518-4186 | NDC:68071-3222 | NDC:0187-0993 | NDC:63187-574 | NDC:69452-291 | NDC:75834-122 | NDC:67046-1083 | NDC:68462-746 | NDC:23155-228 | NDC:70518-2518 | NDC:82804-005 | NDC:71335-1222 | NDC:71205-391 | NDC:50090-6561 | NDC:23155-227 | NDC:55154-7629 | NDC:0904-5790 | NDC:68084-109 | NDC:71205-243 | NDC:71335-0280 | NDC:51407-852 | NDC:50090-6335 | NDC:72162-1735 | NDC:50090-7275 | NDC:62135-019 | NDC:68382-791 | NDC:70518-0427 | NDC:71335-1381 | NDC:69117-0018 | NDC:51407-145 | NDC:51407-146 | NDC:71205-371 | NDC:68071-5100 | NDC:71209-005 | NDC:50090-6578 | NDC:0591-1159 | NDC:70518-2455 | NDC:76483-042 | NDC:55154-4332 | NDC:68071-4799 | NDC:70518-2117 | NDC:72578-101 | NDC:59651-493 | NDC:50090-0645 | NDC:60505-5306 | NDC:33342-439 | NDC:0093-3630 | NDC:50090-3250 | NDC:71335-2229 | NDC:70700-107 | NDC:80425-0270 | Acyclovir | NDC:17856-0083 | NDC:45802-044 | NDC:50090-7277 | NDC:51655-965 | NDC:71335-1757 | NDC:54348-627 | NDC:67296-1495 | NDC:67296-0710 | NDC:67296-1723 | NDC:51079-550 | NDC:51655-679 | NDC:62135-039 | NDC:66267-399 | NDC:31722-777 | NDC:69117-0039 | NDC:43063-928 | NDC:63187-366 | NDC:68788-8203 | NDC:65841-803 | NDC:63187-253 | NDC:50090-7276 | NDC:71209-006 | NDC:63629-1678 | NDC:50090-3254 | NDC:71209-004 | NDC:69117-0019 | NDC:65162-836 | NDC:51672-1360 | NDC:43547-499 | NDC:68071-2299 | NDC:70771-1808 | NDC:68071-2811 | NDC:72241-027 | NDC:68071-2447 | CAS RN:88713-38-6 | NDC:71205-388 | NDC:71335-2555 | NDC:67296-2040 | NDC:60760-606 | NDC:70954-188 | NDC:69452-290 | NDC:69367-138 | NDC:67296-1543 | NDC:72162-2327 | NDC:68788-7575 | NDC:76483-047 | NDC:70934-907 | NDC:68071-1841 | NDC:69367-137 | NDC:50090-1567 | NDC:68071-2247 | NDC:71205-209 | NDC:31722-681 | NDC:63629-2327 | NDC:69076-146 | NDC:63629-9174 | NDC:65841-829 | NDC:72888-079 | CAS RN:141294-79-3 | NDC:43063-826 | NDC:62332-248 | NDC:72162-1704 | UNII:X4HES1O11F | NDC:63187-192 | NDC:72162-1908 | NDC:68788-8724 | NDC:71335-1290 | NDC:42291-017 | NDC:60760-778 | NDC:67296-1707 | NDC:71335-9620 | NDC:71205-056 | NDC:60505-0042 | NDC:75834-123 | NDC:51672-1361 | 2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one | ACYCLOVIR | NDC:70771-1371 | PubChem CID:135398513 | NDC:68382-792 | NDC:72205-170 | NDC:51655-300 | NDC:65841-802 | NDC:68084-108 | NDC:75834-124 | NDC:71335-9721 | NDC:68788-8247 | NDC:70518-3436 | NDC:69097-656 | NDC:66689-342 | NDC:71335-1053 | NDC:16714-885 | NDC:61442-112 | NDC:50090-5610 | NDC:50090-1624 | NDC:67046-1031
+BMGC_DG03015,BMG_DG082039,PubChem SID:198978199 | PubChem CID:135398514 | CAS RN:140651-18-9 | CAN-508 | UNII:ZG0O47K626
+BMGC_DG03016,BMG_DG082040,"PubChem CID:135398516 | DrugBank ID:DB12387 | OSI-027 | CAS RN:1187559-66-5 | UNII:25MKH1SZ0M | CAS RN:936890-98-1 | PubChem SID:198985896 | 4-[4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylic acid | Cerc 006"
+BMGC_DG03017,BMG_DG082049,"CAS RN:68538-85-2 | PubChem SID:198977931 | CAS RN:58-05-9 | UNII:990S25980Y | PubChem CID:135398559 | DrugBank ID:DB11596 | LEVOLEUCOVORIN | Levoleucovorin | (2S)-2-[[4-[[(6S)-2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid"
+BMGC_DG03018,BMG_DG082051,"Levomefolic acid | PubChem CID:135398561 | PubChem SID:175266264 | LEVOMEFOLIC ACID | DrugBank ID:DB11256 | (2S)-2-[[4-[[(6S)-2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid | UNII:8S95DH25XC | CAS RN:31690-09-2"
+BMGC_DG03019,BMG_DG082053,"5-(AMINOMETHYL)-2-AZANYL-1,7-DIHYDROPYRROLO(2,3-D)PYRIMIDIN-4-ONE | PubChem CID:135398563 | UNII:KC54F6G5HS | 2-amino-5-(aminomethyl)-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one | CAS RN:69251-45-2 | 7-Aminomethyl-7-carbaguanine | DrugBank ID:DB03304"
+BMGC_DG03020,BMG_DG082057,"PubChem CID:135398568 | 2-AMINO-6-(HYDROXYMETHYL)-7,8-DIHYDRO-3H-PTERIDIN-4-ONE | 6-Hydroxymethyl-7,8-dihydropterin | 2-amino-6-(hydroxymethyl)-7,8-dihydro-3H-pteridin-4-one | DrugBank ID:DB02119 | PubChem SID:472425053 | UNII:B46L5LR2XM | CAS RN:3672-03-5"
+BMGC_DG03021,BMG_DG082059,"DrugBank ID:DB02315 | 9-[(4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl]-2-amino-1H-purin-6-one | Cyclic GMP | PubChem CID:135398570 | PubChem SID:198946721 | CAS RN:7665-99-8 | CYCLIC GMP | UNII:H2D2X058MU"
+BMGC_DG03022,BMG_DG082066,"Guanosine-5'-diphosphate-rhamnose | PubChem CID:135398578 | DrugBank ID:DB02547 | [[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl] hydrogen phosphate"
+BMGC_DG03023,BMG_DG082067,"Sepiapterin | CAS RN:17094-01-8 | SEPIAPTERIN | UNII:CJQ26KO7HP | PubChem CID:135398579 | PubChem SID:313183777 | 2-amino-6-[(2S)-2-hydroxypropanoyl]-7,8-dihydro-3H-pteridin-4-one"
+BMGC_DG03024,BMG_DG082075,"CAS RN:116002-28-9 | PubChem CID:135398592 | 2'-DEOXYGUANOSINE | CAS RN:961-07-9 | CAS RN:38559-49-8 | CAS RN:19916-78-0 | 2-amino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one | UNII:G9481N71RO | Deoxyguanosine | CAS RN:663615-45-0 | PubChem SID:198942132"
+BMGC_DG03025,BMG_DG082076,"PubChem CID:135398593 | PubChem SID:198954279 | UNII:HN0RQ6SBWQ | CAS RN:29868-32-4 | CAS RN:890-38-0 | 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one | Deoxyinosine | DrugBank ID:DB02380 | 2'-DEOXYINOSINE"
+BMGC_DG03026,BMG_DG082078,"DrugBank ID:DB03491 | 2'-DEOXYGUANOSINE-5'-DIPHOSPHATE | [(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate | 2'-Deoxyguanosine-5'-diphosphate | CAS RN:3493-09-2 | UNII:4RQT5B7A8J | PubChem CID:135398595 | PubChem SID:474492504"
+BMGC_DG03027,BMG_DG082080,"PubChem SID:198944745 | UNII:7EAM4TG712 | CAS RN:902-04-5 | [(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate | 2'-Deoxyguanosine 5'-phosphate | PubChem CID:135398597 | 2'-DEOXYGUANOSINE 5'-PHOSPHATE | DrugBank ID:DB04457 | CAS RN:52558-16-4"
+BMGC_DG03028,BMG_DG082082,"UNII:8C2O37Y44Q | PubChem CID:135398599 | [[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | DrugBank ID:DB02181 | PubChem SID:313390099 | CAS RN:2564-35-4 | DEOXYGUANOSINE TRIPHOSPHATE | 2'-Deoxyguanosine-5'-triphosphate"
+BMGC_DG03029,BMG_DG082085,"2-amino-6-[(1S,2R)-1,2,3-trihydroxypropyl]-7,8-dihydro-3H-pteridin-4-one | PubChem CID:135398602 | 7,8-Dihydroneopterin | DrugBank ID:DB04425 | CAS RN:1218-98-0"
+BMGC_DG03030,BMG_DG082087,"Dihydrofolic acid | (2S)-2-[[4-[(2-amino-4-oxo-7,8-dihydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | PubChem SID:252319440 | PubChem CID:135398604 | DrugBank ID:DB02015 | CAS RN:4033-27-6 | DIHYDROFOLIC ACID | UNII:KXP0KNM559"
+BMGC_DG03031,BMG_DG082100,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate | DrugBank ID:DB04315 | CAS RN:105184-12-1 | PubChem CID:135398619 | Guanosine Diphosphate | CAS RN:146-91-8 | CAS RN:105184-46-1"
+BMGC_DG03032,BMG_DG082107,"GUANOSINE DIPHOSPHATE MANNOSE | PubChem CID:135398627 | UNII:SA0B77H8CS | PubChem SID:198984436 | Guanosine diphosphate mannose | CAS RN:3123-67-9 | [[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate"
+BMGC_DG03033,BMG_DG082109,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy(phosphonooxy)phosphoryl]oxyphosphoryl]oxymethyl]oxolan-3-yl] phosphono hydrogen phosphate | PubChem CID:135398629 | Guanosine 3'-diphosphate 5'-triphosphate | CAS RN:38918-96-6"
+BMGC_DG03034,BMG_DG082111,"PubChem CID:135398631 | CAS RN:85-32-5 | Guanosine Monophosphate | CAS RN:128952-18-1 | [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | 5'-GUANYLIC ACID | DrugBank ID:DB01972 | UNII:16597955EP | PubChem SID:198981466 | CAS RN:29593-02-0"
+BMGC_DG03035,BMG_DG082113,"DrugBank ID:DB04137 | CAS RN:56001-37-7 | CAS RN:86-01-1 | Guanosine Triphosphate | CAS RN:136295-02-8 | PubChem CID:135398633 | CAS RN:154765-83-0 | CAS RN:24905-71-3 | PubChem SID:313389965 | GUANOSINE TRIPHOSPHATE | CAS RN:36051-31-7 | [[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | CAS RN:139021-15-1 | UNII:01WV7J708X"
+BMGC_DG03036,BMG_DG082114,"2-amino-1,7-dihydropurin-6-one | CAS RN:73-40-5 | GUANINE | PubChem SID:175267673 | Guanine | DrugBank ID:DB02377 | PubChem CID:135398634 | UNII:5Z93L87A1R | CAS RN:66224-64-4 | CAS RN:71660-36-1"
+BMGC_DG03037,BMG_DG082115,"UNII:12133JR80S | PubChem CID:135398635 | GUANOSINE | DrugBank ID:DB02857 | CAS RN:85-30-3 | PubChem SID:198953711 | 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one | CAS RN:118-00-3 | Guanosine"
+BMGC_DG03038,BMG_DG082117,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] phosphono hydrogen phosphate | CAS RN:33503-72-9 | PubChem CID:135398637 | CAS RN:32452-17-8 | Guanosine-5',3'-tetraphosphate | DrugBank ID:DB04022"
+BMGC_DG03039,BMG_DG082118,"CAS RN:95121-06-5 | CAS RN:1246820-04-1 | 1,7-dihydropurin-6-one | PubChem SID:198935612 | CAS RN:51953-04-9 | CAS RN:146469-94-5 | Hypoxanthine | CAS RN:146469-96-7 | CAS RN:68-94-0 | PubChem CID:135398638 | DrugBank ID:DB04076 | UNII:2TN51YD919 | CAS RN:146469-95-6 | CAS RN:146445-70-7 | HYPOXANTHINE | CAS RN:51953-23-2"
+BMGC_DG03040,BMG_DG082120,"CAS RN:131-99-7 | UNII:TAO7US05G5 | Inosinic Acid | INOSINIC ACID | PubChem CID:135398640 | CAS RN:25249-22-3 | CAS RN:30918-54-8 | DrugBank ID:DB04566 | PubChem SID:198970987 | [(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate"
+BMGC_DG03041,BMG_DG082121,"Inosine | DrugBank ID:DB04335 | INOSINE | PubChem SID:198971754 | PubChem CID:135398641 | CAS RN:58-63-9 | UNII:5A614L51CT | 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one"
+BMGC_DG03042,BMG_DG082123,"INOSINE TRIPHOSPHATE | UNII:212A76R77X | CAS RN:132-06-9 | PubChem CID:135398643 | Inosine Triphosphate | PubChem SID:336286739 | [[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate"
+BMGC_DG03043,BMG_DG082128,"PubChem CID:135398650 | (6S)-5,6,7,8-Tetrahydrofolate | (2S)-2-[[4-[[(6S)-2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid | DrugBank ID:DB02031"
+BMGC_DG03044,BMG_DG082129,"Inosine Diphosphate | INOSINE DIPHOSPHATE | PubChem CID:135398651 | UNII:F15JU6D39T | [(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate | PubChem SID:346537661 | CAS RN:86-04-4"
+BMGC_DG03045,BMG_DG082131,"(6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-6,7-dihydro-3H-pteridin-4-one | DrugBank ID:DB02562 | PubChem CID:135398653 | 4a-Carbinolamine tetrahydrobiopterin | CAS RN:79647-29-3"
+BMGC_DG03046,BMG_DG082132,"PubChem CID:135398654 | UNII:EGX657432I | PubChem SID:175267933 | DrugBank ID:DB00360 | CAS RN:62989-33-7 | (6R)-2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-5,6,7,8-tetrahydro-3H-pteridin-4-one | SAPROPTERIN | CAS RN:27070-47-9 | Sapropterin"
+BMGC_DG03047,BMG_DG082135,FOLIC ACID | DrugBank ID:DB00158 | CAS RN:59-30-3 | CAS RN:112339-08-9 | CAS RN:112339-32-9 | UNII:935E97BOY8 | (2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | PubChem SID:175267888 | PubChem CID:135398658 | CAS RN:6484-89-5 | Folic Acid | Folic acid
+BMGC_DG03048,BMG_DG082138,"DrugBank ID:DB04104 | 3-Methyladenine | 3-methyl-7H-purin-6-imine | PubChem SID:443624443 | PubChem SID:440089794 | UNII:3899G64TKW | 3,9-DIHYDRO-3-METHYL-6H-PURIN-6-IMINE | CAS RN:60192-57-6 | CAS RN:5142-23-4 | PubChem CID:135398661 | 3-METHYLADENINE | UNII:DR88TV7SNU"
+BMGC_DG03049,BMG_DG082145,"CAS RN:32988-50-4 | CAS RN:37883-00-4 | PubChem CID:135398671 | DrugBank ID:DB06827 | VIOMYCIN | PubChem SID:198939760 | (3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R,6S)-2-amino-6-hydroxy-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide | Viomycin | UNII:YVU35998K5"
+BMGC_DG03050,BMG_DG082154,"Dihydrobiopterin | CAS RN:6779-87-9 | PubChem CID:135398687 | DrugBank ID:DB04400 | 2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-7,8-dihydro-3H-pteridin-4-one"
+BMGC_DG03051,BMG_DG082160,"DrugBank ID:DB08326 | 2-(6-HYDROXY-2-BENZOTHIAZOLYL)-4(5H)-THIAZOLONE | 2-(6-hydroxy-1,3-benzothiazol-2-yl)-1,3-thiazol-4-one | PubChem CID:135398698 | UNII:8T3Z7X2Y9G | CAS RN:17002-50-5 | 2-(6-hydroxy-1,3-benzothiazol-2-yl)-1,3-thiazol-4(5H)-one | 2-(6-Hydroxy-2-benzothiazolyl)-4(5H)-thiazolone | PubChem SID:472422230"
+BMGC_DG03052,BMG_DG082162,"7-Methyl-5′-guanylic acid | PubChem SID:478838394 | CAS RN:47442-17-1 | [(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | PubChem CID:135398701 | CAS RN:10162-58-0 | 7-METHYL-5'-GUANYLIC ACID | DrugBank ID:DB03593 | 7-Methylguanosine 5'-phosphate | UNII:M5SL28EU5R"
+BMGC_DG03053,BMG_DG082173,"PubChem CID:135398727 | [(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate | Guanosine-3'-monophosphate | PubChem SID:198934922 | CAS RN:117-68-0 | UNII:839SG0O89X | DrugBank ID:DB03315 | 3'-GUANYLIC ACID"
+BMGC_DG03054,BMG_DG082176,".BETA.,.GAMMA.-METHYLENE GUANOSINE 5'-TRIPHOSPHATE | PubChem SID:252319641 | CAS RN:13912-93-1 | [[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methylphosphonic acid | DrugBank ID:DB03725 | UNII:4E15I11U9B | 5'-Guanylylmethylenediphosphonate | PubChem CID:135398731 | CAS RN:14997-54-7"
+BMGC_DG03055,BMG_DG082179,"NDC:68180-658 | Rifampin | PubChem CID:135398735 | NDC:68180-659 | RIFAMPIN | NDC:24658-801 | NDC:63629-4042 | NDC:60687-575 | NDC:0185-0799 | NDC:60687-586 | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-26-[(E)-(4-methylpiperazin-1-yl)iminomethyl]-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate | NDC:0185-0801 | PubChem SID:175268846 | NDC:50090-5709 | NDC:76420-060 | NDC:67457-445 | CAS RN:13292-46-1 | UNII:VJT6J7R4TR | NDC:0143-9230 | DrugBank ID:DB01045 | NDC:62135-316 | NDC:42806-799 | NDC:0068-0599 | NDC:24658-802 | NDC:62135-315 | NDC:0068-0597 | NDC:50090-4961 | NDC:63323-351 | NDC:42806-801"
+BMGC_DG03056,BMG_DG082180,"Azactam | PubChem CID:135398736 | (2S,3S)-3-[[(2Z)-2-(2-amino-1,3-thiazol-3-ium-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-2-methyl-4-oxoazetidine-1-sulfonate | DrugBank ID:DB00355"
+BMGC_DG03057,BMG_DG082181,"UNII:J60AR2IKIC | NDC:0378-0825 | NDC:0904-7406 | NDC:51079-749 | NDC:0378-0973 | NDC:57664-211 | CAS RN:5786-21-0 | NDC:0378-3813 | NDC:59651-262 | NDC:57664-347 | NDC:51079-921 | NDC:51079-922 | PubChem SID:175265604 | NDC:60687-415 | NDC:0093-5419 | NDC:0378-0972 | CLOZAPINE | NDC:63629-2362 | NDC:0093-5417 | NDC:0378-3815 | DrugBank ID:DB00363 | NDC:52817-601 | 3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine | NDC:65862-847 | NDC:0378-3816 | NDC:65862-844 | NDC:60687-426 | NDC:59651-263 | NDC:72162-1638 | NDC:0378-0860 | NDC:16729-142 | NDC:57664-345 | NDC:55154-3568 | NDC:0378-3817 | NDC:69809-0126 | NDC:69809-0127 | CAS RN:1333667-72-3 | NDC:63629-2360 | NDC:51079-288 | NDC:65862-845 | NDC:59651-261 | NDC:0904-7089 | NDC:0093-5377 | NDC:59651-260 | NDC:60687-404 | PubChem CID:135398737 | NDC:0093-5376 | NDC:0904-7087 | NDC:16729-141 | NDC:60687-548 | NDC:65862-846 | NDC:0904-7088 | NDC:0093-5416 | NDC:63629-2361 | NDC:59651-264 | Clozapine | NDC:57664-241"
+BMGC_DG03058,BMG_DG082182,NDC:71288-174 | NDC:0143-9245 | UNII:7GR28W0FJI | NDC:63323-128 | CAS RN:94361-71-4 | DACARBAZINE | 4-[(E)-dimethylaminodiazenyl]-1H-imidazole-5-carboxamide | PubChem SID:175265531 | CAS RN:4342-03-4 | NDC:63323-127 | CAS RN:750512-03-9 | Dacarbazine | PubChem CID:135398738 | DrugBank ID:DB00851
+BMGC_DG03059,BMG_DG082183,"DIDANOSINE | UNII:K3GDH6OH08 | CAS RN:69655-05-6 | Didanosine | 9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one | PubChem SID:175267368 | PubChem CID:135398739 | DrugBank ID:DB00900"
+BMGC_DG03060,BMG_DG082184,"PubChem CID:135398740 | NDC:24208-535 | PubChem SID:175266008 | CAS RN:82410-32-0 | GANCICLOVIR | NDC:51754-2500 | DrugBank ID:DB01004 | Ganciclovir | 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one | UNII:P9G3CKZ4P5"
+BMGC_DG03061,BMG_DG082185,NDC:63187-776 | NDC:50090-2575 | NDC:69117-0010 | NDC:71335-1862 | NDC:57237-042 | NDC:68071-4885 | NDC:68071-3749 | NDC:72189-594 | NDC:43063-778 | NDC:65841-629 | NDC:50090-6918 | NDC:72789-452 | CAS RN:136489-37-7 | NDC:63187-627 | NDC:82804-006 | NDC:57237-043 | NDC:72162-2366 | NDC:67296-1551 | NDC:51407-108 | NDC:49483-691 | NDC:69117-0011 | NDC:70518-2402 | NDC:63187-832 | NDC:68071-4728 | NDC:71335-2534 | NDC:68788-7587 | NDC:60760-469 | NDC:69097-153 | NDC:68788-8482 | NDC:67296-1499 | NDC:82804-093 | NDC:70518-4100 | NDC:50090-6581 | NDC:31722-704 | NDC:55154-7985 | NDC:63187-950 | NDC:68071-3624 | NDC:0173-0565 | NDC:50090-5852 | NDC:50090-2224 | NDC:70518-2266 | NDC:69367-262 | VALACYCLOVIR HYDROCHLORIDE | NDC:70518-2039 | NDC:82009-040 | NDC:50090-2101 | NDC:50090-7270 | NDC:69367-263 | NDC:82868-055 | NDC:51655-633 | NDC:62135-613 | UNII:G447S0T1VC | NDC:63739-077 | NDC:71335-0708 | NDC:50090-7484 | NDC:0378-4276 | NDC:16714-697 | NDC:68071-2738 | NDC:50268-789 | NDC:76420-053 | NDC:72789-263 | NDC:0173-0933 | NDC:67296-1473 | NDC:69097-154 | NDC:63304-904 | NDC:31722-705 | NDC:70518-3451 | NDC:70934-628 | NDC:68788-8705 | NDC:43063-730 | NDC:82009-041 | NDC:65862-449 | Valacyclovir Hydrochloride | NDC:51655-703 | NDC:65862-448 | NDC:68071-3037 | NDC:51407-107 | NDC:67296-1226 | PubChem SID:175267986 | NDC:65841-630 | NDC:82804-009 | NDC:68071-4783 | NDC:0904-6565 | NDC:55700-913 | NDC:62135-614 | NDC:71335-0630 | NDC:68084-215 | NDC:0378-4275 | NDC:68084-309 | NDC:68788-8820 | NDC:16714-698 | NDC:59746-325 | NDC:50090-1735 | NDC:63304-905 | NDC:51079-093 | NDC:68071-3747 | NDC:68788-6896 | NDC:59746-324 | PubChem CID:135398741 | NDC:68071-4805 | NDC:49483-690 | NDC:67296-1297 | NDC:63187-538 | NDC:43063-771 | NDC:71335-1341 | 2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate;hydrochloride | CAS RN:124832-27-5 | NDC:72789-264 | NDC:76420-600 | NDC:60760-757 | NDC:50268-788
+BMGC_DG03062,BMG_DG082186,UNII:MZ1IW7Q79D | CAS RN:124832-26-4 | DrugBank ID:DB00577 | VALACYCLOVIR | 2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate | PubChem CID:135398742 | Valacyclovir | PubChem SID:175265642
+BMGC_DG03063,BMG_DG082187,"DrugBank ID:DB00615 | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(32),2,4,9,19,21,24,26,30-nonaene-28,4'-piperidine]-13-yl] acetate | PubChem CID:135398743 | Mycobutin"
+BMGC_DG03064,BMG_DG082188,"CAS RN:139755-83-2 | UNII:3M7OB98Y7H | NDC:60219-2651 | DrugBank ID:DB00203 | 5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one | PubChem SID:175266907 | PubChem CID:135398744 | NDC:69238-1574 | SILDENAFIL | Sildenafil"
+BMGC_DG03065,BMG_DG082189,"PubChem SID:175266633 | CAS RN:132539-06-1 | DrugBank ID:DB00334 | UNII:N7U69T4SZR | 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine | Olanzapine | PubChem CID:135398745 | OLANZAPINE"
+BMGC_DG03066,BMG_DG082190,PubChem CID:135398747 | DrugBank ID:DB00733 | (NE)-N-[(1-methylpyridin-1-ium-2-yl)methylidene]hydroxylamine | PubChem SID:175266128 | UNII:P7MU9UTP52 | Pralidoxime | CAS RN:6735-59-7 | PRALIDOXIME | CAS RN:25615-00-3
+BMGC_DG03067,BMG_DG082191,2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-1H-purin-6-one | NDC:0093-3186 | CAS RN:39809-25-1 | NDC:13668-661 | NDC:45802-440 | NDC:0378-9720 | NDC:0378-0896 | PubChem SID:175268711 | PENCICLOVIR | UNII:359HUE8FJC | Penciclovir | DrugBank ID:DB00299 | PubChem CID:135398748
+BMGC_DG03068,BMG_DG082194,"UNII:G97OZE5068 | OXYPURINOL | PubChem CID:135398752 | Oxypurinol | CAS RN:2465-59-0 | PubChem SID:198942586 | CAS RN:187486-05-1 | 1,7-dihydropyrazolo[3,4-d]pyrimidine-4,6-dione | CAS RN:184764-63-4 | CAS RN:187486-06-2 | DrugBank ID:DB05262"
+BMGC_DG03069,BMG_DG082199,"UNII:GXT25D5DS0 | ZAPRINAST | 5-(2-propoxyphenyl)-2,6-dihydrotriazolo[4,5-d]pyrimidin-7-one | CAS RN:37762-06-4 | PubChem CID:135399235 | PubChem SID:198940160 | Zaprinast | CAS RN:1110670-37-5"
+BMGC_DG03070,BMG_DG082208,PubChem SID:198941421 | m-Chlorophenylbiguanide | 1-(3-CHLOROPHENYL)BIGUANIDE | PubChem CID:1354 | 2-(3-chlorophenyl)-1-(diaminomethylidene)guanidine | CAS RN:48144-44-1 | UNII:910A4X901V
+BMGC_DG03071,BMG_DG082212,RALTITREXED | PubChem SID:198970094 | CAS RN:112887-68-0 | Raltitrexed | PubChem CID:135400182 | (2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid | UNII:FCB9EGG971 | DrugBank ID:DB00293
+BMGC_DG03072,BMG_DG082214,PubChem SID:198944928 | DrugBank ID:DB12912 | UNII:K75ZUN743Q | NOLATREXED | 2-amino-6-methyl-5-pyridin-4-ylsulfanyl-3H-quinazolin-4-one | CAS RN:147149-76-6 | PubChem CID:135400184 | Nolatrexed
+BMGC_DG03073,BMG_DG082215,"UNII:0SXY5ET48B | (2S)-2-[[4-(3-amino-1-oxo-2,5,6,6a,7,9-hexahydroimidazo[1,5-f]pteridin-8-yl)benzoyl]amino]pentanedioic acid | PubChem SID:198982794 | PubChem CID:135400185 | CAS RN:3432-99-3 | FOLITIXORIN | 5,10-Methylenetetrahydrofolic acid"
+BMGC_DG03074,BMG_DG082216,"NDC:33342-154 | PubChem SID:175266045 | NDC:33342-152 | UNII:UCE6F4125H | Vardenafil | NDC:33342-151 | NDC:33342-153 | 2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one | VARDENAFIL | PubChem CID:135400189 | DrugBank ID:DB00862 | CAS RN:224785-90-4"
+BMGC_DG03075,BMG_DG082237,"NDC:63629-2111 | NDC:69315-292 | NDC:55154-5534 | DrugBank ID:DB00437 | NDC:51655-968 | NDC:55700-947 | NDC:67544-736 | NDC:0378-0137 | NDC:62135-516 | NDC:62135-517 | NDC:14445-170 | NDC:43353-501 | NDC:63629-1781 | NDC:72189-437 | NDC:50090-0044 | NDC:68788-8364 | PubChem SID:175268285 | NDC:50090-6968 | NDC:80425-0383 | NDC:67046-1431 | NDC:0603-2116 | NDC:29300-350 | NDC:66267-665 | NDC:60760-134 | NDC:16729-134 | NDC:71335-2347 | NDC:70771-1127 | CAS RN:916980-04-6 | NDC:0603-2115 | NDC:63629-2112 | CAS RN:180749-07-9 | NDC:16571-885 | NDC:71610-676 | NDC:16571-883 | NDC:51079-206 | NDC:23155-693 | NDC:71335-9634 | NDC:70934-882 | NDC:43063-976 | NDC:16714-041 | NDC:16729-135 | NDC:51655-782 | NDC:43063-935 | 1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one | NDC:63629-2113 | CAS RN:73334-58-4 | NDC:70518-1576 | NDC:71335-1656 | CAS RN:184789-03-5 | NDC:50090-7351 | NDC:72189-417 | NDC:31722-252 | NDC:68788-8713 | NDC:80425-0206 | NDC:50090-6716 | NDC:71610-253 | CAS RN:180749-06-8 | NDC:60687-677 | NDC:70518-1806 | NDC:51079-205 | NDC:31722-253 | NDC:50090-4663 | NDC:71610-197 | ALLOPURINOL | NDC:0378-0181 | NDC:70518-4062 | NDC:29300-349 | NDC:50090-7353 | NDC:50090-5168 | NDC:55154-2338 | NDC:60760-989 | NDC:68071-3672 | NDC:43063-934 | NDC:70518-3660 | NDC:70518-0451 | NDC:0904-6572 | NDC:51655-546 | NDC:71205-049 | NDC:43353-186 | NDC:71335-0112 | NDC:16714-042 | UNII:63CZ7GJN5I | NDC:51655-945 | NDC:70771-1126 | NDC:67544-313 | NDC:16714-577 | NDC:70710-1209 | NDC:71921-240 | NDC:63187-463 | NDC:50090-6715 | NDC:68788-8458 | NDC:68788-8424 | NDC:71921-242 | CAS RN:180749-08-0 | NDC:53489-157 | NDC:71335-0467 | NDC:55154-5454 | NDC:70710-1210 | CAS RN:315-30-0 | NDC:0615-8385 | NDC:71335-9641 | NDC:72162-1149 | NDC:14445-171 | NDC:71335-2332 | NDC:60760-656 | NDC:50090-4662 | NDC:51655-523 | NDC:50090-5194 | NDC:50090-6882 | NDC:67046-1274 | NDC:16571-884 | NDC:71335-2542 | CAS RN:9002-17-9 | NDC:69315-409 | NDC:71205-208 | NDC:72162-1150 | NDC:70518-3704 | NDC:67046-1424 | NDC:0591-5543 | NDC:68788-6323 | NDC:71610-194 | NDC:82638-112 | NDC:55111-729 | NDC:68788-8337 | NDC:63187-240 | Allopurinol | CAS RN:180749-09-1 | NDC:71205-377 | NDC:69315-291 | NDC:71610-064 | NDC:43063-975 | NDC:0904-7041 | NDC:0615-8517 | NDC:53489-156 | NDC:0591-5544 | NDC:16714-576 | NDC:51655-082 | NDC:70518-3999 | NDC:71610-678 | NDC:71335-9676 | NDC:71335-2416 | CAS RN:291279-53-3 | NDC:55111-730 | NDC:60760-139 | NDC:68788-7383 | NDC:67296-1897 | PubChem CID:135401907 | NDC:55154-7981 | NDC:71610-681 | NDC:23155-694 | NDC:60687-688 | NDC:68071-3605 | NDC:82638-113 | NDC:55700-935 | NDC:68788-8727"
+BMGC_DG03076,BMG_DG082240,"CAS RN:58-05-9 | CAS RN:22350-60-3 | PubChem CID:135402009 | 2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | Folinic acid"
+BMGC_DG03077,BMG_DG082242,"2-amino-6-(1,2-dihydroxypropyl)-7,8-dihydro-3H-pteridin-4-one | PubChem CID:135402011 | CAS RN:6779-87-9 | 7,8-Dihydro-L-biopterin"
+BMGC_DG03078,BMG_DG082245,"PubChem CID:135402045 | 2-amino-6-(1,2-dihydroxypropyl)-5,6,7,8-tetrahydro-3H-pteridin-4-one | Tetrahydrobiopterin | CAS RN:17528-72-2"
+BMGC_DG03079,BMG_DG082256,"CAS RN:1850358-61-0 | Azaguanine | 5-amino-2,6-dihydrotriazolo[4,5-d]pyrimidin-7-one | PubChem SID:198953976 | UNII:Q150359I72 | PubChem CID:135403646 | CAS RN:134-58-7 | 8-AZAGUANINE | DrugBank ID:DB01667"
+BMGC_DG03080,BMG_DG082257,"NDC:0054-8496 | NDC:25021-813 | NDC:69315-185 | NDC:50742-182 | CAS RN:1492-18-8 | NDC:70436-118 | NDC:0555-0485 | NDC:25021-815 | NDC:42806-359 | UNII:RPR1R4C0P4 | NDC:25021-814 | NDC:68001-416 | NDC:0143-9552 | NDC:68001-417 | NDC:69315-184 | NDC:71288-163 | NDC:71288-164 | NDC:60687-227 | PubChem CID:135403647 | NDC:63323-711 | NDC:42806-133 | LEUCOVORIN CALCIUM | calcium;(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioate | NDC:71288-160 | NDC:67457-529 | NDC:70436-117 | NDC:0054-4499 | NDC:63323-631 | NDC:71288-162 | PubChem SID:198950072 | NDC:67457-528 | NDC:50742-184 | NDC:67457-530 | NDC:70436-120 | NDC:25021-828 | NDC:69315-187 | NDC:70436-119 | NDC:0054-4496 | NDC:0054-4498 | NDC:42806-134 | CAS RN:80433-71-2 | NDC:0555-0484 | NDC:50742-183 | NDC:0054-4497 | NDC:0143-9555 | NDC:0143-9553 | NDC:0143-9554 | NDC:25021-816 | NDC:0143-9368 | NDC:50742-181 | NDC:63323-710 | NDC:69315-186 | NDC:71205-908 | NDC:71288-161 | NDC:42806-358 | NDC:68001-418 | Leucovorin Calcium | NDC:0904-6703 | NDC:70436-116"
+BMGC_DG03081,BMG_DG082258,"(2S)-2-[[4-[(2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | CAS RN:58-05-9 | UNII:Q573I9DVLP | Leucovorin | PubChem SID:175271994 | DrugBank ID:DB00650 | CAS RN:1492-18-8 | PubChem CID:135403648 | LEUCOVORIN"
+BMGC_DG03082,BMG_DG082260,"PubChem SID:474492608 | Guanylyl Imidodiphosphate | UNII:9L7GM5N7EG | PubChem CID:135403657 | CAS RN:34273-04-6 | DrugBank ID:DB02082 | [[[[(2R,3S,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]amino]phosphonic acid | 5'-GUANYLYL IMIDODIPHOSPHATE"
+BMGC_DG03083,BMG_DG082271,"PubChem SID:175268349 | CAS RN:61379-65-5 | NDC:0088-2102 | UNII:XJM390A33U | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate | PubChem CID:135403821 | RIFAPENTINE | Rifapentine | DrugBank ID:DB01201"
+BMGC_DG03084,BMG_DG082281,PubChem SID:485660962 | ACYCLOVIR TRIPHOSPHATE | UNII:C7MDQ8H7RV | CAS RN:66341-18-2 | Acyclovir triphosphate | [2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]ethoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | PubChem CID:135405018
+BMGC_DG03085,BMG_DG082346,(Z)-[(2S)-2-amino-2-carboxyethyl]-hydroxyimino-oxidoazanium | PubChem CID:135409347 | CAS RN:16931-22-9 | UNII:2CNI71214Y | DrugBank ID:DB05540 | CAS RN:5854-93-3 | PubChem SID:198956851 | ALANOSINE | Alanosine | CAS RN:5854-95-5
+BMGC_DG03086,BMG_DG082351,"PubChem CID:135409387 | 4-(1,2-oxazol-3-yl)-12-oxa-3,5,8-triazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraene | PubChem SID:440088910 | DrugBank ID:DB06504 | S-8510 FREE BASE | S-8510 free base | CAS RN:151224-83-8 | UNII:92SP8RX873"
+BMGC_DG03087,BMG_DG082354,"PubChem CID:135409400 | PubChem SID:175266749 | 6,7-dichloro-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one | CAS RN:68475-42-3 | ANAGRELIDE | DrugBank ID:DB00261 | Anagrelide | UNII:K9X45X0051"
+BMGC_DG03088,BMG_DG082355,"DrugBank ID:DB06185 | UNII:426X066ELK | PubChem CID:135409409 | 7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one | FORODESINE | PubChem SID:198952847 | CAS RN:209799-67-7 | Forodesine | CAS RN:188948-53-0"
+BMGC_DG03089,BMG_DG082360,PubChem CID:135409453 | PubChem SID:175267903 | CAS RN:1044642-88-7 | UNII:458VC51857 | CAS RN:145158-71-0 | Tegaserod | 1-[(E)-(5-methoxy-1H-indol-3-yl)methylideneamino]-2-pentylguanidine | CAS RN:189188-57-6 | DrugBank ID:DB01079 | TEGASEROD
+BMGC_DG03090,BMG_DG082371,"AZILSARTAN MEDOXOMIL | PubChem CID:135409642 | UNII:LL0G25K7I2 | DrugBank ID:DB08822 | Azilsartan medoxomil | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate | PubChem SID:175266956 | CAS RN:863031-21-4"
+BMGC_DG03091,BMG_DG082380,"UNII:01Z3256K33 | PubChem SID:198956356 | 1,5-dihydro-7-(1-piperidinyl)-imidazo(2,1-b)quinazolin-2(3H)-one | PubChem CID:135410273 | CAS RN:96086-67-8 | DN-9693 FREE BASE | 7-piperidin-1-yl-3,5-dihydro-1H-imidazo[2,1-b]quinazolin-2-one"
+BMGC_DG03092,BMG_DG082384,"UNII:04Q9AIZ7NO | NDC:83831-132 | CAS RN:1006872-74-7 | PEMETREXED | (2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid | PubChem CID:135410875 | PubChem SID:175265576 | CAS RN:137281-23-3 | Pemetrexed | DrugBank ID:DB00642 | NDC:83831-131"
+BMGC_DG03093,BMG_DG082390,6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic Acid | CAS RN:125316-60-1 | 6-[3-(1-adamantyl)-4-hydroxyphenyl]naphthalene-2-carboxylic acid | PubChem CID:135411
+BMGC_DG03094,BMG_DG082395,CAS RN:149-17-7 | N'-(4-hydroxy-3-methoxybenzylidene)isonicotinohydrazide | N-[(E)-(4-hydroxy-3-methoxyphenyl)methylideneamino]pyridine-4-carboxamide | PubChem CID:135412163
+BMGC_DG03095,BMG_DG082405,CAS RN:7683-36-5 | PubChem CID:135412781 | PubChem SID:198934913 | OBIDOXIME | DrugBank ID:DB13750 | UNII:N6KNE1QA9O | (NE)-N-[[1-[[4-[(E)-hydroxyiminomethyl]pyridin-1-ium-1-yl]methoxymethyl]pyridin-1-ium-4-yl]methylidene]hydroxylamine | Obidoxime
+BMGC_DG03096,BMG_DG082406,"UNII:66JKK43S1Z | PubChem CID:135412795 | DrugBank ID:DB14719 | BENTAZEPAM | Bentazepam | PubChem SID:198957961 | 5-phenyl-1,3,6,7,8,9-hexahydro-[1]benzothiolo[2,3-e][1,4]diazepin-2-one | CAS RN:29462-18-8"
+BMGC_DG03097,BMG_DG082410,2-amino-5-bromo-4-phenyl-1H-pyrimidin-6-one | PubChem SID:198938087 | BROPIRIMINE | Bropirimine | CAS RN:56741-95-8 | DrugBank ID:DB04168 | UNII:J57CTF25XJ | PubChem CID:135413497
+BMGC_DG03098,BMG_DG082414,Alizapride | PubChem CID:135413504 | CAS RN:59338-93-1 | DrugBank ID:DB01425 | ALIZAPRIDE | PubChem SID:198984926 | UNII:P55703ZRZY | 6-methoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-3H-benzotriazole-5-carboxamide
+BMGC_DG03099,BMG_DG082418,"UNII:1UD32YR59G | PubChem CID:135413511 | TIRAPAZAMINE | DrugBank ID:DB04858 | PubChem SID:198940743 | Tirapazamine | CAS RN:27314-97-2 | 1,4-dioxido-1,2,4-benzotriazine-1,4-diium-3-amine"
+BMGC_DG03100,BMG_DG082421,"(2S)-2-[[4-[2-[(6R)-2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]amino]pentanedioic acid | DrugBank ID:DB12769 | CAS RN:106400-81-1 | PubChem SID:198960031 | Lometrexol | PubChem CID:135413518 | UNII:6P3AVY8A7Q | LOMETREXOL"
+BMGC_DG03101,BMG_DG082422,"CAS RN:127759-89-1 | UNII:8U5PYQ1R2E | CAS RN:126062-18-8 | 2-amino-9-[(1R,2R,3S)-2,3-bis(hydroxymethyl)cyclobutyl]-1H-purin-6-one | PubChem CID:135413519 | PubChem SID:198975041 | Lobucavir | LOBUCAVIR | DrugBank ID:DB12531"
+BMGC_DG03102,BMG_DG082427,"UNII:7B646RJ70F | PubChem SID:198976166 | DrugBank ID:DB02568 | PubChem CID:135413525 | Peldesine | CAS RN:133432-71-0 | 2-amino-7-(pyridin-3-ylmethyl)-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one | PELDESINE"
+BMGC_DG03103,BMG_DG082434,PubChem CID:135413535 | DrugBank ID:DB01610 | VALGANCICLOVIR | CAS RN:175865-60-8 | PubChem SID:175271640 | NDC:70010-051 | Valganciclovir | NDC:70069-810 | [2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate | NDC:71921-210 | UNII:GCU97FKN3R
+BMGC_DG03104,BMG_DG082435,"NDC:0006-0464 | NDC:47426-201 | UNII:1NF15YR6UY | NDC:0781-2323 | NDC:0781-2321 | PubChem CID:135413536 | NDC:0006-0462 | NDC:13668-593 | Aprepitant | NDC:68462-584 | NDC:0006-3066 | PubChem SID:175268021 | NDC:47426-401 | 3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one | NDC:68462-583 | NDC:13668-592 | CAS RN:170729-80-3 | NDC:0781-2322 | DrugBank ID:DB00673 | CAS RN:321125-94-4 | NDC:0006-0461 | NDC:13668-591 | APREPITANT | NDC:68462-585"
+BMGC_DG03105,BMG_DG082437,"Fosaprepitant | PubChem CID:135413538 | CAS RN:172673-20-0 | [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4H-1,2,4-triazol-1-yl]phosphonic acid | DrugBank ID:DB06717 | PubChem SID:175267250 | FOSAPREPITANT | UNII:6L8OF9XRDC"
+BMGC_DG03106,BMG_DG082438,UNII:E5XNT3RF5A | PubChem SID:175266596 | (Z)-but-2-enedioic acid;1-[(E)-(5-methoxy-1H-indol-3-yl)methylideneamino]-2-pentylguanidine | TEGASEROD MALEATE | Tegaserod Maleate | CAS RN:189188-57-6 | PubChem CID:135413539
+BMGC_DG03107,BMG_DG082441,"CEFTOBIPROLE | DrugBank ID:DB04918 | CAS RN:209467-52-7 | PubChem SID:198959125 | Ceftobiprole | PubChem CID:135413542 | UNII:5T97333YZK | (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-pyrrolidin-3-yl]pyrrolidin-3-ylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid"
+BMGC_DG03108,BMG_DG082442,"Unii-N99027V28J | sodium;(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(E)-[1-[(3R)-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]pyrrolidin-3-yl]-2-oxopyrrolidin-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | CAS RN:252188-71-9 | UNII:N99027V28J | Ceftobiprole Medocaril Sodium | PubChem SID:198959442 | CEFTOBIPROLE MEDOCARIL SODIUM | PubChem CID:135413543"
+BMGC_DG03109,BMG_DG082443,"Ceftobiprole medocaril free acid | DrugBank ID:DB14733 | CAS RN:376653-43-9 | UNII:YXV28V1B07 | (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-hydroxyiminoacetyl]amino]-3-[(E)-[1-[(3R)-1-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methoxycarbonyl]pyrrolidin-3-yl]-2-oxopyrrolidin-3-ylidene]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem CID:135413544 | CEFTOBIPROLE MEDOCARIL FREE ACID | PubChem SID:198963134"
+BMGC_DG03110,BMG_DG082445,PubChem SID:441658721 | UNII:5WMS4GA67M | HYMENIALDISINE | PubChem CID:135413546 | CAS RN:82005-12-7
+BMGC_DG03111,BMG_DG082446,"UDENAFIL | 3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulfonamide | Udenafil | CAS RN:268203-93-6 | UNII:L5IB4XLY36 | DrugBank ID:DB06267 | PubChem SID:198985467 | PubChem CID:135413547"
+BMGC_DG03112,BMG_DG082449,"ETIFOXINE | CAS RN:21715-46-8 | UNII:X24X82MX4X | DrugBank ID:DB08986 | 6-chloro-N-ethyl-4-methyl-4-phenyl-1H-3,1-benzoxazin-2-imine | PubChem CID:135413553 | PubChem SID:198973753 | Etifoxine"
+BMGC_DG03113,BMG_DG082454,"AG-24322 | DrugBank ID:DB13035 | PubChem CID:135413565 | Ag-24322 | UNII:926F8X7TNO | N-[[5-[3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methylpyridin-3-yl]methyl]ethanamine | CAS RN:837364-57-5 | PubChem SID:198955582"
+BMGC_DG03114,BMG_DG082472,"PubChem SID:175267510 | UNII:1W306TDA6S | NDC:59762-1350 | CAS RN:72559-06-9 | PubChem CID:135415564 | NDC:70954-041 | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,32-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-1'-(2-methylpropyl)-6,23-dioxospiro[8,33-dioxa-24,27,29-triazapentacyclo[23.6.1.14,7.05,31.026,30]tritriaconta-1(31),2,4,9,19,21,25(32),26,29-nonaene-28,4'-piperidine]-13-yl] acetate | RIFABUTIN | NDC:0013-5301 | NDC:70518-4254 | NDC:10135-738 | Rifabutin"
+BMGC_DG03115,BMG_DG082480,"DrugBank ID:DB01649 | 7-Methyl-Gpppa | PubChem CID:135415790 | [[(2R,3S,4R,5R)-5-(2-amino-7-methyl-6-oxo-1H-purin-9-ium-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate"
+BMGC_DG03116,BMG_DG082482,"Azilsartan | 2-ethoxy-3-[[4-[2-(5-oxo-4H-1,2,4-oxadiazol-3-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid | PubChem SID:175265877 | UNII:F9NUX55P23 | PubChem CID:135415867 | CAS RN:147403-03-0 | AZILSARTAN"
+BMGC_DG03117,BMG_DG082483,"CAS RN:134-35-0 | 5-Methyltetrahydrofolic acid | UNII:TYK22LML8F | PubChem CID:135415868 | (2S)-2-[[4-[(2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | DrugBank ID:DB04789 | PubChem SID:175272119 | 5-METHYLTETRAHYDROFOLIC ACID"
+BMGC_DG03118,BMG_DG082485,"PubChem CID:135416229 | PubChem SID:310825690 | CAS RN:1025821-33-3 | GSK-626616 | (5Z)-2-(2,6-dichlorophenyl)imino-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolidin-4-one | 4(5H)-Thiazolone, 2-((2,6-dichlorophenyl)amino)-5-(6-quinoxalinylmethylene)-, (5Z)- | UNII:OKY0RM282V"
+BMGC_DG03119,BMG_DG082496,PubChem SID:198964832 | PubChem CID:135418296 | UNII:D1Q7F6C2FP | CAS RN:70018-51-8 | QUAZINONE
+BMGC_DG03120,BMG_DG082521,PubChem CID:135421197 | CAS RN:315183-21-2 | CAS RN:1044929-62-5 | Pac-1 | PubChem SID:198983073 | DrugBank ID:DB13048 | PAC-1 | UNII:9LIS8N0B2C | 2-(4-benzylpiperazin-1-yl)-N-[(E)-(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]acetamide
+BMGC_DG03121,BMG_DG082544,CAS RN:656247-17-5 | PubChem SID:198986794 | Nintedanib | methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate | UNII:G6HRD2P839 | CAS RN:1160294-26-7 | PubChem CID:135423438 | CAS RN:928326-83-4 | NINTEDANIB | DrugBank ID:DB09079
+BMGC_DG03122,BMG_DG082545,"PubChem CID:135423666 | CAS RN:1193-96-0 | PubChem SID:198943154 | PYRIDINE-2-ALDOXIME, (E)- | UNII:2WFO9N5MQE"
+BMGC_DG03123,BMG_DG082550,"PubChem CID:135424953 | PubChem SID:241179392 | CAS RN:914471-09-3 | UNII:2HR315841W | 4-Amino-N-(3-chloro-4-fluorophenyl)-N'-hydroxy-1,2,5-oxadiazole-3-carboximidamide | 4-amino-N'-(3-chloro-4-fluorophenyl)-N-hydroxy-1,2,5-oxadiazole-3-carboximidamide | 4-AMINO-N-(3-CHLORO-4-FLUOROPHENYL)-N'-HYDROXY-1,2,5-OXADIAZOLE-3-CARBOXIMIDAMIDE"
+BMGC_DG03124,BMG_DG082610,"PLEVITREXED | CAS RN:153537-73-6 | CAS RN:172521-94-7 | (2S)-2-[[4-[(2,7-dimethyl-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]-2-fluorobenzoyl]amino]-4-(2H-tetrazol-5-yl)butanoic acid | DrugBank ID:DB06163 | PubChem CID:135430970 | PubChem SID:198971042 | Plevitrexed | UNII:L9P2881C3H"
+BMGC_DG03125,BMG_DG082614,"Pelitrexol | CAS RN:446022-33-9 | DrugBank ID:DB12757 | PubChem CID:135431074 | UNII:DHT6E8M4KP | PubChem SID:198967241 | PELITREXOL | (2S)-2-[[5-[2-[(6S)-2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pyrido[2,3-d]pyrimidin-6-yl]ethyl]-4-methylthiophene-2-carbonyl]amino]pentanedioic acid"
+BMGC_DG03126,BMG_DG082615,"Rifalazil | CAS RN:129791-92-0 | RIFALAZIL | PubChem SID:198973936 | DrugBank ID:DB04934 | PubChem CID:135431094 | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,6,15,17-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-30-[4-(2-methylpropyl)piperazin-1-yl]-23,32,37-trioxo-8,27,38-trioxa-24,34-diazahexacyclo[23.11.1.14,7.05,36.026,35.028,33]octatriaconta-1,3,5,9,19,21,25,28,30,33,35-undecaen-13-yl] acetate | UNII:S1976TE8QK"
+BMGC_DG03127,BMG_DG082640,UNII:5ULT4V6WKY | CAS RN:1489265-31-7 | [(4-hydroxy-3-methoxyphenyl)methylideneamino]thiourea | PubChem SID:482553677 | ((4-HYDROXY-3-METHOXYPHENYL)METHYLIDENEAMINO)THIOUREA | PubChem CID:135434842
+BMGC_DG03128,BMG_DG082641,"2-[2,3-dihydroxy-4-[3-hydroxy-5-(4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl)oxy-4-methoxy-6-methyloxan-2-yl]oxy-5,5-dimethyl-6-[(1E,3E)-penta-1,3-dienyl]oxan-2-yl]-N-[(2E,4E)-7-[3,4-dihydroxy-5-[(1E,3E,5E)-7-(4-hydroxy-1-methyl-2-oxopyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]butanamide | DrugBank ID:DB11401 | PubChem CID:135434844"
+BMGC_DG03129,BMG_DG082666,"PubChem CID:135436543 | CAS RN:15302-16-6 | FENOZOLONE | PubChem SID:198969684 | UNII:1NZI4LMU6G | DrugBank ID:DB13341 | 2-ethylimino-5-phenyl-1,3-oxazolidin-4-one | Fenozolone"
+BMGC_DG03130,BMG_DG082684,"CAS RN:76849-19-9 | (2S)-2-[[4-[(2-amino-4-oxo-3H-quinazolin-6-yl)methyl-prop-2-ynylamino]benzoyl]amino]pentanedioic acid | DrugBank ID:DB03541 | 10-Propargyl-5,8-dideazafolic acid | PubChem CID:135438608"
+BMGC_DG03131,BMG_DG082698,"PubChem SID:381608352 | CAS RN:88847-89-6 | 2-amino-9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,7-dihydropurine-6,8-dione | 8-HYDROXY-2'-DEOXYGUANOSINE | PubChem CID:135440064 | 8-Hydroxy-2'-deoxyguanosine | DrugBank ID:DB02502 | UNII:4RGB38T3IB"
+BMGC_DG03132,BMG_DG082736,"PubChem CID:135442972 | 4-methylbenzenesulfonate;5,10,15,20-tetrakis(1-methylpyridin-1-ium-4-yl)-21,23-dihydroporphyrin | Tmpyp"
+BMGC_DG03133,BMG_DG082748,"PubChem CID:135444742 | CAS RN:135-16-0 | PubChem SID:241181388 | UNII:43ZWB253H4 | TETRAHYDROFOLIC ACID | DrugBank ID:DB00116 | (2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | Tetrahydrofolic acid"
+BMGC_DG03134,BMG_DG082751,"CAS RN:5334-23-6 | UNII:79F9I2R16M | PubChem SID:198956388 | DrugBank ID:DB13807 | TISOPURINE | Tisopurine | PubChem CID:135445058 | 1,7-dihydropyrazolo[3,4-d]pyrimidine-4-thione"
+BMGC_DG03135,BMG_DG082762,"7-Methylguanosine | 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-methyl-1H-purin-9-ium-6-one | DrugBank ID:DB03493 | PubChem CID:135445750 | CAS RN:20244-86-4"
+BMGC_DG03136,BMG_DG082805,N-benzyl-4-[4-(3-chlorophenyl)-1H-pyrazol-5-yl]-1H-pyrrole-2-carboxamide | PubChem CID:135449325 | DrugBank ID:DB07010 | N-Benzyl-4-(4-(3-chlorophenyl)-1H-pyrazol-3-yl)-1H-pyrrole-2-carboxamide
+BMGC_DG03137,BMG_DG082807,DrugBank ID:DB11409 | FEBANTEL | UNII:S75C401OS1 | methyl N-[N'-[2-[(2-methoxyacetyl)amino]-4-phenylsulfanylphenyl]-N-methoxycarbonylcarbamimidoyl]carbamate | CAS RN:58306-30-2 | PubChem SID:175265592 | Febantel | PubChem CID:135449328
+BMGC_DG03138,BMG_DG082810,"PubChem CID:135449332 | ELTROMBOPAG | CAS RN:496775-61-2 | CAS RN:1807882-48-9 | Eltrombopag | CAS RN:376591-99-0 | 3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid | UNII:S56D65XJ9G | PubChem SID:175266113 | DrugBank ID:DB06210"
+BMGC_DG03139,BMG_DG082811,"2-methyl-2-[4-[3-[1-[(4-methylphenyl)methyl]-5-oxo-4H-1,2,4-triazol-3-yl]propyl]phenoxy]propanoic acid | CAS RN:425671-29-0 | PubChem SID:241177571 | LY-518674 | DrugBank ID:DB12988 | Ly-518674 | UNII:U8I57RC739 | PubChem CID:135449333"
+BMGC_DG03140,BMG_DG082821,"DrugBank ID:DB12353 | PubChem CID:135449518 | PubChem SID:198987557 | 7-[[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one | ULODESINE | Ulodesine | CAS RN:548486-59-5 | UNII:JNG8L9460Y"
+BMGC_DG03141,BMG_DG082828,"PubChem CID:135450591 | CAS RN:2800-34-2 | 10-FORMYLTETRAHYDROFOLIC ACID | (2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methyl-formylamino]benzoyl]amino]pentanedioic acid | 10-Formyltetrahydropteroylglutamic acid | 10-Formyltetrahydrofolic acid | PubChem SID:474492509 | UNII:43SUG29HQR"
+BMGC_DG03142,BMG_DG082876,"CAS RN:130581-13-4 | 4-[(E,3Z)-3-[2-(dimethylamino)ethoxyimino]-3-(2-fluorophenyl)prop-1-enyl]phenol | UNII:3CO94WO6DJ | PubChem CID:135456190 | CAS RN:130579-75-8 | Eplivanserin | DrugBank ID:DB12177 | EPLIVANSERIN | PubChem SID:198938514"
+BMGC_DG03143,BMG_DG082897,"CAS RN:12237-07-9 | CAS RN:12222-09-2 | [(2R,3R,4R,5R)-2-(2-amino-6-oxo-1H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate | CAS RN:12238-07-2 | DrugBank ID:DB01937 | CAS RN:12222-03-6 | CAS RN:130-50-7 | PubChem CID:135460966 | CAS RN:12237-24-0 | CAS RN:12223-03-9 | CAS RN:12238-01-6 | CAS RN:12237-00-2 | Guanosine-2'-monophosphate | CAS RN:12237-02-4"
+BMGC_DG03144,BMG_DG082914,"PubChem SID:198948509 | PubChem CID:135463437 | FOSDENOPTERIN | CAS RN:150829-29-1 | (1R,10R,12S,17R)-5-amino-11,11,14-trihydroxy-14-oxo-13,15,18-trioxa-2,4,6,9-tetraza-14lambda5-phosphatetracyclo[8.8.0.03,8.012,17]octadeca-3(8),4-dien-7-one | Fosdenopterin | UNII:4X7K2681Y7"
+BMGC_DG03145,BMG_DG083031,"UNII:WS1IH75AJT | CAS RN:188913-58-8 | PubChem SID:198987519 | PubChem CID:135484128 | DrugBank ID:DB06251 | 2-hydroxy-5-[[4-[(Z)-3-[4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]piperidin-1-yl]-3-oxo-1-phenylprop-1-enyl]phenyl]diazenyl]benzoic acid | DERSALAZINE | Dersalazine"
+BMGC_DG03146,BMG_DG083042,"UNII:VR9EYV4XBE | CAS RN:58-05-9 | PubChem CID:135484651 | DrugBank ID:DB03256 | (2S)-2-[[4-[[(6R)-2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid | Folinic acid, (6R)- | PubChem SID:496143267 | FOLINIC ACID, (6R)- | 6R-Leucovorin | CAS RN:73951-54-9"
+BMGC_DG03147,BMG_DG083051,"PubChem SID:404859297 | N-(4-{[(6s)-2-(Hydroxymethyl)-4-Oxo-4,6,7,8-Tetrahydro-1h-Cyclopenta[g]quinazolin-6-Yl](Prop-2-Yn-1-Yl)amino}benzoyl)-L-Gamma-Glutamyl-D-Glutamic Acid | IDETREXED | UNII:Q718FS1C7X | CAS RN:501332-69-0 | PubChem CID:135487419 | (2R)-2-[[(4S)-4-carboxy-4-[[4-[[(6S)-2-(hydroxymethyl)-4-oxo-3,6,7,8-tetrahydrocyclopenta[g]quinazolin-6-yl]-prop-2-ynylamino]benzoyl]amino]butanoyl]amino]pentanedioic acid"
+BMGC_DG03148,BMG_DG083095,Alizapride hydrochloride | 6-methoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-3H-benzotriazole-5-carboxamide;hydrochloride | CAS RN:59338-87-3 | PubChem CID:135497066
+BMGC_DG03149,BMG_DG083099,"DrugBank ID:DB11792 | UNII:504G362H0H | 5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3H-pyrrolo[3,2-d]pyrimidin-4-one | PubChem SID:198957517 | MIRODENAFIL | Mirodenafil | CAS RN:862189-95-5 | PubChem CID:135497803"
+BMGC_DG03150,BMG_DG083103,"CAS RN:38819-10-2 | PubChem CID:135499520 | ARAGUANOSINE | UNII:0Z99WX0GPF | PubChem SID:384648152 | 2-amino-9-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one | 9-beta-d-Arabinofuranosylguanine"
+BMGC_DG03151,BMG_DG083111,DrugBank ID:DB12110 | CAS RN:6640-24-0 | PubChem CID:1355 | 1-(3-Chlorophenyl)piperazine | 1-(3-chlorophenyl)piperazine | PubChem SID:198936570 | M-CHLOROPHENYLPIPERAZINE | UNII:REY0CNO998 | m-Chlorophenylpiperazine
+BMGC_DG03152,BMG_DG083150,"Aurodox | PubChem SID:198985241 | CAS RN:12704-90-4 | (2S)-N-[(2E,4E,6S,7R)-7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-[(1E,3E,5E)-7-(4-hydroxy-1-methyl-2-oxopyridin-3-yl)-6-methyl-7-oxohepta-1,3,5-trienyl]oxolan-2-yl]-6-methoxy-5-methylocta-2,4-dienyl]-2-[(2R,3R,4R,6S)-2,3,4-trihydroxy-5,5-dimethyl-6-[(1E,3Z)-penta-1,3-dienyl]oxan-2-yl]butanamide | AURODOX | PubChem CID:135509117 | UNII:PGP5RZH64G | DrugBank ID:DB04124"
+BMGC_DG03153,BMG_DG083184,UNII:83U8LY5WB8 | PubChem CID:135516730 | Ro-15-2041 | RO-15-2041 | CAS RN:77448-87-4 | PubChem SID:485664307
+BMGC_DG03154,BMG_DG083191,"8-Aminoguanosine | PubChem SID:433968802 | CAS RN:3868-32-4 | 8-AMINOGUANOSINE | UNII:SHO2CA1BRO | CAS RN:180288-69-1 | 2,8-diamino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one | PubChem CID:135518164"
+BMGC_DG03155,BMG_DG083260,"GISADENAFIL | 5-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylpyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-6H-pyrazolo[4,3-d]pyrimidin-7-one | CAS RN:334826-98-1 | UNII:S6G4R7DI1C | PubChem CID:135536943 | DrugBank ID:DB11902 | Gisadenafil | PubChem SID:198945523"
+BMGC_DG03156,BMG_DG083279,"PubChem SID:198974570 | PubChem CID:135539077 | LUMINESPIB | 5-(2,4-dihydroxy-5-propan-2-ylphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide | Luminespib | UNII:C6V1DAR5EB | CAS RN:747412-49-3"
+BMGC_DG03157,BMG_DG083301,PubChem CID:135544014 | VALOMACICLOVIR | DrugBank ID:DB06575 | UNII:F094Y61748 | CAS RN:195157-34-7 | PubChem SID:198952264 | [(3R)-3-[(2-amino-6-oxo-1H-purin-9-yl)methyl]-4-hydroxybutyl] (2S)-2-amino-3-methylbutanoate | Valomaciclovir
+BMGC_DG03158,BMG_DG083323,DrugBank ID:DB03256 | PubChem CID:135548 | (6R)-Folinic acid
+BMGC_DG03159,BMG_DG083402,PubChem CID:135564529 | PubChem SID:249492882 | UNII:552Y49K43E | 2'3'-CYCLIC GUANOSINE MONOPHOSPHATE-ADENOSINE MONOPHOSPHATE | CAS RN:1441190-66-4
+BMGC_DG03160,BMG_DG083404,"SIMUROSERTIB | 2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1H-pyrazol-4-yl)-3H-thieno[3,2-d]pyrimidin-4-one | CAS RN:1330782-76-7 | Simurosertib | PubChem CID:135564531 | UNII:LST350G3XU | PubChem SID:346537494"
+BMGC_DG03161,BMG_DG083412,"EDELINONTRINE | 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(oxan-4-yl)-5H-pyrazolo[3,4-d]pyrimidin-4-one | Edelinontrine | CAS RN:1082744-20-4 | PubChem SID:198979098 | PubChem CID:135564558 | UNII:7N969W8Y4O | DrugBank ID:DB11953 | 6-((3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one"
+BMGC_DG03162,BMG_DG083420,CAS RN:612487-72-6 | PubChem SID:377307812 | PubChem CID:135564570 | AZD-1080 | UNII:0TII45R8IJ
+BMGC_DG03163,BMG_DG083446,"PubChem CID:135564632 | CAS RN:1169562-71-3 | BMS-863233 | DrugBank ID:DB12357 | UNII:8QK62S7492 | 8-chloro-2-[(2S)-pyrrolidin-2-yl]-3H-[1]benzofuro[3,2-d]pyrimidin-4-one | CAS RN:1169558-38-6 | PubChem SID:198952036 | Bms-863233"
+BMGC_DG03164,BMG_DG083454,"Guadecitabine | GUADECITABINE | DrugBank ID:DB11918 | UNII:2KT4YN1DP7 | PubChem CID:135564655 | CAS RN:929901-49-5 | PubChem SID:198963631 | [(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl [(2R,3S,5R)-5-(4-amino-2-oxo-1,3,5-triazin-1-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate"
+BMGC_DG03165,BMG_DG083490,"PubChem CID:135564749 | APABETALONE | Apabetalone | 2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-3H-quinazolin-4-one | DrugBank ID:DB12000 | CAS RN:1044870-39-4 | UNII:8R4A7GDZ1D | PubChem SID:198972554"
+BMGC_DG03166,BMG_DG083525,"1-(4-(1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime | (1R,2S,3R)-1-[2-[(E)-N-hydroxy-C-methylcarbonimidoyl]-1H-imidazol-5-yl]butane-1,2,3,4-tetrol | PubChem CID:135564845 | DrugBank ID:DB06297 | CAS RN:948840-25-3 | PubChem SID:317229051 | UNII:C5AGI979T7 | LX-2931"
+BMGC_DG03167,BMG_DG083546,"Epacadostat | PubChem CID:135564890 | PubChem SID:252164121 | CAS RN:1204669-37-3 | CAS RN:1771804-57-9 | UNII:71596A9R13 | CAS RN:1204669-58-8 | EPACADOSTAT | DrugBank ID:DB11717 | N'-(3-bromo-4-fluorophenyl)-N-hydroxy-4-[2-(sulfamoylamino)ethylamino]-1,2,5-oxadiazole-3-carboximidamide"
+BMGC_DG03168,BMG_DG083569,"PubChem SID:198934914 | CAS RN:583037-91-6 | (2S)-5-amino-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]-[2-[(3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-yl)carbamothioylamino]ethyl]amino]-5-oxopentanoic acid | DrugBank ID:DB12559 | UNII:V7YQ6134AE | EC-17 | Ec-17 | PubChem CID:135564966"
+BMGC_DG03169,BMG_DG083578,"UNII:2E8412Y946 | GANETESPIB | Ganetespib | DrugBank ID:DB12047 | CAS RN:888216-25-9 | CAS RN:1143571-94-1 | 3-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-(1-methylindol-5-yl)-1H-1,2,4-triazol-5-one | PubChem CID:135564985 | PubChem SID:175267656"
+BMGC_DG03170,BMG_DG083583,XENOCLAUXIN | PubChem SID:313389964 | UNII:8P2YHR7U28 | PubChem CID:135564990 | CAS RN:7599-61-3
+BMGC_DG03171,BMG_DG083586,PubChem CID:135564996 | AMELUBANT | CAS RN:346735-24-8 | UNII:E0018IF0K4 | DrugBank ID:DB06248 | ethyl N-[4-[[3-[[4-[2-(4-hydroxyphenyl)propan-2-yl]phenoxy]methyl]phenyl]methoxy]benzenecarboximidoyl]carbamate | PubChem SID:198951976 | Amelubant
+BMGC_DG03172,BMG_DG083600,N-[(E)-1-(5-chloro-2-hydroxyphenyl)ethylideneamino]-3-(4-methylpiperazin-1-yl)sulfonylbenzamide | SECLIDEMSTAT | CAS RN:1423715-37-0 | PubChem CID:135565033 | Seclidemstat | PubChem SID:346540432 | UNII:TYH386V3WJ
+BMGC_DG03173,BMG_DG083606,"PubChem CID:135565042 | DrugBank ID:DB14918 | BRANAPLAM | PubChem SID:316918166 | Branaplam | UNII:P12R69543A | CAS RN:1562338-42-4 | 5-(1H-pyrazol-4-yl)-2-[6-(2,2,6,6-tetramethylpiperidin-4-yl)oxypyridazin-3-yl]phenol"
+BMGC_DG03174,BMG_DG083623,"TALAZOPARIB | PubChem CID:135565082 | (11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(2-methyl-1,2,4-triazol-3-yl)-2,3,10-triazatricyclo[7.3.1.05,13]trideca-1,5(13),6,8-tetraen-4-one | DrugBank ID:DB11760 | Talazoparib | CAS RN:1207456-01-6 | UNII:9QHX048FRV | PubChem SID:198987937"
+BMGC_DG03175,BMG_DG083654,"Iowh-032 | UNII:8Y3GDT6YWV | DrugBank ID:DB12959 | 3-(3,5-dibromo-4-hydroxyphenyl)-N-[(4-phenoxyphenyl)methyl]-1,2,4-oxadiazole-5-carboxamide | IOWH-032 | PubChem SID:198974208 | PubChem CID:135565181 | CAS RN:1191252-49-9"
+BMGC_DG03176,BMG_DG083678,"Homosildenafil | PubChem SID:198940238 | PubChem CID:135565273 | UNII:0Z3JH0S0QK | 5-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one | CAS RN:1216711-61-3 | HOMOSILDENAFIL | CAS RN:642928-07-2"
+BMGC_DG03177,BMG_DG083693,"DrugBank ID:DB08993 | CAS RN:33103-22-9 | PubChem CID:135565326 | UNII:XU299C23A2 | PubChem SID:198944827 | (3R,4R)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R)-2-amino-1,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]-4-hydroxyhexanamide | ENVIOMYCIN | Enviomycin"
+BMGC_DG03178,BMG_DG083702,"PubChem CID:135565361 | DrugBank ID:DB12963 | CCX-354 | UNII:22PQS5K5TY | 1-[4-(4-chloro-3-methoxyphenyl)piperazin-1-yl]-2-[3-(1H-imidazol-2-yl)pyrazolo[3,4-b]pyridin-1-yl]ethanone | PubChem SID:313183491 | CAS RN:1010073-75-2 | Ccx-354"
+BMGC_DG03179,BMG_DG083743,"ethyl (5R,26S)-5,11,16,21-tetraethyl-12,17,22,26-tetramethyl-7,25-diaza-23,24-diazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1(22),2(6),3,7,9,11,13(25),14,16,18,20-undecaene-4-carboxylate;tin(4+);chloride | DrugBank ID:DB06659 | PubChem CID:135565472 | Tin ethyl etiopurpurin"
+BMGC_DG03180,BMG_DG083765,"CAS RN:1071848-28-6 | PubChem CID:135565545 | UNII:XO23PGZ0SM | PubChem SID:198964618 | PF-477736 | CAS RN:952021-60-2 | (2R)-2-amino-2-cyclohexyl-N-[2-(1-methylpyrazol-4-yl)-9-oxo-3,10,11-triazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaen-6-yl]acetamide | DrugBank ID:DB12611"
+BMGC_DG03181,BMG_DG083782,"UNII:WI6V529FZ9 | DrugBank ID:DB12483 | COPANLISIB | PubChem SID:198981113 | PubChem CID:135565596 | Copanlisib | 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide | CAS RN:1032568-63-0"
+BMGC_DG03182,BMG_DG083792,"PAFOLACIANINE | PubChem SID:241179548 | PubChem CID:135565623 | 2-[(E)-2-[(3E)-2-[4-[(2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-2-carboxyethyl]phenoxy]-3-[(2E)-2-[3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)indol-2-ylidene]ethylidene]cyclohexen-1-yl]ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)indol-1-ium-5-sulfonate | CAS RN:1628423-76-6 | UNII:F7BD3Z4X8L | Pafolacianine | DrugBank ID:DB15413"
+BMGC_DG03183,BMG_DG083800,"TALAZOPARIB TOSYLATE | NDC:0069-1501 | NDC:0069-1235 | NDC:0069-0546 | NDC:0069-0353 | NDC:0069-1751 | NDC:0069-0252 | (11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(2-methyl-1,2,4-triazol-3-yl)-2,3,10-triazatricyclo[7.3.1.05,13]trideca-1,5(13),6,8-tetraen-4-one;4-methylbenzenesulfonic acid | NDC:0069-1031 | CAS RN:1373431-65-2 | NDC:0069-0757 | NDC:63539-051 | NDC:0069-0655 | PubChem CID:135565654 | UNII:02WK9U5NZC | NDC:63539-295 | NDC:0069-0454 | Talazoparib Tosylate | NDC:0069-1195 | NDC:0069-0296 | PubChem SID:198988017"
+BMGC_DG03184,BMG_DG083810,"CAS RN:945635-15-4 | PubChem CID:135565672 | (4S)-2-[2-hydroxy-3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]phenyl]-4-methyl-5H-1,3-thiazole-4-carboxylic acid | PubChem SID:198938381 | Deferitazole | DrugBank ID:DB13120 | DEFERITAZOLE | UNII:4D8DC53Y1L"
+BMGC_DG03185,BMG_DG083812,DrugBank ID:DB06695 | CAS RN:1019206-66-6 | CAS RN:1610666-09-5 | CAS RN:211915-06-9 | DABIGATRAN ETEXILATE | PubChem SID:175266836 | PubChem CID:135565674 | UNII:2E18WX195X | Dabigatran Etexilate | ethyl 3-[[2-[[4-(N-hexoxycarbonylcarbamimidoyl)anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate
+BMGC_DG03186,BMG_DG083827,"PubChem CID:135565709 | DrugBank ID:DB14883 | CAS RN:1467093-03-3 | Adavivint | N-[5-[3-[7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl]-1H-indazol-5-yl]pyridin-3-yl]-3-methylbutanamide | UNII:42EK42WHI5 | LORECIVIVINT | PubChem SID:346540485"
+BMGC_DG03187,BMG_DG083880,"DrugBank ID:DB15035 | UNII:AG9MHG098Z | PubChem SID:346540833 | CAS RN:1691249-45-2 | CAS RN:1651179-04-2 | ZANUBRUTINIB | Zanubrutinib | (7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide | PubChem CID:135565884"
+BMGC_DG03188,BMG_DG083884,"UNII:Y5929UIJ5N | OPICAPONE | NDC:64896-402 | 5-[3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-1,2,4-oxadiazol-5-yl]-3-nitrobenzene-1,2-diol | PubChem CID:135565903 | Opicapone | NDC:64896-403 | CAS RN:923287-50-7 | PubChem SID:198969827 | DrugBank ID:DB11632"
+BMGC_DG03189,BMG_DG083888,"PubChem CID:135565923 | UNII:08O3FQ4UNP | Repotrectinib | (3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one | NDC:0003-4040 | CAS RN:1802220-02-5 | NDC:0003-4160 | REPOTRECTINIB | PubChem SID:346540938"
+BMGC_DG03190,BMG_DG083893,"PubChem SID:198972252 | Setrobuvir | PubChem CID:135565932 | DrugBank ID:DB12051 | SETROBUVIR | CAS RN:1071517-39-9 | N-[3-[(1R,2S,7R,8S)-3-[(4-fluorophenyl)methyl]-6-hydroxy-4-oxo-3-azatricyclo[6.2.1.02,7]undec-5-en-5-yl]-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazin-7-yl]methanesulfonamide | UNII:T5B2GI8F84"
+BMGC_DG03191,BMG_DG083905,"CAS RN:1118915-78-8 | UNII:E1942E7K32 | CAS RN:83712-60-1 | [5-hydroxy-4-[4-(1-methylindol-5-yl)-5-oxo-1H-1,2,4-triazol-3-yl]-2-propan-2-ylphenyl] dihydrogen phosphate | PubChem SID:198990585 | STA-1474 | Sta-1474 | PubChem CID:135565962 | CAS RN:1201923-87-6"
+BMGC_DG03192,BMG_DG083972,PubChem CID:135567293 | PubChem SID:472424581 | UNII:ETX6QAL2UR | CAS RN:319461-60-4 | PF-1367550
+BMGC_DG03193,BMG_DG083997,"ULIPRISTAL | (8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | CAS RN:159811-51-5 | DrugBank ID:DB08867 | UNII:6J5J15Q2X8 | PubChem CID:13559281 | PubChem SID:175266288 | Ulipristal"
+BMGC_DG03194,BMG_DG084065,DrugBank ID:DB12931 | Fenobam | PubChem CID:135659063 | CAS RN:57653-26-6 | (3Z)-1-(3-chlorophenyl)-3-(1-methyl-4-oxoimidazolidin-2-ylidene)urea
+BMGC_DG03195,BMG_DG084070,PubChem CID:135665340 | PubChem SID:402404545 | 4'-O-DEMETHYL ISTRADEFYLLINE | CAS RN:160434-48-0 | UNII:I2P9NA76OG
+BMGC_DG03196,BMG_DG084099,PubChem CID:13569172 | UNII:NG9HS65MAS | PubChem SID:478838437 | 1-(2-Phenoxyethyl)imidazole | CAS RN:30170-83-3 | 1-(2-PHENOXYETHYL)IMIDAZOLE
+BMGC_DG03197,BMG_DG084100,UNII:X4KD3DE9YZ | PubChem CID:13569177 | CAS RN:75912-57-1 | PubChem SID:445500205 | 4-(2-(1H-IMIDAZOL-1-YL)ETHOXY)BENZAMIDE
+BMGC_DG03198,BMG_DG084134,"2-(2,5-dimethoxy-4-methylphenyl)ethanamine | PubChem SID:198963578 | 2,5-Dimethoxy-4-methylphenethylamine | PubChem CID:135740 | UNII:7J43GY6ONS | 2C-D | CAS RN:24333-19-5"
+BMGC_DG03199,BMG_DG084165,"CAS RN:86471-16-1 | PubChem SID:478836827 | PubChem CID:135754 | UNII:RZ9P7E65QA | 5',6',7',8'-TETRAHYDRO-5',5',8',8'-TETRAMETHYL(2,2'-BINAPHTHALENE)-6-CARBOXYLIC ACID | 5′,6′,7′,8′-Tetrahydro-5′,5′,8′,8′-tetramethyl[2,2′-binaphthalene]-6-carboxylic acid"
+BMGC_DG03200,BMG_DG084240,PubChem CID:13583 | UNII:YWY9OD6A2K | CAS RN:124-22-1 | Dodecylamine | DODECYLAMINE | PubChem SID:198937342 | dodecan-1-amine
+BMGC_DG03201,BMG_DG084367,"PubChem SID:404859857 | PubChem CID:135908617 | CAS RN:1189767-28-9 | 1-(oxan-4-yl)-6-(pyridin-2-ylmethyl)-5H-pyrazolo[3,4-d]pyrimidin-4-one | Osoresnontrine | UNII:O9OC34WOAY | OSORESNONTRINE"
+BMGC_DG03202,BMG_DG084499,GUANOSINE-5'-DIPHOSPHATE | CAS RN:146-91-8 | UNII:HLJ737P865 | PubChem SID:472424205 | PubChem CID:136026707
+BMGC_DG03203,BMG_DG084506,"(5aR,8R,9aR)-2-amino-4-oxo-8-(phosphonooxymethyl)-3,5,5a,8,9a,10-hexahydropyrano[3,2-g]pteridine-6,7-dithiolate;dioxomolybdenum(2+) | PubChem CID:136033744 | PubChem SID:363908517 | CAS RN:872689-63-9 | CAS RN:73508-07-3 | UNII:EPP8L4V5E3 | Molybdenum cofactor | MOLYBDOPTERIN"
+BMGC_DG03204,BMG_DG084529,"LORGLUMIDE, (R)- | CAS RN:118919-27-0 | UNII:IF62287E88 | PubChem SID:472407879 | PubChem CID:13605417"
+BMGC_DG03205,BMG_DG084584,CAS RN:932-52-5 | PubChem CID:13611 | UNII:R2O7EKY9G9 | 5-Aminouracil | PubChem SID:198947705 | 5-AMINOURACIL | DrugBank ID:DB03792
+BMGC_DG03206,BMG_DG084587,"PubChem CID:136117105 | N-(4-{[(2-Amino-4-oxo-3,4-dihydroquinazolin-6-YL)amino]sulfonyl}benzoyl)glutamic acid | (2S)-2-[[4-[(2-amino-4-oxo-3H-quinazolin-6-yl)sulfamoyl]benzoyl]amino]pentanedioic acid"
+BMGC_DG03207,BMG_DG084595,"5-Formlyl-5,6,7,8-tetrahydrofolic acid,calcium salt | CAS RN:58-05-9 | (2R)-2-[[4-[[(6R)-2-amino-5-formyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]pentanedioic acid | PubChem CID:136123990"
+BMGC_DG03208,BMG_DG084686,CID 136234041 | CAS RN:134-35-0 | PubChem CID:136234041
+BMGC_DG03209,BMG_DG084701,1H-benzimidazol-2-amine | PubChem CID:13624 | 2-AMINOBENZIMIDAZOLE | 2-Aminobenzimidazole | CAS RN:162938-41-2 | PubChem SID:198940398 | CAS RN:934-32-7 | UNII:E65DE7521V
+BMGC_DG03210,BMG_DG084720,"PubChem SID:198991176 | Benzothiazolone | BENZOTHIAZOLONE | CAS RN:934-34-9 | UNII:7T26K7NG46 | CAS RN:74343-69-4 | PubChem CID:13625 | 3H-1,3-benzothiazol-2-one"
+BMGC_DG03211,BMG_DG084772,"PubChem CID:136297 | CAS RN:1156-92-9 | DrugBank ID:DB01526 | UNII:G10EHA9I0D | 4-Androstenediol | PubChem SID:198951169 | (3S,8R,9S,10R,13S,14S,17S)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol | 4-ANDROSTENEDIOL"
+BMGC_DG03212,BMG_DG084832,"2-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-6-(4-methylpiperazin-1-yl)-1H-benzimidazole | CAS RN:1627826-19-0 | PubChem CID:136387462 | CID 136387462"
+BMGC_DG03213,BMG_DG084833,METHYL TRITYL ETHER | UNII:IUO13CXB2Q | PubChem SID:377308766 | PubChem CID:136388 | CAS RN:596-31-6
+BMGC_DG03214,BMG_DG084846,"PubChem CID:136419 | CAS RN:1157-39-7 | UNII:F5547DW3CO | 4',7-DIMETHOXYISOFLAVONE | PubChem SID:198944379"
+BMGC_DG03215,BMG_DG084879,"PubChem CID:13647412 | 3-[4,5-Dihydroxy-6-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one | 3-[4,5-dihydroxy-6-(hydroxymethyl)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one"
+BMGC_DG03216,BMG_DG084891,UNII:RQX0CMD9PN | PubChem SID:198940619 | CAS RN:43070-85-5 | PubChem CID:13650 | CAS RN:939-19-5 | 3-hydroxychromen-2-one | 3-HYDROXYCOUMARIN | 3-Hydroxycoumarin
+BMGC_DG03217,BMG_DG084905,2-Ethylnaphthalene | CAS RN:939-27-5 | PubChem SID:474490079 | PubChem CID:13652 | UNII:QR6992R4PR | 2-ETHYLNAPHTHALENE
+BMGC_DG03218,BMG_DG084925,PubChem CID:13655 | 3-NITRO-4-CHLOROBENZONITRILE | CAS RN:939-80-0 | UNII:LN9NCA5P2M | 3-Nitro-4-chlorobenzonitrile | PubChem SID:496141495
+BMGC_DG03219,BMG_DG084946,"CAS RN:1402057-88-8 | PubChem CID:136618371 | PubChem SID:478838278 | ethyl 4-hydroxy-5-[(Z)-pyrrolo[2,3-b]pyridin-3-ylidenemethyl]-2-[[4-(2,2,2-trifluoroethyl)piperazin-1-yl]amino]furan-3-carboxylate | MONZOSERTIB | UNII:HOY1L711NL | Monzosertib"
+BMGC_DG03220,BMG_DG084948,CAS RN:941-69-5 | UNII:9U9KT462VW | PubChem CID:13662 | PubChem SID:198962367 | N-PHENYLMALEIMIDE
+BMGC_DG03221,BMG_DG084991,PubChem SID:363909234 | 1-AMINOBENZOTRIAZOLE | UNII:9EFF75BJ1O | PubChem CID:1367 | CAS RN:1614-12-6
+BMGC_DG03222,BMG_DG084999,"N6,N6-DIPROPYL-4,5,6,7-TETRAHYDRO-1,3-BENZOTHIAZOLE-2,6-DIAMINE | UNII:4G9YDM8VMF | CAS RN:104617-76-7 | PubChem CID:13670706 | N<SUP>6</SUP>,N<SUP>6</SUP>-dipropyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine | PubChem SID:485664527"
+BMGC_DG03223,BMG_DG085010,"PubChem CID:136734737 | 6-Hydroxy-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4(9),5,7,15,17,19-octaen-14-one | 6-hydroxy-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4(9),5,7,15,17,19-octaen-14-one"
+BMGC_DG03224,BMG_DG085070,UNII:1EST92W9M2 | 2-BUTYNAL | CAS RN:1119-19-3 | PubChem CID:136875 | PubChem SID:198958482
+BMGC_DG03225,BMG_DG085076,"PubChem SID:329904278 | UNII:K9H9854X63 | FADROZOLE, (S)- | PubChem CID:13688212 | CAS RN:102676-86-8"
+BMGC_DG03226,BMG_DG085082,1-ANILINO-8-NAPHTHALENESULFONIC ACID | CAS RN:82-76-8 | UNII:630I4V6051 | PubChem CID:1369 | 8-anilinonaphthalene-1-sulfonic acid | PubChem SID:198977184 | DrugBank ID:DB04474
+BMGC_DG03227,BMG_DG085130,"US10093650, Example 14 | BMS-986172 | PubChem SID:485663903 | (2S)-4-[1-(cyclopropylmethyl)pyrazol-3-yl]-2-[2-fluoro-4-(4,4,4-trifluorobutoxy)phenyl]-5-(5-oxo-1H-tetrazol-4-yl)-2-(trifluoromethyl)-1,3-dihydropyridin-6-one | UNII:E9L8QD5F8B | PubChem CID:136970071 | CAS RN:1808258-99-2"
+BMGC_DG03228,BMG_DG085137,5-amino-4-oxopentanoic acid | PubChem SID:175267603 | DrugBank ID:DB00855 | PubChem CID:137 | CAS RN:106-60-5 | AMINOLEVULINIC ACID | UNII:88755TAZ87 | Aminolevulinic acid | Aminolevulinic Acid
+BMGC_DG03229,BMG_DG085163,2-(2-NAPHTHAMIDO)BENZOIC ACID | PubChem SID:459276104 | CAS RN:106696-36-0 | PubChem CID:13707619 | UNII:28Q2KP79SJ
+BMGC_DG03230,BMG_DG085166,PubChem SID:198976643 | UNII:UE1A2XL95H | METHYL PARAOXON | CAS RN:950-35-6 | PubChem CID:13708
+BMGC_DG03231,BMG_DG085186,"Bms-986224 | PubChem CID:137106310 | 3-[5-[(5-chloropyridin-2-yl)methyl]-1,3,4-oxadiazol-2-yl]-5-(2,6-dimethoxyphenyl)-6-(ethoxymethyl)-4-hydroxy-1H-pyridin-2-one | UNII:N5O33BF03F | CAS RN:2055200-88-7 | PubChem SID:459276161 | BMS-986224"
+BMGC_DG03232,BMG_DG085194,"CAS RN:951-77-9 | PubChem CID:13711 | UNII:0W860991D6 | DOXECITINE | PubChem SID:198985801 | CAS RN:207121-53-7 | 2'-Deoxycytidine | Doxecitine | DrugBank ID:DB02594 | CAS RN:56905-41-0 | 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one"
+BMGC_DG03233,BMG_DG085197,"1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione | DrugBank ID:DB02256 | 2'-Deoxyuridine | CAS RN:951-78-0 | UNII:W78I7AY22C | PubChem SID:198966590 | Deoxyuridine | DEOXYURIDINE | PubChem CID:13712"
+BMGC_DG03234,BMG_DG085211,"UNII:Z6BYC0F36E | CAS RN:1983983-41-0 | PubChem CID:137150099 | Avotaciclib | PubChem SID:433968939 | AVOTACICLIB | 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol"
+BMGC_DG03235,BMG_DG085250,2-(aminomethyl)-N-ethyl-1-phenylcyclopropane-1-carboxamide | PubChem CID:13718739
+BMGC_DG03236,BMG_DG085259,1-BENZYL-5-METHOXY-2-METHYL-3-INDOLEACETIC ACID | DrugBank ID:DB03121 | (1-Benzyl-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid | 1-Benzyl-5-methoxy-2-methyl-3-indoleacetic acid | PubChem CID:1372 | PubChem SID:485661501 | CAS RN:59283-35-1 | UNII:5JSR5TT2JJ
+BMGC_DG03237,BMG_DG085287,"1,3-DIHYDROBENZO(F)BENZIMIDAZOL-2-ONE | UNII:3D7R7T2SV3 | PubChem CID:13724742 | CAS RN:5649-76-3"
+BMGC_DG03238,BMG_DG085311,"UNII:2B2VM6UC8G | CAS RN:2296729-00-3 | DrugBank ID:DB15569 | CAS RN:2296729-66-1 | SOTORASIB | NDC:55513-512 | Sotorasib | NDC:55513-504 | PubChem CID:137278711 | CAS RN:2252403-56-6 | 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one | PubChem SID:384158348 | NDC:55513-488"
+BMGC_DG03239,BMG_DG085324,"6-(PYRIDIN-3-YL)-3,4-DIHYDROQUINOLIN-2(1H)-ONE | PubChem CID:13728862 | 6-(Pyridin-3-yl)-3,4-dihydroquinolin-2(1H)-one | UNII:D9ZYM3XCP6 | PubChem SID:485663582"
+BMGC_DG03240,BMG_DG085333,"CAS RN:958-09-8 | 2'-DEOXYADENOSINE | (2R,3S,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol | PubChem SID:198974568 | 2'-Deoxyadenosine | UNII:P582C98ULC | CAS RN:663188-78-1 | CAS RN:40627-14-3 | PubChem CID:13730"
+BMGC_DG03241,BMG_DG085345,"4H-Imidazol-4-one, 2-amino-1,5-dihydro-1-methyl- | CAS RN:82016-55-5 | PubChem CID:137319715 | DrugBank ID:DB11846 | 2-imino-1-methylimidazolidin-4-one"
+BMGC_DG03242,BMG_DG085487,"cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl phosphate;cyanide | CAS RN:68-19-9 | PubChem CID:137332389"
+BMGC_DG03243,BMG_DG085488,"CAS RN:2244992-76-3 | PubChem CID:137333450 | (2S)-2-amino-N-[5-[6-chloro-5-[(3-methylphenyl)sulfonylamino]pyridin-3-yl]-4-methyl-1,3-thiazol-2-yl]-3-methylbutanamide | Chmfl-PI3KD-317"
+BMGC_DG03244,BMG_DG085559,"6,6-dimethyl-1-[4-(phenylsulfanylmethyl)phenyl]-1,3,5-triazine-2,4-diamine | 4,6-Diamino-1,2-dihydro-2,2-dimethyl-1-(4-phenylthiomethylphenyl)-1,3,5-triazine | PubChem CID:137346 | CAS RN:87739-93-3"
+BMGC_DG03245,BMG_DG085569,"US10501449, Example 83-I | 4-methyl-6-[4-[[(3S,5R)-3-methyl-5-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)piperazin-1-yl]methyl]triazol-2-yl]pyridine-3-carbonitrile | PubChem CID:137351107"
+BMGC_DG03246,BMG_DG085575,"CAS RN:2180923-05-9 | 4-[4-[[8-(4-chlorophenyl)spiro[3.5]non-7-en-7-yl]methyl]piperazin-1-yl]-N-[4-[[(2S)-1,4-dioxan-2-yl]methylamino]-3-nitrophenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide | Lisaftoclax | LISAFTOCLAX | PubChem SID:443623770 | UNII:OSL3FEZ1IF | PubChem CID:137355972"
+BMGC_DG03247,BMG_DG085581,"PubChem CID:137359492 | 1-[2-[4-(2,4-difluorophenoxy)piperidin-1-yl]-3-[[(3R)-oxolan-3-yl]amino]-7,8-dihydro-5H-pyrido[3,4-b]pyrazin-6-yl]ethanone | UNII:XO01711URG | CVN-424 | PubChem SID:461434186 | Cvn-424 | CAS RN:2254706-21-1 | SOLENGEPRAS"
+BMGC_DG03248,BMG_DG085584,PubChem SID:485663345 | PubChem CID:137363247 | UNII:TIN5O0W1AY | BCX-9250 FREE BASE
+BMGC_DG03249,BMG_DG085599,"2-(hydroxymethyl)piperidine-3,4,5-triol | 2-(Hydroxymethyl)piperidine-3,4,5-triol | CAS RN:16647-80-6 | PubChem CID:1374 | CAS RN:70956-02-4"
+BMGC_DG03250,BMG_DG085606,"CAS RN:2146097-17-6 | BA-1049, (S)- | PubChem SID:474494763 | UNII:WGV737HBT9 | PubChem CID:137411001"
+BMGC_DG03251,BMG_DG085609,PubChem CID:137419776 | CAS RN:2265899-49-6 | UNII:ZY54BP1CK3 | PubChem SID:433968677 | VORNOREXANT
+BMGC_DG03252,BMG_DG085618,"UNII:XK5ILZ28KI | Navacaprant | NAVACAPRANT | CAS RN:2244614-14-8 | 4-Piperidinamine, 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-quinolinyl]-N-(tetrahydro-2H-pyran-4-yl)- | PubChem SID:383470600 | 1-[6-ethyl-8-fluoro-4-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)quinolin-2-yl]-N-(oxan-4-yl)piperidin-4-amine | PubChem CID:137434175"
+BMGC_DG03253,BMG_DG085624,"CAS RN:2272904-53-5 | UNII:C293MNS6TQ | PubChem SID:474492484 | N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-ylpyridin-3-yl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide | Zasocitinib | PubChem CID:137441492 | ZASOCITINIB"
+BMGC_DG03254,BMG_DG085629,"UNII:TTY12Q00LY | PubChem SID:461433124 | CAS RN:2271119-26-5 | Elzovantinib | (11S)-16-amino-2-ethyl-6-fluoro-11-methyl-14-oxo-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaene-5-carbonitrile | PubChem CID:137455315 | ELZOVANTINIB"
+BMGC_DG03255,BMG_DG085635,"PubChem SID:472422800 | (6S)-5-[4-(4-fluorophenyl)-3-(trifluoromethyl)phenyl]-6-methyl-3,6-dihydro-1,3,4-oxadiazin-2-one | CAS RN:2275774-60-0 | BAY-2666605 | Bay-2666605 | PubChem CID:137465182 | UNII:XC4ZA6OSY6"
+BMGC_DG03256,BMG_DG085636,UNII:QG8FX78K6V | NDT-19795 | CAS RN:2272917-12-9 | PubChem CID:137465770 | PubChem SID:485665769
+BMGC_DG03257,BMG_DG085648,"Bms-986299 | UNII:VS58MO4P47 | CAS RN:2242952-69-6 | PubChem CID:137498152 | BMS-986299 | PubChem SID:461432545 | N-[[4-amino-7-(1H-pyrazol-5-yl)-3H-imidazo[4,5-c]quinolin-2-yl]methyl]-N-ethylacetamide"
+BMGC_DG03258,BMG_DG085661,"UNII:E1C0J49GTW | PubChem SID:485663350 | (7R,16R)-19,23-dichloro-10-{[2-(4-{[(2R)-1,4-dioxan-2-yl]methoxy}phenyl)pyrimidin-4-yl]methoxy}-1-(4-fluorophenyl)-20,22-dimethyl-16-[(4-methylpiperazin-1-yl)methyl]-7,8,15,16-tetrahydro-18,21-etheno-13,9-(metheno)-6,14,17-trioxa-2-thia-3,5-diazacyclononadeca[1,2,3-cd]indene-7-carboxylic acid | ABBV-467 | (11R,20R)-23,26-dichloro-14-[[2-[4-[[(2R)-1,4-dioxan-2-yl]methoxy]phenyl]pyrimidin-4-yl]methoxy]-3-(4-fluorophenyl)-24,25-dimethyl-20-[(4-methylpiperazin-1-yl)methyl]-10,18,21-trioxa-4-thia-6,8-diazapentacyclo[20.2.2.12,5.113,17.09,28]octacosa-1(25),2,5,7,9(28),13,15,17(27),22(26),23-decaene-11-carboxylic acid | PubChem CID:137517950"
+BMGC_DG03259,BMG_DG085662,"(11R,20R)-23,26-dichloro-14-[[2-[4-[[(2S)-1,4-dioxan-2-yl]methoxy]phenyl]pyrimidin-4-yl]methoxy]-3-(4-fluorophenyl)-24,25-dimethyl-20-[(4-methylpiperazin-1-yl)methyl]-10,18,21-trioxa-4-thia-6,8-diazapentacyclo[20.2.2.12,5.113,17.09,28]octacosa-1(25),2,5,7,9(28),13,15,17(27),22(26),23-decaene-11-carboxylic acid | PubChem CID:137517954 | CAS RN:2287186-66-5 | Abbv467 hydrate"
+BMGC_DG03260,BMG_DG085695,BEROTRALSTAT | UNII:XZA0KB1BDQ | CAS RN:1809010-50-1 | 2-[3-(aminomethyl)phenyl]-N-[5-[(R)-(3-cyanophenyl)-(cyclopropylmethylamino)methyl]-2-fluorophenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide | PubChem CID:137528262 | PubChem SID:381608503 | Berotralstat
+BMGC_DG03261,BMG_DG085718,Sulfaethoxypyridazine | DrugBank ID:DB11462 | PubChem CID:13755 | UNII:880RIW1DED | PubChem SID:198946596 | 4-amino-N-(6-ethoxypyridazin-3-yl)benzenesulfonamide | CAS RN:963-14-4 | SULFAETHOXYPYRIDAZINE
+BMGC_DG03262,BMG_DG085738,CAS RN:2244579-87-9 | N-[5-bromo-1-[(4-fluorophenyl)methyl]-4-methyl-2-oxopyridin-3-yl]cycloheptanecarboxamide | PubChem CID:137553165 | CB2R Pam
+BMGC_DG03263,BMG_DG085775,"CAS RN:1328987-85-4 | PubChem CID:137628629 | Glucokinase activator 1 | 4-[[2-[[(2R)-2-(4-cyclopropylsulfonylphenyl)-2-(2,4-difluorophenoxy)acetyl]amino]-1,3-thiazol-5-yl]oxy]benzoic acid"
+BMGC_DG03264,BMG_DG085778,"CAS RN:2361659-61-0 | 4-[(4-tert-butylphenyl)methyl-[2-[(4-fluorophenyl)sulfonyl-[(2,3,4,5,6-pentafluorophenyl)methyl]amino]acetyl]amino]-N-hydroxybenzamide | PubChem CID:137628685"
+BMGC_DG03265,BMG_DG085786,CAS RN:1430634-79-9 | AB-002 | PubChem CID:137632278 | UNII:4PH0NMD7GJ | PubChem SID:438788354
+BMGC_DG03266,BMG_DG085787,"DNDI-0690 | UNII:QAU2EGM5Q7 | (7R)-7-[[6-(4-fluorophenyl)pyridin-3-yl]oxymethyl]-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine | PubChem SID:472424016 | CAS RN:2097881-13-3 | PubChem CID:137634027 | Dndi-0690"
+BMGC_DG03267,BMG_DG085794,EC-508 | CAS RN:1644459-05-1 | UNII:N7ZU267AZB | PubChem SID:445498708 | PubChem CID:137649257
+BMGC_DG03268,BMG_DG085795,DNDI-8219 | CAS RN:2222660-40-2 | PubChem SID:472424017 | PubChem CID:137649582 | UNII:3YN4655VVY
+BMGC_DG03269,BMG_DG085796,"(8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol | ETHYLESTRENOL | DrugBank ID:DB01493 | UNII:ADC79EK5Q8 | CAS RN:965-90-2 | Ethylestrenol | PubChem CID:13765 | PubChem SID:198984175"
+BMGC_DG03270,BMG_DG085831,"(4aS,4bR,10aR,10bS,12aS)-10a,12a-dimethyl-4,4a,4b,5,6,10b,11,12-octahydro-3H-naphtho[2,1-f]chromene-2,8-dione | DrugBank ID:DB00894 | PubChem SID:175265391 | TESTOLACTONE | Testolactone | CAS RN:968-93-4 | UNII:6J9BLA949Q | PubChem CID:13769"
+BMGC_DG03271,BMG_DG085839,azane;2-methylbutane;trimethyl-[[4-(5-phenylhexan-3-yl)phenyl]methyl]azanium;chloride | PubChem CID:137699107 | CAS RN:11041-12-6 | Cholestyramine resin
+BMGC_DG03272,BMG_DG086085,"3-[2-[(3aR,7aR)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol | PubChem CID:137704803 | CAS RN:19356-17-3"
+BMGC_DG03273,BMG_DG086090,CAS RN:52263-68-0 | 2-(9H-CARBAZOL-2-YL)PROPANOIC ACID | PubChem CID:13771052 | PubChem SID:198962859 | UNII:461G26691F
+BMGC_DG03274,BMG_DG086112,PubChem SID:485666335 | NDI-091143 | CAS RN:2375840-87-0 | PubChem CID:137796782 | UNII:P867JW2Q2J
+BMGC_DG03275,BMG_DG086151,"UNII:78O20X9J0U | CANRENONE | CAS RN:976-71-6 | PubChem CID:13789 | DrugBank ID:DB12221 | PubChem SID:198936122 | (8R,9S,10R,13S,14S,17R)-10,13-dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione | Canrenone"
+BMGC_DG03276,BMG_DG086157,"PubChem SID:175265554 | NDC:70700-275 | NDC:0143-9289 | NDC:0143-9291 | NDC:70700-274 | DrugBank ID:DB13956 | Estradiol Valerate | NDC:70700-273 | PubChem CID:13791 | Estradiol valerate | NDC:42023-110 | NDC:0517-0420 | NDC:0517-0440 | NDC:42023-111 | [(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate | CAS RN:979-32-8 | UNII:OKG364O896 | NDC:0143-9290 | ESTRADIOL VALERATE"
+BMGC_DG03277,BMG_DG086189,DrugBank ID:DB12449 | CAS RN:2226-96-2 | Tempol | TEMPOL | PubChem CID:137994 | PubChem SID:198968098 | UNII:U78ZX2F65X
+BMGC_DG03278,BMG_DG086214,"CAS RN:987-78-0 | DrugBank ID:DB04290 | PubChem SID:198957061 | PubChem CID:13804 | DrugBank ID:DB12153 | [[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-(trimethylazaniumyl)ethyl phosphate | Citicoline | CITICOLINE | UNII:536BQ2JVC7"
+BMGC_DG03279,BMG_DG086218,"2-[[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxyethyl-trimethylazanium | CAS RN:987-78-0 | [2-Cytidylate-O'-phosphonyloxyl]-ethyl-trimethyl-ammonium | PubChem CID:13805"
+BMGC_DG03280,BMG_DG086254,"PubChem SID:198956030 | UNII:037VRW83CF | PubChem CID:13806 | Rhodamine 6G | [9-(2-ethoxycarbonylphenyl)-6-(ethylamino)-2,7-dimethylxanthen-3-ylidene]-ethylazanium;chloride | BASIC RED 1 | CAS RN:989-38-8 | DrugBank ID:DB03825"
+BMGC_DG03281,BMG_DG086312,"Orlistat, (R,S,S,S)- | PubChem CID:13817938 | UNII:7QMQ98VHOQ | PubChem SID:198949191 | CAS RN:104872-28-8 | ORLISTAT, (R,S,S,S)-"
+BMGC_DG03282,BMG_DG086314,PubChem SID:198972897 | METHYLPHOSPHONIC ACID | UNII:329W4YM10Z | Methylphosphonic acid | PubChem CID:13818 | methylphosphonic acid | CAS RN:993-13-5
+BMGC_DG03283,BMG_DG086396,"HP-beta-CD | (1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36S,37S,38S,39S,40S,41S,42S,43S,44S,45S,46S,47S,48S,49S)-5,10,15,20,25,30,35-heptakis(2-hydroxypropoxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol | PubChem CID:138319308"
+BMGC_DG03284,BMG_DG086399,"PubChem CID:138319677 | UNII:D6UWM02W81 | CAS RN:2252316-16-6 | TBAJ-587 | Tbaj-587 | PubChem SID:433968197 | (1S,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-2-(2,6-dimethoxypyridin-4-yl)-4-(dimethylamino)-1-(2-fluoro-3-methoxyphenyl)butan-2-ol"
+BMGC_DG03285,BMG_DG086400,"PubChem CID:138319683 | [(1R)-2-(1-benzofuran-3-yl)-1-[[(1S,2R,4R)-7-oxabicyclo[2.2.1]heptane-2-carbonyl]amino]ethyl]boronic acid | CAS RN:2285330-15-4 | M3258"
+BMGC_DG03286,BMG_DG086421,"PubChem SID:384158470 | UNII:BJA1EEB3GR | PS-13 C-11 | 1-(4-methoxyphenyl)-5-(4-(111C)methoxyphenyl)-3-(2,2,2-trifluoroethoxy)-1,2,4-triazole | PubChem CID:138320044"
+BMGC_DG03287,BMG_DG086430,UNII:1TQ5N1N404 | PubChem CID:13833941 | CAS RN:24704-84-5 | PubChem SID:287446154 | 6.ALPHA.-HYDROXYANDROSTENEDIONE
+BMGC_DG03288,BMG_DG086437,CAS RN:7003-89-6 | UNII:8SUZ1123XX | CHLORMEQUAT | PubChem CID:13837 | 2-chloroethyl(trimethyl)azanium | PubChem SID:198980120 | Chlormequat
+BMGC_DG03289,BMG_DG086453,"3'-Carbamoyl-[1,1'-biphenyl]-3-yl cyclohexylcarbamate | UNII:PX47LB88FO | CAS RN:546141-08-6 | PubChem SID:312525169 | [3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate | PubChem CID:1383884 | URB-597"
+BMGC_DG03290,BMG_DG086595,PubChem CID:138454771 | CAS RN:2270879-07-5 | N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]propanamide | Chmfl-abl-121
+BMGC_DG03291,BMG_DG086678,"POCENBRODIB | Pocenbrodib | (1R,3R)-3-[(7S)-2-[(R)-(5-fluoro-2-methoxyphenyl)-hydroxymethyl]-6-methoxycarbonyl-7-methyl-8,9-dihydro-7H-imidazo[4,5-f]quinolin-3-yl]cyclohexane-1-carboxylic acid | PubChem SID:478838401 | CAS RN:2304372-79-8 | PubChem CID:138472434 | UNII:EI2N46W53Z"
+BMGC_DG03292,BMG_DG086704,"PubChem SID:440089203 | PubChem CID:1385 | CAS RN:135812-04-3 | 1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE | 1-METHYL ETHYL 1-CHLORO-5-(((5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL)AMINO)BENZOATE | UNII:IJ5WR6SKU5 | DrugBank ID:DB08682"
+BMGC_DG03293,BMG_DG086707,"UNII:9OCI30QIY0 | 4,5-OCTANEDIONE | PubChem SID:198953748 | PubChem CID:138508 | CAS RN:5455-24-3"
+BMGC_DG03294,BMG_DG086713,"CAS RN:2144751-78-8 | 2-[(1R)-1-fluoroethyl]-5-[[6-(4-methoxypyrrolo[2,1-f][1,2,4]triazin-5-yl)-2-methylimidazo[4,5-b]pyridin-1-yl]methyl]-1,3,4-oxadiazole | Rogocekib | PubChem SID:496141775 | UNII:XE88VQP94E | PubChem CID:138522180 | ROGOCEKIB"
+BMGC_DG03295,BMG_DG086714,"PubChem CID:138523649 | US11278534, Example 7(-) | 2-[4-(2,5-difluorophenyl)phenyl]-N-methyl-N-[4-methyl-5-(methylsulfonimidoyl)-1,3-thiazol-2-yl]acetamide"
+BMGC_DG03296,BMG_DG086717,"3,4,5-TRIMETHYLPYRAZOLE | UNII:U620SU1FNR | PubChem SID:198985590 | PubChem CID:138528 | CAS RN:5519-42-6"
+BMGC_DG03297,BMG_DG086762,"UNII:YO3W29IM33 | Bms-986318 | BMS-986318 | PubChem SID:461434356 | PubChem CID:138592025 | 6-[2-[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]-7-azaspiro[3.5]non-2-en-7-yl]-4-(trifluoromethyl)quinoline-2-carboxylic acid | CAS RN:2314378-09-9"
+BMGC_DG03298,BMG_DG086765,TRITYLAMINE | Tritylamine | CAS RN:5824-40-8 | PubChem SID:474492445 | UNII:UR7TF3NW3P | PubChem CID:138598
+BMGC_DG03299,BMG_DG086768,"[(3S)-1-[(E)-4-(dimethylamino)but-2-enoyl]pyrrolidin-3-yl] 4-[(5-methyl-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-7-yl)amino]piperidine-1-carboxylate | Cdk7-IN-2 | PubChem CID:138608760 | CAS RN:2326428-19-5"
+BMGC_DG03300,BMG_DG086772,"CAS RN:2326521-71-3 | 2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile | NDC:80739-812 | ADAGRASIB | PubChem CID:138611145 | UNII:8EOO6HQF8Y | PubChem SID:405055395 | Adagrasib"
+BMGC_DG03301,BMG_DG086775,"PubChem SID:198959144 | UNII:V2D262MF0L | CAS RN:1004-36-0 | PubChem CID:13862 | 2,6-DIMETHYL-4-PYRANONE"
+BMGC_DG03302,BMG_DG086780,"UNII:DQN3V3R84U | PubChem SID:485663689 | Lepzacitinib | CAS RN:2321488-47-3 | LEPZACITINIB | ethyl 4-[[(3R)-1-(2-cyanoacetyl)piperidin-3-yl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxylate | PubChem CID:138624627"
+BMGC_DG03303,BMG_DG086803,CAS RN:6118-65-6 | 3-ACETAMIDOPHTHALIMIDE | UNII:8J9L7A5A3K | PubChem CID:138666
+BMGC_DG03304,BMG_DG086804,"UNII:BO0V7196L2 | PubChem CID:138669688 | MURIZATOCLAX | (3'R,4S,6'R,7'R,8'E,11'S,12'R)-7'-[[(9aR)-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl]methyl]-7-chloro-7'-methoxy-11',12'-dimethyl-13',13'-dioxospiro[2,3-dihydro-1H-naphthalene-4,22'-20-oxa-13lambda6-thia-1,14-diazatetracyclo[14.7.2.03,6.019,24]pentacosa-8,16(25),17,19(24)-tetraene]-15'-one | PubChem SID:404859536 | CAS RN:2245848-05-7 | Murizatoclax"
+BMGC_DG03305,BMG_DG086806,CAS RN:2311863-36-0 | [4-(6-aminopyridazin-3-yl)piperidin-1-yl]-[5-(4-fluorophenoxy)-4-methoxypyridin-2-yl]methanone | PubChem CID:138674835 | UNII:3GKI6RVI0V | (4-(6-Amino-3-pyridazinyl)-1-piperidinyl)(5-(4-fluorophenoxy)-4-methoxy-2-pyridinyl)methanone | PubChem SID:459056351 | (4-(6-AMINO-3-PYRIDAZINYL)-1-PIPERIDINYL)(5-(4-FLUOROPHENOXY)-4-METHOXY-2-PYRIDINYL)METHANONE
+BMGC_DG03306,BMG_DG086807,"3-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]spiro[6H-[1]benzoxepino[3,2-b]pyridine-5,1'-cyclopropane]-9-carboxylic acid | PubChem CID:138675487 | CAS RN:2181834-03-5"
+BMGC_DG03307,BMG_DG086819,CAS RN:2172907-10-5 | UNII:UA8DB5XZ56 | PubChem SID:441097170 | PubChem CID:138691314 | AGH-107
+BMGC_DG03308,BMG_DG086820,AH-494 | PubChem CID:138691364 | UNII:7HG7TA6D63 | PubChem SID:441097479 | CAS RN:2172907-22-9
+BMGC_DG03309,BMG_DG086824,"PubChem CID:1387 | 1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide | DrugBank ID:DB03294"
+BMGC_DG03310,BMG_DG086835,"6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-methylpyridazine-3-carboxamide | CAS RN:2417137-50-7 | 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-METHYLPYRIDAZINE-3-CARBOXAMIDE | PubChem CID:138713709 | UNII:G6VUZ3V58L | 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-methylpyridazine-3-carboxamide | PubChem SID:485665688"
+BMGC_DG03311,BMG_DG086844,"GUNAGRATINIB | PubChem SID:443623973 | Gunagratinib | PubChem CID:138734912 | UNII:9D589FD91A | 3-[2-(3,5-dimethoxyphenyl)ethynyl]-5-(methylamino)-1-[(3S)-1-prop-2-enoylpyrrolidin-3-yl]pyrazole-4-carboxamide | CAS RN:2211082-53-8"
+BMGC_DG03312,BMG_DG086930,CAS RN:1008-76-0 | DIHYDRO-5-PHENYL-2(3H)-FURANONE | PubChem CID:13884 | UNII:MSP7V2HE35
+BMGC_DG03313,BMG_DG086933,"PubChem SID:485663677 | 6-Imidazol-1-yl-3,4-dihydro-1H-quinolin-2-one | 6-IMIDAZOL-1-YL-3,4-DIHYDRO-1H-QUINOLIN-2-ONE | CAS RN:119924-94-6 | PubChem CID:13885278 | UNII:5EWV7BHG3S"
+BMGC_DG03314,BMG_DG086936,CAS RN:1008-88-4 | UNII:EDZ6KB7JVC | 3-PHENYLPYRIDINE | PubChem CID:13886 | PubChem SID:198967030
+BMGC_DG03315,BMG_DG086970,UNII:17NL0QLS6P | PubChem CID:13889849 | PubChem SID:316908727 | CAS RN:83209-65-8 | HELMINTHOSPORIUM CARBONUM TOXIN I
+BMGC_DG03316,BMG_DG087018,PubChem CID:138911318 | CAS RN:2230836-55-0 | UNII:P49LSH4TMF | BI-3406
+BMGC_DG03317,BMG_DG087020,"5-bromo-4-N-(5-dimethylphosphorylquinoxalin-6-yl)-2-N-[2-methoxy-5-methyl-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine | PubChem CID:138911391 | CAS RN:2267329-76-8 | Egfr-IN-7"
+BMGC_DG03318,BMG_DG087068,CAS RN:616-47-7 | PubChem CID:1390 | PubChem SID:198949458 | 1-METHYLIMIDAZOLE | UNII:P4617QS63Y
+BMGC_DG03319,BMG_DG087075,"CAS RN:9050-36-6 | CID 139024271 | PubChem CID:139024271 | (3S,4R,6R)-2-(hydroxymethyl)-6-[(3S,4S,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol"
+BMGC_DG03320,BMG_DG087145,PubChem SID:316909385 | PubChem CID:13903191 | CAS RN:129540-12-1 | UNII:VSM44B5G3G | JNJ-7925476 FREE BASE
+BMGC_DG03321,BMG_DG087403,PubChem CID:139035066 | NED-3238 | CAS RN:2389062-09-1 | UNII:FA766MS2G4 | PubChem SID:443623887
+BMGC_DG03322,BMG_DG087463,"2-[6-[6-[6-[6-[4,5-Dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | (2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-6-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | CAS RN:34620-78-5 | PubChem CID:13908996"
+BMGC_DG03323,BMG_DG087490,CAS RN:1018-71-9 | 3-chloro-4-(3-chloro-2-nitrophenyl)-1H-pyrrole | PYRROLNITRIN | UNII:N0P24B6EDQ | PubChem CID:13916 | PubChem SID:198941370 | Pyrrolnitrin | DrugBank ID:DB13603
+BMGC_DG03324,BMG_DG087526,PubChem SID:198942167 | EDELFOSINE | PubChem CID:1392 | Edelfosine | CAS RN:70641-51-9 | UNII:1Y6SNA8L5S | (2-methoxy-3-octadecoxypropyl) 2-(trimethylazaniumyl)ethyl phosphate | CAS RN:65492-82-2
+BMGC_DG03325,BMG_DG087559,"PubChem SID:346540837 | UNII:F6R7D8UJO5 | PubChem CID:13926 | CAS RN:1022-46-4 | 2-PHENYL-3,1-BENZOXAZIN-4-ONE"
+BMGC_DG03326,BMG_DG087604,N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-1-[[4-[(5-fluoro-2-oxopyridin-1-yl)methyl]phenyl]methyl]-3-(methoxymethyl)pyrazole-4-carboxamide | PubChem CID:139301832 | PubChem SID:461434459 | Feniralstat | UNII:925YUK8Y75 | CAS RN:2166320-76-7 | FENIRALSTAT
+BMGC_DG03327,BMG_DG087605,UNII:EK5ZX23XTU | CAS RN:876170-46-6 | PubChem SID:459055258 | PubChem CID:1393052 | 2'-CHLOROBIPHENYL-2-METHYLAMINE
+BMGC_DG03328,BMG_DG087653,"Aficamten | N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methylpyrazole-4-carboxamide | PubChem CID:139331495 | UNII:B1I77MH6K1 | CAS RN:2364554-48-1 | PubChem SID:459276085 | AFICAMTEN"
+BMGC_DG03329,BMG_DG087667,PubChem SID:461432883 | PubChem CID:13934286 | UNII:Z99BBB5WR6 | CAS RN:104700-96-1 | GANODEROL B
+BMGC_DG03330,BMG_DG087676,"PubChem CID:139360137 | CID 139360137 | N-[(3S,4S)-1-(cyclopropylmethyl)-3-[(1-pyrimidin-2-ylcyclopropyl)carbamoyl]piperidin-4-yl]-5-(2,4-difluorophenyl)-1,2-oxazole-3-carboxamide | CAS RN:2178049-58-4"
+BMGC_DG03331,BMG_DG087694,"CAS RN:2370913-42-9 | PubChem CID:139390026 | UNII:Q6460P4C0B | Inixaciclib | 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[5-(1-methylpiperidin-4-yl)pyridin-2-yl]pyrimidin-2-amine | PubChem SID:474492520 | INIXACICLIB"
+BMGC_DG03332,BMG_DG087749,"DEOXYCYTIDINE 5'-MONOPHOSPHATE | DrugBank ID:DB03798 | CAS RN:29795-73-1 | CAS RN:1032-65-1 | PubChem SID:198986042 | 2'-Deoxycytidine-5'-Monophosphate | [(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate | UNII:W7A9174XQL | PubChem CID:13945 | Deoxycytidine 5'-monophosphate | CAS RN:13085-50-2"
+BMGC_DG03333,BMG_DG087765,PubChem CID:139488606 | CAS RN:2173387-57-8 | PubChem SID:441096734 | AGH-192 | UNII:ZJ3VJS5PM7
+BMGC_DG03334,BMG_DG087778,"(3R)-1'-[3-(3,4-dihydro-2H-1,5-naphthyridin-1-yl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]spiro[3H-1-benzofuran-2,4'-piperidine]-3-amine | CAS RN:2377352-49-1 | PubChem CID:139512018 | Migoprotafib | UNII:ABR1HZ0ZG8 | PubChem SID:478838297 | MIGOPROTAFIB"
+BMGC_DG03335,BMG_DG087874,Enitociclib | PubChem CID:139593425 | PubChem SID:387065252 | 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-[4-[(methylsulfonimidoyl)methyl]pyridin-2-yl]pyridin-2-amine | UNII:1255AT22ZJ | ENITOCICLIB | CAS RN:1610408-97-3
+BMGC_DG03336,BMG_DG088210,"4-hydroxy-3,5-dinitrobenzenesulfonamide | Oryzalin metabolite OR-20 | PubChem CID:139597735"
+BMGC_DG03337,BMG_DG088250,PubChem CID:1396 | 1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole | DrugBank ID:DB03477
+BMGC_DG03338,BMG_DG088255,2-[[1-[2-fluoro-4-[[5-methyl-4-(1-propan-2-ylpyrazol-4-yl)pyrimidin-2-yl]amino]phenyl]piperidin-4-yl]-methylamino]ethanol | PubChem CID:139600335 | Jak2/flt3-IN-1 | CAS RN:2387765-27-5
+BMGC_DG03339,BMG_DG088349,"UNII:DZM75MW32X | MEPENZOLATE BROMIDE, (R)- | PubChem CID:13981863 | CAS RN:92842-81-4"
+BMGC_DG03340,BMG_DG088350,"CAS RN:92842-82-5 | UNII:L8R5E84K76 | PubChem CID:13981864 | MEPENZOLATE BROMIDE, (S)-"
+BMGC_DG03341,BMG_DG088371,"PubChem CID:13990016 | CAS RN:35818-31-6 | Cladosporin | (3R)-6,8-dihydroxy-3-[[(2R,6S)-6-methyloxan-2-yl]methyl]-3,4-dihydroisochromen-1-one | CLADOSPORIN | UNII:81PR0D5FI4 | PubChem SID:313368758"
+BMGC_DG03342,BMG_DG088384,CAS RN:115841-09-3 | UNII:I16H9Z53ZL | PubChem CID:13991590 | SALVIANOLIC ACID C | PubChem SID:241179827
+BMGC_DG03343,BMG_DG088431,"DrugBank ID:DB01809 | UNII:SA2ND7EHY4 | CAS RN:172889-26-8 | 1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine | PubChem CID:1400 | PP1 | PubChem SID:445498618"
+BMGC_DG03344,BMG_DG088453,CAS RN:1182-68-9 | PubChem CID:14009404 | UNII:12V8PA4WCH | MENAQUINONE | PubChem SID:472409524
+BMGC_DG03345,BMG_DG088454,"1-tert-butyl-3-[2-[4-(diethylamino)butylamino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]urea | CAS RN:219580-11-7 | 1-(tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea | UNII:A4TLL8634Y | PD-173074 | PubChem CID:1401 | PubChem SID:198938480"
+BMGC_DG03346,BMG_DG088492,"CAS RN:56857-57-9 | [2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl] hydrogen sulfate | PubChem CID:14016780 | Luteolin 7-sulfate"
+BMGC_DG03347,BMG_DG088496,PubChem SID:313184003 | PubChem CID:14017299 | HOMOEDUDIOL | CAS RN:77369-92-7 | UNII:DUN1JP1MPF
+BMGC_DG03348,BMG_DG088498,"CAS RN:131-48-6 | PubChem CID:14017587 | CAS RN:83248-83-3 | DrugBank ID:DB11797 | ACENEURAMIC ACID | Aceneuramic acid | UNII:GZP2782OP0 | PubChem SID:198965297 | (4S,5R,6R,7S,8R)-5-acetamido-4,6,7,8,9-pentahydroxy-2-oxononanoic acid"
+BMGC_DG03349,BMG_DG088604,CAS RN:26575-95-1 | UNII:72Y3NE3ZV8 | ALISOL B 23-ACETATE | PubChem CID:14036811 | PubChem SID:461432240
+BMGC_DG03350,BMG_DG088605,PubChem SID:461432400 | PubChem CID:14036813 | UNII:TF3DV2XK24 | ALISOL C 23-ACETATE | CAS RN:26575-93-9
+BMGC_DG03351,BMG_DG088619,UNII:SK0DPC9098 | acetohydrazide | PubChem SID:198972421 | Acetohydrazide | CAS RN:1068-57-1 | PubChem CID:14039 | ACETYLHYDRAZINE
+BMGC_DG03352,BMG_DG088661,"UNII:QE4VW5FO07 | CAS RN:1070-11-7 | PubChem CID:14051 | PubChem SID:175266372 | ETHAMBUTOL DIHYDROCHLORIDE, DL- | (2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol;dihydrochloride | NDC:54879-001 | NDC:42806-102 | NDC:68180-280 | Ethambutol Hydrochloride | NDC:68084-280 | NDC:54879-002 | CAS RN:29326-86-1 | NDC:70518-2966 | NDC:68180-281 | ETHAMBUTOL HYDROCHLORIDE | CAS RN:22196-75-4 | UNII:JNG307DJ5X | NDC:42806-101 | PubChem SID:198942370"
+BMGC_DG03353,BMG_DG088663,CAS RN:74-55-5 | PubChem CID:14052 | ETHAMBUTOL | UNII:8G167061QZ | PubChem SID:175266344 | (2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol | Ethambutol | DrugBank ID:DB00330
+BMGC_DG03354,BMG_DG088687,"PubChem CID:14056555 | PubChem SID:472421780 | 4,5-DIBROMO-1H-PYRROLE-2-CARBOXAMIDE | UNII:HQK4JP7EWK | CAS RN:34649-20-2 | 4,5-Dibromo-1H-pyrrole-2-carboxamide"
+BMGC_DG03355,BMG_DG088764,"2-((2,5-DICHLOROPHENYL)AMINO)PHENYLACETIC ACID | UNII:QJ4B6NZW9L | PubChem SID:472422234 | PubChem CID:14076674 | CAS RN:127792-31-8"
+BMGC_DG03356,BMG_DG088795,"Xeruborbactam | PubChem SID:443624483 | UNII:DE79L822UY | CAS RN:2170834-63-4 | PubChem CID:140830474 | XERUBORBACTAM | (1aR,7bS)-5-fluoro-2-hydroxy-1a,7b-dihydro-1H-cyclopropa[c][1,2]benzoxaborinine-4-carboxylic acid"
+BMGC_DG03357,BMG_DG088811,"DrugBank ID:DB08048 | PubChem CID:14086997 | 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL"
+BMGC_DG03358,BMG_DG088853,UNII:4SJE4EN2VV | CAS RN:65535-49-1 | PubChem CID:14101447 | PubChem SID:459275445 | 8-ETHANOYL-7-PHENYLMETHOXY-CHROMEN-2-ONE
+BMGC_DG03359,BMG_DG088904,UNII:Y24RF8B979 | PubChem CID:14109406 | GANODERIC ACID D | CAS RN:108340-60-9 | PubChem SID:478838288
+BMGC_DG03360,BMG_DG088924,4-Amino-3-phenylbutanoic acid | DrugBank ID:DB13455 | PHENIBUT | UNII:T2M58D6LA8 | 4-amino-3-phenylbutanoic acid | CAS RN:1078-21-3 | PubChem CID:14113 | PubChem SID:198946487
+BMGC_DG03361,BMG_DG088927,"PubChem SID:198984266 | CAS RN:140627-35-6 | PHENYLHYDROQUINONE | UNII:GPT41T80FJ | 2-phenylbenzene-1,4-diol | Phenylhydroquinone | PubChem CID:14116 | CAS RN:1079-21-6"
+BMGC_DG03362,BMG_DG088930,CAS RN:89019-07-8 | PubChem CID:14116752 | 8-ACETYL-7-METHOXYCOUMARIN | UNII:85L6MH46UB
+BMGC_DG03363,BMG_DG088955,PubChem CID:14123494 | Octylphenoxy polyethoxyethanol | DrugBank ID:DB04682
+BMGC_DG03364,BMG_DG088974,PubChem SID:198939121 | 4-[4-Nitrobenzyl]pyridine | 4-[(4-nitrophenyl)methyl]pyridine | PubChem CID:14129 | UNII:0Z6GS37N7H | 4-(4-NITROBENZYL)PYRIDINE | CAS RN:1083-48-3
+BMGC_DG03365,BMG_DG089007,"(2E,4E,8E,10E,12E)-N-(2-hydroxy-2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide | Hydroxy-Gamma-Isosanshool | PubChem CID:14135316 | CAS RN:127514-62-9"
+BMGC_DG03366,BMG_DG089019,CAS RN:94414-19-4 | (+)-23-HYDROXYURSOLIC ACID | UNII:1I1MDP27ZG | PubChem SID:375086196 | PubChem CID:14136881
+BMGC_DG03367,BMG_DG089041,PubChem SID:461432536 | UNII:CL92X4LP4N | CAS RN:1607447-79-9 | NT-102 | PubChem CID:141401321
+BMGC_DG03368,BMG_DG089130,"PubChem CID:14160522 | Gibberellin A101 | (1R,2S,5S,7S,8R,9S,10S,11R)-5,7-dihydroxy-11-methyl-6-methylidene-12-oxo-13-oxapentacyclo[9.3.3.15,8.01,10.02,8]octadecane-9-carboxylic acid"
+BMGC_DG03369,BMG_DG089172,"PubChem CID:14167253 | CAS RN:119318-15-9 | (3S,4S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol | 24-Hydroxy-beta-amyrin"
+BMGC_DG03370,BMG_DG089185,"PubChem CID:14169 | N1-(9-ACRIDINYL)-N3,N3-DIMETHYL-1,3-PROPANEDIAMINE | UNII:C9LK54B52H | PubChem SID:440088885 | CAS RN:13365-37-2"
+BMGC_DG03371,BMG_DG089193,"Tambiciclib | TAMBICICLIB | 4-[[[4-[5-chloro-2-[[4-[[(2R)-1-methoxypropan-2-yl]amino]cyclohexyl]amino]pyridin-4-yl]-1,3-thiazol-2-yl]amino]methyl]oxane-4-carbonitrile | PubChem CID:141725841 | PubChem SID:496141567 | UNII:XDZ7VK8CXC | CAS RN:2247481-08-7"
+BMGC_DG03372,BMG_DG089203,"CAS RN:2215022-45-8 | Azd-8154 | AZD-8154 | UNII:J5M3TCK9Y9 | PubChem SID:472426103 | 2-[(1S)-1-cyclopropylethyl]-5-[4-methyl-2-[[6-(2-oxopyrrolidin-1-yl)pyridin-2-yl]amino]-1,3-thiazol-5-yl]-7-methylsulfonyl-3H-isoindol-1-one | PubChem CID:141754136"
+BMGC_DG03373,BMG_DG089223,"UNII:R67CDS9QK4 | PubChem CID:14179008 | PubChem SID:472424100 | CAS RN:154003-17-5 | CAS RN:84625-61-6 | 2-[(2R)-butan-2-yl]-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one | ITRACONAZOLE, (S)-(+)- | itraconazole, (S)-(+)-"
+BMGC_DG03374,BMG_DG089225,"PubChem CID:14179013 | 4-(4-(4-(4-(((2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-2,4-dihydro-2-((1S)-1-methylpropyl)-3H-1,2,4-triazol-3-one | 2-[(2S)-butan-2-yl]-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one | ITRACONAZOLE, (R)-(+)- | PubChem SID:472424099 | UNII:HZ72DKP4U9 | CAS RN:84625-61-6 | itraconazole, (R)-(+)- | CAS RN:154003-18-6"
+BMGC_DG03375,BMG_DG089227,"PubChem SID:198981825 | PubChem CID:14180 | [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate | NICOTINAMIDE MONONUCLEOTIDE | Nicotinamide mononucleotide | CAS RN:1094-61-7 | UNII:2KG6QX4W0V"
+BMGC_DG03376,BMG_DG089279,CAS RN:1098-97-1 | UNII:AK5Q5FZH2R | PubChem CID:14190 | Pyritinol | PYRITINOL | 5-[[[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyldisulfanyl]methyl]-4-(hydroxymethyl)-2-methylpyridin-3-ol | Pyrithioxin | PubChem SID:198961319 | DrugBank ID:DB13084
+BMGC_DG03377,BMG_DG089282,2-AMINO-4-METHOXYPHENOL | UNII:LD5Q3R5K5H | PubChem CID:1419108 | CAS RN:20734-76-3
+BMGC_DG03378,BMG_DG089325,"PubChem CID:14205264 | DrugBank ID:DB06905 | PubChem SID:474492644 | UNII:VKL2NS279Z | (2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid | CAS RN:126456-06-2 | ADDA"
+BMGC_DG03379,BMG_DG089339,CAS RN:1113-02-6 | UNII:28U28EWE79 | 2-dimethoxyphosphorylsulfanyl-N-methylacetamide | OMETHOATE | PubChem CID:14210 | PubChem SID:198942335 | Omethoate
+BMGC_DG03380,BMG_DG089366,"NODULARIN | UNII:0979BIK2QU | PubChem SID:198981516 | (2Z,5R,6S,9S,12S,13S,16R)-9-[3-(diaminomethylideneamino)propyl]-2-ethylidene-12-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,6,13-trimethyl-3,7,10,14,19-pentaoxo-1,4,8,11,15-pentazacyclononadecane-5,16-dicarboxylic acid | PubChem CID:14217092 | CAS RN:118399-22-7 | Nodularin R"
+BMGC_DG03381,BMG_DG089369,"CAS RN:119240-82-3 | PubChem CID:14218027 | 5,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-2,3-dihydrochromen-4-one | Licoflavanone"
+BMGC_DG03382,BMG_DG089444,"CAS RN:2241808-52-4 | UNII:TTU6QSK1G5 | BERSIPOROCIN | (2R,3S)-2-[3-(4,5-dichlorobenzimidazol-1-yl)propyl]piperidin-3-ol | PubChem SID:440089202 | Bersiporocin | PubChem CID:142411678"
+BMGC_DG03383,BMG_DG089456,"7-fluoro-6-methoxy-4-[6-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | Ker-047 | PubChem CID:142464264 | KER-047 | UNII:8DLP7XK3VH | CAS RN:2248154-85-8 | PubChem SID:461432543"
+BMGC_DG03384,BMG_DG089457,"CAS RN:2250013-34-2 | UNII:CHV5R328VS | PubChem CID:142469248 | 7-(((4R)-1-(6-CYANO-3-PYRIDAZINYL)-3,3-DIMETHYL-4-PIPERIDINYL)AMINO)-2-(6-METHOXY-2-PYRIDINYL)PYRAZOLO(1,5-A)PYRIMIDINE-6-CARBOXAMIDE"
+BMGC_DG03385,BMG_DG089469,UNII:8483H94W1E | trimethyl(tetradecyl)azanium;bromide | CAS RN:8044-71-1 | PubChem CID:14250 | CAS RN:1119-97-7 | TETRADONIUM BROMIDE | Myristyltrimethylammonium bromide | PubChem SID:198985488
+BMGC_DG03386,BMG_DG089472,Tetradecyltrimethylammonium | TETRADONIUM | trimethyl(tetradecyl)azanium | UNII:Y3IR7RCT6J | PubChem CID:14251 | PubChem SID:198960353 | CAS RN:10182-92-0
+BMGC_DG03387,BMG_DG089498,"PubChem SID:316914538 | ORNIPRESSIN | Ornipressin | (2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide | CAS RN:3397-23-7 | PubChem CID:14257660 | DrugBank ID:DB13464 | UNII:1KTH6N080W"
+BMGC_DG03388,BMG_DG089499,"UNII:17N2918V6G | FELYPRESSIN | Felypressin | PubChem CID:14257662 | CAS RN:56-59-7 | PubChem SID:375083984 | (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13,16-dibenzyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide | DrugBank ID:DB00093"
+BMGC_DG03389,BMG_DG089580,CAS RN:6778-33-2 | PubChem CID:14274897 | .DELTA.-VALEROBETAINE | UNII:725A8L267W | PubChem SID:318691469
+BMGC_DG03390,BMG_DG089614,MANNITOL BUSULFAN | UNII:6STO1P091F | DrugBank ID:DB12097 | PubChem SID:198984325 | CAS RN:1187-00-4 | PubChem CID:142775 | Mannitol busulfan
+BMGC_DG03391,BMG_DG089633,PubChem SID:198986735 | UNII:PFP1R6P0S8 | CAS RN:1122-58-3 | 4-Dimethylaminopyridine | 4-DIMETHYLAMINOPYRIDINE | PubChem CID:14284
+BMGC_DG03392,BMG_DG089699,3-METHYLISOQUINOLINE | PubChem SID:198959119 | PubChem CID:14306 | UNII:4QUO6NYB5J | CAS RN:1125-80-0
+BMGC_DG03393,BMG_DG089706,CAS RN:1126-48-3 | DrugBank ID:DB01671 | PubChem CID:14309 | (4-carboxyphenyl)mercury;hydrate | p-Hydroxymercuribenzoic acid
+BMGC_DG03394,BMG_DG089731,UNII:C35A9KWT4G | 7-METHYLISATIN | CAS RN:1127-59-9 | PubChem SID:376231164 | PubChem CID:14313
+BMGC_DG03395,BMG_DG089768,DrugBank ID:DB08784 | PubChem CID:1432578 | 2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID
+BMGC_DG03396,BMG_DG089774,"CAS RN:96686-73-6 | ABLUKAST, (R)- | PubChem CID:14329741 | UNII:AA2PLU36WV | PubChem SID:251965803"
+BMGC_DG03397,BMG_DG089775,1400W | N'-[[3-(aminomethyl)phenyl]methyl]ethanimidamide | UNII:M1VB8VP8OH | N-[3-(aminomethyl)benzyl]acetamidine | CAS RN:180001-34-7 | PubChem CID:1433 | PubChem SID:404859717 | DrugBank ID:DB02044
+BMGC_DG03398,BMG_DG089780,"CAS RN:141980-53-2 | N-[(2S,3R,4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]hexadecanamide | N-hexadecanoylsphinga-(4E,8E)-dienine | PubChem CID:14331917"
+BMGC_DG03399,BMG_DG089801,"CAS RN:1134-35-6 | UNII:H79UAE6A72 | PubChem CID:14338 | PubChem SID:482554846 | 4,4′-Dimethyl-2,2′-bipyridine | 4,4'-DIMETHYL-2,2'-BIPYRIDINE"
+BMGC_DG03400,BMG_DG089856,PubChem CID:14355117 | CAS RN:40434-07-9 | TETRAHYDROAUROGLAUCIN | UNII:4869C436N3 | PubChem SID:312524907
+BMGC_DG03401,BMG_DG089865,"2,6-NAPTHALENEDICARBOXYLIC ACID | PubChem CID:14357 | 2,6-dicarboxynaphthalene | PubChem SID:198984796 | UNII:K3C4DYZ29O | CAS RN:1141-38-4 | DrugBank ID:DB08262"
+BMGC_DG03402,BMG_DG089869,"PubChem CID:14358 | PubChem SID:440793411 | UNII:Y75Q7B8EAE | 2,2'-DIAMINODIPHENYL DISULFIDE | CAS RN:1141-88-4"
+BMGC_DG03403,BMG_DG089893,CAS RN:3563-49-3 | PubChem CID:14373 | UNII:VOU69C02JP | Pyrovalerone | PYROVALERONE | PubChem SID:198989703 | 1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one
+BMGC_DG03404,BMG_DG090038,PubChem CID:14425906 | PubChem SID:443624923 | UNII:GN40DP00S1 | CAS RN:131786-83-9 | 2-(4-METHOXYPHENYL)-5-PHENYLTHIAZOL-4-OL
+BMGC_DG03405,BMG_DG090142,"PubChem CID:14463 | .BETA.-HYDROXY-L-ASPARTIC ACID, ERYTHRO- | DrugBank ID:DB03640 | Beta-Hydroxyaspartic Acid | CAS RN:7298-98-8 | UNII:GDV0MSK2SG | PubChem SID:198946756"
+BMGC_DG03406,BMG_DG090176,"PubChem CID:14476155 | [(7S)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate | Dolasetronum"
+BMGC_DG03407,BMG_DG090198,CAS RN:54113-95-0 | UNII:SJT5EC4FM4 | 15-HYDROXYDEHYDROABIETIC ACID | PubChem CID:14487943 | PubChem SID:461434224
+BMGC_DG03408,BMG_DG090250,Nitric Oxide | NDC:83202-3285 | NDC:83202-3751 | NDC:83202-9575 | DrugBank ID:DB00435 | PubChem SID:175267011 | NDC:59579-102 | CAS RN:10102-43-9 | NDC:64693-003 | NDC:83202-6841 | NDC:82605-008 | NDC:83202-6255 | PubChem CID:145068 | NDC:72385-001 | NDC:83202-1405 | NDC:83202-1766 | NDC:83202-8841 | NDC:83202-2288 | nitric oxide | NDC:83202-5785 | NDC:83202-2278 | NDC:83202-5578 | NDC:83202-6518 | NITRIC OXIDE | NDC:83202-6923 | NDC:72385-002 | NDC:64693-002 | NDC:83202-9723 | NDC:59579-101 | NDC:83202-1469 | NDC:83202-5813 | NDC:83202-6447 | UNII:31C4KY9ESH
+BMGC_DG03409,BMG_DG090282,N-(2-oxothiolan-3-yl)acetamide | CAS RN:17896-21-8 | PubChem SID:198988659 | CITIOLONE | DrugBank ID:DB13442 | UNII:70JKL15MUH | CAS RN:1195-16-0 | PubChem CID:14520 | Citiolone
+BMGC_DG03410,BMG_DG090334,"QUINOLINE, 2,4-DIMETHYL- | UNII:7JL3KN3WTD | PubChem SID:374388772 | PubChem CID:14536 | CAS RN:1198-37-4"
+BMGC_DG03411,BMG_DG090351,"5-[6-(2-hydroxypropan-2-yl)-5,6-dihydrofuro[3,2-f][1]benzofuran-2-yl]benzene-1,3-diol | Moracin O | PubChem CID:14539883"
+BMGC_DG03412,BMG_DG090352,"Moracin P | 5-(6-hydroxy-7,7-dimethyl-5,6-dihydrofuro[3,2-g]chromen-2-yl)benzene-1,3-diol | PubChem CID:14539884 | CAS RN:102841-46-3"
+BMGC_DG03413,BMG_DG090379,"PubChem CID:14550 | PubChem SID:485662821 | UNII:252EC33EVE | 1-(2-CHLOROPHENYL)-1H-PYRROLE-2,5-DIONE | 1-(2-Chlorophenyl)-1H-pyrrole-2,5-dione | CAS RN:1203-24-3"
+BMGC_DG03414,BMG_DG090390,PubChem SID:461434013 | PubChem CID:14554138 | UNII:5TC65UK919 | N-FORMYL-DESLORATADINE | CAS RN:117810-61-4 | 5TC65UK919
+BMGC_DG03415,BMG_DG090408,PubChem CID:14562 | 2-AMINO-4-PHENYLPHENOL | CAS RN:1134-36-7 | UNII:3D49P06660 | PubChem SID:198938811
+BMGC_DG03416,BMG_DG090415,PubChem SID:318164450 | UNII:PP96PV8E87 | PubChem CID:14565 | 4-AMINO-4'-HYDROXYBIPHENYL | CAS RN:1204-79-1
+BMGC_DG03417,BMG_DG090418,"CAS RN:2306-27-6 | PubChem CID:145659 | Sinensetin | SINENSETIN | UNII:240LNZ51AT | PubChem SID:198976997 | 2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxychromen-4-one"
+BMGC_DG03418,BMG_DG090434,"PubChem CID:145705668 | 5-[2-[(7aR)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]-1-deuterioethylidene]-4-(dideuteriomethylidene)cyclohexane-1,3-diol | CAS RN:32222-06-3"
+BMGC_DG03419,BMG_DG090435,"PubChem CID:145705670 | 3-[2-[(7aR)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]-1-deuterioethylidene]-4-(dideuteriomethylidene)cyclohexan-1-ol | CAS RN:19356-17-3"
+BMGC_DG03420,BMG_DG090439,"CAS RN:13422-55-4 | carbanide;cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(3R,13S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl phosphate | PubChem CID:145705915"
+BMGC_DG03421,BMG_DG090445,"CAS RN:13408-78-1 | PubChem CID:145705982 | Cyanocobalamin;Cyanocob(III)alamin | CAS RN:68-19-9 | cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(3R,13S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl phosphate;cyanide"
+BMGC_DG03422,BMG_DG090609,"UNII:KOH101S66V | 3',4'-DIHYDROXYFLAVONE | PubChem SID:198975836 | PubChem CID:145726 | CAS RN:4143-64-0"
+BMGC_DG03423,BMG_DG090610,"PubChem SID:482553277 | DrugBank ID:DB03413 | Deoxyuridine-5'-diphosphate | Deoxyuridine-5'-Diphosphate | [(2R,3S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate | PubChem CID:145729 | CAS RN:4208-67-7 | UNII:B2SK7999YL | DEOXYURIDINE-5'-DIPHOSPHATE"
+BMGC_DG03424,BMG_DG090619,CAS RN:4305-67-3 | CAS RN:147-85-3 | Proline | PROLINE | DrugBank ID:DB00172 | PubChem SID:175268025 | CAS RN:37159-97-0 | PubChem CID:145742 | UNII:9DLQ4CIU6V | (2S)-pyrrolidine-2-carboxylic acid
+BMGC_DG03425,BMG_DG090631,"UNII:86VGY3VW2J | PubChem CID:145761 | PubChem SID:472423800 | CAS RN:4732-70-1 | 3,4-DIMETHOXYPHENYLGLYOXYLIC ACID"
+BMGC_DG03426,BMG_DG090657,"(+)-α-Dihydrotetrabenazine | UNII:OHZ3DQX6Q3 | PubChem CID:14580381 | (+)-.ALPHA.-DIHYDROTETRABENAZINE | (2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol | .ALPHA.-DIHYDROTETRABENAZINE | CAS RN:171598-74-6 | α-Dihydrotetrabenazine | UNII:IFRYDMLSGE | CAS RN:85081-18-1 | PubChem SID:346540552 | (+)-alpha-Dihydrotetrabenazine | PubChem SID:405055521"
+BMGC_DG03427,BMG_DG090662,"CAS RN:5959-95-5 | PubChem SID:198942994 | UNII:63HB36CA2Y | D-Glutamine | DrugBank ID:DB02174 | D-glutamine | PubChem CID:145815 | D-GLUTAMINE | (2R)-2,5-diamino-5-oxopentanoic acid"
+BMGC_DG03428,BMG_DG090665,"UNII:R1I1R1C88V | PubChem CID:145826 | 2-(3,4-dihydroxyphenyl)-3-hydroxychromen-4-one | CAS RN:6068-78-6 | PubChem SID:249492900 | 3',4'-Dihydroxyflavonol | 3',4'-DIHYDROXYFLAVONOL"
+BMGC_DG03429,BMG_DG090675,DrugBank ID:DB01463 | Fencamfamin | PubChem CID:14584 | UNII:NME1I5IGBK | N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine | CAS RN:1209-98-9 | PubChem SID:198967653 | FENCAMFAMIN
+BMGC_DG03430,BMG_DG090740,"PubChem CID:145875202 | CAS RN:68-19-9 | cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,5Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-22-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide"
+BMGC_DG03431,BMG_DG090756,"Omeprazole sulfone | CAS RN:88546-55-8 | 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfonyl]-1H-benzimidazole | PubChem CID:145900 | PubChem SID:198970254 | OMEPRAZOLE SULFONE | UNII:76X040Z74O"
+BMGC_DG03432,BMG_DG090762,CAS RN:493-92-5 | Prolintane | PROLINTANE | 1-(1-phenylpentan-2-yl)pyrrolidine | PubChem CID:14592 | UNII:EM4YZW677H | PubChem SID:198961383 | DrugBank ID:DB13438
+BMGC_DG03433,BMG_DG090778,PubChem CID:145937 | CAS RN:88798-74-7 | UNII:4A5E8354UB | PubChem SID:381608463 | ECKOL
+BMGC_DG03434,BMG_DG090837,"1,2,3,4-TETRAHYDROPYRAZINO(1,2-A)INDOLE | PubChem CID:14595509 | CAS RN:41838-39-5 | PubChem SID:459276164 | UNII:4U5URU4XP8"
+BMGC_DG03435,BMG_DG090838,"PubChem CID:14595512 | 8-CHLORO-1,2,3,4-TETRAHYDROPYRAZINO(1,2-A)INDOLE | CAS RN:126718-22-7 | UNII:M6YUV8HB6L"
+BMGC_DG03436,BMG_DG090839,"CAS RN:130182-74-0 | MDL-28618A, (+)- | PubChem CID:14595987 | PubChem SID:375083276 | UNII:9O1J7OU9Q5"
+BMGC_DG03437,BMG_DG090848,3-[1-[1-(4-bromophenyl)ethyl]piperidin-4-yl]-1H-benzimidazol-2-one | PubChem CID:145975294 | BRORPHINE | CAS RN:2244737-98-0 | Brorphine | PubChem SID:472421868 | UNII:38H2BE6LU4
+BMGC_DG03438,BMG_DG090853,"PubChem SID:443623633 | PubChem CID:145981271 | UNII:HF3L2K2XZ4 | (3R)-3-METHYL-4-(6-(1-METHYLSULFONYLCYCLOPROPYL)-2-(1H-PYRROLO(2,3-C)PYRIDIN-4-YL)PYRIMIDIN-4-YL)MORPHOLINE"
+BMGC_DG03439,BMG_DG090866,"PubChem CID:145994596 | 3-[7,12,17-tris(2-carboxyethyl)-3,8,13,18-tetramethyl-21,23-dihydroporphyrin-2-yl]propanoic acid | DrugBank ID:DB03727 | 3,8,13,18-tetramethyl-2,7,12,17-Porphinetetrapropionate"
+BMGC_DG03440,BMG_DG090869,"PubChem CID:145994616 | (7S,11S,12S,13S,14R,15R,16R,17S,18S,19Z,21Z)-26-[(E)-(4-cyclopentylpiperazin-1-yl)iminomethyl]-2,13,15,17,27,29-hexahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaene-6,23-dione | CAS RN:79039-56-8 | DrugBank ID:DB15213"
+BMGC_DG03441,BMG_DG090873,"PubChem CID:145994868 | (4S)-5-[[2-[[(2S,3S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-5-amino-1-[[(2R)-1-[[(2R)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[2-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-2-oxoethyl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-4-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]-5-oxopentanoic acid | H-His-Gly-Glu-Gly-aThr-Phe-aThr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-D-Ala-D-Ala-Lys-Glu-Phe-aIle-D-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | CAS RN:782500-75-8"
+BMGC_DG03442,BMG_DG090886,"CAS RN:2349386-89-4 | MOLNUPIRAVIR | PubChem CID:145996610 | NDC:0006-5055 | UNII:YA84KI1VEW | CAS RN:2492423-29-5 | CAS RN:2635324-86-4 | PubChem SID:404859336 | Molnupiravir | [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate"
+BMGC_DG03443,BMG_DG090962,UNII:V3ZW15O8B6 | PubChem SID:198951415 | CAS RN:7245-02-5 | 3-METHOXYFLAVONE | PubChem CID:146013
+BMGC_DG03444,BMG_DG090967,"PubChem CID:146014417 | CAS RN:13422-51-0 | cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydroxide"
+BMGC_DG03445,BMG_DG091043,"N-ethyl-2-[[4-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-1,3,5-triazin-2-yl]amino]benzenesulfonamide | CAS RN:2428743-04-6 | Fgfr3-IN-1 | PubChem CID:146018254"
+BMGC_DG03446,BMG_DG091107,PubChem SID:198988686 | UNII:129FW80TG4 | MANGAFODIPIR TRISODIUM | trisodium;2-[2-[carboxylatomethyl-[[3-hydroxy-2-methyl-5-(phosphonatooxymethyl)pyridin-4-yl]methyl]amino]ethyl-[[3-hydroxy-2-methyl-5-(phosphonatooxymethyl)pyridin-4-yl]methyl]amino]acetate;hydron;manganese(2+) | PubChem CID:146019693 | CAS RN:140678-14-4 | Mangafodipir trisodium [vandf]
+BMGC_DG03447,BMG_DG091163,"UNII:HE3QJ0MMVA | (1R,3S,5R)-3-[(6-chloropyridin-3-yl)oxymethyl]-2-azabicyclo[3.1.0]hexane;hydrochloride | PubChem SID:461432605 | PubChem CID:146026958 | ROPANICANT HYDROCHLORIDE | CAS RN:2414674-71-6 | Ropanicant hydrochloride"
+BMGC_DG03448,BMG_DG091303,UNII:9YHZ9HG5PN | (+/-)-PHILANTHOTOXIN 343 | CAS RN:123949-34-8 | PubChem CID:14608128 | (±)-Philanthotoxin 343 | PubChem SID:485666061
+BMGC_DG03449,BMG_DG091307,"UNII:7OYG5MD7P9 | PubChem SID:440089501 | CAS RN:89820-00-8 | DrugBank ID:DB08612 | 1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE | PubChem CID:146089"
+BMGC_DG03450,BMG_DG091308,"PubChem CID:146093 | 2-(3,4-dimethoxyphenyl)-3,5,7,8-tetramethoxychromen-4-one | CAS RN:7741-47-1 | Gossypetin hexamethyl ether"
+BMGC_DG03451,BMG_DG091315,CAS RN:18887-19-9 | METHYL TANSHINONATE | UNII:59MG2UDU6P | PubChem SID:482553961 | Methyl tanshinonate | PubChem CID:14610613
+BMGC_DG03452,BMG_DG091316,DrugBank ID:DB08659 | 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide | PubChem CID:14611919
+BMGC_DG03453,BMG_DG091341,"CAS RN:13422-51-0 | PubChem CID:146156970 | cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(3R,13S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate"
+BMGC_DG03454,BMG_DG091345,"PubChem CID:146157058 | 2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(3R,13S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate | CAS RN:13870-90-1 | Coenzyme B12;Cobamamide;AdoCbl"
+BMGC_DG03455,BMG_DG091445,RR-49 | CAS RN:2376328-79-7 | PubChem CID:146167150 | PubChem SID:472425887 | UNII:G9884GP5UD
+BMGC_DG03456,BMG_DG091509,"CAS RN:2379422-72-5 | 2-(2,6-dichlorophenyl)-1-((1S,3R)-3-(hydroxymethyl)-1-methyl-5-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one | PubChem CID:146192952 | 2-(2,6-dichlorophenyl)-1-[(1S,3R)-3-(hydroxymethyl)-1-methyl-5-(1-methylpyrazol-4-yl)-3,4-dihydro-1H-isoquinolin-2-yl]ethanone"
+BMGC_DG03457,BMG_DG091522,"UNII:S743GOJ5LJ | PubChem CID:146219790 | (3S,4R)-4-[[5-chloro-4-[7-fluoro-2-(2-hydroxypropan-2-yl)-3-propan-2-ylbenzimidazol-5-yl]pyrimidin-2-yl]amino]oxan-3-ol | PubChem SID:496141569 | Cdk4/6-IN-6 | Atirmociclib | ATIRMOCICLIB | CAS RN:2380321-51-5"
+BMGC_DG03458,BMG_DG091529,"PubChem CID:146225852 | Ocadusertib | CAS RN:2382811-41-6 | PubChem SID:496141727 | UNII:S53J4A7ME4 | OCADUSERTIB | 5-benzyl-N-[(3S)-7-(3-hydroxy-3-methylbut-1-ynyl)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide"
+BMGC_DG03459,BMG_DG091555,"2-[(3-methylphenyl)methyl]-6-(1,2-thiazol-3-yl)pyrazolo[3,4-d]pyrimidin-4-amine | PubChem CID:146268692 | Adenosine receptor antagonist 3 | CAS RN:2400864-80-2"
+BMGC_DG03460,BMG_DG091556,"CAS RN:2397679-77-3 | PubChem CID:146269047 | Pitcoin2 | N-[4-(3-hydroxyphenyl)-1,3-thiazol-2-yl]-2-[4-oxo-3-(2-phenylethyl)pteridin-2-yl]sulfanylacetamide"
+BMGC_DG03461,BMG_DG091560,"UNII:UA6B2TI4MO | UA6B2TI4MO | CAS RN:2403733-82-2 | PubChem SID:474492556 | GLPG-3970 | 8-methoxy-6-[7-(2-morpholin-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one | PubChem CID:146273261"
+BMGC_DG03462,BMG_DG091567,CAS RN:63659-12-1 | PubChem CID:146294 | CICLOPROLOL | PubChem SID:198947851 | UNII:1K2ACH4U3R
+BMGC_DG03463,BMG_DG091595,PubChem SID:441583318 | PubChem CID:146332 | AMPHETHINILE | UNII:RC773C3LTD | CAS RN:91531-98-5
+BMGC_DG03464,BMG_DG091615,"BBP-398 | UNII:C825F38B80 | PubChem CID:146364430 | PubChem SID:485663633 | 6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2,5-dimethylpyrimidin-4-one | 4(3H)-Pyrimidinone, 6-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]dec-8-yl]-3-(2,3-dichlorophenyl)-2,5-dimethyl-"
+BMGC_DG03465,BMG_DG091617,CAS RN:119410-05-8 | PubChem CID:14637770 | PubChem SID:434369855 | 6-HYDROXYDESLORATADINE | UNII:ZW1TK7TV04
+BMGC_DG03466,BMG_DG091618,PubChem CID:14637775 | UNII:KE8G39GEF7 | 5-HYDROXYDESLORATADINE | CAS RN:117811-12-8 | PubChem SID:434369876
+BMGC_DG03467,BMG_DG091622,"Ezm-0414 | UNII:KCY37T9RXU | PubChem SID:461433819 | EZM-0414 | PubChem CID:146395245 | CAS RN:2411748-50-8 | N-[(1R,3S)-3-(4-acetylpiperazin-1-yl)cyclohexyl]-4-fluoro-7-methyl-1H-indole-2-carboxamide"
+BMGC_DG03468,BMG_DG091624,2-(4-ethoxyphenyl)-6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazole | PubChem SID:198959703 | UNII:99KZS6CNZX | PubChem CID:1464 | BISBENZIMIDE ETHOXIDE | Bisbenzimide | CAS RN:23491-52-3
+BMGC_DG03469,BMG_DG091628,PubChem CID:146408604 | TUL-01101 | CAS RN:2411222-96-1 | UNII:DBA7WU5NH4 | PubChem SID:475550530
+BMGC_DG03470,BMG_DG091634,CAS RN:1219-38-1 | PubChem SID:198943080 | OCTYLPARABEN | PubChem CID:14642 | UNII:4UVK431K6B
+BMGC_DG03471,BMG_DG091638,"UNII:4PXO8WQ1GP | PubChem CID:146422953 | CAS RN:2639372-47-5 | 2-[5-(3-ethoxypyridin-2-yl)oxypyridin-3-yl]-N-[(3S,5S)-5-fluoropiperidin-3-yl]pyrimidine-5-carboxamide | 4Pxo8WQ1GP | PubChem SID:485663801 | PF-07202954"
+BMGC_DG03472,BMG_DG091651,"PubChem CID:146448634 | 5-[(4R)-3,3-difluoro-1-methylpiperidin-4-yl]oxy-6-methoxy-N-[3-methyl-4-([1,2,4]triazolo[1,5-c]pyrimidin-7-yloxy)phenyl]quinazolin-4-amine | CAS RN:2414056-31-6 | US11723908, Example 37"
+BMGC_DG03473,BMG_DG091657,BAFREKALANT | UNII:W27RSH2UEF | CAS RN:2256770-44-0 | PubChem SID:461433015 | PubChem CID:146462757
+BMGC_DG03474,BMG_DG091672,8-hydroxy-7-methoxychromen-2-one | PubChem CID:146487 | CAS RN:19492-03-6 | 8-Hydroxy-7-methoxycoumarin | PubChem SID:461432386 | UNII:H43B8D33LB | DAPHNETIN 7-METHYL ETHER
+BMGC_DG03475,BMG_DG091684,"UNII:F7J6KSY5I8 | PubChem SID:485663807 | ISTISOCICLIB | Istisociclib | CAS RN:2416873-83-9 | PubChem CID:146502834 | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine"
+BMGC_DG03476,BMG_DG091689,(2S)-4-((5-(2-FLUORO-4-METHYLPHENOXY)-2-PYRAZINYL)METHYL)-N-METHYL-2-MORPHOLINECARBOXAMIDE | UNII:7JRA3F47TD | PubChem CID:146526316 | (2S)-4-[[5-(2-Fluoro-4-methylphenoxy)-2-pyrazinyl]methyl]-N-methyl-2-morpholinecarboxamide | CAS RN:2416269-15-1 | PubChem SID:445499503
+BMGC_DG03477,BMG_DG091709,"N,N-DIPHENYLGUANIDINE | UNII:CL047JBJ5Q | PubChem SID:198952129 | PubChem CID:14657 | CAS RN:20277-92-3"
+BMGC_DG03478,BMG_DG091710,(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile | PubChem CID:146570 | CAS RN:128196-01-0 | Escitalopram | PubChem SID:175268728 | UNII:4O4S742ANY | DrugBank ID:DB01175 | ESCITALOPRAM
+BMGC_DG03479,BMG_DG091731,Pf-07059013 | CAS RN:2435610-93-6 | PubChem CID:146591762 | PF-07059013 | PubChem SID:438787943 | UNII:FXK42BP3GL | 6-[(1S)-1-(2-amino-6-fluoroquinolin-3-yl)oxyethyl]-5-pyrazol-1-yl-1H-pyridin-2-one
+BMGC_DG03480,BMG_DG091735,"IMLUNESTRANT | PubChem SID:459055182 | UNII:9CXQ3PF69U | (5R)-5-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-8-(trifluoromethyl)-5H-chromeno[4,3-c]quinolin-2-ol | CAS RN:2408840-26-4 | PubChem CID:146603228 | Imlunestrant"
+BMGC_DG03481,BMG_DG091759,"PubChem CID:146662729 | 7-dimethylphosphoryl-3-[2-[[(3S)-6,6-dimethylpiperidin-3-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]-1H-indole-6-carbonitrile | UNII:TW6044C3O6 | CAS RN:2417302-07-7 | PubChem SID:472421690 | SY-5609 | Sy-5609"
+BMGC_DG03482,BMG_DG091852,"(2S,3S,4R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate | CAS RN:13870-90-1 | PubChem CID:146678993"
+BMGC_DG03483,BMG_DG091874,PubChem CID:146681255 | (2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate
+BMGC_DG03484,BMG_DG091893,"CAS RN:303-69-5 | DrugBank ID:DB12958 | PubChem CID:14670 | PROTHIPENDYL | PubChem SID:198986598 | Prothipendyl | N,N-dimethyl-3-pyrido[3,2-b][1,4]benzothiazin-10-ylpropan-1-amine | UNII:5O6VWA87VA"
+BMGC_DG03485,BMG_DG091902,DrugBank ID:DB03673 | CAS RN:22951-96-8 | beta-2-Thienyl-L-alanine | UNII:2EMW41BM77 | PubChem SID:376231556 | PubChem CID:146719 | .BETA.-2-THIENYL-L-ALANINE
+BMGC_DG03486,BMG_DG091911,PubChem CID:14677 | METHDILAZINE | CAS RN:1982-37-2 | PubChem SID:198962718 | 10-[(1-methylpyrrolidin-3-yl)methyl]phenothiazine | DrugBank ID:DB00902 | Methdilazine | UNII:4Q13LY9Z8X
+BMGC_DG03487,BMG_DG091947,"UNII:9E01C36A9S | (3S,8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol | Ethynodiol | ETHYNODIOL | DrugBank ID:DB13866 | PubChem CID:14687 | CAS RN:1231-93-2 | Etynodiol | PubChem SID:175266742"
+BMGC_DG03488,BMG_DG091959,PubChem CID:146921 | L-650719 | PubChem SID:363908921 | UNII:1701W6XC9T | CAS RN:96803-89-3
+BMGC_DG03489,BMG_DG091986,(2R)-2-amino-3-methylselanylpropanoic acid | Se-methylselenocysteine | PubChem CID:147004 | PubChem SID:198972849 | Methylselenocysteine | METHYLSELENOCYSTEINE | UNII:TWK220499Z | CAS RN:26046-90-2 | DrugBank ID:DB12697
+BMGC_DG03490,BMG_DG092009,"CAS RN:58073-76-0 | CAS RN:127-35-5 | PubChem CID:14707 | Phenazocine | 1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol"
+BMGC_DG03491,BMG_DG092010,"DrugBank ID:DB01960 | PubChem CID:147071 | 7-methyl-7,8-dihydroguanosine-5'-diphosphate"
+BMGC_DG03492,BMG_DG092021,"BIS-(5-MERCAPTO-1,3,4-OXADIAZOL-2-YL)-METHANE | UNII:FC7UZU06B2 | CAS RN:90748-72-4 | PubChem CID:14711339 | PubChem SID:445499799"
+BMGC_DG03493,BMG_DG092027,PubChem CID:147157 | 6-METHOXYFLAVONE | CAS RN:26964-24-9 | PubChem SID:440089928 | UNII:QAX7R06N2Q
+BMGC_DG03494,BMG_DG092040,"UNII:EH5R4IAX6Q | HT-2157, (Z)- | CAS RN:1000273-85-7 | PubChem SID:348481737 | PubChem SID:348481205 | CAS RN:303149-14-6 | CAS RN:1000273-87-9 | PubChem CID:1471834 | UNII:WW4KZW83BX | Ht-2157 | 1-phenyl-3-[3-(trifluoromethyl)phenyl]iminoindol-2-one | HT-2157, (E)-"
+BMGC_DG03495,BMG_DG092045,NDC:80425-0449 | NDC:70518-3209 | NDC:65862-721 | NDC:50090-4751 | NDC:80425-0094 | NDC:51407-184 | NDC:67877-443 | NDC:63187-788 | NDC:80425-0363 | NDC:45865-269 | PubChem CID:14720269 | NDC:71335-1558 | NDC:55700-767 | CAS RN:171440-19-0 | NDC:80425-0134 | NDC:68788-7459 | NDC:63187-555 | CAS RN:117976-90-6 | NDC:60760-972 | NDC:71335-2304 | NDC:50090-6887 | NDC:72189-169 | UNII:3L36P16U4R | sodium;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]benzimidazol-1-ide | NDC:71335-0244 | NDC:68788-8536 | PubChem SID:175271472 | NDC:76420-223 | NDC:70518-2590 | NDC:71205-292 | NDC:13668-107 | NDC:71335-1100 | NDC:76420-107 | NDC:62135-503 | NDC:62175-302 | NDC:71205-603 | RABEPRAZOLE SODIUM | NDC:72189-142 | NDC:76420-818 | NDC:65162-724 | Rabeprazole Sodium | NDC:72888-059 | NDC:72162-2367 | NDC:60760-560 | NDC:63187-259
+BMGC_DG03496,BMG_DG092072,"CAS RN:4626-22-6 | PubChem CID:14730796 | 7-hydroxy-3-(4-methoxyphenyl)-2,3-dihydrochromen-4-one | Dihydroformononetin"
+BMGC_DG03497,BMG_DG092097,"(2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one | PubChem CID:147394 | Hesperetin 7-O-glucoside | CAS RN:31712-49-9"
+BMGC_DG03498,BMG_DG092099,"2,2'-Bipyridine | 2,2'-BIPYRIDINE | PubChem CID:1474 | PubChem SID:198990750 | UNII:551W113ZEP | 2-pyridin-2-ylpyridine | CAS RN:366-18-7"
+BMGC_DG03499,BMG_DG092117,"PubChem CID:14749 | Carmine | 3,5,6,8-tetrahydroxy-1-methyl-9,10-dioxo-7-[(2R,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracene-2-carboxylic acid"
+BMGC_DG03500,BMG_DG092132,"UNII:85FDJ14553 | PubChem CID:147525 | CAS RN:118292-41-4 | 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylic acid | TAZAROTENIC ACID | PubChem SID:251965089 | Tazarotenic acid"
+BMGC_DG03501,BMG_DG092140,"CAS RN:1300-25-0 | SODIUM 1-GLYCEROPHOSPHATE | CAS RN:1555-56-2 | DrugBank ID:DB09561 | Sodium 1-glycerophosphate | disodium;2,3-dihydroxypropyl phosphate | PubChem CID:14754 | UNII:G43E72677U | PubChem SID:198989175 | CAS RN:1334-74-3"
+BMGC_DG03502,BMG_DG092162,5-methyl-2-pentylphenol | CAS RN:1300-94-3 | PubChem SID:198948839 | Amylmetacresol | AMYLMETACRESOL | PubChem CID:14759 | UNII:05W904P57F | DrugBank ID:DB13908
+BMGC_DG03503,BMG_DG092201,"PubChem CID:14771671 | 1,3-Bis(4-ethylphenyl)guanidine | UNII:ECZ9UAY336 | 1,3-BIS(4-ETHYLPHENYL)GUANIDINE | PubChem SID:482553872 | CAS RN:128413-47-8"
+BMGC_DG03504,BMG_DG092202,CAS RN:124190-31-4 | UNII:I9DT08YNH7 | PubChem SID:363907698 | PubChem CID:14771696 | N-(ADAMANTAN-1-YL)-N'-(2-METHYLPHENYL)GUANIDINE
+BMGC_DG03505,BMG_DG092209,"PubChem CID:147740 | CAS RN:164017-31-6 | Gianvi | (1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5'-oxolane]-2',7-dione;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol"
+BMGC_DG03506,BMG_DG092231,"PubChem CID:1478 | 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium | DrugBank ID:DB04055"
+BMGC_DG03507,BMG_DG092261,CAS RN:1317-74-4 | CAS RN:146024-94-4 | Magnesium oxide | PubChem CID:14792 | oxomagnesium | DrugBank ID:DB01377 | Magnesium Oxide
+BMGC_DG03508,BMG_DG092269,CAS RN:1310-58-3 | Potassium hydroxide | PubChem CID:14797 | PubChem SID:175268484 | potassium;hydroxide | DrugBank ID:DB11153 | POTASSIUM HYDROXIDE | Potassium Hydroxide | UNII:WZH3C48M4T
+BMGC_DG03509,BMG_DG092270,PubChem CID:14798 | SODIUM HYDROXIDE | UNII:55X04QC32I | CAS RN:1310-73-2 | CAS RN:81133-20-2 | DrugBank ID:DB11151 | Sodium hydroxide | PubChem SID:175266644 | sodium;hydroxide | Sodium Hydroxide
+BMGC_DG03510,BMG_DG092287,Zinc White | DrugBank ID:DB09321 | CAS RN:174846-84-5 | Zinc oxide | oxozinc | CAS RN:1314-13-2 | PubChem CID:14806
+BMGC_DG03511,BMG_DG092304,"PubChem SID:198971311 | (5S,5aS,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-5-(4-nitroanilino)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one | CAS RN:127882-73-9 | PubChem CID:148091 | GL-331 | GL 331 | UNII:0I81858VSZ"
+BMGC_DG03512,BMG_DG092309,"NDC:72893-005 | CAS RN:146464-95-1 | NDC:72893-003 | NDC:65219-552 | (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid | DrugBank ID:DB06813 | PubChem SID:175271513 | Pralatrexate | NDC:65219-550 | UNII:A8Q8I19Q20 | PubChem CID:148121 | PRALATREXATE"
+BMGC_DG03513,BMG_DG092310,"NDC:43598-610 | NDC:0409-4235 | NDC:57884-3043 | Docetaxel trihydrate | NDC:0955-1020 | NDC:45963-734 | NDC:83831-102 | NDC:0409-0365 | NDC:23155-904 | NDC:66758-050 | UNII:15H5577CQD | NDC:43598-259 | NDC:57884-3041 | NDC:0955-1021 | NDC:57884-3042 | PubChem SID:175267270 | NDC:72485-215 | NDC:67457-781 | NDC:0409-0368 | NDC:72485-214 | NDC:43066-006 | DOCETAXEL | NDC:0409-0367 | NDC:0409-5068 | NDC:72485-216 | NDC:0955-1022 | NDC:43066-010 | NDC:83831-103 | CAS RN:148408-66-6 | NDC:23155-903 | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate;trihydrate | NDC:45963-765 | NDC:0143-9205 | NDC:83831-101 | NDC:0143-9204 | PubChem CID:148123 | NDC:43066-001 | NDC:0409-0366 | NDC:43598-611 | NDC:43598-258 | NDC:43598-389 | NDC:23155-905"
+BMGC_DG03514,BMG_DG092311,"NDC:70121-1221 | NDC:68083-401 | NDC:70121-1223 | NDC:0409-0201 | NDC:0409-7870 | NDC:0409-0016 | NDC:67457-533 | NDC:55150-378 | NDC:47335-323 | NDC:62332-678 | NDC:71288-144 | PubChem CID:148124 | NDC:68083-400 | NDC:0409-1732 | NDC:47335-895 | PubChem SID:175265346 | NDC:16729-267 | NDC:55150-379 | NDC:72078-040 | NDC:0409-2026 | NDC:70121-1222 | NDC:46708-678 | DOCETAXEL ANHYDROUS | DrugBank ID:DB01248 | NDC:55150-380 | Docetaxel | NDC:47335-939 | NDC:50742-431 | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate | CAS RN:114977-28-5 | NDC:25021-254 | NDC:67457-532 | NDC:68083-399 | NDC:67457-531 | UNII:699121PHCA | NDC:50742-463 | NDC:25021-245 | CAS RN:114915-20-7"
+BMGC_DG03515,BMG_DG092318,DrugBank ID:DB12769 | Lometrexol | PubChem CID:148138
+BMGC_DG03516,BMG_DG092321,"CAS RN:129075-56-5 | 3,4-Dihydro-5-Methyl-Isoquinolinone | DrugBank ID:DB03722 | PubChem SID:440089728 | 5-METHYL-3,4-DIHYDROISOQUINOLIN-1(2H)-ONE | PubChem CID:148140 | UNII:FI8AN8XP0W"
+BMGC_DG03517,BMG_DG092339,"CAS RN:157716-52-4 | (1,1-dimethylpiperidin-1-ium-4-yl) octadecyl phosphate | UNII:2GWV496552 | PubChem CID:148177 | Perifosine | PubChem SID:198990275 | DrugBank ID:DB06641 | PERIFOSINE"
+BMGC_DG03518,BMG_DG092342,DrugBank ID:DB06247 | Ampalex | CAS RN:154235-83-3 | CAS RN:173047-75-1 | piperidin-1-yl(quinoxalin-6-yl)methanone | PubChem CID:148184 | CX516 | UNII:Z5QU38B4V9 | PubChem SID:198939588
+BMGC_DG03519,BMG_DG092345,"PubChem SID:198974260 | Irofulven | CAS RN:158440-71-2 | PubChem CID:148189 | DrugBank ID:DB05786 | (5'R)-5'-hydroxy-1'-(hydroxymethyl)-2',5',7'-trimethylspiro[cyclopropane-1,6'-indene]-4'-one | IROFULVEN | UNII:6B799IH05A"
+BMGC_DG03520,BMG_DG092349,"ATAZANAVIR | CAS RN:198904-31-3 | Atazanavir | PubChem SID:175265996 | UNII:QZU4H47A3S | methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate | DrugBank ID:DB01072 | PubChem CID:148192"
+BMGC_DG03521,BMG_DG092350,"CAS RN:192185-68-5 | 6-[amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one | 2(1H)-Quinolinone, 6-(amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl)-4-(3-chlorophenyl)-1-methyl- | PubChem CID:148193"
+BMGC_DG03522,BMG_DG092351,"CAS RN:193275-84-2 | NDC:73079-075 | UNII:IOW153004F | PubChem CID:148195 | Lonafarnib | 4-[2-[4-[(2R)-6,15-dibromo-13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl]piperidin-1-yl]-2-oxoethyl]piperidine-1-carboxamide | DrugBank ID:DB06448 | LONAFARNIB | PubChem SID:198959604 | NDC:73079-050"
+BMGC_DG03523,BMG_DG092353,"Diquafosol | [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate | DIQUAFOSOL | CAS RN:59985-21-6 | PubChem CID:148197 | UNII:7828VC80FJ | PubChem SID:198972786"
+BMGC_DG03524,BMG_DG092354,CAS RN:200484-11-3 | 2-[6-(4-chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine | 2-[6-(4-Chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine | PubChem CID:148198 | UNII:8LAP87DNSZ | CHS-828 | DrugBank ID:DB12980 | PubChem SID:198971798
+BMGC_DG03525,BMG_DG092358,"Zonampanel | 2-(7-imidazol-1-yl-6-nitro-2,3-dioxo-4H-quinoxalin-1-yl)acetic acid | PubChem SID:198962498 | PubChem CID:148200 | CAS RN:210245-80-0 | ZONAMPANEL ANHYDROUS | UNII:9X33544ILS"
+BMGC_DG03526,BMG_DG092359,"Tariquidar | PubChem CID:148201 | DrugBank ID:DB06240 | UNII:J58862DTVD | N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide | CAS RN:206873-63-4 | TARIQUIDAR | PubChem SID:198936031"
+BMGC_DG03527,BMG_DG092360,"Cositecan | (19S)-19-ethyl-19-hydroxy-10-(2-trimethylsilylethyl)-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione | PubChem CID:148202 | UNII:24R60NVC41 | COSITECAN | PubChem SID:198949673 | CAS RN:203923-89-1 | DrugBank ID:DB05806"
+BMGC_DG03528,BMG_DG092364,"UNII:YZS3R7LP44 | (3aR)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one | PALONOSETRON, (3AR)- | PubChem CID:148211 | CAS RN:135729-73-6 | Palonosetron, (3aR)- | PubChem SID:348481136"
+BMGC_DG03529,BMG_DG092368,methyl 2-[4-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetate | (4-{(R)-2-[(R)-2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-propyl}-phenoxy)-acetic acid methyl ester | PubChem CID:14823035
+BMGC_DG03530,BMG_DG092409,"DrugBank ID:DB02417 | 2,4,6-tribromophenol | CAS RN:118-79-6 | UNII:YS6K3EU393 | 2,4,6-TRIBROMOPHENOL | 2,4,6-Tribromophenol | PubChem SID:198979203 | PubChem CID:1483"
+BMGC_DG03531,BMG_DG092432,UNII:XW3XX77N7Y | PubChem SID:459275720 | 1-(4-FLUOROPHENYL)-2-(PHENYLSULFONYL)ETHANONE | PubChem CID:1483401 | CAS RN:41024-58-2
+BMGC_DG03532,BMG_DG092487,UNII:J6N933N3XE | N-DEFORMYL-N-BENZYLOXYCARBONYL ORLISTAT | CAS RN:108051-94-1 | PubChem CID:14847017
+BMGC_DG03533,BMG_DG092489,"(4-AMINO-2-((1,1-DIMETHYLETHYL)AMINO)-5-THIAZOLYL)PHENYLMETHANONE | PubChem SID:482553865 | [4-Amino-2-[(1,1-dimethylethyl)amino]-5-thiazolyl]phenylmethanone | PubChem CID:1484819 | CAS RN:339020-31-4 | DrugBank ID:DB08778 | UNII:VVD6G32BMR | [4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone"
+BMGC_DG03534,BMG_DG092542,PubChem SID:198989191 | CAS RN:13912-80-6 | DrugBank ID:DB12911 | 2-butoxyethyl pyridine-3-carboxylate | Nicoboxil | PubChem CID:14866 | UNII:GSD5B9US0W | NICOBOXIL | CAS RN:1322-29-8
+BMGC_DG03535,BMG_DG092551,UNII:QI22Q9QE3I | PubChem CID:14869 | CAS RN:4638-48-6 | PubChem SID:198939435 | CHLOROSALICYLANILIDE
+BMGC_DG03536,BMG_DG092561,"CAS RN:55085-47-7 | UNII:DYC5EDM6W7 | PubChem CID:148724 | PubChem SID:445499661 | 5,6,7-TRIMETHOXYCOUMARIN"
+BMGC_DG03537,BMG_DG092566,CAS RN:55610-00-9 | UNII:G3ACC55KFQ | PubChem SID:445500311 | PubChem CID:148745 | ARISTOLACTAM II
+BMGC_DG03538,BMG_DG092572,"PubChem SID:376230972 | CAS RN:55939-28-1 | UNII:ZS09RD1A9O | PubChem CID:148769 | 6,7-DIACETOXY-4-METHYLCOUMARIN"
+BMGC_DG03539,BMG_DG092598,CAS RN:152735-23-4 | UPIDOSIN | PubChem SID:198988301 | UNII:TXG28R7G4Y | PubChem CID:148842
+BMGC_DG03540,BMG_DG092616,"1,2-Dioctanoyl-sn-glycerol | CAS RN:60514-48-9 | PubChem CID:148879 | [(2S)-3-hydroxy-2-octanoyloxypropyl] octanoate"
+BMGC_DG03541,BMG_DG092617,Arsenic oxide (As2O3) | arsenic(3+);oxygen(2-) | PubChem CID:14888
+BMGC_DG03542,BMG_DG092620,"CAS RN:60548-62-1 | UNII:LPB26EJX5S | PubChem CID:148886 | PubChem SID:478837090 | SULFAMIC ACID, TETRAMETHYLENE ESTER | Sulfamic acid, tetramethylene ester"
+BMGC_DG03543,BMG_DG092645,"DrugBank ID:DB15574 | beta-Pinene | CAS RN:127-91-3 | PubChem CID:14896 | 6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptane | CAS RN:177698-19-0"
+BMGC_DG03544,BMG_DG092652,PubChem SID:445499289 | 1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE | CAS RN:131906-57-5 | UNII:MA965OF9ZR | PubChem CID:14899645 | DrugBank ID:DB08085
+BMGC_DG03545,BMG_DG092683,"PubChem SID:175266817 | UNII:RIX4E89Y14 | CAS RN:100986-85-4 | DrugBank ID:DB01137 | Levofloxacin | LEVOFLOXACIN ANHYDROUS | PubChem CID:149096 | (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid"
+BMGC_DG03546,BMG_DG092684,"CAS RN:89-86-1 | DrugBank ID:DB02839 | 2,4-Dihydroxybenzoic acid | PubChem CID:1491 | 2,4-DIHYDROXYBENZOIC ACID | 2,4-dihydroxybenzoic acid | PubChem SID:175265747 | 2,4-Dihydroxybenzoic Acid | UNII:LU39SC9JYL"
+BMGC_DG03547,BMG_DG092691,UNII:I91BP9H8PF | PubChem CID:149138 | CAS RN:65907-75-7 | PubChem SID:434370196 | DANSHENXINKUN A
+BMGC_DG03548,BMG_DG092697,NDC:37662-0980 | PubChem CID:14917 | CAS RN:12381-92-9 | fluorane | Hydrofluoric Acid | NDC:0220-2561 | CAS RN:7664-39-3 | CAS RN:37249-79-9 | NDC:0220-2564 | NDC:0220-2565 | NDC:37662-0978 | CAS RN:32057-09-3 | NDC:55346-0942 | NDC:55346-0943 | PubChem SID:175268849 | NDC:0220-2563 | HYDROFLUORIC ACID | NDC:37662-0977 | NDC:37662-0979 | Hydrogen fluoride | NDC:37662-0976 | DrugBank ID:DB11072 | NDC:37662-0973 | NDC:37662-0975 | NDC:0220-2534 | UNII:RGL5YE86CZ | NDC:0220-2562 | NDC:37662-0974
+BMGC_DG03549,BMG_DG092735,"PROPANE TRICARBOXYLIC ACID | DrugBank ID:DB04562 | UNII:RA5QH2J020 | CAS RN:99-14-9 | Tricarballylic acid | PubChem SID:198947265 | propane-1,2,3-tricarboxylic acid | PubChem CID:14925"
+BMGC_DG03550,BMG_DG092744,"CAS RN:51-28-5 | 2,4-Dinitrophenol | CAS RN:1326-82-5 | 2,4-DINITROPHENOL | PubChem CID:1493 | UNII:Q13SKS21MN | PubChem SID:198979830 | 2,4-dinitrophenol | DrugBank ID:DB04528"
+BMGC_DG03551,BMG_DG092752,PubChem CID:149351 | DrugBank ID:DB00770 | Alprostadil
+BMGC_DG03552,BMG_DG092789,DrugBank ID:DB11596 | Levoleucovorin | PubChem CID:149436
+BMGC_DG03553,BMG_DG092818,"PubChem CID:149553242 | N-[4-[(4-hydroxy-4-methylcyclohexyl)methylamino]-3-nitrophenyl]sulfonyl-4-[2-[(2S)-2-(2-propan-2-ylphenyl)pyrrolidin-1-yl]-7-azaspiro[3.5]nonan-7-yl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide | UNII:30R67U9KYS | SONROTOCLAX | Sonrotoclax | CAS RN:2383086-06-2 | PubChem SID:478838439"
+BMGC_DG03554,BMG_DG092820,"Antimycin A | PubChem SID:198979101 | UNII:75G3NMU1TS | PubChem CID:14957 | [(2R,3S,6S,7R,8R)-3-[(3-formamido-2-hydroxybenzoyl)amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 3-methylbutanoate | ANTIMYCIN A1B | CAS RN:1397-94-0 | CAS RN:116095-18-2"
+BMGC_DG03555,BMG_DG092843,"(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid | VANCOMYCIN | UNII:6Q205EH1VU | PubChem CID:14969 | PubChem SID:175267718 | Vancomycin | CAS RN:1404-90-6 | DrugBank ID:DB00512"
+BMGC_DG03556,BMG_DG092845,"PubChem SID:485663652 | CAS RN:146830-80-0 | 1-Allyl-3,7-dihydro-purine-2,6-dione | PubChem CID:14969716 | UNII:ZJU5Y2U35J | 1-ALLYL-3,7-DIHYDRO-PURINE-2,6-DIONE"
+BMGC_DG03557,BMG_DG092846,"Vancocin HCL | CAS RN:1404-93-9 | PubChem CID:14970 | (1S,2R,18R,22S,25R,28R,40R)-48-[(2R,3S,4R,5R,6S)-3-[(2R,4R,5R,6R)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid;hydrochloride"
+BMGC_DG03558,BMG_DG092864,"PubChem SID:363909294 | PubChem CID:14978 | UNII:L8YQ8Z3T9T | Sangivamycin | CAS RN:18417-89-5 | SANGIVAMYCIN | 4-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidine-5-carboxamide"
+BMGC_DG03559,BMG_DG092866,"PubChem CID:149784 | CAS RN:79813-68-6 | CAS RN:51350-19-7 | (2R,3S)-3-(6-aminopurin-9-yl)nonan-2-ol | (2R,3S)-3-(6-amino-9H-purin-9-yl)nonan-2-ol"
+BMGC_DG03560,BMG_DG092867,"PubChem CID:149790 | (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol | DrugBank ID:DB07711"
+BMGC_DG03561,BMG_DG092878,"Glycyrrhizin | (2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | PubChem SID:175265976 | CAS RN:132215-36-2 | PubChem CID:14982 | CAS RN:1405-86-3 | DrugBank ID:DB13751 | GLYCYRRHIZIN | UNII:6FO62043WK"
+BMGC_DG03562,BMG_DG092882,"NDC:83872-181 | NDC:72162-2272 | Vitamin E | PubChem CID:14985 | (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol | UNII:N9PR3490H9 | NDC:42494-434 | Alpha-Tocopherol | NDC:72162-2273 | CAS RN:2074-53-5 | DrugBank ID:DB00163 | NDC:42494-432 | CAS RN:1406-18-4 | CAS RN:18920-62-2 | .ALPHA.-TOCOPHEROL, D- | NDC:72162-2274 | PubChem SID:175266251 | CAS RN:59-02-9 | NDC:42494-433 | NDC:42192-341"
+BMGC_DG03563,BMG_DG092889,"CAS RN:602-85-7 | Lysergol | [(6aR,9R)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]methanol | UNII:NTR684Z1AZ | LYSERGOL | PubChem CID:14987 | CAS RN:1413-67-8 | PubChem SID:198947085"
+BMGC_DG03564,BMG_DG092894,Choline C 11 | PubChem SID:198952756 | CAS RN:87591-54-6 | 2-hydroxyethyl-dimethyl-(111C)methylazanium;chloride | PubChem CID:14989482 | CHOLINE CHLORIDE C-11 | UNII:381E0BTR5Q | DrugBank ID:DB09277 | Choline chloride C-11
+BMGC_DG03565,BMG_DG092911,N-Palmitoyl-L-leucine | UNII:HRN9U423SZ | CAS RN:14379-42-1 | PubChem CID:14993928 | PubChem SID:485666070 | N-PALMITOYL-L-LEUCINE
+BMGC_DG03566,BMG_DG092916,"CAS RN:142557-61-7 | 7-amino-1-cyclopropyl-3-ethyl-2,4-dioxopyrido[2,3-d]pyrimidine-6-carboxamide | 7-Amino-1-cyclopropyl-3-ethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carboxamide | PubChem CID:14998470"
+BMGC_DG03567,BMG_DG092936,propyl 2-[4-[2-(diethylamino)-2-oxoethoxy]-3-methoxyphenyl]acetate | CAS RN:1421-14-3 | PROPANIDID | PubChem CID:15004 | Propanidid | PubChem SID:198958084 | DrugBank ID:DB13234 | UNII:AO82L471NS
+BMGC_DG03568,BMG_DG092938,PubChem CID:15006 | 1-BENZYLBIGUANIDE | CAS RN:18030-95-0 | UNII:T25K4Y63E9
+BMGC_DG03569,BMG_DG092960,"UNII:UW9YPK64EU | PubChem CID:15011385 | 4,5-DHP-DMT | CAS RN:135360-97-3 | PubChem SID:441097251"
+BMGC_DG03570,BMG_DG092981,"PubChem CID:15020 | CAS RN:1424-00-6 | MESTEROLONE | DrugBank ID:DB13587 | PubChem SID:198973767 | Mesterolone | (1S,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | UNII:0SRQ75X9I9"
+BMGC_DG03571,BMG_DG092984,CAS RN:53297-68-0 | 4-AMINO-3-CHLOROBENZENESULFONAMIDE | PubChem CID:1502014 | PubChem SID:445500164 | UNII:PQA6DTJ2BX
+BMGC_DG03572,BMG_DG092985,PubChem CID:1502041 | PubChem SID:485663827 | CAS RN:324080-83-3 | UNII:3V6GC2SPR6 | (+)-CIS-2-AMINOMETHYLCYCLOPROPANE CARBOXYLIC ACID | (+)-cis-2-Aminomethylcyclopropane carboxylic acid
+BMGC_DG03573,BMG_DG092993,9-amino-n-[3-(dimethylamino)propyl]acridine-4-carboxamide | UNII:0LY4HYL6F8 | PubChem SID:438788023 | PubChem CID:150238 | CAS RN:89459-44-9 | 9-AMINO-N-(3-(DIMETHYLAMINO)PROPYL)ACRIDINE-4-CARBOXAMIDE | DrugBank ID:DB02842
+BMGC_DG03574,BMG_DG092996,RO-5-3590 | CAS RN:1427-45-8 | PubChem SID:363908622 | UNII:6NIM4Z45PY | PubChem CID:15024
+BMGC_DG03575,BMG_DG092997,UNII:TGB3B74HZP | PubChem SID:472423064 | PubChem CID:15024254 | CAS RN:6704-31-0 | 3-OXETANONE
+BMGC_DG03576,BMG_DG093016,"EZETIMIBE | CAS RN:947332-80-1 | UNII:EOR26LQQ24 | Ezetimibe | (3R,4S)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)azetidin-2-one | CAS RN:163222-33-1 | PubChem SID:175266657 | DrugBank ID:DB00973 | PubChem CID:150311"
+BMGC_DG03577,BMG_DG093021,CAS RN:1434-54-4 | PubChem SID:461434382 | UNII:BA9WH84QAJ | PubChem CID:15032 | PREGNENOLONE CARBONITRILE
+BMGC_DG03578,BMG_DG093054,"PubChem CID:1504717 | DrugBank ID:DB08228 | 5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one"
+BMGC_DG03579,BMG_DG093058,2-Methyladenine | 2-Methyl-6-aminopurine | 2-METHYL-6-AMINOPURINE | UNII:J5S7AW6A3C | CAS RN:1445-08-5 | 2-methyl-7H-purin-6-amine | PubChem CID:15048 | PubChem SID:482554582
+BMGC_DG03580,BMG_DG093091,"UNII:G32F6EID2H | ERTAPENEM | PubChem CID:150610 | (4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxyphenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid | PubChem SID:175265685 | Ertapenem | DrugBank ID:DB00303 | CAS RN:153832-46-3"
+BMGC_DG03581,BMG_DG093095,PubChem CID:15061422 | CAS RN:29586-66-1 | PubChem SID:441331840 | L-LYSYL-L-ARGININE | UNII:HX25W9VLX3
+BMGC_DG03582,BMG_DG093127,DrugBank ID:DB02463 | PubChem CID:1507 | 2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine
+BMGC_DG03583,BMG_DG093134,"PubChem SID:329904077 | CETIRIZINE, (S)- | CAS RN:130018-76-7 | UNII:V57G6B5I8Z | PubChem CID:150716"
+BMGC_DG03584,BMG_DG093175,PubChem CID:15083623 | DrugBank ID:DB08658 | Ethyl hydrogen diethylamidophosphate
+BMGC_DG03585,BMG_DG093176,2-(1H-imidazol-5-yl)acetaldehyde | UNII:B4S3Z68DDD | Imidazole-4-acetaldehyde | PubChem SID:485663617 | Imidazole acetylaldehyde | CAS RN:645-14-7 | PubChem CID:150841 | IMIDAZOLE ACETYLALDEHYDE
+BMGC_DG03586,BMG_DG093180,"Deoxycytidine diphosphate | DEOXYCYTIDINE 5'-DIPHOSPHATE | PubChem SID:198958029 | UNII:M07S1BKN37 | CAS RN:800-73-7 | PubChem CID:150855 | [(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate"
+BMGC_DG03587,BMG_DG093181,"5-Fluorouridine monophosphate | UNII:BMW6RNK254 | PubChem SID:198944474 | PubChem CID:150856 | 5-FLUOROURIDINE MONOPHOSPHATE | [(2R,3S,4R,5R)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | CAS RN:796-66-7"
+BMGC_DG03588,BMG_DG093196,PubChem CID:150885 | UNII:MZ25L5SJ6Z | N-METHYLSEROTONIN | CAS RN:1134-01-6 | PubChem SID:459055502 | 3-[2-(methylamino)ethyl]-1H-indol-5-ol | N-Methylserotonin
+BMGC_DG03589,BMG_DG093202,"PubChem CID:150893 | 2-(3,4-dimethoxyphenyl)-3,5,6,7,8-pentamethoxychromen-4-one | 3,5,6,7,8,3',4'-HEPTAMETHPHOXYFLAVONE | UNII:288R4CAV1V | CAS RN:1178-24-1 | PubChem SID:198950839 | 3,5,6,7,8,3',4'-Heptamethphoxyflavone"
+BMGC_DG03590,BMG_DG093239,(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carboxylic acid | PubChem CID:151003 | Arginylproline | CAS RN:2418-69-1
+BMGC_DG03591,BMG_DG093242,PubChem SID:312525091 | UNII:OZM0C31BLL | 4-METHOXYPHENCYCLIDINE | CAS RN:2201-35-6 | PubChem CID:15100753
+BMGC_DG03592,BMG_DG093243,N-hexadecanoylglycine | N-Palmitoylglycine | PALMITOYL GLYCINE | DrugBank ID:DB03440 | PubChem CID:151008 | PubChem SID:175267955 | UNII:M6V3RIU5KI | 2-(hexadecanoylamino)acetic acid | CAS RN:2441-41-0
+BMGC_DG03593,BMG_DG093246,2-[(4-hydroxybenzoyl)amino]acetic acid | CAS RN:2482-25-9 | P-HYDROXYHIPPURIC ACID | PubChem CID:151012 | UNII:4E2MH5995F | 4-Hydroxyhippuric acid | PubChem SID:198938004
+BMGC_DG03594,BMG_DG093269,PubChem SID:198979665 | UNII:02X37521XE | CAS RN:551-09-7 | N-1-NAPHTHYLETHYLENEDIAMINE | PubChem CID:15107
+BMGC_DG03595,BMG_DG093271,CAS RN:78281-72-8 | NEPAFENAC | Nepafenac | NDC:82667-400 | DrugBank ID:DB06802 | PubChem SID:175266122 | UNII:0J9L7J6V8C | 2-(2-amino-3-benzoylphenyl)acetamide | PubChem CID:151075 | NDC:82667-500
+BMGC_DG03596,BMG_DG093277,UNII:ZD7D2TE69K | 7-Methoxy-5-prenyloxycoumarin | CAS RN:35590-41-1 | 7-METHOXY-5-PRENYLOXYCOUMARIN | PubChem CID:15108314 | PubChem SID:485666090 | 7-methoxy-5-(3-methylbut-2-enoxy)chromen-2-one
+BMGC_DG03597,BMG_DG093281,"PubChem CID:15109 | 2,6-DIMETHOXYBENZOIC ACID | 2,6-dimethoxybenzoic acid | CAS RN:1466-76-8 | 2,6-Dimethoxybenzoic acid | PubChem SID:198937338 | UNII:G6B3P1LO43"
+BMGC_DG03598,BMG_DG093282,PubChem CID:151090 | PubChem SID:478836798 | CAS RN:60285-35-0 | 10-Piperazinylpropylphenothiazine | UNII:3YGA7J86MH | CAS RN:3240-48-0 | 10-(3-piperazin-1-ylpropyl)phenothiazine | DESMETHYLPERAZINE | Desmethylperazine
+BMGC_DG03599,BMG_DG093283,PubChem CID:151091 | PubChem SID:198975054 | CAS RN:3250-74-6 | 5-(3-PYRIDYL)TETRAZOLE | UNII:ZC84PPS834
+BMGC_DG03600,BMG_DG093288,DrugBank ID:DB04010 | 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide | PubChem CID:1511
+BMGC_DG03601,BMG_DG093299,"(10S,23S)-23-amino-10-ethyl-18-fluoro-10-hydroxy-19-methyl-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaene-5,9-dione | DrugBank ID:DB12185 | PubChem CID:151115 | UNII:OC71PP0F89 | PubChem SID:198958838 | CAS RN:171335-80-1 | EXATECAN | Exatecan"
+BMGC_DG03602,BMG_DG093306,PubChem CID:15113 | DrugBank ID:DB01875 | 8-azaxanthine
+BMGC_DG03603,BMG_DG093310,ASPARTYLGLYCINE | UNII:69Y3FAP7XY | CAS RN:3790-51-0 | PubChem CID:151148 | PubChem SID:404859237
+BMGC_DG03604,BMG_DG093316,PubChem CID:151166 | LUMIRACOXIB | Lumiracoxib | CAS RN:220991-20-8 | DrugBank ID:DB01283 | PubChem SID:198961419 | UNII:V91T9204HU | 2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid
+BMGC_DG03605,BMG_DG093317,PubChem CID:151170 | CAS RN:1794779-92-2 | DrugBank ID:DB03849 | Cilomilast | PubChem SID:198977834 | CILOMILAST | CAS RN:153259-69-9 | UNII:8ATB1C1R6X | CAS RN:153259-65-5 | 4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane-1-carboxylic acid | CAS RN:164414-71-5
+BMGC_DG03606,BMG_DG093318,"PubChem SID:175266283 | CONIVAPTAN | N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide | Conivaptan | DrugBank ID:DB00872 | PubChem CID:151171 | UNII:0NJ98Y462X | CAS RN:210101-16-9"
+BMGC_DG03607,BMG_DG093319,CARIPORIDE | PubChem CID:151172 | UNII:7E3392891K | PubChem SID:198961660 | CAS RN:159138-80-4 | Cariporide | N-(diaminomethylidene)-3-methylsulfonyl-4-propan-2-ylbenzamide | DrugBank ID:DB06468 | CAS RN:159138-73-5
+BMGC_DG03608,BMG_DG093320,PubChem CID:151174 | N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-propan-2-ylpyridine-2-sulfonamide | UNII:64J9J55263 | PubChem SID:198939441 | CAS RN:180384-57-0 | Tezosentan | DrugBank ID:DB06558 | TEZOSENTAN
+BMGC_DG03609,BMG_DG093328,"UNII:12D06G8W8E | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-propan-2-ylpropan-2-amine | 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE | CAS RN:4021-34-5 | 5-Methoxy-N,N-diisopropyltryptamine | DrugBank ID:DB01441 | PubChem SID:198984839 | PubChem CID:151182 | 5-Methoxy-N,N-Diisopropyltryptamine"
+BMGC_DG03610,BMG_DG093330,DrugBank ID:DB08775 | PubChem CID:15118984 | Benzoyl-tyrosine-alanine-fluoro-methyl ketone
+BMGC_DG03611,BMG_DG093332,DrugBank ID:DB04879 | UNII:5DX9U76296 | Vatalanib | N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine | CAS RN:212141-54-3 | PubChem CID:151194 | PubChem SID:198989869 | VATALANIB
+BMGC_DG03612,BMG_DG093339,"PubChem SID:472421746 | 3,3-DIPHENYL-N-DIMETHYLPROPYLAMINE | CAS RN:4646-55-3 | PubChem CID:151221 | UNII:FCJ7Q4D8PL"
+BMGC_DG03613,BMG_DG093345,"DrugBank ID:DB03380 | UNII:05LU01CS4T | PubChem SID:198970994 | TYROSINAMIDE, L- | L-tyrosinamide | PubChem CID:151243 | CAS RN:4985-46-0"
+BMGC_DG03614,BMG_DG093346,alpha-Fluoro-beta-ureidopropionic acid | PubChem CID:151244 | CAS RN:5006-64-4 | 3-(carbamoylamino)-2-fluoropropanoic acid | .ALPHA.-FLUOROURIDOPROPIONIC ACID | UNII:0BXG1I9G0W | PubChem SID:363908758
+BMGC_DG03615,BMG_DG093350,"CAS RN:1950593-39-1 | 3-(3,4-DIMETHOXYPHENYL)-N-(2-(4-METHOXYPHENYL)-ETHYL)ACRYLAMIDE, (E)- | PubChem CID:15125273 | PubChem SID:405218123 | UNII:LWX93T9MWA"
+BMGC_DG03616,BMG_DG093354,"UNII:DJM6K5T6YA | RIBULOSE, D- | CAS RN:488-84-6 | UNII:Z7U4KG0138 | PubChem CID:151261 | (3R,4R)-1,3,4,5-tetrahydroxypentan-2-one | CAS RN:5556-48-9 | RIBULOSE, DL- | D-ribulose | PubChem SID:249492095 | PubChem SID:316916369"
+BMGC_DG03617,BMG_DG093362,HOMOVANILLIN | Homovanillin | PubChem CID:151276 | CAS RN:5703-24-2 | PubChem SID:461433523 | UNII:UR4FHW3APJ | 2-(4-hydroxy-3-methoxyphenyl)acetaldehyde
+BMGC_DG03618,BMG_DG093366,GLYCYLMETHIONINE | CAS RN:554-94-9 | PubChem SID:252823764 | PubChem CID:151282 | UNII:0H4L5K3198
+BMGC_DG03619,BMG_DG093369,"DrugBank ID:DB01227 | UNII:R3B637Y991 | Levomethadyl Acetate | PubChem SID:198966824 | [(3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate | CAS RN:1477-40-3 | CAS RN:34433-66-4 | Levacetylmethadol | LEVOMETHADYL ACETATE | PubChem CID:15130"
+BMGC_DG03620,BMG_DG093380,UNII:3F56RA64JN | CAS RN:1477-57-2 | PubChem SID:198938210 | FERTILYSIN | PubChem CID:15134
+BMGC_DG03621,BMG_DG093391,UNII:HL43FKA3K5 | PubChem SID:485661165 | 3-Acetylaminocarbazole | 3-ACETYLAMINOCARBAZOLE | CAS RN:57102-95-1 | PubChem CID:151368
+BMGC_DG03622,BMG_DG093397,1-(4-fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one | PubChem SID:198963922 | CAS RN:1480-19-9 | FLUANISONE | Fluanisone | DrugBank ID:DB13665 | UNII:1D0W98U1I4 | PubChem CID:15139
+BMGC_DG03623,BMG_DG093401,DrugBank ID:DB04371 | PubChem CID:1514 | AL6528
+BMGC_DG03624,BMG_DG093405,PubChem CID:1514158 | PubChem SID:472410592 | (2-(Aminomethyl)phenyl)acetic acid | UNII:623T25PB6H | CAS RN:40851-65-8 | (2-(AMINOMETHYL)PHENYL)ACETIC ACID
+BMGC_DG03625,BMG_DG093408,"UNII:B88HVM1NMZ | PubChem CID:151419 | 1-(3-CARBOXYPROPYL)THEOBROMINE | 1-(3-Carboxypropyl)-3,7-dimethylxanthine | CAS RN:6493-07-8 | PubChem SID:198955590 | 4-(3,7-dimethyl-2,6-dioxopurin-1-yl)butanoic acid"
+BMGC_DG03626,BMG_DG093442,"DrugBank ID:DB02710 | 2,3,-Dihydroxybenzoylserine | PubChem CID:151483"
+BMGC_DG03627,BMG_DG093452,"(2S,4R)-pyrrolidine-2,4-dicarboxylic acid | PubChem CID:1515192 | trans-4-Carboxy-L-proline | CAS RN:64769-66-0"
+BMGC_DG03628,BMG_DG093457,UNII:873480KS4A | PubChem SID:198942658 | CAS RN:58546-56-8 | PubChem CID:151529 | SCHISANTHERIN A
+BMGC_DG03629,BMG_DG093509,"PubChem CID:151725 | 2-(3,4-dihydroxyphenyl)-2-hydroxyacetaldehyde | CAS RN:13023-73-9 | 3,4-Dihydroxymandelaldehyde"
+BMGC_DG03630,BMG_DG093513,"1-(2,4,5-Trimethoxyphenyl)-1,2-propanedione | PubChem CID:15172937 | 1-(2,4,5-trimethoxyphenyl)propane-1,2-dione | CAS RN:2020-84-0"
+BMGC_DG03631,BMG_DG093539,CAS RN:89913-60-0 | PubChem SID:381608474 | PubChem CID:15181201 | UNII:BIO9XQ683U | ACETYL-.ALPHA.-BOSWELLIC ACID
+BMGC_DG03632,BMG_DG093546,"4-AMINO-2-(4-BORONOBUTYL)-D-PROLINE, (4S)- | UNII:JYT5PWQ695 | CAS RN:2374807-39-1 | PubChem CID:151845994"
+BMGC_DG03633,BMG_DG093568,"UNII:XS499WOZ93 | CAS RN:211100-13-9 | SABARUBICIN | PubChem CID:151897 | DrugBank ID:DB12410 | (7S,9S)-7-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione | Sabarubicin | PubChem SID:198938143"
+BMGC_DG03634,BMG_DG093569,4-METHYLTHIOAMPHETAMINE | 4-Methylthioamphetamine | CAS RN:14116-06-4 | PubChem CID:151900 | PubChem SID:316914809 | 1-(4-methylsulfanylphenyl)propan-2-amine | UNII:6JP2T8KXTR
+BMGC_DG03635,BMG_DG093571,zinc;2-aminoacetate | CAS RN:7214-08-6 | PubChem SID:175267847 | ZINC GLYCINATE | CAS RN:14281-83-5 | DrugBank ID:DB14493 | Zinc Glycinate | UNII:681VJX72FE | PubChem CID:151910
+BMGC_DG03636,BMG_DG093576,CHROMIUM PICOLINATE | UNII:S71T8B8Z6P | DrugBank ID:DB11255 | CAS RN:15713-60-7 | PubChem CID:151932 | chromium(3+);pyridine-2-carboxylate | Chromium Picolinate | PubChem SID:175265846 | CAS RN:14639-25-9
+BMGC_DG03637,BMG_DG093611,"PubChem CID:152031485 | UNII:S7V5RX5WBZ | S7V5RX5Wbz | NT-0796 | CAS RN:2272917-13-0 | PubChem SID:485665768 | propan-2-yl (2R)-2-(1,2,3,5,6,7-hexahydro-s-indacen-4-ylcarbamoyloxy)-3-pyrimidin-2-ylpropanoate"
+BMGC_DG03638,BMG_DG093612,1-ISOAMYL-3-ISOBUTYLXANTHINE | PubChem SID:198950237 | CAS RN:63908-26-9 | PubChem CID:152034 | UNII:976SW405SB
+BMGC_DG03639,BMG_DG093626,"PubChem SID:175268451 | DrugBank ID:DB00846 | NDC:45802-928 | (1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one | UNII:8EUL29XUQT | PubChem CID:15209 | Flurandrenolide | FLURANDRENOLIDE | NDC:16110-587 | NDC:51672-5301 | NDC:63629-8657 | NDC:72162-1439 | CAS RN:1524-88-5"
+BMGC_DG03640,BMG_DG093629,"PubChem CID:1521 | DrugBank ID:DB02072 | 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid"
+BMGC_DG03641,BMG_DG093640,"4,4'-DINITROBIPHENYL | PubChem CID:15216 | UNII:6X8N704C9U | CAS RN:1528-74-1 | 1-nitro-4-(4-nitrophenyl)benzene | PubChem SID:198949841 | 4,4'-Dinitrobiphenyl"
+BMGC_DG03642,BMG_DG093692,DrugBank ID:DB02542 | PubChem CID:15227560 | (4s)-5-Fluoro-L-Leucine
+BMGC_DG03643,BMG_DG093696,N-CAFFEOYLALANINE | CAS RN:170663-16-8 | UNII:C7G6G5T5J7 | PubChem SID:461432322 | PubChem CID:15228041
+BMGC_DG03644,BMG_DG093705,"UNII:C238FB5W7N | PubChem CID:152300 | PubChem SID:472421954 | 1H-INDOLE-4,7-DIONE | CAS RN:20342-64-7"
+BMGC_DG03645,BMG_DG093707,"[(2R,3R,4R,5S)-2,3,4,5,6-pentahydroxyhexyl] dihydrogen phosphate | Sorbitol 6-phosphate | CAS RN:20479-58-7 | D-glucitol 6-phosphate | PubChem CID:152306 | DrugBank ID:DB02548"
+BMGC_DG03646,BMG_DG093723,"PENICILLIN G BENZATHINE ANHYDROUS | N,N'-dibenzylethane-1,2-diamine;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem CID:15232 | CAS RN:1538-09-6 | Benzathine benzylpenicillin | PubChem SID:198943275 | UNII:SSZ1S4I0US"
+BMGC_DG03647,BMG_DG093730,"CAS RN:164123-54-0 | UNII:MM2Q83EZ8W | PubChem CID:15233562 | Glabrocoumarone B | PubChem SID:198962120 | GLABROCOUMARONE B | 6-(6-hydroxy-1-benzofuran-2-yl)-2,2-dimethylchromen-5-ol"
+BMGC_DG03648,BMG_DG093761,"PubChem CID:152430 | PubChem SID:440793554 | CAS RN:21763-80-4 | UNII:MRF3C7FE9G | 5-HYDROXY-3',4',6,7-TETRAMETHOXYFLAVONE"
+BMGC_DG03649,BMG_DG093763,Aspartyl phosphate | PubChem CID:152441 | CAS RN:22138-53-0 | (2S)-2-amino-4-oxo-4-phosphonooxybutanoic acid | Phosphoaspartate | DrugBank ID:DB01857
+BMGC_DG03650,BMG_DG093768,"UNII:HB9CUU5ZAF | CAS RN:75919-74-3 | N4-(7-((7-AMINO-2-METHYLQUINOLIN-4-YL)AMINO)HEPTYL)-2-METHYLQUINOLINE-4,7-DIAMINE | N4-{7-[(7-amino-2-methylquinolin-4-yl)amino]heptyl}-2-methylquinoline-4,7-diamine | PubChem SID:475550222 | PubChem CID:152481"
+BMGC_DG03651,BMG_DG093770,IBUFENAC | CAS RN:1553-60-2 | PubChem SID:198980720 | PubChem CID:15250 | UNII:5V4WIX44VI
+BMGC_DG03652,BMG_DG093877,"MOXIFLOXACIN | CAS RN:151096-09-2 | PubChem SID:175266173 | 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid | DrugBank ID:DB00218 | UNII:U188XYD42P | PubChem CID:152946 | Moxifloxacin"
+BMGC_DG03653,BMG_DG093878,PHENYLPHOSPHONIC ACID | CAS RN:1571-33-1 | UNII:BYD76T2868 | PubChem SID:198963644 | PubChem CID:15295
+BMGC_DG03654,BMG_DG093879,"ARGATROBAN ANHYDROUS, (21R)- | UNII:0DW7MIH1VX | Argatroban anhydrous, (21R)- | PubChem SID:198943625 | DrugBank ID:DB00278 | CAS RN:121785-71-5 | (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(3R)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid | PubChem CID:152951 | Argatroban"
+BMGC_DG03655,BMG_DG093883,"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione | PubChem CID:15295578 | DrugBank ID:DB07234"
+BMGC_DG03656,BMG_DG093893,"CAS RN:29625-79-4 | 3-deoxy-D-arabino-hexonic acid | DrugBank ID:DB03303 | (2S,4S,5R)-2,4,5,6-tetrahydroxyhexanoic acid | PubChem CID:152990 | 3-Deoxy-arabino-hexonic acid | CAS RN:1518-59-8"
+BMGC_DG03657,BMG_DG093895,"2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | 2-AMINO-1-METHYL-6-PHENYLIMIDAZO(4,5-B)PYRIDINE | UNII:909C6UN66T | PubChem SID:198966617 | PubChem CID:1530 | 1-methyl-6-phenylimidazo[4,5-b]pyridin-2-amine | CAS RN:1185024-97-8 | CAS RN:138370-35-1 | DrugBank ID:DB08398 | CAS RN:105650-23-5"
+BMGC_DG03658,BMG_DG093918,PubChem CID:15311937 | (5-Amino-1-phenyl-1H-pyrazol-4-yl)phenylmethanone | PubChem SID:485663501 | (5-AMINO-1-PHENYL-1H-PYRAZOL-4-YL)PHENYLMETHANONE | CAS RN:54606-37-0 | UNII:U479A4Y3YR
+BMGC_DG03659,BMG_DG093937,PubChem CID:153224 | CAS RN:104499-47-0 | PubChem SID:198971136 | UNII:ZSB2WGJ69E | 2-((2-METHYLAMINOETHYL)(P-METHOXYBENZYL)AMINO)PYRIDINE
+BMGC_DG03660,BMG_DG093944,"CAS RN:198821-22-6 | [(3S)-oxolan-3-yl] N-[[3-[[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]carbamoylamino]phenyl]methyl]carbamate | DrugBank ID:DB04862 | PubChem SID:198954413 | PubChem CID:153241 | Merimepodib | MERIMEPODIB | UNII:2ZL2BA06FU"
+BMGC_DG03661,BMG_DG093951,"CAS RN:192755-52-5 | (4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide | UNII:N986NI319S | Pralnacasan | PubChem CID:153270 | PRALNACASAN | DrugBank ID:DB04875 | PubChem SID:198960507"
+BMGC_DG03662,BMG_DG093961,CAS RN:695-34-1 | PubChem CID:1533 | 2-Amino-4-methylpyridine | PubChem SID:198984816 | 2-AMINO-4-METHYLPYRIDINE | UNII:394N1Z644H
+BMGC_DG03663,BMG_DG093963,"DAMINOZIDE | 4-(2,2-dimethylhydrazinyl)-4-oxobutanoic acid | PubChem SID:198956852 | Daminozide | PubChem CID:15331 | UNII:F6KF33M5UB | CAS RN:1596-84-5"
+BMGC_DG03664,BMG_DG093990,INDOMETHACIN METHYL ESTER | PubChem SID:474492192 | Indomethacin methyl ester | PubChem CID:15339 | UNII:V7N8G32K46 | CAS RN:1601-18-9
+BMGC_DG03665,BMG_DG094017,"PubChem CID:15345559 | 4-(3-Trifluoromethyl-4H-thiochromeno[4,3-c]pyrazol-1-yl)-benzenesulfonamide | CAS RN:178975-20-7 | 4-[3-(trifluoromethyl)-4H-thiochromeno[4,3-c]pyrazol-1-yl]benzenesulfonamide"
+BMGC_DG03666,BMG_DG094023,UNII:Y2WWD85QY6 | 2-AMINO-3-METHYLPYRIDINE | CAS RN:1603-40-3 | PubChem SID:198961110 | PubChem CID:15347
+BMGC_DG03667,BMG_DG094026,UNII:8UM54T43WT | PubChem SID:198990360 | CAS RN:1603-41-4 | PubChem CID:15348 | 2-AMINO-5-METHYLPYRIDINE | 6-AMINO-3-METHYLPYRIDINE
+BMGC_DG03668,BMG_DG094038,"sodium;[(2R,5R)-2-fluoro-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] sulfate | ANT-3310 | CAS RN:2410688-61-6 | UNII:U3DY8Q9XZB | ANT3310 sodium | PubChem CID:153516440"
+BMGC_DG03669,BMG_DG094058,PubChem CID:1535935 | DrugBank ID:DB04048 | N-Carbamoyl-Alanine
+BMGC_DG03670,BMG_DG094067,UNII:3NWJ8FHG2R | PubChem CID:153626314 | CAS RN:2445366-94-7 | RELICPIXANT
+BMGC_DG03671,BMG_DG094082,"2,4-DIAMINOPROPOXYBENZENE | PubChem CID:153693 | PubChem SID:485660815 | CAS RN:37878-54-9 | 2,4-Diaminopropoxybenzene | UNII:YED28LA622"
+BMGC_DG03672,BMG_DG094097,"CAS RN:1617-90-9 | PubChem SID:175265816 | Vincamine | DrugBank ID:DB13374 | UNII:996XVD0JHT | PubChem CID:15376 | VINCAMINE | methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate"
+BMGC_DG03673,BMG_DG094106,"2,5-dihydroxy-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]cyclohexa-2,5-diene-1,4-dione | CAS RN:34198-83-9 | (E,E)-Boviquinone 3 | PubChem CID:15379534"
+BMGC_DG03674,BMG_DG094122,"PubChem CID:15384 | PubChem SID:443623685 | CAS RN:3483-84-9 | 3-HYDROXY-N,N,N-TRIMETHYLBENZENAMINIUM | UNII:D8U2MF6NR2"
+BMGC_DG03675,BMG_DG094136,Melperone | 1-(4-fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one | PubChem CID:15387 | DrugBank ID:DB09224 | CAS RN:3575-80-2 | PubChem SID:198971642 | UNII:J8WA3K39B7 | MELPERONE
+BMGC_DG03676,BMG_DG094171,MONOISOPROPYL PHOSPHATE | PubChem SID:438789000 | PubChem CID:15391 | CAS RN:1623-24-1 | Phosphorylisopropane | DrugBank ID:DB03976 | UNII:7H0HVR60ZW
+BMGC_DG03677,BMG_DG094188,DrugBank ID:DB00442 | PubChem CID:153941 | Entecavir
+BMGC_DG03678,BMG_DG094191,"PubChem SID:198989475 | RANIRESTAT | Ranirestat | (3R)-2'-[(4-bromo-2-fluorophenyl)methyl]spiro[pyrrolidine-3,4'-pyrrolo[1,2-a]pyrazine]-1',2,3',5-tetrone | CAS RN:147254-64-6 | PubChem CID:153948 | DrugBank ID:DB05327 | UNII:Z26P56GFTV"
+BMGC_DG03679,BMG_DG094197,"SAPACITABINE | PubChem CID:153970 | DrugBank ID:DB06365 | Sapacitabine | N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide | PubChem SID:198973580 | UNII:W335P73C3L | CAS RN:151823-14-2"
+BMGC_DG03680,BMG_DG094199,"ROSTAFUROXIN | UNII:P848LCX62B | PubChem SID:198977882 | DrugBank ID:DB12350 | CAS RN:156722-18-8 | Rostafuroxin | PubChem CID:153976 | (3S,5R,8R,9S,10S,13S,14S,17S)-17-(furan-3-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,14,17-triol"
+BMGC_DG03681,BMG_DG094207,"PubChem CID:15399 | UNII:LB7TXV3P6M | CAS RN:1631-28-3 | N,P-TOLYLMALEIMIDE | PubChem SID:472387832"
+BMGC_DG03682,BMG_DG094210,"CAS RN:167221-71-8 | Clevidipine | NDC:10122-610 | PubChem SID:175272096 | CLEVIDIPINE | NDC:10122-611 | UNII:19O2GP3B7Q | NDC:18124-011 | PubChem CID:153994 | CAS RN:166432-28-6 | 5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | DrugBank ID:DB04920"
+BMGC_DG03683,BMG_DG094212,"PubChem SID:198952861 | CAS RN:167465-36-3 | UNII:813AGY3126 | Zosuquidar Trihydrochloride | PubChem CID:153997 | ZOSUQUIDAR TRIHYDROCHLORIDE | Zosuquidar | (2R)-1-[4-[(2S,4R)-3,3-difluoro-11-tetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaenyl]piperazin-1-yl]-3-quinolin-5-yloxypropan-2-ol;trihydrochloride | DrugBank ID:DB06191"
+BMGC_DG03684,BMG_DG094213,"PubChem CID:153999 | CAS RN:169939-94-0 | PubChem SID:198935331 | RUBOXISTAURIN | UNII:721809WQCP | Ruboxistaurin | (18S)-18-[(dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione | DrugBank ID:DB11829"
+BMGC_DG03685,BMG_DG094215,DrugBank ID:DB06948 | 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE | PubChem CID:1540
+BMGC_DG03686,BMG_DG094216,PubChem CID:15400 | UNII:7M36TYL94R | N-(4-CHLOROPHENYL)MALEIMIDE | PubChem SID:474490177 | N-(4-Chlorophenyl)maleimide | CAS RN:1631-29-4
+BMGC_DG03687,BMG_DG094217,"CAS RN:170861-63-9 | UNII:P9UTN18JVV | Reglitazar | PubChem SID:198972357 | PubChem CID:154000 | 4-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1,2-oxazolidine-3,5-dione | REGLITAZAR | DrugBank ID:DB04971"
+BMGC_DG03688,BMG_DG094238,"SOLIFENACIN | UNII:A8910SQJ1U | PubChem CID:154059 | [(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate | Solifenacin | PubChem SID:175267327 | CAS RN:1172613-99-8 | DrugBank ID:DB01591 | CAS RN:242478-37-1"
+BMGC_DG03689,BMG_DG094265,NDC:50458-588 | NDC:13107-382 | NDC:43602-329 | NDC:10702-102 | NDC:0078-0441 | NDC:43386-861 | NDC:0078-0371 | NDC:10702-101 | NDC:63629-2176 | NDC:27808-059 | NDC:72162-2430 | NDC:0406-1860 | NDC:24478-324 | NDC:72162-1992 | PubChem SID:175271545 | NDC:51862-611 | NDC:50268-547 | NDC:67877-618 | NDC:72865-122 | NDC:31722-927 | NDC:63629-2172 | NDC:24478-075 | NDC:0781-2686 | NDC:16714-567 | NDC:31722-928 | NDC:72865-123 | NDC:66758-263 | NDC:0093-5295 | UNII:4B3SC438HI | NDC:72162-2041 | NDC:72162-2428 | methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate;hydrochloride | NDC:16714-566 | NDC:67877-603 | NDC:72162-2429 | NDC:13811-706 | NDC:57664-376 | NDC:65038-286 | NDC:0093-5562 | NDC:0527-8113 | NDC:0115-1683 | NDC:72162-1993 | NDC:72162-1636 | NDC:63629-1923 | NDC:0406-1850 | NDC:13811-700 | NDC:63629-1919 | NDC:62037-725 | NDC:43602-328 | NDC:55466-123 | NDC:71930-025 | NDC:0115-1685 | NDC:70010-007 | NDC:43602-334 | NDC:72865-134 | NDC:70010-010 | NDC:68025-088 | NDC:57664-609 | NDC:50268-528 | NDC:72162-2087 | NDC:42858-078 | NDC:0527-4581 | NDC:59630-750 | NDC:72162-1286 | NDC:0115-1686 | NDC:70010-011 | NDC:0078-0608 | NDC:63629-2307 | NDC:66758-274 | NDC:42858-404 | NDC:0406-1840 | NDC:62175-310 | NDC:10702-075 | NDC:16714-569 | NDC:70010-012 | NDC:43598-440 | NDC:51407-528 | NDC:62037-734 | NDC:75834-327 | NDC:42858-076 | NDC:63629-1176 | NDC:75834-326 | NDC:51862-610 | NDC:24478-323 | NDC:50268-529 | NDC:31722-233 | NDC:68025-098 | NDC:72162-2040 | NDC:57664-710 | NDC:72865-124 | METHYLPHENIDATE HYDROCHLORIDE | NDC:43547-486 | NDC:49884-049 | NDC:0093-5347 | NDC:0527-8112 | NDC:13107-381 | NDC:70010-009 | NDC:72162-1493 | NDC:70010-014 | NDC:51862-609 | NDC:0406-1830 | NDC:16714-565 | NDC:0078-0381 | NDC:66758-236 | NDC:49884-430 | NDC:0781-2362 | NDC:43386-931 | NDC:0078-0493 | NDC:0093-5346 | NDC:42858-407 | NDC:0527-8108 | NDC:0093-5550 | NDC:0078-0434 | UNII:1678OK0E08 | NDC:42858-405 | NDC:70752-132 | NDC:0093-5045 | NDC:64980-221 | NDC:13811-710 | NDC:60687-532 | NDC:0406-1820 | NDC:0591-3862 | NDC:68025-084 | NDC:16714-563 | NDC:0406-1144 | NDC:66758-275 | NDC:0115-9919 | NDC:66758-260 | NDC:13107-380 | NDC:72162-1473 | NDC:51407-927 | NDC:68084-823 | NDC:66758-239 | NDC:42858-079 | NDC:65162-231 | NDC:24478-322 | NDC:27808-093 | NDC:16729-480 | NDC:64980-223 | NDC:43602-330 | NDC:71376-201 | NDC:67877-616 | NDC:57664-607 | NDC:69654-581 | NDC:0406-0154 | NDC:42858-403 | NDC:50458-587 | NDC:68025-096 | NDC:63629-1921 | NDC:72865-135 | NDC:0093-5046 | NDC:31722-954 | NDC:50268-546 | NDC:0078-0439 | NDC:27808-058 | NDC:71376-202 | NDC:43386-571 | NDC:75907-053 | NDC:66758-240 | NDC:0115-1737 | NDC:31722-174 | NDC:0527-8106 | NDC:72162-1472 | NDC:75907-049 | NDC:31722-234 | NDC:49884-248 | NDC:0115-1739 | NDC:57664-379 | NDC:68084-805 | NDC:62175-311 | NDC:10702-076 | NDC:0781-2363 | NDC:50458-585 | NDC:0078-0370 | NDC:51862-614 | NDC:0591-3869 | NDC:57664-378 | NDC:0527-4583 | NDC:66758-241 | NDC:31722-236 | NDC:63629-2306 | NDC:72865-136 | NDC:50458-586 | NDC:0406-0136 | NDC:43386-573 | NDC:65162-233 | NDC:0093-5551 | NDC:67877-657 | NDC:69654-584 | NDC:60687-565 | NDC:72162-1488 | NDC:50268-548 | NDC:69654-580 | NDC:0406-0127 | Dexmethylphenidate Hydrochloride | NDC:72162-1502 | NDC:31722-926 | NDC:71376-204 | NDC:66758-242 | NDC:0591-3895 | NDC:0093-5554 | NDC:13811-707 | NDC:43386-574 | NDC:0115-1741 | NDC:10702-108 | NDC:72865-125 | NDC:66758-262 | NDC:0527-4579 | NDC:62037-727 | NDC:57664-608 | NDC:72865-126 | NDC:62175-313 | NDC:67877-602 | NDC:0115-9920 | NDC:0406-1473 | NDC:57664-606 | NDC:63629-2460 | NDC:68025-095 | NDC:0093-5297 | NDC:0115-9921 | NDC:55466-103 | NDC:0078-0431 | NDC:0078-0382 | NDC:65038-561 | NDC:0078-0430 | NDC:49884-428 | NDC:66758-252 | NDC:10702-107 | NDC:24478-076 | NDC:16714-568 | NDC:0591-3854 | NDC:13811-709 | NDC:72162-1496 | NDC:43598-441 | NDC:10702-163 | NDC:69654-583 | NDC:0527-4582 | NDC:31722-953 | NDC:16714-562 | NDC:0115-1802 | NDC:55466-101 | NDC:42858-080 | NDC:51862-612 | NDC:0406-1146 | NDC:59630-755 | NDC:70010-004 | NDC:39328-054 | CAS RN:23655-65-4 | NDC:50268-545 | NDC:10702-164 | NDC:75907-051 | NDC:55466-102 | NDC:70010-016 | NDC:16729-478 | NDC:31722-952 | NDC:0115-1684 | NDC:43598-438 | NDC:67877-656 | NDC:72162-1284 | NDC:24478-074 | NDC:51407-527 | NDC:63629-2178 | NDC:43386-570 | NDC:49884-546 | NDC:66758-237 | NDC:0406-1445 | NDC:63629-2461 | NDC:72162-2019 | NDC:67877-617 | DEXMETHYLPHENIDATE HYDROCHLORIDE | NDC:49884-048 | NDC:49884-339 | NDC:0781-2685 | NDC:31722-229 | NDC:42858-402 | NDC:63629-1172 | NDC:63629-2459 | NDC:0781-2688 | NDC:72162-2427 | NDC:0115-1710 | NDC:72162-2086 | NDC:70010-008 | NDC:0078-0433 | NDC:43602-332 | NDC:0591-3873 | NDC:63629-2175 | NDC:10147-0686 | NDC:43602-333 | NDC:31722-230 | NDC:63629-2305 | NDC:0078-0440 | NDC:0115-1800 | NDC:57664-230 | NDC:42858-075 | NDC:43386-572 | NDC:13811-708 | NDC:31722-231 | NDC:70752-131 | NDC:0078-0432 | NDC:0527-4584 | NDC:62175-312 | NDC:16729-479 | NDC:65038-429 | NDC:0591-3902 | PubChem SID:175266195 | NDC:0078-0424 | NDC:72162-2395 | NDC:0781-2684 | CAS RN:19262-68-1 | NDC:0591-3891 | NDC:42858-077 | NDC:72865-133 | NDC:70010-015 | NDC:10147-0688 | NDC:27808-092 | NDC:0781-2689 | NDC:0406-1142 | NDC:66758-238 | NDC:69654-579 | NDC:63629-2177 | NDC:66758-261 | NDC:39328-154 | NDC:16714-564 | NDC:43386-575 | NDC:75834-328 | NDC:0115-1801 | NDC:0078-0609 | NDC:24478-321 | NDC:72162-1507 | NDC:71376-205 | NDC:63629-2171 | NDC:0527-4580 | NDC:55466-122 | NDC:0078-0372 | NDC:0093-5348 | NDC:67877-655 | NDC:72162-2394 | NDC:10702-106 | NDC:71335-1219 | NDC:70010-005 | NDC:0527-8110 | NDC:42858-081 | NDC:75834-324 | NDC:43602-327 | NDC:10147-0687 | NDC:69654-582 | NDC:75907-050 | NDC:60687-543 | NDC:60687-554 | NDC:0406-1810 | NDC:13811-711 | NDC:10702-100 | NDC:68025-097 | NDC:0781-2683 | NDC:0115-1682 | NDC:43386-860 | NDC:0527-8111 | NDC:66758-235 | NDC:43547-488 | NDC:31722-955 | NDC:70010-006 | NDC:0093-5552 | NDC:43386-930 | NDC:27808-091 | NDC:66758-250 | NDC:0527-8109 | NDC:0781-2364 | NDC:70010-013 | NDC:0781-2361 | NDC:43386-862 | NDC:0781-2682 | NDC:43598-439 | NDC:64980-222 | NDC:0115-9918 | NDC:63629-2174 | NDC:62037-726 | NDC:51407-924 | NDC:42858-406 | NDC:71376-203 | NDC:72865-127 | NDC:68025-089 | NDC:0115-1709 | NDC:72162-1306 | NDC:57664-228 | NDC:57664-229 | NDC:51407-925 | NDC:31722-232 | NDC:0078-0380 | NDC:0781-2687 | NDC:0093-5553 | NDC:0115-9922 | NDC:0115-1740 | NDC:0115-1736 | NDC:0115-1738 | NDC:31722-175 | NDC:75907-052 | NDC:31722-235 | NDC:66758-251 | NDC:43602-331 | NDC:72162-1285 | NDC:63629-1175 | NDC:31722-173 | NDC:10147-0685 | NDC:51407-926 | NDC:71930-024 | NDC:49884-333 | NDC:75834-325 | NDC:65162-237 | PubChem CID:154100 | NDC:65162-235 | NDC:42858-401 | NDC:66758-273 | NDC:63629-2173 | NDC:72162-2426 | NDC:43547-487 | NDC:0527-8107 | NDC:72162-1503
+BMGC_DG03690,BMG_DG094266,DrugBank ID:DB06701 | UNII:M32RH9MFGP | methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate | PubChem CID:154101 | CAS RN:40572-71-2 | PubChem SID:175265480 | DEXMETHYLPHENIDATE | Dexmethylphenidate | CAS RN:40431-64-9
+BMGC_DG03691,BMG_DG094268,"UNII:1G26B32139 | DrugBank ID:DB12402 | PubChem CID:154104 | PUMOSETRAG | PubChem SID:198950268 | N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-7-oxo-4H-thieno[3,2-b]pyridine-6-carboxamide | CAS RN:153062-94-3 | Pumosetrag | CAS RN:1055328-70-5"
+BMGC_DG03692,BMG_DG094278,"CAS RN:199294-70-7 | PubChem CID:154118 | PubChem SID:459055639 | UNII:R83EK9ELX5 | N-((6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL)-2-(6-METHYL-2-OXO-3-((2-PHENYLETHYL)AMINO)-1,2-DIHYDROPYRAZIN-1-YL)ACETAMIDE"
+BMGC_DG03693,BMG_DG094280,TETRABUTYLTHIURAM DISULFIDE | CAS RN:1634-02-2 | UNII:D969886EAB | PubChem SID:198950981 | PubChem CID:15412
+BMGC_DG03694,BMG_DG094321,"(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid | PubChem SID:198964312 | CAS RN:330600-85-6 | PERAMIVIR, (+/-)- | CAS RN:229614-55-5 | UNII:IDL9Q29886 | PubChem CID:154234 | DrugBank ID:DB06614 | CAS RN:229614-56-6 | PERAMIVIR ANHYDROUS | UNII:9ZS94HQO3B | PubChem SID:198936098 | PERAMIVIR, (±)- | Peramivir"
+BMGC_DG03695,BMG_DG094326,CAS RN:198481-33-3 | UNII:J70472UD3D | NDC:63539-122 | NDC:0008-1123 | Bazedoxifene acetate | acetic acid;1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol | PubChem SID:175266781 | BAZEDOXIFENE ACETATE | PubChem CID:154256
+BMGC_DG03696,BMG_DG094327,PubChem SID:175267431 | PubChem CID:154257 | DrugBank ID:DB06401 | Bazedoxifene | BAZEDOXIFENE | UNII:Q16TT9C5BK | 1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol | CAS RN:198481-32-2
+BMGC_DG03697,BMG_DG094336,UNII:CVF7AS78X7 | CAS RN:150208-44-9 | PubChem CID:15428989 | PubChem SID:474492681 | BD1031
+BMGC_DG03698,BMG_DG094343,"PubChem CID:1543 | UNII:BZ7Z2Q49PA | Brequinar Analog | CAS RN:96187-27-8 | DrugBank ID:DB03480 | 2-(1,1'-BIPHENYL)-4-YL-6-FLUORO-3-METHYL-4-QUINOLINECARBOXYLIC ACID"
+BMGC_DG03699,BMG_DG094347,"PubChem CID:154315 | (7S)-5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene | UNII:A1AD8U189I | MIANSERIN, (S)- | PubChem SID:346537664 | CAS RN:51152-88-6 | Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (14bS)-"
+BMGC_DG03700,BMG_DG094353,"UNII:4F6FC4MI8W | PubChem SID:175266506 | DrugBank ID:DB04147 | PubChem CID:15433 | Dodecyldimethylamine N-oxide | LAURAMINE OXIDE | N,N-dimethyldodecan-1-amine oxide | CAS RN:1643-20-5 | Lauramine oxide"
+BMGC_DG03701,BMG_DG094395,"UNII:PX44XO846X | PubChem CID:154417 | PubChem SID:175266156 | CAS RN:101-31-5 | Hyoscyamine | [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate | HYOSCYAMINE | DrugBank ID:DB00424 | CAS RN:912642-93-4"
+BMGC_DG03702,BMG_DG094401,CAS RN:1649-18-9 | UNII:19BV78AK7W | PubChem SID:198964669 | PubChem CID:15443 | DrugBank ID:DB11376 | 1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one | AZAPERONE | Azaperone
+BMGC_DG03703,BMG_DG094419,"CAS RN:138154-38-8 | 5-((2-(DIMETHYLAMINO)ETHYL)AMINO)-8-HYDROXY-1-METHYL-6H-IMIDAZO(4,5,1-DE)ACRIDIN-6-ONE | UNII:C4NPB77AWN | PubChem CID:154479"
+BMGC_DG03704,BMG_DG094455,"CID 154562176 | CAS RN:2055732-84-6 | PubChem CID:154562176 | 1-[(2R,6S)-6-[[[(2S,6R)-2-[[[(2R,6S)-2-(2-amino-6-oxo-1H-purin-9-yl)-6-[[[(2S,6R)-2-[[[(2R,6S)-2-(2-amino-6-oxo-1H-purin-9-yl)-6-[[[(2R,6S)-2-(2-amino-6-oxo-1H-purin-9-yl)-6-[[[(2S,6R)-2-[[[(2S,6R)-2-[[[(2R,6S)-2-(2-amino-6-oxo-1H-purin-9-yl)-6-[[[(2S,6R)-2-[[[(2S,6R)-2-[[[(2S,6R)-2-[[[(2S,6R)-2-[[[(2R,6S)-2-(2-amino-6-oxo-1H-purin-9-yl)-6-[[[(2R,6S)-2-(2-amino-6-oxo-1H-purin-9-yl)-6-[[[(2R,6S)-2-(4-amino-2-oxopyrimidin-1-yl)-6-[[[(2R,6S)-2-(4-amino-2-oxopyrimidin-1-yl)-6-[[[(2S,6R)-2-[[[(2R,6S)-2-(4-amino-2-oxopyrimidin-1-yl)-6-[[[(2R,6S)-2-(4-amino-2-oxopyrimidin-1-yl)-6-(hydroxymethyl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-6-(5-methyl-2,4-dioxopyrimidin-1-yl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-6-(5-methyl-2,4-dioxopyrimidin-1-yl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-6-(5-methyl-2,4-dioxopyrimidin-1-yl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-6-(4-amino-2-oxopyrimidin-1-yl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-6-(5-methyl-2,4-dioxopyrimidin-1-yl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-6-(6-aminopurin-9-yl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-6-(6-aminopurin-9-yl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-6-(5-methyl-2,4-dioxopyrimidin-1-yl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-6-(5-methyl-2,4-dioxopyrimidin-1-yl)morpholin-4-yl]-(dimethylamino)phosphoryl]oxymethyl]-4-[[(2S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)morpholin-2-yl]methoxy-(dimethylamino)phosphoryl]morpholin-2-yl]-5-methylpyrimidine-2,4-dione"
+BMGC_DG03705,BMG_DG094504,PubChem CID:154572856 | CAS RN:3616-06-6 | PubChem SID:433968396 | UNII:I839TB018F | UDP-ALPHA-D-XYLOPYRANOSE
+BMGC_DG03706,BMG_DG094521,"PubChem CID:154572876 | 2-[[5-[3-[[6-[[(5S)-5-carboxy-5-[[(1S)-1,3-dicarboxypropyl]carbamoylamino]pentyl]amino]-6-oxohexyl]amino]-3-oxopropyl]-2-oxidophenyl]methyl-[2-[[5-(2-carboxyethyl)-2-oxidophenyl]methyl-(carboxylatomethyl)amino]ethyl]amino]acetate;gallium-68(3+);hydron | CAS RN:1906894-20-9 | Gallium Ga-68 gozetotide"
+BMGC_DG03707,BMG_DG094580,"Piclamilast | PubChem CID:154575 | DrugBank ID:DB01791 | PubChem SID:198987688 | 3-cyclopentyloxy-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide | PICLAMILAST | UNII:WM58D7C3ZT | CAS RN:144035-83-6"
+BMGC_DG03708,BMG_DG094683,"NDC:80425-0084 | Metaxalone | NDC:68040-712 | NDC:60760-289 | NDC:0276-0508 | NDC:51655-602 | NDC:71205-326 | NDC:50090-3670 | NDC:60687-663 | NDC:76420-898 | NDC:71335-2066 | NDC:50228-323 | NDC:72789-122 | NDC:50090-3650 | NDC:65162-553 | NDC:50268-530 | NDC:51655-792 | NDC:71205-426 | NDC:72162-1083 | NDC:63187-490 | NDC:69097-998 | NDC:80425-0122 | NDC:50228-474 | NDC:69306-311 | NDC:63629-2097 | NDC:67296-1778 | NDC:69306-100 | CAS RN:1665-48-1 | NDC:70518-0771 | DrugBank ID:DB00660 | NDC:71205-470 | PubChem CID:15459 | NDC:71335-0958 | NDC:63629-8014 | NDC:55700-494 | NDC:72789-028 | NDC:0115-1745 | NDC:45865-161 | NDC:71335-1320 | NDC:51655-171 | NDC:60760-093 | NDC:76420-232 | 5-[(3,5-dimethylphenoxy)methyl]-1,3-oxazolidin-2-one | NDC:0527-1435 | NDC:55111-650 | NDC:71335-0375 | UNII:1NMA9J598Y | NDC:68001-485 | PubChem SID:175272168 | NDC:68788-7499 | NDC:80425-0131 | NDC:63629-2398 | NDC:68788-8678 | NDC:0904-6831 | METAXALONE | NDC:53746-553 | NDC:70518-3778 | NDC:72162-1808 | NDC:0591-2341 | NDC:68788-7018 | NDC:61919-832 | NDC:71205-016 | NDC:68788-7675"
+BMGC_DG03709,BMG_DG094688,PubChem CID:15460 | DIPHENYL DISELENIDE | CAS RN:1666-13-3 | PubChem SID:472406438 | UNII:9ATU3Z459Q | (phenyldiselanyl)benzene | Diphenyl diselenide
+BMGC_DG03710,BMG_DG094703,"Tagtociclib | TEGTOCICLIB | [(1R,3S)-3-[3-[[5-(methoxymethyl)-2-methylpyrazole-3-carbonyl]amino]-1H-pyrazol-5-yl]cyclopentyl] N-propan-2-ylcarbamate | CAS RN:2460249-19-6 | UNII:XBD0JF5EHJ | PubChem SID:482554084 | PubChem CID:154616422"
+BMGC_DG03711,BMG_DG094743,"Pcsk9-IN-12 | 1-[6-[[(1S,3S)-3-[[5-(difluoromethoxy)pyrimidin-2-yl]amino]cyclopentyl]amino]pyridin-3-yl]pyridin-2-one | LAROPROVSTAT | CAS RN:2455427-91-3 | UNII:9EEL3YMY29 | PubChem CID:154653847"
+BMGC_DG03712,BMG_DG094753,"PubChem CID:154663238 | CAS RN:2459489-66-6 | (5R)-4-[(1S,6R)-5-[(2S)-2-(4-chlorophenyl)-3-(propan-2-ylamino)propanoyl]-2,5-diazabicyclo[4.1.0]heptan-2-yl]-5-methyl-6,8-dihydro-5H-pyrido[2,3-d]pyrimidin-7-one"
+BMGC_DG03713,BMG_DG094757,"Prosetin | PubChem CID:154677753 | CAS RN:2375591-69-6 | 2-[4-[[4-[3-(3-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl]phenyl]methyl]piperazin-1-yl]ethanol"
+BMGC_DG03714,BMG_DG095482,"CAS RN:19356-17-3 | PubChem CID:154701712 | (1S,3Z)-3-[2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol"
+BMGC_DG03715,BMG_DG095648,UNII:F8GU4PSP29 | SCH-51866 | PubChem SID:198988512 | CAS RN:167298-74-0 | PubChem CID:15473392
+BMGC_DG03716,BMG_DG095663,CAS RN:16699-20-0 | CAS RN:298-57-7 | PubChem SID:198985337 | Cinnarizine | 1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine | UNII:3DI2E1X18L | PubChem CID:1547484 | CINNARIZINE
+BMGC_DG03717,BMG_DG095688,"Zolunicant, (-)- | 18-Methoxycoronaridine, (+/-)- | methyl (1S,15R,17R,18S)-17-(2-methoxyethyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate | UNII:KX8NQX91Z8 | CAS RN:188125-42-0 | CAS RN:308123-60-6 | PubChem SID:198979165 | UNII:VG463BM9RL | PubChem SID:198939182 | ZOLUNICANT | ZOLUNICANT, (-)- | PubChem CID:15479177 | Zolunicant | DrugBank ID:DB15096"
+BMGC_DG03718,BMG_DG095699,"DrugBank ID:DB03513 | PubChem CID:15480320 | (S)-2-Amino-3-(4h-Selenolo[3,2-B]-Pyrrol-6-Yl)-Propionic Acid"
+BMGC_DG03719,BMG_DG095700,"(S)-2-Amino-3-(6h-Selenolo[2,3-B]-Pyrrol-4-Yl)-Propionic Acid | DrugBank ID:DB03043 | PubChem CID:15480321"
+BMGC_DG03720,BMG_DG095795,"SULINDAC, TRANS- | trans-Sulindac | CAS RN:53933-60-1 | 2-[(3E)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid | UNII:5NVO8803F9 | PubChem CID:1548885 | PubChem SID:198974308 | CAS RN:38194-50-2 | CAS RN:32004-68-5 | CAS RN:49627-22-7"
+BMGC_DG03721,BMG_DG095796,NDC:0904-7334 | NDC:53489-479 | 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetic acid | PubChem SID:175271920 | PubChem CID:1548887 | UNII:184SNS8VUH | CAS RN:38194-50-2 | NDC:42806-011 | DrugBank ID:DB00605 | NDC:24658-771 | CAS RN:32004-68-5 | NDC:55289-930 | NDC:72789-373 | NDC:0591-5661 | NDC:72789-374 | SULINDAC | NDC:0591-5660 | NDC:50090-2093 | NDC:42806-018 | Sulindac | NDC:71205-648 | NDC:53489-478 | NDC:24658-770 | NDC:0904-7335
+BMGC_DG03722,BMG_DG095806,"RESVERATROL, (Z)- | cis-Resveratrol | UNII:AUA0K06FSB | PubChem SID:198988609 | CAS RN:61434-67-1 | PubChem CID:1548910 | 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol"
+BMGC_DG03723,BMG_DG095812,ZUCAPSAICIN | Zucapsaicin | PubChem SID:198959804 | DrugBank ID:DB09120 | (Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide | UNII:15OX67P384 | PubChem CID:1548942 | CAS RN:25775-90-0
+BMGC_DG03724,BMG_DG095813,NDC:84834-542 | NDC:27495-014 | NDC:83569-005 | NDC:59779-381 | NDC:65923-161 | NDC:83873-004 | NDC:76069-100 | NDC:82345-855 | NDC:84721-002 | NDC:35192-023 | NDC:52000-046 | NDC:71101-030 | UNII:S07O44R1ZM | NDC:51824-094 | NDC:63187-067 | NDC:72683-003 | NDC:72490-018 | NDC:69375-006 | NDC:53225-1020 | DrugBank ID:DB06774 | NDC:72839-026 | NDC:63868-308 | NDC:63187-660 | NDC:80425-0256 | NDC:50268-197 | NDC:72490-013 | NDC:83262-001 | NDC:67510-0303 | NDC:0536-2525 | NDC:83676-435 | PubChem CID:1548943 | NDC:72490-038 | NDC:76420-644 | NDC:84680-529 | CAPSAICIN | NDC:52000-040 | NDC:50090-1353 | NDC:0363-0837 | NDC:65923-146 | NDC:72490-037 | NDC:0363-9902 | NDC:55264-110 | NDC:11822-7884 | NDC:71574-605 | NDC:79643-007 | NDC:14448-316 | NDC:69396-103 | NDC:71205-153 | NDC:50268-195 | NDC:84205-005 | NDC:72683-006 | NDC:71205-334 | NDC:35356-963 | NDC:83009-169 | NDC:83873-001 | NDC:46122-753 | NDC:72189-541 | NDC:41250-842 | NDC:50488-1075 | (E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide | CAS RN:7553-53-9 | NDC:76018-100 | NDC:84618-006 | Capsaicin | CAS RN:1217899-52-9 | NDC:63187-136 | NDC:71574-600 | NDC:72490-035 | NDC:50488-1060 | NDC:63044-030 | NDC:80425-0452 | NDC:53943-904 | NDC:71574-601 | NDC:84618-003 | NDC:45865-232 | NDC:68788-8599 | NDC:72490-014 | NDC:72490-039 | NDC:69420-6025 | NDC:11822-4210 | NDC:83676-436 | NDC:65923-123 | NDC:68788-7696 | NDC:70000-0556 | NDC:80425-0367 | NDC:84413-481 | NDC:72847-316 | NDC:41167-7514 | NDC:70512-016 | NDC:71238-847 | NDC:83158-387 | NDC:83295-4000 | NDC:10742-8127 | NDC:72490-040 | NDC:68788-8314 | NDC:73486-100 | NDC:11993-000 | NDC:81533-200 | NDC:72490-036 | NDC:50488-1025 | NDC:35356-642 | NDC:51316-265 | NDC:49873-608 | NDC:82319-240 | NDC:24286-1559 | NDC:82345-856 | NDC:69693-001 | NDC:72490-012 | NDC:27854-499 | NDC:76420-947 | NDC:72490-019 | NDC:59779-770 | NDC:35192-040 | NDC:50268-198 | NDC:68788-7821 | NDC:84205-001 | NDC:80425-0458 | NDC:72490-010 | NDC:76420-038 | NDC:83881-001 | NDC:71101-904 | NDC:49035-890 | NDC:55614-410 | NDC:50268-196 | PubChem SID:175268506 | NDC:70000-0549 | NDC:69420-7025 | NDC:80425-0332 | NDC:27495-008 | NDC:84721-001 | NDC:79643-002 | NDC:0536-1264 | NDC:73557-180 | NDC:73141-558 | NDC:43405-007 | NDC:84205-007 | NDC:68981-900 | NDC:83295-3313 | NDC:50488-1129 | NDC:0536-1118 | NDC:62742-4216 | NDC:50488-2025 | NDC:83873-003 | NDC:41167-7516 | NDC:83591-417 | NDC:0363-1065 | NDC:71205-771 | NDC:71436-3025 | CAS RN:404-86-4 | NDC:83873-002 | NDC:72137-555 | NDC:72490-034 | NDC:60954-001 | NDC:69159-910 | NDC:79643-006 | NDC:43136-101 | NDC:76420-753
+BMGC_DG03725,BMG_DG095814,"PubChem SID:198962245 | DrugBank ID:DB06735 | 2-[4-[(E)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine | CAS RN:911-45-5 | PubChem CID:1548953 | CAS RN:15690-57-0 | UNII:R6D2UI4FLS | ENCLOMIPHENE | Enclomiphene"
+BMGC_DG03726,BMG_DG095815,"2-[4-[(Z)-2-chloro-1,2-diphenylethenyl]phenoxy]-N,N-diethylethanamine | CAS RN:911-45-5 | PubChem SID:198941582 | CAS RN:15690-55-8 | Zuclomiphene | PubChem CID:1548955 | ZUCLOMIPHENE | UNII:3JU1DU3652"
+BMGC_DG03727,BMG_DG095817,"UNII:6MYD4C025Q | PubChem SID:329903579 | PubChem CID:1548968 | (S)-Fluoxetine | DrugBank ID:DB08544 | (3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | FLUOXETINE, (S)- | CAS RN:100568-02-3"
+BMGC_DG03728,BMG_DG095819,"Fluvastatin | (E,3S,5R)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid | UNII:4L066368AS | PubChem CID:1548972 | CAS RN:155229-76-8 | PubChem SID:175271648 | FLUVASTATIN | DrugBank ID:DB01095 | CAS RN:93957-54-1"
+BMGC_DG03729,BMG_DG095823,UNII:3K7670861M | Metiamide | METIAMIDE | PubChem SID:198939253 | DrugBank ID:DB08805 | PubChem CID:1548992 | 1-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]thiourea | CAS RN:34839-70-8
+BMGC_DG03730,BMG_DG095824,"CAS RN:308831-37-0 | (2R,3R)-3,5,7-trihydroxy-2-[(2S,3S)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one | UNII:853OHH1429 | PubChem SID:198958212 | CAS RN:142797-34-0 | SILIBININ B | Silibinin B | PubChem CID:1548994 | CAS RN:65666-07-1"
+BMGC_DG03731,BMG_DG095825,"AMINOGLUTETHIMIDE, (S)- | PubChem CID:1548995 | CAS RN:57288-03-6 | UNII:5S1T2OED7F | PubChem SID:252165419"
+BMGC_DG03732,BMG_DG095826,PubChem SID:175267409 | CAS RN:130018-77-8 | UNII:6U5EA9RT2O | DrugBank ID:DB06282 | 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid | Levocetirizine | PubChem CID:1549000 | LEVOCETIRIZINE
+BMGC_DG03733,BMG_DG095828,"[(E)-6,6-dimethylhept-2-en-4-ynyl]-methyl-(naphthalen-1-ylmethyl)azanium | PubChem CID:1549007 | Lamisil"
+BMGC_DG03734,BMG_DG095829,"PubChem SID:175265608 | DrugBank ID:DB00857 | (E)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine | Terbinafine | UNII:G7RIW8S0XP | CAS RN:91161-71-6 | PubChem CID:1549008 | TERBINAFINE"
+BMGC_DG03735,BMG_DG095834,CAS RN:141-12-8 | PubChem CID:1549025 | NERYL ACETATE | PubChem SID:198944669 | UNII:OF82IJU18H
+BMGC_DG03736,BMG_DG095835,"UNII:3W81YG7P9R | CAS RN:33843-18-4 | PubChem SID:198955323 | CAS RN:8022-83-1 | GERANYL ACETATE | PubChem CID:1549026 | Geranyl acetate | CAS RN:68311-13-7 | CAS RN:105-87-3 | [(2E)-3,7-dimethylocta-2,6-dienyl] acetate"
+BMGC_DG03737,BMG_DG095849,PubChem CID:1549093 | cyclohexylazanium | Cyclohexylammonium Ion | DrugBank ID:DB02995
+BMGC_DG03738,BMG_DG095851,CONIFERYL ALCOHOL | CAS RN:32811-40-8 | NDC:44911-0253 | 4-[(E)-3-hydroxyprop-1-enyl]-2-methoxyphenol | CAS RN:458-35-5 | PubChem CID:1549095 | PubChem SID:175266622 | Coniferyl Alcohol | UNII:E7SM92591P
+BMGC_DG03739,BMG_DG095853,"CAS RN:1115-65-7 | UNII:56X032NVQL | PubChem CID:1549098 | 3-sulfino-L-alanine | DrugBank ID:DB02153 | (2R)-2-amino-3-sulfinopropanoic acid | PubChem SID:333495836 | L-Cysteinesulfinic acid | CYSTEINESULFINIC ACID, L-"
+BMGC_DG03740,BMG_DG095860,"Farnesol | (2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol | CAS RN:16106-95-9 | DrugBank ID:DB02509 | FARNESOL, (2Z,6Z)- | PubChem CID:1549107 | UNII:J03523NK03 | CAS RN:4602-84-0 | cis,cis-Farnesol | PubChem SID:198976547"
+BMGC_DG03741,BMG_DG095866,"EPALRESTAT | DrugBank ID:DB15293 | PubChem SID:175267046 | UNII:424DV0807X | Epalrestat | PubChem CID:1549120 | CAS RN:82159-09-9 | 2-[(5Z)-5-[(E)-2-methyl-3-phenylprop-2-enylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid"
+BMGC_DG03742,BMG_DG095934,CAS RN:114360-54-2 | PubChem CID:1549477 | UNII:98ZC4255U2 | N-(9-FLUORENYLMETHOXYCARBONYL)-D-LEUCINE | N-(9-Fluorenylmethoxycarbonyl)-D-leucine | PubChem SID:478839252
+BMGC_DG03743,BMG_DG095963,"CAS RN:23178-88-3 | UNII:105S6I733Z | CAS RN:515-69-5 | CAS RN:25428-43-7 | Bisabolol | NDC:83566-996 | .ALPHA.-BISABOLOL, (+)- | (2R)-6-methyl-2-[(1R)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol | PubChem SID:175271710 | PubChem SID:198942117 | UNII:36HQN158VC | PubChem CID:1549992 | .ALPHA.-BISABOLOL, (+/-)- | .ALPHA.-BISABOLOL, (±)-"
+BMGC_DG03744,BMG_DG095981,"PubChem CID:1550302 | 2-(pyridin-3-ylmethylidene)-3,4-dihydronaphthalen-1-one | UNII:LN5L29GS4L | 2-(PYRIDIN-3-YLMETHYLIDENE)-3,4-DIHYDRONAPHTHALEN-1-ONE | CAS RN:160488-10-8 | PubChem SID:475550204"
+BMGC_DG03745,BMG_DG095997,Butylcyclohexane | butylcyclohexane | PubChem CID:15506 | CAS RN:1678-93-9 | CAS RN:69-67-0
+BMGC_DG03746,BMG_DG095998,"Auraptene | 7-[(2E)-3,7-dimethylocta-2,6-dienoxy]chromen-2-one | CAS RN:495-02-3 | AURAPTENE | UNII:F79I1ZEL2E | PubChem SID:198947035 | PubChem CID:1550607"
+BMGC_DG03747,BMG_DG096010,ASP-8731 | PubChem SID:482554378 | CAS RN:2488255-42-9 | PubChem CID:155083551 | UNII:UY57S27WMN
+BMGC_DG03748,BMG_DG096028,UNII:34WZT58X7C | CAS RN:555-59-9 | MALEANILIC ACID | PubChem CID:1550938 | PubChem SID:198989038
+BMGC_DG03749,BMG_DG096081,PubChem CID:155148 | PubChem SID:198984165 | UNII:K8B360AVZG | CAS RN:68421-13-6 | RACEMOSIN
+BMGC_DG03750,BMG_DG096093,UNII:TUH6B83HJW | CAS RN:68592-15-4 | PubChem CID:155160 | 4-METHOXYHONOKIOL | PubChem SID:474492537 | 4-Methoxyhonokiol
+BMGC_DG03751,BMG_DG096097,"UNII:2M7GF488BL | PubChem SID:252823910 | PubChem CID:1551643 | GLYCYLALANINE, L- | CAS RN:3695-73-6"
+BMGC_DG03752,BMG_DG096117,UNII:PL64C996QA | CAS RN:207390-14-5 | PubChem CID:15519735 | PubChem SID:441097267 | 3-BROMOCYTISINE
+BMGC_DG03753,BMG_DG096128,"PubChem CID:155210486 | PF-06842874 | 3-acetyl-1-cyclopentyl-7-[[(3S,4R)-3-hydroxyoxan-4-yl]amino]-4-methyl-1,6-naphthyridin-2-one | PubChem SID:461433743 | UNII:AX8OYB2MWW | Pf-06842874 | CAS RN:2516247-98-4"
+BMGC_DG03754,BMG_DG096130,"PubChem SID:485664119 | Imdatifan | UNII:BL9SLT39J6 | PubChem CID:155214362 | CAS RN:2511247-29-1 | IMDATIFAN | 3-fluoro-5-[[(4R,6S)-2,2,3,3,6-pentafluoro-4-hydroxy-8-tricyclo[5.3.1.04,11]undeca-1(11),7,9-trienyl]oxy]benzonitrile"
+BMGC_DG03755,BMG_DG096140,"PubChem CID:155248 | Moracin C | PubChem SID:472421749 | MORACIN C | UNII:TGZ4GH2N64 | CAS RN:69120-06-5 | 5-(6-hydroxy-1-benzofuran-2-yl)-2-(3-methylbut-2-enyl)benzene-1,3-diol"
+BMGC_DG03756,BMG_DG096205,SOXATALTINIB | CAS RN:2546116-88-3 | UNII:AZ4Q643U3D | PubChem CID:155296190
+BMGC_DG03757,BMG_DG096208,"Lirafugratinib | PubChem SID:474492555 | UNII:7HY6IMH87S | PubChem CID:155309155 | LIRAFUGRATINIB | N-[4-[4-amino-5-[3-fluoro-4-(4-methylpyrimidin-2-yl)oxyphenyl]-7-methylpyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-2-methylprop-2-enamide | CAS RN:2549174-42-5"
+BMGC_DG03758,BMG_DG096226,PubChem CID:155346 | Cyanopindolol | 4-[3-(tert-butylamino)-2-hydroxypropoxy]-1H-indole-2-carbonitrile | CAS RN:69906-85-0
+BMGC_DG03759,BMG_DG096237,2-[4-[2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl]pyrazol-1-yl]-1-piperazin-1-ylethanone | UNII:7CGD89QSX8 | PubChem CID:155385439 | PubChem SID:496141573 | Khk-IN-3 | LY-3522348 | CAS RN:2568608-48-8
+BMGC_DG03760,BMG_DG096251,"UNII:93AKI1U6QF | SPECTINOMYCIN | (1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one | DrugBank ID:DB00919 | PubChem SID:175266915 | CAS RN:1695-77-8 | Spectinomycin | PubChem CID:15541"
+BMGC_DG03761,BMG_DG096254,CAS RN:10355-13-2 | UNII:K99274P3DK | PubChem SID:459275922 | PubChem CID:15541180 | 4-(4-TRIFLUOROMETHYLPHENYL)PHENOL
+BMGC_DG03762,BMG_DG096279,"PubChem CID:15543761 | UNII:OFB1X61K47 | CAS RN:26844-80-4 | 5-METHYL-2,3'-BIPYRIDINE | PubChem SID:375085927"
+BMGC_DG03763,BMG_DG096285,B-nonylglucoside | CAS RN:69984-73-2 | UNII:Q5TS785PG5 | PubChem CID:155448 | PubChem SID:482554132 | NONYL .BETA.-D-GLUCOPYRANOSIDE | DrugBank ID:DB02451 | Nonyl β-D-glucopyranoside
+BMGC_DG03764,BMG_DG096286,"2-[3-[3-methyl-1-(4-methyl-1,2,4-triazol-3-yl)cyclobutyl]phenyl]-6-[[(3S)-3-methylpiperidin-1-yl]methyl]-4-(trifluoromethyl)-3H-isoindol-1-one | Cbl-b-IN-3 | NX-1607 free base | PubChem CID:155449671 | CAS RN:2573775-59-2 | UNII:Y9AV5Y4VQ4 | NX-1607 FREE BASE | PubChem SID:496141784"
+BMGC_DG03765,BMG_DG096303,cyclopentyl (2S)-2-[[(2R)-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl]amino]-2-phenylacetate | UNII:KZK563J2UW | PubChem SID:198964464 | Tosedostat | TOSEDOSTAT | DrugBank ID:DB11781 | CAS RN:238750-77-1 | PubChem CID:15547703
+BMGC_DG03766,BMG_DG096304,"(+-)-Laudanosine | PubChem CID:15548 | 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinoline | CAS RN:20412-65-1 | CAS RN:1699-51-0"
+BMGC_DG03767,BMG_DG096401,"PubChem CID:155510360 | (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-2-(2,6-dimethoxypyridin-4-yl)-4-(dimethylamino)-1-(2,3,6-trimethoxypyridin-4-yl)butan-2-ol | TBAJ-876 | Tbaj-876 | CAS RN:2332841-25-3 | UNII:OYN1GF5B1M | PubChem SID:472421812"
+BMGC_DG03768,BMG_DG096411,"4-fluoro-N-[(2S)-1-oxo-1-[[(E,3S)-6-oxo-1-phenylhept-4-en-3-yl]amino]-3-phenylpropan-2-yl]benzamide | PubChem CID:155537428 | 4-Fluoro-N-[(2S)-1-oxo-1-[[(E,3S)-6-oxo-1-phenylhept-4-en-3-yl]amino]-3-phenylpropan-2-yl]benzamide"
+BMGC_DG03769,BMG_DG096474,.BETA.-KETO-CARFENTANIL | β-keto-Carfentanil | UNII:4WDU6UFD98 | PubChem CID:155548948 | PubChem SID:478839547
+BMGC_DG03770,BMG_DG096484,UNII:E2G5LHA2KZ | PubChem SID:485664843 | PubChem CID:155559194 | CAS RN:2379736-38-4 | Ortho-hydroxycarfentanil | ORTHO-HYDROXYCARFENTANIL
+BMGC_DG03771,BMG_DG096520,"PubChem SID:198990528 | UNII:I3020O28I3 | Aflatoxin M1 | (3R,7R)-3-hydroxy-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione | CAS RN:25325-49-9 | CAS RN:6795-23-9 | AFLATOXIN M1 | PubChem CID:15558498"
+BMGC_DG03772,BMG_DG096524,"(2-methyl-4-oxo-3-prop-2-enylcyclopent-2-en-1-yl) (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate | PubChem CID:15558638 | BIOALLETHRIN | Bioallethrin | DrugBank ID:DB13746 | PubChem SID:198949257 | CAS RN:28057-48-9 | CAS RN:260359-57-7 | UNII:G79DM7O471"
+BMGC_DG03773,BMG_DG096529,"UNII:Y6UHU32G5Z | N-[[4-(1-methylpyrazol-4-yl)phenyl]methyl]-6-[7-(3-pyrrolidin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]pyrimidin-4-amine | PubChem SID:474492896 | IDRX-42 | CAS RN:2590556-80-0 | PubChem CID:155587867"
+BMGC_DG03774,BMG_DG096610,CAS RN:14382-79-7 | PubChem SID:438788458 | PubChem CID:15560576 | SPECIOCILIATIN | UNII:M3NN8Z8ZJW
+BMGC_DG03775,BMG_DG096611,CAS RN:4697-67-0 | PubChem SID:438787983 | UNII:BB185OF16A | SPECIOGYNINE | PubChem CID:15560577
+BMGC_DG03776,BMG_DG096652,UNII:Y3R871DUQ5 | LOFLAZEPIC ACID | PubChem SID:198957144 | CAS RN:71735-10-9 | PubChem CID:155667
+BMGC_DG03777,BMG_DG096667,PubChem CID:15569631 | PubChem SID:472422622 | (SULFAMOYLAMINO)BENZENE | UNII:KB7R36ZAV6 | CAS RN:15959-53-2
+BMGC_DG03778,BMG_DG096680,"ANGUIDINE | [(1S,2R,7R,9R,10R,11S,12S)-11-acetyloxy-10-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-2-yl]methyl acetate | CAS RN:109547-11-7 | PubChem SID:319891988 | PubChem CID:15571694 | UNII:UYL28I099N | CAS RN:2270-40-8 | Diacetoxyscirpenol"
+BMGC_DG03779,BMG_DG096693,"PubChem SID:198980263 | DrugBank ID:DB08795 | (2S,5R,6R)-6-[[(2R)-2-azido-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Azidocillin | CAS RN:17243-38-8 | PubChem CID:15574941 | UNII:R8XDP7L3SL | AZIDOCILLIN"
+BMGC_DG03780,BMG_DG096709,PubChem CID:155774 | CAS RN:81801-12-9 | Xamoterol | CAS RN:73210-73-8 | CAS RN:69630-08-6 | UNII:7HE0JQL703 | DrugBank ID:DB13781 | XAMOTEROL | N-[2-[[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide | PubChem SID:198967274
+BMGC_DG03781,BMG_DG096719,PubChem SID:198958138 | UFIPRAZOLE | CAS RN:73590-85-9 | UNII:6FFV1V867C | PubChem CID:155794
+BMGC_DG03782,BMG_DG096745,"PubChem CID:155801580 | ROPANICANT HYDROCHLORIDE, (-)- | CAS RN:2414674-13-6 | UNII:RVE9RLZ25R | PubChem SID:440793419"
+BMGC_DG03783,BMG_DG096788,UNII:969Z767TQQ | DS-79932728 | PubChem SID:472425148 | CAS RN:2757191-62-9 | PubChem CID:155804443
+BMGC_DG03784,BMG_DG096854,UNII:L460QHM1YN | Desmethylastemizole | DESMETHYLASTEMIZOLE | CAS RN:73736-50-2 | PubChem SID:198977263 | PubChem CID:155805 | 4-[2-[4-[[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]amino]piperidin-1-yl]ethyl]phenol
+BMGC_DG03785,BMG_DG096858,UNII:2Q3P98DATH | DrugBank ID:DB11909 | VARESPLADIB | PubChem CID:155815 | CAS RN:172732-68-2 | PubChem SID:198960974 | 2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid | Varespladib
+BMGC_DG03786,BMG_DG096898,"UNII:VAD5Q9VDSM | Dehydroabietinol | [(1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl]methanol | CAS RN:3772-55-2 | DEHYDROABIETYL ALCOHOL | PubChem CID:15586718 | PubChem SID:198989112"
+BMGC_DG03787,BMG_DG096981,"acetic acid;6-amino-2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-(2,6-diaminohexanoylamino)-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]hexanoic acid | PubChem CID:155886531 | CAS RN:825600-90-6 | H-DL-Lys-DL-Leu-DL-Leu-DL-Leu-DL-Leu-DL-Lys-DL-Leu-DL-Leu-DL-Leu-DL-Leu-DL-Lys-DL-Leu-DL-Leu-DL-Leu-DL-Leu-DL-Lys-DL-Leu-DL-Leu-DL-Leu-DL-Leu-DL-Lys-OH.CH3CO2H"
+BMGC_DG03788,BMG_DG097012,"PubChem SID:441332163 | UNII:7R9A5P7H32 | PubChem CID:155903259 | (1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl]-3-[(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide | NIRMATRELVIR | Nirmatrelvir | CAS RN:2628280-40-8"
+BMGC_DG03789,BMG_DG097063,"Adb-butinaca | CAS RN:2682867-55-4 | UNII:ZJ6LS4NVM9 | PubChem CID:155907792 | PubChem SID:441331682 | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butylindazole-3-carboxamide | ADB-BUTINACA"
+BMGC_DG03790,BMG_DG097092,CAS RN:1721-93-3 | PubChem SID:198981493 | PubChem CID:15592 | UNII:Z96HOX9RT9 | 1-METHYLISOQUINOLINE
+BMGC_DG03791,BMG_DG097372,"PubChem CID:155957 | Naphthalene 1,2-oxide, (+)- | PubChem SID:482553944 | NAPHTHALENE 1,2-OXIDE, (+)- | CAS RN:73136-20-6 | UNII:LNX35YV95K"
+BMGC_DG03792,BMG_DG097391,CAS RN:1771691-34-9 | 6-(cyclopropanecarbonylamino)-4-[3-(5-fluoropyrimidin-2-yl)-2-methoxyanilino]-N-(trideuteriomethyl)pyridine-3-carboxamide | UNII:J2Q5XQZ64C | Bms-986202 | BMS-986202 | PubChem SID:459275801 | PubChem CID:155981972
+BMGC_DG03793,BMG_DG097424,"PubChem CID:15602222 | (4bR,8aS)-4b-(hydroxymethyl)-8,8-dimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthrene-3,4-diol | 11,20-Dihydroxyferruginol"
+BMGC_DG03794,BMG_DG097448,"DrugBank ID:DB07362 | 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea | PubChem CID:15602701"
+BMGC_DG03795,BMG_DG097572,PubChem CID:15602982 | DrugBank ID:DB07858 | (2S)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine
+BMGC_DG03796,BMG_DG097573,DrugBank ID:DB07857 | PubChem CID:15602983 | (2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine
+BMGC_DG03797,BMG_DG097579,UNII:DRG21OQ517 | PubChem CID:15604015 | Opaganib | PubChem SID:198989827 | 3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide | DrugBank ID:DB12764 | CAS RN:915385-81-8 | OPAGANIB
+BMGC_DG03798,BMG_DG097582,SAR-407899 | UNII:3B974D670O | PubChem SID:346540059 | 6-piperidin-4-yloxy-2H-isoquinolin-1-one | CAS RN:923359-38-0 | PubChem CID:15604510 | Sar-407899
+BMGC_DG03799,BMG_DG097592,Almasilate | PubChem CID:156054 | dialuminum;magnesium;dihydroxy(oxo)silane;hydrate
+BMGC_DG03800,BMG_DG097597,methyl nonanoate | Methyl nonanoate | CAS RN:1731-84-6 | UNII:7XKD6QOH68 | METHYL NONANOATE | PubChem CID:15606 | DrugBank ID:DB01631 | PubChem SID:198985907
+BMGC_DG03801,BMG_DG097626,"CAS RN:112592-90-2 | (2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid | TUFTSIN | UNII:QF5336J16C | Tuftsin | CAS RN:72103-53-8 | CAS RN:9015-71-8 | CAS RN:9063-57-4 | PubChem SID:198978676 | PubChem CID:156080"
+BMGC_DG03802,BMG_DG097652,"CAS RN:2621928-55-8 | PubChem CID:156124857 | UNII:DU32DM9CHD | 4-[4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-[[(2R,8S)-2-fluoro-1,2,3,5,6,7-hexahydropyrrolizin-8-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]-5-ethynyl-6-fluoronaphthalen-2-ol | MRTX-1133 | PubChem SID:475550874 | 4-[4-(3,8-Diazabicyclo[3.2.1]oct-3-yl)-8-fluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]pyrido[4,3-d]pyrimidin-7-yl]-5-ethynyl-6-fluoro-2-naphthalenol"
+BMGC_DG03803,BMG_DG097653,Vinylglycine | DrugBank ID:DB03214 | PubChem CID:156126
+BMGC_DG03804,BMG_DG097667,"(S)-7-((6-((dimethylamino)-methyl)-5-(tetrahydrofuran-3-yl)pyridin-2-yl)amino)-4-(7-fluoroimidazo [1,2-a]pyridin-3-yl)isoindolin-1-one | 7-[[6-[(dimethylamino)methyl]-5-[(3S)-oxolan-3-yl]pyridin-2-yl]amino]-4-(7-fluoroimidazo[1,2-a]pyridin-3-yl)-2,3-dihydroisoindol-1-one | PubChem CID:156152735"
+BMGC_DG03805,BMG_DG097683,"UNII:745KX6V3FG | 7-butoxychromen-2-one | CAS RN:71783-00-1 | 2H-1-Benzopyran-2-one, 7-butoxy- | PubChem SID:441658635 | PubChem CID:156219 | 7-BUTOXYCOUMARIN"
+BMGC_DG03806,BMG_DG097694,"PubChem CID:15625 | PubChem SID:198947597 | 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN | CAS RN:56795-67-6 | 2,3,7,8-tetrachlorodibenzo-p-dioxin | 2,3,7,8-Tetrachlorodibenzo-P-dioxin | NDC:43742-2222 | UNII:DO80M48B6O | CAS RN:1746-01-6 | NDC:43742-1453"
+BMGC_DG03807,BMG_DG097697,UNII:K3KQZ35XQR | PubChem CID:15625175 | 1-CYCLOPROPANE MYCOPHENOLIC ACID | CAS RN:125198-40-5
+BMGC_DG03808,BMG_DG097705,2-(Phenylsulfonyl)-1-(p-tolyl)ethanone | CAS RN:38488-14-1 | UNII:XFA83Y7LQD | PubChem CID:15627039 | 2-(PHENYLSULFONYL)-1-(P-TOLYL)ETHANONE | PubChem SID:482554133
+BMGC_DG03809,BMG_DG097708,"PubChem CID:156274257 | PubChem SID:496142853 | 4-(aminomethyl)-1-[5-(2-methoxy-6-propan-2-ylpyridin-3-yl)imidazo[2,1-b][1,3,4]thiadiazol-2-yl]piperidin-4-ol | CAS RN:2640567-43-5 | INE-963 | UNII:4HRQ96CC7C | Nvp-ine963"
+BMGC_DG03810,BMG_DG097725,"19-chloro-22-[(2S,5R)-2,5-dimethyl-4-prop-2-enoylpiperazin-1-yl]-13,16-difluoro-3-propan-2-yl-8,11-dioxa-1,4,23,26-tetrazapentacyclo[16.6.2.02,7.012,17.021,25]hexacosa-2(7),3,5,12,14,16,18,20,22,25-decaen-24-one | PubChem CID:156295589"
+BMGC_DG03811,BMG_DG097730,"CAS RN:2639957-39-2 | PubChem CID:156297592 | PubChem SID:472424743 | UNII:2VPX8HL8AB | (3S)-N-[3-[2-[[(2R)-1-hydroxypropan-2-yl]amino]-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide | Exarafenib | EXARAFENIB"
+BMGC_DG03812,BMG_DG097734,UNII:LAT2842YVX | CAS RN:1747-60-0 | PubChem SID:198940357 | PubChem CID:15630 | 2-AMINO-6-METHOXYBENZOTHIAZOLE
+BMGC_DG03813,BMG_DG097740,"PubChem SID:252164759 | trans-3,4-Dihydro-3,4-dihydroxy-7,12-dimethylbenz[a]anthracene | CAS RN:74938-86-6 | PubChem CID:156317 | 7,12-DIMETHYL-3,4-DIHYDROBENZO(A)ANTHRACENE-3,4-DIOL, TRANS- | UNII:86LQ63P8OJ | CAS RN:92693-62-4 | (3S,4S)-7,12-dimethyl-3,4-dihydrobenzo[a]anthracene-3,4-diol | CAS RN:68162-13-0 | 7,12-DIMETHYL-3,4-DIHYDROBENZO(A)ANTHRACENE-3,4-DIOL, (3S,4S)- | UNII:U6AIJ1G484 | PubChem SID:252164119"
+BMGC_DG03814,BMG_DG097748,"N-[1,3-bis[3-[3-[5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]-2-[[3-[3-[5-[3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]methyl]propan-2-yl]-12-(4-hydroxy-2-methylpyrrolidin-1-yl)-12-oxododecanamide | PubChem CID:156323004"
+BMGC_DG03815,BMG_DG097751,PubChem CID:156328 | UNII:5K3N2D15WW | CAS RN:253450-09-8 | BESONPRODIL | PubChem SID:198941363
+BMGC_DG03816,BMG_DG097752,"CAS RN:75272-39-8 | CAS RN:187139-87-3 | PubChem CID:156333 | UNII:Q88T5P3444 | PubChem SID:198975437 | N-[(2R,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide | NEMONAPRIDE | Nemonapride"
+BMGC_DG03817,BMG_DG097771,PubChem CID:156375 | PubChem SID:198944291 | IOFETAMINE I-123 | UNII:LV23B78IJC | DrugBank ID:DB09480 | CAS RN:75917-92-9 | Iofetamine (123I) | 1-(4-(123I)iodanylphenyl)-N-propan-2-ylpropan-2-amine
+BMGC_DG03818,BMG_DG097776,NDC:25000-138 | CAS RN:131991-52-1 | NDC:65862-522 | NDC:50090-0482 | NDC:68788-7946 | NDC:71205-469 | NDC:80425-0050 | NDC:68788-7090 | NDC:69097-852 | NDC:82982-013 | NDC:66267-373 | NDC:43353-211 | NDC:71335-1850 | NDC:72162-1935 | NDC:50090-4638 | NDC:50228-436 | NDC:63629-8511 | NDC:25000-140 | NDC:63629-8513 | NDC:70518-3822 | NDC:50090-6762 | NDC:67296-1910 | NDC:65862-520 | NDC:65162-189 | NDC:51655-743 | NDC:71335-0345 | NDC:80425-0175 | NDC:50090-0483 | NDC:50090-6980 | NDC:70010-137 | NDC:60760-564 | NDC:65862-521 | NDC:43353-201 | NDC:67296-1609 | NDC:0615-8094 | NDC:51655-363 | NDC:63629-8514 | NDC:43353-216 | NDC:51655-621 | NDC:67296-1797 | NDC:43063-920 | NDC:72189-136 | NDC:49483-617 | NDC:76420-788 | NDC:70010-139 | NDC:76282-342 | NDC:66267-153 | NDC:53746-190 | NDC:71335-1869 | NDC:80425-0048 | NDC:69097-855 | NDC:71610-592 | NDC:71610-436 | NDC:71205-060 | NDC:68071-4510 | NDC:69097-854 | NDC:49483-619 | NDC:43063-650 | NDC:68788-8797 | NDC:80425-0378 | NDC:53746-189 | NDC:76282-341 | NDC:50090-3041 | NDC:63187-535 | NDC:70954-925 | NDC:50090-6666 | NDC:69097-853 | NDC:70954-928 | NDC:71610-591 | NDC:69437-415 | NDC:42494-454 | NDC:42494-453 | NDC:0054-3630 | PubChem CID:156391 | NDC:31722-682 | NDC:49483-618 | NDC:66267-807 | NDC:71335-0095 | NDC:63629-8512 | NDC:60687-491 | NDC:67296-1521 | NDC:72789-003 | NDC:68462-189 | NDC:71610-597 | NDC:0093-1005 | NDC:68788-8602 | CAS RN:22204-53-1 | NDC:60760-644 | NDC:63739-403 | NDC:50090-3036 | NDC:52817-381 | NDC:68071-4006 | NDC:69437-416 | NDC:50090-4636 | NDC:51655-626 | NDC:71205-597 | NDC:68382-014 | NDC:70010-138 | NDC:71335-0255 | NDC:65841-678 | NDC:42708-140 | NDC:77771-435 | NDC:63187-461 | NDC:71335-0973 | NDC:69097-851 | NDC:69784-500 | NDC:68071-4381 | NDC:72189-425 | NDC:70518-3486 | NDC:50268-595 | NDC:72162-2275 | NDC:43063-600 | NDC:80425-0049 | NDC:50268-594 | NDC:63187-455 | NDC:43063-937 | NDC:43353-218 | NDC:50090-4752 | NDC:63629-8515 | NDC:50090-4637 | NDC:70954-151 | NDC:71610-489 | NDC:42192-619 | NDC:68382-013 | UNII:57Y76R9ATQ | NDC:50090-5645 | NDC:63187-028 | NDC:50090-0481 | NDC:65162-190 | NDC:50090-7198 | NDC:69784-501 | NDC:65841-676 | NDC:71511-701 | NDC:71335-0217 | NDC:50090-6667 | NDC:50228-435 | NAPROXEN | NDC:53746-188 | NDC:68462-188 | NDC:77771-436 | NDC:68382-012 | NDC:42708-043 | NDC:65841-677 | NDC:45865-238 | NDC:52817-380 | NDC:69784-505 | NDC:76420-264 | NDC:60760-190 | NDC:77771-434 | NDC:80425-0010 | NDC:80425-0051 | NDC:76282-340 | DrugBank ID:DB00788 | NDC:72162-2276 | NDC:69437-316 | NDC:50228-434 | NDC:69238-1730 | NDC:76420-042 | NDC:60760-140 | NDC:72789-321 | NDC:71335-2485 | NDC:55700-888 | NDC:63629-2484 | (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid | NDC:65162-188 | NDC:76420-787 | NDC:67296-0406 | NDC:50090-1584 | NDC:68462-190 | Naproxen | PubChem SID:175266381 | NDC:25000-139 | NDC:55700-987 | NDC:50090-1585 | NDC:51655-657 | NDC:50090-1583
+BMGC_DG03819,BMG_DG097785,DrugBank ID:DB05424 | CAS RN:267243-28-7 | PubChem CID:156414 | N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide | PubChem SID:198935120 | Canertinib | UNII:C78W1K5ASF | CANERTINIB
+BMGC_DG03820,BMG_DG097787,NDC:16729-442 | NDC:70436-009 | NDC:63629-8764 | NDC:69097-410 | NDC:31722-104 | NDC:47335-600 | NDC:0904-7067 | NDC:65862-832 | NDC:69097-411 | NDC:50268-153 | NDC:43598-367 | NDC:72162-1845 | NDC:64380-883 | NDC:43598-369 | NDC:67877-504 | NDC:70436-007 | Cinacalcet Hydrochloride | NDC:63629-8763 | NDC:31722-105 | CAS RN:364782-34-3 | NDC:76282-674 | NDC:43598-368 | NDC:42291-459 | NDC:65862-831 | NDC:55513-075 | NDC:63629-9606 | NDC:65162-213 | NDC:63629-9607 | NDC:16729-441 | NDC:55513-073 | NDC:64380-885 | NDC:16729-440 | NDC:42291-460 | NDC:60687-525 | NDC:65862-833 | NDC:72162-1843 | NDC:64380-884 | NDC:72865-150 | NDC:72865-152 | NDC:63629-9608 | NDC:42543-962 | NDC:70436-008 | CINACALCET HYDROCHLORIDE | NDC:47335-380 | NDC:76282-675 | NDC:76282-676 | NDC:67877-505 | NDC:42543-961 | UNII:1K860WSG25 | NDC:42543-963 | PubChem CID:156418 | NDC:65162-157 | NDC:72865-151 | PubChem SID:175267465 | NDC:50090-7096 | NDC:65162-155 | NDC:69097-412 | NDC:42291-461 | NDC:55513-074 | NDC:31722-103 | NDC:67877-503 | NDC:72162-1844 | NDC:63629-8765 | NDC:47335-379 | N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine;hydrochloride
+BMGC_DG03821,BMG_DG097790,N-[(1R)-1-naphthalen-1-ylethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine | CAS RN:1025064-29-2 | UNII:UAZ6V7728S | CAS RN:226256-56-0 | PubChem CID:156419 | DrugBank ID:DB01012 | PubChem SID:175268532 | Cinacalcet | CINACALCET
+BMGC_DG03822,BMG_DG097795,DrugBank ID:DB03044 | CAS RN:285983-48-4 | Doramapimod | 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea | DORAMAPIMOD | UNII:HO1A8B3YVV | PubChem SID:198975228 | PubChem CID:156422
+BMGC_DG03823,BMG_DG097812,CAS RN:2649372-20-1 | MOSPERAFENIB | UNII:47HG5BT4PA | PubChem CID:156473463
+BMGC_DG03824,BMG_DG097822,"PubChem CID:156498110 | CAS RN:2654081-35-1 | BLEXIMENIB | UNII:DCN5WEN78T | Bleximenib | PubChem SID:485663924 | N-ethyl-5-fluoro-2-[[5-[2-[(3R)-6-[2-methoxyethyl(methyl)amino]-2-methylhexan-3-yl]-2,7-diazaspiro[3.4]octan-7-yl]-1,2,4-triazin-6-yl]oxy]-N-propan-2-ylbenzamide"
+BMGC_DG03825,BMG_DG097826,OPNURASIB | PubChem SID:472423442 | 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one | Opnurasib | Jdq-443 | CAS RN:2653994-10-4 | PubChem CID:156501355 | CAS RN:2653994-08-0 | UNII:Q3W0H3V1LQ
+BMGC_DG03826,BMG_DG097831,CAS RN:1758-46-9 | PubChem SID:198946389 | 2-PHENOXYETHANAMINE | PubChem CID:15651 | UNII:8DGQ1B38R5
+BMGC_DG03827,BMG_DG097838,"PubChem SID:472424024 | UNII:CRG69FR93G | 2-methyl-3-[(1R)-1-[(4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-yl)amino]ethyl]benzonitrile | Mrtx0902 | CAS RN:2654743-22-1 | MRTX-0902 | PubChem CID:156526655"
+BMGC_DG03828,BMG_DG097842,"CAS RN:2660250-10-0 | N-[2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl]-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]-5-propan-2-ylisoquinolin-3-amine | TIGOZERTINIB | PA4Pth5HL9 | PubChem CID:156538665 | UNII:PA4PTH5HL9 | PubChem SID:472425669 | Tigozertinib"
+BMGC_DG03829,BMG_DG097859,"DrugBank ID:DB09193 | UNII:R0YEK8P3H4 | PubChem SID:438787571 | CP-39,332 | PubChem CID:15657209 | CAS RN:61764-60-1 | CP-39332"
+BMGC_DG03830,BMG_DG098218,"CAS RN:13422-55-4 | carbanide;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,7S,12S,13S,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | PubChem CID:156599003"
+BMGC_DG03831,BMG_DG098478,"PubChem CID:156619666 | cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate;hydrochloride | CAS RN:13422-51-0"
+BMGC_DG03832,BMG_DG098505,ABAMETAPIR | 5-methyl-2-(5-methylpyridin-2-yl)pyridine | PubChem CID:15664 | DrugBank ID:DB11932 | PubChem SID:198975440 | UNII:6UO390AMFB | CAS RN:1762-34-1 | Abametapir | NDC:43598-921
+BMGC_DG03833,BMG_DG098535,"UNII:S5016F5ZH4 | CAS RN:210891-04-6 | N-[[2-[2-[(4,5-dimethyl-1,2-oxazol-3-yl)sulfamoyl]phenyl]-5-(1,3-oxazol-2-yl)phenyl]methyl]-N,3,3-trimethylbutanamide | Edonentan | PubChem CID:156690 | PubChem SID:198972503 | EDONENTAN ANHYDROUS"
+BMGC_DG03834,BMG_DG098540,Mercaptoethanol | 2-MERCAPTOETHANOL | Beta-Mercaptoethanol | PubChem CID:1567 | CAS RN:60-24-2 | UNII:14R9K67URN | PubChem SID:198954081 | DrugBank ID:DB03345 | 2-sulfanylethanol
+BMGC_DG03835,BMG_DG098543,"UNII:D6Z4GR94BH | EPITHIAZIDE, (-)- | PubChem SID:440090002 | CAS RN:96783-09-4 | CAS RN:1764-85-8 | PubChem CID:15671 | CAS RN:96783-08-3 | PubChem SID:440089653 | EPITHIAZIDE, (+)- | EPITHIAZIDE | UNII:5B266B85J1 | UNII:W8B42Z8CTX | PubChem SID:198975182"
+BMGC_DG03836,BMG_DG098547,"Fulzerasib | CAS RN:2641747-54-6 | (7R)-16-chloro-15-(2-fluoro-6-hydroxyphenyl)-9-methyl-12-(4-methyl-2-propan-2-ylpyridin-3-yl)-5-prop-2-enoyl-2,5,9,12,14-pentazatetracyclo[8.8.0.02,7.013,18]octadeca-1(10),13,15,17-tetraene-8,11-dione | PubChem CID:156732294"
+BMGC_DG03837,BMG_DG098587,PubChem CID:156793 | CAS RN:75425-27-3 | BARBIGERONE | PubChem SID:472422918 | UNII:9BE3F2B4GD
+BMGC_DG03838,BMG_DG098602,"PubChem CID:15684 | DrugBank ID:DB13269 | CAS RN:1777-82-8 | (2,4-dichlorophenyl)methanol | DICHLOROBENZYL ALCOHOL | UNII:1NKX3648J9 | PubChem SID:175266989 | Dichlorobenzyl Alcohol"
+BMGC_DG03839,BMG_DG098617,"UNII:N95U3A7N57 | (Rac)-RP-6306 | LUNRESERTIB | Lunresertib | CAS RN:2719793-90-3 | PubChem CID:156869388 | PubChem SID:474493022 | CAS RN:2719749-28-5 | CAS RN:2719793-91-4 | 2-amino-1-(3-hydroxy-2,6-dimethylphenyl)-5,6-dimethylpyrrolo[2,3-b]pyridine-3-carboxamide"
+BMGC_DG03840,BMG_DG098625,DrugBank ID:DB02335 | PubChem SID:252164006 | 2-Aminothiazoline | UNII:5JC2YZG56Q | PubChem CID:15689 | CAS RN:1779-81-3 | 2-AMINO-2-THIAZOLINE
+BMGC_DG03841,BMG_DG098626,"CAS RN:77303-19-6 | PubChem CID:156890 | PubChem SID:478836841 | 2-(2,4-DIMETHOXYPHENYL)-3H-IMIDAZO(4,5-B)PYRIDINE | UNII:EP8TS2YQJ5 | 2-(2,4-Dimethoxyphenyl)-3H-imidazo[4,5-b]pyridine"
+BMGC_DG03842,BMG_DG098636,UNII:H95MS4M8V2 | PubChem SID:461434536 | N-((1S)-1-(((1S)-1-CYANO-2-((3S)-2-OXOPYRROLIDIN-3-YL)ETHYL)CARBAMOYL)-3-METHYL-BUTYL)-4-METHOXY-1H-INDOLE-2-CARBOXAMIDE | PubChem CID:156907357 | CAS RN:2713433-13-5
+BMGC_DG03843,BMG_DG099228,Pyrithione | CAS RN:1121-30-8 | UNII:6GK82EC25D | 1-hydroxypyridine-2-thione | CAS RN:1121-31-9 | PubChem SID:175268466 | DrugBank ID:DB06815 | PYRITHIONE | PubChem CID:1570
+BMGC_DG03844,BMG_DG099298,PubChem SID:459056370 | UNII:A59U94JDE5 | CAS RN:2677687-49-7 | PubChem CID:157010706 | MP-135
+BMGC_DG03845,BMG_DG099313,"CAS RN:77162-51-7 | VIGABATRIN, (R)- | UNII:ODN92S847A | PubChem SID:241180852 | PubChem CID:157018"
+BMGC_DG03846,BMG_DG099320,"PubChem SID:198961984 | Ertiprotafib | DrugBank ID:DB06521 | (2R)-2-[4-(9-bromo-2,3-dimethylbenzo[f][1]benzothiol-4-yl)-2,6-dimethylphenoxy]-3-phenylpropanoic acid | CAS RN:251303-04-5 | ERTIPROTAFIB | UNII:5TPM2EB426 | PubChem CID:157049"
+BMGC_DG03847,BMG_DG099341,"DYRK2 inhibitor C17 | [2,7-dimethoxy-9-[[(3S)-pyrrolidin-3-yl]methylsulfanyl]acridin-4-yl]methanol | PubChem CID:157049314 | CAS RN:2416195-65-6"
+BMGC_DG03848,BMG_DG099359,"PERFLUORO TERT-BUTYLCYCLOHEXANE | 1,1,2,2,3,3,4,4,5,5,6-undecafluoro-6-[1,1,1,3,3,3-hexafluoro-2-(trifluoromethyl)propan-2-yl]cyclohexane | PubChem CID:15710945 | CAS RN:84808-64-0 | UNII:3ZX1Z33VUU | DrugBank ID:DB12477 | Perfluoro tert-butylcyclohexane | PubChem SID:198986827"
+BMGC_DG03849,BMG_DG099378,"CAS RN:137397-56-9 | heme O | PubChem CID:15719509 | 3-[18-(2-carboxyethyl)-7-ethenyl-12-[(4E,8E)-1-hydroxy-5,9,13-trimethyltetradeca-4,8,12-trienyl]-3,8,13,17-tetramethylporphyrin-21,23-diid-2-yl]propanoic acid;iron(2+)"
+BMGC_DG03850,BMG_DG099386,PubChem CID:15723 | PubChem SID:198965332 | UNII:2MMR990PEM | Azacyclonol | CAS RN:115-46-8 | diphenyl(piperidin-4-yl)methanol | AZACYCLONOL
+BMGC_DG03851,BMG_DG099400,"3,4-DICHLOROBENZYL ALCOHOL | PubChem SID:438788126 | UNII:G2EM844U91 | PubChem CID:15728 | CAS RN:1805-32-9"
+BMGC_DG03852,BMG_DG099417,Hydroxyl Radical | CAS RN:3352-57-6 | lambda1-oxidane | PubChem CID:157350
+BMGC_DG03853,BMG_DG099420,"(2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-1,2,3,5,6-pentol | Lactitol | UNII:L2B0WJF7ZY | PubChem CID:157355 | LACTITOL | DrugBank ID:DB12942 | PubChem SID:175268045 | CAS RN:585-86-4"
+BMGC_DG03854,BMG_DG099431,"PubChem CID:157385 | (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-4-ethylpiperidine-2-carboxamide | PIRLIMYCIN | UNII:LM19JT6G5K | CAS RN:79548-73-5 | DrugBank ID:DB11537 | PubChem SID:175266428 | Pirlimycin"
+BMGC_DG03855,BMG_DG099435,2-Methyl-5-hydroxytryptamine | 2-METHYL-5-HYDROXYTRYPTAMINE | PubChem SID:474492529 | PubChem CID:1574 | UNII:D77Z9HJT2U | CAS RN:78263-90-8
+BMGC_DG03856,BMG_DG099441,CAS RN:142542-83-4 | GLYCYRDIONE A | UNII:MJ378UN8U6 | PubChem CID:15742118 | PubChem SID:459275379
+BMGC_DG03857,BMG_DG099477,PubChem SID:241179440 | Methcathinone | 2-(methylamino)-1-phenylpropan-1-one | UNII:386QA522QG | CAS RN:5650-44-2 | PubChem CID:1576 | DrugBank ID:DB15339 | METHCATHINONE
+BMGC_DG03858,BMG_DG099492,UNII:35ANN6MRBM | PubChem CID:15765 | 2-AMINO-6-METHYLPYRIDINE | PubChem SID:198962439 | CAS RN:1824-81-3
+BMGC_DG03859,BMG_DG099504,"3-[(2R)-1-methylpyrrolidin-2-yl]pyridine | CAS RN:25162-00-9 | (R)-Nicotine | NICOTINE, (+)- | PubChem CID:157672 | UNII:42XNU684Z1 | PubChem SID:198970712"
+BMGC_DG03860,BMG_DG099509,Deacetoxyvinzolidine | PubChem CID:157684 | UNII:6PBV11IO5E | DEACETOXYVINZOLIDINE | PubChem SID:198986334 | CAS RN:165659-77-8 | DrugBank ID:DB02868
+BMGC_DG03861,BMG_DG099512,"PubChem CID:15769 | 1,4-DICHLORONAPHTHALENE | UNII:91H687K062 | PubChem SID:198937564 | CAS RN:1825-31-6"
+BMGC_DG03862,BMG_DG099515,"Gemcabene | 6-(5-carboxy-5-methylhexoxy)-2,2-dimethylhexanoic acid | CAS RN:183293-82-5 | PubChem CID:157692 | PubChem SID:198954923 | UNII:B96UX1DDKS | GEMCABENE | DrugBank ID:DB05123"
+BMGC_DG03863,BMG_DG099519,"NITRENDIPINE, (S)- | PubChem SID:317228924 | UNII:I3TBK07DB4 | CAS RN:80873-62-7 | PubChem CID:157702"
+BMGC_DG03864,BMG_DG099558,"DrugBank ID:DB07063 | PubChem SID:198982860 | 2-[3-[(4,5,7-trifluoro-1,3-benzothiazol-2-yl)methyl]indol-1-yl]acetic acid | Lidorestat | UNII:R3734K0M7L | PubChem CID:157839 | LIDORESTAT ANHYDROUS | CAS RN:245116-90-9"
+BMGC_DG03865,BMG_DG099591,LUBAZODONE | CAS RN:161178-07-0 | Lubazodone | PubChem SID:198973190 | DrugBank ID:DB09196 | UNII:850TB2B172 | PubChem CID:157919
+BMGC_DG03866,BMG_DG099593,"CAS RN:333963-40-9 | DrugBank ID:DB01046 | PubChem CID:157920 | UNII:7662KG2R6K | CAS RN:136790-76-6 | LUBIPROSTONE | Lubiprostone | 7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid | PubChem SID:175268736"
+BMGC_DG03867,BMG_DG099594,Methyl Aminolevulinate Hydrochloride | CAS RN:79416-27-6 | PubChem CID:157921 | methyl 5-amino-4-oxopentanoate;hydrochloride | UNII:7S73606O1A | METHYL AMINOLEVULINATE HYDROCHLORIDE | PubChem SID:175268264
+BMGC_DG03868,BMG_DG099595,Methyl Aminolevulinate | UNII:585NM85KYM | Methyl aminolevulinate | PubChem CID:157922 | PubChem SID:175268075 | CAS RN:33320-16-0 | METHYL AMINOLEVULINATE | DrugBank ID:DB00992 | methyl 5-amino-4-oxopentanoate
+BMGC_DG03869,BMG_DG099597,UNII:FFV58UNY7O | octadecan-1-amine | STEARAMINE | PubChem SID:175267728 | Octadecylamine | PubChem CID:15793 | CAS RN:124-30-1
+BMGC_DG03870,BMG_DG099642,"CAS RN:61281-37-6 | CAS RN:69176-52-9 | gomisin N | PubChem CID:158103 | UNII:DKO6O75Z5V | PubChem SID:346538431 | GOMISIN N | PubChem SID:252163669 | CAS RN:82467-52-5 | SCHISANDRIN B, (±)- | (9R,10S)-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.02,7.014,18]nonadeca-1(19),2,4,6,12,14(18)-hexaene | UNII:02XA4X3KZW | SCHISANDRIN B, (+/-)-"
+BMGC_DG03871,BMG_DG099665,"DrugBank ID:DB01530 | 3.ALPHA.-ANDROSTANEDIOL | PubChem CID:15818 | 5alpha-androstane-3alpha,17beta-diol | PubChem SID:198938377 | CAS RN:1852-53-5 | (3R,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol | 5alpha-Androstane-3alpha,17beta-diol | UNII:J34MX0M30Y"
+BMGC_DG03872,BMG_DG099669,"1-methoxy-2-(3-methylbut-2-enyl)-6H-[1]benzofuro[3,2-c]chromene-3,9-diol | GLYURALLIN A | PubChem CID:15818598 | UNII:X25VV8RRP9 | Glyurallin A | CAS RN:213130-81-5 | PubChem SID:459276023 | CAS RN:199331-36-7"
+BMGC_DG03873,BMG_DG099670,"Glyurallin B | PubChem CID:15818599 | 3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-enyl)chromen-4-one | CAS RN:199331-53-8"
+BMGC_DG03874,BMG_DG099692,CAS RN:77201-66-2 | N-P-COUMAROYLTYROSINE | UNII:NBS8NYY2M5 | PubChem SID:461433030 | PubChem CID:15825666
+BMGC_DG03875,BMG_DG099708,"CAS RN:185913-78-4 | UNII:AJS8S3P31H | N-tert-butyl-4-[5'-ethoxy-4-(2-morpholin-4-ylethoxy)-2'-oxospiro[cyclohexane-1,3'-indole]-1'-yl]sulfonyl-3-methoxybenzamide | PubChem SID:198974765 | SATAVAPTAN | DrugBank ID:DB14923 | PubChem CID:158348 | Satavaptan"
+BMGC_DG03876,BMG_DG099710,"PubChem CID:158376 | FURO(2,3D)PYRIMIDINE ANTIFOLATE | PubChem SID:482553290 | UNII:VBP3BN3U2V | DrugBank ID:DB02026 | CAS RN:156595-85-6 | Furo[2,3d]Pyrimidine Antifolate | Furo(2,3d)pyrimidine antifolate"
+BMGC_DG03877,BMG_DG099712,"PubChem SID:241180282 | CAS RN:246252-06-2 | UNII:0BG5NE3APZ | Motexafin gadolinium | DrugBank ID:DB05428 | MOTEXAFIN GADOLINIUM ANHYDROUS | PubChem CID:158385 | 3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;gadolinium(3+);diacetate | CAS RN:156436-89-4"
+BMGC_DG03878,BMG_DG099714,"(S)-AMPA | AMPA, L- | DrugBank ID:DB02057 | CAS RN:83643-88-3 | PubChem SID:198956813 | PubChem CID:158397 | UNII:9280SC28GD"
+BMGC_DG03879,BMG_DG099750,"CAS RN:72573-82-1 | PubChem CID:158536 | Gadoteric acid | PubChem SID:198962134 | GADOTERIC ACID | UNII:QVF9Y6955W | 2-[4,7-bis(carboxylatomethyl)-10-(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+) | DrugBank ID:DB09132"
+BMGC_DG03880,BMG_DG099773,"NDC:84372-025 | NDC:84423-048 | PubChem SID:175268721 | Alpha-Arbutin | NDC:84372-024 | NDC:84423-004 | PubChem CID:158637 | CAS RN:84380-01-8 | NDC:84423-049 | NDC:82160-818 | NDC:85164-001 | NDC:84712-002 | NDC:74458-134 | NDC:84423-020 | NDC:84423-057 | NDC:84423-063 | NDC:84423-009 | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol | ALPHA-ARBUTIN | UNII:72VUP07IT5 | DrugBank ID:DB14109 | NDC:84372-026 | NDC:84581-002 | NDC:84423-033 | NDC:84117-007 | NDC:84423-005 | NDC:84785-0010 | NDC:83566-134 | NDC:81309-010 | NDC:84423-030 | NDC:84423-016"
+BMGC_DG03881,BMG_DG099797,"UNII:H6G4VMQ24K | ROLIPRAM, (S)- | PubChem CID:158758 | CAS RN:85416-73-5 | PubChem SID:198939252 | (S)-Rolipram | DrugBank ID:DB03606"
+BMGC_DG03882,BMG_DG099802,CAS RN:144689-24-7 | UNII:8W1IQP3U10 | PubChem SID:175267256 | DrugBank ID:DB00275 | PubChem CID:158781 | Olmesartan | 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid | OLMESARTAN
+BMGC_DG03883,BMG_DG099803,"EDOTREOTIDE | UNII:U194AS08HZ | CAS RN:204318-14-9 | 2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid | PubChem CID:158782 | CAS RN:173606-11-6 | Edotreotide | PubChem SID:198948449"
+BMGC_DG03884,BMG_DG099804,"PubChem CID:158784 | UNII:Q5O76TA0ML | CAS RN:189681-70-7 | DrugBank ID:DB06620 | APLINDORE | Aplindore | (2S)-2-[(benzylamino)methyl]-2,3,7,9-tetrahydro-[1,4]dioxino[2,3-e]indol-8-one | PubChem SID:198942198"
+BMGC_DG03885,BMG_DG099811,"UNII:GZ1X96601Z | DrugBank ID:DB04954 | CAS RN:204512-90-3 | PubChem SID:198937424 | (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[[(3R)-oxolan-3-yl]amino]purin-9-yl]oxolane-3,4-diol | Tecadenoson | PubChem CID:158795 | TECADENOSON"
+BMGC_DG03886,BMG_DG099812,"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL | PubChem CID:1587957 | DrugBank ID:DB08393"
+BMGC_DG03887,BMG_DG099816,CAS RN:1878-66-6 | 4-Chlorophenylacetic acid | 2-(4-chlorophenyl)acetic acid | PubChem CID:15880 | PubChem SID:472409993 | 4-CHLOROBENZENEACETIC ACID | UNII:LLQ6PU28WR
+BMGC_DG03888,BMG_DG099834,CAS RN:226566-43-4 | PubChem CID:15887336 | N-[2-(diaminomethylideneamino)oxyethyl]-2-[6-methyl-3-[(3-methylphenyl)sulfonylamino]-2-oxopyridin-1-yl]acetamide | CID 15887336
+BMGC_DG03889,BMG_DG099848,UNII:C6C3GB68TV | CAS RN:56161-70-7 | PubChem SID:441331504 | N-METHYL-PPPA | PubChem CID:15894873
+BMGC_DG03890,BMG_DG099855,"CAS RN:86540-95-6 | UNII:YV88341QW3 | PubChem SID:434369757 | PROXYPHYLLINE, (S)- | PubChem CID:158961"
+BMGC_DG03891,BMG_DG099856,"CAS RN:86540-96-7 | PubChem CID:158962 | PROXYPHYLLINE, (R)- | UNII:S0ELR18QO5 | PubChem SID:434369852"
+BMGC_DG03892,BMG_DG099858,CAS RN:1886-26-6 | NORFENFLURAMINE | PubChem CID:15897 | Norfenfluramine | PubChem SID:272993815 | 1-[3-(trifluoromethyl)phenyl]propan-2-amine | UNII:037A9J3PSW
+BMGC_DG03893,BMG_DG099863,"UNII:YL9NJ9QS6V | 4'-HYDROXY-PHIP | 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol | PubChem CID:15897928 | 4-(2-amino-1-methylimidazo[4,5-b]pyridin-6-yl)phenol | CAS RN:126861-72-1 | PubChem SID:482554126 | 4′-Hydroxy-PhIP | DrugBank ID:DB06898"
+BMGC_DG03894,BMG_DG099869,"CAS RN:55700-58-8 | CAS RN:55721-11-4 | PubChem CID:1590 | 6-[4-[2-(5-hydroxy-2-methylidenecyclohexylidene)ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol"
+BMGC_DG03895,BMG_DG099879,"NDC:76305-302 | NDC:82600-222 | NDC:73647-602 | NDC:63255-122 | NDC:49035-700 | NDC:79804-282 | NDC:79974-210 | NDC:51367-022 | NDC:51316-885 | NDC:10742-1112 | NDC:83552-126 | NDC:83056-001 | NDC:10210-0038 | NDC:70039-298 | NDC:63868-060 | NDC:71856-423 | NDC:59321-032 | NDC:52241-301 | NDC:70677-1061 | NDC:83552-127 | NDC:66761-329 | NDC:73048-005 | NDC:73492-716 | NDC:0573-2031 | NDC:70039-302 | NDC:84334-001 | NDC:84126-302 | NDC:70673-298 | NDC:55614-700 | NDC:69618-052 | NDC:41167-0078 | NDC:41167-0080 | NDC:83552-123 | NDC:55264-107 | NDC:30400-702 | NDC:68016-821 | NDC:70927-001 | NDC:79804-618 | NDC:43405-017 | NDC:55614-740 | NDC:55301-412 | NDC:84716-006 | NDC:42681-0001 | NDC:55264-108 | NDC:82645-902 | NDC:57538-003 | NDC:80770-033 | NDC:66761-308 | NDC:72524-641 | NDC:66761-309 | NDC:66761-324 | NDC:65923-148 | NDC:72342-220 | NDC:48256-0011 | NDC:55264-109 | NDC:72839-147 | NDC:58503-171 | NDC:83191-003 | NDC:30142-248 | NDC:83191-004 | NDC:11822-7957 | NDC:48201-004 | NDC:71662-003 | NDC:49873-620 | NDC:62106-1113 | NDC:71101-907 | NDC:55264-101 | NDC:52920-133 | NDC:73635-5809 | NDC:70039-300 | NDC:72937-310 | NDC:52000-013 | NDC:68354-131 | NDC:70512-104 | NDC:10157-1199 | NDC:10742-6000 | NDC:71856-559 | NDC:83056-002 | NDC:75849-304 | NDC:10210-0022 | NDC:72854-352 | NDC:29485-6536 | NDC:83501-101 | NDC:43493-0008 | NDC:85152-001 | NDC:61658-002 | NDC:82442-311 | NDC:0363-9425 | NDC:10157-8407 | NDC:81790-001 | NDC:53943-907 | NDC:51824-084 | PubChem SID:175266218 | NDC:41167-0074 | NDC:52862-016 | NDC:36800-670 | NDC:83570-560 | NDC:59321-031 | NDC:84844-004 | NDC:63255-330 | NDC:66902-280 | NDC:79804-265 | NDC:71856-516 | NDC:24286-1581 | NDC:24909-042 | NDC:55614-210 | NDC:44224-1230 | NDC:81379-003 | NDC:46581-110 | NDC:70673-297 | NDC:0220-1121 | NDC:70631-057 | NDC:49873-018 | NDC:51824-045 | NDC:52862-041 | NDC:21130-248 | NDC:65923-532 | NDC:43493-0012 | NDC:82645-920 | NDC:58933-595 | NDC:83552-125 | NDC:62011-0075 | NDC:83084-282 | NDC:72476-412 | NDC:70947-010 | NDC:72937-301 | NDC:55319-820 | NDC:43493-0009 | NDC:68016-248 | NDC:10742-8168 | NDC:70677-1201 | NDC:55614-690 | NDC:54473-334 | NDC:0280-0050 | NDC:55614-600 | NDC:24286-1564 | NDC:70947-103 | NDC:24909-013 | NDC:77338-321 | NDC:82198-0009 | NDC:66761-323 | NDC:11383-256 | NDC:10742-0003 | NDC:83552-121 | NDC:55614-630 | NDC:83552-129 | NDC:55758-039 | NDC:59779-792 | NDC:29784-602 | Camphor (synthetic) | NDC:70947-031 | NDC:33992-7992 | NDC:52920-135 | NDC:49348-148 | NDC:10578-001 | NDC:41167-0790 | NDC:74446-345 | NDC:0220-5349 | NDC:63868-692 | NDC:72683-008 | NDC:60954-007 | NDC:72524-640 | NDC:69876-1740 | NDC:73076-129 | NDC:72524-604 | NDC:83345-103 | NDC:56062-248 | NDC:10107-431 | NDC:73386-151 | NDC:65753-400 | NDC:83345-602 | NDC:85136-001 | NDC:71101-032 | NDC:66761-354 | NDC:84667-001 | NDC:52241-100 | NDC:24286-1580 | NDC:71856-070 | NDC:48256-0041 | NDC:73128-614 | NDC:11673-412 | NDC:66761-129 | NDC:24286-1563 | NDC:79903-039 | NDC:73647-206 | NDC:84214-005 | NDC:24286-1558 | NDC:84010-012 | NDC:72937-103 | NDC:72476-248 | NDC:54273-011 | NDC:72524-010 | NDC:67510-0305 | NDC:55614-670 | NDC:58933-003 | NDC:41250-824 | NDC:69968-0538 | NDC:73386-150 | NDC:69070-301 | NDC:51316-200 | NDC:50130-316 | NDC:72524-009 | NDC:80465-003 | NDC:72562-167 | NDC:43742-1620 | NDC:72342-040 | NDC:72342-180 | NDC:69901-522 | NDC:70039-201 | NDC:63868-490 | NDC:52410-3022 | NDC:69536-109 | UNII:N20HL7Q941 | NDC:55614-730 | NDC:82600-220 | NDC:37808-105 | NDC:73492-711 | NDC:76162-030 | NDC:52000-039 | NDC:72937-260 | NDC:63255-123 | NDC:73044-102 | NDC:83570-540 | NDC:71262-008 | NDC:69693-416 | NDC:73386-149 | (1R,4R)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one | NDC:71101-028 | NDC:49348-398 | NDC:11344-248 | NDC:0280-0049 | NDC:69536-110 | NDC:70039-303 | NDC:37808-397 | NDC:81379-002 | NDC:57483-101 | NDC:71101-027 | NDC:67676-002 | NDC:10742-2112 | NDC:20276-100 | NDC:0363-9903 | NDC:71611-127 | NDC:55264-007 | NDC:71917-001 | NDC:61577-2800 | NDC:76305-300 | NDC:55614-661 | NDC:46122-392 | NDC:83084-618 | NDC:72342-080 | NDC:55715-001 | NDC:73647-062 | NDC:79903-308 | NDC:26052-489 | NDC:83552-128 | NDC:65923-987 | NDC:70000-0546 | NDC:61658-005 | CAMPHOR (SYNTHETIC) | NDC:83084-265 | NDC:84214-004 | NDC:59779-790 | NDC:73647-103 | NDC:11822-7883 | NDC:66059-0004 | NDC:36800-418 | NDC:66761-422 | NDC:84126-303 | NDC:84338-000 | NDC:22431-123 | NDC:49035-770 | NDC:59088-488 | NDC:72524-064 | NDC:69070-307 | NDC:55614-620 | NDC:61658-006 | NDC:55319-482 | NDC:55758-430 | NDC:10742-0002 | NDC:55264-114 | NDC:68007-300 | NDC:71101-036 | NDC:59088-203 | NDC:50066-454 | NDC:73647-026 | NDC:60954-010 | NDC:73647-041 | NDC:70039-301 | NDC:73769-450 | NDC:59321-056 | NDC:55614-671 | NDC:43405-014 | NDC:50017-033 | NDC:55328-900 | NDC:79481-9928 | NDC:85009-001 | NDC:72937-010 | NDC:71391-139 | NDC:41167-0801 | NDC:85136-002 | NDC:66902-142 | NDC:76305-402 | NDC:73048-004 | NDC:72937-062 | NDC:71927-020 | NDC:55910-248 | NDC:48951-1184 | NDC:71101-202 | NDC:69561-006 | NDC:10157-9951 | NDC:55301-248 | NDC:55264-020 | NDC:49283-145 | NDC:59321-055 | NDC:57337-160 | NDC:24909-012 | NDC:60954-013 | NDC:55264-012 | NDC:78691-141 | NDC:66902-000 | NDC:41250-907 | NDC:41167-0079 | NDC:76305-301 | NDC:55614-711 | NDC:0573-6555 | NDC:63941-248 | NDC:10210-0039 | NDC:48256-0002 | NDC:82442-213 | NDC:72562-125 | NDC:58933-671 | NDC:67091-410 | NDC:54473-335 | NDC:62212-004 | NDC:72937-300 | NDC:43493-0007 | NDC:43493-0013 | NDC:66902-140 | NDC:55614-680 | NDC:79903-105 | NDC:70000-0208 | NDC:70000-0396 | NDC:0363-4262 | NDC:46122-762 | NDC:84334-000 | NDC:66761-322 | NDC:0363-0907 | NDC:52000-113 | NDC:70947-130 | NDC:70000-0480 | NDC:83552-122 | PubChem CID:159055 | NDC:72133-100 | NDC:66761-321 | NDC:55038-001 | NDC:55910-833 | NDC:41250-411 | NDC:49873-068 | NDC:51367-021 | NDC:70039-283 | NDC:54273-013 | NDC:73647-040 | NDC:69842-256 | NDC:60954-201 | NDC:0395-0467 | NDC:66096-808 | NDC:51367-034 | NDC:83570-536 | NDC:55758-417 | NDC:71101-205 | NDC:83559-005 | NDC:55264-116 | NDC:49873-060 | NDC:66902-001 | NDC:43405-013 | NDC:71856-176 | NDC:79903-135 | NDC:63255-111 | NDC:83324-266 | NDC:60954-012 | NDC:63347-223 | NDC:84733-302 | NDC:49035-099 | NDC:52862-040 | NDC:64616-094 | NDC:64336-001 | NDC:46122-645 | NDC:50804-078 | NDC:46581-210 | NDC:79481-1220 | CAS RN:76-22-2 | NDC:43405-100 | NDC:90100-222 | NDC:69968-0721 | NDC:55264-103 | NDC:33992-7991 | NDC:11822-4205 | NDC:53943-105 | NDC:49873-065 | NDC:72342-190 | NDC:0363-0055 | NDC:84214-003 | NDC:73132-004 | NDC:82198-0015 | NDC:72839-987 | NDC:66897-001 | NDC:55758-449 | NDC:43742-2185 | NDC:82372-014 | NDC:70000-0368 | NDC:73076-156 | NDC:83570-523 | NDC:62168-0210 | NDC:0536-1268 | NDC:72342-050 | NDC:69070-300 | NDC:80465-100 | NDC:82198-0007 | NDC:49873-622 | NDC:71101-200 | NDC:79804-260 | NDC:66059-0003 | NDC:55614-641 | NDC:70947-115 | NDC:70000-0563 | NDC:41250-833 | NDC:67091-442 | NDC:37808-248 | NDC:0220-1122 | NDC:67510-0289 | NDC:68747-3022 | NDC:43493-0010 | NDC:43493-0011 | NDC:72342-230 | NDC:11822-8545 | NDC:63941-256 | NDC:49035-872 | NDC:79481-0051 | NDC:84890-282 | NDC:10742-8731 | NDC:84046-001 | NDC:83570-491 | NDC:60954-014 | NDC:73769-451 | NDC:72197-007 | NDC:30400-701 | NDC:72342-200 | NDC:62003-422 | NDC:57597-043 | CAS RN:464-49-3 | NDC:61734-030 | NDC:43405-009 | NDC:90100-221 | NDC:84859-111 | NDC:80396-020 | NDC:73076-155 | NDC:48951-8404 | NDC:84618-008 | NDC:11822-9993 | NDC:49873-621 | NDC:60954-017 | NDC:83552-124 | NDC:55264-102 | DrugBank ID:DB01744 | NDC:48951-1278 | NDC:71399-4589 | NDC:82026-611 | NDC:69536-108 | NDC:75849-897 | NDC:43136-102 | NDC:41163-248 | NDC:0280-0063 | PubChem SID:175272110 | NDC:51316-992 | NDC:70947-013 | NDC:55264-021 | NDC:33992-7996 | NDC:73386-148 | NDC:84991-0208 | NDC:71101-909 | NDC:53943-467 | NDC:24286-1521 | NDC:24909-011 | NDC:53943-262 | NDC:55614-310 | NDC:72036-907 | NDC:0363-9904 | NDC:53943-256 | NDC:58933-544 | NDC:72288-397 | NDC:11822-3506 | NDC:66761-341 | NDC:73061-003 | NDC:59088-202 | NDC:0316-0229 | NDC:51367-031 | NDC:67091-161 | NDC:71391-140 | NDC:72937-026 | NDC:69842-626 | NDC:59088-283 | NDC:43493-0003 | NDC:79903-194 | UNII:5TJD82A1ET | NDC:79481-0047 | NDC:72602-003 | NDC:79974-206 | NDC:66506-188 | NDC:71101-034 | NDC:41250-024 | NDC:81980-727 | NDC:43493-0004 | NDC:10157-1194 | NDC:63868-800 | NDC:10742-8096 | NDC:11822-3197 | NDC:61924-189 | NDC:72863-076 | NDC:43405-012 | NDC:57337-051 | NDC:62212-003 | NDC:69842-695 | NDC:72288-248 | CAMPHOR (NATURAL) | NDC:24286-1554 | NDC:58037-010 | NDC:36800-596 | NDC:72524-005 | NDC:55910-256 | Camphor | NDC:46122-573 | NDC:69396-031 | NDC:65923-564 | NDC:11673-501 | NDC:51367-020 | NDC:11673-667 | NDC:81522-725 | NDC:0363-1199 | NDC:24286-1576 | NDC:66761-327 | NDC:73044-103 | NDC:75849-301 | NDC:72562-105 | NDC:55910-907 | NDC:30142-892 | NDC:84338-001 | NDC:52000-012"
+BMGC_DG03896,BMG_DG099880,PubChem SID:198958168 | 2-HYDROXYETHYL DISULFIDE | UNII:45543L74BS | DrugBank ID:DB02486 | CAS RN:1892-29-1 | PubChem CID:15906 | 2-Hydroxyethyl Disulfide
+BMGC_DG03897,BMG_DG099890,UNII:336B74JK56 | CAS RN:87413-09-0 | PubChem CID:159087 | PubChem SID:198950781 | TRIACETOXYPERIODINANE
+BMGC_DG03898,BMG_DG099893,PHENYLTRIMETHYLAMMONIUM | trimethyl(phenyl)azanium | PubChem CID:15914 | CAS RN:3426-74-2 | UNII:6N2P1DR953 | PubChem SID:363908088 | Phenyltrimethylammonium
+BMGC_DG03899,BMG_DG099928,2-(Chloromethyl)oxirane;prop-2-en-1-amine;hydrochloride | PubChem CID:159247 | CAS RN:182683-00-7 | CAS RN:152751-57-0 | 2-(chloromethyl)oxirane;prop-2-en-1-amine;hydrochloride
+BMGC_DG03900,BMG_DG099930,DrugBank ID:DB14489 | Ferrous succinate | PubChem CID:159252
+BMGC_DG03901,BMG_DG099938,"DrugBank ID:DB01265 | UNII:2OC4HKD3SF | Telbivudine | TELBIVUDINE | PubChem CID:159269 | 1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | CAS RN:3424-98-4 | PubChem SID:175267960"
+BMGC_DG03902,BMG_DG099940,CAS RN:180200-68-4 | UNII:G6VI5P84SX | PubChem SID:198938472 | TILMACOXIB | PubChem CID:159271
+BMGC_DG03903,BMG_DG099948,CI-959 FREE ACID | PubChem CID:159289 | UNII:Y8M8A93SU8 | CAS RN:104795-66-6 | PubChem SID:198984880
+BMGC_DG03904,BMG_DG099953,"Adenosine 3',5'-diphosphate | Adenosine-3'-5'-diphosphate | PubChem SID:318164159 | PubChem CID:159296 | CAS RN:1053-73-2 | DrugBank ID:DB01812 | UNII:C65F80D52U | ADENOSINE 3',5'-DIPHOSPHATE | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate"
+BMGC_DG03905,BMG_DG099956,"CAS RN:19356-17-3 | 3-[2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol | CAS RN:73809-05-9 | PubChem CID:1593"
+BMGC_DG03906,BMG_DG099962,CAS RN:192185-72-1 | PubChem CID:159324 | PubChem SID:198985107 | DrugBank ID:DB04960 | UNII:MAT637500A | 6-[(R)-amino-(4-chlorophenyl)-(3-methylimidazol-4-yl)methyl]-4-(3-chlorophenyl)-1-methylquinolin-2-one | Tipifarnib | TIPIFARNIB
+BMGC_DG03907,BMG_DG099963,"PubChem CID:159325 | PubChem SID:198955213 | ethyl (2R,4S)-4-[[3,5-bis(trifluoromethyl)phenyl]methyl-methoxycarbonylamino]-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinoline-1-carboxylate | UNII:4N4457MV2U | CAS RN:262350-59-4 | Torcetrapib | TORCETRAPIB | DrugBank ID:DB06281 | CAS RN:262352-17-0"
+BMGC_DG03908,BMG_DG099964,"ABAFUNGIN | CAS RN:129639-79-8 | UNII:11DI31LWXF | 4-[2-(2,4-dimethylphenoxy)phenyl]-N-(1,4,5,6-tetrahydropyrimidin-2-yl)-1,3-thiazol-2-amine | PubChem CID:159326 | CAS RN:178886-71-0 | DrugBank ID:DB06395 | PubChem SID:198981194 | Abafungin"
+BMGC_DG03909,BMG_DG099999,"PubChem CID:15938964 | CAS RN:15666-52-1 | [[2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate | Thiamine(1+) triphosphate(4-)"
+BMGC_DG03910,BMG_DG100000,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate | Adenosine-5-monophosphate(2-) | PubChem CID:15938965"
+BMGC_DG03911,BMG_DG100005,"Nicotinamide adenine dinucleotide phosphate | CAS RN:53-59-8 | PubChem CID:15938972 | CAS RN:165676-60-8 | [(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate"
+BMGC_DG03912,BMG_DG100024,CAS RN:914382-60-8 | DrugBank ID:DB15321 | cyclopentyl (2S)-2-[[4-[[8-(hydroxyamino)-8-oxooctanoyl]amino]phenyl]methylamino]-2-phenylacetate | Tefinostat | UNII:ZAU91150SB | TEFINOSTAT | PubChem CID:15940949 | PubChem SID:198986145
+BMGC_DG03913,BMG_DG100037,MB-07344 | UNII:R1ZW9H43ZJ | PubChem SID:198943466 | CAS RN:852947-39-8 | PubChem CID:15941848
+BMGC_DG03914,BMG_DG100040,"PubChem SID:198977315 | Phenol, 4-((4-(((2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-2-yl)methoxy)-2,6-dimethylphenyl)methyl)-2-(1-methylethyl)- | PubChem CID:15942005 | 4-[[4-[[(2R,4S)-4-(3-chlorophenyl)-2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl]methoxy]-2,6-dimethylphenyl]methyl]-2-propan-2-ylphenol | UNII:3Z11398FNQ | DrugBank ID:DB15137 | CAS RN:852948-13-1 | VK-2809"
+BMGC_DG03915,BMG_DG100048,"PubChem CID:15942651 | (1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE | DrugBank ID:DB08170"
+BMGC_DG03916,BMG_DG100049,"PubChem CID:15942652 | DrugBank ID:DB07024 | 2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE"
+BMGC_DG03917,BMG_DG100050,"PubChem CID:15942655 | DrugBank ID:DB07247 | [2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA"
+BMGC_DG03918,BMG_DG100051,3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID | PubChem CID:15942657 | DrugBank ID:DB07976
+BMGC_DG03919,BMG_DG100052,"PubChem CID:15942658 | 3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID | DrugBank ID:DB07977 | 3-({[3,5-Difluoro-3'-(Trifluoromethoxy)biphenyl-4-Yl]amino}carbonyl)thiophene-2-Carboxylic Acid | 3-[[2,6-difluoro-4-[3-(trifluoromethoxy)phenyl]phenyl]carbamoyl]thiophene-2-carboxylic acid"
+BMGC_DG03920,BMG_DG100054,"DrugBank ID:DB08595 | PubChem CID:15942662 | 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL"
+BMGC_DG03921,BMG_DG100055,PubChem CID:15942672 | 1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA | DrugBank ID:DB08043
+BMGC_DG03922,BMG_DG100056,"DrugBank ID:DB08198 | PubChem CID:15942673 | [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE"
+BMGC_DG03923,BMG_DG100057,"(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE | PubChem CID:15942677 | DrugBank ID:DB08280"
+BMGC_DG03924,BMG_DG100059,PubChem CID:15942713 | PubChem SID:363907813 | UNII:FR0M0E7AZM | CAS RN:478946-89-3 | OPC-28326 | DrugBank ID:DB05461
+BMGC_DG03925,BMG_DG100060,MEPROSCILLARIN | PubChem CID:15942714 | CAS RN:33396-37-1 | PubChem SID:198938134 | UNII:WYR1723LO7
+BMGC_DG03926,BMG_DG100074,"UNII:4S465RYF7M | DrugBank ID:DB12873 | DIANHYDROGALACTITOL | (1S,2R)-1-[(2S)-oxiran-2-yl]-2-[(2R)-oxiran-2-yl]ethane-1,2-diol | PubChem SID:198945332 | PubChem CID:15942827 | Dianhydrogalactitol | CAS RN:23261-20-3"
+BMGC_DG03927,BMG_DG100104,CAS RN:13020-19-4 | PubChem SID:482553856 | CIRSIMARIN | UNII:72U3YNK7DV | PubChem CID:159460 | Cirsimarin
+BMGC_DG03928,BMG_DG100105,PubChem CID:159461 | CAS RN:13027-33-3 | PubChem SID:318164325 | UNII:YO7G6S09N3 | YAKKASTERONE
+BMGC_DG03929,BMG_DG100120,UNII:6K32LCR80R | MF-498 | PubChem SID:198952975 | CAS RN:915191-42-3 | PubChem CID:15948325
+BMGC_DG03930,BMG_DG100130,"FLUTEMETAMOL F-18 | Flutemetamol (18F) | NDC:17156-067 | PubChem CID:15950376 | UNII:L49M066S0O | CAS RN:765922-62-1 | DrugBank ID:DB09151 | Flutemetamol F-18 | 2-[3-(18F)fluoranyl-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol | PubChem SID:198940408"
+BMGC_DG03931,BMG_DG100139,"CAS RN:915036-97-4 | PubChem CID:15951194 | N-[3-(1,2,3,6-Tetrahydro-1-methyl-4-pyridinyl)-1H-indol-5-yl]-2-thiophenecarboximidamide | N'-[3-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)-1H-indol-5-yl]thiophene-2-carboximidamide"
+BMGC_DG03932,BMG_DG100141,"Lobeglitazone sulfate | CAS RN:763108-62-9 | PubChem SID:198963451 | LOBEGLITAZONE SULFATE | UNII:95C712E83P | PubChem CID:15951505 | 5-[[4-[2-[[6-(4-methoxyphenoxy)pyrimidin-4-yl]-methylamino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione;sulfuric acid"
+BMGC_DG03933,BMG_DG100144,"DrugBank ID:DB08899 | Enzalutamide | 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide | NDC:0469-1725 | CAS RN:915087-33-1 | NDC:0469-0125 | PubChem SID:175267791 | ENZALUTAMIDE | NDC:0469-0625 | NDC:0469-1125 | PubChem CID:15951529 | UNII:93T0T9GKNU | NDC:0469-0725"
+BMGC_DG03934,BMG_DG100145,CELASTROL METHYL ESTER | PubChem SID:198953041 | PubChem CID:159516 | UNII:28ZK7PR57S | CAS RN:1258-84-0
+BMGC_DG03935,BMG_DG100151,"(1'R,4R,10'S)-2-(2,2,2-Trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide | UNII:DJ2AZE88DE | PubChem SID:472406220 | PubChem CID:15953832 | (1'R,4R,10'S)-2-(2,2,2-trifluoroethyl)-5'-[(E)-3-[4-(trifluoromethyl)piperidin-1-yl]prop-1-enyl]spiro[1,2,5-thiadiazolidine-4,13'-tricyclo[8.2.1.03,8]trideca-3(8),4,6-triene] 1,1-dioxide | CAS RN:623165-93-5 | CAS RN:423167-89-9 | MRK-003"
+BMGC_DG03936,BMG_DG100152,"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine | DrugBank ID:DB07021 | PubChem CID:15953860"
+BMGC_DG03937,BMG_DG100153,PubChem SID:241178078 | UNII:IAN358A69K | CAS RN:925701-49-1 | KU-60019 | PubChem CID:15953870
+BMGC_DG03938,BMG_DG100163,Philanthotoxin-343 | PHILANTHOTOXIN-343 | PubChem SID:482554926 | PubChem CID:159548 | CAS RN:115976-93-7 | UNII:VS3BZ5F9WP
+BMGC_DG03939,BMG_DG100175,"UNII:V6D7VK2215 | 4-(1,3-BENZODIOXOL-5-YL)-1-(2-(DIBUTYLAMINO)-2-OXOETHYL)-2-(4-METHOXYPHENYL)-3-PYRROLIDINECARBOXYLIC ACID, (2R,3R,4S)-REL- | PubChem SID:198977266 | ATRASENTAN | CAS RN:173937-91-2 | 4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic acid, (2R,3R,4S)-rel- | CAS RN:195704-72-4 | PubChem CID:159594 | PubChem SID:496142912 | Atrasentan | (2R,3R,4S)-4-(1,3-benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid | DrugBank ID:DB06199 | UNII:P6FLG98GBJ"
+BMGC_DG03940,BMG_DG100178,DrugBank ID:DB04368 | PubChem CID:159596 | Bb-3497
+BMGC_DG03941,BMG_DG100183,"CAS RN:144875-48-9 | RESIQUIMOD | 1-[4-amino-2-(ethoxymethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol | DrugBank ID:DB06530 | PubChem SID:198951685 | UNII:V3DMU7PVXF | PubChem CID:159603 | Resiquimod"
+BMGC_DG03942,BMG_DG100199,UNII:792VG4M5YM | PubChem SID:478836806 | 4-(4-METHOXYPHENYL)THIAZOL-2-AMINE | CAS RN:2104-04-3 | PubChem CID:159644 | 4-(4-Methoxyphenyl)thiazol-2-amine
+BMGC_DG03943,BMG_DG100206,UNII:7W8X3AXG75 | L-054522 | PubChem SID:459055453 | PubChem CID:15965425 | CAS RN:214348-67-1
+BMGC_DG03944,BMG_DG100213,PubChem SID:443624866 | PubChem CID:159665 | UNII:K89VS3UAD8 | 5-HYDROXYINDOMETHACIN | 5-Hydroxyindomethacin | CAS RN:2504-32-7 | 2-[1-(4-chlorobenzoyl)-5-hydroxy-2-methylindol-3-yl]acetic acid
+BMGC_DG03945,BMG_DG100225,"PubChem SID:198969799 | PubChem CID:15969 | METHYL N-(3,4-DICHLOROPHENYL)CARBAMATE | methyl N-(3,4-dichlorophenyl)carbamate | Methyl N-(3,4-dichlorophenyl)carbamate | UNII:6A0988TW71 | CAS RN:1918-18-9"
+BMGC_DG03946,BMG_DG100245,PubChem CID:159738 | DrugBank ID:DB04218 | 1-Deaza-Adenosine
+BMGC_DG03947,BMG_DG100254,4-Guanidinobenzoic acid | PubChem CID:159772 | UNII:XFP29CVC4Z | 4-GUANIDINOBENZOIC ACID | CAS RN:16060-65-4 | DrugBank ID:DB02459 | PubChem SID:496141552 | 4-guanidinobenzoic acid
+BMGC_DG03948,BMG_DG100262,"Stannsoporfin | CAS RN:106344-20-1 | PubChem CID:15978579 | DrugBank ID:DB04912 | PubChem SID:198986980 | UNII:0KAE1U0G7Q | STANNSOPORFIN | 3-[18-(2-carboxyethyl)-8,13-diethyl-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid;tin(4+);dichloride"
+BMGC_DG03949,BMG_DG100267,2-amino-5-(4-chlorophenyl)-3-(4-sulfamoylphenyl)benzamide | CAS RN:928655-63-4 | 2-Amino-5-(4-chlorophenyl)-3-(4-sulfamoylphenyl)benzamide | PubChem CID:15979284
+BMGC_DG03950,BMG_DG100272,PubChem CID:1598 | 2-AMINOETHOXYDIPHENYLBORATE | UNII:E4ES684O93 | CAS RN:524-95-8 | PubChem SID:252164586
+BMGC_DG03951,BMG_DG100279,"PubChem SID:198950296 | Resmetirom | UNII:RE0V0T1ES0 | DrugBank ID:DB12914 | PubChem CID:15981237 | 2-[3,5-dichloro-4-[(6-oxo-5-propan-2-yl-1H-pyridazin-3-yl)oxy]phenyl]-3,5-dioxo-1,2,4-triazine-6-carbonitrile | RESMETIROM | CAS RN:920509-32-6"
+BMGC_DG03952,BMG_DG100281,CAS RN:881681-00-1 | Vonoprazan | PubChem SID:198949666 | VONOPRAZAN | PubChem CID:15981397 | DrugBank ID:DB11739 | UNII:1R5L3J156G | 1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine
+BMGC_DG03953,BMG_DG100284,PubChem CID:15981486 | UNII:FC2VW8EJD2 | GSK-188909 | CAS RN:706802-34-8 | PubChem SID:445499118
+BMGC_DG03954,BMG_DG100294,PubChem CID:15983287 | Toludesvenlafaxine | DrugBank ID:DB15052 | PubChem SID:377308061 | [4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenyl] 4-methylbenzoate | CAS RN:916918-80-4 | TOLUDESVENLAFAXINE | UNII:A7CGH459FN
+BMGC_DG03955,BMG_DG100296,PubChem CID:15983948 | CAS RN:524-14-1 | Malonyl coenzyme A | PubChem SID:474494185 | MALONYL COENZYME A | UNII:LNB9YCJ9F9
+BMGC_DG03956,BMG_DG100297,"[(2R,3R,4R,5R)-2-(6-aminopurin-9-yl)-5-[[[[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate | NADPH(4-) | PubChem CID:15983949 | CAS RN:2646-71-1"
+BMGC_DG03957,BMG_DG100304,CAS RN:929095-18-1 | (R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide | PubChem SID:198971762 | PubChem CID:15983966 | UNII:8QO27TK6Q4 | GSK-461364 | 5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide
+BMGC_DG03958,BMG_DG100306,"TRELAGLIPTIN | Trelagliptin | DrugBank ID:DB15323 | PubChem CID:15983988 | 2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile | PubChem SID:198935033 | CAS RN:865759-25-7 | UNII:Q836OWG55H"
+BMGC_DG03959,BMG_DG100316,CAS RN:923565-21-3 | PubChem SID:198965694 | CAMICINAL | DrugBank ID:DB12567 | PubChem CID:15984937 | UNII:3C8348951H | Camicinal | 1-[4-(3-fluoroanilino)piperidin-1-yl]-2-[4-[[(3S)-3-methylpiperazin-1-yl]methyl]phenyl]ethanone
+BMGC_DG03960,BMG_DG100319,DOMATINOSTAT | (E)-N-(2-aminophenyl)-3-[1-[4-(1-methylpyrazol-4-yl)phenyl]sulfonylpyrrol-3-yl]prop-2-enamide | CAS RN:910462-43-0 | 4SC-202 | DrugBank ID:DB13101 | UNII:264ARM7UXX | PubChem CID:15985904 | PubChem SID:252823622 | (E)-N-(2-aminophenyl)-3-(1-((4-(1-methyl-1H-pyrazol-4-yl)phenyl)sulfonyl)-1H-pyrrol-3-yl)acrylamide
+BMGC_DG03961,BMG_DG100323,"3,6,9,12,15-PENTAOXATRICOSAN-1-OL | PubChem CID:159866 | DrugBank ID:DB08249"
+BMGC_DG03962,BMG_DG100348,"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE | PubChem CID:15991546 | DrugBank ID:DB06986"
+BMGC_DG03963,BMG_DG100349,"PubChem CID:15991547 | DrugBank ID:DB07066 | 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE"
+BMGC_DG03964,BMG_DG100351,PubChem SID:443624361 | 3-(2-AZANYLQUINAZOLIN-6-YL)-4-METHYL-N-(3-(TRIFLUOROMETHYL)PHENYL)BENZAMIDE | CAS RN:882664-95-1 | 3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE | PubChem CID:15991573 | DrugBank ID:DB06925 | UNII:T52FE17W1Y
+BMGC_DG03965,BMG_DG100352,"PubChem CID:15991574 | CAS RN:20790-72-1 | DrugBank ID:DB04527 | UNII:9J17BCS69U | PubChem SID:318164072 | 3-HYDROXYASPARAGINE, (3S)- | beta-Hydroxyasparagine"
+BMGC_DG03966,BMG_DG100353,4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE | DrugBank ID:DB08672 | PubChem CID:15991577
+BMGC_DG03967,BMG_DG100354,"DrugBank ID:DB08389 | PubChem CID:15991588 | 6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE"
+BMGC_DG03968,BMG_DG100360,"DrugBank ID:DB03222 | UNII:K8KCC8SH6N | 2'-Deoxyadenosine 5'-triphosphate | [[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | CAS RN:1927-31-7 | CAS RN:67460-17-7 | CAS RN:111907-01-8 | 2'-DEOXYADENOSINE TRIPHOSPHATE | PubChem CID:15993 | dATP | PubChem SID:252164674"
+BMGC_DG03969,BMG_DG100373,"ERITADENINE | UNII:41T27K4B9F | PubChem SID:198942078 | PubChem CID:159961 | Eritadenine | D-Eritadenine | (2R,3R)-4-(6-aminopurin-9-yl)-2,3-dihydroxybutanoic acid | DrugBank ID:DB03769 | CAS RN:23918-98-1"
+BMGC_DG03970,BMG_DG100375,AKNADININE | CAS RN:24148-86-5 | PubChem CID:159966 | PubChem SID:441583909 | UNII:V5XGU77PZ9
+BMGC_DG03971,BMG_DG100393,PubChem CID:160023 | L-691121 FREE BASE | PubChem SID:348481216 | UNII:YZC4LVT590 | CAS RN:136075-61-1
+BMGC_DG03972,BMG_DG100394,PubChem SID:198958698 | UNII:8SH8T1164U | DrugBank ID:DB02021 | FIDARESTAT | PubChem CID:160024 | CAS RN:136087-85-9 | Fidarestat
+BMGC_DG03973,BMG_DG100402,NDC:66215-812 | CAS RN:441798-33-0 | 5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine | MACITENTAN | DrugBank ID:DB08932 | NDC:66215-814 | PubChem SID:198971703 | Macitentan | NDC:66215-501 | UNII:Z9K9Y9WMVL | PubChem CID:16004692
+BMGC_DG03974,BMG_DG100404,2-(chloromethyl)oxirane;prop-2-en-1-amine;N-prop-2-enyldecan-1-amine;trimethyl-[6-(prop-2-enylamino)hexyl]azanium;chloride;hydrochloride | CAS RN:182815-44-7 | Welchol | PubChem CID:160051
+BMGC_DG03975,BMG_DG100416,"AZD-5672 | Azd-5672 | UNII:61XQN688TW | N-[1-[(3R)-3-(3,5-difluorophenyl)-3-(4-methylsulfonylphenyl)propyl]piperidin-4-yl]-N-ethyl-2-(4-methylsulfonylphenyl)acetamide | PubChem CID:16007088 | CAS RN:780750-65-4 | PubChem SID:198946126 | DrugBank ID:DB11804"
+BMGC_DG03976,BMG_DG100418,UNII:172V4FBZ75 | CAS RN:659730-32-2 | PubChem CID:16007367 | AMG-517 | PubChem SID:198971960
+BMGC_DG03977,BMG_DG100419,UNII:29P8LWS24N | 2-[3-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]quinazolin-4-yl]amino]-1H-pyrazol-5-yl]-N-(3-fluorophenyl)acetamide | PubChem SID:198941332 | DEFOSBARASERTIB | Azd-1152hqpa | CAS RN:722544-51-6 | CAS RN:1218904-24-5 | PubChem CID:16007391
+BMGC_DG03978,BMG_DG100424,"4-Chloro-3,5-dinitrobenzonitrile | CAS RN:1930-72-9 | PubChem SID:485661635 | 4-CHLORO-3,5-DINITROBENZONITRILE | UNII:AN6ZWE3GJE | PubChem CID:16008"
+BMGC_DG03979,BMG_DG100434,PubChem CID:160134 | CAS RN:26717-47-5 | CLOFIBRIDE | UNII:0S9SLS3L93 | DrugBank ID:DB13849 | [4-(dimethylamino)-4-oxobutyl] 2-(4-chlorophenoxy)-2-methylpropanoate | Clofibride | PubChem SID:198982659
+BMGC_DG03980,BMG_DG100438,DrugBank ID:DB03938 | Deacetoxycephalosporin C | PubChem CID:160139
+BMGC_DG03981,BMG_DG100440,"8,8-dimethyl-2-propan-2-yl-6,7-dihydro-5H-phenanthrene-3,4-dione | CAS RN:27210-57-7 | Miltirone | PubChem CID:160142"
+BMGC_DG03982,BMG_DG100450,"[5-(9H-pyrido[3,4-b]indol-1-yl)furan-2-yl]methanol | PubChem SID:461433814 | Perlolyrine | PERLOLYRINE | UNII:SV3L654T9S | CAS RN:29700-20-7 | PubChem CID:160179"
+BMGC_DG03983,BMG_DG100461,PubChem CID:16019977 | chloro(201Tl)thallium-201 | Thallous Chloride Tl-201
+BMGC_DG03984,BMG_DG100466,CID-16020046 | UNII:5AUY4Y2UPU | PubChem SID:445499854 | CAS RN:834903-43-4 | PubChem CID:16020046
+BMGC_DG03985,BMG_DG100479,"PubChem CID:160237 | CIRSILIOL | Cirsiliol | UNII:8W4Y5JK3XE | PubChem SID:445500732 | CAS RN:34334-69-5 | 2-(3,4-dihydroxyphenyl)-5-hydroxy-6,7-dimethoxychromen-4-one"
+BMGC_DG03986,BMG_DG100486,PubChem SID:316913191 | UNII:5E9SXT166N | PubChem CID:160254 | CAS RN:35825-57-1 | CRYPTOTANSHINONE
+BMGC_DG03987,BMG_DG100492,UNII:CBU2X6BBJR | CAS RN:10549-76-5 | PubChem SID:198946549 | Tetrabutylammonium Ion | TETRABUTYLAMMONIUM | DrugBank ID:DB01851 | tetrabutylazanium | PubChem CID:16028 | Tetrabutylammonium
+BMGC_DG03988,BMG_DG100497,"CAS RN:89020-33-7 | PubChem CID:160306 | Territrem C | (1S,2S,7R,10R)-1,7-dihydroxy-14-(4-hydroxy-3,5-dimethoxyphenyl)-2,6,6,10-tetramethyl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-4,12(17),13-triene-3,16-dione"
+BMGC_DG03989,BMG_DG100514,"PubChem CID:160352 | CAS RN:165456-81-5 | Lamivudine, zidovudine drug combination | 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione"
+BMGC_DG03990,BMG_DG100518,CAS RN:186692-46-6 | PubChem SID:198982002 | Roscovitine | PubChem CID:160355 | DrugBank ID:DB06195 | UNII:0ES1C2KQ94 | Seliciclib | (2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol | SELICICLIB
+BMGC_DG03991,BMG_DG100521,1-(4-Hydroxyphenyl)-2-propen-1-one | UNII:5Q53494FUT | PubChem CID:16036927 | 1-(4-HYDROXYPHENYL)-2-PROPEN-1-ONE | PubChem SID:485663430 | CAS RN:95605-38-2
+BMGC_DG03992,BMG_DG100525,PubChem SID:198959115 | CAS RN:761439-42-3 | TAE-684 | PubChem CID:16038120 | UNII:EH1713MN4K
+BMGC_DG03993,BMG_DG100532,A-803467 | PubChem CID:16038374 | PubChem SID:198975580 | CAS RN:944261-79-4 | UNII:339LBH1395
+BMGC_DG03994,BMG_DG100537,PubChem CID:16039797 | UNII:660M185X4D | 3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-5-[(2S)-1-methoxypropan-2-yl]oxy-N-(5-methylpyrazin-2-yl)benzamide | DrugBank ID:DB14810 | CAS RN:919783-22-5 | Azd-1656 | AZD-1656 | PubChem SID:346540598
+BMGC_DG03995,BMG_DG100538,PubChem CID:1604 | AL7182 | DrugBank ID:DB02602
+BMGC_DG03996,BMG_DG100542,"2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE | PubChem CID:16040257 | DrugBank ID:DB08277"
+BMGC_DG03997,BMG_DG100543,"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE | PubChem CID:16040261 | DrugBank ID:DB07804"
+BMGC_DG03998,BMG_DG100544,"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile | PubChem CID:16040268 | DrugBank ID:DB06972"
+BMGC_DG03999,BMG_DG100545,"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE | PubChem CID:16040279 | DrugBank ID:DB07830"
+BMGC_DG04000,BMG_DG100546,PubChem CID:16040281 | DrugBank ID:DB08221 | N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE
+BMGC_DG04001,BMG_DG100547,PubChem CID:16040289 | N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide | DrugBank ID:DB07183
+BMGC_DG04002,BMG_DG100549,PubChem CID:16040294 | DrugBank ID:DB07966 | [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
+BMGC_DG04003,BMG_DG100551,"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one | DrugBank ID:DB07519 | PubChem CID:16040323"
+BMGC_DG04004,BMG_DG100558,CAS RN:934353-76-1 | PubChem SID:198971242 | 6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]pyrimidin-4-amine | PubChem CID:16041424 | ENMD-981693 | UNII:J6U9WP10T7 | CAS RN:934353-77-2 | Enmd-2076
+BMGC_DG04005,BMG_DG100559,"PubChem CID:16041426 | PubChem SID:198990691 | UNII:MQ908Y1ZB2 | DrugBank ID:DB12644 | 5-(3-chlorophenyl)-3-[(1R)-1-[(4-methyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)oxy]ethyl]-1,2-oxazole | CAS RN:934282-55-0 | Azd2066 | CAS RN:1403991-95-6 | AZD-2066"
+BMGC_DG04006,BMG_DG100567,MF-438 | UNII:HI3FN320OX | CAS RN:921605-87-0 | PubChem SID:198949750 | PubChem CID:16042458
+BMGC_DG04007,BMG_DG100571,"TERT-BUTYLHYDROQUINONE | Tert-Butylhydroquinone | DrugBank ID:DB07726 | CAS RN:1948-33-0 | t-Butylhydroquinone | 2-tert-butylbenzene-1,4-diol | PubChem SID:175265833 | UNII:C12674942B | PubChem CID:16043"
+BMGC_DG04008,BMG_DG100576,"DrugBank ID:DB07235 | PubChem CID:16043304 | N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE"
+BMGC_DG04009,BMG_DG100577,PubChem CID:160434 | 2-hydroxybutanedioate | Malate | CAS RN:149-61-1
+BMGC_DG04010,BMG_DG100591,3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile | PubChem CID:16045336 | DrugBank ID:DB08154
+BMGC_DG04011,BMG_DG100598,PubChem CID:16045730 | 2-[4-(3-ethynylanilino)-6-(2-methoxyethoxy)quinazolin-7-yl]oxyethanol | PubChem SID:198982060 | UNII:EBL2O556JZ | CAS RN:183320-29-8 | CP-373413
+BMGC_DG04012,BMG_DG100605,"Raxatrigine | VIXOTRIGINE | Vixotrigine | UNII:QQS4J85K6Y | DrugBank ID:DB11706 | CAS RN:934240-30-9 | (2S,5R)-5-[4-[(2-fluorophenyl)methoxy]phenyl]pyrrolidine-2-carboxamide | PubChem SID:310825980 | PubChem CID:16046068"
+BMGC_DG04013,BMG_DG100607,"PubChem CID:16046126 | DrugBank ID:DB06888 | (13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE"
+BMGC_DG04014,BMG_DG100622,"(2S)-5,7-dihydroxy-2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one | PubChem CID:160481 | PubChem SID:198972493 | CAS RN:480-43-3 | ISOSAKURANETIN | Isosakuranetin | UNII:U02X7TF8UA"
+BMGC_DG04015,BMG_DG100626,Agg-523 | DrugBank ID:DB15460 | PubChem SID:329904272 | CAS RN:920289-29-8 | (4S)-5-[[1-(4-fluorophenyl)-2-methylpropan-2-yl]amino]-5-oxo-4-[(4-phenylbenzoyl)amino]pentanoic acid | PubChem CID:16048422 | AGG-523 | UNII:WO23I2827Q
+BMGC_DG04016,BMG_DG100630,"PubChem CID:16048564 | CAS RN:136271-61-9 | UNII:IME4LIZ1ZO | PubChem SID:381132165 | 4-(4-chlorophenyl)-1-[(4S)-4-(4-fluorophenyl)-4-hydroxybutyl]piperidin-4-ol | DIHYDROHALOPERIDOL, (S)- | Dihydrohaloperidol, (S)-"
+BMGC_DG04017,BMG_DG100635,"N(2)-formyl-N(1)-(5-phospho-D-ribosyl)glycinamide | [(2R,3S,4R)-5-[(2-formamidoacetyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | PubChem CID:16048611 | CAS RN:349-34-8"
+BMGC_DG04018,BMG_DG100642,PubChem SID:198984536 | D-106669 | CAS RN:938444-93-0 | PubChem CID:16048654 | UNII:9575Q08390
+BMGC_DG04019,BMG_DG100648,GUVACOLINE | PubChem SID:252164635 | CAS RN:495-19-2 | PubChem CID:160492 | UNII:YT3OF85P98
+BMGC_DG04020,BMG_DG100649,"DrugBank ID:DB12303 | UNII:WP6PY72ZH3 | 2-amino-N,N-dipropyl-8-[4-(pyrrolidine-1-carbonyl)phenyl]-3H-1-benzazepine-4-carboxamide | PubChem CID:16049404 | PubChem SID:198967684 | CAS RN:926927-61-9 | Motolimod | MOTOLIMOD"
+BMGC_DG04021,BMG_DG100651,UNII:L094VD806K | CAS RN:676559-83-4 | PubChem SID:198960706 | ABT-279 | PubChem CID:16049769
+BMGC_DG04022,BMG_DG100652,PubChem SID:312524724 | CAS RN:914458-26-7 | JWH-307 | UNII:06QTR14ONW | PubChem CID:16049783
+BMGC_DG04023,BMG_DG100653,PubChem CID:16049784 | UNII:2LM4LL393Y | JWH-369 | CAS RN:914458-27-8 | PubChem SID:441331935
+BMGC_DG04024,BMG_DG100659,"CORYTUBERINE | CAS RN:517-56-6 | (6aS)-2,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-1,11-diol | PubChem SID:198973218 | Corytuberine | PubChem CID:160500 | UNII:4YJ94A3D8W"
+BMGC_DG04025,BMG_DG100665,"UNII:NNZ7TH999H | Xylopine, (-)- | PubChem SID:472423068 | XYLOPINE, (-)- | CAS RN:517-71-5 | PubChem CID:160503"
+BMGC_DG04026,BMG_DG100672,PubChem CID:160512 | UNII:1944T899NO | CAS RN:532-65-0 | (+)-ar-Turmerone | (+)-AR-TURMERONE | PubChem SID:198975247
+BMGC_DG04027,BMG_DG100701,"CAS RN:547-96-6 | (3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol | PubChem CID:160520 | 5beta-Cholestane-3alpha,7alpha,12alpha-triol"
+BMGC_DG04028,BMG_DG100705,PubChem CID:16052011 | GOSERELIN ACETATE | PubChem SID:376072145 | Goserelin Acetate | CAS RN:145781-92-6 | NDC:70720-951 | acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | NDC:70720-950 | UNII:6YUU2PV0U8
+BMGC_DG04029,BMG_DG100709,"UNII:FRJ46XRJ28 | PubChem SID:461432534 | ISOLARICIRESINOL, (+)- | PubChem CID:160521 | CAS RN:548-29-8"
+BMGC_DG04030,BMG_DG100713,"PubChem CID:160531 | UNII:HEE11L5C3G | (8R,9S,10R,13S,14S)-10,13-dimethyl-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | Androst-5-ene-3,17-dione | PubChem SID:252320006 | DrugBank ID:DB01456 | 5-androstenedione | CAS RN:571-36-8 | 5-ANDROSTENEDIONE"
+BMGC_DG04031,BMG_DG100716,5-HYDROXYINDOLE | UNII:320UN7XZYN | PubChem SID:198955294 | CAS RN:1953-54-4 | PubChem CID:16054
+BMGC_DG04032,BMG_DG100722,CAS RN:997-68-2 | L-Saccharopine | PubChem SID:249492661 | UNII:WBQ73O8W32 | PubChem CID:160556 | DrugBank ID:DB04207 | (2S)-2-[[(5S)-5-amino-5-carboxypentyl]amino]pentanedioic acid | SACCHAROPINE | Saccharopine
+BMGC_DG04033,BMG_DG100727,"3,5-DIIODOTHYROPROPIONIC ACID | PubChem CID:160565 | DrugBank ID:DB12629 | 3,5-Diiodothyropropionic acid | 3,5-diiodothyropropionic acid | CAS RN:1158-10-7 | UNII:1HTO2X0SJ9 | PubChem SID:198979714 | 3-[4-(4-hydroxyphenoxy)-3,5-diiodophenyl]propanoic acid"
+BMGC_DG04034,BMG_DG100730,"UNII:FJX8O3OJCD | PubChem SID:316916403 | Cannabidiolic acid | 2,4-dihydroxy-3-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-6-pentylbenzoic acid | CAS RN:1244-58-2 | PubChem CID:160570 | CANNABIDIOLIC ACID"
+BMGC_DG04035,BMG_DG100738,ETOGLUCID | DrugBank ID:DB13339 | 2-[2-[2-[2-(oxiran-2-ylmethoxy)ethoxy]ethoxy]ethoxymethyl]oxirane | UNII:4F9KUA0T4D | PubChem CID:16058 | Ethoglucid | CAS RN:1954-28-5 | PubChem SID:198935738
+BMGC_DG04036,BMG_DG100748,"DrugBank ID:DB07213 | PubChem CID:16058617 | (5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL"
+BMGC_DG04037,BMG_DG100749,DrugBank ID:DB07028 | (2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID | PubChem CID:16058629
+BMGC_DG04038,BMG_DG100750,PubChem CID:16058630 | DrugBank ID:DB07030 | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID
+BMGC_DG04039,BMG_DG100752,CAS RN:929007-72-7 | PubChem CID:16058637 | DB-07268 | PubChem SID:441097424 | 2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE | DrugBank ID:DB07268 | UNII:MU563H6ION
+BMGC_DG04040,BMG_DG100753,"DrugBank ID:DB07134 | PubChem CID:16058639 | 5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE"
+BMGC_DG04041,BMG_DG100754,"PubChem CID:16058650 | (3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE | DrugBank ID:DB08164"
+BMGC_DG04042,BMG_DG100755,"PubChem CID:16058668 | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE | DrugBank ID:DB06964"
+BMGC_DG04043,BMG_DG100758,"Jnj-37822681 | N-[1-[(3,4-difluorophenyl)methyl]piperidin-4-yl]-6-(trifluoromethyl)pyridazin-3-amine | PubChem SID:198934640 | PubChem CID:16058752 | UNII:GJB2URS7NJ | DrugBank ID:DB12579 | CAS RN:935776-74-2 | JNJ-37822681"
+BMGC_DG04044,BMG_DG100766,"[(7S,8S,8aS)-7-hydroxy-7-methyl-6-oxo-3-[(E)-prop-1-enyl]-8,8a-dihydro-1H-isochromen-8-yl] 2,4-dihydroxy-6-methylbenzoate | PubChem CID:16059797 | CAS RN:926885-92-9"
+BMGC_DG04045,BMG_DG100770,2-isocyanatoethylbenzene | CAS RN:1943-82-4 | PubChem SID:384647910 | PHENETHYL ISOCYANATE | UNII:W78MJV7AIA | Phenethyl isocyanate | PubChem CID:160602
+BMGC_DG04046,BMG_DG100771,Allysine | PubChem CID:160603 | CAS RN:6665-12-9 | (2S)-2-amino-6-oxohexanoic acid | DrugBank ID:DB02571 | PubChem SID:198951974 | UNII:425I4Y24YZ | ALLYSINE
+BMGC_DG04047,BMG_DG100786,PubChem SID:329589320 | 4-Hydroxybenzyl isothiocyanate | CAS RN:2086-86-4 | PubChem CID:160611 | 4-(isothiocyanatomethyl)phenol | UNII:318HJ2034L | P-HYDROXYBENZYL ISOTHIOCYANATE
+BMGC_DG04048,BMG_DG100835,"(1S,2S,4S,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-piperidine]-16-ol | CAS RN:126-17-0 | PubChem CID:16061352"
+BMGC_DG04049,BMG_DG100845,"(8R,9S,10R,13S,14S,17S)-4,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | DrugBank ID:DB01485 | PubChem CID:160615 | 4-Hydroxytestosterone | 4-HYDROXYTESTOSTERONE | CAS RN:2141-17-5 | UNII:912GOZ167T | PubChem SID:198978880"
+BMGC_DG04050,BMG_DG100846,PubChem SID:198953087 | BAVISANT | CAS RN:929622-08-2 | Bavisant | PubChem CID:16061509 | (4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone | DrugBank ID:DB12299 | UNII:9827P7LFVH
+BMGC_DG04051,BMG_DG100847,"Orotidylic acid | 3-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]-2,6-dioxopyrimidine-4-carboxylic acid | PubChem SID:363907680 | OROTIDYLIC ACID | DrugBank ID:DB02957 | CAS RN:2149-82-8 | PubChem CID:160617 | UNII:H0ARN8U4Y9"
+BMGC_DG04052,BMG_DG100853,"UNII:W3Y53JA9W3 | 3,4-DCPG, (S)- | PubChem SID:474492689 | PubChem CID:16062593 | CAS RN:201730-11-2"
+BMGC_DG04053,BMG_DG100856,PubChem SID:198950282 | PubChem CID:16063245 | UNII:I284LJY110 | RADOTINIB | Radotinib | 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyrazin-2-ylpyrimidin-2-yl)amino]benzamide | DrugBank ID:DB12323 | CAS RN:926037-48-1
+BMGC_DG04054,BMG_DG100879,"PF-03635659 | DrugBank ID:DB12408 | CAS RN:931409-24-4 | 1-Azetidinepentanamide, 3-(3-hydroxyphenoxy)-delta,delta-dimethyl-alpha,alpha-diphenyl- | PubChem CID:16065403 | UNII:O0RG3QM34H | 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide | PubChem SID:198962251"
+BMGC_DG04055,BMG_DG100880,PubChem CID:16065773 | PubChem SID:443624059 | HBX-41108 | CAS RN:924296-39-9 | UNII:C7JH7KSP8Z
+BMGC_DG04056,BMG_DG100885,"(2S)-2-[[5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]imidazole-4-carbonyl]amino]butanedioic acid | UNII:K1PVR64RIF | Saicar | SAICAR | PubChem SID:249493232 | CAS RN:3031-95-6 | PubChem CID:160666"
+BMGC_DG04057,BMG_DG100887,"CAS RN:936500-94-6 | 1-(5-chlorothiophen-2-yl)sulfonyl-3-[4-[6-fluoro-7-(methylamino)-2,4-dioxo-1H-quinazolin-3-yl]phenyl]urea | DrugBank ID:DB06350 | PubChem CID:16066663 | PubChem SID:198951229 | ELINOGREL | UNII:915Y8E749J | Elinogrel"
+BMGC_DG04058,BMG_DG100899,PubChem SID:433968406 | (2E)-3-(2-BUTYL-1-(2-(ETHYLAMINO)ETHYL)-1H-BENZIMIDAZOL-5-YL)-N-HYDROXY-2-PROPENAMIDE | UNII:9H0143U14X | CAS RN:929017-34-5 | PubChem CID:16068493
+BMGC_DG04059,BMG_DG100917,"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid | PubChem CID:16070039 | DrugBank ID:DB07395"
+BMGC_DG04060,BMG_DG100918,PubChem CID:16070041 | PubChem SID:198968785 | CAS RN:892549-43-8 | UNII:7TU641M876 | MF-63
+BMGC_DG04061,BMG_DG100931,"DrugBank ID:DB12229 | PubChem CID:16071605 | UNII:EK40PJ0V49 | Cerlapirdine | N,N-dimethyl-3-[(3-naphthalen-1-ylsulfonyl-2H-indazol-5-yl)oxy]propan-1-amine | CERLAPIRDINE | CAS RN:925448-93-7 | PubChem SID:198981997"
+BMGC_DG04062,BMG_DG100934,CAS RN:925676-48-8 | PubChem CID:16071896 | UNII:3EBU6WKP85 | PubChem SID:445500512 | LAS-101057
+BMGC_DG04063,BMG_DG100940,CAS RN:76530-44-4 | PubChem CID:16072188 | PubChem SID:198940057 | UNII:875AQ866X1 | AZAMULIN
+BMGC_DG04064,BMG_DG100954,PubChem CID:16075 | CAS RN:1967-27-7 | PubChem SID:474492092 | 3-Chlorophenylurea | 3-CHLOROPHENYLUREA | UNII:YM6G7RE55S
+BMGC_DG04065,BMG_DG100955,"CAS RN:4416-57-3 | PubChem CID:160753 | PubChem SID:313390077 | (4aS,4bR,10aR,10bS,12aS)-10a,12a-dimethyl-4,4a,4b,5,6,9,10,10b,11,12-decahydro-3H-naphtho[2,1-f]chromene-2,8-dione | Testololactone | UNII:3RQL9VE1NB | TESTOLOLACTONE"
+BMGC_DG04066,BMG_DG100963,"PubChem SID:198943682 | DrugBank ID:DB11586 | CAS RN:630420-16-5 | UNII:S9X0KRJ00S | PubChem CID:16076883 | tert-butyl N-[(2S)-1-[(2S,4R)-4-(7-chloro-4-methoxyisoquinolin-1-yl)oxy-2-[[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate | Asunaprevir | ASUNAPREVIR"
+BMGC_DG04067,BMG_DG100966,"NDC:53097-572 | NDC:60687-386 | NDC:67877-755 | NDC:42858-867 | PubChem CID:16078 | DRONABINOL | CAS RN:1972-08-3 | NDC:53097-573 | NDC:72162-1880 | PubChem SID:175265965 | NDC:0904-7145 | NDC:31722-960 | CAS RN:6465-30-1 | NDC:63629-9166 | NDC:63629-8861 | DrugBank ID:DB00470 | NDC:0527-4125 | NDC:0904-7144 | NDC:53097-570 | NDC:60687-375 | NDC:31722-961 | NDC:67877-754 | NDC:53097-571 | NDC:78613-201 | NDC:67877-753 | UNII:7J8897W37S | NDC:31722-962 | NDC:42858-869 | NDC:63629-8862 | NDC:53097-568 | NDC:72162-1879 | NDC:53097-569 | NDC:72162-1878 | Dronabinol | NDC:42858-868 | (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol"
+BMGC_DG04068,BMG_DG100969,PubChem CID:160785 | PubChem SID:198955079 | UNII:5PC734Y32N | CAS RN:5555-46-4 | UNDECENOVANILLYLAMIDE
+BMGC_DG04069,BMG_DG100976,UNII:2R4M366F8L | EF-31 | CAS RN:342808-24-6 | PubChem CID:16079040 | PubChem SID:445500659
+BMGC_DG04070,BMG_DG100991,"2,2'-(2-NAPHTHYLIMINO)DIETHANOL | UNII:WMW74U6UN6 | CAS RN:6270-13-9 | PubChem SID:475549768 | 2,2′-(2-Naphthylimino)diethanol | PubChem CID:160818"
+BMGC_DG04071,BMG_DG101008,DrugBank ID:DB07404 | BPH-608 | PubChem CID:16086422
+BMGC_DG04072,BMG_DG101016,"CAS RN:6871-21-2 | ASIMILOBINE, (-)- | PubChem CID:160875 | Asimilobine, (-)- | UNII:Q4H26TGS8S | PubChem SID:474492844"
+BMGC_DG04073,BMG_DG101017,EPIBERBERINE ION | PubChem CID:160876 | CAS RN:6873-09-2 | PubChem SID:472425715 | UNII:VWP9N35AYS
+BMGC_DG04074,BMG_DG101024,"PubChem CID:160883 | UNII:2Z3E1OF81V | BUTYLSCOPOLAMINE | CAS RN:7182-53-8 | DrugBank ID:DB09300 | Butylscopolamine | PubChem SID:175271486 | [(1R,2R,4S,5S)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate"
+BMGC_DG04075,BMG_DG101031,"PubChem SID:175271511 | Methylnaltrexone [VANDF] | (3R,4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one | DrugBank ID:DB06800 | METHYLNALTREXONE | Methylnaltrexone | PubChem CID:16089915 | UNII:0RK7M7IABE | CAS RN:916055-93-1"
+BMGC_DG04076,BMG_DG101032,"PubChem CID:1609 | 3,4-DICHLOROISOCOUMARIN | UNII:SD08W1HH6E | CAS RN:51050-59-0 | PubChem SID:441096978 | DrugBank ID:DB04459 | 3,4-Dichloroisocoumarin | 3,4-dichloroisochromen-1-one"
+BMGC_DG04077,BMG_DG101037,2-[1-[3-(6-benzoyl-1-propylnaphthalen-2-yl)oxypropyl]indol-4-yl]oxy-2-methylpropanoic acid | 2-[(1-{3-[(6-Benzoyl-1-propyl-2-naphthyl)oxy]propyl}-1H-indol-4-YL)oxy]-2-methylpropanoic acid | PubChem CID:16090858
+BMGC_DG04078,BMG_DG101041,"PubChem SID:472423401 | UNII:K343GZ6PUY | [(2R,3S,4R,5R)-5-[(2-aminoacetyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | PubChem CID:160913 | GLYCINEAMIDE RIBONUCLEOTIDE | CAS RN:10074-18-7 | Glycinamide ribonucleotide | CAS RN:147651-18-1"
+BMGC_DG04079,BMG_DG101050,"CAS RN:10176-66-6 | CAS RN:152743-19-6 | 5,7-dihydroxy-6,8-dimethoxy-2-(4-methoxyphenyl)chromen-4-one | PubChem CID:160921 | Nevadensin"
+BMGC_DG04080,BMG_DG101059,ABT-670 | CAS RN:630119-43-6 | PubChem CID:16094676 | UNII:4L6071XH2J | PubChem SID:198987580
+BMGC_DG04081,BMG_DG101061,"quinolin-3-ylmethyl (2S)-2-[[(5S)-3-bromo-4,5-dihydro-1,2-oxazol-5-yl]methylcarbamoyl]pyrrolidine-1-carboxylate | PubChem CID:16094751 | Erw1041E"
+BMGC_DG04082,BMG_DG101063,UNII:F89KMM7TE2 | PubChem CID:16095342 | PubChem SID:445499030 | CAS RN:850664-21-0 | GSK-269962A
+BMGC_DG04083,BMG_DG101079,AZ-23 | PubChem CID:16097523 | UNII:009OMI967N | PubChem SID:198948572 | CAS RN:915720-21-7
+BMGC_DG04084,BMG_DG101085,CAS RN:927823-01-6 | UNII:MUA7QA3W73 | PubChem CID:16097752 | KCN-1 | PubChem SID:445500018
+BMGC_DG04085,BMG_DG101089,"PubChem SID:443624555 | 5-METHYL-1-(5-(TRIPHENYLMETHOXY)PENTYL)-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE | CAS RN:921587-92-0 | UNII:QD87K4T67C | PubChem CID:16098859"
+BMGC_DG04086,BMG_DG101090,"5-METHYL-1-(7-(TRIPHENYLMETHYL)OXYHEPTYL)PYRIMIDINE-2,4-DIONE | PubChem CID:16098874 | CAS RN:921587-94-2 | UNII:4YX69D5Y93 | PubChem SID:443624694"
+BMGC_DG04087,BMG_DG101104,"11-(4-Methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine | UNII:L8J8TZV54G | CAS RN:1977-07-7 | PubChem SID:485666573 | 11-(4-METHYL-1-PIPERAZINYL)-5H-DIBENZO(B,E)(1,4)DIAZEPINE | PubChem CID:16103"
+BMGC_DG04088,BMG_DG101109,"2-CHLORO-11-(4-METHYL-1-PIPERAZINYL)-5H-DIBENZO(B,E)(1,4)DIAZEPINE | PubChem SID:445499905 | CAS RN:1977-08-8 | UNII:4Q6V732VRT | PubChem CID:16104"
+BMGC_DG04089,BMG_DG101116,"DrugBank ID:DB07310 | (5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one | PubChem CID:16105493"
+BMGC_DG04090,BMG_DG101118,PubChem SID:198953233 | CAS RN:1977-11-3 | UNII:4N8UJJ27IM | PERLAPINE | PubChem CID:16106
+BMGC_DG04091,BMG_DG101142,N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine | PubChem CID:16113377 | DrugBank ID:DB07936
+BMGC_DG04092,BMG_DG101143,PubChem CID:16113484 | AZD-5597 | PubChem SID:198936925 | UNII:N7855W19GY | CAS RN:924641-59-8
+BMGC_DG04093,BMG_DG101145,CAS RN:925238-44-4 | PubChem CID:16113692 | UNII:3R9ZPW1KDL | PubChem SID:198939533 | JMV-2810
+BMGC_DG04094,BMG_DG101153,PubChem CID:16115004 | DrugBank ID:DB07264 | (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE
+BMGC_DG04095,BMG_DG101158,"DrugBank ID:DB06916 | CAS RN:402934-09-2 | N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE | N-(2-(1,3-BENZODIOXOL-5-YL)ETHYL)-1-(2-IMIDAZOL-1-YL-6-METHYLPYRIMIDIN-4-YL)PYRROLIDINE-2-CARBOXAMIDE, (2R)- | PubChem CID:16115747 | UNII:RT8DF4MCG2"
+BMGC_DG04096,BMG_DG101165,CAS RN:2922-83-0 | PubChem SID:241179572 | UNII:02JW4J5R44 | (2S)-2-amino-4-(2-aminophenyl)-4-oxobutanoic acid | PubChem CID:161166 | DrugBank ID:DB02070 | KYNURENINE | L-kynurenine | Kynurenine
+BMGC_DG04097,BMG_DG101168,PubChem SID:310825870 | UNII:4I8MLM7L2H | CG-200745 | DrugBank ID:DB12259 | (E)-N-[3-(dimethylamino)propyl]-N'-hydroxy-2-(naphthalen-1-yloxymethyl)oct-2-enediamide | IVALTINOSTAT | PubChem CID:16117309 | CAS RN:936221-33-9 | Cg-200745
+BMGC_DG04098,BMG_DG101172,"PubChem CID:16118392 | CAS RN:928037-13-2 | 1-N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | GOLVATINIB | Golvatinib | DrugBank ID:DB11977 | PubChem SID:198990522 | CAS RN:1196681-49-8 | UNII:516Z3YP58E"
+BMGC_DG04099,BMG_DG101177,PF-03654764 | DrugBank ID:DB12360 | 3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutane-1-carboxamide | PubChem CID:16119082 | CAS RN:935840-35-0 | PubChem SID:198958697 | UNII:FPI2G03BJ1 | H3 receptor antagonist 1 | CAS RN:935840-13-4
+BMGC_DG04100,BMG_DG101178,UNII:G3QE979K1X | DrugBank ID:DB12201 | CAS RN:935840-31-6 | PubChem CID:16119086 | PubChem SID:198936455 | N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide | PF-03654746
+BMGC_DG04101,BMG_DG101179,"PubChem SID:198965294 | N-FERULOYL DOPAMINE, TRANS- | UNII:NGL0OTK5E8 | PubChem CID:16119330 | CAS RN:142350-99-0"
+BMGC_DG04102,BMG_DG101186,"PubChem SID:175266530 | UNII:F0XDI6ZL63 | PubChem CID:16119814 | Caspofungin | (10R,12S)-N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide | CASPOFUNGIN | CAS RN:162808-62-0"
+BMGC_DG04103,BMG_DG101199,PubChem CID:16122553 | DrugBank ID:DB07410 | [2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID
+BMGC_DG04104,BMG_DG101200,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID | PubChem CID:16122554 | DrugBank ID:DB07409"
+BMGC_DG04105,BMG_DG101201,"DrugBank ID:DB07426 | PubChem CID:16122556 | [1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)"
+BMGC_DG04106,BMG_DG101203,PubChem SID:241181483 | N4-.BETA.-D-GLUCOSYLSULFANILAMIDE | PubChem CID:16122563 | UNII:66NOY53CX2 | CAS RN:53274-53-6
+BMGC_DG04107,BMG_DG101204,DrugBank ID:DB07680 | [(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID | PubChem CID:16122567
+BMGC_DG04108,BMG_DG101209,ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE | PubChem CID:16122582 | DrugBank ID:DB08157
+BMGC_DG04109,BMG_DG101210,CAS RN:300657-03-8 | UNII:M5X9XSU6J5 | PubChem CID:16122583 | BMS-309403 | PubChem SID:198959849
+BMGC_DG04110,BMG_DG101211,PubChem CID:16122585 | 3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE | DrugBank ID:DB08323
+BMGC_DG04111,BMG_DG101212,4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME | PubChem CID:16122594 | DrugBank ID:DB08333
+BMGC_DG04112,BMG_DG101213,"PubChem CID:16122596 | N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE | DrugBank ID:DB06939"
+BMGC_DG04113,BMG_DG101214,PubChem CID:16122612 | 1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE | DrugBank ID:DB06833
+BMGC_DG04114,BMG_DG101215,PubChem CID:16122632 | (S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE | DrugBank ID:DB07855
+BMGC_DG04115,BMG_DG101216,DrugBank ID:DB07856 | PubChem CID:16122633 | 6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE
+BMGC_DG04116,BMG_DG101217,PubChem CID:16122634 | DrugBank ID:DB08070 | 2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE
+BMGC_DG04117,BMG_DG101218,(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE | PubChem CID:16122635 | DrugBank ID:DB07860
+BMGC_DG04118,BMG_DG101219,"PubChem CID:16122638 | (5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE | DrugBank ID:DB08033"
+BMGC_DG04119,BMG_DG101220,"DrugBank ID:DB08569 | 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE | PubChem CID:16122642"
+BMGC_DG04120,BMG_DG101221,"PubChem CID:16122643 | 1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA | DrugBank ID:DB07314"
+BMGC_DG04121,BMG_DG101228,"PubChem CID:16123056 | Voxtalisib | DrugBank ID:DB12400 | CAS RN:934493-76-2 | UNII:CVL1685GPH | PubChem SID:198984049 | VOXTALISIB | 2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7-one"
+BMGC_DG04122,BMG_DG101236,NDC:65174-660 | phosphonomethylphosphonic acid | MEDRONIC ACID | PubChem SID:175265424 | CAS RN:1984-15-2 | UNII:73OS0QIN3O | PubChem CID:16124 | DrugBank ID:DB14078 | Medronic Acid
+BMGC_DG04123,BMG_DG101237,"PubChem CID:16124208 | PubChem SID:252165326 | 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide | CAS RN:934541-31-8 | DrugBank ID:DB12756 | TAK-901 | UNII:DM9UIR23R7 | 5-(3-ethylsulfonylphenyl)-3,8-dimethyl-N-(1-methylpiperidin-4-yl)-9H-pyrido[2,3-b]indole-7-carboxamide"
+BMGC_DG04124,BMG_DG101241,"PubChem CID:16124688 | N-[(1S,2S,6R,7R,8R,10S)-3,5-dioxo-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide | DrugBank ID:DB12020 | CAS RN:816458-31-8 | TECOVIRIMAT | UNII:F925RR824R | NDC:50072-010 | Tecovirimat | CAS RN:869572-92-9 | PubChem SID:175267737"
+BMGC_DG04125,BMG_DG101244,PubChem CID:16125106 | CAS RN:819058-89-4 | 4-(4-AMINOPHENYL)-1H-INDAZOL-3-AMINE | 4-(4-Aminophenyl)-1H-indazol-3-amine | UNII:E4PN5258T7 | PubChem SID:482554016
+BMGC_DG04126,BMG_DG101245,UNII:GFW3FF2SN5 | PubChem SID:485663450 | N-[4-(3-Amino-1H-indazol-4-yl)phenyl]benzamide | CAS RN:935660-76-7 | N-(4-(3-AMINO-1H-INDAZOL-4-YL)PHENYL)BENZAMIDE | PubChem CID:16125109
+BMGC_DG04127,BMG_DG101252,"PubChem CID:16126651 | CAS RN:936563-87-0 | 1-[3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one | PCI-32765 Racemate"
+BMGC_DG04128,BMG_DG101261,VTP-27999 | Vtp-27999 | CAS RN:942142-51-0 | UNII:254XY8NV84 | methyl N-[2-[(R)-(3-chlorophenyl)-[(3R)-1-[[(2S)-2-(methylamino)-3-[(3R)-oxan-3-yl]propyl]carbamoyl]piperidin-3-yl]methoxy]ethyl]carbamate | PubChem CID:16126898 | PubChem SID:255509038 | DrugBank ID:DB12416
+BMGC_DG04129,BMG_DG101264,"SALVIGENIN | Salvigenin | CAS RN:19103-54-9 | 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)chromen-4-one | UNII:V522YCM28A | PubChem SID:459055739 | PubChem CID:161271"
+BMGC_DG04130,BMG_DG101265,"DIHYDROPROSTAGLANDIN E1 | PubChem SID:251966034 | 13,14-Dihydro-PGE1 | PubChem CID:161273 | 7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoctyl]-5-oxocyclopentyl]heptanoic acid | UNII:C1R6440YGW | CAS RN:19313-28-1"
+BMGC_DG04131,BMG_DG101280,PubChem CID:16129574 | DrugBank ID:DB07075 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE
+BMGC_DG04132,BMG_DG101281,"DrugBank ID:DB07246 | PubChem CID:16129579 | (2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE"
+BMGC_DG04133,BMG_DG101282,"DrugBank ID:DB07285 | PubChem CID:16129580 | (3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID"
+BMGC_DG04134,BMG_DG101283,PubChem CID:16129582 | DrugBank ID:DB08005 | 4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide
+BMGC_DG04135,BMG_DG101284,"4-[[5-amino-2-[[2-[[2-[[6-amino-2-[[2-[[2-[[2-[[22-amino-16-(2-amino-2-oxoethyl)-7-(1-hydroxyethyl)-10,19-bis(hydroxymethyl)-13-(2-methylpropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-[[1-[[1-[[6-amino-1-[[1-[[5-amino-1-[[1-[[1-[2-[[1-[[1-[[4-amino-1-[[1-[[2-[[1-[[2-[[1-(2-carbamoylpyrrolidin-1-yl)-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | PubChem CID:16129616 | Fortical | CAS RN:9007-12-9 | CAS RN:135506-95-5"
+BMGC_DG04136,BMG_DG101290,"PubChem CID:16129629 | Daptomicina [Spanish] | CAS RN:103060-53-3 | (3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-(1-carboxypropan-2-yl)-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid"
+BMGC_DG04137,BMG_DG101296,CZEN 002 | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-[[1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | DrugBank ID:DB05479 | PubChem CID:16129664
+BMGC_DG04138,BMG_DG101297,"PubChem CID:16129665 | SECRETIN, UNSPECIFIED | UNII:88C55N56UU | Secrepan | 5-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[1-[[5-amino-1-[[1-[[1-[[1-[[5-amino-1-[[2-[[1-[(1-carboxy-2-methylpropyl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-amino-3-(1H-imidazol-2-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoic acid | CAS RN:1393-25-5 | PubChem SID:472422300"
+BMGC_DG04139,BMG_DG101300,"PubChem CID:16129670 | Cholecystokinin | HUMAN CHOLECYSTOKININ-33 | UNII:00XI8W60QF | 3-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[1-[2-[[2-[[4-amino-2-[[5-amino-2-[[2-[[4-amino-2-[[6-amino-2-[[2-[[2-[[2-[[2-[[5-carbamimidamido-2-[[2-[[2-[[1-[2-(2,6-diaminohexanoylamino)propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]pentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-carboxypropanoyl]amino]-2-(4-sulfooxyphenyl)acetyl]amino]-4-methylsulfanylbutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-[(1-amino-1-oxo-3-phenylpropan-2-yl)amino]-4-oxobutanoic acid | PubChem SID:375085605 | CAS RN:9011-97-6"
+BMGC_DG04140,BMG_DG101302,"PubChem CID:16129675 | CAS RN:17650-98-5 | Ceruletide | UNII:888Y08971B | PubChem SID:198963693 | DrugBank ID:DB00403 | (3S)-3-[[(2S)-5-amino-5-oxo-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoyl]amino]-4-[[(2S)-1-[[(2S,3R)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid | CERULETIDE"
+BMGC_DG04141,BMG_DG101304,"CAS RN:51110-01-1 | PubChem CID:16129681 | Somatostatin | Stilamin | 19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-(2-aminopropanoylamino)acetyl]amino]-13,25,28-tribenzyl-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid | DrugBank ID:DB09099"
+BMGC_DG04142,BMG_DG101305,"Teriparatide acetate hydrate | CAS RN:52232-67-4 | 4-[[2-[[2-[[4-amino-2-[[2-[[2-[[6-amino-2-[[2-[[2-[[4-amino-2-[[2-[[2-[[2-[[5-amino-2-[[2-[[2-[[2-[[2-[(2-amino-3-hydroxypropanoyl)amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-[[1-[[1-[[1-[[1-[[1-[[1-[[6-amino-1-[[6-amino-1-[[1-[[5-amino-1-[[1-[[1-[[1-[[4-amino-1-[(1-carboxy-2-phenylethyl)amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | PubChem CID:16129682"
+BMGC_DG04143,BMG_DG101306,"Motilin (26-47), human, porcine | 5-amino-2-[[2-[[6-amino-2-[[4-amino-2-[[2-[[2-[[6-amino-2-[[2-[[5-amino-2-[[2-[[2-[[5-amino-2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[1-[2-[(2-amino-3-phenylpropanoyl)amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-oxopentanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-4-carboxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-oxobutanoyl]amino]hexanoyl]amino]acetyl]amino]-5-oxopentanoic acid | PubChem CID:16129683 | CAS RN:52906-92-0"
+BMGC_DG04144,BMG_DG101308,"(d5 major; contains D0) | CAS RN:103060-53-3 | PubChem CID:16129688 | 3-[[4-amino-2-[[2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-(1-carboxypropan-2-yl)-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid"
+BMGC_DG04145,BMG_DG101309,"H-DL-Cys(1)-DL-Lys-Gly-DL-Lys-Gly-DL-Ala-DL-Lys-DL-Cys(2)-DL-Ser-DL-Arg-DL-Leu-DL-Met-DL-Tyr-DL-Asp-DL-Cys(3)-DL-Cys(1)-DL-xiThr-Gly-DL-Ser-DL-Cys(2)-DL-Arg-DL-Ser-Gly-DL-Lys-DL-Cys(3)-NH2 | CAS RN:107452-89-1 | 2-[63-amino-13,45,54,60-tetrakis(4-aminobutyl)-4,36-bis(3-carbamimidamidopropyl)-16-carbamoyl-71-(1-hydroxyethyl)-7,39,77-tris(hydroxymethyl)-27-[(4-hydroxyphenyl)methyl]-48-methyl-33-(2-methylpropyl)-30-(2-methylsulfanylethyl)-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,62,69,72,75,78,85-tetracosaoxo-18,19,65,66,81,82-hexathia-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,61,70,73,76,79,84-tetracosazatricyclo[40.37.4.221,68]pentaoctacontan-24-yl]acetic acid | PubChem CID:16129690"
+BMGC_DG04146,BMG_DG101312,"CAS RN:120993-53-5 | UNII:U0JZ726775 | Desirudin | (2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S,3R)-2-[[(2S)-2-[[(1R,6R,9S,12S,15S,18S,24S,27S,33S,36S,39R,44R,47S,53S,56S,59S,67S,73S,76S)-15,76-bis(4-aminobutyl)-44-[[(2S)-2-[[(4R,7S,10S,13S,19S,22S,25S,28R)-28-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-carboxypropanoyl]amino]-10-(2-amino-2-oxoethyl)-13-(3-amino-3-oxopropyl)-22-(2-carboxyethyl)-25-[(1R)-1-hydroxyethyl]-19-(hydroxymethyl)-7-(2-methylpropyl)-6,9,12,15,18,21,24,27-octaoxo-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carbonyl]amino]-4-methylpentanoyl]amino]-12,56,73-tris(2-amino-2-oxoethyl)-9,67-bis(3-amino-3-oxopropyl)-36-[(2S)-butan-2-yl]-18,47-bis(2-carboxyethyl)-24-(carboxymethyl)-27,53-bis(hydroxymethyl)-33-(2-methylpropyl)-8,11,14,17,20,23,26,29,32,35,38,45,48,51,54,57,60,62,65,68,71,74,77-tricosaoxo-59-propan-2-yl-3,4,41,42-tetrathia-7,10,13,16,19,22,25,28,31,34,37,46,49,52,55,58,61,63,66,69,72,75,78-tricosazabicyclo[37.22.17]octaheptacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoic acid | DESIRUDIN | PubChem SID:381608428 | PubChem CID:16129703"
+BMGC_DG04147,BMG_DG101313,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[2-[[2-[[2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2R)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]-4-oxobutanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoic acid | PubChem CID:16129704 | DrugBank ID:DB00006 | CAS RN:1191386-55-6 | CAS RN:128270-60-0 | Bivalirudin"
+BMGC_DG04148,BMG_DG101315,"Somatostatin | PubChem CID:16129706 | SOMATOSTATIN | (4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid | PubChem SID:381608481 | CAS RN:38916-34-6 | UNII:6E20216Q0L | DrugBank ID:DB09099"
+BMGC_DG04149,BMG_DG101316,"Atrial Natriuretic Factor | CAS RN:89213-87-6 | CAS RN:85637-73-6 | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-19-(3-amino-3-oxopropyl)-49-benzyl-28-[(2S)-butan-2-yl]-31,40-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16-(hydroxymethyl)-22-methyl-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid | PubChem CID:16129708"
+BMGC_DG04150,BMG_DG101325,"CAS RN:86631-39-2 | Cinnamtannin A3 | (2R,3R,4R)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol | PubChem CID:16129741"
+BMGC_DG04151,BMG_DG101326,"Lysozyme | CAS RN:9001-63-2 | PubChem CID:16129749 | (2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[2-[[(2S)-5-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-carboxypropanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoic acid"
+BMGC_DG04152,BMG_DG101327,"PubChem CID:16129778 | UNII:28F9E0DJY6 | [2,3-dihydroxy-5-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate | TANNIC ACID | CAS RN:5424-20-4 | Gallotannin | CAS RN:1401-55-4 | PubChem SID:472386301"
+BMGC_DG04153,BMG_DG101331,"2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid | CAS RN:110703-94-1 | PubChem SID:198967019 | DrugBank ID:DB08772 | Zopolrestat | ZOPOLRESTAT | PubChem CID:1613 | UNII:1PV3S9WP3D"
+BMGC_DG04154,BMG_DG101336,"(4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-4-amino-4-oxobutanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid | PubChem CID:16130199 | Enfuvirtide"
+BMGC_DG04155,BMG_DG101340,"PubChem CID:16130295 | Trasylol | CAS RN:9087-70-1 | (3S)-4-[[(2S)-1-[[(1R,2aS,4S,5aS,8aS,11aS,13S,14aS,16S,17aR,19S,20aS,25S,26aS,29aS,31S,32aS,34S,35aS,37R,38aS,41aS,42R,44aS,45S,47aS,48S,50aS,51S,53aS,54R,56aS,57S,59aS,60S,62aS,63S,66S,69S,72S,75S,78S,81S,84S,87S,90S,93R)-29a,62a,69,84-tetrakis(4-aminobutyl)-35a,75,78-tris(2-amino-2-oxoethyl)-14a-(3-amino-3-oxopropyl)-8a,41a,72-tribenzyl-50a,53a-bis[(2S)-butan-2-yl]-47a,48,56a,81,90-pentakis(3-carbamimidamidopropyl)-31,60-bis(2-carboxyethyl)-42-[[2-[[2-[[(1S)-1-carboxyethyl]amino]-2-oxoethyl]amino]-2-oxoethyl]carbamoyl]-57-(carboxymethyl)-11a,13,45-tris[(1R)-1-hydroxyethyl]-66-(hydroxymethyl)-2a,16,38a,44a-tetrakis[(4-hydroxyphenyl)methyl]-26a,32a,59a,63,87-pentamethyl-20a,34-bis(2-methylpropyl)-51-(2-methylsulfanylethyl)-1a,3,4a,7a,9,10a,12,13a,15,16a,18,19a,22a,24,25a,28a,30,31a,33,34a,36,37a,40a,43a,44,46a,47,49a,50,52a,53,55a,56,58a,59,61a,62,64a,65,68,71,74,77,80,83,86,89,92,95,98-pentacontaoxo-5a-propan-2-yl-39,40,66a,67a,70a,71a-hexathia-a,2,3a,6a,8,9a,11,12a,14,15a,17,18a,21a,23,24a,27a,29,30a,32,33a,35,36a,39a,42a,43,45a,46,48a,49,51a,52,54a,55,57a,58,60a,61,63a,64,67,70,73,76,79,82,85,88,91,94,97-pentacontazahexacyclo[91.71.4.454,117.04,8.019,23.025,29]doheptacontahectan-37-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoic acid"
+BMGC_DG04156,BMG_DG101351,"CAS RN:251562-00-2 | PubChem SID:375084352 | Tifuvirtide | DrugBank ID:DB05413 | UNII:M6W86MD258 | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(1H-indol-3-yl)propanoyl]amino]-5-amino-5-oxopentanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-amino-5-oxopentanoyl]amino]-6-aminohexanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]-5-amino-5-oxopentanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoyl]amino]-3-methylpentanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-amino-5-oxopentanoyl]amino]-5-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid | PubChem CID:16130644 | TIFUVIRTIDE"
+BMGC_DG04157,BMG_DG101359,PubChem SID:312524802 | UNII:IX503L9WN0 | Ganirelix | PubChem CID:16130957 | GANIRELIX | CAS RN:124904-93-4 | CAS RN:123246-29-7 | DrugBank ID:DB06785 | (2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]amino]-4-methylpentanoyl]amino]-6-[bis(ethylamino)methylideneamino]hexanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide
+BMGC_DG04158,BMG_DG101368,PubChem CID:16130982 | CAS RN:58976-46-8 | UNII:O1208M5SQ8 | 8-D-TRYPTOPHAN-SOMATOSTATIN | PubChem SID:249817651
+BMGC_DG04159,BMG_DG101389,(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]-methylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-N-[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]butanediamide | DrugBank ID:DB00106 | PubChem CID:16131215 | Abarelix | CAS RN:183552-38-7
+BMGC_DG04160,BMG_DG101395,"CAS RN:72401-53-7 | PubChem CID:16131300 | Tannic Acid | DrugBank ID:DB09372 | [2,3-dihydroxy-5-[[(2R,3R,4S,5R)-3,4,5,6-tetrakis[[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy]oxan-2-yl]methoxycarbonyl]phenyl] 3,4,5-trihydroxybenzoate"
+BMGC_DG04161,BMG_DG101396,"PubChem CID:16131310 | Heplisav | (3S)-3-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-[(2S)-2-[[(2S)-1-[[(2S)-1-[2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-amino-5-carbamimidamidopentanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]acetyl]amino]acetyl]oxy-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid | CAS RN:104504-34-9"
+BMGC_DG04162,BMG_DG101404,PubChem SID:241179299 | NOCICEPTIN | CAS RN:170713-75-4 | PubChem CID:16131448 | UNII:7AYI9N34FF
+BMGC_DG04163,BMG_DG101408,"PubChem CID:16131923 | Targocid(TM) | (1S,2R,19R,22R,34S,37R,40R,52R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-amino-5,15-dichloro-64-[(2S,3R,4R,5S,6R)-3-(decanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-26,31,44,49-tetrahydroxy-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14,16,23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,62,65-henicosaene-52-carboxylic acid | CAS RN:61036-62-2"
+BMGC_DG04164,BMG_DG101433,Corticotropin | PubChem CID:16132265 | CORTICOTROPIN | CAS RN:12427-33-7 | Acthargel | CAS RN:9002-60-2 | UNII:K0U68Q2TXA | PubChem SID:375084017 | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-4-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-4-oxobutanoyl]amino]acetyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-4-carboxy-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
+BMGC_DG04165,BMG_DG101434,CAS RN:4419-81-2 | CAS RN:11029-61-1 | PubChem CID:16132269 | VALINEGRAMICIDIN A | Gramicidin A | (2R)-2-[[(2S)-2-[[2-[[(2S)-2-formamido-3-methylbutanoyl]amino]acetyl]amino]propanoyl]amino]-N-[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-(2-hydroxyethylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]-4-methylpentanamide | PubChem SID:198967073 | UNII:93AG3Q5T2V
+BMGC_DG04166,BMG_DG101436,"CAS RN:16941-32-5 | Glucagon | PubChem CID:16132283 | PubChem SID:375084780 | CAS RN:9007-92-5 | UNII:76LA80IG2G | GLUCAGON | (3S)-3-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid"
+BMGC_DG04167,BMG_DG101449,"PubChem CID:16132344 | DrugBank ID:DB09067 | Corticorelin ovine triflutate | CORTICORELIN OVINE | CAS RN:79804-71-0 | PubChem SID:375086068 | Corticorelin Ovine | (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoic acid | UNII:Y124TZ0513"
+BMGC_DG04168,BMG_DG101451,"SOMATORELIN | UNII:4UR7N9Z9MM | PubChem CID:16132353 | Somatorelin | CAS RN:83930-13-6 | (4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-carboxypropanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | PubChem SID:375084431"
+BMGC_DG04169,BMG_DG101455,"PubChem CID:16132393 | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S)-1-carboxy-2-phenylethyl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | CID 16132393"
+BMGC_DG04170,BMG_DG101458,"UNII:89243S03TE | SERMORELIN | PubChem SID:375083341 | Sermorelin | (3S)-4-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-4-oxobutanoic acid | PubChem CID:16132413 | CAS RN:86168-78-7"
+BMGC_DG04171,BMG_DG101459,"CAS RN:115966-23-9 | DrugBank ID:DB05034 | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(4R,10S,16S,19S,22S,28S,31S,34S,37S,40S,49S,52R)-52-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-19-(3-amino-3-oxopropyl)-49-benzyl-28-[(2S)-butan-2-yl]-31,40-bis(3-carbamimidamidopropyl)-34-(carboxymethyl)-16-(hydroxymethyl)-22-methyl-10-(2-methylpropyl)-37-(2-methylsulfanylethyl)-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51-hexadecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecazacyclotripentacontane-4-carbonyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid | PubChem CID:16132416 | CAS RN:118812-69-4 | Ularitide"
+BMGC_DG04172,BMG_DG101463,"PubChem CID:16132438 | Insulin lispro (5.97 MG) | CAS RN:133107-64-9 | (4S)-4-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-5-[[(2S)-4-amino-1-[[(2S)-1-[[(2R)-1-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-oxopentanoic acid;(4S)-4-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[(2S)-2-[[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid"
+BMGC_DG04173,BMG_DG101465,"Lactoferricin B | PubChem CID:16132444 | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]hexanoyl]amino]-3-sulfanylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylsulfanylbutanoyl]amino]hexanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-sulfanylpropanoyl]amino]-3-methylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-3-phenylpropanoic acid"
+BMGC_DG04174,BMG_DG101466,"Pramlintide acetate hydrate | PubChem CID:16132446 | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[(2S)-2-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[(2S)-2-[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]-2-[[(2S,3R)-2-[[(2S)-2-[[(2R)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-4-amino-2-[[(2R)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-sulfanylpropanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]-3-sulfanylpropanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]amino]pentanediamide"
+BMGC_DG04175,BMG_DG101476,DrugBank ID:DB01284 | Tetracosactide | PubChem SID:375085687 | UNII:72YY86EA29 | NDC:0404-9839 | CAS RN:16960-16-0 | NDC:0781-3440 | NDC:51662-1567 | NDC:71872-7318 | NDC:0548-5900 | PubChem CID:16133751 | NDC:71872-7313 | COSYNTROPIN
+BMGC_DG04176,BMG_DG101480,PubChem SID:198953931 | UNII:PX9AZU7QPK | PubChem CID:16133800 | BOMBESIN | CAS RN:31362-50-2
+BMGC_DG04177,BMG_DG101481,CAS RN:16960-16-0 | (2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]acetyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]acetyl]amino]hexanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid | PubChem CID:16133802 | Cosyntropin
+BMGC_DG04178,BMG_DG101482,"PubChem SID:363909561 | CAS RN:80448-90-4 | UNII:9M18T0TD14 | DYNORPHIN A | (2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoic acid | PubChem CID:16133805 | Dynorphin A (swine)"
+BMGC_DG04179,BMG_DG101486,PubChem CID:16133821 | ST-003 | PubChem SID:472426722 | UNII:HSN8WK37D7 | CAS RN:143896-17-7
+BMGC_DG04180,BMG_DG101498,"CAS RN:103060-53-3 | (3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid | Cubicin | Daptomycin | DrugBank ID:DB00080 | PubChem CID:16134395"
+BMGC_DG04181,BMG_DG101504,"CAS RN:171500-79-1 | DALBAVANCIN B0 | Dalbavancin | (2S,3S,4R,5R,6S)-6-[[(1S,2R,19R,22R,34S,37R,40R,52S)-5,32-dichloro-52-[3-(dimethylamino)propylcarbamoyl]-2,26,31,44,49-pentahydroxy-22-(methylamino)-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,65-henicosaen-64-yl]oxy]-3,4-dihydroxy-5-(10-methylundecanoylamino)oxane-2-carboxylic acid | PubChem SID:316914220 | PubChem CID:16134627 | UNII:B0U42518WL"
+BMGC_DG04182,BMG_DG101506,"CGRP 8-37 (human) | PubChem CID:16134896 | (2S)-N-[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,4-dioxobutan-2-yl]-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]acetyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]butanediamide"
+BMGC_DG04183,BMG_DG101507,"CAS RN:204656-20-2 | (2S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-5-carbamimidamido-1-(carboxymethylamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-oxohexyl]amino]-2-(hexadecanoylamino)-5-oxopentanoic acid | Liraglutide | PubChem CID:16134956"
+BMGC_DG04184,BMG_DG101510,TEVERELIX | CAS RN:151272-78-5 | PubChem SID:198962631 | DrugBank ID:DB05624 | (2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-(carbamoylamino)hexanoyl]amino]-4-methylpentanoyl]amino]-6-(propan-2-ylamino)hexanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide | PubChem CID:16135076 | Teverelix | UNII:D19V7048JK
+BMGC_DG04185,BMG_DG101512,PubChem SID:198938872 | UNII:38P86ZU018 | CAS RN:21302-79-4 | PubChem CID:161352 | CEANOTHIC ACID
+BMGC_DG04186,BMG_DG101513,"CAS RN:107452-89-1 | PubChem CID:16135415 | UNII:7I64C51O16 | CAS RN:150770-63-1 | Ziconotide | PubChem SID:375086015 | 2-[(1R,4S,7S,13S,16R,21R,24S,27S,30S,33S,36S,39S,42R,45S,48S,54S,60S,63R,68R,71S,77S)-63-amino-13,45,54,60-tetrakis(4-aminobutyl)-4,36-bis(3-carbamimidamidopropyl)-16-carbamoyl-71-[(1R)-1-hydroxyethyl]-7,39,77-tris(hydroxymethyl)-27-[(4-hydroxyphenyl)methyl]-48-methyl-33-(2-methylpropyl)-30-(2-methylsulfanylethyl)-2,5,8,11,14,23,26,29,32,35,38,41,44,47,50,53,56,59,62,69,72,75,78,85-tetracosaoxo-18,19,65,66,81,82-hexathia-3,6,9,12,15,22,25,28,31,34,37,40,43,46,49,52,55,58,61,70,73,76,79,84-tetracosazatricyclo[40.37.4.221,68]pentaoctacontan-24-yl]acetic acid | ZICONOTIDE"
+BMGC_DG04187,BMG_DG101516,"PubChem SID:198987854 | Dhurrin | PubChem CID:161355 | UNII:P5999IY65C | CAS RN:499-20-7 | DHURRIN | (2S)-2-(4-hydroxyphenyl)-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyacetonitrile"
+BMGC_DG04188,BMG_DG101517,"UNII:H564L1W5J2 | PubChem CID:16135625 | DrugBank ID:DB04974 | Rimiducid | PubChem SID:198944450 | RIMIDUCID | CAS RN:195514-63-7 | [(1R)-3-(3,4-dimethoxyphenyl)-1-[3-[2-[2-[[2-[3-[(1R)-3-(3,4-dimethoxyphenyl)-1-[(2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carbonyl]oxypropyl]phenoxy]acetyl]amino]ethylamino]-2-oxoethoxy]phenyl]propyl] (2S)-1-[(2S)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carboxylate"
+BMGC_DG04189,BMG_DG101522,"Degarelix | PubChem CID:16136245 | DEGARELIX | (4S)-N-[4-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2R)-1-amino-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-6-(propan-2-ylamino)hexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[4-(carbamoylamino)phenyl]-1-oxopropan-2-yl]amino]-3-oxopropyl]phenyl]-2,6-dioxo-1,3-diazinane-4-carboxamide | PubChem SID:175267405 | DrugBank ID:DB06699 | UNII:SX0XJI3A11 | CAS RN:214766-78-6"
+BMGC_DG04190,BMG_DG101523,"CAS RN:52906-92-0 | (2S)-5-amino-2-[[2-[[(2S)-6-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-oxopentanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-4-carboxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-oxobutanoyl]amino]hexanoyl]amino]acetyl]amino]-5-oxopentanoic acid | HUMAN MOTILIN | CAS RN:9072-41-7 | PubChem CID:16136567 | Motilin | PubChem SID:375083605 | UNII:D85V250YSI"
+BMGC_DG04191,BMG_DG101526,"Apidra | (4S)-4-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74R,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]hexanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-47-[[(1S)-3-amino-1-carboxy-3-oxopropyl]carbamoyl]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2S)-butan-2-yl]-24,56-bis(2-carboxyethyl)-83-[(1R)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-4-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-5-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[(2S)-2-[[(2S)-4-carboxy-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | PubChem SID:375085566 | INSULIN GLULISINE | PubChem CID:16136701 | NDC:0088-2502 | CAS RN:207748-29-6 | UNII:7XIY785AZD | NDC:0088-2500"
+BMGC_DG04192,BMG_DG101529,"ORITAVANCIN | DrugBank ID:DB04911 | PubChem SID:198949372 | (1S,2R,18R,19R,22S,25R,28R,40S)-2-[(2R,4S,5R,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5R,6S)-4-[[4-(4-chlorophenyl)phenyl]methylamino]-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-18,32,35,37-tetrahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8,10,12(48),14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid | Oritavancin | NDC:70842-140 | CAS RN:171099-57-3 | PubChem CID:16136912 | UNII:PUG62FRZ2E"
+BMGC_DG04193,BMG_DG101531,"UNII:4FT78T86XV | NDC:0169-6438 | Levemir | NDC:0169-6432 | (2S)-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74R,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-47-[[(1S)-3-amino-1-carboxy-3-oxopropyl]carbamoyl]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2S)-butan-2-yl]-24,56-bis(2-carboxyethyl)-83-[(1R)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-4-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-4-carboxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-6-(tetradecanoylamino)hexanoic acid | INSULIN DETEMIR | CAS RN:169148-63-4 | NDC:50090-1276 | NDC:50090-6414 | PubChem SID:375084092 | NDC:0169-3687 | PubChem CID:16137271 | NDC:50090-6391"
+BMGC_DG04194,BMG_DG101532,PubChem SID:443623625 | PubChem CID:161373 | UNII:OX44IYL9MP | DI-O-ETHYLFLUORESCEIN | CAS RN:21934-70-3
+BMGC_DG04195,BMG_DG101533,CAS RN:170157-13-8 | (2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-acetamidophenyl)propanoyl]amino]-3-(4-acetamidophenyl)propanoyl]amino]-4-methylpentanoyl]amino]-6-(propan-2-ylamino)hexanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide | DrugBank ID:DB11906 | ACYLINE | UNII:S3439D3B35 | PubChem CID:16137348 | Acyline | PubChem SID:313182627
+BMGC_DG04196,BMG_DG101540,"Egrifta | PubChem CID:16137828 | (4S)-4-[[2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-3-carboxy-2-[[(2S)-2-[[(2S)-2-[[(E)-hex-3-enoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]propanoyl]amino]propanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-carboxypropanoyl]amino]-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | CAS RN:218949-48-5 | CAS RN:804475-66-9"
+BMGC_DG04197,BMG_DG101550,"CAS RN:287714-30-1 | (2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S,3R)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]butanedioic acid | PubChem CID:16139605 | Teduglutide | CAS RN:197922-42-2"
+BMGC_DG04198,BMG_DG101552,"CAS RN:4764-17-4 | DrugBank ID:DB01509 | UNII:XJZ28FJ27W | 1-(1,3-benzodioxol-5-yl)propan-2-amine | CAS RN:51497-09-7 | TENAMFETAMINE | Tenamfetamine | PubChem CID:1614 | PubChem SID:198937879"
+BMGC_DG04199,BMG_DG101574,PubChem CID:16143507 | CAS RN:244293-04-7 | PubChem SID:198974932 | VENORPHIN | UNII:6609GD750Q
+BMGC_DG04200,BMG_DG101581,AMG-131 | DrugBank ID:DB05490 | PubChem CID:16145453
+BMGC_DG04201,BMG_DG101592,methylarsonous acid | PubChem CID:161491 | CAS RN:25400-23-1 | Methylarsonite
+BMGC_DG04202,BMG_DG101595,"CAS RN:42542-10-9 | DrugBank ID:DB01454 | UNII:KE1SEN21RM | 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine | 3,4-Methylenedioxymethamphetamine | Midomafetamine | MIDOMAFETAMINE | PubChem SID:198990579 | PubChem CID:1615"
+BMGC_DG04203,BMG_DG101596,"CAS RN:25635-88-5 | [(2R,3S,4R,5R)-5-(5-aminoimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | 5-Aminoimidazole ribonucleotide | PubChem CID:161500"
+BMGC_DG04204,BMG_DG101606,"PubChem SID:198953392 | UNII:Q645668975 | 1,12,23-trihydroxy-1,6,12,17,23,28-hexazacyclotritriacontane-2,5,13,16,24,27-hexone | PubChem CID:161532 | CAS RN:26605-16-3 | Desferrioxamine E | NOCARDAMIN"
+BMGC_DG04205,BMG_DG101615,UNII:3E6IB3P0LT | PubChem SID:438788694 | TEICOPLANIN AGLYCONE | CAS RN:89139-42-4 | PubChem CID:16154789
+BMGC_DG04206,BMG_DG101622,"UNII:KD8QND6427 | CAS RN:27200-12-0 | (2R,3R)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-4-one | Dihydromyricetin | DIHYDROMYRICETIN | PubChem SID:198990669 | PubChem CID:161557"
+BMGC_DG04207,BMG_DG101637,"(4S)-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-4-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]-5-oxopentanoic acid | Exenatide free base | PubChem CID:16157882"
+BMGC_DG04208,BMG_DG101647,"LINACLOTIDE | NDC:0456-1203 | (2S)-2-[[(1R,4S,7S,13S,16R,21R,24R,27S,30S,33R,38R,44S)-21-amino-13-(2-amino-2-oxoethyl)-27-(2-carboxyethyl)-44-[(1R)-1-hydroxyethyl]-30-[(4-hydroxyphenyl)methyl]-4-methyl-3,6,12,15,22,25,28,31,40,43,46,51-dodecaoxo-18,19,35,36,48,49-hexathia-2,5,11,14,23,26,29,32,39,42,45,52-dodecazatetracyclo[22.22.4.216,33.07,11]dopentacontane-38-carbonyl]amino]-3-(4-hydroxyphenyl)propanoic acid | DrugBank ID:DB08890 | NDC:0456-1201 | Linaclotide | CAS RN:851199-59-2 | PubChem SID:381132602 | PubChem CID:16158208 | NDC:0456-1202 | UNII:N0TXR0XR5X"
+BMGC_DG04209,BMG_DG101650,"Vgrpewwmdyqkryg | PubChem CID:16158367 | (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-6-amino-1-[[(2S)-5-carbamimidamido-1-[[(2S)-1-(carboxymethylamino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-[[(2S)-1-[(2S)-2-[[2-[[(2S)-2-amino-3-methylbutanoyl]amino]acetyl]amino]-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid | CAS RN:412961-36-5"
+BMGC_DG04210,BMG_DG101652,"(4S)-5-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoic acid | L-Histidyl-L-seryl-L-a-aspartylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-a-glutamyl-L-leucyl-L-seryl-L-arginyl-L-leucyl-L-arginyl-L-a-glutamylglycyl-L-alanyl-L-arginyl-L-leucyl-L-glutaminyl-L-arginyl-L-leucyl-L-leucyl-L-glutaminylglycyl-L-leucyl-L-valinamide | PubChem CID:16158474"
+BMGC_DG04211,BMG_DG101666,"PubChem CID:1616126 | .ALPHA.-BISABOLOL, (-)-EPI- | UNII:37VB7WIC8L | CAS RN:78148-59-1 | PubChem SID:198962130"
+BMGC_DG04212,BMG_DG101671,CAS RN:10047-33-3 | Little gastrin I | CAS RN:60748-06-3 | PubChem CID:16162108 | (4S)-5-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-[[(2S)-4-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-4-carboxy-2-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[[(2S)-1-[2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]butanoyl]amino]butanoyl]amino]butanoyl]amino]butanoyl]amino]-5-oxopentanoic acid
+BMGC_DG04213,BMG_DG101680,6-hydroxyuridine-5'-phosphate | PubChem CID:161647 | DrugBank ID:DB02890
+BMGC_DG04214,BMG_DG101684,"DEMANNOSE | DrugBank ID:DB12907 | CAS RN:3458-28-4 | Demannose | PubChem CID:161658 | UNII:PHA4727WTP | CAS RN:30142-85-9 | PubChem SID:175266751 | (2S,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal | CAS RN:31103-86-3 | Mannose"
+BMGC_DG04215,BMG_DG101686,"CORYDALMINE, (-)- | CAS RN:30413-84-4 | PubChem SID:440793691 | PubChem CID:161665 | UNII:DV8DX4568D"
+BMGC_DG04216,BMG_DG101710,"AP-7, (-)- | PubChem CID:1617430 | PubChem SID:198984336 | CAS RN:81338-23-0 | Heptanoic acid, 2-amino-7-phosphono-, (2R)- | (2R)-2-amino-7-phosphonoheptanoic acid | UNII:89FET0690I"
+BMGC_DG04217,BMG_DG101746,"PubChem CID:161824 | 2-(diethylamino)-N-(3-hydroxy-2,6-dimethylphenyl)acetamide | CAS RN:34604-55-2 | 3-Hydroxylidocaine"
+BMGC_DG04218,BMG_DG101759,2'-Hydroxyflavone | 2-(2-hydroxyphenyl)chromen-4-one | PubChem CID:161860 | CAS RN:35244-11-2
+BMGC_DG04219,BMG_DG101761,"GE-2270A | (2S)-1-[(4S)-2-[2-[(18S,25S,35S)-35-[(S)-hydroxy(phenyl)methyl]-28-(methoxymethyl)-21-methyl-18-[2-(methylamino)-2-oxoethyl]-16,23,30,33-tetraoxo-25-propan-2-yl-3,13,20,27,37-pentathia-7,17,24,31,34,39,40,41,42,43-decazaheptacyclo[34.2.1.12,5.112,15.119,22.126,29.06,11]tritetraconta-1(38),2(43),4,6(11),7,9,12(42),14,19(41),21,26(40),28,36(39)-tridecaen-8-yl]-1,3-thiazol-4-yl]-4,5-dihydro-1,3-oxazole-4-carbonyl]pyrrolidine-2-carboxamide | PubChem SID:317229627 | UNII:JB4J58L2K1 | PubChem CID:16186054 | DrugBank ID:DB02975 | CAS RN:134861-34-0"
+BMGC_DG04220,BMG_DG101763,"CORTICORELIN | UNII:305OE8862Y | PubChem SID:375085523 | (4S)-5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S,3S)-1-amino-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-carboxybutanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]amino]-5-oxopentanoic acid | Corticorelin | PubChem CID:16186200 | CAS RN:86784-80-7"
+BMGC_DG04221,BMG_DG101777,"ICILIN | CAS RN:36945-98-9 | 3-(2-hydroxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one | UNII:CS70PZQ4QJ | Icilin | PubChem CID:161930 | PubChem SID:198944657"
+BMGC_DG04222,BMG_DG101792,"4-hydroxy-3,3,5-trimethyl-4-[(E)-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybut-1-enyl]cyclohexan-1-one | PubChem CID:16196969 | CAS RN:142235-28-7 | Dihydroroseoside | CAS RN:351343-53-8"
+BMGC_DG04223,BMG_DG101793,PubChem CID:16197 | CAS RN:2012-74-0 | 2-(4-chlorophenyl)-3-methylbutanoic acid | 2-(4-Chlorophenyl)-3-methylbutanoic acid
+BMGC_DG04224,BMG_DG101801,DrugBank ID:DB04931 | PubChem CID:16197727 | Afamelanotide | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-5-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
+BMGC_DG04225,BMG_DG101808,"(4S)-5-[[(2S)-6-amino-1-[[(2S,3S)-1-[[2-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-5-carbamimidamido-1-[[(2S,3R)-1-[[(2S)-4-carboxy-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-1-oxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-5-oxopentanoic acid | ROPOCAMPTIDE | CAS RN:154947-66-7 | LL-37 | PubChem CID:16198951 | PubChem SID:375084076 | UNII:3DD771JO2H"
+BMGC_DG04226,BMG_DG101817,"PubChem SID:198953931 | Bombesin | PubChem CID:16201612 | UNII:PX9AZU7QPK | BOMBESIN | (2S)-N-[(2S)-1-[[(2S)-1-[[2-[[(2S)-4-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanediamide | CAS RN:31362-50-2"
+BMGC_DG04227,BMG_DG101820,"UNII:R60DZX1E2N | CAS RN:630100-90-2 | PubChem CID:16202132 | E7107 | [(2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-2-[(2E,4E,6R)-6-hydroxy-7-[(2R,3R)-3-[(2R,3S)-3-hydroxypentan-2-yl]oxiran-2-yl]-6-methylhepta-2,4-dien-2-yl]-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl] 4-cycloheptylpiperazine-1-carboxylate | DrugBank ID:DB12508 | 1-Piperazinecarboxylic acid, 4-cycloheptyl-, (2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-2-((1E,3E,5R)-5-hydroxy-6-((2R,3R)-3-((1R,2S)-2-hydroxy-1-methylbutyl)oxiranyl)-1,5-dimethyl-1,3-hexadienyl)-3,7-dimethyl-12-oxooxacyclododec-4-en-6-yl ester | PubChem SID:198947911"
+BMGC_DG04228,BMG_DG101821,UNII:8N349V9Q27 | CCT-129202 | CAS RN:942947-93-5 | PubChem CID:16202152 | PubChem SID:198941487
+BMGC_DG04229,BMG_DG101842,NDC:71335-1718 | NDC:62584-994 | NDC:70518-0280 | NDC:51672-4035 | NDC:72162-2230 | NDC:50090-2613 | NDC:50090-5058 | NDC:65162-766 | NDC:70518-0266 | NDC:57237-121 | NDC:65162-769 | NDC:50090-2586 | NDC:50090-2654 | NDC:51407-346 | NDC:65841-064 | NDC:51407-785 | NDC:57237-123 | NDC:50090-5004 | NDC:71205-955 | NDC:70518-1006 | NDC:71335-2314 | NDC:68382-057 | NDC:72189-210 | NDC:43353-053 | NDC:55154-4695 | NDC:76282-335 | NDC:65841-054 | NDC:65841-053 | NDC:68382-059 | NDC:51672-4030 | NDC:63187-674 | NDC:51407-342 | NDC:71610-173 | NDC:63629-8418 | NDC:71335-0243 | NDC:43353-021 | NDC:55154-4696 | NDC:0832-1211 | NDC:63629-8843 | NDC:68788-8402 | NDC:50090-2582 | NDC:68788-7515 | NDC:68382-054 | NDC:63187-745 | NDC:51672-4034 | NDC:71335-1824 | NDC:72189-405 | NDC:65162-763 | NDC:65162-768 | NDC:70518-2382 | NDC:76282-330 | NDC:76282-331 | NDC:65162-767 | NDC:68382-058 | WARFARIN SODIUM | NDC:70518-2900 | NDC:51655-620 | NDC:51407-345 | NDC:43063-176 | NDC:70518-0273 | NDC:71610-575 | NDC:51672-4031 | NDC:76282-332 | NDC:51407-344 | NDC:71610-574 | NDC:51655-993 | NDC:65841-057 | NDC:0093-1718 | NDC:51407-788 | NDC:68382-064 | NDC:65162-765 | NDC:70518-0253 | NDC:0093-1712 | NDC:0832-1216 | NDC:71335-2309 | NDC:51407-787 | PubChem SID:175271830 | NDC:0832-1212 | NDC:0832-1219 | NDC:50090-2936 | NDC:71610-179 | NDC:51407-791 | NDC:51407-784 | CAS RN:67430-45-9 | NDC:51672-4029 | NDC:65841-058 | NDC:51672-4027 | NDC:76282-328 | NDC:76282-329 | NDC:71610-589 | NDC:76282-333 | NDC:0832-1218 | NDC:71610-519 | NDC:68788-7357 | NDC:71610-593 | NDC:65162-761 | NDC:71205-954 | NDC:0093-1713 | NDC:51407-792 | NDC:71610-448 | NDC:70518-1467 | NDC:71335-2148 | NDC:0832-1214 | NDC:51407-347 | NDC:71205-952 | sodium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate | NDC:57237-119 | NDC:62584-984 | NDC:50090-5440 | NDC:57237-120 | NDC:71335-2336 | NDC:51672-4032 | NDC:67296-2111 | NDC:71205-950 | NDC:57237-126 | NDC:65841-056 | NDC:71610-490 | NDC:50090-2645 | NDC:65162-764 | NDC:70518-1492 | NDC:71335-0348 | NDC:51672-4033 | PubChem CID:16204922 | NDC:0093-1720 | NDC:71335-9643 | NDC:72162-2229 | NDC:63187-750 | NDC:65841-059 | NDC:0832-1217 | UNII:6153CWM0CL | NDC:43353-033 | NDC:68788-7358 | NDC:50090-2033 | NDC:0093-1715 | NDC:65841-052 | NDC:70518-0727 | NDC:71335-9700 | NDC:65162-762 | NDC:68382-052 | NDC:43353-030 | NDC:51407-790 | NDC:71335-1786 | NDC:51672-4028 | NDC:0093-1723 | NDC:63629-4543 | NDC:50090-7464 | NDC:68382-056 | NDC:43353-028 | NDC:51407-786 | NDC:57237-124 | NDC:43353-029 | NDC:51407-789 | NDC:0832-1215 | CAS RN:5543-79-3 | CAS RN:129-06-6 | NDC:0093-1714 | NDC:0093-1716 | NDC:57237-127 | NDC:70518-0255 | NDC:55154-4697 | NDC:51407-343 | NDC:67046-1068 | NDC:76282-334 | NDC:0832-1213 | NDC:68382-053 | NDC:76282-327 | NDC:71610-491 | NDC:71205-953 | NDC:71335-1059 | NDC:50090-2646 | NDC:50090-7229 | NDC:57237-125 | NDC:43353-054 | NDC:70518-0261 | NDC:65841-055 | NDC:71610-458 | NDC:71205-951 | Warfarin Sodium | NDC:71610-462 | NDC:51655-629 | NDC:68084-027 | NDC:43353-023 | NDC:68382-055 | NDC:57237-122 | NDC:0093-1721 | NDC:50090-2617
+BMGC_DG04230,BMG_DG101962,"2H-INDOL-2-ONE, 1,3-DIHYDRO-3,3-BIS(4-HYDROXY-3-METHYLPHENYL)- | 2H-Indol-2-one, 1,3-dihydro-3,3-bis(4-hydroxy-3-methylphenyl)- | UNII:8JKQ5E4TXE | PubChem SID:485666972 | PubChem CID:162076 | CAS RN:47465-97-4"
+BMGC_DG04231,BMG_DG101982,"CAS RN:11072-93-8 | Escin | PubChem CID:16211024 | (2S,3S,4S,5R,6R)-6-[[(4S,6bS,8R,9R)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(E)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-2-carboxylic acid | CAS RN:6805-41-0"
+BMGC_DG04232,BMG_DG102049,PubChem CID:16211978 | DrugBank ID:DB06215 | Ferumoxytol
+BMGC_DG04233,BMG_DG102086,"Cyanocobalamin (B12), analytical standard | cobalt(3+);[(2R,3S,4R)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide | PubChem CID:16212801 | CAS RN:68-19-9"
+BMGC_DG04234,BMG_DG102099,"PubChem CID:16213095 | (2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;2-[[(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis(2-hydroxyethoxy)oxan-2-yl]methoxy]ethanol | CAS RN:9005-27-0 | CID 16213095"
+BMGC_DG04235,BMG_DG102133,CAS RN:943549-47-1 | PubChem CID:16214849 | PubChem SID:198982990 | GSK-8062 | UNII:37IS6K16XE
+BMGC_DG04236,BMG_DG102134,PubChem CID:16214871 | CAS RN:618385-42-5 | UNII:7467O90MW3 | PubChem SID:241181404 | SCH-602539
+BMGC_DG04237,BMG_DG102149,MYRISTYLAMINE | CAS RN:2016-42-4 | PubChem CID:16217 | PubChem SID:198982322 | UNII:NOM20L9LFT
+BMGC_DG04238,BMG_DG102174,UNII:3KBX9104IR | Desmethylcitalopram | PubChem CID:162180 | 1-(4-fluorophenyl)-1-[3-(methylamino)propyl]-3H-2-benzofuran-5-carbonitrile | CAS RN:62498-67-3 | DESMETHYLCITALOPRAM | PubChem SID:198947112
+BMGC_DG04239,BMG_DG102202,sodium;2-[4-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetate | BRL-37344 sodium | UNII:H7P384313Z | PubChem SID:249817448 | BRL-37344 SODIUM | PubChem CID:16219010 | CAS RN:127299-93-8
+BMGC_DG04240,BMG_DG102236,UNII:S6C28CTI07 | CAS RN:103877-07-2 | PubChem SID:313182829 | DIMETHYLPHYSOSTIGMINE | PubChem CID:16219608
+BMGC_DG04241,BMG_DG102274,"(4S)-4-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(4R,7S,10S,13S,16S,19S,22R)-22-amino-16-(2-amino-2-oxoethyl)-7-[(1R)-1-hydroxyethyl]-10,19-bis(hydroxymethyl)-13-(2-methylpropyl)-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S,3R)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S,3R)-1-[[(2S)-4-amino-1-[[(2S,3R)-1-[[2-[[(2S)-1-[[2-[[(2S,3R)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid | Calcitonin Salmon | CAS RN:9007-12-9 | CAS RN:135506-95-5 | PubChem CID:16220016"
+BMGC_DG04242,BMG_DG102290,"NDC:51167-600 | NDC:51167-500 | CAS RN:873054-44-5 | NDC:51167-200 | NDC:51167-770 | NDC:51167-809 | NDC:51167-300 | NDC:51167-785 | CAS RN:1134822-00-6 | PubChem SID:175266660 | N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide | PubChem CID:16220172 | NDC:51167-900 | NDC:51167-700 | NDC:51167-400 | NDC:51167-122 | UNII:1Y740ILL1Z | CAS RN:1413431-05-6 | DrugBank ID:DB08820 | IVACAFTOR | Ivacaftor"
+BMGC_DG04243,BMG_DG102291,"PubChem SID:198955771 | Pamapimod | PubChem CID:16220188 | 6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | CAS RN:449811-01-2 | PAMAPIMOD | UNII:8S2C9V11K4"
+BMGC_DG04244,BMG_DG102307,"[3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]-[3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl]methanone | COBIMETINIB | Cobimetinib | CAS RN:934660-93-2 | DrugBank ID:DB05239 | UNII:ER29L26N1X | PubChem CID:16222096 | PubChem SID:198942121"
+BMGC_DG04245,BMG_DG102314,PubChem CID:16224058 | DrugBank ID:DB07546 | [1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid
+BMGC_DG04246,BMG_DG102317,CAS RN:936349-47-2 | UNII:B1Z78DJ75Y | PubChem CID:16224456 | PubChem SID:198938600 | AM-103 FREE ACID
+BMGC_DG04247,BMG_DG102319,"CAS RN:891495-88-8 | PubChem CID:16224745 | 6-bromo-3-(1-methylpyrazol-4-yl)-5-piperidin-3-ylpyrazolo[1,5-a]pyrimidin-7-amine | 6-bromo-3-(1-methyl-1H-pyrazol-4-yl)-5-(piperidin-3-yl)pyrazolo[1,5-a]pyrimidin-7-amine"
+BMGC_DG04248,BMG_DG102345,CAS RN:38115-21-8 | PubChem CID:162287 | DESACETYLCEPHAPIRIN | UNII:XX90DN99PA | PubChem SID:198965238
+BMGC_DG04249,BMG_DG102346,"8-benzyl-7-[2-[ethyl(2-hydroxyethyl)amino]ethyl]-1,3-dimethylpurine-2,6-dione | Bamifylline | DrugBank ID:DB13203 | UNII:ZTY15D026H | CAS RN:2016-63-9 | PubChem SID:198970083 | PubChem CID:16229 | BAMIFYLLINE"
+BMGC_DG04250,BMG_DG102350,"NDC:49884-117 | 3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide;hydrochloride | PubChem SID:175267033 | UNII:7M458Q65S3 | NDC:42794-005 | NDC:63629-2114 | PubChem CID:16230 | Amiloride hydrochloride | AMILORIDE HYDROCHLORIDE ANHYDROUS | CAS RN:2016-88-8"
+BMGC_DG04251,BMG_DG102355,"Amiloride | DrugBank ID:DB00594 | AMILORIDE | CAS RN:137053-86-2 | PubChem SID:175267552 | NDC:17089-260 | 3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide | PubChem CID:16231 | CAS RN:2609-46-3 | UNII:7DZO8EB0Z3"
+BMGC_DG04252,BMG_DG102372,"CAS RN:13422-55-4 | PubChem CID:162342675 | carbanide;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(1R,2R,3R,7S,12S,13S,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate"
+BMGC_DG04253,BMG_DG102377,"PubChem CID:162346700 | Leucettinib-21 | 5-(6-benzothiazolylmethylene)-3,5-dihydro-2-[[(1S)-1-(methoxymethyl)-3-methylbutyl]amino]-4H-Imidazol-4-one, (5Z)- | PubChem SID:496142695 | 5-(6-BENZOTHIAZOLYLMETHYLENE)-3,5-DIHYDRO-2-(((1S)-1-(METHOXYMETHYL)-3-METHYLBUTYL)AMINO)-4H-IMIDAZOL-4-ONE, (5Z)- | (5Z)-5-(1,3-benzothiazol-6-ylmethylidene)-2-[(2R)-1-methoxy-4-methylpentan-2-yl]iminoimidazolidin-4-one | UNII:F5A38P48PV | CAS RN:2732859-77-5"
+BMGC_DG04254,BMG_DG102379,ISOVITEXIN | UNII:KTQ9R9MS0Q | CAS RN:38953-85-4 | PubChem CID:162350 | PubChem SID:198956262
+BMGC_DG04255,BMG_DG102387,"CAS RN:2745060-92-6 | INX-315 | 2QD8YT8Rwz | 4-[(12-oxospiro[1,3,5,10,11-pentazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-4-yl)amino]benzenesulfonamide | PubChem SID:496141746 | PubChem CID:162360412 | UNII:2QD8YT8RWZ"
+BMGC_DG04256,BMG_DG102393,PubChem CID:162365111 | Ofirnoflast | OFIRNOFLAST | CAS RN:2731294-23-6 | PubChem SID:496141614 | UNII:54PY2PBN7S
+BMGC_DG04257,BMG_DG102481,"CAS RN:2750709-91-0 | UNII:W728TB393W | PubChem CID:162381323 | Resigratinib | RESIGRATINIB | PubChem SID:485664054 | 3-[2-(1-cyclopropyl-4,6-difluorobenzimidazol-5-yl)ethynyl]-1-[(3S,5R)-5-(methoxymethyl)-1-prop-2-enoylpyrrolidin-3-yl]-5-(methylamino)pyrazole-4-carboxamide"
+BMGC_DG04258,BMG_DG102584,UNII:A6178K128R | PubChem SID:375578921 | PubChem CID:16244 | CAS RN:2032-36-2 | THIOBENZOYLMORPHOLINE
+BMGC_DG04259,BMG_DG102592,UNII:970C666H5W | 4-METHOXY-2-METHYL-N-PHENYLANILINE | PubChem SID:249492952 | PubChem CID:162461 | CAS RN:41317-15-1
+BMGC_DG04260,BMG_DG102608,DrugBank ID:DB03233 | 3'-deoxy-3'-aminothymidine monophosphate | PubChem CID:162501
+BMGC_DG04261,BMG_DG102612,"PubChem CID:162506461 | (7S)-10-fluorospiro[5,14-dioxa-2,12,17,21,22,25-hexazapentacyclo[17.5.2.02,7.08,13.022,26]hexacosa-1(25),8(13),9,11,19(26),20,23-heptaene-16,1'-cyclopropane]-18-one"
+BMGC_DG04262,BMG_DG102634,"Ensitrelvir | 6-[(6-chloro-2-methylindazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-1,3,5-triazine-2,4-dione | PubChem SID:461432542 | PubChem CID:162533924 | ENSITRELVIR | CAS RN:2796272-89-2 | UNII:PX665RAA3H | CAS RN:2647530-73-0"
+BMGC_DG04263,BMG_DG102645,PubChem SID:440089475 | UNII:Q071BHM3ZE | 3-(BENZO(D)THIAZOL-2-YLTHIO)PROPANE-1-SULFONIC ACID | 3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid | PubChem CID:162569 | CAS RN:4720-61-0 | DrugBank ID:DB03132
+BMGC_DG04264,BMG_DG102653,DrugBank ID:DB04410 | 3-PHENYLPROPYLAMINE | PubChem CID:16259 | PubChem SID:198949234 | CAS RN:2038-57-5 | UNII:P8326EZ31P | 3-Phenylpropylamine
+BMGC_DG04265,BMG_DG102779,CAS RN:2071683-99-1 | Ethyl leucyl-1-methyl-D-tryptophanate hydrochloride | PubChem CID:162623745 | ethyl (2R)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-(1-methylindol-3-yl)propanoate;hydrochloride | UNII:RQ0HRS3JUX | PubChem SID:461433588 | ETHYL LEUCYL-1-METHYL-D-TRYPTOPHANATE HYDROCHLORIDE
+BMGC_DG04266,BMG_DG102895,2-amino-3H-benzimidazol-5-ol | CAS RN:51276-85-8 | DrugBank ID:DB03729 | 2-Amino-1H-benzimidazol-5-ol | 2-Amino-1H-benzo[d]imidazol-5-ol | PubChem CID:162636
+BMGC_DG04267,BMG_DG102896,"PubChem CID:162637 | CAS RN:51307-92-7 | DISODIUM (+/-)-TARTRATE | DISODIUM (±)-TARTRATE | Sodium tartrate | disodium;(2R,3R)-2,3-dihydroxybutanedioate | UNII:WDT27AD907 | PubChem SID:318691843 | CAS RN:6106-24-7 | SODIUM TARTRATE | DrugBank ID:DB13707 | Disodium tartrate | PubChem SID:175265792 | CAS RN:868-18-8 | UNII:QTO9JB4MDD"
+BMGC_DG04268,BMG_DG102929,"PubChem SID:475550311 | PubChem CID:162640850 | CAS RN:2382768-62-7 | [(1R,2R,4S)-2-methoxy-4-[(2R)-2-[(1R,9S,12S,14R,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,14,18-trihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,20-tetraoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]cyclohexyl] N-[2-[2-[2-[2-[2-[2-[2-[2-[3-[6-[[4-amino-3-(2-amino-1,3-benzoxazol-5-yl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-3-oxopropoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]carbamate | UNII:S6PL6DS4XK | RMC-5552"
+BMGC_DG04269,BMG_DG102943,"UNII:RK23MQ4BAH | 9-[2-(2,5-Difluorophenyl)ethyl]-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one, (2S)- | CAS RN:2535970-15-9 | PubChem CID:162659525 | 9-(2-(2,5-DIFLUOROPHENYL)ETHYL)-4-ETHYL-2-METHYL-1-OXA-4,9-DIAZASPIRO(5.5)UNDECAN-3-ONE, (2S)- | PubChem SID:496142954"
+BMGC_DG04270,BMG_DG102948,UNII:457LR3ZQ7R | CAS RN:930005-82-6 | PubChem CID:16267445 | 2-(4-(4-Methylphenyl)sulfonylpiperazin-1-yl)pyridine-3-carbonitrile | PubChem SID:478838490 | 2-(4-(4-METHYLPHENYL)SULFONYLPIPERAZIN-1-YL)PYRIDINE-3-CARBONITRILE
+BMGC_DG04271,BMG_DG103018,DrugBank ID:DB01734 | 3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid | PubChem CID:1628
+BMGC_DG04272,BMG_DG103036,PubChem CID:162834 | Fenobam | DrugBank ID:DB12931
+BMGC_DG04273,BMG_DG103100,"PubChem CID:162955 | UNII:ZX3KEK657Z | Tixocortol | CAS RN:61951-99-3 | DrugBank ID:DB09091 | PubChem SID:175268722 | TIXOCORTOL | (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-17-(2-sulfanylacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one"
+BMGC_DG04274,BMG_DG103109,DIDESMETHYLCITALOPRAM | 1-(3-aminopropyl)-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile | UNII:ZE9YVI4ZEE | PubChem CID:162976 | PubChem SID:376231430 | CAS RN:62498-69-5 | Didesmethylcitalopram
+BMGC_DG04275,BMG_DG103155,"PubChem CID:163091 | (2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene | CAS RN:1412458-61-7 | NDC:46708-198 | NDC:62332-199 | CAS RN:65576-45-6 | Asenapine | NDC:42794-016 | NDC:42794-017 | NDC:62332-198 | NDC:62332-544 | NDC:46708-544 | NDC:46708-199 | CAS RN:135883-07-7 | ASENAPINE | UNII:JKZ19V908O | PubChem SID:175271572"
+BMGC_DG04276,BMG_DG103167,"2,3-DICHLORONAPHTHALENE | CAS RN:2050-75-1 | 2,3-Dichloronaphthalene | PubChem SID:478837273 | PubChem CID:16312 | UNII:TAJ2ZK654M"
+BMGC_DG04277,BMG_DG103384,1-chloro-4-phenylbenzene | 4-Chlorobiphenyl | PubChem SID:198983913 | PubChem CID:16323 | UNII:QA22Z3NGLU | 4-CHLOROBIPHENYL | CAS RN:2051-62-9
+BMGC_DG04278,BMG_DG103410,"(1R,3S)-5-[(2E)-2-[(1R,3aS)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | CAS RN:32222-06-3 | PubChem CID:163285334"
+BMGC_DG04279,BMG_DG103419,"20-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-20-oxoicosanoic acid | CID 163285897 | CAS RN:2023788-19-2 | PubChem CID:163285897"
+BMGC_DG04280,BMG_DG103430,CAS RN:191150-83-1 | PubChem CID:163296 | UNII:9BAN2XG1ZW | Tipranavir Disodium | PubChem SID:198973227 | TIPRANAVIR DISODIUM | disodium;(2R)-6-oxo-2-(2-phenylethyl)-2-propyl-5-[(1R)-1-[3-[5-(trifluoromethyl)pyridin-2-yl]sulfonylazanidylphenyl]propyl]-3H-pyran-4-olate
+BMGC_DG04281,BMG_DG103434,"((6R,8S)-6-(2-CHLOROPHENYL)-6,7,8,9-TETRAHYDRO-1-METHYL-4H,5H-CYCLOPENTA(4,5)THIENO(3,2-F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPIN-8-YL)((2S,6S)-2,6-DIMETHYL-4-MORPHOLINYL)METHANONE | UNII:9K4HH98CH5 | CAS RN:2770850-22-9 | PubChem CID:163298883"
+BMGC_DG04282,BMG_DG103435,PubChem CID:1633 | 3-[4-(1-formylpiperazin-4-yl)-benzylidenyl]-2-indolinone | DrugBank ID:DB02058
+BMGC_DG04283,BMG_DG103440,"CAS RN:2899209-55-1 | US11384066, Example 78 | (2R,4R)-1-[(3-chloro-2-fluorophenyl)methyl]-4-[[5-fluoro-4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyridin-2-yl]methyl]-2-methylpiperidine-4-carboxylic acid | PubChem CID:163303906"
+BMGC_DG04284,BMG_DG103560,CAS RN:2787582-17-4 | TP-0556351 | UNII:74RNN4L7X5 | PubChem CID:163410393 | PubChem SID:474494576
+BMGC_DG04285,BMG_DG103573,"8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzothiazepine | UNII:Z05HCY0X1T | PubChem CID:16351 | CAS RN:2058-52-8 | Clothiapine | PubChem SID:198980207 | DrugBank ID:DB13256 | CLOTHIAPINE"
+BMGC_DG04286,BMG_DG103580,NAPHTHALENE-1-SULFONAMIDE | PubChem SID:461433689 | PubChem CID:163571 | CAS RN:606-25-7 | UNII:2L9V2DQ59A
+BMGC_DG04287,BMG_DG103582,UNII:CNV9DH4SXQ | PubChem SID:474492252 | PubChem CID:16358 | N-Methylisatin | CAS RN:2058-74-4 | N-METHYLISATIN
+BMGC_DG04288,BMG_DG103589,"NDC:49884-347 | NDC:49884-348 | DrugBank ID:DB01100 | PubChem SID:175267146 | CAS RN:2062-78-4 | PIMOZIDE | Pimozide | 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one | PubChem CID:16362 | UNII:1HIZ4DL86F"
+BMGC_DG04289,BMG_DG103590,"2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE | DrugBank ID:DB04736 | PubChem CID:163626 | (2R,6S)-6-[[(4R)-4-[[(2S)-2-[[(2R)-2-[[(1R,2S,3R,4R,5R)-4-acetamido-2-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6,8-dioxabicyclo[3.2.1]octan-3-yl]oxy]propanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]-2-amino-7-[[(1R)-1-carboxyethyl]amino]-7-oxoheptanoic acid | CAS RN:94102-64-4 | Tat-BP | CAS RN:118013-66-4"
+BMGC_DG04290,BMG_DG103591,PubChem CID:16363 | DrugBank ID:DB12867 | Benperidol | UNII:97O6X78C53 | CAS RN:983-42-6 | CAS RN:2062-84-2 | 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl]-1H-benzimidazol-2-one | BENPERIDOL | PubChem SID:198972872
+BMGC_DG04291,BMG_DG103594,"CAS RN:97666-60-9 | Plicamycin | CAS RN:18378-89-7 | PubChem CID:163659 | (2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4-[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one | PLICAMYCIN | PubChem SID:198943464 | UNII:NIJ123W41V | DrugBank ID:DB06810"
+BMGC_DG04292,BMG_DG103623,"CAS RN:110880-55-2 | UNII:8V0QAFPRXV | DrugBank ID:DB05875 | Bhsar-SP | (SAR9,MET(O2)11)SUBSTANCE P | PubChem CID:163829 | (2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-N-[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfonyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]-methylamino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]pentanediamide | PubChem SID:383470572"
+BMGC_DG04293,BMG_DG103627,PubChem SID:198974892 | PubChem CID:163844 | UNII:K9Q4R9S81O | CAS RN:111205-55-1 | CGS-20625
+BMGC_DG04294,BMG_DG103640,"4-[[(3S,4R)-4-(4-fluorophenyl)piperidin-3-yl]methoxy]-2-methoxyphenol | CAS RN:112058-90-9 | PubChem CID:163876 | PubChem SID:461434512 | 4-(4-Fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine | PHENOL, 4-((4-(4-FLUOROPHENYL)-3-PIPERIDINYL)METHOXY)-2-METHOXY-, (3S-TRANS)- | UNII:Q8ZXG5RT43"
+BMGC_DG04295,BMG_DG103642,Carba-nicotinamide-adenine-dinucleotide | DrugBank ID:DB02498 | PubChem CID:163884
+BMGC_DG04296,BMG_DG103648,"UNII:ZF80H5GXUF | CAS RN:61-82-5 | CAS RN:65312-62-1 | 1H-1,2,4-triazol-5-amine | CAS RN:155-25-9 | CAS RN:1794936-83-6 | CAS RN:65380-04-3 | PubChem SID:198988023 | AMITROLE | Amitrole | CAS RN:65312-61-0 | PubChem CID:1639 | CAS RN:218787-12-3"
+BMGC_DG04297,BMG_DG103650,PubChem CID:163913 | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(2-chloroacetyl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | S-(2-chloroacetyl)glutathione | CAS RN:113668-38-5
+BMGC_DG04298,BMG_DG103675,"PubChem CID:163998 | CAS RN:116229-36-8 | Bactenecin | 2-[[28-[[2-[[2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-13,22-di(butan-2-yl)-10,25-bis[3-(diaminomethylideneamino)propyl]-6,9,12,15,18,21,24,27-octaoxo-7,16,19-tri(propan-2-yl)-1,2-dithia-5,8,11,14,17,20,23,26-octazacyclononacosane-4-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid"
+BMGC_DG04299,BMG_DG103686,"PubChem SID:198940682 | UNII:07GV37SOFN | PubChem CID:16401639 | DrugBank ID:DB12434 | STEVIOLBIOSIDE | CAS RN:41093-60-1 | (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid | Steviolbioside"
+BMGC_DG04300,BMG_DG103689,"CAS RN:284474-80-2 | hexane-1,6-diamine | UNII:ZRA5J5B2QW | PubChem CID:16402 | HEXAMETHYLENEDIAMINE | DrugBank ID:DB03260 | Hexamethylenediamine | Hexamethylene diamine | PubChem SID:198989556 | CAS RN:124-09-4"
+BMGC_DG04301,BMG_DG103698,CAS RN:7647-63-4 | PubChem SID:198956575 | DrugBank ID:DB13840 | 2-hydroxyethyl-dimethyl-(1-phenothiazin-10-ylpropan-2-yl)azanium | PROMETHAZINE HYDROXYETHYL | PubChem CID:16406 | UNII:571559SLAJ | Hydroxyethylpromethazine
+BMGC_DG04302,BMG_DG103706,PubChem CID:164089 | CAS RN:90402-40-7 | UNII:F738MWY53L | ABANOQUIL | PubChem SID:198953750
+BMGC_DG04303,BMG_DG103737,PubChem SID:443623866 | UNII:0IK34IT82U | SIGMOIDIN F | CAS RN:126005-97-8 | PubChem CID:164215
+BMGC_DG04304,BMG_DG103777,"PubChem CID:164509 | PubChem SID:198945173 | Talampanel | UNII:CVS43XG1L5 | CAS RN:161832-65-1 | TALAMPANEL | DrugBank ID:DB04982 | 1-[(8R)-5-(4-aminophenyl)-8-methyl-8,9-dihydro-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-7-yl]ethanone"
+BMGC_DG04305,BMG_DG103931,PubChem CID:164517032 | UNII:WC3BRW6EWP | CAS RN:2767422-72-8 | PubChem SID:475550330 | HS-276
+BMGC_DG04306,BMG_DG103935,BEPOTASTINE | PubChem SID:175266558 | UNII:HYD2U48IAS | Bepotastine | CAS RN:125602-71-3 | CAS RN:190786-43-7 | 4-[4-[(S)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid | PubChem CID:164522
+BMGC_DG04307,BMG_DG104015,4-BENZYLPYRIDINE | CAS RN:2116-65-6 | PubChem CID:16458 | UNII:1P29GQM0OH | PubChem SID:198948579
+BMGC_DG04308,BMG_DG104021,PubChem SID:175268801 | Tramiprosate | DrugBank ID:DB06527 | CAS RN:3687-18-1 | UNII:5K8EAX0G53 | TRAMIPROSATE | 3-aminopropane-1-sulfonic acid | PubChem CID:1646
+BMGC_DG04309,BMG_DG104032,"PubChem SID:241181370 | METHYLINOSITOL, (±)- | CAS RN:10284-63-6 | (1R,2S,4S,5S)-6-methoxycyclohexane-1,2,3,4,5-pentol | UNII:TF9HZN9T0M | PubChem SID:252319652 | D-Pinitol | DrugBank ID:DB12969 | PubChem SID:198981490 | PubChem CID:164619 | CAS RN:6090-97-7 | PINITOL | CAS RN:484-68-4 | ONONITOL, (+)- | UNII:A998ME07KR | Methylinositol | METHYLINOSITOL, (+/-)- | UNII:N55OCE7X7M"
+BMGC_DG04310,BMG_DG104036,"Thymidine-5'-diphosphate | THYMIDINE 5'-DIPHOSPHATE | DrugBank ID:DB03103 | [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl phosphono hydrogen phosphate | CAS RN:125376-11-6 | PubChem CID:164628 | PubChem SID:433968841 | UNII:QQ3K1P45DF | Thymidine-5'- Diphosphate | CAS RN:491-97-4"
+BMGC_DG04311,BMG_DG104055,"PubChem SID:198982513 | CAS RN:566-58-5 | Allopregnane-3alpha,20alpha-diol | (3R,5S,8R,9S,10S,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol | UNII:97N2Q625GO | ALLOPREGNANEDIOL | PubChem CID:164674"
+BMGC_DG04312,BMG_DG104057,"PubChem SID:241179961 | UNII:4GPC9FQG6L | CAS RN:568-72-9 | PubChem CID:164676 | TANSHINONE IIA | 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[1,2-g][1]benzofuran-10,11-dione | Tanshinone IIA"
+BMGC_DG04313,BMG_DG104058,5-FLUOROTRYPTAMINE | UNII:AY99XA22FG | PubChem CID:164682 | PubChem SID:461434633 | CAS RN:576-16-9
+BMGC_DG04314,BMG_DG104065,CAS RN:151-18-8 | PubChem CID:1647 | UNII:38D5LJ4KH2 | 3-aminopropanenitrile | 3-Aminopropanenitrile | 3-AMINOPROPANENITRILE | PubChem SID:198962456 | CAS RN:60585-38-8
+BMGC_DG04315,BMG_DG104067,PubChem SID:318164118 | CAS RN:626-69-7 | L-serine O-sulfate | DrugBank ID:DB03497 | PubChem CID:164701 | UNII:81K4VO7FNP | SULFOSERINE
+BMGC_DG04316,BMG_DG104080,PubChem CID:16473 | 6-chloro-2-cyclohexyl-3-oxo-1H-isoindole-5-sulfonamide | Clorexolone | CAS RN:2127-01-7 | CLOREXOLONE | PubChem SID:198990350 | UNII:Q2PLT3FS05 | DrugBank ID:DB13617
+BMGC_DG04317,BMG_DG104082,"CAS RN:815-91-8 | [(2R,3R,4R,5S)-2,3,4,5-tetrahydroxy-6-oxo-7-phosphonooxyheptyl] dihydrogen phosphate | Sedoheptulose 1,7-bisphosphate | PubChem CID:164735"
+BMGC_DG04318,BMG_DG104083,"CAS RN:74812-63-8 | CAS RN:829-74-3 | PubChem SID:175267417 | PubChem SID:198984361 | UNII:R81X549E70 | LEVONORDEFRIN | 4-[(1R,2S)-2-amino-1-hydroxypropyl]benzene-1,2-diol | Levonordefrin | DrugBank ID:DB06707 | PubChem CID:164739 | UNII:V008L6478D | NORDEFRIN"
+BMGC_DG04319,BMG_DG104112,Epsilon-N-methyllysine | UNII:FCR6T2IYVU | DrugBank ID:DB01714 | N6-METHYLLYSINE | PubChem SID:317229684 | PubChem CID:164795 | CAS RN:1188-07-4
+BMGC_DG04320,BMG_DG104127,"(5R,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-one | PubChem CID:164838 | CAS RN:1482-50-4 | Dihydrocortisol"
+BMGC_DG04321,BMG_DG104130,"PubChem SID:198961758 | 2-Azetidinecarboxylic acid, (S)- | UNII:5GZ3E0L9ZU | 2-AZETIDINECARBOXYLIC ACID, (S)- | PubChem CID:16486 | (2S)-azetidine-2-carboxylic acid | CAS RN:2133-34-8"
+BMGC_DG04322,BMG_DG104201,3-Bromo-7-Nitroindazole | DrugBank ID:DB01997 | PubChem CID:1649
+BMGC_DG04323,BMG_DG104202,"(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | PubChem SID:175265495 | CAS RN:2135-17-3 | UNII:LR3CD8SX89 | Flumethasone | PubChem CID:16490 | DrugBank ID:DB00663 | FLUMETHASONE"
+BMGC_DG04324,BMG_DG104224,Tnik&map4K4-IN-2 | 2-[5-(4-fluorophenyl)-3-propan-2-ylimidazol-4-yl]-N-[4-(4-methylpiperazin-1-yl)phenyl]-1H-imidazole-5-carboxamide | PubChem CID:164938183 | CAS RN:2828567-39-9
+BMGC_DG04325,BMG_DG104260,"DrugBank ID:DB01774 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate | CAS RN:2140-58-1 | Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester | ADP-glucose | PubChem CID:16500"
+BMGC_DG04326,BMG_DG104284,N-5-BENZOTHIAZOLYL-6-(DIMETHYLPHOSPHINYL)-7-(TRIFLUOROMETHOXY)-4-QUINOLINAMINE | CAS RN:2772600-37-8 | UNII:7UYY9STF7D | PubChem CID:165123366
+BMGC_DG04327,BMG_DG104285,"PubChem CID:165124 | CAS RN:80387-96-8 | UNII:843C4UPZ2F | DIFEMERINE | DrugBank ID:DB13380 | Difemerine | CAS RN:3477-97-2 | PubChem SID:198976241 | [2-(dimethylamino)-2-methylpropyl] 2-hydroxy-2,2-diphenylacetate"
+BMGC_DG04328,BMG_DG104290,PubChem CID:165138 | DrugBank ID:DB03609 | 3'-deoxyguanosine
+BMGC_DG04329,BMG_DG104294,"CAS RN:3715-64-8 | 2',3'-Dideoxythymidine-5'-Monophosphate | UNII:R6VJB6HJ6Y | 3'-DEOXY-5'-THYMIDYLIC ACID | DrugBank ID:DB03150 | PubChem SID:440088479 | PubChem CID:165151"
+BMGC_DG04330,BMG_DG104307,CAS RN:4282-07-9 | CHONEMORPHINE | UNII:3AYM0KA3QK | PubChem CID:165208 | PubChem SID:198955780
+BMGC_DG04331,BMG_DG104313,"PubChem CID:16523 | CAS RN:2150-47-2 | METHYL 2,4-DIHYDROXYBENZOATE | UNII:XE68BU3OYJ | PubChem SID:198975239"
+BMGC_DG04332,BMG_DG104314,2'-Monophosphoadenosine-5'-Diphosphate | DrugBank ID:DB02363 | PubChem CID:165230
+BMGC_DG04333,BMG_DG104321,CAS RN:4795-57-7 | ARGININE GLUTAMATE | (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid;(2S)-2-aminopentanedioic acid | CAS RN:4320-30-3 | UNII:TU1X77K34Q | DrugBank ID:DB13207 | PubChem CID:165268 | PubChem SID:198959126 | Arginine glutamate
+BMGC_DG04334,BMG_DG104322,PubChem CID:165271 | CAS RN:4836-52-6 | (2S)-2-amino-3-(1H-imidazol-5-yl)propan-1-ol | L-histidinol
+BMGC_DG04335,BMG_DG104329,PubChem CID:165308 | PubChem SID:329589208 | NCI-35847 FREE BASE | CAS RN:14599-52-1 | UNII:8M49S9380J
+BMGC_DG04336,BMG_DG104331,"DrugBank ID:DB07632 | CAS RN:5541-92-4 | PubChem CID:165323 | 5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide | UNII:J1RC4Y1VF0 | CHLORZOLAMIDE | PubChem SID:438788903"
+BMGC_DG04337,BMG_DG104332,"NDC:63187-687 | NDC:51672-4188 | NDC:50090-3134 | NDC:70700-141 | NDC:0168-0041 | NDC:68071-4278 | NDC:45802-053 | UNII:9IFA5XM7R2 | BETAMETHASONE VALERATE | [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate | CAS RN:2152-44-5 | NDC:71205-364 | NDC:70518-0721 | NDC:0713-0327 | NDC:50090-4696 | NDC:68788-7827 | Betamethasone Valerate | NDC:0168-0033 | NDC:0168-0040 | NDC:68788-8450 | NDC:71205-040 | PubChem SID:175266894 | NDC:67296-0573 | NDC:51672-1269 | NDC:50090-3794 | NDC:62332-708 | NDC:68788-7451 | NDC:50090-1647 | NDC:67296-2080 | NDC:68788-8496 | NDC:68071-5224 | PubChem CID:16533 | NDC:63187-276 | NDC:0713-0326"
+BMGC_DG04338,BMG_DG104333,S-Mercaptocysteine | (2R)-2-amino-3-(disulfanyl)propanoic acid | Thiocysteine | CAS RN:6165-31-7 | S-MERCAPTOCYSTEINE | CAS RN:5652-32-4 | DrugBank ID:DB02761 | PubChem CID:165331 | UNII:3RZ74WA9J2 | PubChem SID:333495663
+BMGC_DG04339,BMG_DG104335,2-methylpropanoate | CAS RN:5711-69-3 | PubChem CID:165337 | Isobutyrate
+BMGC_DG04340,BMG_DG104336,S-Hydroxycysteine | PubChem SID:198986868 | CAS RN:73243-12-6 | PubChem CID:165339 | CYSTEINESULFENIC ACID | UNII:FB8KIA847T | DrugBank ID:DB01915
+BMGC_DG04341,BMG_DG104338,"PubChem CID:165339223 | CAS RN:68-19-9 | cobalt(3+);[(2R,3S,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide"
+BMGC_DG04342,BMG_DG104558,"methacrylyl-CoA | PubChem CID:165390 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 2-methylprop-2-enethioate | UNII:FZ43RKZ3NL | Methacryloyl-CoA | METHACRYLOYL-COA | DrugBank ID:DB01675 | PubChem SID:474492456 | Methacrylyl-Coenzyme A | CAS RN:6008-91-9"
+BMGC_DG04343,BMG_DG104882,"PubChem CID:165413063 | N-[3-[(4S)-2-amino-4-methyl-1-[(2S,4S)-2-methyloxan-4-yl]-6-oxo-5H-pyrimidin-4-yl]-2-chlorophenyl]-3-cyanobenzamide | CAS RN:2610631-17-7"
+BMGC_DG04344,BMG_DG104928,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-methylbutanethioate | PubChem CID:165435 | CAS RN:6244-91-3 | Isovaleryl-coa"
+BMGC_DG04345,BMG_DG104930,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] dodecanethioate | DrugBank ID:DB03264 | Lauroyl-coa | CAS RN:6244-92-4 | PubChem CID:165436 | Dodecyl-Coa"
+BMGC_DG04346,BMG_DG104943,"DrugBank ID:DB04099 | deamido-NAD(+) | 1-[(2R,3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-3,4-dihydroxyoxolan-2-yl]pyridin-1-ium-3-carboxylic acid | PubChem CID:165491 | Deamido-Nad+"
+BMGC_DG04347,BMG_DG104946,"2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | PubChem SID:198950327 | 4'-HYDROXYFLAVANONE | CAS RN:6515-37-3 | PubChem CID:165506 | UNII:5K6L8O868Y | 4'-Hydroxyflavanone"
+BMGC_DG04348,BMG_DG104948,"PubChem CID:165511 | CAS RN:6561-58-6 | 3-Hydroxy-5-cholestenoic acid | (6R)-6-[(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid"
+BMGC_DG04349,BMG_DG104950,"PubChem SID:485660895 | 4',5-DIHYDROXYFLAVONE | UNII:K3T4JUA4EP | 4′,5-Dihydroxyflavone | CAS RN:6665-67-4 | PubChem CID:165521"
+BMGC_DG04350,BMG_DG104972,"(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol sulfate | (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol;sulfate | PubChem CID:165579"
+BMGC_DG04351,BMG_DG104973,"PubChem CID:165580 | UNII:61JJC8N5ZK | PubChem SID:175265290 | CAS RN:134235-09-9 | PAROMOMYCIN | Paromomycin | (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol | DrugBank ID:DB01421 | CAS RN:7542-37-2"
+BMGC_DG04352,BMG_DG104978,"14-Demethyllanosterol | (3S,5R,10S,13R,14R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylhept-5-en-2-yl]-1,2,3,5,6,7,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol | CAS RN:7448-02-4 | PubChem CID:165609"
+BMGC_DG04353,BMG_DG104987,"CAS RN:2165-19-7 | PubChem CID:16564 | DrugBank ID:DB13211 | UNII:9V0MRL0R5Y | PubChem SID:198990704 | 2-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)guanidine | GUANOXAN | Guanoxan"
+BMGC_DG04354,BMG_DG104999,"ESTRADIOL DIENANTHATE | PubChem SID:198957366 | PubChem CID:165688 | [(8R,9S,13S,14S,17S)-3-heptanoyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] heptanoate | CAS RN:7732-97-0 | UNII:65C72P1860 | DrugBank ID:DB13955 | Estradiol dienanthate"
+BMGC_DG04355,BMG_DG105012,PubChem CID:16573 | PubChem SID:198953537 | UNII:11558LRZ50 | BOLDINE 2-METHYL ETHER | CAS RN:2169-44-0
+BMGC_DG04356,BMG_DG105045,DrugBank ID:DB01800 | UNII:HD9MHQ536A | PubChem CID:165879 | CAS RN:10485-66-2 | 2-HYDROXY-5-NITROPHENYL SULFATE | PubChem SID:198980962 | 4-Nitrocatechol sulfate
+BMGC_DG04357,BMG_DG105175,UNII:F9CEF23GHV | CHF-6366 .BETA.-2 METABOLITE | PubChem SID:474494055 | PubChem CID:166177238 | CHF-6366 .beta.-2 metabolite
+BMGC_DG04358,BMG_DG105248,CAS RN:503-49-1 | DrugBank ID:DB04377 | PubChem CID:1662 | MEGLUTOL | PubChem SID:198990889 | Meglutol | UNII:CLA99KCD53 | 3-hydroxy-3-methylpentanedioic acid
+BMGC_DG04359,BMG_DG105252,"Hydrocortisone hemisuccinate | PubChem CID:16623 | CAS RN:125-04-2 | PubChem SID:175265487 | HYDROCORTISONE HEMISUCCINATE ANHYDROUS | DrugBank ID:DB14545 | UNII:IHV1VP592V | 4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid | CAS RN:2203-97-6"
+BMGC_DG04360,BMG_DG105260,"DrugBank ID:DB01490 | UNII:2SH16612I9 | AMINOREX | Aminorex | PubChem CID:16630 | 5-phenyl-4,5-dihydro-1,3-oxazol-2-amine | PubChem SID:198978665 | CAS RN:2207-50-3"
+BMGC_DG04361,BMG_DG105280,"UNII:SPW36WUI5Z | MOFEBUTAZONE | CAS RN:2210-63-1 | Mofebutazone | PubChem SID:198961353 | PubChem CID:16639 | 4-butyl-1-phenylpyrazolidine-3,5-dione | DrugBank ID:DB13629"
+BMGC_DG04362,BMG_DG105408,"PubChem SID:175266135 | ANIDULAFUNGIN | NDC:0049-0114 | Anidulafungin | N-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,21,25-tetrahydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-4-[4-(4-pentoxyphenyl)phenyl]benzamide | NDC:0049-0116 | UNII:9HLM53094I | PubChem CID:166548 | CAS RN:166663-25-8 | NDC:0049-2242 | DrugBank ID:DB00362"
+BMGC_DG04363,BMG_DG105414,"Buparlisib | PubChem CID:16654980 | 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine | PubChem SID:198945584 | CAS RN:1202777-78-3 | UNII:0ZM2Z182GD | DrugBank ID:DB11666 | BUPARLISIB | CAS RN:944396-07-0"
+BMGC_DG04364,BMG_DG105415,PubChem CID:16654987 | PubChem SID:198985748 | UNII:86NAB50A9A | IN-1166 | CAS RN:945244-71-3
+BMGC_DG04365,BMG_DG105417,PubChem CID:16655023 | CAS RN:452314-01-1 | UNII:0878P6YAG6 | R-226161 | PubChem SID:348481479
+BMGC_DG04366,BMG_DG105424,"PubChem SID:198989658 | PubChem CID:166558 | CAS RN:166518-60-1 | AVASIMIBE | Avasimibe | [2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulfamate | DrugBank ID:DB06442 | UNII:28LQ20T5RC"
+BMGC_DG04367,BMG_DG105425,PubChem SID:198950367 | AXITIROME | PubChem CID:166559 | CAS RN:156740-57-7 | UNII:V477CK910J
+BMGC_DG04368,BMG_DG105431,"BEXLOSTERIDE | PubChem CID:166562 | Bexlosteride | (4aR,10bR)-8-chloro-4-methyl-1,2,4a,5,6,10b-hexahydrobenzo[f]quinolin-3-one | PubChem SID:198957276 | CAS RN:148905-79-7 | UNII:36X732P4P0 | CAS RN:148905-78-6"
+BMGC_DG04369,BMG_DG105432,"UNII:6KSS4P8BYK | CAS RN:2866464-02-8 | (2S,4S)-4-(5-ETHYNYL-3-((9S)-9-METHYL-2,5-DIOXA-8-AZASPIRO(3.5)NONAN-8-YL)PYRIDIN-2-YL)OXY-1-(2-(TRIFLUOROMETHYL)-(1)BENZOFURO(3,2-D)PYRIMIDIN-4-YL)PYRROLIDINE-2-CARBOXYLIC ACID | PubChem CID:166564424"
+BMGC_DG04370,BMG_DG105436,PubChem CID:16656782 | CAS RN:1028291-66-8 | PubChem SID:485661571 | UNII:548N5X8LTS | BC-7013
+BMGC_DG04371,BMG_DG105438,"Linzagolix | 3-[5-[(2,3-difluoro-6-methoxyphenyl)methoxy]-2-fluoro-4-methoxyphenyl]-2,4-dioxo-1H-thieno[3,4-d]pyrimidine-5-carboxylic acid | UNII:7CDW97HUEX | CAS RN:935283-04-8 | PubChem CID:16656889 | PubChem SID:363908840 | LINZAGOLIX"
+BMGC_DG04372,BMG_DG105450,"CAS RN:19356-17-3 | (1S)-3-[2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol | PubChem CID:166583"
+BMGC_DG04373,BMG_DG105455,UNII:PB4B4XG4XX | CAS RN:940948-68-5 | GRL-7234 | PubChem SID:443623731 | PubChem CID:16659106
+BMGC_DG04374,BMG_DG105459,UNII:VWK5QZV94D | BM-3103 | PubChem SID:482553803 | PubChem CID:16659342
+BMGC_DG04375,BMG_DG105466,"PubChem CID:16659826 | PubChem SID:198962863 | N-CAFFEOYL SEROTONIN | (E)-3-(3,4-dihydroxyphenyl)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]prop-2-enamide | N-Caffeoyl serotonin | CAS RN:928765-97-3 | UNII:574297D1EQ"
+BMGC_DG04376,BMG_DG105467,"Azd-1480 | AZD-1480 | CAS RN:935666-88-9 | DrugBank ID:DB12588 | 5-chloro-2-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine | PubChem CID:16659841 | UNII:KL2Z2TLF01 | PubChem SID:198974218"
+BMGC_DG04377,BMG_DG105469,UNII:S654887958 | FIMX | CAS RN:932737-71-8 | PubChem CID:16660294 | PubChem SID:198936669
+BMGC_DG04378,BMG_DG105478,UNII:97LG4X5P2E | PubChem CID:16661882 | PubChem SID:472423150 | CAS RN:929607-23-8 | NNI-351
+BMGC_DG04379,BMG_DG105484,"PubChem SID:198954287 | 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-3-methyl-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4-one | CAS RN:1044040-56-3 | CAS RN:945380-27-8 | FAMITINIB | UNII:768FW21J3L | Famitinib | PubChem CID:16662431 | DrugBank ID:DB11741"
+BMGC_DG04380,BMG_DG105502,PubChem SID:313183989 | UNII:E6AYD7RQ2V | AZD-2184 | PubChem CID:16663275 | CAS RN:945400-24-8
+BMGC_DG04381,BMG_DG105590,"NDC:75712-033 | NDC:75712-040 | NDC:11822-6514 | NDC:83002-043 | (1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol | NDC:55910-760 | CAS RN:98167-53-4 | RACEMENTHOL | NDC:75712-036 | LEVOMENTHOL | NDC:84165-101 | NDC:59779-910 | NDC:82944-200 | UNII:BZ1R15MTK7 | NDC:51824-105 | DrugBank ID:DB00825 | NDC:75712-041 | PubChem SID:175271510 | NDC:75712-034 | NDC:83002-039 | NDC:75712-030 | Levomenthol | NDC:75712-039 | PubChem SID:175267487 | CAS RN:89-78-1 | UNII:YS08XHA860 | CAS RN:2216-51-5 | NDC:75712-035 | NDC:75712-031 | PubChem CID:16666 | l-Menthol | NDC:49873-619 | NDC:83002-041 | NDC:83002-042 | CAS RN:114376-98-6 | NDC:83002-040 | NDC:83002-038 | NDC:75712-032 | NDC:83002-037"
+BMGC_DG04382,BMG_DG105591,PubChem SID:252163689 | UNII:51JM065FZ0 | MK-0674 | CAS RN:887781-62-6 | PubChem CID:16666183
+BMGC_DG04383,BMG_DG105597,"PubChem CID:16666708 | UNII:G4990BOZ66 | CAS RN:869357-68-6 | PubChem SID:198941374 | AZD-8330 | DrugBank ID:DB06061 | CAS RN:1204531-17-8 | Azd-8330 | 2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxopyridine-3-carboxamide"
+BMGC_DG04384,BMG_DG105608,"Chlorophyll-A | CHLOROPHYLL A | UNII:YF5Q9EJC8Y | PubChem SID:198935833 | CAS RN:479-61-8 | PubChem CID:16667503 | magnesium;(3R,21S,22S)-16-ethenyl-11-ethyl-3-methoxycarbonyl-12,17,21,26-tetramethyl-22-[3-oxo-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enoxy]propyl]-23,24,25-triaza-7-azanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1(23),2(6),4,8(26),9,11,13(25),14,16,18(24),19-undecaen-4-olate | DrugBank ID:DB02133"
+BMGC_DG04385,BMG_DG105610,"PubChem CID:16667669 | Auranofin | gold(1+);(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane"
+BMGC_DG04386,BMG_DG105627,"3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol | PubChem CID:1667 | DrugBank ID:DB02395"
+BMGC_DG04387,BMG_DG105644,UNII:LT9E3VZD1C | PubChem SID:198990106 | PubChem CID:16678 | 2-TERT-BUTYL-6-METHYLPHENOL | CAS RN:2219-82-1
+BMGC_DG04388,BMG_DG105648,"LUMACAFTOR | UNII:EGP8L81APK | CAS RN:936727-05-8 | DrugBank ID:DB09280 | PubChem CID:16678941 | 3-[6-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-3-methylpyridin-2-yl]benzoic acid | PubChem SID:198968159 | Lumacaftor"
+BMGC_DG04389,BMG_DG105652,"PubChem CID:166792554 | (2R)-2-(N-[4-amino-5-(4-methoxybenzoyl)-1,3-thiazol-2-yl]-4-fluoroanilino)propanamide | CAS RN:2732902-08-6"
+BMGC_DG04390,BMG_DG105659,"DrugBank ID:DB01282 | PubChem SID:316914834 | Carbetocin | PubChem CID:16681432 | CAS RN:37025-55-1 | (2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-1-[(3R,6S,9S,12S,15S)-6-(2-amino-2-oxoethyl)-9-(3-amino-3-oxopropyl)-12-[(2S)-butan-2-yl]-15-[(4-methoxyphenyl)methyl]-5,8,11,14,17-pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane-3-carbonyl]pyrrolidine-2-carboxamide | CARBETOCIN | UNII:88TWF8015Y"
+BMGC_DG04391,BMG_DG105664,BX 667 | PubChem CID:16681707 | CAS RN:937395-08-9 | (4S)-5-(4-ethoxycarbonylpiperazin-1-yl)-4-[[4-(1-ethoxy-2-methyl-1-oxopropan-2-yl)oxy-7-methylquinoline-2-carbonyl]amino]-5-oxopentanoic acid
+BMGC_DG04392,BMG_DG105670,"5-phenyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoic acid | PubChem CID:16681750 | xi-3-Hydroxy-5-phenylpentanoic acid O-beta-D-Glucopyranoside"
+BMGC_DG04393,BMG_DG105678,CAS RN:14882-18-9 | PubChem CID:16682734 | DrugBank ID:DB01294 | CAS RN:87-27-4 | Bismuth subsalicylate
+BMGC_DG04394,BMG_DG105709,nitrooxy(phenyl)mercury | PubChem CID:16682924 | CAS RN:55-68-5 | Phe-Mer-Nite | DrugBank ID:DB13388
+BMGC_DG04395,BMG_DG105740,CAS RN:7047-84-9 | Aluminium monostearate | PubChem CID:16682987 | DrugBank ID:DB01375 | Aluminum monostearate
+BMGC_DG04396,BMG_DG105742,"2,7-Dihydroxy-1,3,2-benzodioxabismole-5-carboxylic acid | DrugBank ID:DB13909 | PubChem CID:16682999 | CAS RN:99-26-3"
+BMGC_DG04397,BMG_DG105748,"Sodium stibogluconate | trisodium;(4R,5S,6R)-2-[[(4R,5S,6R)-4-carboxylato-6-[(1R)-1,2-dihydroxyethyl]-5-hydroxy-2-oxo-1,3,2lambda5-dioxastibinan-2-yl]oxy]-6-[(1R)-1,2-dihydroxyethyl]-5-hydroxy-2-oxo-1,3,2lambda5-dioxastibinane-4-carboxylate;nonahydrate | CAS RN:16037-91-5 | PubChem CID:16683012"
+BMGC_DG04398,BMG_DG105852,PubChem CID:16684434 | UNII:2225PI3MOV | DrugBank ID:DB11590 | Thimerosal | THIMEROSAL | PubChem SID:175268666 | sodium;(2-carboxylatophenyl)sulfanyl-ethylmercury | CAS RN:54-64-8
+BMGC_DG04399,BMG_DG105862,"CAS RN:2227-13-6 | DrugBank ID:DB12838 | Tetrasul | PubChem CID:16685 | 1,2,4-trichloro-5-(4-chlorophenyl)sulfanylbenzene | UNII:BEO7JP5U0R | PubChem SID:198976120 | TETRASUL"
+BMGC_DG04400,BMG_DG105873,"carbanide;cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | CAS RN:13422-55-4 | PubChem CID:16686083 | Methyl-5,6-dimethylbenzimidazolylcobalamin"
+BMGC_DG04401,BMG_DG105886,UNII:JCH2767EDP | 4-(2-aminoethyl)-2-methoxyphenol | CAS RN:554-52-9 | PubChem SID:198974083 | 4-(2-Aminoethyl)-2-methoxyphenol | 3-O-METHYLDOPAMINE | PubChem CID:1669
+BMGC_DG04402,BMG_DG105895,2-methyl-N-[2-methyl-4-[[(1R)-1-(1-methylpiperidin-4-yl)ethyl]sulfamoyl]phenyl]benzamide | (R)-2-Methyl-N-(2-methyl-4-(N-(1-(1-methylpiperidin-4-yl)ethyl)sulfamoyl)phenyl)benzamide | PubChem SID:485663875 | IPG-7236 | CAS RN:2756350-91-9 | PubChem CID:166926318 | UNII:29C3JBY7XM
+BMGC_DG04403,BMG_DG105956,PubChem CID:167093 | 1-(4-Hydroxyphenyl)nonan-1-one | CAS RN:14392-69-9 | 1-(4-hydroxyphenyl)nonan-1-one
+BMGC_DG04404,BMG_DG105964,PubChem CID:167159 | Unii-56PS9HY5XI | CAS RN:14729-84-1 | FERROUS GLYCINE SULFATE | PubChem SID:198961805 | Ferrous glycine sulfate | DrugBank ID:DB14501 | UNII:56PS9HY5XI | 2-aminoacetate;hydron;iron(2+);sulfate
+BMGC_DG04405,BMG_DG105979,"N,1,4,4-tetramethyl-8-[4-(4-methylpiperazin-1-yl)anilino]-5H-pyrazolo[4,3-h]quinazoline-3-carboxamide | Milciclib | PubChem SID:198956112 | UNII:688000M8S8 | CAS RN:802539-81-7 | PubChem CID:16718576 | MILCICLIB"
+BMGC_DG04406,BMG_DG105985,AVUTOMETINIB | CAS RN:1415559-58-8 | 3-[[3-fluoro-2-(methylsulfamoylamino)pyridin-4-yl]methyl]-4-methyl-7-pyrimidin-2-yloxychromen-2-one | DrugBank ID:DB15254 | PubChem CID:16719221 | CAS RN:946128-88-7 | PubChem SID:346540401 | Avutometinib | UNII:D0D4252V97
+BMGC_DG04407,BMG_DG105989,Iodide Ion I-131 | IODIDE ION I-131 | DrugBank ID:DB09293 | PubChem CID:167195 | UNII:4GC1FOQ22U | CAS RN:14914-30-8 | iodine-131(1-) | Iodide I-131 | PubChem SID:175267895
+BMGC_DG04408,BMG_DG105993,"N-Hydroxy-3-[2-oxo-1-(3-phenylpropyl)-1,2,5,6-tetrahydropyridin-3-yl]propionamide | N-hydroxy-3-[6-oxo-1-(3-phenylpropyl)-2,3-dihydropyridin-5-yl]propanamide | CAS RN:798543-50-7 | PubChem CID:16720331"
+BMGC_DG04409,BMG_DG105996,"UNII:S3AZD8D215 | [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl sulfamate | PubChem CID:16720766 | PubChem SID:198950004 | DrugBank ID:DB11759 | Pevonedistat | PEVONEDISTAT | CAS RN:905579-51-3"
+BMGC_DG04410,BMG_DG105998,"(2R)-1,1,1-trifluoro-2-[3-[(2R)-4-[4-fluoro-2-(trifluoromethyl)phenyl]-2-methylpiperazin-1-yl]sulfonylphenyl]propan-2-ol | HSD-016 | DrugBank ID:DB12419 | Hsd-016 | PubChem SID:198956659 | UNII:C4I13768E1 | PubChem CID:16721125 | CAS RN:946396-92-5"
+BMGC_DG04411,BMG_DG106013,PubChem CID:16722836 | N-tert-butyl-3-[[5-methyl-2-[4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]amino]benzenesulfonamide | DrugBank ID:DB12500 | Fedratinib | CAS RN:936091-26-8 | PubChem SID:198945651 | UNII:6L1XP550I6 | CAS RN:945381-69-1 | FEDRATINIB
+BMGC_DG04412,BMG_DG106017,PubChem CID:167232 | periodate | UNII:B45A1BUM4Q | Periodate | CAS RN:15056-35-6 | PERIODATE ION | PubChem SID:198987468
+BMGC_DG04413,BMG_DG106024,CAS RN:15132-04-4 | Dimethylarsinate | dimethylarsinate | PubChem CID:167250
+BMGC_DG04414,BMG_DG106025,CAS RN:1000998-59-3 | UNII:39TL5L7XDX | BMS-687453 | PubChem SID:198966454 | PubChem CID:16725047
+BMGC_DG04415,BMG_DG106029,"UNII:GWH480321B | Gsk-690693 | 4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(3S)-piperidin-3-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol | CAS RN:937174-76-0 | PubChem CID:16725726 | PubChem SID:198975457 | GSK-690693 | DrugBank ID:DB12745"
+BMGC_DG04416,BMG_DG106032,CAS RN:848576-43-2 | PubChem CID:16725912 | N-(1-(PHENYLMETHYL)PIPERIDIN-4-YL)NAPHTHALENE-2-CARBOXAMIDE | PubChem SID:472421778 | UNII:56XB596P3V
+BMGC_DG04417,BMG_DG106035,"PubChem CID:16726072 | N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide | DrugBank ID:DB07619"
+BMGC_DG04418,BMG_DG106043,CAS RN:1000998-62-8 | UNII:E2C4891M77 | PubChem SID:198970942 | PubChem CID:16727109 | BMS-711939
+BMGC_DG04419,BMG_DG106060,PubChem CID:1673 | DrugBank ID:DB04104 | 3-Methyladenine
+BMGC_DG04420,BMG_DG106077,PubChem SID:478839379 | PubChem CID:167312403 | MC-7404 | UNII:74V87G4R62
+BMGC_DG04421,BMG_DG106081,SYNTi | (2S)-2-[[(2S)-3-[4-(5-acetyl-2-fluorophenyl)phenyl]-2-(6-bromo-3-oxo-1H-isoindol-2-yl)propanoyl]amino]propanoic acid | PubChem CID:167312474
+BMGC_DG04422,BMG_DG106089,3-chloro-N-[4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl]-4-(methylaminomethyl)thiophene-2-carboxamide | 3-chloro-N-{4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl}-4-[(methylamino)methyl]thiophene-2-carboxamide | PubChem CID:16731825
+BMGC_DG04423,BMG_DG106095,PubChem CID:16734800 | PubChem SID:198947161 | 2-(2-Chloro-4-fluorobenzyl)-3-(4-fluorophenyl)-7-(trifluoromethyl)-2H-indazole | 2-[(2-chloro-4-fluorophenyl)methyl]-3-(4-fluorophenyl)-7-(trifluoromethyl)indazole | UNII:4W82FEU838 | CAS RN:875787-07-8 | LX-623
+BMGC_DG04424,BMG_DG106099,UNII:97T42JF76Q | ISOF | CAS RN:851705-46-9 | PubChem CID:16734986 | PubChem SID:241177995
+BMGC_DG04425,BMG_DG106105,"PubChem SID:441658761 | UNII:L4A6E7Q76T | CAS RN:945457-84-1 | LJ-2698 | (2R,3R,4S)-2-[2-chloro-6-[(3-chlorophenyl)methylamino]purin-9-yl]thiolane-3,4-diol | PubChem CID:16735504"
+BMGC_DG04426,BMG_DG106109,"5-METHYL-3-(2-PHENYLETHYNYL)-1,2,4-TRIAZINE | PubChem CID:16736030 | CAS RN:945915-49-1 | PubChem SID:482554131 | UNII:J9V6B72KWT | 5-Methyl-3-(2-phenylethynyl)-1,2,4-triazine"
+BMGC_DG04427,BMG_DG106110,"3-(2-(3-CHLOROPHENYL)ETHYNYL)-5-METHYL-1,2,4-TRIAZINE | PubChem CID:16736031 | UNII:V4GK6N52XW | CAS RN:945915-51-5 | 3-[2-(3-Chlorophenyl)ethynyl]-5-methyl-1,2,4-triazine | PubChem SID:485663384"
+BMGC_DG04428,BMG_DG106112,DrugBank ID:DB13120 | Deferitazole | PubChem CID:16736198
+BMGC_DG04429,BMG_DG106113,"2-((2-AMINO-6-CHLORO-9H-PURIN-9-YL)METHYL)-3,5-DIMETHYL-4-PYRIDINOL | o-Desmethyl BIIB021 | UNII:2V5W2R9ZRQ | PubChem SID:443624300 | CAS RN:848695-83-0 | 2-[(2-amino-6-chloropurin-9-yl)methyl]-3,5-dimethyl-1H-pyridin-4-one | PubChem CID:16736319"
+BMGC_DG04430,BMG_DG106114,"BIIB021 | PubChem SID:175265940 | PubChem CID:16736529 | UNII:851B9FQ7Q0 | DrugBank ID:DB12359 | CAS RN:848695-25-0 | Biib021 | 6-chloro-9-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]purin-2-amine | BIIB-021"
+BMGC_DG04431,BMG_DG106116,"PubChem CID:16736978 | Ku-0063794 | [5-[2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-morpholin-4-ylpyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol | UNII:81HJG228AB | CAS RN:938440-64-3 | PubChem SID:198969288 | KU-0063794"
+BMGC_DG04432,BMG_DG106121,SP-203 | PubChem SID:198943132 | UNII:T35FOR92W2 | PubChem CID:16737207 | CAS RN:945933-41-5
+BMGC_DG04433,BMG_DG106126,"DrugBank ID:DB14900 | N-[4-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)butyl]-2-(2-(18F)fluoranylethoxy)-5-methylbenzamide | CAS RN:945992-47-2 | ISO-1 F-18 | UNII:3G67X40A29 | Iso-1 F-18 | PubChem SID:252163789 | PubChem CID:16737780"
+BMGC_DG04434,BMG_DG106134,"PubChem SID:198946407 | DrugBank ID:DB11649 | 5-[3,5-diethyl-1-(2-hydroxyethyl)pyrazol-4-yl]oxybenzene-1,3-dicarbonitrile | Lersivirine | PubChem CID:16739244 | CAS RN:473921-12-9 | LERSIVIRINE | UNII:R3ZGC15A9A"
+BMGC_DG04435,BMG_DG106135,"CAS RN:129557-13-7 | PubChem CID:16739289 | (2S)-2,6-diamino-N-[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S,3S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2R)-1-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]hexanamide | Tachyplesin III"
+BMGC_DG04436,BMG_DG106137,"PubChem CID:16739331 | DrugBank ID:DB08051 | (2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE"
+BMGC_DG04437,BMG_DG106139,"UNII:PH8858757I | Bezisterim | DrugBank ID:DB05212 | Triolex | HE3286 | PubChem CID:16739648 | PubChem SID:198962616 | (3S,7R,8R,9S,10R,13S,14S,17R)-17-ethynyl-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,7,17-triol | BEZISTERIM | CAS RN:1001100-69-1"
+BMGC_DG04438,BMG_DG106140,"ZOTIRACICLIB | Zotiraciclib | PubChem CID:16739650 | PubChem SID:346541184 | CAS RN:937270-47-8 | (16E)-14-methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene | CAS RN:1204918-72-8 | UNII:40D08182TT"
+BMGC_DG04439,BMG_DG106141,"UNII:214U33M1RL | 3-METHYLCHOLANTHRENE | PubChem CID:1674 | 3-methyl-1,2-dihydrobenzo[j]aceanthrylene | CAS RN:56-49-5 | PubChem SID:198966202 | Methylcholanthrene"
+BMGC_DG04440,BMG_DG106146,CAS RN:2257-09-2 | DrugBank ID:DB12695 | UNII:6U7TFK75KV | PHENETHYL ISOTHIOCYANATE | 2-isothiocyanatoethylbenzene | PubChem CID:16741 | Phenethyl Isothiocyanate | PubChem SID:198961433 | Phenethyl isothiocyanate
+BMGC_DG04441,BMG_DG106147,Methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy)phosphoryl}-L-alanyl-L-prolinate | DrugBank ID:DB01989 | PubChem CID:16741116
+BMGC_DG04442,BMG_DG106151,DrugBank ID:DB07981 | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1R)-1-(hydroxymethyl)propyl]acetamide | PubChem CID:16741227
+BMGC_DG04443,BMG_DG106152,PubChem CID:16741228 | DrugBank ID:DB07984 | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-n-[(1S)-1-(hydroxymethyl)propyl]acetamide
+BMGC_DG04444,BMG_DG106153,"PubChem CID:16741237 | (4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE | DrugBank ID:DB07406"
+BMGC_DG04445,BMG_DG106154,DrugBank ID:DB08749 | 3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE | PubChem CID:16741238
+BMGC_DG04446,BMG_DG106155,"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE | PubChem CID:16741245 | DrugBank ID:DB07403"
+BMGC_DG04447,BMG_DG106156,DrugBank ID:DB07351 | PubChem CID:16741275 | O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE
+BMGC_DG04448,BMG_DG106162,UNII:DQ4LKH74UY | JNJ-38893777 | CAS RN:951135-00-5 | PubChem SID:440089881 | PubChem CID:16742146
+BMGC_DG04449,BMG_DG106193,"PubChem CID:16745403 | PubChem SID:318691956 | HYDROXYSYDONIC ACID, (±)- | CAS RN:1649441-60-0 | UNII:G7S0F27G2L | HYDROXYSYDONIC ACID, (+/-)-"
+BMGC_DG04450,BMG_DG106200,UNII:CLY9MRR8FV | CAS RN:2574-78-9 | PubChem SID:198943339 | PubChem CID:167459 | ORAZAMIDE
+BMGC_DG04451,BMG_DG106214,CAS RN:951650-22-9 | 2-[3-[5-(2-Hydroxypropan-2-yl)benzimidazol-1-yl]phenyl]benzonitrile | UNII:1PTH9FK74J | PubChem SID:198954290 | PubChem CID:16747643 | 2-[3-[5-(2-hydroxypropan-2-yl)benzimidazol-1-yl]phenyl]benzonitrile | NS-11394
+BMGC_DG04452,BMG_DG106215,PubChem SID:322058798 | AZD-5438 | CAS RN:602306-29-6 | 4-(2-methyl-3-propan-2-ylimidazol-4-yl)-N-(4-methylsulfonylphenyl)pyrimidin-2-amine | 4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(methylsulfonyl)phenyl)pyrimidin-2-amine | PubChem CID:16747683 | UNII:276Z913G29
+BMGC_DG04453,BMG_DG106226,ARISTOLOCHIC ACID IV | UNII:L28X6WY776 | PubChem SID:478836928 | CAS RN:15918-62-4 | Aristolochic acid IV | PubChem CID:167493
+BMGC_DG04454,BMG_DG106229,N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE | PubChem CID:16750040 | DrugBank ID:DB07991
+BMGC_DG04455,BMG_DG106230,"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE | PubChem CID:16750059 | (3R,4S)-1-[6-(3-methylsulfonylphenyl)pyrimidin-4-yl]-4-(2,4,5-trifluorophenyl)pyrrolidin-3-amine | DrugBank ID:DB07666 | (3r,4s)-1-{6-[3-(Methylsulfonyl)phenyl]pyrimidin-4-Yl}-4-(2,4,5-Trifluorophenyl)pyrrolidin-3-Amine"
+BMGC_DG04456,BMG_DG106231,"PubChem CID:16750071 | DrugBank ID:DB08461 | 3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL"
+BMGC_DG04457,BMG_DG106232,"PubChem CID:16750073 | DrugBank ID:DB07717 | (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE"
+BMGC_DG04458,BMG_DG106233,"PubChem CID:16750074 | (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL | DrugBank ID:DB08737"
+BMGC_DG04459,BMG_DG106235,"PubChem CID:16750094 | DrugBank ID:DB08350 | 5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE"
+BMGC_DG04460,BMG_DG106237,DrugBank ID:DB06933 | PubChem CID:16750106 | N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide
+BMGC_DG04461,BMG_DG106238,DrugBank ID:DB07512 | PubChem CID:16750123 | 7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE
+BMGC_DG04462,BMG_DG106242,"UNII:27H8PR7JGK | PubChem CID:16750192 | DrugBank ID:DB05234 | 6-[(2R,5R)-2-methyl-5-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-4-(trifluoromethyl)-1,2-dihydroquinolin-2-one | LGD-2941 | CAS RN:847235-85-2 | 6-[(2R,5R)-2-methyl-5-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-4-(trifluoromethyl)-1H-quinolin-2-one | PubChem SID:461434814 | LGD2941"
+BMGC_DG04463,BMG_DG106243,"SB-1578 | CAS RN:937273-04-6 | PubChem SID:346537624 | Sb-1578 | DrugBank ID:DB15294 | (9E)-15-(2-pyrrolidin-1-ylethoxy)-7,12,26-trioxa-19,21,24-triazatetracyclo[18.3.1.12,5.114,18]hexacosa-1(24),2,4,9,14,16,18(25),20,22-nonaene | UNII:4T71DC0G0A | PubChem CID:16750271"
+BMGC_DG04464,BMG_DG106244,DrugBank ID:DB12611 | PubChem CID:16750408 | PF-477736
+BMGC_DG04465,BMG_DG106254,"PubChem CID:16752 | PubChem SID:198978326 | [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] pyridine-4-carboxylate | DEXAMETHASONE ISONICOTINATE | UNII:8LGC0BOA71 | DrugBank ID:DB11487 | CAS RN:2265-64-7 | Dexamethasone Isonicotinate"
+BMGC_DG04466,BMG_DG106256,"DrugBank ID:DB06922 | 2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid | PubChem CID:16752640"
+BMGC_DG04467,BMG_DG106269,"PubChem CID:16754 | (6aS)-1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline | UNII:NU19306XA7 | GLAUCINE | Glaucine | PubChem SID:175265763 | CAS RN:475-81-0"
+BMGC_DG04468,BMG_DG106272,CAS RN:11034-77-8 | PubChem CID:167551 | Anacardic acid | UNII:8H693KBS2W | 2-HYDROXY-6-PENTADECYLBENZOIC ACID | PubChem SID:474492437 | CAS RN:16611-84-0 | 2-hydroxy-6-pentadecylbenzoic acid | 2-Hydroxy-6-pentadecylbenzoic acid
+BMGC_DG04469,BMG_DG106274,"PubChem SID:313184357 | Asp-4058 | 3-(3H-benzimidazol-5-yl)-5-[3-(trifluoromethyl)-4-[(2S)-1,1,1-trifluoropropan-2-yl]oxyphenyl]-1,2,4-oxadiazole | PubChem CID:16755143 | UNII:01J7526K2Q | CAS RN:952565-91-2 | DrugBank ID:DB11819 | ASP-4058"
+BMGC_DG04470,BMG_DG106283,UNII:FJA1772CVW | CAS RN:675576-97-3 | PubChem CID:16755649 | NUTLIN-3B | PubChem SID:198988929
+BMGC_DG04471,BMG_DG106285,"PubChem CID:16755766 | 1H-1,2,4-Triazole-1-propanamide, 3-((2,2-difluoro-1,3-benzodioxol-5-yl)amino)-N,N-dimethyl-5-(4-pyridinyl)- | CAS RN:953428-73-4 | DrugBank ID:DB11867 | JNJ-39393406 | 3-[3-[(2,2-difluoro-1,3-benzodioxol-5-yl)amino]-5-pyridin-4-yl-1,2,4-triazol-1-yl]-N,N-dimethylpropanamide | PubChem SID:198979245 | UNII:T930SOU82P"
+BMGC_DG04472,BMG_DG106286,3-(4-((1-(3-ETHOXYPHENYL)-2-(4-METHYLPHENYL)-1H-IMIDAZOL-4-YL)CARBONYL)PIPERAZIN-1-YL)NAPHTHALENE-1-CARBOXYLIC ACID | PubChem SID:472407181 | CAS RN:954397-95-6 | UNII:U7DR3EKC3L | PubChem CID:16755781
+BMGC_DG04473,BMG_DG106290,5-PHENYLVALERIC ACID | PubChem SID:198987835 | PubChem CID:16757 | 5-Phenylvaleric Acid | UNII:XYJ5U8LCQ8 | 5-phenylpentanoic acid | DrugBank ID:DB04051 | CAS RN:2270-20-4
+BMGC_DG04474,BMG_DG106297,"UNII:IL870Q3Z8I | PubChem CID:16757521 | COBIPROSTONE | CAS RN:333963-42-1 | 7-[(2R,4aR,5R,7aR)-2-[(3S)-1,1-difluoro-3-methylpentyl]-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid | Cobiprostone | PubChem SID:198970953 | DrugBank ID:DB05514"
+BMGC_DG04475,BMG_DG106298,"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one | DrugBank ID:DB07149 | PubChem CID:16757525"
+BMGC_DG04476,BMG_DG106315,"DrugBank ID:DB07036 | PubChem CID:16758226 | (3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol"
+BMGC_DG04477,BMG_DG106316,1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine | DrugBank ID:DB07122 | PubChem CID:16758228
+BMGC_DG04478,BMG_DG106322,CAS RN:189744-46-5 | RO-10-5824 | PubChem SID:441096685 | PubChem CID:16759175 | UNII:8X35VUU4YY
+BMGC_DG04479,BMG_DG106336,"sodium;(2R)-2-[[(2R)-2-[[(2S)-2-[[(2R,6S)-2,6-dimethylpiperidine-1-carbonyl]amino]-4,4-dimethylpentanoyl]amino]-3-(1-methoxycarbonylindol-3-yl)propanoyl]amino]hexanoate | PubChem CID:16759603 | CAS RN:156161-89-6 | PubChem SID:198962839 | Bq 788 | UNII:44OLL8XEJ4 | BQ-788"
+BMGC_DG04480,BMG_DG106338,"CAS RN:41078-02-8 | Enprofylline | ENPROFYLLINE | UNII:DT7DT5E518 | 3-propyl-7H-purine-2,6-dione | DrugBank ID:DB00824 | PubChem CID:1676 | PubChem SID:198976173"
+BMGC_DG04481,BMG_DG106346,CAS RN:129318-43-0 | PubChem SID:198982888 | PubChem CID:16760285 | Fosamax | sodium;(4-amino-1-hydroxy-1-phosphonobutyl)-hydroxyphosphinate | ALENDRONATE SODIUM ANHYDROUS | UNII:4988K7X26P
+BMGC_DG04482,BMG_DG106347,Sodium aurothiomalate | DrugBank ID:DB09276 | PubChem CID:16760302
+BMGC_DG04483,BMG_DG106349,"methyl (4S)-5-[[(2S)-1-[[(3S)-5-fluoro-1-methoxy-1,4-dioxopentan-3-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-[[(2S)-4-methoxy-4-oxo-2-(phenylmethoxycarbonylamino)butanoyl]amino]-5-oxopentanoate | PubChem CID:16760394 | Z-Devd-fmk | CAS RN:210344-95-9"
+BMGC_DG04484,BMG_DG106353,"DrugBank ID:DB13620 | PubChem SID:175266404 | POTASSIUM GLUCONATE | Potassium gluconate | UNII:12H3K5QKN9 | PubChem CID:16760467 | CAS RN:299-27-4 | potassium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate"
+BMGC_DG04485,BMG_DG106358,2-Methoxyestradiol | PubChem CID:16760554 | DrugBank ID:DB02342
+BMGC_DG04486,BMG_DG106369,"PubChem CID:16760627 | N-(3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl)-N-methylbenzamide"
+BMGC_DG04487,BMG_DG106396,"4-Piperazin-1-ylthieno[2,3-d]pyrimidine | PubChem CID:16768198 | PubChem SID:478838443 | 4-PIPERAZIN-1-YLTHIENO(2,3-D)PYRIMIDINE | CAS RN:373356-48-0 | UNII:Q8PG3ZF4BZ"
+BMGC_DG04488,BMG_DG106398,"PubChem CID:167685 | 22R-hydroxycholesterol | CAS RN:17954-98-2 | (3S,8S,9S,10R,13S,14S,17R)-17-[(2S,3R)-3-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"
+BMGC_DG04489,BMG_DG106406,PubChem CID:1677 | PubChem SID:438788277 | UNII:JLC765W4PN | DrugBank ID:DB02797 | 3-Nitrophenylboronic Acid | CAS RN:13331-27-6 | 3-NITROPHENYLBORONIC ACID
+BMGC_DG04490,BMG_DG106509,"PROPYLNORAPOMORPHINE | N-Propylnorapomorphine | UNII:NH381P1BR8 | (6aR)-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol | CAS RN:18426-20-5 | PubChem SID:377308893 | PubChem CID:167715"
+BMGC_DG04491,BMG_DG106522,CAS RN:926259-99-6 | UNII:12P6IK4ZUX | BG-45 | PubChem CID:16773791 | PubChem SID:346541464
+BMGC_DG04492,BMG_DG106546,UNII:QGW9M0L9SJ | BROMO-WILLARDIINE | PubChem SID:438788043 | DrugBank ID:DB04000 | Bromo-Willardiine | PubChem CID:167842 | CAS RN:19772-78-2
+BMGC_DG04493,BMG_DG106551,"UNII:74ACJ5NG5T | PubChem SID:461433369 | 6,7-DICHLOROISATIN | CAS RN:18711-12-1 | PubChem CID:16786802"
+BMGC_DG04494,BMG_DG106556,2-HYDROXY-1-NAPHTHOIC ACID | UNII:E3H4QZ94UY | CAS RN:2283-08-1 | PubChem CID:16790 | PubChem SID:198950643
+BMGC_DG04495,BMG_DG106570,UNII:8CS486VL3D | TRIFLUNORDAZEPAM | PubChem SID:440793414 | PubChem CID:16795 | CAS RN:2285-16-7
+BMGC_DG04496,BMG_DG106572,"CAS RN:24948-14-9 | CAS RN:21104-28-9 | 3,5-dimethyl-3-(4-methylpent-3-enyl)-11H-pyrano[3,2-a]carbazole | Mahanimbine | PubChem CID:167963"
+BMGC_DG04497,BMG_DG106673,PubChem SID:198964096 | TENITRAMINE | PubChem CID:168009 | DrugBank ID:DB13637 | 2-[2-[bis(2-nitrooxyethyl)amino]ethyl-(2-nitrooxyethyl)amino]ethyl nitrate | Tenitramine | CAS RN:21946-79-2 | UNII:CKB16BAQ3S
+BMGC_DG04498,BMG_DG106755,"(3S,8S,9S,10R,13S,14S,17R)-17-[(2S,3S)-3-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | (22S)-22-hydroxycholesterol | PubChem CID:168038 | CAS RN:22348-64-7"
+BMGC_DG04499,BMG_DG106772,"CAS RN:23235-01-0 | L-Propargylglycine | PROPARGYLGLYCINE, L- | PubChem SID:198935672 | UNII:8R9U8RVT6V | (2S)-2-aminopent-4-ynoic acid | PubChem CID:168091"
+BMGC_DG04500,BMG_DG106778,PubChem SID:241181353 | UNII:LB0IJB138K | CAS RN:23513-08-8 | (8)-GINGEROL | PubChem CID:168114
+BMGC_DG04501,BMG_DG106779,UNII:ND6ZLI4J0V | (10)-GINGEROL | PubChem CID:168115 | CAS RN:23513-15-7 | PubChem SID:252165404
+BMGC_DG04502,BMG_DG106780,PubChem CID:168120 | DrugBank ID:DB03349 | 8-Bromo-Adenosine-5'-Monophosphate
+BMGC_DG04503,BMG_DG106782,"PubChem CID:168131 | DrugBank ID:DB02310 | 3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium"
+BMGC_DG04504,BMG_DG106785,"hydroxy-dimethoxy-sulfanylidene-lambda5-phosphane | DIMETHYL THIOPHOSPHATE | CAS RN:59401-04-6 | DrugBank ID:DB04687 | O,O-DIMETHYL THIOPHOSPHATE | PubChem CID:168140 | Dimethyl thiophosphate | PubChem SID:441659577 | CAS RN:1112-38-5 | UNII:6KM8HRE9WB"
+BMGC_DG04505,BMG_DG106794,PubChem CID:168182 | VALYLTRYPTOPHAN | PubChem SID:316916293 | UNII:3G64B4AFQN | CAS RN:24587-37-9
+BMGC_DG04506,BMG_DG106801,UNII:8DM1R7808M | PubChem CID:1682 | DrugBank ID:DB03379 | CAS RN:5962-42-5 | 2-Carboxyethylphosphonic Acid | PubChem SID:440088538 | 3-PHOSPHONOPROPANOIC ACID
+BMGC_DG04507,BMG_DG106805,.GAMMA.-DODECALACTONE | 5-octyloxolan-2-one | UNII:YX9N4581LU | PubChem SID:198964499 | CAS RN:2305-05-7 | CAS RN:57084-18-1 | PubChem CID:16821 | Gamma-Dodecalactone
+BMGC_DG04508,BMG_DG106836,"(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3,5-dichlorobenzoate | 3-Tropanyl-3,5-dichlorobenzoate | CAS RN:329912-91-6 | CAS RN:40796-97-2 | PubChem CID:1683"
+BMGC_DG04509,BMG_DG106906,"PubChem CID:168318470 | Kadcyla | [(1S,2R,3S,5S,6S,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] (2S)-2-[3-[1-[(4-carbamoylcyclohexyl)methyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoyl-methylamino]propanoate"
+BMGC_DG04510,BMG_DG106910,"Mylotarg | PubChem CID:168322462 | S-[(2R,3S,4S,6S)-6-[[(2R,3S,4R,5R,6R)-5-[(2S,4S,5R)-5-[acetyl(ethyl)amino]-4-methoxy-5-methyloxan-2-yl]oxy-6-[[(2S,9R)-13-[2-[[4-[2-[1-[4-(4-amino-4-oxobutoxy)phenyl]ethylidene]hydrazinyl]-2-methyl-4-oxobutan-2-yl]disulfanyl]ethylidene]-9-hydroxy-12-(methoxycarbonylamino)-11-oxo-2-bicyclo[7.3.1]trideca-1(12),5-dien-3,7-diynyl]oxy]-4-hydroxy-2-methyloxan-3-yl]amino]oxy-4-hydroxy-2-methyloxan-3-yl] 4-[(3R,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-3-hydroxy-5-iodo-2-methoxy-6-methylbenzenecarbothioate"
+BMGC_DG04511,BMG_DG106966,PubChem SID:346540447 | UNII:TVBOMP5FUC | CAS RN:25520-98-3 | PubChem CID:168386 | DIMETHYLAMINOETHYL-2-CYCLOHEXYL-2-HYDROXY-2-PHENYLACETATE
+BMGC_DG04512,BMG_DG106967,"UNII:9H4570Q89D | CAS RN:153168-05-9 | 3-[3,5-dimethyl-4-[3-(3-methyl-1,2-oxazol-5-yl)propoxy]phenyl]-5-(trifluoromethyl)-1,2,4-oxadiazole | PubChem SID:198960500 | PLECONARIL | PubChem CID:1684 | DrugBank ID:DB05105 | Pleconaril"
+BMGC_DG04513,BMG_DG106969,"CAS RN:2314-78-5 | N-ETHYLSUCCINIMIDE | PubChem SID:440089408 | UNII:MC084H847A | PubChem CID:16842 | DrugBank ID:DB01902 | 1-ethylpyrrolidine-2,5-dione | N-Ethylsuccinimide | 1-Ethyl-Pyrrolidine-2,5-Dione"
+BMGC_DG04514,BMG_DG107119,"CAS RN:13870-90-1 | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,7S,12S,13S,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | PubChem CID:168432540"
+BMGC_DG04515,BMG_DG107121,"CAS RN:68-19-9 | cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,7S,12S,13S,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide | Cyanocobalamin (Vitamin B12) | PubChem CID:168432548"
+BMGC_DG04516,BMG_DG107203,"3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one | CAS RN:2321-07-5 | Fluorescein | PubChem SID:175265985 | FLUORESCEIN | PubChem CID:16850 | UNII:TPY09G7XIR | DrugBank ID:DB00693"
+BMGC_DG04517,BMG_DG107237,CAS RN:90111-29-8 | UNII:NR134FJ5E3 | PubChem CID:168625 | 2-STYRENESULFONIC ACID | PubChem SID:198938920
+BMGC_DG04518,BMG_DG107246,CAS RN:2857868-82-5 | UNII:8TE669PH9F | 2-(1H-IMIDAZOL-1-YL)-N-(2-(2-METHOXYETHOXY)-5-PYRIMIDINYL)-6-(TRIFLUOROMETHYL)-4-PYRIMIDINECARBOXAMIDE | PubChem CID:168679856
+BMGC_DG04519,BMG_DG107271,PubChem SID:198939705 | CLOBENZTROPINE | CAS RN:5627-46-3 | PubChem CID:1687 | UNII:M8CDT278F8
+BMGC_DG04520,BMG_DG107274,EQUILIN SULFATE | UNII:D507VOE6VN | PubChem SID:198987363 | PubChem CID:168708 | CAS RN:27540-07-4
+BMGC_DG04521,BMG_DG107275,UNII:39020BUT1D | PubChem SID:241177746 | CAS RN:2348-82-5 | 2-METHOXYNAPHTHOQUINONE | PubChem CID:16871
+BMGC_DG04522,BMG_DG107276,"PubChem CID:168718 | CAS RN:27718-41-8 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 4-hydroxybenzenecarbothioate | 4-hydroxybenzoyl-CoA | DrugBank ID:DB01652"
+BMGC_DG04523,BMG_DG107292,"4'-Chlorodiazepam | UNII:2QW0IK1742 | 7-chloro-5-(4-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one | PubChem CID:1688 | CHLORDIAZEPAM | CAS RN:14439-61-3 | PubChem SID:198965137"
+BMGC_DG04524,BMG_DG107302,"4-Amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one | CAS RN:22432-95-7 | PubChem CID:16886 | 4-amino-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one"
+BMGC_DG04525,BMG_DG107306,"DIHYDROERGOCORNINE | PubChem SID:175267615 | DrugBank ID:DB11273 | PubChem CID:168871 | UNII:IK4C1OC8NE | (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-2-hydroxy-5,8-dioxo-4,7-di(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | Dihydroergocornine | CAS RN:25447-65-8"
+BMGC_DG04526,BMG_DG107330,DrugBank ID:DB06792 | Lanthanum carbonate | UNII:0M78EU4V9H | PubChem CID:168924 | lanthanum(3+);tricarbonate | Lanthanum Carbonate | PubChem SID:198942426 | LANTHANUM CARBONATE ANHYDROUS | CAS RN:587-26-8
+BMGC_DG04527,BMG_DG107331,"PubChem CID:168928 | UNII:B252M1YO2V | .BETA.-BOSWELLIC ACID | Beta-Boswellic Acid | CAS RN:631-69-6 | PubChem SID:198947452 | (3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picene-4-carboxylic acid"
+BMGC_DG04528,BMG_DG107361,"CAS RN:7290-03-1 | (2R,13bS)-2,12-dimethoxy-2,6,8,9-tetrahydro-1H-indolo[7a,1-a]isoquinolin-11-ol | Erysodine | UNII:6WZ3T41Y11 | PubChem SID:287445844 | ERYSODINE | PubChem CID:169017"
+BMGC_DG04529,BMG_DG107376,"PubChem CID:169118 | UNII:484XV9323P | CAS RN:23979-41-1 | NAPROXEN, (-)- | PubChem SID:198973018"
+BMGC_DG04530,BMG_DG107384,"(2S)-2-amino-5-[(N,N'-dimethylcarbamimidoyl)amino]pentanoic acid | DrugBank ID:DB02302 | Symmetric dimethylarginine | N,N'-DIMETHYLARGININE | PubChem CID:169148 | UNII:49787G1ULV | CAS RN:30344-00-4 | PubChem SID:252164709"
+BMGC_DG04531,BMG_DG107398,"Methylprednisolone Hemisuccinate | 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid | PubChem SID:175265678 | CAS RN:2921-57-5 | DrugBank ID:DB14644 | METHYLPREDNISOLONE HEMISUCCINATE | PubChem CID:16923 | UNII:5GMR90S4KN"
+BMGC_DG04532,BMG_DG107401,MEDIORESINOL DIMETHYL ETHER | PubChem SID:472407225 | PubChem CID:169234 | UNII:95DA2NWV8P | CAS RN:31008-18-1
+BMGC_DG04533,BMG_DG107422,"1,3-DIPROPYLXANTHINE | CAS RN:31542-62-8 | PubChem SID:198987312 | PubChem CID:169317 | UNII:Z02T66W92D"
+BMGC_DG04534,BMG_DG107428,PubChem SID:198955683 | 11-DEACETOXYWORTMANNIN | CAS RN:31652-69-4 | UNII:ULH6669QAN | PubChem CID:169340
+BMGC_DG04535,BMG_DG107434,"PubChem CID:169371 | Aminopterin | UNII:JYB41CTM2Q | DrugBank ID:DB08878 | CAS RN:54-62-6 | (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | PubChem SID:198947839 | AMINOPTERIN"
+BMGC_DG04536,BMG_DG107440,PubChem CID:1694 | Tetrabromo-2-Benzotriazole | DrugBank ID:DB04462
+BMGC_DG04537,BMG_DG107559,PubChem CID:169445 | CAS RN:32545-60-1 | PubChem SID:482553246 | AMINOBUTANE BISPHOSPHONATE | UNII:BQQ4VYG98L | Aminobutane bisphosphonate
+BMGC_DG04538,BMG_DG107583,"3-((S)-1-(7,7-DIFLUORO-2-((S)-2-METHYLAZETIDIN-1-YL)-6,7-DIHYDRO-5H-CYCLOPENTA(D)PYRIMIDIN-4-YL)PYRROLIDIN-3-YL)PROPANOIC ACID | CAS RN:3034829-40-5 | UNII:CQT7H3C9Z6 | PubChem CID:169450086"
+BMGC_DG04539,BMG_DG107587,PubChem SID:496141625 | CAS RN:2858632-01-4 | UNII:C3TU3CHH6L | PubChem CID:169450714 | SURZETOCLAX | Surzetoclax
+BMGC_DG04540,BMG_DG107890,ARGININOSUCCINIC ACID | PubChem SID:472422959 | UNII:T67NZ5MU4H | PubChem CID:16950 | (2S)-2-[[N'-[(4S)-4-amino-4-carboxybutyl]carbamimidoyl]amino]butanedioic acid | L-Argininosuccinic acid | CAS RN:2387-71-5
+BMGC_DG04541,BMG_DG107897,UNII:MA10QYF1Z0 | PubChem SID:198953078 | CAS RN:33725-54-1 | PubChem CID:169535 | DrugBank ID:DB15598 | iron(3+);2-methyl-4-oxopyran-3-olate | NDC:73059-001 | Ferric Maltol | FERRIC MALTOL
+BMGC_DG04542,BMG_DG107899,PubChem CID:16954 | UNII:8RD3NXV2ZV | CAS RN:20096-11-1 | PubChem SID:441097515 | THIOFLAVIN T ION
+BMGC_DG04543,BMG_DG107924,CAS RN:34272-58-7 | PubChem SID:478837100 | PubChem CID:169581 | MICONIDIN | Miconidin | UNII:69U794LZ3G
+BMGC_DG04544,BMG_DG107928,"(3S)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine | DEXBROMPHENIRAMINE | Dexbrompheniramine | CAS RN:132-21-8 | UNII:75T64B71RP | DrugBank ID:DB00405 | PubChem CID:16960 | PubChem SID:175267559"
+BMGC_DG04545,BMG_DG107938,"UNII:TO89JGK3SC | PubChem SID:434370197 | (6AR,8R,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6H,6AH,7H,8H,10AH-BENZO(C)ISOCHROMENE-1,8-DIOL | PubChem CID:169652 | CAS RN:38456-07-4 | UNII:671A0K1FQE | CAS RN:34984-78-6 | PubChem SID:472385836 | 8.BETA.-HYDROXY-.DELTA.9-TETRAHYDROCANNABINOL"
+BMGC_DG04546,BMG_DG107948,UNII:WIA59Y34CJ | CAS RN:35303-76-5 | 4-(2-AMINOETHYL)BENZENESULFONAMIDE | PubChem SID:438787652 | DrugBank ID:DB08782 | PubChem CID:169682
+BMGC_DG04547,BMG_DG107952,"CAS RN:145915-58-8 | 5,6-dianilinoisoindole-1,3-dione | CAS RN:157168-02-0 | PubChem SID:313368874 | UNII:Z13D008FZ2 | PubChem CID:1697 | 4,5-DIANILINOPHTHALIMIDE | 4,5-Dianilinophthalimide"
+BMGC_DG04548,BMG_DG107958,CAS RN:2941025-37-0 | UNII:7CU8MX7DPD | 1-(4-((5-FLUORO-7-(2-METHOXYETHOXY)QUINAZOLIN-4-YL)AMINO)PHENYL)-3-(3-FLUORO-3-METHYLBUTYL)UREA | PubChem CID:169717712
+BMGC_DG04549,BMG_DG107959,"PubChem CID:169721 | CARBOXYMEFLOQUINE | UNII:462L37KS1K | 2,8-bis(trifluoromethyl)quinoline-4-carboxylic acid | 2,8-Bis(trifluoromethyl)quinoline-4-carboxylic acid | CAS RN:35853-50-0 | PubChem SID:251965407"
+BMGC_DG04550,BMG_DG107966,CAS RN:2398-81-4 | PubChem SID:198954983 | PubChem CID:16976 | Oxiniacic Acid | UNII:YY03Q39E6L | OXINIACIC ACID
+BMGC_DG04551,BMG_DG107973,"PubChem CID:1698 | 4,7-Dioxosebacic Acid | DrugBank ID:DB04560"
+BMGC_DG04552,BMG_DG107985,"Procyanidin C1 | PubChem SID:252164610 | CAS RN:37064-30-5 | PubChem CID:169853 | UNII:33516LCW4F | PROCYANIDIN C1 | (2R,3R,4S)-2-(3,4-dihydroxyphenyl)-4-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-3,4-dihydro-2H-chromene-3,5,7-triol"
+BMGC_DG04553,BMG_DG107987,"DrugBank ID:DB06789 | [(8R,9S,10R,13S,14S,17R)-17-acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] hexanoate | NDC:55150-311 | UNII:276F2O42F5 | HYDROXYPROGESTERONE CAPROATE | PubChem SID:175265862 | Hydroxyprogesterone caproate | PubChem CID:169870 | Hydroxyprogesterone Caproate | CAS RN:630-56-8"
+BMGC_DG04554,BMG_DG107990,"PubChem CID:169886 | DIMOXAMINE, (±)- | CAS RN:52842-58-7 | UNII:8AE293HY9Y | DIMOXAMINE, (+/-)- | PubChem SID:441096703 | Dimoxamine, (+/-)- | 1-(2,5-dimethoxy-4-methylphenyl)butan-2-amine"
+BMGC_DG04555,BMG_DG108019,"UNII:T4Y7SN7BXW | PubChem CID:1700 | DrugBank ID:DB07742 | PubChem SID:459056341 | CAS RN:235088-49-0 | N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE"
+BMGC_DG04556,BMG_DG108026,"PubChem CID:170018 | DrugBank ID:DB04530 | S,S-(2-Hydroxyethyl)Thiocysteine | UNII:7N9D5X3NW4 | PubChem SID:440089882 | S-(2-HYDROXYETHYLTHIO)CYSTEINE | CAS RN:38254-63-6"
+BMGC_DG04557,BMG_DG108040,4-(2-aminoethyl)benzenesulfonylfluoride | UNII:F5D36L5354 | DrugBank ID:DB07347 | PubChem CID:1701 | 4-(2-aminoethyl)benzenesulfonyl fluoride | CAS RN:34284-75-8 | 4-(2-Aminoethyl)benzenesulfonyl fluoride | PubChem SID:472386258 | 4-(2-AMINOETHYL)BENZENESULFONYLFLUORIDE | 4-(2-Aminoethyl)Benzenesulfonyl Fluoride
+BMGC_DG04558,BMG_DG108085,GKT-136901 | CAS RN:955272-06-7 | PubChem SID:472421743 | PubChem CID:17027464 | UNII:DH3KL5M2VQ
+BMGC_DG04559,BMG_DG108116,"UNII:895X917GYE | ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate | Etilevodopa | CAS RN:37178-37-3 | PubChem CID:170345 | PubChem SID:175265299 | ETILEVODOPA | DrugBank ID:DB06535"
+BMGC_DG04560,BMG_DG108129,"5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene | PubChem CID:170361 | DrugBank ID:DB01273 | 6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine, 7,8,9,10-tetrahydro- | CAS RN:249296-44-4"
+BMGC_DG04561,BMG_DG108131,"PubChem CID:170364 | (2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid | PubChem SID:198947133 | FARGLITAZAR | Farglitazar | UNII:3433GY7132 | CAS RN:196808-45-4"
+BMGC_DG04562,BMG_DG108227,DrugBank ID:DB02973 | 4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide | PubChem CID:1707
+BMGC_DG04563,BMG_DG108268,TROPARIL | PubChem CID:170832 | UNII:AH3LC885W8 | CAS RN:50372-80-0 | PubChem SID:377308622
+BMGC_DG04564,BMG_DG108310,DrugBank ID:DB03500 | Tricosanoic acid | UNII:MUC9A0MS6V | CAS RN:2433-96-7 | PubChem SID:198988115 | TRICOSANOIC ACID | tricosanoic acid | PubChem CID:17085
+BMGC_DG04565,BMG_DG108359,UNII:9H2F26A7A6 | CAS RN:50850-92-5 | 6-(METHYLTHIO)-2-BENZOTHIAZOLAMINE | PubChem CID:170922 | 6-(Methylthio)-2-benzothiazolamine | PubChem SID:485662121
+BMGC_DG04566,BMG_DG108383,"CAS RN:68-19-9 | PubChem CID:170924234 | cobalt(3+);[(2S,3R,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,7S,12S,13S,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-1,2,7,12,17,23-hexahydrocorrin-3-yl]propanoylamino]propan-2-yl] hydrogen phosphate;formonitrile"
+BMGC_DG04567,BMG_DG108400,"PubChem CID:17097 | UNII:4470AQR07D | 2,2',4,4'-TETRACHLOROBIPHENYL | CAS RN:2437-79-8 | PubChem SID:198957092"
+BMGC_DG04568,BMG_DG108416,DrugBank ID:DB03304 | PubChem CID:171 | 7-Deaza-7-Aminomethyl-Guanine
+BMGC_DG04569,BMG_DG108463,"CAS RN:13422-51-0 | PubChem CID:171039542 | cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(9Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydroxide"
+BMGC_DG04570,BMG_DG108482,"CAS RN:87-96-7 | (3S,4R,5S,6S)-6-methyloxane-2,3,4,5-tetrol | PubChem CID:17106 | L-Fucose"
+BMGC_DG04571,BMG_DG108502,"PubChem SID:198941905 | 4(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine | UNII:59IR9L62QF | 4-[4-(4-chlorophenyl)-3,6-dihydro-2H-pyridin-1-yl]-1-(4-fluorophenyl)butan-1-one | PubChem CID:171187 | CAS RN:52669-92-8 | 4-(4-(P-CHLOROPHENYL)-2,5,6-TRIHYDROPYRIDINO)-4'-FLUOROBUTYROPHENONE"
+BMGC_DG04572,BMG_DG108513,"DrugBank ID:DB06844 | PubChem CID:1712 | 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE"
+BMGC_DG04573,BMG_DG108516,L-LYSYL-L-PROLINE | PubChem CID:171204 | UNII:XVP6HTX9KN | CAS RN:52766-27-5
+BMGC_DG04574,BMG_DG108527,"CAS RN:14009-24-6 | Drotaverine | DROTAVERINE | PubChem CID:1712095 | PubChem SID:198964651 | DrugBank ID:DB06751 | UNII:98QS4N58TW | (1Z)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-3,4-dihydro-2H-isoquinoline | CAS RN:985-12-6"
+BMGC_DG04575,BMG_DG108540,PubChem SID:441096655 | UNII:7BF49L8BR5 | O-CHLOROPHENYLACETIC ACID | CAS RN:2444-36-2 | PubChem CID:17124
+BMGC_DG04576,BMG_DG108552,4-METHYLUMBELLIFERYL .BETA.-D-NN'-DIACETYLCHITOBIOSIDE | UNII:SYW68VG2T6 | DrugBank ID:DB02759 | 4-methyl-umbelliferyl-N-acetyl-chitobiose | CAS RN:53643-12-2 | PubChem SID:472422253 | PubChem CID:171284
+BMGC_DG04577,BMG_DG108569,"PubChem SID:175266004 | SULFADOXINE | CAS RN:1173021-35-6 | UNII:88463U4SM5 | DrugBank ID:DB01299 | 4-amino-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide | PubChem CID:17134 | CAS RN:2447-57-6 | Sulfadoxine"
+BMGC_DG04578,BMG_DG109041,"DrugBank ID:DB02984 | 4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline | PubChem CID:1714"
+BMGC_DG04579,BMG_DG109059,"CAS RN:56005-10-8 | PubChem CID:171489 | PubChem SID:441659241 | 5-O-METHYLEMBELIN | 5-O-Methylembelin | UNII:4H3R9623BA | 2-hydroxy-5-methoxy-3-undecylcyclohexa-2,5-diene-1,4-dione"
+BMGC_DG04580,BMG_DG109064,PubChem CID:1715 | JTV-519 FREE BASE | PubChem SID:198956251 | CAS RN:145903-06-6 | UNII:EBY0ENK2GQ | DrugBank ID:DB02929 | K201 free base
+BMGC_DG04581,BMG_DG109065,"UNII:Z2MMV08KUQ | Formebolone | (8S,9S,10R,11R,13S,14S,17S)-11,17-dihydroxy-10,13,17-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-2-carbaldehyde | PubChem SID:198959076 | DrugBank ID:DB01569 | FORMEBOLONE | CAS RN:2454-11-7 | PubChem CID:17150"
+BMGC_DG04582,BMG_DG109096,"NDC:83872-288 | NDC:74458-275 | NDC:83872-507 | NDC:83872-432 | CAS RN:56846-45-8 | NDC:83872-503 | NDC:84732-074 | CAS RN:58-85-5 | NDC:83872-510 | NDC:83872-314 | NDC:83872-468 | NDC:83872-350 | NDC:83767-301 | NDC:83872-479 | 5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid | NDC:84148-007 | NDC:83872-420 | NDC:83872-285 | NDC:84355-001 | NDC:83872-286 | NDC:63545-633 | NDC:84148-001 | NDC:83872-534 | NDC:83872-495 | NDC:83767-601 | NDC:63545-631 | NDC:83988-004 | PubChem SID:175267223 | NDC:84355-002 | NDC:84019-010 | NDC:84117-026 | NDC:83767-001 | NDC:83872-482 | NDC:63545-630 | NDC:83767-401 | NDC:84542-259 | NDC:63545-638 | NDC:83566-249 | NDC:85038-004 | NDC:83566-185 | NDC:83872-494 | NDC:63545-635 | NDC:83766-103 | NDC:83872-169 | NDC:84614-001 | NDC:83872-496 | NDC:63545-632 | NDC:83767-002 | NDC:72211-009 | NDC:85038-003 | NDC:83872-493 | NDC:83872-185 | NDC:83872-253 | NDC:83872-261 | Biotin | PubChem CID:171548 | NDC:83988-003 | NDC:83872-114 | NDC:83872-410 | NDC:84148-008 | NDC:83767-004 | NDC:84542-713 | NDC:63545-634 | NDC:83872-168 | NDC:83872-514 | UNII:6SO6U10H04 | NDC:72951-130 | NDC:83872-540 | DrugBank ID:DB00121 | CAS RN:22377-59-9 | NDC:83872-312 | NDC:83872-184 | NDC:84952-001 | NDC:83872-508 | NDC:84025-201 | NDC:83872-538 | NDC:84025-058 | NDC:84117-023 | NDC:83872-455 | NDC:83566-277 | NDC:84732-025 | NDC:63545-636 | NDC:83872-340 | NDC:83872-287 | NDC:83872-167 | NDC:83988-002 | NDC:83872-187 | BIOTIN | NDC:83872-021 | NDC:83872-530 | NDC:84117-028 | NDC:84614-003 | NDC:84660-011"
+BMGC_DG04583,BMG_DG109099,"PubChem CID:171558 | Amiloride hydrochloride and hydrochlorothiazide | 6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide;3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide;hydrochloride | CAS RN:57017-78-4"
+BMGC_DG04584,BMG_DG109104,"5-(((4S,5S,6R)-3,3,5,6-TETRAFLUORO-4-HYDROXY-2,2-DIOXO-2LAMBDA6-THIATRICYCLO(5.3.1.04,11)UNDECA-1(11),7,9-TRIEN-8-YL)OXY)PYRIDINE-3-CARBONITRILE | CAS RN:2826252-88-2 | UNII:5BZT6LTA46 | PubChem CID:171575798"
+BMGC_DG04585,BMG_DG109179,CAS RN:2466-76-4 | 1-imidazol-1-ylethanone | PubChem SID:310825441 | N-Acetylimidazole | PubChem CID:17174 | UNII:ZMP8X1Y11G | N-ACETYLIMIDAZOLE
+BMGC_DG04586,BMG_DG109182,"TEMOCILLIN | PubChem CID:171758 | Temocillin | DrugBank ID:DB12343 | (2S,5R,6S)-6-[(2-carboxy-2-thiophen-3-ylacetyl)amino]-6-methoxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem SID:198971543 | UNII:03QB156W6I | CAS RN:66148-78-5"
+BMGC_DG04587,BMG_DG109191,DIXYRAZINE | 2-[2-[4-(2-methyl-3-phenothiazin-10-ylpropyl)piperazin-1-yl]ethoxy]ethanol | Dixyrazine | PubChem CID:17182 | PubChem SID:198958035 | CAS RN:2470-73-7 | DrugBank ID:DB13784 | UNII:7H368W3AYC
+BMGC_DG04588,BMG_DG109193,"DrugBank ID:DB08605 | 6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL | PubChem CID:171833"
+BMGC_DG04589,BMG_DG109203,"PubChem CID:1718647 | CAS RN:306325-13-3 | 6-Bromo-5-methyl-1H-indole-2,3-dione | 6-BROMO-5-METHYL-1H-INDOLE-2,3-DIONE | PubChem SID:472422621 | UNII:YSL49USS46"
+BMGC_DG04590,BMG_DG109223,"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE | DrugBank ID:DB07096 | 4-Amino-1,8-naphthalimide | PubChem CID:1720 | 6-aminobenzo[de]isoquinoline-1,3-dione | 4-AMINO-1,8-NAPHTHALIMIDE | UNII:S529AR2S8B | PubChem SID:472406428 | CAS RN:1742-95-6"
+BMGC_DG04591,BMG_DG109245,"PubChem SID:375085749 | UNII:M089EFU921 | PubChem CID:172198 | angiotensin II | Angiotensin II | NDC:68547-005 | DrugBank ID:DB11842 | (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | ANGIOTENSIN II | CAS RN:4474-91-3 | NDC:68547-501"
+BMGC_DG04592,BMG_DG109258,"DrugBank ID:DB07756 | PubChem CID:1723 | 1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL"
+BMGC_DG04593,BMG_DG109267,"D-fructofuranose 1,6-bisphosphate | [(2R,3S,4S)-3,4,5-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate | CAS RN:488-69-7 | PubChem CID:172313"
+BMGC_DG04594,BMG_DG109271,UNII:BCD8KEA5TE | PubChem SID:482553853 | Butyrylcholine | BUTYRYLCHOLINE | CAS RN:3922-86-9 | PubChem CID:17233
+BMGC_DG04595,BMG_DG109359,"DrugBank ID:DB02633 | CAS RN:84166-13-2 | PubChem CID:172469 | 1-amino-4-[4-[[4-chloro-6-(2-sulfoanilino)-1,3,5-triazin-2-yl]amino]-3-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid | Cibacron Blue"
+BMGC_DG04596,BMG_DG109361,PubChem SID:252165226 | UNII:9IKH79PSWL | PubChem CID:17249 | TETRAPENTYLAMMONIUM | CAS RN:15959-61-2 | Tetrapentylammonium | tetrapentylazanium
+BMGC_DG04597,BMG_DG109362,4-Aminobenzamidine | PubChem SID:252319905 | UNII:63GK9KT599 | 4-AMINOBENZAMIDINE | CAS RN:1329499-33-3 | PubChem CID:1725 | 4-aminobenzenecarboximidamide | CAS RN:3858-83-1
+BMGC_DG04598,BMG_DG109381,NDC:51407-246 | NDC:0591-2533 | DALFAMPRIDINE | NDC:42571-275 | pyridin-4-amine | DrugBank ID:DB06637 | NDC:10144-427 | UNII:BH3B64OKL9 | PubChem CID:1727 | NDC:51407-876 | NDC:65862-863 | NDC:62756-429 | NDC:63629-9450 | CAS RN:504-24-5 | Dalfampridine | NDC:67877-444 | PubChem SID:175267082 | NDC:16729-292 | CAS RN:286367-79-1
+BMGC_DG04599,BMG_DG109392,"PubChem SID:175266542 | CAS RN:6014-30-8 | PubChem CID:17277 | CAS RN:2544-09-4 | UNII:2579Z4P04J | ethyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoate | Methyldopate | METHYLDOPATE"
+BMGC_DG04600,BMG_DG109431,"PubChem SID:198968309 | LIXIVAPTAN | Lixivaptan | PubChem CID:172997 | CAS RN:168079-32-1 | UNII:8F5X4B082E | N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide | DrugBank ID:DB06666"
+BMGC_DG04601,BMG_DG109434,PubChem SID:198961725 | UNII:E1LE0WZ4BO | CAS RN:59-85-8 | (4-carboxyphenyl)-chloromercury | P-CHLOROMERCURIBENZOIC ACID | 4-Chloromercuribenzoic acid | PubChem CID:1730
+BMGC_DG04602,BMG_DG109449,"CAMPESTEROL | UNII:5L5O665639 | PubChem SID:175265683 | PubChem CID:173183 | Campesterol | CAS RN:474-62-4 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"
+BMGC_DG04603,BMG_DG109472,"PubChem CID:17336 | PROXIBARBAL, (-)- | CAS RN:42013-23-0 | Proxibarbal | PubChem SID:440088604 | UNII:Y54BSX54CS | DrugBank ID:DB13253 | PubChem SID:198976208 | CAS RN:42013-34-3 | UNII:F97OMS297F | PROXIBARBAL, (+)- | 5-(2-hydroxypropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | CAS RN:42013-22-9 | CAS RN:2537-29-3 | PROXIBARBAL | PubChem SID:440088863 | UNII:RE966VDY2Y"
+BMGC_DG04604,BMG_DG109475,"PubChem SID:441097353 | 4-DAMP CATION | CAS RN:81405-11-0 | 4-DAMP cation | 4-Diphenylacetoxy-1,1-dimethylpiperidinium | PubChem CID:1734 | (1,1-dimethylpiperidin-1-ium-4-yl) 2,2-diphenylacetate | UNII:T2C393VHB9 | CAS RN:106458-69-9"
+BMGC_DG04605,BMG_DG109498,SULFUR HEXAFLUORIDE | hexafluoro-lambda6-sulfane | PubChem SID:198947794 | Sulfur Hexafluoride | CAS RN:2551-62-4 | PubChem CID:17358 | DrugBank ID:DB11104 | UNII:WS7LR3I1D6 | Sulfur hexafluoride
+BMGC_DG04606,BMG_DG109532,2-(4-hydroxy-3-methoxyphenyl)acetic acid | PubChem SID:198946904 | UNII:X77S6GMS36 | HOMOVANILLIC ACID | Homovanillic Acid | CAS RN:306-08-1 | PubChem CID:1738
+BMGC_DG04607,BMG_DG109534,"N-Acetylglucosamine | PubChem CID:1738118 | CAS RN:27555-50-6 | N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide | N-ACETYLGLUCOSAMINE | UNII:V956696549 | PubChem SID:175268260 | CAS RN:7512-17-6 | DrugBank ID:DB00141"
+BMGC_DG04608,BMG_DG109553,"UNII:1QSS0Q62W5 | PubChem SID:348480862 | CAS RN:63094-36-0 | PubChem CID:173894 | 2-METHOXY-11-OXO-11H-PYRIDO(2,1-B)QUINAZOLINE-8-CARBOXYLIC ACID"
+BMGC_DG04609,BMG_DG109568,"PubChem CID:17397714 | CAS RN:148465-45-6 | N-[(2-methoxyphenyl)methyl]-5-phenyl-1,2-oxazole-3-carboxamide"
+BMGC_DG04610,BMG_DG109571,"PubChem CID:174 | Ethylene Glycol | ethane-1,2-diol | PubChem SID:175266316 | UNII:FC72KVT52F | Ethylene glycol | CAS RN:107-21-1 | ETHYLENE GLYCOL"
+BMGC_DG04611,BMG_DG109594,"5,5'-METHYLENEDI-2,3-CRESOTIC ACID | PubChem SID:348481003 | PubChem CID:17413 | CAS RN:2581-36-4 | UNII:S3D8KC88KC"
+BMGC_DG04612,BMG_DG109597,"PubChem CID:17414308 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DrugBank ID:DB07115"
+BMGC_DG04613,BMG_DG109602,"DrugBank ID:DB00572 | NDC:71053-591 | NDC:11704-105 | ATROPINE | CAS RN:51-55-8 | NDC:11704-104 | NDC:11704-107 | PubChem CID:174174 | CAS RN:16175-85-2 | Atropine | CAS RN:5908-99-6 | NDC:11704-106 | NDC:71053-592 | PubChem SID:175271524 | NDC:64616-099 | NDC:11704-101 | NDC:71053-590 | NDC:73002-713 | [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate | UNII:7C0697DR9I"
+BMGC_DG04614,BMG_DG109604,CAS RN:5351-23-5 | PubChem CID:1742 | 4-HYDROXYBENZOIC ACID HYDRAZIDE | PubChem SID:440793816 | UNII:Y4G7G6U5GQ
+BMGC_DG04615,BMG_DG109613,PubChem CID:174251 | Coenzyme A persulfide | DrugBank ID:DB04036
+BMGC_DG04616,BMG_DG109619,N-Formylpiperidine | N-FORMYLPIPERIDINE | PubChem SID:252165316 | piperidine-1-carbaldehyde | DrugBank ID:DB04113 | UNII:ZIQ29H6CZG | PubChem CID:17429 | CAS RN:2591-86-8
+BMGC_DG04617,BMG_DG109622,PubChem SID:482553931 | VALIOLAMINE | UNII:QHW83U8Q5B | CAS RN:83465-22-9 | PubChem CID:174312 | Valiolamine
+BMGC_DG04618,BMG_DG109623,1-(2-DEOXY-2-FLUOROARABINOFURANOSYL)-5-ETHYLURACIL | UNII:2AGF6PBM87 | PubChem CID:174316 | CAS RN:83546-42-3 | PubChem SID:433968905
+BMGC_DG04619,BMG_DG109673,PubChem CID:1746 | 4-Iodobenzo[B]Thiophene-2-Carboxamidine | DrugBank ID:DB03136
+BMGC_DG04620,BMG_DG109674,"tetrasodium;4-amino-6-[[4-[4-[(8-amino-1-hydroxy-5,7-disulfonatonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]-5-hydroxynaphthalene-1,3-disulfonate | PubChem CID:17460 | Chicago Sky Blue 6B | UNII:8NN34MAQ6H | PubChem SID:198963351 | DIRECT BLUE 1 | CAS RN:2610-05-1"
+BMGC_DG04621,BMG_DG109688,4-IODOBENZO(B)THIOPHENE-2-CARBOXIMIDAMIDE | CAS RN:154628-42-9 | PubChem SID:475550262 | PubChem CID:1747 | UNII:QZT7G76BRK | 4-Iodobenzo[b]thiophene-2-carboximidamide
+BMGC_DG04622,BMG_DG109692,"PubChem SID:198976871 | PubChem CID:17473 | CAS RN:2616-64-0 | UNII:04SZC4MEFQ | DrugBank ID:DB03041 | URIDINE DIPHOSPHATE GLUCURONIC ACID | (2S,3S,4S,5R,6R)-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | Uridine diphosphate glucuronic acid | UDP-alpha-D-glucuronic acid"
+BMGC_DG04623,BMG_DG109699,"Ioglycamic acid | IOGLYCAMIC ACID | DrugBank ID:DB13741 | 3-[[2-[2-(3-carboxy-2,4,6-triiodoanilino)-2-oxoethoxy]acetyl]amino]-2,4,6-triiodobenzoic acid | Ioglycamic Acid | UNII:ET36GPP4T7 | PubChem CID:17477 | PubChem SID:198990325 | CAS RN:2618-25-9"
+BMGC_DG04624,BMG_DG109718,PubChem CID:174907 | 3-METHYL-1-PROPYLXANTHINE | UNII:8YM307PRAS | PubChem SID:198983441 | CAS RN:72117-78-3
+BMGC_DG04625,BMG_DG109727,NDC:84302-008 | PubChem CID:175 | Acetate | DrugBank ID:DB14511 | ACETATE ION | UNII:569DQM74SC | acetate | CAS RN:71-50-1 | PubChem SID:175265989 | NDC:84302-006
+BMGC_DG04626,BMG_DG109736,"2,5-dihydroxybenzenesulfonic acid | DOBESILIC ACID | Dobesilic acid | CAS RN:88-46-0 | CAS RN:20676-50-0 | DrugBank ID:DB13529 | PubChem SID:175267591 | PubChem CID:17507 | UNII:TO0PAT081I"
+BMGC_DG04627,BMG_DG109742,"5-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]imidazole-4-carboxamide | UNII:53IEF47846 | DrugBank ID:DB04944 | PubChem SID:198939288 | Acadesine | ACADESINE | PubChem CID:17513 | CAS RN:2627-69-2"
+BMGC_DG04628,BMG_DG109755,CAS RN:104-40-5 | 4-nonylphenol | 4-Nonylphenol | PubChem CID:1752
+BMGC_DG04629,BMG_DG109756,"CAS RN:40991-37-5 | BENZISOTHIAZOLINONE | CAS RN:2634-33-5 | PubChem CID:17520 | UNII:HRA0F1A4R3 | 1,2-benzothiazol-3-one | 1,2-Benzisothiazol-3(2H)-one | CAS RN:1329616-16-1 | PubChem SID:175266586"
+BMGC_DG04630,BMG_DG109769,CAS RN:2642-98-0 | 6-CHRYSENAMINE | chrysen-6-amine | 6-Chrysenamine | PubChem SID:198966635 | PubChem CID:17534 | UNII:I56L81BL2L
+BMGC_DG04631,BMG_DG109770,"UNII:4Q81NBO3IA | PubChem CID:17535 | CAS RN:4806-87-5 | PubChem SID:363908214 | 3,4-DICHLOROPHENYL-2-AMINOPROPANE"
+BMGC_DG04632,BMG_DG109777,12-Bromododecanoic Acid | CAS RN:73367-80-3 | UNII:RP072ZQ00E | 12-BROMODODECANOIC ACID | PubChem CID:175468 | DrugBank ID:DB02405 | PubChem SID:198977498
+BMGC_DG04633,BMG_DG109782,PubChem CID:175496 | DrugBank ID:DB04217 | L-2-amino-3-butynoic acid
+BMGC_DG04634,BMG_DG109783,DrugBank ID:DB02260 | 4-Oxosebacic Acid | PubChem CID:1755
+BMGC_DG04635,BMG_DG109791,DrugBank ID:DB13443 | CAS RN:93379-54-5 | UNII:DPF757BOSR | PubChem CID:175540 | ESATENOLOL | Esatenolol | PubChem SID:198961443 | 2-[4-[(2S)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
+BMGC_DG04636,BMG_DG109814,4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN | DrugBank ID:DB07480 | PubChem CID:1757
+BMGC_DG04637,BMG_DG109828,4-Sulfonamide-[1-(4-Aminobutane)]Benzamide | PubChem CID:1758 | N-(4-AMINOBUTYL)-4-(AMINOSULFONYL)BENZAMIDE | DrugBank ID:DB03697 | PubChem SID:485663620 | UNII:9DST2S4XXZ | N-(4-Aminobutyl)-4-(aminosulfonyl)benzamide | CAS RN:180989-15-5
+BMGC_DG04638,BMG_DG109830,"(2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide;hydrochloride | CAS RN:98717-15-8 | PubChem SID:198988034 | Ropivacaine hydrochloride | ROPIVACAINE HYDROCHLORIDE ANHYDROUS | UNII:35504LBE2T | PubChem CID:175804"
+BMGC_DG04639,BMG_DG109831,"ROPIVACAINE | Ropivacaine | DrugBank ID:DB00296 | (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide | UNII:7IO5LYA57N | CAS RN:84057-95-4 | PubChem CID:175805 | PubChem SID:175266235"
+BMGC_DG04640,BMG_DG109842,"PubChem CID:17589822 | CAS RN:134523-03-8 | Atorvastatin(1-) | (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate"
+BMGC_DG04641,BMG_DG109843,DrugBank ID:DB04002 | 4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide | PubChem CID:1759
+BMGC_DG04642,BMG_DG109861,PubChem SID:198978523 | PubChem CID:17599 | 3-AMINOFLUORANTHENE | CAS RN:2693-46-1 | UNII:8UN5PRH090
+BMGC_DG04643,BMG_DG109862,Acetic acid | ACETIC ACID | PubChem CID:176 | CAS RN:64-19-7 | PubChem SID:175267055 | DrugBank ID:DB03166 | Acetic Acid | CAS RN:77671-22-8 | UNII:Q40Q9N063P | acetic acid
+BMGC_DG04644,BMG_DG109865,PubChem CID:1760285 | 2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide | (s)-n-(1-Phenylpropyl)-2-phenylquinoline-4-carboxamide
+BMGC_DG04645,BMG_DG109873,"PubChem SID:198975997 | CAS RN:108147-54-2 | PubChem CID:176077 | DrugBank ID:DB05018 | UNII:C4XNY919FW | (2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol | MIGALASTAT | Migalastat"
+BMGC_DG04646,BMG_DG109881,UNII:OU13V1EYWQ | 4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine | PubChem CID:176155 | ADEZMAPIMOD | 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole | PubChem SID:249492542 | CAS RN:152121-47-6
+BMGC_DG04647,BMG_DG109889,"DrugBank ID:DB06486 | Enzastaurin | 3-(1-methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione | CAS RN:170364-57-5 | PubChem CID:176167 | UNII:UC96G28EQF | ENZASTAURIN | PubChem SID:198964567"
+BMGC_DG04648,BMG_DG109907,"UNII:JQ95208805 | 4-[2,2-bis[di(propan-2-yloxy)phosphoryl]ethyl]-2,6-ditert-butylphenol | PubChem SID:198985894 | APOMINE | TETRAISOPROPYL 2-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)ETHYL-1,1-BIPHOSPHONATE | PubChem CID:176405 | Apomine | DrugBank ID:DB12276 | CAS RN:126411-13-0"
+BMGC_DG04649,BMG_DG109908,"UNII:5NIC36BO71 | CAS RN:139180-30-6 | PubChem SID:433969051 | ZM-241385 | DrugBank ID:DB08770 | PubChem CID:176407 | 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol"
+BMGC_DG04650,BMG_DG109909,"PubChem SID:198945991 | 2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine | CAS RN:160098-96-4 | 4-(furan-2-yl)-10-(2-phenylethyl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine | PubChem CID:176408 | UNII:4309023MAH | SCH-58261"
+BMGC_DG04651,BMG_DG109930,UNII:83E56U9G2L | PubChem SID:485663003 | PubChem CID:17654 | 6-METHOXYTRYPTAMINE | CAS RN:3610-36-4 | 6-Methoxytryptamine
+BMGC_DG04652,BMG_DG109932,"PubChem SID:198938824 | 2,4-DICHLORO-5-SULFAMOYLBENZOIC ACID | PubChem CID:17655 | UNII:LEG53TF0SN | CAS RN:2736-23-4"
+BMGC_DG04653,BMG_DG109944,PubChem SID:198962966 | ACETOPHENAZINE | PubChem CID:17676 | CAS RN:2751-68-0 | UNII:8620H6K4QH | 1-[10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-2-yl]ethanone | Acetophenazine | DrugBank ID:DB01063
+BMGC_DG04654,BMG_DG109956,"DrugBank ID:DB00530 | PubChem SID:175266942 | Erlotinib | NDC:63304-096 | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine | ERLOTINIB | UNII:J4T82NDH7E | CAS RN:1429636-49-6 | NDC:63304-135 | NDC:63304-095 | PubChem CID:176870 | CAS RN:183321-74-6"
+BMGC_DG04655,BMG_DG109959,"Cilengitide | DrugBank ID:DB11890 | CILENGITIDE | PubChem SID:198962979 | UNII:4EDF46E4GI | PubChem CID:176873 | 2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid | CAS RN:188968-51-6"
+BMGC_DG04656,BMG_DG109977,CAS RN:17276-15-2 | HEMINIGERONE | PubChem CID:176918 | UNII:TLJ90R747F | PubChem SID:198984444
+BMGC_DG04657,BMG_DG109979,PubChem CID:176920 | PubChem SID:198941678 | 4'-METHYL-EPIGALLOCATECHIN | CAS RN:17291-05-3 | UNII:WM87TQ077U
+BMGC_DG04658,BMG_DG109992,CAS RN:75-07-0 | NDC:43742-1456 | NDC:43742-1759 | NDC:62185-0064 | NDC:43742-1257 | NDC:43742-2064 | NDC:73518-0001 | NDC:43742-2038 | ACETALDEHYDE | NDC:62185-0053 | Acetaldehyde | NDC:64578-0109 | NDC:43742-1490 | NDC:43857-0358 | NDC:44911-0179 | NDC:62185-0061 | acetaldehyde | UNII:GO1N1ZPR3B | PubChem CID:177 | PubChem SID:175265977 | NDC:43742-1246 | NDC:43742-1566 | NDC:64578-0148
+BMGC_DG04659,BMG_DG110036,"DARUSENTAN | PubChem CID:177236 | (2S)-2-(4,6-dimethoxypyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid | UNII:33JD57L6RW | DrugBank ID:DB04883 | Darusentan | CAS RN:171714-84-4 | PubChem SID:198979503"
+BMGC_DG04660,BMG_DG110037,PubChem CID:177238 | UNII:ZC6062V1O9 | PubChem SID:198974156 | CAS RN:171746-21-7 | AGN-193109
+BMGC_DG04661,BMG_DG110041,"CAS RN:2783-17-7 | PubChem SID:252164581 | 1,12-DODECANEDIAMINE | UNII:J3LM80W9NT | PubChem CID:17727"
+BMGC_DG04662,BMG_DG110053,"N-[(1-butylpiperidin-4-yl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide | DrugBank ID:DB04873 | CAS RN:152811-62-6 | PubChem CID:177336 | PubChem SID:198990333 | UNII:4UQ3S81B25 | Piboserod | PIBOSEROD"
+BMGC_DG04663,BMG_DG110067,PubChem SID:198944266 | DIHYDROEUGENOL | UNII:A3XE712277 | 2-Methoxy-4-propylphenol | PubChem CID:17739 | 2-methoxy-4-propylphenol | CAS RN:2785-87-7
+BMGC_DG04664,BMG_DG110074,"PubChem SID:198990555 | UNII:C40SQV4QCZ | CAS RN:14717-90-9 | 1,2,8-TRIHYDROXY-6-METHOXY-3-METHYLANTHRAQUINONE | PubChem CID:177458"
+BMGC_DG04665,BMG_DG110083,DrugBank ID:DB12806 | Gsk-1004723 | GSK-1004723 | CAS RN:955359-72-5 | UNII:S08212J4ZR | PubChem CID:17747460 | 2-[[(2R)-1-[4-[4-[3-(azepan-1-yl)propoxy]phenyl]butyl]pyrrolidin-2-yl]methyl]-4-[(4-chlorophenyl)methyl]phthalazin-1-one | PubChem SID:198947315
+BMGC_DG04666,BMG_DG110095,DrugBank ID:DB06995 | N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide | PubChem CID:17748441
+BMGC_DG04667,BMG_DG110103,UNII:YW13F86W9W | PubChem SID:318691570 | PubChem CID:177491 | CAS RN:14857-77-3 | L-HOMOCYSTEIC ACID
+BMGC_DG04668,BMG_DG110114,"DrugBank ID:DB07369 | N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide | PubChem CID:17749728"
+BMGC_DG04669,BMG_DG110116,"PubChem CID:17749735 | (6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one | DrugBank ID:DB07874"
+BMGC_DG04670,BMG_DG110120,"PubChem CID:1775 | NDC:0121-0892 | NDC:70518-4149 | 5,5-diphenylimidazolidine-2,4-dione | PHENYTOIN | NDC:66993-372 | NDC:51672-4069 | NDC:59762-0531 | DrugBank ID:DB00252 | PubChem SID:175265328 | NDC:0071-0007 | NDC:70518-0841 | NDC:58151-115 | NDC:66689-036 | NDC:0904-7199 | NDC:0615-8424 | Phenytoin | NDC:51672-4146 | NDC:60687-275 | UNII:6158TKW0C5 | NDC:66689-775 | NDC:60687-156 | NDC:0071-2214 | NDC:64980-573 | CAS RN:57-41-0 | NDC:17856-4070"
+BMGC_DG04671,BMG_DG110136,MAVATREP | PubChem SID:198952488 | 2-[2-[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-3H-benzimidazol-5-yl]phenyl]propan-2-ol | PubChem CID:17751090 | DrugBank ID:DB12875 | UNII:F197218T99 | CAS RN:956274-94-5 | Mavatrep
+BMGC_DG04672,BMG_DG110150,2-Phenylheme | PubChem CID:17753777 | DrugBank ID:DB03906
+BMGC_DG04673,BMG_DG110153,5'-O-(N-Ethyl-Sulfamoyl)Adenosine | PubChem CID:17753791 | DrugBank ID:DB02162
+BMGC_DG04674,BMG_DG110155,PubChem CID:17753797 | DrugBank ID:DB04246 | CRA_23653
+BMGC_DG04675,BMG_DG110156,PubChem CID:17753799 | CRA_9678 | DrugBank ID:DB04563
+BMGC_DG04676,BMG_DG110158,"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid | PubChem CID:17753820 | DrugBank ID:DB02506"
+BMGC_DG04677,BMG_DG110162,DrugBank ID:DB02081 | PubChem CID:17753851 | Bis-Benzamidine
+BMGC_DG04678,BMG_DG110163,PubChem CID:17753867 | 2-Benzyl-3-Iodopropanoic Acid | DrugBank ID:DB03441
+BMGC_DG04679,BMG_DG110166,DrugBank ID:DB03963 | PubChem CID:17753880 | S-(Dimethylarsenic)Cysteine
+BMGC_DG04680,BMG_DG110167,Cephalosporin analog | DrugBank ID:DB02136 | PubChem CID:17753890
+BMGC_DG04681,BMG_DG110171,"PubChem CID:17753915 | DrugBank ID:DB03948 | 6-Chloropurine Riboside, 5'-Monophosphate"
+BMGC_DG04682,BMG_DG110175,S-Selanyl Cysteine | DrugBank ID:DB03049 | PubChem CID:17753926
+BMGC_DG04683,BMG_DG110183,"DrugBank ID:DB04392 | PubChem CID:17753965 | Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]"
+BMGC_DG04684,BMG_DG110184,1-Hydroxy-2-S-glutathionyl-3-para-nitrophenoxy-propane | PubChem CID:17753973 | DrugBank ID:DB03706
+BMGC_DG04685,BMG_DG110186,PubChem CID:17753979 | DrugBank ID:DB03821 | 2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid
+BMGC_DG04686,BMG_DG110188,S-(N-hydroxy-N-bromophenylcarbamoyl)glutathione | PubChem CID:17753992 | DrugBank ID:DB03889
+BMGC_DG04687,BMG_DG110190,S-(N-hydroxy-N-iodophenylcarbamoyl)glutathione | PubChem CID:17753999 | DrugBank ID:DB03330
+BMGC_DG04688,BMG_DG110193,"Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide | DrugBank ID:DB01970 | PubChem CID:17754023"
+BMGC_DG04689,BMG_DG110195,Hymenialdisine | DrugBank ID:DB02950 | PubChem CID:17754027
+BMGC_DG04690,BMG_DG110196,"DrugBank ID:DB03344 | PubChem CID:17754035 | Inositol-(1,3,4,5,6)-Pentakisphosphate"
+BMGC_DG04691,BMG_DG110197,PubChem CID:17754054 | PubChem SID:472388402 | CAS RN:45101-60-8 | UNII:J9ET8AZ2P7 | N6-CARBOXY-L-LYSINE | DrugBank ID:DB03801 | Lysine Nz-Carboxylic Acid
+BMGC_DG04692,BMG_DG110200,Lysophosphotidylserine | PubChem CID:17754066 | DrugBank ID:DB04136
+BMGC_DG04693,BMG_DG110201,"2,6-Diamino-Hexanoic Acid Amide | DrugBank ID:DB03988 | PubChem CID:17754068"
+BMGC_DG04694,BMG_DG110206,DrugBank ID:DB01805 | PubChem CID:17754078 | Monoisopropylphosphorylserine
+BMGC_DG04695,BMG_DG110209,Selenomethionine Selenoxide | DrugBank ID:DB02958 | PubChem CID:17754089
+BMGC_DG04696,BMG_DG110213,PubChem CID:17754111 | Tetrazolyl Histidine | DrugBank ID:DB02528
+BMGC_DG04697,BMG_DG110214,DrugBank ID:DB01662 | PubChem CID:17754112 | Trans-O-Hydroxy-Alpha-Methyl Cinnamate
+BMGC_DG04698,BMG_DG110219,Phosphatidylethanolamine | PubChem CID:17754130 | DrugBank ID:DB04327
+BMGC_DG04699,BMG_DG110220,PubChem CID:17754131 | DrugBank ID:DB01966 | Di-Stearoyl-3-Sn-Phosphatidylethanolamine | [(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-octadecanoyloxypropyl] octadecanoate | DI-Stearoyl-3-SN-phosphatidylethanolamine
+BMGC_DG04700,BMG_DG110224,PubChem CID:17754156 | A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor | DrugBank ID:DB02090
+BMGC_DG04701,BMG_DG110229,PubChem CID:17754162 | O-Benzylsulfonyl-Serine | DrugBank ID:DB01973
+BMGC_DG04702,BMG_DG110231,DrugBank ID:DB02996 | 2-(Thiomethylene)-4-Methylpentanoic Acid | PubChem CID:17754166
+BMGC_DG04703,BMG_DG110232,PubChem CID:17754171 | DrugBank ID:DB02442 | Dioxyselenocysteine
+BMGC_DG04704,BMG_DG110233,"PubChem CID:17754173 | N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide | DrugBank ID:DB01877"
+BMGC_DG04705,BMG_DG110234,(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester | PubChem CID:17754181 | DrugBank ID:DB03333
+BMGC_DG04706,BMG_DG110235,"PubChem CID:17754184 | 2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol | DrugBank ID:DB01998"
+BMGC_DG04707,BMG_DG110239,"DrugBank ID:DB02559 | 6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine | PubChem CID:17754203"
+BMGC_DG04708,BMG_DG110244,S-(2-AMINO-2-OXOETHYL)CYSTEINE | PubChem SID:319892255 | UNII:LAH55Q7GIH | DrugBank ID:DB02987 | Cysteine-S-acetamide | CAS RN:17528-66-4 | PubChem CID:17754220
+BMGC_DG04709,BMG_DG110246,PubChem CID:17754356 | Spinosad | DrugBank ID:DB08823
+BMGC_DG04710,BMG_DG110247,PubChem CID:17754357 | UNII:Z6Y1J258EG | PubChem SID:198988957 | A-836339 | CAS RN:959746-77-1
+BMGC_DG04711,BMG_DG110248,"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine | DrugBank ID:DB06932 | PubChem CID:17754396"
+BMGC_DG04712,BMG_DG110249,"PF-04217903 | DrugBank ID:DB12848 | UNII:CYJ9ATV1IJ | CAS RN:956905-27-4 | CAS RN:1159490-85-3 | PubChem SID:198969694 | PubChem CID:17754438 | 2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol | Pf-04217903"
+BMGC_DG04713,BMG_DG110251,CAS RN:940943-37-3 | KD-5170 | UNII:26UQK478QL | PubChem CID:17754557 | PubChem SID:198963747
+BMGC_DG04714,BMG_DG110253,"3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile | CAS RN:1160597-27-2 | PubChem CID:17754772 | CAS RN:941688-05-7 | 3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1-pyrazolyl]propanenitrile"
+BMGC_DG04715,BMG_DG110256,"CAS RN:957054-50-1 | DrugBank ID:DB11663 | 4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine | UNII:ICY00EMP8P | Pictilisib | CAS RN:957054-30-7 | PubChem CID:17755052 | PICTILISIB | PubChem SID:198949003"
+BMGC_DG04716,BMG_DG110262,PubChem CID:17755582 | DrugBank ID:DB07325 | N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
+BMGC_DG04717,BMG_DG110277,"PubChem CID:17756743 | 5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE | DrugBank ID:DB07297"
+BMGC_DG04718,BMG_DG110285,"(1S,9R,11S,14S,15S)-15-methyl-9-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol | PubChem CID:17756771 | Fulvestrant | DrugBank ID:DB00947 | (7R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol"
+BMGC_DG04719,BMG_DG110299,4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE | DrugBank ID:DB07809 | PubChem CID:17758361
+BMGC_DG04720,BMG_DG110301,5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID | DrugBank ID:DB07289 | PubChem CID:17758920
+BMGC_DG04721,BMG_DG110303,4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID | PubChem CID:17759780 | DrugBank ID:DB06829
+BMGC_DG04722,BMG_DG110319,PubChem CID:177700 | CAS RN:15853-39-1 | Sulfamate | UNII:873YS6FC7C | SULFAMATE ION | sulfamate | PubChem SID:441658947
+BMGC_DG04723,BMG_DG110326,UNII:A4PYT135BE | PubChem CID:177747 | CAS RN:16449-27-7 | 4-BROMOBENZOATE | PubChem SID:198990875
+BMGC_DG04724,BMG_DG110339,PubChem CID:177831 | L-734217 | PubChem SID:348480774 | UNII:3JRV8H947H | CAS RN:146144-48-1
+BMGC_DG04725,BMG_DG110342,"DrugBank ID:DB03081 | [N-[N-(4-Methoxy-2,3,6-trimethylphenylsulfonyl)-L-aspartyl]-D-(4-amidino-phenylalanyl)]-piperidine | PubChem CID:177837"
+BMGC_DG04726,BMG_DG110349,PubChem SID:478836864 | CAS RN:148869-05-0 | PubChem CID:177865 | YM-511 | UNII:TK6QEB6SVR
+BMGC_DG04727,BMG_DG110364,5-Amino-2-[[1-[5-amino-2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid | PubChem CID:17787981 | 5-amino-2-[[1-[5-amino-2-[[1-[2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid
+BMGC_DG04728,BMG_DG110368,"5,7-DICHLOROKYNURENIC ACID | 5,7-Dichlorokynurenic Acid | CAS RN:123158-59-8 | PubChem SID:198975274 | CAS RN:131123-76-7 | 5,7-Dichlorokynurenic acid | 5,7-dichloro-4-oxo-1H-quinoline-2-carboxylic acid | PubChem CID:1779 | UNII:T61ORK73PY | DrugBank ID:DB01931"
+BMGC_DG04729,BMG_DG110377,DrugBank ID:DB12850 | Etalocib | ETALOCIB | PubChem SID:198959012 | 2-[3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]-2-propylphenoxy]benzoic acid | PubChem CID:177941 | CAS RN:152608-41-8 | UNII:THY6RIW44R | CAS RN:161172-51-6
+BMGC_DG04730,BMG_DG110390,ANTALARMIN | Antalarmin | CAS RN:157284-96-3 | UNII:G3DNT7X7YL | PubChem SID:474492549 | PubChem CID:177990
+BMGC_DG04731,BMG_DG110391,"Dmp 777 | UNII:3Q0469283P | PubChem CID:177992 | PubChem SID:198958258 | (2S)-N-[(1R)-1-(1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2-[4-(4-methylpiperazine-1-carbonyl)phenoxy]-4-oxoazetidine-1-carboxamide | CAS RN:157341-41-8 | DMP-777"
+BMGC_DG04732,BMG_DG110394,CAS RN:74330-92-0 | UNII:8XOE1JSO29 | PubChem CID:178 | DrugBank ID:DB02736 | acetamide | PubChem SID:175265503 | Acetamide | CAS RN:60-35-5 | ACETAMIDE
+BMGC_DG04733,BMG_DG110395,"CAS RN:1191-85-1 | UNII:5FEJ8J06DR | PubChem SID:404859521 | 5,8,11,14-EICOSATETRAYNOIC ACID | PubChem CID:1780"
+BMGC_DG04734,BMG_DG110407,"UNII:GJ0EGN38UL | Ibutamoren | 2-amino-2-methyl-N-[(2R)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propanamide | IBUTAMOREN | CAS RN:192511-65-2 | CAS RN:159633-92-8 | CAS RN:159634-47-6 | PubChem SID:198966446 | PubChem CID:178024"
+BMGC_DG04735,BMG_DG110417,"PubChem SID:198961997 | UNII:89RBZ66NVC | INDISETRON | PubChem CID:178039 | Indisetron | N-[(1R,5S)-3,9-dimethyl-3,9-diazabicyclo[3.3.1]nonan-7-yl]-1H-indazole-3-carboxamide | CAS RN:141549-75-9"
+BMGC_DG04736,BMG_DG110419,PubChem CID:178051 | DrugBank ID:DB04125 | N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine
+BMGC_DG04737,BMG_DG110420,2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine | POZANICLINE | PubChem CID:178052 | UNII:CL2002R563 | DrugBank ID:DB05458 | CAS RN:161417-03-4 | Pozanicline | PubChem SID:198983979
+BMGC_DG04738,BMG_DG110422,CAS RN:162203-65-8 | UNII:ASG803L8RD | PubChem SID:363907893 | JTP-4819 | PubChem CID:178060
+BMGC_DG04739,BMG_DG110425,CAS RN:162490-89-3 | PubChem SID:459055891 | UNII:D2PP33VT2P | PubChem CID:178067 | F-1394
+BMGC_DG04740,BMG_DG110430,PubChem CID:178077 | CAS RN:163136-03-6 | UNII:J7U9L4JZ77 | PubChem SID:440089246 | FK-143 | 4-[3-[3-[bis[4-(2-methylpropyl)phenyl]methylamino]benzoyl]indol-1-yl]butanoic acid
+BMGC_DG04741,BMG_DG110431,UNII:EDB3ZEZ46R | PubChem SID:434369803 | PD-147693 | PubChem CID:178078 | CAS RN:163239-24-5
+BMGC_DG04742,BMG_DG110438,"PubChem CID:178103 | DrugBank ID:DB06460 | PubChem SID:198967114 | UNII:QG16H8A6ZH | CAS RN:167256-08-8 | Enrasentan | ENRASENTAN | (1S,2R,3S)-1-(1,3-benzodioxol-5-yl)-3-[2-(2-hydroxyethoxy)-4-methoxyphenyl]-5-propoxy-2,3-dihydro-1H-indene-2-carboxylic acid"
+BMGC_DG04743,BMG_DG110453,CAS RN:23838-17-7 | PubChem SID:198987761 | PubChem CID:1781413 | UMBELLIPRENIN | UNII:MSD8N8A1LQ
+BMGC_DG04744,BMG_DG110458,"UNII:8K4J4SAQ0B | PubChem SID:443624698 | 3-(1H-INDOL-3-YL)-4-PHENYLAZANYL-PYRROLE-2,5-DIONE | CAS RN:257878-66-3 | PubChem CID:17814743"
+BMGC_DG04745,BMG_DG110460,PubChem SID:198952094 | PubChem CID:17815 | 4-Amino-1-naphthol | 1-AMINO-4-NAPHTHOL | CAS RN:2834-90-4 | 4-aminonaphthalen-1-ol | UNII:02W29959D9
+BMGC_DG04746,BMG_DG110479,"[5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)imidazol-2-yl]methyl carbamate | UNII:VHC779598X | CAPRAVIRINE | PubChem SID:198935871 | PubChem CID:1783 | DrugBank ID:DB08502 | CAS RN:178979-85-6 | Capravirine"
+BMGC_DG04747,BMG_DG110520,PubChem SID:346537650 | UNII:25B75ID70W | ABBOTT-79175 | PubChem CID:178577 | CAS RN:141579-87-5
+BMGC_DG04748,BMG_DG110549,UNII:8ZT2BA5NS7 | PubChem SID:474491260 | 1-AMINO-4-CHLOROANTHRAQUINONE | CAS RN:2872-47-1 | PubChem CID:17884 | 1-Amino-4-chloroanthraquinone
+BMGC_DG04749,BMG_DG110594,5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID | 5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID) | 5-(Dimethylamino)-1-naphthalenesulfonic acid | CAS RN:4272-77-9 | UNII:Q7GT975TCW | DrugBank ID:DB07376 | PubChem CID:1792 | PubChem SID:485660928
+BMGC_DG04750,BMG_DG110599,"7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one | DELORAZEPAM | PubChem CID:17925 | UNII:O91W32476G | CAS RN:2894-67-9 | PubChem SID:175267134 | DrugBank ID:DB01511 | Delorazepam"
+BMGC_DG04751,BMG_DG110601,UNII:85V98E6A3M | PubChem CID:179269 | VARACIN | CAS RN:134029-48-4 | PubChem SID:474492609
+BMGC_DG04752,BMG_DG110606,DIMETHYLAMILORIDE | UNII:3GC547293P | CAS RN:1214-79-5 | PubChem SID:198978841 | PubChem CID:1793
+BMGC_DG04753,BMG_DG110616,ARZOXIFENE | PubChem CID:179337 | Arzoxifene | UNII:E569WG6E60 | CAS RN:182133-25-1 | DrugBank ID:DB06249 | PubChem SID:198990358 | 2-(4-methoxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)phenoxy]-1-benzothiophen-6-ol
+BMGC_DG04754,BMG_DG110618,"ASIMADOLINE | PubChem CID:179340 | CAS RN:153205-46-0 | DrugBank ID:DB05104 | UNII:D0VK52NV5M | Asimadoline | N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide | PubChem SID:198945270"
+BMGC_DG04755,BMG_DG110621,"NDC:63402-208 | [(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate | ESLICARBAZEPINE ACETATE | NDC:31722-428 | Eslicarbazepine Acetate | Eslicarbazepine acetate | NDC:63402-202 | DrugBank ID:DB09119 | NDC:31722-431 | PubChem CID:179344 | PubChem SID:175267566 | CAS RN:236395-14-5 | NDC:63402-204 | NDC:63402-206 | UNII:BEA68ZVB2K | NDC:31722-429 | NDC:31722-430"
+BMGC_DG04756,BMG_DG110634,"2-AMINO-4-PHOSPHONOBUTYRIC ACID, (S)- | UNII:C8M58SS68H | CAS RN:23052-81-5 | PubChem CID:179394 | PubChem SID:461434035"
+BMGC_DG04757,BMG_DG110635,"CAS RN:1428-95-1 | 3-amino-5-(azepan-1-yl)-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide | CAS RN:1345839-29-3 | 5-(N,N-Hexamethylene)amiloride | PubChem CID:1794"
+BMGC_DG04758,BMG_DG110644,"(1S,3R,4R,5R)-3-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid | Chlorogenic Acid | CAS RN:202650-88-2 | PubChem SID:175267864 | UNII:318ADP12RI | DrugBank ID:DB12029 | CHLOROGENIC ACID | CAS RN:327-97-9 | PubChem CID:1794427"
+BMGC_DG04759,BMG_DG110656,PubChem CID:1795 | 3-amino-6-chloro-N-(diaminomethylidene)-5-[ethyl(propan-2-yl)amino]pyrazine-2-carboxamide | CAS RN:1154-25-2 | PubChem SID:198940189 | UNII:VW50CE070T | ETHYLISOPROPYLAMILORIDE | Ethylisopropylamiloride
+BMGC_DG04760,BMG_DG110680,"Limonin | PubChem CID:179651 | (1R,2R,7S,10R,13R,14R,16S,19S,20S)-19-(furan-3-yl)-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo[11.9.0.02,7.02,10.014,16.014,20]docosane-5,12,17-trione | CAS RN:1180-71-8 | CAS RN:1809582-56-6 | LIMONIN | PubChem SID:241177980 | UNII:L0F260866S"
+BMGC_DG04761,BMG_DG110681,"PubChem CID:1796510 | CAS RN:25137-00-2 | PubChem SID:475550671 | NIPECOTIC ACID, (R)-(-)- | Nipecotic acid, (R)-(-)- | UNII:J4Z8PAL7EZ"
+BMGC_DG04762,BMG_DG110689,PubChem CID:1797 | CAS RN:157798-12-4 | UNII:TV6CHD9VPT | 5-(NONYLOXY)TRYPTAMINE | PubChem SID:474492536 | 5-(Nonyloxy)tryptamine
+BMGC_DG04763,BMG_DG110693,1-[4-(hydroxymethyl)phenyl]guanidine | DrugBank ID:DB06900 | PubChem CID:17975425
+BMGC_DG04764,BMG_DG110708,"CAS RN:130073-98-2 | 9-Amino-1,2,3,4-tetrahydroacridin-2-ol | PubChem CID:179849 | UNII:MN46M3RB6G | 9-amino-1,2,3,4-tetrahydroacridin-2-ol | 2-HYDROXYTACRINE | PubChem SID:433968799"
+BMGC_DG04765,BMG_DG110709,"4-Hydroxytacrine | 9-amino-1,2,3,4-tetrahydroacridin-4-ol | PubChem SID:445499703 | UNII:6FP9C7ZG3K | 4-HYDROXYTACRINE | CAS RN:130073-99-3 | PubChem CID:179850"
+BMGC_DG04766,BMG_DG110719,"PubChem SID:346538455 | 3H-IMIDAZO(4,5-B)PYRIDIN-2-AMINE | CAS RN:132898-03-4 | PubChem CID:179897 | UNII:111KPI0HZA"
+BMGC_DG04767,BMG_DG110732,DrugBank ID:DB01939 | 5-Amidino-Benzimidazole | 5-Amidino-benzimidazole | [amino(3H-benzimidazol-5-yl)methylidene]azanium | PubChem CID:1800
+BMGC_DG04768,BMG_DG110737,PubChem SID:375579176 | THIOCARBOSTYRIL | UNII:XW9BW0P3YZ | PubChem CID:1800393 | CAS RN:2637-37-8
+BMGC_DG04769,BMG_DG110750,"CAS RN:77086-21-6 | UNII:7PY8KH681I | PubChem SID:198949394 | DIZOCILPINE | (1S,9R)-1-methyl-16-azatetracyclo[7.6.1.02,7.010,15]hexadeca-2,4,6,10,12,14-hexaene | Dizocilpine | PubChem CID:180081"
+BMGC_DG04770,BMG_DG110752,"CAS RN:252722-52-4 | PubChem SID:472422008 | UNII:QB8UC7WSZ9 | PubChem CID:18008465 | 4-PIPERAZIN-1-YL-1H-PYRROLO(2,3-D)PYRIMIDINE"
+BMGC_DG04771,BMG_DG110777,PubChem SID:198967400 | UNII:DCP58J201D | PubChem CID:18047 | TOLIPROLOL | CAS RN:2933-94-0
+BMGC_DG04772,BMG_DG110787,"CAS RN:56105-81-8 | PubChem SID:198936305 | PubChem CID:180540 | KETOPROFEN, (R)- | UNII:S03709D0TH"
+BMGC_DG04773,BMG_DG110790,"(R)-Atenolol | UNII:YG132I00WY | PubChem CID:180559 | ATENOLOL, (+)- | DrugBank ID:DB06987 | CAS RN:56715-13-0 | PubChem SID:198954468"
+BMGC_DG04774,BMG_DG110793,4-NITROINDAZOLE | PubChem SID:384647850 | PubChem CID:18057 | UNII:99ML8W90BD | CAS RN:2942-40-7
+BMGC_DG04775,BMG_DG110797,N4-(ALPHA-MORPHOLINOACETYL)SULFANILAMIDE | PubChem CID:180598 | PubChem SID:461434577 | CAS RN:91533-01-6 | UNII:758F79HC9H
+BMGC_DG04776,BMG_DG110799,"UNII:4KQ8G4M9DE | PubChem SID:440090050 | CAS RN:94991-73-8 | PubChem CID:180621 | DrugBank ID:DB07129 | MEXILETINE, (R)- | (2R)-1-(2,6-dimethylphenoxy)propan-2-amine"
+BMGC_DG04777,BMG_DG110809,"Galactose-uridine-5'-diphosphate | PubChem CID:18068 | [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate | PubChem SID:434370092 | DrugBank ID:DB03501 | URIDINE 5'-DIPHOSPHOGALACTOSE | UNII:O2HY4WY2W1 | CAS RN:2956-16-3"
+BMGC_DG04778,BMG_DG110817,5-BROMONICOTINAMIDE | PubChem SID:438789111 | CAS RN:28733-43-9 | 5-Bromonicotinamide | UNII:FCT9J0CUP7 | DrugBank ID:DB01854 | PubChem CID:1808
+BMGC_DG04779,BMG_DG110823,CAS RN:74885-09-9 | UNII:91H76044O0 | PubChem CID:1809 | 5-CARBOXAMIDOTRYPTAMINE | 5-Carboxamidotryptamine | 3-(2-aminoethyl)-1H-indole-5-carboxamide | PubChem SID:198944795
+BMGC_DG04780,BMG_DG110824,UNII:AC2BZ3JS4G | PubChem CID:18091 | PubChem SID:474491535 | PIPERONYLIDENEMALONONITRILE | CAS RN:2972-82-9 | Piperonylidenemalononitrile
+BMGC_DG04781,BMG_DG110826,(1-Naphthylmethylene)malononitrile | CAS RN:2972-83-0 | (1-NAPHTHYLMETHYLENE)MALONONITRILE | PubChem SID:482553603 | PubChem CID:18092 | UNII:X3RBT3WY4W
+BMGC_DG04782,BMG_DG110837,PubChem SID:198934883 | CARPHENAZINE | PubChem CID:18104 | Carphenazine | Carfenazine | UNII:CLY16Y8Z7E | CAS RN:2622-30-2 | DrugBank ID:DB01038 | 1-[10-[3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl]phenothiazin-2-yl]propan-1-one
+BMGC_DG04783,BMG_DG110839,4-CHLORO-7-METHYL ISATIN | PubChem CID:1810509 | PubChem SID:461432801 | UNII:PMB88XVB49 | CAS RN:61258-72-8
+BMGC_DG04784,BMG_DG110847,DrugBank ID:DB07723 | PubChem CID:181137 | PubChem SID:440089532 | 3-(5-methoxy-1H-indol-3-yl)propanoic acid | 3-(5-METHOXY-1H-INDOL-3-YL)PROPANOIC ACID | UNII:CS268A9K9W | CAS RN:39547-16-5
+BMGC_DG04785,BMG_DG110849,"3-[(2S)-1-methyl-3,4-dihydro-2H-pyrrol-1-ium-2-yl]pyridine | Nicotine iminium | CAS RN:42459-13-2 | PubChem CID:181139"
+BMGC_DG04786,BMG_DG110867,CAS RN:60347-67-3 | PubChem CID:181271 | 3-[2-(2-hydroxyphenyl)ethyl]-5-methoxyphenol | BATATASIN IV | Batatasin IV | UNII:P52XXM9HLN
+BMGC_DG04787,BMG_DG110883,PubChem CID:181426 | N-(Chlorophenyl)-N'-hydroxyguanidine | DrugBank ID:DB04559
+BMGC_DG04788,BMG_DG110905,UNII:66Y63L379N | MALTOSE ANHYDROUS | PubChem CID:181526 | PubChem SID:198954138 | CAS RN:69-79-4
+BMGC_DG04789,BMG_DG110908,"N,N'-1,3-PHENYLENEDIMALEIMIDE | PubChem CID:18156 | PubChem SID:252165269 | CAS RN:3006-93-7 | UNII:MD8KF155CT"
+BMGC_DG04790,BMG_DG110917,Chromone-3-carboxylic acid | PubChem SID:485663422 | CHROMONE-3-CARBOXYLIC ACID | CAS RN:39079-62-4 | UNII:HKW8G9Q7D4 | PubChem CID:181620
+BMGC_DG04791,BMG_DG110931,PubChem SID:198948197 | Benzyl Thiocyanate | BENZYL THIOCYANATE | benzyl thiocyanate | PubChem CID:18170 | CAS RN:3012-37-1 | UNII:YX8TAO9O90
+BMGC_DG04792,BMG_DG110956,"UNII:10A5O25ILE | PubChem SID:472408610 | CAS RN:66635-93-6 | KETOROLAC, (R)- | PubChem CID:181818"
+BMGC_DG04793,BMG_DG110988,3-HYDROXYGLUTARIC ACID | 3-hydroxyglutaric acid | PubChem SID:402404597 | UNII:C3FG9S37DY | 3-hydroxypentanedioic acid | 3-Hydroxyglutaric acid | CAS RN:638-18-6 | PubChem CID:181976 | DrugBank ID:DB04594
+BMGC_DG04794,BMG_DG110995,CAS RN:399-76-8 | PubChem CID:1820 | PubChem SID:478839076 | 5-Fluoroindole-2-carboxylic acid | 5-FLUOROINDOLE-2-CARBOXYLIC ACID | UNII:LFV2Z936CQ
+BMGC_DG04795,BMG_DG111000,PubChem SID:472387848 | 1-PHENYL-1H-INDOLE | UNII:NCW9WE9Z9V | PubChem CID:182029 | CAS RN:16096-33-6
+BMGC_DG04796,BMG_DG111016,DrugBank ID:DB11823 | ESKETAMINE | PubChem CID:182137 | CAS RN:33643-46-8 | (2S)-2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one | PubChem SID:175268861 | UNII:50LFG02TXD | Esketamine
+BMGC_DG04797,BMG_DG111019,CAS RN:33676-00-5 | UNII:22ZZ21E33P | HYPOPHYLLANTHIN | PubChem SID:198989239 | PubChem CID:182140
+BMGC_DG04798,BMG_DG111020,2-(3-hydroxy-5-methylphenoxy)-5-methoxy-3-methylphenol | CAS RN:33716-82-4 | CYPERIN | UNII:TK2QWV3FU8 | PubChem CID:182142 | Cyperine
+BMGC_DG04799,BMG_DG111052,ACEGLUTAMIDE | PubChem SID:198986855 | CAS RN:2490-97-3 | DrugBank ID:DB04167 | Aceglutamide | (2S)-2-acetamido-5-amino-5-oxopentanoic acid | PubChem CID:182230 | UNII:01J18G9G97
+BMGC_DG04800,BMG_DG111053,"(+)-Epicatechin | (2S,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol | PubChem SID:381132326 | PubChem CID:182232 | UNII:LD6B6TT8Q5 | DEXEPICATECHIN | CAS RN:35323-91-2"
+BMGC_DG04801,BMG_DG111073,"CAS RN:63046-09-3 | UNII:05J1QNC3FW | PubChem CID:182362 | 4',6-DIHYDROXYFLAVONE | PubChem SID:313390053"
+BMGC_DG04802,BMG_DG111091,5-HYDROXYINDOLE-3-ACETIC ACID | PubChem SID:198940366 | UNII:YHC763JY1P | CAS RN:54-16-0 | PubChem CID:1826 | 5-Hydroxyindole-3-acetic acid | 2-(5-hydroxy-1H-indol-3-yl)acetic acid | CAS RN:1321-73-9
+BMGC_DG04803,BMG_DG111110,"1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione | Stavudine | PubChem SID:175267957 | UNII:BO9LE4QFZF | CAS RN:220020-60-0 | DrugBank ID:DB00649 | STAVUDINE | PubChem CID:18283 | CAS RN:3056-17-5"
+BMGC_DG04804,BMG_DG111117,Novo Nordisk a/S Compound | DrugBank ID:DB02662 | PubChem CID:1829
+BMGC_DG04805,BMG_DG111132,CAS RN:131580-36-4 | PubChem CID:183073 | UNII:AVU6KBU363 | CALYSTEGINE A3
+BMGC_DG04806,BMG_DG111140,"PubChem CID:183134 | CAS RN:133240-46-7 | 2-ethyl-5,7-dimethyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazo[4,5-b]pyridine | 2-Ethyl-5,7-dimethyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazo(4,5-b)pyridine"
+BMGC_DG04807,BMG_DG111155,"CAS RN:1019-45-0 | MEBUFOTENIN | 2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine | Mebufotenin | PubChem CID:1832 | DrugBank ID:DB14010 | N,N-Dimethyl-5-methoxytryptamine | UNII:X0MKX3GWU9 | PubChem SID:175268895"
+BMGC_DG04808,BMG_DG111169,CAS RN:608-07-1 | 5-Methoxytryptamine | UNII:3VMW6141KC | PubChem CID:1833 | 2-(5-methoxy-1H-indol-3-yl)ethanamine | PubChem SID:175266864 | 5-METHOXYTRYPTAMINE
+BMGC_DG04809,BMG_DG111190,"DOXIFLURIDINE | CAS RN:3094-09-5 | PubChem SID:198984918 | DrugBank ID:DB12947 | Doxifluridine | UNII:V1JK16Y2JP | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoropyrimidine-2,4-dione | PubChem CID:18343"
+BMGC_DG04810,BMG_DG111218,"PubChem CID:1836 | 5-METHYL-5-(4-PHENOXYPHENYL)-1,3-DIAZINANE-2,4,6-TRIONE | 5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione | PubChem SID:443623462 | UNII:4MPM14604G | CAS RN:288102-94-3 | DrugBank ID:DB03368"
+BMGC_DG04811,BMG_DG111229,CAS RN:3109-12-4 | DESCHLOROHALOPERIDOL | PubChem SID:198977756 | Deschlorohaloperidol | UNII:QKZ09O18R6 | PubChem CID:18367
+BMGC_DG04812,BMG_DG111246,TAPRENEPAG | PubChem SID:198947684 | DrugBank ID:DB12623 | 2-[3-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid | CAS RN:752187-80-7 | UNII:9CD894KUMJ | Taprenepag | PubChem CID:18376177
+BMGC_DG04813,BMG_DG111253,PubChem CID:183782 | CAS RN:160845-95-4 | RS-67333 | UNII:39N8XG5C9A | PubChem SID:474492787
+BMGC_DG04814,BMG_DG111254,CAS RN:144966-96-1 | ADATANSERIN HYDROCHLORIDE | PubChem CID:183784 | UNII:48BX75B06D | PubChem SID:198985686
+BMGC_DG04815,BMG_DG111257,"PubChem SID:198950300 | TAK-779 cation | CAS RN:263765-56-6 | TAK-779 CATION | UNII:RN3X97C29H | PubChem CID:183790 | dimethyl-[[4-[[3-(4-methylphenyl)-8,9-dihydro-7H-benzo[7]annulene-6-carbonyl]amino]phenyl]methyl]-(oxan-4-yl)azanium"
+BMGC_DG04816,BMG_DG111260,Melagatran | PubChem CID:183797 | PubChem SID:198939790 | CAS RN:159776-70-2 | DrugBank ID:DB13616 | MELAGATRAN | UNII:2A9QP32MD4 | 2-[[(1R)-2-[(2S)-2-[(4-carbamimidoylphenyl)methylcarbamoyl]azetidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]acetic acid
+BMGC_DG04817,BMG_DG111265,"DICLOXACILLIN | PubChem SID:175267785 | CAS RN:3116-76-5 | UNII:COF19H7WBK | PubChem CID:18381 | DrugBank ID:DB00485 | (2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Dicloxacillin"
+BMGC_DG04818,BMG_DG111267,PubChem SID:198938125 | SIBENADET | UNII:N32934RHGW | PubChem CID:183812 | CAS RN:154189-40-9
+BMGC_DG04819,BMG_DG111365,"PubChem CID:18432427 | 2,4,6-TRIBROMO-5-AMINO-ISOPHTHALIC ACID | UNII:T86LB7G8ZX | CAS RN:35453-30-6 | PubChem SID:482553824 | 5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid | DrugBank ID:DB07491 | 5-Amino-2,4,6-Tribromobenzene-1,3-Dicarboxylic Acid | 2,4,6-Tribromo-5-amino-isophthalic acid"
+BMGC_DG04820,BMG_DG111374,BGC-20-1531 free base | BGC-20-1531 FREE BASE | PubChem CID:18444613 | 4-[[4-(5-methoxypyridin-2-yl)phenoxy]methyl]-5-methyl-N-(2-methylphenyl)sulfonylfuran-2-carboxamide | UNII:Z49JYU6T3P | CAS RN:736183-35-0
+BMGC_DG04821,BMG_DG111407,"3,5-DIBROMOSALICYLIC ACID | UNII:T5JO5UA21H | PubChem CID:18464 | CAS RN:3147-55-5 | 3,5-dibromo-2-hydroxybenzoic acid | NDC:83566-578 | PubChem SID:198976440 | 3,5-Dibromosalicylic acid | CAS RN:509092-66-4"
+BMGC_DG04822,BMG_DG111428,"1,2-Diphenyl ethanedioate | UNII:7BB9D5HPC2 | 1,2-DIPHENYL ETHANEDIOATE | PubChem CID:18475 | PubChem SID:474491850 | CAS RN:3155-16-6"
+BMGC_DG04823,BMG_DG111454,Kuwanon L | UNII:K7L2NL4ZQF | KUWANON L | CAS RN:88524-65-6 | PubChem CID:184877 | PubChem SID:478838371
+BMGC_DG04824,BMG_DG111457,PubChem SID:198946113 | CAS RN:3166-62-9 | PubChem CID:18493 | UNII:M35Q3X4F69 | METHYLBENACTYZIUM BROMIDE
+BMGC_DG04825,BMG_DG111458,"CAS RN:68-19-9 | PubChem CID:184933 | cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;cyanide"
+BMGC_DG04826,BMG_DG111459,PubChem SID:198977383 | PubChem CID:18496 | 6-AMINONICOTINIC ACID | CAS RN:3167-49-5 | UNII:9VR2O1OK60
+BMGC_DG04827,BMG_DG111492,TETRAHYDROPAPAVEROLINE | PubChem CID:18519 | CAS RN:4747-99-3 | PubChem SID:241178976 | UNII:V1EWJ6B8KY
+BMGC_DG04828,BMG_DG111529,UNII:M6AY4VCZ0A | PubChem SID:198946002 | PubChem CID:18538 | CAS RN:536-24-3 | ETHYLNOREPINEPHRINE
+BMGC_DG04829,BMG_DG111532,"CAS RN:95093-99-5 | UNII:N6E193E020 | PubChem SID:316914932 | CARVEDILOL, (+)- | PubChem CID:185394"
+BMGC_DG04830,BMG_DG111533,"(S)-Carvedilol | (2S)-1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol | CAS RN:95094-00-1 | CARVEDILOL, (-)- | UNII:GW13D96IND | PubChem SID:241179258 | PubChem CID:185395"
+BMGC_DG04831,BMG_DG111536,PubChem CID:1854 | 6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID | DrugBank ID:DB08397
+BMGC_DG04832,BMG_DG111547,DrugBank ID:DB14082 | NDC:45567-0655 | Betiatide | UNII:9NV2SR34P8 | CAS RN:103725-47-9 | NDC:69945-096 | PubChem SID:175265491 | 2-[[2-[[2-[(2-benzoylsulfanylacetyl)amino]acetyl]amino]acetyl]amino]acetic acid | PubChem CID:185457 | NDC:65174-261 | BETIATIDE
+BMGC_DG04833,BMG_DG111550,2-[4-[2-[4-[1-(2-ethoxyethyl)benzimidazol-2-yl]piperidin-1-yl]ethyl]phenyl]-2-methylpropanoic acid | UNII:PA1123N395 | PubChem CID:185460 | BILASTINE | CAS RN:202189-78-4 | DrugBank ID:DB11591 | Bilastine | PubChem SID:198946340
+BMGC_DG04834,BMG_DG111563,6-(Dihydroxy-Isobutyl)-Thymine | PubChem CID:1855 | DrugBank ID:DB02500
+BMGC_DG04835,BMG_DG111579,PubChem CID:185617 | UNII:16IGP0ML9A | CAS RN:27740-01-8 | PubChem SID:198942791 | SCUTELLARIN
+BMGC_DG04836,BMG_DG111580,UNII:8W94T9026R | CAS RN:27750-10-3 | PubChem CID:185620 | HYDROXYCITRIC ACID | PubChem SID:175268658
+BMGC_DG04837,BMG_DG111590,".ALPHA.-D-MANNOPYRANOSE | CAS RN:137498-12-5 | CAS RN:12046-12-7 | UNII:W3F28J9G0W | CAS RN:101357-07-7 | CAS RN:135317-04-3 | alpha-D-Mannopyranose | PubChem CID:185698 | PubChem SID:198985885 | CAS RN:7296-15-3 | CAS RN:101357-35-1 | (2S,3S,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol"
+BMGC_DG04838,BMG_DG111593,"UNII:E6VV2T4ZKS | PubChem CID:185717 | 4-(4-CHLOROPHENYL)-1,2,3,6-TETRAHYDROPYRIDINE | CAS RN:30005-58-4 | 4-(4-chlorophenyl)-1,2,3,6-tetrahydropyridine | 4-(4-Chlorophenyl)-1,2,3,6-tetrahydropyridine"
+BMGC_DG04839,BMG_DG111602,CAS RN:55094-22-9 | PubChem CID:185792 | dimethylarsinous acid | Dimethylarsinous acid
+BMGC_DG04840,BMG_DG111606,"UNII:O684SO61PI | PubChem CID:185834 | 2,6-DIMETHYL-4-TRIDECYLMORPHOLINE, CIS- | PubChem SID:198989160 | CAS RN:56048-48-7"
+BMGC_DG04841,BMG_DG111607,"VERAPHENOL | PubChem SID:252165096 | 5-(6-hydroxy-1-benzofuran-2-yl)benzene-1,3-diol | PubChem CID:185848 | CAS RN:56317-21-6 | UNII:L9FI83128D | Moracin M"
+BMGC_DG04842,BMG_DG111610,D-HOMOCYSTEIC ACID | CAS RN:56892-03-6 | PubChem CID:185861 | UNII:39C2MM4U51 | PubChem SID:318690964
+BMGC_DG04843,BMG_DG111616,"PubChem CID:185914 | CAS RN:58436-28-5 | PubChem SID:438788872 | DIHYDRORESVERATROL | DrugBank ID:DB08466 | UNII:CBY43AY0TT | 5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol"
+BMGC_DG04844,BMG_DG111617,DrugBank ID:DB01766 | PubChem CID:185915 | CAS RN:58438-03-2 | UNII:W425Q6KV9R | 2-NAPHTHYLALANINE | Beta-(2-Naphthyl)-Alanine | PubChem SID:241179813
+BMGC_DG04845,BMG_DG111618,PubChem CID:18593 | UNII:AW9FQB8XRR | CAS RN:3225-97-6 | 1-AMINO-4-CHLORO-2-METHYLANTHRAQUINONE
+BMGC_DG04846,BMG_DG111631,SECALONIC ACID F | PubChem CID:185991 | UNII:48937PRF7X | CAS RN:60687-07-2 | PubChem SID:198961613
+BMGC_DG04847,BMG_DG111633,DrugBank ID:DB02897 | CAS RN:590-54-5 | PubChem CID:186 | ACETYLPHOSPHATE | PubChem SID:438788070 | phosphono acetate | Acetyl phosphate | Acetylphosphate | UNII:54979W5TJB
+BMGC_DG04848,BMG_DG111634,"5H-Cyclopenta(b)pyridine-6-carboxylic acid, 5-(1,3-benzodioxol-5-yl)-2-butyl-7-(2-((2S)-2-carboxypropyl)-4-methoxyphenyl)-6,7-dihydro-, (5S,6R,7R)- | UNII:N71Z6M3T0I | PubChem SID:252165076 | PubChem CID:186002 | CAS RN:224448-58-2 | J-104132 | (5S,6R,7R)-5-(1,3-benzodioxol-5-yl)-2-butyl-7-[2-[(2S)-2-carboxypropyl]-4-methoxyphenyl]-6,7-dihydro-5H-cyclopenta[b]pyridine-6-carboxylic acid | CAS RN:198279-45-7"
+BMGC_DG04849,BMG_DG111658,FURFURYLIDENEMALONONITRILE | CAS RN:3237-22-7 | UNII:L7FT4U2XXU | Furfurylidenemalononitrile | PubChem SID:474492097 | PubChem CID:18606
+BMGC_DG04850,BMG_DG111669,"acetic acid;[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate | CAS RN:71-58-9 | PubChem CID:18609376"
+BMGC_DG04851,BMG_DG111686,PubChem CID:186169 | PubChem SID:438788451 | N-(5-CHLORO-2-METHOXYPHENYL)-2-HYDROXY-3-NITROBENZAMIDE | UNII:H06U8IR75A | CAS RN:33581-05-4
+BMGC_DG04852,BMG_DG111727,"OCTACHLORODIBENZO-P-DIOXIN | Octachlorodibenzo-p-dioxin | UNII:YW59P10266 | 1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin | PubChem CID:18636 | PubChem SID:198934865 | CAS RN:3268-87-9"
+BMGC_DG04853,BMG_DG111734,N-[2-(6-hydroxy-5-methoxy-1H-indol-3-yl)ethyl]acetamide | PubChem CID:1864 | 6-HYDROXYMELATONIN | UNII:TV437T5077 | PubChem SID:252823985 | 6-Hydroxymelatonin | CAS RN:2208-41-5
+BMGC_DG04854,BMG_DG111751,"6-Hydroxypropylthymine | UNII:E5AK9SKZ52 | DrugBank ID:DB04139 | 6-(3-Hydroxypropyl)-5-methyl-2,4(1H,3H)-pyrimidinedione | CAS RN:156569-47-0 | 6-(3-HYDROXYPROPYL)-5-METHYL-2,4(1H,3H)-PYRIMIDINEDIONE | PubChem SID:485663509 | PubChem CID:1865"
+BMGC_DG04855,BMG_DG111795,UNII:RK7Y56WLV3 | PubChem SID:441583830 | 6-CHLORANYL-2-PYRIDIN-2-YL-1H-BENZIMIDAZOLE | CAS RN:63053-15-6 | PubChem CID:186763
+BMGC_DG04856,BMG_DG111800,"PubChem CID:1868 | CAS RN:20315-68-8 | 6-methoxy-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole | 6-METHOXYTRYPTOLINE | UNII:BR3W85U4GS | PubChem SID:472390435"
+BMGC_DG04857,BMG_DG111823,"Aflatoxin B1 | CAS RN:10279-73-9 | AFLATOXIN B1 | (3S,7R)-11-methoxy-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,4,9,11,13(17)-pentaene-16,18-dione | CAS RN:1162-65-8 | PubChem SID:198974563 | NDC:43857-0547 | PubChem CID:186907 | UNII:9N2N2Y55MH"
+BMGC_DG04858,BMG_DG111836,Acetylcholine | PubChem CID:187 | DrugBank ID:DB03128 | CAS RN:51-84-3 | UNII:N9YNS0M02X | CAS RN:14047-05-3 | PubChem SID:175267065 | 2-acetyloxyethyl(trimethyl)azanium | ACETYLCHOLINE
+BMGC_DG04859,BMG_DG111843,"CAS RN:148714-88-9 | EMD-53998, (-)- | UNII:3U8DR83SGS | UNII:3L67D8JK8X | EMD-53998 | UNII:Q66R347ATA | PubChem CID:187079 | PubChem SID:316914113 | CAS RN:120223-04-3 | CAS RN:147527-31-9 | 5-[1-(3,4-dimethoxybenzoyl)-3,4-dihydro-2H-quinolin-6-yl]-6-methyl-3,6-dihydro-1,3,4-thiadiazin-2-one | EMD-53998, (+)- | PubChem SID:441097536 | PubChem SID:441096726"
+BMGC_DG04860,BMG_DG111861,"1-(1,2-DIBROMOETHYL)-3,4-DIBROMOCYCLOHEXANE | CAS RN:3322-93-8 | 1,2-Dibromo-4-(1,2-dibromoethyl)cyclohexane | PubChem SID:198949616 | 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane | PubChem CID:18728 | UNII:502D5Q149T"
+BMGC_DG04861,BMG_DG111867,"UNII:A77U8G9H84 | PubChem CID:18735 | CAS RN:125-55-3 | ENIBOMAL | PubChem SID:198959861 | DrugBank ID:DB13229 | Narcobarbital | 5-(2-bromoprop-2-enyl)-1-methyl-5-propan-2-yl-1,3-diazinane-2,4,6-trione"
+BMGC_DG04862,BMG_DG111869,"DrugBank ID:DB11860 | UNII:QE1Q24M65Y | PubChem CID:18738120 | (4R)-4-[(3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-dihydroxy-3-(icosanoylamino)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | Aramchol | ICOMIDOCHOLIC ACID | CAS RN:246529-22-6 | PubChem SID:198952611"
+BMGC_DG04863,BMG_DG111880,"PubChem CID:18753314 | 4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3-yl]piperazine-1-carboxamide"
+BMGC_DG04864,BMG_DG111884,3-METHYL-1-(3'-CHLOROPHENYL)-2-PYRAZOLIN-5-ONE | PubChem CID:18756420 | PubChem SID:317229056 | CAS RN:90-31-3 | UNII:76806T6L7I
+BMGC_DG04865,BMG_DG111903,"PubChem CID:18770812 | UNII:V6353DJC6Q | PubChem SID:459276090 | 6,7-DIMETHOXY-4-(2-PHENYLETHYNYL)QUINAZOLINE | CAS RN:167410-40-4"
+BMGC_DG04866,BMG_DG111927,"(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-[4-[(6-methoxypyridazin-3-yl)sulfamoyl]anilino]methanesulfonic acid | Sulfamazone | UNII:D7B8U8VA9J | DrugBank ID:DB13556 | CAS RN:65761-24-2 | PubChem SID:198980631 | PubChem CID:187764 | SULFAMAZONE"
+BMGC_DG04867,BMG_DG111956,"DrugBank ID:DB07050 | 5-(benzenesulfonamido)-1,3,4-thiadiazole-2-sulfonamide | PubChem CID:18794 | Benzolamide | UNII:FC5AAH89R5 | PubChem SID:198939969 | BENZOLAMIDE | CAS RN:3368-13-6 | 5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide"
+BMGC_DG04868,BMG_DG111959,"PubChem SID:363909276 | UNII:AZW7UG6S0K | PubChem CID:187970 | CAS RN:60287-96-9 | 3-METHYLDIBENZ(B,F)(1,4)OXAZEPINE"
+BMGC_DG04869,BMG_DG111961,"7,8-DIHYDROXYFLAVONE | CAS RN:38183-03-8 | UNII:ADB6MA8ZV2 | PubChem CID:1880 | PubChem SID:404859814"
+BMGC_DG04870,BMG_DG111974,"DrugBank ID:DB07862 | PubChem CID:1881 | 7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE"
+BMGC_DG04871,BMG_DG111987,PubChem CID:1882 | 7-(CHLOROETHYL)THEOPHYLLINE | UNII:Y7202UN6B7 | CAS RN:5878-61-5 | PubChem SID:198960061
+BMGC_DG04872,BMG_DG111993,"PubChem CID:1882365 | 2-amino-N-cyclopentyl-1-(3-methoxypropyl)pyrrolo[3,2-b]quinoxaline-3-carboxamide | SIRT1 Activator 3"
+BMGC_DG04873,BMG_DG112003,7-AMINOCLONAZEPAM | CAS RN:4959-17-5 | PubChem SID:198972206 | PubChem CID:188298 | UNII:17D6640Q7Y
+BMGC_DG04874,BMG_DG112010,"Cirsimaritin | UNII:F59VJ7UX6B | 5-hydroxy-2-(4-hydroxyphenyl)-6,7-dimethoxychromen-4-one | CIRSIMARITIN | CAS RN:6601-62-3 | PubChem CID:188323 | PubChem SID:459056177"
+BMGC_DG04875,BMG_DG112013,DrugBank ID:DB04121 | Guanosine-3'-monophosphate-5'-diphosphate | PubChem CID:188347
+BMGC_DG04876,BMG_DG112015,DrugBank ID:DB02933 | PubChem CID:188350 | 5'-Deoxy-5'-(Methylthio)-Tubercidin
+BMGC_DG04877,BMG_DG112025,"CAS RN:3401-80-7 | 3,6-DICHLOROSALICYLIC ACID | 3,6-Dichloro-2-hydroxybenzoic acid | 3,6-dichloro-2-hydroxybenzoic acid | PubChem SID:198939107 | PubChem CID:18844 | UNII:4YBF44H2O7"
+BMGC_DG04878,BMG_DG112030,METHOPROMAZINE | PubChem SID:198983584 | CAS RN:61-01-8 | PubChem CID:18847 | UNII:A6F645Q9HQ
+BMGC_DG04879,BMG_DG112043,CAS RN:3408-21-7 | UNII:C00JE2LO5P | PubChem CID:18869 | 1-BENZOYL-2-ISOPROPYLHYDRAZINE | PubChem SID:375579667
+BMGC_DG04880,BMG_DG112051,4-PHENOXYPIPERIDINE | UNII:AOF4M4L61Z | PubChem CID:18878 | PubChem SID:198950778 | CAS RN:3202-33-3
+BMGC_DG04881,BMG_DG112054,PubChem SID:198985475 | UNII:1W8M12WXYL | ISOSPAGLUMIC ACID | CAS RN:3106-85-2 | (2S)-2-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]pentanedioic acid | PubChem CID:188803 | Spaglumic acid
+BMGC_DG04882,BMG_DG112060,"7-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | 4H-1-Benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-(4-hydroxyphenyl)- | CAS RN:41680-09-5 | CAS RN:69097-97-8 | PubChem CID:1889"
+BMGC_DG04883,BMG_DG112061,BD-1047 | UNII:1S3X75QGDO | PubChem SID:198967679 | CAS RN:138356-20-4 | PubChem CID:188914
+BMGC_DG04884,BMG_DG112065,UNII:DO9M06BFRJ | PubChem SID:346539047 | CAS RN:178928-68-2 | 2-PHENYL-5-(4-((2-PYRIMIDINYL)-PIPERAZIN-1-YL)-METHYL)-IMIDAZOLE | PubChem CID:188942
+BMGC_DG04885,BMG_DG112073,"UNII:APQ916I0QD | DEOXYADENOSINE DIPHOSPHATE | 2'-Deoxyadenosine-5'-diphosphate | PubChem SID:314915347 | CAS RN:72003-83-9 | CAS RN:2793-06-8 | PubChem CID:188966 | [(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate"
+BMGC_DG04886,BMG_DG112086,"7-Hydroxyflavanone | 7-hydroxy-2-phenyl-2,3-dihydrochromen-4-one | PubChem CID:1890 | CAS RN:6515-36-2 | UNII:CC64495H41 | 7-HYDROXYFLAVANONE | CAS RN:41680-08-4 | PubChem SID:316913577"
+BMGC_DG04887,BMG_DG112091,(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid | CAS RN:7763-65-7 | Histidylleucine | PubChem CID:189008
+BMGC_DG04888,BMG_DG112098,PubChem SID:478837032 | UNII:C46YDH55ZN | PubChem CID:189061 | PROCURCUMENOL | CAS RN:21698-40-8
+BMGC_DG04889,BMG_DG112106,PubChem SID:440794028 | S-FORMYLGLUTATHIONE | CAS RN:50409-81-9 | UNII:3U89C4DNE8 | S-Formylglutathione | PubChem CID:189122 | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-formylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
+BMGC_DG04890,BMG_DG112110,"DrugBank ID:DB02512 | 1,6-Fructose Diphosphate (Linear Form) | PubChem CID:189150"
+BMGC_DG04891,BMG_DG112116,"7-(2-hydroxyethyl)-1,3-dimethylpurine-2,6-dione | PubChem SID:198964251 | PubChem CID:1892 | ETOFYLLINE | UNII:L164909TBI | Etofylline | CAS RN:519-37-9"
+BMGC_DG04892,BMG_DG112140,UNII:UX0N37CMVH | PubChem CID:1893 | PubChem SID:198947986 | 7-nitro-1H-indazole | CAS RN:909091-71-0 | DrugBank ID:DB02207 | 7-Nitroindazole | 7-NITROINDAZOLE | CAS RN:2942-42-9
+BMGC_DG04893,BMG_DG112150,PubChem CID:1893668 | UNII:KPC5K8BPP7 | TG-003 | CAS RN:719277-26-6 | PubChem SID:472423992
+BMGC_DG04894,BMG_DG112157,PubChem CID:1894 | 7-Nitroindazole-2-Carboxamidine | DrugBank ID:DB03065
+BMGC_DG04895,BMG_DG112176,"PubChem CID:18950 | D-Mannose | (3S,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol | CAS RN:530-26-7 | CAS RN:46032-76-2"
+BMGC_DG04896,BMG_DG112189,"NDC:43547-525 | DEXNEBIVOLOL | NDC:71335-2516 | CAS RN:118457-15-1 | CAS RN:118457-14-0 | PubChem SID:175272187 | NDC:43547-526 | NEBIVOLOL | NDC:50090-7301 | PubChem SID:198946903 | (1R)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-[[(2R)-2-[(2R)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl]amino]ethanol | NDC:70518-4032 | NDC:50090-7185 | PubChem CID:189562 | UNII:I43D0296P8 | UNII:030Y90569U | NDC:63629-9589 | NDC:72189-592 | NDC:43547-524 | NDC:71335-2443 | Dexnebivolol | NDC:43547-527"
+BMGC_DG04897,BMG_DG112211,UNII:X3MM60SOVP | PubChem CID:189729 | Ceronapril | PubChem SID:198974128 | CAS RN:111223-26-8 | (2S)-1-[(2S)-6-amino-2-[hydroxy(4-phenylbutyl)phosphoryl]oxyhexanoyl]pyrrolidine-2-carboxylic acid | CERONAPRIL | CAS RN:428863-50-7 | CAS RN:120122-26-1
+BMGC_DG04898,BMG_DG112218,2-[(2-Butoxypyrimidin-4-yl)amino]benzoic acid | PubChem CID:1897784 | UNII:R47LH539SD | CAS RN:324778-34-9 | PubChem SID:478838363 | 2-((2-BUTOXYPYRIMIDIN-4-YL)AMINO)BENZOIC ACID
+BMGC_DG04899,BMG_DG112222,"NDC:0832-0817 | NDC:52856-501 | NDC:0832-0816 | UNII:KR5YZ6AE4B | NDC:0832-0815 | PubChem SID:175266945 | NDC:52856-505 | PubChem CID:189821 | NDC:52856-502 | CAS RN:14484-47-0 | NDC:59651-600 | NDC:59651-599 | NDC:52856-503 | NDC:0832-0814 | DEFLAZACORT | DrugBank ID:DB11921 | NDC:52856-504 | [2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-6,9,13-trimethyl-16-oxo-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-8-yl]-2-oxoethyl] acetate | Deflazacort | NDC:27808-249 | NDC:59651-602 | NDC:59651-601"
+BMGC_DG04900,BMG_DG112226,"3-(2,3,4,5-tetrahydropyridin-6-yl)pyridine | CAS RN:3471-05-4 | UNII:DYE103K23I | PubChem CID:18985 | ANABASEINE | PubChem SID:316913751 | Anabaseine"
+BMGC_DG04901,BMG_DG112229,5-Methoxyindole-3-acetic acid | 5-METHOXYINDOLEACETIC ACID | CAS RN:142396-09-6 | 2-(5-methoxy-1H-indol-3-yl)acetic acid | UNII:MSN7CK6ETH | PubChem SID:461434562 | PubChem CID:18986 | CAS RN:3471-31-6
+BMGC_DG04902,BMG_DG112231,BISFENAZONE | CAS RN:55837-24-6 | PubChem SID:198948400 | PubChem CID:189866 | UNII:3OA32ZIB31
+BMGC_DG04903,BMG_DG112249,"CAS RN:3475-65-8 | THIAMINE TRIPHOSPHORATE | PubChem SID:198975255 | [[2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate | UNII:464M6AQ7IV | Thiamine triphosphorate | PubChem CID:18989"
+BMGC_DG04904,BMG_DG112251,BUTEDRONIC ACID | CAS RN:51395-42-7 | PubChem CID:189891 | UNII:26PB1U68YF | PubChem SID:198990413
+BMGC_DG04905,BMG_DG112252,"N-(4-DIMETHYLAMINO-3,5-DINITROPHENYL)MALEIMIDE | CAS RN:3475-74-9 | PubChem CID:18990 | UNII:FS6SN3F7XE"
+BMGC_DG04906,BMG_DG112273,"UNII:70D5FBB392 | CAS RN:27138-57-4 | DrugBank ID:DB01672 | PubChem CID:19 | 2,3-dihydroxybenzoic acid | 2,3-Dihydroxybenzoic acid | CAS RN:303-38-8 | 2,3-Dihydroxy-Benzoic Acid | 2,3-DIHYDROXY BENZOIC ACID | PubChem SID:198943444"
+BMGC_DG04907,BMG_DG112274,NDC:0942-9398 | NDC:0942-6326 | NDC:14537-832 | CAS RN:134461-75-9 | CAS RN:66224-66-6 | UNII:JAC85A2161 | NDC:0942-6316 | NDC:0942-6320 | CAS RN:134434-49-4 | PubChem SID:175268060 | NDC:14537-833 | NDC:0942-6322 | NDC:0942-9394 | NDC:53877-109 | NDC:14537-826 | NDC:14537-828 | CAS RN:134434-48-3 | CAS RN:71660-29-2 | Adenine | NDC:53877-110 | NDC:0942-6305 | NDC:14537-834 | NDC:23731-7000 | DrugBank ID:DB00173 | 7H-purin-6-amine | ADENINE | PubChem CID:190 | NDC:14537-966 | CAS RN:71660-30-5 | NDC:14537-824 | NDC:0942-6307 | NDC:0942-9393 | NDC:53157-136 | NDC:0942-6312 | NDC:53877-108 | NDC:53157-736 | CAS RN:134454-76-5 | NDC:0942-6308 | CAS RN:73-24-5
+BMGC_DG04908,BMG_DG112279,"PubChem SID:198937842 | Cyclacillin | (2S,5R,6R)-6-[(1-aminocyclohexanecarbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | CAS RN:3485-14-1 | UNII:72ZJ154X86 | CYCLACILLIN | DrugBank ID:DB01000 | PubChem CID:19003"
+BMGC_DG04909,BMG_DG112285,"UNII:G50C034217 | PALMATINE | Palmatine | CAS RN:3486-67-7 | PubChem SID:175265606 | PubChem CID:19009 | 2,3,9,10-tetramethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium"
+BMGC_DG04910,BMG_DG112291,"1-((3,4-DICHLOROPHENYL)METHYL)INDOLE-2,3-DIONE | CAS RN:79183-19-0 | UNII:RSY8DE8DGH | PubChem CID:1901244 | PubChem SID:441658698"
+BMGC_DG04911,BMG_DG112350,IPROCLOZIDE | PubChem SID:198948872 | PubChem CID:19063 | DrugBank ID:DB09247 | 2-(4-chlorophenoxy)-N'-propan-2-ylacetohydrazide | Iproclozide | UNII:1II9D6CB3J | CAS RN:3544-35-2
+BMGC_DG04912,BMG_DG112379,"PubChem CID:1908 | 4-(1,3-dimethyl-2,6-dioxo-7H-purin-8-yl)benzenesulfonic acid | 8-(4-Sulfophenyl)theophylline | CAS RN:80206-91-3"
+BMGC_DG04913,BMG_DG112380,PubChem CID:19080 | UNII:R9EB8YPL49 | CAS RN:3548-09-2 | 9-AMINO-6-CHLORO-2-METHOXYACRIDINE | 9-Amino-6-chloro-2-methoxyacridine | PubChem SID:474489787 | 6-chloro-2-methoxyacridin-9-amine
+BMGC_DG04914,BMG_DG112394,"(8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one | CAS RN:3562-63-8 | Megestrol | MEGESTROL | UNII:EA6LD1M70M | PubChem CID:19090 | PubChem SID:175267131"
+BMGC_DG04915,BMG_DG112395,"N-METHYL-N-(1-PHENYL-2-(1-PYRROLIDINYL)ETHYL)BENZENEACETAMIDE, (S)- | UNII:0G3RS2P5HF | CAS RN:157947-87-0 | PubChem SID:313184040 | PubChem CID:190901"
+BMGC_DG04916,BMG_DG112399,"CAS RN:86680-34-4 | 1,5-dihydroxy-2,3,4-trimethoxy-10-methylacridin-9-one | PubChem CID:19093029 | Citbrasine"
+BMGC_DG04917,BMG_DG112400,"DrugBank ID:DB01534 | PubChem CID:19094 | Chloralodol | PubChem SID:198946911 | CHLORALODOL | Chlorhexadol | UNII:W8RD4N93R2 | 2-methyl-4-(2,2,2-trichloro-1-hydroxyethoxy)pentan-2-ol | CAS RN:3563-58-4"
+BMGC_DG04918,BMG_DG112405,DIHYDROCARBAMAZEPINE | PubChem CID:19099 | UNII:EC017VA9FR | PubChem SID:198960197 | CAS RN:3564-73-6
+BMGC_DG04919,BMG_DG112413,PubChem CID:19103 | 5-Nitroso-8-hydroxyquinoline | HYDRON III | 5-nitrosoquinolin-8-ol | CAS RN:3565-26-2 | PubChem SID:374388659 | UNII:P302KW5VDN
+BMGC_DG04920,BMG_DG112451,PubChem SID:198959909 | UNII:KBU4V9QUHY | CAS RN:3571-71-9 | METATEROL | PubChem CID:19136
+BMGC_DG04921,BMG_DG112459,UNII:ZSJ254W6SF | PubChem CID:19142 | CAS RN:3572-74-5 | MOXASTINE | PubChem SID:198947159
+BMGC_DG04922,BMG_DG112460,"PubChem CID:19143 | PubChem SID:198987742 | CYCLAZOCINE | 10-(cyclopropylmethyl)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | UNII:J5W1B1159C | CAS RN:7346-09-0 | CAS RN:3572-80-3 | Cyclazocine"
+BMGC_DG04923,BMG_DG112461,DrugBank ID:DB03042 | PubChem CID:191445 | 5-Phosphoarabinonic Acid
+BMGC_DG04924,BMG_DG112464,"CAS RN:3577-01-3 | UNII:HD2D469W6U | DrugBank ID:DB00689 | (6R,7R)-3-(acetyloxymethyl)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem SID:198977000 | PubChem CID:19150 | Cephaloglycin | CEPHALOGLYCIN ANHYDROUS"
+BMGC_DG04925,BMG_DG112467,PubChem SID:198947756 | UNII:ATD81G944M | DrugBank ID:DB13286 | CAS RN:3583-64-0 | 2-[anilino(phenyl)carbamoyl]hexanoic acid | Bumadizone | BUMADIZONE | PubChem CID:19161
+BMGC_DG04926,BMG_DG112471,"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE | PubChem CID:1916699 | DrugBank ID:DB08788"
+BMGC_DG04927,BMG_DG112473,"8-Cyclopentyl-1,3-dimethylxanthine | PubChem SID:375578983 | 8-cyclopentyl-1,3-dimethyl-7H-purine-2,6-dione | UNII:U7PWT4CPL5 | PubChem CID:1917 | 8-CYCLOPENTYLTHEOPHYLLINE | CAS RN:35873-49-5"
+BMGC_DG04928,BMG_DG112484,CANNABIRIPSOL | PubChem CID:192007 | UNII:4P2CG6T3K9 | PubChem SID:459275680 | CAS RN:72236-32-9
+BMGC_DG04929,BMG_DG112493,"CAS RN:78393-43-8 | Prednefrin | PubChem CID:192155 | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate;3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride"
+BMGC_DG04930,BMG_DG112498,"PubChem SID:198976802 | UNII:10BI795R7D | Hexestrol | 4-[(3S,4R)-4-(4-hydroxyphenyl)hexan-3-yl]phenol | PubChem CID:192197 | HEXESTROL | DrugBank ID:DB07931 | CAS RN:84-16-2"
+BMGC_DG04931,BMG_DG112499,UNII:E6M543P3BL | 8-PHENYLTHEOPHYLLINE | PubChem SID:287446392 | CAS RN:961-45-5 | PubChem CID:1922
+BMGC_DG04932,BMG_DG112508,"CAS RN:99697-24-2 | Norursodeoxycholic acid | PubChem SID:198955617 | (3R)-3-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]butanoic acid | UNII:8A5G600D9V | NORUCHOLIC ACID | PubChem CID:192254"
+BMGC_DG04933,BMG_DG112510,PubChem CID:192280 | UNII:FG5VG9E6UY | 2-Ethyl-4-(3-pyridyl)-1(2H)-phthalazinone | PubChem SID:478838427 | 2-ETHYL-4-(3-PYRIDYL)-1(2H)-PHTHALAZINONE | CAS RN:137381-66-9
+BMGC_DG04934,BMG_DG112512,PubChem CID:1923 | quinolin-8-ol | OXYQUINOLINE | Oxyquinoline | UNII:5UTX5635HP | PubChem SID:175265362 | CAS RN:148-24-3 | DrugBank ID:DB11145
+BMGC_DG04935,BMG_DG112516,"UDP-xylose | [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl] hydrogen phosphate | UDP-alpha-D-xylose | DrugBank ID:DB01713 | CAS RN:3616-06-6 | PubChem CID:19235"
+BMGC_DG04936,BMG_DG112522,CAS RN:245365-80-4 | 1-(2-METHYL-6-BENZOTHIAZOLYL)-3-(1-(PHENYLMETHYL)-4-PIPERIDINYL)-1-PROPANONE | PubChem SID:348481042 | PubChem CID:192442 | UNII:VG83TH3J1J
+BMGC_DG04937,BMG_DG112527,"PubChem CID:19254 | UNII:3T5TIX1AYI | PubChem SID:198936644 | REPOSAL | Reposal | 5-(3-bicyclo[3.2.1]oct-2-enyl)-5-ethyl-1,3-diazinane-2,4,6-trione | DrugBank ID:DB13805 | CAS RN:3625-25-0"
+BMGC_DG04938,BMG_DG112528,UNII:PB0234915O | CAS RN:3625-52-3 | PubChem CID:19255 | LACCEROIC ACID | PubChem SID:198973252
+BMGC_DG04939,BMG_DG112541,PubChem CID:19266 | CAS RN:556-08-1 | ACEDOBEN | UNII:04Z20NMK31 | Acedoben | PubChem SID:198936404 | DrugBank ID:DB04500
+BMGC_DG04940,BMG_DG112544,"PubChem SID:198973052 | BUNTANETAP, (+/-)- | UNII:N8142NV8UM | [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-phenylcarbamate | Phenserine | DrugBank ID:DB04892 | CAS RN:159652-53-6 | PHENSERINE | CAS RN:101246-66-6 | BUNTANETAP, (±)- | UNII:SUE285UG3S | PubChem SID:198975219 | PubChem CID:192706"
+BMGC_DG04941,BMG_DG112545,PubChem SID:241180161 | UNII:58S83M36V6 | CNS-5161 | Cns-5161 | 2-(2-chloro-5-methylsulfanylphenyl)-1-methyl-1-(3-methylsulfanylphenyl)guanidine | PubChem CID:192711 | DrugBank ID:DB05824 | CAS RN:160754-76-7
+BMGC_DG04942,BMG_DG112546,DrugBank ID:DB05426 | Talactoferrin alfa | PubChem CID:192716
+BMGC_DG04943,BMG_DG112555,"PubChem CID:192735 | PubChem SID:198951207 | UNII:1644H18038 | CAS RN:1167-48-2 | 17,21-DIHYDROXYPREGNENOLONE | 1-[(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone | 17,21-Dihydroxypregnenolone"
+BMGC_DG04944,BMG_DG112572,"CAS RN:9005-82-7 | (2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | DrugBank ID:DB03277 | CAS RN:6401-81-6 | PubChem SID:472407161 | alpha-maltotriose | UNII:7TDQ74Y18L | CAS RN:1109-28-0 | PubChem CID:192826 | CAS RN:133137-05-0 | alpha-Maltotriose | AMYLOSE, UNSPECIFIED SOURCE"
+BMGC_DG04945,BMG_DG112573,CAS RN:6512-67-0 | THUJAPLICATIN METHYL ETHER | UNII:2VJD5SJF7V | PubChem CID:192827 | PubChem SID:318164296
+BMGC_DG04946,BMG_DG112585,UNII:7MWG08F2MG | 2-METHYL-9H-CARBAZOLE | CAS RN:3652-91-3 | PubChem SID:198963868 | PubChem CID:19290
+BMGC_DG04947,BMG_DG112622,9-N-Phenylmethylamino-Tacrine | PubChem CID:1933 | DrugBank ID:DB03672
+BMGC_DG04948,BMG_DG112624,UNII:B517ZPX7HX | (2S)-2-amino-5-oxopentanoic acid | CAS RN:2886-91-1 | (2S)-2-AMINO-5-OXOPENTANOIC ACID | DrugBank ID:DB04388 | CAS RN:496-92-4 | PubChem SID:438787927 | PubChem CID:193305 | 4-Carboxy-4-Aminobutanal
+BMGC_DG04949,BMG_DG112627,"PubChem SID:485663420 | 5-(2-Fluorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one | PubChem CID:193319 | CAS RN:844-11-1 | 5-(2-FLUOROPHENYL)-1-METHYL-3H-1,4-BENZODIAZEPIN-2-ONE | UNII:6ECU4C9VJT"
+BMGC_DG04950,BMG_DG112628,"PubChem CID:193321 | CAS RN:862-53-3 | 5beta-Cholestane-3alpha,7alpha,12alpha,26-tetrol | (3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-17-[(2R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol"
+BMGC_DG04951,BMG_DG112643,"CAS RN:4675-38-1 | CAS RN:192187-67-0 | 7alpha,26-Dihydroxycholest-4-en-3-one | (7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-17-[(2R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | PubChem CID:193396"
+BMGC_DG04952,BMG_DG112660,PubChem CID:193491 | DrugBank ID:DB02738 | Adenosine-5'-Pentaphosphate
+BMGC_DG04953,BMG_DG112667,"PubChem SID:175267172 | DrugBank ID:DB00382 | UNII:4VX7YNB537 | CAS RN:321-64-2 | 1,2,3,4-tetrahydroacridin-9-amine | TACRINE | Tacrine | PubChem CID:1935"
+BMGC_DG04954,BMG_DG112671,DrugBank ID:DB04203 | 3-Mercuri-4-Aminobenzenesulfonamide | PubChem CID:193512
+BMGC_DG04955,BMG_DG112675,"4alpha-Methylfecosterol | PubChem CID:193524 | CAS RN:17757-07-2 | (3S,4S,5S,10S,13R,14R,17R)-4,10,13-trimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | 4.ALPHA.-METHYLFECOSTEROL | 4α-Methylfecosterol | PubChem SID:474492462 | UNII:PKH3GWV3BE"
+BMGC_DG04956,BMG_DG112683,PubChem CID:193545 | 2-(1-methylimidazol-4-yl)acetaldehyde | CAS RN:19639-03-3 | Methylimidazole acetaldehyde
+BMGC_DG04957,BMG_DG112689,CAS RN:3054-01-1 | PubChem SID:316914014 | DrugBank ID:DB04531 | S-BENZYLCYSTEINE | UNII:9VRE13M548 | S-Benzylcysteine | PubChem CID:193613
+BMGC_DG04958,BMG_DG112690,CAS RN:194358-72-0 | UNII:7MV5OX2NX0 | PubChem CID:19363402 | JTE-7-31 | PubChem SID:312525179
+BMGC_DG04959,BMG_DG112694,CAS RN:186537-58-6 | CAS RN:638-23-3 | CARBOCYSTEINE | UNII:740J2QX53R | PubChem CID:193653 | DrugBank ID:DB04339 | Carbocisteine | CAS RN:1391068-19-1 | (2R)-2-amino-3-(carboxymethylsulfanyl)propanoic acid | Carbocysteine | PubChem SID:175267899
+BMGC_DG04960,BMG_DG112709,"Alcaftadine | NDC:58602-605 | PubChem CID:19371515 | ALCAFTADINE | UNII:7Z8O94ECSX | DrugBank ID:DB06766 | NDC:62332-147 | CAS RN:147084-10-4 | PubChem SID:175268090 | NDC:0023-4290 | 11-(1-methylpiperidin-4-ylidene)-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carbaldehyde | NDC:0023-4291 | NDC:68083-649 | CAS RN:1794775-80-6"
+BMGC_DG04961,BMG_DG112720,"CAS RN:38231-86-6 | 6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol | DrugBank ID:DB02120 | (1S,2S,3R,6S)-6-amino-4-(hydroxymethyl)cyclohex-4-ene-1,2,3-triol | Valienamine | PubChem CID:193758"
+BMGC_DG04962,BMG_DG112728,"S-[2-[3-[[4-[[[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-hydroxyoctadecanethioate | PubChem CID:193824 | 3-hydroxyoctadecanoyl-coenzyme A | CAS RN:42578-91-6"
+BMGC_DG04963,BMG_DG112749,DrugBank ID:DB11497 | UNII:V41BK2EE8X | CAS RN:3689-24-5 | diethoxyphosphinothioyloxy-diethoxy-sulfanylidene-lambda5-phosphane | SULFOTEP | PubChem CID:19395 | PubChem SID:198972671 | Sulfotep
+BMGC_DG04964,BMG_DG112755,"UNII:305MB38V1C | UNII:5GP9538P4S | 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine | DrugBank ID:DB13820 | PubChem SID:198938453 | PubChem SID:329589365 | PubChem CID:19396 | PubChem SID:329589056 | OXOMEMAZINE | CAS RN:174508-13-5 | CAS RN:174508-14-6 | UNII:Q824SGH3RN | OXOMEMAZINE, (-)- | CAS RN:3689-50-7 | Oxomemazine | OXOMEMAZINE, (+)-"
+BMGC_DG04965,BMG_DG112756,"NDC:59676-572 | NDC:60219-1721 | NDC:59676-571 | NDC:60219-1722 | NDC:59676-570 | NDC:80005-113 | NDC:69315-286 | DrugBank ID:DB06414 | NDC:69238-1721 | NDC:42291-474 | NDC:80005-112 | 4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile | CAS RN:269055-15-4 | PubChem CID:193962 | UNII:0C50HW4FO1 | NDC:42291-473 | NDC:69238-1722 | NDC:69238-1720 | NDC:69315-285 | PubChem SID:175265730 | ETRAVIRINE | CAS RN:394729-17-0 | NDC:60219-1720 | Etravirine"
+BMGC_DG04966,BMG_DG112771,"(2S,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-piperidin-1-yl-2-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]butanamide | PubChem CID:193987"
+BMGC_DG04967,BMG_DG112791,"PubChem CID:1941 | DrugBank ID:DB02636 | 9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid"
+BMGC_DG04968,BMG_DG112797,PubChem SID:316910629 | CAS RN:64199-78-6 | UNII:8LE3S4VZXX | PubChem CID:194183 | BARBINERVIC ACID
+BMGC_DG04969,BMG_DG112802,PubChem CID:1942 | CAS RN:14047-26-8 | UNII:ZUM52ZV2VD | 9-(2-HYDROXYPROPYL)ADENINE
+BMGC_DG04970,BMG_DG112805,2-(4-HYDROXY-3-METHOXYBENZYLIDENE)MALONONITRILE | UNII:YHV7VCM2BN | PubChem SID:482553720 | 2-(4-hydroxy-3-methoxybenzylidene)malononitrile | CAS RN:3696-12-6 | PubChem CID:19424
+BMGC_DG04971,BMG_DG112820,DrugBank ID:DB01689 | PubChem CID:1944 | Inhibitor Idd 384
+BMGC_DG04972,BMG_DG112825,CAS RN:72818-36-1 | 3-Isopropyl-3-(1-imidazolylmethyl)indole | UNII:XR92SXL6ZE | 3-ISOPROPYL-3-(1-IMIDAZOLYLMETHYL)INDOLE | PubChem CID:194468 | PubChem SID:474492370
+BMGC_DG04973,BMG_DG112829,UNII:PF467U2V7J | PubChem SID:443624707 | CGS-4270 | CAS RN:73631-29-5 | PubChem CID:194530
+BMGC_DG04974,BMG_DG112830,"(3R,5aS,6S,10aR)-6-hydroxy-3-(hydroxymethyl)-2-methyl-3,10a-bis(methylsulfanyl)-6,10-dihydro-5aH-pyrazino[1,2-a]indole-1,4-dione | PubChem CID:194564 | Bisdethiobis(methylthio)gliotoxin | CAS RN:74149-38-5"
+BMGC_DG04975,BMG_DG112852,PubChem CID:194777 | CAS RN:108383-58-0 | DrugBank ID:DB08403 | METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID | (2R)-N'-hydroxy-N-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-2-(2-methylpropyl)butanediamide | Methylamino-phenylalanyl-leucyl-hydroxamic acid
+BMGC_DG04976,BMG_DG112853,[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DrugBank ID:DB07986 | PubChem CID:1948
+BMGC_DG04977,BMG_DG112856,PubChem SID:474490066 | Ro-48-8071 | UNII:YDR69X9Q9M | DrugBank ID:DB02016 | CAS RN:161582-11-2 | R048-8071 | RO-48-8071 | PubChem CID:1949
+BMGC_DG04978,BMG_DG112858,"PubChem SID:175271856 | PubChem CID:19493 | TRANYLCYPROMINE | (1R,2S)-2-phenylcyclopropan-1-amine | CAS RN:95-62-5 | CAS RN:155-09-9 | CAS RN:3721-26-4 | Tranylcypromine | UNII:3E3V44J4Z9"
+BMGC_DG04979,BMG_DG112862,"9'-fluoro-10'-(4-methyl-1-piperazinyl)-7'-oxospiro(cyclopropane-1,3'(2'H)-(7H)pyrido(1,2,3-de)(1,4)benzoxazine)-6'-carboxylic acid | PubChem CID:194999 | 7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxospiro[4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-2,1'-cyclopropane]-11-carboxylic acid | CAS RN:113211-53-3"
+BMGC_DG04980,BMG_DG112879,DrugBank ID:DB03098 | PubChem CID:1952 | [Methylseleno]Acetate
+BMGC_DG04981,BMG_DG112886,"CAS RN:3736-08-1 | FENETHYLLINE | PubChem SID:198967557 | CAS RN:765207-54-3 | Fenethylline | FENETHYLLINE, (-)- | PubChem SID:440089235 | DrugBank ID:DB01482 | PubChem SID:440088689 | PubChem CID:19527 | CAS RN:802018-96-8 | 1,3-dimethyl-7-[2-(1-phenylpropan-2-ylamino)ethyl]purine-2,6-dione | UNII:76284FBU6H | FENETHYLLINE, (+)- | UNII:YZ0N7VL5R3 | UNII:CP55WHR66R"
+BMGC_DG04982,BMG_DG112889,"UNII:YP4N72IW34 | PubChem CID:19529 | CAS RN:3736-81-0 | PubChem SID:198982485 | DILOXANIDE FUROATE | Diloxanide furoate | [4-[(2,2-dichloroacetyl)-methylamino]phenyl] furan-2-carboxylate | DrugBank ID:DB14638"
+BMGC_DG04983,BMG_DG112892,"UNII:PS3UC84IQA | DrugBank ID:DB08077 | PubChem CID:195347 | 2-(4-((3,5-DICHLOROPHENYL)CARBAMOYLAMINO)PHENOXY)-2-METHYLPROPANOIC ACID | 2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID | PubChem SID:440089761 | CAS RN:121809-80-1"
+BMGC_DG04984,BMG_DG112895,PubChem SID:272993897 | CAS RN:3739-38-6 | UNII:69DC2655VH | 3-Phenoxybenzoic acid | 3-PHENOXYBENZOIC ACID | 3-phenoxybenzoic acid | PubChem CID:19539
+BMGC_DG04985,BMG_DG112914,"DrugBank ID:DB05830 | (7R)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one | PubChem CID:19582 | CID 19582 | Trestolone"
+BMGC_DG04986,BMG_DG112926,"PubChem CID:19592 | Nafenopin | UNII:093W78U96W | NAFENOPIN | 2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid | PubChem SID:198935089 | CAS RN:3771-19-5"
+BMGC_DG04987,BMG_DG112930,4-amino-N-(6-methoxy-2-methylpyrimidin-4-yl)benzenesulfonamide | Sulfametomidine | UNII:940ZL3AHKB | PubChem CID:19596 | DrugBank ID:DB13485 | CAS RN:3772-76-7 | SULFAMETOMIDINE | PubChem SID:198988082
+BMGC_DG04988,BMG_DG112982,"N-(5-nitro-1,3-thiazol-2-yl)thiophene-2-carboxamide | UNII:PBQ7WLE1WP | DrugBank ID:DB13659 | CAS RN:3810-35-3 | Tenonitrozole | PubChem SID:198965383 | PubChem CID:19646 | TENONITROZOLE"
+BMGC_DG04989,BMG_DG112985,PubChem SID:198987398 | UNII:9BKY99A8HJ | PubChem CID:196473 | CAS RN:4271-30-1 | N-(P-AMINOBENZOYL)GLUTAMIC ACID
+BMGC_DG04990,BMG_DG112988,"DrugBank ID:DB01082 | STREPTOMYCIN | PubChem SID:175267935 | PubChem CID:19649 | 2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine | CAS RN:57-92-1 | UNII:Y45QSO73OB | Streptomycin"
+BMGC_DG04991,BMG_DG113004,NDC:48951-3007 | NDC:48951-3269 | UNII:7UJQ5OPE7D | Carbonate Ion | CARBONATE ION | NDC:48951-3006 | PubChem CID:19660 | NDC:48951-4195 | DrugBank ID:DB14531 | carbonate | NDC:48951-3167 | NDC:48951-3225 | PubChem SID:175266842 | CAS RN:3812-32-6
+BMGC_DG04992,BMG_DG113013,PubChem CID:196672 | DB-03376 | CAS RN:112921-04-7 | 5'-O-(N-(Alanyl)sulfamoyl)adenosine | DrugBank ID:DB03376 | PubChem SID:313183627 | UNII:48GG0U2X78
+BMGC_DG04993,BMG_DG113026,"[4,5-bis(4-methoxyphenyl)-1,3-thiazol-2-yl]-(4-methylpiperazin-1-yl)methanone | FR122047 | PubChem CID:196841"
+BMGC_DG04994,BMG_DG113042,.DELTA.4-ABIRATERONE | PubChem SID:474492931 | CAS RN:154229-21-7 | PubChem CID:196941 | UNII:Z2L6XS2R7H
+BMGC_DG04995,BMG_DG113045,4-(4-fluoronaphthalen-1-yl)-6-propan-2-ylpyrimidin-2-amine | 4-(4-Fluoronaphthalen-1-yl)-6-isopropylpyrimidin-2-amine | PubChem CID:196968 | CAS RN:199864-87-4 | MT-500 | UNII:0JAU3P8OBM | PubChem SID:241179982
+BMGC_DG04996,BMG_DG113046,PubChem CID:196970 | UNII:TVH5K7949N | CAS RN:289483-69-8 | E-7820 | PubChem SID:198940922 | 3-cyano-N-(3-cyano-4-methyl-1H-indol-7-yl)benzenesulfonamide | DrugBank ID:DB12505 | N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide
+BMGC_DG04997,BMG_DG113050,"CAS RN:518-83-2 | PubChem CID:196978 | 1,3-dihydroxyanthracene-9,10-dione | 1,3-DIHYDROXYANTHRAQUINONE | PubChem SID:198948165 | UNII:9RBB2G1GQB | 1,3-Dihydroxyanthraquinone"
+BMGC_DG04998,BMG_DG113051,PubChem CID:196979 | FRANGULIN A | PubChem SID:198938712 | CAS RN:521-62-0 | UNII:HXU301W02A
+BMGC_DG04999,BMG_DG113059,PubChem SID:198959956 | NANTENINE | PubChem CID:197001 | CAS RN:2565-01-7 | UNII:XE0AU8C122
+BMGC_DG05000,BMG_DG113069,"N(4)-Hydroxycytidine | N4-HYDROXYCYTIDINE | CAS RN:3258-02-4 | PubChem CID:197020 | UNII:C3D11PV2O4 | PubChem SID:404859908 | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one"
+BMGC_DG05001,BMG_DG113079,"Latrepirdine | UNII:OD9237K1Z6 | CAS RN:1227953-42-5 | PubChem CID:197033 | 2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-3,4-dihydro-1H-pyrido[4,3-b]indole | DrugBank ID:DB11725 | LATREPIRDINE | PubChem SID:198968507 | CAS RN:3613-73-8"
+BMGC_DG05002,BMG_DG113139,"PubChem CID:1972 | Ambisome | CAS RN:1397-89-3 | 33-(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid"
+BMGC_DG05003,BMG_DG113149,"GADOBENATE DIMEGLUMINE | CAS RN:127000-20-8 | UNII:3Q6PPC19PO | PubChem SID:318691801 | NDC:0270-5164 | Meglumine gadobenate | 2-[2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]-3-phenylmethoxypropanoate;gadolinium(3+);hydron;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol | PubChem CID:197281 | NDC:0270-5264"
+BMGC_DG05004,BMG_DG113151,"5-(3-bromophenyl)-7-(6-morpholin-4-ylpyridin-3-yl)pyrido[2,3-d]pyrimidin-4-amine | PubChem SID:198962337 | PubChem CID:1973 | ABT-702 | UNII:2P206WS5B3 | Abt 702 | CAS RN:214697-26-4"
+BMGC_DG05005,BMG_DG113185,FUBERIDAZOLE | CAS RN:3878-19-1 | 2-(furan-2-yl)-1H-benzimidazole | CAS RN:101575-84-2 | UNII:RXD450F6C7 | PubChem SID:198957835 | Fuberidazole | PubChem CID:19756
+BMGC_DG05006,BMG_DG113201,PubChem CID:19764 | N-LAURYLACETAMIDE | PubChem SID:376071989 | UNII:63S7IEZ5KS | CAS RN:3886-80-4
+BMGC_DG05007,BMG_DG113208,"8-Chloro-1,2,3,4-tetrahydro-9-acridinamine | UNII:LQ2J553F8W | 8-CHLORO-1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE | PubChem CID:19770285 | PubChem SID:472421973 | CAS RN:122994-74-5"
+BMGC_DG05008,BMG_DG113211,"UNII:7B43003091 | PubChem CID:197712 | AMBRISENTAN, (+/-)- | PubChem SID:198977888 | AMBRISENTAN, (±)- | CAS RN:713516-99-5"
+BMGC_DG05009,BMG_DG113242,PubChem CID:1978 | UNII:67P356D8GH | ACEBUTOLOL | CAS RN:28197-63-9 | Acebutolol | DrugBank ID:DB01193 | N-[3-acetyl-4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]butanamide | CAS RN:37517-30-9 | PubChem SID:175272193
+BMGC_DG05010,BMG_DG113252,PubChem SID:198987200 | HYDRASTINE | PubChem CID:197835 | CAS RN:118-08-1 | UNII:8890V3217X
+BMGC_DG05011,BMG_DG113258,ADIPHENINE METHYL BROMIDE | PubChem SID:198937296 | UNII:2OVU84VI37 | PubChem CID:197841 | CAS RN:6113-04-8
+BMGC_DG05012,BMG_DG113285,PubChem SID:198981323 | Aceclidine | DrugBank ID:DB13262 | ACECLIDINE | UNII:0578K3ELIO | PubChem CID:1979 | 1-azabicyclo[2.2.2]octan-3-yl acetate | CAS RN:827-61-2
+BMGC_DG05013,BMG_DG113351,DrugBank ID:DB13783 | UNII:5V141XK28X | 2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid | PubChem SID:198982033 | CAS RN:53164-05-9 | PubChem CID:1981 | Acemetacin | ACEMETACIN
+BMGC_DG05014,BMG_DG113395,DrugBank ID:DB07038 | CAS RN:10286-53-0 | 2-(CYCLOHEXYLAMINO)BENZOIC ACID | PubChem SID:443625020 | 2-(cyclohexylamino)benzoic acid | PubChem CID:19826721 | UNII:B519KGK87P
+BMGC_DG05015,BMG_DG113404,"3,4-DIHYDROXY-5-METHOXYBENZOIC ACID | UNII:8JA4OZ7166 | 3,4-dihydroxy-5-methoxybenzoic acid | 3,4-Dihydroxy-5-methoxybenzoic acid | PubChem CID:19829 | PubChem SID:198965825 | CAS RN:3934-84-7"
+BMGC_DG05016,BMG_DG113409,PubChem CID:1983 | CAS RN:103-90-2 | ACETAMINOPHEN | Acetaminophen | DrugBank ID:DB00316 | N-(4-hydroxyphenyl)acetamide | UNII:362O9ITL9D | PubChem SID:175267138
+BMGC_DG05017,BMG_DG113439,PubChem SID:241178878 | UNII:2HXG8QSO3D | DrugBank ID:DB08711 | METHYL VANILLATE | PubChem CID:19844 | Methyl vanillate | CAS RN:3943-74-6
+BMGC_DG05018,BMG_DG113462,PubChem SID:198945653 | PubChem CID:1985 | DrugBank ID:DB13268 | UNII:806529YU1N | ACETARSOL | (3-acetamido-4-hydroxyphenyl)arsonic acid | CAS RN:97-44-9 | Acetarsol
+BMGC_DG05019,BMG_DG113493,"NDC:70710-1238 | NDC:81005-104 | NDC:29033-030 | NDC:63739-257 | NDC:23155-288 | NDC:72888-047 | NDC:51672-4022 | NDC:51672-4023 | PubChem SID:175268295 | PubChem CID:1986 | NDC:72162-1979 | NDC:81005-105 | NDC:42291-089 | NDC:72162-1978 | NDC:65841-762 | NDC:55289-720 | NDC:10135-772 | NDC:70710-1591 | NDC:23155-287 | NDC:71205-308 | NDC:10135-773 | NDC:23155-787 | NDC:70954-034 | NDC:71930-009 | CAS RN:59-66-5 | NDC:62332-349 | NDC:27241-133 | NDC:60687-619 | NDC:72578-150 | NDC:72789-237 | NDC:70771-1827 | NDC:71335-2215 | NDC:69367-209 | NDC:62135-612 | NDC:70756-720 | DrugBank ID:DB00819 | NDC:72888-048 | NDC:46708-349 | NDC:63629-1195 | NDC:70710-1239 | NDC:27241-132 | NDC:60687-578 | NDC:72789-045 | NDC:71930-008 | NDC:50268-054 | NDC:16729-331 | NDC:63629-1194 | NDC:51655-331 | NDC:64380-834 | NDC:50090-5617 | NDC:50090-5593 | NDC:52817-201 | NDC:70771-1828 | NDC:70954-033 | NDC:62135-608 | NDC:68071-3632 | NDC:62135-607 | NDC:72578-149 | CAS RN:124442-28-0 | NDC:50742-233 | NDC:52817-200 | NDC:42571-243 | NDC:50090-5945 | NDC:72789-238 | NDC:68071-3728 | NDC:71335-9729 | ACETAZOLAMIDE | NDC:42291-090 | NDC:70756-721 | UNII:O3FX965V0I | Acetazolamide | NDC:64380-833 | NDC:50268-042 | NDC:0904-6663 | N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide"
+BMGC_DG05020,BMG_DG113500,"CAS RN:3964-81-6 | AZATADINE | UNII:94Z39NID6C | PubChem SID:198960451 | PubChem CID:19861 | Azatadine | DrugBank ID:DB00719 | 2-(1-methylpiperidin-4-ylidene)-4-azatricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaene"
+BMGC_DG05021,BMG_DG113517,"PubChem SID:198975784 | CAS RN:110283-79-9 | UNII:4HVE799MEJ | 1-[2-[bis[4-(trifluoromethyl)phenyl]methoxy]ethyl]-3,6-dihydro-2H-pyridine-5-carboxylic acid | CI-966 FREE BASE | PubChem CID:198693"
+BMGC_DG05022,BMG_DG113538,"5-(3-((2S)-(1,4-Benzodioxan-2-ylmethyl)amino)propoxy)-1,3-benzodioxol hydrochloride | MN-305 | CAS RN:137275-80-0 | UNII:F0WKFYPQL8 | OSEMOZOTAN HYDROCHLORIDE | 3-(1,3-benzodioxol-5-yloxy)-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propan-1-amine;hydrochloride | PubChem CID:198746 | PubChem SID:363907868 | DrugBank ID:DB05339"
+BMGC_DG05023,BMG_DG113541,"PubChem CID:198752 | DrugBank ID:DB04859 | 3-(1-benzylpiperidin-4-yl)-1-(2,3,4,5-tetrahydro-1H-1-benzazepin-8-yl)propan-1-one | ZANAPEZIL | PubChem SID:198953565 | Zanapezil | CAS RN:142852-50-4 | UNII:0A0800O89N"
+BMGC_DG05024,BMG_DG113543,"UNII:05PB82Z52L | REPINOTAN | PubChem CID:198757 | 2-[4-[[(2R)-3,4-dihydro-2H-chromen-2-yl]methylamino]butyl]-1,1-dioxo-1,2-benzothiazol-3-one | PubChem SID:198975668 | DrugBank ID:DB06506 | Repinotan | CAS RN:144980-29-0"
+BMGC_DG05025,BMG_DG113578,PubChem CID:1989 | DrugBank ID:DB00414 | Acetohexamide | ACETOHEXAMIDE | CAS RN:968-81-0 | UNII:QGC8W08I6I | PubChem SID:198955498 | CAS RN:2468796-77-0 | 1-(4-acetylphenyl)sulfonyl-3-cyclohexylurea
+BMGC_DG05026,BMG_DG113589,PubChem CID:199 | UNII:70J407ZL5Q | Agmatine | 2-(4-aminobutyl)guanidine | AGMATINE | PubChem SID:198959565 | CAS RN:306-60-5 | DrugBank ID:DB08838
+BMGC_DG05027,BMG_DG113590,Acetohydroxamic acid | Acetohydroxamic Acid | ACETOHYDROXAMIC ACID | PubChem CID:1990 | UNII:4RZ82L2GY5 | DrugBank ID:DB00551 | CAS RN:546-88-3 | N-hydroxyacetamide | PubChem SID:175268351
+BMGC_DG05028,BMG_DG113595,CAS RN:109485-43-0 | 1-((3-FLUOROPHENYL)METHYL)IMIDAZOLE | UNII:YM9TAM8D25 | PubChem CID:19902087
+BMGC_DG05029,BMG_DG113602,UNII:A8M33244M6 | NITROXOLINE | PubChem CID:19910 | Nitroxoline | PubChem SID:198955868 | DrugBank ID:DB01422 | CAS RN:4008-48-4 | 5-nitroquinolin-8-ol
+BMGC_DG05030,BMG_DG113615,PubChem SID:475550280 | (2-Chlorophenyl)methyl carbamimidothioate | PubChem CID:199162 | UNII:V2BL3DVA7L | (2-CHLOROPHENYL)METHYL CARBAMIMIDOTHIOATE | CAS RN:14122-38-4
+BMGC_DG05031,BMG_DG113616,PubChem CID:19916609 | N-METHYLPHENOTHIAZINE-10-CARBOXAMIDE | PubChem SID:485663614 | N-Methylphenothiazine-10-carboxamide | CAS RN:52985-78-1 | UNII:H8SNT7K92Z
+BMGC_DG05032,BMG_DG113629,2-acetyloxypropyl(trimethyl)azanium | DrugBank ID:DB06709 | CAS RN:55-92-5 | Methacholine | PubChem SID:175272130 | UNII:03V657ZD3V | METHACHOLINE | PubChem CID:1993
+BMGC_DG05033,BMG_DG113630,"PubChem SID:336286678 | UNII:31YM8O4QFT | 4,6-DIAMINO-1,2-DIHYDRO-2,2-DIMETHYL-1-PHENYL-S-TRIAZINE | PubChem CID:19931 | CAS RN:4022-58-6"
+BMGC_DG05034,BMG_DG113631,PubChem CID:19933 | (4-CHLOROPHENYL)BIGUANIDE | 2-(4-chlorophenyl)-1-(diaminomethylidene)guanidine | 4-Chlorophenylbiguanide | PubChem SID:252165476 | CAS RN:5304-59-6 | UNII:61UQ98597T
+BMGC_DG05035,BMG_DG113645,"PubChem SID:252165220 | PubChem CID:199472 | UNII:IRW3C4Y31Q | [(2S,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | GALLOCATECHIN GALLATE, (-)- | (-)-Gallocatechin gallate | CAS RN:4233-96-9"
+BMGC_DG05036,BMG_DG113647,PubChem SID:198968532 | DrugBank ID:DB13226 | PubChem CID:1995 | CAS RN:99-15-0 | Acetylleucine | UNII:K76S41V71X | 2-acetamido-4-methylpentanoic acid | ACETYLLEUCINE
+BMGC_DG05037,BMG_DG113703,PubChem CID:19988 | CAS RN:4065-45-6 | UNII:1W6L629B4K | 5-benzoyl-4-hydroxy-2-methoxybenzenesulfonic acid | Sulisobenzone | DrugBank ID:DB11185 | SULISOBENZONE | PubChem SID:175265501
+BMGC_DG05038,BMG_DG113704,CAS RN:4067-01-0 | N-2-TOLYLMALEIMIDE | UNII:85M9K7F3R8 | PubChem SID:375579782 | PubChem CID:19989
+BMGC_DG05039,BMG_DG113706,PubChem SID:198956827 | CAS RN:13402-08-9 | ACETYLPHENETURIDE | UNII:G083008IJ0 | PubChem CID:1999
+BMGC_DG05040,BMG_DG113723,4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE | DrugBank ID:DB07368 | PubChem CID:199994
+BMGC_DG05041,BMG_DG113770,PubChem CID:20027470 | PubChem SID:441096899 | M-CHLOROAMPHETAMINE | CAS RN:32560-59-1 | UNII:8V8DE89CJE
+BMGC_DG05042,BMG_DG113800,"PubChem SID:474489890 | PubChem CID:20043 | UNII:524YYF9P6Q | CAS RN:4097-53-4 | 4-HYDROXY-3,5-DINITROBIPHENYL | 4-Hydroxy-3,5-dinitrobiphenyl"
+BMGC_DG05043,BMG_DG113806,PubChem CID:2005 | CAS RN:57-08-9 | PubChem SID:198987662 | UNII:7IC4BO7D3R | 6-acetamidohexanoic acid | ACEXAMIC ACID | Acexamic Acid
+BMGC_DG05044,BMG_DG113818,"UNII:0P5B94FVD5 | methyl (1R,15S,17R,18R,19S,20S)-3-[2-(diethylamino)ethyl]-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-11,12,14,15,16,17,18,19,20,21-decahydro-1H-yohimban-19-carboxylate | PubChem CID:20054848 | DrugBank ID:DB13575 | BIETASERPINE | CAS RN:53-18-9 | PubChem SID:198969740 | Bietaserpine"
+BMGC_DG05045,BMG_DG113824,"Cimetropium | [(1R,2R,4S,5S)-9-(cyclopropylmethyl)-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate | PubChem SID:198968812 | CIMETROPIUM | PubChem CID:20054871 | UNII:1N3H74AYTK | DrugBank ID:DB09271 | CAS RN:150521-16-7"
+BMGC_DG05046,BMG_DG113861,"UNII:IF8PQP966U | PubChem SID:198987524 | PubChem CID:20055008 | PREDNYLIDENE | DrugBank ID:DB13208 | Prednylidene | (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-16-methylidene-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-3-one | CAS RN:599-33-7"
+BMGC_DG05047,BMG_DG113866,"UNII:Q2VYF0562D | (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-phenyl-2-sulfoacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem CID:20055036 | CAS RN:34779-28-7 | DrugBank ID:DB13693 | PubChem SID:198985313 | CAS RN:41744-40-5 | Sulbenicillin | SULBENICILLIN"
+BMGC_DG05048,BMG_DG113879,"coenzyme B12 | CAS RN:13870-90-1 | PubChem CID:20055083 | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate"
+BMGC_DG05049,BMG_DG113882,"ETHYBENZTROPINE | PubChem CID:20055089 | Ethybenztropine | CAS RN:524-83-4 | DrugBank ID:DB13468 | PubChem SID:175265392 | UNII:G1X2X9N95N | (1R,5S)-3-benzhydryloxy-8-ethyl-8-azabicyclo[3.2.1]octane"
+BMGC_DG05050,BMG_DG113909,"[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl] 2-hydroxybenzoate | UNII:43XOA705ZD | DrugBank ID:DB11201 | CAS RN:89-46-3 | Menthyl salicylate | PubChem SID:175272053 | MENTHYL SALICYLATE, (+/-)- | MENTHYL SALICYLATE, (±)- | PubChem CID:20055232 | CAS RN:138876-17-2"
+BMGC_DG05051,BMG_DG113917,DrugBank ID:DB08993 | CAS RN:33103-22-9 | PubChem SID:198944827 | UNII:XU299C23A2 | ENVIOMYCIN | Enviomycin | PubChem CID:20055267
+BMGC_DG05052,BMG_DG113921,"Gitoformate | [(2R,3R,4S,6R)-3-[(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-4,5-diformyloxy-6-methyloxan-2-yl]oxy-4-formyloxy-6-methyloxan-2-yl]oxy-6-[[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-16-formyloxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-4-yl] formate | DrugBank ID:DB13537 | CAS RN:10176-39-3 | PubChem CID:20055283 | PubChem SID:198979384 | GITOFORMATE | CAS RN:7685-23-6 | UNII:B69U29O7J9"
+BMGC_DG05053,BMG_DG113928,CAS RN:33279-57-1 | K-STROPHANTHOSIDE | PubChem SID:241178344 | UNII:8141H9654J | PubChem CID:20055295
+BMGC_DG05054,BMG_DG113973,"PubChem CID:20055414 | CAS RN:108785-69-9 | DrugBank ID:DB09195 | (1S,8R)-5-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-3,4,6-triazatricyclo[6.3.0.02,6]undeca-2,4-diene | (1S,8R)-5-[2-[4-[3-(Trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-3,4,6-triazatricyclo[6.3.0.02,6]undeca-2,4-diene | Lorpiprazole | CAS RN:1640293-37-3"
+BMGC_DG05055,BMG_DG113998,"UNII:135FQ40L36 | PubChem SID:198944044 | [(2R,3S,4S,5R)-3,4-dihydroxy-2,5,6-tris(methylsulfonyloxy)hexyl] methanesulfonate | CAS RN:7518-35-6 | Mannosulfan | MANNOSULFAN | PubChem CID:20055482 | DrugBank ID:DB13334"
+BMGC_DG05056,BMG_DG114001,"Scopolamine hydrobromide trihydrate | [(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;trihydrate;hydrobromide | CAS RN:6533-68-2 | PubChem CID:20055509 | SCOPOLAMINE HYDROBROMIDE | UNII:451IFR0GXB | PubChem SID:175267752"
+BMGC_DG05057,BMG_DG114002,PubChem CID:20055510 | DrugBank ID:DB04258 | Seocalcitol
+BMGC_DG05058,BMG_DG114031,UNII:R8V77RPA42 | S-(2-HYDROXY-5-NITROBENZYL)-6-THIOINOSINE | PubChem SID:381132438 | CAS RN:56964-73-9 | PubChem CID:20055595
+BMGC_DG05059,BMG_DG114032,"(4aR,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,2,4a,6a,6b,9,9,12a-octamethyl-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picen-13-one | 11-Oxo-beta-amyrin | CAS RN:38242-02-3 | PubChem CID:20055661"
+BMGC_DG05060,BMG_DG114178,"[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl acetate | UNII:2WP61F175M | NDC:50633-220 | URIDINE TRIACETATE | Uridine triacetate | CAS RN:4105-38-8 | PubChem SID:198941075 | DrugBank ID:DB09144 | PubChem CID:20058"
+BMGC_DG05061,BMG_DG114183,UNII:99Y8VJ356G | CAS RN:114607-46-4 | ACITAZANOLAST | PubChem CID:2006 | PubChem SID:198986543
+BMGC_DG05062,BMG_DG114185,"1,4-DIBENZYLPIPERAZINE | CAS RN:1034-11-3 | PubChem SID:316918407 | PubChem CID:200601 | UNII:616774W5JF"
+BMGC_DG05063,BMG_DG114209,"Levopropoxyphene | [(2R,3S)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate | PubChem CID:200742 | DrugBank ID:DB06793 | PubChem SID:198952961 | LEVOPROPOXYPHENE | CAS RN:2338-37-6 | UNII:U75VZ9PK1J"
+BMGC_DG05064,BMG_DG114214,"PubChem SID:485664781 | 1,3,5-Triazin-2-amine | UNII:QD6Q84R3LQ | 1,3,5-TRIAZIN-2-AMINE | PubChem CID:20077 | CAS RN:4122-04-7"
+BMGC_DG05065,BMG_DG114228,ACLATONIUM | PubChem SID:198958372 | UNII:UC6I41G62N | CAS RN:55077-25-3 | PubChem CID:2009
+BMGC_DG05066,BMG_DG114257,"CAS RN:1092578-47-6 | PubChem CID:20111936 | UNII:C3EP7ZZ9UQ | TOFACITINIB, (3S,4S)- | PubChem SID:441583732"
+BMGC_DG05067,BMG_DG114302,PubChem CID:2014 | 1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea | DrugBank ID:DB04336
+BMGC_DG05068,BMG_DG114303,PubChem SID:198951366 | VALNOCTAMIDE | CAS RN:4171-13-5 | DrugBank ID:DB13099 | 2-ethyl-3-methylpentanamide | PubChem CID:20140 | Valnoctamide | UNII:3O25NRX9YG
+BMGC_DG05069,BMG_DG114326,Acridone | 10H-acridin-9-one | CAS RN:643-62-9 | CAS RN:578-95-0 | PubChem CID:2015 | PubChem SID:198953564 | ACRIDONE | UNII:6BK306GUQA
+BMGC_DG05070,BMG_DG114333,UNII:1USW70QZGV | APOMORPHINE DIACETATE | PubChem SID:198941437 | PubChem CID:201536 | CAS RN:6191-56-6
+BMGC_DG05071,BMG_DG114347,"3,6-Diamino-10-methylacridinium | 3,6-DIAMINO-10-METHYLACRIDINIUM | PubChem SID:485663510 | CAS RN:837-73-0 | UNII:J276XBF77Z | PubChem CID:2016"
+BMGC_DG05072,BMG_DG114349,UNII:A6EOX47QK0 | CAS RN:4191-73-5 | PubChem CID:20161 | PubChem SID:175268559 | ISOPROPYLPARABEN
+BMGC_DG05073,BMG_DG114363,"UNII:WIX85M1A6R | CAS RN:442-16-0 | ETHACRIDINE | PubChem SID:175265288 | Ethacridine | 7-ethoxyacridine-3,9-diamine | PubChem CID:2017"
+BMGC_DG05074,BMG_DG114365,"UNII:FP7F5WF7R4 | CAS RN:4198-90-7 | PubChem CID:20176 | PubChem SID:472407978 | 3,5-DIMETHYL-4-HYDROXYBENZONITRILE"
+BMGC_DG05075,BMG_DG114378,"PubChem CID:2019 | 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide | CAS RN:50-76-0 | Cosmegen"
+BMGC_DG05076,BMG_DG114386,"PubChem CID:20196 | 3',5-DICHLOROSALICYLANILIDE | CAS RN:22203-98-1 | PubChem SID:198980344 | UNII:L9HQV0JFNH"
+BMGC_DG05077,BMG_DG114407,PubChem CID:2022 | Acyclovir | DrugBank ID:DB00787
+BMGC_DG05078,BMG_DG114413,"[(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] acetate | PubChem CID:202225 | PubChem SID:198956335 | TROLEANDOMYCIN | DrugBank ID:DB13179 | UNII:C4DZ64560D | CAS RN:2751-09-9 | Troleandomycin"
+BMGC_DG05079,BMG_DG114428,"PubChem SID:376072900 | 1,2-DIHYDRO-6-METHYL-2-OXO-5-PHENYL-3-PYRIDINECARBONITRILE | CAS RN:4241-12-7 | PubChem CID:20231 | UNII:PN83EB65I5"
+BMGC_DG05080,BMG_DG114456,"PRECLAMOL, (R)- | CAS RN:85976-54-1 | UNII:8L7H229K4I | PubChem SID:198966349 | PubChem CID:202478"
+BMGC_DG05081,BMG_DG114491,UNII:YG5VEG5S5A | CAS RN:13150-57-7 | ANHYDRO PRIDINOL | PubChem CID:202718
+BMGC_DG05082,BMG_DG114495,"3-(4-NITROANILINO)-1-(2,4,6-TRICHLOROPHENYL)-5-PYRAZOLONE | UNII:PIS1J5Z0NA | CAS RN:34320-82-6 | PubChem SID:438788912 | 3-(4-Nitroanilino)-1-(2,4,6-trichlorophenyl)-5-pyrazolone | PubChem CID:20274197"
+BMGC_DG05083,BMG_DG114501,"Cladribine | PubChem SID:175266722 | NDC:0143-9871 | UNII:47M74X9YT5 | CAS RN:24757-90-2 | NDC:44087-4000 | NDC:42658-010 | CLADRIBINE | PubChem CID:20279 | (2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol | CAS RN:4291-63-8 | DrugBank ID:DB00242 | NDC:63323-140"
+BMGC_DG05084,BMG_DG114529,PubChem CID:20299 | PubChem SID:198977908 | TRIDIHEXETHYL | DrugBank ID:DB00505 | CAS RN:60-49-1 | UNII:7HE50A367X | Tridihexethyl | (3-cyclohexyl-3-hydroxy-3-phenylpropyl)-triethylazanium
+BMGC_DG05085,BMG_DG114530,"CAS RN:102185-22-8 | ALLANTOIC ACID | PubChem CID:203 | UNII:02WGT7SHWJ | Allantoic acid | CAS RN:99-16-1 | PubChem SID:318164182 | 2,2-bis(carbamoylamino)acetic acid"
+BMGC_DG05086,BMG_DG114539,"ADIPHENINE | UNII:YKG6OR043Q | PubChem SID:198936418 | CAS RN:64-95-9 | 2-(diethylamino)ethyl 2,2-diphenylacetate | Adiphenine | PubChem CID:2031"
+BMGC_DG05087,BMG_DG114543,"Amitriptylinoxide | N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine oxide | CAS RN:4317-14-0 | UNII:TYR2U59WMA | PubChem CID:20313 | PubChem SID:198955064 | DrugBank ID:DB13114 | AMITRIPTYLINOXIDE"
+BMGC_DG05088,BMG_DG114607,"UNII:LU4B53JYVE | NDC:58657-326 | NDC:58657-325 | CAS RN:4345-03-3 | NDC:10542-011 | PubChem SID:175268150 | DrugBank ID:DB14001 | 4-oxo-4-[[(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid | CAS RN:55134-51-5 | NDC:10542-014 | NDC:10542-009 | NDC:58657-327 | .ALPHA.-TOCOPHEROL SUCCINATE, D- | Vitamin e succinate | PubChem CID:20353"
+BMGC_DG05089,BMG_DG114624,"ALPRENOLOL, (R)- | PubChem CID:203685 | UNII:4146VEC819 | PubChem SID:252164909 | CAS RN:23846-72-2"
+BMGC_DG05090,BMG_DG114650,PubChem SID:198962670 | AMINOETHYLISOTHIOUREA | PubChem CID:2039 | 2-aminoethyl carbamimidothioate | beta-Aminoethyl Isothiourea | CAS RN:151-16-6 | UNII:2GIH68G0MX | CAS RN:871-25-0
+BMGC_DG05091,BMG_DG114654,"DEPTROPINE | (1R,5S)-8-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyloxy)-8-azabicyclo[3.2.1]octane | Deptropine | PubChem SID:198985022 | CAS RN:604-51-3 | DrugBank ID:DB13466 | PubChem CID:203911 | UNII:AY31301GKG"
+BMGC_DG05092,BMG_DG114667,"UNII:344S277G0Z | CAS RN:5377-33-3 | PubChem CID:204 | CAS RN:97-59-6 | ALLANTOIN | Allantoin | (2,5-dioxoimidazolidin-4-yl)urea | PubChem SID:175271919 | DrugBank ID:DB11100"
+BMGC_DG05093,BMG_DG114674,"UNII:2VC35C3CU2 | 7-(3-(2-(CYCLOPROPYLMETHYL)-3-METHOXY-4-((METHYLAMINO)CARBONYL)PHENOXY)PROPOXY)-3,4-DIHYDRO-8-PROPYL-2H-1-BENZOPYRAN-2-PROPANOIC ACID, (2S)- | CAS RN:153633-01-3 | PubChem CID:204058"
+BMGC_DG05094,BMG_DG114681,RAZAXABAN | CAS RN:218298-21-6 | PubChem CID:204102 | UNII:3K2509846L | PubChem SID:198934777
+BMGC_DG05095,BMG_DG114683,"REVAPRAZAN | CAS RN:199463-33-7 | PubChem SID:198964022 | Revaprazan | UNII:5P184180P5 | N-(4-fluorophenyl)-4,5-dimethyl-6-(1-methyl-3,4-dihydro-1H-isoquinolin-2-yl)pyrimidin-2-amine | PubChem CID:204104"
+BMGC_DG05096,BMG_DG114684,"CAS RN:82059-50-5 | PubChem CID:204105 | UNII:EZ15I5D6C1 | DrugBank ID:DB06582 | (5R)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine | DEXTOFISOPAM | Dextofisopam | PubChem SID:198972132"
+BMGC_DG05097,BMG_DG114685,"PubChem SID:198965368 | ECOPLADIB | UNII:48TI67E57Q | Ecopladib | 4-[2-[1-benzhydryl-5-chloro-2-[2-[(3,4-dichlorophenyl)methylsulfonylamino]ethyl]indol-3-yl]ethoxy]benzoic acid | PubChem CID:204106 | CAS RN:381683-92-7"
+BMGC_DG05098,BMG_DG114688,NETOGLITAZONE | PubChem SID:198961439 | UNII:QOV2JZ647A | DrugBank ID:DB09199 | Netoglitazone | PubChem CID:204109 | CAS RN:161600-01-7
+BMGC_DG05099,BMG_DG114692,"DrugBank ID:DB13160 | Alphaprodine | [(3R,4S)-1,3-dimethyl-4-phenylpiperidin-4-yl] propanoate | PubChem CID:204163"
+BMGC_DG05100,BMG_DG114718,PubChem CID:2044 | TYRPHOSTIN AG-1024 | UNII:NF4XN6A8V9 | Tyrphostin AG-1024 | CAS RN:65678-07-1 | PubChem SID:472410765
+BMGC_DG05101,BMG_DG114726,"PubChem SID:348481520 | UNII:AF3HZ0ZAN4 | PubChem CID:20445 | 6,6'-BI-2-PICOLINE | CAS RN:4411-80-7"
+BMGC_DG05102,BMG_DG114740,AG-126 | CAS RN:118409-62-4 | 2-[(3-hydroxy-4-nitrophenyl)methylidene]propanedinitrile | UNII:7YA4AMD1JC | PubChem SID:198985799 | Tyrphostin AG 126 | PubChem CID:2046
+BMGC_DG05103,BMG_DG114747,"ALPRENOLOL, (S)- | CAS RN:23846-71-1 | UNII:3J532ZIY9K | PubChem CID:204665 | PubChem SID:252164910"
+BMGC_DG05104,BMG_DG114750,"(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | UNII:KGZ1SLC28Z | PubChem SID:175266666 | BECLOMETHASONE | CAS RN:4419-39-0 | PubChem CID:20469 | Beclomethasone"
+BMGC_DG05105,BMG_DG114768,DrugBank ID:DB02664 | 1-Butane Boronic Acid | PubChem CID:20479
+BMGC_DG05106,BMG_DG114769,"6,7-Dimethyl-2-phenylquinoxaline | 6,7-DIMETHYL-2-PHENYLQUINOXALINE | UNII:FWH2FYS649 | CAS RN:71897-07-9 | PubChem SID:474492379 | PubChem CID:2048"
+BMGC_DG05107,BMG_DG114814,"CAS RN:153436-53-4 | CAS RN:175178-82-2 | UNII:SUH0SEZ9HY | N-(3-chlorophenyl)-6,7-dimethoxyquinazolin-4-amine | AG-1478 | Tyrphostins | PubChem CID:2051 | PubChem SID:381132544"
+BMGC_DG05108,BMG_DG114820,(1-PHENYLCYCLOPENTYL)METHANAMINE | CAS RN:17511-89-6 | PubChem CID:205131 | PubChem SID:440089571 | UNII:03L0BL8FBI | DrugBank ID:DB04577 | 1-(1-phenylcyclopentyl)methylamine
+BMGC_DG05109,BMG_DG114824,"CAS RN:118409-57-7 | PubChem SID:198958627 | Tyrphostin A23 | PubChem CID:2052 | 2-[(3,4-dihydroxyphenyl)methylidene]propanedinitrile | UNII:RV0GCD31OJ | TYRPHOSTIN A23"
+BMGC_DG05110,BMG_DG114833,"PubChem SID:485664982 | PubChem CID:20525178 | UNII:9AY74TFP5U | 1-(3,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol | CAS RN:27523-05-3 | 1-(3,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHANOL"
+BMGC_DG05111,BMG_DG114847,PubChem CID:20541332 | DrugBank ID:DB07342 | 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone
+BMGC_DG05112,BMG_DG114850,PubChem CID:20544 | ACETYLTHIOCHOLINE | UNII:4V9VG6MX6E | PubChem SID:472422964 | CAS RN:4468-05-7
+BMGC_DG05113,BMG_DG114869,Anabasine | 3-[(2S)-piperidin-2-yl]pyridine | PubChem CID:205586 | PubChem SID:198965124 | CAS RN:494-52-0 | ANABASINE | UNII:LMS11II2LO
+BMGC_DG05114,BMG_DG114906,"NDC:83872-208 | NDC:83872-209 | NDC:83872-214 | PubChem SID:198938442 | 4-Butylresorcinol | 4-butylbenzene-1,3-diol | NDC:83872-205 | NDC:83872-215 | UNII:2IK4UQ3ZGA | CAS RN:18979-61-8 | NDC:83872-200 | NDC:83872-206 | PubChem CID:205912 | NDC:83872-204 | 4-BUTYLRESORCINOL | NDC:83872-393"
+BMGC_DG05115,BMG_DG114915,"PubChem CID:2059510 | 2-[5,6-Bis-(4-methoxy-phenyl)-furo[2,3-d]pyrimidin-4-ylamino]-ethanol | 2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL | 2-[[5,6-bis(4-methoxyphenyl)furo[2,3-d]pyrimidin-4-yl]amino]ethanol | DrugBank ID:DB08392 | CAS RN:378775-98-5"
+BMGC_DG05116,BMG_DG114930,ICI-58301 | PubChem SID:496142615 | UNII:EWD26AFN9G | CAS RN:23280-04-8 | PubChem CID:205981
+BMGC_DG05117,BMG_DG114941,"PubChem SID:198972613 | MURAGLITAZAR | CAS RN:331741-94-7 | Muraglitazar | PubChem CID:206044 | 2-[(4-methoxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]amino]acetic acid | DrugBank ID:DB06510 | UNII:W1MKM70WQI"
+BMGC_DG05118,BMG_DG114948,BENZOTRIPT | Benzotript | PubChem CID:2060890 | (2S)-2-[(4-chlorobenzoyl)amino]-3-(1H-indol-3-yl)propanoic acid | PubChem SID:198985033 | CAS RN:39544-74-6 | UNII:LS5O682BRO
+BMGC_DG05119,BMG_DG114951,"UNII:C878BF87UY | PubChem CID:2061 | 2-[(3,4,5-trihydroxyphenyl)methylidene]propanedinitrile | CAS RN:118409-58-8 | Tyrphostin A25 | TYRPHOSTIN-25 | PubChem SID:474489567"
+BMGC_DG05120,BMG_DG114972,PubChem SID:198951768 | CAS RN:342577-38-2 | 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide | PubChem CID:20629114 | DrugBank ID:DB12889 | UNII:09BQ2KJ22J | VELNEPERIT | Velneperit
+BMGC_DG05121,BMG_DG114973,Tyrphostin A1 | PubChem CID:2063 | 2-[(4-methoxyphenyl)methylidene]propanedinitrile | CAS RN:2826-26-8
+BMGC_DG05122,BMG_DG114978,"UNII:CG6N5PST22 | CAS RN:492434-57-8 | 3-(METHYLAMINO)-2-(NAPHTHALEN-2-YL)-1-PHENYLPROPAN-1-OL, (1R,2R)- | PubChem SID:474493834 | 3-(Methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol, (1R,2R)- | PubChem CID:20631901"
+BMGC_DG05123,BMG_DG114979,"PubChem CID:20631904 | PubChem SID:474493833 | UNII:V9MLT2S334 | CAS RN:492434-87-4 | PRC200-SS | .BETA.-((METHYLAMINO)METHYL)-.ALPHA.-PHENYL-2-NAPHTHALENEETHANOL, (.ALPHA.R,.BETA.R)-REL- | PubChem SID:474492627 | β-[(Methylamino)methyl]-α-phenyl-2-naphthaleneethanol, (αR,βR)-rel- | CAS RN:492434-58-9 | UNII:HRC7AN5M2H"
+BMGC_DG05124,BMG_DG114989,PubChem CID:2063868 | CAS RN:55755-16-3 | 2-METHYLPHENETHYLAMINE | UNII:B2VHM2W3X9 | PubChem SID:472423261
+BMGC_DG05125,BMG_DG114995,"methyl 17-(2-methoxyethyl)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate | PubChem CID:20642899 | (+/-)-18-Methoxycoronaridine"
+BMGC_DG05126,BMG_DG115026,"PubChem SID:377308941 | UNII:E5P2L57CYH | PubChem CID:20678881 | N,N-DIMETHYL-4-(3-PYRIDINYL)-3-BUTEN-1-AMINE | CAS RN:20173-36-8"
+BMGC_DG05127,BMG_DG115036,PubChem CID:20689 | DrugBank ID:DB04250 | BUTYRYLTHIOCHOLINE | PubChem SID:438787950 | Butyrylthiocholine | UNII:K8D83KI04M | CAS RN:4555-00-4
+BMGC_DG05128,BMG_DG115051,"PubChem CID:2071 | CAS RN:168560-79-0 | 1-amino-2,3-dihydroindene-1,5-dicarboxylic acid | Aida"
+BMGC_DG05129,BMG_DG115105,PubChem CID:20760 | PubChem SID:443623552 | UNII:TF9AXG6CBX | 4-CARBOXY-N-PHENYLPHTHALIMIDE | CAS RN:4649-27-8
+BMGC_DG05130,BMG_DG115144,"2-(1,3-BENZODIOXOL-5-YL)-5-(((3-FLUORO-4-METHOXYPHENYL)METHYL)THIO)-1,3,4-OXADIAZOLE | CAS RN:757198-76-8 | UNII:CG29TW6UG8 | 2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole | 2-(1,3-Benzodioxol-5-yl)-5-[[(3-fluoro-4-methoxyphenyl)methyl]thio]-1,3,4-oxadiazole | DrugBank ID:DB07014 | PubChem SID:485663432 | PubChem CID:2079916"
+BMGC_DG05131,BMG_DG115157,DrugBank ID:DB13233 | PubChem CID:2081 | [1-(4-chlorophenyl)-2-methylpropan-2-yl] 2-aminopropanoate | CAS RN:60719-82-6 | ALAPROCLATE | PubChem SID:198938216 | UNII:C4R42570ZO | Alaproclate
+BMGC_DG05132,BMG_DG115158,PubChem CID:20810 | PubChem SID:198935841 | UNII:N9VWZ34G5E | CAS RN:3551-18-6 | ACETRYPTINE
+BMGC_DG05133,BMG_DG115159,"DrugBank ID:DB09249 | UNII:2NJ66SLA5C | PubChem SID:198954937 | PubChem SID:255509165 | Octamoxin | UNII:0HXY3M6S54 | PubChem SID:255508914 | OCTAMOXIN, (-)- | OCTAMOXIN, (+)- | OCTAMOXIN | CAS RN:4684-87-1 | CAS RN:65500-65-4 | UNII:895PL98ZMY | octan-2-ylhydrazine | PubChem CID:20811"
+BMGC_DG05134,BMG_DG115166,NDC:72162-2359 | NDC:42799-110 | NDC:63629-9278 | NDC:0591-2712 | NDC:69097-237 | NDC:51407-258 | NDC:63629-1221 | NDC:62332-681 | NDC:70710-1021 | NDC:0115-1701 | Albendazole | NDC:78482-110 | PubChem SID:175266686 | methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate | NDC:64896-693 | NDC:72205-051 | NDC:69539-151 | ALBENDAZOLE | NDC:43598-452 | DrugBank ID:DB00518 | PubChem CID:2082 | UNII:F4216019LN | CAS RN:54965-21-8 | NDC:70771-1103 | NDC:72162-1309 | NDC:46708-681
+BMGC_DG05135,BMG_DG115173,"CAS RN:4697-36-3 | PubChem SID:175271886 | Carbenicillin | DrugBank ID:DB00578 | CARBENICILLIN | UNII:G42ZU72N5G | PubChem CID:20824 | (2S,5R,6R)-6-[(2-carboxy-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"
+BMGC_DG05136,BMG_DG115174,PubChem CID:20825 | N-(CARBOXYMETHYL)PHTHALIMIDE | CAS RN:4702-13-0 | UNII:6J5LY4N0CG | PubChem SID:241179978
+BMGC_DG05137,BMG_DG115177,CAS RN:148563-15-9 | CAS RN:18559-94-9 | UNII:QF8SVZ843E | PubChem SID:175271577 | DrugBank ID:DB01001 | ALBUTEROL | CAS RN:35763-26-9 | Albuterol | PubChem CID:2083 | 4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol
+BMGC_DG05138,BMG_DG115270,PubChem CID:2084 | (3-Chloro-4-Propoxy-Phenyl)-Acetic Acid | DrugBank ID:DB02773
+BMGC_DG05139,BMG_DG115298,"PubChem CID:20843156 | (2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE | DrugBank ID:DB07113"
+BMGC_DG05140,BMG_DG115406,Alendronic Acid | Alendronic acid | PubChem CID:2088 | ALENDRONIC ACID | UNII:X1J18R4W8P | (4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid | PubChem SID:175266207 | CAS RN:66376-36-1 | DrugBank ID:DB00630
+BMGC_DG05141,BMG_DG115441,DRONEDARONE | Dronedarone | NDC:55154-8104 | PubChem CID:208898 | DrugBank ID:DB04855 | PubChem SID:175268727 | UNII:JQZ1L091Y2 | N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide | NDC:0024-4142 | CAS RN:141626-36-0
+BMGC_DG05142,BMG_DG115443,(2S)-2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid | DrugBank ID:DB06536 | TESAGLITAZAR | CAS RN:251565-85-2 | PubChem CID:208901 | Tesaglitazar | UNII:6734037O3L | PubChem SID:198940776 | DrugBank ID:DB07399
+BMGC_DG05143,BMG_DG115444,"NDC:0591-2191 | NDC:72189-484 | NDC:55700-874 | PubChem CID:208902 | PubChem SID:175267113 | NDC:72189-153 | NDC:72162-2176 | NDC:71205-918 | NDC:71335-1853 | NDC:50268-708 | NDC:43598-741 | NDC:70710-1344 | NDC:70518-4257 | NDC:72162-2161 | NDC:60687-692 | NDC:72319-005 | CAS RN:196597-26-9 | NDC:0832-1250 | DrugBank ID:DB00980 | NDC:59651-505 | NDC:42571-375 | Ramelteon | NDC:63629-8531 | RAMELTEON | NDC:52817-235 | NDC:72162-2169 | UNII:901AS54I69 | NDC:72189-369 | NDC:71335-2186 | NDC:71335-2411 | NDC:64764-805 | NDC:70010-028 | NDC:42291-776 | N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide | NDC:70771-1495 | NDC:80425-0203 | NDC:71335-2310 | NDC:76420-628 | NDC:51407-523 | NDC:69367-356 | NDC:76420-880 | NDC:80425-0343 | NDC:0904-7494 | NDC:70700-272"
+BMGC_DG05144,BMG_DG115448,"LADOSTIGIL | Ladostigil | PubChem SID:198961730 | CAS RN:209394-27-4 | PubChem CID:208907 | [(3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl] N-ethyl-N-methylcarbamate | UNII:SW3H1USR4Q"
+BMGC_DG05145,BMG_DG115449,CAS RN:913989-15-8 | PubChem SID:175266255 | Lapatinib | N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine | LAPATINIB | DrugBank ID:DB01259 | PubChem CID:208908 | UNII:0VUA21238F | CAS RN:1092929-10-6 | CAS RN:1210608-87-9 | CAS RN:231277-92-2
+BMGC_DG05146,BMG_DG115450,"FIROCOXIB | DrugBank ID:DB09217 | PubChem CID:208910 | PubChem SID:175265593 | Firocoxib | 3-(cyclopropylmethoxy)-5,5-dimethyl-4-(4-methylsulfonylphenyl)furan-2-one | UNII:Y6V2W4S4WT | CAS RN:189954-96-9"
+BMGC_DG05147,BMG_DG115456,PubChem CID:208917 | CAS RN:115464-77-2 | PubChem SID:198982450 | UNII:419A0R564U | ELOPIPRAZOLE
+BMGC_DG05148,BMG_DG115460,ARIMOCLOMOL | CAS RN:289893-25-0 | N-[(2R)-2-hydroxy-3-piperidin-1-ylpropoxy]-1-oxidopyridin-1-ium-3-carboximidoyl chloride | PubChem CID:208924 | Arimoclomol | DrugBank ID:DB05025 | CAS RN:289893-23-8 | PubChem SID:198981593 | UNII:EUT3557RT5
+BMGC_DG05149,BMG_DG115461,(2R)-2-propyloctanoic acid | PubChem CID:208925 | ARUNDIC ACID | PubChem SID:198967322 | DrugBank ID:DB05343 | Arundic acid | UNII:F2628ZD0FO | CAS RN:185517-21-9
+BMGC_DG05150,BMG_DG115466,ERSENTILIDE | CAS RN:125279-79-0 | UNII:L2JY6Z298S | PubChem SID:198939002 | PubChem CID:208932
+BMGC_DG05151,BMG_DG115481,"DrugBank ID:DB04888 | PubChem CID:208951 | BIFEPRUNOX | UNII:AP69E83Z79 | 7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3H-1,3-benzoxazol-2-one | CAS RN:350992-10-8 | Bifeprunox | PubChem SID:198958585"
+BMGC_DG05152,BMG_DG115482,"DrugBank ID:DB12073 | ALBACONAZOLE | PubChem SID:198944608 | PubChem CID:208952 | CAS RN:187949-02-6 | 7-chloro-3-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]quinazolin-4-one | Albaconazole | UNII:YDW24Y8IAB"
+BMGC_DG05153,BMG_DG115485,PubChem SID:175271402 | PubChem CID:2090 | CAS RN:22573-93-9 | ALEXIDINE | UNII:GVN71CAL3G
+BMGC_DG05154,BMG_DG115487,PubChem CID:20906 | FLUOROSALAN | PubChem SID:198958373 | UNII:80OFG3WPYD | CAS RN:4776-06-1
+BMGC_DG05155,BMG_DG115496,"N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide | CAS RN:1100050-87-0 | CAS RN:81403-80-7 | Alfuzosin | DrugBank ID:DB00346 | UNII:90347YTW5F | PubChem CID:2092 | ALFUZOSIN | PubChem SID:175271875"
+BMGC_DG05156,BMG_DG115499,CAS RN:4792-58-9 | ETHYL 5-METHOXYINDOLE-2-CARBOXYLATE | PubChem CID:20926 | PubChem SID:198958086 | UNII:D63U367GNZ
+BMGC_DG05157,BMG_DG115505,DrugBank ID:DB00437 | Allopurinol | PubChem CID:2094
+BMGC_DG05158,BMG_DG115520,2-[4-(2-methylprop-2-enylamino)phenyl]propanoic acid | PubChem CID:2097 | CAS RN:39718-89-3 | Alminoprofen | DrugBank ID:DB13314 | CAS RN:54362-71-9 | UNII:0255AHR9GJ | PubChem SID:198979128 | ALMINOPROFEN
+BMGC_DG05159,BMG_DG115551,"PubChem SID:175268748 | Alosetron | ALOSETRON | PubChem CID:2099 | UNII:13Z9HTH115 | 5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one | DrugBank ID:DB00969 | CAS RN:122852-42-0"
+BMGC_DG05160,BMG_DG115553,"1,6-BISMALEIMIDOHEXANE | PubChem SID:472411211 | PubChem CID:20992 | UNII:XC3NMJ9SCH | CAS RN:4856-87-5 | 1,6-Bismaleimidohexane"
+BMGC_DG05161,BMG_DG115579,CAS RN:21181-90-8 | PubChem CID:210230 | 4-(2-(BENZYLTHIO)ETHYL)PYRIDINE | UNII:QU7T3DUW7X
+BMGC_DG05162,BMG_DG115580,CAS RN:733734-61-7 | SB-706375 | PubChem CID:21023902 | PubChem SID:383470623 | UNII:96711H97SD
+BMGC_DG05163,BMG_DG115591,PubChem SID:198948102 | CAS RN:79313-75-0 | PubChem CID:210319 | SOPROMIDINE | UNII:XVO1973XSP
+BMGC_DG05164,BMG_DG115592,DrugBank ID:DB08835 | CAS RN:4910-46-7 | SPAGLUMIC ACID | Acide spaglumique | (2S)-2-[[(3S)-3-acetamido-3-carboxypropanoyl]amino]pentanedioic acid | PubChem CID:210320 | UNII:X81L78B3RB | PubChem SID:198970622 | Spaglumic acid
+BMGC_DG05165,BMG_DG115601,PubChem CID:210332 | CAS RN:656820-32-5 | Reversine | UNII:Z499CLJ023 | REVERSINE | PubChem SID:198988166 | DrugBank ID:DB07340
+BMGC_DG05166,BMG_DG115618,UNII:74AT05RAYI | PubChem CID:21059574 | CAS RN:344585-41-7 | PubChem SID:198944003 | AP-23317
+BMGC_DG05167,BMG_DG115622,"DrugBank ID:DB08531 | PubChem CID:21066087 | 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine"
+BMGC_DG05168,BMG_DG115623,"DrugBank ID:DB08534 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | PubChem CID:21066096"
+BMGC_DG05169,BMG_DG115624,"DrugBank ID:DB06983 | (5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol | PubChem CID:21066379"
+BMGC_DG05170,BMG_DG115627,CAS RN:101541-58-6 | PubChem SID:441583491 | CAS RN:304-52-9 | 3-(2-aminopropyl)-1H-indol-5-ol | .ALPHA.-METHYL-5-HYDROXYTRYPTAMINE | PubChem CID:2107 | UNII:5Y83TBC5NM
+BMGC_DG05171,BMG_DG115631,"Idalopirdine | DrugBank ID:DB11957 | PubChem SID:198939679 | UNII:59WCJ0YNWM | CAS RN:467459-31-0 | PubChem CID:21071390 | 2-(6-fluoro-1H-indol-3-yl)-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine | IDALOPIRDINE"
+BMGC_DG05172,BMG_DG115640,"DrugBank ID:DB07834 | PubChem CID:21078798 | N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide"
+BMGC_DG05173,BMG_DG115644,"PubChem CID:21081761 | 1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide | DrugBank ID:DB06896"
+BMGC_DG05174,BMG_DG115666,PubChem CID:21102 | Benorilate | DrugBank ID:DB13657 | (4-acetamidophenyl) 2-acetyloxybenzoate | CAS RN:5003-48-5 | UNII:W1QX9DV96G | BENORILATE | PubChem SID:198958216
+BMGC_DG05175,BMG_DG115672,"Trimetazidine | 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine | TRIMETAZIDINE | PubChem CID:21109 | UNII:N9A0A0R9S8 | DrugBank ID:DB09069 | CAS RN:127881-54-3 | PubChem SID:198964837 | CAS RN:5011-34-7"
+BMGC_DG05176,BMG_DG115674,"UNII:HY7EV5X6GJ | CAS RN:756520-67-9 | PubChem SID:496142661 | 3-(1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)PYRIDIN-2-AMINE, (+/-)- | PubChem CID:21111396 | 3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine, (±)-"
+BMGC_DG05177,BMG_DG115675,"5-Bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine, (±)- | UNII:KR9V2K2U2Z | 5-BROMO-3-(1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)PYRIDIN-2-AMINE, (+/-)- | PubChem CID:21111478 | PubChem SID:496143599 | CAS RN:756503-69-2"
+BMGC_DG05178,BMG_DG115731,"CAS RN:22574-29-4 | UNII:1II66H6AHR | PubChem SID:445499333 | 6-METHOXY-1,9-DIMETHYL-PYRIDO(3,4-B)INDOLE | PubChem CID:211174"
+BMGC_DG05179,BMG_DG115743,"CAS RN:64296-20-4 | Neosaxitoxin | DrugBank ID:DB12989 | [(3aS,4R,10aS)-2-amino-5,10,10-trihydroxy-6-imino-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate | UNII:6YRL8BWD9H | PubChem SID:313183877 | PubChem CID:21117946 | NEOSAXITOXIN"
+BMGC_DG05180,BMG_DG115799,"PubChem CID:21120798 | [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate | hederagenin 28-O-beta-D-glucopyranosyl ester | CAS RN:53931-25-2"
+BMGC_DG05181,BMG_DG115867,"UNII:VJM83TU3PQ | N-METHYLDEPTROPINE | (3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE | DrugBank ID:DB07494 | PubChem SID:485665909 | CAS RN:99287-13-5 | PubChem CID:21124461 | N-Methyldeptropine"
+BMGC_DG05182,BMG_DG115925,"EMERAMIDE | DrugBank ID:DB12192 | PubChem SID:249493414 | Emeramide | 1-N,3-N-bis(2-sulfanylethyl)benzene-1,3-dicarboxamide | CAS RN:351994-94-0 | PubChem CID:21133161 | UNII:4U7K5X4ANS"
+BMGC_DG05183,BMG_DG115937,DrugBank ID:DB03322 | UNII:PG6KY07UD7 | PubChem CID:21138 | CAS RN:13071-11-9 | PubChem SID:198945913 | CAS RN:5051-22-9 | Dexpropranolol | DEXPROPRANOLOL | (2R)-1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
+BMGC_DG05184,BMG_DG115992,"5beta-Dihydrocorticosterone | CAS RN:566-01-8 | PubChem CID:21145110 | (5R,8S,9S,10S,11S,13S,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG05185,BMG_DG116081,UNII:LW4108Q0BV | PubChem CID:21157 | BUTHIONINE SULFOXIMINE | Buthionine sulfoximine | CAS RN:5072-26-4 | PubChem SID:198952128 | DrugBank ID:DB12870 | 2-amino-4-(butylsulfonimidoyl)butanoic acid
+BMGC_DG05186,BMG_DG116101,"(2E)-2-[(1S,9Z,11S,13S,14R,17S,25Z,27S,30R,33S,35S,36S,38E)-38-(2-hydroxyethylidene)-14,30-bis(prop-2-enyl)-8,24-diaza-14,30-diazoniaundecacyclo[25.5.2.211,14.11,26.110,17.02,7.013,17.018,23.030,33.08,35.024,36]octatriaconta-2,4,6,9,18,20,22,25-octaen-28-ylidene]ethanol | PubChem CID:21158560 | UNII:S8U3J5W06N | CAS RN:23214-96-2 | DrugBank ID:DB13648 | ALCURONIUM | Alcuronium | PubChem SID:198941688"
+BMGC_DG05187,BMG_DG116125,"NDC:15370-105 | CAS RN:1411583-24-8 | NDC:15370-103 | NDC:15370-104 | NDC:65219-335 | CAS RN:113085-06-6 | DL-alpha-Tocopherol | UNII:7QWA1RIO01 | CAS RN:10191-41-0 | PubChem CID:2116 | NDC:65219-337 | CAS RN:1406-18-4 | 2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-ol | NDC:75854-312 | NDC:65219-339 | PubChem SID:175271871 | .ALPHA.-TOCOPHEROL, DL- | DrugBank ID:DB14476"
+BMGC_DG05188,BMG_DG116139,"UNII:Q97V5BUT9D | CAS RN:5096-57-1 | (S)-Canadine | PubChem SID:198968423 | CANADINE, (-)- | PubChem CID:21171 | (1S)-16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene"
+BMGC_DG05189,BMG_DG116141,"NDC:82804-035 | NDC:58151-506 | NDC:70954-509 | NDC:49884-213 | NDC:0009-0057 | NDC:0009-0094 | NDC:72789-328 | NDC:60760-550 | NDC:72789-024 | NDC:71610-734 | NDC:80425-0161 | NDC:71335-1129 | NDC:72189-443 | NDC:71205-718 | NDC:49884-110 | ALPRAZOLAM | NDC:0228-4025 | NDC:60687-388 | NDC:59762-0066 | NDC:59762-0059 | NDC:59762-3720 | NDC:63187-966 | NDC:65162-813 | NDC:50090-5262 | NDC:65862-454 | NDC:50090-5078 | NDC:65862-678 | NDC:65162-810 | NDC:70518-3259 | NDC:82868-061 | NDC:68071-2236 | NDC:60687-377 | NDC:71335-1092 | NDC:55700-929 | NDC:0781-1089 | NDC:51991-704 | NDC:71335-9667 | NDC:0228-4024 | NDC:80425-0444 | NDC:70518-3730 | NDC:82804-027 | NDC:65862-456 | CAS RN:1246182-61-5 | PubChem CID:2118 | NDC:67544-347 | NDC:71610-696 | NDC:0009-0068 | NDC:0228-4022 | NDC:71335-9660 | NDC:68071-2976 | 8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | NDC:51991-705 | NDC:70954-511 | NDC:50090-2896 | NDC:59762-3721 | NDC:71205-614 | NDC:0228-2039 | NDC:0781-1079 | NDC:50090-2819 | NDC:63187-444 | NDC:58151-503 | NDC:71610-112 | NDC:65162-812 | NDC:63187-445 | NDC:69339-200 | CAS RN:28981-97-7 | NDC:63187-518 | NDC:50090-5261 | NDC:59762-0068 | NDC:68071-2292 | NDC:0054-3068 | NDC:80425-0110 | NDC:0228-2031 | PubChem SID:175266682 | NDC:69339-201 | NDC:67544-414 | NDC:67544-415 | NDC:70518-4137 | NDC:0009-0066 | NDC:45865-257 | NDC:0228-2027 | NDC:68071-5243 | NDC:72189-450 | NDC:50090-5257 | NDC:0781-1061 | NDC:71335-0849 | NDC:0228-2029 | NDC:68071-2220 | NDC:72789-042 | NDC:43063-609 | NDC:80425-0284 | Alprazolam | NDC:63187-443 | NDC:49884-111 | NDC:71335-1576 | NDC:72789-151 | NDC:65862-457 | NDC:76420-651 | NDC:17224-624 | NDC:65862-676 | NDC:65862-679 | NDC:58151-504 | NDC:71335-1894 | NDC:71335-1907 | NDC:0009-0059 | NDC:68788-8394 | NDC:83008-010 | NDC:49884-214 | NDC:80425-0099 | NDC:55289-523 | NDC:71205-227 | NDC:58151-505 | NDC:0781-1077 | NDC:67296-2072 | NDC:68788-8414 | NDC:65862-677 | NDC:80425-0100 | NDC:65862-455 | NDC:51991-707 | NDC:71205-652 | NDC:72162-1059 | DrugBank ID:DB00404 | NDC:63187-225 | NDC:69339-199 | NDC:63187-916 | NDC:17856-2027 | UNII:YU55MQ3IZY | NDC:0228-3083 | NDC:0228-3086 | NDC:76420-663 | NDC:0009-0090 | NDC:50090-5258 | NDC:76420-664 | NDC:70954-508 | NDC:0009-0029 | NDC:0228-3087 | NDC:67296-0757 | NDC:67296-2117 | NDC:59762-3722 | NDC:71335-1669 | NDC:72189-442 | NDC:68071-5263 | NDC:71335-1386 | NDC:68071-3481 | NDC:59762-3719 | NDC:71335-1839 | NDC:53002-0341 | NDC:71335-9666 | NDC:0228-4019 | NDC:71335-2133 | NDC:76420-665 | NDC:51991-706 | NDC:69339-202 | NDC:68071-2966 | NDC:68071-5113 | NDC:17856-2029 | NDC:68788-8410 | NDC:70954-510 | NDC:71610-113 | CAS RN:51339-48-1 | NDC:76420-652 | NDC:59762-0057 | NDC:72789-313 | NDC:71335-0920 | NDC:76420-666 | NDC:71205-284 | NDC:0228-3084 | NDC:65162-809 | NDC:71335-1477 | NDC:76420-653 | NDC:63187-971 | NDC:68071-5128 | NDC:0009-0055 | NDC:76420-654 | NDC:60760-678"
+BMGC_DG05190,BMG_DG116160,DrugBank ID:DB00866 | ALPRENOLOL | CAS RN:122259-67-0 | 1-(propan-2-ylamino)-3-(2-prop-2-enylphenoxy)propan-2-ol | PubChem CID:2119 | UNII:877K5MQ27W | CAS RN:13655-52-2 | Alprenolol | PubChem SID:198955184
+BMGC_DG05191,BMG_DG116161,PubChem CID:2119214 | UNII:MH9X2VT6FK | PubChem SID:461434643 | CAS RN:22876-20-6 | 6-CHLORO-2-BENZOXAZOLINETHIONE
+BMGC_DG05192,BMG_DG116167,"CAS RN:51411-04-2 | PubChem CID:2120 | Alrestatin | ALRESTATIN | UNII:515DHK15LG | DrugBank ID:DB02020 | PubChem SID:198939114 | 2-(1,3-dioxobenzo[de]isoquinolin-2-yl)acetic acid"
+BMGC_DG05193,BMG_DG116183,"PubChem CID:2122 | PubChem SID:198979295 | CAS RN:133585-76-9 | CAS RN:133562-97-7 | CAS RN:5588-16-9 | UNII:GI8CB72B0D | Althiazide | 6-chloro-1,1-dioxo-3-(prop-2-enylsulfanylmethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | ALTHIAZIDE"
+BMGC_DG05194,BMG_DG116197,"CAS RN:645-05-6 | Altretamine | PubChem CID:2123 | UNII:Q8BIH59O7H | DrugBank ID:DB00488 | PubChem SID:175268785 | ALTRETAMINE | 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine"
+BMGC_DG05195,BMG_DG116198,"DrugBank ID:DB01336 | UNII:V0M92G2U26 | Metocurine | PubChem SID:198937952 | (1S,16R)-9,10,21,25-tetramethoxy-15,15,30,30-tetramethyl-7,23-dioxa-15,30-diazoniaheptacyclo[22.6.2.23,6.18,12.118,22.027,31.016,34]hexatriaconta-3(36),4,6(35),8(34),9,11,18(33),19,21,24,26,31-dodecaene | PubChem CID:21233 | METOCURINE | CAS RN:5152-30-7"
+BMGC_DG05196,BMG_DG116201,(2S)-2-aminohexanoic acid | NORLEUCINE | CAS RN:496-90-2 | PubChem SID:198939691 | L-Norleucine | PubChem CID:21236 | CAS RN:327-57-1 | UNII:832C8OV84S | DrugBank ID:DB15458
+BMGC_DG05197,BMG_DG116212,PubChem CID:2125 | CAS RN:183232-66-8 | UNII:3I4FA44MAI | AM-251 | PubChem SID:198944343
+BMGC_DG05198,BMG_DG116214,"(4R)-4-[(3R,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | (3alpha,7alpha)-3,7-Dihydroxycholan-24-oic acid | CAS RN:30634-99-2 | PubChem CID:21252245"
+BMGC_DG05199,BMG_DG116254,"CAS RN:102121-60-8 | PubChem SID:198958949 | PubChem CID:2126 | 4-[(5,5,8,8-tetramethyl-6,7-dihydronaphthalene-2-carbonyl)amino]benzoic acid | UNII:VZ5S5G9ZFZ | 4-{[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid | 4-((5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)CARBOXAMIDO)BENZOIC ACID"
+BMGC_DG05200,BMG_DG116310,PubChem SID:175267010 | NDC:17772-170 | CAS RN:768-94-5 | NDC:17772-085 | NDC:70482-085 | DrugBank ID:DB00915 | Amantadine | CAS RN:40933-03-7 | adamantan-1-amine | PubChem CID:2130 | NDC:70482-170 | AMANTADINE | UNII:BF4C9Z1J53
+BMGC_DG05201,BMG_DG116316,Boscalid | UNII:32MS8ZRD1V | CAS RN:188425-85-6 | BOSCALID | DrugBank ID:DB12792 | 2-chloro-N-[2-(4-chlorophenyl)phenyl]pyridine-3-carboxamide | PubChem SID:198960637 | PubChem CID:213013
+BMGC_DG05202,BMG_DG116324,"Lumateperone | PubChem SID:287445958 | CAS RN:313369-37-8 | UNII:70BSQ12069 | LUMATEPERONE | 1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one | CAS RN:313368-91-1 | DrugBank ID:DB06077 | PubChem CID:21302490"
+BMGC_DG05203,BMG_DG116335,Ataciguat | DrugBank ID:DB12805 | PubChem CID:213037 | PubChem SID:198974679 | ATACIGUAT | UNII:QP166M390Q | 5-chloro-2-[(5-chlorothiophen-2-yl)sulfonylamino]-N-(4-morpholin-4-ylsulfonylphenyl)benzamide | CAS RN:254877-67-3
+BMGC_DG05204,BMG_DG116336,"DARUNAVIR | NDC:31722-567 | DrugBank ID:DB01264 | PubChem SID:175265700 | Darunavir | NDC:72205-185 | NDC:43598-705 | [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate | NDC:60219-1145 | NDC:72205-184 | NDC:70771-1746 | NDC:70771-1745 | NDC:60219-1144 | NDC:31722-568 | PubChem CID:213039 | NDC:72578-148 | NDC:43598-704 | CAS RN:206361-99-1 | UNII:YO603Y8113 | NDC:72578-147"
+BMGC_DG05205,BMG_DG116337,"UNII:0BJK6B565B | PubChem SID:198989227 | PubChem CID:213040 | 1-[4-(2-hydroxy-3-quinolin-5-yloxypropyl)piperazin-1-yl]-2,2-diphenylethanone | DOFEQUIDAR | Dofequidar | CAS RN:129716-58-1 | DrugBank ID:DB14067"
+BMGC_DG05206,BMG_DG116338,AGK-2 | UNII:DDF0L8606A | CAS RN:304896-28-4 | PubChem SID:198987897 | PubChem CID:2130404
+BMGC_DG05207,BMG_DG116340,"UNII:42445HUU0O | Iclaprim | CAS RN:192314-93-5 | DrugBank ID:DB06358 | 5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4-diamine | PubChem CID:213043 | ICLAPRIM | PubChem SID:198951150"
+BMGC_DG05208,BMG_DG116343,"(1S,2R,6S,7R)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione | DrugBank ID:DB08815 | UNII:22IC88528T | PubChem CID:213046 | LURASIDONE | CAS RN:367514-87-2 | Lurasidone | PubChem SID:175265796"
+BMGC_DG05209,BMG_DG116345,"(5R)-3-[4-[1-[(2S)-2,3-dihydroxypropanoyl]-3,6-dihydro-2H-pyridin-4-yl]-3,5-difluorophenyl]-5-(1,2-oxazol-3-yloxymethyl)-1,3-oxazolidin-2-one | PubChem CID:213049 | POSIZOLID | PubChem SID:198988070 | CAS RN:252260-02-9 | DrugBank ID:DB04850 | UNII:82V2M8K24R | Posizolid"
+BMGC_DG05210,BMG_DG116346,PubChem CID:213052 | DrugBank ID:DB06368 | Alamifovir
+BMGC_DG05211,BMG_DG116347,CIMICOXIB | CAS RN:265114-23-6 | PubChem SID:198948073 | 4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide | PubChem CID:213053 | Cimicoxib | DrugBank ID:DB05095 | UNII:W7FHJ107MC
+BMGC_DG05212,BMG_DG116349,"PubChem SID:198977294 | CAS RN:176027-90-0 | CAS RN:176199-48-7 | PubChem CID:213056 | (1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid | Eglumetad | UNII:ONU5A67T2S | EGLUMETAD"
+BMGC_DG05213,BMG_DG116351,"UNII:I38CB53794 | 2-Phenyl-1,3-propanediol monocarbamate | PubChem CID:213060 | CAS RN:25451-53-0 | (3-hydroxy-2-phenylpropyl) carbamate | PubChem SID:198937630 | 3-HYDROXY-2-PHENYLPROPYL CARBAMATE"
+BMGC_DG05214,BMG_DG116352,"6-methyl-N-phenyl-2,3-dihydro-1,4-oxathiine-5-carboxamide | DrugBank ID:DB04657 | CAS RN:5234-68-4 | Carboxin | CARBOXIN | UNII:5A8K850HDE | PubChem SID:198967866 | PubChem CID:21307"
+BMGC_DG05215,BMG_DG116358,AMBENONIUM | CAS RN:7648-98-8 | PubChem SID:175265408 | Ambenonium | PubChem CID:2131 | DrugBank ID:DB01122 | (2-chlorophenyl)methyl-[2-[[2-[2-[(2-chlorophenyl)methyl-diethylazaniumyl]ethylamino]-2-oxoacetyl]amino]ethyl]-diethylazanium | UNII:L16PUN799N
+BMGC_DG05216,BMG_DG116370,"Floxacillin | DrugBank ID:DB00301 | (2S,5R,6R)-6-[[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem SID:198978091 | FLUCLOXACILLIN | Flucloxacillin | PubChem CID:21319 | CAS RN:1847-24-1 | UNII:43B2M34G2V | CAS RN:5250-39-5"
+BMGC_DG05217,BMG_DG116371,"UNII:200168S0CL | UNII:QH6ZT6J071 | Ambroxol | AMBROXOL | PubChem SID:404859616 | AMBROXOL, CIS- | 4-[(2-amino-3,5-dibromophenyl)methylamino]cyclohexan-1-ol | PubChem CID:2132 | DrugBank ID:DB06742 | CAS RN:36557-04-7 | CAS RN:18683-91-5 | PubChem SID:198977050 | CAS RN:107814-37-9"
+BMGC_DG05218,BMG_DG116376,N-benzyl-1-methylpyridin-1-ium-4-carboxamide | ENISAMIUM | UNII:99SS65Q7OY | PubChem SID:198970325 | PubChem CID:2132298 | Enisamium | CAS RN:116533-18-7
+BMGC_DG05219,BMG_DG116388,"3-(2,5-DIMETHYLPYRROL-1-YL)BENZOIC ACID | PubChem CID:213329 | PubChem SID:485663389 | CAS RN:26180-28-9 | 3-(2,5-Dimethylpyrrol-1-yl)benzoic acid | UNII:FRU7G67S4W"
+BMGC_DG05220,BMG_DG116392,"UNII:PNT6041ST1 | 1,4-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione | CAS RN:64862-96-0 | AMETANTRONE | PubChem SID:198986309 | Ametantrone | PubChem CID:2134"
+BMGC_DG05221,BMG_DG116418,PubChem CID:2136 | AMFENAC | PubChem SID:198961794 | UNII:28O5C1J38A | CAS RN:51579-82-9
+BMGC_DG05222,BMG_DG116421,"DrugBank ID:DB06912 | UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE | PubChem CID:21363450"
+BMGC_DG05223,BMG_DG116427,PubChem SID:198981532 | PubChem CID:2137 | AMFONELIC ACID | UNII:RR302AR19Y | CAS RN:15180-02-6
+BMGC_DG05224,BMG_DG116432,DrugBank ID:DB02018 | PubChem CID:2138 | Amido Phenyl Pyruvic Acid
+BMGC_DG05225,BMG_DG116437,"Imidocarb | PubChem CID:21389 | CAS RN:27885-92-3 | UNII:8USS3K0VDH | PubChem SID:198970050 | 1,3-bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea | DrugBank ID:DB11521 | IMIDOCARB"
+BMGC_DG05226,BMG_DG116449,"DrugBank ID:DB00271 | PubChem SID:175268321 | PubChem CID:2140 | 3,5-diacetamido-2,4,6-triiodobenzoic acid | UNII:5UVC90J1LK | Diatrizoate | Diatrizoic Acid | CAS RN:117-96-4 | DIATRIZOIC ACID"
+BMGC_DG05227,BMG_DG116464,2-(3-aminopropylamino)ethylsulfanylphosphonic acid | CAS RN:20537-88-6 | PubChem CID:2141 | PubChem SID:175265695 | DrugBank ID:DB01143 | UNII:ILA426L95O | Amifostine | AMIFOSTINE ANHYDROUS
+BMGC_DG05228,BMG_DG116500,"UNII:TCN4MG2VXS | PubChem SID:198967137 | DrugBank ID:DB08639 | DAPIVIRINE | 4-[[4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile | PubChem CID:214347 | Dapivirine | CAS RN:244767-67-7"
+BMGC_DG05229,BMG_DG116501,"NDC:43598-854 | NDC:68462-496 | NDC:0078-0470 | NDC:59651-410 | NDC:67877-551 | NDC:70710-1011 | NDC:0078-0656 | NDC:0078-0713 | NDC:62756-570 | CAS RN:1044764-54-6 | NDC:69452-159 | NDC:67877-552 | NDC:67877-553 | NDC:69097-570 | NDC:70771-1411 | NDC:72205-075 | NDC:0480-7011 | NDC:72603-232 | NDC:69539-199 | 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid | NDC:0480-7013 | NDC:69238-1486 | NDC:69539-023 | NDC:0480-7012 | NDC:57664-770 | NDC:59651-412 | NDC:0078-0654 | NDC:31722-011 | NDC:43598-851 | NDC:0078-0727 | NDC:70771-1410 | NDC:42806-373 | NDC:46708-411 | NDC:69238-1487 | NDC:45963-455 | NDC:69238-1703 | NDC:69539-022 | NDC:46708-410 | NDC:69238-1488 | NDC:57664-768 | NDC:62332-412 | NDC:67877-676 | NDC:0591-4735 | NDC:67877-549 | NDC:31722-012 | NDC:69539-073 | NDC:0078-0720 | NDC:62332-411 | NDC:72205-176 | NDC:69238-1704 | NDC:70771-1409 | NDC:69539-200 | CAS RN:201530-41-8 | NDC:69539-074 | NDC:69097-560 | NDC:46708-326 | PubChem CID:214348 | NDC:43598-856 | NDC:46708-412 | NDC:0078-0469 | NDC:62756-569 | NDC:69097-550 | NDC:69238-1702 | PubChem SID:175266885 | NDC:43598-855 | NDC:70771-1472 | NDC:69097-391 | NDC:70771-1473 | NDC:0591-4730 | NDC:69097-392 | NDC:0591-4740 | NDC:72205-076 | NDC:59651-411 | NDC:62332-324 | NDC:68462-495 | NDC:62332-410 | NDC:72603-231 | NDC:69539-303 | NDC:69539-021 | NDC:70771-1471 | NDC:68462-494 | NDC:31722-031 | NDC:45963-456 | NDC:46708-324 | NDC:70710-1275 | NDC:31722-013 | NDC:0078-0468 | DrugBank ID:DB01609 | Deferasirox | NDC:67877-550 | NDC:69452-160 | NDC:0078-0655 | NDC:69452-161 | NDC:43598-853 | NDC:70700-269 | NDC:62756-568 | NDC:70710-1012 | NDC:31722-030 | NDC:45963-454 | NDC:57664-769 | NDC:42806-372 | NDC:62332-325 | NDC:69097-393 | NDC:70710-1276 | NDC:70700-270 | NDC:70710-1277 | NDC:62332-326 | NDC:69539-075 | NDC:70700-271 | NDC:46708-325 | NDC:72603-233 | NDC:42806-371 | NDC:67877-677 | NDC:67877-554 | NDC:67877-675 | NDC:70710-1013 | NDC:31722-029 | DEFERASIROX | NDC:43598-852 | UNII:V8G4MOF2V9"
+BMGC_DG05230,BMG_DG116502,CAS RN:187523-35-9 | Flindokalner | UNII:J57O328W4W | PubChem CID:214350 | FLINDOKALNER | PubChem SID:198964399 | (3S)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1H-indol-2-one
+BMGC_DG05231,BMG_DG116503,PubChem CID:214351 | DrugBank ID:DB11964 | Ilaprazole | UNII:776Q6XX45J | CAS RN:172152-36-2 | 2-[(4-methoxy-3-methylpyridin-2-yl)methylsulfinyl]-6-pyrrol-1-yl-1H-benzimidazole | PubChem SID:198973981 | ILAPRAZOLE
+BMGC_DG05232,BMG_DG116512,2-Aminobenzyl alcohol | PubChem SID:440089848 | DrugBank ID:DB03058 | (2-aminophenyl)methanol | 2-AMINOBENZYL ALCOHOL | UNII:JK3AH3NG9C | PubChem CID:21439 | CAS RN:5344-90-1
+BMGC_DG05233,BMG_DG116513,CAS RN:165618-72-4 | N-(2-(2-(2-AMINOETHOXY)ETHOXY)ETHYL)-4-(AMINOSULFONYL)BENZAMIDE | PubChem CID:2144 | PubChem SID:475550264 | Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide | DrugBank ID:DB02535 | UNII:P7AMK4J5SW | N-[2-[2-(2-Aminoethoxy)ethoxy]ethyl]-4-(aminosulfonyl)benzamide
+BMGC_DG05234,BMG_DG116528,"CAS RN:125-84-8 | Aminoglutethimide | AMINOGLUTETHIMIDE | UNII:0O54ZQ14I9 | 3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione | PubChem SID:175272154 | PubChem CID:2145 | DrugBank ID:DB00357"
+BMGC_DG05235,BMG_DG116533,UNII:3ED9JU5XWE | CAS RN:5355-42-0 | PubChem SID:377308629 | PubChem CID:21454 | N-SKATYLPIPERIDINE
+BMGC_DG05236,BMG_DG116538,2-aminoguanidine | Pimagedine | UNII:SCQ4EZQ113 | PIMAGEDINE | CAS RN:79-17-4 | PubChem CID:2146 | DrugBank ID:DB05383 | PubChem SID:198975275 | Aminoguanidine
+BMGC_DG05237,BMG_DG116555,UNII:Y79XT83BJ9 | 2-[(4-aminobenzoyl)amino]acetic acid | PubChem CID:2148 | Aminohippuric acid | CAS RN:94-16-6 | CAS RN:61-78-9 | PubChem SID:175266562 | AMINOHIPPURIC ACID | DrugBank ID:DB00345
+BMGC_DG05238,BMG_DG116568,UNII:1ZHM019FLD | PubChem CID:2149 | CAS RN:924-49-2 | PubChem SID:198982183 | .GAMMA.-AMINO-.BETA.-HYDROXYBUTYRIC ACID
+BMGC_DG05239,BMG_DG116582,PubChem CID:215 | Aminoacetone | CAS RN:298-08-8 | AMINOACETONE | UNII:ZB4ES38S4R | PubChem SID:198986088 | 1-aminopropan-2-one
+BMGC_DG05240,BMG_DG116583,UNII:235Y7P37ZD | PubChem SID:241180328 | 5-Nitroindazole | CAS RN:5401-94-5 | 5-NITROINDAZOLE | PubChem CID:21501 | DrugBank ID:DB04534
+BMGC_DG05241,BMG_DG116589,"UNII:7NVZ9DW9Q5 | PubChem CID:21507 | 2-AMINO-4,6-DIMETHYLPYRIDINE | CAS RN:5407-87-4 | PubChem SID:348481368"
+BMGC_DG05242,BMG_DG116592,"PubChem CID:2151 | 4-Aminoantipyrine | PubChem SID:198951923 | AMPYRONE | 4-amino-1,5-dimethyl-2-phenylpyrazol-3-one | UNII:0M0B7474RA | CAS RN:83-07-8"
+BMGC_DG05243,BMG_DG116593,"2,8-Dichlorodibenzofuran | CAS RN:5409-83-6 | 2,8-DICHLORODIBENZOFURAN | UNII:GNF0836UQJ | 2,8-dichlorodibenzofuran | PubChem CID:21510 | PubChem SID:198977072"
+BMGC_DG05244,BMG_DG116598,PubChem SID:198950709 | CAS RN:602-07-3 | TASPINE | UNII:V53XN9L07O | PubChem CID:215159
+BMGC_DG05245,BMG_DG116611,"CAS RN:50857-74-4 | NDC:17856-0038 | NDC:62332-026 | CAS RN:58-55-9 | NDC:29033-059 | NDC:42858-701 | NDC:52244-300 | NDC:68462-722 | NDC:51407-319 | NDC:62135-556 | NDC:29033-058 | Theophylline | NDC:60219-2046 | NDC:46708-026 | NDC:68462-380 | NDC:72789-442 | DrugBank ID:DB00277 | NDC:72578-174 | NDC:69452-267 | NDC:42291-922 | NDC:62135-457 | NDC:46708-025 | PubChem SID:175265808 | NDC:62332-025 | UNII:0I55128JYK | NDC:29033-002 | PubChem CID:2153 | NDC:72578-173 | NDC:29033-001 | CAS RN:8061-56-1 | NDC:60219-2045 | NDC:51407-318 | CAS RN:75448-53-2 | NDC:31722-077 | NDC:31722-078 | NDC:68462-356 | NDC:70771-1782 | THEOPHYLLINE ANHYDROUS | NDC:64380-243 | NDC:23155-741 | NDC:23155-742 | 1,3-dimethyl-7H-purine-2,6-dione | NDC:82638-105 | NDC:72162-2038 | NDC:82638-106 | NDC:70095-017 | CAS RN:1246816-25-0 | NDC:70095-018 | NDC:64380-244 | NDC:70771-1783 | NDC:52244-200 | NDC:52244-400 | NDC:27808-033 | NDC:70408-644 | NDC:52244-100 | NDC:68462-721 | NDC:29033-057 | NDC:72789-441"
+BMGC_DG05246,BMG_DG116629,"ETHYL 3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLATE | PubChem SID:440089581 | UNII:SS3UNU86DP | DrugBank ID:DB04271 | PubChem CID:215436 | CAS RN:35691-93-1 | 3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester"
+BMGC_DG05247,BMG_DG116639,PubChem SID:198937767 | AMINOTHIAZOLE | CAS RN:96-50-4 | PubChem CID:2155 | UNII:5K8WKN668K
+BMGC_DG05248,BMG_DG116652,PubChem CID:21563 | METHAFURYLENE | PubChem SID:198971583 | CAS RN:531-06-6 | UNII:HU5BZT118T
+BMGC_DG05249,BMG_DG116660,"AMIODARONE | PubChem CID:2157 | PubChem SID:175266463 | Amiodarone | UNII:N3RQ532IUT | (2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone | DrugBank ID:DB01118 | CAS RN:1951-25-3"
+BMGC_DG05250,BMG_DG116691,"Piperolein B | CAS RN:30505-89-6 | PubChem CID:21580213 | (E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnon-8-en-1-one"
+BMGC_DG05251,BMG_DG116692,"PubChem CID:21580417 | methyl (1R,2S,12S,14R,16S)-16-hydroxy-2,6,6,11,14,16-hexamethyl-18-methylidene-8,15,17-trioxo-7-oxatetracyclo[12.3.1.02,12.05,10]octadeca-4,10-diene-1-carboxylate | Berkeleydione"
+BMGC_DG05252,BMG_DG116708,"sodium;1,1-dioxo-1,2-benzothiazol-3-one | CAS RN:128-44-9 | PubChem CID:21583979 | Sodium saccharin"
+BMGC_DG05253,BMG_DG116712,CAS RN:19022-77-6 | UNII:5W12C1HF5I | DrugBank ID:DB13280 | PubChem SID:198948018 | aluminum;3-oxobutanoate | ALUMINUM ACETOACETATE | PubChem CID:21584777 | Aluminium acetoacetate
+BMGC_DG05254,BMG_DG116715,"CAS RN:103060-53-3 | NDC:25021-179 | NDC:0143-9378 | NDC:0338-0718 | NDC:16729-434 | NDC:72572-102 | PubChem CID:21585658 | NDC:42658-011 | NDC:25021-174 | NDC:31722-216 | NDC:71839-107 | NDC:16729-435 | NDC:16714-892 | NDC:70377-093 | NDC:43598-476 | NDC:67457-941 | NDC:71839-108 | NDC:72572-100 | PubChem SID:175268948 | DAPTOMYCIN | Daptomycin | DrugBank ID:DB00080 | (3S)-3-[[(2R)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid | NDC:71288-016 | NDC:71288-017 | NDC:67457-813 | NDC:67919-012 | NDC:0409-0122 | NDC:31722-102 | NDC:55150-344 | NDC:60977-145 | NDC:69097-850 | NDC:31722-215 | NDC:70436-033 | NDC:14335-120 | NDC:70594-034 | NDC:0338-0714 | NDC:60505-6229 | NDC:68001-376 | UNII:NWQ5N31VKK | NDC:0338-0712 | NDC:70594-053 | NDC:72603-152 | NDC:63323-371 | NDC:69097-807 | NDC:0338-0716 | NDC:70594-060 | NDC:83634-107 | NDC:72603-147 | NDC:0409-0120 | NDC:67184-0549 | NDC:43598-413 | NDC:70594-066"
+BMGC_DG05255,BMG_DG116731,PubChem CID:2159 | UNII:8110R61I4U | NDC:71390-125 | CAS RN:71675-85-9 | Amisulpride | PubChem SID:198947817 | 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide | DrugBank ID:DB06288 | AMISULPRIDE
+BMGC_DG05256,BMG_DG116738,"Isoangustone A | UNII:58NM254N9T | 3-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-6-(3-methylbut-2-enyl)chromen-4-one | CAS RN:129280-34-8 | PubChem SID:461433624 | PubChem CID:21591148 | ISOANGUSTONE A"
+BMGC_DG05257,BMG_DG116754,"PubChem CID:21593830 | 3,5-dioxa-11-azahexacyclo[9.9.2.02,6.08,21.014,22.015,20]docosa-1(21),2(6),7,14(22),15,17,19-heptaene-12,13-dione | Lettowianthine"
+BMGC_DG05258,BMG_DG116774,"PubChem CID:21596130 | Steppogenin | CAS RN:121694-88-0 | 2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydrochromen-4-one"
+BMGC_DG05259,BMG_DG116775,PubChem SID:241177838 | UNII:909I60JU7Q | 30-NORHEDERAGENIN | PubChem CID:21596158 | CAS RN:117654-06-5
+BMGC_DG05260,BMG_DG116798,"UNII:1806D8D52K | N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine | DrugBank ID:DB00321 | PubChem SID:175267098 | AMITRIPTYLINE | Amitriptyline | CAS RN:50-48-6 | PubChem CID:2160"
+BMGC_DG05261,BMG_DG116844,"PubChem CID:2161 | PubChem SID:198967827 | 2-amino-5-oxo-7-propan-2-ylchromeno[2,3-b]pyridine-3-carboxylic acid | DrugBank ID:DB01025 | Amlexanox | AMLEXANOX | CAS RN:68302-57-8 | UNII:BRL1C2459K"
+BMGC_DG05262,BMG_DG116858,"NDC:64380-216 | NDC:13668-385 | NDC:64380-215 | NDC:13668-386 | NDC:51407-774 | NDC:64380-214 | 3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | NDC:23155-845 | PubChem SID:175271535 | NDC:51407-773 | NDC:23155-844 | NDC:51407-771 | AMLODIPINE | NDC:13668-382 | NDC:46287-035 | NDC:23155-847 | PubChem CID:2162 | NDC:13668-383 | NDC:64380-217 | NDC:51407-772 | UNII:1J444QC288 | CAS RN:88150-42-9 | DrugBank ID:DB00381 | NDC:13668-397 | NDC:23155-846 | Amlodipine"
+BMGC_DG05263,BMG_DG116859,"CAS RN:193273-66-4 | PubChem CID:216208 | DrugBank ID:DB15205 | N-[(2R)-1-[(3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-phenylmethoxypropan-2-yl]-2-amino-2-methylpropanamide | UNII:0MQ44VUN84 | PubChem SID:198982121 | CAPROMORELIN | Capromorelin"
+BMGC_DG05264,BMG_DG116860,CAS RN:211914-51-1 | UNII:I0VM4M70GC | DrugBank ID:DB14726 | DABIGATRAN | PubChem CID:216210 | PubChem SID:175265508 | Dabigatran | 3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid
+BMGC_DG05265,BMG_DG116878,ELAROFIBAN ANHYDROUS | UNII:T9YH5NSL8U | PubChem SID:198955588 | CAS RN:198958-88-2 | PubChem CID:216230
+BMGC_DG05266,BMG_DG116881,"SITAXENTAN | PubChem CID:216235 | DrugBank ID:DB06268 | Sitaxentan | PubChem SID:198974562 | N-(4-chloro-3-methyl-1,2-oxazol-5-yl)-2-[2-(6-methyl-1,3-benzodioxol-5-yl)acetyl]thiophene-3-sulfonamide | UNII:J9QH779MEM | CAS RN:184036-34-8"
+BMGC_DG05267,BMG_DG116882,"4-amino-5-chloro-2-methoxy-N-[(3S,4R)-3-methoxypiperidin-4-yl]benzamide | CAS RN:83863-69-8 | DrugBank ID:DB06422 | UNII:U221XI117N | PubChem CID:216236 | UNII:QNG273A81O | Ticalopride | PubChem SID:383470489 | CAS RN:202590-69-0 | NORCISAPRIDE, (+)- | PubChem SID:198934705 | NORCISAPRIDE"
+BMGC_DG05268,BMG_DG116883,"CAS RN:150683-30-0 | PubChem SID:175271590 | N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide | UNII:21G72T1950 | TOLVAPTAN | Tolvaptan | PubChem CID:216237"
+BMGC_DG05269,BMG_DG116885,NDC:51407-760 | 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide | CAS RN:284461-73-0 | PubChem CID:216239 | NDC:50419-488 | NDC:24979-715 | DrugBank ID:DB00398 | UNII:9ZOQ3TZI87 | PubChem SID:175265530 | NDC:50419-489 | NDC:51990-201 | NDC:13668-682 | CAS RN:100012-18-8 | SORAFENIB | Sorafenib
+BMGC_DG05270,BMG_DG116889,CAS RN:219311-44-1 | UNII:LGX4GZ74WO | PubChem SID:198976064 | DABUZALGRON | PubChem CID:216249
+BMGC_DG05271,BMG_DG116894,"PubChem CID:216258 | pentasodium;[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate | CAS RN:12705-41-8 | Colistinmethanesulfonic acid | CAS RN:8068-37-9"
+BMGC_DG05272,BMG_DG116904,UNII:7E4LT54X4D | PubChem SID:443625005 | TRIPHLORETHOL B | CAS RN:79005-83-7 | PubChem CID:21626545
+BMGC_DG05273,BMG_DG116909,"CAS RN:468-54-2 | PubChem CID:216272 | Mesembrenone, (+)- | MESEMBRENONE, (+)- | PubChem SID:474493073 | UNII:HT8JNS8E79"
+BMGC_DG05274,BMG_DG116930,UNII:8892KM4U61 | IMANIXIL | PubChem CID:216289 | PubChem SID:198978998 | CAS RN:75689-93-9
+BMGC_DG05275,BMG_DG116939,"PubChem SID:198978044 | 2-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)-N-[1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl]acetamide | PubChem CID:216294 | FRESELESTAT | CAS RN:208848-19-5 | UNII:1CW4RL23VP | Freselestat"
+BMGC_DG05276,BMG_DG116960,"SUCCINOBUCOL | Succinobucol | PubChem SID:198961047 | 4-[2,6-ditert-butyl-4-[2-(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylpropan-2-ylsulfanyl]phenoxy]-4-oxobutanoic acid | UNII:J1J54V24R4 | DrugBank ID:DB05399 | CAS RN:216167-82-7 | PubChem CID:216325"
+BMGC_DG05277,BMG_DG116961,"NDC:0378-1940 | 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione | NDC:70710-1033 | NDC:0480-1242 | NDC:31722-260 | NDC:0378-1942 | NDC:43598-511 | NDC:69097-384 | PubChem CID:216326 | NDC:43598-512 | NDC:0480-1241 | NDC:60505-4533 | NDC:69097-381 | NDC:31722-257 | Lenalidomide | CAS RN:443912-14-9 | NDC:70771-1680 | NDC:31722-262 | NDC:59651-342 | NDC:70710-1035 | NDC:43598-513 | NDC:0480-1246 | DrugBank ID:DB00480 | LENALIDOMIDE | NDC:47781-485 | NDC:59572-402 | NDC:63304-046 | NDC:70771-1681 | NDC:69097-382 | NDC:0378-1941 | PubChem SID:175271649 | NDC:70710-1032 | NDC:47781-488 | NDC:63304-045 | CAS RN:191732-72-6 | NDC:63304-043 | NDC:70710-1030 | NDC:69097-604 | NDC:0378-1935 | NDC:0480-1243 | NDC:76282-698 | NDC:59572-410 | NDC:31722-261 | NDC:59651-343 | NDC:31722-259 | NDC:47781-483 | NDC:76282-696 | NDC:60505-4536 | NDC:43598-514 | NDC:31722-258 | NDC:43598-516 | NDC:60505-4537 | NDC:60505-4532 | NDC:0378-1937 | NDC:0480-1244 | NDC:59572-420 | NDC:60505-4534 | NDC:60505-4535 | NDC:47781-487 | NDC:0480-1245 | NDC:59651-346 | NDC:76282-699 | NDC:70771-1677 | NDC:70710-1034 | NDC:63304-041 | NDC:76282-697 | NDC:70710-1031 | NDC:70771-1679 | NDC:69097-383 | NDC:59651-344 | NDC:59572-415 | NDC:76282-700 | NDC:59572-425 | NDC:59651-347 | NDC:0378-1936 | NDC:76282-701 | NDC:63304-044 | NDC:69097-385 | NDC:59651-345 | UNII:F0P408N6V4 | NDC:59572-405 | NDC:70771-1676 | NDC:63304-042 | NDC:70771-1678 | NDC:47781-486 | NDC:47781-484 | NDC:43598-515"
+BMGC_DG05278,BMG_DG116963,"PubChem SID:198956389 | CAS RN:289656-45-7 | Senicapoc | UNII:TS6G201A6Q | PubChem CID:216327 | SENICAPOC | DrugBank ID:DB06280 | 2,2-bis(4-fluorophenyl)-2-phenylacetamide"
+BMGC_DG05279,BMG_DG117000,"CAS RN:137215-12-4 | Odiparcil | 4-methyl-7-[(2R,3R,4S,5S)-3,4,5-trihydroxythian-2-yl]oxychromen-2-one | UNII:FIK1414ZI8 | DrugBank ID:DB06609 | ODIPARCIL | PubChem SID:198980703 | PubChem CID:216385"
+BMGC_DG05280,BMG_DG117003,"UNII:GWH6IJ239E | DrugBank ID:DB01351 | 5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione | CAS RN:57-43-2 | PubChem SID:175267584 | Amobarbital | AMOBARBITAL | PubChem CID:2164"
+BMGC_DG05281,BMG_DG117007,"Lasofoxifene | PubChem CID:216416 | PubChem SID:198945374 | CAS RN:180916-16-9 | UNII:337G83N988 | LASOFOXIFENE | (5R,6S)-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol | CAS RN:180915-78-0 | DrugBank ID:DB06202"
+BMGC_DG05282,BMG_DG117016,4-[[5-[[4-(3-chlorophenyl)-3-oxopiperazin-1-yl]methyl]imidazol-1-yl]methyl]benzonitrile | L-778123 | L-778123 FREE BASE | PubChem SID:255509309 | DrugBank ID:DB07227 | CAS RN:183499-57-2 | PubChem CID:216454 | L-778123 free base | UNII:31ZXM8ZKQ3
+BMGC_DG05283,BMG_DG117017,"OCINAPLON | CAS RN:96604-21-6 | pyridin-2-yl-(7-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-3-yl)methanone | UNII:2H6KVC5E76 | PubChem SID:198982742 | Ocinaplon | PubChem CID:216456 | DrugBank ID:DB06529"
+BMGC_DG05284,BMG_DG117022,"PubChem CID:216466 | 3-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-bicyclo[2.2.2]octanyl]propanoic acid | TONAPOFYLLINE | Tonapofylline | UNII:83VNU4U44T | PubChem SID:198988154 | CAS RN:340021-17-2 | DrugBank ID:DB12569"
+BMGC_DG05285,BMG_DG117023,"Indisulam | CAS RN:165668-41-7 | INDISULAM | PubChem SID:198956059 | UNII:WJ98J3NM90 | 4-N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide | PubChem CID:216468 | DrugBank ID:DB06370"
+BMGC_DG05286,BMG_DG117026,UNII:7QY1MH15BG | 4-(4-Hydroxyphenyl)-2-butanone | CAS RN:5471-51-2 | 4-(P-HYDROXYPHENYL)-2-BUTANONE | PubChem SID:198962099 | PubChem CID:21648 | 4-(4-hydroxyphenyl)butan-2-one
+BMGC_DG05287,BMG_DG117030,CAS RN:1021496-19-4 | CAS RN:86-42-0 | PubChem SID:175266231 | AMODIAQUINE | UNII:220236ED28 | Amodiaquine | 4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol | PubChem CID:2165 | DrugBank ID:DB00613
+BMGC_DG05288,BMG_DG117036,ISOQUINE | PubChem CID:2166 | CAS RN:1643-45-4 | PubChem SID:485663622 | UNII:GKN7GKK6EY | Isoquine
+BMGC_DG05289,BMG_DG117110,[2-hydroxy-2-(4-hydroxyphenyl)ethyl]azanium | Octopaminium | PubChem CID:21680226
+BMGC_DG05290,BMG_DG117118,"PubChem CID:21680713 | Pyopen | (2S,5R,6R)-6-[(2-carboxylato-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate"
+BMGC_DG05291,BMG_DG117136,"AMOXAPINE | UNII:R63VQ857OT | Amoxapine | 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine | NDC:0591-5716 | DrugBank ID:DB00543 | NDC:62135-701 | NDC:0591-5713 | PubChem SID:175267621 | NDC:0591-5715 | NDC:62135-700 | NDC:62135-703 | PubChem CID:2170 | CAS RN:14028-44-5 | NDC:0591-5714 | NDC:62135-702"
+BMGC_DG05292,BMG_DG117137,"NDC:59310-304 | Beclomethasone Dipropionate | Beclomethasone dipropionate | NDC:59310-302 | DrugBank ID:DB00394 | NDC:50090-3458 | CAS RN:5534-09-8 | NDC:50090-5031 | NDC:50090-3459 | BECLOMETHASONE DIPROPIONATE | PubChem CID:21700 | PubChem SID:175266482 | NDC:50090-5032 | NDC:59310-406 | NDC:59310-410 | UNII:5B307S63B2 | [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate"
+BMGC_DG05293,BMG_DG117142,"PubChem CID:21704 | Vidarabine | UNII:3XQD2MEW34 | CAS RN:5536-17-4 | VIDARABINE ANHYDROUS | (2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | DrugBank ID:DB00194 | PubChem SID:198949958"
+BMGC_DG05294,BMG_DG117143,"PubChem CID:21706 | CAS RN:5542-28-9 | CAS RN:102783-36-8 | Diadenosine tetraphosphate | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate"
+BMGC_DG05295,BMG_DG117165,"UNII:69U0IKR8FP | IPRINDOLE | CAS RN:5560-72-5 | 3-(6,7,8,9,10,11-hexahydrocycloocta[b]indol-5-yl)-N,N-dimethylpropan-1-amine | DrugBank ID:DB13496 | PubChem CID:21722 | PubChem SID:198965400 | Iprindole"
+BMGC_DG05296,BMG_DG117202,PubChem CID:21733122 | Tetrodotoxin | DrugBank ID:DB05232
+BMGC_DG05297,BMG_DG117254,"PubChem SID:198990176 | CAS RN:15686-37-0 | CAS RN:35941-65-2 | UNII:Z22441975X | N,N,2-trimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)propan-1-amine | Butriptyline | PubChem CID:21772 | BUTRIPTYLINE | DrugBank ID:DB09016"
+BMGC_DG05298,BMG_DG117263,"PubChem SID:255508961 | UNII:7FT4O2NC8G | PubChem SID:198936153 | N-(3-chloropropyl)-1-phenylpropan-2-amine | PubChem SID:255509385 | UNII:K98M4N387W | CAS RN:111051-41-3 | MEFENOREX, (-)- | DrugBank ID:DB13852 | PubChem CID:21777 | CAS RN:17243-57-1 | UNII:85052999IT | CAS RN:111051-42-4 | MEFENOREX | MEFENOREX, (+)- | Mefenorex"
+BMGC_DG05299,BMG_DG117269,CAS RN:13082-85-4 | AMPROLIUM ION | Amprolium ion | PubChem SID:175267665 | UNII:H2T307KMZR | 5-[(2-methylpyridin-1-ium-1-yl)methyl]-2-propylpyrimidin-4-amine | PubChem CID:2178
+BMGC_DG05300,BMG_DG117285,2-piperidin-1-ylethyl 1-cyclohexylcyclohexane-1-carboxylate | CAS RN:561-77-3 | Dihexyverine | DrugBank ID:DB13678 | UNII:J2FQ66RU9W | DIHEXYVERINE | PubChem CID:21788 | PubChem SID:198963673
+BMGC_DG05301,BMG_DG117287,N-[4-(acridin-9-ylamino)-3-methoxyphenyl]methanesulfonamide | AMSACRINE | PubChem CID:2179 | PubChem SID:198940643 | Amsacrine | CAS RN:51264-14-3 | DrugBank ID:DB00276 | UNII:00DPD30SOY
+BMGC_DG05302,BMG_DG117298,"PubChem CID:218 | 2-AMINO-6-(HYDROXYMETHYL)-7,8-DIHYDRO-3H-PTERIDIN-4-ONE | 6-Hydroxymethyl-7,8-Dihydropterin | PubChem SID:472425053 | UNII:B46L5LR2XM | DrugBank ID:DB02119 | CAS RN:3672-03-5"
+BMGC_DG05303,BMG_DG117299,"2-Phenyl-2-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | CAS RN:1173199-73-9 | PubChem CID:2180 | 2-phenyl-2-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | CAS RN:51371-34-7 | CAS RN:29883-15-6"
+BMGC_DG05304,BMG_DG117300,"NDC:51407-273 | NDC:63629-9324 | NDC:45802-505 | NDC:63187-286 | NDC:66993-938 | NDC:51672-4048 | PubChem CID:21800 | NDC:50090-0235 | NDC:0472-0382 | NDC:70518-4187 | NDC:45802-889 | PubChem SID:175268365 | NDC:70518-3884 | NDC:72162-1415 | NDC:63629-2520 | NDC:45802-376 | NDC:78206-124 | NDC:0713-0659 | NDC:0472-0380 | NDC:68071-4556 | NDC:59651-699 | NDC:50090-6474 | NDC:68788-6990 | NDC:45802-021 | NDC:67296-0426 | NDC:70771-1380 | NDC:51672-1390 | NDC:51672-1317 | NDC:63629-8617 | NDC:70518-4217 | NDC:51672-1309 | NDC:63629-8614 | NDC:0472-0379 | NDC:68788-7670 | NDC:68071-4814 | NDC:66993-897 | NDC:71205-524 | NDC:0168-0057 | NDC:68788-8419 | NDC:0168-0056 | NDC:68180-947 | NDC:0472-0381 | NDC:68788-8388 | NDC:70518-2352 | NDC:71205-275 | NDC:0168-0267 | [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate | NDC:50090-4680 | NDC:50090-2182 | NDC:67296-1369 | NDC:50090-0741 | NDC:70518-3562 | NDC:72189-182 | NDC:76420-858 | NDC:68040-714 | NDC:0713-0807 | NDC:68788-9219 | NDC:0168-0265 | NDC:50090-3121 | NDC:52817-824 | NDC:72189-518 | NDC:51672-1274 | NDC:35573-107 | NDC:50222-501 | NDC:72578-093 | CAS RN:5593-20-4 | NDC:72162-1428 | NDC:51672-1308 | NDC:63629-8758 | NDC:63629-9323 | NDC:50090-5232 | UNII:826Y60901U | NDC:73499-001 | NDC:45802-816 | NDC:68462-290 | NDC:72162-1405 | NDC:0168-0055 | NDC:68462-298 | NDC:51672-1340 | NDC:51672-1402 | NDC:50090-0236 | NDC:63629-8613 | NDC:0168-0258 | NDC:70771-1550 | NDC:50090-3276 | NDC:68071-4134 | NDC:70710-1233 | NDC:0168-0268 | NDC:50090-4679 | NDC:50090-4876 | Betamethasone Dipropionate | NDC:16714-496 | NDC:50222-302 | NDC:80425-0344 | BETAMETHASONE DIPROPIONATE | NDC:70518-0339 | NDC:70518-3701 | NDC:50090-6787 | NDC:0713-0848 | NDC:51672-1310 | NDC:63187-095 | NDC:16714-996"
+BMGC_DG05305,BMG_DG117314,CAS RN:13078-04-1 | 3-Piperidin-2-ylpyridine | CAS RN:40774-73-0 | PubChem CID:2181 | 3-piperidin-2-ylpyridine
+BMGC_DG05306,BMG_DG117315,PubChem SID:318164586 | 2-AMINO-4-CHLORO-6-METHYLPYRIMIDINE | CAS RN:5600-21-5 | UNII:8ZBB1FM476 | PubChem CID:21810
+BMGC_DG05307,BMG_DG117324,DrugBank ID:DB00261 | Anagrelide | PubChem CID:2182
+BMGC_DG05308,BMG_DG117326,"[(2R,3S,4R,5R)-5-(2-amino-6-methylsulfanylpurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | CAS RN:34020-33-2 | PubChem CID:21820757 | 6-Methylthioguanosine monophosphate"
+BMGC_DG05309,BMG_DG117329,"TRIAMCINOLONE HEXACETONIDE | Triamcinolone Hexacetonide | PubChem CID:21826 | CAS RN:5611-51-8 | NDC:59137-570 | [2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 3,3-dimethylbutanoate | UNII:I7GT1U99Y9 | PubChem SID:175266730"
+BMGC_DG05310,BMG_DG117334,CUMI-101 | UNII:N4Y2V13I7F | PubChem CID:21830793 | CAS RN:179756-61-7 | PubChem SID:198951843
+BMGC_DG05311,BMG_DG117346,"CAS RN:14051-33-3 | PubChem SID:198986807 | PubChem CID:21847 | 3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione | Benzetimide | BENZETIMIDE | UNII:B987T0L5FX | CAS RN:119391-55-8"
+BMGC_DG05312,BMG_DG117352,"2-amino-2-methylpropan-1-ol;1,3-dimethyl-7H-purine-2,6-dione | CAS RN:5634-34-4 | DrugBank ID:DB13812 | Ambuphylline | AMBUPHYLLINE | PubChem SID:198968461 | PubChem CID:21850 | UNII:VOU5V0B772"
+BMGC_DG05313,BMG_DG117358,"UNII:34ON63CCO3 | 2-(1-IODOETHYL)-1,3-DIOXOLANE-4-METHANOL | Iodinated glycerol | CAS RN:5634-39-9 | PubChem SID:198957693 | PubChem CID:21852 | [2-(1-iodoethyl)-1,3-dioxolan-4-yl]methanol"
+BMGC_DG05314,BMG_DG117363,CAS RN:63097-26-7 | 4-HO-PYR-T | PubChem SID:472422901 | UNII:55L8SYC7EQ | PubChem CID:21854226
+BMGC_DG05315,BMG_DG117366,"Dimethindene | DIMETHINDENE | PubChem CID:21855 | DrugBank ID:DB08801 | UNII:661FH77Z3P | Dimetindene | PubChem SID:175272114 | CAS RN:5636-83-9 | N,N-dimethyl-2-[3-(1-pyridin-2-ylethyl)-1H-inden-2-yl]ethanamine"
+BMGC_DG05316,BMG_DG117372,"PubChem CID:21861202 | UNII:B3VAT0VP73 | CAS RN:155877-54-6 | 3-(5-(3-HYDROXYPHENYL)-1,3,4-THIADIAZOL-2-YL)PHENOL | PubChem SID:443624743"
+BMGC_DG05317,BMG_DG117407,PubChem CID:21867154 | Anisotropine methylbromide | DrugBank ID:DB00517
+BMGC_DG05318,BMG_DG117420,"UNII:2Z07MYW1AZ | NDC:72789-342 | ANASTROZOLE | NDC:68071-5203 | NDC:69117-0003 | NDC:76420-004 | NDC:65841-743 | NDC:68071-1543 | CAS RN:120511-73-1 | NDC:70518-2484 | DrugBank ID:DB01217 | NDC:23155-857 | 2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile | NDC:42291-085 | NDC:63629-5269 | NDC:68071-1682 | NDC:0093-7536 | NDC:63187-080 | Anastrozole | NDC:43063-383 | NDC:62135-490 | PubChem SID:175265575 | NDC:71335-1879 | NDC:0904-6195 | NDC:50090-2453 | PubChem CID:2187 | NDC:50268-075 | NDC:42291-016 | NDC:62559-670 | NDC:82804-162 | NDC:63850-0010 | NDC:50090-5002 | NDC:68001-155 | NDC:72189-415 | NDC:70518-4195 | NDC:60687-112 | NDC:59651-236 | NDC:51991-620 | NDC:68382-209 | NDC:72789-008 | NDC:16729-035"
+BMGC_DG05319,BMG_DG117436,"CAS RN:9007-28-7 | 6-(3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | PubChem CID:21873177 | CAS RN:39455-18-0 | Chondroitin, hydrogen sulfate"
+BMGC_DG05320,BMG_DG117442,"PubChem SID:175267210 | VIPADENANT | 3-[(4-amino-3-methylphenyl)methyl]-7-(furan-2-yl)triazolo[4,5-d]pyrimidin-5-amine | DrugBank ID:DB06625 | UNII:LDR3USH1NJ | CAS RN:442908-10-3 | Vipadenant | PubChem CID:21874557"
+BMGC_DG05321,BMG_DG117446,UNII:9M18MC2SIE | DIMOXYLINE PHOSPHATE | PubChem SID:198945543 | CAS RN:5667-46-9 | PubChem CID:21877
+BMGC_DG05322,BMG_DG117491,PubChem CID:21894739 | UNII:8Y492B8RSN | 5-Iodo-1H-indazole | PubChem SID:485663603 | CAS RN:55919-82-9 | 5-IODO-1H-INDAZOLE
+BMGC_DG05323,BMG_DG117516,"NDC:0409-1401 | NDC:0641-6253 | PubChem SID:175267893 | Regadenoson | DrugBank ID:DB06213 | PubChem CID:219024 | NDC:43598-616 | REGADENOSON ANHYDROUS | NDC:76329-3321 | UNII:7AXV542LZ4 | 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide | CAS RN:313348-27-5"
+BMGC_DG05324,BMG_DG117533,"ROXINDOLE | PubChem CID:219050 | PubChem SID:198986031 | Roxindole | 3-[4-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)butyl]-1H-indol-5-ol | CAS RN:112192-04-8 | UNII:43227SMS0O"
+BMGC_DG05325,BMG_DG117549,"DrugBank ID:DB04872 | PubChem CID:219077 | PubChem SID:198978083 | Osanetant | CAS RN:160492-56-8 | OSANETANT | N-[1-[3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl]-4-phenylpiperidin-4-yl]-N-methylacetamide | UNII:K7G81N94DT"
+BMGC_DG05326,BMG_DG117550,CAS RN:175481-36-4 | Lacosamide | LACOSAMIDE | PubChem SID:175266112 | (2R)-2-acetamido-N-benzyl-3-methoxypropanamide | UNII:563KS2PQY5 | DrugBank ID:DB06218 | PubChem CID:219078
+BMGC_DG05327,BMG_DG117560,PubChem CID:219090 | Fosaprepitant | DrugBank ID:DB06717
+BMGC_DG05328,BMG_DG117563,"PubChem SID:198979878 | CAS RN:109623-97-4 | propan-2-yl 5-(4-chlorophenoxy)-4-(methoxymethyl)-9H-pyrido[3,4-b]indole-3-carboxylate | UNII:BWP53NPW3F | DrugBank ID:DB13534 | GEDOCARNIL | PubChem CID:219095 | Gedocarnil"
+BMGC_DG05329,BMG_DG117576,PubChem CID:219100 | UNII:995FT1W541 | CAS RN:81267-65-4 | PubChem SID:198937807 | IDRONOXIL | Idronoxil | DrugBank ID:DB04915 | 3-(4-hydroxyphenyl)-2H-chromen-7-ol
+BMGC_DG05330,BMG_DG117578,"Traxoprodil | TRAXOPRODIL | UNII:UTC046R5HM | CAS RN:134234-12-1 | 1-[(1S,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]-4-phenylpiperidin-4-ol | PubChem CID:219101 | PubChem SID:198987879"
+BMGC_DG05331,BMG_DG117579,2-(butan-2-yldisulfanyl)-1H-imidazole | CAS RN:141400-58-0 | PubChem CID:219104 | UNII:8PQ9CZ8BTJ | 2-(Sec-butyldisulfanyl)-1h-imidazole | PubChem SID:316914269 | DrugBank ID:DB05448 | PX-12
+BMGC_DG05332,BMG_DG117581,GEPEFRINE | PubChem SID:198989536 | Gepefrine | UNII:V51RRX51VH | CAS RN:18840-47-6 | PubChem CID:219105 | 3-[(2S)-2-aminopropyl]phenol | DrugBank ID:DB13703
+BMGC_DG05333,BMG_DG117644,PubChem CID:219301 | 3-Carbazol-9-ylpropanoic acid | PubChem SID:485663386 | 3-CARBAZOL-9-YLPROPANOIC ACID | CAS RN:6622-54-4 | UNII:LFA72K58ZF
+BMGC_DG05334,BMG_DG117675,PubChem CID:2194 | ANETHOLTRITHION | PubChem SID:198975387 | 5-(4-methoxyphenyl)dithiole-3-thione | CAS RN:532-11-6 | Anethole trithione | UNII:QUY32964DJ | DrugBank ID:DB13853
+BMGC_DG05335,BMG_DG117690,"PubChem CID:21944094 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24Z,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone | Rapamycin (Sirolimus)"
+BMGC_DG05336,BMG_DG117692,"NDC:60687-694 | Methenamine Hippurate | NDC:47781-577 | NDC:50742-142 | 2-benzamidoacetic acid;1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane | NDC:42571-332 | NDC:59746-797 | PubChem CID:21945 | METHENAMINE HIPPURATE | NDC:51407-880 | NDC:50268-549 | CAS RN:5714-73-8 | PubChem SID:175267795 | NDC:69452-470 | UNII:M329791L57 | NDC:65862-782"
+BMGC_DG05337,BMG_DG117711,"UNII:589NV24LHC | UK-459,979 | CAS RN:473921-15-2 | PubChem SID:443624867 | PubChem CID:21949819"
+BMGC_DG05338,BMG_DG117733,"Maleic hydrazide | CAS RN:123-33-1 | 1,2-dihydropyridazine-3,6-dione | UNII:TQ7L3FCV66 | CAS RN:116595-47-2 | PubChem SID:198943645 | PubChem CID:21954 | MALEIC HYDRAZIDE"
+BMGC_DG05339,BMG_DG117754,"PubChem SID:313390106 | 2,2',4,4'-TETRAHYDROXYBENZIL | PubChem CID:219592 | UNII:38153NAW4H | CAS RN:5394-98-9"
+BMGC_DG05340,BMG_DG117756,PubChem CID:2196 | UNII:5L16LKN964 | Aniracetam | DrugBank ID:DB04599 | ANIRACETAM | 1-(4-methoxybenzoyl)pyrrolidin-2-one | CAS RN:72432-10-1 | PubChem SID:198959336
+BMGC_DG05341,BMG_DG117763,"PubChem CID:219605 | CAS RN:3457-55-4 | 1-Phenyl-1,2-butanedione | UNII:WKX2KUZ8HH | 1-PHENYL-1,2-BUTANEDIONE | PubChem SID:474493425"
+BMGC_DG05342,BMG_DG117800,"UNII:S747T1ERAJ | Anisindione | CAS RN:117-37-3 | PubChem SID:198952227 | PubChem CID:2197 | DrugBank ID:DB01125 | ANISINDIONE | 2-(4-methoxyphenyl)indene-1,3-dione"
+BMGC_DG05343,BMG_DG117810,PubChem SID:198970169 | UNII:N667F17JP1 | calcium;2-acetyloxybenzoate;urea | CAS RN:5749-67-7 | PubChem CID:21975 | Carbasalate calcium | DrugBank ID:DB13612 | CARBASPIRIN CALCIUM
+BMGC_DG05344,BMG_DG117811,"PubChem CID:219751 | CAS RN:23000-43-3 | UNII:EAD5BMA4P6 | 4-CHLORO-1-METHYL-1H-PYRAZOLO(3,4-D)PYRIMIDINE | 4-Chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine | PubChem SID:474493242"
+BMGC_DG05345,BMG_DG117816,"PubChem CID:21976428 | CAS RN:442847-46-3 | UNII:6XYQ5X5HP4 | 4-(2-FURANYL)-7H-PYRROLO(2,3-D)PYRIMIDIN-2-AMINE"
+BMGC_DG05346,BMG_DG117834,"PubChem SID:198947691 | (3R,5R,8R,9S,10S,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol | CAS RN:666752-60-9 | Pregnanediol | PREGNANDIOL | CAS RN:80-92-2 | UNII:JR3JD1Y22C | PubChem CID:219833"
+BMGC_DG05347,BMG_DG117838,"PubChem CID:219854 | 3-METHYL-1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-AMINE | UNII:APM58D7U9L | CAS RN:5399-44-0"
+BMGC_DG05348,BMG_DG117840,"PubChem SID:474493057 | PubChem CID:219860 | 1,3-Dimethyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine | 1,3-DIMETHYL-1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-AMINE | UNII:W22EBD6BK3 | CAS RN:5346-58-7"
+BMGC_DG05349,BMG_DG117871,"DrugBank ID:DB08799 | CAS RN:91-75-8 | UNII:DHA8014SS1 | PubChem CID:2200 | ANTAZOLINE | PubChem SID:175266860 | N-benzyl-N-(4,5-dihydro-1H-imidazol-2-ylmethyl)aniline | NDC:50967-410 | Antazoline"
+BMGC_DG05350,BMG_DG117874,"2,3-BUTANEDIOL, ERYTHRO- | DrugBank ID:DB02418 | CAS RN:5341-95-7 | meso-2,3-Butanediol | PubChem CID:220010 | (R,R)-2,3-Butanediol | PubChem SID:198989693 | UNII:F5IA8X9O8M | (2R,3S)-butane-2,3-diol"
+BMGC_DG05351,BMG_DG117877,LP-20 | CAS RN:1386927-90-7 | PubChem CID:22001618 | UNII:3RQ1LHQ82N | PubChem SID:198983857
+BMGC_DG05352,BMG_DG117883,PubChem SID:478838497 | CAS RN:1218922-39-4 | PubChem CID:22004198 | 2-(4-bromophenylsulfonamido)-N-hydroxyacetamide | 2-(4-BROMOPHENYLSULFONAMIDO)-N-HYDROXYACETAMIDE | UNII:HT9VCA96YD
+BMGC_DG05353,BMG_DG117916,CAS RN:5330-97-2 | N-HYDROXY-2-PHENYLACETAMIDE | UNII:N7FN9UU6A9 | PubChem CID:220184
+BMGC_DG05354,BMG_DG117922,"PubChem SID:175268209 | PubChem CID:2202 | Anthralin | UNII:U8CJK0JH5M | CAS RN:1143-38-0 | DrugBank ID:DB11157 | 1,8-dihydroxy-10H-anthracen-9-one | ANTHRALIN"
+BMGC_DG05355,BMG_DG117927,DrugBank ID:DB07474 | PubChem CID:22021390 | 3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE
+BMGC_DG05356,BMG_DG117943,"PubChem SID:198986148 | N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine | CAS RN:610798-31-7 | Icotinib | PubChem CID:22024915 | ICOTINIB | UNII:9G6U5L461Q | DrugBank ID:DB11737"
+BMGC_DG05357,BMG_DG117944,"PubChem CID:22025663 | 2-(2-FLUORO-4-IODOANILINO)-3,4-DIFLUOROBENZOIC ACID | UNII:5A6V9RGK6M | PubChem SID:443624185 | CAS RN:391211-97-5"
+BMGC_DG05358,BMG_DG117958,"CAS RN:633303-90-9 | 3-(PHENYLSULFONYL)-1H-PYRROLO(2,3-B)PYRIDINE | UNII:B2K79XS4SY | PubChem SID:443623834 | PubChem CID:22028181"
+BMGC_DG05359,BMG_DG117961,"PubChem CID:220295 | 2,4'-DIHYDROXYBENZOPHENONE | UNII:T6FT7G2A39 | PubChem SID:482553861 | CAS RN:606-12-2 | 2,4′-Dihydroxybenzophenone"
+BMGC_DG05360,BMG_DG117985,"Demecolcine | CAS RN:477-30-5 | DrugBank ID:DB13318 | UNII:Z01IVE25KI | PubChem CID:220401 | (7S)-1,2,3,10-tetramethoxy-7-(methylamino)-6,7-dihydro-5H-benzo[a]heptalen-9-one | PubChem SID:198977155 | DEMECOLCINE"
+BMGC_DG05361,BMG_DG117998,"3,3'-(DITHIOBIS(1-METHYL-1H-PYRROLE-5,2-DIYL))BIS-PYRIDINE | PubChem CID:220466 | CAS RN:5392-32-5 | UNII:23BE6CY1LW | PubChem SID:375578886"
+BMGC_DG05362,BMG_DG118002,"UNII:GEL7GRJ3R6 | CAS RN:1358027-80-1 | 3-(3-Bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide | 3-[3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxopyridin-1-yl]-N,4-dimethylbenzamide | DrugBank ID:DB07941 | PubChem CID:22049997 | PH-797804 | UNII:SI09I1V827 | CAS RN:586379-66-0 | PHA-797804 | PubChem SID:198942221 | PH-797804, (-)- | CAS RN:1073667-47-6 | PubChem SID:381132233"
+BMGC_DG05363,BMG_DG118015,4-phenylbutanoate | 4-Phenylbutyrate | PubChem CID:22053264
+BMGC_DG05364,BMG_DG118031,"1,5-dimethyl-2-phenylpyrazol-3-one | Antipyrine | PubChem SID:175266531 | DrugBank ID:DB01435 | CAS RN:60-80-0 | NDC:43742-2219 | PubChem CID:2206 | UNII:T3CHA1B51H | NDC:58264-0125 | NDC:43742-1413 | ANTIPYRINE"
+BMGC_DG05365,BMG_DG118047,UNII:H8B59H10OK | PubChem CID:2207 | 2-Amino-4-phosphonobutyric acid | 2-AMINO-4-PHOSPHONOBUTYRIC ACID | 2-amino-4-phosphonobutanoic acid | CAS RN:20263-07-4 | PubChem SID:317229040 | CAS RN:6323-99-5
+BMGC_DG05366,BMG_DG118094,"UNII:6073C2A77I | CAS RN:79-54-9 | LEVOPIMARIC ACID | (1R,4aR,4bS,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,9,10,10a-octahydrophenanthrene-1-carboxylic acid | Levopimaric acid | PubChem SID:198940377 | PubChem CID:221062"
+BMGC_DG05367,BMG_DG118102,2-(2-HEPTYNYLTHIO)-PHENOL ACETATE | UNII:GNC4EUY582 | PubChem CID:2211 | PubChem SID:472422179 | CAS RN:209125-28-0
+BMGC_DG05368,BMG_DG118108,UNII:FP92FP7NHU | CAS RN:10507-69-4 | N-Hydroxy-4-methoxybenzamide | N-HYDROXY-4-METHOXYBENZAMIDE | PubChem SID:474493176 | PubChem CID:221131
+BMGC_DG05369,BMG_DG118123,DrugBank ID:DB05540 | PubChem CID:22128 | Alanosine
+BMGC_DG05370,BMG_DG118141,N-ISOBUTYLFORMAMIDE | PubChem SID:482554312 | CAS RN:6281-96-5 | PubChem CID:221387 | UNII:UQH86RX4EL | N-Isobutylformamide
+BMGC_DG05371,BMG_DG118143,CAS RN:16522-48-8 | PubChem CID:2214 | 1-(4-hydroxy-3-methoxyphenyl)ethanone | Apocynin | DrugBank ID:DB12618 | PubChem SID:198963200 | CAS RN:498-02-2 | Acetovanillone | APOCYNIN | UNII:B6J7B9UDTR
+BMGC_DG05372,BMG_DG118157,PubChem CID:221427 | CAS RN:2327-17-5 | N-PHENYL-N'-2-PYRIDINYLUREA | UNII:M3JU59YUY6 | PubChem SID:445500626
+BMGC_DG05373,BMG_DG118168,"UNII:G1JO7801AE | (4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | CAS RN:81-25-4 | CAS RN:129874-08-4 | Cholic Acid | CAS RN:10321-98-9 | NDC:48951-4139 | NDC:45043-002 | CAS RN:361-09-1 | CHOLIC ACID | DrugBank ID:DB02659 | NDC:45043-001 | PubChem SID:198984028 | PubChem CID:221493"
+BMGC_DG05374,BMG_DG118192,"APRACLONIDINE | PubChem SID:175266986 | DrugBank ID:DB00964 | CAS RN:66711-21-5 | PubChem CID:2216 | UNII:843CEN85DI | 2,6-dichloro-1-N-(4,5-dihydro-1H-imidazol-2-yl)benzene-1,4-diamine | Apraclonidine"
+BMGC_DG05375,BMG_DG118218,3-methylpentanoate | PubChem CID:22173963 | 3-Methylpentanoate
+BMGC_DG05376,BMG_DG118220,4-Dimethylaminophenol | DrugBank ID:DB13549 | PubChem SID:198974604 | CAS RN:619-60-3 | UNII:X387L5559O | PubChem CID:22174 | 4-DIMETHYLAMINOPHENOL | 4-(dimethylamino)phenol
+BMGC_DG05377,BMG_DG118221,2-Methylpentanoate | 2-methylpentanoate | PubChem CID:22174055
+BMGC_DG05378,BMG_DG118227,N-PHENYLACRYLAMIDE | UNII:A2AQJ9FV2G | PubChem CID:221792 | CAS RN:2210-24-4 | PubChem SID:440088266
+BMGC_DG05379,BMG_DG118228,"PubChem SID:198949331 | UNII:5Y48085P9Q | Aprindine | N'-(2,3-dihydro-1H-inden-2-yl)-N,N-diethyl-N'-phenylpropane-1,3-diamine | APRINDINE | DrugBank ID:DB01429 | CAS RN:37640-71-4 | PubChem CID:2218"
+BMGC_DG05380,BMG_DG118264,UNII:5138Q19F1X | NDC:0395-0073 | CAS RN:7664-41-7 | CAS RN:8007-57-6 | NDC:37662-3621 | CAS RN:82168-61-4 | NDC:37662-3619 | NDC:37662-3620 | NDC:82749-150 | PubChem CID:222 | NDC:37662-3622 | azane | NDC:37662-3616 | NDC:37662-3623 | NDC:37662-3618 | AMMONIA | NDC:67777-251 | NDC:37662-3617 | NDC:0924-5401 | NDC:51027-0007 | Ammonia | NDC:46414-3333 | NDC:71872-7261 | NDC:68599-7100
+BMGC_DG05381,BMG_DG118292,"CAS RN:6283-46-1 | PubChem SID:441331263 | 1,2-DI(PHENOTHIAZIN-10-YL)ETHANE-1,2-DIONE | UNII:WIA4105SMC | PubChem CID:222149"
+BMGC_DG05382,BMG_DG118331,"Beta-Sitosterol | DrugBank ID:DB14038 | UNII:S347WMO6M4 | PubChem SID:175268335 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | CAS RN:83-46-5 | CAS RN:76772-70-8 | β-sitosterol | .BETA.-SITOSTEROL | PubChem CID:222284"
+BMGC_DG05383,BMG_DG118332,"PubChem SID:175267460 | UNII:RA96B954X6 | CAS RN:10030-58-7 | DrugBank ID:DB04481 | CAS RN:149-32-6 | NDC:84716-110 | (2S,3R)-butane-1,2,3,4-tetrol | Erythritol | ERYTHRITOL | PubChem CID:222285"
+BMGC_DG05384,BMG_DG118352,CAS RN:569352-88-1 | PubChem CID:22238483 | UNII:NUF3S8WJU8 | PubChem SID:472422623 | 6-METHOXY-5-(5-OXAZOLYL)-2-PHENYL-1H-INDOLE
+BMGC_DG05385,BMG_DG118355,5-[3-(difluoromethyl)-4-fluorophenyl]-3-[(2-methylimidazol-1-yl)methyl]pyridazine | EVT-101 FREE BASE | PubChem SID:198947545 | PubChem CID:22240172 | UNII:14DN1WB87S | CAS RN:627525-33-1 | EVT-101 free base
+BMGC_DG05386,BMG_DG118360,PubChem CID:22244 | UNII:IV5Z0PHL5D | CAS RN:5959-52-4 | PubChem SID:198965751 | 3-AMINO-2-NAPHTHOIC ACID
+BMGC_DG05387,BMG_DG118373,"PubChem CID:2225 | Aranidipine | CAS RN:86780-90-7 | DrugBank ID:DB09229 | 3-O-methyl 5-O-(2-oxopropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | ARANIDIPINE | UNII:4Y7UR6X2PO | PubChem SID:198946546"
+BMGC_DG05388,BMG_DG118380,"CAS RN:1080463-00-8 | PubChem CID:22251426 | Sodium glycerophosphate | Disodium;2,3-dihydroxypropyl phosphate;hydrate | disodium;2,3-dihydroxypropyl phosphate;hydrate | DrugBank ID:DB09561"
+BMGC_DG05389,BMG_DG118384,"UNII:005990WHZZ | Deoxycholic acid | PubChem SID:175265383 | PubChem CID:222528 | DEOXYCHOLIC ACID | (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | NDC:61168-101 | Deoxycholic Acid | CAS RN:83-44-3 | DrugBank ID:DB03619"
+BMGC_DG05390,BMG_DG118386,"PubChem SID:241179106 | PubChem CID:22253 | (3R,4S)-1,3,4,5-tetrahydroxypentan-2-one | UNII:DL1M07LQ7A | XYLULOSE, L- | CAS RN:527-50-4 | L-Xylulose"
+BMGC_DG05391,BMG_DG118391,UNII:YR93N9S6QL | CAS RN:635755-66-7 | 8-(CYCLOHEXYLMETHOXY)-2-QUINOLINAMINE | PubChem CID:22254551 | PubChem SID:485663721 | 8-(Cyclohexylmethoxy)-2-quinolinamine
+BMGC_DG05392,BMG_DG118403,"MALIC ACID, L- | (2S)-2-Hydroxybutanedioic acid | (2S)-2-hydroxybutanedioic acid | PubChem SID:175267873 | UNII:J3TZF807X5 | CAS RN:26999-59-7 | CAS RN:97-67-6 | PubChem CID:222656"
+BMGC_DG05393,BMG_DG118411,"LEVOMETHADONE | CAS RN:125-58-6 | Levomethadone | (6R)-6-(dimethylamino)-4,4-diphenylheptan-3-one | PubChem SID:198945476 | PubChem CID:22267 | DrugBank ID:DB13515 | UNII:6Y75Z4E8NS"
+BMGC_DG05394,BMG_DG118419,UNII:749BPW07H4 | K-10085 | PubChem SID:198967200 | CAS RN:217094-22-9 | PubChem CID:22272658
+BMGC_DG05395,BMG_DG118421,UNII:86H6HFH34L | CAS RN:651744-16-0 | PubChem SID:198959972 | PubChem CID:22273644 | BMS-645737
+BMGC_DG05396,BMG_DG118426,"ESTRADIOL BENZOATE | UNII:1S4CJB5ZGN | DrugBank ID:DB13953 | [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] benzoate | CAS RN:50-50-0 | Estradiol Benzoate | PubChem SID:175268331 | Estradiol benzoate | PubChem CID:222757"
+BMGC_DG05397,BMG_DG118428,UNII:7D4542I59V | PHENPROMETHAMINE | CAS RN:93-88-9 | PubChem SID:198953675 | PubChem CID:22276
+BMGC_DG05398,BMG_DG118434,"(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11-dione | CAS RN:53-06-5 | PubChem CID:222786 | Cortisone | NDC:48951-3133 | UNII:V27W9254FZ | PubChem SID:175266298 | CORTISONE | DrugBank ID:DB14681"
+BMGC_DG05399,BMG_DG118442,"8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one | CAS RN:55331-29-8 | PubChem CID:22283 | Ralgro"
+BMGC_DG05400,BMG_DG118449,"PubChem CID:222865 | (5S,8R,9S,10S,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | DIHYDROANDROSTENEDIONE | DrugBank ID:DB01561 | UNII:2KR72RNR8Z | PubChem SID:198976101 | Androstanedione | CAS RN:846-46-8"
+BMGC_DG05401,BMG_DG118452,PubChem SID:485666408 | SUCCINIC ACID MONOHYDRAZIDE | CAS RN:4604-20-0 | PubChem CID:222878 | Succinic acid monohydrazide | UNII:N9AJB5A25M
+BMGC_DG05402,BMG_DG118468,UNII:8K8XT2KBG3 | PubChem SID:445499140 | CAS RN:503555-55-3 | PubChem CID:22291652 | PHA-408
+BMGC_DG05403,BMG_DG118495,"UNII:Y7L24THH6T | N,6-dimethylhept-5-en-2-amine | Isometheptene | PubChem SID:175271749 | PubChem CID:22297 | ISOMETHEPTENE | CAS RN:503-01-5 | DrugBank ID:DB06706"
+BMGC_DG05404,BMG_DG118520,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole | PubChem CID:22298966 | DrugBank ID:DB03250"
+BMGC_DG05405,BMG_DG118525,"CAS RN:63-75-2 | UNII:4ALN5933BH | methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate | Arecoline | DrugBank ID:DB04365 | ARECOLINE | PubChem CID:2230 | PubChem SID:198982110"
+BMGC_DG05406,BMG_DG118527,HYDROHYDRASTININE | PubChem SID:198973617 | CAS RN:494-55-3 | PubChem CID:22301 | UNII:7UYL6N5J89
+BMGC_DG05407,BMG_DG118533,"PubChem CID:22308 | DrugBank ID:DB01555 | PubChem SID:198965773 | ALPHACETYLMETHADOL | UNII:BXF83S0HEL | CAS RN:17199-58-5 | Alphacetylmethadol | [(3R,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate"
+BMGC_DG05408,BMG_DG118550,CAS RN:12244-57-4 | GOLD DISODIUM THIOMALATE | PubChem SID:198938173 | CAS RN:74916-57-7 | PubChem CID:22318 | DrugBank ID:DB09276 | UNII:HRS6S09A0H | Sodium aurothiomalate | disodium;gold(1+);2-sulfidobutanedioate
+BMGC_DG05409,BMG_DG118566,"DrugBank ID:DB14541 | PubChem CID:223253 | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 3-cyclopentylpropanoate | PubChem SID:175266315 | CAS RN:508-99-6 | HYDROCORTISONE CYPIONATE | Hydrocortisone Cypionate | UNII:4XDY25L70B"
+BMGC_DG05410,BMG_DG118568,"5-[(1,3-diphenylpyrazol-4-yl)methylidene]-1,3-diazinane-2,4,6-trione | PubChem CID:2232587 | CAS RN:221619-35-8 | 5-(1,3-Diphenyl-1H-pyrazol-4-ylmethylene)-pyrimidine-2,4,6-trione"
+BMGC_DG05411,BMG_DG118592,"PubChem SID:198960962 | EQUILIN | CAS RN:474-86-2 | Equilin | UNII:08O86EX0J4 | DrugBank ID:DB02187 | (9S,13S,14S)-3-hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-one | PubChem CID:223368"
+BMGC_DG05412,BMG_DG118624,"PubChem SID:198937138 | Aristolochic acid | PubChem CID:2236 | ARISTOLOCHIC ACID | CAS RN:1246815-48-4 | CAS RN:313-67-7 | 8-methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid | UNII:94218WFP5T"
+BMGC_DG05413,BMG_DG118628,CAS RN:5450-40-8 | PubChem SID:374388241 | 2-NAPHTHALIMIDOETHYL ALCOHOL | PubChem CID:223681 | UNII:D1N3AMB16I
+BMGC_DG05414,BMG_DG118632,PubChem SID:198973677 | CAS RN:5614-56-2 | 1-THEOBROMINEACETIC ACID | UNII:6XL1I8J8NT | PubChem CID:22375
+BMGC_DG05415,BMG_DG118641,UNII:7X3WV51F4N | BUTANILICAINE | DrugBank ID:DB13328 | CAS RN:3785-21-5 | CAS RN:6027-28-7 | Butanilicaine | PubChem SID:198968959 | PubChem CID:22379 | 2-(butylamino)-N-(2-chloro-6-methylphenyl)acetamide
+BMGC_DG05416,BMG_DG118657,"PubChem CID:2239 | CAS RN:68377-92-4 | AROTINOLOL | 5-[2-[3-(tert-butylamino)-2-hydroxypropyl]sulfanyl-1,3-thiazol-4-yl]thiophene-2-carboxamide | Arotinolol | DrugBank ID:DB09204 | PubChem SID:198935814 | UNII:394E3P3B99"
+BMGC_DG05417,BMG_DG118670,"CAS RN:82043-34-3 | (8S,9S,10R,13S,14S)-10,13-dimethyl-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,11,17-trione | Adrenosterone | PubChem SID:198984508 | CAS RN:382-45-6 | CAS RN:911474-75-4 | UNII:AE4E9102GY | ADRENOSTERONE | PubChem CID:223997"
+BMGC_DG05418,BMG_DG118675,"Dromostanolone Propionate | PubChem SID:198955020 | DROMOSTANOLONE PROPIONATE | DrugBank ID:DB14655 | UNII:X20UZ57G4O | CAS RN:521-12-0 | PubChem CID:224004 | [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate"
+BMGC_DG05419,BMG_DG118687,5-BROMO-N-8-QUINOLINYL-2-THIOPHENESULFONAMIDE | PubChem SID:485663602 | UNII:U22NCR3PHX | PubChem CID:2240993 | CAS RN:620103-87-9 | 5-Bromo-N-8-quinolinyl-2-thiophenesulfonamide
+BMGC_DG05420,BMG_DG118689,"PubChem SID:459276194 | CAS RN:17280-75-0 | N-(3-PHENYL-1,2,4-THIADIAZOL-5-YL)BENZAMIDE | PubChem CID:2241548 | UNII:PQP2U9E4NE"
+BMGC_DG05421,BMG_DG118697,CAS RN:1004301-38-5 | DrugBank ID:DB01250 | UNII:ULS5I8J03O | PubChem CID:22419 | Olsalazine | 5-[(3-carboxy-4-hydroxyphenyl)diazenyl]-2-hydroxybenzoic acid | CAS RN:15722-48-2 | OLSALAZINE | PubChem SID:175266820
+BMGC_DG05422,BMG_DG118706,"UNII:55P9TUL75S | ISOFLUPREDONE ACETATE | DrugBank ID:DB14640 | CAS RN:338-98-7 | Isoflupredone Acetate | [2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | PubChem SID:175265582 | PubChem CID:224246"
+BMGC_DG05423,BMG_DG118710,"PIPAZETHATE | CAS RN:2167-85-3 | UNII:M5EK1T5V2L | PubChem SID:198947095 | Pipazethate | 2-(2-piperidin-1-ylethoxy)ethyl pyrido[3,2-b][1,4]benzothiazine-10-carboxylate | PubChem CID:22425 | DrugBank ID:DB08796"
+BMGC_DG05424,BMG_DG118717,NDC:68016-689 | NDC:66715-6526 | NDC:49035-768 | NDC:41163-741 | NDC:68998-146 | NDC:37808-174 | NDC:70677-1260 | NDC:10956-501 | NDC:68788-8334 | PubChem SID:175266844 | NDC:55758-363 | NDC:56062-118 | NDC:63629-2952 | NDC:68998-205 | NDC:30142-467 | NDC:70000-0014 | NDC:49314-1163 | NDC:37808-867 | NDC:57344-018 | NDC:11673-493 | NDC:84324-017 | NDC:74458-208 | NDC:83324-075 | NDC:83139-288 | NDC:71335-1774 | NDC:17856-0922 | NDC:55910-600 | NDC:53185-249 | NDC:68210-4178 | NDC:70677-1150 | NDC:59779-439 | NDC:55154-8149 | NDC:50804-157 | NDC:69168-457 | NDC:66715-9603 | NDC:49035-467 | NDC:53943-081 | NDC:63941-402 | NDC:0363-0157 | NDC:47682-617 | NDC:47682-618 | NDC:47682-456 | NDC:41250-600 | NDC:69729-104 | NDC:47682-921 | NDC:55319-892 | NDC:50844-157 | NDC:69168-312 | NDC:55301-157 | NDC:72090-037 | NDC:69396-158 | NDC:82804-167 | NDC:17714-010 | NDC:36800-157 | NDC:21130-397 | NDC:41250-768 | NDC:30142-391 | NDC:73089-081 | NDC:0363-0227 | NDC:0924-0105 | NDC:21130-957 | NDC:63941-600 | NDC:57896-901 | NDC:43063-862 | NDC:81533-600 | NDC:21130-600 | NDC:71205-442 | NDC:84269-2501 | NDC:0904-4040 | NDC:63736-200 | NDC:55319-870 | NDC:73057-356 | NDC:72714-405 | NDC:0904-6751 | NDC:70677-1121 | NDC:83324-058 | NDC:71992-154 | NDC:50201-7682 | NDC:51662-1633 | NDC:49638-102 | NDC:67091-389 | NDC:53942-883 | NDC:50804-422 | NDC:55910-695 | NDC:0280-1400 | NDC:63029-501 | NDC:55758-362 | NDC:51662-1356 | NDC:16103-351 | NDC:72036-146 | NDC:46122-691 | NDC:53943-152 | NDC:83324-066 | NDC:55319-875 | NDC:72162-1470 | NDC:0363-0875 | NDC:37808-600 | NDC:69168-318 | NDC:80425-0293 | NDC:0615-8414 | NDC:17714-121 | NDC:71679-010 | NDC:29485-7533 | NDC:50844-675 | NDC:49483-330 | NDC:0280-2150 | NDC:71335-1800 | NDC:63941-241 | NDC:55301-821 | NDC:0280-2100 | NDC:69790-616 | NDC:71610-034 | NDC:0404-0164 | NDC:69168-372 | NDC:73598-1112 | NDC:56062-358 | DrugBank ID:DB00945 | NDC:63941-397 | NDC:68788-8565 | NDC:11822-4130 | NDC:47682-135 | NDC:56062-063 | NDC:82804-156 | NDC:70677-1134 | NDC:0904-7056 | NDC:79739-6094 | NDC:70000-0147 | NDC:50844-600 | CAS RN:50-78-2 | NDC:11673-181 | NDC:70771-1172 | NDC:49035-157 | NDC:68599-1311 | NDC:68210-4128 | NDC:75920-0465 | NDC:70000-0603 | NDC:46122-761 | NDC:63629-8875 | NDC:0280-0024 | NDC:53943-146 | NDC:66715-5504 | NDC:57243-157 | NDC:68210-4098 | NDC:16103-366 | NDC:72476-263 | NDC:79481-0168 | NDC:0574-7034 | NDC:37808-246 | NDC:51662-1277 | NDC:79481-6450 | NDC:21130-081 | NDC:0363-6450 | NDC:68382-618 | NDC:66715-6403 | NDC:69168-006 | Acetylsalicylic acid | NDC:73089-325 | NDC:79903-481 | NDC:49483-481 | NDC:50332-0143 | NDC:71335-1382 | NDC:0280-1510 | NDC:59726-065 | NDC:63941-246 | NDC:71141-158 | NDC:63868-568 | NDC:59779-600 | NDC:0904-6794 | NDC:36800-545 | NDC:41163-563 | NDC:41250-118 | NDC:76162-980 | NDC:63868-029 | NDC:71335-0622 | NDC:54257-274 | NDC:24385-028 | NDC:0280-2080 | NDC:63739-434 | NDC:69238-1993 | NDC:76420-224 | NDC:0781-2270 | NDC:55910-563 | NDC:37808-157 | NDC:59779-467 | NDC:69536-181 | NDC:27854-755 | NDC:0280-1545 | NDC:30142-860 | NDC:0280-0068 | NDC:50090-6195 | NDC:11822-2180 | NDC:63029-665 | NDC:57896-983 | NDC:81522-018 | NDC:49483-334 | NDC:11822-0600 | NDC:71205-112 | NDC:80136-921 | NDC:41250-123 | NDC:0280-2110 | NDC:49483-349 | NDC:68788-8256 | NDC:49348-981 | NDC:67091-123 | NDC:36800-467 | NDC:63029-200 | NDC:67091-110 | NDC:30142-875 | NDC:72036-205 | NDC:54738-128 | NDC:68210-4093 | NDC:83324-089 | NDC:36800-127 | NDC:50090-6928 | NDC:84289-356 | NDC:47682-038 | NDC:51662-1494 | NDC:59961-616 | NDC:55910-769 | NDC:68210-2500 | NDC:68391-867 | NDC:73057-365 | NDC:49314-8218 | NDC:49483-387 | NDC:70000-0604 | NDC:61245-616 | NDC:0280-0023 | NDC:41163-797 | NDC:55681-403 | NDC:55910-040 | NDC:72476-252 | NDC:63029-990 | NDC:63941-081 | NDC:41226-011 | NDC:69168-405 | NDC:50804-873 | NDC:67091-430 | NDC:50090-7028 | NDC:71406-128 | NDC:68016-747 | NDC:68016-722 | NDC:50090-4830 | NDC:68210-5029 | NDC:55910-945 | NDC:49483-382 | NDC:59779-143 | NDC:0280-0020 | NDC:69842-927 | NDC:56062-274 | NDC:63868-352 | NDC:69536-281 | NDC:68210-5100 | NDC:80513-289 | NDC:71335-0157 | NDC:53943-157 | NDC:71679-115 | NDC:72789-039 | NDC:70677-1189 | NDC:69618-066 | NDC:46122-791 | NDC:0904-6783 | NDC:49781-097 | NDC:29485-6526 | NDC:53329-985 | NDC:65162-596 | NDC:63941-873 | NDC:63868-228 | NDC:41163-768 | NDC:42571-274 | NDC:41250-467 | NDC:50844-563 | NDC:46122-596 | NDC:71399-1014 | NDC:50844-254 | NDC:50564-555 | NDC:37808-768 | NDC:36800-274 | NDC:68998-018 | NDC:36800-880 | 2-acetyloxybenzoic acid | NDC:68391-063 | NDC:29033-215 | NDC:70000-0419 | NDC:57344-146 | NDC:80136-904 | NDC:56062-467 | ASPIRIN | NDC:62011-0019 | NDC:50090-2940 | NDC:59779-274 | NDC:0363-0587 | NDC:11822-0397 | NDC:60760-854 | NDC:41250-681 | NDC:50991-999 | NDC:11822-6910 | NDC:0280-0064 | NDC:70000-0253 | NDC:21130-918 | NDC:72036-080 | NDC:37835-738 | NDC:41163-918 | NDC:72036-252 | NDC:48433-129 | NDC:11673-702 | NDC:83324-090 | NDC:42291-116 | NDC:69168-288 | NDC:0536-1232 | NDC:56062-867 | NDC:11822-6451 | NDC:41250-274 | NDC:79903-161 | NDC:72090-001 | NDC:69168-430 | NDC:24385-278 | NDC:55681-402 | NDC:16103-365 | NDC:0363-0218 | NDC:41163-522 | NDC:49638-101 | NDC:71679-050 | NDC:79481-0073 | NDC:0280-0121 | NDC:0924-6020 | NDC:68788-8606 | Aspirin | NDC:68998-080 | NDC:42806-061 | NDC:0536-1054 | NDC:68210-0150 | NDC:50804-880 | NDC:79739-7192 | NDC:61504-080 | NDC:49483-328 | NDC:0280-0103 | NDC:37808-861 | NDC:63029-992 | NDC:71205-318 | NDC:73408-821 | NDC:49348-757 | NDC:70000-0420 | NDC:84014-532 | NDC:0280-0021 | NDC:0615-8257 | NDC:54738-111 | NDC:47682-533 | NDC:66715-9726 | NDC:70677-1122 | NDC:51824-057 | NDC:66715-6426 | NDC:36800-768 | NDC:67751-219 | NDC:55910-134 | NDC:70677-0071 | NDC:50090-6929 | NDC:71399-1003 | NDC:81522-105 | NDC:83324-018 | NDC:54738-541 | NDC:72090-034 | NDC:47682-048 | NDC:69842-875 | NDC:0280-2020 | NDC:41163-157 | NDC:57896-911 | NDC:75920-0464 | NDC:0280-2000 | NDC:70677-1245 | NDC:29485-6924 | NDC:46122-615 | NDC:17714-011 | NDC:63868-469 | NDC:63868-363 | NDC:68462-405 | NDC:50564-490 | NDC:50090-7029 | NDC:0363-8712 | NDC:69607-0867 | NDC:68196-901 | NDC:17714-009 | NDC:60760-930 | NDC:63941-157 | NDC:57344-080 | NDC:51991-074 | NDC:71205-517 | NDC:70264-013 | NDC:41250-143 | NDC:0280-1555 | NDC:11822-0157 | NDC:59726-867 | NDC:47682-616 | NDC:63941-105 | NDC:0536-1234 | NDC:11822-2270 | NDC:63981-563 | NDC:63187-717 | NDC:50332-0139 | NDC:50564-554 | NDC:70677-0163 | NDC:53943-873 | NDC:63868-661 | NDC:49884-007 | NDC:79739-7182 | NDC:63029-302 | NDC:69618-015 | NDC:46994-157 | NDC:71205-328 | NDC:55910-873 | NDC:0280-0084 | NDC:68210-4177 | NDC:72036-018 | NDC:67091-448 | NDC:0904-2015 | NDC:68071-5192 | NDC:53943-205 | NDC:41520-157 | NDC:70000-0127 | NDC:36800-968 | NDC:53329-020 | NDC:53943-080 | NDC:63629-8878 | NDC:36800-789 | NDC:63868-332 | NDC:79481-2270 | NDC:66715-6503 | NDC:68016-642 | NDC:70385-2006 | NDC:71141-181 | NDC:69842-826 | NDC:72036-181 | NDC:71993-307 | NDC:17856-6794 | NDC:63868-898 | NDC:59779-945 | NDC:42961-104 | NDC:49483-011 | NDC:66715-9735 | NDC:84289-366 | NDC:10135-729 | NDC:72476-018 | NDC:0363-6455 | NDC:41163-945 | NDC:68210-0025 | NDC:50269-006 | NDC:49483-390 | NDC:49035-274 | PubChem CID:2244 | NDC:55910-467 | NDC:51824-077 | NDC:55910-249 | NDC:21130-051 | NDC:16714-964 | NDC:72476-205 | NDC:63941-249 | NDC:62135-433 | NDC:83139-316 | NDC:51316-359 | NDC:53943-431 | NDC:50269-005 | NDC:67091-109 | NDC:72476-867 | NDC:63941-118 | NDC:79481-1570 | NDC:0280-2090 | NDC:59779-157 | NDC:84014-531 | NDC:73408-618 | NDC:55154-2635 | NDC:63941-080 | NDC:0536-1008 | NDC:0904-6713 | NDC:37808-630 | NDC:67751-129 | NDC:55154-6755 | NDC:63941-181 | NDC:66715-5206 | NDC:63940-320 | NDC:57896-981 | NDC:0113-0274 | NDC:62011-0028 | NDC:66715-6840 | NDC:50201-8752 | NDC:61825-302 | NDC:57237-302 | NDC:41250-780 | NDC:55154-6752 | NDC:47682-039 | NDC:73376-001 | NDC:46122-598 | NDC:66715-9815 | NDC:63868-373 | NDC:57896-984 | NDC:70000-0035 | NDC:50844-218 | NDC:50844-413 | NDC:71993-304 | NDC:0527-1552 | NDC:41250-146 | NDC:0363-0691 | UNII:R16CO5Y76E | NDC:68016-690 | NDC:0280-0060 | NDC:0363-0563 | NDC:61825-305 | NDC:68788-8598 | NDC:55319-601 | NDC:47682-821 | NDC:69517-104 | NDC:71335-0513 | NDC:49035-563 | NDC:57896-921 | NDC:51662-1583 | NDC:54162-940 | NDC:55700-842 | NDC:49483-381 | NDC:55301-600 | NDC:54738-559 | NDC:63029-311 | NDC:71679-104 | NDC:0280-1520 | NDC:0280-0087 | NDC:50844-219 | NDC:72288-467 | NDC:29485-1017 | NDC:83139-372 | NDC:43598-339 | NDC:68196-481
+BMGC_DG05425,BMG_DG118749,CAS RN:68844-77-9 | PubChem CID:2247 | 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine | DrugBank ID:DB00637 | ASTEMIZOLE | PubChem SID:198971370 | Astemizole | UNII:7HU6337315
+BMGC_DG05426,BMG_DG118763,"DrugBank ID:DB07020 | N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide | PubChem CID:22479942"
+BMGC_DG05427,BMG_DG118775,"PubChem SID:445499284 | CAS RN:288862-78-2 | PubChem CID:22486203 | UNII:GXK38L3KXD | 1-((1,3)OXAZOLO(4,5-B)PYRIDIN-2-YL)PENTAN-1-ONE"
+BMGC_DG05428,BMG_DG118782,"PubChem CID:22489160 | N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide | DrugBank ID:DB07455"
+BMGC_DG05429,BMG_DG118784,PubChem CID:224895 | UNII:69MW5QV5E6 | CAS RN:5430-24-0 | PubChem SID:441658557 | 2-NITRO-4-STIBONOBENZOIC ACID
+BMGC_DG05430,BMG_DG118786,NDC:50090-5738 | NDC:52427-383 | NDC:43353-986 | NDC:63187-201 | NDC:68382-022 | NDC:63187-092 | NDC:43063-952 | DrugBank ID:DB00335 | NDC:65862-170 | CAS RN:106020-65-9 | NDC:50090-6241 | NDC:50090-6935 | NDC:42708-012 | NDC:70954-390 | NDC:0093-0752 | NDC:72162-2326 | NDC:72189-152 | NDC:71335-1616 | NDC:51655-533 | NDC:29300-401 | NDC:71335-1264 | NDC:71610-861 | NDC:65862-169 | NDC:51079-759 | NDC:29300-400 | NDC:68382-023 | NDC:71610-658 | NDC:60760-787 | NDC:24979-257 | PubChem SID:175271646 | NDC:68071-4526 | NDC:50090-6311 | NDC:68071-3694 | NDC:71335-9611 | NDC:29300-412 | NDC:60429-026 | NDC:10135-734 | NDC:70518-4099 | NDC:72162-2325 | NDC:55154-5455 | NDC:70710-1167 | NDC:50090-0448 | NDC:75834-282 | NDC:55289-993 | NDC:71205-496 | NDC:65841-022 | Atenolol | NDC:71205-096 | NDC:0615-8372 | NDC:68788-7616 | NDC:70518-3531 | NDC:52427-430 | NDC:68382-024 | NDC:61919-279 | NDC:42708-143 | NDC:51655-736 | NDC:65841-023 | NDC:65862-168 | NDC:60760-643 | NDC:60429-027 | NDC:71335-2531 | NDC:83008-052 | NDC:51655-491 | NDC:70518-2939 | NDC:42708-162 | NDC:50090-5408 | NDC:64980-437 | NDC:0093-0753 | NDC:0093-0787 | NDC:0904-7187 | NDC:0378-0757 | NDC:16714-936 | NDC:24979-256 | NDC:60760-437 | NDC:71610-857 | NDC:16714-937 | CAS RN:60966-51-0 | NDC:51079-685 | NDC:68071-5162 | NDC:65841-024 | NDC:55154-5511 | NDC:52427-431 | NDC:63187-710 | NDC:70518-3036 | NDC:51655-709 | NDC:68071-4751 | NDC:50090-5363 | 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide | NDC:68788-7876 | NDC:50090-5741 | NDC:67544-240 | NDC:71335-1535 | NDC:71205-229 | NDC:72189-396 | NDC:68071-4538 | NDC:0378-0231 | NDC:70954-391 | NDC:10135-733 | NDC:72189-135 | NDC:70771-1372 | NDC:52427-429 | NDC:70771-1373 | NDC:29300-410 | NDC:51079-684 | NDC:0615-8373 | UNII:50VV3VW0TI | NDC:50090-6779 | NDC:75834-281 | NDC:43353-834 | NDC:52427-382 | NDC:51655-928 | NDC:72162-2324 | NDC:70710-1168 | NDC:0591-5782 | NDC:75834-283 | NDC:64980-439 | NDC:43063-765 | NDC:64980-438 | ATENOLOL | CAS RN:1309283-25-7 | PubChem CID:2249 | NDC:70518-3007 | NDC:50090-5367 | NDC:67544-161 | NDC:66267-029 | NDC:68788-8527 | NDC:51655-104 | NDC:60687-605 | NDC:68071-4527 | NDC:70518-4111 | NDC:72789-144 | NDC:68788-7535 | NDC:67544-332 | NDC:0591-5783 | NDC:68788-8739 | NDC:0378-0218 | NDC:72189-146 | NDC:60429-025 | NDC:71335-0912 | NDC:63187-537 | CAS RN:29122-68-7 | NDC:29300-411 | NDC:60760-642 | NDC:43063-805 | NDC:71335-0954 | NDC:68071-4553
+BMGC_DG05431,BMG_DG118790,"UNII:ZE32NYP4EA | PubChem CID:22493 | 7-CHLORO-1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE | 7-Chloro-1,2,3,4-tetrahydro-9-acridinamine | PubChem SID:482554116 | CAS RN:6115-67-9"
+BMGC_DG05432,BMG_DG118815,"PubChem CID:22502 | UNII:17R794ESYN | 2-(diethylamino)ethyl 4-aminobenzoate;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate | PENICILLIN G PROCAINE | Procaine penicillin | PubChem SID:175266849 | CAS RN:6130-64-9"
+BMGC_DG05433,BMG_DG118835,"8-cyclohexyl-1,3,7-trimethylpurine-2,6-dione | PubChem CID:225229 | 1,3,7-Trimethyl-8-cyclohexylxanthine"
+BMGC_DG05434,BMG_DG118837,"CID 22524140 | DrugBank ID:DB11752 | CAS RN:83314-01-6 | Bryostatin 1 | PubChem CID:22524140 | [(1S,3S,5Z,7R,8Z,11S,12S,13E,15S,17R,21R,23R,25S)-25-acetyloxy-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate"
+BMGC_DG05435,BMG_DG118852,"PubChem CID:22530 | Mebhydrolin | MEBHYDROLIN | DrugBank ID:DB13808 | PubChem SID:198959507 | UNII:9SUK9B7XVY | 5-benzyl-2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole | CAS RN:524-81-2"
+BMGC_DG05436,BMG_DG118869,PubChem CID:22556917 | CRA_9785 | DrugBank ID:DB03595
+BMGC_DG05437,BMG_DG118872,"CAS RN:102029-43-6 | PubChem SID:198968813 | PubChem CID:2256 | DrugBank ID:DB07392 | 6-chloro-4-N-ethyl-2-N-propan-2-yl-1,3,5-triazine-2,4-diamine | CAS RN:1912-24-9 | Atrazine | ATRAZINE | UNII:QJA9M5H4IM"
+BMGC_DG05438,BMG_DG118873,"NDC:68084-288 | UNII:V47IF0PVH4 | PubChem SID:175268676 | NDC:0615-6562 | [2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | NDC:0115-7033 | NDC:70954-252 | NDC:0904-7317 | NDC:72578-164 | NDC:63629-8806 | NDC:69238-7033 | Fludrocortisone Acetate | NDC:55154-6645 | NDC:50268-330 | CAS RN:514-36-3 | NDC:70771-1893 | NDC:71335-2454 | NDC:42291-764 | PubChem CID:225609 | NDC:0555-0997 | NDC:72603-170 | FLUDROCORTISONE ACETATE"
+BMGC_DG05439,BMG_DG118917,PubChem CID:2259 | CAS RN:4431-00-9 | AURINE TRICARBOXYLIC ACID | PubChem SID:405055508 | UNII:NP9O8E29QW
+BMGC_DG05440,BMG_DG118919,"UNII:9RT16RBU2Y | MK-0736 | CAS RN:1304733-16-1 | DrugBank ID:DB15209 | PubChem CID:22591684 | 3-[4-(3-ethylsulfonylpropyl)-1-bicyclo[2.2.2]octanyl]-4-methyl-5-[2-(trifluoromethyl)phenyl]-1,2,4-triazole | CAS RN:719272-79-4 | Mk-0736 | PubChem SID:346541366"
+BMGC_DG05441,BMG_DG118921,"3-[4,5-Bis([1,1′-biphenyl]-4-yl)-1H-imidazol-2-yl]phenol | UNII:DWX62J44NS | PubChem CID:2259222 | 3-(4,5-BIS((1,1'-BIPHENYL)-4-YL)-1H-IMIDAZOL-2-YL)PHENOL | PubChem SID:485663535 | CAS RN:296792-52-4"
+BMGC_DG05442,BMG_DG118949,CAS RN:233275-76-8 | UNII:9VSE02330I | MRK-409 | PubChem CID:22609888 | PubChem SID:252165170
+BMGC_DG05443,BMG_DG118960,1-2-(Phenylmethoxyphenyl)piperazine | PubChem SID:478838498 | UNII:UH49W5HEP9 | PubChem CID:22615724 | CAS RN:96221-84-0 | 1-2-(PHENYLMETHOXYPHENYL)PIPERAZINE
+BMGC_DG05444,BMG_DG118964,UNII:971Z4W1S09 | DrugBank ID:DB09161 | NDC:45548-141 | 1-isocyano-2-methoxy-2-methylpropane;technetium | TECHNETIUM TC-99M SESTAMIBI | PubChem SID:322058825 | PubChem CID:22617237 | Technetium (99mTc) sestamibi | CAS RN:109581-73-9 | NDC:45567-0555 | Technetium Tc-99m sestamibi | NDC:65857-500
+BMGC_DG05445,BMG_DG118988,CAS RN:6260-97-5 | PubChem SID:198976688 | 1-(P-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE | PubChem CID:22630 | UNII:W075O86E5T
+BMGC_DG05446,BMG_DG118996,"UNII:77HC7URR9Z | CAS RN:123040-95-9 | PubChem SID:198982892 | CAS RN:123039-99-6 | N-(1-azabicyclo[2.2.2]octan-3-yl)-6-chloro-4-methyl-3-oxo-1,4-benzoxazine-8-carboxamide | Azasetron | CAS RN:123040-69-7 | AZASETRON | PubChem CID:2264"
+BMGC_DG05447,BMG_DG118997,"CAS RN:6266-58-6 | UNII:S0G6PB6SQ2 | PubChem SID:375085597 | 7,8-DIMETHYL-10-(2-ACETOXYETHYL)ISOALLOXAZINE | PubChem CID:22641"
+BMGC_DG05448,BMG_DG119005,PubChem CID:22644374 | DrugBank ID:DB11132 | Silicon dioxide
+BMGC_DG05449,BMG_DG119011,"PubChem CID:22648 | CAS RN:6268-03-7 | PubChem SID:374388279 | N,N'-BIS(2-METHOXYPHENYL)GUANIDINE | UNII:I75KL19QFE"
+BMGC_DG05450,BMG_DG119015,NDC:67877-494 | Azathioprine | NDC:65841-602 | NDC:68382-120 | NDC:65649-241 | NDC:68084-229 | AZATHIOPRINE | NDC:68071-3772 | NDC:72789-129 | NDC:51407-182 | NDC:71610-124 | NDC:67877-493 | NDC:68682-241 | NDC:70771-1141 | NDC:16571-835 | NDC:70771-1140 | NDC:68462-502 | NDC:60219-2036 | NDC:67877-492 | NDC:68382-118 | NDC:67877-495 | NDC:68382-003 | CAS RN:446-86-6 | NDC:60219-2037 | NDC:54766-590 | NDC:70518-3544 | PubChem CID:2265 | NDC:42291-071 | 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine | NDC:70771-1139 | UNII:MRK240IY2L | NDC:60219-1076 | PubChem SID:175266063 | DrugBank ID:DB00993 | NDC:68682-231 | NDC:65649-231 | NDC:42291-063 | NDC:68382-119 | NDC:69238-1076
+BMGC_DG05451,BMG_DG119023,nonanedioic acid | PubChem SID:175267994 | DrugBank ID:DB00548 | AZELAIC ACID | CAS RN:123-99-9 | Azelaic acid | UNII:F2VW3D43YT | Azelaic Acid | PubChem CID:2266
+BMGC_DG05452,BMG_DG119037,UNII:ZQI909440X | PubChem CID:2267 | DrugBank ID:DB00972 | CAS RN:758637-88-6 | AZELASTINE | CAS RN:58581-89-8 | PubChem SID:175272097 | 4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one | Azelastine
+BMGC_DG05453,BMG_DG119052,DrugBank ID:DB07099 | N-[4-(benzyloxy)phenyl]glycinamide | PubChem CID:22690393
+BMGC_DG05454,BMG_DG119055,PubChem CID:22692237 | PubChem SID:478838392 | 4-AMINO-N-(4-(PHENYLMETHOXY)PHENYL)BUTANAMIDE | CAS RN:590350-83-7 | DrugBank ID:DB07104 | UNII:2SXE223PVW | 4-amino-N-[4-(benzyloxy)phenyl]butanamide | 4-Amino-N-[4-(phenylmethoxy)phenyl]butanamide
+BMGC_DG05455,BMG_DG119056,"PubChem CID:22694 | PubChem SID:440793890 | UNII:5Y988K56L8 | N-(2-DIETHYLAMINOETHYL)-2-CHLORO-2-(TETRACHLORO-2,4-CYCLOPENTADIEN-1-YLIDENE)ACETAMIDE | CAS RN:6284-49-7"
+BMGC_DG05456,BMG_DG119064,CAS RN:1321-11-5 | CAS RN:80206-34-4 | UNII:0YS975XI6W | 2-aminobenzoic acid | CAS RN:98072-80-1 | CAS RN:15442-49-6 | Anthranilic acid | DrugBank ID:DB04166 | CAS RN:50816-84-7 | ANTHRANILIC ACID | CAS RN:118-92-3 | PubChem CID:227 | PubChem SID:198970512
+BMGC_DG05457,BMG_DG119066,UNII:4321510DG9 | PubChem SID:241177447 | 2-AMINO-6-NITROBENZOTHIAZOLE | PubChem CID:22704 | CAS RN:6285-57-0
+BMGC_DG05458,BMG_DG119073,"3,4-DICHLOROBENZALDEHYDE | UNII:I6Z632WSJ5 | PubChem SID:249493267 | PubChem CID:22710 | CAS RN:6287-38-3"
+BMGC_DG05459,BMG_DG119108,DrugBank ID:DB08961 | 2-chloro-5-(2H-tetrazol-5-yl)-4-(thiophen-2-ylmethylamino)benzenesulfonamide | PubChem SID:198948956 | UNII:MR40VT1L8Z | AZOSEMIDE | Azosemide | CAS RN:27589-33-9 | PubChem CID:2273
+BMGC_DG05460,BMG_DG119115,PubChem CID:227328 | CAS RN:5381-20-4 | PubChem SID:474493424 | BENZO(B)THIOPHENE-3-CARBOXALDEHYDE | UNII:88C6MH2ME3 | Benzo(b)thiophene-3-carboxaldehyde
+BMGC_DG05461,BMG_DG119187,NAFAZATROM | PubChem CID:22769190 | PubChem SID:198944488 | CAS RN:59040-30-1 | UNII:K94216221B
+BMGC_DG05462,BMG_DG119199,TENULIN | PubChem CID:227830 | UNII:8O6QE3MHR3 | CAS RN:19202-92-7 | PubChem SID:316918002
+BMGC_DG05463,BMG_DG119200,UNII:TUF52O8Y8B | 4-NITROBENZENESULFONAMIDE | CAS RN:6325-93-5 | PubChem SID:198987922 | PubChem CID:22784
+BMGC_DG05464,BMG_DG119274,PubChem CID:22809970 | (R)-M-Methoxyamphetamine | (2R)-1-(3-methoxyphenyl)propan-2-amine
+BMGC_DG05465,BMG_DG119275,Bis(5-Amidino-2-Benzimidazolyl)Methanone | DrugBank ID:DB01876 | PubChem CID:2281
+BMGC_DG05466,BMG_DG119276,2-(4-Biphenylyl)propionic acid | PubChem CID:22810 | CAS RN:6341-72-6 | PubChem SID:198955752 | UNII:V55W126F9Y | 2-(4-BIPHENYLYL)PROPIONIC ACID
+BMGC_DG05467,BMG_DG119473,"CAS RN:68-19-9 | PubChem CID:22836442 | cobalt(3+);[(2R,3S,4R)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide"
+BMGC_DG05468,BMG_DG119481,NDC:50090-6868 | NDC:80425-0459 | NDC:63629-2131 | NDC:67296-1909 | NDC:63629-1227 | NDC:63739-479 | NDC:69844-085 | NDC:72789-480 | NDC:71335-0103 | NDC:71610-614 | NDC:68788-9246 | NDC:80425-0467 | NDC:58657-730 | NDC:83008-057 | NDC:0615-8467 | NDC:68788-8572 | NDC:80425-0112 | NDC:80425-0466 | NDC:72888-009 | NDC:29300-343 | NDC:80425-0391 | NDC:83008-015 | NDC:66794-156 | NDC:63629-1228 | NDC:82868-013 | NDC:72162-2450 | NDC:66794-151 | NDC:63629-2128 | NDC:68788-8783 | NDC:63739-233 | NDC:69844-135 | NDC:70756-288 | NDC:70771-1449 | NDC:59651-394 | NDC:68071-3468 | NDC:72162-2342 | NDC:72162-2372 | NDC:63629-1225 | NDC:68788-8726 | NDC:62135-473 | NDC:16714-071 | NDC:0615-8518 | NDC:71335-2497 | NDC:60687-804 | NDC:63629-2080 | NDC:63629-2130 | NDC:60687-826 | NDC:25021-678 | NDC:66794-157 | NDC:63629-2081 | NDC:16714-072 | NDC:70756-289 | NDC:16571-169 | NDC:71610-660 | NDC:70121-2496 | NDC:63187-280 | NDC:71205-474 | NDC:72162-1152 | NDC:63739-230 | NDC:42571-429 | NDC:72834-602 | NDC:55289-757 | NDC:63187-313 | NDC:16571-172 | NDC:71225-140 | NDC:50268-106 | NDC:80425-0282 | NDC:71335-1797 | NDC:68134-403 | NDC:45865-275 | NDC:67457-563 | NDC:62135-474 | NDC:0832-1054 | NDC:68788-8575 | NDC:71335-1356 | NDC:72888-145 | NDC:43063-864 | NDC:71335-0949 | NDC:68788-8737 | NDC:67457-562 | DrugBank ID:DB00181 | NDC:69528-302 | NDC:68134-401 | NDC:70511-122 | NDC:70710-1285 | NDC:42571-428 | NDC:62135-472 | NDC:0603-2407 | NDC:62559-204 | NDC:70756-085 | NDC:0527-1333 | NDC:71335-0344 | NDC:72189-565 | NDC:70710-1609 | NDC:72789-479 | NDC:52817-321 | NDC:52652-6001 | NDC:0115-1011 | NDC:50090-4682 | NDC:76420-241 | NDC:63629-1224 | NDC:71335-2219 | NDC:55154-7876 | NDC:83008-018 | NDC:70710-1666 | NDC:0527-1337 | NDC:14789-161 | NDC:29300-474 | NDC:69844-086 | NDC:70518-4249 | 4-amino-3-(4-chlorophenyl)butanoic acid | NDC:50090-6869 | NDC:64896-078 | NDC:52536-600 | NDC:71335-2392 | NDC:0615-8466 | NDC:72888-147 | NDC:64896-077 | NDC:83008-062 | BACLOFEN | NDC:0904-6475 | NDC:59651-395 | NDC:68071-2289 | NDC:63739-480 | NDC:68788-8584 | NDC:71335-2482 | NDC:70518-3115 | NDC:70710-1286 | NDC:29300-344 | CAS RN:1134-47-0 | NDC:72888-010 | NDC:0172-4096 | NDC:80425-0080 | Baclofen | NDC:68788-8555 | NDC:72162-2373 | NDC:58657-732 | NDC:70518-3614 | NDC:71610-444 | NDC:71610-446 | NDC:70771-1448 | UNII:H789N3FKE8 | NDC:0904-6476 | NDC:10135-532 | NDC:10135-533 | NDC:58657-731 | NDC:10135-780 | NDC:25021-680 | NDC:66794-155 | NDC:72162-2448 | NDC:67457-564 | NDC:72162-2374 | NDC:52817-319 | NDC:67544-671 | NDC:25021-679 | NDC:0832-1055 | NDC:72789-478 | NDC:71610-452 | NDC:52817-318 | NDC:72888-146 | NDC:64896-076 | NDC:71335-9638 | NDC:31722-998 | NDC:80425-0205 | NDC:76420-242 | NDC:63629-2084 | NDC:10135-782 | NDC:50268-105 | NDC:55154-4349 | NDC:63187-147 | NDC:70771-1868 | NDC:52817-320 | NDC:70511-123 | NDC:72162-1079 | NDC:80425-0156 | NDC:0115-1010 | NDC:60687-815 | NDC:72189-504 | NDC:68071-3700 | NDC:0603-2406 | NDC:63629-2083 | NDC:71335-9681 | NDC:63187-274 | NDC:72888-103 | NDC:52817-620 | NDC:72888-011 | NDC:63629-2082 | NDC:0115-1012 | NDC:50090-6149 | NDC:25021-681 | NDC:55154-7635 | NDC:42571-427 | PubChem SID:175271859 | NDC:31722-138 | NDC:31722-999 | NDC:72162-2449 | NDC:68788-8333 | NDC:50090-5855 | NDC:72789-312 | NDC:71335-1796 | NDC:80425-0157 | NDC:70771-1586 | NDC:10135-781 | NDC:68071-5252 | NDC:0527-1330 | NDC:70511-121 | NDC:70511-124 | PubChem CID:2284 | NDC:80425-0081 | NDC:72162-1080 | NDC:70518-3467 | NDC:50268-107 | NDC:43063-865 | NDC:70518-4235 | NDC:0172-4097 | NDC:67296-1882 | NDC:71335-9759 | NDC:16571-171
+BMGC_DG05469,BMG_DG119516,"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE | PubChem CID:22850133 | DrugBank ID:DB07219"
+BMGC_DG05470,BMG_DG119544,Bisphenol A diglycidyl ether | CAS RN:1675-54-3 | BISPHENOL A DIGLYCIDYL ETHER | 2-[[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]methyl]oxirane | PubChem SID:175271567 | DrugBank ID:DB14083 | CAS RN:91384-80-4 | PubChem CID:2286 | UNII:F3XRM1NX4H
+BMGC_DG05471,BMG_DG119578,"FLUOCORTIN | UNII:03837V0H1Y | PubChem CID:22875828 | Fluocortin | CAS RN:33124-50-4 | DrugBank ID:DB13223 | 2-[(6S,8S,9S,10R,11S,13S,14S,16R,17S)-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetic acid | PubChem SID:198965725"
+BMGC_DG05472,BMG_DG119587,2-HYDROXY-N-(3-PHENYLPROPYL)BENZAMIDE | CAS RN:153810-66-3 | PubChem SID:472421784 | UNII:M6RXY7JL5U | PubChem CID:2287872
+BMGC_DG05473,BMG_DG119590,N-METHYL-D-ASPARTIC ACID | N-methyl-D-aspartic acid | PubChem SID:241181375 | CAS RN:6384-92-5 | UNII:1903B9Q6PI | (2R)-2-(methylamino)butanedioic acid | PubChem CID:22880
+BMGC_DG05474,BMG_DG119626,CAS RN:4143-63-9 | 4'-Hydroxyflavone | 2-(4-hydroxyphenyl)chromen-4-one | PubChem CID:229016 | 4'-HYDROXYFLAVONE | PubChem SID:198936721 | UNII:8I6VZR0K67
+BMGC_DG05475,BMG_DG119641,BAMETHAN | 4-[2-(butylamino)-1-hydroxyethyl]phenol | PubChem CID:2292 | Bamethan | PubChem SID:198983929 | CAS RN:3703-79-5 | UNII:Y08ZFJ9TFK | DrugBank ID:DB13206
+BMGC_DG05476,BMG_DG119643,PubChem CID:22922043 | 3-methyl-2-(3-methylbutanoyloxy)butanoic acid | R-2-Hydroxy-3-methylbutanoic acid 3-Methylbutanoyl
+BMGC_DG05477,BMG_DG119654,"CAS RN:3836-23-5 | PubChem CID:229295 | PubChem SID:198936059 | DrugBank ID:DB14678 | [(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate | Norethindrone enanthate | NORETHINDRONE ENANTHATE | UNII:HY3S2K0J0F"
+BMGC_DG05478,BMG_DG119675,"DrugBank ID:DB01483 | PubChem CID:2294 | UNII:5WZ53ENE2P | PubChem SID:175265443 | BARBITAL | Barbital | 5,5-diethyl-1,3-diazinane-2,4,6-trione | CAS RN:57-44-3"
+BMGC_DG05479,BMG_DG119691,"UNII:KF7Z9K2T3W | NANDROLONE PHENPROPIONATE | [(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-phenylpropanoate | PubChem SID:198968945 | Nandrolone Phenpropionate | PubChem CID:229455 | CAS RN:62-90-8 | DrugBank ID:DB00984 | Nandrolone phenpropionate"
+BMGC_DG05480,BMG_DG119743,"PubChem CID:22991950 | [2-hydroxy-6-(3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)heptyl]-trimethylazanium | Lithocholylcholine"
+BMGC_DG05481,BMG_DG119747,"PubChem CID:22995178 | CAS RN:31542-64-0 | 1,3-DIALLYLXANTHINE | PubChem SID:443623872 | UNII:Q0U9B1VB4F"
+BMGC_DG05482,BMG_DG119760,PubChem SID:198956986 | PubChem CID:23009 | 4-[2-(5-nitroimidazol-1-yl)ethyl]morpholine | DrugBank ID:DB12172 | Nimorazole | CAS RN:6506-37-2 | UNII:469ULX0H4G | NIMORAZOLE
+BMGC_DG05483,BMG_DG119762,1-METHYL-CARBAZOLE | PubChem SID:363909069 | CAS RN:6510-65-2 | UNII:9IP20N6O32 | PubChem CID:23011
+BMGC_DG05484,BMG_DG119767,CAS RN:6976-69-8 | propyl 4-methylbenzoate | CAS RN:9015-73-0 | PubChem CID:230181 | Propyl 4-methylbenzoate
+BMGC_DG05485,BMG_DG119773,UNII:5VCD2BB2FU | 3-CYANOINDOLE | CAS RN:5457-28-3 | PubChem CID:230282
+BMGC_DG05486,BMG_DG119775,"CAS RN:93468-89-4 | 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | CAS RN:71145-03-4 | PubChem CID:2303 | methyl 2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)phenyl]-1,4-dihydropyridine-3-carboxylate"
+BMGC_DG05487,BMG_DG119790,"PubChem CID:2303947 | UNII:BN7LTH2D2H | CAS RN:20954-77-2 | PubChem SID:478838472 | 4-Amino-2,6-diphenyl-5-pyrimidinecarbonitrile | 4-AMINO-2,6-DIPHENYL-5-PYRIMIDINECARBONITRILE"
+BMGC_DG05488,BMG_DG119809,"3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione | Pf-06840003 | PubChem CID:23063810 | UNII:5K1FUI0T2C | CAS RN:198474-05-4 | PubChem SID:346540533 | PF-06840003"
+BMGC_DG05489,BMG_DG119821,1-METHYLINDOLE-3-CARBONITRILE | UNII:M3RSC92FMW | PubChem CID:2307681 | PubChem SID:472421877 | CAS RN:24662-37-1
+BMGC_DG05490,BMG_DG119826,PubChem SID:445499750 | UNII:VH3F3DR5X3 | CAS RN:776309-04-7 | PubChem CID:23080446 | JTT-551
+BMGC_DG05491,BMG_DG119831,DrugBank ID:DB12358 | PubChem SID:198972936 | ENBUCRILATE | CAS RN:6606-65-1 | UNII:F8CEP82QNP | PubChem CID:23087 | Enbucrilate | butyl 2-cyanoprop-2-enoate | CAS RN:25154-80-7
+BMGC_DG05492,BMG_DG119835,1-[7-[2-hydroxy-3-(propan-2-ylamino)propoxy]-1-benzofuran-2-yl]ethanone | PubChem SID:198977503 | UNII:418546MT3A | Befunolol | PubChem CID:2309 | BEFUNOLOL | CAS RN:39552-01-7 | DrugBank ID:DB09013
+BMGC_DG05493,BMG_DG119839,"1-Phenyl-1H-naphtho[2,3-d]triazole-4,9-dione | UNII:P4PE73CM6A | PubChem CID:230916 | 1-PHENYL-1H-NAPHTHO(2,3-D)TRIAZOLE-4,9-DIONE | PubChem SID:485662870 | CAS RN:5466-47-7"
+BMGC_DG05494,BMG_DG119846,CAS RN:1843-21-6 | PubChem CID:230981 | UNII:K2SX7MY84E | 2-ANILINOBENZOTHIAZOLE | 2-Anilinobenzothiazole | PubChem SID:485661232
+BMGC_DG05495,BMG_DG119847,"CAS RN:64-65-3 | BEMEGRIDE | PubChem SID:198952352 | UNII:57DQA39DO2 | DrugBank ID:DB13740 | 4-ethyl-4-methylpiperidine-2,6-dione | PubChem CID:2310 | Bemegride"
+BMGC_DG05496,BMG_DG119870,2-((4-AMINOBENZOYL)AMINO)-5-(6-METHYL-2-BENZOTHIAZOLYL)BENZENESULFONIC ACID | CAS RN:7147-36-6 | PubChem CID:231116 | PubChem SID:441659071 | UNII:89WQ28WKB4
+BMGC_DG05497,BMG_DG119877,"UNII:3D8X5HG29Y | PubChem CID:23116 | CAS RN:6631-87-4 | ANILINE, N-(P-CHLOROPHENYLTHIOMETHYL)-P-NITRO- | Aniline, N-(p-chlorophenylthiomethyl)-p-nitro- | PubChem SID:485662887"
+BMGC_DG05498,BMG_DG119886,"DrugBank ID:DB13488 | 3-(1-benzylcycloheptyl)oxy-N,N-dimethylpropan-1-amine | Bencyclane | PubChem SID:198950664 | PubChem CID:2312 | UNII:6I97Z6S135 | CAS RN:2179-37-5 | BENCYCLANE"
+BMGC_DG05499,BMG_DG119900,PubChem CID:2313 | CAS RN:20187-55-7 | PubChem SID:198965980 | BENDAZAC | DrugBank ID:DB13501 | Bendazac | 2-(1-benzylindazol-3-yl)oxyacetic acid | UNII:G4AG71204O
+BMGC_DG05500,BMG_DG119923,"PubChem CID:2314 | (2,2-dimethyl-1,3-benzodioxol-4-yl) N-methylcarbamate | BENDIOCARB | CAS RN:22781-23-3 | UNII:QFH0ZU0A5U | Bendiocarb | PubChem SID:198962978"
+BMGC_DG05501,BMG_DG119937,"BENDROFLUMETHIAZIDE | UNII:5Q52X6ICJI | PubChem CID:2315 | DrugBank ID:DB00436 | 3-benzyl-1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | CAS RN:73-48-3 | PubChem SID:175271668 | Bendroflumethiazide"
+BMGC_DG05502,BMG_DG119955,"Benextramine | BENEXTRAMINE | PubChem SID:461433589 | CAS RN:68535-69-3 | CAS RN:69790-18-7 | N'-[(2-methoxyphenyl)methyl]-N-[2-[2-[6-[(2-methoxyphenyl)methylamino]hexylamino]ethyldisulfanyl]ethyl]hexane-1,6-diamine | PubChem CID:2317 | UNII:2UGY4ETX3L"
+BMGC_DG05503,BMG_DG119961,2-[1-[3-(trifluoromethyl)phenyl]propan-2-ylamino]ethyl benzoate | UNII:403FO0NQG3 | PubChem SID:198974838 | BENFLUOREX | DrugBank ID:DB09022 | CAS RN:23602-78-0 | Benfluorex | PubChem CID:2318
+BMGC_DG05504,BMG_DG119967,CAS RN:6736-58-9 | DrugBank ID:DB04546 | PubChem CID:23190 | UNII:037V4520IY | PubChem SID:198988279 | 3-Deazaadenosine | 3-DEAZAADENOSINE
+BMGC_DG05505,BMG_DG119977,"CAS RN:7200-25-1 | UNII:FL26NTK3EP | DL-Arginine | PubChem CID:232 | ARGININE, DL- | 2-amino-5-(diaminomethylideneamino)pentanoic acid | PubChem SID:198964080 | CAS RN:7004-12-8"
+BMGC_DG05506,BMG_DG119980,"PubChem SID:198939653 | CAS RN:6754-13-8 | PubChem CID:23205 | HELENALIN | Helenalin | UNII:4GUY9L896T | (3aR,5R,5aR,8aR,9S,9aS)-9-hydroxy-5,8a-dimethyl-1-methylidene-3a,4,5,5a,9,9a-hexahydroazuleno[6,7-b]furan-2,8-dione"
+BMGC_DG05507,BMG_DG120010,"PubChem CID:2324 | 5-O-(1-benzylpiperidin-3-yl) 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 3-Methyl 5-(1-(phenylmethyl)-3-piperidinyl) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate | CAS RN:91599-75-6"
+BMGC_DG05508,BMG_DG120022,"DrugBank ID:DB07485 | PubChem SID:198961594 | UNII:64ZF6464QY | PubChem CID:232446 | CAS RN:843-55-0 | Bisphenol Z | 4,4'-CYCLOHEXYLIDENEBISPHENOL"
+BMGC_DG05509,BMG_DG120030,PubChem SID:319891946 | UNII:CLQ52DLW7V | PubChem CID:23247895 | CAS RN:98665-15-7 | GANODERIC ACID F
+BMGC_DG05510,BMG_DG120078,CAS RN:6836-98-2 | 3-phenyloxolan-2-one | 3-Phenyloxolan-2-one | PubChem CID:23269
+BMGC_DG05511,BMG_DG120080,"CAS RN:322-35-0 | UNII:762OS3ZEJU | BENSERAZIDE | 2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide | DrugBank ID:DB12783 | Benserazide | PubChem SID:198965367 | PubChem CID:2327"
+BMGC_DG05512,BMG_DG120082,"DrugBank ID:DB07339 | PubChem CID:23270857 | (3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione"
+BMGC_DG05513,BMG_DG120152,CAS RN:47309-59-1 | benzyl-dimethyl-tridecylazanium | Benzyl-dimethyl-tridecylazanium | PubChem CID:2330
+BMGC_DG05514,BMG_DG120163,benzamide | CAS RN:55-21-0 | Benzamide | PubChem CID:2331 | UNII:6X80438640 | CAS RN:55738-52-8 | BENZAMIDE | PubChem SID:198987389
+BMGC_DG05515,BMG_DG120172,UNII:KUE3ZY3J1F | CAS RN:618-39-3 | CAS RN:123920-06-9 | PubChem CID:2332 | Benzamidine | CAS RN:125772-71-6 | BENZAMIDINE | PubChem SID:198956152 | benzenecarboximidamide
+BMGC_DG05516,BMG_DG120180,UNII:C59S3E32RV | 1h-Benoximidazole-2-Carboxylic Acid | 1H-benzimidazole-2-carboxylic acid | CAS RN:2849-93-6 | 2-BENZIMIDAZOLECARBOXYLIC ACID | PubChem SID:472421934 | DrugBank ID:DB03028 | 1H-Benzimidazole-2-carboxylic acid | PubChem CID:233240
+BMGC_DG05517,BMG_DG120186,PubChem SID:175266664 | D-Glutamic Acid | CAS RN:138-16-9 | DrugBank ID:DB02517 | UNII:Q479989WEA | D-GLUTAMIC ACID | D-glutamic acid | CAS RN:6893-26-1 | PubChem CID:23327 | (2R)-2-aminopentanedioic acid
+BMGC_DG05518,BMG_DG120189,"(3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone | PubChem SID:198942918 | BENZBROMARONE | PubChem CID:2333 | UNII:4POG0RL69O | Benzbromarone | CAS RN:3562-84-3 | DrugBank ID:DB12319"
+BMGC_DG05519,BMG_DG120200,PubChem SID:198977251 | PubChem CID:2334 | CAS RN:517-60-2 | Benzene Hexacarboxylic Acid | MELLITIC ACID | DrugBank ID:DB01681 | UNII:P80QSP14DM
+BMGC_DG05520,BMG_DG120213,PubChem SID:318164689 | 4-NITROESTRONE | CAS RN:5976-74-9 | PubChem CID:233497 | UNII:IM60NNH5BH
+BMGC_DG05521,BMG_DG120215,"UNII:1VU15B70BP | CAS RN:10172-60-8 | benzyl-dimethyl-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium | DrugBank ID:DB11125 | PubChem SID:175265979 | PubChem CID:2335 | CAS RN:498-77-1 | Benzethonium | BENZETHONIUM"
+BMGC_DG05522,BMG_DG120217,PubChem CID:23351 | CAS RN:6921-29-5 | PubChem SID:198946815 | TRIPROPARGYLAMINE | UNII:5E92GFJ1AJ
+BMGC_DG05523,BMG_DG120227,BENZO(A)PYRENE | PubChem CID:2336 | CAS RN:6699-27-0 | benzo[a]pyrene | UNII:3417WMA06D | CAS RN:34505-58-3 | CAS RN:50-32-8 | CAS RN:42299-33-2 | Benzo[a]pyrene | PubChem SID:198936791
+BMGC_DG05524,BMG_DG120229,2-BENZYLAMINOPYRIDINE | UNII:2M6W78559O | PubChem SID:198980539 | PubChem CID:23362 | CAS RN:6935-27-9
+BMGC_DG05525,BMG_DG120238,NDC:10237-792 | NDC:69004-004 | NDC:69483-006 | NDC:72766-012 | NDC:10223-0202 | NDC:68987-007 | NDC:53045-135 | NDC:53045-144 | NDC:53045-136 | NDC:60913-031 | NDC:63029-531 | NDC:10237-783 | NDC:70721-005 | NDC:59779-644 | NDC:68400-352 | NDC:67172-022 | NDC:43498-312 | NDC:43498-314 | NDC:69484-004 | NDC:71363-104 | NDC:10733-171 | NDC:68987-005 | NDC:70000-0552 | NDC:10733-173 | NDC:66975-340 | NDC:37000-928 | NDC:59050-102 | NDC:0283-1886 | NDC:0363-5820 | NDC:55346-2903 | NDC:69301-001 | NDC:69510-353 | NDC:0363-2311 | NDC:71101-049 | NDC:68400-477 | NDC:67172-017 | NDC:72854-266 | NDC:69509-006 | NDC:45591-002 | NDC:52642-036 | NDC:68229-700 | NDC:69301-004 | NDC:79364-0932 | NDC:69681-432 | NDC:84010-017 | NDC:69509-009 | NDC:16864-680 | NDC:67172-023 | NDC:66467-4001 | NDC:73635-7101 | NDC:83608-108 | NDC:72304-009 | NDC:43305-0008 | NDC:53045-132 | NDC:41250-066 | NDC:10733-167 | NDC:50227-1002 | NDC:69483-002 | NDC:67239-0223 | NDC:69509-003 | NDC:43305-0007 | NDC:69301-007 | NDC:63736-050 | NDC:67172-015 | NDC:81417-001 | NDC:61010-8100 | NDC:0363-1113 | NDC:55621-016 | ethyl 4-aminobenzoate | NDC:43498-317 | NDC:16864-690 | NDC:72839-343 | NDC:70721-006 | NDC:70742-360 | NDC:66467-4003 | NDC:11822-0345 | NDC:69004-001 | NDC:71730-009 | NDC:50227-1009 | NDC:25047-755 | NDC:71363-102 | PubChem CID:2337 | NDC:68400-355 | NDC:63736-205 | NDC:68400-359 | NDC:0283-0220 | NDC:66975-353 | NDC:67239-0218 | NDC:69634-027 | NDC:68400-459 | NDC:67172-021 | NDC:68421-8100 | NDC:0924-5204 | NDC:36800-443 | NDC:55346-2901 | NDC:68400-323 | NDC:65753-350 | NDC:53045-140 | NDC:43305-0002 | NDC:17433-9877 | NDC:53045-147 | NDC:52412-350 | NDC:66467-4006 | NDC:59779-123 | NDC:70742-503 | NDC:50227-1001 | NDC:69301-006 | NDC:68987-006 | NDC:10237-796 | NDC:70721-002 | NDC:48201-012 | NDC:63868-949 | NDC:68400-478 | NDC:71347-101 | NDC:78589-233 | NDC:71922-102 | NDC:43305-0005 | NDC:43498-315 | NDC:0283-0520 | NDC:10733-166 | NDC:72459-016 | NDC:70721-001 | NDC:17856-0732 | NDC:72932-004 | NDC:10237-200 | NDC:67172-018 | NDC:71363-105 | NDC:0283-0871 | NDC:10157-2106 | NDC:69509-004 | NDC:69484-005 | NDC:10223-0201 | NDC:52412-200 | NDC:71101-035 | NDC:0699-3100 | NDC:69483-008 | NDC:71363-100 | NDC:66975-352 | NDC:0363-9095 | NDC:63736-040 | NDC:48201-015 | NDC:69483-004 | NDC:69634-021 | NDC:35418-010 | NDC:73341-001 | NDC:25047-752 | NDC:59050-706 | NDC:63824-732 | NDC:42961-107 | NDC:50332-0050 | NDC:66467-4004 | NDC:0283-0569 | NDC:69509-007 | NDC:10210-0048 | NDC:66975-343 | NDC:70742-288 | NDC:53045-134 | NDC:10129-072 | NDC:69634-022 | NDC:0699-7011 | NDC:83608-107 | NDC:0363-1079 | NDC:69509-001 | NDC:0404-0036 | NDC:71888-101 | NDC:63736-375 | NDC:71922-105 | NDC:63941-047 | NDC:51316-991 | NDC:56152-1470 | NDC:48201-014 | NDC:43305-0004 | NDC:0404-0039 | NDC:0283-0622 | NDC:50804-025 | NDC:70721-007 | NDC:37808-691 | NDC:68400-461 | NDC:10237-790 | NDC:0924-5250 | NDC:58593-782 | NDC:71347-105 | NDC:0404-0038 | NDC:11527-062 | NDC:10237-797 | UNII:U3RSY48JW5 | Benzocaine | NDC:69842-588 | NDC:79903-966 | NDC:69626-0049 | NDC:69842-693 | NDC:53045-131 | NDC:50227-1007 | NDC:66467-4002 | NDC:0283-1016 | NDC:43498-316 | NDC:10157-2127 | NDC:59050-415 | NDC:37808-062 | NDC:43498-313 | NDC:43305-0001 | NDC:68400-351 | NDC:63824-744 | NDC:10202-853 | NDC:59779-582 | NDC:43498-310 | NDC:55910-346 | NDC:50227-1005 | NDC:68400-479 | NDC:27854-177 | NDC:73492-717 | NDC:73288-004 | NDC:0283-0522 | NDC:55346-2902 | NDC:79481-0006 | NDC:42961-810 | NDC:10223-0217 | NDC:53045-138 | NDC:54723-006 | NDC:66975-358 | NDC:55910-816 | NDC:10129-036 | NDC:68987-001 | NDC:10223-0226 | NDC:10157-9477 | NDC:69469-200 | NDC:80070-220 | NDC:17856-6255 | NDC:61787-070 | NDC:55636-000 | NDC:10733-415 | NDC:59779-743 | NDC:50227-1003 | NDC:54723-015 | NDC:69301-005 | NDC:0283-0886 | NDC:68400-358 | NDC:42961-020 | NDC:69484-002 | NDC:70742-282 | NDC:82645-918 | NDC:0283-0914 | NDC:25047-751 | NDC:67777-246 | NDC:69004-002 | NDC:71922-101 | NDC:71922-100 | NDC:43305-0009 | NDC:67239-0221 | NDC:70742-286 | NDC:68987-008 | NDC:55910-065 | NDC:60306-115 | NDC:72854-265 | NDC:70721-004 | NDC:69509-005 | NDC:0404-0018 | NDC:68400-475 | NDC:57554-120 | NDC:0924-5201 | NDC:0283-1116 | NDC:69634-025 | NDC:69510-355 | NDC:82895-857 | NDC:10733-162 | NDC:72484-433 | NDC:63736-378 | NDC:69301-002 | NDC:42961-182 | NDC:67091-198 | CAS RN:94-09-7 | NDC:66975-351 | PubChem SID:175267685 | NDC:69498-001 | NDC:11822-5880 | NDC:58228-2204 | NDC:69510-358 | NDC:59397-3310 | NDC:66467-4000 | NDC:81923-365 | NDC:69483-005 | NDC:0363-2053 | NDC:0283-0679 | NDC:43498-318 | NDC:57896-139 | NDC:0699-7031 | NDC:58552-135 | NDC:66975-356 | NDC:69509-008 | NDC:68987-002 | NDC:0404-0032 | NDC:0363-1605 | NDC:59050-414 | NDC:69004-005 | NDC:71347-103 | NDC:68987-004 | NDC:37000-935 | NDC:0904-7301 | NDC:41250-068 | NDC:65517-0005 | NDC:10223-0221 | NDC:69498-004 | NDC:67239-0219 | NDC:68400-353 | NDC:0404-0035 | NDC:69483-007 | NDC:84415-044 | NDC:10157-9302 | NDC:73288-006 | NDC:43498-319 | NDC:66975-355 | NDC:36800-832 | NDC:11509-4402 | NDC:70742-284 | NDC:71363-101 | NDC:68987-003 | NDC:69842-353 | NDC:70742-292 | NDC:68400-357 | NDC:83608-100 | NDC:59779-830 | NDC:0699-7051 | NDC:50227-1004 | NDC:80070-230 | NDC:61333-215 | NDC:10223-0225 | NDC:82749-010 | NDC:11822-0043 | NDC:0404-0033 | NDC:69842-660 | NDC:69484-003 | NDC:0283-0920 | NDC:10742-8902 | NDC:67777-405 | NDC:69498-005 | NDC:83608-104 | NDC:54859-503 | NDC:0283-0610 | NDC:68599-8247 | NDC:36800-836 | NDC:68400-508 | NDC:69509-002 | NDC:11822-1343 | NDC:53045-142 | NDC:83324-019 | NDC:71363-103 | NDC:53045-146 | NDC:81923-367 | NDC:68400-460 | NDC:67172-114 | NDC:0699-7071 | NDC:79903-042 | NDC:0404-0034 | NDC:50486-550 | NDC:59779-444 | NDC:50227-1011 | NDC:0699-7021 | NDC:70742-180 | NDC:69510-351 | NDC:81923-369 | NDC:47682-234 | NDC:59050-104 | NDC:10733-170 | NDC:69423-901 | NDC:11822-1616 | NDC:70372-727 | NDC:69004-003 | NDC:53045-133 | NDC:0363-5061 | NDC:66975-350 | NDC:11822-0316 | NDC:11822-5340 | NDC:43498-311 | NDC:52412-300 | NDC:69498-003 | NDC:69498-002 | NDC:69842-377 | NDC:69484-006 | NDC:53045-145 | NDC:69301-003 | NDC:50227-1010 | NDC:71347-100 | NDC:10733-169 | NDC:41163-021 | NDC:43473-306 | NDC:70721-003 | NDC:68400-350 | NDC:53045-130 | NDC:71734-340 | NDC:71363-106 | NDC:83608-102 | NDC:71347-102 | NDC:67239-0220 | NDC:66975-354 | NDC:0283-0998 | NDC:63824-713 | NDC:67172-016 | NDC:0363-0316 | NDC:65923-094 | NDC:69483-003 | NDC:71922-103 | NDC:46414-2040 | NDC:69484-001 | NDC:71363-107 | NDC:71347-104 | NDC:69483-009 | NDC:25047-753 | NDC:69634-023 | NDC:72304-008 | NDC:54723-722 | NDC:65282-1815 | NDC:10237-782 | NDC:69634-020 | NDC:83608-106 | NDC:69004-006 | NDC:0404-0037 | NDC:0924-5202 | NDC:10742-8915 | NDC:68400-354 | NDC:72459-282 | NDC:10733-176 | NDC:66975-341 | DrugBank ID:DB01086 | NDC:71922-104 | NDC:36800-512 | NDC:54859-504 | NDC:69139-203 | NDC:53045-141 | NDC:81777-106 | NDC:0283-0293 | NDC:11822-6170 | NDC:0283-1820 | NDC:79481-0118 | NDC:24286-1577 | NDC:55319-108 | NDC:69498-006 | NDC:34645-4190 | NDC:82659-1000 | NDC:69510-352 | NDC:43305-0003 | NDC:59779-545 | NDC:10733-175 | NDC:43305-0010 | NDC:55346-2904 | NDC:69483-001 | NDC:55758-300 | NDC:84806-147 | NDC:41520-043 | NDC:66975-357 | NDC:72854-683 | NDC:11509-5103 | NDC:53045-137 | NDC:0363-5334 | NDC:72459-013 | BENZOCAINE | NDC:25047-754 | NDC:10733-174 | NDC:67239-0222 | NDC:71734-113 | NDC:58593-783 | NDC:0904-6255 | NDC:54723-007 | NDC:72839-069 | NDC:43305-0006 | NDC:70000-0554 | NDC:50332-0048
+BMGC_DG05526,BMG_DG120270,"PubChem CID:233952 | CAS RN:4281-72-5 | 1H-INDOLE, 3-((4-PHENYL-1-PIPERAZINYL)METHYL)- | UNII:HM79AG684R | PubChem SID:441659103"
+BMGC_DG05527,BMG_DG120273,DrugBank ID:DB08082 | PubChem SID:438787878 | UNII:9CYV9RP6X6 | N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE | PubChem CID:233979 | 4-CHLORO-N-(2-HYDROXYETHYL)BENZAMIDE | CAS RN:7400-54-6
+BMGC_DG05528,BMG_DG120275,"PubChem CID:23400214 | N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | DrugBank ID:DB08242"
+BMGC_DG05529,BMG_DG120278,PubChem CID:23403 | Tiadenol | DrugBank ID:DB13348 | UNII:22251270CX | CAS RN:6964-20-1 | PubChem SID:198949821 | TIADENOL | 2-[10-(2-hydroxyethylsulfanyl)decylsulfanyl]ethanol
+BMGC_DG05530,BMG_DG120285,"PubChem SID:316912245 | CAS RN:101-47-3 | PubChem CID:2341 | UNII:QZH832I91B | BENZPHETAMINE, (+/-)- | BENZPHETAMINE, (±)-"
+BMGC_DG05531,BMG_DG120287,UNII:2JV36G5X6D | 11-OXOURSOLIC ACID ACETATE | PubChem SID:478838357 | PubChem CID:234102 | 11-Oxoursolic acid acetate | CAS RN:35959-01-4
+BMGC_DG05532,BMG_DG120288,"NDC:70771-1590 | NDC:50090-7205 | PubChem SID:198990580 | NDC:16714-039 | NDC:70771-1396 | COLCHICEINE | PubChem CID:234105 | CAS RN:477-27-0 | NDC:70710-1351 | Colchiceine | UNII:HJ30158L57 | NDC:70710-1571 | N-[(7S)-10-hydroxy-1,2,3-trimethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide"
+BMGC_DG05533,BMG_DG120294,"UNII:M3EFS94984 | ORMETOPRIM | CAS RN:6981-18-6 | Ormetoprim | PubChem CID:23418 | PubChem SID:175267814 | 5-[(4,5-dimethoxy-2-methylphenyl)methyl]pyrimidine-2,4-diamine"
+BMGC_DG05534,BMG_DG120297,"CAS RN:23844-24-8 | PubChem CID:2342 | CAS RN:63-12-7 | [3-(diethylcarbamoyl)-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] acetate | DrugBank ID:DB00767 | Benzquinamide"
+BMGC_DG05535,BMG_DG120339,"Benzthiazide | PubChem SID:198952985 | 3-(benzylsulfanylmethyl)-6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | CAS RN:91-33-8 | BENZTHIAZIDE | DrugBank ID:DB00562 | UNII:1TD8J48L61 | PubChem CID:2343"
+BMGC_DG05536,BMG_DG120355,FERRIC SULFATE | CAS RN:142906-29-4 | PubChem CID:23443659 | DrugBank ID:DB11171 | PubChem SID:175266668 | UNII:3HWS7HF5XD | Ferric sulfate
+BMGC_DG05537,BMG_DG120364,CAS RN:347840-01-1 | CAS RN:120-51-4 | DrugBank ID:DB00676 | PubChem SID:175267736 | Benzyl benzoate | UNII:N863NB338G | benzyl benzoate | BENZYL BENZOATE | PubChem CID:2345 | Benzyl Benzoate
+BMGC_DG05538,BMG_DG120369,CAS RN:2555-20-6 | 3-CARBOXY-8-METHOXYCOUMARIN | PubChem CID:234562 | UNII:8GK9E9M6VR | PubChem SID:441659738
+BMGC_DG05539,BMG_DG120376,UNII:871J6YOR8Q | BENZYL ISOTHIOCYANATE | PubChem CID:2346 | isothiocyanatomethylbenzene | CAS RN:622-78-6 | Benzyl Isothiocyanate | PubChem SID:198979644
+BMGC_DG05540,BMG_DG120392,CAS RN:1824-50-6 | PubChem SID:198981716 | BENZYLHYDROCHLOROTHIAZIDE | UNII:176437APQH | PubChem CID:2348
+BMGC_DG05541,BMG_DG120393,"DrugBank ID:DB13725 | PubChem SID:198957313 | PubChem CID:23480 | TERODILINE | Terodiline | N-tert-butyl-4,4-diphenylbutan-2-amine | CAS RN:15793-40-5 | UNII:70KG06964W"
+BMGC_DG05542,BMG_DG120395,PubChem CID:234811 | RRD-251 | PubChem SID:445500224 | UNII:2ZZB8KVZ96 | CAS RN:131916-62-6
+BMGC_DG05543,BMG_DG120404,"PubChem CID:2349 | CAS RN:7005-30-3 | 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | CAS RN:1232134-74-5 | Cillin"
+BMGC_DG05544,BMG_DG120412,"Melevodopa | CAS RN:7101-51-1 | PubChem SID:198940907 | MELEVODOPA | UNII:M30686U4X4 | methyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate | PubChem CID:23497 | DrugBank ID:DB13313"
+BMGC_DG05545,BMG_DG120417,PubChem CID:2350 | 4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid | 4-[4-[(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid | Bepotastine | DrugBank ID:DB04890 | CAS RN:1070505-53-1 | CAS RN:190786-43-7
+BMGC_DG05546,BMG_DG120435,BEPRIDIL | UNII:755BO701MA | N-benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline | Bepridil | PubChem CID:2351 | PubChem SID:198943296 | CAS RN:864868-68-8 | DrugBank ID:DB01244 | CAS RN:64706-54-3
+BMGC_DG05547,BMG_DG120452,4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE | DrugBank ID:DB07459 | PubChem CID:2352168 | UNII:6J2NXX77VH | CAS RN:380211-59-6 | PubChem SID:445500494
+BMGC_DG05548,BMG_DG120453,"11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,14,16,18-hexaene | PubChem CID:235224 | (R)-Roemerine | CAS RN:15548-23-9"
+BMGC_DG05549,BMG_DG120466,"16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene | DrugBank ID:DB04115 | BERBERINE | UNII:0I8Y3P32UF | Berberine | PubChem CID:2353 | CAS RN:2086-83-1 | PubChem SID:175265374"
+BMGC_DG05550,BMG_DG120481,PubChem SID:198976957 | PubChem CID:2354 | CAS RN:1443105-71-2 | CAS RN:536-71-0 | 4-[2-(4-carbamimidoylphenyl)iminohydrazinyl]benzenecarboximidamide | DIMINAZENE | Diminazene | UNII:Y5G36EEA5Z | DrugBank ID:DB03608
+BMGC_DG05551,BMG_DG120492,"Bergapten | DrugBank ID:DB12216 | BERGAPTEN | 4-methoxyfuro[3,2-g]chromen-7-one | UNII:4FVK84C92X | CAS RN:484-20-8 | PubChem SID:198936762 | PubChem CID:2355"
+BMGC_DG05552,BMG_DG120511,PubChem SID:474492507 | CAS RN:6305-91-5 | UNII:H3BTZ8TH8D | 4-((5-Azanylnaphthalen-2-yl)sulfonylamino)benzoic acid | 4-((5-AZANYLNAPHTHALEN-2-YL)SULFONYLAMINO)BENZOIC ACID | PubChem CID:235593
+BMGC_DG05553,BMG_DG120527,CAS RN:3604-79-3 | 2-Amino-3-(4-hydroxy-3-nitrophenyl)propanoic acid | PubChem CID:235719 | 2-amino-3-(4-hydroxy-3-nitrophenyl)propanoic acid
+BMGC_DG05554,BMG_DG120530,CAS RN:7182-51-6 | TALOPRAM | Talopram | PubChem CID:23573 | DrugBank ID:DB09190 | PubChem SID:198947870 | UNII:5PY881HC79
+BMGC_DG05555,BMG_DG120532,"3,5-dibenzyl-8-thionia-3,5-diazatricyclo[6.3.0.02,6]undecan-4-one | TRIMETHAPHAN | PubChem SID:198953705 | DrugBank ID:DB01116 | UNII:6G8X656T45 | Trimethaphan | CAS RN:7187-66-8 | PubChem CID:23576"
+BMGC_DG05556,BMG_DG120539,"[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydrate;hydrochloride | IRINOTECAN HCl)trihydrate) | PubChem CID:23581792"
+BMGC_DG05557,BMG_DG120546,AZD-7325 | DrugBank ID:DB13994 | CAS RN:942437-37-8 | PubChem SID:241181130 | PubChem CID:23581869 | UNII:KNM216XOUH | 4-amino-8-(2-fluoro-6-methoxyphenyl)-N-propylcinnoline-3-carboxamide | Azd7325
+BMGC_DG05558,BMG_DG120551,"CAS RN:872365-14-5 | FEVIPIPRANT | PubChem CID:23582412 | DrugBank ID:DB12011 | 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid | Fevipiprant | PubChem SID:198980566 | UNII:2PEX5N7DQ4"
+BMGC_DG05559,BMG_DG120554,"(5Z)-5-[(4-pyridin-4-ylquinolin-6-yl)methylidene]-1,3-thiazolidine-2,4-dione | PubChem SID:198938796 | DrugBank ID:DB11962 | PubChem CID:23582824 | CAS RN:958852-01-2 | Gsk-1059615 | GSK-1059615 | UNII:07YMO87363"
+BMGC_DG05560,BMG_DG120571,DrugBank ID:DB08422 | [PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE | PubChem CID:23586040
+BMGC_DG05561,BMG_DG120572,"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE | DrugBank ID:DB07685 | PubChem CID:23586145"
+BMGC_DG05562,BMG_DG120573,"PubChem CID:23586146 | 4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE | DrugBank ID:DB07686"
+BMGC_DG05563,BMG_DG120574,"(5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one | DrugBank ID:DB08574 | PubChem CID:23586154"
+BMGC_DG05564,BMG_DG120575,"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE | PubChem CID:23586165 | DrugBank ID:DB08250"
+BMGC_DG05565,BMG_DG120577,DrugBank ID:DB04360 | 1-benzothiophen-2-ylboronic acid | Benzo[B]thiophene-2-boronic acid | Benzo[B]Thiophene-2-Boronic Acid | BENZO(B)THIOPHENE-2-BORONIC ACID | UNII:SME05QG1FJ | CAS RN:98437-23-1 | PubChem SID:438788728 | PubChem CID:2359
+BMGC_DG05566,BMG_DG120580,"Allylestrenol | (8R,9S,10R,13S,14S,17R)-13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol | CAS RN:432-60-0 | PubChem CID:235905 | DrugBank ID:DB01431 | PubChem SID:198956599 | UNII:I47VB5DZ8O | ALLYLESTRENOL"
+BMGC_DG05567,BMG_DG120585,CAS RN:6267-28-3 | PubChem CID:235964 | UNII:HM5GT67GMW | 4-AMINO-N-(3-AMINOPHENYL)BENZENESULFONAMIDE | PubChem SID:441583460
+BMGC_DG05568,BMG_DG120602,"PubChem SID:316918349 | Beta-Naphthoflavone | 5,6-BENZOFLAVONE | beta-Naphthoflavone | DrugBank ID:DB06732 | CAS RN:6051-87-2 | PubChem CID:2361 | 3-phenylbenzo[f]chromen-1-one | UNII:1BT0256Y8O"
+BMGC_DG05569,BMG_DG120688,"PubChem SID:198972731 | CAS RN:18829-42-0 | CAS RN:699014-53-4 | DrugBank ID:DB14488 | CAS RN:299-29-6 | PubChem CID:23616740 | iron(2+);(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate | UNII:781E2AXH0K | Ferrous Gluconate | FERROUS GLUCONATE ANHYDROUS"
+BMGC_DG05570,BMG_DG120753,"PubChem CID:23618794 | CAS RN:7642-54-8 | 7.ALPHA.-METHYL-5.ALPHA.-ANDROSTANE-3.BETA.,17.BETA.-DIOL | UNII:7QD8FUS26R | PubChem SID:198969770"
+BMGC_DG05571,BMG_DG120835,UNII:EEQ2P5TT77 | PubChem CID:23622616 | CAS RN:305379-00-4 | L-IDO MIGLUSTAT
+BMGC_DG05572,BMG_DG120857,Perphenazine enanthate | DrugBank ID:DB14651 | PubChem CID:23623915
+BMGC_DG05573,BMG_DG120872,PubChem CID:23624249 | DrugBank ID:DB07168 | [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile
+BMGC_DG05574,BMG_DG120873,DrugBank ID:DB12047 | PubChem CID:23624255 | Ganetespib
+BMGC_DG05575,BMG_DG120874,PubChem SID:485664393 | UNII:DDT5N8PP96 | PubChem CID:23625650 | CAS RN:173400-13-0 | ALISKIREN CARBOXYLIC ACID | Aliskiren Carboxylic Acid
+BMGC_DG05576,BMG_DG120882,3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol | PubChem CID:23627203 | DrugBank ID:DB07079
+BMGC_DG05577,BMG_DG120884,"CAS RN:942614-99-5 | JTS-653 | (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2-trifluoroethoxy)pyridin-3-yl]-2,3-dihydro-1,4-benzoxazine-8-carboxamide | PubChem CID:23628017 | PubChem SID:459055544 | UNII:2TM92XK3YA | Unii-2TM92XK3YA"
+BMGC_DG05578,BMG_DG120886,[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid | Tenofovir exalidex | PubChem CID:23628250 | CAS RN:911208-73-6 | PubChem SID:198960951 | DrugBank ID:DB14925 | TENOFOVIR EXALIDEX | UNII:K7J545MEMA
+BMGC_DG05579,BMG_DG120888,"DrugBank ID:DB07765 | METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE | PubChem CID:23629645"
+BMGC_DG05580,BMG_DG120891,DrugBank ID:DB06845 | (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide | PubChem CID:23629654
+BMGC_DG05581,BMG_DG120892,"CAS RN:942436-93-3 | UNII:B9Z1OEH19D | Azd-6280 | PubChem CID:23630026 | DrugBank ID:DB12210 | 4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide | PubChem SID:198975685 | AZD-6280"
+BMGC_DG05582,BMG_DG120897,"CAS RN:945976-76-1 | LX-1031 | PubChem CID:23633604 | PubChem SID:198954724 | UNII:J08E1J78GK | (2S)-2-amino-3-[4-[2-amino-6-[(1R)-2,2,2-trifluoro-1-[4-(3-methoxyphenyl)phenyl]ethoxy]pyrimidin-4-yl]phenyl]propanoic acid"
+BMGC_DG05583,BMG_DG120898,PubChem SID:319891858 | CAS RN:942937-80-6 | AZD-1386 | UNII:210323T9CP | PubChem CID:23633673
+BMGC_DG05584,BMG_DG120899,"5-(4-METHOXYPHENYL)-13-((PROP-2-YN-1-YL)AMINO)-8-THIA-3,5,10-TRIAZATRICYCLO(7.4.0.0^(2,7))TRIDECA-1(13),2(7),3,9,11-PENTAEN-6-ONE | PubChem CID:23634102 | UNII:3S4N4U44G8 | CAS RN:902747-98-2 | PubChem SID:198936854"
+BMGC_DG05585,BMG_DG120900,"3-(4-CHLOROPHENYL)-9-(2-PROPYN-1-YLAMINO)PYRIDO(3',2':4,5)THIENO(3,2-D)PYRIMIDIN-4(3H)-ONE | PubChem SID:198953676 | PubChem CID:23634171 | CAS RN:902747-93-7 | UNII:RWS6U82B77"
+BMGC_DG05586,BMG_DG120901,EMD-534085 | CAS RN:858668-07-2 | PubChem SID:198958061 | UNII:AL67QX8036 | PubChem CID:23634407
+BMGC_DG05587,BMG_DG120903,DrugBank ID:DB12255 | UNII:I60W9520VV | PubChem CID:23634441 | NDC:59922-642 | Vadadustat | NDC:59922-641 | 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid | CAS RN:1000025-07-9 | VADADUSTAT | PubChem SID:252164330 | NDC:59922-643
+BMGC_DG05588,BMG_DG120904,CAS RN:956103-77-8 | PubChem CID:23634523 | PubChem SID:472425347 | UNII:C83SC7337B | COCHINCHINENIN B
+BMGC_DG05589,BMG_DG120906,COCHINCHINENIN C | CAS RN:956103-79-0 | PubChem CID:23634528 | UNII:A9CME97XV3 | PubChem SID:472425087
+BMGC_DG05590,BMG_DG120908,CARBOXYFENTANYL | CAS RN:52994-23-7 | UNII:9B5MX9FN8R | PubChem SID:441331492 | PubChem CID:23635044
+BMGC_DG05591,BMG_DG120909,NDC:16110-391 | PubChem SID:198936538 | UNII:4V9848RS5G | N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]acetamide | Tirbanibulin | CAS RN:897016-82-9 | DrugBank ID:DB06137 | PubChem CID:23635314 | TIRBANIBULIN
+BMGC_DG05592,BMG_DG120916,3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL | PubChem CID:23640750 | DrugBank ID:DB08447
+BMGC_DG05593,BMG_DG120917,PubChem CID:23640756 | methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate | DrugBank ID:DB08505
+BMGC_DG05594,BMG_DG120919,UNII:U2YW502S1Q | BETULIN DIACETATE | PubChem SID:198941586 | PubChem CID:236415 | CAS RN:1721-69-3
+BMGC_DG05595,BMG_DG120921,CAS RN:13251-86-0 | 6.ALPHA.-METHYLTESTOSTERONE | PubChem SID:198956487 | PubChem CID:236417 | UNII:YQ2E301IZP
+BMGC_DG05596,BMG_DG120924,CAS RN:960374-59-8 | (2S)-3-(4-methoxyphenyl)-N-[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide | PubChem CID:23642227 | (S)-3-(4-methoxyphenyl)-N-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)propanamido)propanamide
+BMGC_DG05597,BMG_DG120925,CAS RN:1000578-26-6 | PubChem SID:440088869 | UNII:LA5AQ5R6QS | PubChem CID:23642275 | AS-19
+BMGC_DG05598,BMG_DG120927,"Elacestrant | PubChem SID:346540946 | NDC:72187-0101 | ELACESTRANT | (6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol | UNII:FM6A2627A8 | CAS RN:722533-56-4 | PubChem CID:23642301 | DrugBank ID:DB06374 | NDC:72187-0102"
+BMGC_DG05599,BMG_DG120928,PubChem CID:23642319 | A-867744 | UNII:O6NW23A765 | CAS RN:1000279-69-5 | PubChem SID:198966761
+BMGC_DG05600,BMG_DG120933,PubChem SID:445499011 | CAS RN:1185136-22-4 | LP-12 | PubChem CID:23643664 | UNII:Q77EAZ9TG9
+BMGC_DG05601,BMG_DG120939,PubChem CID:23644529 | DrugBank ID:DB04648 | S-propylamine-L-cysteine
+BMGC_DG05602,BMG_DG120940,"(5R)-2-[(2-Fluorophenyl)amino]-5-isopropyl-1,3-thiazol-4(5H)-one | DrugBank ID:DB08771 | PubChem CID:23644575"
+BMGC_DG05603,BMG_DG120943,"PubChem CID:23644582 | 4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde | DrugBank ID:DB07832"
+BMGC_DG05604,BMG_DG120946,CAS RN:25081-93-0 | 3-((1RS)-1-(DIMETHYLAMINO)ETHYL)PHENYL DIMETHYLCARBAMATE | PubChem CID:23645310 | UNII:JNM2N2FC5F
+BMGC_DG05605,BMG_DG120947,"DrugBank ID:DB07687 | PubChem CID:23645578 | 4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE"
+BMGC_DG05606,BMG_DG120948,"(1S,3S,5S)-2-[(2S)-2-amino-2-(3,5-dihydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile | UNII:PB91NV4HAN | PubChem CID:23645678 | PubChem SID:438787920 | (1S,3S,5S)-2-((2S)-2-AMINO-2-(3,5-DIHYDROXYTRICYCLO(3.3.1.13,7)DEC-1-YL)ACETYL)-2-AZABICYCLO(3.1.0)HEXANE-3-CARBONITRILE | 5-Hydroxy saxagliptin | CAS RN:841302-24-7"
+BMGC_DG05607,BMG_DG120949,"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE | PubChem CID:23645698 | DrugBank ID:DB07067"
+BMGC_DG05608,BMG_DG120950,PubChem CID:23645973 | (3S)-3-[[2-(4-butan-2-ylphenoxy)phenyl]sulfonylamino]-4-oxobutanoic acid | (3S)-3-({2-[4-(butan-2-yl)phenoxy]benzene}sulfonamido)-4-oxobutanoic acid
+BMGC_DG05609,BMG_DG120951,3-(3-METHYL-2-THIENYL)PYRIDINE | PubChem CID:23646069 | UNII:JG23HS7UFT | PubChem SID:472421909 | CAS RN:837376-35-9
+BMGC_DG05610,BMG_DG120952,"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE | DrugBank ID:DB08674 | PubChem CID:23646577"
+BMGC_DG05611,BMG_DG120953,PubChem SID:198979579 | FLUTIAZIN | CAS RN:7220-56-6 | PubChem CID:23647 | UNII:8VNN85Y884
+BMGC_DG05612,BMG_DG120954,DrugBank ID:DB08588 | PubChem CID:23647311 | 2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE
+BMGC_DG05613,BMG_DG120955,"DrugBank ID:DB07160 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE | PubChem CID:23647357"
+BMGC_DG05614,BMG_DG120956,"DrugBank ID:DB07224 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE | PubChem CID:23647358"
+BMGC_DG05615,BMG_DG120957,"PubChem CID:23647361 | DrugBank ID:DB07231 | N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE"
+BMGC_DG05616,BMG_DG120959,"4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]-2-Furyl}-N-Methylbenzenesulfonamide | DrugBank ID:DB07533 | PubChem CID:23647652"
+BMGC_DG05617,BMG_DG120960,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE | PubChem CID:23647657 | DrugBank ID:DB07538"
+BMGC_DG05618,BMG_DG120961,"PubChem CID:23647659 | 4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE | DrugBank ID:DB07540"
+BMGC_DG05619,BMG_DG120962,DrugBank ID:DB07746 | 3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID | PubChem CID:23647763
+BMGC_DG05620,BMG_DG120964,PubChem CID:23648296 | Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide | DrugBank ID:DB03837
+BMGC_DG05621,BMG_DG120967,N-[5-[[5-fluoro-4-(4-prop-2-ynoxyanilino)pyrimidin-2-yl]amino]-2-methylphenyl]sulfonylpropanamide | PubChem CID:23648971 | PubChem SID:317229472 | R-348 | CAS RN:916742-11-5 | CAS RN:1092707-60-2 | DrugBank ID:DB06321 | UNII:3J396119JY
+BMGC_DG05622,BMG_DG120968,"PubChem CID:23649154 | DrugBank ID:DB11852 | 5-[[6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl]methyl]-2-(2-fluorophenyl)imidazo[4,5-c]pyridine | TEGOBUVIR | CAS RN:100078-77-1 | CAS RN:1000787-75-6 | UNII:5NOK5X389M | PubChem SID:316916626 | Tegobuvir"
+BMGC_DG05623,BMG_DG120970,DrugBank ID:DB11692 | 3-(methanesulfonamido)-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide | PubChem SID:198974890 | PAVINETANT | Pavinetant | PubChem CID:23649245 | CAS RN:941690-55-7 | UNII:3U471ZVC5K
+BMGC_DG05624,BMG_DG120971,PubChem SID:472426069 | AZD-1283 | UNII:KDT372MQ8M | PubChem CID:23649325 | CAS RN:919351-41-0
+BMGC_DG05625,BMG_DG120979,PubChem SID:348480968 | CAS RN:295337-71-2 | BMS-317180 | UNII:D9Y5DGD9EI | PubChem CID:23649669
+BMGC_DG05626,BMG_DG120981,DrugBank ID:DB09348 | UNII:6RC3ZT4HB0 | PROPIOLACTONE | PubChem SID:175267226 | CAS RN:25037-58-5 | CAS RN:57-57-8 | Propiolactone | oxetan-2-one | PubChem CID:2365
+BMGC_DG05627,BMG_DG120983,"UNII:U6LA7G393X | TOREFORANT | DrugBank ID:DB12522 | CAS RN:952494-46-1 | 5-(4,6-dimethyl-1H-benzimidazol-2-yl)-4-methyl-N-[3-(1-methylpiperidin-4-yl)propyl]pyrimidin-2-amine | PubChem CID:23650961 | PubChem SID:198964957 | Toreforant"
+BMGC_DG05628,BMG_DG120988,9-DESFLUORO LEVOFLOXACIN | UNII:YUN0U61KHH | CAS RN:117620-85-6 | PubChem CID:23651701 | PubChem SID:198943970
+BMGC_DG05629,BMG_DG120990,"PubChem CID:23652686 | UNII:K5GDY88W5X | PubChem SID:310825941 | (2R,3R,11bR)-9-(3-fluoropropoxy)-10-methoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol | CAS RN:937245-42-6 | Florbenazine | FLORBENAZINE"
+BMGC_DG05630,BMG_DG120991,"PubChem SID:198954573 | ELIGLUSTAT | CAS RN:1000191-50-3 | UNII:DR40J4WA67 | NDC:58468-0220 | PubChem CID:23652731 | DrugBank ID:DB09039 | N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide | CAS RN:491833-29-5 | Eliglustat"
+BMGC_DG05631,BMG_DG120993,"PubChem CID:23652834 | CAS RN:103197-54-2 | 3-(4-HYDROXYPHENYL)-N-PHENETHYLPROP-2-ENAMIDE, (E)- | PubChem SID:461432473 | UNII:8ZB3K5ZYZ6"
+BMGC_DG05632,BMG_DG120995,DEOXYDONEPEZIL | PubChem CID:23653045 | CAS RN:844694-84-4 | PubChem SID:198988499 | UNII:R1RR44GBEN
+BMGC_DG05633,BMG_DG121000,(2S)-2-(3-Carbamimidamidophenyl)-3-[hydroxy(3-phenylpropyl)phosphoryl]propanoic acid | PubChem CID:23653500 | DrugBank ID:DB07182
+BMGC_DG05634,BMG_DG121001,"DrugBank ID:DB07157 | PubChem CID:23653502 | (5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE"
+BMGC_DG05635,BMG_DG121002,DrugBank ID:DB07269 | (2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID | PubChem CID:23653503
+BMGC_DG05636,BMG_DG121003,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID | DrugBank ID:DB06835 | PubChem CID:23653507
+BMGC_DG05637,BMG_DG121004,(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID | DrugBank ID:DB06921 | PubChem CID:23653508
+BMGC_DG05638,BMG_DG121005,"PubChem CID:23653514 | N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide | DrugBank ID:DB07048"
+BMGC_DG05639,BMG_DG121007,"PubChem CID:23653530 | DrugBank ID:DB08072 | 4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE"
+BMGC_DG05640,BMG_DG121008,"PubChem CID:23653531 | 4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide | DrugBank ID:DB07625"
+BMGC_DG05641,BMG_DG121009,"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide | PubChem CID:23653532 | DrugBank ID:DB08697"
+BMGC_DG05642,BMG_DG121010,"PubChem CID:23653533 | DrugBank ID:DB07626 | 4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide"
+BMGC_DG05643,BMG_DG121013,"CAS RN:903580-39-2 | UNII:336H22ETCG | Prx-07034 | PubChem SID:316915819 | PubChem CID:23653584 | DrugBank ID:DB05993 | N-[1-(5-chloro-2,3-dimethoxyphenyl)ethyl]-2-methylsulfonyl-5-piperazin-1-ylaniline;hydrochloride | PRX-07034"
+BMGC_DG05644,BMG_DG121014,"PubChem CID:23653789 | Serlopitant | UNII:277V92K32B | DrugBank ID:DB12973 | PubChem SID:198959657 | SERLOPITANT | CAS RN:860642-69-9 | 3-[(3aR,4R,5S,7aS)-5-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-4-(4-fluorophenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]cyclopent-2-en-1-one"
+BMGC_DG05645,BMG_DG121020,"DrugBank ID:DB08435 | PubChem CID:23654841 | (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid"
+BMGC_DG05646,BMG_DG121021,"PubChem SID:313183668 | UNII:7L3WOA232W | PubChem CID:23654987 | [(2R)-3-(4-hydroxy-3,5-dimethylphenyl)-1-(4-morpholin-4-ylpiperidin-1-yl)-1-oxopropan-2-yl] 4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidine-1-carboxylate | BI-44370 | CAS RN:866086-05-7 | Bi-44370"
+BMGC_DG05647,BMG_DG121022,DrugBank ID:DB08334 | 3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME | PubChem CID:23655000
+BMGC_DG05648,BMG_DG121029,"disodium;[(1Z,3Z)-1-[7-bromo-2-(3-bromo-4-hydroxyphenyl)-1-benzofuran-5-yl]-4-[7-bromo-2-(3-bromo-4-hydroxyphenyl)-3-carboxy-1-benzofuran-5-yl]-3-sulfonatooxybuta-1,3-dien-2-yl] sulfate | 8-carboxy-iso-iantheran A | PubChem CID:23656757"
+BMGC_DG05649,BMG_DG121030,"iso-iantheran A | disodium;[(1Z,3Z)-1,4-bis[7-bromo-2-(3-bromo-4-hydroxyphenyl)-1-benzofuran-5-yl]-3-sulfonatooxybuta-1,3-dien-2-yl] sulfate | PubChem CID:23656759"
+BMGC_DG05650,BMG_DG121034,"DrugBank ID:DB08362 | PubChem CID:23656870 | N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE"
+BMGC_DG05651,BMG_DG121037,PubChem SID:376231516 | FLUORO-DASATINIB | PubChem CID:23657441 | UNII:FMQ8L442D7 | CAS RN:957218-02-9
+BMGC_DG05652,BMG_DG121041,1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA | DrugBank ID:DB07228 | PubChem CID:23657800
+BMGC_DG05653,BMG_DG121055,"DrugBank ID:DB07326 | PubChem CID:23658582 | 6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide"
+BMGC_DG05654,BMG_DG121065,PubChem CID:23659732 | DrugBank ID:DB08516 | (S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE]
+BMGC_DG05655,BMG_DG121068,DrugBank ID:DB06698 | PubChem SID:175266257 | BETAHISTINE | Betahistine | N-methyl-2-pyridin-2-ylethanamine | PubChem CID:2366 | UNII:X32KK4201D | CAS RN:5638-76-6
+BMGC_DG05656,BMG_DG121073,PubChem SID:198958682 | PF-429242 | CAS RN:947303-87-9 | PubChem CID:23661637 | UNII:49WB3OA7VN
+BMGC_DG05657,BMG_DG121075,"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE | PubChem CID:23661697 | DrugBank ID:DB07081"
+BMGC_DG05658,BMG_DG121099,NDC:50742-354 | NDC:10019-953 | NDC:83703-559 | sodium;2-sulfanylethanesulfonate | UNII:NR7O1405Q9 | CAS RN:19767-45-4 | PubChem CID:23662354 | NDC:0338-1305 | NDC:10019-951 | MESNA | NDC:0143-9260 | NDC:25021-201 | NDC:0338-1307 | NDC:67108-3565 | Mesna | NDC:63323-733 | PubChem SID:175267978 | NDC:68083-161
+BMGC_DG05659,BMG_DG121161,"PubChem CID:23663404 | DrugBank ID:DB05229 | Beraprost Sodium | PubChem SID:198984492 | sodium;4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate | UNII:15K99VDU5F | CAS RN:88475-69-8 | Beraprost | CAS RN:1290611-29-8 | BERAPROST SODIUM | CAS RN:496807-11-5"
+BMGC_DG05660,BMG_DG121224,NDC:0054-9628 | CAS RN:502-85-2 | SODIUM OXYBATE | NDC:68727-100 | NDC:13551-002 | PubChem SID:175267192 | Sodium Oxybate | Sodium oxybate | sodium;4-hydroxybutanoate | NDC:13551-004 | PubChem CID:23663870 | DrugBank ID:DB09072 | NDC:69238-2391 | NDC:13551-003 | NDC:13551-001 | UNII:7G33012534
+BMGC_DG05661,BMG_DG121255,"CAS RN:94061-80-0 | PubChem CID:23663976 | Lescol | sodium;(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoate | CAS RN:93957-55-2"
+BMGC_DG05662,BMG_DG121311,"PubChem CID:23664980 | CAS RN:150374-95-1 | sivelestat sodium anhydrous | sodium;2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetate | UNII:0CLL4232KD | PubChem SID:198945855 | SIVELESTAT SODIUM ANHYDROUS"
+BMGC_DG05663,BMG_DG121353,CAS RN:61373-78-2 | Sodium cyclamate | CAS RN:139-05-9 | PubChem CID:23665706 | UNII:1I6F42RME1 | sodium;N-cyclohexylsulfamate | SODIUM CYCLAMATE | PubChem SID:198984719
+BMGC_DG05664,BMG_DG121365,Sodium Hypochlorite | UNII:DY38VHM5OD | CAS RN:7681-52-9 | SODIUM HYPOCHLORITE | PubChem SID:175266407 | sodium;hypochlorite | Sodium hypochlorite | PubChem CID:23665760
+BMGC_DG05665,BMG_DG121368,sodium;hydrogen sulfite | DrugBank ID:DB14015 | SODIUM BISULFITE | Sodium Bisulfite | PubChem SID:175265931 | UNII:TZX5469Z6I | PubChem CID:23665763 | CAS RN:7631-90-5
+BMGC_DG05666,BMG_DG121373,PubChem CID:23665770 | PubChem SID:198945795 | SODIUM MYRISTYL SULFATE | CAS RN:1191-50-0 | Sodium tetradecyl sulfate | sodium;tetradecyl sulfate | UNII:2X50FW96YS
+BMGC_DG05667,BMG_DG121375,CAS RN:139-88-8 | PubChem CID:23665772 | Sotradecol | Sodium tetradecyl sulfate | DrugBank ID:DB00464 | UNII:Q1SUG5KBD6 | SODIUM TETRADECYL SULFATE | NDC:24201-201 | sodium;(7-ethyl-2-methylundecan-4-yl) sulfate | PubChem SID:175271434
+BMGC_DG05668,BMG_DG121391,"NDC:71288-028 | NDC:25021-190 | NDC:70771-1683 | NDC:63323-729 | NDC:42023-230 | NDC:70377-076 | NDC:70771-1684 | NDC:72572-427 | NDC:0469-3250 | NDC:70710-1725 | NDC:0469-3211 | CAS RN:208538-73-2 | NDC:0338-9055 | NDC:0338-9051 | NDC:42023-229 | NDC:63323-728 | UNII:IS1UP79R56 | NDC:16714-164 | sodium;[5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] sulfate | NDC:70377-075 | NDC:70594-037 | PubChem CID:23666118 | PubChem SID:175265788 | NDC:70594-036 | MICAFUNGIN SODIUM | NDC:70710-1724 | Micafungin Sodium | NDC:71288-029 | NDC:0338-9053 | NDC:16714-301 | NDC:25021-191"
+BMGC_DG05669,BMG_DG121415,CAS RN:72-17-3 | PubChem CID:23666456 | UNII:TU7HW0W0QT | Sodium Lactate | Sodium lactate | CAS RN:201595-71-3 | CAS RN:312-85-6 | PubChem SID:175271725 | SODIUM LACTATE | sodium;2-hydroxypropanoate
+BMGC_DG05670,BMG_DG121424,"PubChem SID:198966219 | 1-TESTOSTERONE | DrugBank ID:DB01481 | CAS RN:65-06-5 | PubChem CID:236666 | UNII:Y984BV1Q0G | (5S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | 1-Testosterone"
+BMGC_DG05671,BMG_DG121441,"sodium;(2S,3R,4S)-4-[(2S,5R,7S,8R,9S)-2-[(2R,5S)-5-ethyl-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate | CAS RN:22373-78-0 | PubChem CID:23667299 | Monensin sodium salt"
+BMGC_DG05672,BMG_DG121451,"SODIUM ASCORBATE | PubChem SID:175268070 | DrugBank ID:DB14482 | CAS RN:134-03-2 | PubChem CID:23667548 | sodium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2H-furan-3-olate | Sodium Ascorbate | UNII:S033EH8359"
+BMGC_DG05673,BMG_DG121462,"PubChem SID:198974909 | sodium;(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | PubChem CID:23667631 | UNII:4TWD2995UP | OXACILLIN SODIUM ANHYDROUS | CAS RN:1173-88-2 | Oxacillin Sodium"
+BMGC_DG05674,BMG_DG121491,Sodium nitrite | UNII:M0KG633D4F | CAS RN:7632-00-0 | Nitrous acid | DrugBank ID:DB09112 | PubChem SID:175267132 | PubChem CID:23668193 | SODIUM NITRITE | sodium;nitrite | Sodium Nitrite
+BMGC_DG05675,BMG_DG121495,SODIUM CHLORITE | NDC:75124-0011 | NDC:75124-0004 | NDC:75124-0009 | NDC:75124-0006 | PubChem CID:23668197 | UNII:G538EBV4VF | Sodium Chlorite | NDC:75124-0008 | DrugBank ID:DB13210 | PubChem SID:175265914 | NDC:75124-0012 | NDC:75124-0010 | NDC:75124-0003 | NDC:75124-0005 | CAS RN:7758-19-2 | NDC:75124-0013 | NDC:75124-0002 | NDC:81391-001 | sodium;chlorite
+BMGC_DG05676,BMG_DG121507,"NDC:82982-055 | NDC:68071-2113 | UNII:43Y000U234 | potassium;4-[(4-fluorophenyl)methylcarbamoyl]-1-methyl-2-[2-[(5-methyl-1,3,4-oxadiazole-2-carbonyl)amino]propan-2-yl]-6-oxopyrimidin-5-olate | NDC:0006-0477 | NDC:71205-777 | NDC:50090-1085 | NDC:0006-3603 | PubChem SID:175267209 | RALTEGRAVIR POTASSIUM | NDC:67296-1235 | NDC:0006-0227 | CAS RN:871038-72-1 | Raltegravir Potassium | PubChem CID:23668479 | NDC:0006-3080 | NDC:0006-0473"
+BMGC_DG05677,BMG_DG121602,"PubChem SID:175266779 | CAS RN:987-24-6 | [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | PubChem CID:236702 | CAS RN:1177-87-3 | DEXAMETHASONE ACETATE ANHYDROUS | Dexamethasone acetate | DrugBank ID:DB14649 | UNII:K7V8P532WP"
+BMGC_DG05678,BMG_DG121644,"PubChem CID:23671663 | DrugBank ID:DB09483 | Potassium lactate | potassium;2-hydroxypropanoate | POTASSIUM LACTATE, DL- | PubChem SID:198975094 | CAS RN:996-31-6 | UNII:276897E67U"
+BMGC_DG05679,BMG_DG121659,"Sodium phosphate, monobasic | DrugBank ID:DB09449 | Monosodium phosphate | sodium;dihydrogen phosphate | CAS RN:7558-80-7 | UNII:KH7I04HPUU | CAS RN:89140-32-9 | PubChem SID:175265933 | CAS RN:7632-05-5 | PubChem CID:23672064 | SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS"
+BMGC_DG05680,BMG_DG121762,"NDC:67618-101 | NDC:76162-006 | NDC:68998-420 | NDC:70000-0091 | NDC:70000-0445 | NDC:0363-1172 | NDC:69842-829 | NDC:46122-687 | NDC:53345-008 | NDC:53943-153 | NDC:59726-755 | NDC:30142-883 | NDC:60687-622 | NDC:11673-209 | NDC:55910-829 | NDC:59726-059 | NDC:59726-853 | NDC:80513-105 | NDC:70677-1246 | NDC:69842-862 | NDC:51013-819 | NDC:76162-764 | NDC:11673-192 | NDC:59726-058 | NDC:82804-097 | NDC:72789-399 | NDC:69842-633 | NDC:0132-0402 | NDC:50090-7479 | NDC:49035-828 | NDC:55910-853 | NDC:55154-4341 | NDC:63868-875 | NDC:70677-0083 | NDC:69842-522 | NDC:59726-141 | NDC:30142-407 | NDC:30142-529 | NDC:0904-7281 | NDC:70000-0365 | NDC:83324-135 | NDC:84289-399 | NDC:71335-9738 | NDC:68071-3784 | NDC:11822-3165 | NDC:68788-7674 | NDC:55301-486 | NDC:0536-1304 | NDC:68391-853 | UNII:F05Q2T2JA0 | NDC:37808-293 | NDC:55319-565 | NDC:63187-476 | NDC:70677-1071 | NDC:21130-578 | NDC:0904-6999 | NDC:72476-041 | NDC:0904-6998 | NDC:55154-3369 | NDC:11822-1572 | NDC:0761-0910 | NDC:30142-778 | NDC:49035-085 | NDC:41163-875 | NDC:0363-0785 | NDC:35916-0440 | NDC:68196-853 | NDC:68071-2874 | NDC:21130-829 | NDC:11673-853 | NDC:67091-366 | NDC:53345-015 | NDC:24689-130 | NDC:11822-6328 | NDC:57896-423 | NDC:46122-625 | NDC:83324-136 | NDC:0363-0827 | NDC:62011-0421 | NDC:45802-486 | NDC:63981-853 | NDC:49035-377 | NDC:11822-0017 | NDC:68788-8780 | NDC:41250-746 | NDC:53943-154 | NDC:21130-883 | NDC:41163-853 | NDC:69842-830 | NDC:55910-855 | NDC:49035-207 | NDC:21130-041 | NDC:41163-107 | NDC:30142-553 | NDC:68788-8501 | NDC:69842-523 | CAS RN:577-11-7 | NDC:59726-852 | NDC:17433-9886 | NDC:37808-878 | NDC:54257-902 | NDC:63868-585 | NDC:70677-1069 | NDC:50804-424 | NDC:41163-878 | NDC:50804-855 | NDC:59726-142 | NDC:68071-3438 | NDC:68210-4176 | NDC:59726-179 | NDC:55319-578 | NDC:16103-399 | NDC:41250-376 | NDC:72789-166 | NDC:17433-9884 | NDC:70677-1095 | NDC:63868-874 | NDC:17433-9876 | NDC:27495-012 | NDC:59726-879 | NDC:55910-939 | NDC:49035-848 | NDC:57896-304 | NDC:53345-018 | NDC:0363-3010 | NDC:68210-4104 | NDC:53943-250 | NDC:57896-413 | NDC:51316-902 | NDC:0904-7280 | NDC:55910-968 | NDC:68210-3002 | NDC:71205-970 | NDC:80136-951 | NDC:63739-478 | NDC:70677-0167 | NDC:50090-6140 | NDC:80136-555 | NDC:55289-493 | NDC:79903-073 | NDC:37808-222 | NDC:72090-030 | NDC:70000-0685 | NDC:67618-201 | NDC:41250-729 | NDC:50804-862 | NDC:56062-241 | NDC:69517-124 | NDC:69842-317 | NDC:46122-693 | NDC:11822-1574 | NDC:41163-241 | NDC:68016-257 | NDC:69842-893 | NDC:69168-424 | NDC:55319-044 | NDC:50804-829 | NDC:67091-373 | NDC:54859-813 | NDC:48433-220 | NDC:10956-621 | NDC:63868-638 | NDC:79481-0853 | NDC:0363-8991 | NDC:17856-0771 | NDC:0904-7183 | NDC:37808-584 | NDC:41250-859 | NDC:11822-3489 | NDC:84328-001 | NDC:49035-584 | NDC:68210-0305 | NDC:51316-903 | NDC:11822-1372 | NDC:46122-669 | NDC:50090-7167 | NDC:72476-107 | NDC:69842-310 | NDC:59726-855 | NDC:0132-0113 | NDC:69842-887 | NDC:69618-065 | NDC:68016-763 | NDC:0904-7279 | NDC:59726-778 | NDC:16103-378 | NDC:37808-084 | NDC:63868-662 | NDC:0363-0584 | NDC:37808-457 | NDC:50488-0901 | NDC:41163-755 | NDC:36800-938 | NDC:70000-0442 | NDC:49035-385 | NDC:80513-100 | NDC:0363-0883 | NDC:50804-304 | NDC:0363-0016 | NDC:0904-6750 | NDC:17856-6999 | NDC:72789-274 | NDC:57896-555 | NDC:63941-853 | NDC:62011-0273 | NDC:41163-862 | NDC:57896-411 | NDC:0363-5790 | NDC:69842-881 | NDC:55319-561 | NDC:35916-0454 | NDC:63561-0187 | NDC:17856-1248 | NDC:41250-683 | NDC:41163-778 | NDC:84324-013 | NDC:49873-404 | NDC:21130-853 | NDC:59726-729 | NDC:71335-1677 | NDC:0363-8540 | NDC:70000-0526 | NDC:69842-714 | NDC:0363-0679 | NDC:63868-946 | NDC:68196-995 | PubChem SID:175271930 | NDC:46122-692 | NDC:63941-855 | NDC:69842-319 | NDC:69517-131 | NDC:0363-8550 | NDC:30142-830 | NDC:72288-486 | NDC:53345-029 | NDC:69842-776 | NDC:59726-829 | NDC:50090-5524 | NDC:55910-938 | NDC:0615-8331 | NDC:0363-9944 | NDC:41163-829 | NDC:0363-4202 | NDC:68788-8919 | NDC:57896-426 | NDC:69842-794 | NDC:55319-855 | NDC:71335-2522 | NDC:11822-1573 | NDC:69842-782 | NDC:67618-310 | NDC:69729-151 | NDC:76420-225 | NDC:70000-0684 | NDC:72162-2255 | NDC:0363-8780 | NDC:55319-618 | NDC:70677-1096 | NDC:36800-568 | NDC:79903-009 | NDC:36800-861 | NDC:71205-282 | NDC:0536-1248 | NDC:71335-1674 | NDC:0363-4100 | NDC:0904-6920 | Docusate Sodium | NDC:53345-023 | NDC:68196-998 | NDC:63868-878 | NDC:41167-0221 | NDC:63868-884 | NDC:72476-855 | NDC:53329-989 | NDC:66267-888 | NDC:35916-0453 | NDC:0363-7140 | NDC:21130-855 | NDC:49035-378 | NDC:67618-110 | NDC:17856-7281 | NDC:0280-1012 | NDC:36800-638 | NDC:76162-777 | NDC:30142-451 | NDC:21130-219 | NDC:68210-0302 | NDC:62011-0474 | NDC:76162-761 | NDC:49035-526 | NDC:69168-420 | NDC:68016-623 | NDC:70000-0520 | NDC:0363-8760 | NDC:11822-0652 | NDC:69842-861 | NDC:10956-781 | NDC:37808-862 | NDC:70000-0519 | NDC:68210-0350 | NDC:69842-879 | NDC:70677-1094 | NDC:72476-862 | NDC:36800-555 | NDC:80425-0345 | NDC:54257-089 | NDC:41250-258 | NDC:41250-739 | NDC:0363-8530 | NDC:62011-0386 | NDC:55910-048 | NDC:69842-883 | NDC:62011-0417 | NDC:11673-678 | NDC:68210-4103 | NDC:21130-830 | NDC:49035-270 | PubChem CID:23673837 | NDC:37808-853 | NDC:50268-268 | NDC:51316-107 | NDC:53345-035 | NDC:55154-2346 | NDC:30142-084 | NDC:37808-879 | NDC:72476-883 | NDC:55910-879 | NDC:71335-0294 | NDC:36800-783 | NDC:67091-380 | NDC:55910-978 | NDC:21130-902 | NDC:63941-878 | NDC:60687-129 | NDC:80513-101 | NDC:11822-0584 | NDC:72476-878 | NDC:72476-853 | NDC:57896-421 | NDC:11822-2039 | NDC:49035-360 | NDC:0536-1247 | NDC:67618-111 | NDC:0761-0434 | NDC:55319-878 | NDC:69842-740 | NDC:73057-378 | NDC:0615-8557 | NDC:69842-579 | NDC:80267-020 | NDC:71335-9731 | NDC:37808-355 | NDC:79903-170 | NDC:55154-2578 | NDC:55910-762 | NDC:67091-374 | NDC:30142-876 | NDC:41167-0281 | NDC:0904-7440 | sodium;1,4-bis(2-ethylhexoxy)-1,4-dioxobutane-2-sulfonate | NDC:68788-8658 | DOCUSATE SODIUM | NDC:67091-328 | NDC:68016-587 | NDC:50804-701 | NDC:36800-084 | NDC:72789-295 | NDC:68196-578 | NDC:0615-8041 | NDC:11822-0862 | NDC:55910-223 | NDC:68391-041 | NDC:57896-401 | NDC:68016-471 | NDC:54629-601 | NDC:41226-714 | NDC:10135-669 | NDC:41163-883 | NDC:11673-341 | NDC:21130-878 | NDC:71406-106 | NDC:70677-0034 | NDC:59726-878 | NDC:59726-078"
+BMGC_DG05681,BMG_DG121768,PubChem SID:198984050 | PubChem CID:23674101 | CAS RN:223490-49-1 | EVATANEPAG SODIUM | UNII:U6GMO13KCQ
+BMGC_DG05682,BMG_DG121798,"sodium;3-[[(2S,4S)-4-[[(4R,5S,6S)-2-carboxy-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]sulfanyl]pyrrolidine-2-carbonyl]amino]benzoate | Ertapenem Sodium | CAS RN:153773-82-1 | PubChem CID:23674512"
+BMGC_DG05683,BMG_DG121839,"CAS RN:128-44-9 | CAS RN:82385-42-0 | sodium;1,1-dioxo-1,2-benzothiazol-3-olate | PubChem CID:23675258 | Saccharin sodium salt"
+BMGC_DG05684,BMG_DG121846,"NDC:0781-3452 | NDC:60505-6142 | NDC:0143-9665 | NDC:0338-0096 | NDC:44567-840 | NDC:72189-584 | NDC:71205-679 | UNII:P380M0454Z | NDC:0781-3451 | NDC:0404-9834 | NDC:60505-6143 | NDC:44567-845 | NDC:0143-9261 | NDC:0404-9835 | NDC:72572-055 | NDC:0143-9924 | NDC:71872-7141 | NDC:0409-2585 | NDC:50090-4256 | NDC:60505-6231 | NDC:66288-1300 | sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | NDC:52584-924 | NDC:60505-6266 | NDC:0143-9140 | NDC:60505-6243 | NDC:0143-9923 | NDC:44567-707 | NDC:63323-237 | CAS RN:27164-46-1 | NDC:0143-9262 | PubChem CID:23675322 | NDC:0338-3508 | NDC:0404-9833 | NDC:25021-101 | NDC:44567-708 | NDC:71872-7027 | NDC:25021-102 | NDC:72572-056 | NDC:0264-3107 | NDC:25021-100 | NDC:44567-706 | CEFAZOLIN SODIUM | NDC:67184-1001 | NDC:0264-3103 | NDC:70518-3047 | NDC:0781-3450 | NDC:63323-236 | NDC:44567-120 | NDC:0143-9983 | NDC:0338-3503 | NDC:60505-6244 | NDC:63323-238 | NDC:66288-1100 | NDC:0264-3105 | NDC:0143-9139 | PubChem SID:175266745 | Cefazolin Sodium"
+BMGC_DG05685,BMG_DG122045,UNII:ZL9GA44H2A | CAS RN:16241-25-1 | POTASSIUM 4-GUAIACOLSULFONATE | PubChem SID:198941977 | PubChem CID:23679005
+BMGC_DG05686,BMG_DG122071,"Bethanidine | CAS RN:114-85-2 | CAS RN:55-73-2 | 1-benzyl-2,3-dimethylguanidine | PubChem SID:198944926 | UNII:W8S3YM7AUU | BETHANIDINE | DrugBank ID:DB00217 | PubChem CID:2368"
+BMGC_DG05687,BMG_DG122075,CAS RN:127792-45-4 | UNII:KNU55BV96W | PubChem CID:23680224 | SODIUM 2-(2-((2-BROMO-6-CHLOROPHENYL)AMINO)PHENYL)ACETATE
+BMGC_DG05688,BMG_DG122103,"DrugBank ID:DB11107 | CAS RN:868-14-4 | PubChem SID:175266570 | POTASSIUM BITARTRATE | UNII:NPT6P8P3UU | NDC:0283-1023 | PubChem CID:23681127 | NDC:0283-0808 | Potassium bitartrate | potassium;(2R,3R)-2,3,4-trihydroxy-4-oxobutanoate"
+BMGC_DG05689,BMG_DG122221,"PubChem CID:23685176 | sodium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | UNII:DWV1EFW947 | AZLOCILLIN SODIUM | CAS RN:37091-65-9 | PubChem SID:198977374 | Azlocillin Sodium"
+BMGC_DG05690,BMG_DG122338,NDC:69945-140 | NDC:69945-035 | NDC:69945-015 | TECHNETIUM TC-99M SODIUM PERTECHNETATE | NDC:11994-090 | NDC:69945-190 | sodium;oxido(trioxo)(99Tc)technetium-99 | NDC:69945-060 | CAS RN:23288-60-0 | NDC:69945-160 | NDC:69945-010 | PubChem SID:198968655 | NDC:69945-051 | NDC:69945-020 | NDC:69945-030 | Technetium Tc-99m Sodium Pertechnetate | PubChem CID:23689036 | NDC:69945-025 | NDC:69945-075 | UNII:A0730CX801 | NDC:69945-110 | NDC:11994-091
+BMGC_DG05691,BMG_DG122363,CAS RN:108008-51-1 | PubChem CID:2369 | 1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol | UNII:O0ZR1R6RZ2 | DrugBank ID:DB00195 | CAS RN:63659-18-7 | Betaxolol | PubChem SID:175271556 | BETAXOLOL
+BMGC_DG05692,BMG_DG122376,PubChem CID:23690429 | sodium;2-sulfanylbenzoate | PubChem SID:198972542 | UNII:C2D9ITW04B | CAS RN:134-23-6 | Sodium Thiosalicylate | SODIUM THIOSALICYLATE
+BMGC_DG05693,BMG_DG122523,"UNII:406FL5G00V | sodium;2-[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetate | PubChem SID:198951034 | RIGOSERTIB SODIUM | PubChem CID:23696523 | CAS RN:592542-60-4 | Rigosertib sodium | CAS RN:1225497-78-8"
+BMGC_DG05694,BMG_DG122570,"PubChem SID:198970511 | UNII:H0C805XYDE | QUINACRINE | CAS RN:83-89-6 | Quinacrine | DrugBank ID:DB01103 | 4-N-(6-chloro-2-methoxyacridin-9-yl)-1-N,1-N-diethylpentane-1,4-diamine | PubChem CID:237"
+BMGC_DG05695,BMG_DG122571,Bethanechol | DrugBank ID:DB01019 | PubChem SID:175271621 | 2-carbamoyloxypropyl(trimethyl)azanium | CAS RN:674-38-4 | PubChem CID:2370 | BETHANECHOL | UNII:004F72P8F4
+BMGC_DG05696,BMG_DG122572,DrugBank ID:DB02196 | Uridine-Diphosphate-N-Acetylgalactosamine | PubChem CID:23700
+BMGC_DG05697,BMG_DG122654,UNII:D9FKN7348U | CAS RN:6314-43-8 | Benzo[b]thiophene-2-methanamine | PubChem SID:474493397 | BENZO(B)THIOPHENE-2-METHANAMINE | PubChem CID:237074
+BMGC_DG05698,BMG_DG122685,Ladarixin (sodium) | CAS RN:865625-56-5 | sodium;methylsulfonyl-[(2R)-2-[4-(trifluoromethylsulfonyloxy)phenyl]propanoyl]azanide | PubChem CID:23709380
+BMGC_DG05699,BMG_DG122745,"sodium;(Z)-7-[2-[(E)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate | PubChem CID:23716436 | sodium (5Z)-7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl]hept-5-enoate | CAS RN:55028-72-3"
+BMGC_DG05700,BMG_DG122777,"BEVANTOLOL | 1-[2-(3,4-dimethoxyphenyl)ethylamino]-3-(3-methylphenoxy)propan-2-ol | PubChem SID:198938725 | CAS RN:59170-23-9 | Bevantolol | PubChem CID:2372 | DrugBank ID:DB01295 | UNII:34ZXW6ZV21"
+BMGC_DG05701,BMG_DG122804,"UDP-D-xylose | PubChem CID:23724459 | CAS RN:3616-06-6 | [[(2R,3S,4R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl] hydrogen phosphate"
+BMGC_DG05702,BMG_DG122812,"(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,18R,19R,21R,23S,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0^{4,9}]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate | DrugBank ID:DB06287 | [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate | Temsirolimus | CAS RN:162635-04-3 | PubChem CID:23724530"
+BMGC_DG05703,BMG_DG122821,"9xi-Episterol | CAS RN:474-68-0 | PubChem CID:23724571 | (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"
+BMGC_DG05704,BMG_DG122867,Methscopolamine bromide | DrugBank ID:DB00462 | PubChem CID:23724781
+BMGC_DG05705,BMG_DG122891,"Dalvance | Dalbavancin | DrugBank ID:DB06219 | (2S,3S,4R,5R,6S)-6-[[(1S,2R,19R,22R,34S,37R,40R)-5,32-dichloro-52-[3-(dimethylamino)propylcarbamoyl]-2,26,31,44,49-pentahydroxy-22-(methylamino)-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,65-henicosaen-64-yl]oxy]-3,4-dihydroxy-5-(10-methylundecanoylamino)oxane-2-carboxylic acid | PubChem CID:23724878 | CAS RN:171500-79-1"
+BMGC_DG05706,BMG_DG122914,"DrugBank ID:DB12425 | CAS RN:20196-64-9 | (2S)-2-amino-3-[4-(4-hydroxy-3-(131I)iodanylphenoxy)-3,5-bis(131I)(iodanyl)phenyl]propanoic acid | PubChem SID:198958008 | PubChem CID:23724940 | Liothyronine I-131 | UNII:86AZ0G22V2 | LIOTHYRONINE I-131"
+BMGC_DG05707,BMG_DG122935,PubChem SID:485663040 | UNII:7SWA85EH4H | Parellic acid | PARELLIC ACID | CAS RN:7299-11-8 | PubChem CID:23725
+BMGC_DG05708,BMG_DG122984,CAS RN:857290-04-1 | PubChem SID:198960505 | UNII:388927163B | PF-915275 | PubChem CID:23725123
+BMGC_DG05709,BMG_DG122987,UNII:T90A75S60M | PubChem CID:23725128 | PubChem SID:198969619 | PSI-7409 | CAS RN:1015073-42-3
+BMGC_DG05710,BMG_DG122994,OLAPARIB | DrugBank ID:DB09074 | CAS RN:937799-91-2 | PubChem CID:23725625 | Olaparib | CAS RN:763113-22-0 | PubChem SID:198944753 | CAS RN:1021843-02-6 | UNII:WOH1JD9AR8 | 4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one
+BMGC_DG05711,BMG_DG122995,CAS RN:942510-68-1 | UNII:J5PMS063XX | (5-CHLORO-6-((6-METHYLPYRIDIN-3-YL)AMINO)PYRIDIN-3-YL)-((2R)-2-ETHYLPIPERIDIN-1-YL)METHANONE | PubChem CID:23725699 | PubChem SID:316916540
+BMGC_DG05712,BMG_DG123003,"CAS RN:1266467-63-3 | CAS RN:871224-64-5 | CAS RN:913358-93-7 | (2R)-2-[(1S)-6,7-dimethoxy-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-3,4-dihydro-1H-isoquinolin-2-yl]-N-methyl-2-phenylacetamide | PubChem CID:23727689 | UNII:9KCW39P2EI | PubChem SID:198975299 | DrugBank ID:DB06673 | ALMOREXANT | Almorexant"
+BMGC_DG05713,BMG_DG123004,"MERIOLIN 3 | PubChem SID:445498643 | PubChem CID:23727981 | DrugBank ID:DB08178 | 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine | CAS RN:954143-48-7 | UNII:MP2RY8OR8X"
+BMGC_DG05714,BMG_DG123005,"DrugBank ID:DB08182 | UNII:7A6FRA2U0Z | 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine | PubChem SID:443624445 | MERIOLIN 5 | PubChem CID:23727982 | CAS RN:1011711-76-4"
+BMGC_DG05715,BMG_DG123007,UNII:5780K492K3 | PubChem SID:313183268 | MELEAGRIN | CAS RN:71751-77-4 | PubChem CID:23728435
+BMGC_DG05716,BMG_DG123008,"DrugBank ID:DB07707 | PubChem CID:23728517 | (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL"
+BMGC_DG05717,BMG_DG123009,PubChem CID:23728722 | CAS RN:675103-36-3 | PubChem SID:459055932 | BAY-678 | UNII:WD9FU5A8DR
+BMGC_DG05718,BMG_DG123011,UNII:81LDP7XIYG | CAS RN:1005549-94-9 | propan-2-yl 2-[3-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetate | TAPRENEPAG ISOPROPYL | Taprenepag Isopropyl | PubChem SID:198969309 | PubChem CID:23729077
+BMGC_DG05719,BMG_DG123012,"DrugBank ID:DB07642 | PubChem CID:23729147 | 5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine"
+BMGC_DG05720,BMG_DG123013,"PubChem SID:198934685 | UNII:G8WSM7R635 | TIRASEMTIV | CAS RN:1005491-05-3 | DrugBank ID:DB12209 | Tirasemtiv | PubChem CID:23729157 | 5-ethynyl-3-pentan-3-yl-1H-imidazo[4,5-b]pyrazin-2-one"
+BMGC_DG05721,BMG_DG123015,UNII:K3976EA8Z4 | CAS RN:944919-15-7 | PubChem CID:23729483 | JNJ-37654032 | PubChem SID:198983086
+BMGC_DG05722,BMG_DG123020,5-(hydroxymethyl)furan-2-carbaldehyde | 5-Hydroxymethylfurfural | DrugBank ID:DB12298 | PubChem CID:237332 | PubChem SID:198937487 | UNII:70ETD81LF0 | 5-(HYDROXYMETHYL)-2-FURALDEHYDE | CAS RN:67-47-0
+BMGC_DG05723,BMG_DG123024,"UNII:26XK13B61B | 2,5-Di-tert-butylhydroquinone | DrugBank ID:DB04638 | PubChem CID:2374 | DI-TERT-BUTYLHYDROQUINONE | PubChem SID:198979607 | 2,5-di-tert-butylhydroquinone | CAS RN:88-58-4 | 2,5-ditert-butylbenzene-1,4-diol"
+BMGC_DG05724,BMG_DG123034,NDC:63629-8308 | N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide | BICALUTAMIDE | PubChem CID:2375 | NDC:0904-6019 | NDC:62559-890 | NDC:60429-177 | NDC:62559-680 | Bicalutamide | NDC:16714-816 | CAS RN:90357-06-5 | NDC:47335-485 | DrugBank ID:DB01128 | NDC:16729-023 | NDC:71205-577 | NDC:82804-082 | PubChem SID:175271892 | UNII:A0Z3NAU9DP | NDC:51407-010
+BMGC_DG05725,BMG_DG123039,PubChem CID:23757 | 2-DEMETHYLCOLCHICINE | CAS RN:7336-36-9 | UNII:V9U19L3N0J | PubChem SID:252165128
+BMGC_DG05726,BMG_DG123052,PubChem SID:198940769 | 4-(2-benzylphenoxy)-N-methylbutan-1-amine | UNII:Z4501GN13G | DrugBank ID:DB13550 | CAS RN:90293-01-9 | Bifemelane | BIFEMELANE | PubChem CID:2377
+BMGC_DG05727,BMG_DG123059,Bifonazole | BIFONAZOLE | 1-[phenyl-(4-phenylphenyl)methyl]imidazole | PubChem CID:2378 | UNII:QYJ305Z91O | PubChem SID:198949353 | CAS RN:60628-96-8 | DrugBank ID:DB04794
+BMGC_DG05728,BMG_DG123077,PubChem SID:175267713 | Biperiden | PubChem CID:2381 | UNII:0FRP6G56LD | BIPERIDEN | DrugBank ID:DB00810 | 1-(2-bicyclo[2.2.1]hept-5-enyl)-1-phenyl-3-piperidin-1-ylpropan-1-ol | CAS RN:514-65-8
+BMGC_DG05729,BMG_DG123095,UNII:Z3BYY2SD4K | CAS RN:6311-90-6 | 2-(2-(1-PYRROLIDINYL)ETHYL)PYRIDINE | PubChem SID:441332057 | PubChem CID:238317
+BMGC_DG05730,BMG_DG123105,4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenol | UNII:BR971OUC9M | PubChem SID:198990629 | CAS RN:7376-66-1 | Deterenol | DETERENOL | PubChem CID:23843 | CAS RN:3506-31-8
+BMGC_DG05731,BMG_DG123106,UNII:YGK7RN9FSZ | PubChem SID:474492541 | 4-(2-(1-PYRROLIDINYL)ETHYL)PYRIDINE | CAS RN:67580-65-8 | PubChem CID:238432 | 4-[2-(1-Pyrrolidinyl)ethyl]pyridine
+BMGC_DG05732,BMG_DG123108,"PubChem CID:23843929 | CAS RN:2624351-87-5 | UNII:8S66U66RDM | Kuwanon H, (±)- | PubChem SID:474494446 | UNII:KH2D7L4JRM | Kuwanon H, (+)- | KUWANON H, (+)- | CAS RN:79056-23-8 | PubChem SID:474494537 | KUWANON H, (+/-)-"
+BMGC_DG05733,BMG_DG123110,"2,5-DIMETHOXY-4-FLUOROAMPHETAMINE | CAS RN:125903-69-7 | UNII:93WSW5GYR6 | PubChem CID:23844155 | PubChem SID:316908625"
+BMGC_DG05734,BMG_DG123115,"PubChem SID:478838434 | PubChem CID:2385541 | 2,2-DIPHENYL-N-(3-PHENYLPROPYL)ACETAMIDE | 2,2-Diphenyl-N-(3-phenylpropyl)acetamide | CAS RN:353471-19-9 | UNII:J23ZZC9SZY"
+BMGC_DG05735,BMG_DG123118,PubChem SID:461433049 | PubChem CID:2385968 | CAS RN:72857-25-1 | 4-(2-OXO-2-PHENYLACETYL)BENZOIC ACID | UNII:GK3EUQ4VGG
+BMGC_DG05736,BMG_DG123142,"CAS RN:68745-38-0 | 5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one | PubChem CID:238782 | 5,7-Dihydroxyflavanone"
+BMGC_DG05737,BMG_DG123158,disodium;hydroxy-[1-hydroxy-1-[hydroxy(oxido)phosphoryl]ethyl]phosphinate | UNII:M16PXG993G | CAS RN:7414-83-7 | ETIDRONATE DISODIUM | PubChem CID:23894 | PubChem SID:175267170 | Etidronate Disodium
+BMGC_DG05738,BMG_DG123164,"DrugBank ID:DB01618 | CAS RN:7416-34-4 | 3-ethyl-2-methyl-5-(morpholin-4-ylmethyl)-1,5,6,7-tetrahydroindol-4-one | Molindone | UNII:RT3Y3QMF8N | MOLINDONE | PubChem CID:23897 | PubChem SID:175271653"
+BMGC_DG05739,BMG_DG123167,PubChem CID:239 | DrugBank ID:DB03107 | beta-Alanine | CAS RN:107-95-9 | 3-aminopropanoic acid | UNII:11P2JDE17B | PubChem SID:175265601 | .BETA.-ALANINE | CAS RN:87867-95-6 | CAS RN:25513-34-2
+BMGC_DG05740,BMG_DG123175,(3-PYRIDYLMETHYLENE)MALONONITRILE | (3-Pyridylmethylene)malononitrile | UNII:35MD2WSM7Q | CAS RN:7424-56-8 | PubChem CID:23905 | PubChem SID:474491499
+BMGC_DG05741,BMG_DG123179,NDC:0132-0401 | NDC:70677-1091 | NDC:55910-253 | NDC:30142-827 | NDC:50804-327 | NDC:56062-676 | NDC:59779-107 | NDC:49035-706 | NDC:70677-1086 | NDC:11673-182 | NDC:83324-061 | NDC:37808-676 | NDC:70000-0538 | NDC:0904-7142 | NDC:68016-084 | CAS RN:603-50-9 | NDC:36800-327 | NDC:0574-7050 | NDC:55319-697 | NDC:71335-1754 | NDC:55910-327 | NDC:55319-327 | NDC:67091-215 | NDC:46122-429 | NDC:55910-457 | NDC:79903-178 | NDC:70000-0573 | NDC:80136-871 | NDC:55910-792 | NDC:80513-409 | NDC:11673-116 | NDC:69842-816 | NDC:41250-665 | NDC:0363-6760 | DrugBank ID:DB09020 | NDC:36800-676 | NDC:13709-321 | NDC:68998-398 | NDC:41415-121 | NDC:70000-0228 | NDC:71335-2010 | NDC:67091-286 | NDC:37808-680 | NDC:58980-415 | NDC:41250-676 | NDC:41167-0290 | BISACODYL | NDC:50804-190 | NDC:41250-191 | NDC:0363-3011 | NDC:49348-032 | NDC:0904-6407 | NDC:68016-197 | NDC:57237-337 | NDC:11822-0790 | NDC:43749-460 | NDC:37808-877 | NDC:0132-0703 | NDC:0904-6748 | NDC:0363-0327 | NDC:21130-827 | NDC:63868-573 | NDC:41250-339 | NDC:41167-0200 | NDC:57896-441 | NDC:53943-676 | NDC:71335-1531 | PubChem CID:2391 | NDC:56062-327 | PubChem SID:175267678 | NDC:46122-767 | NDC:0363-0466 | NDC:59779-327 | NDC:53943-677 | UNII:10X0709Y6I | [4-[(4-acetyloxyphenyl)-pyridin-2-ylmethyl]phenyl] acetate | NDC:67091-452 | NDC:53943-805 | NDC:68210-4106 | NDC:70000-0221 | NDC:62011-0277 | NDC:70000-0570 | NDC:63868-572 | NDC:71399-8460 | NDC:55301-676 | NDC:71610-700 | NDC:63868-908 | Bisacodyl | NDC:68998-404 | NDC:41167-0400 | NDC:46122-529 | NDC:49035-327 | NDC:72701-102 | NDC:76162-676 | NDC:68163-116 | NDC:37808-327 | NDC:50844-327 | NDC:41163-607 | NDC:55154-6897 | NDC:57896-443 | NDC:59779-676 | NDC:41415-116 | NDC:49483-003 | NDC:56062-976 | NDC:41167-0210 | NDC:70692-167 | NDC:41167-0101 | NDC:11822-0676 | NDC:11822-4890 | NDC:69168-398 | NDC:76457-003 | NDC:69168-404 | NDC:68016-688 | NDC:11673-151 | NDC:46122-608 | NDC:57237-327 | NDC:71610-453
+BMGC_DG05742,BMG_DG123190,NDC:37662-0837 | NDC:0220-2046 | PubChem CID:23925 | NDC:48951-4065 | NDC:48951-8005 | NDC:37662-0841 | DrugBank ID:DB01592 | NDC:48951-4151 | NDC:53645-1471 | NDC:0220-2050 | NDC:48951-4132 | NDC:48951-4161 | NDC:0220-2055 | NDC:48951-4095 | NDC:48951-8087 | NDC:48951-4072 | NDC:37662-0835 | IRON | CAS RN:12597-68-1 | NDC:48951-8088 | NDC:48951-4104 | UNII:E1UOL152H7 | NDC:48951-4190 | NDC:0220-2051 | CAS RN:7439-89-6 | NDC:0220-2085 | NDC:48951-4070 | NDC:37662-0839 | NDC:37662-0836 | NDC:48951-4062 | NDC:48951-7051 | NDC:0220-2047 | NDC:48951-8238 | NDC:48951-8004 | NDC:53645-1470 | NDC:69449-1010 | NDC:15631-2741 | NDC:48951-4054 | NDC:48951-4157 | NDC:15631-0190 | NDC:48951-4187 | NDC:48951-4114 | iron | NDC:37662-0842 | NDC:37662-0838 | CAS RN:8048-10-0 | NDC:37662-0834 | NDC:37662-0840 | NDC:53645-1472 | NDC:48951-4067 | NDC:53645-1080 | Iron | NDC:48951-4071 | NDC:0220-2054 | NDC:48951-4068
+BMGC_DG05743,BMG_DG123191,NDC:37662-3196 | Lanthanum | CAS RN:7439-91-0 | NDC:37662-3195 | NDC:37662-3192 | PubChem CID:23926 | NDC:37662-3191 | NDC:37662-3193 | UNII:6I3K30563S | lanthanum | LANTHANUM | NDC:37662-3190 | NDC:37662-3194 | NDC:37662-3189
+BMGC_DG05744,BMG_DG123197,UNII:42Z2K6ZL8P | NDC:37662-1130 | manganese | NDC:37662-1127 | Manganese | PubChem CID:23930 | MANGANESE | NDC:0220-3299 | NDC:37662-1125 | NDC:37662-1126 | NDC:37662-1128 | NDC:37662-1129 | CAS RN:7439-96-5 | NDC:37662-1123 | NDC:37662-1124
+BMGC_DG05745,BMG_DG123200,NDC:37662-1842 | UNII:FXS1BY2PGL | NDC:61657-0961 | MERCURY | NDC:0220-3442 | NDC:48951-7208 | NDC:48951-8425 | NDC:48951-7137 | NDC:53645-1181 | NDC:37662-1839 | NDC:53645-1180 | NDC:48951-7038 | NDC:37662-1838 | NDC:48951-7207 | NDC:48951-8385 | NDC:48951-7120 | NDC:48951-7156 | NDC:48951-7044 | CAS RN:7439-97-6 | NDC:0220-3432 | Mercury | NDC:0220-3438 | NDC:0220-3443 | NDC:37662-1836 | NDC:48951-8089 | mercury | NDC:37662-1841 | NDC:37662-1840 | NDC:37662-1843 | NDC:48951-7212 | NDC:48951-7040 | NDC:37662-1837 | PubChem CID:23931 | NDC:48951-7172 | NDC:37662-1835
+BMGC_DG05746,BMG_DG123210,NDC:0220-4094 | UNII:49DFR088MY | NDC:37662-2066 | NDC:37662-2073 | NDC:37662-2074 | NDC:0220-4084 | PubChem CID:23939 | NDC:37662-2071 | NDC:37662-2070 | CAS RN:7440-06-4 | NDC:37662-2069 | DrugBank ID:DB12257 | NDC:37662-2072 | NDC:0220-4083 | NDC:37662-2067 | Platinum | PLATINUM | NDC:37662-2068 | platinum
+BMGC_DG05747,BMG_DG123223,NDC:37662-3023 | Samarium | PubChem CID:23951 | NDC:37662-3027 | UNII:42OD65L39F | NDC:37662-3028 | DrugBank ID:DB12403 | samarium | NDC:37662-3026 | NDC:37662-3025 | SAMARIUM | NDC:37662-3021 | CAS RN:7440-19-9 | NDC:37662-3024 | NDC:37662-3022
+BMGC_DG05748,BMG_DG123225,N-HYDROXYTHIOPHENE-2-CARBOXAMIDE | PubChem CID:239511 | N-hydroxythiophene-2-carboxamide | CAS RN:17698-15-6 | PubChem SID:475550582 | UNII:CM497MU7RW
+BMGC_DG05749,BMG_DG123226,"N-HYDROXY-2,2-DIPHENYLACETAMIDE | N-Hydroxy-2,2-diphenylacetamide | CAS RN:4099-51-8 | PubChem CID:239512 | UNII:ZR6KC9X4LN | PubChem SID:475550277"
+BMGC_DG05750,BMG_DG123229,Silver | NDC:52166-001 | NDC:0220-0476 | NDC:48951-1371 | NDC:72363-005 | NDC:48951-1087 | SILVER | NDC:43857-0227 | NDC:63545-113 | CAS RN:7440-22-4 | NDC:72363-025 | NDC:72363-021 | NDC:0220-0477 | NDC:53645-1033 | NDC:52166-002 | NDC:72363-004 | NDC:72363-019 | NDC:72363-027 | NDC:53645-1032 | NDC:55926-0024 | NDC:72363-016 | DrugBank ID:DB12965 | NDC:63545-116 | NDC:72363-013 | NDC:72363-011 | NDC:48951-1317 | NDC:72363-017 | NDC:72363-024 | NDC:63545-111 | NDC:55926-0025 | NDC:63545-108 | NDC:63545-109 | NDC:48951-1328 | NDC:66096-787 | NDC:48951-1074 | NDC:48951-1383 | NDC:72363-018 | NDC:72363-006 | PubChem CID:23954 | NDC:72363-023 | NDC:72363-014 | NDC:48951-1370 | NDC:72363-012 | NDC:72363-015 | NDC:63545-112 | NDC:52166-015 | NDC:48951-1085 | NDC:63545-110 | NDC:52166-018 | UNII:3M4G523W1G | NDC:63545-115 | NDC:63545-114 | NDC:55926-0027 | NDC:72363-010 | NDC:0220-0478 | silver | NDC:52166-020 | NDC:48951-1084
+BMGC_DG05751,BMG_DG123233,Technetium | CAS RN:7440-26-8 | PubChem CID:23957 | technetium
+BMGC_DG05752,BMG_DG123237,PubChem SID:198954469 | 9-DEHYDROANDROSTENEDIONE | PubChem CID:239595 | CAS RN:1035-69-4 | UNII:9329RS039I
+BMGC_DG05753,BMG_DG123238,"DrugBank ID:DB03777 | PubChem SID:198937844 | CAS RN:133052-90-1 | GO-6850 | Bisindolylmaleimide i | UNII:L79H6N0V6C | PubChem CID:2396 | 3-[1-[3-(dimethylamino)propyl]indol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione | Bisindolylmaleimide I"
+BMGC_DG05754,BMG_DG123250,PubChem CID:23973 | NDC:63545-582 | DrugBank ID:DB14085 | CAS RN:7440-43-9 | cadmium | NDC:63545-590 | CADMIUM | NDC:0220-1006 | NDC:63545-587 | UNII:00BH33GNGH | NDC:63545-589 | NDC:66096-803 | NDC:0220-1007 | NDC:63545-588 | NDC:63545-586 | Cadmium | CAS RN:81271-94-5 | NDC:63545-585 | NDC:63545-584
+BMGC_DG05755,BMG_DG123253,NDC:75854-343 | UNII:0R0008Q3JB | CAS RN:19498-56-7 | chromium | DrugBank ID:DB11136 | NDC:37662-0406 | NDC:37662-0407 | NDC:37662-0401 | NDC:37662-0405 | CAS RN:7440-47-3 | PubChem CID:23976 | Chromium | CHROMIUM | NDC:37662-0403 | NDC:37662-0404 | NDC:37662-0408 | NDC:37662-0402
+BMGC_DG05756,BMG_DG123254,NDC:0220-1627 | NDC:0220-1631 | NDC:37662-0607 | DrugBank ID:DB09130 | NDC:0220-1616 | NDC:48951-3266 | NDC:48951-8374 | NDC:53645-1100 | NDC:66343-116 | NDC:53645-1300 | COPPER | NDC:15631-0163 | NDC:48951-3064 | NDC:76472-4046 | NDC:37662-0608 | NDC:37662-0605 | NDC:82969-5105 | UNII:789U1901C5 | NDC:0220-1652 | NDC:53645-1101 | NDC:48951-3145 | NDC:59365-5129 | NDC:37662-0609 | NDC:37662-0603 | NDC:48951-3138 | NDC:59365-5128 | NDC:0220-1623 | NDC:0220-1635 | NDC:53645-1102 | NDC:61727-310 | PubChem CID:23978 | NDC:15631-2714 | NDC:53645-1050 | NDC:37662-0606 | NDC:66096-826 | NDC:37662-0602 | CAS RN:7440-50-8 | Copper | NDC:0220-1651 | NDC:48951-3238 | NDC:0220-9228 | NDC:0220-1613 | NDC:48951-3170 | NDC:0220-1624 | NDC:48951-3280 | NDC:0220-1628 | NDC:37662-0604 | copper | NDC:61727-334 | NDC:48951-3166 | NDC:0220-1636 | NDC:48951-8405 | NDC:48951-3213 | NDC:0220-1648
+BMGC_DG05757,BMG_DG123257,"PubChem CID:2398 | DrugBank ID:DB07457 | 3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE"
+BMGC_DG05758,BMG_DG123263,PubChem CID:23982 | NDC:37662-2585 | Gadolinium | GADOLINIUM | gadolinium | CAS RN:7440-54-2 | NDC:37662-2587 | NDC:37662-2588 | NDC:37662-2590 | NDC:37662-2589 | DrugBank ID:DB12091 | UNII:AU0V1LM3JT | NDC:37662-2586 | NDC:37662-2584 | NDC:37662-2591
+BMGC_DG05759,BMG_DG123266,"PubChem CID:23983765 | BROLAMFETAMINE, (S)- | UNII:NXQ58PZ30E | CAS RN:43061-16-1 | PubChem SID:255509183"
+BMGC_DG05760,BMG_DG123267,"1-(4-Acetyl-2,5-dimethoxyphenyl)-2-aminopropane | PubChem CID:23983771 | 1-[4-(2-aminopropyl)-2,5-dimethoxyphenyl]ethanone"
+BMGC_DG05761,BMG_DG123272,helium | DrugBank ID:DB09155 | CAS RN:71086-78-7 | CAS RN:7440-59-7 | Helium | PubChem CID:23987 | HELIUM | UNII:206GF3GB41
+BMGC_DG05762,BMG_DG123275,PubChem CID:2399 | BISINDOLYLMALEIMIDE | UNII:MBK3OO5K8T | CAS RN:119139-23-0 | PubChem SID:198990052
+BMGC_DG05763,BMG_DG123277,UNII:3H3U766W84 | CAS RN:20222-53-1 | CAS RN:7440-63-3 | XENON | Xenon | DrugBank ID:DB13453 | xenon | PubChem CID:23991
+BMGC_DG05764,BMG_DG123280,NDC:37662-3134 | UNII:58784XQC3Y | CAS RN:7440-65-5 | NDC:37662-3136 | NDC:37662-3133 | NDC:37662-3139 | PubChem CID:23993 | Yttrium | NDC:37662-3135 | yttrium | NDC:37662-3138 | NDC:37662-3132 | NDC:37662-3137 | YTTRIUM
+BMGC_DG05765,BMG_DG123281,NDC:44911-0176 | Zinc | NDC:0220-5440 | NDC:37662-2139 | NDC:15631-3020 | NDC:0220-5439 | NDC:37662-2140 | NDC:76472-4055 | NDC:0220-5434 | NDC:37662-2146 | NDC:37662-2145 | CAS RN:7440-66-6 | CAS RN:14018-82-7 | NDC:0220-5465 | zinc | NDC:43406-0713 | NDC:37662-2143 | NDC:37662-2141 | PubChem CID:23994 | NDC:37662-2144 | NDC:0220-5438 | NDC:37662-2147 | UNII:J41CSQ7QDS | NDC:0220-5437 | NDC:0220-5433 | NDC:0220-5436 | DrugBank ID:DB01593 | ZINC | NDC:37662-2142 | NDC:15631-0469 | NDC:0220-5435
+BMGC_DG05766,BMG_DG123287,CAS RN:55279-75-9 | CAS RN:100-52-7 | Benzaldehyde | UNII:TA269SD04T | BENZALDEHYDE | benzaldehyde | PubChem CID:240 | PubChem SID:175267677
+BMGC_DG05767,BMG_DG123298,Selenium sulfide | CAS RN:7446-34-6 | PubChem CID:24011
+BMGC_DG05768,BMG_DG123302,trichloroalumane | NDC:37662-2704 | CAS RN:7446-70-0 | NDC:37662-2707 | DrugBank ID:DB11081 | PubChem CID:24012 | CAS RN:7371-55-3 | PubChem SID:175267450 | NDC:37662-2703 | NDC:37662-2706 | Aluminum chloride | UNII:LIF1N9568Y | ALUMINUM CHLORIDE ANHYDROUS | NDC:37662-2709 | NDC:37662-2708 | NDC:37662-2702 | NDC:37662-2705 | Aluminum Chloride
+BMGC_DG05769,BMG_DG123305,NDC:37662-0610 | dichlorocopper | NDC:37662-0616 | NDC:37662-0617 | Cupric Chloride | NDC:37662-0613 | NDC:37662-0611 | NDC:37662-0615 | PubChem SID:198955971 | CAS RN:7447-39-4 | DrugBank ID:DB09131 | UNII:P484053J2Y | NDC:37662-0614 | NDC:37662-0612 | PubChem CID:24014 | CUPRIC CHLORIDE ANHYDROUS
+BMGC_DG05770,BMG_DG123314,"UNII:Y6197FQK8I | RO-31-7549 | Bisindolylmaleimide VIII | CAS RN:125313-65-7 | DrugBank ID:DB01946 | 3-[1-(3-aminopropyl)indol-3-yl]-4-(1-methylindol-3-yl)pyrrole-2,5-dione | PubChem SID:198974922 | PubChem CID:2403"
+BMGC_DG05771,BMG_DG123332,PubChem CID:2405 | 1-(propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol | DrugBank ID:DB00612 | UNII:Y41JS2NL6U | BISOPROLOL | Bisoprolol | CAS RN:104344-23-2 | CAS RN:66722-44-9 | PubChem SID:175271629
+BMGC_DG05772,BMG_DG123334,UNII:19I9PY8G1D | CAS RN:7466-54-8 | PubChem SID:198938372 | 2-METHOXYBENZOYL HYDRAZIDE | PubChem CID:24051
+BMGC_DG05773,BMG_DG123343,CAS RN:7471-03-6 | PubChem CID:24057 | PubChem SID:198984167 | UNII:OBI166S5VM | 2-AMINO-4-HYDROXYBENZOTHIAZOLE
+BMGC_DG05774,BMG_DG123346,"PubChem SID:198972394 | 2,4-dichloro-6-(3,5-dichloro-2-hydroxyphenyl)sulfanylphenol | CAS RN:97-18-7 | CAS RN:1394-04-3 | Bithionol | BITHIONOL | DrugBank ID:DB04813 | UNII:AMT77LS62O | PubChem CID:2406"
+BMGC_DG05775,BMG_DG123349,"4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | ZALCITABINE | PubChem SID:175268500 | PubChem CID:24066 | Zalcitabine | DrugBank ID:DB00943 | CAS RN:7481-89-2 | UNII:6L3XT8CB3I"
+BMGC_DG05776,BMG_DG123353,"PubChem SID:474494188 | DOET, (S)- | CAS RN:53305-83-2 | PubChem CID:24066917 | UNII:7GSB3N9WN8"
+BMGC_DG05777,BMG_DG123359,"FLUOROMETHOLONE ACETATE | UNII:9I50C3I3OK | PubChem CID:240767 | CAS RN:3801-06-7 | NDC:71776-100 | [(6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11-hydroxy-6,10,13-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate | Fluorometholone Acetate | PubChem SID:175268352"
+BMGC_DG05778,BMG_DG123363,magnesium;sulfate | PubChem CID:24083 | CAS RN:7487-88-9 | NDC:52268-201 | PubChem SID:175267203 | DrugBank ID:DB00653 | Magnesium Sulfate | CAS RN:139939-75-6 | NDC:40032-700 | UNII:ML30MJ2U7I | CAS RN:18939-43-0 | Magnesium sulfate | NDC:43386-700 | MAGNESIUM SULFATE ANHYDROUS
+BMGC_DG05779,BMG_DG123366,NDC:0536-1995 | NDC:41167-1651 | NDC:69423-525 | NDC:30142-816 | NDC:49035-534 | NDC:76162-171 | NDC:45802-040 | NDC:69423-526 | DrugBank ID:DB00971 | CAS RN:7488-56-4 | NDC:58657-478 | NDC:0363-4139 | NDC:63148-209 | NDC:69367-229 | NDC:16477-422 | NDC:64724-1016 | NDC:69423-524 | NDC:0363-4136 | NDC:71573-121 | NDC:72288-551 | Selenium disulfide | NDC:72476-025 | NDC:63629-1149 | PubChem SID:383470559 | NDC:41167-6061 | NDC:59779-589 | NDC:55319-949 | NDC:51316-387 | NDC:69423-527 | NDC:79481-0071 | NDC:63629-1148 | NDC:82442-308 | NDC:41250-816 | NDC:71899-068 | NDC:83342-974 | NDC:41167-6032 | NDC:37808-816 | NDC:41250-545 | Selenium Sulfide | NDC:69423-523 | NDC:82442-384 | NDC:0363-4902 | NDC:50090-0242 | SELENIUM SULFIDE | NDC:69423-642 | NDC:70000-0531 | NDC:72476-816 | NDC:16477-423 | NDC:0363-9422 | NDC:71899-069 | NDC:52187-550 | NDC:49967-974 | NDC:72162-1666 | PubChem CID:24087 | UNII:Z69D9E381Q
+BMGC_DG05780,BMG_DG123373,PubChem CID:24094116 | PubChem SID:319892524 | UNII:6AQ318S49N | ILICICOLIN C | CAS RN:22562-67-0
+BMGC_DG05781,BMG_DG123383,CAS RN:54682-86-9 | BENZENE | benzene | UNII:J64922108F | CAS RN:25053-22-9 | Benzene | CAS RN:26181-88-4 | CAS RN:3355-34-8 | PubChem SID:175268236 | CAS RN:62485-97-6 | CAS RN:71-43-2 | PubChem CID:241
+BMGC_DG05782,BMG_DG123401,6-NITROCHRYSENE | 6-Nitrochrysene | CAS RN:7496-02-8 | UNII:82ZK83O33Y | 6-nitrochrysene | PubChem CID:24121 | PubChem SID:198940859
+BMGC_DG05783,BMG_DG123402,"CAS RN:6641-13-0 | PubChem CID:241211 | UNII:3QM8LU7NC8 | 3,3'-METHYLENEBIS(6-HYDROXY-5-METHYLBENZENEMETHANOL)"
+BMGC_DG05784,BMG_DG123414,"CAS RN:137630-09-2 | UNII:8P59336F68 | N-ACETYL-.BETA.-D-GLUCOSAMINE | N-[(2R,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | PubChem SID:198991181 | N-ACETYL-beta-D-GLUCOSAMINE | CAS RN:103094-10-6 | CAS RN:14131-68-1 | CAS RN:1398-61-4 | CAS RN:72-87-7 | PubChem CID:24139"
+BMGC_DG05785,BMG_DG123417,"acridin-9-amine;4-hexylbenzene-1,3-diol | PubChem CID:24144 | ACRISORCIN | CAS RN:7527-91-5 | UNII:2U918O4BEV | PubChem SID:198983822 | Acrisorcin"
+BMGC_DG05786,BMG_DG123427,"PubChem CID:241543 | CAS RN:30915-20-9 | 11.ALPHA.,17.BETA.-DIHYDROXYANDROST-1,4-DIEN-3-ONE | UNII:X618L115Y2 | PubChem SID:198964256"
+BMGC_DG05787,BMG_DG123445,N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide | DrugBank ID:DB08029 | PubChem CID:24178109
+BMGC_DG05788,BMG_DG123447,"PubChem CID:24178119 | (3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one | DrugBank ID:DB07468"
+BMGC_DG05789,BMG_DG123448,"PubChem CID:24178120 | (3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one | DrugBank ID:DB07469"
+BMGC_DG05790,BMG_DG123449,"PubChem CID:24178121 | (3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one | DrugBank ID:DB07470"
+BMGC_DG05791,BMG_DG123454,SRT-1460 | UNII:FN6D3F3HTG | CAS RN:925432-73-1 | PubChem SID:472423530 | PubChem CID:24180124
+BMGC_DG05792,BMG_DG123455,UNII:DX3FHY76FZ | CAS RN:925434-55-5 | PubChem CID:24180125 | SRT-1720 | PubChem SID:441097180
+BMGC_DG05793,BMG_DG123456,CAS RN:1001908-89-9 | PubChem SID:472423531 | UNII:6FKU9G9CX6 | SRT-2183 | PubChem CID:24180126
+BMGC_DG05794,BMG_DG123457,"PubChem CID:24180585 | (3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE | DrugBank ID:DB08445"
+BMGC_DG05795,BMG_DG123464,"DrugBank ID:DB06979 | PubChem CID:24180714 | 5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid"
+BMGC_DG05796,BMG_DG123465,UNII:B700BD3K5Y | PubChem CID:24180717 | CAS RN:1025795-11-2 | DrugBank ID:DB06962 | JNJ-27390467 | JNJ-27390467 FREE BASE | PubChem SID:198974475
+BMGC_DG05797,BMG_DG123466,"DrugBank ID:DB07125 | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid | PubChem CID:24180718"
+BMGC_DG05798,BMG_DG123467,DrugBank ID:DB06999 | PubChem CID:24180719 | CAS RN:918505-84-7 | PLX-4720 | PubChem SID:198989262 | UNII:EQY31RO8HA
+BMGC_DG05799,BMG_DG123468,"DrugBank ID:DB07000 | PubChem CID:24180720 | N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide"
+BMGC_DG05800,BMG_DG123469,"CAS RN:918511-03-2 | PubChem CID:24180721 | DrugBank ID:DB07524 | UNII:B1XYZ89TUA | PubChem SID:438789106 | N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine | N-PHENYL-1H-PYRROLO(2,3-B)PYRIDIN-3-AMINE"
+BMGC_DG05801,BMG_DG123470,"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine | DrugBank ID:DB07525 | PubChem CID:24180722"
+BMGC_DG05802,BMG_DG123478,Crystallose | PubChem CID:24181110 | CAS RN:128-44-9
+BMGC_DG05803,BMG_DG123513,"BMY-7378 FREE BASE | CAS RN:21102-94-3 | 8-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-8-azaspiro[4.5]decane-7,9-dione | CAS RN:1348935-37-4 | PubChem CID:2419 | UNII:08EI0K81OL | 8-(2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl)-8-azaspiro[4.5]decane-7,9-dione | PubChem SID:198949361"
+BMGC_DG05804,BMG_DG123515,"methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid | PubChem CID:241902 | Vinblastine sulphate | CAS RN:143-67-9"
+BMGC_DG05805,BMG_DG123516,"methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | CAS RN:72401-36-6 | CAS RN:132142-72-4 | CAS RN:865-21-4 | PubChem CID:241903"
+BMGC_DG05806,BMG_DG123573,"1-cyclohexyl-2-(4,4-dimethylpiperazin-4-ium-1-yl)-1-phenylethanol | PubChem CID:24199 | UNII:LL3147PI1T | CAS RN:6004-98-4 | Hexocyclium | DrugBank ID:DB06787 | PubChem SID:198970097 | HEXOCYCLIUM"
+BMGC_DG05807,BMG_DG123575,"gold(1+);3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane | PubChem CID:24199313 | CAS RN:34031-32-8 | CID 24199313"
+BMGC_DG05808,BMG_DG123585,"PubChem CID:242 | CAS RN:766-76-7 | Benzoic acid, ion(1-) | benzoate"
+BMGC_DG05809,BMG_DG123598,"N-[(2R,3S,4S,6S)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide | PubChem CID:24202429"
+BMGC_DG05810,BMG_DG123601,"NDC:0517-7305 | DrugBank ID:DB14502 | UNII:22ADO53M6F | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | PubChem SID:175268465 | CAS RN:7558-79-4 | NDC:43386-030 | NDC:63323-881 | NDC:63323-884 | disodium;hydrogen phosphate | NDC:0409-7391 | Disodium hydrogen phosphate | NDC:0517-7350 | NDC:0517-7315 | PubChem CID:24203 | NDC:54973-6436 | NDC:63323-170 | NDC:63323-886"
+BMGC_DG05811,BMG_DG123608,"PubChem CID:242062 | UNII:SH8ZC3EJ5X | CAS RN:6344-22-5 | 6-METHOXY-2-(2-METHOXYPHENYL)-2,3-DIHYDRO-4H-CHROMEN-4-ONE"
+BMGC_DG05812,BMG_DG123649,"3.BETA.-ANDROSTANEDIOL | 5-Alpha-Androstane-3-Beta,17beta-Diol | CAS RN:571-20-0 | UNII:6J0K4253QD | (3S,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol | DrugBank ID:DB03882 | PubChem SID:198950233 | PubChem CID:242332 | 5alpha-Androstane-3beta,17beta-diol"
+BMGC_DG05813,BMG_DG123658,PubChem CID:24239 | 6-Nitroindazole | DrugBank ID:DB03100
+BMGC_DG05814,BMG_DG123664,"CAS RN:65185-91-3 | Trisodium phosphate | SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS | PubChem SID:175268710 | CAS RN:7601-54-9 | trisodium;phosphate | CAS RN:96337-98-3 | PubChem CID:24243 | UNII:SX01TZO3QZ"
+BMGC_DG05815,BMG_DG123666,"UNII:O0U0E87X7F | PubChem CID:24244 | METOCURINE IODIDE | PubChem SID:198966719 | Metocurine Iodide | Metocurine iodide | CAS RN:7601-55-0 | DrugBank ID:DB00416 | (1S,16R)-9,10,21,25-tetramethoxy-15,15,30,30-tetramethyl-7,23-dioxa-15,30-diazoniaheptacyclo[22.6.2.23,6.18,12.118,22.027,31.016,34]hexatriaconta-3(36),4,6(35),8(34),9,11,18(33),19,21,24,26,31-dodecaene;diiodide"
+BMGC_DG05816,BMG_DG123677,"PubChem CID:24250 | DrugBank ID:DB04333 | 1,8-Diaminooctane | Octamethylenediamine | octane-1,8-diamine | UNII:53A6694PIE | CAS RN:373-44-4 | OCTAMETHYLENEDIAMINE | PubChem SID:198948886"
+BMGC_DG05817,BMG_DG123690,"UNII:72M7S95J3U | PubChem SID:445499372 | PubChem CID:2426 | N-(3-BROMOPHENYL)QUINAZOLINE-4,6,7-TRIAMINE | CAS RN:169205-87-2"
+BMGC_DG05818,BMG_DG123691,NDC:82969-3025 | NDC:10893-730 | NDC:53645-1340 | NDC:37662-2089 | NDC:37662-2090 | NDC:44911-0699 | CAS RN:112945-52-5 | SILICON DIOXIDE | NDC:44911-0183 | NDC:0220-4668 | NDC:48951-3210 | NDC:37662-2095 | NDC:48951-3178 | NDC:62106-1061 | NDC:10893-710 | CAS RN:7631-86-9 | NDC:84613-058 | NDC:84732-085 | NDC:84732-094 | CAS RN:92283-58-4 | NDC:53645-1161 | CAS RN:15468-32-3 | NDC:0220-4671 | NDC:54973-8081 | NDC:37662-2096 | NDC:53645-1163 | NDC:53645-1160 | NDC:0220-4660 | CAS RN:99439-28-8 | NDC:76472-1162 | NDC:54973-4098 | PubChem CID:24261 | NDC:0220-4669 | NDC:0220-4664 | NDC:0220-4667 | CAS RN:60676-86-0 | NDC:48951-1098 | NDC:0220-4675 | CAS RN:14464-46-1 | NDC:48951-8109 | dioxosilane | NDC:48951-1097 | CAS RN:112926-00-8 | CAS RN:13778-38-6 | NDC:48951-8334 | NDC:37662-2093 | CAS RN:17679-64-0 | NDC:37662-2088 | NDC:53645-1162 | NDC:48951-8231 | NDC:0220-4670 | NDC:82969-1012 | NDC:54973-4083 | NDC:58264-0138 | UNII:ETJ7Z6XBU4 | NDC:84634-004 | PubChem SID:175267593 | NDC:48951-8343 | NDC:15631-2955 | NDC:37662-2091 | NDC:0220-4683 | NDC:48951-3184 | Silicon Dioxide | NDC:0220-4672 | NDC:48951-3245 | NDC:73666-0610 | NDC:15631-0404 | NDC:71753-8012 | NDC:76670-0014 | NDC:44911-0341 | NDC:37662-2092 | NDC:0220-4680 | CAS RN:15723-40-7 | NDC:48951-8183 | CAS RN:14808-60-7 | NDC:48951-8108 | NDC:0220-4684 | NDC:82662-070 | NDC:37662-2094 | NDC:48951-8241 | NDC:53645-1342 | NDC:0220-4679 | CAS RN:13778-37-5
+BMGC_DG05819,BMG_DG123694,NDC:55882-3477 | NDC:76357-175 | NDC:58733-001 | NDC:42681-0019 | NDC:84132-100 | NDC:61543-1751 | NDC:51009-902 | NDC:53567-0033 | NDC:69423-959 | NDC:73656-027 | NDC:53567-0036 | NDC:65954-786 | NDC:51009-202 | NDC:71141-186 | NDC:53567-0040 | NDC:53567-0030 | NDC:35000-978 | NDC:41520-724 | NDC:35000-748 | NDC:52410-9005 | NDC:82168-002 | NDC:78151-060 | DrugBank ID:DB09484 | NDC:82976-101 | NDC:52000-112 | NDC:42555-060 | NDC:35000-758 | NDC:35000-974 | NDC:58701-002 | NDC:53567-0032 | NDC:39892-0602 | NDC:35000-980 | NDC:35000-916 | NDC:37808-411 | NDC:53329-083 | NDC:84516-010 | NDC:35000-682 | NDC:83861-005 | NDC:69423-790 | PubChem CID:24266 | NDC:78151-040 | NDC:69510-010 | NDC:53247-131 | NDC:67751-118 | NDC:65954-060 | NDC:65954-068 | NDC:56153-002 | NDC:62685-231 | NDC:82168-003 | NDC:51824-067 | NDC:35000-959 | NDC:52000-108 | NDC:82168-001 | NDC:11673-441 | NDC:70766-003 | PubChem SID:175265632 | NDC:51009-917 | NDC:62839-1155 | NDC:84045-005 | NDC:65954-785 | NDC:53567-0041 | NDC:69423-837 | NDC:35000-749 | NDC:54897-701 | NDC:35000-747 | NDC:81275-010 | NDC:66923-123 | NDC:51009-912 | CAS RN:12331-99-6 | NDC:67777-181 | NDC:69423-896 | NDC:51009-911 | NDC:53567-0037 | NDC:52000-107 | Sodium Monofluorophosphate | disodium;fluoro-dioxido-oxo-lambda5-phosphane | CAS RN:10163-15-2 | NDC:35000-973 | NDC:42681-5002 | SODIUM MONOFLUOROPHOSPHATE | NDC:73656-026 | NDC:56153-001 | NDC:58701-001 | NDC:35000-893 | NDC:69968-0701 | NDC:62839-1151 | NDC:84126-604 | NDC:69423-874 | NDC:65954-063 | NDC:83672-001 | NDC:82662-060 | NDC:68599-0123 | NDC:51009-854 | NDC:58933-012 | NDC:82168-004 | NDC:35000-919 | NDC:51009-916 | NDC:67777-190 | NDC:84045-004 | NDC:65954-765 | NDC:11673-385 | NDC:51009-203 | NDC:30142-146 | NDC:0135-0577 | NDC:69510-020 | NDC:76357-106 | NDC:52862-500 | NDC:82168-005 | NDC:82976-100 | NDC:70766-005 | NDC:35000-678 | NDC:77573-011 | NDC:51009-910 | NDC:35000-913 | UNII:C810JCZ56Q | NDC:52000-111 | NDC:65954-768 | NDC:35000-979 | NDC:52862-501 | NDC:51009-219 | NDC:42681-5276 | NDC:51009-205 | NDC:67777-175 | NDC:53567-0031 | NDC:53247-129 | NDC:50555-200 | NDC:79481-0020 | NDC:35000-982 | NDC:51009-919 | NDC:70766-001 | NDC:35000-977 | NDC:84045-006 | NDC:51009-206 | CAS RN:7631-97-2 | NDC:69423-752 | NDC:69423-760
+BMGC_DG05820,BMG_DG123697,"Bpiq-i | CAS RN:174709-30-9 | PubChem CID:2427 | N-(3-bromophenyl)-3-methylimidazo[4,5-g]quinazolin-8-amine"
+BMGC_DG05821,BMG_DG123705,DrugBank ID:DB03780 | PubChem CID:242831 | 2-Aminoquinazolin-4(3h)-One
+BMGC_DG05822,BMG_DG123714,"DrugBank ID:DB04007 | Bromo-WR99210 | 1-(3-(4-BROMANYLPHENOXY)PROPOXY)-6,6-DIMETHYL-1,3,5-TRIAZINE-2,4-DIAMINE | PubChem SID:443625088 | PubChem CID:2429 | CAS RN:179184-06-6 | UNII:8S51TS26BA"
+BMGC_DG05823,BMG_DG123725,CAS RN:65-85-0 | Benzoic Acid | CAS RN:14322-82-8 | UNII:8SKN0B0MIM | BENZOIC ACID | PubChem CID:243 | PubChem SID:175268913 | DrugBank ID:DB03793 | benzoic acid | Benzoic acid
+BMGC_DG05824,BMG_DG123731,BRETYLIUM | CAS RN:59-41-6 | DrugBank ID:DB01158 | Bretylium | PubChem SID:175267511 | (2-bromophenyl)methyl-ethyl-dimethylazanium | UNII:RZR75EQ2KJ | PubChem CID:2431
+BMGC_DG05825,BMG_DG123738,Cyclic GMP | PubChem CID:24316 | DrugBank ID:DB02315
+BMGC_DG05826,BMG_DG123745,"PubChem CID:24326 | CAS RN:7677-99-8 | UNII:28D17I2DOG | PubChem SID:198987764 | 4',5-DICHLOROSALICYLANILIDE"
+BMGC_DG05827,BMG_DG123757,"CAS RN:59803-98-4 | Brimonidine | DrugBank ID:DB00484 | BRIMONIDINE | PubChem CID:2435 | PubChem SID:175266791 | 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine | UNII:E6GNX3HHTE"
+BMGC_DG05828,BMG_DG123760,PubChem CID:24352 | UNII:Y1BCT334I7 | CAS RN:3568-24-9 | PROPIONYLPROMAZINE | PubChem SID:198947538
+BMGC_DG05829,BMG_DG123761,"UNII:X915771SGZ | PubChem CID:243556 | 2,6-DIBROMO-4-PHENYLPHENOL | DrugBank ID:DB08102 | PubChem SID:440088410 | CAS RN:4400-05-9 | 3,5-dibromobiphenyl-4-ol"
+BMGC_DG05830,BMG_DG123766,"UNII:XT3Z54Z28A | Camptothecin | (19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione | CAS RN:7689-03-4 | CAMPTOTHECIN | PubChem CID:24360 | DrugBank ID:DB04690 | PubChem SID:198949235"
+BMGC_DG05831,BMG_DG123776,CAS RN:90730-96-4 | 2-[4-[2-[[2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetic acid | 2-[4-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetic acid | CAS RN:114333-71-0 | PubChem CID:2437
+BMGC_DG05832,BMG_DG123781,PubChem SID:198980797 | UNII:538CX0LPPO | PubChem CID:243725 | DIHYDROROTENONE | CAS RN:6659-45-6
+BMGC_DG05833,BMG_DG123803,DrugBank ID:DB13257 | CAS RN:7720-78-7 | UNII:2IDP3X9OUD | Ferrous Sulfate | PubChem SID:198938304 | FERROUS SULFATE ANHYDROUS | CAS RN:16547-58-3 | CAS RN:8063-79-4 | iron(2+);sulfate | PubChem CID:24393
+BMGC_DG05834,BMG_DG123809,phenylmethanol | PubChem SID:175267939 | BENZYL ALCOHOL | Benzyl Alcohol | DrugBank ID:DB06770 | CAS RN:185532-71-2 | UNII:LKG8494WBH | Benzyl alcohol | CAS RN:100-51-6 | PubChem CID:244 | CAS RN:66072-40-0
+BMGC_DG05835,BMG_DG123813,PubChem CID:24403 | UNII:O352864B8Z | tetrasodium;phosphonato phosphate | Sodium Pyrophosphate | NDC:83778-009 | SODIUM PYROPHOSPHATE | CAS RN:7722-88-5 | CAS RN:1004291-85-3 | NDC:69945-094 | PubChem SID:175267180
+BMGC_DG05836,BMG_DG123816,"RIBOPRINE | PubChem CID:24405 | DrugBank ID:DB11933 | Riboprine | (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(3-methylbut-2-enylamino)purin-9-yl]oxolane-3,4-diol | UNII:8EU82FAZ5J | CAS RN:7724-76-7 | PubChem SID:175267107"
+BMGC_DG05837,BMG_DG123819,"Bromazepam | PubChem CID:2441 | UNII:X015L14V0O | 7-bromo-5-pyridin-2-yl-1,3-dihydro-1,4-benzodiazepin-2-one | CAS RN:1812-30-2 | BROMAZEPAM | DrugBank ID:DB01558 | PubChem SID:198951384"
+BMGC_DG05838,BMG_DG123824,NDC:32909-116 | DrugBank ID:DB11150 | NDC:32909-121 | barium(2+);sulfate | NDC:32909-105 | NDC:32909-746 | CAS RN:13462-86-7 | PubChem SID:175268739 | NDC:32909-747 | Barium sulfate | NDC:32909-744 | NDC:32909-814 | BARIUM SULFATE | NDC:32909-146 | CAS RN:7727-43-7 | NDC:32909-750 | NDC:32909-122 | UNII:25BB7EKE2E | NDC:32909-764 | Barium Sulfate | NDC:32909-167 | NDC:32909-927 | NDC:32909-125 | NDC:32909-187 | NDC:32909-770 | NDC:32909-741 | PubChem CID:24414 | NDC:10361-778 | NDC:32909-742
+BMGC_DG05839,BMG_DG123826,"N-(2,6-dimethylphenyl)-2-(ethylamino)acetamide | PubChem SID:198947295 | PubChem CID:24415 | CAS RN:7728-40-7 | CAS RN:1216698-89-3 | Monoethylglycinexylidide | UNII:D8Q99HC770 | NORLIDOCAINE"
+BMGC_DG05840,BMG_DG123829,PubChem SID:198982467 | S-METHYLCYSTEINE | S-Methylcysteine | PubChem CID:24417 | CAS RN:1187-84-4 | DrugBank ID:DB02216 | UNII:A34I1H07YM
+BMGC_DG05841,BMG_DG123834,"PubChem CID:2442 | Bromhexine | DrugBank ID:DB09019 | CAS RN:3572-43-8 | PubChem SID:198951495 | BROMHEXINE | 2,4-dibromo-6-[[cyclohexyl(methyl)amino]methyl]aniline | UNII:Q1J152VB1P"
+BMGC_DG05842,BMG_DG123836,CAS RN:7733-02-0 | DrugBank ID:DB09322 | ZINC SULFATE ANHYDROUS | Zinc sulfate | zinc;sulfate | UNII:0J6Z13X3WO | PubChem SID:175267466 | Zinc Sulfate | PubChem CID:24424
+BMGC_DG05843,BMG_DG123840,PubChem SID:175267909 | UNII:RU45X2JN0Z | Potassium Nitrate | POTASSIUM NITRATE | DrugBank ID:DB11090 | Potassium nitrate | potassium;nitrate | CAS RN:7757-79-1 | PubChem CID:24434
+BMGC_DG05844,BMG_DG123844,Sodium sulfate | CAS RN:15124-09-1 | SODIUM SULFATE ANHYDROUS | disodium;sulfate | PubChem CID:24436 | PubChem SID:175268814 | UNII:36KCS0R750 | NDC:54973-6440 | DrugBank ID:DB09472 | Sodium Sulfate | CAS RN:7757-82-6 | CAS RN:13759-07-4
+BMGC_DG05845,BMG_DG123849,MAGNESIUM PHOSPHATE ANHYDROUS | Trimagnesium phosphate | PubChem SID:198950564 | UNII:XMK14ETW2D | trimagnesium;diphosphate | PubChem CID:24439 | DrugBank ID:DB13862 | CAS RN:7757-87-1
+BMGC_DG05846,BMG_DG123850,"BROMODIPHENHYDRAMINE | CAS RN:118-23-0 | PubChem CID:2444 | Bromazine | 2-[(4-bromophenyl)-phenylmethoxy]-N,N-dimethylethanamine | UNII:T032BI7727 | PubChem SID:198969277 | DrugBank ID:DB01237 | Bromodiphenhydramine"
+BMGC_DG05847,BMG_DG123856,NDC:37662-1739 | NDC:0220-2966 | NDC:0220-2969 | NDC:70069-747 | NDC:0220-2967 | NDC:58264-0340 | CAS RN:7758-11-4 | DIBASIC POTASSIUM PHOSPHATE | PubChem SID:175266554 | NDC:37662-1732 | NDC:0220-2963 | NDC:54973-4077 | NDC:54973-3331 | NDC:70069-746 | NDC:0220-2965 | DrugBank ID:DB09414 | NDC:37662-1734 | Dipotassium phosphate | NDC:37662-1736 | UNII:CI71S98N1Z | CAS RN:7558-11-4 | NDC:58264-0132 | NDC:0220-2968 | NDC:37662-1737 | PubChem CID:24450 | NDC:34666-403 | NDC:37662-1733 | NDC:0220-2970 | NDC:37662-1735 | NDC:37662-1740 | NDC:37662-1738 | NDC:71753-8006 | NDC:0220-2964 | dipotassium;hydrogen phosphate | NDC:0220-2962 | NDC:0409-7295
+BMGC_DG05848,BMG_DG123865,pentasodium;[oxido(phosphonatooxy)phosphoryl] phosphate | CAS RN:9010-08-6 | CAS RN:7758-29-4 | Pentasodium Triphosphate | PubChem SID:198990688 | DrugBank ID:DB11493 | UNII:9SW4PFD2FZ | PubChem CID:24455 | SODIUM TRIPOLYPHOSPHATE ANHYDROUS
+BMGC_DG05849,BMG_DG123866,Calcium Phosphate | tricalcium;diphosphate | UNII:K4C08XP666 | PubChem CID:24456 | CAS RN:21063-37-6 | TRICALCIUM PHOSPHATE | DrugBank ID:DB11348 | CAS RN:7758-87-4 | CAS RN:10103-46-5 | PubChem SID:175266057
+BMGC_DG05850,BMG_DG123872,PubChem SID:198970121 | DrugBank ID:DB09018 | PubChem CID:2446 | BROMOPRIDE | 4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide | Bromopride | UNII:75473V2YZK | CAS RN:4093-35-0
+BMGC_DG05851,BMG_DG123874,CAS RN:13907-45-4 | UNII:9S2Y101D6M | dioxido(dioxo)chromium | CAS RN:11104-59-9 | CHROMATE ION | Chromate | PubChem SID:198960873 | PubChem CID:24461
+BMGC_DG05852,BMG_DG123875,DrugBank ID:DB06778 | CAS RN:10124-44-4 | Cupric sulfate | CUPRIC SULFATE ANHYDROUS | UNII:KUW2Q3U1VV | PubChem CID:24462 | copper;sulfate | CAS RN:7758-98-7 | CAS RN:18939-61-2 | PubChem SID:175267012 | Cupric Sulfate | CAS RN:1332-14-5
+BMGC_DG05853,BMG_DG123879,Tungstate | PubChem CID:24465 | TUNGSTATE ION | CAS RN:12737-86-9 | UNII:SW0Y0WQ46I | CAS RN:51682-10-1 | dioxido(dioxo)tungsten | CAS RN:14311-52-5 | PubChem SID:313182812
+BMGC_DG05854,BMG_DG123881,"DrugBank ID:DB04655 | CAS RN:7761-45-7 | PubChem SID:198935081 | UNII:2L9RKX796Q | Metoprine | 5-(3,4-dichlorophenyl)-6-methylpyrimidine-2,4-diamine | PubChem CID:24466 | METOPRINE"
+BMGC_DG05855,BMG_DG123882,UNII:469GW8R486 | Bromisoval | PubChem SID:198951186 | PubChem CID:2447 | CAS RN:496-67-3 | 2-bromo-N-carbamoyl-3-methylbutanamide | CAS RN:66101-52-8 | BROMISOVAL | DrugBank ID:DB13370
+BMGC_DG05856,BMG_DG123888,"FLUOREN-9-ONE O-(3-TERT-BUTYLAMINO-2-HYDROXYPROPYL)OXIME, (S)- | PubChem CID:2447484 | UNII:WM43RDG3W8 | CAS RN:81522-07-8"
+BMGC_DG05857,BMG_DG123889,"CAS RN:81522-06-7 | FLUOREN-9-ONE O-(3-TERT-BUTYLAMINO-2-HYDROXYPROPYL)OXIME, (R)- | PubChem CID:2447486 | UNII:C9G4BG2VNG"
+BMGC_DG05858,BMG_DG123891,PubChem SID:175266253 | UNII:L0IYT1O31N | Sodium Thiosulfate | disodium;dioxido-oxo-sulfanylidene-lambda6-sulfane | CAS RN:7772-98-7 | SODIUM THIOSULFATE ANHYDROUS | PubChem CID:24477
+BMGC_DG05859,BMG_DG123892,PubChem CID:24478 | PubChem SID:175266476 | DrugBank ID:DB09499 | Thiosulfuric acid | sulfurothioic O-acid | CAS RN:13686-28-7 | UNII:7K79Y2EKKP | THIOSULFURIC ACID
+BMGC_DG05860,BMG_DG123894,Bromperidol | PubChem SID:198983194 | DrugBank ID:DB12401 | UNII:LYH6F7I22E | BROMPERIDOL | 4-[4-(4-bromophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one | CAS RN:10457-90-6 | PubChem CID:2448
+BMGC_DG05861,BMG_DG123897,"PubChem CID:244809 | EPIMESTROL | (8R,9S,13S,14S,16R,17S)-3-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-16,17-diol | DrugBank ID:DB13386 | Epimestrol | PubChem SID:198980292 | CAS RN:7004-98-0 | UNII:7IVE3SDZ38"
+BMGC_DG05862,BMG_DG123899,NDC:37662-2445 | NDC:37662-2440 | NDC:37662-2441 | MERCURIC IODIDE | Mercuric iodide | UNII:R03O05RB0P | NDC:0220-3403 | DrugBank ID:DB04445 | PubChem SID:175268430 | NDC:37662-2439 | NDC:37662-2442 | diiodomercury | NDC:37662-2438 | NDC:0220-3401 | NDC:37662-2443 | PubChem CID:24485 | CAS RN:7774-29-0 | NDC:37662-2444
+BMGC_DG05863,BMG_DG123908,"UNII:4U58JM421N | DrugBank ID:DB06739 | CAS RN:112665-43-7 | 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic acid | Seratrodast | CAS RN:103186-19-2 | SERATRODAST | CAS RN:103185-78-0 | PubChem SID:198938131 | PubChem CID:2449"
+BMGC_DG05864,BMG_DG123915,"Bronopol | CAS RN:52-51-7 | PubChem SID:175267521 | 2-bromo-2-nitropropane-1,3-diol | BRONOPOL | DrugBank ID:DB13960 | PubChem CID:2450 | UNII:6PU1E16C9W"
+BMGC_DG05865,BMG_DG123933,Potassium sulfate | UNII:1K573LC5TV | CAS RN:7778-80-5 | dipotassium;sulfate | POTASSIUM SULFATE | DrugBank ID:DB14499 | Potassium Sulfate | PubChem CID:24507 | PubChem SID:175267802
+BMGC_DG05866,BMG_DG123935,"PubChem CID:2451 | UNII:5XZM1R3DKF | Brotizolam | 4-bromo-7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene | PubChem SID:198979556 | CAS RN:57801-81-7 | BROTIZOLAM | DrugBank ID:DB09017"
+BMGC_DG05867,BMG_DG123944,UNII:EDO66F5U49 | PubChem SID:198983327 | PubChem CID:24518 | Zinc Nitrate | ZINC NITRATE | CAS RN:7779-88-6 | zinc;dinitrate | CAS RN:13778-30-8
+BMGC_DG05868,BMG_DG123954,CAS RN:7782-50-5 | PubChem CID:24526 | NDC:37662-0249 | NDC:37662-0247 | NDC:37662-0248 | NDC:37662-0245 | NDC:37662-0244 | UNII:4R7X1O2820 | NDC:0220-1333 | molecular chlorine | NDC:0327-0001 | DrugBank ID:DB11109 | Chlorine | CHLORINE | NDC:37662-0243 | CAS RN:81859-29-2 | NDC:37662-0246 | NDC:58264-0159
+BMGC_DG05869,BMG_DG123958,CAS RN:7782-77-6 | Nitrous Acid | PubChem SID:198978247 | DrugBank ID:DB09112 | PubChem CID:24529 | UNII:T2I5UM75DN | nitrous acid | NITROUS ACID
+BMGC_DG05870,BMG_DG123960,PubChem CID:24530 | HYDROGEN AZIDE | UNII:6P5C4D5D7I | PubChem SID:198961354 | CAS RN:7782-79-8
+BMGC_DG05871,BMG_DG123975,"PubChem SID:252164018 | .DELTA.6,7-ESTRADIOL | CAS RN:7291-41-0 | UNII:N4K670423X | PubChem CID:245468"
+BMGC_DG05872,BMG_DG123980,CAS RN:7783-47-3 | DrugBank ID:DB11092 | Stannous fluoride | PubChem CID:24550 | difluorotin | Stannous Fluoride
+BMGC_DG05873,BMG_DG123996,PubChem SID:478838014 | PubChem CID:2456 | P-TOLUENESULFONANILIDE | UNII:U2P2PZ5R29 | CAS RN:68-34-8
+BMGC_DG05874,BMG_DG124026,"Antimycin A3 | PubChem SID:241177977 | ANTIMYCIN A3B | CAS RN:522-70-3 | PubChem CID:245869 | [(2R,3S,6S,7R,8R)-8-butyl-3-[(3-formamido-2-hydroxybenzoyl)amino]-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 3-methylbutanoate | CAS RN:116095-17-1 | UNII:97YBD5W80B"
+BMGC_DG05875,BMG_DG124037,PubChem SID:198956982 | ACTIPHENOL | CAS RN:526-02-3 | PubChem CID:245940 | UNII:1M5597X03D
+BMGC_DG05876,BMG_DG124042,Chromic nitrate | PubChem SID:198978297 | chromium(3+);trinitrate | DrugBank ID:DB14527 | CAS RN:13548-38-4 | PubChem CID:24598 | UNII:C6H0RE016B | CHROMIC NITRATE
+BMGC_DG05877,BMG_DG124063,"CAS RN:51372-29-3 | PubChem CID:2462 | 11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | 6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one | CAS RN:1134189-63-1 | CAS RN:51333-22-3"
+BMGC_DG05878,BMG_DG124095,CAS RN:7791-12-0 | Thallium chloride | THALLOUS CHLORIDE | PubChem SID:198940734 | Thallous chloride | DrugBank ID:DB09316 | chlorothallium | PubChem CID:24642 | UNII:37CB58V15B
+BMGC_DG05879,BMG_DG124116,Bufexamac | BUFEXAMAC | 2-(4-butoxyphenyl)-N-hydroxyacetamide | CAS RN:2438-72-4 | PubChem SID:198986545 | UNII:4T3C38J78L | DrugBank ID:DB13346 | PubChem CID:2466
+BMGC_DG05880,BMG_DG124119,"PubChem CID:2467 | BUFLOMEDIL | UNII:V7I71DQ432 | DrugBank ID:DB13510 | 4-pyrrolidin-1-yl-1-(2,4,6-trimethoxyphenyl)butan-1-one | Buflomedil | CAS RN:55837-25-7 | PubChem SID:198990752"
+BMGC_DG05881,BMG_DG124132,UNII:W2115E9C7B | PubChem CID:2468 | Buformin | CAS RN:1215700-80-3 | 2-butyl-1-(diaminomethylidene)guanidine | PubChem SID:198959811 | CAS RN:692-13-7 | DrugBank ID:DB04830 | BUFORMIN
+BMGC_DG05882,BMG_DG124151,"CAS RN:79-63-0 | PubChem SID:198956768 | Lanosterol | (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol | DrugBank ID:DB03696 | UNII:1J05Z83K3M | PubChem CID:246983 | LANOSTEROL"
+BMGC_DG05883,BMG_DG124154,BETAINE | UNII:3SCV180C9W | NDC:0713-0352 | Betaine | NDC:71863-115 | PubChem CID:247 | CAS RN:107-43-7 | DrugBank ID:DB06756 | NDC:17089-350 | NDC:52276-400 | NDC:83071-020 | 2-(trimethylazaniumyl)acetate | PubChem SID:175267822
+BMGC_DG05884,BMG_DG124157,"21-Hydroxypregnenolone | PubChem SID:198991023 | UNII:A1L3K6161X | CAS RN:1164-98-3 | 21-HYDROXYPREGNENOLONE | 2-hydroxy-1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone | PubChem CID:247020"
+BMGC_DG05885,BMG_DG124165,"Ovral | (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol | CAS RN:8056-51-7 | PubChem CID:24706 | CAS RN:39366-37-5"
+BMGC_DG05886,BMG_DG124166,NDC:50090-6304 | NDC:50090-6137 | NDC:68382-526 | NDC:0641-6007 | NDC:42799-120 | NDC:69238-1491 | NDC:43353-288 | NDC:65219-570 | NDC:68462-469 | NDC:69238-1489 | NDC:0832-0542 | NDC:51662-1449 | NDC:55154-3572 | NDC:68462-470 | NDC:50090-5666 | NDC:68382-525 | UNII:0Y2S3XUQ5H | NDC:70771-1024 | NDC:70748-323 | NDC:63629-4968 | BUMETANIDE | NDC:50090-5663 | NDC:0904-7016 | PubChem SID:175267176 | NDC:0832-0540 | NDC:50090-6138 | NDC:72572-041 | NDC:71335-1692 | NDC:72162-2197 | NDC:51672-4223 | NDC:23155-902 | DrugBank ID:DB00887 | NDC:72888-019 | NDC:72888-021 | NDC:55154-1527 | 3-(butylamino)-4-phenoxy-5-sulfamoylbenzoic acid | NDC:50268-132 | NDC:51672-4225 | PubChem CID:2471 | NDC:50268-130 | NDC:0641-6284 | NDC:50090-6139 | NDC:72888-020 | NDC:16571-678 | NDC:0185-0128 | CAS RN:28395-03-1 | NDC:0615-8394 | NDC:65219-572 | NDC:72572-040 | NDC:69238-1490 | NDC:70860-406 | NDC:0641-6008 | NDC:0641-6285 | NDC:50090-5664 | NDC:42799-119 | NDC:60687-535 | NDC:60687-384 | NDC:51672-4224 | NDC:43353-292 | NDC:16571-679 | NDC:70860-405 | NDC:72162-2196 | NDC:72205-102 | NDC:50090-6308 | NDC:0615-8544 | NDC:0185-0130 | NDC:25021-321 | NDC:0185-0129 | NDC:23155-901 | NDC:55154-4345 | NDC:16571-677 | NDC:68083-497 | NDC:82804-119 | NDC:68382-527 | NDC:0615-8393 | NDC:72162-2195 | NDC:70771-1026 | NDC:68083-496 | NDC:50090-6345 | NDC:50090-7350 | Bumetanide | NDC:50268-131 | NDC:70771-1025 | NDC:0832-0541 | NDC:72205-101 | NDC:42799-121
+BMGC_DG05887,BMG_DG124172,"DrugBank ID:DB12230 | CAS RN:80755-51-7 | BUNAZOSIN | Bunazosin | PubChem SID:198955531 | 1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one | PubChem CID:2472 | UNII:9UUW4V7G2H"
+BMGC_DG05888,BMG_DG124198,PubChem CID:24721360 | CAS RN:103775-09-3 | EPI-ETHOXYCARBONYL QUINAPRIL | PubChem SID:198989386 | UNII:N8W8Q83EKY
+BMGC_DG05889,BMG_DG124217,PubChem CID:24723 | DEMETON-S | UNII:3UQ7N6O63K | Demeton-S | PubChem SID:198985413 | 1-diethoxyphosphorylsulfanyl-2-ethylsulfanylethane | CAS RN:126-75-0
+BMGC_DG05890,BMG_DG124222,4-Iodo-1H-indazole | CAS RN:885522-11-2 | 4-IODO-1H-INDAZOLE | UNII:888C626XEP | PubChem SID:478838317 | PubChem CID:24728219
+BMGC_DG05891,BMG_DG124226,"PubChem SID:198940879 | PubChem CID:24728635 | CAS RN:207740-26-9 | 2C-T-7 | 2-(2,5-dimethoxy-4-propylsulfanylphenyl)ethanamine | UNII:TJG366J9BA | DrugBank ID:DB01458 | 2,5-Dimethoxy-4-(n)-propylthiophenethylamine"
+BMGC_DG05892,BMG_DG124229,"PubChem SID:316916253 | 2C-E | CAS RN:71539-34-9 | PubChem CID:24729233 | 2-(4-ethyl-2,5-dimethoxyphenyl)ethanamine | 2,5-Dimethoxy-4-ethylphenethylamine | UNII:I190284UXX"
+BMGC_DG05893,BMG_DG124236,"2-Hydroxyestradiol | PubChem SID:198988226 | PubChem CID:247304 | (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-2,3,17-triol | 2-HYDROXYESTRADIOL | UNII:AYU2L67YUU | CAS RN:362-05-0 | DrugBank ID:DB07706"
+BMGC_DG05894,BMG_DG124241,"PubChem SID:198942130 | N-[[2,6-difluoro-4-[3-(1H-1,2,4-triazol-5-yl)phenyl]phenyl]methyl]-2,3-dihydro-1H-inden-2-amine | UNII:W0UTB622GK | Gsk-1521498 | DrugBank ID:DB12886 | PubChem CID:24737629 | CAS RN:1007573-18-3 | GSK-1521498"
+BMGC_DG05895,BMG_DG124242,"UNII:6TNS415Y3P | CAS RN:1005342-46-0 | DrugBank ID:DB12085 | PubChem SID:249492656 | LCL-161 | (2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide | Lcl161 | PubChem CID:24737642"
+BMGC_DG05896,BMG_DG124243,"PubChem CID:24737742 | Inarigivir Soproxil | [[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl]oxyphosphoryl]sulfanylmethyl propan-2-yl carbonate | INARIGIVIR SOPROXIL | CAS RN:942123-43-5 | UNII:365052M0DK | DrugBank ID:DB15063 | PubChem SID:329589041"
+BMGC_DG05897,BMG_DG124246,[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]quinazolin-6-yl]furan-2-yl]methanol | PubChem CID:24738004 | CAS RN:320337-48-2 | Des(sulfonylethyl)amino Hydroxy Lapatinib
+BMGC_DG05898,BMG_DG124252,"NDC:47426-304 | NDC:47426-303 | Bupivacaine | BUPIVACAINE | 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide | NDC:47426-302 | DrugBank ID:DB00297 | CAS RN:38396-39-3 | PubChem CID:2474 | CAS RN:119427-31-5 | PubChem SID:175272188 | UNII:Y8335394RO | NDC:47426-504 | NDC:47426-501 | NDC:65250-266 | NDC:65250-133 | NDC:47426-502 | NDC:57884-3251 | NDC:47426-503 | CAS RN:2180-92-9 | NDC:57884-3252 | NDC:47426-301"
+BMGC_DG05899,BMG_DG124260,PubChem CID:24742039 | UNII:KP5TW22ME7 | CAS RN:955376-42-8 | PubChem SID:472424218 | MES-IMPY
+BMGC_DG05900,BMG_DG124264,"PubChem SID:346538927 | 2-[4-[4-[(3aR,6aR)-5-methyl-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrol-1-yl]phenyl]phenyl]pyridazin-3-one | CAS RN:948845-91-8 | UNII:5MEI1M3NHH | ABT-288 | DrugBank ID:DB15192 | PubChem CID:24743471 | Abt-288"
+BMGC_DG05901,BMG_DG124265,9-Propylpurin-6-amine | PubChem SID:482554019 | PubChem CID:247436 | CAS RN:707-98-2 | UNII:YEL2Q32QJ3 | 9-PROPYLPURIN-6-AMINE
+BMGC_DG05902,BMG_DG124266,"UNII:91WL7OD122 | PubChem SID:461434381 | N-[4-(6-fluoro-3,4-dihydro-1H-isoquinolin-2-yl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide | Encukalner | AZETUKALNER | CAS RN:1009344-33-5 | PubChem CID:24743936 | Azetukalner"
+BMGC_DG05903,BMG_DG124270,"PubChem SID:346540395 | UNII:832663U2NB | DrugBank ID:DB15024 | Apararenone | CAS RN:945966-46-1 | N-[4-(4-fluorophenyl)-2,2-dimethyl-3-oxo-1,4-benzoxazin-7-yl]methanesulfonamide | PubChem CID:24744336 | APARARENONE"
+BMGC_DG05904,BMG_DG124274,"4-N-(cyclopropylmethyl)-6-[(3R)-3-(methylamino)pyrrolidin-1-yl]pyrimidine-2,4-diamine | ADRIFORANT | Adriforant | PubChem CID:24745335 | CAS RN:943057-12-3 | DrugBank ID:DB15027 | UNII:D65H9YE9VU | PubChem SID:333495525"
+BMGC_DG05905,BMG_DG124285,DrugBank ID:DB07346 | PubChem CID:24748050 | 4-(2-aminoethyl)-2-ethylphenol
+BMGC_DG05906,BMG_DG124286,4-(2-aminoethyl)-2-cyclohexylphenol | DrugBank ID:DB07345 | PubChem CID:24748051
+BMGC_DG05907,BMG_DG124287,"DrugBank ID:DB12556 | PubChem SID:198943204 | CAS RN:1010085-13-8 | PubChem CID:24748204 | 4-(3-chloro-2-fluorophenoxy)-1-[[6-(1,3-thiazol-2-ylamino)pyridin-2-yl]methyl]cyclohexane-1-carboxylic acid | UNII:H8J407531S | MK-5108"
+BMGC_DG05908,BMG_DG124289,"PubChem SID:198951496 | UNII:C6RWP0N0L2 | 5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid | PubChem CID:24748573 | DrugBank ID:DB15408 | CAS RN:1009820-21-6 | SILMITASERTIB | Silmitasertib"
+BMGC_DG05909,BMG_DG124290,"CAS RN:25191-16-6 | 2,3,4,5,6-pentahydroxyhexanal | CAS RN:15572-79-9 | CAS RN:101615-89-8 | CAS RN:8027-56-3 | CAS RN:93780-23-5 | PubChem CID:24749 | CAS RN:3458-28-4 | CAS RN:110187-42-3 | CAS RN:138079-87-5 | CAS RN:2595-97-3 | CAS RN:314062-47-0 | CAS RN:4205-23-6 | CAS RN:67759-25-5 | L-Galactose | CAS RN:31103-86-3 | CAS RN:5934-56-5"
+BMGC_DG05910,BMG_DG124292,PubChem CID:24749268 | (Z)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]octadec-9-enamide | CAS RN:1002100-44-8 | (9Z)-N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]octadec-9-enamide
+BMGC_DG05911,BMG_DG124293,Setogepram | 2-(3-pentylphenyl)acetic acid | UNII:879OVM0Y1S | DrugBank ID:DB15447 | CAS RN:1002101-19-0 | PubChem SID:317229406 | FEZAGEPRAS | PubChem CID:24749700
+BMGC_DG05912,BMG_DG124294,CAS RN:14556-46-8 | Bupranolol | DrugBank ID:DB08808 | CAS RN:23284-25-5 | UNII:858YGI5PIT | PubChem SID:198989041 | BUPRANOLOL | PubChem CID:2475 | 1-(tert-butylamino)-3-(2-chloro-5-methylphenoxy)propan-2-ol
+BMGC_DG05913,BMG_DG124303,"(5S)-5-[[4-(5-chloropyridin-2-yl)oxypiperidin-1-yl]sulfonylmethyl]-5-methylimidazolidine-2,4-dione | DrugBank ID:DB11961 | Azd-1236 | AZD-1236 | CAS RN:1374026-24-0 | CAS RN:459814-90-5 | UNII:B4OQY51WZS | CAS RN:459814-89-2 | PubChem SID:313184304 | PubChem CID:24751752"
+BMGC_DG05914,BMG_DG124306,"DrugBank ID:DB07629 | N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE | PubChem CID:24752832"
+BMGC_DG05915,BMG_DG124307,"PubChem CID:24752833 | N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE | DrugBank ID:DB07630"
+BMGC_DG05916,BMG_DG124308,"PubChem CID:24752837 | DrugBank ID:DB08320 | DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE"
+BMGC_DG05917,BMG_DG124309,"PubChem CID:24752838 | DrugBank ID:DB07243 | (3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE"
+BMGC_DG05918,BMG_DG124310,"DrugBank ID:DB07015 | (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine | PubChem CID:24752844"
+BMGC_DG05919,BMG_DG124313,PCI-34051 | CAS RN:950762-95-5 | PubChem CID:24753719 | UNII:PUI52VXV61 | PubChem SID:198960057
+BMGC_DG05920,BMG_DG124316,PubChem CID:24754814 | {(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate | DrugBank ID:DB08152
+BMGC_DG05921,BMG_DG124319,"PubChem CID:24755476 | 6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine | DrugBank ID:DB08352"
+BMGC_DG05922,BMG_DG124334,CAS RN:874958-61-9 | GSK-894490A FREE BASE | PubChem CID:24755624 | PubChem SID:198978892 | UNII:0MI70K310Z
+BMGC_DG05923,BMG_DG124336,6-[6-(hydroxymethyl)pyrimidin-4-yl]oxy-N-[3-(trifluoromethyl)phenyl]naphthalene-1-carboxamide | PubChem SID:313183659 | UNII:T1IV236CVP | CAS RN:890128-81-1 | Bfh-772 | BFH-772 | PubChem CID:24756034
+BMGC_DG05924,BMG_DG124338,"DrugBank ID:DB08338 | PubChem CID:24756824 | 19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one"
+BMGC_DG05925,BMG_DG124339,CUDC-101 | Cudc-101 | UNII:1A7Y9MP123 | DrugBank ID:DB12174 | 7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide | PubChem SID:198955528 | PubChem CID:24756910 | CAS RN:1313875-12-5 | CAS RN:1012054-59-9
+BMGC_DG05926,BMG_DG124348,"PubChem CID:24759 | (2S,3S,4S,5R,6R)-6-[(2S,3R,5S,6R)-3-acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | DrugBank ID:DB08818 | CAS RN:125935-84-4 | (2S,3S,4R,5R,6R)-3-{[(2S,3R,5S,6R)-4-{[(2R,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-{[(2R,3R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4,5-dihydroxyoxane-2-carboxylic acid | Hyaluronic acid"
+BMGC_DG05927,BMG_DG124361,"PubChem CID:24762195 | 1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine | DrugBank ID:DB08148"
+BMGC_DG05928,BMG_DG124365,DrugBank ID:DB00638 | Inulin | PubChem CID:24763
+BMGC_DG05929,BMG_DG124368,UNII:TB180WQ919 | CAS RN:887289-02-3 | PubChem SID:198967604 | PubChem CID:24763642 | CBS-0550
+BMGC_DG05930,BMG_DG124373,"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE | PubChem CID:24764430 | DrugBank ID:DB08617"
+BMGC_DG05931,BMG_DG124375,3-phenyl-5-(1H-pyrazol-3-yl)isoxazole | DrugBank ID:DB07613 | PubChem CID:24764436
+BMGC_DG05932,BMG_DG124376,"4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline | PubChem CID:24764440 | DrugBank ID:DB08579"
+BMGC_DG05933,BMG_DG124378,"PubChem CID:24764442 | 4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid | DrugBank ID:DB08581"
+BMGC_DG05934,BMG_DG124379,"DrugBank ID:DB08582 | PubChem CID:24764443 | N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide"
+BMGC_DG05935,BMG_DG124380,UNII:4535RW5Y3A | CAS RN:913376-83-7 | AMG-458 | PubChem SID:198966042 | PubChem CID:24764449
+BMGC_DG05936,BMG_DG124382,"PubChem SID:333495892 | PubChem CID:24764487 | Gefapixant | GEFAPIXANT | DrugBank ID:DB15097 | CAS RN:1015787-98-0 | UNII:6K6L7E3F1L | 5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide"
+BMGC_DG05937,BMG_DG124383,PubChem SID:198946677 | UNII:WN8TEM4Q1F | DWK-1339 | CAS RN:1018946-38-7 | PubChem CID:24764491
+BMGC_DG05938,BMG_DG124385,CAS RN:1073667-64-7 | PubChem CID:24765037 | UNII:3750D0U8B5 | 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[[5-fluoro-2-[1-(2-hydroxyethyl)indazol-5-yl]oxyphenyl]methyl]urea | CAS RN:945614-12-0 | PEXMETINIB | Pexmetinib | PubChem SID:198949457
+BMGC_DG05939,BMG_DG124386,"UNII:CV3X74AO1H | CAS RN:923590-37-8 | VANIPREVIR | Vaniprevir | DrugBank ID:DB11929 | PubChem SID:198949212 | PubChem CID:24765256 | (1R,21S,24S)-21-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-ethylcyclopropyl]-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.14,7.06,11]heptacosa-6(11),7,9-triene-24-carboxamide"
+BMGC_DG05940,BMG_DG124387,"SUVECALTAMIDE | UNII:MIA4WMP8QN | PubChem CID:24765479 | 2-(4-propan-2-ylphenyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide | Suvecaltamide | CAS RN:953778-58-0 | PubChem SID:346539005"
+BMGC_DG05941,BMG_DG124389,"PubChem SID:472418357 | CAS RN:39455-18-0 | CAS RN:25322-46-7 | (2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | CAS RN:9007-28-7 | UNII:7LWQ6472SP | PubChem CID:24766 | CHONDROITIN 6-SULFATE | Chondroitin 4-sulfate"
+BMGC_DG05942,BMG_DG124394,PubChem CID:247678 | CAS RN:6961-60-0 | 9-Cycloheptylpurin-6-amine | PubChem SID:485663578 | UNII:J6H9CCA5SA | 9-CYCLOHEPTYLPURIN-6-AMINE
+BMGC_DG05943,BMG_DG124395,"Tak-593 | UNII:H3I42X8XX7 | TAK-593 | DrugBank ID:DB13093 | CAS RN:1005780-62-0 | PubChem CID:24767976 | PubChem SID:198988423 | N-[5-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]oxy-2-methylphenyl]-2,5-dimethylpyrazole-3-carboxamide"
+BMGC_DG05944,BMG_DG124400,"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE | PubChem CID:24768527 | DrugBank ID:DB07019"
+BMGC_DG05945,BMG_DG124401,DrugBank ID:DB07013 | TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE | PubChem CID:24768528
+BMGC_DG05946,BMG_DG124404,PubChem CID:24768537 | (2R)-2-benzyl-3-nitropropanoic acid | DrugBank ID:DB06924
+BMGC_DG05947,BMG_DG124405,"PubChem CID:24768547 | DrugBank ID:DB06994 | (2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine"
+BMGC_DG05948,BMG_DG124406,(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid | DrugBank ID:DB06982 | PubChem CID:24768548
+BMGC_DG05949,BMG_DG124407,PubChem CID:24768549 | (2S)-2-(1H-indol-3-yl)hexanoic acid | DrugBank ID:DB06980
+BMGC_DG05950,BMG_DG124408,PubChem CID:24768551 | DrugBank ID:DB06981 | (2S)-2-(1H-indol-3-yl)pentanoic acid
+BMGC_DG05951,BMG_DG124409,DrugBank ID:DB07102 | (2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid | PubChem CID:24768560
+BMGC_DG05952,BMG_DG124417,"PubChem SID:496143997 | (2R,3S,5R)-2-(2,5-DIFLUOROPHENYL)-5-(4,6-DIHYDROPYRROLO(3,4-C)PYRAZOL-5(1H)-YL)TETRAHYDRO-2H-PYRAN-3-AMINE | PubChem CID:24769723 | UNII:JDY68RMF44 | (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-(4,6-dihydropyrrolo[3,4-c]pyrazol-5(1H)-yl)tetrahydro-2H-pyran-3-amine | CAS RN:951127-17-6"
+BMGC_DG05953,BMG_DG124419,"UNII:TK65WKS8HL | BUSPIRONE | PubChem CID:2477 | PubChem SID:175268357 | CAS RN:116753-41-4 | CAS RN:36505-84-7 | 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione | Buspirone | DrugBank ID:DB00490"
+BMGC_DG05954,BMG_DG124422,"DrugBank ID:DB05053 | PubChem CID:24770445 | Mb-07803 | UNII:GG81XF45C2 | ethyl 2-[[[5-[2-amino-5-(2,2-dimethylpropanoyl)-1,3-thiazol-4-yl]furan-2-yl]-[(1-ethoxy-2-methyl-1-oxopropan-2-yl)amino]phosphoryl]amino]-2-methylpropanoate | MB-07803 | CAS RN:882757-24-6 | PubChem SID:198948650"
+BMGC_DG05955,BMG_DG124423,"Devimistat | PubChem SID:198937294 | DEVIMISTAT | PubChem CID:24770514 | 6,8-Bis(benzylthio)octanoic acid | UNII:E76113IR49 | CAS RN:95809-78-2 | DrugBank ID:DB12109 | 6,8-bis(benzylsulfanyl)octanoic acid"
+BMGC_DG05956,BMG_DG124426,"PubChem CID:24771368 | UNII:41WC0AZ27V | PubChem SID:198946490 | DrugBank ID:DB12929 | Jnj-39220675 | (4-cyclobutyl-1,4-diazepan-1-yl)-[6-(4-fluorophenoxy)pyridin-3-yl]methanone | JNJ-39220675 | CAS RN:959740-39-7"
+BMGC_DG05957,BMG_DG124429,"PubChem CID:24771758 | 5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide | DrugBank ID:DB08729"
+BMGC_DG05958,BMG_DG124440,PF-04457845 | PubChem SID:198971245 | REDAFAMDASTAT | N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide | CAS RN:1020315-31-4 | UNII:H4C81M8YYW | DrugBank ID:DB12012 | PubChem CID:24771824 | Redafamdastat
+BMGC_DG05959,BMG_DG124441,"ALISERTIB | 4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid | PubChem SID:198972240 | UNII:T66ES73M18 | CAS RN:1028486-01-2 | Alisertib | PubChem CID:24771867 | DrugBank ID:DB05220"
+BMGC_DG05960,BMG_DG124443,"(2S)-2-[[(4S)-4-[[(4S)-4-[[(4S)-4-[[(2S)-4-[[12-[[(3S,3aR,4S,6S,6aR,7S,8S,9bS)-6-acetyloxy-3,3a-dihydroxy-3,6,9-trimethyl-8-[(Z)-2-methylbut-2-enoyl]oxy-7-octanoyloxy-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-4-yl]oxy]-12-oxododecyl]amino]-2-amino-4-oxobutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]amino]pentanedioic acid | Mipsagargin | CAS RN:1245732-48-2 | MIPSAGARGIN | PubChem SID:198940477 | PubChem CID:24772106 | UNII:Q032I35QMX | DrugBank ID:DB11813"
+BMGC_DG05961,BMG_DG124445,"PubChem SID:438788299 | PubChem CID:24772484 | AZD-7268 | Azd-7268 | UNII:958Y70F3HQ | CAS RN:1018988-00-5 | N-(2-hydroxyethyl)-N-methyl-4-[quinolin-8-yl-[1-(1,3-thiazol-4-ylmethyl)piperidin-4-ylidene]methyl]benzamide"
+BMGC_DG05962,BMG_DG124446,CAS RN:908112-43-6 | PubChem SID:198941412 | SNX-2112 | PubChem CID:24772860 | UNII:10C9P3FFOW
+BMGC_DG05963,BMG_DG124452,"CAS RN:571-31-3 | EPIETIOCHOLANOLONE | (3S,5R,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one | PubChem SID:287446359 | UNII:C1751JYC6P | Epietiocholanolone | PubChem CID:247732"
+BMGC_DG05964,BMG_DG124460,"PubChem SID:198968789 | SONIDEGIB | PubChem CID:24775005 | UNII:0RLU3VTK5M | DrugBank ID:DB09143 | CAS RN:956697-53-3 | Sonidegib | N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide"
+BMGC_DG05965,BMG_DG124467,CAS RN:903895-98-7 | PubChem CID:24776341 | PubChem SID:198966739 | UNII:T77D5438IM | 3-(4-CHLOROPHENYL)-1-(1-METHYL-3-OXO-2-PHENYL-5-PROPAN-2-YLPYRAZOL-4-YL)UREA
+BMGC_DG05966,BMG_DG124469,VISMODEGIB | NDC:50242-140 | Vismodegib | UNII:25X868M3DS | CAS RN:879085-55-9 | PubChem CID:24776445 | DrugBank ID:DB08828 | 2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide | PubChem SID:175265446
+BMGC_DG05967,BMG_DG124476,"DrugBank ID:DB07644 | PubChem CID:24778299 | 5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine"
+BMGC_DG05968,BMG_DG124478,"PubChem CID:24778473 | DrugBank ID:DB07226 | N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE"
+BMGC_DG05969,BMG_DG124680,"PubChem CID:24779674 | N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE | DrugBank ID:DB08340"
+BMGC_DG05970,BMG_DG124681,"PubChem CID:24779675 | DrugBank ID:DB08353 | 2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE"
+BMGC_DG05971,BMG_DG124682,"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE | PubChem CID:24779676 | DrugBank ID:DB08354"
+BMGC_DG05972,BMG_DG124683,"DrugBank ID:DB08360 | PubChem CID:24779677 | 2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE"
+BMGC_DG05973,BMG_DG124684,"DrugBank ID:DB08345 | 4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE | PubChem CID:24779678"
+BMGC_DG05974,BMG_DG124694,NDC:71288-116 | PubChem SID:175267422 | 4-methylsulfonyloxybutyl methanesulfonate | NDC:72485-210 | NDC:55150-395 | NDC:0409-1112 | NDC:59148-070 | NDC:71288-158 | BUSULFAN | Busulfan | DrugBank ID:DB01008 | UNII:G1LN9045DK | NDC:80725-620 | NDC:51817-170 | NDC:16729-351 | PubChem CID:2478 | NDC:67457-893 | CAS RN:55-98-1 | NDC:70121-1244 | NDC:25021-241
+BMGC_DG05975,BMG_DG124698,CAS RN:954126-98-8 | PubChem CID:24780598 | UNII:R318PGH5VP | Danirixin | PubChem SID:198949449 | DrugBank ID:DB11922 | DANIRIXIN | 1-[4-chloro-2-hydroxy-3-[(3S)-piperidin-3-yl]sulfonylphenyl]-3-(3-fluoro-2-methylphenyl)urea
+BMGC_DG05976,BMG_DG124701,"CAS RN:54707-85-6 | PubChem SID:445498644 | PubChem CID:24782016 | 2-((2,6-DIMETHYLPHENYL)METHYL)-4,5-DIHYDRO-1H-IMIDAZOLE | UNII:NWK24469LD"
+BMGC_DG05977,BMG_DG124707,"MEDRYSONE | UNII:D2UFC189XF | DrugBank ID:DB00253 | Medrysone | PubChem SID:175266363 | CAS RN:2668-66-8 | PubChem CID:247839 | (6S,8S,9S,10R,11S,13S,14S,17S)-17-acetyl-11-hydroxy-6,10,13-trimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG05978,BMG_DG124710,"UNII:W9E3353E8J | BMS-754807 | PubChem SID:198943016 | Bms-754807 | CAS RN:100135-09-9 | (2S)-1-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrrolo[2,1-f][1,2,4]triazin-2-yl]-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide | CAS RN:1001350-96-4 | PubChem CID:24785538 | DrugBank ID:DB15399"
+BMGC_DG05979,BMG_DG124722,"Ipatasertib | PubChem SID:198969746 | UNII:524Y3IB4HQ | IPATASERTIB | DrugBank ID:DB11743 | CAS RN:1001264-89-6 | PubChem CID:24788740 | (2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one"
+BMGC_DG05980,BMG_DG124724,"PubChem CID:2479 | UNII:P0078O25A9 | 5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione | CAS RN:125-40-6 | BUTABARBITAL | PubChem SID:175271696 | Butabarbital | DrugBank ID:DB00237"
+BMGC_DG05981,BMG_DG124731,PubChem CID:247942 | 7.ALPHA.-METHYLTESTOSTERONE | PubChem SID:198968292 | CAS RN:7642-58-2 | UNII:K76V9O14LF
+BMGC_DG05982,BMG_DG124735,"PubChem CID:24794392 | N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine | DrugBank ID:DB07683"
+BMGC_DG05983,BMG_DG124736,PubChem CID:24794406 | DrugBank ID:DB07800 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
+BMGC_DG05984,BMG_DG124737,PubChem SID:198952609 | UNII:A3MMS6HDO1 | DrugBank ID:DB12064 | BMS-777607 | PubChem CID:24794418 | CAS RN:1196681-44-3 | CAS RN:1025720-94-8 | Bms-777607 | N-[4-(2-amino-3-chloropyridin-4-yl)oxy-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide
+BMGC_DG05985,BMG_DG124738,4-amino-1-[(2R)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid | PubChem SID:252163810 | Difelikefalin | DIFELIKEFALIN | CAS RN:1024828-77-0 | PubChem CID:24794466 | UNII:NA1U919MRO | DrugBank ID:DB11938
+BMGC_DG05986,BMG_DG124740,"Valbenazine | UNII:54K37P50KH | [(2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] (2S)-2-amino-3-methylbutanoate | PubChem SID:198945028 | PubChem CID:24795069 | CAS RN:1025504-45-3 | VALBENAZINE | DrugBank ID:DB11915"
+BMGC_DG05987,BMG_DG124741,"UNII:72AUA0603W | N-[(1-methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine | PubChem CID:24795070 | CAS RN:1025065-69-3 | DrugBank ID:DB12494 | PubChem SID:312525017 | Sgi-1776 | SGI-1776"
+BMGC_DG05988,BMG_DG124742,"PubChem CID:24795080 | AZD 1446;3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane | 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl-(5-chlorofuran-2-yl)methanone | CAS RN:1025007-04-8"
+BMGC_DG05989,BMG_DG124744,"MAPRACORAT | PubChem SID:198977760 | DrugBank ID:DB12041 | Mapracorat | CAS RN:887375-26-0 | (2R)-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydro-1-benzofuran-7-yl)-4-methyl-2-[[(2-methylquinolin-5-yl)amino]methyl]pentan-2-ol | UNII:145V79YBVP | PubChem CID:24795088"
+BMGC_DG05990,BMG_DG124746,PubChem SID:441331290 | PubChem CID:24795576 | UNII:5TVW7VFN92 | CAS RN:1010096-65-7 | LY-2183240 2'-ISOMER
+BMGC_DG05991,BMG_DG124752,"1-(3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl)ethanone | CAS RN:1887-95-2 | PubChem CID:247974 | CAS RN:387-79-1 | 3,17-Dihydroxypregn-5-en-20-one"
+BMGC_DG05992,BMG_DG124757,"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE | DrugBank ID:DB08018 | PubChem CID:24798097"
+BMGC_DG05993,BMG_DG124758,UNII:DZ4NDW1LZX | PubChem CID:24798598 | LEXANOPADOL | PubChem SID:198959372 | CAS RN:1357348-09-4
+BMGC_DG05994,BMG_DG124764,"PubChem CID:24798711 | CAS RN:138149-18-5 | trans-2,3-didehydroadipoyl-CoA | (E)-6-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-6-oxohex-4-enoic acid"
+BMGC_DG05995,BMG_DG124767,"PubChem CID:24798721 | (3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE | DrugBank ID:DB07851"
+BMGC_DG05996,BMG_DG124769,"PubChem CID:24798741 | N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | DrugBank ID:DB07584"
+BMGC_DG05997,BMG_DG124770,"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine | DrugBank ID:DB07585 | PubChem CID:24798742"
+BMGC_DG05998,BMG_DG124778,"DrugBank ID:DB04455 | CAS RN:6640-00-2 | CAS RN:6915-17-9 | PubChem CID:248 | N,N,N-trimethylglycinium | carboxymethyl(trimethyl)azanium"
+BMGC_DG05999,BMG_DG124779,3-(dibutylamino)propyl 4-aminobenzoate | BUTACAINE | DrugBank ID:DB11502 | CAS RN:149-16-6 | PubChem SID:198944166 | PubChem CID:2480 | UNII:Z84S23CGJJ | Butacaine
+BMGC_DG06000,BMG_DG124780,UNII:8NMK0UG3HV | PubChem SID:440089539 | MCOPPB | PubChem CID:24800108 | CAS RN:1028969-49-4
+BMGC_DG06001,BMG_DG124783,"[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid | DrugBank ID:DB11956 | UNII:6IF28942WO | CAS RN:847499-27-8 | PubChem SID:198990028 | DELANZOMIB | PubChem CID:24800541 | Delanzomib"
+BMGC_DG06002,BMG_DG124784,"DrugBank ID:DB07147 | methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate | PubChem CID:24800833"
+BMGC_DG06003,BMG_DG124785,CAS RN:954143-47-6 | UNII:228SG64R6R | PubChem SID:485663715 | Meriolin 2 | MERIOLIN 2 | PubChem CID:24801699
+BMGC_DG06004,BMG_DG124787,"PubChem CID:24801862 | N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine | DrugBank ID:DB08023"
+BMGC_DG06005,BMG_DG124788,"DrugBank ID:DB08026 | PubChem CID:24801863 | 2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide"
+BMGC_DG06006,BMG_DG124791,"PubChem CID:24801909 | (2R)-2-phenyl-2-[(2R,4R,5S)-3,4,5-trihydroxy-6-[[(2R,4R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | CAS RN:29883-15-6"
+BMGC_DG06007,BMG_DG124796,6-CHLOROFLAVONE | 6-Chloroflavone | PubChem CID:248021 | UNII:R27742K399 | CAS RN:10420-73-2 | PubChem SID:474492381
+BMGC_DG06008,BMG_DG124816,"Rel-1-(3,4-dichlorophenyl)-6-(methoxymethyl)-3-azabicyclo[4.1.0]heptane | PubChem CID:24802842 | (1R,6S)-6-(3,4-dichlorophenyl)-1-(methoxymethyl)-3-azabicyclo[4.1.0]heptane"
+BMGC_DG06009,BMG_DG124828,UNII:Z310X5O5RP | Chromic Chloride | PubChem SID:175265807 | trichlorochromium | PubChem CID:24808 | CAS RN:10025-73-7 | CHROMIC CHLORIDE ANHYDROUS
+BMGC_DG06010,BMG_DG124829,"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione | DrugBank ID:DB07156 | PubChem CID:24808489"
+BMGC_DG06011,BMG_DG124830,"PubChem CID:24808495 | DrugBank ID:DB06992 | (3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone"
+BMGC_DG06012,BMG_DG124831,"DrugBank ID:DB07263 | PubChem CID:24808499 | [{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid"
+BMGC_DG06013,BMG_DG124837,"UNII:KHS0AZ4JVK | PubChem CID:2481 | PubChem SID:175266092 | DrugBank ID:DB00241 | 5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | BUTALBITAL | Butalbital | CAS RN:77-26-9"
+BMGC_DG06014,BMG_DG124839,"PubChem SID:198970110 | ASP-5854 | PubChem CID:24810000 | 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-propan-2-ylpyridin-2-one | 2(1H)-Pyridinone, 5-(5-amino-3-(4-fluorophenyl)-2-pyrazinyl)-1-(1-methylethyl)- | CAS RN:851087-60-0 | UNII:BJS8Y4IC5V"
+BMGC_DG06015,BMG_DG124847,"PubChem CID:24812717 | 3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one | DrugBank ID:DB07514"
+BMGC_DG06016,BMG_DG124848,"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide | PubChem CID:24812718 | DrugBank ID:DB07537"
+BMGC_DG06017,BMG_DG124849,3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one | DrugBank ID:DB07528 | PubChem CID:24812719
+BMGC_DG06018,BMG_DG124850,(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine | PubChem CID:24812720 | DrugBank ID:DB07049
+BMGC_DG06019,BMG_DG124851,"DrugBank ID:DB08557 | 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide | PubChem CID:24812721"
+BMGC_DG06020,BMG_DG124853,"Canagliflozin | UNII:6S49DGR869 | PubChem CID:24812758 | CANAGLIFLOZIN ANHYDROUS | DrugBank ID:DB08907 | (2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | PubChem SID:175266021 | CAS RN:842133-18-0"
+BMGC_DG06021,BMG_DG124854,"PubChem SID:198961311 | CAS RN:794495-43-5 | PubChem CID:24812808 | UNII:UU226QGU97 | CAS RN:775351-65-0 | Imeglimin | IMEGLIMIN | DrugBank ID:DB12509 | (4R)-6-N,6-N,4-trimethyl-1,4-dihydro-1,3,5-triazine-2,6-diamine"
+BMGC_DG06022,BMG_DG124860,CAS RN:946846-83-9 | PubChem CID:24815904 | UNII:S3UN2146K9 | PubChem SID:198974940 | DrugBank ID:DB12288 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-4-oxopyran-2-carboxamide | Piromelatine | PIROMELATINE
+BMGC_DG06023,BMG_DG124868,butyl 4-aminobenzoate | Butyl 4-aminobenzoate | PubChem SID:175266832 | PubChem CID:2482 | DrugBank ID:DB11148 | UNII:EFW857872Q | Butamben | CAS RN:94-25-7 | BUTAMBEN
+BMGC_DG06024,BMG_DG124870,DrugBank ID:DB08007 | (2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID | PubChem CID:24820112
+BMGC_DG06025,BMG_DG124890,"PubChem CID:24821023 | IBRUTINIB, (S)- | CAS RN:936563-97-2 | UNII:Y6K7EN3Q6V | PubChem SID:461432446"
+BMGC_DG06026,BMG_DG124891,"PubChem SID:175267389 | UNII:1X70OSD4VX | CAS RN:936563-96-1 | PubChem CID:24821094 | 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one | NDC:57962-280 | Ibrutinib | NDC:57962-560 | DrugBank ID:DB09053 | NDC:57962-070 | NDC:57962-140 | NDC:57962-420 | NDC:57962-007 | IBRUTINIB | NDC:57962-014"
+BMGC_DG06027,BMG_DG124892,"1-[4-[4-Amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one | CAS RN:936563-92-7 | PubChem SID:485664588 | PubChem CID:24821880 | UNII:6F2N4XGL8K | 1-(4-(4-AMINO-3-(4-PHENOXYPHENYL)PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)PIPERIDIN-1-YL)PROP-2-EN-1-ONE"
+BMGC_DG06028,BMG_DG124896,PubChem SID:175266764 | FLORBETAPIR F-18 | DrugBank ID:DB09149 | 4-[(E)-2-[6-[2-[2-(2-(18F)fluoranylethoxy)ethoxy]ethoxy]pyridin-3-yl]ethenyl]-N-methylaniline | Florbetapir F-18 | UNII:6W15Z5R0RU | CAS RN:956103-76-7 | NDC:0002-1200 | PubChem CID:24822371
+BMGC_DG06029,BMG_DG124909,PubChem SID:198958392 | UNII:BL7XSD8R7B | PubChem CID:24825710 | BMS-066 | CAS RN:914946-88-6
+BMGC_DG06030,BMG_DG124910,"CAS RN:1034148-04-3 | PubChem SID:198971107 | AZD-5423 | 2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorophenyl)indazol-5-yl]oxy-1-(3-methoxyphenyl)propan-2-yl]acetamide | DrugBank ID:DB12280 | UNII:641H0Q518W | PubChem CID:24825740"
+BMGC_DG06031,BMG_DG124913,"N,N-DIMETHYL-3-(1,3,5-TRIMETHYL-1H-PYRAZOL-4-YL)BENZENEETHANAMINE | CAS RN:1034142-33-0 | N,N-Dimethyl-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)benzeneethanamine | UNII:4KQ7F7PL4L | PubChem CID:24825775 | PubChem SID:482554187"
+BMGC_DG06032,BMG_DG124917,"Ponatinib | CAS RN:943319-70-8 | PubChem CID:24826799 | UNII:4340891KFS | DrugBank ID:DB08901 | 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide | PONATINIB | PubChem SID:175266091"
+BMGC_DG06033,BMG_DG124918,"Benzamide, 3-(2-imidazo(1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-(4-(1-piperazinylmethyl)-3-(trifluoromethyl)phenyl)- | PubChem SID:252164338 | PubChem CID:24826880 | CAS RN:943319-87-7 | UNII:5EMP4AZ4U5 | AP-24567 | 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-(piperazin-1-ylmethyl)-3-(trifluoromethyl)phenyl]benzamide"
+BMGC_DG06034,BMG_DG124931,PubChem SID:472409190 | UNII:9TKD7LKT48 | CAS RN:6928-56-9 | PubChem CID:248316 | 3-AMINO-2-PHENYLCHROMEN-4-ONE
+BMGC_DG06035,BMG_DG124932,"Sotagliflozin | PubChem CID:24831714 | NDC:70183-241 | (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol | SOTAGLIFLOZIN | NDC:70183-221 | PubChem SID:198963852 | CAS RN:1018899-04-1 | UNII:6B4ZBS263Y | DrugBank ID:DB12713 | NDC:70183-220"
+BMGC_DG06036,BMG_DG124935,"PubChem CID:24832019 | 2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM | DrugBank ID:DB08615"
+BMGC_DG06037,BMG_DG124936,"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE | DrugBank ID:DB07324 | PubChem CID:24832022"
+BMGC_DG06038,BMG_DG124937,"PubChem CID:24832027 | OCTANE-1,3,5,7-TETRACARBOXYLIC ACID | DrugBank ID:DB08368"
+BMGC_DG06039,BMG_DG124938,"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide | PubChem CID:24832041 | DrugBank ID:DB07181"
+BMGC_DG06040,BMG_DG124949,"UNII:X8YN71D5WC | PubChem CID:24832676 | [(1S,2R,3R,4R,5R,6S,7S,8R,9R,10R,13R,14R,16S,17S,18R)-8-acetyloxy-11-ethyl-5,7,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] benzoate | PubChem SID:198954556 | CAS RN:302-27-2 | Aconitin | ACONITINE"
+BMGC_DG06041,BMG_DG124959,PubChem SID:482554043 | Zedoarondiol | UNII:2758Q22LPQ | ZEDOARONDIOL | CAS RN:98644-24-7 | PubChem CID:24834047
+BMGC_DG06042,BMG_DG124980,PHLOROGLUCIDE | UNII:U4GNW4D2BR | CAS RN:491-45-2 | PubChem SID:375579602 | PubChem CID:248349
+BMGC_DG06043,BMG_DG124995,"(3-phenyl-6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)-[5-(2,2,2-trifluoro-1,1-dihydroxyethyl)thiophen-2-yl]methanone | 2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL | 2,2,2-Trifluoro-1-{5-[(3-Phenyl-5,6-Dihydroimidazo[1,2-A]pyrazin-7(8h)-Yl)carbonyl]thiophen-2-Yl}ethane-1,1-Diol | DrugBank ID:DB08613 | PubChem CID:24836810"
+BMGC_DG06044,BMG_DG124996,"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide | DrugBank ID:DB07879 | PubChem CID:24836811"
+BMGC_DG06045,BMG_DG124997,"PubChem CID:24836812 | N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE | DrugBank ID:DB07251"
+BMGC_DG06046,BMG_DG124998,"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE | DrugBank ID:DB07250 | PubChem CID:24836813"
+BMGC_DG06047,BMG_DG124999,"(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM | PubChem CID:24836815 | DrugBank ID:DB07221"
+BMGC_DG06048,BMG_DG125000,"DrugBank ID:DB07601 | PubChem CID:24836816 | 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol"
+BMGC_DG06049,BMG_DG125001,DrugBank ID:DB15026 | CAS RN:88127-53-1 | CAS RN:875685-46-4 | CXA-10 | 10-Nitrooleic acid | PubChem CID:24836820 | (E)-10-nitrooctadec-9-enoic acid | UNII:1N19AGY57Y | PubChem SID:381608426
+BMGC_DG06050,BMG_DG125018,"UNII:85113MO9BC | PubChem SID:313184419 | PubChem CID:24839550 | CAS RN:60676-77-9 | N,N-DIALLYLTRYPTAMINE"
+BMGC_DG06051,BMG_DG125021,N-[(2r)-Butan-2-Yl]-1-(2-Chlorophenyl)-N-Methylisoquinoline-3-Carboxamide | CAS RN:205934-46-9 | N-[(2R)-butan-2-yl]-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide | PubChem CID:24839733
+BMGC_DG06052,BMG_DG125024,PubChem SID:175268882 | 1-(4-tert-butylphenyl)-N-methyl-N-(naphthalen-1-ylmethyl)methanamine | CAS RN:101828-21-1 | BUTENAFINE | UNII:91Y494NL0X | Butenafine | PubChem CID:2484 | DrugBank ID:DB01091
+BMGC_DG06053,BMG_DG125034,"iodane | Hydriodic acid | CAS RN:10034-85-2 | IODINE, ATOMIC | PubChem SID:485665690 | UNII:694C0EFT9Q | PubChem SID:175266912 | UNII:5D3DB66WM3 | PubChem CID:24841 | CAS RN:14362-44-8 | HYDROGEN IODIDE | Iodine, atomic"
+BMGC_DG06054,BMG_DG125057,"5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol | CAS RN:9004-62-0 | Hydroxyethyl cellulose | PubChem CID:24846132"
+BMGC_DG06055,BMG_DG125065,"(1R,6S,8R)-6-tert-butyl-3-azapentacyclo[11.8.1.03,8.09,22.016,21]docosa-9,11,13(22),16,18,20-hexaen-6-ol | Butaclamolum | CAS RN:51152-91-1 | PubChem CID:24847750"
+BMGC_DG06056,BMG_DG125082,Gadodiamide | Omniscan | 2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+) | CAS RN:131410-48-5 | PubChem CID:24847884 | DrugBank ID:DB00225
+BMGC_DG06057,BMG_DG125104,"(3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate | CAS RN:147511-69-1 | PubChem CID:24848419 | (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate"
+BMGC_DG06058,BMG_DG125119,"PubChem CID:24849132 | (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate | Pravachol"
+BMGC_DG06059,BMG_DG125121,CRX-526 | PubChem SID:198952719 | PubChem CID:24849153 | CAS RN:245515-64-4 | UNII:8NLO017HHA
+BMGC_DG06060,BMG_DG125125,"(3R,4R)-3-N-(5-chloropyridin-2-yl)-1-(2,2-difluoroethyl)-4-N-[2-fluoro-4-(2-oxopyridin-1-yl)phenyl]pyrrolidine-3,4-dicarboxamide | UNII:H5XZ7LKC6C | PubChem SID:443625249 | CAS RN:865451-66-7 | PubChem CID:24849206 | R-1663"
+BMGC_DG06061,BMG_DG125127,dialuminum;trisulfate | PubChem SID:175266623 | Aluminum Sulfate | DrugBank ID:DB11239 | CAS RN:10043-01-3 | ALUMINUM SULFATE ANHYDROUS | PubChem CID:24850 | UNII:I7T908772F | Aluminum sulfate
+BMGC_DG06062,BMG_DG125132,Firibastat | UNII:638KY4573I | CAS RN:648927-86-0 | PubChem SID:310825835 | DrugBank ID:DB13107 | CAS RN:1601301-49-8 | QGC-001 | PubChem CID:24851355 | FIRIBASTAT | (3S)-3-amino-4-[[(2S)-2-amino-4-sulfobutyl]disulfanyl]butane-1-sulfonic acid
+BMGC_DG06063,BMG_DG125133,"PubChem CID:24851688 | (4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile | DrugBank ID:DB07242"
+BMGC_DG06064,BMG_DG125134,"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile | DrugBank ID:DB08166 | PubChem CID:24851689"
+BMGC_DG06065,BMG_DG125147,PubChem SID:175268693 | POTASSIUM ALUM ANHYDROUS | UNII:09OXB01F3O | PubChem CID:24856 | DrugBank ID:DB09087 | Aluminum potassium sulfate | Potassium alum | aluminum;potassium;disulfate | CAS RN:10043-67-1 | CAS RN:15007-61-1
+BMGC_DG06066,BMG_DG125148,N-[4-[3-(2-aminopyrimidin-4-yl)pyridin-2-yl]oxyphenyl]-4-(4-methylthiophen-2-yl)phthalazin-1-amine | CAS RN:945595-80-2 | Amg-900 | PubChem CID:24856041 | UNII:9R2G075611 | AMG-900 | PubChem SID:198981726
+BMGC_DG06067,BMG_DG125150,DrugBank ID:DB08484 | 4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE | PubChem CID:24856357
+BMGC_DG06068,BMG_DG125151,"DrugBank ID:DB07624 | 1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide | PubChem CID:24856362"
+BMGC_DG06069,BMG_DG125152,"N-CYCLOPROPYL-3-(4-(CYCLOPROPYLMETHYLCARBAMOYL)PHENYL)-4-METHYL-BENZAMIDE | N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide | PubChem CID:24856363 | PubChem SID:440793522 | CAS RN:515134-70-0 | UNII:ATH2GHG7LR | DrugBank ID:DB07835"
+BMGC_DG06070,BMG_DG125154,"PubChem SID:198966582 | PubChem CID:24856436 | Adavosertib | CAS RN:1075739-30-8 | 1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one | UNII:K2T6HJX3I3 | CAS RN:955365-80-7 | ADAVOSERTIB | DrugBank ID:DB11740"
+BMGC_DG06071,BMG_DG125156,"UNII:GLP1W4JXAH | DrugBank ID:DB12491 | FASIGLIFAM | PubChem CID:24857286 | 2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]acetic acid | CAS RN:1000413-72-8 | Fasiglifam | PubChem SID:198984389"
+BMGC_DG06072,BMG_DG125159,PubChem CID:24857887 | UNII:E8S33VNW75 | PubChem SID:441331772 | CAS RN:910376-39-5 | PF-03550096
+BMGC_DG06073,BMG_DG125160,2-[1-[6-[2-fluoroethyl(methyl)amino]naphthalen-2-yl]ethylidene]propanedinitrile | FDDNP | PubChem CID:24858429 | PubChem SID:198987394 | CAS RN:590365-47-2 | Fddnp | UNII:9U8TYP0V3P
+BMGC_DG06074,BMG_DG125173,"Tildipirosin | CAS RN:328898-40-4 | PubChem CID:24860548 | UNII:S795AT66JB | DrugBank ID:DB11470 | PubChem SID:175266999 | (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4S,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-5,9,13-trimethyl-7-(2-piperidin-1-ylethyl)-15-(piperidin-1-ylmethyl)-1-oxacyclohexadeca-11,13-diene-2,10-dione | TILDIPIROSIN"
+BMGC_DG06075,BMG_DG125174,CAS RN:1040718-40-8 | WAY-361789 | PubChem CID:24860582 | PubChem SID:198962188 | UNII:T264JJ4F2S
+BMGC_DG06076,BMG_DG125177,"PubChem CID:24861080 | DrugBank ID:DB07256 | 3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE"
+BMGC_DG06077,BMG_DG125185,4-ACETAMIDO-N-(4-FLUOROPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE | PubChem SID:441331692 | 4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide | UNII:U5RM7N7H82 | CAS RN:844440-86-4 | PubChem CID:24864077 | DrugBank ID:DB08136
+BMGC_DG06078,BMG_DG125186,PubChem CID:24864078 | (4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide | DrugBank ID:DB08137
+BMGC_DG06079,BMG_DG125187,"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide | PubChem CID:24864079 | DrugBank ID:DB08138"
+BMGC_DG06080,BMG_DG125188,"PubChem CID:24864082 | 4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide | DrugBank ID:DB08141"
+BMGC_DG06081,BMG_DG125193,"E-6005 | DrugBank ID:DB12776 | CAS RN:947620-48-6 | methyl 4-[[3-[6,7-dimethoxy-2-(methylamino)quinazolin-4-yl]phenyl]carbamoyl]benzoate | PubChem SID:198936509 | PubChem CID:24864553 | Methyl 4-((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl)carbamoyl)benzoate | LOTAMILAST | UNII:TO043KKB9C"
+BMGC_DG06082,BMG_DG125195,"7-Methoxy-4-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline | DrugBank ID:DB08079 | PubChem SID:198982198 | 7-methoxy-4-[(6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline | UNII:Y2SR66P7VM | PubChem CID:24864821 | CAS RN:1002304-34-8 | AMG-208"
+BMGC_DG06083,BMG_DG125196,"UNII:LP62329LQ7 | 1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | DrugBank ID:DB08699 | PubChem SID:441097124 | CAS RN:956025-83-5 | PubChem CID:24865390 | 3MB-PP1"
+BMGC_DG06084,BMG_DG125197,"DrugBank ID:DB07866 | PubChem CID:24866443 | (5S)-2-(Cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one"
+BMGC_DG06085,BMG_DG125200,"PubChem CID:24867245 | CAS RN:136271-60-8 | DIHYDROHALOPERIDOL, (R)- | PubChem SID:381608534 | UNII:UDG360XW3S"
+BMGC_DG06086,BMG_DG125201,"ITRACONAZOLE, (S)-(-)- | Itraconazole, (S)-(-)- | UNII:Q5QC3ER69K | CAS RN:154003-20-0 | PubChem CID:24867300 | 2-[(2S)-butan-2-yl]-4-[4-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one | PubChem SID:472426131"
+BMGC_DG06087,BMG_DG125215,"(4S)-5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]amino]propanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid | CID 24868176 | CAS RN:75976-10-2 | PubChem CID:24868176 | CAS RN:59763-91-6"
+BMGC_DG06088,BMG_DG125216,"PubChem CID:24868177 | (4S)-5-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S,3S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-[[2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-5-oxopentanoic acid | human Neuropeptide Y"
+BMGC_DG06089,BMG_DG125230,NDC:75124-0007 | Chlorine Dioxide | CAS RN:10049-04-4 | UNII:8061YMS4RM | NDC:75124-0001 | DrugBank ID:DB12453 | CHLORINE DIOXIDE | PubChem CID:24870 | Chlorine dioxide | PubChem SID:175266777
+BMGC_DG06090,BMG_DG125248,PubChem CID:24871491 | [4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID | DrugBank ID:DB08513
+BMGC_DG06091,BMG_DG125249,Apabetalone | PubChem CID:24871506 | DrugBank ID:DB12000
+BMGC_DG06092,BMG_DG125250,PubChem CID:24871823 | UNII:UN4C7N5KVB | PubChem SID:485664784 | PF-04254644 | CAS RN:959584-91-9
+BMGC_DG06093,BMG_DG125256,"Apalutamide | NDC:59676-604 | PubChem CID:24872560 | PubChem SID:198977777 | UNII:4T36H88UA7 | DrugBank ID:DB11901 | CAS RN:956104-40-8 | NDC:59676-600 | 4-[7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide | APALUTAMIDE"
+BMGC_DG06094,BMG_DG125262,"DrugBank ID:DB06290 | (1R,4R,6S,7Z,15R,17R)-N-cyclopropylsulfonyl-17-[7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)quinolin-4-yl]oxy-13-methyl-2,14-dioxo-3,13-diazatricyclo[13.3.0.04,6]octadec-7-ene-4-carboxamide | PubChem SID:387065186 | SIMEPREVIR | PubChem CID:24873435 | CAS RN:1217263-04-1 | CAS RN:923604-59-5 | UNII:9WS5RD66HZ | Simeprevir"
+BMGC_DG06095,BMG_DG125274,"Antroquinonol | PubChem SID:310825600 | CAS RN:1010081-09-0 | PubChem CID:24875259 | (4R,5R,6R)-4-hydroxy-2,3-dimethoxy-6-methyl-5-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]cyclohex-2-en-1-one | UNII:AX9P92T7JZ | ANTROQUINONOL | DrugBank ID:DB12326"
+BMGC_DG06096,BMG_DG125276,"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid | DrugBank ID:DB07111 | PubChem CID:24875301"
+BMGC_DG06097,BMG_DG125277,"PubChem CID:24875302 | (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid | DrugBank ID:DB07172"
+BMGC_DG06098,BMG_DG125279,"DrugBank ID:DB07789 | 1-[5-Methyl-2-(trifluoromethyl)furan-3-yl]-3-[5-[2-[[6-(1H-1,2,4-triazol-5-ylamino)pyrimidin-4-yl]amino]ethyl]-1,3-thiazol-2-yl]urea | UNII:CL76HU6PN3 | N-(5-METHYL-2-(TRIFLUOROMETHYL)-3-FURANYL)-N'-(5-(2-((6-(1H-1,2,4-TRIAZOL-5-YLAMINO)-4-PYRIMIDINYL)AUREA | CAS RN:1126803-62-0 | PubChem CID:24875313 | PubChem SID:443623588"
+BMGC_DG06099,BMG_DG125282,PubChem CID:24875320 | 5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide | DrugBank ID:DB07970
+BMGC_DG06100,BMG_DG125286,CAS RN:10058-44-3 | PubChem CID:24877 | UNII:QK8899250F | DrugBank ID:DB09147 | CAS RN:10402-25-2 | PubChem SID:198967256 | CAS RN:312619-28-6 | Ferric pyrophosphate | NDC:82969-1004 | FERRIC PYROPHOSPHATE | iron(3+);phosphonato phosphate
+BMGC_DG06101,BMG_DG125288,UNII:2FJ6Y9S5AK | CAS RN:908027-55-4 | PubChem CID:24877503 | PubChem SID:445500424 | MI-219 FREE BASE
+BMGC_DG06102,BMG_DG125294,"PubChem CID:24880018 | DrugBank ID:DB07766 | (2Z,3E)-2,3'-biindole-2',3(1H,1'H)-dione 3-{O-[(3R)-3,4-dihydroxybutyl]oxime}"
+BMGC_DG06103,BMG_DG125295,"PubChem CID:24880024 | DrugBank ID:DB07360 | 1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea"
+BMGC_DG06104,BMG_DG125302,"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine | PubChem CID:24882195 | DrugBank ID:DB08006"
+BMGC_DG06105,BMG_DG125303,CAS RN:913071-81-5 | UNII:9M9524T8GW | GRL-8234 | PubChem CID:24882306 | PubChem SID:445498707
+BMGC_DG06106,BMG_DG125308,UNII:67F8A5A4KD | 2-(4-CHLORO-2-PROP-2-ENYLPHENOXY)ACETIC ACID | PubChem CID:248828 | PubChem SID:485666691 | 2-(4-Chloro-2-prop-2-enylphenoxy)acetic acid | CAS RN:6964-26-7
+BMGC_DG06107,BMG_DG125312,"CAS RN:1034174-88-3 | UNII:ZY63TG2NHL | PubChem CID:24883191 | PubChem SID:440793474 | 2-PYRIDINECARBOXAMIDE, N-((1S,3S)-3-(4-AMINO-5-FLUORO-2-OXO-1(2H)-PYRIMIDINYL)CYCLOPENTYL)-4-BENZO(B)THIEN-2-YL-"
+BMGC_DG06108,BMG_DG125314,"PubChem CID:24883422 | ent-Kaurenol | [(1S,4S,5R,9S,10R,13S)-5,9-dimethyl-14-methylidene-5-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]methanol"
+BMGC_DG06109,BMG_DG125337,"PubChem CID:24883477 | DrugBank ID:DB07315 | 5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide"
+BMGC_DG06110,BMG_DG125339,"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate | PubChem CID:24883486 | DrugBank ID:DB08497"
+BMGC_DG06111,BMG_DG125340,"DrugBank ID:DB08499 | N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide | PubChem CID:24883488"
+BMGC_DG06112,BMG_DG125343,"PubChem CID:24883860 | CAS RN:1394-02-1 | (19E,21E,23E,25E,27E,29E,31E)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-17-[7-(4-aminophenyl)-5-hydroxy-7-oxoheptan-2-yl]-1,3,5,7,9,37-hexahydroxy-18-methyl-13,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid;(19Z,21E,23E,25E,27E,29E,31E)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-17-[7-(4-aminophenyl)-5-hydroxy-7-oxoheptan-2-yl]-1,3,5,9,11,37-hexahydroxy-18-methyl-13,15-dioxo-16,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid | Cabimicina"
+BMGC_DG06113,BMG_DG125367,RIVICICLIB | PubChem SID:198972203 | PubChem CID:24887371 | CAS RN:920113-02-6 | UNII:9EK26WE8QN
+BMGC_DG06114,BMG_DG125369,PubChem CID:24888322 | PubChem SID:440088840 | Bjb-432 | CAS RN:960058-94-0 | UNII:Y1FUG6Z8KL | (E)-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide | BJB-432
+BMGC_DG06115,BMG_DG125372,"PubChem CID:24889392 | PubChem SID:198974101 | Quizartinib | DrugBank ID:DB12874 | CAS RN:950769-58-1 | UNII:7LA4O6Q0D3 | 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea | QUIZARTINIB"
+BMGC_DG06116,BMG_DG125384,"CAS RN:13870-90-1 | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | Deoxyadenosylcobalamin | PubChem CID:24892716"
+BMGC_DG06117,BMG_DG125390,"NDC:68083-562 | NDC:70756-636 | NDC:0143-9619 | NDC:76420-075 | NDC:72603-650 | NDC:0517-0032 | NDC:25021-502 | NDC:76420-618 | NDC:67457-400 | NDC:69680-112 | Dicopac | NDC:69680-121 | NDC:51662-1440 | PubChem SID:346541296 | NDC:71288-302 | NDC:71288-303 | NDC:70771-1688 | NDC:68001-542 | cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide | CAS RN:68-19-9 | NDC:70069-172 | NDC:71288-300 | CYANOCOBALAMIN | NDC:55150-364 | NDC:49884-270 | NDC:0517-0130 | NDC:0404-9995 | UNII:P6YC3EG204 | NDC:51662-1394 | NDC:0404-9840 | NDC:63323-044 | NDC:70771-1690 | NDC:71288-301 | NDC:84341-002 | NDC:70710-1663 | NDC:76420-111 | NDC:50090-6229 | NDC:70512-840 | NDC:0143-9621 | NDC:70710-1665 | NDC:68083-449 | PubChem CID:24892734 | NDC:0143-9620 | NDC:0517-0031 | NDC:43386-237 | NDC:67457-399 | NDC:69680-113 | NDC:70710-1664 | NDC:45802-491 | NDC:51662-1647 | NDC:70069-005 | NDC:68083-561 | NDC:70771-1689 | NDC:70069-171 | NDC:70756-635"
+BMGC_DG06118,BMG_DG125397,"CID 24892769 | carbanide;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | CAS RN:13422-55-4 | PubChem CID:24892769"
+BMGC_DG06119,BMG_DG125398,"cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate | PubChem CID:24892771 | CAS RN:13422-51-0"
+BMGC_DG06120,BMG_DG125415,PubChem CID:24892821 | DrugBank ID:DB08385 | 4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid
+BMGC_DG06121,BMG_DG125416,PubChem SID:312525180 | CAS RN:1010396-29-8 | DrugBank ID:DB07419 | S-23 | PubChem CID:24892822 | UNII:XDK89456WM
+BMGC_DG06122,BMG_DG125417,PubChem CID:24892823 | (2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide | DrugBank ID:DB07039
+BMGC_DG06123,BMG_DG125421,"PubChem SID:198981608 | DrugBank ID:DB13581 | CAS RN:53716-44-2 | ROCIVERINE | PubChem CID:24892842 | Rociverine | UNII:VI08KS44V0 | 1-(diethylamino)propan-2-yl (1S,2S)-2-cyclohexyl-2-hydroxycyclohexane-1-carboxylate"
+BMGC_DG06124,BMG_DG125434,PubChem CID:24893974 | N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide | DrugBank ID:DB07801
+BMGC_DG06125,BMG_DG125435,"(5-ETHYLSULFONYL-2-(OXAN-4-YL)-3,4-DIHYDRO-1H-PYRIDO(4,3-B)INDOL-8-YL)-(4-METHYLPIPERIDIN-1-YL)METHANONE | UNII:4L8EG56VDA | CAS RN:910798-82-2 | PubChem SID:461433868 | PubChem CID:24894028"
+BMGC_DG06126,BMG_DG125437,PubChem CID:24894130 | DrugBank ID:DB07266 | AKI-001
+BMGC_DG06127,BMG_DG125438,"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE | DrugBank ID:DB08750 | PubChem CID:24894149"
+BMGC_DG06128,BMG_DG125439,DrugBank ID:DB07306 | PubChem CID:24894151 | ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE
+BMGC_DG06129,BMG_DG125440,"(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine | DrugBank ID:DB07003 | PubChem CID:24894153"
+BMGC_DG06130,BMG_DG125441,"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine | DrugBank ID:DB07007 | PubChem CID:24894155"
+BMGC_DG06131,BMG_DG125442,DrugBank ID:DB07608 | PubChem CID:24894158 | N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide
+BMGC_DG06132,BMG_DG125443,"PubChem CID:24894167 | DrugBank ID:DB07676 | 3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one"
+BMGC_DG06133,BMG_DG125451,PubChem SID:198984087 | FLUTAFURANOL | PubChem CID:24896605 | Flutafuranol | CAS RN:1054629-49-0 | 2-[2-fluoro-6-(methylamino)pyridin-3-yl]-1-benzofuran-5-ol | UNII:G5K506J69E
+BMGC_DG06134,BMG_DG125465,PubChem SID:375579566 | DrugBank ID:DB04401 | trimethyl(2-oxoethyl)azanium | PubChem CID:249 | Betaine aldehyde | UNII:DEI7V5X7RB | BETAINE ALDEHYDE | CAS RN:7418-61-3
+BMGC_DG06135,BMG_DG125467,PubChem SID:198948399 | UNII:10521U3EQA | APD-916 | PubChem CID:24900259 | CAS RN:1021169-11-8
+BMGC_DG06136,BMG_DG125468,"UNII:S85YZ8U3Z6 | 4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol | PubChem SID:443623816 | DrugBank ID:DB08111 | 4-((6-PHENYL-(1,2,4)TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)METHYL)PHENOL | PubChem CID:24901696 | CAS RN:940057-42-1"
+BMGC_DG06137,BMG_DG125469,"UNII:93M6577H9D | N-(3-FLUORO-4-(2-(1-METHYL-1H-IMIDAZOL-4-YL)THIENO(3,2-B)PYRIDIN-7-YLOXY)PHENYLCARBAMOTHIOYL)-2-PHENYLACETAMIDE | PubChem CID:24901704 | PubChem SID:249492384 | CAS RN:875337-44-3"
+BMGC_DG06138,BMG_DG125470,PubChem CID:24901723 | DrugBank ID:DB07791 | 4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE
+BMGC_DG06139,BMG_DG125475,PubChem CID:24905 | PubChem SID:461434604 | UNII:R8FGF42R4A | CAS RN:10075-50-0 | 5-BROMOINDOLE
+BMGC_DG06140,BMG_DG125476,DrugBank ID:DB08052 | PubChem CID:24905142 | UNII:5B9VB06146 | PubChem SID:322058947 | CAS RN:1092788-83-4 | PP-121
+BMGC_DG06141,BMG_DG125477,"3-(4-AZANYL-1-PROPAN-2-YL-PYRAZOLO(3,4-D)PYRIMIDIN-3-YL)PHENOL | UNII:E6993R9V55 | CAS RN:833481-69-9 | PubChem CID:24905143 | DrugBank ID:DB07335 | PubChem SID:461433003 | 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL"
+BMGC_DG06142,BMG_DG125478,"PubChem CID:24905144 | DrugBank ID:DB08300 | 1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine"
+BMGC_DG06143,BMG_DG125479,"PubChem CID:24905152 | DrugBank ID:DB08054 | 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine"
+BMGC_DG06144,BMG_DG125480,"PubChem CID:24905153 | 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | DrugBank ID:DB08053"
+BMGC_DG06145,BMG_DG125483,AT-13148 | PubChem SID:198970628 | (S)-1-(4-(1H-Pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol | CAS RN:1056901-62-2 | UNII:A49037RP1E | PubChem CID:24905401 | (1S)-2-amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)phenyl]ethanol
+BMGC_DG06146,BMG_DG125499,2-(HYDRAZINECARBONYL)BENZENESULFONAMIDE | 2-(Hydrazinecarbonyl)benzenesulfonamide | PubChem SID:475550298 | PubChem CID:2490720 | UNII:S3J8YCJ4GZ | CAS RN:102169-52-8
+BMGC_DG06147,BMG_DG125509,"DrugBank ID:DB08346 | PubChem CID:24916788 | (5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE"
+BMGC_DG06148,BMG_DG125522,PubChem SID:376073073 | CAS RN:17496-14-9 | UNII:OS704F44DR | PubChem CID:249262 | 2-METHYLINDANONE
+BMGC_DG06149,BMG_DG125523,PubChem CID:249266 | PubChem SID:198985176 | UNII:2E08SP4D3P | CAS RN:27323-18-8 | 2-Chlorobiphenyl | 2-CHLOROBIPHENYL | 1-chloro-2-phenylbenzene | CAS RN:2051-60-7
+BMGC_DG06150,BMG_DG125532,Sodium Selenite | SODIUM SELENITE | UNII:HIW548RQ3W | disodium;selenite | PubChem CID:24934 | CAS RN:10102-18-8 | PubChem SID:175265555
+BMGC_DG06151,BMG_DG125554,"PubChem CID:24941243 | DrugBank ID:DB08042 | N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine"
+BMGC_DG06152,BMG_DG125555,"PubChem CID:24941248 | DrugBank ID:DB06897 | 3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol"
+BMGC_DG06153,BMG_DG125556,"DrugBank ID:DB06963 | 3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide | PubChem CID:24941249"
+BMGC_DG06154,BMG_DG125557,N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide | DrugBank ID:DB07307 | PubChem CID:24941253
+BMGC_DG06155,BMG_DG125558,"DrugBank ID:DB07691 | 2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid | PubChem CID:24941254"
+BMGC_DG06156,BMG_DG125559,"PubChem CID:24941258 | N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE | DrugBank ID:DB07318"
+BMGC_DG06157,BMG_DG125560,PubChem SID:459055094 | 5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide | PubChem CID:24941262 | UNII:SQH4947NDN | CAS RN:1093070-16-6 | DrugBank ID:DB08656 | GRL-0617
+BMGC_DG06158,BMG_DG125561,"DrugBank ID:DB07001 | (3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine | PubChem CID:24941263"
+BMGC_DG06159,BMG_DG125572,UNII:3JL137394Y | AZD-4017 | PubChem CID:24946280 | PubChem SID:198939334 | CAS RN:1024033-43-9 | 2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]piperidin-3-yl]acetic acid | DrugBank ID:DB14875 | Azd-4017
+BMGC_DG06160,BMG_DG125573,"BITOPERTIN | UNII:Q8L6AN59YY | Bitopertin | DrugBank ID:DB12426 | PubChem CID:24946690 | [4-[3-fluoro-5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]-[5-methylsulfonyl-2-[(2S)-1,1,1-trifluoropropan-2-yl]oxyphenyl]methanone | CAS RN:845614-11-1 | PubChem SID:316910237"
+BMGC_DG06161,BMG_DG125587,"Bml-281 | tert-butyl N-[4-[3-[[7-(hydroxyamino)-7-oxoheptyl]carbamoyl]-1,2-oxazol-5-yl]phenyl]carbamate | PubChem CID:24951314 | CAS RN:1045792-66-2"
+BMGC_DG06162,BMG_DG125588,PubChem SID:198976881 | PubChem CID:24951655 | CAS RN:949575-20-6 | UNII:9T6EBU5ER1 | IOFOLASTAT
+BMGC_DG06163,BMG_DG125596,CAS RN:949575-22-8 | PubChem CID:24957011 | UNII:754M4I9737 | PubChem SID:329904014 | MIP-1095
+BMGC_DG06164,BMG_DG125597,"CAS RN:473719-41-4 | PubChem SID:198965646 | AMG-487 | N-[(1R)-1-[3-(4-ethoxyphenyl)-4-oxopyrido[2,3-d]pyrimidin-2-yl]ethyl]-N-(pyridin-3-ylmethyl)-2-[4-(trifluoromethoxy)phenyl]acetamide | UNII:355CGR2CBL | PubChem CID:24957182"
+BMGC_DG06165,BMG_DG125600,PubChem SID:198976487 | Niraparib | DrugBank ID:DB11793 | CAS RN:1038915-60-4 | 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide | UNII:HMC2H89N35 | PubChem CID:24958200 | NIRAPARIB
+BMGC_DG06166,BMG_DG125602,PubChem CID:24958668 | GTPL-5804 | UNII:0T87WD317S | PubChem SID:198962316 | CAS RN:1009082-19-2
+BMGC_DG06167,BMG_DG125610,PubChem CID:24963033 | N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE | DrugBank ID:DB07790
+BMGC_DG06168,BMG_DG125611,(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide | PubChem CID:24963035 | DrugBank ID:DB07088
+BMGC_DG06169,BMG_DG125612,PubChem CID:24963036 | (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide | DrugBank ID:DB07091
+BMGC_DG06170,BMG_DG125613,(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide | PubChem CID:24963037 | DrugBank ID:DB07095
+BMGC_DG06171,BMG_DG125614,PubChem CID:24963046 | N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide | DrugBank ID:DB08351
+BMGC_DG06172,BMG_DG125615,PubChem CID:24963047 | DrugBank ID:DB07162 | 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide
+BMGC_DG06173,BMG_DG125616,"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide | PubChem CID:24963048 | DrugBank ID:DB07812"
+BMGC_DG06174,BMG_DG125617,"3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7-dione | PubChem CID:24963252 | TAK-733 | Tak-733 | UNII:5J61HSP0QJ | DrugBank ID:DB12241 | PubChem SID:313182946 | CAS RN:1035555-63-5"
+BMGC_DG06175,BMG_DG125618,"3-[4-(2-hydroxyethyl)piperazin-1-yl]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2-one | CAS RN:954138-07-9 | 3-[4-(2-hydroxyethyl)piperazin-1-yl]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-1H,2H-pyrido[3,4-b]pyrazin-2-one | CAS RN:402955-58-2 | PubChem SID:346537658 | UNII:9CZX3Z9945 | PF-03049423 FREE BASE | PubChem CID:24963293"
+BMGC_DG06176,BMG_DG125623,"MK-2206 FREE BASE | MK-2206 | 8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-2H-[1,2,4]triazolo[3,4-f][1,6]naphthyridin-3-one | PubChem SID:198991166 | PubChem CID:24964624 | UNII:51HZG6MP1K | CAS RN:1032349-93-1"
+BMGC_DG06177,BMG_DG125624,"PubChem CID:24964679 | 5-[1'-(1-cyclopropyl-4-methoxy-3-methylindole-6-carbonyl)-4-oxospiro[3H-chromene-2,4'-piperidine]-6-yl]pyridine-3-carboxylic acid | CAS RN:1039758-22-9"
+BMGC_DG06178,BMG_DG125628,"Suvorexant | PubChem SID:175266695 | UNII:081L192FO9 | NDC:0006-0033 | SUVOREXANT | [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone | NDC:0006-0325 | DrugBank ID:DB09034 | NDC:0006-0005 | NDC:0006-0335 | CAS RN:1030377-33-3 | PubChem CID:24965990"
+BMGC_DG06179,BMG_DG125631,"DrugBank ID:DB14857 | UNII:28DZS29F59 | AVADOMIDE | PubChem SID:329589011 | PubChem CID:24967599 | CAS RN:1015474-32-4 | 3-(5-amino-2-methyl-4-oxoquinazolin-3-yl)piperidine-2,6-dione | Avadomide"
+BMGC_DG06180,BMG_DG125641,"PubChem SID:478838438 | 5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile | PubChem CID:24971312 | 5-Chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile | 5-CHLORO-7-((1-METHYLETHYL)AMINO)PYRAZOLO(1,5-A)PYRIMIDINE-3-CARBONITRILE | CAS RN:1048675-56-4 | DrugBank ID:DB08139 | UNII:LW4J8Q7HMC"
+BMGC_DG06181,BMG_DG125642,"PubChem CID:24971313 | 5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE | DrugBank ID:DB08140"
+BMGC_DG06182,BMG_DG125643,"PubChem CID:24971327 | UNII:HF7ZTD598U | CAS RN:1048983-24-9 | PubChem SID:459055700 | BENZENETHIOL, 3-(1H-IMIDAZOL-5-YL)-"
+BMGC_DG06183,BMG_DG125663,"PubChem CID:24978486 | 5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine | DrugBank ID:DB07643"
+BMGC_DG06184,BMG_DG125674,"PubChem CID:24978538 | CAS RN:923564-51-6 | PubChem SID:198955115 | 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide | DrugBank ID:DB12340 | Navitoclax | NAVITOCLAX | UNII:XKJ5VVK2WD"
+BMGC_DG06185,BMG_DG125683,"(2R,3S)-3-[[6-[(4,6-dimethylpyridin-3-yl)methylamino]-9-propan-2-ylpurin-2-yl]amino]pentan-2-ol | PubChem CID:24983461 | PubChem SID:433968628 | CAS RN:1070790-89-4 | UNII:YET2XNU791 | DrugBank ID:DB15425 | FADRACICLIB | Fadraciclib"
+BMGC_DG06186,BMG_DG125691,PubChem SID:198957346 | Pf-4191834 | PubChem CID:24986635 | UNII:YX55DXP4T1 | 4-[3-[4-(2-methylpyrazol-3-yl)phenyl]sulfanylphenyl]oxane-4-carboxamide | CAS RN:1029317-21-2 | PF-4191834 | DrugBank ID:DB11645
+BMGC_DG06187,BMG_DG125692,"2-[2,6-difluoro-4-(3-methoxyphenyl)anilino]pyridine-3-carboxylic acid | PubChem SID:376230919 | UNII:I58WE41H6X | CAS RN:1035688-66-4 | Farudodstat | FARUDODSTAT | PubChem CID:24986824"
+BMGC_DG06188,BMG_DG125697,"UNII:X2JZ0451H8 | VOLIXIBAT | CAS RN:1025216-57-2 | [(2R,3R,4S,5R,6R)-6-[[3-[(3S,4R,5R)-3-butyl-7-(dimethylamino)-3-ethyl-4-hydroxy-1,1-dioxo-4,5-dihydro-2H-1lambda6-benzothiepin-5-yl]phenyl]carbamoylamino]-3,5-dihydroxy-4-phenylmethoxyoxan-2-yl]methyl hydrogen sulfate | DrugBank ID:DB13914 | PubChem SID:252165472 | Volixibat | PubChem CID:24987688"
+BMGC_DG06189,BMG_DG125701,"4-[4-[5-(5-chloro-6-propan-2-yloxypyridin-3-yl)-1,2,4-oxadiazol-3-yl]indol-1-yl]butanoic acid | PubChem CID:24988201 | Gsk-2018682 | PubChem SID:313183142 | GSK-2018682 | DrugBank ID:DB11987 | UNII:NJL503AIJA | CAS RN:1034688-30-6"
+BMGC_DG06190,BMG_DG125702,"UNII:537E7QE8LX | PubChem CID:24988881 | Mk-8245 | MK-8245 | CAS RN:1030612-90-8 | PubChem SID:198959755 | 2-[5-[3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2-oxazol-5-yl]tetrazol-2-yl]acetic acid | DrugBank ID:DB13024"
+BMGC_DG06191,BMG_DG125705,UNII:WI6V529FZ9 | DrugBank ID:DB12483 | PubChem CID:24989044 | COPANLISIB | PubChem SID:198981113 | Copanlisib | CAS RN:1032568-63-0
+BMGC_DG06192,BMG_DG125713,4-[(3R)-3-aminopyrrolidin-1-yl]-6-propan-2-ylpyrimidin-2-amine | UNII:5RV7T5BNMG | PubChem SID:252319593 | CAS RN:1046447-90-8 | JNJ-39758979 | PubChem CID:24994634 | Jnj-39758979
+BMGC_DG06193,BMG_DG125715,"Sns-314 | 1-(3-chlorophenyl)-3-[5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl]urea | UNII:802IFJ0Z8X | DrugBank ID:DB07361 | DrugBank ID:DB06134 | SNS-314 | PubChem CID:24995524 | CAS RN:1057249-41-8 | PubChem SID:198969974"
+BMGC_DG06194,BMG_DG125716,"GSK-1292263 | 5-[4-[[6-(4-methylsulfonylphenyl)pyridin-3-yl]oxymethyl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole | PubChem SID:198986192 | PubChem CID:24996872 | CAS RN:1032823-75-8 | UNII:R1J57STA6O | DrugBank ID:DB12627 | Gsk-1292263"
+BMGC_DG06195,BMG_DG125719,PubChem SID:445499054 | CAS RN:1072467-37-8 | HJP-272 | PubChem CID:24997097 | UNII:2PBW62RN9T
+BMGC_DG06196,BMG_DG125728,PubChem SID:198959244 | UNII:RIK029813G | DrugBank ID:DB11809 | PubChem CID:24999143 | Artefenomel | CAS RN:1029939-86-3 | ARTEFENOMEL
+BMGC_DG06197,BMG_DG125729,PF-02575799 | UNII:I6KF9AF7F7 | CAS RN:863491-70-7 | PubChem SID:198952591 | PubChem CID:24999167
+BMGC_DG06198,BMG_DG125740,PubChem SID:198946319 | UNII:86KF5VSV88 | CAS RN:1050656-06-8 | MF-766 | PubChem CID:25003075
+BMGC_DG06199,BMG_DG125745,PubChem CID:25006676 | CAS RN:1050478-18-6 | UNII:505K9LJ4MX | LBP-1 | PubChem SID:440089031
+BMGC_DG06200,BMG_DG125746,AZD-8329 | PubChem SID:198975595 | Azd8329 | PubChem CID:25006684 | CAS RN:1048668-70-7 | UNII:5B38CV1212 | 4-[4-(2-adamantylcarbamoyl)-5-tert-butylpyrazol-1-yl]benzoic acid
+BMGC_DG06201,BMG_DG125752,"Azd-9742 | PubChem SID:346537728 | 1-[2-[(3R,4S)-4-(2,3-dihydro-[1,4]dioxino[2,3-c]pyridin-7-ylmethylamino)-3-fluoropiperidin-1-yl]ethyl]-2-oxoquinoline-7-carbonitrile | PubChem CID:25008769 | UNII:1T5080OCPW | AZD-9742 | CAS RN:1033748-95-6"
+BMGC_DG06202,BMG_DG125784,"PubChem CID:25011728 | DrugBank ID:DB07252 | 3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide"
+BMGC_DG06203,BMG_DG125785,"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine | DrugBank ID:DB07253 | PubChem CID:25011729"
+BMGC_DG06204,BMG_DG125786,"PubChem CID:25011730 | DrugBank ID:DB07254 | N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE"
+BMGC_DG06205,BMG_DG125787,"PubChem CID:25011731 | N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE | DrugBank ID:DB07255"
+BMGC_DG06206,BMG_DG125788,PubChem CID:25011732 | D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide | DrugBank ID:DB06919
+BMGC_DG06207,BMG_DG125789,PubChem CID:25011733 | DrugBank ID:DB07027 | D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide
+BMGC_DG06208,BMG_DG125790,PubChem CID:25013811 | AZD-2906 | CAS RN:1034148-15-6 | UNII:SN8JN2RU5L | PubChem SID:474492901
+BMGC_DG06209,BMG_DG125791,[4-Methyl-3-[methyl-[2-[(3-methylsulfonyl-5-morpholin-4-yl-phenyl)amino]pyrimidin-4-yl]amino]phenyl]methanol | PubChem CID:25014511 | [4-methyl-3-[methyl-[2-(3-methylsulfonyl-5-morpholin-4-ylanilino)pyrimidin-4-yl]amino]phenyl]methanol
+BMGC_DG06210,BMG_DG125792,"UNII:36O410ZD4I | CAS RN:742092-03-1 | VINTAFOLIDE | (2S)-2-[[4-[(2-amino-4-oxo-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[(2S)-3-carboxy-1-[[(2S)-3-carboxy-1-[[(1R)-1-carboxy-2-[2-[[[(1R,9R,10S,11R,12R,19R)-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carbonyl]amino]carbamoyloxy]ethyldisulfanyl]ethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | PubChem SID:198971819 | PubChem CID:25014653 | Vintafolide"
+BMGC_DG06211,BMG_DG125794,PubChem CID:25014899 | BPH-715 | PubChem SID:198972782 | UNII:YD43M7UAP4 | CAS RN:1059677-23-4
+BMGC_DG06212,BMG_DG125795,UNII:M6E70B7AHM | CAS RN:1072100-81-2 | PF-04577806 | PubChem CID:25014995 | PubChem SID:198939459
+BMGC_DG06213,BMG_DG125802,PubChem SID:461434237 | CAS RN:1048346-74-2 | PubChem CID:25016538 | UNII:YK98JFQ52U | RO-5166017
+BMGC_DG06214,BMG_DG125803,DrugBank ID:DB12963 | CCX-354 | PubChem CID:25016615
+BMGC_DG06215,BMG_DG125807,PubChem CID:25017411 | CATEQUENTINIB | Catequentinib | Anlotinib | DrugBank ID:DB11885 | 1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxyquinolin-7-yl]oxymethyl]cyclopropan-1-amine | CAS RN:1058156-90-3 | PubChem SID:313183764 | UNII:GKF8S4C432
+BMGC_DG06216,BMG_DG125808,JSM-10292 | PubChem CID:25019714 | PubChem SID:198977650 | CAS RN:1064674-16-3 | UNII:1Q3KX3563S
+BMGC_DG06217,BMG_DG125809,"PubChem CID:25019940 | UNII:5C44M1QYCC | 2-[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-N-[(2R)-2'-oxospiro[1,3-dihydroindene-2,3'-1H-pyrrolo[2,3-b]pyridine]-5-yl]acetamide | Mk-3207 | CAS RN:957118-49-9 | MK-3207 | DrugBank ID:DB12424 | PubChem SID:198958701"
+BMGC_DG06218,BMG_DG125813,UNII:7MZ1I2J68A | CAS RN:1101854-58-3 | PubChem SID:198946290 | JZL-184 | PubChem CID:25021165
+BMGC_DG06219,BMG_DG125817,PubChem CID:25021183 | DrugBank ID:DB07133 | D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide
+BMGC_DG06220,BMG_DG125818,"PubChem CID:25021186 | N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine | DrugBank ID:DB08019"
+BMGC_DG06221,BMG_DG125861,"(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one | EVOGLIPTIN | PubChem SID:198960695 | UNII:09118300L7 | PubChem CID:25022354 | DrugBank ID:DB12625 | Evogliptin | CAS RN:1222102-29-5"
+BMGC_DG06222,BMG_DG125865,PubChem CID:25022668 | GSK-650394 | PubChem SID:198978264 | UNII:56887611DJ | CAS RN:890842-28-1
+BMGC_DG06223,BMG_DG125876,"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine | PubChem CID:25023709 | DrugBank ID:DB08130"
+BMGC_DG06224,BMG_DG125877,"(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one | DrugBank ID:DB07017 | PubChem CID:25023710"
+BMGC_DG06225,BMG_DG125878,"2-((3,5-DIFLUORO-4-HYDROXYPHENYL)AMINO)-7,8-DIHYDRO-5,7-DIMETHYL-8-(3-METHYLBUTYL)-6(5H)-PTERIDINONE | UNII:WLN44M8WHJ | PubChem SID:482553148 | 2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridinone | PubChem CID:25023738 | CAS RN:501437-28-1"
+BMGC_DG06226,BMG_DG125879,"4-methyl-3-[[6-methylsulfonyl-7-[2-(morpholin-4-ylmethyl)-1,3-thiazol-4-yl]quinolin-4-yl]amino]phenol | 4-Methyl-3-((6-(methylsulfonyl)-7-(2-(morpholinomethyl)thiazol-4-yl)quinolin-4-yl)amino)phenol | PubChem CID:25023834 | CAS RN:955879-81-9"
+BMGC_DG06227,BMG_DG125880,"(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID) | DrugBank ID:DB08529 | PubChem CID:25023881"
+BMGC_DG06228,BMG_DG125888,"CAS RN:1037792-44-1 | UNII:B5TRY67L51 | PubChem CID:25025505 | DrugBank ID:DB12345 | 2-[1-(5-ethylpyrimidin-2-yl)piperidin-4-yl]-4-[[4-(tetrazol-1-yl)phenoxy]methyl]-1,3-thiazole | PubChem SID:198965856 | Mbx-2982 | MBX-2982"
+BMGC_DG06229,BMG_DG125890,"CAS RN:1037210-93-7 | UNII:JT96FPU35X | PubChem CID:25027363 | PubChem SID:198976713 | DrugBank ID:DB12655 | PATIDEGIB | Patidegib | N-[(3R,3'R,3'aS,4aR,6'S,6aR,6bS,7'aR,9S,12aS,12bS)-3',6',11,12b-tetramethylspiro[1,2,3,4,4a,5,6,6a,6b,7,8,10,12,12a-tetradecahydronaphtho[2,1-a]azulene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-3-yl]methanesulfonamide"
+BMGC_DG06230,BMG_DG125898,CR665 | CAS RN:228546-92-7 | UNII:3BX9UG06GG | CR-665 | DrugBank ID:DB05155 | PubChem SID:198967765 | PubChem CID:25030387 | (2R)-2-[[(2R)-2-[[(2R)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-N-[(2R)-5-(diaminomethylideneamino)-1-oxo-1-(pyridin-4-ylmethylamino)pentan-2-yl]hexanamide
+BMGC_DG06231,BMG_DG125903,PubChem SID:198970413 | PubChem CID:25031915 | LUCITANIB | Lucitanib | CAS RN:1058137-23-7 | UNII:PP449XA4BH | DrugBank ID:DB11845 | 6-[7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl]oxy-N-methylnaphthalene-1-carboxamide
+BMGC_DG06232,BMG_DG125910,"PubChem SID:198978074 | DrugBank ID:DB11974 | PubChem CID:25033539 | PF-04691502 | CAS RN:1013101-36-4 | UNII:4W39NS61KI | 2-amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one"
+BMGC_DG06233,BMG_DG125914,PubChem CID:25034551 | CAS RN:1048038-90-9 | PubChem SID:440088786 | UNII:S723GJY405 | SER-601
+BMGC_DG06234,BMG_DG125926,CAS RN:76254-81-4 | 4-(ALLYLAMINO)-3-PYRIDINESULFONAMIDE | UNII:EZ5LNG2QXV | PubChem CID:25044690 | PubChem SID:459276048
+BMGC_DG06235,BMG_DG125932,"PubChem CID:25049750 | DrugBank ID:DB07189 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid"
+BMGC_DG06236,BMG_DG125938,UNII:N62TGJ04A1 | PubChem SID:316915486 | PubChem CID:25052023 | Esaxerenone | CAS RN:1632006-28-0 | CAS RN:880780-76-7 | 1-(2-hydroxyethyl)-4-methyl-N-(4-methylsulfonylphenyl)-5-[2-(trifluoromethyl)phenyl]pyrrole-3-carboxamide | ESAXERENONE | DrugBank ID:DB15207
+BMGC_DG06237,BMG_DG125952,"UNII:5U58D99D1L | PubChem CID:25058047 | 3,7-BIS(2-HYDROXYETHYL)ICARITIN | CAS RN:1067198-74-6 | PubChem SID:310825778"
+BMGC_DG06238,BMG_DG125956,"DrugBank ID:DB08234 | PubChem SID:472422254 | CAS RN:1088496-61-0 | UNII:GEW9C9EK4M | 5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine | PubChem CID:25058133 | 5-(3-(2,5-DIMETHOXYPHENYL)-1-PROPYN-1-YL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE"
+BMGC_DG06239,BMG_DG125957,"DrugBank ID:DB07171 | 5-(2-hydroxyethyl)nonane-1,9-diol | PubChem CID:25058136"
+BMGC_DG06240,BMG_DG125960,"DrugBank ID:DB08442 | PubChem CID:25058141 | 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol"
+BMGC_DG06241,BMG_DG125979,CAS RN:945749-05-3 | PubChem SID:496143779 | PubChem CID:25061438 | 4-(2-((4-(4-MORPHOLINYL)PHENYL)AMINO)-4-PYRIMIDINYL)BENZAMIDE | UNII:HF42FXE3SN | 4-[2-[[4-(4-Morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide
+BMGC_DG06242,BMG_DG125981,"PubChem CID:25061501 | N-[[(3S)-3-amino-1-(5-ethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrrolidin-3-yl]methyl]-2,4-difluorobenzamide | N-{[(3s)-3-Amino-1-(5-Ethyl-7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)pyrrolidin-3-Yl]methyl}-2,4-Difluorobenzamide | CAS RN:1004990-28-6"
+BMGC_DG06243,BMG_DG125985,MOMELOTINIB | PubChem CID:25062766 | CAS RN:1056634-68-4 | Momelotinib | PubChem SID:198982471 | DrugBank ID:DB11763 | N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide | UNII:6O01GMS00P
+BMGC_DG06244,BMG_DG126000,UNII:75017Q6I97 | CAS RN:1020172-07-9 | PubChem CID:25066467 | Rebastinib | 4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide | DrugBank ID:DB13005 | REBASTINIB | PubChem SID:198983986
+BMGC_DG06245,BMG_DG126001,PubChem SID:459055401 | UNII:6JP4F7KKX5 | PubChem CID:25066764 | MMP-408 | CAS RN:1025716-81-7
+BMGC_DG06246,BMG_DG126002,"5-Bromo-4,7-diazaindole | 5-BROMO-4,7-DIAZAINDOLE | CAS RN:875781-43-4 | PubChem CID:25067308 | UNII:TC8BC9REU8 | PubChem SID:496142067"
+BMGC_DG06247,BMG_DG126004,"CAS RN:935888-69-0 | OPROZOMIB | DrugBank ID:DB11991 | UNII:MZ37792Y8J | N-[(2S)-3-methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide | PubChem CID:25067547 | PubChem SID:198978909 | Oprozomib"
+BMGC_DG06248,BMG_DG126006,PubChem CID:25067561 | AZD-3783 | UNII:3NC9ASE900 | CAS RN:1162658-64-1 | PubChem SID:384647906
+BMGC_DG06249,BMG_DG126010,A-943931 | PubChem CID:25068753 | UNII:Q598HK01AO | PubChem SID:198972978 | CAS RN:1027330-97-7
+BMGC_DG06250,BMG_DG126014,UNII:WH7ISP34KA | PubChem SID:198989058 | Irdabisant | IRDABISANT | PubChem CID:25070031 | CAS RN:1005402-19-6 | 3-[4-[3-[(2R)-2-methylpyrrolidin-1-yl]propoxy]phenyl]-1H-pyridazin-6-one | DrugBank ID:DB12900
+BMGC_DG06251,BMG_DG126016,"PubChem CID:25070582 | CAS RN:1065110-62-4 | PubChem SID:485663392 | UNII:9FG4RA5VAJ | 2-Benzyl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepine | 2-BENZYL-6,7,8,9-TETRAHYDRO-5H-PYRIMIDO(4,5-D)AZEPINE"
+BMGC_DG06252,BMG_DG126022,UNII:8U5620H545 | CAS RN:1027330-82-0 | A-940894 | PubChem SID:198989500 | PubChem CID:25071319
+BMGC_DG06253,BMG_DG126025,PubChem SID:346540207 | UNII:L2BD0MW4OL | 2-[[2-(2-methoxy-4-morpholin-4-ylanilino)-5-(trifluoromethyl)pyridin-4-yl]amino]-N-methylbenzamide | PubChem CID:25073775 | VS-4718 | CAS RN:1061353-68-1 | Vs-4718 | DrugBank ID:DB15273
+BMGC_DG06254,BMG_DG126031,TRIPTORELIN | PubChem SID:472398099 | CAS RN:57773-63-4 | DrugBank ID:DB06825 | Triptorelin | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | PubChem CID:25074470 | UNII:9081Y98W2V
+BMGC_DG06255,BMG_DG126032,"Cetrorelix trifluoroacetate | CETRORELIX TRIFLUOROACETATE | UNII:26089221C6 | PubChem CID:25074886 | CAS RN:130289-71-3 | PubChem SID:313183015 | (2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide;2,2,2-trifluoroacetic acid"
+BMGC_DG06256,BMG_DG126033,PubChem CID:25074887 | PubChem SID:316910783 | CAS RN:130143-01-0 | (2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide | UNII:OON1HFZ4BA | CETRORELIX | Cetrorelix | CAS RN:120287-85-6 | DrugBank ID:DB00050
+BMGC_DG06257,BMG_DG126036,PubChem SID:363908678 | UNII:K41YC3AEI8 | PubChem CID:25075991 | CAS RN:83335-41-5 | DYNORPHIN B
+BMGC_DG06258,BMG_DG126037,"PubChem SID:363907769 | (2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]-4-methylpentanoyl]amino]hexanoic acid | DYNORPHIN A 1-13 | CAS RN:72957-38-1 | Dynorphin A (1-13) | PubChem CID:25075996 | UNII:VFC23V742Z"
+BMGC_DG06259,BMG_DG126038,"SELENOCYSTEINE | Alanine, 3-selenyl- | UNII:0CH9049VIS | CAS RN:10236-58-5 | PubChem SID:198945063 | PubChem CID:25076 | (2R)-2-amino-3-selanylpropanoic acid"
+BMGC_DG06260,BMG_DG126040,Nafarelin | DrugBank ID:DB00666 | UNII:1X0094V6JV | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | CAS RN:76932-56-4 | PubChem SID:175267922 | PubChem CID:25077405 | NAFARELIN
+BMGC_DG06261,BMG_DG126041,NEUROTENSIN | PubChem CID:25077406 | CAS RN:39379-15-2 | UNII:XHB61LG5QS | PubChem SID:384647889
+BMGC_DG06262,BMG_DG126042,NONA-ARGININE | Nona-arginine | DrugBank ID:DB12648 | CAS RN:143413-47-2 | PubChem CID:25077438 | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid | UNII:PK7O6W0U44 | PubChem SID:375083997
+BMGC_DG06263,BMG_DG126044,CAS RN:57773-65-6 | PubChem CID:25077495 | DESLORELIN | Deslorelin | PubChem SID:175267249 | UNII:TKG3I66TVE | DrugBank ID:DB11510 | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
+BMGC_DG06264,BMG_DG126049,(2S)-6-amino-2-[[(2S)-3-(4-hydroxyphenyl)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2S)-2-[[(2S)-1-[(2S)-3-(1H-imidazol-5-yl)-2-[[(2S)-pyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]hexanoic acid | PubChem CID:25077620 | CAS RN:75645-19-1 | H-Pro-his-pro-phe-his-phe-phe-val-tyr-lys-OH
+BMGC_DG06265,BMG_DG126050,N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | PubChem CID:25077649 | CAS RN:6918-10-1 | H-DL-Pyr-DL-His-DL-Trp-DL-Ser-DL-Tyr-DL-2Nal-DL-Leu-DL-Arg-DL-Pro-Gly-NH2
+BMGC_DG06266,BMG_DG126051,PubChem CID:25077993 | UNII:H50H3S3W74 | PubChem SID:313183617 | Histrelin | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-3-(1-benzylimidazol-4-yl)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | HISTRELIN | CAS RN:76712-82-8
+BMGC_DG06267,BMG_DG126060,CETRORELIX MONOACETATE | Cetrotide | UNII:XPQ226310Q | PubChem CID:25078429 | (2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide;acetic acid | CAS RN:1631741-31-5 | PubChem SID:317229075 | CAS RN:145672-81-7
+BMGC_DG06268,BMG_DG126071,PubChem CID:25080293 | DrugBank ID:DB12581 | Ozarelix | CAS RN:295350-45-7 | (2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]-methylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-(carbamoylamino)hexanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide | OZARELIX | UNII:Q1IF8M2YL3 | PubChem SID:198979434
+BMGC_DG06269,BMG_DG126085,(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-1-[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]acetyl]pyrrolidine-2-carbonyl]amino]-4-methylsulfanylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid | CAS RN:217082-60-5 | [Pyr1]apelin-13 | PubChem CID:25085173
+BMGC_DG06270,BMG_DG126107,4-(2-Hydroxycyclohexyl)-2-(trifluoromethyl)benzonitrile | PubChem CID:25093229 | CAS RN:1076225-26-7 | 4-(2-hydroxycyclohexyl)-2-(trifluoromethyl)benzonitrile
+BMGC_DG06271,BMG_DG126108,"PF-998425 | PubChem SID:198940934 | PubChem CID:25093231 | 4-((1R,2R)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile | 4-[(1R,2R)-2-hydroxycyclohexyl]-2-(trifluoromethyl)benzonitrile | UNII:OY0E00K11M | CAS RN:1076225-27-8"
+BMGC_DG06272,BMG_DG126109,"DrugBank ID:DB07140 | PubChem CID:25093369 | 5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine"
+BMGC_DG06273,BMG_DG126110,CAS RN:926294-00-0 | HYDROXYPHENYL DIHYDROXYBENZAMIDE | PubChem CID:25093729 | PubChem SID:198935071 | UNII:3G97F5R2CO
+BMGC_DG06274,BMG_DG126112,"CAS RN:2919-66-6 | UNII:4W5HDS3936 | PubChem SID:198965664 | PubChem CID:250948 | Melengestrol Acetate | MELENGESTROL ACETATE | [(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-16-methylidene-3-oxo-1,2,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-17-yl] acetate | DrugBank ID:DB14659"
+BMGC_DG06275,BMG_DG126126,CAS RN:905586-69-8 | AZ-960 | PubChem CID:25099184 | UNII:M63IS9PTJF | PubChem SID:198964561
+BMGC_DG06276,BMG_DG126127,CAS RN:1103522-45-7 | APROCITENTAN | NDC:80491-8012 | DrugBank ID:DB15059 | Aprocitentan | PubChem CID:25099191 | 5-(4-bromophenyl)-4-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-6-(sulfamoylamino)pyrimidine | PubChem SID:249492830 | UNII:MZI81HV01P
+BMGC_DG06277,BMG_DG126128,PubChem SID:318691425 | N-(5-FLUORO-3-METHYL-1H-INDOL-1-YL)-4-METHYL-2-(PYRIDIN-2-YL)PYRIMIDINE-5-CARBOXAMIDE | CAS RN:1068967-96-3 | PubChem CID:25099474 | UNII:EL407C86FF
+BMGC_DG06278,BMG_DG126134,"GEPOTIDACIN | DrugBank ID:DB12134 | PubChem SID:249492251 | PubChem CID:25101874 | Gepotidacin | (3R)-3-[[4-(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione | CAS RN:1075236-89-3 | UNII:DVF0PR037D"
+BMGC_DG06279,BMG_DG126140,"(7R,13S)-6-[(2S)-4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(4R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one | PubChem CID:25102720 | (7R,13S)-6-[(2S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(4R)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one"
+BMGC_DG06280,BMG_DG126143,"DrugBank ID:DB08739 | PubChem CID:25102845 | 2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione"
+BMGC_DG06281,BMG_DG126145,"CABOZANTINIB | PubChem CID:25102847 | CAS RN:849217-68-1 | 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | PubChem SID:175266754 | DrugBank ID:DB08875 | Cabozantinib | UNII:1C39JW444G"
+BMGC_DG06282,BMG_DG126151,"2-[2-(3-butoxyphenyl)ethylamino]-N,N-dimethylacetamide | EVENAMIDE | PubChem CID:25105689 | Evenamide | PubChem SID:252164217 | UNII:ON5S6N53JS | CAS RN:1092977-61-1"
+BMGC_DG06283,BMG_DG126156,PubChem SID:445500524 | LP-211 | CAS RN:1052147-86-0 | UNII:NCS2VAH93R | PubChem CID:25107716
+BMGC_DG06284,BMG_DG126161,"PubChem SID:316914462 | 5-Thiazolecarboxamide, 4-methyl-N-[2-[3-(4-morpholinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-(3-pyridinyl)- | DrugBank ID:DB12186 | UNII:4521NR0J09 | PubChem CID:25108829 | CAS RN:1093403-33-8 | 4-methyl-N-[2-[3-(morpholin-4-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-pyridin-3-yl-1,3-thiazole-5-carboxamide | SRT-2104"
+BMGC_DG06285,BMG_DG126164,"PubChem SID:198950488 | UNII:645R07LF0D | DrugBank ID:DB12888 | CAS RN:945531-77-1 | PubChem CID:25109292 | Ezutromid | 5-ethylsulfonyl-2-naphthalen-2-yl-1,3-benzoxazole | EZUTROMID"
+BMGC_DG06286,BMG_DG126167,"5-[3-[1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile | CAS RN:1201447-13-3 | PubChem CID:25110515 | 5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile"
+BMGC_DG06287,BMG_DG126174,PubChem CID:25111933 | (4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid | DrugBank ID:DB08783
+BMGC_DG06288,BMG_DG126182,"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine | PubChem CID:25113123 | DrugBank ID:DB06848"
+BMGC_DG06289,BMG_DG126183,"DrugBank ID:DB06849 | 1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine | PubChem CID:25113124"
+BMGC_DG06290,BMG_DG126184,PubChem CID:25113125 | DrugBank ID:DB07143 | D-phenylalanyl-N-benzyl-L-prolinamide
+BMGC_DG06291,BMG_DG126185,DrugBank ID:DB06878 | PubChem CID:25113126 | 1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide
+BMGC_DG06292,BMG_DG126186,PubChem CID:25113127 | DrugBank ID:DB06911 | D-leucyl-N-(3-chlorobenzyl)-L-prolinamide
+BMGC_DG06293,BMG_DG126187,1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide | DrugBank ID:DB06947 | PubChem CID:25113128
+BMGC_DG06294,BMG_DG126191,PubChem SID:198936139 | CAS RN:564482-79-7 | UNII:40R868KZFF | DrugBank ID:DB07754 | DCFBC | PubChem CID:25113157
+BMGC_DG06295,BMG_DG126193,"PubChem CID:25113171 | 2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide | DrugBank ID:DB07845"
+BMGC_DG06296,BMG_DG126194,"DrugBank ID:DB07194 | PubChem CID:25113172 | 2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide"
+BMGC_DG06297,BMG_DG126195,3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol | DrugBank ID:DB07969 | PubChem CID:25113181
+BMGC_DG06298,BMG_DG126218,PubChem CID:25113614 | N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | DrugBank ID:DB06853
+BMGC_DG06299,BMG_DG126219,N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide | DrugBank ID:DB06942 | PubChem CID:25113615
+BMGC_DG06300,BMG_DG126220,1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | PubChem CID:25113616 | DrugBank ID:DB06929
+BMGC_DG06301,BMG_DG126221,PubChem CID:25113617 | N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide | DrugBank ID:DB06936
+BMGC_DG06302,BMG_DG126222,UNII:HF1O6B8YOW | Resveratrol-3-O-sulfate | [3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenyl] hydrogen sulfate | RESVERATROL-3-SULFATE | PubChem SID:404859524 | CAS RN:553662-69-4 | PubChem CID:25113755
+BMGC_DG06303,BMG_DG126224,PubChem SID:198946214 | 1-(4-fluorobenzoyl)-3-[(6-methoxynaphthalen-2-yl)oxymethyl]azetidine-3-carboxylic acid | DrugBank ID:DB12024 | UNII:I7Z38E70VF | PF-04418948 | Pf-04418948 | PubChem CID:25114442 | CAS RN:1078166-57-0
+BMGC_DG06304,BMG_DG126225,DrugBank ID:DB11953 | PF-04447943 | PubChem CID:25115162
+BMGC_DG06305,BMG_DG126228,"UNII:TE20GB753F | 2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-5-[(2R)-2-hydroxy-3-morpholin-4-ylpropyl]-3-methyl-1,6,7,8-tetrahydropyrrolo[3,2-c]azepin-4-one | DrugBank ID:DB13019 | PubChem CID:25116064 | HENATINIB | Henatinib | PubChem SID:198935989 | CAS RN:1239269-51-2"
+BMGC_DG06306,BMG_DG126230,CAS RN:1073154-85-4 | CAS RN:1345713-71-4 | PubChem CID:25117126 | DEFACTINIB | N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide | PubChem SID:198950697 | UNII:53O87HA2QU | DrugBank ID:DB12282 | Defactinib
+BMGC_DG06307,BMG_DG126233,"4-[4-[4-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methylimidazol-2-yl]piperidin-1-yl]-1H-pyrazolo[3,4-d]pyrimidine | UNII:I4965C6W4O | PubChem CID:25118925 | DrugBank ID:DB12690 | LY-2584702 | PubChem SID:198940186 | CAS RN:1082949-67-4 | Ly-2584702"
+BMGC_DG06308,BMG_DG126242,"PubChem CID:25125 | PubChem SID:287445778 | UNII:I4C10U12C8 | CAS RN:1126-71-2 | N,N-DIMETHYL-2-PHENETHYLAMINE"
+BMGC_DG06309,BMG_DG126251,"NDC:50881-010 | Ruxolitinib | (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile | PubChem CID:25126798 | NDC:50881-015 | NDC:50881-020 | RUXOLITINIB | DrugBank ID:DB08877 | NDC:50881-025 | NDC:50881-005 | CAS RN:941678-49-5 | PubChem SID:175267965 | UNII:82S8X8XX8H"
+BMGC_DG06310,BMG_DG126255,"PubChem CID:25127152 | UNII:5D8VHL5WH5 | PubChem SID:445500439 | Gsk-1795091 | (2S)-2-[[(3R)-3-decoxytetradecanoyl]amino]-3-[(2R,3R,4R,5S,6R)-3-[[(3R)-3-decoxytetradecanoyl]amino]-4-[(3R)-3-decoxytetradecanoyl]oxy-6-(hydroxymethyl)-5-phosphonooxyoxan-2-yl]oxypropanoic acid | CAS RN:1233589-81-5 | GSK-1795091"
+BMGC_DG06311,BMG_DG126257,"UNII:OEI6OOU6IK | CAS RN:1092364-38-9 | PubChem CID:25127713 | 1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one | PubChem SID:198961468 | DrugBank ID:DB12114 | POZIOTINIB | Poziotinib"
+BMGC_DG06312,BMG_DG126258,"PubChem CID:25128145 | [(2R,5R)-5-[(5-fluoropyridin-2-yl)oxymethyl]-2-methylpiperidin-1-yl]-(5-methyl-2-pyrimidin-2-ylphenyl)methanone | UNII:E6BTT8VA5Z | Filorexant | FILOREXANT | PubChem SID:198976880 | DrugBank ID:DB12158 | CAS RN:1088991-73-4"
+BMGC_DG06313,BMG_DG126260,PubChem CID:2513 | Cacodylic Acid | CAS RN:75-60-5 | PubChem SID:198954516 | dimethylarsinic acid | DrugBank ID:DB02994 | UNII:AJ2HL7EU8K | Cacodylic acid | CAS RN:917-76-0 | CACODYLIC ACID
+BMGC_DG06314,BMG_DG126275,DrugBank ID:DB07131 | PubChem CID:25134248 | (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide
+BMGC_DG06315,BMG_DG126276,PubChem CID:25134249 | DrugBank ID:DB07734 | N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide
+BMGC_DG06316,BMG_DG126277,"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide | DrugBank ID:DB07735 | PubChem CID:25134250"
+BMGC_DG06317,BMG_DG126278,DrugBank ID:DB07736 | PubChem CID:25134251 | (2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide
+BMGC_DG06318,BMG_DG126279,PubChem CID:25134252 | (2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide | DrugBank ID:DB07737
+BMGC_DG06319,BMG_DG126280,"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide | PubChem CID:25134253 | DrugBank ID:DB07738"
+BMGC_DG06320,BMG_DG126281,"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione | DrugBank ID:DB07507 | PubChem CID:25134257"
+BMGC_DG06321,BMG_DG126284,"Ilacirnon | ILACIRNON | UNII:380F68J5PH | PubChem CID:25134303 | CAS RN:1100318-47-5 | 4-chloro-N-[5-methyl-2-(7H-pyrrolo[2,3-d]pyrimidine-4-carbonyl)pyridin-3-yl]-3-(trifluoromethyl)benzenesulfonamide | PubChem SID:433968992"
+BMGC_DG06322,BMG_DG126286,"CAS RN:1097917-15-1 | PubChem SID:198957018 | 2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]-4-N-(2-propan-2-ylsulfonylphenyl)-1,3,5-triazine-2,4-diamine | PubChem CID:25134326 | DrugBank ID:DB12729 | UNII:HP4L6MXF10 | ASP-3026 | Asp-3026"
+BMGC_DG06323,BMG_DG126288,PubChem SID:198952608 | UNII:73F8XED6YP | CAS RN:1094873-14-9 | PubChem CID:25134625 | JNJ-31020028
+BMGC_DG06324,BMG_DG126289,"CAS RN:1100598-15-9 | EMD-1204831 FREE BASE | UNII:GVM730CHWW | 4-(2-(2-(3-(3-(1-Methyl-1hpyrazol-4-yl)-6-oxo-1,6-dihydropyridazin-1-ylmethyl)-phenyl)-pyrimidin-5-yloxy)-ethyl)-morpholine) | PubChem SID:346539456 | CAS RN:1362819-72-4 | 6-(1-methylpyrazol-4-yl)-2-[[3-[5-(2-morpholin-4-ylethoxy)pyrimidin-2-yl]phenyl]methyl]pyridazin-3-one | PubChem CID:25134692"
+BMGC_DG06325,BMG_DG126301,"(5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] | (2R)-5'-methyl-4-azaspiro[bicyclo[2.2.2]octane-2,2'-[1,4]oxathiolane] | DrugBank ID:DB00185 | Cevimeline | CAS RN:1933761-49-9 | CAS RN:112425-76-0 | CAS RN:107233-08-9 | PubChem CID:25137844"
+BMGC_DG06326,BMG_DG126305,"PubChem CID:25137868 | Dextropropoxyphene-M | [(3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate"
+BMGC_DG06327,BMG_DG126308,"DrugBank ID:DB09323 | PubChem CID:25137901 | benzyl-[2-(benzylazaniumyl)ethyl]azanium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | Bicillin L-A"
+BMGC_DG06328,BMG_DG126318,N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide | PubChem CID:25138203 | DrugBank ID:DB07175
+BMGC_DG06329,BMG_DG126319,N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE | PubChem CID:25138278 | DrugBank ID:DB08066
+BMGC_DG06330,BMG_DG126320,DrugBank ID:DB08067 | PubChem CID:25138280 | 4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM
+BMGC_DG06331,BMG_DG126321,DrugBank ID:DB07448 | (2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid | PubChem CID:25138289
+BMGC_DG06332,BMG_DG126322,CAS RN:1132610-45-7 | UNII:3QF3J56NXP | N-(5-(5-FLUORO-6-METHYL-2-PYRIDINYL)-4-(6-QUINOXALINYL)-1H-IMIDAZOL-2-YL)ACETAMIDE | N-[5-(5-Fluoro-6-methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1H-imidazol-2-yl]acetamide | DrugBank ID:DB07152 | N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide | PubChem CID:25138294 | PubChem SID:482553984
+BMGC_DG06333,BMG_DG126323,PubChem CID:25138295 | DrugBank ID:DB06985 | 2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid
+BMGC_DG06334,BMG_DG126325,UNII:6W8B801TZM | PubChem CID:25138363 | 4-(7-hydroxy-4-oxo-2-propan-2-ylquinazolin-3-yl)benzonitrile | PubChem SID:461434558 | Libvatrep | CAS RN:871814-52-7 | LIBVATREP
+BMGC_DG06335,BMG_DG126336,"PubChem SID:252164339 | Entrectinib | NDC:50242-091 | CAS RN:1108743-60-7 | UNII:L5ORF0AN1I | NDC:50242-094 | ENTRECTINIB | PubChem CID:25141092 | N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide | NDC:50242-623 | DrugBank ID:DB11986"
+BMGC_DG06336,BMG_DG126351,UNII:ET9Q0750O6 | PubChem CID:25143721 | CAS RN:1006604-91-6 | PubChem SID:316914381 | MM-433593
+BMGC_DG06337,BMG_DG126354,"UNII:R8MEF6D6PS | CAS RN:1793065-08-3 | PubChem CID:25144422 | CAS RN:1092970-12-1 | PubChem SID:440793646 | ethyl 4-(2-bromo-4-fluorophenyl)-6-(morpholin-4-ylmethyl)-2-(1,3-thiazol-2-yl)-1,4-dihydropyrimidine-5-carboxylate | Morphothiadin | MORPHOTHIADINE"
+BMGC_DG06338,BMG_DG126360,"PubChem CID:25145656 | 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide | DrugBank ID:DB11791 | PubChem SID:198989884 | CAS RN:1029712-80-8 | UNII:TY34L4F9OZ | CAS RN:1362837-07-7 | Capmatinib | CAPMATINIB"
+BMGC_DG06339,BMG_DG126368,5'-deoxy-5'-piperidin-1-ylthymidine | PubChem CID:25147494 | DrugBank ID:DB08596
+BMGC_DG06340,BMG_DG126369,"DrugBank ID:DB08661 | PubChem CID:25147495 | 1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione"
+BMGC_DG06341,BMG_DG126371,"UNII:UM3821998K | PubChem CID:25147644 | DrugBank ID:DB06090 | Bradanicline | CAS RN:639489-84-2 | BRADANICLINE | N-[(2S,3R)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide | PubChem SID:198946527"
+BMGC_DG06342,BMG_DG126372,"[(3R)-1-azabicyclo[2.2.2]octan-3-yl] N-(3-fluorophenyl)-N-[(3,4,5-trifluorophenyl)methyl]carbamate | PubChem CID:25147683 | Tarafenacin | PubChem SID:198940844 | UNII:LDV98UN52Y | CAS RN:385367-47-5 | TARAFENACIN"
+BMGC_DG06343,BMG_DG126373,1-[4-(difluoromethoxy)-3-(oxolan-3-yloxy)phenyl]-3-methylbutan-1-one | PubChem CID:25147798 | Roflupram | CAS RN:1093412-18-0
+BMGC_DG06344,BMG_DG126374,PubChem SID:441331300 | CAS RN:902154-32-9 | UR-AK49 | PubChem CID:25149433 | UNII:5HML8P3QAT
+BMGC_DG06345,BMG_DG126375,UNII:8T96I3U713 | PubChem CID:2515 | PubChem SID:198976300 | Cadralazine | DrugBank ID:DB13452 | ethyl N-[[6-[ethyl(2-hydroxypropyl)amino]pyridazin-3-yl]amino]carbamate | CAS RN:64241-34-5 | CADRALAZINE
+BMGC_DG06346,BMG_DG126379,PubChem CID:25150857 | BIX-01294 | CAS RN:935693-62-2 | PubChem SID:472425859 | UNII:2PZ9U8BQ9B
+BMGC_DG06347,BMG_DG126381,"PEXIDARTINIB | UNII:6783M2LV5X | CAS RN:1029044-16-3 | Pexidartinib | DrugBank ID:DB12978 | PubChem SID:316917222 | 5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine | PubChem CID:25151352"
+BMGC_DG06348,BMG_DG126382,"DrugBank ID:DB09065 | 1,3-thiazol-5-ylmethyl N-[(2R,5R)-5-[[(2S)-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]-4-morpholin-4-ylbutanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate | NDC:50090-1723 | PubChem SID:175265978 | COBICISTAT | NDC:70518-0568 | NDC:59676-575 | NDC:59676-800 | Cobicistat | CAS RN:1004316-88-4 | UNII:LW2E03M5PG | PubChem CID:25151504 | NDC:61958-1401 | NDC:61958-1901"
+BMGC_DG06349,BMG_DG126391,DACLATASVIR | UNII:LI2427F9CI | methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate | CAS RN:1009119-64-5 | CAS RN:1214735-16-6 | Daclatasvir | DrugBank ID:DB09102 | PubChem SID:198955366 | PubChem CID:25154714
+BMGC_DG06350,BMG_DG126392,"CAS RN:30457-35-3 | PubChem SID:485663697 | PubChem CID:25154730 | N-(5-Ethyl-1,3,4-thiadiazol-2-yl)sulfamide | N-(5-ETHYL-1,3,4-THIADIAZOL-2-YL)SULFAMIDE | UNII:QA25P9MHX5"
+BMGC_DG06351,BMG_DG126393,PF-3845 | PubChem SID:198964764 | PubChem CID:25154867 | UNII:Q3PW846TYN | CAS RN:1196109-52-0
+BMGC_DG06352,BMG_DG126397,1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one | DrugBank ID:DB08738 | PubChem CID:25155578
+BMGC_DG06353,BMG_DG126415,"DrugBank ID:DB15266 | UNII:ZN90E4027M | Tovorafenib | PubChem CID:25161177 | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide | CAS RN:1096708-71-2 | TOVORAFENIB | PubChem SID:198960773"
+BMGC_DG06354,BMG_DG126421,"MIBOLERONE | (7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,13,17-trimethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | Mibolerone | DrugBank ID:DB11429 | PubChem CID:251636 | CAS RN:3704-09-4 | PubChem SID:198938532 | UNII:9OGY4BOR8D"
+BMGC_DG06355,BMG_DG126425,"PubChem CID:25163987 | DrugBank ID:DB07046 | 2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide"
+BMGC_DG06356,BMG_DG126434,"PubChem CID:25164607 | Sch-900229 | (4S,4aS,10bS)-10b-(4-chlorophenyl)sulfonyl-7,10-difluoro-4-(2-methylsulfonylethyl)-2,4,4a,5-tetrahydro-1H-pyrano[3,4-c]chromene | CAS RN:1100361-36-1 | PubChem SID:255508978 | SCH-900229 | UNII:5RY1XQ9DDH"
+BMGC_DG06357,BMG_DG126436,"PubChem SID:198988649 | UNII:K673DMO5H9 | NDC:0069-0298 | CAS RN:1095173-27-5 | NDC:0069-1531 | Glasdegib | GLASDEGIB | DrugBank ID:DB11978 | 1-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methylpiperidin-4-yl]-3-(4-cyanophenyl)urea | PubChem CID:25166913"
+BMGC_DG06358,BMG_DG126437,"UNII:6611F8KYCV | PubChem CID:25167017 | DrugBank ID:DB11861 | N-[(5R)-4-(2,2-dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide | LITRONESIB | CAS RN:910634-41-2 | Litronesib | PubChem SID:198963100"
+BMGC_DG06359,BMG_DG126438,"OMIPALISIB | UNII:1X8F5A3NA0 | DrugBank ID:DB12703 | PubChem CID:25167777 | Omipalisib | 2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide | PubChem SID:198943133 | CAS RN:1086062-66-9"
+BMGC_DG06360,BMG_DG126439,"PubChem CID:25167947 | CAS RN:1098189-15-1 | GS-9451 | UNII:KGD958X2B9 | VEDROPREVIR | (1R,2R)-1-[[(2S,4R)-1-[(2S)-2-[[(1R,5S)-3-bicyclo[3.1.0]hexanyl]oxycarbonylamino]-3,3-dimethylbutanoyl]-4-[8-chloro-7-(2-morpholin-4-ylethoxy)-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxypyrrolidine-2-carbonyl]amino]-2-ethylcyclopropane-1-carboxylic acid | Vedroprevir | CAS RN:1310824-24-8 | PubChem SID:198958833 | DrugBank ID:DB12037"
+BMGC_DG06361,BMG_DG126441,PubChem SID:405055233 | CAS RN:1093734-27-0 | RGH-618 | PubChem CID:25168930 | UNII:5900NS9ZHI
+BMGC_DG06362,BMG_DG126456,Tepotinib | TEPOTINIB | CAS RN:1100598-32-0 | CAS RN:1100598-30-8 | PubChem SID:198971853 | UNII:1IJV77EI07 | PubChem CID:25171648 | DrugBank ID:DB15133 | 3-[1-[[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxopyridazin-3-yl]benzonitrile
+BMGC_DG06363,BMG_DG126460,"PubChem CID:25174099 | (5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide | DrugBank ID:DB07397"
+BMGC_DG06364,BMG_DG126461,PubChem CID:25174101 | DrugBank ID:DB06882 | 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
+BMGC_DG06365,BMG_DG126463,N-DESMETHYL ENTRECTINIB | PubChem CID:25176014 | CAS RN:1108743-80-1 | PubChem SID:402404595 | UNII:RHW80OZE1E
+BMGC_DG06366,BMG_DG126469,"PubChem SID:376072310 | PubChem CID:251786 | 2-AMINO-N(1),N(3)-BIS(4-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENYL)ISOPHTHALAMIDE | CAS RN:21696-26-4 | UNII:4IGO887R37"
+BMGC_DG06367,BMG_DG126471,"PubChem SID:441583919 | CAS RN:1092578-46-5 | UNII:B64WR5WNB7 | PubChem CID:25180101 | EPITOFACITINIB, (3R,4S)-"
+BMGC_DG06368,BMG_DG126472,"PubChem SID:443623940 | 6-PYRIDIN-3-YL-3,4-DIHYDRO-1H-NAPHTHALEN-2-ONE | PubChem CID:25180108 | UNII:0GR932LM4W | CAS RN:1092522-85-4"
+BMGC_DG06369,BMG_DG126476,PubChem CID:25181315 | 5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine | DrugBank ID:DB08163
+BMGC_DG06370,BMG_DG126477,"PubChem CID:25181321 | DrugBank ID:DB07058 | 5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione | 5-[3-(4-methoxyphenyl)benzimidazol-5-yl]-3H-1,3,4-oxadiazole-2-thione"
+BMGC_DG06371,BMG_DG126478,"Glesatinib | PubChem SID:310825666 | DrugBank ID:DB06302 | N-[[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-(4-fluorophenyl)acetamide | GLESATINIB | CAS RN:936694-12-1 | UNII:7Q29OXD98N | PubChem CID:25181472"
+BMGC_DG06372,BMG_DG126480,"PubChem CID:25181577 | CAS RN:1033805-22-9 | NDC:70720-125 | PubChem SID:198960063 | DrugBank ID:DB12095 | ethyl (2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoate | TELOTRISTAT ETHYL | UNII:8G388563M7 | Telotristat Ethyl | NDC:70183-125"
+BMGC_DG06373,BMG_DG126481,"DrugBank ID:DB15382 | Sar-125844 | UNII:XH93U6NIJE | CAS RN:1116743-46-4 | SAR-125844 | PubChem CID:25182860 | 1-[6-[[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]-1,3-benzothiazol-2-yl]-3-(2-morpholin-4-ylethyl)urea | PubChem SID:346540157"
+BMGC_DG06374,BMG_DG126492,"IXAZOMIB | Ixazomib | [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid | CAS RN:1072833-77-2 | UNII:71050168A2 | PubChem SID:198939582 | PubChem CID:25183872 | DrugBank ID:DB09570"
+BMGC_DG06375,BMG_DG126496,"PubChem CID:25184541 | CONTEZOLID | (5S)-5-[(1,2-oxazol-3-ylamino)methyl]-3-[2,3,5-trifluoro-4-(4-oxo-2,3-dihydropyridin-1-yl)phenyl]-1,3-oxazolidin-2-one | MRX-I | DrugBank ID:DB12796 | PubChem SID:249493181 | Contezolid | UNII:B669M62ELP | CAS RN:1112968-42-9"
+BMGC_DG06376,BMG_DG126497,"DrugBank ID:DB12825 | Xenleta | Lefamulin | [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[(1R,2R,4R)-4-amino-2-hydroxycyclohexyl]sulfanylacetate | PubChem CID:25185057 | CAS RN:1061337-51-6"
+BMGC_DG06377,BMG_DG126501,"PubChem CID:25187896 | DrugBank ID:DB07153 | 6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine"
+BMGC_DG06378,BMG_DG126505,PubChem SID:443624073 | CAS RN:868686-01-5 | (2S)-2-((S)-(2-METHYLPHENOXY)PHENYLMETHYL)MORPHOLINE | UNII:4T66VH9CFL | PubChem CID:25188770
+BMGC_DG06379,BMG_DG126508,"NDC:0517-2502 | NDC:58809-389 | NDC:63545-619 | NDC:72036-020 | NDC:49483-343 | NDC:63545-618 | NDC:82876-830 | NDC:30142-284 | NDC:84509-032 | NDC:58602-747 | NDC:68998-076 | NDC:83872-025 | Caffeine | NDC:68210-4151 | CAS RN:58-08-2 | NDC:11822-2260 | NDC:76162-002 | NDC:84716-001 | NDC:83872-085 | NDC:63545-614 | NDC:41163-226 | NDC:84660-016 | CAFFEINE | NDC:74458-029 | NDC:82876-831 | PubChem SID:175267102 | NDC:0363-5009 | NDC:66715-9899 | NDC:83872-060 | NDC:84509-027 | NDC:49035-226 | NDC:83872-057 | NDC:46122-457 | NDC:68016-680 | NDC:63545-620 | NDC:84509-031 | NDC:72476-102 | NDC:63545-615 | NDC:52389-155 | PubChem CID:2519 | NDC:83872-067 | NDC:63545-617 | NDC:63545-616 | NDC:82876-833 | NDC:69842-509 | NDC:55301-226 | 1,3,7-trimethylpurine-2,6-dione | NDC:84751-088 | NDC:84793-005 | CAS RN:114303-55-8 | NDC:56062-030 | NDC:71179-018 | NDC:83324-074 | NDC:69842-500 | NDC:82876-832 | NDC:84752-020 | NDC:84509-030 | NDC:83059-0008 | NDC:67751-226 | NDC:52389-306 | DrugBank ID:DB00201 | NDC:70677-1126 | NDC:24470-917 | NDC:83566-159 | UNII:3G6A5W338E | NDC:52389-406 | NDC:70000-0409 | NDC:41250-320 | NDC:50804-262 | NDC:57344-220 | NDC:52389-656 | NDC:67091-117 | NDC:83872-059 | NDC:0713-0166 | NDC:84509-028 | NDC:21130-944 | NDC:63941-020 | NDC:0363-3440 | NDC:21130-226 | NDC:55910-226 | NDC:50844-226 | NDC:63545-621 | NDC:30142-726 | NDC:69168-076 | NDC:84732-037 | NDC:83872-084 | NDC:63868-114 | NDC:83872-086 | NDC:83872-058 | NDC:36800-844 | CAS RN:95789-13-2 | NDC:83872-020 | NDC:57243-226 | NDC:41163-434 | NDC:15579-201 | NDC:15579-200 | NDC:62011-0340 | NDC:66715-5530 | NDC:72988-0034 | NDC:84509-029 | NDC:53943-320 | NDC:84509-026"
+BMGC_DG06380,BMG_DG126510,"PubChem CID:25190761 | (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol | DrugBank ID:DB08285"
+BMGC_DG06381,BMG_DG126511,"PubChem SID:485663414 | UNII:9SF5AQC287 | 4,6-Dichloroisatin | 4,6-DICHLOROISATIN | PubChem CID:251908 | CAS RN:18711-15-4"
+BMGC_DG06382,BMG_DG126512,"DrugBank ID:DB14866 | Amcasertib | UNII:GLY8ABW25V | PubChem CID:25190990 | CAS RN:1129403-56-0 | N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-[2-oxo-5-(2-phenyl-1,3-thiazol-4-yl)-1H-indol-3-ylidene]methyl]-1H-pyrrole-3-carboxamide | PubChem SID:252163740 | AMCASERTIB"
+BMGC_DG06383,BMG_DG126514,"PubChem CID:25191018 | 3-(4-methoxybenzyl)-2,4-dioxo-N-(2-(piperidin-1-yl)ethyl)-1,2,3,4-tetrahydroquinazoline-7-carboxamide | 3-[(4-methoxyphenyl)methyl]-2,4-dioxo-N-(2-piperidin-1-ylethyl)-1H-quinazoline-7-carboxamide"
+BMGC_DG06384,BMG_DG126526,CAS RN:949575-24-0 | Iofolastat I-123 | Iofolastat (123I) | UNII:AQF0A29T2V | DrugBank ID:DB12514 | PubChem SID:198948532 | PubChem CID:25194767 | (2S)-2-[[(1S)-1-carboxy-5-[(4-(123I)iodanylphenyl)methylamino]pentyl]carbamoylamino]pentanedioic acid | IOFOLASTAT I-123
+BMGC_DG06385,BMG_DG126529,UNII:3L2XB4VZA6 | CAS RN:1132922-57-6 | URB-447 | PubChem CID:25195055 | PubChem SID:441332122
+BMGC_DG06386,BMG_DG126530,UNII:7N4E1X2RJM | LGD-3303 | PubChem SID:312524747 | PubChem CID:25195253 | CAS RN:917891-35-1
+BMGC_DG06387,BMG_DG126531,PubChem SID:198985797 | PubChem CID:25195294 | LDN-193189 | CAS RN:1062368-24-4 | UNII:W69H5YQU9O
+BMGC_DG06388,BMG_DG126533,"PubChem CID:25195347 | DrugBank ID:DB07045 | (2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol"
+BMGC_DG06389,BMG_DG126542,JNJ-40411813 | UNII:612BYT76F3 | PubChem CID:25195461 | CAS RN:1127498-03-6 | DrugBank ID:DB12059 | 1-butyl-3-chloro-4-(4-phenylpiperidin-1-yl)pyridin-2-one | PubChem SID:313183348 | Jnj-40411813
+BMGC_DG06390,BMG_DG126543,"DrugBank ID:DB14822 | CAS RN:380899-24-1 | SB-649868 | PubChem SID:346540998 | (S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide | UNII:1L1V1K2M4V | PubChem CID:25195495 | N-[[(2S)-1-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]piperidin-2-yl]methyl]-1-benzofuran-4-carboxamide"
+BMGC_DG06391,BMG_DG126546,"NDC:51407-918 | NDC:82381-2174 | BEXAGLIFLOZIN | PubChem SID:316910553 | PubChem CID:25195624 | DrugBank ID:DB12236 | CAS RN:1118567-05-7 | UNII:EY00JF42FV | (2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-(2-cyclopropyloxyethoxy)phenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | Bexagliflozin | NDC:82381-2000"
+BMGC_DG06392,BMG_DG126549,8-BROMOXANTHINE | PubChem CID:25198 | UNII:1JQ13K1223 | CAS RN:10357-68-3 | PubChem SID:310825843
+BMGC_DG06393,BMG_DG126556,PubChem CID:25199766 | Tetrathiomolybdate | DrugBank ID:DB05088
+BMGC_DG06394,BMG_DG126559,"(2S,3S,4R,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | CAS RN:13870-90-1 | PubChem CID:25199905"
+BMGC_DG06395,BMG_DG126562,"CID 25199964 | CAS RN:13422-51-0 | cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate | PubChem CID:25199964"
+BMGC_DG06396,BMG_DG126566,"CAS RN:56949-77-0 | PubChem CID:2520 | UNII:CJ0O37KU29 | DrugBank ID:DB00661 | CAS RN:52-53-9 | PubChem SID:175271814 | 2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile | Verapamil | VERAPAMIL"
+BMGC_DG06397,BMG_DG126611,"CAS RN:46495-39-0 | 1D-myo-inositol 4-phosphate(2-) | [(2S,3S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl] phosphate | PubChem CID:25200523"
+BMGC_DG06398,BMG_DG126958,"PubChem CID:25202509 | CAS RN:987-78-0 | [[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(trimethylazaniumyl)ethyl phosphate | CAS RN:99470-45-8 | Cytidine diphosphate choline"
+BMGC_DG06399,BMG_DG127123,2-[(2-Ammoniopropanoyl)amino]pentanedioate | PubChem CID:25203511 | 2-(2-azaniumylpropanoylamino)pentanedioate
+BMGC_DG06400,BMG_DG127190,"DrugBank ID:DB08555 | PubChem CID:25203945 | 1-(3-bromophenyl)-7-chloro-6-methoxy-3,4-dihydroisoquinoline"
+BMGC_DG06401,BMG_DG127191,"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one | PubChem CID:25203955 | DrugBank ID:DB08703"
+BMGC_DG06402,BMG_DG127195,"TERN-101 | PubChem SID:461434510 | PubChem CID:25204767 | 6-[4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]piperidin-1-yl]-1-methylindole-3-carboxylic acid | CAS RN:1103500-20-4 | Tern-101 | UNII:VVA2ZDV3LX"
+BMGC_DG06403,BMG_DG127197,CAS RN:1015439-77-6 | PubChem SID:198964547 | UNII:0K6PF1S692 | AX-9657 | PubChem CID:25205741
+BMGC_DG06404,BMG_DG127202,PubChem CID:25207689 | PubChem SID:198936216 | UNII:0E8LA9H0RY | GNE-477 | CAS RN:1032754-81-6
+BMGC_DG06405,BMG_DG127208,PubChem CID:25208880 | PBR-06 | PubChem SID:198970752 | UNII:FS47VOF3O7 | CAS RN:1104493-11-9
+BMGC_DG06406,BMG_DG127213,UNII:9QV7JG4XYZ | PubChem SID:441331481 | BGC-20-1531 | PubChem CID:25209437 | sodium;[4-[[4-(5-methoxypyridin-2-yl)phenoxy]methyl]-5-methylfuran-2-carbonyl]-(2-methylphenyl)sulfonylazanide | Bgc-20-1531 | CAS RN:1186532-61-5
+BMGC_DG06407,BMG_DG127216,CAS RN:62-37-3 | CAS RN:873376-80-8 | PubChem CID:25210 | Chlormerodrin | CAS RN:10375-56-1 | DrugBank ID:DB00534 | [3-(carbamoylamino)-2-methoxypropyl]-chloromercury
+BMGC_DG06408,BMG_DG127217,"DrugBank ID:DB06969 | 2-AMINO-4-(2,4-DICHLORO-5-(2-(1-PYRROLIDINYL)ETHOXY)PHENYL)-N-ETHYLTHIENO(2,3-D)PYRIMIDINE-6-CARBOXAMIDE | 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide | PubChem CID:25210273 | CAS RN:847559-80-2 | UNII:GWB3R6VBE7"
+BMGC_DG06409,BMG_DG127223,3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid | PubChem CID:25210476 | DrugBank ID:DB07139
+BMGC_DG06410,BMG_DG127226,"PubChem CID:25210493 | 1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine | DrugBank ID:DB07692"
+BMGC_DG06411,BMG_DG127227,"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid | DrugBank ID:DB07760 | PubChem CID:25210531"
+BMGC_DG06412,BMG_DG127228,UNII:53D46B0TIH | PubChem CID:25210550 | CAS RN:926922-22-7 | PubChem SID:198950625 | AP-24226
+BMGC_DG06413,BMG_DG127234,PubChem CID:25210792 | PubChem SID:441331379 | ASP-9521 | CAS RN:1126084-37-4 | Asp-9521 | UNII:AA79G37CPR | [4-(2-hydroxy-2-methylpropyl)piperidin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone
+BMGC_DG06414,BMG_DG127239,PubChem SID:198966370 | GSK-7227 | CAS RN:1067214-81-6 | UNII:WJD96ZH2B0 | PubChem CID:25211876
+BMGC_DG06415,BMG_DG127240,"CAS RN:1125746-49-7 | 4-((2-CYCLOBUTYL-1H-IMIDAZO(4,5-B)PYRAZIN-1-YL)METHYL)-7,8-DIFLUORO-2(1H)-QUINOLINONE | UNII:WTC48RN4RM | PubChem CID:25211910"
+BMGC_DG06416,BMG_DG127242,"DrugBank ID:DB15036 | CAS RN:1123837-84-2 | PubChem SID:310825564 | CAS RN:1609655-67-5 | Sitravatinib | 1-N'-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | PubChem CID:25212148 | CAS RN:1123837-88-6 | UNII:CWG62Q1VTB | SITRAVATINIB"
+BMGC_DG06417,BMG_DG127248,NDC:72839-214 | CAS RN:2174-16-5 | NDC:83520-214 | NDC:69993-200 | Trolamine salicylate | DrugBank ID:DB11079 | Trolamine Salicylate | NDC:41250-418 | NDC:0363-3630 | NDC:0225-0360 | NDC:72562-223 | NDC:69993-500 | TROLAMINE SALICYLATE | NDC:46122-713 | PubChem SID:175267461 | NDC:73287-001 | NDC:79903-117 | NDC:73287-022 | NDC:69993-300 | UNII:H8O4040BHD | NDC:51316-990 | NDC:41167-0570 | 2-[bis(2-hydroxyethyl)amino]ethanol;2-hydroxybenzoic acid | NDC:62742-4198 | PubChem CID:25213 | NDC:72562-103 | NDC:62742-4091 | NDC:50804-214 | NDC:72562-123 | NDC:73287-021 | NDC:70000-0169 | NDC:41250-356
+BMGC_DG06418,BMG_DG127250,PubChem SID:198951136 | CAS RN:1474-02-8 | DrugBank ID:DB09182 | UNII:9BV2D1A57H | Benzylfentanyl | PubChem CID:252141 | BENZYLFENTANYL
+BMGC_DG06419,BMG_DG127252,"PubChem SID:198964555 | DrugBank ID:DB13324 | CAS RN:10379-14-3 | PubChem CID:25215 | UNII:FO92091VP8 | Tetrazepam | 7-chloro-5-(cyclohexen-1-yl)-1-methyl-3H-1,4-benzodiazepin-2-one | TETRAZEPAM"
+BMGC_DG06420,BMG_DG127264,D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | PubChem CID:25220914 | DrugBank ID:DB06996
+BMGC_DG06421,BMG_DG127272,PubChem CID:25221720 | (1R)-3-amino-1-[3-(cyclohexylmethoxy)phenyl]propan-1-ol | UNII:02DZ1HBF0M | PubChem SID:198963348 | DrugBank ID:DB12608 | Emixustat | EMIXUSTAT | CAS RN:1141777-14-1
+BMGC_DG06422,BMG_DG127278,UNII:4FA88HM3IX | DrugBank ID:DB01527 | CAS RN:10389-73-8 | PubChem CID:25223 | Clortermine | 1-(2-chlorophenyl)-2-methylpropan-2-amine | CLORTERMINE | PubChem SID:198978061
+BMGC_DG06423,BMG_DG127291,"Capivasertib | NDC:0310-9500 | DrugBank ID:DB12218 | 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide | UNII:WFR23M21IE | PubChem SID:198977279 | CAPIVASERTIB | NDC:0310-9501 | PubChem CID:25227436 | CAS RN:1143532-39-1"
+BMGC_DG06424,BMG_DG127293,"N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide | CAS RN:898044-15-0 | N-((1S)-2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno(3,2-d)pyrimidin-4-yl)amino)-4,6-dihydropyrrolo(3,4-C)pyrazole-5(1H)-carboxamide | PubChem SID:198960926 | CAS RN:1279200-38-2 | PF-03758309 | DrugBank ID:DB11775 | UNII:PK459EA5I2 | PubChem CID:25227462"
+BMGC_DG06425,BMG_DG127294,"PubChem SID:198988414 | IOCARMIC ACID | PubChem CID:25229 | DrugBank ID:DB13755 | 3-[[6-[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)anilino]-6-oxohexanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid | CAS RN:10397-75-8 | UNII:82PB24K6TZ | Iocarmic acid"
+BMGC_DG06426,BMG_DG127299,"PubChem CID:25229537 | DrugBank ID:DB08791 | 1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE"
+BMGC_DG06427,BMG_DG127300,"PubChem CID:25229546 | DrugBank ID:DB08602 | 3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one"
+BMGC_DG06428,BMG_DG127301,"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide | PubChem CID:25229552 | DrugBank ID:DB08118"
+BMGC_DG06429,BMG_DG127311,PubChem CID:25229646 | UNII:BV2QA32ZHT | 1-((4-CYANO-4-(2-PYRIDINYL)-1-PIPERIDINYL)METHYL)-4-OXO-4H-QUINOLIZINE-3-CARBOXYLIC ACID | CAS RN:1144504-35-7
+BMGC_DG06430,BMG_DG127316,"PubChem SID:198960577 | CAS RN:1133819-87-0 | 5-[[4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | PubChem CID:25230266 | UNII:81MXZ6QOBM | Msdc-0602 | AZEMIGLITAZONE"
+BMGC_DG06431,BMG_DG127336,UNII:FM7JG3L4SR | CAS RN:1133432-49-1 | PubChem CID:25234918 | GDC-0834 | PubChem SID:198964790
+BMGC_DG06432,BMG_DG127349,"19-HYDROXYANDROSTENEDIONE | UNII:A546CQ0584 | CAS RN:61342-08-3 | 19-Hydroxyandrost-4-ene-3,17-dione | (8R,9S,10S,13S,14S)-10-(hydroxymethyl)-13-methyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | CAS RN:510-64-5 | PubChem SID:249817542 | PubChem CID:252379"
+BMGC_DG06433,BMG_DG127353,"5-{2-[1-(5-Hydroxy-1,5-dimethyl-hexyl)-7A-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol | 5-[2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | PubChem CID:2524 | CAS RN:78782-99-7 | CAS RN:73837-24-8 | CAS RN:32222-06-3"
+BMGC_DG06434,BMG_DG127356,"CAS RN:374675-21-5 | PubChem CID:25240297 | Kisspeptin-10 | (2S)-N-[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]butanediamide"
+BMGC_DG06435,BMG_DG127400,GNE-493 | UNII:0L843LS9YK | PubChem CID:25242324 | CAS RN:1033735-94-2 | PubChem SID:198968821
+BMGC_DG06436,BMG_DG127402,"12-epi-Salvinorin A | methyl (2R,4aR,6aR,7R,9S,10aS,10bR)-9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate | PubChem CID:25242485"
+BMGC_DG06437,BMG_DG127403,"PubChem CID:25242512 | UNII:9U1ETH79CK | SOLITHROMYCIN | CAS RN:760981-83-7 | DrugBank ID:DB09308 | Solithromycin | (1S,2R,5S,7R,8R,9R,11R,13R,14R)-15-[4-[4-(3-aminophenyl)triazol-1-yl]butyl]-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-5-fluoro-9-methoxy-1,5,7,9,11,13-hexamethyl-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone | PubChem SID:198967877"
+BMGC_DG06438,BMG_DG127405,DrugBank ID:DB08400 | 4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid | PubChem CID:25243828
+BMGC_DG06439,BMG_DG127406,"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE | DrugBank ID:DB07689 | PubChem CID:25243853"
+BMGC_DG06440,BMG_DG127493,"PubChem CID:25244225 | (4S,6R)-6-[(2R,4R)-4,6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-5-sulfonatooxyoxane-2-carboxylate"
+BMGC_DG06441,BMG_DG127494,2-[(2-azaniumyl-3-sulfanylpropanoyl)amino]acetate | PubChem CID:25244227 | [(2-Ammonio-3-mercaptopropanoyl)amino]acetate
+BMGC_DG06442,BMG_DG127567,Phosphinothricin | 2-azaniumyl-4-[methyl(oxido)phosphoryl]butanoate | PubChem CID:25244585
+BMGC_DG06443,BMG_DG127662,"N-Trans-Sinapoyltyramine | (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide | PubChem CID:25245053 | CAS RN:200125-11-7"
+BMGC_DG06444,BMG_DG127934,"(3S)-3-[[(2S)-4-amino-2-[[(2S)-2-(decanoylamino)-3-(1H-indol-3-yl)propanoyl]amino]-4-oxobutanoyl]amino]-4-[[(3S,6S,9R,15S,18R,21S,24S,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2S)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonazacyclohentriacont-30-yl]amino]-4-oxobutanoic acid | decanoyl-Trp-Asn-Asp-Thr(1)-Gly-Orn-Asp-D-Ala-Asp-Gly-D-Ser-Glu(3S-Me)-Asp(Ph(2-NH2))-(1) | PubChem CID:25246315"
+BMGC_DG06445,BMG_DG127943,"UNII:4R1VB9P8V3 | PubChem SID:175266940 | PubChem CID:25249 | CAS RN:302-96-5 | CAS RN:10418-03-8 | Stanozolol | (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol | DrugBank ID:DB06718 | STANOZOLOL"
+BMGC_DG06446,BMG_DG127953,"(2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one | UNII:1C854K1MIJ | CAS RN:1032754-93-0 | PubChem SID:198974042 | APITOLISIB | Apitolisib | DrugBank ID:DB12180 | PubChem CID:25254071"
+BMGC_DG06447,BMG_DG127956,"Retrofractamide C | PubChem CID:25255091 | CAS RN:96386-33-3 | (2E,8E)-9-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)nona-2,8-dienamide"
+BMGC_DG06448,BMG_DG127957,UNII:6X97K9I3QN | PubChem SID:198967066 | CAS RN:873541-45-8 | PubChem CID:25255436 | ASB-16165
+BMGC_DG06449,BMG_DG127961,PubChem CID:25256804 | CAS RN:1149350-68-4 | FTI-2600 | PubChem SID:443625098 | UNII:GN8X39GD6J
+BMGC_DG06450,BMG_DG127968,"1,3-dihydroxypropan-2-yl dihydrogen phosphate | CAS RN:17181-54-3 | DrugBank ID:DB01779 | UNII:WWH06G87W6 | PubChem CID:2526 | Glycerol 2-phosphate | beta-Glycerophosphoric acid | PubChem SID:198975912 | GLYCERYL 2-PHOSPHATE"
+BMGC_DG06451,BMG_DG127972,"PubChem SID:198984517 | VISTUSERTIB | CAS RN:1009298-59-2 | UNII:0BSC3P4H5X | Vistusertib | 3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide | DrugBank ID:DB11925 | PubChem CID:25262792"
+BMGC_DG06452,BMG_DG127973,"AZD-8055 | PubChem SID:198965343 | DrugBank ID:DB12774 | [5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol | CAS RN:1009298-09-2 | [5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol | PubChem CID:25262965 | UNII:970JJ37FPW"
+BMGC_DG06453,BMG_DG127974,"PubChem CID:25263223 | DrugBank ID:DB07316 | N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide"
+BMGC_DG06454,BMG_DG127975,"PubChem SID:445500210 | DrugBank ID:DB08008 | CAS RN:898743-92-5 | UNII:A94AKH2DCP | DSM-74 | PubChem CID:25263414 | 5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine"
+BMGC_DG06455,BMG_DG127981,PubChem SID:348481496 | CAS RN:1144035-53-9 | PF-8380 | UNII:T582DIM5A4 | PubChem CID:25265312
+BMGC_DG06456,BMG_DG127988,"NDC:64842-0727 | PubChem SID:363908061 | CAS RN:1141397-80-9 | (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one | CEDAZURIDINE | UNII:39IS23Q1EW | Cedazuridine | PubChem CID:25267009"
+BMGC_DG06457,BMG_DG127996,N-(4-((3-CHLORO-4-(2-PYRIDINYLMETHOXY)PHENYL)AMINO)-3-CYANO-7-ETHOXY-6-QUINOLINYL)ACETAMIDE | UNII:XV5WRB7CU8 | N-[4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]acetamide | PubChem CID:25267994 | PubChem SID:472425517 | CAS RN:915941-95-6
+BMGC_DG06458,BMG_DG127999,UNII:JG1E8503OI | PubChem CID:252682 | PubChem SID:198968048 | CAS RN:501919-59-1 | S31-201
+BMGC_DG06459,BMG_DG128010,beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide | PubChem CID:25271577 | DrugBank ID:DB07083
+BMGC_DG06460,BMG_DG128011,(2R)-4-methyl-2-[(4-phenylphenyl)sulfonylamino]pentanoic acid | PubChem CID:25271580 | DrugBank ID:DB07446 | N-(biphenyl-4-ylsulfonyl)-D-leucine
+BMGC_DG06461,BMG_DG128013,"3,6-dichloro-2-(4-methyl-2-propan-2-yloxyphenyl)chromen-4-one | 3,6-Dichloro-2'-isopropyloxy-4'-methylflavone | PubChem CID:252716 | CAS RN:70460-45-6"
+BMGC_DG06462,BMG_DG128045,"PubChem CID:25271869 | UNII:SI0GI3B15S | BERLAFENONE, (R)- | CAS RN:1394906-83-2 | PubChem SID:252319240"
+BMGC_DG06463,BMG_DG128067,"3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoic acid | UNII:CM1N99QR1M | DrugBank ID:DB09346 | METRIZOIC ACID | Metrizoic acid | PubChem CID:2528 | CAS RN:1949-45-7 | PubChem SID:198935624"
+BMGC_DG06464,BMG_DG128077,"Chloropyramine | PubChem CID:25295 | UNII:2K3L8O9SOV | CHLOROPYRAMINE | CAS RN:59-32-5 | N'-[(4-chlorophenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine | PubChem SID:198970786 | DrugBank ID:DB08800"
+BMGC_DG06465,BMG_DG128089,"PubChem CID:2531 | PubChem SID:316916272 | Calmidazolium | UNII:4R9H38JAWL | CALMIDAZOLIUM ION | 1-[bis(4-chlorophenyl)methyl]-3-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazol-3-ium | CAS RN:95013-41-5"
+BMGC_DG06466,BMG_DG128097,"TOFENACIN | N-methyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine | PubChem SID:440088474 | Tofenacin | PubChem SID:198989622 | CAS RN:33431-04-8 | TOFENACIN, (+)- | UNII:D67B6M43WW | CAS RN:15301-93-6 | PubChem CID:25315 | PubChem SID:440088400 | UNII:WV5MS5T7YD | CAS RN:33431-05-9 | TOFENACIN, (-)- | UNII:C4A112M10H"
+BMGC_DG06467,BMG_DG128126,"PubChem CID:2533 | CAS RN:924657-57-8 | CAS RN:121263-19-2 | 1-[3,10-dihydroxy-12-[2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl benzoate | 1-[3,10-Dihydroxy-12-(2-{[(4-hydroxyphenoxy)carbonyl]oxy}propyl)-2,6,7,11-tetramethoxy-4,9-dioxo-4,9-dihydroperylen-1-yl]propan-2-yl benzoate"
+BMGC_DG06468,BMG_DG128132,UNII:RH5JA4Q3UX | PubChem CID:25333445 | 1-Phenyl-4-[[4-(1H-pyrazol-1-yl)phenyl]methyl]piperazine | 1-PHENYL-4-((4-(1H-PYRAZOL-1-YL)PHENYL)METHYL)PIPERAZINE | CAS RN:896717-74-1 | PubChem SID:482554107
+BMGC_DG06469,BMG_DG128146,CAMOSTAT | Camostat | CAS RN:59721-28-7 | UNII:0FD207WKDU | PubChem CID:2536 | [4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl] 4-(diaminomethylideneamino)benzoate | PubChem SID:198975915 | DrugBank ID:DB13729
+BMGC_DG06470,BMG_DG128147,"PubChem CID:253602 | CAS RN:22862-76-6 | UNII:6C74YM2NGI | Anisomycin | CAS RN:21497-40-5 | PubChem SID:198967374 | ANISOMYCIN | DrugBank ID:DB07374 | CAS RN:11023-48-6 | [(2R,3S,4S)-4-hydroxy-2-[(4-methoxyphenyl)methyl]pyrrolidin-3-yl] acetate"
+BMGC_DG06471,BMG_DG128153,"CAS RN:76-22-2 | PubChem CID:2537 | 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one | DrugBank ID:DB14156 | CAS RN:21368-68-3 | Camphor"
+BMGC_DG06472,BMG_DG128158,"PubChem CID:25378 | CAS RN:10563-26-5 | 1,5,8,12-TETRAAZADODECANE | UNII:0EXW8894XX | PubChem SID:198987719"
+BMGC_DG06473,BMG_DG128160,CURINE | PubChem CID:253793 | UNII:6037FRH2SX | PubChem SID:198965650 | CAS RN:436-05-5
+BMGC_DG06474,BMG_DG128162,"DrugBank ID:DB13384 | PubChem CID:25382 | 3-(10,10-dimethylanthracen-9-ylidene)-N,N-dimethylpropan-1-amine | UNII:Q7T0Y1109Z | CAS RN:5118-29-6 | Melitracen | PubChem SID:198977975 | MELITRACEN"
+BMGC_DG06475,BMG_DG128163,PubChem CID:253834 | UNII:KY2D9CAQ7P | EDULEINE | PubChem SID:441658311 | 7-methoxy-1-methyl-2-phenylquinolin-4-one | CAS RN:483-51-2 | Eduleine
+BMGC_DG06476,BMG_DG128176,NDC:49884-660 | Candesartan cilexetil | NDC:63629-9842 | 1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate | CAS RN:145040-37-5 | NDC:62332-343 | NDC:70771-1207 | CANDESARTAN CILEXETIL | NDC:62559-643 | NDC:62559-662 | NDC:43547-459 | NDC:70771-1204 | NDC:51407-883 | NDC:62559-650 | NDC:33342-133 | NDC:63629-2126 | NDC:62559-688 | UNII:R85M2X0D68 | NDC:46708-342 | NDC:70771-1326 | PubChem SID:175271989 | NDC:0378-3002 | NDC:62332-060 | NDC:33342-132 | NDC:46708-341 | NDC:49884-658 | NDC:0378-3003 | NDC:46708-060 | NDC:60687-241 | NDC:0378-3001 | NDC:33342-117 | NDC:72162-1510 | NDC:70771-1325 | NDC:70771-1205 | NDC:62559-640 | NDC:62332-341 | NDC:62559-641 | NDC:0378-3224 | NDC:0378-3225 | NDC:49884-661 | Candesartan Cilexetil | NDC:72162-1511 | NDC:49884-659 | NDC:60687-130 | NDC:46708-343 | NDC:51407-885 | NDC:60687-119 | NDC:62559-652 | NDC:0378-3231 | NDC:62559-686 | NDC:62559-689 | NDC:62559-687 | NDC:70771-1327 | NDC:62559-661 | DrugBank ID:DB00796 | NDC:33342-116 | NDC:62559-642 | NDC:70771-1206 | NDC:62559-660 | NDC:51407-884 | NDC:43547-461 | NDC:62559-651 | NDC:0378-3232 | NDC:33342-115 | NDC:33342-114 | NDC:43547-460 | NDC:62332-342 | PubChem CID:2540 | NDC:63629-2127 | NDC:51407-882 | NDC:33342-131
+BMGC_DG06477,BMG_DG128178,"UNII:BDQ30W2KTS | SXR-1096 | CAS RN:1087624-28-9 | 6-ethoxy-7-methoxy-2-[2-(methylsulfanyl)phenyl]-4H-3,1-benzoxazin-4-one | 6-ethoxy-7-methoxy-2-(2-methylsulfanylphenyl)-3,1-benzoxazin-4-one | PubChem CID:25400580 | PubChem SID:329903723"
+BMGC_DG06478,BMG_DG128184,CANDESARTAN | 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid | UNII:S8Q36MD2XX | DrugBank ID:DB13919 | Candesartan | CAS RN:139481-59-7 | PubChem CID:2541 | PubChem SID:175267827
+BMGC_DG06479,BMG_DG128196,Clodronic acid | DrugBank ID:DB00720 | [dichloro(phosphono)methyl]phosphonic acid | CLODRONIC ACID | Clodronic Acid | PubChem SID:175267351 | CAS RN:10596-23-3 | UNII:0813BZ6866 | PubChem CID:25419
+BMGC_DG06480,BMG_DG128201,CARBENDAZIM | PubChem SID:198977126 | PubChem CID:25429 | DrugBank ID:DB13009 | CAS RN:10605-21-7 | CAS RN:105268-95-9 | CAS RN:37953-07-4 | UNII:H75J14AA89 | Carbendazim | CAS RN:39413-19-9 | methyl N-(1H-benzimidazol-2-yl)carbamate
+BMGC_DG06481,BMG_DG128202,"PubChem SID:198959880 | Cannabinol | UNII:7UYP6MC9GH | CANNABINOL | CAS RN:521-35-7 | 6,6,9-trimethyl-3-pentylbenzo[c]chromen-1-ol | DrugBank ID:DB14737 | PubChem CID:2543"
+BMGC_DG06482,BMG_DG128203,"2-Methyl-2-propylpropane-1,3-diyl dinitrate | PubChem CID:25430 | PubChem SID:198982969 | DrugBank ID:DB13408 | [2-methyl-2-(nitrooxymethyl)pentyl] nitrate | CAS RN:10605-24-0 | UNII:C317706XA7 | 2-METHYL-2-PROPYLPROPANE-1,3-DIYL DINITRATE"
+BMGC_DG06483,BMG_DG128209,"COFORMYCIN | PubChem SID:198946609 | (2R,3R,4S,5R)-2-[(8R)-8-hydroxy-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-3-yl]-5-(hydroxymethyl)oxolane-3,4-diol | CAS RN:11033-22-0 | UNII:E49510ZL0H | PubChem CID:25447 | Coformycin"
+BMGC_DG06484,BMG_DG128226,"2,3,4,5-Tetrachloro-6-(3-hydroxy-2,4,5,7-tetraiodo-6-oxo-xanthen-9-yl)benzoic acid | CAS RN:152-74-9 | DrugBank ID:DB11182 | PubChem CID:25474 | CAS RN:11121-48-5 | 2,3,4,5-tetrachloro-6-(3-hydroxy-2,4,5,7-tetraiodo-6-oxoxanthen-9-yl)benzoic acid"
+BMGC_DG06485,BMG_DG128227,CAS RN:11128-99-7 | PubChem CID:25476 | 3-amino-4-[[1-[[1-[[1-[[1-[[1-[2-[(1-carboxy-2-phenylethyl)carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
+BMGC_DG06486,BMG_DG128242,"NICOFURANOSE | CAS RN:15351-13-0 | CAS RN:12041-87-1 | Nicofuranose | PubChem CID:25495 | UNII:GF99P6327K | PubChem SID:198955412 | [(2R,3R,4S,5R)-5-hydroxy-3,4-bis(pyridine-3-carbonyloxy)-5-(pyridine-3-carbonyloxymethyl)oxolan-2-yl]methyl pyridine-3-carboxylate | DrugBank ID:DB13422"
+BMGC_DG06487,BMG_DG128244,bis(4-nitrophenyl) hydrogen phosphate | DrugBank ID:DB07418 | CAS RN:645-15-8 | UNII:1MF77LEI63 | BIS(4-NITROPHENYL)PHOSPHATE | PubChem SID:438788635 | Bis(4-nitrophenyl)phosphate | PubChem CID:255
+BMGC_DG06488,BMG_DG128249,DrugBank ID:DB00411 | PubChem CID:2551 | CARBAMOYLCHOLINE | PubChem SID:175267269 | 2-carbamoyloxyethyl(trimethyl)azanium | UNII:54Z8M50D6Q | CAS RN:2260-51-7 | CAS RN:462-58-8 | Carbamoylcholine
+BMGC_DG06489,BMG_DG128257,Ammonium Chloride | CAS RN:12125-02-9 | Ammonium chloride | PubChem CID:25517 | AMMONIUM CHLORIDE | PubChem SID:175268845 | UNII:01Q9PC255D | DrugBank ID:DB06767 | azanium;chloride | CAS RN:99011-95-7
+BMGC_DG06490,BMG_DG128264,NDC:71610-782 | NDC:50268-172 | NDC:0781-5987 | NDC:71930-074 | NDC:50268-170 | Carbamazepine | NDC:62135-802 | NDC:27241-232 | NDC:0078-0510 | NDC:43353-953 | NDC:71335-0691 | NDC:0093-0778 | NDC:68071-2701 | NDC:50268-171 | NDC:60505-2807 | NDC:70518-3911 | NDC:0078-0512 | NDC:70518-2456 | NDC:0093-0090 | NDC:70518-1433 | NDC:63629-8720 | NDC:51672-4123 | NDC:66993-408 | NDC:60505-2806 | NDC:69238-1213 | NDC:0615-8125 | NDC:60687-479 | NDC:16714-065 | NDC:42806-275 | NDC:51672-4047 | NDC:29033-020 | PubChem CID:2554 | NDC:35561-355 | NDC:70771-1468 | NDC:60687-583 | NDC:13668-271 | NDC:50742-259 | NDC:62135-867 | NDC:0078-0511 | NDC:51672-4124 | NDC:70518-4042 | NDC:59746-790 | NDC:68788-7825 | CARBAMAZEPINE | NDC:72162-2021 | NDC:62135-930 | NDC:70518-3773 | NDC:70771-1469 | NDC:0078-0508 | NDC:60429-032 | NDC:59746-791 | NDC:75834-220 | NDC:50742-257 | NDC:51407-895 | NDC:62135-928 | NDC:72664-218 | NDC:68084-444 | NDC:60429-934 | NDC:71930-073 | NDC:71335-1730 | NDC:71205-025 | NDC:50090-5740 | NDC:16571-680 | NDC:13668-268 | NDC:60290-059 | NDC:62135-927 | NDC:55154-1396 | NDC:70518-4167 | NDC:68382-556 | NDC:68382-555 | UNII:33CM23913M | NDC:72189-157 | NDC:16714-063 | benzo[b][1]benzazepine-11-carboxamide | NDC:16714-064 | NDC:51672-4041 | NDC:70771-1470 | NDC:50742-258 | NDC:68382-557 | NDC:0615-8493 | NDC:68788-7210 | NDC:29033-004 | PubChem SID:175266830 | NDC:27241-231 | NDC:51672-4149 | NDC:63629-9292 | NDC:0781-8016 | NDC:63629-8753 | NDC:0093-0109 | NDC:16571-681 | NDC:70518-3699 | NDC:0781-5988 | NDC:42806-274 | NDC:54092-172 | NDC:54092-173 | NDC:0832-6023 | NDC:51407-897 | NDC:60505-2805 | NDC:35561-356 | NDC:70518-3146 | NDC:69238-1215 | NDC:60505-0183 | NDC:0615-8545 | NDC:69238-1214 | NDC:51672-4050 | NDC:0904-6885 | NDC:66993-407 | NDC:29033-019 | NDC:51672-4005 | NDC:51672-4125 | NDC:75834-221 | NDC:51407-896 | NDC:43063-328 | NDC:0904-6172 | NDC:71930-072 | NDC:66993-409 | NDC:0832-6022 | NDC:51672-4151 | NDC:35561-357 | CAS RN:298-46-4 | NDC:70518-2242 | NDC:70954-240 | NDC:63629-8715 | NDC:0904-3854 | NDC:0832-6024 | NDC:67386-621 | DrugBank ID:DB00564 | NDC:63629-8721 | NDC:70518-2841 | NDC:70518-2489 | NDC:29300-382 | NDC:16571-682 | NDC:54092-171 | NDC:60687-594 | NDC:0904-7116 | NDC:27241-233 | NDC:60290-060 | NDC:51672-4150 | NDC:69452-312 | NDC:71335-0461 | NDC:51407-215 | NDC:60290-058 | NDC:70518-2426 | NDC:0078-0509 | NDC:42806-276 | NDC:59746-789
+BMGC_DG06491,BMG_DG128268,"CAS RN:36507-30-9 | Carbamazepine epoxide | CARBAMAZEPINE-10,11-EPOXIDE | UNII:QC9505F279 | PubChem SID:198961749 | 3-oxa-11-azatetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaene-11-carboxamide | PubChem CID:2555"
+BMGC_DG06492,BMG_DG128277,2-Ethoxycarbonylpyrrole | UNII:82UQX6WL9N | PubChem SID:474492454 | PubChem CID:255670 | 2-ETHOXYCARBONYLPYRROLE | CAS RN:2199-43-1
+BMGC_DG06493,BMG_DG128287,PubChem CID:255799 | CAS RN:875-66-1 | 4-CINNOLINOL | PubChem SID:374388645 | UNII:KUS8838BCK
+BMGC_DG06494,BMG_DG128307,"6,7-Dibromoquinoline-5,8-dione | UNII:LBN9K78MS5 | CAS RN:18633-05-1 | PubChem SID:474492493 | PubChem CID:255964 | 6,7-DIBROMOQUINOLINE-5,8-DIONE"
+BMGC_DG06495,BMG_DG128308,CAS RN:1477-19-6 | UNII:23ZW4BG89C | (2-ethyl-1-benzofuran-3-yl)-(4-hydroxyphenyl)methanone | Benzarone | BENZARONE | PubChem SID:198974085 | PubChem CID:255968
+BMGC_DG06496,BMG_DG128321,UNII:32C726X12W | PubChem SID:175266205 | PENTOXYVERINE | Carbetapentane | 2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate | Pentoxyverine | PubChem CID:2562 | DrugBank ID:DB11186 | CAS RN:77-23-6
+BMGC_DG06497,BMG_DG128332,"DrugBank ID:DB00748 | PubChem CID:2564 | CARBINOXAMINE | CAS RN:486-16-8 | PubChem SID:175271771 | Carbinoxamine | UNII:982A7M02H5 | 2-[(4-chlorophenyl)-pyridin-2-ylmethoxy]-N,N-dimethylethanamine"
+BMGC_DG06498,BMG_DG128333,4-HEPTYLOXYPHENOL | PubChem SID:313390091 | CAS RN:13037-86-0 | UNII:W9GSE02182 | PubChem CID:25641
+BMGC_DG06499,BMG_DG128338,"PubChem CID:25654 | REPROTEROL | DrugBank ID:DB12846 | Reproterol | PubChem SID:198943943 | 7-[3-[[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino]propyl]-1,3-dimethylpurine-2,6-dione | CAS RN:54063-54-6 | UNII:11941YC6RN"
+BMGC_DG06500,BMG_DG128344,"CAS RN:1563-66-2 | (2,2-dimethyl-3H-1-benzofuran-7-yl) N-methylcarbamate | PubChem CID:2566 | PubChem SID:198962696 | UNII:SKF77S6Y67 | Carbofuran | CARBOFURAN"
+BMGC_DG06501,BMG_DG128353,"CAS RN:1228-72-4 | 17.ALPHA.-ESTRIOL | PubChem CID:256737 | PubChem SID:198975099 | DrugBank ID:DB07702 | (8R,9S,13S,14S,16R,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol | 17-Epiestriol | UNII:4G7IHY560Z | 17alpha-Estriol"
+BMGC_DG06502,BMG_DG128366,"UNII:1CB0HBT12C | Carbazilquinone | PubChem CID:2569 | PubChem SID:198949109 | DrugBank ID:DB13677 | [2-[2,5-bis(aziridin-1-yl)-4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl]-2-methoxyethyl] carbamate | CARBOQUONE | CAS RN:24279-91-2"
+BMGC_DG06503,BMG_DG128369,"PubChem CID:25701 | 2-amino-3-sulfopropanoic acid | CAS RN:13100-82-8 | 3-Sulfoalanine | UNII:A3OGP4C37W | CYSTEIC ACID, DL- | PubChem SID:198956210 | CAS RN:3024-83-7"
+BMGC_DG06504,BMG_DG128372,"PubChem SID:241180379 | CAS RN:13114-72-2 | UNII:NR12XN9HWN | PubChem CID:25711 | N-METHYL-N',N'-DIPHENYLUREA"
+BMGC_DG06505,BMG_DG128402,"[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol | 5-(4'-{[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl}biphenyl-2-yl)tetrazol-1-ide | PubChem CID:25749227"
+BMGC_DG06506,BMG_DG128410,NDC:65862-158 | NDC:68071-5075 | [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate | NDC:72789-182 | NDC:45865-233 | NDC:76420-852 | PubChem CID:2576 | NDC:62135-241 | NDC:76420-853 | NDC:70518-2800 | NDC:71205-704 | NDC:63629-8478 | NDC:71610-617 | NDC:29033-214 | NDC:71335-9613 | NDC:63187-786 | NDC:72189-310 | NDC:55700-954 | UNII:21925K482H | NDC:50742-656 | NDC:52536-688 | NDC:61919-878 | NDC:72162-1524 | NDC:69584-111 | NDC:63561-0127 | NDC:29033-207 | NDC:70518-3792 | NDC:50090-5953 | NDC:71335-1203 | NDC:71205-241 | NDC:63629-8477 | NDC:82868-062 | NDC:63629-8479 | NDC:72789-190 | NDC:72162-1928 | NDC:80425-0291 | DrugBank ID:DB00395 | NDC:76420-646 | Carisoprodol | NDC:50228-109 | NDC:42543-700 | NDC:71205-339 | NDC:63629-9144 | NDC:50090-5955 | NDC:65862-693 | NDC:16571-780 | CAS RN:78-44-4 | NDC:0037-2250 | NDC:63629-2416 | NDC:71610-531 | CARISOPRODOL | NDC:71335-9621 | NDC:71610-430 | NDC:72189-386 | NDC:52536-682 | NDC:60429-508 | NDC:0037-2001 | PubChem SID:175271615 | NDC:16571-781 | NDC:51525-5901 | NDC:55289-049 | NDC:71610-761
+BMGC_DG06507,BMG_DG128415,"Hydroxydione | PubChem SID:198984627 | PubChem CID:257630 | DrugBank ID:DB08956 | CAS RN:303-01-5 | (5R,8R,9S,10S,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | HYDROXYDIONE | UNII:B7VFN88375"
+BMGC_DG06508,BMG_DG128421,"CARMOFUR | 5-fluoro-N-hexyl-2,4-dioxopyrimidine-1-carboxamide | CAS RN:61422-45-5 | UNII:HA82M3RAB2 | PubChem CID:2577 | PubChem SID:198956718 | DrugBank ID:DB09010 | Carmofur"
+BMGC_DG06509,BMG_DG128431,"Carmustine | DrugBank ID:DB00262 | CARMUSTINE | PubChem SID:175267191 | UNII:U68WG3173Y | 1,3-bis(2-chloroethyl)-1-nitrosourea | PubChem CID:2578 | NDC:24338-050 | CAS RN:154-93-8"
+BMGC_DG06510,BMG_DG128433,UNII:2UC9XAN8CV | PubChem SID:441583910 | CAS RN:41781-86-6 | ESTRADIOL 3-TETRAHYDROPYRANYL ETHER | PubChem CID:257864
+BMGC_DG06511,BMG_DG128445,PubChem SID:485666417 | N-BENZYLOXYCARBONYL-L-LYSINYL-L-PROLINE | N-Benzyloxycarbonyl-L-lysinyl-L-proline | PubChem CID:25796551 | CAS RN:72169-44-9 | UNII:YW9LLN8LNC
+BMGC_DG06512,BMG_DG128449,(2S)-5-[[amino-(hydroxyamino)methylidene]amino]-2-azaniumylpentanoate | Nomega-hydroxy-L-arginine | PubChem CID:25799416
+BMGC_DG06513,BMG_DG128451,"CARPIPRAMINE | PubChem CID:2580 | UNII:8AFK6F91EQ | Carpipramine | CAS RN:5942-95-0 | PubChem SID:198957665 | 1-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]-4-piperidin-1-ylpiperidine-4-carboxamide"
+BMGC_DG06514,BMG_DG128453,"CAS RN:13246-02-1 | PubChem CID:25803 | DrugBank ID:DB13303 | FEBARBAMATE | UNII:5Z48ONN38P | [1-butoxy-3-(5-ethyl-2,4,6-trioxo-5-phenyl-1,3-diazinan-1-yl)propan-2-yl] carbamate | PubChem SID:198941761 | Febarbamate"
+BMGC_DG06515,BMG_DG128462,PubChem CID:2581 | CARPROFEN | DrugBank ID:DB00821 | UNII:FFL0D546HO | CAS RN:53716-49-7 | 2-(6-chloro-9H-carbazol-2-yl)propanoic acid | CAS RN:52263-47-5 | Carprofen | PubChem SID:175271389
+BMGC_DG06516,BMG_DG128475,"UNII:8NF31401XG | PubChem CID:2583 | DrugBank ID:DB00521 | 5-[3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-1H-quinolin-2-one | CAS RN:51781-06-7 | CARTEOLOL | PubChem SID:175271547 | Carteolol"
+BMGC_DG06517,BMG_DG128487,NDC:65862-142 | NDC:67296-1899 | NDC:43063-126 | NDC:68001-154 | NDC:51655-029 | NDC:68788-8252 | NDC:80725-139 | NDC:72189-372 | NDC:58657-753 | NDC:60760-494 | NDC:68084-854 | NDC:72888-034 | NDC:0904-6303 | NDC:80725-140 | NDC:68462-165 | NDC:0904-7305 | NDC:82804-138 | NDC:50090-1069 | NDC:50090-2175 | NDC:68001-153 | NDC:60760-376 | NDC:68462-164 | NDC:68645-350 | NDC:70518-4004 | NDC:51079-932 | NDC:0615-8389 | NDC:68001-151 | NDC:43063-125 | NDC:82009-126 | NDC:55111-253 | NDC:68788-8231 | NDC:0615-8387 | NDC:51655-030 | NDC:63187-570 | NDC:82009-128 | NDC:0093-0135 | NDC:68071-2230 | NDC:55154-7278 | NDC:63187-131 | UNII:0K47UL67F2 | CARVEDILOL | NDC:65841-617 | NDC:67046-2005 | NDC:0904-6300 | NDC:43353-832 | NDC:55154-6885 | NDC:71335-2026 | NDC:42708-072 | NDC:43353-874 | NDC:68071-5275 | NDC:51407-040 | NDC:58657-751 | NDC:63187-447 | NDC:58657-750 | NDC:70518-3945 | NDC:0781-5221 | NDC:58657-752 | NDC:67046-1022 | NDC:76385-112 | DrugBank ID:DB01136 | NDC:51655-397 | NDC:71335-2101 | NDC:63629-4060 | NDC:68788-7910 | PubChem SID:175272180 | NDC:67296-1497 | NDC:68071-3138 | NDC:63187-424 | NDC:68462-163 | NDC:0904-7306 | NDC:50090-6865 | NDC:68071-2780 | NDC:68382-093 | NDC:68788-9789 | NDC:65841-619 | NDC:68382-092 | NDC:70518-0356 | NDC:55111-255 | NDC:50090-6949 | NDC:55154-5676 | NDC:0904-7308 | NDC:76385-113 | NDC:51655-033 | NDC:43353-838 | NDC:68071-4600 | NDC:51655-943 | NDC:65862-144 | NDC:72789-431 | NDC:68788-8151 | NDC:60760-582 | NDC:68071-4956 | Carvedilol | NDC:68071-4816 | NDC:68382-095 | NDC:50090-1067 | NDC:65862-143 | NDC:55154-6883 | NDC:42708-181 | NDC:55154-2641 | NDC:70518-0426 | NDC:0378-3634 | NDC:0093-0051 | NDC:63187-941 | NDC:67046-1006 | NDC:71610-063 | NDC:0904-6301 | PubChem CID:2585 | NDC:0378-3633 | NDC:55154-5678 | NDC:51079-931 | NDC:71335-0273 | NDC:72789-440 | NDC:68382-094 | NDC:72789-411 | NDC:68001-152 | NDC:51407-039 | NDC:0093-7296 | NDC:70518-0123 | NDC:70518-1377 | NDC:68788-9265 | NDC:43063-129 | NDC:50090-6742 | NDC:71610-062 | NDC:71335-1545 | NDC:80725-142 | NDC:0615-8390 | NDC:51079-930 | NDC:70518-3640 | 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol | NDC:71335-2033 | NDC:0781-5224 | NDC:50090-2079 | NDC:71335-1813 | NDC:63187-946 | NDC:0904-7307 | NDC:71335-1463 | NDC:50090-6878 | NDC:55154-5675 | NDC:71610-066 | NDC:71335-1407 | NDC:71335-2474 | NDC:72888-036 | NDC:0615-8388 | NDC:50090-5726 | CAS RN:72956-09-3 | NDC:51407-041 | NDC:55154-2640 | NDC:68788-7458 | NDC:0093-7295 | NDC:50090-2119 | NDC:82009-127 | NDC:70518-1826 | NDC:55154-6884 | NDC:51407-042 | NDC:65841-616 | NDC:80725-141 | CAS RN:107741-96-8 | NDC:51655-713 | NDC:55111-254 | NDC:63187-409 | NDC:68788-7539 | NDC:65841-618 | NDC:0781-5223 | NDC:71335-1937 | NDC:71610-132 | NDC:71610-067 | NDC:72888-035 | NDC:43063-833 | NDC:50090-2066 | NDC:68462-162 | NDC:71335-1128 | NDC:70518-3524 | NDC:71335-1457 | NDC:71335-2023 | NDC:50090-4171 | NDC:55111-252 | NDC:51655-034 | NDC:0781-5222 | NDC:72888-037 | NDC:65862-145 | NDC:71335-1533 | NDC:0378-3632 | NDC:71335-1623 | NDC:67296-1901 | NDC:68788-7603 | NDC:67296-1900 | NDC:76385-110 | NDC:76385-111 | NDC:50090-1062 | NDC:68645-496 | NDC:0904-6302 | NDC:82009-125 | NDC:68645-351 | NDC:43353-837
+BMGC_DG06518,BMG_DG128495,"O-Desmethyl Mycophenolic Acid | CAS RN:31858-65-8 | (E)-6-(4,6-dihydroxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid | PubChem CID:25879063"
+BMGC_DG06519,BMG_DG128504,CHLORCYCLOGUANIL | PubChem CID:25889 | CAS RN:13344-99-5 | PubChem SID:198987131 | UNII:0624073F45 | Chlorcycloguanil
+BMGC_DG06520,BMG_DG128507,"CAS RN:13345-25-0 | Benzo(a)pyrene 7,8-dihydrodiol | CAS RN:861441-06-7 | PubChem CID:25892 | 7,8-dihydrobenzo[a]pyrene-7,8-diol"
+BMGC_DG06521,BMG_DG128516,PubChem SID:175267259 | PubChem CID:259 | CAS RN:24959-67-9 | bromide | Bromide ion | BROMIDE ION | UNII:952902IX06
+BMGC_DG06522,BMG_DG128518,1-METHYLBENZOTRIAZOLE | PubChem CID:25902 | CAS RN:13351-73-0 | PubChem SID:472411300 | 1-Methylbenzotriazole | UNII:SZL55XL4Y6 | 1-methylbenzotriazole
+BMGC_DG06523,BMG_DG128533,"UNII:LFH8R03S8J | 2-BENZYL-2,3-DIHYDRO-1H-NAPHTHO(1,2-E)(1,3)OXAZIN-9-OL | PubChem CID:259166 | PubChem SID:363909277 | CAS RN:35141-71-0"
+BMGC_DG06524,BMG_DG128541,"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide | DrugBank ID:DB08341 | PubChem CID:25920890"
+BMGC_DG06525,BMG_DG128542,"11-DEOXYCORTICOSTERONE, P-BROMOBENZENESULFONATE | CAS RN:21170-34-3 | UNII:J6CZ92K8RU | PubChem CID:259210 | PubChem SID:441659626"
+BMGC_DG06526,BMG_DG128543,"5-Methoxycanthin-6-one | 5-METHOXYCANTHIN-6-ONE | CAS RN:15071-56-4 | PubChem SID:198938317 | 3-methoxy-1,6-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-3,5(16),6,8,10,12,14-heptaen-2-one | PubChem CID:259218 | UNII:VVM1A8LM35"
+BMGC_DG06527,BMG_DG128547,"DrugBank ID:DB14674 | [(8R,9S,13S,14S,17S)-13-methyl-17-phosphonooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate | PubChem CID:259329 | UNII:MUZ9585Y7B | CAS RN:4891-15-0 | ESTRAMUSTINE PHOSPHATE | Estramustine phosphate | PubChem SID:198976538"
+BMGC_DG06528,BMG_DG128548,"PubChem CID:259331 | ESTRAMUSTINE | UNII:35LT29625A | Estramustine | [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate | DrugBank ID:DB01196 | PubChem SID:175266702 | CAS RN:2998-57-4"
+BMGC_DG06529,BMG_DG128552,N-phenyl-N-piperidin-4-ylpropanamide | UNII:2MK6D8JV6J | NORFENTANYL | PubChem SID:198988214 | PubChem CID:259381 | Norfentanyl | CAS RN:1609-66-1
+BMGC_DG06530,BMG_DG128556,CAS RN:13392-69-3 | UNII:H5EVV4LP59 | PubChem SID:438788942 | PubChem CID:25945 | 5-hydroxyvaleric acid | DrugBank ID:DB04781 | 5-HYDROXYPENTANOIC ACID
+BMGC_DG06531,BMG_DG128564,UNII:FLX0VIC39Y | CAS RN:13408-63-4 | PubChem CID:25959 | PubChem SID:316912549 | FERROCYANIDE ION
+BMGC_DG06532,BMG_DG128592,"CAS RN:545-47-1 | PubChem CID:259846 | Lupeol | (1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol | DrugBank ID:DB12622 | PubChem SID:198982901 | LUPEOL | UNII:O268W13H3O"
+BMGC_DG06533,BMG_DG128599,"R-1,2-Propanediol | UNII:602HN5L69H | (R)-Propylene glycol | DrugBank ID:DB02159 | (2R)-propane-1,2-diol | PROPYLENE GLYCOL, (R)- | PubChem CID:259994 | PubChem SID:175265943 | CAS RN:4254-14-2 | CAS RN:16922-04-6"
+BMGC_DG06534,BMG_DG128600,NDC:37662-2956 | bromane | NDC:37662-2955 | NDC:37662-2950 | PubChem SID:175266466 | NDC:37662-2951 | NDC:37662-2952 | HYDROBROMIC ACID | NDC:37662-2957 | PubChem CID:260 | NDC:37662-2953 | CAS RN:10035-10-6 | UNII:3IY7CNP8XJ | NDC:37662-2954 | Hydrobromic Acid
+BMGC_DG06535,BMG_DG128608,"UNII:D6VU9BI62I | 4,7-BENZIMIDAZOLEDIONE | CAS RN:7711-39-9 | PubChem CID:260064 | PubChem SID:376072057"
+BMGC_DG06536,BMG_DG128613,2-[(3-chlorophenyl)hydrazinylidene]propanedinitrile | CAS RN:555-60-2 | CARBONYL CYANIDE (M-CHLOROPHENYL)HYDRAZONE | PubChem CID:2603 | UNII:4D4NW27CG5 | (3-Chlorophenyl)hydrazonomalononitrile | PubChem SID:440794115
+BMGC_DG06537,BMG_DG128614,NDC:63545-312 | UNII:15443PR153 | Gold trichloride | NDC:0220-0677 | NDC:63545-309 | NDC:63545-310 | trichlorogold | NDC:63545-308 | NDC:0220-0675 | PubChem SID:175267286 | NDC:0220-0676 | CAS RN:13453-07-1 | NDC:63545-316 | NDC:63545-314 | GOLD TRICHLORIDE | NDC:63545-311 | NDC:0220-0640 | NDC:75053-0001 | NDC:63545-315 | NDC:0220-0674 | NDC:63545-313 | PubChem CID:26030
+BMGC_DG06538,BMG_DG128619,PubChem SID:198936101 | ACEPROMETAZINE | CAS RN:13461-01-3 | PubChem CID:26035 | Aceprometazine | UNII:984N9YTM4Y | DrugBank ID:DB01615 | 1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]ethanone
+BMGC_DG06539,BMG_DG128626,PubChem CID:26040 | PubChem SID:175265435 | UNII:6WQ62TAQ6Z | Iron pentacarbonyl | formaldehyde;iron | IRON PENTACARBONYL | CAS RN:13463-40-6
+BMGC_DG06540,BMG_DG128627,NDC:79903-897 | NDC:69423-160 | NDC:55910-153 | NDC:59779-311 | NDC:69423-571 | NDC:84126-053 | NDC:62673-016 | NDC:69423-720 | NDC:12022-036 | NDC:83037-002 | NDC:49035-185 | CAS RN:13463-41-7 | NDC:0363-4673 | NDC:37808-296 | NDC:69423-669 | NDC:42507-281 | NDC:37000-070 | NDC:12022-019 | PubChem SID:175267432 | NDC:55910-921 | NDC:74553-003 | NDC:41163-296 | NDC:70947-001 | NDC:35324-004 | NDC:49967-795 | NDC:69423-647 | NDC:59779-153 | NDC:0363-0688 | NDC:81277-801 | NDC:82157-004 | NDC:69423-608 | NDC:68998-132 | NDC:71819-017 | NDC:70533-004 | zinc;1-oxidopyridin-1-ium-2-thiolate | NDC:79903-900 | NDC:63148-417 | NDC:12022-029 | NDC:73528-100 | NDC:69423-316 | NDC:41167-6020 | NDC:37000-079 | NDC:73503-012 | NDC:50804-153 | NDC:52000-415 | NDC:63766-003 | NDC:84126-054 | NDC:41163-266 | DrugBank ID:DB06815 | NDC:12022-038 | NDC:79903-004 | NDC:10967-650 | NDC:41250-045 | NDC:41163-024 | NDC:55301-281 | NDC:76162-362 | NDC:49967-056 | NDC:69423-620 | NDC:69423-668 | NDC:67777-139 | NDC:35324-001 | NDC:74781-001 | NDC:84126-023 | NDC:69423-344 | NDC:37808-612 | NDC:71819-002 | NDC:0363-4666 | NDC:69423-278 | NDC:12022-027 | NDC:59779-296 | NDC:64024-153 | NDC:69423-343 | NDC:71819-016 | PubChem CID:26041 | NDC:37000-094 | NDC:37808-311 | NDC:69423-329 | NDC:72476-153 | NDC:21130-296 | NDC:37000-095 | NDC:53942-281 | NDC:0363-2606 | NDC:69423-307 | NDC:81457-012 | NDC:79903-899 | NDC:69188-100 | NDC:49035-683 | NDC:57337-027 | NDC:71819-018 | NDC:69423-171 | NDC:69423-309 | NDC:69423-415 | NDC:57337-026 | NDC:69423-463 | NDC:36800-497 | NDC:49967-871 | NDC:81457-020 | NDC:11673-153 | NDC:49967-052 | NDC:69423-345 | NDC:59779-281 | NDC:0363-4288 | NDC:72476-281 | NDC:71440-001 | NDC:69188-200 | NDC:84126-022 | NDC:69423-326 | NDC:72811-002 | NDC:50718-0035 | Pyrithione Zinc | NDC:63941-311 | NDC:61995-0029 | NDC:41250-311 | NDC:49967-388 | NDC:50804-311 | NDC:73324-090 | NDC:72474-100 | NDC:69423-315 | NDC:49967-266 | NDC:73597-020 | NDC:55319-691 | NDC:69423-619 | NDC:51326-203 | NDC:30142-788 | NDC:35324-002 | NDC:71819-005 | NDC:68998-134 | NDC:12022-024 | NDC:67751-053 | NDC:67091-179 | NDC:82157-009 | NDC:70000-0533 | NDC:69423-721 | NDC:69423-294 | NDC:55910-311 | NDC:72474-101 | NDC:41250-153 | NDC:0363-4289 | NDC:69423-348 | NDC:82157-008 | NDC:30142-311 | NDC:0363-0755 | NDC:37000-078 | NDC:49967-389 | NDC:54111-169 | NDC:84126-024 | Pyrithione | NDC:64724-1017 | NDC:55910-898 | NDC:79903-002 | NDC:63941-153 | NDC:75376-320 | NDC:72288-153 | NDC:82157-005 | NDC:69423-417 | NDC:72474-103 | NDC:49035-263 | NDC:72476-253 | NDC:82157-007 | NDC:50718-0021 | NDC:71819-001 | NDC:71566-100 | NDC:55319-386 | NDC:74781-010 | NDC:69423-671 | NDC:41163-153 | NDC:49035-250 | NDC:72476-362 | NDC:63941-296 | NDC:49967-298 | NDC:21130-153 | NDC:49035-184 | NDC:41250-952 | NDC:37808-070 | NDC:72288-911 | NDC:36800-153 | NDC:62839-6745 | NDC:72288-012 | NDC:12022-005 | NDC:10056-006 | NDC:0363-4138 | NDC:83324-320 | NDC:69423-042 | NDC:69423-698 | NDC:76162-353 | NDC:63148-580 | NDC:45334-206 | NDC:69423-648 | NDC:41250-281 | NDC:69423-346 | NDC:75376-321 | PYRITHIONE ZINC | NDC:45334-392 | NDC:69423-319 | NDC:53942-311 | NDC:72476-296 | NDC:30142-296 | NDC:57337-029 | NDC:69423-722 | CAS RN:1698050-37-1 | NDC:69188-300 | NDC:57577-077 | NDC:72476-612 | NDC:36800-087 | NDC:56062-311 | NDC:53942-153 | NDC:11673-643 | NDC:70533-003 | NDC:69423-350 | NDC:36800-281 | NDC:12022-020 | NDC:71819-007 | NDC:37000-071 | NDC:61995-2439 | NDC:37000-077 | NDC:69423-172 | NDC:69423-412 | NDC:72496-1038 | NDC:75712-470 | NDC:11509-5225 | NDC:71566-200 | NDC:49035-680 | NDC:55301-153 | NDC:35324-003 | NDC:57337-025 | NDC:79903-003 | NDC:37000-093 | NDC:62001-0330 | NDC:81457-123 | NDC:69423-279 | NDC:67091-176 | NDC:69423-327 | NDC:63766-002 | NDC:55910-353 | NDC:69423-311 | NDC:83037-001 | NDC:73324-091 | NDC:76162-970 | NDC:82157-003 | NDC:84718-004 | NDC:37808-281 | NDC:69423-197 | NDC:69423-672 | NDC:55301-311 | NDC:72036-153 | NDC:69423-347 | NDC:21130-942 | NDC:69423-696 | NDC:64024-311 | NDC:90089-153 | NDC:75376-322 | NDC:63148-208 | NDC:63941-952 | NDC:69423-247 | NDC:73088-401 | NDC:69423-697 | NDC:49967-242 | NDC:71819-010 | NDC:49035-254 | NDC:84718-003 | NDC:37000-092 | NDC:37000-081 | NDC:50594-153 | UNII:R953O2RHZ5 | NDC:69423-312 | NDC:51870-007 | NDC:55910-942 | NDC:51316-178 | NDC:30142-153 | NDC:69423-293 | NDC:52261-1400 | NDC:71819-019 | NDC:83324-322 | NDC:57337-028 | NDC:59779-836 | NDC:73528-400 | NDC:49035-728 | NDC:56062-153 | NDC:72476-311 | NDC:69423-591 | NDC:37808-153 | NDC:71819-008 | NDC:52000-416 | NDC:12022-030 | NDC:69423-103 | NDC:83324-321 | NDC:71990-712 | NDC:69423-416 | NDC:12022-023 | NDC:69423-349 | NDC:59779-079 | NDC:55319-768 | NDC:68998-133 | NDC:53942-253 | NDC:69423-670 | NDC:49035-256 | NDC:67091-178 | NDC:72288-953 | NDC:69423-589 | NDC:69423-646 | NDC:69423-521 | NDC:69423-638 | NDC:69423-568 | NDC:73503-010 | NDC:69423-522 | NDC:84126-055 | NDC:41163-253 | NDC:49035-249 | NDC:57337-024
+BMGC_DG06541,BMG_DG128628,CAS RN:1317-80-2 | CAS RN:98084-96-9 | DrugBank ID:DB09536 | Titanium dioxide | PubChem CID:26042 | CAS RN:13463-67-7 | dioxotitanium | Titanium Dioxide | CAS RN:1317-70-0
+BMGC_DG06542,BMG_DG128638,PubChem CID:2605 | DrugBank ID:DB02741 | CD564
+BMGC_DG06543,BMG_DG128656,"CAS RN:3721-28-6 | (1S,2R)-2-phenylcyclopropan-1-amine | (1S,2R)-2-phenylcyclopropanamine | CAS RN:155-09-9 | PubChem CID:26070"
+BMGC_DG06544,BMG_DG128663,DrugBank ID:DB03307 | PubChem CID:2608 | 4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide
+BMGC_DG06545,BMG_DG128665,"CAS RN:17994-17-1 | PubChem CID:260803 | Indol-5-ol, 1-acetyl-3-(2-aminoethyl)- | 1-[3-(2-aminoethyl)-5-hydroxyindol-1-yl]ethanone"
+BMGC_DG06546,BMG_DG128676,"Azapropazone | APAZONE | CAS RN:13539-59-8 | UNII:K2VOT966ZI | PubChem CID:26098 | 5-(dimethylamino)-9-methyl-2-propylpyrazolo[1,2-a][1,2,4]benzotriazine-1,3-dione | PubChem SID:198983246"
+BMGC_DG06547,BMG_DG128678,7-[[2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CAS RN:1181570-19-3 | PubChem CID:2610 | 7-((2-Amino-2-(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
+BMGC_DG06548,BMG_DG128679,DrugBank ID:DB02998 | METRIBOLONE | UNII:2C323EGI97 | Metribolone | PubChem CID:261000 | CAS RN:965-93-5 | PubChem SID:198977476
+BMGC_DG06549,BMG_DG128680,Arsenic trioxide | PubChem CID:261004 | Arsenic(III) oxide | DrugBank ID:DB01169
+BMGC_DG06550,BMG_DG128682,CAS RN:13551-87-6 | MISONIDAZOLE | Misonidazole | DrugBank ID:DB11716 | PubChem SID:198968183 | PubChem CID:26105 | 1-methoxy-3-(2-nitroimidazol-1-yl)propan-2-ol | CAS RN:95120-44-8 | UNII:8FE7LTN8XE
+BMGC_DG06551,BMG_DG128706,"NDC:51672-4074 | [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate | NDC:51672-4083 | Hydrocortisone Butyrate | NDC:68682-384 | NDC:68180-951 | NDC:51672-4061 | PubChem SID:175265516 | HYDROCORTISONE BUTYRATE | DrugBank ID:DB14540 | CAS RN:13609-67-1 | NDC:68682-271 | NDC:68682-392 | PubChem CID:26133 | UNII:05RMF7YPWN | NDC:82160-127 | NDC:83148-012 | NDC:16781-392"
+BMGC_DG06552,BMG_DG128709,CAS RN:1645-21-2 | UNII:A96898YA6S | 4'-FLUOROFLAVONE | PubChem CID:261391 | PubChem SID:317229585
+BMGC_DG06553,BMG_DG128723,SOTERENOL | UNII:9364W7589B | PubChem CID:26162 | PubChem SID:198968201 | CAS RN:13642-52-9
+BMGC_DG06554,BMG_DG128733,"DrugBank ID:DB01442 | MMDA | UNII:RG7FY73ZAA | PubChem CID:26175 | 1-(7-methoxy-1,3-benzodioxol-5-yl)propan-2-amine | PubChem SID:316911829 | 5-Methoxy-3,4-methylenedioxyamphetamine | CAS RN:13674-05-0"
+BMGC_DG06555,BMG_DG128745,CAS RN:21187-73-5 | UNII:24J0W87Z43 | PubChem CID:261859 | PubChem SID:198981675 | GARDENIN A
+BMGC_DG06556,BMG_DG128761,N-(1-piperidin-1-ylpropan-2-yl)-N-pyridin-2-ylpropanamide | CAS RN:52373-67-8 | PubChem SID:198943441 | CAS RN:15686-91-6 | Propiram | UNII:WT6247U6PX | PROPIRAM | PubChem CID:26216
+BMGC_DG06557,BMG_DG128762,METAVANADATE ION | PubChem CID:26218 | CAS RN:13981-20-9 | PubChem SID:198960511 | UNII:3WHH0066W5
+BMGC_DG06558,BMG_DG128767,10-BENZOYLPHENOTHIAZINE | PubChem CID:262319 | CAS RN:38076-73-2 | PubChem SID:441659543 | UNII:9HA99HYS3S
+BMGC_DG06559,BMG_DG128773,"UNII:4HU6J11EL5 | DIACEREIN | CAS RN:13739-02-1 | PubChem SID:175265553 | PubChem CID:26248 | DrugBank ID:DB11994 | CAS RN:112118-18-0 | 4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid | Diacerein"
+BMGC_DG06560,BMG_DG128782,TETRAFLUOROBORATE ION | CAS RN:14874-70-5 | UNII:4YCF3545OY | CAS RN:61674-41-7 | PubChem SID:198964258 | CAS RN:17085-33-5 | tetrafluoroborate | Tetrafluoroborate | PubChem CID:26255
+BMGC_DG06561,BMG_DG128812,butan-1-ol | BUTYL ALCOHOL | PubChem SID:175267481 | CAS RN:35296-72-1 | CAS RN:1219794-84-9 | UNII:8PJ61P6TS3 | DrugBank ID:DB02145 | CAS RN:71-36-3 | PubChem CID:263 | CAS RN:64118-16-7 | CAS RN:6167-45-9 | Butyl alcohol | 1-Butanol
+BMGC_DG06562,BMG_DG128843,PubChem CID:263366 | DrugBank ID:DB07412 | 1-biphenyl-2-ylmethanamine
+BMGC_DG06563,BMG_DG128867,Nequinate | NEQUINATE | DrugBank ID:DB11433 | PubChem CID:26383 | PubChem SID:198969322 | CAS RN:13997-19-8 | UNII:91ZE013933 | methyl 6-butyl-4-oxo-7-phenylmethoxy-1H-quinoline-3-carboxylate
+BMGC_DG06564,BMG_DG128870,UNII:238S75V9AV | PubChem CID:26388 | Metopimazine | PubChem SID:198950507 | CAS RN:14008-44-7 | DrugBank ID:DB13591 | METOPIMAZINE | 1-[3-(2-methylsulfonylphenothiazin-10-yl)propyl]piperidine-4-carboxamide
+BMGC_DG06565,BMG_DG128881,butanoic acid | CAS RN:107-92-6 | Butyric Acid | PubChem SID:175266581 | UNII:40UIR9Q29H | DrugBank ID:DB03568 | PubChem CID:264 | BUTYRIC ACID
+BMGC_DG06566,BMG_DG128896,"2-AMINO-4,5,6,7-TETRAHYDRO-6-METHYLTHIENO(2,3-C)PYRIDINE-3-CARBONITRILE | 2-Amino-4,5,6,7-tetrahydro-6-methylthieno[2,3-c]pyridine-3-carbonitrile | CAS RN:37578-06-6 | PubChem CID:264296 | PubChem SID:485663139 | UNII:Q4SL2AGW94"
+BMGC_DG06567,BMG_DG128920,PubChem SID:175267807 | SELENATE ION | CAS RN:14124-68-6 | selenate | PubChem CID:26473 | UNII:6X37R1DB70 | Selenate
+BMGC_DG06568,BMG_DG128934,"PubChem CID:265117 | 7-(CARBOXYMETHYL)-2-HYDROXY-3-OXO-1,4,6-CYCLOHEPTATRIENE-1-CARBOXYLIC ACID | PubChem SID:376072439 | CAS RN:4666-80-2 | UNII:KDY22YR35W"
+BMGC_DG06569,BMG_DG128939,BIS(SALICYLALDEHYDE)ETHYLENEDIIMINE | 2-[2-[(2-hydroxyphenyl)methylideneamino]ethyliminomethyl]phenol | PubChem CID:26518 | Salen | CAS RN:94-93-9 | CAS RN:129409-01-4 | PubChem SID:198981120 | UNII:M122L9EGR6
+BMGC_DG06570,BMG_DG128942,"PubChem SID:241179203 | Withaferin A | CAS RN:5119-48-2 | WITHAFERIN A | PubChem CID:265237 | (1S,2R,6S,7R,9R,11S,12S,15R,16S)-6-hydroxy-15-[(1S)-1-[(2R)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-3-one | UNII:L6DO3QW4K5"
+BMGC_DG06571,BMG_DG128951,Tiletamine | UNII:2YFC543249 | PubChem SID:175271529 | 2-(ethylamino)-2-thiophen-2-ylcyclohexan-1-one | CAS RN:14176-49-9 | TILETAMINE | PubChem CID:26533 | DrugBank ID:DB11549
+BMGC_DG06572,BMG_DG128980,3-HYDROXY-2-(4-METHYLPHENYL)-4H-CHROMEN-4-ONE | PubChem SID:375579896 | UNII:ZED9EDX82X | PubChem CID:265711 | CAS RN:19275-68-4
+BMGC_DG06573,BMG_DG128982,"PubChem CID:265724 | UNII:F9J53MVN3M | CAS RN:58544-90-4 | 2-(3,4-DIMETHOXYPHENYL)-3-HYDROXY-7-METHOXY-4H-CHROMEN-4-ONE | PubChem SID:376231032"
+BMGC_DG06574,BMG_DG128998,UNII:8U2ZPK2XZA | 2-(Pyridin-4-yl)quinoline-4-carboxylic acid | PubChem SID:474491579 | PubChem CID:26587 | 2-(PYRIDIN-4-YL)QUINOLINE-4-CARBOXYLIC ACID | CAS RN:14228-23-0
+BMGC_DG06575,BMG_DG129016,3-HYDROXYOCTANOIC ACID | UNII:8M44B02CSJ | PubChem CID:26613 | CAS RN:14292-27-4 | PubChem SID:198988209
+BMGC_DG06576,BMG_DG129018,"4-chloro-N-(2,6-dimethylphenyl)-2-hydroxy-5-sulfamoylbenzamide | XIPAMIDE | PubChem SID:198954583 | Xipamide | CAS RN:14293-44-8 | DrugBank ID:DB13803 | UNII:4S9EY0NUEC | PubChem CID:26618"
+BMGC_DG06577,BMG_DG129020,NDC:58151-082 | NDC:62135-023 | NDC:83301-0012 | NDC:0904-6503 | NDC:80425-0037 | NDC:46708-268 | NDC:65162-819 | CAS RN:169590-42-5 | NDC:67296-1399 | NDC:72789-259 | NDC:70518-3733 | NDC:29300-374 | NDC:71205-020 | NDC:62332-143 | NDC:75834-236 | NDC:63187-301 | NDC:77771-158 | NDC:71209-054 | NDC:16714-733 | NDC:80425-0040 | NDC:13668-441 | NDC:82009-069 | NDC:70247-007 | NDC:50228-157 | NDC:76420-243 | NDC:42571-143 | NDC:45865-234 | 4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide | PubChem SID:175265305 | NDC:72241-025 | NDC:68180-398 | NDC:50268-168 | NDC:57582-214 | NDC:55154-7645 | NDC:62135-021 | NDC:63187-562 | NDC:80425-0167 | NDC:72241-022 | NDC:50090-6577 | NDC:51655-253 | NDC:65862-907 | NDC:72189-123 | NDC:50228-158 | NDC:0615-8528 | NDC:58151-083 | NDC:76420-727 | NDC:57582-211 | NDC:42571-144 | NDC:0904-6502 | NDC:63739-297 | NDC:71610-283 | NDC:68071-3642 | NDC:33342-158 | Celecoxib | NDC:76420-843 | NDC:82804-151 | CELECOXIB | NDC:71335-2019 | NDC:76420-714 | NDC:46708-270 | NDC:50090-6759 | NDC:63629-5503 | NDC:51655-059 | NDC:57582-213 | NDC:65162-818 | NDC:71335-0936 | NDC:69097-422 | NDC:80425-0281 | NDC:76420-844 | NDC:68180-395 | NDC:68788-8206 | NDC:45865-240 | NDC:69367-301 | NDC:71335-1804 | NDC:69117-0020 | NDC:71335-2456 | UNII:JCX84Q7J1L | NDC:68180-396 | NDC:65162-820 | NDC:68071-4392 | NDC:43353-257 | NDC:0025-1525 | NDC:42806-721 | NDC:13668-733 | NDC:50228-159 | NDC:59762-1517 | NDC:62332-140 | NDC:71205-439 | NDC:71209-056 | NDC:72162-2421 | NDC:83008-075 | NDC:55700-613 | NDC:27808-297 | NDC:13668-307 | NDC:71335-2220 | NDC:71205-664 | NDC:51655-437 | NDC:60505-3847 | NDC:13668-442 | NDC:50228-156 | NDC:69097-421 | NDC:59762-1516 | NDC:70247-006 | NDC:80425-0323 | NDC:80425-0382 | NDC:29300-158 | NDC:57582-212 | NDC:80425-0039 | NDC:75834-238 | NDC:77771-157 | NDC:82868-034 | NDC:65162-817 | NDC:46708-269 | NDC:71335-0868 | NDC:60760-649 | NDC:71209-057 | NDC:80425-0142 | NDC:63187-079 | NDC:42571-142 | NDC:16714-732 | NDC:50090-5178 | NDC:0025-1520 | NDC:50090-7072 | NDC:60687-436 | NDC:72162-2175 | DrugBank ID:DB00482 | NDC:60687-447 | NDC:50090-4789 | NDC:70247-009 | NDC:76420-845 | NDC:83301-0028 | NDC:60505-3848 | NDC:71205-027 | NDC:43063-669 | NDC:72241-024 | NDC:72241-023 | NDC:72189-360 | NDC:69117-0023 | NDC:70247-008 | NDC:70518-1650 | NDC:83301-0011 | NDC:72162-2254 | NDC:67296-1847 | NDC:0591-3983 | NDC:69117-0022 | NDC:82009-068 | NDC:33342-157 | NDC:27808-295 | NDC:76420-842 | NDC:65862-909 | NDC:70518-4009 | NDC:29300-157 | NDC:42806-723 | CAS RN:194044-54-7 | NDC:0615-8338 | NDC:0591-3982 | NDC:27808-296 | NDC:69557-333 | NDC:70518-4175 | NDC:77771-156 | NDC:63187-643 | NDC:42571-145 | NDC:0591-3984 | NDC:62135-022 | NDC:68071-2733 | NDC:76420-009 | NDC:83008-013 | NDC:71205-055 | NDC:71209-055 | NDC:66869-564 | NDC:58151-084 | NDC:29300-373 | NDC:69367-302 | NDC:43063-825 | NDC:71335-0292 | NDC:43063-967 | NDC:50268-169 | NDC:63739-298 | NDC:77771-159 | NDC:0591-3985 | NDC:42806-722 | NDC:76420-726 | NDC:62332-141 | NDC:13668-731 | NDC:60760-824 | NDC:33342-155 | NDC:68180-399 | NDC:75834-239 | NDC:71335-2222 | NDC:60505-3849 | NDC:63187-633 | NDC:65862-908 | NDC:60760-742 | PubChem CID:2662 | NDC:16714-734 | NDC:33342-156 | NDC:72162-2380 | NDC:80425-0321 | NDC:58151-085 | NDC:13668-310 | NDC:60760-823 | NDC:55154-7646 | NDC:69097-420 | NDC:50090-6758 | NDC:70518-2233 | NDC:50090-6380 | NDC:68788-7286 | NDC:68788-8679 | NDC:76420-728 | NDC:13668-732 | NDC:16714-731 | NDC:71610-584 | NDC:65862-910 | NDC:69097-423 | NDC:46708-267 | NDC:68788-7264 | NDC:70518-3826 | NDC:62332-142 | NDC:72162-2357 | CAS RN:184007-95-2 | NDC:13668-730 | NDC:50090-5638 | NDC:69117-0021 | NDC:68788-8197 | NDC:80425-0209 | NDC:51655-436 | NDC:75834-237 | NDC:80425-0096 | NDC:71335-1066 | NDC:51655-060 | NDC:42806-720
+BMGC_DG06578,BMG_DG129026,"DrugBank ID:DB04846 | CAS RN:56980-93-9 | UNII:DRB57K47QC | Celiprolol | PubChem SID:198948527 | CELIPROLOL | 3-[3-acetyl-4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-1,1-diethylurea | CAS RN:83688-50-0 | PubChem CID:2663"
+BMGC_DG06579,BMG_DG129052,CAS RN:14437-41-3 | PubChem SID:198950972 | UNII:2Q9A409N0B | CLIOXANIDE | PubChem CID:26695
+BMGC_DG06580,BMG_DG129062,"PubChem CID:26721 | DrugBank ID:DB01497 | (1R,2S,6R)-19-(2-hydroxypentan-2-yl)-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol | CID 26721 | Etorphine"
+BMGC_DG06581,BMG_DG129085,SELEGILINE | (2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine | NDC:49502-900 | UNII:2K1V7GP655 | PubChem SID:175267457 | CAS RN:14611-51-9 | CAS RN:102741-42-4 | NDC:49502-901 | PubChem CID:26757 | NDC:49502-902 | Selegiline | DrugBank ID:DB01037
+BMGC_DG06582,BMG_DG129091,DrugBank ID:DB00341 | CAS RN:83881-51-0 | Cetirizine | PubChem CID:2678 | UNII:YO7261ME24 | CETIRIZINE | 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid | CAS RN:774596-22-4 | PubChem SID:175271899
+BMGC_DG06583,BMG_DG129097,CAS RN:34675-84-8 | CETRAXATE | Cetraxate | PubChem SID:198957027 | UNII:5VPA8CPF0N | PubChem CID:2680 | 3-[4-[4-(aminomethyl)cyclohexanecarbonyl]oxyphenyl]propanoic acid
+BMGC_DG06584,BMG_DG129100,PubChem SID:198937249 | CETRIMONIUM | UNII:Z7FF1XKL7A | Cetrimonium | hexadecyl(trimethyl)azanium | CAS RN:6899-10-1 | PubChem CID:2681 | DrugBank ID:DB01718
+BMGC_DG06585,BMG_DG129104,CAS RN:75736-52-6 | UNII:936JST6JCN | PubChem SID:175267287 | DrugBank ID:DB09494 | CAS RN:36653-82-4 | hexadecan-1-ol | Cetyl alcohol | PubChem CID:2682 | CETYL ALCOHOL | Cetyl Alcohol | CAS RN:124-29-8
+BMGC_DG06586,BMG_DG129108,CETYLPYRIDINIUM | PubChem CID:2683 | 1-hexadecylpyridin-1-ium | PubChem SID:175268712 | DrugBank ID:DB11073 | CAS RN:7773-52-6 | Cetylpyridinium | UNII:CUB7JI0JV3
+BMGC_DG06587,BMG_DG129109,"CAS RN:124620-88-8 | CAS RN:107233-08-9 | PubChem CID:2684 | 2-Methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane] | 2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane]"
+BMGC_DG06588,BMG_DG129110,"3,7,11,15-tetramethylhexadecanoic acid | PubChem CID:26840 | CAS RN:14721-66-5 | Phytanic Acid"
+BMGC_DG06589,BMG_DG129113,2-Hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide | UNII:SIO2UEZ19H | CAS RN:137888-49-4 | CAS RN:81015-67-0 | PubChem SID:198979895 | PubChem CID:2685 | 2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenoxy]propyl]amino]ethoxy]benzamide | CGP-20712
+BMGC_DG06590,BMG_DG129115,"PubChem SID:198956531 | CGP-12177, (+/-)- | 4-(3-tert-Butylamino-2-hydroxypropoxy)benzimidazol-2-one | UNII:R89UMZ82MJ | PubChem CID:2687 | CGP-12177, (±)- | 4-[3-(tert-butylamino)-2-hydroxypropoxy]-1,3-dihydrobenzimidazol-2-one | CAS RN:81047-99-6"
+BMGC_DG06591,BMG_DG129116,"Levamisole | DrugBank ID:DB00848 | PubChem SID:175266967 | PubChem CID:26879 | LEVAMISOLE | UNII:2880D3468G | CAS RN:14769-73-4 | CAS RN:49548-36-9 | (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole"
+BMGC_DG06592,BMG_DG129117,CAS RN:14770-86-6 | PubChem CID:26880 | N-(5-PHENYL-2-THIENYL)ACETAMIDE | UNII:B4GHO0T9WY | PubChem SID:198939560
+BMGC_DG06593,BMG_DG129124,"4-(4-Methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline | UNII:5TB4SXQ7HG | 4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline | CAS RN:109028-09-3 | CGS 12066B-PARENT | PubChem CID:2689 | PubChem SID:255509275"
+BMGC_DG06594,BMG_DG129126,UNII:Y5A5D5E2AQ | CGS-15943 | CAS RN:104615-18-1 | PubChem CID:2690 | PubChem SID:440088641
+BMGC_DG06595,BMG_DG129130,"PubChem CID:2691 | 3-[4-[2-[[6-Amino-9-[5-(ethylcarbamoyl)-3,4-dihydroxy-2-oxolanyl]-2-purinyl]amino]ethyl]phenyl]propanoic acid | 3-[4-[2-[[6-amino-9-[5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid"
+BMGC_DG06596,BMG_DG129139,"UNII:7875H6443P | PubChem SID:252823768 | CAS RN:37577-28-9 | PHENYLPROPANOLAMINE, (+)- | (1S,2R)-2-amino-1-phenylpropan-1-ol | CAS RN:14838-15-4 | DrugBank ID:DB00397 | Norephedrine | PubChem CID:26934 | Phenylpropanolamine"
+BMGC_DG06597,BMG_DG129141,"CAS RN:14860-49-2 | PubChem CID:26937 | UNII:1NY2IX043A | 1-(4-chlorophenyl)-4-(dimethylamino)-2,3-dimethylbutan-2-ol | Clobutinol | PubChem SID:198977543 | DrugBank ID:DB09004 | CLOBUTINOL"
+BMGC_DG06598,BMG_DG129145,"PubChem SID:198981484 | CAS RN:14875-96-8 | Protoheme | UNII:42VZT0U6YR | 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid;iron(2+) | PubChem CID:26945 | FERROHEME"
+BMGC_DG06599,BMG_DG129155,UNII:P385M92GYG | 1-(4-methoxyphenyl)piperazine | N-(P-METHOXYPHENYL)PIPERAZINE | PubChem CID:269722 | CAS RN:38212-30-5 | PubChem SID:316915294 | 1-(4-Methoxyphenyl)piperazine
+BMGC_DG06600,BMG_DG129161,PubChem CID:26987 | PubChem SID:175268105 | CAS RN:15686-51-8 | CAS RN:63813-90-1 | (2R)-2-[2-[(1R)-1-(4-chlorophenyl)-1-phenylethoxy]ethyl]-1-methylpyrrolidine | DrugBank ID:DB00283 | Clemastine | UNII:95QN29S1ID | CLEMASTINE
+BMGC_DG06601,BMG_DG129184,"PubChem CID:27022 | CAS RN:15089-03-9 | P-ANISIC ACID, 2-PHENYLHYDRAZIDE | PubChem SID:375579848 | UNII:OWJ7BCI3J1"
+BMGC_DG06602,BMG_DG129188,"CAS RN:34316-15-9 | 1,2-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-12-ium | CHELERYTHRINE | PubChem CID:2703 | PubChem SID:198963308 | Chelerythrine | UNII:E3B045W6X0"
+BMGC_DG06603,BMG_DG129202,"PubChem CID:2707 | PubChem SID:175266354 | Chloral Hydrate | UNII:418M5916WG | 2,2,2-trichloroethane-1,1-diol | Chloral hydrate | CAS RN:302-17-0 | CHLORAL HYDRATE | DrugBank ID:DB01563"
+BMGC_DG06604,BMG_DG129206,4-[4-[bis(2-chloroethyl)amino]phenyl]butanoic acid | UNII:18D0SL7309 | DrugBank ID:DB00291 | PubChem CID:2708 | CAS RN:305-03-3 | NDC:80725-610 | CHLORAMBUCIL | PubChem SID:175267080 | Chlorambucil
+BMGC_DG06605,BMG_DG129214,"UNII:52A4VA7G1E | PubChem SID:375578972 | 2,5-BIS(4-ETHYLPHENYL)-3,6-DIHYDROXYBENZO-1,4-QUINONE | CAS RN:24909-18-0 | PubChem CID:270944"
+BMGC_DG06606,BMG_DG129219,PubChem SID:175265291 | DrugBank ID:DB14577 | CAS RN:11079-03-1 | CALCIUM CATION | UNII:2M83C4R6ZB | calcium(2+) | PubChem CID:271 | CAS RN:125302-08-1 | CAS RN:14127-61-8 | Calcium Cation
+BMGC_DG06607,BMG_DG129220,1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine | UNII:M26C4IP44P | PubChem SID:175272111 | PubChem CID:2710 | Chlorcyclizine | CHLORCYCLIZINE | DrugBank ID:DB08936 | CAS RN:82-93-9
+BMGC_DG06608,BMG_DG129224,"CAS RN:58-25-3 | PubChem CID:2712 | DrugBank ID:DB00475 | CHLORDIAZEPOXIDE | 7-chloro-4-hydroxy-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-imine | Chlordiazepoxide | UNII:6RZ6XEZ3CR | PubChem SID:175266100"
+BMGC_DG06609,BMG_DG129225,"UNII:ENB39R14VF | CAS RN:16127-99-4 | (8R,9S,13S,14S,15R,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,15,16,17-tetrol | PubChem SID:198949676 | PubChem CID:27125 | ESTETROL ANHYDROUS | DrugBank ID:DB12235 | CAS RN:15183-37-6 | Estetrol"
+BMGC_DG06610,BMG_DG129250,"CAS RN:102818-66-6 | Chlormezanone | 2-(4-chlorophenyl)-3-methyl-1,1-dioxo-1,3-thiazinan-4-one | PubChem SID:319892474 | PubChem CID:2717 | PubChem SID:198988348 | UNII:C14WB33Y0S | DrugBank ID:DB01178 | PubChem SID:319891870 | UNII:GP568V9G19 | CHLORMEZANONE, (-)- | CAS RN:102818-67-7 | CHLORMEZANONE, (+)- | CHLORMEZANONE | CAS RN:80-77-3 | UNII:4BU37OM8KL"
+BMGC_DG06611,BMG_DG129257,"CAS RN:117399-83-4 | CHLOROQUINE | 4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine | CAS RN:54-05-7 | CAS RN:1246815-14-4 | Chloroquine | PubChem CID:2719 | DrugBank ID:DB00608 | UNII:886U3H6UFF | PubChem SID:175272016"
+BMGC_DG06612,BMG_DG129264,"PubChem CID:2720 | CAS RN:58-94-6 | PubChem SID:175268031 | CHLOROTHIAZIDE | Chlorothiazide | UNII:77W477J15H | DrugBank ID:DB00880 | NDC:65649-311 | 6-chloro-1,1-dioxo-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide"
+BMGC_DG06613,BMG_DG129265,"CAS RN:15318-45-3 | CAS RN:3785-14-6 | RACEPHENICOL | CAS RN:847-25-6 | 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-methylsulfonylphenyl)propan-2-yl]acetamide | DrugBank ID:DB08621 | PubChem SID:198977608 | UNII:283383NO13 | Thiamphenicol | PubChem CID:27200 | THIAMPHENICOL | PubChem SID:175265822 | UNII:FLQ7571NPM"
+BMGC_DG06614,BMG_DG129271,"4,4,7a-Trimethyl-5,6,7,7a-tetrahydrobenzofuran-2(4H)-one | PubChem CID:27209 | DIHYDROACTINIDIOLIDE, (+/-)- | CAS RN:15356-74-8 | UNII:BH8469LVA9 | 4,4,7a-trimethyl-6,7-dihydro-5H-1-benzofuran-2-one | DIHYDROACTINIDIOLIDE, (±)- | PubChem SID:198944013"
+BMGC_DG06615,BMG_DG129276,"Chloroxine | PubChem CID:2722 | PubChem SID:175267377 | DrugBank ID:DB01243 | 5,7-dichloroquinolin-8-ol | CAS RN:773-76-2 | UNII:2I8BD50I8B | CHLOROXINE"
+BMGC_DG06616,BMG_DG129280,"NDC:65585-562 | NDC:67996-876 | NDC:30805-016 | NDC:65585-365 | NDC:82077-701 | NDC:62654-231 | NDC:62832-701 | NDC:63621-335 | 4-chloro-3,5-dimethylphenol | NDC:43374-876 | NDC:55319-956 | NDC:59110-082 | NDC:59723-101 | NDC:84955-841 | NDC:55118-900 | NDC:49436-291 | NDC:74934-015 | NDC:73487-007 | NDC:35000-068 | NDC:31507-544 | NDC:62257-976 | NDC:57468-141 | NDC:68638-876 | NDC:66885-080 | NDC:21749-750 | NDC:11429-1005 | NDC:21749-080 | NDC:21749-541 | NDC:42584-0081 | NDC:47593-465 | NDC:50536-127 | NDC:52220-701 | NDC:55319-713 | NDC:11429-1006 | NDC:59900-211 | NDC:62832-080 | NDC:63830-544 | NDC:66155-544 | NDC:66949-129 | NDC:61666-003 | NDC:70542-301 | NDC:71906-701 | NDC:49436-377 | NDC:47593-503 | NDC:21749-501 | NDC:57337-086 | NDC:71896-051 | NDC:71907-701 | NDC:81591-001 | NDC:71906-080 | NDC:59900-128 | NDC:75632-876 | NDC:21749-975 | NDC:63830-876 | NDC:68599-5204 | NDC:75990-914 | NDC:21749-531 | CHLOROXYLENOL | NDC:55443-0600 | NDC:61924-092 | NDC:64536-8308 | NDC:70415-901 | NDC:61666-004 | NDC:79481-0200 | NDC:80434-051 | NDC:59900-217 | NDC:52220-080 | NDC:61666-901 | NDC:54057-082 | NDC:62257-875 | NDC:71896-081 | NDC:71907-301 | NDC:62257-012 | NDC:66908-083 | NDC:64009-203 | NDC:16496-544 | NDC:50865-060 | NDC:47593-479 | NDC:62672-300 | NDC:63146-315 | NDC:67777-318 | NDC:76378-017 | NDC:82078-301 | NDC:21749-555 | NDC:73487-006 | NDC:21749-551 | Chloroxylenol | UNII:0F32U78V2Q | NDC:60933-210 | NDC:61666-005 | NDC:47593-573 | NDC:83042-701 | NDC:70542-701 | NDC:73487-001 | NDC:50536-090 | NDC:60456-876 | NDC:49698-006 | NDC:21749-523 | NDC:71897-080 | NDC:49557-701 | NDC:76378-021 | NDC:47593-308 | NDC:42584-0080 | NDC:55910-589 | NDC:62257-686 | NDC:21749-522 | NDC:49698-001 | NDC:64536-8748 | NDC:50536-139 | NDC:49514-081 | NDC:11084-800 | NDC:0404-4441 | NDC:72202-301 | NDC:82076-301 | NDC:21749-581 | CAS RN:88-04-0 | NDC:68642-876 | NDC:0404-4438 | NDC:63146-308 | NDC:62257-161 | NDC:63146-111 | NDC:50536-192 | NDC:21749-457 | NDC:24205-080 | NDC:53329-923 | NDC:68978-708 | NDC:49514-051 | DrugBank ID:DB11121 | NDC:59900-127 | NDC:61924-093 | NDC:21749-521 | NDC:21749-060 | NDC:50536-195 | NDC:47593-493 | NDC:73487-003 | NDC:84126-008 | NDC:61010-1122 | NDC:79481-0190 | NDC:66294-523 | NDC:49698-010 | NDC:71912-521 | NDC:43097-876 | NDC:53341-080 | NDC:47593-501 | NDC:59900-208 | NDC:52674-544 | NDC:66294-521 | NDC:84126-007 | NDC:47593-477 | NDC:17271-116 | NDC:61010-8600 | NDC:31507-876 | NDC:63039-1005 | NDC:47593-506 | NDC:64009-336 | NDC:69423-287 | NDC:70542-201 | NDC:70542-303 | NDC:63146-110 | NDC:71925-301 | NDC:66077-708 | NDC:69842-946 | NDC:83019-101 | NDC:51628-0033 | NDC:61924-198 | NDC:66949-125 | NDC:21749-580 | NDC:71874-080 | NDC:17271-502 | PubChem SID:175265339 | NDC:21749-622 | NDC:72024-708 | NDC:83019-103 | NDC:54679-0001 | NDC:21749-095 | NDC:61666-007 | NDC:71875-080 | NDC:50536-163 | NDC:30805-006 | NDC:72202-201 | NDC:66294-082 | NDC:79016-141 | NDC:64987-0266 | NDC:83919-600 | NDC:71212-103 | NDC:40096-0081 | NDC:63146-105 | NDC:72379-544 | NDC:69423-286 | NDC:73487-004 | NDC:77955-004 | NDC:69771-006 | NDC:0404-5987 | NDC:73062-055 | NDC:63146-108 | NDC:18949-051 | NDC:65585-568 | NDC:76402-408 | NDC:35000-069 | NDC:50865-025 | NDC:66294-080 | PubChem CID:2723 | NDC:50685-008 | NDC:71906-713 | NDC:71897-566 | NDC:49698-007 | NDC:63533-876 | NDC:69423-053 | NDC:21749-528 | NDC:40096-0051 | NDC:37000-616 | NDC:47593-515 | NDC:49514-080 | NDC:65601-841 | NDC:68978-141 | NDC:72024-841 | NDC:21749-423 | NDC:66949-123 | NDC:63981-933 | NDC:72234-876 | NDC:49698-008 | NDC:63998-758 | NDC:60933-050 | NDC:62257-380 | NDC:62257-160 | NDC:60933-106 | NDC:62257-876 | NDC:78016-106 | NDC:0404-5990 | NDC:66908-081 | NDC:72528-141 | NDC:62257-544 | NDC:62257-950 | NDC:69335-001 | NDC:37000-617 | NDC:63146-102 | NDC:64987-2661 | NDC:21749-211 | NDC:76287-876 | NDC:76378-022 | NDC:64009-335 | NDC:66910-600 | NDC:63146-319 | NDC:53125-708 | NDC:74934-014 | NDC:60933-056 | NDC:11429-1010 | NDC:49698-009 | NDC:40096-0080 | NDC:52031-0876 | NDC:47593-362 | NDC:21749-090 | NDC:50536-181 | NDC:63146-121 | NDC:59110-081 | NDC:64536-8760 | NDC:59503-0544 | NDC:66885-081 | NDC:69423-291 | NDC:77617-017 | NDC:68776-1005 | NDC:72379-876 | NDC:71907-201 | NDC:11084-036 | NDC:54057-083 | NDC:63146-124 | NDC:79903-136 | NDC:57424-708 | NDC:63830-950 | NDC:64009-338 | NDC:73062-523 | NDC:79258-841 | NDC:84128-004 | NDC:21749-085 | NDC:68663-876 | NDC:11822-0281"
+BMGC_DG06617,BMG_DG129284,"UNII:WIX31ZPX66 | 2-amino-3,7-dihydropurine-6-thione | THIOGUANINE ANHYDROUS | PubChem SID:175267523 | CAS RN:157646-93-0 | CAS RN:154-42-7 | Thioguanine | DrugBank ID:DB00352 | Tioguanine | CAS RN:1330266-29-9 | CAS RN:611-67-6 | PubChem CID:2723601 | CAS RN:5580-03-0"
+BMGC_DG06618,BMG_DG129301,PubChem CID:2723639 | CAS RN:1668-10-6 | GLYCINAMIDE HYDROCHLORIDE | Glycinamide hydrochloride | PubChem SID:474493612 | UNII:9SPG4KUG6A
+BMGC_DG06619,BMG_DG129309,"PubChem SID:198965632 | CAS RN:32873-56-6 | PubChem CID:2723687 | N-(5-MERCAPTO-1,3,4-THIADIAZOL-2-YL)ACETAMIDE | UNII:6B8475348K"
+BMGC_DG06620,BMG_DG129311,UNII:EE982KT952 | PubChem SID:198979871 | 2-MERCAPTOPYRIDINE | 2-Pyridinethiol | PubChem CID:2723698 | DrugBank ID:DB03329 | CAS RN:73018-10-7
+BMGC_DG06621,BMG_DG129341,CAS RN:17356-08-0 | THIOUREA | PubChem SID:198980610 | thiourea | PubChem CID:2723790 | UNII:GYV9AM2QAG | CAS RN:62-56-6 | Thiourea
+BMGC_DG06622,BMG_DG129344,"CAS RN:3179-31-5 | 3-MERCAPTO-1,2,4-TRIAZOLE | PubChem SID:313390108 | UNII:RUS62L885R | PubChem CID:2723802"
+BMGC_DG06623,BMG_DG129350,5-CHLORO-2-MERCAPTOBENZOTHIAZOLE | UNII:R9099U429R | PubChem SID:252165324 | PubChem CID:2723842 | CAS RN:5331-91-9
+BMGC_DG06624,BMG_DG129355,"5-amino-1,3,4-thiadiazole-2-thiol | CAS RN:2349-67-9 | 5-AMINO-1,3,4-THIADIAZOLE-2-THIOL | UNII:B1HEG7V21S | DrugBank ID:DB12348 | PubChem SID:198979768 | 5-amino-3H-1,3,4-thiadiazole-2-thione | PubChem CID:2723847 | 5-Amino-1,3,4-thiadiazole-2-thiol"
+BMGC_DG06625,BMG_DG129362,"D-Fructose | (3S,4R,5R)-2-(hydroxymethyl)oxane-2,3,4,5-tetrol | PubChem CID:2723872"
+BMGC_DG06626,BMG_DG129371,CAS RN:19501-58-7 | PubChem SID:485662925 | (4-Methoxyphenyl)hydrazine hydrochloride | (4-METHOXYPHENYL)HYDRAZINE HYDROCHLORIDE | PubChem CID:2723904 | UNII:4KX8TEV7KM
+BMGC_DG06627,BMG_DG129386,UNII:M8U5Q5R3SA | PubChem CID:2723947 | 3-HYDROXY-2(1H)-PYRIDINETHIONE | CAS RN:23003-22-7 | PubChem SID:198950979
+BMGC_DG06628,BMG_DG129454,PubChem CID:2724251 | DrugBank ID:DB06783 | Prussian blue | Ferric ferrocyanide | iron(2+);iron(3+);octadecacyanide
+BMGC_DG06629,BMG_DG129474,"(2S,3R)-2,3-bis(sulfanyl)butanedioic acid | UNII:DX1U2629QE | NDC:55292-201 | Succimer | SUCCIMER | NDC:71083-0020 | CAS RN:304-55-2 | DrugBank ID:DB00566 | PubChem CID:2724354 | PubChem SID:175268497"
+BMGC_DG06630,BMG_DG129485,"CAS RN:14930-96-2 | (1S,6R,10R,14S,15S,17S,18S,19S)-19-benzyl-6,15-dihydroxy-10,17-dimethyl-16-methylidene-2-oxa-20-azatricyclo[12.7.0.01,18]henicosa-4,12-diene-3,21-dione | PubChem CID:2724383 | Cytochalasin B-CASMI2016 Category 1-Challenge 3"
+BMGC_DG06631,BMG_DG129486,"PubChem SID:175268012 | DIGOXIN | Digoxin | 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | DrugBank ID:DB00390 | PubChem CID:2724385 | UNII:73K4184T59 | CAS RN:20830-75-5"
+BMGC_DG06632,BMG_DG129487,"UNII:C558LI0K8P | 6-Thioguanosine | THIOGUANOSINE | CAS RN:85-31-4 | PubChem SID:198956490 | 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione | PubChem CID:2724387"
+BMGC_DG06633,BMG_DG129495,UNII:OH8N7NE9ZG | PubChem CID:2724431 | NORCARFENTANIL | CAS RN:72996-78-2 | PubChem SID:377308723
+BMGC_DG06634,BMG_DG129497,4-(4-FLUOROBENZOYL)PIPERIDINE | UNII:4K4JJ6US7T | PubChem SID:459275754 | CAS RN:56346-57-7 | PubChem CID:2724440
+BMGC_DG06635,BMG_DG129531,N-FLUORENYLMETHOXYCARBONYL-.BETA.-ALANINE | N-Fluorenylmethoxycarbonyl-β-alanine | CAS RN:35737-10-1 | PubChem SID:478839307 | PubChem CID:2724630 | UNII:7G6VG65WAL
+BMGC_DG06636,BMG_DG129569,"CAS RN:35132-20-8 | UNII:JZ5DV7MKY6 | PubChem SID:472422812 | 1,2-DIPHENYLETHYLENEDIAMINE, (1R,2R)-(+)- | PubChem CID:2724998 | 1,2-Diphenylethylenediamine, (1R,2R)-(+)-"
+BMGC_DG06637,BMG_DG129570,"CHLORPHENIRAMINE | CAS RN:132-22-9 | CAS RN:113-92-8 | UNII:3U6IO1965U | PubChem CID:2725 | Chlorpheniramine | DrugBank ID:DB01114 | PubChem SID:175271598 | 3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine"
+BMGC_DG06638,BMG_DG129578,"UNII:KXQ5HR3BJH | PubChem CID:2725651 | PubChem SID:461433787 | CAS RN:103826-87-5 | 2,2-DIMETHYL-N-(4-SULFAMOYLPHENYL)PROPANAMIDE"
+BMGC_DG06639,BMG_DG129580,"Chlorpromazine | CHLORPROMAZINE | PubChem CID:2726 | DrugBank ID:DB00477 | CAS RN:50-53-3 | CAS RN:146702-01-4 | 3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine | PubChem SID:175268229 | UNII:U42B7VYA4P | CAS RN:34468-21-8"
+BMGC_DG06640,BMG_DG129581,"4-METHYL-7,8-DIHYDRO-5H-THIOPYRANO(4,3-D)PYRIMIDIN-2-AMINE | UNII:AN8UFC8Y2Y | PubChem CID:2726820 | 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine | DrugBank ID:DB08194 | CAS RN:685123-96-0 | PubChem SID:443624493"
+BMGC_DG06641,BMG_DG129583,CHLORPROPAMIDE | CAS RN:94-20-2 | Chlorpropamide | UNII:WTM2C3IL2X | PubChem CID:2727 | DrugBank ID:DB00672 | PubChem SID:175268750 | 1-(4-chlorophenyl)sulfonyl-3-propylurea
+BMGC_DG06642,BMG_DG129599,"PubChem SID:198963864 | UNII:EFA30X554H | PHENETICILLIN | DrugBank ID:DB13337 | CAS RN:147-55-7 | PubChem CID:272833 | (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxypropanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Pheneticillin"
+BMGC_DG06643,BMG_DG129608,"2-methyl-1,1-dioxo-1,2-benzothiazol-3-one | CAS RN:15448-99-4 | UNII:T63VBY3AYH | PubChem CID:27290 | PubChem SID:198975279 | N-Methylsaccharin | N-METHYLSACCHARIN"
+BMGC_DG06644,BMG_DG129620,"pentane-1,5-diamine | PubChem SID:198986338 | PubChem CID:273 | DrugBank ID:DB03854 | CAS RN:462-94-2 | Cadaverine | CADAVERINE | UNII:L90BEN6OLL"
+BMGC_DG06645,BMG_DG129627,"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide | DrugBank ID:DB08479 | PubChem CID:2730282"
+BMGC_DG06646,BMG_DG129629,OXIDRONIC ACID | Oxidronic Acid | PubChem SID:175267716 | PubChem CID:27304 | UNII:71MR4V32TI | CAS RN:15468-10-7 | [hydroxy(phosphono)methyl]phosphonic acid | DrugBank ID:DB14159
+BMGC_DG06647,BMG_DG129641,NDC:68382-970 | NDC:50090-6126 | NDC:71205-592 | NDC:70199-017 | NDC:50090-6957 | NDC:29300-333 | NDC:64980-304 | NDC:70756-011 | NDC:70771-1369 | NDC:68788-8294 | NDC:43598-167 | NDC:59746-760 | NDC:72162-2134 | NDC:51224-118 | NDC:72162-2133 | NDC:71610-472 | NDC:63629-2465 | NDC:46708-677 | NDC:0904-6900 | NDC:62332-676 | NDC:64980-599 | NDC:63629-8761 | NDC:75834-110 | NDC:51079-058 | CAS RN:77-36-1 | NDC:71610-021 | NDC:72189-507 | NDC:46708-676 | NDC:51655-790 | NDC:27241-216 | 2-chloro-5-(1-hydroxy-3-oxo-2H-isoindol-1-yl)benzenesulfonamide | NDC:43598-170 | Chlorthalidone | NDC:62135-505 | NDC:50268-167 | NDC:63629-4446 | NDC:71610-029 | NDC:64980-600 | NDC:67877-696 | NDC:63629-8762 | NDC:68382-971 | NDC:67877-697 | NDC:16714-128 | NDC:71335-2072 | NDC:51655-477 | NDC:71610-682 | NDC:62332-677 | NDC:72162-2010 | NDC:50090-6958 | NDC:70518-4078 | NDC:70518-3954 | NDC:43598-719 | NDC:43598-720 | NDC:51224-018 | PubChem SID:175271663 | NDC:70771-1370 | NDC:50090-5183 | NDC:72789-358 | NDC:65162-247 | NDC:55289-067 | NDC:29300-334 | DrugBank ID:DB00310 | NDC:57664-649 | NDC:51655-992 | NDC:60687-317 | NDC:63629-9298 | NDC:71335-2223 | NDC:57664-648 | NDC:0378-0213 | NDC:72789-359 | UNII:Q0MQD1073Q | NDC:72189-356 | NDC:71335-0906 | NDC:70199-001 | NDC:50090-5643 | NDC:51655-526 | NDC:51655-961 | NDC:71335-2269 | NDC:0378-0222 | NDC:64980-303 | NDC:27241-217 | NDC:59746-761 | NDC:16714-129 | CHLORTHALIDONE | NDC:62135-506 | NDC:65162-250 | NDC:75834-109 | PubChem CID:2732 | NDC:67046-2070 | CAS RN:74658-80-3 | NDC:70756-020 | NDC:70518-3718 | NDC:71335-1829
+BMGC_DG06648,BMG_DG129645,PubChem SID:475550263 | PubChem CID:2732752 | CAS RN:169037-23-4 | 5-(Trifluoromethoxy)isatin | UNII:BGN7HVV394 | 5-(TRIFLUOROMETHOXY)ISATIN
+BMGC_DG06649,BMG_DG129648,"NDC:50090-0315 | PubChem SID:175268245 | NDC:69499-330 | DrugBank ID:DB00356 | NDC:59651-307 | NDC:55289-633 | NDC:71335-1914 | NDC:0254-2053 | NDC:24470-940 | NDC:0254-2005 | NDC:71335-2009 | NDC:63629-1586 | NDC:59651-306 | CHLORZOXAZONE | NDC:71335-2433 | NDC:60760-619 | NDC:0591-2520 | NDC:59651-305 | PubChem CID:2733 | NDC:16571-727 | NDC:71205-711 | NDC:63187-317 | NDC:80425-0315 | NDC:69844-054 | NDC:60760-578 | NDC:16571-726 | NDC:50090-6689 | Chlorzoxazone | CAS RN:95-25-0 | NDC:51862-339 | NDC:42494-426 | NDC:70954-085 | NDC:24470-923 | NDC:64980-582 | NDC:55700-951 | 5-chloro-3H-1,3-benzoxazol-2-one | NDC:16571-725 | UNII:H0DE420U8G | NDC:63629-9158"
+BMGC_DG06650,BMG_DG129650,CCG-50014 | PubChem CID:2733079 | PubChem SID:198955301 | UNII:RA72G28VE9 | CAS RN:883050-24-6
+BMGC_DG06651,BMG_DG129680,PubChem CID:2733484 | PubChem SID:198940786 | CAPSAZEPINE | UNII:LFW48MY844 | CAS RN:138977-28-3
+BMGC_DG06652,BMG_DG129684,"PubChem CID:2733504 | UNII:7M9D81YZ2N | Diphenyleneiodonium chloride | 8-iodoniatricyclo[7.4.0.02,7]trideca-1(13),2,4,6,9,11-hexaene;chloride | CAS RN:4673-26-1 | DIPHENYLENEIODONIUM CHLORIDE | PubChem SID:198943145"
+BMGC_DG06653,BMG_DG129686,PubChem CID:2733506 | UNII:G5QA32XVN5 | (2S)-2-amino-6-(1-aminoethylideneamino)hexanoic acid | N(6)-acetimidoyl-L-lysine | CAS RN:53774-63-3 | PubChem SID:472407847 | N-IMINOETHYL-L-LYSINE
+BMGC_DG06654,BMG_DG129689,PubChem CID:2733514 | DrugBank ID:DB03953 | Thiocitrulline | CAS RN:156719-37-8 | (2S)-2-amino-5-(carbamothioylamino)pentanoic acid
+BMGC_DG06655,BMG_DG129692,"NDC:63187-976 | NDC:50090-0485 | TAMOXIFEN CITRATE | NDC:0378-0274 | NDC:68382-826 | 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid | CAS RN:54965-24-1 | NDC:70771-1185 | NDC:51862-682 | NDC:68382-827 | NDC:51862-642 | NDC:51407-440 | NDC:70771-1184 | NDC:72162-2208 | NDC:51862-643 | Tamoxifen citrate | NDC:0378-0144 | PubChem CID:2733525 | NDC:0591-2473 | NDC:50090-0942 | UNII:7FRV7310N6 | NDC:72162-2209 | NDC:75907-059 | PubChem SID:175267237 | NDC:75907-058 | NDC:59651-300 | NDC:68071-5254 | NDC:59651-299 | NDC:72162-2225 | NDC:0591-2472"
+BMGC_DG06656,BMG_DG129693,"PubChem SID:175267406 | DrugBank ID:DB00675 | TAMOXIFEN | 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine | UNII:094ZI81Y45 | CAS RN:10540-29-1 | Tamoxifen | PubChem CID:2733526"
+BMGC_DG06657,BMG_DG129717,"CAS RN:516-50-7 | PubChem CID:2733768 | TAURODEOXYCHOLIC ACID | PubChem SID:312524869 | 2-[[(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | UNII:20668G0RPI | Taurodeoxycholic Acid"
+BMGC_DG06658,BMG_DG129718,"CAS RN:18997-57-4 | 4-methyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one | PubChem CID:2733779 | DrugBank ID:DB13177 | 4-Methylumbelliferyl glucoside"
+BMGC_DG06659,BMG_DG129726,".GAMMA.-AMINO-.BETA.-HYDROXYBUTYRIC ACID, (-)- | UNII:592W66MW4A | PubChem CID:2733883 | PubChem SID:198989707 | CAS RN:7013-07-2"
+BMGC_DG06660,BMG_DG129753,PubChem CID:2734054 | DrugBank ID:DB03253 | (2s)-Pyrrolidin-2-Ylmethylamine
+BMGC_DG06661,BMG_DG129759,"PubChem CID:2734086 | UNII:ZO763K43XR | 2-[(3R,7R,11R)-3-hydroxy-3,7,11,15-tetramethylhexadecyl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione | CAS RN:78419-32-6 | TOCOQUINONE | CAS RN:7559-04-8 | PubChem SID:175266211 | DrugBank ID:DB14094 | alpha-Tocopherolquinone"
+BMGC_DG06662,BMG_DG129796,PubChem SID:474493556 | UNII:PLE7H7N7YB | PubChem CID:2734232 | 1-Hexadecyl-3-methylimidazolium | 1-HEXADECYL-3-METHYLIMIDAZOLIUM | CAS RN:81995-03-1
+BMGC_DG06663,BMG_DG129811,PubChem SID:485663439 | PubChem CID:2734315 | (3-Phenylphenyl)boronic acid | (3-PHENYLPHENYL)BORONIC ACID | UNII:LD5RSH6TTV | CAS RN:5122-95-2
+BMGC_DG06664,BMG_DG129813,(4-cyanophenyl)boronic acid | CAS RN:126747-14-6 | 4-Cyanophenylboronic acid | PubChem CID:2734326
+BMGC_DG06665,BMG_DG129814,"UNII:JD5DY73A3Z | CAS RN:156545-07-2 | PubChem CID:2734338 | (3,5-DIFLUOROPHENYL)BORONIC ACID"
+BMGC_DG06666,BMG_DG129817,PubChem CID:2734360 | UNII:U8AX2ASL53 | 4-HYDROXYPHENYLBORONIC ACID | CAS RN:71597-85-8
+BMGC_DG06667,BMG_DG129819,CAS RN:10365-98-7 | PubChem SID:472422287 | PubChem CID:2734370 | (3-METHOXYPHENYL)BORONIC ACID | UNII:T4XV2NE6NL
+BMGC_DG06668,BMG_DG129820,CAS RN:32316-92-0 | PubChem CID:2734375 | PubChem SID:445498858 | 2-NAPHTHALENEBORONIC ACID | UNII:QP24ZQS9BM
+BMGC_DG06669,BMG_DG129843,6-HYDROXYFLAVANONE | CAS RN:4250-77-5 | PubChem SID:198982146 | PubChem CID:2734580 | UNII:1F174812MP
+BMGC_DG06670,BMG_DG129860,PubChem SID:198938977 | PRAXADINE | UNII:12L58GX4AS | PubChem CID:2734673 | Praxadine | CAS RN:4023-00-1
+BMGC_DG06671,BMG_DG129872,"4,7-DICHLOROISATIN | UNII:DG6F5LLA76 | 4,7-Dichloroisatin | PubChem SID:485663526 | PubChem CID:2734793 | CAS RN:18711-13-2"
+BMGC_DG06672,BMG_DG129896,"CAS RN:68-19-9 | cobalt(3+);[(2R,3R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(2S,12R,18R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl phosphate;cyanide | PubChem CID:2734998"
+BMGC_DG06673,BMG_DG129897,"Pancuronium Bromide | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;dibromide | PANCURONIUM BROMIDE | UNII:U9LY9Y75X2 | PubChem SID:175266537 | PubChem CID:27350 | CAS RN:15500-66-0"
+BMGC_DG06674,BMG_DG129901,Potassium ethylxanthate | PubChem SID:198976788 | potassium;ethoxymethanedithioate | CAS RN:140-89-6 | UNII:1A6K3Y576K | PubChem CID:2735045 | POTASSIUM ETHYLXANTHATE
+BMGC_DG06675,BMG_DG129925,PubChem SID:375083195 | DrugBank ID:DB15279 | CAS RN:218457-67-1 | Limantrafin | LIMANTRAFIN | Cb-103 | PubChem CID:2735289 | UNII:Q5BB91JL0V | 6-(4-tert-butylphenoxy)pyridin-3-amine
+BMGC_DG06676,BMG_DG129927,"CAS RN:53696-59-6 | PubChem CID:2735431 | [[(2R,3S,4R,5R)-5-(6-amino-8-azidopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | 8-Azidoadenosine 5'-triphosphate"
+BMGC_DG06677,BMG_DG129952,PubChem CID:2735867 | UNII:EZR7UV88N3 | CAS RN:50916-55-7 | 3-(2-BROMOACETYL)BENZONITRILE
+BMGC_DG06678,BMG_DG129988,BUTETAMATE | CAS RN:14007-64-8 | PubChem CID:27368 | UNII:2VO6TC90PU | PubChem SID:198942272
+BMGC_DG06679,BMG_DG129997,3-(4-NITROPHENYL)-1H-PYRAZOLE | CAS RN:20583-31-7 | PubChem SID:440090048 | UNII:K0B6P40GV5 | PubChem CID:2737071 | DrugBank ID:DB08695 | 3-(4-nitrophenyl)-1H-pyrazole
+BMGC_DG06680,BMG_DG130007,CAS RN:180698-18-4 | PubChem SID:445500469 | 1-(2-DIPHENYL)PIPERAZINE | UNII:T5S5265H6V | PubChem CID:2737389
+BMGC_DG06681,BMG_DG130019,2-PHENYLIMIDAZOLE-4-CARBOXYLIC ACID | PubChem SID:376231221 | DrugBank ID:DB07803 | 2-phenyl-1H-imidazole-4-carboxylic acid | UNII:HGH57KDY8T | CAS RN:77498-98-7 | PubChem CID:2738139
+BMGC_DG06682,BMG_DG130023,"1-methyl-4-(6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-2-ylidene)piperidine | UNII:0BY8440V3N | PIZOTYLINE | Pizotifen | Pizotyline | CAS RN:15574-96-6 | DrugBank ID:DB06153 | PubChem CID:27400 | PubChem SID:198961793"
+BMGC_DG06683,BMG_DG130025,DrugBank ID:DB07901 | 5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE | PubChem CID:2740174
+BMGC_DG06684,BMG_DG130026,"CAS RN:22004-32-6 | 2,5-Dimethoxy-4-ethylamphetamine | UNII:9SK6K682UL | PubChem CID:27402 | PubChem SID:316911995 | DOET | DrugBank ID:DB01467"
+BMGC_DG06685,BMG_DG130030,PubChem SID:198971286 | CHROMOCARB | UNII:FY38S0790W | CAS RN:4940-39-0 | PubChem CID:2741
+BMGC_DG06686,BMG_DG130031,PubChem SID:472421776 | CAS RN:22508-51-6 | UNII:L9NTG6LV7J | 1-ADAMANTYL(PYRROLIDIN-1-YL)METHANONE | PubChem CID:2741656
+BMGC_DG06687,BMG_DG130035,3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE | DrugBank ID:DB08560 | PubChem CID:2742752
+BMGC_DG06688,BMG_DG130048,"Cephalexin | UNII:5SFF1W6677 | DrugBank ID:DB00567 | (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CAS RN:15686-71-2 | CAS RN:34632-04-7 | PubChem SID:175268071 | PubChem CID:27447 | CEPHALEXIN ANHYDROUS"
+BMGC_DG06689,BMG_DG130055,PubChem CID:27453 | CAS RN:15687-14-6 | Embutramide | UNII:3P4TQG94T1 | DrugBank ID:DB01487 | N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxybutanamide | EMBUTRAMIDE | PubChem SID:175265720
+BMGC_DG06690,BMG_DG130061,4-acetamido-N-(2-aminophenyl)benzamide | PubChem SID:198951507 | CAS RN:112522-64-2 | UNII:UMF554N5FG | DrugBank ID:DB12291 | PubChem CID:2746 | Tacedinaline | TACEDINALINE
+BMGC_DG06691,BMG_DG130066,"Cibenzoline | UNII:Z7489237QT | PubChem SID:198989957 | DrugBank ID:DB13358 | CIFENLINE | 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole | CAS RN:53267-01-9 | PubChem CID:2747"
+BMGC_DG06692,BMG_DG130078,NDC:62135-814 | NDC:72162-1126 | NDC:72162-1321 | NDC:0591-2159 | CAS RN:29342-05-0 | NDC:21922-053 | CICLOPIROX | PubChem CID:2749 | NDC:63629-8623 | Ciclopirox | NDC:68788-6797 | NDC:63629-8621 | UNII:19W019ZDRJ | NDC:50090-6562 | NDC:63629-8620 | NDC:45802-401 | NDC:72162-2298 | 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one | NDC:45802-141 | NDC:68462-455 | NDC:0574-2061 | NDC:63629-8622 | NDC:68788-8755 | DrugBank ID:DB01188 | PubChem SID:175266383 | NDC:72162-2076 | NDC:51672-1351 | NDC:42192-715
+BMGC_DG06693,BMG_DG130086,"DrugBank ID:DB09201 | CIGLITAZONE | PubChem SID:198974451 | 5-[[4-[(1-methylcyclohexyl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | UNII:U8QXS1WU8G | CAS RN:74772-77-3 | PubChem CID:2750 | Ciglitazone"
+BMGC_DG06694,BMG_DG130088,"PubChem CID:27501 | CAS RN:318-23-0 | N,N-diethyl-2-(5-imino-3-phenyl-1,2,4-oxadiazol-4-yl)ethanamine | UNII:K5F4RU5VQJ | IMOLAMINE | Imolamine | DrugBank ID:DB09284 | PubChem SID:198982958"
+BMGC_DG06695,BMG_DG130101,"Berbamine | UNII:V5KM4XJ0WM | CAS RN:478-61-5 | PubChem CID:275182 | CAS RN:6078-17-7 | (1S,14R)-20,21,25-trimethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.18,12.114,18.027,31.022,33]hexatriaconta-3(36),4,6(35),8,10,12(34),18,20,22(33),24,26,31-dodecaen-9-ol | BERBAMINE | PubChem SID:198940628"
+BMGC_DG06696,BMG_DG130103,"CAS RN:128-62-1 | (3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl]-3H-2-benzofuran-1-one | CAS RN:6035-40-1 | NOSCAPINE | PubChem CID:275196 | PubChem SID:175267992 | NOSCAPINE, (±)- | UNII:A4C6WE7BZN | NOSCAPINE, (+/-)- | UNII:8V32U4AOQU | DrugBank ID:DB06174 | Noscapine | PubChem SID:198970379"
+BMGC_DG06697,BMG_DG130116,CAS RN:68550-75-4 | N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide | PubChem CID:2753 | PubChem SID:198959997 | CILOSTAMIDE | UNII:45S5605Q18 | Cilostamide
+BMGC_DG06698,BMG_DG130119,"NDC:71610-037 | NDC:60505-2522 | DrugBank ID:DB01166 | CAS RN:73963-72-1 | PubChem SID:175266132 | NDC:50268-177 | NDC:60505-2521 | NDC:0093-2065 | CILOSTAZOL | NDC:70436-157 | NDC:63629-8796 | NDC:72189-116 | NDC:50090-6690 | NDC:42291-453 | NDC:63629-8795 | UNII:N7Z035406B | NDC:71610-813 | NDC:71610-822 | PubChem CID:2754 | Cilostazol | 6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one | NDC:50268-176 | NDC:70436-156 | NDC:0093-2064"
+BMGC_DG06699,BMG_DG130127,PubChem CID:2755 | CIMATEROL | 2-amino-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzonitrile | Cimaterol | UNII:ZPY8VRF0GB | CAS RN:54239-37-1 | PubChem SID:198957597
+BMGC_DG06700,BMG_DG130134,CAS RN:104-22-3 | PubChem SID:198974209 | PubChem CID:2755709 | BENZYLSULFAMIDE | UNII:AI9WDT80FQ
+BMGC_DG06701,BMG_DG130136,CAS RN:15923-78-1 | PubChem CID:27559 | PubChem SID:445499228 | PNU-22394 | UNII:J7HPJ854EA
+BMGC_DG06702,BMG_DG130139,NDC:0093-8305 | CAS RN:2984-61-4 | NDC:62135-632 | NDC:59640-022 | CAS RN:270574-63-5 | NDC:0363-0022 | CAS RN:943920-67-0 | NDC:0378-0372 | PubChem CID:2756 | NDC:63029-222 | NDC:59651-826 | PubChem SID:175267799 | Cimetidine | NDC:62135-630 | NDC:59651-823 | NDC:0113-0022 | NDC:50090-0500 | NDC:62135-633 | NDC:49035-820 | UNII:80061L1WGD | 1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine | NDC:55289-581 | NDC:0093-8192 | CIMETIDINE | NDC:59651-824 | NDC:51655-697 | NDC:59651-825 | NDC:62135-631 | CAS RN:51481-61-9 | NDC:72288-022 | CAS RN:76181-71-0 | NDC:0378-0317 | NDC:50090-3574 | DrugBank ID:DB00501 | NDC:63029-223 | NDC:24385-111 | NDC:52183-223 | NDC:59779-022 | NDC:63187-333 | NDC:0378-0053 | NDC:0378-0541 | NDC:0093-8204
+BMGC_DG06703,BMG_DG130169,PubChem SID:482553219 | PubChem CID:2757788 | CAS RN:45964-97-4 | N-(4-CHLOROPHENYL)GUANIDINE | UNII:3QJ5KU64Y3
+BMGC_DG06704,BMG_DG130173,"NDC:11673-072 | NDC:63941-001 | NDC:63941-664 | NDC:63981-664 | NDC:83324-180 | NDC:55301-318 | NDC:41250-664 | NDC:56062-664 | NDC:50804-318 | NDC:11344-855 | NDC:68998-664 | NDC:37808-434 | NDC:55319-972 | NDC:63940-072 | NDC:49035-855 | NDC:50594-664 | NDC:71569-664 | NDC:72476-592 | NDC:11822-3108 | NDC:30142-855 | NDC:55301-664 | NDC:69968-0790 | NDC:56062-434 | NDC:56062-318 | NDC:49035-664 | NDC:30142-318 | NDC:69968-0539 | NDC:72476-318 | NDC:83324-181 | NDC:67860-072 | NDC:72476-434 | NDC:36800-664 | NDC:67860-318 | NDC:66715-6861 | NDC:49035-072 | Eucalyptol | NDC:59779-898 | NDC:11344-664 | NDC:0363-0855 | NDC:72288-664 | DrugBank ID:DB03852 | NDC:71141-156 | NDC:59998-101 | NDC:30142-434 | NDC:59779-942 | PubChem CID:2758 | NDC:11673-664 | NDC:56062-072 | NDC:67860-664 | NDC:68016-941 | NDC:76162-855 | NDC:53942-855 | NDC:79481-0567 | NDC:67091-102 | NDC:0869-0072 | NDC:84117-030 | NDC:37808-855 | NDC:63940-664 | NDC:83324-179 | NDC:41250-434 | NDC:10202-664 | NDC:41250-855 | NDC:83566-585 | NDC:55319-664 | CAS RN:470-82-6 | NDC:37808-664 | NDC:55301-072 | NDC:72036-664 | NDC:30142-072 | NDC:36800-072 | NDC:53942-072 | NDC:41163-055 | NDC:41250-318 | NDC:55910-318 | NDC:69968-0788 | NDC:68016-664 | NDC:68998-072 | NDC:69968-0791 | NDC:0363-0664 | NDC:55301-434 | NDC:0869-0318 | NDC:36800-434 | NDC:55910-099 | NDC:70677-1232 | NDC:59779-434 | NDC:59998-201 | NDC:70677-1234 | NDC:11344-434 | NDC:68998-318 | NDC:59450-901 | NDC:0869-0664 | NDC:70677-1233 | NDC:36800-318 | NDC:59779-072 | NDC:21130-318 | NDC:71141-157 | NDC:63940-318 | NDC:69968-0550 | NDC:62011-0467 | NDC:69968-0792 | NDC:71141-160 | NDC:64024-576 | NDC:53943-514 | NDC:55910-747 | NDC:41163-072 | NDC:67751-216 | NDC:59998-202 | NDC:72476-072 | NDC:30142-664 | NDC:55301-326 | NDC:72288-072 | NDC:67091-103 | NDC:41250-072 | EUCALYPTOL | NDC:11822-0664 | NDC:11344-318 | NDC:11673-434 | NDC:59998-102 | NDC:70000-0528 | NDC:0363-0072 | NDC:59779-855 | NDC:72288-318 | NDC:79903-153 | NDC:63941-003 | NDC:21130-072 | NDC:72036-072 | NDC:53943-072 | NDC:30142-326 | NDC:11673-318 | NDC:53943-556 | NDC:11822-5829 | NDC:63940-855 | NDC:11822-0434 | 1,3,3-trimethyl-2-oxabicyclo[2.2.2]octane | NDC:50804-072 | NDC:69968-0818 | NDC:72476-558 | NDC:11344-072 | NDC:63940-434 | NDC:76162-567 | NDC:55319-585 | NDC:53942-664 | NDC:69968-0400 | NDC:79903-151 | NDC:59779-664 | NDC:50594-072 | NDC:41163-318 | NDC:69968-0239 | NDC:41163-855 | NDC:69892-072 | NDC:62011-0466 | NDC:46994-664 | NDC:50804-664 | NDC:67091-106 | NDC:53943-756 | NDC:71141-155 | UNII:RV6J6604TK | NDC:37808-318 | NDC:68016-318 | NDC:69892-664 | NDC:53942-318 | NDC:55319-318 | NDC:36800-941 | NDC:21130-664 | NDC:72476-664 | NDC:55910-664 | PubChem SID:175265653 | NDC:11822-0072 | NDC:37808-072 | NDC:72036-318 | NDC:79903-152 | NDC:57243-664 | NDC:0363-0318"
+BMGC_DG06705,BMG_DG130211,"CAS RN:683274-67-1 | PubChem CID:2760428 | UNII:H9R4RCX2NA | 4-(1-PIPERAZINYL)THIENO(3,2-D)PYRIMIDINE | PubChem SID:478838444 | 4-(1-Piperazinyl)thieno[3,2-d]pyrimidine | 4-(Piperazin-1-yl)thieno[3,2-d]pyrimidine | 4-piperazin-1-ylthieno[3,2-d]pyrimidine"
+BMGC_DG06706,BMG_DG130216,1-(Diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine | 1-benzhydryl-4-(3-phenylprop-2-enyl)piperazine | Cinnarizine | DrugBank ID:DB00568 | PubChem CID:2761
+BMGC_DG06707,BMG_DG130218,PubChem CID:2761171 | UNII:OAY8ORS3CQ | DrugBank ID:DB00609 | Ethionamide | NDC:0008-4117 | 2-ethylpyridine-4-carbothioamide | ETHIONAMIDE | CAS RN:536-33-4 | PubChem SID:175265659
+BMGC_DG06708,BMG_DG130223,PubChem CID:2761494 | UNII:Y3C5V2444R | 3-Methylphenylalanine | 3-METHYL-L-PHENYLALANINE | PubChem SID:438787752 | CAS RN:114926-37-3 | DrugBank ID:DB02685
+BMGC_DG06709,BMG_DG130233,PubChem CID:2761815 | Biphenylalanine | DrugBank ID:DB04639
+BMGC_DG06710,BMG_DG130234,"UNII:LMK22VUH23 | 1-ethyl-4-oxo-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid | Cinoxacin | CAS RN:28657-80-9 | CINOXACIN | PubChem CID:2762 | PubChem SID:198969841 | DrugBank ID:DB00827"
+BMGC_DG06711,BMG_DG130260,PubChem SID:474492851 | 5-FLUORO-DMT | PubChem CID:2762738 | UNII:67P3LCN6RM | CAS RN:22120-36-1
+BMGC_DG06712,BMG_DG130269,"DrugBank ID:DB09064 | CAS RN:52214-84-3 | PubChem SID:175271929 | CIPROFIBRATE | 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropanoic acid | PubChem CID:2763 | UNII:F8252JGO9S | Ciprofibrate"
+BMGC_DG06713,BMG_DG130272,UNII:Z8CH38Y9L3 | FLASH-EDT2 | PubChem CID:2763100 | CAS RN:212118-77-9 | PubChem SID:472423332
+BMGC_DG06714,BMG_DG130284,CAS RN:6962-54-5 | 2-Quinoxalinethiol | PubChem CID:2763605 | UNII:PXW8JT3NXP | 2-QUINOXALINETHIOL | PubChem SID:474493420
+BMGC_DG06715,BMG_DG130286,"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID | PubChem CID:2763754 | DrugBank ID:DB07852"
+BMGC_DG06716,BMG_DG130288,"UNII:MBC2CX42TJ | CAS RN:318234-44-5 | PubChem SID:478838471 | 2-PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE | DrugBank ID:DB07614 | PubChem CID:2763788 | PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE"
+BMGC_DG06717,BMG_DG130290,"2,4-DIPHENYL-5-THIAZOLEACETIC ACID | PubChem SID:478838377 | UNII:J2X5TF29TZ | 2,4-Diphenyl-5-thiazoleacetic acid | PubChem CID:2763923 | CAS RN:21256-15-5"
+BMGC_DG06718,BMG_DG130291,PubChem CID:2764 | CAS RN:85721-33-1 | NDC:42195-128 | UNII:5E8K9I0O4U | NDC:25021-192 | NDC:0409-3300 | NDC:0409-2300 | PubChem SID:175265754 | CIPROFLOXACIN | NDC:66992-128 | 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid | Ciprofloxacin | DrugBank ID:DB00537 | NDC:69543-457 | NDC:25021-114
+BMGC_DG06719,BMG_DG130296,"UNII:FA675Q0E3E | PubChem CID:27648 | DrugBank ID:DB09403 | IOCETAMIC ACID | 3-(N-acetyl-3-amino-2,4,6-triiodoanilino)-2-methylpropanoic acid | CAS RN:16034-77-8 | PubChem SID:198961476 | Iocetamic Acid"
+BMGC_DG06720,BMG_DG130297,"CIRAZOLINE | CAS RN:59939-16-1 | PubChem SID:198982784 | Cirazoline | DrugBank ID:DB09202 | PubChem CID:2765 | 2-[(2-cyclopropylphenoxy)methyl]-4,5-dihydro-1H-imidazole | UNII:QK318GVY3Y"
+BMGC_DG06721,BMG_DG130300,"DrugBank ID:DB08707 | PubChem SID:459275515 | UNII:QJ8ZMA6BSL | 4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine | PIM-1 INHIBITOR 2 | CAS RN:477845-12-8 | PubChem CID:2765355"
+BMGC_DG06722,BMG_DG130302,CHLOROSUCCINIC ACID | UNII:E7056CM1PK | PubChem CID:27655 | PubChem SID:198967408 | CAS RN:16045-92-4
+BMGC_DG06723,BMG_DG130306,"NDC:62135-587 | NDC:23155-519 | NDC:71335-2194 | NDC:42677-305 | NDC:50090-7038 | NDC:81665-102 | NDC:50742-175 | NDC:13668-106 | NDC:13668-105 | NDC:71335-1117 | NDC:50742-176 | NDC:0615-7768 | NDC:59651-539 | NDC:71335-2532 | NDC:60687-783 | ISOSORBIDE MONONITRATE | NDC:50090-7496 | NDC:62135-586 | NDC:62175-107 | NDC:50742-177 | DrugBank ID:DB01020 | NDC:60687-794 | NDC:67046-1421 | NDC:70518-2956 | UNII:LX1OH63030 | NDC:42799-958 | NDC:68071-4290 | NDC:0615-7767 | NDC:42677-307 | NDC:42799-959 | NDC:71610-825 | NDC:50090-4009 | NDC:55154-7291 | NDC:51407-210 | PubChem CID:27661 | NDC:71335-2192 | NDC:42799-960 | [(3S,3aR,6R,6aS)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate | NDC:0228-2631 | NDC:68071-3081 | Isosorbide mononitrate | NDC:50090-5686 | NDC:62135-588 | NDC:71610-788 | NDC:70518-3585 | NDC:0228-2620 | NDC:51407-208 | NDC:50090-6798 | NDC:55154-7292 | NDC:63187-900 | NDC:62175-106 | NDC:42677-306 | Isosorbide Mononitrate | NDC:50090-6661 | NDC:59651-541 | NDC:13668-104 | CAS RN:16051-77-7 | NDC:51407-209 | NDC:51655-922 | NDC:23155-178 | NDC:23155-628 | NDC:81665-103 | NDC:59651-540 | PubChem SID:175266479 | NDC:0904-6450 | NDC:63187-700 | NDC:71610-772 | NDC:0904-6449"
+BMGC_DG06724,BMG_DG130308,JNJ-5207852 | 1-[3-[4-(piperidin-1-ylmethyl)phenoxy]propyl]piperidine | PubChem SID:198982782 | UNII:4I9OVB1G7D | CAS RN:398473-34-2 | 1-[4-(3-Piperidinopropoxy)benzyl]piperidine | PubChem CID:2766326
+BMGC_DG06725,BMG_DG130314,PubChem CID:2767 | azanide;dichloroplatinum(2+) | DrugBank ID:DB00515 | CAS RN:26035-31-4 | Cisplatin | Cantide + Cisplatin
+BMGC_DG06726,BMG_DG130316,UNII:A6Z3X49LJW | CAS RN:4108-90-1 | 1-PIPERIDINESULFONAMIDE | PubChem SID:485663969 | PubChem CID:276741 | 1-Piperidinesulfonamide
+BMGC_DG06727,BMG_DG130324,Propulsid | PubChem CID:2769 | CAS RN:81098-60-4 | 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide | CAS RN:104860-73-3
+BMGC_DG06728,BMG_DG130326,"UNII:ZB7D2N4DQQ | CAS RN:147508-61-0 | PubChem CID:2769183 | PubChem SID:461433435 | 3-(2-METHYLPHENYL)-5H-INDENO(1,2-C)PYRIDAZIN-5-ONE"
+BMGC_DG06729,BMG_DG130327,"UNII:UK294JA983 | 6,7-DIMETHOXY-2-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE | PubChem SID:474492377 | CAS RN:16620-96-5 | 6,7-Dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline | 6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinoline | PubChem CID:27694"
+BMGC_DG06730,BMG_DG130330,CAS RN:10206-89-0 | UNII:1P958G9T1V | PubChem CID:27697 | PubChem SID:313183986 | EXP-561
+BMGC_DG06731,BMG_DG130333,DrugBank ID:DB04261 | CARBAMIC ACID | Carbamic Acid | CAS RN:463-77-4 | PubChem SID:198946116 | UNII:O0UC6XOS4H | PubChem CID:277 | carbamic acid
+BMGC_DG06732,BMG_DG130339,NDC:37662-0342 | NDC:37662-0337 | PubChem SID:175271361 | NDC:37662-0338 | PubChem CID:2771 | NDC:37662-0343 | NDC:37662-0339 | NDC:37662-0341 | UNII:0DHU5B8D6V | 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile | CITALOPRAM | NDC:37662-0336 | NDC:37662-0340 | CAS RN:59729-33-8 | DrugBank ID:DB00215 | Citalopram
+BMGC_DG06733,BMG_DG130400,PubChem SID:198981344 | CAS RN:194423-06-8 | N-(4-((3-bromophenyl)amino)quinazolin-6-yl)but-2-ynamide | PubChem CID:2776 | CAS RN:253310-44-0 | N-[4-(3-bromoanilino)quinazolin-6-yl]but-2-ynamide | UNII:B4W27J1Z8B | CL-387785
+BMGC_DG06734,BMG_DG130410,4-(2-Thienyl)benzenemethanamine | PubChem SID:485663456 | CAS RN:203436-48-0 | DrugBank ID:DB07259 | 4-(2-THIENYL)BENZENEMETHANAMINE | UNII:Q2BU42LG8C | 1-(4-thiophen-2-ylphenyl)methanamine | PubChem CID:2776332
+BMGC_DG06735,BMG_DG130413,"DrugBank ID:DB07094 | 1-(2,2'-bithiophen-5-yl)methanamine | PubChem CID:2776424"
+BMGC_DG06736,BMG_DG130421,N-(4-morpholin-4-ylbutyl)-1-benzofuran-2-carboxamide | CL82198 | PubChem CID:2777 | CAS RN:307002-71-7
+BMGC_DG06737,BMG_DG130430,T0070907 | UNII:N2LK5944GW | CAS RN:313516-66-4 | PubChem CID:2777391 | PubChem SID:475550271
+BMGC_DG06738,BMG_DG130435,"PubChem CID:27775 | Pentamethylmelamine | PENTAMETHYLMELAMINE | 2-N,2-N,4-N,4-N,6-N-pentamethyl-1,3,5-triazine-2,4,6-triamine | UNII:UEF6R96K8R | PubChem SID:313183513 | CAS RN:16268-62-5"
+BMGC_DG06739,BMG_DG130438,PubChem CID:277767 | UNII:ZE2BI297KA | CAS RN:36417-16-0 | DICHLOROALLYL LAWSONE | PubChem SID:381132543
+BMGC_DG06740,BMG_DG130476,"PubChem SID:482553825 | UNII:J2NA6BPS7N | PubChem CID:2779383 | 2,3-DIOXOINDOLINE-7-CARBOXYLIC ACID | CAS RN:25128-35-2 | 2,3-Dioxoindoline-7-carboxylic acid"
+BMGC_DG06741,BMG_DG130479,"1-(4-CHLOROBENZYL)INDOLINE-2,3-DIONE | PubChem CID:277990 | PubChem SID:475550037 | 1-(4-Chlorobenzyl)indoline-2,3-dione | UNII:72RW29KS2L | CAS RN:26960-66-7"
+BMGC_DG06742,BMG_DG130481,UNII:GC5KZW01Q3 | phosphono carbamate | PubChem SID:404859424 | PubChem CID:278 | CARBAMYL PHOSPHATE | Carbamoyl phosphate | CAS RN:590-55-6
+BMGC_DG06743,BMG_DG130482,4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro-2-methoxybenzamide | UNII:I0A84520Y9 | PubChem CID:2780 | CLEBOPRIDE | Clebopride | PubChem SID:198984555 | DrugBank ID:DB13511 | CAS RN:55905-53-8
+BMGC_DG06744,BMG_DG130483,"CAS RN:24123-92-0 | 8,9-dimethoxy-3,3,5-trimethyl-11H-pyrano[3,2-a]carbazole | PubChem CID:278055 | Koenigicine"
+BMGC_DG06745,BMG_DG130492,"Gestrinone | GESTRINONE | PubChem SID:198952858 | DrugBank ID:DB11619 | (8S,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | CAS RN:16320-04-0 | PubChem CID:27812 | UNII:1421533RCM"
+BMGC_DG06746,BMG_DG130497,PubChem SID:474491841 | PubChem CID:27815 | UNII:MLW3MG733L | 4-NITRO-7-PHENYLTHIOBENZOFURAZAN | CAS RN:16322-23-9 | 4-Nitro-7-phenylthiobenzofurazan
+BMGC_DG06747,BMG_DG130500,"CAS RN:61977-29-5 | 6-Chlorobenzo[d]isoxazol-3-ol | PubChem CID:2781852 | 6-chloro-1,2-benzoxazol-3-one"
+BMGC_DG06748,BMG_DG130501,PubChem CID:2782 | CLEMIZOLE | CAS RN:442-52-4 | PubChem SID:198939431 | Clemizole | 1-[(4-chlorophenyl)methyl]-2-(pyrrolidin-1-ylmethyl)benzimidazole | UNII:T97CB3796L
+BMGC_DG06749,BMG_DG130518,"PubChem SID:405218111 | DrugBank ID:DB07108 | UNII:1UPF6UD3CR | 4-(4-FLUOROPHENYL)BENZOIC ACID | 4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID | CAS RN:5731-10-2 | PubChem CID:2782689"
+BMGC_DG06750,BMG_DG130524,"PubChem CID:2783 | CAS RN:37148-27-9 | CLENBUTEROL | Clenbuterol | UNII:XTZ6AXU7KN | DrugBank ID:DB01407 | PubChem SID:175271716 | 1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol"
+BMGC_DG06751,BMG_DG130525,PubChem SID:445499211 | NW-1689 | CAS RN:405-85-6 | PubChem CID:2783081 | UNII:9KQ2XQY9HW
+BMGC_DG06752,BMG_DG130532,2-FLUOROPYRIDINE-5-BORONIC ACID | PubChem SID:485663628 | UNII:H7MRK5DJM8 | 2-Fluoropyridine-5-boronic acid | PubChem CID:2783397 | CAS RN:351019-18-6
+BMGC_DG06753,BMG_DG130537,"DrugBank ID:DB00771 | (1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate | Clidinium | PubChem SID:175272124 | CLIDINIUM | UNII:BO76JF850N | PubChem CID:2784 | CAS RN:7020-55-5"
+BMGC_DG06754,BMG_DG130553,MANGANOUS CATION | Manganese cation | manganese(2+) | PubChem SID:175266752 | DrugBank ID:DB06757 | CAS RN:15365-82-9 | CAS RN:16397-91-4 | PubChem CID:27854 | UNII:H6EP7W5457 | Manganous cation
+BMGC_DG06755,BMG_DG130559,UNII:8AON0U1UBT | CAS RN:16401-99-3 | PubChem CID:27861 | INDOMETHACIN ETHYL | PubChem SID:384436473
+BMGC_DG06756,BMG_DG130565,UNII:0374EZJ8CU | CAS RN:30299-08-2 | Clinofibrate | CLINOFIBRATE | PubChem SID:198937184 | DrugBank ID:DB09006 | PubChem CID:2787
+BMGC_DG06757,BMG_DG130577,CAS RN:130-26-7 | UNII:7BHQ856EJ5 | PubChem CID:2788 | Clioquinol | 5-chloro-7-iodoquinolin-8-ol | DrugBank ID:DB04815 | PubChem SID:175267966 | CLIOQUINOL | NDC:69683-101
+BMGC_DG06758,BMG_DG130601,"NDC:10094-210 | PubChem SID:175266088 | NDC:60687-423 | CLOBAZAM | NDC:31722-641 | UNII:2MRO291B4U | NDC:51407-585 | NDC:10094-205 | NDC:51672-4227 | NDC:70710-1325 | NDC:72205-048 | NDC:69539-153 | NDC:69238-1535 | NDC:0832-0580 | NDC:0781-8013 | NDC:42571-316 | NDC:69238-1305 | NDC:70771-1440 | NDC:0781-8014 | NDC:67386-315 | NDC:69539-154 | NDC:62135-527 | NDC:0832-0581 | NDC:72205-047 | NDC:51991-958 | NDC:10094-220 | NDC:70771-1441 | NDC:16714-888 | NDC:59651-401 | NDC:31722-639 | NDC:67877-666 | NDC:66689-058 | NDC:42571-315 | CAS RN:22316-47-8 | PubChem CID:2789 | NDC:67386-313 | NDC:51672-4203 | NDC:67877-665 | 7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione | Clobazam | NDC:69238-1306 | NDC:67386-314 | NDC:51991-901 | NDC:16714-887 | NDC:68180-157 | NDC:16714-087 | NDC:67877-658 | NDC:51672-4202 | NDC:68180-158 | NDC:51407-586 | NDC:69452-116 | NDC:70710-1326 | NDC:67877-664 | DrugBank ID:DB00349 | NDC:31722-640 | NDC:51991-900"
+BMGC_DG06759,BMG_DG130607,Clobenpropit | PubChem SID:198948919 | 3-(1H-imidazol-5-yl)propyl N'-[(4-chlorophenyl)methyl]carbamimidothioate | PubChem CID:2790 | UNII:RKU631JF4H | CLOBENPROPIT | CAS RN:145231-45-4
+BMGC_DG06760,BMG_DG130609,Thenalidine | THENALIDINE | PubChem CID:27901 | CAS RN:86-12-4 | DrugBank ID:DB04826 | 1-methyl-N-phenyl-N-(thiophen-2-ylmethyl)piperidin-4-amine | UNII:6U94N2D00F | PubChem SID:198943024
+BMGC_DG06761,BMG_DG130618,"PubChem SID:198983325 | [(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate | UNII:NI40JAQ945 | PHORBOL 12-MYRISTATE 13-ACETATE DIESTER | Phorbol 12-myristate 13-acetate | CAS RN:16561-29-8 | PubChem CID:27924 | CAS RN:11016-13-0"
+BMGC_DG06762,BMG_DG130621,UNII:6EEL1GB72K | CAS RN:47739-98-0 | CLOCAPRAMINE | PubChem CID:2793 | Clocapramine | PubChem SID:198968847 | DrugBank ID:DB09003
+BMGC_DG06763,BMG_DG130624,PubChem SID:474492477 | 3-[2-(4-Pyridyl)ethyl]indole | Inhibitor of P38 Kinase | DrugBank ID:DB01953 | CAS RN:16571-49-6 | UNII:2X6GDX4TXP | PubChem CID:27934 | 3-(2-(4-PYRIDYL)ETHYL)INDOLE
+BMGC_DG06764,BMG_DG130630,"DrugBank ID:DB00845 | Clofazimine | PubChem SID:198966298 | CLOFAZIMINE | CAS RN:2458811-14-6 | PubChem CID:2794 | CAS RN:2030-63-9 | N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine | UNII:D959AE5USF"
+BMGC_DG06765,BMG_DG130634,PubChem SID:198986009 | CAS RN:190653-73-7 | UNII:7LQ52UF48A | PubChem CID:2794188 | CGP-74514
+BMGC_DG06766,BMG_DG130644,"CAS RN:81078-84-4 | PubChem CID:2794808 | PubChem SID:485666911 | 4-Piperazin-1-ylfuro[3,2-c]pyridine | 4-PIPERAZIN-1-YLFURO(3,2-C)PYRIDINE | UNII:YLF5B7R2ES"
+BMGC_DG06767,BMG_DG130648,CAS RN:791-35-5 | CHLOPHEDIANOL | UNII:42C50P12AP | DrugBank ID:DB04837 | PubChem SID:175271638 | 1-(2-chlorophenyl)-3-(dimethylamino)-1-phenylpropan-1-ol | PubChem CID:2795 | Clofedanol
+BMGC_DG06768,BMG_DG130655,UNII:DR25BS8RW9 | PubChem CID:2795542 | CAS RN:850375-11-0 | PubChem SID:472422210 | 3-(1H-PYRAZOL-3-YL)BENZOIC ACID
+BMGC_DG06769,BMG_DG130658,UNII:HPN91K7FU3 | PubChem SID:198937241 | CAS RN:637-07-0 | DrugBank ID:DB00636 | ethyl 2-(4-chlorophenoxy)-2-methylpropanoate | PubChem CID:2796 | Clofibrate | CLOFIBRATE
+BMGC_DG06770,BMG_DG130667,PubChem CID:2797 | CAS RN:882-09-7 | 2-(4-chlorophenoxy)-2-methylpropanoic acid | Clofibric Acid | UNII:53PF01Q249 | CLOFIBRIC ACID | PubChem SID:198966336
+BMGC_DG06771,BMG_DG130670,UNII:JI046KHA6S | PYRAZINETHIOCARBOXAMIDE | CAS RN:4604-72-2 | PubChem CID:2797467 | PubChem SID:375579709
+BMGC_DG06772,BMG_DG130673,"PubChem CID:2797541 | 4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID | DrugBank ID:DB07498"
+BMGC_DG06773,BMG_DG130674,CAS RN:218156-96-8 | SRPIN340 | UNII:9QS4MR9N9D | PubChem SID:485663527 | PubChem CID:2797577
+BMGC_DG06774,BMG_DG130677,4-(4-chlorophenyl)butyl-diethyl-heptylazanium | CAS RN:68379-02-2 | PubChem SID:198985509 | PubChem CID:2798 | UNII:847G178BMC | Clofilium | CLOFILIUM
+BMGC_DG06775,BMG_DG130683,"DrugBank ID:DB13237 | UNII:704083NI0R | Clofoctol | CAS RN:37693-01-9 | 2-[(2,4-dichlorophenyl)methyl]-4-(2,4,4-trimethylpentan-2-yl)phenol | CLOFOCTOL | PubChem SID:198957823 | PubChem CID:2799"
+BMGC_DG06776,BMG_DG130685,"Ddavp | N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide | PubChem CID:27991 | CAS RN:6917-99-3"
+BMGC_DG06777,BMG_DG130695,N-HYDROXY-4-PHENYLBUTANAMIDE | PubChem SID:376072735 | PubChem CID:279980 | UNII:QX182FOM5S | CAS RN:32153-46-1
+BMGC_DG06778,BMG_DG130697,DrugBank ID:DB09157 | CARBON DIOXIDE | UNII:142M471B3J | PubChem CID:280 | CAS RN:18923-20-1 | Carbon Dioxide | Carbon dioxide | PubChem SID:175265600 | CAS RN:18983-82-9 | CAS RN:124-38-9
+BMGC_DG06779,BMG_DG130698,"PubChem CID:2800 | 2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethylethanamine | CAS RN:911-45-5 | Clomiphene | Clomifene | DrugBank ID:DB00882"
+BMGC_DG06780,BMG_DG130702,PubChem SID:461432631 | UNII:DD8MJ95LTV | GSK-3787 | CAS RN:188591-46-0 | PubChem CID:2800647
+BMGC_DG06781,BMG_DG130704,"PubChem CID:2801 | CAS RN:2241983-11-7 | PubChem SID:175266646 | CAS RN:303-49-1 | DrugBank ID:DB01242 | Clomipramine | UNII:NUV44L116D | CLOMIPRAMINE | 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine"
+BMGC_DG06782,BMG_DG130714,"NDC:59651-722 | NDC:63629-1116 | NDC:62332-365 | CAS RN:106955-87-7 | NDC:70518-3745 | NDC:63187-603 | NDC:63187-888 | NDC:70518-3144 | NDC:61269-610 | NDC:49884-307 | NDC:0904-7728 | NDC:62135-769 | NDC:70518-2507 | NDC:50268-174 | NDC:71335-1856 | PubChem SID:175267382 | NDC:46708-364 | NDC:63629-1206 | NDC:46708-366 | NDC:58118-0153 | NDC:70518-3960 | NDC:72603-308 | NDC:71610-863 | NDC:80425-0357 | PubChem CID:2802 | NDC:55154-4318 | NDC:71610-061 | NDC:0093-9293 | NDC:68788-8401 | NDC:59651-723 | NDC:68071-3613 | NDC:63629-8988 | NDC:71335-1810 | NDC:62332-364 | NDC:62332-366 | NDC:0904-7227 | NDC:70518-3849 | NDC:50090-2088 | NDC:68071-4021 | CLONAZEPAM | NDC:43547-408 | NDC:55700-830 | NDC:71205-529 | NDC:71610-040 | NDC:71610-852 | NDC:72888-154 | NDC:71335-2414 | 5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one | NDC:50268-175 | NDC:43547-407 | NDC:49884-310 | UNII:5PE9FDE8GB | NDC:0093-3213 | NDC:72162-1364 | NDC:0093-9290 | NDC:16729-136 | NDC:80425-0358 | NDC:46708-365 | NDC:51407-524 | NDC:70518-2533 | NDC:70518-4074 | NDC:0093-9292 | CAS RN:1622-61-3 | NDC:70518-2232 | NDC:55700-564 | NDC:43063-788 | NDC:70518-2334 | NDC:16729-138 | NDC:0093-0832 | NDC:16729-137 | NDC:71205-252 | NDC:50268-173 | NDC:71610-084 | NDC:71335-0113 | NDC:62332-367 | NDC:72789-315 | NDC:63629-1207 | NDC:62135-770 | NDC:71610-023 | NDC:59651-724 | NDC:71610-855 | NDC:49884-308 | NDC:71205-827 | NDC:70518-3583 | NDC:0093-9291 | NDC:72789-314 | NDC:68788-8499 | NDC:72888-153 | NDC:0093-9294 | NDC:72189-081 | NDC:63629-1204 | NDC:46708-367 | NDC:63629-1201 | NDC:71610-368 | NDC:71610-817 | NDC:71335-2509 | NDC:49884-309 | NDC:68788-7738 | NDC:55154-4319 | NDC:50090-4841 | NDC:72162-1366 | NDC:80425-0402 | NDC:70518-2392 | NDC:0093-3212 | NDC:72789-307 | NDC:72888-152 | NDC:49884-306 | NDC:71335-0333 | NDC:71335-1843 | NDC:43547-406 | NDC:72603-307 | NDC:71610-771 | Clonazepam | NDC:58118-0154 | NDC:71610-039 | NDC:71335-0022 | DrugBank ID:DB01068 | NDC:58118-0832 | NDC:61269-605 | NDC:71610-749 | NDC:43063-794 | NDC:46708-368 | NDC:70518-3891 | NDC:62332-368 | NDC:71335-9747 | NDC:67544-529 | NDC:71610-790 | NDC:43063-797 | NDC:63629-1202 | NDC:58118-0152 | NDC:61269-620 | NDC:62135-771 | NDC:70518-2467 | NDC:63187-226 | NDC:63629-1205 | NDC:80425-0135 | NDC:63629-1203 | NDC:68788-7181 | NDC:72189-475 | NDC:60687-555 | NDC:60687-544 | NDC:72603-309 | NDC:68788-8473 | NDC:80425-0125 | NDC:68788-8420 | NDC:70518-1353 | NDC:68071-5247 | NDC:50090-2022"
+BMGC_DG06783,BMG_DG130726,"DrugBank ID:DB00575 | NDC:68134-603 | NDC:0591-3510 | CAS RN:4205-90-7 | NDC:75907-023 | Clonidine | NDC:51862-455 | NDC:52817-610 | NDC:82089-101 | NDC:51862-454 | NDC:0378-0873 | NDC:82089-102 | NDC:52817-375 | NDC:75907-025 | NDC:0591-3508 | NDC:0378-0872 | NDC:71511-503 | N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine | NDC:0591-3509 | NDC:52817-611 | UNII:MN3L5RMN02 | NDC:75907-024 | CLONIDINE | PubChem CID:2803 | NDC:0378-0871 | PubChem SID:175267290 | NDC:52817-612 | NDC:82089-103 | NDC:51862-453"
+BMGC_DG06784,BMG_DG130734,"4-chloro-N-(2,6-dimethylpiperidin-1-yl)-3-sulfamoylbenzamide | CAS RN:3563-77-7 | PubChem CID:2804"
+BMGC_DG06785,BMG_DG130740,CLOPERASTINE | PubChem CID:2805 | 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine | CAS RN:3703-76-2 | Cloperastine | DrugBank ID:DB09002 | UNII:69M5L7BXEK | PubChem SID:198954921
+BMGC_DG06786,BMG_DG130744,Ornidazole | ORNIDAZOLE | 1-chloro-3-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol | PubChem CID:28061 | CAS RN:16773-42-5 | UNII:62XCK0G93T | PubChem SID:175272058 | DrugBank ID:DB13026
+BMGC_DG06787,BMG_DG130749,UNII:DC9CUH9LJY | SSYA-10-001 | PubChem SID:472425972 | CAS RN:675104-49-1 | PubChem CID:2807230
+BMGC_DG06788,BMG_DG130751,"CAS RN:354812-17-2 | 4-AMINO(2,3'-BITHIOPHENE)-5-CARBOXAMIDE | PubChem SID:475550273 | PubChem CID:2807869 | 4-Amino[2,3′-bithiophene]-5-carboxamide | UNII:EU3S753TY9"
+BMGC_DG06789,BMG_DG130754,"Clorazepic acid | CAS RN:23887-31-2 | CAS RN:20432-69-3 | PubChem SID:175271801 | 7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid | UNII:D51WO0G0L4 | CAS RN:149128-44-9 | Clorazepic Acid | PubChem CID:2809 | CLORAZEPIC ACID | DrugBank ID:DB00628"
+BMGC_DG06790,BMG_DG130756,UNII:62521S57AU | PubChem CID:2809273 | JNJ-1661010 | CAS RN:681136-29-8 | PubChem SID:198939445
+BMGC_DG06791,BMG_DG130758,"3,5-Diiodotyrosine | PubChem CID:28094582 | (2S)-2-azaniumyl-3-(3,5-diiodo-4-oxidophenyl)propanoate"
+BMGC_DG06792,BMG_DG130760,CAS RN:681801-59-2 | PubChem CID:2809754 | UNII:N426J8B4NS | N-butyl-4-(diphenylmethyl)piperazine-1-carboxamide | N-BUTYL-4-(DIPHENYLMETHYL)PIPERAZINE-1-CARBOXAMIDE | PubChem SID:482553927
+BMGC_DG06793,BMG_DG130761,CAS RN:35907-63-2 | Carbon Monoxide | PubChem SID:175266905 | UNII:7U1EE4V452 | DrugBank ID:DB11588 | carbon monoxide | CARBON MONOXIDE | CAS RN:630-08-0 | Carbon monoxide | PubChem CID:281
+BMGC_DG06794,BMG_DG130762,PubChem SID:198963394 | CLORPRENALINE | 1-(2-chlorophenyl)-2-(propan-2-ylamino)ethanol | UNII:3W4327W76O | PubChem CID:2810 | CAS RN:3811-25-4 | Clorprenaline
+BMGC_DG06795,BMG_DG130766,"Clotiazepam | CLOTIAZEPAM | PubChem CID:2811 | CAS RN:33671-46-4 | DrugBank ID:DB01559 | PubChem SID:198987699 | UNII:ZCN055599V | 5-(2-chlorophenyl)-7-ethyl-1-methyl-3H-thieno[2,3-e][1,4]diazepin-2-one"
+BMGC_DG06796,BMG_DG130771,"2,3-DIHYDROXYPYRIDINE | CAS RN:16867-04-2 | PubChem CID:28115 | PubChem SID:198936278 | UNII:7HY4BCJ130"
+BMGC_DG06797,BMG_DG130775,NDC:11673-062 | NDC:70954-036 | NDC:59779-514 | NDC:11523-6549 | NDC:41520-305 | NDC:41415-056 | NDC:24909-026 | NDC:30142-510 | NDC:55614-650 | CAS RN:23593-75-1 | NDC:67234-009 | NDC:70000-0667 | NDC:67777-231 | NDC:24909-207 | NDC:50090-4971 | NDC:70677-1231 | NDC:77338-312 | NDC:49348-379 | NDC:71399-0500 | NDC:55621-003 | NDC:52817-800 | NDC:0536-1181 | NDC:68788-8330 | NDC:36800-508 | NDC:72162-2178 | NDC:0536-1272 | NDC:11822-3078 | NDC:70403-925 | NDC:69396-143 | NDC:50090-7376 | NDC:69822-254 | NDC:54633-314 | CLOTRIMAZOLE | NDC:52389-647 | NDC:73715-004 | NDC:11822-0220 | NDC:83474-003 | NDC:11527-071 | NDC:24909-212 | NDC:59779-305 | NDC:66977-023 | NDC:24909-037 | NDC:21130-210 | NDC:24909-203 | NDC:71205-432 | NDC:0536-1443 | NDC:51672-2003 | NDC:63187-559 | NDC:51672-2158 | NDC:24909-104 | NDC:51672-1260 | NDC:63187-501 | NDC:69396-001 | NDC:55758-102 | NDC:68788-9665 | NDC:24909-106 | NDC:82739-019 | NDC:0363-2105 | NDC:11822-1110 | NDC:37808-305 | NDC:47832-071 | NDC:59088-642 | NDC:51824-093 | NDC:68071-3395 | NDC:69070-303 | NDC:65923-052 | NDC:50228-502 | NDC:56062-814 | NDC:10135-671 | NDC:71205-434 | NDC:0054-4146 | NDC:11673-893 | NDC:59088-441 | NDC:49035-837 | NDC:68071-4225 | NDC:54633-017 | NDC:0904-7822 | NDC:45861-099 | NDC:51143-002 | NDC:84010-014 | NDC:30142-305 | NDC:69396-087 | NDC:69848-001 | CAS RN:117829-71-7 | NDC:52410-3024 | NDC:50090-4574 | NDC:82460-344 | NDC:68788-8216 | NDC:72162-2340 | NDC:0363-2109 | NDC:24909-214 | NDC:68788-8091 | NDC:83324-041 | NDC:83324-154 | NDC:63868-259 | NDC:21130-870 | NDC:61269-220 | NDC:50090-1770 | NDC:11523-1125 | NDC:59779-510 | NDC:55758-434 | 1-[(2-chlorophenyl)-diphenylmethyl]imidazole | NDC:67234-014 | PubChem CID:2812 | NDC:80684-039 | NDC:54633-214 | NDC:70677-1228 | NDC:0574-0107 | Clotrimazole | NDC:70518-4037 | NDC:56062-817 | NDC:68001-475 | NDC:51824-063 | NDC:70000-0493 | NDC:73581-449 | NDC:67091-196 | PubChem SID:175267719 | UNII:G07GZ97H65 | NDC:0054-8146 | NDC:50090-0562 | NDC:49035-253 | NDC:66267-980 | NDC:49035-812 | NDC:71205-438 | NDC:55315-008 | NDC:68788-8491 | NDC:24385-205 | NDC:49348-793 | NDC:70677-1002 | NDC:80489-002 | NDC:29978-918 | NDC:0168-0133 | NDC:54633-018 | NDC:71205-738 | NDC:52389-733 | NDC:0536-1265 | NDC:79503-105 | NDC:69842-062 | NDC:52389-600 | NDC:73352-570 | NDC:84010-030 | NDC:45802-434 | NDC:82442-022 | NDC:69396-038 | NDC:70677-1262 | NDC:50090-0614 | NDC:51672-2002 | NDC:24909-102 | NDC:68747-3024 | NDC:24909-208 | NDC:70856-3585 | NDC:36800-495 | NDC:0363-0220 | NDC:70010-229 | NDC:11523-0963 | NDC:64412-2010 | NDC:59088-476 | NDC:71399-0666 | NDC:11822-3423 | DrugBank ID:DB00257 | NDC:50090-6546 | NDC:51672-2037 | NDC:84387-004 | NDC:51672-1275 | NDC:16571-686 | NDC:49348-279 | NDC:83035-1062 | NDC:24385-110 | NDC:51672-2062 | NDC:11822-0351 | NDC:68071-4026 | NDC:11673-910 | NDC:0363-2062 | NDC:68788-7402 | NDC:70673-747 | NDC:68462-181 | NDC:70000-0542
+BMGC_DG06798,BMG_DG130781,"PubChem SID:474493145 | PubChem CID:281242 | UNII:Y7VFP43VZ5 | 1,2-DIAMINOETHYLPHOSPHONIC ACID | CAS RN:16606-66-9"
+BMGC_DG06799,BMG_DG130819,Nb-001 | UNII:J89QT81NBQ | 5-[2-(6-aminopurin-9-yl)ethylamino]pentan-1-ol | CAS RN:686301-48-4 | CAS RN:934409-11-7 | DrugBank ID:DB12716 | NB-001 | PubChem CID:2815031 | PubChem SID:198976474
+BMGC_DG06800,BMG_DG130823,"CLOXAZOLAM | UNII:GYL649Z0HY | DrugBank ID:DB01553 | PubChem CID:2816 | PubChem SID:198950744 | CAS RN:24166-13-0 | 10-chloro-11b-(2-chlorophenyl)-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one | Cloxazolam"
+BMGC_DG06801,BMG_DG130829,"PubChem SID:316918723 | CAS RN:16967-79-6 | TRICHLOROETHYLENE EPOXIDE | Trichloroepoxyethane | UNII:DXK2817N87 | 2,2,3-trichlorooxirane | PubChem CID:28167"
+BMGC_DG06802,BMG_DG130831,CAS RN:130-16-5 | PubChem SID:198963355 | UNII:BPF36H1G6S | PubChem CID:2817 | CLOXYQUIN
+BMGC_DG06803,BMG_DG130833,PubChem CID:2817259 | GLUCOSYLUREA | UNII:7GF386763Z | CAS RN:33204-32-9 | PubChem SID:313183843
+BMGC_DG06804,BMG_DG130834,"{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid | DrugBank ID:DB08098 | PubChem CID:2817424"
+BMGC_DG06805,BMG_DG130838,PubChem CID:28179 | CAS RN:16984-48-8 | UNII:Q80VPU408O | PubChem SID:175267797 | Fluoride ion | Fluoride Ion | DrugBank ID:DB11257 | FLUORIDE ION | fluoride
+BMGC_DG06806,BMG_DG130839,Clozapine | PubChem CID:2818 | DrugBank ID:DB00363
+BMGC_DG06807,BMG_DG130858,"Calusterone | PubChem SID:198944761 | DrugBank ID:DB01564 | (7S,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,10,13,17-tetramethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | PubChem CID:28204 | CALUSTERONE | UNII:0678G6Q58A | CAS RN:17021-26-0"
+BMGC_DG06808,BMG_DG130880,2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide | PubChem CID:2823014 | DrugBank ID:DB07004
+BMGC_DG06809,BMG_DG130894,ethyl 3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | Ethylbenzoylecgonine | PubChem CID:2825
+BMGC_DG06810,BMG_DG130909,Methyl 3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | CAS RN:21206-60-0 | CAS RN:50-36-2 | methyl 3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | PubChem CID:2826
+BMGC_DG06811,BMG_DG130914,PubChem SID:198990813 | CAS RN:234779-34-1 | PubChem CID:2826530 | ALE-0540 | UNII:1R1L47BXMJ
+BMGC_DG06812,BMG_DG130915,"DIETHYL 4-(3-(HYDROXY(OXIDO)AMINO)PHENYL)-2,6-DIMETHYL-1,4-DIHYDRO-3,5-PYRIDINEDICARBOXYLATE | UNII:J8G2HHY7Q2 | PubChem SID:474491151 | Diethyl 4-(3-(hydroxy(oxido)amino)phenyl)-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylate | PubChem CID:282663 | CAS RN:21829-28-7"
+BMGC_DG06813,BMG_DG130916,"UNII:WX671898JF | PubChem SID:198966344 | ALPHA-GALACTOSYLCERAMIDE | DrugBank ID:DB12232 | N-[(2S,3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]hexacosanamide | PubChem CID:2826713 | alpha-GalCer | CAS RN:158021-47-7 | KRN-7000"
+BMGC_DG06814,BMG_DG130917,"Cancidas | N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide | PubChem CID:2826718 | CAS RN:162808-62-0"
+BMGC_DG06815,BMG_DG130942,UNII:770M9U0F8Q | PubChem CID:28292 | EDIFENPHOS | [ethoxy(phenylsulfanyl)phosphoryl]sulfanylbenzene | Edifenphos | CAS RN:17109-49-8 | PubChem SID:198965627
+BMGC_DG06816,BMG_DG130950,formate | Formate | PubChem CID:283 | CAS RN:71-47-6
+BMGC_DG06817,BMG_DG130990,"DrugBank ID:DB13592 | CAS RN:59547-58-9 | ETAMIPHYLLIN | Etamiphylline | PubChem SID:198960079 | CAS RN:314-35-2 | UNII:221A91BQ2S | PubChem CID:28329 | 7-[2-(diethylamino)ethyl]-1,3-dimethylpurine-2,6-dione"
+BMGC_DG06818,BMG_DG130991,"DrugBank ID:DB01394 | Colchicine | CAS RN:54192-66-4 | N-(1,2,3,10-Tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide | PubChem CID:2833 | CAS RN:209810-38-8 | N-(1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide"
+BMGC_DG06819,BMG_DG130993,"[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;naphthalene-2-sulfonic acid | Propoxyphene Napsylate | PROPOXYPHENE NAPSYLATE ANHYDROUS | CAS RN:17140-78-2 | PubChem CID:28332 | PubChem SID:198956801 | UNII:5O7IW35N3C"
+BMGC_DG06820,BMG_DG130998,"CAS RN:392-74-5 | Carbamodithioic acid, diethyl-, ion(1-) | PubChem CID:28343 | N,N-diethylcarbamodithioate"
+BMGC_DG06821,BMG_DG131022,PubChem CID:2837872 | PubChem SID:482554063 | CAS RN:4426-90-8 | UNII:UH3KA8XT39 | 4-(Methylsulfonylamino)benzenesulfonamide | 4-(METHYLSULFONYLAMINO)BENZENESULFONAMIDE
+BMGC_DG06822,BMG_DG131025,PubChem CID:28391387 | UNII:520O970L95 | ADAMANTANYL HYDROXYBENZAMIDE | CAS RN:850334-50-8 | PubChem SID:198976495
+BMGC_DG06823,BMG_DG131029,UNII:0YIW783RG1 | CAS RN:82069-14-5 | DrugBank ID:DB01942 | FORMIC ACID | PubChem SID:175268869 | Formic Acid | Formic acid | formic acid | PubChem CID:284 | CAS RN:64-18-6
+BMGC_DG06824,BMG_DG131038,"DANAZOL | NDC:0527-1369 | DrugBank ID:DB01406 | (1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-oxa-6-azapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9-trien-17-ol | NDC:62135-476 | NDC:71205-861 | NDC:0555-0633 | NDC:0555-0635 | NDC:0527-1392 | PubChem SID:175266614 | NDC:62135-475 | NDC:62135-477 | NDC:0555-0634 | NDC:0527-1368 | NDC:71205-862 | CAS RN:17230-88-5 | PubChem CID:28417 | Danazol | UNII:N29QWW3BUO"
+BMGC_DG06825,BMG_DG131043,"N-methyl-1-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)methanamine | PubChem CID:28425 | PubChem SID:198968990 | CAS RN:17243-39-9 | UNII:734MM7Y191 | BENZOCTAMINE | DrugBank ID:DB09021 | Benzoctamine"
+BMGC_DG06826,BMG_DG131057,PubChem CID:2845469 | 1-(3-CHLOROPHENYL)-4-(2-PHENYLETHYL)PIPERAZINE | CAS RN:147429-37-6 | PubChem SID:474492944 | 1-(3-Chlorophenyl)-4-(2-phenylethyl)piperazine | UNII:3LEH2E7AEU
+BMGC_DG06827,BMG_DG131074,Lithium Cation | DrugBank ID:DB01356 | lithium(1+) | PubChem CID:28486 | UNII:8H8Z5UER66 | LITHIUM CATION | PubChem SID:175265813 | Lithium cation | CAS RN:17341-24-1
+BMGC_DG06828,BMG_DG131083,"OXOPURPUREINE | UNII:QMU2D8YT5P | 4,5,14,15,16-pentamethoxy-10-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2,4,6,9,11,13(17),14-octaen-8-one | Oxopurpureine | CAS RN:32845-27-5 | PubChem SID:485663586 | PubChem CID:284998"
+BMGC_DG06829,BMG_DG131086,"CAS RN:36811-70-8 | 2,3-DIHYDROIMIDAZO(1,2-F)PHENANTHRIDINE | PubChem CID:285026 | UNII:W6SAN3C3Y7 | PubChem SID:459056217"
+BMGC_DG06830,BMG_DG131087,"Omacetaxine mepesuccinate | UNII:6FG8041S5B | OMACETAXINE MEPESUCCINATE | PubChem CID:285033 | CAS RN:26833-87-4 | PubChem SID:175266169 | Omacetaxine Mepesuccinate | 1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate | DrugBank ID:DB04865"
+BMGC_DG06831,BMG_DG131094,"DrugBank ID:DB01034 | (2R,3S)-3-nona-4,7-dienoyloxirane-2-carboxamide | Cerulenin | PubChem CID:28517 | (2R,3S)-3-(1-oxonona-4,7-dienyl)-2-oxiranecarboxamide"
+BMGC_DG06832,BMG_DG131098,PubChem CID:285225 | UNII:53YOW08UQI | PubChem SID:249492835 | METHYL BENZOYLSALICYLATE | CAS RN:610-60-6
+BMGC_DG06833,BMG_DG131116,PubChem CID:2856 | 2-({6-[(3-Chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)ethanol | DrugBank ID:DB08325
+BMGC_DG06834,BMG_DG131117,"3-PHENYL-1,2,4-THIADIAZOL-5-AMINE | PubChem SID:474490883 | PubChem CID:28561 | CAS RN:17467-15-1 | 3-Phenyl-1,2,4-thiadiazol-5-amine | UNII:M64KC294Z6"
+BMGC_DG06835,BMG_DG131120,PubChem CID:285645 | PubChem SID:472422602 | UNII:F9BF8EKZ8R | (4-FLUOROPHENYL)BORONIC ACID | CAS RN:1765-93-1
+BMGC_DG06836,BMG_DG131129,CAS RN:758679-97-9 | CID-2858522 | UNII:Z744D8S6JG | PubChem SID:443623561 | PubChem CID:2858523
+BMGC_DG06837,BMG_DG131133,CAS RN:17573-21-6 | UNII:VE62PY8U9F | 9-HYDROXYBENZO(A)PYRENE | 9-Hydroxybenzo[a]pyrene | PubChem SID:485660922 | PubChem CID:28598
+BMGC_DG06838,BMG_DG131135,UNII:14I68GI3OQ | PubChem SID:198957890 | Aminooxyacetic acid | PubChem CID:286 | Aminooxyacetic Acid | AMINOOXYACETIC ACID | DrugBank ID:DB02079 | 2-aminooxyacetic acid | CAS RN:645-88-5
+BMGC_DG06839,BMG_DG131138,AMFETAMINIL | PubChem SID:198949887 | CAS RN:17590-01-1 | PubChem CID:28615 | UNII:0XU0V77JVE
+BMGC_DG06840,BMG_DG131141,"PubChem SID:198989218 | Deslanoside | CAS RN:17598-65-1 | DrugBank ID:DB01078 | DESLANOSIDE | PubChem CID:28620 | UNII:YGY317RK75 | 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one"
+BMGC_DG06841,BMG_DG131172,"METIZOLINE | Metizoline | UNII:Z27L8N105U | CAS RN:17692-22-7 | PubChem CID:28688 | DrugBank ID:DB13614 | 2-[(2-methyl-1-benzothiophen-3-yl)methyl]-4,5-dihydro-1H-imidazole | PubChem SID:198941213"
+BMGC_DG06842,BMG_DG131174,"DrugBank ID:DB09219 | Bisoxatin | BISOXATIN | PubChem CID:28689 | UNII:7C75N0L7FP | PubChem SID:198990198 | 2,2-bis(4-hydroxyphenyl)-4H-1,4-benzoxazin-3-one | CAS RN:17692-24-9"
+BMGC_DG06843,BMG_DG131177,"PubChem CID:28693 | UNII:1501393LY5 | CAS RN:17692-51-2 | benzyl N-[[(6aR,9S,10aR)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinolin-9-yl]methyl]carbamate | DrugBank ID:DB13520 | PubChem SID:198955578 | Metergoline | METERGOLINE"
+BMGC_DG06844,BMG_DG131185,"PubChem CID:287064 | CAS RN:2150-43-8 | PubChem SID:241179002 | UNII:G72J90268X | PROTOCATECHUIC ACID, METHYL ESTER"
+BMGC_DG06845,BMG_DG131187,3-chloro-7-diethoxyphosphinothioyloxy-4-methylchromen-2-one | COUMAPHOS | CAS RN:56-72-4 | PubChem CID:2871 | UNII:L08SZ5Z5JC | PubChem SID:198962418 | Coumaphos | DrugBank ID:DB11390
+BMGC_DG06846,BMG_DG131191,CLONIXIN | UNII:V7DXN0M42R | DrugBank ID:DB09218 | 2-(3-chloro-2-methylanilino)pyridine-3-carboxylic acid | Clonixin | PubChem CID:28718 | CAS RN:17737-65-4 | PubChem SID:198980832
+BMGC_DG06847,BMG_DG131192,DrugBank ID:DB00817 | Rosoxacin | PubChem CID:287180 | PubChem SID:198943144 | UNII:3Y1OT3J4NW | 1-ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid | CAS RN:40034-42-2 | ROSOXACIN
+BMGC_DG06848,BMG_DG131222,BENOMYL | PubChem CID:28780 | Benomyl | UNII:TLW21058F5 | CAS RN:17804-35-2 | PubChem SID:198950165 | methyl N-[1-(butylcarbamoyl)benzimidazol-2-yl]carbamate
+BMGC_DG06849,BMG_DG131227,PubChem SID:198939148 | P-Cresol | CAS RN:2876-02-0 | UNII:1MXY2UM8NV | PARACRESOL | 4-methylphenol | CAS RN:106-44-5 | PubChem CID:2879 | DrugBank ID:DB01688
+BMGC_DG06850,BMG_DG131231,CAS RN:4643-06-5 | (E)-3-chloroprop-2-en-1-ol | trans-3-Chloroallyl alcohol | PubChem CID:287955 | CAS RN:4643-05-4
+BMGC_DG06851,BMG_DG131233,Carnitine | CAS RN:461-06-3 | DL-CARNITINE | PubChem CID:288 | PubChem SID:175271939 | CAS RN:406-76-8 | 3-hydroxy-4-(trimethylazaniumyl)butanoate | UNII:S7UI8SM58A
+BMGC_DG06852,BMG_DG131234,CAS RN:77175-51-0 | CROCONAZOLE | PubChem CID:2880 | PubChem SID:198935104 | UNII:446254H55G
+BMGC_DG06853,BMG_DG131241,PubChem CID:2881 | Cromoglycate(2-) | 5-[3-(2-carboxylato-4-oxochromen-5-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylate
+BMGC_DG06854,BMG_DG131247,5-[3-(2-carboxy-4-oxochromen-5-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid | DrugBank ID:DB01003 | Cromolyn | Cromoglicic acid | PubChem CID:2882 | CAS RN:16110-51-3 | UNII:Y0TK0FS77W | CROMOLYN | PubChem SID:175268910 | CAS RN:105878-73-7
+BMGC_DG06855,BMG_DG131248,"UNII:5317337V7V | PubChem CID:288216 | TEGAFUR, (R)- | PubChem SID:198983542 | CAS RN:37076-68-9"
+BMGC_DG06856,BMG_DG131252,PubChem CID:2883 | N-ethyl-N-(2-methylphenyl)but-2-enamide | DrugBank ID:DB00265 | Crotamiton
+BMGC_DG06857,BMG_DG131285,"PubChem SID:175267560 | UNII:E0QN3D755O | LISURIDE | DrugBank ID:DB00589 | CAS RN:140387-89-9 | CAS RN:18016-80-3 | PubChem CID:28864 | Lisuride | 3-[(6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea"
+BMGC_DG06858,BMG_DG131291,"DrugBank ID:DB13217 | UNII:0YHF6E6NLS | PubChem SID:198990002 | 2-[4-(4-chlorophenyl)-2-phenyl-1,3-thiazol-5-yl]acetic acid | Fentiazac | FENTIAZAC | CAS RN:18046-21-4 | PubChem CID:28871"
+BMGC_DG06859,BMG_DG131294,UNII:EYX738UZ5P | CAS RN:24701-51-7 | PubChem SID:198937004 | PubChem CID:28876 | DrugBank ID:DB08998 | Demexiptiline | DEMEXIPTILINE
+BMGC_DG06860,BMG_DG131296,PubChem CID:2888648 | N-(3-carbazol-9-yl-2-hydroxypropyl)-N-(furan-2-ylmethyl)methanesulfonamide | KL001 | CAS RN:309928-48-1
+BMGC_DG06861,BMG_DG131299,"CAS RN:120-80-9 | UNII:LF3AJ089DQ | CAS RN:12385-08-9 | Catechol | 1,2-Dihydroxybenzene | CAS RN:26982-53-6 | PubChem CID:289 | DrugBank ID:DB02232 | PubChem SID:198987364 | PYROCATECHOL | benzene-1,2-diol"
+BMGC_DG06862,BMG_DG131303,"CAS RN:2825-60-7 | FORMOCORTAL | UNII:8E21R0Z4M5 | PubChem CID:289085 | PubChem SID:198941647 | [2-[(1S,2S,4R,8S,9S,11S,12R,13S)-16-(2-chloroethoxy)-12-fluoro-19-formyl-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-16,18-dien-8-yl]-2-oxoethyl] acetate | Formocortal | DrugBank ID:DB13664"
+BMGC_DG06863,BMG_DG131308,N-(TRIMETHYLSILYL)IMIDAZOLE | N-(Trimethylsilyl)imidazole | UNII:PX8K4R8KWX | CAS RN:18156-74-6 | PubChem CID:28925 | PubChem SID:474490170
+BMGC_DG06864,BMG_DG131313,"CYCLANDELATE | PubChem SID:198967489 | CAS RN:456-59-7 | Cyclandelate | DrugBank ID:DB04838 | UNII:4139O1OAY2 | PubChem CID:2893 | (3,3,5-trimethylcyclohexyl) 2-hydroxy-2-phenylacetate"
+BMGC_DG06865,BMG_DG131321,"PubChem SID:175268655 | CYCLOBENZAPRINE | DrugBank ID:DB00924 | N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine | CAS RN:303-53-7 | UNII:69O5WQQ5TI | Cyclobenzaprine | PubChem CID:2895"
+BMGC_DG06866,BMG_DG131329,[4-[(4-acetyloxyphenyl)-cyclohexylidenemethyl]phenyl] acetate | DrugBank ID:DB13472 | Cyclofenil | CYCLOFENIL | PubChem CID:2898 | UNII:J468V64WZ1 | PubChem SID:198952868 | CAS RN:2624-43-3
+BMGC_DG06867,BMG_DG131334,"UNII:3LL7DMK9LT | CAS RN:39265-57-1 | PubChem SID:482554577 | Corey lactone, (±)- | Corey lactone, (+)- | PubChem CID:289982 | CAS RN:54382-73-9 | COREY LACTONE, (+)- | UNII:PX3L2BJ5EP | COREY LACTONE, (+/-)- | PubChem SID:482555200"
+BMGC_DG06868,BMG_DG131342,1-aminocyclopentane-1-carboxylic acid | Cycloleucine | UNII:0TQU7668EI | PubChem CID:2901 | PubChem SID:198953214 | DrugBank ID:DB04620 | CYCLOLEUCINE | CAS RN:52-52-8
+BMGC_DG06869,BMG_DG131345,"PIOGLITAZONE, (S)- | UNII:RX5TJ6429Q | CAS RN:959687-66-2 | PubChem SID:440088356 | PubChem CID:29010893"
+BMGC_DG06870,BMG_DG131346,"PubChem CID:29010894 | CAS RN:959687-65-1 | PIOGLITAZONE, (R)- | PubChem SID:440089727 | UNII:V5CQ1OD6GQ"
+BMGC_DG06871,BMG_DG131351,"CAS RN:4994-89-2 | 5,6-DIMETHYLTHIENO(2,3-D)PYRIMIDIN-4-AMINE | PubChem SID:377308182 | PubChem CID:290232 | UNII:B117HKI8P0"
+BMGC_DG06872,BMG_DG131355,"PubChem CID:29029 | (2S,4R)-N-[2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide | DrugBank ID:DB01190 | CAS RN:13441-63-9 | Cleocin (TN)"
+BMGC_DG06873,BMG_DG131362,"UNII:T7817XC41U | PubChem SID:346537739 | CAS RN:742-20-1 | PubChem CID:2904 | CAS RN:96783-06-1 | CYCLOPENTHIAZIDE | CYCLOPENTHIAZIDE, (-)- | DrugBank ID:DB13532 | Cyclopenthiazide | PubChem SID:346539226 | 6-chloro-3-(cyclopentylmethyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | UNII:866GEV195O | PubChem SID:198957537 | UNII:VX4S2N85F5 | CAS RN:96783-05-0 | CYCLOPENTHIAZIDE, (+)-"
+BMGC_DG06874,BMG_DG131366,CYCLOPENTOLATE | UNII:I76F4SHP7J | CAS RN:512-15-2 | PubChem SID:175271616 | DrugBank ID:DB00979 | Cyclopentolate | PubChem CID:2905 | 2-(dimethylamino)ethyl 2-(1-hydroxycyclopentyl)-2-phenylacetate
+BMGC_DG06875,BMG_DG131374,"CYCLOPHOSPHAMIDE ANHYDROUS | NDC:75907-191 | PubChem CID:2907 | UNII:6UXW23996M | PubChem SID:175271900 | DrugBank ID:DB00531 | NDC:50742-520 | CAS RN:50-18-0 | NDC:68001-565 | NDC:68001-564 | NDC:51407-748 | NDC:50742-519 | NDC:75907-190 | NDC:51407-749 | NDC:75907-189 | Cyclophosphamide | NDC:50742-521 | NDC:51407-750 | N,N-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine"
+BMGC_DG06876,BMG_DG131381,"DrugBank ID:DB09254 | Caroxazone | UNII:807N226MNL | PubChem CID:29083 | 2-(2-oxo-4H-1,3-benzoxazin-3-yl)acetamide | CAS RN:18464-39-6 | CAROXAZONE | PubChem SID:198970766"
+BMGC_DG06877,BMG_DG131382,"PubChem CID:29088 | Ditazole | UNII:H2BQI5Z8FT | PubChem SID:198961050 | CAS RN:18471-20-0 | DITAZOLE | 2-[(4,5-diphenyl-1,3-oxazol-2-yl)-(2-hydroxyethyl)amino]ethanol | DrugBank ID:DB08994"
+BMGC_DG06878,BMG_DG131383,"NDC:0116-0506 | NDC:0121-0893 | NDC:0924-0159 | NDC:10819-1080 | NDC:16571-111 | NDC:0116-0038 | NDC:10819-4076 | NDC:16571-128 | NDC:49348-115 | NDC:21749-225 | NDC:0116-0101 | NDC:69464-901 | NDC:42939-124 | NDC:0116-3678 | NDC:53329-244 | NDC:0116-0003 | NDC:55154-1980 | NDC:0404-0177 | NDC:59779-722 | NDC:68599-5400 | NDC:0404-6720 | NDC:68016-228 | NDC:65222-800 | NDC:68071-1837 | NDC:63187-524 | NDC:0374-5080 | NDC:53462-705 | NDC:0116-0200 | NDC:41250-162 | NDC:0116-0113 | NDC:0116-2001 | NDC:17518-082 | NDC:11084-039 | NDC:55154-3573 | NDC:55154-1981 | NDC:21749-850 | NDC:47593-463 | NDC:10819-4077 | NDC:11822-3678 | CHLORHEXIDINE GLUCONATE | NDC:50090-0722 | NDC:68788-9546 | NDC:47593-464 | NDC:0116-0228 | NDC:0126-0272 | NDC:46122-137 | NDC:54365-401 | NDC:67296-1715 | NDC:76420-535 | NDC:84215-004 | NDC:0234-0575 | NDC:63187-685 | NDC:66975-600 | NDC:0116-1061 | NDC:0116-6000 | NDC:0363-1061 | NDC:0116-0244 | NDC:68788-8173 | NDC:42939-125 | NDC:0116-1221 | NDC:0116-0175 | NDC:0116-0901 | NDC:47593-467 | NDC:84128-003 | NDC:66467-2560 | NDC:21749-106 | NDC:17271-107 | PubChem CID:29089 | NDC:63868-940 | NDC:46122-659 | NDC:0126-0282 | NDC:17856-2002 | NDC:0116-0407 | NDC:54365-400 | NDC:70677-1221 | NDC:36800-401 | NDC:62135-650 | NDC:67618-200 | NDC:11701-172 | NDC:0116-0162 | NDC:69339-138 | NDC:0116-6720 | NDC:63739-052 | NDC:0116-0301 | NDC:11084-038 | NDC:0116-8500 | NDC:0116-0115 | NDC:53329-994 | NDC:55154-3574 | PubChem SID:175266060 | NDC:21749-461 | NDC:66689-106 | NDC:0116-0039 | NDC:39892-0960 | NDC:0404-0175 | NDC:0116-1021 | NDC:0404-1061 | NDC:0116-0722 | NDC:63868-280 | CAS RN:18472-51-0 | NDC:0116-0137 | NDC:0404-0178 | NDC:68599-5401 | NDC:0116-0620 | NDC:0116-1022 | NDC:58345-104 | NDC:17271-505 | NDC:67239-0225 | Chlorhexidine Digluconate (20% in Water) | NDC:0404-4075 | NDC:0116-2800 | NDC:0404-0176 | NDC:55305-134 | NDC:17518-083 | NDC:0116-0575 | NDC:65785-034 | NDC:0116-0767 | NDC:71584-0106 | NDC:61037-469 | NDC:0116-0505 | NDC:60687-714 | NDC:42939-127 | 2-[6-[[amino-[[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid | NDC:0904-7035 | NDC:0116-0161 | NDC:0116-4075 | NDC:53329-301 | NDC:0116-1060 | NDC:62135-649 | NDC:70000-0407 | NDC:39892-0961 | NDC:0116-0237 | NDC:42939-128 | NDC:17856-0272 | NDC:61037-414 | NDC:11822-0891 | NDC:59883-175 | NDC:21749-416 | UNII:MOR84MUD8E | NDC:0116-0800 | NDC:81033-512 | NDC:0116-0401 | NDC:59779-767 | NDC:68071-3630 | NDC:47593-468 | NDC:11822-0116 | NDC:0116-0061 | NDC:73141-512 | NDC:62011-0237 | NDC:48878-0620"
+BMGC_DG06879,BMG_DG131390,"CYCLOTHIAZIDE | CAS RN:2259-96-3 | PubChem SID:198949910 | DrugBank ID:DB00606 | 3-(2-bicyclo[2.2.1]hept-5-enyl)-6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | Cyclothiazide | UNII:P71U09G5BW | PubChem CID:2910"
+BMGC_DG06880,BMG_DG131391,UNII:2SYF3JM98W | N-METHYLPSILOCYBINE | CAS RN:18483-72-2 | PubChem CID:29101 | PubChem SID:461432663
+BMGC_DG06881,BMG_DG131393,CAS RN:77-39-4 | CYCRIMINE | DrugBank ID:DB00942 | Cycrimine | PubChem SID:198990824 | PubChem CID:2911 | UNII:543567RFQQ | 1-cyclopentyl-1-phenyl-3-piperidin-1-ylpropan-1-ol
+BMGC_DG06882,BMG_DG131395,PubChem SID:175267968 | PubChem CID:29112 | ethyl 6-decoxy-7-ethoxy-4-oxo-1H-quinoline-3-carboxylate | Decoquinate | DrugBank ID:DB11394 | CAS RN:18507-89-6 | UNII:534I52PVWH | DECOQUINATE
+BMGC_DG06883,BMG_DG131399,"CAS RN:211504-93-7 | CYPERMETHRIN | PubChem CID:2912 | CAS RN:52315-07-8 | CAS RN:71697-59-1 | Cypermethrin | PubChem SID:198937334 | CAS RN:86753-92-6 | CAS RN:97955-44-7 | UNII:1TR49121NP | DrugBank ID:DB13721 | CAS RN:67375-30-8 | CAS RN:137497-61-1 | [cyano-(3-phenoxyphenyl)methyl] 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate | CAS RN:72204-44-5"
+BMGC_DG06884,BMG_DG131401,"PubChem CID:291270 | CAS RN:13794-67-7 | UNII:OG122HP7DZ | PubChem SID:434370082 | N6-((3,4,5-TRIMETHOXYPHENYL)METHYL)QUINAZOLINE-2,4,6-TRIAMINE"
+BMGC_DG06885,BMG_DG131404,"CAS RN:129-03-3 | NDC:39328-544 | CYPROHEPTADINE | 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine | NDC:58657-697 | PubChem SID:175265372 | UNII:2YHB6175DO | DrugBank ID:DB00434 | PubChem CID:2913 | Cyproheptadine"
+BMGC_DG06886,BMG_DG131412,PubChem SID:198959696 | methyl (2R)-2-amino-3-sulfanylpropanoate | CAS RN:18598-63-5 | UNII:RQ6L463N3B | MECYSTEINE | PubChem CID:29145 | Mecysteine | CAS RN:2485-62-3
+BMGC_DG06887,BMG_DG131429,PubChem SID:198983463 | CAS RN:433695-36-4 | BRL-50481 | PubChem CID:2921148 | UNII:03G869PR3P
+BMGC_DG06888,BMG_DG131441,CAS RN:17040-20-9 | PubChem CID:292331 | 4-anilinobenzoic acid | 4-(Phenylamino)benzoic acid
+BMGC_DG06889,BMG_DG131443,"PubChem CID:29243 | PubChem SID:198968459 | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one | Tetrahydrouridine | CAS RN:18771-50-1 | TETRAHYDROURIDINE | UNII:0NIZ8H6OL8 | DrugBank ID:DB12484"
+BMGC_DG06890,BMG_DG131453,"UNII:WZD2M6Q8CC | 2,4,6-Triaminoquinazoline | CAS RN:13741-90-7 | PubChem CID:292661 | 2,4,6-TRIAMINOQUINAZOLINE | PubChem SID:440089277 | DrugBank ID:DB02532"
+BMGC_DG06891,BMG_DG131460,INDIBULIN | UNII:80K4H2RB8P | CAS RN:204205-90-3 | Indibulin | DrugBank ID:DB06169 | PubChem SID:198979077 | PubChem CID:2929 | 2-[1-[(4-chlorophenyl)methyl]indol-3-yl]-2-oxo-N-pyridin-4-ylacetamide
+BMGC_DG06892,BMG_DG131461,PubChem CID:2930014 | CAS RN:72926-24-0 | PubChem SID:198978485 | UNII:ZA4OIM722G | K-858
+BMGC_DG06893,BMG_DG131466,"UNII:8H27GUR065 | .ALPHA.-STREPTOZOCIN | CAS RN:66395-18-4 | PubChem CID:29327 | Streptozocin | 1-methyl-1-nitroso-3-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]urea | DrugBank ID:DB00428 | PubChem SID:312524919"
+BMGC_DG06894,BMG_DG131499,"CAS RN:528-50-7 | CAS RN:80446-85-1 | beta-D-Glucopyranose, 4-O-beta-D-galactopyranosyl- | CAS RN:9005-84-9 | PubChem CID:294 | 2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol | CAS RN:28072-80-2 | CAS RN:20869-27-6 | CAS RN:69-79-4 | CAS RN:9004-34-6 | CAS RN:13360-52-6"
+BMGC_DG06895,BMG_DG131500,"PubChem CID:2940 | 8-tricyclo[5.2.1.02,6]decanyloxymethanedithioate | 8-Tricyclo[5.2.1.02,6]decanyloxymethanedithioate"
+BMGC_DG06896,BMG_DG131502,"Tricyclo-decan-9-yl-xanthogenate (racemate) | 8-tricyclo[5.2.1.02,6]decanyloxymethanedithioic acid | PubChem CID:2941 | CAS RN:83373-60-8"
+BMGC_DG06897,BMG_DG131513,"1-Deoxynojirimycin | PubChem CID:29435 | PubChem SID:198947634 | DrugBank ID:DB03206 | UNII:FZ56898FLE | DUVOGLUSTAT | CAS RN:19130-96-2 | (2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol | Duvoglustat"
+BMGC_DG06898,BMG_DG131529,PubChem CID:2948 | UNII:WUC3CB63CD | Damnacanthal | PubChem SID:472405797 | CAS RN:477-84-9 | DAMNACANTHAL
+BMGC_DG06899,BMG_DG131536,"CAS RN:117-10-2 | DrugBank ID:DB04816 | UNII:Z4XE6IBF3V | DANTHRON | 1,8-dihydroxyanthracene-9,10-dione | PubChem CID:2950 | Dantron | Danthron | PubChem SID:198986722"
+BMGC_DG06900,BMG_DG131537,"UNII:N2VRC6C8HU | PubChem SID:404859545 | 6,7-DIMETHOXY-N2,N2-DIMETHYL-2,4-QUINAZOLINEDIAMINE | PubChem CID:29503 | CAS RN:19216-53-6"
+BMGC_DG06901,BMG_DG131540,CAS RN:19224-27-2 | TETRAMETHYLENE DIBENZOATE | PubChem SID:374388632 | UNII:0QW8JPF0XE | PubChem CID:29511
+BMGC_DG06902,BMG_DG131550,NDC:69238-1627 | NDC:69367-379 | NDC:64980-566 | PubChem CID:2955 | PubChem SID:175265955 | NDC:42291-008 | NDC:49938-101 | NDC:51672-4197 | NDC:72578-094 | NDC:16110-526 | NDC:13668-605 | NDC:0713-0886 | NDC:51672-4198 | NDC:70771-1538 | NDC:70954-135 | NDC:29033-036 | NDC:0378-4830 | NDC:49938-102 | NDC:16714-975 | NDC:82804-989 | 4-(4-aminophenyl)sulfonylaniline | NDC:83098-101 | NDC:52817-832 | NDC:83098-102 | NDC:51672-1388 | NDC:0023-3670 | NDC:29033-037 | NDC:43353-222 | NDC:21922-018 | NDC:62332-663 | NDC:43353-223 | NDC:16110-367 | NDC:64980-567 | NDC:16714-956 | Dapsone | DAPSONE | NDC:52817-831 | NDC:68308-342 | NDC:60429-495 | DrugBank ID:DB00250 | UNII:8W5C518302 | NDC:82804-988 | NDC:65162-339 | NDC:60758-670 | NDC:69367-378 | NDC:51862-123 | NDC:51672-1387 | NDC:70954-136 | CAS RN:80-08-0
+BMGC_DG06903,BMG_DG131558,"DrugBank ID:DB12473 | Taurolidine | PubChem SID:175266603 | UNII:8OBZ1M4V3V | CAS RN:19388-87-5 | PubChem CID:29566 | TAUROLIDINE | 4-[(1,1-dioxo-1,2,4-thiadiazinan-4-yl)methyl]-1,2,4-thiadiazinane 1,1-dioxide"
+BMGC_DG06904,BMG_DG131581,UNII:V7WFL4GX8N | CAS RN:3613-16-9 | PubChem CID:296314 | 1-((2-(DIETHYLAMINO)ETHYL)AMINO)-4-(HYDROXYMETHYL)-9H-XANTHEN-9-ONE | PubChem SID:376072473
+BMGC_DG06905,BMG_DG131591,"PubChem CID:2966 | PubChem SID:198958991 | CAS RN:1131-64-2 | Debrisoquine | DrugBank ID:DB04840 | Debrisoquin | 3,4-dihydro-1H-isoquinoline-2-carboximidamide | UNII:X31CDK040E | DEBRISOQUIN | CAS RN:581-88-4"
+BMGC_DG06906,BMG_DG131597,PubChem CID:29669 | CAS RN:49872-43-7 | UNII:GQ6L3T7RNE | 1-(2-CHLOROPHENYL)BIGUANIDE
+BMGC_DG06907,BMG_DG131602,CAS RN:156-74-1 | trimethyl-[10-(trimethylazaniumyl)decyl]azanium | PubChem CID:2968 | Decamethonium | DECAMETHONIUM | DrugBank ID:DB01245 | UNII:C1CG1S3T2W | PubChem SID:198962022
+BMGC_DG06908,BMG_DG131604,CAPRIC ACID | PubChem SID:175265845 | Capric Acid | Capric acid | decanoic acid | UNII:4G9EDB6V73 | CAS RN:334-48-5 | PubChem CID:2969 | DrugBank ID:DB03600
+BMGC_DG06909,BMG_DG131607,CAS RN:19622-55-0 | UNII:VQ8UH664ZJ | PubChem SID:474489449 | MEGAZOL | PubChem CID:29698 | Megazol
+BMGC_DG06910,BMG_DG131608,CAS RN:150036-83-2 | METHANE | Activated charcoal | UNII:OP0UW79H66 | CAS RN:8006-14-2 | PubChem CID:297 | DrugBank ID:DB09278 | methane | Methane | CAS RN:14493-06-2 | CAS RN:74-82-8
+BMGC_DG06911,BMG_DG131610,"Decylubiquinone | UNII:DP8EJ59CQN | CAS RN:55486-00-5 | DECYLUBIQUINONE | DrugBank ID:DB07640 | 2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | PubChem SID:440088273 | PubChem CID:2971"
+BMGC_DG06912,BMG_DG131612,"NDC:10122-100 | DEFERIPRONE | NDC:51672-4237 | NDC:10122-101 | NDC:0054-0576 | PubChem SID:175266299 | NDC:51672-4196 | PubChem CID:2972 | NDC:10122-103 | NDC:0054-0711 | DrugBank ID:DB08826 | UNII:2BTY8KH53L | 3-hydroxy-1,2-dimethylpyridin-4-one | CAS RN:30652-11-0 | NDC:10122-104 | Deferiprone"
+BMGC_DG06913,BMG_DG131615,PubChem SID:175268725 | CAS RN:1950-39-6 | N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide | CAS RN:70-51-9 | UNII:J06Y7MXW4D | DEFEROXAMINE | PubChem CID:2973 | Deferoxamine | DrugBank ID:DB00746
+BMGC_DG06914,BMG_DG131618,"PubChem SID:198970236 | OXADIAZON | UNII:C6U0E0YTP6 | 5-tert-butyl-3-(2,4-dichloro-5-propan-2-yloxyphenyl)-1,3,4-oxadiazol-2-one | PubChem CID:29732 | CAS RN:19666-30-9 | Oxadiazon"
+BMGC_DG06915,BMG_DG131629,PubChem CID:297589 | UNII:5K2QDA6F3S | CAS RN:4079-26-9 | PubChem SID:461433065 | PD-146176
+BMGC_DG06916,BMG_DG131635,"PubChem CID:2978 | 6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | CAS RN:16849-50-6"
+BMGC_DG06917,BMG_DG131649,"PubChem SID:198987464 | Denbufylline | CAS RN:57076-71-8 | DENBUFYLLINE | 1,3-dibutyl-7-(2-oxopropyl)purine-2,6-dione | PubChem CID:2984 | UNII:04B949KO6F"
+BMGC_DG06918,BMG_DG131666,2-Amino-4-chlorobenzothiazole | UNII:2PAW227HMB | 2-AMINO-4-CHLOROBENZOTHIAZOLE | CAS RN:19952-47-7 | PubChem SID:485660836 | PubChem CID:29872
+BMGC_DG06919,BMG_DG131721,DEQUALINIUM | Dequalinium | DrugBank ID:DB04209 | PubChem SID:198936120 | UNII:E7QC7V26B8 | CAS RN:6707-58-0 | 1-[10-(4-amino-2-methylquinolin-1-ium-1-yl)decyl]-2-methylquinolin-1-ium-4-amine | PubChem CID:2993
+BMGC_DG06920,BMG_DG131739,PubChem SID:175266138 | DrugBank ID:DB13949 | Ferric cation | FERRIC CATION | iron(3+) | PubChem CID:29936 | UNII:91O4LML611 | CAS RN:20074-52-6
+BMGC_DG06921,BMG_DG131752,"Desipramine | DrugBank ID:DB01151 | PubChem CID:2995 | UNII:TG537D343B | CAS RN:50-47-5 | PubChem SID:175267894 | DESIPRAMINE | 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine"
+BMGC_DG06922,BMG_DG131759,"calcium;2,5-dihydroxybenzenesulfonate | CAS RN:20123-80-2 | Calcium Dobesilate | PubChem SID:198954908 | CALCIUM DOBESILATE | PubChem CID:29963 | UNII:5921X1560Q"
+BMGC_DG06923,BMG_DG131760,PubChem CID:299664 | PubChem SID:198963928 | 3-DESMETHYLCOLCHICINE | CAS RN:7336-33-6 | UNII:C939KS8QEL
+BMGC_DG06924,BMG_DG131762,"DrugBank ID:DB14028 | Nordazepam | UNII:67220MCM01 | 7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one | PubChem CID:2997 | PubChem SID:198984597 | NORDAZEPAM | CAS RN:1088-11-5"
+BMGC_DG06925,BMG_DG131802,"CAS RN:88441-14-9 | PubChem SID:198938249 | 2C-C | 2,5-Dimethoxy-4-chlorophenethylamine | UNII:0RO7MZY2LS | PubChem CID:29979100 | 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine"
+BMGC_DG06926,BMG_DG131811,PubChem CID:2998 | NONIVAMIDE | CAS RN:2444-46-4 | DrugBank ID:DB11324 | PubChem SID:198965296 | UNII:S846B891OR | Nonivamide | N-[(4-hydroxy-3-methoxyphenyl)methyl]nonanamide
+BMGC_DG06927,BMG_DG131829,4-((1S)-3-(Methylamino)-1-(2-thienyl)propoxy)-1-naphthalenol | CAS RN:662149-13-5 | 4-[(1S)-3-(methylamino)-1-thiophen-2-ylpropoxy]naphthalen-1-ol | PubChem CID:29981497
+BMGC_DG06928,BMG_DG131831,"PubChem SID:433968195 | CAS RN:741693-83-4 | 4-HYDROXY DULOXETINE .BETA.-D-GLUCURONIDE | 4-Hydroxy duloxetine beta-D-glucuronide | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-[(1S)-3-(methylamino)-1-thiophen-2-ylpropoxy]naphthalen-1-yl]oxyoxane-2-carboxylic acid | UNII:GF5FP4W1EJ | PubChem CID:29981513"
+BMGC_DG06929,BMG_DG131837,CAS RN:741693-79-8 | UNII:B18NZM26WW | 5-HYDROXY-6-METHOXY DULOXETINE | PubChem SID:198960264 | PubChem CID:29981679
+BMGC_DG06930,BMG_DG131855,UNII:ZZ5M934ECV | LORATADINE N-OXIDE | PubChem SID:478839112 | Loratadine N-oxide | CAS RN:165739-62-8 | PubChem CID:29982763
+BMGC_DG06931,BMG_DG131893,"Zeranol | UNII:76LO2L2V39 | (4S,8R)-8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),15,17-trien-2-one | CAS RN:26538-44-3 | PubChem SID:175268837 | DrugBank ID:DB11478 | ZERANOL | PubChem CID:2999413"
+BMGC_DG06932,BMG_DG131895,CAS RN:79-11-8 | PubChem CID:300 | Chloroacetic Acid | CHLOROACETIC ACID | PubChem SID:198970400 | UNII:5GD84Y125G | 2-chloroacetic acid | Chloroacetic acid
+BMGC_DG06933,BMG_DG131899,"Fusidic Acid | FUSIDIC ACID | DrugBank ID:DB02703 | UNII:59XE10C19C | PubChem SID:175266845 | Fusidic acid | PubChem CID:3000226 | CAS RN:6990-06-3 | (2Z)-2-[(3R,4S,5S,8S,9S,10S,11R,13R,14S,16S)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoic acid"
+BMGC_DG06934,BMG_DG131903,"NDC:70710-1846 | NDC:0591-2258 | NDC:70771-1787 | SCOPOLAMINE | DrugBank ID:DB00747 | Scopolamine | NDC:10019-553 | NDC:0378-6470 | UNII:DL48G20X8X | PubChem SID:175268401 | NDC:50090-7188 | NDC:63629-8450 | Hyoscine | NDC:63629-8452 | NDC:42858-150 | NDC:50090-5349 | PubChem CID:3000322 | NDC:50742-505 | NDC:72162-1419 | NDC:63629-8451 | NDC:45802-580 | [(1R,2R,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate | CAS RN:51-34-3"
+BMGC_DG06935,BMG_DG131907,PubChem SID:322058822 | CAS RN:23407-35-4 | UNII:QMP2RF3L41 | PubChem CID:3000341 | CORYNANTHEIDINE
+BMGC_DG06936,BMG_DG131909,Tetrachlorodecaoxide | molecular oxygen;tetrachlorite;hydrate | CAS RN:92047-76-2 | PubChem CID:3000391 | DrugBank ID:DB05389
+BMGC_DG06937,BMG_DG131911,"DrugBank ID:DB13851 | PubChem CID:3000469 | PubChem SID:472385909 | CAS RN:75887-54-6 | ARTEMOTIL | CAS RN:109716-83-8 | Artemotil | UNII:XGL7GFB9YI | (1R,4S,5R,8S,9R,10S,12R,13R)-10-ethoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane"
+BMGC_DG06938,BMG_DG131915,"PubChem CID:3000502 | (3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-(hydroxymethyl)-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide;(3S)-3,6-diamino-N-[[(2S,5S,8E,11S,15S)-15-amino-11-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-8-[(carbamoylamino)methylidene]-2-methyl-3,6,9,12,16-pentaoxo-1,4,7,10,13-pentazacyclohexadec-5-yl]methyl]hexanamide | DrugBank ID:DB00314 | Capreomycin"
+BMGC_DG06939,BMG_DG131917,"PubChem SID:445499431 | CAS RN:148690-80-6 | THREO-MEFLOQUINE, (-)- | CAS RN:51744-84-4 | (R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol | (R)-[2,8-bis(trifluoromethyl)-4-quinolyl]-[(2R)-2-piperidyl]methanol | PubChem CID:3000506 | UNII:P4QYS7TV8C"
+BMGC_DG06940,BMG_DG131918,"(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol | CAS RN:51744-85-5 | CAS RN:58737-31-8 | UNII:GB2GL4S36Z | PubChem SID:441583484 | PubChem CID:3000516 | REL-(.ALPHA.R)-.ALPHA.-(2R)-2-PIPERIDINYL-2,8-BIS(TRIFLUOROMETHYL)-4-QUINOLINEMETHANOL"
+BMGC_DG06941,BMG_DG131919,"PubChem CID:3000518 | UNII:6A9O50735X | PubChem SID:198948019 | CAS RN:81496-82-4 | Artenimol | CAS RN:71939-50-9 | (1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol | ARTENIMOL"
+BMGC_DG06942,BMG_DG131920,"(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide | UNII:BOD072YW0F | NDC:70436-035 | Lincomycin | LINCOMYCIN | CAS RN:154-21-2 | NDC:70436-034 | PubChem CID:3000540 | PubChem SID:175267361 | DrugBank ID:DB01627"
+BMGC_DG06943,BMG_DG131925,Sulfathiourea | PubChem SID:198980008 | SULFATHIOUREA | (4-aminophenyl)sulfonylthiourea | PubChem CID:3000579 | CAS RN:515-49-1 | DrugBank ID:DB13699 | UNII:MXF9G4I1V5
+BMGC_DG06944,BMG_DG131926,UNII:BB49X70V53 | ISONICOTYL THIOSEMICARBAZONE | PubChem CID:3000601 | CAS RN:14397-24-1 | PubChem SID:375579899
+BMGC_DG06945,BMG_DG131933,"UNII:NI2GJ8B986 | 3-METHYL(1,2,4)TRIAZOLO(3,4-B)(1,3,4)THIADIAZOLE-6(5H)-THIONE | PubChem SID:374388377 | PubChem CID:3000629 | CAS RN:3173-11-3"
+BMGC_DG06946,BMG_DG131941,"Valinomycin | DrugBank ID:DB14057 | (3S,6S,9R,12R,15S,18S,21R,24R,27S,30S,33R,36R)-6,18,30-trimethyl-3,9,12,15,21,24,27,33,36-nona(propan-2-yl)-1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexazacyclohexatriacontane-2,5,8,11,14,17,20,23,26,29,32,35-dodecone | PubChem SID:198975198 | UNII:N561YS75MN | CAS RN:2001-95-8 | VALINOMYCIN | PubChem CID:3000706"
+BMGC_DG06947,BMG_DG131943,"CAS RN:76-75-5 | UNII:JI8Z5M7NA3 | DrugBank ID:DB00599 | PubChem SID:175272070 | PubChem CID:3000715 | THIOPENTAL | 5-ethyl-5-pentan-2-yl-2-sulfanylidene-1,3-diazinane-4,6-dione | Thiopental | CAS RN:71-73-8"
+BMGC_DG06948,BMG_DG131944,PubChem CID:3000722 | PubChem SID:375579715 | UNII:V0HK644WMS | PHENYLTHIOHYDANTOIC ACID | CAS RN:2215-20-5
+BMGC_DG06949,BMG_DG131954,DrugBank ID:DB05871 | CAS RN:178870-32-1 | UC-781 | PubChem CID:3000926 | UNII:L7K247H29H | N-[4-chloro-3-(3-methylbut-2-enoxy)phenyl]-2-methylfuran-3-carbothioamide | PubChem SID:198935846
+BMGC_DG06950,BMG_DG131970,"PubChem CID:3001028 | DrugBank ID:DB04574 | CAS RN:481-97-0 | ESTRONE SULFATE | PubChem SID:198937603 | UNII:QTL48N278K | Estrone sulfate | [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate"
+BMGC_DG06951,BMG_DG131973,"PubChem CID:3001055 | CAS RN:82530-72-1 | (E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine | CAS RN:66357-35-5 | DrugBank ID:DB00863 | Ranitidine | Zantac"
+BMGC_DG06952,BMG_DG131993,"Aplaviroc | PubChem SID:198945612 | DrugBank ID:DB06497 | 4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid | APLAVIROC | CAS RN:674782-28-6 | CAS RN:461443-59-4 | UNII:98B425P30V | PubChem CID:3001322"
+BMGC_DG06953,BMG_DG131997,"1,3-bis[4-(3-methylbutoxy)phenyl]thiourea | CAS RN:910-86-1 | TIOCARLIDE | UNII:43M23X81Y2 | PubChem SID:198971104 | DrugBank ID:DB13608 | Tiocarlide | PubChem CID:3001386"
+BMGC_DG06954,BMG_DG132006,CAS RN:106518-63-2 | PubChem CID:3001811 | GANODERMANONTRIOL | UNII:6NB33MKR8F | PubChem SID:472406143
+BMGC_DG06955,BMG_DG132014,PubChem SID:198945515 | CAS RN:500-89-0 | PubChem CID:3002003 | UNII:X92J960C7P | THIAMBUTOSINE
+BMGC_DG06956,BMG_DG132023,"UNII:KI8H7H19WL | DrugBank ID:DB00976 | (1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-9-methoxy-1,5,7,9,11,13-hexamethyl-15-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone | CAS RN:191114-48-4 | PubChem CID:3002190 | PubChem SID:175268627 | Telithromycin | TELITHROMYCIN"
+BMGC_DG06957,BMG_DG132032,"(2E)-2-[4-(2-chlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile | LANOCONAZOLE | CAS RN:101530-10-3 | Lanoconazole | CAS RN:153222-93-6 | PubChem CID:3002820 | CAS RN:126509-69-1 | PubChem SID:198962442 | UNII:4E7858311F"
+BMGC_DG06958,BMG_DG132034,"MARAVIROC | PubChem SID:175265823 | 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide | Maraviroc, endo- | CAS RN:376348-65-1 | Maraviroc | PubChem SID:474494135 | UNII:A3C7SRV8DV | DrugBank ID:DB04835 | CAS RN:2414315-81-2 | UNII:MD6P741W8A | MARAVIROC, ENDO- | PubChem CID:3002977"
+BMGC_DG06959,BMG_DG132037,"Luliconazole | NDC:99207-850 | PubChem CID:3003141 | (2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile | LULICONAZOLE | CAS RN:187164-19-8 | NDC:68682-850 | DrugBank ID:DB08933 | UNII:RE91AN4S8G | PubChem SID:198977577"
+BMGC_DG06960,BMG_DG132038,"UNII:R1JI58032B | PubChem CID:3003157 | PubChem SID:313183255 | DrugBank ID:DB01496 | Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione | DIHYDRO-2-THIOXO-5-((5-(2-(TRIFLUOROMETHYL)PHENYL)-2-FURANYL)METHYL)-4,6(1H,5H)-PYRIMIDINEDIONE | CAS RN:959343-20-5"
+BMGC_DG06961,BMG_DG132073,"N,N'-DI(1H-INDAZOL-6-YL)THIOUREA | UNII:WT922UDA9S | CAS RN:7255-94-9 | PubChem SID:376072275 | PubChem CID:3003797"
+BMGC_DG06962,BMG_DG132094,"PubChem CID:3003914 | 7-METHYL-1,2,4-TRIAZOLO(3,4-B)BENZOTHIAZOLE-3(2H)-THIONE | CAS RN:42438-69-7 | UNII:8M2FO7FUO3 | PubChem SID:375579407"
+BMGC_DG06963,BMG_DG132111,"UNII:X5RCK1XO4F | PubChem SID:377308595 | 1,4-DIMETHYOXY-9(10H)-ACRIDINONE | CAS RN:141992-47-4 | PubChem CID:3004085"
+BMGC_DG06964,BMG_DG132118,Fti 277 | methyl (2S)-2-[[4-[[(2R)-2-amino-3-sulfanylpropyl]amino]-2-phenylbenzoyl]amino]-4-methylsulfanylbutanoate | PubChem CID:3005532 | CAS RN:170006-73-2
+BMGC_DG06965,BMG_DG132119,"Toremifene Citrate | TOREMIFENE CITRATE | NDC:42747-327 | NDC:64980-404 | NDC:69539-152 | NDC:72205-050 | PubChem SID:175267622 | PubChem CID:3005572 | CAS RN:89778-27-8 | 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid | UNII:2498Y783QT"
+BMGC_DG06966,BMG_DG132120,"TOREMIFENE | CAS RN:89778-29-0 | CAS RN:89778-26-7 | Toremifene | 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine | PubChem CID:3005573 | DrugBank ID:DB00539 | CAS RN:275360-73-1 | UNII:7NFE54O27T | PubChem SID:175267258"
+BMGC_DG06967,BMG_DG132136,NDC:70165-025 | 1-phenylpropan-2-amine | NDC:70165-015 | UNII:CK833KGX7E | NDC:24478-110 | CAS RN:300-62-9 | PubChem CID:3007 | NDC:24478-108 | PubChem SID:175271504 | NDC:24478-109 | NDC:70165-030 | NDC:24478-106 | AMPHETAMINE | DrugBank ID:DB00182 | CAS RN:60-15-1 | Amphetamine | NDC:70165-010 | NDC:70165-005 | NDC:70165-020 | NDC:24478-102
+BMGC_DG06968,BMG_DG132139,UNII:86Q357L16B | PubChem SID:175266535 | ZINC CHLORIDE | PubChem CID:3007855 | CAS RN:7646-85-7 | Zinc chloride
+BMGC_DG06969,BMG_DG132141,PubChem CID:3007857 | ZINC OXIDE | Zinc oxide | PubChem SID:175267730 | CAS RN:1314-13-2 | UNII:SOI2LOH54Z | zinc;oxygen(2-) | Zinc Oxide
+BMGC_DG06970,BMG_DG132144,"4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene | Racemethorphan | PubChem CID:3008 | CAS RN:510-53-2"
+BMGC_DG06971,BMG_DG132148,RWJ-67657 | CAS RN:215303-72-3 | PubChem CID:3008319 | UNII:MXN26D3ZUN | PubChem SID:459056389
+BMGC_DG06972,BMG_DG132154,"8,8-BIECKOL | PubChem CID:3008867 | UNII:7J2CFB3NBV | PubChem SID:472423552 | CAS RN:89445-12-5"
+BMGC_DG06973,BMG_DG132155,UNII:ZU0ESU4399 | DIECKOL | PubChem CID:3008868 | CAS RN:88095-77-6 | PubChem SID:381608365
+BMGC_DG06974,BMG_DG132157,"UNII:ZQN1G5V6SR | DrugBank ID:DB06243 | PubChem CID:3009 | Eflornithine | PubChem SID:175271600 | 2,5-diamino-2-(difluoromethyl)pentanoic acid | CAS RN:67037-37-0 | EFLORNITHINE | CAS RN:70050-56-5 | CAS RN:70052-12-9"
+BMGC_DG06975,BMG_DG132161,"Vicriviroc | CAS RN:306296-47-9 | PubChem SID:198947606 | (4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone | DrugBank ID:DB06652 | CAS RN:394730-30-4 | PubChem CID:3009355 | VICRIVIROC | UNII:TL515DW4QS"
+BMGC_DG06976,BMG_DG132162,FR-221647 | PubChem CID:3009363 | PubChem SID:198958635 | UNII:4Z97161Z8Y | CAS RN:256461-28-6
+BMGC_DG06977,BMG_DG132174,"Telaprevir | PubChem CID:3010818 | TELAPREVIR | (3S,3aS,6aR)-2-[(2S)-2-[[(2S)-2-cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxamide | PubChem SID:175266405 | CAS RN:569364-34-7 | DrugBank ID:DB05521 | CAS RN:402957-28-2 | UNII:655M5O3W0U"
+BMGC_DG06978,BMG_DG132179,"NDC:14789-114 | NDC:0078-0683 | NDC:66758-165 | UNII:60158CV180 | PubChem SID:175266277 | NDC:80978-111 | (2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | NDC:71288-165 | NDC:43598-142 | NDC:72205-154 | DrugBank ID:DB01280 | NELARABINE | CAS RN:121032-29-9 | NDC:70771-1685 | NDC:70121-1743 | NDC:70710-1839 | NDC:68083-233 | NDC:70710-1726 | NDC:62332-813 | NDC:46708-813 | PubChem CID:3011155 | Nelarabine | NDC:25021-259"
+BMGC_DG06979,BMG_DG132187,"UNII:PF550QIT3I | R-59-022 | CAS RN:93076-89-2 | Diacylglycerol kinase inhibitor i | 6-[2-[4-[(4-fluorophenyl)-phenylmethylidene]piperidin-1-yl]ethyl]-7-methyl-[1,3]thiazolo[3,2-a]pyrimidin-5-one | PubChem CID:3012 | PubChem SID:198988611"
+BMGC_DG06980,BMG_DG132189,"Femoxetine | CAS RN:59859-58-4 | (3R,4S)-3-[(4-methoxyphenoxy)methyl]-1-methyl-4-phenylpiperidine | FEMOXETINE | UNII:8Y719ZLX8C | PubChem SID:198988911 | PubChem CID:3012003"
+BMGC_DG06981,BMG_DG132197,"DrugBank ID:DB13787 | PubChem SID:198963607 | PubChem SID:198975108 | Dextilidine | CAS RN:32447-90-8 | UNII:2728MV084C | ethyl (1S,2R)-2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate | CAS RN:51931-66-9 | PubChem CID:30131 | DEXTILIDINE | UNII:GY33N31E9Y | TILIDINE | CAS RN:20380-58-9"
+BMGC_DG06982,BMG_DG132204,CAS RN:704-15-4 | PubChem CID:3013625 | UNII:BJZ69WB3VD | N-GLYCYLPROLINE | Glycyl-L-proline | (2S)-1-(2-aminoacetyl)pyrrolidine-2-carboxylic acid | PubChem SID:252164528
+BMGC_DG06983,BMG_DG132208,AL7089A | DrugBank ID:DB02220 | PubChem CID:3013848
+BMGC_DG06984,BMG_DG132220,PubChem SID:377308473 | UNII:9ZQ0A5SY7A | PubChem CID:3013891 | CAS RN:484-27-5 | VISNAGINONE
+BMGC_DG06985,BMG_DG132240,4-fluorobenzoate | 4-Fluorobenzoate | PubChem CID:3014095 | CAS RN:2365-27-7
+BMGC_DG06986,BMG_DG132486,"NDC:0054-3188 | NDC:67544-020 | DIAZEPAM | NDC:71610-424 | NDC:70518-3776 | NDC:43353-276 | NDC:72162-1900 | NDC:72252-510 | NDC:68788-8466 | NDC:63187-544 | NDC:10094-305 | NDC:0641-6243 | NDC:55289-092 | NDC:49999-018 | NDC:0404-9848 | NDC:59651-654 | NDC:70518-3775 | NDC:72189-570 | NDC:43063-718 | NDC:50090-2249 | NDC:58118-3926 | NDC:71335-2198 | NDC:80725-005 | 7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one | NDC:68788-9207 | NDC:71610-427 | NDC:71335-2239 | UNII:Q3JTX2Q7TU | NDC:0172-3926 | NDC:71335-1584 | NDC:63187-846 | NDC:43063-840 | NDC:0904-7117 | PubChem CID:3016 | NDC:43353-825 | NDC:68071-4829 | NDC:0172-3925 | NDC:43598-106 | NDC:0641-6244 | NDC:61919-906 | NDC:0378-0345 | NDC:71335-2306 | NDC:43353-281 | NDC:0140-0004 | NDC:62332-811 | NDC:59651-653 | NDC:0409-1273 | NDC:67544-019 | NDC:70518-2358 | NDC:68788-7452 | NDC:70518-1713 | NDC:0172-3927 | NDC:68071-3682 | NDC:68788-8281 | NDC:10094-310 | NDC:76420-784 | NDC:72572-140 | NDC:55154-5074 | NDC:68788-8462 | NDC:71335-2196 | NDC:0054-3185 | NDC:72252-515 | NDC:71610-270 | NDC:68682-650 | NDC:50090-1913 | NDC:80725-004 | NDC:51079-285 | NDC:72252-505 | NDC:70518-0162 | NDC:0378-0271 | NDC:62135-767 | NDC:50090-0195 | NDC:69339-136 | PubChem SID:175267820 | NDC:71610-460 | NDC:58118-3925 | NDC:71335-0444 | NDC:62135-787 | NDC:82804-186 | NDC:76045-204 | NDC:76420-783 | NDC:62135-788 | NDC:17856-3188 | NDC:60687-755 | NDC:62135-786 | NDC:10094-315 | NDC:43386-281 | NDC:10094-307 | NDC:71335-2247 | NDC:67296-0084 | NDC:80425-0120 | CAS RN:11100-37-1 | NDC:71610-459 | NDC:63187-173 | NDC:43063-987 | NDC:63629-1523 | NDC:55154-5554 | NDC:0121-0905 | NDC:80725-006 | NDC:46708-811 | NDC:70518-0014 | NDC:10094-312 | NDC:68071-4770 | CAS RN:439-14-5 | NDC:11704-600 | NDC:72252-520 | NDC:0409-3213 | NDC:0378-0477 | NDC:71872-7260 | NDC:58118-4047 | Diazepam | DrugBank ID:DB00829 | NDC:11534-202 | NDC:43353-278 | NDC:68682-655 | NDC:71872-7259 | NDC:11534-199 | NDC:51079-284 | NDC:61919-409 | NDC:68682-652 | NDC:63187-867 | NDC:51079-286 | NDC:50090-1726 | NDC:0404-9849 | NDC:11534-203 | NDC:43063-970 | NDC:63629-2948 | NDC:59651-652 | NDC:71335-2197 | NDC:68094-750 | NDC:50090-3390 | NDC:76420-533 | NDC:43386-280 | NDC:69339-137 | NDC:68071-3686 | NDC:68071-4922 | NDC:62135-768 | NDC:72189-552 | NDC:55700-058"
+BMGC_DG06987,BMG_DG132585,"6-Hydroxy-5-undecyl-4,7-benzothiazoledione | PubChem CID:3016416 | DrugBank ID:DB04799"
+BMGC_DG06988,BMG_DG132609,Iodide Ion | PubChem CID:30165 | iodide | PubChem SID:175265710 | UNII:09G4I6V86Q | IODIDE ION | CAS RN:100934-04-1 | CAS RN:20461-54-5 | Iodide | DrugBank ID:DB12754
+BMGC_DG06989,BMG_DG132680,LERIMAZOLINE | UNII:1YZY0ACA91 | PubChem SID:198944064 | PubChem CID:3016908 | CAS RN:54765-26-3
+BMGC_DG06990,BMG_DG132693,diethoxy-(6-methyl-2-propan-2-ylpyrimidin-4-yl)oxy-sulfanylidene-lambda5-phosphane | DIMPYLATE | PubChem SID:198973394 | Diazinon | CAS RN:333-41-5 | PubChem CID:3017 | UNII:YUS1M1Q929
+BMGC_DG06991,BMG_DG132845,UNII:DX60OV32AE | PubChem CID:3018598 | SULMEPRIDE | CAS RN:57479-88-6 | PubChem SID:198970751
+BMGC_DG06992,BMG_DG132867,"UNII:O5CB12L4FN | PubChem SID:175268405 | NDC:13517-100 | PubChem CID:3019 | 7-chloro-3-methyl-4H-1lambda6,2,4-benzothiadiazine 1,1-dioxide | NDC:0254-1010 | NDC:0575-6200 | CAS RN:364-98-7 | DIAZOXIDE | DrugBank ID:DB01119 | Diazoxide"
+BMGC_DG06993,BMG_DG132908,PubChem CID:3019427 | Norcisapride | CAS RN:84946-16-7 | 4-amino-5-chloro-2-methoxy-N-(3-methoxypiperidin-4-yl)benzamide
+BMGC_DG06994,BMG_DG133185,"PubChem SID:316912465 | UNII:5F491CKG2C | CAS RN:109745-32-6 | CI-930 | 3-(4-imidazol-1-ylphenyl)-4-methyl-4,5-dihydro-1H-pyridazin-6-one | 4,5-dihydro-6-(4-(imidazol-1-yl)phenyl)-5-methyl-3(2H)-pyridazinone | CAS RN:86798-59-6 | PubChem CID:3021729"
+BMGC_DG06995,BMG_DG133188,CANNABICHROMENE | PubChem CID:30219 | Cannabichromene | PubChem SID:198986682 | UNII:K4497H250W | 2-methyl-2-(4-methylpent-3-enyl)-7-pentylchromen-5-ol | CAS RN:18793-28-7 | CAS RN:20675-51-8 | DrugBank ID:DB14735
+BMGC_DG06996,BMG_DG133249,2-[(2-Ethoxyphenoxy)-phenylmethyl]morpholine | CAS RN:98769-81-4 | 2-[(2-ethoxyphenoxy)-phenylmethyl]morpholine | PubChem CID:3022645
+BMGC_DG06997,BMG_DG133530,NDC:0536-1211 | NDC:57896-131 | DIBUCAINE | Cinchocaine | Dibucaine | CAS RN:85-79-0 | UNII:L6JW2TJG99 | DrugBank ID:DB00527 | NDC:69396-023 | PubChem CID:3025 | NDC:71399-2829 | PubChem SID:175265856 | 2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide
+BMGC_DG06998,BMG_DG133552,PubChem CID:3025746 | 3-carbamoyloxy-2-phenylpropanoic acid | CAS RN:139262-66-1 | 3-Carbamoyloxy-2-phenylpropionic acid | 3-CARBAMOYL-2-PHENYL-PROPIONIC ACID | UNII:D2V2FDH9KE | PubChem SID:445500102
+BMGC_DG06999,BMG_DG133554,"UNII:S6RXB5KF56 | 6-[2-(3,4-diethoxyphenyl)-1,3-thiazol-4-yl]pyridine-2-carboxylic acid | PubChem SID:198951502 | Tetomilast | DrugBank ID:DB05298 | PubChem CID:3025803 | CAS RN:145739-56-6 | TETOMILAST"
+BMGC_DG07000,BMG_DG133566,PubChem SID:198985425 | CAS RN:192441-08-0 | PubChem CID:3025944 | UNII:S79265T71M | LOMEGUATRIB
+BMGC_DG07001,BMG_DG133568,UNII:7VC0YVI27Y | PubChem CID:3025961 | 2-METHYL-6-(PHENYLETHYNYL)PYRIDINE | PubChem SID:198960489 | 2-methyl-6-(2-phenylethynyl)pyridine | CAS RN:96206-92-7 | 2-Methyl-6-(phenylethynyl)pyridine
+BMGC_DG07002,BMG_DG133580,"DrugBank ID:DB05969 | N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide | N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide | PubChem SID:198951361 | PubChem CID:3025986 | CAS RN:345627-80-7 | UNII:9979I93686 | SNS-032"
+BMGC_DG07003,BMG_DG133586,"dibutyl benzene-1,2-dicarboxylate | UNII:2286E5R2KE | DIBUTYL PHTHALATE | CAS RN:84-74-2 | PubChem CID:3026 | Dibutyl Phthalate | PubChem SID:175268121 | DrugBank ID:DB13716"
+BMGC_DG07004,BMG_DG133588,"N,N,N-TRIMETHYL-3-NITROANILINIUM | UNII:Y98EQR47CX | CAS RN:51570-70-8 | PubChem CID:3026753"
+BMGC_DG07005,BMG_DG133596,UNII:9FN79X2M3F | CAS RN:7439-93-2 | NDC:37662-3180 | lithium | Lithium | NDC:37662-3183 | PubChem CID:3028194 | NDC:37662-3186 | NDC:37662-3185 | NDC:37662-3184 | NDC:37662-3181 | NDC:37662-3188 | LITHIUM | NDC:37662-3182 | NDC:37662-3187
+BMGC_DG07006,BMG_DG133623,2-(N-TERT-BUTYLAMINO)-3'-BROMOPROPIOPHENONE | UNII:BA7SW58FKS | PubChem CID:3031062 | PubChem SID:441583782 | CAS RN:1049974-35-7
+BMGC_DG07007,BMG_DG133626,PubChem CID:3031066 | PubChem SID:461434289 | 2-(TERT-BUTYLAMINO)-4'-CHLOROPROPIOPHENONE | UNII:YX53NS5D33 | CAS RN:252193-58-1
+BMGC_DG07008,BMG_DG133629,"PubChem CID:3031263 | CAS RN:83173-13-1 | PubChem SID:485661399 | 2-[(2,3-Dihydro-1H-inden-5-yl)amino]-1,9-dihydro-6H-purin-6-one | UNII:FUP8UWY576 | 2-((2,3-DIHYDRO-1H-INDEN-5-YL)AMINO)-1,9-DIHYDRO-6H-PURIN-6-ONE"
+BMGC_DG07009,BMG_DG133642,"2-[2-(2,6-dichloroanilino)phenyl]acetate | PubChem CID:3032 | CAS RN:86522-08-9 | Solaraze"
+BMGC_DG07010,BMG_DG133646,"PubChem CID:3032285 | UNII:01T23W89FR | 5-pentan-2-yl-5-prop-2-enyl-2-sulfanylidene-1,3-diazinane-4,6-dione | CAS RN:77-27-0 | THIAMYLAL | Thiamylal | PubChem SID:198935686 | DrugBank ID:DB01154"
+BMGC_DG07011,BMG_DG133654,"DrugBank ID:DB00694 | PubChem CID:30323 | PubChem SID:175268398 | Daunorubicin | UNII:ZS7284E0ZP | CAS RN:20830-81-3 | DAUNORUBICIN | (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione"
+BMGC_DG07012,BMG_DG133685,"6-sulfanylidene-7,9-dihydro-3H-purine-2,8-dione | UNII:7F23ZQP3EM | 6-Thiouric acid | PubChem CID:3032417 | THIOURIC ACID | CAS RN:2002-60-0 | PubChem SID:198952520"
+BMGC_DG07013,BMG_DG133722,"gold(1+);3,4,5-trihydroxy-6-(hydroxymethyl)oxane-2-thiolate | CAS RN:12192-57-3 | PubChem CID:3032577 | CID 3032577"
+BMGC_DG07014,BMG_DG133723,CAS RN:301-03-1 | MANEB | manganese(2+);N-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate | UNII:K221E12G7T | Maneb | PubChem CID:3032581 | CAS RN:12427-38-2 | PubChem SID:198938342 | CAS RN:8018-01-7
+BMGC_DG07015,BMG_DG133724,"CAS RN:13002-65-8 | TAMOXIFEN, (E)- | PubChem CID:3032583 | UNII:56SY0DIL6N | PubChem SID:198936920"
+BMGC_DG07016,BMG_DG133743,PubChem CID:3032732 | CAS RN:688-73-3 | DrugBank ID:DB08601 | TRIBUTYLTIN HYDRIDE | Tributyl tin | UNII:4XDX163P3D | Tributyltin
+BMGC_DG07017,BMG_DG133748,PubChem CID:3032771 | S-[(Z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-phosphonooxypent-2-en-3-yl] benzenecarbothioate | S-Benzoylthiamine monophosphate | CAS RN:22457-89-2 | DrugBank ID:DB11748 | CAS RN:775256-41-2 | Benfotiamine
+BMGC_DG07018,BMG_DG133762,"PubChem SID:175266359 | UNII:2GQB349IUB | 5-Hydroxylysine | PubChem CID:3032849 | (2S,5R)-2,6-diamino-5-hydroxyhexanoic acid | HYDROXYLYSINE | CAS RN:1190-94-9"
+BMGC_DG07019,BMG_DG133772,BURIMAMIDE | UNII:TN5A4OD2TV | 1-[4-(1H-imidazol-5-yl)butyl]-3-methylthiourea | Burimamide | CAS RN:34970-69-9 | PubChem CID:3032915 | PubChem SID:198934936
+BMGC_DG07020,BMG_DG133782,"PubChem SID:175267810 | DICLOFENAC | CAS RN:15307-86-5 | Diclofenac | UNII:144O8QL0L1 | DrugBank ID:DB00586 | 2-[2-(2,6-dichloroanilino)phenyl]acetic acid | CAS RN:128402-48-2 | PubChem CID:3033"
+BMGC_DG07021,BMG_DG133785,"PubChem SID:198981795 | Dezocine | DrugBank ID:DB01209 | CAS RN:53648-55-8 | PubChem CID:3033053 | DEZOCINE | (1R,9S,15S)-15-amino-1-methyltricyclo[7.5.1.02,7]pentadeca-2(7),3,5-trien-4-ol | UNII:VHX8K5SV4X"
+BMGC_DG07022,BMG_DG133803,"PubChem SID:198943087 | Dapiprazole | UNII:5RNZ8GJO7K | DrugBank ID:DB00298 | DAPIPRAZOLE | CAS RN:72822-12-9 | PubChem CID:3033538 | 3-[2-[4-(2-methylphenyl)piperazin-1-yl]ethyl]-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridine"
+BMGC_DG07023,BMG_DG133807,PubChem SID:377308438 | 4-HYDROXY-2(3H)-BENZOXAZOLETHIONE | CAS RN:73713-92-5 | PubChem CID:3033576 | UNII:2MBI8Y7D07
+BMGC_DG07024,BMG_DG133811,"Cinolazepam | CINOLAZEPAM | 3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-3H-1,4-benzodiazepin-1-yl]propanenitrile | DrugBank ID:DB01594 | PubChem SID:198991149 | UNII:68P0556B0U | CAS RN:75696-02-5 | PubChem CID:3033621"
+BMGC_DG07025,BMG_DG133816,"Nizax | DrugBank ID:DB00585 | CAS RN:1246833-99-7 | (E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine | CAS RN:76963-41-2 | Nizatidine | PubChem CID:3033637"
+BMGC_DG07026,BMG_DG133822,CAS RN:76330-71-7 | Altanserin | 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2-sulfanylidene-1H-quinazolin-4-one | UNII:5015H744JQ | ALTANSERIN | PubChem SID:198985478 | PubChem CID:3033677
+BMGC_DG07027,BMG_DG133825,"PubChem SID:198946924 | UNII:QS56V5Y7EC | PubChem CID:3033702 | CAS RN:83602-05-5 | SPIRAPRILAT | (8S)-7-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid | Spiraprilat"
+BMGC_DG07028,BMG_DG133837,"3,5-dichloro-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | PubChem SID:198978423 | RACLOPRIDE | Raclopride | PubChem CID:3033769 | DrugBank ID:DB12518 | UNII:430K3SOZ7G | CAS RN:84225-95-6 | CAS RN:104953-11-9"
+BMGC_DG07029,BMG_DG133840,"DOLASETRON | Dolasetron | [(3S,7R)-10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl] 1H-indole-3-carboxylate | PubChem CID:3033818 | PubChem SID:175271627 | CAS RN:115956-13-3 | UNII:82WI2L7Q6E | DrugBank ID:DB00757 | CAS RN:115956-12-2"
+BMGC_DG07030,BMG_DG133842,UNII:V4PW0S7ZP7 | PANADIPLON | PubChem SID:198936219 | PubChem CID:3033821 | CAS RN:124423-84-3
+BMGC_DG07031,BMG_DG133844,"DrugBank ID:DB00922 | UNII:C6T4514L4E | CAS RN:141505-33-1 | PubChem SID:198949793 | LEVOSIMENDAN | Levosimendan | 2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile | PubChem CID:3033825"
+BMGC_DG07032,BMG_DG133857,"CAS RN:63146-73-6 | DrugBank ID:DB13643 | UNII:759N8462G8 | LOPRAZOLAM | Loprazolam | PubChem CID:3033860 | PubChem SID:198945890 | CAS RN:61197-73-7 | (2Z)-6-(2-chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4H-imidazo[1,2-a][1,4]benzodiazepin-1-one"
+BMGC_DG07033,BMG_DG133870,"Tamoxifen N-oxide | CAS RN:75504-34-6 | PubChem CID:3033895 | 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine oxide"
+BMGC_DG07034,BMG_DG133878,"N-(1,3-Benzodioxol-5-ylmethyl)-N'-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine | PubChem CID:3033952 | (Z)-1-N'-(1,3-benzodioxol-5-ylmethyl)-1-N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine | CAS RN:84845-75-0 | DrugBank ID:DB13760"
+BMGC_DG07035,BMG_DG133885,PubChem CID:3033962 | CAS RN:123955-10-2 | Almokalant | 4-[3-[ethyl(3-propylsulfinylpropyl)amino]-2-hydroxypropoxy]benzonitrile
+BMGC_DG07036,BMG_DG133890,"GESTODENE | Gestodene | DrugBank ID:DB06730 | (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14-decahydrocyclopenta[a]phenanthren-3-one | PubChem CID:3033968 | UNII:1664P6E6MI | PubChem SID:175266900 | CAS RN:60282-87-3"
+BMGC_DG07037,BMG_DG133899,"PubChem SID:198961447 | UNII:GQ8ADD54E1 | DrugBank ID:DB13684 | CAS RN:74512-12-2 | CAS RN:105102-19-0 | Omoconazole | OMOCONAZOLE | PubChem CID:3033988 | 1-[(Z)-1-[2-(4-chlorophenoxy)ethoxy]-1-(2,4-dichlorophenyl)prop-1-en-2-yl]imidazole"
+BMGC_DG07038,BMG_DG133910,"NDC:61269-565 | UNII:95M8R751W8 | CAS RN:104872-04-0 | NDC:71610-805 | PubChem CID:3034010 | ORLISTAT | DrugBank ID:DB01083 | NDC:61269-460 | [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate | Orlistat | PubChem SID:175268188 | CAS RN:96829-58-2 | NDC:0135-0461"
+BMGC_DG07039,BMG_DG133911,UNII:456UXE9867 | 1-[2-[4-[(E)-1-(4-iodophenyl)-2-phenylbut-1-enyl]phenoxy]ethyl]pyrrolidine | Idoxifene | CAS RN:116057-75-1 | IDOXIFENE | PubChem SID:198981730 | PubChem CID:3034011
+BMGC_DG07040,BMG_DG133912,"LORECLEZOLE | UNII:6DJ32STZ5W | Loreclezole | PubChem CID:3034012 | PubChem SID:198985978 | 1-[(Z)-2-chloro-2-(2,4-dichlorophenyl)ethenyl]-1,2,4-triazole | CAS RN:117857-45-1"
+BMGC_DG07041,BMG_DG133917,UNII:3OLH2HAK9F | PubChem CID:3034019 | DrugBank ID:DB13547 | SULFATOLAMIDE | 4-(aminomethyl)benzenesulfonamide;(4-aminophenyl)sulfonylthiourea | CAS RN:1161-88-2 | Sulfatolamide | PubChem SID:198964339
+BMGC_DG07042,BMG_DG133924,"(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol | Quinine | DrugBank ID:DB00468 | QUININE | CAS RN:72402-53-0 | PubChem SID:175267838 | PubChem CID:3034034 | CAS RN:130-95-0 | UNII:A7V27PHC7A"
+BMGC_DG07043,BMG_DG133927,"(1S,5R)-3-(6H-benzo[c][1]benzothiepin-11-ylidene)-8-methyl-8-azabicyclo[3.2.1]octane | Tropatepine | CAS RN:27574-24-9 | PubChem SID:198941128 | TROPATEPINE | PubChem CID:3034047 | UNII:C27HY5RFU5 | DrugBank ID:DB13252"
+BMGC_DG07044,BMG_DG133928,ZOFENOPRILAT | PubChem CID:3034048 | CAS RN:75176-37-3 | UNII:4G4WDK2YBS | Zofenoprilat | DrugBank ID:DB08766 | PubChem SID:198970522
+BMGC_DG07045,BMG_DG133936,KAURENOIC ACID | PubChem SID:474491886 | CAS RN:6730-83-2 | PubChem CID:3034087 | UNII:D572D9R2TZ | Kaurenoic acid
+BMGC_DG07046,BMG_DG133987,methyl (E)-2-[2-[6-(2-cyanophenoxy)pyrimidin-4-yl]oxyphenyl]-3-methoxyprop-2-enoate | Azoxystrobin | PubChem CID:3034285 | PubChem SID:198981222 | CAS RN:131860-33-8 | DrugBank ID:DB07401 | CAS RN:215934-32-0 | AZOXYSTROBIN | UNII:NYH7Y08IPM
+BMGC_DG07047,BMG_DG133997,PubChem SID:175266783 | GLUCOSAMINE | CAS RN:3416-24-8 | UNII:N08U5BOQ1K | PubChem CID:3034366
+BMGC_DG07048,BMG_DG134005,"[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-sulfanylidene-3H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate | Thioinosinic acid | PubChem SID:249491949 | UNII:76CK4YA5ZP | THIOINOSINIC ACID | CAS RN:53-83-8 | PubChem CID:3034391"
+BMGC_DG07049,BMG_DG134008,"PubChem SID:198941327 | methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate | MITRAGYNINE | Mitragynine | CAS RN:4098-40-2 | UNII:EP479K822J | PubChem CID:3034396"
+BMGC_DG07050,BMG_DG134045,"PubChem SID:376231546 | PubChem CID:3034525 | 1,3,6,9-TETRAHYDRO-1,3-DIMETHYL-8-(METHYLTHIO)-6-THIOXO-2H-PURIN-2-ONE | CAS RN:4791-34-8 | UNII:29H5UXZ2VK"
+BMGC_DG07051,BMG_DG134070,"PubChem SID:375579362 | CAS RN:6559-86-0 | 1,3,6,9-TETRAHYDRO-1,3-DIMETHYL-8-((2-(1-PYRROLIDINYL)ETHYL)THIO)-6-THIOXO-2H-PURIN-2-ONE | PubChem CID:3034554 | UNII:Z451PDS8P0"
+BMGC_DG07052,BMG_DG134096,"6-Thioguanosine monophosphate | 6-THIOGUANYLIC ACID | PubChem CID:3034646 | CAS RN:15867-02-4 | UNII:7Y3025NR1U | PubChem SID:376072923 | [(2R,3S,4R,5R)-5-(2-amino-6-sulfanylidene-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate"
+BMGC_DG07053,BMG_DG134102,"PubChem CID:3034656 | L-(-)-Fucose | Elfucose | PubChem SID:198965172 | DrugBank ID:DB15236 | ELFUCOSE | (2S,3R,4R,5S)-2,3,4,5-tetrahydroxyhexanal | UNII:28RYY2IV3F | CAS RN:2438-80-4"
+BMGC_DG07054,BMG_DG134114,"ANATOXIN A | 1-[(1R,6R)-9-azabicyclo[4.2.1]non-2-en-2-yl]ethanone | Anatoxin A | PubChem CID:3034748 | UNII:80023A73NK | CAS RN:64285-06-9 | PubChem SID:198954141"
+BMGC_DG07055,BMG_DG134118,"PubChem CID:3034756 | CAS RN:67346-48-9 | CAS RN:73573-87-2 | (S,S)-Formoterol | N-[2-hydroxy-5-[(1S)-1-hydroxy-2-[[(2S)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide"
+BMGC_DG07056,BMG_DG134128,Glucose-6-Phosphate | PubChem CID:3034794 | DrugBank ID:DB03581
+BMGC_DG07057,BMG_DG134134,"MR 2266 | PubChem CID:3034816 | (1R,9R,13R)-1,13-diethyl-10-(furan-3-ylmethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | CAS RN:56649-76-4"
+BMGC_DG07058,BMG_DG134147,"VAMOROLONE | UNII:8XP29XMB43 | (8S,10S,13S,14S,16R,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one | Vamorolone | CAS RN:13209-41-1 | DrugBank ID:DB15114 | PubChem SID:198962400 | PubChem CID:3035000"
+BMGC_DG07059,BMG_DG134149,"UNII:P8E807JA4N | PubChem CID:3035008 | PubChem SID:316909915 | 2,3-DIHYDRO-2,3-DIHYDROXYAFLATOXIN B1 | CAS RN:50668-79-6"
+BMGC_DG07060,BMG_DG134151,"AMRUBICIN | UNII:93N13LB4Z2 | DrugBank ID:DB06263 | (7S,9S)-9-acetyl-9-amino-7-[(2S,4S,5R)-4,5-dihydroxyoxan-2-yl]oxy-6,11-dihydroxy-8,10-dihydro-7H-tetracene-5,12-dione | CAS RN:110267-81-7 | PubChem SID:198947162 | PubChem CID:3035016 | Amrubicin"
+BMGC_DG07061,BMG_DG134153,"PubChem CID:3035026 | CAS RN:360-65-6 | GLYCODEOXYCHOLIC ACID | UNII:DS124M0828 | PubChem SID:312525034 | 2-[[(4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid | CAS RN:16409-34-0 | Glycodeoxycholic Acid"
+BMGC_DG07062,BMG_DG134172,CAS RN:110503-62-3 | PubChem CID:3035198 | PubChem SID:316909166 | UNII:WTW99894I6 | 4-HYDROXYTOREMIFENE
+BMGC_DG07063,BMG_DG134178,BRASSININ | PubChem SID:381132615 | UNII:J2IBO1B8VH | CAS RN:105748-59-2 | PubChem CID:3035211 | Brassinin | methyl N-(1H-indol-3-ylmethyl)carbamodithioate
+BMGC_DG07064,BMG_DG134200,"PubChem CID:3035406 | N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-3-[(1R)-3-amino-1-hydroxypropyl]-21-[(2-aminoethyl)amino]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0^{9,13}]heptacosan-18-yl]-10,12-dimethyltetradecanamide | DrugBank ID:DB00520 | Caspofungin | N-[(3S,6S,9S,11R,15S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide"
+BMGC_DG07065,BMG_DG134205,"PubChem SID:198934898 | PubChem CID:3035433 | ASPERLICIN | UNII:U0MJE9LRXV | Asperlicin | (7S)-7-[[(2S,3aS,4S)-4-hydroxy-2-(2-methylpropyl)-1-oxo-3,3a-dihydro-2H-imidazo[1,2-a]indol-4-yl]methyl]-6,7-dihydroquinazolino[3,2-a][1,4]benzodiazepine-5,13-dione | CAS RN:93413-04-8"
+BMGC_DG07066,BMG_DG134208,"UNII:PDQ3ME68U3 | PubChem CID:3035442 | Amibegron | CAS RN:121524-08-1 | ethyl 2-[[(7S)-7-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]acetate | DrugBank ID:DB05395 | PubChem SID:198971673 | AMIBEGRON"
+BMGC_DG07067,BMG_DG134217,PubChem SID:441658721 | PubChem CID:3035462 | UNII:5WMS4GA67M | HYMENIALDISINE | CAS RN:82005-12-7
+BMGC_DG07068,BMG_DG134224,PubChem CID:3035604 | 7-phenylmethoxyquinoline | CAS RN:131802-60-3 | 7-Benzyloxyquinoline
+BMGC_DG07069,BMG_DG134225,4-phenyl-1-(4-phenylbutyl)piperidine | PubChem SID:472422894 | CAS RN:136534-70-8 | UNII:HDL2DSB8CH | PubChem CID:3035672 | 4-PHENYL-1-(4-PHENYLBUTYL)PIPERIDINE
+BMGC_DG07070,BMG_DG134234,CAS RN:857447-92-8 | Abt-751 | N-[2-(4-hydroxyanilino)pyridin-3-yl]-4-methoxybenzenesulfonamide | CAS RN:141430-65-1 | PubChem CID:3035714 | ABT-751 | DrugBank ID:DB12254 | PubChem SID:198989698 | UNII:WDT5V5OB9F
+BMGC_DG07071,BMG_DG134235,PubChem CID:3035746 | UNII:3SH45L9H3Z | Iodophenpropit | CAS RN:143407-29-8 | 3-(1H-imidazol-5-yl)propyl N'-[2-(4-iodophenyl)ethyl]carbamimidothioate | PubChem SID:198954508 | IODOPHENPROPIT | CAS RN:145196-88-9
+BMGC_DG07072,BMG_DG134236,CAS RN:146537-07-7 | PubChem CID:3035776 | PubChem SID:198947711 | WIN-33377 | UNII:21E5KLJ2ZB
+BMGC_DG07073,BMG_DG134238,"PubChem CID:3035817 | UNII:IV7H45AM5B | K-252a | DrugBank ID:DB02152 | K252A | CAS RN:99533-80-9 | Antibiotic K 252a | methyl (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylate | PubChem SID:198974133"
+BMGC_DG07074,BMG_DG134240,PubChem CID:3035842 | CAS RN:151070-83-6 | UNII:PZS44KB9KC | IMMEPIP | PubChem SID:472423295
+BMGC_DG07075,BMG_DG134242,"NAMODENOSON | CAS RN:163042-96-4 | Namodenoson | Chloro-IB-MECA | PubChem CID:3035850 | DrugBank ID:DB12885 | (2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide | PubChem SID:198987487 | UNII:Z07JR07J6C"
+BMGC_DG07076,BMG_DG134245,Thioperamide | CAS RN:106243-16-7 | PubChem SID:198982124 | PubChem CID:3035905 | UNII:II4319BWUI | THIOPERAMIDE | N-cyclohexyl-4-(1H-imidazol-5-yl)piperidine-1-carbothioamide
+BMGC_DG07077,BMG_DG134249,"CLOFENOTANE | 1-chloro-4-[2,2,2-trichloro-1-(4-chlorophenyl)ethyl]benzene | PubChem SID:198939385 | PubChem CID:3036 | UNII:CIW5S16655 | DrugBank ID:DB13424 | Clofenotane | CAS RN:50-29-3"
+BMGC_DG07078,BMG_DG134255,CAS RN:179120-92-4 | PubChem SID:198965301 | UNII:RJ9V9V09VM | PubChem CID:3036156 | ALTINICLINE
+BMGC_DG07079,BMG_DG134256,"N,N-Didesmethyl Tamoxifen | PubChem SID:474492431 | UNII:LHP6JE56UZ | N,N-DIDESMETHYL TAMOXIFEN | CAS RN:80234-20-4 | Desdimethyltamoxifen | PubChem CID:3036172 | 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]ethanamine"
+BMGC_DG07080,BMG_DG134259,"ALAZOCINE, (+)- | CAS RN:58640-82-7 | PubChem CID:3036222 | UNII:YR49MN7Q8G | PubChem SID:441331336"
+BMGC_DG07081,BMG_DG134276,"PubChem SID:472388031 | 2-(3,4-dichlorophenyl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide | 3,4-dichloro-n-methyl-n-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-isomer | U-50488 | PubChem CID:3036289 | CAS RN:67198-13-4 | UNII:39K8JHE8XN"
+BMGC_DG07082,BMG_DG134289,"PubChem CID:3036505 | OSPEMIFENE | 2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]ethanol | NDC:59630-580 | CAS RN:128607-22-7 | DrugBank ID:DB04938 | NDC:55494-580 | UNII:B0P231ILBK | PubChem SID:175267362 | Ospemifene"
+BMGC_DG07083,BMG_DG134298,"UNII:E6X4UJ2JN6 | CAS RN:97151-02-5 | PubChem CID:3036580 | alpha-Hydroxytamoxifen | (E)-4-[4-[2-(dimethylamino)ethoxy]phenyl]-3,4-diphenylbut-3-en-2-ol | .ALPHA.-HYDROXYTAMOXIFEN"
+BMGC_DG07084,BMG_DG134307,"PubChem SID:198975988 | PubChem CID:3036703 | ZOSUQUIDAR | Zosuquidar | (2R)-1-[4-[(2R,4S)-3,3-difluoro-11-tetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaenyl]piperazin-1-yl]-3-quinolin-5-yloxypropan-2-ol | UNII:AB5K82X98Y | CAS RN:167354-41-8 | DrugBank ID:DB06191"
+BMGC_DG07085,BMG_DG134313,PubChem CID:3036746 | (S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol | Quinact
+BMGC_DG07086,BMG_DG134315,"PubChem CID:3036760 | CAS RN:71942-12-6 | 2-bromo-7-oxabicyclo[4.1.0]hepta-2,4-diene | Bromobenzene-2,3-oxide"
+BMGC_DG07087,BMG_DG134316,"PubChem CID:3036780 | (2R,6R)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene | CAS RN:65576-45-6 | CAS RN:65576-39-8 | (R,R)-asenapine"
+BMGC_DG07088,BMG_DG134319,UNII:UGT5535REQ | PubChem CID:3036864 | CAS RN:87075-17-0 | PubChem SID:198967178 | SCH-23390
+BMGC_DG07089,BMG_DG134324,"CAS RN:27067-77-2 | PubChem CID:3036905 | CAS RN:34717-03-8 | magnesium;2,4-dioxo-1H-pyrimidine-6-carboxylate | PubChem SID:175267294 | DrugBank ID:DB13786 | Magnesium orotate | MAGNESIUM OROTATE | Magnesium Orotate | UNII:GI96W46M5A"
+BMGC_DG07090,BMG_DG134327,"(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(2,2,2-trichloroethoxy)oxane-2-carboxylic acid | PubChem CID:3036914 | UNII:QQK44OGN65 | Urochloralic acid | PubChem SID:198987813 | UROCHLORALIC ACID | CAS RN:97-25-6"
+BMGC_DG07091,BMG_DG134332,"[[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-sulfanylidene-3H-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | PubChem CID:3036942 | 6-Mercaptopurine ribonucleoside triphosphate | CAS RN:27652-34-2"
+BMGC_DG07092,BMG_DG134333,UNII:QRE9D4HPH8 | CAS RN:29472-77-3 | PubChem SID:459275403 | PubChem CID:3036945 | GAMBIRINE
+BMGC_DG07093,BMG_DG134339,CAS RN:1322-43-6 | PubChem SID:198938900 | Dichlorophene | CAS RN:97-23-4 | DICHLOROPHEN | UNII:T1J0JOU64O | PubChem CID:3037 | 4-chloro-2-[(5-chloro-2-hydroxyphenyl)methyl]phenol | DrugBank ID:DB11396
+BMGC_DG07094,BMG_DG134344,DrugBank ID:DB01440 | PubChem CID:3037032 | CAS RN:1320-61-2 | 4-hydroxybutanoate | gamma-Hydroxybutyric acid | 4-Hydroxybutanoate
+BMGC_DG07095,BMG_DG134385,"PubChem CID:3037206 | PubChem SID:198940546 | CAS RN:52093-21-7 | DrugBank ID:DB13274 | Micronomicin | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(methylaminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol | MICRONOMICIN | UNII:S9AZ0R40QV"
+BMGC_DG07096,BMG_DG134386,"UNII:G7K224460P | DrugBank ID:DB13540 | Isepamicin | PubChem CID:3037209 | ISEPAMICIN | CAS RN:58152-03-7 | PubChem SID:198938127 | (2S)-3-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxypropanamide"
+BMGC_DG07097,BMG_DG134391,"PubChem CID:3037233 | Ifetroban | UNII:E833KT807K | PubChem SID:198946718 | 3-[2-[[(1S,2R,3S,4R)-3-[4-(pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]heptan-2-yl]methyl]phenyl]propanoic acid | CAS RN:143443-90-7 | IFETROBAN | DrugBank ID:DB12321"
+BMGC_DG07098,BMG_DG134392,"UNII:5153M06QEA | DrugBank ID:DB01187 | CAS RN:1320-11-2 | PubChem CID:3037234 | PubChem SID:198987166 | Iophendylate | CAS RN:2517967-66-5 | ethyl 10-(2-iodophenyl)undecanoate | BENZENEDECANOIC ACID, 2-IODO-.IOTA.-METHYL-, ETHYL ESTER | Ethyl 10-(2-iodophenyl)undecanoate"
+BMGC_DG07099,BMG_DG134397,CAS RN:183849-43-6 | UNII:40755Z8956 | PubChem SID:198977652 | ABAPERIDONE | PubChem CID:3037308
+BMGC_DG07100,BMG_DG134405,"CAS RN:26566-61-0 | (2R,3S,4S,5R)-2,3,4,5,6-pentahydroxyhexanal | DrugBank ID:DB11735 | PubChem CID:3037556 | CAS RN:59-23-4 | UNII:X2RN3Q8DNE | PubChem SID:175265817 | Galactose | GALACTOSE"
+BMGC_DG07101,BMG_DG134407,"(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal | PubChem SID:384436217 | ANHYDROUS LACTOSE | UNII:3SY5LH9PMK | CAS RN:63-42-3 | PubChem CID:3037558 | Lactose, anhydrous"
+BMGC_DG07102,BMG_DG134408,UNII:XTZ5NBR55T | PubChem CID:3037565 | DARUTIGENOL | PubChem SID:474489881 | CAS RN:5940-00-1
+BMGC_DG07103,BMG_DG134410,"PubChem CID:3037617 | UNII:3KG76X4KJK | DrugBank ID:DB04851 | Biricodar | 1,7-dipyridin-3-ylheptan-4-yl (2S)-1-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate | BIRICODAR | CAS RN:159997-94-1 | PubChem SID:198959360"
+BMGC_DG07104,BMG_DG134412,UNII:YLG43M4U5V | CAS RN:4697-66-9 | PubChem CID:3037629 | PubChem SID:438787847 | PAYNANTHEINE
+BMGC_DG07105,BMG_DG134413,"Methenolone | METHENOLONE | PubChem CID:3037705 | DrugBank ID:DB13710 | UNII:9062ZT8Q5C | PubChem SID:198949869 | CAS RN:153-00-4 | (5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-1,10,13-trimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG07106,BMG_DG134419,"CAS RN:7021-52-5 | PubChem CID:3037883 | [(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-methyl-6-sulfanylidene-3H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate | 6-Methylthiopurine ribonucleoside-5'-phosphate"
+BMGC_DG07107,BMG_DG134420,CAS RN:7729-23-9 | UNII:W596OF93C7 | PubChem SID:251965481 | HIRSUTINE | PubChem CID:3037884
+BMGC_DG07108,BMG_DG134421,"(1R,9S,13R)-1,10,13-trimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | Methobenzmorphan | PubChem CID:3037886"
+BMGC_DG07109,BMG_DG134422,"DIMEMORFAN | PubChem SID:198948216 | DrugBank ID:DB13810 | (1S,9S,10S)-4,17-dimethyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene | CAS RN:36309-01-0 | UNII:623OAC38YU | Dimemorfan | CAS RN:36304-82-2 | PubChem CID:3037918"
+BMGC_DG07110,BMG_DG134424,"CYCLAZOCINE, (-)- | CAS RN:7313-86-2 | PubChem CID:3037926 | UNII:RY2XTW4OJO | PubChem SID:363909846"
+BMGC_DG07111,BMG_DG134432,CAS RN:32988-50-4 | DrugBank ID:DB06827 | VIOMYCIN | PubChem SID:198939760 | Viomycin | PubChem CID:3037981 | UNII:YVU35998K5
+BMGC_DG07112,BMG_DG134436,"Diclofenamide | NDC:71090-001 | NDC:72065-001 | NDC:70709-085 | DICHLORPHENAMIDE | DrugBank ID:DB01144 | UNII:VVJ6673MHY | 4,5-dichlorobenzene-1,3-disulfonamide | PubChem CID:3038 | NDC:13668-676 | Dichlorphenamide | PubChem SID:175265467 | CAS RN:120-97-8"
+BMGC_DG07113,BMG_DG134476,"N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]naphthalene-2-carboxamide | 2-Naphthalenecarboxamide, N-(4-(4-(2-methoxyphenyl)-1-piperazinyl)butyl)- | PubChem CID:3038495 | DO-687 | CAS RN:192384-87-5 | UNII:2FVL90IM8I | PubChem SID:198955573"
+BMGC_DG07114,BMG_DG134477,"Fospropofol Disodium | UNII:30868AY0IF | PubChem SID:175266449 | CAS RN:258516-87-9 | PubChem CID:3038497 | disodium;[2,6-di(propan-2-yl)phenoxy]methyl phosphate | FOSPROPOFOL DISODIUM"
+BMGC_DG07115,BMG_DG134478,"Fospropofol | PubChem SID:175268607 | FOSPROPOFOL | DrugBank ID:DB06716 | PubChem CID:3038498 | UNII:LZ257RZP7K | [2,6-di(propan-2-yl)phenoxy]methyl dihydrogen phosphate | CAS RN:258516-89-1"
+BMGC_DG07116,BMG_DG134480,"L-796568 free base | CAS RN:211031-01-5 | MK-0634 FREE BASE | PubChem CID:3038500 | UNII:P50A5YTO0O | N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-4-[4-[4-(trifluoromethyl)phenyl]-1,3-thiazol-2-yl]benzenesulfonamide | PubChem SID:198987067"
+BMGC_DG07117,BMG_DG134484,"PubChem CID:3038505 | DAGLUTRIL | CAS RN:182821-27-8 | Daglutril | DrugBank ID:DB05796 | 2-[(3S)-3-[[1-[(2R)-2-ethoxycarbonyl-4-phenylbutyl]cyclopentanecarbonyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid | UNII:KKV299446X | PubChem SID:198965767"
+BMGC_DG07118,BMG_DG134485,"OPC-51803 | 2-[(5R)-1-(2-chloro-4-pyrrolidin-1-ylbenzoyl)-2,3,4,5-tetrahydro-1-benzazepin-5-yl]-N-propan-2-ylacetamide | PubChem CID:3038506 | Opc-51803 | PubChem SID:438788676 | UNII:1IGV6WTK9I | CAS RN:192514-54-8 | DrugBank ID:DB05838"
+BMGC_DG07119,BMG_DG134487,"SUFUGOLIX | UNII:56S17Z6X9M | CAS RN:308831-61-0 | PubChem CID:3038517 | DrugBank ID:DB06494 | Sufugolix | PubChem SID:198985490 | 1-[4-[5-[[benzyl(methyl)amino]methyl]-1-[(2,6-difluorophenyl)methyl]-2,4-dioxo-3-phenylthieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea"
+BMGC_DG07120,BMG_DG134490,4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide | PubChem CID:3038522 | CAS RN:387867-13-2 | CAS RN:1227636-17-0 | PubChem SID:198955979 | Tandutinib | DrugBank ID:DB05465 | UNII:E1IO3ICJ9A | TANDUTINIB
+BMGC_DG07121,BMG_DG134491,"CAS RN:209410-46-8 | PubChem CID:3038525 | Neflamapimod | PubChem SID:198935707 | NEFLAMAPIMOD | DrugBank ID:DB07138 | 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyrimido[1,6-b]pyridazin-6-one | UNII:TYL52QM320"
+BMGC_DG07122,BMG_DG134501,"DICHLORVOS | DrugBank ID:DB11397 | UNII:7U370BPS14 | CAS RN:62-73-7 | PubChem CID:3039 | Dichlorvos | 2,2-dichloroethenyl dimethyl phosphate | PubChem SID:198969015"
+BMGC_DG07123,BMG_DG134514,PubChem SID:249492104 | N1-(2-HYDROXYETHYL)FLURAZEPAM | CAS RN:20971-53-3 | PubChem CID:30401 | UNII:2Z6WHH283E
+BMGC_DG07124,BMG_DG134538,"PubChem SID:316911252 | CAS RN:53758-22-8 | 3-METHYLFENTANYL, CIS- | (+)-cis-3-Methylfentanyl | UNII:9M8WAZ5Y3E | UNII:P57PR7Y64W | 3-METHYLFENTANYL, (3R,4S)- | PubChem CID:3041260 | CAS RN:78995-19-4 | PubChem SID:312524814 | N-[(3R,4S)-3-methyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylpropanamide"
+BMGC_DG07125,BMG_DG134554,DrugBank ID:DB00804 | Dicyclomine | CAS RN:104959-55-9 | DICYCLOMINE | UNII:4KV4X8IF6V | PubChem SID:175265454 | PubChem CID:3042 | 2-(diethylamino)ethyl 1-cyclohexylcyclohexane-1-carboxylate | CAS RN:77-19-0
+BMGC_DG07126,BMG_DG134612,"CAS RN:69839-83-4 | Didox | DIDOX | DrugBank ID:DB12948 | N,3,4-trihydroxybenzamide | PubChem CID:3045 | UNII:L106XFV0RQ | PubChem SID:198958009"
+BMGC_DG07127,BMG_DG134613,UNII:VTV38S7D39 | YM-348 | PubChem SID:474492372 | PubChem CID:3045225 | CAS RN:372163-84-3
+BMGC_DG07128,BMG_DG134614,RO -60-0175 FREE BASE | UNII:A74GH2T4WD | PubChem CID:3045227 | CAS RN:169675-08-5
+BMGC_DG07129,BMG_DG134637,"PubChem CID:3045401 | LUSAPERIDONE | PubChem SID:198974457 | UNII:5KTD2O86CB | Lusaperidone | CAS RN:214548-46-6 | 3-[2-(3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)ethyl]-2-methylpyrido[1,2-a]pyrimidin-4-one"
+BMGC_DG07130,BMG_DG134650,PubChem SID:459055938 | CAS RN:61035-04-9 | UNII:GN32P32RPI | 2-PYRROLIDIN-1-YLBENZO(H)CHROMEN-4-ONE | PubChem CID:3045696
+BMGC_DG07131,BMG_DG134657,"(2R)-1-(1,3-benzodioxol-5-yl)propan-2-amine | UNII:M3P34V176U | CAS RN:61614-60-6 | PubChem SID:198975669 | (R)-alpha-Methyl-1,3-benzodioxole-5-ethanamine | TENAMFETAMINE, (R)- | PubChem CID:3046161"
+BMGC_DG07132,BMG_DG134669,"PubChem CID:3047246 | CAS RN:63094-33-7 | PubChem SID:249492250 | 2-METHYL-11-OXO-11H-PYRIDO(2,1-B)QUINAZOLINE-8-CARBOXYLIC ACID | UNII:KR595247MT"
+BMGC_DG07133,BMG_DG134672,"PubChem CID:3047299 | 1-PROPANONE, 2-((1,1-DIMETHYLETHYL)AMINO)-1-PHENYL- | 2-(TERT-BUTYLAMINO)PROPIOPHENONE | UNII:5RQB4CW0AJ | PubChem SID:461434691 | CAS RN:34509-36-9"
+BMGC_DG07134,BMG_DG134676,PubChem CID:3047716 | UNII:2027T69J24 | METESIND | PubChem SID:198947741 | CAS RN:138384-68-6
+BMGC_DG07135,BMG_DG134706,"PubChem SID:198957317 | DrugBank ID:DB13239 | CAS RN:99453-84-6 | N-[2,4-dibromo-6-[[(4-hydroxycyclohexyl)amino]methyl]phenyl]thiophene-2-carboxamide | PubChem CID:3047787 | NELTENEXINE | Neltenexine | UNII:U942DGM90X"
+BMGC_DG07136,BMG_DG134707,"NEPINALONE | PubChem SID:198949726 | Nepinalone | 1-methyl-1-(2-piperidin-1-ylethyl)-3,4-dihydronaphthalen-2-one | CAS RN:22443-11-4 | DrugBank ID:DB13445 | UNII:L9806LPR7G | PubChem CID:3047788"
+BMGC_DG07137,BMG_DG134722,PANAMESINE | CAS RN:139225-22-2 | PubChem CID:3047810 | UNII:023D9E916L | PubChem SID:198954309
+BMGC_DG07138,BMG_DG134761,"1,3-DIISOBUTYLXANTHINE | UNII:369S55T7DX | CAS RN:63908-24-7 | PubChem CID:3048504 | PubChem SID:445500598"
+BMGC_DG07139,BMG_DG134762,"CAS RN:634-03-7 | PubChem CID:30487 | PubChem SID:175267540 | (2S,3S)-3,4-dimethyl-2-phenylmorpholine | PHENDIMETRAZINE | UNII:AB2794W8KV | Phendimetrazine | DrugBank ID:DB01579"
+BMGC_DG07140,BMG_DG134770,CAS RN:62-49-7 | DrugBank ID:DB00122 | 2-hydroxyethyl(trimethyl)azanium | Choline | PubChem SID:175267761 | UNII:N91BDP6H0X | CHOLINE | PubChem CID:305
+BMGC_DG07141,BMG_DG134772,"TENAMFETAMINE, (S)- | UNII:940U7323I4 | CAS RN:65620-66-8 | (2S)-1-(1,3-benzodioxol-5-yl)propan-2-amine | PubChem SID:198959900 | PubChem CID:3050061 | (S)-alpha-Methyl-1,3-benzodioxole-5-ethanamine"
+BMGC_DG07142,BMG_DG134796,"CAS RN:90-89-1 | PubChem CID:3052 | Diethylcarbamazine | DrugBank ID:DB00711 | UNII:V867Q8X3ZD | DIETHYLCARBAMAZINE | N,N-diethyl-4-methylpiperazine-1-carboxamide | PubChem SID:175268777"
+BMGC_DG07143,BMG_DG134799,"PubChem SID:316918664 | 5-HYDROXYDICLOFENAC | PubChem CID:3052566 | UNII:GS38436703 | CAS RN:69002-84-2 | 5-Hydroxydiclofenac | 2-[2-(2,6-dichloroanilino)-5-hydroxyphenyl]acetic acid"
+BMGC_DG07144,BMG_DG134800,"4',5-Dihydroxydiclofenac | CAS RN:69002-86-4 | PubChem SID:316917881 | PubChem CID:3052567 | 2-[2-(2,6-dichloro-4-hydroxyanilino)-5-hydroxyphenyl]acetic acid | UNII:6US4Q8M8J7 | 4',5-DIHYDROXYDICLOFENAC"
+BMGC_DG07145,BMG_DG134802,"PubChem SID:198942073 | DrugBank ID:DB06480 | PRUCALOPRIDE | CAS RN:179474-81-8 | 4-amino-5-chloro-N-[1-(3-methoxypropyl)piperidin-4-yl]-2,3-dihydro-1-benzofuran-7-carboxamide | UNII:0A09IUW5TP | Prucalopride | PubChem CID:3052762"
+BMGC_DG07146,BMG_DG134811,"methanesulfonic acid;(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine | NDC:42291-780 | NDC:23155-746 | NDC:33342-309 | NDC:62135-676 | NDC:16714-770 | CAS RN:161735-79-1 | PubChem CID:3052775 | NDC:68546-142 | NDC:0093-3060 | NDC:47781-683 | NDC:62135-677 | NDC:68546-229 | NDC:33342-308 | NDC:67877-259 | NDC:42571-220 | UNII:LH8C2JI290 | NDC:72162-2383 | RASAGILINE MESYLATE | NDC:42571-221 | NDC:47781-690 | PubChem SID:175266782 | NDC:16714-771 | NDC:67877-260 | NDC:0093-3061 | Rasagiline Mesylate | NDC:23155-747"
+BMGC_DG07147,BMG_DG134812,"CAS RN:136236-51-6 | CAS RN:1204184-69-9 | (1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine | RASAGILINE | Rasagiline | UNII:003N66TS6T | PubChem SID:175267772 | DrugBank ID:DB01367 | PubChem CID:3052776"
+BMGC_DG07148,BMG_DG134814,DrugBank ID:DB04917 | PubChem CID:3052778 | UNII:RDZ4A6N5U9 | Renzapride | CAS RN:1347281-05-3 | 4-AMINO-N-1-AZABICYCLO(3.3.1)NON-4-YL-3-CHLORO-2-METHOXYBENZAMIDE | PubChem SID:384436194
+BMGC_DG07149,BMG_DG134818,DrugBank ID:DB14007 | NDC:65174-288 | UNII:7A314HQM0I | CAS RN:67-43-6 | PubChem CID:3053 | PENTETIC ACID | Pentetic Acid | 2-[bis[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid | CAS RN:1004765-76-7 | PubChem SID:175268066
+BMGC_DG07150,BMG_DG134823,PubChem CID:3053755 | Lortalamine | DrugBank ID:DB09187
+BMGC_DG07151,BMG_DG134825,Diethylstilbestrol | PubChem CID:3054 | 4-[4-(4-Hydroxyphenyl)hex-3-en-3-yl]phenol | 4-[4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol | CAS RN:6898-97-1 | DrugBank ID:DB00255
+BMGC_DG07152,BMG_DG134826,NDC:0363-0926 | CAS RN:21245-02-3 | Padimate O | PubChem CID:30541 | PubChem SID:175272064 | DrugBank ID:DB11570 | UNII:Z11006CMUZ | 2-ethylhexyl 4-(dimethylamino)benzoate | NDC:71014-025 | NDC:66990-1019 | PADIMATE O
+BMGC_DG07153,BMG_DG134836,UNII:6IO4IG518S | PubChem CID:3054741 | CAS RN:36292-69-0 | KETAZOCINE | PubChem SID:198938901
+BMGC_DG07154,BMG_DG134839,"PubChem CID:3055 | 1,1-diphenyl-4-piperidin-1-ylbutan-1-ol | PubChem SID:198939879 | Diphenidol | DIPHENIDOL | DrugBank ID:DB01231 | CAS RN:19-11-4 | CAS RN:972-02-1 | UNII:NQO8R319LY"
+BMGC_DG07155,BMG_DG134841,"5-[[4-[(6-methoxy-1-methylbenzimidazol-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | CAS RN:185428-18-6 | Rivoglitazone | PubChem CID:3055168 | UNII:3A3N0634Q6 | PubChem SID:198967821 | RIVOGLITAZONE | DrugBank ID:DB09200"
+BMGC_DG07156,BMG_DG134842,"Robalzotan | UNII:I18M56OGME | PubChem SID:198970138 | PubChem CID:3055171 | CAS RN:169758-66-1 | (3R)-3-[di(cyclobutyl)amino]-8-fluoro-3,4-dihydro-2H-chromene-5-carboxamide | DrugBank ID:DB06538 | ROBALZOTAN"
+BMGC_DG07157,BMG_DG134875,"4,5-DICHLOROTHIOPHENE-2-CARBOXYLIC ACID | CAS RN:31166-29-7 | UNII:LUT5N3337G | PubChem SID:485665956 | 4,5-Dichlorothiophene-2-carboxylic acid | PubChem CID:305687"
+BMGC_DG07158,BMG_DG134912,SARIPIDEM | PubChem CID:3058746 | UNII:0J6174G60N | CAS RN:103844-86-6 | PubChem SID:198986032
+BMGC_DG07159,BMG_DG134916,DrugBank ID:DB06731 | CAS RN:126924-38-7 | PubChem CID:3058751 | (3S)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | PubChem SID:198957502 | SEPROXETINE | Seproxetine | UNII:25CO3X0R31
+BMGC_DG07160,BMG_DG134918,UNII:VX29JB5XWV | PubChem SID:175267489 | DERACOXIB | CAS RN:169590-41-4 | DrugBank ID:DB11395 | PubChem CID:3058754 | 4-[3-(difluoromethyl)-5-(3-fluoro-4-methoxyphenyl)pyrazol-1-yl]benzenesulfonamide | Deracoxib
+BMGC_DG07161,BMG_DG134919,"NDC:74157-009 | NDC:14539-673 | NDC:74157-101 | CAS RN:1286107-99-0 | 5-(2,4-difluorophenyl)-2-hydroxybenzoic acid | DIFLUNISAL | UNII:7C546U4DEN | PubChem SID:175267083 | Diflunisal | CAS RN:22494-42-4 | NDC:0093-9222 | NDC:62135-456 | NDC:68382-530 | NDC:70771-1083 | DrugBank ID:DB00861 | PubChem CID:3059"
+BMGC_DG07162,BMG_DG134946,"PubChem SID:363909089 | UNII:YI7IFA9P4W | 1,2,3,4-TETRAHYDRO-2-METHYL-1,3-DIOXO-4-ISOQUINOLINE CARBOXANILIDE | CAS RN:21389-75-3 | PubChem CID:30611"
+BMGC_DG07163,BMG_DG134957,"Razoxane | PubChem SID:198945774 | UNII:5AR83PR647 | CAS RN:21416-87-5 | PubChem CID:30623 | CAS RN:21416-67-1 | 4-[2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione | RAZOXANE"
+BMGC_DG07164,BMG_DG134958,"CAS RN:302962-49-8 | DrugBank ID:DB01254 | PubChem CID:3062316 | Dasatinib | DASATINIB ANHYDROUS | N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide | PubChem SID:175268213 | UNII:X78UG0A0RN"
+BMGC_DG07165,BMG_DG134965,PubChem SID:472408668 | VUF-8430 | PubChem CID:3063228 | UNII:XL2Z3NH23V | CAS RN:98021-17-1
+BMGC_DG07166,BMG_DG134977,Hydroxyfasudil | PubChem SID:438788087 | DrugBank ID:DB04707 | CAS RN:105628-72-6 | UNII:EYH4AU7P63 | PubChem CID:3064778 | HYDROXYFASUDIL
+BMGC_DG07167,BMG_DG134982,"Dihydroegotamine | PubChem CID:3066 | N-(7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide"
+BMGC_DG07168,BMG_DG134989,"DrugBank ID:DB04948 | PubChem CID:30668 | 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole | Lofexidine | PubChem SID:198938595 | CAS RN:31036-80-3 | LOFEXIDINE | UNII:UI82K0T627"
+BMGC_DG07169,BMG_DG134996,"Emetine dihydrochloride | PubChem CID:3068143 | EMETINE HYDROCHLORIDE | UNII:U52OG12P96 | CAS RN:83029-37-2 | (2S,3R,11bS)-2-[[(1R)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl]-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine;dihydrochloride | CAS RN:316-42-7 | PubChem SID:198980732"
+BMGC_DG07170,BMG_DG135015,"Cefapirin | DrugBank ID:DB01139 | CAS RN:21593-23-7 | PubChem CID:30699 | Cephapirin | (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-pyridin-4-ylsulfanylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem SID:175266904 | CEPHAPIRIN | UNII:89B59H32VN"
+BMGC_DG07171,BMG_DG135041,"DrugBank ID:DB11875 | 3-(1H-indol-3-ylmethyl)-1H-indole | PubChem CID:3071 | UNII:SSZ9HQT61Z | NDC:43742-1590 | NDC:43742-2184 | 3,3'-DIINDOLYLMETHANE | 3,3'-diindolylmethane | 3,3'-Diindolylmethane | CAS RN:1968-05-4 | PubChem SID:198940703"
+BMGC_DG07172,BMG_DG135059,Diisopropyl methylphosphonate | DrugBank ID:DB02127 | CAS RN:1445-75-6 | DIISOPROPYL METHYLPHOSPHONATE | PubChem SID:198952254 | UNII:56V3OG5DC7 | PubChem CID:3073 | 2-[methyl(propan-2-yloxy)phosphoryl]oxypropane
+BMGC_DG07173,BMG_DG135064,"CAS RN:152378-30-8 | (1S,2S,4R)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane | PubChem CID:3073763 | (+)-Epibatidine"
+BMGC_DG07174,BMG_DG135066,"DrugBank ID:DB13715 | PubChem CID:3074 | UNII:F8KLC2BD5Z | PubChem SID:198939262 | 3-[4-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]-1,4-diazepan-1-yl]propyl 3,4,5-trimethoxybenzoate | CAS RN:35898-87-4 | Dilazep | DILAZEP"
+BMGC_DG07175,BMG_DG135074,UNII:F1043V1890 | PubChem CID:3074858 | CAS RN:154154-90-2 | N-DEETHYLDORZOLAMIDE | PubChem SID:198970090
+BMGC_DG07176,BMG_DG135075,"PubChem SID:175266528 | Fludarabine Phosphate | NDC:59923-604 | NDC:0480-9772 | PubChem CID:30751 | NDC:25021-242 | [(2R,3S,4S,5R)-5-(6-amino-2-fluoropurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | NDC:45963-609 | UNII:1X9VK9O1SC | CAS RN:75607-67-9 | NDC:63323-192 | FLUDARABINE PHOSPHATE | NDC:0527-1242"
+BMGC_DG07177,BMG_DG135078,PubChem CID:3075615 | CAS RN:189152-50-9 | N-[4-[2-(4-phenylpiperazin-1-yl)ethyl]cyclohexyl]pyrimidin-2-amine | trans-N-(4-(2-(4-Phenyl-1-piperazinyl)ethyl)cyclohexyl)-2-pyrimidinamine
+BMGC_DG07178,BMG_DG135081,PubChem SID:198960273 | CAS RN:198283-73-7 | TEBANICLINE | PubChem CID:3075702 | UNII:9KX8NKV538
+BMGC_DG07179,BMG_DG135086,"CAS RN:34933-06-7 | Dilacor XR | [5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate | PubChem CID:3076 | CAS RN:112259-41-3"
+BMGC_DG07180,BMG_DG135093,DrugBank ID:DB08986 | Etifoxine | PubChem CID:30768
+BMGC_DG07181,BMG_DG135095,UNII:ZZQ699148P | CAS RN:65119-89-3 | PubChem SID:198949187 | DIMAPRIT | 3-(dimethylamino)propyl carbamimidothioate | PubChem CID:3077 | Dimaprit
+BMGC_DG07182,BMG_DG135106,"CAS RN:121569-61-7 | PubChem CID:3078519 | Ucn-01 | (2S,3R,4R,6R,18S)-18-hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one"
+BMGC_DG07183,BMG_DG135114,"DIMERCAPROL | Dimercaprol | CAS RN:59-52-9 | UNII:0CPP32S55X | 2,3-bis(sulfanyl)propan-1-ol | PubChem SID:175271397 | DrugBank ID:DB06782 | PubChem CID:3080"
+BMGC_DG07184,BMG_DG135122,"CAS RN:516-59-6 | UNII:K215Y6L2TC | (5S,8R,9S,10S,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | Allopregnan-20alpha-ol-3-one | PubChem CID:3080558 | PubChem SID:198949776 | ALLOPREGNAN-20.ALPHA.-OL-3-ONE"
+BMGC_DG07185,BMG_DG135124,PubChem SID:474489571 | ASTERRIC ACID | UNII:J3Q23XL4KN | CAS RN:577-64-0 | PubChem CID:3080568
+BMGC_DG07186,BMG_DG135126,PubChem SID:441583905 | GLYCYL-L-LYSINE | UNII:SC93X84LZ9 | PubChem CID:3080576 | CAS RN:997-62-6
+BMGC_DG07187,BMG_DG135130,PubChem CID:3080594 | PubChem SID:198969882 | UNII:0GPW365VZ9 | 3-METHOXYACETAMINOPHEN | CAS RN:3251-55-6
+BMGC_DG07188,BMG_DG135136,PubChem CID:3080614 | CAS RN:5262-39-5 | N-(CARBOXYCARBONYL)GLYCINE | PubChem SID:249492186 | UNII:VVW38EB8YS
+BMGC_DG07189,BMG_DG135173,CAS RN:57413-43-1 | ethyl 2-phenyl-2-piperidin-2-ylacetate | Ethylphenidate | PubChem CID:3080846
+BMGC_DG07190,BMG_DG135175,PubChem CID:3080870 | CAS RN:60535-02-6 | Methionyltryptophan | (2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoic acid
+BMGC_DG07191,BMG_DG135177,"Estrofem | CAS RN:65296-29-9 | (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol;(8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol | PubChem CID:3080904"
+BMGC_DG07192,BMG_DG135190,"3beta,7alpha-Dihydroxy-5-cholestenoate | CAS RN:115538-84-6 | PubChem CID:3081084 | (6R)-6-[(3S,7S,8S,9S,10R,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid"
+BMGC_DG07193,BMG_DG135191,"(6R)-6-[(7R,8S,9S,10R,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-methylheptanoic acid | PubChem CID:3081085 | 7alpha-Hydroxy-3-oxo-4-cholestenoic acid | CAS RN:115538-85-7"
+BMGC_DG07194,BMG_DG135197,CAS RN:119229-65-1 | NERISPIRDINE | N-(3-fluoropyridin-4-yl)-3-methyl-N-propylindol-1-amine | UNII:G7M7YWO6CG | PubChem CID:3081185 | DrugBank ID:DB12714 | Nerispirdine | PubChem SID:198936657
+BMGC_DG07195,BMG_DG135204,"CAS RN:166981-13-1 | CT-2584 | DrugBank ID:DB13098 | 1-[11-(dodecylamino)-10-hydroxyundecyl]-3,7-dimethylpurine-2,6-dione | PubChem SID:198977421 | Ct-2584 | CAS RN:160944-05-8 | UNII:67E5N3R22H | PubChem CID:3081346"
+BMGC_DG07196,BMG_DG135207,PubChem CID:3081349 | UNII:14J2G0U3NQ | PubChem SID:198946334 | DrugBank ID:DB05817 | Laromustine | LAROMUSTINE | CAS RN:173424-77-6 | 1-[2-chloroethyl(methylsulfonyl)amino]-3-methyl-1-methylsulfonylurea
+BMGC_DG07197,BMG_DG135209,PubChem CID:3081361 | NDC:58468-7840 | CAS RN:443913-73-3 | DrugBank ID:DB05294 | NDC:58468-7820 | VANDETANIB | UNII:YO460OQ37K | CAS RN:338992-00-0 | PubChem SID:175268485 | Vandetanib | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine
+BMGC_DG07198,BMG_DG135210,"DrugBank ID:DB06402 | Telavancin | UNII:XK134822Z0 | PubChem CID:3081362 | CAS RN:372151-71-8 | TELAVANCIN | PubChem SID:175266514 | (1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-5,15-dichloro-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-[2-(decylamino)ethylamino]-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,18,32,35,37-pentahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-36-[(phosphonomethylamino)methyl]-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid"
+BMGC_DG07199,BMG_DG135215,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoic acid | Angiotensin I | UNII:9C880YQG7C | PubChem CID:3081372 | ANGIOTENSIN I | CAS RN:9041-90-1 | PubChem SID:375086201 | CAS RN:484-42-4"
+BMGC_DG07200,BMG_DG135218,"Glutaryl-coa | GLUTARYL-COA | CAS RN:3131-84-8 | UNII:UB84B82P7Y | PubChem CID:3081383 | Glutaryl-CoA | PubChem SID:474492396 | 5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-5-oxopentanoic acid | CAS RN:103192-48-9"
+BMGC_DG07201,BMG_DG135219,"6-Thioxanthine 5'-monophosphate | CAS RN:3237-49-8 | [(2R,3S,4R,5R)-3,4-dihydroxy-5-(2-oxo-6-sulfanylidene-3H-purin-9-yl)oxolan-2-yl]methyl dihydrogen phosphate | PubChem CID:3081384"
+BMGC_DG07202,BMG_DG135229,PubChem SID:363908953 | UNII:T1LWN33J2P | 21-Desacetyldeflazacort | PubChem CID:3081431 | 21-DESACETYLDEFLAZACORT | CAS RN:13649-57-5
+BMGC_DG07203,BMG_DG135238,"Apramycin | UNII:388K3TR36Z | (2R,3R,4S,5S,6S)-2-[[(2R,3S,4R,4aR,6S,7R,8aS)-7-amino-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-4-hydroxy-3-(methylamino)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-2-yl]oxy]-5-amino-6-(hydroxymethyl)oxane-3,4-diol | DrugBank ID:DB04626 | CAS RN:37321-09-8 | PubChem SID:198985346 | PubChem CID:3081545 | APRAMYCIN"
+BMGC_DG07204,BMG_DG135251,"PubChem CID:3081832 | (2S,3R)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-hydroxybutanoic acid | CAS RN:137201-62-8 | Spinorphin"
+BMGC_DG07205,BMG_DG135254,"CAS RN:147245-92-9 | CID 3081884 | PubChem CID:3081884 | acetic acid;(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid"
+BMGC_DG07206,BMG_DG135256,UNII:2R86C98KDX | PubChem CID:30819 | (2S)-2-amino-3-(4-phosphonooxyphenyl)propanoic acid | O-Phospho-L-tyrosine | Phosphonotyrosine | DrugBank ID:DB01962 | TYROSINE O-PHOSPHATE | PubChem SID:312525116 | CAS RN:21820-51-9
+BMGC_DG07207,BMG_DG135257,"Motexafin lutetium | CAS RN:156436-90-7 | PubChem SID:198986346 | MOTEXAFIN LUTETIUM | UNII:0A85BJ22L6 | 3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;lutetium(3+);diacetate;hydrate | DrugBank ID:DB05296 | PubChem CID:3081907"
+BMGC_DG07208,BMG_DG135264,"UNII:D874R9PZ9T | 2-[7-(2,2-dimethylpropanoylamino)-4,6-dimethyl-1-octyl-2,3-dihydroindol-5-yl]acetic acid | PACTIMIBE | DrugBank ID:DB12971 | Pactimibe | PubChem CID:3081927 | PubChem SID:198988592 | CAS RN:189198-30-9"
+BMGC_DG07209,BMG_DG135266,CAS RN:1242-67-7 | UNII:MK7IHZ7MIM | PubChem CID:3081957 | CANNABIDIOL DIMETHYL ETHER | PubChem SID:363909343
+BMGC_DG07210,BMG_DG135267,"(7R,8R,9S,10R,12S,13R,14S,17R)-7,12-dihydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | 7alpha,12alpha-Dihydroxycholest-4-en-3-one | PubChem CID:3081958 | CAS RN:1254-03-1"
+BMGC_DG07211,BMG_DG135281,"ANGIOTENSIN III | UNII:XH7F04LXTF | PubChem SID:381608350 | PubChem CID:3082042 | CAS RN:13602-53-4 | (2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid | CAS RN:12687-51-3 | Angiotensin III"
+BMGC_DG07212,BMG_DG135288,"PubChem CID:3082127 | CAS RN:18274-81-2 | PubChem SID:405055018 | 3H-1,2-DITHIOLE-3-THIONE, 5-(4-HYDROXYPHENYL)- | UNII:P3SE9K2LHV"
+BMGC_DG07213,BMG_DG135293,"CAS RN:19774-86-8 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-oxohexanethioate | 3-Oxohexanoyl-CoA | PubChem CID:3082152"
+BMGC_DG07214,BMG_DG135320,"UNII:J1J4P3PQZD | TRV-120027 | CAS RN:1234510-46-3 | PubChem SID:198978456 | DrugBank ID:DB12199 | (2R)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid | PubChem CID:3082475 | D-Alanine, N-methylglycyl-L-arginyl-L-valyl-L-tyrosyl-L-isoleucyl-L-histidyl-L-prolyl-"
+BMGC_DG07215,BMG_DG135321,PubChem SID:374388482 | CAS RN:42160-26-9 | PubChem CID:308248 | UNII:4IIO6GJS6V | 2-AMINO-3-CYANO-4-METHYL-5-PHENYLTHIOPHENE
+BMGC_DG07216,BMG_DG135331,"6,10-DIMETHYL-5,6,6A,7-TETRAHYDRO-4H-DIBENZO(DE,G)QUINOLINE-11-OL, (6AR)- | UNII:AUL82ME93B | CAS RN:111635-19-9 | PubChem SID:478839195 | PubChem CID:3082625 | 6,10-dimethyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-11-ol, (6aR)-"
+BMGC_DG07217,BMG_DG135335,"PubChem CID:3082654 | 1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE) | DrugBank ID:DB08119"
+BMGC_DG07218,BMG_DG135338,PubChem CID:3082718 | PubChem SID:440089802 | UNII:Q5R50X7L6M | ICI-199441 | CAS RN:116508-24-8
+BMGC_DG07219,BMG_DG135367,"PubChem CID:3083542 | (6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid | Lenabasum | PubChem SID:198945130 | LENABASUM | Ajulemic acid | DrugBank ID:DB12193 | UNII:OGN7X90BT8 | CAS RN:137945-48-3"
+BMGC_DG07220,BMG_DG135369,ARFORMOTEROL | UNII:F91H02EBWT | CAS RN:67346-49-0 | UNII:5ZZ84GCW8B | PubChem CID:3083544 | PubChem SID:175271563 | CAS RN:73573-87-2 | N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]phenyl]formamide | DrugBank ID:DB01274 | PubChem SID:175266951 | FORMOTEROL | Arformoterol
+BMGC_DG07221,BMG_DG135413,3-(Trimethylazaniumyl)propane-1-sulfonate | 3-(TRIMETHYLAZANIUMYL)PROPANE-1-SULFONATE | PubChem SID:474492003 | PubChem CID:30837 | CAS RN:21865-17-8 | UNII:7CBL522F69
+BMGC_DG07222,BMG_DG135418,"8-HYDROXYBERGAPTEN | 8-Hydroxybergapten | PubChem SID:472422236 | UNII:KBZ9E8KHG6 | CAS RN:1603-47-0 | PubChem CID:3083726 | 9-hydroxy-4-methoxyfuro[3,2-g]chromen-7-one"
+BMGC_DG07223,BMG_DG135423,"CAS RN:2020-90-8 | PubChem SID:459275383 | UNII:DLB6EBD3DX | ACORAMONE | 1-(2,4,5-trimethoxyphenyl)propan-2-one | 1-(2,4,5-Trimethoxyphenyl)propan-2-one | PubChem CID:3083746"
+BMGC_DG07224,BMG_DG135446,SEDANOLIDE | UNII:9GXU758IFX | CAS RN:4567-33-3 | PubChem CID:3083857 | PubChem SID:318164755
+BMGC_DG07225,BMG_DG135506,"Hyaluronan | PubChem CID:3084049 | sodium;(2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid"
+BMGC_DG07226,BMG_DG135518,"FUSAFUNGINE | (3S,9S,15S)-4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone | PubChem SID:198984041 | PubChem CID:3084092 | Fusafungine | DrugBank ID:DB08965 | CAS RN:1393-87-9 | UNII:65DD690W0C"
+BMGC_DG07227,BMG_DG135523,UNII:G3MHA25XDD | 4-((4-(DIMETHYLAMINO)BENZYLIDENE)AMINO)BENZENESULFONAMIDE | CAS RN:1089307-13-0 | PubChem CID:308411 | PubChem SID:478838570
+BMGC_DG07228,BMG_DG135527,"11,11'-DIDEOXYVERTICILLIN A | UNII:L03PG2D98P | PubChem CID:3084126 | PubChem SID:317230011"
+BMGC_DG07229,BMG_DG135564,"16-methoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaen-17-ol | Thalifendine | CAS RN:18207-71-1 | PubChem CID:3084288"
+BMGC_DG07230,BMG_DG135566,"(3S)-3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione | DrugBank ID:DB08997 | Dexetimide | UNII:43477QYX3D | PubChem SID:198959635 | PubChem CID:30843 | DEXETIMIDE | CAS RN:21888-98-2"
+BMGC_DG07231,BMG_DG135657,"DrugBank ID:DB13396 | PubChem SID:316911731 | PubChem CID:3084726 | UNII:7L5LMT7B2H | CAS RN:38964-88-4 | NEOCITRULLAMON | Neocitrullamon | 2-amino-5-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)pentanoic acid"
+BMGC_DG07232,BMG_DG135658,"4-AMINO-3,5-DIBROMOBENZENESULFONAMIDE | UNII:G88Z5C5E4Z | PubChem CID:3084733 | CAS RN:39150-45-3 | PubChem SID:459055841"
+BMGC_DG07233,BMG_DG135674,CAS RN:51059-44-0 | OROXINDIN | PubChem CID:3084961 | PubChem SID:241181373 | UNII:ETX4944Z3R
+BMGC_DG07234,BMG_DG135681,CAS RN:1392212-84-8 | CAS RN:52757-95-6 | 2-(Chloromethyl)oxirane; prop-2-en-1-amine | UNII:941N5DUU5C | PubChem CID:3085017 | SEVELAMER | DrugBank ID:DB00658 | PubChem SID:472386543 | 2-(chloromethyl)oxirane;prop-2-en-1-amine | Sevelamer
+BMGC_DG07235,BMG_DG135692,"PubChem CID:3085076 | PubChem SID:443623504 | 4,5,6,7-TETRAHYDROTHIENO(3,2-C)PYRIDINE | CAS RN:54903-50-3 | UNII:I3AKK727FU"
+BMGC_DG07236,BMG_DG135695,"PubChem SID:175266475 | PubChem CID:3085092 | (2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid | UNII:62UXS86T64 | Salinomycin | DrugBank ID:DB11544 | CAS RN:53003-10-4 | SALINOMYCIN"
+BMGC_DG07237,BMG_DG135717,"PubChem SID:198943138 | (7S)-5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene | CAS RN:61337-87-9 | ESMIRTAZAPINE | DrugBank ID:DB06678 | UNII:4685R51V7M | PubChem CID:3085218 | Esmirtazapine"
+BMGC_DG07238,BMG_DG135760,CAS RN:72908-87-3 | ALDISINE | PubChem CID:3085877 | PubChem SID:445500739 | UNII:TDF8482E6R
+BMGC_DG07239,BMG_DG135767,DrugBank ID:DB08938 | aluminum;magnesium;hydroxide;sulfate | Magaldrate | PubChem CID:3086011 | Riopan Plus
+BMGC_DG07240,BMG_DG135780,"CAS RN:79755-43-4 | UNII:4XFW436FVZ | 3,5-DIBROMO-2-(2,4-DIBROMOPHENOXY)PHENOL | PubChem CID:3086109"
+BMGC_DG07241,BMG_DG135797,"Photofrin II | PubChem CID:3086257 | sodium;3-[18-(2-carboxyethyl)-8-ethyl-13-(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid"
+BMGC_DG07242,BMG_DG135802,"UNII:8RS28W7CVB | CAS RN:91147-46-5 | PubChem CID:3086326 | 5-CHLORO-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-6-QUINOXALINAMINE"
+BMGC_DG07243,BMG_DG135813,"CAS RN:87056-78-8 | CAS RN:140630-80-4 | PubChem CID:3086401 | DrugBank ID:DB09097 | (3S,4aS,10aR)-3-(diethylsulfamoylamino)-6-hydroxy-1-propyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinoline | Quinagolide"
+BMGC_DG07244,BMG_DG135817,"PubChem CID:3086464 | Normosang | CAS RN:100438-92-4 | (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid;3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid;iron(2+)"
+BMGC_DG07245,BMG_DG135826,"ZILPATEROL | CAS RN:119520-05-7 | Zilpaterol | PubChem CID:3086576 | (9R,10R)-9-hydroxy-10-(propan-2-ylamino)-1,3-diazatricyclo[6.4.1.04,13]trideca-4,6,8(13)-trien-2-one | DrugBank ID:DB11479 | PubChem SID:198965680 | CAS RN:117827-79-9 | UNII:S384A1Y12J"
+BMGC_DG07246,BMG_DG135827,"PubChem SID:198970009 | CAS RN:124182-57-6 | 2-(4-(2-Carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | UNII:T5HB1E831H | CGS-21680 | 3-[4-[2-[[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid | CAS RN:120225-54-9 | PubChem CID:3086599"
+BMGC_DG07247,BMG_DG135838,CAS RN:138742-43-5 | ZANKIREN | PubChem SID:198976006 | PubChem CID:3086652 | UNII:I36B16A34Q
+BMGC_DG07248,BMG_DG135840,CAS RN:149556-49-0 | UNII:I5MPG6F043 | PubChem SID:198982718 | SUSALIMOD | PubChem CID:3086668
+BMGC_DG07249,BMG_DG135842,ATRELEUTON | CAS RN:154355-76-7 | Atreleuton | 1-[(2R)-4-[5-[(4-fluorophenyl)methyl]thiophen-2-yl]but-3-yn-2-yl]-1-hydroxyurea | PubChem CID:3086671 | PubChem SID:198960908 | DrugBank ID:DB12758 | UNII:U301T88E1M
+BMGC_DG07250,BMG_DG135844,"CAS RN:155798-07-5 | NDC:17156-210 | PubChem CID:3086674 | DrugBank ID:DB08824 | Ioflupane I-123 | UNII:3MM99T8R5Q | IOFLUPANE I-123 | NDC:69945-166 | methyl (1R,2S,3S,5S)-8-(3-fluoropropyl)-3-(4-(123I)iodanylphenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate | PubChem SID:175267475"
+BMGC_DG07251,BMG_DG135845,"CAS RN:146961-76-4 | PubChem SID:198956260 | CAS RN:157182-32-6 | UNII:7QVV6I50DT | 7-[(1S,5R)-6-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid | PubChem CID:3086677 | DrugBank ID:DB09335 | Alatrofloxacin | ALATROFLOXACIN"
+BMGC_DG07252,BMG_DG135848,Lanepitant | LANEPITANT | UNII:17G8FN2E1F | PubChem SID:198954428 | PubChem CID:3086681 | CAS RN:170566-84-4 | N-[(2R)-1-[acetyl-[(2-methoxyphenyl)methyl]amino]-3-(1H-indol-3-yl)propan-2-yl]-2-(4-piperidin-1-ylpiperidin-1-yl)acetamide
+BMGC_DG07253,BMG_DG135863,"PubChem SID:198983378 | FONAZINE | UNII:1FTA475ZDB | Dimetotiazine | CAS RN:7456-24-8 | PubChem CID:3089 | 10-[2-(dimethylamino)propyl]-N,N-dimethylphenothiazine-2-sulfonamide | DrugBank ID:DB08967"
+BMGC_DG07254,BMG_DG135864,UNII:3BG8N9724B | Bromophene | PubChem SID:472386343 | CAS RN:21987-62-2 | BROMOPHENE | PubChem CID:30891
+BMGC_DG07255,BMG_DG135868,"UNII:TA5S7QH7CX | CAS RN:22020-68-4 | PubChem CID:30897 | 2,5-BIS(2-METHYLPHENYL)-1,3,4-OXADIAZOLE"
+BMGC_DG07256,BMG_DG135871,PubChem SID:175265463 | CAS RN:551-92-8 | DIMETRIDAZOLE | PubChem CID:3090 | UNII:K59P7XNB8X
+BMGC_DG07257,BMG_DG135883,PubChem SID:198938063 | UNII:HYE7315Z4C | CAS RN:301326-22-7 | PubChem CID:3091786 | CH-223191
+BMGC_DG07258,BMG_DG135884,"PubChem SID:175268277 | DrugBank ID:DB11480 | 2-methyl-3,5-dinitrobenzamide | DINITOLMIDE | PubChem CID:3092 | Dinitolmide | CAS RN:148-01-6 | UNII:AOX68RY4TV"
+BMGC_DG07259,BMG_DG135895,PubChem CID:3092847 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DrugBank ID:DB04394
+BMGC_DG07260,BMG_DG135896,PubChem CID:30931 | CAS RN:22071-22-3 | UNII:57OG4Q7B6Y | PubChem SID:198983582 | (3-BENZOYLPHENYL)ACETIC ACID
+BMGC_DG07261,BMG_DG135897,9-phenethylpurin-6-amine | PubChem CID:309375 | UNII:XQ7Q7SKB8M | CAS RN:7051-86-7 | 9-PHENETHYLPURIN-6-AMINE | PubChem SID:478839361
+BMGC_DG07262,BMG_DG135901,"UNII:140T9JTG43 | PubChem SID:198935653 | PubChem CID:30949 | BUTALAMINE | N',N'-dibutyl-N-(3-phenyl-1,2,4-oxadiazol-5-yl)ethane-1,2-diamine | CAS RN:22131-35-7 | Butalamine | DrugBank ID:DB13681"
+BMGC_DG07263,BMG_DG135903,PubChem CID:30951 | CAS RN:22131-79-9 | PubChem SID:198953975 | UNII:M9CP5H21N8 | Alclofenac | ALCLOFENAC | DrugBank ID:DB13167 | 2-(3-chloro-4-prop-2-enoxyphenyl)acetic acid
+BMGC_DG07264,BMG_DG135918,"PubChem CID:30976 | UNII:49P95BAU4Z | 2,6-DIAMINOPURINE | CAS RN:1904-98-9 | 7H-purine-2,6-diamine | PubChem SID:198958942 | 2,6-Diaminopurine | CAS RN:133762-79-5"
+BMGC_DG07265,BMG_DG135936,"Diphenhydramine | CAS RN:2122800-18-2 | UNII:8GTS82S83M | DrugBank ID:DB01075 | CAS RN:58-73-1 | CAS RN:110491-04-8 | NDC:67234-023 | DIPHENHYDRAMINE | 2-benzhydryloxy-N,N-dimethylethanamine | PubChem SID:175266775 | PubChem CID:3100"
+BMGC_DG07266,BMG_DG135947,"PubChem SID:198990542 | 3,4,5-Trimethoxyamphetamine | DrugBank ID:DB01516 | UNII:P2K02L3YON | PubChem CID:31016 | CAS RN:1082-88-8 | 3,4,5-TRIMETHOXYAMPHETAMINE"
+BMGC_DG07267,BMG_DG135951,Benzophenone | diphenylmethanone | PubChem SID:175266049 | CAS RN:119-61-9 | UNII:701M4TTV9O | PubChem CID:3102 | BENZOPHENONE | DrugBank ID:DB01878
+BMGC_DG07268,BMG_DG135956,Diphenylpyraline | DIPHENYLPYRALINE | UNII:33361OE3AV | 4-benzhydryloxy-1-methylpiperidine | PubChem CID:3103 | PubChem SID:198969105 | CAS RN:147-20-6 | DrugBank ID:DB01146
+BMGC_DG07269,BMG_DG135957,"Cyclohexyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate | CAS RN:313967-18-9 | cyclohexyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,6,8-tetrahydroquinoline-3-carboxylate | PubChem CID:3103157"
+BMGC_DG07270,BMG_DG135959,PubChem CID:31036 | PubChem SID:313183578 | UNII:1DW8U29X8S | CAS RN:2153-13-1 | 4-((2-AMINO-4-PYRIMIDINYL)AMINO)BENZENESULFONAMIDE
+BMGC_DG07271,BMG_DG135960,PubChem CID:310360 | UNII:ANM9DBL9JT | 1-(4-fluorophenyl)-3-(4-sulfamoylphenyl)urea | PubChem SID:472426587 | Slc-0111 | CAS RN:178606-66-1 | SLC-0111
+BMGC_DG07272,BMG_DG135962,PubChem SID:198966210 | NS-1738 | CAS RN:501684-93-1 | UNII:9822RX831L | PubChem CID:310378
+BMGC_DG07273,BMG_DG135969,"PubChem SID:175272105 | UNII:8Q1PVL543G | CAS RN:52365-63-6 | DrugBank ID:DB00449 | PubChem CID:3105 | Dipivefrin | DIPIVEFRIN | [2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate"
+BMGC_DG07274,BMG_DG135987,PubChem CID:31072 | CAS RN:22232-54-8 | CARBIMAZOLE | DrugBank ID:DB00389 | UNII:8KQ660G60G | ethyl 3-methyl-2-sulfanylideneimidazole-1-carboxylate | Carbimazole | PubChem SID:175268033
+BMGC_DG07275,BMG_DG135990,"NDC:64980-134 | NDC:65841-663 | NDC:0404-9852 | NDC:64980-135 | 2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol | NDC:0115-1070 | NDC:69584-183 | NDC:68382-189 | NDC:64980-133 | NDC:71205-894 | DIPYRIDAMOLE | PubChem SID:175266039 | DrugBank ID:DB00975 | NDC:0115-1071 | PubChem CID:3108 | NDC:0115-1072 | CAS RN:58-32-2 | NDC:51662-1447 | NDC:69584-182 | NDC:69584-181 | NDC:65841-664 | NDC:65841-662 | NDC:68382-187 | NDC:71205-895 | Dipyridamole | NDC:68382-188 | UNII:64ALC7F90C | NDC:0641-2569 | NDC:71205-896"
+BMGC_DG07276,BMG_DG135995,UNII:9L87N86R9A | 1-oxido-2-[(1-oxidopyridin-1-ium-2-yl)disulfanyl]pyridin-1-ium | PubChem SID:175267557 | DIPYRITHIONE | CAS RN:3696-28-4 | Dipyrithione | DrugBank ID:DB11327 | PubChem CID:3109
+BMGC_DG07277,BMG_DG135998,"CAS RN:134367-01-4 | NDC:0904-7316 | Citric Acid | NDC:11673-187 | NDC:67091-108 | CAS RN:79586-22-4 | NDC:60687-832 | NDC:72000-030 | NDC:0942-9202 | NDC:23731-6051 | NDC:0121-1190 | NDC:11822-4212 | DrugBank ID:DB04272 | NDC:70000-0574 | NDC:55566-6800 | 2-hydroxypropane-1,2,3-tricarboxylic acid | NDC:0942-9001 | CAS RN:77-92-9 | NDC:29485-6503 | NDC:36800-421 | NDC:0942-0641 | NDC:50268-183 | NDC:50804-421 | NDC:63868-569 | NDC:69842-542 | NDC:53942-421 | NDC:55154-5777 | NDC:53943-421 | NDC:63868-229 | NDC:21130-421 | NDC:63479-0112 | NDC:50269-307 | NDC:0280-0211 | NDC:0363-0541 | NDC:63479-1403 | NDC:41520-444 | NDC:30142-421 | NDC:37808-540 | NDC:41163-421 | NDC:50201-0421 | NDC:50268-182 | NDC:60687-834 | Citric acid | NDC:0327-0012 | NDC:64578-0065 | NDC:69842-421 | PubChem SID:175268283 | NDC:66715-5106 | NDC:67751-143 | NDC:66715-9703 | PubChem CID:311 | NDC:0363-0421 | ANHYDROUS CITRIC ACID | NDC:56062-421 | NDC:63941-421 | NDC:0942-9201 | NDC:50201-4212 | NDC:0280-4000 | NDC:70264-014 | NDC:55910-422 | NDC:17856-0595 | NDC:37808-421 | NDC:0121-0595 | NDC:10361-793 | NDC:49035-421 | NDC:50201-4213 | NDC:59469-321 | NDC:64578-0085 | NDC:83027-0027 | UNII:XF417D3PSL | CAS RN:141633-96-7 | NDC:0942-9005 | NDC:41250-222 | NDC:29485-7535"
+BMGC_DG07278,BMG_DG136000,"NDC:68382-110 | (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid | PubChem CID:31100 | NDC:65841-654 | NDC:0781-5325 | CAS RN:22260-51-1 | NDC:0378-7096 | NDC:73515-123 | BROMOCRIPTINE MESYLATE | UNII:FFP983J3OD | NDC:68012-258 | Bromocriptine Mesylate | NDC:0574-0106 | PubChem SID:175268909"
+BMGC_DG07279,BMG_DG136001,"PubChem CID:31101 | BROMOCRIPTINE | CAS RN:25614-03-3 | Bromocriptine | CAS RN:22260-51-1 | PubChem SID:175266818 | UNII:3A64E3G5ZO | (6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | DrugBank ID:DB01200"
+BMGC_DG07280,BMG_DG136003,"PubChem CID:3111 | UNII:934T64RMNJ | [(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-methylamino]methanesulfonic acid | METAMIZOLE | PubChem SID:175268586 | DrugBank ID:DB04817 | Metamizole | CAS RN:50567-35-6"
+BMGC_DG07281,BMG_DG136016,DrugBank ID:DB00280 | Disopyramide | UNII:GFO928U8MQ | CAS RN:3737-09-5 | PubChem CID:3114 | PubChem SID:175271562 | 4-[di(propan-2-yl)amino]-2-phenyl-2-pyridin-2-ylbutanamide | DISOPYRAMIDE
+BMGC_DG07282,BMG_DG136018,PubChem SID:441659305 | PNU-120596 | PubChem CID:311434 | CAS RN:501925-31-1 | UNII:9EZT3PTH2J
+BMGC_DG07283,BMG_DG136019,UNII:M3L07R4ZEP | PubChem CID:3114900 | CAS RN:325850-81-5 | PubChem SID:198983395 | GRI-977143
+BMGC_DG07284,BMG_DG136020,Stallimycin | CAS RN:636-47-5 | PubChem CID:3115 | PubChem SID:198966165 | N-[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-formamido-1-methylpyrrole-2-carboxamide | STALLIMYCIN | UNII:80O63P88IS
+BMGC_DG07285,BMG_DG136026,CAS RN:17299-00-2 | Distigmine | PubChem CID:3116 | DISTIGMINE | UNII:T940307O7B | PubChem SID:198935969 | (1-methylpyridin-1-ium-3-yl) N-methyl-N-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate | DrugBank ID:DB13694
+BMGC_DG07286,BMG_DG136030,"diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate | NDC:62135-431 | NDC:42794-028 | NDC:62135-432 | Disulfiram | DISULFIRAM | NDC:60429-196 | CAS RN:97-77-8 | PubChem SID:175268085 | NDC:47781-607 | NDC:42794-029 | DrugBank ID:DB00822 | PubChem CID:3117 | UNII:TR3MLJ1UAI"
+BMGC_DG07287,BMG_DG136043,ISOQUINOLIN-3-AMINE | UNII:AEY32ZN5CU | PubChem CID:311869 | PubChem SID:478838641 | CAS RN:25475-67-6 | Isoquinolin-3-amine
+BMGC_DG07288,BMG_DG136054,DrugBank ID:DB14547 | CAS RN:139512-37-1 | UNII:Q32ZN48698 | PubChem CID:312 | CAS RN:54071-91-9 | CAS RN:155522-09-1 | CAS RN:131500-00-0 | chloride | CHLORIDE ION | PubChem SID:175265475 | Chloride Ion | CAS RN:62770-30-3 | CAS RN:147258-25-1 | CAS RN:16887-00-6
+BMGC_DG07289,BMG_DG136055,"Diuron | CAS RN:330-54-1 | PubChem CID:3120 | PubChem SID:198984118 | 3-(3,4-dichlorophenyl)-1,1-dimethylurea | UNII:9I3SDS92WY | DIURON"
+BMGC_DG07290,BMG_DG136065,NDC:63739-253 | NDC:0121-1350 | NDC:43353-107 | NDC:70518-3805 | NDC:71335-2250 | VALPROIC ACID | Valproic Acid | NDC:62559-266 | NDC:63739-086 | UNII:614OI1Z5WI | NDC:62135-874 | CAS RN:99-66-1 | NDC:0832-0310 | NDC:0121-0675 | NDC:70518-0079 | NDC:17856-0675 | 2-propylpentanoic acid | NDC:70752-202 | NDC:72603-253 | NDC:0121-4675 | NDC:0527-5250 | PubChem CID:3121 | NDC:17856-0792 | NDC:63629-2454 | NDC:0591-4012 | NDC:43353-279 | PubChem SID:175267979 | NDC:69452-150 | NDC:0615-8205 | DrugBank ID:DB00313 | NDC:43353-085 | NDC:62135-196 | Valproic acid
+BMGC_DG07291,BMG_DG136069,CAS RN:122-48-5 | DrugBank ID:DB15589 | PubChem CID:31211 | UNII:4MMW850892 | Zingerone | PubChem SID:175265526 | ZINGERONE | 4-(4-hydroxy-3-methoxyphenyl)butan-2-one
+BMGC_DG07292,BMG_DG136072,"WORTMANNIN | UNII:XVA4O219QW | DrugBank ID:DB08059 | CAS RN:19545-26-7 | Wortmannin | PubChem SID:241179293 | PubChem CID:312145 | [(1R,3R,5S,9R,18S)-18-(methoxymethyl)-1,5-dimethyl-6,11,16-trioxo-13,17-dioxapentacyclo[10.6.1.02,10.05,9.015,19]nonadeca-2(10),12(19),14-trien-3-yl] acetate"
+BMGC_DG07293,BMG_DG136081,"PubChem SID:198938772 | PubChem CID:31222 | 1,2-Diphenylhydrazine | UNII:1G3CS09TUK | CAS RN:38622-18-3 | CAS RN:122-66-7 | 1,2-diphenylhydrazine | 1,2-DIPHENYLHYDRAZINE"
+BMGC_DG07294,BMG_DG136096,CAS RN:56257-90-0 | CAS RN:9004-78-8 | PHENOXYETHANOL | CAS RN:122-99-6 | NDC:83566-582 | PubChem SID:175267667 | NDC:84025-050 | UNII:HIE492ZZ3T | PubChem CID:31236 | NDC:84025-068 | Phenoxyethanol | NDC:83566-583 | DrugBank ID:DB11304 | NDC:84025-233 | NDC:84025-049 | 2-phenoxyethanol
+BMGC_DG07295,BMG_DG136106,4-methoxybenzaldehyde | CAS RN:50984-52-6 | PubChem CID:31244 | P-ANISALDEHYDE | CAS RN:68894-36-0 | p-Anisaldehyde | PubChem SID:198956598 | UNII:9PA5V6656V | CAS RN:123-11-5
+BMGC_DG07296,BMG_DG136125,ISOAMYL ALCOHOL | Isoamyl alcohol | CAS RN:6423-06-9 | PubChem CID:31260 | 3-methylbutan-1-ol | DrugBank ID:DB02296 | PubChem SID:198963527 | UNII:DEM9NIT1J4 | CAS RN:123-51-3 | Isoamyl Alcohol
+BMGC_DG07297,BMG_DG136126,"CAS RN:14024-62-5 | PubChem SID:198974965 | UNII:46R950BP4J | CAS RN:81235-32-7 | Acetylacetone | ACETYLACETONE | CAS RN:123-54-6 | PubChem CID:31261 | pentane-2,4-dione"
+BMGC_DG07298,BMG_DG136129,"CAS RN:123-63-7 | Paraldehyde | CAS RN:1499-02-1 | UNII:S6M3YBG8QA | DrugBank ID:DB09117 | PubChem SID:175271896 | PARALDEHYDE | 2,4,6-trimethyl-1,3,5-trioxane | PubChem CID:31264"
+BMGC_DG07299,BMG_DG136133,UNII:LJU5627FYV | PYRROLIDINE | CAS RN:89014-29-9 | Pyrrolidine | PubChem SID:198959435 | CAS RN:123-75-1 | PubChem CID:31268 | pyrrolidine
+BMGC_DG07300,BMG_DG136135,UNII:897NVD4A52 | P-CHLOROAMPHETAMINE | CAS RN:2275-84-5 | PubChem CID:3127 | CAS RN:64-12-0 | 1-(4-chlorophenyl)propan-2-amine | p-CHLOROAMPHETAMINE | PubChem SID:441097104
+BMGC_DG07301,BMG_DG136141,"UNII:J8A3S10O7S | CAS RN:123-91-1 | PubChem CID:31275 | PubChem SID:198967258 | 1,4-Dioxane | DrugBank ID:DB03316 | CAS RN:28552-22-9 | 1,4-dioxane | DIOXANE"
+BMGC_DG07302,BMG_DG136143,"UNII:UB24Z27Z5N | 2,3-BIS(((AMINOCARBONYL)OXY)METHYL)-5,8-DIHYDROXY-1,4-NAPHTHALENEDIONE | PubChem SID:434369669 | CAS RN:57999-04-9 | PubChem CID:312765"
+BMGC_DG07303,BMG_DG136168,NDC:69469-650 | CARBAMIDE PEROXIDE | NDC:11673-793 | NDC:71205-136 | Carbamide peroxide | DrugBank ID:DB11129 | NDC:0363-2068 | NDC:49035-862 | NDC:50090-5273 | hydrogen peroxide;urea | NDC:50090-7426 | NDC:53943-835 | NDC:63029-321 | NDC:63941-835 | NDC:13709-312 | NDC:59256-836 | NDC:63941-836 | NDC:72724-001 | NDC:13709-314 | NDC:59256-001 | NDC:11527-143 | NDC:50090-4201 | NDC:63029-322 | NDC:13709-313 | NDC:46122-557 | NDC:69428-001 | NDC:11822-6117 | NDC:75712-301 | NDC:21130-793 | NDC:36800-835 | NDC:52412-600 | CAS RN:14479-85-7 | PubChem SID:175268208 | NDC:69256-117 | NDC:53943-838 | NDC:41250-282 | NDC:41250-835 | NDC:41163-835 | NDC:76162-836 | NDC:71205-260 | NDC:51316-822 | NDC:62011-0483 | NDC:0395-9133 | NDC:0904-7478 | NDC:15579-838 | NDC:63868-026 | NDC:0904-6627 | UNII:31PZ2VAU81 | NDC:68016-793 | NDC:82645-910 | CAS RN:124-43-6 | NDC:70000-0490 | NDC:70677-1154 | NDC:82498-149 | NDC:52412-175 | NDC:65923-639 | NDC:67172-361 | NDC:68229-102 | NDC:69452-377 | NDC:69428-002 | NDC:11673-761 | NDC:69842-097 | NDC:70000-0688 | NDC:68788-8586 | NDC:61715-171 | PubChem CID:31294 | NDC:11822-1224 | NDC:13709-230 | NDC:68093-4503 | Carbamide Peroxide | NDC:63029-500 | NDC:72476-838 | NDC:63868-027
+BMGC_DG07304,BMG_DG136174,PubChem CID:313 | CAS RN:1082661-04-8 | UNII:QTT17582CB | DrugBank ID:DB13366 | Hydrochloric acid | CAS RN:7647-01-0 | Hydrochloric Acid | PubChem SID:175266669 | HYDROCHLORIC ACID | chlorane
+BMGC_DG07305,BMG_DG136177,"(1R,3R,5S,8S,13R,14S)-1-hydroxy-14-(2-hydroxypropan-2-yl)-13-methyl-4,7,10-trioxapentacyclo[6.4.1.19,12.03,5.05,13]tetradecane-6,11-dione;(1R,5S,8S,13R,14R)-1-hydroxy-13-methyl-14-prop-1-en-2-yl-4,7,10-trioxapentacyclo[6.4.1.19,12.03,5.05,13]tetradecane-6,11-dione | Picrotoxin | CAS RN:124-87-8 | PubChem CID:31304 | DrugBank ID:DB00466"
+BMGC_DG07306,BMG_DG136179,"CAS RN:124-94-7 | TRIAMCINOLONE | (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | Triamcinolone | DrugBank ID:DB00620 | CAS RN:51855-44-8 | PubChem CID:31307 | PubChem SID:198956419 | UNII:1ZK20VI6TY"
+BMGC_DG07307,BMG_DG136184,"PubChem CID:31315 | PubChem SID:198969919 | CAS RN:125-13-3 | DrugBank ID:DB04823 | UNII:3BT0VQG2GQ | Oxyphenisatin | OXYPHENISATIN | 3,3-bis(4-hydroxyphenyl)-1H-indol-2-one"
+BMGC_DG07308,BMG_DG136186,UNII:B79L7B5X3Z | THIORPHAN | 2-[(2-benzyl-3-sulfanylpropanoyl)amino]acetic acid | PubChem SID:198966844 | Thiorphan | CAS RN:76721-89-6 | PubChem CID:3132
+BMGC_DG07309,BMG_DG136201,"6,6-DIMETHYLADENINE | PubChem CID:3134 | 6-Dimethylaminopurine | CAS RN:104245-07-0 | CAS RN:938-55-6 | PubChem SID:198969149 | UNII:649SA4S2CV | N,N-dimethyl-7H-purin-6-amine"
+BMGC_DG07310,BMG_DG136210,"PubChem CID:313474 | CAS RN:868-84-8 | S,S-DIMETHYL CARBONODITHIOATE | UNII:3VA2L63KTH | PubChem SID:478837141"
+BMGC_DG07311,BMG_DG136211,"2-hydroxypropane-1,2,3-tricarboxylate | PubChem SID:375085003 | UNII:664CCH53PI | Citrate | PubChem CID:31348 | CAS RN:126-44-3 | CITRATE ION"
+BMGC_DG07312,BMG_DG136226,"PubChem SID:472406959 | 2,3-DIMETHOXY-1,4-NAPHTHOQUINONE | CAS RN:6956-96-3 | UNII:MFW94A3JEK | PubChem CID:3136"
+BMGC_DG07313,BMG_DG136231,"6-CHLORO-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINE | PubChem SID:474493245 | PubChem CID:313624 | UNII:ED5NK55VZ7 | 6-Chloro-1,2,4-triazolo[4,3-b]pyridazine | CAS RN:28593-24-0"
+BMGC_DG07314,BMG_DG136243,"Fludrocortisone | PubChem CID:31378 | FLUDROCORTISONE | (8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | DrugBank ID:DB00687 | PubChem SID:175266519 | CAS RN:127-31-1 | UNII:U0476M545B"
+BMGC_DG07315,BMG_DG136247,PubChem CID:31386 | PubChem SID:198988854 | UNII:V25W2CFS3M | CAS RN:127-63-9 | DIPHENYL SULFONE
+BMGC_DG07316,BMG_DG136255,"NDC:0904-7168 | NDC:0591-3159 | NDC:72162-1988 | NDC:0591-3005 | NDC:68001-377 | NDC:58914-790 | (4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | CAS RN:128-13-2 | NDC:24658-780 | NDC:24658-999 | NDC:63629-2287 | NDC:68462-474 | NDC:70710-1128 | NDC:71930-015 | NDC:70771-1408 | NDC:60687-527 | NDC:0904-6890 | NDC:42385-946 | NDC:42291-923 | NDC:62135-430 | NDC:42806-503 | NDC:70771-1407 | PubChem CID:31401 | DrugBank ID:DB01586 | NDC:50268-797 | NDC:72664-217 | NDC:72887-144 | NDC:63629-1173 | NDC:72162-1500 | NDC:69238-1540 | NDC:70771-1524 | NDC:58914-785 | NDC:49884-413 | NDC:72162-2168 | NDC:70710-1127 | Ursodiol | NDC:51407-754 | PubChem SID:175266909 | NDC:68001-378 | NDC:79739-7144 | NDC:63629-8353 | UNII:724L30Y2QR | NDC:59651-421 | NDC:64380-918 | NDC:80056-143 | NDC:49884-412 | NDC:42291-931 | NDC:63629-2286 | NDC:0904-6221 | NDC:72789-205 | NDC:80056-144 | CAS RN:108609-27-4 | NDC:0591-2998 | NDC:60687-100 | NDC:55154-2633 | NDC:64380-919 | NDC:68462-473 | NDC:72887-143 | NDC:70710-1483 | URSODIOL | NDC:64380-844 | Ursodeoxycholic acid | NDC:0527-1326 | NDC:72162-1501 | NDC:79739-7143"
+BMGC_DG07317,BMG_DG136256,"UNII:BXO86P3XXW | ELTANOLONE | Eltanolone | DrugBank ID:DB12308 | CAS RN:110350-90-8 | PubChem SID:198950797 | Pregnanolone | PubChem CID:31402 | CAS RN:128-20-1 | 1-[(3R,5R,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone"
+BMGC_DG07318,BMG_DG136257,"PubChem SID:198988410 | CAS RN:128-37-0 | BUTYLATED HYDROXYTOLUENE | Butylated Hydroxytoluene | 2,6-ditert-butyl-4-methylphenol | PubChem CID:31404 | UNII:1P9D0Z171K"
+BMGC_DG07319,BMG_DG136258,"PubChem CID:31405 | CAS RN:128-39-2 | PubChem SID:198984293 | UNII:21294V58PF | 2,6-DI-TERT-BUTYLPHENOL"
+BMGC_DG07320,BMG_DG136264,"PubChem SID:438788569 | PubChem CID:314123 | CAS RN:52837-71-5 | DrugBank ID:DB03490 | 3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole | 3-PYRIDIN-4-YL-1,4-DIHYDROINDENO(1,2-C)PYRAZOLE | UNII:0EMS99B8D6"
+BMGC_DG07321,BMG_DG136272,CAS RN:128-95-0 | UNII:N21HDQ0TKN | PubChem CID:31420 | PubChem SID:252823948 | DISPERSE VIOLET 1
+BMGC_DG07322,BMG_DG136276,UNII:9E0T7WFW93 | CAS RN:1346601-04-4 | PYRENE | CAS RN:129-00-0 | PubChem SID:198966444 | Pyrene | CAS RN:41496-25-7 | PubChem CID:31423 | pyrene
+BMGC_DG07323,BMG_DG136298,"CAS RN:22662-39-1 | UNII:22F4FLA7DH | N-[3-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3,5-diiodobenzamide | PubChem CID:31475 | RAFOXANIDE | PubChem SID:198941031 | Rafoxanide"
+BMGC_DG07324,BMG_DG136301,"UNII:X39AL81KEB | DrugBank ID:DB01214 | [4-[2-hydroxy-3-(propan-2-ylamino)propoxy]-2,3,6-trimethylphenyl] acetate | METIPRANOLOL | CAS RN:22664-55-7 | PubChem SID:175272013 | PubChem CID:31477 | Metipranolol"
+BMGC_DG07325,BMG_DG136304,"(10-oxo-8-azatricyclo[5.3.1.03,8]undecan-5-yl) 1H-indole-3-carboxylate | PubChem CID:3148 | CAS RN:139014-62-3 | 3-Oxooctahydro-2h-2,6-methanoquinolizin-8-yl 1h-indole-3-carboxylate"
+BMGC_DG07326,BMG_DG136309,"PubChem SID:474490958 | PubChem CID:314924 | 6-[(1-Naphthalenylamino)methyl]-2,4-pteridinediamine | UNII:PLG2NKF4GY | CAS RN:70583-39-0 | 6-((1-NAPHTHALENYLAMINO)METHYL)-2,4-PTERIDINEDIAMINE"
+BMGC_DG07327,BMG_DG136311,PubChem CID:31494 | UNII:EAT6GLQ2BR | 4-METHOXYBENZIL | PubChem SID:474491006 | CAS RN:22711-21-3 | 4-Methoxybenzil
+BMGC_DG07328,BMG_DG136321,PubChem SID:198949142 | PubChem CID:31508 | Proquazone | DrugBank ID:DB13649 | PROQUAZONE | UNII:42VPJ2980S | CAS RN:22760-18-5 | 7-methyl-4-phenyl-1-propan-2-ylquinazolin-2-one
+BMGC_DG07329,BMG_DG136323,Domperidone | PubChem SID:175267948 | 6-chloro-3-[1-[3-(2-oxo-3H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1H-benzimidazol-2-one | UNII:5587267Z69 | CAS RN:57808-66-9 | PubChem CID:3151 | DOMPERIDONE | DrugBank ID:DB01184
+BMGC_DG07330,BMG_DG136328,UNII:DP4677AX41 | PubChem CID:31515 | CARBOXYPHOSPHAMIDE | PubChem SID:316918389 | CAS RN:22788-18-7 | 3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropanoic acid | Carboxyphosphamide
+BMGC_DG07331,BMG_DG136329,"PubChem CID:3152 | DONEPEZIL | 2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one | UNII:8SSC91326P | PubChem SID:175271368 | CAS RN:120014-06-4 | DrugBank ID:DB00843 | CAS RN:142057-79-2 | Donepezil"
+BMGC_DG07332,BMG_DG136331,"2-AMINO-6,7-DIHYDROXYTETRALIN, (±)- | 2-AMINO-6,7-DIHYDROXYTETRALIN, (+/-)- | CAS RN:53463-78-8 | PubChem CID:3153 | 6-amino-5,6,7,8-tetrahydronaphthalene-2,3-diol | PubChem SID:316918006 | 6,7-Dihydroxy-2-aminotetralin | UNII:ZTM7UYI7VX"
+BMGC_DG07333,BMG_DG136339,"(2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one | CAS RN:22888-70-6 | PubChem SID:198951051 | PubChem CID:31553 | SILIBININ A | UNII:33X338MNE4 | CAS RN:1265089-69-7 | Silybin | Silibinin | CAS RN:65666-07-1 | CAS RN:802918-57-6 | CAS RN:36804-17-8 | DrugBank ID:DB09298"
+BMGC_DG07334,BMG_DG136341,"UNII:94F3830Q73 | DrugBank ID:DB00561 | Doxapram | PubChem SID:175271995 | CAS RN:309-29-5 | DOXAPRAM | 1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one | PubChem CID:3156"
+BMGC_DG07335,BMG_DG136352,"CAS RN:74191-85-8 | DOXAZOSIN | PubChem SID:175271848 | CAS RN:137888-77-8 | UNII:NW1291F1W8 | [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone | Doxazosin | PubChem CID:3157 | DrugBank ID:DB00590"
+BMGC_DG07336,BMG_DG136355,"3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine | CAS RN:1668-19-5 | PubChem CID:3158 | Zonalon | PubChem SID:175271917 | UNII:5ASJ6HUZ7D | DOXEPIN"
+BMGC_DG07337,BMG_DG136357,PubChem CID:31593 | N-benzyl-2-(2-nitroimidazol-1-yl)acetamide | Benznidazole | PubChem SID:175268912 | NDC:0642-7463 | NDC:0642-7464 | BENZNIDAZOLE | UNII:YC42NRJ1ZD | CAS RN:22994-85-0 | DrugBank ID:DB11989
+BMGC_DG07338,BMG_DG136364,CAS RN:90610-69-8 | UNII:U9RZF328WH | 3-(4-Sulfamoylphenyl)propanoic acid | PubChem CID:3161908 | PubChem SID:478838479 | 3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID | 3-(4-SULFAMOYLPHENYL)PROPANOIC ACID | DrugBank ID:DB08156
+BMGC_DG07339,BMG_DG136365,"DrugBank ID:DB00366 | N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine | PubChem SID:175271734 | Doxylamine | PubChem CID:3162 | CAS RN:469-21-6 | DOXYLAMINE | UNII:95QB77JKPL"
+BMGC_DG07340,BMG_DG136375,"UNII:320YC168LF | CAS RN:23092-17-3 | 7-chloro-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one | PubChem CID:31640 | Halazepam | DrugBank ID:DB00801 | PubChem SID:198946459 | HALAZEPAM"
+BMGC_DG07341,BMG_DG136392,"CAS RN:6373-11-1 | PubChem SID:474492514 | PubChem CID:316765 | 1,2-Aceanthrylenedione | UNII:F84VGY5ACR | 1,2-ACEANTHRYLENEDIONE"
+BMGC_DG07342,BMG_DG136394,"PubChem CID:3168 | CAS RN:548-73-2 | Droperidol | UNII:O9U0F09D5X | 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one | DROPERIDOL | NDC:0143-9515 | PubChem SID:175267519 | NDC:0143-9514 | DrugBank ID:DB00450 | NDC:0517-9702"
+BMGC_DG07343,BMG_DG136395,"PubChem CID:3169 | DrugBank ID:DB13785 | PubChem SID:198963849 | DROPROPIZINE | Dropropizine | 3-(4-phenylpiperazin-1-yl)propane-1,2-diol | UNII:U0K8WHL37U | CAS RN:17692-31-8"
+BMGC_DG07344,BMG_DG136397,"PubChem CID:31703 | UNII:80168379AG | PubChem SID:175267696 | DrugBank ID:DB00997 | CAS RN:1392315-46-6 | DOXORUBICIN | (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione | Doxorubicin | CAS RN:23214-92-8"
+BMGC_DG07345,BMG_DG136402,CAS RN:23239-32-9 | 4-Methoxyamphetamine | PubChem CID:31721 | UNII:OVB8F8P39Q | CAS RN:64-13-1 | 4-METHOXYAMPHETAMINE | 1-(4-methoxyphenyl)propan-2-amine | PubChem SID:198935953 | DrugBank ID:DB01472
+BMGC_DG07346,BMG_DG136435,PubChem SID:198982528 | CAS RN:23255-54-1 | UNII:RBN56W7U63 | DIHYDRO-.BETA.-ERYTHROIDINE | PubChem CID:31762
+BMGC_DG07347,BMG_DG136439,Sulforidazine | SULFORIDAZINE | 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfonylphenothiazine | CAS RN:14759-06-9 | PubChem CID:31765 | PubChem SID:198956705 | UNII:B7599I244X
+BMGC_DG07348,BMG_DG136452,"DUP-697 | PubChem CID:3177 | UNII:MRWLZPOFPA | 5-bromo-2-(4-fluorophenyl)-3-(4-methylsulfonylphenyl)thiophene | CAS RN:88149-94-4 | PubChem SID:346537638 | Thiophene, 5-bromo-2-(4-fluorophenyl)-3-(4-(methylsulfonyl)phenyl)-"
+BMGC_DG07349,BMG_DG136471,"DICENTRINE, (-)- | UNII:5O9KK11109 | PubChem SID:198935583 | PubChem CID:317843 | CAS RN:28832-07-7"
+BMGC_DG07350,BMG_DG136482,DrugBank ID:DB00645 | CAS RN:586-60-7 | UNII:078A24Q30O | PubChem SID:175268528 | DYCLONINE | PubChem CID:3180 | 1-(4-butoxyphenyl)-3-piperidin-1-ylpropan-1-one | Dyclonine
+BMGC_DG07351,BMG_DG136483,"CAS RN:33371-53-8 | (1,1-dimethylpiperidin-1-ium-2-yl)methyl 2-hydroxy-2,2-diphenylacetate | DrugBank ID:DB13542 | UNII:34B0471E08 | PubChem CID:31800 | BEVONIUM | PubChem SID:198942056 | Bevonium"
+BMGC_DG07352,BMG_DG136490,CAS RN:35264-29-0 | 4-(HYDRAZINECARBONYL)BENZENESULFONAMIDE | UNII:WB9D74L8ZW | PubChem SID:474492500 | 4-(Hydrazinecarbonyl)benzenesulfonamide | PubChem CID:318174
+BMGC_DG07353,BMG_DG136491,"DrugBank ID:DB00651 | PubChem CID:3182 | UNII:263T0E9RR9 | Dyphylline | DYPHYLLINE | PubChem SID:175271660 | CAS RN:479-18-5 | 7-(2,3-dihydroxypropyl)-1,3-dimethylpurine-2,6-dione"
+BMGC_DG07354,BMG_DG136508,N-METHYLDESLORATADINE | PubChem SID:198938713 | UNII:70V8053T5G | PubChem CID:31843 | CAS RN:38092-89-6
+BMGC_DG07355,BMG_DG136512,UNII:1L1K8X5DF9 | CAS RN:113558-89-7 | PubChem CID:3185 | PubChem SID:440088709 | N-[4-[1-[2-(6-methylpyridin-2-yl)ethyl]piperidine-4-carbonyl]phenyl]methanesulfonamide | E-4031
+BMGC_DG07356,BMG_DG136517,UNII:HBO2D49I2S | 1-Phenylcyclohexylamine | 1-PHENYLCYCLOHEXYLAMINE | PubChem CID:31862 | CAS RN:2201-24-3 | DrugBank ID:DB01506 | PubChem SID:252320466 | 1-phenylcyclohexan-1-amine
+BMGC_DG07357,BMG_DG136534,4-(4-benzhydryloxypiperidin-1-yl)-1-(4-tert-butylphenyl)butan-1-one | Ebastine | CAS RN:90729-43-4 | UNII:TQD7Q784P1 | PubChem SID:198935680 | PubChem CID:3191 | DrugBank ID:DB11742 | EBASTINE
+BMGC_DG07358,BMG_DG136546,"PubChem CID:3194 | DrugBank ID:DB12610 | Ebselen | EBSELEN | 2-phenyl-1,2-benzoselenazol-3-one | CAS RN:60940-34-3 | UNII:40X2P7DPGH | PubChem SID:198971621"
+BMGC_DG07359,BMG_DG136560,"PubChem SID:175271426 | CAS RN:27220-47-9 | Econazole | DrugBank ID:DB01127 | ECONAZOLE | UNII:6Z1Y2V4A7M | PubChem CID:3198 | 1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole"
+BMGC_DG07360,BMG_DG136578,ethyl-(3-hydroxyphenyl)-dimethylazanium | Edrophonium | DrugBank ID:DB01010 | EDROPHONIUM | CAS RN:312-48-1 | UNII:70FP3JLY7N | PubChem CID:3202 | PubChem SID:175266694
+BMGC_DG07361,BMG_DG136595,PubChem CID:32051 | CAS RN:1492823-75-2 | Zinc Cation | zinc(2+) | CAS RN:9025-42-7 | CAS RN:126603-04-1 | CAS RN:23713-49-7 | UNII:13S1S8SF37 | DrugBank ID:DB14532 | ZINC CATION | PubChem SID:175266124
+BMGC_DG07362,BMG_DG136599,CAS RN:59262-86-1 | 9-(2-Hydroxy-3-nonyl)adenine | 3-(6-aminopurin-9-yl)nonan-2-ol | PubChem CID:3206
+BMGC_DG07363,BMG_DG136618,"CAS RN:2624-63-7 | coproporphyrinogen III | 3-[8,12,17-tris(2-carboxyethyl)-3,7,13,18-tetramethyl-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoic acid | PubChem CID:321 | DrugBank ID:DB04461 | Coproporphyrinogen III"
+BMGC_DG07364,BMG_DG136624,"PubChem CID:3213 | UNII:117VLW7484 | Ellipticine | 5,11-dimethyl-6H-pyrido[4,3-b]carbazole | CAS RN:519-23-3 | PubChem SID:198937378 | ELLIPTICINE"
+BMGC_DG07365,BMG_DG136635,CAS RN:161448-79-9 | methyl 4-methyl-3-[2-(propylamino)propanoylamino]thiophene-2-carboxylate;hydrochloride | UNII:QS9014Q792 | NDC:66975-418 | NDC:45146-120 | ARTICAINE HYDROCHLORIDE | NDC:66975-417 | NDC:0362-9048 | NDC:0404-6625 | CAS RN:23964-57-0 | NDC:45146-110 | Articaine hydrochloride | PubChem SID:175271720 | NDC:66312-601 | PubChem CID:32169 | NDC:43128-101 | NDC:0362-9049 | NDC:67239-0209 | NDC:43128-102 | NDC:0404-6620 | NDC:0362-0830 | NDC:50227-1050 | NDC:66312-602 | NDC:50227-1040 | NDC:67239-0210 | NDC:43498-993 | NDC:43498-816
+BMGC_DG07366,BMG_DG136636,Articaine | PubChem CID:32170 | PubChem SID:175271831 | UNII:D3SQ406G9X | Carticaine | ARTICAINE | methyl 4-methyl-3-[2-(propylamino)propanoylamino]thiophene-2-carboxylate | DrugBank ID:DB09009 | CAS RN:23964-58-1
+BMGC_DG07367,BMG_DG136637,"Oxindole | PubChem CID:321710 | UNII:0S9338U62H | OXINDOLE | 1,3-dihydroindol-2-one | PubChem SID:198938973 | CAS RN:59-48-3"
+BMGC_DG07368,BMG_DG136638,PubChem SID:198955995 | 6-Methoxy-2-naphthylacetic acid | UNII:9H7K3YOD7Q | 2-(6-methoxynaphthalen-2-yl)acetic acid | 6-METHOXY-2-NAPHTHYLACETIC ACID | PubChem CID:32176 | CAS RN:23981-47-7
+BMGC_DG07369,BMG_DG136639,PubChem CID:3218 | UNII:SHC6U8F5ER | CAS RN:550-24-3 | EMBELIN | PubChem SID:198958396
+BMGC_DG07370,BMG_DG136644,"1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole | UNII:9J1H7Y9OJV | PubChem SID:175266282 | PubChem CID:3219 | CAS RN:87233-61-2 | DrugBank ID:DB01084 | EMEDASTINE | Emedastine"
+BMGC_DG07371,BMG_DG136650,"DrugBank ID:DB07715 | CAS RN:518-82-1 | Emodin | UNII:KA46RNI6HN | PubChem CID:3220 | PubChem SID:198986463 | EMODIN | 1,3,8-trihydroxy-6-methylanthracene-9,10-dione"
+BMGC_DG07372,BMG_DG136657,"PubChem CID:32224 | 2-CHLORO-11-(4-METHYLPIPERAZINO)DIBENZ(B,F)OXEPIN | UNII:3Y353LOH79 | CAS RN:22013-22-5 | PubChem SID:252319850"
+BMGC_DG07373,BMG_DG136663,PubChem SID:475550092 | PubChem CID:322353 | UNII:ER85UN5LYN | 3-AMINO-2-PYRIDINOL | CAS RN:33630-99-8
+BMGC_DG07374,BMG_DG136664,"DESCHLOROBENZYL ECONAZOLE | alpha-(2,4-Dichlorophenyl)-1H-imidazole-1-ethanol | 1-(2,4-dichlorophenyl)-2-imidazol-1-ylethanol | PubChem SID:198959369 | CAS RN:24155-42-8 | PubChem CID:32238 | UNII:CP4AM80T68"
+BMGC_DG07375,BMG_DG136665,"PubChem CID:3224 | CAS RN:115-29-7 | 1,9,10,11,12,12-hexachloro-4,6-dioxa-5lambda4-thiatricyclo[7.2.1.02,8]dodec-10-ene 5-oxide | Endosulfan"
+BMGC_DG07376,BMG_DG136673,"CAS RN:32502-16-2 | PubChem SID:376072704 | 3-(3,4-DIMETHOXYPHENYL)TOXOFLAVINE | PubChem CID:322478 | UNII:5PZ2F5VUW0"
+BMGC_DG07377,BMG_DG136674,"PubChem SID:377308843 | PubChem CID:322479 | 3-(1,3-BENZODIOXOL-5-YL)-1,6-DIMETHYLPYRIMIDO(5,4-E)-1,2,4-TRIAZINE-5,7(1H,6H)-DIONE | CAS RN:52199-05-0 | UNII:SCC7A7FS0B"
+BMGC_DG07378,BMG_DG136687,"ENFLURANE | DrugBank ID:DB00228 | CAS RN:13838-16-9 | Enflurane | 2-chloro-1-(difluoromethoxy)-1,1,2-trifluoroethane | PubChem SID:175272106 | PubChem CID:3226 | UNII:91I69L5AY5"
+BMGC_DG07379,BMG_DG136694,PubChem CID:32281 | N-[1-(2-carbamoylpyrrolidin-1-yl)-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | Protirelina | CAS RN:194100-83-9
+BMGC_DG07380,BMG_DG136700,"ENOXACIN | 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid | UNII:325OGW249P | DrugBank ID:DB00467 | CAS RN:74011-58-8 | PubChem CID:3229 | PubChem SID:198986773 | Enoxacin"
+BMGC_DG07381,BMG_DG136706,PubChem SID:175266697 | chromen-2-one | CAS RN:103802-83-1 | COUMARIN | DrugBank ID:DB04665 | PubChem CID:323 | UNII:A4VZ22K1WT | NDC:44911-0418 | NDC:43857-0272 | CAS RN:91-64-5 | Coumarin
+BMGC_DG07382,BMG_DG136739,"UNII:3A7M692XBV | CAS RN:2850-37-5 | 1-METHYL-8-PHENYL-3,7-DIHYDROPURINE-2,6-DIONE | PubChem CID:323342 | PubChem SID:475550279"
+BMGC_DG07383,BMG_DG136748,CAS RN:1939-53-3 | PubChem CID:323484 | UNII:KRH8M57WD7 | 2-PYRIDIN-3-YLBENZO(H)CHROMEN-4-ONE | PubChem SID:475550276
+BMGC_DG07384,BMG_DG136752,PubChem CID:3236 | EPERISONE | UNII:2M2P0551D3 | PubChem SID:198968031 | 1-(4-ethylphenyl)-2-methyl-3-piperidin-1-ylpropan-1-one | Eperisone | CAS RN:64840-90-0 | DrugBank ID:DB08992
+BMGC_DG07385,BMG_DG136759,DrugBank ID:DB07572 | PubChem CID:3236724 | 3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate
+BMGC_DG07386,BMG_DG136784,"2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine | PubChem SID:175271918 | UNII:Q13WX941EF | Epinastine | CAS RN:80012-43-7 | EPINASTINE | PubChem CID:3241 | DrugBank ID:DB00751"
+BMGC_DG07387,BMG_DG136790,Normeperidine | CAS RN:77-17-8 | UNII:JG096PMW2N | PubChem SID:198938926 | NORMEPERIDINE | PubChem CID:32414 | ethyl 4-phenylpiperidine-4-carboxylate
+BMGC_DG07388,BMG_DG136793,PubChem SID:198965455 | CAS RN:18694-40-1 | Epirizole | PubChem CID:3242 | EPIRIZOLE | UNII:3B46O2FH8I | 4-methoxy-2-(5-methoxy-3-methylpyrazol-1-yl)-6-methylpyrimidine | DrugBank ID:DB08991
+BMGC_DG07389,BMG_DG136817,C.I. Mordant black 11 | CAS RN:25747-08-4 | 3-hydroxy-4-[(1-hydroxynaphthalen-2-yl)diazenyl]-7-nitronaphthalene-1-sulfonic acid | PubChem CID:3246023
+BMGC_DG07390,BMG_DG136832,DrugBank ID:DB15493 | Cambinol | PubChem CID:3246390 | CAS RN:14513-15-6 | 5-[(2-hydroxynaphthalen-1-yl)methyl]-6-phenyl-2-sulfanylidene-1H-pyrimidin-4-one | PubChem SID:441659080 | CAMBINOL | UNII:8S2PHY4FNC
+BMGC_DG07391,BMG_DG136846,DrugBank ID:DB07440 | UNII:YV1D0UF57S | CAS RN:1133-17-1 | PubChem SID:438788137 | 4-TERT-BUTYLBENZENESULFONIC ACID | PubChem CID:324690
+BMGC_DG07392,BMG_DG136849,DrugBank ID:DB08324 | PubChem CID:3246941 | N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE
+BMGC_DG07393,BMG_DG136868,PubChem CID:3248571 | UNII:54BP69J53F | CAS RN:209480-63-7 | PubChem SID:474492856 | SB-258585
+BMGC_DG07394,BMG_DG136874,(3-(ETHOXYCARBONYL)PHENYL)BORONIC ACID | UNII:63752S6NBJ | (3-(Ethoxycarbonyl)phenyl)boronic acid | PubChem CID:3249312 | CAS RN:4334-87-6 | PubChem SID:474492550
+BMGC_DG07395,BMG_DG136876,PubChem CID:3249988 | CAS RN:54-89-7 | 2-[(4-aminobenzoyl)amino]acetate | p-Aminohippurate
+BMGC_DG07396,BMG_DG136878,"PubChem CID:3250 | N-(1-hydroxypropan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide"
+BMGC_DG07397,BMG_DG136885,"5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman | PubChem CID:3251 | N-(7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | CAS RN:113-15-5"
+BMGC_DG07398,BMG_DG136887,UNII:E7V2NA9T3K | 1-METHOXY-2-(4-METHOXY-3-PROP-2-ENYL-PHENYL)-4-PROP-2-ENYL-BENZENE | CAS RN:68592-18-7 | PubChem SID:475550260 | PubChem CID:325144
+BMGC_DG07399,BMG_DG136906,PubChem SID:485663529 | 2-METHYL-N-(4-SULFAMOYLPHENYL)PROPANAMIDE | 2-Methyl-N-(4-sulfamoylphenyl)propanamide | UNII:MBJ3CHN7DJ | CAS RN:114841-20-2 | PubChem CID:3253857
+BMGC_DG07400,BMG_DG136915,"PubChem CID:3255 | Eritrocina | 6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione | CAS RN:959119-26-7"
+BMGC_DG07401,BMG_DG136927,PubChem CID:3256857 | N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE | DrugBank ID:DB08289
+BMGC_DG07402,BMG_DG136928,PubChem CID:3256859 | 4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION | DrugBank ID:DB08295
+BMGC_DG07403,BMG_DG136929,DrugBank ID:DB08296 | PubChem CID:3256861 | 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
+BMGC_DG07404,BMG_DG136939,"CAS RN:15905-32-5 | TETRAIODOFLUORESCEIN | PubChem SID:198959780 | Erythrosin B | UNII:1A878FZQ9B | PubChem CID:3259 | 3',6'-dihydroxy-2',4',5',7'-tetraiodospiro[2-benzofuran-3,9'-xanthene]-1-one"
+BMGC_DG07405,BMG_DG136944,PubChem SID:198961869 | 2-Isobutyl-3-methoxypyrazine | DrugBank ID:DB04512 | CAS RN:24683-00-9 | 2-ISOBUTYL-3-METHOXYPYRAZINE | UNII:S327O0T12O | PubChem CID:32594 | 2-methoxy-3-(2-methylpropyl)pyrazine
+BMGC_DG07406,BMG_DG136950,UNII:O0893NC35F | CUMINALDEHYDE | CAS RN:122-03-2 | PubChem CID:326 | PubChem SID:198969346 | 4-propan-2-ylbenzaldehyde | Cuminaldehyde
+BMGC_DG07407,BMG_DG136952,DrugBank ID:DB02637 | PubChem CID:3260017 | Oxaloacetate Ion
+BMGC_DG07408,BMG_DG136955,"PubChem CID:326023 | PubChem SID:374388598 | CAS RN:32835-39-5 | 7-METHYL(1,2,4)TRIAZOLO(3,4-B)(1,3)BENZOTHIAZOLE | UNII:37L3H85Z90"
+BMGC_DG07409,BMG_DG136957,"PubChem CID:32603 | [6-[2-Chloro-1-[(1-methyl-4-propylpyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate | CAS RN:24729-96-2 | [6-[2-chloro-1-[(1-methyl-4-propylpyrrolidine-2-carbonyl)amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate"
+BMGC_DG07410,BMG_DG136958,"PubChem CID:326031 | PubChem SID:348481740 | 5,7-DIMETHYL(1,2,4)TRIAZOLO(3,4-B)(1,3)BENZOTHIAZOLE | UNII:G6GU7GHZ98 | CAS RN:68925-82-6"
+BMGC_DG07411,BMG_DG136960,"UNII:36S3EQV54C | 8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | PubChem CID:3261 | DrugBank ID:DB01215 | NDC:75907-028 | NDC:51862-074 | NDC:70954-481 | PubChem SID:175265512 | NDC:0591-0745 | NDC:0591-0744 | NDC:75907-029 | NDC:70954-480 | CAS RN:53180-72-6 | Estazolam | CAS RN:29975-16-4 | NDC:51862-073 | ESTAZOLAM"
+BMGC_DG07412,BMG_DG136965,"PubChem CID:3262017 | 6-Methyl-2,2-dioxooxathiazin-4-olate | 6-methyl-2,2-dioxooxathiazin-4-olate"
+BMGC_DG07413,BMG_DG137005,"PubChem CID:32681 | (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[1-oxo-3-(3,4,5-trimethoxyphenyl)prop-2-enoxy]-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylic acid methyl ester | Rescinnamine | DrugBank ID:DB01180 | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[3-(3,4,5-trimethoxyphenyl)prop-2-enoyloxy]-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate"
+BMGC_DG07414,BMG_DG137016,"CAS RN:54824-17-8 | 2-[2-(dimethylamino)ethyl]-5-nitrobenzo[de]isoquinoline-1,3-dione | Mitonafide | PubChem SID:198988916 | PubChem CID:327044 | UNII:06Q0V17SI9 | MITONAFIDE"
+BMGC_DG07415,BMG_DG137017,PubChem CID:327045 | PubChem SID:198959075 | UNII:1OZ94FI615 | CAS RN:54824-20-3 | PINAFIDE
+BMGC_DG07416,BMG_DG137023,"UNII:8LZ6Q43V2S | CAS RN:118876-58-7 | 6-nitro-2,3-dioxo-1,4-dihydrobenzo[f]quinoxaline-7-sulfonamide | PubChem CID:3272524 | NBQX | PubChem SID:472388023 | 2,3-Dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline"
+BMGC_DG07417,BMG_DG137040,"CAS RN:29574-57-0 | UNII:4GA6RL5B4W | PubChem SID:472422385 | 1,2-DINAPHTHALEN-2-YLETHANE-1,2-DIONE | 1,2-Dinaphthalen-2-ylethane-1,2-dione | PubChem CID:3274712"
+BMGC_DG07418,BMG_DG137041,Etafenone | ETAFENONE | 1-[2-[2-(diethylamino)ethoxy]phenyl]-3-phenylpropan-1-one | PubChem CID:3275 | UNII:0I14K589E7 | CAS RN:90-54-0 | PubChem SID:198963723 | DrugBank ID:DB13845
+BMGC_DG07419,BMG_DG137050,ETANIDAZOLE | CAS RN:22668-01-5 | PubChem SID:198980791 | UNII:30DKA3Q1HL | N-(2-hydroxyethyl)-2-(2-nitroimidazol-1-yl)acetamide | Etanidazole | PubChem CID:3276 | DrugBank ID:DB12736
+BMGC_DG07420,BMG_DG137056,"PubChem CID:3277 | CAS RN:51022-77-6 | ethyl 1-ethyl-4-(2-propan-2-ylidenehydrazinyl)pyrazolo[3,4-b]pyridine-5-carboxylate | PubChem SID:198942147 | UNII:I89Y79062L | Etazolate | ETAZOLATE"
+BMGC_DG07421,BMG_DG137059,SB-204741 | PubChem SID:461434435 | UNII:9VHM49MS42 | CAS RN:152239-46-8 | PubChem CID:3277600
+BMGC_DG07422,BMG_DG137060,"CAS RN:65183-61-1 | 7-ETHYLISOXAZOLO(3,4-D)PYRIMIDINE-4,6(5H,7H)-DIONE | UNII:36RAZ8WS5A | PubChem SID:441658978 | PubChem CID:327764"
+BMGC_DG07423,BMG_DG137062,"GLISOXEPIDE | PubChem SID:198959702 | DrugBank ID:DB01289 | UNII:H7SC0I332I | Glisoxepide | N-[2-[4-(azepan-1-ylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-1,2-oxazole-3-carboxamide | CAS RN:25046-79-1 | PubChem CID:32778"
+BMGC_DG07424,BMG_DG137063,"NDC:52817-367 | NDC:68682-011 | 2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid | PubChem CID:3278 | Etacrynic acid | CAS RN:58-54-8 | NDC:42799-405 | Ethacrynic acid | NDC:68180-159 | ETHACRYNIC ACID | NDC:69238-1126 | NDC:25010-215 | NDC:0832-1690 | UNII:M5DP350VZV | NDC:50228-334 | DrugBank ID:DB00903 | PubChem SID:175266725 | NDC:72162-2257 | NDC:60760-773"
+BMGC_DG07425,BMG_DG137065,CAS RN:51230-49-0 | 2-Chlorodibenzofuran | UNII:MGI055773B | PubChem CID:32781 | 2-CHLORODIBENZOFURAN | 2-chlorodibenzofuran | PubChem SID:198955550
+BMGC_DG07426,BMG_DG137071,"NDC:0168-0269 | NDC:69238-1732 | DrugBank ID:DB01013 | NDC:70771-1080 | NDC:63629-9461 | NDC:68180-536 | NDC:0168-0163 | NDC:50090-5264 | NDC:45802-637 | NDC:0472-0403 | NDC:33342-321 | NDC:72603-323 | NDC:42571-362 | NDC:62332-547 | NDC:45802-961 | NDC:68462-625 | NDC:70771-1498 | NDC:68180-956 | NDC:71085-007 | NDC:21922-017 | NDC:42291-077 | NDC:82804-133 | NDC:63629-9460 | NDC:72578-085 | NDC:51672-1259 | NDC:50090-5979 | NDC:63629-2393 | NDC:0299-3848 | NDC:68788-8238 | NDC:70771-1209 | NDC:33342-506 | NDC:21922-016 | NDC:72162-1273 | NDC:51672-1293 | NDC:63629-2331 | NDC:0472-0404 | NDC:63629-2329 | NDC:70700-106 | NDC:63629-8639 | [(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | NDC:70771-1442 | NDC:13668-569 | NDC:40032-028 | NDC:51672-1350 | NDC:50090-6717 | NDC:70710-1456 | NDC:40032-096 | NDC:69238-1532 | NDC:43538-950 | NDC:71205-151 | PubChem CID:32798 | NDC:21922-061 | NDC:62332-465 | NDC:70752-153 | NDC:50090-6731 | NDC:42291-076 | NDC:0168-0162 | NDC:63629-2457 | NDC:81772-007 | NDC:68040-713 | NDC:59651-732 | NDC:0591-4039 | NDC:68462-608 | NDC:72162-1961 | NDC:0168-0293 | NDC:82804-083 | Clobetasol propionate | NDC:68462-530 | NDC:43386-096 | NDC:68788-7963 | NDC:63629-2330 | UNII:779619577M | NDC:50090-6402 | NDC:51672-4193 | NDC:68462-480 | NDC:84277-5665 | NDC:51672-1294 | NDC:50090-7392 | NDC:72162-2300 | NDC:45802-437 | NDC:16714-030 | NDC:0168-0301 | NDC:50090-5488 | NDC:63629-2332 | NDC:63629-2458 | NDC:62332-425 | NDC:51672-1258 | NDC:50090-5079 | NDC:0713-0656 | NDC:72189-262 | NDC:68462-529 | NDC:68308-664 | NDC:62332-707 | NDC:43386-028 | NDC:0299-3847 | NDC:63629-8638 | NDC:51672-1347 | NDC:81046-0319 | NDC:50090-5778 | NDC:51672-1371 | NDC:50090-0549 | NDC:51407-737 | NDC:62332-486 | NDC:0299-3849 | NDC:70710-1401 | CAS RN:25122-46-7 | NDC:63629-2395 | Clobetasol Propionate | NDC:63629-2455 | NDC:51672-1297 | NDC:43538-952 | CLOBETASOL PROPIONATE | NDC:72162-1438 | NDC:72162-1807 | NDC:45802-925 | NDC:63629-2456 | NDC:63629-8637 | NDC:70700-109 | NDC:63629-2394 | NDC:68382-998 | NDC:84659-9040 | NDC:62332-548 | NDC:16714-782 | NDC:68462-532 | PubChem SID:175268871"
+BMGC_DG07427,BMG_DG137073,"UNII:2H2HC19DYZ | PubChem CID:3280 | ETHAVERINE | Ethaverine | 1-[(3,4-diethoxyphenyl)methyl]-6,7-diethoxyisoquinoline | PubChem SID:198939614 | CAS RN:486-47-5"
+BMGC_DG07428,BMG_DG137086,PubChem CID:3282 | ETHENZAMIDE | PubChem SID:198970183 | DrugBank ID:DB13544 | Ethenzamide | CAS RN:938-73-8 | 2-ethoxybenzamide | UNII:L929ZCK4BF
+BMGC_DG07429,BMG_DG137087,"CAS RN:26091-76-9 | 9-(2,3-Dihydroxy-3-methylbutoxy)furo[3,2-g]chromen-7-one | PubChem CID:328236 | CAS RN:118407-74-2 | 9-(2,3-dihydroxy-3-methylbutoxy)furo[3,2-g]chromen-7-one"
+BMGC_DG07430,BMG_DG137090,NDC:37662-2578 | UNII:0F5N573A2Y | NDC:37662-2577 | CAS RN:60-29-7 | NDC:37662-2579 | ethoxyethane | NDC:37662-2582 | PubChem CID:3283 | ETHER | DrugBank ID:DB13598 | Diethyl Ether | NDC:37662-2583 | PubChem SID:175265771 | CAS RN:667919-88-2 | NDC:37662-2581 | NDC:37662-2580
+BMGC_DG07431,BMG_DG137101,CAS RN:126-52-3 | (1-ethynylcyclohexyl) carbamate | DrugBank ID:DB01031 | ETHINAMATE | UNII:IAN371PP48 | PubChem SID:198963123 | PubChem CID:3284 | Ethinamate
+BMGC_DG07432,BMG_DG137114,"PubChem CID:32874 | Adriblastin | (7S,9S)-7-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride"
+BMGC_DG07433,BMG_DG137119,"CAS RN:69408-83-9 | PubChem CID:328774 | PubChem SID:376231539 | 5-AMINO-2-(2-(1-PYRROLIDINYL)ETHYL)-1H-BENZO(DE)ISOQUINOLINE-1,3(2H)-DIONE | UNII:1TW4LP4IB1"
+BMGC_DG07434,BMG_DG137134,Levamfetamine | LEVAMFETAMINE | (2R)-1-phenylpropan-2-amine | PubChem CID:32893 | CAS RN:156-34-3 | UNII:R87US8P740 | PubChem SID:198971899
+BMGC_DG07435,BMG_DG137139,"Profenamine | UNII:7WI4P02YN1 | PubChem CID:3290 | N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine | DrugBank ID:DB00392 | CAS RN:522-00-9 | PubChem SID:198955809 | PROFENAMINE"
+BMGC_DG07436,BMG_DG137143,"PubChem CID:3291 | NDC:62135-790 | PubChem SID:175271633 | NDC:63629-8005 | NDC:64380-878 | Ethosuximide | NDC:69452-152 | NDC:0121-0670 | NDC:59762-2350 | ETHOSUXIMIDE | CAS RN:77-67-8 | DrugBank ID:DB00593 | NDC:42806-711 | NDC:42806-708 | UNII:5SEH9X1D1D | 3-ethyl-3-methylpyrrolidine-2,5-dione | NDC:23155-532 | NDC:0071-0237 | NDC:0071-2418"
+BMGC_DG07437,BMG_DG137146,"PubChem CID:3292 | Ethotoin | ETHOTOIN | PubChem SID:175272175 | 3-ethyl-5-phenylimidazolidine-2,4-dione | DrugBank ID:DB00754 | UNII:46QG38NC4U | CAS RN:86-35-1"
+BMGC_DG07438,BMG_DG137151,UNII:ZM4360761C | PubChem SID:318691398 | SB-216641 | PubChem CID:3292447 | CAS RN:170230-39-4
+BMGC_DG07439,BMG_DG137162,PubChem CID:3294 | UNII:59AF853SW7 | 7-ethoxyphenoxazin-3-one | CAS RN:5725-91-7 | PubChem SID:472388674 | 7-ETHOXYRESORUFIN | 7-Ethoxyresorufin
+BMGC_DG07440,BMG_DG137168,"CAS RN:452-35-7 | UNII:Z52H4811WX | PubChem CID:3295 | Ethoxzolamide | DrugBank ID:DB00311 | ETHOXZOLAMIDE | 6-ethoxy-1,3-benzothiazole-2-sulfonamide | PubChem SID:198950247"
+BMGC_DG07441,BMG_DG137182,"PubChem SID:198959481 | Ethyl loflazepate | ethyl 7-chloro-5-(2-fluorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepine-3-carboxylate | ETHYL LOFLAZEPATE | UNII:VJB5FW9W9J | PubChem CID:3299 | CAS RN:29177-84-2 | DrugBank ID:DB01545"
+BMGC_DG07442,BMG_DG137186,"PubChem CID:329983 | MENTHOFURAN, (±)- | 3,6-dimethyl-4,5,6,7-tetrahydro-1-benzofuran | Menthofuran | UNII:LK024V9U3C | CAS RN:494-90-6 | PubChem SID:198990115 | MENTHOFURAN, (+/-)-"
+BMGC_DG07443,BMG_DG137187,PubChem CID:33 | CAS RN:107-20-0 | UNII:CF069F5D9C | CHLOROACETALDEHYDE | 2-chloroacetaldehyde | PubChem SID:198944861 | Chloroacetaldehyde
+BMGC_DG07444,BMG_DG137193,"UNII:60V9STC53F | PubChem SID:175268268 | Ethylenediamine | DrugBank ID:DB14189 | ETHYLENEDIAMINE | ethane-1,2-diamine | CAS RN:107-15-3 | PubChem CID:3301"
+BMGC_DG07445,BMG_DG137202,Glutamic Acid | CAS RN:25513-46-6 | UNII:3KX376GY7L | Glutamic acid | CAS RN:56-86-0 | GLUTAMIC ACID | PubChem SID:175265460 | (2S)-2-aminopentanedioic acid | DrugBank ID:DB00142 | CAS RN:6899-05-4 | PubChem CID:33032 | NDC:83117-008
+BMGC_DG07446,BMG_DG137203,"DrugBank ID:DB13679 | PubChem CID:33036 | CAS RN:25523-97-1 | Dexchlorpheniramine | UNII:3Q9Q0B929N | (3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine | DEXCHLORPHENIRAMINE | PubChem SID:175265674"
+BMGC_DG07447,BMG_DG137204,"PubChem CID:33037 | DrugBank ID:DB03603 | (2S,3S,4S,5R)-2,3,4,5-tetrahydroxyhexanedioic acid | CAS RN:25525-21-7 | UNII:QLZ991V4A2 | CAS RN:87-73-0 | PubChem SID:198957290 | GLUCARIC ACID | Glucaric acid"
+BMGC_DG07448,BMG_DG137207,"PubChem SID:198987252 | DrugBank ID:DB06198 | 1-[(2R,4S,5R)-4-fluoro-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | PubChem CID:33039 | UNII:PG53R0DWDQ | CAS RN:25526-93-6 | Alovudine | ALOVUDINE"
+BMGC_DG07449,BMG_DG137210,"DrugBank ID:DB03615 | (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol | CAS RN:25546-65-0 | PubChem SID:198984005 | Ribostamycin | RIBOSTAMYCIN | PubChem CID:33042 | UNII:2Q5JOU7T53"
+BMGC_DG07450,BMG_DG137213,N-ACETYLPHENOXAZINE | PubChem CID:3304561 | PubChem SID:198945917 | CAS RN:6192-43-4 | UNII:VVA9DLS3TV
+BMGC_DG07451,BMG_DG137217,UNII:M2F465ROXU | (1-hydroxy-1-phosphonoethyl)phosphonic acid | ETIDRONIC ACID | Etidronic acid | Etidronic Acid | PubChem CID:3305 | DrugBank ID:DB01077 | CAS RN:2809-21-4 | CAS RN:358730-93-5 | PubChem SID:175266486
+BMGC_DG07452,BMG_DG137221,DrugBank ID:DB08985 | UNII:ZB6F8MY53V | CAS RN:709-55-7 | PubChem CID:3306 | Etilefrine | ETILEFRINE | CAS RN:10128-36-6 | PubChem SID:198950034 | 3-[2-(ethylamino)-1-hydroxyethyl]phenol
+BMGC_DG07453,BMG_DG137222,"CAS RN:40054-69-1 | DrugBank ID:DB09166 | Etizolam | ETIZOLAM | 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene | PubChem SID:198952354 | UNII:A76XI0HL37 | PubChem CID:3307"
+BMGC_DG07454,BMG_DG137223,"5-(3-NITRO-4-PIPERIDINOPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE | UNII:HGM26E28GV | 5-(3-Nitro-4-piperidinophenyl)-6-ethyl-2,4-pyrimidinediamine | PubChem CID:330712 | CAS RN:104484-42-6 | PubChem SID:472411317"
+BMGC_DG07455,BMG_DG137227,"NDC:80425-0381 | NDC:68382-273 | PubChem CID:3308 | NDC:71335-0982 | NDC:69238-1343 | NDC:55700-592 | NDC:68788-7300 | NDC:51672-4018 | NDC:71205-140 | NDC:69306-020 | NDC:0093-1122 | NDC:68788-8580 | NDC:70518-3839 | NDC:80425-0181 | NDC:0185-0675 | NDC:51672-4052 | NDC:0093-7172 | NDC:62135-911 | NDC:43063-856 | NDC:80425-0190 | NDC:51672-4016 | NDC:62559-250 | NDC:63187-374 | NDC:65841-778 | NDC:60760-378 | NDC:65841-777 | NDC:71610-850 | NDC:63187-793 | NDC:65841-779 | NDC:62559-251 | NDC:68071-3731 | NDC:50090-6739 | NDC:71610-794 | NDC:60505-0102 | NDC:51672-4017 | NDC:16714-499 | NDC:71610-859 | NDC:71610-779 | NDC:50090-3963 | NDC:63629-8598 | NDC:71610-816 | NDC:0093-1118 | NDC:68382-272 | NDC:60505-0040 | NDC:0185-0687 | NDC:71335-1230 | NDC:72162-1756 | NDC:63629-1935 | NDC:68788-7315 | NDC:60505-0041 | NDC:51672-4053 | NDC:68382-271 | NDC:60760-552 | PubChem SID:175271585 | NDC:51672-4051 | NDC:51655-423 | NDC:71335-1958 | NDC:60429-244 | NDC:60429-314 | NDC:62135-910 | NDC:50090-1790 | NDC:60429-311 | NDC:68788-8673 | NDC:60429-243 | NDC:60429-312 | NDC:16714-497 | NDC:43063-578 | UNII:2M36281008 | NDC:50090-2133 | NDC:83008-073 | NDC:43063-834 | 2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid | NDC:42799-112 | NDC:51655-166 | NDC:72162-1757 | NDC:43353-294 | NDC:45865-206 | NDC:70518-3845 | NDC:80425-0126 | NDC:51655-735 | NDC:50090-2132 | NDC:16714-498 | NDC:50090-4053 | NDC:69238-1342 | NDC:71610-804 | NDC:50090-1789 | NDC:71335-2259 | NDC:71205-467 | NDC:71335-0126 | NDC:63629-1936 | NDC:60505-0039 | NDC:63187-736 | NDC:71335-0399 | NDC:80425-0140 | NDC:71610-795 | NDC:51672-4036 | NDC:50090-3974 | NDC:60760-298 | CAS RN:41340-25-4 | NDC:42799-111 | NDC:63629-8805 | DrugBank ID:DB00749 | ETODOLAC | Etodolac | NDC:43063-671 | NDC:71205-743 | NDC:60429-313"
+BMGC_DG07456,BMG_DG137250,DrugBank ID:DB02991 | S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea | PubChem CID:3311
+BMGC_DG07457,BMG_DG137253,DrugBank ID:DB00926 | Etretinate | PubChem CID:3312
+BMGC_DG07458,BMG_DG137260,"8-(4-METHOXYPHENYL)NAPHTHO(2',1':4,5)THIAZOLO(2,3-C)(1,2,4)TRIAZOLE | CAS RN:69484-91-9 | PubChem CID:331326 | UNII:BIM3OQ585E | PubChem SID:375579292"
+BMGC_DG07459,BMG_DG137267,EUGENOL | CAS RN:97-53-0 | NDC:10742-0009 | Eugenol | PubChem SID:175268363 | DrugBank ID:DB09086 | NDC:27854-178 | 2-methoxy-4-prop-2-enylphenol | UNII:3T8H1794QW | PubChem CID:3314
+BMGC_DG07460,BMG_DG137279,2-Isopropyl-3-methoxypyrazine | UNII:1FL7L111A6 | PubChem CID:33166 | DrugBank ID:DB01760 | 2-Methoxy-3-Isopropylpyrazine | 2-methoxy-3-propan-2-ylpyrazine | PubChem SID:198970086 | CAS RN:25773-40-4 | 2-ISOPROPYL-3-METHOXYPYRAZINE
+BMGC_DG07461,BMG_DG137286,"UNII:FRG4N852F7 | (1R,2R,3S,3aR,8bS)-1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-2,3-dihydro-1H-cyclopenta[b][1]benzofuran-2-carboxamide | ROCAGLAMIDE | Rocaglamide | PubChem SID:441331866 | PubChem CID:331783 | DrugBank ID:DB15495 | CAS RN:84573-16-0 | CAS RN:117894-34-5"
+BMGC_DG07462,BMG_DG137295,2-METHOXY-4-VINYLPHENOL | PubChem SID:198950653 | 2-Methoxy-4-vinylphenol | 4-ethenyl-2-methoxyphenol | CAS RN:31853-85-7 | DrugBank ID:DB03514 | 4-Vinylguaiacol | UNII:DA069CTH0O | CAS RN:7786-61-0 | PubChem CID:332
+BMGC_DG07463,BMG_DG137302,"1-METHYL-2,3-CYCLOHEXADIONE | PubChem SID:198987505 | UNII:2GKY1ALK5L | PubChem CID:3321360 | CAS RN:3008-43-3"
+BMGC_DG07464,BMG_DG137308,"Cx-717 | 2,1,3-benzoxadiazol-5-yl(morpholin-4-yl)methanone | PubChem SID:404859293 | CAS RN:867276-98-0 | CAS RN:211735-82-9 | DrugBank ID:DB05047 | PubChem CID:3323368 | CX-717 | UNII:7I12YTA3QM"
+BMGC_DG07465,BMG_DG137309,CAS RN:104227-87-4 | NDC:65862-466 | NDC:33342-024 | NDC:63187-920 | NDC:71205-609 | NDC:33342-025 | NDC:42291-416 | NDC:65862-467 | NDC:64980-351 | NDC:42291-415 | [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate | NDC:63187-919 | NDC:0093-8117 | UNII:QIC03ANI02 | NDC:31722-708 | DrugBank ID:DB00426 | NDC:64980-350 | PubChem CID:3324 | NDC:63187-998 | NDC:55289-168 | Famciclovir | NDC:33342-026 | NDC:42291-414 | NDC:60505-3246 | NDC:31722-707 | FAMCICLOVIR | NDC:0093-8118 | NDC:31722-706 | NDC:64980-349 | NDC:60505-3245 | NDC:60505-3247 | NDC:65862-465 | NDC:0093-8119 | PubChem SID:175266420
+BMGC_DG07466,BMG_DG137310,"4-[[(3R,4R,5S)-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)oxolan-3-yl]methyl]-2-methoxyphenol | CAS RN:27003-73-2 | UNII:73XCE5OZB0 | Lariciresinol | PubChem CID:332427 | PubChem SID:241179692 | LARICIRESINOL"
+BMGC_DG07467,BMG_DG137316,"NDC:69842-063 | NDC:49035-589 | NDC:43386-500 | NDC:65862-860 | NDC:0832-6045 | NDC:55111-119 | NDC:70756-051 | NDC:11673-697 | NDC:16837-889 | NDC:72789-331 | NDC:68001-398 | NDC:70518-3829 | NDC:58602-859 | NDC:70518-3831 | NDC:50090-7196 | NDC:67296-1795 | NDC:69238-2090 | NDC:83008-091 | NDC:72189-543 | NDC:68788-7922 | NDC:67877-775 | NDC:49884-366 | NDC:68788-8518 | NDC:71335-2190 | NDC:0113-0194 | NDC:25021-753 | NDC:71335-0370 | NDC:71335-1950 | NDC:83059-0005 | NDC:58602-706 | NDC:71335-9615 | DrugBank ID:DB00927 | NDC:71205-257 | NDC:56062-194 | NDC:68645-594 | NDC:21130-022 | NDC:80425-0422 | NDC:59779-141 | NDC:70000-0048 | NDC:80005-119 | NDC:50594-002 | NDC:69306-266 | NDC:69844-096 | NDC:50268-299 | NDC:71821-012 | NDC:70748-312 | NDC:36800-141 | NDC:72789-027 | NDC:71335-0409 | NDC:0172-5729 | NDC:68016-800 | NDC:67457-457 | NDC:68071-2306 | NDC:83008-089 | NDC:62332-002 | NDC:73581-108 | Pepcid | NDC:0363-4400 | NDC:37808-301 | NDC:68391-300 | NDC:69844-095 | NDC:21130-023 | NDC:72205-146 | NDC:72657-113 | NDC:0113-0141 | NDC:70518-0461 | NDC:69168-445 | NDC:60760-843 | CAS RN:76824-35-6 | NDC:31722-315 | NDC:50090-3888 | NDC:55910-194 | NDC:0187-4440 | NDC:46708-293 | NDC:70860-751 | NDC:83324-003 | NDC:70771-1703 | NDC:43063-086 | NDC:36800-194 | NDC:76420-712 | NDC:68094-054 | NDC:55154-4313 | NDC:49035-396 | NDC:63941-011 | NDC:50090-7180 | NDC:60760-736 | NDC:71335-2442 | NDC:67296-1859 | NDC:43602-602 | NDC:71335-9748 | NDC:72036-026 | NDC:0574-0147 | NDC:11673-031 | NDC:70710-1783 | NDC:50090-6932 | NDC:67296-1121 | NDC:71872-7235 | NDC:62332-001 | NDC:46122-735 | NDC:69367-400 | NDC:55111-120 | NDC:63868-583 | NDC:69842-924 | NDC:71821-010 | NDC:68001-397 | NDC:55315-435 | NDC:51662-1375 | FAMOTIDINE | NDC:63323-739 | NDC:63629-2015 | NDC:70677-1101 | NDC:50090-1044 | NDC:68001-494 | NDC:50090-7178 | NDC:63739-645 | NDC:63941-009 | NDC:0172-5728 | NDC:57896-319 | NDC:11822-0141 | NDC:50090-6916 | NDC:72476-150 | NDC:68071-4197 | NDC:69256-002 | NDC:70710-1782 | NDC:60429-721 | NDC:69842-267 | NDC:57896-317 | NDC:49035-507 | NDC:76420-891 | NDC:63323-738 | NDC:50090-1432 | NDC:30142-141 | NDC:72603-171 | NDC:37808-042 | NDC:69842-659 | NDC:71610-470 | NDC:46122-737 | NDC:64980-623 | NDC:0363-1899 | NDC:67457-448 | NDC:61442-121 | NDC:67046-1427 | NDC:0536-1298 | NDC:70771-1702 | NDC:63629-8891 | NDC:72789-453 | NDC:43063-533 | NDC:72288-194 | NDC:0363-9607 | NDC:55319-427 | NDC:71335-9724 | NDC:51407-684 | NDC:76162-300 | NDC:69230-327 | NDC:70860-753 | NDC:71205-276 | NDC:72162-1737 | NDC:11822-6123 | NDC:68071-3420 | NDC:43598-824 | NDC:55111-118 | NDC:69842-266 | NDC:72189-207 | NDC:53943-100 | NDC:66715-6458 | NDC:11822-1014 | NDC:11822-1194 | NDC:58602-828 | NDC:63187-908 | NDC:16837-872 | NDC:41163-001 | NDC:10267-5689 | NDC:63629-7013 | NDC:70518-1415 | NDC:25000-086 | NDC:46708-294 | NDC:43598-960 | NDC:70377-113 | NDC:43063-695 | NDC:68788-8269 | NDC:68475-400 | NDC:72559-032 | NDC:31722-017 | NDC:50090-6582 | NDC:43602-501 | NDC:69842-928 | NDC:62135-807 | NDC:59779-194 | NDC:58602-829 | NDC:0338-5197 | NDC:61442-122 | NDC:68071-3584 | NDC:70710-1683 | NDC:55910-141 | NDC:55154-2628 | NDC:16837-855 | NDC:49348-817 | NDC:56062-141 | NDC:70710-1784 | NDC:83324-116 | NDC:25000-087 | NDC:63629-2782 | NDC:68645-140 | NDC:67046-1224 | NDC:0641-6022 | NDC:63981-194 | NDC:55111-396 | NDC:49035-118 | NDC:70000-0710 | NDC:67877-889 | NDC:73581-109 | NDC:41520-901 | NDC:66715-9748 | NDC:68788-8733 | NDC:41167-0360 | NDC:62135-808 | NDC:70756-052 | NDC:68788-7853 | NDC:68788-8285 | NDC:67296-1383 | NDC:0641-6023 | NDC:41167-0361 | NDC:21130-033 | NDC:49348-128 | NDC:68788-8485 | NDC:21130-249 | NDC:71872-7220 | NDC:60760-327 | NDC:72865-214 | NDC:24385-385 | NDC:50090-5241 | NDC:11673-061 | NDC:10267-5690 | NDC:21130-777 | NDC:79903-115 | NDC:55910-814 | NDC:67457-433 | NDC:0363-0141 | NDC:70518-0163 | NDC:67296-1776 | NDC:43063-696 | NDC:55319-426 | NDC:43602-544 | NDC:69842-087 | PubChem CID:3325 | NDC:59640-023 | NDC:81522-141 | NDC:49035-505 | NDC:63187-129 | NDC:41226-719 | NDC:43602-502 | NDC:70677-1102 | NDC:80425-0329 | NDC:63187-723 | NDC:55681-342 | NDC:25021-754 | NDC:70518-1877 | NDC:72288-329 | NDC:68016-801 | NDC:49483-720 | NDC:69168-443 | NDC:67296-1523 | NDC:69230-326 | NDC:50269-156 | NDC:63629-2014 | NDC:58602-705 | NDC:11673-414 | NDC:21130-039 | NDC:80267-501 | NDC:80425-0384 | NDC:72288-151 | NDC:41163-313 | NDC:50268-304 | NDC:75987-010 | NDC:72476-299 | NDC:72789-345 | NDC:83324-008 | NDC:31722-018 | NDC:60219-2090 | NDC:72288-141 | NDC:63187-999 | UNII:5QZO15J2Z8 | NDC:45865-881 | NDC:0904-5529 | NDC:67296-0963 | NDC:60687-595 | NDC:72789-427 | NDC:71335-2527 | NDC:63868-584 | NDC:71205-637 | NDC:67046-1473 | NDC:0615-8301 | NDC:53943-101 | NDC:65862-859 | NDC:70771-1847 | NDC:67877-626 | PubChem SID:175266759 | NDC:41167-0364 | NDC:46122-394 | NDC:55681-341 | NDC:0904-7193 | NDC:42571-433 | NDC:76420-713 | NDC:30142-194 | NDC:0187-4420 | NDC:31722-063 | NDC:69844-098 | NDC:67751-214 | NDC:0641-6021 | NDC:72205-145 | NDC:64980-624 | NDC:68382-444 | NDC:70000-0049 | NDC:43602-511 | NDC:68196-121 | NDC:69844-097 | 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide | NDC:49035-650 | NDC:72288-363 | NDC:50090-1045 | NDC:0363-1203 | NDC:43598-572 | NDC:41520-707 | NDC:69367-401 | NDC:59640-001 | NDC:66715-9758 | NDC:70954-316 | NDC:72865-215 | NDC:51407-452 | NDC:54257-802 | NDC:70000-0654 | NDC:72189-141 | NDC:67296-1892 | NDC:71205-535 | NDC:0363-5300 | NDC:41250-493 | NDC:51655-312 | NDC:68788-6859 | NDC:51655-233 | NDC:71335-0231 | NDC:11822-6141 | NDC:72657-112 | NDC:0363-0701 | NDC:70710-1684 | NDC:70860-752 | NDC:71205-634 | NDC:71335-1520 | NDC:80267-194 | NDC:27241-249 | NDC:55154-6843 | NDC:68071-3201 | NDC:51407-683 | NDC:72657-132 | NDC:71610-399 | NDC:50269-155 | NDC:71205-781 | NDC:55910-665 | NDC:51655-102 | NDC:70518-4084 | NDC:41250-712 | NDC:21130-191 | NDC:68788-7191 | NDC:71205-663 | NDC:0615-4582 | NDC:67877-843 | NDC:70771-1846 | NDC:67877-842 | NDC:50383-913 | NDC:68180-150 | NDC:70771-1845 | NDC:50090-6790 | Famotidine | NDC:21130-027 | NDC:83059-0031 | NDC:54257-180 | NDC:0904-5780"
+BMGC_DG07468,BMG_DG137320,"PubChem CID:33255 | PubChem SID:175266960 | CEFAZOLIN | (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CAS RN:25953-19-9 | UNII:IHS69L0Y4T | Cefazolin | DrugBank ID:DB01327"
+BMGC_DG07469,BMG_DG137326,1-methyl-5-[[methyl(1-phenylpropan-2-yl)amino]methyl]-2-phenyl-4-propan-2-ylpyrazol-3-one | UNII:HN0NCX453C | Famprofazone | FAMPROFAZONE | CAS RN:22881-35-2 | PubChem CID:3326 | PubChem SID:198988760
+BMGC_DG07470,BMG_DG137333,"3,7,11-trimethyldodeca-2,6,10-trien-1-ol | Farnesol | CAS RN:4602-84-0 | PubChem CID:3327"
+BMGC_DG07471,BMG_DG137338,"PubChem CID:332806 | PubChem SID:474492565 | Dihydroclusin, (-)- | UNII:JZY8N27PKT | DIHYDROCLUSIN, (-)- | CAS RN:73149-51-6"
+BMGC_DG07472,BMG_DG137352,PubChem CID:3330 | CAS RN:370-86-5 | CARBONYL CYANIDE P-TRIFLUOROMETHOXYPHENYLHYDRAZONE | UNII:SQR3W2FLV5 | 2-[[4-(trifluoromethoxy)phenyl]hydrazinylidene]propanedinitrile | PubChem SID:461434321 | Carbonyl cyanide p-trifluoromethoxyphenylhydrazone
+BMGC_DG07473,BMG_DG137355,PubChem SID:318164003 | OXYPEUCEDANIN | CAS RN:26091-73-6 | UNII:S1Y67F37PI | PubChem CID:33306
+BMGC_DG07474,BMG_DG137357,"Cambendazole | PubChem CID:33309 | propan-2-yl N-[2-(1,3-thiazol-4-yl)-3H-benzimidazol-5-yl]carbamate | CAS RN:9039-53-6 | CAS RN:26097-80-3 | UNII:079X63S3DU | DrugBank ID:DB11380 | PubChem SID:198968417 | CAMBENDAZOLE"
+BMGC_DG07475,BMG_DG137359,NDC:0037-0430 | NDC:0037-0431 | NDC:51525-0430 | NDC:51525-0431 | NDC:51672-4186 | NDC:72162-1770 | NDC:72162-1771 | Felbamate | (3-carbamoyloxy-2-phenylpropyl) carbamate | NDC:51525-0442 | NDC:65162-686 | NDC:70954-051 | NDC:70771-1078 | PubChem SID:175265407 | NDC:72578-057 | DrugBank ID:DB00949 | NDC:62559-730 | NDC:72578-056 | UNII:X72RBB02N8 | NDC:63629-1937 | PubChem CID:3331 | NDC:51672-4172 | CAS RN:25451-15-4 | NDC:53746-735 | NDC:65162-734 | NDC:65162-735 | NDC:16714-775 | FELBAMATE | NDC:63629-1944 | NDC:0037-0442 | NDC:62559-731 | NDC:70771-1077 | NDC:51672-4185 | NDC:53746-734
+BMGC_DG07476,BMG_DG137363,PubChem CID:3332 | Felbinac | CAS RN:5728-52-9 | FELBINAC | DrugBank ID:DB07477 | 2-(4-phenylphenyl)acetic acid | UNII:94WNJ5U8L7 | PubChem SID:198985184
+BMGC_DG07477,BMG_DG137367,"NDC:69117-0028 | NDC:72162-1158 | NDC:0603-3581 | NDC:13668-134 | NDC:68462-235 | NDC:72162-1743 | NDC:72162-1744 | NDC:63629-2193 | NDC:50090-7206 | NDC:65862-675 | NDC:61442-432 | FELODIPINE | NDC:71335-2175 | 5-O-ethyl 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | NDC:57237-109 | NDC:69367-266 | NDC:50090-1124 | NDC:69367-264 | NDC:63629-2192 | NDC:63629-2194 | NDC:72162-1160 | CAS RN:1217716-73-8 | NDC:62135-646 | NDC:57237-108 | NDC:23155-048 | NDC:69367-265 | NDC:61442-433 | NDC:71205-922 | DrugBank ID:DB01023 | NDC:63629-2017 | NDC:65862-674 | NDC:68462-234 | NDC:63629-2191 | NDC:71335-1318 | CAS RN:1217744-87-0 | NDC:72162-1742 | NDC:23155-049 | NDC:51407-089 | PubChem CID:3333 | NDC:23155-050 | NDC:62135-648 | NDC:63629-2195 | NDC:13668-132 | CAS RN:72509-76-3 | NDC:57237-110 | NDC:13668-133 | NDC:50090-5870 | NDC:62135-647 | NDC:68462-233 | NDC:71205-920 | NDC:63629-2196 | NDC:69117-0029 | NDC:63629-2018 | NDC:71335-1486 | NDC:71205-921 | NDC:0603-3582 | NDC:69117-0030 | NDC:0603-3583 | PubChem SID:175271822 | UNII:OL961R6O2C | Felodipine | NDC:51407-088 | NDC:65862-673 | NDC:63629-2016 | NDC:61442-431"
+BMGC_DG07478,BMG_DG137370,Fenbendazole | CAS RN:43210-67-9 | DrugBank ID:DB11410 | methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl)carbamate | FENBENDAZOLE | PubChem SID:175267027 | PubChem CID:3334 | UNII:621BVT9M36
+BMGC_DG07479,BMG_DG137374,CAS RN:86455-91-6 | UNII:FT9763S4HA | 1-[[2-(Dimethylamino)ethyl]amino]-7-hydroxy-4-(hydroxymethyl)-9H-thioxanthen-9-one | PubChem SID:474491109 | PubChem CID:333459 | 1-((2-(DIMETHYLAMINO)ETHYL)AMINO)-7-HYDROXY-4-(HYDROXYMETHYL)-9H-THIOXANTHEN-9-ONE
+BMGC_DG07480,BMG_DG137379,CAS RN:36330-85-5 | PubChem SID:198953042 | 4-oxo-4-(4-phenylphenyl)butanoic acid | PubChem CID:3335 | FENBUFEN | DrugBank ID:DB08981 | Fenbufen | UNII:9815R1WR9B
+BMGC_DG07481,BMG_DG137380,"UNII:JKE3T5ATM7 | PubChem CID:333509 | PubChem SID:376231438 | 4,5-DIHYDRO-1H-PYRAZOLO(4',3':3,4)PYRIDO(2,1-A)ISOINDOLE-1,7(2H)-DIONE | CAS RN:66799-57-3"
+BMGC_DG07482,BMG_DG137384,"Fendiline | FENDILINE | DrugBank ID:DB08980 | PubChem CID:3336 | 3,3-diphenyl-N-(1-phenylethyl)propan-1-amine | CAS RN:13042-18-7 | UNII:S253D559A8 | PubChem SID:198937516"
+BMGC_DG07483,BMG_DG137390,PubChem SID:198941480 | DrugBank ID:DB00574 | N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine | Fenfluramine | CAS RN:458-24-2 | PubChem CID:3337 | NDC:43376-322 | FENFLURAMINE | UNII:2DS058H2CF
+BMGC_DG07484,BMG_DG137397,NDC:42858-067 | NDC:43353-272 | NDC:27437-109 | NDC:35561-346 | NDC:70756-214 | NDC:50090-7208 | NDC:35561-250 | NDC:63187-640 | NDC:63304-444 | NDC:42385-935 | NDC:0615-8530 | NDC:46708-555 | NDC:43975-444 | PubChem SID:175266634 | NDC:68788-7932 | NDC:51655-009 | NDC:55111-395 | NDC:72789-310 | NDC:43547-430 | NDC:0115-1523 | NDC:35561-343 | NDC:83008-072 | NDC:63629-9474 | NDC:68071-2369 | NDC:60687-713 | NDC:63304-443 | NDC:63304-901 | NDC:35561-345 | NDC:27437-108 | NDC:62559-305 | NDC:71335-1286 | NDC:43975-305 | NDC:68788-8106 | NDC:62332-086 | NDC:42385-936 | NDC:46708-085 | NDC:71205-949 | NDC:62559-460 | NDC:0615-8270 | NDC:51407-204 | NDC:35561-344 | NDC:35561-347 | NDC:60219-5511 | NDC:68071-5101 | Fenofibrate | NDC:82619-102 | PubChem CID:3339 | NDC:0378-7101 | NDC:70756-215 | NDC:42385-950 | NDC:65862-769 | NDC:67046-1361 | NDC:62332-360 | NDC:62332-555 | NDC:0378-4390 | NDC:27241-117 | NDC:50090-7209 | NDC:50090-5854 | NDC:27437-110 | NDC:62135-893 | NDC:68462-581 | NDC:50090-6974 | NDC:0378-4391 | NDC:43598-909 | NDC:51655-433 | NDC:51655-856 | NDC:50090-5244 | NDC:46708-361 | NDC:82868-018 | NDC:69315-289 | NDC:31722-595 | NDC:71205-666 | NDC:68788-7816 | NDC:65862-768 | NDC:71335-2413 | DrugBank ID:DB01039 | NDC:63304-449 | NDC:62135-838 | NDC:60505-3121 | NDC:63629-1101 | NDC:27241-120 | NDC:69844-009 | NDC:13668-439 | NDC:60687-618 | NDC:0378-3066 | NDC:69097-895 | NDC:42858-660 | NDC:59651-201 | NDC:69238-1263 | NDC:51655-866 | NDC:50090-6973 | NDC:72789-410 | NDC:43353-898 | NDC:42858-134 | NDC:62332-538 | NDC:63629-1099 | NDC:60505-3120 | NDC:69238-1260 | NDC:71205-050 | NDC:46708-360 | NDC:46708-351 | UNII:U202363UOS | NDC:13668-440 | NDC:60760-318 | NDC:62559-461 | NDC:63187-940 | NDC:71335-0872 | NDC:68180-360 | NDC:69367-254 | NDC:51079-599 | NDC:0074-3173 | NDC:62332-350 | NDC:35561-249 | NDC:50090-6934 | NDC:62559-306 | NDC:62332-361 | NDC:70518-2907 | NDC:82009-060 | NDC:43598-910 | NDC:68462-580 | NDC:51655-554 | NDC:68462-582 | NDC:43975-306 | NDC:69097-458 | NDC:51079-608 | NDC:50090-3056 | NDC:69238-1262 | NDC:50268-338 | NDC:51407-094 | NDC:42291-045 | NDC:59651-202 | NDC:62135-899 | NDC:55700-876 | NDC:59651-576 | NDC:50090-5327 | NDC:50090-2899 | NDC:50090-3044 | NDC:60687-629 | NDC:63304-900 | NDC:51407-093 | NDC:42858-454 | NDC:70518-2947 | NDC:46708-086 | NDC:27241-119 | NDC:42385-951 | NDC:51407-205 | NDC:69844-012 | NDC:50268-312 | NDC:62332-351 | NDC:50090-6120 | NDC:69844-008 | NDC:71205-190 | NDC:46708-084 | NDC:62332-085 | NDC:71610-027 | NDC:0904-7161 | NDC:68180-131 | NDC:62332-084 | NDC:59651-203 | CAS RN:49562-28-9 | NDC:31722-596 | NDC:62135-894 | NDC:42858-200 | propan-2-yl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate | NDC:71335-2016 | NDC:42291-427 | NDC:50090-6227 | NDC:62135-837 | NDC:71205-366 | NDC:0904-7128 | NDC:71335-0891 | NDC:69097-894 | NDC:50268-313 | NDC:27437-107 | NDC:69315-290 | NDC:50090-7242 | NDC:68180-361 | NDC:69844-013 | NDC:0115-5511 | NDC:43547-431 | NDC:68180-363 | NDC:50090-3887 | NDC:55111-349 | NDC:71335-1701 | NDC:69097-459 | NDC:59651-575 | NDC:0115-1522 | NDC:51655-234 | NDC:68180-231 | NDC:69315-288 | NDC:69315-287 | NDC:62332-554 | NDC:72162-2152 | NDC:62332-539 | NDC:63629-2505 | NDC:13668-438 | NDC:51407-092 | NDC:60219-5522 | NDC:68180-389 | NDC:63304-448 | NDC:69097-896 | NDC:71335-1756 | NDC:72162-2170 | NDC:43353-001 | NDC:71335-0741 | NDC:68180-362 | NDC:82619-101 | NDC:63187-760 | NDC:0378-7100 | NDC:51407-091 | NDC:0378-3065 | NDC:0074-3189 | NDC:0115-5522 | NDC:68180-388 | NDC:46708-350 | NDC:46708-554 | NDC:63187-681 | NDC:68071-4991 | NDC:27241-116 | NDC:50090-5796 | NDC:69238-1261 | NDC:51407-090 | NDC:68180-232 | NDC:63629-1100 | NDC:27241-118 | FENOFIBRATE | NDC:68180-130
+BMGC_DG07485,BMG_DG137403,"9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol | PubChem CID:3341 | CAS RN:1092382-99-4 | DrugBank ID:DB00800 | FENOLDOPAM | UNII:INU8H2KAWG | PubChem SID:175271349 | Fenoldopam | CAS RN:67227-56-9"
+BMGC_DG07486,BMG_DG137407,PubChem CID:3342 | UNII:RA33EAC7KY | CAS RN:29679-58-1 | Fenoprofen | PubChem SID:175271916 | DrugBank ID:DB00573 | 2-(3-phenoxyphenyl)propanoic acid | FENOPROFEN | CAS RN:31879-05-7
+BMGC_DG07487,BMG_DG137409,CTS-1027 | PubChem SID:198978070 | PubChem CID:3342298 | 4-[4-(4-Chloro-phenoxy)-benzenesulfonylmethyl]-tetrahydro-pyran-4-carboxylic acid hydroxyamide | DrugBank ID:DB08490 | 4-[[4-(4-chlorophenoxy)phenyl]sulfonylmethyl]-N-hydroxyoxane-4-carboxamide | UNII:2QD3F58224 | CAS RN:193022-04-7
+BMGC_DG07488,BMG_DG137414,"DrugBank ID:DB01288 | 5-[1-hydroxy-2-[1-(4-hydroxyphenyl)propan-2-ylamino]ethyl]benzene-1,3-diol | CAS RN:391234-95-0 | CAS RN:13392-18-2 | PubChem CID:3343 | Fenoterol"
+BMGC_DG07489,BMG_DG137427,"PubChem CID:3344 | Fenspiride | 8-(2-phenylethyl)-1-oxa-3,8-diazaspiro[4.5]decan-2-one | UNII:S983QC7HKM | PubChem SID:198982140 | CAS RN:5053-06-5 | FENSPIRIDE | DrugBank ID:DB08979"
+BMGC_DG07490,BMG_DG137441,NDC:55700-597 | NDC:47781-424 | NDC:60505-7015 | NDC:0378-9122 | NDC:60505-7084 | NDC:0378-9121 | NDC:0406-9175 | NDC:47781-428 | NDC:60505-7008 | NDC:50742-555 | UNII:UF599785JZ | NDC:60505-7087 | CAS RN:437-38-7 | NDC:55700-772 | NDC:60505-7017 | NDC:0378-9124 | NDC:0406-9150 | NDC:50742-551 | NDC:50742-553 | NDC:60505-7006 | NDC:60505-7083 | NDC:47781-427 | NDC:50742-550 | NDC:50742-554 | NDC:60505-7086 | NDC:63629-4976 | NDC:60505-7082 | NDC:47781-423 | NDC:0378-9119 | NDC:0378-9126 | NDC:0406-9112 | NDC:47781-426 | NDC:50742-556 | NDC:55700-753 | NDC:60505-7081 | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | NDC:55700-973 | NDC:60505-7013 | NDC:55700-748 | NDC:50742-552 | NDC:60505-7009 | DrugBank ID:DB00813 | NDC:60505-7080 | NDC:0378-9127 | Fentanyl | NDC:60505-7007 | NDC:60505-7014 | NDC:60505-7016 | NDC:0406-9037 | NDC:0406-9100 | FENTANYL | NDC:0406-9062 | NDC:60505-7085 | NDC:63629-4813 | PubChem CID:3345 | CAS RN:201415-26-1 | NDC:50742-549 | NDC:0406-9125 | NDC:60505-7010 | NDC:60505-7011 | NDC:60505-7012 | NDC:63629-4974 | PubChem SID:175268467 | NDC:0378-9123 | NDC:0378-9125 | NDC:55700-749
+BMGC_DG07491,BMG_DG137443,dimethoxy-(3-methyl-4-methylsulfanylphenoxy)-sulfanylidene-lambda5-phosphane | CAS RN:55-38-9 | PubChem CID:3346 | Fenthion | UNII:BL0L45OVKT | PubChem SID:198962118 | DrugBank ID:DB11412 | FENTHION
+BMGC_DG07492,BMG_DG137469,"Marmesin | MARMESIN | (2S)-2-(2-hydroxypropan-2-yl)-2,3-dihydrofuro[3,2-g]chromen-7-one | PubChem SID:346539225 | CAS RN:13849-08-6 | UNII:H5D33D6K5D | PubChem CID:334704"
+BMGC_DG07493,BMG_DG137473,"PubChem CID:33478 | PubChem SID:198935744 | DrugBank ID:DB01604 | Pivampicillin | 2,2-dimethylpropanoyloxymethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | PIVAMPICILLIN | CAS RN:33817-20-8 | UNII:0HLM346LL7"
+BMGC_DG07494,BMG_DG137476,CAS RN:1319714-86-7 | CAS RN:83799-24-0 | PubChem SID:472422501 | DrugBank ID:DB00950 | 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid | CAS RN:138452-21-8 | FEXOFENADINE | UNII:E6582LOH6V | Fexofenadine | PubChem CID:3348
+BMGC_DG07495,BMG_DG137501,"UNII:TG44VME01D | PubChem SID:198960791 | DrugBank ID:DB13790 | FIPEXIDE | 1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(4-chlorophenoxy)ethanone | CAS RN:34161-24-5 | PubChem CID:3351 | Fipexide"
+BMGC_DG07496,BMG_DG137505,"FIPRONIL | UNII:QGH063955F | CAS RN:120068-37-3 | 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile | PubChem SID:175267576 | Fipronil | PubChem CID:3352"
+BMGC_DG07497,BMG_DG137521,CAS RN:15301-69-6 | PubChem SID:175266323 | Flavoxate | FLAVOXATE | DrugBank ID:DB01148 | 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate | PubChem CID:3354 | UNII:3E74Y80MEY
+BMGC_DG07498,BMG_DG137535,PubChem CID:33558 | CAS RN:14343-69-2 | UNII:88BIA49L8P | AZIDE ION | PubChem SID:198945128
+BMGC_DG07499,BMG_DG137538,"DrugBank ID:DB01195 | UNII:K94FTS1806 | FLECAINIDE | Flecainide | PubChem CID:3356 | PubChem SID:175272181 | N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide | CAS RN:54143-55-4"
+BMGC_DG07500,BMG_DG137553,"DrugBank ID:DB04576 | UNII:N804LDH51K | CAS RN:79660-53-0 | PubChem CID:3357 | PubChem SID:198950746 | Fleroxacin | FLEROXACIN | 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid | CAS RN:79660-72-3"
+BMGC_DG07501,BMG_DG137554,"Ritodrinium | 4-[2-[[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol | Ritodrine | PubChem CID:33572 | DrugBank ID:DB00867 | CAS RN:154095-90-6"
+BMGC_DG07502,BMG_DG137562,PubChem CID:33584 | PubChem SID:198960709 | HALOFENATE | CAS RN:24136-24-1 | UNII:K9TZK4MNO6 | 2-acetamidoethyl 2-(4-chlorophenyl)-2-[3-(trifluoromethyl)phenoxy]acetate | CAS RN:26718-25-2 | Halofenate
+BMGC_DG07503,BMG_DG137575,"UNII:O04HVX6A9Q | PubChem CID:3360 | DrugBank ID:DB08976 | 2,3-dihydroxypropyl 2-[[8-(trifluoromethyl)quinolin-4-yl]amino]benzoate | Floctafenine | CAS RN:23779-99-9 | PubChem SID:198943064 | FLOCTAFENINE"
+BMGC_DG07504,BMG_DG137589,"AMOXICILLIN ANHYDROUS | (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | CAS RN:26787-78-0 | UNII:9EM05410Q9 | DrugBank ID:DB01060 | Amoxicillin | PubChem SID:175265691 | PubChem CID:33613 | CAS RN:61336-70-7"
+BMGC_DG07505,BMG_DG137591,"PubChem SID:198956604 | Flopropione | 1-(2,4,6-trihydroxyphenyl)propan-1-one | CAS RN:2295-58-1 | UNII:05V5NVB5Y1 | PubChem CID:3362 | FLOPROPIONE"
+BMGC_DG07506,BMG_DG137598,"TIMOLOL ANHYDROUS | DrugBank ID:DB00373 | (2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol | NDC:70069-698 | CAS RN:26839-75-8 | Timolol | NDC:70069-696 | NDC:70069-697 | PubChem CID:33624 | PubChem SID:175266810 | UNII:5JKY92S7BR"
+BMGC_DG07507,BMG_DG137601,PubChem SID:198950576 | INDORAMIN | PubChem CID:33625 | Indoramin | DrugBank ID:DB08950 | UNII:0Z802HMY7H | CAS RN:26844-12-2 | N-[1-[2-(1H-indol-3-yl)ethyl]piperidin-4-yl]benzamide
+BMGC_DG07508,BMG_DG137607,"1-[4,4-bis(4-fluorophenyl)butyl]-4-[4-chloro-3-(trifluoromethyl)phenyl]piperidin-4-ol | CAS RN:26864-56-2 | PubChem CID:33630 | UNII:25TLU22Q8H | DrugBank ID:DB13791 | PENFLURIDOL | PubChem SID:198935571 | Penfluridol"
+BMGC_DG07509,BMG_DG137611,"MEDICARPIN | CAS RN:33983-40-3 | PubChem SID:198947032 | PubChem CID:336327 | UNII:6TX086I6IG | (6aR,11aR)-9-methoxy-6a,11a-dihydro-6H-[1]benzofuro[3,2-c]chromen-3-ol | CAS RN:32383-76-9 | Medicarpin"
+BMGC_DG07510,BMG_DG137639,"NDC:70518-4020 | NDC:68084-728 | NDC:51672-4067 | DrugBank ID:DB00196 | NDC:57237-003 | NDC:68071-3474 | NDC:51655-435 | NDC:0049-3450 | NDC:68001-253 | NDC:70518-3918 | NDC:0143-9668 | NDC:65862-059 | NDC:70518-4193 | NDC:62559-992 | NDC:65862-058 | NDC:68788-8526 | NDC:0143-9669 | NDC:62135-133 | FLUCONAZOLE | NDC:70518-0560 | NDC:70518-3092 | NDC:0338-6045 | NDC:55289-824 | NDC:51407-426 | NDC:71205-283 | NDC:63629-9091 | NDC:70518-3312 | NDC:68001-254 | NDC:70985-016 | NDC:72189-149 | NDC:72189-140 | NDC:65862-060 | NDC:59762-5016 | NDC:14335-180 | NDC:76420-587 | NDC:71205-104 | NDC:59762-5029 | NDC:67296-1875 | NDC:71335-0686 | NDC:68084-735 | NDC:68001-252 | PubChem SID:175268153 | NDC:16714-695 | NDC:71205-573 | NDC:43063-645 | NDC:70710-1140 | NDC:70771-1064 | NDC:68462-119 | NDC:71205-081 | NDC:68071-3768 | NDC:0049-3430 | NDC:70985-015 | NDC:0409-3435 | NDC:51672-4064 | NDC:68001-251 | NDC:82982-070 | NDC:50090-5764 | NDC:67296-1627 | NDC:68071-3515 | NDC:67296-2077 | NDC:70710-1138 | NDC:68462-101 | NDC:71335-1948 | NDC:65862-299 | NDC:0904-6500 | NDC:50090-6842 | NDC:61919-493 | NDC:51407-427 | NDC:51672-4066 | NDC:63187-584 | NDC:0338-6046 | NDC:0409-4688 | NDC:50090-6733 | Fluconazole | NDC:71205-650 | CAS RN:86386-73-4 | NDC:68071-3578 | NDC:57237-006 | NDC:70518-3901 | NDC:16714-693 | NDC:71335-2235 | NDC:59762-5018 | NDC:59762-5015 | NDC:51407-424 | NDC:51672-4065 | NDC:67296-1606 | NDC:70518-4242 | NDC:63739-115 | NDC:70771-1063 | NDC:70771-1065 | NDC:71205-563 | UNII:8VZV102JFY | NDC:60760-950 | NDC:65862-300 | NDC:68788-7293 | NDC:82868-033 | NDC:51655-889 | NDC:71335-1895 | NDC:62135-131 | NDC:50090-6751 | NDC:57237-005 | NDC:72189-342 | NDC:50090-5299 | NDC:70710-1137 | NDC:0904-6501 | NDC:70518-3924 | NDC:63187-613 | NDC:55111-144 | NDC:55154-7875 | NDC:63629-9134 | NDC:50090-2195 | NDC:68462-102 | NDC:70436-227 | NDC:51407-425 | NDC:16714-692 | NDC:71335-1448 | NDC:16714-691 | NDC:55700-916 | 2-(2,4-difluorophenyl)-1,3-bis(1,2,4-triazol-1-yl)propan-2-ol | NDC:70518-2415 | NDC:60760-803 | NDC:70985-013 | NDC:76420-164 | NDC:62559-993 | NDC:71335-0769 | NDC:72789-209 | NDC:62135-132 | NDC:71205-796 | NDC:59762-5030 | NDC:0143-9667 | NDC:62559-990 | NDC:65862-061 | NDC:67296-1167 | NDC:70710-1139 | NDC:71335-2268 | NDC:55111-146 | NDC:70985-014 | NDC:50090-0947 | CAS RN:123631-92-5 | NDC:55111-145 | NDC:50268-339 | NDC:72189-143 | NDC:25021-184 | NDC:68788-7959 | NDC:71205-094 | NDC:59762-5017 | NDC:57237-149 | NDC:16714-694 | NDC:55111-143 | NDC:0409-4321 | NDC:55154-3400 | NDC:0049-3420 | NDC:71335-1268 | NDC:63187-878 | NDC:0143-9899 | NDC:70771-1066 | NDC:72189-516 | NDC:50268-337 | NDC:68788-8220 | NDC:43063-642 | PubChem CID:3365 | NDC:68462-104 | NDC:16714-696 | NDC:57237-004 | NDC:67296-1498 | NDC:82804-146 | NDC:0143-9666 | NDC:62559-991 | NDC:63629-8970 | NDC:57237-150 | NDC:68071-4501 | NDC:82804-030 | NDC:62135-130 | NDC:63187-096"
+BMGC_DG07511,BMG_DG137645,NDC:0187-3555 | NDC:63629-2147 | NDC:42494-339 | NDC:59651-332 | NDC:72162-1327 | NDC:63629-2148 | NDC:50268-332 | UNII:D83282DT06 | NDC:42794-010 | PubChem CID:3366 | NDC:63629-9156 | NDC:0904-6835 | NDC:40032-770 | NDC:40032-771 | DrugBank ID:DB01099 | NDC:42494-340 | CAS RN:117969-88-7 | NDC:23155-860 | NDC:60687-599 | NDC:43386-771 | NDC:50268-331 | 6-amino-5-fluoro-1H-pyrimidin-2-one | Flucytosine | NDC:72162-1326 | PubChem SID:175265921 | NDC:59651-331 | NDC:63629-9157 | CAS RN:130256-61-0 | NDC:0904-6834 | CAS RN:2022-85-7 | NDC:42794-009 | NDC:60687-610 | NDC:0187-3554 | NDC:43386-770 | FLUCYTOSINE | NDC:23155-861
+BMGC_DG07512,BMG_DG137653,"CARBENICILLIN PHENYL | Carfecillin | PubChem CID:33672 | UNII:9UU4XDB74X | CAS RN:27025-49-6 | PubChem SID:198960726 | (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(3-oxo-3-phenoxy-2-phenylpropanoyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | DrugBank ID:DB13506"
+BMGC_DG07513,BMG_DG137657,PubChem CID:33675 | CAS RN:27035-30-9 | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-N-hydroxyacetamide | Oxametacin | DrugBank ID:DB13308 | UNII:8G02RSW5CM | PubChem SID:198967854 | OXAMETACIN
+BMGC_DG07514,BMG_DG137659,"PubChem CID:33676 | 4-KETOCYCLOPHOSPHAMIDE | CAS RN:27046-19-1 | PubChem SID:198989143 | UNII:N9DU5QVF19 | 4-Ketocyclophosphamide | 2-[bis(2-chloroethyl)amino]-2-oxo-1,3,2lambda5-oxazaphosphinan-4-one"
+BMGC_DG07515,BMG_DG137665,"UNII:7F64A2K16Z | Fludiazepam | PubChem SID:198979290 | PubChem CID:3369 | 7-chloro-5-(2-fluorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one | DrugBank ID:DB01567 | FLUDIAZEPAM | CAS RN:3900-31-0"
+BMGC_DG07516,BMG_DG137669,"PubChem SID:374388746 | CAS RN:78831-36-4 | PubChem CID:336912 | UNII:1BR6ZZ33GT | 1,10-PHENANTHROLINE-2,9-DIYLDIMETHANOL"
+BMGC_DG07517,BMG_DG137680,DrugBank ID:DB02266 | UNII:60GCX7Y6BH | FLUFENAMIC ACID | Flufenamic Acid | PubChem CID:3371 | PubChem SID:198961257 | CAS RN:530-78-9 | Flufenamic acid | 2-[3-(trifluoromethyl)anilino]benzoic acid
+BMGC_DG07518,BMG_DG137693,2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol | FLUPHENAZINE | CAS RN:69-23-8 | UNII:S79426A41Z | DrugBank ID:DB00623 | PubChem SID:175267324 | PubChem CID:3372 | Fluphenazine
+BMGC_DG07519,BMG_DG137705,"ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate | NDC:51662-1254 | CAS RN:78755-81-4 | PubChem SID:175265841 | NDC:0143-9684 | NDC:71872-7321 | DrugBank ID:DB01205 | NDC:71872-7008 | NDC:51662-1579 | FLUMAZENIL | NDC:0143-9783 | NDC:0143-9683 | Flumazenil | NDC:36000-148 | NDC:51662-1253 | NDC:0404-9859 | NDC:63323-424 | UNII:40P7XK9392 | NDC:71872-7206 | NDC:71872-7038 | NDC:0143-9784 | PubChem CID:3373 | NDC:0404-9860 | NDC:36000-149"
+BMGC_DG07520,BMG_DG137708,"DrugBank ID:DB02712 | UNII:G4186B906P | CAS RN:68367-52-2 | PubChem CID:337359 | Sorbinil | CAS RN:112420-09-4 | PubChem SID:198935949 | SORBINIL | (4S)-6-fluorospiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione"
+BMGC_DG07521,BMG_DG137714,CAS RN:86455-98-3 | UNII:K44K33VWT2 | PubChem SID:474491291 | PubChem CID:337396 | 1-((2-(DIMETHYLAMINO)ETHYL)AMINO)-7-HYDROXY-4-(HYDROXYMETHYL)-9H-XANTHEN-9-ONE
+BMGC_DG07522,BMG_DG137717,"PubChem CID:3374 | DrugBank ID:DB08972 | CAS RN:42835-25-6 | PubChem SID:198983409 | 7-fluoro-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid | FLUMEQUINE | UNII:UVG8VSP2SJ | Flumequine"
+BMGC_DG07523,BMG_DG137718,"TRAMADOL | UNII:0NG5TTM63P | CAS RN:123154-38-1 | PubChem SID:346540455 | DrugBank ID:DB00193 | Tramadol | UNII:39J1LGJ30J | CAS RN:27203-92-5 | CAS RN:181289-58-7 | PubChem SID:175272071 | PubChem CID:33741 | TRAMADOL, (+)- | (1R,2R)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexan-1-ol"
+BMGC_DG07524,BMG_DG137728,"PubChem SID:440088909 | PubChem SID:440089890 | KETAZOLAM, (+)- | UNII:424J5HGB8E | UNII:92A214MD7Y | UNII:9ZBH5G9835 | Ketazolam | KETAZOLAM | CAS RN:106938-99-2 | KETAZOLAM, (-)- | PubChem CID:33746 | PubChem SID:198986213 | CAS RN:27223-35-4 | DrugBank ID:DB01587 | CAS RN:106939-00-8 | 11-chloro-2,8-dimethyl-12b-phenyl-6H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7-dione"
+BMGC_DG07525,BMG_DG137746,PubChem CID:33776 | Tirapazamine | DrugBank ID:DB04858
+BMGC_DG07526,BMG_DG137748,SB 224289 | PubChem SID:251965677 | UNII:F95C648W4N | PubChem CID:3378093 | CAS RN:180083-23-2
+BMGC_DG07527,BMG_DG137764,SALICYLIC ACID | Salicylic acid | 2-hydroxybenzoic acid | CAS RN:69-72-7 | PubChem SID:175266504 | PubChem CID:338 | UNII:O414PZ4LPZ | Salicylic Acid | CAS RN:29656-58-4 | DrugBank ID:DB00936
+BMGC_DG07528,BMG_DG137765,"Flunitrazepam | 5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one | CAS RN:1622-62-4 | DrugBank ID:DB01544 | PubChem CID:3380 | UNII:620X0222FQ | FLUNITRAZEPAM | PubChem SID:198960206"
+BMGC_DG07529,BMG_DG137787,PubChem CID:3383 | 2-(3-hydroxy-6-oxoxanthen-9-yl)benzoic acid | fluorescein (acid form) | CAS RN:518-45-6
+BMGC_DG07530,BMG_DG137788,PubChem CID:3383616 | DrugBank ID:DB07681 | DODECANESULFONATE ION
+BMGC_DG07531,BMG_DG137792,"PubChem CID:3384 | 17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | Fluoromethalone"
+BMGC_DG07532,BMG_DG137795,"NDC:0378-4791 | NDC:55150-497 | NDC:46708-779 | NDC:68083-269 | CAS RN:191047-65-1 | NDC:68001-525 | NDC:75907-095 | NDC:16729-276 | NDC:71288-170 | PubChem SID:175267680 | NDC:68001-627 | NDC:25021-215 | NDC:28105-421 | NDC:55150-499 | NDC:55150-496 | NDC:55150-498 | NDC:68001-524 | FLUOROURACIL | CAS RN:2794-13-0 | 5-fluoro-1H-pyrimidine-2,4-dione | PubChem CID:3385 | NDC:68083-270 | NDC:70700-186 | NDC:51672-4118 | Fluorouracil | CAS RN:51-21-8 | CAS RN:191115-88-5 | NDC:51672-4062 | NDC:68083-292 | DrugBank ID:DB00544 | CAS RN:1004-03-1 | NDC:68083-293 | NDC:70700-189 | NDC:46708-751 | NDC:70700-187 | NDC:16729-542 | NDC:62332-779 | NDC:63323-117 | CAS RN:191047-64-0 | NDC:68001-628 | UNII:U3P01618RT | NDC:21922-041 | NDC:62332-751 | NDC:16714-178 | NDC:51862-362 | NDC:51672-4063 | NDC:70700-188"
+BMGC_DG07533,BMG_DG137800,CAS RN:54910-89-3 | N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | CAS RN:57226-07-0 | PubChem SID:175271693 | FLUOXETINE | PubChem CID:3386 | UNII:01K63SUP8D | NDC:64380-900 | DrugBank ID:DB00472 | Fluoxetine
+BMGC_DG07534,BMG_DG137805,"PubChem CID:3387240 | 1,2,4-Triazole-Carboxamidine | DrugBank ID:DB02048"
+BMGC_DG07535,BMG_DG137808,SB-218078 | PubChem SID:319892297 | PubChem CID:3387354 | UNII:S6U3J3UP11 | CAS RN:135897-06-2
+BMGC_DG07536,BMG_DG137816,PubChem CID:3388 | CAS RN:5002-47-1 | NDC:68083-476 | UNII:FMU62K1L3C | 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate | NDC:42023-129 | NDC:25021-838 | NDC:55150-267 | NDC:72205-100 | PubChem SID:175266897 | NDC:67457-359 | FLUPHENAZINE DECANOATE | NDC:0143-9529 | NDC:63323-272 | Fluphenazine Decanoate
+BMGC_DG07537,BMG_DG137818,"CAS RN:27469-53-0 | Almitrine | DrugBank ID:DB01430 | ALMITRINE | PubChem CID:33887 | PubChem SID:198947132 | UNII:9A1222NBG4 | 6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-N,4-N-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine"
+BMGC_DG07538,BMG_DG137820,Fluphenazine enanthate | PubChem SID:198952560 | CAS RN:2746-81-8 | PubChem CID:3389 | Fluphenazine Enanthate | FLUPHENAZINE ENANTHATE | UNII:QSB34YF0W9 | 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl heptanoate
+BMGC_DG07539,BMG_DG137824,PubChem CID:339 | UNII:AH00YJQ334 | CAS RN:2041-14-7 | PubChem SID:198988287 | 2-AMINOETHYLPHOSPHONIC ACID
+BMGC_DG07540,BMG_DG137836,2-phenyl-3H-benzimidazole-5-sulfonic acid | NDC:67623-004 | NDC:72330-196 | PubChem SID:175268232 | NDC:51150-380 | NDC:53208-052 | NDC:72330-195 | NDC:53863-004 | NDC:11559-058 | NDC:53208-600 | NDC:76398-015 | NDC:53208-195 | NDC:58411-657 | NDC:67623-005 | NDC:53208-800 | NDC:53208-053 | NDC:50390-002 | NDC:22700-201 | NDC:61957-2406 | NDC:50390-001 | NDC:61957-2403 | NDC:61957-2405 | NDC:81417-009 | NDC:53208-196 | NDC:72330-800 | UNII:9YQ9DI1W42 | NDC:58411-483 | NDC:49967-767 | NDC:49967-676 | NDC:22700-157 | NDC:82281-239 | NDC:85179-000 | NDC:10056-030 | NDC:10356-323 | PubChem CID:33919 | NDC:72330-600 | NDC:61957-2408 | NDC:50390-004 | NDC:10056-025 | NDC:72330-063 | NDC:61957-2404 | NDC:61957-2400 | NDC:53208-063 | NDC:72330-062 | NDC:61957-2409 | NDC:72330-601 | NDC:53208-062 | NDC:53863-005 | NDC:72330-053 | NDC:76398-014 | ENSULIZOLE | NDC:50390-011 | Ensulizole | NDC:58411-670 | CAS RN:27503-81-7 | NDC:53208-601 | DrugBank ID:DB11115 | NDC:51150-676 | NDC:82733-294 | NDC:61957-2401 | NDC:49967-380 | NDC:76398-010 | NDC:61957-2410 | NDC:61957-2402 | NDC:72330-052 | NDC:69259-3488 | NDC:50390-010 | NDC:61957-2407 | NDC:49527-220
+BMGC_DG07541,BMG_DG137841,PubChem SID:461432687 | UNII:NTL2A9CAZ7 | PubChem CID:3392731 | GW-7647 | CAS RN:265129-71-3
+BMGC_DG07542,BMG_DG137844,"Flurazepam | CAS RN:17617-23-1 | UNII:IHP475989U | PubChem SID:175265966 | FLURAZEPAM | 7-chloro-1-[2-(diethylamino)ethyl]-5-(2-fluorophenyl)-3H-1,4-benzodiazepin-2-one | PubChem CID:3393 | DrugBank ID:DB00690"
+BMGC_DG07543,BMG_DG137851,NDC:43063-992 | FLURBIPROFEN | NDC:45865-918 | PubChem CID:3394 | CAS RN:5104-49-4 | 2-(3-fluoro-4-phenylphenyl)propanoic acid | NDC:63629-8808 | NDC:64950-218 | NDC:68788-7341 | NDC:72988-0041 | NDC:68071-4436 | PubChem SID:175271496 | UNII:5GRO578KLP | DrugBank ID:DB00712 | CAS RN:51543-38-5 | NDC:0093-0711 | NDC:63629-8338 | Flurbiprofen
+BMGC_DG07544,BMG_DG137854,"DrugBank ID:DB12549 | CAS RN:99009-20-8 | PYRAZOLOACRIDINE | 3-(4-methoxy-10-nitro-8,14,15-triazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-14-yl)-N,N-dimethylpropan-1-amine | UNII:L24XJN68OW | Pyrazoloacridine | PubChem CID:339455 | PubChem SID:198988612"
+BMGC_DG07545,BMG_DG137856,PubChem SID:198957668 | O-IODOXYBENZOIC ACID | UNII:3K0C43POH0 | CAS RN:64297-64-9 | PubChem CID:339496
+BMGC_DG07546,BMG_DG137857,FLURBIPROFEN AXETIL | Flurbiprofen Axetil | PubChem CID:3395 | CAS RN:91503-79-6 | UNII:I0OU31PUI5 | 1-acetyloxyethyl 2-(3-fluoro-4-phenylphenyl)propanoate | PubChem SID:198968085 | DrugBank ID:DB14938
+BMGC_DG07547,BMG_DG137865,"PubChem CID:3396 | Fluspirilene | 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | CAS RN:1841-19-6 | UNII:C5QA4GLR9M | FLUSPIRILENE | DrugBank ID:DB04842 | PubChem SID:198962465"
+BMGC_DG07548,BMG_DG137868,NDC:80725-143 | CAS RN:13311-84-7 | Flutamide | DrugBank ID:DB00499 | 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide | CAS RN:37209-54-4 | UNII:76W6J0943E | PubChem CID:3397 | NDC:80725-600 | NDC:69097-915 | FLUTAMIDE | PubChem SID:175265910
+BMGC_DG07549,BMG_DG137878,"CAS RN:78605-10-4 | 6-PHENYL(5H)PYRROLO(2,3-B)PYRAZINE | PubChem SID:474492979 | UNII:T5JSW5LGX8 | PubChem CID:339916"
+BMGC_DG07550,BMG_DG137890,"CAS RN:488-17-5 | DrugBank ID:DB03454 | 3-methylbenzene-1,2-diol | 3-methyl-benzene-1,2-diol | UNII:0HUZ4Q9R8C | PubChem CID:340 | 3-METHYLCATECHOL | 3-Methylcatechol | PubChem SID:198970887"
+BMGC_DG07551,BMG_DG137891,PubChem CID:3400 | PubChem SID:198946139 | FLUTOPRAZEPAM | UNII:2GHY1101MM | CAS RN:25967-29-7
+BMGC_DG07552,BMG_DG137899,"3-chloro-N-[4-chloro-2-[(5-chloropyridin-2-yl)carbamoyl]-6-methoxyphenyl]-4-[[4,5-dihydro-1,3-oxazol-2-yl(methyl)amino]methyl]thiophene-2-carboxamide | PubChem CID:3400921 | 3-Chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-[[(4,5-dihydro-2-oxazolyl)methylamino]methyl]-2-thiophenecarboxamide"
+BMGC_DG07553,BMG_DG137900,1-[(2-fluorophenyl)-(4-fluorophenyl)-phenylmethyl]imidazole | Flutrimazole | CAS RN:119006-77-8 | DrugBank ID:DB13425 | PubChem SID:198947663 | UNII:776S0UP252 | FLUTRIMAZOLE | PubChem CID:3401
+BMGC_DG07554,BMG_DG137917,CAS RN:54739-18-3 | 2-[[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine | CAS RN:61718-81-8 | PubChem CID:3404 | 2-[[5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine | Fluvoxamine | DrugBank ID:DB00176
+BMGC_DG07555,BMG_DG137918,"UNII:JCV8365FWN | NICERGOLINE | PubChem SID:198987902 | DrugBank ID:DB00699 | Nicergoline | CAS RN:27848-84-6 | [(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-6a,8,9,10-tetrahydro-6H-indolo[4,3-fg]quinolin-9-yl]methyl 5-bromopyridine-3-carboxylate | PubChem CID:34040"
+BMGC_DG07556,BMG_DG137921,"SAFRAZINE | CAS RN:33419-68-0 | Safrazine | UNII:F5G0P5378C | 4-(1,3-benzodioxol-5-yl)butan-2-ylhydrazine | PubChem CID:34042 | DrugBank ID:DB09253 | CAS RN:858830-96-3 | PubChem SID:198966127"
+BMGC_DG07557,BMG_DG137926,"4,4-diphenylbutan-2-yl-ethyl-dimethylazanium | EMEPRONIUM | PubChem SID:198945762 | DrugBank ID:DB13505 | CAS RN:27892-33-7 | PubChem CID:34055 | Emepronium | UNII:04QQ8SWA4U"
+BMGC_DG07558,BMG_DG137928,Fomepizole | CAS RN:7554-65-6 | NDC:70710-1478 | FOMEPIZOLE | DrugBank ID:DB01213 | 4-methyl-1H-pyrazole | NDC:67457-211 | NDC:0517-0710 | NDC:68475-510 | UNII:83LCM6L2BY | NDC:68083-510 | PubChem SID:175268577 | PubChem CID:3406 | NDC:25021-829 | CAS RN:615557-09-0
+BMGC_DG07559,BMG_DG137938,CAS RN:27959-26-8 | PubChem SID:198940525 | UNII:215U8X2R44 | NICOMOL | PubChem CID:34081
+BMGC_DG07560,BMG_DG137951,N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide | CAS RN:126587-85-7 | Formoterol | DrugBank ID:DB00983 | CAS RN:73573-87-2 | CAS RN:128954-45-0 | PubChem CID:3410
+BMGC_DG07561,BMG_DG137965,phosphonatoformate | Foscavir | PubChem CID:3414
+BMGC_DG07562,BMG_DG137979,FOSCARNET | CAS RN:4428-95-9 | PubChem SID:175265349 | DrugBank ID:DB00529 | PubChem CID:3415 | phosphonoformic acid | Foscarnet | UNII:364P9RVW4X
+BMGC_DG07563,BMG_DG137982,"PubChem SID:198968039 | UNII:U993RH5585 | Tymazoline | TYMAZOLINE | CAS RN:24243-97-8 | PubChem CID:34154 | DrugBank ID:DB08803 | 2-[(5-methyl-2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole"
+BMGC_DG07564,BMG_DG138014,2-OXO-N-PHENYLCHROMENE-3-CARBOXAMIDE | UNII:UNL77RV7HQ | CAS RN:54396-25-7 | PubChem SID:441659246 | PubChem CID:341782
+BMGC_DG07565,BMG_DG138031,CAS RN:108-39-4 | 3-methylphenol | M-Cresol | PubChem SID:175266370 | PubChem CID:342 | DrugBank ID:DB01776 | METACRESOL | UNII:GGO4Y809LO
+BMGC_DG07566,BMG_DG138035,"6-(4-Nitrophenyl)-2,3-diphenylimidazo[1,2-b][1,2,4]triazine | PubChem CID:342017 | 6-(4-NITROPHENYL)-2,3-DIPHENYLIMIDAZO(1,2-B)(1,2,4)TRIAZINE | PubChem SID:474491385 | CAS RN:70111-79-4 | UNII:HBM4CE5G3W"
+BMGC_DG07567,BMG_DG138063,"UNII:RRU6GY95IS | NIGERICIN | DrugBank ID:DB14056 | PubChem CID:34230 | PubChem SID:198981026 | CAS RN:28643-80-3 | CAS RN:28380-24-7 | (2R)-2-[(2R,3S,6R)-6-[[(2S,4R,5R,6R,7R,9R)-2-[(2R,5S)-5-[(2R,3S,5R)-5-[(2S,3S,5R,6R)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-7-methoxy-2,4,6-trimethyl-1,10-dioxaspiro[4.5]decan-9-yl]methyl]-3-methyloxan-2-yl]propanoic acid | Nigericin"
+BMGC_DG07568,BMG_DG138067,PubChem CID:3423265 | CAS RN:12765-21-8 | Sodium dodecyl sulfate | UNII:368GB5141J | sodium;dodecyl sulfate | PubChem SID:175267700 | Sodium lauryl sulfate | CAS RN:1334-67-4 | CAS RN:12738-53-3 | DrugBank ID:DB00815 | SODIUM LAURYL SULFATE | CAS RN:151-21-3
+BMGC_DG07569,BMG_DG138069,Carbamoyl phosphate(2-) | carbamoyl phosphate | PubChem CID:3423467 | CAS RN:63082-13-3
+BMGC_DG07570,BMG_DG138115,NDC:0904-7262 | NDC:72888-088 | NDC:72603-252 | NDC:60505-4130 | NDC:50268-679 | NDC:71205-411 | NDC:72888-087 | NDC:72865-284 | NDC:70518-3237 | NDC:63629-3816 | NDC:70377-117 | NDC:70518-2370 | NDC:70518-4079 | Oxcarbazepine | NDC:51991-292 | NDC:70518-2377 | NDC:72162-2088 | PubChem CID:34312 | NDC:50268-681 | NDC:68462-138 | NDC:27241-304 | NDC:70518-3921 | NDC:50268-649 | NDC:70518-3940 | NDC:42806-600 | NDC:72603-271 | NDC:62756-185 | NDC:60429-063 | NDC:63629-9186 | NDC:72865-283 | NDC:70518-2276 | NDC:31722-687 | NDC:60429-062 | NDC:71335-0090 | NDC:0078-0357 | NDC:0615-8448 | NDC:68788-7866 | NDC:71335-2548 | NDC:0078-0457 | NDC:0781-6270 | NDC:17772-122 | NDC:60687-711 | NDC:72189-339 | NDC:60505-4128 | NDC:31722-024 | NDC:0078-0456 | NDC:55154-4320 | NDC:68094-123 | NDC:70518-0894 | NDC:72189-573 | DrugBank ID:DB00776 | NDC:0904-7264 | NDC:17772-123 | NDC:72888-089 | NDC:27241-239 | NDC:51991-294 | PubChem SID:175266493 | NDC:55154-2139 | NDC:51672-4106 | NDC:68462-139 | NDC:0078-0337 | NDC:55154-4323 | NDC:51991-293 | NDC:31722-025 | NDC:51672-1393 | OXCARBAZEPINE | NDC:0615-8447 | NDC:72162-1594 | NDC:31722-023 | NDC:72865-285 | NDC:72888-074 | NDC:70518-1027 | NDC:55154-2138 | NDC:60687-722 | NDC:50268-680 | 5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide | NDC:67046-1073 | NDC:70518-2253 | NDC:0904-7263 | NDC:81033-113 | NDC:70518-2254 | NDC:51672-4107 | NDC:60687-733 | NDC:60505-4129 | UNII:VZI5B1W380 | NDC:51672-4105 | NDC:27241-306 | NDC:27241-305 | NDC:27241-237 | NDC:62135-841 | NDC:17772-121 | NDC:63629-6834 | NDC:68462-137 | CAS RN:28721-07-5 | NDC:62756-183 | NDC:70518-1842 | NDC:62756-184 | NDC:63629-2075 | NDC:72603-272 | NDC:60429-061 | NDC:70518-3925 | NDC:69452-125 | NDC:27241-238 | NDC:65162-649
+BMGC_DG07571,BMG_DG138125,"Difenoxin | UNII:3ZZ5BJ9F2Q | PubChem CID:34328 | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid | PubChem SID:175267553 | CAS RN:28782-42-5 | DrugBank ID:DB01501 | DIFENOXIN"
+BMGC_DG07572,BMG_DG138127,"UNII:C2087G0XX3 | PubChem SID:198972451 | 3-(furan-2-ylmethyl)-1,8-dimethyl-7H-purine-2,6-dione | Furafylline | CAS RN:80288-49-9 | PubChem CID:3433 | FURAFYLLINE"
+BMGC_DG07573,BMG_DG138136,"3-[(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one | Furoxone | DrugBank ID:DB00614 | PubChem CID:3435 | CAS RN:67-45-8 | Furazolidone"
+BMGC_DG07574,BMG_DG138139,"DrugBank ID:DB00190 | PubChem SID:175266789 | CAS RN:1426847-87-1 | CARBIDOPA ANHYDROUS | (2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid | PubChem CID:34359 | Carbidopa | CAS RN:28860-95-9 | UNII:KR87B45RGH"
+BMGC_DG07575,BMG_DG138145,"UNII:3NK7CWM2JW | PubChem CID:343759 | CAS RN:7473-19-0 | PubChem SID:474492455 | 4-ETHOXYNAPHTHALENE-1,2-DIONE"
+BMGC_DG07576,BMG_DG138149,PubChem SID:313182683 | FURFURYLAMINE | UNII:86GAN59F7R | CAS RN:617-89-0 | PubChem CID:3438
+BMGC_DG07577,BMG_DG138163,NDC:71335-0842 | NDC:71872-7314 | NDC:0054-8299 | NDC:0615-8368 | NDC:42291-470 | NDC:43063-849 | NDC:63187-739 | NDC:60760-707 | NDC:63629-1217 | NDC:69844-052 | NDC:73043-025 | NDC:68083-434 | NDC:42291-469 | NDC:17224-185 | NDC:0409-6102 | NDC:63629-1215 | NDC:71610-843 | 4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid | DrugBank ID:DB00695 | NDC:62135-753 | NDC:69315-117 | NDC:50090-6646 | NDC:72162-1361 | NDC:0143-9155 | NDC:60760-858 | NDC:67296-1547 | NDC:71610-284 | NDC:0054-3298 | NDC:71610-096 | NDC:50090-6937 | NDC:71610-636 | NDC:43547-402 | FUROSEMIDE | NDC:51655-310 | NDC:71610-634 | NDC:68071-2360 | NDC:67046-1439 | NDC:63629-1216 | NDC:25021-311 | NDC:16729-502 | NDC:51662-1226 | NDC:68094-867 | NDC:0054-4301 | NDC:55150-322 | NDC:69315-118 | PubChem SID:175266863 | NDC:62135-754 | NDC:0904-7178 | NDC:43353-018 | NDC:55154-2364 | NDC:51662-1572 | NDC:50090-3339 | NDC:72603-251 | NDC:71872-7308 | NDC:72603-474 | NDC:72789-157 | NDC:55150-323 | NDC:72789-033 | NDC:69844-051 | NDC:51662-1575 | NDC:68094-756 | NDC:0615-8369 | NDC:71872-7277 | NDC:68788-7265 | NDC:68071-4445 | NDC:50090-6642 | NDC:0615-8370 | NDC:63629-1214 | NDC:71335-1632 | NDC:81565-201 | NDC:43063-716 | NDC:36000-284 | NDC:71872-7295 | PubChem CID:3440 | NDC:0054-4299 | NDC:63323-280 | NDC:68071-1809 | NDC:70121-1076 | NDC:70518-3061 | NDC:68083-432 | NDC:43353-069 | NDC:0054-3294 | NDC:63187-506 | NDC:0404-9864 | NDC:16729-500 | NDC:82868-050 | NDC:63629-1120 | NDC:51407-114 | NDC:68788-6948 | NDC:68083-433 | NDC:0404-9863 | NDC:50090-5429 | NDC:73043-024 | NDC:51662-1227 | NDC:70518-0251 | NDC:0404-9862 | NDC:64980-563 | NDC:43353-341 | NDC:42291-468 | UNII:7LXU5N7ZO5 | NDC:63187-437 | NDC:70756-618 | NDC:43353-747 | NDC:50090-2560 | NDC:67296-1665 | NDC:71872-7127 | NDC:71767-100 | NDC:68071-4534 | NDC:71335-0384 | NDC:0143-9157 | NDC:0054-4297 | NDC:50090-6219 | NDC:55154-2348 | NDC:55154-2365 | NDC:70518-0050 | NDC:71335-2317 | NDC:50090-6942 | NDC:71872-7236 | NDC:67046-1430 | NDC:73043-022 | NDC:70756-619 | NDC:51655-269 | NDC:68071-1708 | NDC:23155-473 | NDC:36000-065 | NDC:55154-9582 | NDC:50090-2713 | Furosemide | NDC:68071-4522 | NDC:51662-1574 | NDC:73043-026 | NDC:36000-063 | NDC:50090-3338 | NDC:51655-517 | NDC:36000-064 | NDC:68788-6784 | CAS RN:54-31-9 | NDC:55154-9581 | NDC:72603-133 | NDC:63187-517 | NDC:43547-403 | NDC:0143-9158 | NDC:68071-3273 | NDC:63187-097 | NDC:63187-790 | NDC:71872-7059 | NDC:83634-302 | NDC:68071-3673 | NDC:50090-6647 | NDC:55154-4452 | NDC:36000-283 | NDC:68788-7354 | NDC:42708-123 | NDC:71335-2319 | NDC:71610-635 | NDC:71872-7278 | NDC:17224-178 | NDC:55154-2349 | NDC:68788-8799 | NDC:16729-501 | NDC:63629-1119 | NDC:72162-1362 | NDC:51655-481 | NDC:51662-1336 | NDC:83980-003 | NDC:69844-053 | NDC:64980-562 | NDC:71610-049 | NDC:83980-004 | NDC:0054-8301 | NDC:51407-113 | NDC:71288-203 | NDC:50090-3313 | NDC:72162-1360 | NDC:0143-9156 | NDC:55150-324 | NDC:67296-1469 | NDC:69315-116 | NDC:72789-030 | NDC:70121-1164 | NDC:83980-002 | NDC:0054-8297 | NDC:0904-7177 | NDC:0143-9159 | NDC:50090-5702 | NDC:43063-702 | NDC:71335-0852 | NDC:64980-564 | NDC:72572-190 | NDC:43547-401 | NDC:73043-023 | NDC:72789-032 | NDC:70121-1163 | NDC:36000-282 | NDC:70756-620
+BMGC_DG07578,BMG_DG138167,PubChem SID:474492552 | 7-Chloroisatin | CAS RN:7477-63-6 | 7-CHLOROISATIN | UNII:CCB49FJV8D | PubChem CID:344135
+BMGC_DG07579,BMG_DG138170,PubChem SID:198979518 | CAS RN:536-69-6 | PubChem CID:3442 | FUSARIC ACID | Fusaric Acid | 5-butylpyridine-2-carboxylic acid | UNII:JWJ963070N
+BMGC_DG07580,BMG_DG138180,"PubChem CID:3444 | BROMUCONAZOLE | PubChem SID:198956445 | Bromuconazole | 1-[[4-bromo-2-(2,4-dichlorophenyl)oxolan-2-yl]methyl]-1,2,4-triazole | CAS RN:116255-48-2 | UNII:PHS29ZMZ81"
+BMGC_DG07581,BMG_DG138194,"PREDNIMUSTINE | DrugBank ID:DB12832 | PubChem CID:34457 | CAS RN:29069-24-7 | PubChem SID:198956952 | Prednimustine | UNII:9403SIO2S8 | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate"
+BMGC_DG07582,BMG_DG138195,"UNII:V2SSH085X8 | CAS RN:29074-38-2 | 16,17-dimethoxy-5,7-dioxa-13-azapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-2,4(8),9,15(20),16,18-hexaene | PubChem CID:34458 | CANADINE | PubChem SID:198978622 | CAS RN:522-97-4 | Canadine"
+BMGC_DG07583,BMG_DG138197,NDC:58151-282 | NDC:43602-470 | NDC:80425-0031 | NDC:68382-607 | NDC:65162-698 | NDC:76420-868 | NDC:71335-0254 | NDC:43602-471 | NDC:71205-774 | NDC:58151-285 | NDC:71610-185 | NDC:80425-0158 | NDC:67877-222 | NDC:76282-321 | NDC:51224-121 | NDC:42806-509 | NDC:58151-283 | NDC:72189-092 | NDC:53746-101 | NDC:71610-621 | NDC:50228-179 | NDC:71335-1007 | NDC:69844-091 | NDC:31722-148 | NDC:71205-457 | NDC:50090-4893 | DrugBank ID:DB00996 | NDC:72789-217 | NDC:69097-815 | NDC:72189-471 | NDC:76282-406 | NDC:68071-4784 | NDC:80425-0150 | NDC:0071-0803 | UNII:6CW7F3G59X | NDC:80425-0097 | NDC:59762-5050 | NDC:52427-890 | NDC:65862-523 | NDC:69367-135 | NDC:80425-0033 | NDC:68382-205 | NDC:71610-057 | NDC:67046-1327 | NDC:72789-127 | NDC:16714-661 | NDC:68788-7774 | NDC:55154-8194 | NDC:72189-394 | NDC:0071-2012 | NDC:68788-9509 | NDC:74157-013 | NDC:42582-114 | NDC:63187-057 | NDC:68788-8688 | NDC:71610-410 | NDC:83008-063 | NDC:63629-8492 | NDC:70518-2323 | NDC:71205-808 | NDC:71610-044 | NDC:70518-2614 | NDC:71205-931 | NDC:80425-0128 | NDC:65862-199 | NDC:68788-8563 | NDC:60760-814 | NDC:71610-757 | NDC:69367-134 | NDC:50090-6854 | NDC:68788-7840 | NDC:71335-2004 | NDC:43063-673 | NDC:80425-0201 | NDC:71335-2281 | NDC:72189-419 | NDC:71205-661 | NDC:68094-589 | NDC:72888-132 | NDC:63187-785 | NDC:63629-8487 | NDC:65162-103 | NDC:62756-137 | NDC:0904-6823 | NDC:68071-3783 | NDC:80425-0036 | NDC:50228-181 | NDC:71610-421 | NDC:70518-4261 | NDC:55154-8189 | NDC:83301-0003 | NDC:72162-1533 | NDC:58118-1167 | NDC:71335-2005 | NDC:67877-429 | NDC:25000-104 | NDC:63187-248 | NDC:76420-837 | NDC:71335-1199 | NDC:55700-815 | NDC:60687-507 | NDC:68788-8790 | NDC:68071-5193 | NDC:71335-0351 | NDC:71205-514 | NDC:83301-0004 | NDC:71610-059 | NDC:69367-347 | NDC:64380-868 | NDC:53746-103 | NDC:63739-904 | NDC:62207-922 | NDC:71335-1991 | NDC:31722-150 | Gabapentin | NDC:63187-148 | NDC:16571-116 | NDC:50090-0949 | NDC:71093-120 | NDC:82868-051 | NDC:58118-3224 | NDC:55154-8193 | NDC:68788-8816 | NDC:70518-2356 | NDC:45865-216 | NDC:42385-979 | NDC:76420-870 | NDC:55154-7993 | NDC:31722-167 | NDC:71335-1348 | NDC:71610-069 | NDC:63187-149 | NDC:69367-346 | NDC:71205-638 | NDC:42582-115 | NDC:55154-3363 | NDC:77771-177 | NDC:60687-602 | NDC:42806-510 | NDC:49483-606 | NDC:72189-392 | NDC:71610-667 | NDC:71610-630 | NDC:50090-1597 | NDC:82619-142 | NDC:71610-756 | NDC:68071-2206 | NDC:71205-532 | NDC:0904-6665 | NDC:42806-657 | NDC:71335-1041 | NDC:69844-092 | NDC:68788-7038 | NDC:71205-619 | NDC:71610-090 | NDC:60760-669 | NDC:68071-2876 | NDC:49483-607 | NDC:69367-344 | NDC:0071-0513 | NDC:68788-8476 | NDC:72189-460 | NDC:72162-1318 | NDC:71610-211 | NDC:68462-127 | NDC:45865-194 | NDC:71205-064 | NDC:50228-180 | NDC:72162-2141 | NDC:0228-2637 | NDC:72162-1530 | NDC:68788-8176 | NDC:70518-0293 | NDC:63629-8489 | NDC:68788-7838 | NDC:50090-6855 | NDC:31722-092 | NDC:70518-2912 | NDC:77771-178 | NDC:67046-1415 | NDC:60760-740 | NDC:80425-0286 | NDC:76282-323 | NDC:25000-103 | NDC:71205-930 | NDC:67046-1364 | NDC:71610-777 | NDC:68071-3759 | NDC:70518-2970 | NDC:71610-767 | NDC:31722-069 | NDC:71610-188 | NDC:72189-384 | NDC:72865-254 | NDC:43353-081 | NDC:50268-326 | NDC:63187-392 | GABAPENTIN | NDC:76420-259 | NDC:50090-4445 | NDC:71205-766 | NDC:52427-803 | NDC:70518-1807 | NDC:50090-7400 | NDC:71335-1490 | NDC:50090-7420 | NDC:72189-313 | NDC:71335-2381 | NDC:65862-200 | NDC:68788-8194 | NDC:68788-8703 | NDC:61919-640 | NDC:83008-049 | NDC:72189-178 | NDC:0904-7108 | NDC:50090-7269 | NDC:68788-8738 | NDC:69844-055 | NDC:72162-1532 | NDC:76282-706 | NDC:71610-198 | NDC:51407-048 | NDC:82009-072 | NDC:51407-049 | NDC:72865-256 | NDC:64380-753 | NDC:70518-2960 | NDC:72865-253 | NDC:76282-707 | NDC:31722-091 | NDC:63629-8488 | NDC:62756-202 | NDC:63629-8491 | NDC:71205-929 | NDC:50090-3200 | NDC:68788-7119 | NDC:80425-0182 | NDC:76420-014 | NDC:71335-1132 | NDC:82982-067 | NDC:71093-121 | NDC:63739-560 | NDC:72789-055 | NDC:16714-332 | NDC:71335-1169 | NDC:71335-1997 | NDC:71093-112 | NDC:68788-7848 | NDC:45963-556 | NDC:42385-974 | NDC:50090-7388 | NDC:58151-284 | NDC:50090-7389 | NDC:25000-105 | NDC:16714-330 | NDC:50090-1072 | NDC:60760-674 | NDC:58118-1103 | NDC:69844-057 | NDC:69367-132 | NDC:80425-0035 | NDC:82009-071 | NDC:71610-125 | NDC:50090-7169 | NDC:71335-2279 | NDC:71205-928 | NDC:68071-2214 | NDC:72162-1813 | NDC:0228-2636 | NDC:60760-741 | NDC:71093-122 | NDC:43602-466 | NDC:63187-372 | NDC:67046-1414 | NDC:50090-7081 | NDC:71205-485 | NDC:72789-123 | NDC:80425-0196 | NDC:0071-0805 | NDC:42385-973 | NDC:63629-8490 | NDC:70010-927 | NDC:71093-111 | NDC:76420-789 | NDC:55700-950 | NDC:64380-754 | NDC:71335-1198 | NDC:71205-533 | NDC:82619-143 | NDC:67877-428 | NDC:44523-120 | CAS RN:60142-96-3 | NDC:68071-4978 | NDC:68001-411 | NDC:72789-289 | NDC:71335-1093 | NDC:23155-868 | NDC:68788-8475 | NDC:17856-0600 | NDC:68094-489 | NDC:71610-135 | NDC:74157-111 | NDC:76420-234 | NDC:72189-158 | NDC:82804-178 | NDC:55154-3357 | NDC:68788-8488 | NDC:72865-252 | NDC:50090-6718 | NDC:69844-056 | NDC:55154-8195 | NDC:70518-3329 | NDC:52427-850 | NDC:71205-671 | NDC:16714-663 | NDC:72162-1531 | NDC:76420-047 | NDC:76420-617 | NDC:63187-006 | NDC:62207-924 | NDC:50090-7268 | NDC:60760-987 | NDC:71335-1269 | NDC:50090-2539 | NDC:72865-255 | NDC:50228-177 | NDC:68382-608 | NDC:50090-0896 | NDC:60760-605 | NDC:67877-223 | NDC:69367-343 | NDC:70518-0053 | NDC:50090-7421 | NDC:72189-524 | NDC:53746-102 | NDC:71610-737 | NDC:16714-662 | NDC:70518-2842 | NDC:76282-627 | NDC:76420-235 | NDC:67046-1422 | NDC:31722-149 | NDC:63187-231 | NDC:55700-949 | NDC:63187-056 | NDC:68788-8489 | NDC:71335-0214 | NDC:58151-290 | NDC:76420-015 | NDC:65862-198 | NDC:71610-072 | NDC:71335-1496 | NDC:55154-7992 | NDC:49483-605 | NDC:76282-405 | NDC:76420-836 | NDC:68788-8712 | NDC:63629-7307 | NDC:50268-325 | NDC:82619-145 | NDC:42806-511 | NDC:31722-166 | NDC:80425-0204 | NDC:42806-656 | NDC:60687-580 | NDC:80425-0082 | NDC:16571-117 | NDC:63629-8486 | NDC:71610-166 | NDC:71610-426 | NDC:55700-812 | NDC:43063-611 | NDC:62756-204 | NDC:71610-181 | NDC:68071-5017 | NDC:0904-6666 | NDC:71335-1454 | NDC:42385-980 | NDC:70010-118 | NDC:68071-3664 | NDC:58118-1102 | NDC:76420-497 | NDC:69367-345 | NDC:64380-731 | NDC:0071-0401 | NDC:16571-869 | NDC:71335-2280 | NDC:43602-467 | NDC:63187-031 | NDC:60760-743 | NDC:69367-131 | NDC:68788-7757 | NDC:70010-109 | NDC:70518-3708 | NDC:50090-6875 | NDC:71205-160 | NDC:72189-109 | NDC:50090-2107 | NDC:43353-864 | NDC:71610-146 | NDC:80425-0199 | NDC:55289-959 | NDC:63629-8485 | NDC:70518-1760 | NDC:23155-867 | NDC:70010-928 | NDC:71610-778 | NDC:68788-8687 | CAS RN:1126623-20-8 | NDC:45963-555 | NDC:68788-7024 | NDC:71335-2053 | NDC:71610-143 | NDC:83301-0005 | NDC:52427-806 | NDC:72162-2142 | NDC:80425-0032 | NDC:63739-903 | NDC:82804-015 | NDC:45963-557 | NDC:68788-8641 | NDC:60760-088 | NDC:76420-869 | NDC:83301-0001 | NDC:43602-469 | NDC:63187-810 | NDC:71335-0073 | NDC:69097-943 | NDC:68001-412 | NDC:71335-2478 | NDC:82619-146 | NDC:70771-1862 | NDC:43353-863 | NDC:71610-126 | NDC:71335-2048 | NDC:60760-818 | NDC:50090-6189 | NDC:69097-811 | NDC:63739-902 | NDC:68788-8468 | PubChem CID:3446 | NDC:72162-2139 | NDC:16571-868 | NDC:67877-224 | NDC:83301-0002 | NDC:68462-126 | NDC:76420-020 | NDC:70010-926 | NDC:72162-2138 | NDC:43353-075 | NDC:71335-1375 | NDC:63187-988 | NDC:70010-227 | NDC:71335-0820 | NDC:23155-866 | NDC:60687-518 | NDC:70010-108 | NDC:71335-2521 | NDC:71205-317 | NDC:71205-373 | PubChem SID:175267655 | NDC:70518-1469 | NDC:80425-0079 | NDC:65162-102 | NDC:64380-869 | NDC:16571-867 | NDC:63629-8484 | NDC:71335-2037 | NDC:64380-867 | NDC:50090-7080 | NDC:0904-6667 | NDC:71335-0993 | NDC:43353-862 | NDC:58151-281 | NDC:55154-3366 | NDC:42192-608 | NDC:65862-524 | NDC:50228-178 | NDC:72162-2140 | NDC:71335-1453 | NDC:42385-972 | NDC:71335-2038 | NDC:76420-790 | NDC:71335-1197 | NDC:63187-983 | NDC:70771-1861 | NDC:65841-706 | NDC:63629-7306 | NDC:63187-010 | NDC:71335-1200 | NDC:52427-804 | NDC:72888-131 | NDC:69097-813 | NDC:71205-932 | NDC:71610-753 | NDC:62756-139 | NDC:69097-812 | NDC:68788-8546 | NDC:72162-1534 | NDC:80425-0163 | NDC:71610-088 | NDC:65162-101 | NDC:71205-295 | NDC:68382-204 | NDC:70010-228 | NDC:67296-1142 | NDC:42582-116 | NDC:71610-060 | NDC:71335-1026 | NDC:68788-8199 | NDC:58118-2101 | NDC:68788-7847 | NDC:55700-780 | NDC:63187-909 | NDC:69367-133 | NDC:62207-923 | NDC:72888-104 | 2-[1-(aminomethyl)cyclohexyl]acetic acid | NDC:71335-1655 | NDC:65841-705 | NDC:0071-0806 | NDC:71335-0220 | NDC:60687-591 | NDC:58118-0166 | NDC:51407-047 | NDC:16571-226 | NDC:62756-138 | NDC:51224-021 | NDC:82619-144 | NDC:72189-113
+BMGC_DG07584,BMG_DG138203,Gabexate | ethyl 4-[6-(diaminomethylideneamino)hexanoyloxy]benzoate | GABEXATE | DrugBank ID:DB12831 | CAS RN:39492-01-8 | PubChem CID:3447 | PubChem SID:198945816 | UNII:4V7M9137X9
+BMGC_DG07585,BMG_DG138208,"CAS RN:64603-91-4 | Gaboxadol | PubChem SID:198969413 | GABOXADOL | PubChem CID:3448 | DrugBank ID:DB06554 | 4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one | UNII:K1M5RVL18S"
+BMGC_DG07586,BMG_DG138213,"Flaxedil | UNII:VYJ027LZ05 | PubChem SID:198956563 | 2-[2,3-bis[2-(triethylazaniumyl)ethoxy]phenoxy]ethyl-triethylazanium | TRIETHYLGALLAMINE | CAS RN:7006-17-9 | PubChem CID:3450"
+BMGC_DG07587,BMG_DG138222,"TOLOXATONE | PubChem CID:34521 | CAS RN:29218-27-7 | UNII:5T206015T5 | DrugBank ID:DB09245 | PubChem SID:198955371 | 5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one | Toloxatone"
+BMGC_DG07588,BMG_DG138230,"3-acetamido-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodobenzoic acid | UNII:967RDI7Z6K | DrugBank ID:DB13444 | PubChem SID:198982191 | CAS RN:28179-44-4 | Ioxitalamic Acid | PubChem CID:34536 | IOXITALAMIC ACID"
+BMGC_DG07589,BMG_DG138233,DrugBank ID:DB01004 | Ganciclovir | PubChem CID:3454
+BMGC_DG07590,BMG_DG138236,PubChem SID:198985300 | 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine | CAS RN:67469-69-6 | Vanoxerine | UNII:90X28IKH43 | DrugBank ID:DB03701 | VANOXERINE | CAS RN:110872-73-6 | PubChem CID:3455
+BMGC_DG07591,BMG_DG138243,GBR-12935 | UNII:9J9974WIBA | CAS RN:76778-22-8 | 1-(2-benzhydryloxyethyl)-4-(3-phenylpropyl)piperazine | PubChem SID:255509037 | 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine | PubChem CID:3456
+BMGC_DG07592,BMG_DG138251,PubChem CID:345772 | 5-METHYL-2-(2-PYRIDYL)BENZIMIDAZOLE | UNII:9RVR7V4EAG | PubChem SID:445498837 | CAS RN:7471-12-7
+BMGC_DG07593,BMG_DG138277,"UNII:Q8X02027X3 | NDC:66267-436 | NDC:71335-2025 | NDC:63187-772 | NDC:0071-0737 | NDC:50090-7233 | DrugBank ID:DB01241 | NDC:65862-624 | NDC:71205-169 | NDC:50268-350 | NDC:16571-784 | NDC:71335-0971 | GEMFIBROZIL | NDC:72162-2119 | NDC:72578-066 | NDC:72603-206 | NDC:68788-6447 | NDC:63187-146 | NDC:71335-1996 | NDC:71610-107 | NDC:51655-143 | NDC:50090-6939 | NDC:16714-101 | NDC:68071-1733 | Gemfibrozil | NDC:70518-1563 | NDC:71610-601 | NDC:71335-1902 | NDC:31722-128 | NDC:72865-186 | NDC:43602-452 | NDC:76282-225 | NDC:75834-131 | NDC:69097-821 | NDC:62135-160 | NDC:70771-1431 | NDC:68788-7964 | PubChem CID:3463 | NDC:71335-0051 | NDC:50090-5808 | CAS RN:114413-98-8 | NDC:71610-824 | NDC:50090-7234 | NDC:60687-224 | NDC:71209-008 | NDC:71610-200 | NDC:43063-745 | CAS RN:25812-30-0 | NDC:50090-6913 | NDC:68382-553 | PubChem SID:175268537 | NDC:43063-921 | NDC:42806-260 | NDC:24658-260 | NDC:0615-8354 | 5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid"
+BMGC_DG07594,BMG_DG138280,ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate | PubChem SID:175268763 | MORICIZINE | CAS RN:31883-05-3 | DrugBank ID:DB00680 | PubChem CID:34633 | UNII:2GT1D0TMX1 | Moricizine
+BMGC_DG07595,BMG_DG138292,CAS RN:29676-71-9 | UNII:QSH3O4TNJT | PubChem SID:241178834 | 2-AMINOTHIAZOLE-4-ACETIC ACID | PubChem CID:34665
+BMGC_DG07596,BMG_DG138294,"CAS RN:1294497-75-8 | 2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol | DrugBank ID:DB00798 | CAS RN:1403-66-3 | Gentamicin | PubChem CID:3467"
+BMGC_DG07597,BMG_DG138296,PubChem SID:474492384 | CAS RN:82506-00-1 | 2-(2-CYCLOHEXYLPHENOXY)ACETIC ACID | PubChem CID:346737 | 2-(2-Cyclohexylphenoxy)acetic acid | UNII:D8QDT99WMH
+BMGC_DG07598,BMG_DG138297,STO-609 | CAS RN:52029-86-4 | UNII:CV7Q6X3C4Q | PubChem SID:482553325 | PubChem CID:3467590
+BMGC_DG07599,BMG_DG138299,"2-Aminotetralin, (±)- | UNII:LGX8T83G7X | 2-AMINOTETRALIN, (+/-)- | CAS RN:2954-50-9 | PubChem CID:34677 | PubChem SID:472405618"
+BMGC_DG07600,BMG_DG138300,"[4-[bis[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium | GENTIAN VIOLET CATION | UNII:3GVJ31T6YY | PubChem SID:175267232 | PubChem CID:3468 | DrugBank ID:DB00406 | CAS RN:7438-46-2 | Gentian violet cation"
+BMGC_DG07601,BMG_DG138302,"PubChem CID:3469 | CAS RN:490-79-9 | UNII:VP36V95O3T | GENTISIC ACID | PubChem SID:175266992 | 2,5-dihydroxybenzoic acid | 2,5-Dihydroxybenzoic acid"
+BMGC_DG07602,BMG_DG138303,"4-(2-AMINO-4-THIAZOLYL)PHENOL | 4-(2-amino-1,3-thiazol-4-yl)phenol | CAS RN:57634-55-6 | UNII:MLP0GI2196 | PubChem CID:346926 | DrugBank ID:DB07292 | PubChem SID:438787749"
+BMGC_DG07603,BMG_DG138315,5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one | CAS RN:39886-76-5 | 5-Hydroxy-1-(4-Hydroxy-3-Methoxyphenyl)Decan-3-One | PubChem CID:3473
+BMGC_DG07604,BMG_DG138316,"CAS RN:3820-67-5 | UNII:46HL4I09AH | Glafenine | PubChem CID:3474 | GLAFENINE | 2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate | PubChem SID:198975252"
+BMGC_DG07605,BMG_DG138317,DrugBank ID:DB04105 | PubChem CID:347402 | PubChem SID:438788829 | N-HEPTYLFORMAMIDE | N-Heptylformamide | N-heptylformamide | UNII:E80SN819M5 | CAS RN:59734-16-6
+BMGC_DG07606,BMG_DG138326,"1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea | DrugBank ID:DB01120 | CAS RN:21187-98-4 | PubChem CID:3475 | Gliclazide"
+BMGC_DG07607,BMG_DG138329,"CAS RN:96420-61-0 | 2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | PubChem CID:34751 | CAS RN:51371-34-7 | [(6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy](phenyl)acetonitrile | CAS RN:29883-15-6"
+BMGC_DG07608,BMG_DG138332,"UNII:6EZ5466ZUX | (2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylsulfonio]butanoate | CAS RN:29908-03-0 | PubChem CID:34755 | PubChem SID:252165038 | Ademetionine | PubChem SID:198958446 | ADEMETIONINE, (S)- | ADEMETIONINE, (R)- | DrugBank ID:DB00118 | CAS RN:78548-84-2 | NDC:83027-0095 | PubChem SID:252164467 | UNII:K093C397UL | UNII:7LP2MPO46S | CAS RN:91279-78-6 | ADEMETIONINE"
+BMGC_DG07609,BMG_DG138337,PubChem CID:347590 | S-Ethyl-N-Phenyl-Isothiourea | DrugBank ID:DB03707
+BMGC_DG07610,BMG_DG138338,"NDC:50090-1526 | NDC:68001-585 | NDC:71335-2409 | NDC:72789-048 | NDC:68788-8066 | CAS RN:93479-97-1 | NDC:69543-123 | NDC:51655-489 | NDC:69543-125 | NDC:71205-773 | NDC:61442-116 | NDC:51655-120 | NDC:63629-3043 | NDC:43063-698 | NDC:68071-2228 | NDC:68001-177 | NDC:82804-140 | UNII:24T6XIR2MZ | NDC:50090-6426 | NDC:68001-584 | NDC:68001-586 | NDC:68084-326 | Glimepiride | NDC:67046-1114 | NDC:68788-8095 | NDC:71335-9657 | NDC:60760-800 | NDC:71335-9655 | NDC:55111-322 | PubChem SID:175265662 | NDC:42571-105 | NDC:70518-3786 | NDC:0615-8333 | NDC:50090-7187 | NDC:68645-573 | NDC:50268-359 | NDC:50090-7406 | NDC:42571-100 | NDC:43547-396 | NDC:63187-641 | NDC:50268-360 | NDC:42571-101 | NDC:70518-4025 | NDC:63187-698 | NDC:43063-121 | GLIMEPIRIDE, CIS- | 4-ethyl-3-methyl-N-[2-[4-[(4-methylcyclohexyl)carbamoylsulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide | NDC:55111-320 | NDC:64764-304 | NDC:16571-774 | NDC:0615-8332 | NDC:72789-370 | NDC:71335-0484 | NDC:71921-214 | NDC:16571-773 | NDC:50268-358 | NDC:68788-7694 | NDC:60429-920 | NDC:71921-215 | NDC:50090-6322 | NDC:70518-3782 | CAS RN:684286-46-2 | NDC:82804-065 | NDC:70518-4196 | NDC:60429-919 | NDC:16571-775 | NDC:16729-002 | NDC:43063-699 | NDC:70518-3627 | NDC:65862-579 | NDC:60429-918 | NDC:50090-7407 | NDC:72189-485 | PubChem CID:3476 | NDC:50090-7247 | GLIMEPIRIDE | NDC:70518-4039 | NDC:71205-779 | NDC:71610-236 | NDC:60760-248 | NDC:71335-0180 | NDC:66993-821 | NDC:72336-641 | UNII:6KY687524K | NDC:50090-3172 | NDC:50090-6910 | NDC:0615-8334 | NDC:64764-302 | NDC:72189-453 | NDC:50090-6415 | NDC:43063-122 | NDC:68645-572 | NDC:68084-327 | NDC:70518-4140 | NDC:50090-6852 | NDC:50090-7090 | NDC:61442-117 | NDC:61442-115 | NDC:43063-697 | NDC:68084-788 | NDC:43063-587 | NDC:72189-585 | NDC:42571-104 | NDC:68788-8728 | NDC:71335-1885 | NDC:71335-2367 | NDC:50090-3189 | NDC:55111-321 | NDC:70518-3665 | NDC:71335-9654 | NDC:50090-1006 | NDC:42571-102 | NDC:16729-003 | NDC:66993-822 | CAS RN:261361-60-8 | NDC:55154-8175 | NDC:42571-103 | NDC:65862-580 | NDC:63187-486 | DrugBank ID:DB00222 | NDC:82868-042 | NDC:68788-8432 | NDC:50090-6394 | NDC:68001-179 | NDC:71921-216 | NDC:50090-1987 | NDC:69543-124 | NDC:43063-630 | NDC:68071-3639 | NDC:43547-394 | NDC:16729-001 | NDC:51655-383 | NDC:68001-178 | NDC:43063-946 | PubChem SID:198938953 | NDC:51655-565 | NDC:43547-395 | NDC:65862-581 | NDC:70518-2670 | NDC:50090-7246"
+BMGC_DG07611,BMG_DG138345,"PubChem SID:459055658 | 5,6-DINITROACENAPHTHOQUINONE | CAS RN:27471-02-9 | UNII:W6B8U4RW8E | PubChem CID:3477013"
+BMGC_DG07612,BMG_DG138354,NDC:72789-463 | NDC:70518-0908 | NDC:50090-6975 | NDC:64980-281 | NDC:68382-336 | NDC:68788-8487 | NDC:51655-810 | NDC:72888-116 | NDC:82868-035 | NDC:71335-2528 | NDC:50090-5040 | NDC:62135-731 | NDC:71610-388 | NDC:51655-966 | NDC:71610-668 | NDC:68382-186 | CAS RN:29094-61-9 | NDC:71335-1130 | NDC:71610-105 | NDC:52817-385 | NDC:50090-7405 | NDC:55154-7987 | NDC:50268-362 | PubChem CID:3478 | NDC:63187-811 | NDC:16714-895 | NDC:16714-896 | NDC:0049-0178 | NDC:50090-6746 | NDC:67296-2042 | NDC:23155-117 | NDC:51655-337 | NDC:62135-733 | NDC:71205-041 | NDC:50090-7404 | NDC:63629-1398 | N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide | NDC:70518-0579 | NDC:72162-2215 | NDC:51655-180 | NDC:55289-806 | NDC:70518-1063 | NDC:0591-0460 | NDC:59651-780 | NDC:68382-335 | NDC:68071-4939 | NDC:68788-8550 | NDC:71335-0618 | PubChem SID:175267608 | NDC:71335-0930 | NDC:0049-0174 | NDC:43353-379 | NDC:50090-6848 | NDC:70518-3898 | NDC:71335-9742 | NDC:59651-782 | NDC:51655-361 | NDC:51655-106 | NDC:0615-8408 | NDC:23155-116 | NDC:0591-0845 | NDC:68788-0141 | NDC:64980-280 | NDC:60687-768 | NDC:71335-9614 | NDC:65841-660 | DrugBank ID:DB01067 | NDC:62559-316 | NDC:80425-0437 | NDC:16714-894 | NDC:68071-4223 | NDC:62135-732 | NDC:51407-620 | NDC:68071-4643 | NDC:0591-0461 | NDC:50268-361 | NDC:68071-4124 | NDC:50090-2492 | NDC:55289-301 | UNII:X7WDT95N5C | NDC:43353-369 | NDC:71335-2520 | NDC:82868-025 | NDC:50090-2556 | NDC:60760-165 | NDC:0904-6637 | NDC:0093-7455 | NDC:70518-2573 | NDC:72888-117 | NDC:72162-2103 | NDC:72888-115 | NDC:60760-793 | NDC:71335-1031 | NDC:68788-7856 | NDC:60760-794 | NDC:65841-661 | NDC:68382-337 | NDC:60687-480 | NDC:50090-6849 | NDC:50090-0505 | NDC:65841-659 | NDC:68382-184 | NDC:55700-585 | NDC:70771-1098 | NDC:0615-8407 | NDC:67046-1153 | NDC:0093-7457 | NDC:68645-574 | NDC:60687-701 | NDC:68084-111 | NDC:70518-1848 | NDC:72789-464 | NDC:60505-0142 | NDC:50090-5806 | NDC:63187-255 | NDC:51407-621 | NDC:70518-4128 | NDC:70518-1594 | NDC:67544-097 | NDC:62559-315 | NDC:67046-1204 | NDC:59651-781 | NDC:59651-269 | NDC:59651-270 | NDC:68645-575 | NDC:70771-1100 | NDC:70518-2624 | NDC:70518-2888 | NDC:82804-174 | NDC:42291-306 | NDC:66267-099 | NDC:50090-7197 | NDC:60687-690 | NDC:71335-2540 | NDC:50090-6996 | NDC:60505-0141 | NDC:50090-6765 | NDC:50090-6473 | NDC:68788-8192 | NDC:42708-109 | NDC:59651-268 | NDC:70518-3896 | NDC:50090-7403 | NDC:70518-3645 | NDC:70518-3688 | NDC:60760-329 | NDC:23155-115 | NDC:72162-2102 | NDC:71610-680 | NDC:67544-302 | NDC:68788-0142 | NDC:68788-8512 | NDC:68382-185 | NDC:60760-568 | NDC:42291-305 | NDC:50090-7402 | Glipizide | NDC:43063-861 | GLIPIZIDE | NDC:64980-279 | NDC:68071-4857 | NDC:70518-0552 | NDC:0591-0900 | NDC:71610-393 | NDC:71610-175 | NDC:0591-0844 | NDC:68071-4085 | NDC:71205-270 | NDC:51655-982 | NDC:63187-993 | NDC:68071-4232 | NDC:71335-2353 | NDC:71335-1042 | NDC:51655-983 | NDC:72189-070 | NDC:50090-0502 | NDC:0093-7456 | CAS RN:172964-66-8 | NDC:72789-130 | NDC:55289-779 | NDC:43353-207 | NDC:68788-8138 | NDC:70771-1099 | NDC:50090-4297 | NDC:63187-477
+BMGC_DG07613,BMG_DG138367,"3-(3,4-dihydroxyphenyl)propanoic acid | PubChem CID:348154 | Dihydrocaffeic acid | CAS RN:1078-61-1 | PubChem SID:318164412 | UNII:MSW0228VUB | 3-(3,4-DIHYDROXYPHENYL) PROPIONIC ACID | CAS RN:71693-95-3"
+BMGC_DG07614,BMG_DG138389,"(3,4-DICHLOROPHENYL)METHYL CARBAMIMIDOTHIOATE | CAS RN:22297-13-8 | PubChem CID:348494 | UNII:J9ZA892FYX | (3,4-Dichlorophenyl)methyl carbamimidothioate | PubChem SID:474492390"
+BMGC_DG07615,BMG_DG138391,CAS RN:111-30-8 | PubChem SID:175265651 | DrugBank ID:DB03266 | UNII:T3C89M417N | pentanedial | PubChem CID:3485 | Glutaral | GLUTARAL
+BMGC_DG07616,BMG_DG138393,CAS RN:49558-04-5 | AMYL NICOTINATE | PubChem CID:348507 | PubChem SID:472407592 | UNII:MG2KMS9D5T
+BMGC_DG07617,BMG_DG138406,"UNII:RTM432Q8P2 | PubChem SID:472425455 | PubChem CID:348669 | CAS RN:1127-93-1 | 2,4-PTERIDINEDIAMINE"
+BMGC_DG07618,BMG_DG138407,"CAS RN:30272-08-3 | PubChem SID:198980831 | UNII:A5P604A12R | CID 34869 | Amineptine | DrugBank ID:DB04836 | 6-carboxyhexyl(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)azanium;chloride | PubChem CID:34869 | AMINEPTINE HYDROCHLORIDE"
+BMGC_DG07619,BMG_DG138409,"PubChem SID:198953629 | CAS RN:77-21-4 | GLUTETHIMIDE | UNII:C8I4BVN78E | 3-ethyl-3-phenylpiperidine-2,6-dione | PubChem CID:3487 | Glutethimide | DrugBank ID:DB01437"
+BMGC_DG07620,BMG_DG138410,"7-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylamino)heptanoic acid | CAS RN:57574-09-1 | AMINEPTINE | Amineptine | DrugBank ID:DB04836 | UNII:27T1I13L6G | PubChem SID:198981995 | PubChem CID:34870"
+BMGC_DG07621,BMG_DG138416,NDC:0093-8344 | NDC:23155-235 | NDC:67046-1345 | NDC:51655-942 | NDC:68071-3677 | NDC:50090-0495 | NDC:72241-040 | NDC:68382-655 | NDC:70518-1646 | NDC:67046-1426 | PubChem CID:3488 | NDC:50090-6607 | NDC:0093-8343 | NDC:68071-4695 | NDC:23155-056 | NDC:62135-584 | NDC:68788-8343 | NDC:68382-656 | DrugBank ID:DB01016 | NDC:65862-080 | NDC:71209-009 | NDC:70518-3504 | NDC:0093-9477 | NDC:0093-8034 | NDC:0093-9364 | NDC:71335-0967 | NDC:68382-657 | NDC:57237-025 | Glyburide | NDC:50090-7408 | NDC:65841-825 | NDC:68788-8791 | NDC:23155-058 | NDC:66267-103 | NDC:68071-4718 | NDC:50090-0887 | NDC:68788-7180 | NDC:65841-826 | NDC:65841-824 | NDC:65862-081 | NDC:71335-0360 | NDC:68382-653 | 5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide | NDC:0093-9433 | NDC:71209-011 | CAS RN:10238-21-8 | NDC:68071-5217 | NDC:62135-585 | NDC:75834-204 | NDC:68788-8508 | NDC:57237-024 | NDC:68071-5215 | NDC:23155-057 | NDC:50090-2031 | NDC:68071-5030 | NDC:70518-4035 | NDC:71209-010 | NDC:0093-8342 | NDC:50090-0888 | NDC:72789-275 | NDC:51655-659 | NDC:50090-2030 | NDC:0093-8036 | NDC:50090-6196 | NDC:65841-833 | NDC:71335-0069 | NDC:23155-233 | NDC:63187-667 | NDC:71335-2508 | NDC:65841-832 | NDC:23155-234 | NDC:62135-583 | NDC:68788-8341 | NDC:68071-3702 | NDC:75834-203 | NDC:65862-082 | NDC:82804-150 | NDC:0093-8035 | NDC:68788-8634 | NDC:65841-834 | NDC:68382-658 | NDC:75834-202 | NDC:50090-5776 | PubChem SID:175268429 | NDC:51655-492 | NDC:72241-039 | NDC:63187-659 | NDC:71335-0150 | NDC:68382-654 | NDC:63187-848 | NDC:72241-038 | NDC:57237-023 | NDC:67046-1349 | GLYBURIDE | UNII:SX6K58TVWC
+BMGC_DG07622,BMG_DG138429,1-dimethylphosphoryldecane | Decyl(dimethyl)phosphine oxide | PubChem SID:438787937 | UNII:BQ0G8CN4H9 | Decyl(Dimethyl)phosphine Oxide | DIMETHYLDECYL PHOSPHINE OXIDE | DrugBank ID:DB07641 | PubChem CID:3492020 | CAS RN:2190-95-6
+BMGC_DG07623,BMG_DG138434,"PubChem CID:3494 | (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate | Glycopyrronium bromide | CAS RN:13283-82-4 | DrugBank ID:DB00986"
+BMGC_DG07624,BMG_DG138435,"PubChem SID:472424875 | 1,3(2H,4H)-ISOQUINOLINEDIONE | PubChem CID:349435 | CAS RN:4456-77-3 | UNII:36C8TUT4R4"
+BMGC_DG07625,BMG_DG138441,PubChem CID:349626 | 2-(4-METHYLPHENYL)-1-(4-MORPHOLINYL)ETHANETHIONE | UNII:UAB2VH6VTN | 2-(4-Methylphenyl)-1-(4-morpholinyl)ethanethione | CAS RN:14182-63-9 | PubChem SID:474494472
+BMGC_DG07626,BMG_DG138448,"3-[1-[3-(Dimethylamino)propyl]-5-methoxy-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione | CAS RN:133053-19-7 | 3-[1-[3-(dimethylamino)propyl]-5-methoxyindol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione | PubChem CID:3499"
+BMGC_DG07627,BMG_DG138452,"PubChem CID:3501 | PubChem SID:198966948 | UNII:B9IQO7JZ16 | Go-6976 | GO-6976 | CAS RN:136194-77-9 | 3-(23-methyl-14-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)propanenitrile"
+BMGC_DG07628,BMG_DG138471,"Gossypol | CAS RN:1189561-66-7 | PubChem SID:472385919 | GOSSYPOL | UNII:8DY2X8LXW4 | CAS RN:90141-22-3 | PubChem SID:472423078 | PubChem CID:3503 | UNII:XNA7DR63CQ | 7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde | UNII:KAV15B369O | CAS RN:20300-26-9 | GOSSYPOL, (S)- | CAS RN:303-45-7 | PubChem SID:472404270 | DrugBank ID:DB13044 | GOSSYPOL, (R)-"
+BMGC_DG07629,BMG_DG138477,PubChem CID:3505 | CAS RN:126766-31-2 | PubChem SID:441583789 | UNII:YXV3Q43RS9 | GR-89696
+BMGC_DG07630,BMG_DG138480,"PubChem CID:3505109 | 4-NITROCATECHOL | CAS RN:3316-09-4 | PubChem SID:198943399 | 4-Nitrocatechol | 4-nitrobenzene-1,2-diol | DrugBank ID:DB03407 | UNII:SW60NG75EN"
+BMGC_DG07631,BMG_DG138481,"PubChem CID:3506204 | 2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID | DrugBank ID:DB07034"
+BMGC_DG07632,BMG_DG138484,"Sodium;2-(2,4,5,7-tetraiodo-3-oxido-6-oxo-9-xanthenyl)benzoate | PubChem CID:3507056 | 2-(2,4,5,7-tetraiodo-3-oxido-6-oxoxanthen-9-yl)benzoate"
+BMGC_DG07633,BMG_DG138489,CAS RN:124998-65-8 | 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide | CAS RN:1224925-64-7 | CAS RN:1364914-39-5 | PubChem CID:3510 | CAS RN:109889-09-0 | (3H)granisetron
+BMGC_DG07634,BMG_DG138490,UNII:G92UUU86L8 | CAS RN:4538-08-3 | PubChem CID:3510137 | N-(4-sulfamoylphenyl)butanamide | N-(4-SULFAMOYLPHENYL)BUTANAMIDE | PubChem SID:485663426
+BMGC_DG07635,BMG_DG138501,"PubChem CID:351236 | CAS RN:2527-66-4 | UNII:81PV9X5Y68 | 2-METHYL-1,2-BENZOISOTHIAZOLIN-3-ONE | PubChem SID:241181361"
+BMGC_DG07636,BMG_DG138505,PubChem SID:241179429 | 3-PHENYLPROPYLGUANIDINE | UNII:RCU844M3TV | PubChem CID:3513127 | CAS RN:7565-21-1
+BMGC_DG07637,BMG_DG138514,"UNII:2OZ1K9JKQC | PubChem SID:198970910 | 1,4-dimethyl-7-propan-2-ylazulene | PubChem CID:3515 | DrugBank ID:DB13329 | CAS RN:489-84-9 | GUAIAZULENE | Guaiazulene"
+BMGC_DG07638,BMG_DG138517,"NDC:53942-203 | NDC:51316-008 | NDC:60687-874 | NDC:36800-794 | NDC:46122-794 | NDC:59726-832 | NDC:55111-799 | NDC:63824-951 | NDC:73057-389 | NDC:55319-857 | NDC:62207-827 | NDC:0536-1137 | Guaifenesin | NDC:79481-0119 | NDC:72036-203 | NDC:68196-996 | NDC:58602-833 | NDC:21130-399 | NDC:54738-981 | NDC:50090-6542 | NDC:56062-144 | NDC:57483-280 | NDC:69842-335 | NDC:63629-7886 | NDC:17714-152 | NDC:41520-731 | NDC:36800-137 | NDC:57896-714 | NDC:0363-0570 | NDC:51467-009 | NDC:62207-839 | NDC:68163-743 | NDC:51660-077 | NDC:69822-200 | NDC:84324-009 | NDC:83324-024 | NDC:63187-954 | NDC:63824-008 | NDC:11673-731 | NDC:51660-567 | NDC:17856-0008 | NDC:10135-789 | NDC:0904-6718 | NDC:68094-048 | NDC:72288-298 | NDC:11822-4260 | NDC:63824-041 | NDC:41163-731 | NDC:68210-4130 | NDC:63868-871 | NDC:70000-0141 | NDC:0536-1333 | NDC:10956-059 | NDC:55681-301 | NDC:24385-602 | NDC:37808-762 | NDC:53942-204 | NDC:11822-0731 | NDC:43598-108 | NDC:41250-892 | NDC:0363-7480 | NDC:55319-732 | NDC:79481-1002 | NDC:41250-654 | NDC:51316-743 | NDC:43598-110 | NDC:55319-891 | NDC:57483-270 | NDC:59640-621 | NDC:72559-013 | NDC:0121-1744 | NDC:79903-124 | NDC:53499-0232 | NDC:84447-101 | NDC:36800-226 | NDC:30142-962 | NDC:63739-067 | NDC:70677-1056 | NDC:36800-932 | NDC:11673-539 | NDC:68084-572 | NDC:46122-700 | NDC:58657-509 | NDC:76162-123 | NDC:63981-532 | NDC:71679-119 | NDC:41415-997 | NDC:11673-732 | NDC:69842-997 | NDC:62207-570 | NDC:0536-1430 | NDC:71335-9616 | NDC:67091-403 | NDC:0121-0744 | NDC:63941-986 | NDC:30142-137 | NDC:69848-018 | NDC:53041-233 | NDC:41415-994 | NDC:55301-932 | NDC:0363-9569 | NDC:65162-036 | NDC:68016-170 | NDC:70010-199 | NDC:76457-004 | NDC:69618-068 | NDC:36800-989 | NDC:0121-1488 | NDC:21130-101 | NDC:50090-0818 | NDC:81522-203 | NDC:0113-0061 | NDC:69822-212 | NDC:24689-144 | NDC:69842-487 | NDC:70677-1263 | NDC:69842-211 | NDC:37808-777 | NDC:67091-404 | NDC:63868-148 | NDC:63629-7115 | NDC:54738-980 | NDC:69842-806 | NDC:68210-0611 | NDC:54859-605 | NDC:72162-2278 | NDC:73581-402 | NDC:58552-146 | NDC:60687-863 | NDC:71610-098 | NDC:62207-840 | NDC:69618-061 | NDC:83720-503 | NDC:46122-785 | NDC:83324-097 | NDC:0536-1392 | PubChem SID:175272095 | NDC:59640-300 | NDC:58552-336 | NDC:0363-0532 | NDC:53041-234 | CAS RN:93-14-1 | NDC:64024-222 | NDC:58716-433 | NDC:58602-853 | NDC:55154-4680 | NDC:81522-204 | NDC:54859-507 | NDC:80513-403 | NDC:76864-209 | NDC:54257-776 | NDC:73057-379 | NDC:0904-6763 | NDC:68210-4173 | NDC:79481-0709 | NDC:41250-547 | NDC:0904-5154 | NDC:49035-284 | NDC:69517-148 | NDC:41226-724 | NDC:72090-009 | NDC:70677-1013 | NDC:72288-650 | NDC:0536-1182 | NDC:0121-2232 | NDC:80267-002 | NDC:50804-857 | NDC:57896-693 | NDC:55154-4153 | NDC:11673-840 | NDC:69168-370 | NDC:0363-0832 | NDC:68001-561 | NDC:81179-007 | NDC:68998-845 | NDC:58602-865 | NDC:70000-0580 | NDC:41226-723 | NDC:43598-009 | NDC:11822-2123 | NDC:63941-987 | NDC:69848-017 | NDC:0363-0077 | NDC:49035-261 | NDC:55111-798 | NDC:67544-149 | NDC:63824-023 | NDC:69842-732 | NDC:59726-734 | NDC:0363-0144 | NDC:0485-0208 | NDC:53041-190 | NDC:70000-0004 | NDC:71679-148 | NDC:58593-829 | NDC:49348-135 | NDC:71309-461 | NDC:69517-119 | NDC:41250-732 | NDC:50090-1076 | NDC:58593-265 | NDC:70677-1258 | NDC:80267-010 | NDC:63868-872 | NDC:76162-004 | NDC:41250-713 | NDC:76162-801 | NDC:82649-732 | NDC:0363-0033 | NDC:30142-961 | NDC:55910-904 | NDC:70000-0608 | NDC:59800-1365 | NDC:0536-1309 | NDC:21130-179 | NDC:69256-144 | 3-(2-methoxyphenoxy)propane-1,2-diol | NDC:70677-1011 | NDC:63824-057 | NDC:69256-731 | NDC:62011-0060 | NDC:0904-6986 | GUAIFENESIN | NDC:63187-587 | NDC:83813-003 | NDC:50804-371 | NDC:69168-459 | NDC:49348-729 | NDC:72036-204 | NDC:70677-1273 | NDC:79903-125 | NDC:11822-7399 | NDC:63868-149 | NDC:70677-1052 | NDC:0363-0134 | NDC:51316-970 | NDC:58657-508 | NDC:63187-960 | NDC:63868-770 | NDC:53041-191 | NDC:53943-511 | NDC:68016-545 | NDC:11822-3252 | NDC:72090-019 | NDC:70677-1257 | NDC:0363-1604 | NDC:0363-7043 | NDC:41163-701 | NDC:0363-0028 | NDC:10135-790 | NDC:57896-794 | NDC:68210-4158 | NDC:50090-2301 | NDC:11822-2252 | NDC:51316-071 | NDC:63941-731 | NDC:60687-852 | NDC:76162-523 | NDC:57896-293 | NDC:0113-2023 | NDC:50991-736 | NDC:0363-9946 | NDC:62207-828 | NDC:67091-370 | NDC:82725-1012 | NDC:49580-0389 | NDC:50090-2380 | NDC:50991-212 | NDC:0363-8708 | NDC:67296-1467 | NDC:70000-0055 | NDC:72090-013 | NDC:73581-401 | NDC:46122-683 | NDC:58593-255 | NDC:71179-002 | NDC:79903-271 | NDC:59726-831 | NDC:67296-1804 | NDC:70677-1054 | NDC:83335-003 | NDC:49483-272 | NDC:81033-102 | NDC:83139-175 | NDC:0363-9930 | NDC:25000-041 | NDC:58552-332 | NDC:58602-834 | NDC:36800-515 | NDC:68210-4102 | NDC:65162-037 | NDC:77333-360 | NDC:11822-0046 | NDC:58552-145 | NDC:0031-9303 | NDC:83324-096 | NDC:10135-682 | DrugBank ID:DB00874 | NDC:49483-724 | NDC:76281-507 | PubChem CID:3516 | NDC:66424-563 | NDC:72090-035 | NDC:10135-681 | NDC:68391-000 | NDC:0536-1311 | NDC:68196-405 | NDC:71141-135 | NDC:30142-471 | NDC:55910-732 | NDC:55319-551 | NDC:50090-6078 | NDC:46122-750 | NDC:0363-7064 | NDC:46122-801 | NDC:55154-9450 | NDC:41226-272 | NDC:51660-074 | NDC:58602-864 | NDC:57344-203 | NDC:59726-857 | NDC:58602-810 | NDC:51316-993 | NDC:37808-830 | NDC:70677-1186 | NDC:0536-1314 | NDC:50090-1340 | NDC:49483-723 | NDC:71679-075 | NDC:79481-7430 | NDC:41415-996 | NDC:0363-2389 | NDC:72559-017 | NDC:49348-774 | NDC:55681-311 | NDC:69842-095 | NDC:68163-748 | NDC:62011-0475 | NDC:41163-113 | NDC:71610-499 | NDC:83335-101 | NDC:50090-1075 | NDC:70000-0479 | NDC:70000-0696 | NDC:69168-916 | NDC:84379-313 | NDC:37808-935 | NDC:70677-1272 | NDC:0536-1163 | NDC:81522-006 | NDC:70677-1051 | NDC:41250-684 | NDC:62011-0382 | NDC:58602-811 | NDC:43598-008 | NDC:67296-0569 | NDC:69168-460 | NDC:21130-554 | NDC:71610-434 | NDC:63824-537 | NDC:69256-732 | NDC:11673-421 | NDC:51660-566 | NDC:41520-732 | NDC:10956-845 | UNII:495W7451VQ | NDC:55910-739 | NDC:11822-0732 | NDC:55910-626 | NDC:51316-437 | NDC:0113-3650 | NDC:62207-569 | NDC:0363-0542 | NDC:53943-507 | NDC:68210-6110 | NDC:0363-0931 | NDC:63868-801 | NDC:25000-042 | NDC:55154-5780 | NDC:0363-7504 | NDC:63868-998"
+BMGC_DG07639,BMG_DG138518,PubChem SID:472426250 | PubChem CID:351652 | 6-AMINOPYRIDINE-2-CARBOXYLIC ACID | CAS RN:23628-31-1 | UNII:R6NBL985SU
+BMGC_DG07640,BMG_DG138520,"Guanabenz | 2-[(2,6-Dichlorophenyl)methylideneamino]guanidine | CAS RN:5051-62-7 | PubChem CID:3517 | 2-[(2,6-dichlorophenyl)methylideneamino]guanidine | DrugBank ID:DB00629"
+BMGC_DG07641,BMG_DG138522,2-AMINO-5-METHYL-THIAZOLE | PubChem SID:198937808 | CAS RN:7305-71-7 | PubChem CID:351770 | UNII:7RAB78AF2P
+BMGC_DG07642,BMG_DG138525,2-[2-(azocan-1-yl)ethyl]guanidine | PubChem CID:3518 | CAS RN:55-65-2 | UNII:ZTI6C33Q2Q | DrugBank ID:DB01170 | Guanethidine | GUANETHIDINE | PubChem SID:175267472
+BMGC_DG07643,BMG_DG138528,"NDC:60429-962 | NDC:71205-944 | UNII:30OMY4G3MK | CAS RN:29110-47-2 | Guanfacine | NDC:24979-536 | NDC:60429-960 | NDC:60429-961 | NDC:71205-946 | NDC:70518-3809 | PubChem SID:175268360 | NDC:60687-710 | NDC:29300-459 | NDC:24979-534 | NDC:29300-458 | NDC:24979-538 | NDC:71205-945 | GUANFACINE | NDC:24979-533 | NDC:71205-947 | NDC:60429-963 | DrugBank ID:DB01018 | NDC:70518-3516 | N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide | NDC:70518-2771 | PubChem CID:3519"
+BMGC_DG07644,BMG_DG138530,"PubChem CID:3519901 | 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one | CAS RN:68682-01-9 | 6-Prenyl-rac-naringenin"
+BMGC_DG07645,BMG_DG138531,PubChem SID:175266876 | guanidine | Guanidine | GUANIDINE | DrugBank ID:DB00536 | CAS RN:113-00-8 | UNII:JU58VJ6Y3B | PubChem CID:3520
+BMGC_DG07646,BMG_DG138550,UNII:S73ZBX63N5 | 4-AMINO-3-BROMOBENZENESULFONAMIDE | PubChem CID:3526523 | CAS RN:53297-69-1
+BMGC_DG07647,BMG_DG138571,"PubChem SID:198943986 | DrugBank ID:DB08848 | UNII:41538P325K | Guvacine | PubChem CID:3532 | CAS RN:498-96-4 | GUVACINE | 1,2,3,6-tetrahydropyridine-5-carboxylic acid"
+BMGC_DG07648,BMG_DG138575,UNII:9KY0QXD6LI | DrugBank ID:DB00901 | BITOLTEROL | [4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(4-methylbenzoyl)oxyphenyl] 4-methylbenzoate | PubChem CID:35330 | PubChem SID:198973360 | Bitolterol | CAS RN:30392-40-6
+BMGC_DG07649,BMG_DG138578,"DrugBank ID:DB02001 | 5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine | PubChem CID:3534"
+BMGC_DG07650,BMG_DG138589,"PubChem CID:3537 | DrugBank ID:DB01958 | 5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine"
+BMGC_DG07651,BMG_DG138590,"NDC:49702-211 | NDC:65862-048 | DrugBank ID:DB00495 | PubChem CID:35370 | CAS RN:399024-19-2 | NDC:49702-212 | NDC:49702-213 | 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | ZIDOVUDINE | PubChem SID:175268082 | NDC:65862-024 | Zidovudine | CAS RN:30516-87-1 | NDC:65862-107 | NDC:31722-509 | UNII:4B9XT59T7S"
+BMGC_DG07652,BMG_DG138591,DrugBank ID:DB08984 | CAS RN:30544-47-9 | PubChem CID:35375 | ETOFENAMATE | Etofenamate | PubChem SID:198983424 | UNII:KZF0XM66JC | 2-(2-hydroxyethoxy)ethyl 2-[3-(trifluoromethyl)anilino]benzoate
+BMGC_DG07653,BMG_DG138595,"GYKI-52466 | PubChem SID:198978968 | CAS RN:102771-26-6 | UNII:471V8NZ5X3 | PubChem CID:3538 | 4-(8-Methyl-9H-1,3-dioxolo(4,5-h)(2,3)benzodiazepin-5-yl)benzenamine | 4-(8-methyl-9H-[1,3]dioxolo[4,5-h][2,3]benzodiazepin-5-yl)aniline"
+BMGC_DG07654,BMG_DG138604,N-[2-(methylamino)ethyl]isoquinoline-5-sulfonamide | N-(2-(METHYLAMINO)ETHYL)ISOQUINOLINE-5-SULFONAMIDE | N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE | N-(2-(Methylamino)ethyl)-5-isoquinolinesulfonamide | PubChem CID:3540 | CAS RN:84478-11-5 | PubChem SID:440089372 | DrugBank ID:DB07997 | UNII:TX277E49WT
+BMGC_DG07655,BMG_DG138616,N-METHYL-3-PHENYLPROPAN-1-AMINE | PubChem CID:35417 | CAS RN:23580-89-4 | PubChem SID:404859866 | UNII:PM142C9WRQ
+BMGC_DG07656,BMG_DG138618,5-(2-methylpiperazine-1-sulfonyl)isoquinoline | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 5-(2-methylpiperazin-1-yl)sulfonylisoquinoline | CAS RN:84477-87-2 | 1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE | DrugBank ID:DB07996 | PubChem SID:198974671 | PubChem CID:3542 | UNII:487H9Q0F9N
+BMGC_DG07657,BMG_DG138621,2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine | PubChem CID:3543 | DrugBank ID:DB04288
+BMGC_DG07658,BMG_DG138625,N-(2-aminoethyl)isoquinoline-5-sulfonamide | CAS RN:84468-17-7 | PubChem CID:3544
+BMGC_DG07659,BMG_DG138627,PubChem CID:354471 | UNII:8K56E4P9P8 | CGP-62464 | CAS RN:121405-24-1 | PubChem SID:461434784
+BMGC_DG07660,BMG_DG138630,"PubChem SID:198978447 | UNII:HF5S8P28CC | 1,2,3,4-tetrachlorodibenzo-p-dioxin | PubChem CID:35454 | CAS RN:30746-58-8 | 1,2,3,4-TETRACHLORODIBENZO-P-DIOXIN | 1,2,3,4-Tetrachlorodibenzo-p-dioxin"
+BMGC_DG07661,BMG_DG138631,"PubChem CID:35455 | FEPRAZONE | Feprazone | 4-(3-methylbut-2-enyl)-1,2-diphenylpyrazolidine-3,5-dione | DrugBank ID:DB13364 | PubChem SID:198988651 | CAS RN:30748-29-9 | UNII:7BVX6J0CGR"
+BMGC_DG07662,BMG_DG138633,N-(2-guanidinoethyl)-5-isoquinolinesulfonamide | CAS RN:91742-10-8 | PubChem CID:3546 | 2-[2-(isoquinolin-5-ylsulfonylamino)ethyl]guanidine
+BMGC_DG07663,BMG_DG138637,"CAS RN:103745-39-7 | FASUDIL | UNII:Q0CH43PGXS | Fasudil | 5-(1,4-diazepan-1-ylsulfonyl)isoquinoline | DrugBank ID:DB08162 | PubChem SID:198953028 | PubChem CID:3547"
+BMGC_DG07664,BMG_DG138638,PubChem CID:3549980 | 2-propylpentanoate | Valproate
+BMGC_DG07665,BMG_DG138644,"CAS RN:55827-09-3 | 2,5-Bis(4-methoxyphenyl)thiophene | PubChem CID:3552928 | UNII:57BM6QP4HF | PubChem SID:485663404 | 2,5-BIS(4-METHOXYPHENYL)THIOPHENE"
+BMGC_DG07666,BMG_DG138653,NDC:0904-7389 | NDC:65841-838 | NDC:72162-1685 | NDC:72205-068 | NDC:55154-5059 | NDC:71247-155 | NDC:0904-6661 | NDC:69292-584 | NDC:0832-1540 | NDC:10135-752 | NDC:71247-154 | NDC:72205-067 | NDC:58657-703 | UNII:J6292F8L3D | NDC:69292-582 | NDC:72205-066 | NDC:51079-734 | NDC:55154-3566 | NDC:0378-0214 | NDC:0121-0581 | NDC:35573-442 | PubChem CID:3559 | NDC:0378-0327 | NDC:0378-0334 | NDC:70518-2687 | NDC:0904-6733 | NDC:63629-9272 | NDC:72162-1683 | NDC:67046-1255 | NDC:60687-161 | NDC:72205-064 | HALOPERIDOL | NDC:0378-0351 | NDC:10135-753 | NDC:63629-9273 | NDC:70756-004 | NDC:69292-586 | NDC:72162-1684 | NDC:68084-250 | 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one | Haloperidol | NDC:51079-733 | NDC:68382-079 | NDC:68382-409 | NDC:70518-2893 | NDC:63629-2326 | NDC:60687-799 | NDC:65841-839 | NDC:68084-249 | NDC:10135-754 | NDC:10135-755 | NDC:68382-081 | NDC:72205-069 | NDC:70756-236 | NDC:0378-0257 | NDC:67296-2067 | NDC:0904-6782 | NDC:58657-702 | NDC:70518-2680 | NDC:0904-7391 | NDC:70518-3587 | NDC:72162-1688 | NDC:70756-002 | NDC:0832-1560 | NDC:59651-789 | NDC:51079-431 | NDC:0615-8355 | NDC:70756-003 | NDC:70756-242 | NDC:51079-736 | NDC:63629-9274 | NDC:71247-151 | CAS RN:177716-59-5 | NDC:0615-8547 | NDC:69292-580 | NDC:65841-627 | NDC:58657-704 | NDC:71247-153 | PubChem SID:175266495 | NDC:70518-1269 | NDC:0378-0335 | NDC:58657-705 | NDC:0832-1520 | NDC:71247-150 | NDC:70756-001 | NDC:70518-3608 | NDC:58657-701 | NDC:68382-408 | CAS RN:52-86-8 | NDC:72162-1687 | DrugBank ID:DB00502 | NDC:59651-791 | NDC:0832-1510 | NDC:67046-1266 | NDC:68382-080 | NDC:10135-756 | NDC:72888-173 | NDC:65841-628 | NDC:58657-700 | NDC:63187-842 | NDC:10135-757 | NDC:67296-1462 | NDC:63629-9271 | NDC:65841-837 | NDC:71247-152 | NDC:0832-1530 | NDC:35573-441 | NDC:72205-065 | NDC:63629-9275 | NDC:68382-407 | NDC:51079-735 | NDC:59651-790 | NDC:63629-9270 | NDC:0904-7390 | NDC:70518-2682 | NDC:69292-588 | NDC:70518-3021 | NDC:72162-1686 | NDC:69292-590 | NDC:65841-626 | NDC:0832-1550 | NDC:59651-793 | NDC:59651-794 | NDC:59651-792
+BMGC_DG07667,BMG_DG138660,"DrugBank ID:DB00793 | Haloprogin | PubChem SID:198949670 | PubChem CID:3561 | UNII:AIU7053OWL | 1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene | HALOPROGIN | CAS RN:777-11-7"
+BMGC_DG07668,BMG_DG138661,"UNII:UQT9G45D1P | DrugBank ID:DB01159 | PubChem CID:3562 | CAS RN:151-67-7 | PubChem SID:175271936 | Halothane | CAS RN:51230-18-3 | HALOTHANE | 2-bromo-2-chloro-1,1,1-trifluoroethane"
+BMGC_DG07669,BMG_DG138666,"PubChem CID:3564 | UNII:CN58I4TOET | DrugBank ID:DB13875 | Harmaline | CAS RN:304-21-2 | 7-methoxy-1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indole | HARMALINE | PubChem SID:198935632"
+BMGC_DG07670,BMG_DG138671,"CAS RN:137-30-4 | PubChem CID:3566770 | Dimethyldithiocarbamate | N,N-dimethylcarbamodithioate"
+BMGC_DG07671,BMG_DG138672,"RS-100329 | 5-methyl-3-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propyl]-1H-pyrimidine-2,4-dione | PubChem CID:3567002 | CAS RN:232953-52-5"
+BMGC_DG07672,BMG_DG138684,CAS RN:31005-02-4 | 7-ETHOXYCOUMARIN | 7-ethoxychromen-2-one | PubChem SID:443624288 | UNII:C8K66XCQ6L | PubChem CID:35703 | 7-Ethoxycoumarin
+BMGC_DG07673,BMG_DG138689,"N-Acetyl-D-Galactosamine | CAS RN:1136-42-1 | CAS RN:31022-50-1 | CAS RN:6082-29-7 | N-[(3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | CAS RN:14215-68-0 | PubChem CID:35717"
+BMGC_DG07674,BMG_DG138693,UNII:ANCAJYD3FV | DrugBank ID:DB02035 | PubChem SID:346538965 | PubChem CID:3572 | HEXADECANESULFONYL FLUORIDE | Hexadecanesulfonyl fluoride | CAS RN:86855-26-7
+BMGC_DG07675,BMG_DG138700,"PubChem CID:35740 | Iodoxamic acid | 3-[3-[2-[2-[2-[3-(3-carboxy-2,4,6-triiodoanilino)-3-oxopropoxy]ethoxy]ethoxy]ethoxy]propanoylamino]-2,4,6-triiodobenzoic acid | UNII:NS1Y283HW4 | DrugBank ID:DB13539 | CAS RN:31127-82-9 | PubChem SID:198978741 | IODOXAMIC ACID"
+BMGC_DG07676,BMG_DG138714,"DrugBank ID:DB11555 | Zolazepam | 4-(2-fluorophenyl)-1,3,8-trimethyl-6H-pyrazolo[3,4-e][1,4]diazepin-7-one | PubChem SID:175265687 | CAS RN:31352-82-6 | ZOLAZEPAM | PubChem CID:35775 | UNII:G1R474U58U"
+BMGC_DG07677,BMG_DG138726,UNII:R8M46911LR | Flubendazole | methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate | PubChem CID:35802 | DrugBank ID:DB08974 | PubChem SID:198944851 | CAS RN:31430-15-6 | FLUBENDAZOLE
+BMGC_DG07678,BMG_DG138727,UNII:JF3KQ40J31 | DrugBank ID:DB13465 | PubChem CID:35803 | CYCLOBENDAZOLE | Ciclobendazole | CAS RN:31431-43-3 | methyl N-[6-(cyclopropanecarbonyl)-1H-benzimidazol-2-yl]carbamate | PubChem SID:198973257
+BMGC_DG07679,BMG_DG138728,"PubChem CID:35805 | 1-[2-[4-[(3R,4R)-7-methoxy-2,2-dimethyl-3-phenyl-3,4-dihydrochromen-4-yl]phenoxy]ethyl]pyrrolidine | PubChem SID:198954617 | UNII:44AXY5VE90 | ORMELOXIFENE | UNII:9512UKZ352 | CAS RN:78994-23-7 | DrugBank ID:DB13310 | CAS RN:78994-24-8 | CAS RN:31477-60-8 | Levormeloxifene | PubChem SID:198939365 | LEVORMELOXIFENE"
+BMGC_DG07680,BMG_DG138729,UNII:KSJ78WBX6K | CAS RN:145315-42-0 | DrugBank ID:DB08291 | PubChem CID:3581192 | N-(3-Aminopropyl)-2-nitrobenzenamine | PubChem SID:482554013 | N-(3-AMINOPROPYL)-2-NITROBENZENAMINE
+BMGC_DG07681,BMG_DG138734,"1,2,4-trichloro-5-(3,4-dichlorophenyl)benzene | PubChem CID:35823 | 2,3',4,4',5-PENTACHLOROBIPHENYL | CAS RN:31508-00-6 | 2,3',4,4',5-Pentachlorobiphenyl | PubChem SID:198944584 | UNII:2B2AQE8U50"
+BMGC_DG07682,BMG_DG138745,"4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine | CAS RN:50808-41-8 | Sulfamethoxazole; Trimethoprim | CAS RN:8064-90-2 | PubChem CID:358641"
+BMGC_DG07683,BMG_DG138748,PubChem CID:3587356 | 3-methylbutanoate | Isovalerate
+BMGC_DG07684,BMG_DG138767,"DrugBank ID:DB12944 | CAS RN:108-73-6 | Phloroglucinol | PHLOROGLUCINOL | benzene-1,3,5-triol | UNII:DHD7FFG6YS | PubChem CID:359 | PubChem SID:198937213"
+BMGC_DG07685,BMG_DG138768,PubChem CID:3590 | DrugBank ID:DB13574 | CAS RN:372-66-7 | Heptaminol | UNII:3DQS188SY5 | 6-amino-2-methylheptan-2-ol | PubChem SID:198973656 | HEPTAMINOL
+BMGC_DG07686,BMG_DG138778,"2-[3-chloro-4-(2,5-dihydropyrrol-1-yl)phenyl]propanoic acid | DrugBank ID:DB13722 | Pirprofen | PubChem CID:35935 | PubChem SID:198988465 | PIRPROFEN | UNII:T7KN291890 | CAS RN:31793-07-4"
+BMGC_DG07687,BMG_DG138789,"CAS RN:139411-96-4 | 3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxyphenyl)methyl]phenol | UNII:IWW5FV6NK2 | PubChem CID:3598 | HEXACHLOROPHENE | Hexachlorophene | CAS RN:70-30-4 | DrugBank ID:DB00756 | PubChem SID:175268718"
+BMGC_DG07688,BMG_DG138790,2-[3-(2-Methylphenyl)phenyl]ethanamine | 2-(3-(2-METHYLPHENYL)PHENYL)ETHANAMINE | PubChem CID:35985234 | CAS RN:943761-65-7 | UNII:HNH7A98N7D | PubChem SID:478838334
+BMGC_DG07689,BMG_DG138791,NDC:69051-300 | PubChem SID:198972619 | PubChem CID:3599 | DrugBank ID:DB09031 | hexadecyl 2-(trimethylazaniumyl)ethyl phosphate | MILTEFOSINE | Miltefosine | UNII:53EY29W7EC | CAS RN:58066-85-6
+BMGC_DG07690,BMG_DG138793,PubChem SID:198983942 | Hexafluronium | CAS RN:4844-10-4 | PubChem CID:3601 | HEXAFLUORENIUM | UNII:55W5L6G81R | Hexafluorenium | 9H-fluoren-9-yl-[6-[9H-fluoren-9-yl(dimethyl)azaniumyl]hexyl]-dimethylazanium | DrugBank ID:DB00941
+BMGC_DG07691,BMG_DG138796,cyclohexyl-hydroxy-phenyl-(3-piperidin-1-ylpropyl)silane | PubChem CID:3602 | HEXAHYDROSILADIFENIDOL | Hexahydrosiladifenidol | UNII:LXZ2G00X0W | CAS RN:98299-40-2 | PubChem SID:198977767
+BMGC_DG07692,BMG_DG138804,trimethyl-[6-(trimethylazaniumyl)hexyl]azanium | Hexamethonium | PubChem SID:198978335 | HEXAMETHONIUM | CAS RN:60-26-4 | UNII:3C9PSP36Z2 | PubChem CID:3604 | DrugBank ID:DB08960
+BMGC_DG07693,BMG_DG138806,PubChem CID:36054 | UNII:7N05KQ38YI | GUANAZODINE | DrugBank ID:DB13604 | 2-(azocan-2-ylmethyl)guanidine | CAS RN:32059-15-7 | PubChem SID:198955290 | Guanazodine
+BMGC_DG07694,BMG_DG138808,CAS RN:5635-50-7 | Dihydrodiethylstilbestrol | PubChem CID:3606 | 4-[4-(4-hydroxyphenyl)hexan-3-yl]phenol
+BMGC_DG07695,BMG_DG138809,2-Benzhydryloxyethanamine | DINORDIPHENHYDRAMINE | 2-benzhydryloxyethanamine | PubChem SID:384647986 | CAS RN:17349-94-9 | PubChem CID:36060 | UNII:YCO6ZP0WF3
+BMGC_DG07696,BMG_DG138813,"PubChem CID:3607 | 1,3-bis(2-ethylhexyl)-5-methyl-1,3-diazinan-5-amine | UNII:852A84Y8LS | CAS RN:141-94-6 | DrugBank ID:DB08958 | HEXETIDINE | PubChem SID:198945603 | Hexetidine"
+BMGC_DG07697,BMG_DG138817,"PubChem CID:3608 | PubChem SID:198967814 | CAS RN:56-29-1 | 5-(cyclohexen-1-yl)-1,5-dimethyl-1,3-diazinane-2,4,6-trione | HEXOBARBITAL | UNII:AL8Z8K3P6S | Hexobarbital | DrugBank ID:DB01355"
+BMGC_DG07698,BMG_DG138824,"PubChem SID:198964579 | Hexoprenaline | UNII:G9L6B3W684 | HEXOPRENALINE | DrugBank ID:DB08957 | PubChem CID:3609 | CAS RN:3215-70-1 | 4-[2-[6-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]hexylamino]-1-hydroxyethyl]benzene-1,2-diol"
+BMGC_DG07699,BMG_DG138830,"UNII:R9QTB5E82N | 4-hexylbenzene-1,3-diol | NDC:69846-860 | HEXYLRESORCINOL | Hexylresorcinol | NDC:24909-041 | DrugBank ID:DB11254 | NDC:72854-261 | NDC:72854-262 | PubChem SID:175267105 | CAS RN:136-77-6 | PubChem CID:3610"
+BMGC_DG07700,BMG_DG138834,"PubChem CID:36109 | MEDIFOXAMINE | CAS RN:32359-34-5 | N,N-dimethyl-2,2-diphenoxyethanamine | Medifoxamine | DrugBank ID:DB13219 | PubChem SID:198971365 | UNII:KWU7C2A1NT"
+BMGC_DG07701,BMG_DG138835,"PubChem SID:175266355 | Hinokitiol | 2-hydroxy-6-propan-2-ylcyclohepta-2,4,6-trien-1-one | CAS RN:499-44-5 | .BETA.-THUJAPLICIN | PubChem CID:3611 | UNII:U5335D6EBI"
+BMGC_DG07702,BMG_DG138842,"Sisomicin | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol | PubChem CID:36119 | DrugBank ID:DB12604 | CAS RN:32385-11-8 | UNII:X55XSL74YQ | SISOMICIN | PubChem SID:198951261"
+BMGC_DG07703,BMG_DG138848,PubChem CID:36131 | PubChem SID:198964275 | CAS RN:32421-46-8 | BUNAFTINE | DrugBank ID:DB13652 | Bunaftine | N-butyl-N-[2-(diethylamino)ethyl]naphthalene-1-carboxamide | UNII:GH09PRQ3FU
+BMGC_DG07704,BMG_DG138856,PubChem CID:3614 | 2-(1-methylimidazol-4-yl)ethanamine | CAS RN:501-75-7 | PubChem SID:198946623 | 1-Methylhistamine | UNII:KCB81T4EOF | 1-METHYLHISTAMINE
+BMGC_DG07705,BMG_DG138857,Oxfenicine | CAS RN:32462-30-9 | DrugBank ID:DB04291 | OXFENICINE | UNII:9YH0WH2Z02 | PubChem SID:198951767 | PubChem CID:36143 | (2S)-2-amino-2-(4-hydroxyphenyl)acetic acid
+BMGC_DG07706,BMG_DG138866,PubChem CID:361510 | UNII:EXD4256WVW | CAS RN:478-45-5 | EMODIC ACID
+BMGC_DG07707,BMG_DG138882,"3,3',4,4'-TETRACHLOROBIPHENYL | PubChem SID:198957139 | PubChem CID:36187 | 3,3',4,4'-Tetrachlorobiphenyl | CAS RN:80333-65-9 | UNII:Y2I6546TMI | 1,2-dichloro-4-(3,4-dichlorophenyl)benzene | CAS RN:32598-13-3"
+BMGC_DG07708,BMG_DG138883,"UNII:0S596V3MLH | 2,3,3',4,4'-PENTACHLOROBIPHENYL | 1,2,3-trichloro-4-(3,4-dichlorophenyl)benzene | CAS RN:32598-14-4 | 2,3,3',4,4'-Pentachlorobiphenyl | PubChem CID:36188 | PubChem SID:198944725"
+BMGC_DG07709,BMG_DG138898,PubChem CID:3623 | CAS RN:87-00-3 | CAS RN:114173-36-3 | (8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenylacetate | Homotropine
+BMGC_DG07710,BMG_DG138903,"PubChem CID:3624 | Ethidium | CAS RN:3546-21-2 | 5-ethyl-6-phenylphenanthridin-5-ium-3,8-diamine | PubChem SID:198970577 | HOMIDIUM | UNII:EN464416SI"
+BMGC_DG07711,BMG_DG138915,CAS RN:519-53-9 | UNII:DHU37V4Q3Q | AROMOLINE | PubChem CID:362574 | PubChem SID:317229092
+BMGC_DG07712,BMG_DG138918,"CAS RN:79580-20-4 | AMDINOCILLIN | Amdinocillin | (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem SID:198978028 | PubChem CID:36273 | DrugBank ID:DB01163 | CAS RN:32887-01-7 | UNII:V10579P3QZ"
+BMGC_DG07713,BMG_DG138922,PubChem SID:316918348 | CAS RN:36878-93-0 | UNII:URT1FLO407 | 4-IPOMEANOL | PubChem CID:36284 | CAS RN:55659-41-1 | CAS RN:32954-58-8 | 1-(furan-3-yl)-4-hydroxypentan-1-one | 4-Ipomeanol
+BMGC_DG07714,BMG_DG138925,"NDC:47335-171 | NDC:66993-195 | NDC:70756-617 | NDC:60760-583 | PubChem SID:175268469 | NDC:10122-820 | NDC:63187-973 | NDC:72603-630 | NDC:24492-850 | NDC:61919-642 | NDC:16714-119 | NDC:68083-374 | PubChem CID:36294 | NDC:49502-345 | NDC:70756-604 | DrugBank ID:DB00684 | NDC:76420-092 | NDC:68071-2272 | NDC:59651-129 | NDC:70644-899 | NDC:76420-791 | NDC:71205-101 | NDC:63187-024 | NDC:43598-605 | NDC:70518-1370 | NDC:63187-902 | NDC:46708-518 | NDC:0093-4085 | NDC:61314-643 | NDC:24208-290 | NDC:72603-430 | NDC:55700-747 | (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol | UNII:VZ8RRZ51VK | CAS RN:32986-56-4 | NDC:60687-731 | NDC:66267-936 | NDC:68180-962 | NDC:68788-7252 | TOBRAMYCIN | NDC:50090-2127 | NDC:67877-678 | Tobramycin | NDC:62332-518 | NDC:80425-0341 | NDC:0093-3750 | NDC:67296-1639 | NDC:0078-0813 | NDC:67296-0391 | NDC:65162-914 | NDC:70436-110 | NDC:42571-408 | NDC:50090-4190 | NDC:49502-401 | NDC:70069-131 | NDC:62250-110 | NDC:68788-8248"
+BMGC_DG07715,BMG_DG138929,"1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one | UNII:T5WT3QN49G | PubChem CID:36303 | Proroxan | CAS RN:33743-96-3 | PROROXAN | PubChem SID:198990647"
+BMGC_DG07716,BMG_DG138933,PubChem SID:198944378 | UNII:B41555M19R | PubChem CID:363128 | JUSTICIDIN E | CAS RN:27792-97-8
+BMGC_DG07717,BMG_DG138935,"7-O-acetylpaclitaxel | PubChem SID:475550731 | NDC:0703-3216 | NDC:16714-137 | NDC:46708-620 | NDC:46708-621 | NDC:62332-622 | PACLITAXEL | NDC:0781-3531 | NDC:24979-710 | UNII:P88XT4IS4D | NDC:69339-229 | NDC:0703-3218 | NDC:23155-884 | NDC:60505-6230 | 7-O-ACETYLPACLITAXEL | NDC:72205-063 | PubChem CID:36314 | NDC:69339-227 | NDC:68083-179 | Paclitaxel | CAS RN:33069-62-4 | NDC:69539-157 | NDC:68083-180 | NDC:0517-4300 | NDC:0703-3213 | NDC:72205-061 | NDC:0703-3217 | NDC:68001-516 | NDC:23155-882 | CAS RN:1203669-79-7 | NDC:62332-621 | DrugBank ID:DB01229 | CAS RN:92950-39-5 | UNII:3PPC5TL76P | NDC:46708-622 | NDC:68817-134 | NDC:63323-763 | NDC:69539-159 | NDC:69339-228 | NDC:0480-3290 | NDC:25021-255 | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate | NDC:23155-883 | NDC:61703-342 | PubChem SID:175266704 | NDC:72205-062 | NDC:68083-178 | NDC:69539-158 | NDC:62332-620"
+BMGC_DG07718,BMG_DG138939,"Amitraz | PubChem SID:175267530 | N'-(2,4-dimethylphenyl)-N-[(2,4-dimethylphenyl)iminomethyl]-N-methylmethanimidamide | CAS RN:33089-61-1 | DrugBank ID:DB11373 | PubChem CID:36324 | AMITRAZ | UNII:33IAH5017S"
+BMGC_DG07719,BMG_DG138952,PubChem CID:36339 | CAS RN:33125-97-2 | CAS RN:15301-65-2 | Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate | ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
+BMGC_DG07720,BMG_DG138953,CAS RN:23255-93-8 | DrugBank ID:DB14061 | HYCANTHONE | CAS RN:3105-97-3 | Hycanthone | PubChem SID:198976795 | 1-[2-(diethylamino)ethylamino]-4-(hydroxymethyl)thioxanthen-9-one | PubChem CID:3634 | UNII:2BXX5EVN2A
+BMGC_DG07721,BMG_DG138963,CAS RN:1044569-46-1 | PubChem CID:3637 | phthalazin-1-ylhydrazine | CAS RN:86-54-4 | PubChem SID:175268130 | UNII:26NAK24LS8 | HYDRALAZINE | Hydralazine | CAS RN:59275-69-3 | DrugBank ID:DB01275
+BMGC_DG07722,BMG_DG138966,PubChem CID:3638243 | PubChem SID:198972264 | UNII:A806Y8IDMB | CAS RN:181530-09-6 | ZINQUIN ETHYL ESTER
+BMGC_DG07723,BMG_DG138970,"NDC:72189-263 | NDC:63187-367 | NDC:62332-083 | NDC:71335-0152 | NDC:68788-7893 | NDC:46708-151 | NDC:71335-0652 | NDC:51655-414 | NDC:46708-443 | NDC:51655-722 | NDC:60760-861 | NDC:72189-288 | NDC:42291-502 | NDC:62332-116 | NDC:50090-6752 | NDC:42292-017 | NDC:50090-5402 | NDC:50090-7438 | NDC:70518-1550 | NDC:71205-793 | NDC:50090-3576 | NDC:70771-1125 | NDC:63187-050 | NDC:72162-1528 | NDC:62332-081 | NDC:59746-339 | NDC:71610-471 | NDC:63629-2430 | NDC:63187-599 | NDC:46708-449 | NDC:72789-296 | NDC:66267-106 | NDC:63187-394 | NDC:72162-1084 | NDC:71205-419 | NDC:43063-458 | NDC:72789-303 | NDC:51655-582 | NDC:65862-550 | NDC:71205-327 | NDC:68645-510 | NDC:71335-2200 | NDC:71610-274 | NDC:68071-2533 | NDC:0597-0043 | NDC:71335-9686 | NDC:50090-7058 | NDC:68788-8241 | NDC:43063-747 | PubChem CID:3639 | NDC:68180-217 | NDC:0591-0860 | NDC:71610-382 | NDC:42708-034 | NDC:65862-134 | NDC:62135-448 | NDC:63629-1071 | NDC:78206-140 | NDC:70518-2737 | NDC:71205-015 | NDC:43353-717 | NDC:0597-0044 | NDC:71610-139 | NDC:68788-8159 | NDC:62332-051 | NDC:63187-943 | NDC:68788-8417 | NDC:0054-0254 | NDC:63629-1069 | NDC:46708-210 | NDC:70518-0382 | NDC:70518-4083 | NDC:0713-0863 | NDC:53746-846 | NDC:0078-0315 | NDC:0172-2089 | NDC:50090-6204 | NDC:60760-572 | NDC:71205-980 | NDC:62756-369 | NDC:50090-5450 | NDC:50090-2974 | NDC:52427-436 | NDC:72189-326 | NDC:70010-187 | NDC:71335-2102 | NDC:43547-315 | NDC:43386-712 | NDC:52427-437 | NDC:50090-6027 | NDC:69584-362 | NDC:70518-1662 | NDC:63187-553 | NDC:68382-142 | NDC:50090-2744 | NDC:62332-149 | NDC:0378-6323 | NDC:0591-0348 | NDC:51655-831 | NDC:71335-0853 | NDC:68788-9807 | NDC:16714-225 | NDC:71610-488 | NDC:50090-1745 | NDC:16714-226 | NDC:0078-0383 | NDC:42658-142 | NDC:50090-6537 | NDC:69315-131 | NDC:50090-0724 | NDC:43547-441 | NDC:50090-6034 | NDC:69367-219 | NDC:62332-048 | NDC:62756-370 | NDC:82868-016 | NDC:65862-781 | NDC:0378-0445 | NDC:68180-414 | NDC:68071-2740 | NDC:68788-8187 | NDC:71205-042 | NDC:46708-438 | NDC:63187-347 | NDC:71610-261 | NDC:43547-443 | NDC:68788-9809 | NDC:70756-812 | CAS RN:8049-49-8 | NDC:66993-188 | NDC:43547-397 | NDC:65862-043 | NDC:0078-0472 | NDC:68788-8463 | NDC:72189-289 | NDC:43547-393 | NDC:71610-500 | NDC:46708-211 | NDC:50090-6062 | NDC:65841-733 | NDC:68788-8700 | NDC:50090-5937 | NDC:68788-8510 | NDC:62332-117 | NDC:59746-337 | NDC:29300-129 | NDC:50090-5333 | NDC:50090-6944 | NDC:65862-113 | NDC:68071-1834 | NDC:72189-327 | NDC:70518-3956 | NDC:68071-2291 | NDC:43547-313 | NDC:63187-319 | NDC:72162-2315 | NDC:50228-146 | NDC:63629-8991 | NDC:43547-421 | NDC:50268-404 | NDC:72578-090 | NDC:42291-924 | NDC:60760-199 | NDC:51655-674 | NDC:43353-240 | NDC:68382-856 | NDC:68180-194 | NDC:42291-965 | NDC:55700-394 | NDC:16729-184 | NDC:33342-175 | NDC:33342-074 | NDC:63187-051 | NDC:35356-807 | NDC:0615-8449 | NDC:50090-6836 | NDC:68788-8813 | NDC:70518-3420 | NDC:51655-515 | NDC:68071-2183 | NDC:65862-631 | NDC:65862-978 | NDC:53746-848 | NDC:50090-6862 | NDC:68462-842 | NDC:71335-0504 | NDC:71335-2338 | NDC:71205-004 | NDC:76282-154 | NDC:43353-975 | NDC:0093-8238 | NDC:83008-042 | NDC:29300-191 | NDC:62135-529 | NDC:60505-2657 | NDC:53746-845 | NDC:16729-366 | NDC:50090-3701 | NDC:71335-0479 | NDC:42291-968 | NDC:70518-3633 | NDC:62332-070 | NDC:82868-006 | NDC:71610-015 | NDC:30698-462 | NDC:68180-519 | NDC:50090-2565 | NDC:59746-382 | NDC:68788-8224 | NDC:53746-849 | NDC:72189-012 | NDC:68180-215 | NDC:68788-6329 | NDC:72888-095 | NDC:72162-1356 | NDC:16729-183 | NDC:63187-467 | NDC:62332-210 | NDC:68462-841 | NDC:65862-976 | NDC:46708-453 | NDC:82804-031 | NDC:65862-044 | NDC:43547-398 | NDC:68084-750 | NDC:68180-413 | NDC:68788-7526 | NDC:46708-115 | NDC:0093-8232 | NDC:68645-557 | NDC:0071-5212 | NDC:63187-918 | NDC:68645-558 | NDC:50090-7059 | NDC:50090-1109 | NDC:50090-1270 | NDC:65862-133 | NDC:29300-128 | NDC:67296-1682 | NDC:51407-332 | NDC:43353-719 | NDC:50090-7045 | NDC:0591-0424 | NDC:63187-981 | NDC:50090-4872 | NDC:59746-338 | NDC:63629-1068 | NDC:50090-5570 | NDC:65862-045 | NDC:60760-586 | NDC:68462-840 | NDC:71610-431 | NDC:63187-653 | NDC:46708-448 | NDC:50090-6532 | NDC:65862-162 | NDC:71205-589 | NDC:72789-162 | NDC:65862-469 | NDC:76282-446 | UNII:0J48LPH2TH | NDC:65862-163 | NDC:67296-0921 | NDC:46708-209 | NDC:42708-086 | NDC:60760-860 | NDC:72888-094 | NDC:62332-052 | NDC:67544-739 | NDC:71335-1787 | NDC:70518-3780 | NDC:30698-461 | NDC:63187-312 | NDC:71335-2425 | NDC:46708-444 | NDC:50090-0140 | NDC:65862-630 | NDC:76282-448 | NDC:51655-502 | NDC:76282-155 | NDC:50090-2632 | NDC:42291-966 | NDC:43547-423 | NDC:50090-6736 | NDC:71610-605 | NDC:69097-969 | NDC:72189-290 | NDC:42291-503 | NDC:71205-249 | NDC:43063-755 | NDC:68071-3652 | NDC:51655-088 | NDC:69097-831 | NDC:72162-1357 | NDC:71335-2091 | NDC:65162-848 | NDC:68071-4518 | NDC:42708-036 | NDC:0378-6324 | NDC:0713-0865 | NDC:65862-779 | NDC:72789-183 | NDC:46708-117 | NDC:67046-1039 | NDC:71335-2202 | NDC:71335-9730 | HYDROCHLOROTHIAZIDE | NDC:51655-630 | NDC:50090-6232 | NDC:60760-783 | NDC:68180-103 | NDC:71335-1451 | NDC:33342-050 | NDC:68001-327 | NDC:63629-4307 | NDC:50090-6988 | NDC:29300-215 | NDC:71335-0770 | NDC:52427-435 | DrugBank ID:DB00999 | NDC:65841-732 | NDC:43547-391 | NDC:43547-442 | NDC:71335-2560 | NDC:72189-129 | NDC:63629-7782 | NDC:65862-551 | NDC:50090-6014 | NDC:63187-465 | NDC:65862-547 | NDC:71335-2424 | NDC:68001-387 | NDC:63187-427 | NDC:68071-3008 | NDC:72189-098 | NDC:68180-520 | NDC:71205-090 | NDC:82868-054 | 6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | NDC:50090-5801 | NDC:68180-105 | NDC:71610-276 | NDC:70518-3404 | NDC:71610-684 | NDC:70756-813 | NDC:70518-4113 | NDC:50090-0142 | NDC:50090-7437 | NDC:42708-079 | NDC:68382-514 | NDC:0093-7369 | NDC:46708-456 | NDC:65862-470 | NDC:71335-2558 | NDC:70771-1487 | NDC:72189-297 | NDC:69097-971 | NDC:33342-174 | NDC:0591-0347 | NDC:50090-1088 | NDC:0025-1021 | NDC:51655-243 | NDC:43063-482 | NDC:65162-846 | NDC:62332-050 | NDC:43547-422 | NDC:46708-455 | NDC:23155-009 | NDC:71335-1976 | NDC:71205-256 | NDC:68788-8253 | NDC:71335-0845 | NDC:42291-462 | NDC:51655-698 | NDC:23155-764 | NDC:71205-258 | NDC:63629-2585 | NDC:68382-143 | NDC:0378-6321 | NDC:50090-6931 | NDC:68180-518 | NDC:43547-392 | NDC:68180-102 | NDC:33342-078 | NDC:63629-8498 | NDC:68788-7790 | NDC:29300-216 | NDC:68382-857 | NDC:50090-5672 | NDC:33342-077 | NDC:62332-079 | NDC:51407-330 | NDC:67046-1016 | NDC:43547-331 | NDC:68788-7683 | NDC:68645-556 | NDC:68071-3323 | NDC:0591-0862 | NDC:63187-398 | NDC:42291-967 | NDC:50090-7237 | NDC:51407-286 | CAS RN:58-93-5 | NDC:0024-5856 | NDC:43547-314 | NDC:43063-468 | NDC:43063-986 | NDC:16729-182 | NDC:50090-1641 | NDC:71335-1783 | NDC:71610-602 | NDC:43386-711 | NDC:55289-090 | NDC:70771-1489 | NDC:70756-814 | NDC:69315-130 | NDC:63187-571 | NDC:70518-4251 | NDC:33342-076 | NDC:68788-8378 | NDC:50090-6636 | NDC:71205-063 | NDC:0228-2820 | NDC:78206-139 | NDC:68180-104 | NDC:50090-7127 | NDC:16729-367 | NDC:70771-1486 | NDC:63187-727 | NDC:16729-368 | NDC:55289-488 | NDC:65862-977 | NDC:62756-368 | NDC:65162-845 | NDC:70518-3889 | NDC:55700-979 | NDC:63187-440 | NDC:68788-8539 | NDC:65862-548 | NDC:43386-710 | NDC:68788-8632 | NDC:50090-4377 | NDC:69315-155 | NDC:62332-150 | NDC:51655-412 | NDC:50090-5962 | NDC:51407-331 | NDC:50090-6976 | NDC:0378-0424 | NDC:33342-058 | NDC:63187-602 | NDC:72162-1035 | NDC:33342-051 | NDC:71335-0067 | NDC:71335-1097 | NDC:71335-9647 | NDC:42658-141 | NDC:68071-2263 | NDC:71610-697 | NDC:71205-161 | NDC:51655-655 | NDC:16714-224 | NDC:71610-868 | NDC:62332-209 | NDC:50090-6094 | NDC:63187-694 | NDC:71335-1392 | NDC:50090-6210 | NDC:51655-272 | NDC:72789-176 | NDC:63187-428 | NDC:70771-1362 | NDC:69584-361 | NDC:42291-504 | NDC:71335-0547 | NDC:72789-381 | NDC:46708-149 | NDC:71610-383 | NDC:70518-4096 | NDC:70518-0196 | NDC:43547-424 | NDC:78206-141 | NDC:50090-6157 | NDC:50090-0523 | NDC:68382-513 | NDC:63629-4470 | NDC:60687-683 | NDC:68180-195 | NDC:63187-552 | NDC:70010-189 | NDC:42708-164 | NDC:62135-667 | NDC:71335-0968 | NDC:65862-549 | NDC:69097-829 | NDC:71335-1481 | NDC:57237-002 | NDC:72162-2317 | NDC:59762-5014 | NDC:42708-027 | NDC:65862-468 | NDC:70518-0174 | NDC:50090-6158 | NDC:60760-968 | NDC:0378-0434 | NDC:72162-1701 | NDC:62332-211 | NDC:70518-2550 | NDC:72162-1700 | NDC:63629-1219 | NDC:71610-671 | NDC:71205-022 | NDC:63187-548 | NDC:50090-7444 | NDC:68788-6844 | NDC:50090-0141 | NDC:0078-0314 | NDC:0615-8344 | NDC:62135-738 | NDC:33342-173 | NDC:50090-2028 | NDC:80425-0207 | NDC:29300-190 | NDC:43547-420 | NDC:68071-1945 | NDC:63187-441 | NDC:0378-6325 | NDC:83008-086 | NDC:51655-413 | NDC:0378-6322 | NDC:42291-463 | NDC:51655-616 | NDC:68788-8517 | NDC:68071-2303 | NDC:50090-7199 | NDC:71610-838 | NDC:72189-139 | NDC:43547-312 | NDC:62135-669 | NDC:62332-115 | NDC:68001-328 | NDC:42708-150 | NDC:72189-167 | NDC:33342-052 | NDC:72189-325 | NDC:71335-2034 | NDC:0024-5855 | NDC:63629-1220 | NDC:50090-5345 | NDC:50090-3561 | NDC:67296-1487 | NDC:63629-8992 | NDC:50090-6156 | NDC:67296-1423 | NDC:71335-1713 | NDC:42291-926 | NDC:63629-1218 | NDC:65862-780 | NDC:0071-3112 | NDC:68071-4687 | NDC:0591-0861 | NDC:71335-0269 | NDC:46708-116 | NDC:29300-130 | NDC:62135-449 | NDC:70518-2269 | NDC:70518-1347 | NDC:68788-9808 | NDC:46708-450 | NDC:71335-1992 | NDC:68382-855 | NDC:0054-0255 | NDC:69097-828 | NDC:50090-0372 | NDC:70771-1123 | NDC:65162-849 | NDC:70771-1485 | NDC:30698-463 | NDC:0378-0403 | NDC:68071-4435 | NDC:33342-057 | NDC:60760-662 | NDC:50090-1834 | NDC:63629-8732 | NDC:50090-7478 | NDC:50090-6838 | NDC:65162-847 | NDC:68180-193 | NDC:60687-593 | NDC:60760-519 | NDC:70518-2666 | NDC:42291-925 | NDC:50090-5985 | NDC:68788-8075 | NDC:70771-1124 | NDC:76282-447 | NDC:50090-4839 | NDC:70771-1474 | NDC:71205-763 | NDC:67046-0378 | NDC:46708-150 | NDC:68071-4933 | NDC:70010-188 | NDC:51655-311 | NDC:65862-629 | NDC:51655-422 | NDC:62135-668 | NDC:71205-751 | NDC:50228-111 | NDC:67296-2043 | NDC:62332-151 | NDC:63187-405 | NDC:65862-161 | NDC:43547-425 | NDC:50090-7442 | NDC:46708-454 | NDC:50090-6160 | NDC:42291-969 | NDC:72162-1625 | NDC:60505-2656 | NDC:0093-7368 | NDC:46708-457 | NDC:71335-2099 | NDC:0713-0864 | NDC:50090-6372 | NDC:62332-053 | NDC:82804-103 | NDC:70771-1361 | NDC:51655-389 | NDC:68788-6452 | NDC:0597-0042 | NDC:62332-082 | NDC:68180-101 | NDC:68788-8624 | NDC:70771-1488 | NDC:82868-032 | NDC:43547-330 | NDC:62332-080 | NDC:60760-315 | NDC:68180-216 | NDC:70518-3962 | NDC:33342-075 | NDC:68071-5211 | NDC:68001-388 | NDC:51655-522 | NDC:53489-144 | NDC:63187-074 | NDC:63187-905 | NDC:68071-4963 | NDC:68382-515 | NDC:68788-6812 | NDC:71335-0356 | NDC:62332-049 | NDC:0172-2083 | NDC:50228-112 | NDC:71335-0326 | NDC:82868-022 | NDC:42708-028 | NDC:23155-008 | NDC:43063-933 | NDC:43547-311 | NDC:71610-014 | NDC:68071-3608 | NDC:70518-3398 | NDC:70518-3505 | NDC:0093-7367 | NDC:71335-2127 | NDC:71610-374 | NDC:69097-968 | NDC:50090-7443 | PubChem SID:175266740 | NDC:55700-006 | NDC:50090-6153 | NDC:53746-847 | NDC:68071-3177 | NDC:50090-2727 | NDC:63629-7282 | NDC:70518-2057 | NDC:72189-513 | NDC:0615-8450 | NDC:50090-5960 | NDC:71335-2180 | NDC:29300-192 | NDC:63629-3739 | NDC:51655-506 | NDC:0781-2074 | NDC:42291-464 | Hydrochlorothiazide | NDC:71335-0862 | NDC:71335-0145 | NDC:46708-442 | NDC:63629-2431 | NDC:0078-0471"
+BMGC_DG07724,BMG_DG138976,"2,3-DIAMINOPROPIONIC ACID | PubChem SID:198972587 | CAS RN:515-94-6 | PubChem CID:364 | UNII:8908T5BN6R"
+BMGC_DG07725,BMG_DG138978,"2,3,4,5-Tetrachlorobiphenyl | PubChem CID:36401 | PubChem SID:198976140 | CAS RN:33284-53-6 | CAS RN:26914-33-0 | UNII:392EXD3SC9 | 1,2,3,4-tetrachloro-5-phenylbenzene | 2,3,4,5-TETRACHLOROBIPHENYL"
+BMGC_DG07726,BMG_DG138988,PubChem SID:474492733 | CAS RN:181632-25-7 | SB-242084 | PubChem CID:3644637 | UNII:9FEE9A2U4Z
+BMGC_DG07727,BMG_DG138989,PubChem SID:441096769 | CAS RN:190383-31-4 | UNII:2A5XS99U8Q | PubChem CID:3645619 | PD-168077
+BMGC_DG07728,BMG_DG138991,UNII:LSA5YS5PNZ | PubChem SID:472424832 | PubChem CID:3645780 | CHLOROHYDROXYPHENYLGLYCINE | CAS RN:170846-74-9 | 2-amino-2-(2-chloro-5-hydroxyphenyl)acetic acid | 2-Chloro-5-hydroxyphenylglycine
+BMGC_DG07729,BMG_DG138993,"PubChem CID:36462 | NDC:0143-9376 | UNII:6PLQ3CP4P3 | NDC:16729-114 | DrugBank ID:DB00773 | (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one | NDC:0143-9510 | NDC:0378-3266 | CAS RN:33419-42-0 | CAS RN:121471-01-0 | NDC:63323-104 | ETOPOSIDE | NDC:0143-9511 | Etoposide | NDC:68001-265 | NDC:0143-9512 | PubChem SID:175266867"
+BMGC_DG07730,BMG_DG138995,"1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | DrugBank ID:DB00774 | HYDROFLUMETHIAZIDE | UNII:501CFL162R | PubChem CID:3647 | PubChem SID:175265597 | Hydroflumethiazide | CAS RN:135-09-1"
+BMGC_DG07731,BMG_DG139014,Hydroxyamphetamine | UNII:FQR280JW2N | DrugBank ID:DB09352 | PubChem SID:175272061 | CAS RN:103-86-6 | CAS RN:1518-86-1 | HYDROXYAMPHETAMINE | 4-(2-Aminopropyl)phenol | PubChem CID:3651 | 4-(2-aminopropyl)phenol
+BMGC_DG07732,BMG_DG139015,"CAS RN:11035-08-8 | SUBSTANCE P | PubChem CID:36511 | UNII:675VGV5J1D | CAS RN:12769-48-1 | CAS RN:33507-63-0 | (2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-N-[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]pentanediamide | PubChem SID:375085943 | Substance P"
+BMGC_DG07733,BMG_DG139016,"PubChem CID:3651377 | 3-[3-tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid | PubChem SID:316909361 | UNII:080626SQ8C | 3-[3-Tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid | CAS RN:118414-82-7 | MK-886"
+BMGC_DG07734,BMG_DG139018,DrugBank ID:DB01611 | CAS RN:118-42-3 | 2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol | PubChem CID:3652 | UNII:4QWG6N8QKH | PubChem SID:175271759 | HYDROXYCHLOROQUINE | Hydroxychloroquine
+BMGC_DG07735,BMG_DG139019,CAS RN:71447-49-9 | CAS RN:33515-09-2 | PubChem SID:472411529 | LUTEINIZING HORMONE | PubChem CID:36523 | N-[1-[[1-[[1-[[1-[[2-[[1-[[1-[2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | Gonadorelin diacetate | DrugBank ID:DB00644 | CAS RN:9002-67-9 | CAS RN:9034-40-6 | UNII:8XA4VN1LH4 | CAS RN:6918-09-8 | Gonadorelin
+BMGC_DG07736,BMG_DG139020,ILLUDALIC ACID | CAS RN:18508-77-5 | UNII:HW3U676A69 | PubChem SID:319892011 | PubChem CID:3653077
+BMGC_DG07737,BMG_DG139021,"CAS RN:50892-62-1 | 8-CHLORO-5,10-DIHYDRO-11H-DIBENZO(B,E)(1,4)DIAZEPIN-11-ONE | PubChem SID:461433878 | UNII:QT944N7MN3 | PubChem CID:3653116"
+BMGC_DG07738,BMG_DG139026,"Brl 15572 | PubChem SID:249817508 | 3-[4-(3-chlorophenyl)piperazin-1-yl]-1,1-diphenylpropan-2-ol | PubChem CID:3654103 | CAS RN:734517-40-9 | BRL-15572 | UNII:LY8CZE6XUD"
+BMGC_DG07739,BMG_DG139029,"Velnacrine | UNII:OQL6V4U301 | PubChem SID:198946630 | VELNACRINE | VELNACRINE, (-)- | PubChem SID:313182777 | UNII:Y2P6NV151K | 9-amino-1,2,3,4-tetrahydroacridin-1-ol | CAS RN:121445-26-9 | PubChem SID:313183729 | VELNACRINE, (+)- | CAS RN:124027-47-0 | CAS RN:121445-24-7 | UNII:JFN3Z63E2C | PubChem CID:3655 | CAS RN:104675-29-8"
+BMGC_DG07740,BMG_DG139032,4-Hydroxytolbutamide | CAS RN:5719-85-7 | PubChem SID:252163967 | UNII:52K8J94779 | PubChem CID:3656 | HYDROXYMETHYLTOLBUTAMIDE | 1-butyl-3-[4-(hydroxymethyl)phenyl]sulfonylurea
+BMGC_DG07741,BMG_DG139038,DrugBank ID:DB01005 | PubChem CID:3657 | Hydroxyurea | CAS RN:127-07-1 | PubChem SID:175266011 | HYDROXYUREA | CAS RN:8029-68-3 | hydroxyurea | UNII:X6Q56QN5QC
+BMGC_DG07742,BMG_DG139039,"PubChem CID:365701 | UNII:G4T2FA57Q6 | Acylfulvene, (-)- | CAS RN:125392-76-9 | PubChem SID:472423942 | ACYLFULVENE, (-)-"
+BMGC_DG07743,BMG_DG139041,"UNII:MA3UYZ6K1H | 6-methyl-2,2-dioxooxathiazin-4-one | Acesulfame | CAS RN:33665-90-6 | PubChem CID:36573 | PubChem SID:175265636 | ACESULFAME"
+BMGC_DG07744,BMG_DG139043,CAS RN:68-88-2 | HYDROXYZINE | Hydroxyzine | PubChem SID:175271709 | 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol | PubChem CID:3658 | DrugBank ID:DB00557 | UNII:30S50YM8OG
+BMGC_DG07745,BMG_DG139055,NDC:0363-0564 | NDC:55910-265 | (2R)-N-methyl-1-phenylpropan-2-amine | NDC:36800-294 | LEVMETAMFETAMINE | NDC:63868-267 | NDC:79481-0300 | PubChem CID:36604 | PubChem SID:175268098 | NDC:50804-281 | DrugBank ID:DB09571 | NDC:41163-031 | NDC:63941-981 | UNII:Y24T9BT2Q2 | Levmetamfetamine | CAS RN:33817-09-3
+BMGC_DG07746,BMG_DG139059,L-Hyoscyamine | PubChem CID:3661 | CAS RN:83454-31-3 | (8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate
+BMGC_DG07747,BMG_DG139062,"2,3,7-trichlorodibenzo-p-dioxin | 2,3,7-TRICHLORODIBENZO-P-DIOXIN | UNII:UC7ILE15NN | PubChem SID:198969953 | PubChem CID:36614 | CAS RN:33857-28-2 | 2,3,7-Trichlorodibenzo-P-dioxin"
+BMGC_DG07748,BMG_DG139063,MRS-1523 | PubChem SID:443624536 | UNII:6D9Q2QUU75 | CAS RN:212329-37-8 | propyl 6-ethyl-5-ethylsulfanylcarbonyl-2-phenyl-4-propylpyridine-3-carboxylate | Propyl 6-ethyl-5-ethylsulfanylcarbonyl-2-phenyl-4-propylpyridine-3-carboxylate | PubChem CID:3661570
+BMGC_DG07749,BMG_DG139070,PubChem CID:366233 | 2-((2-AMINOPHENYL)THIO)BENZONITRILE | CAS RN:140425-65-6 | UNII:5V73N2R8VT
+BMGC_DG07750,BMG_DG139074,"HYPERICIN | CAS RN:1372719-41-9 | PubChem CID:3663 | UNII:7V2F1075HD | 9,11,13,16,18,20-hexahydroxy-5,24-dimethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-1(26),2,4(25),5,8,10,12,14(28),15(27),16,18,20,23-tridecaene-7,22-dione | CAS RN:548-04-9 | PubChem SID:175268744 | Hypericin"
+BMGC_DG07751,BMG_DG139089,PubChem SID:198967683 | FLAZALONE | PubChem CID:36663 | CAS RN:21221-18-1 | UNII:5A1Y43ML91
+BMGC_DG07752,BMG_DG139098,"3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]-N-methyloxolane-2-carboxamide | 3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-N-methyl-2-oxolanecarboxamide | PubChem CID:3668"
+BMGC_DG07753,BMG_DG139101,"UNII:9M372QW755 | PubChem CID:36687769 | CAS RN:108393-62-0 | PubChem SID:329903978 | FENDILINE, (R)-"
+BMGC_DG07754,BMG_DG139110,PubChem SID:198977207 | UNII:79ZC206302 | CAS RN:103833-16-5 | PubChem CID:36688130 | EPI-CARBOXY QUINAPRIL
+BMGC_DG07755,BMG_DG139112,"2-[(1S,6S)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol | PubChem SID:485665435 | 2-[(1S,6S)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol | 2-((1S,6S)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)-5-PENTYL-1,3-BENZENEDIOL | CAS RN:74219-29-7 | 1,3-Benzenediol, 2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, (1R-trans)- | PubChem CID:36688143 | UNII:T9W6TL93VP"
+BMGC_DG07756,BMG_DG139125,(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol | PubChem CID:36688409 | DrugBank ID:DB08129
+BMGC_DG07757,BMG_DG139161,"CAS RN:34184-77-5 | PubChem SID:198934712 | PubChem CID:36709 | Promegestone | DrugBank ID:DB13602 | PROMEGESTONE | UNII:9XE0V2SQYX | (8S,13S,14S,17S)-13,17-dimethyl-17-propanoyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG07758,BMG_DG139162,"2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one | PubChem CID:3671 | Ibudilast | DrugBank ID:DB05266 | UNII:M0TTH61XC5 | PubChem SID:198956751 | CAS RN:50847-11-5 | IBUDILAST"
+BMGC_DG07759,BMG_DG139163,"[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | PubChem CID:367141"
+BMGC_DG07760,BMG_DG139166,NDC:63629-1467 | NDC:48792-7811 | NDC:49348-196 | NDC:69168-368 | NDC:50090-5445 | NDC:41250-255 | NDC:70264-043 | NDC:49035-865 | NDC:70677-1115 | NDC:0363-0240 | NDC:29485-6939 | NDC:72789-187 | NDC:68788-8148 | NDC:21130-585 | NDC:49035-408 | NDC:0904-7914 | NDC:48792-7813 | NDC:51407-369 | NDC:11822-0292 | NDC:54473-306 | NDC:71679-111 | NDC:51655-354 | NDC:59726-279 | NDC:65162-466 | NDC:66715-6307 | NDC:70677-0046 | NDC:55301-745 | NDC:50594-018 | NDC:55700-445 | NDC:69452-302 | NDC:50844-352 | NDC:62207-365 | NDC:69396-145 | NDC:59779-685 | NDC:80425-0424 | NDC:11822-0660 | NDC:11822-6159 | NDC:42708-097 | NDC:55111-682 | NDC:56062-074 | NDC:62207-320 | NDC:68788-8244 | NDC:0573-0171 | NDC:69842-329 | NDC:72288-311 | NDC:36800-348 | NDC:50844-393 | NDC:83008-050 | NDC:62011-0070 | NDC:49035-660 | NDC:53041-572 | NDC:0113-0660 | NDC:49035-635 | NDC:21130-361 | NDC:49035-521 | NDC:70518-0761 | NDC:0363-0222 | NDC:67046-1302 | NDC:71335-1218 | NDC:68016-645 | NDC:68788-8710 | NDC:11673-166 | NDC:72189-266 | NDC:49483-114 | NDC:50090-3408 | NDC:66715-9839 | NDC:67877-320 | NDC:55910-830 | NDC:49035-166 | NDC:63981-121 | NDC:67296-1757 | NDC:36800-286 | NDC:41250-057 | NDC:51672-2146 | NDC:60760-603 | NDC:68071-3442 | NDC:11822-4461 | NDC:36800-570 | NDC:37808-922 | NDC:21130-261 | NDC:51316-365 | NDC:69367-396 | NDC:70000-0263 | NDC:70518-1409 | NDC:70677-1113 | NDC:71610-645 | NDC:41163-255 | NDC:11673-314 | NDC:49035-716 | UNII:WK2XYI10QM | NDC:68071-3053 | NDC:68788-8322 | NDC:11673-183 | NDC:55319-971 | NDC:0113-0074 | NDC:63941-762 | NDC:49483-602 | NDC:70677-1144 | NDC:81522-938 | NDC:53746-131 | NDC:49348-642 | NDC:67091-368 | NDC:0363-0103 | NDC:55319-150 | NDC:63868-427 | NDC:29485-6512 | NDC:47682-700 | NDC:69842-745 | NDC:55154-1380 | NDC:53746-143 | NDC:50844-292 | NDC:49035-553 | NDC:51013-422 | NDC:55910-651 | NDC:37808-897 | NDC:71335-1270 | NDC:0573-0154 | NDC:72288-500 | NDC:63941-111 | NDC:11822-7893 | NDC:67046-2037 | NDC:0113-0517 | NDC:62135-400 | NDC:63868-759 | NDC:69452-305 | NDC:72476-365 | NDC:11673-593 | NDC:25000-136 | NDC:53746-466 | NDC:11822-9380 | NDC:53943-112 | NDC:61245-085 | NDC:67296-1686 | DrugBank ID:DB01050 | NDC:68998-110 | NDC:71335-2068 | NDC:72789-185 | NDC:82179-001 | NDC:0363-9612 | NDC:21130-011 | NDC:49035-912 | NDC:51013-103 | NDC:71610-176 | NDC:50580-604 | NDC:36800-604 | NDC:41163-116 | NDC:43063-914 | NDC:55910-255 | NDC:41226-612 | NDC:62207-396 | NDC:50090-6676 | NDC:66715-9812 | NDC:0113-0647 | NDC:59779-660 | NDC:63868-470 | NDC:71335-1503 | NDC:72789-363 | NDC:66220-287 | NDC:83615-0001 | NDC:47682-783 | NDC:72789-198 | NDC:72789-200 | NDC:68645-563 | NDC:49348-374 | NDC:67751-150 | NDC:41250-897 | NDC:41163-509 | NDC:50090-2549 | NDC:68998-185 | NDC:51655-759 | NDC:11673-604 | NDC:30142-166 | NDC:55319-745 | NDC:21130-035 | NDC:46122-548 | NDC:50090-4129 | NDC:50804-199 | NDC:69618-078 | NDC:73408-809 | NDC:59556-811 | NDC:59779-971 | NDC:51824-064 | NDC:50269-000 | NDC:60760-929 | NDC:80425-0089 | NDC:72476-109 | NDC:21130-699 | NDC:59556-805 | NDC:30142-053 | NDC:62207-356 | NDC:63629-1468 | NDC:73086-211 | NDC:66715-6407 | NDC:72789-186 | NDC:83059-0019 | NDC:55758-310 | NDC:52412-910 | NDC:56062-166 | NDC:50090-3007 | NDC:49035-604 | NDC:49035-684 | NDC:50090-6616 | NDC:65162-770 | NDC:45802-140 | NDC:70677-0152 | NDC:55910-513 | NDC:0573-1174 | NDC:62207-354 | NDC:71610-550 | NDC:0924-0076 | NDC:0363-1610 | CAS RN:15687-27-1 | NDC:53041-634 | NDC:69230-309 | NDC:36800-897 | NDC:41520-057 | NDC:63629-8851 | NDC:61245-084 | NDC:63187-527 | NDC:63629-1470 | NDC:37808-709 | NDC:63981-517 | NDC:50844-921 | NDC:41250-293 | NDC:68016-635 | NDC:69168-914 | NDC:70000-0571 | NDC:72189-231 | NDC:21130-070 | NDC:45865-437 | NDC:42681-0026 | NDC:59726-661 | NDC:50090-7321 | NDC:68071-4009 | NDC:0573-0175 | NDC:51660-423 | NDC:68016-633 | NDC:0904-6747 | NDC:36800-517 | NDC:10202-150 | NDC:53345-039 | NDC:58602-008 | NDC:57344-185 | NDC:62207-321 | NDC:53943-292 | NDC:59779-166 | NDC:50090-6645 | NDC:63941-761 | NDC:67091-321 | NDC:70677-0151 | NDC:59556-806 | NDC:68016-943 | NDC:41163-685 | NDC:0113-0604 | NDC:76281-126 | NDC:59726-199 | NDC:67296-1756 | NDC:0904-5309 | NDC:53345-050 | NDC:21130-220 | NDC:53746-464 | NDC:55910-102 | NDC:58602-879 | NDC:67091-369 | NDC:68071-5134 | NDC:25000-117 | NDC:70000-0239 | NDC:55301-291 | NDC:63941-745 | NDC:73598-1102 | NDC:21130-911 | NDC:55910-685 | NDC:36800-255 | NDC:51655-042 | NDC:58602-801 | NDC:21130-745 | NDC:70000-0175 | NDC:0363-0749 | NDC:50580-933 | NDC:36800-745 | NDC:63187-614 | NDC:70000-0262 | NDC:72288-897 | NDC:55910-503 | NDC:61504-109 | NDC:63981-750 | NDC:71610-275 | NDC:0573-0174 | NDC:68788-7745 | NDC:55319-843 | NDC:0363-1521 | NDC:10267-3852 | NDC:50580-198 | NDC:11822-4258 | NDC:0363-0897 | NDC:58602-713 | NDC:0363-9600 | NDC:64024-003 | NDC:68788-7983 | NDC:0904-5853 | NDC:0363-8139 | NDC:0904-5577 | NDC:36800-440 | NDC:60687-468 | NDC:53943-291 | NDC:63981-393 | NDC:81522-185 | NDC:47682-600 | NDC:69729-157 | NDC:30142-402 | NDC:68788-9112 | NDC:37808-750 | NDC:68071-3696 | NDC:70512-780 | NDC:41250-726 | NDC:72789-191 | NDC:41250-604 | NDC:53041-632 | NDC:72288-513 | NDC:51655-275 | NDC:62011-0368 | NDC:11822-0393 | NDC:71205-213 | NDC:56062-423 | NDC:36800-660 | NDC:0363-0604 | NDC:11673-685 | NDC:68210-4205 | NDC:70000-0606 | NDC:49483-700 | NDC:70000-0602 | NDC:72189-564 | NDC:11673-741 | NDC:69842-649 | NDC:49035-438 | NDC:72162-1912 | NDC:51672-1409 | NDC:83324-012 | NDC:68788-8757 | NDC:30142-281 | NDC:67296-1799 | NDC:49035-745 | NDC:53746-460 | NDC:63187-856 | NDC:50844-754 | NDC:56062-560 | NDC:41250-752 | NDC:62936-0941 | NDC:0573-0149 | NDC:25000-114 | NDC:25000-121 | NDC:0363-9611 | NDC:37808-604 | NDC:66267-964 | NDC:66715-6739 | NDC:11673-850 | NDC:53943-212 | NDC:62135-402 | NDC:69230-308 | NDC:70000-0360 | NDC:53942-119 | NDC:50844-438 | NDC:76420-575 | NDC:53746-142 | NDC:67296-0877 | NDC:55319-136 | NDC:68094-503 | NDC:43063-867 | NDC:47682-710 | NDC:50090-7053 | NDC:0573-0207 | NDC:63941-210 | NDC:55111-683 | NDC:50090-7320 | NDC:21130-818 | NDC:56062-647 | NDC:55319-893 | NDC:51407-371 | NDC:68001-521 | NDC:64380-997 | NDC:0121-2044 | NDC:55910-758 | CAS RN:58560-75-1 | NDC:68016-813 | NDC:68071-4968 | NDC:72036-212 | NDC:82804-137 | NDC:69452-212 | NDC:59726-046 | NDC:41250-685 | NDC:54348-835 | NDC:70518-0005 | NDC:66715-9700 | NDC:59726-843 | NDC:73086-212 | NDC:55910-845 | NDC:0573-0160 | NDC:71205-395 | NDC:41250-991 | NDC:59556-812 | NDC:50090-5444 | NDC:62207-366 | NDC:69452-262 | NDC:60760-941 | NDC:58602-843 | NDC:47682-610 | NDC:55681-401 | NDC:58602-902 | NDC:72036-015 | NDC:72476-366 | NDC:11822-0255 | NDC:37808-255 | NDC:55154-1577 | NDC:71921-182 | NDC:0113-0057 | NDC:67414-240 | NDC:67091-185 | NDC:50844-353 | NDC:0113-2461 | NDC:59779-074 | NDC:0573-0150 | NDC:0904-5855 | NDC:81522-119 | NDC:66267-115 | NDC:56062-404 | NDC:72162-1911 | NDC:82982-033 | NDC:47682-714 | NDC:30142-660 | NDC:59651-362 | NDC:49035-897 | NDC:68071-3778 | NDC:80267-604 | NDC:49483-601 | NDC:69842-489 | NDC:51013-319 | NDC:0363-9601 | NDC:80425-0154 | NDC:51655-474 | NDC:11822-0291 | NDC:0121-1022 | NDC:0363-9594 | NDC:0363-1106 | NDC:50090-2629 | NDC:56062-897 | NDC:68071-5066 | NDC:0573-0169 | NDC:68071-3589 | NDC:65162-465 | NDC:33992-0745 | NDC:41250-286 | NDC:67296-1685 | NDC:11822-0894 | NDC:11822-6604 | NDC:41250-331 | NDC:67296-1588 | NDC:58602-839 | NDC:11822-3307 | 2-[4-(2-methylpropyl)phenyl]propanoic acid | NDC:81522-700 | NDC:50844-257 | NDC:59726-139 | NDC:0536-1147 | NDC:51660-490 | NDC:67046-1165 | NDC:0363-0660 | NDC:51672-5321 | NDC:50594-843 | NDC:64380-807 | NDC:66715-5803 | NDC:66715-6452 | NDC:42543-965 | NDC:63187-022 | NDC:68788-8576 | NDC:41520-943 | NDC:53041-639 | NDC:55910-647 | NDC:56062-604 | NDC:21130-359 | NDC:67296-1449 | NDC:67296-1518 | PubChem SID:175271890 | NDC:29485-8152 | NDC:42543-966 | NDC:56062-801 | NDC:41163-604 | NDC:70000-0597 | NDC:41250-993 | NDC:55154-1342 | NDC:58602-858 | NDC:55910-046 | NDC:69842-706 | NDC:69848-011 | NDC:50580-120 | NDC:68998-109 | NDC:59779-604 | NDC:24385-905 | NDC:55154-0669 | NDC:50090-7281 | NDC:37808-609 | NDC:0573-0165 | NDC:30142-745 | NDC:43063-872 | NDC:36800-166 | NDC:33992-0843 | NDC:58602-003 | NDC:59556-855 | NDC:59779-430 | NDC:68210-6114 | NDC:70518-4010 | NDC:72288-763 | NDC:50090-3507 | NDC:76420-848 | NDC:54162-941 | NDC:45802-057 | NDC:55319-750 | NDC:21130-992 | NDC:68998-011 | NDC:69842-391 | IBUPROFEN | NDC:29485-6749 | NDC:37808-023 | NDC:69256-843 | NDC:70677-1114 | NDC:70518-4259 | NDC:50090-2996 | NDC:72189-324 | NDC:71610-629 | NDC:71610-222 | NDC:68071-1628 | NDC:0113-4501 | NDC:80267-999 | NDC:21130-396 | NDC:63868-570 | NDC:69238-1101 | NDC:83324-059 | NDC:69848-012 | NDC:58602-803 | NDC:66715-6839 | NDC:0615-8311 | NDC:68210-0026 | NDC:71141-178 | NDC:72789-218 | NDC:36800-292 | NDC:30142-423 | NDC:46122-593 | NDC:47682-718 | NDC:63981-291 | NDC:67091-347 | NDC:68788-8278 | NDC:70677-1132 | NDC:68071-4952 | NDC:11822-0897 | NDC:53746-132 | NDC:58602-227 | NDC:69452-260 | NDC:72476-843 | NDC:68210-0200 | NDC:49483-604 | NDC:68071-3679 | NDC:0363-0166 | NDC:0363-1461 | NDC:80425-0132 | NDC:11822-0231 | NDC:50090-7286 | NDC:73086-210 | NDC:50090-2625 | NDC:59556-857 | NDC:68210-4140 | NDC:71610-627 | NDC:37808-393 | NDC:58602-852 | NDC:0573-0161 | NDC:0363-4381 | NDC:68071-4243 | NDC:0573-0168 | NDC:72036-110 | NDC:55910-521 | NDC:0363-1517 | NDC:45802-897 | NDC:69396-141 | NDC:37808-699 | NDC:68788-9111 | NDC:55319-137 | NDC:70518-3178 | NDC:69517-111 | NDC:68788-7984 | NDC:67296-0913 | NDC:41163-312 | NDC:21130-358 | NDC:0113-0685 | NDC:63868-773 | NDC:0363-0438 | NDC:64380-809 | NDC:63868-571 | NDC:24385-604 | NDC:41163-647 | NDC:21130-843 | NDC:42961-203 | NDC:50090-7249 | NDC:55700-446 | NDC:67296-1217 | NDC:67751-120 | NDC:55319-637 | NDC:67296-1716 | NDC:55910-741 | NDC:41250-660 | NDC:68998-012 | NDC:68016-940 | NDC:72789-201 | NDC:66715-6920 | NDC:68196-981 | NDC:69452-239 | NDC:50594-020 | NDC:56062-057 | NDC:41163-166 | NDC:0904-5854 | NDC:30142-728 | NDC:72288-255 | NDC:50090-5446 | NDC:50090-7274 | NDC:70677-1145 | NDC:0573-0184 | NDC:72288-660 | NDC:50090-5223 | NDC:0404-0017 | NDC:11673-992 | NDC:42708-175 | NDC:47682-608 | NDC:63868-979 | NDC:70677-1118 | NDC:30142-255 | NDC:68001-435 | NDC:60760-597 | NDC:0924-0075 | NDC:35356-699 | NDC:50844-291 | NDC:63941-680 | NDC:70000-0291 | NDC:72476-745 | NDC:0363-0291 | NDC:63187-489 | NDC:66715-9752 | NDC:72162-2286 | NDC:50580-184 | NDC:70729-002 | NDC:55910-166 | NDC:76420-577 | NDC:29485-1005 | NDC:36800-662 | NDC:53943-119 | NDC:30142-743 | NDC:37808-200 | NDC:68071-3415 | NDC:60760-596 | NDC:72162-1910 | NDC:0363-0705 | NDC:0615-8309 | NDC:71921-181 | NDC:59779-291 | NDC:68788-7114 | NDC:11822-0166 | NDC:10267-3909 | NDC:36800-663 | NDC:68788-7080 | NDC:43063-843 | NDC:10202-711 | NDC:50332-0130 | NDC:83324-014 | NDC:71205-716 | NDC:50090-5818 | NDC:72288-166 | NDC:46122-609 | NDC:67751-148 | NDC:0113-0897 | NDC:0363-0945 | NDC:43063-845 | NDC:68071-2939 | NDC:71335-0690 | NDC:53746-140 | NDC:46122-580 | NDC:53746-144 | NDC:37808-158 | NDC:24385-647 | NDC:30142-517 | NDC:69367-395 | NDC:67296-2104 | NDC:55910-399 | NDC:49035-381 | NDC:55319-574 | NDC:21130-701 | NDC:50090-7282 | NDC:70518-0176 | NDC:72288-057 | NDC:80425-0047 | NDC:51407-370 | NDC:72036-185 | NDC:58602-708 | Ibuprofen | NDC:59779-438 | NDC:49035-265 | NDC:41163-057 | NDC:68788-8201 | NDC:51655-385 | NDC:72789-364 | NDC:55758-014 | NDC:51672-2144 | NDC:55758-304 | NDC:0472-2002 | NDC:41520-660 | NDC:41520-604 | NDC:59651-361 | NDC:70000-0176 | NDC:50580-436 | NDC:60687-457 | NDC:0904-5463 | NDC:0904-7912 | NDC:47682-709 | NDC:67296-1584 | NDC:67877-319 | NDC:51655-851 | NDC:11673-990 | NDC:53746-137 | NDC:72288-131 | NDC:59779-313 | NDC:0573-0166 | NDC:69842-323 | NDC:68788-8288 | NDC:41520-255 | NDC:0573-0232 | NDC:70000-0181 | NDC:11822-3061 | NDC:53746-462 | NDC:68071-5135 | NDC:0363-0292 | NDC:50090-6677 | NDC:59779-897 | NDC:51655-048 | NDC:50090-7283 | NDC:49483-600 | NDC:36800-221 | NDC:55319-366 | NDC:60760-604 | NDC:69842-521 | NDC:80425-0426 | NDC:81522-897 | NDC:60687-743 | NDC:68071-4887 | NDC:41163-897 | NDC:57243-291 | NDC:70677-1244 | NDC:81522-521 | NDC:24385-372 | NDC:56062-517 | NDC:51655-757 | NDC:68071-4949 | NDC:71610-547 | NDC:55301-292 | NDC:69168-335 | NDC:67877-321 | NDC:79395-003 | NDC:41163-710 | NDC:41250-292 | NDC:69790-709 | NDC:70264-041 | NDC:76420-847 | NDC:55154-0741 | NDC:53041-638 | NDC:68391-604 | NDC:71610-505 | NDC:21130-363 | NDC:68071-3362 | NDC:63868-268 | NDC:55319-046 | NDC:70264-029 | NDC:67296-1912 | NDC:66715-5607 | NDC:68016-634 | NDC:68210-4201 | NDC:43063-847 | NDC:69168-382 | NDC:71610-532 | NDC:37808-921 | NDC:67296-1706 | NDC:76282-714 | NDC:66220-284 | NDC:41520-166 | NDC:37808-221 | NDC:50580-230 | NDC:56062-131 | NDC:29485-9291 | NDC:59779-517 | NDC:25000-133 | NDC:0363-0743 | NDC:53185-381 | NDC:55910-849 | NDC:63868-428 | NDC:79481-0392 | NDC:49483-611 | NDC:83474-002 | NDC:57344-109 | NDC:0113-0166 | NDC:52412-911 | NDC:69230-311 | NDC:29485-7938 | NDC:70677-1146 | NDC:76281-128 | NDC:76282-713 | NDC:72288-604 | NDC:83008-066 | NDC:71205-787 | NDC:66715-9739 | NDC:36800-811 | NDC:70729-291 | NDC:68210-4200 | NDC:0363-4560 | NDC:50844-993 | NDC:71610-154 | NDC:69790-609 | NDC:37808-057 | NDC:46122-110 | NDC:53746-465 | NDC:41226-700 | NDC:68788-8354 | NDC:50594-005 | NDC:70000-0298 | NDC:69367-394 | NDC:68210-0800 | NDC:57344-110 | NDC:45802-133 | NDC:76282-712 | NDC:84269-2525 | NDC:71205-464 | NDC:80425-0046 | NDC:47682-683 | NDC:58602-802 | NDC:63187-451 | NDC:65162-464 | NDC:59726-123 | NDC:11822-1879 | NDC:70518-1364 | NDC:47682-609 | NDC:80425-0243 | NDC:11673-749 | NDC:11673-683 | NDC:50090-2626 | NDC:51013-429 | NDC:29485-6500 | NDC:72476-110 | NDC:10267-3846 | NDC:55301-393 | NDC:68210-4139 | NDC:70264-044 | NDC:11822-7891 | NDC:70677-0153 | NDC:53943-214 | NDC:76420-846 | NDC:50090-7288 | NDC:53345-014 | NDC:68645-562 | NDC:0363-9370 | NDC:63941-109 | NDC:41163-158 | NDC:36800-057 | NDC:36800-749 | NDC:41520-745 | NDC:69842-092 | NDC:36800-074 | NDC:51013-421 | NDC:68016-942 | NDC:81033-018 | NDC:66715-5507 | NDC:29485-6552 | NDC:58602-002 | NDC:29485-7006 | NDC:41250-647 | NDC:25000-135 | NDC:69238-1103 | NDC:63187-962 | NDC:70000-0264 | NDC:0573-1711 | NDC:71205-423 | NDC:24385-058 | NDC:71335-2047 | NDC:63629-8853 | NDC:67296-1474 | NDC:71205-357 | NDC:21130-393 | NDC:11822-1685 | NDC:25000-123 | NDC:68788-9110 | NDC:69452-263 | NDC:55301-392 | NDC:0573-0151 | NDC:62207-357 | NDC:50804-750 | NDC:0573-0191 | NDC:43063-936 | NDC:63941-209 | NDC:68196-745 | NDC:60760-529 | NDC:0536-1390 | NDC:72189-556 | NDC:55910-847 | NDC:68196-291 | NDC:63868-796 | NDC:59779-647 | NDC:65162-356 | NDC:66715-6500 | NDC:68788-8754 | NDC:49348-706 | NDC:36800-705 | NDC:63187-967 | NDC:71205-110 | NDC:68210-4199 | NDC:49483-612 | NDC:70518-2432 | NDC:66715-6339 | NDC:62207-358 | NDC:83059-0049 | NDC:69168-467 | NDC:42543-964 | NDC:70677-1116 | NDC:36800-647 | NDC:68094-600 | NDC:71335-1396 | NDC:73408-509 | NDC:59556-856 | NDC:69842-851 | NDC:70677-0072 | NDC:41226-610 | NDC:55910-791 | NDC:11673-517 | NDC:70692-175 | NDC:59556-858 | NDC:68210-4192 | NDC:66715-6552 | NDC:41163-185 | NDC:55910-953 | NDC:50090-5021 | NDC:0573-0180 | NDC:49035-647 | NDC:53041-637 | NDC:70000-0308 | NDC:0363-9593 | NDC:71335-1517 | NDC:0113-0298 | NDC:75712-006 | PubChem CID:3672 | NDC:66715-6434 | NDC:76420-576 | NDC:49035-517 | NDC:67296-1611 | NDC:68016-944 | NDC:72927-805 | NDC:82501-1582 | NDC:57344-811 | NDC:70677-1136 | NDC:72476-358 | NDC:37808-410 | NDC:67296-1581 | NDC:24385-059 | NDC:55319-199 | NDC:62207-395 | NDC:11822-0084 | NDC:11822-1521 | NDC:11673-991 | NDC:25000-062 | NDC:76281-119 | NDC:46122-632 | NDC:0363-0225 | NDC:63629-8540 | NDC:37808-363 | NDC:72789-212 | NDC:27854-777 | NDC:63739-798 | NDC:35916-0989 | NDC:66715-6412 | NDC:54348-825 | NDC:70518-3313 | NDC:0363-0221 | NDC:50580-932 | NDC:69168-381 | NDC:79481-3000 | NDC:71610-501 | NDC:0573-0290 | NDC:55910-518 | NDC:21130-006 | NDC:30142-965 | NDC:63548-0234 | NDC:68071-5126 | NDC:72288-461 | NDC:73598-1104 | NDC:63941-760 | NDC:70264-042 | NDC:59556-895 | NDC:68788-8319 | NDC:0121-0914 | NDC:71335-1073 | NDC:50580-601 | NDC:49314-1003 | NDC:11822-3310 | NDC:68196-601 | NDC:55319-114 | NDC:11673-349 | NDC:59651-360 | NDC:72288-517 | NDC:63629-8852 | NDC:0363-0806 | NDC:81522-604 | NDC:49483-603 | NDC:51013-410 | NDC:69168-390 | NDC:69842-892 | NDC:68071-5228 | NDC:53746-458 | NDC:68210-8100 | NDC:72476-112 | NDC:0573-0199 | NDC:11822-5158 | NDC:67751-146 | NDC:29485-2893 | NDC:24385-361 | NDC:49035-228 | NDC:21130-032 | NDC:41226-600 | NDC:43063-352 | NDC:50580-603 | NDC:30142-513 | NDC:68071-5140 | NDC:70677-1117 | NDC:71205-604 | NDC:72288-685 | NDC:11822-8925 | NDC:66715-6720 | NDC:11673-745 | NDC:50090-6886 | NDC:71610-646 | NDC:37808-109 | NDC:72476-111 | NDC:62135-401 | NDC:37808-647 | NDC:63868-805 | NDC:70000-0003 | NDC:63981-192 | NDC:46994-291 | NDC:11822-0131 | NDC:0113-1212 | NDC:46122-617 | NDC:71141-114 | NDC:36800-193 | NDC:83324-005 | NDC:0363-0393 | NDC:66267-963 | NDC:59779-995 | NDC:72162-2285 | NDC:80425-0393 | NDC:41520-685 | NDC:50844-392 | NDC:55319-929 | NDC:29485-1465 | NDC:55910-901 | NDC:55319-552 | NDC:63187-980 | NDC:68071-4845 | NDC:70518-1051 | NDC:71610-456 | NDC:68094-494 | NDC:67091-348 | NDC:0573-0179 | NDC:41250-158 | NDC:55910-604 | NDC:41226-601 | NDC:49035-601 | NDC:41250-074 | NDC:71205-367 | NDC:69842-643 | NDC:0363-0423 | NDC:49314-0993 | NDC:66715-9819 | NDC:62011-0399 | NDC:64024-002 | NDC:51672-1385 | NDC:68391-212 | NDC:68599-8051 | NDC:0573-1769 | NDC:50580-100 | NDC:55111-684 | NDC:72789-382 | NDC:59726-745 | NDC:55910-750 | NDC:72036-109 | NDC:41520-633 | NDC:69103-2525 | NDC:63941-301 | NDC:11673-660 | NDC:53329-674 | NDC:67060-001 | NDC:59556-764 | NDC:71335-1911 | NDC:11822-7892 | NDC:41520-897 | NDC:68788-8531 | NDC:72162-2341 | NDC:68071-4459 | NDC:21130-877 | NDC:82649-199 | NDC:50090-2548 | NDC:51660-493 | NDC:63187-992 | NDC:45802-952 | NDC:0615-8310 | NDC:43063-858 | NDC:50269-157 | NDC:50580-409 | NDC:55910-197 | NDC:0363-5100 | NDC:0573-0170 | NDC:66715-6512 | NDC:69842-493 | NDC:36800-993 | NDC:0761-0908 | NDC:72036-211 | NDC:41520-495 | NDC:0363-8901 | NDC:29485-7012 | NDC:30142-647 | NDC:24385-009 | NDC:50090-2597 | NDC:72288-521 | NDC:55910-897 | NDC:53943-111 | NDC:48792-7812 | NDC:54348-830 | NDC:55319-252 | NDC:83059-0020 | NDC:71921-180 | NDC:66715-5539 | NDC:25000-122 | NDC:63981-598 | NDC:41250-419 | NDC:51013-405 | NDC:57896-941 | NDC:11673-993 | NDC:63981-604 | NDC:0121-1828 | NDC:64380-808 | NDC:70677-0150 | NDC:55910-074 | NDC:83324-056 | NDC:68788-8438 | NDC:61504-110 | NDC:83324-013 | NDC:47682-614 | NDC:36800-685 | NDC:51672-2130 | NDC:55910-768 | NDC:69230-310 | NDC:71610-644 | NDC:11673-514 | NDC:11673-255 | NDC:50332-0152 | NDC:11822-0392 | NDC:41520-647 | NDC:49035-693 | NDC:50090-5819 | NDC:49483-133 | NDC:59651-032 | NDC:69238-1102 | NDC:67296-2095 | NDC:62207-355 | NDC:63548-0185 | NDC:71205-425 | NDC:24385-550 | NDC:71205-522 | NDC:68788-8590 | NDC:11822-0589 | NDC:30142-897 | NDC:60687-446
+BMGC_DG07761,BMG_DG139171,DrugBank ID:DB02082 | PubChem CID:36735 | Phosphoaminophosphonic acid guanylate ester
+BMGC_DG07762,BMG_DG139176,2-phenylethylhydrazine | DrugBank ID:DB00780 | CAS RN:51-71-8 | Phenelzine | CAS RN:14847-47-3 | UNII:O408N561GF | PubChem SID:175268017 | PHENELZINE | PubChem CID:3675
+BMGC_DG07763,BMG_DG139180,CAS RN:90086-89-8 | 2-(furan-2-yl)pyrrolidine | 2-(Furan-2-yl)pyrrolidine | PubChem CID:3675988
+BMGC_DG07764,BMG_DG139181,"NDC:84214-002 | NDC:84165-103 | NDC:80425-0351 | NDC:71205-549 | NDC:62217-070 | NDC:82718-1110 | NDC:0603-1880 | NDC:21922-076 | NDC:49947-001 | NDC:84010-042 | NDC:11822-9989 | NDC:84180-001 | NDC:68071-1625 | NDC:69618-075 | NDC:83881-402 | NDC:83569-002 | NDC:83553-001 | NDC:63742-002 | NDC:70518-3056 | NDC:0363-9110 | NDC:83364-007 | NDC:46122-555 | NDC:69903-007 | NDC:83364-012 | NDC:68788-8150 | NDC:71085-075 | NDC:84555-001 | NDC:70000-0037 | NDC:76092-201 | NDC:46122-450 | NDC:73638-901 | NDC:0363-0985 | NDC:70000-0624 | NDC:70942-121 | NDC:63135-581 | NDC:69693-419 | NDC:71205-500 | NDC:82433-446 | NDC:70518-3972 | NDC:0363-2178 | NDC:84023-401 | NDC:62332-424 | NDC:76420-550 | NDC:11822-4216 | NDC:63629-2503 | NDC:68788-8630 | NDC:76420-641 | NDC:41167-1720 | NDC:73352-835 | NDC:83589-302 | NDC:0121-0970 | NDC:0496-0883 | NDC:69396-134 | NDC:71101-914 | NDC:71205-348 | NDC:51142-100 | NDC:80513-813 | NDC:69993-400 | NDC:70512-013 | NDC:71085-001 | NDC:58980-824 | NDC:83037-423 | NDC:79218-001 | NDC:41520-162 | NDC:72839-226 | NDC:72162-2084 | NDC:71331-116 | NDC:72559-018 | NDC:55700-142 | NDC:84165-106 | NDC:71205-288 | NDC:0574-2042 | NDC:71399-0049 | NDC:82460-262 | NDC:53943-911 | NDC:73557-159 | NDC:62168-0585 | DrugBank ID:DB00281 | NDC:66902-225 | NDC:71574-900 | NDC:0362-0221 | NDC:82944-102 | NDC:63742-006 | NDC:72839-263 | NDC:69968-0614 | NDC:84787-001 | NDC:73352-845 | NDC:68788-7159 | NDC:83800-430 | NDC:69903-004 | NDC:72854-682 | NDC:80425-0404 | NDC:55636-101 | NDC:70518-3746 | NDC:41226-740 | NDC:63742-038 | NDC:72162-2068 | NDC:65162-791 | NDC:49035-788 | NDC:84019-018 | NDC:76420-125 | NDC:66312-110 | NDC:41167-0585 | NDC:62217-200 | NDC:76420-036 | NDC:63868-309 | NDC:71331-119 | NDC:55264-106 | NDC:79903-038 | NDC:21130-961 | NDC:55629-019 | NDC:84722-3041 | NDC:69903-005 | NDC:0363-3033 | NDC:33342-405 | NDC:71205-429 | NDC:82929-010 | NDC:41250-841 | NDC:0496-0978 | NDC:84019-301 | NDC:59088-910 | NDC:11822-9992 | NDC:68016-614 | NDC:69968-0793 | NDC:71205-342 | NDC:82347-0505 | NDC:82944-100 | NDC:54723-008 | NDC:73581-001 | NDC:53225-1123 | NDC:69903-003 | NDC:75568-016 | NDC:83120-378 | NDC:71331-117 | NDC:67510-0284 | NDC:83295-6400 | NDC:71205-717 | NDC:76420-144 | NDC:84010-018 | NDC:0536-1202 | NDC:71391-151 | NDC:46122-574 | NDC:41167-1715 | NDC:69315-301 | NDC:69968-0794 | NDC:71331-113 | NDC:83364-010 | NDC:73287-040 | NDC:79481-0004 | NDC:84844-015 | NDC:21130-988 | NDC:63742-003 | NDC:50090-6589 | NDC:78280-712 | NDC:63187-975 | NDC:66902-276 | NDC:11523-0404 | NDC:83559-007 | NDC:41167-1740 | NDC:72839-218 | NDC:75568-018 | NDC:69375-005 | NDC:73076-301 | NDC:80425-0380 | NDC:84019-101 | NDC:80425-0374 | NDC:21130-960 | NDC:63629-8755 | NDC:72162-2085 | NDC:84165-104 | NDC:0573-2890 | NDC:73287-020 | NDC:24689-124 | NDC:69805-786 | NDC:0363-2179 | NDC:70942-183 | NDC:36800-156 | NDC:71101-917 | NDC:71811-002 | NDC:39328-025 | NDC:83566-143 | NDC:46581-840 | NDC:83838-153 | NDC:84615-006 | NDC:83881-401 | NDC:66902-257 | NDC:68788-7617 | NDC:0363-2182 | NDC:69618-082 | NDC:84732-082 | NDC:51316-226 | NDC:73557-158 | NDC:62332-582 | NDC:68788-9555 | NDC:71101-011 | NDC:72189-488 | NDC:83008-025 | NDC:70000-0557 | NDC:75568-023 | NDC:79481-0021 | NDC:84010-020 | NDC:69968-0615 | NDC:69842-543 | NDC:70466-001 | NDC:73287-025 | NDC:54859-415 | NDC:79481-0003 | NDC:67194-014 | NDC:81877-514 | NDC:80425-0325 | NDC:62168-1720 | NDC:80425-0248 | NDC:82944-104 | NDC:82739-021 | NDC:63742-001 | NDC:70518-3902 | NDC:69452-409 | NDC:49035-136 | NDC:73557-172 | NDC:84273-001 | NDC:60760-201 | NDC:41167-0583 | NDC:55700-932 | NDC:71101-029 | NDC:42291-495 | NDC:80425-0324 | NDC:81902-101 | NDC:82865-002 | NDC:60771-0005 | NDC:61566-279 | NDC:52000-407 | NDC:71101-916 | NDC:72559-026 | NDC:72288-967 | NDC:83589-301 | NDC:71318-115 | NDC:76420-146 | NDC:75568-019 | NDC:71811-001 | NDC:72839-173 | NDC:58980-823 | NDC:51407-827 | NDC:70512-017 | NDC:51672-3020 | NDC:83035-1137 | NDC:49947-002 | NDC:73715-002 | NDC:84097-001 | NDC:69993-450 | NDC:84165-102 | NDC:60760-880 | NDC:11527-191 | NDC:70942-357 | NDC:72839-223 | NDC:68788-8594 | NDC:84205-002 | NDC:60760-657 | NDC:73557-157 | NDC:71101-915 | NDC:69968-0795 | NDC:61566-201 | NDC:73354-1280 | NDC:83559-006 | NDC:76420-131 | NDC:67194-022 | NDC:69842-236 | NDC:69903-006 | NDC:73076-162 | NDC:80425-0450 | NDC:73715-001 | NDC:41167-0598 | NDC:63135-312 | NDC:0591-3525 | NDC:71101-058 | NDC:76420-149 | NDC:70000-0558 | NDC:63187-577 | NDC:69561-005 | NDC:53943-003 | NDC:83602-172 | NDC:0363-9657 | NDC:55910-912 | NDC:68788-8396 | NDC:57707-050 | NDC:70518-3821 | NDC:70000-0366 | NDC:84010-019 | NDC:11822-0265 | NDC:51672-5305 | NDC:70000-0650 | NDC:42291-378 | NDC:51407-383 | NDC:71073-207 | NDC:84023-601 | NDC:79481-0048 | NDC:62742-4222 | NDC:71811-003 | NDC:55154-7813 | NDC:84010-025 | NDC:71399-0050 | NDC:0363-9943 | NDC:41250-625 | NDC:80425-0385 | NDC:76420-887 | NDC:63481-687 | NDC:84023-201 | NDC:80327-008 | NDC:72839-071 | NDC:68788-7405 | CAS RN:137-58-6 | NDC:71318-114 | NDC:55239-459 | NDC:68788-7865 | NDC:0168-0357 | NDC:84019-019 | NDC:60000-911 | NDC:63135-727 | NDC:72189-499 | NDC:79903-036 | NDC:0591-2679 | NDC:55700-336 | NDC:67510-0636 | NDC:72189-493 | NDC:63187-836 | NDC:75568-004 | NDC:63629-8848 | NDC:11673-744 | NDC:72578-165 | NDC:69805-400 | NDC:67777-009 | NDC:55154-2665 | NDC:71436-3104 | NDC:83559-004 | NDC:55621-011 | NDC:71101-003 | NDC:81877-725 | NDC:83987-001 | NDC:66902-215 | NDC:0363-1002 | NDC:50488-2004 | NDC:73287-042 | NDC:83655-109 | NDC:84010-045 | NDC:63135-924 | NDC:72654-002 | NDC:35192-026 | NDC:83008-044 | NDC:83566-300 | NDC:82739-020 | NDC:10135-672 | NDC:71101-002 | NDC:82728-001 | NDC:84322-004 | NDC:84767-001 | NDC:85150-001 | NDC:81533-201 | NDC:70512-014 | NDC:81033-025 | NDC:24357-701 | NDC:16714-878 | NDC:82620-001 | NDC:68788-7376 | NDC:10882-529 | NDC:55319-826 | NDC:27854-311 | NDC:83566-142 | NDC:72189-165 | NDC:69903-001 | NDC:55636-590 | NDC:72594-1002 | NDC:71205-745 | NDC:84007-334 | NDC:35192-027 | NDC:63629-2504 | NDC:83295-8000 | NDC:10882-526 | NDC:84410-001 | NDC:69693-418 | NDC:76420-313 | NDC:75568-017 | NDC:71335-1934 | NDC:0496-0882 | NDC:71662-000 | NDC:71574-905 | NDC:0363-3038 | NDC:73287-026 | NDC:41250-972 | NDC:69557-111 | NDC:59651-591 | NDC:66902-156 | NDC:0363-2180 | NDC:59316-899 | NDC:0536-1267 | NDC:80513-814 | NDC:71101-912 | NDC:71399-6544 | NDC:72559-023 | NDC:72189-387 | NDC:50804-838 | NDC:59088-396 | NDC:71205-814 | NDC:72189-168 | NDC:79903-197 | NDC:71331-115 | NDC:70512-812 | NDC:71101-041 | NDC:83008-024 | NDC:63135-811 | NDC:70771-1872 | NDC:74458-257 | NDC:73287-029 | NDC:69664-003 | NDC:83184-221 | NDC:83822-003 | NDC:69159-920 | NDC:72189-211 | NDC:82461-611 | NDC:54723-016 | NDC:55700-048 | NDC:76420-581 | NDC:62168-0584 | NDC:71262-006 | NDC:63629-9604 | NDC:68462-418 | NDC:0536-1357 | NDC:50090-1359 | NDC:73076-302 | NDC:10882-527 | NDC:80425-0438 | NDC:83602-157 | NDC:80425-0442 | NDC:70907-098 | NDC:68071-3620 | NDC:50488-1001 | NDC:71101-911 | NDC:84214-007 | NDC:55154-7228 | NDC:82517-002 | NDC:84308-159 | NDC:72189-601 | NDC:51672-3008 | NDC:61959-001 | PubChem SID:175267763 | NDC:63187-934 | NDC:69396-070 | NDC:71335-1971 | NDC:76162-007 | NDC:82598-101 | NDC:72559-016 | NDC:63629-5094 | NDC:30142-583 | NDC:49911-884 | NDC:69664-001 | NDC:71662-002 | NDC:84273-002 | NDC:83602-158 | NDC:83008-067 | NDC:49035-717 | NDC:67194-018 | NDC:69747-040 | NDC:71436-3571 | NDC:65162-918 | NDC:0363-5722 | NDC:81902-104 | NDC:71383-024 | NDC:84010-022 | UNII:98PI200987 | NDC:72189-553 | NDC:75568-013 | NDC:71101-918 | NDC:79481-0005 | NDC:41167-1710 | NDC:72839-141 | NDC:82429-203 | NDC:72559-024 | NDC:51142-101 | NDC:68016-066 | NDC:0168-0204 | NDC:64380-789 | NDC:71205-137 | NDC:70512-012 | NDC:76420-899 | NDC:66902-286 | NDC:39328-024 | NDC:27789-911 | NDC:71101-931 | NDC:83881-441 | NDC:68016-876 | LIDOCAINE | NDC:71383-014 | 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide | NDC:75568-014 | NDC:83720-523 | NDC:78280-703 | NDC:62221-935 | NDC:49436-099 | NDC:79643-001 | NDC:73076-161 | NDC:50804-756 | NDC:73557-373 | NDC:79903-106 | NDC:36800-031 | NDC:79903-109 | NDC:73076-160 | NDC:84205-003 | NDC:73581-911 | NDC:83391-001 | NDC:42291-477 | NDC:58980-826 | NDC:85056-001 | NDC:65923-149 | NDC:75568-022 | NDC:11822-6541 | Lidocaine | NDC:66902-220 | NDC:83035-1138 | NDC:0536-1278 | NDC:51316-229 | NDC:69423-971 | NDC:84615-005 | NDC:55700-681 | NDC:27854-333 | NDC:72036-911 | NDC:84023-301 | NDC:80327-002 | NDC:79740-009 | NDC:82944-103 | PubChem CID:3676 | NDC:73287-028 | NDC:79481-2183 | NDC:46581-830 | NDC:73352-830 | NDC:24357-702 | NDC:72559-012 | NDC:73581-105 | NDC:73492-712 | NDC:72667-072 | NDC:73287-016 | NDC:79643-005 | NDC:84010-037 | NDC:79481-0989 | NDC:70752-113 | NDC:76420-037 | NDC:67194-017 | NDC:84010-001 | NDC:72559-025 | NDC:36590-6461 | NDC:43473-302 | NDC:70677-1188 | NDC:69145-201 | NDC:71888-102 | NDC:72839-265 | NDC:80327-010 | NDC:0496-0892 | NDC:73486-102 | NDC:72839-021 | NDC:78663-201 | NDC:84664-001 | NDC:70518-4192 | NDC:42291-399 | NDC:82191-001 | NDC:63629-7059 | NDC:71101-001 | NDC:72162-1125 | NDC:75834-333 | NDC:83016-171 | NDC:84555-002 | NDC:69771-010 | NDC:83910-003 | NDC:80425-0247 | NDC:71331-118 | NDC:71662-001 | NDC:73287-024 | NDC:79643-008 | NDC:68788-8344 | NDC:71662-010 | NDC:82517-001 | NDC:0378-9055 | NDC:69423-970"
+BMGC_DG07765,BMG_DG139182,UNII:4HDD4R2AEW | PubChem CID:3676069 | CAS RN:52820-49-2 | 3-(AMINOIMINOMETHYL)BENZOIC ACID | PubChem SID:440089157
+BMGC_DG07766,BMG_DG139183,"DrugBank ID:DB01365 | UNII:TEZ91L71V4 | Mephentermine | MEPHENTERMINE | N,2-dimethyl-1-phenylpropan-2-amine | CAS RN:100-92-5 | PubChem CID:3677 | PubChem SID:198965787"
+BMGC_DG07767,BMG_DG139185,"UNII:H375PQ9FBA | PubChem CID:367790 | 4-(4-Ethoxyanilino)-1,2-naphthalenedione | 4-(4-ETHOXYANILINO)-1,2-NAPHTHALENEDIONE | PubChem SID:474491765 | CAS RN:75140-06-6"
+BMGC_DG07768,BMG_DG139186,N-ethyl-3-phenyl-N-(3-phenylpropyl)propan-1-amine | CAS RN:150-59-4 | DrugBank ID:DB01616 | PubChem CID:3678 | Alverine | PubChem SID:198961612 | ALVERINE | UNII:46TIR1560O
+BMGC_DG07769,BMG_DG139193,"DrugBank ID:DB00841 | PubChem CID:36811 | CAS RN:34368-04-2 | Dobutamine | PubChem SID:175271691 | 4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol | DOBUTAMINE | UNII:3S12J47372"
+BMGC_DG07770,BMG_DG139195,Hydrogen phosphate | PubChem CID:3681305 | CAS RN:29505-79-1 | PHOSPHATE ION(2-) | PubChem SID:255508891 | CAS RN:14066-19-4 | hydrogen phosphate | UNII:33UE6C4909
+BMGC_DG07771,BMG_DG139197,"CAS RN:72795-20-1 | CAS RN:72795-26-7 | 1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)butan-2-ol | CAS RN:91021-57-7 | PubChem CID:3682 | CAS RN:72795-19-8"
+BMGC_DG07772,BMG_DG139213,"CAS RN:26020-55-3 | OXETORONE | 3-(12H-[1]benzofuro[3,2-c][1]benzoxepin-6-ylidene)-N,N-dimethylpropan-1-amine | UNII:T3XOS33TIQ | PubChem CID:36846 | Oxetorone | PubChem SID:198980543"
+BMGC_DG07773,BMG_DG139218,"PubChem SID:175268171 | PubChem CID:3686 | IDEBENONE | 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | UNII:HB6PN45W4J | CAS RN:58186-27-9 | Idebenone"
+BMGC_DG07774,BMG_DG139229,UNII:R8OE3P6O5S | Ifenprodil | IFENPRODIL | PubChem CID:3689 | PubChem SID:198947464 | DrugBank ID:DB08954 | CAS RN:23210-58-4 | CAS RN:136172-79-7 | CAS RN:23210-56-2 | 4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol
+BMGC_DG07775,BMG_DG139232,"PubChem SID:175271729 | NDC:63323-142 | NDC:0143-9530 | NDC:10019-929 | NDC:10019-926 | Ifosfamide | CAS RN:3778-73-2 | DrugBank ID:DB01181 | NDC:0338-3991 | NDC:10019-925 | IFOSFAMIDE | NDC:10019-927 | NDC:0143-9531 | CAS RN:66849-34-1 | N,3-bis(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine | NDC:0338-3993 | PubChem CID:3690 | UNII:UM20QQM95Y"
+BMGC_DG07776,BMG_DG139233,PubChem SID:252320050 | BIS-(MALEIMIDOETHOXY) ETHANE | CAS RN:115597-84-7 | UNII:R20U86RE9F | PubChem CID:3690297
+BMGC_DG07777,BMG_DG139235,PubChem SID:316913503 | 5-MEO-AMT | UNII:U5XOB9AQ15 | CAS RN:1137-04-8 | PubChem CID:36906
+BMGC_DG07778,BMG_DG139237,PubChem CID:36910 | UNII:G5MUV8139H | PubChem SID:198975749 | Zipeprol | 1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol | CAS RN:34758-83-3 | ZIPEPROL | DrugBank ID:DB13564
+BMGC_DG07779,BMG_DG139239,2-(1H-imidazol-5-yl)ethyl carbamimidothioate | Imetit | PubChem CID:3692 | PubChem SID:198952140 | IMETIT | UNII:677MJ4VPZC | CAS RN:102203-18-9
+BMGC_DG07780,BMG_DG139240,"TERTATOLOL | PubChem CID:36920 | 1-(tert-butylamino)-3-(3,4-dihydro-2H-thiochromen-8-yloxy)propan-2-ol | DrugBank ID:DB13775 | Tertatolol | CAS RN:83688-84-0 | PubChem SID:198934796 | CAS RN:34784-64-0 | UNII:9ZO341YQXP"
+BMGC_DG07781,BMG_DG139241,"(2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Ticarcillin | TICARCILLIN | UNII:F93UJX4SWT | PubChem SID:175265320 | CAS RN:34787-01-4 | PubChem CID:36921 | DrugBank ID:DB01607"
+BMGC_DG07782,BMG_DG139245,PubChem SID:249492282 | PubChem CID:369312 | Perilla alcohol | CAS RN:18457-55-1 | [(4S)-4-prop-1-en-2-ylcyclohexen-1-yl]methanol | UNII:3UL4QIY642 | PERILLA ALCOHOL | DrugBank ID:DB15289
+BMGC_DG07783,BMG_DG139247,"1,2,7,8-Tetrachlorodibenzo-p-dioxin | 1,2,7,8-TETRACHLORODIBENZO-P-DIOXIN | CAS RN:34816-53-0 | PubChem SID:198987556 | UNII:61CLS478M1 | 1,2,7,8-tetrachlorodibenzo-p-dioxin | PubChem CID:36934"
+BMGC_DG07784,BMG_DG139250,"PubChem SID:474492374 | N-(5-(5-(2,4-Dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)pentanoyl)-2,4-dimethoxyphenyl)-4-(trifluoromethyl)benzenesulfonamide | N-[5-[5-(2,4-dioxo-1,3,8-triazaspiro[4.5]decan-8-yl)pentanoyl]-2,4-dimethoxyphenyl]-4-(trifluoromethyl)benzenesulfonamide | CAS RN:185376-97-0 | RS-102221 | UNII:48D22QR8GY | PubChem CID:3693566"
+BMGC_DG07785,BMG_DG139257,PAULLONE | PubChem CID:369401 | CAS RN:142273-18-5 | UNII:2JD8V46QDE
+BMGC_DG07786,BMG_DG139258,"PubChem CID:3695754 | 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine | DrugBank ID:DB08787"
+BMGC_DG07787,BMG_DG139260,5-Hydroxy-7-methoxy-6-methylflavone | CAS RN:55969-57-8 | 5-hydroxy-7-methoxy-6-methyl-2-phenylchromen-4-one | PubChem CID:369599
+BMGC_DG07788,BMG_DG139261,"PubChem CID:3696 | PubChem SID:175265478 | DrugBank ID:DB00458 | CAS RN:2241983-10-6 | 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine | UNII:OGG85SX4E4 | IMIPRAMINE | Imipramine | CAS RN:50-49-7"
+BMGC_DG07789,BMG_DG139264,PubChem CID:36976 | CARBUTEROL | DrugBank ID:DB13625 | PubChem SID:198963424 | [5-[2-(tert-butylamino)-1-hydroxyethyl]-2-hydroxyphenyl]urea | Carbuterol | CAS RN:34866-47-2 | UNII:0N12JR32MR
+BMGC_DG07790,BMG_DG139265,PubChem CID:3698 | CAS RN:60719-84-8 | PubChem SID:175265306 | 3-amino-5-pyridin-4-yl-1H-pyridin-2-one | Amrinone | UNII:JUT23379TN | DrugBank ID:DB01427 | INAMRINONE
+BMGC_DG07791,BMG_DG139272,Incadronic Acid | CAS RN:124351-85-5 | INCADRONIC ACID | [(cycloheptylamino)-phosphonomethyl]phosphonic acid | PubChem SID:198985373 | DrugBank ID:DB06255 | PubChem CID:3699 | UNII:G5C4M8847E | Incadronic acid
+BMGC_DG07792,BMG_DG139274,"PubChem CID:369976 | PubChem SID:198988000 | DrugBank ID:DB08633 | O-(chloroacetylcarbamoyl)fumagillol | UNII:X47GR46481 | TNP-470 | CAS RN:129298-91-5 | [(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] N-(2-chloroacetyl)carbamate"
+BMGC_DG07793,BMG_DG139275,4-(4-FLUOROBENZYL)PIPERIDINE | DrugBank ID:DB07110 | PubChem CID:3699841
+BMGC_DG07794,BMG_DG139276,"Gallic Acid | CAS RN:65271-60-5 | 3,4,5-trihydroxybenzoic acid | CAS RN:149-91-7 | PubChem SID:175265492 | CAS RN:137657-43-3 | NDC:43742-0835 | GALLIC ACID | PubChem CID:370 | UNII:632XD903SP"
+BMGC_DG07795,BMG_DG139278,CAS RN:34966-41-1 | UNII:8K93Z46WPY | CARTAZOLATE | PubChem SID:198937555 | PubChem CID:37015
+BMGC_DG07796,BMG_DG139279,"NDC:68788-7247 | 4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide | NDC:63629-1953 | NDC:72162-1766 | NDC:0228-2571 | PubChem CID:3702 | NDC:72162-1767 | Indapamide | NDC:51407-025 | NDC:62559-510 | NDC:62559-511 | NDC:16571-875 | INDAPAMIDE | CAS RN:26807-65-8 | NDC:51407-024 | UNII:F089I0511L | NDC:63629-1954 | NDC:71335-1541 | NDC:16571-876 | PubChem SID:175272191 | DrugBank ID:DB00808 | NDC:0228-2597 | NDC:72189-591"
+BMGC_DG07797,BMG_DG139283,"2,2',4,4',5,5'-Hexachlorobiphenyl | PubChem CID:37034 | UNII:ZRU0C9E32O | PubChem SID:198973340 | 1,2,4-trichloro-5-(2,4,5-trichlorophenyl)benzene | CAS RN:35065-27-1 | 2,2',4,4',5,5'-HEXACHLOROBIPHENYL"
+BMGC_DG07798,BMG_DG139285,HALENAQUINONE | PubChem CID:370346 | PubChem SID:443625107 | UNII:X57WT4EJ87 | CAS RN:86690-14-4
+BMGC_DG07799,BMG_DG139296,INDIGOTINDISULFONIC ACID | UNII:X7OI7JF73P | PubChem CID:3705 | 2-(3-hydroxy-5-sulfo-1H-indol-2-yl)-3-oxoindole-5-sulfonic acid | CAS RN:483-20-5 | DrugBank ID:DB11577 | PubChem SID:175266711 | Indigotindisulfonic acid
+BMGC_DG07800,BMG_DG139311,4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid | DrugBank ID:DB02936 | PubChem CID:3710
+BMGC_DG07801,BMG_DG139315,[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid | DrugBank ID:DB02504 | PubChem CID:3711
+BMGC_DG07802,BMG_DG139319,PubChem CID:3712 | DrugBank ID:DB12881 | 1H-indol-3-ylmethanol | Indole-3-carbinol | INDOLE-3-CARBINOL | PubChem SID:198981765 | Indole-3-Carbinol | UNII:C11E72455F | CAS RN:700-06-1
+BMGC_DG07803,BMG_DG139338,NDC:71335-1568 | NDC:43063-773 | NDC:55289-469 | NDC:43063-929 | NDC:72578-038 | NDC:50268-431 | NDC:43063-777 | NDC:70771-1005 | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid | NDC:31722-565 | NDC:63323-659 | NDC:70518-0254 | NDC:71205-215 | NDC:62135-067 | NDC:51655-443 | NDC:65162-506 | NDC:72162-1300 | NDC:60760-916 | NDC:76420-029 | NDC:10702-016 | NDC:50090-0053 | NDC:63187-282 | NDC:69344-101 | NDC:50090-0054 | NDC:50090-2803 | NDC:62135-068 | NDC:31722-542 | NDC:66267-119 | NDC:50090-0050 | NDC:71335-9754 | NDC:0054-1950 | NDC:68462-325 | NDC:63629-1914 | PubChem CID:3715 | NDC:71205-159 | NDC:68462-406 | NDC:50090-0051 | NDC:68788-6448 | NDC:68788-8092 | NDC:51655-963 | NDC:70771-1766 | NDC:60760-294 | NDC:50268-430 | NDC:51655-329 | NDC:61919-526 | Indomethacin | NDC:70518-1512 | NDC:72578-039 | NDC:72162-1299 | NDC:80425-0271 | NDC:50090-2987 | NDC:68084-411 | NDC:68788-6983 | NDC:67296-1525 | NDC:68071-3277 | PubChem SID:175266838 | NDC:70771-1203 | NDC:70710-1852 | NDC:68462-302 | NDC:70771-1004 | NDC:61919-164 | NDC:67296-0886 | NDC:76420-148 | INDOMETHACIN | NDC:72865-148 | NDC:63629-1913 | NDC:70518-0515 | NDC:67296-0723 | NDC:68788-8117 | CAS RN:53-86-1 | NDC:68382-371 | NDC:72865-149 | NDC:43063-368 | NDC:63629-8993 | NDC:63187-852 | NDC:66267-120 | NDC:43063-930 | NDC:71335-0355 | NDC:31722-543 | NDC:63187-948 | NDC:72162-1302 | NDC:71335-0747 | NDC:50090-0055 | NDC:70954-637 | NDC:63629-8994 | NDC:70518-1458 | NDC:71335-0992 | NDC:51655-596 | UNII:XXE1CET956 | NDC:70710-1958 | NDC:69344-102 | DrugBank ID:DB00328 | NDC:63629-1915 | NDC:67296-0954 | NDC:71205-822 | NDC:71335-0107 | NDC:50090-0052 | NDC:71335-0756
+BMGC_DG07804,BMG_DG139347,"PubChem SID:198958067 | PubChem CID:37175 | CAS RN:73790-28-0 | ENILCONAZOLE | CAS RN:1398065-91-2 | UNII:6K0NOF3XQ6 | Enilconazole | 1-[2-(2,4-dichlorophenyl)-2-prop-2-enoxyethyl]imidazole | CAS RN:35554-44-0"
+BMGC_DG07805,BMG_DG139351,CAS RN:31842-01-0 | Indoprofen | PubChem SID:198974295 | PubChem CID:3718 | UNII:CPE46ZU14N | DrugBank ID:DB08951 | 2-[4-(3-oxo-1H-isoindol-2-yl)phenyl]propanoic acid | INDOPROFEN
+BMGC_DG07806,BMG_DG139360,"Inositol nicotinate | DrugBank ID:DB08949 | INOSITOL NIACINATE | CAS RN:6556-11-2 | [2,3,4,5,6-pentakis(pyridine-3-carbonyloxy)cyclohexyl] pyridine-3-carboxylate | PubChem SID:175267338 | Inositol niacinate | UNII:A99MK953KZ | PubChem CID:3720 | CAS RN:497820-05-0"
+BMGC_DG07807,BMG_DG139363,1-CHLORODIBENZO-P-DIOXIN | UNII:BT477ZL85J | CAS RN:35656-51-0 | PubChem CID:37207 | 1-chlorodibenzo-p-dioxin | CAS RN:39227-53-7 | PubChem SID:198965727 | 1-Chlorodibenzo-P-dioxin
+BMGC_DG07808,BMG_DG139366,"UNII:4RII332O0R | PubChem CID:3723 | DrugBank ID:DB08948 | IODAMIDE | 3-acetamido-5-(acetamidomethyl)-2,4,6-triiodobenzoic acid | CAS RN:440-58-4 | PubChem SID:198939257 | Iodamide"
+BMGC_DG07809,BMG_DG139367,"NDC:65219-381 | Iodixanol | UNII:HW8W27HTXX | CAS RN:92339-11-2 | NDC:0407-2223 | PubChem SID:175267857 | PubChem CID:3724 | NDC:65219-383 | 5-[acetyl-[3-[N-acetyl-3,5-bis(2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodoanilino]-2-hydroxypropyl]amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide | IODIXANOL | DrugBank ID:DB01249 | NDC:0407-2222"
+BMGC_DG07810,BMG_DG139380,"PubChem CID:37264 | UNII:31L760807H | CAS RN:35795-16-5 | Trimazosin | (2-hydroxy-2-methylpropyl) 4-(4-amino-6,7,8-trimethoxyquinazolin-2-yl)piperazine-1-carboxylate | DrugBank ID:DB09206 | PubChem SID:198936808 | TRIMAZOSIN"
+BMGC_DG07811,BMG_DG139387,"Iodoquinol | CAS RN:83-73-8 | IODOQUINOL | PubChem SID:175265543 | Diiodohydroxyquinoline | 5,7-diiodoquinolin-8-ol | PubChem CID:3728 | UNII:63W7IE88K8 | DrugBank ID:DB09115"
+BMGC_DG07812,BMG_DG139395,"NDC:0407-1414 | NDC:0407-1416 | PubChem SID:175271707 | IOHEXOL | 5-[acetyl(2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide | NDC:0407-1411 | Iohexol | UNII:4419T9MX03 | NDC:0407-1401 | DrugBank ID:DB01362 | PubChem CID:3730 | NDC:0407-1412 | NDC:0407-1415 | NDC:0407-1413 | CAS RN:66108-95-0"
+BMGC_DG07813,BMG_DG139401,"Iomeprol | NDC:76381-930 | NDC:0270-9350 | NDC:0270-9300 | NDC:0270-9400 | CAS RN:78649-41-9 | NDC:76381-730 | NDC:76381-725 | NDC:0270-7250 | NDC:76381-935 | PubChem SID:198950713 | NDC:76381-735 | UNII:17E17JBP8L | IOMEPROL | 1-N,3-N-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzene-1,3-dicarboxamide | DrugBank ID:DB11705 | NDC:0270-7400 | NDC:0270-7300 | CAS RN:1185146-41-1 | NDC:76381-740 | PubChem CID:3731 | NDC:0270-7350 | NDC:76381-940"
+BMGC_DG07814,BMG_DG139414,"PubChem SID:198946241 | IOPANOIC ACID | CAS RN:96-83-3 | Iopanoic Acid | Iopanoic acid | PubChem CID:3735 | UNII:FE9794P71J | 2-[(3-amino-2,4,6-triiodophenyl)methyl]butanoic acid | DrugBank ID:DB08946"
+BMGC_DG07815,BMG_DG139417,"UNII:712BAC33MZ | NDC:50419-344 | Iopromide | DrugBank ID:DB09156 | NDC:50419-348 | PubChem CID:3736 | IOPROMIDE | 1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-3-N-methylbenzene-1,3-dicarboxamide | NDC:50419-346 | CAS RN:73334-07-3 | NDC:50419-347 | PubChem SID:175272158"
+BMGC_DG07816,BMG_DG139421,"(7-chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl) N,N-dimethylcarbamate | PubChem CID:37367 | UNII:HZ3XRH03C3 | CAMAZEPAM | Camazepam | CAS RN:36104-80-0 | DrugBank ID:DB01489 | PubChem SID:198953346"
+BMGC_DG07817,BMG_DG139425,"3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid | DrugBank ID:DB09133 | CAS RN:2276-90-6 | Iothalamic Acid | Iothalamic acid | PubChem SID:175268641 | UNII:16CHD79MIX | IOTHALAMIC ACID | PubChem CID:3737"
+BMGC_DG07818,BMG_DG139427,"PubChem CID:3738 | IOTROLAN | PubChem SID:198975471 | UNII:16FL47B687 | 2,4,6-triiodo-5-[methyl-[3-oxo-3-[2,4,6-triiodo-N-methyl-3,5-bis(1,3,4-trihydroxybutan-2-ylcarbamoyl)anilino]propanoyl]amino]-1-N,3-N-bis(1,3,4-trihydroxybutan-2-yl)benzene-1,3-dicarboxamide | Iotrolan | DrugBank ID:DB09487 | CAS RN:79770-24-4"
+BMGC_DG07819,BMG_DG139436,"UNII:TKQ858A3VW | IODIPAMIDE | PubChem CID:3739 | CAS RN:606-17-7 | DrugBank ID:DB04711 | Iodipamide | 3-[[6-(3-carboxy-2,4,6-triiodoanilino)-6-oxohexanoyl]amino]-2,4,6-triiodobenzoic acid | PubChem SID:175268883"
+BMGC_DG07820,BMG_DG139438,"HALOFANTRINE HYDROCHLORIDE | PubChem SID:198939429 | Halofantrine Hydrochloride | UNII:2B7ENL644K | CAS RN:66051-64-7 | PubChem CID:37392 | PubChem SID:346538522 | UNII:H77DL0Y630 | CAS RN:106927-11-1 | 3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol;hydrochloride | CAS RN:36167-63-2 | HALOFANTRINE HYDROCHLORIDE, (-)-"
+BMGC_DG07821,BMG_DG139439,"CAS RN:66051-74-9 | Halofantrine | UNII:Q2OS4303HZ | PubChem SID:175271459 | DrugBank ID:DB01218 | CAS RN:66051-76-1 | PubChem CID:37393 | CAS RN:69756-53-2 | 3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol | HALOFANTRINE"
+BMGC_DG07822,BMG_DG139447,"NDC:0019-1323 | IOVERSOL | PubChem SID:175268554 | NDC:0019-1333 | CAS RN:87771-40-2 | CAS RN:8771-40-2 | Ioversol | PubChem CID:3741 | DrugBank ID:DB09134 | 1-N,3-N-bis(2,3-dihydroxypropyl)-5-[(2-hydroxyacetyl)-(2-hydroxyethyl)amino]-2,4,6-triiodobenzene-1,3-dicarboxamide | UNII:N3RIB7X24K | NDC:0019-1332"
+BMGC_DG07823,BMG_DG139451,"PubChem CID:3742 | CAS RN:59017-64-0 | UNII:Z40X7EI2AF | DrugBank ID:DB09313 | IOXAGLIC ACID | PubChem SID:175265400 | 3-[[2-[[3-[acetyl(methyl)amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoyl]amino]acetyl]amino]-5-(2-hydroxyethylcarbamoyl)-2,4,6-triiodobenzoic acid | Ioxaglic acid"
+BMGC_DG07824,BMG_DG139454,DrugBank ID:DB13860 | PubChem SID:198977660 | 2-hydroxybenzoic acid;1H-imidazole | Imidazole salicylate | UNII:4JVD4X01MJ | CAS RN:36364-49-5 | PubChem CID:37425 | IMIDAZOLE SALICYLATE
+BMGC_DG07825,BMG_DG139456,"Ioxilan | 5-[acetyl(2,3-dihydroxypropyl)amino]-3-N-(2,3-dihydroxypropyl)-1-N-(2-hydroxyethyl)-2,4,6-triiodobenzene-1,3-dicarboxamide | PubChem SID:175271829 | CAS RN:107793-72-6 | IOXILAN | PubChem CID:3743 | UNII:A4YJ7J11TG | DrugBank ID:DB09135"
+BMGC_DG07826,BMG_DG139457,DrugBank ID:DB02758 | PubChem SID:198971704 | CAS RN:830-96-6 | PubChem CID:3744 | UNII:JF49U1Q7KN | Indolepropionic acid | 3-Indolepropionic acid | 3-INDOLEPROPIONIC ACID | CAS RN:10265-77-7 | 3-(1H-indol-3-yl)propanoic acid
+BMGC_DG07827,BMG_DG139461,"CAS RN:36504-65-1 | 6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),2(8),3,9,11,13(21),14,16,18-nonaene | PubChem CID:37455 | Benzo[a]pyrene-7,8-oxide"
+BMGC_DG07828,BMG_DG139464,"(1S,6S,8S)-6-tert-butyl-3-azapentacyclo[11.8.1.03,8.09,22.016,21]docosa-9,11,13(22),16,18,20-hexaen-6-ol | UNII:W85H7VQ3L6 | (+)-Butaclamol | PubChem CID:37459 | CAS RN:56245-67-1 | BUTACLAMOL, (+)-"
+BMGC_DG07829,BMG_DG139466,(8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate | Atrovent Hfa | PubChem CID:3746
+BMGC_DG07830,BMG_DG139468,"(1R,6R,8R)-6-tert-butyl-3-azapentacyclo[11.8.1.03,8.09,22.016,21]docosa-9,11,13(22),16,18,20-hexaen-6-ol | Butaclamol | BUTACLAMOL | PubChem SID:198958502 | CAS RN:36504-93-5 | PubChem CID:37461 | UNII:A7A2802VNL"
+BMGC_DG07831,BMG_DG139471,PubChem CID:37463 | 4-METHYLHISTAMINE | UNII:54ST71P9EE | CAS RN:36507-31-0 | PubChem SID:198955968
+BMGC_DG07832,BMG_DG139472,PubChem SID:175266991 | PubChem CID:37464 | PENBUTOLOL | DrugBank ID:DB01359 | (2S)-1-(tert-butylamino)-3-(2-cyclopentylphenoxy)propan-2-ol | CAS RN:38363-40-5 | UNII:78W62V43DY | CAS RN:38363-32-5 | Penbutolol
+BMGC_DG07833,BMG_DG139474,3-phenyl-7-propan-2-yloxychromen-4-one | PubChem SID:175266533 | PubChem CID:3747 | UNII:80BJ7WN25Z | Ipriflavone | DrugBank ID:DB13618 | CAS RN:35212-22-7 | IPRIFLAVONE
+BMGC_DG07834,BMG_DG139476,DrugBank ID:DB04818 | UNII:D892HFI3XA | PubChem SID:198940878 | CAS RN:54-92-2 | Iproniazid | IPRONIAZID | PubChem CID:3748 | N'-propan-2-ylpyridine-4-carbohydrazide
+BMGC_DG07835,BMG_DG139481,"NDC:71335-0071 | CAS RN:1185120-76-6 | NDC:70518-2685 | NDC:50090-1284 | NDC:29300-212 | NDC:59746-449 | NDC:65162-285 | NDC:83008-084 | NDC:70518-2245 | NDC:31722-160 | NDC:71335-1547 | NDC:29300-214 | NDC:72162-2354 | NDC:62332-042 | NDC:65162-284 | NDC:65862-639 | NDC:46708-440 | DrugBank ID:DB01029 | NDC:46708-441 | NDC:71335-1826 | NDC:42658-123 | NDC:65162-286 | CAS RN:1242281-36-2 | NDC:72162-2355 | NDC:50228-161 | NDC:68382-300 | NDC:50228-162 | NDC:83008-085 | NDC:59746-447 | NDC:31722-731 | NDC:71335-1244 | NDC:63629-5241 | NDC:71205-404 | NDC:42658-122 | NDC:63187-737 | NDC:62332-041 | NDC:0024-5851 | NDC:70518-1690 | NDC:31722-161 | NDC:46708-439 | NDC:63187-757 | Irbesartan | NDC:68382-299 | NDC:29300-213 | PubChem CID:3749 | NDC:70771-1161 | CAS RN:138402-11-6 | NDC:0024-5852 | NDC:65862-638 | NDC:50268-440 | NDC:31722-730 | NDC:72189-201 | 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one | NDC:43547-374 | NDC:68382-301 | NDC:68788-8670 | NDC:72189-205 | NDC:33342-049 | NDC:43547-376 | NDC:50268-441 | NDC:33342-048 | NDC:71335-2168 | NDC:68180-411 | NDC:70771-1159 | NDC:62332-043 | NDC:31722-729 | NDC:68180-412 | NDC:50268-442 | NDC:71205-379 | PubChem SID:175267917 | NDC:42658-121 | NDC:43547-375 | NDC:71205-452 | NDC:50090-2017 | NDC:33342-047 | NDC:72189-270 | NDC:59746-448 | NDC:65862-637 | NDC:70518-2246 | NDC:50090-6938 | IRBESARTAN | NDC:50228-160 | NDC:31722-162 | NDC:70771-1160 | NDC:0024-5850 | UNII:J0E2756Z7N | NDC:71205-082"
+BMGC_DG07836,BMG_DG139486,"UNII:Y83XVY9AQ8 | Etidocaine | CAS RN:60108-68-1 | UNII:K9D2CE52PU | ETIDOCAINE | N-(2,6-dimethylphenyl)-2-[ethyl(propyl)amino]butanamide | UNII:I6CQM0F31V | CAS RN:36637-18-0 | CAS RN:38188-42-0 | CAS RN:38188-41-9 | PubChem SID:346540081 | PubChem SID:198958765 | PubChem CID:37497 | PubChem SID:346541342 | DrugBank ID:DB08987 | ETIDOCAINE, (+)- | ETIDOCAINE, (-)-"
+BMGC_DG07837,BMG_DG139490,PubChem CID:3750424 | UNII:ACC2Z8RFT6 | CAS RN:55315-12-3 | PubChem SID:472424275 | 2-PHENYLAMINO-5-NITROANILINE
+BMGC_DG07838,BMG_DG139492,DIBA | UNII:K7254LUC92 | PubChem SID:472408550 | PubChem CID:375084 | CAS RN:171744-39-1
+BMGC_DG07839,BMG_DG139498,"3,5-dimethyl-3-(4-methylpent-3-enyl)-11H-pyrano[3,2-a]carbazol-9-ol | PubChem CID:375151 | (R)-Mahanine"
+BMGC_DG07840,BMG_DG139504,"DrugBank ID:DB13056 | 6-(2,5-dichlorophenyl)-1,3,5-triazine-2,4-diamine | CAS RN:57381-26-7 | PubChem CID:3752 | UNII:QBX79NZC1D | IRSOGLADINE | PubChem SID:198985600 | Irsogladine"
+BMGC_DG07841,BMG_DG139510,"NDC:37662-4138 | NDC:68475-003 | NDC:68382-127 | NDC:37662-4136 | NDC:37662-4141 | CAS RN:36791-04-5 | NDC:72162-1331 | DrugBank ID:DB00811 | NDC:37662-4137 | NDC:68382-260 | NDC:0187-0007 | NDC:65862-290 | NDC:68382-129 | NDC:65841-603 | PubChem CID:37542 | NDC:68382-395 | NDC:68682-019 | PubChem SID:175268603 | NDC:65841-046 | NDC:68382-046 | NDC:37662-4142 | CAS RN:66510-90-5 | NDC:65841-129 | UNII:49717AWG6K | RIBAVIRIN | NDC:65862-207 | NDC:65841-260 | NDC:37662-4140 | NDC:65841-632 | NDC:37662-4139 | Ribavirin | CAS RN:252269-50-4 | NDC:68382-128 | NDC:42494-423 | NDC:37662-4143 | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide | NDC:63629-2149"
+BMGC_DG07842,BMG_DG139512,"PubChem SID:346541238 | CAS RN:150258-65-4 | 5-(2-(2,5-DIHYDROXYPHENYL)ETHYL)-2-HYDROXYBENZOIC ACID | PubChem CID:375473 | UNII:V0ZFP1IW3G"
+BMGC_DG07843,BMG_DG139517,"UNII:TBT296U68M | 1-methyl-3-(2-methylpropyl)-7H-purine-2,6-dione | PubChem SID:198951333 | CAS RN:28822-58-4 | 3-isobutyl-1-methyl-7H-xanthine | ISOBUTYLMETHYLXANTHINE | PubChem CID:3758 | DrugBank ID:DB07954 | 3-Isobutyl-1-methylxanthine"
+BMGC_DG07844,BMG_DG139522,"PubChem SID:175267943 | Isocarboxazid | CAS RN:59-63-2 | ISOCARBOXAZID | UNII:34237V843T | DrugBank ID:DB01247 | N'-benzyl-5-methyl-1,2-oxazole-3-carbohydrazide | PubChem CID:3759"
+BMGC_DG07845,BMG_DG139526,"1-[2-(2,4-dichlorophenyl)-2-[(2,6-dichlorophenyl)methoxy]ethyl]imidazole | PubChem SID:198975754 | DrugBank ID:DB08943 | CAS RN:27523-40-6 | UNII:GRI7WFR424 | ISOCONAZOLE | Isoconazole | PubChem CID:3760"
+BMGC_DG07846,BMG_DG139530,"4-[1-hydroxy-2-(propan-2-ylamino)butyl]benzene-1,2-diol | DrugBank ID:DB00221 | Isoetharine | CAS RN:530-08-5 | PubChem CID:3762"
+BMGC_DG07847,BMG_DG139531,"UNII:CYS9AKD70P | DrugBank ID:DB00753 | PubChem SID:175272024 | 2-chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane | Isoflurane | CAS RN:26675-46-7 | ISOFLURANE | NDC:12164-012 | NDC:66794-020 | NDC:66794-017 | PubChem CID:3763 | NDC:10019-360 | NDC:66794-019"
+BMGC_DG07848,BMG_DG139532,"Adinazolam | UNII:KN08449444 | DrugBank ID:DB00546 | CAS RN:37115-32-5 | ADINAZOLAM | PubChem CID:37632 | PubChem SID:198955325 | 1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine"
+BMGC_DG07849,BMG_DG139533,CAS RN:486-63-5 | Isoformononetin | 3-(4-hydroxyphenyl)-7-methoxychromen-4-one | DrugBank ID:DB04202 | PubChem CID:3764
+BMGC_DG07850,BMG_DG139535,"UNII:YTF580771Y | Isoguvacine | 1,2,3,6-tetrahydropyridine-4-carboxylic acid | PubChem CID:3765 | ISOGUVACINE | PubChem SID:198966313 | CAS RN:64603-90-3"
+BMGC_DG07851,BMG_DG139536,CAS RN:6508-43-6 | PubChem CID:3765615 | L-152804 | UNII:AP9351PWPR | PubChem SID:316911396
+BMGC_DG07852,BMG_DG139538,NDC:62135-550 | NDC:64950-217 | Isoniazid | NDC:50090-0410 | NDC:0555-0071 | NDC:71610-108 | NDC:62135-709 | PubChem SID:175266377 | NDC:51079-083 | ISONIAZID | NDC:0781-3056 | NDC:68788-9405 | NDC:81665-107 | NDC:0555-0066 | NDC:64950-216 | NDC:43063-463 | PubChem CID:3767 | pyridine-4-carbohydrazide | UNII:V83O1VOZ8L | CAS RN:54-85-3 | NDC:70518-2576 | NDC:71610-395 | NDC:50090-0370 | NDC:46287-009 | DrugBank ID:DB00951 | NDC:81665-108 | NDC:60687-553 | NDC:63187-978
+BMGC_DG07853,BMG_DG139543,"4-(4-Benzylphenyl)-1,3-thiazol-2-amine | PubChem CID:3768902 | CAS RN:68729-05-5 | 4-(4-benzylphenyl)-1,3-thiazol-2-amine"
+BMGC_DG07854,BMG_DG139552,"[(2R,3R,4S,5R)-2-hydroxy-5-[(2S,3R,4S,5R)-5-hydroxy-3,4-disulfooxyoxan-2-yl]oxy-3-sulfooxyoxan-4-yl] hydrogen sulfate | PubChem CID:37720 | CAS RN:11096-31-4 | CAS RN:39432-58-1 | PubChem SID:472407435 | CAS RN:37300-21-3 | PENTOSAN POLYSULFATE | CAS RN:2763886-11-7 | UNII:F59P8B75R4 | Pentosan Polysulfate | Pentosan polysulfate | DrugBank ID:DB00686"
+BMGC_DG07855,BMG_DG139555,PubChem CID:3772821 | 2-(5-hydroxy-1H-indol-3-yl)acetate | (5-Hydroxyindol-3-yl)acetate
+BMGC_DG07856,BMG_DG139557,Isonipecotic acid | PubChem CID:3773 | CAS RN:498-94-2 | ISONIPECOTIC ACID | PubChem SID:198943519 | UNII:M5TZP1RWIE
+BMGC_DG07857,BMG_DG139558,CAS RN:66721-07-1 | PubChem CID:3773589 | PHENYL PHENOTHIAZINE-10-CARBOXYLATE | PubChem SID:459055899 | UNII:LB8W3K57KJ
+BMGC_DG07858,BMG_DG139559,"PubChem CID:3775 | Isopropamide | DrugBank ID:DB01625 | UNII:8B9I31H724 | PubChem SID:198947966 | ISOPROPAMIDE | (4-amino-4-oxo-3,3-diphenylbutyl)-methyl-di(propan-2-yl)azanium | CAS RN:7492-32-2"
+BMGC_DG07859,BMG_DG139560,PubChem CID:37750349 | TAKINIB | UNII:Z56NTB3YHJ | PubChem SID:472423980 | CAS RN:1111556-37-6
+BMGC_DG07860,BMG_DG139562,NDC:53943-098 | NDC:55319-821 | NDC:51316-275 | NDC:69740-212 | NDC:79903-273 | NDC:36800-071 | NDC:68599-8635 | NDC:70000-0478 | NDC:72727-0001 | NDC:89156-000 | NDC:60913-045 | NDC:0363-0275 | NDC:73769-006 | NDC:0924-0015 | NDC:47682-331 | NDC:63517-452 | NDC:65517-0001 | NDC:67091-804 | NDC:52410-4097 | NDC:78691-026 | NDC:36800-589 | NDC:72476-810 | NDC:69842-098 | NDC:49580-0275 | NDC:47682-035 | NDC:0363-0380 | NDC:83937-152 | NDC:60913-207 | NDC:72766-002 | NDC:70000-0026 | NDC:52862-024 | NDC:11822-3183 | NDC:41163-073 | NDC:49035-275 | NDC:34645-3111 | NDC:59050-444 | NDC:82645-914 | NDC:49035-989 | NDC:60000-326 | NDC:55415-005 | NDC:49035-076 | NDC:55319-570 | NDC:73769-000 | NDC:47682-262 | NDC:55415-006 | NDC:81603-625 | NDC:70108-106 | NDC:74213-382 | NDC:76436-319 | NDC:63940-810 | NDC:83629-019 | NDC:51628-4232 | NDC:58228-2610 | NDC:70677-1251 | NDC:8290-3268 | NDC:59779-756 | NDC:11344-408 | NDC:63736-327 | NDC:59050-242 | NDC:69771-015 | NDC:0363-0804 | NDC:52000-030 | NDC:30400-601 | NDC:42961-201 | NDC:30142-809 | NDC:52000-412 | NDC:58037-003 | NDC:83324-173 | NDC:46122-771 | NDC:59846-810 | NDC:75262-101 | NDC:34645-3110 | NDC:73928-012 | NDC:51628-4236 | NDC:72476-804 | NDC:84361-0003 | NDC:0924-0017 | NDC:82645-915 | NDC:53329-828 | NDC:51628-4233 | NDC:47682-263 | NDC:70000-0658 | NDC:70000-0112 | DrugBank ID:DB02325 | NDC:61734-012 | NDC:68093-4501 | NDC:78440-010 | NDC:55319-571 | NDC:59294-001 | NDC:52862-029 | NDC:50814-001 | NDC:52000-050 | NDC:30142-804 | NDC:52000-010 | NDC:70000-0690 | NDC:61504-810 | NDC:56062-810 | NDC:69103-5500 | NDC:82749-004 | NDC:82645-913 | NDC:11673-804 | NDC:67777-011 | NDC:67091-100 | NDC:30400-505 | NDC:82749-002 | NDC:53943-910 | NDC:39892-0803 | NDC:68196-500 | NDC:73769-002 | NDC:0363-0277 | NDC:76436-318 | NDC:71584-0101 | NDC:34645-0008 | NDC:42961-128 | NDC:47593-363 | NDC:52000-009 | NDC:70000-0691 | NDC:72288-810 | NDC:71310-113 | NDC:42961-057 | NDC:82771-999 | NDC:78149-206 | NDC:41250-804 | NDC:72520-317 | NDC:21130-539 | NDC:50594-845 | NDC:53329-797 | NDC:11673-810 | NDC:0363-0809 | NDC:81351-001 | NDC:65517-0006 | NDC:59779-033 | NDC:50804-810 | NDC:63517-244 | NDC:82771-070 | NDC:84238-317 | NDC:0869-0864 | NDC:76737-001 | NDC:69256-276 | NDC:60913-038 | NDC:58228-2176 | NDC:69842-240 | NDC:0924-0301 | NDC:55910-277 | NDC:55319-277 | UNII:ND2M416302 | NDC:11344-845 | NDC:72288-864 | NDC:83629-018 | NDC:0363-0472 | NDC:52380-3105 | NDC:49580-0277 | NDC:36800-077 | NDC:60913-007 | NDC:65517-0002 | NDC:76162-326 | NDC:50804-007 | NDC:70000-0497 | NDC:80684-137 | NDC:42423-271 | NDC:50685-006 | NDC:67326-035 | NDC:24385-207 | NDC:59294-000 | NDC:71677-5036 | NDC:39892-0100 | NDC:0363-0845 | NDC:42339-001 | NDC:42961-226 | NDC:76162-107 | NDC:49035-277 | NDC:21130-976 | NDC:59050-703 | NDC:71734-112 | NDC:59900-122 | NDC:51628-0032 | NDC:60913-025 | NDC:67860-845 | NDC:72459-010 | NDC:83446-001 | NDC:84238-316 | NDC:63941-804 | NDC:0395-0098 | NDC:52000-053 | NDC:11673-326 | NDC:51628-3794 | NDC:53329-807 | NDC:0168-0126 | NDC:10565-003 | NDC:34645-3018 | NDC:46122-778 | NDC:60913-107 | NDC:21130-845 | NDC:68786-300 | NDC:51628-0031 | NDC:62379-005 | NDC:69886-112 | NDC:34645-0006 | NDC:68196-277 | NDC:73769-004 | NDC:11673-139 | NDC:76436-316 | NDC:58037-004 | NDC:68599-5804 | NDC:37808-810 | NDC:53329-812 | NDC:69256-277 | NDC:50594-804 | NDC:73408-033 | NDC:34645-5505 | NDC:47682-219 | NDC:76370-0012 | NDC:59779-922 | NDC:68356-103 | NDC:55319-071 | ISOPROPYL ALCOHOL | NDC:68356-117 | NDC:73317-4417 | NDC:71870-103 | NDC:68786-122 | NDC:84018-001 | NDC:71611-401 | NDC:50814-082 | NDC:79903-227 | NDC:42681-6573 | NDC:11822-3709 | NDC:51142-445 | NDC:41250-845 | NDC:71611-056 | NDC:34645-0001 | NDC:73317-4416 | NDC:42681-0023 | NDC:11344-112 | NDC:71310-009 | NDC:82996-000 | NDC:52410-4096 | NDC:21130-977 | NDC:50804-275 | NDC:83506-018 | NDC:63029-325 | NDC:71884-013 | NDC:81849-001 | NDC:76436-314 | NDC:49035-814 | NDC:55550-222 | NDC:67751-002 | NDC:37808-804 | NDC:21130-804 | NDC:59898-402 | NDC:63029-323 | NDC:82645-925 | NDC:76567-2642 | NDC:83324-174 | NDC:84238-315 | NDC:67091-307 | NDC:52000-049 | NDC:53942-810 | NDC:83629-017 | NDC:72766-006 | NDC:84361-0004 | NDC:30400-101 | NDC:51142-444 | NDC:57915-004 | NDC:63868-185 | NDC:84822-002 | NDC:79481-0049 | NDC:67860-810 | NDC:60913-024 | NDC:58037-702 | NDC:36800-064 | NDC:58037-211 | NDC:59779-845 | NDC:76436-315 | NDC:83324-172 | NDC:0404-9408 | NDC:52410-4091 | NDC:11822-1076 | NDC:80773-004 | NDC:67326-030 | NDC:49035-662 | NDC:79906-001 | NDC:52000-406 | NDC:50804-845 | NDC:76123-121 | NDC:51628-0030 | NDC:55910-275 | NDC:63517-500 | PubChem SID:175267317 | NDC:10202-002 | NDC:76123-001 | NDC:77133-000 | NDC:79903-285 | NDC:52000-001 | PubChem CID:3776 | NDC:80436-004 | NDC:11822-5156 | NDC:51628-4239 | NDC:52410-1051 | NDC:52000-413 | NDC:81280-001 | NDC:0404-9406 | NDC:0404-0002 | NDC:52410-4110 | NDC:51628-4237 | NDC:83600-001 | NDC:79903-278 | NDC:56062-804 | NDC:11673-275 | NDC:52000-411 | NDC:73408-031 | NDC:72976-001 | NDC:47682-031 | NDC:70082-002 | CAS RN:555-31-7 | NDC:70677-1250 | NDC:55239-362 | NDC:68016-804 | NDC:0363-0810 | NDC:36800-804 | NDC:52410-1050 | NDC:53329-800 | NDC:51628-4235 | NDC:61333-206 | NDC:52000-052 | NDC:70393-400 | NDC:76162-809 | NDC:53943-091 | NDC:34645-3025 | CAS RN:67-63-0 | NDC:36800-864 | NDC:47682-222 | NDC:55681-135 | NDC:56062-826 | NDC:34645-0005 | NDC:0869-0845 | NDC:71611-402 | NDC:0404-0007 | NDC:53329-827 | NDC:70677-1207 | NDC:11822-5122 | NDC:63517-242 | NDC:50332-0046 | NDC:78440-009 | NDC:53943-804 | NDC:83937-154 | NDC:80948-019 | NDC:12258-153 | NDC:60913-018 | NDC:55301-810 | NDC:83506-810 | NDC:53329-798 | NDC:0869-0211 | NDC:83937-153 | NDC:77039-027 | NDC:68016-810 | NDC:36800-276 | NDC:58037-704 | NDC:77267-006 | NDC:74934-072 | NDC:69256-970 | NDC:10565-007 | NDC:10565-002 | NDC:49580-0272 | NDC:72520-316 | NDC:0869-0810 | NDC:55758-422 | NDC:83629-015 | NDC:72766-015 | NDC:53329-811 | NDC:49687-0018 | NDC:81893-111 | NDC:39892-0101 | NDC:67777-300 | NDC:37808-098 | NDC:62011-0272 | NDC:70000-0498 | NDC:63940-804 | NDC:71870-105 | NDC:30400-504 | NDC:70082-001 | NDC:55910-810 | NDC:41163-804 | NDC:60913-010 | NDC:49687-0012 | NDC:65517-2022 | NDC:72459-014 | NDC:55239-327 | NDC:63148-518 | NDC:41163-816 | NDC:21130-978 | NDC:49035-271 | NDC:58228-2078 | NDC:73598-0651 | NDC:83629-016 | NDC:60913-206 | NDC:68786-120 | NDC:84449-001 | NDC:39892-0500 | NDC:67777-121 | NDC:71734-341 | NDC:60913-009 | NDC:34645-3008 | NDC:72459-280 | NDC:73769-001 | NDC:50814-039 | NDC:59779-804 | NDC:11673-077 | NDC:70082-222 | NDC:37808-809 | NDC:46122-332 | NDC:0395-1249 | NDC:55319-569 | NDC:59779-808 | NDC:49348-175 | NDC:0404-0103 | NDC:50594-864 | NDC:76567-3792 | NDC:68599-2302 | NDC:83324-305 | NDC:50804-864 | NDC:41520-809 | NDC:81351-002 | NDC:53329-826 | NDC:51628-4234 | NDC:71412-110 | NDC:58037-007 | NDC:11344-810 | NDC:69250-661 | NDC:68016-809 | NDC:0924-0009 | NDC:46994-810 | NDC:75712-805 | NDC:34645-0020 | NDC:68016-845 | NDC:69256-275 | NDC:60913-006 | NDC:82308-001 | NDC:72520-315 | NDC:41250-773 | NDC:73288-001 | NDC:21130-875 | NDC:69556-650 | NDC:37808-356 | NDC:47682-299 | NDC:52862-022 | NDC:63868-963 | NDC:21130-810 | NDC:78824-625 | NDC:11673-845 | NDC:51316-557 | NDC:58988-1100 | NDC:72932-001 | NDC:60913-039 | NDC:52000-051 | NDC:53329-805 | NDC:81428-073 | NDC:50241-330 | NDC:53943-070 | NDC:84354-105 | NDC:11822-3500 | NDC:57915-001 | NDC:0924-0500 | NDC:52000-008 | NDC:76458-400 | NDC:83878-101 | NDC:63941-810 | NDC:83506-009 | NDC:83118-010 | NDC:55910-804 | NDC:81085-0001 | NDC:77039-032 | NDC:81641-001 | NDC:58228-2510 | NDC:52000-002 | propan-2-ol | NDC:51316-277 | NDC:81085-0002 | NDC:70000-0578 | NDC:84361-0006 | NDC:84361-0005 | NDC:71870-104 | NDC:47682-218 | NDC:50804-804 | NDC:78691-025 | NDC:49348-030 | NDC:50685-002 | NDC:82501-0810 | NDC:84899-001 | NDC:50332-0213 | NDC:76567-3794 | NDC:52000-011 | NDC:58037-002 | NDC:34645-0021 | NDC:55319-072 | NDC:63941-845 | NDC:49580-0276 | NDC:72288-904 | Isopropyl Alcohol | NDC:79481-5670 | NDC:84361-0002 | NDC:52862-025 | NDC:62011-0045 | NDC:41250-265 | NDC:76436-320 | NDC:0924-0252 | NDC:41250-810 | NDC:34645-1042 | NDC:49035-272 | NDC:47682-315 | NDC:0869-0804 | NDC:51628-1015 | NDC:72766-027 | NDC:21130-969 | NDC:55910-864 | NDC:83017-6895 | NDC:52862-023 | NDC:46122-772 | NDC:51628-3792 | NDC:51048-005 | NDC:63517-600 | NDC:84219-000 | NDC:55239-361 | NDC:0404-9407 | NDC:46122-043 | NDC:71927-014 | NDC:77267-001 | NDC:82098-814 | NDC:54365-014 | NDC:49348-896 | NDC:10565-071 | NDC:51628-1016 | NDC:36800-275 | NDC:50814-055 | NDC:0536-1103 | NDC:41250-276 | NDC:70108-105 | NDC:50090-6279 | NDC:78927-005 | NDC:63868-408 | NDC:84269-3502 | NDC:72288-212 | NDC:43128-002 | NDC:11822-3935 | NDC:83446-002 | NDC:57243-810 | NDC:53175-810 | NDC:76162-845 | NDC:80579-001 | NDC:80337-301 | NDC:83986-810 | NDC:0924-7019 | NDC:34645-0016 | NDC:73769-003 | NDC:83937-151 | NDC:52862-028 | NDC:59050-244 | NDC:60913-041 | NDC:60913-017 | NDC:30142-810 | NDC:68776-1007 | NDC:51316-979 | NDC:82167-000 | NDC:59640-864 | NDC:28691-7000 | NDC:41250-865 | NDC:59050-448 | NDC:46122-331 | NDC:60913-008 | NDC:11822-5826 | NDC:81428-071 | NDC:37808-055 | NDC:66354-001 | NDC:0924-0251 | NDC:68599-2306 | NDC:30142-845 | NDC:72036-810 | NDC:81326-111 | NDC:71584-0102 | NDC:80579-000 | NDC:39892-0801 | NDC:41163-845 | NDC:84238-314 | NDC:72476-015 | NDC:30400-100 | NDC:63868-980 | NDC:70000-0657 | NDC:70430-001 | NDC:71310-005 | NDC:84354-103 | NDC:73769-005 | NDC:55301-845 | NDC:10565-006 | NDC:21130-685 | NDC:68016-820 | NDC:63148-519 | NDC:49348-174 | NDC:55910-211 | NDC:60913-217 | NDC:58037-005 | NDC:72036-804 | NDC:83118-015 | NDC:51628-4501 | NDC:70677-1249 | NDC:0395-4202 | NDC:11673-276 | NDC:41250-040 | NDC:55319-810 | NDC:66715-6845 | NDC:47682-264 | NDC:51628-4240 | NDC:52000-410 | NDC:11822-1233 | NDC:67091-406 | NDC:75983-008 | Isopropyl alcohol | NDC:55319-275 | NDC:71310-116 | NDC:50594-810 | NDC:59050-266 | NDC:71870-106 | NDC:11344-864
+BMGC_DG07861,BMG_DG139566,CAS RN:37517-26-3 | UNII:4Q3H01QRMI | Pipotiazine Palmitate | PIPOTIAZINE PALMITATE | PubChem SID:198947960 | PubChem CID:37767 | 2-[1-[3-[2-(dimethylsulfamoyl)phenothiazin-10-yl]propyl]piperidin-4-yl]ethyl hexadecanoate
+BMGC_DG07862,BMG_DG139567,"NDC:71558-590 | AMIKACIN | UNII:84319SGC3C | PubChem CID:37768 | (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide | CAS RN:37517-28-5 | DrugBank ID:DB00479 | Amikacin | PubChem SID:175268115"
+BMGC_DG07863,BMG_DG139569,DrugBank ID:DB08786 | 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine | PubChem CID:3777900
+BMGC_DG07864,BMG_DG139570,"PROPYPHENAZONE | CAS RN:479-92-5 | UNII:OED8FV75PY | PubChem CID:3778 | Propyphenazone | DrugBank ID:DB13524 | PubChem SID:198938152 | 1,5-dimethyl-2-phenyl-4-propan-2-ylpyrazol-3-one"
+BMGC_DG07865,BMG_DG139573,"PHORBOL 12,13-DIBUTYRATE | Phorbol 12,13-dibutyrate | PubChem CID:37783 | CAS RN:37558-16-0 | CAS RN:61557-88-8 | PubChem SID:198962533 | UNII:67MX82CL58 | [(1S,2S,6R,10S,11R,13S,14R,15R)-13-butanoyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] butanoate"
+BMGC_DG07866,BMG_DG139574,"PubChem CID:37786 | CAS RN:64437-52-1 | CAS RN:37574-47-3 | CAS RN:72010-12-9 | CAS RN:72010-13-0 | Benzo[a]pyrene-4,5-oxide | 18-oxahexacyclo[10.7.2.03,8.09,20.016,21.017,19]henicosa-1,3,5,7,9(20),10,12(21),13,15-nonaene"
+BMGC_DG07867,BMG_DG139576,"PubChem SID:175271844 | UNII:L628TT009W | ISOPROTERENOL | CAS RN:114-45-4 | PubChem CID:3779 | 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol | DrugBank ID:DB01064 | CAS RN:149-53-1 | CAS RN:7683-59-2 | Isoprenaline | Isoproterenol"
+BMGC_DG07868,BMG_DG139577,PubChem CID:37792 | 5'-Guanosine-Diphosphate-Monothiophosphate | DrugBank ID:DB01864
+BMGC_DG07869,BMG_DG139578,4-Nitrophenyl phosphate | CAS RN:330-13-2 | CAS RN:12778-12-0 | PubChem CID:378 | PubChem SID:440088677 | 4-NITROPHENYL PHOSPHATE | UNII:59NF9TE3BA | 4-Nitrophenyl Phosphate | DrugBank ID:DB04214 | (4-nitrophenyl) dihydrogen phosphate
+BMGC_DG07870,BMG_DG139587,"ISOTHIPENDYL | CAS RN:482-15-5 | PubChem CID:3781 | UNII:WVZ7K9P0JY | DrugBank ID:DB08802 | Isothipendyl | PubChem SID:198940521 | N,N-dimethyl-1-pyrido[3,2-b][1,4]benzothiazin-10-ylpropan-2-amine"
+BMGC_DG07871,BMG_DG139589,UNII:HAW3U8B8S3 | 2-Nitrobenzohydrazide | PubChem SID:474490817 | PubChem CID:3781218 | CAS RN:606-26-8 | 2-NITROBENZOHYDRAZIDE
+BMGC_DG07872,BMG_DG139598,4-[1-hydroxy-2-(1-phenoxypropan-2-ylamino)propyl]phenol | CAS RN:395-28-8 | PubChem CID:3783 | Duvadilan
+BMGC_DG07873,BMG_DG139602,4-Methoxybenzoate | 4-methoxybenzoate | PubChem CID:3783514
+BMGC_DG07874,BMG_DG139606,PubChem CID:37839 | CAS RN:37841-91-1 | UNII:475W04BXJ7 | ISOVELLERAL | PubChem SID:198936511
+BMGC_DG07875,BMG_DG139607,"NDC:16252-539 | NDC:42291-062 | NDC:16252-540 | Isradipine | NDC:42806-264 | ISRADIPINE | NDC:64850-910 | CAS RN:131970-21-3 | PubChem CID:3784 | UNII:YO1UK1S598 | DrugBank ID:DB00270 | 3-O-methyl 5-O-propan-2-yl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | NDC:42806-263 | PubChem SID:175271455 | CAS RN:75695-93-1 | NDC:64850-911"
+BMGC_DG07876,BMG_DG139612,2-(Trimethylammonium)ethyl thiol | PubChem CID:37851 | 2-(Trimethylammonium)Ethyl Thiol | DrugBank ID:DB01803 | trimethyl(2-sulfanylethyl)azanium
+BMGC_DG07877,BMG_DG139618,"PubChem CID:3787955 | N,N-BIS(((4-METHYLPHENYL)SULFONYL)METHYL)BENZENEMETHANAMINE | N,N-Bis[[(4-methylphenyl)sulfonyl]methyl]benzenemethanamine | UNII:C4N28TWG4M | PubChem SID:485663580 | CAS RN:65950-40-5"
+BMGC_DG07878,BMG_DG139646,CAS RN:287111-08-4 | CAS RN:287111-23-3 | NDC:84025-129 | PubChem CID:379 | NDC:84025-131 | DrugBank ID:DB04519 | octanoic acid | CAS RN:124-07-2 | UNII:OBL58JN025 | CAPRYLIC ACID | Caprylic acid | PubChem SID:175268169 | Octanoic Acid
+BMGC_DG07879,BMG_DG139649,"CAS RN:38083-17-9 | Climbazole | PubChem CID:37907 | CLIMBAZOLE | UNII:9N42CW7I54 | 1-(4-chlorophenoxy)-1-imidazol-1-yl-3,3-dimethylbutan-2-one | DrugBank ID:DB15580 | PubChem SID:175271901"
+BMGC_DG07880,BMG_DG139657,"PubChem SID:198979354 | N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4-dimethoxybenzamide | DrugBank ID:DB04924 | CAS RN:122898-67-3 | UNII:81BMQ80QRL | Itopride | ITOPRIDE | PubChem CID:3792"
+BMGC_DG07881,BMG_DG139664,"CAS RN:84604-65-9 | Canditral | CAS RN:2049588-24-9 | PubChem CID:3793 | CAS RN:84625-61-6 | 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one | CAS RN:1217512-35-0"
+BMGC_DG07882,BMG_DG139666,"UNII:RN69YUV5AV | 3-PHENYL-5H-INDENO(1,2-C)PYRIDAZIN-5-ONE | PubChem CID:379337 | PubChem SID:461434998 | CAS RN:77152-22-8"
+BMGC_DG07883,BMG_DG139667,"UNII:GB848H7RD3 | CAS RN:147508-58-5 | 3-(4-METHOXYPHENYL)-5H-INDENO(1,2-C)PYRIDAZIN-5-ONE | PubChem CID:379338"
+BMGC_DG07884,BMG_DG139670,PubChem CID:3794 | JANEX-1 | PubChem SID:377308037 | CAS RN:202475-60-3 | UNII:1J8Q49TR3I
+BMGC_DG07885,BMG_DG139679,PubChem CID:3795 | UNII:PG8BT6T9MB | PubChem SID:445500198 | CAS RN:211555-04-3 | WHI-P 154
+BMGC_DG07886,BMG_DG139680,ZM-39923 | PubChem CID:3797 | PubChem SID:319892581 | CAS RN:273727-89-2 | UNII:M0ZX82000S
+BMGC_DG07887,BMG_DG139684,ZINTEROL | UNII:7167N7AJJR | CAS RN:37000-20-7 | PubChem SID:198989185 | Zinterol | N-[2-hydroxy-5-[1-hydroxy-2-[(2-methyl-1-phenylpropan-2-yl)amino]ethyl]phenyl]methanesulfonamide | PubChem CID:37990
+BMGC_DG07888,BMG_DG139689,"2-Dehydropantoate | DrugBank ID:DB03795 | 2-DEHYDROPANTOATE | PubChem SID:475550304 | PubChem CID:38 | 4-hydroxy-3,3-dimethyl-2-oxobutanoic acid | CAS RN:470-30-4 | UNII:GZM7NYS95Z"
+BMGC_DG07889,BMG_DG139690,"PubChem CID:380 | CAS RN:1264-52-4 | S-[2-[3-[[4-[[[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] octanethioate | capryloyl-CoA"
+BMGC_DG07890,BMG_DG139708,"PubChem SID:198985841 | 1,2,3,4-tetrachloro-5-(3,4-dichlorophenyl)benzene | 2,3,3',4,4',5-Hexachlorobiphenyl | PubChem CID:38019 | CAS RN:38380-08-4 | UNII:4D6049M2OC | 2,3,3',4,4',5-HEXACHLOROBIPHENYL"
+BMGC_DG07891,BMG_DG139709,"8-METHYL-6-(4-METHYL-1-PIPERAZINYL)-11H-PYRIDO(2,3-B)(1,4)BENZODIAZEPINE | PubChem CID:3802 | PubChem SID:485663701 | CAS RN:147395-65-1 | UNII:2TT8RV9JY8 | 8-Methyl-6-(4-methyl-1-piperazinyl)-11H-pyrido[2,3-b][1,4]benzodiazepine"
+BMGC_DG07892,BMG_DG139713,"PubChem CID:3802528 | Zinc protoporphyrin | CAS RN:15442-64-5 | zinc-protoporphyrin IX | DrugBank ID:DB03934 | zinc;3-[18-(2-carboxyethyl)-7,12-bis(ethenyl)-3,8,13,17-tetramethylporphyrin-21,23-diid-2-yl]propanoic acid"
+BMGC_DG07893,BMG_DG139739,"PubChem SID:198977322 | UNII:W6Q80SK9L6 | PubChem CID:3806 | 5-hydroxynaphthalene-1,4-dione | Juglone | CAS RN:481-13-0 | CAS RN:481-39-0 | JUGLONE"
+BMGC_DG07894,BMG_DG139741,DrugBank ID:DB13674 | PubChem CID:38072 | CRIDANIMOD | CAS RN:38609-97-1 | PubChem SID:198941901 | 2-(9-oxoacridin-10-yl)acetic acid | UNII:X91E9EME19 | Cridanimod
+BMGC_DG07895,BMG_DG139745,FLUNIXIN | DrugBank ID:DB11518 | PubChem SID:175268634 | CAS RN:38677-85-9 | UNII:356IB1O400 | Flunixin | 2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid | PubChem CID:38081
+BMGC_DG07896,BMG_DG139759,"CEPHRADINE ANHYDROUS | Cefradine | PubChem CID:38103 | DrugBank ID:DB01333 | PubChem SID:198984498 | UNII:9YA6SX5S4D | (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CAS RN:38821-53-3 | CAS RN:58456-86-3 | Cephradine"
+BMGC_DG07897,BMG_DG139772,"PubChem SID:459055941 | UNII:HAJ5XS5HPF | 3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-12-one | STAUROSPORINONE | DrugBank ID:DB08036 | 6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one | PubChem CID:3815 | CAS RN:85753-43-1"
+BMGC_DG07898,BMG_DG139780,UNII:KUO32K2TRD | PubChem SID:198987720 | CAS RN:38955-22-5 | PubChem CID:38191 | PINADOLINE
+BMGC_DG07899,BMG_DG139783,"PubChem CID:38193 | PubChem SID:198960390 | 2,8-dichlorodibenzo-p-dioxin | CAS RN:38964-22-6 | UNII:JPA391PZI1 | 2,8-DICHLORODIBENZO-P-DIOXIN | 2,8-Dichlorodibenzo-P-dioxin"
+BMGC_DG07900,BMG_DG139787,PubChem CID:3820 | PubChem SID:474491255 | UNII:T72H2BL53P | Kenpaullone | CAS RN:142273-20-9 | KENPAULLONE
+BMGC_DG07901,BMG_DG139790,"CAS RN:56433-44-4 | PubChem SID:198980313 | 1-(methylamino)-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-2-ol | OXAPROTILINE | UNII:3V3Z2HK4LS | Oxaprotiline | PubChem CID:38207"
+BMGC_DG07902,BMG_DG139792,DrugBank ID:DB01221 | CAS RN:1246911-76-1 | Ketamine | CAS RN:100477-72-3 | UNII:690G0D6V8H | 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one | PubChem CID:3821 | CAS RN:6740-88-1 | PubChem SID:175272163 | KETAMINE
+BMGC_DG07903,BMG_DG139793,"CAS RN:83846-83-7 | PubChem SID:198963897 | CAS RN:74050-98-9 | DrugBank ID:DB12465 | KETANSERIN | Ketanserin | UNII:97F9DE4CT4 | PubChem CID:3822 | 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione"
+BMGC_DG07904,BMG_DG139797,"DrugBank ID:DB01026 | CAS RN:79156-75-5 | Ketoconazole | CAS RN:65277-42-1 | PubChem CID:3823 | 1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | 1-[4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone"
+BMGC_DG07905,BMG_DG139804,"UNII:4VD83UL6Y6 | PubChem CID:3824 | Kebuzone | DrugBank ID:DB08940 | CAS RN:853-34-9 | 4-(3-oxobutyl)-1,2-diphenylpyrazolidine-3,5-dione | KEBUZONE | PubChem SID:198940998"
+BMGC_DG07906,BMG_DG139805,CAS RN:39201-82-6 | UNII:Q13F1C1N8I | PubChem CID:38240 | ESCALINE | PubChem SID:312524977
+BMGC_DG07907,BMG_DG139806,NDC:0276-0504 | NDC:63187-018 | CAS RN:154907-35-4 | NDC:0276-0506 | KETOPROFEN | Ketoprofen | UNII:90Y4QC304K | DrugBank ID:DB01009 | PubChem SID:175271852 | CAS RN:22071-15-4 | CAS RN:22161-86-0 | NDC:0378-8200 | NDC:73352-504 | CAS RN:1189508-77-7 | PubChem CID:3825 | 2-(3-benzoylphenyl)propanoic acid
+BMGC_DG07908,BMG_DG139807,"PubChem CID:38251 | 1,2,3,4,7,8-Hexachlorodibenzodioxin | 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin | UNII:5R0UY33JFS | CAS RN:39227-28-6 | PubChem SID:198948164 | 1,2,3,4,7,8-HEXACHLORODIBENZO-P-DIOXIN"
+BMGC_DG07909,BMG_DG139811,"CAS RN:39227-58-2 | PubChem CID:38253 | 1,2,4-TRICHLORODIBENZO-P-DIOXIN | PubChem SID:198988293 | 1,2,4-Trichlorodibenzo-P-dioxin | 1,2,4-trichlorodibenzo-p-dioxin | UNII:N788AO107G"
+BMGC_DG07910,BMG_DG139812,"1,2,3,4,7-pentachlorodibenzo-p-dioxin | 1,2,3,4,7-PENTACHLORODIBENZO-P-DIOXIN | 1,2,3,4,7-Pentachlorodibenzo-p-dioxin | UNII:WAL6D1393Q | PubChem CID:38254 | PubChem SID:198987825 | CAS RN:39227-61-7"
+BMGC_DG07911,BMG_DG139815,"PubChem CID:38258 | DrugBank ID:DB14075 | 1-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-3-[[[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoylamino]methyl]urea | UNII:M629807ATL | CAS RN:39236-46-9 | IMIDUREA | PubChem SID:175271914 | Imidurea"
+BMGC_DG07912,BMG_DG139817,"5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid | DrugBank ID:DB00465 | PubChem SID:175272036 | Ketorolac | CAS RN:66635-83-4 | PubChem CID:3826 | KETOROLAC | CAS RN:74103-06-3 | NDC:82604-600 | UNII:YZI5105V0L"
+BMGC_DG07913,BMG_DG139824,"2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one | KETOTIFEN | DrugBank ID:DB00920 | Ketotifen | PubChem CID:3827 | UNII:X49220T18G | CAS RN:34580-13-7 | CAS RN:116655-76-6 | PubChem SID:175265613"
+BMGC_DG07914,BMG_DG139827,"Khellin | KHELLIN | PubChem SID:198948615 | UNII:5G117T0TJZ | 4,9-dimethoxy-7-methylfuro[3,2-g]chromen-5-one | CAS RN:82-02-0 | PubChem CID:3828"
+BMGC_DG07915,BMG_DG139828,PubChem CID:38282 | CAS RN:39512-49-7 | 4-(4-chlorophenyl)piperidin-4-ol | PubChem SID:198958923 | 4-(4-CHLOROPHENYL)-4-PIPERIDINOL | UNII:UND92FKS0W | 4-(4-Chlorophenyl)-4-hydroxypiperidine
+BMGC_DG07916,BMG_DG139830,CAS RN:13849-91-7 | PubChem CID:382831 | PubChem SID:198939957 | POMOLIC ACID | UNII:60HAB1ZK1T
+BMGC_DG07917,BMG_DG139841,CAS RN:69235-69-4 | CAS RN:6046-79-3 | DrugBank ID:DB11336 | CAS RN:525-79-1 | Kinetin | PubChem CID:3830 | PubChem SID:175266069 | N-(furan-2-ylmethyl)-7H-purin-6-amine | KINETIN | UNII:P39Y9652YJ
+BMGC_DG07918,BMG_DG139853,"UNII:3BXK7PG5FR | PubChem CID:383280 | CAS RN:128944-81-0 | PubChem SID:472411486 | 1-(4-(DIMETHYLAMINO)PHENYL)-3-(4-METHOXYPHENYL)-4,5-BIS((4-METHOXYPHENYL)IMINO)-2-IMIDAZOLIDINETHIONE | 1-[4-(Dimethylamino)phenyl]-3-(4-methoxyphenyl)-4,5-bis[(4-methoxyphenyl)imino]-2-imidazolidinethione"
+BMGC_DG07919,BMG_DG139854,UNII:C7GA9U9TN1 | 5-METHOXYISATIN | CAS RN:39755-95-8 | PubChem CID:38333 | PubChem SID:375579281
+BMGC_DG07920,BMG_DG139857,"CAS RN:760176-26-9 | acetic acid;10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | ([ring-D5]Phe3)-Octreotide | PubChem CID:383413 | CAS RN:79517-01-4"
+BMGC_DG07921,BMG_DG139876,"12,19-dimethyl-3-oxapentacyclo[9.8.0.02,4.05,10.013,18]nonadeca-1(19),5,7,9,11,13,15,17-octaene | CAS RN:39834-38-3 | 7,12-Dimethyl-5,6-epoxy-5,6-dihydrobenz(a)anthracene | PubChem CID:38354"
+BMGC_DG07922,BMG_DG139902,NDC:84423-003 | NDC:84019-015 | NDC:83872-023 | NDC:84423-050 | NDC:84019-017 | NDC:83872-414 | NDC:83872-522 | PubChem CID:3840 | NDC:84019-008 | NDC:84025-095 | NDC:83872-524 | NDC:84764-705 | NDC:74458-351 | CAS RN:123712-78-7 | NDC:83872-517 | PubChem SID:175267793 | UNII:6K23F1TT52 | NDC:83872-368 | NDC:74458-206 | NDC:74458-404 | Kojic acid | CAS RN:501-30-4 | NDC:83872-027 | NDC:83872-416 | NDC:84025-102 | NDC:83872-519 | KOJIC ACID | DrugBank ID:DB01759 | 5-hydroxy-2-(hydroxymethyl)pyran-4-one
+BMGC_DG07923,BMG_DG139905,"DrugBank ID:DB04831 | Ticrynafen | CAS RN:40180-04-9 | Tienilic acid | PubChem SID:198978081 | 2-[2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy]acetic acid | TICRYNAFEN | PubChem CID:38409 | UNII:HC95205SY4"
+BMGC_DG07924,BMG_DG139912,"1,2,3,7,8-pentachlorodibenzo-p-dioxin | 1,2,3,7,8-Pentachlorodibenzo-p-dioxin | CAS RN:40321-76-4 | UNII:2NE6H0QPCH | PubChem SID:198958835 | 1,2,3,7,8-PENTACHLORODIBENZO-P-DIOXIN | PubChem CID:38439"
+BMGC_DG07925,BMG_DG139919,CAS RN:492-27-3 | Kynurenic Acid | 4-oxo-1H-quinoline-2-carboxylic acid | DrugBank ID:DB11937 | CAS RN:13593-94-7 | UNII:H030S2S85J | Kynurenic acid | PubChem SID:198970616 | KYNURENIC ACID | PubChem CID:3845
+BMGC_DG07926,BMG_DG139927,UNII:SC6T4O59BK | PubChem CID:3848 | PubChem SID:374388535 | DL-3-Phenyllactic acid | 3-PHENYL-DL-LACTIC ACID | CAS RN:156-05-8 | 2-hydroxy-3-phenylpropanoic acid | CAS RN:828-01-3
+BMGC_DG07927,BMG_DG139929,DrugBank ID:DB01856 | PubChem SID:198949717 | CAS RN:111-16-0 | PIMELIC ACID | Pimelic Acid | heptanedioic acid | Pimelic acid | UNII:BZQ96WX25F | PubChem CID:385
+BMGC_DG07928,BMG_DG139939,"Guanadrel | UNII:765C9332T4 | DrugBank ID:DB00226 | 2-(1,4-dioxaspiro[4.5]decan-3-ylmethyl)guanidine | GUANADREL | PubChem CID:38521 | PubChem SID:198988522 | CAS RN:40580-59-4"
+BMGC_DG07929,BMG_DG139951,PubChem SID:485663485 | 1-(2-Bromophenyl)-3-(2-hydroxy-4-nitrophenyl)urea | 1-(2-BROMOPHENYL)-3-(2-HYDROXY-4-NITROPHENYL)UREA | CAS RN:182498-32-4 | UNII:SSX8FD4H24 | PubChem CID:3854666
+BMGC_DG07930,BMG_DG139955,CAS RN:20263-06-3 | PubChem SID:317229613 | CAS RN:5652-28-8 | PubChem CID:3857 | 2-AMINO-3-PHOSPHONOPROPIONIC ACID | 2-Amino-3-phosphonopropionic acid | 2-amino-3-phosphonopropanoic acid | UNII:0H89G8110O
+BMGC_DG07931,BMG_DG139964,"2-Amino-3-(3-hydroxy-4-oxopyridin-1-yl)propanoic acid | CAS RN:10182-82-8 | PubChem SID:241180418 | MIMOSINE, (+/-)- | PubChem CID:3862 | UNII:X9W047UL80 | MIMOSINE, (±)- | 2-amino-3-(3-hydroxy-4-oxopyridin-1-yl)propanoic acid | CAS RN:2116-55-4 | CAS RN:27678-82-6"
+BMGC_DG07932,BMG_DG139979,"Doxefazepam | DrugBank ID:DB13837 | 7-chloro-5-(2-fluorophenyl)-3-hydroxy-1-(2-hydroxyethyl)-3H-1,4-benzodiazepin-2-one | CAS RN:40762-15-0 | DOXEFAZEPAM | PubChem SID:198970937 | UNII:231RV72C8L | PubChem CID:38668"
+BMGC_DG07933,BMG_DG139984,"PubChem CID:386817 | 1-benzyl 7-methyl 6-(4-methylbenzenesulfonyl)-4,5-dioxo-3H,4H,5H,6H-pyrrolo[3,2-e]indole-1,7-dicarboxylate | UNII:7KQA7N4UAT | 1-BENZYL 7-METHYL 6-(4-METHYLBENZENESULFONYL)-4,5-DIOXO-3H,4H,5H,6H-PYRROLO(3,2-E)INDOLE-1,7-DICARBOXYLATE | PubChem SID:474491356 | CAS RN:106674-03-7"
+BMGC_DG07934,BMG_DG139991,NDC:10135-711 | NDC:10135-713 | NDC:72162-1676 | NDC:63629-1161 | NDC:72162-1675 | NDC:63629-1163 | NDC:63629-1165 | Labetalol | NDC:58657-604 | DrugBank ID:DB00598 | CAS RN:36894-69-6 | PubChem CID:3869 | UNII:R5H8897N95 | 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide | NDC:58657-602 | NDC:58657-603 | NDC:10135-712 | PubChem SID:175268399 | CAS RN:32780-40-8 | NDC:72162-1677 | NDC:71335-9690 | NDC:63629-1164 | NDC:63629-1162 | NDC:71335-2057 | LABETALOL | NDC:70518-4201 | NDC:63629-1166
+BMGC_DG07935,BMG_DG139993,"3,5-DINITROCATECHOL | CAS RN:7659-29-2 | 3,5-Dinitrocatechol | 3,5-dinitrobenzene-1,2-diol | DrugBank ID:DB02105 | PubChem CID:3870203 | PubChem SID:198988163 | UNII:VK0VA22GY2"
+BMGC_DG07936,BMG_DG140006,"10,16-diazatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2,4,6,9,11,13(17),14-octaen-8-one | UNII:F1EAG7D138 | SAMPANGINE | PubChem CID:387195 | CAS RN:116664-93-8 | PubChem SID:363908949 | Sampangine"
+BMGC_DG07937,BMG_DG140008,"PubChem CID:387316 | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | UNII:651KU15938 | Taurochenodeoxycholic acid | CAS RN:6009-98-9 | PubChem SID:346537627 | DrugBank ID:DB08833 | TAUROCHENODEOXYCHOLIC ACID | CAS RN:516-35-8"
+BMGC_DG07938,BMG_DG140015,NDC:72603-270 | NDC:70511-161 | NDC:63759-3032 | NDC:60505-6050 | NDC:72338-200 | NDC:50742-484 | NDC:25021-244 | NDC:67184-0530 | NDC:68001-534 | NDC:68001-541 | UNII:69G8BD63PP | NDC:71288-118 | NDC:72205-183 | DrugBank ID:DB00188 | NDC:70511-162 | BORTEZOMIB | PubChem CID:387447 | NDC:51817-586 | NDC:0409-1703 | NDC:43598-865 | NDC:31722-303 | [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid | CAS RN:179324-69-7 | Bortezomib | NDC:70121-2484 | NDC:83090-008 | NDC:0781-3258 | PubChem SID:175265351 | NDC:55150-337 | NDC:10019-991 | NDC:70710-1411 | NDC:68001-540 | NDC:0409-1704 | NDC:43598-426 | NDC:0143-9098 | CAS RN:1610526-91-4 | NDC:63323-821 | NDC:0409-1700 | NDC:63020-049 | NDC:70771-1708
+BMGC_DG07939,BMG_DG140022,"NDC:71335-2071 | NDC:65841-682 | NDC:65162-956 | NDC:16714-623 | NDC:69918-360 | NDC:16714-195 | NDC:65862-227 | NDC:70518-2406 | NDC:55111-221 | NDC:13668-047 | NDC:62332-419 | NDC:70518-3740 | NDC:0228-1410 | NDC:29300-112 | NDC:69097-151 | NDC:69117-0049 | NDC:0228-1453 | NDC:68084-319 | NDC:69102-150 | NDC:65862-228 | NDC:50228-320 | NDC:67877-166 | NDC:72189-063 | NDC:16714-626 | LAMOTRIGINE | NDC:82868-005 | NDC:68382-109 | NDC:46708-274 | NDC:62332-095 | NDC:51672-4130 | NDC:65862-229 | NDC:65841-683 | NDC:68382-008 | NDC:70518-2563 | NDC:0115-1526 | NDC:0173-0777 | NDC:69102-319 | NDC:46708-418 | NDC:49884-485 | NDC:68084-318 | NDC:62332-418 | NDC:68788-7647 | NDC:31722-243 | NDC:70518-1978 | NDC:59746-246 | NDC:0115-9939 | NDC:0228-1580 | NDC:0904-7007 | NDC:46708-417 | NDC:50090-5850 | NDC:62332-096 | NDC:0115-9942 | NDC:55111-718 | NDC:13668-048 | NDC:65841-687 | NDC:70771-1518 | NDC:55111-223 | NDC:68382-981 | NDC:68788-7871 | NDC:72888-025 | NDC:46708-419 | NDC:71335-2328 | NDC:50090-2131 | NDC:67877-165 | NDC:68382-009 | NDC:0115-1528 | NDC:62332-038 | NDC:65162-958 | NDC:68462-229 | NDC:0173-0772 | NDC:70518-2108 | NDC:0173-0776 | NDC:71335-1469 | NDC:49884-484 | NDC:55111-225 | NDC:0615-7964 | NDC:68788-8392 | NDC:50228-321 | NDC:65162-988 | NDC:70771-1514 | NDC:67877-164 | NDC:69117-0044 | NDC:71335-1110 | NDC:72189-467 | NDC:59746-248 | NDC:43598-551 | NDC:70518-3043 | NDC:13668-339 | NDC:0115-1527 | NDC:29300-113 | NDC:60760-543 | NDC:65841-686 | NDC:51672-4131 | NDC:49884-561 | NDC:69097-149 | NDC:65841-690 | NDC:16571-786 | NDC:16714-893 | NDC:70518-1479 | NDC:55111-428 | NDC:42291-444 | NDC:55154-2331 | NDC:55111-222 | NDC:69102-301 | NDC:71205-245 | NDC:31722-245 | NDC:65162-986 | NDC:71335-2384 | NDC:43598-553 | NDC:68071-3607 | NDC:69102-639 | NDC:16571-785 | DrugBank ID:DB00555 | NDC:60687-693 | NDC:27241-185 | NDC:62332-417 | NDC:51672-4133 | NDC:68382-979 | NDC:69117-0048 | 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine | NDC:69117-0047 | NDC:65162-949 | NDC:0228-1422 | NDC:42291-369 | NDC:42291-443 | NDC:68462-228 | NDC:82804-105 | NDC:68788-7544 | NDC:0115-9940 | NDC:68382-983 | NDC:65862-361 | NDC:68788-7223 | NDC:69117-0045 | NDC:59746-245 | NDC:0228-1435 | NDC:29300-111 | NDC:43063-203 | NDC:63187-744 | NDC:65862-230 | NDC:67877-167 | NDC:80425-0289 | UNII:U3H27498KS | NDC:62332-039 | NDC:0173-0774 | NDC:43598-552 | NDC:68382-006 | NDC:72789-206 | NDC:69097-148 | NDC:50228-319 | NDC:13668-045 | NDC:0615-8150 | NDC:27241-183 | NDC:68382-982 | NDC:16714-194 | NDC:71335-0706 | NDC:55154-2065 | NDC:68788-7168 | NDC:68382-011 | NDC:55111-720 | NDC:82804-022 | NDC:51655-855 | NDC:31722-240 | NDC:27241-184 | NDC:0615-8267 | NDC:49884-487 | NDC:42291-366 | NDC:55111-226 | NDC:70518-2473 | NDC:46708-095 | NDC:65841-684 | NDC:69918-350 | NDC:72189-560 | NDC:42291-445 | NDC:49884-562 | NDC:76420-182 | CAS RN:84057-84-1 | NDC:49884-605 | NDC:69117-0046 | NDC:70518-3602 | NDC:71335-1179 | NDC:49884-486 | NDC:50090-5827 | NDC:69918-380 | NDC:50228-322 | NDC:50090-3914 | NDC:62332-040 | NDC:55111-717 | NDC:72888-027 | NDC:70518-2535 | NDC:42291-448 | NDC:49884-563 | Lamotrigine | NDC:71335-1919 | NDC:50090-6028 | NDC:31722-241 | NDC:59746-247 | NDC:0904-7008 | NDC:46708-277 | NDC:82009-134 | NDC:0115-9941 | NDC:70771-1517 | NDC:69918-370 | NDC:51672-4132 | NDC:55111-419 | NDC:70518-1908 | NDC:50090-2130 | NDC:42291-447 | NDC:69097-152 | NDC:68382-980 | NDC:49884-604 | NDC:16714-625 | NDC:46708-276 | NDC:55111-719 | NDC:63187-487 | NDC:72888-026 | NDC:13668-341 | NDC:27241-186 | NDC:68382-007 | NDC:29300-114 | NDC:70771-1516 | NDC:51655-719 | NDC:31722-242 | NDC:46708-096 | NDC:46708-275 | NDC:65162-990 | NDC:68382-984 | NDC:13668-340 | NDC:82804-068 | NDC:50090-2129 | NDC:43598-550 | NDC:60687-704 | NDC:68382-010 | NDC:71335-0830 | NDC:82009-132 | NDC:16714-196 | NDC:49884-564 | NDC:42291-368 | NDC:42291-446 | NDC:43063-238 | NDC:13668-049 | NDC:16714-197 | NDC:31722-244 | NDC:65841-685 | NDC:16714-624 | NDC:82009-131 | NDC:65862-362 | NDC:68788-6868 | NDC:70771-1515 | PubChem CID:3878 | NDC:0115-1529 | NDC:0615-7975 | NDC:55154-2330 | NDC:55111-220 | NDC:82009-133 | NDC:70518-1523 | NDC:0228-1638 | NDC:68382-108 | NDC:65841-689 | NDC:70771-1519 | NDC:72888-028 | NDC:70518-4121 | PubChem SID:175267091 | NDC:42291-367 | NDC:69102-320 | NDC:16714-627 | NDC:62332-037"
+BMGC_DG07940,BMG_DG140033,"NDC:0904-6662 | NDC:0093-7350 | NDC:82009-039 | NDC:63868-429 | PubChem CID:3883 | NDC:72476-020 | NDC:11822-0016 | NDC:0363-0037 | NDC:70000-0069 | NDC:11822-0019 | NDC:16571-697 | NDC:81522-001 | NDC:0363-1419 | NDC:36800-295 | NDC:16571-698 | NDC:70700-263 | DrugBank ID:DB00448 | NDC:72288-829 | NDC:67877-274 | NDC:63981-117 | NDC:51079-121 | NDC:46122-107 | NDC:68196-045 | NDC:55111-398 | NDC:0093-3008 | NDC:30142-192 | NDC:46122-698 | NDC:50090-6079 | NDC:71335-9680 | NDC:30142-288 | NDC:68071-4456 | NDC:68788-7742 | NDC:68071-3572 | NDC:72162-1976 | NDC:65841-770 | NDC:70677-0124 | NDC:65841-769 | NDC:55910-307 | LANSOPRAZOLE | NDC:0113-0117 | NDC:64764-544 | NDC:0093-7351 | 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole | NDC:0093-3009 | NDC:68071-2274 | NDC:71335-9693 | NDC:43598-883 | NDC:68382-543 | NDC:83324-001 | NDC:27241-020 | NDC:11673-280 | NDC:11673-324 | NDC:65862-895 | NDC:0113-0116 | NDC:0113-6002 | NDC:70756-806 | NDC:41163-150 | NDC:56062-283 | NDC:71335-1820 | NDC:64764-543 | NDC:0378-8030 | NDC:68382-771 | NDC:0378-6981 | NDC:71335-9694 | NDC:21130-181 | NDC:72189-370 | NDC:60687-111 | NDC:68382-544 | PubChem SID:175271526 | NDC:0378-8015 | NDC:50090-5180 | NDC:80425-0148 | NDC:51407-324 | NDC:60687-123 | NDC:68071-3634 | NDC:68071-5119 | NDC:33342-311 | NDC:68196-075 | NDC:71335-1425 | NDC:41520-816 | NDC:70677-1103 | NDC:76420-621 | NDC:57896-761 | NDC:55111-739 | NDC:37808-934 | NDC:70771-1132 | NDC:64764-046 | NDC:51316-006 | NDC:63981-582 | NDC:68391-117 | NDC:79903-068 | NDC:16571-742 | NDC:70771-1133 | NDC:68382-772 | NDC:0363-0739 | NDC:72288-301 | NDC:70756-807 | NDC:43598-109 | NDC:72603-314 | NDC:63629-7552 | NDC:11673-117 | NDC:27241-019 | NDC:49035-739 | NDC:63187-152 | NDC:69842-755 | NDC:72603-313 | NDC:67877-275 | NDC:68788-6390 | CAS RN:1261394-42-6 | NDC:68001-112 | NDC:43598-560 | NDC:16714-185 | NDC:0113-6117 | NDC:68071-3633 | NDC:72288-343 | NDC:45802-245 | NDC:71335-0058 | NDC:30142-983 | NDC:43598-161 | NDC:0363-1212 | NDC:46122-744 | NDC:50090-6154 | NDC:68071-3687 | NDC:43598-561 | Lansoprazole | NDC:41250-391 | NDC:33342-310 | NDC:0378-6982 | NDC:70700-262 | NDC:45802-878 | NDC:69842-507 | NDC:65862-896 | NDC:68016-758 | NDC:70000-0612 | NDC:49035-411 | NDC:80425-0174 | UNII:0K5C5T2QPG | NDC:55154-4848 | NDC:0536-1368 | NDC:31722-571 | NDC:0113-1114 | NDC:68071-3585 | NDC:68196-279 | NDC:50090-6830 | NDC:21130-046 | NDC:69256-401 | NDC:21130-564 | NDC:63629-2341 | NDC:63629-2340 | NDC:49035-373 | NDC:71335-9695 | NDC:36800-117 | NDC:36800-392 | NDC:68788-8621 | NDC:31722-570 | NDC:56062-117 | NDC:16714-186 | NDC:68001-111 | NDC:63187-510 | CAS RN:103577-45-3 | NDC:63629-2342 | NDC:55111-399"
+BMGC_DG07941,BMG_DG140038,"CAS RN:4707-32-8 | DrugBank ID:DB11948 | beta-Lapachone | PubChem SID:198946622 | Lapachone | PubChem CID:3885 | UNII:6N4FA2QQ6A | 2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione | LAPACHONE"
+BMGC_DG07942,BMG_DG140039,"PubChem CID:38852 | Methyldopa sesquihydrate | NDC:62135-321 | NDC:64980-572 | UNII:56LH93261Y | (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate | NDC:62135-322 | METHYLDOPA | CAS RN:41372-08-1 | PubChem SID:175268856"
+BMGC_DG07943,BMG_DG140040,"METHYLDOPA ANHYDROUS | PubChem CID:38853 | PubChem SID:175266998 | (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid | UNII:M4R0H12F6M | CAS RN:555-30-6 | CAS RN:27289-76-5 | CAS RN:88620-56-8 | Methyldopa | DrugBank ID:DB00968 | CAS RN:41372-08-1"
+BMGC_DG07944,BMG_DG140061,"azane;cyclobutane-1,1-dicarboxylic acid;platinum | PubChem CID:38904 | diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum | DrugBank ID:DB00958 | Carboplatin"
+BMGC_DG07945,BMG_DG140067,DrugBank ID:DB03017 | UNII:1160N9NU9U | CAS RN:143-07-7 | Lauric acid | PubChem CID:3893 | LAURIC ACID | Lauric Acid | CAS RN:7632-48-6 | dodecanoic acid | CAS RN:203714-07-2 | PubChem SID:175266448 | CAS RN:8000-62-2
+BMGC_DG07946,BMG_DG140070,"CAS RN:125697-92-9 | UNII:3Y0G32G2RV | 5-[(2,5-dihydroxyphenyl)methyl-[(2-hydroxyphenyl)methyl]amino]-2-hydroxybenzoic acid | PubChem CID:3894 | LAVENDUSTIN A | Lavendustin A | PubChem SID:198937428"
+BMGC_DG07947,BMG_DG140073,"TOCAINIDE | PubChem CID:38945 | 2-amino-N-(2,6-dimethylphenyl)propanamide | CAS RN:41708-72-9 | Tocainide | CAS RN:53984-26-2 | CAS RN:76213-25-7 | PubChem SID:198946717 | DrugBank ID:DB01056 | UNII:27DXO59SAN"
+BMGC_DG07948,BMG_DG140076,LAVENDUSTIN B | PubChem SID:198962518 | PubChem CID:3895 | UNII:7T53EGQ52Z | CAS RN:125697-91-8
+BMGC_DG07949,BMG_DG140078,PubChem SID:198974759 | LAVENDUSTIN C | PubChem CID:3896 | UNII:HJM06BIW5M | CAS RN:125697-93-0
+BMGC_DG07950,BMG_DG140120,"NDC:0088-2161 | NDC:62135-794 | NDC:70710-1157 | NDC:0955-1737 | NDC:71335-2256 | NDC:70748-130 | PubChem CID:3899 | Leflunomide | 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide | NDC:59651-348 | NDC:35573-447 | NDC:35573-448 | NDC:70710-1158 | NDC:42291-421 | NDC:70771-1491 | NDC:72162-2410 | NDC:42291-420 | PubChem SID:175265602 | NDC:70771-1492 | NDC:50268-477 | NDC:46708-437 | NDC:62332-062 | UNII:G162GK9U4W | NDC:23155-043 | NDC:72162-2409 | NDC:63629-9728 | NDC:23155-044 | NDC:50090-5992 | NDC:59651-349 | DrugBank ID:DB01097 | NDC:10702-277 | CAS RN:75706-12-6 | NDC:60505-2502 | NDC:46708-436 | NDC:0088-2162 | NDC:71335-2403 | NDC:70748-129 | NDC:68071-3764 | NDC:10702-278 | NDC:50268-478 | NDC:62332-061 | NDC:62135-793 | NDC:60505-2503 | LEFLUNOMIDE | NDC:0088-2160 | NDC:68071-3763"
+BMGC_DG07951,BMG_DG140121,"UNII:62T278S1MX | PubChem SID:198964270 | DrugBank ID:DB03759 | 6,7-Dinitro-1,4-dihydroquinoxaline-2,3-dione | PubChem CID:3899541 | CAS RN:2379-57-9 | FG-9041 | 6,7-dinitro-1,4-dihydroquinoxaline-2,3-dione"
+BMGC_DG07952,BMG_DG140124,"4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile | NDC:71335-1526 | NDC:59651-180 | PubChem SID:175268594 | NDC:24979-726 | NDC:71205-587 | NDC:50090-3474 | NDC:68071-5264 | CAS RN:112809-51-5 | PubChem CID:3902 | NDC:0078-0249 | NDC:63629-7819 | LETROZOLE | NDC:55111-646 | NDC:42291-374 | NDC:23155-875 | UNII:7LKK855W8I | NDC:16729-034 | NDC:71335-2396 | NDC:0093-7620 | NDC:50268-476 | NDC:63850-0025 | NDC:62135-491 | NDC:69117-0004 | NDC:51991-759 | NDC:68071-2167 | DrugBank ID:DB01006 | Letrozole"
+BMGC_DG07953,BMG_DG140129,"PubChem CID:39040 | Tricyclazole | CAS RN:41814-78-2 | TRICYCLAZOLE | PubChem SID:198962074 | UNII:R7U3MEU7VR | 8-methyl-[1,2,4]triazolo[3,4-b][1,3]benzothiazole | DrugBank ID:DB02891"
+BMGC_DG07954,BMG_DG140131,UNII:Y9449Q51XH | 2-[4-[2-[(4-chlorobenzoyl)amino]ethyl]phenoxy]-2-methylpropanoic acid | PubChem SID:198965104 | CAS RN:41859-67-0 | PubChem CID:39042 | Bezafibrate | BEZAFIBRATE | DrugBank ID:DB01393
+BMGC_DG07955,BMG_DG140134,"PubChem SID:376231386 | PubChem CID:390508 | METHYL 4-((2,5-DIHYDROXYBENZYL)AMINO)-2-HYDROXYBENZOATE | CAS RN:151391-92-3 | UNII:L0CH9I9BQF"
+BMGC_DG07956,BMG_DG140140,PubChem CID:39065 | 5-(3-methylphenoxy)-1H-pyrimidin-2-one | PubChem SID:198952755 | UNII:MU3JD8E9IS | Tolimidone | TOLIMIDONE | CAS RN:41964-07-2
+BMGC_DG07957,BMG_DG140142,PubChem SID:474492673 | WAY-161503 | UNII:SCG2HM6F3D | PubChem CID:3906894 | CAS RN:75704-24-4
+BMGC_DG07958,BMG_DG140150,PubChem CID:390929 | UNII:4A83KG8VD5 | PubChem SID:441659073 | N-PROPARGYLSACCHARIN | CAS RN:41335-57-3
+BMGC_DG07959,BMG_DG140162,"NDC:76385-133 | CAS RN:1403-22-1 | NDC:72664-211 | NDC:71335-1972 | NDC:62332-403 | NDC:68001-318 | PubChem SID:175271964 | NDC:70771-1091 | NDC:69097-868 | NDC:46708-403 | NADOLOL | NDC:10135-688 | NDC:59651-251 | NDC:69097-867 | CAS RN:1164498-31-0 | Nadolol | NDC:69238-1123 | NDC:68382-732 | NDC:68382-734 | NDC:70771-1089 | NDC:68001-631 | NDC:68001-317 | NDC:72664-213 | DrugBank ID:DB01203 | NDC:69238-1124 | NDC:10135-686 | NDC:76282-347 | UNII:FEN504330V | NDC:0904-7071 | NDC:62332-402 | NDC:69097-869 | NDC:0904-7070 | NDC:10135-687 | NDC:68382-733 | NDC:72162-2198 | NDC:67046-1416 | NDC:60687-313 | NDC:68001-630 | CAS RN:42200-33-9 | NDC:76282-349 | NDC:46708-402 | NDC:62332-404 | NDC:70771-1090 | NDC:46708-404 | NDC:59651-252 | NDC:71335-0697 | NDC:76282-348 | NDC:59651-589 | NDC:71335-2131 | NDC:76385-134 | PubChem CID:39147 | (2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol | NDC:60687-302 | NDC:69238-1125 | NDC:72162-2234 | NDC:68001-632 | NDC:76385-135 | CAS RN:220045-89-6 | NDC:68001-319 | NDC:72664-212 | NDC:72162-2233"
+BMGC_DG07960,BMG_DG140173,"17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol | Racemorphan | PubChem CID:3918"
+BMGC_DG07961,BMG_DG140178,"DrugBank ID:DB00343 | Diltiazem | [(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate | CAS RN:42399-41-7 | UNII:EE92BBP03H | DILTIAZEM | PubChem SID:175265785 | PubChem CID:39186"
+BMGC_DG07962,BMG_DG140183,UNII:0S726V972K | NIMUSTINE | CAS RN:42471-28-3 | PubChem CID:39214 | PubChem SID:198975759 | DrugBank ID:DB13069 | 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-1-(2-chloroethyl)-1-nitrosourea | Nimustine
+BMGC_DG07963,BMG_DG140186,DrugBank ID:DB01941 | LG 100268 | LG-100268 | UNII:UVU4X1103P | PubChem SID:198987930 | PubChem CID:3922 | CAS RN:153559-76-3
+BMGC_DG07964,BMG_DG140203,"CAS RN:3416-26-0 | PubChem CID:3926 | PubChem SID:198951134 | 2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]-N-(2,6-dimethylphenyl)acetamide | DrugBank ID:DB13766 | Lidoflazine | LIDOFLAZINE | UNII:J4ZHN3HBTE"
+BMGC_DG07965,BMG_DG140204,"PubChem CID:392622 | NDC:65162-061 | DrugBank ID:DB00503 | CAS RN:155213-67-5 | UNII:O3J8G9O825 | Ritonavir | 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate | NDC:60687-420 | NDC:31722-597 | NDC:67046-1251 | NDC:0074-3333 | NDC:65862-687 | RITONAVIR | NDC:69097-655 | PubChem SID:175266104 | NDC:0074-3399 | NDC:0074-2340"
+BMGC_DG07966,BMG_DG140209,"CAS RN:12768-69-3 | CAS RN:1397321-28-6 | N-[2-hydroxy-1-(3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl)propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide | Lincomycin A | PubChem CID:3928"
+BMGC_DG07967,BMG_DG140211,8-QUINOLINYL-4-METHYL-3-(1-PIPERIDINYLSULFONYL)BENZOATE | PubChem SID:312524975 | CAS RN:312606-87-4 | UNII:55Q8B94HS5 | PubChem CID:3929482
+BMGC_DG07968,BMG_DG140213,UNII:V2U7C65UET | CAS RN:42797-18-2 | PubChem SID:485663124 | 2-(4-Phenylbenzoyl)benzoic acid | PubChem CID:39302 | 2-(4-PHENYLBENZOYL)BENZOIC ACID
+BMGC_DG07969,BMG_DG140214,UNII:6U6PT5XJ7G | PubChem SID:472411520 | PubChem CID:393037 | 4-CHLORO-1H-INDAZOLE | CAS RN:13096-96-3 | 4-Chloro-1H-indazole
+BMGC_DG07970,BMG_DG140218,"LINOPIRDINE | PubChem SID:198953648 | UNII:I5TB3NZ94T | DrugBank ID:DB13806 | Linopirdine | 1-phenyl-3,3-bis(pyridin-4-ylmethyl)indol-2-one | CAS RN:105431-72-9 | PubChem CID:3932"
+BMGC_DG07971,BMG_DG140233,"N-[9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl]-2-phenylacetamide | CAS RN:183721-15-5 | N-(9-chloro-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-2-phenylacetamide | PubChem CID:393595"
+BMGC_DG07972,BMG_DG140242,"6-Thioguanine ribonucleoside | 2-amino-9-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-6-thione | CAS RN:26017-62-9 | CAS RN:32976-84-4 | PubChem CID:3938248 | CAS RN:7602-04-2 | CAS RN:32865-28-4"
+BMGC_DG07973,BMG_DG140243,"PubChem SID:198940383 | 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one | UNII:1HW039CJF0 | PubChem CID:39385 | Triadimefon | CAS RN:43121-43-3 | TRIADIMEFON"
+BMGC_DG07974,BMG_DG140247,PubChem CID:3939 | LITHIUM HYDROXIDE ANHYDROUS | PubChem SID:175265698 | UNII:903YL31JAS | CAS RN:1310-65-2
+BMGC_DG07975,BMG_DG140257,"2,5-bis(aziridin-1-yl)-3-(hydroxymethyl)-6-methylcyclohexa-2,5-diene-1,4-dione | DrugBank ID:DB04090 | UNII:IJ5CEP760Y | RH-1 | 2,5-Bis(1-aziridinyl)-3-(hydroxymethyl)-6-methyl-2,5-cyclohexadiene-1,4-dione | PubChem SID:198966131 | CAS RN:221635-42-3 | PubChem CID:394347"
+BMGC_DG07976,BMG_DG140259,PubChem CID:3945 | Lobelin | CAS RN:10122-32-4 | 2-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]-1-phenylethanone
+BMGC_DG07977,BMG_DG140264,"PubChem CID:39468 | DrugBank ID:DB01210 | 5-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-3,4-dihydro-2H-naphthalen-1-one | LEVOBUNOLOL | UNII:G6317AOI7K | CAS RN:47141-42-4 | Levobunolol | PubChem SID:175268158"
+BMGC_DG07978,BMG_DG140266,"LOFEPRAMINE | PubChem CID:3947 | PubChem SID:198950803 | DrugBank ID:DB13411 | Lofepramine | 1-(4-chlorophenyl)-2-[3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-methylamino]ethanone | UNII:OCA4JT7PAW | CAS RN:23047-25-8"
+BMGC_DG07979,BMG_DG140268,"PubChem CID:3948 | PubChem SID:175272069 | CAS RN:98079-51-7 | UNII:L6BR2WJD8V | Lomefloxacin | DrugBank ID:DB00978 | 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid | LOMEFLOXACIN"
+BMGC_DG07980,BMG_DG140270,UNII:R865A5OY8J | 1-methyl-4-phenylpyridin-1-ium | CAS RN:48134-75-4 | 1-Methyl-4-phenylpyridinium | PubChem CID:39484 | CYPERQUAT | PubChem SID:198950338
+BMGC_DG07981,BMG_DG140272,"UNII:WPR9RGW25V | N-(5-SULFAMOYL-1,3,4-THIADIAZOL-2-YL)BENZAMIDE | CAS RN:86029-44-9 | PubChem CID:394898"
+BMGC_DG07982,BMG_DG140273,"PubChem CID:3949 | PubChem SID:198979485 | 1-[bis(4-fluorophenyl)methyl]-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine | DrugBank ID:DB14065 | CAS RN:101477-55-8 | UNII:DEE37CY4VO | LOMERIZINE | Lomerizine"
+BMGC_DG07983,BMG_DG140274,UNII:597YJ9V3Y7 | CAS RN:49546-71-6 | PubChem CID:39492 | 5-(4-METHOXYBENZYLIDENE)BARBITURIC ACID | PubChem SID:377307933
+BMGC_DG07984,BMG_DG140277,PubChem SID:175265909 | NDC:58181-3040 | DrugBank ID:DB01206 | CAS RN:13010-47-4 | NDC:58181-3041 | LOMUSTINE | NDC:58181-3042 | Lomustine | 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea | PubChem CID:3950 | UNII:7BRF0Z81KG
+BMGC_DG07985,BMG_DG140282,"(2R,13R,14S,15S,17S)-17-hydroxy-2,13,14,15-tetramethyl-14-propanoyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one | PubChem CID:39507 | (10R,11S,13S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one"
+BMGC_DG07986,BMG_DG140286,PubChem CID:3952261 | DrugBank ID:DB03033 | 4-methoxybenzenesulfinate
+BMGC_DG07987,BMG_DG140293,CAS RN:115687-05-3 | (4-chlorophenyl)-[4-(8-nitroquinolin-5-yl)piperazin-1-yl]methanone | 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline | PubChem CID:3953303
+BMGC_DG07988,BMG_DG140299,"4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide | CAS RN:53179-11-6 | PubChem CID:3955 | Loperamide | LOPERAMIDE | DrugBank ID:DB00836 | UNII:6X9OC3H4II | PubChem SID:175268175"
+BMGC_DG07989,BMG_DG140304,"PubChem CID:39562 | CAS RN:50264-69-2 | LONIDAMINE | UNII:U78804BIDR | PubChem SID:198960073 | 1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid | DrugBank ID:DB06266 | Lonidamine"
+BMGC_DG07990,BMG_DG140305,"NDC:59556-882 | NDC:0904-5833 | PubChem SID:175267925 | NDC:11822-0919 | NDC:68391-314 | NDC:41520-131 | NDC:11523-0800 | NDC:16714-898 | NDC:41163-633 | NDC:37808-427 | NDC:69842-242 | NDC:68084-248 | NDC:0113-7777 | NDC:70677-1043 | NDC:0363-9994 | NDC:55910-611 | NDC:70000-0162 | NDC:21130-780 | NDC:72288-200 | NDC:72162-2181 | NDC:46122-550 | NDC:51672-2092 | NDC:21130-042 | NDC:68016-053 | NDC:68788-8286 | NDC:21130-526 | NDC:60505-0147 | NDC:71610-423 | NDC:51316-502 | NDC:50090-0836 | NDC:63548-0753 | NDC:55910-629 | NDC:11523-0007 | NDC:51660-527 | NDC:55154-4976 | NDC:55910-807 | NDC:25000-092 | NDC:68210-4110 | NDC:63981-724 | NDC:83324-147 | NDC:51316-821 | NDC:11673-310 | NDC:21130-139 | NDC:51079-246 | NDC:67751-163 | NDC:21130-646 | NDC:57243-200 | NDC:68788-8659 | NDC:73629-003 | NDC:69842-641 | NDC:58602-423 | NDC:70677-1018 | NDC:21130-195 | NDC:66267-653 | NDC:41250-629 | NDC:51660-724 | NDC:0363-1686 | NDC:50090-6701 | NDC:68788-8657 | NDC:30142-446 | NDC:49035-612 | NDC:51316-915 | NDC:68016-055 | NDC:11673-996 | NDC:11523-7202 | NDC:0615-8503 | NDC:72288-452 | NDC:69842-895 | NDC:63629-7772 | NDC:70677-1022 | NDC:49738-686 | NDC:69168-309 | NDC:57483-955 | NDC:66715-6551 | NDC:79481-7870 | NDC:58602-831 | NDC:0904-6767 | NDC:49035-611 | NDC:36800-612 | NDC:11523-0104 | NDC:53943-193 | NDC:69230-322 | DrugBank ID:DB00455 | NDC:64024-703 | NDC:37808-131 | NDC:66715-6532 | NDC:67091-246 | NDC:43353-259 | NDC:11822-0558 | NDC:56062-990 | NDC:68788-8629 | NDC:11523-7237 | NDC:50090-6164 | NDC:72789-380 | NDC:11523-7157 | NDC:50090-1454 | NDC:37205-378 | NDC:72036-193 | NDC:49483-686 | NDC:55289-728 | NDC:68016-526 | NDC:69842-686 | NDC:11822-8329 | NDC:70985-017 | NDC:63941-526 | NDC:67091-350 | NDC:63868-577 | NDC:68788-8349 | NDC:80070-100 | NDC:71335-1651 | NDC:36800-363 | NDC:79903-156 | NDC:68788-7291 | NDC:68016-131 | NDC:51660-754 | NDC:51824-075 | NDC:36800-853 | NDC:0904-7426 | NDC:62207-787 | NDC:70677-1058 | NDC:36800-608 | NDC:51672-2073 | NDC:66715-8815 | NDC:21130-724 | NDC:58602-744 | NDC:57483-950 | NDC:50090-7049 | NDC:63868-669 | NDC:66715-9732 | NDC:72288-446 | NDC:46122-539 | NDC:0363-2010 | NDC:69842-894 | NDC:72288-612 | NDC:63187-601 | NDC:11822-1055 | NDC:47682-912 | NDC:21130-914 | NDC:72288-511 | NDC:46122-167 | NDC:55910-985 | NDC:59556-917 | NDC:30142-723 | NDC:80513-711 | NDC:37808-529 | NDC:0363-9150 | NDC:11523-4360 | NDC:0363-9603 | NDC:70000-0213 | NDC:0363-0858 | NDC:11822-7240 | NDC:11523-0102 | NDC:11673-612 | NDC:11822-9999 | NDC:11523-4329 | NDC:10135-763 | NDC:11523-4328 | NDC:68016-088 | NDC:68788-8335 | Loratadine | NDC:80070-110 | NDC:0363-0725 | NDC:46122-787 | NDC:49035-643 | NDC:56062-092 | NDC:81522-393 | NDC:0363-1612 | NDC:68788-7769 | NDC:0113-1719 | NDC:72162-2323 | NDC:68998-414 | NDC:79903-008 | NDC:29485-8156 | NDC:11822-3276 | NDC:47682-913 | NDC:64024-023 | NDC:46122-455 | NDC:54838-554 | NDC:68788-8605 | NDC:58602-847 | NDC:11523-4331 | NDC:49035-538 | NDC:69452-283 | NDC:11523-4364 | NDC:70677-1057 | NDC:21130-221 | NDC:68196-711 | NDC:72983-500 | NDC:0113-1191 | NDC:50090-7108 | NDC:70000-0252 | NDC:0363-9995 | NDC:11523-4359 | NDC:56062-724 | NDC:21130-452 | NDC:71335-0100 | NDC:41520-918 | NDC:68001-449 | NDC:60760-569 | NDC:42961-120 | NDC:72559-033 | NDC:71335-2431 | NDC:69452-211 | NDC:82501-1580 | NDC:30142-066 | NDC:45802-650 | NDC:70000-0504 | NDC:21130-482 | NDC:16571-822 | NDC:11523-7333 | NDC:58602-821 | NDC:0536-1367 | NDC:24385-543 | NDC:68788-8628 | NDC:50090-4316 | NDC:49035-061 | NDC:70000-0125 | NDC:72789-347 | NDC:83324-150 | NDC:41163-612 | NDC:54838-558 | NDC:24385-531 | NDC:0113-1019 | NDC:69842-954 | NDC:30142-846 | NDC:56062-921 | NDC:11822-2131 | NDC:73581-230 | NDC:29485-5515 | NDC:11523-4330 | NDC:68071-3596 | NDC:69230-317 | NDC:55910-806 | NDC:46122-423 | NDC:66715-6432 | NDC:60760-831 | NDC:62011-0305 | UNII:7AJO3BO7QN | NDC:41520-612 | NDC:63654-415 | NDC:50090-7048 | NDC:55910-718 | NDC:79903-933 | NDC:70677-0145 | NDC:51672-2108 | NDC:0113-9755 | NDC:69230-328 | NDC:69842-540 | NDC:51660-112 | NDC:36800-706 | NDC:69168-414 | NDC:60760-609 | NDC:0363-9787 | NDC:43598-756 | CAS RN:79794-75-5 | NDC:47682-403 | NDC:72288-901 | NDC:63981-612 | NDC:58602-818 | NDC:0363-9937 | NDC:53943-975 | NDC:53943-035 | NDC:30142-786 | NDC:55910-594 | ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate | NDC:50090-5532 | NDC:11673-997 | NDC:51660-491 | NDC:41250-716 | NDC:70000-0583 | NDC:80136-658 | NDC:70264-030 | NDC:70010-162 | NDC:67091-408 | NDC:21130-301 | NDC:59556-301 | NDC:0363-0752 | NDC:68071-2934 | NDC:55910-970 | NDC:45802-122 | NDC:41250-724 | NDC:41163-364 | NDC:41250-890 | NDC:49035-092 | NDC:11822-0801 | NDC:69848-019 | NDC:11673-115 | NDC:68599-4784 | NDC:30142-996 | NDC:62011-0071 | NDC:51316-503 | NDC:51660-526 | NDC:70677-0036 | NDC:53117-414 | NDC:36800-611 | NDC:63941-131 | NDC:11523-4332 | NDC:59779-612 | NDC:72559-031 | NDC:72983-501 | NDC:68001-438 | NDC:51672-2085 | NDC:70677-1240 | NDC:69842-337 | NDC:11822-1019 | NDC:0113-0612 | NDC:63868-414 | NDC:68071-4451 | NDC:11822-0620 | NDC:50090-7158 | NDC:67091-245 | NDC:49483-732 | NDC:55154-8082 | NDC:49348-543 | NDC:11822-9990 | NDC:69230-323 | NDC:81522-612 | NDC:49035-806 | NDC:50268-489 | NDC:50090-2387 | NDC:71335-2551 | NDC:30142-612 | NDC:51316-133 | NDC:11822-0446 | NDC:58602-881 | NDC:63187-305 | NDC:63654-309 | NDC:61504-193 | NDC:68071-2208 | NDC:58602-702 | NDC:55681-303 | NDC:70677-1024 | NDC:49035-953 | NDC:21130-963 | NDC:46122-383 | NDC:11673-111 | NDC:41520-716 | NDC:30142-062 | NDC:11523-7160 | NDC:36800-755 | NDC:68788-8266 | NDC:50594-010 | NDC:82725-1042 | NDC:80425-0352 | NDC:70677-1053 | NDC:51824-103 | NDC:50090-7051 | NDC:41250-954 | NDC:0363-9985 | NDC:69842-085 | NDC:11673-558 | NDC:51672-2131 | NDC:41250-539 | NDC:56062-132 | NDC:51660-753 | NDC:68788-8616 | NDC:17856-0557 | NDC:11523-7162 | NDC:83324-103 | NDC:11523-0101 | NDC:72983-503 | NDC:30142-565 | NDC:0113-2007 | NDC:69842-535 | NDC:69536-195 | NDC:68391-301 | NDC:41520-510 | NDC:63187-100 | NDC:50804-840 | NDC:25000-021 | NDC:50090-6837 | NDC:67751-153 | NDC:21130-123 | NDC:37808-506 | NDC:41250-612 | NDC:79481-0446 | NDC:69842-953 | NDC:0904-6852 | NDC:11523-7200 | NDC:82442-207 | NDC:66715-9742 | NDC:0363-2108 | NDC:51660-106 | NDC:68788-8614 | LORATADINE | NDC:0363-9955 | NDC:55319-938 | NDC:43598-758 | NDC:11523-6655 | NDC:63941-193 | NDC:0113-0671 | NDC:59726-915 | NDC:0363-7023 | NDC:71141-132 | NDC:72888-029 | NDC:30142-984 | NDC:57344-193 | NDC:63981-723 | NDC:43598-707 | NDC:63868-151 | NDC:60000-950 | NDC:11822-0612 | NDC:56062-555 | NDC:0113-1612 | NDC:70677-0029 | NDC:56062-900 | NDC:69536-190 | NDC:0363-4020 | NDC:55301-612 | NDC:50090-7066 | NDC:58602-830 | NDC:30142-017 | NDC:47682-203 | NDC:62011-0248 | NDC:49348-636 | NDC:68016-094 | NDC:72288-451 | NDC:0363-0754 | NDC:68196-301 | NDC:83324-146 | PubChem CID:3957 | NDC:37808-724 | NDC:11523-1527 | NDC:0378-8880 | NDC:0363-2131 | NDC:71335-2529 | NDC:50090-4300 | NDC:80070-120 | NDC:51660-726 | NDC:71610-553 | NDC:21130-999 | NDC:68016-167 | NDC:24385-471 | NDC:73581-203 | NDC:63868-462 | NDC:59779-528 | NDC:57896-658 | NDC:70000-0473"
+BMGC_DG07991,BMG_DG140306,"NDC:0641-6051 | NDC:71610-600 | NDC:0641-6046 | NDC:71205-235 | NDC:0641-6048 | NDC:72789-236 | PubChem SID:175271611 | NDC:0187-0065 | UNII:O26FZP769L | NDC:76329-8261 | NDC:67296-1332 | NDC:67296-1629 | NDC:0409-1985 | NDC:67296-1622 | NDC:70518-1520 | NDC:68071-5022 | NDC:71335-0329 | NDC:68788-7533 | NDC:76420-872 | NDC:68788-7428 | NDC:69315-906 | NDC:71205-228 | NDC:70518-2186 | NDC:80425-0465 | NDC:71205-166 | NDC:62559-196 | NDC:0641-6002 | NDC:68071-3242 | NDC:60687-627 | NDC:0054-3532 | NDC:50090-5508 | NDC:13107-085 | NDC:68071-3121 | NDC:68071-5250 | NDC:0093-3425 | NDC:71610-225 | NDC:62135-861 | NDC:67544-142 | NDC:72789-226 | NDC:0187-0063 | NDC:0641-6003 | NDC:71610-229 | NDC:62135-549 | NDC:71610-768 | NDC:71610-828 | NDC:62135-863 | PubChem CID:3958 | NDC:71335-1138 | NDC:71610-654 | NDC:63304-774 | NDC:67544-191 | NDC:70518-2194 | NDC:0904-6009 | NDC:72789-376 | NDC:0641-6207 | NDC:71335-0655 | NDC:68071-5068 | NDC:76420-873 | NDC:72189-351 | NDC:0904-6008 | NDC:69315-904 | NDC:54348-049 | NDC:71610-764 | NDC:63187-576 | NDC:68071-4916 | NDC:71610-827 | NDC:76420-647 | NDC:0641-6000 | NDC:71610-255 | NDC:0093-3426 | NDC:0641-6050 | NDC:65219-368 | NDC:68071-3010 | NDC:0641-6049 | NDC:0187-0064 | NDC:71610-655 | NDC:0093-3427 | NDC:52427-663 | NDC:76420-874 | NDC:71335-1694 | NDC:72789-356 | LORAZEPAM | NDC:63304-772 | NDC:69315-905 | NDC:58118-0904 | NDC:62559-197 | NDC:0904-6007 | NDC:60687-649 | NDC:67296-1445 | NDC:0121-0770 | NDC:68071-4918 | NDC:72789-339 | NDC:50090-5509 | NDC:55154-7977 | NDC:52427-667 | NDC:72789-197 | NDC:58118-1095 | 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one | NDC:65162-017 | CAS RN:846-49-1 | NDC:71610-122 | NDC:65162-018 | NDC:72789-357 | NDC:67296-1478 | NDC:68071-3096 | NDC:13107-083 | NDC:63304-773 | NDC:67296-1436 | NDC:50090-5563 | NDC:60687-638 | NDC:71335-1467 | DrugBank ID:DB00186 | NDC:72789-355 | NDC:43353-255 | NDC:65162-687 | NDC:13107-084 | NDC:0641-6047 | NDC:65162-015 | NDC:62559-195 | NDC:67544-261 | NDC:58118-1096 | NDC:61919-062 | NDC:71335-1455 | NDC:71610-842 | Lorazepam | NDC:71610-674 | NDC:55154-7975 | NDC:70518-0275 | NDC:68071-3751 | NDC:70518-0445 | NDC:71610-199 | NDC:71610-178 | NDC:52427-661 | NDC:68071-3227 | NDC:72572-380 | NDC:50090-5562 | NDC:62135-862 | NDC:55154-7976 | NDC:0641-6001 | NDC:0641-6044 | NDC:52427-658 | NDC:63187-536 | NDC:68788-7355 | NDC:71205-756 | NDC:0641-6045 | NDC:71610-008"
+BMGC_DG07992,BMG_DG140311,"LORGLUMIDE | PubChem CID:3960 | PubChem SID:198991037 | 4-[(3,4-dichlorobenzoyl)amino]-5-(dipentylamino)-5-oxopentanoic acid | Lorglumide | CAS RN:97964-56-2 | UNII:LAD1UQ73BE"
+BMGC_DG07993,BMG_DG140313,"CAS RN:14141-47-0 | PubChem CID:3960826 | Mrs 2219 | 3-hydroxy-8-methyl-3-oxo-1,5-dihydro-[1,3,2]dioxaphosphepino[5,6-c]pyridin-9-ol"
+BMGC_DG07994,BMG_DG140315,UNII:JMS50MPO89 | PubChem CID:3961 | PubChem SID:175268271 | Losartan | LOSARTAN | DrugBank ID:DB00678 | [2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol | CAS RN:114798-26-4
+BMGC_DG07995,BMG_DG140321,"Loxapine | LOXAPINE | DrugBank ID:DB00408 | PubChem SID:175265885 | 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine | CAS RN:1977-10-2 | PubChem CID:3964 | NDC:51097-001 | UNII:LER583670J"
+BMGC_DG07996,BMG_DG140322,DrugBank ID:DB09212 | CAS RN:68767-14-6 | Loxoprofen | PubChem CID:3965 | UNII:3583H0GZAP | 2-[4-[(2-oxocyclopentyl)methyl]phenyl]propanoic acid | PubChem SID:198958963 | LOXOPROFEN
+BMGC_DG07997,BMG_DG140333,TOMELUKAST | PubChem SID:198976595 | UNII:59762X5CLS | PubChem CID:3969 | 1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]ethanone | CAS RN:88107-10-2 | Tomelukast
+BMGC_DG07998,BMG_DG140334,Indole-3-acetamide | UNII:O9SEW65XW3 | CAS RN:879-37-8 | PubChem SID:374388567 | 3-INDOLEACETAMIDE | 2-(1H-indol-3-yl)acetamide | DrugBank ID:DB08652 | CAS RN:879-06-1 | Indoleacetamide | PubChem CID:397
+BMGC_DG07999,BMG_DG140338,"UNII:04PL7F455E | PubChem CID:39729 | 2,3,7,8-TETRABROMODIBENZO-P-DIOXIN | PubChem SID:198956651 | CAS RN:50585-41-6"
+BMGC_DG08000,BMG_DG140339,UNII:31M2U1DVID | PubChem SID:198987051 | LY-294002 | CAS RN:15447-36-6 | CAS RN:154447-36-6 | PubChem CID:3973 | 2-morpholin-4-yl-8-phenylchromen-4-one | DrugBank ID:DB02656 | 2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
+BMGC_DG08001,BMG_DG140340,"UNII:85WEE3RG9K | PubChem SID:198975751 | 1,3,7,8-TETRACHLORODIBENZO-P-DIOXIN | CAS RN:50585-46-1 | 1,3,7,8-Tetrachlorodibenzo-P-dioxin | 1,3,7,8-tetrachlorodibenzo-p-dioxin | PubChem CID:39732"
+BMGC_DG08002,BMG_DG140345,"CAS RN:177262-30-5 | PubChem CID:397614 | (1R,2R,3S,3aR,8bS)-1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-3-phenyl-2,3-dihydro-1H-cyclopenta[b][1]benzofuran-2-carboxamide | DrugBank ID:DB15496 | Didesmethylrocaglamide"
+BMGC_DG08003,BMG_DG140346,"PubChem SID:198952612 | CAS RN:50700-49-7 | Acetimidoquinone | PubChem CID:39763 | UNII:G6S9BN13TI | ACETIMIDOQUINONE | N-(4-oxocyclohexa-2,5-dien-1-ylidene)acetamide"
+BMGC_DG08004,BMG_DG140347,"CAS RN:50700-72-6 | NDC:63323-781 | NDC:68083-139 | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate;bromide | NDC:68083-140 | PubChem CID:39764 | NDC:25021-685 | NDC:0143-9234 | NDC:47335-931 | NDC:67457-475 | NDC:67457-438 | NDC:0143-9232 | UNII:7E4PHP5N1D | NDC:81565-206 | Vecuronium Bromide | NDC:51662-1547 | NDC:55150-236 | PubChem SID:175265548 | NDC:47335-932 | NDC:0409-1632 | NDC:55150-235 | NDC:63323-782 | VECURONIUM BROMIDE | NDC:25021-686"
+BMGC_DG08005,BMG_DG140348,"PubChem SID:175266821 | UNII:5438723848 | PubChem CID:39765 | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate | DrugBank ID:DB01339 | CAS RN:86029-43-8 | Vecuronium | VECURONIUM"
+BMGC_DG08006,BMG_DG140355,PubChem SID:445498842 | CAS RN:226927-89-5 | PubChem CID:397855 | LB-42908 | UNII:6HW5QF8XFD
+BMGC_DG08007,BMG_DG140359,"UNII:29BY7HQV0T | 20-[3-(2-hydroxyethylamino)propyl]-15,16-dimethoxy-5,7-dioxa-20-azapentacyclo[10.8.0.02,10.04,8.013,18]icosa-1(12),2,4(8),9,13,15,17-heptaene-11,19-dione | PubChem SID:346539044 | LMP-744 | PubChem CID:397888 | 5H-(1,3)Dioxolo(5,6)indeno(1,2-C)isoquinoline-5,12(6H)-dione, 6-(3-((2-hydroxyethyl)amino)propyl)-2,3-dimethoxy- | CAS RN:308246-52-8"
+BMGC_DG08008,BMG_DG140362,CAS RN:65167-63-7 | O-Ethyl S-(2-diisopropylaminoethyl) methylphosphonothioate | O-ETHYL S-2-DIISOPROPYLAMINOETHYL METHYLPHOSPHONOTHIOATE | PubChem CID:39793 | PubChem SID:198938387 | CAS RN:65167-64-8 | CAS RN:50782-69-9 | UNII:9A4381183B | N-[2-[ethoxy(methyl)phosphoryl]sulfanylethyl]-N-propan-2-ylpropan-2-amine
+BMGC_DG08009,BMG_DG140367,"DrugBank ID:DB08312 | 6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE | PubChem CID:398148"
+BMGC_DG08010,BMG_DG140369,PubChem CID:39836 | UNII:V55S2QJN2X | CAS RN:50903-99-6 | N-omega-nitro-L-arginine methyl ester | methyl (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoate | NG-Nitroarginine Methyl Ester | PubChem SID:198981198 | DrugBank ID:DB12750 | L-NAME
+BMGC_DG08011,BMG_DG140370,UNII:4JCE4LAL96 | PubChem SID:459275334 | CAS RN:143603-26-3 | 1-BENZO(B)THIEN-2-YLCYCLOHEXANAMINE | PubChem CID:398415
+BMGC_DG08012,BMG_DG140379,"PubChem CID:39860 | CAS RN:56496-90-3 | 1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one"
+BMGC_DG08013,BMG_DG140387,UNII:ZC8A99XGG4 | O-METHYLFAGARONINE | CAS RN:51116-32-6 | PubChem CID:39898
+BMGC_DG08014,BMG_DG140391,"PubChem CID:3991 | M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene | DrugBank ID:DB03359"
+BMGC_DG08015,BMG_DG140392,DrugBank ID:DB09213 | CAS RN:51146-56-6 | PubChem CID:39912 | UNII:671DKG7P5S | PubChem SID:198989681 | DEXIBUPROFEN | Dexibuprofen | (2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid
+BMGC_DG08016,BMG_DG140396,"2,3,7,8-Tetrachlorodibenzofuran | CAS RN:51207-31-9 | PubChem SID:198967984 | 2,3,7,8-tetrachlorodibenzofuran | 2,3,7,8-TETRACHLORODIBENZOFURAN | UNII:XZJ41GQI5D | PubChem CID:39929"
+BMGC_DG08017,BMG_DG140397,PubChem SID:459275507 | PubChem CID:3994 | CAS RN:251456-60-7 | M-344 | DrugBank ID:DB02565 | UNII:J8W4VF5ZEJ | 4-(dimethylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)benzamide | 4-(dimethylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]benzamide
+BMGC_DG08018,BMG_DG140398,"UNII:17SZX404IM | PubChem CID:39941 | BENOXAPROFEN | Benoxaprofen | PubChem SID:198951706 | 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid | CAS RN:67434-14-4 | DrugBank ID:DB04812 | CAS RN:51234-28-7"
+BMGC_DG08019,BMG_DG140399,"PubChem CID:3994476 | 1-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]pyrrolidine-2,5-dione | 1-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)pyrrolidine-2,5-dione"
+BMGC_DG08020,BMG_DG140407,"DrugBank ID:DB07488 | {4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone | PubChem CID:399618"
+BMGC_DG08021,BMG_DG140417,DrugBank ID:DB06795 | Mafenide | PubChem SID:175266376 | MAFENIDE | 4-(aminomethyl)benzenesulfonamide | PubChem CID:3998 | UNII:58447S8P4L | CAS RN:138-39-6
+BMGC_DG08022,BMG_DG140418,Sparfosic Acid | UNII:78QVZ7RG8L | Sparfosic acid | DrugBank ID:DB03459 | CAS RN:51321-79-0 | PubChem SID:198944857 | PubChem CID:39981 | SPARFOSIC ACID | (2S)-2-[(2-phosphonoacetyl)amino]butanedioic acid
+BMGC_DG08023,BMG_DG140430,"(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylic acid | PubChem CID:400010 | CAS RN:218600-44-3 | UNII:7HT68L8941 | Bardoxolone | PubChem SID:198971800 | BARDOXOLONE | DrugBank ID:DB12651"
+BMGC_DG08024,BMG_DG140435,UNII:S6M9P5HZ69 | PubChem CID:40012125 | PubChem SID:485663671 | 4-CYCLOPENTYL-N-(PHENYLMETHYL)-1-PIPERAZINECARBOXAMIDE | 4-Cyclopentyl-N-(phenylmethyl)-1-piperazinecarboxamide | CAS RN:929095-93-2
+BMGC_DG08025,BMG_DG140443,UNII:U5N7SU872W | NDC:51672-5293 | PubChem CID:4004 | PubChem SID:175272019 | NDC:68022-0001 | diethyl 2-dimethoxyphosphinothioylsulfanylbutanedioate | DrugBank ID:DB00772 | MALATHION | CAS RN:121-75-5 | Malathion | NDC:51672-5294
+BMGC_DG08026,BMG_DG140451,"methyl (4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicene-4a-carboxylate | CAS RN:218600-53-4 | DrugBank ID:DB05983 | Bardoxolone methyl | BARDOXOLONE METHYL | PubChem CID:400769 | UNII:CEG1Q6OGU1 | PubChem SID:198986787"
+BMGC_DG08027,BMG_DG140454,"DrugBank ID:DB09238 | CAS RN:120092-68-4 | 5-O-[2-(4-benzhydrylpiperazin-1-yl)ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | Manidipine | PubChem SID:198981973 | CAS RN:89226-50-6 | MANIDIPINE | PubChem CID:4008 | UNII:6O4754US88"
+BMGC_DG08028,BMG_DG140462,"DrugBank ID:DB00934 | CAS RN:10262-69-8 | Maprotiline | UNII:2U1W68TROF | MAPROTILINE | N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine | PubChem SID:175267017 | PubChem CID:4011"
+BMGC_DG08029,BMG_DG140464,"[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,5-dihydroxy-4-methoxybenzoate | PubChem CID:401129 | PubChem SID:198976624 | 4''-Methylepigallocatechin gallate | CAS RN:224434-07-5 | 4''-METHYLEPIGALLOCATECHIN GALLATE | UNII:CUX41G3911"
+BMGC_DG08030,BMG_DG140465,"CAS RN:51753-57-2 | PubChem CID:40113 | Phenazepam | 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one | PHENAZEPAM | PubChem SID:198985807 | UNII:3DSB43090Z"
+BMGC_DG08031,BMG_DG140466,UNII:GDA8H34CW7 | 7-aminonaphthalen-1-ol | 7-Amino-1-naphthol | 7-AMINO-1-NAPHTHOL | CAS RN:4384-92-3 | PubChem CID:40116 | PubChem SID:363909512
+BMGC_DG08032,BMG_DG140467,"PubChem SID:241177565 | 3-CARBOXYTHIOXANTHONE 10,10-DIOXIDE | CAS RN:51762-52-8 | PubChem CID:40118 | UNII:D922HIK89Q"
+BMGC_DG08033,BMG_DG140468,"UNII:U5Q9UW0HCH | DOXANTRAZOLE | PubChem CID:40119 | 10,10-dioxo-3-(2H-tetrazol-5-yl)thioxanthen-9-one | PubChem SID:198971908 | CAS RN:51762-95-9 | Doxantrazole"
+BMGC_DG08034,BMG_DG140492,PubChem SID:198982200 | Hydrogen Sulfide | CAS RN:7783-06-4 | CAS RN:63705-05-5 | HYDROGEN SULFIDE | PubChem CID:402 | UNII:YY9FVM7NSN | CAS RN:37331-50-3 | sulfane
+BMGC_DG08035,BMG_DG140493,"PubChem SID:198951106 | CAS RN:22232-71-9 | UNII:C56709M5NH | PubChem CID:4020 | MAZINDOL | DrugBank ID:DB00579 | Mazindol | 5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol"
+BMGC_DG08036,BMG_DG140495,NDC:0781-3527 | NDC:68083-500 | NDC:39822-4500 | EDARAVONE | UNII:S798V6YJRP | DrugBank ID:DB12243 | NDC:68083-501 | NDC:81298-7050 | 5-methyl-2-phenyl-4H-pyrazol-3-one | PubChem SID:198948709 | PubChem CID:4021 | NDC:39822-4510 | CAS RN:89-25-8 | Edaravone | NDC:66794-259 | NDC:70510-2171
+BMGC_DG08037,BMG_DG140498,CAS RN:7614-29-1 | PubChem SID:198975653 | PubChem CID:4022 | (4-(M-CHLOROPHENYLCARBAMOYLOXY)-2-BUTYNYL)TRIMETHYLAMMONIUM | UNII:JO67EL43YO
+BMGC_DG08038,BMG_DG140502,UNII:30760ZE777 | Isopto cetamide | sodium;acetyl-(4-aminophenyl)sulfonylazanide | PubChem CID:4022878 | PubChem SID:198986034 | CAS RN:127-56-0 | SULFACETAMIDE SODIUM ANHYDROUS
+BMGC_DG08039,BMG_DG140512,PubChem SID:198973718 | MDL72527 | MDL-72527 FREE BASE | CAS RN:99207-33-7 | UNII:G28L05X0YB | DrugBank ID:DB04188 | PubChem CID:4026
+BMGC_DG08040,BMG_DG140520,4-aminophenol | p-Aminophenol | PubChem CID:403 | PubChem SID:175265938 | P-AMINOPHENOL | UNII:R7P8FRP05V | DrugBank ID:DB14144 | CAS RN:123-30-8
+BMGC_DG08041,BMG_DG140521,NDC:64896-669 | CAS RN:31431-39-7 | DrugBank ID:DB00643 | UNII:81G6I5V05I | methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate | MEBENDAZOLE | PubChem CID:4030 | PubChem SID:175267660 | NDC:50458-675 | Mebendazole
+BMGC_DG08042,BMG_DG140523,CAS RN:2010-06-2 | PubChem SID:255509097 | PubChem CID:40302 | PHENTHIAZAMINE | UNII:WF2822RIUS
+BMGC_DG08043,BMG_DG140526,PubChem SID:472424712 | FAGARONINE CHLORIDE | UNII:8NA32GM9TE | PubChem CID:40304 | CAS RN:52259-64-0
+BMGC_DG08044,BMG_DG140528,"4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate | MEBEVERINE | PubChem SID:198958004 | CAS RN:3625-06-7 | Mebeverine | PubChem CID:4031 | UNII:7F80CC3NNV | DrugBank ID:DB12554"
+BMGC_DG08045,BMG_DG140533,"N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine | DrugBank ID:DB00657 | CAS RN:60-40-2 | Mecamylamine | PubChem CID:4032"
+BMGC_DG08046,BMG_DG140534,PubChem SID:198979450 | (2-amino-3H-benzimidazol-5-yl)-phenylmethanone | CAS RN:52329-60-9 | 2-Amino-5-benzoylbenzimidazole | R-18986 | UNII:X6Y3DED23D | PubChem CID:40320
+BMGC_DG08047,BMG_DG140535,"NDC:0472-0242 | NDC:46122-108 | NDC:45802-269 | NDC:50090-5888 | NDC:63471-3006 | CAS RN:52341-32-9 | NDC:63736-030 | NDC:36800-629 | CAS RN:82523-59-9 | NDC:70000-0041 | NDC:70518-2945 | NDC:67296-1058 | UNII:509F88P9SZ | NDC:0113-1910 | CAS RN:52341-33-0 | NDC:59651-834 | NDC:0363-0955 | PubChem SID:175267691 | (3-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate | NDC:67296-1057 | NDC:59779-769 | Permethrin | NDC:68788-8439 | CAS RN:52645-53-1 | PubChem CID:40326 | PERMETHRIN | DrugBank ID:DB04930 | NDC:21922-021 | NDC:16714-897 | NDC:72162-2171 | CAS RN:93389-07-2"
+BMGC_DG08048,BMG_DG140536,UNII:50D9XSG0VR | CAS RN:51-75-2 | NDC:69639-120 | MECHLORETHAMINE | PubChem CID:4033 | 2-chloro-N-(2-chloroethyl)-N-methylethanamine | DrugBank ID:DB00888 | Mechlorethamine | PubChem SID:175265570
+BMGC_DG08049,BMG_DG140537,DrugBank ID:DB00737 | MECLIZINE | Meclizine | PubChem SID:175272030 | 1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine | CAS RN:569-65-3 | UNII:3L5TQ84570 | PubChem CID:4034
+BMGC_DG08050,BMG_DG140543,"2-[(2,6-Dichloro-3-methylphenyl)amino]benzoate | 2-(2,6-dichloro-3-methylanilino)benzoate | PubChem CID:4036"
+BMGC_DG08051,BMG_DG140546,"DrugBank ID:DB00939 | MECLOFENAMIC ACID | PubChem SID:175266333 | PubChem CID:4037 | Meclofenamic acid | CAS RN:644-62-2 | Meclofenamic Acid | 2-(2,6-dichloro-3-methylanilino)benzoic acid | UNII:48I5LU4ZWD"
+BMGC_DG08052,BMG_DG140547,"PubChem SID:485663378 | UNII:G7W3R5VC9Y | PubChem CID:403788 | CAS RN:5735-41-1 | 1-HYDROXY-2,1-BENZOXABOROLANE | 1-Hydroxy-2,1-benzoxaborolane"
+BMGC_DG08053,BMG_DG140554,Meclofenoxate | DrugBank ID:DB13758 | MECLOFENOXATE | 2-(dimethylamino)ethyl 2-(4-chlorophenoxy)acetate | PubChem SID:175267919 | UNII:C76QQ2I0RG | PubChem CID:4039 | CAS RN:51-68-3
+BMGC_DG08054,BMG_DG140555,"UNII:5286RBZ882 | PubChem CID:40391 | 7-chloro-5-phenyl-1-prop-2-ynyl-3H-1,4-benzodiazepin-2-one | Pinazepam | CAS RN:52463-83-9 | DrugBank ID:DB13335 | PINAZEPAM | PubChem SID:198951077"
+BMGC_DG08055,BMG_DG140558,"Fumitremorgin C | CAS RN:118974-02-0 | (1S,12S,15S)-7-methoxy-12-(2-methylprop-1-enyl)-10,13,19-triazapentacyclo[11.7.0.03,11.04,9.015,19]icosa-3(11),4(9),5,7-tetraene-14,20-dione | PubChem CID:403923"
+BMGC_DG08056,BMG_DG140559,UNII:38K9TOD4EG | PubChem CID:40399 | PubChem SID:198959775 | CAS RN:52479-85-3 | EXIFONE
+BMGC_DG08057,BMG_DG140561,"7-chloro-1-methyl-5-phenyl-2,3-dihydro-1,4-benzodiazepine | PubChem SID:198965930 | Medazepam | UNII:P0J3387W3S | DrugBank ID:DB13437 | CAS RN:2898-12-6 | PubChem CID:4041 | MEDAZEPAM"
+BMGC_DG08058,BMG_DG140580,"S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate | DrugBank ID:DB08217 | PubChem CID:40428878"
+BMGC_DG08059,BMG_DG140593,CAS RN:1236-21-1 | PubChem SID:485665627 | 3-Benzo[a]anthracen-12-ylthiophene | 3-BENZO(A)ANTHRACEN-12-YLTHIOPHENE | PubChem CID:4043484 | UNII:6SES3N2NUD
+BMGC_DG08060,BMG_DG140594,"PubChem SID:175266319 | NDC:68180-185 | UNII:367589PJ2C | PubChem CID:4044 | NDC:80425-0306 | NDC:62250-677 | NDC:42571-258 | NDC:72162-2382 | Mefenamic Acid | MEFENAMIC ACID | Mefenamic acid | CAS RN:61-68-7 | DrugBank ID:DB00784 | NDC:80425-0423 | 2-(2,3-dimethylanilino)benzoic acid"
+BMGC_DG08061,BMG_DG140602,"Lariam | CAS RN:49752-90-1 | [2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol | DrugBank ID:DB00358 | PubChem CID:4046 | Mefloquine"
+BMGC_DG08062,BMG_DG140631,"PubChem SID:249493126 | ADEZMAPIMOD, (R)- | UNII:WS78QR6DSV | PubChem CID:40467016 | 4-[4-(4-Fluorophenyl)-2-[4-[(R)-methylsulfinyl]phenyl]-1H-imidazol-5-yl]pyridine | CAS RN:652162-77-1 | DrugBank ID:DB08521"
+BMGC_DG08063,BMG_DG140655,"[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate | Dexamethasone phosphate(2-) | PubChem CID:40468194"
+BMGC_DG08064,BMG_DG140667,"PubChem SID:198967152 | UNII:X1NS9SNS92 | CAS RN:7195-27-9 | PubChem CID:4047 | DrugBank ID:DB13405 | Mefruside | MEFRUSIDE | 4-chloro-1-N-methyl-1-N-[(2-methyloxolan-2-yl)methyl]benzene-1,3-disulfonamide"
+BMGC_DG08065,BMG_DG140689,"Betulinate | PubChem CID:40473200 | (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate"
+BMGC_DG08066,BMG_DG140705,"CAS RN:52663-72-6 | PubChem SID:198978607 | PubChem CID:40479 | 2,3',4,4',5,5'-Hexachlorobiphenyl | 2,3',4,4',5,5'-HEXACHLOROBIPHENYL | 1,2,3-trichloro-5-(2,4,5-trichlorophenyl)benzene | UNII:HD4MZI40CH"
+BMGC_DG08067,BMG_DG140749,"PubChem CID:4049 | 6-(methylamino)hexane-1,2,3,4,5-pentol | 6-(Methylamino)hexane-1,2,3,4,5-pentol | CAS RN:90191-92-7"
+BMGC_DG08068,BMG_DG140782,DrugBank ID:DB12827 | PubChem SID:198978805 | Indoximod | INDOXIMOD | CAS RN:110117-83-4 | UNII:TX5CYN1KMZ | (2R)-2-amino-3-(1-methylindol-3-yl)propanoic acid | PubChem CID:405012
+BMGC_DG08069,BMG_DG140813,NE-58018 | PubChem SID:198961072 | PubChem CID:405372 | CAS RN:105462-23-5 | UNII:0QRY57BJCX
+BMGC_DG08070,BMG_DG140819,"CAS RN:70010-82-1 | [{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate | (((5-CHLORO-2-PYRIDINYL)AMINO) METHYLENE)-1,1-BISPHOSPHONATE | UNII:UIQ69AB4DJ | PubChem SID:440089872 | PubChem CID:405389 | DrugBank ID:DB03649"
+BMGC_DG08071,BMG_DG140820,"CAS RN:52809-07-1 | PubChem SID:198936415 | (2S)-2-amino-3-(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)propanoic acid | PubChem CID:40539 | Quisqualic Acid | DrugBank ID:DB02999 | Quisqualic acid | UNII:8OC22C1B99 | QUISQUALIC ACID"
+BMGC_DG08072,BMG_DG140821,"Memantine | PubChem SID:175267292 | CAS RN:19982-08-2 | UNII:W8O17SJF3T | DrugBank ID:DB01043 | 3,5-dimethyladamantan-1-amine | PubChem CID:4054 | MEMANTINE"
+BMGC_DG08073,BMG_DG140825,"Menadione | PubChem CID:4055 | 2-methylnaphthalene-1,4-dione | CAS RN:58-27-5 | CAS RN:34524-96-4 | NDC:44911-0550 | DrugBank ID:DB00170 | PubChem SID:175267675 | MENADIONE | UNII:723JX6CXY5"
+BMGC_DG08074,BMG_DG140856,"PubChem SID:175271755 | (1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate | Mepenzolate | CAS RN:25990-43-6 | DrugBank ID:DB04843 | PubChem CID:4057 | UNII:ONW3LB39P7 | MEPENZOLATE"
+BMGC_DG08075,BMG_DG140880,PubChem CID:4058 | DrugBank ID:DB00454 | CAS RN:57-42-1 | MEPERIDINE | PubChem SID:175267872 | UNII:9E338QE28F | ethyl 1-methyl-4-phenylpiperidine-4-carboxylate | CAS RN:53484-75-6 | Meperidine
+BMGC_DG08076,BMG_DG140889,UNII:BN6QHA4JW4 | PubChem CID:4058452 | VAS-2870 | CAS RN:722456-31-7 | PubChem SID:472422116
+BMGC_DG08077,BMG_DG140892,"PubChem CID:40585 | PubChem SID:198934590 | UNII:2JTS8R821G | DELTAMETHRIN | CAS RN:62229-77-0 | [(S)-cyano-(3-phenoxyphenyl)methyl] (1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylate | CAS RN:52918-63-5 | Deltamethrin | DrugBank ID:DB13600"
+BMGC_DG08078,BMG_DG140893,"DrugBank ID:DB09194 | UNII:KAI6MVO39Z | PubChem SID:198947512 | 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-4,5-diethyl-1,2,4-triazol-3-one | CAS RN:52942-31-1 | PubChem CID:40589 | Etoperidone | ETOPERIDONE"
+BMGC_DG08079,BMG_DG140894,"DrugBank ID:DB13583 | Mephenesin | MEPHENESIN | 3-(2-methylphenoxy)propane-1,2-diol | PubChem SID:198979937 | CAS RN:59-47-2 | PubChem CID:4059 | UNII:7B8PIR2954"
+BMGC_DG08080,BMG_DG140897,PubChem SID:478839260 | UNII:NX9VGZ9SAE | CAS RN:971-34-6 | N-(1-BENZYL-4-PIPERIDINYL)BENZAMIDE | PubChem CID:40598 | N-(1-Benzyl-4-piperidinyl)benzamide
+BMGC_DG08081,BMG_DG140898,"PubChem SID:175271443 | MEPHENYTOIN | Mephenytoin | DrugBank ID:DB00532 | 5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione | UNII:R420KW629U | CAS RN:50-12-4 | PubChem CID:4060"
+BMGC_DG08082,BMG_DG140904,1H-indol-2-yl(4-methylpiperazin-1-yl)methanone | UNII:RTJ6P5MVP9 | 1H-INDOL-2-YL(4-METHYLPIPERAZIN-1-YL)METHANONE | CAS RN:73187-30-1 | PubChem SID:478838324 | PubChem CID:4060730
+BMGC_DG08083,BMG_DG140909,"DrugBank ID:DB00961 | Mepivacaine | N-(2,6-dimethylphenyl)-1-methylpiperidine-2-carboxamide | PubChem SID:175271542 | CAS RN:96-88-8 | MEPIVACAINE | PubChem CID:4062 | CAS RN:22801-44-1 | UNII:B6E06QE59J"
+BMGC_DG08084,BMG_DG140915,NDC:50228-443 | NDC:50228-441 | NDC:76282-717 | NDC:69097-987 | 5-methyl-1-phenylpyridin-2-one | UNII:D7NLD2JX7U | NDC:50242-121 | NDC:16729-467 | NDC:42385-923 | NDC:0781-8085 | NDC:62332-480 | NDC:69539-120 | NDC:72205-182 | NDC:42571-335 | NDC:72603-258 | CAS RN:53179-13-8 | Pirfenidone | PubChem CID:40632 | NDC:69539-119 | NDC:70954-870 | PubChem SID:175268923 | NDC:60505-4682 | NDC:69097-988 | DrugBank ID:DB04951 | NDC:0480-3611 | NDC:42385-925 | NDC:72205-181 | NDC:0781-8086 | NDC:69238-1640 | PIRFENIDONE | NDC:0480-3610 | NDC:16729-468 | NDC:76282-715 | NDC:50228-442 | NDC:42571-336 | NDC:60219-1642 | NDC:51407-913 | NDC:51407-914 | NDC:69238-1641 | NDC:31722-873 | NDC:70954-869 | NDC:42291-490 | NDC:0904-7398 | NDC:0904-7397 | NDC:42385-924 | NDC:42385-926 | NDC:0781-2158 | NDC:50242-123 | NDC:69097-940 | NDC:76282-716 | NDC:46708-480 | NDC:46708-479 | NDC:69238-1642 | NDC:42291-492 | NDC:72603-259 | NDC:50242-122 | NDC:62332-479 | NDC:60219-1640 | NDC:31722-872 | NDC:60219-1641 | NDC:42291-491 | NDC:60505-4681
+BMGC_DG08085,BMG_DG140916,"PubChem SID:198989637 | CAS RN:56305-04-5 | Trolox | CAS RN:53188-07-1 | PubChem CID:40634 | 6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromene-2-carboxylic acid | UNII:S18UL9710X | 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID"
+BMGC_DG08086,BMG_DG140923,DrugBank ID:DB00371 | NDC:51672-4147 | NDC:62332-019 | NDC:62332-020 | PubChem SID:175268791 | [2-(carbamoyloxymethyl)-2-methylpentyl] carbamate | NDC:46708-020 | UNII:9I7LNY769Q | PubChem CID:4064 | Meprobamate | NDC:69097-974 | MEPROBAMATE | NDC:46708-019 | NDC:51672-4148 | CAS RN:57-53-4 | NDC:69097-975
+BMGC_DG08087,BMG_DG140924,UNII:960006OI1S | PubChem CID:406400 | CAS RN:105462-25-7 | NE-58043 | PubChem SID:198938827
+BMGC_DG08088,BMG_DG140931,PubChem CID:4066 | UNII:Y463242LY2 | Mequitazine | CAS RN:29216-28-2 | PubChem SID:198977154 | 10-(1-azabicyclo[2.2.2]octan-3-ylmethyl)phenothiazine | MEQUITAZINE | DrugBank ID:DB01071
+BMGC_DG08089,BMG_DG140942,"CAS RN:147368-41-0 | PubChem SID:496143555 | CAS RN:51742-87-1 | Mefloquine | CAS RN:53230-10-7 | UNII:TML814419R | MEFLOQUINE | PubChem SID:175271599 | MEFLOQUINE, (+)- | Mefloquine, (+)- | PubChem CID:40692 | (S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol | UNII:5G5QQ725P9"
+BMGC_DG08090,BMG_DG140945,"PubChem CID:40703 | 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-2-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium;bromide | CAS RN:53251-94-8 | Pinaverium Bromide"
+BMGC_DG08091,BMG_DG140947,"Pinaverium | 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethyl-2-bicyclo[3.1.1]heptanyl)ethoxy]ethyl]morpholin-4-ium | CAS RN:59995-65-2 | PubChem CID:40704 | DrugBank ID:DB09090"
+BMGC_DG08092,BMG_DG140958,"PubChem SID:387065298 | PubChem CID:407233 | 1-(3-CHLOROPHENYL)-6,6-DIMETHYL-1,3,5-TRIAZINE-2,4-DIAMINE | UNII:47GU3ESV2R | CAS RN:13351-02-5"
+BMGC_DG08093,BMG_DG140959,"1-(3-Bromophenyl)-1,6-dihydro-6,6-dimethyl-1,3,5-triazine-2,4-diamine | PubChem SID:482553664 | PubChem CID:407235 | UNII:A9X5HV65HP | 1-(3-BROMOPHENYL)-1,6-DIHYDRO-6,6-DIMETHYL-1,3,5-TRIAZINE-2,4-DIAMINE | CAS RN:24849-96-5"
+BMGC_DG08094,BMG_DG140962,"3-Carbamimidamido-1,1-diphenylurea | DrugBank ID:DB07120 | PubChem CID:4073054"
+BMGC_DG08095,BMG_DG140968,5-(2-Phenylethynyl)pyrimidine | 5-(2-PHENYLETHYNYL)PYRIMIDINE | PubChem CID:4074142 | PubChem SID:475550295 | CAS RN:71418-88-7 | UNII:LA7G57CJ2R
+BMGC_DG08096,BMG_DG140972,NDC:63304-089 | UNII:4Q81I59GXC | PubChem CID:4075 | NDC:50090-3002 | NDC:60687-650 | NDC:62332-724 | NDC:0591-2245 | DrugBank ID:DB00244 | CAS RN:89-57-6 | NDC:67877-717 | NDC:54092-189 | NDC:68382-435 | NDC:70771-1353 | NDC:0378-1375 | NDC:72162-2302 | NDC:0023-5853 | NDC:0037-0066 | NDC:51407-900 | PubChem SID:175266516 | NDC:58914-501 | NDC:62135-714 | NDC:70771-1071 | NDC:63629-2397 | NDC:54092-191 | NDC:31722-005 | NDC:50742-371 | NDC:70710-1543 | NDC:64980-282 | NDC:70771-1625 | NDC:72162-1804 | NDC:72162-2213 | NDC:72162-2231 | MESALAMINE | NDC:70771-1110 | NDC:0093-9224 | NDC:63304-175 | NDC:45802-098 | CAS RN:51481-17-5 | NDC:70710-1302 | Mesalamine | NDC:54092-100 | NDC:59651-397 | NDC:68382-711 | NDC:31722-043 | NDC:69918-560 | NDC:60687-397 | NDC:51407-274 | Mesalazine | NDC:54092-476 | NDC:43353-884 | NDC:0904-6832 | NDC:0093-5907 | NDC:65649-103 | NDC:70748-214 | NDC:0832-6056 | NDC:46708-724 | NDC:0527-3012 | NDC:70771-1513 | NDC:0472-1915 | NDC:60687-556 | NDC:62559-420 | NDC:63629-8827 | NDC:72603-304 | NDC:0037-0022 | NDC:68382-452 | NDC:16714-830 | NDC:60687-408 | 5-amino-2-hydroxybenzoic acid | NDC:59762-0117 | NDC:68682-113 | NDC:42291-489 | NDC:16714-245 | NDC:0480-7750 | NDC:50268-577 | NDC:21922-045
+BMGC_DG08097,BMG_DG140979,"2-(3,4,5-trimethoxyphenyl)ethanamine | Mescaline | MESCALINE | CAS RN:54-04-6 | UNII:RHO99102VC | PubChem CID:4076 | PubChem SID:198961939"
+BMGC_DG08098,BMG_DG140989,"5-[4-phenyl-5-(trifluoromethyl)thiophen-2-yl]-3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole | CAS RN:256414-75-2 | PubChem CID:4077460 | Sew2871"
+BMGC_DG08099,BMG_DG140994,DrugBank ID:DB00933 | MESORIDAZINE | CAS RN:5588-33-0 | 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine | PubChem SID:175271394 | PubChem CID:4078 | Mesoridazine | UNII:5XE4NWM740
+BMGC_DG08100,BMG_DG141011,"2-Pyrrolidinone, 1-methyl-5-(3-pyridinyl)- | PubChem CID:408 | 1-methyl-5-pyridin-3-ylpyrrolidin-2-one | CAS RN:66269-66-7 | CAS RN:15569-85-4"
+BMGC_DG08101,BMG_DG141017,"Morphinan, 6,7,8,14-tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methyl-, (5alpha)- | 7,9-dimethoxy-3-methyl-2,4,7a,13-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline | PubChem CID:408120"
+BMGC_DG08102,BMG_DG141023,PubChem SID:198938481 | UNII:9Z709558TZ | FENDOSAL | CAS RN:53597-27-6 | PubChem CID:40821
+BMGC_DG08103,BMG_DG141031,CAS RN:2038-03-1 | PubChem CID:408285 | 2-Morpholinoethylamine | UNII:T92F2H779P | DrugBank ID:DB03096 | 2-MORPHOLINOETHYLAMINE | PubChem SID:272993956
+BMGC_DG08104,BMG_DG141035,"PubChem CID:40839 | methyl (13S,15S,17S)-13-[(1R,9R,10S,11R,12R,19R)-10-carbamoyl-12-ethyl-10,11-dihydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraen-4-yl]-17-ethyl-17-hydroxy-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraene-13-carboxylate | Vindesine | DrugBank ID:DB00309 | CAS RN:53643-48-4"
+BMGC_DG08105,BMG_DG141042,DrugBank ID:DB11446 | Oxfendazole | OXFENDAZOLE | PubChem SID:175266715 | CAS RN:53716-50-0 | methyl N-[6-(benzenesulfinyl)-1H-benzimidazol-2-yl]carbamate | PubChem CID:40854 | UNII:OMP2H17F9E
+BMGC_DG08106,BMG_DG141044,"PubChem CID:4086 | 5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,3-diol | Orciprenaline | DrugBank ID:DB00816 | UNII:53QOG569E0 | METAPROTERENOL | CAS RN:586-06-1 | Metaproterenol | PubChem SID:175271809"
+BMGC_DG08107,BMG_DG141058,"3-(diaminomethylidene)-1,1-dimethylguanidine | METFORMIN | Metformin | PubChem CID:4091 | PubChem SID:175267504 | DrugBank ID:DB00331 | CAS RN:657-24-9 | UNII:9100L32L2N"
+BMGC_DG08108,BMG_DG141061,PubChem CID:40915 | Lodoxamide ethyl | ethyl 2-[2-chloro-5-cyano-3-[(2-ethoxy-2-oxoacetyl)amino]anilino]-2-oxoacetate | LODOXAMIDE ETHYL | PubChem SID:198963914 | CAS RN:53882-13-6 | UNII:TQY1B8145B
+BMGC_DG08109,BMG_DG141066,"Act-462206 | UNII:64ONO62P28 | (2S)-N-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxamide | PubChem CID:40924317 | CAS RN:1361321-96-1 | PubChem SID:317229425 | ACT-462206"
+BMGC_DG08110,BMG_DG141071,"METHADONE | CAS RN:76-99-3 | UNII:UC6VBE7V1Z | PubChem CID:4095 | DrugBank ID:DB00333 | Methadone | 6-(dimethylamino)-4,4-diphenylheptan-3-one | PubChem SID:175272113"
+BMGC_DG08111,BMG_DG141074,DrugBank ID:DB14972 | PubChem CID:4096 | Methamidophos | [amino(methylsulfanyl)phosphoryl]oxymethane | CAS RN:10265-92-6 | UNII:8Z083FM94W | PubChem SID:198951217 | METHAMIDOPHOS
+BMGC_DG08112,BMG_DG141078,DrugBank ID:DB00940 | PubChem SID:198968480 | diethyl-methyl-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium | Methantheline | METHANTHELINE | CAS RN:5818-17-7 | UNII:36EI79TX7I | PubChem CID:4097
+BMGC_DG08113,BMG_DG141079,"Desogestrel | (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-11-methylidene-1,2,3,6,7,8,9,10,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol | PubChem SID:175267238 | PubChem CID:40973 | DrugBank ID:DB00304 | CAS RN:54024-22-5 | DESOGESTREL | UNII:81K9V7M3A3"
+BMGC_DG08114,BMG_DG141082,PubChem CID:4097574 | [Hydroxy(oxido)phosphoryl] phosphate | CAS RN:42499-21-8 | [hydroxy(oxido)phosphoryl] phosphate
+BMGC_DG08115,BMG_DG141083,"Digitin | PubChem CID:409778 | CAS RN:11024-24-1 | 2-[2-[2-[6-(3,15-dihydroxy-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-yl)oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol"
+BMGC_DG08116,BMG_DG141085,"METHAPYRILENE | N,N-dimethyl-N'-pyridin-2-yl-N'-(thiophen-2-ylmethyl)ethane-1,2-diamine | PubChem SID:198947704 | Methapyrilene | CAS RN:91-80-5 | UNII:A01LX40298 | DrugBank ID:DB04819 | PubChem CID:4098"
+BMGC_DG08117,BMG_DG141092,"Metharbital | UNII:02OS7K758T | PubChem CID:4099 | METHARBITAL | 5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trione | DrugBank ID:DB00463 | CAS RN:50-11-3 | PubChem SID:198967192"
+BMGC_DG08118,BMG_DG141095,"NDC:51407-026 | NDC:42571-240 | NDC:72162-1755 | PubChem CID:4100 | METHAZOLAMIDE | NDC:0574-0791 | NDC:72162-1754 | NDC:67046-1193 | NDC:62559-241 | NDC:51407-027 | NDC:68094-908 | NDC:24208-022 | PubChem SID:175266203 | NDC:24208-023 | UNII:W733B0S9SD | NDC:51224-124 | N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide | NDC:72603-166 | NDC:63629-1987 | Methazolamide | NDC:72603-167 | METHAZOLAMIDE, (Z)- | NDC:0574-0790 | NDC:68682-022 | NDC:42571-239 | UNII:DA43GW06P1 | NDC:62559-240 | NDC:51224-024 | NDC:68682-023 | CAS RN:554-57-4 | NDC:55806-020 | DrugBank ID:DB00703 | NDC:63629-1986 | CAS RN:1164547-86-7 | PubChem SID:312525207 | NDC:68094-808 | CAS RN:2101958-72-7"
+BMGC_DG08119,BMG_DG141098,3-METHYLPHENETHYLAMINE | PubChem CID:410085 | CAS RN:55755-17-4 | UNII:46YT56V48J | PubChem SID:472423066
+BMGC_DG08120,BMG_DG141099,4-(BUTYLPHENYL)BORONIC ACID | CAS RN:145240-28-4 | UNII:3X72JB299N | PubChem CID:4100860
+BMGC_DG08121,BMG_DG141100,PubChem CID:410087 | Povidone iodine | 1-ethenylpyrrolidin-2-one;molecular iodine
+BMGC_DG08122,BMG_DG141101,"2,3-DIAMINOPHENAZINE | CAS RN:655-86-7 | PubChem CID:410099 | UNII:0B20H27U1Y | PubChem SID:198970714"
+BMGC_DG08123,BMG_DG141102,"NDC:51316-777 | NDC:57237-332 | NDC:11822-4892 | NDC:69693-518 | 1,3,5,7-tetrazatricyclo[3.3.1.13,7]decane | NDC:36800-314 | NDC:0363-1277 | NDC:69693-513 | DrugBank ID:DB06799 | Methenamine | NDC:49973-011 | NDC:69842-314 | NDC:0363-4404 | NDC:68016-003 | CAS RN:37604-90-3 | NDC:69693-512 | CAS RN:100-97-0 | NDC:70985-030 | NDC:41250-557 | PubChem CID:4101 | METHENAMINE | NDC:73712-804 | NDC:10956-763 | UNII:J50OIX95QV | PubChem SID:175265474 | NDC:46122-622 | NDC:63868-187"
+BMGC_DG08124,BMG_DG141116,UNII:18Y7S5JKZD | PubChem CID:41049 | DrugBank ID:DB13478 | PubChem SID:198974514 | 3-(3-ethyl-1-methylazepan-3-yl)phenol | CAS RN:54340-58-8 | Meptazinol | MEPTAZINOL
+BMGC_DG08125,BMG_DG141119,"1-methyl-4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazine | METITEPINE | PubChem SID:198965112 | PubChem CID:4106 | CAS RN:20229-30-5 | Methiothepin | UNII:55D94103HL"
+BMGC_DG08126,BMG_DG141120,NDC:50090-0182 | NDC:70868-910 | NDC:25021-675 | NDC:72162-1929 | NDC:0904-7058 | NDC:10135-722 | NDC:35356-887 | NDC:72789-021 | NDC:63629-1622 | NDC:55154-2129 | NDC:70010-754 | NDC:71335-1795 | NDC:68083-317 | NDC:0641-6103 | NDC:43547-405 | NDC:70868-901 | NDC:71610-174 | NDC:31722-533 | NDC:68788-7980 | NDC:72789-481 | NDC:76385-124 | NDC:72865-233 | NDC:51655-575 | NDC:71205-019 | NDC:50090-1781 | NDC:71205-097 | NDC:63629-8995 | NDC:61919-148 | NDC:45865-242 | CAS RN:3967-43-9 | NDC:72789-398 | NDC:70069-101 | NDC:72789-110 | NDC:50090-4162 | NDC:70518-1738 | NDC:35561-349 | NDC:60687-568 | NDC:80425-0138 | UNII:125OD7737X | NDC:71610-242 | NDC:63187-087 | NDC:70518-1723 | NDC:67296-1825 | NDC:60760-770 | NDC:63629-2420 | NDC:69367-256 | NDC:61919-616 | NDC:68788-8213 | NDC:50090-5846 | NDC:69584-612 | NDC:51407-467 | NDC:71610-134 | NDC:82804-121 | NDC:51407-468 | NDC:68788-7973 | NDC:68788-8172 | NDC:72162-1363 | NDC:63739-992 | NDC:80425-0021 | NDC:72887-873 | NDC:72789-429 | NDC:0615-8507 | NDC:10135-723 | NDC:68071-3636 | METHOCARBAMOL | NDC:72189-284 | NDC:60687-559 | NDC:50090-1783 | NDC:63629-2418 | NDC:50090-3556 | PubChem CID:4107 | DrugBank ID:DB00423 | NDC:66267-146 | NDC:76420-638 | NDC:55700-990 | NDC:68071-4505 | NDC:70010-770 | NDC:50268-521 | NDC:71335-2305 | NDC:51655-574 | NDC:76420-667 | NDC:71335-2383 | NDC:36000-302 | NDC:71610-599 | NDC:60760-592 | NDC:55154-2130 | NDC:72789-012 | NDC:50090-5006 | NDC:59651-341 | NDC:71335-0251 | NDC:66267-803 | NDC:71205-167 | NDC:62207-754 | NDC:71205-285 | NDC:80425-0171 | NDC:51655-195 | NDC:72789-428 | NDC:31722-534 | CAS RN:145841-69-6 | NDC:60760-725 | NDC:69584-611 | NDC:63187-130 | NDC:71335-0828 | NDC:55154-2334 | NDC:63629-1123 | NDC:67296-1662 | NDC:35561-211 | NDC:50090-0183 | NDC:71610-832 | NDC:70518-3096 | NDC:71288-716 | NDC:72162-1930 | NDC:43063-905 | NDC:43598-839 | NDC:76420-626 | PubChem SID:175272174 | NDC:50090-5847 | NDC:80425-0275 | NDC:43547-226 | NDC:50268-520 | NDC:69367-255 | Methocarbamol | NDC:50090-5008 | NDC:80425-0020 | NDC:35573-414 | NDC:59651-340 | NDC:63323-778 | NDC:55154-2335 | NDC:71610-833 | NDC:43063-903 | NDC:55150-223 | NDC:72789-397 | NDC:0276-0510 | NDC:50090-4164 | NDC:71610-223 | NDC:71205-375 | NDC:35573-413 | NDC:67296-1049 | NDC:67296-1435 | NDC:76420-258 | NDC:63629-2419 | NDC:76420-040 | NDC:68071-4520 | [2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate | NDC:72789-022 | NDC:76385-123 | NDC:70518-3117 | NDC:72789-041 | NDC:71205-103 | NDC:63629-4882 | NDC:67296-1453 | NDC:63629-9288 | NDC:63629-2417 | NDC:50090-5907 | NDC:0641-6217 | NDC:51655-205 | NDC:71610-598 | NDC:50090-0184 | NDC:72865-234 | NDC:35561-212 | NDC:80425-0283 | CAS RN:532-03-6 | NDC:63739-991 | NDC:72245-873 | NDC:61919-368 | NDC:69306-500 | NDC:70934-756 | NDC:0615-8506 | NDC:71205-068 | NDC:82982-038 | NDC:70436-149 | NDC:0904-7057 | NDC:71335-0970 | NDC:0404-9992 | NDC:62207-770 | NDC:71335-1727 | NDC:55700-890 | NDC:83008-008 | NDC:63187-019
+BMGC_DG08127,BMG_DG141121,"CAS RN:104807-40-1 | PubChem SID:249817744 | UNII:NVJ76B897D | CAS RN:3967-44-0 | PubChem CID:4108 | N,N'-bis[6-[(2-methoxyphenyl)methylamino]hexyl]octane-1,8-diamine | METHOCTRAMINE FREE BASE | Methoctramine"
+BMGC_DG08128,BMG_DG141144,"2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid | DL-Amethopterin | METHOTREXATE, (+/-)- | PubChem SID:319892031 | UNII:99ITO15X8S | PubChem CID:4112 | CAS RN:60388-53-6 | METHOTREXATE, (±)-"
+BMGC_DG08129,BMG_DG141145,"DrugBank ID:DB07646 | UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE | PubChem CID:4112111"
+BMGC_DG08130,BMG_DG141149,Methoxyamine | CAS RN:67-62-9 | DrugBank ID:DB06328 | PubChem SID:198964853 | O-methylhydroxylamine | CAS RN:199807-37-9 | METHOXYAMINE | PubChem CID:4113 | UNII:9TZH4WY30J
+BMGC_DG08131,BMG_DG141152,"CAS RN:1246819-63-5 | CAS RN:298-81-7 | CAS RN:12692-94-3 | PubChem CID:4114 | UNII:U4VJ29L7BQ | 9-methoxyfuro[3,2-g]chromen-7-one | NDC:64067-216 | Methoxsalen | METHOXSALEN | PubChem SID:175267416 | DrugBank ID:DB00553"
+BMGC_DG08132,BMG_DG141156,"UNII:30905R8O7B | 2,2-dichloro-1,1-difluoro-1-methoxyethane | METHOXYFLURANE | CAS RN:76-38-0 | PubChem SID:198981352 | PubChem CID:4116 | DrugBank ID:DB01028 | Methoxyflurane"
+BMGC_DG08133,BMG_DG141161,CAS RN:93-30-1 | Methoxyphenamine | 1-(2-methoxyphenyl)-N-methylpropan-2-amine | UNII:J3Z5SRI26Z | PubChem CID:4117 | PubChem SID:198988476 | DrugBank ID:DB13624 | METHOXYPHENAMINE
+BMGC_DG08134,BMG_DG141162,PubChem SID:475550331 | PubChem CID:411735 | Phenylethylpyrrolidine | PHENYLETHYLPYRROLIDINE | UNII:WKH6XT5AZ7 | CAS RN:6908-75-4
+BMGC_DG08135,BMG_DG141163,"PubChem SID:482553816 | UNII:H446JCN86R | PubChem CID:4117381 | 5-(1-Pyrrolidinylsulfonyl)-1H-indole-2,3-dione | 5-(1-PYRROLIDINYLSULFONYL)-1H-INDOLE-2,3-DIONE | CAS RN:220510-17-8"
+BMGC_DG08136,BMG_DG141164,"CAS RN:329905-79-5 | UNII:FE7LRT9ZCP | PubChem CID:4117383 | 5-(1-PIPERIDINYLSULFONYL)-1H-INDOLE-2,3-DIONE"
+BMGC_DG08137,BMG_DG141167,"DrugBank ID:DB15012 | CAS RN:211735-93-2 | 2,1,3-benzoxadiazol-5-yl(piperidin-1-yl)methanone | FARAMPATOR | CAS RN:211735-76-1 | Farampator | PubChem CID:4118151 | PubChem SID:198944660 | UNII:7X6P5N8K2L"
+BMGC_DG08138,BMG_DG141174,CAS RN:13450-58-3 | PubChem CID:412 | Nornicotine | CAS RN:5746-86-1 | 3-pyrrolidin-2-ylpyridine
+BMGC_DG08139,BMG_DG141178,"METHYCLOTHIAZIDE | PubChem SID:175271359 | PubChem SID:441584218 | CAS RN:96783-14-1 | UNII:R00UUL4SRN | 6-chloro-3-(chloromethyl)-2-methyl-1,1-dioxo-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide | PubChem CID:4121 | PubChem SID:440088825 | UNII:R6KDH2S0SX | CAS RN:135-07-9 | METHYCLOTHIAZIDE, (+)- | METHYCLOTHIAZIDE, (-)- | Methyclothiazide | DrugBank ID:DB00232 | CAS RN:96783-15-2 | UNII:L3H46UAC61"
+BMGC_DG08140,BMG_DG141179,"PubChem SID:198963882 | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate | CAS RN:84-21-9 | PubChem CID:41211 | 3'-Adenylic acid | UNII:R438H7I3KZ | 3'-ADENYLIC ACID"
+BMGC_DG08141,BMG_DG141184,methyl N-[6-(thiophene-2-carbonyl)-1H-benzimidazol-2-yl]carbamate | PubChem SID:198979666 | CAS RN:31430-18-9 | UNII:SH1WY3R615 | NOCODAZOLE | PubChem CID:4122 | DrugBank ID:DB08313 | Nocodazole
+BMGC_DG08142,BMG_DG141222,"4-oxahexacyclo[11.6.2.02,8.03,5.010,20.017,21]henicosa-1(20),2(8),9,11,13(21),14,16,18-octaene-6,7-diol | 7,8-Dihydro-7,8-dihydroxybenzo[a]pyrene 9,10-oxide | CAS RN:55097-80-8 | PubChem CID:41322"
+BMGC_DG08143,BMG_DG141223,methyl 2-hydroxybenzoate | PubChem SID:175267453 | Methyl Salicylate | UNII:LAV5U5022Y | CAS RN:8024-54-2 | CAS RN:9041-28-5 | CAS RN:302912-49-8 | CAS RN:119-36-8 | CAS RN:135952-76-0 | CAS RN:90045-28-6 | Methyl salicylate | PubChem CID:4133 | CAS RN:1335435-40-9 | METHYL SALICYLATE | DrugBank ID:DB09543
+BMGC_DG08144,BMG_DG141231,"PubChem CID:4135 | CAS RN:72013-76-4 | UNII:NJX1653L36 | PubChem SID:198958647 | Benzyldimethyl(2-(2-((4-(1,1,3,3-tetramethylbutyl)-o-tolyl)oxy)ethoxy)ethyl)ammonium | benzyl-dimethyl-[2-[2-[2-methyl-4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium | BENZYLDIMETHYL(2-(2-((4-(1,1,3,3-TETRAMETHYLBUTYL)-O-TOLYL)OXY)ETHOXY)ETHYL)AMMONIUM"
+BMGC_DG08145,BMG_DG141239,PubChem CID:41376 | CAS RN:55273-05-7 | 2-[3-(1H-imidazol-5-yl)propyl]-1-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine | UNII:931L4X5WMM | Impromidine | IMPROMIDINE | PubChem SID:198950151
+BMGC_DG08146,BMG_DG141247,"DrugBank ID:DB13801 | PubChem SID:198945934 | PubChem CID:41386 | Muzolimine | UNII:07Z36289ZX | 5-amino-2-[1-(3,4-dichlorophenyl)ethyl]-4H-pyrazol-3-one | CAS RN:55294-15-0 | MUZOLIMINE"
+BMGC_DG08147,BMG_DG141250,DrugBank ID:DB08167 | UNII:ZMZ79891ZH | METHYLENE BLUE CATION | Methylthioninium | PubChem CID:4139 | [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium | CAS RN:7060-82-4 | CAS RN:1001913-24-1 | Methylene blue cation | PubChem SID:175267130
+BMGC_DG08148,BMG_DG141251,"PubChem CID:413901 | PubChem SID:363909080 | 4',4''-BIS(IMIDAZOLIN-2-YL)ISOPHTHALANILIDE | CAS RN:5697-54-1 | UNII:27M3JIS0OF"
+BMGC_DG08149,BMG_DG141256,"CAS RN:54808-91-2 | CAS RN:479-03-8 | Isomethergine | N-(1-hydroxybutan-2-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | PubChem CID:4140"
+BMGC_DG08150,BMG_DG141261,UNII:T1W11CO5XU | 5-METHYLFURTRETHONIUM | PubChem CID:4141 | PubChem SID:461432723 | CAS RN:14172-53-3 | 5-Methylfurmethide | trimethyl-[(5-methylfuran-2-yl)methyl]azanium
+BMGC_DG08151,BMG_DG141268,UNII:5ES434GE9P | PubChem SID:313184281 | CAS RN:87099-13-6 | ACID BLUE 22 FREE ACID | PubChem CID:414251
+BMGC_DG08152,BMG_DG141274,PubChem CID:41448 | UNII:2KH283Q0Z5 | ISOXEPAC | CAS RN:55453-87-7 | PubChem SID:198951633
+BMGC_DG08153,BMG_DG141284,PubChem CID:414707 | 9-ISOPROPYL-9H-PURIN-6-AMINE | PubChem SID:459055601 | UNII:GG274D9X7Z | CAS RN:31601-35-1
+BMGC_DG08154,BMG_DG141289,"Hydroxypioglitazone | CAS RN:146062-44-4 | PubChem CID:4147757 | PubChem SID:333495523 | DrugBank ID:DB15021 | LERIGLITAZONE | 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | UNII:K824X25AYA"
+BMGC_DG08155,BMG_DG141301,N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE | DrugBank ID:DB08256 | PubChem CID:4149241
+BMGC_DG08156,BMG_DG141339,PubChem CID:415628 | UNII:QR3YBZ8V72 | PubChem SID:482554395 | 1-(2-CHLOROPHENYL)PIPERAZINE | CAS RN:39512-50-0 | 1-(2-Chlorophenyl)piperazine
+BMGC_DG08157,BMG_DG141345,"UNII:QBD9NT4XHL | CAS RN:77746-90-8 | N-(1,3-DIPHENYL-1H-PYRAZOL-5-YL)BENZAMIDE | PubChem SID:459276070 | PubChem CID:4156919"
+BMGC_DG08158,BMG_DG141350,PubChem CID:4158 | CAS RN:113-45-1 | DrugBank ID:DB00422 | Methylphenidate | methyl 2-phenyl-2-piperidin-2-ylacetate
+BMGC_DG08159,BMG_DG141365,PubChem SID:461433515 | PubChem CID:4161540 | CAS RN:609806-40-8 | UNII:W2PK8Q54XB | 4-HYDROXYMETHYL LORATADINE
+BMGC_DG08160,BMG_DG141366,"PubChem CID:4162 | UNII:P66Z3UR32T | 3,3-diethyl-5-methylpiperidine-2,4-dione | PubChem SID:440090069 | CAS RN:125-64-4 | CAS RN:30590-00-2 | PubChem SID:440088594 | METHYPRYLON, (-)- | UNII:CUT48I42ON | METHYPRYLON | UNII:X66M7YN35V | METHYPRYLON, (+)- | CAS RN:30590-01-3 | DrugBank ID:DB01107 | Methyprylon | PubChem SID:198966678"
+BMGC_DG08161,BMG_DG141378,"Meticrane | PubChem CID:4165 | 6-methyl-1,1-dioxo-3,4-dihydro-2H-thiochromene-7-sulfonamide | METICRANE | PubChem SID:198947919 | CAS RN:1084-65-7 | UNII:I7EKN1924Q | DrugBank ID:DB13284"
+BMGC_DG08162,BMG_DG141384,EPI-001 | PubChem CID:4166922 | UNII:A9PRH4DC8H | CAS RN:227947-06-0 | PubChem SID:474492870
+BMGC_DG08163,BMG_DG141386,METHIXENE | PubChem CID:4167 | DrugBank ID:DB00340 | UNII:32VY6L26ZW | 1-methyl-3-(9H-thioxanthen-9-ylmethyl)piperidine | PubChem SID:198981823 | CAS RN:4969-02-2 | Metixene
+BMGC_DG08164,BMG_DG141389,METOCLOPRAMIDE | 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide | DrugBank ID:DB01233 | CAS RN:364-62-5 | Metoclopramide | UNII:L4YEB44I46 | PubChem SID:175265995 | PubChem CID:4168
+BMGC_DG08165,BMG_DG141390,"[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate | Nitazoxanide | PubChem SID:175265640 | NITAZOXANIDE | UNII:SOA12P041N | DrugBank ID:DB00507 | PubChem CID:41684 | NDC:64980-526 | NDC:27437-106 | CAS RN:55981-09-4"
+BMGC_DG08166,BMG_DG141398,UNII:AFE2YW0IIZ | SUFENTANIL | DrugBank ID:DB00708 | N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide | CAS RN:56030-54-7 | NDC:61621-430 | Sufentanil | PubChem CID:41693 | PubChem SID:175268924
+BMGC_DG08167,BMG_DG141401,"NDC:58657-741 | NDC:60687-624 | NDC:72888-052 | NDC:43353-931 | NDC:60687-635 | NDC:69292-566 | NDC:76385-137 | NDC:81005-125 | NDC:10135-767 | Metolazone | NDC:43353-890 | NDC:58657-740 | NDC:72888-053 | NDC:62332-533 | NDC:51407-431 | PubChem SID:175271961 | NDC:69292-564 | NDC:76385-138 | NDC:46708-532 | NDC:51407-432 | NDC:71335-1944 | UNII:TZ7V40X7VX | 7-chloro-2-methyl-3-(2-methylphenyl)-4-oxo-1,2-dihydroquinazoline-6-sulfonamide | NDC:0904-7329 | NDC:58657-742 | NDC:51079-023 | NDC:63629-8733 | NDC:62332-534 | NDC:72162-2391 | NDC:0904-7328 | NDC:81005-124 | NDC:63629-7875 | NDC:51407-433 | NDC:50742-349 | METOLAZONE, (+)- | NDC:0185-0055 | NDC:46708-533 | NDC:71610-285 | NDC:50742-351 | PubChem SID:287445890 | NDC:50090-6972 | CAS RN:17560-51-9 | NDC:71610-142 | METOLAZONE, (-)- | NDC:43353-999 | NDC:76385-136 | PubChem CID:4170 | CAS RN:56436-31-8 | NDC:72162-2389 | NDC:0378-6173 | NDC:50742-350 | NDC:0378-6174 | METOLAZONE | NDC:46708-534 | NDC:72162-1050 | NDC:0378-6172 | NDC:72162-2390 | NDC:0185-5600 | NDC:72888-054 | NDC:51079-024 | NDC:10135-766 | NDC:50090-6802 | NDC:81005-126 | UNII:NM7V2Y3G0U | UNII:NN9U607695 | NDC:62332-532 | DrugBank ID:DB00524 | CAS RN:56436-32-9 | NDC:10135-765 | NDC:63629-8722 | NDC:0185-5050 | NDC:69292-562 | PubChem SID:287446185"
+BMGC_DG08168,BMG_DG141404,UNII:GEB06NHM23 | METOPROLOL | DrugBank ID:DB00264 | CAS RN:51384-51-1 | CAS RN:54163-88-1 | CAS RN:37350-58-6 | Metoprolol | 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol | PubChem SID:175271988 | PubChem CID:4171
+BMGC_DG08169,BMG_DG141410,NDC:67046-1269 | NDC:61919-032 | NDC:82982-072 | NDC:63187-511 | NDC:68788-8674 | NDC:50090-0213 | NDC:68001-365 | NDC:15955-388 | NDC:46708-435 | NDC:76420-800 | NDC:70518-3265 | NDC:65862-695 | NDC:70518-2663 | NDC:71209-062 | NDC:81033-066 | DrugBank ID:DB00916 | NDC:43063-719 | NDC:50090-0211 | NDC:63629-1388 | NDC:71335-0358 | NDC:51672-4116 | NDC:68071-2409 | NDC:25021-131 | NDC:62332-017 | NDC:0299-3836 | NDC:0404-9991 | NDC:70518-1536 | NDC:68682-455 | NDC:0299-3820 | NDC:70934-970 | NDC:72789-007 | NDC:55154-8190 | NDC:50090-7345 | NDC:70771-1834 | NDC:46708-429 | NDC:0642-7466 | NDC:70518-3042 | CAS RN:56010-45-8 | NDC:71209-063 | NDC:0264-5535 | NDC:43063-738 | NDC:16571-664 | NDC:72578-007 | NDC:50090-5787 | NDC:68308-663 | NDC:68788-6960 | NDC:64380-780 | NDC:76420-801 | NDC:16571-665 | NDC:68071-5073 | NDC:64980-236 | NDC:70518-1241 | NDC:50090-7160 | NDC:70882-131 | NDC:59651-813 | NDC:66993-962 | NDC:68071-2288 | NDC:72578-129 | NDC:21922-046 | NDC:50268-534 | NDC:70518-0088 | NDC:68071-5283 | NDC:67296-1418 | NDC:66993-960 | NDC:67296-1747 | NDC:55700-298 | NDC:68071-1876 | NDC:71335-1775 | NDC:46708-428 | NDC:68071-2251 | NDC:23155-652 | NDC:0338-9541 | NDC:70518-1240 | NDC:62135-836 | NDC:66993-961 | NDC:50090-0212 | NDC:60760-664 | NDC:65862-694 | NDC:68462-184 | NDC:68788-7815 | NDC:62135-796 | NDC:71335-1681 | NDC:50090-5687 | NDC:0245-0860 | NDC:72162-2259 | NDC:70518-0013 | NDC:21922-039 | NDC:68682-202 | NDC:29300-226 | NDC:82868-014 | NDC:70518-3110 | NDC:71335-1838 | NDC:70518-0058 | NDC:66993-936 | NDC:51407-376 | NDC:0713-0633 | NDC:50111-333 | NDC:50090-5691 | NDC:60687-526 | NDC:64980-235 | NDC:0904-7156 | NDC:50090-4809 | NDC:0338-1055 | NDC:62332-630 | NDC:69292-208 | NDC:51672-4164 | Metronidazole | NDC:47335-993 | NDC:58657-739 | NDC:80830-2465 | NDC:70882-130 | NDC:0299-3838 | NDC:0904-7126 | NDC:50090-5688 | NDC:51655-974 | NDC:23155-651 | NDC:70771-1045 | NDC:51407-372 | NDC:71335-1703 | NDC:0409-0152 | NDC:70771-1046 | NDC:51672-4215 | NDC:0168-0323 | NDC:50111-334 | NDC:0713-0637 | NDC:62332-016 | NDC:54348-745 | NDC:0187-5202 | NDC:62135-795 | NDC:71656-066 | NDC:67296-1283 | NDC:68788-8552 | NDC:63629-1386 | NDC:0025-1942 | NDC:60687-550 | 2-(2-methyl-5-nitroimidazol-1-yl)ethanol | NDC:68083-373 | NDC:46708-021 | NDC:50268-535 | NDC:68001-364 | NDC:72789-005 | NDC:67296-1806 | NDC:71335-0858 | UNII:140QMO216E | NDC:50090-2126 | NDC:70518-3073 | NDC:16714-557 | METRONIDAZOLE | NDC:70518-2305 | NDC:69292-207 | NDC:51655-441 | NDC:72578-008 | NDC:29300-227 | NDC:63187-827 | PubChem CID:4173 | NDC:54348-740 | NDC:70518-2814 | NDC:72789-011 | CAS RN:443-48-1 | NDC:45802-139 | NDC:72162-2159 | NDC:15955-389 | NDC:64380-779 | NDC:72789-195 | NDC:67296-2087 | NDC:0168-0383 | NDC:60760-539 | PubChem SID:175267997 | NDC:73473-303 | NDC:67296-0078 | NDC:0713-0575 | NDC:62332-018 | NDC:50090-0201 | NDC:0713-0574 | NDC:71335-1922 | NDC:63187-035 | NDC:72162-2403
+BMGC_DG08170,BMG_DG141413,"UNII:ZS9KD92H6V | CAS RN:54-36-4 | 2-methyl-1,2-dipyridin-3-ylpropan-1-one | METYRAPONE | NDC:76336-455 | PubChem SID:175267204 | DrugBank ID:DB01011 | Metyrapone | PubChem CID:4174"
+BMGC_DG08171,BMG_DG141414,UNII:9ZX6URA78L | CAS RN:56107-02-9 | PubChem SID:474490760 | 4-CHLORO-3-NITROBENZOPHENONE | PubChem CID:41743 | 4-Chloro-3-nitrobenzophenone
+BMGC_DG08172,BMG_DG141415,"PubChem CID:41744 | CAS RN:136816-53-0 | [2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate | 2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-{[5-hydroxy-6-methyl-4-(trifluoroacetamido)oxan-2-yl]oxy}-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl]ethyl pentanoate"
+BMGC_DG08173,BMG_DG141424,"PubChem SID:198951238 | CAS RN:31868-18-5 | Mexazolam | DrugBank ID:DB15489 | UNII:S5969B6237 | 10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one | PubChem CID:4177 | MEXAZOLAM"
+BMGC_DG08174,BMG_DG141426,"Glucobay | PubChem CID:41774 | (3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol"
+BMGC_DG08175,BMG_DG141428,"MEXILETINE | PubChem SID:175271833 | DrugBank ID:DB00379 | UNII:1U511HHV4Z | 1-(2,6-dimethylphenoxy)propan-2-amine | Mexiletine | CAS RN:31828-71-4 | PubChem CID:4178"
+BMGC_DG08176,BMG_DG141429,NDC:73502-287 | NDC:50111-917 | NDC:50111-916 | 1-[4-(3-methylanilino)pyridin-3-yl]sulfonyl-3-propan-2-ylurea | NDC:42291-816 | NDC:50111-918 | PubChem SID:175267084 | NDC:62135-818 | NDC:23155-872 | NDC:31722-530 | NDC:72865-258 | NDC:51407-596 | Torasemide | NDC:50268-755 | UNII:W31X2H97FB | NDC:65862-125 | NDC:50268-756 | Torsemide | NDC:50090-6499 | NDC:63629-1346 | NDC:72189-102 | NDC:73502-687 | NDC:43353-315 | NDC:62135-820 | NDC:65862-128 | NDC:73502-786 | NDC:31722-532 | NDC:57237-141 | NDC:50090-6495 | NDC:57237-138 | NDC:0054-0077 | NDC:62135-821 | NDC:0615-7997 | PubChem CID:41781 | NDC:42291-818 | NDC:71335-2143 | NDC:0904-7283 | NDC:23155-871 | NDC:65862-126 | NDC:57237-140 | NDC:42291-817 | NDC:50090-7261 | NDC:50268-757 | NDC:31722-531 | NDC:65862-127 | TORSEMIDE | NDC:50268-754 | NDC:67296-1471 | NDC:68084-539 | NDC:50111-915 | NDC:70518-2744 | NDC:57237-139 | NDC:23155-874 | NDC:42291-819 | NDC:0615-8521 | NDC:72865-259 | NDC:51407-362 | NDC:72162-2412 | NDC:51407-598 | DrugBank ID:DB00214 | NDC:50090-7425 | NDC:51407-597 | NDC:23155-873 | NDC:70518-4139 | NDC:73502-586 | NDC:72865-260 | CAS RN:56211-40-6 | NDC:71610-819 | NDC:31722-529 | NDC:62135-819 | NDC:72865-261
+BMGC_DG08177,BMG_DG141432,"PubChem CID:4179055 | CAS RN:56983-23-4 | [[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate | [[[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate"
+BMGC_DG08178,BMG_DG141447,"MEDROXALOL | Medroxalol | PubChem CID:41835 | PubChem SID:198989733 | 5-[2-[4-(1,3-benzodioxol-5-yl)butan-2-ylamino]-1-hydroxyethyl]-2-hydroxybenzamide | UNII:7PX96289JA | CAS RN:56290-94-9"
+BMGC_DG08179,BMG_DG141449,"5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene | MIANSERIN | Mianserin | DrugBank ID:DB06148 | PubChem SID:198948115 | PubChem CID:4184 | UNII:250PJI13LM | CAS RN:24219-97-4"
+BMGC_DG08180,BMG_DG141462,"CAS RN:56420-45-2 | DrugBank ID:DB00445 | EPIRUBICIN | UNII:3Z8479ZZ5X | (7S,9S)-7-[(2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione | PubChem CID:41867 | Epirubicin | PubChem SID:175268237"
+BMGC_DG08181,BMG_DG141472,"PubChem CID:4189 | NDC:61825-303 | 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole | UNII:7NNO0D7S5M | MICONAZOLE | Miconazole | NDC:84746-003 | CAS RN:75319-47-0 | CAS RN:22916-47-8 | PubChem SID:175271817 | DrugBank ID:DB01110"
+BMGC_DG08182,BMG_DG141474,"UNII:RH2OV4NMX3 | PubChem SID:363908071 | 1-(3-(4-(3-AMINOPHENYL)BUTYL)PHENYL)-1,6-DIHYDRO-6,6-DIMETHYL-1,3,5-TRIAZINE-2,4-DIAMINE | PubChem CID:419052 | CAS RN:151648-38-3"
+BMGC_DG08183,BMG_DG141485,"PubChem SID:175265628 | PubChem CID:4192 | DrugBank ID:DB00683 | MIDAZOLAM | NDC:44567-610 | UNII:R60L0SM5BC | NDC:71053-595 | 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine | CAS RN:59467-70-8 | NDC:50474-500 | NDC:44567-611 | Midazolam"
+BMGC_DG08184,BMG_DG141497,"UNII:V17MYO89WO | CAS RN:56611-65-5 | Oxagrelate | OXAGRELATE | PubChem SID:198946082 | PubChem CID:41946 | ethyl 1-(hydroxymethyl)-5,7-dimethyl-4-oxo-3H-phthalazine-6-carboxylate"
+BMGC_DG08185,BMG_DG141499,"2-amino-N-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide | PubChem CID:4195 | CAS RN:42794-76-3 | Midodrine | UNII:6YE7PBM15H | PubChem SID:175271672 | CAS RN:97476-58-9 | CAS RN:133163-28-7 | DrugBank ID:DB00211 | MIDODRINE"
+BMGC_DG08186,BMG_DG141505,CAS RN:23060-85-7 | PubChem CID:4196858 | 3-hydroxy-2-methylpyran-4-thione | 3-hydroxy-2-methyl-4H-pyran-4-thione
+BMGC_DG08187,BMG_DG141508,CAS RN:78415-72-2 | UNII:JU9YAX04C7 | PubChem SID:175267403 | PubChem CID:4197 | MILRINONE | DrugBank ID:DB00235 | 6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile | Milrinone
+BMGC_DG08188,BMG_DG141511,PubChem CID:41987 | DrugBank ID:DB04832 | Zimelidine
+BMGC_DG08189,BMG_DG141513,MINAPRINE | PubChem CID:4199 | CAS RN:25905-77-5 | DrugBank ID:DB00805 | 4-methyl-N-(2-morpholin-4-ylethyl)-6-phenylpyridazin-3-amine | UNII:00U7GX0NLM | PubChem SID:198944402 | Minaprine
+BMGC_DG08190,BMG_DG141518,"PubChem CID:42008 | CEFMETAZOLE | DrugBank ID:DB00274 | UNII:3J962UJT8H | (6R,7S)-7-[[2-(cyanomethylsulfanyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Cefmetazole | PubChem SID:198970111 | CAS RN:56796-20-4"
+BMGC_DG08191,BMG_DG141519,NDC:63629-1086 | NDC:83566-555 | NDC:83648-004 | NDC:83872-412 | NDC:11673-382 | NDC:84025-188 | NDC:51672-2129 | NDC:49884-256 | NDC:83788-201 | NDC:11822-0115 | NDC:84025-064 | NDC:82269-607 | NDC:84232-001 | NDC:83462-021 | NDC:83872-011 | NDC:84249-001 | NDC:42291-619 | NDC:63940-202 | NDC:72484-095 | NDC:51326-161 | NDC:84026-101 | NDC:83648-003 | NDC:68391-294 | NDC:83872-056 | NDC:49035-294 | NDC:84693-003 | NDC:56062-322 | NDC:82987-301 | NDC:84979-020 | UNII:5965120SH1 | NDC:63940-582 | NDC:84025-053 | NDC:68391-302 | NDC:83835-231 | NDC:79903-072 | NDC:69842-797 | NDC:82372-482 | NDC:70550-576 | NDC:83804-109 | NDC:83717-004 | NDC:84025-063 | NDC:0363-0032 | NDC:83872-466 | PubChem CID:4201 | NDC:71205-757 | NDC:70550-116 | NDC:69113-483 | NDC:84213-002 | NDC:84432-001 | NDC:71700-112 | NDC:63981-032 | NDC:84148-005 | NDC:61269-066 | NDC:83462-020 | NDC:0113-1032 | NDC:84550-003 | NDC:63629-9299 | NDC:11822-1260 | NDC:57483-535 | NDC:69113-004 | NDC:21130-273 | NDC:63629-9620 | NDC:74458-269 | NDC:84329-465 | NDC:83910-002 | NDC:84550-002 | NDC:72288-701 | NDC:0113-0798 | NDC:70550-578 | NDC:84183-101 | NDC:69113-462 | NDC:69113-431 | NDC:72789-279 | NDC:83566-145 | NDC:41250-428 | NDC:69842-598 | NDC:82376-6006 | NDC:21130-750 | NDC:84372-011 | NDC:63629-1085 | NDC:83872-006 | NDC:11822-0114 | NDC:83872-429 | NDC:63940-385 | NDC:59640-000 | NDC:83804-112 | NDC:84693-002 | NDC:83462-019 | NDC:49884-257 | NDC:57483-540 | NDC:79481-0070 | NDC:83910-001 | NDC:0363-9971 | NDC:72789-278 | NDC:71713-093 | NDC:83887-003 | NDC:71730-000 | NDC:51407-902 | NDC:71730-116 | PubChem SID:175268687 | NDC:84372-007 | NDC:0113-5129 | NDC:11822-1323 | NDC:59726-151 | NDC:56062-798 | NDC:0363-9091 | NDC:69113-432 | NDC:84372-008 | NDC:82372-011 | NDC:82987-201 | NDC:83566-270 | NDC:84372-033 | NDC:83872-424 | NDC:84372-032 | NDC:64942-2110 | NDC:84732-089 | NDC:49035-746 | NDC:84693-001 | NDC:21130-611 | NDC:83766-102 | NDC:53489-386 | NDC:30142-632 | NDC:83383-398 | NDC:64942-2115 | NDC:63981-294 | NDC:83454-404 | NDC:85173-001 | NDC:79903-222 | NDC:83566-402 | NDC:0363-2294 | NDC:68084-205 | NDC:84232-003 | NDC:59726-115 | NDC:83596-003 | NDC:83988-001 | NDC:63940-491 | NDC:85003-546 | NDC:82372-009 | NDC:84867-005 | NDC:84745-001 | NDC:84033-007 | NDC:59726-122 | NDC:84117-020 | NDC:84427-001 | NDC:69423-558 | NDC:59726-116 | NDC:72288-129 | NDC:30142-719 | NDC:83872-010 | NDC:84049-002 | DrugBank ID:DB00350 | NDC:50663-395 | NDC:84372-005 | NDC:83889-101 | NDC:74458-270 | NDC:68196-469 | NDC:70000-0653 | NDC:63629-2230 | NDC:83804-106 | NDC:51407-901 | NDC:71730-023 | NDC:82429-200 | NDC:37808-798 | NDC:82796-100 | 3-hydroxy-2-imino-6-piperidin-1-ylpyrimidin-4-amine | NDC:37808-202 | NDC:63981-380 | NDC:84095-005 | NDC:68196-032 | NDC:51326-160 | NDC:69113-001 | NDC:0363-9973 | NDC:83872-465 | CAS RN:38304-91-5 | NDC:64942-2111 | NDC:21130-163 | NDC:82376-6007 | NDC:68016-006 | NDC:61269-094 | NDC:59450-211 | NDC:71713-092 | NDC:83566-403 | NDC:71713-094 | NDC:83788-301 | NDC:0113-1129 | NDC:85092-001 | NDC:84561-514 | NDC:84010-041 | NDC:84454-001 | NDC:83675-033 | NDC:69113-003 | NDC:78192-400 | NDC:72288-294 | NDC:57483-542 | NDC:63629-2232 | NDC:84372-035 | NDC:85158-001 | NDC:83804-104 | NDC:71205-490 | NDC:59450-210 | NDC:84213-001 | NDC:74866-414 | NDC:63981-798 | NDC:83808-002 | NDC:81352-560 | NDC:83566-701 | NDC:0363-9090 | NDC:83767-201 | NDC:68788-8273 | NDC:72288-202 | NDC:11822-0798 | NDC:84856-604 | NDC:54340-211 | NDC:84450-001 | NDC:11673-157 | NDC:84019-006 | NDC:0363-9970 | NDC:84232-011 | NDC:84117-006 | NDC:69968-0089 | NDC:71730-115 | NDC:83872-516 | NDC:11673-707 | NDC:69113-128 | NDC:81632-408 | NDC:69968-0090 | NDC:84117-016 | NDC:83804-108 | NDC:84049-001 | NDC:11673-431 | NDC:84033-008 | NDC:0363-0703 | NDC:51672-2128 | NDC:56062-070 | NDC:84117-017 | NDC:84561-524 | NDC:58602-607 | NDC:60771-0008 | NDC:68016-382 | NDC:84302-005 | NDC:85174-001 | NDC:11673-158 | NDC:63629-9433 | NDC:59726-125 | NDC:59779-294 | NDC:84302-003 | NDC:11673-189 | NDC:82987-101 | NDC:84372-012 | NDC:83872-436 | NDC:70550-503 | NDC:69113-002 | NDC:51316-213 | MINOXIDIL | NDC:83872-411 | NDC:84732-014 | NDC:70550-602 | NDC:56062-202 | NDC:69423-559 | NDC:84025-079 | Minoxidil | NDC:0591-5642 | NDC:63629-2231 | NDC:84019-401 | NDC:84856-603 | NDC:37808-833 | NDC:71730-129 | NDC:83675-035 | NDC:83719-427 | NDC:83462-022 | NDC:83804-105 | NDC:85097-576 | NDC:84249-002 | NDC:80855-201 | NDC:84232-002 | NDC:69968-0030 | NDC:83872-421 | NDC:83563-003 | NDC:53489-387 | NDC:11822-0606 | NDC:0363-9972 | NDC:84693-004 | NDC:49035-905 | NDC:59779-202 | NDC:21130-819 | NDC:84519-003 | NDC:68084-204 | NDC:43353-342 | NDC:83566-556 | NDC:83767-101 | NDC:71713-091 | NDC:83872-413 | NDC:11673-317 | NDC:83566-401 | NDC:72162-1490 | NDC:58602-608 | NDC:84778-022 | NDC:71730-294 | NDC:83766-101 | NDC:84117-021 | NDC:11673-919 | NDC:11822-0702 | NDC:72162-1489 | NDC:84372-009 | NDC:72288-798 | NDC:84550-001 | NDC:71290-813 | NDC:70550-605 | NDC:0591-5643 | NDC:11673-798 | NDC:84372-004 | NDC:83804-110 | NDC:84542-367 | NDC:81352-561 | NDC:84329-466 | NDC:84372-003 | NDC:84025-180 | NDC:68196-823 | NDC:84372-010 | NDC:69842-599 | NDC:72484-097 | NDC:84025-181 | NDC:84979-016 | NDC:11822-0202 | NDC:84372-006 | NDC:69968-0031 | NDC:69113-129 | NDC:84372-013 | NDC:84372-034 | NDC:84232-004 | NDC:51316-212 | NDC:42291-618 | NDC:84033-002 | NDC:11673-632 | NDC:84025-179 | NDC:57483-530 | NDC:41250-294 | NDC:30142-294
+BMGC_DG08192,BMG_DG141530,PubChem CID:4204917 | CAS RN:23981-25-1 | 8-chloroquinolin-2(1H)-one | 8-chloro-1H-quinolin-2-one
+BMGC_DG08193,BMG_DG141531,"NDC:68788-7251 | NDC:78206-159 | PubChem SID:175271532 | NDC:72162-1640 | NDC:68084-120 | NDC:60687-584 | NDC:67046-2054 | MIRTAZAPINE | NDC:60505-0247 | NDC:51407-352 | NDC:65862-032 | NDC:71610-717 | NDC:66993-607 | NDC:50090-1057 | NDC:71610-853 | NDC:13107-031 | NDC:57664-499 | NDC:71335-1534 | NDC:71205-481 | NDC:83008-006 | NDC:71610-100 | NDC:68788-8459 | NDC:66993-608 | NDC:13107-032 | NDC:63187-206 | NDC:72162-1639 | NDC:51407-350 | NDC:65862-003 | NDC:71335-2471 | NDC:63187-554 | NDC:71335-0664 | NDC:50090-2558 | NDC:57664-500 | CAS RN:85650-52-8 | NDC:68788-7492 | NDC:57237-012 | NDC:51079-088 | NDC:68071-4989 | NDC:51079-086 | NDC:78206-161 | NDC:71335-0964 | NDC:63629-5086 | NDC:63629-2367 | NDC:65862-021 | NDC:57664-501 | NDC:65862-031 | NDC:57664-510 | NDC:61919-153 | NDC:76483-111 | NDC:0378-3530 | NDC:0615-8489 | NDC:63629-2366 | NDC:0904-6519 | NDC:72578-105 | NDC:71610-115 | CAS RN:61337-67-5 | DrugBank ID:DB00370 | NDC:57237-009 | NDC:55154-5355 | NDC:70518-2453 | NDC:49999-629 | NDC:51079-087 | NDC:63187-471 | NDC:71335-2412 | NDC:71335-1055 | NDC:66993-609 | Mirtazapine | NDC:70518-1309 | NDC:42291-494 | NDC:63629-9255 | NDC:0378-3545 | NDC:65862-001 | NDC:70518-2819 | NDC:71610-475 | NDC:76483-112 | NDC:67046-0003 | NDC:80425-0305 | NDC:13107-003 | PubChem CID:4205 | NDC:57237-007 | NDC:66993-606 | NDC:57237-008 | NDC:50090-2800 | NDC:71610-121 | NDC:78206-158 | NDC:76483-110 | NDC:70518-0180 | NDC:13107-001 | NDC:72578-104 | NDC:63629-2368 | NDC:65862-022 | NDC:71610-713 | 5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene | NDC:71335-0286 | NDC:71610-523 | NDC:60505-0248 | NDC:0378-3515 | NDC:51407-351 | NDC:57237-010 | UNII:A051Q2099Q | NDC:57237-011 | NDC:63739-099 | NDC:63739-098 | NDC:71335-1332 | NDC:55154-8335 | NDC:63187-403 | NDC:68084-119 | NDC:43353-378 | NDC:63629-3346 | NDC:65862-023 | NDC:72578-103 | NDC:68084-121 | NDC:68788-7324 | NDC:67046-1232 | NDC:70518-2581 | NDC:0615-8269 | NDC:55154-7297 | NDC:71335-0441 | NDC:57237-013 | NDC:60505-0249 | NDC:78206-160 | NDC:0615-8268 | NDC:71610-846 | NDC:70518-2058 | NDC:78206-156 | NDC:68788-7754"
+BMGC_DG08194,BMG_DG141570,"NDC:76336-080 | Mitotane | UNII:78E4J5IB5J | 1-chloro-2-[2,2-dichloro-1-(4-chlorophenyl)ethyl]benzene | MITOTANE | PubChem SID:175272073 | CAS RN:53-19-0 | DrugBank ID:DB00648 | PubChem CID:4211"
+BMGC_DG08195,BMG_DG141571,"NDC:52584-641 | DrugBank ID:DB01189 | NDC:0781-6172 | NDC:10019-644 | NDC:10019-646 | Desflurane | CAS RN:57041-67-5 | PubChem SID:175272084 | DESFLURANE | NDC:10019-641 | PubChem CID:42113 | 2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane | UNII:CRS35BZ94Q | NDC:0404-9961"
+BMGC_DG08196,BMG_DG141575,"PubChem SID:175268898 | PubChem CID:4212 | UNII:BZ114NVM5P | MITOXANTRONE | 1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione | Mitoxantrone | DrugBank ID:DB01204 | CAS RN:65271-80-9"
+BMGC_DG08197,BMG_DG141579,"2,3,4,7,8-pentachlorodibenzofuran | PubChem SID:198973217 | UNII:U4C2RV3124 | 2,3,4,7,8-Pentachlorodibenzofuran | PubChem CID:42128 | 2,3,4,7,8-PENTACHLORODIBENZOFURAN | CAS RN:57117-31-4"
+BMGC_DG08198,BMG_DG141580,"CAS RN:57717-32-5 | CAS RN:57117-32-5 | 2,3,8-Trichlorodibenzofuran | 2,3,8-trichlorodibenzofuran | UNII:NGT8F9S3ZM | 2,3,8-TRICHLORODIBENZOFURAN | PubChem CID:42129 | PubChem SID:198977673"
+BMGC_DG08199,BMG_DG141582,"PubChem CID:42131 | 2,3,4-Trichlorodibenzofuran | 2,3,4-TRICHLORODIBENZOFURAN | 2,3,4-trichlorodibenzofuran | CAS RN:57117-34-7 | UNII:0797B39OEC | PubChem SID:198969964 | CAS RN:57717-34-7"
+BMGC_DG08200,BMG_DG141585,"2,3,6,8-Tetrachlorodibenzofuran | 2,3,6,8-tetrachlorodibenzofuran | CAS RN:57117-37-0 | 2,3,6,8-TETRACHLORODIBENZOFURAN | PubChem SID:198965544 | PubChem CID:42134 | UNII:5ZLJ7S7VBK"
+BMGC_DG08201,BMG_DG141590,"PubChem CID:42138 | 1,2,3,7,8-pentachlorodibenzofuran | UNII:QNE7ZLB7SS | 1,2,3,7,8-PENTACHLORODIBENZOFURAN | CAS RN:57117-41-6 | PubChem SID:198957953 | 1,2,3,7,8-Pentachlorodibenzofuran"
+BMGC_DG08202,BMG_DG141592,"PubChem SID:198952598 | CAS RN:57117-44-9 | 1,2,3,6,7,8-HEXACHLORODIBENZOFURAN | 1,2,3,6,7,8-hexachlorodibenzofuran | 1,2,3,6,7,8-Hexachlorodibenzofuran | PubChem CID:42140 | UNII:1ZG4RG6I9O"
+BMGC_DG08203,BMG_DG141597,"ML-7 | UNII:E2C2LB77BF | 1-(5-iodonaphthalen-1-yl)sulfonyl-1,4-diazepane | CAS RN:109376-83-2 | PubChem CID:4216 | 1H-1,4-Diazepine, hexahydro-1-((5-iodo-1-naphthalenyl)sulfonyl)- | PubChem SID:198966909"
+BMGC_DG08204,BMG_DG141602,UNII:LTJ3F5128V | CAS RN:110448-31-2 | PubChem CID:4217 | ML-9 FREE BASE | PubChem SID:198967126
+BMGC_DG08205,BMG_DG141612,Naphthalene-1-sulfonate | PubChem CID:4224596 | naphthalene-1-sulfonate
+BMGC_DG08206,BMG_DG141617,TIROPRAMIDE | DrugBank ID:DB13091 | Tiropramide | N-[3-[4-[2-(diethylamino)ethoxy]phenyl]-1-(dipropylamino)-1-oxopropan-2-yl]benzamide | CAS RN:55837-29-1 | PubChem CID:42262 | UNII:R7S0904CN2 | PubChem SID:198950021
+BMGC_DG08207,BMG_DG141634,UNII:T6CD4C8ZX8 | PubChem CID:4229592 | CAS RN:10080-04-3 | PubChem SID:472422262 | 1-PHENYL-3-(2-(4-SULFAMOYLPHENYL)ETHYL)UREA
+BMGC_DG08208,BMG_DG141641,CAS RN:71320-77-9 | PubChem SID:198979887 | MOCLOBEMIDE | UNII:PJ0Y7AZB63 | 4-chloro-N-(2-morpholin-4-ylethyl)benzamide | CAS RN:108375-13-9 | PubChem CID:4235 | Moclobemide | DrugBank ID:DB01171
+BMGC_DG08209,BMG_DG141643,PubChem CID:4236 | 2-benzhydrylsulfinylacetamide | NDC:46708-385 | NDC:55253-802 | NDC:60505-2527 | NDC:23155-604 | NDC:63459-201 | CAS RN:68693-11-8 | NDC:23155-605 | Modafinil | NDC:57237-154 | NDC:71335-1402 | NDC:63629-7315 | NDC:62332-386 | NDC:71335-1173 | NDC:62332-385 | NDC:43353-925 | DrugBank ID:DB00745 | NDC:71610-873 | NDC:72578-005 | NDC:68084-721 | NDC:72578-006 | NDC:68788-8653 | MODAFINIL | NDC:71610-685 | NDC:46708-386 | NDC:50268-571 | NDC:51407-928 | NDC:71205-544 | NDC:69452-342 | NDC:50268-570 | NDC:60505-2526 | UNII:R3UK8X3U3D | NDC:70771-1052 | NDC:68071-5121 | NDC:70771-1051 | NDC:65862-602 | NDC:69452-343 | NDC:68084-621 | NDC:65862-601 | NDC:57237-155 | NDC:68788-8280 | NDC:82804-126 | NDC:71335-1122 | PubChem SID:175271865 | NDC:23155-862 | NDC:63459-101 | NDC:0904-6791 | NDC:68788-8079 | NDC:71205-477 | NDC:0904-6792 | NDC:71335-2501 | CAS RN:112111-49-6 | NDC:55253-801 | NDC:71335-2258
+BMGC_DG08210,BMG_DG141645,"PubChem SID:198950398 | PubChem CID:4237 | Mofezolac | CAS RN:78967-07-4 | MOFEZOLAC | 2-[3,4-bis(4-methoxyphenyl)-1,2-oxazol-5-yl]acetic acid | UNII:RVJ0BV3H3Y"
+BMGC_DG08211,BMG_DG141650,4-[(2S)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenol | DrugBank ID:DB13777 | PRENALTEROL | PubChem CID:42396 | UNII:M4G34404CX | Prenalterol | PubChem SID:198954444 | CAS RN:57526-81-5
+BMGC_DG08212,BMG_DG141666,PubChem SID:198984886 | MOPERONE | UNII:OU730881W5 | Moperone | CAS RN:1050-79-9 | DrugBank ID:DB13554 | PubChem CID:4249 | 1-(4-fluorophenyl)-4-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]butan-1-one
+BMGC_DG08213,BMG_DG141677,"Morphinan-3,6alpha-diol, 7,8-didehydro-4,5alpha-epoxy-17-methyl- | 3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol | PubChem CID:4253"
+BMGC_DG08214,BMG_DG141684,CAS RN:57683-71-3 | PubChem CID:42546 | methyl 2-sulfamoylbenzoate | Methyl 2-(aminosulfonyl)benzoate
+BMGC_DG08215,BMG_DG141686,"N',N'-diethyl-N-(6-methoxy-4-methylquinolin-8-yl)hexane-1,6-diamine | SITAMAQUINE | PubChem CID:42548 | UNII:5AIJ4TGC6B | DrugBank ID:DB04909 | CAS RN:57695-04-2 | PubChem SID:198979460 | Sitamaquine | CAS RN:5330-29-0"
+BMGC_DG08216,BMG_DG141691,SEQUIFENADINE | 1-azabicyclo[2.2.2]octan-3-yl-bis(2-methylphenyl)methanol | PubChem SID:198950064 | CAS RN:57734-69-7 | UNII:C7Q3TBR3FP | DrugBank ID:DB13566 | PubChem CID:42553 | Sequifenadine
+BMGC_DG08217,BMG_DG141698,"PubChem CID:4257 | CAS RN:89419-40-9 | MOSAPRAMINE | PubChem SID:198937352 | Mosapramine | UNII:04UZQ7O9SJ | 1'-[3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl]spiro[1,5,6,7,8,8a-hexahydroimidazo[1,2-a]pyridine-3,4'-piperidine]-2-one | DrugBank ID:DB13676"
+BMGC_DG08218,BMG_DG141699,"PubChem SID:198951193 | CAS RN:57808-65-8 | PubChem CID:42574 | UNII:EUL532EI54 | N-[5-chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide | Closantel | CLOSANTEL"
+BMGC_DG08219,BMG_DG141702,DrugBank ID:DB08478 | N-[2-Chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide | PubChem CID:425841
+BMGC_DG08220,BMG_DG141706,"CAS RN:103343-47-1 | PubChem SID:440088572 | 3-AMINO-5-PHENYL-1,3-DIHYDRO-1,4-BENZODIAZEPIN-2-ONE | PubChem CID:4259649 | UNII:8AHA6SN6LL"
+BMGC_DG08221,BMG_DG141708,"N-Butyl-11-(3-chloro-4-fluorophenyl)dibenzo[b,f][1,4]thiazepine-8-carboxamide | PubChem CID:42596959 | UNII:FH4TX3X6EA | N-BUTYL-11-(3-CHLORO-4-FLUOROPHENYL)DIBENZO(B,F)(1,4)THIAZEPINE-8-CARBOXAMIDE | CAS RN:1019839-52-1 | PubChem SID:485663662"
+BMGC_DG08222,BMG_DG141711,PubChem CID:4260 | CAS RN:54-32-0 | DrugBank ID:DB09205 | UNII:PW8QYA7KI0 | PubChem SID:198955387 | [4-[2-(dimethylamino)ethoxy]-2-methyl-5-propan-2-ylphenyl] acetate | MOXISYLYTE | Moxisylyte
+BMGC_DG08223,BMG_DG141716,"PubChem SID:198971781 | Faldaprevir | (1R,2S)-1-[[(2S,4R)-4-[8-bromo-7-methoxy-2-[2-(2-methylpropanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxy-1-[(2S)-2-(cyclopentyloxycarbonylamino)-3,3-dimethylbutanoyl]pyrrolidine-2-carbonyl]amino]-2-ethenylcyclopropane-1-carboxylic acid | FALDAPREVIR | DrugBank ID:DB11808 | PubChem CID:42601552 | UNII:958X4J301A | CAS RN:801283-95-4"
+BMGC_DG08224,BMG_DG141753,UNII:0536M66IHB | PubChem SID:198977456 | CAS RN:161099-57-6 | PubChem CID:42607541 | PARATOCARPIN B
+BMGC_DG08225,BMG_DG141784,PubChem CID:42608445 | (Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide | DrugBank ID:DB06941
+BMGC_DG08226,BMG_DG141785,PubChem CID:42608447 | N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide | DrugBank ID:DB08429
+BMGC_DG08227,BMG_DG141796,"DrugBank ID:DB08733 | PubChem CID:42609673 | (2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE"
+BMGC_DG08228,BMG_DG141804,PubChem CID:42609861 | PubChem SID:441658914 | CAS RN:1160489-55-3 | UNII:QJ6KY7R5SS | TMC-558445
+BMGC_DG08229,BMG_DG141805,PubChem CID:4261 | DrugBank ID:DB11841 | ENTINOSTAT | Entinostat | CAS RN:209783-80-2 | PubChem SID:198965300 | pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate | UNII:1ZNY4FKK9H
+BMGC_DG08230,BMG_DG141808,"cis-3-{[(1R)-1-{4-[5-(4-Isobutylphenyl)-1,2,4-oxadiazol-3-yl]phenyl}ethyl]amino}cyclobutanecarboxylic acid | PubChem CID:42610387 | 3-[[(1R)-1-[4-[5-[4-(2-methylpropyl)phenyl]-1,2,4-oxadiazol-3-yl]phenyl]ethyl]amino]cyclobutane-1-carboxylic acid | CAS RN:1149727-90-1"
+BMGC_DG08231,BMG_DG141811,"PubChem SID:198955328 | DrugBank ID:DB06307 | PubChem CID:42611099 | CAS RN:183387-50-0 | (3R,5S,8R,9S,10S,13S,14S,17R)-17-ethynyl-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol | UNII:891O182ZP5 | Apoptone | APOPTONE"
+BMGC_DG08232,BMG_DG141813,"PubChem CID:42611257 | UNII:207SMY3FQT | DrugBank ID:DB08881 | CAS RN:918504-65-1 | N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide | CAS RN:1029872-54-5 | VEMURAFENIB | CAS RN:1415041-85-8 | PubChem SID:175267423 | NDC:50242-090 | Vemurafenib"
+BMGC_DG08233,BMG_DG141815,PubChem CID:42611896 | 3-(Trifluoromethyl)-9H-carbazole | 3-(TRIFLUOROMETHYL)-9H-CARBAZOLE | CAS RN:2467-83-6 | PubChem SID:485666006 | UNII:PWX89A5DF6
+BMGC_DG08234,BMG_DG141819,"NDC:80735-820 | DrugBank ID:DB12615 | PubChem SID:198963178 | UNII:LYO9XZ250J | (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide | NDC:71045-010 | CAS RN:1154757-24-0 | PLAZOMICIN | PubChem CID:42613186 | Plazomicin | NDC:69097-820"
+BMGC_DG08235,BMG_DG141823,DrugBank ID:DB06868 | PubChem CID:42615253 | N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide
+BMGC_DG08236,BMG_DG141824,DrugBank ID:DB07190 | 3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide | PubChem CID:42615254
+BMGC_DG08237,BMG_DG141826,"PubChem CID:42618030 | UNII:A52X8DVF6F | PubChem SID:485663375 | 6,8-DIMETHOXY-4-METHYL-2(1H)-QUINOLINONE | CAS RN:249737-05-1 | 6,8-Dimethoxy-4-methyl-2(1H)-quinolinone"
+BMGC_DG08238,BMG_DG141841,UNII:96ER5DQD27 | PubChem CID:42623951 | CAS RN:1159824-67-5 | PubChem SID:461432909 | CZC-24832
+BMGC_DG08239,BMG_DG141847,PubChem SID:377308884 | PubChem CID:42625451 | NOS | CAS RN:1146620-35-0 | UNII:R1W11H9AUK
+BMGC_DG08240,BMG_DG141849,PubChem SID:461434549 | PubChem CID:42625621 | CAS RN:1146620-61-2 | UNII:44E8D7K7HM | 4-METHYL-6-(2-METHYLPROP-1-ENYL)PYRIDIN-2-AMINE
+BMGC_DG08241,BMG_DG141855,"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL | PubChem CID:42627296 | DrugBank ID:DB07678"
+BMGC_DG08242,BMG_DG141856,"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium | PubChem CID:42627562 | DrugBank ID:DB08150"
+BMGC_DG08243,BMG_DG141859,"N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine | PubChem CID:42627755 | DrugBank ID:DB07382"
+BMGC_DG08244,BMG_DG141860,PubChem CID:42627769 | DrugBank ID:DB07233 | N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan
+BMGC_DG08245,BMG_DG141861,PubChem CID:42628060 | DrugBank ID:DB07872 | 5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide
+BMGC_DG08246,BMG_DG141862,"PubChem CID:42628063 | 5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE | DrugBank ID:DB08143"
+BMGC_DG08247,BMG_DG141863,4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine | PubChem CID:42628075 | DrugBank ID:DB07415
+BMGC_DG08248,BMG_DG141879,CAS RN:1025725-91-0 | MARITUPIRDINE | PubChem SID:313368829 | UNII:6MHR5IV28S | AVN-101 | PubChem CID:42631003
+BMGC_DG08249,BMG_DG141888,PubChem SID:440089474 | CAS RN:1160247-92-6 | PubChem CID:42633508 | VU-0238429 | UNII:ZH1ZWF5Q3P
+BMGC_DG08250,BMG_DG141892,"PubChem SID:346540540 | 2-[3-[1-(4-chlorophenyl)cyclopropyl]-[1,2,4]triazolo[4,3-a]pyridin-8-yl]propan-2-ol | PubChem CID:42634627 | BMS-823778 free base | CAS RN:1140897-32-0 | UNII:8JYO8VTR11 | BMS-823778 FREE BASE"
+BMGC_DG08251,BMG_DG141893,LC-15-0636 | UNII:FK527M26GN | PubChem CID:42635875 | CAS RN:1173174-99-6 | PubChem SID:433721048
+BMGC_DG08252,BMG_DG141895,"AZD-7687 | DrugBank ID:DB14949 | UNII:6QTJ9P2NYT | {4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid | PubChem CID:42636350 | 2-[4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl]acetic acid | CAS RN:1166827-44-6 | PubChem SID:322058949"
+BMGC_DG08253,BMG_DG141900,LY-2623091 | UNII:6FHZ595FNM | PubChem SID:363909766 | Ly-2623091 | [5-[(E)-(3-fluoro-6H-benzo[c][1]benzoxepin-11-ylidene)methyl]-1-[(2R)-1-morpholin-4-ylpropan-2-yl]benzimidazol-2-yl]urea | DrugBank ID:DB15367 | CAS RN:1162264-07-4 | PubChem CID:42636651
+BMGC_DG08254,BMG_DG141901,UNII:UL78GH28WX | PubChem SID:459055179 | NB-533 | PubChem CID:42636932 | CAS RN:1146544-18-4
+BMGC_DG08255,BMG_DG141910,PubChem CID:42641861 | UNII:S15N98QQ2K | PubChem SID:198962679 | A-967079 | CAS RN:1170613-55-4
+BMGC_DG08256,BMG_DG141911,DrugBank ID:DB12272 | PubChem SID:198981442 | Vidupiprant | UNII:61OTZ32XNC | VIDUPIPRANT | 2-[4-[4-(tert-butylcarbamoyl)-2-[(2-chloro-4-cyclopropylphenyl)sulfonylamino]phenoxy]-5-chloro-2-fluorophenyl]acetic acid | CAS RN:1169483-24-2 | PubChem CID:42641863
+BMGC_DG08257,BMG_DG141914,"Foretinib | FORETINIB | CAS RN:937176-80-2 | PubChem SID:198948852 | UNII:81FH7VK1C4 | PubChem CID:42642645 | CAS RN:849217-64-7 | DrugBank ID:DB12307 | 1-N'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide"
+BMGC_DG08258,BMG_DG141915,"4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine | VARLITINIB | PubChem CID:42642648 | Varlitinib | UNII:846Y8197W1 | CAS RN:845272-21-1 | PubChem SID:198943673 | DrugBank ID:DB05944"
+BMGC_DG08259,BMG_DG141916,"DrugBank ID:DB11982 | GDC-0623 | PubChem SID:198946807 | Gdc-0623 | CAS RN:1168091-68-6 | UNII:HW67545I4Q | 5-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)imidazo[1,5-a]pyridine-6-carboxamide | PubChem CID:42642654"
+BMGC_DG08260,BMG_DG141923,"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | PubChem CID:42647297 | DrugBank ID:DB08349"
+BMGC_DG08261,BMG_DG141924,DrugBank ID:DB07942 | 2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine | PubChem CID:42647299
+BMGC_DG08262,BMG_DG141930,"PubChem CID:4266 | CAS RN:2763-96-4 | DrugBank ID:DB12458 | 5-(aminomethyl)-1,2-oxazol-3-one | PubChem SID:198953952 | UNII:D5M179TY2E | Muscimol | MUSCIMOL"
+BMGC_DG08263,BMG_DG141940,"CAS RN:41575-94-4 | Paraplatin | azanide;cyclobutane-1,1-dicarboxylic acid;platinum(2+) | PubChem CID:426756"
+BMGC_DG08264,BMG_DG141953,"UNII:1F1959S062 | 2,5,11-trimethyl-6H-pyrido[4,3-b]carbazol-2-ium-9-ol | 9-Hydroxy-2,5,11-trimethyl-6H-pyrido(4,3-b)carbazolium | PubChem SID:198939488 | ELLIPTINIUM | PubChem CID:42723 | CAS RN:58337-34-1"
+BMGC_DG08265,BMG_DG141956,UNII:W4FL204T10 | CAS RN:155471-08-2 | (2-Methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone | JHW-015 | (2-methyl-1-propylindol-3-yl)-naphthalen-1-ylmethanone | PubChem CID:4273754 | PubChem SID:198973429
+BMGC_DG08266,BMG_DG141958,NDC:17156-026 | NDC:17156-024 | UNII:3J0KPB596Q | DrugBank ID:DB11180 | Tetrofosmin | TETROFOSMIN | CAS RN:127502-06-1 | PubChem SID:175267321 | PubChem CID:4274 | 2-[bis(2-ethoxyethyl)phosphanyl]ethyl-bis(2-ethoxyethyl)phosphane
+BMGC_DG08267,BMG_DG141964,4-methylpentanoate | PubChem CID:4275592 | 4-Methylpentanoate
+BMGC_DG08268,BMG_DG141968,"UNII:ZV7823VVIM | 1,3-DICYCLOHEXYLUREA | PubChem SID:198982038 | PubChem CID:4277 | CAS RN:2387-23-7"
+BMGC_DG08269,BMG_DG141974,3-Amino-5-(4-methoxyphenyl)-2-thiophenecarboxamide | 3-amino-5-(4-methoxyphenyl)thiophene-2-carboxamide | CAS RN:354812-16-1 | PubChem CID:4278270
+BMGC_DG08270,BMG_DG141976,"CAS RN:18773-03-0 | 1,3-Diaminopropane | PubChem SID:198982686 | propane-1,3-diamine | 1,3-PROPANEDIAMINE | UNII:CB3ISL56KG | CAS RN:109-76-2 | CAS RN:54018-94-9 | PubChem CID:428"
+BMGC_DG08271,BMG_DG141984,"DrugBank ID:DB06445 | UNII:HLI827Z1ST | PubChem CID:4282 | CAS RN:1044709-86-5 | DIETHYLNORSPERMINE | N1,N11-Bis(ethyl)norspermine | N-ethyl-N'-[3-[3-(ethylamino)propylamino]propyl]propane-1,3-diamine | CAS RN:121749-39-1 | PubChem SID:198950283"
+BMGC_DG08272,BMG_DG141986,CAS RN:58728-64-6 | PubChem SID:461434426 | PubChem CID:42828 | 4-AMINO-1-NAPHTHALENECARBONITRILE | UNII:B66LVG7MQ2
+BMGC_DG08273,BMG_DG141992,"PubChem SID:198938135 | PubChem CID:42836 | 1,2,4,7,8-Pentachlorodibenzo-p-dioxin | CAS RN:58802-08-7 | UNII:W411W6AKOM | 1,2,4,7,8-pentachlorodibenzo-p-dioxin | 1,2,4,7,8-PENTACHLORODIBENZO-P-DIOXIN"
+BMGC_DG08274,BMG_DG141995,"PubChem SID:198943225 | 1,2,4,7,8-PENTACHLORODIBENZOFURAN | 1,2,4,7,8-pentachlorodibenzofuran | PubChem CID:42839 | 1,2,4,7,8-Pentachlorodibenzofuran | CAS RN:58802-15-6 | UNII:8617WM0JI5"
+BMGC_DG08275,BMG_DG141998,"DIETHYLTOLUAMIDE | PubChem SID:198936325 | Diethyltoluamide | NDC:72988-0005 | PubChem CID:4284 | UNII:FB0C1XZV4Y | CAS RN:134-62-3 | DrugBank ID:DB11282 | N,N-diethyl-3-methylbenzamide"
+BMGC_DG08276,BMG_DG141999,"PubChem SID:198986604 | PubChem CID:42840 | 1,3,4,7,8-PENTACHLORODIBENZOFURAN | 1,3,4,7,8-Pentachlorodibenzofuran | UNII:O1M260BDDK | 1,3,4,7,8-pentachlorodibenzofuran | CAS RN:58802-16-7"
+BMGC_DG08277,BMG_DG142010,PubChem CID:42853213 | PubChem SID:433721065 | N-BENZYLFURANYLFENTANYL | UNII:57C1B6YU31 | N-Benzylfuranylfentanyl | CAS RN:497240-21-8
+BMGC_DG08278,BMG_DG142013,DrugBank ID:DB03782 | N-(1-adamantyl)-N'-(4-guanidinobenzyl)urea | PubChem CID:4286
+BMGC_DG08279,BMG_DG142020,"DrugBank ID:DB03844 | N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide | PubChem CID:4288"
+BMGC_DG08280,BMG_DG142022,DrugBank ID:DB13653 | UNII:KGJ2T0N7IQ | PubChem SID:198968076 | N-(4-chlorophenyl)-2-phenyl-N-(1-propan-2-ylpiperidin-4-yl)acetamide | CAS RN:59729-31-6 | LORCAINIDE | Lorcainide | PubChem CID:42884
+BMGC_DG08281,BMG_DG142024,"IDARUBICIN | PubChem CID:42890 | UNII:ZRP63D75JW | PubChem SID:175266858 | CAS RN:58957-92-9 | DrugBank ID:DB01177 | Idarubicin | (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione"
+BMGC_DG08282,BMG_DG142030,PubChem CID:4290 | DrugBank ID:DB02069 | N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide
+BMGC_DG08283,BMG_DG142033,DrugBank ID:DB07387 | PubChem CID:4290313 | 3-(BUTYLSULPHONYL)-PROPANOIC ACID
+BMGC_DG08284,BMG_DG142039,PubChem CID:4292 | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-N-(2-phenylethyl)acetamide | N-(2-Phenylethyl)indomethacin Amide | CAS RN:261766-32-9
+BMGC_DG08285,BMG_DG142045,"DrugBank ID:DB02986 | N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide | PubChem CID:4293"
+BMGC_DG08286,BMG_DG142060,CAS RN:15532-75-9 | 1-[3-(trifluoromethyl)phenyl]piperazine | PubChem SID:198942388 | PubChem CID:4296 | 1-(3-TRIFLUOROMETHYLPHENYL)PIPERAZINE | 1-[3-(Trifluoromethyl)phenyl]piperazine | UNII:25R3ONU51C
+BMGC_DG08287,BMG_DG142081,"2-HYDROXYGLUTARIC ACID, (±)- | CAS RN:2889-31-8 | PubChem SID:472423597 | 2-HYDROXYGLUTARIC ACID, (+/-)- | 2-hydroxypentanedioic acid | 2-Hydroxyglutaric acid | PubChem CID:43 | UNII:RS4M3UYS95"
+BMGC_DG08288,BMG_DG142083,N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE | PubChem CID:4300 | DrugBank ID:DB06857
+BMGC_DG08289,BMG_DG142088,Alizapride | PubChem CID:43008 | CAS RN:59338-93-1 | CID 43008 | ALIZAPRIDE | DrugBank ID:DB01425 | PubChem SID:198984926 | UNII:P55703ZRZY | 6-methoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-2H-benzotriazole-5-carboxamide
+BMGC_DG08290,BMG_DG142091,"PubChem CID:4301922 | 4-[6-(diethylamino)-3-(diethyliminio)-3H-xanthen-9-yl]benzene-1,3-disulfonate | 4-[3-(diethylamino)-6-diethylazaniumylidenexanthen-9-yl]benzene-1,3-disulfonate"
+BMGC_DG08291,BMG_DG142095,"PubChem CID:430245 | 1,2,3,4,4a,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol | Base normorphine"
+BMGC_DG08292,BMG_DG142097,PubChem SID:198946331 | CAS RN:162408-66-4 | GR-103691 | GR 103691 | UNII:0Y0CM1A77L | PubChem CID:4302960 | 4-(4-acetylphenyl)-N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]benzamide
+BMGC_DG08293,BMG_DG142098,CAS RN:202463-68-1 | PubChem CID:4302962 | AM-281 | PubChem SID:348480958 | UNII:SBP4A4DYH2
+BMGC_DG08294,BMG_DG142099,[6-iodo-2-methyl-1-(2-morpholin-4-ylethyl)indol-3-yl]-(4-methoxyphenyl)methanone | UNII:U1LNJ6NBKA | 6-IODOPRAVADOLINE | PubChem CID:4302963 | CAS RN:1356019-56-1 | (6-iodo-2-methyl-1-(2-morpholinoethyl)-1H-indol-3-yl)(4-methoxyphenyl)methanone | PubChem SID:252319684 | CAS RN:164178-33-0
+BMGC_DG08295,BMG_DG142115,5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole | 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole | PubChem CID:4306515 | PubChem SID:485663372 | UNII:6QX8U7AHB4 | CAS RN:188817-13-2 | 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)pyrazole | 5-(4-CHLOROPHENYL)-1-(4-METHOXYPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE
+BMGC_DG08296,BMG_DG142121,PubChem CID:43082 | CAS RN:64294-95-7 | SETASTINE | PubChem SID:198945593 | UNII:6G3OCF528J
+BMGC_DG08297,BMG_DG142155,"PubChem SID:198972353 | Eniluracil | DrugBank ID:DB03516 | CAS RN:59989-18-3 | 5-ethynyl-1H-pyrimidine-2,4-dione | ENILURACIL | UNII:2E2W0W5XIU | PubChem CID:43157"
+BMGC_DG08298,BMG_DG142156,DrugBank ID:DB03526 | AL5927 | PubChem CID:4316
+BMGC_DG08299,BMG_DG142183,"1-(propan-2-ylamino)-3-(2-propylphenoxy)propan-2-ol | DIHYDROALPRENOLOL, (±)- | DIHYDROALPRENOLOL, (+/-)- | PubChem SID:317229487 | PubChem CID:43216 | Dihydroalprenolol | UNII:2ZT5710I4T | CAS RN:60106-89-0"
+BMGC_DG08300,BMG_DG142199,"4-amino-6-(1,2,2-trichloroethenyl)benzene-1,3-disulfonamide | CAS RN:60200-06-8 | DrugBank ID:DB11389 | CLORSULON | UNII:EG1ZDO6LRD | PubChem CID:43231 | Clorsulon | PubChem SID:175266756"
+BMGC_DG08301,BMG_DG142201,"UNII:142KW8TBSR | Propiconazole | PROPICONAZOLE | PubChem CID:43234 | 1-[[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole | CAS RN:60207-90-1 | CAS RN:120523-07-1 | CAS RN:75881-82-2 | PubChem SID:198985038"
+BMGC_DG08302,BMG_DG142218,"2,6-Dichlorodibenzofuran | PubChem SID:198978761 | CAS RN:60390-27-4 | PubChem CID:43255 | 2,6-DICHLORODIBENZOFURAN | 2,6-dichlorodibenzofuran | UNII:82D8XYM8UE"
+BMGC_DG08303,BMG_DG142221,"DESGLYMIDODRINE | CAS RN:3600-87-1 | PubChem CID:43260 | PubChem SID:252163816 | Desglymidodrine | UNII:S57K35I2FV | 2-amino-1-(2,5-dimethoxyphenyl)ethanol"
+BMGC_DG08304,BMG_DG142230,PubChem CID:4327 | WGB-BC-15 | N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide | n-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-3-pyridinecarboxamide | N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]pyridine-3-carboxamide | UNII:Q8SP783P3P | PubChem SID:443625146 | CAS RN:309760-28-9 | DrugBank ID:DB03878
+BMGC_DG08305,BMG_DG142232,"Hydroxyethyl cellulose | 1-[[3,4,5-tris(2-hydroxypropoxy)-6-[4,5,6-tris(2-hydroxypropoxy)-2-(2-hydroxypropoxymethyl)oxan-3-yl]oxyoxan-2-yl]methoxy]propan-2-ol | PubChem CID:4327536 | Cellulose hydroxyethylate | CAS RN:1041187-47-6 | DrugBank ID:DB11602"
+BMGC_DG08306,BMG_DG142234,UNII:V4WLW77V5Q | PubChem CID:432824 | OXAFLOZANE | DrugBank ID:DB13457 | CAS RN:26629-87-8 | PubChem SID:198973202 | Oxaflozane | 4-propan-2-yl-2-[3-(trifluoromethyl)phenyl]morpholine
+BMGC_DG08307,BMG_DG142243,SB-408124 | CAS RN:288150-92-5 | PubChem CID:4331799 | PubChem SID:474492757 | UNII:C3YT74C744
+BMGC_DG08308,BMG_DG142245,CAS RN:123557-91-5 | BHFF | UNII:K3W3822BMV | PubChem CID:4332683 | PubChem SID:472425879
+BMGC_DG08309,BMG_DG142246,UNII:G4962QA067 | NDC:37662-1518 | CAS RN:7447-41-8 | CAS RN:59217-69-5 | NDC:37662-1520 | LITHIUM CHLORIDE | lithium;chloride | PubChem SID:175267611 | NDC:37662-1513 | NDC:37662-1515 | NDC:37662-1516 | NDC:37662-1517 | Lithium Chloride | PubChem CID:433294 | NDC:37662-1519 | NDC:37662-1514
+BMGC_DG08310,BMG_DG142251,"PubChem CID:43345 | UNII:RA77IZ6B2F | P-1075 | CAS RN:60559-98-0 | PubChem SID:384648003 | N-Cyano-N'-(1,1-dimethylpropyl)-N''-3-pyridylguanidine | 1-cyano-2-(2-methylbutan-2-yl)-3-pyridin-3-ylguanidine"
+BMGC_DG08311,BMG_DG142274,"4'-DIMETHYLAMINO-3,4,5-TRIMETHOXY BENZANILIDE | UNII:JQW86KK01O | PubChem CID:43380 | CAS RN:60634-68-6 | PubChem SID:363908764"
+BMGC_DG08312,BMG_DG142303,PubChem SID:198942363 | PubChem CID:4342 | ACECAINIDE | 4-acetamido-N-[2-(diethylamino)ethyl]benzamide | CAS RN:32795-44-1 | Acecainide | UNII:910Q707V6F
+BMGC_DG08313,BMG_DG142318,PubChem CID:4347 | N-(Phenylmethyl)-4-sulfamoyl-benzamide | CAS RN:107619-27-2 | N-(PHENYLMETHYL)-4-SULFAMOYL-BENZAMIDE | PubChem SID:485663431 | DrugBank ID:DB01748 | N-Benzyl-4-Sulfamoyl-Benzamide | UNII:6LQK8L3YE9
+BMGC_DG08314,BMG_DG142332,"2,3,4,6,7,8-HEXACHLORODIBENZOFURAN | 2,3,4,6,7,8-Hexachlorodibenzofuran | UNII:IMR03169ES | CAS RN:60851-34-5 | PubChem SID:198962905 | PubChem CID:43495 | 2,3,4,6,7,8-hexachlorodibenzofuran"
+BMGC_DG08315,BMG_DG142336,"UNII:8M1YF8951V | PubChem SID:198962808 | Ceforanide | CAS RN:60925-61-3 | CEFORANIDE | (6R,7R)-7-[[2-[2-(aminomethyl)phenyl]acetyl]amino]-3-[[1-(carboxymethyl)tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem CID:43507 | DrugBank ID:DB00923"
+BMGC_DG08316,BMG_DG142339,"11-methyl-11,21-diazatetracyclo[12.7.0.03,8.015,20]henicosa-1(14),3,5,7,15,17,19-heptaene | PubChem CID:4350931 | CAS RN:274694-98-3 | 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine"
+BMGC_DG08317,BMG_DG142371,PubChem CID:4357 | DrugBank ID:DB02029 | N-Cyclohexyl-N'-(4-Iodophenyl)Urea
+BMGC_DG08318,BMG_DG142376,PubChem CID:4358 | N-Cyclohexyl-N'-(Propyl)Phenyl Urea | DrugBank ID:DB04213
+BMGC_DG08319,BMG_DG142380,PubChem CID:4359 | N-Cyclohexyl-N'-Decylurea | DrugBank ID:DB03677
+BMGC_DG08320,BMG_DG142385,"UNII:6532B86WFG | PubChem CID:43594 | (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-8-oxo-3-[[1-(sulfomethyl)tetrazol-5-yl]sulfanylmethyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Cefonicid | CEFONICID | DrugBank ID:DB01328 | PubChem SID:198970416 | CAS RN:61270-58-4"
+BMGC_DG08321,BMG_DG142386,4-Chlorobenzoate | 4-chlorobenzoate | PubChem CID:4359436
+BMGC_DG08322,BMG_DG142399,"1-ethylpyrrole-2,5-dione | CAS RN:128-53-0 | UNII:O3C74ACM9V | PubChem CID:4362 | N-ETHYLMALEIMIDE | DrugBank ID:DB02967 | Ethylmaleimide | PubChem SID:198940172 | CAS RN:25668-22-8 | N-Ethylmaleimide"
+BMGC_DG08323,BMG_DG142410,"UNII:9I628532GX | (2S,5R,6R)-6-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PIPERACILLIN ANHYDROUS | CAS RN:61477-96-1 | DrugBank ID:DB00319 | Piperacillin | PubChem SID:175266788 | PubChem CID:43672"
+BMGC_DG08324,BMG_DG142414,WAY-151693 | PubChem CID:4368 | DrugBank ID:DB02071
+BMGC_DG08325,BMG_DG142419,PubChem CID:4369 | DrugBank ID:DB08491 | N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE
+BMGC_DG08326,BMG_DG142421,DrugBank ID:DB04738 | PubChem CID:4369034 | Motuporin
+BMGC_DG08327,BMG_DG142423,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2YL)-ureido]-N-methyl-3-pentafluorophenyl-propionamide | 2-[3-(5-Mercapto-[1,3,4]thiadiazol-2yl)-ureido]-N-methyl-3-pentafluorophenyl-propionamide | DrugBank ID:DB07988 | CAS RN:198701-34-7 | PubChem CID:4369080 | (2S)-N-methyl-3-(2,3,4,5,6-pentafluorophenyl)-2-[(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)carbamoylamino]propanamide"
+BMGC_DG08328,BMG_DG142424,"benzyl N-[(1R)-3-oxo-1-phenyl-3-[(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)amino]propyl]carbamate | [2-(5-Mercapto-[1,3,4]thiadiazol-2-ylcarbamoyl)-1-phenyl-ethyl]-carbamic acid benzyl ester | DrugBank ID:DB07987 | PubChem CID:4369082"
+BMGC_DG08329,BMG_DG142425,"2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-YL)-ureido]-N-methyl-3-phenyl-propionamide | DrugBank ID:DB07390 | 2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-yl)-ureido]-N-methyl-3-phenyl-propionamide | PubChem CID:4369084 | CAS RN:198700-58-2 | (2S)-N-methyl-3-phenyl-2-[(2-sulfanylidene-3H-1,3,4-thiadiazol-5-yl)carbamoylamino]propanamide"
+BMGC_DG08330,BMG_DG142426,AL7099A | PubChem CID:4369101 | DrugBank ID:DB03221
+BMGC_DG08331,BMG_DG142427,AL-4623 | PubChem SID:348481748 | CAS RN:138890-59-2 | DrugBank ID:DB03877 | UNII:1M7AKN51DU | PubChem CID:4369102
+BMGC_DG08332,BMG_DG142428,DrugBank ID:DB04089 | PubChem CID:4369103 | AL5300
+BMGC_DG08333,BMG_DG142430,PubChem CID:4369141 | DrugBank ID:DB08643 | 2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER
+BMGC_DG08334,BMG_DG142432,"DrugBank ID:DB02964 | 8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one | PubChem CID:4369162"
+BMGC_DG08335,BMG_DG142433,"DrugBank ID:DB03598 | PubChem CID:4369171 | Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]"
+BMGC_DG08336,BMG_DG142434,"DrugBank ID:DB03262 | PubChem CID:4369172 | Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]"
+BMGC_DG08337,BMG_DG142436,"DrugBank ID:DB03907 | N-[(E)-3-[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitrobenzamide | N-[(E)-3-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]prop-2-enyl]-2,3-dihydroxy-5-nitrobenzamide | PubChem CID:4369234 | N-{3-[5-(6-Amino-purin-9-YL)-3,4-dihydroxy-tetrahydro-furan-2-YL]-allyl}-2,3-dihydroxy-5-nitro-benzamide"
+BMGC_DG08338,BMG_DG142437,DrugBank ID:DB02654 | 6-hydroxy-FAD | PubChem CID:4369241
+BMGC_DG08339,BMG_DG142438,"PubChem SID:198987286 | UNII:S63WOD4VOL | DIGITOXIGENIN | CAS RN:143-62-4 | DrugBank ID:DB04177 | 3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | PubChem CID:4369270 | Digitoxigenin"
+BMGC_DG08340,BMG_DG142439,BIA | UNII:X6H65DT067 | BIA-3-335 FREE BASE | PubChem CID:4369285 | DrugBank ID:DB03336 | PubChem SID:198985798 | CAS RN:747401-28-1
+BMGC_DG08341,BMG_DG142442,IDD594 | PubChem CID:4369325 | DrugBank ID:DB08084
+BMGC_DG08342,BMG_DG142443,"PubChem CID:4369343 | DrugBank ID:DB02628 | 1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide"
+BMGC_DG08343,BMG_DG142445,"NDC:70771-1771 | DrugBank ID:DB01261 | Sitagliptin | UNII:QFP0P1DV7Z | NDC:70710-1901 | (3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one | NDC:70710-1899 | SITAGLIPTIN | NDC:70771-1792 | NDC:70710-1242 | CAS RN:790712-60-6 | NDC:70771-1772 | NDC:70710-1240 | PubChem CID:4369359 | PubChem SID:175268642 | NDC:70710-1900 | NDC:70710-1241 | NDC:70771-1770 | NDC:70771-1790 | CAS RN:486460-32-6 | NDC:70771-1791"
+BMGC_DG08344,BMG_DG142447,PubChem CID:4369379 | DrugBank ID:DB01988 | 6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine
+BMGC_DG08345,BMG_DG142448,"PubChem CID:4369380 | Thiorphan | Thiorphan, (S)- | UNII:XJ8Z52GK3X | DrugBank ID:DB08626 | PubChem SID:485665552 | CAS RN:95909-00-5 | THIORPHAN, (S)-"
+BMGC_DG08346,BMG_DG142450,"DrugBank ID:DB04685 | 1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE | PubChem CID:4369390"
+BMGC_DG08347,BMG_DG142451,"PubChem CID:4369393 | 4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE | DrugBank ID:DB04618"
+BMGC_DG08348,BMG_DG142452,"PubChem CID:4369394 | 4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose | DrugBank ID:DB04453"
+BMGC_DG08349,BMG_DG142453,"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE | DrugBank ID:DB04601 | PubChem CID:4369413"
+BMGC_DG08350,BMG_DG142454,"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE | DrugBank ID:DB04600 | PubChem CID:4369414"
+BMGC_DG08351,BMG_DG142455,DrugBank ID:DB07912 | PubChem SID:459276124 | CAS RN:69639-73-2 | UNII:E9NR6YG6JA | PubChem CID:4369424 | 2-OXOHEPTYLPHOSPHONIC ACID
+BMGC_DG08352,BMG_DG142458,"2-[3-chloro-6-[2,2-difluoro-2-(1-oxidopyridin-1-ium-2-yl)ethyl]imino-1-hydroxypyridin-2-yl]-N-[(1R)-1-(3-chlorophenyl)ethyl]acetamide | PubChem CID:4369429 | DrugBank ID:DB04722"
+BMGC_DG08353,BMG_DG142459,"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC | DrugBank ID:DB07654 | PubChem CID:4369432"
+BMGC_DG08354,BMG_DG142460,"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE | PubChem CID:4369433 | DrugBank ID:DB07655"
+BMGC_DG08355,BMG_DG142461,"PubChem CID:4369434 | (2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL | DrugBank ID:DB07647"
+BMGC_DG08356,BMG_DG142462,"PubChem CID:4369435 | (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL | DrugBank ID:DB07648"
+BMGC_DG08357,BMG_DG142463,2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE | PubChem CID:4369443 | DrugBank ID:DB08395
+BMGC_DG08358,BMG_DG142464,"PubChem CID:4369446 | 1,6-DI-O-PHOSPHONO-D-MANNITOL | DrugBank ID:DB04733"
+BMGC_DG08359,BMG_DG142466,"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE | DrugBank ID:DB08591 | PubChem CID:4369451"
+BMGC_DG08360,BMG_DG142467,"UNII:L4SBH33TJR | CAS RN:612530-44-6 | 1,1-Dioxo-5-phenyl-1,2,5-thiadiazolidin-3-one | DrugBank ID:DB08593 | 1,1-DIOXO-5-PHENYL-1,2,5-THIADIAZOLIDIN-3-ONE | PubChem CID:4369452 | 1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE | PubChem SID:478838376"
+BMGC_DG08361,BMG_DG142471,"PubChem CID:4369485 | DrugBank ID:DB08546 | 4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE"
+BMGC_DG08362,BMG_DG142474,"DrugBank ID:DB04608 | PubChem CID:4369491 | 9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE"
+BMGC_DG08363,BMG_DG142475,PubChem CID:4369496 | DrugBank ID:DB04739 | 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
+BMGC_DG08364,BMG_DG142476,"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE | PubChem CID:4369497 | DrugBank ID:DB07334"
+BMGC_DG08365,BMG_DG142477,"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE | DrugBank ID:DB07333 | PubChem CID:4369498"
+BMGC_DG08366,BMG_DG142478,"PubChem CID:4369502 | DrugBank ID:DB04770 | O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL"
+BMGC_DG08367,BMG_DG142479,DrugBank ID:DB04787 | UNII:W9F9H8GXWR | PubChem CID:4369524 | CAS RN:304853-42-7 | Tanaproget | TANAPROGET | PubChem SID:198936196
+BMGC_DG08368,BMG_DG142481,DrugBank ID:DB07236 | PubChem CID:4369551 | 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL
+BMGC_DG08369,BMG_DG142483,DrugBank ID:DB08374 | Phenylalanylmethylchloride | PubChem CID:4369560
+BMGC_DG08370,BMG_DG142485,"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL | DrugBank ID:DB08224 | PubChem CID:4369567"
+BMGC_DG08371,BMG_DG142486,"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL | DrugBank ID:DB07567 | PubChem CID:4369568"
+BMGC_DG08372,BMG_DG142487,2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID | DrugBank ID:DB04723 | PubChem CID:4369579
+BMGC_DG08373,BMG_DG142489,"PubChem CID:4369593 | DrugBank ID:DB07579 | Bis-1,2-{[(Z)-2-carboxy-2-methyl-1,3-dioxane]-5-yloxycarbamoyl}-ethane"
+BMGC_DG08374,BMG_DG142490,"BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE | DrugBank ID:DB07580 | PubChem CID:4369594"
+BMGC_DG08375,BMG_DG142491,"UNII:XTT10TQ5NV | N1-(6-METHOXY-5-(4-METHOXYPHENOXY)-8-QUINOLINYL)-N5-(1-METHYLETHYL)-1,5-PENTANEDIAMINE | PubChem SID:377308516 | CAS RN:61895-40-7 | PubChem CID:436997"
+BMGC_DG08376,BMG_DG142495,"PubChem CID:43708 | CEFOTIAM | (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Cefotiam | DrugBank ID:DB00229 | CAS RN:61622-34-2 | CAS RN:66309-69-1 | PubChem SID:198976567 | UNII:91W6Z2N718"
+BMGC_DG08377,BMG_DG142507,"FG-7142 | N-methyl-9H-pyrido[3,4-b]indole-3-carboxamide | PubChem SID:198953082 | N-Methyl-beta-carboline-3-carboxamide | PubChem CID:4375 | CAS RN:78538-74-6 | UNII:60PO70N1BP"
+BMGC_DG08378,BMG_DG142510,PubChem CID:4376 | N-METHYL-DL-ASPARTIC ACID | PubChem SID:316914866 | CAS RN:17833-53-3 | UNII:EU52DFC4WJ
+BMGC_DG08379,BMG_DG142513,DrugBank ID:DB13010 | 3-cyanopropyl carbamimidothioate | 4-Isothioureidobutyronitrile | 4-ISOTHIOUREIDOBUTYRONITRILE | CAS RN:500863-50-3 | UNII:C3059TG1KN | PubChem CID:437740 | 4-isothioureidobutyronitrile | PubChem SID:198988048
+BMGC_DG08380,BMG_DG142529,UNII:LZ6FG54Y5X | CAS RN:61785-84-0 | PubChem CID:43795 | PubChem SID:474489464 | 7-(BENZYLPIPERAZINYL)-4-NITROBENZOFUROXAN | 7-(Benzylpiperazinyl)-4-nitrobenzofuroxan
+BMGC_DG08381,BMG_DG142535,"Clorgiline | UNII:LYJ16FZU9Q | Clorgyline | CLORGILINE | 3-(2,4-dichlorophenoxy)-N-methyl-N-prop-2-ynylpropan-1-amine | PubChem SID:198975950 | DrugBank ID:DB04017 | CAS RN:17780-72-2 | PubChem CID:4380"
+BMGC_DG08382,BMG_DG142536,"[(1R,2R)-2-azanidylcyclohexyl]azanide;oxalate;platinum(4+) | Lipoxal | PubChem CID:43805"
+BMGC_DG08383,BMG_DG142539,"PubChem CID:4381 | 2-(hydroxymethyl)-1-methylpiperidine-3,4,5-triol | 2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol"
+BMGC_DG08384,BMG_DG142541,"Paroxetine | UNII:32Q7TW8BX7 | PAROXETINE, (+/-)- | UNII:41VRH5220H | CAS RN:130855-15-1 | (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine | CAS RN:61869-08-7 | PAROXETINE | PubChem CID:43815 | DrugBank ID:DB00715 | PubChem SID:459056051 | CAS RN:110429-35-1 | PubChem SID:175266208 | PAROXETINE, (±)-"
+BMGC_DG08385,BMG_DG142542,PubChem CID:4381769 | ETHYL 4-(3-OXO-2(3H)-ISOTHIAZOLYL)BENZOATE | UNII:ZAF2KX423G
+BMGC_DG08386,BMG_DG142543,"UNII:R7339QLN1C | PubChem CID:4382 | CAS RN:501-15-5 | Deoxyepinephrine | 4-[2-(methylamino)ethyl]benzene-1,2-diol | DEOXYEPINEPHRINE | PubChem SID:198942291 | DrugBank ID:DB13917"
+BMGC_DG08387,BMG_DG142552,PubChem SID:433968913 | PubChem CID:438550 | C-1330 | UNII:WH2PZ15PPN | CAS RN:138154-31-1
+BMGC_DG08388,BMG_DG142556,PubChem CID:4386 | FENAMIC ACID | CAS RN:91-40-7 | N-phenylanthranilic acid | PubChem SID:198953853 | UNII:952VN06WBB | 2-anilinobenzoic acid
+BMGC_DG08389,BMG_DG142557,"[(2R,3S,4R,5R)-5-(5-amino-7-methyl-2,6,7,9,11-pentazatricyclo[6.3.1.04,12]dodeca-1(12),3,5,8,10-pentaen-2-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | CAS RN:61966-08-3 | DrugBank ID:DB14636 | PubChem CID:43860 | UNII:5L5GE3DV88 | Tcn-P | TRICIRIBINE PHOSPHATE | PubChem SID:198989926"
+BMGC_DG08390,BMG_DG142575,"CAS RN:343247-32-5 | 9-methyl-N-[2-[2-[2-[(9-methylphenazine-1-carbonyl)amino]ethylamino]ethylamino]ethyl]phenazine-1-carboxamide | MLN-944 | N,N'-(1,2-Ethanediylbis(imino-2,1-ethanediyl))bis(9-methyl-1-phenazinecarboxamide) | DrugBank ID:DB06364 | UNII:LJH9XG66Q9 | PubChem SID:459055878 | PubChem CID:439035"
+BMGC_DG08391,BMG_DG142577,"1,4-Dihydronicotinamide adenine dinucleotide | NADH | DrugBank ID:DB00157 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate | PubChem CID:439153 | CAS RN:58-68-4 | PubChem SID:198939070 | UNII:4J24DQ0916"
+BMGC_DG08392,BMG_DG142579,"DrugBank ID:DB01752 | (2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylsulfanyl]butanoic acid | S-adenosyl-L-homocysteine | PubChem SID:252319725 | PubChem CID:439155 | UNII:8K31Q2S66S | CAS RN:979-92-0 | S-ADENOSYL-L-HOMOCYSTEINE"
+BMGC_DG08393,BMG_DG142585,"UNII:370V52HE4B | sn-Glycerol 3-phosphate | [(2R)-2,3-dihydroxypropyl] dihydrogen phosphate | DrugBank ID:DB02515 | sn-glycerol 3-phosphate | CAS RN:17989-41-2 | PubChem SID:198985289 | GLYCERYL 1-PHOSPHATE, (R)- | PubChem CID:439162"
+BMGC_DG08394,BMG_DG142590,"PubChem CID:439168 | DrugBank ID:DB02263 | D-Glyceraldehyde 3-Phosphate | [(2R)-2-hydroxy-3-oxopropyl] dihydrogen phosphate | CAS RN:142-10-9 | UNII:TD9ZNF8JPW | PubChem SID:472407428 | CAS RN:591-57-1 | D-glyceraldehyde 3-phosphate | CAS RN:91469-44-2 | 3-PHOSPHOGLYCERALDEHYDE, D-"
+BMGC_DG08395,BMG_DG142592,"CAS RN:57301-10-7 | (2R,3R,4S,5S)-2-(6-aminopurin-9-yl)-5-(methylsulfanylmethyl)oxolane-3,4-diol | 5'-METHYLTHIOADENOSINE | CAS RN:2457-80-9 | DrugBank ID:DB02282 | PubChem CID:439176 | PubChem SID:198983088 | UNII:634Z2VK3UQ | 5'-S-methyl-5'-thioadenosine | 5'-Methylthioadenosine"
+BMGC_DG08396,BMG_DG142594,"D-(+)-Cellobiose | PubChem CID:439178 | DrugBank ID:DB02061 | CAS RN:528-50-7 | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol | Cellobiose | CAS RN:28072-80-2 | CAS RN:16462-44-5"
+BMGC_DG08397,BMG_DG142596,"CAS RN:4754-39-6 | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methyloxolane-3,4-diol | 5'-DEOXYADENOSINE | 5'-Deoxyadenosine | PubChem SID:433968368 | PubChem CID:439182 | UNII:2U0TYC8Y5A"
+BMGC_DG08398,BMG_DG142597,3-phospho-D-glyceric acid | UNII:46ABA554FY | DrugBank ID:DB04510 | CAS RN:3443-58-1 | (2R)-2-hydroxy-3-phosphonooxypropanoic acid | PubChem CID:439183 | D-3-PHOSPHOGLYCERIC ACID
+BMGC_DG08399,BMG_DG142598,"CAS RN:551-85-9 | PubChem SID:472423373 | D-Ribulose 5-phosphate | [(2R,3R)-2,3,5-trihydroxy-4-oxopentyl] dihydrogen phosphate | CAS RN:4151-19-3 | D-RIBULOSE 5-PHOSPHATE | PubChem CID:439184 | UNII:THU37VTP7Y"
+BMGC_DG08400,BMG_DG142599,"DrugBank ID:DB03323 | Maltose | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol | PubChem CID:439186 | CAS RN:69-79-4 | CAS RN:16984-36-4"
+BMGC_DG08401,BMG_DG142600,"D-Xylulose 5-phosphate | Ribulose-5-Phosphate | PubChem SID:472421979 | [(2R,3S)-2,3,5-trihydroxy-4-oxopentyl] dihydrogen phosphate | PubChem CID:439190 | DrugBank ID:DB04034 | CAS RN:4212-65-1 | UNII:6MF87847MR | CAS RN:60802-29-1 | D-XYLULOSE 5-PHOSPHATE"
+BMGC_DG08402,BMG_DG142601,phosphono (2R)-2-hydroxy-3-phosphonooxypropanoate | 3-phospho-D-glyceroyl dihydrogen phosphate | PubChem CID:439191 | CAS RN:38168-82-0
+BMGC_DG08403,BMG_DG142603,"Isomaltose | PubChem CID:439193 | (3R,4S,5S,6R)-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol | CAS RN:499-40-1"
+BMGC_DG08404,BMG_DG142606,"CAS RN:16096-97-2 | (2R,3R)-1,4-bis(sulfanyl)butane-2,3-diol | UNII:T8ID5YZU6Y | PubChem CID:439196 | CAS RN:3483-12-3 | 2,3-Dihydroxy-1,4-dithiobutane | PubChem SID:198940140 | 1,4-Dithiothreitol | DITHIOTHREITOL | DrugBank ID:DB04447"
+BMGC_DG08405,BMG_DG142607,"PubChem CID:439197 | CAS RN:131-48-6 | (4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid | CAS RN:489-46-3 | N-Acetyl-Neuraminic Acid"
+BMGC_DG08406,BMG_DG142609,Glycyl-N-methylglycinamide | PubChem CID:439199 | CAS RN:92235-99-9 | 2-amino-N-[2-(methylamino)-2-oxoethyl]acetamide | UNII:9BKZ7NA5HT | PubChem SID:387065268 | GLYCYL-N-METHYLGLYCINAMIDE | CAS RN:9001-31-4
+BMGC_DG08407,BMG_DG142610,Bradykinin | CAS RN:121283-65-6 | BRADYKININ | DrugBank ID:DB12126 | UNII:S8TIM42R2W | (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid | PubChem SID:198973777 | CAS RN:58-82-2 | PubChem CID:439201
+BMGC_DG08408,BMG_DG142611,(2S)-2-amino-4-(diaminomethylideneamino)oxybutanoic acid | L-canavanine | Canavanine | CAS RN:543-38-4 | PubChem SID:198939959 | CANAVANINE | UNII:3HZV514J4B | DrugBank ID:DB01833 | PubChem CID:439202
+BMGC_DG08409,BMG_DG142616,"PubChem CID:439213 | DrugBank ID:DB01296 | D-Glucosamine | CAS RN:90-77-7 | Glucosamine | (3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol"
+BMGC_DG08410,BMG_DG142619,"Dihydroorotic Acid | UNII:4LPL64ZNA5 | CAS RN:5988-19-2 | HYDROOROTIC ACID, L- | (4S)-2,6-dioxo-1,3-diazinane-4-carboxylic acid | PubChem CID:439216 | PubChem SID:198984990 | L-Dihydroorotic acid | DrugBank ID:DB02129"
+BMGC_DG08411,BMG_DG142620,"Glucosamine 6-Phosphate | DrugBank ID:DB02657 | PubChem CID:439217 | Glucosamine 6-phosphate | [(2R,3S,4R,5R,6S)-5-amino-3,4,6-trihydroxyoxan-2-yl]methyl dihydrogen phosphate | CAS RN:55722-81-1"
+BMGC_DG08412,BMG_DG142621,"CAS RN:1553-55-5 | PubChem CID:439218 | (3S)-5-[2-[3-[[4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-3-hydroxy-3-methyl-5-oxopentanoic acid"
+BMGC_DG08413,BMG_DG142623,PubChem CID:439220 | 2'-Deoxyguanosine-5'-Diphosphate | DrugBank ID:DB03491
+BMGC_DG08414,BMG_DG142626,CAS RN:305-84-0 | DrugBank ID:DB11695 | PubChem SID:175265340 | (2S)-2-(3-aminopropanoylamino)-3-(1H-imidazol-5-yl)propanoic acid | PubChem CID:439224 | Carnosine | CARNOSINE | CAS RN:1370422-07-3 | UNII:8HO6PVN24W
+BMGC_DG08415,BMG_DG142627,"CAS RN:3105-95-1 | l-Pipecolic acid | UNII:69374CKB33 | PIPECOLIC ACID, (-)- | PubChem SID:241179424 | (2S)-piperidine-2-carboxylic acid | PubChem CID:439227"
+BMGC_DG08416,BMG_DG142629,"PubChem CID:439230 | (3R)-3,5-dihydroxy-3-methylpentanoic acid | DrugBank ID:DB03518 | CAS RN:17817-88-8 | Mevalonic acid"
+BMGC_DG08417,BMG_DG142630,"PubChem CID:439231 | CAS RN:3913-64-2 | UNII:BS76EN9C35 | Lactaldehyde | DrugBank ID:DB03776 | (2S)-2-hydroxypropanal | (S)-lactaldehyde | PubChem SID:459275478 | LACTALDEHYDE, L-"
+BMGC_DG08418,BMG_DG142631,CAS RN:6205-08-9 | N-acetylornithine | PubChem CID:439232 | (2S)-2-acetamido-5-aminopentanoic acid
+BMGC_DG08419,BMG_DG142634,"PubChem CID:439236 | 1-O-phosphono-alpha-D-ribofuranose | Ribose-1-Phosphate | DrugBank ID:DB03101 | [(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl] dihydrogen phosphate"
+BMGC_DG08420,BMG_DG142637,"PubChem CID:439242 | RAFFINOSE | PubChem SID:175267861 | UNII:N5O3QU595M | (2S,3R,4S,5R,6R)-2-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | CAS RN:512-69-6 | Raffinose"
+BMGC_DG08421,BMG_DG142640,"NARINGENIN | CAS RN:13308-00-4 | PubChem SID:175268760 | PubChem CID:439246 | DrugBank ID:DB03467 | UNII:HN5425SBF2 | CAS RN:480-41-1 | (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | Naringenin"
+BMGC_DG08422,BMG_DG142645,"L-arabinitol | (2S,4S)-pentane-1,2,3,4,5-pentol | ARABINITOL, L- | CAS RN:7643-75-6 | UNII:45Z1K06N9V | PubChem CID:439255 | PubChem SID:198936550"
+BMGC_DG08423,BMG_DG142646,"CAS RN:56-88-2 | UNII:375YFJ481O | PubChem SID:198948070 | PubChem CID:439258 | L-cystathionine | CYSTATHIONINE, L- | (2S)-2-amino-4-[(2R)-2-amino-2-carboxyethyl]sulfanylbutanoic acid"
+BMGC_DG08424,BMG_DG142647,"PubChem CID:439260 | Norepinephrine | NOREPINEPHRINE | NDC:43857-0161 | UNII:X4W3ENH1CV | NDC:43857-0260 | PubChem SID:175265587 | CAS RN:65277-62-5 | DrugBank ID:DB00368 | CAS RN:51-41-2 | 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol"
+BMGC_DG08425,BMG_DG142648,"PubChem CID:439262 | CAS RN:9041-22-9 | Beta-Glucan | (2S,3R,4S,5S,6R)-2-[(2R,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol"
+BMGC_DG08426,BMG_DG142652,"PubChem CID:439271 | N-[(2R,3R,4R,5S,6R)-2,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide | N-Acetyllactosamine | CAS RN:32181-59-2"
+BMGC_DG08427,BMG_DG142655,PubChem SID:472409688 | 2-phospho-D-glyceric acid | DrugBank ID:DB01709 | 2-PHOSPHO-D-GLYCERIC ACID | (2R)-3-hydroxy-2-phosphonooxypropanoic acid | CAS RN:3443-57-0 | 2-Phospho-D-Glyceric Acid | UNII:DZ2LFC6KEU | PubChem CID:439278
+BMGC_DG08428,BMG_DG142657,NDC:44911-0264 | PubChem CID:439280 | DrugBank ID:DB02959 | PubChem SID:175265672 | Oxitriptan | UNII:C1LJO185Q9 | (2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid | OXITRIPTAN | CAS RN:4350-09-8
+BMGC_DG08429,BMG_DG142658,"PubChem CID:439281 | N-[(3S,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | N-Acetyl-D-Mannosamine | CAS RN:1136-44-3 | CAS RN:4773-29-9 | CAS RN:72-87-7"
+BMGC_DG08430,BMG_DG142659,"PubChem CID:439283 | PubChem SID:440088814 | CAS RN:14289-34-0 | DIAMINOPIMELIC ACID, (6S,2S)- | UNII:K3I8AN6S7F | DrugBank ID:DB03590 | (2S,6S)-2,6-diaminoheptanedioic acid | 2,6-Diaminopimelic Acid"
+BMGC_DG08431,BMG_DG142660,".ALPHA.-D-GLUCOPYRANOSE 6-PHOSPHATE | UNII:03JQ7I74CO | PubChem SID:376072126 | [(2R,3S,4S,5R,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate | PubChem CID:439284 | DrugBank ID:DB02007 | CAS RN:15209-11-7 | alpha-D-glucose 6-phosphate"
+BMGC_DG08432,BMG_DG142662,"PubChem SID:482553920 | 2-DEOXY-D-RIBOSE 1-PHOSPHATE | CAS RN:17210-42-3 | 2-Deoxy-D-ribose 1-phosphate | Deoxyribose 1-phosphate | UNII:RBH273D9YF | [(4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl] dihydrogen phosphate | PubChem CID:439287"
+BMGC_DG08433,BMG_DG142667,"XANTHOSINE 5'-TRIPHOSPHATE | PubChem SID:474492405 | Xanthosine 5′-triphosphate | UNII:AM28CL5N94 | CAS RN:6253-56-1 | PubChem CID:439296 | Xanthosine 5'-triphosphate | [[(2R,3S,4R,5R)-5-(2,6-dioxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate"
+BMGC_DG08434,BMG_DG142668,"CAS RN:50-56-6 | Oxytocin | (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide | PubChem SID:375085180 | UNII:1JQS135EYN | OXYTOCIN | PubChem CID:439302"
+BMGC_DG08435,BMG_DG142676,DrugBank ID:DB04364 | CAS RN:53584-56-8 | PubChem CID:439314 | (R)-acetoin | (3R)-3-hydroxybutan-2-one
+BMGC_DG08436,BMG_DG142677,"(2S)-2-amino-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoic acid | UNII:8F09Y50AX6 | CAS RN:25520-73-4 | PubChem SID:198955361 | PubChem CID:439316 | Dopaquinone | DOPAQUINONE"
+BMGC_DG08437,BMG_DG142678,"UNII:15JT14C3GI | (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol | CAS RN:4696-76-8 | BEKANAMYCIN | PubChem SID:198958470 | PubChem CID:439318 | DrugBank ID:DB13673 | Bekanamycin"
+BMGC_DG08438,BMG_DG142680,"PANTETHEINE | PubChem SID:198949415 | CAS RN:496-65-1 | PubChem CID:439322 | (2R)-2,4-dihydroxy-3,3-dimethyl-N-[3-oxo-3-(2-sulfanylethylamino)propyl]butanamide | Pantetheine | UNII:VCH6X4IARE"
+BMGC_DG08439,BMG_DG142683,PubChem CID:439326 | DrugBank ID:DB03013 | N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine
+BMGC_DG08440,BMG_DG142689,".ALPHA.-MALTOSE | CAS RN:9050-36-6 | CAS RN:9005-84-9 | PubChem CID:439341 | CAS RN:4482-75-1 | UNII:15SUG9AD26 | PubChem SID:198972483 | alpha-Maltose | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol"
+BMGC_DG08441,BMG_DG142693,"PubChem SID:472408976 | UNII:Q8HL497GUU | 3-Dehydroquinic Acid | (1R,3R,4S)-1,3,4-trihydroxy-5-oxocyclohexane-1-carboxylic acid | 3-DEHYDROQUINIC ACID | DrugBank ID:DB03868 | PubChem CID:439351 | CAS RN:10534-44-8"
+BMGC_DG08442,BMG_DG142694,"PubChem SID:381132432 | UNII:R4SVL81GQI | (2R,3S)-1,4-bis(sulfanyl)butane-2,3-diol | PubChem CID:439352 | DrugBank ID:DB01692 | Dithioerythritol | CAS RN:6892-68-8 | DITHIOERYTHRITOL"
+BMGC_DG08443,BMG_DG142695,".BETA.-D-GALACTOPYRANOSE | β-D-Galactopyranose | CAS RN:7296-64-2 | CAS RN:105430-43-1 | (2R,3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol | beta-D-GALACTOPYRANOSE | PubChem CID:439353 | CAS RN:9031-11-2 | UNII:RQ6K52J67A | PubChem SID:175268148"
+BMGC_DG08444,BMG_DG142697,CAS RN:20696-57-5 | PubChem CID:439356 | UNII:0K2B9SB26H | Tryptophanamide | DrugBank ID:DB04537 | TRYPTOPHANAMIDE | PubChem SID:198956372
+BMGC_DG08445,BMG_DG142698,"alpha-D-GALACTOSE | PubChem CID:439357 | .ALPHA.-D-GALACTOPYRANOSE | α-D-Galactopyranose | (2S,3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol | PubChem SID:198954088 | UNII:7IOF6H4H77 | CAS RN:3646-73-9"
+BMGC_DG08446,BMG_DG142699,"CAS RN:1115-78-2 | UNII:C7641UJG3Q | PubChem CID:439360 | UNII:3CUV6EVI23 | PubChem SID:318691859 | L-ALANYL-D-ALANINE, (+/-)- | PubChem SID:318691830 | L-ALANYL-D-ALANINE, (±)- | D-ALANYL-L-ALANINE"
+BMGC_DG08447,BMG_DG142701,"CAS RN:128-46-1 | 2-[(1R,2R,3S,4R,5R,6S)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine | PubChem CID:439369 | DIHYDROSTREPTOMYCIN | UNII:P2I6R8W6UA | Dihydrostreptomycin | DrugBank ID:DB11512 | PubChem SID:175266882"
+BMGC_DG08448,BMG_DG142703,"L-GULONO-.GAMMA.-LACTONE | PubChem CID:439373 | UNII:56830VTX9G | (3S,4R,5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-one | L-Gulonolactone | PubChem SID:375083332 | CAS RN:1128-23-0"
+BMGC_DG08449,BMG_DG142707,PubChem CID:439378 | UNII:8021PR16QO | (2S)-2-amino-5-(ethylamino)-5-oxopentanoic acid | Theanine | CAS RN:3081-61-6 | DrugBank ID:DB12444 | THEANINE | PubChem SID:175266612
+BMGC_DG08450,BMG_DG142711,"CAS RN:13095-47-1 | UNII:R9UK2G8Y79 | CAS RN:636-67-9 | (2R)-2-hydroxypentanedioic acid | 2-HYDROXYGLUTARIC ACID, (R)- | PubChem CID:439391 | PubChem SID:472422897"
+BMGC_DG08451,BMG_DG142715,[(2S)-2-amino-3-(1H-imidazol-5-yl)propyl] dihydrogen phosphate | CAS RN:25679-93-0 | PubChem CID:439398 | L-histidinol phosphate | DrugBank ID:DB03997 | l-Histidinol phosphate
+BMGC_DG08452,BMG_DG142721,"CAS RN:16096-98-3 | (4R,5R)-1,2-DITHIANE-4,5-DIOL | (4R,5R)-dithiane-4,5-diol | UNII:3OED5PX4AN | DrugBank ID:DB01822 | CAS RN:51621-02-4 | CAS RN:14193-38-5 | PubChem CID:439407 | (4R,5R)-1,2-dithiane-4,5-diol | PubChem SID:440089473 | Dithiane diol"
+BMGC_DG08453,BMG_DG142726,"CAS RN:434-16-2 | (3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol | UNII:BK1IU07GKF | PubChem CID:439423 | 7-DEHYDROCHOLESTEROL | PubChem SID:175266199 | 7-Dehydrocholesterol"
+BMGC_DG08454,BMG_DG142727,"Pseudouridine 5'-phosphate | [(2R,3S,4R,5S)-5-(2,4-dioxo-1H-pyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | UNII:88NC65Q5EZ | PSEUDOURIDINE 5'-PHOSPHATE | Pseudouridine-5'-Monophosphate | CAS RN:1157-60-4 | DrugBank ID:DB03829 | PubChem SID:482553964 | Pseudouridine 5′-phosphate | PubChem CID:439424"
+BMGC_DG08455,BMG_DG142729,"PubChem CID:439427 | PubChem SID:376072104 | UNII:G6FRT62N3J | beta-D-glucose 6-phosphate | DrugBank ID:DB04122 | CAS RN:15209-12-8 | .BETA.-D-GLUCOPYRANOSE 6-PHOSPHATE | Beta-D-Glucose 6-phosphate | [(2R,3S,4S,5R,6R)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate"
+BMGC_DG08456,BMG_DG142736,"1D-myo-inositol 1,4-bisphosphate | [(2R,3R,5R,6S)-2,3,5,6-tetrahydroxy-4-phosphonooxycyclohexyl] dihydrogen phosphate | PubChem CID:439444 | D-Myo-Inositol-1,4-Bisphosphate | DrugBank ID:DB03158 | CAS RN:74465-19-3 | CAS RN:47055-78-7"
+BMGC_DG08457,BMG_DG142737,"[(2R,3S,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-4-hydroxy-2-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-3-yl] phosphono hydrogen phosphate | DrugBank ID:DB04022 | PubChem CID:439450 | Guanosine tetraphosphate"
+BMGC_DG08458,BMG_DG142741,"1D-myo-inositol 1,3,4-trisphosphate | CAS RN:93133-76-7 | [(1S,2R,3R,4S,5S,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate | DrugBank ID:DB01729 | Inositol 1,3,4-trisphosphate | PubChem CID:439455"
+BMGC_DG08459,BMG_DG142742,"INOSITOL 1,4,5-TRISPHOSPHATE | [(1R,2S,3R,4R,5S,6R)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate | DrugBank ID:DB03401 | 1D-myo-inositol 1,4,5-trisphosphate | CAS RN:85166-31-0 | PubChem CID:439456 | PubChem SID:472425872 | UNII:MU34XVK5NR | Inositol 1,4,5-Trisphosphate | CAS RN:88269-39-0 | CAS RN:142656-03-9"
+BMGC_DG08460,BMG_DG142749,"(6R)-2-methyl-6-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanal | 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al | CAS RN:3836-01-9 | PubChem CID:439479"
+BMGC_DG08461,BMG_DG142751,"CAS RN:66701-25-5 | (2R,3R)-3-[[(2S)-1-[4-(diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylic acid | PubChem CID:439487 | trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane"
+BMGC_DG08462,BMG_DG142754,PubChem SID:198987632 | CAS RN:19246-18-5 | 2-[[(2R)-2-amino-3-sulfanylpropanoyl]amino]acetic acid | UNII:384644SZ9T | Cysteinylglycine | CYSTEINYLGLYCINE | PubChem CID:439498
+BMGC_DG08463,BMG_DG142756,"DrugBank ID:DB01092 | UNII:5ACL011P69 | 3-[(1R,3S,5S,8R,9S,10R,11R,13R,14S,17R)-1,5,11,14-tetrahydroxy-10-(hydroxymethyl)-13-methyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | CAS RN:630-60-4 | Ouabain | OUABAIN | PubChem CID:439501 | PubChem SID:198973799"
+BMGC_DG08464,BMG_DG142757,"PubChem SID:175268782 | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol | UNII:4649620TBZ | Salicin | SALICIN | PubChem CID:439503 | CAS RN:138-52-3"
+BMGC_DG08465,BMG_DG142764,"PubChem CID:439514 | 6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one | CAS RN:531-44-2 | SCOPOLIN | PubChem SID:198981895 | UNII:1Y49270PY8 | Scopolin"
+BMGC_DG08466,BMG_DG142767,"PubChem CID:439518 | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-5-methylhexanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]butanedioic acid | CAS RN:67655-94-1 | Amastatin"
+BMGC_DG08467,BMG_DG142769,(2R)-2-amino-4-methylpentanoic acid | D-Leucine | PubChem SID:198937162 | PubChem CID:439524 | CAS RN:328-38-1 | UNII:965COD96YA | D-LEUCINE | DrugBank ID:DB01746
+BMGC_DG08468,BMG_DG142772,"PubChem SID:198957524 | (2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide | PUROMYCIN | UNII:4A6ZS6Q2CL | CAS RN:58-58-2 | CAS RN:53-79-2 | DrugBank ID:DB08437 | PubChem CID:439530 | Puromycin"
+BMGC_DG08469,BMG_DG142773,"CAS RN:10094-58-3 | CAS RN:470-55-3 | PubChem CID:439531 | (2S,3R,4S,5R,6R)-2-[[(2R,3R,4S,5R,6S)-6-[[(2R,3S,4S,5R,6R)-6-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | Stachyose | CAS RN:54261-98-2"
+BMGC_DG08470,BMG_DG142774,"PubChem SID:363909760 | CAS RN:17654-26-1 | UNII:9SOB9E3987 | TAXIFOLIN, (±)- | Taxifolin | UNII:EAS93SC1VS | (2R,3R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-2,3-dihydrochromen-4-one | PubChem SID:198937828 | CAS RN:20254-28-8 | DrugBank ID:DB02224 | TAXIFOLIN | CAS RN:24198-97-8 | CAS RN:480-18-2 | TAXIFOLIN, (+/-)- | PubChem CID:439533"
+BMGC_DG08471,BMG_DG142779,"N,N'-Diacetylchitobiose | PubChem CID:439544 | CAS RN:35061-50-8 | CAS RN:2706-64-1 | N-[(3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide"
+BMGC_DG08472,BMG_DG142781,"PubChem CID:439551 | DrugBank ID:DB07814 | Gibberellic acid | (1R,2R,5S,8S,9S,10R,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylic acid"
+BMGC_DG08473,BMG_DG142783,PubChem CID:439553 | CAS RN:41579-20-8 | UNII:WR469VI1J3 | Fructose | .BETA.-L-FRUCTOFURANOSE | PubChem SID:376231476 | DrugBank ID:DB04173
+BMGC_DG08474,BMG_DG142784,"PubChem SID:198989906 | PubChem CID:439554 | .ALPHA.-L-FUCOPYRANOSE | UNII:OF086I9H7W | alpha-L-fucose | CAS RN:6696-41-9 | (2R,3S,4R,5S,6S)-6-methyloxane-2,3,4,5-tetrol | CAS RN:51348-50-6 | alpha-L-fucopyranose | DrugBank ID:DB04473"
+BMGC_DG08475,BMG_DG142792,LAURYL ALCOHOL DIPHOSPHONIC ACID | DrugBank ID:DB07873 | CAS RN:16610-63-2 | PubChem SID:198990825 | Lauryl alcohol diphosphonic acid | UNII:S888WM4024 | PubChem CID:4395717
+BMGC_DG08476,BMG_DG142795,"CAS RN:2013-12-9 | PubChem SID:198977929 | PubChem CID:439575 | NORVALINE, D- | UNII:102E6YF9W5"
+BMGC_DG08477,BMG_DG142797,"Desmosterol | CAS RN:313-04-2 | DESMOSTEROL | UNII:ANP93865R8 | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | PubChem SID:198962901 | PubChem CID:439577"
+BMGC_DG08478,BMG_DG142805,"(2R)-2,4-diamino-4-oxobutanoic acid | ASPARAGINE, D- | CAS RN:2058-58-4 | D-Asparagine | DrugBank ID:DB03943 | UNII:T6QV1010K6 | PubChem CID:439600 | PubChem SID:198951324"
+BMGC_DG08479,BMG_DG142810,"DrugBank ID:DB03357 | UNII:L0UMW58G3T | (S)-Mandelic acid | (2S)-2-hydroxy-2-phenylacetic acid | PubChem SID:198943222 | MANDELIC ACID, (S)- | CAS RN:17199-29-0 | PubChem CID:439616"
+BMGC_DG08480,BMG_DG142818,PubChem SID:316918249 | UNII:P598716LJT | N-[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]-4-methylbenzenesulfonamide | Tosylphenylalanyl chloromethyl ketone | CAS RN:402-71-1 | N-TOSYL-L-PHENYLALANYL CHLOROMETHYL KETONE | PubChem CID:439647
+BMGC_DG08481,BMG_DG142819,"Beta-D-Fucose | DrugBank ID:DB04062 | PubChem SID:375579078 | (2R,3R,4S,5R,6R)-6-methyloxane-2,3,4,5-tetrol | UNII:ZU9GS9H79G | CAS RN:28161-52-6 | beta-D-fucose | .BETA.-D-FUCOPYRANOSE | PubChem CID:439650"
+BMGC_DG08482,BMG_DG142820,"UNII:N50DYZ2H5Q | PubChem SID:198938037 | (2S)-2-phenyl-2,3-dihydrochromen-4-one | PubChem CID:439652 | (2S)-Flavanone | FLAVANONE, (-)- | CAS RN:17002-31-2"
+BMGC_DG08483,BMG_DG142822,"(S)-Scoulerine | CAS RN:6451-73-6 | PubChem CID:439654 | (13aS)-3,10-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,9-diol"
+BMGC_DG08484,BMG_DG142823,"(2S,3S)-2,3-dihydroxybutanedioic acid | Tartaric acid, D- | CAS RN:133-37-9 | CAS RN:106449-07-4 | D-tartaric acid | CAS RN:147-71-7 | PubChem CID:439655 | CAS RN:1007601-97-9 | UNII:RRX6A4PL3C | TARTARIC ACID, D- | PubChem SID:175266445 | DrugBank ID:DB01694"
+BMGC_DG08485,BMG_DG142831,UNII:TQP297C4HN | D-PIDOLIC ACID | D-Pidolic acid | PubChem CID:439685 | CAS RN:4042-36-8 | PubChem SID:472426485
+BMGC_DG08486,BMG_DG142833,"CAS RN:2623-91-8 | UNII:G9ZRL3F2M6 | PubChem CID:439691 | D-2-Aminobutyric acid | .ALPHA.-AMINOBUTYRIC ACID, D- | Alpha-Aminobutyric Acid | (2R)-2-aminobutanoic acid | DrugBank ID:DB04454"
+BMGC_DG08487,BMG_DG142835,"DrugBank ID:DB00552 | NDC:0409-0801 | UNII:395575MZO7 | PubChem CID:439693 | (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol | PubChem SID:175267509 | CAS RN:53910-25-1 | Pentostatin | PENTOSTATIN"
+BMGC_DG08488,BMG_DG142856,3-CYANO-L-ALANINE | PubChem CID:439742 | PubChem SID:440793984 | UNII:B75AJA4DCJ | CAS RN:6232-19-5 | 3-Cyano-L-alanine
+BMGC_DG08489,BMG_DG142857,UNII:FRQ98U4U27 | 3-Iodo-Tyrosine | DrugBank ID:DB01758 | (2S)-2-amino-3-(4-hydroxy-3-iodophenyl)propanoic acid | PubChem CID:439744 | CAS RN:70-78-0 | PubChem SID:198949225 | 3-Iodo-L-tyrosine | 3-IODOTYROSINE
+BMGC_DG08490,BMG_DG142859,PubChem SID:198977122 | DrugBank ID:DB04464 | PubChem CID:439750 | (2S)-2-formamido-4-methylsulfanylbutanoic acid | N-Formylmethionine | UNII:PS9357B4XH | CAS RN:4289-98-9 | FORMYLMETHIONINE
+BMGC_DG08491,BMG_DG142862,"2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | CAS RN:516-90-5 | PubChem CID:439763 | Taurolithocholic Acid"
+BMGC_DG08492,BMG_DG142888,"PubChem CID:439824 | UNII:4IDV8RJ3ZE | CAS RN:96999-03-0 | PubChem SID:381132441 | OCTANOYLCARNITINE, D-"
+BMGC_DG08493,BMG_DG142894,"(S)-propane-1,2-diol | PubChem SID:198960639 | DrugBank ID:DB04349 | PubChem CID:439846 | S-1,2-Propanediol | CAS RN:4254-15-3 | (2S)-propane-1,2-diol | UNII:942194N4TD | PROPYLENE GLYCOL, (S)-"
+BMGC_DG08494,BMG_DG142913,Guanosine-5'-Diphosphate-Rhamnose | PubChem CID:439912 | DrugBank ID:DB02547
+BMGC_DG08495,BMG_DG142918,"UNII:0I8H2M0L7N | DrugBank ID:DB14933 | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyridin-1-ium-3-carboxamide | CAS RN:1341-23-7 | PubChem CID:439924 | NICOTINAMIDE RIBOSIDE | PubChem SID:329904161 | Nicotinamide Riboside"
+BMGC_DG08496,BMG_DG142922,"2-HYDROXYGLUTARIC ACID, (S)- | CAS RN:13095-48-2 | PubChem CID:439939 | (2S)-2-hydroxypentanedioic acid | PubChem SID:472424251 | UNII:7Z2F3DYB8K"
+BMGC_DG08497,BMG_DG142930,PubChem SID:198985607 | UNII:375AW34SQA | GLUCOSE-6-PHOSPHATE | CAS RN:56-73-5 | PubChem CID:439958
+BMGC_DG08498,BMG_DG142941,2-[[N'-[(4S)-4-amino-4-carboxybutyl]carbamimidoyl]amino]butanedioic acid | (N(omega)-L-arginino)succinic acid | PubChem CID:439998 | CAS RN:2387-71-5
+BMGC_DG08499,BMG_DG142942,Tartronate | DrugBank ID:DB03680 | 2-hydroxypropanedioate | PubChem CID:44
+BMGC_DG08500,BMG_DG142945,NITROARGININE | Nitroarginine | UNII:7O8V7H6P2J | PubChem CID:440005 | (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoic acid | CAS RN:2149-70-4 | DrugBank ID:DB04223 | PubChem SID:198961255
+BMGC_DG08501,BMG_DG142946,"CAS RN:618-27-9 | cis-4-Hydroxy-L-proline | (2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid | HYDROXYPROLINE, CIS- | UNII:43V78B6A3B | CAS RN:81666-01-5 | PubChem CID:440015 | PubChem SID:198972793"
+BMGC_DG08502,BMG_DG142954,DrugBank ID:DB03915 | PubChem CID:440033 | 2-Amino-3-Ketobutyric Acid | L-2-Amino-3-oxobutanoic acid | (2S)-2-amino-3-oxobutanoic acid
+BMGC_DG08503,BMG_DG142957,"CAS RN:46495-39-0 | PubChem CID:440043 | [(2S,3S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate | CAS RN:69256-52-6 | 1D-myo-inositol 4-phosphate"
+BMGC_DG08504,BMG_DG142959,"3,4-dihydro-2H-pyrrole-5-carboxylic acid | PubChem CID:440046 | 3,4-DIHYDRO-2H-PYRROLE-5-CARBOXYLIC ACID | DrugBank ID:DB02838 | PubChem SID:482553312 | 3,4-Dihydro-2h-Pyrrolium-5-Carboxylate | CAS RN:2139-03-9 | 3,4-Dihydro-2H-pyrrole-5-carboxylic acid | UNII:497H5RPL8F"
+BMGC_DG08505,BMG_DG142961,UNII:X2R4I0X4W9 | PubChem SID:438788766 | DrugBank ID:DB04129 | PubChem CID:440053 | Willardiine | CAS RN:21416-43-3 | L-WILLARDIINE
+BMGC_DG08506,BMG_DG142964,"Taurolithocholic acid 3-sulfate | PubChem CID:440071 | 2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | CAS RN:15324-65-9"
+BMGC_DG08507,BMG_DG142975,(2S)-2-hydroxy-2-(4-hydroxyphenyl)acetonitrile | (S)-4-Hydroxymandelonitrile | PubChem CID:440104 | (2S)-HYDROXY(4-HYDROXYPHENYL)ETHANENITRILE | DrugBank ID:DB03430 | UNII:9BAR4IH1OD | CAS RN:71807-09-5 | PubChem SID:313183717 | (S)-4-hydroxymandelonitrile
+BMGC_DG08508,BMG_DG142978,4-Hydroxyphenylacetaldehyde | PubChem SID:472422280 | 2-(4-hydroxyphenyl)acetaldehyde | PubChem CID:440113 | UNII:HDJ7B4KB3X | CAS RN:7339-87-9 | 4-HYDROXYPHENYLACETALDEHYDE
+BMGC_DG08509,BMG_DG142979,"UNII:213MVW2TZD | Etiocholanedione | CAS RN:1229-12-5 | ETIOCHOLANEDIONE | (5R,8R,9S,10S,13S,14S)-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | DrugBank ID:DB07375 | PubChem SID:198946284 | PubChem CID:440114"
+BMGC_DG08510,BMG_DG142983,PubChem SID:198975193 | [(5S)-5-amino-5-carboxypentyl]-trimethylazanium | Trimethyllysine | N-Trimethyllysine | CAS RN:19253-88-4 | PubChem CID:440121 | DrugBank ID:DB03977 | TRIMETHYLLLYSINE | UNII:3YGF0495O2
+BMGC_DG08511,BMG_DG142989,DrugBank ID:DB02098 | Adenosine-2'-5'-Diphosphate | PubChem CID:440141
+BMGC_DG08512,BMG_DG143008,7-methyl-5'-guanylic acid | PubChem CID:440190 | DrugBank ID:DB03593
+BMGC_DG08513,BMG_DG143015,"Bis(Adenosine)-5'-Pentaphosphate | DrugBank ID:DB01717 | PubChem CID:440210 | bis[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate | CAS RN:41708-91-2 | CAS RN:14220-10-1 | Bis(adenosine)-5'-pentaphosphate"
+BMGC_DG08514,BMG_DG143019,"PubChem CID:440221 | CAS RN:23363-08-8 | 1,6-bis-O-galloyl-beta-D-glucose | [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(3,4,5-trihydroxybenzoyl)oxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate"
+BMGC_DG08515,BMG_DG143021,"PubChem SID:198984552 | (13aS)-3,9,10-trimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-2-ol | Tetrahydrocolumbamine | ISOCORYPALMINE, (-)- | UNII:MX470OL19D | PubChem CID:440229 | CAS RN:483-34-1"
+BMGC_DG08516,BMG_DG143022,3-(2-nitro-1-phenylethyl)-2-phenyl-1H-indole | CAS RN:102704-40-5 | PubChem CID:4402318
+BMGC_DG08517,BMG_DG143030,"OCTOPAMINE, (-)- | UNII:H1P36W1J84 | 4-[(1R)-2-amino-1-hydroxyethyl]phenol | CAS RN:876-04-0 | PubChem CID:440266 | PubChem SID:198936814"
+BMGC_DG08518,BMG_DG143042,"UNII:MD4L7VNE2T | CAS RN:79886-49-0 | PubChem SID:474492450 | 1,2,6-Trigalloylglucose | [(2R,3S,4S,5R,6S)-3,4-dihydroxy-5,6-bis[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate | 1,2,6-TRIGALLOYLGLUCOSE | PubChem CID:440308"
+BMGC_DG08519,BMG_DG143049,"CAS RN:117750-47-7 | DrugBank ID:DB02930 | PubChem CID:440317 | Adenosine 5'-[gamma-thio]triphosphate | CAS RN:35094-46-3 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] dihydroxyphosphinothioyl hydrogen phosphate | Phosphothiophosphoric acid-adenylate ester"
+BMGC_DG08520,BMG_DG143060,"(20S)-17,20-dihydroxypregn-4-en-3-one | CAS RN:652-69-7 | (8R,9S,10R,13S,14S,17R)-17-hydroxy-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | PubChem CID:440368"
+BMGC_DG08521,BMG_DG143080,CAS RN:500-44-7 | PubChem SID:241178255 | (2S)-2-amino-3-(3-hydroxy-4-oxopyridin-1-yl)propanoic acid | Mimosine | MIMOSINE | DrugBank ID:DB01055 | UNII:Z46B1LUI5N | PubChem CID:440473
+BMGC_DG08522,BMG_DG143091,"(3S,9S,10R,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol | PubChem CID:440558 | 7-Dehydrodesmosterol | CAS RN:1715-86-2"
+BMGC_DG08523,BMG_DG143093,"UNII:9H273A8B2X | (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol | CAS RN:79-62-9 | PubChem SID:198970970 | PubChem CID:440560 | 24,25-Dihydrolanosterol | DIHYDROLANOSTEROL"
+BMGC_DG08524,BMG_DG143098,"16alpha-Hydroxyandrostenedione | CAS RN:63-02-5 | PubChem SID:310825697 | UNII:JN8H7214IR | 16.ALPHA.-HYDROXYANDROSTENEDIONE | (8R,9S,10R,13S,14S,16R)-16-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | PubChem CID:440574"
+BMGC_DG08525,BMG_DG143099,"UNII:8ZWY97A2NG | PubChem CID:440575 | CAS RN:4298-08-2 | PubChem SID:333495695 | 3-HYDROXY-L-PROLINE, (3S)-"
+BMGC_DG08526,BMG_DG143114,N(alpha)-(2-Naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide | PubChem CID:4406 | CAS RN:86125-48-6 | CAS RN:117091-16-4 | N-[3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-ylpropan-2-yl]-2-(naphthalen-2-ylsulfonylamino)acetamide
+BMGC_DG08527,BMG_DG143126,"2-HYDROXYESTRONE | UNII:UQS3A06ILY | CAS RN:362-06-1 | PubChem CID:440623 | (8R,9S,13S,14S)-2,3-dihydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one | 2-Hydroxyestrone | PubChem SID:198988244"
+BMGC_DG08528,BMG_DG143127,"PubChem SID:198966495 | 2-METHOXYESTRONE | UNII:SJ5857RRL3 | (8R,9S,13S,14S)-3-hydroxy-2-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one | CAS RN:362-08-3 | PubChem CID:440624 | 2-Methoxyestrone"
+BMGC_DG08529,BMG_DG143132,"Tautomycin | PubChem CID:440646 | [(3R,4R,5R,8S,9S,12R)-12-[(2S,3S,6R,8S,9R)-3,9-dimethyl-8-[(3S)-3-methyl-4-oxopentyl]-1,7-dioxaspiro[5.5]undecan-2-yl]-5,9-dihydroxy-4-methoxy-2,8-dimethyl-7-oxotridecan-3-yl] (3R)-3-hydroxy-3-(4-methyl-2,5-dioxofuran-3-yl)propanoate"
+BMGC_DG08530,BMG_DG143143,"DrugBank ID:DB08830 | DEHYDROASCORBIC ACID | PubChem SID:198982379 | Dehydroascorbic acid | (5R)-5-[(1S)-1,2-dihydroxyethyl]oxolane-2,3,4-trione | CAS RN:490-83-5 | PubChem CID:440667 | UNII:Y2Z3ZTP9UM"
+BMGC_DG08531,BMG_DG143156,"CORTODOXONE | UNII:WDT5SLP0HQ | PubChem CID:440707 | (8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | CAS RN:152-58-9 | Cortodoxone | PubChem SID:198951986"
+BMGC_DG08532,BMG_DG143158,"DrugBank ID:DB04704 | 20-hydroxycholesterol | PubChem CID:440711 | (3beta,20R)-Cholest-5-ene-3,20-diol | (3S,8S,9S,10R,13S,14S,17S)-17-[(2R)-2-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"
+BMGC_DG08533,BMG_DG143159,"UNII:32835P5TLT | 17beta-Estradiol 3-(beta-D-glucuronide) | CAS RN:15270-30-1 | Estradiol 3-glucuronide | PubChem CID:440713 | ESTRADIOL 3-GLUCURONIDE | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]oxy]oxane-2-carboxylic acid | PubChem SID:474492551"
+BMGC_DG08534,BMG_DG143160,UNII:8D5GA7PEG6 | PubChem SID:438787600 | PubChem CID:440717 | DrugBank ID:DB02156 | Sulfopyruvate | CAS RN:98022-26-5 | SULFOPYRUVATE | 2-oxo-3-sulfopropanoic acid
+BMGC_DG08535,BMG_DG143167,CAS RN:50594-66-6 | 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid | PubChem CID:44073 | ACIFLUORFEN | PubChem SID:198976161 | UNII:OI60IB203A | DrugBank ID:DB07338 | Acifluorfen
+BMGC_DG08536,BMG_DG143168,"PubChem SID:198964264 | Eriodictyol | PubChem CID:440735 | UNII:Q520486B8Y | ERIODICTYOL | CAS RN:552-58-9 | (2S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydrochromen-4-one"
+BMGC_DG08537,BMG_DG143189,"PubChem SID:198970159 | UNII:VE4S15CI8D | 1,4-Dihydro-1-methyl-4-oxo-3-pyridinecarboxamide | 1-methyl-4-oxopyridine-3-carboxamide | 1,4-DIHYDRO-1-METHYL-4-OXO-3-PYRIDINECARBOXAMIDE | PubChem CID:440810 | CAS RN:769-49-3"
+BMGC_DG08538,BMG_DG143193,"CAS RN:7690-51-9 | 2-(4-hydroxyphenyl)chromenylium-3,5,7-triol | Pelargonidin | PubChem CID:440832"
+BMGC_DG08539,BMG_DG143208,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] acetate | CAS RN:13015-87-7 | PubChem CID:440867 | Acetyl adenylate"
+BMGC_DG08540,BMG_DG143219,NDC:51655-733 | NDC:55700-840 | NDC:50090-6167 | NDC:15370-170 | NDC:51655-446 | NDC:60760-369 | NDC:63629-8508 | NDC:68788-7597 | NDC:71335-2292 | NDC:76420-210 | NDC:79739-7077 | NDC:71335-1391 | NDC:79739-7078 | UNII:LW0TIW155Z | NDC:70518-3830 | Nabumetone | NDC:71335-2293 | NDC:72189-184 | NDC:63187-378 | NDC:63187-484 | NDC:68180-141 | NDC:69097-966 | NDC:50090-5294 | NDC:50228-466 | NDC:70954-784 | NDC:62135-145 | NDC:70518-4047 | NDC:79739-7076 | NDC:55700-845 | NDC:63187-307 | NDC:68788-7765 | NDC:80425-0104 | NDC:71205-978 | NDC:80425-0054 | NDC:72189-072 | NDC:62135-146 | NDC:50090-5386 | NDC:72162-1557 | NDC:72162-1558 | NDC:0591-3670 | NDC:70518-3835 | NDC:60760-368 | NDC:60687-630 | NDC:63629-8509 | NDC:69097-965 | NDC:80425-0053 | NDC:76282-257 | NDC:72789-040 | DrugBank ID:DB00461 | NDC:68180-142 | NDC:71335-1559 | NDC:43063-972 | CAS RN:42924-53-8 | NDC:69367-242 | NDC:71205-030 | NABUMETONE | NDC:63629-8506 | NDC:69367-241 | PubChem CID:4409 | NDC:71205-977 | NDC:63629-8510 | NDC:50228-465 | 4-(6-methoxynaphthalen-2-yl)butan-2-one | NDC:76282-258 | PubChem SID:175268381 | NDC:0591-3671 | NDC:70954-785 | NDC:71205-530 | NDC:51655-396
+BMGC_DG08541,BMG_DG143221,"(2S,3S)-2-amino-3-hydroxy-4-phosphonooxybutanoic acid | 4-(Phosphonooxy)-L-threonine | CAS RN:6917-68-6 | DrugBank ID:DB02609 | 4-Hydroxy-L-Threonine-5-Monophosphate | PubChem CID:440901"
+BMGC_DG08542,BMG_DG143230,"CAS RN:5989-27-5 | PubChem SID:175265568 | DrugBank ID:DB08921 | LIMONENE, (+)- | PubChem CID:440917 | NDC:71217-0053 | (4R)-1-methyl-4-prop-1-en-2-ylcyclohexene | Limonene, (+)- | UNII:GFD7C86Q1W | NDC:71217-0055 | CAS RN:7705-13-7 | NDC:71217-0070"
+BMGC_DG08543,BMG_DG143235,Captopril | NDC:69292-526 | NDC:51407-600 | NDC:16571-830 | NDC:31722-141 | NDC:51407-602 | NDC:63629-8727 | NDC:43547-365 | NDC:16571-829 | NDC:58657-737 | NDC:10135-792 | NDC:43547-363 | NDC:58657-736 | NDC:71335-2358 | NDC:0143-1174 | NDC:10135-793 | (2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid | NDC:43547-366 | NDC:58657-735 | NDC:31722-144 | NDC:51407-601 | NDC:63629-8729 | NDC:27241-163 | NDC:31722-143 | CAS RN:62571-86-2 | NDC:69292-528 | NDC:27241-161 | NDC:60687-315 | NDC:69292-524 | PubChem SID:175265387 | NDC:0143-1171 | NDC:55289-344 | PubChem CID:44093 | UNII:9G64RSX1XD | NDC:27241-160 | NDC:58657-738 | NDC:16571-827 | NDC:0904-7106 | NDC:16571-828 | NDC:43547-364 | NDC:63629-8728 | NDC:71335-1918 | NDC:0143-1172 | NDC:60687-304 | NDC:27241-162 | NDC:0904-7105 | NDC:51407-603 | CAPTOPRIL | NDC:31722-142 | DrugBank ID:DB01197 | NDC:69292-522 | NDC:10135-791 | NDC:63629-8730 | NDC:0143-1173
+BMGC_DG08544,BMG_DG143237,"1-Methylpyrrolinium | CAS RN:16032-02-3 | 1-methyl-3,4-dihydro-2H-pyrrol-1-ium | PubChem CID:440932"
+BMGC_DG08545,BMG_DG143239,"NDC:83872-531 | NDC:83872-193 | DrugBank ID:DB11217 | NDC:83566-139 | NDC:83872-192 | NDC:83872-335 | NDC:83872-529 | NDC:83872-213 | NDC:83872-332 | NDC:83872-191 | NDC:83872-334 | NDC:83872-344 | NDC:74458-315 | NDC:83872-199 | NDC:83566-002 | NDC:83872-230 | NDC:83872-478 | UNII:C5INA23HXF | NDC:83872-123 | NDC:83872-194 | NDC:83872-232 | PubChem SID:175266204 | NDC:83872-403 | NDC:84753-004 | PubChem CID:440936 | ARBUTIN | NDC:74458-020 | NDC:84613-059 | NDC:83872-443 | NDC:83872-197 | NDC:83872-198 | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol | NDC:83872-331 | CAS RN:497-76-7 | NDC:83872-532 | NDC:84025-307 | NDC:83872-018 | NDC:83872-231 | Arbutin"
+BMGC_DG08546,BMG_DG143258,"PubChem CID:440985 | 7alpha,27-Dihydroxycholesterol | CAS RN:4725-24-0 | (3S,7S,8S,9S,10R,13R,14S,17R)-17-[(2R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol"
+BMGC_DG08547,BMG_DG143259,3-methylquinolin-2(1H)-one | CAS RN:2721-59-7 | PubChem CID:440987 | 3-methyl-1H-quinolin-2-one
+BMGC_DG08548,BMG_DG143260,"PubChem CID:440988 | (1R)-1-[(4-hydroxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol | CAS RN:106032-53-5 | PubChem SID:255509046 | UNII:6016M93W29 | HIGENAMINE, (+)- | (+)-Higenamine"
+BMGC_DG08549,BMG_DG143262,"TETRAHYDROPAPAVEROLINE, (+)- | UNII:ZDC4P56AQS | PubChem CID:440990 | CAS RN:57073-16-2 | PubChem SID:445499655"
+BMGC_DG08550,BMG_DG143267,"Galbeta1,3GlcNAc | CAS RN:50787-09-2 | CAS RN:489-52-1 | N-[(3R,4R,5S,6R)-2,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide | PubChem CID:440994"
+BMGC_DG08551,BMG_DG143268,"Lactobiose | (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol | Lactose | DrugBank ID:DB04465 | PubChem CID:440995"
+BMGC_DG08552,BMG_DG143269,"DrugBank ID:DB03951 | N-acetyl-D-glucosamine-6-phosphate | PubChem CID:440996 | CAS RN:18191-20-3 | N-Acetyl-D-glucosamine 6-phosphate | [(2R,3S,4R,5R)-5-acetamido-3,4,6-trihydroxyoxan-2-yl]methyl dihydrogen phosphate"
+BMGC_DG08553,BMG_DG143272,"DrugBank ID:DB12447 | 7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid | NADIFLOXACIN | PubChem CID:4410 | PubChem SID:472388709 | CAS RN:124858-35-1 | UNII:6CL9Y5YZEQ | Nadifloxacin"
+BMGC_DG08554,BMG_DG143275,"2,3,4,6-TETRACHLORODIBENZOFURAN | CAS RN:83704-30-7 | PubChem CID:44101 | 2,3,4,6-Tetrachlorodibenzofuran | UNII:42YYT843EO | PubChem SID:198986769 | 2,3,4,6-tetrachlorodibenzofuran"
+BMGC_DG08555,BMG_DG143285,WIN-54954 | DrugBank ID:DB08723 | PubChem SID:348481742 | PubChem CID:441048 | CAS RN:107355-45-3 | UNII:IY9RJD7JGI
+BMGC_DG08556,BMG_DG143287,CAS RN:479-37-8 | OBAMEGINE | PubChem SID:317229895 | UNII:75K1EI2HDP | PubChem CID:441064
+BMGC_DG08557,BMG_DG143289,"PubChem SID:175266899 | UNII:H9Y79VD43J | CAS RN:57-24-9 | PubChem CID:441071 | Strychnine | (4aR,5aS,8aR,13aS,15aS,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14-one | STRYCHNINE"
+BMGC_DG08558,BMG_DG143292,"PubChem SID:175266712 | DrugBank ID:DB00908 | CAS RN:56-54-2 | (S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol | UNII:ITX08688JL | Quinidine | QUINIDINE | PubChem CID:441074"
+BMGC_DG08559,BMG_DG143294,"Ajmaline | PubChem CID:441080 | (5aR,6S,8S,10S,11S,11aS,12aR,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol | (1R,9R,10S,12R,13S,14R,16S,18R)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol | DrugBank ID:DB01426"
+BMGC_DG08560,BMG_DG143296,UNII:EZ38J9BBDF | CONESSINE | CAS RN:546-06-5 | PubChem SID:198955589 | PubChem CID:441082
+BMGC_DG08561,BMG_DG143303,"5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol | PubChem CID:4411 | CAS RN:42200-33-9 | Solgol"
+BMGC_DG08562,BMG_DG143312,CAS RN:69010-88-4 | PubChem CID:44112 | CAS RN:62658-63-3 | Bopindolol | PubChem SID:198991195 | BOPINDOLOL | UNII:KT304VZO57 | [1-(tert-butylamino)-3-[(2-methyl-1H-indol-4-yl)oxy]propan-2-yl] benzoate | DrugBank ID:DB08807
+BMGC_DG08563,BMG_DG143315,"NDC:63323-508 | NDC:0781-3000 | PubChem SID:175268587 | NDC:44567-402 | NDC:72485-412 | NDC:70842-120 | MEROPENEM | Meropenem Hydrate | NDC:44567-145 | NDC:0409-0222 | NDC:67184-0552 | NDC:0409-1390 | NDC:72572-415 | NDC:44567-400 | NDC:0409-3412 | NDC:81962-001 | NDC:70594-076 | NDC:0781-3098 | NDC:68083-146 | NDC:67184-0553 | PubChem CID:441129 | NDC:70121-1454 | NDC:81962-000 | NDC:0264-3183 | (4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;trihydrate | NDC:55150-207 | NDC:0143-9430 | NDC:63323-507 | NDC:55150-208 | NDC:0409-1391 | NDC:72485-411 | NDC:70594-075 | NDC:44567-146 | NDC:68001-324 | NDC:68083-147 | UNII:FV9J3JU8B1 | NDC:44567-401 | NDC:68001-323 | NDC:70121-1453 | NDC:72572-416 | NDC:0264-3185 | NDC:0143-9431 | CAS RN:119478-56-7"
+BMGC_DG08564,BMG_DG143316,"(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid | PubChem SID:175267254 | Meropenem | PubChem CID:441130 | DrugBank ID:DB00760 | CAS RN:96036-03-2 | MEROPENEM ANHYDROUS | UNII:YOP6PX0BAO"
+BMGC_DG08565,BMG_DG143322,"NDC:23155-863 | NDC:62135-495 | NDC:0781-5828 | DrugBank ID:DB00400 | NDC:0781-5515 | NDC:0713-0850 | NDC:42794-012 | NDC:0472-0013 | NDC:0115-1724 | NDC:42794-014 | NDC:0115-1725 | NDC:0781-5827 | CAS RN:126-07-8 | NDC:0781-5514 | NDC:62135-496 | PubChem SID:175268821 | UNII:32HRV3E3D5 | NDC:62135-968 | (2S,5'R)-7-chloro-3',4,6-trimethoxy-5'-methylspiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione | NDC:62135-494 | Griseofulvin | CAS RN:2884-22-2 | NDC:42794-013 | PubChem CID:441140 | NDC:23155-864 | NDC:23155-865 | GRISEOFULVIN | CAS RN:107912-37-8 | NDC:69097-361"
+BMGC_DG08566,BMG_DG143330,"CAS RN:62666-20-0 | DrugBank ID:DB00837 | UNII:112E50TORV | PubChem SID:313182450 | UNII:38C836J57Z | Progabide | PROGABIDE | CAS RN:90656-51-2 | PubChem SID:198939570 | PROGABIDE, (Z)- | CAS RN:104880-78-6 | 4-[[(4-chlorophenyl)-(5-fluoro-2-hydroxyphenyl)methylidene]amino]butanamide | PubChem CID:44115"
+BMGC_DG08567,BMG_DG143345,"(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid;3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid | CAS RN:57308-51-7 | PubChem CID:441193 | Carbidopa; Levodopa"
+BMGC_DG08568,BMG_DG143351,"CAS RN:73356-24-8 | CAS RN:35607-66-0 | Cefoxitin | UNII:6OEV9DX57Y | DrugBank ID:DB01331 | PubChem SID:175265517 | CEFOXITIN | (6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem CID:441199"
+BMGC_DG08569,BMG_DG143357,Neoplatin | DrugBank ID:DB00515 | PubChem CID:441203 | azane;dichloroplatinum(2+)
+BMGC_DG08570,BMG_DG143359,"3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | PubChem CID:441207 | CAS RN:1339-93-1 | DIGITOXIN | DrugBank ID:DB01396 | PubChem SID:198963341 | UNII:E90NZP2L9U | CAS RN:71-63-6 | Digitoxin"
+BMGC_DG08571,BMG_DG143364,"2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol | CAS RN:83002-04-4 | CP55,667 | PubChem CID:4412255"
+BMGC_DG08572,BMG_DG143416,"SAQUINAVIR | Saquinavir | PubChem CID:441243 | CAS RN:127779-20-8 | PubChem SID:175267801 | DrugBank ID:DB01232 | (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide | UNII:L3JE09KZ2F"
+BMGC_DG08573,BMG_DG143417,CAS RN:1152234-18-8 | NDC:61570-131 | DrugBank ID:DB05245 | NDC:63629-8773 | CAS RN:22199-08-2 | NDC:63629-8772 | SILVER SULFADIAZINE | Silver sulfadiazine | NDC:50090-0717 | NDC:70518-2373 | NDC:80425-0221 | NDC:67296-1013 | NDC:67877-124 | NDC:43598-210 | NDC:76420-208 | Silver Sulfadiazine | NDC:50090-0230 | NDC:49999-185 | UNII:W46JY43EJR | NDC:63187-023 | NDC:63629-8768 | NDC:63629-8770 | NDC:50090-7447 | PubChem CID:441244 | PubChem SID:175268942 | NDC:63629-8769 | NDC:50090-0607 | NDC:50090-0763 | NDC:68788-8074 | NDC:50090-2152 | NDC:60760-962 | NDC:70518-1562 | NDC:63629-8771 | silver;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide | NDC:59762-0131 | NDC:68788-0600
+BMGC_DG08574,BMG_DG143422,7-O-METHYLLUTEONE | UNII:ST6SCG8ZUC | PubChem SID:461434827 | PubChem CID:441251 | CAS RN:122290-50-0
+BMGC_DG08575,BMG_DG143429,"PubChem CID:44126237 | 2-PIPERIDINONE, 1-((2S)-2-AMINO-4-(5,8-DIHYDRO-2,4-BIS(TRIFLUOROMETHYL)PYRIDO(3,4-D)PYRIMIDIN-7(6H)-YL)-4-OXOBUTYL)-5,5-DIFLUORO-6-HYDROXY-, (6R)- | UNII:Q2T6S838TV | PubChem SID:433720978 | CAS RN:1173174-97-4"
+BMGC_DG08576,BMG_DG143434,"Paclitaxel (Taxol) | PubChem CID:441276 | [(1S,2S,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
+BMGC_DG08577,BMG_DG143435,"PubChem SID:175272120 | PENTAZOCINE HYDROCHLORIDE | UNII:A36BXO4PPX | PubChem CID:441277 | Pentazocine Hydrochloride | CAS RN:64024-15-3 | (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;hydrochloride"
+BMGC_DG08578,BMG_DG143436,"Pentazocine | DrugBank ID:DB00652 | UNII:768DQ5A5AI | CAS RN:359-83-1 | PENTAZOCINE | PubChem SID:198969176 | UNII:RP4A60D26L | CAS RN:7488-49-5 | PubChem CID:441278 | PubChem SID:175271517 | PENTAZOCINE, (-)- | (1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol"
+BMGC_DG08579,BMG_DG143438,PubChem CID:441281 | DrugBank ID:DB00985 | Dimenhydrinate
+BMGC_DG08580,BMG_DG143442,"PubChem CID:441289 | DrugBank ID:DB01337 | CAS RN:16974-53-1 | UNII:J76UF062FS | PubChem SID:175267188 | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-10,13-dimethyl-2,16-bis(1-methylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate | PANCURONIUM | Pancuronium | CAS RN:15500-66-0"
+BMGC_DG08581,BMG_DG143444,"UNII:WRE554RFEZ | CAS RN:143558-00-3 | ROCURONIUM | PubChem CID:441290 | PubChem SID:175266560 | DrugBank ID:DB00728 | Rocuronium | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate"
+BMGC_DG08582,BMG_DG143450,"PubChem CID:44129601 | DrugBank ID:DB08789 | 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE"
+BMGC_DG08583,BMG_DG143451,"PubChem CID:44129603 | DrugBank ID:DB08355 | 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid"
+BMGC_DG08584,BMG_DG143452,"PubChem CID:44129608 | 1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine | DrugBank ID:DB08774"
+BMGC_DG08585,BMG_DG143453,"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one | PubChem CID:44129612 | DrugBank ID:DB08236"
+BMGC_DG08586,BMG_DG143454,DrugBank ID:DB07260 | PubChem CID:44129620 | N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline
+BMGC_DG08587,BMG_DG143455,5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole | PubChem CID:44129621 | DrugBank ID:DB06828
+BMGC_DG08588,BMG_DG143456,(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol | DrugBank ID:DB07258 | PubChem CID:44129623
+BMGC_DG08589,BMG_DG143457,{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone | DrugBank ID:DB07237 | PubChem CID:44129624
+BMGC_DG08590,BMG_DG143459,"PubChem CID:44129629 | (3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide | DrugBank ID:DB08303"
+BMGC_DG08591,BMG_DG143460,"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide | PubChem CID:44129630 | DrugBank ID:DB08304"
+BMGC_DG08592,BMG_DG143461,"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide | PubChem CID:44129631 | DrugBank ID:DB08305"
+BMGC_DG08593,BMG_DG143462,2-[(2-methoxy-5-methylphenoxy)methyl]pyridine | DrugBank ID:DB07427 | PubChem CID:44129642
+BMGC_DG08594,BMG_DG143463,"UNII:1OQF7TT3PF | Relebactam | DrugBank ID:DB12377 | CAS RN:1174018-99-5 | PubChem SID:198940782 | [(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate | RELEBACTAM ANHYDROUS | PubChem CID:44129647"
+BMGC_DG08595,BMG_DG143464,"DrugBank ID:DB12341 | 4-[4-[[(2S)-2-(3,5-dimethylphenyl)pyrrolidin-1-yl]methyl]phenoxy]-3-fluorobenzamide | Aticaprant | ATICAPRANT | PubChem CID:44129648 | PubChem SID:198979705 | (S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide | UNII:DE4G8X55F5 | CAS RN:1174130-61-0"
+BMGC_DG08596,BMG_DG143465,PubChem SID:198955777 | GNF-5 | PubChem CID:44129660 | CAS RN:778277-15-9 | UNII:3ZUA56XMQQ
+BMGC_DG08597,BMG_DG143466,PubChem SID:472421569 | CAS RN:213769-33-6 | UNII:23FM92X9QD | CYT-1010 | PubChem CID:44129692
+BMGC_DG08598,BMG_DG143467,"Hyperforin | (1R,5R,7S,8R)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione | DrugBank ID:DB01892 | PubChem CID:441298 | HYPERFORIN | UNII:RM741E34FP | PubChem SID:198951052 | CAS RN:11079-53-1"
+BMGC_DG08599,BMG_DG143468,PubChem CID:4413 | CAS RN:81525-10-2 | (6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate | NAFAMOSTAT | PubChem SID:198971060 | UNII:Y25LQ0H97D | Nafamostat | DrugBank ID:DB12598
+BMGC_DG08600,BMG_DG143469,"ABACAVIR | PubChem SID:175267614 | DrugBank ID:DB01048 | [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol | Abacavir | CAS RN:136470-78-5 | PubChem CID:441300 | UNII:WR2TIP26VS"
+BMGC_DG08601,BMG_DG143471,"PubChem SID:198958211 | UNII:8TR252Z538 | PubChem CID:441302 | Epiandrosterone | (3S,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one | EPIANDROSTERONE | CAS RN:481-29-8"
+BMGC_DG08602,BMG_DG143473,"(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol | DrugBank ID:DB00955 | UNII:4O5J85GJJB | PubChem CID:441306 | CAS RN:56391-57-2 | CAS RN:56391-56-1 | Netilmicin | NETILMICIN | PubChem SID:198947331"
+BMGC_DG08603,BMG_DG143477,"CAS RN:107133-36-8 | NDC:65862-288 | Perindopril Erbumine | (2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine | PubChem SID:175266539 | PubChem CID:441313 | NDC:65862-286 | NDC:65862-287 | UNII:1964X464OJ | PERINDOPRIL ERBUMINE"
+BMGC_DG08604,BMG_DG143478,"CAS RN:1204250-58-7 | Miglitol | NDC:71205-937 | PubChem CID:441314 | MIGLITOL | NDC:69367-304 | NDC:69367-305 | NDC:71205-935 | UNII:0V5436JAQW | NDC:69367-303 | PubChem SID:175266934 | NDC:71205-936 | DrugBank ID:DB00491 | (2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol | CAS RN:72432-03-2"
+BMGC_DG08605,BMG_DG143494,"CAS RN:105102-22-5 | NDC:60505-0830 | (8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | UNII:8HR4QJ6DW8 | PubChem SID:175268486 | MOMETASONE | Mometasone | NDC:60429-664 | PubChem CID:441335 | DrugBank ID:DB00764"
+BMGC_DG08606,BMG_DG143495,"NDC:68788-8548 | NDC:65162-891 | NDC:68462-192 | NDC:51672-1305 | PubChem SID:175268804 | NDC:68462-225 | PubChem CID:441336 | NDC:50090-2991 | NDC:71205-413 | NDC:63629-8682 | NDC:68462-385 | NDC:78206-115 | NDC:68788-8345 | NDC:10599-003 | NDC:63629-8686 | NDC:63629-8681 | NDC:0713-0635 | NDC:13668-527 | NDC:72162-1392 | NDC:78206-113 | NDC:45802-119 | MOMETASONE FUROATE | NDC:50090-1633 | NDC:63629-9305 | NDC:78206-112 | NDC:63629-8685 | NDC:45802-118 | NDC:78206-111 | NDC:78206-114 | NDC:51672-1315 | NDC:63187-288 | NDC:68788-8357 | Mometasone Furoate | UNII:04201GDN4R | NDC:63629-9306 | CAS RN:83919-23-7 | NDC:72162-1393 | NDC:0113-1999 | NDC:0713-0634 | [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate | NDC:51672-1311 | NDC:63187-432 | NDC:45802-257 | NDC:63629-8683 | NDC:63629-8684 | DrugBank ID:DB14512 | NDC:72162-1404 | NDC:21922-072"
+BMGC_DG08607,BMG_DG143534,(2S)-2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid | PubChem SID:175268174 | UNII:DOQ0J0TPF7 | DrugBank ID:DB00765 | METYROSINE | NDC:25010-305 | NDC:68682-310 | NDC:69238-1621 | Metyrosine | PubChem CID:441350 | CAS RN:672-87-7
+BMGC_DG08608,BMG_DG143535,"NDC:71872-7317 | NDC:68083-364 | NDC:72572-650 | NDC:71288-700 | NDC:67457-228 | NDC:55150-225 | NDC:68083-365 | NDC:71839-142 | Rocuronium Bromide | NDC:65145-130 | NDC:71872-7262 | NDC:51662-1546 | NDC:71872-7207 | NDC:51662-1545 | NDC:51662-1640 | NDC:0409-5160 | NDC:51662-1641 | NDC:43066-013 | NDC:71872-7202 | NDC:81565-204 | NDC:51662-1354 | CAS RN:119302-91-9 | NDC:65219-065 | NDC:66794-229 | NDC:65145-131 | NDC:70748-349 | NDC:72611-756 | NDC:72611-757 | NDC:66794-228 | NDC:71839-141 | NDC:43547-530 | NDC:0409-3189 | NDC:82449-001 | NDC:72572-651 | NDC:71872-7036 | NDC:51662-1355 | NDC:43066-007 | NDC:39822-4200 | NDC:0143-9251 | UNII:I65MW4OFHZ | PubChem CID:441351 | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate;bromide | NDC:0409-1403 | NDC:55150-226 | NDC:43547-531 | PubChem SID:175267881 | NDC:71288-718 | NDC:0143-9250 | NDC:63323-426 | NDC:70748-348 | NDC:72162-2263 | ROCURONIUM BROMIDE | NDC:0409-7037 | NDC:0409-9558 | NDC:0781-3220 | NDC:25021-687 | NDC:25021-662"
+BMGC_DG08609,BMG_DG143555,"PubChem CID:44137675 | Azd-6482 | PubChem SID:348481798 | 2-[[(1R)-1-(7-methyl-2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-9-yl)ethyl]amino]benzoic acid | DrugBank ID:DB14980 | AZD-6482 | CAS RN:1173900-33-8 | UNII:78G6MP5PZ5"
+BMGC_DG08610,BMG_DG143556,"PubChem CID:44137686 | UNII:1EJT54415A | PubChem SID:333495517 | VK-5211 | CAS RN:1165910-22-4 | DrugBank ID:DB13934 | Ligandrol | 4-[(2R)-2-[(1R)-2,2,2-trifluoro-1-hydroxyethyl]pyrrolidin-1-yl]-2-(trifluoromethyl)benzonitrile"
+BMGC_DG08611,BMG_DG143559,"14-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene | PubChem CID:44137946 | UNII:4200RD53XF | MK-2461 | CAS RN:917879-39-1 | PubChem SID:198939386 | Mk-2461 | CAS RN:1196681-15-8"
+BMGC_DG08612,BMG_DG143560,PubChem CID:44138039 | PubChem SID:478838462 | [4-(4-fluorophenyl)phenyl]-[4-(1H-imidazol-2-ylmethyl)piperidin-1-yl]methanone | (4-(4-FLUOROPHENYL)PHENYL)-(4-(1H-IMIDAZOL-2-YLMETHYL)PIPERIDIN-1-YL)METHANONE | CAS RN:1159096-95-3 | UNII:HZ8BP9M28T
+BMGC_DG08613,BMG_DG143565,"CAS RN:67915-31-5 | PubChem CID:441383 | 1-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine | CAS RN:172587-59-6 | Terconazole | DrugBank ID:DB00251"
+BMGC_DG08614,BMG_DG143572,"PubChem CID:441397 | PubChem SID:198972426 | BACAMPICILLIN | UNII:8GM2J22278 | DrugBank ID:DB01602 | CAS RN:50972-17-3 | 1-ethoxycarbonyloxyethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | Bacampicillin"
+BMGC_DG08615,BMG_DG143573,"CAS RN:928134-65-0 | PubChem SID:198943233 | UNII:5YL4IQ1078 | OSILODROSTAT | CAS RN:1304733-26-3 | Osilodrostat | PubChem CID:44139752 | 4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile | DrugBank ID:DB11837"
+BMGC_DG08616,BMG_DG143578,"NDC:31722-865 | NDC:0009-4992 | NDC:31722-749 | NDC:43386-022 | NDC:64980-561 | NDC:0009-5140 | NDC:66298-5137 | NDC:33342-352 | NDC:60687-309 | NDC:62135-442 | NDC:60687-754 | NDC:59762-1307 | Linezolid | CAS RN:165800-03-3 | NDC:0781-3431 | NDC:0009-5136 | NDC:57664-682 | NDC:70771-1111 | NDC:66794-236 | NDC:63629-8576 | NDC:66794-219 | NDC:66298-7807 | NDC:46708-183 | NDC:0009-5137 | NDC:59762-1308 | N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide | NDC:0143-9534 | PubChem CID:441401 | NDC:0009-5138 | NDC:0009-7807 | NDC:67877-419 | NDC:70518-4034 | NDC:55150-242 | PubChem SID:175267428 | NDC:57664-683 | NDC:65162-777 | NDC:0781-3433 | NDC:68382-413 | NDC:66298-5140 | NDC:0904-6553 | DrugBank ID:DB00601 | LINEZOLID | UNII:ISQ9I6J12J | NDC:0054-0319 | NDC:0409-4883 | NDC:63323-713 | NDC:66298-7131 | NDC:62332-183"
+BMGC_DG08617,BMG_DG143580,"NDC:50090-7435 | NDC:76420-065 | UNII:M0XW1UBI14 | DrugBank ID:DB13943 | NDC:0143-9005 | NDC:70700-289 | NDC:76420-741 | NDC:72603-286 | NDC:63187-647 | NDC:76420-746 | NDC:50090-4920 | NDC:69097-536 | NDC:52536-625 | NDC:55150-278 | NDC:0143-9726 | Testosterone Cypionate | NDC:0009-0085 | NDC:47781-910 | NDC:71205-289 | NDC:71335-2473 | NDC:0009-0417 | NDC:71335-2470 | NDC:76420-645 | CAS RN:58-20-8 | NDC:76420-752 | NDC:24338-055 | NDC:62756-016 | PubChem CID:441404 | NDC:47781-911 | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate | NDC:0574-0827 | NDC:0009-0086 | NDC:0009-0347 | NDC:55150-276 | PubChem SID:175266329 | NDC:0409-6557 | NDC:69097-802 | NDC:62756-017 | NDC:63629-8705 | TESTOSTERONE CYPIONATE | NDC:69097-537 | NDC:55150-277 | NDC:72162-2348 | NDC:70700-288 | NDC:70700-290 | NDC:0574-0820 | NDC:72162-2375 | NDC:63629-8706 | NDC:76420-747 | NDC:0591-4128 | NDC:24338-056 | NDC:0517-1830 | NDC:62756-015 | NDC:0409-6562 | NDC:50090-4147 | NDC:0143-9659"
+BMGC_DG08618,BMG_DG143581,"CAS RN:113299-38-0 | PubChem SID:319892022 | UNII:R8K39AN732 | PubChem CID:441405 | BICALUTAMIDE, (S)-"
+BMGC_DG08619,BMG_DG143584,"CAS RN:3863-59-0 | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate | PubChem SID:198965609 | HYDROCORTISONE PHOSPHATE | DrugBank ID:DB14542 | UNII:2Y87E22X71 | Hydrocortisone phosphate | PubChem CID:441407"
+BMGC_DG08620,BMG_DG143585,"NDC:0121-0777 | NDC:63187-215 | NDC:44523-182 | NDC:42799-816 | NDC:66993-844 | disodium;[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate | PubChem SID:175268862 | NDC:66993-846 | NDC:68788-7708 | NDC:67296-1505 | NDC:68071-1650 | NDC:13925-166 | NDC:69238-2122 | NDC:42799-812 | NDC:62135-330 | NDC:24208-317 | NDC:0121-4759 | NDC:59212-702 | NDC:66993-845 | NDC:42799-813 | NDC:42799-815 | UNII:IV021NXA9J | NDC:59212-700 | NDC:59212-701 | PubChem CID:441409 | NDC:24208-715 | PREDNISOLONE SODIUM PHOSPHATE | NDC:68791-104 | Prednisolone Sodium Phosphate | NDC:17856-0815 | NDC:0121-0759 | NDC:0121-0773 | CAS RN:125-02-0 | NDC:50090-1582"
+BMGC_DG08621,BMG_DG143595,PubChem CID:44141860 | DrugBank ID:DB06850 | (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide
+BMGC_DG08622,BMG_DG143597,2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline | PubChem CID:44141871 | DrugBank ID:DB08384
+BMGC_DG08623,BMG_DG143599,"PubChem CID:44141939 | DrugBank ID:DB08781 | 1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE"
+BMGC_DG08624,BMG_DG143614,PubChem SID:363909287 | DrugBank ID:DB02821 | (2S)-2-amino-4-aminooxybutanoic acid | UNII:T7H2XP1ZNS | Canaline | CAS RN:496-93-5 | CANALINE | PubChem CID:441443
+BMGC_DG08625,BMG_DG143615,"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | DrugBank ID:DB07141 | PubChem CID:44144378"
+BMGC_DG08626,BMG_DG143616,"DrugBank ID:DB07142 | 5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | PubChem CID:44144379"
+BMGC_DG08627,BMG_DG143617,"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine | PubChem CID:44144380 | DrugBank ID:DB07144"
+BMGC_DG08628,BMG_DG143618,"PubChem CID:44144383 | DrugBank ID:DB08083 | 2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide"
+BMGC_DG08629,BMG_DG143619,"CAS RN:1066-17-7 | Colistina | DrugBank ID:DB00803 | N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(6R,9S,12R,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide | PubChem CID:44144393"
+BMGC_DG08630,BMG_DG143705,"PubChem CID:44146714 | Insulin-glargine | (4S)-4-[[2-[[(1R,6R,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,50S,53S,56S,59S,62S,65S,68S,71S,74R,77S,80S,83S,88R)-88-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-53-(2-amino-2-oxoethyl)-62-(3-amino-3-oxopropyl)-77-[(2S)-butan-2-yl]-24,56-bis(2-carboxyethyl)-47-(carboxymethylcarbamoyl)-83-[(1R)-1-hydroxyethyl]-12,71,80-tris(hydroxymethyl)-33,50,65-tris[(4-hydroxyphenyl)methyl]-15-(1H-imidazol-5-ylmethyl)-27-methyl-18,30,36,59,68-pentakis(2-methylpropyl)-7,10,13,16,19,22,25,28,31,34,37,40,49,52,55,58,61,64,67,70,73,76,79,82,85,87-hexacosaoxo-21,39-di(propan-2-yl)-3,4,44,45,90,91-hexathia-8,11,14,17,20,23,26,29,32,35,38,41,48,51,54,57,60,63,66,69,72,75,78,81,84,86-hexacosazabicyclo[72.11.7]dononacontane-42-carbonyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[(2S)-2-[[(2S)-6-amino-1-[[(2S,3R)-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxohexan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid"
+BMGC_DG08631,BMG_DG143753,"beta-D-Galactopyranuronic acid | CAS RN:18968-14-4 | .BETA.-D-GALACTOPYRANURONIC ACID | PubChem CID:441476 | beta-D-galactopyranuronic acid | (2S,3R,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid | PubChem SID:376231593 | UNII:55NG3O9NDD | DrugBank ID:DB03652"
+BMGC_DG08632,BMG_DG143771,DrugBank ID:DB03773 | alpha-D-quinovopyranose | PubChem SID:376231621 | UNII:68BDH91OBS | PubChem CID:441480 | CAS RN:551-63-3 | .ALPHA.-D-QUINOVOPYRANOSE
+BMGC_DG08633,BMG_DG143777,"CAS RN:7296-60-8 | PubChem SID:376231508 | CAS RN:115794-07-5 | (2R,3R,4R,5R)-oxane-2,3,4,5-tetrol | beta-D-Ribopyranose | PubChem CID:441481 | UNII:49X539P7H4 | DrugBank ID:DB04286 | .BETA.-D-RIBOPYRANOSE"
+BMGC_DG08634,BMG_DG144039,PubChem SID:474492817 | UNII:L6B63H3RXJ | CAS RN:1173103-84-8 | AVN-211 | PubChem CID:44155874
+BMGC_DG08635,BMG_DG144045,"CAS RN:1173239-39-8 | UNII:3U6T9EE6UX | N-[(3-chloro-4-fluorophenyl)methyl]-1-methyl-N-[[(1R,5S)-3-methyl-3-azabicyclo[3.1.0]hexan-6-yl]methyl]imidazole-4-carboxamide | PF-03463275 | DrugBank ID:DB11993 | PubChem SID:198953973 | PubChem CID:44156901 | CAS RN:1173177-11-1"
+BMGC_DG08636,BMG_DG144046,"CUDC-305 | UNII:0V278OKN9G | CAS RN:1061318-81-7 | 2-[[6-(dimethylamino)-1,3-benzodioxol-5-yl]sulfanyl]-1-[2-(2,2-dimethylpropylamino)ethyl]imidazo[4,5-c]pyridin-4-amine | PubChem SID:405054924 | PubChem CID:44156921 | Cudc-305"
+BMGC_DG08637,BMG_DG144052,AM-211 | PubChem SID:198985751 | CAS RN:1175526-27-8 | UNII:SZB129M7SZ | PubChem CID:44158492
+BMGC_DG08638,BMG_DG144055,PubChem SID:474491789 | Hemeanthamin | HEMEANTHAMIN | PubChem CID:441593 | UNII:VBL6HZX2ZB | CAS RN:466-75-1
+BMGC_DG08639,BMG_DG144057,AM-156 FREE ACID | CAS RN:1175525-98-0 | UNII:WVX3404D8K | PubChem SID:198971859 | PubChem CID:44159646
+BMGC_DG08640,BMG_DG144060,"PubChem SID:198983433 | 1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine | CAS RN:1845-11-0 | PubChem CID:4416 | Nafoxidine | NAFOXIDINE | UNII:4RIY10WM82"
+BMGC_DG08641,BMG_DG144070,"3-Hydroxytirucallic acid | PubChem SID:472421992 | (2S)-2-[(3R,5R,10S,13S,14S,17S)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid | 3-HYDROXYTIRUCALLIC ACID | PubChem CID:441677 | UNII:8L9Q67LR3K | CAS RN:28282-27-1 | alpha-Elemolic acid"
+BMGC_DG08642,BMG_DG144077,PubChem CID:441697 | PubChem SID:472423949 | CAS RN:784079-49-8 | 6-HYDROXYCYANIDIN | UNII:8JXK5TBK67
+BMGC_DG08643,BMG_DG144079,DrugBank ID:DB13588 | CAS RN:31329-57-4 | 2-(diethylamino)ethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate | UNII:42H8PQ0NMJ | PubChem SID:198965595 | Nafronyl | NAFTIDROFURYL | PubChem CID:4417
+BMGC_DG08644,BMG_DG144080,"LUTEOLINIDIN CATION | 2-(3,4-dihydroxyphenyl)chromenylium-5,7-diol | Luteolinidin | UNII:935OS7WHP6 | PubChem SID:316910586 | CAS RN:16975-93-2 | PubChem CID:441701"
+BMGC_DG08645,BMG_DG144087,"DrugBank ID:DB07484 | (2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid | PubChem CID:44176354"
+BMGC_DG08646,BMG_DG144088,"DrugBank ID:DB07300 | PubChem CID:44176356 | 2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine"
+BMGC_DG08647,BMG_DG144100,"CAS RN:1175017-90-9 | UNII:Y66IS3CS0R | PubChem SID:198980044 | Akn-028 | DrugBank ID:DB12746 | AKN-028 | 3-N-(1H-indol-5-yl)-5-pyridin-4-ylpyrazine-2,3-diamine | PubChem CID:44177328"
+BMGC_DG08648,BMG_DG144101,"UNII:T544D7TZQ8 | Petunidin | PETUNIDIN | PubChem SID:485663730 | PubChem CID:441774 | 2-(3,4-dihydroxy-5-methoxyphenyl)chromenylium-3,5,7-triol | 1-Benzopyrylium, 2-(3,4-dihydroxy-5-methoxyphenyl)-3,5,7-trihydroxy- | CAS RN:13270-60-5"
+BMGC_DG08649,BMG_DG144107,MK-1925 | PubChem SID:445499170 | UNII:L8V3HK4J7M | PubChem CID:44178080 | CAS RN:932705-04-9
+BMGC_DG08650,BMG_DG144118,PubChem SID:198986541 | Naftopidil | UNII:R9PHW59SFN | CAS RN:57149-07-2 | 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol | NAFTOPIDIL | DrugBank ID:DB12092 | PubChem CID:4418
+BMGC_DG08651,BMG_DG144123,"PubChem SID:318691647 | CAS RN:1416790-17-4 | AMG-337 | UNII:08WG8S0L8D | 6-[(1R)-1-[8-fluoro-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5-one | PubChem CID:44181686 | Amg-337 | CAS RN:1173699-31-4"
+BMGC_DG08652,BMG_DG144136,"DrugBank ID:DB06309 | CAS RN:923032-36-4 | PubChem CID:44182295 | UNII:JPX07AFM0N | REFAMETINIB | N-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide | PubChem SID:198960555 | Refametinib | CAS RN:923032-37-5"
+BMGC_DG08653,BMG_DG144138,PubChem CID:44182375 | UNII:IT5P8PS8IK | PubChem SID:375084613 | AZD-9821 | CAS RN:1182820-70-7
+BMGC_DG08654,BMG_DG144142,"6-[2-[4-[[4-bromo-3-(2-methoxyethoxy)phenyl]methyl]piperidin-1-yl]ethyl]-2,3-dihydrochromen-4-one | PubChem CID:44182694 | CAS RN:1176326-76-3 | 6-(2-(4-(3-(2-Methoxyethoxy)-4-bromobenzyl)piperidino)ethyl)-2H-1-benzopyran-4(3H)-one"
+BMGC_DG08655,BMG_DG144155,"PubChem CID:44185 | Cefoperazone | (6R,7R)-7-[[2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | DrugBank ID:DB01329"
+BMGC_DG08656,BMG_DG144157,"Convallatoxin | CONVALLATOXIN | (3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde | PubChem SID:198963511 | CAS RN:508-75-8 | UNII:JY264VIR1Y | PubChem CID:441852"
+BMGC_DG08657,BMG_DG144158,"(3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-3-[(2R,4S,5R,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde | CYMARIN | Cymarine | PubChem SID:198985228 | PubChem CID:441853 | UNII:UK3LS8435E | CAS RN:508-77-0 | DrugBank ID:DB13240"
+BMGC_DG08658,BMG_DG144169,"PubChem CID:44187 | CAS RN:62893-19-0 | UNII:7U75I1278D | CAS RN:62893-20-3 | Cefoperazone | CEFOPERAZONE | DrugBank ID:DB01329 | PubChem SID:175268149 | (6R,7R)-7-[[(2R)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid"
+BMGC_DG08659,BMG_DG144173,"UNII:6ON9RK82AL | DrugBank ID:DB14904 | PubChem SID:198984263 | CAS RN:1236699-92-5 | PIMASERTIB | Pimasertib | PubChem CID:44187362 | N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)pyridine-4-carboxamide | CAS RN:1204531-26-9"
+BMGC_DG08660,BMG_DG144176,PubChem SID:445500129 | CAS RN:1173204-81-3 | PKI-402 | PubChem CID:44187953 | UNII:A5XSH56P2N
+BMGC_DG08661,BMG_DG144197,N-OLEOYL-L-SERINE | UNII:SCD7H2827O | CAS RN:107743-37-3 | PubChem CID:44190514 | PubChem SID:383470505
+BMGC_DG08662,BMG_DG144198,PubChem SID:198985338 | PubChem CID:44190553 | CAS RN:848591-89-9 | UNII:2MUW0L49BN | A-582941 FREE BASE
+BMGC_DG08663,BMG_DG144206,"Ginsenoside Rg1 | PubChem CID:441923 | (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | GINSENOSIDE RG1 | DrugBank ID:DB06750 | UNII:PJ788634QY | PubChem SID:252164703 | CAS RN:22427-39-0"
+BMGC_DG08664,BMG_DG144214,"DrugBank ID:DB14898 | Retagliptin | PubChem SID:333495559 | UNII:328C4R3P9L | RETAGLIPTIN | methyl 7-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(trifluoromethyl)-6,8-dihydro-5H-imidazo[1,5-a]pyrazine-1-carboxylate | CAS RN:1174122-54-3 | PubChem CID:44193830"
+BMGC_DG08665,BMG_DG144224,SNX-5422 MESYLATE | PubChem SID:198959701 | UNII:K3BO8V06RM | PubChem CID:44195570 | CAS RN:1173111-67-5
+BMGC_DG08666,BMG_DG144225,"DrugBank ID:DB06070 | SNX-5422 | CAS RN:908116-67-6 | UNII:BF52J69Q8T | PubChem CID:44195571 | Snx-5422 | CAS RN:908115-27-5 | PubChem SID:198964165 | [4-[2-carbamoyl-5-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]anilino]cyclohexyl] 2-aminoacetate"
+BMGC_DG08667,BMG_DG144229,3-methoxy-4-(6-methoxy-1-benzofuran-2-yl)phenol | PubChem CID:441958 | VIGNAFURAN | UNII:G9CLF6S56A | PubChem SID:287446004 | CAS RN:57800-41-6 | Vignafuran
+BMGC_DG08668,BMG_DG144237,PubChem SID:445500094 | DDD-85646 | CAS RN:1215010-55-1 | UNII:DTX5CVK89G | PubChem CID:44199337
+BMGC_DG08669,BMG_DG144238,4-nitrobenzoate | CAS RN:7227-54-5 | 4-Nitrobenzoate | PubChem CID:4419940
+BMGC_DG08670,BMG_DG144243,"PubChem CID:44200882 | VOSILASARM | DrugBank ID:DB13939 | CAS RN:1182367-47-0 | 2-chloro-4-[[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino]-3-methylbenzonitrile | PubChem SID:312525097 | Rad-140 | UNII:4O87Q44KNC"
+BMGC_DG08671,BMG_DG144244,"CARNOSOL | PubChem CID:442009 | CAS RN:5957-80-2 | Carnosol | PubChem SID:198951581 | (1R,8S,10S)-3,4-dihydroxy-11,11-dimethyl-5-propan-2-yl-16-oxatetracyclo[6.6.2.01,10.02,7]hexadeca-2,4,6-trien-15-one | UNII:483O455CKD"
+BMGC_DG08672,BMG_DG144245,"PubChem CID:44201003 | PubChem SID:198945431 | Dbpr-108 | PRUSOGLIPTIN | CAS RN:1186426-66-3 | (2S,4S)-4-fluoro-1-[2-[(2-methyl-4-oxo-4-pyrrolidin-1-ylbutan-2-yl)amino]acetyl]pyrrolidine-2-carbonitrile | UNII:E329HG23ZT"
+BMGC_DG08673,BMG_DG144257,"SureCN179964 | PubChem CID:44202892 | (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-3,5-dihydroxy-2-[[(1S,2S,4S,5R,9R,10S,13S,17S,18R)-2-hydroxy-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracos-15-en-10-yl]oxy]-6-methyloxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol"
+BMGC_DG08674,BMG_DG144266,SAR-020106 | CAS RN:1184843-57-9 | UNII:43GTC52NG2 | PubChem CID:44203948
+BMGC_DG08675,BMG_DG144267,"INGENOL | PubChem CID:442042 | (1S,4S,5R,6R,9S,10R,12R,14R)-4,5,6-trihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyltetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dien-15-one | UNII:IC77UZI9G8 | PubChem SID:252163874 | Ingenol | CAS RN:30220-46-3"
+BMGC_DG08676,BMG_DG144268,"Isopimaric Acid | PubChem SID:198941726 | UNII:1E37K85HHK | ISOPIMARIC ACID | PubChem CID:442048 | CAS RN:5835-26-7 | (1R,4aR,4bS,7S,10aR)-7-ethenyl-1,4a,7-trimethyl-3,4,4b,5,6,8,10,10a-octahydro-2H-phenanthrene-1-carboxylic acid"
+BMGC_DG08677,BMG_DG144273,"(5R)-3-[3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one | UNII:43EP6XV33E | DrugBank ID:DB13077 | CAS RN:1219707-39-7 | Delpazolid | PubChem SID:249817480 | PubChem CID:44205191 | DELPAZOLID"
+BMGC_DG08678,BMG_DG144274,"NDC:0002-6885 | PubChem SID:198946894 | 2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile | UNII:ISP4442I3Y | DrugBank ID:DB11817 | NDC:0002-4732 | BARICITINIB | CAS RN:1187594-09-7 | Baricitinib | NDC:0002-4479 | PubChem CID:44205240 | NDC:0002-4182"
+BMGC_DG08679,BMG_DG144276,PubChem CID:44206133 | UNII:QG3J28E7L8 | AB-CHMINACA | PubChem SID:313184065 | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)indazole-3-carboxamide | AB-Chminaca | CAS RN:1185887-21-1
+BMGC_DG08680,BMG_DG144279,"Phorbol | UNII:XUZ76S9127 | CAS RN:17673-25-5 | CAS RN:26241-63-4 | PubChem SID:198943384 | PubChem CID:442070 | PHORBOL | (1S,2S,6R,10S,11R,13S,14R,15R)-1,6,13,14-tetrahydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyltetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dien-5-one"
+BMGC_DG08681,BMG_DG144289,CAS RN:518-17-2 | UNII:C01825BVNL | EVODIAMINE | PubChem SID:241180070 | PubChem CID:442088
+BMGC_DG08682,BMG_DG144292,"CAS RN:57817-89-7 | UNII:0YON5MXJ9P | PubChem SID:175266758 | Stevioside | STEVIOSIDE | [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1R,4S,5R,9S,10R,13S)-13-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylate | PubChem CID:442089"
+BMGC_DG08683,BMG_DG144299,"PubChem SID:175267139 | UNII:3B91HWA56M | Nalidixic acid | 1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid | PubChem CID:4421 | Nalidixic Acid | CAS RN:389-08-2 | NALIDIXIC ACID | DrugBank ID:DB00779"
+BMGC_DG08684,BMG_DG144304,"CAS RN:83-74-9 | PubChem CID:442108 | (1R,15S,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene | CID 442108"
+BMGC_DG08685,BMG_DG144307,CAS RN:6091-05-0 | PubChem SID:241180969 | PubChem CID:442113 | PHYSOVENINE | UNII:H67Q5553UW
+BMGC_DG08686,BMG_DG144312,"Decursin | DECURSIN | CAS RN:5928-25-6 | PubChem SID:198980244 | PubChem CID:442126 | UNII:E95RTO3YQR | [(3S)-2,2-dimethyl-8-oxo-3,4-dihydropyrano[3,2-g]chromen-3-yl] 3-methylbut-2-enoate"
+BMGC_DG08687,BMG_DG144313,"PubChem CID:442127 | DECURSINOL | Decursinol | CAS RN:23458-02-8 | UNII:UBI4YB704B | (3S)-3-hydroxy-2,2-dimethyl-3,4-dihydropyrano[3,2-g]chromen-8-one | PubChem SID:198986501"
+BMGC_DG08688,BMG_DG144339,PubChem CID:44219292 | PubChem SID:198953462 | Ralinepag | 2-[[4-[[(4-chlorophenyl)-phenylcarbamoyl]oxymethyl]cyclohexyl]methoxy]acetic acid | UNII:CQY12ZJN6E | RALINEPAG | DrugBank ID:DB12462 | CAS RN:1187856-49-0
+BMGC_DG08689,BMG_DG144340,"(1R)-1-[[(2S,3R,11bS)-3-ethyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl]methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-6-ol | CEPHAELINE | PubChem SID:198940488 | UNII:QA971541A1 | Cephaeline | PubChem CID:442195 | CAS RN:483-17-0 | CAS RN:5483-17-0"
+BMGC_DG08690,BMG_DG144341,"CAS RN:1230627-78-7 | UNII:T44AA70FKR | PubChem SID:445500593 | PubChem CID:44219619 | 1,3-DINITROOXY-2-PROPYL 2-ACETOXYBENZOATE"
+BMGC_DG08691,BMG_DG144343,UNII:Z8JC838JKO | PubChem SID:198940083 | DRIMENIN | CAS RN:2326-89-8 | PubChem CID:442202
+BMGC_DG08692,BMG_DG144358,PubChem SID:461433032 | CAS RN:613262-61-6 | PubChem CID:44224215 | M-62812 FREE BASE | UNII:D98NBX7QJ5
+BMGC_DG08693,BMG_DG144359,CAS RN:1025717-75-2 | MMP-145 | UNII:Y845RI1Z4S | PubChem SID:198986122 | PubChem CID:44224245
+BMGC_DG08694,BMG_DG144360,"FILANESIB | (2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide | Filanesib | PubChem SID:198950022 | CAS RN:885060-09-3 | PubChem CID:44224257 | UNII:8A49OSO368 | DrugBank ID:DB06040"
+BMGC_DG08695,BMG_DG144361,PubChem CID:44224261 | DrugBank ID:DB08021 | 5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide
+BMGC_DG08696,BMG_DG144383,PubChem CID:44229079 | DrugBank ID:DB03923 | Feruloyl Coenzyme A
+BMGC_DG08697,BMG_DG144391,PICROTIN | UNII:U06Z6QD7N2 | PubChem SID:198983475 | PubChem CID:442291 | CAS RN:21416-53-5
+BMGC_DG08698,BMG_DG144433,Omidenepag | OMIDENEPAG | CAS RN:1187451-41-7 | PubChem CID:44230575 | PubChem SID:310825606 | UNII:Z95F9F9LU4 | 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]pyridin-2-yl]amino]acetic acid
+BMGC_DG08699,BMG_DG144434,UNII:39RRC0G27V | PubChem SID:346540325 | N-(bis(4-methoxyphenyl)methyl)-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide | PubChem CID:44230662 | N-[bis(4-methoxyphenyl)methyl]-6-oxo-2-pyridazin-3-yl-1H-pyrimidine-5-carboxamide | CAS RN:1187990-87-9 | MK-8617
+BMGC_DG08700,BMG_DG144435,CAS RN:1187451-19-9 | DrugBank ID:DB15071 | PubChem SID:346540734 | PubChem CID:44230999 | propan-2-yl 2-[[6-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]pyridin-2-yl]amino]acetate | UNII:G0G0H52U6K | Omidenepag Isopropyl | OMIDENEPAG ISOPROPYL
+BMGC_DG08701,BMG_DG144444,"RIVIPANSEL | CAS RN:1189037-60-2 | DrugBank ID:DB12778 | PubChem CID:44232546 | UNII:4B115V09LB | CAS RN:927881-99-0 | Rivipansel | (2S)-2-[(2R,3R,4S,5S,6R)-3-benzoyloxy-2-[(1R,2R,3S,5R)-3-[(2,4-dioxo-1H-pyrimidine-6-carbonyl)amino]-5-[2-[[2-[2-[2-oxo-2-[(3,6,8-trisulfonaphthalen-1-yl)amino]ethoxy]ethoxy]acetyl]amino]ethylcarbamoyl]-2-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid | PubChem SID:198970850"
+BMGC_DG08702,BMG_DG144447,"CAS RN:320347-97-5 | UNII:N2EN87KJ5D | QUINUCLDIN-3-YL HYDROXYBIS(2-THIENYL)ACETATE, (R)- | PubChem SID:472421759 | Quinucldin-3-yl hydroxybis(2-thienyl)acetate, (R)- | PubChem CID:44232927"
+BMGC_DG08703,BMG_DG144455,DrugBank ID:DB13153 | CAS RN:515-69-5 | LEVOMENOL | CAS RN:23089-26-1 | PubChem CID:442343 | Levomenol | UNII:24WE03BX2T | (2S)-6-methyl-2-[(1S)-4-methylcyclohex-3-en-1-yl]hept-5-en-2-ol | PubChem SID:175266178
+BMGC_DG08704,BMG_DG144459,PubChem CID:44234673 | CAS RN:1182735-51-8 | RISAD-P | PubChem SID:440090045 | UNII:YF0WVD4UKZ
+BMGC_DG08705,BMG_DG144469,"DrugBank ID:DB08691 | ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate | PubChem CID:44237094"
+BMGC_DG08706,BMG_DG144580,IOWH-032 | PubChem CID:44241539 | DrugBank ID:DB12959
+BMGC_DG08707,BMG_DG144587,"PubChem SID:252165164 | CAS RN:6902-77-8 | PubChem CID:442424 | UNII:A3V2NE52YG | Genipin | GENIPIN | methyl (1R,4aS,7aS)-1-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate | CAS RN:1202641-87-9"
+BMGC_DG08708,BMG_DG144590,"CAS RN:132203-74-8 | NARINGIN | PubChem SID:175267283 | (2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | UNII:N7TD9J649B | CAS RN:10236-47-2 | PubChem CID:442428 | Naringin"
+BMGC_DG08709,BMG_DG144592,"PubChem CID:442431 | NARIRUTIN | PubChem SID:316910409 | CAS RN:14259-46-2 | Narirutin | UNII:06M5EAT0YC | (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one"
+BMGC_DG08710,BMG_DG144600,PubChem CID:442456 | PubChem SID:314915353 | UNII:8MUY4P95B4 | PONCIRIN | CAS RN:14941-08-3
+BMGC_DG08711,BMG_DG144609,UNII:ZW18DSD1H4 | PubChem SID:312524992 | PubChem CID:44247568 | CAS RN:878141-96-9 | E-52862 | 4-[2-(5-methyl-1-naphthalen-2-ylpyrazol-3-yl)oxyethyl]morpholine
+BMGC_DG08712,BMG_DG144610,CAS RN:1192348-73-4 | PubChem SID:381132431 | PubChem CID:44247584 | UNII:EQI6KP1AIU | TAK-259
+BMGC_DG08713,BMG_DG144614,"PubChem SID:198935688 | PubChem CID:442478 | CAS RN:17957-94-7 | UNII:9N0IS8189W | (+)-Menthofuran | MENTHOFURAN, (+)- | (6R)-3,6-dimethyl-4,5,6,7-tetrahydro-1-benzofuran"
+BMGC_DG08714,BMG_DG144615,UNII:WQ8PCH72SD | NBI-3 (NON-LABELED) | CAS RN:867036-04-2 | PubChem CID:44247806 | PubChem SID:433968237
+BMGC_DG08715,BMG_DG144627,PubChem SID:474494229 | PubChem CID:44249745 | 3-(2-oxo-3-{2-[4-(trifluoromethyl)piperidin-1-yl]ethyl}imidazolidin-1-yl)benzonitrile | UNII:8K5G4U34CU | 3-(2-OXO-3-(2-(4-(TRIFLUOROMETHYL)PIPERIDIN-1-YL)ETHYL)IMIDAZOLIDIN-1-YL)BENZONITRILE | CAS RN:1185338-21-9
+BMGC_DG08716,BMG_DG144628,PubChem CID:44249821 | 1-cyano-3-(2-methyl-1-benzofuran-5-yl)-2-[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]guanidine | 1-Cyano-2-(2-Methyl-1-Benzofuran-5-Yl)-3-[(3s)-2-Oxo-1-(2-Oxo-2-Pyrrolidin-1-Ylethyl)azepan-3-Yl]guanidine
+BMGC_DG08717,BMG_DG144645,"CAS RN:517-28-2 | PubChem CID:442514 | PubChem SID:198953668 | CAS RN:8005-33-2 | UNII:YKM8PY2Z55 | (6aS,11bR)-7,11b-dihydro-6H-indeno[2,1-c]chromene-3,4,6a,9,10-pentol | CAS RN:1621-46-1 | CAS RN:1412-19-7 | HEMATOXYLIN | Hematoxylin"
+BMGC_DG08718,BMG_DG144649,"CAS RN:1194044-20-6 | (S)-4-(2,4-Difluoro-5-(pyrimidin-5-yl)phenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine | DrugBank ID:DB13065 | PubChem SID:312525006 | PubChem CID:44251605 | LY-2811376 | (4S)-4-(2,4-difluoro-5-pyrimidin-5-ylphenyl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine | UNII:UR18YJ97SJ"
+BMGC_DG08719,BMG_DG144675,Sapropterin | DrugBank ID:DB00360 | PubChem CID:44257
+BMGC_DG08720,BMG_DG144715,"5,7-dimethoxy-6-methyl-2-phenylchromen-4-one | Dimethylstrobochrysin | PubChem CID:44257640 | CAS RN:109251-29-8"
+BMGC_DG08721,BMG_DG144727,"PubChem CID:44258296 | PubChem SID:482554611 | KUWANON A | UNII:UKY8P8K8Y7 | CAS RN:62949-77-3 | Kuwanon A | 5,7-dihydroxy-2-(5-hydroxy-2,2-dimethylchromen-8-yl)-3-(3-methylbut-2-enyl)chromen-4-one"
+BMGC_DG08722,BMG_DG144742,"(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one | UNII:H88EPA0A3N | PubChem SID:198978482 | CAS RN:62996-74-1 | CAS RN:109189-95-9 | PubChem CID:44259 | DrugBank ID:DB02010 | STAUROSPORINE | Staurosporine"
+BMGC_DG08723,BMG_DG144746,CTN-986 | UNII:WL62JB5J9G | PubChem SID:472422872 | CAS RN:63947-67-1 | PubChem CID:44259159
+BMGC_DG08724,BMG_DG144812,"PubChem CID:44263483 | (5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol | DrugBank ID:DB08151"
+BMGC_DG08725,BMG_DG144820,"2-[[(1R,3S,5R,7S,9R,11S,12S,14S,16R,18S,20R,21Z,24S,26R,28S,30R,31R,33S,35R,37S,42R,44S,46R,48S)-12-hydroxy-1,3,11,24,31,41,44-heptamethyl-39-oxo-2,6,10,15,19,25,29,34,38,43,47-undecaoxaundecacyclo[26.22.0.03,26.05,24.07,20.09,18.011,16.030,48.033,46.035,44.037,42]pentaconta-21,40-dien-14-yl]methyl]prop-2-enal | alpha-Bungarotoxin | PubChem CID:44264212"
+BMGC_DG08726,BMG_DG144824,"PubChem SID:198982103 | UNII:9O0A545W4L | 3-(3,4-dihydro-2H-pyrrol-5-yl)pyridine | PubChem CID:442649 | Myosmine | MYOSMINE | CAS RN:532-12-7"
+BMGC_DG08727,BMG_DG144828,UNII:8A0E1G55M9 | CAS RN:349536-41-0 | 6'-HYDROXYMETHYL ETORICOXIB | PubChem CID:44266438 | [5-[5-chloro-3-(4-methylsulfonylphenyl)pyridin-2-yl]pyridin-2-yl]methanol | PubChem SID:434370266 | 6-Hydroxymethyletoricoxib
+BMGC_DG08728,BMG_DG144829,CAS RN:349536-39-6 | 6'-CARBOXY ETORICOXIB | PubChem CID:44266451 | PubChem SID:434370057 | UNII:3G75T52B7D
+BMGC_DG08729,BMG_DG144830,PubChem CID:44266508 | ETORICOXIB-N1'-OXIDE | CAS RN:325855-74-1 | Etoricoxib-N1'-oxide | 5-chloro-2-(6-methyl-1-oxidopyridin-1-ium-3-yl)-3-(4-methylsulfonylphenyl)pyridine | UNII:FP09886CY9 | PubChem SID:434370190
+BMGC_DG08730,BMG_DG144836,"CAS RN:23094-71-5 | 2-[(4R,5S,7R,25S,26R,29S,30S,31S)-13,14,15,18,19,20,31,35,36-nonahydroxy-2,10,23,28,32-pentaoxo-5-(3,4,5-trihydroxybenzoyl)oxy-3,6,9,24,27,33-hexaoxaheptacyclo[28.7.1.04,25.07,26.011,16.017,22.034,38]octatriaconta-1(37),11,13,15,17,19,21,34(38),35-nonaen-29-yl]acetic acid | PubChem CID:442674 | CID 442674"
+BMGC_DG08731,BMG_DG144839,"PubChem CID:442679 | Eugeniin | CAS RN:58970-75-5 | [(10R,11S,12R,13S,15R)-3,4,5,21,22,23-hexahydroxy-8,18-dioxo-12,13-bis[(3,4,5-trihydroxybenzoyl)oxy]-9,14,17-trioxatetracyclo[17.4.0.02,7.010,15]tricosa-1(23),2,4,6,19,21-hexaen-11-yl] 3,4,5-trihydroxybenzoate"
+BMGC_DG08732,BMG_DG144840,"2-(4-TERT-BUTYLPHENYL)-4,5-DIHYDRO-1H-IMIDAZOLE | PubChem CID:44269078 | PubChem SID:475550259 | 2-(4-tert-Butylphenyl)-4,5-dihydro-1H-imidazole | UNII:E366N9N56N | CAS RN:67277-66-1"
+BMGC_DG08733,BMG_DG144847,"CAS RN:14531-52-3 | Dihydropinosylvin | 5-(2-phenylethyl)benzene-1,3-diol | PubChem CID:442700"
+BMGC_DG08734,BMG_DG144848,"(4R,7S,10R,13S,16R,19S)-10-(4-aminobutyl)-N-[(2S)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | H-DNal-cyclo[Cys-Tyr-DTrp-Lys-Val-DCys]-Thr-NH2 | PubChem CID:44270249"
+BMGC_DG08735,BMG_DG144854,PubChem CID:442729 | PubChem SID:287446511 | UNII:85C8LBB1GL | CAS RN:18521-72-7 | 7-CHLOROEMODIN
+BMGC_DG08736,BMG_DG144856,"PubChem CID:44273397 | (1S,13R)-10-(cyclopropylmethyl)-1-ethyl-4-hydroxy-13-methyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-8-one | Ethylketocyclazocine"
+BMGC_DG08737,BMG_DG144862,PubChem CID:442744 | UNII:8CIK094KBU | CAS RN:14101-04-3 | PubChem SID:198962110 | FRANGULIN B
+BMGC_DG08738,BMG_DG144864,PubChem CID:44274898 | 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]-N-[(2S)-2-hydroxy-2-phenylethyl]acetamide | 2-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-N-(2-hydroxy-2-phenyl-ethyl)-acetamide
+BMGC_DG08739,BMG_DG144866,UNII:8XBV72641V | PubChem CID:442757 | PubChem SID:198946951 | NANAFROCIN | CAS RN:52934-83-5
+BMGC_DG08740,BMG_DG144869,"17-Debromoaplysiatoxin | (1S,3R,4S,9R,13S,14R)-13-hydroxy-9-[(1R)-1-hydroxyethyl]-3-[(2S,5S)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | PubChem CID:44276054 | CAS RN:52423-28-6"
+BMGC_DG08741,BMG_DG144870,2-[[(2R)-2-[[2-[[(2S)-2-[[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]-methylamino]-3-phenylpropanoyl]amino]acetic acid | H-D-Tyr-Ala-Gly-D-N(Me)Phe-Gly-OH | PubChem CID:44276294
+BMGC_DG08742,BMG_DG144879,PubChem SID:198968745 | HISPAGLABRIDIN A | UNII:DQ76ZS34U8 | PubChem CID:442774 | CAS RN:68978-03-0
+BMGC_DG08743,BMG_DG144882,"Glucagon recombinant | (3S)-3-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(1S,2R)-1-carboxy-2-hydroxypropyl]amino]-1,4-dioxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid | PubChem CID:44278361"
+BMGC_DG08744,BMG_DG144888,(5S)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)decan-3-one | GINGEROL | Gingerol | PubChem CID:442793 | UNII:925QK2Z900 | PubChem SID:198950598 | CAS RN:1391-73-7 | CAS RN:23513-14-6
+BMGC_DG08745,BMG_DG144896,"CAS RN:486-62-4 | PubChem CID:442813 | UNII:Z0Z637970U | Ononin | PubChem SID:198944799 | ONONIN | 3-(4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one"
+BMGC_DG08746,BMG_DG144901,PubChem CID:44282409 | CAS RN:339003-68-8 | CDP-840 N-OXIDE | PubChem SID:434369834 | UNII:2DG4LMG5UL
+BMGC_DG08747,BMG_DG144904,"(3R,4R)-4-(1,3-benzodioxol-5-ylmethyl)-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one | PubChem CID:442835 | Yatein | CAS RN:40456-50-6"
+BMGC_DG08748,BMG_DG144908,UNII:6CW84ZG3JR | CAS RN:158778-58-6 | Demethyl Irbesartan | PubChem SID:485664350 | DEMETHYL IRBESARTAN | PubChem CID:44285267
+BMGC_DG08749,BMG_DG144909,"UNII:5S6MPF62YZ | 3-(4-CHLORO-10H-PHENOTHIAZIN-10-YL)-N,N-DIMETHYLPROPAN-1-AMINE | PubChem SID:375579339 | CAS RN:13094-24-1 | PubChem CID:44285992"
+BMGC_DG08750,BMG_DG144917,"CAS RN:26543-89-5 | Hinokinin | PubChem CID:442879 | (3R,4R)-3,4-bis(1,3-benzodioxol-5-ylmethyl)oxolan-2-one"
+BMGC_DG08751,BMG_DG144920,(4S)-4-amino-5-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[2-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-5-oxopentanoic acid | H-Glu-Gly-Pro-Trp-Leu-Glu-Glu-D-Glu-D-Glu-D-Glu-D-Ala-D-Tyr-Gly-D-Trp-D-Met-D-Asp-D-Phe-NH2 | PubChem CID:44288444
+BMGC_DG08752,BMG_DG144923,DEOXYPEGANINE | PubChem CID:442894 | UNII:A3P6YTL6RH | CAS RN:495-59-0 | PubChem SID:459055562
+BMGC_DG08753,BMG_DG144926,"(6R)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one | Humulone | PubChem CID:442911 | CAS RN:26472-41-3"
+BMGC_DG08754,BMG_DG144927,"Ala-Gly-c(Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys)-OH | (4R,7S,10R,13S,16R,19S,22R,25S,28R,31S,34R,37S)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid | PubChem CID:44291156"
+BMGC_DG08755,BMG_DG144942,"CAS RN:210776-65-1 | UNII:F7LN3N6ZLA | PubChem SID:461433751 | 3,4-DICHLOROMETHYLPHENIDATE, R,R- | PubChem SID:313183742 | PubChem CID:44296390 | UNII:1MM9174NWD | CAS RN:1364331-88-3 | 3,4-DICHLOROMETHYLPHENIDATE"
+BMGC_DG08756,BMG_DG144945,"CAS RN:11051-96-0 | PubChem SID:198969637 | Cyclopamine | CYCLOPAMINE | UNII:ZH658AJ192 | (3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',10,11b-tetramethylspiro[2,3,4,6,6a,6b,7,8,11,11a-decahydro-1H-benzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-3-ol | PubChem CID:442972 | CAS RN:4449-51-8"
+BMGC_DG08757,BMG_DG144952,UNII:618227L15H | PubChem SID:249492376 | KURCHESSINE | PubChem CID:442979 | CAS RN:6869-45-0
+BMGC_DG08758,BMG_DG144962,"Indolocarbazole nitrogen derivative | (2S,3R,4R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one | CAS RN:62996-74-1 | PubChem CID:44299148"
+BMGC_DG08759,BMG_DG144968,PubChem CID:44301524 | CAS RN:174418-82-7 | UNII:2T3TWA75R0 | 7-HYDROXYMITRAGYNINE | PubChem SID:198935421
+BMGC_DG08760,BMG_DG144969,PubChem CID:44301701 | CAS RN:2035457-43-1 | MITRAGYNINE PSEUDOINDOXYL | UNII:BKA67VHE3B | PubChem SID:461434774
+BMGC_DG08761,BMG_DG144972,"CAS RN:21453-69-0 | PubChem SID:317229938 | PubChem CID:443023 | CAS RN:1177-14-6 | SYRINGARESINOL, (±)- | SYRINGARESINOL, (+)- | PubChem SID:441097428 | UNII:6YWP8N8R9S | UNII:155K1084GO | SYRINGARESINOL, (+/-)-"
+BMGC_DG08762,BMG_DG144993,PubChem CID:44307335 | UNII:Q6P6W9SNR2 | PubChem SID:482555153 | CAS RN:51768-60-6 | JWH-091
+BMGC_DG08763,BMG_DG144995,"CAS RN:25577-70-2 | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[(8R,9S,13S,14S)-2-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-2-carboxylic acid | PubChem CID:443077 | 2-Methoxyestrone 3-glucuronide"
+BMGC_DG08764,BMG_DG144996,"(2S,3S,4S,5R,6R)-6-[[(3R,5R,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | Etiocholan-3alpha-ol-17-one 3-glucuronide | ETIOCHOLANOLONE GLUCURONIDE | PubChem SID:441583320 | PubChem CID:443078 | CAS RN:3602-09-3 | UNII:9LK4DML9R2"
+BMGC_DG08765,BMG_DG144998,PubChem CID:44308490 | DrugBank ID:DB04098 | Balanol
+BMGC_DG08766,BMG_DG145001,"PubChem CID:4431 | UNII:LQE19CTV54 | 2-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]isoindole-1,3-dione | PubChem SID:440089883 | Nan 190 | NAN-190 | CAS RN:102392-05-2"
+BMGC_DG08767,BMG_DG145003,"CAS RN:68518-47-8 | CAS RN:65589-70-0 | acridine-3,6-diamine;10-methylacridin-10-ium-3,6-diamine;chloride | Acriflavine neutral | CAS RN:8048-52-0 | PubChem CID:443101"
+BMGC_DG08768,BMG_DG145007,(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-octylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | S-octylglutathione | DrugBank ID:DB03032 | PubChem CID:443115 | S-Octylglutathione | CAS RN:24435-27-6
+BMGC_DG08769,BMG_DG145009,CAS RN:110044-82-1 | acetylleucyl-leucyl-norleucinal | PubChem CID:443118 | DrugBank ID:DB07558 | (2S)-2-acetamido-4-methyl-N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxohexan-2-yl]amino]pentan-2-yl]pentanamide | Acetylleucyl-leucyl-norleucinal
+BMGC_DG08770,BMG_DG145010,"PubChem CID:443119 | DrugBank ID:DB01683 | Chymostatin | (2S)-2-[[(1S)-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-phenylpropan-2-yl]amino]pentan-2-yl]amino]-2-oxoethyl]carbamoylamino]-3-phenylpropanoic acid | CAS RN:9076-44-2"
+BMGC_DG08771,BMG_DG145013,CAS RN:486-67-9 | DrugBank ID:DB09338 | Mersalyl | PubChem CID:443130 | CAS RN:879642-25-8 | [3-[[2-(carboxymethoxy)benzoyl]amino]-2-methoxypropyl]mercury;hydrate | Mersalyl acid
+BMGC_DG08772,BMG_DG145020,"CAS RN:110221-53-9 | (2S)-2-[[(2S,6R)-4-(carboxymethyl)-5-oxo-2-thiophen-2-yl-1,4-thiazepan-6-yl]amino]-4-phenylbutanoic acid | PubChem SID:198958046 | UNII:2D6A12Q12R | Temocaprilat | PubChem CID:443151 | TEMOCAPRILAT"
+BMGC_DG08773,BMG_DG145048,PubChem SID:198941349 | CAS RN:129-67-9 | UNII:RZ5H9H2D2J | ENDOTHAL-DISODIUM | PubChem CID:44318676
+BMGC_DG08774,BMG_DG145059,"DrugBank ID:DB03687 | 4-CDP-2-C-methyl-D-erythritol | PubChem CID:443199 | 4-Diphosphocytidyl-2-C-methyl-D-erythritol | [[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S)-2,3,4-trihydroxy-3-methylbutyl] hydrogen phosphate | CAS RN:263016-94-0 | PubChem SID:474492444 | UNII:FB44VKC5JD | 4-(Cytidine 5'-diphospho)-2-C-methyl-D-erythritol | 4-DIPHOSPHOCYTIDYL-2-C-METHYL-D-ERYTHRITOL"
+BMGC_DG08775,BMG_DG145061,"[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S)-2,4-dihydroxy-3-methyl-3-phosphonooxybutyl] hydrogen phosphate | PubChem CID:443200 | 4-CDP-2-C-methyl-D-erythritol 2-phosphate | DrugBank ID:DB01859 | CAS RN:263016-95-1"
+BMGC_DG08776,BMG_DG145062,"1-deoxy-D-xylulose 5-phosphate | PubChem CID:443201 | CAS RN:190079-18-6 | 1-DEOXY-D-XYLULOSE 5-PHOSPHATE | 1-Deoxy-D-xylulose 5-phosphate | UNII:I4C288B3TN | PubChem SID:440089337 | [(2R,3S)-2,3-dihydroxy-4-oxopentyl] dihydrogen phosphate | DrugBank ID:DB02496"
+BMGC_DG08777,BMG_DG145064,"CAS RN:2196-62-5 | [hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate | TDP-GLUCOSE | PubChem SID:474492495 | UNII:Q9XRK94HEF | DrugBank ID:DB03751 | 2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose | 2'Deoxy-thymidine-5'-diphospho-alpha-D-glucose | PubChem CID:443210 | TDP-glucose"
+BMGC_DG08778,BMG_DG145066,"4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol | CAS RN:64284-64-6 | PubChem CID:443212 | (3S,5R,10S,13R,17R)-4,4,10,13-tetramethyl-17-[(2R)-6-methylhept-5-en-2-yl]-1,2,3,5,6,7,11,12,16,17-decahydrocyclopenta[a]phenanthren-3-ol"
+BMGC_DG08779,BMG_DG145068,"[(3R,5R,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate | 3alpha-Hydroxy-5beta-pregnane-20-one sulfate | PubChem CID:44322229"
+BMGC_DG08780,BMG_DG145077,"5'-Dehydroadenosine | (2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolane-2-carbaldehyde | PubChem CID:443234 | CAS RN:3110-98-3"
+BMGC_DG08781,BMG_DG145082,"CAS RN:308364-86-5 | UNII:IU92DC6Q4C | PubChem CID:44323766 | PubChem SID:405055238 | 2(3H)-FURANONE, DIHYDRO-4-(4-(METHYLSULFONYL)PHENYL)-3-PHENYL-, (3R,4R)-REL-"
+BMGC_DG08782,BMG_DG145083,"CAS RN:326604-36-8 | UNII:N7Q5T51WVF | PubChem SID:316914958 | ROFECOXIB-THREO-3,4-DIHYDROHYDROXY ACID | PubChem CID:44323831"
+BMGC_DG08783,BMG_DG145084,".BETA.-HYDROXY-L-ASPARTIC ACID, THREO- | PubChem SID:198948542 | CAS RN:7298-99-9 | UNII:Z9Q5W0U8VW | PubChem CID:443239"
+BMGC_DG08784,BMG_DG145091,"[(1R,2R,3S,4R,5S,6S)-2,3-dihydroxy-4,5,6-triphosphonooxycyclohexyl] dihydrogen phosphate | CAS RN:121010-58-0 | CAS RN:109837-24-3 | PubChem CID:443266 | 1D-myo-inositol 1,4,5,6-tetrakisphosphate"
+BMGC_DG08785,BMG_DG145092,"PubChem CID:44326612 | Levofloxacin Methyl Ester | CAS RN:862690-19-5 | methyl (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate"
+BMGC_DG08786,BMG_DG145095,UNII:J41VUN24GM | CP-125611 | PubChem CID:44327794 | CAS RN:145742-29-6 | PubChem SID:433968460
+BMGC_DG08787,BMG_DG145101,"BQ-123 | PubChem SID:198973221 | DrugBank ID:DB12054 | UNII:S2A8YZM151 | Bq-123 | 2-[(3R,6R,9S,12R,15S)-6-(1H-indol-3-ylmethyl)-9-(2-methylpropyl)-2,5,8,11,14-pentaoxo-12-propan-2-yl-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-3-yl]acetic acid | PubChem CID:443289 | CAS RN:136553-81-6"
+BMGC_DG08788,BMG_DG145103,PubChem CID:443292 | PubChem SID:441658720 | E-3040 | UNII:T4AB9WQ98U | CAS RN:145096-30-6
+BMGC_DG08789,BMG_DG145105,N-Formyl-Met-Leu-Phe | N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE | UNII:LO6AVJ8RCE | PubChem SID:438788686 | (2S)-2-[[(2S)-2-[[(2S)-2-formamido-4-methylsulfanylbutanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoic acid | CAS RN:59880-97-6 | PubChem CID:443295
+BMGC_DG08790,BMG_DG145115,PubChem CID:44334030 | HOPEAPHENOL | CAS RN:17912-85-5 | UNII:8K2E6922LC | PubChem SID:474491559 | Hopeaphenol
+BMGC_DG08791,BMG_DG145123,"CAS RN:82362-17-2 | UNII:9JEZ9OD3AS | DrugBank ID:DB12668 | CAS RN:58569-55-4 | (2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic acid | METENKEFALIN | PubChem SID:175267742 | Enkephalin, Methionine | PubChem CID:443363 | Metenkefalin"
+BMGC_DG08792,BMG_DG145129,PubChem SID:198940221 | LEVISOPRENALINE | PubChem CID:443372 | CAS RN:51-31-0 | UNII:588N0603CT
+BMGC_DG08793,BMG_DG145130,"Devazepide | DEVAZEPIDE | UNII:JE6P7QY7NH | N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide | PubChem CID:443375 | PubChem SID:198989133 | CAS RN:103420-77-5"
+BMGC_DG08794,BMG_DG145132,"PubChem CID:443378 | 5-CHLORO-3-(4-(METHYLSULFONYL)PHENYL)-2,3'-BIPYRIDINE | 5-Chloro-3-[4-(methylsulfonyl)phenyl]-2,3′-bipyridine | UNII:LBS494H5G7 | PubChem SID:485665067 | CAS RN:202409-31-2"
+BMGC_DG08795,BMG_DG145134,CAS RN:123122-54-3 | UNII:7WU8BZ90TH | PubChem SID:198986304 | PubChem CID:443380 | DrugBank ID:DB11623 | Candoxatrilat | CANDOXATRILAT | 4-[[1-[(2S)-2-carboxy-3-(2-methoxyethoxy)propyl]cyclopentanecarbonyl]amino]cyclohexane-1-carboxylic acid
+BMGC_DG08796,BMG_DG145138,"PubChem CID:443385 | NDC:70771-1414 | NDC:71872-7186 | NDC:0338-9553 | NDC:45802-263 | NDC:71872-7253 | NDC:63629-9459 | NDC:0338-3814 | NDC:59762-3744 | NDC:71872-7199 | NDC:71872-7324 | NDC:16781-462 | NDC:43066-995 | NDC:71872-7284 | NDC:63629-8632 | NDC:21922-002 | NDC:69238-2031 | NDC:45802-562 | NDC:51672-1399 | NDC:63629-8630 | NDC:63629-8628 | NDC:0009-3448 | NDC:0009-0870 | NDC:71872-7194 | NDC:16714-246 | NDC:50090-6072 | NDC:50090-5779 | NDC:0168-0277 | NDC:68462-866 | NDC:0168-0202 | NDC:0338-9549 | NDC:59762-3743 | NDC:68788-7810 | NDC:72578-084 | NDC:25021-115 | NDC:50090-6593 | NDC:0338-9545 | NDC:45802-128 | NDC:51672-1400 | NDC:59762-5009 | NDC:71872-7200 | NDC:45802-660 | UNII:EH6D7113I8 | NDC:0338-4114 | NDC:51672-4194 | NDC:43538-170 | NDC:21922-027 | NDC:71872-7191 | NDC:16714-161 | NDC:50090-2611 | NDC:0404-9837 | NDC:0404-9838 | NDC:0168-0201 | NDC:0009-4073 | NDC:0009-5095 | NDC:73473-302 | NDC:63629-8633 | NDC:72603-321 | CAS RN:24729-96-2 | NDC:63629-8634 | NDC:0338-3616 | NDC:62332-623 | NDC:21922-036 | NDC:70771-1855 | NDC:73473-300 | NDC:50090-5958 | NDC:0338-3410 | NDC:71872-7192 | NDC:69238-2030 | NDC:0472-1790 | CLINDAMYCIN PHOSPHATE | NDC:63629-9309 | NDC:68462-605 | NDC:71872-7189 | NDC:71872-7165 | NDC:71872-7197 | NDC:73473-306 | Clindamycin Phosphate | NDC:21922-050 | NDC:45802-042 | NDC:72162-2147 | NDC:0009-0902 | NDC:72162-1436 | NDC:68682-300 | NDC:51672-4081 | NDC:68788-7990 | NDC:99207-300 | NDC:0009-3329 | PubChem SID:175267177 | NDC:63629-8629 | NDC:0168-0203 | NDC:0338-3612 | NDC:43538-179 | NDC:50090-6592 | NDC:68682-462 | NDC:45802-900 | NDC:0009-3051 | NDC:43066-993 | NDC:50090-1932 | NDC:72578-118 | NDC:0009-7667 | NDC:43538-172 | NDC:66993-959 | NDC:72162-1395 | NDC:78206-189 | NDC:0009-0728 | NDC:0009-0775 | NDC:63629-8631 | [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate"
+BMGC_DG08797,BMG_DG145139,"Hetacillin | (2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | DrugBank ID:DB00739 | PubChem CID:443387 | HETACILLIN | UNII:TN4JSC48CV | PubChem SID:175267726 | CAS RN:3511-16-8"
+BMGC_DG08798,BMG_DG145140,"PubChem CID:443388 | DrugBank ID:DB03541 | 10-Propargyl-5,8-Dideazafolic Acid"
+BMGC_DG08799,BMG_DG145141,SB-228357 | PubChem SID:255509157 | PubChem CID:443390 | CAS RN:181629-93-6 | UNII:5RDN2E8E97
+BMGC_DG08800,BMG_DG145142,PubChem SID:363908637 | CAS RN:200940-22-3 | PubChem CID:443391 | UNII:R6MR8DB4PZ | SB-243213 FREE BASE
+BMGC_DG08801,BMG_DG145149,"PubChem CID:443405 | PubChem SID:198954400 | UNII:7UZW80C91Q | Phenazocine, (-)- | CAS RN:58073-76-0 | CAS RN:58640-87-2 | DrugBank ID:DB13606 | PHENAZOCINE, (-)- | PHENAZOCINE | PubChem SID:198939472 | UNII:J0ND6N0AQC | (1R,9R,13R)-1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol"
+BMGC_DG08802,BMG_DG145152,"Diprenorphine | UNII:1F0L5N25ZZ | DrugBank ID:DB01548 | DIPRENORPHINE | PubChem CID:443408 | (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol | PubChem SID:198947188 | CAS RN:14357-78-9"
+BMGC_DG08803,BMG_DG145156,PubChem SID:348481166 | PubChem CID:44342184 | CAS RN:172341-15-0 | CP-108671 FREE BASE | UNII:49R6GO0FWP
+BMGC_DG08804,BMG_DG145158,PubChem CID:44342229 | CID 44342229 | 2-[[(2S)-1-[[(2S)-2-carboxy-2-hydroxyethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-phenylbutanoic acid
+BMGC_DG08805,BMG_DG145164,"(2R,3R,4S,5R)-2-[6-((1R,2R)-2-Hydroxy-cyclopentylamino)-purin-9-yl]-5-hydroxymethyl-tetrahydro-furan-3,4-diol | PubChem CID:44343895 | (2R,3R,4S,5R)-2-[6-[[(1R,2R)-2-hydroxycyclopentyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol"
+BMGC_DG08806,BMG_DG145165,UNII:BI1K7EM7IA | 3-(TETRADECYLAMINO)PROPYLPHOSPHONIC ACID | CAS RN:725724-60-7 | PubChem CID:44344193 | PubChem SID:443625236
+BMGC_DG08807,BMG_DG145166,CAS RN:741693-77-6 | PubChem SID:198949251 | 5-HYDROXYDULOXETINE | 5-[(1S)-3-(methylamino)-1-thiophen-2-ylpropoxy]naphthalen-1-ol | 5-Hydroxyduloxetine | UNII:24CAA38X5F | PubChem CID:44344235
+BMGC_DG08808,BMG_DG145167,"NDC:68016-118 | NDC:69842-691 | NDC:79903-054 | NDC:71179-350 | NDC:41250-936 | NDC:71179-320 | NDC:69842-435 | ZINC GLUCONATE | PubChem SID:175266650 | NDC:0363-1188 | NDC:47682-478 | NDC:11822-1181 | NDC:63868-287 | NDC:0363-1180 | NDC:71179-340 | Zinc Gluconate | NDC:69842-434 | NDC:11673-118 | NDC:0363-1181 | UNII:U6WSN5SQ1Z | NDC:36800-805 | NDC:46122-540 | NDC:30142-999 | NDC:68163-118 | DrugBank ID:DB11248 | NDC:36800-806 | NDC:49035-881 | NDC:69842-687 | NDC:21130-880 | NDC:71179-324 | NDC:21130-881 | NDC:70000-0391 | NDC:69842-690 | PubChem CID:443445 | NDC:42961-105 | NDC:11822-1182 | NDC:69842-688 | NDC:11822-1183 | zinc;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate | CAS RN:4468-02-4 | NDC:71205-349 | Zinc gluconate"
+BMGC_DG08809,BMG_DG145182,"UNII:YAV5JM7M39 | SANDARACOPIMARADIENE, (-) | CAS RN:1686-56-2 | (4aS,4bS,7R,10aS)-7-ethenyl-1,1,4a,7-tetramethyl-3,4,4b,5,6,9,10,10a-octahydro-2H-phenanthrene | Sandaracopimaradiene | PubChem CID:443469 | PubChem SID:318164338"
+BMGC_DG08810,BMG_DG145193,"(1S,3S,8S)-4,8,12,15,15-pentamethyltricyclo[9.3.1.03,8]pentadeca-4,11-diene | PubChem CID:443484 | Taxa-4,11-diene | CAS RN:163594-75-0"
+BMGC_DG08811,BMG_DG145200,UNII:48OVY2OC72 | Sodium Arsenite | CAS RN:7784-46-5 | PubChem SID:198948240 | sodium;oxoarsinite | PubChem CID:443495 | SODIUM ARSENITE
+BMGC_DG08812,BMG_DG145201,CAS RN:52762-28-4 | PubChem CID:44349539 | PubChem SID:433968730 | 17-O-DEMETHYLGELDANAMYCIN | UNII:QVM5N55HUK
+BMGC_DG08813,BMG_DG145203,CAS RN:90109-57-2 | PubChem CID:44349865 | PubChem SID:472422847 | THIOBUSCALINE | UNII:45ZTS7GX2F
+BMGC_DG08814,BMG_DG145235,CAS RN:1174207-86-3 | 1-(7-METHOXY-2-NAPHTHALENYL)PIPERAZINE | 1-(7-Methoxy-2-naphthalenyl)piperazine | UNII:PQ9Q6B5BKV | PubChem CID:44351692 | PubChem SID:472421768
+BMGC_DG08815,BMG_DG145242,"CAS RN:121569-61-7 | (2R,3S,4S,6S,18R)-18-hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one | PubChem CID:44352972 | 7-epi-Hydroxystaurosporine"
+BMGC_DG08816,BMG_DG145249,"Isosarcodine | PubChem CID:44358214 | N-[(3S,5S,8R,9S,10S,13S,14S,17S)-17-[(1S)-1-(dimethylamino)ethyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]-N-methylacetamide"
+BMGC_DG08817,BMG_DG145251,Dihydroxyphenylglycine | DIHYDROXYPHENYLGLYCINE | PubChem CID:443586 | UNII:CF5G2G268A | DrugBank ID:DB04228 | CAS RN:162870-29-3 | PubChem SID:312524959
+BMGC_DG08818,BMG_DG145254,"UNII:E6T3DJ8ZVE | CAS RN:252023-70-4 | SURFACTIN C1 | CAS RN:24730-31-2 | PubChem CID:443592 | CAS RN:1393353-89-3 | 3-[(3S,6R,9S,12S,15R,18S,21S,25R)-9-(carboxymethyl)-3,6,15,18-tetrakis(2-methylpropyl)-25-(10-methylundecyl)-2,5,8,11,14,17,20,23-octaoxo-12-propan-2-yl-1-oxa-4,7,10,13,16,19,22-heptazacyclopentacos-21-yl]propanoic acid | PubChem SID:496141386 | Surfactin C1 | Surfactin"
+BMGC_DG08819,BMG_DG145257,"PubChem CID:44359514 | 17-ethyl-(1R,17S)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-yl methyl ether (ibogaine) | (1S,17R)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene"
+BMGC_DG08820,BMG_DG145259,"CAS RN:835-31-4 | CAS RN:10061-11-7 | Naphazoline | PubChem CID:4436 | UNII:H231GF11BV | NAPHAZOLINE | PubChem SID:175265644 | 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole | DrugBank ID:DB06711"
+BMGC_DG08821,BMG_DG145260,PubChem CID:443600 | Actinonin | 2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide | CAS RN:13434-13-4 | UNII:P18SPA8N0K | ACTINONIN | DrugBank ID:DB04310 | PubChem SID:198951036 | (2R)-N'-hydroxy-N-[(2S)-1-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]-2-pentylbutanediamide
+BMGC_DG08822,BMG_DG145270,"UNII:ZWG9VB324Z | (2R,3R)-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol | CAS RN:24808-04-6 | Epiafzelechin, (-)- | (-)-Epiafzelechin | EPIAFZELECHIN, (-)- | PubChem SID:485665015 | PubChem CID:443639"
+BMGC_DG08823,BMG_DG145281,"(3R)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one | Meclonazepam, (R)- | Meclonazepam, (R)-isomer | PubChem SID:475549801 | PubChem CID:44366192 | UNII:JG77XGJ84L | MECLONAZEPAM, (R)- | CAS RN:86630-81-1"
+BMGC_DG08824,BMG_DG145282,PubChem SID:441332136 | DIFLUDIAZEPAM | UNII:7N3B9XEC7B | CAS RN:39080-67-6 | PubChem CID:44366236
+BMGC_DG08825,BMG_DG145286,"benzyl N-[(2S,3S)-3-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate | Z-Ile-Leu-aldehyde | PubChem CID:44366908 | CAS RN:161710-10-7"
+BMGC_DG08826,BMG_DG145292,PubChem SID:287445838 | JWH-016 | UNII:Q9029X7V2B | CAS RN:155471-09-3 | PubChem CID:44368310
+BMGC_DG08827,BMG_DG145294,2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate | PubChem CID:4436967 | Gadopentetic acid
+BMGC_DG08828,BMG_DG145296,Naphthalene Trisulfonate | PubChem CID:4437 | DrugBank ID:DB04409
+BMGC_DG08829,BMG_DG145297,UNII:IQ3Q8N1287 | PubChem SID:198951961 | TULOPAFANT | PubChem CID:44370579 | CAS RN:116289-53-3
+BMGC_DG08830,BMG_DG145303,"PubChem CID:443722 | Sanguinine | CAS RN:60755-80-8 | O-DESMETHYLGALANTAMINE | (1S,12S,14R)-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraene-9,14-diol | UNII:L7ZOW3CZ7W | PubChem SID:198947899"
+BMGC_DG08831,BMG_DG145304,PubChem SID:198943749 | PubChem CID:443723 | LYCORAMINE | CAS RN:21133-52-8 | UNII:TAG8LU84K2
+BMGC_DG08832,BMG_DG145320,"Calcium Pantothenate | CAS RN:137-08-6 | NDC:59088-643 | PubChem SID:175268242 | UNII:568ET80C3D | NDC:59088-112 | NDC:13925-118 | CALCIUM PANTOTHENATE | calcium;3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate | PubChem CID:443753"
+BMGC_DG08833,BMG_DG145324,"(4S,7R,10S,13R,16S,19R,22S,25R,28S,31R,34S,37R)-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-37-[[2-[[(2S)-2-aminopropanoyl]amino]acetyl]amino]-13,25,28-tribenzyl-16-(1-hydroxyethyl)-10-[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid | SRIF-D-Trp8 | PubChem CID:44377662"
+BMGC_DG08834,BMG_DG145340,"UNII:E7437K3983 | PubChem CID:443831 | Carubicin | CAS RN:50935-04-1 | (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4,6,9,11-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione | PubChem SID:198954223 | CARUBICIN | CAS RN:39472-31-6"
+BMGC_DG08835,BMG_DG145341,PubChem CID:443832 | PubChem SID:198976695 | CAS RN:28008-55-1 | UNII:YDU8YIP30L | DAUNORUBICINOL
+BMGC_DG08836,BMG_DG145344,"FALINTOLOL, (S,E)- | PubChem CID:44383465 | CAS RN:96479-91-3 | PubChem SID:312524834 | UNII:DFE9AZN98S"
+BMGC_DG08837,BMG_DG145353,"PubChem CID:443866 | Pemirolast Potassium | PEMIROLAST POTASSIUM | potassium;9-methyl-3-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one | CAS RN:100299-08-9 | UNII:497A17OUUE | PubChem SID:175266628"
+BMGC_DG08838,BMG_DG145356,"Barnidipine | PubChem CID:443869 | CAS RN:104713-75-9 | PubChem SID:198965318 | 5-O-[(3S)-1-benzylpyrrolidin-3-yl] 3-O-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | DrugBank ID:DB09227 | UNII:2VBY96ASWJ | BARNIDIPINE"
+BMGC_DG08839,BMG_DG145359,"NDC:63629-9414 | NDC:16729-294 | NDC:31722-050 | NDC:0025-1720 | NDC:71205-864 | EPLERENONE | NDC:70436-099 | UNII:6995V82D0B | PubChem SID:175267681 | NDC:59762-1710 | NDC:66993-344 | NDC:42291-454 | Eplerenone | NDC:16571-174 | NDC:59762-1107 | NDC:69367-307 | DrugBank ID:DB00700 | NDC:70436-098 | methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxospiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylate | NDC:51991-877 | NDC:58151-142 | NDC:60687-451 | CAS RN:107724-20-9 | NDC:66993-343 | NDC:69367-308 | NDC:51991-878 | NDC:16729-293 | NDC:0025-1710 | NDC:71335-2355 | NDC:71205-863 | NDC:59762-1108 | NDC:58151-143 | NDC:59762-1720 | PubChem CID:443872 | NDC:16571-173 | NDC:31722-049 | NDC:42291-455"
+BMGC_DG08840,BMG_DG145361,"UNII:18IZ008EU6 | PubChem SID:198955032 | Temocapril | DrugBank ID:DB08836 | CAS RN:111902-57-9 | PubChem CID:443874 | TEMOCAPRIL | 2-[(2S,6R)-6-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-5-oxo-2-thiophen-2-yl-1,4-thiazepan-4-yl]acetic acid"
+BMGC_DG08841,BMG_DG145363,"TOLTERODINE TARTRATE | NDC:29300-240 | NDC:59762-0048 | NDC:0093-7164 | NDC:16571-126 | NDC:33342-098 | NDC:60687-330 | Tolterodine Tartrate | NDC:31722-806 | NDC:0904-6593 | NDC:58151-099 | PubChem SID:175268020 | NDC:51407-740 | NDC:59762-0800 | NDC:31722-607 | (2R,3R)-2,3-dihydroxybutanedioic acid;2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol | NDC:51407-739 | NDC:43975-323 | NDC:27241-191 | NDC:33342-097 | NDC:70985-022 | NDC:31722-805 | NDC:58151-098 | NDC:0904-6592 | NDC:29300-239 | UNII:5T619TQR3R | NDC:13668-189 | NDC:58151-104 | NDC:60687-319 | NDC:50090-3475 | NDC:58151-103 | NDC:73152-026 | NDC:0009-4544 | NDC:0093-7163 | NDC:73152-027 | NDC:71205-319 | NDC:70436-161 | NDC:29300-307 | NDC:29300-306 | NDC:27241-192 | NDC:59762-0047 | NDC:0093-0018 | NDC:70985-023 | NDC:16571-127 | NDC:59762-0170 | NDC:70436-160 | NDC:0093-0010 | NDC:31722-608 | CAS RN:124937-52-6 | PubChem CID:443878 | NDC:43975-322 | NDC:13668-190"
+BMGC_DG08842,BMG_DG145364,PubChem CID:443879 | CAS RN:124937-51-5 | PubChem SID:175265551 | Tolterodine | UNII:WHE7A56U7K | TOLTERODINE | DrugBank ID:DB01036 | 2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
+BMGC_DG08843,BMG_DG145368,"Ergonovine | UNII:WH41D8433D | DrugBank ID:DB01253 | PubChem SID:175268027 | ERGONOVINE | (6aR,9R)-N-[(2S)-1-hydroxypropan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | Ergometrine | CAS RN:60-79-7 | PubChem CID:443884"
+BMGC_DG08844,BMG_DG145370,"CAS RN:331947-66-1 | UNII:1E2497LPNY | Tolvaptan | PubChem CID:443894 | Tolvaptan, (R)- | PubChem SID:312525137 | DrugBank ID:DB06212 | TOLVAPTAN, (R)-"
+BMGC_DG08845,BMG_DG145374,"PubChem SID:459276059 | 5-METHOXY-N,N-DIMETHYL-1H-INDOLE-3-PROPANAMINE | UNII:RNK2F3W66Q | PubChem CID:44390371 | CAS RN:709028-93-3"
+BMGC_DG08846,BMG_DG145385,"CAS RN:727428-71-9 | UNII:UT98243SCH | 2-METHYL-4-(2-(4-METHYLPHENYL)ETHYNYL)-1,3-THIAZOLE | PubChem CID:44393040 | PubChem SID:461433098"
+BMGC_DG08847,BMG_DG145388,"UNII:S8A06QG2QE | CAS RN:23674-86-4 | NDC:69097-341 | DIFLUPREDNATE | DrugBank ID:DB06781 | [(6S,8S,9R,10S,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoate | NDC:0781-6000 | Difluprednate | NDC:66758-086 | NDC:69238-1380 | PubChem CID:443936 | NDC:0078-0862 | PubChem SID:175268498 | NDC:43598-588 | NDC:65145-161"
+BMGC_DG08848,BMG_DG145393,"CAS RN:3093-35-4 | NDC:0003-0249 | (1S,2S,4R,8S,9S,11S,12R,13S)-8-(2-chloroacetyl)-12-fluoro-11-hydroxy-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icos-17-en-16-one | NDC:21922-069 | Halcinonide | PubChem SID:175266212 | NDC:57664-698 | DrugBank ID:DB06786 | NDC:10631-094 | NDC:0378-8056 | UNII:SI86V6QNEG | PubChem CID:443943 | HALCINONIDE"
+BMGC_DG08849,BMG_DG145396,"PubChem SID:198977628 | METILDIGOXIN | DrugBank ID:DB13401 | CAS RN:30685-43-9 | PubChem CID:443946 | Metildigoxin | 3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5S,6R)-4-hydroxy-5-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | UNII:I7GG1YUC5V"
+BMGC_DG08850,BMG_DG145400,"9-(4-(1-OXIDO-4-(((4'-(TRIFLUOROMETHYL)(1,1'-BIPHENYL)-2-YL)CARBONYL)AMINO)-1-PIPERIDINYL)BUTYL)-N-(2,2,2-TRIFLUOROETHYL)-9H-FLUORENE-9-CARBOXAMIDE | PubChem SID:384647715 | CAS RN:182430-98-4 | UNII:71G1A1S0OG | PubChem CID:44394967"
+BMGC_DG08851,BMG_DG145402,"CAS RN:37686-84-3 | UNII:21OJT43Q88 | Terguride | PubChem SID:175268337 | TERGURIDE | 3-[(6aR,9S,10aR)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea | PubChem CID:443951 | DrugBank ID:DB13399"
+BMGC_DG08852,BMG_DG145403,"NDC:24338-110 | NDC:62559-630 | NDC:62559-631 | NDC:75834-294 | NDC:24338-132 | NDC:80005-152 | NDC:80005-155 | NDC:60219-1504 | CAS RN:1264-62-6 | NDC:52536-134 | Erythromycin Ethylsuccinate | PubChem CID:443953 | NDC:72162-1614 | NDC:71209-102 | NDC:24338-130 | NDC:24338-136 | PubChem SID:175265317 | 4-O-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] 1-O-ethyl butanedioate | NDC:71209-103 | NDC:75834-295 | NDC:52536-136 | NDC:52536-130 | NDC:80005-161 | UNII:1014KSJ86F | ERYTHROMYCIN ETHYLSUCCINATE | NDC:80005-153 | NDC:52536-132 | CAS RN:41342-53-4 | NDC:60219-1503 | NDC:63629-2500 | NDC:69238-1503 | NDC:69238-1504 | NDC:62559-440 | NDC:24338-134 | NDC:24338-100"
+BMGC_DG08853,BMG_DG145404,"UNII:543512OBTC | DrugBank ID:DB12131 | ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate | CAS RN:115986-87-3 | CAS RN:68780-77-8 | PubChem CID:443955 | VINPOCETINE | Vinpocetine | CAS RN:42971-09-5 | PubChem SID:175265415"
+BMGC_DG08854,BMG_DG145406,"UNII:423W026MA9 | NDC:69499-410 | CAS RN:51022-69-6 | NDC:51672-4060 | NDC:74157-006 | AMCINONIDE | NDC:0168-0278 | NDC:73308-407 | [2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-9,13-dimethyl-16-oxospiro[5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-6,1'-cyclopentane]-8-yl]-2-oxoethyl] acetate | PubChem CID:443958 | DrugBank ID:DB00288 | PubChem SID:175266120 | Amcinonide"
+BMGC_DG08855,BMG_DG145411,"CAS RN:987-24-6 | UNII:TI05AO53L7 | PubChem SID:175268011 | NDC:76420-240 | PubChem CID:443967 | NDC:0517-0791 | NDC:0517-0799 | NDC:51754-5060 | NDC:0517-0720 | NDC:76420-007 | NDC:78206-118 | NDC:80425-0347 | [2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | BETAMETHASONE ACETATE | Betamethasone Acetate"
+BMGC_DG08856,BMG_DG145417,PubChem CID:44397333 | UNII:ZW7N2KTX23 | CAS RN:864445-57-8 | JWH-303 | PubChem SID:375084654
+BMGC_DG08857,BMG_DG145418,UNII:H988KQV4U9 | JWH-249 | PubChem SID:313183249 | CAS RN:864445-60-3 | PubChem CID:44397335
+BMGC_DG08858,BMG_DG145419,JWH-253 | PubChem SID:375085107 | CAS RN:864445-46-5 | PubChem CID:44397405 | UNII:E28U9TD6JM
+BMGC_DG08859,BMG_DG145420,"UNII:FPV89QBL57 | CAS RN:143322-55-8 | PubChem CID:44397420 | 3-((1-METHYLPYRROLIDIN-2-YL)METHYL)-1H-INDOLE, (R)- | PubChem SID:461433615"
+BMGC_DG08860,BMG_DG145421,CAS RN:864445-38-5 | PubChem CID:44397436 | PubChem SID:375085995 | UNII:13OTY4DTE7 | JWH-205
+BMGC_DG08861,BMG_DG145422,CAS RN:864445-41-0 | UNII:BDU1DA9SRY | PubChem SID:375086090 | PubChem CID:44397464 | JWH-208
+BMGC_DG08862,BMG_DG145423,JWH-209 | PubChem SID:375085686 | UNII:2A7P4YEN6H | PubChem CID:44397465 | CAS RN:864445-42-1
+BMGC_DG08863,BMG_DG145424,UNII:52CP80V8FY | JWH-203 | CAS RN:864445-54-5 | PubChem SID:252319911 | PubChem CID:44397500 | 2-(2-chlorophenyl)-1-(1-pentylindol-3-yl)ethanone | Jwh-203
+BMGC_DG08864,BMG_DG145425,UNII:LQX1W3537N | PubChem SID:313184176 | PubChem CID:44397502 | JWH-167 | CAS RN:864445-37-4
+BMGC_DG08865,BMG_DG145426,PubChem CID:44397532 | PubChem SID:375084867 | CAS RN:864445-58-9 | UNII:KC06JV2SNX | JWH-206
+BMGC_DG08866,BMG_DG145427,UNII:828QKW93YY | JWH-207 | CAS RN:864445-59-0 | PubChem CID:44397533 | PubChem SID:375083555
+BMGC_DG08867,BMG_DG145428,PubChem CID:44397540 | CAS RN:864445-43-2 | 2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone | UNII:IP9911R8A0 | 2-(2-methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone | JWH-250 | PubChem SID:198950986
+BMGC_DG08868,BMG_DG145429,JWH-201 | PubChem SID:441332138 | PubChem CID:44397641 | CAS RN:864445-47-6 | UNII:TE8PAU3VSY
+BMGC_DG08869,BMG_DG145431,CAS RN:864445-56-7 | JWH-237 | PubChem CID:44397713 | UNII:NR611I7X19 | PubChem SID:375579713
+BMGC_DG08870,BMG_DG145434,"PubChem CID:44398114 | EMOPAMIL, (R)- | CAS RN:101238-50-0 | PubChem SID:314915419 | UNII:7K9X1OPO10"
+BMGC_DG08871,BMG_DG145442,PubChem CID:444 | Bupropion | DrugBank ID:DB01156 | CAS RN:34841-39-9 | BUPROPION | PubChem SID:175271705 | CAS RN:34911-55-2 | 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one | UNII:01ZG3TPX31
+BMGC_DG08872,BMG_DG145443,DrugBank ID:DB00952 | NARATRIPTAN | UNII:QX3KXL1ZA2 | PubChem SID:175268422 | CAS RN:121679-13-8 | N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide | PubChem CID:4440 | Naratriptan
+BMGC_DG08873,BMG_DG145448,"Gallium oxodotreotide ga-68 | PubChem CID:44400135 | DrugBank ID:DB13925 | gallium;2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate"
+BMGC_DG08874,BMG_DG145453,"CAS RN:117467-28-4 | 2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | PubChem CID:444006"
+BMGC_DG08875,BMG_DG145456,"TIBOLONE | (7R,8R,9S,13S,14S,17R)-17-ethynyl-17-hydroxy-7,13-dimethyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | Tibolone | CAS RN:5630-53-5 | PubChem CID:444008 | DrugBank ID:DB09070 | PubChem SID:198967371 | UNII:FF9X0205V2"
+BMGC_DG08876,BMG_DG145458,PubChem CID:444013 | UNII:RLM74T3Z9D | 2-[bis[2-[carboxylatomethyl-[2-(2-methoxyethylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+) | DrugBank ID:DB00538 | CAS RN:131069-91-5 | PubChem SID:175266220 | GADOVERSETAMIDE | Gadoversetamide
+BMGC_DG08877,BMG_DG145460,"PubChem SID:198946321 | VOGLIBOSE | UNII:S77P977AG8 | Voglibose | (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol | CAS RN:112653-29-9 | DrugBank ID:DB04878 | PubChem CID:444020 | CAS RN:83480-29-9"
+BMGC_DG08878,BMG_DG145462,"DrugBank ID:DB12127 | PubChem SID:198941715 | CAS RN:76497-13-7 | Sultamicillin | PubChem CID:444022 | UNII:65DT0ML581 | SULTAMICILLIN | [(2S,5R)-3,3-dimethyl-4,4,7-trioxo-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carbonyl]oxymethyl (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate"
+BMGC_DG08879,BMG_DG145463,"NDC:24208-507 | NDC:24208-353 | NDC:82260-361 | DrugBank ID:DB14596 | chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate | NDC:24208-299 | NDC:72162-1895 | Loteprednol Etabonate | NDC:82260-299 | CAS RN:82034-46-6 | LOTEPREDNOL ETABONATE | NDC:72485-665 | NDC:24208-503 | NDC:24208-358 | NDC:71571-121 | PubChem CID:444025 | NDC:72485-653 | NDC:72603-324 | NDC:24208-508 | NDC:60219-1367 | NDC:71571-333 | NDC:72485-630 | PubChem SID:175266502 | UNII:YEH1EZ96K6 | NDC:60219-1366 | NDC:82260-508 | NDC:68682-299 | NDC:62756-232 | NDC:24208-443"
+BMGC_DG08880,BMG_DG145464,"Risperidon | PubChem CID:44402564 | 3-[2-[4-(6-fluoro-2,3-dihydro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one"
+BMGC_DG08881,BMG_DG145468,"DARIFENACIN HYDROBROMIDE | PubChem SID:175265686 | NDC:69097-431 | NDC:33342-277 | NDC:65862-862 | NDC:13668-202 | CAS RN:133099-07-7 | NDC:52605-067 | NDC:16571-768 | UNII:CR02EYQ8GV | NDC:46708-224 | Darifenacin Hydrobromide | NDC:52605-068 | NDC:69097-432 | PubChem CID:444030 | NDC:46708-223 | NDC:16571-767 | 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide;hydrobromide | NDC:62332-223 | NDC:65862-861 | NDC:33342-276 | NDC:13668-203 | NDC:62332-224"
+BMGC_DG08882,BMG_DG145469,"CAS RN:133099-04-4 | UNII:APG9819VLM | 2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide | PubChem SID:175268333 | PubChem CID:444031 | DrugBank ID:DB00496 | Darifenacin | DARIFENACIN"
+BMGC_DG08883,BMG_DG145474,"NDC:63654-380 | FLUTICASONE PROPIONATE | NDC:0173-0696 | NDC:30142-258 | NDC:37835-997 | NDC:50090-4211 | NDC:63629-8662 | NDC:68788-7788 | NDC:50090-4214 | NDC:76420-903 | NDC:50090-0934 | NDC:68196-210 | NDC:72162-1402 | NDC:50090-4504 | NDC:68788-8446 | NDC:55301-506 | NDC:66993-080 | NDC:41250-634 | NDC:59310-520 | NDC:0173-0717 | NDC:68391-133 | NDC:0363-0881 | NDC:0363-0024 | NDC:66993-078 | NDC:68788-8762 | NDC:11673-262 | NDC:50090-3513 | NDC:36800-128 | Fluticasone Propionate | NDC:50090-4213 | NDC:59310-812 | NDC:64024-007 | NDC:53943-006 | NDC:0168-0332 | NDC:51316-181 | NDC:72162-1401 | NDC:68788-8453 | NDC:0713-0632 | NDC:63629-8658 | NDC:0135-0576 | NDC:41520-703 | NDC:0093-7516 | NDC:37808-340 | NDC:0378-9322 | NDC:66993-079 | NDC:63629-8663 | NDC:50090-2880 | PubChem CID:444036 | NDC:55910-773 | NDC:50594-319 | NDC:0093-3608 | NDC:0173-0719 | Fluticasone propionate | NDC:55700-714 | NDC:0536-1183 | NDC:60505-0829 | NDC:58602-017 | NDC:79903-295 | NDC:69842-900 | NDC:66993-790 | NDC:68788-8704 | NDC:70000-0110 | NDC:0054-3270 | NDC:76420-106 | NDC:59310-525 | NDC:0173-0720 | NDC:0378-9321 | NDC:59310-822 | NDC:0173-0697 | NDC:60505-0955 | NDC:50090-3271 | NDC:0713-0631 | NDC:72288-119 | NDC:0093-3607 | NDC:50090-6823 | NDC:66993-585 | NDC:66993-791 | NDC:41163-023 | NDC:63629-8809 | NDC:0135-0582 | NDC:64525-6560 | NDC:71143-375 | NDC:50090-6055 | NDC:50090-6419 | NDC:70518-1655 | NDC:0054-0326 | NDC:71205-443 | NDC:76162-656 | NDC:50090-1245 | NDC:59310-136 | NDC:50090-0968 | NDC:55910-607 | NDC:67296-1644 | NDC:68788-6926 | NDC:49035-063 | NDC:0093-3609 | NDC:69168-448 | NDC:50090-3272 | NDC:37808-205 | NDC:63187-638 | NDC:66993-792 | NDC:45802-222 | NDC:63187-806 | NDC:67296-1463 | NDC:0363-0652 | NDC:68998-600 | NDC:63629-8660 | NDC:59310-200 | NDC:63187-021 | CAS RN:80474-14-2 | NDC:11822-0901 | NDC:70000-0703 | NDC:59310-311 | NDC:59310-805 | NDC:72288-333 | NDC:50090-6053 | NDC:66993-087 | NDC:50090-4502 | NDC:69168-452 | [(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | NDC:66993-586 | NDC:46122-386 | NDC:0173-0716 | NDC:81522-005 | NDC:63629-8811 | NDC:0363-4023 | NDC:68462-427 | NDC:70677-1021 | NDC:68071-1638 | NDC:21130-122 | NDC:66993-088 | NDC:0054-0328 | NDC:0173-0601 | NDC:0378-9320 | NDC:63629-8810 | NDC:50090-0910 | NDC:58602-018 | NDC:45802-441 | NDC:60429-195 | NDC:11673-388 | NDC:63629-8661 | NDC:59310-515 | NDC:0093-7517 | NDC:79903-071 | NDC:50090-1187 | NDC:66993-086 | NDC:66993-584 | NDC:0054-0327 | NDC:0173-0718 | NDC:0363-1205 | NDC:70518-3968 | NDC:68016-723 | NDC:49035-200 | NDC:62135-810 | NDC:0113-0285 | NDC:63187-959 | NDC:0173-0715 | NDC:69842-770 | NDC:81522-002 | NDC:50090-0916 | NDC:60505-6205 | NDC:41520-553 | NDC:68196-503 | NDC:69842-765 | NDC:63187-957 | NDC:69168-380 | UNII:O2GMZ0LF5W | NDC:11673-103 | NDC:11822-1177 | NDC:45802-221 | NDC:49035-362 | NDC:69842-757 | NDC:51316-197 | DrugBank ID:DB00588 | NDC:56062-107 | NDC:76162-121 | NDC:0093-7518 | NDC:63868-656 | NDC:63981-001 | NDC:0173-0600 | NDC:68071-4868 | PubChem SID:175268790 | NDC:0173-0602 | NDC:21130-089 | NDC:0173-0695 | NDC:46122-684 | NDC:50090-7076 | NDC:68788-9678 | NDC:59310-530 | NDC:36800-222 | NDC:51672-4095 | NDC:50090-3387 | NDC:83324-294 | NDC:50090-6058 | NDC:59310-129 | NDC:50090-4310 | NDC:36800-572 | NDC:49348-182 | NDC:63629-8659 | NDC:71205-262 | NDC:0113-0028"
+BMGC_DG08884,BMG_DG145476,"CAS RN:571-24-4 | PubChem SID:287446433 | (5S,8R,9S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | UNII:6CT050X63M | 17-EPI-DIHYDROTESTOSTERONE | 17-epi-Dihydrotestosterone | PubChem CID:44403751"
+BMGC_DG08885,BMG_DG145478,UNII:LMX71OP17X | PubChem SID:198964162 | PubChem CID:44403763 | L-888607 | CAS RN:860033-06-3
+BMGC_DG08886,BMG_DG145481,"UNII:JV039JZZ3A | (1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-5,10,15,20,25,30,35-heptakis(hydroxymethyl)-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.23,6.28,11.213,16.218,21.223,26.228,31]nonatetracontane-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecol | Betadex | CAS RN:79647-56-6 | PubChem CID:444041 | PubChem SID:175268002 | DrugBank ID:DB03995 | BETADEX | CAS RN:7585-39-9 | CAS RN:37331-89-8"
+BMGC_DG08887,BMG_DG145483,CAS RN:1465-16-3 | 1-METHYLPSILOCIN | PubChem SID:445500652 | PubChem CID:44404883 | UNII:65MKC68UST
+BMGC_DG08888,BMG_DG145485,PubChem SID:472422467 | UNII:RXC5XKT32K | CAS RN:803728-11-2 | DIFLUORO-(4-METHYLPHENYL)METHANESULFONAMIDE | difluoro-(4-methylphenyl)methanesulfonamide | PubChem CID:44405177
+BMGC_DG08889,BMG_DG145486,DrugBank ID:DB03447 | Uridylyl-2'-5'-phospho-adenosine | PubChem CID:444053
+BMGC_DG08890,BMG_DG145497,"CAS RN:14875-96-8 | 3-[18-(2-carboxyethyl)-7,12-bis(ethenyl)-3,8,13,17-tetramethylporphyrin-21,23-diid-2-yl]propanoic acid;iron(2+) | protoheme IX | PubChem CID:444097"
+BMGC_DG08891,BMG_DG145500,CAS RN:3773-07-7 | GLUTATHIONESULFONIC ACID | PubChem CID:444104 | PubChem SID:443624331 | Glutathione sulfonic acid | DrugBank ID:DB03003 | UNII:ZU672FB3GH
+BMGC_DG08892,BMG_DG145502,DrugBank ID:DB07893 | PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE | PubChem CID:444107
+BMGC_DG08893,BMG_DG145504,CAS RN:887615-85-2 | PubChem CID:44410800 | PubChem SID:443623904 | 3-(FURAN-3-YL)-1-METHYL-1H-INDOLE | UNII:LW24799SHL
+BMGC_DG08894,BMG_DG145508,"4,6-dideoxy-4-amino-alpha-D-glucose | PubChem CID:444139 | DrugBank ID:DB03439"
+BMGC_DG08895,BMG_DG145510,"DrugBank ID:DB07784 | [4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID | PubChem CID:444144"
+BMGC_DG08896,BMG_DG145511,Aminophosphonic acid-guanylate ester | DrugBank ID:DB02623 | PubChem CID:444148
+BMGC_DG08897,BMG_DG145512,"PubChem CID:444150 | [(2R,3S)-2,3-dihydroxy-3-(1H-indol-3-yl)propyl] dihydrogen phosphate | Indole-3-glycerol phosphate | Indole-3-Glycerol Phosphate | DrugBank ID:DB04143"
+BMGC_DG08898,BMG_DG145515,UNII:82JC37QRA6 | 2-METHYL-6-(5-PHENYLPENT-1-YNYL)PYRIDINE | PubChem SID:472422402 | PubChem CID:44416004 | CAS RN:851854-15-4
+BMGC_DG08899,BMG_DG145519,"Fenugreekine | PubChem CID:444170 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S)-5-(6-carbamoylpyridin-2-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate | Cpad | DrugBank ID:DB04071"
+BMGC_DG08900,BMG_DG145522,PubChem CID:444182 | DrugBank ID:DB02497 | L-Alpha-Glycerophosphorylserine
+BMGC_DG08901,BMG_DG145524,PubChem CID:44418304 | UNII:JRT5F2Y0NA | CAS RN:914458-19-8 | PubChem SID:440089815 | JWH-145
+BMGC_DG08902,BMG_DG145525,UNII:MQ6N4B8QWE | JWH-147 | PubChem SID:440089862 | PubChem CID:44418307 | CAS RN:914458-20-1
+BMGC_DG08903,BMG_DG145526,PubChem CID:44418308 | CAS RN:914458-21-2 | PubChem SID:441331565 | JWH-146 | UNII:5446SVK6LH
+BMGC_DG08904,BMG_DG145527,PubChem CID:44418312 | PubChem SID:441331219 | UNII:HJZ9JN4HNM | JWH-370 | CAS RN:914458-22-3
+BMGC_DG08905,BMG_DG145528,PubChem CID:44418331 | UNII:HYS2YS4WNM | CAS RN:914458-31-4 | JWH-368 | PubChem SID:433721009
+BMGC_DG08906,BMG_DG145529,PubChem CID:44418355 | PubChem SID:482553934 | UNII:NER93KF8CN | (5-(4-FLUOROPHENYL)-1-PENTYL-1H-PYRROL-3-YL)-1-NAPHTHALENYLMETHANONE | [5-(4-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenylmethanone | CAS RN:914458-39-2
+BMGC_DG08907,BMG_DG145530,CAS RN:914458-42-7 | PubChem CID:44418371 | PubChem SID:441331190 | JWH-309 | UNII:5LC7L6AM73
+BMGC_DG08908,BMG_DG145531,"5-METHYL-1-(6-TRITYLOXYHEXYL) PYRIMIDINE-2,4-DIONE | PubChem SID:443623524 | CAS RN:921587-93-1 | PubChem CID:44418795 | UNII:IA6DUG553Y"
+BMGC_DG08909,BMG_DG145533,"CAS RN:210776-65-1 | UNII:F7LN3N6ZLA | PubChem SID:461433751 | PubChem CID:44418862 | 3,4-DICHLOROMETHYLPHENIDATE"
+BMGC_DG08910,BMG_DG145535,PubChem SID:459275482 | PubChem CID:44419358 | UNII:W4XBS7AED8 | GNETUCLEISTOL D | CAS RN:629643-26-1
+BMGC_DG08911,BMG_DG145538,PubChem CID:444200 | UNII:K15K52FOK4 | CAS RN:6189-71-5 | alpha-D-Fucopyranose | DrugBank ID:DB03485 | .ALPHA.-D-FUCOPYRANOSE | PubChem SID:198945421
+BMGC_DG08912,BMG_DG145546,PubChem CID:444215 | DrugBank ID:DB03020 | 5-beta-D-ribofuranosylnicotinamide adenine dinucleotide
+BMGC_DG08913,BMG_DG145547,"PubChem SID:317229478 | PubChem CID:44421596 | UNII:1BCQ2C7O9W | TALAROZOLE, (R)- | CAS RN:870093-23-5"
+BMGC_DG08914,BMG_DG145549,1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE | DrugBank ID:DB07400 | PubChem CID:444224
+BMGC_DG08915,BMG_DG145550,"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine | DrugBank ID:DB08056 | PubChem CID:44422489"
+BMGC_DG08916,BMG_DG145557,1-Methylimidazole | DrugBank ID:DB02671 | PubChem CID:444235
+BMGC_DG08917,BMG_DG145558,CAS RN:745733-78-2 | UNII:XMQ955AQC4 | N-OLEOYL-L-ALANINE | PubChem CID:44423663
+BMGC_DG08918,BMG_DG145560,"CAS RN:57680-56-5 | UNII:P7V86EYZ5L | DrugBank ID:DB01901 | SUCROSOFATE | PubChem CID:444237 | [(2R,3R,4S,5R,6R)-2-[(2S,3S,4R,5R)-3,4-disulfooxy-2,5-bis(sulfooxymethyl)oxolan-2-yl]oxy-3,5-disulfooxy-6-(sulfooxymethyl)oxan-4-yl] hydrogen sulfate | Sucrosofate | PubChem SID:198948908"
+BMGC_DG08919,BMG_DG145561,PubChem CID:444238 | DrugBank ID:DB07366 | 2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER
+BMGC_DG08920,BMG_DG145563,"DrugBank ID:DB00361 | Vinorelbine | PubChem CID:44424639 | methyl (1R,9R,10R,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | Vinorelbine Ditartarate"
+BMGC_DG08921,BMG_DG145567,"Precose | (2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol | PubChem CID:444254"
+BMGC_DG08922,BMG_DG145568,PubChem CID:44425872 | UNII:L6EYT9ZAP3 | PubChem SID:405055674 | CAS RN:851529-42-5 | SELADELPAR SULFOXIDE
+BMGC_DG08923,BMG_DG145572,Maleic Acid | UNII:91XW058U2C | (Z)-but-2-enedioic acid | MALEIC ACID | PubChem CID:444266 | PubChem SID:175266181 | Maleic acid | DrugBank ID:DB04299 | CAS RN:10237-70-4 | CAS RN:110-16-7
+BMGC_DG08924,BMG_DG145573,"PubChem SID:474492716 | UNII:EC9K3C78V8 | CAS RN:143183-63-5 | PubChem CID:44427225 | Adhyperforin | (1R,5R,7S,8R)-4-hydroxy-8-methyl-1-(2-methylbutanoyl)-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)bicyclo[3.3.1]non-3-ene-2,9-dione | ADHYPERFORIN"
+BMGC_DG08925,BMG_DG145581,"UNII:213N3S8275 | NDC:84575-068 | NDC:72937-006 | NDC:84575-034 | NDC:84575-009 | NDC:84575-027 | DrugBank ID:DB11345 | NDC:84575-037 | NDC:84575-039 | NDC:84575-015 | NDC:84575-029 | NDC:84575-026 | NDC:84575-028 | NDC:84575-046 | NDC:84575-099 | NDC:73076-172 | NDC:82198-0010 | NDC:84575-058 | NDC:84575-042 | NDC:73076-175 | NDC:73076-167 | NDC:73076-165 | NDC:84575-030 | NDC:84575-035 | NDC:69901-523 | NDC:73076-173 | NDC:84575-038 | NDC:84575-055 | NDC:84575-100 | NDC:73076-170 | NDC:84575-031 | NDC:84575-043 | PubChem CID:444294 | NDC:84575-036 | NDC:84575-054 | NDC:84575-021 | NDC:84575-051 | NDC:84575-032 | NDC:84445-006 | NDC:84575-041 | NDC:84575-020 | CAMPHOR, (-)- | NDC:84575-025 | NDC:84575-050 | NDC:73076-174 | NDC:72988-0028 | (1S,4S)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one | NDC:84575-022 | NDC:84575-047 | (-)-Camphor | NDC:50066-456 | NDC:52000-045 | NDC:84575-052 | NDC:84575-069 | NDC:84445-009 | NDC:50804-077 | NDC:84575-001 | NDC:84575-023 | NDC:84575-019 | NDC:73076-176 | NDC:84575-024 | NDC:73076-177 | NDC:84575-033 | NDC:73076-169 | CAS RN:464-48-2 | NDC:73076-171 | NDC:84575-057 | NDC:73076-168 | NDC:84575-066 | PubChem SID:198959082 | NDC:84575-048"
+BMGC_DG08926,BMG_DG145584,"4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole | PubChem CID:444302 | DrugBank ID:DB04374 | 5-(UNDECAN-6-YLSULFANYL)-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID | CAS RN:190080-32-1 | PubChem SID:445500287 | UNII:QUK2CK0JPA"
+BMGC_DG08927,BMG_DG145586,"UNII:4J4Z8788N8 | (2R,3R)-2,3-dihydroxybutanedioic acid | CAS RN:144814-09-5 | PubChem SID:175265580 | CAS RN:133-37-9 | CAS RN:138508-61-9 | TARTARIC ACID | L-tartaric acid | DrugBank ID:DB09459 | CAS RN:132517-61-4 | TARTARIC ACID, DL- | L-Tartaric acid | PubChem SID:198959855 | UNII:W4888I119H | CAS RN:87-69-4 | PubChem CID:444305"
+BMGC_DG08928,BMG_DG145587,PubChem CID:444306 | DrugBank ID:DB02570 | PD150606
+BMGC_DG08929,BMG_DG145588,"PubChem CID:44431176 | UNII:K2NW6QS5EC | 3-AMINO-1-(5,6-DIHYDRO-3-(TRIFLUOROMETHYL)-1,2,4-TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)-4-(2,3,6-TRIFLUOROPHENYL)-1-BUTANONE, (3R)- | CAS RN:945261-50-7"
+BMGC_DG08930,BMG_DG145600,"2',3-BIS(TRIFLUOROMETHYL)(1,1'-BIPHENYL)-4-CARBONITRILE | CAS RN:582293-27-4 | PubChem CID:44434099 | PubChem SID:461432717 | UNII:ERG6R5RTY5"
+BMGC_DG08931,BMG_DG145603,Aeruginosin 98-B | PubChem CID:444346 | DrugBank ID:DB04391
+BMGC_DG08932,BMG_DG145604,DrugBank ID:DB01733 | L-Phospholactate | PubChem CID:444348
+BMGC_DG08933,BMG_DG145609,PubChem CID:444378 | DrugBank ID:DB02716 | 7-methyl-guanosine-5'-triphosphate
+BMGC_DG08934,BMG_DG145612,"DrugBank ID:DB03959 | N,O6-Disulfo-Glucosamine | PubChem CID:444389"
+BMGC_DG08935,BMG_DG145614,PubChem CID:444390 | DrugBank ID:DB02264 | O2-Sulfo-Glucuronic Acid
+BMGC_DG08936,BMG_DG145616,"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL | DrugBank ID:DB07909 | PubChem CID:444394"
+BMGC_DG08937,BMG_DG145618,"Heptane-1,2,3-Triol | PubChem CID:444397 | DrugBank ID:DB04079"
+BMGC_DG08938,BMG_DG145619,DrugBank ID:DB07985 | +/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE | PubChem CID:444406
+BMGC_DG08939,BMG_DG145620,DrugBank ID:DB11256 | Levomefolic acid | PubChem CID:444412
+BMGC_DG08940,BMG_DG145624,"PubChem CID:444440 | N-[4-hydroxymethyl-cyclohexan-6-yl-1,2,3-triol]-4,6-dideoxy-4-aminoglucopyranoside | DrugBank ID:DB02218"
+BMGC_DG08941,BMG_DG145626,7-Spiroindanyloxymorphone | CAS RN:150380-34-0 | UNII:35UF85T692 | PubChem SID:474492570 | 7-SPIROINDANYLOXYMORPHONE | PubChem CID:44444966
+BMGC_DG08942,BMG_DG145627,DrugBank ID:DB03726 | PubChem CID:444450 | Purine Riboside-5'-Monophosphate
+BMGC_DG08943,BMG_DG145628,DrugBank ID:DB03070 | Selenazole-4-carboxyamide-adenine dinucleotide | PubChem CID:444451
+BMGC_DG08944,BMG_DG145631,4-S-Glutathionyl-5-pentyl-tetrahydro-furan-2-ol | PubChem CID:444455 | DrugBank ID:DB04521
+BMGC_DG08945,BMG_DG145635,1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide | PubChem CID:444456 | DrugBank ID:DB04013
+BMGC_DG08946,BMG_DG145638,"(9S,10S)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene | PubChem CID:444461 | DrugBank ID:DB04187"
+BMGC_DG08947,BMG_DG145641,PubChem CID:444475 | DrugBank ID:DB03886 | Biopterin
+BMGC_DG08948,BMG_DG145646,"2-[(4-hydroxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]amino]acetic acid | O-Demethyl muraglitazar | CAS RN:331742-23-5 | PubChem SID:440089379 | O-DEMETHYL MURAGLITAZAR | PubChem CID:44448345 | UNII:AM48L7G8WK"
+BMGC_DG08949,BMG_DG145648,"2-[[4-[2-[5-(hydroxymethyl)-2-phenyl-1,3-oxazol-4-yl]ethoxy]phenyl]methyl-(4-methoxyphenoxy)carbonylamino]acetic acid | PubChem CID:44448403 | 12-HYDROXY MURAGLITAZAR | CAS RN:875430-23-2 | PubChem SID:440089152 | 12-Hydroxy muraglitazar | UNII:VVC144MRE2"
+BMGC_DG08950,BMG_DG145649,CAS RN:875430-18-5 | 12-HYDROXY-O-DEMETHYL MURAGLITAZAR | PubChem CID:44448484 | UNII:VM7LN2S4ZT | PubChem SID:433721028
+BMGC_DG08951,BMG_DG145651,CAS RN:875430-16-3 | 2-[(4-hydroxyphenyl)methyl-(4-methoxyphenoxy)carbonylamino]acetic acid | N-[(4-Hydroxyphenyl)methyl]-N-[(4-methoxyphenoxy)carbonyl]glycine | PubChem SID:433721033 | UNII:2I7SBH0S7A | N-((4-HYDROXYPHENYL)METHYL)-N-((4-METHOXYPHENOXY)CARBONYL)GLYCINE | PubChem CID:44448487
+BMGC_DG08952,BMG_DG145652,"dephospho-CoA | DrugBank ID:DB03170 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate | Dephospho Coenzyme A | CAS RN:3633-59-8 | PubChem CID:444485"
+BMGC_DG08953,BMG_DG145653,"CAS RN:875430-28-7 | PubChem SID:440089638 | PubChem CID:44448593 | GLYCINE, N-((4-(3-(ACETYLBENZOYLAMINO)-3-OXOPROPOXY)PHENYL)METHYL)-N-((4-METHOXYPHENOXY)CARBONYL)- | UNII:2VN0C6C5AT"
+BMGC_DG08954,BMG_DG145655,"PubChem CID:44448632 | CAS RN:875430-22-1 | UNII:Y3DG1KPS95 | GLYCINE, N-((4-(3-(BENZOYLAMINO)-3-OXOPROPOXY)PHENYL)METHYL)-N-((4-METHOXYPHENOXY)CARBONYL)- | PubChem SID:440089258"
+BMGC_DG08955,BMG_DG145659,"CAS RN:139729-89-8 | PubChem SID:377308146 | PubChem CID:44448712 | 2'-DEOXY-2',2'-DIFLUORO-5'-URIDYLIC ACID | UNII:D1OE4MXZ8A"
+BMGC_DG08956,BMG_DG145660,CAS RN:779323-43-2 | PubChem CID:44448831 | MRS-2500 | UNII:DWQ8UHZ38S | PubChem SID:459055332
+BMGC_DG08957,BMG_DG145662,"PubChem CID:444493 | Acetyl Coenzyme A | CAS RN:72-89-9 | NDC:43742-1324 | UNII:76Q83YLO3O | NDC:43742-1484 | PubChem SID:198985477 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] ethanethioate | ACETYL COENZYME A | NDC:83027-0116"
+BMGC_DG08958,BMG_DG145663,PubChem CID:444498 | Immucillin-G | DrugBank ID:DB02230
+BMGC_DG08959,BMG_DG145664,Forodesine | DrugBank ID:DB06185 | PubChem CID:444499
+BMGC_DG08960,BMG_DG145665,"2',3'-dideoxy-3'-fluoro-urididine-5'-diphosphate | PubChem CID:444503 | DrugBank ID:DB04068"
+BMGC_DG08961,BMG_DG145674,"Triacetylchitotriose | CAS RN:13319-32-9 | PubChem CID:444514 | DrugBank ID:DB04194 | N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide"
+BMGC_DG08962,BMG_DG145675,"PubChem CID:44451457 | 1-Deoxyrubralactone | 6-hydroxy-8-methoxy-1-methyl-1,2-dihydrocyclopenta[c]isochromene-3,5-dione"
+BMGC_DG08963,BMG_DG145679,CINNAMIC ACID | UNII:U14A832J8D | PubChem CID:444539 | CAS RN:140-10-3 | PubChem SID:175267542 | (E)-3-phenylprop-2-enoic acid | CAS RN:621-82-9 | Cinnamic Acid
+BMGC_DG08964,BMG_DG145680,"CAS RN:1018679-79-2 | (4aR)-4a-(ethoxymethyl)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinoline | Cort 108297 | PubChem SID:198966246 | UNII:A17W0640NB | CORT-108297 | PubChem CID:44454750"
+BMGC_DG08965,BMG_DG145681,"PubChem CID:444552 | 1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid | DrugBank ID:DB03981"
+BMGC_DG08966,BMG_DG145682,DrugBank ID:DB04379 | PubChem CID:444567 | N-Methyl-N-(Methylbenzyl)Formamide
+BMGC_DG08967,BMG_DG145683,PubChem CID:44456883 | UNII:BS3YU156EO | PubChem SID:461434134 | CAS RN:1018480-89-1 | MCI
+BMGC_DG08968,BMG_DG145684,1-Hydroxy-2-Amino-3-Cyclohexylpropane | PubChem CID:444569 | DrugBank ID:DB04387
+BMGC_DG08969,BMG_DG145685,"PubChem SID:472423918 | 1,5,5-TRIMETHYLPYRROLIDIN-2-ONE | 1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine | PubChem CID:444570 | CAS RN:119715-71-8 | UNII:6BC49782CZ | DrugBank ID:DB03968"
+BMGC_DG08970,BMG_DG145686,DrugBank ID:DB01937 | Guanosine-2'-monophosphate | PubChem CID:444571
+BMGC_DG08971,BMG_DG145687,PubChem SID:472422191 | CAS RN:1788-08-5 | 4-ETHYNYLBENZENESULFONAMIDE | PubChem CID:44457221 | UNII:3EQY8KZ2US
+BMGC_DG08972,BMG_DG145688,"Ins48823 | [[(3aR,4R,6R,6aR)-2-benzyl-4-(2,4-dioxopyrimidin-1-yl)-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methoxy-hydroxyphosphoryl] [[(2S,3R,4S,5S)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate | PubChem CID:44457307"
+BMGC_DG08973,BMG_DG145697,DrugBank ID:DB03337 | PubChem CID:444581 | 1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea
+BMGC_DG08974,BMG_DG145699,"{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid | PubChem CID:444590 | DrugBank ID:DB01723"
+BMGC_DG08975,BMG_DG145702,CAS RN:88244-32-0 | Hydroxyaminovaline | PubChem CID:444599 | (2R)-2-amino-N-hydroxy-3-methylbutanamide | DrugBank ID:DB02697
+BMGC_DG08976,BMG_DG145703,"PubChem CID:44459941 | UNII:NV803J2V3C | 1,3-DIALLYL-7-METHYLXANTHINE | CAS RN:102284-65-1 | PubChem SID:438788114"
+BMGC_DG08977,BMG_DG145707,"PubChem CID:444607 | CAS RN:220402-80-2 | DrugBank ID:DB07363 | N2-((4-METHYLPHENYL)METHYL)THIOPHENE-2,5-DISULFONAMIDE | PubChem SID:445499616 | THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE) | UNII:409XZT1EFW"
+BMGC_DG08978,BMG_DG145709,AL5424 | PubChem CID:444612 | DrugBank ID:DB01964
+BMGC_DG08979,BMG_DG145711,"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine | PubChem CID:444617 | DrugBank ID:DB02583"
+BMGC_DG08980,BMG_DG145713,DrugBank ID:DB04395 | Phosphoaminophosphonic Acid-Adenylate Ester | PubChem CID:44462678
+BMGC_DG08981,BMG_DG145714,"GLPG-0259 | 4-[8-[4-[(1S,4S)-5-propan-2-yl-2,5-diazabicyclo[2.2.1]heptan-2-yl]anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]furan-2-carboxamide | UNII:52EG7RFE6Y | DrugBank ID:DB15190 | CAS RN:1195065-29-2 | CAS RN:1448363-08-3 | PubChem CID:44462738 | PubChem SID:376072564 | Glpg-0259"
+BMGC_DG08982,BMG_DG145716,"P505-15 | PubChem SID:346539487 | 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[3-(triazol-2-yl)anilino]pyrimidine-5-carboxamide | CAS RN:1370261-96-3 | PRT-062607 | PubChem CID:44462758 | UNII:K9C42672RH | CAS RN:1194954-52-3"
+BMGC_DG08983,BMG_DG145717,"PubChem SID:175265791 | Dabrafenib | DrugBank ID:DB08912 | CAS RN:1195765-45-7 | UNII:QGP4HA4G1B | N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide | DABRAFENIB | PubChem CID:44462760"
+BMGC_DG08984,BMG_DG145718,PubChem SID:198948384 | PubChem CID:44462785 | UNII:A5ZX7J376H | CAS RN:1043446-39-4 | CH-5137291
+BMGC_DG08985,BMG_DG145721,"PubChem CID:44463 | PubChem SID:198986763 | Ciramadol | CIRAMADOL | 3-[(R)-dimethylamino-[(1R,2R)-2-hydroxycyclohexyl]methyl]phenol | UNII:9NQ109OW0G | CAS RN:63269-31-8"
+BMGC_DG08986,BMG_DG145722,DrugBank ID:DB02385 | D-threo-neopterin | PubChem CID:444632
+BMGC_DG08987,BMG_DG145723,DrugBank ID:DB01818 | PubChem CID:444635 | O3-Sulfonylgalactose
+BMGC_DG08988,BMG_DG145727,UNII:MEY37JZ4XR | PubChem SID:433968975 | MRT-67307 | CAS RN:1190378-57-4 | PubChem CID:44464263
+BMGC_DG08989,BMG_DG145732,DrugBank ID:DB06951 | PubChem CID:444650 | (3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid
+BMGC_DG08990,BMG_DG145734,DrugBank ID:DB03127 | Benzamidine | PubChem CID:444655
+BMGC_DG08991,BMG_DG145735,UNII:44147RI31X | (4-methylnaphthalen-1-yl)-(1-pentylindol-3-yl)methanone | PubChem SID:252319692 | (4-Methyl-1-naphthyl)-(1-pentylindol-3-yl)methanone | PubChem CID:44466638 | CAS RN:619294-47-2 | JWH-122
+BMGC_DG08992,BMG_DG145739,"4SC-203 | PubChem CID:44467821 | 1-(2-methoxy-5-methylphenyl)-3-[6-[[6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinazolin-4-yl]amino]-1,3-benzothiazol-2-yl]urea | 4Sc-203 | PubChem SID:252823788 | CAS RN:895533-09-2 | DrugBank ID:DB12669 | UNII:RFG3GJ6251"
+BMGC_DG08993,BMG_DG145740,"CAS RN:57-87-4 | Ergosterol | UNII:Z30RAY509F | PubChem CID:444679 | ERGOSTEROL | DrugBank ID:DB04038 | (3S,9S,10R,13R,14R,17R)-17-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol | PubChem SID:198958856"
+BMGC_DG08994,BMG_DG145746,"PubChem SID:198949674 | DrugBank ID:DB12306 | CAS RN:1193314-23-6 | CIPARGAMIN | CAS RN:1252008-89-1 | Cipargamin | PubChem CID:44469321 | UNII:Z7Q4FWA04P | (3R,3'S)-5,7'-dichloro-6'-fluoro-3'-methylspiro[1H-indole-3,1'-2,3,4,9-tetrahydropyrido[3,4-b]indole]-2-one"
+BMGC_DG08995,BMG_DG145747,DrugBank ID:DB03714 | 4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid | PubChem CID:444695
+BMGC_DG08996,BMG_DG145749,"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid | PubChem CID:444698 | DrugBank ID:DB03207"
+BMGC_DG08997,BMG_DG145750,PubChem CID:4447 | UNII:MW7J9SU4JQ | 2-[[(benzhydrylamino)-(4-cyanoanilino)methylidene]amino]acetic acid | CAS RN:138460-25-0 | N-(P-Cyanophenyl)-N'-diphenylmethyl-guanidine-acetic acid | PubChem SID:472408818 | DrugBank ID:DB07816 | N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID | CAS RN:1808181-85-2
+BMGC_DG08998,BMG_DG145755,Trazeolide | DrugBank ID:DB08647 | PubChem CID:444705
+BMGC_DG08999,BMG_DG145757,DrugBank ID:DB01911 | PubChem CID:444708 | N-Methylmesoporphyrin
+BMGC_DG09000,BMG_DG145758,"UNII:KW7SNV9X8B | PubChem SID:374388153 | PubChem CID:444718 | 3-PHENYLLACTIC ACID, (S)- | CAS RN:20312-36-1 | (2S)-2-hydroxy-3-phenylpropanoic acid | (S)-3-phenyllactic acid | L-(-)-3-Phenyllactic acid | DrugBank ID:DB02494"
+BMGC_DG09001,BMG_DG145762,"10-formyl-5,8,10-trideazafolic acid | DrugBank ID:DB02540 | PubChem CID:444725"
+BMGC_DG09002,BMG_DG145765,"CAS RN:1190389-15-1 | Vibegron | PubChem CID:44472635 | UNII:M5TSE03W5U | (6S)-N-[4-[[(2S,5R)-5-[(R)-hydroxy(phenyl)methyl]pyrrolidin-2-yl]methyl]phenyl]-4-oxo-7,8-dihydro-6H-pyrrolo[1,2-a]pyrimidine-6-carboxamide | NDC:73336-075 | PubChem SID:198966669 | DrugBank ID:DB14895 | VIBEGRON"
+BMGC_DG09003,BMG_DG145766,DrugBank ID:DB02755 | 1-3 Sugar Ring of Pentamannosyl 6-Phosphate | PubChem CID:444727
+BMGC_DG09004,BMG_DG145768,"DrugBank ID:DB04264 | PubChem CID:444729 | (10R)-10-formyl-5,8,10-trideazafolic acid"
+BMGC_DG09005,BMG_DG145769,"CAS RN:288079-93-6 | PubChem SID:198943903 | PubChem CID:44473100 | 2-N,2-N-dimethyl-5-N-[N-(2-methyl-1-benzofuran-5-yl)-N'-[(3S)-2-oxo-1-(2-oxo-2-pyrrolidin-1-ylethyl)azepan-3-yl]carbamimidoyl]pyridine-2,5-dicarboxamide | BMS-344577 | Bms-344577 | UNII:U259PQB19A"
+BMGC_DG09006,BMG_DG145772,"Fiboflapon | 3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoic acid | DrugBank ID:DB06346 | CAS RN:936350-00-4 | FIBOFLAPON | PubChem CID:44473151 | UNII:Y1NA96IX3T | PubChem SID:198935695"
+BMGC_DG09007,BMG_DG145774,"CAS RN:58880-19-6 | (2E,4E,6R)-7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide | Trichostatin A | PubChem CID:444732 | PubChem SID:198977144 | UNII:3X2S926L3Z | DrugBank ID:DB04297 | trichostatin A | TRICHOSTATIN A"
+BMGC_DG09008,BMG_DG145777,CAS RN:7370-34-5 | PubChem CID:4447360 | UNII:E7PGJ2OBS2 | PubChem SID:443624932 | ETHYL(TRIPHENYLMETHYL)AMINE
+BMGC_DG09009,BMG_DG145779,DrugBank ID:DB02985 | 8-iodo-guanine | PubChem CID:444737
+BMGC_DG09010,BMG_DG145781,"PubChem SID:198966065 | 1H-Indole-2-carboxamide, 5-chloro-N-((1S)-1-((4-fluorophenyl)methyl)-2-(4-hydroxy-1-piperidinyl)-2-oxoethyl)- | CAS RN:186430-23-9 | DrugBank ID:DB03383 | CP-320626 | 5-chloro-N-[(2S)-3-(4-fluorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide | PubChem CID:444746 | UNII:FKX709RK3Q"
+BMGC_DG09011,BMG_DG145783,"PubChem SID:346537523 | Hydroxocobalamin | CAS RN:13422-51-0 | NDC:50633-310 | cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydroxide | PubChem CID:44475014 | HYDROXOCOBALAMIN | UNII:Q40X8H422O"
+BMGC_DG09012,BMG_DG145785,DrugBank ID:DB04446 | Benzo[B]Thiophene-2-Carboxamidine | PubChem CID:444753
+BMGC_DG09013,BMG_DG145789,CAS RN:1189641-81-3 | PubChem SID:443624060 | N-(3-PHENYLAZANYLPYRIDIN-4-YL)METHANESULFONAMIDE | UNII:R45CX8I425 | PubChem CID:44475843
+BMGC_DG09014,BMG_DG145791,"DrugBank ID:DB02393 | PubChem CID:444761 | D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate"
+BMGC_DG09015,BMG_DG145792,DrugBank ID:DB04001 | 6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid | UNII:WM8KMK01TA | PubChem CID:444763 | 6-(CARBOXYCARBONYLAMINO)-1H-INDOLE-5-CARBOXYLIC ACID | CAS RN:243967-44-4 | PubChem SID:445500622
+BMGC_DG09016,BMG_DG145793,DrugBank ID:DB02622 | CAS RN:5651-01-4 | 2-(Oxalyl-amino)-benzoic acid | 2-(Oxalyl-Amino)-Benzoic Acid | PubChem CID:444764 | 2-(oxaloamino)benzoic acid
+BMGC_DG09017,BMG_DG145795,"DrugBank ID:DB03102 | 2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid | PubChem CID:444765"
+BMGC_DG09018,BMG_DG145797,"DrugBank ID:DB03670 | 2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid | PubChem CID:444766"
+BMGC_DG09019,BMG_DG145798,UNII:DA4HT8614K | BI-135585 | PubChem CID:44476893 | PubChem SID:313183384 | CAS RN:1114561-85-1
+BMGC_DG09020,BMG_DG145801,"1H-IMIDAZO(2,1-F)PURINE-2,4(3H,8H)-DIONE, 7-(5-HYDROXY-2-METHYLPHENYL)-8-(2-METHOXYPHENYL)-1-METHYL- | PubChem CID:44478401 | PubChem SID:485661278 | 1H-Imidazo[2,1-f]purine-2,4(3H,8H)-dione, 7-(5-hydroxy-2-methylphenyl)-8-(2-methoxyphenyl)-1-methyl- | CAS RN:1192216-03-7 | UNII:8S7CMB69GB"
+BMGC_DG09021,BMG_DG145802,PubChem CID:444789 | 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid | DrugBank ID:DB02449
+BMGC_DG09022,BMG_DG145803,PubChem CID:44479007 | CAS RN:1191448-17-5 | 2-[4-[6-amino-2-[[4-[[3-(cyclohexylamino)propylamino]methyl]cyclohexyl]methylamino]pyrimidin-4-yl]piperazin-1-yl]ethylphosphonic acid | PubChem SID:198936718 | BURIXAFOR | Burixafor | UNII:2G17Y0Q20G | DrugBank ID:DB11970
+BMGC_DG09023,BMG_DG145805,2-O-METHYL-.ALPHA.-L-FUCOPYRANOSE | UNII:ZN7HRG4F33 | PubChem SID:375579508 | DrugBank ID:DB04515 | CAS RN:1887228-22-9 | 2-O-methyl-alpha-L-fucopyranose | PubChem CID:444792
+BMGC_DG09024,BMG_DG145806,"(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid | Tretinoin | PubChem SID:175266959 | PubChem CID:444795 | TRETINOIN | UNII:5688UTC01R | CAS RN:302-79-4 | CAS RN:97950-17-9 | DrugBank ID:DB00755"
+BMGC_DG09025,BMG_DG145807,"DrugBank ID:DB07506 | PubChem CID:444797 | 2-BENZYLSUCCINIC ACID, (R)- | L-BENZYLSUCCINIC ACID | UNII:7NNA3JFN4J | CAS RN:21307-97-1"
+BMGC_DG09026,BMG_DG145809,"NDC:63020-210 | PubChem SID:251966108 | UNII:49DXG3M5ZW | DrugBank ID:DB11679 | FRUQUINTINIB | PubChem CID:44480399 | CAS RN:1194506-26-7 | NDC:63020-225 | Fruquintinib | 6-(6,7-dimethoxyquinazolin-4-yl)oxy-N,2-dimethyl-1-benzofuran-3-carboxamide"
+BMGC_DG09027,BMG_DG145811,1-thio-beta-D-glucopyranose | UNII:NG6BJW0OE1 | PubChem SID:375579825 | CAS RN:7534-35-2 | .BETA.-D-1-THIOGLUCOPYRANOSE | DrugBank ID:DB03859 | PubChem CID:444809
+BMGC_DG09028,BMG_DG145814,PubChem CID:444818 | DrugBank ID:DB03510 | 6-O-Phosphoryl Inosine Monophosphate
+BMGC_DG09029,BMG_DG145827,CoA-s-acetyl tryptamine | DrugBank ID:DB02931 | PubChem CID:444837
+BMGC_DG09030,BMG_DG145829,DrugBank ID:DB03931 | PubChem CID:444841 | Diguanosine-5'-Triphosphate
+BMGC_DG09031,BMG_DG145830,PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE | PubChem CID:444849 | DrugBank ID:DB07710
+BMGC_DG09032,BMG_DG145831,DrugBank ID:DB07394 | PubChem CID:444853 | AUROVERTIN B
+BMGC_DG09033,BMG_DG145835,"(2S,3S,4R,5S,6S)-6-methyloxane-2,3,4,5-tetrol | beta-L-fucose | CAS RN:11116-03-3 | beta-L-fucopyranose | CAS RN:13224-93-6 | .BETA.-L-FUCOPYRANOSE | PubChem SID:375579381 | PubChem CID:444863 | CAS RN:156228-03-4 | UNII:3MLV1G4S4M | DrugBank ID:DB03283"
+BMGC_DG09034,BMG_DG145836,UNII:W8FTJ17C4J | CAS RN:517-09-9 | DrugBank ID:DB03515 | Equilenin | EQUILENIN | PubChem SID:198951559 | PubChem CID:444865
+BMGC_DG09035,BMG_DG145838,alpha-Fluoro-carboxymethyldethia coenzyme A complex | DrugBank ID:DB03182 | PubChem CID:444883
+BMGC_DG09036,BMG_DG145839,"CAS RN:131-48-6 | (2R,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid | DrugBank ID:DB03721 | CAS RN:17245-21-5 | N-ACETYL-.ALPHA.-NEURAMINIC ACID | CAS RN:21646-00-4 | PubChem SID:252823650 | UNII:04A90EXP8V | N-acetyl-alpha-neuraminic acid | PubChem CID:444885 | CAS RN:114942-08-4 | N-Acetyl-alpha-neuraminic acid"
+BMGC_DG09037,BMG_DG145840,"PubChem CID:444894 | DrugBank ID:DB06843 | 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE"
+BMGC_DG09038,BMG_DG145841,"CAS RN:93444-49-6 | CAS RN:506-32-1 | PubChem CID:444899 | Arachidonic Acid | UNII:27YG812J1I | DrugBank ID:DB04557 | ARACHIDONIC ACID | PubChem SID:175266837 | (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoic acid"
+BMGC_DG09039,BMG_DG145842,"PubChem SID:175268308 | NEFAZODONE | CAS RN:83366-66-9 | PubChem CID:4449 | 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one | UNII:59H4FCV1TF | Nefazodone | DrugBank ID:DB01149"
+BMGC_DG09040,BMG_DG145845,4-Deoxy-Alpha-D-Glucose | DrugBank ID:DB02670 | PubChem CID:444914
+BMGC_DG09041,BMG_DG145846,CAS RN:2642-43-5 | PubChem SID:348480754 | PubChem CID:444920 | THYMIDINE 3'-MONOPHOSPHATE | UNII:Q84LAH3NDH
+BMGC_DG09042,BMG_DG145848,".ALPHA.-RIBAZOLE 5'-PHOSPHATE | alpha-Ribazole-5'-phosphate | α-Ribazole 5′-phosphate | Alpha-Ribazole-5'-Phosphate | PubChem SID:472421788 | DrugBank ID:DB02030 | UNII:TT4G266KJN | CAS RN:975-91-7 | [(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | PubChem CID:444941"
+BMGC_DG09043,BMG_DG145849,DrugBank ID:DB01983 | 2(S)-Amino-6-Boronohexanoic Acid | PubChem CID:444965
+BMGC_DG09044,BMG_DG145850,Fumaric acid | CAS RN:6915-18-0 | Fumaric Acid | PubChem CID:444972 | (E)-but-2-enedioic acid | PubChem SID:175267707 | UNII:88XHZ13131 | CAS RN:110-17-8 | DrugBank ID:DB01677 | FUMARIC ACID
+BMGC_DG09045,BMG_DG145853,"PubChem CID:4450 | Nefopam | CAS RN:13669-70-0 | DrugBank ID:DB12293 | UNII:4UP8060B7J | PubChem SID:198984381 | 5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine | NEFOPAM"
+BMGC_DG09046,BMG_DG145858,"PubChem CID:445015 | [(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID | DrugBank ID:DB07771"
+BMGC_DG09047,BMG_DG145859,PubChem CID:445018 | DrugBank ID:DB04140 | 1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide
+BMGC_DG09048,BMG_DG145862,"CAS RN:12022-42-3 | DESTHIOBIOTIN, (±)- | UNII:I64P0B487B | DrugBank ID:DB03775 | DESTHIOBIOTIN | DESTHIOBIOTIN, (+/-)- | PubChem SID:198985450 | PubChem SID:198976879 | Dethiobiotin | UNII:71U5JB52KS | CAS RN:636-20-4 | PubChem CID:445027 | 6-[(4R,5S)-5-methyl-2-oxoimidazolidin-4-yl]hexanoic acid | CAS RN:533-48-2"
+BMGC_DG09049,BMG_DG145863,DrugBank ID:DB02299 | PubChem CID:445032 | Arginineamide
+BMGC_DG09050,BMG_DG145867,"PROSTAGLANDIN H2 | UNII:J670X3LRU2 | (Z)-7-[(1R,4S,5R,6R)-6-[(E,3S)-3-hydroxyoct-1-enyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid | PubChem CID:445049 | Prostaglandin h2 | PubChem SID:198983831 | CAS RN:42935-17-1"
+BMGC_DG09051,BMG_DG145868,L-Rhamnitol | CAS RN:488-28-8 | L-RHAMNITOL | UNII:IHI9UGC58P | PubChem SID:374388253 | PubChem CID:445052 | DrugBank ID:DB02399
+BMGC_DG09052,BMG_DG145869,PubChem CID:445062 | DrugBank ID:DB02824 | N-Pyridoxyl-Glycine-5-Monophosphate
+BMGC_DG09053,BMG_DG145870,"PubChem SID:198988137 | CAS RN:131-48-6 | (2S,4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid | CAS RN:19342-33-7 | UNII:TIP79W5HPN | PubChem CID:445063 | CAS RN:489-46-3 | N-acetyl-beta-neuraminic acid | DrugBank ID:DB04265 | N-ACETYL-.BETA.-NEURAMINIC ACID"
+BMGC_DG09054,BMG_DG145871,"CAS RN:106-28-5 | PubChem CID:445070 | (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol | trans,trans-Farnesol | FARNESOL, (2E,6E)- | UNII:X23PI60R17 | CAS RN:4602-84-0 | PubChem SID:175266106"
+BMGC_DG09055,BMG_DG145872,DrugBank ID:DB04322 | PubChem CID:445072 | LY249543
+BMGC_DG09056,BMG_DG145873,DrugBank ID:DB02358 | PubChem CID:445076 | LY374571
+BMGC_DG09057,BMG_DG145878,"PubChem CID:445109 | 2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine | DrugBank ID:DB02911"
+BMGC_DG09058,BMG_DG145883,"PubChem CID:445114 | DrugBank ID:DB02557 | Phosphoramidon | CAS RN:36357-77-4 | (2S)-2-[[(2S)-2-[[hydroxy-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid | UNII:T3G94E2LB1 | PubChem SID:249491935 | PHOSPHORAMIDON | CAS RN:119942-99-3"
+BMGC_DG09059,BMG_DG145886,"UNII:Y569TM2AT2 | (5R)-4,5-DIHYDRO-5-METHYL-5-((4-(4-(4-(TRIFLUOROMETHOXY)PHENOXY)-1-PIPERIDINYL)PHENOXY)METHYL)-2-OXAZOLAMINE | PubChem CID:44511499 | PubChem SID:441658671 | CAS RN:1202875-92-0"
+BMGC_DG09060,BMG_DG145888,"Tc-6987 | PubChem CID:44511587 | DrugBank ID:DB14854 | 3,5-difluoro-N-[(2S,3R)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]benzamide | UNII:Q2U4R164OG | CAS RN:1196701-27-5 | TC-6987 | PubChem SID:346540517"
+BMGC_DG09061,BMG_DG145895,"PubChem CID:445127 | (3S)-5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-3-hydroxy-3-methyl-5-oxopentanoic acid | (S)-3-Hydroxy-3-methylglutaryl-CoA | CAS RN:26926-09-0 | CAS RN:1553-55-5"
+BMGC_DG09062,BMG_DG145900,"PubChem SID:198963891 | N-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide | ANAGLIPTIN | UNII:K726J96838 | DrugBank ID:DB12417 | PubChem CID:44513473 | Anagliptin | CAS RN:739366-20-2"
+BMGC_DG09063,BMG_DG145913,"CAS RN:133294-37-8 | PubChem SID:175266592 | CAS RN:31100-06-8 | Resveratrol | CAS RN:375823-41-9 | RESVERATROL | NDC:84732-042 | DrugBank ID:DB02709 | CAS RN:501-36-0 | 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol | PubChem CID:445154 | UNII:Q369O8926L"
+BMGC_DG09064,BMG_DG145915,"UNII:4YBM839JAC | CAS RN:121785-72-6 | PubChem CID:445156 | 21S-Argatroban | ARGATROBAN ANHYDROUS, (21S)- | PubChem SID:198981646 | (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid"
+BMGC_DG09065,BMG_DG145916,1-[n-(Naphthalen-2-Ylsulfonyl)glycyl-4-Carbamimidoyl-D-Phenylalanyl]piperidine | PubChem CID:445157 | N-[(2R)-3-(4-carbamimidoylphenyl)-1-oxo-1-piperidin-1-ylpropan-2-yl]-2-(naphthalen-2-ylsulfonylamino)acetamide
+BMGC_DG09066,BMG_DG145923,"PubChem CID:44516953 | CAS RN:1197160-78-3 | 1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea | Gedatolisib | PubChem SID:198948743 | GEDATOLISIB | UNII:96265TNH2R | DrugBank ID:DB11896"
+BMGC_DG09067,BMG_DG145924,[(3R)-1-[2-(4-fluorophenyl)ethyl]-1-azoniabicyclo[2.2.2]octan-3-yl] (2S)-2-phenyl-2-piperidin-1-ylpropanoate | PubChem SID:310825799 | PubChem CID:44517831 | CAS RN:1034978-04-5 | Azd-9164 | AZD-9164 | DrugBank ID:DB12115 | UNII:977LWC4O5D
+BMGC_DG09068,BMG_DG145926,"DrugBank ID:DB01740 | PubChem CID:445180 | 4-butyl-5-propyl-1,3-selenazol-2-amine"
+BMGC_DG09069,BMG_DG145932,N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide | PubChem CID:4452 | CAS RN:93664-94-9 | CAS RN:70325-83-6
+BMGC_DG09070,BMG_DG145934,PubChem CID:445210 | DrugBank ID:DB03000 | S-9-(2-hydroxypropyl)adenine
+BMGC_DG09071,BMG_DG145935,"DrugBank ID:DB02765 | PubChem SID:255509527 | CAS RN:14047-28-0 | PubChem CID:445211 | UNII:43H6SBP55W | 9-(2-HYDROXYPROPYL)ADENINE, (R)- | R-9-(2-hydroxypropyl)adenine"
+BMGC_DG09072,BMG_DG145936,"(NORTH)-METHANOCARBATHYMIDINE | UNII:LTM5S02010 | PubChem SID:318164120 | CAS RN:156126-12-4 | 1-[(1S,2S,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-bicyclo[3.1.0]hexanyl]-5-methylpyrimidine-2,4-dione | (North)-methanocarbathymidine | PubChem CID:445212"
+BMGC_DG09073,BMG_DG145938,"PubChem CID:445226 | PubChem SID:375579394 | UNII:H0QPM375HE | DrugBank ID:DB04282 | (2S,3R,4S,5S,6R)-3-fluoro-6-(hydroxymethyl)oxane-2,4,5-triol | .ALPHA.-D-FLUDEOXYGLUCOPYRANOSE | 2-deoxy-2-fluoro-alpha-D-glucopyranose | CAS RN:62182-10-9 | 2-deoxy-2-fluoro-α-D-glucose"
+BMGC_DG09074,BMG_DG145940,"DrugBank ID:DB02185 | 2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One | PubChem CID:445228 | (2R)-2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one"
+BMGC_DG09075,BMG_DG145941,"1,4-dithio-alpha-D-glucopyranose | PubChem CID:445237 | DrugBank ID:DB01870"
+BMGC_DG09076,BMG_DG145942,"CAS RN:25360-07-0 | PubChem CID:445238 | CAS RN:709-50-2 | methyl beta-D-glucopyranoside | DrugBank ID:DB01642 | Methyl beta-D-glucopyranoside | CAS RN:7000-27-3 | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol"
+BMGC_DG09077,BMG_DG145943,DrugBank ID:DB02471 | PubChem CID:445245 | Nojirimycine Tetrazole
+BMGC_DG09078,BMG_DG145944,PubChem CID:445246 | 2-acetylamino-2-deoxy-b-D-allopyranose | DrugBank ID:DB03109
+BMGC_DG09079,BMG_DG145945,"D-gluconhydroximo-1,5-lactam | PubChem CID:445248 | DrugBank ID:DB02376"
+BMGC_DG09080,BMG_DG145953,DrugBank ID:DB03790 | UNII:V3Z9QH81BX | L-Methionine sulfone | PubChem CID:445282 | CAS RN:7314-32-1 | (2S)-2-amino-4-methylsulfonylbutanoic acid | PubChem SID:374388453 | L-methionine sulfone | METHIONINE SULFONE
+BMGC_DG09081,BMG_DG145956,Acetic Acid Salicyloyl-Amino-Ester | DrugBank ID:DB03667 | PubChem CID:445302
+BMGC_DG09082,BMG_DG145966,DrugBank ID:DB04018 | S-Isopropyl-Isothiourea | PubChem CID:445319
+BMGC_DG09083,BMG_DG145970,"octanoyl-CoA | Octanoyl-Coenzyme A | DrugBank ID:DB02910 | CAS RN:324518-20-9 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] octanethioate | CAS RN:1264-52-4 | PubChem CID:445344"
+BMGC_DG09084,BMG_DG145971,"CAS RN:11103-57-4 | NDC:83872-348 | PubChem CID:445354 | UNII:G2SH0XKK91 | NDC:84732-081 | NDC:83872-388 | DrugBank ID:DB00162 | Vitamin A | NDC:83872-282 | NDC:83872-419 | NDC:84372-027 | NDC:84778-028 | NDC:83872-422 | NDC:83872-425 | NDC:84019-011 | NDC:84372-023 | (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol | NDC:83872-353 | RETINOL | NDC:83872-347 | NDC:84117-009 | NDC:84372-019 | PubChem SID:198980479 | NDC:83872-427 | NDC:83872-423 | CAS RN:68-26-8 | NDC:84372-021 | Retinol | NDC:83872-483 | NDC:83872-454"
+BMGC_DG09085,BMG_DG145976,Phosphonoacetohydroxamic Acid | ((HYDROXYCARBAMOYL)METHYL)PHOSPHONIC ACID | UNII:QMJ2VH9SGQ | CAS RN:89873-30-3 | PubChem SID:472409342 | DrugBank ID:DB03645 | PubChem CID:445375
+BMGC_DG09086,BMG_DG145978,PubChem SID:384158306 | CAS RN:929916-05-2 | PubChem CID:44537807 | (S)-4-(2-((4-(4-chlorophenoxy)phenoxy)methyl)pyrrolidin-1-yl)butanoic acid | 4-[(2S)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]pyrrolidin-1-yl]butanoic acid | DG-051 FREE BASE | UNII:T6WM2IY2LM
+BMGC_DG09087,BMG_DG145979,"1-[(2R)-1-[(4S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl]-3-methyl-1-oxobutan-2-yl]-3-(2-hydroxy-2-methylpropyl)urea | PubChem SID:346539370 | Bms-817399 | CAS RN:1202400-18-7 | DrugBank ID:DB14941 | BMS-817399 | PubChem CID:44537841 | UNII:AKQ3X6FEH0"
+BMGC_DG09088,BMG_DG145982,"PubChem SID:363908616 | PubChem CID:44537963 | CAS RN:1202402-40-1 | UNII:8KFO2187CP | CIFORADENANT | 7-(5-methylfuran-2-yl)-3-[[6-[[(3S)-oxolan-3-yl]oxymethyl]pyridin-2-yl]methyl]triazolo[4,5-d]pyrimidin-5-amine | Ciforadenant"
+BMGC_DG09089,BMG_DG145985,DrugBank ID:DB02320 | N-beta-D-glucopyranosylacetamide | PubChem CID:445382
+BMGC_DG09090,BMG_DG145986,CP-526423 | PubChem CID:445383 | DrugBank ID:DB02089
+BMGC_DG09091,BMG_DG145987,PubChem CID:44538833 | PubChem SID:198976890 | UNII:6BVK16R925 | A-987306 | CAS RN:1082954-71-9
+BMGC_DG09092,BMG_DG145989,"CAS RN:1197420-06-6 | DrugBank ID:DB14787 | Bms-830216 | PubChem CID:44539266 | UNII:ISL723GVQ8 | [(1R)-2-[4-[6-(4-chlorophenyl)-4-oxothieno[3,2-d]pyrimidin-3-yl]-2-methoxyphenoxy]-1-cyclopropylethyl] dihydrogen phosphate | PubChem SID:381608604 | BMS-830216"
+BMGC_DG09093,BMG_DG145990,"PubChem CID:445393 | Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester | DrugBank ID:DB02894"
+BMGC_DG09094,BMG_DG145993,"4,6-Diamino-2-{[3-o-(2,6-diamino-2,6-dideoxyhexopyranosyl)pentofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxyhexopyranoside | 5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol | PubChem CID:4454"
+BMGC_DG09095,BMG_DG145994,ULIXACALTAMIDE | N-[[1-[2-(tert-butylamino)-2-oxoethyl]piperidin-4-yl]methyl]-3-chloro-5-fluorobenzamide | CAS RN:1199236-64-0 | N-((1-(2-(tert-Butylamino)-2-oxoethyl)piperidin-4-yl)methyl)-3-chloro-5-fluorobenzamide | UNII:QT2PJH89C3 | PubChem SID:461433116 | Ulixacaltamide | PubChem CID:44540045
+BMGC_DG09096,BMG_DG145996,7-Methylguanosine | DrugBank ID:DB03493 | PubChem CID:445404
+BMGC_DG09097,BMG_DG146001,PubChem SID:198968758 | PubChem CID:445420 | UNII:SRQ9WWM084 | CAS RN:76343-93-6 | LATRUNCULIN A
+BMGC_DG09098,BMG_DG146004,"5-CHLOROBUPROPION | UNII:MZ54X0ANF3 | PubChem CID:44542511 | PubChem SID:461434152 | 2-(TERT-BUTYLAMINO)-3,5-DICHLOROPROPIOPHENONE | CAS RN:1193779-48-4"
+BMGC_DG09099,BMG_DG146008,"microcystin-LR | PubChem SID:198955864 | MICROCYSTIN-LR | PubChem CID:445434 | UNII:EQ8332842Y | CAS RN:98226-43-8 | CAS RN:101043-37-2 | (5R,8S,11R,12S,15S,18S,19S,22R)-15-[3-(diaminomethylideneamino)propyl]-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,5,12,19-tetramethyl-2-methylidene-8-(2-methylpropyl)-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid"
+BMGC_DG09100,BMG_DG146010,5'-O-(L-Threonylsulfamoyl)adenosine | PubChem CID:445439 | DrugBank ID:DB03355
+BMGC_DG09101,BMG_DG146011,"Unii-KQ33evh4KU | PubChem SID:459055641 | CAS RN:1198784-72-3 | PubChem CID:44543970 | UNII:KQ33EVH4KU | BI-653048 FREE BASE | 2-[(4R)-4-[(5-ethylsulfonyl-1H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl]-5-fluorobenzamide"
+BMGC_DG09102,BMG_DG146012,PubChem CID:445443 | Zinc trihydroxide | DrugBank ID:DB02165
+BMGC_DG09103,BMG_DG146015,"PubChem CID:445455 | DrugBank ID:DB07031 | 3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid"
+BMGC_DG09104,BMG_DG146016,DrugBank ID:DB03279 | Dodecyl-Alpha-D-Maltoside | PubChem CID:445456
+BMGC_DG09105,BMG_DG146018,"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate | PubChem CID:445459 | DrugBank ID:DB03744"
+BMGC_DG09106,BMG_DG146019,"DrugBank ID:DB07294 | 3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid | PubChem CID:445460"
+BMGC_DG09107,BMG_DG146020,"4-(N,N-Dimethylamino)cinnamoyl-CoA | DrugBank ID:DB04117 | PubChem CID:445461"
+BMGC_DG09108,BMG_DG146024,B-2-Octylglucoside | DrugBank ID:DB03152 | PubChem CID:445463
+BMGC_DG09109,BMG_DG146025,"PubChem CID:445468 | [(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] hexadecanoate | 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | CAS RN:923-61-5 | PubChem SID:198959295 | UNII:4FWH120Z1Z | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | DrugBank ID:DB01728 | 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine"
+BMGC_DG09110,BMG_DG146028,CAS RN:1201689-10-2 | PubChem CID:44547965 | AE-92686 | PubChem SID:377308344 | UNII:ND06TNJ6W7
+BMGC_DG09111,BMG_DG146030,"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE | PubChem CID:445480 | DrugBank ID:DB07261"
+BMGC_DG09112,BMG_DG146031,"DrugBank ID:DB08426 | THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE | PubChem CID:445481"
+BMGC_DG09113,BMG_DG146032,"[(1R)-2-[(3S)-3-[[5-chloro-2-(tetrazol-1-yl)phenyl]methylcarbamoyl]-3,4-dihydropyrazol-2-yl]-1-(4-fluorophenyl)-2-oxoethyl] propanoate | UNII:7WO8I5IY24 | AZD-8165 | PubChem SID:346537436 | PubChem CID:44548240 | CAS RN:1201686-72-7 | DrugBank ID:DB15132 | Azd-8165"
+BMGC_DG09114,BMG_DG146034,DrugBank ID:DB01951 | PubChem CID:445501 | Gpi-1046
+BMGC_DG09115,BMG_DG146036,DrugBank ID:DB02752 | Tosyl-D-Proline | PubChem CID:445504
+BMGC_DG09116,BMG_DG146045,UNII:OE4L5BBV9M | PubChem SID:461434695 | DrugBank ID:DB03321 | PubChem CID:445533 | Des(carbamimidoyl) zanamivir | CAS RN:130525-62-1 | DES(CARBAMIMIDOYL) ZANAMIVIR
+BMGC_DG09117,BMG_DG146051,UNII:01IC75R817 | CAS RN:1202265-63-1 | IMARIKIREN | PubChem SID:319892123 | PubChem CID:44554894
+BMGC_DG09118,BMG_DG146052,PubChem SID:198939357 | UNII:3U024732VA | MK-3328 | CAS RN:1201323-97-8 | PubChem CID:44555286
+BMGC_DG09119,BMG_DG146053,"PubChem CID:445555 | 2,5-Anhydroglucitol-1,6-Biphosphate | DrugBank ID:DB02778"
+BMGC_DG09120,BMG_DG146054,"CAS RN:34693-23-7 | Fructose-1,6-diphosphate | .ALPHA.-D-FOSFRUCTOFURANOSE | PubChem CID:445557 | [(2S,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate | PubChem SID:375579773 | UNII:ANW5CM3PJ7"
+BMGC_DG09121,BMG_DG146057,UNII:3U3L5QR4KV | PubChem SID:198935679 | DrugBank ID:DB01830 | PubChem CID:445561 | AP-22408 | CAS RN:268741-43-1
+BMGC_DG09122,BMG_DG146063,BMS184394 | PubChem CID:445575 | DrugBank ID:DB03466
+BMGC_DG09123,BMG_DG146064,BMS-181156 | PubChem SID:384647669 | PubChem CID:445576 | CAS RN:110368-35-9 | UNII:C9FL8WH6S4 | DrugBank ID:DB02466
+BMGC_DG09124,BMG_DG146065,"DrugBank ID:DB12733 | DIPRAGLURANT | CAS RN:872363-17-2 | 6-fluoro-2-(4-pyridin-2-ylbut-3-ynyl)imidazo[1,2-a]pyridine | PubChem SID:198990098 | UNII:CV8JZR21A1 | PubChem CID:44557636 | Dipraglurant"
+BMGC_DG09125,BMG_DG146067,"UNII:ZAD9OKH9JC | Docosahexaenoic Acid | CAS RN:6217-54-5 | CAS RN:1024594-51-1 | PubChem SID:175267937 | DOCONEXENT | (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid | DrugBank ID:DB03756 | Doconexent | PubChem CID:445580"
+BMGC_DG09126,BMG_DG146081,"PubChem CID:44559227 | Territrema(RG) | (1S,2S,7R,10R)-1,7-dihydroxy-14-(7-methoxy-1,3-benzodioxol-5-yl)-2,6,6,10-tetramethyl-11,15-dioxatetracyclo[8.8.0.02,7.012,17]octadeca-4,12(17),13-triene-3,16-dione"
+BMGC_DG09127,BMG_DG146090,"Topostatin | [1-amino-3-[(3S,6S)-6,13-dimethyl-10-methylidene-2,5,9,12-tetraoxo-14-[(5E,7E)-3,7,10-trimethyl-4-oxoheptadeca-5,7-dienyl]-1-oxa-4,8,11-triazacyclotetradec-3-yl]-1-oxopropan-2-yl] hydrogen sulfate | PubChem CID:44559995"
+BMGC_DG09128,BMG_DG146091,[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium | DrugBank ID:DB01400 | CAS RN:59-99-4 | NEOSTIGMINE | UNII:3982TWQ96G | Neostigmine | PubChem SID:175265326 | PubChem CID:4456
+BMGC_DG09129,BMG_DG146095,"5-[(2S,3S)-3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-2-yl]-3-(4-methylphenyl)-1,2-oxazole | PubChem CID:44560493 | (2S,3S)-3-(4-chlorophenyl)-8-methyl-2-(3-p-tolylisoxazol-5-yl)-8-aza-bicyclo[3.2.1]octane hydrochloride"
+BMGC_DG09130,BMG_DG146102,MCHB-1 | CAS RN:1046140-32-2 | UNII:W8QNY2T4YC | PubChem SID:441583934 | PubChem CID:44561533
+BMGC_DG09131,BMG_DG146110,"PubChem CID:44563121 | CAS RN:99217-63-7 | UNII:S7LW4HSS6R | Kushenol A | (2S)-5,7-dihydroxy-2-(2-hydroxyphenyl)-8-[(2R)-5-methyl-2-prop-1-en-2-ylhex-4-enyl]-2,3-dihydrochromen-4-one | PubChem SID:482553827 | KUSHENOL A"
+BMGC_DG09132,BMG_DG146111,"PubChem CID:44563262 | DrugBank ID:DB08055 | N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine"
+BMGC_DG09133,BMG_DG146113,PubChem CID:44563762 | PubChem SID:474492829 | CAS RN:629643-27-2 | UNII:Y5XLT99N4N | GNETUCLEISTOL E
+BMGC_DG09134,BMG_DG146114,DrugBank ID:DB04257 | CAS RN:373-49-9 | PubChem CID:445638 | (Z)-hexadec-9-enoic acid | PALMITOLEIC ACID | PubChem SID:198967736 | UNII:209B6YPZ4I | Palmitoleic Acid
+BMGC_DG09135,BMG_DG146116,CAS RN:112-80-1 | Oleic Acid | OLEIC ACID | (Z)-octadec-9-enoic acid | UNII:2UMI9U37CP | PubChem SID:175266347 | PubChem CID:445639 | CAS RN:99148-48-8 | Oleic acid
+BMGC_DG09136,BMG_DG146118,Lodoxamide | 2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid | CAS RN:53882-12-5 | PubChem CID:44564 | DrugBank ID:DB06794 | PubChem SID:175267846 | UNII:SPU695OD73 | LODOXAMIDE
+BMGC_DG09137,BMG_DG146121,"PubChem CID:44564107 | CID 44564107 | nonadecasodium;[(2R,3R,4S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4S,5R)-3-[[(2R,3R,4S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-3-[[(2R,3S,5R)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2R,3R,4S,5R)-3-[[(2S,3S,4R,5S)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2S,3S,4R,5S)-3-[[(2S,3S,4R,5S)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-[[(2S,3S,4S,5S)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3-hydroxy-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-5-(6-aminopurin-9-yl)-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-5-(2-amino-6-oxo-1H-purin-9-yl)-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyloxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyloxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyloxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-4-(2-methoxyethoxy)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-oxidophosphoryl]sulfanyl-4-(2-methoxyethoxy)oxolan-2-yl]methoxy-[(2R,3R,4S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-2-(hydroxymethyl)-4-(2-methoxyethoxy)oxolan-3-yl]sulfanylphosphinate"
+BMGC_DG09138,BMG_DG146124,"(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | DrugBank ID:DB00864 | PubChem SID:175266076 | Tacrolimus | CAS RN:104987-11-3 | TACROLIMUS ANHYDROUS | UNII:Y5L2157C4J | PubChem CID:445643"
+BMGC_DG09139,BMG_DG146125,"DrugBank ID:DB08520 | PubChem CID:445646 | (21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE"
+BMGC_DG09140,BMG_DG146126,PubChem CID:445649 | PubChem SID:381132189 | UNII:4ZNA144ZS0 | CAS RN:314266-76-7 | OM-99-2
+BMGC_DG09141,BMG_DG146127,PubChem CID:445650 | DrugBank ID:DB08562 | 4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID
+BMGC_DG09142,BMG_DG146128,1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID | PubChem CID:445651 | DrugBank ID:DB07329
+BMGC_DG09143,BMG_DG146136,"4-(2-Hydroxy-2-propyl)cyclohexene-1-methanol, (S)- | UNII:A7CJ9GF36P | PubChem SID:482554211 | PubChem CID:44566704 | 4-(2-HYDROXY-2-PROPYL)CYCLOHEXENE-1-METHANOL, (S)- | CAS RN:19894-91-8"
+BMGC_DG09144,BMG_DG146140,"Uridine-Diphosphate-N-Acetylglucosamine | PubChem CID:445675 | [(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl] [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate | DrugBank ID:DB03397 | Uridine-diphosphate-N-acetylglucosamine | CAS RN:528-04-1 | CAS RN:91183-98-1"
+BMGC_DG09145,BMG_DG146151,Phenylalanylamide | CAS RN:5241-58-7 | UNII:PV9T9B2S11 | PHENYLALANYLAMIDE | PubChem SID:198982093 | PubChem CID:445694 | DrugBank ID:DB04029
+BMGC_DG09146,BMG_DG146152,CAS RN:7621-14-9 | PubChem CID:445697 | PubChem SID:198953180 | UNII:N6F7N11105 | HISTIDINAMIDE
+BMGC_DG09147,BMG_DG146157,S-benzylglutathione | DrugBank ID:DB03602 | PubChem CID:445707
+BMGC_DG09148,BMG_DG146159,UNII:4NVH197M39 | PubChem SID:198937461 | CAS RN:1133706-08-7 | GSK-256471 | PubChem CID:44570980
+BMGC_DG09149,BMG_DG146160,PubChem CID:44571 | 4-(7-bromo-5-methoxy-1-benzofuran-2-yl)piperidine | UNII:6WV4B8Q07H | DrugBank ID:DB13876 | BROFAROMINE | PubChem SID:198971308 | Brofaromine | CAS RN:63638-91-5
+BMGC_DG09150,BMG_DG146161,"Farnesyl diphosphate | CAS RN:372-97-4 | CAS RN:13058-04-3 | PubChem CID:445713 | PubChem SID:485666680 | DrugBank ID:DB07780 | phosphono [(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl] hydrogen phosphate | UNII:G8X8WT527W | PubChem SID:198950714 | FARNESYL PYROPHOSPHATE | UNII:79W6B01D07 | Farnesyl diphosphate, (2E,6E)-"
+BMGC_DG09151,BMG_DG146162,DrugBank ID:DB02386 | Leucine Phosphonic Acid | PubChem CID:445715
+BMGC_DG09152,BMG_DG146163,"(5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione | PubChem CID:445717 | DrugBank ID:DB01843"
+BMGC_DG09153,BMG_DG146164,"PubChem CID:445718 | 3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione | DrugBank ID:DB02447"
+BMGC_DG09154,BMG_DG146165,"DrugBank ID:DB03479 | 8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione | PubChem CID:445720"
+BMGC_DG09155,BMG_DG146167,DrugBank ID:DB03657 | 1-deoxy-1-methoxycarbamido-beta-D-glucopyranose | PubChem CID:445722
+BMGC_DG09156,BMG_DG146168,"CAS RN:1141802-49-4 | PubChem SID:445498809 | PubChem CID:44572264 | 5-PHENYL-(1,1'-BIPHENYL)-3-YL N-CYCLOPENTYLCARBAMATE | UNII:6XGG437C7W"
+BMGC_DG09157,BMG_DG146169,DrugBank ID:DB04544 | 1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide | PubChem CID:445723
+BMGC_DG09158,BMG_DG146171,UNII:Z34JI7B0E3 | CAS RN:1152568-15-4 | 8-BROMO-9-CYCLOHEXYL-9H-PURIN-6-AMINE | PubChem CID:44572356 | PubChem SID:445499676
+BMGC_DG09159,BMG_DG146172,L-FUCITOL | PubChem CID:445724 | CAS RN:13074-06-1 | DrugBank ID:DB03815 | UNII:961570X3WO | PubChem SID:318164708 | Fucitol
+BMGC_DG09160,BMG_DG146173,"2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One | DrugBank ID:DB02391 | PubChem CID:445732"
+BMGC_DG09161,BMG_DG146179,DrugBank ID:DB04426 | PubChem CID:445750 | Alpha-Methyl-N-Acetyl-D-Glucosamine
+BMGC_DG09162,BMG_DG146186,DrugBank ID:DB02354 | PubChem CID:445756 | 4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine
+BMGC_DG09163,BMG_DG146196,"n-(2,3,4,5,6-Pentaflouro-benzyl)-4-sulfamoyl-benzamide | UNII:TB7ZN7UZ52 | N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide | CAS RN:235088-65-0 | DrugBank ID:DB02610 | N-[(2,3,4,5,6-pentafluorophenyl)methyl]-4-sulfamoylbenzamide | 4-(AMINOSULFONYL)-N-((2,3,4,5,6-PENTAFLUOROPHENYL)METHYL)BENZAMIDE | PubChem CID:445770"
+BMGC_DG09164,BMG_DG146197,"PubChem SID:318691564 | CAS RN:74950-96-2 | PubChem CID:44577222 | Vanilloloside | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-(hydroxymethyl)-2-methoxyphenoxy]oxane-3,4,5-triol | VANILLOLOSIDE | UNII:UU9VCO3B28"
+BMGC_DG09165,BMG_DG146201,PubChem SID:443624205 | CAS RN:345266-97-9 | PubChem CID:445784 | DrugBank ID:DB02436 | {4-[(2S)-2-({[(1S)-1-Carboxy-2-phenylethyl]carbamoyl}amino)-3-oxo-3-(pentylamino)propyl]phenoxy}malonic acid | PNU-177496 | UNII:BSW3GP3Z2B
+BMGC_DG09166,BMG_DG146202,PubChem CID:445785 | N-(3-Carboxypropanoyl)-L-phenylalanyl-3-carboxy-O-(carboxymethyl)-N-pentyl-L-tyrosinamide | DrugBank ID:DB04525
+BMGC_DG09167,BMG_DG146208,"PubChem CID:44579714 | (1R,2R,3S,4R,5S)-4-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]bicyclo[3.1.0]hexane-2,3-diol | (1R,2R,3S,4R,5S)-4-(2-chloro-6-(3-iodobenzylamino)-9H-purin-9-yl)bicyclo[3.1.0]hexane-2,3-diol"
+BMGC_DG09168,BMG_DG146212,JWH-229 | PubChem CID:44581105 | PubChem SID:198990833 | CAS RN:832111-99-6 | UNII:8HHX5B1WP5
+BMGC_DG09169,BMG_DG146217,"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE | DrugBank ID:DB07383 | PubChem CID:445824"
+BMGC_DG09170,BMG_DG146219,alpha-D-glucopyranosyl-2-carboxylic acid amide | DrugBank ID:DB02720 | PubChem CID:445825
+BMGC_DG09171,BMG_DG146220,UNII:385MMD5A7N | MH.MZ | PubChem CID:44582675 | PubChem SID:474494259
+BMGC_DG09172,BMG_DG146221,"ELRAGLUSIB | CAS RN:1034895-42-5 | PubChem SID:319892032 | PubChem CID:44582816 | 3-(5-fluoro-1-benzofuran-3-yl)-4-(5-methyl-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione | Elraglusib | UNII:ND1SOF0DLU"
+BMGC_DG09173,BMG_DG146224,"DrugBank ID:DB04186 | PubChem CID:445840 | N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea"
+BMGC_DG09174,BMG_DG146227,"PubChem CID:445841 | DrugBank ID:DB06976 | 1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA"
+BMGC_DG09175,BMG_DG146229,6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine | DrugBank ID:DB03865 | PubChem CID:445843
+BMGC_DG09176,BMG_DG146234,6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE | DrugBank ID:DB06856 | PubChem CID:445849
+BMGC_DG09177,BMG_DG146235,PubChem CID:44585557 | (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one | DrugBank ID:DB07317
+BMGC_DG09178,BMG_DG146236,"2-Amino-N,3,3-Trimethylbutanamide | PubChem CID:445856 | DrugBank ID:DB01949"
+BMGC_DG09179,BMG_DG146237,CAS RN:1135-24-6 | UNII:AVM951ZWST | CAS RN:537-98-4 | Ferulic acid | FERULIC ACID | CAS RN:97274-61-8 | PubChem SID:175266615 | PubChem CID:445858 | (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoic acid | DrugBank ID:DB07767
+BMGC_DG09180,BMG_DG146238,CP-654577 | PubChem CID:44586019 | PubChem SID:198941343 | UNII:W39547M0FP | CAS RN:639087-64-2
+BMGC_DG09181,BMG_DG146241,NAX-5055 | PubChem SID:375924136 | UNII:7J6HRA05J2 | PubChem CID:44587984 | CAS RN:944087-28-9
+BMGC_DG09182,BMG_DG146247,DrugBank ID:DB04556 | 3-[(1S)-1-(Dimethylamino)ethyl]phenol | CAS RN:139306-10-8 | NAP-226-90 | PubChem CID:445892 | 3-[(1S)-1-(dimethylamino)ethyl]phenol | UNII:1608PLR9ZO | PubChem SID:198970419
+BMGC_DG09183,BMG_DG146253,"Crisaborole | 4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile | CAS RN:1073669-75-6 | PubChem SID:198949363 | PubChem CID:44591583 | DrugBank ID:DB05219 | CAS RN:906673-24-3 | CAS RN:906673-25-4 | NDC:55724-211 | UNII:Q2R47HGR7P | CRISABOROLE"
+BMGC_DG09184,BMG_DG146255,PubChem SID:440089866 | DrugBank ID:DB08773 | 2-(4-hydroxyphenyl)benzo[b]thiophen-6-ol | UNII:8ZK5PJ1CM3 | PubChem CID:445920 | CAS RN:63676-22-2 | 2-(4-HYDROXYPHENYL)-1-BENZOTHIOPHENE-6-OL
+BMGC_DG09185,BMG_DG146256,1-[2-Naphthalen-2-ylethyl]piperazine | UNII:2F6XFV6WB7 | PubChem CID:44592243 | CAS RN:194943-70-9 | PubChem SID:472422099 | 1-(2-NAPHTHALEN-2-YLETHYL)PIPERAZINE
+BMGC_DG09186,BMG_DG146258,"GARDIQUIMOD | Gardiquimod | CAS RN:1020412-43-4 | PubChem SID:440089497 | PubChem CID:44592366 | UNII:Y3W4QVW5BY | 1-[4-amino-2-(ethylaminomethyl)imidazo[4,5-c]quinolin-1-yl]-2-methylpropan-2-ol"
+BMGC_DG09187,BMG_DG146261,"PubChem SID:198972653 | DrugBank ID:DB03511 | UNII:CEP8I6411H | alpha-D-galacturonic acid | CAS RN:6294-16-2 | alpha-D-GALACTURONIC ACID | PubChem CID:445929 | (2S,3R,4S,5R,6S)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid | .ALPHA.-D-GALACTURONIC ACID"
+BMGC_DG09188,BMG_DG146265,"PubChem CID:44593387 | (3S,6S,9S,12R)-3-[(2R)-butan-2-yl]-6-[(1-methoxy-3-indolyl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone | (3S,6S,9S,12R)-3-[(2R)-butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone"
+BMGC_DG09189,BMG_DG146267,"CAS RN:38029-69-5 | (2R,3R,4R,5S)-5-(hydroxymethyl)oxolane-2,3,4-triol | .ALPHA.-L-ARABINOFURANOSE | Alpha-L-Arabinose | PubChem CID:445935 | alpha-L-arabinofuranose | DrugBank ID:DB03142 | UNII:R0L7IU6KYJ | PubChem SID:376231159"
+BMGC_DG09190,BMG_DG146270,"Methyl 4,6-O-[(1R)-1-carboxyethylidene]-beta-D-galactopyranoside | DrugBank ID:DB01651 | PubChem CID:445936"
+BMGC_DG09191,BMG_DG146271,PubChem SID:198949748 | UNII:69MB5VHL5J | CAS RN:1050381-35-5 | PubChem CID:44593666 | BMS-694153
+BMGC_DG09192,BMG_DG146272,"DrugBank ID:DB03779 | Glucosaminyl-(Alpha-6)-D-Myo-Inositol | PubChem CID:445937 | (1R,2R,4R,5S)-6-[(2R,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexane-1,2,3,4,5-pentol | 6-(alpha-D-glucosaminyl)-1D-myo-inositol"
+BMGC_DG09193,BMG_DG146276,"PubChem CID:445940 | 1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol | DrugBank ID:DB03663"
+BMGC_DG09194,BMG_DG146281,"DrugBank ID:DB07751 | PubChem CID:445950 | (2S)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol"
+BMGC_DG09195,BMG_DG146282,UNII:D1LXQ45S1O | PubChem CID:44595079 | PubChem SID:198989969 | CAS RN:1198300-79-6 | DrugBank ID:DB15499 | Cerdulatinib | CERDULATINIB | 4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide
+BMGC_DG09196,BMG_DG146283,"(2R)-1-[4-({6-[(2,6-Difluorophenyl)amino]-4-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol | PubChem CID:445951 | DrugBank ID:DB07761"
+BMGC_DG09197,BMG_DG146284,"(2R)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol | DrugBank ID:DB07750 | PubChem CID:445952"
+BMGC_DG09198,BMG_DG146285,"DrugBank ID:DB07755 | (2S)-1-[4-({4-[(2,5-Dichlorophenyl)amino]-2-pyrimidinyl}amino)phenoxy]-3-(dimethylamino)-2-propanol | PubChem CID:445953"
+BMGC_DG09199,BMG_DG146286,DrugBank ID:DB07504 | (2R)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol | PubChem CID:445957
+BMGC_DG09200,BMG_DG146287,PubChem CID:445958 | DrugBank ID:DB07501 | (2S)-1-{4-[(4-Anilino-5-bromo-2-pyrimidinyl)amino]phenoxy}-3-(dimethylamino)-2-propanol
+BMGC_DG09201,BMG_DG146288,PubChem CID:44595848 | CAS RN:1204535-44-3 | PubChem SID:375083810 | (2-methylpyridin-3-yl)-[(2S)-2-methyl-4-[4-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]methanone | DrugBank ID:DB15229 | UNII:SSB9S6N20R | CNV-2197944 | Cnv-2197944
+BMGC_DG09202,BMG_DG146294,(5R)-5-{[(2-Amino-3H-purin-6-yl)oxy]methyl}-2-pyrrolidinone | PubChem CID:445966 | DrugBank ID:DB02898
+BMGC_DG09203,BMG_DG146295,"CAS RN:872556-74-6 | 4-(CYCLOHEXYLMETHOXY)-3H-IMIDAZO(4,5-C)PYRIDIN-6-AMINE | DrugBank ID:DB02603 | UNII:T9B8HV823A | PubChem CID:445967 | 1-Amino-6-Cyclohex-3-Enylmethyloxypurine"
+BMGC_DG09204,BMG_DG146301,"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone | DrugBank ID:DB03234 | PubChem CID:445986"
+BMGC_DG09205,BMG_DG146302,(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE | DrugBank ID:DB08458 | PubChem CID:445987
+BMGC_DG09206,BMG_DG146303,PubChem CID:445989 | DrugBank ID:DB03888 | N-Allyl-6-{[3-(4-bromophenyl)-1-methyl-1H-indazol-6-yl]oxy}-N-methyl-1-hexanamine
+BMGC_DG09207,BMG_DG146306,PubChem CID:445990 | (2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine | DrugBank ID:DB02139
+BMGC_DG09208,BMG_DG146307,"PubChem CID:445992 | DrugBank ID:DB02544 | N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine"
+BMGC_DG09209,BMG_DG146308,DrugBank ID:DB12371 | CAS RN:1230487-00-9 | SIPONIMOD | PubChem SID:198975654 | Siponimod | CAS RN:1230487-85-0 | UNII:RR6P8L282I | 1-[[4-[(E)-N-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]-C-methylcarbonimidoyl]-2-ethylphenyl]methyl]azetidine-3-carboxylic acid | PubChem CID:44599207
+BMGC_DG09210,BMG_DG146309,Tyrosinal | DrugBank ID:DB03978 | PubChem CID:445993
+BMGC_DG09211,BMG_DG146312,"[(2E)-3,7-dimethylocta-2,6-dienyl] phosphono hydrogen phosphate | CAS RN:763-10-0 | PubChem CID:445995 | Geranyl diphosphate | UNII:7X7DBM66JG | GERANYL PYROPHOSPHATE | Geranyl pyrophosphate | Geranyl Diphosphate | PubChem SID:474490057 | DrugBank ID:DB02552"
+BMGC_DG09212,BMG_DG146313,"N-[2-(dimethylamino)ethyl]-N-methyl-4-[[4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)pyrrolo[2,3-d]pyrimidin-2-yl]phenyl]carbamoylamino]benzamide | N-[2-(Dimethylamino)ethyl]-N-methyl-4-[({4-[4-morpholin-4-yl-7-(2,2,2-trifluoroethyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]phenyl}carbamoyl)amino]benzamide | CAS RN:1202884-94-3 | PubChem CID:44599690"
+BMGC_DG09213,BMG_DG146314,CAS RN:1202647-54-8 | PubChem SID:198937758 | 2-methyl-N-[[4-(2-pyrrolidin-1-ylsulfonylphenyl)phenyl]methyl]propan-1-amine | UNII:Y3530Z78QD | PubChem CID:44599828 | PF-4455242 FREE BASE | PF-4455242 free base
+BMGC_DG09214,BMG_DG146319,"(S)-Baclofen | (3S)-4-amino-3-(4-chlorophenyl)butanoic acid | CAS RN:66514-99-6 | PubChem SID:198936612 | UNII:3OHN4989XM | BACLOFEN, (S)- | L-Baclofen | DrugBank ID:DB12098 | PubChem CID:44600"
+BMGC_DG09215,BMG_DG146327,PubChem CID:44601455 | CAS RN:1206731-57-8 | N'-hydroxy-N-[(E)-[4-(N-phenylanilino)phenyl]methylideneamino]octanediamide
+BMGC_DG09216,BMG_DG146328,DrugBank ID:DB04489 | Guanidinoethylmercaptosuccinic acid | PubChem CID:446018
+BMGC_DG09217,BMG_DG146329,UNII:NYU6UTW25B | PubChem CID:44602 | ARBACLOFEN | DrugBank ID:DB08891 | CAS RN:69308-37-8 | Arbaclofen | PubChem SID:175266631 | (3R)-4-amino-3-(4-chlorophenyl)butanoic acid
+BMGC_DG09218,BMG_DG146332,"PubChem CID:44602427 | DrugBank ID:DB08335 | 4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME"
+BMGC_DG09219,BMG_DG146342,"UNII:3V7GQ1260K | CAS RN:1206163-45-2 | Solcitinib | PubChem SID:198947679 | PubChem CID:44603362 | N-[5-[4-(3,3-dimethylazetidine-1-carbonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide | SOLCITINIB"
+BMGC_DG09220,BMG_DG146345,"PubChem CID:44603531 | CAS RN:1356446-42-8 | CAS RN:1350514-68-9 | GRAZOPREVIR ANHYDROUS | PubChem SID:198962050 | UNII:8YE81R1X1J | DrugBank ID:DB11575 | Grazoprevir | (1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide"
+BMGC_DG09221,BMG_DG146346,UNII:5OGS5K699E | CAS RN:1206799-15-6 | PubChem SID:249492803 | MERESTINIB | DrugBank ID:DB12381 | N-[3-fluoro-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxyphenyl]-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide | Merestinib | PubChem CID:44603533
+BMGC_DG09222,BMG_DG146347,D-[(N-Hydroxyamino)Carbonyl]Phenylalanine | PubChem CID:446049 | DrugBank ID:DB04316
+BMGC_DG09223,BMG_DG146348,"naphthalene-2,6-disulfonate | CAS RN:55077-34-4 | 2,6-Naphthalenedisulfonate | PubChem CID:4460503"
+BMGC_DG09224,BMG_DG146349,UNII:7XS3UG99LC | PubChem SID:322058755 | DrugBank ID:DB04058 | N-CARBAMOYLPHENYLALANINE | PubChem CID:446054 | CAS RN:949-45-1 | N-Carbamoylphenylalanine
+BMGC_DG09225,BMG_DG146350,DrugBank ID:DB02652 | PubChem CID:446056 | L-[(N-Hydroxyamino)Carbonyl]Phenylalanine
+BMGC_DG09226,BMG_DG146354,"CAS RN:14875-96-8 | Hematin | PubChem CID:446067 | 3-[18-(2-carboxyethyl)-7,12-bis(ethenyl)-3,8,13,17-tetramethylporphyrin-21,23-diid-2-yl]propanoic acid;iron(2+);hydrate"
+BMGC_DG09227,BMG_DG146360,CAS RN:1213269-23-8 | PubChem SID:198976577 | UNII:6BQ432Z61M | N-[3-[5-chloro-2-[2-methoxy-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]oxyphenyl]prop-2-enamide | WZ-4002 | PubChem CID:44607530 | WZ4002
+BMGC_DG09228,BMG_DG146366,"UNII:0YP1ME85GH | Epaminurad | (3,5-dibromo-4-hydroxyphenyl)-(2,3-dihydropyrido[4,3-b][1,4]oxazin-4-yl)methanone | CAS RN:1198153-15-9 | PubChem CID:44608229 | PubChem SID:363907794 | EPAMINURAD"
+BMGC_DG09229,BMG_DG146368,Paliperidone ketone | PubChem CID:44608359 | CAS RN:1189516-65-1 | PubChem SID:251966012 | UNII:17V05YK3XQ | PALIPERIDONE KETONE
+BMGC_DG09230,BMG_DG146369,3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate | PubChem CID:446090 | DrugBank ID:DB04366
+BMGC_DG09231,BMG_DG146370,PubChem CID:44609327 | AZD-1897 | UNII:FAJ9F9K7LH | CAS RN:1204181-93-0 | PubChem SID:363908298
+BMGC_DG09232,BMG_DG146374,PubChem CID:4461 | NETROPSIN | PubChem SID:198978529 | N-[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]-4-[[2-(diaminomethylideneamino)acetyl]amino]-1-methylpyrrole-2-carboxamide | Netropsin | CAS RN:1438-30-8 | UNII:64B3O0RD7N
+BMGC_DG09233,BMG_DG146375,2-deoxy-2-acetamido-beta-D-galactose-4-sulfate | PubChem CID:446101 | DrugBank ID:DB01872
+BMGC_DG09234,BMG_DG146385,2-Deoxy-2-Amino Glucitol-6-Phosphate | DrugBank ID:DB02445 | PubChem CID:446113
+BMGC_DG09235,BMG_DG146387,PubChem SID:363909316 | PubChem CID:44611919 | FLAG-003 FREE BASE | CAS RN:1204408-18-3 | UNII:LB2951OCS5
+BMGC_DG09236,BMG_DG146390,DrugBank ID:DB03731 | S-2-(Boronoethyl)-L-Cysteine | PubChem CID:446122
+BMGC_DG09237,BMG_DG146392,nor-NOHA | (2S)-2-amino-4-[[amino-(hydroxyamino)methylidene]amino]butanoic acid | CAS RN:189302-40-7 | PubChem SID:313184224 | UNII:U0F1149OFR | PubChem CID:446124 | CAS RN:291758-32-2 | NOR-NOHA | DrugBank ID:DB02381
+BMGC_DG09238,BMG_DG146393,"DrugBank ID:DB02803 | (2S)-3-PHENYLPROPANE-1,2-DIOL | PubChem SID:438788378 | UNII:6PQ7U3G5W6 | 3-Phenyl-1,2-Propandiol | PubChem CID:446127 | CAS RN:61475-32-9"
+BMGC_DG09239,BMG_DG146396,PubChem CID:446134 | DrugBank ID:DB03753 | Flurbiprofen Methyl Ester
+BMGC_DG09240,BMG_DG146401,PubChem CID:446143 | DrugBank ID:DB04318 | Nα-[(2S)-2-{[(S)-[(1S)-1-{[(Benzyloxy)carbonyl]amino}-2-phenylethyl](hydroxy)phosphoryl]methyl}-5-phenylpentanoyl]-L-tryptophanamide
+BMGC_DG09241,BMG_DG146405,"UNII:2PW4S9RUR4 | FLUVASTATIN, (3R,5S)- | CAS RN:155229-75-7 | PubChem CID:446155 | (3R,5S)-Fluvastatin | CAS RN:93957-54-1 | (E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid"
+BMGC_DG09242,BMG_DG146406,"CAS RN:145599-86-6 | UNII:AM91H2KS67 | DrugBank ID:DB00439 | Cerivastatin | PubChem CID:446156 | CERIVASTATIN | CAS RN:159813-78-2 | CAS RN:143201-11-0 | (E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]-3,5-dihydroxyhept-6-enoic acid | PubChem SID:198953954"
+BMGC_DG09243,BMG_DG146407,"NDC:50090-7240 | NDC:17856-0186 | NDC:50090-7431 | Rosuvastatin | CAS RN:1354641-88-5 | NDC:71610-798 | NDC:51407-850 | NDC:50228-118 | NDC:71335-2440 | NDC:50090-7482 | NDC:50228-117 | DrugBank ID:DB01098 | CAS RN:287714-41-4 | ROSUVASTATIN | PubChem SID:175267626 | UNII:413KH5ZJ73 | NDC:51407-849 | NDC:50090-7430 | NDC:71335-2498 | NDC:68788-8698 | NDC:71335-2539 | NDC:70518-4098 | NDC:71610-796 | PubChem CID:446157 | NDC:50090-7483 | NDC:71335-2406 | NDC:50090-7241 | NDC:17856-0183 | NDC:50228-116 | NDC:51407-851 | NDC:51407-848 | NDC:50228-119 | NDC:71610-797 | (E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid"
+BMGC_DG09244,BMG_DG146410,"DrugBank ID:DB04416 | R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid | PubChem CID:446165"
+BMGC_DG09245,BMG_DG146411,PubChem CID:446167 | 4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid | DrugBank ID:DB01832
+BMGC_DG09246,BMG_DG146415,"DrugBank ID:DB03331 | PubChem CID:446186 | N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine"
+BMGC_DG09247,BMG_DG146418,"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol | DrugBank ID:DB03928 | PubChem CID:446195"
+BMGC_DG09248,BMG_DG146419,"DrugBank ID:DB08689 | PubChem CID:4462 | 2,3-dimethoxy-5-methyl-6-(3-methylbut-2-enyl)cyclohexa-2,5-diene-1,4-dione | CAS RN:727-81-1 | UNII:JR17826E4G | Ubiquinone Q1 | COENZYME Q1 | PubChem SID:241178557"
+BMGC_DG09249,BMG_DG146420,PubChem CID:446201 | DrugBank ID:DB02323 | EM-1745
+BMGC_DG09250,BMG_DG146421,PubChem CID:446202 | Tryptophanyl-5'amp | DrugBank ID:DB01831
+BMGC_DG09251,BMG_DG146422,PubChem SID:445498706 | PubChem CID:44620894 | UNII:SK574R8X7V | CYM-50260 | CAS RN:1355026-60-6
+BMGC_DG09252,BMG_DG146426,"PubChem CID:446220 | CAS RN:50-36-2 | Cocaine | COCAINE | PubChem SID:175266196 | UNII:I5Y540LHVR | DrugBank ID:DB00907 | methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate"
+BMGC_DG09253,BMG_DG146427,PubChem CID:446221 | DrugBank ID:DB04095 | 9-Deazahypoxanthine
+BMGC_DG09254,BMG_DG146433,4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DrugBank ID:DB02429 | PubChem CID:446237
+BMGC_DG09255,BMG_DG146434,"PubChem CID:446238 | DrugBank ID:DB04180 | 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide"
+BMGC_DG09256,BMG_DG146435,"PubChem CID:446239 | 4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide | DrugBank ID:DB03039"
+BMGC_DG09257,BMG_DG146437,DrugBank ID:DB12206 | UNII:80LIU5P95D | CAS RN:1208315-24-5 | PubChem CID:44623946 | 3-[1-(4-carbamoyl-2-methylphenyl)-5-(4-imidazol-1-ylphenyl)pyrrol-2-yl]propanoic acid | N-6022 | 3-(5-(4-(1H-Imidazol-1-yl)phenyl)-1-(4-carbamoyl-2-methylphenyl)-1H-pyrrol-2-yl)propanoic acid | PubChem SID:198988335
+BMGC_DG09258,BMG_DG146438,"ETRASIMOD | 2-[(3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid | Etrasimod | PubChem CID:44623998 | DrugBank ID:DB14766 | PubChem SID:255509174 | CAS RN:1206123-37-6 | UNII:6WH8495MMH"
+BMGC_DG09259,BMG_DG146439,"DrugBank ID:DB04549 | 4-sulfamoyl-N-[(2,3,4-trifluorophenyl)methyl]benzamide | PubChem CID:446240 | 4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide | 4-(Aminosulfonyl)-N-[(2,3,4-trifluorophenyl)methyl]-benzamide"
+BMGC_DG09260,BMG_DG146440,"DrugBank ID:DB02221 | PubChem CID:446241 | 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide"
+BMGC_DG09261,BMG_DG146441,"DrugBank ID:DB02861 | 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide | PubChem CID:446242"
+BMGC_DG09262,BMG_DG146443,"5-Phenylsulfanyl-2,4-Quinazolinediamine | DrugBank ID:DB04163 | PubChem CID:446244"
+BMGC_DG09263,BMG_DG146444,"DrugBank ID:DB04306 | PubChem CID:446245 | 5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine"
+BMGC_DG09264,BMG_DG146447,"CAS RN:1207989-09-0 | LGD-6972 | DrugBank ID:DB14779 | 2-[[4-[(2R)-2-[4-(4-tert-butylphenyl)phenyl]-3-oxo-3-[4-(2,4,6-trimethylphenyl)anilino]propyl]benzoyl]amino]ethanesulfonic acid | UNII:6IJ842I0Z2 | PubChem SID:346538848 | Lgd-6972 | PubChem CID:44625560"
+BMGC_DG09265,BMG_DG146451,"CAS RN:1204317-86-1 | UNII:AF3Z6434KS | PubChem CID:44626120 | CAS RN:1373467-99-2 | PubChem SID:316918710 | DrugBank ID:DB15010 | EDASALONEXENT | N-[2-[[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]amino]ethyl]-2-hydroxybenzamide | Edasalonexent"
+BMGC_DG09266,BMG_DG146453,"UNII:8F8H9MH5WP | PubChem SID:252823783 | CAS RN:1199943-43-5 | (1-BUTYL-1H-INDOL-3-YL)(2,2,3,3-TETRAMETHYLCYCLOPROPYL)METHANONE | PubChem CID:44626514"
+BMGC_DG09267,BMG_DG146454,"PubChem CID:44626619 | UR-144 | CAS RN:1199943-44-6 | UNII:1TYA7HVP1B | PubChem SID:252319788 | (1-pentylindol-3-yl)-(2,2,3,3-tetramethylcyclopropyl)methanone | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone"
+BMGC_DG09268,BMG_DG146455,"3,3-DIETHYL-1-PYRIDIN-3-YL-AZETIDINE-2,4-DIONE | PubChem CID:44626811 | PubChem SID:443625193 | UNII:J8Y9W47OLE | CAS RN:104510-01-2"
+BMGC_DG09269,BMG_DG146457,UNII:65KJ8P7M9D | CAS RN:1206880-66-1 | PubChem CID:44627267 | PubChem SID:198960474 | AM-679
+BMGC_DG09270,BMG_DG146458,PubChem SID:440089468 | (2(FORMYL-HYDROXY-AMINO)-ETHYL)-PHOSPHONIC ACID | PubChem CID:446273 | UNII:8Y97C7OS7S | [2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid | DrugBank ID:DB03135 | CAS RN:104752-57-0
+BMGC_DG09271,BMG_DG146459,"PubChem SID:472421747 | 2,6-DIFLUOROBENZENESULFONAMIDE | UNII:XUJ3WJ7RKA | DrugBank ID:DB03270 | PubChem CID:446274 | CAS RN:60230-37-7 | 2,6-Difluorobenzenesulfonamide"
+BMGC_DG09272,BMG_DG146460,"UNII:PTI28JEB8Q | 3,5-DIFLUOROBENZENESULFONAMIDE | 3,5-Difluorobenzenesulfonamide | PubChem CID:446275 | DrugBank ID:DB02087 | CAS RN:140480-89-3 | PubChem SID:440089652"
+BMGC_DG09273,BMG_DG146461,DrugBank ID:DB02479 | PubChem CID:446276 | (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide
+BMGC_DG09274,BMG_DG146462,DrugBank ID:DB03950 | PubChem CID:446277 | (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide
+BMGC_DG09275,BMG_DG146464,"CAS RN:25377-48-4 | UNII:AAN7QOV9EA | ICOSAPENT | DrugBank ID:DB00159 | (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid | Icosapent | PubChem CID:446284 | CAS RN:10417-94-4 | PubChem SID:175266006"
+BMGC_DG09276,BMG_DG146465,"CAS RN:13126-37-9 | PubChem SID:198944430 | 12-OCTADECENOIC ACID, (12Z)- | PubChem CID:446285 | UNII:G18P32P8GW"
+BMGC_DG09277,BMG_DG146466,"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One | PubChem CID:446286 | DrugBank ID:DB03944"
+BMGC_DG09278,BMG_DG146472,"PubChem CID:44629554 | N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine | DrugBank ID:DB08538"
+BMGC_DG09279,BMG_DG146473,"PubChem CID:44629555 | 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine | DrugBank ID:DB07065"
+BMGC_DG09280,BMG_DG146484,"NDC:0378-4890 | PubChem CID:4463 | NEVIRAPINE | NDC:0597-0047 | Nevirapine | NDC:33342-238 | NDC:64380-709 | NDC:65162-209 | NDC:31722-505 | NDC:65862-027 | PubChem SID:175266919 | NDC:0378-4050 | CAS RN:129618-40-2 | 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one | NDC:42571-131 | NDC:33342-004 | DrugBank ID:DB00238 | UNII:99DK7FVK1H"
+BMGC_DG09281,BMG_DG146485,DrugBank ID:DB04003 | PubChem CID:446300 | {4-[(2S)-2-Acetamido-3-({(1S)-1-[3-carbamoyl-4-(cyclohexylmethoxy)phenyl]ethyl}amino)-3-oxopropyl]-2-phosphonophenoxy}acetic acid
+BMGC_DG09282,BMG_DG146509,"DrugBank ID:DB02080 | 1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene | PubChem CID:446308"
+BMGC_DG09283,BMG_DG146512,PubChem CID:446313 | UNII:6Q7MN2PVB9 | PubChem SID:438788581 | SR-12813 | DrugBank ID:DB04466 | SR12813 | CAS RN:126411-39-0
+BMGC_DG09284,BMG_DG146514,"DrugBank ID:DB03423 | CAS RN:239127-61-8 | Se-Adenosylselenohomocysteine | PubChem CID:446317 | (2S)-2-amino-4-[[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methylselanyl]butanoic acid | S-Adenosyl-L-Homoselenocysteine"
+BMGC_DG09285,BMG_DG146516,PubChem CID:44631842 | UNII:XU2CA8MHF5 | NB-216 | PubChem SID:445499891 | CAS RN:943924-04-7
+BMGC_DG09286,BMG_DG146518,"UNII:N4H5CH3E5S | PF-3644022 | PubChem CID:44631903 | DrugBank ID:DB07430 | (10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one | CAS RN:1276121-88-0"
+BMGC_DG09287,BMG_DG146519,"PubChem CID:44631912 | Ribociclib | PubChem SID:198983029 | 7-cyclopentyl-N,N-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide | RIBOCICLIB | CAS RN:1211441-98-3 | DrugBank ID:DB11730 | UNII:TK8ERE8P56"
+BMGC_DG09288,BMG_DG146522,"Oclacitinib | UNII:99GS5XTB51 | CAS RN:1208319-26-9 | OCLACITINIB | PubChem SID:198983930 | N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide | PubChem CID:44631938"
+BMGC_DG09289,BMG_DG146523,"DrugBank ID:DB01890 | N,N-BIS(3-(D-GLUCONAMIDO)PROPYL)DEOXYCHOLAMIDE | UNII:8A64ND3B39 | PubChem SID:241181281 | N,N-Bis(3-(D-gluconamido)propyl)deoxycholamide | CAS RN:86303-23-3 | PubChem CID:446320"
+BMGC_DG09290,BMG_DG146531,DrugBank ID:DB01649 | PubChem CID:446336 | 7-methyl-GpppA
+BMGC_DG09291,BMG_DG146533,"CAS RN:1207253-08-4 | UNII:O812716S9E | PubChem CID:44633765 | 5-(5-chloropyridin-3-yl)-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-pyridin-2-ylpyridine-3-carboxamide | Mk-1064 | PubChem SID:317229947 | MK-1064 | DrugBank ID:DB15028"
+BMGC_DG09292,BMG_DG146536,DrugBank ID:DB08745 | 4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE | PubChem CID:446345
+BMGC_DG09293,BMG_DG146537,DrugBank ID:DB08746 | PubChem CID:446346 | 1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE
+BMGC_DG09294,BMG_DG146541,"PubChem CID:446355 | PubChem SID:381132131 | UNII:61F6J48NHR | 4-[(1S)-1-amino-1-carboxyethyl]benzoic acid | (S)-Mcpg | DrugBank ID:DB04256 | CAS RN:150145-89-4 | .ALPHA.-METHYL-4-CARBOXYPHENYLGLYCINE, (S)- | (S)-alpha-methyl-4-carboxyphenylglycine"
+BMGC_DG09295,BMG_DG146546,"Thapsigargin | PubChem SID:198981502 | [(3S,3aR,4S,6S,6aR,7S,8S,9bS)-6-acetyloxy-4-butanoyloxy-3,3a-dihydroxy-3,6,9-trimethyl-8-[(Z)-2-methylbut-2-enoyl]oxy-2-oxo-4,5,6a,7,8,9b-hexahydroazuleno[4,5-b]furan-7-yl] octanoate | PubChem CID:446378 | CAS RN:67526-95-8 | UNII:Z96BQ26RZD | CAS RN:123269-03-4 | THAPSIGARGIN"
+BMGC_DG09296,BMG_DG146549,Phenylalanine-N-Sulfonamide | PubChem CID:446382 | DrugBank ID:DB03012
+BMGC_DG09297,BMG_DG146550,DrugBank ID:DB02477 | N-({4-[4-(2-Methyl-1H-imidazol-1-yl)butyl]phenyl}acetyl)-L-seryl-N-(2-cyclohexylethyl)-L-lysinamide | PubChem CID:446385
+BMGC_DG09298,BMG_DG146551,DrugBank ID:DB03062 | (1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone | PubChem CID:446386
+BMGC_DG09299,BMG_DG146554,"DrugBank ID:DB01836 | [4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone | PubChem CID:446399"
+BMGC_DG09300,BMG_DG146555,(S)-5-(4-Benzyloxy-phenyl)-4-(7-phenyl-heptanoylamino)-pentanoic acid | PubChem CID:446400 | CAS RN:393569-31-8 | (4S)-4-(7-phenylheptanoylamino)-5-(4-phenylmethoxyphenyl)pentanoic acid | KH064 | DrugBank ID:DB04287
+BMGC_DG09301,BMG_DG146557,"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine | PubChem CID:446411 | DrugBank ID:DB04012"
+BMGC_DG09302,BMG_DG146558,FKB-001 | PubChem CID:446414 | DrugBank ID:DB02888
+BMGC_DG09303,BMG_DG146561,"PubChem CID:446429 | DrugBank ID:DB03861 | (2R,3R,4S,5R)-2-acetamido-3,4-dihydroxy-5-hydroxymethyl-piperidine"
+BMGC_DG09304,BMG_DG146568,"PubChem CID:446468 | N,O-didansyl-L-tyrosine | DrugBank ID:DB03157"
+BMGC_DG09305,BMG_DG146570,(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE | DrugBank ID:DB07883 | PubChem CID:446476
+BMGC_DG09306,BMG_DG146576,DrugBank ID:DB07957 | METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE | PubChem CID:446501
+BMGC_DG09307,BMG_DG146577,PubChem SID:363908743 | CAS RN:161314-70-1 | PubChem CID:446504 | CGS-27023 | UNII:80AXY59IT2 | DrugBank ID:DB07556
+BMGC_DG09308,BMG_DG146578,"PubChem CID:446505 | 5-[4-(2-Hydroxyethyl)-1-piperidinyl]-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione | DrugBank ID:DB03622"
+BMGC_DG09309,BMG_DG146579,PubChem CID:446506 | 1-Deoxy-1-Thio-Heptaethylene Glycol | DrugBank ID:DB02404
+BMGC_DG09310,BMG_DG146581,"Okadaic Acid | CAS RN:78111-17-8 | PubChem CID:446512 | UNII:1W21G5Q4N2 | 9,10-Deepithio-9,10-Didehydroacanthifolicin | DrugBank ID:DB02169 | OKADAIC ACID | PubChem SID:198972531 | (2R)-3-[(2S,6R,8S,11R)-2-[(E,2R)-4-[(2S,2'R,4R,4aS,6R,8aR)-4-hydroxy-2-[(1S,3S)-1-hydroxy-3-[(2S,3R,6S)-3-methyl-1,7-dioxaspiro[5.5]undecan-2-yl]butyl]-3-methylidenespiro[4a,7,8,8a-tetrahydro-4H-pyrano[3,2-b]pyran-6,5'-oxolane]-2'-yl]but-3-en-2-yl]-11-hydroxy-4-methyl-1,7-dioxaspiro[5.5]undec-4-en-8-yl]-2-hydroxy-2-methylpropanoic acid"
+BMGC_DG09311,BMG_DG146586,Mycophenolic acid | (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoic acid | UNII:HU9DX48N0T | DrugBank ID:DB01024 | CAS RN:1162256-90-7 | PubChem SID:175267522 | Mycophenolic Acid | CAS RN:483-60-3 | NDC:72819-155 | PubChem CID:446541 | NDC:72819-156 | CAS RN:24280-93-1 | MYCOPHENOLIC ACID
+BMGC_DG09312,BMG_DG146588,PubChem CID:446556 | Pemetrexed | DrugBank ID:DB00642
+BMGC_DG09313,BMG_DG146591,Hydantocidin-5'-phosphate | DrugBank ID:DB02493 | PubChem CID:446561
+BMGC_DG09314,BMG_DG146593,CAS RN:1947-37-1 | UNII:0OL293AV80 | PubChem SID:198949139 | PubChem CID:446569 | TETRAGASTRIN
+BMGC_DG09315,BMG_DG146594,"Autoinducer-2 | PubChem CID:446576 | (1R,5S,8S)-3,3-dihydroxy-5-methyl-2,4,6-trioxa-3-boranuidabicyclo[3.3.0]octane-1,8-diol | CAS RN:406683-36-1"
+BMGC_DG09316,BMG_DG146595,DrugBank ID:DB03879 | alpha-L-methyl-fucose | PubChem CID:446578 | PubChem SID:375579083 | UNII:EZI2C7VVU0 | CAS RN:14687-15-1 | METHYL .ALPHA.-L-FUCOPYRANOSIDE
+BMGC_DG09317,BMG_DG146601,"UNII:D0GX863OA5 | NDC:81033-020 | NDC:63187-151 | PubChem CID:446596 | NDC:80425-0246 | DrugBank ID:DB00410 | NDC:68788-8534 | NDC:0904-7284 | NDC:45802-112 | CAS RN:12650-69-0 | 9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoic acid | NDC:63629-8687 | NDC:68071-4789 | NDC:50090-1587 | NDC:60760-960 | NDC:67296-0767 | NDC:68071-4321 | NDC:63187-525 | NDC:50268-568 | Mupirocin | PubChem SID:175265428 | NDC:67296-0646 | NDC:63187-015 | NDC:0093-1010 | NDC:68788-7993 | NDC:68788-8642 | NDC:63187-261 | CAS RN:115074-43-6 | NDC:68462-180 | NDC:80425-0254 | NDC:17856-0112 | NDC:76420-128 | NDC:70518-1808 | CAS RN:80558-54-9 | NDC:72162-2270 | NDC:49999-644 | MUPIROCIN | NDC:51672-1312 | NDC:68071-4111 | NDC:67296-0428"
+BMGC_DG09318,BMG_DG146603,"NDC:0781-3289 | Clindamycin | NDC:0781-3288 | NDC:0143-9267 | PubChem SID:175266244 | NDC:0143-9269 | PubChem CID:446598 | DrugBank ID:DB01190 | (2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide | NDC:71872-7168 | UNII:3U02EL437C | NDC:72572-074 | CAS RN:58207-19-5 | CAS RN:18323-44-9 | NDC:0781-3290 | NDC:71428-003 | NDC:0143-9268 | NDC:72572-076 | CLINDAMYCIN"
+BMGC_DG09319,BMG_DG146604,DrugBank ID:DB04295 | PubChem CID:446600 | N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine
+BMGC_DG09320,BMG_DG146605,N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid | PubChem CID:446604 | DrugBank ID:DB04238
+BMGC_DG09321,BMG_DG146606,N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester | DrugBank ID:DB01745 | PubChem CID:446605
+BMGC_DG09322,BMG_DG146607,"2,4-DIHYDROXYCINNAMIC ACID | 2,4-Dihydroxy-Trans Cinnamic Acid | PubChem CID:446611 | DrugBank ID:DB01704 | CAS RN:99699-42-0 | PubChem SID:472407961 | UNII:U8G3LS2JEX"
+BMGC_DG09323,BMG_DG146617,GW-409544 | UNII:L0LT4RER76 | PubChem CID:446642 | CAS RN:258345-41-4 | PubChem SID:198957603
+BMGC_DG09324,BMG_DG146622,{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid | PubChem CID:446662 | DrugBank ID:DB03154
+BMGC_DG09325,BMG_DG146623,PubChem CID:446665 | DrugBank ID:DB04204 | [(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid
+BMGC_DG09326,BMG_DG146627,PubChem CID:446676 | DrugBank ID:DB08476 | 3-AMINO-AZACYCLOTRIDECAN-2-ONE
+BMGC_DG09327,BMG_DG146628,DrugBank ID:DB08953 | CAS RN:63758-79-2 | Indalpine | UNII:V35562QSVT | PubChem CID:44668 | INDALPINE | 3-(2-piperidin-4-ylethyl)-1H-indole | PubChem SID:198957429
+BMGC_DG09328,BMG_DG146639,PubChem CID:446725 | 5-Bromothienyldeoxyuridine | DrugBank ID:DB03804
+BMGC_DG09329,BMG_DG146640,"UNII:2M3055079H | PubChem CID:446727 | 5-[(E)-2-bromoethenyl]-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione | PubChem SID:198936870 | CAS RN:69304-47-8 | BRIVUDINE | Brivudine | DrugBank ID:DB03312"
+BMGC_DG09330,BMG_DG146641,"DrugBank ID:DB08406 | 6-(benzo[b][1]benzazepin-11-ylmethyl)pteridine-2,4-diamine | PubChem CID:446744 | [N-(2,4-Diaminopteridin-6-YL)-methyl]-dibenz[B,F]azepine | [N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE"
+BMGC_DG09331,BMG_DG146642,Sri-9439 | DrugBank ID:DB03351 | PubChem CID:446752
+BMGC_DG09332,BMG_DG146643,Sri-9662 | DrugBank ID:DB03060 | PubChem CID:446753
+BMGC_DG09333,BMG_DG146644,N-[4-(4-nitrophenylphospho)butanoyl]-D-alanine | PubChem CID:446756 | DrugBank ID:DB08377
+BMGC_DG09334,BMG_DG146645,METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER | PubChem CID:446757 | DrugBank ID:DB08413
+BMGC_DG09335,BMG_DG146646,(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid | PubChem CID:446758 | DrugBank ID:DB04270
+BMGC_DG09336,BMG_DG146648,PubChem CID:446761 | DrugBank ID:DB02093 | 5-phospho-D-arabinohydroxamic acid
+BMGC_DG09337,BMG_DG146649,6-phenyl-4(R)-(7-phenyl-heptanoylamino)-hexanoic acid | DrugBank ID:DB03471 | PubChem CID:446783
+BMGC_DG09338,BMG_DG146650,PubChem CID:446795 | N6-Benzyl Adenosine-5'-Diphosphate | DrugBank ID:DB01893
+BMGC_DG09339,BMG_DG146654,PubChem CID:446801 | N-acetyl-N'-beta-D-glucopyranosyl urea | DrugBank ID:DB03218
+BMGC_DG09340,BMG_DG146655,CAS RN:429658-95-7 | UNII:KJ4EH9410G | Dabigatran ethyl ester | PubChem CID:446804 | PubChem SID:249492152 | DABIGATRAN ETHYL ESTER
+BMGC_DG09341,BMG_DG146656,4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE | PubChem CID:446805 | DrugBank ID:DB07508
+BMGC_DG09342,BMG_DG146658,CAS RN:30591-62-9 | PubChem CID:446807 | UNII:5G2WS8D321 | 4-(HYDROGEN SULFATE)-.BETA.-D-GALACTOPYRANOSE | PubChem SID:198946575 | 4-(Hydrogen sulfate)-beta-D-galactopyranose | DrugBank ID:DB02837
+BMGC_DG09343,BMG_DG146659,DrugBank ID:DB03341 | PubChem CID:446811 | CoA-S-acetyl 5-bromotryptamine
+BMGC_DG09344,BMG_DG146660,PubChem CID:446814 | DrugBank ID:DB01777 | CoA-S-trimethylene-acetyl-tryptamine
+BMGC_DG09345,BMG_DG146661,DrugBank ID:DB02277 | 1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea | PubChem CID:446816
+BMGC_DG09346,BMG_DG146663,3'-Oxo-Adenosine | PubChem CID:446824 | DrugBank ID:DB03273
+BMGC_DG09347,BMG_DG146665,PubChem CID:446833 | Bis-Napthyl Beta-Ketophosphonic Acid | DrugBank ID:DB02360
+BMGC_DG09348,BMG_DG146669,DrugBank ID:DB07778 | (S)-famoxadone | PubChem CID:446845
+BMGC_DG09349,BMG_DG146670,"CAS RN:221368-54-3 | UNII:89HTC2NWF3 | 2,8-CHRYSENEDIOL, 5,11-DIETHYL-5,6,11,12-TETRAHYDRO-, (5R,11R)-REL- | PubChem SID:441096986 | CAS RN:138090-06-9 | UNII:JDD6B8E8CW | PubChem SID:441097451 | 2,8-CHRYSENEDIOL, 5,11-DIETHYL-5,6,11,12-TETRAHYDRO-, (5R,11R)- | PubChem CID:446849"
+BMGC_DG09350,BMG_DG146677,"DrugBank ID:DB02827 | 7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid | PubChem CID:446871"
+BMGC_DG09351,BMG_DG146679,PubChem CID:446873 | UNII:ZL1D9LZ2KD | 3-Phosphono-D-alanine | PubChem SID:438788622 | (2S)-2-AMINO-3-PHOSPHONOPROPANOIC ACID | DrugBank ID:DB03292 | CAS RN:128241-72-5
+BMGC_DG09352,BMG_DG146681,PubChem CID:446876 | DrugBank ID:DB03633 | Lpc-Ether
+BMGC_DG09353,BMG_DG146690,Mdl-29951 | PubChem CID:446916 | DrugBank ID:DB04175
+BMGC_DG09354,BMG_DG146693,"PubChem CID:446925 | PubChem SID:175265513 | LYCOPENE | Lycopene | DrugBank ID:DB11231 | (6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-2,6,10,14,19,23,27,31-octamethyldotriaconta-2,6,8,10,12,14,16,18,20,22,24,26,30-tridecaene | CAS RN:502-65-8 | UNII:SB0N2N0WV6"
+BMGC_DG09355,BMG_DG146694,"PubChem SID:310825586 | DrugBank ID:DB03926 | UNII:0IF82ZEY2K | 5alpha-Androstane-3beta,17alpha-diol | PubChem CID:446934 | (3S,5S,8R,9S,10S,13S,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol | 5.ALPHA.-ANDROSTAN-3.BETA.,17.ALPHA.-DIOL | CAS RN:5856-11-1 | 5alpha-androstane-3beta,17alpha-diol"
+BMGC_DG09356,BMG_DG146696,2H-Benzimidazol-2-amine | PubChem CID:4469371 | DrugBank ID:DB01665
+BMGC_DG09357,BMG_DG146697,DrugBank ID:DB01756 | 4-phospho-L-threonic acid | PubChem CID:446947
+BMGC_DG09358,BMG_DG146701,"PubChem CID:446965 | 3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID | DrugBank ID:DB07441"
+BMGC_DG09359,BMG_DG146702,PubChem CID:446966 | 9-(2-carboxyethyl)-10-methylanthracene endoperoxide | DrugBank ID:DB08332
+BMGC_DG09360,BMG_DG146703,3-(10-methyl-9-anthryl)propanoic acid | PubChem CID:446967 | DrugBank ID:DB07371
+BMGC_DG09361,BMG_DG146707,DrugBank ID:DB08222 | PubChem CID:446977 | METHOXYUNDECYLPHOSPHINIC ACID
+BMGC_DG09362,BMG_DG146708,PubChem CID:446978 | [4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium | DrugBank ID:DB02269
+BMGC_DG09363,BMG_DG146709,PubChem CID:446980 | DrugBank ID:DB08200 | (1R)-menthyl hexyl phosphonate group
+BMGC_DG09364,BMG_DG146710,"PubChem CID:4469805 | DrugBank ID:DB03626 | 5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione"
+BMGC_DG09365,BMG_DG146711,"3-Aza-2,3-Dihydrogeranyl Diphosphate | DrugBank ID:DB02369 | PubChem CID:4469807"
+BMGC_DG09366,BMG_DG146712,(1S)-menthyl hexyl phosphonate group | DrugBank ID:DB08201 | PubChem CID:446981
+BMGC_DG09367,BMG_DG146713,DrugBank ID:DB03483 | PubChem CID:446986 | (4S)-5-[[(2S)-1-[[(2S)-1-Amino-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-3-[4-[difluoro(phosphono)methyl]phenyl]-1-oxopropan-2-yl]amino]-4-benzamido-5-oxopentanoic acid
+BMGC_DG09368,BMG_DG146714,"CAS RN:25030-76-6 | FOSFOMYCIN | PubChem CID:446987 | DrugBank ID:DB00828 | PubChem SID:175266349 | Fosfomycin | CAS RN:23155-02-4 | UNII:2N81MY12TE | [(2R,3S)-3-methyloxiran-2-yl]phosphonic acid"
+BMGC_DG09369,BMG_DG146715,DrugBank ID:DB02337 | S-(D-Carboxybutyl)-L-Homocysteine | PubChem CID:446994
+BMGC_DG09370,BMG_DG146717,"PubChem CID:446998 | DrugBank ID:DB03125 | 2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium"
+BMGC_DG09371,BMG_DG146719,"CAS RN:768386-03-4 | 1-(2,4-diamino-5,6,7,8-tetrahydropteridin-6-yl)propane-1,2-diol | H4-Aminobiopterin | PubChem CID:4469991 | CAS RN:206885-38-3"
+BMGC_DG09372,BMG_DG146720,PubChem CID:4469994 | DrugBank ID:DB01695 | N-Hydroxy-4-phosphonobutanamide
+BMGC_DG09373,BMG_DG146727,"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline | DrugBank ID:DB02427 | PubChem CID:447021"
+BMGC_DG09374,BMG_DG146728,"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine | DrugBank ID:DB03987 | PubChem CID:447022"
+BMGC_DG09375,BMG_DG146729,"PubChem CID:447027 | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol | DrugBank ID:DB04141"
+BMGC_DG09376,BMG_DG146730,PubChem CID:447029 | 1-hydroxy-2-isopropylguanidine | DrugBank ID:DB02143
+BMGC_DG09377,BMG_DG146731,PubChem CID:447030 | 2-butyl-1-hydroxyguanidine | DrugBank ID:DB02727
+BMGC_DG09378,BMG_DG146732,ZK-805623 | PubChem CID:4470378 | DrugBank ID:DB04432
+BMGC_DG09379,BMG_DG146733,"DrugBank ID:DB00207 | CAS RN:83905-01-5 | NDC:63187-604 | UNII:J2KLZ20U1M | (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one | NDC:63187-594 | Azithromycin | PubChem CID:447043 | AZITHROMYCIN ANHYDROUS | PubChem SID:175265448"
+BMGC_DG09380,BMG_DG146734,PubChem CID:447048 | DrugBank ID:DB02059 | Adenosine-5-Diphosphoribose
+BMGC_DG09381,BMG_DG146735,"[(2S,3R,4R,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2,4-dihydroxyoxolan-3-yl] acetate | 2'-O-Acetyl Adenosine-5-Diphosphoribose | DrugBank ID:DB03478 | PubChem CID:447049"
+BMGC_DG09382,BMG_DG146736,"DrugBank ID:DB03507 | 6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One | PubChem CID:4470566"
+BMGC_DG09383,BMG_DG146738,7-Deazaguanine | PubChem CID:4470573 | DrugBank ID:DB02245
+BMGC_DG09384,BMG_DG146740,DrugBank ID:DB03455 | (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid | PubChem CID:447066
+BMGC_DG09385,BMG_DG146741,PubChem CID:447076 | 1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine | DrugBank ID:DB03267
+BMGC_DG09386,BMG_DG146742,PD173955 | DrugBank ID:DB02567 | PubChem CID:447077
+BMGC_DG09387,BMG_DG146744,PubChem CID:4470790 | UNII:1XI90I177M | PubChem SID:198988481 | DrugBank ID:DB02400 | ES-936 | CAS RN:192820-78-3
+BMGC_DG09388,BMG_DG146748,".ALPHA.-D-MANNOPYRANOSE 6-PHOSPHATE | UNII:C77UQ006XD | CAS RN:40436-60-0 | [(2R,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxan-2-yl]methyl dihydrogen phosphate | PubChem SID:376072719 | PubChem CID:447096 | alpha-D-mannose 6-phosphate | DrugBank ID:DB02900"
+BMGC_DG09389,BMG_DG146749,"PubChem CID:447098 | DrugBank ID:DB02402 | 5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine"
+BMGC_DG09390,BMG_DG146750,"PubChem CID:447099 | 7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE | DrugBank ID:DB08203"
+BMGC_DG09391,BMG_DG146753,gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine | PubChem CID:447108 | DrugBank ID:DB03597
+BMGC_DG09392,BMG_DG146754,[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE | PubChem CID:447110 | DrugBank ID:DB08763
+BMGC_DG09393,BMG_DG146756,CAS RN:32260-87-0 | DrugBank ID:DB04153 | PubChem CID:447123 | UNII:E9B4W9G9WS | S-Hydroxymethyl Glutathione | S-(Hydroxymethyl)glutathione | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(hydroxymethylsulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | S-(HYDROXYMETHYL)GLUTATHIONE
+BMGC_DG09394,BMG_DG146758,"(2S)-2-[[9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]purin-6-yl]amino]butanedioic acid | DrugBank ID:DB04418 | CAS RN:19046-78-7 | UNII:X1B4ZJ0IIV | PubChem SID:363908159 | ADENYLOSUCCINIC ACID | Adenylosuccinic acid | PubChem CID:447145"
+BMGC_DG09395,BMG_DG146764,"UNII:I14VR7T96O | 2,3-Difluorobenzyl Alcohol | PubChem CID:447153 | 2,3-DIFLUOROBENZYL ALCOHOL | DrugBank ID:DB04312 | PubChem SID:440089266 | CAS RN:75853-18-8"
+BMGC_DG09396,BMG_DG146766,DrugBank ID:DB07881 | PubChem CID:447154 | N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE
+BMGC_DG09397,BMG_DG146773,N.OMEGA.-PROPYL-L-ARGININE | PubChem SID:474492404 | Nω-Propyl-L-arginine | UNII:G7F9U4R2AC | CAS RN:137361-05-8 | PubChem CID:447180
+BMGC_DG09398,BMG_DG146776,PubChem CID:4471892 | DrugBank ID:DB02108 | 2-Aminoethanimidic Acid
+BMGC_DG09399,BMG_DG146782,"UNII:3961V7J60A | PubChem CID:44719475 | 2,5-DIMETHOXY-4-PHENYLTHIOAMPHETAMINE | PubChem SID:316915137 | CAS RN:952006-44-9"
+BMGC_DG09400,BMG_DG146789,PubChem CID:447195 | (S)-DES-ME-AMPA | DrugBank ID:DB01664
+BMGC_DG09401,BMG_DG146812,PubChem CID:447196 | DrugBank ID:DB02818 | Iodo-Willardiine
+BMGC_DG09402,BMG_DG146817,"Formycin | PubChem CID:447199 | CAS RN:6742-12-7 | (2S,3R,4S,5R)-2-(7-amino-2H-pyrazolo[4,3-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol | DrugBank ID:DB02281"
+BMGC_DG09403,BMG_DG146818,UNII:T2Q0RYM725 | PubChem SID:198943979 | N-benzyl-3-[2-(pyridine-4-carbonyl)hydrazinyl]propanamide | NIALAMIDE | Nialamide | PubChem CID:4472 | CAS RN:51-12-7 | DrugBank ID:DB04820
+BMGC_DG09404,BMG_DG146820,PubChem CID:447202 | p1-(5'-adenosyl)p5-(5'-thymidyl)pentaphosphate | DrugBank ID:DB03280
+BMGC_DG09405,BMG_DG146827,"DrugBank ID:DB07548 | 2-(6-Chloro-3-{[2,2-difluoro-2-(2-pyridinyl)ethyl]amino}-2-oxo-1(2H)-pyrazinyl)-N-[(2-fluoro-6-pyridinyl)methyl]acetamide | PubChem CID:447219"
+BMGC_DG09406,BMG_DG146828,"PubChem CID:447221 | 2-[3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-6-methyl-2-oxopyrazin-1-yl]-N-[(3-fluoro-4-methylpyridin-2-yl)methyl]acetamide | 2-[3-(2,2-Difluoro-2-pyridin-2-yl-ethylamino)-6-methyl-2-oxo-2H-pyrazin-1-yl]-N-(3-fluoro-4-methyl-pyridin-2-ylmethyl)-acetamide"
+BMGC_DG09407,BMG_DG146829,DrugBank ID:DB03738 | PubChem CID:447227 | Pantothenoylaminoethenethiol
+BMGC_DG09408,BMG_DG146830,"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine | PubChem CID:447229 | DrugBank ID:DB02919"
+BMGC_DG09409,BMG_DG146831,"CAS RN:51017-33-5 | Hydroxy-phenyl-acetic acid 8-methyl-8-aza-bicyclo[3.2.1]oct-3-YL ester | [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2R)-2-hydroxy-2-phenylacetate | Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester | PubChem CID:447234 | DrugBank ID:DB02161"
+BMGC_DG09410,BMG_DG146835,2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid | DrugBank ID:DB02347 | PubChem CID:447249
+BMGC_DG09411,BMG_DG146837,2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One | PubChem CID:447256 | DrugBank ID:DB01884
+BMGC_DG09412,BMG_DG146843,Ulodesine | PubChem CID:447268 | DrugBank ID:DB12353
+BMGC_DG09413,BMG_DG146844,"PubChem CID:447271 | 2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione | DrugBank ID:DB03181"
+BMGC_DG09414,BMG_DG146849,"PubChem CID:447277 | DrugBank ID:DB07841 | UNII:N21T0D88LX | PubChem SID:318164488 | phosphono [(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl] hydrogen phosphate | GERANYLGERANYL PYROPHOSPHATE | CAS RN:6699-20-3 | Geranylgeranyl diphosphate"
+BMGC_DG09415,BMG_DG146850,PubChem CID:447278 | 2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE | DrugBank ID:DB08180
+BMGC_DG09416,BMG_DG146851,PubChem SID:348481590 | PubChem CID:447280 | CAS RN:160470-73-5 | APSTATIN | UNII:JZK8P9AG86 | Apstatin | DrugBank ID:DB04092
+BMGC_DG09417,BMG_DG146853,"PubChem SID:461432509 | UNII:AJJ39UGP8V | N,4-DIMETHYL-N-(1-PHENYL-1H-PYRAZOL-5-YL)BENZENESULFONAMIDE | DrugBank ID:DB07670 | PubChem CID:447297 | CAS RN:374632-71-0 | N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide"
+BMGC_DG09418,BMG_DG146855,"TARTARIC ACID, MESO- | UNII:JQO211TF1A | D-tartaric acid | PubChem SID:198959572 | DrugBank ID:DB01694 | CAS RN:147-73-9 | PubChem CID:447315"
+BMGC_DG09419,BMG_DG146859,"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One | PubChem CID:447329 | DrugBank ID:DB03372"
+BMGC_DG09420,BMG_DG146860,DrugBank ID:DB03577 | Alpha-Benzyl-Aminobenzyl-Phosphonic Acid | PubChem CID:447336
+BMGC_DG09421,BMG_DG146861,DrugBank ID:DB02616 | FR117016 | PubChem CID:447339
+BMGC_DG09422,BMG_DG146862,PubChem CID:447340 | FR221647 | DrugBank ID:DB02096
+BMGC_DG09423,BMG_DG146863,FR230513 | PubChem CID:447341 | DrugBank ID:DB03572
+BMGC_DG09424,BMG_DG146866,PubChem CID:447359 | DrugBank ID:DB08487 | 3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE
+BMGC_DG09425,BMG_DG146867,"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE | DrugBank ID:DB08488 | PubChem CID:447360"
+BMGC_DG09426,BMG_DG146868,DrugBank ID:DB08495 | PubChem CID:447362 | 4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE
+BMGC_DG09427,BMG_DG146869,DrugBank ID:DB08294 | PubChem CID:447364 | 2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID
+BMGC_DG09428,BMG_DG146872,1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine | DrugBank ID:DB02008 | PubChem CID:447371
+BMGC_DG09429,BMG_DG146873,DrugBank ID:DB02684 | PubChem CID:447377 | 5'-O-(L-Cysteinylsulfamoyl)adenosine
+BMGC_DG09430,BMG_DG146874,5'-O-(L-Prolylsulfamoyl)adenosine | DrugBank ID:DB02510 | PubChem CID:447378
+BMGC_DG09431,BMG_DG146876,2-{[4-(2-Acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-YL]-oxalyl-amino}-benzoic acid | PubChem CID:447392 | DrugBank ID:DB01820
+BMGC_DG09432,BMG_DG146877,"5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | Nicardipine | UNII:CZ5312222S | NICARDIPINE | CAS RN:55985-32-5 | CAS RN:106664-28-2 | PubChem SID:175271377 | DrugBank ID:DB00622 | PubChem CID:4474"
+BMGC_DG09433,BMG_DG146878,DrugBank ID:DB06862 | PubChem CID:447400 | 2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID
+BMGC_DG09434,BMG_DG146879,3'-Fluoro-3'-deoxythymidine 5'-monophosphate | DrugBank ID:DB03195 | 3'-FLUORO-3'-DEOXYTHYMIDINE 5'-MONOPHOSPHATE | PubChem CID:447405 | UNII:K6W0IAP44B | PubChem SID:198948775 | CAS RN:25520-83-6
+BMGC_DG09435,BMG_DG146881,PubChem SID:198968019 | CAS RN:76568-02-0 | UNII:6NB119DLU7 | DrugBank ID:DB13228 | CAS RN:154504-94-6 | PubChem CID:4474062 | FLOSEQUINAN | 7-fluoro-1-methyl-3-methylsulfinylquinolin-4-one | Flosequinan
+BMGC_DG09436,BMG_DG146882,"PubChem CID:447411 | DrugBank ID:DB03982 | Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid"
+BMGC_DG09437,BMG_DG146884,DrugBank ID:DB07684 | 5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID | PubChem CID:4474224
+BMGC_DG09438,BMG_DG146887,"DrugBank ID:DB08683 | PubChem CID:447446 | REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE"
+BMGC_DG09439,BMG_DG146888,DrugBank ID:DB02620 | PubChem CID:447450 | 3-(4-{2-[2-(2-bromo-acetylamino)-ethyldisulfanyl]-ethylcarbamoyl}-cyclohexylcarbamoyl)-pyrazine-2-carboxylic acid
+BMGC_DG09440,BMG_DG146889,"Cethromycin | PubChem SID:198952855 | DrugBank ID:DB06419 | PubChem CID:447451 | UNII:J0086219X6 | (1S,2R,5R,7R,8R,9R,11R,13R,14R)-8-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-1,5,7,9,11,13-hexamethyl-9-[(E)-3-quinolin-3-ylprop-2-enoxy]-3,17-dioxa-15-azabicyclo[12.3.0]heptadecane-4,6,12,16-tetrone | CETHROMYCIN | Restanza | CAS RN:205110-48-1"
+BMGC_DG09441,BMG_DG146891,(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID | PubChem CID:447458 | CAS RN:222834-30-2 | (2S)-2-ethoxy-3-[4-(2-phenoxazin-10-ylethoxy)phenyl]propanoic acid | (2S)-2-Ethoxy-3-{4-[2-(10H-phenoxazin-10-YL)ethoxy]phenyl}propanoic acid | DrugBank ID:DB07675
+BMGC_DG09442,BMG_DG146893,DrugBank ID:DB03399 | Ethyl Isocyanide | PubChem CID:4474585
+BMGC_DG09443,BMG_DG146895,"CROTONALDEHYDE, (2E)- | CAS RN:123-73-9 | PubChem CID:447466 | CAS RN:4170-30-3 | DrugBank ID:DB04381 | UNII:6PUW625907 | PubChem SID:198970507 | (E)-but-2-enal | Crotonaldehyde"
+BMGC_DG09444,BMG_DG146896,CRA_8696 | PubChem CID:447476 | DrugBank ID:DB03159
+BMGC_DG09445,BMG_DG146898,PubChem CID:447478 | DrugBank ID:DB03173 | CRA_10433
+BMGC_DG09446,BMG_DG146899,CRA_10991 | PubChem CID:447488 | DrugBank ID:DB01771
+BMGC_DG09447,BMG_DG146900,"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE | DrugBank ID:DB07229 | PubChem CID:447492"
+BMGC_DG09448,BMG_DG146903,DrugBank ID:DB04215 | PubChem CID:447508 | CRA_9076
+BMGC_DG09449,BMG_DG146905,DrugBank ID:DB04495 | PubChem CID:447518 | Paratoulene phosphate
+BMGC_DG09450,BMG_DG146906,RU90395 | PubChem CID:447522 | DrugBank ID:DB02432
+BMGC_DG09451,BMG_DG146907,PubChem CID:447523 | DrugBank ID:DB03591 | RU82209
+BMGC_DG09452,BMG_DG146908,RU85053 | PubChem CID:447524 | DrugBank ID:DB03712
+BMGC_DG09453,BMG_DG146909,DrugBank ID:DB02336 | PubChem CID:447527 | RU83876
+BMGC_DG09454,BMG_DG146910,PubChem CID:447531 | DPI59 | DrugBank ID:DB03217
+BMGC_DG09455,BMG_DG146911,RU79072 | PubChem CID:447532 | DrugBank ID:DB02762
+BMGC_DG09456,BMG_DG146912,PubChem SID:472422009 | UNII:MM7HGA3EJM | CAS RN:473707-40-3 | DrugBank ID:DB03628 | PubChem CID:447534 | ISO24
+BMGC_DG09457,BMG_DG146913,DrugBank ID:DB01866 | PubChem CID:447536 | RU79256
+BMGC_DG09458,BMG_DG146914,PubChem CID:447537 | DrugBank ID:DB02908 | RU78783
+BMGC_DG09459,BMG_DG146916,DrugBank ID:DB02830 | PubChem CID:447546 | FR236913
+BMGC_DG09460,BMG_DG146925,PubChem CID:447559 | DrugBank ID:DB03771 | Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine
+BMGC_DG09461,BMG_DG146926,DrugBank ID:DB02339 | Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin | PubChem CID:447560
+BMGC_DG09462,BMG_DG146928,Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester | PubChem CID:447562 | DrugBank ID:DB03748
+BMGC_DG09463,BMG_DG146930,3-Oxiran-2ylalanine | DrugBank ID:DB03191 | PubChem CID:447569
+BMGC_DG09464,BMG_DG146933,"DrugBank ID:DB01780 | [(2S)-2-[(1E,3R,4S,8R,9R,10R,11S,14S)-8-[(2S,3R,4S,5R,6R)-4-acetyloxy-3,5-dihydroxy-6-(2-methylbut-3-en-2-yloxymethyl)oxan-2-yl]oxy-4,9-dihydroxy-14-(methoxymethyl)-3,10-dimethyl-6-tricyclo[9.3.0.03,7]tetradeca-1,6-dienyl]propyl] acetate | CAS RN:20108-30-9 | PubChem CID:447573 | Fusicoccin"
+BMGC_DG09465,BMG_DG146936,2-Amino-Adenosine | DrugBank ID:DB04102 | PubChem CID:447594
+BMGC_DG09466,BMG_DG146937,"PubChem SID:198987441 | NICERITROL | [3-(pyridine-3-carbonyloxy)-2,2-bis(pyridine-3-carbonyloxymethyl)propyl] pyridine-3-carboxylate | Niceritrol | DrugBank ID:DB13441 | PubChem CID:4476 | UNII:F54EHJ34MV | CAS RN:5868-05-3"
+BMGC_DG09467,BMG_DG146939,"PubChem CID:447607 | DrugBank ID:DB04545 | (3R,4R,5R)-5-(hydroxymethyl)piperidine-3,4-diol | AFEGOSTAT | Afegostat | PubChem SID:198971374 | CAS RN:169105-89-9 | UNII:G23AP190YS"
+BMGC_DG09468,BMG_DG146940,DrugBank ID:DB02491 | PubChem CID:447622 | 4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine
+BMGC_DG09469,BMG_DG146941,DrugBank ID:DB02921 | (South)-Methanocarba-Thymidine | PubChem CID:447628
+BMGC_DG09470,BMG_DG146942,PubChem CID:447634 | .BETA.-D-RIBOSE-5-PHOSPHATE | DrugBank ID:DB04352 | CAS RN:34980-66-0 | UNII:BVJ0IQF3T8 | PubChem SID:241178263 | beta-D-Ribose-5-phosphate
+BMGC_DG09471,BMG_DG146943,DrugBank ID:DB03864 | Monothioglycerol | PubChem CID:447638
+BMGC_DG09472,BMG_DG146944,PubChem CID:447649 | DrugBank ID:DB08233 | 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE
+BMGC_DG09473,BMG_DG146945,"DrugBank ID:DB02538 | N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide | PubChem CID:447652"
+BMGC_DG09474,BMG_DG146946,"PubChem CID:447653 | (2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol | DrugBank ID:DB07889"
+BMGC_DG09475,BMG_DG146947,PubChem CID:447655 | 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE | DrugBank ID:DB08248
+BMGC_DG09476,BMG_DG146948,DrugBank ID:DB08241 | 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE | PubChem CID:447656
+BMGC_DG09477,BMG_DG146953,"(5-hydroxyindolo[1,2-a]quinazolin-7-yl)acetic acid | DrugBank ID:DB01765 | PubChem CID:447682"
+BMGC_DG09478,BMG_DG146956,PubChem CID:447695 | DrugBank ID:DB07295 | 2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID
+BMGC_DG09479,BMG_DG146959,DrugBank ID:DB06803 | NICLOSAMIDE | PubChem SID:198957198 | 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide | PubChem CID:4477 | Niclosamide | CAS RN:50-65-7 | UNII:8KK8CQ2K8G
+BMGC_DG09480,BMG_DG146960,PubChem CID:447700 | CAS RN:185039-91-2 | DrugBank ID:DB08339 | PD-166326 | PubChem SID:198957883 | UNII:0H77F2T4U3
+BMGC_DG09481,BMG_DG146961,"N-Alpha-Acetyl-3,5-Diiodotyrosylglycine | DrugBank ID:DB02598 | PubChem CID:447701"
+BMGC_DG09482,BMG_DG146962,"Obeticholic Acid | (4R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | CAS RN:459789-99-2 | PubChem CID:447715 | NDC:69516-010 | DrugBank ID:DB05990 | Obeticholic acid | UNII:0462Z4S4OZ | OBETICHOLIC ACID | PubChem SID:175265866 | NDC:69516-005"
+BMGC_DG09483,BMG_DG146963,"CAS RN:28083-34-3 | (4R)-4-[(5S,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | 7alpha-Hydroxy-5beta-cholan-24-oic Acid | PubChem CID:447718"
+BMGC_DG09484,BMG_DG146965,4-[5-[2-(1-phenyl-ethylamino)-pyrimidin-4-yl]-1-methyl-4-(3-trifluoromethylphenyl)-1H-imidazol-2-yl]-piperidine | PubChem CID:447721 | DrugBank ID:DB01761
+BMGC_DG09485,BMG_DG146968,"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One | DrugBank ID:DB01948 | PubChem CID:447725"
+BMGC_DG09486,BMG_DG146969,"DrugBank ID:DB02551 | PubChem CID:447731 | 6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine"
+BMGC_DG09487,BMG_DG146970,DrugBank ID:DB01977 | PubChem CID:447732 | 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine
+BMGC_DG09488,BMG_DG146971,DrugBank ID:DB02398 | PubChem CID:447733 | 6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine
+BMGC_DG09489,BMG_DG146972,PubChem CID:447734 | 6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE | DrugBank ID:DB07076
+BMGC_DG09490,BMG_DG146973,"PubChem CID:447735 | 6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine | DrugBank ID:DB02473"
+BMGC_DG09491,BMG_DG146974,"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine | PubChem CID:447736 | DrugBank ID:DB02705"
+BMGC_DG09492,BMG_DG146975,PubChem CID:447739 | DrugBank ID:DB07958 | (2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID
+BMGC_DG09493,BMG_DG146976,PubChem CID:447742 | PubChem SID:438787893 | UNII:TJZ8V4IIP7 | 4'-DEOXY-4'-ACETYLYAMINO-PYRIDOXAL-5'-PHOSPHATE | CAS RN:19988-33-1 | DrugBank ID:DB02783 | 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate
+BMGC_DG09494,BMG_DG146979,DrugBank ID:DB07163 | 5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE | PubChem CID:447766
+BMGC_DG09495,BMG_DG146983,C-(1-hydrogyl-beta-D-glucopyranosyl) formamide | PubChem CID:447771 | DrugBank ID:DB02719
+BMGC_DG09496,BMG_DG146990,Isocitric Acid | DrugBank ID:DB01727 | PubChem CID:447805
+BMGC_DG09497,BMG_DG146992,"DrugBank ID:DB02104 | 2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine | PubChem CID:447815"
+BMGC_DG09498,BMG_DG146995,2-(N-morpholino)ethanesulfonic acid | DrugBank ID:DB03814 | PubChem CID:4478249
+BMGC_DG09499,BMG_DG146999,DrugBank ID:DB03752 | PubChem CID:447834 | P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid
+BMGC_DG09500,BMG_DG147000,DrugBank ID:DB07983 | 1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID | PubChem CID:447835
+BMGC_DG09501,BMG_DG147007,"PubChem CID:447865 | DrugBank ID:DB01873 | UNII:T0358E0YUF | (4S,7R,8S,9S,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione | CAS RN:189453-10-9 | EPOTHILONE D | Epothilone D | PubChem SID:198969321"
+BMGC_DG09502,BMG_DG147008,DrugBank ID:DB02943 | PubChem CID:447867 | N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine
+BMGC_DG09503,BMG_DG147009,"DrugBank ID:DB03084 | Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | PubChem CID:447872"
+BMGC_DG09504,BMG_DG147010,"DrugBank ID:DB02388 | Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine | PubChem CID:447873"
+BMGC_DG09505,BMG_DG147012,PubChem CID:447877 | DrugBank ID:DB03192 | (R)-3-hydroxydecanoyl-CoA
+BMGC_DG09506,BMG_DG147017,PubChem SID:198939615 | DrugBank ID:DB03791 | PubChem CID:447905 | UNII:6JI5YOG7RC | GW-3965 | CAS RN:405911-09-3
+BMGC_DG09507,BMG_DG147018,gold(1+);2-sulfidobutanedioate | PubChem CID:4479093 | Disodium aurothiomalate
+BMGC_DG09508,BMG_DG147021,"PubChem CID:447911 | DrugBank ID:DB07082 | 1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL"
+BMGC_DG09509,BMG_DG147022,TO-901317 | CAS RN:293754-55-9 | DrugBank ID:DB07080 | T0901317 | PubChem CID:447912 | PubChem SID:313183689 | UNII:A07663A39I
+BMGC_DG09510,BMG_DG147031,PubChem CID:447945 | DrugBank ID:DB03957 | SP2456
+BMGC_DG09511,BMG_DG147033,PubChem CID:447950 | (R)-minalrestat | DrugBank ID:DB07450
+BMGC_DG09512,BMG_DG147034,"DrugBank ID:DB03019 | 4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine | PubChem CID:447955"
+BMGC_DG09513,BMG_DG147035,"UNII:NTZ47MG2A4 | PubChem CID:447956 | DrugBank ID:DB02091 | CAS RN:364334-94-1 | PubChem SID:472422487 | 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine | 4-(2,4-DIMETHYL-1,3-THIAZOL-5-YL)PYRIMIDIN-2-AMINE"
+BMGC_DG09514,BMG_DG147036,"PubChem CID:447958 | DrugBank ID:DB02915 | 4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine"
+BMGC_DG09515,BMG_DG147037,"PubChem CID:447959 | DrugBank ID:DB04518 | 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol"
+BMGC_DG09516,BMG_DG147038,PubChem CID:447960 | 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol | DrugBank ID:DB04407
+BMGC_DG09517,BMG_DG147039,CAS RN:507487-89-0 | DrugBank ID:DB02833 | 4-(2-AMINO-4-METHYL-5-THIAZOLYL)-N-(3-NITROPHENYL)-2-PYRIMIDINAMINE | PubChem CID:447961 | PubChem SID:459275672 | UNII:2L9NBR9W3T | [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine
+BMGC_DG09518,BMG_DG147040,"DrugBank ID:DB07562 | N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE | PubChem CID:447962"
+BMGC_DG09519,BMG_DG147041,DrugBank ID:DB03921 | 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline | PubChem CID:447966
+BMGC_DG09520,BMG_DG147045,"CAS RN:338777-69-8 | N,N-Bis[(4-chlorophenyl)methyl]-2H-tetrazol-5-amine | N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine | UNII:P725KF5TYY | PubChem CID:447980 | PubChem SID:485663458 | DrugBank ID:DB04037 | N,N-BIS((4-CHLOROPHENYL)METHYL)-2H-TETRAZOL-5-AMINE"
+BMGC_DG09521,BMG_DG147048,"DrugBank ID:DB02014 | 5-(2-Fluoro-5-{(1E)-3-[3-hydroxy-2-(methoxycarbonyl)phenoxy]-1-propen-1-yl}phenyl)-1,2-oxazole-3-carboxylic acid | PubChem CID:447994"
+BMGC_DG09522,BMG_DG147051,UNII:9P3H27MP46 | PubChem SID:472421955 | CAS RN:161314-17-6 | PubChem CID:448002 | NNGH | N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID | DrugBank ID:DB08271
+BMGC_DG09523,BMG_DG147053,"PubChem CID:448006 | 2-(4-BIPHENYLYL)PROPIONIC ACID, (S)- | 2-(4-Biphenylyl)propionic acid, (S)- | DrugBank ID:DB02047 | (+)-2-(4-biphenyl)propionic acid | UNII:E4ZV1V9C3W | CAS RN:10532-14-6 | PubChem SID:198978225"
+BMGC_DG09524,BMG_DG147054,PubChem CID:448008 | SB-409513 | DrugBank ID:DB01793
+BMGC_DG09525,BMG_DG147058,PubChem CID:448011 | GC-24 | DrugBank ID:DB03788
+BMGC_DG09526,BMG_DG147060,"DrugBank ID:DB03010 | CAS RN:152044-54-7 | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione | Epothilone B | PubChem SID:198964552 | PubChem CID:448013 | PATUPILONE | Patupilone | UNII:UEC0H0URSE"
+BMGC_DG09527,BMG_DG147061,PubChem CID:448014 | CAS RN:487021-52-3 | DrugBank ID:DB01950 | AR-AO-14418 | PubChem SID:198988118 | UNII:87KSH90Q6D
+BMGC_DG09528,BMG_DG147063,PubChem CID:448022 | Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate | DrugBank ID:DB04523
+BMGC_DG09529,BMG_DG147064,"DrugBank ID:DB02651 | PubChem CID:448024 | {[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)"
+BMGC_DG09530,BMG_DG147065,"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid | DrugBank ID:DB04285 | PubChem CID:448025"
+BMGC_DG09531,BMG_DG147069,Y-27632 | DrugBank ID:DB08756 | UNII:0X370ROP6H | 4-[(1R)-1-aminoethyl]-N-pyridin-4-ylcyclohexane-1-carboxamide | PubChem SID:255509532 | Y-27632 dihydrochloride | CAS RN:146986-50-7 | CAS RN:521059-79-0 | PubChem CID:448042
+BMGC_DG09532,BMG_DG147070,(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE | DrugBank ID:DB07876 | PubChem CID:448043
+BMGC_DG09533,BMG_DG147071,"DrugBank ID:DB04149 | ROLIPRAM, (R)- | PubChem CID:448055 | CAS RN:85416-75-7 | UNII:DPX51KUP08 | PubChem SID:198983688 | (R)-Rolipram"
+BMGC_DG09534,BMG_DG147074,Zk-806450 | DrugBank ID:DB02112 | PubChem CID:448062
+BMGC_DG09535,BMG_DG147081,PubChem CID:448087 | RB106 | DrugBank ID:DB02669
+BMGC_DG09536,BMG_DG147085,Adenylate-3'-phosphate-[[2'-deoxy-uridine-5'-phosphate]-3'-phosphate] | PubChem CID:448108 | DrugBank ID:DB03186
+BMGC_DG09537,BMG_DG147086,PubChem CID:448110 | 9-(4-hydroxybutyl)-N2-phenylguanine | DrugBank ID:DB02495
+BMGC_DG09538,BMG_DG147088,6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID | DrugBank ID:DB06865 | PubChem CID:448123
+BMGC_DG09539,BMG_DG147089,7-Keto-8-aminopelargonic acid | DrugBank ID:DB02274 | PubChem CID:448124 | 7-Keto-8-Aminopelargonic Acid | CAS RN:682799-71-9 | (8S)-8-amino-7-oxononanoic acid
+BMGC_DG09540,BMG_DG147091,"PubChem CID:4481259 | 2-[2-(3,4-Dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | 2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromenylium-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol"
+BMGC_DG09541,BMG_DG147095,"Lgh-447 | N-[4-[(1R,3S,5S)-3-amino-5-methylcyclohexyl]pyridin-3-yl]-6-(2,6-difluorophenyl)-5-fluoropyridine-2-carboxamide | PubChem SID:381132627 | UNII:9TG5O4V25H | DrugBank ID:DB14943 | LGH-447 | CAS RN:1210608-43-7 | PubChem CID:44814409"
+BMGC_DG09542,BMG_DG147096,"DrugBank ID:DB11827 | PubChem SID:198984080 | Ertugliflozin | UNII:6C282481IP | CAS RN:1210344-57-2 | (1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol | PubChem CID:44814423 | ERTUGLIFLOZIN"
+BMGC_DG09543,BMG_DG147102,"2,3-Dihydroxy-Valerianic Acid | PubChem CID:448154 | (2R,3R)-2,3-dihydroxy-3-methylpentanoic acid | DrugBank ID:DB03675"
+BMGC_DG09544,BMG_DG147107,"DrugBank ID:DB01687 | beta-Mannobiose | PubChem CID:448165 | (2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5S,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol"
+BMGC_DG09545,BMG_DG147109,"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE | PubChem CID:448167 | DrugBank ID:DB07940"
+BMGC_DG09546,BMG_DG147110,"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine | PubChem CID:448171 | DrugBank ID:DB03023"
+BMGC_DG09547,BMG_DG147111,DrugBank ID:DB03338 | HEPTYL GLUCOSIDE | CAS RN:78617-12-6 | Heptyl glucoside | PubChem CID:448173 | PubChem SID:384158325 | UNII:BU2OC48XBR
+BMGC_DG09548,BMG_DG147115,LEQ-803 | UNII:DHW0CP4K4J | PubChem CID:44818949 | PubChem SID:377308102 | CAS RN:1211441-59-6
+BMGC_DG09549,BMG_DG147117,PubChem CID:44819241 | DrugBank ID:DB11760 | Talazoparib
+BMGC_DG09550,BMG_DG147123,"DrugBank ID:DB02485 | CAS RN:3063-71-6 | CYTIDINE 5'-MONOPHOSPHATE-N-ACETYLNEURAMINIC ACID | PubChem SID:443624892 | Cytidine Monophosphate N-Acetylneuraminic Acid | (2R,4S,5R,6R)-5-acetamido-2-[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid | UNII:T8I6M8AXA0 | Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid | CAS RN:22-12-8 | PubChem CID:448209"
+BMGC_DG09551,BMG_DG147126,"PubChem CID:448222 | CAS RN:100111-00-0 | PubChem SID:485660947 | CAS RN:35920-39-9 | (2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide | 5'-N-Ethylcarboxamidoadenosine | NECA | UNII:3WC8SJ5ZLJ"
+BMGC_DG09552,BMG_DG147129,"DrugBank ID:DB03396 | (2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide | PubChem CID:448235"
+BMGC_DG09553,BMG_DG147130,"PubChem CID:448238 | 3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione | DrugBank ID:DB01772"
+BMGC_DG09554,BMG_DG147132,N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine | PubChem CID:448249 | DrugBank ID:DB02558
+BMGC_DG09555,BMG_DG147134,DrugBank ID:DB02689 | PubChem CID:448254 | S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine
+BMGC_DG09556,BMG_DG147135,"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE | PubChem CID:448258 | DrugBank ID:DB07929"
+BMGC_DG09557,BMG_DG147136,DrugBank ID:DB03414 | 5-Thio-a/B-D-Mannopyranosylamine | PubChem CID:448267
+BMGC_DG09558,BMG_DG147137,4R-Fluoro-N6-ethanimidoyl-L-lysine | PubChem CID:448269 | DrugBank ID:DB01835
+BMGC_DG09559,BMG_DG147138,DrugBank ID:DB07416 | (2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE | PubChem CID:448271
+BMGC_DG09560,BMG_DG147139,"PubChem SID:198969480 | DrugBank ID:DB12271 | (S,S)-2-{1-Carboxy-2-[3-(3,5-dichloro-benzyl)-3H-imidazol-4-YL]-ethylamino}-4-methyl-pentanoic acid | ORE-1001 | (2S)-2-[[(1S)-1-carboxy-2-[3-[(3,5-dichlorophenyl)methyl]imidazol-4-yl]ethyl]amino]-4-methylpentanoic acid | CAS RN:305335-31-3 | UNII:4LD0ZHV25K | PubChem CID:448281"
+BMGC_DG09561,BMG_DG147142,UNII:7YW2S3Z2CB | PubChem CID:44828492 | Org-27569 | CAS RN:868273-06-7 | PubChem SID:472408592 | ORG-27569
+BMGC_DG09562,BMG_DG147143,"DrugBank ID:DB07377 | N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE | PubChem CID:448285"
+BMGC_DG09563,BMG_DG147146,"2'-deoxycytidine-2'-deoxyadenosine-3',5'-monophosphate | PubChem CID:448286 | DrugBank ID:DB02573"
+BMGC_DG09564,BMG_DG147149,"PubChem CID:448288 | N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide | DrugBank ID:DB03086"
+BMGC_DG09565,BMG_DG147151,"DrugBank ID:DB03772 | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol | PubChem CID:448294"
+BMGC_DG09566,BMG_DG147152,"DrugBank ID:DB07357 | 4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL | PubChem CID:448295"
+BMGC_DG09567,BMG_DG147153,"DrugBank ID:DB07378 | 4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL | PubChem CID:448297"
+BMGC_DG09568,BMG_DG147162,DrugBank ID:DB02177 | PubChem CID:448317 | 1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine
+BMGC_DG09569,BMG_DG147165,PubChem CID:448326 | DrugBank ID:DB02611 | Balanol Analog 1
+BMGC_DG09570,BMG_DG147166,3-[(3-sec-butyl-4-hydroxybenzoyl)amino]azepan-4-yl 4-(2-hydroxy-5-methoxybenzoyl)benzoate | DrugBank ID:DB02155 | PubChem CID:448327
+BMGC_DG09571,BMG_DG147168,"PubChem SID:198937271 | OCTOPAMINE, (+)- | PubChem CID:448337 | UNII:72SH47FL4X | CAS RN:826-01-7"
+BMGC_DG09572,BMG_DG147178,PubChem CID:448372 | 2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate | DrugBank ID:DB01840
+BMGC_DG09573,BMG_DG147182,"PubChem CID:448381 | 2'-Deoxyuridine 5'-alpha,beta-imido-triphosphate | DrugBank ID:DB01965"
+BMGC_DG09574,BMG_DG147183,"PubChem CID:448384 | DrugBank ID:DB04405 | 2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid"
+BMGC_DG09575,BMG_DG147185,DrugBank ID:DB02508 | Isopentyl Pyrophosphate | PubChem CID:448400
+BMGC_DG09576,BMG_DG147197,"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine | PubChem CID:448436 | DrugBank ID:DB02004"
+BMGC_DG09577,BMG_DG147198,"PubChem SID:198944400 | DrugBank ID:DB03460 | CAS RN:126-29-4 | VIOLAXANTHIN | PubChem CID:448438 | (1R,3S,6S)-6-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1S,4S,6R)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol | UNII:51C926029A | Violaxanthin"
+BMGC_DG09578,BMG_DG147200,"DrugBank ID:DB02056 | (Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid | PubChem SID:198990440 | CAS RN:41598-07-6 | UNII:RXY07S6CZ2 | Prostaglandin D2 | PROSTAGLANDIN D2 | prostaglandin D2 | PubChem CID:448457"
+BMGC_DG09579,BMG_DG147206,DrugBank ID:DB03486 | Phosphomethylphosphonic acid guanosyl ester | PubChem CID:448477
+BMGC_DG09580,BMG_DG147212,"PubChem CID:4485 | UNII:I9ZF7L6G2L | DrugBank ID:DB01115 | CAS RN:101539-70-2 | NIFEDIPINE | CAS RN:193689-82-6 | dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | Nifedipine | PubChem SID:175265858 | CAS RN:21829-25-4 | CAS RN:915092-63-6"
+BMGC_DG09581,BMG_DG147213,PubChem CID:448503 | DrugBank ID:DB03637 | Guanidine-3-propanol
+BMGC_DG09582,BMG_DG147214,DrugBank ID:DB02607 | PubChem CID:448505 | Adenosine Phosphonoacetic Acid
+BMGC_DG09583,BMG_DG147215,PubChem SID:482553965 | UNII:E678E6SN42 | CAS RN:68382-17-2 | 4-(Hydroxymethyl)benzenecarboximidamide | PubChem CID:448513 | DrugBank ID:DB02585 | 4-(HYDROXYMETHYL)BENZENECARBOXIMIDAMIDE | 4-(Hydroxymethyl)Benzamidine
+BMGC_DG09584,BMG_DG147219,4-Hydroxybutan-1-Aminium | DrugBank ID:DB02541 | PubChem CID:448524
+BMGC_DG09585,BMG_DG147221,"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE | 4-[4-Amino-6-(5-chloro-1H-indol-4-ylmethyl)-[1,3,5]triazin-2-ylamino]-benzonitrile | 4-[[4-amino-6-[(5-chloro-1H-indol-4-yl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile | PubChem CID:448533 | DrugBank ID:DB07337"
+BMGC_DG09586,BMG_DG147223,"5-Bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide | PubChem CID:448535 | DrugBank ID:DB03115"
+BMGC_DG09587,BMG_DG147224,Diethylstilbestrol | DIETHYLSTILBESTROL | PubChem SID:175267507 | 4-[(E)-4-(4-hydroxyphenyl)hex-3-en-3-yl]phenol | UNII:731DCA35BT | CAS RN:56-53-1 | CAS RN:6898-97-1 | DrugBank ID:DB00255 | PubChem CID:448537
+BMGC_DG09588,BMG_DG147225,"BMS-214662 | PubChem SID:198961168 | PubChem CID:448545 | DrugBank ID:DB12234 | Bms-214662 | CAS RN:195987-41-8 | UNII:L2U9GFD244 | (3R)-3-benzyl-1-(1H-imidazol-5-ylmethyl)-4-thiophen-2-ylsulfonyl-3,5-dihydro-2H-1,4-benzodiazepine-7-carbonitrile"
+BMGC_DG09589,BMG_DG147226,PubChem CID:448548 | UNII:28BBA7Q6U3 | PubChem SID:252319855 | BENZYLSULFONYLSERYLGLYCINE AMIDINOBENZAMIDE | CAS RN:380237-57-0
+BMGC_DG09590,BMG_DG147229,DrugBank ID:DB03384 | PubChem CID:448573 | Fica
+BMGC_DG09591,BMG_DG147230,DrugBank ID:DB03245 | S-4-Nitrobutyryl-CoA | PubChem CID:448575
+BMGC_DG09592,BMG_DG147231,"DrugBank ID:DB03742 | (2S,3R)-3-(4-hydroxyphenyl)-2-[4-(2-piperidin-1-ylethoxy)phenyl]-2,3-dihydro-1,4-benzoxathiin-6-ol | (2S,3R)-2-(4-(2-(Piperidin-1-YL)ethoxy)phenyl)-2,3-dihydro-3-(4-hydroxyphenyl)benzo[B][1,4]oxathiin-6-OL | PubChem CID:448577 | Compound 4-D"
+BMGC_DG09593,BMG_DG147232,PubChem CID:448580 | PubChem SID:198978866 | UNII:9J12WX5B6A | CAS RN:65-82-7 | N-Acetylmethionine | DrugBank ID:DB01646 | N-ACETYLMETHIONINE | (2S)-2-acetamido-4-methylsulfanylbutanoic acid
+BMGC_DG09594,BMG_DG147236,"CAS RN:130636-43-0 | 6-[2-[2-hydroxyethyl-[3-(4-nitrophenyl)propyl]amino]ethylamino]-1,3-dimethylpyrimidine-2,4-dione | NIFEKALANT | UNII:5VZ7GZM43E | Nifekalant | PubChem SID:198953067 | PubChem CID:4486"
+BMGC_DG09595,BMG_DG147237,"PubChem SID:175267952 | (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | OCTREOTIDE | PubChem CID:448601 | UNII:RWM8CCW8GP | NDC:10122-550 | CAS RN:83150-76-9 | DrugBank ID:DB00104 | Octreotide | NDC:69880-120 | CAS RN:79517-01-4"
+BMGC_DG09596,BMG_DG147238,PubChem CID:448605 | DrugBank ID:DB03082 | 6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide
+BMGC_DG09597,BMG_DG147240,PubChem CID:448610 | 8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide | DrugBank ID:DB04059
+BMGC_DG09598,BMG_DG147241,PubChem CID:448632 | DrugBank ID:DB02974 | 4-(4-Chlorophenyl)Imidazole
+BMGC_DG09599,BMG_DG147242,"DrugBank ID:DB07458 | 3-(1H-indol-3-yl)-4-{1-[2-(1-methylpyrrolidin-2-yl)ethyl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione | PubChem CID:448642"
+BMGC_DG09600,BMG_DG147243,"4-Hydroxy-1,2,5-oxadiazole-3-carboxylic acid | PubChem CID:448650 | DrugBank ID:DB02401"
+BMGC_DG09601,BMG_DG147244,DrugBank ID:DB02111 | 3-hydroxyisoxazole-4-carboxylic acid | PubChem CID:448651
+BMGC_DG09602,BMG_DG147245,"PubChem CID:448652 | 4-oxo-4,5-dihydro-1,2,5-thiadiazole-3-carboxylic acid | DrugBank ID:DB03162"
+BMGC_DG09603,BMG_DG147246,"(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide | PubChem CID:448653 | DrugBank ID:DB03690"
+BMGC_DG09604,BMG_DG147248,DrugBank ID:DB02834 | PubChem CID:448658 | IDD552
+BMGC_DG09605,BMG_DG147249,"PubChem CID:448660 | DrugBank ID:DB04142 | 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide"
+BMGC_DG09606,BMG_DG147251,"DrugBank ID:DB02259 | PubChem CID:448661 | 3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide"
+BMGC_DG09607,BMG_DG147253,"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide | DrugBank ID:DB03311 | PubChem CID:448662"
+BMGC_DG09608,BMG_DG147254,"PubChem CID:448667 | DrugBank ID:DB03141 | 3-{[(5R,6R)-5-Benzyl-6-hydroxy-2,4-bis(4-hydroxybenzyl)-3-oxo-1,2,4-triazepan-1-yl]sulfonyl}benzonitril"
+BMGC_DG09609,BMG_DG147255,(S)-wiskostatin | PubChem CID:448668 | DrugBank ID:DB01731
+BMGC_DG09610,BMG_DG147261,1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE | DrugBank ID:DB06869 | PubChem CID:448677
+BMGC_DG09611,BMG_DG147266,"UNII:8780F0K71U | Nifenazone | N-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)pyridine-3-carboxamide | NIFENAZONE | PubChem SID:198935537 | DrugBank ID:DB13407 | CAS RN:2139-47-1 | PubChem CID:4487"
+BMGC_DG09612,BMG_DG147268,PubChem CID:448718 | DrugBank ID:DB02267 | Argininosuccinate
+BMGC_DG09613,BMG_DG147275,Aminomethylcyclohexane | PubChem CID:448748 | DrugBank ID:DB02435
+BMGC_DG09614,BMG_DG147276,PubChem SID:496141452 | PubChem CID:448749 | 4-FLUOROBENZYLAMINE | 4-Fluorobenzylammonium | CAS RN:140-75-0 | DrugBank ID:DB03243 | (4-fluorophenyl)methylazanium | 4-Fluorobenzylamine | UNII:P5W29VUB78
+BMGC_DG09615,BMG_DG147282,(2S)-N-[(4-aminocyclohexyl)methyl]-1-[(2R)-2-(methylamino)-3-phenylpropanoyl]pyrrolidine-2-carboxamide | PubChem CID:448763 | Methyl-phe-pro-amino-cyclohexylglycine | DrugBank ID:DB08187 | N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide
+BMGC_DG09616,BMG_DG147284,CAS RN:90053-09-1 | UNII:23N7C49PW9 | PubChem CID:448769 | Carbazole Butanoic Acid | 4-CARBAZOL-9-YL-BUTANOIC ACID | 4-Carbazol-9-yl-butanoic acid | DrugBank ID:DB03851 | PubChem SID:485663373
+BMGC_DG09617,BMG_DG147292,NIFLUMIC ACID | 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid | CAS RN:1794811-58-7 | PubChem CID:4488 | PubChem SID:198938963 | CAS RN:4394-00-7 | Niflumic Acid | DrugBank ID:DB04552 | Niflumic acid | UNII:4U5MP5IUD8
+BMGC_DG09618,BMG_DG147293,"DrugBank ID:DB02696 | 6-Aminohexyl-uridine-C1,5'-diphosphate | PubChem CID:448803"
+BMGC_DG09619,BMG_DG147296,"NDC:52958-402 | NDC:70121-1003 | NDC:55150-218 | NDC:72078-025 | NDC:71288-413 | NDC:83634-300 | NDC:70436-026 | CAS RN:188627-80-7 | NDC:67457-630 | NDC:70121-1002 | NDC:67457-629 | NDC:52958-040 | NDC:70436-027 | CAS RN:157630-07-4 | NDC:67457-631 | UNII:NA8320J834 | EPTIFIBATIDE | NDC:72078-027 | NDC:0338-9558 | Eptifibatide | PubChem CID:448812 | NDC:55150-220 | NDC:70436-162 | NDC:55150-219 | NDC:83634-301 | NDC:72078-026 | NDC:70436-163 | PubChem SID:175266937 | NDC:71288-412 | 2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid | NDC:25021-408"
+BMGC_DG09620,BMG_DG147300,"DrugBank ID:DB01922 | Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam | PubChem CID:448828"
+BMGC_DG09621,BMG_DG147303,Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine | DrugBank ID:DB03476 | PubChem CID:448841
+BMGC_DG09622,BMG_DG147310,Uridine-5'-diphosphate-4-deoxy-4-fluoro-alpha-D-galactose | PubChem CID:448872 | DrugBank ID:DB04097
+BMGC_DG09623,BMG_DG147311,Uridine-5'-diphosphate-mannose | DrugBank ID:DB02421 | PubChem CID:448873
+BMGC_DG09624,BMG_DG147312,PubChem CID:448875 | 3-thiaoctanoyl-CoA | DrugBank ID:DB03415
+BMGC_DG09625,BMG_DG147317,"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone | PubChem CID:448889 | DrugBank ID:DB03072"
+BMGC_DG09626,BMG_DG147318,"PubChem CID:448890 | 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE | DrugBank ID:DB07787"
+BMGC_DG09627,BMG_DG147320,PubChem CID:448894 | DrugBank ID:DB03664 | P1-(adenosine-5'-P5-(uridine-5')pentaphosphate
+BMGC_DG09628,BMG_DG147322,DrugBank ID:DB07783 | 1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | PubChem CID:448903
+BMGC_DG09629,BMG_DG147333,"PubChem CID:448915 | 2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol | DrugBank ID:DB04471"
+BMGC_DG09630,BMG_DG147334,PubChem CID:448923 | Uridine-5'-diphosphate-2-deoxy-2-fluoro-alpha-D-galactose | DrugBank ID:DB03488
+BMGC_DG09631,BMG_DG147340,DrugBank ID:DB02118 | PubChem CID:448940 | CP-271485
+BMGC_DG09632,BMG_DG147341,PF-00356231 | DrugBank ID:DB03367 | PubChem CID:448942
+BMGC_DG09633,BMG_DG147342,"3-(1H-indol-3-yl)-4-(1-{2-[(2S)-1-methylpyrrolidinyl]ethyl}-1H-indol-3-yl)-1H-pyrrole-2,5-dione | PubChem CID:448943 | DrugBank ID:DB07456"
+BMGC_DG09634,BMG_DG147343,PubChem CID:448953 | [[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE | DrugBank ID:DB07934
+BMGC_DG09635,BMG_DG147344,N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE | DrugBank ID:DB07944 | PubChem CID:448955
+BMGC_DG09636,BMG_DG147347,"DrugBank ID:DB02754 | 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine | PubChem CID:448965"
+BMGC_DG09637,BMG_DG147348,"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H- | PubChem CID:448968 | DrugBank ID:DB08436"
+BMGC_DG09638,BMG_DG147349,"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine | PubChem CID:448969 | DrugBank ID:DB02359"
+BMGC_DG09639,BMG_DG147350,"PubChem CID:448970 | DrugBank ID:DB03504 | 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine"
+BMGC_DG09640,BMG_DG147351,"DrugBank ID:DB04505 | PubChem CID:448971 | 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine"
+BMGC_DG09641,BMG_DG147352,"DrugBank ID:DB02550 | PubChem CID:448972 | 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine"
+BMGC_DG09642,BMG_DG147353,"DrugBank ID:DB03093 | 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine | PubChem CID:448973"
+BMGC_DG09643,BMG_DG147354,"DrugBank ID:DB04054 | PubChem CID:448974 | 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine"
+BMGC_DG09644,BMG_DG147355,"PubChem CID:448976 | DrugBank ID:DB04254 | 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine"
+BMGC_DG09645,BMG_DG147356,"DICLOFOP, (R)- | CAS RN:71283-28-8 | DrugBank ID:DB03781 | 2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid | PubChem SID:461434948 | UNII:AAN3U3U7X5 | PubChem CID:448978"
+BMGC_DG09646,BMG_DG147357,PubChem SID:198990605 | PubChem CID:448979 | HALOXYFOP-P | DrugBank ID:DB07870 | Haloxyfop-P | (2R)-2-[4-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxyphenoxy]propanoic acid | UNII:I57833604I | CAS RN:95977-29-0
+BMGC_DG09647,BMG_DG147358,Purvalanol | DrugBank ID:DB02733 | PubChem CID:448991
+BMGC_DG09648,BMG_DG147360,(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL | PubChem CID:448994 | DrugBank ID:DB07054
+BMGC_DG09649,BMG_DG147362,"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine | PubChem CID:448999 | DrugBank ID:DB04260"
+BMGC_DG09650,BMG_DG147364,"DrugBank ID:DB08210 | 2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE | PubChem CID:449003"
+BMGC_DG09651,BMG_DG147365,"Tetrastearoylcardiolipin | DrugBank ID:DB03429 | [(2R)-3-[[3-[[(2R)-2,3-di(octadecanoyloxy)propoxy]-hydroxyphosphoryl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxy-2-octadecanoyloxypropyl] octadecanoate | Tetrastearoyl cardiolipin | PubChem CID:449005"
+BMGC_DG09652,BMG_DG147370,CAS RN:256461-79-7 | PubChem CID:449013 | FR-234938 | UNII:10302WQ21V | PubChem SID:198990831 | DrugBank ID:DB03220
+BMGC_DG09653,BMG_DG147371,PubChem CID:449014 | DrugBank ID:DB03370 | FR239087
+BMGC_DG09654,BMG_DG147372,"PubChem CID:449015 | DrugBank ID:DB07785 | 1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE"
+BMGC_DG09655,BMG_DG147373,PubChem CID:449021 | DrugBank ID:DB03449 | N-(4-{2-[(3-chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide
+BMGC_DG09656,BMG_DG147377,PubChem SID:198979848 | PubChem CID:449035 | UNII:246FR6022S | Niraxostat | DrugBank ID:DB03841 | CAS RN:206884-98-2 | NIRAXOSTAT
+BMGC_DG09657,BMG_DG147378,L-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid | PubChem CID:449042 | DrugBank ID:DB08693
+BMGC_DG09658,BMG_DG147380,CAS RN:446859-33-2 | RepSox | UNII:JT8ZW3H2ST | PubChem CID:449054 | PubChem SID:485666475 | REPSOX
+BMGC_DG09659,BMG_DG147385,PubChem CID:449087 | DrugBank ID:DB06944 | PubChem SID:198962564 | PNU-292137 | CAS RN:326823-27-2 | UNII:64H5U84UFB | N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide
+BMGC_DG09660,BMG_DG147386,DrugBank ID:DB02647 | N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide | PubChem CID:449088
+BMGC_DG09661,BMG_DG147387,UNII:7I6OOJ9GR6 | PubChem CID:449093 | (E)-2-methyl-4-(7H-purin-6-ylamino)but-2-en-1-ol | CAS RN:131140-27-7 | CAS RN:1637-39-4 | DrugBank ID:DB11337 | PubChem SID:198961218 | trans-Zeatin | ZEATIN
+BMGC_DG09662,BMG_DG147390,N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide | DrugBank ID:DB02917 | PubChem CID:449096
+BMGC_DG09663,BMG_DG147391,PubChem SID:198944590 | PubChem CID:449097 | UNII:04L1E4J3ZT | CAS RN:591778-68-6 | CP-640186
+BMGC_DG09664,BMG_DG147396,"Hexanoyl-coenzyme a | Hexanoyl-CoA | CAS RN:5060-32-2 | PubChem CID:449118 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] hexanethioate | DrugBank ID:DB02563"
+BMGC_DG09665,BMG_DG147397,(3r)-1-Acetyl-3-Methylpiperidine | PubChem CID:449120 | DrugBank ID:DB01742
+BMGC_DG09666,BMG_DG147399,Argadin | PubChem CID:449123 | DrugBank ID:DB04350
+BMGC_DG09667,BMG_DG147400,DrugBank ID:DB03632 | Argifin | PubChem CID:449124
+BMGC_DG09668,BMG_DG147401,"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid, | DrugBank ID:DB02420 | PubChem CID:449125"
+BMGC_DG09669,BMG_DG147402,PubChem CID:449126 | UNII:3M2B2SQW0I | CAS RN:156336-70-8 | PubChem SID:445499595 | DrugBank ID:DB08061 | 4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE | 4-(5-(4-CHLOROPHENYL)-1H-PYRAZOL-3-YL)PIPERIDINE
+BMGC_DG09670,BMG_DG147403,"3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-1H-1,2,4-TRIAZOLE | 3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE | PubChem SID:485663674 | DrugBank ID:DB08062 | 3-(4-Chlorophenyl)-5-(methylthio)-1H-1,2,4-triazole | CAS RN:57295-49-5 | UNII:L7GWP3G5UB | PubChem CID:449127"
+BMGC_DG09671,BMG_DG147410,"UNII:Z33JA2LC96 | Trencam-3,2-Hopo | PubChem SID:478838320 | 2,3-Dihydroxybenzamide | 2,3-DIHYDROXYBENZAMIDE | DrugBank ID:DB04476 | CAS RN:13189-89-4 | PubChem CID:449146"
+BMGC_DG09672,BMG_DG147412,"PubChem CID:449157 | (S,R)-fidarestat | DrugBank ID:DB02101"
+BMGC_DG09673,BMG_DG147413,"DrugBank ID:DB01644 | PubChem CID:449159 | 3,6-dihydroxy-xanthene-9-propionic acid"
+BMGC_DG09674,BMG_DG147414,PubChem CID:449162 | DrugBank ID:DB08001 | 5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID
+BMGC_DG09675,BMG_DG147415,"PubChem CID:449164 | 4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose | DrugBank ID:DB02889"
+BMGC_DG09676,BMG_DG147416,"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose | DrugBank ID:DB03495 | PubChem CID:449165"
+BMGC_DG09677,BMG_DG147417,DrugBank ID:DB03971 | Acarbose Derived Hexasaccharide | PubChem CID:449167
+BMGC_DG09678,BMG_DG147418,PubChem SID:459055459 | UNII:ZT4887FB5E | LFA703 | PubChem CID:449169 | LFA-703 | DrugBank ID:DB03932 | CAS RN:288324-06-1
+BMGC_DG09679,BMG_DG147419,PubChem CID:449170 | UNII:ZN9WFS3G4L | LFA-878 | CAS RN:288323-75-1 | PubChem SID:445498670
+BMGC_DG09680,BMG_DG147420,"Alitretinoin | PubChem SID:175266870 | UNII:1UA8E65KDZ | ALITRETINOIN | PubChem CID:449171 | NDC:59212-601 | (2E,4E,6Z,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid | DrugBank ID:DB00523 | CAS RN:5300-03-8"
+BMGC_DG09681,BMG_DG147421,PubChem CID:449178 | Glutamine hydroxamate | DrugBank ID:DB02446
+BMGC_DG09682,BMG_DG147422,"3-Carboxy-N,N,N-trimethyl-2-(octanoyloxy)propan-1-aminium | PubChem CID:449186 | [(2R)-3-carboxy-2-octanoyloxypropyl]-trimethylazanium | 3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium | DrugBank ID:DB03832"
+BMGC_DG09683,BMG_DG147423,PubChem CID:449190 | CAS RN:189940-24-7 | DrugBank ID:DB01647 | UNII:0RB5T277IY | DAXALIPRAM | Daxalipram | PubChem SID:198960718
+BMGC_DG09684,BMG_DG147424,"UNII:0P6C6ZOP5U | Roflumilast | PubChem CID:449193 | CAS RN:162401-32-3 | DrugBank ID:DB01656 | ROFLUMILAST | 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide | PubChem SID:175267663"
+BMGC_DG09685,BMG_DG147426,Compound 18 | PubChem CID:449208 | DrugBank ID:DB02715
+BMGC_DG09686,BMG_DG147427,Compound 19 | DrugBank ID:DB02615 | PubChem CID:449209
+BMGC_DG09687,BMG_DG147428,LEVCYCLOSERINE | PubChem SID:198978737 | CAS RN:339-72-0 | UNII:AK7DRB7FMO | PubChem CID:449215
+BMGC_DG09688,BMG_DG147429,DrugBank ID:DB02378 | PubChem CID:449218 | MMI-175
+BMGC_DG09689,BMG_DG147432,"(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2S)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide | DEMOXYTOCIN | DrugBank ID:DB13798 | PubChem SID:198949249 | CAS RN:113-78-0 | UNII:2N9HM3X95F | PubChem CID:449224 | Demoxytocin"
+BMGC_DG09690,BMG_DG147434,CAS RN:1000995-75-4 | H-89 | PubChem CID:449241 | N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-[2-[[(E)-3-(4-bromophenyl)prop-2-enyl]amino]ethyl]isoquinoline-5-sulfonamide | UNII:M876330O56 | CAS RN:127243-85-0 | DrugBank ID:DB07995 | PubChem SID:198969481
+BMGC_DG09691,BMG_DG147435,PubChem CID:449242 | DrugBank ID:DB08409 | 4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE
+BMGC_DG09692,BMG_DG147436,DrugBank ID:DB08410 | PARA-NITROBENZYL GLUTARYL GLYCINIC ACID | PubChem CID:449243
+BMGC_DG09693,BMG_DG147437,PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE | DrugBank ID:DB08394 | PubChem CID:449244
+BMGC_DG09694,BMG_DG147438,PubChem CID:449245 | DrugBank ID:DB08412 | 6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID
+BMGC_DG09695,BMG_DG147443,"PubChem CID:4493 | UNII:51G6I8B902 | PubChem SID:175266180 | NDC:62559-173 | NDC:66993-212 | Nilutamide | NILUTAMIDE | NDC:59212-111 | CAS RN:63612-50-0 | 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione | DrugBank ID:DB00665"
+BMGC_DG09696,BMG_DG147444,4-Phospho-D-erythronohydroxamic acid | PubChem CID:449303 | DrugBank ID:DB04496
+BMGC_DG09697,BMG_DG147445,"4-phospho-D-erythronic acid | (2R,3R)-2,3-dihydroxy-4-phosphonooxybutanoic acid | PubChem CID:449304 | DrugBank ID:DB03108 | CAS RN:57229-25-1 | 4-Phospho-D-erythronate"
+BMGC_DG09698,BMG_DG147447,"DrugBank ID:DB03390 | PubChem CID:449346 | (2R,3R)-2,3-Dihydroxy-4-oxo-4-(propylamino)butanoic acid"
+BMGC_DG09699,BMG_DG147448,S-(2-oxo)pentadecylcoa | DrugBank ID:DB02271 | PubChem CID:449362
+BMGC_DG09700,BMG_DG147449,"DrugBank ID:DB01834 | (9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene | PubChem CID:449366"
+BMGC_DG09701,BMG_DG147453,"PubChem CID:449381 | Oseltamivir Acid | OSELTAMIVIR ACID | UNII:K6106LV5Q8 | CAS RN:187227-45-8 | DrugBank ID:DB02600 | (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylic acid | PubChem SID:198961522 | Oseltamivir acid"
+BMGC_DG09702,BMG_DG147454,DrugBank ID:DB03448 | 2'-Deoxyuridine 3'-Monophosphate | PubChem CID:449392
+BMGC_DG09703,BMG_DG147456,"PubChem CID:4494 | NILVADIPINE | PubChem SID:198946599 | UNII:0214FUT37J | Nilvadipine | 3-O-methyl 5-O-propan-2-yl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | DrugBank ID:DB06712 | CAS RN:75530-68-6"
+BMGC_DG09704,BMG_DG147461,Afimoxifene | HYDROXYTAMOXIFEN | CAS RN:68047-06-3 | PubChem SID:198970188 | CAS RN:1077-29-8 | UNII:95K54647BZ | CAS RN:68392-35-8 | PubChem CID:449459 | 4-[(Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol | DrugBank ID:DB04468 | CAS RN:65213-48-1
+BMGC_DG09705,BMG_DG147463,UNII:K8YZM765ZS | PubChem CID:449462 | DrugBank ID:DB02678 | PubChem SID:241180210 | CAS RN:14196-86-2 | .BETA.-D-GALACTOSAMINE | beta-D-Galactosamine
+BMGC_DG09706,BMG_DG147466,PubChem CID:449487 | L-1-naphthyl-2-acetamido-ethane boronic acid | DrugBank ID:DB08565
+BMGC_DG09707,BMG_DG147468,DrugBank ID:DB02324 | 5-Iodo-2'-Deoxyuridine-5'-Monophosphate | PubChem CID:449489
+BMGC_DG09708,BMG_DG147469,PubChem SID:175268691 | DrugBank ID:DB04743 | CAS RN:51803-78-2 | PubChem CID:4495 | N-(4-nitro-2-phenoxyphenyl)methanesulfonamide | CAS RN:1364966-82-4 | NIMESULIDE | UNII:V4TKW1454M | Nimesulide
+BMGC_DG09709,BMG_DG147470,PubChem CID:449500 | DrugBank ID:DB02046 | N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid
+BMGC_DG09710,BMG_DG147471,PubChem CID:449517 | (2S)-2-amino-5-[[(2R)-1-[[2-[4-[3-[[2-[[(2R)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]propylamino]butylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid | Trypanothione | DrugBank ID:DB03470
+BMGC_DG09711,BMG_DG147477,PubChem CID:449555 | Glutathionylspermidine disulfide | DrugBank ID:DB02553
+BMGC_DG09712,BMG_DG147479,DrugBank ID:DB01969 | PubChem CID:449575 | Trifluoroacetonyl coenzyme A
+BMGC_DG09713,BMG_DG147482,PubChem SID:482554322 | CAS RN:660-88-8 | Delta-Amino Valeric Acid | 5-AMINOVALERIC ACID | 5-Aminovaleric acid | DrugBank ID:DB02068 | UNII:BUW4BFJ6SC | PubChem CID:449593
+BMGC_DG09714,BMG_DG147485,"CAS RN:2011-67-8 | Nimetazepam | 1-methyl-7-nitro-5-phenyl-3H-1,4-benzodiazepin-2-one | UNII:4532264KW6 | PubChem SID:198984618 | NIMETAZEPAM | PubChem CID:4496"
+BMGC_DG09715,BMG_DG147489,DrugBank ID:DB02589 | PubChem CID:449633 | Se-Ethyl-Isoselenourea
+BMGC_DG09716,BMG_DG147498,PubChem SID:175268579 | UNII:V7OK6J19HQ | GADOPENTETATE | CAS RN:20694-16-0 | PubChem CID:449677
+BMGC_DG09717,BMG_DG147502,"PubChem SID:346539286 | PubChem CID:449698 | CAS RN:98598-83-5 | Carfentanil, C-11 | DrugBank ID:DB15360 | CARFENTANIL C-11 | UNII:UVI40IC2GN | (111C)methyl 1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate"
+BMGC_DG09718,BMG_DG147503,"3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | PubChem CID:4497 | CAS RN:66085-59-4 | NIMODIPINE | NDC:24338-260 | NDC:23155-512 | Nimodipine | NDC:24338-230 | UNII:57WA9QZ5WH | NDC:69452-209 | NDC:31722-039 | DrugBank ID:DB00393 | PubChem SID:175271447"
+BMGC_DG09719,BMG_DG147514,CAS RN:498-95-3 | UNII:1U1QTN40SY | PubChem SID:198955657 | NIPECOTIC ACID | PubChem CID:4498
+BMGC_DG09720,BMG_DG147524,"NDC:0378-2223 | NDC:0378-2098 | NDC:66993-472 | NDC:66993-475 | Nisoldipine | NDC:70515-501 | NDC:0378-2096 | NDC:70515-500 | NDC:0378-2099 | NISOLDIPINE | NDC:0378-2224 | PubChem CID:4499 | UNII:4I8HAB65SZ | 3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | NDC:0378-2222 | NDC:66993-473 | CAS RN:63675-72-9 | NDC:0378-2097 | NDC:70515-503 | DrugBank ID:DB00401 | PubChem SID:175271684"
+BMGC_DG09721,BMG_DG147529,DrugBank ID:DB09186 | PubChem SID:198947595 | Nisoxetine | NISOXETINE | CAS RN:53179-07-0 | UNII:17NV064B2D | PubChem CID:4500
+BMGC_DG09722,BMG_DG147536,Gadoxate | PubChem CID:450096 | 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic acid;gadolinium(3+)
+BMGC_DG09723,BMG_DG147537,PubChem CID:4501 | UNII:933301178Z | NITIDINE | PubChem SID:198969842 | CAS RN:6872-57-7
+BMGC_DG09724,BMG_DG147545,PubChem CID:450268 | M-HYDROXYHIPPURIC ACID | PubChem SID:198960992 | 3-Hydroxyhippuric Acid | m-Hydroxyhippuric acid | CAS RN:1637-75-8 | DrugBank ID:DB07069 | 2-[(3-hydroxybenzoyl)amino]acetic acid | UNII:17HCX0HNRT
+BMGC_DG09725,BMG_DG147553,"1-METHYL-4-OXO-1,4-DIHYDROPYRIDINE-3-SULFONAMIDE | UNII:6CX6284GS7 | 1-Methyl-4-oxo-1,4-dihydropyridine-3-sulfonamide | CAS RN:182556-18-9 | PubChem CID:45028895 | PubChem SID:482553985"
+BMGC_DG09726,BMG_DG147598,"PubChem CID:450503 | Fludeoxyglucose (18F) | (2S,3R,4S,5S,6R)-3-(18F)fluoranyl-6-(hydroxymethyl)oxane-2,4,5-triol | CAS RN:105851-17-0 | .ALPHA.-D-FLUDEOXYGLUCOPYRANOSE F-18 | PubChem SID:375579675 | UNII:SBT3GBX27W"
+BMGC_DG09727,BMG_DG147632,"NITRAZEPAM | PubChem CID:4506 | 7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one | CAS RN:146-22-5 | PubChem SID:198972190 | UNII:9CLV70W7HS | Nitrazepam | DrugBank ID:DB01595"
+BMGC_DG09728,BMG_DG147633,CAS RN:222727-39-1 | NDC:69932-001 | PubChem CID:450601 | FLUCICLOVINE F-18 | PubChem SID:198964053 | UNII:38R1Q0L1ZE | DrugBank ID:DB13146 | 1-amino-3-(18F)fluoranylcyclobutane-1-carboxylic acid | Fluciclovine (18F)
+BMGC_DG09729,BMG_DG147637,"PubChem CID:4507 | NITRENDIPINE | 5-O-ethyl 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | Nitrendipine | CAS RN:39562-70-4 | UNII:9B627AW319 | PubChem SID:198937443 | DrugBank ID:DB01054"
+BMGC_DG09730,BMG_DG147653,PubChem SID:474492678 | O-1602 | PubChem CID:45073499 | UNII:59F4R2N5N5 | CAS RN:317321-41-8
+BMGC_DG09731,BMG_DG147692,"UNII:G59M7S0WS3 | PubChem SID:175267710 | PubChem CID:4510 | DrugBank ID:DB00727 | 1,3-dinitrooxypropan-2-yl nitrate | NITROGLYCERIN | Nitroglycerin | CAS RN:55-63-0"
+BMGC_DG09732,BMG_DG147693,"Palmostatin B | (3S,4S)-3-decyl-4-[2-(3,4-dimethoxyphenyl)ethyl]oxetan-2-one | PubChem CID:45100481 | CAS RN:1233365-12-2"
+BMGC_DG09733,BMG_DG147695,"NVP-LEQ-506 | Nvp-leq-506 | UNII:6SJX1T5HJD | 2-[5-[(2R)-4-(6-benzyl-4,5-dimethylpyridazin-3-yl)-2-methylpiperazin-1-yl]pyrazin-2-yl]propan-2-ol | PubChem SID:249492257 | PubChem CID:45100669 | DrugBank ID:DB12857 | CAS RN:1204975-42-7"
+BMGC_DG09734,BMG_DG147701,PubChem SID:198937385 | UNII:T4PPL01131 | PubChem CID:45102710 | CAS RN:1193383-09-3 | JNJ-42041935
+BMGC_DG09735,BMG_DG147702,UNII:F2PY7C5QSA | 5-METHOXYURIDINE-5'-TRIPHOSPHATE | PubChem SID:496143067 | PubChem CID:45104419 | 5-Methoxyuridine-5’-triphosphate | CAS RN:847649-65-4
+BMGC_DG09736,BMG_DG147727,N-[4-[[4-[[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]carbamoylamino]naphthalen-1-yl]oxymethyl]pyridin-2-yl]-2-methoxyacetamide | PubChem CID:45109868 | Jnj-49095397 | JNJ-49095397 | UNII:I92MU0V408 | PubChem SID:375084851 | CAS RN:1220626-82-3
+BMGC_DG09737,BMG_DG147731,"PubChem CID:45110509 | Paritaprevir | CAS RN:1216941-48-8 | UNII:OU2YM37K86 | CAS RN:1221573-85-8 | (1S,4R,6S,7Z,14S,18R)-N-cyclopropylsulfonyl-14-[(5-methylpyrazine-2-carbonyl)amino]-2,15-dioxo-18-phenanthridin-6-yloxy-3,16-diazatricyclo[14.3.0.04,6]nonadec-7-ene-4-carboxamide | PubChem SID:198955394 | PARITAPREVIR | DrugBank ID:DB09297"
+BMGC_DG09738,BMG_DG147733,2-[4-[[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]amino]phenyl]acetonitrile | [4-({4-[(5-Cyclopropyl-1h-Pyrazol-3-Yl)amino]pyrimidin-2-Yl}amino)phenyl]acetonitrile | PubChem CID:45111332
+BMGC_DG09739,BMG_DG147757,NDC:0006-3075 | NDC:0006-5086 | Letermovir | PubChem SID:175268695 | NDC:0006-5004 | NDC:0006-5003 | LETERMOVIR | CAS RN:917389-32-3 | UNII:1H09Y5WO1F | PubChem CID:45138674 | NDC:0006-5085 | NDC:0006-3076 | DrugBank ID:DB12070 | 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetic acid
+BMGC_DG09740,BMG_DG147759,CAS RN:23198-01-8 | PubChem CID:451388 | 5-METHYLURIDINE TRIPHOSPHATE | UNII:26L4U23SYM | PubChem SID:472409064
+BMGC_DG09741,BMG_DG147762,UNII:TK02X14ASJ | PubChem SID:198975905 | Rivoceranib Mesylate | RIVOCERANIB MESYLATE | PubChem CID:45139106 | N-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide;methanesulfonic acid | Apatinib | CAS RN:1218779-75-9
+BMGC_DG09742,BMG_DG147764,PubChem CID:4514 | NIZOFENONE | DrugBank ID:DB13546 | PubChem SID:198940974 | (2-chlorophenyl)-[2-[2-(diethylaminomethyl)imidazol-1-yl]-5-nitrophenyl]methanone | Nizofenone | CAS RN:54533-85-6 | UNII:7A2NOC3R88
+BMGC_DG09743,BMG_DG147765,"DrugBank ID:DB11617 | methyl (1R,2R,4S)-4-[(2R,4S,5S,6S)-4-(dimethylamino)-5-[(2S,4S,5S,6S)-4-hydroxy-6-methyl-5-[(2R,6S)-6-methyl-5-oxooxan-2-yl]oxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate | PubChem SID:198953284 | UNII:74KXF8I502 | Aclarubicin | CAS RN:57576-44-0 | PubChem CID:451415 | ACLARUBICIN"
+BMGC_DG09744,BMG_DG147767,"1-[5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-14-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide | PubChem SID:198946654 | Mk-8033 | CAS RN:1001917-37-8 | CAS RN:1196681-38-5 | PubChem CID:45142457 | MK-8033 | UNII:350H6PBQ5Q"
+BMGC_DG09745,BMG_DG147769,"PubChem SID:198969183 | TARIBAVIRIN | Taribavirin | PubChem CID:451448 | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboximidamide | CAS RN:119567-79-2 | UNII:R3B1994K2E | DrugBank ID:DB06408"
+BMGC_DG09746,BMG_DG147774,PubChem CID:451489 | CAS RN:34669-57-3 | PubChem SID:316910945 | UNII:0ENK5NMI1I | SULFOLITHOCHOLIC ACID
+BMGC_DG09747,BMG_DG147787,DrugBank ID:DB04602 | PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE | PubChem CID:451597
+BMGC_DG09748,BMG_DG147788,"CAS RN:22432-95-7 | CAS RN:105597-46-4 | NDC:68083-528 | NDC:72205-036 | NDC:69539-115 | NDC:43598-348 | NDC:75834-190 | NDC:63323-825 | NDC:43598-427 | NDC:67457-316 | NDC:72603-107 | Decitabine | NDC:68001-573 | DrugBank ID:DB01262 | NDC:71288-119 | NDC:16729-224 | NDC:0143-9385 | NDC:25021-231 | NDC:50742-430 | CAS RN:2353-33-5 | NDC:31722-304 | NDC:55111-556 | NDC:70121-1644 | UNII:776B62CQ27 | NDC:55150-376 | NDC:72205-031 | NDC:68001-618 | 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one | PubChem SID:175266226 | NDC:70771-1713 | PubChem CID:451668 | NDC:70710-1656 | DECITABINE | NDC:25021-219 | NDC:67184-0535 | NDC:69097-905"
+BMGC_DG09749,BMG_DG147791,"(2R,3S,4S,6S)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one | 9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-, (9S,10R,11R,13R)- | PubChem CID:451705 | CAS RN:160335-45-5 | CAS RN:62996-74-1"
+BMGC_DG09750,BMG_DG147793,"Muramyl Dipeptide | CAS RN:87420-48-2 | (4R)-4-[[(2S)-2-[[(2R)-2-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoic acid | PubChem CID:451714 | CAS RN:53678-77-6"
+BMGC_DG09751,BMG_DG147808,"CAS RN:187339-50-0 | 1,4-Dideoxy-1,4-imino-d-arabinitol | CAS RN:259140-24-4 | PubChem CID:451991 | (2R,3R,4R)-2-(hydroxymethyl)pyrrolidine-3,4-diol | CAS RN:100937-52-8"
+BMGC_DG09752,BMG_DG147813,"DrugBank ID:DB09114 | CAS RN:63-89-8 | PubChem CID:452110 | PubChem SID:175265844 | UNII:319X2NFW0A | COLFOSCERIL PALMITATE | [(2R)-2,3-di(hexadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate | Colfosceril palmitate"
+BMGC_DG09753,BMG_DG147814,UNII:E1557V1V0N | PubChem CID:4521392 | CAS RN:301836-41-9 | SB-431542 | PubChem SID:255509016
+BMGC_DG09754,BMG_DG147815,"PubChem CID:452142 | UNII:N7HZ7XDP9P | 3′-Deoxy-3′-(1H-1,2,3-triazol-1-yl)thymidine | 3'-DEOXY-3'-(1H-1,2,3-TRIAZOL-1-YL)THYMIDINE | PubChem SID:485663732 | CAS RN:122370-58-5"
+BMGC_DG09755,BMG_DG147824,"CAS RN:16816-67-4 | UNII:7K81IL792L | PANTETHINE | CAS RN:644967-47-5 | PubChem CID:452306 | DrugBank ID:DB11190 | (2R)-N-[3-[2-[2-[3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyldisulfanyl]ethylamino]-3-oxopropyl]-2,4-dihydroxy-3,3-dimethylbutanamide | Pantethine | PubChem SID:175268563"
+BMGC_DG09756,BMG_DG147834,"Teniposide | (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one | TENIPOSIDE | PubChem CID:452548 | DrugBank ID:DB00444 | UNII:957E6438QA | PubChem SID:175267905 | CAS RN:29767-20-2"
+BMGC_DG09757,BMG_DG147860,PubChem CID:452612 | PubChem SID:472422215 | CAS RN:132406-73-6 | UNII:HDB44C64DC | 9-CYCLOBUTYLPURIN-6-AMINE
+BMGC_DG09758,BMG_DG147878,Carboprost tromethamine | DrugBank ID:DB00429 | PubChem CID:45266502
+BMGC_DG09759,BMG_DG147891,"PubChem CID:45266540 | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[[[(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-[2-(3-oxobutanoylsulfanyl)ethylamino]propyl]amino]butoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]oxolan-3-yl] phosphate | CAS RN:1420-36-6 | acetoacetyl-CoA(4-)"
+BMGC_DG09760,BMG_DG147946,"PubChem CID:45266605 | CAS RN:1763-10-6 | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-2-[[[[(3R)-4-[[3-(2-hexadecanoylsulfanylethylamino)-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-4-hydroxyoxolan-3-yl] phosphate | hexadecanoyl CoA"
+BMGC_DG09761,BMG_DG148001,(2R)-2-azaniumyl-3-(disulfanyl)propanoate | CAS RN:5652-32-4 | S-sulfanyl-L-cysteine | PubChem CID:45266695
+BMGC_DG09762,BMG_DG148048,DrugBank ID:DB00895 | Benzylpenicilloyl polylysine | PubChem CID:45266800
+BMGC_DG09763,BMG_DG148051,UNII:8BA8T27317 | CAS RN:1189805-46-6 | 2-(methylamino)-1-(4-methylphenyl)propan-1-one | CAS RN:88783-39-5 | DrugBank ID:DB13108 | PubChem SID:198940626 | MEPHEDRONE | PubChem CID:45266826 | Mephedrone
+BMGC_DG09764,BMG_DG148070,UNII:MB2V93QFR2 | PubChem SID:402404480 | PubChem CID:45267006 | CAS RN:824960-64-7 | JWH-234
+BMGC_DG09765,BMG_DG148071,PubChem SID:375084164 | PubChem CID:45267042 | UNII:B2YM5C862U | JWH-212 | CAS RN:824959-71-9
+BMGC_DG09766,BMG_DG148072,UNII:86F7HL1T40 | PubChem CID:45267043 | PubChem SID:375084103 | JWH-258 | CAS RN:824960-97-6
+BMGC_DG09767,BMG_DG148073,DrugBank ID:DB00027 | Gramicidin D | (2R)-2-[[2-[[(2S)-2-formamido-3-methylbutanoyl]amino]acetyl]amino]-N-[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-(2-hydroxyethylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]-4-methylpentanamide | PubChem CID:45267103 | CAS RN:1393-88-0
+BMGC_DG09768,BMG_DG148075,PubChem CID:45267819 | JWH-148 | UNII:GJ5UPV38RK | CAS RN:824955-99-9 | PubChem SID:474492281
+BMGC_DG09769,BMG_DG148076,UNII:AWD731Y25Z | JWH-149 | PubChem CID:45267820 | CAS RN:548461-82-1 | PubChem SID:312525250
+BMGC_DG09770,BMG_DG148077,PubChem SID:376072229 | PubChem CID:45267831 | UNII:8T0GX6UZQ3 | CAS RN:824960-57-8 | JWH-235
+BMGC_DG09771,BMG_DG148080,PubChem CID:45268455 | CAS RN:1218918-62-7 | UNII:X0LHZ71TLK | PubChem SID:198960168 | MK-7246
+BMGC_DG09772,BMG_DG148081,"PubChem CID:45268539 | DrugBank ID:DB08010 | (3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime"
+BMGC_DG09773,BMG_DG148082,PubChem SID:313183873 | JWH-182 | UNII:7H0XW15CON | PubChem CID:45268702 | CAS RN:824960-02-3
+BMGC_DG09774,BMG_DG148083,JWH-211 | CAS RN:824959-72-0 | UNII:WZL2D4Z9Y5 | PubChem CID:45268706 | PubChem SID:375083870
+BMGC_DG09775,BMG_DG148084,JWH-213 | CAS RN:824959-83-3 | PubChem SID:441331654 | PubChem CID:45268707 | UNII:4S7U3Q8S6W
+BMGC_DG09776,BMG_DG148085,JWH-236 | CAS RN:824960-63-6 | PubChem SID:376072135 | PubChem CID:45268709 | UNII:B0E6QL6VLS
+BMGC_DG09777,BMG_DG148087,"CAS RN:1093108-50-9 | 2-[4,6-bis(dimethylamino)-2-[[4-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methyl]pyrimidin-5-yl]acetic acid | UNII:721F767LHB | 5-Pyrimidineacetic acid, 4,6-bis(dimethylamino)-2-((4-((4-(trifluoromethyl)benzoyl)amino)phenyl)methyl)- | BI-671800 | DrugBank ID:DB12524 | PubChem CID:45270144 | PubChem SID:198974088"
+BMGC_DG09778,BMG_DG148088,"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime | PubChem CID:45270264 | DrugBank ID:DB08015"
+BMGC_DG09779,BMG_DG148089,UNII:R18JYO04PY | JWH-210 | PubChem SID:198986828 | PubChem CID:45270396 | CAS RN:824959-81-1
+BMGC_DG09780,BMG_DG148094,PubChem CID:45271208 | CAS RN:209414-06-2 | UNII:1PRK568FUT | JWH-072 | PubChem SID:252823623
+BMGC_DG09781,BMG_DG148095,JWH-164 | UNII:L3432L6CJJ | CAS RN:824961-61-7 | PubChem CID:45271217 | PubChem SID:440088969
+BMGC_DG09782,BMG_DG148096,PubChem SID:445500643 | 3-(4-BUTYLNAPHTHALENE-1-CARBONYL)-1-PROPYL-1H-INDOLE | CAS RN:824960-04-5 | PubChem CID:45271228 | UNII:PC7MT539NR
+BMGC_DG09783,BMG_DG148100,PubChem CID:45272116 | JWH-098 | CAS RN:316189-74-9 | PubChem SID:272993947 | UNII:T27V33219F
+BMGC_DG09784,BMG_DG148101,"D-Levofloxacin | UNII:36OPE0O92Z | DrugBank ID:DB03034 | PubChem SID:198971571 | PubChem CID:452723 | OFLOXACIN, D- | CAS RN:100986-86-5"
+BMGC_DG09785,BMG_DG148103,"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one | DrugBank ID:DB07431 | PubChem CID:45273683"
+BMGC_DG09786,BMG_DG148106,"2-N-((1S)-1-(5-FLUOROPYRIMIDIN-2-YL)ETHYL)-4-N-(1-METHYLIMIDAZOL-4-YL)-7H-PYRROLO(2,3-D)PYRIMIDINE-2,4-DIAMINE | PubChem SID:319892455 | UNII:7N5LJ2Z26C | PubChem CID:45275255 | CAS RN:1220516-48-2"
+BMGC_DG09787,BMG_DG148108,UNII:SIS5BFO4WL | CAS RN:1221416-43-8 | RELENOPRIDE | PubChem CID:45275554 | PubChem SID:316911235 | Relenopride | DrugBank ID:DB12798 | [(1S)-3-[4-[[(4-amino-5-chloro-2-methoxybenzoyl)amino]methyl]piperidin-1-yl]-1-(4-fluorophenyl)propyl] carbamate
+BMGC_DG09788,BMG_DG148113,"UNII:1LGS5JRP31 | DrugBank ID:DB04821 | NOMIFENSINE | Nomifensine | PubChem SID:198983260 | CAS RN:118184-50-2 | CAS RN:24526-64-5 | 2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-amine | PubChem CID:4528"
+BMGC_DG09789,BMG_DG148130,PubChem SID:241180945 | UNII:333BVY614O | PubChem CID:453131 | CAS RN:3482-37-9 | TRIMETHYLCOLCHICINIC ACID
+BMGC_DG09790,BMG_DG148137,"Nordihydroguaiaretic acid | PubChem CID:4534 | 4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol | CAS RN:500-38-9"
+BMGC_DG09791,BMG_DG148160,"PubChem CID:45357148 | CAS RN:68-19-9 | cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide"
+BMGC_DG09792,BMG_DG148161,"PubChem CID:45357193 | CAS RN:13422-51-0 | cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate"
+BMGC_DG09793,BMG_DG148237,"NDC:61958-1501 | Sofosbuvir | SOFOSBUVIR | NDC:61958-2201 | NDC:61958-2203 | NDC:61958-2204 | NDC:61958-1505 | PubChem CID:45375808 | PubChem SID:198982808 | DrugBank ID:DB08934 | propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate | UNII:WJ6CA3ZU8B | NDC:61958-2205 | NDC:61958-1504 | NDC:61958-2401 | NDC:61958-1503 | CAS RN:1190307-88-0"
+BMGC_DG09794,BMG_DG148241,"5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine | Sapanisertib | PubChem SID:198988197 | DrugBank ID:DB11836 | UNII:JGH0DF1U03 | PubChem CID:45375953 | CAS RN:1224844-38-5 | SAPANISERTIB"
+BMGC_DG09795,BMG_DG148242,"CAS RN:911824-55-0 | PubChem CID:45375955 | 2-(6-fluorobenzimidazol-1-yl)-9-[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]-7H-purin-8-one | (R)-2-(6-Fluoro-1H-benzo[d]imidazol-1-yl)-9-(8-fluorochroman-4-yl)-7H-purin-8(9H)-one"
+BMGC_DG09796,BMG_DG148247,CAS RN:536-21-0 | DrugBank ID:DB13378 | CAS RN:15308-34-6 | Norfenefrine | 3-(2-amino-1-hydroxyethyl)phenol | UNII:D2P3M6SRN5 | PubChem SID:198940943 | NORFENEFRINE | PubChem CID:4538
+BMGC_DG09797,BMG_DG148253,"PubChem CID:45380979 | (2R,3R)-3-[2-[4-(cyclopropylsulfonimidoyl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]oxybutan-2-ol | CID 45380979 | CAS RN:1223498-69-8 | CAS RN:1223498-26-7"
+BMGC_DG09798,BMG_DG148261,1-ethyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid | Norfloxacin | UNII:N0F8P22L1P | CAS RN:70458-96-7 | NORFLOXACIN | PubChem CID:4539 | PubChem SID:175265633 | DrugBank ID:DB01059
+BMGC_DG09799,BMG_DG148265,"UNII:X9U41NXR6M | Norfludiazepam | CAS RN:2886-65-9 | NORFLURAZEPAM | PubChem CID:4540 | PubChem SID:198985964 | 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one"
+BMGC_DG09800,BMG_DG148270,PubChem CID:4541001 | [6-amino-9-(2-methoxycarbonylphenyl)xanthen-3-ylidene]azanium | 6-amino-9-[2-(methoxycarbonyl)phenyl]-3H-xanthen-3-iminium
+BMGC_DG09801,BMG_DG148274,"Troxacitabine | UNII:60KQZ0388Y | TROXACITABINE | PubChem SID:198953987 | CAS RN:145918-75-8 | DrugBank ID:DB04961 | PubChem CID:454194 | 4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2-one"
+BMGC_DG09802,BMG_DG148275,"DrugBank ID:DB09389 | Norgestrel | Ovrette | CAS RN:6533-00-2 | PubChem CID:4542 | 13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG09803,BMG_DG148277,"UNII:2C6NUM6878 | NDC:24201-101 | PubChem SID:175265859 | PubChem CID:454216 | VALRUBICIN | [2-oxo-2-[(2S,4S)-2,5,12-trihydroxy-4-[(2R,4S,5S,6S)-5-hydroxy-6-methyl-4-[(2,2,2-trifluoroacetyl)amino]oxan-2-yl]oxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethyl] pentanoate | NDC:67979-001 | DrugBank ID:DB00385 | CAS RN:56124-62-0 | Valrubicin"
+BMGC_DG09804,BMG_DG148278,CAS RN:60857-08-1 | PubChem SID:404859876 | PubChem CID:454217 | UNII:KO94U6DIQ6 | PROSTRATIN
+BMGC_DG09805,BMG_DG148279,"N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine | CAS RN:72-69-5 | UNII:BL03SY4LXB | DrugBank ID:DB00540 | NORTRIPTYLINE | PubChem SID:175268630 | PubChem CID:4543 | Nortriptyline"
+BMGC_DG09806,BMG_DG148381,"PubChem CID:45480632 | DrugBank ID:DB07716 | (4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL"
+BMGC_DG09807,BMG_DG148382,TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE | DrugBank ID:DB07672 | PubChem CID:45480634
+BMGC_DG09808,BMG_DG148385,"PubChem SID:474494770 | UNII:A37QL5GP6B | PubChem CID:45481701 | 1-(7-ETHYL-1H-FURO(2,3-G)INDAZOL-1-YL)PROPAN-2-AMINE, (2R)- | CAS RN:1174011-02-9 | 1-{7-ethyl-1H-furo[2,3-g]indazol-1-yl}propan-2-amine, (2R)-"
+BMGC_DG09809,BMG_DG148387,PubChem SID:198944780 | PubChem CID:45483949 | INT-777 | CAS RN:1199796-29-6 | UNII:UTD8BCW6B8
+BMGC_DG09810,BMG_DG148393,CAS RN:1187422-25-8 | PubChem CID:45487209 | 4-(Ethylamino)-1-naphthalenol | PubChem SID:478838433 | UNII:SU4EGY7JBJ | 4-(ETHYLAMINO)-1-NAPHTHALENOL
+BMGC_DG09811,BMG_DG148394,"PubChem CID:45487890 | UNII:0RT1GZ9I8Z | 1-(3,4-DICHLOROPHENYL)-2-((1,1-DIMETHYLETHYL)AMINO)-1-PROPANONE | PubChem SID:434370184 | CAS RN:1193779-34-8"
+BMGC_DG09812,BMG_DG148400,CAS RN:107254-86-4 | 5-nitro-2-(3-phenylpropylamino)benzoic acid | PubChem CID:4549 | PubChem SID:198986476 | UNII:3A35O9G3YZ | 5-Nitro-2-(3-phenylpropylamino)benzoic acid | 5-NITRO-2-(3-PHENYLPROPYLAMINO)BENZOIC ACID
+BMGC_DG09813,BMG_DG148410,"(4aR)-5,6-dihydroxy-1,1-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylic acid | PubChem CID:455260 | RoseOx"
+BMGC_DG09814,BMG_DG148411,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | PubChem SID:474493897 | N-[2-(Cyclohexyloxy)-4-nitrophenyl]methanesulfonamide | CAS RN:123653-11-2 | DrugBank ID:DB14060 | PubChem CID:4553 | NS-398 | N-(2-(CYCLOHEXYLOXY)-4-NITROPHENYL)METHANESULFONAMIDE | UNII:9SP55KM2KS
+BMGC_DG09815,BMG_DG148419,"PubChem CID:455658 | Panhematin | HEMIN | UNII:743LRP9S7N | CAS RN:16009-13-5 | NDC:55292-702 | 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid;iron(3+);chloride | PubChem SID:175268079"
+BMGC_DG09816,BMG_DG148421,Zidovudine diphosphate | PubChem CID:455742 | PubChem SID:198953033 | ZIDOVUDINE DIPHOSPHATE | UNII:K7ZG448V5M | CAS RN:106060-89-3 | DrugBank ID:DB04542
+BMGC_DG09817,BMG_DG148425,"CAS RN:24144-61-4 | PubChem SID:377308189 | CAS RN:15645-11-1 | PubChem CID:455821 | UNII:GAS8L324N7 | KHELLACTONE, CIS-(+/-)- | KHELLACTONE, CIS-(±)- | KHELLACTONE, CIS-(+)- | PubChem SID:377308545 | UNII:V04P1S3P1A"
+BMGC_DG09818,BMG_DG148426,"PubChem CID:45588096 | Bydureon | CAS RN:141758-74-9 | (4S)-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-4-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]acetyl]amino]-5-oxopentanoic acid"
+BMGC_DG09819,BMG_DG148441,"(6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine | PubChem SID:198982738 | DrugBank ID:DB05154 | NDC:49502-476 | PRETOMANID | UNII:2XOI31YC4N | Pretomanid | PubChem CID:456199 | CAS RN:187235-37-6"
+BMGC_DG09820,BMG_DG148442,"PubChem CID:456201 | CAS RN:142128-59-4 | (+)-Ketoconazole | 1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | CAS RN:65277-42-1"
+BMGC_DG09821,BMG_DG148443,PubChem CID:456214 | DrugBank ID:DB04751 | Purvalanol A | CAS RN:212844-53-6 | UNII:YP483E75C4 | PubChem SID:440088381 | PURVALANOL A
+BMGC_DG09822,BMG_DG148444,"UNII:5CKP8C2LLI | CAS RN:30034-03-8 | CAS RN:34444-01-4 | PubChem CID:456255 | DrugBank ID:DB01326 | Cefamandole | PubChem SID:175268221 | (6R,7R)-7-[[(2R)-2-hydroxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CEFAMANDOLE"
+BMGC_DG09823,BMG_DG148447,"(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol | CAS RN:51688-68-7 | (+)-Mefloquine | PubChem CID:456309 | CAS RN:51744-83-3"
+BMGC_DG09824,BMG_DG148448,C31G | DrugBank ID:DB05398 | PubChem CID:456362
+BMGC_DG09825,BMG_DG148449,"2-(4-chlorophenyl)-2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]acetonitrile | PubChem CID:456389 | DrugBank ID:DB11398 | Diclazuril | CAS RN:101831-37-2 | UNII:K110K1B1VE | PubChem SID:175271536 | DICLAZURIL"
+BMGC_DG09826,BMG_DG148451,"UNII:L31MM1385E | CAS RN:868851-54-1 | PubChem SID:175271582 | CAS RN:55837-20-2 | 7-bromo-6-chloro-3-[3-[(2R,3S)-3-hydroxypiperidin-2-yl]-2-oxopropyl]quinazolin-4-one | Halofuginone | HALOFUGINONE, (+)- | PubChem CID:456390 | HALOFUGINONE | UNII:H84E4Y7HC9 | DrugBank ID:DB04866 | PubChem SID:461433480"
+BMGC_DG09827,BMG_DG148453,6-O-Cyclohexylmethyl Guanine | UNII:884MN6AR44 | CAS RN:161058-83-9 | PubChem CID:4564 | DrugBank ID:DB02407 | NU-2058 | PubChem SID:459056207
+BMGC_DG09828,BMG_DG148457,4-hydroxy-5-methylfuran-3-one | PubChem CID:4564493 | UNII:MTB57102LQ | PubChem SID:198938918 | 4-Hydroxy-5-methyl-3(2H)-furanone | 4-HYDROXY-5-METHYL-3(2H)-FURANONE | CAS RN:19322-27-1
+BMGC_DG09829,BMG_DG148458,"CAS RN:327-56-0 | DrugBank ID:DB04419 | UNII:VP8G7LX265 | D-norleucine | PubChem SID:198948773 | PubChem CID:456468 | NORLEUCINE, D-(-)-"
+BMGC_DG09830,BMG_DG148460,UNII:7ZB2ZT8JKM | 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE | PubChem CID:4565 | N-(3-CHLOROPHENYL)-6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-AMINE | CAS RN:444722-81-0 | DrugBank ID:DB07203
+BMGC_DG09831,BMG_DG148461,"UNII:9Z22C3QQCJ | DrugBank ID:DB12939 | CAS RN:86003-55-6 | Nikkomycin Z | NIKKOMYCIN Z | (2S)-2-[[(2S,3S,4S)-2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methylbutanoyl]amino]-2-[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid | PubChem SID:198946564 | PubChem CID:456557 | CAS RN:59456-70-1"
+BMGC_DG09832,BMG_DG148463,DrugBank ID:DB07126 | O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE | CAS RN:444722-95-6 | NU-6102 | PubChem SID:441097335 | PubChem CID:4566 | UNII:X5J53DR704
+BMGC_DG09833,BMG_DG148466,PubChem CID:4567 | NYLIDRIN | 4-[1-hydroxy-2-(4-phenylbutan-2-ylamino)propyl]phenol | Nylidrin | CAS RN:447-41-6 | UNII:695DKH33EI | DrugBank ID:DB06152 | PubChem SID:198984394
+BMGC_DG09834,BMG_DG148473,PubChem CID:457 | TRIGONELLAMIDE | PubChem SID:198975697 | DrugBank ID:DB11710 | 1-methylpyridin-1-ium-3-carboxamide | 1-Methylnicotinamide | CAS RN:3106-60-3 | Trigonellamide | UNII:UM47085BXC
+BMGC_DG09835,BMG_DG148478,"NDC:42658-008 | DrugBank ID:DB00970 | NDC:55150-928 | UNII:1CC1JFE158 | Dactinomycin | PubChem CID:457193 | CAS RN:50-76-0 | NDC:71288-129 | PubChem SID:175266072 | 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide | NDC:39822-2100 | NDC:55150-431 | DACTINOMYCIN"
+BMGC_DG09836,BMG_DG148479,CAS RN:518-55-8 | PubChem CID:457194 | .ALPHA.-CONIDENDRIN | PubChem SID:318164626 | UNII:83D6S2EBN0
+BMGC_DG09837,BMG_DG148493,CAS RN:104343-33-1 | PubChem SID:346540726 | PubChem CID:457676 | MDL-25637 | UNII:PUGMWU0AL6
+BMGC_DG09838,BMG_DG148497,6-phenylmethoxy-7H-purin-2-amine | CAS RN:19916-73-5 | CAS RN:1000874-21-4 | PubChem SID:198941077 | 6-O-BENZYLGUANINE | PubChem CID:4578 | UNII:01KC87F8FE | o6-Benzylguanine | DrugBank ID:DB11919 | 6-O-benzylguanine
+BMGC_DG09839,BMG_DG148537,UNII:6TXL33ZFOP | CAS RN:410544-95-5 | PubChem CID:457930 | PubChem SID:198938128 | L-870810
+BMGC_DG09840,BMG_DG148538,"TIAZOFURIN | CAS RN:60084-10-8 | PubChem SID:198978476 | PubChem CID:457954 | DrugBank ID:DB13243 | 2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carboxamide | UNII:ULJ82834RE | Tiazofurin"
+BMGC_DG09841,BMG_DG148539,"PubChem SID:241180502 | APHIDICOLIN, (±)- | PubChem SID:241177900 | APHIDICOLIN, (+/-)- | Aphidicolin | UNII:6B3F8QW8TU | CAS RN:38966-21-1 | UNII:192TJ6PP19 | APHIDICOLIN | (1S,2S,5R,6R,7R,10S,12R,13R)-6,13-bis(hydroxymethyl)-2,6-dimethyltetracyclo[10.3.1.01,10.02,7]hexadecane-5,13-diol | PubChem CID:457964 | CAS RN:69926-98-3"
+BMGC_DG09842,BMG_DG148540,"PubChem CID:457967 | 17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol | 17-Ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol"
+BMGC_DG09843,BMG_DG148542,PubChem SID:198989829 | HERACLENIN | CAS RN:2880-49-1 | PubChem CID:458010 | UNII:G71S84CX12
+BMGC_DG09844,BMG_DG148547,4-(2-amino-1-hydroxyethyl)phenol | UNII:14O50WS8JD | PubChem SID:175272127 | OCTOPAMINE | Octopamine | CAS RN:104-14-3 | PubChem CID:4581 | DrugBank ID:DB13251
+BMGC_DG09845,BMG_DG148549,"NDC:0904-7434 | NDC:68071-3448 | NDC:70756-609 | NDC:75834-120 | NDC:24208-410 | NDC:68071-1630 | DrugBank ID:DB01165 | NDC:71209-097 | NDC:68788-8195 | NDC:67296-1819 | NDC:70756-650 | NDC:11980-779 | NDC:67296-1223 | NDC:70069-686 | NDC:70756-610 | NDC:68071-3604 | 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid | NDC:70069-687 | NDC:68071-3566 | PubChem SID:175272066 | NDC:69238-1615 | NDC:75834-200 | NDC:72189-472 | NDC:72485-613 | NDC:68788-8761 | NDC:70512-793 | NDC:63187-268 | NDC:63187-734 | NDC:71209-099 | NDC:65145-143 | NDC:68788-8551 | OFLOXACIN | NDC:50090-5670 | NDC:65145-142 | NDC:63187-662 | NDC:72603-186 | NDC:71209-098 | NDC:70518-2037 | NDC:63187-184 | NDC:70756-607 | NDC:70518-4147 | NDC:67296-1670 | NDC:50090-5186 | NDC:70518-3842 | NDC:72162-2108 | NDC:69315-327 | NDC:63629-8716 | NDC:82804-061 | NDC:68071-2254 | NDC:70069-411 | NDC:50090-1744 | NDC:71205-682 | CAS RN:82419-36-1 | NDC:75834-199 | NDC:59390-140 | NDC:70518-3984 | NDC:68071-2265 | NDC:72189-490 | NDC:68071-1607 | NDC:72603-192 | NDC:64980-432 | NDC:68788-7693 | UNII:A4P49JAZ9H | CAS RN:83380-47-6 | NDC:71205-420 | NDC:69238-1616 | NDC:76420-749 | NDC:70518-3573 | Ofloxacin | NDC:50090-7207 | NDC:63187-472 | NDC:69315-320 | NDC:50090-6794 | NDC:75834-201 | NDC:50090-7264 | NDC:75834-119 | NDC:82804-101 | NDC:50090-5209 | NDC:72162-1709 | NDC:24208-434 | NDC:70518-4226 | NDC:67296-2076 | NDC:67296-1866 | NDC:60505-0560 | NDC:67296-0344 | NDC:68071-1588 | NDC:65145-144 | NDC:68788-8449 | NDC:70518-3710 | NDC:64980-515 | NDC:50090-5425 | NDC:65145-141 | NDC:72189-108 | NDC:75834-112 | PubChem CID:4583 | NDC:69238-1665 | NDC:50090-1090 | NDC:60505-0363 | NDC:76420-748 | NDC:60760-970"
+BMGC_DG09846,BMG_DG148562,PubChem CID:4585 | Olanzapine | DrugBank ID:DB00334
+BMGC_DG09847,BMG_DG148565,PubChem CID:458519 | CAS RN:18259-37-5 | ETHCATHINONE | PubChem SID:316915558 | UNII:HV3BCK77BB
+BMGC_DG09848,BMG_DG148575,(4-NONYLPHENYL)BORONIC ACID | CAS RN:256383-45-6 | PubChem SID:474492373 | PubChem CID:4589192 | UNII:2SY8DS7Y3D
+BMGC_DG09849,BMG_DG148581,2-[[6-(benzylamino)-9-methylpurin-2-yl]amino]ethanol | DrugBank ID:DB02116 | OLOMOUCINE | Olomoucine | PubChem SID:198975529 | CAS RN:101622-51-9 | UNII:6A839B2HYS | PubChem CID:4592
+BMGC_DG09850,BMG_DG148586,"PubChem SID:198984786 | Olprinone | UNII:4Y8BMI9YGC | OLPRINONE | PubChem CID:4593 | CAS RN:106730-54-5 | 5-imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-1H-pyridine-3-carbonitrile"
+BMGC_DG09851,BMG_DG148608,"NDC:71335-1395 | NDC:60687-608 | NDC:71610-688 | NDC:71205-985 | NDC:71713-201 | NDC:80425-0109 | NDC:51407-816 | NDC:70518-2295 | CAS RN:73590-58-6 | NDC:51407-813 | NDC:80425-0169 | NDC:68196-303 | NDC:68012-052 | NDC:50090-7474 | NDC:63981-915 | NDC:71335-1636 | NDC:79903-305 | NDC:76162-470 | NDC:43598-010 | NDC:60760-489 | NDC:71335-1532 | NDC:0113-1723 | NDC:68382-500 | NDC:0781-2234 | NDC:21130-128 | NDC:58602-725 | NDC:0781-2859 | NDC:50090-7473 | NDC:51407-641 | NDC:80425-0071 | NDC:60760-868 | NDC:72162-1906 | NDC:71610-280 | NDC:50090-7021 | NDC:68071-3007 | NDC:62135-530 | NDC:49348-846 | NDC:68382-502 | NDC:57237-162 | NDC:72288-401 | NDC:75907-138 | NDC:50090-7019 | NDC:60760-833 | NDC:69230-318 | NDC:70518-3278 | NDC:60505-0146 | NDC:67046-1312 | NDC:69665-216 | NDC:72162-2388 | NDC:70700-149 | NDC:50090-6720 | NDC:50090-6697 | NDC:68071-2262 | NDC:49035-915 | NDC:41520-915 | NDC:55111-158 | NDC:63187-170 | NDC:11673-212 | NDC:0113-1803 | Omeprazole | NDC:80425-0415 | NDC:71335-9609 | NDC:62175-136 | NDC:37835-001 | NDC:11822-1040 | NDC:51660-029 | NDC:16714-123 | NDC:81522-915 | NDC:62175-118 | NDC:55154-8191 | NDC:68788-6995 | NDC:0363-0732 | NDC:71335-0299 | NDC:56062-915 | NDC:0113-0520 | NDC:82632-699 | NDC:11673-323 | NDC:11822-0915 | NDC:63187-070 | NDC:46122-616 | NDC:36800-121 | NDC:59779-503 | NDC:21130-991 | NDC:70000-0381 | NDC:50090-7367 | NDC:72288-047 | NDC:59651-003 | NDC:37808-354 | NDC:59651-001 | NDC:70771-1102 | NDC:50228-364 | NDC:59651-002 | NDC:60505-0145 | NDC:82804-166 | NDC:51655-893 | NDC:50090-7018 | NDC:43063-743 | NDC:69367-195 | NDC:71335-1746 | NDC:68382-411 | NDC:79481-0075 | NDC:64024-915 | NDC:53041-664 | NDC:55111-643 | NDC:0113-0058 | NDC:41250-915 | NDC:60505-3952 | NDC:42708-159 | NDC:16714-634 | NDC:57237-161 | NDC:50090-6888 | NDC:68682-990 | NDC:68196-915 | NDC:31722-527 | NDC:80425-0070 | NDC:68012-104 | NDC:70677-1104 | NDC:41250-401 | NDC:63187-787 | NDC:79903-013 | NDC:68382-503 | NDC:36800-601 | NDC:70677-0148 | NDC:71335-0569 | NDC:72036-981 | NDC:64380-182 | NDC:72288-123 | NDC:50228-363 | NDC:63629-2490 | NDC:70677-1098 | NDC:67296-2101 | NDC:27241-029 | NDC:83008-077 | NDC:65841-760 | NDC:71205-960 | NDC:59779-580 | NDC:68788-6881 | NDC:71205-613 | NDC:71610-248 | NDC:50594-011 | UNII:KG60484QX9 | NDC:45802-888 | NDC:51407-287 | NDC:68788-8805 | NDC:37808-915 | NDC:68012-054 | NDC:0615-8406 | NDC:64380-224 | NDC:68084-128 | NDC:27241-030 | NDC:50090-5501 | NDC:68071-4024 | NDC:43598-841 | NDC:72288-915 | NDC:50268-656 | NDC:55111-645 | NDC:49999-265 | NDC:0904-6917 | NDC:50090-2769 | NDC:0781-2790 | NDC:16714-714 | NDC:11673-915 | NDC:68462-396 | NDC:63187-828 | OMEPRAZOLE | NDC:50090-7214 | NDC:50090-6696 | NDC:70700-150 | NDC:71205-501 | NDC:55301-915 | NDC:68391-915 | NDC:11822-0453 | NDC:70677-1275 | NDC:68012-102 | NDC:68071-4906 | NDC:72476-473 | NDC:53041-663 | NDC:63187-820 | NDC:11673-346 | NDC:63187-805 | PubChem CID:4594 | NDC:51407-814 | NDC:55910-915 | NDC:55910-215 | NDC:51407-130 | NDC:68071-2243 | NDC:57483-840 | NDC:63941-997 | NDC:70771-1337 | NDC:64380-183 | NDC:50090-5901 | NDC:64380-223 | NDC:79903-113 | NDC:65841-759 | NDC:82501-0915 | NDC:46122-281 | NDC:50090-7213 | NDC:0363-0007 | NDC:50090-7215 | NDC:68382-501 | NDC:46122-029 | NDC:69367-196 | NDC:75907-237 | NDC:82632-101 | NDC:63868-471 | NDC:70518-2791 | NDC:71610-704 | NDC:68462-395 | NDC:57237-160 | NDC:31722-528 | CAS RN:119141-88-7 | NDC:70518-0199 | NDC:68682-991 | NDC:68788-8771 | NDC:55700-410 | NDC:27241-031 | NDC:0363-6101 | NDC:72288-732 | NDC:50090-6721 | NDC:51655-452 | NDC:68071-3733 | NDC:69097-913 | NDC:68462-397 | NDC:55111-157 | NDC:43598-286 | NDC:55910-713 | NDC:76420-055 | NDC:50090-5111 | NDC:11822-1190 | NDC:71335-1852 | NDC:56062-401 | NDC:43598-307 | CAS RN:161796-78-7 | NDC:65841-761 | NDC:67046-1437 | NDC:82009-023 | NDC:59640-047 | NDC:41520-802 | NDC:69097-914 | NDC:71610-663 | NDC:0113-0915 | NDC:27241-032 | NDC:50090-3876 | NDC:41520-939 | NDC:50090-7472 | NDC:83324-011 | NDC:21130-137 | NDC:76420-879 | NDC:69842-791 | NDC:71335-1851 | NDC:57896-659 | NDC:41163-634 | NDC:37808-401 | NDC:0781-2868 | NDC:62175-114 | NDC:59779-732 | NDC:55111-159 | NDC:72789-257 | 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole | NDC:50268-657 | NDC:72162-1907 | NDC:51407-664 | NDC:55154-2332 | NDC:55910-712 | NDC:46122-739 | NDC:72189-568 | PubChem SID:175271405 | NDC:11673-018 | NDC:68071-2199 | NDC:55681-306 | NDC:50090-7366 | NDC:42708-158 | NDC:71335-9744 | NDC:50090-1157 | NDC:49035-119 | NDC:68071-4025 | NDC:70518-2251 | NDC:68196-700 | NDC:72789-482 | NDC:82868-043 | NDC:82632-100 | NDC:70518-4177 | NDC:71335-1191 | NDC:36800-915 | NDC:71335-0332 | NDC:0781-2785 | NDC:11523-7276 | NDC:71205-157 | NDC:0615-8079 | NDC:30142-992 | NDC:68382-412 | NDC:71205-959 | NDC:60505-0065 | NDC:21130-018 | NDC:41250-938 | NDC:41250-349 | NDC:67296-1346 | NDC:68682-102 | NDC:71205-907 | NDC:69842-661 | NDC:68001-441 | NDC:30142-557 | NDC:63629-2491 | NDC:21130-401 | NDC:42708-170 | NDC:62756-377 | NDC:70771-1101 | CAS RN:326602-80-6 | NDC:82009-022 | DrugBank ID:DB00338 | NDC:76420-878 | NDC:30142-394 | NDC:72789-155 | NDC:43353-829 | NDC:30142-593 | NDC:0363-0915 | NDC:0363-1819 | NDC:64380-222 | NDC:72559-014 | NDC:63187-061 | NDC:41163-915 | NDC:68391-103 | NDC:0363-1607 | NDC:16714-715 | NDC:37808-732 | NDC:55111-644 | NDC:68682-104 | NDC:71205-984 | NDC:51655-061"
+BMGC_DG09852,BMG_DG148610,"NDC:67296-1140 | CAS RN:99614-02-5 | NDC:65862-390 | NDC:68462-158 | NDC:51655-809 | NDC:16729-298 | NDC:55700-672 | NDC:63187-379 | NDC:68071-5167 | 9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one | NDC:67296-0386 | NDC:72336-073 | NDC:67296-0341 | NDC:65862-391 | NDC:70518-1551 | NDC:70934-809 | NDC:80425-0469 | NDC:60760-567 | NDC:76420-251 | NDC:43063-857 | NDC:16714-200 | NDC:63629-4306 | NDC:51655-913 | NDC:80425-0073 | NDC:68071-2284 | NDC:68071-1730 | NDC:76420-056 | NDC:63187-266 | NDC:68071-5021 | NDC:50090-4632 | NDC:68001-246 | NDC:62135-121 | NDC:62135-878 | NDC:68788-8666 | UNII:4AF302ESOS | PubChem SID:175271592 | PubChem CID:4595 | DrugBank ID:DB00904 | NDC:71335-0650 | NDC:50090-1128 | NDC:63187-693 | NDC:63187-002 | NDC:62135-879 | NDC:43063-273 | NDC:55154-3680 | NDC:57237-078 | CAS RN:116002-70-1 | NDC:68071-2763 | NDC:68462-157 | NDC:68071-4570 | NDC:82982-061 | NDC:16714-201 | NDC:67296-0847 | NDC:80425-0473 | NDC:43063-870 | NDC:50090-1201 | NDC:67296-1117 | NDC:63187-670 | ONDANSETRON | NDC:63187-526 | NDC:50090-5346 | NDC:60760-313 | NDC:51655-196 | NDC:63187-199 | NDC:35356-197 | NDC:62756-240 | NDC:50090-1659 | NDC:68788-9559 | NDC:70934-634 | NDC:71335-9726 | Ondansetron | NDC:63187-483 | NDC:51655-008 | NDC:67296-1321 | NDC:50090-1200 | NDC:55154-8339 | NDC:71335-1071 | NDC:71205-713 | NDC:60760-654 | NDC:63187-256 | NDC:68788-7565 | NDC:67296-1550 | NDC:50090-1658 | NDC:50090-2343 | NDC:83008-026 | NDC:71335-1314 | NDC:71335-1731 | NDC:50090-1660 | NDC:68071-5230 | NDC:67296-0815 | NDC:68071-4834 | NDC:68788-7644 | NDC:80425-0228 | NDC:51662-1514 | NDC:55700-952 | NDC:62135-122 | NDC:80425-0227 | NDC:60760-277 | NDC:51662-1246 | NDC:57237-077 | NDC:70518-3512 | NDC:67296-1137 | NDC:68071-4881 | NDC:62756-356 | NDC:55154-4567 | NDC:68001-247 | NDC:60760-306 | NDC:80425-0222 | NDC:76420-217"
+BMGC_DG09853,BMG_DG148615,8-HYDROXY-5-QUINOLINECARBOXYLIC ACID | CAS RN:5852-78-8 | PubChem CID:459617 | PubChem SID:198942941 | UNII:JM015YQC1C
+BMGC_DG09854,BMG_DG148617,"4-OXO-1H-1,10-PHENANTHROLINE-3-CARBOXYLIC ACID | PubChem CID:459803 | UNII:K73A9XJ8TU"
+BMGC_DG09855,BMG_DG148624,CAS RN:9009-62-5 | GUAIACOL | CAS RN:90-05-1 | DrugBank ID:DB11359 | PubChem SID:175267852 | Guaiacol | UNII:6JKA7MAH9C | PubChem CID:460 | 2-methoxyphenol
+BMGC_DG09856,BMG_DG148625,"PubChem CID:460087 | PUUPEHEDINONE, (+)- | Puupehedinone, (+)- | UNII:2B8NU9GHV3 | CAS RN:151345-10-7 | PubChem SID:482554160"
+BMGC_DG09857,BMG_DG148626,"CAS RN:83-98-7 | Orphenadrine | DrugBank ID:DB01173 | ORPHENADRINE | PubChem SID:175271481 | UNII:AL805O9OG9 | PubChem CID:4601 | N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine"
+BMGC_DG09858,BMG_DG148628,CAS RN:526-18-1 | PubChem CID:4602 | OSALMID | 2-hydroxy-N-(4-hydroxyphenyl)benzamide | PubChem SID:198968036 | Osalmid | UNII:89741L759Z
+BMGC_DG09859,BMG_DG148637,"PubChem CID:4604 | Oxonic Acid | Oteracil | DrugBank ID:DB03209 | OTERACIL | UNII:5VT6420TIG | CAS RN:937-13-3 | 4,6-dioxo-1H-1,3,5-triazine-2-carboxylic acid | PubChem SID:198948041"
+BMGC_DG09860,BMG_DG148644,"LY 367265 | CAS RN:210751-39-6 | UNII:SS58UXZ8ZU | 3-[2-[4-(6-fluoro-1H-indol-3-yl)-3,6-dihydro-2H-pyridin-1-yl]ethyl]-2lambda6-thia-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-triene 2,2-dioxide | PubChem CID:4605800 | LY-367265 | PubChem SID:441659742"
+BMGC_DG09861,BMG_DG148649,CAS RN:3223-07-2 | PubChem CID:460612 | PubChem SID:175266192 | CAS RN:148-82-3 | DrugBank ID:DB01042 | Melphalan | (2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid | UNII:Q41OR9510P | CAS RN:8057-25-8 | MELPHALAN
+BMGC_DG09862,BMG_DG148652,UNII:KE4E342X6S | PubChem SID:459055756 | 3-METHYLTOXOFLAVIN | CAS RN:32502-62-8 | PubChem CID:460747
+BMGC_DG09863,BMG_DG148654,5-GALLOYLSHIKIMIC ACID | CAS RN:95719-51-0 | UNII:9XEH2JM56J | PubChem SID:255509186 | PubChem CID:460897
+BMGC_DG09864,BMG_DG148655,PubChem CID:46093 | UNII:9Z3ZT09RRU | MIOTINE | PubChem SID:318691906 | CAS RN:4464-16-8
+BMGC_DG09865,BMG_DG148662,PubChem CID:461195 | PubChem SID:198979731 | UNII:ARZ5J0DL0M | CAS RN:172832-10-9 | PD-146626
+BMGC_DG09866,BMG_DG148663,"Oxamniquine | OXAMNIQUINE | UNII:0O977R722D | UNII:00BCY677OT | PubChem SID:198982366 | DrugBank ID:DB01096 | PubChem CID:4612 | [7-nitro-2-[(propan-2-ylamino)methyl]-1,2,3,4-tetrahydroquinolin-6-yl]methanol | PubChem SID:329589057 | PubChem SID:329589192 | CAS RN:119678-90-9 | CAS RN:40247-39-0 | UNII:7GIJ138H3K | OXAMNIQUINE, (+)- | OXAMNIQUINE, (-)- | CAS RN:21738-42-1"
+BMGC_DG09867,BMG_DG148665,"Cyclic 3',5'-thymidine monophosphate | CAS RN:27646-59-9 | UNII:Q77PE87U4K | STAVUDINE MONOPHOSPHATE | PubChem CID:461278 | DrugBank ID:DB04672 | PubChem SID:445500043"
+BMGC_DG09868,BMG_DG148666,"PubChem CID:461279 | 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate | DrugBank ID:DB02569"
+BMGC_DG09869,BMG_DG148671,"PubChem SID:198941703 | CAS RN:163157-04-8 | CAS RN:273401-03-9 | SITAFLOXACIN ANHYDROUS | CAS RN:155421-11-7 | CAS RN:167355-47-7 | CAS RN:127254-12-0 | 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid | CAS RN:163253-35-8 | PubChem CID:461399 | UNII:3GJC60U4Q8 | Sitafloxacin"
+BMGC_DG09870,BMG_DG148672,"NDC:71335-2295 | NDC:0025-1381 | NDC:71335-0617 | CAS RN:21256-18-8 | NDC:72189-595 | PubChem SID:175265879 | NDC:0185-0141 | NDC:59762-6002 | UNII:MHJ80W9LRB | NDC:69238-1120 | Oxaprozin | DrugBank ID:DB00991 | NDC:62135-176 | PubChem CID:4614 | NDC:60760-382 | NDC:72162-1051 | NDC:71335-0902 | 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid | NDC:60760-203 | NDC:55111-170 | NDC:71335-0393 | NDC:63629-8724 | NDC:69499-403 | NDC:73308-403 | OXAPROZIN"
+BMGC_DG09871,BMG_DG148673,OXATOMIDE | DrugBank ID:DB12877 | 3-[3-(4-benzhydrylpiperazin-1-yl)propyl]-1H-benzimidazol-2-one | UNII:J31IL9Z2EE | PubChem SID:198981414 | CAS RN:60607-34-3 | Oxatomide | PubChem CID:4615
+BMGC_DG09872,BMG_DG148680,"NDC:43353-965 | CAS RN:604-75-1 | NDC:62584-812 | NDC:0228-2067 | NDC:43353-980 | PubChem CID:4616 | NDC:71610-639 | NDC:52817-290 | OXAZEPAM | NDC:52817-292 | DrugBank ID:DB00842 | NDC:0228-2069 | CAS RN:52432-54-9 | NDC:52817-291 | NDC:62584-814 | NDC:62584-813 | UNII:6GOW6DWN2A | PubChem SID:175272087 | NDC:0228-2073 | Oxazepam | 7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one"
+BMGC_DG09873,BMG_DG148683,PubChem SID:363908930 | UNII:8NF0IOG8LP | CAS RN:167887-03-8 | PubChem CID:461663 | CC-1069
+BMGC_DG09874,BMG_DG148684,"1,3-DIHYDRO-1,3-DIOXO-.BETA.-PHENYL-2H-ISOINDOLE-2-PROPANAMIDE | PubChem CID:461665 | CAS RN:180266-88-0 | PubChem SID:363908223 | UNII:67FJ1EG1CJ"
+BMGC_DG09875,BMG_DG148792,"Vitamin B12r | cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | PubChem CID:46173705 | CAS RN:14463-33-3"
+BMGC_DG09876,BMG_DG148794,"PubChem CID:46173708 | CAS RN:18534-66-2 | vitamin B12s | cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] hydrogen phosphate"
+BMGC_DG09877,BMG_DG148900,CAS RN:58822-25-6 | LEUCINE ENKEPHALIN | Leucine enkephalin | CAS RN:59141-40-1 | PubChem CID:461776 | PubChem SID:198939728 | UNII:RI01R707R6 | CAS RN:14-18-6 | (2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid
+BMGC_DG09878,BMG_DG148907,UNII:AJ212MS2O2 | 6-[[(2S)-3-cyclopentyl-2-[4-(trifluoromethyl)imidazol-1-yl]propanoyl]amino]pyridine-3-carboxylic acid | Pf-04991532 | CAS RN:1215197-37-7 | PF-04991532 | PubChem SID:198955258 | PubChem CID:46181428 | DrugBank ID:DB11765
+BMGC_DG09879,BMG_DG148916,"PubChem SID:198948602 | CAS RN:1213269-98-7 | VATIQUINONE | UNII:6O85FK9I0X | Vatiquinone | 2-[(3R,6E,10E)-3-hydroxy-3,7,11,15-tetramethylhexadeca-6,10,14-trienyl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione | PubChem CID:46184405 | DrugBank ID:DB11917"
+BMGC_DG09880,BMG_DG148919,"PubChem SID:198979862 | 4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide | PubChem CID:46184986 | Blz-945 | SOTULETINIB | CAS RN:953769-46-5 | UNII:7W3V82OQ0P"
+BMGC_DG09881,BMG_DG148921,CAS RN:57079-01-3 | UNII:LG78EY7HVB | AM-10 | PubChem CID:4618600 | PubChem SID:198974605
+BMGC_DG09882,BMG_DG148930,"PubChem SID:316914065 | NDC:50419-393 | NDC:50419-392 | NDC:71777-392 | NDC:71777-391 | DrugBank ID:DB14723 | CAS RN:1223403-58-4 | LAROTRECTINIB | NDC:50419-391 | NDC:50419-390 | PubChem CID:46188928 | NDC:71777-390 | Larotrectinib | UNII:PF9462I9HX | (3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide"
+BMGC_DG09883,BMG_DG148932,"PubChem SID:346540433 | AMPRELOXETINE | UNII:19997EZ42I | DrugBank ID:DB15348 | Ampreloxetine | PubChem CID:46189893 | CAS RN:1227056-84-9 | 4-[2-[(2,4,6-trifluorophenoxy)methyl]phenyl]piperidine"
+BMGC_DG09884,BMG_DG148935,CAS RN:1224846-01-8 | PubChem SID:346541463 | MK-3697 | PubChem CID:46190695 | UNII:M8238285OA
+BMGC_DG09885,BMG_DG148937,PubChem SID:443624278 | PubChem CID:46190878 | GSK-1331268 | CAS RN:1207197-70-3 | UNII:5H2QQ669K9
+BMGC_DG09886,BMG_DG148938,"PHA-793887 | PubChem SID:198963872 | DrugBank ID:DB12686 | Pha-793887 | CAS RN:718630-59-2 | UNII:MKS45S912B | PubChem CID:46191454 | N-[6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4-dihydropyrrolo[3,4-c]pyrazol-3-yl]-3-methylbutanamide"
+BMGC_DG09887,BMG_DG148950,DrugBank ID:DB11726 | Encenicline | PubChem SID:198975916 | UNII:5FI5376A0X | CAS RN:1275596-71-8 | N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-7-chloro-1-benzothiophene-2-carboxamide | ENCENICLINE | CAS RN:550999-75-2 | PubChem CID:46196517
+BMGC_DG09888,BMG_DG148954,PubChem CID:46199207 | UNII:RNE1V1F9O1 | LHD-221 | CAS RN:1227633-49-9 | PubChem SID:387065444
+BMGC_DG09889,BMG_DG148955,"TEZACAFTOR | UNII:8RW88Y506K | CAS RN:1152311-62-0 | 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide | PubChem SID:252319752 | Tezacaftor | PubChem CID:46199646 | DrugBank ID:DB11712"
+BMGC_DG09890,BMG_DG148956,Palmitoyl carnitine | CAS RN:7085-35-0 | (3-carboxy-2-hexadecanoyloxypropyl)-trimethylazanium | PubChem CID:462
+BMGC_DG09891,BMG_DG148958,"3-[[2,3,5,6-tetrafluoro-4-[3-(trifluoromethoxy)phenyl]phenyl]carbamoyl]thiophene-2-carboxylic acid | PubChem SID:443624256 | PubChem CID:46200812 | KIO-100 | UNII:02M19CUK9X | CAS RN:717142-73-9 | 3-((2,3,5,6-Tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl)carbamoyl)thiophene-2-carboxylic acid"
+BMGC_DG09892,BMG_DG148959,"Balovaptan | PubChem CID:46200932 | DrugBank ID:DB14823 | BALOVAPTAN | PubChem SID:329589359 | UNII:RAX5D5AGV6 | CAS RN:1228088-30-9 | 8-chloro-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine"
+BMGC_DG09893,BMG_DG148960,CAS RN:1034152-95-8 | MK-7725 | PubChem CID:46200989 | UNII:44SP3I6R9G | PubChem SID:198976947
+BMGC_DG09894,BMG_DG148963,Azd-3839 | AZD-3839 | PubChem CID:46202416 | UNII:I8ID590133 | DrugBank ID:DB12368 | PubChem SID:312524829 | CAS RN:1227163-84-9 | (3S)-3-[2-(difluoromethyl)pyridin-4-yl]-7-fluoro-3-(3-pyrimidin-5-ylphenyl)isoindol-1-amine
+BMGC_DG09895,BMG_DG148967,UNII:4JEH3BL51N | 4JEH3BL51N | CAS RN:1226793-34-5 | 1-(benzenesulfonyl)-2-methyl-4-piperazin-1-ylbenzimidazole | SAM-760 | PubChem SID:461434745 | Pf-05212377 | PubChem CID:46203710
+BMGC_DG09896,BMG_DG148969,(3S)-7-fluoro-3-pyridin-4-yl-3-(3-pyrimidin-5-ylphenyl)isoindol-1-amine | PubChem CID:46205968
+BMGC_DG09897,BMG_DG148975,"DrugBank ID:DB11694 | 1-[4-[4-amino-7-[1-(2-hydroxyethyl)pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-fluorophenyl)urea | CAS RN:1227939-82-3 | Ilorasertib | UNII:6L5D03D975 | PubChem CID:46207586 | ILORASERTIB | PubChem SID:198941668"
+BMGC_DG09898,BMG_DG148979,PubChem SID:472420393 | 2-fluoro-5-methoxy-4-[[4-[(2-methyl-3-oxo-1H-isoindol-4-yl)oxy]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-(1-methylpiperidin-4-yl)benzamide | IFEBEMTINIB | CAS RN:1227948-82-4 | Ifebemtinib | PubChem CID:46207957 | UNII:C57O858DKU
+BMGC_DG09899,BMG_DG148980,CAS RN:1071423-41-0 | PubChem SID:381132659 | UNII:6EL8B8Q1UH | SNUBH-NM-333 | PubChem CID:46207982
+BMGC_DG09900,BMG_DG148985,"N-[2-[[1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide | PubChem CID:46208367 | JNJ-41443532 | Unii-0ojb0les1A | UNII:0OJB0LES1A | PubChem SID:198942211 | DrugBank ID:DB12632 | CAS RN:1228650-83-6"
+BMGC_DG09901,BMG_DG148988,"(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine | UNII:CVP59Q4JE1 | Omarigliptin | OMARIGLIPTIN | PubChem CID:46209133 | CAS RN:1226781-44-7 | DrugBank ID:DB11992 | PubChem SID:198953034"
+BMGC_DG09902,BMG_DG148996,Oxethazaine | DrugBank ID:DB12532 | UNII:IP8QT76V17 | PubChem CID:4621 | 2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide | OXETHAZAINE | PubChem SID:198974322 | CAS RN:126-27-2 | Oxetacaine
+BMGC_DG09903,BMG_DG148997,"Tegatrabetan | PubChem SID:363908800 | TEGAVIVINT | N-[3,6-bis[[(3S,5R)-3,5-dimethylpiperidin-1-yl]sulfonyl]-10-nitrosoanthracen-9-yl]hydroxylamine | UNII:18AP231HUP | PubChem CID:46212391 | CAS RN:1227637-23-1"
+BMGC_DG09904,BMG_DG148999,"CAS RN:1226549-49-0 | PubChem CID:46212971 | (E)-4-(dimethylamino)-N-[3-[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-6-phenylfuro[2,3-d]pyrimidin-5-yl]phenyl]but-2-enamide"
+BMGC_DG09905,BMG_DG149004,"Gandotinib | GANDOTINIB | PubChem CID:46213929 | UNII:ANC71R916O | PubChem SID:198979005 | CAS RN:1229236-86-5 | DrugBank ID:DB13040 | 3-[(4-chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholin-4-ylmethyl)imidazo[1,2-b]pyridazin-6-amine"
+BMGC_DG09906,BMG_DG149007,2-[[5-chloro-2-[(5-methyl-2-propan-2-ylpyrazol-3-yl)amino]pyridin-4-yl]amino]-N-methoxybenzamide | PubChem CID:46214930 | Gsk-2256098 | UNII:R7O0O4110G | CAS RN:1224887-10-8 | GSK-2256098 | PubChem SID:346538960
+BMGC_DG09907,BMG_DG149008,"Bemcentinib | PubChem CID:46215462 | UNII:0ICW2LX8AS | DrugBank ID:DB12411 | CAS RN:1037624-75-1 | BEMCENTINIB | 1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-N-[(7S)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine | PubChem SID:251965898"
+BMGC_DG09908,BMG_DG149012,GSK-2334470 | PubChem CID:46215815 | CAS RN:1227911-45-6 | PubChem SID:459056304 | UNII:QB5BF4GJ87
+BMGC_DG09909,BMG_DG149013,"DOLUTEGRAVIR SODIUM | NDC:49702-246 | UNII:1Q1V9V5WYQ | PubChem SID:198942492 | Dolutegravir Sodium | NDC:49702-226 | NDC:49702-228 | NDC:49702-242 | PubChem CID:46216142 | NDC:49702-227 | CAS RN:1051375-19-9 | NDC:49702-255 | NDC:67296-1818 | sodium;(3S,7R)-13-[(2,4-difluorophenyl)methylcarbamoyl]-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-dien-11-olate"
+BMGC_DG09910,BMG_DG149014,"UNII:E0WBA7B62L | PubChem CID:46216556 | Hsp-990 | (7R)-2-amino-7-[4-fluoro-2-(6-methoxypyridin-2-yl)phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one | HSP-990 | CAS RN:934343-74-5 | PubChem SID:198968137"
+BMGC_DG09911,BMG_DG149017,"CAS RN:937272-79-2 | PubChem SID:198949866 | Pacritinib | NDC:72482-100 | UNII:G22N65IL3O | PubChem CID:46216796 | PACRITINIB | DrugBank ID:DB11697 | (16E)-11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2(27),3,5,8(26),9,11,16,21(25),22-decaene"
+BMGC_DG09912,BMG_DG149027,Oxibendazole | PubChem CID:4622 | methyl N-(6-propoxy-1H-benzimidazol-2-yl)carbamate | DrugBank ID:DB04910 | CAS RN:20559-55-1 | PubChem SID:175266861 | UNII:022N12KJ0X | OXIBENDAZOLE
+BMGC_DG09913,BMG_DG149030,NDC:0002-4483 | ABEMACICLIB | NDC:0002-5337 | DrugBank ID:DB12001 | N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine | CAS RN:1231929-97-7 | NDC:0002-4815 | UNII:60UAB198HK | PubChem SID:198954176 | PubChem CID:46220502 | NDC:0002-6216 | Abemaciclib
+BMGC_DG09914,BMG_DG149031,"Landipirdine | PubChem CID:46220503 | CAS RN:895534-11-9 | PubChem SID:346540155 | LANDIPIRDINE | UNII:J0NX985GDI | [(1R)-6-(3-fluorophenyl)sulfonyl-1,2,3,4-tetrahydronaphthalen-1-yl]methylurea | CAS RN:1000308-25-7"
+BMGC_DG09915,BMG_DG149035,N-(4-Methylphenyl)-1H-imidazole-5-ethanamine | PubChem SID:485666533 | PubChem CID:46222043 | N-(4-METHYLPHENYL)-1H-IMIDAZOLE-5-ETHANAMINE | CAS RN:1225013-15-9 | UNII:2Z4U8Y7V6D
+BMGC_DG09916,BMG_DG149044,"PubChem SID:198955210 | Nirogacestat | UNII:QZ62892OFJ | NDC:82448-100 | (2S)-2-[[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]amino]-N-[1-[1-(2,2-dimethylpropylamino)-2-methylpropan-2-yl]imidazol-4-yl]pentanamide | CAS RN:865773-15-5 | DrugBank ID:DB12005 | PubChem CID:46224413 | NDC:82448-050 | NDC:82448-150 | CAS RN:1290543-63-3 | NIROGACESTAT"
+BMGC_DG09917,BMG_DG149045,UNII:26A103L2FO | UNC-0638 | CAS RN:1255580-76-7 | PubChem CID:46224516 | PubChem SID:198939535
+BMGC_DG09918,BMG_DG149069,PubChem SID:348481134 | K-80003 | PubChem CID:46224594 | UNII:4S7931G4PP | CAS RN:1292821-90-9
+BMGC_DG09919,BMG_DG149076,PubChem CID:46226665 | PubChem SID:496143836 | SURFACTIN B1 | CAS RN:1419881-49-4 | UNII:JK78Y9DQ7Z | Surfactin B1
+BMGC_DG09920,BMG_DG149077,"UNII:LFR2HKH4U9 | 2-PIPERAZIN-1-YL-5,6,7,8-TETRAHYDROQUINOLINE | CAS RN:1207671-23-5 | 2-Piperazin-1-yl-5,6,7,8-tetrahydroquinoline | PubChem SID:485665531 | PubChem CID:46228433"
+BMGC_DG09921,BMG_DG149081,UNII:TP6P2HKJ54 | JZL-195 | PubChem SID:472423268 | PubChem CID:46232606 | CAS RN:1210004-12-8
+BMGC_DG09922,BMG_DG149082,"PubChem CID:46232974 | OLODATEROL, (S)- | UNII:B6QJ6CAW2G | CAS RN:868049-50-7 | PubChem SID:485665591 | Olodaterol, (S)-"
+BMGC_DG09923,BMG_DG149083,UNII:NLW7Q75SNS | Methyl 3-[[[2-methoxy-4-(phenylamino)phenyl]amino]sulfonyl]-2-thiophenecarboxylate | PubChem SID:485663533 | CAS RN:1014691-61-2 | METHYL 3-(((2-METHOXY-4-(PHENYLAMINO)PHENYL)AMINO)SULFONYL)-2-THIOPHENECARBOXYLATE | PubChem CID:46233311
+BMGC_DG09924,BMG_DG149085,"7-hydroxy-1-methyl-N-[(1S,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide | PubChem CID:46233635"
+BMGC_DG09925,BMG_DG149088,PubChem CID:46235580 | AM-643 FREE ACID | PubChem SID:198975569 | CAS RN:1233114-22-1 | UNII:55668SZQ3E
+BMGC_DG09926,BMG_DG149092,CAS RN:1228108-65-3 | SABUTOCLAX | PubChem CID:46236925 | PubChem SID:472404525 | UNII:39Y89ZRK34
+BMGC_DG09927,BMG_DG149096,UNII:RF1P63GW3K | MG-132 | PubChem SID:255509045 | Z-Leu-leu-leu-al | CAS RN:1211877-36-9 | PubChem CID:462382 | CAS RN:133407-82-6 | benzyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate
+BMGC_DG09928,BMG_DG149102,"Mk-8776 | PubChem CID:46239015 | MK-8776 | UNII:K2ZSF0992C | PubChem SID:198959970 | DrugBank ID:DB11899 | 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3R)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine | CAS RN:891494-63-6"
+BMGC_DG09929,BMG_DG149103,"PubChem SID:198936222 | 5-(2-aminoethyl)benzene-1,2,4-triol | OXIDOPAMINE | CAS RN:1199-18-4 | UNII:8HW4YBZ748 | PubChem CID:4624 | Oxidopamine"
+BMGC_DG09930,BMG_DG149108,"PubChem SID:198935848 | DrugBank ID:DB12687 | PubChem CID:46241268 | VESATOLIMOD | UNII:O8M467C50G | 4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one | CAS RN:1228585-88-3 | Vesatolimod"
+BMGC_DG09931,BMG_DG149112,CAS RN:1233339-22-4 | (3R)-4-[2-(1H-indol-4-yl)-6-(1-methylsulfonylcyclopropyl)pyrimidin-4-yl]-3-methylmorpholine | PubChem CID:46244454
+BMGC_DG09932,BMG_DG149118,OXIRACETAM | 2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide | PubChem CID:4626 | CAS RN:68567-97-5 | Oxiracetam | UNII:P7U817352G | PubChem SID:198975978 | DrugBank ID:DB13601 | CAS RN:62613-82-5
+BMGC_DG09933,BMG_DG149124,"5-Chloryl-2,4,6-quinazolinetriamine | PubChem CID:4627204 | DrugBank ID:DB01929"
+BMGC_DG09934,BMG_DG149125,"UNII:L0A22B22FT | CAS RN:14698-29-4 | OXOLINIC ACID | CAS RN:16172-03-5 | Oxolinic Acid | DrugBank ID:DB13627 | 5-ethyl-8-oxo-[1,3]dioxolo[4,5-g]quinoline-7-carboxylic acid | PubChem SID:175268595 | PubChem CID:4628"
+BMGC_DG09935,BMG_DG149129,OXOTREMORINE M | PubChem CID:4629 | PubChem SID:459055507 | CAS RN:63939-65-1 | trimethyl-[4-(2-oxopyrrolidin-1-yl)but-2-ynyl]azanium | UNII:VWS78J9ZUJ | oxotremorine-M
+BMGC_DG09936,BMG_DG149131,DrugBank ID:DB07476 | PubChem CID:462919 | N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE
+BMGC_DG09937,BMG_DG149135,PubChem CID:4630 | PubChem SID:198986666 | Oxotremorine | OXOTREMORINE | CAS RN:70-22-4 | 1-(4-pyrrolidin-1-ylbut-2-ynyl)pyrrolidin-2-one | UNII:5RY0UWH1JL
+BMGC_DG09938,BMG_DG149138,"PubChem CID:4630909 | DrugBank ID:DB02873 | 1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One"
+BMGC_DG09939,BMG_DG149140,Oxprenolol | OXPRENOLOL | 1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol | UNII:519MXN9YZR | CAS RN:6452-71-7 | PubChem SID:175271823 | DrugBank ID:DB01580 | PubChem CID:4631
+BMGC_DG09940,BMG_DG149141,[(4-Methoxyphenyl)iminomethyl](3-(2-pyridyl)isoquinolyl)amine | PubChem CID:463106 | 4-methoxy-N'-(3-pyridin-2-ylisoquinolin-1-yl)benzenecarboximidamide
+BMGC_DG09941,BMG_DG149147,PubChem SID:175267746 | Oxybenzone | PubChem CID:4632 | CAS RN:131-57-7 | UNII:95OOS7VE0Y | DrugBank ID:DB01428 | NDC:10967-674 | NDC:53675-140 | OXYBENZONE | (2-hydroxy-4-methoxyphenyl)-phenylmethanone
+BMGC_DG09942,BMG_DG149152,BENOXINATE | DrugBank ID:DB00892 | UNII:AXQ0JYM303 | CAS RN:99-43-4 | Oxybuprocaine | PubChem SID:175268839 | PubChem CID:4633 | 2-(diethylamino)ethyl 4-amino-3-butoxybenzoate
+BMGC_DG09943,BMG_DG149156,UNII:K9P6MC7092 | PubChem CID:4634 | 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate | DrugBank ID:DB01062 | CAS RN:5633-20-5 | PubChem SID:175271483 | OXYBUTYNIN | Oxybutynin | CAS RN:119579-36-1
+BMGC_DG09944,BMG_DG149157,DrugBank ID:DB07897 | PubChem CID:4634038 | 1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE
+BMGC_DG09945,BMG_DG149158,"DrugBank ID:DB03035 | 1,8-Di-Hydroxy-4-Nitro-Anthraquinone | PubChem CID:4634231"
+BMGC_DG09946,BMG_DG149160,DrugBank ID:DB07955 | (2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE | PubChem CID:4634717
+BMGC_DG09947,BMG_DG149163,(Diaminomethyl-Methyl-Amino)-Acetic Acid | DrugBank ID:DB02490 | PubChem CID:4635864
+BMGC_DG09948,BMG_DG149165,"NDC:13709-325 | PubChem SID:175265323 | PubChem CID:4636 | OXYMETAZOLINE | Oxymetazoline | UNII:8VLN5B44ZY | CAS RN:1491-59-4 | DrugBank ID:DB00935 | 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol"
+BMGC_DG09949,BMG_DG149167,"DrugBank ID:DB08028 | PubChem CID:4636204 | BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE"
+BMGC_DG09950,BMG_DG149177,UNII:8HV55C85DW | GSK-729327 | PubChem CID:46398805 | CAS RN:875927-64-3
+BMGC_DG09951,BMG_DG149178,Hippuric Acid | CAS RN:66407-11-2 | CAS RN:495-69-2 | PubChem CID:464 | 2-benzamidoacetic acid | HIPPURIC ACID | UNII:TE0865N2ET | PubChem SID:198968930
+BMGC_DG09952,BMG_DG149179,"CAS RN:153-87-7 | Oxypertine | PubChem SID:198949217 | UNII:5JGL4G25R7 | OXYPERTINE | 5,6-dimethoxy-2-methyl-3-[2-(4-phenylpiperazin-1-yl)ethyl]-1H-indole | DrugBank ID:DB13403 | PubChem CID:4640"
+BMGC_DG09953,BMG_DG149184,"CAS RN:129-20-4 | DrugBank ID:DB03585 | Oxyphenbutazone | 4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione | PubChem CID:4641 | UNII:A7D84513GV | PubChem SID:198975520 | OXYPHENBUTAZONE ANHYDROUS"
+BMGC_DG09954,BMG_DG149189,"PubChem CID:4642 | Oxyphencyclimine | (1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)methyl 2-cyclohexyl-2-hydroxy-2-phenylacetate | DrugBank ID:DB00383 | CAS RN:125-53-1 | UNII:4V44H1O8XI | PubChem SID:198942753 | OXYPHENCYCLIMINE"
+BMGC_DG09955,BMG_DG149190,UNII:W4HFE001U5 | [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid | TENOFOVIR ANHYDROUS | CAS RN:147127-20-6 | DrugBank ID:DB14126 | Tenofovir | PubChem SID:175266382 | PubChem CID:464205
+BMGC_DG09956,BMG_DG149196,PubChem CID:4644 | Oxypurinol | DrugBank ID:DB05262
+BMGC_DG09957,BMG_DG149201,PubChem CID:4649 | 4-amino-2-hydroxybenzoic acid | AMINOSALICYLIC ACID | CAS RN:65-49-6 | DrugBank ID:DB00233 | UNII:5B2658E0N2 | Aminosalicylic acid | 4-Aminosalicylic acid | PubChem SID:175268132
+BMGC_DG09958,BMG_DG149205,"PubChem CID:4650 | cyclohexa-2,5-diene-1,4-dione | Quinone | CAS RN:3225-29-4 | UNII:3T006GV98U | PubChem SID:175268424 | QUINONE | CAS RN:106-51-4"
+BMGC_DG09959,BMG_DG149210,PubChem SID:198967562 | 2-amino-3-(4-chlorophenyl)propanoic acid | CAS RN:7424-00-2 | FENCLONINE | PubChem CID:4652 | CAS RN:1991-78-2 | UNII:R5J7E3L9SP | Fenclonine
+BMGC_DG09960,BMG_DG149214,PubChem CID:4653 | UNII:S7W3CQD7N7 | P-FLUOROPHENETHYLAMINE | CAS RN:1583-88-6 | PubChem SID:440089274
+BMGC_DG09961,BMG_DG149215,PubChem SID:474490332 | CAS RN:6280-80-4 | 2-FORMYLPHENOXYACETIC ACID | PubChem CID:46533 | 2-Formylphenoxyacetic acid | UNII:CC6J4EUV9T
+BMGC_DG09962,BMG_DG149228,"N-(2,6-dichloro-4-iodophenyl)-4,5-dihydro-1H-imidazol-2-amine | UNII:JJ25E6L8H3 | PubChem SID:459055355 | 4-IODOCLONIDINE | PubChem CID:4656 | 4-Iodoclonidine | CAS RN:108294-53-7"
+BMGC_DG09963,BMG_DG149231,DrugBank ID:DB07826 | PubChem CID:465669 | 2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide
+BMGC_DG09964,BMG_DG149233,UNII:UCE8P23XWF | P-METHOXYPHENETHYLAMINE | PubChem SID:313390105 | PubChem CID:4657 | CAS RN:55-81-2
+BMGC_DG09965,BMG_DG149243,"TOLCAPONE | PubChem SID:175268222 | (3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone | NDC:68682-938 | PubChem CID:4659569 | UNII:CIF6334OLY | Tolcapone | CAS RN:134308-13-7 | NDC:50742-193 | DrugBank ID:DB00323 | NDC:0187-0938"
+BMGC_DG09966,BMG_DG149251,"PubChem CID:466151 | UNII:10T6626FRK | CAS RN:192329-42-3 | PRINOMASTAT | Prinomastat | DrugBank ID:DB05100 | PubChem SID:198937222 | (3S)-N-hydroxy-2,2-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonylthiomorpholine-3-carboxamide"
+BMGC_DG09967,BMG_DG149252,CAS RN:22395-22-8 | UNII:XK561AP5UR | PubChem SID:251965574 | PubChem CID:466268 | 7-METHOXYFLAVONE
+BMGC_DG09968,BMG_DG149255,6-IODANYL-2-(4-METHOXYPHENYL)CHROMEN-4-ONE | CAS RN:1033-44-9 | PubChem CID:466289 | UNII:6CH7VVC67L | PubChem SID:459275212
+BMGC_DG09969,BMG_DG149261,PubChem SID:255508932 | 5-NITROISATIN | PubChem CID:4669250 | CAS RN:611-09-6 | UNII:J4J633881Z
+BMGC_DG09970,BMG_DG149268,PubChem SID:252320071 | CAS RN:1234015-52-1 | 5-[[5-[2-(3-aminopropoxy)-6-methoxyphenyl]-1H-pyrazol-3-yl]amino]pyrazine-2-carbonitrile | PREXASERTIB | Prexasertib | DrugBank ID:DB12008 | PubChem CID:46700756 | UNII:820NH671E6
+BMGC_DG09971,BMG_DG149269,"Tak-448 | PubChem CID:46700761 | PubChem SID:251966077 | UNII:YO029HR229 | (2S)-2-[[(2S,4R)-1-[(2R)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]-4-hydroxypyrrolidine-2-carbonyl]amino]-N-[(2S,3R)-1-[[(2S)-1-[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-[(N'-methylcarbamimidoyl)amino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]hydrazinyl]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]butanediamide | DrugBank ID:DB11975 | TAK-448 | CAS RN:1234319-68-6"
+BMGC_DG09972,BMG_DG149273,"Razuprotafib | UNII:0WAX4UT396 | PubChem CID:46700782 | RAZUPROTAFIB | [4-[(2S)-2-[[(2S)-2-(methoxycarbonylamino)-3-phenylpropanoyl]amino]-2-(2-thiophen-2-yl-1,3-thiazol-4-yl)ethyl]phenyl]sulfamic acid | PubChem SID:329904269 | CAS RN:1008510-37-9"
+BMGC_DG09973,BMG_DG149284,4-(4-FLUORANYLPHENOXY)PYRIDINE-3-SULFONAMIDE | UNII:4CS2FXP5Q6 | PubChem CID:46703770 | CAS RN:1229666-23-2 | PubChem SID:445500713
+BMGC_DG09974,BMG_DG149285,4-(CYANOMETHYLSULFANYL)PYRIDINE-3-SULFONAMIDE | CAS RN:1078160-09-4 | PubChem SID:443624314 | UNII:SYM4KVQ8RK | PubChem CID:46703932
+BMGC_DG09975,BMG_DG149287,CAS RN:1229666-35-6 | 4-(2-METHYLHYDRAZINYL)PYRIDINE-3-SULFONAMIDE | UNII:4M2X6L47KB | PubChem CID:46704078 | PubChem SID:445499127
+BMGC_DG09976,BMG_DG149290,"PubChem CID:46705323 | CAS RN:73809-05-9 | CAS RN:19356-17-3 | (S,E)-3-((E)-2-((1R,3aS,7aR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexanol | (3Z)-3-[(2E)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol"
+BMGC_DG09977,BMG_DG149294,DrugBank ID:DB06410 | Doxercalciferol | PubChem CID:46705423
+BMGC_DG09978,BMG_DG149298,Palmitoylethanolamide | CAS RN:544-31-0 | PubChem SID:198971592 | PALMIDROL | UNII:6R8T1UDM3V | DrugBank ID:DB14043 | PubChem CID:4671 | N-(2-hydroxyethyl)hexadecanamide
+BMGC_DG09979,BMG_DG149301,"Epicatechin 3-O-(3-O-methylgallate) | CAS RN:83104-86-3 | [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4-dihydroxy-5-methoxybenzoate | PubChem CID:467296"
+BMGC_DG09980,BMG_DG149302,"CAS RN:108907-44-4 | Epicatechin 3-O-(4-O-methylgallate) | PubChem CID:467297 | [(2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,5-dihydroxy-4-methoxybenzoate"
+BMGC_DG09981,BMG_DG149303,"[(2R,3R)-7-hydroxy-5-(3,4,5-trihydroxybenzoyl)oxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | Epigallocatechin 3,5-digallate | CAS RN:37484-73-4 | PubChem CID:467299"
+BMGC_DG09982,BMG_DG149304,PAMIDRONATE DISODIUM ANHYDROUS | PubChem SID:198973019 | PubChem CID:4673 | UNII:C7S8VWP5DH | CAS RN:57248-88-1
+BMGC_DG09983,BMG_DG149329,CAS RN:40391-99-9 | Pamidronic Acid | DrugBank ID:DB00282 | PubChem CID:4674 | Pamidronic acid | UNII:OYY3447OMC | PubChem SID:175266369 | CAS RN:106437-12-1 | PAMIDRONIC ACID | CAS RN:1159812-33-5 | (3-amino-1-hydroxy-1-phosphonopropyl)phosphonic acid
+BMGC_DG09984,BMG_DG149340,"PubChem CID:467801 | (3s,6s,9s,12r)-6-[(1-Methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-3-sec-butyl-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone | (3S,6S,9S,12R)-3-butan-2-yl-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone"
+BMGC_DG09985,BMG_DG149397,"Phenol, 5-((4-(4-fluorophenyl)-3-piperidinyl)methoxy)-2-methoxy-, (3S-trans)- | PubChem SID:461433392 | PHENOL, 5-((4-(4-FLUOROPHENYL)-3-PIPERIDINYL)METHOXY)-2-METHOXY-, (3S-TRANS)- | PubChem CID:46781621 | UNII:LEP9GA88HK | CAS RN:112058-89-6 | 5-[[(3S,4R)-4-(4-fluorophenyl)piperidin-3-yl]methoxy]-2-methoxyphenol"
+BMGC_DG09986,BMG_DG149417,"CID 46781992 | CAS RN:499-40-1 | (4S,5S)-6-[[(2S,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol | PubChem CID:46781992"
+BMGC_DG09987,BMG_DG149430,"Ravuconazole | PubChem SID:198980370 | 4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile | DrugBank ID:DB06440 | UNII:95YH599JWV | PubChem CID:467825 | CAS RN:182760-06-1 | CAS RN:194798-96-4 | RAVUCONAZOLE"
+BMGC_DG09988,BMG_DG149474,"UNII:P5BEU74DUV | PubChem CID:467889 | PubChem SID:478838476 | 7-Methylpyrrolo(3,2-f)quinazoline-1,3-diamine | CAS RN:65796-02-3 | 7-METHYLPYRROLO(3,2-F)QUINAZOLINE-1,3-DIAMINE"
+BMGC_DG09989,BMG_DG149475,"CAS RN:102625-70-7 | PANTOPRAZOLE | PubChem CID:4679 | DrugBank ID:DB00213 | 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole | Pantoprazole | CAS RN:164579-32-2 | PubChem SID:175271697 | UNII:D8TST4O562"
+BMGC_DG09990,BMG_DG149480,"CAS RN:58-74-2 | Papaverine | PubChem SID:175268293 | PAPAVERINE | 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline | UNII:DAA13NKG2Q | DrugBank ID:DB01113 | PubChem CID:4680"
+BMGC_DG09991,BMG_DG149494,UNII:QH933GK4LB | PubChem SID:445500653 | CAS RN:1232541-87-5 | N-(2-AZANYL-5-(FURAN-3-YL)PHENYL)BENZAMIDE | PubChem CID:46830327
+BMGC_DG09992,BMG_DG149500,Gemilukast | PubChem SID:198940049 | GEMILUKAST | CAS RN:1232861-58-3 | UNII:42I6GGX6D6 | PubChem CID:46830962 | 4-[1-(3-carboxypropyl)-4-fluoro-7-[2-[4-[4-(3-fluoro-2-methylphenyl)butoxy]phenyl]ethynyl]-2-methylindol-3-yl]butanoic acid
+BMGC_DG09993,BMG_DG149503,BIA-10-2474 | UNII:5AP1ZW859M | PubChem SID:318164759 | CAS RN:1233855-46-3 | PubChem CID:46831476
+BMGC_DG09994,BMG_DG149507,PubChem SID:433968192 | UNII:AVA00PXT60 | CAS RN:1228049-12-4 | GW-630200 | PubChem CID:46832227
+BMGC_DG09995,BMG_DG149508,"PubChem CID:46832368 | PubChem SID:198945759 | CAS RN:1234703-40-2 | Ly-2608204 | UNII:5A0L003HEY | DrugBank ID:DB12284 | LY-2608204 | GLOBALAGLIATIN | (1R,2S)-2-cyclohexyl-1-(4-cyclopropylsulfonylphenyl)-N-[5-(2-pyrrolidin-1-ylethylsulfanyl)-1,3-thiazol-2-yl]cyclopropane-1-carboxamide"
+BMGC_DG09996,BMG_DG149510,LY-2828360 | PubChem CID:46833780 | PubChem SID:363908630 | Ly2828360 | 8-(2-chlorophenyl)-2-methyl-6-(4-methylpiperazin-1-yl)-9-(oxan-4-yl)purine | UNII:O12H7VFU6P | CAS RN:1231220-79-3
+BMGC_DG09997,BMG_DG149511,"DrugBank ID:DB14889 | CAS RN:1814961-15-3 | UNII:N9B0H171MJ | CAS RN:1234356-69-4 | PubChem CID:46834118 | Derazantinib | PubChem SID:329589051 | (6R)-6-(2-fluorophenyl)-N-[3-[2-(2-methoxyethylamino)ethyl]phenyl]-5,6-dihydrobenzo[h]quinazolin-2-amine | DERAZANTINIB"
+BMGC_DG09998,BMG_DG149513,PubChem SID:198942224 | UNII:2Q0G81H7FK | PubChem CID:46835136 | GSK-299423 | CAS RN:1352149-24-6
+BMGC_DG09999,BMG_DG149518,PubChem SID:443625106 | UNII:IGI7VLQ799 | PubChem CID:46835922 | CAS RN:1236188-38-7 | BMS-520
+BMGC_DG10000,BMG_DG149520,PubChem CID:46836227 | UNII:29DKI2H2NY | DrugBank ID:DB15147 | TINOSTAMUSTINE | 7-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]-N-hydroxyheptanamide | CAS RN:1236199-60-2 | Tinostamustine | PubChem SID:329903750
+BMGC_DG10001,BMG_DG149525,"Epetraborole | CAS RN:1093643-37-8 | EPETRABOROLE | UNII:6MC93Z2DF9 | PubChem CID:46836890 | DrugBank ID:DB11744 | 3-[[(3S)-3-(aminomethyl)-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]propan-1-ol | PubChem SID:198971285"
+BMGC_DG10002,BMG_DG149536,UNII:3DLC36A01X | PubChem SID:198936613 | Parachlorophenol | 4-Chlorophenol | PubChem CID:4684 | CAS RN:106-48-9 | PARACHLOROPHENOL | 4-CHLOROPHENOL | DrugBank ID:DB13154 | 4-chlorophenol
+BMGC_DG10003,BMG_DG149539,"UNII:25U4N985O2 | Pf-05089771 | PF-05089771 | DrugBank ID:DB14856 | PubChem SID:333495842 | PubChem CID:46840946 | CAS RN:1235403-62-9 | 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide | CAS RN:1430806-03-3"
+BMGC_DG10004,BMG_DG149540,CAS RN:1235406-00-4 | PF-05150122 | UNII:UG7PAX5TS3 | PubChem SID:496143379 | PubChem CID:46841648
+BMGC_DG10005,BMG_DG149541,"Benzenesulfonamide, 5-chloro-2-fluoro-4-[2-(4-pyridazinyl)-4-(trifluoromethyl)phenoxy]-N-1,3,4-thiadiazol-2-yl- | PubChem CID:46841787 | 5-chloro-2-fluoro-4-[2-pyridazin-4-yl-4-(trifluoromethyl)phenoxy]-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide | PubChem SID:496143296 | CAS RN:1235406-03-7 | UNII:EHH9XEV7DB | PF-05186462"
+BMGC_DG10006,BMG_DG149547,UNII:8739X25QI3 | Afuresertib | CAS RN:1047644-62-1 | AFURESERTIB | PubChem CID:46843057 | N-[(2S)-1-amino-3-(3-fluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)thiophene-2-carboxamide | DrugBank ID:DB11648 | PubChem SID:198985824
+BMGC_DG10007,BMG_DG149552,WMS-1405 | PubChem SID:485665446 | CAS RN:1232196-73-4 | UNII:MC34ZD3CB7 | PubChem CID:46845430
+BMGC_DG10008,BMG_DG149557,CAS RN:895519-90-1 | PubChem CID:46848036 | UNII:R4009Y24AI | DrugBank ID:DB11904 | PubChem SID:198954557 | Flumatinib | FLUMBATINIB | 4-[(4-methylpiperazin-1-yl)methyl]-N-[6-methyl-5-[(4-pyridin-3-ylpyrimidin-2-yl)amino]pyridin-3-yl]-3-(trifluoromethyl)benzamide
+BMGC_DG10009,BMG_DG149558,PubChem CID:46848915 | PubChem SID:329589314 | DrugBank ID:DB14774 | 1-(2-fluoro-4-pyrazol-1-ylphenyl)-5-methoxy-3-(2-phenylpyrazol-3-yl)pyridazin-4-one | 1-(2-fluoro-4-(1H-pyrazol-1-yl)phenyl)-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one | UNII:6650W303H0 | CAS RN:1238697-26-1 | BALIPODECT
+BMGC_DG10010,BMG_DG149560,"CAS RN:55232-43-4 | 1,4-DICHLOROBENZENE | 1,4-dichlorobenzene | CAS RN:106-46-7 | UNII:D149TYB5MK | PubChem CID:4685 | PubChem SID:198940005 | 1,4-Dichlorobenzene"
+BMGC_DG10011,BMG_DG149564,"CAS RN:1235560-28-7 | ABT-639 | DrugBank ID:DB15055 | PubChem SID:319892244 | Abt-639 | 5-[(8aR)-3,4,6,7,8,8a-hexahydro-1H-pyrrolo[1,2-a]pyrazine-2-carbonyl]-4-chloro-2-fluoro-N-(2-fluorophenyl)benzenesulfonamide | UNII:0G7D0CQ88I | PubChem CID:46851313"
+BMGC_DG10012,BMG_DG149565,"PubChem CID:46851625 | CAS RN:1236667-40-5 | IFIDANCITINIB | PubChem SID:404859478 | UNII:R105E71J13 | 5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3H-1,3-benzoxazol-2-one | Ifidancitinib"
+BMGC_DG10013,BMG_DG149571,"Cobalamin | CAS RN:68-19-9 | cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide | PubChem CID:46853873"
+BMGC_DG10014,BMG_DG149584,"4-[4-[4-[4-[[(3R,5R)-5-(2,4-difluorophenyl)-5-(1,2,4-triazol-1-ylmethyl)oxolan-3-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-[(2S,3S)-2-hydroxypentan-3-yl]-1,2,4-triazol-3-one | NDC:63323-685 | Posaconazole | NDC:0254-1016 | NDC:31722-677 | NDC:60687-523 | NDC:70377-038 | UNII:6TK1G07BHZ | PubChem CID:468595 | NDC:17856-2133 | DrugBank ID:DB01263 | NDC:59651-596 | NDC:62135-429 | NDC:0904-7149 | NDC:0085-1328 | NDC:43598-470 | NDC:0054-0449 | NDC:72162-2243 | NDC:42291-919 | NDC:0085-2224 | NDC:63629-2236 | NDC:72319-023 | NDC:51407-676 | NDC:0085-4324 | NDC:50268-683 | CAS RN:177571-33-4 | NDC:68083-577 | NDC:16714-156 | NDC:68462-904 | NDC:69238-1476 | NDC:42023-195 | NDC:69367-248 | NDC:16714-535 | NDC:0406-7711 | NDC:73141-023 | NDC:55150-388 | NDC:67457-665 | PubChem SID:175267202 | CAS RN:171228-49-2 | NDC:0527-2133 | POSACONAZOLE | NDC:0254-2045 | NDC:70748-258 | NDC:0085-4331 | NDC:68462-911"
+BMGC_DG10015,BMG_DG149586,"(4S)-5-amino-4-[[(2S)-4-carboxy-2-[3-[3-[4-(3-chlorophenyl)phenyl]-1,2-oxazol-5-yl]propanoylamino]butanoyl]amino]-5-oxopentanoic acid | PubChem CID:46861564 | N-{3-[3-(3'-Chlorobiphenyl-4-Yl)isoxazol-5-Yl]propanoyl}-L-Alpha-Glutamyl-L-Alpha-Glutamyl-Amide"
+BMGC_DG10016,BMG_DG149587,PubChem CID:46861578 | CAS RN:938067-78-8 | UNII:406GR1485Z | Gtx-758 | PubChem SID:333495758 | DrugBank ID:DB14969 | GTX-758 | 3-fluoro-N-(4-fluorophenyl)-4-hydroxy-N-(4-hydroxyphenyl)benzamide
+BMGC_DG10017,BMG_DG149588,PubChem SID:317229105 | PubChem CID:46861584 | UNII:07ODS257BP | CAS RN:1240516-71-5 | GSK-2239633
+BMGC_DG10018,BMG_DG149589,"CAS RN:2036070-48-9 | PubChem SID:333495883 | 6-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-4H-1,4-benzoxazin-3-one | BRILAROXAZINE | Brilaroxazine | CAS RN:1239729-06-6 | PubChem CID:46861612 | DrugBank ID:DB09226 | UNII:X8L60BA01I"
+BMGC_DG10019,BMG_DG149591,PubChem CID:46861623 | UNII:6Y5629322X | PubChem SID:198953187 | CAS RN:848141-11-7 | DrugBank ID:DB11863 | CAS RN:1229022-06-3 | 6-methyl-5-(2-methylpyrazol-3-yl)-N-[(5-methylsulfonylpyridin-2-yl)methyl]-2-oxo-1-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide | ALVELESTAT | Alvelestat
+BMGC_DG10020,BMG_DG149593,PubChem SID:348480780 | BMS-605339 | CAS RN:630417-82-2 | PubChem CID:46862685 | UNII:X5CV3YW4GQ
+BMGC_DG10021,BMG_DG149594,UNII:Z0O8PGE4TB | CAS RN:1394894-41-7 | PubChem SID:198970963 | JNJ-40355003 | PubChem CID:46863664
+BMGC_DG10022,BMG_DG149601,"CAS RN:1239902-67-0 | UNII:6ZB24XC7HJ | PubChem CID:46864283 | 6-METHOXY-N-(2-((1-METHYLPIPERIDIN-4-YL)METHOXY)-4-(1H-PYRAZOL-4-YL)PHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXAMIDE, (3R)-"
+BMGC_DG10023,BMG_DG149603,CAS RN:731773-64-1 | PubChem CID:46865641 | UNII:79HLX9P5O6 | PubChem SID:249492399 | N-(E)-FERUOYL-L-TYROSINE AMIDE
+BMGC_DG10024,BMG_DG149604,"PubChem CID:46866319 | PubChem SID:310825660 | DrugBank ID:DB12784 | Ilginatinib | 6-N-[(1S)-1-(4-fluorophenyl)ethyl]-4-(1-methylpyrazol-4-yl)-2-N-pyrazin-2-ylpyridine-2,6-diamine | CAS RN:1239358-86-1 | CAS RN:1526932-96-6 | ILGINATINIB | UNII:56R994WX4L"
+BMGC_DG10025,BMG_DG149605,PubChem CID:46866705 | UNII:5PO9J9ZC3X | PF-04979064 | CAS RN:1220699-06-8 | PubChem SID:198974606
+BMGC_DG10026,BMG_DG149616,CAS RN:1395553-31-7 | PubChem CID:46869045 | AS-1669058 FREE BASE | PubChem SID:198984831 | UNII:539P83QV24
+BMGC_DG10027,BMG_DG149620,"PubChem CID:4687 | UNII:Q3565Y41V7 | PubChem SID:198978739 | CAS RN:611-59-6 | 1,7-dimethyl-3H-purine-2,6-dione | Paraxanthine | PARAXANTHINE"
+BMGC_DG10028,BMG_DG149621,"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol | PubChem CID:46870043 | DrugBank ID:DB08047"
+BMGC_DG10029,BMG_DG149625,"PubChem SID:310825632 | Ibrexafungerp | CAS RN:1207753-03-4 | UNII:A92JFM5XNU | IBREXAFUNGERP | DrugBank ID:DB12471 | PubChem CID:46871657 | (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid"
+BMGC_DG10030,BMG_DG149626,"DrugBank ID:DB11814 | PF-03882845 | Pf-03882845 | (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydrobenzo[g]indazole-7-carboxylic acid | UNII:34ZKU73FU3 | PubChem SID:198971635 | CAS RN:1023650-66-9 | PubChem CID:46871935"
+BMGC_DG10031,BMG_DG149628,CAS RN:1358039-07-2 | NMP-7 | PubChem CID:46871949 | UNII:8G2SU6V9L7 | PubChem SID:474492743
+BMGC_DG10032,BMG_DG149634,PubChem SID:474492762 | CAS RN:1240308-45-5 | UNII:3QLJ2AZ8GW | A-971432 | PubChem CID:46872626
+BMGC_DG10033,BMG_DG149747,PubChem SID:198952647 | UNII:9MV14S8G3E | N-benzyl-N-methylprop-2-yn-1-amine | Pargyline | PubChem CID:4688 | DrugBank ID:DB01626 | PARGYLINE | CAS RN:555-57-7
+BMGC_DG10034,BMG_DG149753,"PubChem CID:46882177 | DrugBank ID:DB07788 | (3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE"
+BMGC_DG10035,BMG_DG149760,"UNII:TQ44WWY45Q | AVAGACESTAT | DrugBank ID:DB11893 | CAS RN:1146699-66-2 | (2R)-2-[(4-chlorophenyl)sulfonyl-[[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl]amino]-5,5,5-trifluoropentanamide | PubChem SID:198943217 | PubChem CID:46883536 | Avagacestat"
+BMGC_DG10036,BMG_DG149762,"CAS RN:1034189-82-6 | PubChem CID:46883775 | CAS RN:1036404-17-7 | 5-(2,4-difluorophenoxy)-N-[2-(dimethylamino)ethyl]-1-(2-methylpropyl)indazole-6-carboxamide | Arry-371797"
+BMGC_DG10037,BMG_DG149767,"PubChem CID:46885626 | 3-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethylpyrazol-3-yl]phenyl]-1,1-dimethylurea | 3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea | UNII:8VLB51V7HO | PubChem SID:198945210 | GSK-1070916 | CAS RN:942918-07-2"
+BMGC_DG10038,BMG_DG149768,"PubChem CID:46886319 | N-[3-[5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | N-[3-(5-{2-[(4-Morpholin-4-Ylphenyl)amino]pyrimidin-4-Yl}imidazo[2,1-B][1,3]thiazol-6-Yl)phenyl]-2-Phenylacetamide"
+BMGC_DG10039,BMG_DG149769,PubChem CID:468865 | PubChem SID:482553652 | CAS RN:138355-96-1 | UNII:3FWX866PK4 | NSC-642328
+BMGC_DG10040,BMG_DG149770,"PubChem CID:46886609 | Rimiterol | CAS RN:32953-89-2 | 4-[(R)-hydroxy-[(2S)-piperidin-2-yl]methyl]benzene-1,2-diol | RIMITEROL | UNII:26GIW6ZLPH | DrugBank ID:DB13559 | PubChem SID:198990410"
+BMGC_DG10041,BMG_DG149771,"(2S,3S,4S,5R,6S)-6-[[5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-2-oxo-1H-quinolin-8-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | PubChem SID:443624440 | .BETA.-D-GLUCOPYRANOSIDURONIC ACID, 5-((1R)-2-((5,6-DIETHYL-2,3-DIHYDRO-1H-INDEN-2-YL)AMINO)-1-HYDROXYETHYL)-1,2-DIHYDRO-2-OXO-8-QUINOLINYL | UNII:S3YCF4P4TA | CAS RN:1446354-20-6 | beta-D-Glucopyranosiduronic acid, 5-((1R)-2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-1,2-dihydro-2-oxo-8-quinolinyl | PubChem CID:46887146"
+BMGC_DG10042,BMG_DG149775,MV-061194 | CAS RN:1021423-50-6 | UNII:Q7Z2K47J4G | PubChem CID:46889752
+BMGC_DG10043,BMG_DG149781,PubChem SID:198960086 | PubChem CID:46890602 | CAS RN:1008529-42-7 | ABT-116 | UNII:373JC9FJ2H
+BMGC_DG10044,BMG_DG149808,CAS RN:1241914-87-3 | PubChem CID:46892373 | UNII:E7YVO9NSJ9 | PubChem SID:198958156 | (4-fluorophenyl)-[4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]methanol | AC-430 | Ac-430 | DrugBank ID:DB12535
+BMGC_DG10045,BMG_DG149810,"Azd3514 | PubChem CID:46893585 | UNII:127DSS8X7J | 1-[4-[2-[4-[1-[3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]phenoxy]ethyl]piperazin-1-yl]ethanone | CAS RN:1240299-33-5 | PubChem SID:346539434 | AZD-3514"
+BMGC_DG10046,BMG_DG149816,PubChem SID:475550433 | PubChem CID:46897162 | CAS RN:1240494-13-6 | UNII:36UH926WTQ | SX-517
+BMGC_DG10047,BMG_DG149825,CAS RN:1242137-18-3 | PubChem CID:46898524 | OXO-ENZALUTAMIDE | PubChem SID:461434299 | UNII:286CC9ZV3A
+BMGC_DG10048,BMG_DG149829,"UNII:1K7B1OED4N | PubChem CID:469 | PubChem SID:198976972 | 2-Aminohexanedioic acid | CAS RN:542-32-5 | 2-aminohexanedioic acid | 2-AMINOADIPIC ACID, DL-"
+BMGC_DG10049,BMG_DG149854,PubChem CID:46907400 | 2-(3-SULFAMOYLPYRIDIN-4-YL)SULFANYLETHANAMIDE | UNII:RCC9YY7WJ6 | CAS RN:1078160-11-8 | PubChem SID:441659185
+BMGC_DG10050,BMG_DG149855,UNII:1MRH0IMX0W | CAS RN:1268524-70-4 | JQ1 | PubChem CID:46907787 | PubChem SID:198989400
+BMGC_DG10051,BMG_DG149858,UNII:IQ19DDF3A0 | OLEOYLLEVOCARNITINE | (3R)-3-[(Z)-octadec-9-enoyl]oxy-4-(trimethylazaniumyl)butanoate | Oleoylcarnitine | CAS RN:38677-66-6 | PubChem CID:46907933 | PubChem SID:313182706
+BMGC_DG10052,BMG_DG149865,"UNII:P8DD8KX4O4 | (3S,3'R,4'S,5'S,6'R)-5-[(4-ethylphenyl)methyl]-6'-(hydroxymethyl)spiro[1H-2-benzofuran-3,2'-oxane]-3',4',5'-triol;hydrate | Spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol, 6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)-, hydrate (1:1), (1S,3'R,4'S,5'S,6'R)- | PubChem CID:46908928 | PubChem SID:198983239 | CAS RN:903565-83-3 | CAS RN:1201913-82-7 | TOFOGLIFLOZIN"
+BMGC_DG10053,BMG_DG149866,"PubChem SID:198939949 | PubChem CID:46908929 | Tofogliflozin | CAS RN:903565-83-3 | (3S,3'R,4'S,5'S,6'R)-5-[(4-ethylphenyl)methyl]-6'-(hydroxymethyl)spiro[1H-2-benzofuran-3,2'-oxane]-3',4',5'-triol | UNII:554245W62T | TOFOGLIFLOZIN ANHYDROUS | DrugBank ID:DB11824"
+BMGC_DG10054,BMG_DG149873,PubChem CID:46911296 | PIZUGLANSTAT | CAS RN:1244967-98-3 | UNII:04RV4N7EMO | PubChem SID:381608462
+BMGC_DG10055,BMG_DG149877,"PubChem CID:46911863 | DrugBank ID:DB13113 | CAS RN:943540-75-8 | JNJ-38877605 | PubChem SID:198985194 | UNII:15UDG410PN | Jnj-38877605 | 6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline | CAS RN:1072116-03-0"
+BMGC_DG10056,BMG_DG149884,DrugBank ID:DB12986 | 5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine | UNII:W71J4X250V | CAS RN:1246560-33-7 | VS-5584 | PubChem SID:255509410 | Vs-5584 | PubChem CID:46912230
+BMGC_DG10057,BMG_DG149895,"CAS RN:1264754-13-3 | UNII:S23WCL2V8V | PubChem CID:46916268 | 4-(4-((Z)-(2,4-DIOXO-5-THIAZOLIDINYLIDENE)METHYL)-2-METHOXYPHENOXY)-3-(TRIFLUOROMETHYL)BENZONITRILE"
+BMGC_DG10058,BMG_DG149896,4-[[(6-chloro-5-formyl-2-methylsulfanylpyrimidin-4-yl)amino]methyl]benzenesulfonamide | PubChem CID:46916274 | 4-({[6-Chloro-5-formyl-2-(methylsulfanyl)pyrimidin-4-yl]amino}methyl)benzenesulfonamide
+BMGC_DG10059,BMG_DG149897,"UNII:7E99B9ZM19 | PubChem CID:46916694 | PubChem SID:346540605 | DrugBank ID:DB15009 | Nerigliatin | Pf-04937319 | NERIGLIATIN | CAS RN:1245603-92-2 | N,N-dimethyl-5-[[2-methyl-6-[(5-methylpyrazin-2-yl)carbamoyl]-1-benzofuran-4-yl]oxy]pyrimidine-2-carboxamide"
+BMGC_DG10060,BMG_DG149905,CAS RN:787583-71-5 | PubChem CID:46917559 | ENCALERET | UNII:EF8081AQ6G | Encaleret | 4-[2-[(1R)-1-[(2R)-3-[[1-(4-chloro-3-fluorophenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]phenyl]-2-methylbenzoic acid | PubChem SID:198970115
+BMGC_DG10061,BMG_DG149962,"DrugBank ID:DB12021 | Dinaciclib | UNII:4V8ECV0NBQ | CAS RN:779353-01-4 | 2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol | PubChem SID:198972887 | PubChem CID:46926350 | DINACICLIB"
+BMGC_DG10062,BMG_DG149965,"DrugBank ID:DB14887 | PubChem SID:346540973 | 2-[4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6-yl)phenyl]cyclohexyl]acetic acid | PF-04620110 | PubChem CID:46926360 | CAS RN:1109276-89-2 | UNII:CQ4M18RLJW"
+BMGC_DG10063,BMG_DG149970,"WNT-974 | CAS RN:1243244-14-5 | 2-(2',3-Dimethyl-[2,4'-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide | UNII:U27F40013Q | PubChem CID:46926973 | DrugBank ID:DB12561 | PubChem SID:241178848 | 2-[5-methyl-6-(2-methylpyridin-4-yl)pyridin-3-yl]-N-(5-pyrazin-2-ylpyridin-2-yl)acetamide"
+BMGC_DG10064,BMG_DG150023,CAS RN:1246526-29-3 | PubChem CID:46932843 | PubChem SID:434369954 | UNII:ZU57HFI5YM | CS1P1
+BMGC_DG10065,BMG_DG150036,PubChem CID:46936176 | DrugBank ID:DB00602 | Ivermectin
+BMGC_DG10066,BMG_DG150038,"PubChem CID:46936189 | DrugBank ID:DB01683 | (2R)-2-[[(1R)-1-[(6R)-2-amino-1,4,5,6-tetrahydropyrimidin-6-yl]-2-[[(2R)-4-methyl-1-oxo-1-[[(2R)-1-oxo-3-phenylpropan-2-yl]amino]pentan-2-yl]amino]-2-oxoethyl]carbamoylamino]-3-phenylpropanoic acid | CAS RN:9076-44-2"
+BMGC_DG10067,BMG_DG150039,"PubChem CID:46936196 | DrugBank ID:DB01712 | (3R)-4-(p-toluenesulfonyl)-1,4-thiazane-3-carboxylicacid-L-phenylalanine ethyl ester"
+BMGC_DG10068,BMG_DG150040,Carboxymycobactin S | DrugBank ID:DB01926 | PubChem CID:46936260
+BMGC_DG10069,BMG_DG150043,"Mdl 101,146 | PubChem CID:46936357 | DrugBank ID:DB02341"
+BMGC_DG10070,BMG_DG150044,Adenosine monotungstate | PubChem CID:46936368 | DrugBank ID:DB02373
+BMGC_DG10071,BMG_DG150045,DrugBank ID:DB02426 | PubChem CID:46936378 | Carboxyatractyloside
+BMGC_DG10072,BMG_DG150046,DrugBank ID:DB02457 | Undecyl-Phosphinic Acid Butyl Ester | PubChem CID:46936391
+BMGC_DG10073,BMG_DG150049,2-Deoxy-Glucose-6-Phosphate | DrugBank ID:DB02604 | PubChem CID:46936435
+BMGC_DG10074,BMG_DG150050,"PubChem CID:46936447 | DrugBank ID:DB02661 | Adenosine-5'-diphosphate-2',3'-vanadate"
+BMGC_DG10075,BMG_DG150051,S-(Methylmercury)-L-Cysteine | PubChem CID:46936479 | DrugBank ID:DB02750
+BMGC_DG10076,BMG_DG150052,DrugBank ID:DB03223 | Diphthamide | PubChem CID:46936613
+BMGC_DG10077,BMG_DG150054,PubChem CID:46936633 | DrugBank ID:DB03288 | 5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide
+BMGC_DG10078,BMG_DG150055,PubChem SID:482553277 | DEOXYURIDINE-5'-DIPHOSPHATE | CAS RN:4208-67-7 | PubChem CID:46936665 | UNII:B2SK7999YL
+BMGC_DG10079,BMG_DG150057,DrugBank ID:DB03450 | Cephalothin Group | PubChem CID:46936680
+BMGC_DG10080,BMG_DG150060,"DrugBank ID:DB03512 | PubChem CID:46936702 | Uridine-2',3'-vanadate"
+BMGC_DG10081,BMG_DG150061,"DrugBank ID:DB03749 | PubChem CID:46936782 | 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole"
+BMGC_DG10082,BMG_DG150063,DrugBank ID:DB03925 | Freselestat | PubChem CID:46936829
+BMGC_DG10083,BMG_DG150064,"DrugBank ID:DB03983 | {[2-Amino-4-oxo-6,7-di(sulfanyl-κS)-3,5,5a,8,9a,10-hexahydro-4H-pyrano[3,2-g]pteridin-8-yl]methyl dihydrogenato(2-) phosphate}(dioxo)sulfanylmolybdenum | PubChem CID:46936855"
+BMGC_DG10084,BMG_DG150065,DrugBank ID:DB04043 | Carboxymycobactin T | PubChem CID:46936871
+BMGC_DG10085,BMG_DG150068,DrugBank ID:DB04106 | Fotemustine | PubChem CID:46936889 | 1-(2-chloroethyl)-3-[(1S)-1-diethoxyphosphorylethyl]-1-nitrosourea | Diethyl-1-(3-(2-chloroethyl)-3-nitrosoureido)ethylphosphonate
+BMGC_DG10086,BMG_DG150069,Aspartate beryllium trifluoride | PubChem CID:46936905 | DrugBank ID:DB04156
+BMGC_DG10087,BMG_DG150073,PubChem CID:46936967 | Alpha-D-Glucose-1-Phosphate-6-Vanadate | DrugBank ID:DB04397
+BMGC_DG10088,BMG_DG150076,DrugBank ID:DB04783 | PubChem CID:46937020 | Sphinxolide B
+BMGC_DG10089,BMG_DG150078,Ginsenoside Rb1 | PubChem CID:46937026 | DrugBank ID:DB06749
+BMGC_DG10090,BMG_DG150079,"diethyl [(1R)-1,5-diaminopentyl]boronate | DrugBank ID:DB06840 | PubChem CID:46937028"
+BMGC_DG10091,BMG_DG150080,PubChem CID:46937030 | DrugBank ID:DB06858 | N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide
+BMGC_DG10092,BMG_DG150081,"PubChem CID:46937031 | DrugBank ID:DB06879 | 5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE"
+BMGC_DG10093,BMG_DG150083,"(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide | PubChem CID:46937033 | DrugBank ID:DB06892"
+BMGC_DG10094,BMG_DG150088,D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide | DrugBank ID:DB07005 | PubChem CID:46937043
+BMGC_DG10095,BMG_DG150089,5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE | DrugBank ID:DB07033 | PubChem CID:46937045
+BMGC_DG10096,BMG_DG150090,"DrugBank ID:DB07051 | PubChem CID:46937046 | 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER"
+BMGC_DG10097,BMG_DG150092,"PubChem CID:46937048 | DrugBank ID:DB07087 | 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL"
+BMGC_DG10098,BMG_DG150095,1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE | DrugBank ID:DB07116 | PubChem CID:46937051
+BMGC_DG10099,BMG_DG150096,"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE | DrugBank ID:DB07124 | PubChem CID:46937052"
+BMGC_DG10100,BMG_DG150097,1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA | DrugBank ID:DB07132 | PubChem CID:46937053
+BMGC_DG10101,BMG_DG150098,"PubChem CID:46937054 | DrugBank ID:DB07148 | (6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one"
+BMGC_DG10102,BMG_DG150099,4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one | PubChem CID:46937055 | DrugBank ID:DB07151
+BMGC_DG10103,BMG_DG150100,N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE | DrugBank ID:DB07165 | PubChem CID:46937056
+BMGC_DG10104,BMG_DG150103,"(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid | PubChem CID:46937060 | DrugBank ID:DB07208"
+BMGC_DG10105,BMG_DG150104,"(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid | DrugBank ID:DB07209 | PubChem CID:46937061"
+BMGC_DG10106,BMG_DG150105,"DrugBank ID:DB07225 | N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE | PubChem CID:46937062"
+BMGC_DG10107,BMG_DG150107,"DrugBank ID:DB07341 | octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside | PubChem CID:46937064"
+BMGC_DG10108,BMG_DG150108,"PubChem CID:46937065 | DrugBank ID:DB07353 | 4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL"
+BMGC_DG10109,BMG_DG150111,Azapropazone | PubChem CID:46937068 | DrugBank ID:DB07402
+BMGC_DG10110,BMG_DG150114,"DrugBank ID:DB07421 | PubChem CID:46937071 | 4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile"
+BMGC_DG10111,BMG_DG150116,PubChem CID:46937073 | DrugBank ID:DB07428 | 4-[(5-methoxy-2-methylphenoxy)methyl]pyridine
+BMGC_DG10112,BMG_DG150118,N-[(1S)-1-(aminocarbonyl)-4-(ethanimidoylamino)butyl]benzamide | DrugBank ID:DB07449 | PubChem CID:46937075
+BMGC_DG10113,BMG_DG150119,difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron | PubChem CID:46937076 | DrugBank ID:DB07509
+BMGC_DG10114,BMG_DG150120,"DrugBank ID:DB07529 | (5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one | PubChem CID:46937079"
+BMGC_DG10115,BMG_DG150121,"DrugBank ID:DB07555 | PubChem CID:46937080 | Hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium"
+BMGC_DG10116,BMG_DG150122,"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine | PubChem CID:46937081 | DrugBank ID:DB07563"
+BMGC_DG10117,BMG_DG150124,DrugBank ID:DB07602 | S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE | PubChem CID:46937083
+BMGC_DG10118,BMG_DG150125,octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside | PubChem CID:46937084 | DrugBank ID:DB07633
+BMGC_DG10119,BMG_DG150126,"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE | PubChem CID:46937086 | DrugBank ID:DB07652"
+BMGC_DG10120,BMG_DG150127,PubChem CID:46937089 | methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate | DrugBank ID:DB07696
+BMGC_DG10121,BMG_DG150128,"PubChem CID:46937090 | DrugBank ID:DB07741 | 4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE"
+BMGC_DG10122,BMG_DG150129,"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE | PubChem CID:46937091 | DrugBank ID:DB07786"
+BMGC_DG10123,BMG_DG150130,"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE | DrugBank ID:DB07793 | PubChem CID:46937093"
+BMGC_DG10124,BMG_DG150132,"DrugBank ID:DB07821 | PubChem CID:46937095 | (1R)-1,2,2-trimethylpropyl (R)-methylphosphinate"
+BMGC_DG10125,BMG_DG150133,1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL | DrugBank ID:DB07836 | PubChem CID:46937097
+BMGC_DG10126,BMG_DG150135,S-NONYL-CYSTEINE | DrugBank ID:DB07849 | PubChem CID:46937099
+BMGC_DG10127,BMG_DG150136,"2-[4-[4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]iminocyclohexa-2,5-dien-1-yl]acetonitrile | DrugBank ID:DB07853 | PubChem CID:46937100"
+BMGC_DG10128,BMG_DG150137,"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE | DrugBank ID:DB07878 | PubChem CID:46937102"
+BMGC_DG10129,BMG_DG150138,PubChem CID:46937103 | DrugBank ID:DB07895 | ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID
+BMGC_DG10130,BMG_DG150139,PubChem CID:46937104 | DrugBank ID:DB07899 | (2S) N-acetyl-L-alanyl-αL-phenylalanyl-chloroethylketone
+BMGC_DG10131,BMG_DG150140,HOMOPHENYLALANINYLMETHANE | DrugBank ID:DB07913 | PubChem CID:46937105
+BMGC_DG10132,BMG_DG150141,DrugBank ID:DB07920 | N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide | PubChem CID:46937106
+BMGC_DG10133,BMG_DG150142,2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide | PubChem CID:46937107 | DrugBank ID:DB07921
+BMGC_DG10134,BMG_DG150143,DrugBank ID:DB07922 | N-oxo-2-(phenylsulfonylamino)ethanamide | PubChem CID:46937108
+BMGC_DG10135,BMG_DG150145,"5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID | DrugBank ID:DB07960 | PubChem CID:46937111"
+BMGC_DG10136,BMG_DG150146,"DrugBank ID:DB07978 | 2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID | PubChem CID:46937112"
+BMGC_DG10137,BMG_DG150147,"PubChem CID:46937113 | DrugBank ID:DB07979 | (2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID"
+BMGC_DG10138,BMG_DG150149,"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol | DrugBank ID:DB08004 | PubChem CID:46937115"
+BMGC_DG10139,BMG_DG150150,"PubChem CID:46937116 | DrugBank ID:DB08011 | (3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime"
+BMGC_DG10140,BMG_DG150151,"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile | DrugBank ID:DB08022 | PubChem CID:46937117"
+BMGC_DG10141,BMG_DG150152,"DrugBank ID:DB08038 | PubChem CID:46937118 | L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide"
+BMGC_DG10142,BMG_DG150153,"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine | DrugBank ID:DB08057 | PubChem CID:46937119"
+BMGC_DG10143,BMG_DG150154,DrugBank ID:DB08068 | PubChem CID:46937120 | N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-
+BMGC_DG10144,BMG_DG150161,"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine | DrugBank ID:DB08128 | PubChem CID:46937127"
+BMGC_DG10145,BMG_DG150163,(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE | DrugBank ID:DB08176 | PubChem CID:46937129
+BMGC_DG10146,BMG_DG150165,DrugBank ID:DB08192 | 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE | PubChem CID:46937131
+BMGC_DG10147,BMG_DG150166,"PubChem CID:46937132 | (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime | DrugBank ID:DB08197"
+BMGC_DG10148,BMG_DG150167,PubChem CID:46937133 | DrugBank ID:DB08229 | [N-(3-dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid
+BMGC_DG10149,BMG_DG150168,2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate) | PubChem CID:46937134 | DrugBank ID:DB08237
+BMGC_DG10150,BMG_DG150170,"N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE | PubChem CID:46937137 | DrugBank ID:DB08270"
+BMGC_DG10151,BMG_DG150171,4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION | PubChem CID:46937138 | DrugBank ID:DB08273
+BMGC_DG10152,BMG_DG150175,PubChem CID:46937142 | S-palmitoyl-L-cysteine | S-PALMITOYL CYSTEINE | PubChem SID:249492458 | UNII:08WQ73S7SV | DrugBank ID:DB08342 | CAS RN:114507-35-6
+BMGC_DG10153,BMG_DG150176,DrugBank ID:DB08347 | PubChem CID:46937143 | 4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile
+BMGC_DG10154,BMG_DG150178,"DrugBank ID:DB08378 | 4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID | PubChem CID:46937145"
+BMGC_DG10155,BMG_DG150183,"DrugBank ID:DB08448 | (4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol | PubChem CID:46937152"
+BMGC_DG10156,BMG_DG150184,"PubChem CID:46937155 | DrugBank ID:DB08498 | (1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate"
+BMGC_DG10157,BMG_DG150185,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol | PubChem CID:46937156 | DrugBank ID:DB08500"
+BMGC_DG10158,BMG_DG150186,"DrugBank ID:DB08503 | (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol | PubChem CID:46937157"
+BMGC_DG10159,BMG_DG150187,"DrugBank ID:DB08532 | PubChem CID:46937158 | 6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine"
+BMGC_DG10160,BMG_DG150188,PubChem CID:46937161 | DrugBank ID:DB08566 | D-1-naphthyl-2-acetamido-ethane boronic acid
+BMGC_DG10161,BMG_DG150189,"DrugBank ID:DB08583 | PubChem CID:46937162 | 2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide"
+BMGC_DG10162,BMG_DG150190,"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL | PubChem CID:46937163 | DrugBank ID:DB08611"
+BMGC_DG10163,BMG_DG150192,"1-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-oxopentyl]guanidine | DrugBank ID:DB08624 | PubChem CID:46937165"
+BMGC_DG10164,BMG_DG150193,"DrugBank ID:DB08642 | PubChem CID:46937168 | (2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine"
+BMGC_DG10165,BMG_DG150195,3'-THIO-THYMIDINE-5'-PHOSPHATE | DrugBank ID:DB08651 | PubChem CID:46937170
+BMGC_DG10166,BMG_DG150196,PubChem CID:46937174 | D-1-(4-chlorophenyl)-2-(acetamido)ethane boronic acid | DrugBank ID:DB08692
+BMGC_DG10167,BMG_DG150197,PubChem CID:46937176 | DrugBank ID:DB08755 | N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
+BMGC_DG10168,BMG_DG150199,2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol | DrugBank ID:DB08779 | PubChem CID:46937179
+BMGC_DG10169,BMG_DG150207,PubChem CID:46940575 | PubChem SID:198944039 | UNII:4KW1M48SHS | Gdc-0152 | (2S)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-N-(4-phenylthiadiazol-5-yl)pyrrolidine-2-carboxamide | GDC-0152 | CAS RN:873652-48-3 | DrugBank ID:DB12380
+BMGC_DG10170,BMG_DG150210,TUG-469 | UNII:GZP4K3I8PA | PubChem SID:443624069 | PubChem CID:46941175 | CAS RN:1236109-67-3
+BMGC_DG10171,BMG_DG150213,CAS RN:128-44-9 | PubChem CID:46942257 | Saccharin soluble | CAS RN:82385-42-0 | CAS RN:6155-57-3
+BMGC_DG10172,BMG_DG150215,"PubChem CID:46943432 | CAS RN:1260907-17-2 | Molibresib | UNII:5QIO6SRZ2R | PubChem SID:252164780 | 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide | MOLIBRESIB"
+BMGC_DG10173,BMG_DG150216,CAS RN:170847-18-4 | 1-Amino-5-phosphonoindane-1-carboxylic acid | UNII:XU3SFK6GGN | PubChem SID:482554575 | 1-AMINO-5-PHOSPHONOINDANE-1-CARBOXYLIC ACID | PubChem CID:4694355
+BMGC_DG10174,BMG_DG150220,"CAS RN:1254473-64-7 | PubChem SID:198940191 | 2-[4-[(E)-2-[5-[(1R)-1-(3,5-dichloropyridin-4-yl)ethoxy]-1H-indazol-3-yl]ethenyl]pyrazol-1-yl]ethanol | PubChem CID:46944259 | UNII:E9M363811V | LY-2874455 | DrugBank ID:DB13022 | Ly-2874455"
+BMGC_DG10175,BMG_DG150223,"PubChem CID:46947264 | 1-[4-[4-Morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]phenyl]-3-pyridin-4-ylurea | 1-[4-[4-morpholin-4-yl-6-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)-1,3,5-triazin-2-yl]phenyl]-3-pyridin-4-ylurea | CAS RN:1197160-28-3"
+BMGC_DG10176,BMG_DG150227,"Patulin | PubChem SID:198981908 | 4-hydroxy-4,6-dihydrofuro[3,2-c]pyran-2-one | DrugBank ID:DB15586 | PATULIN | CAS RN:149-29-1 | PubChem CID:4696 | UNII:95X2BV4W8R | CAS RN:247172-18-5"
+BMGC_DG10177,BMG_DG150229,"DrugBank ID:DB06236 | 4-amino-5-fluoro-1-[(2S,5R)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2-one | CAS RN:181785-84-2 | PubChem SID:198968598 | UNII:M09BUF90C0 | ELVUCITABINE | PubChem CID:469717 | Elvucitabine"
+BMGC_DG10178,BMG_DG150247,"CAS RN:153436-54-5 | UNII:TC62B68RSL | N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine | PubChem SID:198977037 | PubChem CID:4705 | PD-153035"
+BMGC_DG10179,BMG_DG150250,DrugBank ID:DB07662 | PubChem SID:198947340 | UNII:3R996Y9T0I | PD-168393 | CAS RN:194423-15-9 | PubChem CID:4708
+BMGC_DG10180,BMG_DG150251,"CAS RN:3331-64-4 | CAS RN:5716-14-3 | (2S,3S,4S,5R,6R)-6-[[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | PubChem CID:470824 | Dehydroepiandrosterone 3-Glucuronide"
+BMGC_DG10181,BMG_DG150253,"PubChem SID:198967880 | UNII:45ZFO9E525 | PubChem CID:470999 | CAS RN:34493-98-6 | DIBEKACIN | DrugBank ID:DB13270 | (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol | Dibekacin"
+BMGC_DG10182,BMG_DG150262,"DrugBank ID:DB06234 | (2S,3S,4R,5S)-2-[5,6-dichloro-2-(propan-2-ylamino)benzimidazol-1-yl]-5-(hydroxymethyl)oxolane-3,4-diol | NDC:64764-800 | PubChem CID:471161 | MARIBAVIR | CAS RN:176161-24-3 | Maribavir | UNII:PTB4X93HE1 | PubChem SID:198936541"
+BMGC_DG10183,BMG_DG150265,CAS RN:152121-53-4 | PubChem SID:255509316 | 4-[4-(4-fluorophenyl)-2-(4-nitrophenyl)-1H-imidazol-5-yl]pyridine | UNII:GX3Y2V80CV | 4-(4-Fluorophenyl)-2-(4-nitrophenyl)-5-(4-pyridyl)-1H-imidazole | PubChem CID:4712 | PD-169316
+BMGC_DG10184,BMG_DG150268,2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | UNII:SJE1IO5E3I | CAS RN:167869-21-8 | PubChem CID:4713 | 2-(2-amino-3-methoxyphenyl)chromen-4-one | PD-98059 | PubChem SID:348481409
+BMGC_DG10185,BMG_DG150277,PubChem SID:198950415 | A-160621 | UNII:P70V90DFSK | PubChem CID:471501 | CAS RN:221447-99-0
+BMGC_DG10186,BMG_DG150294,PubChem CID:4722579 | DrugBank ID:DB08363 | 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
+BMGC_DG10187,BMG_DG150295,"PubChem CID:4723 | DrugBank ID:DB01230 | 2-amino-5-phenyl-1,3-oxazol-4-one | PEMOLINE | UNII:7GAQ2332NK | PubChem SID:175271735 | CAS RN:101053-01-4 | CAS RN:2152-34-3 | Pemoline"
+BMGC_DG10188,BMG_DG150296,"CAS RN:91421-42-0 | PubChem CID:472335 | DrugBank ID:DB06159 | UNII:H19C446XXB | (19S)-19-ethyl-19-hydroxy-8-nitro-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione | PubChem SID:198952523 | RUBITECAN | Rubitecan"
+BMGC_DG10189,BMG_DG150298,Penciclovir | PubChem CID:4725 | DrugBank ID:DB00299
+BMGC_DG10190,BMG_DG150305,4-(N-NITROSOMETHYLAMINO)-1-(3-PYRIDYL)-1-BUTANONE | PubChem SID:198975532 | CAS RN:64091-50-5 | 4-(N-Nitrosomethylamino)-1-(3-pyridyl)-1-butanone | CAS RN:64091-91-4 | UNII:7S395EDO61 | PubChem CID:47289 | N-methyl-N-(4-oxo-4-pyridin-3-ylbutyl)nitrous amide
+BMGC_DG10191,BMG_DG150308,"UNII:93W6H998EZ | 2,3-Dichlorodibenzofuran | 2,3-dichlorodibenzofuran | PubChem SID:198948318 | 2,3-DICHLORODIBENZOFURAN | CAS RN:64126-86-9 | PubChem CID:47299"
+BMGC_DG10192,BMG_DG150309,4-(Methylsulfanyl)-2-oxobutanoic acid | UNII:286060413U | 4-methylsulfanyl-2-oxobutanoic acid | DrugBank ID:DB02238 | 4-(METHYLTHIO)-2-OXOBUTANOIC ACID | PubChem CID:473 | CAS RN:583-92-6 | 4-methylthio-2-oxobutanoic acid | PubChem SID:198962735
+BMGC_DG10193,BMG_DG150310,"PubChem SID:198940928 | 1,2,4,8-Tetrachlorodibenzofuran | 1,2,4,8-tetrachlorodibenzofuran | CAS RN:64126-87-0 | 1,2,4,8-TETRACHLORODIBENZOFURAN | PubChem CID:47300 | UNII:61TDV5S94I"
+BMGC_DG10194,BMG_DG150313,"7beta-hydroxycholesterol | PubChem SID:313184409 | PubChem CID:473141 | (3S,7R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 7-HYDROXYCHOLESTEROL, (7.BETA.)- | CAS RN:566-27-8 | 7Beta-Hydroxycholesterol | UNII:N9616291J4 | DrugBank ID:DB04706"
+BMGC_DG10195,BMG_DG150314,"(3S,7R,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | CAS RN:64907-21-7 | 7beta,25-Dihydroxycholesterol | PubChem CID:473142"
+BMGC_DG10196,BMG_DG150316,Oltipraz | PubChem CID:47318 | PubChem SID:198952051 | OLTIPRAZ | DrugBank ID:DB12539 | 4-methyl-5-pyrazin-2-yldithiole-3-thione | UNII:6N510JUL1Y | CAS RN:64224-21-1
+BMGC_DG10197,BMG_DG150317,"Atracurium | PubChem CID:47319 | CAS RN:64228-79-1 | 5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate"
+BMGC_DG10198,BMG_DG150318,"benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate | CAS RN:64228-81-5 | Atracurium besylate | DrugBank ID:DB00732 | Atracurium Besylate | PubChem CID:47320"
+BMGC_DG10199,BMG_DG150328,PENTAMIDINE | Pentamidine | 4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide | CAS RN:100-33-4 | PubChem SID:175267111 | UNII:673LC5J4LQ | PubChem CID:4735 | DrugBank ID:DB00738
+BMGC_DG10200,BMG_DG150331,"Talwin | CAS RN:39188-58-4 | CAS RN:55643-30-6 | 1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol | CAS RN:7488-49-5 | PubChem CID:4736"
+BMGC_DG10201,BMG_DG150335,"PubChem CID:4737 | DrugBank ID:DB00312 | PENTOBARBITAL | 5-ethyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione | PubChem SID:175271726 | CAS RN:57-33-0 | UNII:I4744080IR | Pentobarbital | CAS RN:76-74-4"
+BMGC_DG10202,BMG_DG150341,"NDC:0615-8511 | CAS RN:6493-05-6 | PubChem CID:4740 | Pentoxifylline | PubChem SID:175266403 | NDC:68682-101 | NDC:0904-5448 | NDC:60505-0033 | PENTOXIFYLLINE | NDC:70518-1285 | NDC:70954-668 | NDC:72162-2113 | NDC:16571-856 | NDC:0615-8305 | NDC:68071-4532 | 3,7-dimethyl-1-(5-oxohexyl)purine-2,6-dione | UNII:SD6QCT3TSU | DrugBank ID:DB00806 | NDC:63629-2910"
+BMGC_DG10203,BMG_DG150353,PubChem CID:4742623 | PubChem SID:348480816 | UNII:VV7LD54HCX | GBR-13119 | CAS RN:76778-24-0
+BMGC_DG10204,BMG_DG150355,DrugBank ID:DB12710 | PubChem SID:198971047 | UNII:8915147A2B | 10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine | PubChem CID:4744 | Perazine | PERAZINE | CAS RN:84-97-9
+BMGC_DG10205,BMG_DG150366,"CAS RN:6621-47-2 | CAS RN:39648-47-0 | CAS RN:39648-48-1 | DrugBank ID:DB01074 | PubChem CID:4746 | CAS RN:35193-73-8 | 2-(2,2-dicyclohexylethyl)piperidine | CAS RN:10118-35-1 | UNII:KU65374X44 | Perhexiline | PubChem SID:198960153 | PERHEXILINE"
+BMGC_DG10206,BMG_DG150368,Periciazine | DrugBank ID:DB01608 | PubChem SID:198974381 | CAS RN:2622-26-6 | PERICIAZINE | 10-[3-(4-hydroxypiperidin-1-yl)propyl]phenothiazine-2-carbonitrile | PubChem CID:4747 | UNII:3405M6FD73
+BMGC_DG10207,BMG_DG150370,"BUTOCONAZOLE NITRATE | UNII:4805237NP5 | CAS RN:64872-77-1 | NDC:45802-396 | Butoconazole Nitrate | PubChem CID:47471 | PubChem SID:175271406 | 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole;nitric acid"
+BMGC_DG10208,BMG_DG150371,"PubChem CID:47472 | UNII:0Q771797PH | PubChem SID:175271643 | Butoconazole | 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole | BUTOCONAZOLE | CAS RN:64872-76-0 | DrugBank ID:DB00639"
+BMGC_DG10209,BMG_DG150372,"DrugBank ID:DB08530 | 7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE | PubChem CID:4747355"
+BMGC_DG10210,BMG_DG150373,NDC:63629-2249 | NDC:68084-602 | NDC:0904-6601 | NDC:68382-591 | NDC:72162-2397 | NDC:52536-162 | CAS RN:58-39-9 | DrugBank ID:DB00850 | NDC:0591-4104 | NDC:68382-592 | NDC:0781-8046 | NDC:23155-800 | NDC:72162-2399 | NDC:52536-170 | NDC:70518-4112 | PubChem CID:4748 | NDC:70771-1042 | NDC:70518-1125 | NDC:62135-799 | NDC:72162-1162 | 2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethanol | NDC:0603-5063 | NDC:33342-451 | NDC:70518-3108 | NDC:72162-2398 | NDC:71205-841 | NDC:0904-6600 | NDC:0591-4102 | NDC:64980-293 | NDC:51407-694 | NDC:0781-8048 | UNII:FTA7XXY4EZ | NDC:63629-2248 | NDC:70771-1043 | Perphenazine | NDC:52536-168 | NDC:70518-1133 | NDC:70518-3106 | NDC:72162-1163 | NDC:51407-697 | NDC:33342-450 | NDC:52536-164 | NDC:63629-2251 | NDC:64980-291 | NDC:33342-448 | NDC:70771-1044 | NDC:23155-801 | NDC:33342-449 | PubChem SID:175266388 | NDC:68382-593 | NDC:0603-5060 | NDC:72162-2396 | NDC:23155-799 | NDC:71205-844 | NDC:72162-1164 | NDC:0904-6599 | NDC:0603-5061 | NDC:68084-607 | NDC:63629-2253 | NDC:70771-1041 | NDC:71205-843 | NDC:70518-3257 | NDC:23155-802 | NDC:63629-2250 | NDC:63629-2252 | NDC:71205-842 | NDC:0603-5062 | NDC:70518-3121 | NDC:0781-8047 | NDC:0591-4103 | NDC:0591-4101 | NDC:0781-8049 | NDC:51407-696 | NDC:64980-292 | NDC:68382-594 | NDC:70518-1109 | NDC:70518-4144 | NDC:51407-695 | PERPHENAZINE | NDC:64980-290
+BMGC_DG10211,BMG_DG150378,"CAS RN:64952-97-2 | (6R,7R)-7-[[2-carboxy-2-(4-hydroxyphenyl)acetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | UNII:VUF6C936Z3 | DrugBank ID:DB04570 | PubChem SID:198963739 | CAS RN:79120-38-0 | PubChem CID:47499 | MOXALACTAM | Latamoxef"
+BMGC_DG10212,BMG_DG150394,PubChem SID:198981037 | NICORANDIL | CAS RN:65141-46-0 | Nicorandil | DrugBank ID:DB09220 | PubChem CID:47528 | 2-(pyridine-3-carbonylamino)ethyl nitrate | UNII:260456HAM0
+BMGC_DG10213,BMG_DG150395,CAS RN:63-98-9 | PHENACEMIDE | DrugBank ID:DB01121 | Phenacemide | PubChem SID:198989859 | N-carbamoyl-2-phenylacetamide | PubChem CID:4753 | UNII:PAI7J52V09
+BMGC_DG10214,BMG_DG150400,Phenacetin | PHENACETIN | PubChem CID:4754 | DrugBank ID:DB03783 | N-(4-ethoxyphenyl)acetamide | CAS RN:40674-52-0 | CAS RN:62-44-2 | UNII:ER0CTH01H9 | PubChem SID:175266467
+BMGC_DG10215,BMG_DG150403,PubChem SID:459056405 | PubChem CID:475513 | L-731988 | UNII:BUT7TVB8DP | CAS RN:251922-77-7
+BMGC_DG10216,BMG_DG150405,"PubChem CID:4756 | DrugBank ID:DB01438 | 3-phenyldiazenylpyridine-2,6-diamine | PHENAZOPYRIDINE | UNII:K2J09EMJ52 | Phenazopyridine | PubChem SID:175268462 | CAS RN:94-78-0"
+BMGC_DG10217,BMG_DG150406,phenazine | PubChem CID:4757 | CAS RN:92-82-0 | UNII:2JHR6K463W | PubChem SID:198985327 | Phenazine | DIBENZOPYRAZINE
+BMGC_DG10218,BMG_DG150408,"NDC:45802-465 | Ketoconazole | NDC:50090-6142 | NDC:63629-8820 | DrugBank ID:DB05667 | NDC:84372-042 | CAS RN:72093-26-6 | NDC:70518-4236 | NDC:68071-1709 | NDC:55505-196 | NDC:51672-1298 | NDC:67296-0448 | NDC:55505-192 | NDC:84745-002 | NDC:70700-160 | PubChem SID:175271387 | NDC:71335-1849 | NDC:71713-097 | NDC:63646-010 | NDC:67296-1807 | NDC:63629-8677 | NDC:50090-3288 | NDC:71205-105 | NDC:84372-040 | NDC:82372-012 | NDC:50090-6046 | NDC:43538-530 | NDC:68788-8257 | NDC:50090-0720 | NDC:45802-532 | NDC:71335-0439 | 1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | NDC:35573-433 | NDC:72189-180 | NDC:50090-5265 | NDC:55505-233 | NDC:68788-7755 | NDC:72789-052 | NDC:72065-003 | NDC:67296-0540 | NDC:84372-039 | NDC:51407-279 | NDC:68788-8233 | NDC:71085-008 | NDC:0093-3219 | NDC:82372-013 | NDC:72189-422 | UNII:2DJ8R0NT7K | CAS RN:65277-42-1 | NDC:16714-955 | NDC:84372-041 | NDC:82372-010 | NDC:70954-662 | NDC:82804-091 | UNII:R9400W927I | NDC:70518-1637 | NDC:84372-037 | NDC:72189-428 | NDC:67296-2089 | NDC:84372-038 | LEVOKETOCONAZOLE | NDC:0168-0099 | PubChem CID:47576 | PubChem SID:198978499 | KETOCONAZOLE | NDC:50090-6069 | NDC:63629-8675 | NDC:21922-025 | NDC:72162-1417 | NDC:63187-774 | NDC:60429-020 | NDC:63629-8676 | NDC:51672-4026 | NDC:84558-005 | NDC:64380-827 | NDC:83364-005 | CAS RN:142128-57-2 | NDC:83462-018 | NDC:63629-8819 | NDC:72162-1409"
+BMGC_DG10219,BMG_DG150411,"CAS RN:83-12-5 | PubChem SID:198966162 | DrugBank ID:DB00498 | UNII:5M7Y6274ZE | PubChem CID:4760 | 2-phenylindene-1,3-dione | PHENINDIONE | Phenindione"
+BMGC_DG10220,BMG_DG150413,"ENDRALAZINE | CAS RN:39715-02-1 | PubChem SID:198987009 | Endralazine | PubChem CID:47608 | (3-hydrazinyl-7,8-dihydro-5H-pyrido[4,3-c]pyridazin-6-yl)-phenylmethanone | UNII:L44741F05P | DrugBank ID:DB13435"
+BMGC_DG10221,BMG_DG150415,"PubChem SID:175272171 | N,N-dimethyl-3-phenyl-3-pyridin-2-ylpropan-1-amine | DrugBank ID:DB01620 | CAS RN:86-21-5 | PubChem CID:4761 | CAS RN:2122800-15-9 | Pheniramine | CAS RN:155683-10-6 | UNII:134FM9ZZ6M | PHENIRAMINE"
+BMGC_DG10222,BMG_DG150417,PubChem CID:4762 | DrugBank ID:DB00830 | CAS RN:134-49-6 | 3-methyl-2-phenylmorpholine | Phenmetrazine
+BMGC_DG10223,BMG_DG150419,"NDC:63739-294 | NDC:51672-5327 | NDC:69367-692 | NDC:70752-157 | NDC:69367-628 | NDC:71205-850 | NDC:69367-211 | NDC:0603-5168 | NDC:72162-1581 | NDC:71205-889 | NDC:63629-1034 | NDC:63629-1035 | NDC:69367-694 | NDC:72162-1583 | NDC:63629-2044 | NDC:60687-671 | NDC:82804-999 | NDC:70752-166 | NDC:69367-691 | NDC:69367-626 | NDC:82804-983 | NDC:71205-847 | NDC:75826-141 | NDC:16571-668 | NDC:69367-625 | NDC:0603-5167 | NDC:13517-693 | NDC:63629-1032 | NDC:13517-691 | NDC:63629-2403 | NDC:63629-2042 | NDC:75826-140 | NDC:63629-2041 | PHENOBARBITAL | NDC:71205-849 | NDC:63629-2045 | NDC:62135-408 | NDC:63739-192 | NDC:64380-166 | NDC:72162-1167 | NDC:62135-410 | NDC:63629-2399 | NDC:75826-143 | NDC:69367-213 | NDC:69367-357 | NDC:0121-1884 | NDC:70752-163 | NDC:72162-1574 | NDC:63629-2046 | NDC:62135-405 | NDC:13517-112 | NDC:0143-1455 | NDC:69367-627 | NDC:82804-985 | NDC:16477-720 | NDC:70518-4016 | NDC:13517-107 | NDC:82804-998 | NDC:13517-628 | NDC:70752-168 | NDC:13517-111 | NDC:13517-625 | NDC:71205-890 | NDC:13517-627 | NDC:63629-1037 | PubChem SID:175265718 | NDC:75826-136 | NDC:71205-891 | NDC:82804-982 | NDC:69367-212 | NDC:63629-1038 | NDC:63629-2289 | NDC:13517-692 | NDC:67296-1427 | NDC:58118-1626 | NDC:70518-3470 | NDC:63187-895 | NDC:51672-5333 | DrugBank ID:DB01174 | NDC:16571-670 | NDC:63629-2047 | NDC:82804-984 | NDC:51293-627 | NDC:0143-1500 | NDC:0121-0942 | NDC:16571-669 | NDC:51672-5329 | NDC:71205-851 | UNII:YQE403BP4D | Phenobarbital | NDC:72162-1267 | NDC:16571-673 | NDC:51672-5334 | NDC:62135-411 | NDC:75826-142 | NDC:51293-626 | NDC:63629-1036 | NDC:70752-164 | NDC:63629-2404 | NDC:0904-6575 | NDC:69367-214 | NDC:54932-501 | NDC:51672-5332 | NDC:72162-1584 | 5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione | NDC:0603-5165 | NDC:63629-1033 | NDC:63629-2401 | NDC:63629-2048 | NDC:51672-5328 | NDC:63629-2400 | NDC:71205-893 | NDC:75826-138 | NDC:16571-671 | NDC:71205-848 | NDC:0603-5166 | NDC:72162-1572 | NDC:51672-5331 | NDC:51293-625 | NDC:69367-693 | NDC:0121-0531 | NDC:70518-3469 | NDC:0143-1458 | NDC:43063-953 | NDC:70752-161 | NDC:72162-1268 | NDC:16571-672 | NDC:51672-5326 | NDC:17856-0174 | NDC:13517-110 | NDC:72162-1265 | NDC:62135-409 | NDC:62135-407 | NDC:51293-628 | NDC:72162-1166 | NDC:72162-1582 | CAS RN:50-06-6 | PubChem CID:4763 | NDC:71205-845 | NDC:62135-412 | NDC:70518-0911 | NDC:70752-165 | NDC:16571-675 | NDC:75826-137 | NDC:13517-626 | NDC:58118-0626 | NDC:71205-846 | NDC:13517-207 | NDC:71205-892 | NDC:16571-674 | NDC:72162-1266 | CAS RN:11097-06-6 | NDC:82804-997 | NDC:63629-1039 | NDC:70752-162 | NDC:62135-406 | NDC:63629-2402 | NDC:70518-4129 | NDC:72162-1168 | NDC:13517-113 | NDC:0143-1495 | NDC:13517-694 | NDC:75826-139 | NDC:16571-667 | NDC:70518-4215 | NDC:0121-2826 | NDC:63629-2043 | NDC:82804-996 | NDC:70752-167"
+BMGC_DG10224,BMG_DG150421,"PubChem SID:175265388 | DrugBank ID:DB04824 | 3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one | CAS RN:77-09-8 | PubChem CID:4764 | UNII:6QK969R2IF | Phenolphthalein | PHENOLPHTHALEIN"
+BMGC_DG10225,BMG_DG150422,UNII:4FB1TON47A | Naftifine | (E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine | PubChem SID:175266913 | PubChem CID:47641 | CAS RN:134274-83-2 | NAFTIFINE | CAS RN:65472-88-0
+BMGC_DG10226,BMG_DG150429,"2',3,4,4',5-Pentachlorobiphenyl | 1,2,3-trichloro-5-(2,4-dichlorophenyl)benzene | PubChem SID:198963314 | UNII:1R4Z1DI9BB | PubChem CID:47650 | 2,3',4,4',5'-PENTACHLOROBIPHENYL | CAS RN:65510-44-3"
+BMGC_DG10227,BMG_DG150435,"PubChem SID:198980901 | PubChem CID:4767 | PHENOTHRIN | CAS RN:188023-86-1 | Phenothrin | CAS RN:26002-80-2 | (3-phenoxyphenyl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate | UNII:707484X33X | DrugBank ID:DB13717"
+BMGC_DG10228,BMG_DG150437,CAS RN:102737-84-8 | Phenoxybenzamine | PubChem SID:175272149 | CAS RN:59-96-1 | UNII:0TTZ664R7Z | DrugBank ID:DB00925 | PHENOXYBENZAMINE | PubChem CID:4768 | N-benzyl-N-(2-chloroethyl)-1-phenoxypropan-2-amine
+BMGC_DG10229,BMG_DG150439,"UNII:53YET703F2 | PubChem SID:198955324 | Terameprocol | DrugBank ID:DB12226 | TERAMEPROCOL | CAS RN:24150-24-1 | 4-[(2S,3R)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,2-dimethoxybenzene | PubChem CID:476861"
+BMGC_DG10230,BMG_DG150444,PubChem CID:4770 | CAS RN:673-31-4 | DrugBank ID:DB13354 | UNII:UJZ473TPS0 | PHENPROBAMATE | Phenprobamate | PubChem SID:198943015 | 3-phenylpropyl carbamate
+BMGC_DG10231,BMG_DG150446,CAS RN:1246819-25-9 | Phentermine | CAS RN:122-09-8 | DrugBank ID:DB00191 | UNII:C045TQL4WP | PubChem CID:4771 | PubChem SID:175266408 | 2-methyl-1-phenylpropan-2-amine | PHENTERMINE
+BMGC_DG10232,BMG_DG150451,"NDC:0143-9361 | PubChem CID:477468 | UNII:R10H71BSWG | DrugBank ID:DB01141 | [5-[(1S,2S)-2-[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-3-[(1R)-3-amino-1-hydroxy-3-oxopropyl]-11,20,21,25-tetrahydroxy-15-[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[5-(4-pentoxyphenyl)-1,2-oxazol-3-yl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-6-yl]-1,2-dihydroxyethyl]-2-hydroxyphenyl] hydrogen sulfate | CAS RN:235114-32-6 | NDC:0143-9362 | MICAFUNGIN | PubChem SID:175266770 | Micafungin"
+BMGC_DG10233,BMG_DG150453,4-phenylbutanoic acid | DrugBank ID:DB06819 | UNII:7WY7YBI87E | PubChem SID:175265485 | CAS RN:1821-12-1 | Phenylbutyric acid | CAS RN:461391-24-2 | CAS RN:1262970-43-3 | PHENYLBUTYRIC ACID | PubChem CID:4775
+BMGC_DG10234,BMG_DG150462,"2-[3-(trifluoromethyl)phenyl]-3,4-dihydropyrazol-5-amine | PubChem SID:313183295 | 3-AMINO-1-(3-(TRIFLUOROMETHYL)PHENYL)-2-PYRAZOLINE | CAS RN:66000-40-6 | UNII:6V6JF56BXO | PubChem CID:47795 | 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine"
+BMGC_DG10235,BMG_DG150463,PubChem CID:4780 | CAS RN:102-02-3 | UNII:W8PKA3T2I3 | PHENYL BIGUANIDE | 1-(diaminomethylidene)-2-phenylguanidine | PubChem SID:198935847 | Phenyl Biguanide
+BMGC_DG10236,BMG_DG150464,"PubChem CID:4781 | 4-butyl-1,2-diphenylpyrazolidine-3,5-dione | DrugBank ID:DB00812 | CAS RN:4297-92-1 | Phenylbutazone | PHENYLBUTAZONE | UNII:GN5P7K3T8S | CAS RN:50-33-9 | PubChem SID:175267775"
+BMGC_DG10237,BMG_DG150465,"CAS RN:66104-22-1 | (6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline | UNII:24MJ822NZ9 | PubChem SID:175267904 | PERGOLIDE | PubChem CID:47811 | DrugBank ID:DB01186 | Pergolide"
+BMGC_DG10238,BMG_DG150473,"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE | PubChem CID:478379 | DrugBank ID:DB08489"
+BMGC_DG10239,BMG_DG150474,CAS RN:329-98-6 | Phenylmethylsulfonyl fluoride | phenylmethanesulfonyl fluoride | PubChem SID:198962389 | PubChem CID:4784 | PHENYLMETHANESULFONYL FLUORIDE | UNII:57KD15003I
+BMGC_DG10240,BMG_DG150477,CAS RN:37577-28-9 | CAS RN:48115-38-4 | CAS RN:58550-13-3 | CAS RN:14838-15-4 | 2-amino-1-phenylpropan-1-ol | 2-Amino-1-phenyl-1-propanol | PubChem CID:4786
+BMGC_DG10241,BMG_DG150485,"PubChem CID:4788 | CAS RN:60-82-2 | PHLORETIN | DrugBank ID:DB07810 | UNII:S5J5OE47MK | Phloretin | 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)propan-1-one | PubChem SID:175267079"
+BMGC_DG10242,BMG_DG150507,"DrugBank ID:DB02587 | CAS RN:64657-11-0 | COLFORSIN | Colforsin | [(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] acetate | CAS RN:66575-29-9 | PubChem CID:47936 | Forskolin | PubChem SID:198938418 | UNII:1F7A44V6OU"
+BMGC_DG10243,BMG_DG150508,"UNII:7U20WEM458 | PubChem CID:47938 | ethyl 2-[4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy]propanoate | PubChem SID:198976582 | Fenoxaprop-ethyl | CAS RN:66441-23-4 | FENOXAPROP-ETHYL | DrugBank ID:DB05252"
+BMGC_DG10244,BMG_DG150513,"PubChem CID:479503 | 5,8-dihydroxy-2-[(1R)-1-hydroxy-4-methylpent-3-enyl]naphthalene-1,4-dione | UNII:3IK6592UBW | SHIKONIN | PubChem SID:241179608 | CAS RN:517-89-5 | Shikonin"
+BMGC_DG10245,BMG_DG150516,Bicifadine | 1-(4-methylphenyl)-3-azabicyclo[3.1.0]hexane | PubChem CID:47953 | DrugBank ID:DB04889 | CAS RN:71195-57-8
+BMGC_DG10246,BMG_DG150518,"NDC:68788-8261 | NDC:68071-4515 | NDC:67296-1727 | NDC:63629-7987 | CAS RN:66592-87-8 | NDC:63187-883 | NDC:65862-084 | NDC:63629-7988 | NDC:0093-4059 | NDC:80425-0400 | NDC:57237-097 | NDC:43063-595 | Cefadroxil Monohydrate | NDC:72189-506 | NDC:57237-098 | NDC:50090-6050 | NDC:72189-445 | NDC:80425-0198 | NDC:65862-083 | NDC:68180-181 | NDC:0093-3196 | NDC:16714-389 | NDC:50090-0580 | NDC:65862-085 | NDC:68788-7484 | NDC:68180-180 | CEFADROXIL | NDC:63629-8253 | PubChem CID:47964 | NDC:70518-3580 | NDC:68071-4938 | NDC:16714-388 | PubChem SID:175265542 | NDC:68788-8479 | NDC:68071-5234 | UNII:280111G160 | NDC:68180-182 | NDC:55289-589 | NDC:72189-103 | NDC:70518-3834 | NDC:80425-0432 | NDC:68071-3597 | NDC:43063-553 | NDC:50090-6356 | NDC:67296-0491 | NDC:57237-096 | (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate | NDC:16714-390"
+BMGC_DG10247,BMG_DG150519,"PubChem CID:47965 | DrugBank ID:DB01140 | (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CAS RN:50370-12-2 | UNII:Q525PA8JJB | CEFADROXIL ANHYDROUS | Cefadroxil | PubChem SID:175268553"
+BMGC_DG10248,BMG_DG150521,DrugBank ID:DB03026 | Phosphoglycolohydroxamic acid | Phosphoglycolohydroxamic Acid | CAS RN:51528-59-7 | UNII:J5JKF7VX5A | PubChem SID:485661556 | PubChem CID:4797 | PHOSPHOGLYCOLOHYDROXAMIC ACID
+BMGC_DG10249,BMG_DG150525,"2,3-dimethoxy-N-[(1-prop-2-enylpyrrolidin-2-yl)methyl]-5-sulfamoylbenzamide | PubChem CID:47979 | Veralipride | DrugBank ID:DB13523 | VERALIPRIDE | PubChem SID:198945873 | UNII:S7064109UD | CAS RN:66644-81-3"
+BMGC_DG10250,BMG_DG150528,"PubChem CID:48 | 5-amino-2,5-dioxopentanoic acid | CAS RN:18465-19-5 | alpha-Ketoglutaramate"
+BMGC_DG10251,BMG_DG150533,UNII:SY3J0147NB | PubChem SID:175272027 | CAS RN:66778-36-7 | DrugBank ID:DB01228 | ENCAINIDE | PubChem CID:48041 | Encainide | 4-methoxy-N-[2-[2-(1-methylpiperidin-2-yl)ethyl]phenyl]benzamide | CAS RN:37612-13-8
+BMGC_DG10252,BMG_DG150534,"Phthalylsulfathiazole | UNII:6875L5852V | PubChem SID:198988764 | CAS RN:85-73-4 | PubChem CID:4806 | PHTHALYLSULFATHIAZOLE | 2-[[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]carbamoyl]benzoic acid | DrugBank ID:DB13248"
+BMGC_DG10253,BMG_DG150536,"CAS RN:55051-77-9 | PubChem CID:480763 | 5,7-Dihydroxy-6-prenylflavanone | 5,7-dihydroxy-6-(3-methylbut-2-enyl)-2-phenyl-2,3-dihydrochromen-4-one | CAS RN:72018-32-7"
+BMGC_DG10254,BMG_DG150537,"UNII:5L872SZR8X | PubChem SID:377307816 | (2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one | 8-Prenylnaringenin | 8-PRENYLNARINGENIN | PubChem CID:480764 | CAS RN:53846-50-7"
+BMGC_DG10255,BMG_DG150538,"7-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one | (S)-4',7-Dihydroxy-3',8-diprenylflavanone | PubChem CID:480768"
+BMGC_DG10256,BMG_DG150540,"8-(7-hydroxy-2H-chromen-3-yl)-2,2-dimethylchromen-5-ol | Glabrene | PubChem CID:480774 | GLABRENE | PubChem SID:198946522 | UNII:C6Y321Q75O | CAS RN:60008-03-9"
+BMGC_DG10257,BMG_DG150542,"PubChem CID:480777 | 4-[4,6-dimethoxy-5-(3-methylbut-2-enyl)-1-benzofuran-2-yl]benzene-1,3-diol | GANCAONIN I | Gancaonin I | CAS RN:126716-36-7 | UNII:6XTP69UV3S | PubChem SID:461432744"
+BMGC_DG10258,BMG_DG150544,"6,8-DIPRENYLGENISTEIN | PubChem CID:480783 | CAS RN:51225-28-6 | PubChem SID:440793395 | UNII:RLK2TR6W3N"
+BMGC_DG10259,BMG_DG150545,"3'-Dimethylallylkievitone | 3-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one | CAS RN:141846-47-1 | PubChem CID:480785"
+BMGC_DG10260,BMG_DG150549,"5,7-dihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-6-(3-methylbut-2-enyl)chromen-4-one | Gancaonin Q | CAS RN:134958-52-4 | PubChem CID:480802"
+BMGC_DG10261,BMG_DG150552,"PubChem CID:480818 | GANCAONIN U | CAS RN:134958-56-8 | UNII:PLL5JDG3P4 | 6,8-bis(3-methylbut-2-enyl)-9,10-dihydrophenanthrene-2,3,5,7-tetrol | Gancaonin U"
+BMGC_DG10262,BMG_DG150555,PubChem SID:461432559 | GLYASPERIN C | PubChem CID:480859 | CAS RN:142474-53-1 | UNII:85CR4734XV
+BMGC_DG10263,BMG_DG150556,UNII:T6ZF2ZY8CW | PubChem CID:480860 | GLYASPERIN D | PubChem SID:461433295 | CAS RN:142561-10-2
+BMGC_DG10264,BMG_DG150558,LICORICIDIN | PubChem CID:480865 | PubChem SID:252165283 | CAS RN:30508-27-1 | UNII:929XTD20VK
+BMGC_DG10265,BMG_DG150559,PubChem SID:459276019 | 1-METHOXYFICIFOLINOL | PubChem CID:480872 | CAS RN:129280-35-9 | UNII:U4JQ9U5MEF
+BMGC_DG10266,BMG_DG150561,"NDC:51672-1302 | PubChem CID:480953 | NDC:51672-1330 | NDC:0168-0346 | NDC:0168-0347 | NDC:50090-0917 | PubChem SID:175271671 | NDC:0713-0552 | NDC:50090-1196 | Triaconazole | NDC:50090-6266 | 1-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-propan-2-ylpiperazine | CAS RN:67915-31-5 | NDC:50090-6299 | NDC:63629-8837 | NDC:51672-1304 | TERCONAZOLE | NDC:68071-1626 | UNII:0KJ2VE664U | NDC:45802-717"
+BMGC_DG10267,BMG_DG150562,"4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methylpyrimidin-5-amine | Moxonidine | MOXONIDINE | UNII:CC6X0L40GW | CAS RN:75438-57-2 | CAS RN:1008754-16-2 | PubChem CID:4810 | DrugBank ID:DB09242 | PubChem SID:198957526"
+BMGC_DG10268,BMG_DG150568,"Picotamide | 4-methoxy-1-N,3-N-bis(pyridin-3-ylmethyl)benzene-1,3-dicarboxamide | UNII:654G2VCI4Q | PubChem SID:198954175 | CAS RN:32828-81-2 | CAS RN:1085306-93-9 | DrugBank ID:DB13327 | PubChem CID:4814 | PICOTAMIDE"
+BMGC_DG10269,BMG_DG150573,RYUVIDINE | PubChem CID:481747 | CAS RN:265312-55-8 | Ryuvidine | PubChem SID:485660831 | UNII:C4QER4DF5C
+BMGC_DG10270,BMG_DG150578,"N-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide | PILSICAINIDE | UNII:AV0X7V6CSE | PubChem CID:4820 | PubChem SID:198986983 | DrugBank ID:DB12712 | CAS RN:88069-67-4 | Pilsicainide"
+BMGC_DG10271,BMG_DG150579,UNII:L4HVG2UA7U | MURAYAQUINONE | CAS RN:100843-91-2 | PubChem SID:485663640 | Murayaquinone | PubChem CID:482190
+BMGC_DG10272,BMG_DG150581,PIMETHIXENE | CAS RN:314-03-4 | PubChem SID:198946263 | PubChem CID:4822 | DrugBank ID:DB13292 | 1-methyl-4-thioxanthen-9-ylidenepiperidine | UNII:T46J20J26F | Pimethixene
+BMGC_DG10273,BMG_DG150582,PubChem SID:198962476 | PubChem CID:48229 | DrugBank ID:DB09295 | TALNIFLUMATE | (3-oxo-1H-2-benzofuran-1-yl) 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate | UNII:JFK78S0U9S | Talniflumate | CAS RN:66898-62-2
+BMGC_DG10274,BMG_DG150583,"UNII:34AP3BBP9T | PubChem SID:175271763 | PIMOBENDAN, (-)- | 3-[2-(4-methoxyphenyl)-3H-benzimidazol-5-yl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one | CAS RN:74150-27-9 | PubChem SID:310825779 | PubChem CID:4823 | CAS RN:118428-38-9 | PubChem SID:310825910 | DrugBank ID:DB11450 | UNII:9HTU209Z0N | CAS RN:118428-37-8 | UNII:613JXV89SU | PIMOBENDAN | PIMOBENDAN, (+)- | CAS RN:118428-36-7 | Pimobendan"
+BMGC_DG10275,BMG_DG150586,"UNII:BB4UGO5K0D | PubChem CID:4826 | 1-cyano-2-(3,3-dimethylbutan-2-yl)-3-pyridin-4-ylguanidine | PubChem SID:198947025 | PINACIDIL ANHYDROUS | DrugBank ID:DB06762 | CAS RN:113563-69-2 | CAS RN:60560-33-0 | Pinacidil"
+BMGC_DG10276,BMG_DG150589,CAS RN:13523-86-9 | NDC:72789-293 | NDC:29033-029 | NDC:57664-656 | UNII:BJ4HF6IU1D | NDC:72789-099 | NDC:70710-1063 | NDC:10135-743 | NDC:29033-028 | DrugBank ID:DB00960 | NDC:63629-4828 | NDC:72789-100 | NDC:70710-1064 | NDC:76385-132 | NDC:10135-744 | NDC:72789-294 | NDC:62559-561 | NDC:0378-0127 | NDC:76385-131 | Pindolol | PubChem CID:4828 | NDC:0378-0052 | PubChem SID:175271843 | PINDOLOL | NDC:70771-1135 | NDC:57664-655 | NDC:70771-1134 | NDC:62559-560 | 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
+BMGC_DG10277,BMG_DG150590,"PIOGLITAZONE | NDC:43547-428 | UNII:X4OV71U42S | PubChem SID:175271456 | CAS RN:111025-46-8 | NDC:43547-426 | NDC:43547-427 | Pioglitazone | PubChem CID:4829 | DrugBank ID:DB01132 | 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | CAS RN:105390-47-4 | CAS RN:198077-89-3 | CAS RN:105355-27-9"
+BMGC_DG10278,BMG_DG150593,PubChem SID:198936485 | Pipamperone | DrugBank ID:DB09286 | PIPAMPERONE | UNII:5402501F0W | CAS RN:1893-33-0 | PubChem CID:4830 | 1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidin-1-ylpiperidine-4-carboxamide
+BMGC_DG10279,BMG_DG150595,"PIPEMIDIC ACID | UNII:LT12J5HVR8 | PubChem SID:198957485 | DrugBank ID:DB13823 | PubChem CID:4831 | CAS RN:51940-44-4 | Pipemidic Acid | 8-ethyl-5-oxo-2-piperazin-1-ylpyrido[2,3-d]pyrimidine-6-carboxylic acid"
+BMGC_DG10280,BMG_DG150600,"PIPENZOLATE | DrugBank ID:DB13844 | PubChem CID:4832 | CAS RN:13473-38-6 | Pipenzolate | UNII:RS3K5YXV34 | PubChem SID:198987458 | (1-ethyl-1-methylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate"
+BMGC_DG10281,BMG_DG150601,NDC:64678-012 | NDC:79622-010 | Brincidofovir | NDC:64678-010 | CAS RN:444805-28-1 | PubChem CID:483477 | DrugBank ID:DB12151 | [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid | PubChem SID:198950391 | BRINCIDOFOVIR | UNII:6794O900AX | NDC:79622-012
+BMGC_DG10282,BMG_DG150604,piperazine | PubChem CID:4837 | DrugBank ID:DB00592 | CAS RN:31977-51-2 | UNII:1RTM4PAL0V | Piperazine | PIPERAZINE | CAS RN:110-85-0 | PubChem SID:175266916
+BMGC_DG10283,BMG_DG150605,UNII:2M8K8ZJJ5U | PubChem SID:440089004 | Piperidine-4-sulfonic acid | PIPERIDINE-4-SULFONIC ACID | PubChem CID:4838 | CAS RN:72450-62-5 | piperidine-4-sulfonic acid
+BMGC_DG10284,BMG_DG150606,"PIPERIDOLATE | Piperidolate | CAS RN:82-98-4 | DrugBank ID:DB13351 | PubChem CID:4839 | UNII:RJO31255V9 | (1-ethylpiperidin-3-yl) 2,2-diphenylacetate | PubChem SID:198984853"
+BMGC_DG10285,BMG_DG150611,PubChem CID:4842 | Pipobroman | UNII:6Q99RDT97R | CAS RN:54-91-1 | PIPOBROMAN | DrugBank ID:DB00236 | 3-bromo-1-[4-(3-bromopropanoyl)piperazin-1-yl]propan-1-one | PubChem SID:198990498
+BMGC_DG10286,BMG_DG150612,Piracetam | PIRACETAM | PubChem SID:198977243 | 2-(2-oxopyrrolidin-1-yl)acetamide | UNII:ZH516LNZ10 | DrugBank ID:DB09210 | CAS RN:7491-74-9 | PubChem CID:4843
+BMGC_DG10287,BMG_DG150615,PubChem CID:4845 | PIRBUTEROL | PubChem SID:175271360 | CAS RN:38677-81-5 | UNII:OG645J8RVW | CAS RN:64856-15-1 | DrugBank ID:DB01291 | Pirbuterol | 6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
+BMGC_DG10288,BMG_DG150618,"PubChem CID:4847 | PubChem SID:198944470 | 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2-methylpyrido[1,2-a]pyrimidin-4-one | PIRENPERONE | UNII:Y9FMC4513X | CAS RN:75444-65-4 | Pirenperone"
+BMGC_DG10289,BMG_DG150619,PubChem SID:474492805 | PubChem CID:484757 | CAS RN:105037-88-5 | UNII:QE5TL72TJ8 | PALLIDOL | Pallidol
+BMGC_DG10290,BMG_DG150620,"UNII:3G0285N20N | Pirenzepine | PubChem SID:198982815 | CAS RN:28797-61-7 | DrugBank ID:DB00670 | PIRENZEPINE | PubChem CID:4848 | 11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one"
+BMGC_DG10291,BMG_DG150621,4-phenoxy-3-pyrrolidin-1-yl-5-sulfamoylbenzoic acid | UNII:DQ6KK6GV93 | Piretanide | CAS RN:55837-27-9 | PIRETANIDE | DrugBank ID:DB02925 | PubChem CID:4849 | PubChem SID:198937143
+BMGC_DG10292,BMG_DG150624,"Piribedil | PubChem CID:4850 | DrugBank ID:DB12478 | CAS RN:3605-01-4 | PIRIBEDIL | 2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]pyrimidine | PubChem SID:198975857 | UNII:DO22K1PRDJ"
+BMGC_DG10293,BMG_DG150633,"CAS RN:19562-30-2 | PubChem SID:198970248 | Piromidic Acid | UNII:3I12WH4EWF | DrugBank ID:DB13744 | PubChem CID:4855 | PIROMIDIC ACID | 8-ethyl-5-oxo-2-pyrrolidin-1-ylpyrido[2,3-d]pyrimidine-6-carboxylic acid"
+BMGC_DG10294,BMG_DG150637,"PubChem CID:4858 | PubChem SID:459055407 | N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE | DrugBank ID:DB08348 | UNII:NA92ZAR7N2 | PJ-34 | CAS RN:344458-19-1"
+BMGC_DG10295,BMG_DG150655,"CAS RN:4135-11-9 | CAS RN:1404-26-8 | PubChem CID:4868 | N-[4-amino-1-[[1-[[4-amino-1-oxo-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide"
+BMGC_DG10296,BMG_DG150660,UNII:8LL8S712J7 | Methylmalonic acid | CAS RN:516-05-2 | 2-methylpropanedioic acid | PubChem CID:487 | Methylmalonic Acid | PubChem SID:198959812 | METHYLMALONIC ACID | CAS RN:1215348-94-9 | DrugBank ID:DB04183
+BMGC_DG10297,BMG_DG150661,"DrugBank ID:DB01324 | PubChem CID:4870 | UNII:SWY93BD8RL | 6-chloro-2-methyl-1,1-dioxo-3-(2,2,2-trifluoroethylsulfanylmethyl)-3,4-dihydro-1lambda6,2,4-benzothiadiazine-7-sulfonamide | PubChem SID:440090083 | CAS RN:96783-10-7 | Polythiazide | POLYTHIAZIDE | UNII:36780APV5N | PubChem SID:175271652 | CAS RN:346-18-9 | POLYTHIAZIDE, (+)-"
+BMGC_DG10298,BMG_DG150663,"PubChem SID:198953819 | 3-(3,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-6-(3-methylbut-2-enyl)pyrano[2,3-h]chromen-4-one | UNII:74YIS40APM | Pomiferin | PubChem CID:4871 | CAS RN:572-03-2 | POMIFERIN"
+BMGC_DG10299,BMG_DG150664,"PubChem SID:198935565 | UNII:6315412YVF | 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid | CAS RN:189279-58-1 | DrugBank ID:DB11943 | Delafloxacin | DELAFLOXACIN | PubChem CID:487101"
+BMGC_DG10300,BMG_DG150668,DrugBank ID:DB00761 | CAS RN:14336-88-0 | CAS RN:7447-40-7 | PubChem CID:4873 | POTASSIUM CHLORIDE | PubChem SID:175265703 | potassium;chloride | Potassium Chloride | Potassium chloride | UNII:660YQ98I10
+BMGC_DG10301,BMG_DG150672,PubChem CID:4875 | Potassium iodide | potassium;iodide | PubChem SID:175268840 | Potassium Iodide | POTASSIUM IODIDE | CAS RN:7681-11-0 | DrugBank ID:DB06715 | UNII:1C4QK22F9J
+BMGC_DG10302,BMG_DG150676,PubChem CID:4876 | CAS RN:2906-28-7 | 4-aminobenzoate | 4-Aminobenzoate
+BMGC_DG10303,BMG_DG150680,CAS RN:172889-27-9 | PubChem CID:4878 | PubChem SID:472424424 | UNII:PK8JPC58XB | PP2
+BMGC_DG10304,BMG_DG150681,"PubChem CID:4881 | 4-[[4-formyl-5-hydroxy-6-methyl-3-(phosphonooxymethyl)pyridin-2-yl]diazenyl]benzene-1,3-disulfonic acid | CAS RN:149017-66-3 | Ppads | UNII:L6K2LJ9BJK | PubChem SID:461434974 | PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID"
+BMGC_DG10305,BMG_DG150683,Practolol | UNII:SUG9176GRW | DrugBank ID:DB01297 | PRACTOLOL | PubChem CID:4883 | PubChem SID:198985573 | CAS RN:6673-35-4 | N-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide
+BMGC_DG10306,BMG_DG150685,"PubChem CID:4885 | 6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine | CAS RN:104617-86-9 | N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine"
+BMGC_DG10307,BMG_DG150687,CAS RN:140-65-8 | PRAMOXINE | Pramoxine | PubChem SID:175268269 | DrugBank ID:DB09345 | PubChem CID:4886 | 4-[3-(4-butoxyphenoxy)propyl]morpholine | Pramocaine | UNII:068X84E056
+BMGC_DG10308,BMG_DG150688,PubChem SID:198972268 | PubChem CID:4887 | DrugBank ID:DB01411 | CAS RN:103177-37-3 | N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide | PRANLUKAST | Pranlukast | UNII:TB8Z891092
+BMGC_DG10309,BMG_DG150690,"PubChem CID:4888 | UNII:2R7O1ET613 | Pranoprofen | DrugBank ID:DB13514 | PRANOPROFEN | 2-(5H-chromeno[2,3-b]pyridin-7-yl)propanoic acid | CAS RN:52549-17-4 | PubChem SID:198941246"
+BMGC_DG10310,BMG_DG150698,"Prazepam | DrugBank ID:DB01588 | UNII:Q30VCC064M | CAS RN:2955-38-6 | PubChem SID:198988005 | 7-chloro-1-(cyclopropylmethyl)-5-phenyl-3H-1,4-benzodiazepin-2-one | PRAZEPAM | PubChem CID:4890"
+BMGC_DG10311,BMG_DG150699,"PubChem CID:4891 | UNII:6490C9U457 | PubChem SID:175272031 | PRAZIQUANTEL | 2-(cyclohexanecarbonyl)-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one | CAS RN:55268-74-1 | NDC:49884-231 | DrugBank ID:DB01058 | CAS RN:135526-78-2 | Praziquantel | NDC:50419-747"
+BMGC_DG10312,BMG_DG150701,"PubChem CID:489181 | PubChem SID:198945048 | EFINACONAZOLE | (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol | CAS RN:164650-44-6 | CAS RN:164905-19-5 | UNII:J82SB7FXWB | DrugBank ID:DB09040 | Efinaconazole | NDC:0187-5400"
+BMGC_DG10313,BMG_DG150703,"UNII:XM03YJ541D | PRAZOSIN | [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone | CAS RN:19216-56-9 | DrugBank ID:DB00457 | Prazosin | PubChem CID:4893 | PubChem SID:175265721"
+BMGC_DG10314,BMG_DG150708,MORONIC ACID | UNII:XW8W7HC4JK | CAS RN:6713-27-5 | PubChem SID:472423329 | PubChem CID:489941
+BMGC_DG10315,BMG_DG150709,alpha-Ketoisovalerate | CAS RN:759-05-7 | UNII:34P71D50E0 | 3-methyl-2-oxobutanoic acid | DrugBank ID:DB04074 | PubChem SID:198968615 | 3-METHYL-2-OXOBUTYRIC ACID | 3-Methyl-2-oxobutanoic acid | PubChem CID:49
+BMGC_DG10316,BMG_DG150710,PubChem CID:490 | DrugBank ID:DB03174 | CAS RN:16051-76-6 | UNII:VPZ8FR5BMZ | Phosphonoacetaldehyde | PHOSPHONOACETALDEHYDE | PubChem SID:459056313
+BMGC_DG10317,BMG_DG150712,UNII:549V4DP94W | PubChem SID:198972828 | CAS RN:179324-22-2 | PS-III | PubChem CID:490002
+BMGC_DG10318,BMG_DG150714,"UNII:9E75Q6SUUB | PubChem CID:4904 | DrugBank ID:DB13642 | PubChem SID:198985905 | PRIDINOL | 1,1-diphenyl-3-piperidin-1-ylpropan-1-ol | CAS RN:511-45-5 | Pridinol"
+BMGC_DG10319,BMG_DG150715,"PubChem CID:490428 | (2R,3R)-2-benzhydryl-N-[(2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine | CAS RN:135095-42-0"
+BMGC_DG10320,BMG_DG150717,"PubChem SID:198978995 | DrugBank ID:DB13254 | Prifinium | UNII:3C7TTK1K7K | PRIFINIUM | CAS RN:10236-81-4 | 3-benzhydrylidene-1,1-diethyl-2-methylpyrrolidin-1-ium | PubChem CID:4905"
+BMGC_DG10321,BMG_DG150719,"methyl (15R,16S,18S)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylate | K-252a, Nocardiopsis sp. | PubChem CID:490561"
+BMGC_DG10322,BMG_DG150720,N-(2-methylphenyl)-2-(propylamino)propanamide | PubChem SID:175271971 | Prilocaine | PRILOCAINE | PubChem CID:4906 | UNII:046O35D44R | DrugBank ID:DB00750 | CAS RN:721-50-6
+BMGC_DG10323,BMG_DG150721,"CAS RN:90-34-6 | PubChem SID:175271528 | PubChem CID:4908 | PRIMAQUINE | DrugBank ID:DB01087 | 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine | UNII:MVR3634GX1 | Primaquine"
+BMGC_DG10324,BMG_DG150722,UNII:4H1AU2V37X | JNJ-7777120 | CAS RN:459168-41-3 | PubChem SID:198975186 | PubChem CID:4908365
+BMGC_DG10325,BMG_DG150723,"NDC:50268-686 | NDC:71610-191 | NDC:51407-637 | PubChem CID:4909 | DrugBank ID:DB00794 | NDC:53746-544 | NDC:68084-202 | NDC:71610-079 | NDC:71610-540 | NDC:69584-684 | NDC:72888-046 | PubChem SID:175267932 | NDC:55111-477 | NDC:65162-544 | NDC:53746-545 | NDC:0615-8206 | NDC:55111-476 | NDC:68084-203 | NDC:80005-118 | NDC:62135-468 | NDC:63629-7811 | NDC:0591-5321 | 5-ethyl-5-phenyl-1,3-diazinane-4,6-dione | NDC:72888-045 | NDC:80005-117 | NDC:72789-177 | NDC:42291-511 | NDC:65162-545 | CAS RN:125-33-7 | NDC:66490-690 | NDC:72789-178 | NDC:72888-160 | NDC:0527-1301 | NDC:0527-1231 | NDC:72189-216 | NDC:71610-590 | NDC:42291-509 | NDC:66490-691 | NDC:69584-685 | NDC:71335-1965 | Primidone | NDC:71610-005 | NDC:51407-638 | UNII:13AFD7670Q | NDC:50268-687 | NDC:52817-117 | PRIMIDONE | NDC:71610-763"
+BMGC_DG10326,BMG_DG150725,"CAS RN:302-33-0 | PubChem SID:198946676 | PROADIFEN | UNII:A510CA4CBT | Proadifen | 2-(diethylamino)ethyl 2,2-diphenylpentanoate | PubChem CID:4910"
+BMGC_DG10327,BMG_DG150726,"DrugBank ID:DB06368 | CAS RN:193681-12-8 | 9-[2-[bis(2,2,2-trifluoroethoxy)phosphorylmethoxy]ethyl]-6-(4-methoxyphenyl)sulfanylpurin-2-amine | PubChem CID:491022 | PubChem SID:198961289 | ALAMIFOVIR | UNII:0N739K2A8A | Alamifovir"
+BMGC_DG10328,BMG_DG150727,NDC:0591-5347 | PubChem SID:175266966 | NDC:16571-831 | UNII:PO572Z7917 | NDC:72162-2237 | DrugBank ID:DB01032 | NDC:10135-541 | NDC:83008-020 | CAS RN:57-66-9 | PubChem CID:4911 | Probenecid | NDC:0527-1367 | NDC:72162-2386 | 4-(dipropylsulfamoyl)benzoic acid | PROBENECID
+BMGC_DG10329,BMG_DG150730,"CAS RN:23288-49-5 | PROBUCOL | Probucol | UNII:P3CTH044XJ | 2,6-ditert-butyl-4-[2-(3,5-ditert-butyl-4-hydroxyphenyl)sulfanylpropan-2-ylsulfanyl]phenol | DrugBank ID:DB01599 | PubChem CID:4912 | PubChem SID:175268459"
+BMGC_DG10330,BMG_DG150732,Procainamide | PubChem SID:175268261 | UNII:L39WTC366D | PROCAINAMIDE | 4-amino-N-[2-(diethylamino)ethyl]benzamide | DrugBank ID:DB01035 | PubChem CID:4913 | CAS RN:51-06-9
+BMGC_DG10331,BMG_DG150734,UNII:4Z8Y51M438 | CAS RN:59-46-1 | PROCAINE | Procaine | DrugBank ID:DB00721 | PubChem SID:175266700 | PubChem CID:4914 | 2-(diethylamino)ethyl 4-aminobenzoate
+BMGC_DG10332,BMG_DG150735,CAS RN:671-16-9 | PubChem SID:175268622 | PROCARBAZINE | DrugBank ID:DB01168 | 4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide | UNII:35S93Y190K | PubChem CID:4915 | Procarbazine
+BMGC_DG10333,BMG_DG150738,CAS RN:72332-33-3 | 8-hydroxy-5-[1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one | Procaterol | CAS RN:60443-17-6 | PubChem CID:4916
+BMGC_DG10334,BMG_DG150739,Prochlorperazine | CAS RN:58-38-8 | UNII:YHP6YLT61T | NDC:0574-7226 | PROCHLORPERAZINE | PubChem CID:4917 | DrugBank ID:DB00433 | PubChem SID:175266160 | NDC:0713-0135 | NDC:55289-119 | 2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine
+BMGC_DG10335,BMG_DG150742,1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol | Procyclidine | UNII:C6QE1Q1TKR | DrugBank ID:DB00387 | CAS RN:77-37-2 | PubChem CID:4919 | PROCYCLIDINE | PubChem SID:175271537
+BMGC_DG10336,BMG_DG150743,"DrugBank ID:DB11844 | PubChem CID:491941 | Pritelivir | N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide | UNII:07HQ1TJ4JE | CAS RN:348086-71-5 | PubChem SID:198969942 | PRITELIVIR"
+BMGC_DG10337,BMG_DG150744,CAS RN:388121-75-3 | PubChem SID:445500565 | PHA-529311 | PubChem CID:491953 | UNII:8FN7ZSA8MC
+BMGC_DG10338,BMG_DG150746,UNII:FV919079LU | CAS RN:57132-53-3 | 3-[4-[2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyethyl]piperazin-1-yl]propyl 4-benzamido-5-(dipropylamino)-5-oxopentanoate | DrugBank ID:DB13527 | PROGLUMETACIN | Proglumetacin | PubChem CID:4921 | PubChem SID:198968851
+BMGC_DG10339,BMG_DG150749,CAS RN:24485-90-3 | 4-benzamido-5-(dipropylamino)-5-oxopentanoic acid | PROGLUMIDE | UNII:EPL8W5565D | Proglumide | PubChem SID:198969134 | PubChem CID:4922 | DrugBank ID:DB13431 | CAS RN:6620-60-6
+BMGC_DG10340,BMG_DG150752,1-[amino-(4-chloroanilino)methylidene]-2-propan-2-ylguanidine | PubChem SID:175267378 | DrugBank ID:DB01131 | PubChem CID:4923 | Proguanil | CAS RN:500-92-5 | PROGUANIL | 1-[Amino-(4-chloroanilino)methylidene]-2-propan-2-ylguanidine | UNII:S61K3P7B2V
+BMGC_DG10341,BMG_DG150753,UNII:EW5GL2X7E0 | DrugBank ID:DB12466 | PubChem SID:198936032 | PubChem CID:492405 | 5-fluoro-2-oxo-1H-pyrazine-3-carboxamide | FAVIPIRAVIR | CAS RN:259793-96-9 | Favipiravir
+BMGC_DG10342,BMG_DG150754,PubChem CID:492406 | PNU-183792 | PubChem SID:459056022 | CAS RN:282536-25-8 | UNII:X9ARA56MXB
+BMGC_DG10343,BMG_DG150755,"Promazine | UNII:O9M39HTM5W | N,N-dimethyl-3-phenothiazin-10-ylpropan-1-amine | PubChem CID:4926 | PROMAZINE | DrugBank ID:DB00420 | CAS RN:58-40-2 | PubChem SID:198974257"
+BMGC_DG10344,BMG_DG150756,"PubChem CID:4927 | PROMETHAZINE | PubChem SID:175271815 | CAS RN:60-87-7 | UNII:FF28EJQ494 | CAS RN:38878-40-9 | Promethazine | DrugBank ID:DB01069 | CAS RN:73745-50-3 | N,N-dimethyl-1-phenothiazin-10-ylpropan-2-amine"
+BMGC_DG10345,BMG_DG150760,CAS RN:54-80-8 | PubChem CID:4930 | PRONETALOL | PubChem SID:198972729 | UNII:XBP4RT1IMQ
+BMGC_DG10346,BMG_DG150764,PubChem CID:4932 | 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one | CAS RN:9083-41-4 | UNII:68IQX3T69U | Propafenone | PubChem SID:175272139 | DrugBank ID:DB01182 | PROPAFENONE | CAS RN:54063-53-5
+BMGC_DG10347,BMG_DG150766,methyl-di(propan-2-yl)-[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium | PROPANTHELINE | UNII:1306V2B0Q8 | DrugBank ID:DB00782 | PubChem SID:175265417 | PubChem CID:4934 | CAS RN:298-50-0 | Propantheline
+BMGC_DG10348,BMG_DG150770,DrugBank ID:DB00807 | PubChem SID:175266685 | Proparacaine | PubChem CID:4935 | UNII:B4OB0JHI1X | PROPARACAINE | 2-(diethylamino)ethyl 3-amino-4-propoxybenzoate | CAS RN:499-67-2
+BMGC_DG10349,BMG_DG150773,"UNII:TLM2976OFR | PubChem SID:175267848 | CAS RN:83-88-5 | 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione | Riboflavin | DrugBank ID:DB00140 | PubChem CID:493570 | RIBOFLAVIN"
+BMGC_DG10350,BMG_DG150778,"DrugBank ID:DB06479 | PubChem SID:198957655 | 3-methyl-1-(5-oxohexyl)-7-propylpurine-2,6-dione | PubChem CID:4938 | Propentofylline | CAS RN:55242-55-2 | PROPENTOFYLLINE | UNII:5RTA398U4H"
+BMGC_DG10351,BMG_DG150779,PubChem SID:198943533 | PubChem CID:49381 | FLUPERLAPINE | Fluperlapine | CAS RN:67121-76-0 | 3-fluoro-6-(4-methylpiperazin-1-yl)-11H-benzo[c][1]benzazepine | UNII:EWG253M961
+BMGC_DG10352,BMG_DG150780,"UNII:TPY2K437O4 | METAZACHLOR | CAS RN:67129-08-2 | PubChem SID:198987749 | PubChem CID:49384 | 2-chloro-N-(2,6-dimethylphenyl)-N-(pyrazol-1-ylmethyl)acetamide | Metazachlor"
+BMGC_DG10353,BMG_DG150781,"PROPIDIUM | DrugBank ID:DB02166 | 3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium | PubChem CID:4939 | CAS RN:36015-30-2 | PubChem SID:198969804 | Propidium | UNII:74NX23J96Y"
+BMGC_DG10354,BMG_DG150789,PubChem SID:198941389 | DrugBank ID:DB00777 | CAS RN:362-29-8 | PROPIOMAZINE | UNII:242Z0PM79Y | Propiomazine | PubChem CID:4940 | 1-[10-[2-(dimethylamino)propyl]phenothiazin-2-yl]propan-1-one
+BMGC_DG10355,BMG_DG150807,"PubChem SID:478838245 | UNII:8E4RMX4N4V | CAS RN:92276-38-5 | 6-BROMO-3H-(1,2,3)TRIAZOLO(4,5-B)PYRIDINE | PubChem CID:494193"
+BMGC_DG10356,BMG_DG150808,"(1-methylpiperidin-4-yl) 2,2-diphenyl-2-propoxyacetate | CAS RN:60569-19-9 | PubChem SID:198955947 | PROPIVERINE | Propiverine | PubChem CID:4942 | DrugBank ID:DB12278 | UNII:468GE2241L"
+BMGC_DG10357,BMG_DG150828,"NDC:72572-590 | UNII:YI7VU623SF | NDC:25021-608 | DrugBank ID:DB00818 | Propofol | NDC:0069-0248 | NDC:80830-2364 | NDC:0069-0234 | NDC:43598-549 | NDC:80830-1188 | NDC:72572-612 | NDC:0641-6195 | PubChem SID:175266661 | PROPOFOL | CAS RN:113981-41-2 | NDC:80830-2365 | NDC:16714-977 | NDC:43598-548 | NDC:23155-345 | NDC:51662-1293 | NDC:51662-1470 | NDC:63323-269 | NDC:51662-1471 | NDC:43598-265 | PubChem CID:4943 | NDC:0069-0209 | NDC:0641-6194 | NDC:16714-528 | 2,6-di(propan-2-yl)phenol | CAS RN:2078-54-8 | NDC:83634-603 | NDC:72572-601 | NDC:0409-6010 | NDC:16714-690 | NDC:0409-4699 | NDC:0641-6196 | NDC:65219-800"
+BMGC_DG10358,BMG_DG150830,Propoxur | CAS RN:114-26-1 | (2-propan-2-yloxyphenyl) N-methylcarbamate | PubChem SID:198977712 | UNII:BFH029TL73 | PubChem CID:4944 | PROPOXUR
+BMGC_DG10359,BMG_DG150833,1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol | CAS RN:525-66-6 | PubChem SID:175271523 | PROPRANOLOL | CAS RN:13013-17-7 | UNII:9Y8NXQ24VQ | Propranolol | PubChem CID:4946 | DrugBank ID:DB00571
+BMGC_DG10360,BMG_DG150834,"Propyl Gallate | PubChem SID:175267015 | Propyl gallate | propyl 3,4,5-trihydroxybenzoate | PubChem CID:4947 | DrugBank ID:DB12450 | PROPYL GALLATE | CAS RN:121-79-9 | CAS RN:56274-95-4 | UNII:8D4SNN7V92"
+BMGC_DG10361,BMG_DG150835,"CAS RN:587-61-1 | PubChem CID:4949 | DrugBank ID:DB09366 | propyl 2-(3,5-diiodo-4-oxopyridin-1-yl)acetate | UNII:5NPJ6BPX36 | Propyliodone | PROPYLIODONE | PubChem SID:198957342"
+BMGC_DG10362,BMG_DG150848,"4-[10,15,20-tris(4-sulfophenyl)-21,24-dihydroporphyrin-5-yl]benzenesulfonic acid | T4SPP;TSPP;Tetraphenylporphine sulfonate | PubChem CID:49561"
+BMGC_DG10363,BMG_DG150857,CAS RN:2491-38-5 | 2-BROMO-4'-HYDROXYACETOPHENONE | UNII:6H0QU4I6BA | PubChem CID:4964 | PubChem SID:198990320
+BMGC_DG10364,BMG_DG150858,UNII:PV5M69J53H | PubChem SID:443623541 | CAS RN:2632-13-5 | BROMOMETHYL 4-METHOXYPHENYL KETONE | PubChem CID:4965
+BMGC_DG10365,BMG_DG150864,PROTOKYLOL | PubChem SID:198957274 | UNII:8Y5Y4EEO2V | PubChem CID:4969 | CAS RN:136-70-9
+BMGC_DG10366,BMG_DG150867,"Protoporphyrin | 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid | protoporphyrin IX | PubChem CID:4971 | PubChem SID:198938238 | DrugBank ID:DB02285 | CAS RN:553-12-8 | PROTOPORPHYRIN | UNII:C2K325S808"
+BMGC_DG10367,BMG_DG150871,"CAS RN:14875-96-8 | Ferroprotoporphyrin IX | PubChem CID:4973 | 3-[18-(2-carboxyethyl)-7,12-bis(ethenyl)-3,8,13,17-tetramethylporphyrin-21,23-diid-2-yl]propanoic acid;iron(2+)"
+BMGC_DG10368,BMG_DG150875,"UNII:XZ2CCP18I2 | 5-METHOXY-2,N,N-TRIMETHYLTRYPTAMINE | CAS RN:67292-68-6 | PubChem SID:363909510 | PubChem CID:49756"
+BMGC_DG10369,BMG_DG150878,"DrugBank ID:DB00344 | PubChem CID:4976 | PROTRIPTYLINE | N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine | PubChem SID:175267486 | Protriptyline | UNII:4NDU154T12 | CAS RN:438-60-8"
+BMGC_DG10370,BMG_DG150881,"MK-1903 | CAS RN:1268882-43-4 | PubChem CID:49763030 | PubChem SID:317229952 | (2R,4R)-8,9-diazatricyclo[4.3.0.02,4]nona-1(6),7-diene-7-carboxylic acid | UNII:62N05GRI0P"
+BMGC_DG10371,BMG_DG150885,CAS RN:1256963-02-6 | 4-(3-chloro-5-propan-2-yl-1H-pyrazol-4-yl)-N-[5-[4-(dimethylamino)piperidin-1-yl]pyridin-2-yl]pyrimidin-2-amine | PubChem CID:49765254 | 4-(5-chloro-3-isopropyl-1H-pyrazol-4-yl)-N-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine
+BMGC_DG10372,BMG_DG150896,"PubChem CID:4977 | PROXYPHYLLINE | 7-(2-hydroxypropyl)-1,3-dimethylpurine-2,6-dione | DrugBank ID:DB13449 | UNII:13G1DMN4P0 | Proxyphylline | PubChem SID:198959512 | CAS RN:603-00-9"
+BMGC_DG10373,BMG_DG150899,"(8S,10R)-19-Cyclohexyl-N-(dimethylsulfamoyl)-5-methoxy-10-(3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-12-azapentacyclo[10.7.0.02,7.08,10.013,18]nonadeca-1(19),2(7),3,5,13(18),14,16-heptaene-15-carboxamide | PubChem CID:49773361 | (8S,10R)-19-cyclohexyl-N-(dimethylsulfamoyl)-5-methoxy-10-(3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl)-12-azapentacyclo[10.7.0.02,7.08,10.013,18]nonadeca-1(19),2(7),3,5,13(18),14,16-heptaene-15-carboxamide | CAS RN:958002-33-0 | CAS RN:1532561-48-0"
+BMGC_DG10374,BMG_DG150901,BMS-337197 | PubChem SID:198990111 | PubChem CID:497792 | UNII:L8TIE69805 | CAS RN:267645-83-0
+BMGC_DG10375,BMG_DG150903,UNII:YD7836VJ3G | CAS RN:1253641-65-4 | PubChem CID:49779607 | PubChem SID:496141593 | TM-38837
+BMGC_DG10376,BMG_DG150906,PubChem CID:49783410 | PubChem SID:346540404 | UNII:GGT8LM8A2O | CAS RN:1256842-49-5 | AM-2389
+BMGC_DG10377,BMG_DG150907,"UNII:4M4E8NZ73C | PubChem CID:49783923 | N-[5-[4-[5-[[(2S,6R)-2,6-dimethylmorpholin-4-yl]methyl]-1,3-oxazol-2-yl]-1H-indazol-6-yl]-2-methoxypyridin-3-yl]methanesulfonamide | CAS RN:1254036-66-2 | GSK-2292767 | Gsk2292767 | PubChem SID:461433089"
+BMGC_DG10378,BMG_DG150909,"2-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-5-[(4-propan-2-ylpiperazin-1-yl)methyl]-1,3-oxazole | NEMIRALISIB | UNII:OEP8JJ3OZR | PubChem SID:317229402 | Nemiralisib | PubChem CID:49784002 | CAS RN:1254036-71-9"
+BMGC_DG10379,BMG_DG150913,"CH-5132799 | CAS RN:1007207-67-1 | UNII:JCL936W835 | PubChem SID:251965653 | Izorlisib | IZORLISIB | DrugBank ID:DB13051 | 5-(7-methylsulfonyl-2-morpholin-4-yl-5,6-dihydropyrrolo[2,3-d]pyrimidin-4-yl)pyrimidin-2-amine | PubChem CID:49784945"
+BMGC_DG10380,BMG_DG150929,UNII:K56X3P8P9Q | PubChem SID:485661527 | CAS RN:872719-49-8 | PubChem CID:49787129 | TAK-683
+BMGC_DG10381,BMG_DG150933,"2-[2-[2-(2,6-dichlorophenyl)propan-2-yl]-1-[2-fluoro-4-[3-fluoro-4-(hydroxymethyl)-5-methylsulfonylphenyl]phenyl]imidazol-4-yl]propan-2-ol | PubChem SID:441331767 | Bms-852927 | UNII:H9649L8MZN | BMS-852927 | PubChem CID:49787490 | CAS RN:1256918-39-4"
+BMGC_DG10382,BMG_DG150976,"PubChem CID:49792850 | 1-[4-[4-[3-methyl-4-[[(1R)-1-phenylethoxy]carbonylamino]-1,2-oxazol-5-yl]phenyl]phenyl]cyclopropane-1-carboxylic acid | UNII:38CTP01B4L | BMS-986020 | Bms-986020 | DrugBank ID:DB14948 | PubChem SID:333495535 | CAS RN:1257213-50-5"
+BMGC_DG10383,BMG_DG150977,"Onvansertib | CAS RN:1034616-18-6 | UNII:67RM91WDHQ | PubChem CID:49792852 | DrugBank ID:DB15110 | 1-(2-hydroxyethyl)-8-[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy)anilino]-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide | PubChem SID:198967041 | ONVANSERTIB"
+BMGC_DG10384,BMG_DG150987,PSILOCIN | CAS RN:520-53-6 | UNII:CMS88KUW0G | PubChem CID:4980 | PubChem SID:198973967 | 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | Psilocin
+BMGC_DG10385,BMG_DG150990,"CID 49800003 | N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide;sulfuric acid | CAS RN:1405-20-5 | PubChem CID:49800003"
+BMGC_DG10386,BMG_DG150991,"CAS RN:1404-26-8 | PubChem CID:49800004 | DrugBank ID:DB00781 | N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide"
+BMGC_DG10387,BMG_DG151009,"UNII:3593C180JO | PubChem SID:313184125 | Mk-3281 | CAS RN:886041-60-7 | MK-3281 | (10R)-19-cyclohexyl-10-[2-(dimethylamino)ethyl-methylamino]-8-oxa-12-azatetracyclo[10.7.0.02,7.013,18]nonadeca-1(19),2,4,6,13(18),14,16-heptaene-15-carboxylic acid | PubChem CID:49800096"
+BMGC_DG10388,BMG_DG151011,"PubChem CID:49801838 | PubChem SID:346540941 | UNII:H9HGK5C4UM | CAS RN:1254035-84-1 | [5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]-[3-[4-(2-oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy]azetidin-1-yl]methanone | (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone | AZD-1979"
+BMGC_DG10389,BMG_DG151015,UNII:83V80O4XY1 | DrugBank ID:DB12795 | CAS RN:910627-26-8 | PubChem SID:272993934 | CMX-2043 | Cmx-2043 | PubChem CID:49802864 | (4S)-5-[[(1S)-1-carboxyethyl]amino]-4-[5-[(3R)-dithiolan-3-yl]pentanoylamino]-5-oxopentanoic acid
+BMGC_DG10390,BMG_DG151019,PubChem SID:316917190 | CAS RN:1254053-43-4 | DrugBank ID:DB12141 | PubChem CID:49803313 | Gilteritinib | 6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide | UNII:66D92MGC8M | GILTERITINIB
+BMGC_DG10391,BMG_DG151021,"[3-[4-[(4-cyclopropylphenyl)methoxy]-3-methoxyphenyl]azetidin-1-yl]-[4-[[(2S)-2,3-dihydroxypropoxy]methyl]pyridin-2-yl]methanone | CAS RN:1255303-54-8 | PubChem CID:49806372 | (3-{4-[(4-cyclopropylphenyl)methoxy]-3-methoxyphenyl}azetidin-1-yl)(4-{[(2S)-2,3-dihydroxypropoxy]methyl}pyridin-2-yl)methanone"
+BMGC_DG10392,BMG_DG151023,"DrugBank ID:DB11363 | ALECTINIB | PubChem SID:198968336 | PubChem CID:49806720 | 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile | CAS RN:1256580-46-7 | Alectinib | UNII:LIJ4CT1Z3Y"
+BMGC_DG10393,BMG_DG151043,PubChem CID:49830591 | CAS RN:1285533-84-7 | UNII:XKD9NF565L | N-METHYL-4-(4-((((3-(TRIFLUOROMETHYL)PHENYL)AMINO)CARBONYL)AMINO)PHENOXY)-2-PYRIDINECARBOXAMIDE
+BMGC_DG10394,BMG_DG151048,"CAS RN:1206161-97-8 | UNII:3XVL385Q0M | PubChem CID:49831257 | FILGOTINIB | PubChem SID:198935143 | N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide | Filgotinib | DrugBank ID:DB14845 | CAS RN:1206101-20-3"
+BMGC_DG10395,BMG_DG151049,"NDC:65757-402 | NDC:65757-404 | CAS RN:1259305-29-7 | Aripiprazole Lauroxil | DrugBank ID:DB14185 | [7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-2-oxo-3,4-dihydroquinolin-1-yl]methyl dodecanoate | NDC:65757-500 | PubChem CID:49831411 | NDC:65757-401 | PubChem SID:198969830 | ARIPIPRAZOLE LAUROXIL | UNII:B786J7A343 | NDC:65757-403"
+BMGC_DG10396,BMG_DG151063,"PubChem SID:198976339 | DrugBank ID:DB11782 | Birinapant | CAS RN:1260251-31-7 | (2S)-N-[(2S)-1-[(2R,4S)-2-[[6-fluoro-2-[6-fluoro-3-[[(2R,4S)-4-hydroxy-1-[(2S)-2-[[(2S)-2-(methylamino)propanoyl]amino]butanoyl]pyrrolidin-2-yl]methyl]-1H-indol-2-yl]-1H-indol-3-yl]methyl]-4-hydroxypyrrolidin-1-yl]-1-oxobutan-2-yl]-2-(methylamino)propanamide | PubChem CID:49836020 | BIRINAPANT | UNII:6O4Z07B57R"
+BMGC_DG10397,BMG_DG151064,PubChem SID:485666243 | CAS RN:1222998-36-8 | TORIN-1 | PubChem CID:49836027 | Torin-1 | UNII:K9HTV88VQZ
+BMGC_DG10398,BMG_DG151066,"EVACETRAPIB | DrugBank ID:DB11655 | Evacetrapib | 4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylic acid | CAS RN:1186486-62-3 | PubChem SID:198940733 | UNII:51XWV9K850 | PubChem CID:49836058"
+BMGC_DG10399,BMG_DG151068,"Funapide | PubChem SID:198948438 | FUNAPIDE | PubChem CID:49836093 | CAS RN:1259933-16-8 | DrugBank ID:DB11769 | UNII:A5595LHJ2L | (7S)-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6H-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one"
+BMGC_DG10400,BMG_DG151069,"PubChem SID:405055027 | CAS RN:1254123-15-3 | PubChem CID:49836152 | UNII:1NN8C998F0 | 4(3H)-QUINAZOLINONE, 3-AMINO-5,6,7,8-TETRAHYDRO-2-(4-(4-(6-HYDROXY-2-QUINOLINYL)-1-PIPERAZINYL)BUTYL)-"
+BMGC_DG10401,BMG_DG151071,"CAS RN:1254123-14-2 | UNII:WCY1J1MH0U | 4(3H)-QUINAZOLINONE, 3-AMINO-5,6,7,8-TETRAHYDRO-2-(4-(4-(3-HYDROXY-2-QUINOLINYL)-1-PIPERAZINYL)BUTYL)- | PubChem SID:405055408 | PubChem CID:49837758"
+BMGC_DG10402,BMG_DG151072,"PubChem CID:49837869 | 4-[[(2S)-2-[2-(4-chlorophenyl)-5,6-difluorobenzimidazol-1-yl]-2-cyclohexylacetyl]amino]-3-fluorobenzoic acid | 4-({(2s)-2-[2-(4-Chlorophenyl)-5,6-Difluoro-1h-Benzimidazol-1-Yl]-2-Cyclohexylacetyl}amino)-3-Fluorobenzoic Acid"
+BMGC_DG10403,BMG_DG151074,"DrugBank ID:DB12547 | UNII:2CQ62IWB67 | LY-2886721 | PubChem CID:49837968 | N-[3-[(4aS,7aS)-2-amino-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide | PubChem SID:198972442 | CAS RN:1262036-50-9 | Ly-2886721"
+BMGC_DG10404,BMG_DG151086,"UNII:O880NM097T | AVACOPAN | DrugBank ID:DB15011 | (2R,3S)-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide | CAS RN:1346623-17-3 | PubChem CID:49841217 | NDC:73556-168 | Avacopan | PubChem SID:310825762"
+BMGC_DG10405,BMG_DG151089,"SETIPIPRANT | CAS RN:866460-33-5 | UNII:BHF20LA2GM | 2-[8-fluoro-2-(naphthalene-1-carbonyl)-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl]acetic acid | Setipiprant | PubChem SID:198987035 | PubChem CID:49843471 | DrugBank ID:DB12562"
+BMGC_DG10406,BMG_DG151090,"PubChem CID:49843517 | (E)-3-[2,6-dichloro-4-[[4-[3-[(1S)-1-hexoxyethyl]-2-methoxyphenyl]-1,3-thiazol-2-yl]carbamoyl]phenyl]-2-methylprop-2-enoic acid | Lusutrombopag | DrugBank ID:DB13125 | NDC:59630-551 | UNII:6LL5JFU42F | CAS RN:1110766-97-6 | LUSUTROMBOPAG | PubChem SID:198952757"
+BMGC_DG10407,BMG_DG151091,CAS RN:1262417-51-5 | PubChem CID:49843531 | UNII:9TSU9SA6UZ | NMS-P118 | PubChem SID:440088563
+BMGC_DG10408,BMG_DG151101,"NDC:0074-0576 | 4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide | PubChem SID:198955872 | VENETOCLAX | DrugBank ID:DB11581 | CAS RN:1257044-40-8 | Venetoclax | UNII:N54AIC43PW | PubChem CID:49846579 | NDC:0074-0566 | NDC:0074-0561"
+BMGC_DG10409,BMG_DG151106,PubChem SID:198968197 | DrugBank ID:DB12550 | CAS RN:1258861-20-9 | 4-fluoro-N-methyl-N-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]piperidin-4-yl]-2-(trifluoromethyl)benzamide | TALADEGIB | PubChem CID:49848070 | UNII:QY8BWX1LJ5 | Taladegib
+BMGC_DG10410,BMG_DG151108,PubChem CID:49848485 | AKB-6899 | UNII:ZIA31378BO | PubChem SID:312524983 | CAS RN:1007377-55-0
+BMGC_DG10411,BMG_DG151125,PubChem CID:49850262 | CAS RN:1252003-15-8 | PubChem SID:346540266 | TUBASTATIN A | UNII:2XTSOX1NF8
+BMGC_DG10412,BMG_DG151130,"Fondaparinux | DrugBank ID:DB00569 | PubChem CID:49852292 | Arixtra | decasodium;[(2R,3R,4S,5S,6R)-6-carboxy-5-[(2R,3R,4R,5R,6R)-5-[(2R,3R,4R,5S,6S)-6-carboxy-5-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]oxy-3-(sulfonatoamino)-4-sulfonatooxy-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4-hydroxy-2-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxyoxan-3-yl] sulfate"
+BMGC_DG10413,BMG_DG151167,UNII:GPO2JN4UON | PubChem SID:198945398 | CAS RN:929016-96-6 | DrugBank ID:DB05223 | Pracinostat | PubChem CID:49855250 | (E)-3-[2-butyl-1-[2-(diethylamino)ethyl]benzimidazol-5-yl]-N-hydroxyprop-2-enamide | PRACINOSTAT
+BMGC_DG10414,BMG_DG151172,"PubChem CID:49856296 | CAS RN:1261113-96-5 | PubChem SID:317229361 | Ganaplacide | UNII:85VMN9JU7A | 2-amino-1-[3-(4-fluoroanilino)-2-(4-fluorophenyl)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7-yl]ethanone | GANAPLACIDE"
+BMGC_DG10415,BMG_DG151173,UNII:Q7ZOK859UK | PubChem CID:49856321 | CAS RN:1243290-37-0 | PubChem SID:198957826 | CP-690550A
+BMGC_DG10416,BMG_DG151176,"UNII:K35A6384QD | N-((3R,4R)-1-BENZYL-4-METHYLPIPERIDIN-3-YL)-N-METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-AMINE | PubChem SID:441583763 | CAS RN:477600-73-0 | PubChem CID:49856703"
+BMGC_DG10417,BMG_DG151180,"2-[(1S,5R)-6-[(6-fluoroquinolin-2-yl)methylamino]-3-azabicyclo[3.1.0]hexan-3-yl]-N-hydroxypyrimidine-5-carboxamide | DrugBank ID:DB15419 | PubChem CID:49857317 | Nanatinostat | NANATINOSTAT | CAS RN:1256448-47-1 | PubChem SID:381132525 | UNII:YTL7A418KQ"
+BMGC_DG10418,BMG_DG151239,UNII:TWK9849JXJ | CAS RN:833457-45-7 | PubChem CID:49863205 | 6-(3-(TRIFLUOROMETHYL)PHENYL)PYRIDINE-2-CARBONITRILE | PubChem SID:440089200
+BMGC_DG10419,BMG_DG151250,"DrugBank ID:DB04579 | PubChem CID:49866368 | N-{[(2S,3S)-3-(Ethoxycarbonyl)-2-oxiranyl]carbonyl}-L-threonyl-L-isoleucine"
+BMGC_DG10420,BMG_DG151255,(2S)-1-{[5-(1H-Indazol-5-yl)-3-pyridinyl]oxy}-3-(7aH-indol-3-yl)-2-propanamine | DrugBank ID:DB06977 | PubChem CID:49866474
+BMGC_DG10421,BMG_DG151265,"Deoxycytidylyl-3',5'-guanosine | DrugBank ID:DB03326 | PubChem CID:49866787"
+BMGC_DG10422,BMG_DG151271,PubChem CID:49866839 | S-oxy-L-cysteine | DrugBank ID:DB03382
+BMGC_DG10423,BMG_DG151276,4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE | PubChem CID:49866889 | DrugBank ID:DB04673
+BMGC_DG10424,BMG_DG151277,2-Deoxy-Glucitol-6-Phosphate | DrugBank ID:DB04516 | PubChem CID:49866901
+BMGC_DG10425,BMG_DG151280,PubChem CID:49866945 | DrugBank ID:DB03732 | Etheno-Nadp
+BMGC_DG10426,BMG_DG151281,PubChem CID:49866981 | DrugBank ID:DB02784 | N-(Bromoacetyl)-beta-alanyl-N-(2-{4-[(carboxycarbonyl)amino]phenyl}ethyl)-L-serinamide
+BMGC_DG10427,BMG_DG151286,"PubChem CID:49867144 | 1,4-Dideoxy-O2-Sulfo-Glucuronic Acid | DrugBank ID:DB03935"
+BMGC_DG10428,BMG_DG151288,"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole | PubChem CID:49867153 | DrugBank ID:DB03133"
+BMGC_DG10429,BMG_DG151289,"DrugBank ID:DB04144 | Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone | PubChem CID:49867154"
+BMGC_DG10430,BMG_DG151299,"1,2-diacyl-sn-glycero-3-phosphoinositol | PubChem CID:49867502 | DrugBank ID:DB02144"
+BMGC_DG10431,BMG_DG151308,BS-181 | UNII:75M620LLBN | PubChem CID:49867929 | CAS RN:1092443-52-1 | PubChem SID:198980010
+BMGC_DG10432,BMG_DG151309,"2,2-dimethyl-N-[(7S)-6-oxo-5,7-dihydrobenzo[d][1]benzazepin-7-yl]-N'-(2,2,3,3,3-pentafluoropropyl)propanediamide | Rg-4733 | UNII:KK8645V7LE | RG-4733 | PubChem SID:198939144 | DrugBank ID:DB11870 | CAS RN:847925-91-1 | PubChem CID:49867930"
+BMGC_DG10433,BMG_DG151310,"UNII:E8R04MBQ04 | IXAZOMIB CITRATE 1,3,2-DIOXABORINANE | 4-(carboxymethyl)-2-((R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid | CAS RN:1201902-80-8 | PubChem SID:198971701 | 4-(carboxymethyl)-2-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-6-oxo-1,3,2-dioxaborinane-4-carboxylic acid | PubChem CID:49867936"
+BMGC_DG10434,BMG_DG151312,"CAS RN:59865-13-3 | PubChem CID:49867938 | cyclo[Abu-Sar-N(Me)Leu-Val-N(Me)Leu-Ala-D-Ala-N(Me)Leu-N(Me)Leu-DL-N(Me)Val-N(Me)Bmt(E)] | (6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone"
+BMGC_DG10435,BMG_DG151316,"PubChem CID:49868036 | CAS RN:68-19-9 | cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide"
+BMGC_DG10436,BMG_DG151332,"Piperidine, 1-((4,6-dimethyl-5-pyrimidinyl)carbonyl)-4-((3S)-4-((1R,2R)-2-ethoxy-2,3-dihydro-5-(trifluoromethyl)-1H-inden-1-yl)-3-methyl-1-piperazinyl)-4-methyl- | UNII:C5D4W25708 | DrugBank ID:DB12960 | PubChem CID:49871007 | CAS RN:925701-76-4 | INCB-9471 | CAS RN:869769-98-2 | PubChem SID:198965190 | (4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone"
+BMGC_DG10437,BMG_DG151333,MK-5046 | PubChem SID:472424584 | CAS RN:1022152-70-0 | PubChem CID:49871766 | UNII:QHZ72H8F6P
+BMGC_DG10438,BMG_DG151335,PubChem CID:49871869 | PubChem SID:346540299 | UNII:UP0K5026VB | 1-(2-chloropyridin-4-yl)-3-(4-methylpyridin-3-yl)imidazolidin-2-one | Cfg-920 | CAS RN:1260006-20-9 | CFG-920
+BMGC_DG10439,BMG_DG151341,"PubChem CID:4988454 | PubChem SID:313182939 | Z-160 | DrugBank ID:DB12743 | 1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one | UNII:TX3R141LEP | CAS RN:41332-24-5 | 1-[4-(Diphenylmethyl)-1-piperazinyl]-3,3-diphenyl-1-propanone"
+BMGC_DG10440,BMG_DG151349,PubChem SID:198986644 | UNII:81R511UV73 | PYRICARBATE | PubChem CID:4990 | Pyridinolcarbamate | CAS RN:1882-26-4 | [6-(methylcarbamoyloxymethyl)pyridin-2-yl]methyl N-methylcarbamate
+BMGC_DG10441,BMG_DG151350,"UNII:YWB9IF596V | Merbarone | PubChem CID:4990817 | CAS RN:97534-21-9 | PubChem SID:322058704 | MERBARONE | 4,6-dioxo-N-phenyl-2-sulfanylidene-1,3-diazinane-5-carboxamide"
+BMGC_DG10442,BMG_DG151351,"Pyridostigmine | PubChem SID:175266258 | PYRIDOSTIGMINE | (1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate | PubChem CID:4991 | UNII:19QM69HH21 | DrugBank ID:DB00545 | CAS RN:155-97-5"
+BMGC_DG10443,BMG_DG151352,"Pyrilamine | CAS RN:102206-59-7 | PubChem SID:175265811 | PYRILAMINE | DrugBank ID:DB06691 | PubChem CID:4992 | N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine | Mepyramine | CAS RN:91-84-9 | UNII:HPE317O9TL"
+BMGC_DG10444,BMG_DG151354,"PubChem SID:198988979 | UNII:QZZ28029Y7 | 1,2,3,4,8-pentachlorodibenzofuran | 1,2,3,4,8-Pentachlorodibenzofuran | PubChem CID:49923 | CAS RN:67517-48-0 | 1,2,3,4,8-PENTACHLORODIBENZOFURAN"
+BMGC_DG10445,BMG_DG151357,"NDC:69413-330 | Pyrimethamine | DrugBank ID:DB00205 | NDC:47781-925 | UNII:Z3614QOX8W | 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine | NDC:83649-330 | NDC:43598-672 | NDC:59651-590 | PYRIMETHAMINE | NDC:72647-330 | NDC:0480-3720 | NDC:72603-262 | PubChem CID:4993 | CAS RN:58-14-0 | PubChem SID:175265857"
+BMGC_DG10446,BMG_DG151358,"PubChem CID:49931 | PubChem SID:198942602 | 1,2,4,6,7,8-HEXACHLORODIBENZOFURAN | 1,2,4,6,7,8-Hexachlorodibenzofuran | 1,2,4,6,7,8-hexachlorodibenzofuran | CAS RN:67562-40-7 | UNII:1K8ZFG7183"
+BMGC_DG10447,BMG_DG151361,"3,3-diethyl-1H-pyridine-2,4-dione | PubChem SID:198985981 | PYRITHYLDIONE | DrugBank ID:DB13331 | UNII:8AB20823CK | Pyrithyldione | PubChem CID:4994 | CAS RN:77-04-3"
+BMGC_DG10448,BMG_DG151366,DECYLSULFONIC ACID | Decylsulfonic acid | DrugBank ID:DB06893 | PubChem CID:49957 | CAS RN:20283-21-0 | PubChem SID:363909560 | UNII:VUY16B7Z2D
+BMGC_DG10449,BMG_DG151367,PubChem SID:472423365 | PubChem CID:4995951 | PD-102807 | UNII:A7U96364HK | CAS RN:23062-91-1
+BMGC_DG10450,BMG_DG151368,N'-hydroxy-N-pyridin-3-yloctanediamide | Pyroxamide | PYROXAMIDE | DrugBank ID:DB12847 | CAS RN:382180-17-8 | UNII:12N86DSS23 | PubChem CID:4996 | PubChem SID:198971555
+BMGC_DG10451,BMG_DG151379,"DrugBank ID:DB01589 | QUAZEPAM | 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepine-2-thione | Quazepam | PubChem CID:4999 | UNII:JF8V0828ZI | CAS RN:36735-22-5 | NDC:71993-265 | PubChem SID:175266458"
+BMGC_DG10452,BMG_DG151380,DrugBank ID:DB04376 | 13-Acetylphorbol | PubChem CID:499953
+BMGC_DG10453,BMG_DG151399,"PubChem SID:175266624 | DrugBank ID:DB01224 | NDC:43547-021 | NDC:43547-020 | NDC:43547-019 | NDC:43547-023 | CAS RN:111974-69-7 | QUETIAPINE | PubChem CID:5002 | 2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol | NDC:43547-022 | Quetiapine | UNII:BGL0JSY5SI"
+BMGC_DG10454,BMG_DG151406,"DrugBank ID:DB08709 | PubChem CID:5003498 | 2,3-DIPHENYL-1H-INDOLE-7-CARBOXYLIC ACID | CAS RN:197313-74-9 | PubChem SID:443624474 | 2,3-diphenyl-1H-indole-7-carboxylic acid | UNII:5BFF2LV9EF"
+BMGC_DG10455,BMG_DG151409,CAS RN:81-61-8 | DrugBank ID:DB08660 | PubChem SID:198951425 | PubChem CID:5004 | QUINALIZARIN | UNII:6D43C3LYSG | Quinalizarin
+BMGC_DG10456,BMG_DG151410,Alsterpaullone | DrugBank ID:DB04014 | PubChem CID:5005498
+BMGC_DG10457,BMG_DG151423,"Isosulfan blue | NDC:71288-805 | Isosulfan Blue | DrugBank ID:DB09136 | NDC:67457-220 | sodium;2-[[4-(diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]benzene-1,4-disulfonate | PubChem SID:175268827 | ISOSULFAN BLUE | CAS RN:68238-36-8 | UNII:39N9K8S2A4 | PubChem CID:50108 | NDC:70069-221 | NDC:55150-240"
+BMGC_DG10458,BMG_DG151425,2-piperazin-1-ylquinoline | CAS RN:130895-61-3 | PubChem CID:5011 | PubChem SID:198972151 | QUIPAZINE | Quipazine | CAS RN:4774-24-7 | UNII:4WCY05C0SJ
+BMGC_DG10459,BMG_DG151428,CAS RN:77372-73-7 | DU-24565 | PubChem CID:5012 | 6-nitro-2-piperazin-1-ylquinoline | 6-Nitroquipazine | PubChem SID:198980015 | UNII:28M0X094BH
+BMGC_DG10460,BMG_DG151429,"PubChem CID:501254 | Lisofylline | PubChem SID:198943107 | CAS RN:100324-81-0 | 1-[(5R)-5-hydroxyhexyl]-3,7-dimethylpurine-2,6-dione | LISOFYLLINE | UNII:L1F2Q2X956 | DrugBank ID:DB12406"
+BMGC_DG10461,BMG_DG151431,PubChem CID:5013 | UNII:0YV1ZIR6S0 | N-METHYLQUIPAZINE | PubChem SID:255509303 | CAS RN:28614-26-8
+BMGC_DG10462,BMG_DG151435,"UNII:GVS3YDM418 | (2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol | CAS RN:141206-42-0 | PubChem CID:501391 | PubChem SID:198982955 | DrugBank ID:DB14872 | LUCERASTAT | Lucerastat"
+BMGC_DG10463,BMG_DG151436,CAS RN:156635-05-1 | PubChem SID:313182842 | PubChem CID:501398 | UNII:CG2Q6688S4 | BIBB-515
+BMGC_DG10464,BMG_DG151440,"PubChem CID:501640 | DrugBank ID:DB08283 | UNII:BTD6DSG4T5 | (2R,3R,4R,5S)-2-(hydroxymethyl)-1-nonylpiperidine-3,4,5-triol | CAS RN:81117-35-3 | (2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL | N-NONYLDEOXYNOJIRIMYCIN"
+BMGC_DG10465,BMG_DG151444,"NDC:80425-0338 | NDC:68001-232 | NDC:63187-222 | NDC:63187-582 | NDC:43598-977 | NDC:70518-2811 | NDC:80425-0238 | NDC:63868-730 | NDC:72189-319 | NDC:69256-012 | NDC:55328-801 | NDC:80425-0405 | NDC:76420-012 | NDC:61442-102 | NDC:68071-3456 | NDC:80425-0361 | NDC:72189-075 | NDC:70000-0555 | NDC:63629-2010 | NDC:50742-278 | NDC:62379-401 | NDC:68788-8720 | NDC:73581-104 | NDC:41167-0573 | NDC:82804-160 | NDC:68788-8784 | NDC:50090-3568 | NDC:50090-7250 | NDC:68788-8193 | NDC:63981-599 | NDC:60760-090 | NDC:70677-1277 | NDC:0527-2170 | NDC:70771-1415 | NDC:71205-991 | NDC:66267-071 | NDC:0067-8152 | NDC:68071-4934 | NDC:61442-103 | NDC:55289-150 | NDC:68071-3688 | NDC:55910-424 | NDC:46122-752 | NDC:72162-2031 | UNII:QTG126297Q | NDC:67296-1480 | NDC:68071-2223 | NDC:21130-313 | NDC:72162-1733 | NDC:71205-789 | NDC:69097-720 | NDC:72603-207 | NDC:60760-264 | NDC:45865-260 | NDC:68016-171 | PubChem CID:5018304 | NDC:37808-087 | NDC:42571-133 | NDC:45802-953 | NDC:80425-0189 | DICLOFENAC SODIUM | NDC:65162-683 | NDC:50090-6713 | NDC:68071-3665 | NDC:58602-604 | NDC:65162-911 | NDC:0472-1783 | NDC:68788-7103 | NDC:76282-103 | NDC:59088-435 | NDC:0363-1210 | NDC:68001-280 | NDC:80425-0330 | NDC:63629-8644 | NDC:80425-0056 | NDC:80425-0237 | NDC:68071-3671 | NDC:17856-0833 | NDC:68788-7772 | NDC:72288-870 | NDC:63629-2077 | NDC:13107-269 | NDC:57483-596 | NDC:72162-1734 | NDC:68788-8456 | NDC:68180-537 | NDC:76420-572 | NDC:71335-2441 | NDC:70518-4044 | NDC:67296-1805 | NDC:36800-526 | NDC:42291-232 | NDC:80425-0234 | NDC:21130-028 | NDC:68001-281 | NDC:11822-8120 | NDC:70518-3315 | NDC:63981-211 | NDC:71335-2543 | NDC:68788-8236 | NDC:80425-0337 | NDC:61145-101 | NDC:57896-140 | NDC:68788-7270 | NDC:42571-134 | NDC:63981-112 | NDC:61314-014 | NDC:80425-0368 | NDC:71205-821 | NDC:49035-269 | NDC:80425-0210 | NDC:71335-0357 | NDC:71205-865 | NDC:76420-261 | NDC:83008-070 | NDC:68071-4231 | NDC:70934-122 | NDC:43386-016 | NDC:72189-479 | NDC:70677-1125 | NDC:11673-569 | NDC:71205-579 | NDC:71205-811 | NDC:72189-273 | NDC:71085-003 | NDC:73469-2053 | NDC:40032-016 | NDC:46122-646 | NDC:57896-147 | NDC:63629-2526 | NDC:60505-0406 | NDC:0591-0397 | NDC:60687-658 | NDC:59390-149 | NDC:69238-2053 | NDC:80425-0235 | NDC:68788-9806 | NDC:45865-237 | NDC:80425-0250 | NDC:45802-160 | NDC:71335-0481 | NDC:72162-1391 | NDC:71205-692 | NDC:80425-0233 | NDC:59762-0028 | NDC:60429-421 | NDC:70518-2707 | NDC:61145-102 | NDC:71205-538 | NDC:49035-262 | NDC:50090-6998 | NDC:0591-0398 | NDC:41520-788 | NDC:63629-2012 | NDC:55319-969 | NDC:63187-522 | NDC:71205-670 | NDC:80425-0197 | NDC:72189-379 | NDC:70518-1903 | NDC:73352-568 | NDC:68788-8743 | NDC:80425-0273 | NDC:83324-306 | NDC:51672-1363 | NDC:71205-494 | NDC:50090-0545 | NDC:42799-953 | NDC:68788-8952 | NDC:11822-7300 | NDC:75987-040 | NDC:0113-1189 | NDC:65162-436 | NDC:56062-878 | NDC:72189-454 | NDC:72189-575 | NDC:72189-473 | NDC:63941-812 | NDC:68788-7715 | NDC:72578-092 | NDC:51316-073 | NDC:61442-101 | NDC:63187-761 | NDC:0363-1871 | NDC:59762-0029 | NDC:41163-087 | NDC:68071-4859 | NDC:83008-048 | NDC:0115-1483 | NDC:42291-233 | NDC:67296-0990 | NDC:16571-202 | NDC:51672-1369 | NDC:75834-265 | NDC:83008-037 | NDC:67296-1197 | NDC:21922-044 | NDC:82429-314 | NDC:71205-752 | NDC:63981-870 | NDC:70518-0627 | NDC:60687-606 | NDC:62332-487 | NDC:62332-581 | NDC:71335-0648 | NDC:43063-467 | NDC:82804-113 | NDC:0228-2550 | NDC:71335-9665 | NDC:72189-546 | NDC:41167-0571 | NDC:58602-609 | NDC:72888-110 | NDC:0363-5123 | NDC:68071-3483 | NDC:53225-1070 | NDC:68682-103 | NDC:71205-866 | NDC:70518-3464 | NDC:51655-280 | NDC:72288-624 | NDC:68788-8237 | NDC:16571-203 | NDC:70518-1104 | NDC:82804-074 | NDC:63629-2011 | NDC:50090-6924 | NDC:63187-762 | NDC:69842-729 | NDC:68788-8500 | NDC:71610-068 | PubChem SID:175265527 | NDC:51655-176 | NDC:71205-062 | NDC:50090-4172 | NDC:42291-231 | NDC:68071-3184 | NDC:0228-2551 | NDC:68001-612 | NDC:50090-0543 | NDC:71205-640 | NDC:59726-012 | NDC:71205-138 | NDC:65162-438 | NDC:80425-0240 | NDC:71205-450 | NDC:70882-128 | sodium;2-[2-(2,6-dichloroanilino)phenyl]acetate | NDC:70934-678 | NDC:50090-7243 | NDC:71335-1183 | NDC:0025-1421 | NDC:80425-0272 | NDC:0280-0039 | NDC:75834-264 | NDC:53225-1076 | NDC:45802-111 | NDC:50090-6202 | NDC:80425-0055 | NDC:63187-012 | Diclofenac sodium | NDC:30142-025 | NDC:0536-1294 | NDC:76420-134 | NDC:53943-523 | NDC:63629-2013 | NDC:63187-822 | NDC:76420-578 | NDC:76420-025 | NDC:82804-052 | NDC:76420-861 | NDC:68788-8541 | NDC:55700-591 | NDC:71335-1238 | NDC:68788-8214 | NDC:83008-028 | NDC:55700-980 | NDC:71205-747 | NDC:51672-1358 | NDC:16571-201 | NDC:50090-4030 | NDC:60760-153 | NDC:35356-714 | NDC:50090-3316 | NDC:71335-0456 | NDC:76420-275 | NDC:55700-735 | NDC:69097-524 | NDC:76282-663 | NDC:70677-0143 | NDC:68071-2239 | NDC:24208-457 | NDC:72036-014 | NDC:50090-0541 | NDC:68462-355 | NDC:68001-279 | NDC:68788-9435 | NDC:69842-974 | NDC:76420-091 | NDC:72162-1086 | NDC:72888-111 | NDC:70518-3779 | NDC:63187-753 | NDC:68788-8084 | NDC:80425-0102 | CAS RN:15307-79-6 | NDC:50090-4020 | NDC:41250-674 | NDC:30142-277 | NDC:45865-247 | NDC:50580-574 | NDC:80425-0236 | NDC:72476-212 | NDC:72559-020 | NDC:80425-0414 | NDC:0363-7065 | NDC:0025-1411 | NDC:70512-106 | NDC:50090-0542 | NDC:42291-230 | NDC:11822-0870 | NDC:70512-038 | NDC:71205-618 | NDC:68001-231 | NDC:71205-995 | NDC:72090-017 | NDC:71205-552 | NDC:73715-005 | NDC:68071-4117 | NDC:68071-3720 | NDC:76420-670 | NDC:51316-012 | NDC:68196-870 | NDC:43598-885 | NDC:42291-055 | NDC:63187-791 | NDC:63187-714 | NDC:83008-019 | NDC:60429-422 | NDC:63187-994 | NDC:76420-571 | NDC:76420-132 | NDC:82649-012 | NDC:63629-3726 | NDC:72888-109 | NDC:76420-598 | NDC:80425-0335 | NDC:83008-017 | NDC:83295-5000"
+BMGC_DG10466,BMG_DG151447,"[(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-17-acetyloxy-2,16-bis(4,4-dimethylpiperazin-4-ium-1-yl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate | CAS RN:68399-58-6 | UNII:1N3O74HM92 | PubChem CID:50192 | PubChem SID:175268160 | PIPECURONIUM | DrugBank ID:DB01338 | Pipecuronium"
+BMGC_DG10467,BMG_DG151453,APYRAMIDE | CAS RN:68483-33-0 | UNII:89832816U3 | PubChem SID:198974857 | PubChem CID:50204
+BMGC_DG10468,BMG_DG151459,"2-(hydroxymethyl)-5-[6-(1-phenylpropan-2-ylamino)purin-9-yl]oxolane-3,4-diol | PubChem CID:5022 | (R)-(Phenylisopropyl)adenosine"
+BMGC_DG10469,BMG_DG151464,CAS RN:68630-75-1 | PubChem CID:50224 | BUSERELIN ACETATE | PubChem SID:316916884 | Buserelin Acetate | UNII:13U86G7YSP | acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
+BMGC_DG10470,BMG_DG151465,CAS RN:57982-77-1 | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | UNII:PXW8U3YXDV | Buserelin | PubChem CID:50225 | BUSERELIN | PubChem SID:316910765
+BMGC_DG10471,BMG_DG151466,"PubChem SID:198972777 | Laninamivir | PubChem CID:502272 | UNII:B408IW3GL5 | DrugBank ID:DB12791 | CAS RN:203120-17-6 | (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-2,3-dihydroxy-1-methoxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid | LANINAMIVIR"
+BMGC_DG10472,BMG_DG151468,"PubChem CID:5024764 | UNII:ZAM4WWA5Y4 | 2,6-ditert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol | PubChem SID:472422992 | 2,6-Ditert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)phenol | CAS RN:28-99-9 | CAS RN:57717-80-3 | CGP-7930"
+BMGC_DG10473,BMG_DG151469,"NDC:0078-0937 | TRICLABENDAZOLE | UNII:4784C8E03O | PubChem SID:198984082 | DrugBank ID:DB12245 | Triclabendazole | 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole | CAS RN:68786-66-3 | PubChem CID:50248"
+BMGC_DG10474,BMG_DG151470,"UNII:WT3HN8U2ZZ | PubChem CID:5025063 | CAS RN:74857-22-0 | 1,1-(PROPANE-1,3-DIYL)BIS(3,7-DIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE) | PubChem SID:440089876"
+BMGC_DG10475,BMG_DG151473,PubChem SID:198957918 | CAS RN:70006-24-5 | UNII:4WV2575JWT | ABT-724 | PubChem CID:5025739
+BMGC_DG10476,BMG_DG151478,UNII:71PN6ZL7TA | PubChem SID:316916248 | CAS RN:76629-87-3 | Carbizocaine | PubChem CID:50266 | 1-(diethylamino)propan-2-yl N-(2-heptoxyphenyl)carbamate | CARBIZOCAINE
+BMGC_DG10477,BMG_DG151480,"UNII:EZU9AIZ69M | PubChem SID:198973299 | 1-cyano-3-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-2-methylguanidine | Tiotidine | PubChem CID:50287 | TIOTIDINE | CAS RN:69014-14-8 | CAS RN:145066-38-2"
+BMGC_DG10478,BMG_DG151483,CAS RN:117976-89-3 | DrugBank ID:DB01129 | 2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole | RABEPRAZOLE | Rabeprazole | PubChem CID:5029 | UNII:32828355LL | PubChem SID:175271393
+BMGC_DG10479,BMG_DG151486,"UNII:0B535E0BN0 | NEDOCROMIL | CAS RN:69049-73-6 | Nedocromil | PubChem SID:175267671 | 9-ethyl-4,6-dioxo-10-propylpyrano[3,2-g]quinoline-2,8-dicarboxylic acid | PubChem CID:50294 | DrugBank ID:DB00716"
+BMGC_DG10480,BMG_DG151494,"DrugBank ID:DB12901 | UNII:4058H365ZB | PubChem CID:50312 | Fiacitabine | PubChem SID:198974937 | CAS RN:69123-90-6 | 4-amino-1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one | FIACITABINE"
+BMGC_DG10481,BMG_DG151495,"UNII:53T7IN77LC | PubChem CID:50313 | Fialuridine | FIALURIDINE | 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione | CAS RN:69123-98-4 | PubChem SID:198974237 | DrugBank ID:DB15427"
+BMGC_DG10482,BMG_DG151496,CAS RN:53214-57-6 | 2-(methylamino)-1-phenylpropan-1-ol | PubChem CID:5032 | Racephedrine
+BMGC_DG10483,BMG_DG151498,PubChem SID:175267924 | [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone | PubChem CID:5035 | CAS RN:84449-90-1 | RALOXIFENE | DrugBank ID:DB00481 | Raloxifene | UNII:YX9162EO3I
+BMGC_DG10484,BMG_DG151502,"UNII:AZD85CW5YA | PubChem SID:474489532 | CAS RN:69267-51-2 | 2-NITRONAPHTHO(2,1-B)FURAN | PubChem CID:50354 | 2-Nitronaphtho[2,1-b]furan"
+BMGC_DG10485,BMG_DG151503,PubChem SID:459055603 | PubChem CID:503580 | UNII:R4UJ6H32NN | CAS RN:292144-10-6 | PNU-243672A FREE BASE
+BMGC_DG10486,BMG_DG151508,"PubChem SID:472407327 | PubChem CID:503731 | 4-[6-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)-1-benzofuran-2-yl]benzene-1,3-diol | LICOCOUMARONE | Licocoumarone | CAS RN:118524-14-4 | UNII:EFB3Z7MN3P"
+BMGC_DG10487,BMG_DG151512,"NDC:0121-0727 | UNII:884KT10YB7 | PubChem SID:175268812 | PubChem CID:5039 | CAS RN:66357-35-5 | RANITIDINE | NDC:0121-4727 | DrugBank ID:DB00863 | Ranitidine | 1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine"
+BMGC_DG10488,BMG_DG151516,CAS RN:51761-07-0 | 9H-Carbazole-3-carbaldehyde | 9H-CARBAZOLE-3-CARBALDEHYDE | 9H-carbazole-3-carbaldehyde | UNII:QWC6E2F7Z5 | PubChem CID:504067 | PubChem SID:461434081
+BMGC_DG10489,BMG_DG151520,PubChem SID:175271636 | Rebamipide | PubChem CID:5042 | REBAMIPIDE | CAS RN:111911-87-6 | CAS RN:90098-04-7 | DrugBank ID:DB11656 | CAS RN:139344-42-6 | UNII:LR583V32ZR | 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
+BMGC_DG10490,BMG_DG151535,PubChem CID:5047209 | Hydrosulfide | sulfanide | CAS RN:15035-72-0
+BMGC_DG10491,BMG_DG151542,"DrugBank ID:DB05022 | UNII:1Q8D39N37L | 5-amino-2-[2-(dimethylamino)ethyl]benzo[de]isoquinoline-1,3-dione | CAS RN:69408-81-7 | AMONAFIDE | PubChem SID:198990553 | Amonafide | PubChem CID:50515"
+BMGC_DG10492,BMG_DG151547,"PubChem SID:175266335 | RESORCINOL | CAS RN:108-46-3 | UNII:YUL4LO94HK | Resorcinol | PubChem CID:5054 | benzene-1,3-diol | DrugBank ID:DB11085"
+BMGC_DG10493,BMG_DG151549,"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL | PubChem CID:505461 | DrugBank ID:DB06874"
+BMGC_DG10494,BMG_DG151555,CAS RN:101910-24-1 | alpha-Pentyl-3-(2-quinolinylmethoxy)benzenemethanol | PubChem SID:461432399 | REV-5901 | PubChem CID:5059 | 1-[3-(quinolin-2-ylmethoxy)phenyl]hexan-1-ol | UNII:WNW5RYD8MG
+BMGC_DG10495,BMG_DG151557,Didanosine | PubChem CID:50599 | DrugBank ID:DB00900
+BMGC_DG10496,BMG_DG151565,"1,2,4,6,8-pentachlorodibenzofuran | PubChem CID:50610 | 1,2,4,6,8-PENTACHLORODIBENZOFURAN | PubChem SID:198976576 | UNII:J783Y751CO | 1,2,4,6,8-Pentachlorodibenzofuran | CAS RN:69698-57-3"
+BMGC_DG10497,BMG_DG151572,"PubChem CID:5063 | CAS RN:83654-05-1 | PubChem SID:438788174 | 1,6-Bis(cyclohexyloximinocarbonyl)hexane | UNII:9VB68H5WIT | 1,6-BIS(CYCLOHEXYLOXIMINOCARBONYL)HEXANE | (cyclohexylideneamino) N-[6-[(cyclohexylideneamino)oxycarbonylamino]hexyl]carbamate"
+BMGC_DG10498,BMG_DG151585,"UNII:CU3H37T766 | Rilmazafone | PubChem SID:198977688 | RILMAZAFONE | PubChem CID:5069 | 5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide | CAS RN:99593-25-6"
+BMGC_DG10499,BMG_DG151587,"NDC:69076-200 | PubChem CID:5070 | UNII:7LJ087RS6F | NDC:68462-381 | NDC:70726-0304 | NDC:70726-0305 | Riluzole | NDC:67877-286 | NDC:0378-4145 | 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine | NDC:42291-775 | RILUZOLE | NDC:70726-0306 | DrugBank ID:DB00740 | PubChem SID:175267723 | CAS RN:1744-22-5 | NDC:62756-538 | NDC:70726-0303"
+BMGC_DG10500,BMG_DG151590,UNII:0T2EF4JQTU | PubChem SID:175271593 | CAS RN:117857-51-9 | Rimantadine | 1-(1-adamantyl)ethanamine | CAS RN:13392-28-4 | RIMANTADINE | DrugBank ID:DB00478 | PubChem CID:5071
+BMGC_DG10501,BMG_DG151591,"NDC:62135-600 | NDC:72789-461 | NDC:51759-630 | NDC:69238-2109 | NDC:62135-605 | NDC:50090-3341 | NDC:63187-439 | NDC:65841-641 | NDC:68084-273 | NDC:68382-116 | Risperidone | NDC:49884-315 | NDC:70518-0364 | CAS RN:1026102-43-1 | NDC:50458-302 | RISPERIDONE | NDC:51759-305 | NDC:69339-184 | NDC:59746-040 | NDC:59746-010 | NDC:62135-602 | NDC:0615-8288 | NDC:13668-035 | NDC:27241-005 | NDC:42291-911 | NDC:50458-305 | NDC:50458-315 | NDC:0904-7364 | NDC:27241-002 | NDC:62135-603 | NDC:65862-167 | NDC:43547-342 | NDC:43063-254 | NDC:65841-640 | NDC:0904-7363 | NDC:43547-343 | NDC:65841-642 | NDC:70518-1568 | CAS RN:106266-06-2 | NDC:71335-0626 | NDC:0904-6361 | NDC:67046-1098 | NDC:49884-402 | PubChem SID:175268531 | NDC:63187-642 | NDC:70518-3741 | NDC:67046-1149 | NDC:50090-3344 | NDC:68382-112 | NDC:68382-115 | NDC:51759-520 | UNII:L6UH7ZF8HC | NDC:69339-181 | NDC:55154-2634 | NDC:50458-300 | NDC:69367-368 | NDC:42291-908 | NDC:65841-670 | NDC:68084-274 | NDC:68084-277 | NDC:59746-030 | NDC:70518-2969 | NDC:51759-410 | NDC:55154-3361 | NDC:0615-8265 | NDC:51759-740 | NDC:0615-8198 | NDC:68382-155 | NDC:70518-0979 | NDC:70518-3760 | NDC:63187-264 | NDC:42291-909 | NDC:62135-604 | NDC:27241-006 | NDC:65841-666 | NDC:70518-1771 | NDC:43353-720 | NDC:49884-401 | NDC:0615-8196 | NDC:62135-601 | NDC:65841-669 | NDC:69238-2111 | NDC:69367-370 | NDC:63304-643 | NDC:0904-6358 | NDC:49884-403 | NDC:63304-950 | NDC:51759-960 | NDC:63187-418 | NDC:69339-182 | NDC:69367-369 | NDC:65841-668 | NDC:70518-3992 | NDC:0904-6362 | NDC:63304-949 | NDC:27241-003 | NDC:50458-325 | NDC:43547-340 | NDC:0615-8197 | NDC:70518-1613 | NDC:70518-3883 | NDC:0904-7360 | NDC:69339-185 | NDC:71335-0130 | NDC:71610-246 | NDC:72162-2037 | NDC:68382-154 | NDC:68382-117 | NDC:70518-1502 | NDC:68382-156 | NDC:27241-001 | NDC:42291-910 | NDC:68084-270 | NDC:65841-667 | NDC:13668-040 | NDC:63304-951 | NDC:50090-3340 | NDC:43353-412 | NDC:0904-7362 | NDC:17856-1002 | NDC:0904-6360 | NDC:71610-259 | NDC:68071-4618 | NDC:13668-036 | NDC:50458-350 | DrugBank ID:DB00734 | NDC:71335-0740 | NDC:59746-020 | NDC:62135-929 | NDC:69238-2110 | NDC:68084-271 | NDC:13668-037 | NDC:65162-673 | NDC:70518-1631 | NDC:68084-272 | NDC:55154-5899 | NDC:67046-1080 | NDC:68382-113 | NDC:13668-038 | NDC:13668-039 | NDC:43547-344 | NDC:51759-850 | NDC:71335-0459 | NDC:49884-212 | NDC:50458-335 | NDC:0904-7361 | NDC:69339-186 | NDC:70518-1575 | NDC:67046-1014 | NDC:43353-432 | NDC:49884-311 | PubChem CID:5073 | NDC:71205-520 | 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one | NDC:43547-339 | NDC:50458-355 | NDC:42291-912 | NDC:42291-913 | NDC:43063-908 | NDC:69339-183 | NDC:50458-330 | NDC:71610-045 | NDC:63304-644 | NDC:67046-2010 | NDC:72189-525 | NDC:43547-341 | NDC:69238-2113 | NDC:68382-114 | NDC:50458-596 | NDC:27808-002 | NDC:59746-050 | NDC:50458-320 | NDC:0904-6359 | NDC:50458-395 | NDC:69238-2112 | NDC:65841-665 | NDC:0904-7365 | NDC:69238-2108 | NDC:27241-004 | NDC:71610-264"
+BMGC_DG10502,BMG_DG151595,"UNII:145TFV465S | Ritanserin | PubChem SID:198939327 | CAS RN:87051-43-2 | DrugBank ID:DB12693 | 6-[2-[4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl]ethyl]-7-methyl-[1,3]thiazolo[3,2-a]pyrimidin-5-one | PubChem CID:5074 | RITANSERIN"
+BMGC_DG10503,BMG_DG151599,[3-[1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate | CAS RN:105601-20-5 | Exelon | PubChem CID:5077
+BMGC_DG10504,BMG_DG151600,"RIZATRIPTAN | DrugBank ID:DB00953 | CAS RN:144034-80-0 | PubChem SID:175266240 | UNII:51086HBW8G | N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine | PubChem CID:5078 | Rizatriptan"
+BMGC_DG10505,BMG_DG151601,"DrugBank ID:DB05532 | BMS-488043 | PubChem CID:507806 | UNII:MKS21EJ435 | CAS RN:452296-83-2 | CAS RN:857500-24-4 | PubChem SID:198989902 | Bms-488043 | 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione"
+BMGC_DG10506,BMG_DG151605,"RO-15-4513 | PubChem SID:198958950 | UNII:S5XGL82O5Y | ethyl 8-azido-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate | CAS RN:91917-65-6 | PubChem CID:5081"
+BMGC_DG10507,BMG_DG151606,IMD-0354 | PubChem SID:198959647 | PubChem CID:5081913 | UNII:76145IS906 | CAS RN:978-62-1
+BMGC_DG10508,BMG_DG151609,"CAS RN:125314-64-9 | UNII:W9A0B5E78O | PubChem CID:5083 | RO-31-8220 | Ro-31-8220 | bisindolylmaleimide IX | PubChem SID:198952157 | 3-[3-[4-(1-methylindol-3-yl)-2,5-dioxopyrrol-3-yl]indol-1-yl]propyl carbamimidothioate"
+BMGC_DG10509,BMG_DG151612,UNII:S2ULN37C9R | 4-(butoxymethyl)-2-methoxyphenol | DrugBank ID:DB11299 | Vanillyl butyl ether | NDC:74458-453 | VANILLYL BUTYL ETHER | PubChem CID:5084146 | Vanillyl Butyl Ether | PubChem SID:175268299 | CAS RN:82654-98-6
+BMGC_DG10510,BMG_DG151618,PubChem SID:198936956 | CAS RN:29925-17-5 | PubChem CID:5087 | UNII:DIW6F13QW2 | 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone | RO-20-1724 | 4-[(3-butoxy-4-methoxyphenyl)methyl]imidazolidin-2-one
+BMGC_DG10511,BMG_DG151622,"PubChem SID:198963752 | CAS RN:928822-98-4 | N,N-DIALLYL-5-METHOXYTRYPTAMINE | PubChem CID:50878551 | UNII:V25VK0QTAA"
+BMGC_DG10512,BMG_DG151623,"PubChem SID:485667043 | RUXOLITINIB, S- | CAS RN:941685-37-6 | PubChem CID:50878566 | UNII:WVA83G6MCW | Ruxolitinib, S-"
+BMGC_DG10513,BMG_DG151628,"PubChem CID:50891 | 1,2,3-trichloro-4-(3,4,5-trichlorophenyl)benzene | 2,3,3',4,4',5'-Hexachlorobiphenyl | PubChem SID:198941379 | CAS RN:69782-90-7 | UNII:NX9G1C1FTV | 2,3,3',4,4',5'-HEXACHLOROBIPHENYL"
+BMGC_DG10514,BMG_DG151645,"DrugBank ID:DB14985 | PubChem SID:346539295 | ENARODUSTAT | Jtz-951 | CAS RN:1262132-81-9 | UNII:JSK7TUA223 | 2-[[7-oxo-5-(2-phenylethyl)-3H-[1,2,4]triazolo[1,5-a]pyridine-8-carbonyl]amino]acetic acid | PubChem CID:50899324"
+BMGC_DG10515,BMG_DG151650,PubChem CID:5090 | UNII:0QTW8Z7MCR | 3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one | PubChem SID:198991048 | ROFECOXIB | DrugBank ID:DB00533 | Rofecoxib | CAS RN:162011-90-7
+BMGC_DG10516,BMG_DG151657,DUVELISIB | UNII:610V23S0JI | Duvelisib | PubChem CID:50905713 | CAS RN:1201438-56-3 | NDC:73116-225 | PubChem SID:198973906 | DrugBank ID:DB11952 | NDC:73116-215 | 8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one
+BMGC_DG10517,BMG_DG151659,"1-[5,7-dihydroxy-8-(2-methylbutanoyl)-6-(3-methylbut-2-enyl)-2-oxochromen-4-yl]propyl acetate | PubChem CID:50908588 | 4-(1-(Acetyloxy)propyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-8-(2-methyl-1-oxobutyl)-2H-1-benzopyran-2-one | CAS RN:26477-65-6"
+BMGC_DG10518,BMG_DG151679,"cobalt;[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate | PubChem CID:50912739 | Cyanocobalamin Impurity 13 | CAS RN:13422-51-0"
+BMGC_DG10519,BMG_DG151680,"PubChem SID:348481731 | Delgocitinib | UNII:9L0Q8KK220 | CAS RN:1263774-59-9 | PubChem CID:50914062 | 3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile | DELGOCITINIB"
+BMGC_DG10520,BMG_DG151685,PubChem SID:346541459 | CAS RN:669770-29-0 | Aqw051 | (3R)-3-[6-(4-methylphenyl)pyridin-3-yl]oxy-1-azabicyclo[2.2.2]octane | UNII:JQH481R778 | AQW-051 | PubChem CID:50914822
+BMGC_DG10521,BMG_DG151686,"DrugBank ID:DB11971 | CAS RN:1262108-14-4 | PubChem CID:50915138 | VILAPRISAN | (8S,11R,13S,14S,17S)-17-hydroxy-13-methyl-11-(4-methylsulfonylphenyl)-17-(1,1,2,2,2-pentafluoroethyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | UNII:IN59K53GI9 | Vilaprisan | PubChem SID:198985445"
+BMGC_DG10522,BMG_DG151693,4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one | PubChem SID:198938017 | CAS RN:61413-54-5 | PubChem CID:5092 | Rolipram | DrugBank ID:DB01954 | ROLIPRAM | UNII:K676NL63N7
+BMGC_DG10523,BMG_DG151696,CAS RN:1269440-17-6 | methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate | PubChem SID:198937762 | UNII:8L7891MRB6 | NDC:70255-025 | ENCORAFENIB | PubChem CID:50922675 | DrugBank ID:DB11718 | Encorafenib
+BMGC_DG10524,BMG_DG151699,"PubChem CID:50922691 | DrugBank ID:DB12591 | PubChem SID:198941008 | N,N-dicyclopropyl-7-[(1,5-dimethylpyrazol-3-yl)amino]-10-ethyl-3-methyl-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,4,6,8,11-pentaene-11-carboxamide | UNII:7N03P021J8 | Bms-911543 | BMS-911543 | CAS RN:1271022-90-2"
+BMGC_DG10525,BMG_DG151721,"CAS RN:69975-86-6 | UNII:MPM23GMO7Z | Doxofylline | 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione | DrugBank ID:DB09273 | PubChem SID:198936110 | DOXOFYLLINE | PubChem CID:50942"
+BMGC_DG10526,BMG_DG151723,"4-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid | CAS RN:1268245-19-7 | PX-102 (trans-isomer) | CAS RN:1268244-88-7 | CAS RN:1268244-85-4 | PubChem CID:50943003"
+BMGC_DG10527,BMG_DG151727,"CAS RN:91374-21-9 | Ropinirole | NDC:43547-557 | DrugBank ID:DB00268 | PubChem SID:175267851 | NDC:43547-556 | PubChem CID:5095 | NDC:43547-558 | NDC:43547-554 | NDC:43547-555 | 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one | ROPINIROLE | UNII:030PYR8953"
+BMGC_DG10528,BMG_DG151735,"PubChem CID:5097 | CAS RN:186692-44-4 | 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol | 2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol | UNII:AIR55KO85E | SELICICLIB, (+/-)- | SELICICLIB, (±)- | PubChem SID:198953386"
+BMGC_DG10529,BMG_DG151738,PubChem CID:50981 | Pimonidazole | DrugBank ID:DB12485 | PIMONIDAZOLE | UNII:46JO4D76R2 | CAS RN:70132-50-2 | PubChem SID:198935620 | 1-(2-nitroimidazol-1-yl)-3-piperidin-1-ylpropan-2-ol
+BMGC_DG10530,BMG_DG151739,"ML-246 | Metarrestin | CAS RN:1443414-10-5 | UNII:Q6A9F9DSX5 | PubChem CID:50985821 | PubChem SID:402404422 | 4-(7-benzyl-4-imino-5,6-diphenylpyrrolo[2,3-d]pyrimidin-3-yl)cyclohexan-1-ol"
+BMGC_DG10531,BMG_DG151811,"VU-0409106 | PubChem SID:445500449 | PubChem CID:50990953 | UNII:J65UDU5WEA | CAS RN:1276617-62-9 | 3-fluoro-N-(4-methyl-1,3-thiazol-2-yl)-5-pyrimidin-5-yloxybenzamide"
+BMGC_DG10532,BMG_DG151814,PubChem SID:316915984 | PubChem CID:50991753 | NICODICOSAPENT | CAS RN:1269181-69-2 | UNII:72995E50VA
+BMGC_DG10533,BMG_DG151815,"[(1S,3R)-3-[[(3S,4S)-3-methoxyoxan-4-yl]amino]-1-propan-2-ylcyclopentyl]-[4-[4-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]methanone | UNII:W6SXW7SQ3F | PubChem SID:475550324 | CAS RN:1310796-72-5 | ((1S,3R)-1-Isopropyl-3-(((3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl)amino)cyclopentyl)(4-(4-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)methanone | INCB10820 | PubChem CID:50992246"
+BMGC_DG10534,BMG_DG151822,PubChem CID:50997095 | ZGWATINIB | CAS RN:1268264-10-3 | Zgwatinib | PubChem SID:485664252 | UNII:PMR8E5X493
+BMGC_DG10535,BMG_DG151823,DMH-1 | CAS RN:1206711-16-1 | PubChem SID:485665514 | PubChem CID:50997747 | UNII:BVR5X3H6XM
+BMGC_DG10536,BMG_DG151834,OXOGLURIC ACID | 2-oxopentanedioic acid | CAS RN:17091-15-5 | UNII:8ID597Z82X | PubChem SID:175268141 | DrugBank ID:DB03806 | CAS RN:328-50-7 | CAS RN:34410-46-3 | DrugBank ID:DB08845 | PubChem CID:51 | CAS RN:378-50-7 | 2-Oxoglutaric acid | DrugBank ID:DB02926
+BMGC_DG10537,BMG_DG151837,VE-821 | CAS RN:1232410-49-9 | PubChem CID:51000408 | PubChem SID:459275643 | UNII:BF884TQ935
+BMGC_DG10538,BMG_DG151841,"Taselisib | PubChem SID:198988665 | PubChem CID:51001932 | UNII:L08J2O299M | 2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide | CAS RN:1395408-87-3 | TASELISIB | CAS RN:1282512-48-4 | DrugBank ID:DB12108"
+BMGC_DG10539,BMG_DG151857,BMS-919373 | Bms-919373 | 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide | CAS RN:1272353-82-8 | UNII:NGB50MQK8N | PubChem SID:317228926 | DrugBank ID:DB15047 | PubChem CID:51030730
+BMGC_DG10540,BMG_DG151858,"CAS RN:1276021-63-6 | UNII:FBS88VEF1N | PubChem SID:433721020 | PubChem CID:51030868 | PQ-912, (+/-)- | PQ-912, (±)-"
+BMGC_DG10541,BMG_DG151859,"UNII:OG7W8H4D1E | PubChem CID:51030869 | CAS RN:1276021-64-7 | PQ-912, (R)- | PubChem SID:440089920"
+BMGC_DG10542,BMG_DG151860,Varoglutamstat | UNII:E3DSH8LL4L | VAROGLUTAMSTAT | CAS RN:1276021-65-8 | PubChem CID:51030870 | PubChem SID:433721047 | (5S)-1-(3H-benzimidazol-5-yl)-5-(4-propoxyphenyl)imidazolidin-2-one
+BMGC_DG10543,BMG_DG151870,3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol | UNII:YP664UDC7T | PubChem SID:440089546 | PubChem CID:51036475 | ISUZINAXIB | 5-phenyl-4-propyl-2-pyridin-2-yl-1H-pyrazol-3-one | CAS RN:1270084-92-8
+BMGC_DG10544,BMG_DG151873,"(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate | NDC:0093-1087 | Cefaclor monohydrate | NDC:61442-172 | CEFACLOR | PubChem CID:51038 | CAS RN:70356-03-5 | UNII:69K7K19H4L | NDC:50090-1602 | PubChem SID:175267562 | NDC:81948-6250 | NDC:61442-171"
+BMGC_DG10545,BMG_DG151874,"PubChem SID:381132419 | 4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide | PubChem CID:51038269 | Olverembatinib | CAS RN:1257628-77-5 | OLVEREMBATINIB | UNII:KV1M7Q3CBP"
+BMGC_DG10546,BMG_DG151876,"TARLOXOTINIB | PubChem CID:51038316 | DrugBank ID:DB14944 | [(E)-4-[[4-(3-bromo-4-chloroanilino)pyrido[3,4-d]pyrimidin-6-yl]amino]-4-oxobut-2-enyl]-dimethyl-[(3-methyl-5-nitroimidazol-4-yl)methyl]azanium | PubChem SID:317228985 | UNII:H8768UL06V | CAS RN:1636938-13-0 | Tarloxotinib"
+BMGC_DG10547,BMG_DG151878,"Cefaclor | CAS RN:143059-69-2 | CAS RN:53994-73-3 | CEFACLOR ANHYDROUS | PubChem SID:175266119 | PubChem CID:51039 | DrugBank ID:DB00833 | UNII:3Z6FS3IK0K | (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid"
+BMGC_DG10548,BMG_DG151879,(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-3-[(2R)-1-methylpyrrolidin-2-yl]prop-2-enamide | PYROTINIB | Pyrotinib | CAS RN:1269662-73-8 | UNII:CJN36EQM0H | PubChem SID:252320018 | PubChem CID:51039030 | DrugBank ID:DB14993
+BMGC_DG10549,BMG_DG151880,"6-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine | PubChem SID:198934691 | PubChem CID:51039094 | DrugBank ID:DB11652 | NDC:51144-001 | UNII:234248D0HH | NDC:51144-002 | TUCATINIB | Tucatinib | CAS RN:937263-43-9"
+BMGC_DG10550,BMG_DG151881,"FEXAGRATINIB | Azd-4547 | PubChem SID:198940588 | AZD-4547 | DrugBank ID:DB12247 | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide | UNII:2167OG1EKJ | Fexagratinib | CAS RN:1035270-39-3 | PubChem CID:51039095"
+BMGC_DG10551,BMG_DG151883,"Bms-813160 | PubChem SID:404859716 | N-[(1R,2S,5R)-5-(tert-butylamino)-2-[(3S)-3-[(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-yl)amino]-2-oxopyrrolidin-1-yl]cyclohexyl]acetamide | UNII:83U7957287 | BMS-813160 | PubChem CID:51039119 | CAS RN:1286279-29-5"
+BMGC_DG10552,BMG_DG151886,UNII:H5GU9YQL7L | PubChem CID:5104 | DrugBank ID:DB11458 | ROXARSONE | Roxarsone | CAS RN:121-19-7 | (4-hydroxy-3-nitrophenyl)arsonic acid | PubChem SID:175266304
+BMGC_DG10553,BMG_DG151887,"NDC:61995-2029 | NDC:57913-2833 | NDC:72296-111 | NDC:76354-444 | NDC:76354-130 | NDC:53208-202 | NDC:68577-153 | NDC:63354-689 | NDC:54111-182 | NDC:11673-934 | NDC:56152-5004 | NDC:36800-280 | NDC:73095-085 | NDC:84326-124 | NDC:59779-674 | NDC:72839-391 | NDC:0363-0066 | NDC:11559-049 | NDC:72288-920 | NDC:37808-979 | NDC:69842-141 | NDC:11673-193 | NDC:59735-225 | NDC:76354-446 | 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione | NDC:11344-059 | NDC:79481-0954 | NDC:62670-6688 | NDC:76151-251 | NDC:79903-250 | NDC:82761-041 | NDC:69968-0890 | NDC:59735-231 | NDC:84126-070 | DrugBank ID:DB09495 | NDC:65692-0521 | NDC:0363-0251 | NDC:72296-107 | NDC:14268-122 | NDC:63354-918 | NDC:70000-0257 | NDC:84294-479 | NDC:72296-103 | NDC:65753-108 | NDC:69842-145 | NDC:63354-773 | NDC:72036-926 | NDC:63354-636 | NDC:79753-023 | NDC:52854-983 | NDC:58418-003 | NDC:0363-2054 | NDC:69423-217 | NDC:72296-123 | NDC:82761-054 | NDC:14222-0425 | NDC:84438-901 | NDC:65912-012 | NDC:0363-0364 | NDC:84438-908 | NDC:60934-004 | NDC:68828-290 | NDC:73586-105 | NDC:72839-083 | NDC:63354-593 | NDC:54473-404 | NDC:63354-500 | NDC:37808-089 | NDC:37808-998 | NDC:10967-651 | NDC:66800-0082 | NDC:49527-048 | NDC:37808-982 | NDC:49967-633 | NDC:37808-951 | NDC:72296-126 | NDC:74690-006 | NDC:72288-933 | NDC:49967-768 | NDC:75936-151 | NDC:58411-671 | NDC:69968-0171 | NDC:82761-004 | NDC:84068-001 | NDC:79481-0055 | NDC:78317-056 | NDC:54860-417 | NDC:62217-079 | NDC:69968-0716 | NDC:52854-515 | NDC:37808-981 | NDC:61995-2027 | NDC:66738-301 | NDC:76309-200 | NDC:85061-102 | NDC:59735-207 | NDC:63354-929 | NDC:69968-0765 | NDC:72839-291 | NDC:71270-157 | NDC:63354-660 | NDC:54111-137 | NDC:66800-7035 | NDC:10056-050 | NDC:47124-127 | NDC:59450-978 | NDC:63354-912 | NDC:70630-0026 | NDC:84127-111 | NDC:0363-0933 | NDC:68634-056 | NDC:84178-008 | NDC:60289-300 | NDC:59450-935 | NDC:72839-151 | NDC:61369-301 | NDC:69968-0670 | NDC:14222-2252 | NDC:10596-802 | NDC:66800-4356 | NDC:83004-010 | NDC:65692-0524 | NDC:41250-103 | NDC:14222-2251 | NDC:52854-933 | NDC:69423-466 | NDC:59899-007 | NDC:72839-215 | NDC:69842-589 | NDC:84821-002 | NDC:49967-394 | NDC:82761-005 | NDC:65692-0584 | NDC:20146-4008 | NDC:50594-155 | NDC:69625-113 | NDC:73453-233 | NDC:73620-001 | NDC:84504-3009 | NDC:61973-105 | NDC:51316-054 | NDC:79753-015 | NDC:63354-911 | NDC:82657-003 | NDC:83140-373 | NDC:53675-165 | NDC:58414-3042 | NDC:61477-207 | NDC:11822-9044 | NDC:11344-769 | NDC:63354-803 | NDC:76309-525 | NDC:69968-0169 | NDC:62296-8292 | NDC:49035-979 | NDC:55910-170 | NDC:65692-0508 | NDC:84661-523 | NDC:61973-103 | NDC:37808-142 | NDC:49527-041 | NDC:58411-481 | NDC:59735-219 | NDC:68577-106 | NDC:63941-929 | NDC:71087-107 | NDC:61369-102 | NDC:73978-005 | NDC:72296-119 | NDC:58414-0019 | NDC:66800-8004 | NDC:68828-003 | NDC:65966-016 | NDC:69842-341 | NDC:60289-287 | NDC:55910-008 | NDC:73690-029 | NDC:71804-232 | NDC:79481-0025 | NDC:76354-452 | NDC:79596-005 | NDC:84504-3010 | NDC:59054-880 | NDC:30142-241 | NDC:84504-3003 | NDC:0363-0135 | NDC:37808-943 | NDC:84504-3019 | NDC:77714-004 | NDC:49527-084 | NDC:0363-0280 | NDC:65008-006 | NDC:66738-300 | NDC:70157-018 | NDC:84122-050 | NDC:64942-1878 | NDC:64942-1355 | NDC:69968-0841 | NDC:79481-9402 | NDC:63354-549 | NDC:69842-148 | NDC:63354-802 | NDC:59735-202 | NDC:66800-3026 | NDC:69423-195 | NDC:58411-628 | NDC:65753-604 | NDC:61369-201 | NDC:84504-3018 | NDC:49527-083 | NDC:66800-0381 | NDC:70630-0033 | NDC:84504-3013 | NDC:69968-0884 | NDC:69842-526 | NDC:69968-0851 | NDC:59735-213 | NDC:82564-000 | NDC:71141-948 | NDC:72476-929 | NDC:55301-022 | NDC:84514-0001 | NDC:70445-300 | NDC:53675-206 | NDC:49967-054 | NDC:82866-005 | NDC:82657-010 | NDC:59735-480 | NDC:66800-4354 | NDC:70630-0027 | NDC:84222-004 | NDC:71513-508 | NDC:76138-219 | NDC:65753-602 | NDC:50184-1013 | NDC:69968-0827 | NDC:59735-228 | NDC:82761-011 | NDC:53755-101 | NDC:59450-942 | NDC:63940-088 | NDC:60289-305 | NDC:37808-954 | NDC:65112-304 | NDC:41250-925 | NDC:71220-085 | NDC:60289-306 | NDC:71270-156 | NDC:50804-083 | NDC:71087-111 | NDC:0363-0249 | NDC:63354-379 | NDC:64760-713 | NDC:55301-041 | NDC:71087-109 | NDC:58668-9920 | NDC:61973-113 | NDC:72296-127 | NDC:65692-0516 | NDC:72839-121 | NDC:69968-0852 | NDC:83885-003 | NDC:72098-002 | NDC:11559-065 | NDC:63354-751 | NDC:80641-013 | NDC:64024-950 | NDC:69625-868 | NDC:69968-0579 | NDC:63354-902 | NDC:72839-543 | NDC:71087-110 | NDC:84257-102 | NDC:46007-203 | NDC:82160-726 | NDC:63354-361 | NDC:82657-001 | NDC:47124-125 | NDC:81100-102 | NDC:82761-049 | NDC:49967-718 | NDC:49967-137 | NDC:11673-231 | NDC:79950-017 | NDC:63354-319 | NDC:72036-941 | NDC:84507-002 | NDC:76354-133 | NDC:82215-0001 | NDC:76354-125 | NDC:0573-0725 | NDC:49967-944 | NDC:82691-142 | NDC:74740-052 | NDC:56152-4008 | NDC:49035-857 | NDC:84754-052 | NDC:10967-689 | NDC:58418-000 | NDC:82761-042 | NDC:63354-494 | NDC:84504-3034 | NDC:72296-122 | NDC:11822-1978 | NDC:72330-510 | NDC:53675-207 | NDC:62217-186 | NDC:63940-086 | NDC:59735-220 | NDC:71278-006 | NDC:66800-7034 | NDC:82723-013 | NDC:36800-940 | NDC:58414-0024 | NDC:62670-6685 | NDC:75936-638 | NDC:55910-936 | NDC:10356-130 | NDC:65692-0568 | NDC:71373-791 | NDC:66800-4109 | NDC:49967-370 | NDC:76147-236 | NDC:79950-021 | NDC:68828-294 | NDC:69842-424 | NDC:59450-924 | NDC:84222-003 | NDC:51150-142 | NDC:49967-207 | NDC:66738-031 | NDC:41520-940 | NDC:70157-015 | NDC:63354-483 | NDC:54111-143 | NDC:41167-0437 | NDC:14222-0420 | NDC:66097-003 | NDC:82866-000 | NDC:81104-248 | NDC:36800-239 | NDC:64942-1871 | NDC:69423-336 | NDC:83022-077 | NDC:75936-361 | NDC:0573-1958 | NDC:10596-197 | NDC:65692-0533 | NDC:49967-664 | NDC:62217-251 | NDC:82761-006 | NDC:61995-3035 | NDC:83324-177 | NDC:61481-3005 | NDC:73609-220 | NDC:36800-356 | NDC:36800-261 | NDC:84445-005 | NDC:10056-041 | NDC:49967-142 | NDC:68828-764 | NDC:81522-954 | NDC:49967-053 | NDC:83453-406 | NDC:0363-0997 | NDC:59450-932 | NDC:74690-016 | NDC:81104-250 | NDC:84504-3026 | NDC:76458-301 | NDC:69968-0572 | NDC:84504-3024 | NDC:84562-511 | NDC:81104-600 | NDC:58414-0020 | NDC:82691-145 | NDC:85179-003 | NDC:51316-026 | NDC:58668-9922 | NDC:11673-968 | NDC:66800-8005 | NDC:49967-099 | NDC:52456-022 | NDC:64024-949 | NDC:66800-4355 | NDC:41163-957 | NDC:69625-496 | NDC:82761-040 | NDC:82691-147 | NDC:69968-0578 | NDC:49967-003 | NDC:81104-102 | NDC:58411-328 | NDC:79481-0934 | NDC:82723-001 | NDC:63354-197 | NDC:50066-704 | NDC:63354-219 | NDC:72296-130 | NDC:72296-121 | NDC:11344-109 | NDC:11822-0027 | NDC:70412-238 | NDC:76309-250 | NDC:37808-139 | NDC:63354-523 | NDC:76138-221 | NDC:65692-0574 | NDC:83741-480 | NDC:69968-0561 | NDC:69968-0616 | NDC:55301-042 | NDC:82866-003 | NDC:58411-629 | NDC:75936-152 | NDC:85034-130 | NDC:49967-293 | NDC:62742-4078 | NDC:54111-136 | NDC:68828-444 | NDC:65692-0554 | NDC:49035-846 | NDC:74690-003 | NDC:84204-0010 | NDC:49035-338 | NDC:51316-010 | NDC:60541-2000 | NDC:68479-872 | NDC:11673-135 | NDC:68026-809 | NDC:63354-851 | NDC:58411-351 | NDC:68479-020 | NDC:65278-105 | NDC:53942-006 | NDC:69842-124 | NDC:79753-076 | NDC:51316-059 | NDC:71160-331 | NDC:50090-6558 | NDC:49967-994 | NDC:84504-3011 | NDC:75936-605 | NDC:68577-197 | NDC:49035-495 | NDC:70000-0536 | NDC:73670-649 | NDC:83880-440 | NDC:66097-001 | NDC:37808-924 | NDC:84821-001 | NDC:76354-447 | NDC:10596-195 | NDC:62217-345 | NDC:51316-030 | NDC:68479-371 | NDC:69968-0599 | NDC:0363-0298 | NDC:81104-802 | NDC:69842-459 | NDC:75936-354 | NDC:63354-211 | NDC:73978-007 | NDC:64024-945 | NDC:69968-0842 | NDC:78317-036 | NDC:37808-958 | NDC:75936-306 | NDC:53942-007 | NDC:75071-006 | NDC:69968-0898 | NDC:84504-3027 | NDC:11822-0946 | NDC:84438-938 | NDC:61477-209 | NDC:0363-0398 | NDC:0299-4118 | NDC:63941-958 | NDC:70157-013 | NDC:79753-045 | NDC:52854-916 | NDC:79481-0949 | NDC:59088-568 | NDC:79950-007 | NDC:37808-967 | NDC:49967-148 | NDC:79950-018 | NDC:65753-110 | NDC:84438-939 | NDC:69968-0887 | NDC:81104-110 | NDC:37808-076 | NDC:82866-002 | NDC:69968-0299 | NDC:49527-069 | NDC:84504-3025 | NDC:66800-5350 | NDC:72098-001 | NDC:11822-0026 | NDC:84504-3015 | NDC:79950-004 | NDC:83852-543 | NDC:66800-2074 | NDC:82761-047 | NDC:82761-052 | NDC:84504-3001 | NDC:37808-962 | NDC:37808-041 | NDC:61369-106 | NDC:60289-296 | NDC:41163-953 | NDC:84326-324 | NDC:66800-0030 | NDC:63354-801 | NDC:52854-981 | NDC:63354-324 | NDC:63354-621 | NDC:70157-008 | NDC:72085-312 | NDC:84309-001 | NDC:75071-005 | NDC:72296-116 | NDC:80641-015 | NDC:83520-165 | NDC:66800-4351 | NDC:49404-155 | NDC:49967-069 | NDC:69968-0101 | NDC:0363-0970 | NDC:71373-420 | NDC:69842-083 | NDC:49967-996 | NDC:41520-769 | NDC:71784-000 | NDC:69494-016 | NDC:68745-2157 | NDC:66800-3350 | NDC:11344-943 | NDC:83888-001 | NDC:84616-005 | NDC:69039-236 | NDC:84504-3016 | NDC:51150-614 | NDC:49967-886 | NDC:73978-010 | NDC:70157-016 | NDC:62670-6609 | NDC:49035-844 | NDC:63354-196 | NDC:57627-203 | NDC:63354-939 | NDC:75936-601 | NDC:21130-739 | NDC:76354-445 | NDC:69968-0823 | NDC:79753-022 | NDC:59450-954 | NDC:69423-389 | NDC:67226-2031 | NDC:75936-210 | NDC:50804-221 | NDC:49967-894 | NDC:66800-4353 | NDC:79950-019 | NDC:73496-005 | NDC:83542-429 | NDC:51514-0368 | NDC:62217-246 | NDC:71014-094 | NDC:71087-112 | NDC:72839-293 | NDC:0363-0261 | NDC:79753-033 | NDC:84504-3008 | NDC:84130-001 | NDC:49035-757 | NDC:73586-107 | NDC:70630-0036 | NDC:54181-015 | NDC:72296-110 | NDC:66800-3351 | NDC:69968-0560 | NDC:72476-117 | NDC:84326-724 | NDC:66800-0096 | NDC:69842-177 | NDC:66800-2669 | NDC:64942-1809 | NDC:63354-388 | NDC:61481-3006 | NDC:72296-114 | NDC:80641-018 | NDC:11489-202 | NDC:51531-0549 | NDC:59735-223 | NDC:80489-232 | NDC:84204-0004 | NDC:66800-4352 | NDC:69968-0654 | NDC:53208-203 | NDC:82953-018 | NDC:66800-5000 | NDC:84075-000 | NDC:77714-006 | NDC:10096-0550 | NDC:62217-072 | NDC:62217-247 | NDC:14141-331 | NDC:49967-112 | NDC:76159-345 | NDC:76354-442 | NDC:41163-966 | NDC:59735-216 | NDC:75071-748 | NDC:71141-949 | NDC:75712-950 | NDC:52854-913 | NDC:63354-971 | NDC:61369-105 | NDC:37808-959 | NDC:82953-025 | NDC:41250-561 | NDC:70157-011 | NDC:74690-015 | NDC:70412-231 | NDC:37808-978 | NDC:75936-136 | NDC:30142-626 | NDC:59735-229 | NDC:72296-113 | NDC:54111-148 | NDC:82691-141 | NDC:69842-140 | NDC:41250-924 | NDC:84204-0008 | NDC:11822-9403 | NDC:13734-157 | NDC:0299-4133 | NDC:69968-0661 | NDC:62217-403 | NDC:63354-453 | NDC:69625-995 | NDC:71087-105 | NDC:49967-036 | NDC:59735-226 | NDC:65692-0528 | NDC:84258-002 | NDC:72036-938 | NDC:75712-116 | NDC:58668-9918 | NDC:41520-714 | NDC:79903-303 | NDC:72169-550 | NDC:52854-927 | NDC:51117-001 | NDC:65753-603 | NDC:11673-938 | NDC:81104-004 | NDC:70412-212 | NDC:84294-484 | NDC:84204-0006 | NDC:65435-0200 | NDC:78317-027 | NDC:66097-002 | NDC:63354-311 | NDC:82761-007 | NDC:51316-025 | NDC:41250-360 | NDC:65912-003 | NDC:63354-634 | NDC:49967-990 | NDC:84610-100 | NDC:81104-249 | NDC:37808-931 | NDC:79903-203 | NDC:63354-581 | NDC:68577-036 | NDC:76151-217 | NDC:66738-065 | NDC:66800-4473 | NDC:69968-0657 | NDC:63354-241 | NDC:30142-197 | NDC:62742-4235 | NDC:84438-909 | NDC:72476-961 | NDC:14222-2131 | NDC:79753-074 | NDC:62217-066 | NDC:72288-940 | NDC:70000-0535 | NDC:65692-0517 | NDC:0299-4136 | NDC:80641-003 | NDC:62217-400 | NDC:62217-061 | NDC:61197-205 | NDC:69968-0702 | NDC:11559-060 | NDC:49527-082 | NDC:71852-060 | NDC:72839-165 | NDC:60289-282 | NDC:37808-048 | NDC:75936-164 | NDC:76209-123 | NDC:69842-476 | NDC:70630-0025 | NDC:65912-001 | NDC:72036-714 | NDC:43419-420 | NDC:0096-0741 | NDC:14222-0002 | NDC:65692-0539 | NDC:80949-002 | NDC:72667-075 | NDC:82761-051 | NDC:51326-001 | NDC:36800-278 | NDC:65692-0543 | NDC:41163-961 | NDC:59735-208 | NDC:49967-313 | NDC:63940-056 | NDC:79903-059 | NDC:11673-970 | NDC:61197-510 | NDC:53675-210 | NDC:63354-420 | NDC:65692-0560 | NDC:63940-076 | NDC:11822-0924 | NDC:42851-096 | NDC:63354-232 | NDC:11822-9832 | NDC:83493-150 | NDC:69039-227 | NDC:70630-0029 | NDC:66800-4350 | NDC:63940-084 | NDC:84821-003 | NDC:77714-002 | NDC:69968-0577 | NDC:70445-303 | NDC:44717-068 | NDC:0363-3890 | NDC:61995-3036 | NDC:81761-113 | NDC:63354-571 | NDC:60289-295 | NDC:70453-001 | NDC:52854-952 | NDC:42472-010 | NDC:69842-597 | NDC:62742-4226 | NDC:69423-588 | NDC:82931-012 | NDC:81522-952 | NDC:57913-2832 | NDC:72839-102 | NDC:49967-291 | NDC:49967-864 | NDC:73586-102 | NDC:49825-201 | NDC:59735-921 | NDC:63354-386 | NDC:84229-0017 | NDC:14141-142 | NDC:72296-120 | NDC:69968-0667 | NDC:63354-631 | NDC:50594-149 | NDC:72288-714 | NDC:69842-339 | NDC:81100-501 | NDC:75936-154 | NDC:41163-968 | NDC:79481-0932 | NDC:11559-052 | NDC:49035-759 | NDC:71238-785 | NDC:70000-0075 | NDC:70157-014 | NDC:41250-921 | NDC:62670-6686 | NDC:79950-015 | NDC:79481-0914 | NDC:83046-370 | NDC:37808-918 | NDC:72476-940 | NDC:73496-009 | NDC:63354-071 | NDC:75897-105 | NDC:83175-331 | NDC:80641-524 | NDC:76138-222 | NDC:59735-221 | NDC:61973-109 | NDC:84504-3012 | NDC:49967-355 | NDC:60892-601 | NDC:63354-641 | NDC:72330-503 | NDC:82761-008 | NDC:83982-1001 | NDC:14268-123 | NDC:82761-009 | NDC:80641-001 | NDC:82691-143 | NDC:11822-9024 | NDC:76151-207 | NDC:63354-081 | NDC:66097-004 | NDC:73586-104 | NDC:84645-800 | NDC:73609-221 | NDC:0363-0136 | NDC:72296-112 | NDC:63354-611 | NDC:69842-127 | NDC:72476-943 | NDC:21130-753 | NDC:51514-0365 | NDC:58411-656 | NDC:82654-000 | NDC:51514-0366 | NDC:84504-3021 | NDC:70157-002 | NDC:61973-111 | NDC:51316-035 | NDC:30142-239 | NDC:79753-018 | NDC:11344-559 | NDC:66800-4094 | NDC:21130-740 | NDC:59735-224 | NDC:79753-039 | NDC:59735-227 | NDC:66820-0500 | NDC:82723-005 | NDC:69842-437 | NDC:10356-575 | NDC:85179-001 | NDC:61477-219 | NDC:37808-974 | NDC:71499-220 | NDC:85178-2025 | NDC:83286-002 | NDC:63354-712 | NDC:69968-0414 | NDC:66800-4087 | NDC:66738-046 | NDC:58443-0646 | NDC:84504-3029 | NDC:64942-1858 | NDC:36800-167 | NDC:11344-940 | NDC:84504-3005 | NDC:68577-038 | NDC:65692-0542 | NDC:0299-4123 | NDC:49967-260 | NDC:66800-0079 | NDC:66800-8164 | NDC:75936-225 | NDC:61477-218 | NDC:70445-308 | NDC:10356-385 | NDC:72476-954 | NDC:63354-804 | NDC:66800-4480 | NDC:53755-100 | NDC:79753-082 | NDC:37808-956 | NDC:84426-001 | NDC:68577-032 | NDC:83809-020 | NDC:71141-946 | NDC:61016-0033 | NDC:69039-224 | NDC:72839-183 | NDC:0096-0685 | NDC:69968-0883 | NDC:11559-055 | NDC:75712-946 | NDC:84504-3036 | NDC:76354-131 | NDC:82657-011 | NDC:70581-003 | NDC:72296-106 | NDC:84504-3031 | NDC:82761-053 | NDC:73978-004 | NDC:10967-692 | NDC:66800-5353 | NDC:65008-008 | NDC:72839-247 | NDC:82761-046 | NDC:75712-954 | NDC:84425-101 | NDC:79481-0943 | NDC:60289-283 | NDC:65692-0552 | NDC:47124-123 | NDC:51316-033 | NDC:62217-316 | NDC:49967-502 | NDC:83453-405 | NDC:59735-230 | NDC:10056-051 | NDC:68391-002 | NDC:49967-095 | NDC:69423-388 | NDC:84130-011 | NDC:52854-956 | NDC:79481-0939 | NDC:37808-108 | NDC:71087-106 | NDC:61995-0371 | NDC:30807-6006 | NDC:79950-002 | NDC:69968-0779 | NDC:71017-001 | NDC:0363-0228 | NDC:47124-124 | NDC:37000-355 | NDC:82761-001 | NDC:62217-401 | NDC:59427-112 | NDC:84255-000 | NDC:68062-9981 | NDC:61995-2028 | NDC:76354-449 | NDC:51861-090 | NDC:75712-949 | NDC:44717-080 | NDC:82723-011 | NDC:68577-170 | NDC:11822-0949 | NDC:69968-0573 | NDC:54565-1645 | NDC:72296-129 | NDC:49527-063 | NDC:71435-0001 | NDC:79753-035 | NDC:72936-777 | NDC:70707-400 | NDC:0869-0769 | NDC:10356-580 | NDC:82761-036 | NDC:82723-014 | NDC:69423-359 | NDC:11822-9393 | NDC:72288-939 | NDC:76159-205 | NDC:64942-1334 | NDC:75587-013 | NDC:0299-4142 | NDC:80641-016 | NDC:72330-501 | NDC:74740-045 | NDC:37808-074 | NDC:49967-048 | NDC:55910-442 | NDC:30142-690 | NDC:10056-040 | NDC:61477-213 | NDC:60232-3537 | NDC:49967-603 | NDC:72156-003 | NDC:43479-209 | NDC:55910-983 | NDC:69968-0737 | NDC:79903-086 | NDC:62217-073 | NDC:65692-0538 | NDC:69968-0816 | NDC:82761-056 | NDC:79950-005 | NDC:73496-008 | NDC:70000-0074 | NDC:63354-927 | NDC:82188-222 | NDC:72476-938 | NDC:64024-944 | NDC:72454-0030 | NDC:65692-0537 | NDC:51316-056 | NDC:72839-515 | NDC:69968-0552 | NDC:66800-0375 | NDC:84326-524 | NDC:84562-512 | NDC:71435-0004 | NDC:60289-301 | NDC:66800-0003 | NDC:84977-0033 | NDC:14141-140 | NDC:51150-726 | NDC:74472-235 | NDC:53208-201 | NDC:54111-134 | NDC:77714-008 | NDC:10356-111 | NDC:65692-0578 | NDC:76138-220 | NDC:76309-400 | NDC:65692-0509 | NDC:58411-857 | NDC:63354-805 | NDC:69968-0885 | NDC:58411-562 | NDC:65753-101 | NDC:11822-0943 | NDC:69968-0397 | NDC:66800-2000 | NDC:59735-214 | NDC:71852-334 | NDC:10096-0650 | NDC:44717-072 | NDC:63354-204 | NDC:66800-1094 | NDC:81761-114 | NDC:63354-512 | NDC:54136-350 | NDC:63354-181 | NDC:0869-9054 | NDC:75712-944 | NDC:69842-080 | NDC:69423-633 | NDC:79481-0948 | NDC:70581-020 | NDC:65692-0564 | NDC:79903-206 | NDC:65692-0519 | NDC:72839-511 | NDC:10096-2650 | NDC:70445-305 | NDC:82761-010 | NDC:84438-903 | NDC:79481-0001 | NDC:75936-216 | NDC:69968-0666 | NDC:72839-289 | NDC:84438-942 | NDC:37808-965 | NDC:79481-1830 | NDC:62217-063 | NDC:66738-020 | NDC:49967-211 | NDC:62217-076 | NDC:77365-006 | NDC:70000-0073 | NDC:61995-0389 | NDC:65435-0100 | NDC:60289-304 | NDC:63354-860 | NDC:39892-0940 | NDC:80641-006 | NDC:54973-4123 | NDC:79753-020 | NDC:63354-821 | NDC:55910-012 | NDC:83852-438 | NDC:69423-089 | NDC:30142-934 | NDC:70381-125 | NDC:41250-928 | NDC:61477-204 | NDC:37808-086 | NDC:63941-946 | NDC:0299-3928 | NDC:62217-402 | NDC:61973-106 | NDC:82657-007 | NDC:68479-852 | NDC:65692-0523 | NDC:36800-132 | NDC:49967-913 | NDC:0363-0254 | NDC:66800-2351 | NDC:85034-107 | NDC:82761-044 | NDC:58411-623 | NDC:51514-0360 | NDC:61995-2072 | NDC:62670-6690 | NDC:84504-3035 | NDC:84504-3017 | NDC:58411-327 | NDC:10967-676 | NDC:65692-0512 | NDC:72220-002 | NDC:72476-941 | NDC:70157-009 | NDC:82657-013 | NDC:76138-223 | NDC:84438-905 | NDC:49967-546 | NDC:23667-801 | NDC:37808-933 | NDC:69968-0778 | NDC:72036-943 | NDC:66800-0004 | NDC:76147-240 | NDC:70325-3001 | NDC:82757-100 | NDC:72296-118 | NDC:49967-410 | NDC:66800-2465 | NDC:69423-719 | NDC:83542-410 | NDC:49967-431 | NDC:68577-190 | NDC:84803-104 | NDC:37808-078 | NDC:11822-2055 | NDC:72330-721 | NDC:83171-001 | NDC:79481-0933 | NDC:64942-1857 | NDC:58668-9611 | NDC:61995-0388 | NDC:68577-040 | NDC:65692-0526 | NDC:66163-4837 | NDC:62670-6607 | NDC:72330-502 | NDC:73302-205 | NDC:84258-001 | NDC:54181-009 | NDC:84326-824 | NDC:65692-0589 | NDC:63354-701 | NDC:59450-955 | NDC:69423-742 | NDC:84504-3002 | NDC:85034-105 | NDC:53208-210 | NDC:11344-055 | NDC:79753-021 | NDC:65692-0530 | NDC:75712-935 | NDC:66820-0400 | NDC:82691-035 | NDC:55910-924 | NDC:59427-012 | NDC:63354-548 | NDC:0363-0965 | NDC:66800-8001 | NDC:53208-722 | NDC:59450-956 | NDC:66800-8002 | NDC:72296-124 | NDC:84438-911 | NDC:70445-302 | NDC:75936-156 | NDC:81104-112 | NDC:63354-841 | NDC:75936-621 | NDC:84504-3020 | NDC:84066-101 | NDC:84440-003 | NDC:50066-119 | NDC:63354-129 | NDC:72839-605 | NDC:49967-861 | NDC:30142-522 | NDC:72296-115 | NDC:42851-095 | NDC:50594-154 | NDC:11822-0945 | NDC:65278-103 | NDC:58411-856 | NDC:63354-454 | NDC:75071-007 | NDC:72475-001 | NDC:49967-584 | NDC:49967-869 | NDC:71278-005 | NDC:0363-0349 | NDC:59735-210 | NDC:75936-227 | NDC:75936-350 | NDC:76354-451 | NDC:13734-158 | NDC:70630-0034 | NDC:79950-008 | NDC:49967-995 | NDC:83724-770 | NDC:60892-602 | NDC:11410-073 | NDC:63354-353 | NDC:72476-924 | NDC:66800-8159 | NDC:72476-959 | NDC:70445-301 | NDC:59427-010 | NDC:79753-075 | NDC:59735-209 | NDC:82761-037 | NDC:82723-010 | NDC:50066-021 | NDC:82761-043 | NDC:82153-276 | NDC:51316-019 | NDC:63940-079 | NDC:66738-048 | NDC:37808-088 | NDC:84857-545 | NDC:68577-039 | NDC:75936-606 | NDC:10356-567 | NDC:63354-894 | NDC:65692-0581 | NDC:81100-502 | NDC:63354-493 | NDC:58331-075 | NDC:10157-1170 | CAS RN:23644-60-2 | NDC:49967-049 | NDC:73978-008 | NDC:84438-912 | NDC:66800-0092 | NDC:62670-6689 | NDC:75936-655 | NDC:61995-3012 | NDC:49967-392 | NDC:70186-700 | NDC:52854-976 | NDC:0096-0721 | NDC:49967-181 | NDC:37808-976 | NDC:82761-050 | NDC:63354-166 | NDC:70000-0072 | NDC:69968-0706 | NDC:79481-0920 | NDC:66800-5049 | NDC:82953-010 | NDC:65692-0529 | NDC:66738-034 | NDC:37808-129 | NDC:82953-002 | NDC:83810-618 | NDC:50594-151 | NDC:10967-665 | NDC:79753-073 | NDC:65692-0561 | NDC:58668-9921 | NDC:52257-1390 | NDC:63354-481 | NDC:68577-196 | NDC:37808-150 | NDC:84803-105 | NDC:53950-7007 | NDC:66800-9013 | NDC:50594-150 | NDC:11489-204 | NDC:66800-4232 | NDC:82761-039 | NDC:47124-121 | NDC:61973-102 | NDC:63354-046 | NDC:83447-003 | NDC:65692-0577 | NDC:72296-105 | NDC:70630-0035 | NDC:70157-022 | NDC:47124-128 | NDC:71141-945 | NDC:41250-440 | NDC:72839-310 | NDC:60289-286 | NDC:77714-007 | NDC:69968-0681 | NDC:63354-179 | NDC:61973-101 | NDC:69968-0683 | NDC:11559-064 | NDC:76354-441 | NDC:83918-002 | NDC:73496-011 | NDC:65692-0573 | NDC:83542-409 | NDC:84504-3023 | NDC:54111-135 | NDC:84572-000 | NDC:69968-0665 | NDC:63354-073 | NDC:70412-316 | NDC:68634-062 | NDC:79481-9400 | NDC:84102-001 | NDC:63354-340 | NDC:75712-948 | NDC:55910-929 | NDC:51316-029 | NDC:11344-048 | NDC:65692-0571 | NDC:85179-004 | NDC:60289-299 | NDC:82761-014 | NDC:61481-3003 | NDC:51316-055 | NDC:77714-005 | NDC:61477-224 | NDC:54111-138 | NDC:83324-185 | NDC:72476-946 | NDC:63354-520 | NDC:72296-125 | NDC:67879-304 | NDC:37808-913 | NDC:0869-9055 | NDC:61369-103 | NDC:49035-969 | NDC:54473-219 | NDC:84309-002 | NDC:68577-152 | NDC:73670-049 | NDC:73978-009 | NDC:84504-3006 | NDC:70707-453 | NDC:69968-0663 | NDC:84204-0003 | NDC:63354-302 | NDC:84504-3032 | NDC:58411-616 | NDC:0363-0265 | NDC:80489-234 | NDC:84326-624 | NDC:69968-0849 | NDC:52854-951 | NDC:49967-910 | NDC:72296-104 | NDC:69625-917 | NDC:51150-953 | NDC:49967-126 | NDC:73453-073 | NDC:37808-914 | NDC:11822-5905 | NDC:83046-360 | NDC:37808-127 | NDC:82761-002 | NDC:52854-950 | NDC:63354-299 | NDC:61477-208 | NDC:64942-1868 | NDC:44717-070 | NDC:49967-443 | NDC:63354-278 | NDC:11822-0049 | NDC:80641-521 | NDC:69231-036 | NDC:80670-003 | NDC:72496-1037 | NDC:68577-199 | NDC:49967-726 | NDC:62217-074 | NDC:69968-0662 | NDC:66800-4086 | NDC:63354-389 | NDC:14141-332 | NDC:53675-208 | NDC:63354-771 | NDC:49967-290 | NDC:59735-475 | NDC:43419-085 | NDC:63354-159 | NDC:53208-710 | NDC:82675-279 | NDC:64024-935 | NDC:79753-067 | NDC:75936-654 | NDC:70157-019 | NDC:76309-100 | NDC:75071-766 | NDC:84504-3030 | NDC:37808-919 | NDC:10356-335 | NDC:68479-807 | NDC:83326-002 | NDC:36800-093 | NDC:11822-0929 | NDC:63354-195 | NDC:69842-078 | NDC:81761-115 | NDC:75936-506 | NDC:82691-146 | NDC:66738-029 | NDC:66800-2350 | NDC:84168-050 | NDC:54291-051 | NDC:70000-0076 | NDC:82800-040 | NDC:41250-438 | NDC:82953-006 | NDC:65692-0525 | NDC:65692-0536 | NDC:51531-0288 | NDC:70157-021 | NDC:21130-752 | NDC:11822-9833 | NDC:49967-517 | NDC:84117-004 | NDC:11084-032 | NDC:64942-1876 | NDC:21130-729 | NDC:76309-551 | NDC:82761-035 | NDC:35192-047 | NDC:69968-0717 | NDC:69968-0850 | NDC:84504-3033 | NDC:72296-128 | NDC:70630-0037 | Avobenzone | NDC:84562-510 | NDC:69968-0576 | NDC:79753-019 | NDC:82761-013 | NDC:10356-395 | NDC:72296-050 | NDC:72330-710 | NDC:65692-0570 | NDC:85179-002 | NDC:37808-912 | NDC:79481-1389 | NDC:66800-4107 | NDC:66800-0026 | NDC:67879-309 | NDC:72839-137 | NDC:78863-3003 | NDC:72476-956 | NDC:71220-082 | NDC:66800-0100 | NDC:69625-685 | NDC:41520-858 | NDC:61973-108 | NDC:72036-940 | NDC:82953-017 | NDC:59735-222 | NDC:59450-940 | NDC:62217-405 | NDC:72476-949 | NDC:84782-703 | NDC:37808-083 | NDC:20146-4007 | NDC:10157-1171 | NDC:58331-060 | NDC:65692-0575 | NDC:84504-3022 | NDC:63941-962 | NDC:61477-221 | NDC:71782-115 | NDC:49967-212 | NDC:68577-033 | NDC:82866-001 | NDC:65753-109 | NDC:81104-801 | NDC:49967-496 | NDC:73676-116 | NDC:69842-375 | NDC:71435-8202 | NDC:85034-103 | NDC:11673-232 | NDC:71425-030 | NDC:70445-309 | NDC:84204-0007 | NDC:70445-304 | NDC:76147-235 | NDC:64942-1877 | NDC:76354-448 | NDC:58411-454 | NDC:51316-036 | NDC:0363-0146 | NDC:71220-086 | NDC:43419-791 | NDC:83175-232 | NDC:80641-005 | NDC:70325-3003 | NDC:81104-800 | NDC:60289-298 | NDC:72839-138 | NDC:81104-984 | NDC:58411-479 | NDC:37808-983 | NDC:66820-0600 | NDC:59779-911 | NDC:56152-5001 | NDC:49404-307 | NDC:0363-0387 | NDC:62742-4237 | NDC:69968-0828 | NDC:66800-8007 | NDC:84204-0001 | NDC:50184-0600 | NDC:65112-303 | NDC:11344-954 | NDC:65692-0580 | NDC:71564-001 | NDC:68577-161 | NDC:72476-934 | NDC:59779-681 | NDC:65692-0586 | NDC:69842-022 | NDC:51150-634 | NDC:65692-0582 | NDC:72288-914 | NDC:14268-119 | NDC:80949-001 | NDC:75936-653 | NDC:81159-132 | NDC:30142-985 | NDC:51531-0850 | NDC:49825-138 | NDC:84326-424 | NDC:49527-065 | NDC:51316-057 | NDC:11822-0938 | NDC:62217-077 | NDC:70445-307 | NDC:73318-7008 | NDC:69039-233 | NDC:59427-114 | NDC:69968-0899 | NDC:49035-789 | NDC:61601-1217 | NDC:11822-0714 | NDC:65692-0579 | NDC:72839-159 | NDC:66738-302 | NDC:0363-0172 | NDC:65278-319 | NDC:69968-0600 | NDC:59735-205 | NDC:51150-240 | NDC:67225-5033 | CAS RN:70356-09-1 | NDC:84204-0005 | NDC:59450-941 | NDC:58414-0023 | NDC:11673-939 | NDC:63940-081 | NDC:66800-4839 | NDC:69842-164 | NDC:79481-1319 | NDC:69423-741 | NDC:65692-0563 | NDC:58668-0961 | NDC:52854-326 | NDC:43479-208 | NDC:82442-005 | NDC:69842-539 | NDC:72296-101 | NDC:71087-113 | NDC:61973-110 | NDC:36800-346 | NDC:37808-972 | NDC:52854-920 | NDC:75712-940 | NDC:49527-050 | NDC:66800-6000 | NDC:84130-003 | NDC:72839-915 | NDC:83149-000 | NDC:59735-338 | NDC:65692-0534 | NDC:65912-002 | NDC:73586-106 | NDC:84301-001 | NDC:84204-0011 | NDC:10596-718 | NDC:72330-101 | NDC:0299-4607 | NDC:84977-0032 | NDC:72476-951 | NDC:36800-312 | NDC:11822-0085 | NDC:69423-639 | NDC:49967-971 | NDC:82442-012 | NDC:49967-312 | NDC:72036-929 | NDC:51316-049 | NDC:72839-119 | NDC:79481-0936 | NDC:0299-4134 | NDC:82761-012 | NDC:55910-940 | NDC:30142-075 | NDC:81100-103 | NDC:49967-287 | NDC:69968-0891 | NDC:82761-003 | NDC:49035-845 | NDC:72839-135 | NDC:37808-984 | NDC:65692-0569 | NDC:63354-613 | NDC:72476-948 | NDC:62217-404 | NDC:80641-010 | NDC:64942-1502 | NDC:49527-081 | NDC:66738-030 | NDC:68577-035 | NDC:63354-649 | NDC:80524-002 | NDC:59735-206 | NDC:66800-2495 | NDC:84258-003 | NDC:79481-9924 | NDC:80489-235 | NDC:80641-019 | NDC:58418-004 | NDC:49527-077 | NDC:0299-4113 | NDC:30142-714 | NDC:49967-011 | NDC:73496-004 | NDC:0363-0996 | NDC:63354-632 | NDC:84204-0013 | NDC:76293-015 | NDC:60541-1110 | NDC:63354-387 | NDC:80641-017 | NDC:59735-204 | NDC:82866-004 | NDC:72476-935 | NDC:11822-0926 | NDC:59735-420 | NDC:74690-013 | NDC:11673-168 | NDC:62839-1630 | NDC:84204-0012 | NDC:65692-0576 | NDC:64024-938 | NDC:81104-700 | NDC:11344-950 | NDC:59735-218 | NDC:37808-908 | NDC:59427-013 | NDC:11559-053 | NDC:84616-003 | NDC:66800-2391 | NDC:66800-0376 | NDC:81309-008 | NDC:59735-991 | NDC:66800-8000 | NDC:81761-116 | NDC:82761-055 | NDC:37808-996 | NDC:79950-003 | NDC:49967-217 | NDC:78317-000 | NDC:11344-947 | NDC:84661-522 | PubChem CID:51040 | NDC:61477-217 | NDC:63354-115 | NDC:72476-978 | NDC:79481-0951 | NDC:84130-006 | NDC:58411-463 | NDC:72330-722 | NDC:68479-851 | NDC:82931-011 | NDC:37808-975 | NDC:72330-301 | NDC:69968-0664 | NDC:84356-001 | NDC:0363-0924 | NDC:73978-006 | NDC:21130-727 | NDC:68828-295 | NDC:76151-106 | NDC:52854-915 | NDC:55910-564 | NDC:0363-0389 | NDC:58411-854 | NDC:68634-054 | NDC:11822-9835 | NDC:85034-109 | NDC:41250-707 | NDC:51531-7385 | NDC:64141-035 | NDC:69423-574 | NDC:84438-937 | NDC:51346-532 | NDC:55910-937 | NDC:81104-500 | NDC:83149-001 | NDC:49967-456 | NDC:73586-103 | NDC:63354-083 | NDC:66800-3074 | NDC:0363-0388 | NDC:50594-156 | NDC:41163-954 | NDC:82953-029 | NDC:10356-353 | NDC:66800-2744 | NDC:79950-016 | NDC:79903-085 | NDC:11822-0922 | NDC:70630-0030 | NDC:63354-341 | NDC:24559-001 | NDC:82046-692 | NDC:52854-538 | NDC:73095-385 | NDC:52854-513 | NDC:81104-900 | NDC:68479-232 | NDC:81208-203 | NDC:40046-0063 | NDC:42851-055 | NDC:49967-888 | NDC:63354-201 | NDC:59450-947 | NDC:62217-245 | NDC:37808-905 | NDC:66738-063 | NDC:70445-306 | NDC:0363-0315 | NDC:70000-1543 | NDC:64942-1862 | NDC:49967-113 | NDC:68828-293 | NDC:55910-874 | NDC:65692-0535 | NDC:66800-1093 | NDC:69842-175 | NDC:72296-102 | NDC:84130-004 | NDC:60289-297 | NDC:63354-470 | NDC:37808-941 | NDC:65692-0556 | NDC:47124-122 | NDC:49967-008 | NDC:75712-943 | NDC:81104-247 | PubChem SID:175268842 | NDC:0363-0035 | NDC:0363-0943 | NDC:66800-2496 | NDC:62217-041 | NDC:53942-001 | NDC:84578-001 | NDC:72476-939 | NDC:83657-600 | NDC:51150-293 | NDC:51239-4921 | NDC:73496-007 | NDC:60289-302 | NDC:75071-008 | NDC:62217-078 | NDC:82691-148 | NDC:53208-721 | NDC:82953-027 | NDC:52993-127 | NDC:49967-038 | NDC:54473-220 | NDC:54860-416 | NDC:84504-3004 | NDC:62839-1638 | NDC:69968-0571 | NDC:70707-450 | NDC:43115-123 | NDC:44717-069 | NDC:70157-017 | NDC:37808-044 | NDC:66800-0104 | NDC:49035-843 | NDC:70325-3002 | NDC:72098-007 | NDC:49035-760 | NDC:69423-216 | NDC:70809-1902 | NDC:49035-963 | NDC:66800-4082 | NDC:68577-173 | NDC:30142-940 | NDC:10742-8980 | NDC:84489-166 | NDC:82953-028 | NDC:36800-186 | NDC:80641-012 | NDC:68828-749 | NDC:37808-114 | NDC:54111-146 | NDC:14222-2300 | NDC:66738-064 | NDC:72476-926 | NDC:82442-006 | NDC:53208-101 | NDC:61973-112 | NDC:65435-0300 | NDC:42893-013 | NDC:61477-220 | NDC:53675-158 | NDC:63354-054 | NDC:11822-1083 | NDC:61973-104 | NDC:70618-030 | NDC:0363-0128 | NDC:63868-531 | NDC:82761-038 | NDC:69842-079 | NDC:52854-982 | NDC:49035-566 | NDC:71270-153 | NDC:66800-3000 | NDC:54473-226 | NDC:55301-021 | NDC:59735-550 | NDC:73676-216 | NDC:75712-947 | NDC:74690-001 | NDC:60232-0043 | NDC:60289-303 | NDC:49404-144 | NDC:11559-056 | NDC:72296-108 | NDC:0363-0053 | NDC:69968-0669 | NDC:70000-0280 | NDC:72296-109 | NDC:71782-141 | NDC:63354-332 | NDC:53208-002 | NDC:62670-6687 | NDC:84977-0031 | NDC:52854-558 | NDC:72839-167 | NDC:49967-194 | NDC:74884-074 | NDC:79950-001 | NDC:49967-504 | NDC:71270-158 | NDC:69842-021 | NDC:68479-382 | NDC:0573-0768 | NDC:82757-101 | NDC:84204-0009 | NDC:49967-941 | NDC:81309-007 | NDC:63941-926 | NDC:65692-0585 | NDC:65692-0562 | NDC:63940-067 | NDC:72098-009 | NDC:0573-1957 | NDC:11822-3115 | NDC:85061-101 | NDC:49967-614 | NDC:49967-240 | NDC:79481-9926 | NDC:69968-0882 | NDC:49527-075 | NDC:69231-032 | NDC:82723-016 | NDC:23667-800 | NDC:69968-0897 | NDC:11673-941 | NDC:30142-955 | NDC:66738-309 | NDC:10096-2550 | NDC:72288-950 | NDC:62839-3904 | NDC:76293-055 | NDC:63354-625 | NDC:66800-8003 | NDC:72288-924 | NDC:66738-045 | NDC:79903-007 | NDC:50804-137 | NDC:84130-012 | NDC:51239-3921 | NDC:62217-069 | NDC:75712-934 | NDC:0363-0976 | NDC:53942-010 | NDC:62217-013 | NDC:64141-019 | NDC:69842-452 | NDC:72476-955 | NDC:71141-943 | NDC:11822-9834 | NDC:14268-118 | NDC:75936-608 | NDC:84126-034 | NDC:69842-385 | NDC:82761-045 | NDC:84438-940 | NDC:75936-649 | NDC:82657-014 | NDC:85178-2125 | NDC:10596-198 | NDC:59427-116 | NDC:69039-234 | NDC:68828-099 | NDC:72476-947 | NDC:0869-0940 | AVOBENZONE | NDC:59450-939 | NDC:84803-101 | NDC:71160-338 | NDC:0096-0687 | UNII:G63QQF2NOX | NDC:49967-812 | NDC:60289-291 | NDC:84130-000 | NDC:59779-861 | NDC:84489-101 | NDC:58411-439 | NDC:59735-922 | NDC:79481-0238 | NDC:30142-237 | NDC:84126-033 | NDC:84782-271 | NDC:72296-117 | NDC:62742-4257 | NDC:61197-219 | NDC:63940-068 | NDC:66738-047 | NDC:63940-077 | NDC:75936-602 | NDC:85034-115 | NDC:61995-0387 | NDC:76354-453 | NDC:68196-603 | NDC:65692-0518 | NDC:68577-157 | NDC:68577-159 | NDC:66800-3900 | NDC:66800-2462 | NDC:66800-2461 | NDC:49967-374 | NDC:70000-0071 | NDC:69968-0553 | NDC:66800-8006 | NDC:62217-067 | NDC:84130-002 | NDC:10356-328 | NDC:11822-9028 | NDC:68828-296 | NDC:70412-211 | NDC:57627-186 | NDC:69625-127 | NDC:82761-048 | NDC:69968-0824 | NDC:49035-765 | NDC:61481-3002 | NDC:49967-047 | NDC:37808-073 | NDC:84126-032 | NDC:62217-068 | NDC:73620-002 | NDC:51316-037 | NDC:71087-114 | NDC:10096-0450 | NDC:63354-039 | NDC:72839-389 | NDC:68828-021 | NDC:50594-152 | NDC:49967-608 | NDC:54111-145 | NDC:65692-0572 | NDC:84803-100 | NDC:59450-943 | NDC:51316-027 | NDC:69968-0777 | NDC:84504-3007 | NDC:49967-082 | NDC:65692-0540 | NDC:72935-002 | NDC:75936-226 | NDC:63354-271 | NDC:11822-1920 | NDC:80573-089 | NDC:79950-006 | NDC:49527-051 | NDC:55910-877 | NDC:70157-023 | NDC:58481-000 | NDC:72036-939 | NDC:72085-146 | NDC:79950-010 | NDC:65692-0531 | NDC:65692-0553 | NDC:66800-3091 | NDC:49967-754 | NDC:63354-207 | NDC:82953-003 | NDC:0924-0802 | NDC:84218-151 | NDC:63354-896 | NDC:66800-4118 | NDC:82657-002 | NDC:61481-3001 | NDC:65692-0527 | NDC:79481-1316 | NDC:84326-224 | NDC:84438-941 | NDC:76159-124 | NDC:80641-008 | NDC:49967-917 | NDC:66800-0000 | NDC:76354-132 | NDC:49967-797 | NDC:66800-5082 | NDC:41250-889 | NDC:61477-222 | NDC:11822-1914 | NDC:61477-210 | NDC:63354-597 | NDC:69968-0601 | NDC:59779-777 | NDC:65692-0532 | NDC:66738-310 | NDC:59735-217 | NDC:84438-926 | NDC:53675-209 | NDC:72476-950 | NDC:10967-640 | NDC:72935-003 | NDC:82657-006 | NDC:30142-240 | NDC:71714-001 | NDC:59735-800 | NDC:59735-203 | NDC:62217-250 | NDC:51316-024 | NDC:41250-555 | NDC:82953-023 | NDC:60289-284 | NDC:49967-952 | NDC:61477-211 | NDC:78863-3004 | NDC:70618-040 | NDC:49967-501 | NDC:79903-205 | NDC:21130-731 | NDC:49404-154 | NDC:78863-1110 | NDC:71270-154 | NDC:47124-126 | NDC:62217-064 | NDC:84438-906 | NDC:84504-3028 | NDC:69968-0672 | NDC:65692-0583 | NDC:72288-932 | NDC:79903-251 | NDC:50594-159 | NDC:63354-832 | NDC:37808-125 | NDC:84258-004 | NDC:51861-060 | NDC:69625-583 | NDC:10596-714 | NDC:75712-941 | NDC:84258-005 | NDC:69968-0829 | NDC:21130-726 | NDC:11489-203 | NDC:61477-223 | NDC:59735-215 | NDC:11822-0941 | NDC:69968-0559 | NDC:61995-0022 | NDC:84504-3014 | NDC:11344-049 | NDC:57627-204 | NDC:72104-082 | NDC:75936-165 | NDC:10356-819 | NDC:84267-005 | NDC:59735-450 | NDC:63354-521 | NDC:75936-652 | NDC:85179-005 | NDC:37808-969 | NDC:84438-930 | NDC:53208-301 | NDC:23667-802 | NDC:49967-103 | NDC:64024-951 | NDC:61477-226 | NDC:69968-0760 | NDC:0363-0366 | NDC:37808-143 | NDC:68577-105 | NDC:70445-310 | NDC:53942-002 | NDC:77714-003 | NDC:84803-102 | NDC:83324-184 | NDC:37808-118 | NDC:68828-515 | NDC:69423-606 | NDC:49967-878 | NDC:81104-251 | NDC:85178-2325 | NDC:10967-707 | NDC:79950-020 | NDC:11822-1013 | NDC:83982-4837 | NDC:65692-0587 | NDC:68577-034 | NDC:84438-902 | NDC:69968-0886 | NDC:82657-012 | NDC:46007-202 | NDC:59450-934 | NDC:68577-151 | NDC:84438-925 | NDC:79481-0941 | NDC:11822-0942 | NDC:63941-149 | NDC:79903-019 | NDC:79481-0938 | NDC:49967-684 | NDC:10210-0056 | NDC:79753-014 | NDC:65692-0557 | NDC:37808-997 | NDC:84438-910 | NDC:63868-913 | NDC:67225-5034 | NDC:80641-007 | NDC:51514-0367 | NDC:64942-1863 | NDC:65692-0522 | NDC:71087-108 | NDC:59735-923 | NDC:68577-155 | NDC:62670-6608 | NDC:42627-102 | NDC:49991-001 | NDC:84838-541 | NDC:0363-0286 | NDC:80641-011 | NDC:0363-0093 | NDC:37808-955 | NDC:63354-078"
+BMGC_DG10554,BMG_DG151891,"DrugBank ID:DB15122 | 3,7-dimethyl-1-[(5S)-4,4,6,6,6-pentadeuterio-5-hydroxyhexyl]purine-2,6-dione | Pcs-499 | PubChem SID:376231117 | UNII:FLV771E8ZV | PubChem CID:51041322 | CAS RN:1268605-91-9 | PCS-499"
+BMGC_DG10555,BMG_DG151896,"UPROSERTIB | PubChem CID:51042438 | Uprosertib | CAS RN:1047634-65-0 | PubChem SID:198988773 | UNII:ZXM835LQ5E | DrugBank ID:DB11969 | N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide"
+BMGC_DG10556,BMG_DG151897,"UNII:7R8ZU2864J | 3,4,4',5-Tetrachlorobiphenyl | 1,2,3-trichloro-5-(4-chlorophenyl)benzene | 3,4,4',5-TETRACHLOROBIPHENYL | CAS RN:70362-50-4 | PubChem CID:51043 | PubChem SID:198938557"
+BMGC_DG10557,BMG_DG151899,DrugBank ID:DB12752 | Bucindolol | CAS RN:71119-11-4 | PubChem SID:198983066 | 2-[2-hydroxy-3-[[1-(1H-indol-3-yl)-2-methylpropan-2-yl]amino]propoxy]benzonitrile | PubChem CID:51045 | CAS RN:111671-41-1 | BUCINDOLOL | UNII:E9UO06K7CE
+BMGC_DG10558,BMG_DG151904,"RIMEGEPANT | Rimegepant | PubChem CID:51049968 | [(5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl] 4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate | CAS RN:1374024-48-2 | DrugBank ID:DB12457 | PubChem SID:198963529 | UNII:997WVV895X | CAS RN:1289023-67-1"
+BMGC_DG10559,BMG_DG151906,"UNII:LAD0ZG7FFO | CAS RN:1292290-38-0 | LY-2881835 | PubChem CID:51049992 | DrugBank ID:DB15046 | PubChem SID:381132496 | (3S)-3-[4-[[4-(spiro[indene-1,4'-piperidine]-1'-ylmethyl)phenyl]methoxy]phenyl]hex-4-ynoic acid"
+BMGC_DG10560,BMG_DG151908,CAS RN:78628-28-1 | PubChem CID:5105 | Roxatidine acetate | DrugBank ID:DB08806 | [2-oxo-2-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]ethyl] acetate | ROXATIDINE ACETATE | UNII:ZUP3LSD0DO | PubChem SID:198937790
+BMGC_DG10561,BMG_DG151911,CAS RN:1333146-24-9 | N-methyl-3-[1-(4-piperazin-1-ylphenyl)-5-[4-[4-(trifluoromethyl)phenyl]phenyl]pyrazol-3-yl]propanamide | Ilk-IN-1 | PubChem CID:51051074
+BMGC_DG10562,BMG_DG151917,PubChem CID:51051629 | CAS RN:107667-60-7 | 3-aminopropanoyl-[(1S)-1-carboxy-2-(1H-imidazol-5-yl)ethyl]azanide;zinc | Polaprezinc | DrugBank ID:DB09221
+BMGC_DG10563,BMG_DG151937,"DrugBank ID:DB08147 | 4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid | PubChem CID:510684"
+BMGC_DG10564,BMG_DG151944,CAS RN:70458-92-3 | DrugBank ID:DB00487 | 1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid | PEFLOXACIN | UNII:2H52Z9F2Q5 | PubChem CID:51081 | PubChem SID:198937094 | Pefloxacin
+BMGC_DG10565,BMG_DG151953,PubChem CID:5111 | 2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide | DrugBank ID:DB02049
+BMGC_DG10566,BMG_DG151965,"CAS RN:70648-21-4 | 1,3,6,7,8-Pentachlorodibenzofuran | PubChem CID:51126 | PubChem SID:198949924 | 1,3,6,7,8-pentachlorodibenzofuran | UNII:479RK92V34 | 1,3,6,7,8-PENTACHLORODIBENZOFURAN"
+BMGC_DG10567,BMG_DG151969,"1,2,3,4,7,8-hexachlorodibenzofuran | PubChem SID:198950669 | UNII:BP4Q20NZGY | HEXACHLOROBENZOFURAN, 1,2,3,4,7,8- | PubChem CID:51130 | 1,2,3,4,7,8-Hexachlorodibenzofuran | CAS RN:55684-94-1 | CAS RN:70648-26-9"
+BMGC_DG10568,BMG_DG151970,"SELISISTAT | UNII:L19ECD5014 | CAS RN:49843-98-3 | PubChem SID:198986653 | 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide | PubChem CID:5113032 | DrugBank ID:DB13978"
+BMGC_DG10569,BMG_DG151983,4-Carboxyphenylglycine | 4-[amino(carboxy)methyl]benzoic acid | CAS RN:7292-81-1 | PubChem CID:5115
+BMGC_DG10570,BMG_DG151989,N-octyl-1-[10-(4-octyliminopyridin-1-yl)decyl]pyridin-4-imine | PubChem CID:51167 | OCTENIDINE | UNII:OZE0372S5A | PubChem SID:198984206 | DrugBank ID:DB12624 | CAS RN:71251-02-0 | Octenidine
+BMGC_DG10571,BMG_DG152017,BX-471 FREE BASE | BX-471 free base | UNII:76K17ZG4ZN | [5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methylpiperazin-1-yl]-2-oxoethoxy]phenyl]urea | PubChem CID:512282 | PubChem SID:198976121 | CAS RN:217645-70-0
+BMGC_DG10572,BMG_DG152025,CAS RN:71195-58-9 | PubChem CID:51263 | Alfentanil | PubChem SID:175268599 | DrugBank ID:DB00802 | N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide | ALFENTANIL | UNII:1N74HM2BS7
+BMGC_DG10573,BMG_DG152030,PubChem CID:5128032 | 2-aminopentanedioate | Glutamate(2-)
+BMGC_DG10574,BMG_DG152034,"CAS RN:18194-25-7 | UNII:31NE1DVE91 | PubChem SID:198945378 | 1,2-DILAUROYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 1,2-Dilauroyl-sn-glycero-3-phosphocholine | [(2R)-2,3-di(dodecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate | CAS RN:127641-86-5 | PubChem CID:512874"
+BMGC_DG10575,BMG_DG152062,"PubChem SID:198983693 | PF-03814735 | PubChem CID:51346455 | Pf-03814735 | UNII:6V5T4O5758 | CAS RN:942487-16-3 | DrugBank ID:DB13059 | N-[2-[(1R,8S)-4-[[4-(cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-11-azatricyclo[6.2.1.02,7]undeca-2(7),3,5-trien-11-yl]-2-oxoethyl]acetamide"
+BMGC_DG10576,BMG_DG152072,PubChem CID:51346964 | UNII:S2JB42BBP5 | CAS RN:1291779-76-4 | BI-99179 | PubChem SID:472422911
+BMGC_DG10577,BMG_DG152074,"2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-lambda6-sulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine | DrugBank ID:DB12397 | PubChem CID:51347395 | Dsm-265 | PubChem SID:287446527 | UNII:0Q42P4YI6B | DSM-265 | CAS RN:1282041-94-4"
+BMGC_DG10578,BMG_DG152078,PubChem CID:51348455 | CAS RN:1275595-86-2 | SELATINIB | UNII:6TLR8U8O3C | PubChem SID:316915562
+BMGC_DG10579,BMG_DG152079,"UNII:305EB53128 | Dotinurad | DOTINURAD | PubChem CID:51349053 | CAS RN:1285572-51-1 | (3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2H-1,3-benzothiazol-3-yl)methanone | PubChem SID:329589334"
+BMGC_DG10580,BMG_DG152080,"PubChem CID:51349239 | UNII:FSY46235ZO | N-[(2S)-6-amino-1-[3-[[(2S)-6-amino-1-[3-[[(2S)-6-amino-1-(3-carbamoyl-4-methoxyanilino)-1-oxohexan-2-yl]carbamoyl]-4-methoxyanilino]-1-oxohexan-2-yl]carbamoyl]-4-methoxyanilino]-1-oxohexan-2-yl]-5-[[(2S)-2,6-diaminohexanoyl]amino]-2-methoxybenzamide | Delparantag | PubChem SID:198947216 | CAS RN:872454-31-4 | DELPARANTAG | DrugBank ID:DB12955"
+BMGC_DG10581,BMG_DG152086,PubChem CID:51351657 | Ferroheme C | DrugBank ID:DB03317
+BMGC_DG10582,BMG_DG152102,"UNII:J1I0P6WT7T | CAS RN:1286770-55-5 | VERUBECESTAT | PubChem CID:51352361 | DrugBank ID:DB12285 | Verubecestat | N-[3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide | PubChem SID:198949186"
+BMGC_DG10583,BMG_DG152104,"JNJ-42396302 | PubChem SID:198962435 | UNII:P5M4972608 | Jnj-42396302 | DrugBank ID:DB12657 | PubChem CID:51352628 | 4-[3-[6-(2-methoxyethyl)pyridin-3-yl]-2-methylimidazo[1,2-b]pyridazin-8-yl]morpholine | CAS RN:1298030-18-8"
+BMGC_DG10584,BMG_DG152105,"2-Propanol, 1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1-F)(1,2,4)triazin-6-yl)oxy)-, 2-(hydrogen sulfate), (2R)- | [(2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-yl] hydrogen sulfate | PubChem SID:433968892 | 2-PROPANOL, 1-((4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-5-METHYLPYRROLO(2,1-F)(1,2,4)TRIAZIN-6-YL)OXY)-, 2-(HYDROGEN SULFATE), (2R)- | CAS RN:1285403-71-5 | UNII:6W0KP2SE7Q | PubChem CID:51352971"
+BMGC_DG10585,BMG_DG152106,"(2R)-1-[4-[[4-fluoro-2-(hydroxymethyl)-1H-indol-5-yl]oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-ol | PubChem CID:51352972"
+BMGC_DG10586,BMG_DG152109,CAS RN:1301167-87-2 | JNJ-42259152 | PubChem CID:51353528 | PubChem SID:198988025 | UNII:B1QHA9M0I6
+BMGC_DG10587,BMG_DG152110,"PubChem SID:198984882 | GI-181771X | UNII:6YF0SHR37T | DrugBank ID:DB12309 | CAS RN:305366-98-7 | PubChem CID:51353551 | 3-[[(3S)-2,4-dioxo-1-[2-oxo-2-(N-propan-2-ylanilino)ethyl]-5-phenyl-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid"
+BMGC_DG10588,BMG_DG152111,"PubChem SID:198940623 | APTAZAPINE | UNII:240J927J1R | 17-methyl-6,14,17-triazatetracyclo[12.4.0.02,6.08,13]octadeca-2,4,8,10,12-pentaene | DrugBank ID:DB09305 | Aptazapine | PubChem CID:51355 | CAS RN:71576-40-4"
+BMGC_DG10589,BMG_DG152144,UNII:N844GJ98J2 | S-BENZYLTHIOUREA | PubChem SID:198981804 | PubChem CID:5138 | CAS RN:621-85-2
+BMGC_DG10590,BMG_DG152163,PubChem SID:317229973 | CAS RN:2986-20-1 | S-Ethylisothiourea | PubChem CID:5139 | s-Ethylisothiourea | S-ETHYLISOTHIOUREA | ethyl carbamimidothioate | DrugBank ID:DB02234 | UNII:236P47H4VR
+BMGC_DG10591,BMG_DG152165,"PubChem SID:461433617 | MRS-1706 | UNII:YEE5LME5K5 | CAS RN:264622-53-9 | PubChem CID:5139184 | N-(4-acetylphenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide"
+BMGC_DG10592,BMG_DG152172,"Ppl-100 | CAS RN:612547-11-2 | DrugBank ID:DB05961 | PubChem SID:346540443 | PPL-100 | PubChem CID:513956 | methyl N-[(2S)-1-[[(5S)-5-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-6-hydroxyhexyl]amino]-1-oxo-3,3-diphenylpropan-2-yl]carbamate | UNII:JRI5GOF0K0"
+BMGC_DG10593,BMG_DG152184,"4,5-Dichloroisatin | CAS RN:1677-47-0 | 4,5-DICHLOROISATIN | UNII:UBC84VJV24 | PubChem CID:5139980 | PubChem SID:485663525"
+BMGC_DG10594,BMG_DG152200,CAS RN:1068-58-2 | UNII:ES8C3884JW | PubChem CID:5142 | CAS RN:2986-19-8 | methyl carbamimidothioate | S-Methylisothiopseudouronium | 2-METHYL-2-THIOPSEUDOUREA | PubChem SID:198969811
+BMGC_DG10595,BMG_DG152201,"CAS RN:81-07-2 | CAS RN:128-44-9 | PubChem SID:175268343 | SACCHARIN | Saccharin | DrugBank ID:DB12418 | UNII:FST467XS7D | 1,1-dioxo-1,2-benzothiazol-3-one | PubChem CID:5143"
+BMGC_DG10596,BMG_DG152218,RS-39604 | PubChem SID:318691571 | UNII:0RP0I19CSC | PubChem CID:5145950 | CAS RN:161362-65-8
+BMGC_DG10597,BMG_DG152222,"1,2,4,7,9-PENTACHLORODIBENZOFURAN | 1,2,4,7,9-pentachlorodibenzofuran | UNII:7U39GHT9YA | CAS RN:71998-74-8 | 1,2,4,7,9-Pentachlorodibenzofuran | PubChem CID:51464 | PubChem SID:198941692"
+BMGC_DG10598,BMG_DG152225,PubChem CID:5147 | SALICYLAMIDE | CAS RN:287492-04-0 | PubChem SID:175268673 | CAS RN:65-45-2 | Salicylamide | DrugBank ID:DB08797 | 2-hydroxybenzamide | UNII:EM8BM710ZC
+BMGC_DG10599,BMG_DG152228,"PubChem SID:441659201 | NONANAMIDE, N-((4-HYDROXY-2-IODO-5-METHOXYPHENYL)METHYL)- | CAS RN:859171-97-4 | UNII:36DPP36EQD | PubChem CID:5149140"
+BMGC_DG10600,BMG_DG152235,SALMETEROL | UNII:2I4BC502BT | CAS RN:89365-50-4 | PubChem SID:175271911 | DrugBank ID:DB00938 | 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol | Salmeterol | PubChem CID:5152
+BMGC_DG10601,BMG_DG152246,"5-Fluoro-2'-deoxycytidine | DrugBank ID:DB12957 | 4-amino-5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | CAS RN:10356-76-0 | 5-FLUORO-2'-DEOXYCYTIDINE | PubChem CID:515328 | PubChem SID:198962977 | 5-fluoro-2'-deoxycytidine | UNII:KUA4693H5W"
+BMGC_DG10602,BMG_DG152256,"Sanguinarium | PubChem CID:5154 | CAS RN:2447-54-3 | UNII:AV9VK043SS | 24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene | SANGUINARIUM | PubChem SID:198982527"
+BMGC_DG10603,BMG_DG152259,UNII:75BNB373NL | PubChem SID:485664128 | PubChem CID:5154691 | CAS RN:221244-14-0 | 1-NM-PP1
+BMGC_DG10604,BMG_DG152264,PubChem SID:198949553 | CAS RN:72131-33-0 | 2-[4-[2-(benzenesulfonamido)ethyl]phenoxy]acetic acid | UNII:74574CO5A6 | SULOTROBAN | Sulotroban | PubChem CID:51550
+BMGC_DG10605,BMG_DG152274,"ACIFRAN | PubChem SID:316914853 | UNII:FP3LLW01BL | PubChem SID:198979479 | ACIFRAN, (+)- | UNII:B1X701S0MV | CAS RN:77103-92-5 | CAS RN:77103-91-4 | PubChem SID:198945524 | PubChem CID:51576 | CAS RN:72420-38-3 | UNII:61IZ92GN57 | ACIFRAN, (-)-"
+BMGC_DG10606,BMG_DG152282,PubChem SID:198960181 | PubChem CID:5160 | 4-[1-(dimethylamino)-3-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]propan-2-yl]oxy-4-oxobutanoic acid | Sarpogrelate | CAS RN:125926-17-2 | SARPOGRELATE | UNII:19P708E787 | DrugBank ID:DB12163
+BMGC_DG10607,BMG_DG152285,NDC:65162-512 | 2-(2-hydroxybenzoyl)oxybenzoic acid | PubChem CID:5161 | SALSALATE | DrugBank ID:DB01399 | NDC:63629-2150 | PubChem SID:175268440 | NDC:63629-9247 | UNII:V9MO595C9I | CAS RN:552-94-3 | NDC:65162-513 | NDC:69367-616 | NDC:72162-1569 | Salsalate | NDC:63629-9248 | NDC:69367-615
+BMGC_DG10608,BMG_DG152287,Dioxo(sulfanyl)molybdenum | DrugBank ID:DB03328 | PubChem CID:5162682
+BMGC_DG10609,BMG_DG152288,"SB-206553 | UNII:AL4387525T | PubChem SID:318164288 | 1-methyl-N-pyridin-3-yl-6,7-dihydropyrrolo[2,3-f]indole-5-carboxamide | PubChem CID:5163 | CAS RN:158942-04-2 | SB 206553"
+BMGC_DG10610,BMG_DG152289,"DrugBank ID:DB00419 | (2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol | UNII:ADN3S497AZ | Miglustat | CAS RN:134282-77-2 | CAS RN:72599-27-0 | PubChem SID:175267081 | PubChem CID:51634 | MIGLUSTAT"
+BMGC_DG10611,BMG_DG152290,SB-220025 | CAS RN:165806-53-1 | SB220025 | PubChem CID:5164 | DrugBank ID:DB04338 | PubChem SID:440089434 | UNII:MX95H97VRG
+BMGC_DG10612,BMG_DG152297,"PubChem SID:249493273 | SB-239063 | 4-[4-(4-fluorophenyl)-5-(2-methoxypyrimidin-4-yl)imidazol-1-yl]cyclohexan-1-ol | CAS RN:193551-21-2 | UNII:HII3DC8CPI | PubChem CID:5166 | Cyclohexanol, 4-(4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl)-, trans-"
+BMGC_DG10613,BMG_DG152301,4-(Phenylsulfonyl)benzenamine | CAS RN:7019-01-4 | 4-(PHENYLSULFONYL)BENZENAMINE | PubChem SID:485665008 | PubChem CID:516666 | UNII:9XV49MR4HC
+BMGC_DG10614,BMG_DG152307,PubChem CID:5167689 | 2-[[1-[5-amino-2-[[2-[[2-[(2-amino-3-phenylpropanoyl)amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-N-[1-[(1-amino-1-oxo-3-phenylpropan-2-yl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pentanediamide | H-DL-Phe-DL-Leu-DL-Phe-DL-Gln-DL-Pro-DL-Gln-DL-Arg-DL-Phe-NH2
+BMGC_DG10615,BMG_DG152316,"Tridolgosir | Swainsonine | CAS RN:72741-87-8 | (1S,2R,8R,8aR)-1,2,3,5,6,7,8,8a-octahydroindolizine-1,2,8-triol | TRIDOLGOSIR | UNII:RSY4RK37KQ | PubChem CID:51683 | DrugBank ID:DB02034 | PubChem SID:198984297"
+BMGC_DG10616,BMG_DG152328,NDC:72603-209 | NDC:0802-2685 | NDC:64980-528 | NDC:55681-307 | Sodium bicarbonate | NDC:71872-7097 | NDC:69367-258 | NDC:81943-502 | NDC:70518-4158 | NDC:0409-4900 | NDC:55154-6754 | NDC:68016-251 | NDC:55758-319 | NDC:0409-4916 | CAS RN:144-55-8 | NDC:51662-1310 | NDC:82449-000 | PubChem SID:175266621 | NDC:63323-089 | NDC:0404-9980 | NDC:11822-0484 | NDC:0404-9950 | NDC:70708-110 | NDC:69618-034 | NDC:70095-050 | NDC:77333-831 | NDC:51662-1255 | NDC:75834-286 | NDC:50090-0530 | NDC:49035-399 | NDC:0395-2685 | NDC:51662-1472 | NDC:51662-1497 | NDC:51754-5002 | NDC:50090-6813 | NDC:0536-1046 | NDC:49035-398 | NDC:72162-2314 | PubChem CID:516892 | NDC:43353-041 | NDC:71872-7247 | NDC:71872-7266 | NDC:72572-740 | NDC:0409-5534 | Sodium Bicarbonate | DrugBank ID:DB01390 | NDC:52682-206 | NDC:59779-408 | UNII:8MDF5V39QO | NDC:51662-1256 | NDC:82645-904 | NDC:49035-539 | NDC:71610-669 | NDC:76328-223 | NDC:55154-4324 | NDC:0404-9985 | NDC:0409-6637 | NDC:42829-408 | NDC:90107-1280 | NDC:51754-5001 | NDC:24689-137 | NDC:83879-001 | sodium;hydrogen carbonate | NDC:0409-6625 | NDC:10237-591 | NDC:77333-827 | NDC:81665-200 | NDC:0904-7261 | NDC:82953-019 | NDC:70000-0270 | SODIUM BICARBONATE | NDC:81298-7620 | NDC:55681-331 | NDC:51754-5011 | NDC:24286-1523 | NDC:82953-020 | NDC:0404-9984 | NDC:54738-020 | NDC:24385-251 | NDC:51662-1573 | NDC:81943-503 | NDC:24286-1537 | NDC:0363-0802 | NDC:51754-5012 | NDC:43353-162 | NDC:71872-7310 | NDC:70708-210 | NDC:0404-9951 | NDC:79481-0502 | NDC:51662-1463 | NDC:76329-3352 | NDC:63323-083 | NDC:84275-503 | NDC:78271-041 | NDC:43116-037 | NDC:0363-0801 | NDC:42829-401 | NDC:51662-1400 | NDC:0536-1047 | NDC:51662-1383 | NDC:76328-221 | NDC:63629-8775 | NDC:54738-035 | NDC:0409-5555 | NDC:41520-938
+BMGC_DG10617,BMG_DG152329,Potassium bicarbonate | NDC:51801-013 | NDC:51801-007 | NDC:0245-5326 | potassium;hydrogen carbonate | NDC:51801-005 | CAS RN:298-14-6 | POTASSIUM BICARBONATE | NDC:51801-014 | NDC:51801-001 | NDC:51801-012 | DrugBank ID:DB11098 | PubChem CID:516893 | Potassium Bicarbonate | NDC:51801-011 | PubChem SID:175268518 | UNII:HM5Z15LEBN | NDC:51801-006
+BMGC_DG10618,BMG_DG152333,potassium;perchlorate | PubChem CID:516900 | DrugBank ID:DB09418 | Potassium Perchlorate | POTASSIUM PERCHLORATE | PubChem SID:198955244 | UNII:42255P5X4D | CAS RN:7778-74-7 | Potassium perchlorate
+BMGC_DG10619,BMG_DG152335,Silver nitrate | PubChem CID:516904 | DrugBank ID:DB11080
+BMGC_DG10620,BMG_DG152342,"PubChem CID:516949 | PubChem SID:175267839 | sodium;dihydrogen phosphate;hydrate | UNII:593YOG76RN | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | CAS RN:10049-21-5 | Sodium dihydrogen phosphate monohydrate"
+BMGC_DG10621,BMG_DG152344,CAS RN:7778-77-0 | potassium;dihydrogen phosphate | DrugBank ID:DB09413 | PubChem CID:516951 | PubChem SID:175268342 | UNII:4J9FJ0HL51 | Potassium dihydrogen phosphate | MONOBASIC POTASSIUM PHOSPHATE | Monopotassium phosphate
+BMGC_DG10622,BMG_DG152354,"diethyl 4-(2,1,3-benzoxadiazol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | UNII:N4AL7X96GL | PubChem SID:198953685 | DrugBank ID:DB09234 | CAS RN:72803-02-2 | PubChem CID:51701 | Darodipine | DARODIPINE"
+BMGC_DG10623,BMG_DG152361,UNII:M911911U02 | Potassium acetate | potassium;acetate | PubChem CID:517044 | POTASSIUM ACETATE | PubChem SID:175265840 | CAS RN:127-08-2 | DrugBank ID:DB14498 | Potassium Acetate
+BMGC_DG10624,BMG_DG152362,NDC:0641-6261 | SODIUM ACETATE ANHYDROUS | NDC:0409-7299 | NDC:0641-6263 | UNII:NVG71ZZ7P0 | NDC:0409-3299 | sodium;acetate | Sodium acetate | PubChem CID:517045 | CAS RN:129085-74-1 | NDC:0641-6262 | Sodium Acetate | CAS RN:127-09-3 | DrugBank ID:DB09395 | PubChem SID:175265865
+BMGC_DG10625,BMG_DG152364,PubChem SID:175267971 | sodium;benzoate | UNII:OJ245FE5EU | CAS RN:532-32-1 | Sodium Benzoate | PubChem CID:517055 | Sodium benzoate | SODIUM BENZOATE
+BMGC_DG10626,BMG_DG152373,DrugBank ID:DB08522 | 4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE | PubChem CID:5171
+BMGC_DG10627,BMG_DG152380,PubChem CID:51712 | UNII:4449F8I3LE | Pramiracetam | PubChem SID:198971320 | PRAMIRACETAM | DrugBank ID:DB13247 | CAS RN:68497-62-1 | N-[2-[di(propan-2-yl)amino]ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
+BMGC_DG10628,BMG_DG152389,DrugBank ID:DB03980 | UNII:R37TCQ1HFT | 4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole | 4-(Fluorophenyl)-1-cyclopropylmethyl-5-(2-amino-4-pyrimidinyl)imidazole | PubChem SID:438789113 | 4-[3-(cyclopropylmethyl)-5-(4-fluorophenyl)imidazol-4-yl]pyrimidin-2-amine | CAS RN:165806-51-9 | 4-(1-(CYCLOPROPYLMETHYL)-4-(4-FLUOROPHENYL)-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-AMINE | PubChem CID:5172
+BMGC_DG10629,BMG_DG152395,"UNII:4FP7WA7ACE | 5-Imino-4-methyl-1,3,4-thiadiazoline-2-sulfonamide | PubChem CID:5172475 | CAS RN:86029-46-1 | PubChem SID:474494749 | 5-IMINO-4-METHYL-1,3,4-THIADIAZOLINE-2-SULFONAMIDE"
+BMGC_DG10630,BMG_DG152430,"UNII:QG05NRB077 | PubChem SID:198935789 | FENTICONAZOLE | DrugBank ID:DB13434 | 1-[2-(2,4-dichlorophenyl)-2-[(4-phenylsulfanylphenyl)methoxy]ethyl]imidazole | PubChem CID:51755 | CAS RN:72479-26-6 | Fenticonazole"
+BMGC_DG10631,BMG_DG152469,"CAS RN:911467-97-5 | (9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl) 3-hydroxy-2-phenylpropanoate | (-)-Scopolamine | CAS RN:138-12-5 | CAS RN:475199-31-6 | PubChem CID:5184 | CAS RN:51-34-3"
+BMGC_DG10632,BMG_DG152476,"SCRIPTAID | Scriptaid | 6-(1,3-dioxobenzo[de]isoquinolin-2-yl)-N-hydroxyhexanamide | PubChem SID:441097245 | CAS RN:287383-59-9 | PubChem CID:5186 | UNII:EJQ8CD8BSV"
+BMGC_DG10633,BMG_DG152484,PubChem CID:518696 | CAS RN:12134-66-6 | Ferric Oxide Red | oxo(oxoferriooxy)iron | DrugBank ID:DB11576
+BMGC_DG10634,BMG_DG152509,"6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-alpha-propyl-, [5alpha,7alpha(R)]- | PubChem CID:518962 | 19-(2-hydroxypentan-2-yl)-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol"
+BMGC_DG10635,BMG_DG152513,CAS RN:97730-95-5 | PubChem CID:5190 | DPI-201-106 | UNII:UI0EP1D878 | 4-[3-[4-(diphenylmethyl)-1-piperazinyl]-2-hydroxypropoxy]-1H-indole-2-carbonitrile | 4-[3-(4-benzhydrylpiperazin-1-yl)-2-hydroxypropoxy]-1H-indole-2-carbonitrile | PubChem SID:348481269
+BMGC_DG10636,BMG_DG152521,PubChem CID:5191 | 2-(diethylamino)ethyl 4-amino-5-chloro-2-methoxybenzoate | CAS RN:137196-67-9 | 2-Methoxy-4-amino-5-chlorobenzoic acid 2-(diethylamino)ethyl ester
+BMGC_DG10637,BMG_DG152529,decanedioic acid | SEBACIC ACID | Sebacic acid | PubChem SID:175267868 | Sebacic Acid | DrugBank ID:DB07645 | PubChem CID:5192 | UNII:97AN39ICTC | CAS RN:111-20-6
+BMGC_DG10638,BMG_DG152539,"PubChem SID:175271924 | 5-pentan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | UNII:1P7H87IN75 | PubChem CID:5193 | CAS RN:76-73-3 | SECOBARBITAL | Secobarbital | DrugBank ID:DB00418"
+BMGC_DG10639,BMG_DG152540,PubChem SID:198962558 | UNII:0S326CI0WT | CAS RN:16790-49-1 | PubChem CID:519309 | BUTAZOLAMIDE
+BMGC_DG10640,BMG_DG152560,CAS RN:2323-36-6 | UNII:DPF682Q08V | PubChem CID:5195 | N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine | DEPRENYL | PubChem SID:198987278 | Deprenyl
+BMGC_DG10641,BMG_DG152589,"SEMUSTINE, TRANS- | UNII:EGU4CMI14D | UNII:2281H4FBL9 | SEMUSTINE | PubChem SID:198946645 | PubChem SID:198979732 | CAS RN:33073-59-5 | 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea | PubChem SID:198943919 | Semustine | CAS RN:13909-09-6 | SEMUSTINE, CIS- | CAS RN:33185-87-4 | PubChem CID:5198 | UNII:6YY7T1T567"
+BMGC_DG10642,BMG_DG152597,"METHYL 2,6-DIHYDROXYBENZOATE | PubChem CID:519869 | UNII:LL97SP38ZD | CAS RN:2150-45-0 | Methyl 2,6-dihydroxybenzoate | PubChem SID:485666749"
+BMGC_DG10643,BMG_DG152602,"CAS RN:517-43-1 | PubChem CID:5199 | Sennoside | CAS RN:62211-03-4 | CAS RN:85085-71-8 | 9-[2-carboxy-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid | DrugBank ID:DB11365"
+BMGC_DG10644,BMG_DG152616,2-Aminoquinoline-3-carboxamide | PubChem CID:5200228 | UNII:HNR763U4PY | PubChem SID:478838328 | CAS RN:31407-28-0 | 2-AMINOQUINOLINE-3-CARBOXAMIDE
+BMGC_DG10645,BMG_DG152625,8-METHOXYCOUMARIN | CAS RN:2445-81-0 | PubChem CID:520130 | UNII:W3OIY9A2QE | PubChem SID:377309111
+BMGC_DG10646,BMG_DG152633,CAS RN:1094000-36-8 | UNII:333DO1RDJY | 3-(2-aminoethyl)-1H-indol-5-ol | Serotonin | PubChem CID:5202 | CAS RN:50-67-9 | SEROTONIN | DrugBank ID:DB08839 | PubChem SID:175266816
+BMGC_DG10647,BMG_DG152635,"PubChem SID:198981894 | UNII:055XLQ0YQ6 | PubChem CID:520217 | 5-(2-fluorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one | CAS RN:2558-30-7 | Norflunitrazepam | NORFLUNITRAZEPAM"
+BMGC_DG10648,BMG_DG152669,"SETIPTILINE | CAS RN:57262-94-9 | 4-methyl-4-azatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),2(7),8,10,12,15,17-heptaene | DrugBank ID:DB09304 | PubChem CID:5205 | PubChem SID:198949456 | Setiptiline | UNII:7L38105Z6E"
+BMGC_DG10649,BMG_DG152677,"NDC:0781-6160 | NDC:66794-012 | NDC:10019-651 | PubChem SID:175268320 | UNII:38LVP0K73A | DrugBank ID:DB01236 | NDC:0074-4456 | NDC:10019-653 | NDC:72162-2245 | CAS RN:28523-86-6 | NDC:12164-005 | NDC:58181-5200 | 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane | PubChem CID:5206 | SEVOFLURANE | NDC:42677-308 | Sevoflurane | NDC:10019-657 | CAS RN:1173021-96-9 | NDC:10019-655 | NDC:0527-6123 | NDC:66794-015 | NDC:66794-022"
+BMGC_DG10650,BMG_DG152692,"CAS RN:85251-58-7 | C.I. Natural Red 20 | CAS RN:23444-65-7 | 5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene-1,4-dione | CAS RN:11019-15-1 | CAS RN:517-88-4 | PubChem CID:5208 | CAS RN:54952-43-1"
+BMGC_DG10651,BMG_DG152715,"CAS RN:106650-56-0 | UNII:WV5EC51866 | SIBUTRAMINE | PubChem CID:5210 | DrugBank ID:DB01105 | Sibutramine | PubChem SID:175271579 | 1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine"
+BMGC_DG10652,BMG_DG152726,PubChem SID:198944624 | UNII:3XFG6MQ9G2 | IPA-3 | PubChem CID:521106 | CAS RN:42521-82-4
+BMGC_DG10653,BMG_DG152730,PubChem CID:5212 | DrugBank ID:DB00203 | Sildenafil
+BMGC_DG10654,BMG_DG152755,UNII:JA8KJ8MS2S | CAS RN:51908-29-3 | PubChem CID:521359 | 4-ISOTHIOCYANATOBENZENESULFONAMIDE | PubChem SID:445500635
+BMGC_DG10655,BMG_DG152759,Silver;[(4-aminophenyl)-oxo-oxoniumylidene-lambda6-sulfanyl]-pyrimidin-2-ylazanium | PubChem CID:5214 | silver;[(4-aminophenyl)-oxo-oxoniumylidene-lambda6-sulfanyl]-pyrimidin-2-ylazanium
+BMGC_DG10656,BMG_DG152764,CAS RN:68-35-9 | 4-amino-N-pyrimidin-2-ylbenzenesulfonamide | CAS RN:141582-64-1 | UNII:0N7609K889 | Sulfadiazine | DrugBank ID:DB00359 | NDC:62135-842 | PubChem SID:175265370 | SULFADIAZINE | PubChem CID:5215 | NDC:42806-757
+BMGC_DG10657,BMG_DG152771,PubChem SID:198979512 | 3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl 2-(4-chlorophenoxy)-2-methylpropanoate | UNII:L2R75RQX26 | Simfibrate | PubChem CID:5217 | DrugBank ID:DB13433 | SIMFIBRATE | CAS RN:14929-11-4
+BMGC_DG10658,BMG_DG152782,PubChem SID:198957616 | 3-morpholin-4-yl-1-oxa-3-azonia-2-azanidacyclopent-3-en-5-imine | CAS RN:33876-97-0 | UNII:5O5U71P6VQ | LINSIDOMINE | Linsidomine | PubChem CID:5219 | DrugBank ID:DB13400
+BMGC_DG10659,BMG_DG152791,INDECAINIDE | PubChem CID:52195 | CAS RN:74517-78-5 | UNII:3AZF20DM1T | DrugBank ID:DB00192 | 9-[3-(propan-2-ylamino)propyl]fluorene-9-carboxamide | PubChem SID:198983189 | Indecainide
+BMGC_DG10660,BMG_DG152812,Ethyl Dimethyl Ammonio Propane Sulfonate | PubChem CID:5221296 | DrugBank ID:DB02618
+BMGC_DG10661,BMG_DG152837,"METAMIZOLE SODIUM | PubChem SID:175266772 | PubChem CID:522325 | CAS RN:54017-59-3 | DrugBank ID:DB04817 | CAS RN:68-89-3 | UNII:VSU62Z74ON | Dipyrone | sodium;[(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-methylamino]methanesulfonate | Metamizole"
+BMGC_DG10662,BMG_DG152856,"1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE | 1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide | DrugBank ID:DB03468 | PubChem CID:5226 | PubChem SID:441097616 | CAS RN:31404-61-2 | UNII:7ASE44P9QJ"
+BMGC_DG10663,BMG_DG152873,UNII:1I4LVX494H | DrugBank ID:DB07106 | PubChem SID:198950243 | SKF-91488 | 4-(dimethylamino)butyl carbamimidothioate | 4-(Dimethylamino)butyl carbamimidothioate | PubChem CID:5227 | CAS RN:68643-23-2
+BMGC_DG10664,BMG_DG152883,"6-(4-Fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole | UNII:9R6QDF1UO7 | 6-(4-fluorophenyl)-5-pyridin-4-yl-2,3-dihydroimidazo[2,1-b][1,3]thiazole | SKF-86002 | PubChem CID:5228 | CAS RN:72873-74-6 | PubChem SID:319892387"
+BMGC_DG10665,BMG_DG152922,UNII:451W47IQ8X | DrugBank ID:DB09153 | Sodium chloride | sodium;chloride | CAS RN:7647-14-5 | SODIUM CHLORIDE | Sodium Chloride | CAS RN:32343-72-9 | CAS RN:14762-51-7 | PubChem SID:175267578 | PubChem CID:5234
+BMGC_DG10666,BMG_DG152926,SODIUM FLUORIDE | sodium;fluoride | DrugBank ID:DB09325 | UNII:8ZYQ1474W7 | Sodium Fluoride | CAS RN:7681-49-4 | Sodium fluoride | PubChem SID:175266675 | PubChem CID:5235
+BMGC_DG10667,BMG_DG152937,2-nitro-4-[(6-nitroquinolin-4-yl)amino]-N-{4-[(pyridin-4-yl)amino]phenyl}benzamide | CAS RN:53221-75-3 | PubChem CID:5236119 | 2-NITRO-4-((6-NITROQUINOLIN-4-YL)AMINO)-N-(4-((PYRIDIN-4-YL)AMINO)PHENYL)BENZAMIDE | UNII:C9J246X8TE | PubChem SID:478838205
+BMGC_DG10668,BMG_DG152939,AC-915 | PubChem SID:198979031 | UNII:ZT6K8RIG8N | PubChem CID:5236783 | CAS RN:259729-84-5
+BMGC_DG10669,BMG_DG152945,UNII:F5WR8N145C | Sodium Iodide | Sodium iodide | SODIUM IODIDE | DrugBank ID:DB11119 | CAS RN:7681-82-5 | sodium;iodide | PubChem SID:175268049 | PubChem CID:5238
+BMGC_DG10670,BMG_DG152952,2-Hydroxy-3-oxobutanedioic acid | CAS RN:5651-05-8 | PubChem CID:524 | 2-hydroxy-3-oxobutanedioic acid
+BMGC_DG10671,BMG_DG152957,"Ipodate | UNII:F604ZKI910 | IPODIC ACID | Iopodic acid | DrugBank ID:DB09333 | 3-[3-(dimethylaminomethylideneamino)-2,4,6-triiodophenyl]propanoic acid | PubChem CID:5241 | CAS RN:5587-89-3 | PubChem SID:198987812"
+BMGC_DG10672,BMG_DG152962,"[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate | PubChem CID:52421 | CAS RN:73771-04-7 | [2-(17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] propanoate"
+BMGC_DG10673,BMG_DG152970,PubChem SID:175268366 | UNII:95D580798S | PubChem CID:5243 | PICOSULFURIC ACID | CAS RN:10040-34-3 | Picosulfuric acid | DrugBank ID:DB09268 | [4-[pyridin-2-yl-(4-sulfooxyphenyl)methyl]phenyl] hydrogen sulfate
+BMGC_DG10674,BMG_DG152975,PubChem SID:175265891 | UNII:KM2Z91756Z | Risedronic acid | Risedronic Acid | CAS RN:105462-24-6 | (1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid | RISEDRONIC ACID | DrugBank ID:DB00884 | PubChem CID:5245
+BMGC_DG10675,BMG_DG152976,6-Hydroxyindole | 6-HYDROXYINDOLE | 1H-indol-6-ol | UNII:3I03JZ599T | CAS RN:2380-86-1 | PubChem SID:198959928 | PubChem CID:524508
+BMGC_DG10676,BMG_DG152978,PubChem SID:175266375 | Tetrathiomolybdate | DrugBank ID:DB05088 | UNII:91U3TGV99T | TIOMOLIBDATE ION | CAS RN:16330-92-0 | PubChem CID:5245480 | bis(sulfanylidene)molybdenum;sulfanide
+BMGC_DG10677,BMG_DG152981,2-Azaniumyl-2-methylpropanoate | PubChem CID:5245672 | 2-azaniumyl-2-methylpropanoate
+BMGC_DG10678,BMG_DG152989,tetradecyl hydrogen sulfate | MYRISTYL SULFATE | UNII:6VOC18EIBH | PubChem CID:5248 | CAS RN:4754-44-3 | Myristyl sulfate | PubChem SID:198954183
+BMGC_DG10679,BMG_DG153002,2-hydroxybutanedioic acid | UNII:817L1N4CKP | Malic acid | PubChem SID:175271595 | CAS RN:6915-15-7 | PubChem CID:525 | CAS RN:617-48-1 | CAS RN:180991-05-3 | Malic Acid | DrugBank ID:DB12751 | MALIC ACID
+BMGC_DG10680,BMG_DG153013,1-(hydroxymethyl)-3-methylthiourea | Noxythiolin | CAS RN:15599-39-0 | UNII:4DN3AF1FU6 | PubChem SID:198952959 | NOXYTIOLIN | PubChem CID:5251503 | DrugBank ID:DB13838
+BMGC_DG10681,BMG_DG153016,DrugBank ID:DB00489 | CAS RN:3930-20-9 | SOTALOL | UNII:A6D97U294I | N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide | PubChem SID:175271894 | Sotalol | PubChem CID:5253
+BMGC_DG10682,BMG_DG153101,"PubChem CID:5265 | Spiperone | 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | UNII:4X6E73CJ0Q | SPIPERONE | PubChem SID:198938734 | CAS RN:749-02-0"
+BMGC_DG10683,BMG_DG153116,"Spiroxatrine | SPIROXATRINE | UNII:DR0QR50ALL | CAS RN:1054-88-2 | PubChem CID:5268 | PubChem SID:198962335 | 8-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one"
+BMGC_DG10684,BMG_DG153141,UNII:4PLG22CQUU | BESIFOVIR | CAS RN:441785-25-7 | PubChem CID:5270766 | PubChem SID:198948963 | [1-[(2-aminopurin-9-yl)methyl]cyclopropyl]oxymethylphosphonic acid | Besifovir
+BMGC_DG10685,BMG_DG153161,"GINKGETIN | UNII:HY5EZW8269 | Ginkgetin | CAS RN:481-46-9 | PubChem SID:441584077 | PubChem CID:5271805 | 5,7-dihydroxy-8-[5-(5-hydroxy-7-methoxy-4-oxochromen-2-yl)-2-methoxyphenyl]-2-(4-hydroxyphenyl)chromen-4-one"
+BMGC_DG10686,BMG_DG153187,"CAS RN:29080-58-8 | 5-HYDROXY-3',4',7-TRIMETHOXYFLAVONE | PubChem CID:5272653 | UNII:LXU4UA4TVC | PubChem SID:440088908"
+BMGC_DG10687,BMG_DG153195,"PubChem CID:5273394 | DrugBank ID:DB08278 | 1-(2-cyclopropylethyl)-3-(1,1-dioxo-2H-1,2,4-benzothiadiazin-3-yl)-6-fluoro-4-hydroxy-2(1H)-quinolinone"
+BMGC_DG10688,BMG_DG153202,PubChem CID:5273567 | PubChem SID:482553951 | CALCEOLARIOSIDE B | Calceolarioside B | CAS RN:105471-98-5 | UNII:B4UBY23XZJ
+BMGC_DG10689,BMG_DG153203,UNII:V7M270Y072 | FRAXIN | PubChem CID:5273568 | PubChem SID:241181142 | CAS RN:524-30-1
+BMGC_DG10690,BMG_DG153204,"UNII:CD3GD44O3K | FRAXETIN | PubChem SID:198977854 | CAS RN:574-84-5 | PubChem CID:5273569 | Fraxetin | 7,8-dihydroxy-6-methoxychromen-2-one"
+BMGC_DG10691,BMG_DG153209,"Abacavir sulfate and Lamivudine | [(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol;4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one | CAS RN:852337-16-7 | PubChem CID:5273759"
+BMGC_DG10692,BMG_DG153219,"CAS RN:502487-67-4 | PubChem SID:198949024 | SQ-109 | DrugBank ID:DB05186 | UNII:9AU7XUV31A | N-Geranyl-N'-(2-adamantyl)ethane-1,2-diamine | PubChem CID:5274428 | N'-(2-adamantyl)-N-[(2E)-3,7-dimethylocta-2,6-dienyl]ethane-1,2-diamine"
+BMGC_DG10693,BMG_DG153222,UNII:RY36PD0CQ2 | CAS RN:22688-79-5 | PubChem CID:5274585 | QUERCITURONE | PubChem SID:198958100
+BMGC_DG10694,BMG_DG153237,5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)dodecan-3-one | PubChem CID:5275725 | CAS RN:77398-92-6 | 5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)dodecan-3-one
+BMGC_DG10695,BMG_DG153238,CAS RN:107257-18-1 | 5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)tetradecan-3-one | 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)tetradecan-3-one | PubChem CID:5275726
+BMGC_DG10696,BMG_DG153247,"DrugBank ID:DB06931 | PubChem CID:5276507 | (1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)"
+BMGC_DG10697,BMG_DG153248,"PubChem CID:5276520 | DrugBank ID:DB06830 | (1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)"
+BMGC_DG10698,BMG_DG153251,"CAS RN:848640-34-6 | PubChem CID:5276854 | Epicept NP-1 | N1-(4-METHYL-2-NITROPHENYL)-1,3-PROPANEDIAMINE | DrugBank ID:DB05492 | N'-(4-methyl-2-nitrophenyl)propane-1,3-diamine | UNII:8JK52K9ENC | N-(3-Aminopropyl)-4-methyl-2-nitrobenzenamine"
+BMGC_DG10699,BMG_DG153252,"[(2R,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | PubChem SID:198956987 | GALLOCATECHIN GALLATE | UNII:0C056HB16M | Gallocatechin gallate | PubChem CID:5276890 | CAS RN:5127-64-0"
+BMGC_DG10700,BMG_DG153258,3-CHLORODIBENZOFURAN | PubChem CID:527713 | CAS RN:25074-67-3 | PubChem SID:198983236 | UNII:3PI7K19TKO
+BMGC_DG10701,BMG_DG153259,DrugBank ID:DB09101 | UNII:4GDQ854U53 | PubChem SID:175266793 | ELVITEGRAVIR | Elvitegravir | CAS RN:697761-98-1 | 6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid | PubChem CID:5277135
+BMGC_DG10702,BMG_DG153261,(2-(BENZOIMIDAZOL-1-YL)ETHYLIDENE)BISPHOSPHONIC ACID | CAS RN:847738-31-2 | UNII:Y8AP3Z4SNQ | PubChem CID:5277505 | [2-(Benzoimidazol-1-yl)ethylidene]bisphosphonic acid | PubChem SID:485663661
+BMGC_DG10703,BMG_DG153267,UNII:O549494L5D | PubChem SID:198954922 | PubChem CID:5278396 | KU-55933 | CAS RN:587871-26-9
+BMGC_DG10704,BMG_DG153277,"PubChem CID:5279 | CAS RN:622996-74-1 | CAS RN:159404-54-3 | Staurosporine HCl | 3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one | CAS RN:62996-74-1"
+BMGC_DG10705,BMG_DG153288,"ERYTHRO-SPHINGOSINE, (+/-)- | DrugBank ID:DB03203 | UNII:NGZ37HRE42 | PubChem CID:5280335 | ERYTHRO-SPHINGOSINE, (±)- | CAS RN:123-78-4 | Sphingosine | SPHINGOSINE | CAS RN:10140-30-4 | PubChem SID:198960878 | CAS RN:89164-20-5 | PubChem SID:198966570 | (E,2S,3R)-2-aminooctadec-4-ene-1,3-diol | CAS RN:2733-29-1 | UNII:0Y6SVQ612Q"
+BMGC_DG10706,BMG_DG153291,"UNII:9IKM0I5T1E | CAS RN:74893-81-5 | NDC:43857-0067 | PubChem SID:175266190 | QUERCETIN | NDC:44911-0013 | DrugBank ID:DB04216 | CAS RN:117-39-5 | Quercetin | 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one | NDC:43742-0217 | PubChem CID:5280343"
+BMGC_DG10707,BMG_DG153293,"PubChem CID:5280346 | PubChem SID:175265762 | 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | CAS RN:1339-63-5 | CAS RN:606-06-4 | CAS RN:7704-04-3 | Ubiquinone-2 | UNII:I7T5V2W47R | UBIQUINONE Q2 | Ubiquinone Q2 | DrugBank ID:DB08690"
+BMGC_DG10708,BMG_DG153294,CAS RN:93891-87-3 | BILIRUBIN | CAS RN:18422-02-1 | Bilirubin | CAS RN:635-65-4 | 3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid | PubChem SID:198956620 | PubChem CID:5280352 | UNII:RFM9X3LJ49
+BMGC_DG10709,BMG_DG153295,"DrugBank ID:DB02073 | PubChem SID:198944388 | BILIVERDIN | Biliverdine IX Alpha | Biliverdin | CAS RN:114-25-0 | PubChem CID:5280353 | 3-[(2Z,5Z)-2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid | UNII:O9MIA842K9"
+BMGC_DG10710,BMG_DG153297,"NDC:0009-3359 | PubChem CID:5280360 | Dinoprostone | UNII:K7Q1JQR04M | DINOPROSTONE | (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid | CAS RN:22230-04-2 | DrugBank ID:DB00917 | NDC:55566-2800 | PubChem SID:175268940 | CAS RN:363-24-6"
+BMGC_DG10711,BMG_DG153300,"UNII:B7IN85G1HY | PubChem CID:5280363 | CAS RN:23518-25-4 | CAS RN:13535-33-6 | CAS RN:551-11-1 | DINOPROST | DrugBank ID:DB12789 | (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid | PubChem SID:175268163 | Dinoprost"
+BMGC_DG10712,BMG_DG153303,"Bergaptol | CAS RN:486-60-2 | UNII:KTC8ANI30F | PubChem SID:198978929 | PubChem CID:5280371 | BERGAPTOL | 4-hydroxyfuro[3,2-g]chromen-7-one"
+BMGC_DG10713,BMG_DG153305,"DrugBank ID:DB15334 | PubChem SID:198989581 | UNII:U13J6U390T | CAS RN:491-80-5 | PubChem CID:5280373 | 5,7-dihydroxy-3-(4-methoxyphenyl)chromen-4-one | Biochanin A | BIOCHANIN A"
+BMGC_DG10714,BMG_DG153307,PubChem SID:198956181 | Formononetin | UNII:295DQC67BJ | DrugBank ID:DB15335 | FORMONONETIN | CAS RN:485-72-3 | 7-hydroxy-3-(4-methoxyphenyl)chromen-4-one | PubChem CID:5280378
+BMGC_DG10715,BMG_DG153310,"PubChem CID:5280382 | CAS RN:22737-96-8 | (2E,4Z,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol | 11-cis-Retinol"
+BMGC_DG10716,BMG_DG153311,"CAS RN:72059-45-1 | PubChem CID:5280383 | 4-[(2S,3S)-3-[(1E,3E,5Z,8Z)-tetradeca-1,3,5,8-tetraenyl]oxiran-2-yl]butanoic acid | UNII:7Y7MPZ6563 | Leukotriene A4 | PubChem SID:198981633 | LEUKOTRIENE A4"
+BMGC_DG10717,BMG_DG153315,"4,6-Dioxo-2-octenedioic acid, (2Z)- | PubChem SID:472422229 | 4,6-DIOXO-2-OCTENEDIOIC ACID, (2Z)- | 4-Maleylacetoacetic acid | CAS RN:5698-52-2 | PubChem CID:5280393 | UNII:5ET93TW8TE | (Z)-4,6-dioxooct-2-enedioic acid"
+BMGC_DG10718,BMG_DG153317,"4-Fumarylacetoacetic acid | PubChem SID:472425873 | PubChem CID:5280398 | UNII:FM3BV7K438 | CAS RN:9032-59-1 | CAS RN:28613-33-4 | (E)-4,6-dioxooct-2-enedioic acid | Fumarylacetoacetic acid | FUMARYLACETOACETIC ACID"
+BMGC_DG10719,BMG_DG153322,"PubChem SID:249492890 | PubChem CID:5280417 | 3,7-DIMETHYLQUERCETIN | 3,7-Di-O-methylquercetin | UNII:V8R92XSR1M | 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,7-dimethoxychromen-4-one | CAS RN:2068-02-2"
+BMGC_DG10720,BMG_DG153323,"DrugBank ID:DB01240 | 5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid | PubChem CID:5280427 | Epoprostenol"
+BMGC_DG10721,BMG_DG153324,"UNII:MZQ4XE15TP | PubChem SID:198989573 | CAS RN:150-86-7 | Phytol | (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol | PubChem CID:5280435 | CAS RN:123164-54-5 | PHYTOL, (E)-"
+BMGC_DG10722,BMG_DG153325,"CAS RN:149301-79-1 | UNII:00XIW1CR0F | Aacocf3 | (6Z,9Z,12Z,15Z)-1,1,1-trifluorohenicosa-6,9,12,15-tetraen-2-one | PubChem SID:198939184 | ARACHIDONYLTRIFLUOROMETHANE | PubChem CID:5280436"
+BMGC_DG10723,BMG_DG153327,"DrugBank ID:DB11475 | PubChem SID:175268550 | PubChem CID:5280440 | TYLOSIN | UNII:YEF4JXN031 | CAS RN:8026-48-0 | Tylosin | CAS RN:1401-69-0 | 2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde"
+BMGC_DG10724,BMG_DG153328,VITEXIN | PubChem SID:198964278 | PubChem CID:5280441 | CAS RN:3681-93-4 | UNII:9VP70K75OK
+BMGC_DG10725,BMG_DG153329,PubChem SID:198991184 | ACACETIN | PubChem CID:5280442 | UNII:KWI7J0A2CC | CAS RN:480-44-4
+BMGC_DG10726,BMG_DG153330,"UNII:7V515PI7F6 | APIGENIN | Apigenin | PubChem SID:175267662 | CAS RN:520-36-5 | DrugBank ID:DB07352 | 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one | PubChem CID:5280443"
+BMGC_DG10727,BMG_DG153331,"CAS RN:491-70-3 | UNII:KUX1ZNC9J2 | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one | CAS RN:1318-21-4 | DrugBank ID:DB15584 | Luteolin | PubChem SID:198980921 | PubChem CID:5280445 | LUTEOLIN"
+BMGC_DG10728,BMG_DG153333,"(9Z,12Z)-octadeca-9,12-dienoic acid | CAS RN:8024-22-4 | CAS RN:60-33-3 | PubChem CID:5280450 | CAS RN:30175-49-6 | PubChem SID:175266153 | DrugBank ID:DB14104 | LINOLEIC ACID | UNII:9KJL21T0QJ | CAS RN:85594-37-2 | Linoleic Acid | CAS RN:80969-37-5"
+BMGC_DG10729,BMG_DG153335,"NDC:71610-870 | NDC:64380-723 | PubChem CID:5280453 | NDC:23155-662 | NDC:63629-2445 | NDC:68308-665 | NDC:0054-3120 | NDC:65162-576 | UNII:FXC9231JVH | NDC:43353-138 | NDC:51407-169 | CAS RN:66772-14-3 | NDC:17856-3120 | NDC:62135-610 | NDC:30698-143 | NDC:0093-7352 | NDC:62756-968 | NDC:63629-8742 | NDC:62756-967 | NDC:72266-251 | CAS RN:32222-06-3 | NDC:0299-2012 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | NDC:69452-208 | NDC:51407-170 | Calcitriol | NDC:71335-1782 | NDC:50090-6711 | NDC:71610-521 | NDC:65162-519 | NDC:62135-611 | CAS RN:1000873-74-4 | NDC:71335-1594 | DrugBank ID:DB00136 | NDC:23155-663 | NDC:63304-239 | NDC:72789-058 | NDC:68083-316 | NDC:63304-240 | PubChem SID:175267862 | NDC:50090-7470 | NDC:63304-241 | CALCITRIOL | NDC:45802-608 | NDC:63629-8741 | NDC:60687-345 | NDC:30698-144 | NDC:0054-0007 | NDC:55154-8186 | NDC:64380-724 | NDC:39328-042 | NDC:69452-207 | NDC:43353-998 | NDC:64980-447 | NDC:71610-468 | NDC:63629-7323 | NDC:0093-7353"
+BMGC_DG10730,BMG_DG153337,"CAS RN:102-61-4 | UNII:881R434AIB | CAS RN:22139-77-1 | Pinosylvin | 5-[(E)-2-phenylethenyl]benzene-1,3-diol | PubChem SID:198944830 | PINOSYLVIN | PubChem CID:5280457"
+BMGC_DG10731,BMG_DG153338,"PSYCHOSINE | UNII:BG5A25U68L | (2R,3R,4S,5R,6R)-2-[(E,2S,3R)-2-amino-3-hydroxyoctadec-4-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | PubChem SID:482553891 | CAS RN:2238-90-6 | PubChem CID:5280458 | Psychosine"
+BMGC_DG10732,BMG_DG153339,"PubChem CID:5280459 | CAS RN:522-12-3 | QUERCITRIN | PubChem SID:198946262 | Quercitrin | UNII:2Y8906LC5P | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one"
+BMGC_DG10733,BMG_DG153340,PubChem SID:198941804 | PubChem CID:5280460 | Scopoletin | 7-hydroxy-6-methoxychromen-2-one | UNII:KLF1HS0SXJ | CAS RN:92-61-5 | SCOPOLETIN
+BMGC_DG10734,BMG_DG153341,"PubChem SID:198991040 | CAS RN:50763-73-0 | UNII:P86438KC5J | CAS RN:23526-45-6 | Vomifoliol | 4-HYDROXY-4-(3-HYDROXY-1-BUTENYL)-3,5,5-TRIMETHYL-2-CYCLOHEXEN-1-ONE, (4S,3R)-(E)-(+/-)- | (4S)-4-hydroxy-4-[(E,3R)-3-hydroxybut-1-enyl]-3,5,5-trimethylcyclohex-2-en-1-one | PubChem CID:5280462 | UNII:B7QV234K84 | PubChem SID:198953654 | VOMIFOLIOL, (+)- | 4-HYDROXY-4-(3-HYDROXY-1-BUTENYL)-3,5,5-TRIMETHYL-2-CYCLOHEXEN-1-ONE, (4S,3R)-(E)-(±)-"
+BMGC_DG10735,BMG_DG153347,"2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione | CAS RN:81818-54-4 | PubChem CID:5280483 | CAS RN:12001-79-5 | CAS RN:27696-10-2 | CAS RN:2581046-19-5 | CAS RN:10485-69-5 | Vitamin K"
+BMGC_DG10736,BMG_DG153349,"PubChem SID:175267221 | BETA CAROTENE | Beta-Carotene | 1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene | Beta carotene | CAS RN:7235-40-7 | DrugBank ID:DB06755 | UNII:01YAE03M7J | CAS RN:116-32-5 | PubChem CID:5280489"
+BMGC_DG10737,BMG_DG153352,"PubChem SID:198989700 | PubChem CID:5280492 | (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid | Leukotriene B4 | LEUKOTRIENE B4 | DrugBank ID:DB12961 | CAS RN:71160-24-2 | CAS RN:101759-15-3 | UNII:1HGW4DR56D"
+BMGC_DG10738,BMG_DG153353,"(5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid | UNII:2CU6TT9V48 | PubChem CID:5280493 | DrugBank ID:DB08855 | LEUKOTRIENE C4 | PubChem SID:198947983 | CAS RN:10-34-4 | CAS RN:72025-60-6 | Leukotriene C4"
+BMGC_DG10739,BMG_DG153354,"PubChem SID:198955845 | UNII:4C2A5G825S | (Z)-7-[(1S,3R,4S,5S)-3-[(E,3S)-3-hydroxyoct-1-enyl]-2,6-dioxabicyclo[3.1.1]heptan-4-yl]hept-5-enoic acid | THROMBOXANE A2 | CAS RN:57576-52-0 | Thromboxane A2 | PubChem CID:5280497"
+BMGC_DG10740,BMG_DG153357,MALEYLACETIC ACID | Maleylacetic acid | UNII:JAD9FA3JG6 | PubChem SID:482554041 | (Z)-4-oxohex-2-enedioic acid | CAS RN:24740-88-3 | PubChem CID:5280500 | 4-Oxohex-2-enedioate
+BMGC_DG10741,BMG_DG153360,"Sinapyl alcohol | PubChem CID:5280507 | SINAPYL ALCOHOL | CAS RN:20675-96-1 | UNII:8O6NO04SMV | CAS RN:537-33-7 | 4-[(E)-3-hydroxyprop-1-enyl]-2,6-dimethoxyphenol | PubChem SID:198969908"
+BMGC_DG10742,BMG_DG153368,"[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate | CAS RN:110067-62-4 | CAS RN:79-81-2 | VITAMIN A PALMITATE | PubChem SID:175266626 | UNII:1D1K0N0VVC | PubChem CID:5280531 | Vitamin A Palmitate | NDC:70199-026"
+BMGC_DG10743,BMG_DG153370,P-COUMARYL ALCOHOL | PubChem CID:5280535 | 4-[(E)-3-hydroxyprop-1-enyl]phenol | CAS RN:3690-05-9 | PubChem SID:316914010 | p-Coumaryl alcohol | UNII:61POZ1QQ11 | CAS RN:20649-40-5
+BMGC_DG10744,BMG_DG153371,UNII:06TPT01AD5 | (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enal | 4-HYDROXY-3-METHOXYCINNAMALDEHYDE | 4-Hydroxy-3-methoxycinnamaldehyde | PubChem CID:5280536 | PubChem SID:198945666 | CAS RN:458-36-6 | CAS RN:20649-42-7
+BMGC_DG10745,BMG_DG153380,PubChem CID:5280567 | HYMECROMONE | PubChem SID:198977836 | CAS RN:79566-13-5 | DrugBank ID:DB07118 | 7-hydroxy-4-methylchromen-2-one | Hymecromone | UNII:3T5NG4Q468 | CAS RN:90-33-5
+BMGC_DG10746,BMG_DG153381,"Daphnetin | 7,8-dihydroxychromen-2-one | CAS RN:486-35-1 | DAPHNETIN | PubChem CID:5280569 | UNII:XC84571RD2 | PubChem SID:198979993"
+BMGC_DG10747,BMG_DG153383,"Dihomo-gamma-linolenic acid | (8Z,11Z,14Z)-icosa-8,11,14-trienoic acid | CAS RN:1783-84-2 | DALEUTON | DrugBank ID:DB00154 | PubChem SID:198986692 | UNII:FC398RK06S | PubChem CID:5280581"
+BMGC_DG10748,BMG_DG153385,"UNII:O8GP21P496 | PubChem SID:198985788 | CAS RN:572-96-3 | PHYTONADIOL | Phytonadiol | 2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-diol | PubChem CID:5280585"
+BMGC_DG10749,BMG_DG153390,"(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienal | PubChem CID:5280598 | FARNESAL, (2E,6E)- | CAS RN:19317-11-4 | CAS RN:502-67-0 | PubChem SID:198936315 | Farnesal | UNII:G4E58106EW"
+BMGC_DG10750,BMG_DG153391,LUTEOLIN 7-GLUCURONIDE | CAS RN:29741-10-4 | UNII:R4346D0X7P | PubChem SID:313184079 | PubChem CID:5280601
+BMGC_DG10751,BMG_DG153401,PubChem SID:198956833 | PubChem CID:5280633 | NEOCHLOROGENIC ACID | CAS RN:906-33-2 | UNII:O4601UER1Z
+BMGC_DG10752,BMG_DG153403,"2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | CAS RN:5373-11-5 | PubChem CID:5280637 | UNII:98J6XDS46I | PubChem SID:198966153 | CAS RN:26811-41-6 | Luteolin 7-O-glucoside | LUTEOLIN 7-O-GLUCOSIDE"
+BMGC_DG10753,BMG_DG153406,PubChem SID:198964512 | UNII:SET4M23ZTM | GOSSYPETIN | PubChem CID:5280647 | CAS RN:489-35-0
+BMGC_DG10754,BMG_DG153416,"PubChem SID:198934631 | UNII:Q813145M20 | CHRYSERIOL | PubChem CID:5280666 | 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one | Chryseriol | CAS RN:491-71-4"
+BMGC_DG10755,BMG_DG153423,UNII:7J92C373RH | 3-METHOXYLUTEOLIN | PubChem CID:5280681 | CAS RN:1486-70-0 | PubChem SID:375579649
+BMGC_DG10756,BMG_DG153424,"PubChem CID:5280682 | PubChem SID:441583648 | CAS RN:572-32-7 | 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,7-dimethoxychromen-4-one | UNII:YA465UF3LK | AYANIN | Ayanin"
+BMGC_DG10757,BMG_DG153432,"PubChem CID:5280701 | (5Z,8Z,11Z,13E)-15-oxoicosa-5,8,11,13-tetraenoic acid | CAS RN:81416-72-0"
+BMGC_DG10758,BMG_DG153433,"UNII:7OF2S66PCH | PubChem CID:5280704 | APIGETRIN | CAS RN:578-74-5 | 5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | PubChem SID:198967232 | Apigetrin"
+BMGC_DG10759,BMG_DG153438,"PubChem CID:5280711 | (Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid | 13,14-Dihydro-15-keto-PGE2 | CAS RN:363-23-5"
+BMGC_DG10760,BMG_DG153440,"CAS RN:115793-61-8 | PubChem CID:5280718 | (2E)-2-(4-chloro-5-oxofuran-2-ylidene)acetic acid | CAS RN:18529-78-7 | cis-2-Chloro-4-carboxymethylenebut-2-en-1,4-olide"
+BMGC_DG10761,BMG_DG153441,"15-KETOPROSTAGLANDIN E2 | CAS RN:26441-05-4 | 15-keto-prostaglandin E2 | PubChem CID:5280719 | UNII:2S0F1FTK13 | (Z)-7-[(1R,2R,3R)-3-hydroxy-5-oxo-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid | PubChem SID:198955851"
+BMGC_DG10762,BMG_DG153442,"CAS RN:33964-75-9 | UNII:KJ4LKU42W8 | PubChem CID:5280720 | (9Z,11E,13S)-13-hydroperoxyoctadeca-9,11-dienoic acid | PubChem SID:472424797 | 13(S)-Hpode | 13-HYDROPEROXY-9,11-OCTADECADIENOIC ACID, (9Z,11E,13S)-"
+BMGC_DG10763,BMG_DG153444,"NDC:0009-5182 | PubChem SID:175266460 | DrugBank ID:DB00770 | 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid | Alprostadil | NDC:52244-040 | CAS RN:745-65-3 | NDC:0009-3169 | NDC:63539-221 | NDC:0009-7686 | UNII:F5TD010360 | NDC:63539-121 | NDC:0009-3701 | NDC:0009-0215 | ALPROSTADIL | NDC:71288-206 | NDC:52244-010 | PubChem CID:5280723 | NDC:52244-020 | NDC:0009-5181"
+BMGC_DG10764,BMG_DG153445,"Icomucret | CAS RN:54845-95-3 | PubChem CID:5280724 | PubChem SID:198935864 | ICOMUCRET | (5Z,8Z,11Z,13E,15S)-15-hydroxyicosa-5,8,11,13-tetraenoic acid | UNII:44JHK6G39Q"
+BMGC_DG10765,BMG_DG153448,"CAS RN:70608-72-9 | UNII:467RNW8T91 | PubChem SID:249492905 | (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid | 5-HETE | 5(S)-Hete | PubChem CID:5280733"
+BMGC_DG10766,BMG_DG153449,"PubChem CID:5280745 | 20-Hydroxy-leukotriene B4 | CAS RN:79516-82-8 | (5S,6Z,8E,10E,12R,14Z)-5,12,20-trihydroxyicosa-6,8,10,14-tetraenoic acid"
+BMGC_DG10767,BMG_DG153450,APIIN | UNII:6QU3EZE37U | CAS RN:26544-34-3 | PubChem CID:5280746 | PubChem SID:198940805
+BMGC_DG10768,BMG_DG153452,"Cyclosporine | CAS RN:59865-13-3 | 30-ethyl-33-[(E)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | CAS RN:83602-39-5 | PubChem CID:5280754"
+BMGC_DG10769,BMG_DG153453,"[(1S,3S,5Z,7R,8E,11S,12S,13E,15S,17R,21R,23R,25S)-25-acetyloxy-1,11,21-trihydroxy-17-[(1R)-1-hydroxyethyl]-5,13-bis(2-methoxy-2-oxoethylidene)-10,10,26,26-tetramethyl-19-oxo-18,27,28,29-tetraoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] (2E,4E)-octa-2,4-dienoate | Bryostatin 1 | BRYOSTATIN 1 | CAS RN:83314-01-6 | PubChem SID:198979842 | PubChem CID:5280757 | UNII:37O2X55Y9E"
+BMGC_DG10770,BMG_DG153454,"PubChem SID:249492211 | (E)-3-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]prop-2-enoic acid | MELILOTOSIDE | PubChem CID:5280759 | UNII:M87W7715UB | CAS RN:618-67-7 | Melilotoside"
+BMGC_DG10771,BMG_DG153470,"PubChem SID:175268434 | Ergocalciferol | DrugBank ID:DB00153 | ERGOCALCIFEROL | (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol | CAS RN:50-14-6 | PubChem CID:5280793 | UNII:VS041H42XC"
+BMGC_DG10772,BMG_DG153471,"PubChem SID:198955770 | STIGMASTEROL | CAS RN:83-48-7 | (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | PubChem CID:5280794 | Stigmasterol | UNII:99WUK5D0Y8"
+BMGC_DG10773,BMG_DG153472,"Cholecalciferol | PubChem CID:5280795 | UNII:1C6V77QF41 | CAS RN:2416217-93-9 | CAS RN:67-97-0 | PubChem SID:175267387 | CAS RN:1406-16-2 | CHOLECALCIFEROL | DrugBank ID:DB00169 | (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol"
+BMGC_DG10774,BMG_DG153477,"2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | CAS RN:482-35-9 | ISOQUERCETIN | PubChem CID:5280804 | PubChem SID:198940203 | DrugBank ID:DB12665 | Isoquercetin | UNII:6HN2PC637T"
+BMGC_DG10775,BMG_DG153478,"UNII:5G06TVY3R7 | RUTIN | CAS RN:207671-50-9 | DrugBank ID:DB01698 | Rutin | PubChem CID:5280805 | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | PubChem SID:175267808 | CAS RN:153-18-4"
+BMGC_DG10776,BMG_DG153479,"CAS RN:17459-92-6 | Bilirubin diglucuronide | BILIRUBIN DIGLUCURONIDE | PubChem CID:5280817 | (2S,3S,4S,5R,6S)-6-[3-[2-[[3-[3-[(2S,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3-oxopropyl]-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | UNII:9L71584RCM | PubChem SID:363908050"
+BMGC_DG10777,BMG_DG153485,"2-Octaprenylphenol | CAS RN:42187-47-3 | DrugBank ID:DB03232 | 2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol | 2-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaenyl]phenol | PubChem CID:5280832"
+BMGC_DG10778,BMG_DG153494,"CAS RN:1592-70-7 | 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-methoxychromen-4-one | Isokaempferide | PubChem CID:5280862"
+BMGC_DG10779,BMG_DG153495,"DrugBank ID:DB01852 | PubChem SID:198938138 | Kaempferol | PubChem CID:5280863 | UNII:731P2LE49E | Kaempherol | 3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one | CAS RN:520-18-3 | KAEMPFEROL"
+BMGC_DG10780,BMG_DG153500,"PubChem SID:198938871 | CAS RN:73836-78-9 | Leukotriene D4 | UNII:5FNY4416UE | (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid | LEUKOTRIENE D4 | DrugBank ID:DB11858 | PubChem CID:5280878"
+BMGC_DG10781,BMG_DG153501,"PubChem SID:198951720 | leukotriene E4 | LEUKOTRIENE E4 | (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-2-carboxyethyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid | CAS RN:75715-89-8 | UNII:8EYT8ATL7G | PubChem CID:5280879"
+BMGC_DG10782,BMG_DG153503,"CAS RN:13367-85-6 | PubChem CID:5280881 | PROSTAGLANDIN B2 | (Z)-7-[2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopenten-1-yl]hept-5-enoic acid | UNII:BIU61O9T9T | Prostaglandin B2 | prostaglandin B2 | PubChem SID:198985059 | DrugBank ID:DB02304"
+BMGC_DG10783,BMG_DG153505,"Prostaglandin G2 | CAS RN:51982-36-6 | DrugBank ID:DB03866 | PubChem CID:5280883 | PubChem SID:459276152 | UNII:AZ87DUD2Y8 | PROSTAGLANDIN G2 | (Z)-7-[(1R,4S,5R,6R)-6-[(E,3S)-3-hydroperoxyoct-1-enyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid"
+BMGC_DG10784,BMG_DG153506,"prostaglandin J2 | PubChem CID:5280884 | CAS RN:60203-57-8 | (Z)-7-[(1S,5R)-5-[(E,3S)-3-hydroxyoct-1-enyl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid"
+BMGC_DG10785,BMG_DG153517,"ZEAXANTHIN | PubChem CID:5280899 | DrugBank ID:DB11176 | (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethylcyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol | UNII:CV0IB81ORO | Zeaxanthin | CAS RN:144-68-3 | PubChem SID:198989780"
+BMGC_DG10786,BMG_DG153521,"PubChem CID:5280914 | UNII:F7C6J3D79J | Lipoxin A4 | PubChem SID:459055725 | LIPOXIN A4 | CAS RN:89663-86-5 | (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid"
+BMGC_DG10787,BMG_DG153523,"CAS RN:506-26-3 | GAMOLENIC ACID | (6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid | UNII:78YC2MAX4O | PubChem SID:175266274 | PubChem CID:5280933 | DrugBank ID:DB13854 | gamma-Linolenic acid"
+BMGC_DG10788,BMG_DG153524,"Linolenic Acid | CAS RN:29857-63-4 | CAS RN:463-40-1 | LINOLENIC ACID | UNII:0RBV727H71 | PubChem SID:175267648 | alpha-Linolenic acid | PubChem CID:5280934 | DrugBank ID:DB00132 | (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid"
+BMGC_DG10789,BMG_DG153530,Harmaline | PubChem CID:5280951 | DrugBank ID:DB13875
+BMGC_DG10790,BMG_DG153531,"7-methoxy-1-methyl-9H-pyrido[3,4-b]indole | PubChem SID:198940833 | CAS RN:122992-92-1 | UNII:4FHH5G48T7 | DrugBank ID:DB07919 | CAS RN:442-51-3 | PubChem CID:5280953 | Harmine | HARMINE"
+BMGC_DG10791,BMG_DG153532,"UNII:Q6W1F7DJ2D | PubChem CID:5280954 | CAS RN:84-34-4 | PubChem SID:198962755 | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate | CAS RN:24815-24-5 | Rescinnamine | RESCINNAMINE"
+BMGC_DG10792,BMG_DG153533,"NARINGENIN CHALCONE | CAS RN:5071-40-9 | PubChem SID:472423089 | CAS RN:25515-46-2 | CAS RN:73692-50-9 | (E)-3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)prop-2-en-1-one | PubChem CID:5280960 | UNII:YCF6Z24AS2 | Naringenin chalcone"
+BMGC_DG10793,BMG_DG153534,"UNII:DH2M523P0H | 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one | Genistein | CAS RN:446-72-0 | PubChem CID:5280961 | DrugBank ID:DB01645 | CAS RN:690224-00-1 | GENISTEIN | PubChem SID:175266087"
+BMGC_DG10794,BMG_DG153535,"DrugBank ID:DB00681 | AMPHOTERICIN B | (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid | CAS RN:1397-89-3 | UNII:7XU7A7DROE | PubChem CID:5280965 | Amphotericin B | PubChem SID:175268944"
+BMGC_DG10795,BMG_DG153539,"CAS RN:58001-44-8 | CAS RN:1365254-41-6 | CAS RN:66428-09-9 | (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | DrugBank ID:DB00766 | Clavulanic acid | PubChem CID:5280980 | Clavulanic Acid | PubChem SID:175268707 | UNII:23521W1S24 | CLAVULANIC ACID"
+BMGC_DG10796,BMG_DG153544,Stearic acid | CAS RN:18639-67-3 | PubChem CID:5281 | octadecanoic acid | PubChem SID:175267118 | UNII:4ELV7Z65AP | DrugBank ID:DB03193 | CAS RN:57-11-4 | STEARIC ACID | Stearic Acid
+BMGC_DG10797,BMG_DG153545,"NDC:50090-4509 | NDC:60687-596 | NDC:76282-640 | NDC:50090-6382 | NDC:0115-1687 | NDC:0591-2510 | NDC:70771-1075 | NDC:72162-1898 | NDC:16714-020 | NDC:16714-829 | NDC:47335-632 | NDC:50090-6586 | NDC:69097-321 | NDC:0093-6816 | NDC:81749-004 | CAS RN:51372-29-3 | NDC:68682-309 | NDC:16714-019 | NDC:0310-7370 | NDC:0310-4616 | NDC:50090-6590 | NDC:0186-0370 | UNII:Q3OKS62Q6X | Budesonide | NDC:68788-8429 | NDC:50090-1467 | NDC:0093-6817 | CAS RN:51333-22-3 | NDC:47335-633 | NDC:62135-823 | NDC:50090-4508 | NDC:0378-7502 | NDC:68180-984 | NDC:65649-651 | NDC:46122-389 | NDC:60687-524 | NDC:65162-778 | NDC:59651-585 | NDC:76282-641 | BUDESONIDE | NDC:68788-7314 | NDC:50090-7173 | NDC:0904-7313 | NDC:69842-001 | NDC:50090-6796 | NDC:51407-128 | NDC:0186-1990 | NDC:0781-7517 | NDC:69097-318 | NDC:50090-6327 | NDC:63629-8294 | NDC:0487-9601 | NDC:76282-642 | NDC:0781-7516 | NDC:0186-1988 | PubChem SID:175271881 | NDC:50090-2239 | NDC:0378-4500 | NDC:55154-4849 | NDC:68788-7290 | NDC:0115-1689 | NDC:64764-105 | NDC:62135-822 | NDC:47335-631 | NDC:0186-0372 | NDC:0378-7503 | NDC:51407-591 | NDC:68012-309 | (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | NDC:61269-509 | NDC:0487-9701 | NDC:16714-018 | NDC:63629-9093 | NDC:0186-0917 | NDC:51407-824 | NDC:0536-1112 | NDC:0781-7515 | NDC:61269-518 | NDC:51407-366 | NDC:68682-658 | NDC:45802-627 | NDC:49035-703 | DrugBank ID:DB01222 | NDC:68382-720 | NDC:0363-0048 | NDC:50090-1403 | NDC:0186-1989 | NDC:50090-4510 | NDC:0093-6815 | NDC:0186-0916 | NDC:11822-1700 | NDC:60505-6129 | NDC:51862-580 | NDC:0574-9855 | NDC:0310-7372 | PubChem CID:5281004 | NDC:68788-8503 | NDC:64980-255 | NDC:50090-7126 | NDC:69097-319"
+BMGC_DG10798,BMG_DG153546,"DrugBank ID:DB01150 | Cefprozil | UNII:S1SDI2FJIY | CEFPROZIL ANHYDROUS, (E)- | PubChem CID:5281006 | CAS RN:92665-29-7 | PubChem SID:198952984 | CAS RN:92676-86-3 | (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid"
+BMGC_DG10799,BMG_DG153554,"DrugBank ID:DB06412 | (2Z,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2-(hydroxymethylidene)-10,13,17-trimethyl-1,4,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | CAS RN:434-07-1 | PubChem SID:175265974 | OXYMETHOLONE | PubChem CID:5281034 | UNII:L76T0ZCA8K | Oxymetholone"
+BMGC_DG10800,BMG_DG153555,"2-[(E)-2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethenyl]-N,N,1-trimethylquinolin-1-ium-6-amine | CAS RN:7187-62-4 | Pyrvinium | PubChem CID:5281035 | PYRVINIUM | UNII:6B9991FLU3 | DrugBank ID:DB06816 | PubChem SID:198985926"
+BMGC_DG10801,BMG_DG153556,4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid | Eprosartan | UNII:2KH13Z0S0Y | PubChem SID:175266444 | DrugBank ID:DB00876 | PubChem CID:5281037 | CAS RN:133040-01-4 | EPROSARTAN
+BMGC_DG10802,BMG_DG153557,2-[1-[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl]sulfanylmethyl]cyclopropyl]acetic acid | CAS RN:1124196-02-6 | NDC:33342-110 | CAS RN:158966-92-8 | NDC:33342-111 | PubChem CID:5281040 | Montelukast | NDC:67296-1482 | CAS RN:142522-28-9 | NDC:72189-223 | MONTELUKAST | NDC:68788-7771 | UNII:MHM278SD3E | NDC:50090-4705 | PubChem SID:175268932 | DrugBank ID:DB00471 | NDC:50090-2921 | NDC:68788-7669 | NDC:31722-728 | NDC:31722-727
+BMGC_DG10803,BMG_DG153558,"MIVACURIUM | CAS RN:106791-40-6 | PubChem SID:175271644 | CAS RN:133814-19-4 | DrugBank ID:DB01226 | Mivacurium | PubChem CID:5281042 | bis[3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] (E)-oct-4-enedioate | UNII:77D66S9Q93"
+BMGC_DG10804,BMG_DG153561,HYPERICIN | DrugBank ID:DB13014 | UNII:7V2F1075HD | PubChem CID:5281051 | CAS RN:548-04-9 | PubChem SID:175268744 | Hypericin
+BMGC_DG10805,BMG_DG153565,"CAS RN:1173-13-3 | PubChem CID:5281058 | DrugBank ID:DB15614 | (1S)-3-[(Z)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol | UNII:HDA46400N5 | PREVITAMIN D3 | PubChem SID:310825654 | previtamin D3"
+BMGC_DG10806,BMG_DG153572,"UNII:B10YD955QW | (Z)-but-2-enedioic acid;(3S)-3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine | DrugBank ID:DB09555 | NDC:69367-334 | NDC:0485-0080 | CAS RN:2438-32-6 | NDC:15370-150 | PubChem CID:5281070 | Dexchlorpheniramine Maleate | PubChem SID:175266144 | Dexchlorpheniramine maleate | DEXCHLORPHENIRAMINE MALEATE"
+BMGC_DG10807,BMG_DG153573,Olopatadine | UNII:D27V6190PM | CAS RN:113805-63-3 | PubChem SID:175266654 | DrugBank ID:DB00768 | OLOPATADINE | CAS RN:113806-05-6 | PubChem CID:5281071 | 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid
+BMGC_DG10808,BMG_DG153577,"UNII:7B5032XT6O | CAS RN:59286-19-0 | CAS RN:35700-23-3 | PubChem CID:5281075 | CARBOPROST | Carboprost | (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-3-methyloct-1-enyl]cyclopentyl]hept-5-enoic acid | PubChem SID:175266324"
+BMGC_DG10809,BMG_DG153578,UNII:6EIM3851UZ | (E)-1-chloro-3-ethylpent-1-en-4-yn-3-ol | DrugBank ID:DB00189 | PubChem SID:198964642 | ETHCHLORVYNOL | Ethchlorvynol | PubChem CID:5281077 | CAS RN:113-18-8
+BMGC_DG10810,BMG_DG153579,NDC:71610-033 | NDC:23155-830 | NDC:68254-5003 | DrugBank ID:DB00688 | NDC:0004-0260 | NDC:70121-1584 | UNII:9242ECW6R0 | NDC:0004-0259 | NDC:23155-848 | NDC:72888-192 | 2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate | NDC:83270-000 | NDC:0378-2250 | NDC:59651-638 | NDC:59651-646 | NDC:60429-070 | NDC:67877-225 | NDC:69238-1595 | NDC:70748-186 | NDC:50268-557 | NDC:51079-721 | NDC:82804-033 | NDC:55154-3571 | NDC:0904-7074 | NDC:50090-4275 | NDC:60687-494 | NDC:67457-386 | NDC:42023-172 | NDC:70518-4036 | PubChem SID:175268388 | NDC:50268-558 | NDC:0527-5160 | NDC:23155-836 | NDC:0378-4472 | NDC:70518-3799 | NDC:72888-185 | NDC:70771-1084 | NDC:0480-1175 | NDC:60219-1595 | NDC:67877-230 | NDC:16729-094 | CAS RN:128794-94-5 | NDC:60219-2135 | Mycophenolate mofetil | NDC:31722-878 | PubChem CID:5281078 | NDC:67877-266 | Mycophenolate Mofetil | NDC:72485-415 | NDC:60687-438 | NDC:0093-7334 | NDC:71288-803 | NDC:66689-307 | NDC:70518-2835 | NDC:31722-879 | NDC:0054-0166 | NDC:0781-2067 | NDC:64380-726 | NDC:16729-019 | NDC:68382-669 | NDC:64380-725 | NDC:0004-0261 | CAS RN:140401-05-4 | NDC:0781-5175 | NDC:68071-3767 | MYCOPHENOLATE MOFETIL | NDC:60429-059 | NDC:70518-3068 | NDC:0054-0163 | NDC:24338-018 | CAS RN:115007-34-6 | NDC:51079-379 | NDC:59651-624 | NDC:63629-9582 | NDC:0904-7078 | NDC:68254-5000
+BMGC_DG10811,BMG_DG153581,"NDC:27241-049 | ENTACAPONE | PubChem CID:5281081 | NDC:0527-1830 | NDC:62332-478 | CAS RN:130929-57-6 | CAS RN:686349-59-7 | NDC:33342-260 | NDC:60687-188 | NDC:65862-654 | NDC:52427-800 | PubChem SID:175268297 | CAS RN:116314-67-1 | NDC:71610-247 | NDC:50268-295 | NDC:0781-5578 | NDC:46708-478 | NDC:47335-007 | NDC:0904-6822 | (E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide | UNII:4975G9NM6T | DrugBank ID:DB00494 | Entacapone | NDC:0615-8298"
+BMGC_DG10812,BMG_DG153584,"UNII:94AJJ30D9E | Oxantel | 3-[(E)-2-(1-methyl-5,6-dihydro-4H-pyrimidin-2-yl)ethenyl]phenol | CAS RN:36531-26-7 | OXANTEL | PubChem SID:198952930 | DrugBank ID:DB13670 | PubChem CID:5281087"
+BMGC_DG10813,BMG_DG153588,"Delvopos | PubChem CID:5281099 | (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid | CAS RN:7681-93-8"
+BMGC_DG10814,BMG_DG153590,"NDC:43598-564 | (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol | CAS RN:131918-61-1 | NDC:0143-9596 | UNII:6702D36OG5 | NDC:55150-214 | NDC:72162-1915 | PubChem CID:5281104 | NDC:43598-563 | NDC:55111-665 | NDC:72162-1916 | NDC:70121-1036 | NDC:65162-823 | NDC:65162-822 | NDC:65862-938 | NDC:25000-014 | NDC:55111-663 | NDC:49483-689 | NDC:55150-212 | NDC:0074-4637 | NDC:65862-937 | NDC:43598-565 | PubChem SID:175267449 | NDC:69452-146 | NDC:43598-562 | NDC:0074-9037 | NDC:55150-215 | Paricalcitol | NDC:70121-1035 | NDC:55111-664 | DrugBank ID:DB00910 | NDC:69452-147 | NDC:25000-012 | NDC:49483-688 | NDC:65862-936 | NDC:16729-311 | NDC:0143-9624 | PARICALCITOL | NDC:70121-1033 | NDC:0074-1658 | NDC:49483-687 | NDC:69452-145 | NDC:55150-213 | NDC:70121-1034 | NDC:65162-824 | NDC:0143-9625 | NDC:25000-017 | NDC:0074-9036 | NDC:63629-2452 | NDC:16729-310 | NDC:63629-2453"
+BMGC_DG10815,BMG_DG153591,"NDC:23155-538 | NDC:70121-1392 | NDC:58468-0123 | UNII:3DIZ9LF5Y9 | NDC:62135-452 | CAS RN:54573-75-0 | NDC:70121-1393 | DrugBank ID:DB06410 | DOXERCALCIFEROL | NDC:55150-358 | NDC:58468-0127 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | NDC:43598-850 | NDC:70121-1408 | PubChem SID:175266149 | NDC:68180-718 | NDC:62135-450 | Doxercalciferol | NDC:55150-357 | NDC:23155-539 | NDC:62332-690 | NDC:68083-359 | PubChem CID:5281107 | NDC:68083-300 | NDC:71288-802 | NDC:62135-451 | NDC:23155-540 | NDC:55150-359"
+BMGC_DG10816,BMG_DG153594,Erucic Acid | CAS RN:112-86-7 | PubChem CID:5281116 | CAS RN:1072-39-5 | UNII:075441GMF2 | (Z)-docos-13-enoic acid | ERUCIC ACID | PubChem SID:198964316
+BMGC_DG10817,BMG_DG153596,PubChem CID:5281119 | (Z)-tetradec-9-enoic acid | PubChem SID:333495722 | UNII:RF23WGD123 | Myristoleic Acid | CAS RN:544-64-9 | MYRISTOLEIC ACID
+BMGC_DG10818,BMG_DG153612,"PubChem SID:198944314 | UNII:6RI5N05OWW | CAS RN:6894-38-8 | 2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetic acid | CAS RN:77026-92-7 | JASMONIC ACID | PubChem CID:5281166 | Jasmonic Acid"
+BMGC_DG10819,BMG_DG153616,UNII:U8B4XHN2DX | PubChem CID:5281220 | PubChem SID:472406840 | AUREUSIDIN | CAS RN:38216-54-5
+BMGC_DG10820,BMG_DG153617,"CAS RN:21849-70-7 | PubChem SID:198988544 | (E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dihydroxyphenyl)prop-2-en-1-one | BUTEIN | CAS RN:487-52-5 | PubChem CID:5281222 | UNII:4WVS5M0LGF | Butein"
+BMGC_DG10821,BMG_DG153619,"DrugBank ID:DB06543 | Astaxanthin | CAS RN:472-61-7 | PubChem CID:5281224 | (6S)-6-hydroxy-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4S)-4-hydroxy-2,6,6-trimethyl-3-oxocyclohexen-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-2,4,4-trimethylcyclohex-2-en-1-one | PubChem SID:175268284 | UNII:8XPW32PR7I | ASTAXANTHIN"
+BMGC_DG10822,BMG_DG153626,"CAS RN:504-39-2 | Crocetin | DrugBank ID:DB05974 | (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioic acid | CAS RN:27876-94-4 | TRANSCROCETIN | PubChem CID:5281232 | PubChem SID:198963880 | UNII:20TC155L9C"
+BMGC_DG10823,BMG_DG153627,"UNII:877GWI46C2 | PubChem SID:198963312 | PubChem CID:5281233 | CAS RN:42553-65-1 | Crocin | CAS RN:94238-00-3 | DrugBank ID:DB11874 | CAS RN:11012-59-2 | CROCIN | bis[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate"
+BMGC_DG10824,BMG_DG153635,"PubChem CID:5281243 | LUTEIN | DrugBank ID:DB00137 | CAS RN:180580-60-3 | Lutein | CAS RN:127-40-2 | NDC:82597-010 | UNII:X72A60C9MT | (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4R)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol | PubChem SID:198959252"
+BMGC_DG10825,BMG_DG153646,CAS RN:92439-14-0 | CAS RN:5786-54-9 | PubChem CID:5281254 | Hispidol | (2Z)-6-hydroxy-2-[(4-hydroxyphenyl)methylidene]-1-benzofuran-3-one | PubChem SID:440088363 | UNII:CS1235I0WT | HISPIDOL
+BMGC_DG10826,BMG_DG153647,CAS RN:20784-50-3 | PubChem CID:5281255 | ISOBAVACHALCONE | PubChem SID:405055632 | UNII:ZWO2SC993A
+BMGC_DG10827,BMG_DG153652,"PubChem CID:5281292 | (2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-6,7-dihydroxy-1-benzofuran-3-one | CAS RN:576-02-3 | Maritimetin"
+BMGC_DG10828,BMG_DG153653,OKANIN | PubChem CID:5281294 | PubChem SID:440793472 | UNII:8R55YLB39F | CAS RN:484-76-4
+BMGC_DG10829,BMG_DG153654,"UNII:M6410VY6MI | CAS RN:120-05-8 | SULFURETIN | Sulfuretin | (2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-6-hydroxy-1-benzofuran-3-one | PubChem SID:198964351 | PubChem CID:5281295"
+BMGC_DG10830,BMG_DG153656,"CAS RN:84323-14-8 | UNII:YU653W6RVU | 4-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-(6-hydroxy-1-benzofuran-2-yl)benzene-1,3-diol | Albafuran A | PubChem CID:5281297 | ALBAFURAN A | PubChem SID:485666613"
+BMGC_DG10831,BMG_DG153657,"CAS RN:11141-17-6 | UNII:O4U1SAF85H | CAS RN:176087-49-3 | PubChem SID:198955732 | AZADIRACHTIN | dimethyl (1S,4S,5R,6S,7S,8R,11S,12R,14S,15R)-12-acetyloxy-4,7-dihydroxy-6-[(1S,2S,6S,8S,9R,11S)-2-hydroxy-11-methyl-5,7,10-trioxatetracyclo[6.3.1.02,6.09,11]dodec-3-en-9-yl]-6-methyl-14-[(E)-2-methylbut-2-enoyl]oxy-3,9-dioxatetracyclo[6.6.1.01,5.011,15]pentadecane-4,11-dicarboxylate | PubChem CID:5281303 | Azadirachtin"
+BMGC_DG10832,BMG_DG153666,"Isofucosterol | ISOFUCOSTEROL | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(Z,2R)-5-propan-2-ylhept-5-en-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | CAS RN:17605-67-3 | CAS RN:481-14-1 | PubChem SID:198947323 | UNII:S4UL5AI3R2 | CAS RN:18472-36-1 | PubChem CID:5281326"
+BMGC_DG10833,BMG_DG153674,PubChem CID:5281371 | UNII:903ARG2Y81 | ARCHANGELICINE | PubChem SID:198944051 | CAS RN:2607-56-9
+BMGC_DG10834,BMG_DG153675,"GENISTIN | UNII:1POG3SCN5T | 5-hydroxy-3-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | PubChem SID:198935755 | CAS RN:529-59-9 | Genistin | PubChem CID:5281377"
+BMGC_DG10835,BMG_DG153685,"CAS RN:486-84-0 | HARMAN | PubChem SID:198940159 | Harman | PubChem CID:5281404 | UNII:82D6J0535P | 1-methyl-9H-pyrido[3,4-b]indole"
+BMGC_DG10836,BMG_DG153688,"UNII:46BQ79VJ8D | Rhynchophylline | CAS RN:76-66-4 | methyl (E)-2-[(3R,6'R,7'S,8'aS)-6'-ethyl-2-oxospiro[1H-indole-3,1'-3,5,6,7,8,8a-hexahydro-2H-indolizine]-7'-yl]-3-methoxyprop-2-enoate | PubChem SID:198986665 | CAS RN:39032-61-6 | PubChem CID:5281408 | RHYNCHOPHYLLINE"
+BMGC_DG10837,BMG_DG153690,"PubChem SID:198989946 | CAS RN:91753-33-2 | Esculetin | PubChem CID:5281416 | UNII:SM2XD6V944 | CAS RN:305-01-1 | ESCULETIN | 6,7-dihydroxychromen-2-one"
+BMGC_DG10838,BMG_DG153691,"Esculin | ESCULIN | 7-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one | DrugBank ID:DB13155 | PubChem CID:5281417 | CAS RN:531-75-9 | PubChem SID:175268228 | UNII:1Y1L18LQAF | CAS RN:66778-17-4"
+BMGC_DG10839,BMG_DG153692,"PubChem CID:5281419 | CAS RN:18483-64-2 | 5,7-dihydroxy-6-(3-methylbutanoyl)-8-(3-methylbut-2-enyl)-4-phenylchromen-2-one | Mammeisin"
+BMGC_DG10840,BMG_DG153695,UMBELLIFERONE | UNII:60Z60NTL4G | CAS RN:32922-68-2 | 7-hydroxychromen-2-one | PubChem SID:198989393 | PubChem CID:5281426 | Umbelliferone | CAS RN:142044-47-1 | CAS RN:93-35-6
+BMGC_DG10841,BMG_DG153698,"PubChem SID:198958045 | UNII:4IK578SA7Z | COSTUNOLIDE | CAS RN:553-21-9 | (3aS,6E,10E,11aR)-6,10-dimethyl-3-methylidene-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-2-one | Costunolide | PubChem CID:5281437"
+BMGC_DG10842,BMG_DG153703,"PubChem SID:175266291 | (1R,4E,9S)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene | CARYOPHYLLENE | UNII:BHW853AU9H | CAS RN:87-44-5 | Caryophyllene | PubChem CID:5281515"
+BMGC_DG10843,BMG_DG153719,PubChem SID:198959959 | FULVOPLUMIERIN | UNII:88W5O194BU | CAS RN:20867-01-0 | PubChem CID:5281541
+BMGC_DG10844,BMG_DG153730,"CID 5281571 | UNII:L3Z7U4N28P | PURPUROGALLIN | CAS RN:569-77-7 | PubChem SID:198953740 | PubChem CID:5281571 | 2,3,4,5-tetrahydroxybenzo[7]annulen-6-one"
+BMGC_DG10845,BMG_DG153733,"Amentoflavone | 8-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-hydroxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one | UNII:9I1VC79L77 | AMENTOFLAVONE | PubChem CID:5281600 | PubChem SID:198975593 | CAS RN:1017-53-4 | CAS RN:1617-53-4"
+BMGC_DG10846,BMG_DG153734,"PubChem CID:5281601 | UNII:LVC8MF8MWR | 7,4'-DI-O-METHYLAPIGENIN | CAS RN:5128-44-9 | Apigenin 7,4'-dimethyl ether | PubChem SID:472411238 | 5-hydroxy-7-methoxy-2-(4-methoxyphenyl)chromen-4-one"
+BMGC_DG10847,BMG_DG153736,UNII:CF7D7U7ZK2 | PubChem SID:472422950 | AXILLARIN | PubChem CID:5281603 | CAS RN:5188-73-8
+BMGC_DG10848,BMG_DG153737,PubChem CID:5281604 | PubChem SID:375083736 | CAS RN:529-51-1 | AZALEATIN | UNII:SO52512D8G
+BMGC_DG10849,BMG_DG153738,"CAS RN:491-67-8 | UNII:49QAH60606 | PubChem SID:198986348 | 5,6,7-trihydroxy-2-phenylchromen-4-one | PubChem CID:5281605 | BAICALEIN | Baicalein"
+BMGC_DG10850,BMG_DG153739,"CHRYSIN | DrugBank ID:DB15581 | UNII:3CN01F5ZJ5 | 5,7-dihydroxy-2-phenylchromen-4-one | CAS RN:480-40-0 | PubChem SID:175268164 | Chrysin | PubChem CID:5281607"
+BMGC_DG10851,BMG_DG153741,"UNII:M8C5EH705I | PubChem CID:5281610 | PubChem SID:198974701 | CAS RN:480-15-9 | 3,5,7-trihydroxy-2-(2-hydroxyphenyl)chromen-4-one | Datiscetin | DATISCETIN"
+BMGC_DG10852,BMG_DG153743,"DIOSMETIN | CAS RN:520-34-3 | DrugBank ID:DB11259 | PubChem CID:5281612 | 5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one | Diosmetin | UNII:TWZ37241OT | PubChem SID:175267282"
+BMGC_DG10853,BMG_DG153744,"PubChem CID:5281613 | UNII:7QM776WJ5N | Diosmin | PubChem SID:175266617 | CAS RN:520-27-4 | 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | DIOSMIN | DrugBank ID:DB08995"
+BMGC_DG10854,BMG_DG153745,"PubChem SID:198956333 | DrugBank ID:DB07795 | CAS RN:528-48-3 | Fisetin | PubChem CID:5281614 | FISETIN | 2-(3,4-dihydroxyphenyl)-3,7-dihydroxychromen-4-one | CAS RN:345909-34-4 | UNII:OO2ABO9578"
+BMGC_DG10855,BMG_DG153746,"PubChem CID:5281616 | PubChem SID:198959894 | GALANGIN | UNII:142FWE6ECS | CAS RN:548-83-4 | 3,5,7-trihydroxy-2-phenylchromen-4-one | Galangin"
+BMGC_DG10856,BMG_DG153747,GENKWANIN | PubChem CID:5281617 | PubChem SID:198945725 | 5-hydroxy-2-(4-hydroxyphenyl)-7-methoxychromen-4-one | UNII:5K3I5D6B2B | CAS RN:437-64-9 | Genkwanin
+BMGC_DG10857,BMG_DG153748,CAS RN:652-78-8 | PubChem CID:5281621 | PubChem SID:198941888 | GOSSYPIN | UNII:A3Q367XWX9
+BMGC_DG10858,BMG_DG153749,UNII:X522Q6XJR9 | CAS RN:2798-25-6 | PubChem CID:5281623 | BELLIDIFOLIN | Bellidifolin | PubChem SID:475549781
+BMGC_DG10859,BMG_DG153750,"PubChem SID:443624717 | NORBELLIDIFOLIN | PubChem CID:5281626 | 1,3,5,8-tetrahydroxyxanthen-9-one | UNII:G78B8Y1AI5 | CAS RN:2980-32-7 | 1,3,5,8-Tetrahydroxyxanthone"
+BMGC_DG10860,BMG_DG153751,UNII:GFF5VYC4NB | PubChem SID:472410852 | HINOKIFLAVONE | CAS RN:19202-36-9 | PubChem CID:5281627
+BMGC_DG10861,BMG_DG153752,CAS RN:1447-88-7 | PubChem SID:329904346 | UNII:N7F61604C2 | PubChem CID:5281628 | HISPIDULIN
+BMGC_DG10862,BMG_DG153753,"PubChem CID:5281631 | Euxanthone | CAS RN:529-61-3 | 1,7-dihydroxyxanthen-9-one | PubChem SID:482553954 | EUXANTHONE | UNII:QN875WE9R7"
+BMGC_DG10863,BMG_DG153760,"2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | Hyperoside | HYPEROSIDE | PubChem CID:5281643 | PubChem SID:198972673 | UNII:8O1CR18L82 | CAS RN:482-36-0"
+BMGC_DG10864,BMG_DG153761,"MANGIFERIN | 1,3,6,7-tetrahydroxy-2-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one | CAS RN:4773-96-0 | UNII:1M84LD0UMD | PubChem CID:5281647 | PubChem SID:175266014 | Mangiferin"
+BMGC_DG10865,BMG_DG153763,"1,3,6-trihydroxy-7-methoxy-2,8-bis(3-methylbut-2-enyl)xanthen-9-one | PubChem SID:198961005 | CAS RN:6147-11-1 | MANGOSTIN | UNII:U6RIV93RU1 | Mangostin | PubChem CID:5281650"
+BMGC_DG10866,BMG_DG153764,"PubChem SID:198945749 | Isorhamnetin | PubChem CID:5281654 | CAS RN:480-19-3 | 3,5,7-trihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one | ISORHAMNETIN | UNII:07X3IB4R4Z"
+BMGC_DG10867,BMG_DG153765,"PubChem CID:5281656 | 1,3,6,7-tetrahydroxyxanthen-9-one | Norathyriol | CAS RN:3542-72-1"
+BMGC_DG10868,BMG_DG153771,"CAS RN:6732-85-0 | 1,3,5-trihydroxyxanthen-9-one | PubChem CID:5281663 | 1,3,5-Trihydroxyxanthone"
+BMGC_DG10869,BMG_DG153773,"CAS RN:491-54-3 | PubChem SID:198973020 | KAEMPFERIDE | 3,5,7-trihydroxy-2-(4-methoxyphenyl)chromen-4-one | PubChem CID:5281666 | UNII:508XL61MPD | Kaempferide"
+BMGC_DG10870,BMG_DG153776,"UNII:8NFQ3F76WR | PubChem CID:5281670 | Morin | PubChem SID:198969123 | 2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one | CAS RN:480-16-0 | MORIN"
+BMGC_DG10871,BMG_DG153777,"Morusin | UNII:T4VGD5NP9B | 2-(2,4-dihydroxyphenyl)-5-hydroxy-8,8-dimethyl-3-(3-methylbut-2-enyl)pyrano[2,3-h]chromen-4-one | MORUSIN | PubChem SID:434369588 | CAS RN:62596-29-6 | PubChem CID:5281671"
+BMGC_DG10872,BMG_DG153778,"CAS RN:529-44-2 | PubChem CID:5281672 | MYRICETIN | PubChem SID:175268427 | DrugBank ID:DB02375 | UNII:76XC01FTOJ | 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one | Myricetin"
+BMGC_DG10873,BMG_DG153779,CAS RN:17912-87-7 | UNII:5Z0ZO61WPJ | PubChem SID:198991140 | PubChem CID:5281673 | MYRICITRIN
+BMGC_DG10874,BMG_DG153781,"Orientin | PubChem SID:241181296 | CAS RN:28608-75-5 | PubChem CID:5281675 | ORIENTIN | UNII:IAX93XCW6C | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one"
+BMGC_DG10875,BMG_DG153782,PubChem CID:5281677 | PubChem SID:363908850 | CAS RN:33708-72-4 | UNII:8AG6B2DMP5 | PACHYPODOL
+BMGC_DG10876,BMG_DG153783,"CAS RN:519-96-0 | PubChem SID:198965675 | PATULETIN | Patuletin | PubChem CID:5281678 | UNII:9BNM33N01N | 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-methoxychromen-4-one"
+BMGC_DG10877,BMG_DG153784,"UNII:SV68G507VO | 2-(3,4-dihydroxyphenyl)-3,5,6,7-tetrahydroxychromen-4-one | PubChem CID:5281680 | QUERCETAGETIN | CAS RN:90-18-6 | PubChem SID:198959014 | Quercetagetin"
+BMGC_DG10878,BMG_DG153785,"PubChem CID:5281691 | PubChem SID:198945665 | Rhamnetin | 2-(3,4-dihydroxyphenyl)-3,5-dihydroxy-7-methoxychromen-4-one | CAS RN:90-19-7 | UNII:71803L5F4S | RHAMNETIN"
+BMGC_DG10879,BMG_DG153786,PubChem CID:5281692 | PubChem SID:198975290 | ROBINETIN | CAS RN:490-31-3 | UNII:KJ6DBC4U7E
+BMGC_DG10880,BMG_DG153788,CAS RN:49620-13-5 | UNII:PJH7GVX7AL | ROBUSTAFLAVONE | PubChem CID:5281694
+BMGC_DG10881,BMG_DG153789,PubChem SID:461432721 | UNII:5785Y952EH | SANTIN | PubChem CID:5281695 | CAS RN:27782-63-4
+BMGC_DG10882,BMG_DG153790,PubChem CID:5281696 | PubChem SID:438788875 | UNII:WL44VY201L | SCIADOPITYSIN | CAS RN:521-34-6
+BMGC_DG10883,BMG_DG153791,"PubChem SID:198967566 | CAS RN:529-53-3 | Scutellarein | SCUTELLAREIN | UNII:P460GTI853 | PubChem CID:5281697 | 5,6,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one"
+BMGC_DG10884,BMG_DG153792,"3,5,7-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one | UNII:73WRA8Z8M8 | PubChem CID:5281699 | CAS RN:603-61-2 | PubChem SID:198941646 | Tamarixetin | TAMARIXETIN"
+BMGC_DG10885,BMG_DG153793,"5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one | Tricetin | DrugBank ID:DB08230 | PubChem SID:198968686 | CAS RN:520-31-0 | UNII:5627PY99ZO | PubChem CID:5281701 | TRICETIN"
+BMGC_DG10886,BMG_DG153795,"Wogonin | PubChem CID:5281703 | CAS RN:632-85-9 | PubChem SID:198968126 | 5,7-dihydroxy-8-methoxy-2-phenylchromen-4-one | UNII:POK93PO28W | WOGONIN"
+BMGC_DG10887,BMG_DG153796,7-hydroxy-6-methoxy-3-(4-methoxyphenyl)chromen-4-one | Afrormosin | PubChem CID:5281704 | AFROMOSIN | UNII:89P1SB9FYW | PubChem SID:438788031 | CAS RN:550-79-8
+BMGC_DG10888,BMG_DG153798,"3,9-dihydroxy-[1]benzofuro[3,2-c]chromen-6-one | COUMESTROL | CAS RN:479-13-0 | PubChem SID:198961879 | UNII:V7NW98OB34 | PubChem CID:5281707 | Coumestrol"
+BMGC_DG10889,BMG_DG153799,DrugBank ID:DB13182 | PubChem CID:5281708 | CAS RN:486-66-8 | 7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one | UNII:6287WC5J2L | Daidzein | PubChem SID:198977205 | DAIDZEIN
+BMGC_DG10890,BMG_DG153803,PubChem CID:5281717 | UNII:6V071CP5CR | CAS RN:29700-22-9 | PubChem SID:198940122 | HYDROXYRESVERATROL
+BMGC_DG10891,BMG_DG153804,"PubChem SID:175266889 | UNII:XM261C37CQ | DrugBank ID:DB11263 | (2S,3R,4S,5S,6R)-2-[3-hydroxy-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | POLYDATIN | CAS RN:27208-80-6 | PubChem CID:5281718 | CAS RN:65914-17-2 | Polydatin"
+BMGC_DG10892,BMG_DG153805,PubChem CID:5281719 | Pinosylvin methyl ether | CAS RN:5150-38-9 | CAS RN:35302-70-6 | 3-methoxy-5-[(E)-2-phenylethenyl]phenol
+BMGC_DG10893,BMG_DG153810,"4-[(E)-2-(3,5-dimethoxyphenyl)ethenyl]phenol | CAS RN:537-42-8 | UNII:26R60S6A5I | PubChem CID:5281727 | PubChem SID:255509407 | Pterostilbene | CAS RN:1318852-41-3 | PTEROSTILBENE | CAS RN:18259-15-9"
+BMGC_DG10894,BMG_DG153826,PubChem SID:198943362 | CAS RN:55954-61-5 | UNII:MQ0U4663ZO | PubChem CID:5281751 | PSEUDOHYPERICIN
+BMGC_DG10895,BMG_DG153840,"Echinacoside | PubChem SID:198977373 | UNII:I04O1DT48T | CAS RN:82854-37-3 | ECHINACOSIDE | CAS RN:737806-07-4 | PubChem CID:5281771 | DrugBank ID:DB15488 | [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate"
+BMGC_DG10896,BMG_DG153842,FORSYTHIASIDE | CAS RN:79916-77-1 | PubChem SID:198973540 | PubChem CID:5281773 | UNII:OUH5BQ893P
+BMGC_DG10897,BMG_DG153845,"9-hydroxy-7-(4-hydroxyphenyl)-[1,3]dioxolo[4,5-g]chromen-8-one | CAS RN:41653-81-0 | PubChem SID:474492438 | UNII:FB3FTT7LYK | IRILONE | PubChem CID:5281779 | Irilone"
+BMGC_DG10898,BMG_DG153846,"4,5-Dicaffeoylquinic acid | 4,5-DICAFFEOYLQUINIC ACID | PubChem CID:5281780 | CAS RN:14534-61-3 | UNII:45777W94HK | PubChem SID:255509048 | (1S,3R,4R,5R)-3,4-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1,5-dihydroxycyclohexane-1-carboxylic acid | CAS RN:102851-07-0 | CAS RN:89886-31-7"
+BMGC_DG10899,BMG_DG153848,PubChem SID:198978976 | ethyl (E)-3-(4-methoxyphenyl)prop-2-enoate | NDC:84487-002 | CAS RN:51507-22-3 | PubChem CID:5281783 | ETHYL METHOXYCINNAMATE | CAS RN:24393-56-4 | UNII:SD418S06XD | NDC:74458-008 | Ethyl p-methoxycinnamate | CAS RN:1929-30-2
+BMGC_DG10900,BMG_DG153850,PubChem SID:198985732 | CAS RN:104594-70-9 | CAFFEIC ACID PHENETHYL ESTER | UNII:G960R9S5SK | PubChem CID:5281787
+BMGC_DG10901,BMG_DG153853,"UNII:MQE6XG29YI | CAS RN:537-15-5 | (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid | ROSMARINIC ACID | PubChem SID:198989630 | Rosmarinic acid | CAS RN:20283-92-5 | PubChem CID:5281792"
+BMGC_DG10902,BMG_DG153854,"UNII:51622542XO | SALVIANOLIC ACID A | (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3,4-dihydroxyphenyl]prop-2-enoyl]oxypropanoic acid | Salvianolic acid A | DrugBank ID:DB15246 | PubChem SID:241177442 | CAS RN:96574-01-5 | PubChem CID:5281793"
+BMGC_DG10903,BMG_DG153855,SHOGAOL | CAS RN:555-66-8 | (E)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one | CAS RN:23513-13-5 | Shogaol | PubChem SID:198988130 | UNII:83DNB5FIRF | PubChem CID:5281794
+BMGC_DG10904,BMG_DG153858,"DrugBank ID:DB12996 | CAS RN:61276-17-3 | Acteoside | Verbascoside | VERBASCOSIDE | PubChem CID:5281800 | UNII:3TGX09BD5B | PubChem SID:198953013 | [(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate"
+BMGC_DG10905,BMG_DG153859,"UNII:LU8UZM1T51 | Orobol | 3-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one | CAS RN:480-23-9 | PubChem SID:198951317 | PubChem CID:5281801 | OROBOL"
+BMGC_DG10906,BMG_DG153861,PubChem CID:5281804 | CAS RN:552-59-0 | PRUNETIN | PubChem SID:198978334 | Prunetin | UNII:1TG4H5H11J | 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxychromen-4-one
+BMGC_DG10907,BMG_DG153862,"UNII:78RRL4HLL9 | Pseudobaptigenin | PSEUDOBAPTIGENIN | PubChem SID:198959093 | 3-(1,3-benzodioxol-5-yl)-7-hydroxychromen-4-one | PubChem CID:5281805 | CAS RN:90-29-9"
+BMGC_DG10908,BMG_DG153863,"PubChem SID:241178654 | UNII:G16ZUQ069L | 3,9-dihydroxy-2-(3-methylbut-2-enyl)-[1]benzofuro[3,2-c]chromen-6-one | PSORALIDIN | Psoralidin | CAS RN:18642-23-4 | PubChem CID:5281806"
+BMGC_DG10909,BMG_DG153864,"DrugBank ID:DB12290 | PubChem CID:5281807 | Puerarin | PUERARIN | PubChem SID:198946754 | 7-hydroxy-3-(4-hydroxyphenyl)-8-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one | UNII:Z9W8997416 | CAS RN:3681-99-0"
+BMGC_DG10910,BMG_DG153867,"TECTORIGENIN | 5,7-dihydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4-one | UNII:855130H9CO | PubChem SID:198968451 | PubChem CID:5281811 | Tectorigenin | CAS RN:548-77-6"
+BMGC_DG10911,BMG_DG153868,CAS RN:897-46-1 | PubChem CID:5281812 | UNII:MMX87X8ZF3 | TEXASIN | PubChem SID:441659213
+BMGC_DG10912,BMG_DG153869,PubChem CID:5281813 | CAS RN:524-12-9 | UNII:0K6L725GNS | PubChem SID:198965475 | WEDELOLACTONE
+BMGC_DG10913,BMG_DG153876,"Arborinine | 1-hydroxy-2,3-dimethoxy-10-methylacridin-9-one | PubChem CID:5281832 | UNII:16XG8UE639 | PubChem SID:374388816 | ARBORININE | CAS RN:5489-57-6"
+BMGC_DG10914,BMG_DG153879,"PubChem CID:5281847 | UNII:E29LP3ZMUH | PubChem SID:198960480 | ROTTLERIN | (E)-1-[6-[(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-5,7-dihydroxy-2,2-dimethylchromen-8-yl]-3-phenylprop-2-en-1-one | Rottlerin | CAS RN:82-08-6"
+BMGC_DG10915,BMG_DG153884,"PubChem CID:5281855 | UNII:19YRN3ZS9P | CAS RN:476-66-4 | Ellagic Acid | PubChem SID:198975549 | CAS RN:122328-15-8 | ELLAGIC ACID | Ellagic acid | 6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione | DrugBank ID:DB08846"
+BMGC_DG10916,BMG_DG153888,"(E)-3-(3,4-dihydroxyphenyl)prop-2-enal | CAS RN:141632-15-7 | PubChem SID:472423522 | UNII:2A5UNB3LNK | CAFFEIC ALDEHYDE | CAS RN:68149-78-0 | PubChem CID:5281871 | Caffeic aldehyde"
+BMGC_DG10917,BMG_DG153893,"(2S,3S,4S,5R,6S)-6-[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | CAS RN:401-10-5 | PubChem CID:5281877 | CAS RN:1004517-36-5 | Retinoyl beta-glucuronide | RETINOYL .BETA.-GLUCURONIDE | UNII:XB6RQ16Y55 | PubChem SID:316917224"
+BMGC_DG10918,BMG_DG153894,"2-[4-[(3E)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol | Flupenthixol | CAS RN:2709-56-0 | FLUPENTIXOL, (E)- | UNII:895OJP78MJ | PubChem CID:5281878 | PubChem SID:317229426 | CAS RN:53772-85-3"
+BMGC_DG10919,BMG_DG153895,"FLUPENTIXOL, (Z)- | CAS RN:2709-56-0 | PubChem CID:5281881 | PubChem SID:198987516 | UNII:FA0UYH6QUO | 2-[4-[(3Z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol | Flupentixol | DrugBank ID:DB00875 | CAS RN:53772-82-0"
+BMGC_DG10920,BMG_DG153896,"(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-1,4,7,10,12,15,19,25,28-nonamethyl-33-[(E,2R)-2-methylhex-4-enoyl]-6,9,18,24-tetrakis(2-methylpropyl)-3,21,30-tri(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | PubChem SID:316910689 | UNII:Q7ZP55KF3X | CAS RN:121584-18-7 | DrugBank ID:DB11869 | Valspodar | VALSPODAR | PubChem CID:5281884"
+BMGC_DG10921,BMG_DG153898,"(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]oxy]oxane-2-carboxylic acid | CAS RN:1806-98-0 | PubChem CID:5281887 | Estradiol-17beta-glucuronide"
+BMGC_DG10922,BMG_DG153899,3-[[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-[3-(dimethylamino)-3-oxopropyl]sulfanylmethyl]sulfanylpropanoic acid | 3-(((3-((1E)-2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)((3-(dimethylamino)-3-oxopropyl)thio)methyl)thio)propanoic acid | CAS RN:778545-32-7 | PubChem CID:5281888 | UNII:76LB1G2X6V | CAS RN:115104-28-4 | PubChem SID:198962627 | MK-571
+BMGC_DG10923,BMG_DG153900,CAS RN:6665-86-7 | PubChem SID:198943153 | 7-Hydroxyflavone | UNII:ZE72458E4L | 7-hydroxy-2-phenylchromen-4-one | PubChem CID:5281894 | 7-HYDROXYFLAVONE
+BMGC_DG10924,BMG_DG153902,Soraphen A | PubChem CID:5281897 | DrugBank ID:DB02859
+BMGC_DG10925,BMG_DG153909,"UNII:EJ27X76M46 | CAS RN:303-98-0 | 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione | PubChem SID:175265626 | Ubidecarenone | NDC:44911-0339 | UBIDECARENONE | PubChem CID:5281915 | DrugBank ID:DB09270"
+BMGC_DG10926,BMG_DG153912,"CAS RN:1211-29-6 | Methyl jasmonate | methyl 2-[(1R,2R)-3-oxo-2-[(Z)-pent-2-enyl]cyclopentyl]acetate | CAS RN:20073-13-6 | UNII:900N171A0F | PubChem CID:5281929 | CAS RN:39924-52-2 | METHYL JASMONATE | PubChem SID:198961221"
+BMGC_DG10927,BMG_DG153914,"UNII:Q1O6DSW23R | 4,4'-DIISOTHIOCYANATO-2,2'-STILBENEDISULFONIC ACID, (E)- | CAS RN:152216-76-7 | PubChem CID:5281951 | PubChem SID:198936653"
+BMGC_DG10928,BMG_DG153917,TECTOCHRYSIN | PubChem SID:375578900 | CAS RN:520-28-5 | UNII:9UBO28W2AK | PubChem CID:5281954
+BMGC_DG10929,BMG_DG153921,"(5Z,8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-5,8,11,14-tetraenamide | ANANDAMIDE | Anandamide | CAS RN:94421-68-8 | PubChem SID:198960210 | CAS RN:924894-98-4 | PubChem CID:5281969 | UNII:UR5G69TJKH"
+BMGC_DG10930,BMG_DG153945,"PubChem CID:5282054 | DrugBank ID:DB01034 | (2R,3S)-3-[(4E,7E)-nona-4,7-dienoyl]oxirane-2-carboxamide | PubChem SID:198988742 | Cerulenin | CERULENIN | UNII:MF286Y830Q | CAS RN:17397-89-6"
+BMGC_DG10931,BMG_DG153951,"(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-17-ethyl-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | CAS RN:104987-12-4 | PubChem SID:316918135 | ASCOMYCIN | CAS RN:135635-46-0 | CAS RN:11011-38-4 | UNII:AUF4U5NSJK | Ascomycin | PubChem CID:5282071"
+BMGC_DG10932,BMG_DG153952,"4',7-DIHYDROXYFLAVONE | PubChem SID:316913262 | CAS RN:2196-14-7 | UNII:53ZZF57X0U | PubChem CID:5282073"
+BMGC_DG10933,BMG_DG153953,"CAS RN:1156-78-1 | 2'-HYDROXYGENISTEIN | 3-(2,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one | PubChem SID:198978752 | 2'-Hydroxygenistein | PubChem CID:5282074 | UNII:1R3U5726T2"
+BMGC_DG10934,BMG_DG153957,"PubChem SID:198958880 | ASTRAGALIN | Astragalin | 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | UNII:APM8UQ3Z9O | PubChem CID:5282102 | CAS RN:480-10-4"
+BMGC_DG10935,BMG_DG153958,CAS RN:199875-69-9 | UNII:Q8NX2KL2YP | PubChem SID:474492722 | N-ARACHIDONOYL DOPAMINE | PubChem CID:5282105
+BMGC_DG10936,BMG_DG153959,"UNII:T87P7X9XSZ | PubChem SID:198955946 | CAS RN:105955-11-1 | N-Oleoyldopamine | N-OLEOYLDOPAMINE | PubChem CID:5282106 | (Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]octadec-9-enamide"
+BMGC_DG10937,BMG_DG153964,"DrugBank ID:DB12770 | LAFUTIDINE, (±)- | CAS RN:206449-93-6 | PubChem CID:5282136 | CAS RN:118288-08-7 | UNII:49S4O7ADLC | LAFUTIDINE, (+/-)- | PubChem SID:198956695 | Lafutidine | 2-(furan-2-ylmethylsulfinyl)-N-[(Z)-4-[4-(piperidin-1-ylmethyl)pyridin-2-yl]oxybut-2-enyl]acetamide"
+BMGC_DG10938,BMG_DG153965,"PubChem CID:5282138 | CILNIDIPINE | PubChem SID:440089968 | 3-O-(2-methoxyethyl) 5-O-[(E)-3-phenylprop-2-enyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | CAS RN:132203-70-4 | CAS RN:132338-87-5 | CILNIDIPINE, (-)- | UNII:97T5AZ1JIP | PubChem SID:440793298 | CILNIDIPINE, (+)- | UNII:S85436ZG85 | PubChem SID:198956979 | CAS RN:132295-21-7 | UNII:4LNU2SU262 | DrugBank ID:DB09232 | CAS RN:118934-76-2 | Cilnidipine"
+BMGC_DG10939,BMG_DG153974,"7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5-hydroxychromen-4-one | Scolymoside | VERONICASTROSIDE | UNII:ALJ2FB4ZDM | PubChem SID:472406447 | PubChem CID:5282152 | CAS RN:25694-72-8"
+BMGC_DG10940,BMG_DG153982,"Josamycin | CAS RN:16846-24-5 | PubChem SID:198948298 | CAS RN:56689-45-3 | DrugBank ID:DB01321 | [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4-acetyloxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate | PubChem CID:5282165 | JOSAMYCIN | UNII:HV13HFS217"
+BMGC_DG10941,BMG_DG153986,"MIDECAMYCIN | UNII:N34Z0Y5UH7 | PubChem SID:198948940 | DrugBank ID:DB13456 | CAS RN:35457-80-8 | Midecamycin | [(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-4-(dimethylamino)-3-hydroxy-5-[(2S,4R,5S,6S)-4-hydroxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-4-yl] propanoate | PubChem CID:5282169"
+BMGC_DG10942,BMG_DG153989,"propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]hept-5-enoate | PubChem CID:5282175 | UNOPROSTONE ISOPROPYL | CAS RN:120373-24-2 | PubChem SID:175266642 | UNII:5M161S5O5P | Unoprostone Isopropyl"
+BMGC_DG10943,BMG_DG153990,"UNII:TSA7W27MF8 | PECILOCIN | Pecilocin | 1-[(2E,4E,6E,8R)-8-hydroxy-6-methyldodeca-2,4,6-trienoyl]pyrrolidin-2-one | CAS RN:19504-77-9 | PubChem SID:198944063 | DrugBank ID:DB13459 | PubChem CID:5282176"
+BMGC_DG10944,BMG_DG153992,"ALFACALCIDOL | PubChem SID:198985193 | UNII:URQ2517572 | PubChem CID:5282181 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | DrugBank ID:DB01436 | Alfacalcidol | CAS RN:41294-56-8"
+BMGC_DG10945,BMG_DG153998,"FALECALCITRIOL | UNII:G70A8514T8 | Falecalcitriol | CAS RN:83805-11-2 | PubChem CID:5282190 | PubChem SID:198979409 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-7,7,7-trifluoro-6-hydroxy-6-(trifluoromethyl)heptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol"
+BMGC_DG10946,BMG_DG153999,"PubChem CID:5282192 | CAS RN:77181-69-2 | SORIVUDINE | Sorivudine | PubChem SID:198957337 | UNII:C7VOZ162LV | DrugBank ID:DB11998 | 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione"
+BMGC_DG10947,BMG_DG154004,"PENTAMYCIN | UNII:1JB340D58S | Fungichromin | PubChem CID:5282200 | DrugBank ID:DB13571 | PubChem SID:198949104 | (3R,4S,6S,8S,10R,12R,14R,15R,16R,17E,19E,21E,23E,25E,27S,28R)-4,6,8,10,12,14,15,16,27-nonahydroxy-3-[(1R)-1-hydroxyhexyl]-17,28-dimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one | CAS RN:6834-98-6"
+BMGC_DG10948,BMG_DG154005,DrugBank ID:DB12150 | PubChem CID:5282203 | Pelubiprofen | CAS RN:69956-77-0 | UNII:1619C79FVJ | PubChem SID:198954632 | PELUBIPROFEN | 2-[4-[(E)-(2-oxocyclohexylidene)methyl]phenyl]propanoic acid
+BMGC_DG10949,BMG_DG154008,"PubChem CID:5282210 | Tripamide | N-[(1R,2R,6S,7S)-4-azatricyclo[5.2.1.02,6]decan-4-yl]-4-chloro-3-sulfamoylbenzamide | TRIPAMIDE | CAS RN:73803-48-2 | PubChem SID:198944184 | UNII:G36A0E9CVT"
+BMGC_DG10950,BMG_DG154009,"UNII:ZPT03UEM0E | PubChem CID:5282211 | Rokitamycin | DrugBank ID:DB13409 | CAS RN:74014-51-0 | ROKITAMYCIN | [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-4,10-dihydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-2,4-dimethyl-4-propanoyloxyoxan-3-yl] butanoate | PubChem SID:198948647"
+BMGC_DG10951,BMG_DG154013,2-[5-(3-methylbut-2-enoxy)-2-[(E)-3-[4-(3-methylbut-2-enoxy)phenyl]prop-2-enoyl]phenoxy]acetic acid | PubChem SID:198956135 | DrugBank ID:DB05197 | CAS RN:153175-87-2 | CAS RN:64506-49-6 | Sofalcone | PubChem CID:5282219 | SOFALCONE | UNII:2B668TJX8E
+BMGC_DG10952,BMG_DG154014,N-METHYLCLONAZEPAM | PubChem SID:441097486 | CAS RN:5527-71-9 | UNII:89WG8CN9AJ | PubChem CID:528222
+BMGC_DG10953,BMG_DG154018,"DrugBank ID:DB00287 | NDC:62332-510 | NDC:0378-9651 | NDC:63629-8840 | propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate | NDC:0078-0946 | NDC:0781-6185 | PubChem SID:175268016 | NDC:68462-943 | NDC:63629-8839 | NDC:68083-601 | NDC:25357-100 | CAS RN:157283-68-6 | NDC:42571-130 | NDC:72162-2432 | NDC:70069-587 | UNII:WJ68R08KX9 | Travoprost | NDC:60505-0593 | NDC:70069-586 | TRAVOPROST | PubChem CID:5282226 | NDC:68083-602 | NDC:51407-731 | NDC:66758-095"
+BMGC_DG10954,BMG_DG154021,"Tranilast | CAS RN:70806-55-2 | UNII:HVF50SMY6E | 2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid | TRANILAST | PubChem SID:175268702 | PubChem CID:5282230 | CAS RN:53902-17-3 | DrugBank ID:DB07615 | CAS RN:53902-12-8"
+BMGC_DG10955,BMG_DG154023,"GEMEPROST | PubChem CID:5282237 | methyl (E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4,4-dimethyloct-1-enyl]-5-oxocyclopentyl]hept-2-enoate | CAS RN:64318-79-2 | PubChem SID:198987634 | UNII:45KZB1FOLS | DrugBank ID:DB08964 | Gemeprost"
+BMGC_DG10956,BMG_DG154025,"PubChem CID:5282241 | UNII:62F4443RWP | (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;dihydrate | CAS RN:118081-34-8 | CEFTIBUTEN DIHYDRATE | PubChem SID:175265767 | Ceftibuten Dihydrate"
+BMGC_DG10957,BMG_DG154026,"Ceftibuten | PubChem SID:175265425 | (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | UNII:IW71N46B4Y | CAS RN:97519-39-6 | PubChem CID:5282242 | CEFTIBUTEN | DrugBank ID:DB01415"
+BMGC_DG10958,BMG_DG154031,"PubChem CID:5282253 | PubChem SID:198954949 | DrugBank ID:DB02852 | Domoic Acid | (2S,3S,4S)-4-[(2Z,4E,6R)-6-carboxyhepta-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid | CAS RN:14277-97-5 | UNII:M02525818H | DOMOIC ACID"
+BMGC_DG10959,BMG_DG154036,"CAS RN:150314-34-4 | PubChem CID:5282272 | (8Z,11Z,14Z)-N-(2-hydroxyethyl)icosa-8,11,14-trienamide"
+BMGC_DG10960,BMG_DG154037,"Adrenoyl-ethanolamine | PubChem CID:5282273 | CAS RN:150314-35-5 | (7Z,10Z,13Z,16Z)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide"
+BMGC_DG10961,BMG_DG154038,"CAS RN:170228-29-2 | PubChem CID:5282279 | (E)-3-(2,4-dichlorophenyl)-N-[(3R)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]prop-2-enamide"
+BMGC_DG10962,BMG_DG154039,"PubChem CID:5282280 | 1,3-dihydroxypropan-2-yl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate | 2-ARACHIDONOYLGLYCEROL | PubChem SID:198979015 | 2-Arachidonoylglycerol | CAS RN:53847-30-6 | CAS RN:924894-97-3 | UNII:8D239QDW64"
+BMGC_DG10963,BMG_DG154045,"CAS RN:119567-63-4 | PubChem CID:5282309 | (E,2S,3R)-2-(dimethylamino)octadec-4-ene-1,3-diol | N,N-dimethylsphingosine"
+BMGC_DG10964,BMG_DG154054,DrugBank ID:DB09309 | PubChem SID:198954664 | UNII:YX09Z4QW5Y | CAS RN:16846-34-7 | PubChem CID:5282322 | LEUCOMYCIN A1 | Kitasamycin
+BMGC_DG10965,BMG_DG154060,Phthalocyanine | PubChem CID:5282330 | DrugBank ID:DB12983
+BMGC_DG10966,BMG_DG154063,UNII:09RR39UU4V | PubChem SID:198988073 | CAS RN:333389-24-5 | PubChem CID:5282335 | BMS-419437
+BMGC_DG10967,BMG_DG154064,"PubChem CID:5282338 | N-[2-[di(propan-2-yl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxamide | PubChem SID:198979231 | UNII:D42OWK5383 | ACOTIAMIDE | CAS RN:185106-16-5 | DrugBank ID:DB12482 | Acotiamide"
+BMGC_DG10968,BMG_DG154065,"PubChem CID:5282340 | NDC:70370-5050 | NDC:70370-5250 | UNII:MFT24BX55I | CRINECERFONT | PubChem SID:317228876 | 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-prop-2-ynyl-1,3-thiazol-2-amine | NDC:70370-5100 | CAS RN:752253-39-7 | NDC:70370-5025 | Crinecerfont"
+BMGC_DG10969,BMG_DG154072,"UNII:C3ZO03450E | 4-Hydroxyestradiol | PubChem CID:5282360 | CAS RN:5976-61-4 | 4-HYDROXYESTRADIOL | PubChem SID:198945793 | (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,4,17-triol"
+BMGC_DG10970,BMG_DG154073,4-Hydroxychalcone | PubChem SID:198971729 | (E)-3-(4-hydroxyphenyl)-1-phenylprop-2-en-1-one | UNII:JO97Q47VBU | 4-HYDROXYCHALCONE | PubChem CID:5282361 | CAS RN:20426-12-4 | CAS RN:38239-55-3
+BMGC_DG10971,BMG_DG154074,4'-HYDROXYCHALCONE | PubChem CID:5282362 | PubChem SID:313390041 | UNII:2K338K8UOA | (E)-1-(4-hydroxyphenyl)-3-phenylprop-2-en-1-one | CAS RN:38239-52-0 | CAS RN:2657-25-2 | 4'-Hydroxychalcone
+BMGC_DG10972,BMG_DG154075,"CAS RN:15058-36-3 | 4,4'-STILBENEDIOL, (E)- | UNII:921UXX4IZL | PubChem SID:198976084 | PubChem CID:5282363"
+BMGC_DG10973,BMG_DG154079,"2-methyl-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione | PubChem CID:5282367 | DrugBank ID:DB12148 | PubChem SID:198937732 | UNII:27Y876D139 | MENATETRENONE | CAS RN:11032-49-8 | CAS RN:6041-00-5 | CAS RN:863-61-6 | Menatetrenone"
+BMGC_DG10974,BMG_DG154082,"PubChem CID:5282375 | ETRETINATE | CAS RN:54350-48-0 | PubChem SID:198959792 | ethyl (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate | UNII:65M2UDR9AG | Etretinate"
+BMGC_DG10975,BMG_DG154083,"NDC:0591-2436 | NDC:0555-1057 | NDC:0591-2434 | NDC:59651-633 | NDC:68308-570 | NDC:57664-024 | NDC:10631-117 | NDC:10631-118 | NDC:0245-0571 | UNII:EH28UP18IF | NDC:70771-1560 | NDC:55111-137 | NDC:72143-252 | NDC:0378-6611 | NDC:10631-134 | NDC:0555-1054 | NDC:70710-1025 | NDC:68308-571 | NDC:57664-023 | CAS RN:4759-48-2 | NDC:0555-1056 | NDC:57664-021 | ISOTRETINOIN | NDC:57664-020 | NDC:70771-1557 | (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid | NDC:0378-6614 | NDC:0832-8303 | NDC:68308-784 | NDC:55111-113 | NDC:10631-116 | PubChem SID:175268747 | NDC:0245-0575 | NDC:59651-632 | NDC:57664-022 | NDC:69238-1017 | NDC:0832-8302 | NDC:0591-2435 | NDC:59651-631 | NDC:0832-8304 | NDC:68308-782 | NDC:69238-1175 | NDC:10631-005 | NDC:0591-2451 | NDC:10631-133 | DrugBank ID:DB00982 | NDC:70710-1023 | NDC:70710-1022 | NDC:0555-1055 | NDC:59651-635 | NDC:0591-2433 | NDC:68308-573 | NDC:69238-1174 | NDC:0591-2501 | Isotretinoin | NDC:10631-002 | NDC:0832-8301 | NDC:72143-254 | NDC:59651-636 | NDC:72143-253 | NDC:10631-115 | NDC:0245-0570 | NDC:68308-575 | NDC:55111-135 | NDC:0245-0573 | NDC:59651-634 | NDC:10631-003 | NDC:72143-251 | NDC:55111-136 | PubChem CID:5282379 | NDC:70771-1559 | NDC:68308-783 | NDC:69238-1176 | NDC:0378-6612 | NDC:70710-1024 | NDC:10631-007 | NDC:57664-025 | NDC:68308-781 | NDC:70771-1558"
+BMGC_DG10976,BMG_DG154084,"PubChem CID:5282380 | CAS RN:913258-34-1 | PubChem SID:404859371 | UNII:ZC39I2T1VW | LATANOPROST, (5E)-"
+BMGC_DG10977,BMG_DG154085,"NDC:43386-161 | NDC:68071-3762 | NDC:70954-443 | NDC:71335-2455 | NDC:40032-160 | NDC:43393-020 | NDC:71335-9631 | NDC:60687-746 | DrugBank ID:DB00929 | MISOPROSTOL | UNII:0E43V0BB57 | NDC:60687-735 | PubChem SID:175271737 | NDC:70954-444 | NDC:42571-253 | NDC:43386-160 | NDC:40032-161 | NDC:43393-200 | NDC:43393-024 | NDC:55154-2145 | NDC:72789-121 | NDC:43393-022 | NDC:59762-5007 | CAS RN:103601-27-0 | Misoprostol | NDC:50268-555 | NDC:0025-1461 | NDC:42571-254 | NDC:43063-707 | NDC:43393-023 | NDC:54348-148 | NDC:0025-1451 | PubChem CID:5282381 | CAS RN:59122-46-2 | NDC:59762-5008 | CAS RN:848849-83-2 | NDC:72789-300 | NDC:68071-4843 | NDC:82804-037 | methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate | NDC:63704-008"
+BMGC_DG10978,BMG_DG154100,"PubChem CID:5282411 | NDC:67457-587 | Epoprostenol | CAS RN:63859-31-4 | UNII:DCR9Z582X0 | DrugBank ID:DB01240 | NDC:67457-588 | NDC:66215-403 | PubChem SID:175267334 | CAS RN:35121-78-9 | (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoic acid | EPOPROSTENOL | NDC:66215-402"
+BMGC_DG10979,BMG_DG154103,"Dinoprost tromethamine | Dinoprost Tromethamine | PubChem SID:175266922 | 2-amino-2-(hydroxymethyl)propane-1,3-diol;(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid | DrugBank ID:DB01160 | UNII:CT6BBQ5A68 | CAS RN:38562-01-5 | PubChem CID:5282415 | DINOPROST TROMETHAMINE"
+BMGC_DG10980,BMG_DG154111,PubChem CID:5282425 | CAS RN:25627-39-8 | Dosulepin chloride | [(3Z)-3-(6H-benzo[c][1]benzothiepin-11-ylidene)propyl]-dimethylazanium;chloride
+BMGC_DG10981,BMG_DG154112,"(3Z)-3-(6H-benzo[c][1]benzothiepin-11-ylidene)-N,N-dimethylpropan-1-amine | UNII:CZ377VWX9P | CAS RN:113-53-1 | DOTHIEPIN, Z- | Dothiepin | PubChem SID:252319625 | CAS RN:25627-38-7 | PubChem CID:5282426"
+BMGC_DG10982,BMG_DG154114,INDIGOTINDISULFONIC ACID | PubChem CID:5282430 | UNII:X7OI7JF73P | CAS RN:483-20-5 | DrugBank ID:DB11577 | PubChem SID:175266711 | Indigotindisulfonic acid
+BMGC_DG10983,BMG_DG154124,UNII:L256JB984D | PubChem SID:198958891 | Ozagrel | CAS RN:82571-53-7 | CAS RN:130952-46-4 | DrugBank ID:DB12017 | (E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoic acid | PubChem CID:5282440 | OZAGREL
+BMGC_DG10984,BMG_DG154126,2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine | TRIPROLIDINE | DrugBank ID:DB00427 | CAS RN:486-12-4 | PubChem CID:5282443 | UNII:2L8T9S52QM | PubChem SID:175267951 | Triprolidine | CAS RN:10191-42-1
+BMGC_DG10985,BMG_DG154127,"Fondaparinux | DrugBank ID:DB00569 | FONDAPARINUX | PubChem SID:175267926 | (2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl]oxy-5-sulfooxyoxan-3-yl]oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl]oxy-4,5-dihydroxyoxane-2-carboxylic acid | PubChem CID:5282448 | UNII:J177FOW5JL | CAS RN:104993-28-4"
+BMGC_DG10986,BMG_DG154130,"PubChem SID:175266302 | NDC:72603-479 | NDC:66869-204 | NDC:31722-875 | NDC:31722-877 | NDC:66869-404 | NDC:0832-6048 | NDC:65162-030 | NDC:66869-104 | UNII:IYD54XEG3W | NDC:65862-813 | NDC:68382-481 | NDC:70771-1784 | PubChem CID:5282451 | calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate | NDC:0378-5057 | PITAVASTATIN CALCIUM | NDC:0378-5056 | CAS RN:147526-32-7 | NDC:42291-905 | NDC:0378-5055 | NDC:0480-3633 | NDC:70771-1785 | NDC:0480-3632 | NDC:31722-876 | NDC:65162-031 | NDC:65862-812 | NDC:68382-483 | NDC:65162-029 | NDC:68382-482 | NDC:0480-3631 | NDC:65862-814 | NDC:0832-6049 | NDC:42291-906 | NDC:70771-1786 | NDC:42291-907 | NDC:72603-480 | NDC:0832-6050 | Pitavastatin Calcium"
+BMGC_DG10987,BMG_DG154131,"DrugBank ID:DB08860 | (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid | NDC:68180-744 | NDC:70771-1117 | NDC:68180-743 | Pitavastatin | NDC:25208-201 | NDC:25208-202 | UNII:M5681Q5F9P | NDC:68180-742 | PubChem SID:175267104 | PubChem CID:5282452 | PITAVASTATIN | NDC:70771-1118 | CAS RN:147511-69-1"
+BMGC_DG10988,BMG_DG154136,"(E)-1-[4-(2-oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one | UNII:67Y4P5C84X | CAS RN:23887-46-9 | CINEPAZIDE | PubChem CID:5282459 | CAS RN:88197-48-2 | PubChem SID:198949260 | Cinepazide | DrugBank ID:DB12123"
+BMGC_DG10989,BMG_DG154150,Ethanolamine oleate | UNII:U4RY8MRX7C | PubChem SID:175267734 | NDC:67871-479 | PubChem CID:5282489 | DrugBank ID:DB06689 | ETHANOLAMINE OLEATE | 2-aminoethanol;(Z)-octadec-9-enoic acid | CAS RN:2272-11-9 | Ethanolamine Oleate
+BMGC_DG10990,BMG_DG154151,"[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] benzoate | PubChem CID:5282492 | BETAMETHASONE BENZOATE | Betamethasone Benzoate | CAS RN:22298-29-9 | UNII:877K0XW47A | PubChem SID:198985410"
+BMGC_DG10991,BMG_DG154152,"PubChem CID:5282493 | Clocortolone Pivalate | [2-[(6S,8S,9R,10S,11S,13S,14S,16R,17S)-9-chloro-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate | UNII:QBL8IZH14X | CLOCORTOLONE PIVALATE | CAS RN:34097-16-0 | NDC:51672-4166 | PubChem SID:175267588"
+BMGC_DG10992,BMG_DG154153,"NDC:68180-954 | UNII:68717P8FUZ | Hydrocortisone valerate | DrugBank ID:DB14544 | [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] pentanoate | Hydrocortisone Valerate | HYDROCORTISONE VALERATE | PubChem SID:175266487 | NDC:21922-007 | NDC:0713-0720 | PubChem CID:5282494 | NDC:51672-1290 | CAS RN:57524-89-7 | NDC:68462-836 | NDC:51672-1292 | NDC:0713-0560 | NDC:72162-2301"
+BMGC_DG10993,BMG_DG154160,"PubChem CID:5282517 | CAS RN:157605-25-9 | 7-[(1S,5R)-6-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid | UNII:2IXX802851 | Alatrofloxacin mesylate | ALATROFLOXACIN MESYLATE | PubChem SID:198962943 | CAS RN:146961-77-5"
+BMGC_DG10994,BMG_DG154161,"Tilmicosin | UNII:XL4103X2E3 | TILMICOSIN | (4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4S,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-7-[2-[(3S,5R)-3,5-dimethylpiperidin-1-yl]ethyl]-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione | CAS RN:108050-54-0 | PubChem SID:175265630 | PubChem CID:5282521 | DrugBank ID:DB11471"
+BMGC_DG10995,BMG_DG154164,"PubChem CID:5282592 | [(1R,5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-hydroxy-2-phenylacetate | PubChem SID:175272162 | UNII:P97OGJ7L1L | CAS RN:31610-86-3 | Methylhomatropine | METHYLHOMATROPINE"
+BMGC_DG10996,BMG_DG154165,"HOMATROPINE | CAS RN:87-00-3 | PubChem SID:175271364 | [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 2-hydroxy-2-phenylacetate | Homatropine | DrugBank ID:DB11181 | CAS RN:16175-57-8 | PubChem CID:5282593 | UNII:8QS6WCL55Z"
+BMGC_DG10997,BMG_DG154200,"(Z)-octadec-11-enoic acid | VACCENIC ACID, CIS- | DrugBank ID:DB04801 | Vaccenic acid, cis- | PubChem CID:5282761 | CAS RN:506-17-2 | PubChem SID:252164049 | UNII:400K7322UW | cis-Vaccenic acid"
+BMGC_DG10998,BMG_DG154202,(Z)-icos-11-enoic acid | PubChem CID:5282768 | UNII:UDX6WPL94T | GONDOIC ACID | CAS RN:5561-99-9 | Gondoic Acid | PubChem SID:175266640 | DrugBank ID:DB14073
+BMGC_DG10999,BMG_DG154215,"(10E,12Z)-octadeca-10,12-dienoic acid | CAS RN:2420-56-6 | (10E,12Z)-octadecadienoic acid | PubChem SID:198979443 | DrugBank ID:DB04746 | PubChem CID:5282800 | UNII:N151ZM4M27 | 10,12-OCTADECADIENOIC ACID, (10E,12Z)-"
+BMGC_DG11000,BMG_DG154233,".ALPHA.-DIMORPHECOLIC ACID, (+/-)- | .ALPHA.-DIMORPHECOLIC ACID, (±)- | CAS RN:98524-19-7 | (10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid | PubChem CID:5282944 | UNII:XL87KT7C6Z | PubChem SID:461434089 | 9-hydroxy-10E,12Z-octadecadienoic acid"
+BMGC_DG11001,BMG_DG154264,PubChem CID:5283056 | UNII:V2N896SN9V | PubChem SID:198972255 | 15-EPIPROSTAGLANDIN E1 | CAS RN:20897-91-0
+BMGC_DG11002,BMG_DG154275,BIMATOPROST ACID | PubChem SID:198963020 | CAS RN:38344-08-0 | UNII:2683MK55HG | PubChem CID:5283081
+BMGC_DG11003,BMG_DG154277,PubChem CID:5283086 | 15-EPI-PROSTAGLANDIN E2 | CAS RN:38873-82-4 | UNII:T3D76GXW94 | PubChem SID:198948856
+BMGC_DG11004,BMG_DG154279,CAS RN:33854-16-9 | UNII:C289Y64HRB | PubChem SID:441331337 | PubChem CID:5283102 | DINOPROST METHYL ESTER
+BMGC_DG11005,BMG_DG154282,CAS RN:130209-76-6 | PubChem CID:5283107 | UNII:1IFH52MD8T | DEHYDROLATANOPROST | PubChem SID:198976684
+BMGC_DG11006,BMG_DG154283,5-TRANS-PROSTAGLANDIN E2 | UNII:6V30L285LP | CAS RN:36150-00-2 | PubChem CID:5283116 | PubChem SID:198982929
+BMGC_DG11007,BMG_DG154290,"6-trans-leukotriene B4 | CAS RN:71652-82-9 | PubChem CID:5283128 | (5S,6E,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid"
+BMGC_DG11008,BMG_DG154305,"CAS RN:98462-03-4 | 8S-Hete | (5Z,8S,9E,11Z,14Z)-8-hydroxyicosa-5,9,11,14-tetraenoic acid | PubChem CID:5283154"
+BMGC_DG11009,BMG_DG154306,"12(S)-Hete | CAS RN:54397-83-0 | PubChem SID:472423273 | UNII:WG8M7C9ALT | PubChem CID:5283155 | (5Z,8Z,10E,12S,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid | 12-HETE, (S)-"
+BMGC_DG11010,BMG_DG154308,"CAS RN:79551-86-3 | 20-Hete | PubChem CID:5283157 | (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoic acid"
+BMGC_DG11011,BMG_DG154310,"5-Oxo-ETE | CAS RN:106154-18-1 | CAS RN:126432-17-5 | (6E,8Z,11Z,14Z)-5-oxoicosa-6,8,11,14-tetraenoic acid | PubChem CID:5283159"
+BMGC_DG11012,BMG_DG154311,"CAS RN:108437-64-5 | PubChem CID:5283162 | 12-oxo-ETE | (5Z,8Z,10E,14Z)-12-oxoicosa-5,8,10,14-tetraenoic acid"
+BMGC_DG11013,BMG_DG154314,"PubChem CID:5283169 | CAS RN:83603-31-0 | (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoic acid | 15R-Hete"
+BMGC_DG11014,BMG_DG154366,PubChem SID:198953390 | CAS RN:128946-65-6 | CAS RN:29343-52-0 | PubChem CID:5283344 | (E)-4-hydroxynon-2-enal | 4-HYDROXY-2-NONENAL | 4-Hydroxynonenal | CAS RN:75899-68-2 | UNII:K1CVM13F96
+BMGC_DG11015,BMG_DG154379,"(E)-octadec-9-enal | CAS RN:5090-41-5 | PubChem SID:198973255 | 9-OCTADECENAL, (9E)- | 9-Octadecenal | PubChem CID:5283381 | UNII:979G27P46D | CAS RN:10009-79-7"
+BMGC_DG11016,BMG_DG154381,PubChem SID:175265968 | (Z)-octadec-9-enamide | Oleamide | PubChem CID:5283387 | OLEAMIDE | CAS RN:301-02-0 | UNII:7L25QK8BWO
+BMGC_DG11017,BMG_DG154382,"N-arachidonoylglycine | CAS RN:179113-91-8 | PubChem CID:5283389 | 2-[[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]amino]acetic acid | PubChem SID:459275730 | N-ARACHIDONYLGLYCINE | UNII:5PB56SQA6E"
+BMGC_DG11018,BMG_DG154383,"Arachidonamide | (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenamide | CAS RN:85146-53-8 | PubChem CID:5283393"
+BMGC_DG11019,BMG_DG154384,"PubChem SID:198940752 | LINOLEIC MONOETHANOLAMIDE | UNII:889DYX0816 | (9Z,12Z)-N-(2-hydroxyethyl)octadeca-9,12-dienamide | CAS RN:68171-52-8 | PubChem CID:5283446 | Linoleoyl ethanolamide"
+BMGC_DG11020,BMG_DG154388,CAS RN:111-58-0 | n-Oleoylethanolamine | OLEIC MONOETHANOLAMIDE | PubChem CID:5283454 | PubChem SID:198987874 | (Z)-N-(2-hydroxyethyl)octadec-9-enamide | UNII:1HI5J9N8E6
+BMGC_DG11021,BMG_DG154389,"2,3-dihydroxypropyl (Z)-octadec-9-enoate | CAS RN:111-03-5 | Glyceryl 1-oleate | PubChem CID:5283468 | PubChem SID:175271803 | GLYCERYL 1-OLEATE | CAS RN:25496-72-4 | CAS RN:925-14-4 | Glyceryl monooleate | DrugBank ID:DB13171 | UNII:D3AEF6S35P"
+BMGC_DG11022,BMG_DG154406,"MENAQUINONE 6 | PubChem CID:5283547 | CAS RN:84-81-1 | PubChem SID:198964773 | Menaquinone-6 | UNII:71ANL51TLA | 2-[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl]-3-methylnaphthalene-1,4-dione | DrugBank ID:DB14936"
+BMGC_DG11023,BMG_DG154408,"UNII:YVE187NJ1U | PubChem SID:377308651 | SPHINGOSINE 1-PHOSPHATE | PubChem CID:5283560 | Sphingosine 1-phosphate | [(E,2S,3R)-2-amino-3-hydroxyoctadec-4-enyl] dihydrogen phosphate | CAS RN:26993-30-6"
+BMGC_DG11024,BMG_DG154411,"N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]hexadecanamide | UNII:FD38GFZ87C | CAS RN:24696-26-2 | CAS RN:477243-06-4 | CAS RN:4201-58-5 | N-Palmitoyl-D-erythro-sphingosine | PubChem SID:485666142 | N-PALMITOYL-D-ERYTHRO-SPHINGOSINE | PubChem CID:5283564 | N-Palmitoylsphingosine"
+BMGC_DG11025,BMG_DG154436,"PubChem SID:329903566 | UNII:6XJ9029P2X | PubChem CID:5283627 | CAS RN:567-72-6 | CHOLESTA-3,5-DIEN-7-ONE"
+BMGC_DG11026,BMG_DG154442,"CAS RN:4651-51-8 | PubChem CID:5283637 | CAS RN:474-62-4 | 22,23-Dihydrobrassicasterol | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"
+BMGC_DG11027,BMG_DG154451,"CAS RN:474-68-0 | Episterol | PubChem CID:5283662 | (3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"
+BMGC_DG11028,BMG_DG154452,PubChem SID:198968485 | PubChem CID:5283663 | CAS RN:481-17-4 | CHONDRILLASTEROL | UNII:20N2XP8UR6
+BMGC_DG11029,BMG_DG154464,"UNII:T0WXW8F54E | PubChem CID:5283731 | PubChem SID:175267092 | CAS RN:19356-17-3 | DrugBank ID:DB00146 | CAS RN:64719-49-9 | CALCIFEDIOL ANHYDROUS | (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol | Calcifediol"
+BMGC_DG11030,BMG_DG154465,"Tacalcitol | UNII:C2W72OJ5ZU | PubChem CID:5283734 | PubChem SID:198957936 | TACALCITOL | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | CAS RN:57333-96-7 | DrugBank ID:DB13689"
+BMGC_DG11031,BMG_DG154466,"(1R,3S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | TRANS-CALCITRIOL | PubChem SID:198950499 | CAS RN:73837-24-8 | UNII:I1L29CLX3C | CAS RN:32222-06-3 | PubChem CID:5283740 | trans-Calcitriol"
+BMGC_DG11032,BMG_DG154469,"UNII:460029IUDA | SECALCIFEROL | (3R,6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol | CAS RN:55721-11-4 | PubChem SID:198971821 | PubChem CID:5283748 | Secalciferol"
+BMGC_DG11033,BMG_DG154476,"CAS RN:83-49-8 | (4R)-4-[(3R,5R,6S,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | DrugBank ID:DB11789 | HYODEOXYCHOLIC ACID | UNII:7A33Y6EHYK | Hyodeoxycholic Acid | PubChem CID:5283820 | PubChem SID:198975795"
+BMGC_DG11034,BMG_DG154477,"PubChem SID:438787954 | Murideoxycholic acid | CAS RN:668-49-5 | MURIDEOXYCHOLIC ACID | UNII:AMB87E8LOH | (4R)-4-[(3R,5R,6R,8S,9S,10R,13R,14S,17R)-3,6-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | PubChem CID:5283821"
+BMGC_DG11035,BMG_DG154506,UNII:96JBM35FXF | CAS RN:1553-56-6 | PubChem SID:198981900 | PubChem CID:5283906 | DEHYDROLITHOCHOLIC ACID
+BMGC_DG11036,BMG_DG154507,"3-OXOCHENODEOXYCHOLIC ACID | (4R)-4-[(5R,7R,8R,9S,10S,13R,14S,17R)-7-hydroxy-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid | UNII:3MY7NM9XNW | 7alpha-Hydroxy-3-oxo-5beta-cholan-24-oic Acid | PubChem CID:5283932 | CAS RN:4185-00-6 | PubChem SID:445499126"
+BMGC_DG11037,BMG_DG154517,"PubChem SID:441658970 | PubChem CID:5284061 | CAS RN:130593-75-8 | UNII:49AM7E73PT | (3.ALPHA.,5.BETA.,7.BETA.)-CHOLANE-3,7,24-TRIOL"
+BMGC_DG11038,BMG_DG154544,"PubChem CID:5284352 | 2-Bromoergocryptine Mesylate | (9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid"
+BMGC_DG11039,BMG_DG154546,PubChem CID:5284359 | DrugBank ID:DB01164 | Calcium chloride | PubChem SID:175268200 | calcium;dichloride | CALCIUM CHLORIDE ANHYDROUS | Calcium Chloride | CAS RN:10043-52-4 | UNII:OFM21057LP
+BMGC_DG11040,BMG_DG154553,"PubChem SID:175268396 | CODEINE ANHYDROUS | UNII:UX6OWY2V7J | CAS RN:76-57-3 | (4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol | Codeine | DrugBank ID:DB00318 | PubChem CID:5284371"
+BMGC_DG11041,BMG_DG154554,"Cyclosporine | NDC:0093-9019 | NDC:65086-001 | NDC:10702-808 | CAS RN:59865-13-3 | NDC:0078-0248 | NDC:68084-921 | NDC:68180-214 | NDC:0378-8760 | NDC:60505-4630 | NDC:64380-127 | CAS RN:104250-72-8 | NDC:0074-3108 | NDC:0078-0241 | NDC:0023-9163 | NDC:0078-0109 | NDC:60505-0133 | NDC:68084-879 | NDC:75907-047 | NDC:0023-5301 | NDC:23155-837 | NDC:23155-839 | NDC:0093-9018 | PubChem SID:175265836 | NDC:64380-129 | NDC:75907-048 | cyclosporin A | NDC:0078-0240 | NDC:0074-7269 | NDC:0078-0246 | NDC:60505-4631 | NDC:0078-0110 | NDC:0172-7313 | PubChem CID:5284373 | NDC:60505-4632 | NDC:0093-9020 | NDC:47335-507 | NDC:50090-4476 | NDC:47335-506 | NDC:0074-3109 | NDC:60505-6202 | NDC:23155-838 | NDC:64380-128 | UNII:83HN0GTJ6D | CYCLOSPORINE | NDC:82667-900 | NDC:73043-005 | DrugBank ID:DB00091 | NDC:0078-0274 | NDC:60505-0134 | NDC:51862-460 | (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | NDC:51862-458"
+BMGC_DG11042,BMG_DG154559,"DrugBank ID:DB12916 | PubChem CID:5284380 | UNII:LJ2P1SIK8Y | Mitolactol | CAS RN:10318-26-0 | (2R,3S,4R,5S)-1,6-dibromohexane-2,3,4,5-tetrol | MITOLACTOL | PubChem SID:198934938"
+BMGC_DG11043,BMG_DG154566,INDOLIDAN | PubChem SID:198955726 | PubChem CID:5284402 | CAS RN:100643-96-7 | UNII:0751ZOW7OR
+BMGC_DG11044,BMG_DG154585,PubChem CID:5284442 | ISBOGREL | Isbogrel | PubChem SID:198950335 | (E)-7-phenyl-7-pyridin-3-ylhept-6-enoic acid | CAS RN:89667-40-3 | UNII:HGB7P08R36
+BMGC_DG11045,BMG_DG154588,"NDC:82667-012 | Natamycin | NDC:71776-005 | (1R,3S,5R,7R,8E,12R,14E,16E,18E,20E,22R,24S,25R,26S)-22-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid | UNII:8O0C852CPO | PubChem SID:175267109 | DrugBank ID:DB00826 | CAS RN:7681-93-8 | NATAMYCIN | PubChem CID:5284447"
+BMGC_DG11046,BMG_DG154592,"PubChem CID:5284456 | Isoptpo Hyoscine | [(1S,2S,4S,5S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate | CAS RN:51-34-3"
+BMGC_DG11047,BMG_DG154618,"DrugBank ID:DB00511 | Acetyldigitoxin | UNII:0ZV4Q4L2FU | CAS RN:1111-39-3 | [(2R,3R,4S,6S)-3-hydroxy-6-[(2R,3S,4S,6S)-4-hydroxy-6-[(2R,3S,4S,6R)-4-hydroxy-6-[[(3S,5R,8R,9S,10S,13R,14S,17R)-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-2-methyloxan-3-yl]oxy-2-methyloxan-3-yl]oxy-2-methyloxan-4-yl] acetate | PubChem SID:198983923 | PubChem CID:5284512 | ACETYLDIGITOXIN | CAS RN:25395-32-8"
+BMGC_DG11048,BMG_DG154619,"NDC:42291-086 | (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoic acid | PubChem CID:5284513 | CAS RN:419534-31-9 | NDC:0093-1138 | NDC:0115-1753 | NDC:0378-7023 | NDC:0115-1752 | NDC:62332-742 | NDC:0115-1750 | NDC:42794-083 | NDC:46708-741 | NDC:46708-742 | NDC:0093-1136 | NDC:42794-080 | UNII:LCH760E9T7 | Acitretin | NDC:62332-743 | DrugBank ID:DB00459 | CAS RN:54757-46-9 | NDC:0093-1135 | NDC:42291-088 | NDC:42291-087 | NDC:42794-081 | NDC:62332-741 | NDC:0378-7020 | NDC:0115-1751 | NDC:72162-2224 | NDC:72162-2222 | NDC:46708-743 | ACITRETIN | PubChem SID:175265984 | NDC:72162-2223 | CAS RN:55079-83-9"
+BMGC_DG11049,BMG_DG154620,(E)-3-[6-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridin-2-yl]prop-2-enoic acid | CAS RN:87848-99-5 | Acrivastine | ACRIVASTINE | UNII:A20F9XAI7W | PubChem CID:5284514 | DrugBank ID:DB09488 | PubChem SID:175268536
+BMGC_DG11050,BMG_DG154626,"DrugBank ID:DB14725 | (6R,7R)-7-[[(2R)-2-formyloxy-2-phenylacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | O-Formylcefamandole | CAS RN:57268-80-1 | PubChem CID:5284527"
+BMGC_DG11051,BMG_DG154628,"Cefroxadine | CAS RN:51762-05-1 | PubChem CID:5284529 | UNII:B908C4MV2R | DrugBank ID:DB11367 | PubChem SID:198938261 | CEFROXADINE | (6R,7R)-7-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid"
+BMGC_DG11052,BMG_DG154629,"UNII:SDS4N642GG | CHLORMADINONE | CAS RN:1961-77-9 | PubChem SID:198980911 | DrugBank ID:DB13528 | Chlormadinone | PubChem CID:5284533 | (8R,9S,10R,13S,14S,17R)-17-acetyl-6-chloro-17-hydroxy-10,13-dimethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one"
+BMGC_DG11053,BMG_DG154630,"PubChem CID:5284535 | Cloprednol | UNII:SYP56O3GJG | PubChem SID:198942009 | CLOPREDNOL | DrugBank ID:DB13843 | (8S,9S,10R,11S,13S,14S,17R)-6-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one | CAS RN:5251-34-3"
+BMGC_DG11054,BMG_DG154631,"PubChem CID:5284537 | PubChem SID:175266415 | CYPROTERONE | UNII:E61Q31EK2F | (1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-15-hydroxy-2,16-dimethylpentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dien-6-one | CAS RN:2098-66-0 | Cyproterone"
+BMGC_DG11055,BMG_DG154635,"PubChem SID:175266000 | (4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol | UNII:N9I9HDB855 | Dihydrocodeine | PubChem CID:5284543 | DrugBank ID:DB01551 | DIHYDROCODEINE | CAS RN:125-28-0"
+BMGC_DG11056,BMG_DG154637,"DrugBank ID:DB00869 | UNII:9JDX055TW1 | CAS RN:120279-96-1 | Dorzolamide | PubChem CID:5284549 | PubChem SID:175267119 | DORZOLAMIDE | (4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide"
+BMGC_DG11057,BMG_DG154638,"trans-Dothiepin | DrugBank ID:DB09167 | PubChem SID:198948064 | CAS RN:113-53-1 | DOTHIEPIN | UNII:W13O82Z7HL | PubChem CID:5284550 | Dosulepin | (3E)-3-(6H-benzo[c][1]benzothiepin-11-ylidene)-N,N-dimethylpropan-1-amine | CAS RN:25627-37-6"
+BMGC_DG11058,BMG_DG154639,"UNII:MN728NK085 | PubChem CID:5284551 | Doxacurium | DrugBank ID:DB01135 | 1-O-[3-[(1S,2R)-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 4-O-[3-[(1R,2S)-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] butanedioate;dichloride | PubChem SID:198956358 | Doxacurium Chloride | CAS RN:106819-53-8 | DOXACURIUM CHLORIDE, MESO-"
+BMGC_DG11059,BMG_DG154640,"PubChem SID:198960209 | 1-O-[3-[(1S,2R)-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] 4-O-[3-[(1R,2S)-6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] butanedioate | UNII:8A4O17EP8T | PubChem CID:5284552 | Meso-doxacurium | CAS RN:133814-18-3 | DOXACURIUM, MESO-"
+BMGC_DG11060,BMG_DG154641,"Erythrityl tetranitrate | PubChem SID:198990457 | Erythrityl Tetranitrate | PubChem CID:5284553 | ERYTHRITYL TETRANITRATE | CAS RN:7297-25-8 | UNII:35X333P19D | DrugBank ID:DB01613 | [(2R,3S)-1,3,4-trinitrooxybutan-2-yl] nitrate"
+BMGC_DG11061,BMG_DG154643,"PubChem SID:175265479 | PubChem CID:5284555 | [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine | Estropipate | CAS RN:7280-37-7 | ESTROPIPATE | UNII:SVI38UY019"
+BMGC_DG11062,BMG_DG154645,"Ethisterone | UNII:P201BVY1MJ | (8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | CAS RN:434-03-7 | PubChem CID:5284557 | ETHISTERONE | PubChem SID:175266946"
+BMGC_DG11063,BMG_DG154649,"PubChem CID:5284566 | GRANISETRON | DrugBank ID:DB00889 | CAS RN:124998-65-8 | Granisetron | 1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide | NDC:47426-101 | UNII:WZG3J2MCOL | CAS RN:1364914-39-5 | NDC:66220-637 | CAS RN:109889-09-0 | PubChem SID:175268823"
+BMGC_DG11064,BMG_DG154650,"DrugBank ID:DB00956 | CAS RN:50678-79-0 | PubChem SID:175268404 | CAS RN:125-29-1 | (4R,4aR,7aR,12bS)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one | UNII:6YKS4Y3WQ7 | PubChem CID:5284569 | HYDROCODONE | Hydrocodone"
+BMGC_DG11065,BMG_DG154651,"PubChem SID:175268533 | Hydromorphone | PubChem CID:5284570 | UNII:Q812464R06 | HYDROMORPHONE | (4R,4aR,7aR,12bS)-9-hydroxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one | DrugBank ID:DB00327 | CAS RN:466-99-9"
+BMGC_DG11066,BMG_DG154656,NDC:43485-104 | NDC:16714-358 | NDC:67457-255 | NDC:50228-189 | NDC:43598-759 | NDC:71205-881 | PubChem CID:5284583 | NDC:60505-3280 | NDC:0264-1009 | NDC:0472-0235 | NDC:65162-529 | NDC:76282-246 | NDC:51672-4143 | NDC:43547-222 | NDC:67877-771 | NDC:69102-105 | NDC:42658-149 | NDC:70518-3804 | NDC:70518-4125 | NDC:51224-013 | NDC:13668-016 | NDC:67877-769 | NDC:50474-597 | NDC:72789-152 | NDC:14789-110 | NDC:65862-246 | NDC:16714-034 | NDC:64980-604 | NDC:31722-537 | NDC:50090-1333 | NDC:68083-154 | NDC:25021-780 | NDC:42385-956 | NDC:25021-793 | NDC:43485-103 | NDC:62135-548 | NDC:72865-187 | NDC:68382-168 | NDC:67457-266 | NDC:50474-598 | NDC:65162-528 | NDC:16714-035 | NDC:44567-501 | NDC:70518-3765 | NDC:42385-957 | NDC:50228-472 | NDC:69452-412 | NDC:70518-0947 | Levetiracetam | NDC:67877-768 | NDC:42571-331 | NDC:70518-3803 | NDC:39328-511 | NDC:35208-031 | NDC:43063-617 | NDC:71335-2337 | NDC:68788-7884 | NDC:70518-0365 | NDC:25021-795 | NDC:0143-9673 | NDC:76494-531 | NDC:0378-5617 | NDC:64980-606 | LEVETIRACETAM | NDC:44567-503 | NDC:16571-788 | NDC:16571-790 | NDC:64980-605 | NDC:70518-4005 | NDC:71093-144 | NDC:70518-3895 | NDC:43547-223 | NDC:16714-310 | NDC:13668-014 | NDC:50474-599 | NDC:65862-247 | NDC:76282-248 | NDC:42385-955 | NDC:82009-124 | NDC:72572-360 | NDC:50228-470 | NDC:68180-113 | NDC:43547-345 | NDC:71205-728 | NDC:50228-471 | NDC:55150-177 | NDC:67296-1486 | NDC:67046-1207 | NDC:67877-770 | NDC:51672-4137 | NDC:55150-247 | NDC:0121-0799 | NDC:0121-1598 | NDC:76282-247 | NDC:43598-755 | NDC:43547-221 | NDC:43598-636 | NDC:60505-3517 | NDC:68001-113 | NDC:72865-190 | NDC:76494-529 | NDC:68180-118 | NDC:50090-6086 | NDC:67457-790 | UNII:44YRR34555 | NDC:42385-954 | NDC:69367-332 | NDC:43598-635 | NDC:50474-596 | NDC:43485-102 | NDC:63629-4675 | NDC:68180-117 | NDC:70518-2230 | NDC:0264-1509 | NDC:70010-521 | NDC:76494-530 | NDC:0904-7125 | NDC:51079-821 | NDC:55150-246 | NDC:25021-794 | NDC:60687-657 | NDC:70518-4123 | NDC:71335-0702 | NDC:82009-121 | NDC:36000-354 | NDC:43598-637 | NDC:27808-265 | NDC:82009-123 | NDC:50474-594 | NDC:51655-325 | NDC:0904-7123 | NDC:72485-106 | NDC:43547-224 | NDC:50474-001 | NDC:27808-266 | NDC:81665-101 | DrugBank ID:DB01202 | NDC:68083-152 | NDC:0264-5009 | NDC:27808-263 | NDC:65862-315 | NDC:65162-538 | NDC:0121-2397 | NDC:16714-355 | NDC:55154-5699 | NDC:43547-346 | NDC:70518-1772 | NDC:72865-188 | NDC:68788-8254 | NDC:0904-7265 | NDC:71335-2098 | NDC:63629-4137 | NDC:43547-454 | NDC:0143-9574 | NDC:36000-352 | NDC:55111-248 | NDC:68788-7430 | NDC:55111-182 | NDC:55150-248 | NDC:80705-101 | NDC:81665-100 | NDC:72205-120 | NDC:72205-094 | NDC:72205-095 | CAS RN:102767-28-2 | NDC:69102-107 | NDC:50090-6378 | NDC:71335-0694 | NDC:63629-9847 | NDC:13668-017 | NDC:50474-595 | NDC:63187-360 | NDC:68180-112 | NDC:0615-8498 | NDC:70010-522 | NDC:71335-2275 | NDC:72189-510 | NDC:65862-245 | NDC:31722-574 | NDC:60687-249 | NDC:70010-523 | NDC:50090-7333 | NDC:55154-3367 | NDC:24689-106 | NDC:66993-100 | NDC:63739-158 | NDC:16714-356 | NDC:68001-403 | NDC:68382-165 | NDC:65841-703 | NDC:63629-7516 | NDC:16714-354 | NDC:55154-5782 | NDC:71205-880 | NDC:69339-157 | NDC:71335-9757 | NDC:72865-189 | NDC:65862-250 | NDC:68084-882 | NDC:70518-2026 | NDC:68001-405 | NDC:80705-100 | NDC:55154-4171 | NDC:16571-789 | NDC:55111-183 | NDC:31722-538 | NDC:43063-499 | NDC:0615-8500 | NDC:60429-349 | NDC:68083-153 | NDC:76494-528 | NDC:31722-539 | NDC:68788-8577 | NDC:65162-685 | NDC:68094-313 | NDC:68001-402 | NDC:35208-032 | NDC:69367-333 | NDC:14789-330 | NDC:43598-757 | NDC:70518-1796 | NDC:70518-3981 | NDC:0615-8499 | NDC:17856-0574 | NDC:16714-357 | NDC:65162-539 | NDC:68180-115 | NDC:68180-114 | NDC:14789-220 | NDC:0121-4799 | NDC:69102-108 | NDC:72189-229 | NDC:51672-4142 | NDC:72189-190 | NDC:70518-4013 | NDC:27808-264 | NDC:42658-148 | NDC:0409-1886 | PubChem SID:175267315 | NDC:0904-7420 | NDC:16714-537 | NDC:63629-8315 | NDC:31722-536 | NDC:13668-015 | NDC:63323-400 | NDC:51672-4141 | NDC:68001-404 | NDC:0378-5615 | NDC:60687-668 | NDC:68001-114 | NDC:50228-473 | NDC:72205-097 | NDC:70010-524 | NDC:0904-7124 | NDC:50228-190 | NDC:67457-265 | NDC:72205-096 | NDC:44567-502 | NDC:55111-181 | NDC:71335-2282 | NDC:16571-787 | NDC:68084-859 | NDC:50405-300 | NDC:50474-002 | NDC:0378-5619 | NDC:43485-101 | NDC:70518-1901 | NDC:0615-8501 | NDC:60505-3518 | NDC:63629-9615 | NDC:69102-106 | NDC:82009-122 | NDC:0409-2011 | NDC:63739-795 | NDC:65841-704 | NDC:55154-4316 | NDC:50090-7368 | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide | NDC:60429-350 | NDC:64980-607 | NDC:72205-037 | NDC:51672-4136 | NDC:36000-356
+BMGC_DG11067,BMG_DG154658,"PubChem CID:5284585 | Loracarbef | LORACARBEF ANHYDROUS | PubChem SID:175266433 | DrugBank ID:DB00447 | (6R,7S)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CAS RN:76470-66-1 | UNII:W72I5ZT78Z"
+BMGC_DG11068,BMG_DG154660,"UNII:67U96J8P35 | DrugBank ID:DB09383 | PubChem CID:5284587 | MEPREDNISONE | CAS RN:1247-42-3 | (8S,9S,10R,13S,14S,16S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione | PubChem SID:198986243 | Meprednisone"
+BMGC_DG11069,BMG_DG154662,"Nabilone | NDC:0187-1231 | CAS RN:61617-09-2 | (6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromen-9-one | DrugBank ID:DB00486 | PubChem CID:5284592 | CAS RN:51022-71-0 | NABILONE | UNII:2N4O9L084N | PubChem SID:175271606"
+BMGC_DG11070,BMG_DG154663,"Nalmefene | (4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol | PubChem CID:5284594 | PubChem SID:175267830 | UNII:TOV02TDP9I | NALMEFENE | DrugBank ID:DB06230 | CAS RN:55096-26-9"
+BMGC_DG11071,BMG_DG154664,"CAS RN:62-67-9 | Nalorphine | PubChem CID:5284595 | DrugBank ID:DB11490 | UNII:U59WB2WRY2 | PubChem SID:198970701 | NALORPHINE | (4R,4aR,7S,7aR,12bS)-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol"
+BMGC_DG11072,BMG_DG154665,"CAS RN:465-65-6 | PubChem SID:175268685 | DrugBank ID:DB01183 | NALOXONE | (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one | UNII:36B82AMQ7N | PubChem CID:5284596 | Naloxone"
+BMGC_DG11073,BMG_DG154666,"NORMETHANDRONE | DrugBank ID:DB13533 | PubChem CID:5284597 | (8R,9S,10R,13S,14S,17S)-17-hydroxy-13,17-dimethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | CAS RN:514-61-4 | PubChem SID:198951847 | Normethandrone | UNII:743F1Z557A"
+BMGC_DG11074,BMG_DG154669,"UNII:CD35PMG570 | NDC:24510-140 | NDC:24510-115 | NDC:24510-110 | OXYCODONE | (4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one | Oxycodone | DrugBank ID:DB00497 | PubChem CID:5284603 | PubChem SID:175266292 | NDC:24510-120 | NDC:24510-130 | CAS RN:76-42-6"
+BMGC_DG11075,BMG_DG154670,"UNII:9VXA968E0C | DrugBank ID:DB01192 | PubChem SID:175267332 | PubChem CID:5284604 | Oxymorphone | (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one | OXYMORPHONE | CAS RN:76-41-5"
+BMGC_DG11076,BMG_DG154671,"DrugBank ID:DB01022 | CAS RN:84-80-0 | PHYTONADIONE, (E)-(+/-)- | UNII:S5Z3U87QHF | PHYTONADIONE, (E)- | PubChem CID:5284607 | CAS RN:11104-38-4 | CAS RN:79083-00-4 | Phylloquinone | PubChem SID:198943960 | Phytonadione | PHYTONADIONE, (E)-(±)- | CAS RN:10485-69-5 | 2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione | PubChem SID:376231230 | UNII:MLF3D1712D"
+BMGC_DG11077,BMG_DG154674,"PubChem SID:198988201 | CAS RN:466-06-8 | UNII:KC6BL281EN | Proscillaridin | PubChem CID:5284613 | PROSCILLARIDIN | DrugBank ID:DB13307 | 5-[(3S,8R,9S,10R,13R,14S,17R)-14-hydroxy-10,13-dimethyl-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one"
+BMGC_DG11078,BMG_DG154676,"NDC:60505-6197 | NDC:31722-316 | NDC:67877-746 | NDC:80803-153 | NDC:67877-747 | UNII:W36ZG6FT64 | NDC:16714-187 | NDC:0008-1042 | NDC:16714-189 | NDC:65841-772 | NDC:0008-1041 | NDC:50268-718 | NDC:55111-654 | CAS RN:53123-88-9 | SIROLIMUS | NDC:68382-520 | NDC:65841-771 | NDC:68382-351 | NDC:59762-1003 | NDC:68462-684 | NDC:68382-352 | PubChem CID:5284616 | NDC:0904-7248 | DrugBank ID:DB00877 | NDC:68462-682 | PubChem SID:175268272 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone | NDC:55111-653 | NDC:68084-915 | NDC:59762-1002 | NDC:59762-1001 | NDC:73683-101 | NDC:66689-347 | NDC:70518-3546 | NDC:69238-1594 | NDC:68462-683 | NDC:72205-099 | NDC:16714-188 | NDC:67877-748 | Sirolimus | NDC:0008-1030 | NDC:59762-1205 | NDC:0008-1040 | NDC:65841-773 | NDC:70518-4194"
+BMGC_DG11079,BMG_DG154678,"NDC:71335-1684 | NDC:68462-108 | NDC:70518-1180 | NDC:68382-139 | NDC:0093-7336 | NDC:43063-735 | NDC:42291-958 | NDC:70518-2391 | NDC:16571-705 | NDC:68382-358 | NDC:68788-7460 | NDC:50458-647 | NDC:60760-075 | NDC:70518-1196 | NDC:50090-5853 | NDC:55154-7142 | NDC:65862-171 | NDC:70518-2104 | NDC:80425-0214 | NDC:65841-846 | NDC:71335-0047 | NDC:70771-1317 | NDC:68382-863 | NDC:63187-228 | NDC:16571-706 | NDC:50090-2203 | NDC:65841-649 | NDC:68382-004 | NDC:43063-612 | NDC:68788-7351 | NDC:70518-3067 | NDC:71205-233 | NDC:68462-373 | NDC:0245-1071 | NDC:43353-696 | NDC:61919-213 | NDC:63187-479 | NDC:31722-183 | NDC:0480-2359 | NDC:50090-2102 | UNII:0H73WJJ391 | NDC:68382-138 | NDC:69097-819 | NDC:68462-370 | NDC:42291-957 | NDC:68084-342 | NDC:16571-707 | NDC:50090-7067 | NDC:43602-457 | NDC:70518-2001 | NDC:80425-0373 | NDC:65862-173 | NDC:63187-059 | NDC:63187-773 | NDC:51655-429 | NDC:0480-2356 | NDC:69097-816 | NDC:68084-343 | NDC:70518-1937 | NDC:69097-818 | NDC:71335-1116 | NDC:71335-2318 | NDC:50090-6827 | NDC:0245-1073 | NDC:71335-1143 | NDC:65841-647 | NDC:71335-9727 | NDC:69097-123 | NDC:43063-734 | NDC:83008-012 | NDC:62756-712 | NDC:69097-122 | NDC:72603-122 | NDC:68382-141 | PubChem CID:5284627 | NDC:43063-605 | NDC:43063-729 | NDC:68071-4877 | NDC:71205-187 | NDC:0832-1071 | NDC:68084-345 | NDC:76420-280 | NDC:51407-893 | NDC:0904-6929 | NDC:71610-492 | NDC:0832-1075 | NDC:70771-1315 | NDC:24979-210 | NDC:17772-102 | NDC:70518-2899 | NDC:80425-0288 | NDC:65862-172 | NDC:68462-153 | NDC:70771-1858 | NDC:68462-374 | NDC:51655-608 | NDC:47335-710 | NDC:55700-995 | NDC:65841-652 | NDC:68071-5165 | NDC:69097-124 | NDC:70710-1039 | NDC:43063-998 | NDC:50458-640 | NDC:0904-6928 | NDC:71205-214 | NDC:65841-648 | NDC:71610-493 | NDC:71610-486 | NDC:63187-060 | NDC:0245-1072 | NDC:68382-498 | NDC:68382-769 | NDC:70710-1041 | NDC:27241-228 | NDC:76420-279 | NDC:10370-367 | NDC:43353-695 | NDC:68071-3660 | NDC:68462-110 | NDC:10370-366 | NDC:80425-0208 | NDC:43602-458 | NDC:83008-011 | NDC:51655-746 | NDC:70771-1659 | NDC:70771-1656 | NDC:0615-8140 | NDC:50458-641 | NDC:50090-3926 | NDC:71610-485 | CAS RN:97240-79-4 | NDC:50458-642 | NDC:70771-1657 | NDC:0480-2357 | NDC:70518-1503 | NDC:23155-895 | NDC:68071-3088 | NDC:29300-116 | NDC:76282-281 | NDC:63187-758 | NDC:10370-365 | NDC:71335-0548 | NDC:52652-9001 | NDC:63187-077 | NDC:68462-371 | NDC:31722-182 | NDC:43353-697 | NDC:29300-115 | NDC:50090-5309 | NDC:68382-005 | NDC:72789-443 | NDC:68788-7468 | NDC:17772-104 | NDC:63187-118 | NDC:76282-279 | NDC:0480-2358 | NDC:27241-230 | NDC:43602-459 | NDC:50090-3389 | NDC:47335-707 | NDC:59651-453 | NDC:80425-0202 | NDC:42291-955 | NDC:43602-460 | DrugBank ID:DB00273 | NDC:80425-0092 | NDC:62756-711 | NDC:47335-711 | NDC:59651-452 | NDC:70771-1316 | NDC:71205-195 | NDC:71205-202 | NDC:72789-004 | NDC:72603-121 | NDC:63187-696 | NDC:60760-577 | NDC:43063-997 | NDC:62756-707 | NDC:72603-124 | NDC:68462-372 | NDC:82009-137 | NDC:72603-120 | NDC:68462-109 | NDC:17772-101 | NDC:0832-1072 | NDC:70518-4247 | NDC:68071-4760 | NDC:71335-0337 | NDC:0245-1074 | NDC:27241-227 | NDC:10370-368 | NDC:68382-140 | NDC:31722-184 | NDC:63187-283 | NDC:72603-123 | NDC:17772-103 | NDC:0615-8139 | NDC:71335-0925 | NDC:50090-6828 | NDC:29300-117 | NDC:23155-894 | NDC:29300-118 | NDC:68788-8817 | NDC:76420-276 | NDC:68382-864 | NDC:71335-1147 | NDC:42291-956 | NDC:62756-710 | NDC:69097-125 | NDC:63187-963 | NDC:70518-0887 | NDC:70771-1658 | NDC:70710-1040 | TOPIRAMATE | [(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate | NDC:67877-869 | NDC:68462-219 | NDC:31722-181 | Topiramate | NDC:65862-174 | NDC:0832-1074 | NDC:70710-1042 | NDC:71205-819 | NDC:76282-278 | NDC:50458-639 | NDC:76282-280 | NDC:24979-211 | NDC:0832-1073 | NDC:27241-229 | NDC:51655-848 | NDC:16571-708 | NDC:72789-471 | NDC:0615-8138 | NDC:51655-606 | NDC:80425-0195 | NDC:70518-1953 | NDC:67877-868 | NDC:68788-7568 | NDC:63187-801 | NDC:50090-6895 | NDC:55154-7146 | NDC:70771-1660 | NDC:80425-0398 | NDC:71335-0487 | NDC:65841-650 | NDC:47335-712 | NDC:68462-218 | NDC:68084-344 | NDC:76420-278 | NDC:71335-0325 | NDC:82009-135 | NDC:51407-894 | NDC:69097-817 | NDC:0093-7335 | NDC:50458-645 | NDC:82009-136 | NDC:0245-1075 | NDC:70710-1043 | NDC:70518-2517 | NDC:68071-1971 | PubChem SID:175266081 | NDC:70518-1718 | NDC:65841-651 | NDC:70518-0233"
+BMGC_DG11080,BMG_DG154679,"NDC:90096-141 | PubChem CID:5284631 | NDC:33342-554 | NDC:71610-812 | CAS RN:10405-02-4 | NDC:76282-336 | [(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate;chloride | NDC:72162-1106 | NDC:72789-348 | Trospium chloride | NDC:0003-0125 | NDC:70436-174 | NDC:72162-1108 | TROSPIUM CHLORIDE | PubChem SID:175271515 | NDC:69097-912 | NDC:70010-027 | NDC:0574-0145 | NDC:0003-0050 | NDC:60429-098 | NDC:63629-8457 | NDC:0574-0118 | NDC:62135-742 | NDC:68462-461 | NDC:0591-3636 | NDC:23155-530 | NDC:0904-7059 | NDC:63629-9279 | NDC:71205-917 | NDC:63629-8458 | UNII:1E6682427E | NDC:68001-427 | NDC:0003-1100"
+BMGC_DG11081,BMG_DG154680,"DrugBank ID:DB00209 | TROSPIUM | UNII:T4Y8ORK057 | PubChem SID:175271913 | PubChem CID:5284632 | [(1S,5R)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate | CAS RN:47608-32-2 | Trospium"
+BMGC_DG11082,BMG_DG154681,"PubChem SID:198947539 | VALSARTAN, D- | PubChem CID:5284633 | (2R)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid | UNII:IDC67444MI | CAS RN:137862-87-4 | Valsartan, D-"
+BMGC_DG11083,BMG_DG154682,"Vinbarbital | CAS RN:75016-38-5 | PubChem SID:198963518 | 5-ethyl-5-[(E)-pent-2-en-2-yl]-1,3-diazinane-2,4,6-trione | VINBARBITAL | PubChem CID:5284636 | CAS RN:125-42-8 | DrugBank ID:DB13377 | UNII:7NZH2C1T6O"
+BMGC_DG11084,BMG_DG154684,PubChem CID:5284643 | CAS RN:82413-23-8 | 4-[(Z)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-phenylbut-1-en-2-yl]phenol | 4'-Hydroxytamoxifen
+BMGC_DG11085,BMG_DG154687,"UNII:T08Y239E7Y | CAS RN:485-63-2 | 3',4',7-TRIHYDROXYISOFLAVONE | PubChem CID:5284648 | 3',4',7-Trihydroxyisoflavone | 3-(3,4-dihydroxyphenyl)-7-hydroxychromen-4-one | PubChem SID:313389847"
+BMGC_DG11086,BMG_DG154688,"PubChem SID:198967035 | CAS RN:17817-31-1 | PubChem CID:5284649 | 6,7,4'-Trihydroxyisoflavone | 4',6,7-TRIHYDROXYISOFLAVONE | UNII:PLM2K574GE | 6,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one"
+BMGC_DG11087,BMG_DG154689,"UNII:S6E4ZX5JSS | CAS RN:6554-98-9 | PubChem SID:472399571 | 4-HYDROXYSTILBENE, TRANS- | PubChem CID:5284650"
+BMGC_DG11088,BMG_DG154705,PubChem CID:5287408 | DrugBank ID:DB02855 | N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline
+BMGC_DG11089,BMG_DG154707,PubChem CID:5287415 | (1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine | DrugBank ID:DB02367
+BMGC_DG11090,BMG_DG154710,5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DrugBank ID:DB03124 | PubChem CID:5287429
+BMGC_DG11091,BMG_DG154711,"DrugBank ID:DB06864 | 2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID | 2-(3-Carboxypropionyl)-6-hydroxy-cyclohexa-2,4-diene carboxylic acid | PubChem CID:5287432 | (1R,6R)-2-(3-carboxypropanoyl)-6-hydroxycyclohexa-2,4-diene-1-carboxylic acid"
+BMGC_DG11092,BMG_DG154712,"DrugBank ID:DB01810 | PubChem CID:5287438 | [1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester"
+BMGC_DG11093,BMG_DG154714,DrugBank ID:DB03268 | PubChem CID:5287443 | RU82197
+BMGC_DG11094,BMG_DG154717,2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL | PubChem CID:5287452 | DrugBank ID:DB06901
+BMGC_DG11095,BMG_DG154718,"5-Carbamoyl-1,1':4',1''-terphenyl-3-carboxylic acid | PubChem CID:5287459 | DrugBank ID:DB04583"
+BMGC_DG11096,BMG_DG154719,PubChem CID:5287461 | DrugBank ID:DB03114 | PAS219
+BMGC_DG11097,BMG_DG154720,PubChem SID:485663625 | 2-(PHOSPHONOOXY)BENZALDEHYDE | PubChem CID:5287463 | CAS RN:439904-19-5 | UNII:UP67646C7V | RU78262 | 2-(Phosphonooxy)benzaldehyde | DrugBank ID:DB01947
+BMGC_DG11098,BMG_DG154721,PubChem CID:5287465 | DrugBank ID:DB03828 | RU78299
+BMGC_DG11099,BMG_DG154722,DrugBank ID:DB06953 | PubChem CID:5287467 | 2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE
+BMGC_DG11100,BMG_DG154723,PubChem CID:5287468 | N-[(2S)-4-Methyl-1-oxo-1-{[(4S)-3-oxo-1-(2-pyridinylsulfonyl)-4-azepanyl]amino}-2-pentanyl]-1-benzofuran-2-carboxamide | DrugBank ID:DB03642
+BMGC_DG11101,BMG_DG154724,PubChem CID:5287488 | DrugBank ID:DB03306 | RU78300
+BMGC_DG11102,BMG_DG154725,"PubChem CID:5287492 | DrugBank ID:DB04591 | N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE"
+BMGC_DG11103,BMG_DG154726,N-omega-propyl-L-arginine | DrugBank ID:DB02644 | PubChem CID:5287494
+BMGC_DG11104,BMG_DG154732,"PubChem CID:5287509 | DrugBank ID:DB02106 | [3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid"
+BMGC_DG11105,BMG_DG154733,Naphthyridine Inhibitor | DrugBank ID:DB04434 | PubChem CID:5287512
+BMGC_DG11106,BMG_DG154735,RU85493 | PubChem CID:5287515 | DrugBank ID:DB01908
+BMGC_DG11107,BMG_DG154738,"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE | PubChem CID:5287523 | DrugBank ID:DB07128"
+BMGC_DG11108,BMG_DG154739,"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole | DrugBank ID:DB04480 | PubChem CID:5287525"
+BMGC_DG11109,BMG_DG154741,"6-(4-{[2-(3-iodobenzyl)-3-oxocyclohex-1-en-1-yl]amino}phenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one | PubChem CID:5287540 | DrugBank ID:DB01640"
+BMGC_DG11110,BMG_DG154742,"CAS RN:288628-05-7 | Irosustat | PubChem CID:5287541 | UNII:366037O6O7 | IROSUSTAT | DrugBank ID:DB02292 | (6-oxo-8,9,10,11-tetrahydro-7H-cyclohepta[c]chromen-3-yl) sulfamate | PubChem SID:198963659"
+BMGC_DG11111,BMG_DG154743,RU84687 | PubChem CID:5287544 | DrugBank ID:DB01678
+BMGC_DG11112,BMG_DG154744,CAS RN:2004-03-7 | DrugBank ID:DB02113 | UNII:SEO6WX0OZG | 6-Methylpurine | 6-METHYLPURINE | PubChem CID:5287547 | PubChem SID:377308759
+BMGC_DG11113,BMG_DG154745,RU79073 | DrugBank ID:DB03525 | PubChem CID:5287550
+BMGC_DG11114,BMG_DG154746,"Menaquinone 7 | DrugBank ID:DB13075 | PubChem CID:5287554 | UNII:8427BML8NY | 2-[(2E,6E,10E,14E,18E,22E)-3,7,11,15,19,23,27-heptamethyloctacosa-2,6,10,14,18,22,26-heptaenyl]-3-methylnaphthalene-1,4-dione | MENAQUINONE 7 | PubChem SID:198971389 | Menaquinone-7 | CAS RN:13425-62-2 | CAS RN:2124-57-4"
+BMGC_DG11115,BMG_DG154747,PubChem CID:5287555 | DrugBank ID:DB03104 | 2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid
+BMGC_DG11116,BMG_DG154748,"DrugBank ID:DB03506 | 5H-pyrrolo[3,2-d]pyrimidin-4-amine | PubChem CID:5287565"
+BMGC_DG11117,BMG_DG154750,"DrugBank ID:DB02222 | PubChem CID:5287571 | 2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine"
+BMGC_DG11118,BMG_DG154754,"DrugBank ID:DB04617 | PubChem CID:5287586 | (9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM"
+BMGC_DG11119,BMG_DG154757,PubChem CID:5287596 | DrugBank ID:DB02812 | RWJ-56423
+BMGC_DG11120,BMG_DG154760,"DrugBank ID:DB03216 | PubChem CID:5287610 | (1'R,2'S)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-yl)Adenine"
+BMGC_DG11121,BMG_DG154762,"PubChem CID:5287617 | 1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol | DrugBank ID:DB03802"
+BMGC_DG11122,BMG_DG154764,"PubChem SID:241179472 | BREFELDIN A | (1R,2R,3E,7S,11E,13S,15S)-2,15-dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one | CAS RN:60132-23-2 | CAS RN:20350-15-6 | PubChem CID:5287620 | brefeldin A | UNII:XG0D35F9K6 | Brefeldin A | CAS RN:11006-23-8 | DrugBank ID:DB07348"
+BMGC_DG11123,BMG_DG154765,"PubChem CID:5287621 | DrugBank ID:DB04281 | 2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone"
+BMGC_DG11124,BMG_DG154768,PubChem CID:5287648 | DrugBank ID:DB04197 | Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine
+BMGC_DG11125,BMG_DG154770,"15,16-dimethoxy-5,7-dioxa-20-azoniapentacyclo[10.8.0.02,10.04,8.013,18]icosa-1(12),2,4(8),9,13,15,17,19-octaene | 2,3-Dimethoxy-12H-[1,3]dioxolo[5,6]indeno[1,2-C]isoquinolin-6-ium | DrugBank ID:DB07354 | 2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM | PubChem CID:5287652"
+BMGC_DG11126,BMG_DG154772,DrugBank ID:DB03539 | 2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose | PubChem CID:5287668
+BMGC_DG11127,BMG_DG154773,PubChem CID:5287671 | DrugBank ID:DB03611 | L-2-amino-4-methoxy-cis-but-3-enoic acid
+BMGC_DG11128,BMG_DG154774,PubChem CID:5287673 | Allosamizoline | DrugBank ID:DB04404
+BMGC_DG11129,BMG_DG154775,UNII:235BBF3K97 | ANHYDROVITAMIN A | DrugBank ID:DB02914 | PubChem SID:198942690 | Anhydrovitamin A | CAS RN:1224-78-8 | PubChem CID:5287678
+BMGC_DG11130,BMG_DG154776,"DrugBank ID:DB04108 | (2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide | PubChem CID:5287684"
+BMGC_DG11131,BMG_DG154777,DrugBank ID:DB07384 | PubChem CID:5287692 | 1-ACETYL-2-CARBOXYPIPERIDINE
+BMGC_DG11132,BMG_DG154779,"DrugBank ID:DB07385 | PubChem CID:5287703 | 3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE"
+BMGC_DG11133,BMG_DG154780,"PubChem SID:348481359 | ALRT-1550 | (2E,4E,6E)-7-(3,5-ditert-butylphenyl)-3-methylocta-2,4,6-trienoic acid | PubChem CID:5287705 | UNII:H62AOA2IYF | CAS RN:178600-20-9 | 7-(3,5-Ditert-butylphenyl)-3-methylocta-2,4,6-trienoic acid"
+BMGC_DG11134,BMG_DG154781,PubChem CID:5287706 | DrugBank ID:DB03892 | 5-N-Allyl-arginine
+BMGC_DG11135,BMG_DG154784,4-Hydroxy-Aconitate Ion | PubChem CID:5287714 | DrugBank ID:DB03964
+BMGC_DG11136,BMG_DG154787,DrugBank ID:DB04632 | PubChem CID:5287728 | 4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE
+BMGC_DG11137,BMG_DG154788,CAS RN:63590-19-2 | UNII:O0N0E1MP23 | BALANOL | PubChem SID:438788870 | PubChem CID:5287736
+BMGC_DG11138,BMG_DG154789,(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE | PubChem CID:5287737 | DrugBank ID:DB07433
+BMGC_DG11139,BMG_DG154790,"DrugBank ID:DB07435 | 1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE | PubChem CID:5287739"
+BMGC_DG11140,BMG_DG154793,"DrugBank ID:DB02809 | PubChem CID:5287754 | Brodimoprim-4,6-Dicarboxylate"
+BMGC_DG11141,BMG_DG154797,Glutamine t-butyl ester | PubChem CID:5287779 | DrugBank ID:DB04636
+BMGC_DG11142,BMG_DG154799,"UNII:C5S376W5UK | (R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE | DrugBank ID:DB07454 | CAS RN:206193-18-2 | 3-BROMO-2-HYDROXY-2-METHYL-N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)PROPANAMIDE, (2R)- | PubChem CID:5287785"
+BMGC_DG11143,BMG_DG154801,"PubChem CID:5287789 | 3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE | DrugBank ID:DB07461"
+BMGC_DG11144,BMG_DG154802,"DrugBank ID:DB01944 | BLEBBISTATIN, (-)- | PubChem SID:198941180 | (S)-blebbistatin | CAS RN:856925-71-8 | PubChem CID:5287792 | UNII:8WII7624I5"
+BMGC_DG11145,BMG_DG154806,DrugBank ID:DB03767 | PubChem CID:5287799 | Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide
+BMGC_DG11146,BMG_DG154812,"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL | DrugBank ID:DB07479 | PubChem CID:5287834"
+BMGC_DG11147,BMG_DG154814,"1-Beta-Ribofuranosyl-1,3-Diazepinone | PubChem CID:5287841 | DrugBank ID:DB03185"
+BMGC_DG11148,BMG_DG154816,PubChem CID:5287844 | DrugBank ID:DB03444 | 6-bromoindirubin-3'-oxime
+BMGC_DG11149,BMG_DG154817,DrugBank ID:DB07493 | 5-Bromoindirubin | PubChem CID:5287845
+BMGC_DG11150,BMG_DG154818,"UNII:V0632559OD | RUTAMARIN ALCOHOL, (+)- | DrugBank ID:DB02205 | PubChem SID:313368871 | (+)-Rutamarin alcohol | PubChem CID:5287846 | CAS RN:14755-47-6"
+BMGC_DG11151,BMG_DG154820,DrugBank ID:DB02953 | 2-Thiomethyl-3-Phenylpropanoic Acid | PubChem CID:5287850
+BMGC_DG11152,BMG_DG154821,"PubChem CID:5287855 | DrugBank ID:DB07503 | (5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE"
+BMGC_DG11153,BMG_DG154823,DrugBank ID:DB02140 | PubChem CID:5287869 | N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide
+BMGC_DG11154,BMG_DG154824,DrugBank ID:DB03984 | PubChem CID:5287870 | Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide
+BMGC_DG11155,BMG_DG154825,"UNII:AIK0XUF3AV | DrugBank ID:DB11383 | Carbomycin A | CAS RN:4564-87-8 | PubChem CID:5287879 | PubChem SID:198945193 | CARBOMYCIN A | [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6S)-6-[[(1S,3R,7R,8S,9S,10R,12R,14E,16S)-7-acetyloxy-8-methoxy-3,12-dimethyl-5,13-dioxo-10-(2-oxoethyl)-4,17-dioxabicyclo[14.1.0]heptadec-14-en-9-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate"
+BMGC_DG11156,BMG_DG154828,N-Cyclopentyl-N-Cyclobutylformamide | DrugBank ID:DB04065 | N-Cyclobutyl-N-cyclopentylformamide | PubChem SID:485666835 | PubChem CID:5287890 | CAS RN:207851-40-9 | N-CYCLOBUTYL-N-CYCLOPENTYLFORMAMIDE | UNII:M756UR7EKU
+BMGC_DG11157,BMG_DG154833,UNII:CU2AD63F3M | Chymostatin A | PubChem SID:475550882 | DrugBank ID:DB01683 | Chymostatin | CAS RN:2698358-09-5 | PubChem CID:5287931 | CHYMOSTATIN A
+BMGC_DG11158,BMG_DG154836,"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | PubChem CID:5287955 | DrugBank ID:DB07574"
+BMGC_DG11159,BMG_DG154837,"UNII:45AD6X575G | PubChem SID:198988266 | ALVOCIDIB | PubChem CID:5287969 | CAS RN:146426-40-6 | DrugBank ID:DB03496 | 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one | Alvocidib"
+BMGC_DG11160,BMG_DG154838,"UNII:6UCA7I41S8 | [(2R)-3-hexadecanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate | PubChem CID:5287971 | 1-PALMITOYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | Palmitoyl-Linoleoyl Phosphatidylcholine | PubChem SID:438788840 | CAS RN:17708-90-6 | DrugBank ID:DB02306 | Lecithin"
+BMGC_DG11161,BMG_DG154839,PubChem CID:5287974 | DrugBank ID:DB03736 | 2-Cyclopropylmethylenepropanal
+BMGC_DG11162,BMG_DG154842,"PubChem CID:5287979 | DrugBank ID:DB07586 | 5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE"
+BMGC_DG11163,BMG_DG154843,"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine | PubChem CID:5287989 | CAS RN:771498-73-8 | PubChem SID:445499121 | (5-CHLOROPYRAZOLO(1,5-A)PYRIMIDIN-7-YL)-(4-METHANESULFONYLPHENYL)AMINE | DrugBank ID:DB02963 | UNII:XNE9CK2X79"
+BMGC_DG11164,BMG_DG154844,"PubChem CID:5287990 | DrugBank ID:DB01888 | 4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide"
+BMGC_DG11165,BMG_DG154845,Cyclotheonamide A | PubChem CID:5287991 | UNII:2Y1TEH8EW7 | DrugBank ID:DB04269 | PubChem SID:198937000 | CYCLOTHEONAMIDE A | CAS RN:129033-04-1
+BMGC_DG11166,BMG_DG154846,"CAS RN:9061-30-7 | (2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | CAS RN:33404-34-1 | PubChem CID:5287993 | Cellotriose"
+BMGC_DG11167,BMG_DG154849,"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE | DrugBank ID:DB07598 | PubChem CID:5288002"
+BMGC_DG11168,BMG_DG154851,DrugBank ID:DB07612 | PubChem CID:5288016 | 6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE
+BMGC_DG11169,BMG_DG154852,"PubChem CID:5288017 | 2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE | DrugBank ID:DB07618"
+BMGC_DG11170,BMG_DG154853,"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA | DrugBank ID:DB07622 | PubChem CID:5288018"
+BMGC_DG11171,BMG_DG154855,DrugBank ID:DB04367 | Debromohymenialdisine | PubChem CID:5288032
+BMGC_DG11172,BMG_DG154856,"PubChem CID:5288033 | 5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione | DrugBank ID:DB07636"
+BMGC_DG11173,BMG_DG154858,DrugBank ID:DB07658 | AC-(D)Phe-pro-borolys-OH | PubChem CID:5288064
+BMGC_DG11174,BMG_DG154859,AC-(D)PHE-PRO-BOROHOMOLYS-OH | DrugBank ID:DB07659 | PubChem CID:5288066
+BMGC_DG11175,BMG_DG154860,DrugBank ID:DB07660 | PubChem CID:5288067 | AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH
+BMGC_DG11176,BMG_DG154861,"CAS RN:998-06-1 | PubChem SID:198983180 | 1,2-DILINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | UNII:7L874P1M1O | DrugBank ID:DB04372 | PubChem CID:5288075 | L-Dilinoleoyllecithin | [(2R)-2,3-bis[[(9Z,12Z)-octadeca-9,12-dienoyl]oxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate | 1,2-Dilinoleoyl-SN-glycero-3-phosphocholine"
+BMGC_DG11177,BMG_DG154863,UNII:GLA35OJ8JH | DrugBank ID:DB07668 | CAS RN:125769-41-7 | 3-(4-(DIETHYLAMINO)-2-HYDROXYPHENYL)-2-METHYLPROP-2-ENOICACID | PubChem SID:440088581 | alpha-Methyl-2-hydroxy-4-diethylaminocinnamic acid | PubChem CID:5288082
+BMGC_DG11178,BMG_DG154864,DrugBank ID:DB02217 | PubChem CID:5288101 | Dpb-T
+BMGC_DG11179,BMG_DG154866,N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE | DrugBank ID:DB04677 | PubChem CID:5288103
+BMGC_DG11180,BMG_DG154867,"PubChem CID:5288113 | DrugBank ID:DB04683 | (2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE"
+BMGC_DG11181,BMG_DG154869,"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine | DrugBank ID:DB04069 | PubChem CID:5288116"
+BMGC_DG11182,BMG_DG154873,"DrugBank ID:DB02308 | 4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium | PubChem CID:5288139"
+BMGC_DG11183,BMG_DG154875,PubChem CID:5288145 | 4-[[(2S)-2-[[(2S)-3-Carboxy-2-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]butyl-(diaminomethylidene)azanium | DrugBank ID:DB04276
+BMGC_DG11184,BMG_DG154876,N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane | DrugBank ID:DB04126 | PubChem CID:5288147
+BMGC_DG11185,BMG_DG154877,"(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3E,5E)-7-ethyl-7-hydroxynona-3,5-dien-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | SEOCALCITOL | PubChem SID:198988491 | DrugBank ID:DB04258 | Seocalcitol | PubChem CID:5288149 | CAS RN:134404-52-7 | UNII:Q0OZ0D9223"
+BMGC_DG11186,BMG_DG154885,PubChem CID:5288190 | 2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE | DrugBank ID:DB07749
+BMGC_DG11187,BMG_DG154888,"UNII:187EJ7QEXL | PubChem SID:198945118 | FENRETINIDE | DrugBank ID:DB05076 | Fenretinide | CAS RN:65646-68-6 | PubChem CID:5288209 | (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide"
+BMGC_DG11188,BMG_DG154889,S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE | PubChem CID:5288215 | DrugBank ID:DB07769
+BMGC_DG11189,BMG_DG154891,"DrugBank ID:DB03737 | PubChem CID:5288222 | 4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One"
+BMGC_DG11190,BMG_DG154893,CAS RN:142-44-9 | PubChem CID:5288227 | (Z)-but-2-enedioate | Maleate
+BMGC_DG11191,BMG_DG154894,DrugBank ID:DB02164 | PubChem CID:5288230 | N-sulfo-flavin mononucleotide
+BMGC_DG11192,BMG_DG154896,"DrugBank ID:DB02195 | 3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine | PubChem CID:5288238"
+BMGC_DG11193,BMG_DG154897,"N-{4-[(Carboxymethyl)carbamoyl]benzoyl}-L-valyl-N-[(3S)-1,1,1-trifluoro-4-methyl-2-oxo-3-pentanyl]-L-prolinamide | PubChem CID:5288240 | DrugBank ID:DB03702"
+BMGC_DG11194,BMG_DG154898,PubChem CID:5288250 | DrugBank ID:DB03453 | Methyl (2S)-2-[[2-[(3R)-1-carbamimidoylpiperidin-3-yl]acetyl]amino]-3-[4-(2-phenylethynyl)phenyl]propanoate
+BMGC_DG11195,BMG_DG154899,"DrugBank ID:DB02581 | N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide | PubChem CID:5288251"
+BMGC_DG11196,BMG_DG154900,"DrugBank ID:DB07796 | PubChem CID:5288257 | (3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE"
+BMGC_DG11197,BMG_DG154901,PubChem CID:5288259 | DrugBank ID:DB01858 | [1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate
+BMGC_DG11198,BMG_DG154903,"(3R)-3-hydroxytetradecanoic acid | UNII:R7C245Y68X | DrugBank ID:DB02767 | (R)-3-Hydroxytetradecanoic acid | PubChem CID:5288266 | (R)-3-hydroxytetradecanoic acid | CAS RN:28715-21-1 | PubChem SID:313182521 | 3-HYDROXYMYRISTIC ACID, (3R)-"
+BMGC_DG11199,BMG_DG154906,"DrugBank ID:DB01685 | 4-(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)pyridine-2-carbonitrile | Topiroxostat | TOPIROXOSTAT | CAS RN:577778-58-6 | PubChem CID:5288320 | PubChem SID:198946713 | UNII:0J877412JV"
+BMGC_DG11200,BMG_DG154908,"DrugBank ID:DB04696 | PubChem CID:5288329 | 4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN"
+BMGC_DG11201,BMG_DG154910,PubChem CID:5288332 | DrugBank ID:DB04697 | TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE
+BMGC_DG11202,BMG_DG154913,DrugBank ID:DB03639 | 1-Guanidinium-7-Aminoheptane | PubChem CID:5288371
+BMGC_DG11203,BMG_DG154914,"DrugBank ID:DB08740 | PubChem CID:5288373 | CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE"
+BMGC_DG11204,BMG_DG154916,"UNII:Z3K3VJ16KU | CAS RN:30562-34-6 | PubChem SID:198936976 | PubChem CID:5288382 | GELDANAMYCIN | [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14,19-trimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate | Geldanamycin | DrugBank ID:DB02424"
+BMGC_DG11205,BMG_DG154917,PubChem CID:5288385 | (4e)-4-Aminohex-4-Enoic Acid | DrugBank ID:DB01699
+BMGC_DG11206,BMG_DG154919,"(4aS,6R,8aS)-11-[8-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)octyl]-6-hydroxy-3-methoxy-5,6,9,10-tetrahydro-4aH-[1]benzofuro[3a,3,2-ef][2]benzazepin-11-ium | DrugBank ID:DB02673 | PubChem CID:5288394"
+BMGC_DG11207,BMG_DG154920,"DrugBank ID:DB03835 | N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide | PubChem CID:5288395"
+BMGC_DG11208,BMG_DG154922,CAS RN:64839-33-4 | 3'-.ALPHA.-SIALYL-.BETA.-LACTOSE | PubChem CID:5288424 | UNII:H668G020YH | PubChem SID:375579107
+BMGC_DG11209,BMG_DG154924,"DrugBank ID:DB01841 | PubChem CID:5288437 | 4,6-Dideoxyglucose"
+BMGC_DG11210,BMG_DG154928,5-THIO-.ALPHA.-D-GLUCOPYRANOSE | PubChem CID:5288443 | PubChem SID:376072105 | CAS RN:10227-19-7 | UNII:08DDM61Q8P
+BMGC_DG11211,BMG_DG154930,DrugBank ID:DB03130 | S-P-Nitrobenzyloxycarbonylglutathione | PubChem CID:5288453
+BMGC_DG11212,BMG_DG154931,DrugBank ID:DB04539 | Glyphosate | PubChem CID:5288464
+BMGC_DG11213,BMG_DG154935,PubChem CID:5288494 | UNII:WEM4BUT8FL | PubChem SID:472387852 | GW-5638 | CAS RN:155701-61-4
+BMGC_DG11214,BMG_DG154936,PubChem CID:5288499 | Heparin Disaccharide I-S | DrugBank ID:DB02322
+BMGC_DG11215,BMG_DG154938,PubChem CID:5288504 | DrugBank ID:DB02353 | Heparin Disaccharide Iii-S
+BMGC_DG11216,BMG_DG154940,"PubChem CID:5288514 | DrugBank ID:DB07882 | 4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID"
+BMGC_DG11217,BMG_DG154941,"UNII:K0O97QF441 | PubChem SID:443624333 | DrugBank ID:DB02197 | CAS RN:328061-37-6 | DB-02197 | PubChem CID:5288527 | 4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide"
+BMGC_DG11218,BMG_DG154942,2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid | PubChem CID:5288538 | DrugBank ID:DB02328
+BMGC_DG11219,BMG_DG154946,PubChem CID:5288557 | DrugBank ID:DB03024 | 2-Methyl-3-(2-Aminothiazolo)Propanal
+BMGC_DG11220,BMG_DG154948,DrugBank ID:DB07900 | 3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE | PubChem CID:5288561
+BMGC_DG11221,BMG_DG154949,"PubChem SID:482554115 | 5-Hydroxymethyl-Chonduritol | (1S,2S,3S,4R)-5-(hydroxymethyl)cyclohex-5-ene-1,2,3,4-tetrol | CAS RN:111136-25-5 | STREPTOL, (+)- | PubChem CID:5288564 | DrugBank ID:DB03092 | UNII:J5344DZ89S | Streptol | Streptol, (+)-"
+BMGC_DG11222,BMG_DG154951,7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN | PubChem CID:5288573 | DrugBank ID:DB07908
+BMGC_DG11223,BMG_DG154953,DrugBank ID:DB07916 | PubChem CID:5288581 | 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID
+BMGC_DG11224,BMG_DG154954,"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine | DrugBank ID:DB04114 | PubChem CID:5288588"
+BMGC_DG11225,BMG_DG154956,PubChem CID:5288593 | DrugBank ID:DB04244 | (2R)-2-(3-Biphenylyl)-N-{(2R)-2-hydroxy-3-[(2-pyridinylsulfonyl)amino]propyl}-4-methylpentanamide
+BMGC_DG11226,BMG_DG154957,PubChem CID:5288596 | SC-74020 | DrugBank ID:DB01630
+BMGC_DG11227,BMG_DG154958,"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid | DrugBank ID:DB04152 | PubChem CID:5288598"
+BMGC_DG11228,BMG_DG154959,"DrugBank ID:DB02028 | PubChem CID:5288599 | (1R,2R,3S,4R,6S)-3,4,6-Trihydroxy-5-{[(S)-hydroxy(3-hydroxy-2-oxopropoxy)phosphoryl]oxy}-1,2-cyclohexanediyl bis[dihydrogen (phosphate)]"
+BMGC_DG11229,BMG_DG154960,IC261 | PubChem CID:5288600 | DrugBank ID:DB03083
+BMGC_DG11230,BMG_DG154961,DrugBank ID:DB07956 | [1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER | PubChem CID:5288602
+BMGC_DG11231,BMG_DG154963,"DrugBank ID:DB02303 | PubChem CID:5288605 | (5S)-5-Iododihydro-2,4(1H,3H)-pyrimidinedione"
+BMGC_DG11232,BMG_DG154964,"PubChem SID:485663700 | UNII:AA4AFP7MFA | PubChem CID:5288606 | 7-IODO-1,2,3,4-TETRAHYDROISOQUINOLINE | 7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline | DrugBank ID:DB03824 | 7-Iodo-1,2,3,4-tetrahydroisoquinoline | CAS RN:72299-62-8"
+BMGC_DG11233,BMG_DG154966,"PubChem CID:5288615 | (3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE | DrugBank ID:DB07964"
+BMGC_DG11234,BMG_DG154967,6-(cyclohexylamino)-9-[2-(4-methylpiperazin-1-yl)-ethyl]-9H-purine-2-carbonitrile | PubChem CID:5288616 | DrugBank ID:DB07965
+BMGC_DG11235,BMG_DG154970,"PubChem CID:5288631 | Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone | DrugBank ID:DB02872"
+BMGC_DG11236,BMG_DG154971,"Dibenzyl (carbonylbis{2,1-hydrazinediyl[(2S)-4-methyl-1-oxo-1,2-pentanediyl]})biscarbamate | PubChem CID:5288634 | DrugBank ID:DB03891"
+BMGC_DG11237,BMG_DG154972,(2R)-2-Acetamido-3-(octadecyloxy)propyl 2-(methylsulfanyl)ethyl hydrogen phosphate | PubChem CID:5288635 | DrugBank ID:DB04112
+BMGC_DG11238,BMG_DG154975,PubChem CID:5288641 | Indirubin-5-sulphonate | DrugBank ID:DB02519
+BMGC_DG11239,BMG_DG154978,"DrugBank ID:DB04150 | N-alpha-Acetyl-3,5-diiodotyrosyl-D-threonine | PubChem CID:5288651"
+BMGC_DG11240,BMG_DG154979,DrugBank ID:DB03850 | Jaspisamide A | PubChem CID:5288653
+BMGC_DG11241,BMG_DG154980,DrugBank ID:DB03616 | PubChem CID:5288658 | Kabiramide C
+BMGC_DG11242,BMG_DG154981,DrugBank ID:DB02247 | Hydrolyzed Cephalothin | PubChem CID:5288660
+BMGC_DG11243,BMG_DG154982,"UNII:9G3DCA3958 | Lexacalcitol | (1R,3S,5Z)-5-[(2E)-2-[(1S,3aS,7aS)-1-[(1R)-1-(4-ethyl-4-hydroxyhexoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | PubChem CID:5288670 | PubChem SID:198951177 | CAS RN:131875-08-6 | LEXACALCITOL | DrugBank ID:DB03451"
+BMGC_DG11244,BMG_DG154983,"[(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-[2-(dimethylamino)ethylamino]-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate | ALVESPIMYCIN | PubChem CID:5288674 | DrugBank ID:DB12442 | CAS RN:150270-08-9 | CAS RN:467214-20-6 | PubChem SID:198969222 | UNII:001L2FE0M3 | Alvespimycin"
+BMGC_DG11245,BMG_DG154985,"PubChem CID:5288679 | 1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE | DrugBank ID:DB08063"
+BMGC_DG11246,BMG_DG154986,"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol | PubChem CID:5288685 | DrugBank ID:DB03996"
+BMGC_DG11247,BMG_DG154987,"[(2S,3S,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl] phosphate | DrugBank ID:DB03542 | L-Myo-Inositol-1-Phosphate | PubChem CID:5288700"
+BMGC_DG11248,BMG_DG154989,"N-Methyl-4-{[(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}benzenesulfonamide | PubChem CID:5288708 | DrugBank ID:DB08122"
+BMGC_DG11249,BMG_DG154990,"N-methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide | DrugBank ID:DB08123 | PubChem CID:5288709"
+BMGC_DG11250,BMG_DG154991,"DrugBank ID:DB08124 | 3-{[(2,2-dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5-(1,3-oxazol-5-yl)-1,3-dihydro-2H-indol-2-one | PubChem CID:5288710"
+BMGC_DG11251,BMG_DG154992,"PubChem CID:5288711 | DrugBank ID:DB08125 | 4-{[(2-Oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]amino}-N-(1,3-thiazol-2-yl)benzenesulfonamide"
+BMGC_DG11252,BMG_DG154993,"PubChem CID:5288712 | DrugBank ID:DB08126 | 3-{[4-([amino(imino)methyl]aminosulfonyl)anilino]methylene}-2-oxo-2,3-dihydro-1H-indole"
+BMGC_DG11253,BMG_DG154995,"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE | DrugBank ID:DB08159 | PubChem CID:5288720"
+BMGC_DG11254,BMG_DG154997,DrugBank ID:DB02730 | PubChem CID:5288724 | 4-Methylthio-Alpha-D-Mannose
+BMGC_DG11255,BMG_DG154998,UNII:H5152L2RBJ | CAS RN:3913-67-5 | PubChem CID:5288725 | PubChem SID:363908925 | N-METHYLALANINE
+BMGC_DG11256,BMG_DG155000,"Calcipotriene | NDC:51672-4154 | NDC:51407-605 | DrugBank ID:DB02300 | PubChem SID:175268784 | NDC:51862-512 | NDC:66993-878 | NDC:68462-501 | CALCIPOTRIENE | NDC:0713-0318 | CAS RN:112828-00-9 | CAS RN:112965-21-6 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | NDC:51672-5278 | NDC:16714-763 | UNII:143NQ3779B | PubChem CID:5288783 | NDC:51862-376 | NDC:68462-310 | NDC:66993-877 | Calcipotriol"
+BMGC_DG11257,BMG_DG155003,"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID | DrugBank ID:DB08175 | PubChem CID:5288795"
+BMGC_DG11258,BMG_DG155005,PubChem CID:5288799 | DrugBank ID:DB04021 | MF268
+BMGC_DG11259,BMG_DG155008,"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide | DrugBank ID:DB02350 | PubChem CID:5288814"
+BMGC_DG11260,BMG_DG155011,DrugBank ID:DB03126 | Mant-Adp | PubChem CID:5288821
+BMGC_DG11261,BMG_DG155012,"Morphine | PubChem SID:175268905 | NDC:42799-217 | NDC:62559-153 | MORPHINE | (4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol | NDC:63629-1965 | CAS RN:57-27-2 | PubChem CID:5288826 | UNII:76I7G6D29C | DrugBank ID:DB00295"
+BMGC_DG11262,BMG_DG155015,"DrugBank ID:DB08213 | PubChem CID:5288850 | 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE"
+BMGC_DG11263,BMG_DG155016,"PubChem CID:5288859 | (4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide | DrugBank ID:DB04081"
+BMGC_DG11264,BMG_DG155018,DrugBank ID:DB04234 | N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide | PubChem CID:5288867
+BMGC_DG11265,BMG_DG155019,PubChem CID:5288869 | 4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide | DrugBank ID:DB02243
+BMGC_DG11266,BMG_DG155020,DrugBank ID:DB08251 | 4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID | PubChem CID:5288878
+BMGC_DG11267,BMG_DG155022,PubChem CID:5288910 | DrugBank ID:DB04678 | H TYPE II TRISACCHARIDE
+BMGC_DG11268,BMG_DG155025,PubChem CID:5288980 | 2-Iminiopropanoate | DrugBank ID:DB04212 | 2-iminopropanoic acid | CAS RN:3125-84-6
+BMGC_DG11269,BMG_DG155028,N2-[(benzyloxy)carbonyl]-n1-[(3S)-1-cyanopyrrolidin-3-yl]-l-leucinamide | DrugBank ID:DB03456 | PubChem CID:5288988
+BMGC_DG11270,BMG_DG155030,DrugBank ID:DB02382 | PubChem CID:5288991 | Namn
+BMGC_DG11271,BMG_DG155031,PubChem CID:5288998 | DrugBank ID:DB08263 | N-(carboxycarbonyl)-D-phenylalanine
+BMGC_DG11272,BMG_DG155035,PubChem SID:198989904 | CAS RN:179030-22-9 | UNII:ML5FHL557A | PubChem CID:5289024 | N-ACETYL-GLUCOSAMINE THIAZOLINE | DrugBank ID:DB03747 | N-Acetyl-glucosamine thiazoline
+BMGC_DG11273,BMG_DG155038,PubChem CID:5289037 | (R)-N-(1-Methyl-Hexyl)-Formamide | DrugBank ID:DB03061
+BMGC_DG11274,BMG_DG155039,DrugBank ID:DB04230 | PubChem CID:5289039 | Nitromethyldethia coenzyme A
+BMGC_DG11275,BMG_DG155049,6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid | DrugBank ID:DB03187 | PubChem CID:5289084
+BMGC_DG11276,BMG_DG155050,PubChem CID:5289085 | CAS RN:103455-29-4 | METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE | Methyl (2Z)-3-methoxy-2-{2-[(E)-2-phenylvinyl]phenyl}acrylate | DrugBank ID:DB08330 | methyl (E)-3-methoxy-2-[2-[(E)-2-phenylethenyl]phenyl]prop-2-enoate
+BMGC_DG11277,BMG_DG155051,PubChem SID:472397393 | Ovalicin | UNII:B05Y6V2CZS | PubChem CID:5289086 | OVALBUMIN | CAS RN:9006-59-1 | DrugBank ID:DB04324
+BMGC_DG11278,BMG_DG155053,"PubChem CID:5289090 | CAS RN:62702-55-0 | 4-Oxoretinol | UNII:6FFM6M3NPT | DrugBank ID:DB02699 | 4-KETORETINOL | PubChem SID:440089747 | 3-[(1E,3E,5E,7E)-9-hydroxy-3,7-dimethylnona-1,3,5,7-tetraenyl]-2,4,4-trimethylcyclohex-2-en-1-one"
+BMGC_DG11279,BMG_DG155055,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5S)-5-(6-carbamoylpyridin-1-ium-2-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate | PubChem CID:5289104 | Cpad"
+BMGC_DG11280,BMG_DG155058,DrugBank ID:DB02878 | PubChem CID:5289108 | 3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid
+BMGC_DG11281,BMG_DG155059,"DrugBank ID:DB04759 | CAS RN:544678-82-2 | PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE) | N4,N6-BIS((3-METHYLPHENYL)METHYL)PYRIMIDINE-4,6-DICARBOXAMIDE | UNII:X969YB2837 | PubChem SID:445499809 | PubChem CID:5289109"
+BMGC_DG11282,BMG_DG155060,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE) | PubChem CID:5289110 | DrugBank ID:DB04760"
+BMGC_DG11283,BMG_DG155061,"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE] | DrugBank ID:DB04761 | PubChem CID:5289111"
+BMGC_DG11284,BMG_DG155062,S-(4-BROMOBENZYL)CYSTEINE | DrugBank ID:DB08370 | PubChem CID:5289112
+BMGC_DG11285,BMG_DG155065,N2-[(Benzyloxy)carbonyl]-N-[(3R)-1-{N-[(benzyloxy)carbonyl]-L-leucyl}-4-oxo-3-pyrrolidinyl]-L-leucinamide | PubChem CID:5289122 | DrugBank ID:DB03405
+BMGC_DG11286,BMG_DG155073,DrugBank ID:DB02423 | PubChem CID:5289158 | Thiopyrophosphate
+BMGC_DG11287,BMG_DG155074,"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM | DrugBank ID:DB04763 | PubChem CID:5289159"
+BMGC_DG11288,BMG_DG155075,"2-[(2,4-dichlorobenzoyl)amino]-5-pyrimidin-2-yloxybenzoic acid | 2-[(2,4-Dichlorobenzoyl)amino]-5-(pyrimidin-2-yloxy)benzoic acid | DrugBank ID:DB08402 | PubChem CID:5289162 | 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID | CAS RN:756813-87-3"
+BMGC_DG11289,BMG_DG155076,"DrugBank ID:DB04006 | [2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone | PubChem CID:5289179"
+BMGC_DG11290,BMG_DG155077,DrugBank ID:DB08420 | 1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID | PubChem CID:5289192
+BMGC_DG11291,BMG_DG155080,"DrugBank ID:DB03015 | PubChem CID:5289205 | 6-hydroxy-1,6-dihydro purine nucleoside"
+BMGC_DG11292,BMG_DG155082,DrugBank ID:DB04767 | PubChem CID:5289214 | N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID
+BMGC_DG11293,BMG_DG155083,PASBN | PubChem CID:5289215 | DrugBank ID:DB03078
+BMGC_DG11294,BMG_DG155085,PubChem CID:5289227 | DrugBank ID:DB03899 | 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
+BMGC_DG11295,BMG_DG155086,DrugBank ID:DB03809 | PubChem CID:5289228 | 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
+BMGC_DG11296,BMG_DG155087,"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine | DrugBank ID:DB03137 | PubChem CID:5289232"
+BMGC_DG11297,BMG_DG155090,"DrugBank ID:DB04769 | PubChem CID:5289247 | 5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE"
+BMGC_DG11298,BMG_DG155091,PubChem CID:5289258 | WRR-99 | DrugBank ID:DB03573
+BMGC_DG11299,BMG_DG155096,PubChem CID:5289284 | Reidispongiolide A | DrugBank ID:DB04774
+BMGC_DG11300,BMG_DG155097,PubChem CID:5289288 | DrugBank ID:DB03903 | Tmr
+BMGC_DG11301,BMG_DG155098,PubChem CID:5289289 | 5-Hydroxy-N-Propargyl-1(R)-Aminoindan | DrugBank ID:DB04307
+BMGC_DG11302,BMG_DG155101,WRR-112 | DrugBank ID:DB03691 | PubChem CID:5289294
+BMGC_DG11303,BMG_DG155102,"UNII:1Y7XS87IZR | CAS RN:124192-87-6 | DrugBank ID:DB02211 | (R)-N-methyl-N-2-propynyl-1-indanamine | PubChem SID:287445964 | PubChem CID:5289295 | N-METHYL-N-2-PROPYNYL-1-INDANAMINE, (R)-"
+BMGC_DG11304,BMG_DG155103,UNII:5563QWW82B | PubChem CID:5289296 | (2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol | DrugBank ID:DB04776 | CAS RN:866893-90-5 | AFTIN-4
+BMGC_DG11305,BMG_DG155109,"RASAGILINE, (S)- | PubChem SID:478839162 | N-Propargyl-1(S)-aminoindan | UNII:4KM7HJ6CBA | DrugBank ID:DB03894 | Rasagiline, (S)- | CAS RN:185517-74-2 | (1S)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine | PubChem CID:5289310 | N-Propargyl-1(S)-Aminoindan"
+BMGC_DG11306,BMG_DG155111,"PubChem CID:5289314 | DrugBank ID:DB08493 | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID"
+BMGC_DG11307,BMG_DG155112,RWJ-51084 | DrugBank ID:DB03251 | PubChem CID:5289320
+BMGC_DG11308,BMG_DG155113,"PubChem CID:5289321 | (2E,3S)-3-hydroxy-5'-[(4-hydroxypiperidin-1-yl)sulfonyl]-3-methyl-1,3-dihydro-2,3'-biindol-2'(1'H)-one | DrugBank ID:DB03583"
+BMGC_DG11309,BMG_DG155114,DrugBank ID:DB08510 | PubChem CID:5289324 | 5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE
+BMGC_DG11310,BMG_DG155119,CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE | DrugBank ID:DB08526 | PubChem CID:5289332
+BMGC_DG11311,BMG_DG155120,"DrugBank ID:DB04369 | 1,3,2-Dioxaborolan-2-Ol | PubChem CID:5289333"
+BMGC_DG11312,BMG_DG155121,"Diamino-N-[3-(1,3,2-dioxaborolan-2-yloxy)propyl]methaniminium | DrugBank ID:DB03129 | PubChem CID:5289336"
+BMGC_DG11313,BMG_DG155122,"[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine | DrugBank ID:DB04109 | PubChem CID:5289339"
+BMGC_DG11314,BMG_DG155124,"PubChem CID:5289347 | UNII:2D08A509S3 | CAS RN:163660-59-1 | PubChem SID:198958460 | MDL-101146, (S)-"
+BMGC_DG11315,BMG_DG155125,DrugBank ID:DB02148 | 3-Amino-4-Oxybenzyl-2-Butanone | PubChem CID:5289348
+BMGC_DG11316,BMG_DG155126,DrugBank ID:DB01684 | 1-Hydroxy-1-Thio-Glycerol | PubChem CID:5289354
+BMGC_DG11317,BMG_DG155127,PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE | DrugBank ID:DB08547 | PubChem CID:5289373
+BMGC_DG11318,BMG_DG155133,PubChem CID:5289389 | N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide | DrugBank ID:DB04232
+BMGC_DG11319,BMG_DG155136,PubChem CID:5289411 | DrugBank ID:DB08572 | 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE
+BMGC_DG11320,BMG_DG155137,DrugBank ID:DB03683 | 2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid | PubChem CID:5289415
+BMGC_DG11321,BMG_DG155138,"PubChem CID:5289417 | DrugBank ID:DB08575 | 2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM"
+BMGC_DG11322,BMG_DG155139,DrugBank ID:DB08577 | 3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE | PubChem CID:5289418
+BMGC_DG11323,BMG_DG155140,CAS RN:377090-84-1 | UNII:FD2SWT2SDI | PubChem CID:5289419 | SU9516 | SU-9516 | PubChem SID:438788194 | DrugBank ID:DB03428
+BMGC_DG11324,BMG_DG155141,[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester | DrugBank ID:DB01871 | PubChem CID:5289424
+BMGC_DG11325,BMG_DG155142,TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE | DrugBank ID:DB08594 | PubChem CID:5289428
+BMGC_DG11326,BMG_DG155143,DrugBank ID:DB02977 | PubChem CID:5289442 | PNU177836
+BMGC_DG11327,BMG_DG155145,"DrugBank ID:DB03202 | 2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide | PubChem CID:5289459"
+BMGC_DG11328,BMG_DG155146,"DrugBank ID:DB08614 | PubChem CID:5289460 | 3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE"
+BMGC_DG11329,BMG_DG155149,"PubChem CID:5289469 | DrugBank ID:DB02597 | [2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala"
+BMGC_DG11330,BMG_DG155151,"DrugBank ID:DB08629 | N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE | PubChem CID:5289474"
+BMGC_DG11331,BMG_DG155152,"2'-Deoxy-2'-[(3,5-dimethoxybenzoyl)amino]-N-[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]adenosine | PubChem CID:5289484 | DrugBank ID:DB04477"
+BMGC_DG11332,BMG_DG155154,"UNII:673M8C29UR | Ttnpb | PubChem CID:5289501 | AROTINOID ACID | DrugBank ID:DB02877 | 4-[(E)-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid | CAS RN:71441-28-6 | PubChem SID:198982342 | Arotinoid acid"
+BMGC_DG11333,BMG_DG155155,"PubChem CID:5289507 | 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium | DrugBank ID:DB02226"
+BMGC_DG11334,BMG_DG155156,"PubChem CID:5289508 | DrugBank ID:DB03005 | 3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium"
+BMGC_DG11335,BMG_DG155158,PubChem CID:5289510 | 2-(Sec-Butyl)Thiazole | DrugBank ID:DB03087
+BMGC_DG11336,BMG_DG155159,PubChem CID:5289514 | Triazolopyridine | DrugBank ID:DB04797
+BMGC_DG11337,BMG_DG155160,DrugBank ID:DB04798 | THIO-ATPA | PubChem CID:5289517
+BMGC_DG11338,BMG_DG155161,DrugBank ID:DB03046 | 7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide | PubChem CID:5289529
+BMGC_DG11339,BMG_DG155162,"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine | PubChem CID:5289531 | DrugBank ID:DB04172"
+BMGC_DG11340,BMG_DG155163,PubChem CID:5289534 | 2'-fluoro-2'-deoxyuridine 3'-monophosphate | DrugBank ID:DB03155
+BMGC_DG11341,BMG_DG155164,PubChem CID:5289535 | DrugBank ID:DB04268 | Methylumbelliferyl chitotriose
+BMGC_DG11342,BMG_DG155167,"UNII:N75R59YD0F | (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S)-butan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-methylidenecyclohexane-1,3-diol | CAS RN:524067-21-8 | BECOCALCIDIOL | DrugBank ID:DB04891 | PubChem SID:198985821 | Becocalcidiol | PubChem CID:5289547"
+BMGC_DG11343,BMG_DG155169,DrugBank ID:DB04235 | 4-Amino Hexanoic Acid | PubChem CID:5289553
+BMGC_DG11344,BMG_DG155178,"CAS RN:551-84-8 | D-xylulose | PubChem SID:249492162 | PubChem SID:241178021 | XYLULOSE, D- | UNII:9N4LZL67SA | CAS RN:5962-29-8 | (3S,4R)-1,3,4,5-tetrahydroxypentan-2-one | XYLULOSE, DL- | PubChem CID:5289590 | UNII:YSC9WAF8X1"
+BMGC_DG11345,BMG_DG155182,PubChem CID:5289613 | PubChem SID:438788300 | UNII:X538NC636R | CAS RN:6093-71-6 | 3-CARBETHOXYUMBELIFERONE | DrugBank ID:DB02728 | 7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester
+BMGC_DG11346,BMG_DG155187,2-Phosphoglycolic Acid | 2-phosphonooxyacetic acid | DrugBank ID:DB02726 | CAS RN:13147-57-4 | UNII:H8593JOP13 | PubChem SID:249492699 | PubChem CID:529 | PHOSPHOGLYCOLATE
+BMGC_DG11347,BMG_DG155200,4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | CAS RN:152459-95-5 | PubChem CID:5291 | IMATINIB | DrugBank ID:DB00619 | Imatinib | UNII:BKJ8M8G5HI | CAS RN:1080014-82-9 | PubChem SID:175267708
+BMGC_DG11348,BMG_DG155202,"PADSEVONIL | DrugBank ID:DB14977 | Padsevonil | CAS RN:1294000-61-5 | UNII:0R1HN52K0N | PubChem CID:52911611 | PubChem SID:317229028 | (4R)-4-(2-chloro-2,2-difluoroethyl)-1-[[2-(methoxymethyl)-6-(trifluoromethyl)imidazo[2,1-b][1,3,4]thiadiazol-5-yl]methyl]pyrrolidin-2-one"
+BMGC_DG11349,BMG_DG155204,tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate | PubChem CID:52912218 | CAS RN:1303512-02-8 | UNII:2KL3NSB2NP | Izilendustat | IZILENDUSTAT | PubChem SID:461433513
+BMGC_DG11350,BMG_DG155206,"PubChem SID:317229672 | CAS RN:1293915-42-0 | UNII:06H865SCMW | 6-[2-[[4-amino-3-(3-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-3-[(2-chlorophenyl)methyl]-4-oxoquinazolin-5-yl]-N,N-bis(2-methoxyethyl)hex-5-ynamide | PubChem CID:52913198 | RV-1729"
+BMGC_DG11351,BMG_DG155207,"DrugBank ID:DB15048 | UNII:57J06X6EI0 | Licogliflozin | CAS RN:1291094-73-9 | PubChem CID:52913524 | LICOGLIFLOZIN | (2S,3R,4R,5S,6R)-2-[3-(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)-4-ethylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | PubChem SID:363908127"
+BMGC_DG11352,BMG_DG155208,"AZD-8186 | CAS RN:1296270-45-5 | UNII:AIQ4OWD0RA | Azd-8186 | PubChem SID:255509018 | PubChem CID:52913813 | 8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide | CAS RN:1627494-13-6 | DrugBank ID:DB15029"
+BMGC_DG11353,BMG_DG155209,"1-[(3R)-3-[2-[4-hydroxy-1-[(2R,3S)-2-propyl-1-[3-(trifluoromethyl)pyridine-2-carbonyl]-3-[5-(trifluoromethyl)thiophen-3-yl]oxypiperidine-3-carbonyl]piperidin-4-yl]phenoxy]butyl]cyclobutane-1-carboxylic acid | PubChem CID:52914022"
+BMGC_DG11354,BMG_DG155218,"1-(4-fluorophenyl)-N-[1-(2-methylsulfonylpyridin-4-yl)cyclopropyl]pyrazolo[3,4-c]pyridine-4-carboxamide | CAS RN:1295298-26-8 | PubChem CID:52916803 | CCR1 antagonist 8"
+BMGC_DG11355,BMG_DG155223,"UNII:N0493335P3 | CAS RN:104138-64-9 | PubChem SID:198956158 | PubChem CID:52918379 | CAS RN:928659-70-5 | N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide;(2R,3R)-2,3-dihydroxybutanedioic acid | Eliglustat Tartrate | ELIGLUSTAT TARTRATE"
+BMGC_DG11356,BMG_DG155227,"LANOPEPDEN | PubChem CID:52918384 | N-[(2R)-3-[2-[6-[(9aS)-3,4,6,7,9,9a-hexahydro-1H-pyrazino[2,1-c][1,4]oxazin-8-yl]-5-fluoro-2-methylpyrimidin-4-yl]hydrazinyl]-2-(cyclopentylmethyl)-3-oxopropyl]-N-hydroxyformamide | PubChem SID:198964338 | Lanopepden | CAS RN:1152107-25-9 | UNII:12M6KFD07E | DrugBank ID:DB11912"
+BMGC_DG11357,BMG_DG155228,DrugBank ID:DB11684 | PubChem CID:52918385 | EPRENETAPOPT | CAS RN:5291-32-7 | 2-(hydroxymethyl)-2-(methoxymethyl)-1-azabicyclo[2.2.2]octan-3-one | UNII:Z41TGB4080 | PubChem SID:198963714 | Eprenetapopt
+BMGC_DG11358,BMG_DG155232,NDC:70756-624 | Haloperidol Decanoate | NDC:68001-580 | NDC:70756-616 | NDC:50458-254 | NDC:68083-137 | NDC:71288-504 | NDC:25021-831 | PubChem SID:175267908 | NDC:70710-1462 | NDC:70069-384 | NDC:0143-9295 | NDC:70771-1854 | NDC:70069-031 | NDC:0143-9296 | NDC:71288-503 | NDC:70518-3743 | NDC:10147-0921 | NDC:70771-1853 | NDC:10147-0922 | NDC:63323-469 | NDC:71288-502 | NDC:72603-230 | NDC:70710-1461 | NDC:70518-4240 | NDC:70069-382 | NDC:70771-1852 | NDC:68083-138 | NDC:25021-833 | NDC:70069-030 | UNII:AC20PJ4101 | CAS RN:74050-97-8 | NDC:67457-410 | NDC:68001-581 | NDC:50458-253 | NDC:70710-1463 | [4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate | NDC:70069-383 | NDC:67457-409 | NDC:70518-3170 | NDC:70756-615 | NDC:70756-625 | NDC:70069-381 | NDC:68001-582 | PubChem CID:52919 | NDC:63323-471 | NDC:68001-578 | NDC:68001-579 | HALOPERIDOL DECANOATE | NDC:70771-1851 | NDC:25021-834 | NDC:70710-1464
+BMGC_DG11359,BMG_DG155240,CAS RN:1816307-67-1 | PubChem SID:363908229 | UNII:B2K5L1L8S9 | SURUFATINIB | Surufatinib | N-[2-(dimethylamino)ethyl]-1-[3-[[4-[(2-methyl-1H-indol-5-yl)oxy]pyrimidin-2-yl]amino]phenyl]methanesulfonamide | DrugBank ID:DB15106 | PubChem CID:52920501 | CAS RN:1308672-74-3
+BMGC_DG11360,BMG_DG157107,"CAS RN:1301214-47-0 | UNII:P826WR56FI | DrugBank ID:DB12096 | PubChem CID:52934180 | Pf-05175157 | PubChem SID:313183866 | PF-05175157 | 1'-(2-methyl-3H-benzimidazole-5-carbonyl)-1-propan-2-ylspiro[4,6-dihydroindazole-5,4'-piperidine]-7-one"
+BMGC_DG11361,BMG_DG157111,"CAS RN:1303420-67-8 | PLX-5622 | Plx-5622 | 6-fluoro-N-[(5-fluoro-2-methoxypyridin-3-yl)methyl]-5-[(5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]pyridin-2-amine | UNII:16A8IGR8L7 | PubChem SID:433968618 | PubChem CID:52936034"
+BMGC_DG11362,BMG_DG157112,"CAS RN:1558680-22-0 | CAS RN:949926-49-2 | CAS RN:10163-13-0 | Vitamin P | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[3,4,5-trihydroxy-6-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxymethyl]oxan-2-yl]oxychromen-4-one | PubChem CID:5293655"
+BMGC_DG11363,BMG_DG157113,HS-173 | UNII:2758X982JL | PubChem CID:52936849 | CAS RN:1276110-06-5 | PubChem SID:461432345
+BMGC_DG11364,BMG_DG157114,UNII:M8VQ6F3WFE | 4-((4-CHLOROPHENYL)METHYL)-2-(2-(1-METHYL-2-PYRROLIDINYL)ETHYL)-1(2H)-PHTHALAZINONE | PubChem CID:52937223 | PubChem SID:445500309 | CAS RN:756415-37-9
+BMGC_DG11365,BMG_DG157118,"OZANIMOD | PubChem SID:249492284 | PubChem CID:52938427 | UNII:Z80293URPV | CAS RN:1306760-87-1 | 5-[3-[(1S)-1-(2-hydroxyethylamino)-2,3-dihydro-1H-inden-4-yl]-1,2,4-oxadiazol-5-yl]-2-propan-2-yloxybenzonitrile | Ozanimod | DrugBank ID:DB12612"
+BMGC_DG11366,BMG_DG157127,"CAS RN:1146594-87-7 | PubChem SID:313182930 | (2S)-2-[3,5-bis[4-(trifluoromethyl)phenyl]phenyl]-4-methylpentanoic acid | UNII:Z1CWW31SGG | PubChem CID:52939724 | Jnj-40418677 | JNJ-40418677"
+BMGC_DG11367,BMG_DG157193,"DrugBank ID:DB07016 | PubChem CID:52942975 | (3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline"
+BMGC_DG11368,BMG_DG157194,7-HYDROXY-8-PROPIONYLCOUMARIN | PubChem SID:459056018 | PubChem CID:52943164 | UNII:XFH3YU7A9E | CAS RN:67752-18-5
+BMGC_DG11369,BMG_DG157201,PubChem CID:52945601 | 7-EPI-HYDROXY-MIDOSTAURIN | UNII:BEF4G8P8SL | PubChem SID:445499754 | CAS RN:945260-14-0
+BMGC_DG11370,BMG_DG157203,CAS RN:1254475-25-6 | UNII:XQ284SXA44 | PubChem CID:52946209 | PubChem SID:472421785 | 3-(1-BENZYLPIPERIDIN-4-YL)OXYBENZAMIDE
+BMGC_DG11371,BMG_DG157206,DrugBank ID:DB04775 | Reidispongiolide C | PubChem CID:52946592
+BMGC_DG11372,BMG_DG157207,Phosphatidyl ethanol | PubChem CID:52946593 | DrugBank ID:DB04752
+BMGC_DG11373,BMG_DG157211,CAS RN:579-13-5 | PubChem SID:198949589 | PubChem CID:52947716 | OLIGOMYCIN A | UNII:05HQS4AI99
+BMGC_DG11374,BMG_DG157215,PubChem CID:52949062 | DrugBank ID:DB01741 | CRA_17693
+BMGC_DG11375,BMG_DG157216,"DrugBank ID:DB12694 | PubChem SID:198974506 | UNII:1FGZ6L9SF2 | N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-6-yl]-N-propan-2-ylacetamide | CAS RN:870615-40-0 | CE-326597 | Ce-326597 | PubChem CID:52949124"
+BMGC_DG11376,BMG_DG157221,7-HYDROXY-6-PROPANOYLCOUMARIN | UNII:F7TK7AU3MZ | PubChem CID:52949920 | CAS RN:144582-52-5 | PubChem SID:441659714
+BMGC_DG11377,BMG_DG157224,PubChem SID:198973337 | UNII:3934EF02T7 | (2S)-2-[[(1S)-1-carboxy-5-[(6-(18F)fluoranylpyridine-3-carbonyl)amino]pentyl]carbamoylamino]pentanedioic acid | Piflufolastat F-18 | PubChem CID:52950901 | NDC:71258-022 | DrugBank ID:DB14805 | PIFLUFOLASTAT F-18 | CAS RN:1207181-29-0
+BMGC_DG11378,BMG_DG157225,"PubChem CID:52951810 | UNII:DQY244459T | (2S)-2-[(2-fluorophenyl)methyl]-3-(2-fluorospiro[4,5-dihydrothieno[2,3-c]pyran-7,4'-piperidine]-1'-yl)-N-methylpropanamide | NOP-1A | DrugBank ID:DB15208 | Nop-1a | CAS RN:1283095-70-4 | PubChem SID:198961951"
+BMGC_DG11379,BMG_DG157226,PubChem CID:52951990 | CAS RN:1287761-01-6 | 1-[3-[5-phenyl-1-(4-sulfamoylphenyl)pyrazol-3-yl]propyl]-3-[4-(trifluoromethyl)phenyl]urea | Ptupb
+BMGC_DG11380,BMG_DG157264,PubChem CID:53001 | CAS RN:103735-00-8 | CAS RN:78218-09-4 | PubChem SID:198967903 | UNII:09ZFC7974Q | 4-(2-imidazol-1-ylethoxy)benzoic acid | DAZOXIBEN | DrugBank ID:DB03052 | Dazoxiben
+BMGC_DG11381,BMG_DG157265,"UNII:A5FDJ8VT8U | 5-Pyridin-4-yl-1,3,4-thiadiazole-2-thiol | PubChem CID:5300214 | PubChem SID:485663481 | 5-PYRIDIN-4-YL-1,3,4-THIADIAZOLE-2-THIOL | CAS RN:13581-25-4"
+BMGC_DG11382,BMG_DG157269,"CAS RN:74356-00-6 | Cefotetan disodium | NDC:0121-0977 | disodium;(6R,7S)-7-[[4-(2-amino-1-carboxylato-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | NDC:0121-0976 | CEFOTETAN DISODIUM | PubChem CID:53024 | NDC:63323-386 | UNII:0GXP746VXB | NDC:63323-385 | PubChem SID:472386255"
+BMGC_DG11383,BMG_DG157270,"CAS RN:69712-56-7 | NDC:0143-9670 | PubChem SID:472385823 | NDC:0143-9671 | UNII:48SPP0PA9Q | DrugBank ID:DB01330 | (6R,7S)-7-[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CEFOTETAN | PubChem CID:53025 | Cefotetan"
+BMGC_DG11384,BMG_DG157271,"PubChem CID:53029828 | 3-(4-Bromophenyl)-8-(methylsulfonyl)-1,4,8-triazaspiro[4.5]dec-3-en-2-one | 3-(4-bromophenyl)-8-methylsulfonyl-1,4,8-triazaspiro[4.5]dec-3-en-2-one"
+BMGC_DG11385,BMG_DG157275,"UNII:86S23H0DSX | 2,3,4,4',5-PENTACHLOROBIPHENYL | PubChem SID:198964582 | 2,3,4,4',5-Pentachlorobiphenyl | CAS RN:74472-37-0 | PubChem CID:53036 | 1,2,3,4-tetrachloro-5-(4-chlorophenyl)benzene"
+BMGC_DG11386,BMG_DG157297,ethyl (2S)-2-amino-5-[[(2R)-3-benzylsulfanyl-1-[[(1R)-2-ethoxy-2-oxo-1-phenylethyl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoate | PubChem SID:198941834 | UNII:057D10I8S8 | DrugBank ID:DB05460 | EZATIOSTAT | PubChem CID:5310939 | Ezatiostat | CAS RN:168682-53-9
+BMGC_DG11387,BMG_DG157299,"(1S,2S)-2-[(S)-amino(carboxy)methyl]cyclopropane-1-carboxylic acid | CAS RN:117857-93-9 | (2S,1'S,2'S)-2-(carboxycyclopropyl)glycine | PubChem CID:5310956"
+BMGC_DG11388,BMG_DG157301,"PubChem CID:5310960 | Mcp-neca | 1-[4-(furan-2-yl)-11-propyl-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(12),2,4,7,9-pentaen-7-yl]-3-(4-methoxyphenyl)urea | CAS RN:252979-43-4"
+BMGC_DG11389,BMG_DG157302,"UNII:W6HS99O8ZO | Varenicline | PubChem SID:175265331 | VARENICLINE | DrugBank ID:DB01273 | PubChem CID:5310966 | (1R,12S)-5,8,14-triazatetracyclo[10.3.1.02,11.04,9]hexadeca-2,4,6,8,10-pentaene | CAS RN:249296-44-4"
+BMGC_DG11390,BMG_DG157303,(E)-N-methyl-4-pyridin-3-ylbut-3-en-1-amine | Rivanicline | CAS RN:538-79-4 | UNII:6H35LF645A | DrugBank ID:DB05855 | CAS RN:15585-43-0 | RIVANICLINE | PubChem SID:198984640 | PubChem CID:5310967
+BMGC_DG11391,BMG_DG157305,UNII:C3VZ57BN3M | AR-R-17779 | PubChem CID:5310971 | CAS RN:178419-47-1 | PubChem SID:381608502
+BMGC_DG11392,BMG_DG157306,"Dcg-IV | (1R,2R)-3-[(S)-amino(carboxy)methyl]cyclopropane-1,2-dicarboxylic acid | CAS RN:147782-19-2 | PubChem CID:5310979"
+BMGC_DG11393,BMG_DG157307,"PubChem CID:5310983 | CAS RN:43170-89-4 | [[(2R,3S,4R,5R)-5-(6-amino-2-methylsulfanylpurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | 2-Mesatp"
+BMGC_DG11394,BMG_DG157308,"GTS-21 | PubChem SID:198950881 | Dmxb-A | UNII:8S399XDN2K | CAS RN:148372-04-7 | DrugBank ID:DB05708 | PubChem CID:5310985 | 3-[(5E)-5-[(2,4-dimethoxyphenyl)methylidene]-3,4-dihydro-2H-pyridin-6-yl]pyridine | CAS RN:156223-05-1"
+BMGC_DG11395,BMG_DG157309,PubChem SID:404859471 | UNII:S2R6R1I2MP | CAS RN:38090-53-8 | 4-AMINOCROTONIC ACID | PubChem CID:5310987
+BMGC_DG11396,BMG_DG157310,"(4R,4aS,6E,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one | 7-Benzylidenenaltrexone | PubChem CID:5310988 | CAS RN:153611-34-8"
+BMGC_DG11397,BMG_DG157312,PubChem CID:5310991 | UNII:5XE882529E | A-192621 | CAS RN:195529-54-5 | PubChem SID:198937369
+BMGC_DG11398,BMG_DG157313,UNII:K9AY9IR2SD | CAS RN:51037-30-0 | ACIPIMOX | Acipimox | PubChem CID:5310993 | DrugBank ID:DB09055 | PubChem SID:198945059 | 5-methyl-4-oxidopyrazin-4-ium-2-carboxylic acid
+BMGC_DG11399,BMG_DG157315,UNII:58IFB293JI | CAS RN:1227736-21-1 | PubChem SID:175265828 | VORINOSTAT | CAS RN:149647-78-9 | PubChem CID:5311 | Vorinostat | N'-hydroxy-N-phenyloctanediamide | DrugBank ID:DB02546 | NDC:0006-0568
+BMGC_DG11400,BMG_DG157316,"Alclometasone | (7R,8S,9S,10R,11S,13S,14S,16R,17R)-7-chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | PubChem CID:5311000 | UNII:136H45TB7B | PubChem SID:175265310 | DrugBank ID:DB00240 | CAS RN:67452-97-5 | ALCLOMETASONE"
+BMGC_DG11401,BMG_DG157318,"PubChem SID:316912584 | PubChem CID:5311010 | DrugBank ID:DB09059 | ATOSIBAN | Atosiban | UNII:081D12SI0Z | CAS RN:90779-69-4 | (2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide"
+BMGC_DG11402,BMG_DG157319,PubChem CID:5311017 | DrugBank ID:DB00865 | (2S)-N-benzyl-N-methyl-1-phenylpropan-2-amine | Benzphetamine | UNII:0M3S43XK27 | CAS RN:156-08-1 | PubChem SID:175267688 | BENZPHETAMINE
+BMGC_DG11403,BMG_DG157320,"β-Funaltrexamine | PubChem CID:5311018 | Beta-Funaltrexamine | CAS RN:72782-05-9 | UNII:9YX958J3X9 | PubChem SID:478836990 | methyl (E)-4-[[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]amino]-4-oxobut-2-enoate | .BETA.-FUNALTREXAMINE"
+BMGC_DG11404,BMG_DG157322,UNII:QKC82E736Q | BIBO-3304 FREE BASE | PubChem SID:198976843 | PubChem CID:5311022 | CAS RN:191868-13-0
+BMGC_DG11405,BMG_DG157323,"UNII:RG9766UGZ8 | CAS RN:159013-54-4 | PubChem SID:474492380 | BIBP-3226 | (2R)-5-(diaminomethylideneamino)-2-[(2,2-diphenylacetyl)amino]-N-[(4-hydroxyphenyl)methyl]pentanamide | PubChem CID:5311023"
+BMGC_DG11406,BMG_DG157324,"NDC:70069-401 | NDC:70069-403 | NDC:0023-3616 | NDC:0023-3205 | NDC:0023-9652 | NDC:60505-0583 | NDC:72266-241 | BIMATOPROST | CAS RN:155206-00-1 | Bimatoprost | NDC:68083-439 | NDC:42571-128 | NDC:65862-802 | NDC:68071-3590 | DrugBank ID:DB00905 | NDC:62332-511 | NDC:72266-140 | NDC:72266-139 | PubChem CID:5311027 | NDC:46708-507 | NDC:46708-511 | (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide | NDC:0781-6206 | PubChem SID:175266561 | UNII:QXS94885MZ | NDC:68083-295 | NDC:68083-296 | NDC:70069-402 | NDC:62332-507 | NDC:68071-3612"
+BMGC_DG11407,BMG_DG157326,PubChem CID:5311035 | PubChem SID:198951555 | UNII:HP16WVP23Y | CAS RN:69648-38-0 | BUTAPROST
+BMGC_DG11408,BMG_DG157328,"UNII:2GZ0LIK7T4 | Istradefylline | NDC:42747-604 | 8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione | CAS RN:606080-73-3 | CAS RN:155270-99-8 | PubChem CID:5311037 | NDC:42747-602 | ISTRADEFYLLINE | PubChem SID:198959942 | DrugBank ID:DB11757"
+BMGC_DG11409,BMG_DG157329,"CAS RN:748136-54-1 | N-[2-[[2-phenyl-6-[4-(3-phenylpropyl)piperazine-1-carbonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethyl]acetamide | PubChem CID:5311041 | N-[2-[[2-phenyl-6-[4-(3-phenylpropyl)piperazine-1-carbonyl]-7H-pyrrolo[3,2-e]pyrimidin-4-yl]amino]ethyl]acetamide"
+BMGC_DG11410,BMG_DG157331,"PubChem CID:5311044 | PubChem SID:198987070 | CICAPROST | UNII:NE94J8CAMD | 2-[(2E)-2-[(3aS,4S,5R,6aS)-5-hydroxy-4-[(3S,4S)-3-hydroxy-4-methylnona-1,6-diynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]ethoxy]acetic acid | CAS RN:95722-07-9 | CAS RN:94079-80-8 | Cicaprost"
+BMGC_DG11411,BMG_DG157333,"4-amino-5-chloro-N-[(3R,4S)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide | CAS RN:81098-60-4 | CAS RN:86719-31-5 | PubChem CID:5311047"
+BMGC_DG11412,BMG_DG157334,"Clobetasol | (8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | CLOBETASOL | DrugBank ID:DB11750 | CAS RN:25122-41-2 | PubChem CID:5311051 | UNII:ADN79D536H | PubChem SID:175268076"
+BMGC_DG11413,BMG_DG157335,"UNII:N8ZUB7XE0H | DrugBank ID:DB00838 | PubChem CID:5311052 | CLOCORTOLONE | Clocortolone | (6S,8S,9R,10S,11S,13S,14S,16R,17S)-9-chloro-6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one | PubChem SID:175268526 | CAS RN:4828-27-7"
+BMGC_DG11414,BMG_DG157336,"UNII:52EJR3Y9IN | (Z)-7-[(1R,2R,3R,5S)-2-[(E,3R)-4-(3-chlorophenoxy)-3-hydroxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoic acid | DrugBank ID:DB11507 | PubChem SID:198961784 | CLOPROSTENOL, (+)- | CAS RN:40665-92-7 | UNII:4208238832 | CLOPROSTENOL | PubChem CID:5311053 | Cloprostenol | CAS RN:54276-21-0 | PubChem SID:175271785 | CAS RN:100786-10-5"
+BMGC_DG11415,BMG_DG157337,"CAS RN:1066-17-7 | Colistin | PubChem CID:5311054 | N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18S,21S)-6,9,18-tris(2-aminoethyl)-3-[(1R)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-5-methylheptanamide"
+BMGC_DG11416,BMG_DG157338,PubChem SID:329903547 | CAS RN:157286-86-7 | UNII:9A549FB00R | CP-154526 | PubChem CID:5311055
+BMGC_DG11417,BMG_DG157339,CP-99994 | CAS RN:136982-36-0 | UNII:5KM4QA7RZC | PubChem SID:348481443 | PubChem CID:5311057
+BMGC_DG11418,BMG_DG157340,"Denopamine | CAS RN:71771-90-9 | PubChem CID:5311064 | UNII:V5F60UPD8P | PubChem SID:198936797 | 4-[(1R)-2-[2-(3,4-dimethoxyphenyl)ethylamino]-1-hydroxyethyl]phenol | DENOPAMINE"
+BMGC_DG11419,BMG_DG157341,"UNII:ENR1LLB0FP | PubChem SID:175266146 | Desmopressin | DrugBank ID:DB00035 | (2S)-N-[(2R)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide | PubChem CID:5311065 | CAS RN:113-81-5 | DESMOPRESSIN | CAS RN:16679-58-6"
+BMGC_DG11420,BMG_DG157342,"NDC:51672-4079 | NDC:63629-8482 | NDC:0472-0803 | NDC:70771-1381 | NDC:80425-0418 | Desonide | NDC:0168-0309 | (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | DrugBank ID:DB01260 | NDC:51672-1280 | NDC:72162-1272 | NDC:72162-2329 | NDC:63629-2507 | NDC:80425-0371 | NDC:0299-5770 | NDC:62332-632 | NDC:16714-729 | PubChem SID:175268455 | NDC:63629-8481 | NDC:21922-004 | NDC:63629-8739 | DESONIDE | UNII:J280872D1O | NDC:24470-920 | NDC:72603-164 | NDC:69482-600 | PubChem CID:5311066 | NDC:51672-1281 | NDC:72578-086 | NDC:62332-550 | NDC:63629-2506 | NDC:0472-0804 | NDC:72162-2005 | NDC:0713-0661 | NDC:0299-5765 | NDC:45802-423 | NDC:63187-747 | CAS RN:638-94-8 | NDC:62332-485"
+BMGC_DG11421,BMG_DG157343,"CAS RN:382-67-2 | NDC:72162-1427 | NDC:51672-1270 | NDC:68180-944 | UNII:4E07GXB7AU | NDC:51672-5202 | NDC:70771-1166 | NDC:63629-8702 | NDC:72578-095 | NDC:51672-1262 | NDC:45802-807 | NDC:51672-1396 | NDC:51672-5203 | NDC:71205-271 | NDC:0472-0478 | DESOXIMETASONE | NDC:72162-1414 | NDC:68180-946 | NDC:68180-950 | NDC:70771-1437 | NDC:68180-948 | CAS RN:140218-14-0 | NDC:63629-8641 | NDC:45802-496 | NDC:51672-1261 | NDC:51672-1271 | NDC:63187-646 | PubChem CID:5311067 | NDC:51672-5263 | NDC:68180-949 | NDC:45802-495 | NDC:50090-0597 | NDC:51672-5281 | DrugBank ID:DB00547 | NDC:72162-2330 | (8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one | PubChem SID:175268184 | Desoximetasone | NDC:72578-091 | NDC:63629-8642 | NDC:68462-531 | NDC:51672-1352 | NDC:51672-5205 | NDC:0472-0479 | NDC:40032-024 | NDC:51672-5204 | NDC:50090-5571"
+BMGC_DG11422,BMG_DG157344,"Dexmedetomidine | PubChem CID:5311068 | CAS RN:113775-47-6 | NDC:81092-1180 | DEXMEDETOMIDINE | 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole | PubChem SID:175267064 | DrugBank ID:DB00633 | UNII:67VB76HONO | NDC:81092-1120"
+BMGC_DG11423,BMG_DG157345,"DrugBank ID:DB12890 | CAS RN:123039-93-0 | PubChem CID:5311070 | DIHYDREXIDINE | Dihydrexidine | PubChem SID:198970796 | UNII:32D64VH037 | PubChem SID:377308849 | DIHYDREXIDINE, (-)- | UNII:U4MPC92UC2 | (6aS,12bR)-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine-10,11-diol | CAS RN:757161-85-6"
+BMGC_DG11424,BMG_DG157346,"PubChem CID:5311071 | (1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol | UNII:R5LM3H112R | PubChem SID:175268671 | Dihydrotachysterol | CAS RN:67-96-9 | DrugBank ID:DB01070 | DIHYDROTACHYSTEROL"
+BMGC_DG11425,BMG_DG157348,CAS RN:189388-22-5 | (2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide | Endomorphin-1 | PubChem CID:5311080
+BMGC_DG11426,BMG_DG157349,Endomorphin 2 | TETRAPEPTIDE-15 | PubChem SID:252823631 | (2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide | CAS RN:141801-26-5 | UNII:3PH5M0466G | PubChem CID:5311081
+BMGC_DG11427,BMG_DG157351,PubChem CID:5311093 | Olvanil | OLVANIL | (Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]octadec-9-enamide | CAS RN:58493-49-5 | PubChem SID:198954404 | UNII:4P7KIU7003
+BMGC_DG11428,BMG_DG157352,PubChem CID:5311096 | PubChem SID:496141696 | SB-277011 | UNII:CHW57ND47C | CAS RN:215803-78-4
+BMGC_DG11429,BMG_DG157353,LY-344864 | PubChem CID:5311097 | PubChem SID:445498701 | UNII:L4WN6HH63L | CAS RN:186544-26-3
+BMGC_DG11430,BMG_DG157354,"PubChem SID:198983226 | UNII:MEH3MCE8X1 | PubChem SID:175271665 | (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoic acid | FLUPROSTENOL | FLUPROSTENOL, (+)- | Fluprostenol | DrugBank ID:DB11519 | PubChem CID:5311100 | UNII:358S7VUE5N | CAS RN:54276-17-4 | CAS RN:40666-16-8"
+BMGC_DG11431,BMG_DG157355,"S-(fluoromethyl) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate | CAS RN:90566-53-3 | UNII:CUT2W21N7U | DrugBank ID:DB13867 | PubChem SID:175265547 | PubChem CID:5311101 | FLUTICASONE | Fluticasone"
+BMGC_DG11432,BMG_DG157357,"CAS RN:622996-74-1 | PubChem CID:5311103 | Staurosporine, from Streptomyces sp. | (2S,3S,4S,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one | CAS RN:62996-74-1"
+BMGC_DG11433,BMG_DG157358,"6-(2,6-Dichlorophenyl)-2-[(4-Fluoro-3-Methylphenyl)amino]-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One | UNII:TSO2IAD7WJ | PubChem CID:5311104 | PD-180970 | 6-(2,6-dichlorophenyl)-2-(4-fluoro-3-methylanilino)-8-methylpyrido[2,3-d]pyrimidin-7-one | PubChem SID:198945866 | CAS RN:287204-45-9"
+BMGC_DG11434,BMG_DG157359,"PubChem CID:5311108 | FR-173657 | CAS RN:167838-64-4 | (E)-3-(6-acetamidopyridin-3-yl)-N-[2-[2,4-dichloro-N-methyl-3-[(2-methylquinolin-8-yl)oxymethyl]anilino]-2-oxoethyl]prop-2-enamide | PubChem SID:434370006 | UNII:262AL91J0Y"
+BMGC_DG11435,BMG_DG157360,"(2R,3R,4R)-2,3,4,5-tetrahydroxypentanal | RIBOSE, D- | PubChem CID:5311110 | CAS RN:50-69-1 | CAS RN:34466-20-1 | PubChem SID:175268403 | UNII:681HV46001 | Ribose, D- | DrugBank ID:DB15073"
+BMGC_DG11436,BMG_DG157362,"CAS RN:212790-31-3 | CP-481715 | PubChem SID:198952256 | N-[(2S,3S,5R)-5-carbamoyl-1-(3-fluorophenyl)-3,8-dihydroxy-8-methylnonan-2-yl]quinoxaline-2-carboxamide | PubChem CID:5311123 | CP-481,715 | UNII:X3TDA066ME"
+BMGC_DG11437,BMG_DG157364,CAS RN:1233494-97-7 | PubChem SID:316914947 | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | PubChem CID:5311128 | UNII:0F65R8P09N | DrugBank ID:DB00014 | Goserelin | CAS RN:65807-02-5 | GOSERELIN
+BMGC_DG11438,BMG_DG157366,UNII:NVF6UYC3CM | L-709049 | CAS RN:143313-51-3 | PubChem CID:5311139 | PubChem SID:459056224 | Ac-Yvad-cho | (3S)-3-[[(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-4-oxobutanoic acid
+BMGC_DG11439,BMG_DG157367,GV-150013 | PubChem CID:5311147 | UNII:WSFVPEEMNO | CAS RN:167355-22-8 | PubChem SID:346540967
+BMGC_DG11440,BMG_DG157368,Z-FA-Fmk | UNII:1Q2Z3U96CG | CAS RN:105637-38-5 | PubChem CID:5311161 | PubChem SID:313184353 | benzyl N-[(2S)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate | MDL-201053
+BMGC_DG11441,BMG_DG157369,"Ulobetasol | PubChem CID:5311167 | UNII:9P6159HM7T | PubChem SID:175268195 | Halobetasol | HALOBETASOL | CAS RN:98651-66-2 | DrugBank ID:DB00596 | (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG11442,BMG_DG157371,HU-243 | CAS RN:140835-14-9 | PubChem SID:346537532 | UNII:SKGOA1RZCT | PubChem CID:5311171
+BMGC_DG11443,BMG_DG157372,"PubChem CID:5311172 | [(1R,4R,5R)-4-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methanol | (1R,4R,5R)-4-[4-(1,1-Dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-methanol | CAS RN:1220887-84-2"
+BMGC_DG11444,BMG_DG157374,"CAS RN:72795-26-7 | (2S,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)butan-2-ol | PubChem CID:5311179 | CAS RN:149115-13-9 | (2s,3s)-1-[(7-Methyl-2,3-Dihydro-1h-Inden-4-Yl)oxy]-3-[(1-Methylethyl)amino]butan-2-Ol"
+BMGC_DG11445,BMG_DG157376,"PubChem SID:175272140 | PubChem CID:5311181 | NDC:83226-2001 | CAS RN:85026-51-3 | DrugBank ID:DB01088 | (5E)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid | CAS RN:78919-13-8 | UNII:JED5K35YGL | NDC:66215-303 | ILOPROST | Iloprost | NDC:66215-302"
+BMGC_DG11446,BMG_DG157378,3-[(3S)-1-propylpiperidin-3-yl]phenol | UNII:9V2O6CRQ6Z | Preclamol | CAS RN:85966-89-8 | PubChem CID:5311189 | PubChem SID:198974289 | PRECLAMOL
+BMGC_DG11447,BMG_DG157379,"PROPYLNORAPOMORPHINE, (S)- | CAS RN:79703-31-4 | UNII:YMM32KDR65 | PubChem CID:5311191 | PubChem SID:441583900"
+BMGC_DG11448,BMG_DG157380,UNII:00M5444DIY | CAS RN:256640-45-6 | PubChem CID:5311194 | PubChem SID:198971131 | J-113397
+BMGC_DG11449,BMG_DG157381,"L-745870 | PubChem CID:5311200 | 3-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine | CAS RN:158985-00-3 | 3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine | UNII:J3OLN3XSX7 | PubChem SID:363907684"
+BMGC_DG11450,BMG_DG157382,UNII:370JHF4586 | PubChem CID:5311201 | PubChem SID:198967245 | L-365260 | CAS RN:118101-09-0
+BMGC_DG11451,BMG_DG157384,"UNII:L4BX842T8C | L-655,708 | CAS RN:130477-52-0 | PubChem SID:472422603 | PubChem CID:5311203"
+BMGC_DG11452,BMG_DG157385,"CAS RN:87-57-0 | CAS RN:87893-55-8 | PubChem SID:255509103 | 15-DEOXY-.DELTA.12,14-PROSTAGLANDIN J2 | UNII:ALI977775J | (Z)-7-[(1S,5E)-5-[(E)-oct-2-enylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid | PubChem CID:5311211 | 15-Deoxy-delta-12,14-prostaglandin J2"
+BMGC_DG11453,BMG_DG157386,"LACIDIPINE | PubChem CID:5311217 | CAS RN:103890-78-4 | diethyl 2,6-dimethyl-4-[2-[(E)-3-[(2-methylpropan-2-yl)oxy]-3-oxoprop-1-enyl]phenyl]-1,4-dihydropyridine-3,5-dicarboxylate | UNII:260080034N | Lacidipine | DrugBank ID:DB09236 | PubChem SID:175265753"
+BMGC_DG11454,BMG_DG157389,"PubChem CID:5311221 | NDC:70069-421 | PubChem SID:175266166 | CAS RN:130209-82-4 | NDC:82584-003 | NDC:61314-547 | NDC:71205-154 | NDC:58151-419 | PubChem SID:346541009 | UNII:6Z5B6HVF6O | NDC:59762-0333 | NDC:50090-7062 | NDC:24208-463 | NDC:47335-317 | NDC:68083-609 | LATANOPROST | NDC:68462-944 | propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate | Latanoprost | NDC:50090-1920 | NDC:64980-516 | UNII:8S5FB3XXG8 | DrugBank ID:DB00654 | NDC:70727-529 | LATANOPROST, (+/-)- | CAS RN:155551-81-8 | NDC:65862-872 | NDC:0013-8303 | LATANOPROST, (±)-"
+BMGC_DG11455,BMG_DG157393,"CAS RN:120373-36-6 | Unoprostone | UNII:6X4F561V3W | DrugBank ID:DB06826 | PubChem CID:5311236 | (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl]hept-5-enoic acid | PubChem SID:175266145 | UNOPROSTONE"
+BMGC_DG11456,BMG_DG157395,"UNII:LS4GH66FAF | 13,14-DIHYDRO PROSTAGLANDIN F1.ALPHA. | 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxyoctyl]cyclopentyl]heptanoic acid | CAS RN:20592-20-5 | PubChem SID:482554052 | 13,14-dihydro Prostaglandin F1α | PubChem CID:5311239"
+BMGC_DG11457,BMG_DG157397,"Carbacyclin | (5Z)-5-[(3aS,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid | CAS RN:69609-77-4 | PubChem CID:5311242"
+BMGC_DG11458,BMG_DG157401,PubChem SID:376072834 | 4-fluoro-N-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]benzamide | CAS RN:182563-08-2 | LY-334370 | UNII:5Q7I1WL2UY | PubChem CID:5311258
+BMGC_DG11459,BMG_DG157402,PubChem CID:5311261 | PubChem SID:241180694 | CAS RN:198419-91-9 | LY-367385 | UNII:D8UW47H17B | 4-[(S)-amino(carboxy)methyl]-3-methylbenzoic acid
+BMGC_DG11460,BMG_DG157403,PubChem SID:198976243 | PubChem CID:5311262 | UNII:8343W0Y6O6 | LY-393675 | CAS RN:394735-81-0
+BMGC_DG11461,BMG_DG157404,CAS RN:65528-98-5 | [(2R)-2-hydroxy-3-phosphonooxypropyl] (Z)-octadec-9-enoate | PubChem CID:5311263 | 1-Oleoyl Lysophosphatidic Acid
+BMGC_DG11462,BMG_DG157405,UNII:FML8G1U0Y3 | dimagnesium;dioxido-bis[[oxido(oxo)silyl]oxy]silane | CAS RN:14987-04-3 | Magnesium Trisilicate | PubChem CID:5311266 | PubChem SID:175267920 | Magnesium trisilicate | MAGNESIUM TRISILICATE ANHYDROUS | DrugBank ID:DB09281
+BMGC_DG11463,BMG_DG157406,PubChem SID:474492470 | CAS RN:475115-35-6 | PubChem CID:5311268 | Galnon | UNII:NK59Y4NQ33 | GALNON
+BMGC_DG11464,BMG_DG157407,"PubChem CID:5311271 | CAS RN:139290-65-6 | VOLINANSERIN | (R)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol | PubChem SID:198966064 | UNII:EW71EE171J | Volinanserin"
+BMGC_DG11465,BMG_DG157409,PubChem SID:459275609 | PubChem CID:5311276 | CAS RN:191034-25-0 | L-168049 | UNII:TY8UDT6Z37
+BMGC_DG11466,BMG_DG157412,"CAS RN:14930-96-2 | UNII:3CHI920QS7 | PubChem CID:5311281 | (1S,4E,6R,10R,12E,14S,15S,17S,18S,19S)-19-benzyl-6,15-dihydroxy-10,17-dimethyl-16-methylidene-2-oxa-20-azatricyclo[12.7.0.01,18]henicosa-4,12-diene-3,21-dione | Cytochalasin B | PubChem SID:198962391 | CAS RN:11032-95-4 | CYTOCHALASIN B"
+BMGC_DG11467,BMG_DG157414,"[(2R,3S,5R)-5-[6-(methylamino)purin-9-yl]-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate | CAS RN:101204-49-3 | PubChem CID:5311303"
+BMGC_DG11468,BMG_DG157415,"Nalbuphine | DrugBank ID:DB00844 | PubChem CID:5311304 | NALBUPHINE | UNII:L2T84IQI2K | PubChem SID:175267073 | CAS RN:20594-83-6 | (4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol"
+BMGC_DG11469,BMG_DG157417,NDC:55111-328 | N-((CIS-4-(1-METHYLETHYL)CYCLOHEXYL)CARBONYL)-D-PHENYLALANINE | NDC:64380-168 | NDC:72241-002 | NDC:75834-205 | NDC:68382-722 | NDC:16571-759 | NDC:68382-721 | NDC:75834-206 | UNII:41X3PWK4O2 | NDC:71209-030 | CAS RN:105816-06-6 | PubChem SID:445500293 | NDC:51407-656 | PubChem SID:175266326 | (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid | DrugBank ID:DB00731 | PubChem CID:5311309 | NDC:64380-167 | NDC:16571-758 | NDC:55111-329 | UNII:XTM4DQP5S5 | CAS RN:105746-37-0 | NDC:60687-673 | NDC:70771-1016 | Nateglinide | NDC:72241-003 | NDC:60687-684 | NDC:0591-3354 | NDC:70771-1015 | NDC:0591-3355 | NDC:71209-031 | NATEGLINIDE | NDC:51407-657 | CAS RN:105816-04-4
+BMGC_DG11470,BMG_DG157418,"Neurokinin A | NEUROKININ A | PubChem CID:5311311 | CAS RN:86933-74-6 | PubChem SID:316914962 | (3S)-3-[[(2S,3R)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid | UNII:94168F9W1D"
+BMGC_DG11471,BMG_DG157419,(3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid | PubChem CID:5311312 | Neurokinin B | CAS RN:86933-75-7
+BMGC_DG11472,BMG_DG157421,Tetrafluoroaluminate Ion | PubChem CID:5311325 | DrugBank ID:DB04444
+BMGC_DG11473,BMG_DG157428,PubChem CID:5311340 | JTC-801 FREE BASE | CAS RN:244218-93-7 | PubChem SID:198975698 | UNII:BXU45ZH6LI
+BMGC_DG11474,BMG_DG157430,"PubChem CID:5311345 | (6S)-1-[4-(dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid | (6S)-1-[[4-(dimethylamino)-3-methylphenyl]methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid | UNII:LZJ8WXG82U | PD123319 | CAS RN:130663-39-7"
+BMGC_DG11475,BMG_DG157431,"PubChem CID:5311346 | (4aR,10bR)-rel-4-Propyl-2,3,4,4a,5,10b-hexahydrochromeno[4,3-b][1,4]oxazin-9-ol | (4aR,10bR)-4-propyl-3,4a,5,10b-tetrahydro-2H-chromeno[4,3-b][1,4]oxazin-9-ol | CAS RN:123671-92-1 | CAS RN:123594-64-9"
+BMGC_DG11476,BMG_DG157433,"CAS RN:509-67-1 | Pholcodine | PubChem SID:198975280 | PubChem CID:5311356 | DrugBank ID:DB09209 | (4R,4aR,7S,7aR,12bS)-3-methyl-9-(2-morpholin-4-ylethoxy)-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol | PHOLCODINE | UNII:LPP64AWZ7L"
+BMGC_DG11477,BMG_DG157436,"(8S,9S,10R,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3,11-dione | 11-Dehydrocorticosterone | PubChem SID:198955792 | CAS RN:72-23-1 | UNII:FO4V44A3G3 | PubChem CID:5311364 | 11-DEHYDROCORTICOSTERONE"
+BMGC_DG11478,BMG_DG157437,"PubChem CID:5311365 | DrugBank ID:DB02860 | Calyculin A | [(2R,3R,5R,7R,8S,9S)-2-[(1S,3S,4S,5R,6R,7E,9E,11E,13Z)-14-cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-pentamethyltetradeca-7,9,11,13-tetraenyl]-9-[(E)-3-[2-[(2S)-4-[[(2S,3S,4S)-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanoyl]amino]butan-2-yl]-1,3-oxazol-4-yl]prop-2-enyl]-7-hydroxy-4,4,8-trimethyl-1,10-dioxaspiro[4.5]decan-3-yl] dihydrogen phosphate | calyculin A | CALYCULIN A | CAS RN:101932-71-2 | PubChem SID:241178070 | UNII:7D07U14TK3"
+BMGC_DG11479,BMG_DG157441,"UNII:EQH27E0WRV | Cgp 77675 | PubChem SID:198957396 | PubChem CID:5311381 | CGP-77675 | 1-[2-[4-[4-amino-5-(3-methoxyphenyl)pyrrolo[2,3-d]pyrimidin-7-yl]phenyl]ethyl]piperidin-4-ol | CAS RN:234772-64-6"
+BMGC_DG11480,BMG_DG157442,"6-(2,6-DICHLOROPHENYL)-2-((4-(2-(DIETHYLAMINO)ETHOXY)PHENYL)AMINO)-8-METHYLPYRIDO(2,3-D)PYRIMIDIN-7(8H)-ONE | UNII:F2UH9R2JT6 | PubChem CID:5311382 | CAS RN:185039-89-8"
+BMGC_DG11481,BMG_DG157446,"PubChem CID:5311397 | CAS RN:185052-09-9 | (2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-2-[[(2S)-2-acetamido-6-aminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-methylpentanoic acid"
+BMGC_DG11482,BMG_DG157448,"DrugBank ID:DB04834 | PubChem CID:5311399 | RAPACURONIUM | PubChem SID:198980716 | UNII:GG1LBM463S | [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-acetyloxy-10,13-dimethyl-2-piperidin-1-yl-16-(1-prop-2-enylpiperidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate | CAS RN:465499-11-0 | Rapacuronium"
+BMGC_DG11483,BMG_DG157449,"PubChem CID:5311412 | (8S,9S,10R,11S,13S,14S,16R,17S)-11-hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | CAS RN:49697-38-3 | DrugBank ID:DB00896 | PubChem SID:175267976 | RIMEXOLONE | Rimexolone | UNII:O7M2E4264D"
+BMGC_DG11484,BMG_DG157450,"CAS RN:77287-05-9 | UNII:7JL402PVQR | Rioprostil | PubChem CID:5311413 | (2R,3R,4R)-4-hydroxy-2-(7-hydroxyheptyl)-3-[(E)-4-hydroxy-4-methyloct-1-enyl]cyclopentan-1-one | RIOPROSTIL | PubChem SID:198939585"
+BMGC_DG11485,BMG_DG157452,CAS RN:174636-32-9 | TALNETANT | PubChem SID:198973884 | Talnetant | PubChem CID:5311424 | 3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide | UNII:CZ3T9T146K
+BMGC_DG11486,BMG_DG157456,"(3S,6S,9S,12R,15S,18S)-9-(4-aminobutyl)-3-benzyl-15-[(4-hydroxyphenyl)methyl]-12-(1H-indol-3-ylmethyl)-1,18-dimethyl-6-propan-2-yl-1,4,7,10,13,16-hexazacyclooctadecane-2,5,8,11,14,17-hexone | PubChem CID:5311430 | CAS RN:81377-02-8 | UNII:5P57R7IR6J | PubChem SID:198979102 | Seglitide | SEGLITIDE"
+BMGC_DG11487,BMG_DG157457,PubChem SID:445499218 | UNII:4X2F5X24UK | SIB-1893 | PubChem CID:5311432 | CAS RN:7370-21-0
+BMGC_DG11488,BMG_DG157459,"SPIRAPRIL | PubChem CID:5311447 | PubChem SID:198942493 | (8S)-7-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-1,4-dithia-7-azaspiro[4.4]nonane-8-carboxylic acid | CAS RN:83647-97-6 | Spirapril | UNII:96U2K78I3V | DrugBank ID:DB01348"
+BMGC_DG11489,BMG_DG157460,DrugBank ID:DB05790 | SR 140333 | PubChem CID:5311449
+BMGC_DG11490,BMG_DG157461,CAS RN:184162-64-9 | UNII:W59C8B2MZS | SR-142948 | PubChem SID:474492823 | PubChem CID:5311451
+BMGC_DG11491,BMG_DG157462,"CAS RN:174689-38-4 | PubChem CID:5311452 | UNII:YZ574930OD | SR-59230A free base | SR-59230A FREE BASE | PubChem SID:318691299 | (2S)-1-(2-ethylphenoxy)-3-[[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]amino]propan-2-ol"
+BMGC_DG11492,BMG_DG157463,"NDC:68418-7942 | NDC:68418-7941 | PubChem SID:198958171 | NDC:68418-7939 | CAS RN:131206-47-8 | CAS RN:49763-96-4 | Stiripentol | NDC:68418-7940 | CAS RN:137767-55-6 | DrugBank ID:DB09118 | PubChem CID:5311454 | UNII:R02XOT8V8I | (E)-1-(1,3-benzodioxol-5-yl)-4,4-dimethylpent-1-en-3-ol | STIRIPENTOL"
+BMGC_DG11493,BMG_DG157468,"CAS RN:152529-79-8 | 4-(2,6-Dioxo-1-propyl-3,7-dihydropurin-8-yl)benzenesulfonic acid | PubChem CID:5311479 | 4-(2,6-dioxo-1-propyl-3,7-dihydropurin-8-yl)benzenesulfonic acid"
+BMGC_DG11494,BMG_DG157471,"dihydroxyphosphinothioyl [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate | PubChem CID:5311494 | UTPgammaS"
+BMGC_DG11495,BMG_DG157472,"CAS RN:71486-22-1 | DrugBank ID:DB00361 | PubChem CID:5311497 | PubChem SID:175266041 | Vinorelbine | VINORELBINE | UNII:Q6C979R91Y | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S,14R)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate"
+BMGC_DG11496,BMG_DG157473,"CAS RN:13408-78-1 | CAS RN:68-19-9 | PubChem CID:5311498 | DrugBank ID:DB00115 | vitamin B12 | cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide"
+BMGC_DG11497,BMG_DG157475,"WIN-55212-2 | UNII:5H31GI9502 | [(11R)-2-methyl-11-(morpholin-4-ylmethyl)-9-oxa-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraen-3-yl]-naphthalen-1-ylmethanone | PubChem CID:5311501 | (2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonate | DrugBank ID:DB13950 | PubChem SID:252319849 | CAS RN:131543-22-1"
+BMGC_DG11498,BMG_DG157476,"PubChem SID:198987362 | ONAPRISTONE | (8S,11R,13R,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | DrugBank ID:DB12637 | PubChem CID:5311505 | UNII:H6H7G23O3N | CAS RN:96346-61-1 | Onapristone"
+BMGC_DG11499,BMG_DG157477,PubChem CID:5311507 | UNII:47ISU063SG | CAS RN:982-24-1 | PubChem SID:198977588 | Zuclopenthixol | ZUCLOPENTHIXOL | CAS RN:53772-83-1 | DrugBank ID:DB01624 | 2-[4-[(3Z)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol | DrugBank ID:DB13841
+BMGC_DG11500,BMG_DG157478,GNF-2 | UNII:6D7Q9Z2W7T | CAS RN:778270-11-4 | PubChem CID:5311510 | PubChem SID:198987329
+BMGC_DG11501,BMG_DG157479,"Succinylacetone | CAS RN:51568-18-4 | 4,6-dioxoheptanoic acid | SUCCINYLACETONE | PubChem SID:404859646 | UNII:KZ0KV2Q190 | PubChem CID:5312"
+BMGC_DG11502,BMG_DG157481,Canfosfamide | (2S)-2-amino-5-[[(2R)-3-[2-[bis[bis(2-chloroethyl)amino]phosphoryloxy]ethylsulfonyl]-1-[[(R)-carboxy(phenyl)methyl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | CANFOSFAMIDE | CAS RN:158382-37-7 | PubChem CID:5312109 | PubChem SID:198953026 | DrugBank ID:DB04972 | UNII:1RS284BFUI
+BMGC_DG11503,BMG_DG157482,CAS RN:192321-23-6 | UNII:E4901JA9JD | CGP-71683A FREE BASE | PubChem CID:5312114 | N-[[4-[[(4-aminoquinazolin-2-yl)amino]methyl]cyclohexyl]methyl]naphthalene-1-sulfonamide | PubChem SID:198970222
+BMGC_DG11504,BMG_DG157487,"NDC:31722-636 | NDC:68180-741 | UNII:CUZ39LUY82 | NDC:72789-351 | NDC:59651-095 | NDC:68180-740 | PubChem CID:5312125 | NDC:72789-090 | NDC:72162-2446 | Silodosin | NDC:82619-113 | NDC:46708-405 | SILODOSIN | NDC:42291-778 | NDC:62332-405 | NDC:27241-145 | NDC:0023-6147 | PubChem SID:175266679 | NDC:69238-1421 | CAS RN:160970-54-7 | NDC:72205-009 | NDC:33342-384 | NDC:69539-053 | NDC:0023-6142 | NDC:42291-777 | NDC:31722-635 | NDC:60219-1421 | NDC:69238-1420 | NDC:46708-406 | NDC:59651-096 | NDC:33342-385 | DrugBank ID:DB06207 | NDC:72162-2447 | NDC:60219-1420 | NDC:82619-114 | 1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide | NDC:72205-010 | NDC:62332-406 | NDC:27241-144 | NDC:69539-052"
+BMGC_DG11505,BMG_DG157488,UNII:63HM46XPOW | PubChem CID:5312126 | (S)-4-(2-(N-methylisoquinoline-5-sulfonamido)-3-oxo-3-(4-phenylpiperazin-1-yl)propyl)phenyl isoquinoline-5-sulfonate | PubChem SID:198946405 | CAS RN:127191-97-3 | [4-[(2S)-2-[isoquinolin-5-ylsulfonyl(methyl)amino]-3-oxo-3-(4-phenylpiperazin-1-yl)propyl]phenyl] isoquinoline-5-sulfonate | KN-62
+BMGC_DG11506,BMG_DG157491,"PubChem CID:5312137 | (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE | DrugBank ID:DB08039"
+BMGC_DG11507,BMG_DG157492,"UNII:742F5K270Q | PubChem SID:198948284 | DOMITROBAN, (+/-)- | Domitroban | PubChem CID:5312138 | DOMITROBAN | (Z)-7-[(1R,2S,3S,4S)-3-(benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid | DOMITROBAN, (±)- | CAS RN:112966-96-8 | UNII:6C4W5D1SE7 | PubChem SID:198987781 | CAS RN:115266-92-7"
+BMGC_DG11508,BMG_DG157494,PubChem CID:5312142 | BM-573 | PubChem SID:198983996 | CAS RN:284464-83-1 | UNII:8E9L957C3G
+BMGC_DG11509,BMG_DG157495,UNII:CU78RAR5ZH | CAS RN:202466-68-0 | Ro-04-6790 | PubChem CID:5312145 | PubChem SID:474492382 | RO-04-6790
+BMGC_DG11510,BMG_DG157496,"SB-258719 | PubChem CID:5312148 | PubChem SID:474492432 | UNII:GF43CP5LXQ | N,3-dimethyl-N-[(2R)-4-(4-methylpiperidin-1-yl)butan-2-yl]benzenesulfonamide | CAS RN:195199-95-2"
+BMGC_DG11511,BMG_DG157497,SB-271046 | PubChem CID:5312149 | CAS RN:209481-20-9 | PubChem SID:348481280 | UNII:L3SK5KX24S
+BMGC_DG11512,BMG_DG157498,"SULPROSTONE | (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R)-3-hydroxy-4-phenoxybut-1-enyl]-5-oxocyclopentyl]-N-methylsulfonylhept-5-enamide | UNII:501Q5EQ1GM | PubChem CID:5312153 | CAS RN:60325-46-4 | PubChem SID:198952014 | DrugBank ID:DB12708 | Sulprostone"
+BMGC_DG11513,BMG_DG157523,"MOROCTIC ACID | CAS RN:20290-75-9 | PubChem SID:198941906 | Stearidonic Acid | CAS RN:111174-40-4 | UNII:P4CEK3495O | PubChem CID:5312508 | (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoic acid"
+BMGC_DG11514,BMG_DG157528,"PubChem CID:5312529 | (11Z,14Z,17Z)-icosa-11,14,17-trienoic acid | 11,14,17-Eicosatrienoic acid | CAS RN:17046-59-2 | CAS RN:2091-27-2"
+BMGC_DG11515,BMG_DG157559,"UNII:YG4GM6X7VP | (3R)-3-HYDROXYDODECANOIC ACID | PubChem CID:5312804 | 3-HYDROXYDODECANOIC ACID, (3R)- | (3R)-3-Hydroxydodecanoic acid | DrugBank ID:DB07930 | CAS RN:28254-78-6 | (3R)-3-hydroxydodecanoic acid"
+BMGC_DG11516,BMG_DG157564,"PubChem CID:5312830 | UNII:42KE04U9BM | 9(S)-HODE | DrugBank ID:DB07302 | CAS RN:73543-67-6 | PubChem SID:318691365 | .ALPHA.-DIMORPHECOLIC ACID, (9S)- | (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid"
+BMGC_DG11517,BMG_DG157580,"PubChem CID:5313082 | 2-[[(2R)-2,3-di(tetradecanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium | CAS RN:83199-49-9 | 3,5,9-Trioxa-4-phosphatricosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotetradecyl)oxy]-, 4-oxide, (R)-"
+BMGC_DG11518,BMG_DG157583,PubChem SID:175265529 | trimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium | SUCCINYLCHOLINE | CAS RN:306-40-1 | PubChem CID:5314 | UNII:J2R869A8YF | DrugBank ID:DB00202 | Succinylcholine
+BMGC_DG11519,BMG_DG157593,"PubChem CID:5315 | 4-oxo-4-[4-(1,3-thiazol-2-ylsulfamoyl)anilino]butanoic acid | DrugBank ID:DB13580 | Succinylsulfathiazole | CAS RN:116-43-8 | PubChem SID:198946183 | UNII:RSS8647O4S | SUCCINYLSULFATHIAZOLE"
+BMGC_DG11520,BMG_DG157597,"PubChem CID:5315126 | Uralenol | CAS RN:139163-15-8 | 2-[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl]-3,5,7-trihydroxychromen-4-one"
+BMGC_DG11521,BMG_DG157612,CAS RN:42934-53-2 | 4-CHLORODIBENZOFURAN | 4-chlorodibenzofuran | 4-Chlorodibenzofuran | PubChem SID:198964958 | UNII:ROT1BKB4L4 | PubChem CID:53154 | CAS RN:74992-96-4
+BMGC_DG11522,BMG_DG157617,"8-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-methoxyphenyl]-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one | CAS RN:521-32-4 | UNII:AJ4UE8X6JZ | PubChem CID:5315459 | Bilobetin | PubChem SID:472422249 | BILOBETIN"
+BMGC_DG11523,BMG_DG157620,"UNII:2EFO1BP34R | Bisdemethoxycurcumin | (1E,6E)-1,7-bis(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione | BISDEMETHOXYCURCUMIN | CAS RN:24939-16-0 | CAS RN:22608-12-4 | PubChem SID:198934901 | CAS RN:33171-05-0 | PubChem CID:5315472"
+BMGC_DG11524,BMG_DG157622,PubChem SID:482554054 | BROUSSONIN A | Broussonin A | CAS RN:73731-87-0 | PubChem CID:5315502 | UNII:44SF3SS9W7
+BMGC_DG11525,BMG_DG157626,"CAS RN:537-15-5 | 3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoic acid | Rosmarinate | CAS RN:179462-74-9 | PubChem CID:5315615"
+BMGC_DG11526,BMG_DG157628,"DrugBank ID:DB14734 | 2-[(2E)-3,7-dimethylocta-2,6-dienyl]-5-pentylbenzene-1,3-diol | CAS RN:25654-31-3 | PubChem SID:198959777 | UNII:J1K406072N | CAS RN:2808-33-5 | Cannabigerol | CANNABIGEROL | PubChem CID:5315659"
+BMGC_DG11527,BMG_DG157634,UNII:548R7290J9 | PubChem SID:198956499 | CENTAUREIDIN | CAS RN:17313-52-9 | PubChem CID:5315773
+BMGC_DG11528,BMG_DG157644,(E)-3-phenylprop-2-en-1-ol | DrugBank ID:DB14186 | Cinnamyl alcohol | CAS RN:104-54-1 | PubChem SID:175266233 | CINNAMYL ALCOHOL | PubChem CID:5315892 | CAS RN:4407-36-7 | UNII:SS8YOP444F
+BMGC_DG11529,BMG_DG157670,7-hydroxy-8-methoxychromen-2-one | CAS RN:485-90-5 | 7-Hydroxy-8-methoxycoumarin | PubChem CID:5316302
+BMGC_DG11530,BMG_DG157676,Demethylsuberosin | PubChem SID:333495825 | 7-DEMETHYLSUBEROSIN | PubChem CID:5316525 | CAS RN:21422-04-8 | UNII:SDM71QIW25 | 7-hydroxy-6-(3-methylbut-2-enyl)chromen-2-one
+BMGC_DG11531,BMG_DG157681,"PubChem SID:317228996 | Afzelin | CAS RN:786711-07-7 | 5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one | PubChem CID:5316673 | UNII:5M86W1YH7O | AFZELIN | CAS RN:482-39-3"
+BMGC_DG11532,BMG_DG157691,PubChem SID:313183858 | UNII:DWA4D52V24 | PINOSYLVIN DIMETHYL ETHER | PubChem CID:5316874 | CAS RN:21956-56-9
+BMGC_DG11533,BMG_DG157705,PubChem CID:5317025 | CAS RN:480-36-4 | LINARIN | UNII:HBH2I685IU | PubChem SID:249493450
+BMGC_DG11534,BMG_DG157717,"UNII:I3O7LF3GED | PubChem SID:198957680 | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-methoxychromen-4-one | Eupafolin | PubChem CID:5317284 | EUPAFOLIN | CAS RN:520-11-6"
+BMGC_DG11535,BMG_DG157718,EUPATIN | UNII:W1TP9G8H92 | PubChem CID:5317287 | CAS RN:19587-65-6 | PubChem SID:375579852
+BMGC_DG11536,BMG_DG157721,"PubChem CID:5317309 | (9Z)-heptadeca-1,9-dien-4,6-diyne-3,8-diol | CAS RN:55297-87-5"
+BMGC_DG11537,BMG_DG157730,PubChem CID:5317419 | FUMARPROTOCETRARIC ACID | UNII:5VJ6J3A960 | PubChem SID:318164144 | CAS RN:489-50-9
+BMGC_DG11538,BMG_DG157744,ALLOXANTHOXYLETIN | UNII:8ZB2VP1WPQ | PubChem SID:198955360 | CAS RN:731-75-9 | PubChem CID:5317485
+BMGC_DG11539,BMG_DG157749,"8-GERANOXYPSORALEN | CAS RN:71612-25-4 | 9-[(2E)-3,7-dimethylocta-2,6-dienoxy]furo[3,2-g]chromen-7-one | CAS RN:7437-55-0 | Xanthotoxol geranyl ether | PubChem CID:5317564 | UNII:GBA7C839QU"
+BMGC_DG11540,BMG_DG157765,"GLABRONE | CAS RN:60008-02-8 | PubChem CID:5317652 | 7-hydroxy-3-(5-hydroxy-2,2-dimethylchromen-6-yl)chromen-4-one | Glabrone | UNII:9U4M81SWUK | PubChem SID:241178267"
+BMGC_DG11541,BMG_DG157771,7-hydroxy-3-(4-hydroxyphenyl)-6-methoxychromen-4-one | UNII:92M5F28TVF | PubChem CID:5317750 | CAS RN:40957-83-3 | GLYCITEIN | Glycitein | PubChem SID:198974069
+BMGC_DG11542,BMG_DG157772,"Glycycoumarin | GLYCYCOUMARIN | PubChem CID:5317756 | UNII:CWQ2B8G346 | PubChem SID:461432564 | CAS RN:94805-82-0 | 3-(2,4-dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methylbut-2-enyl)chromen-2-one"
+BMGC_DG11543,BMG_DG157786,"PubChem SID:175271566 | PubChem CID:5318 | Sulconazole | CAS RN:61318-90-9 | SULCONAZOLE | DrugBank ID:DB06820 | 1-[2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole | UNII:5D9HAA5Q5S"
+BMGC_DG11544,BMG_DG157789,CAS RN:17750-35-5 | 2-hydroxy-1-(3-methylbut-2-enyl)-9H-carbazole-3-carbaldehyde | PubChem CID:5318015 | Heptaphylline
+BMGC_DG11545,BMG_DG157805,PubChem CID:5318169 | 2-Hydroxycinnamaldehyde | (E)-3-(2-hydroxyphenyl)prop-2-enal | CAS RN:60125-23-7 | CAS RN:3541-42-2
+BMGC_DG11546,BMG_DG157806,"UNII:732GA1Z079 | 7-O-METHYLLUTEOLIN | 7-O-Methylluteolin | CAS RN:20243-59-8 | PubChem SID:198950309 | 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxychromen-4-one | PubChem CID:5318214"
+BMGC_DG11547,BMG_DG157809,HYPOLAETIN-8-GLUCOSIDE | CAS RN:27686-36-8 | UNII:82IW02I7T8 | PubChem SID:198969752 | PubChem CID:5318255
+BMGC_DG11548,BMG_DG157810,"UNII:247AW3A88C | CAS RN:20633-67-4 | PubChem CID:5318267 | CALYCOSIN 7-O-.BETA.-D-GLUCOSIDE | PubChem SID:252164710 | 3-(3-hydroxy-4-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one | CALYCOSIN 7-O-beta-D-GLUCOSIDE"
+BMGC_DG11549,BMG_DG157814,"5-methyl-4-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzene-1,2,3-triol | CAS RN:192383-78-1 | 3-Hydroxyneogrifolin | PubChem CID:5318298"
+BMGC_DG11550,BMG_DG157824,UNII:1G5BK41P4F | NDC:37662-3690 | NDC:37662-3692 | CAS RN:64784-13-0 | NDC:37662-3694 | NDC:37662-3691 | PubChem SID:175265581 | NDC:37662-3688 | NDC:37662-3695 | INDIGO | NDC:37662-3693 | PubChem CID:5318432 | NDC:37662-3689
+BMGC_DG11551,BMG_DG157828,CAS RN:18836-52-7 | PubChem CID:5318516 | PELLITORINE | PubChem SID:198984766 | UNII:8IS5231171
+BMGC_DG11552,BMG_DG157829,"PubChem CID:5318517 | PubChem SID:198952381 | (3E,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxyoxolan-2-one | DrugBank ID:DB05767 | CAS RN:5508-58-7 | UNII:410105JHGR | ANDROGRAPHOLIDE | Andrographolide"
+BMGC_DG11553,BMG_DG157830,"CAS RN:98168-69-5 | (2E,4E,8E,10E,12E)-N-(2-methylpropyl)tetradeca-2,4,8,10,12-pentaenamide | PubChem CID:5318518 | N-Isobutyl-2,4,8,10,12-tetradecapentaenamide"
+BMGC_DG11554,BMG_DG157839,"8-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-methoxyphenyl]-5,7-dihydroxy-2-(4-methoxyphenyl)chromen-4-one | CAS RN:548-19-6 | Isoginkgetin | PubChem CID:5318569"
+BMGC_DG11555,BMG_DG157840,PubChem CID:5318575 | UNII:6UE33XXJ1Y | PubChem SID:317229805 | CAS RN:476-34-6 | ISOINDIGOTIN
+BMGC_DG11556,BMG_DG157841,"3,5,7-trihydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chromen-4-one | Isolicoflavonol | CAS RN:94805-83-1 | UNII:355E7H7EHH | ISOLICOFLAVONOL | PubChem SID:482553180 | PubChem CID:5318585"
+BMGC_DG11557,BMG_DG157851,ISORHAPONTIGENIN | UNII:CZ49V3K5HS | CAS RN:32507-66-7 | PubChem CID:5318650 | PubChem SID:472423314
+BMGC_DG11558,BMG_DG157858,PubChem CID:5318767 | UNII:4056D20K3H | KAEMPFEROL-3-O-RUTINOSIDE | PubChem SID:198937591 | CAS RN:17650-84-9
+BMGC_DG11559,BMG_DG157868,"ICARITIN | PubChem SID:198934894 | UNII:UFE666UELY | DrugBank ID:DB12672 | CAS RN:118525-40-9 | PubChem CID:5318980 | Icaritin | 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one"
+BMGC_DG11560,BMG_DG157871,"PubChem CID:5318990 | CAS RN:325144-68-1 | (E)-1-(3,4-dihydroxyphenyl)-3-[4-hydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one | Licoagrochalcone C"
+BMGC_DG11561,BMG_DG157873,"PubChem CID:5318993 | Licoagrone | 2-[4,5-dihydroxy-2-[(Z)-[6-hydroxy-7-(3-methylbut-2-enyl)-3-oxo-1-benzofuran-2-ylidene]methyl]phenyl]-6-hydroxy-2-[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(3-methylbut-2-enyl)-1-benzofuran-3-one | CAS RN:228099-12-5"
+BMGC_DG11562,BMG_DG157874,"5-hydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-4-one | PubChem SID:198975613 | PubChem CID:5318997 | Icariin | CAS RN:489-32-7 | UNII:VNM47R2QSQ | ICARIIN | DrugBank ID:DB12052"
+BMGC_DG11563,BMG_DG157875,CAS RN:58749-22-7 | PubChem SID:198947591 | CAS RN:87080-27-1 | LICOCHALCONE A | UNII:JTV5467968 | Licochalcone a | (E)-3-[4-hydroxy-2-methoxy-5-(2-methylbut-3-en-2-yl)phenyl]-1-(4-hydroxyphenyl)prop-2-en-1-one | PubChem CID:5318998
+BMGC_DG11564,BMG_DG157877,UNII:G58F8OPL4I | DrugBank ID:DB09355 | CAS RN:127-71-9 | PubChem SID:175268385 | SULFABENZAMIDE | N-(4-aminophenyl)sulfonylbenzamide | PubChem CID:5319 | Sulfabenzamide
+BMGC_DG11565,BMG_DG157878,PubChem SID:472406986 | CAS RN:61153-77-3 | PubChem CID:5319000 | UNII:3K78PYN58P | LICOFLAVONE A
+BMGC_DG11566,BMG_DG157891,"2,2-dimethylchromene-6-carboxylic acid | Anofinic acid | CAS RN:34818-56-9 | PubChem CID:5319235"
+BMGC_DG11567,BMG_DG157919,CAS RN:29741-09-1 | APIGENIN 7-O-.BETA.-D-GLUCURONIDE | PubChem SID:377307954 | UNII:2CQ5KB3CH0 | PubChem CID:5319484
+BMGC_DG11568,BMG_DG157922,CAS RN:529-84-0 | UNII:132H8N0A91 | PubChem CID:5319502 | 4-METHYLESCULETIN | PubChem SID:198951927
+BMGC_DG11569,BMG_DG157925,PubChem CID:5319562 | Methyl 4-hydroxycinnamate | methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate | CAS RN:19367-38-5 | CAS RN:3943-97-3
+BMGC_DG11570,BMG_DG157930,"4,4'-DIHYDROXY-2'-METHOXYCHALCONE | UNII:LHE9JFQ1U8 | CAS RN:51828-10-5 | 2'-O-Methylisoliquiritigenin | CAS RN:112408-67-0 | PubChem SID:313183444 | PubChem CID:5319688 | (E)-1-(4-hydroxy-2-methoxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one"
+BMGC_DG11571,BMG_DG157962,DrugBank ID:DB00634 | Sulfacetamide | PubChem SID:175265322 | PubChem CID:5320 | UNII:4965G3J0F5 | N-(4-aminophenyl)sulfonylacetamide | CAS RN:144-80-9 | NDC:42192-121 | SULFACETAMIDE
+BMGC_DG11572,BMG_DG157980,"CAS RN:529-40-8 | OMBUIN | 3,5-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-methoxychromen-4-one | UNII:Z3K3F0YR3W | Ombuin | PubChem CID:5320287 | PubChem SID:363909326"
+BMGC_DG11573,BMG_DG157983,"PubChem CID:5320315 | CAS RN:480-11-5 | Oroxylin A | OROXYLIN A | 5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one | PubChem SID:198956081 | UNII:53K24Z586G"
+BMGC_DG11574,BMG_DG157984,PubChem SID:198942772 | OSTHENOL | CAS RN:484-14-0 | PubChem CID:5320318 | Osthenol | 7-hydroxy-8-(3-methylbut-2-enyl)chromen-2-one | UNII:7X6RF2708X
+BMGC_DG11575,BMG_DG157996,PECTOLINARINGENIN | PubChem SID:198944814 | UNII:4U3UZ1K35N | CAS RN:520-12-7 | PubChem CID:5320438
+BMGC_DG11576,BMG_DG157999,UNII:FD7R8D6VZB | CAS RN:569-80-2 | PubChem SID:478836860 | PubChem CID:5320462 | PENDULETIN
+BMGC_DG11577,BMG_DG158006,"CAS RN:23512-46-1 | Piperanine | (E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpent-2-en-1-one | PIPERANINE | CAS RN:65937-41-9 | UNII:GZC2LZ46CZ | PubChem CID:5320618 | PubChem SID:485661529"
+BMGC_DG11578,BMG_DG158007,"Piperlonguminine | UNII:HN39MC8KIO | CAS RN:5950-12-9 | PIPERLONGUMININE | PubChem CID:5320621 | (2E,4E)-5-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)penta-2,4-dienamide | PubChem SID:198982105"
+BMGC_DG11579,BMG_DG158011,"PubChem SID:175266608 | CAS RN:20316-62-5 | PubChem CID:5320686 | Tiliroside | TILIROSIDE | CAS RN:22153-44-2 | UNII:15M04TXR9M | [(2R,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate"
+BMGC_DG11580,BMG_DG158013,7-hydroxy-2-(4-methoxyphenyl)chromen-4-one | PRATOL | UNII:KU5R959MO7 | PubChem CID:5320693 | CAS RN:487-24-1 | PubChem SID:198950514 | CAS RN:487-17-2 | Pratol
+BMGC_DG11581,BMG_DG158027,"CAS RN:20229-56-5 | UNII:K2B74751XI | PubChem CID:5320844 | Spiraeoside | PubChem SID:198955769 | SPIRAEOSIDE | 3,5,7-trihydroxy-2-[3-hydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one"
+BMGC_DG11582,BMG_DG158038,"(2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-4-hydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1-benzofuran-3-one | PubChem CID:5321164 | CAS RN:633-15-8 | aureusidin 6-O-beta-glucoside"
+BMGC_DG11583,BMG_DG158059,(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | PubChem CID:5321765 | DrugBank ID:DB07500
+BMGC_DG11584,BMG_DG158062,PubChem CID:5321780 | PubChem SID:241178395 | CAS RN:507-79-9 | UNII:76WEU12CSO | TAZETTINE
+BMGC_DG11585,BMG_DG158066,"(6aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | (+)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol | PubChem CID:5321846"
+BMGC_DG11586,BMG_DG158070,"2,3,5,4'-TETRAHYDROXYSTILBENE-2-O-.BETA.-D-GLUCOSIDE | CAS RN:82373-94-2 | PubChem CID:5321884 | UNII:54QRI6OKJ5 | PubChem SID:381132223"
+BMGC_DG11587,BMG_DG158079,DrugBank ID:DB01298 | PubChem CID:5322 | CAS RN:1401-49-6 | Sulfacytine | UNII:T795873AJP | PubChem SID:198969213 | CAS RN:17784-12-2 | 4-amino-N-(1-ethyl-2-oxopyrimidin-4-yl)benzenesulfonamide | SULFACYTINE
+BMGC_DG11588,BMG_DG158083,"(E)-3-(2,4-dihydroxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one | PubChem CID:5322052 | CAS RN:163121-02-6 | (E)-2,4,4'-Trihydroxychalcone"
+BMGC_DG11589,BMG_DG158084,"CAS RN:73046-40-9 | 5,7,2'-Trihydroxyflavone | PubChem CID:5322064 | 5,7-dihydroxy-2-(2-hydroxyphenyl)chromen-4-one"
+BMGC_DG11590,BMG_DG158085,"CAS RN:104666-14-0 | 7,3',4'-TRIHYDROXYFLAVONE | 7,3',4'-Trihydroxyflavone | CAS RN:2150-11-0 | UNII:NS7F7K27CD | 2-(3,4-dihydroxyphenyl)-7-hydroxychromen-4-one | PubChem CID:5322065 | 7,3′,4′-Trihydroxyflavone | PubChem SID:485663505"
+BMGC_DG11591,BMG_DG158096,"PubChem CID:5322399 | LNS-8801 | UNII:Y3V5BV7OKM | CAS RN:881639-98-1 | 1-[(3aS,4R,9bR)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]ethanone | CAS RN:925419-53-0 | UNII:TFS4QE36ZG | PubChem SID:402404554 | PubChem SID:441584171 | G 1 (GPER AGONIST) | 1-(4-(6-Bromobenzo[1,3]dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl)-ethanone"
+BMGC_DG11592,BMG_DG158102,"PubChem SID:175265950 | SULFADIMETHOXINE | PubChem CID:5323 | UNII:30CPC5LDEX | DrugBank ID:DB06150 | 4-amino-N-(2,6-dimethoxypyrimidin-4-yl)benzenesulfonamide | CAS RN:122-11-2 | Sulfadimethoxine"
+BMGC_DG11593,BMG_DG158112,"NDC:68645-567 | NDC:0093-0926 | NDC:43063-939 | NDC:68788-8326 | NDC:71610-709 | NDC:72162-1739 | NDC:0093-0928 | NDC:63187-194 | NDC:51655-558 | NDC:50090-0757 | NDC:68180-467 | NDC:51407-252 | NDC:51655-469 | Lovastatin | NDC:50090-0759 | NDC:51655-686 | CAS RN:74133-25-8 | NDC:63187-345 | LOVASTATIN | [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate | NDC:55289-881 | NDC:0093-0576 | NDC:68071-3615 | NDC:68788-7056 | NDC:68071-3127 | NDC:71335-0819 | NDC:68180-469 | NDC:70518-0113 | NDC:63187-765 | NDC:43063-493 | NDC:68071-3622 | NDC:61442-142 | CAS RN:75330-75-5 | NDC:71335-0045 | NDC:63629-1018 | NDC:68788-9668 | DrugBank ID:DB00227 | PubChem CID:53232 | NDC:66267-561 | NDC:68788-8232 | NDC:63629-1178 | NDC:71205-440 | NDC:51407-253 | NDC:70515-629 | NDC:71205-993 | NDC:71610-775 | NDC:61442-143 | NDC:63629-1191 | NDC:43063-692 | UNII:9LHU78OQFD | NDC:71205-992 | NDC:71205-199 | NDC:43063-548 | NDC:70518-2727 | NDC:63187-090 | NDC:71205-994 | NDC:43063-983 | NDC:68001-314 | NDC:0615-8151 | NDC:68788-9667 | NDC:70515-628 | NDC:70518-2009 | NDC:68788-8287 | NDC:63187-814 | NDC:55289-692 | NDC:50090-3881 | NDC:68180-468 | NDC:50090-3268 | NDC:43353-995 | NDC:51655-873 | NDC:70518-3064 | NDC:51407-251 | NDC:61442-141 | NDC:68001-316 | NDC:50090-0762 | NDC:71335-0882 | NDC:68645-566 | NDC:63629-1464 | NDC:0615-8152 | NDC:70518-0706 | NDC:66267-506 | PubChem SID:175268015 | NDC:68001-315 | NDC:70515-630 | NDC:68071-4955"
+BMGC_DG11594,BMG_DG158114,"(6R,7R)-3-[[3-amino-4-(2-aminoethylcarbamoylamino)-2-methylpyrazol-1-ium-1-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | PubChem SID:198975794 | CEFTOLOZANE | CAS RN:689293-68-3 | Ceftolozane | PubChem CID:53234134 | UNII:37A4IES95Q | DrugBank ID:DB09050"
+BMGC_DG11595,BMG_DG158115,"3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylurea | UNII:A4055ME1VK | DrugBank ID:DB11886 | PubChem CID:53235510 | Infigratinib | INFIGRATINIB | PubChem SID:198987912 | CAS RN:872511-34-7"
+BMGC_DG11596,BMG_DG158124,"3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one | PubChem CID:5323714 | CAS RN:1217222-76-8 | UNII:5J9CPU3RE0 | PubChem SID:175265397 | DrugBank ID:DB00614 | FURAZOLIDONE | CAS RN:67-45-8 | Furazolidone"
+BMGC_DG11597,BMG_DG158142,PubChem CID:5324 | 2-(4-aminophenyl)sulfonylguanidine | CAS RN:6190-55-2 | CAS RN:61116-95-8 | DrugBank ID:DB13726 | PubChem SID:198938174 | SULFAGUANIDINE | CAS RN:57-67-0 | Sulfaguanidine | UNII:15XQ8043FN
+BMGC_DG11598,BMG_DG158145,LY-2812223 | CAS RN:1311385-20-2 | UNII:HY6NFM2VAG | PubChem CID:53240406 | PubChem SID:496143816
+BMGC_DG11599,BMG_DG158147,"CGM-097 | UNII:4UF6MSL0ZH | PubChem CID:53240420 | Nvp-cgm097 | (1S)-1-(4-chlorophenyl)-6-methoxy-2-[4-[methyl-[[4-(4-methyl-3-oxopiperazin-1-yl)cyclohexyl]methyl]amino]phenyl]-7-propan-2-yloxy-1,4-dihydroisoquinolin-3-one | CAS RN:1313363-54-0 | PubChem SID:375083565"
+BMGC_DG11600,BMG_DG158151,"CAS RN:1310347-50-2 | UNII:B67UFT75QS | RO-5508887 | N-[3-[(4r)-2-Azanylidene-5,5-Bis(Fluoranyl)-4-Methyl-1,3-Oxazinan-4-Yl]-4-Fluoranyl-Phenyl]-5-Cyano-Pyridine-2-Carboxamide | N-[3-[(4R)-2-amino-5,5-difluoro-4-methyl-6H-1,3-oxazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide | PubChem SID:346536902 | PubChem CID:53241828"
+BMGC_DG11601,BMG_DG158167,CAS RN:54739-18-3 | UNII:O4L1XPO44W | PubChem CID:5324346 | Fluvoxamine | 2-[(E)-[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxyethanamine | FLUVOXAMINE | DrugBank ID:DB00176 | PubChem SID:175268275
+BMGC_DG11602,BMG_DG158193,CAS RN:219828-99-6 | GRANULATIMIDE | PubChem CID:5324595 | UNII:3R9D9U7DUX
+BMGC_DG11603,BMG_DG158199,PubChem SID:198957128 | CAS RN:1208971-05-4 | UNII:9GY611K4TC | AFTOBETIN | PubChem CID:53246563
+BMGC_DG11604,BMG_DG158215,JWH-176 | UNII:VA60GT97BB | CAS RN:619294-62-1 | PubChem CID:53249197 | PubChem SID:375084207
+BMGC_DG11605,BMG_DG158219,"PubChem CID:5324988 | CAS RN:63791-96-8 | 8-Methoxy-1,4-dimethyl-2(1H)-quinolinone | UNII:H79XDK8GDS | PubChem SID:485665547 | 8-METHOXY-1,4-DIMETHYL-2(1H)-QUINOLINONE"
+BMGC_DG11606,BMG_DG158220,SULFAMERAZINE | Sulfamerazine | DrugBank ID:DB01581 | PubChem SID:175266020 | 4-amino-N-(4-methylpyrimidin-2-yl)benzenesulfonamide | UNII:UR1SAB295F | PubChem CID:5325 | CAS RN:127-79-7
+BMGC_DG11607,BMG_DG158225,"(1S,4R)-4-hydroxy-2,2-dimethyl-4-[5-(3-methyl-5-{[4-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)-1,3-thiazol-2-yl]cyclohexanecarboxylic acid | (1S,4R)-4-hydroxy-2,2-dimethyl-4-[5-[3-methyl-5-[[4-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]-1,3-thiazol-2-yl]cyclohexane-1-carboxylic acid | CAS RN:1312518-84-5 | MK-8457 | PubChem CID:53251506 | UNII:OOA78Q9G2I | PubChem SID:485660999"
+BMGC_DG11608,BMG_DG158227,"MIVAVOTINIB | PubChem CID:53252276 | 6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one | CAS RN:1312691-41-0 | CAS RN:1312691-33-0 | UNII:8QR88H79VX | Mivavotinib | PubChem SID:346540783"
+BMGC_DG11609,BMG_DG158244,RG-3039 FREE BASE | CAS RN:1005504-62-0 | PubChem SID:198954023 | UNII:KSV93L7URW | PubChem CID:53258905
+BMGC_DG11610,BMG_DG158253,DrugBank ID:DB06821 | PubChem CID:5326 | CAS RN:651-06-9 | PubChem SID:198963233 | SULFAMETER | 4-amino-N-(5-methoxypyrimidin-2-yl)benzenesulfonamide | UNII:3L179F09D6 | Sulfameter
+BMGC_DG11611,BMG_DG158284,"PubChem CID:53262401 | CAS RN:1313881-70-7 | 3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine | DrugBank ID:DB14982 | Miransertib | MIRANSERTIB | PubChem SID:329904489 | UNII:T1DQI1B52Y"
+BMGC_DG11612,BMG_DG158288,RPR131247 | PubChem CID:5326514 | DrugBank ID:DB02744
+BMGC_DG11613,BMG_DG158289,"PubChem CID:5326542 | Imino[2-(2-oxo-1,2-dihydro-3-pyridinyl)-1H-benzimidazol-5-yl]methanaminium | DrugBank ID:DB04442"
+BMGC_DG11614,BMG_DG158290,"UNII:99U1UDJ2HM | CAS RN:1086-80-2 | PubChem SID:198938509 | 7,8-dimethyl-1H-benzo[g]pteridine-2,4-dione | DrugBank ID:DB04345 | PubChem CID:5326566 | LUMICHROME | Lumichrome"
+BMGC_DG11615,BMG_DG158292,"PubChem CID:5326608 | DrugBank ID:DB02723 | 4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide"
+BMGC_DG11616,BMG_DG158293,"PubChem CID:5326637 | DrugBank ID:DB02170 | 1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One"
+BMGC_DG11617,BMG_DG158294,CRA_10972 | DrugBank ID:DB02989 | PubChem CID:5326669
+BMGC_DG11618,BMG_DG158295,DrugBank ID:DB03555 | PubChem CID:5326671 | CRA_11092
+BMGC_DG11619,BMG_DG158296,DrugBank ID:DB03016 | CRA_1801 | PubChem CID:5326682
+BMGC_DG11620,BMG_DG158297,Fexaramine | PubChem SID:438788774 | DrugBank ID:DB02545 | FEXARAMINE | PubChem CID:5326713 | UNII:WTG9GFA65U | CAS RN:574013-66-4
+BMGC_DG11621,BMG_DG158298,"9-(4-Hydroxyphenyl)-2,7-Phenanthroline | PubChem CID:5326727 | DrugBank ID:DB03623"
+BMGC_DG11622,BMG_DG158299,Indirubin-3'-monoxime | DrugBank ID:DB02052 | CAS RN:160807-49-8 | PubChem SID:438788743 | INDIRUBIN-3'-MONOXIME | PubChem CID:5326739 | UNII:X6CSG51MBQ
+BMGC_DG11623,BMG_DG158306,DrugBank ID:DB02850 | PubChem CID:5326813 | DAS869
+BMGC_DG11624,BMG_DG158307,"DrugBank ID:DB06937 | PubChem CID:5326826 | 4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL"
+BMGC_DG11625,BMG_DG158308,"PubChem CID:5326827 | DrugBank ID:DB07009 | 2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL"
+BMGC_DG11626,BMG_DG158309,"DrugBank ID:DB07364 | PubChem CID:5326843 | 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE"
+BMGC_DG11627,BMG_DG158312,PubChem CID:5326866 | DrugBank ID:DB08064 | N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA
+BMGC_DG11628,BMG_DG158313,DrugBank ID:DB08091 | PubChem CID:5326868 | 3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE
+BMGC_DG11629,BMG_DG158314,PubChem CID:5326869 | 3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE | DrugBank ID:DB08730
+BMGC_DG11630,BMG_DG158315,3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide | DrugBank ID:DB08092 | PubChem CID:5326870
+BMGC_DG11631,BMG_DG158316,DrugBank ID:DB08093 | 3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE | PubChem CID:5326871
+BMGC_DG11632,BMG_DG158318,3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID | PubChem CID:5326876 | DrugBank ID:DB04593
+BMGC_DG11633,BMG_DG158319,DrugBank ID:DB04758 | PubChem CID:5326883 | 2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE)
+BMGC_DG11634,BMG_DG158320,"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID | DrugBank ID:DB04642 | PubChem CID:5326884"
+BMGC_DG11635,BMG_DG158321,"PubChem CID:5326885 | 4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID | DrugBank ID:DB04643"
+BMGC_DG11636,BMG_DG158322,"DrugBank ID:DB04644 | 4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID | PubChem CID:5326886"
+BMGC_DG11637,BMG_DG158323,"DrugBank ID:DB04645 | 5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID | PubChem CID:5326887"
+BMGC_DG11638,BMG_DG158324,PubChem CID:5326888 | DrugBank ID:DB04606 | 2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE)
+BMGC_DG11639,BMG_DG158325,"PubChem CID:5326911 | (3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE | DrugBank ID:DB04709"
+BMGC_DG11640,BMG_DG158326,"DrugBank ID:DB04724 | PubChem CID:5326914 | (S)-2-((S)-3-isobutyl-2,5-dioxo-4-quinolin-3-ylmethyl-[1,4]diazepan-1yl)-N-methyl-3-naphtalen-2-yl-propionamide"
+BMGC_DG11641,BMG_DG158327,"2,5-bis-O-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-D-glucitol | DrugBank ID:DB04790 | PubChem CID:5326924"
+BMGC_DG11642,BMG_DG158328,"PubChem CID:5326925 | 2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL | DrugBank ID:DB04791"
+BMGC_DG11643,BMG_DG158329,"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL | DrugBank ID:DB04792 | PubChem CID:5326926"
+BMGC_DG11644,BMG_DG158330,"1,4:3,6-Dianhydro-2-O-(3-carbamimidoylphenyl)-5-O-(4-carbamimidoylphenyl)-D-glucitol | DrugBank ID:DB04793 | PubChem CID:5326927"
+BMGC_DG11645,BMG_DG158333,"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE | DrugBank ID:DB07704 | PubChem CID:5326930"
+BMGC_DG11646,BMG_DG158334,"DrugBank ID:DB02840 | PubChem CID:5326934 | 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid"
+BMGC_DG11647,BMG_DG158335,"PubChem CID:5326956 | 1-{4-[4-Amino-6-(4-methoxyphenyl)furo[2,3-d]pyrimidin-5-yl]phenyl}-3-[2-fluoro-5-(trifluoromethyl)phenyl]urea | DrugBank ID:DB04727"
+BMGC_DG11648,BMG_DG158336,DrugBank ID:DB04700 | GLUTATHIONE SULFINATE | PubChem CID:5326960
+BMGC_DG11649,BMG_DG158337,(R)-tacrine(10)-hupyridone | PubChem CID:5326966 | DrugBank ID:DB04614
+BMGC_DG11650,BMG_DG158338,PubChem CID:5326967 | (S)-tacrine(10)-hupyridone | DrugBank ID:DB04615
+BMGC_DG11651,BMG_DG158340,Human blood group H type 1 trisaccharide | PubChem CID:5326971 | DrugBank ID:DB04679
+BMGC_DG11652,BMG_DG158341,DrugBank ID:DB04680 | GALACTOSE GREASE | PubChem CID:5326972
+BMGC_DG11653,BMG_DG158342,"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE | PubChem CID:5326976 | DrugBank ID:DB04719"
+BMGC_DG11654,BMG_DG158343,"S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE | DrugBank ID:DB04720 | PubChem CID:5326977"
+BMGC_DG11655,BMG_DG158344,"DrugBank ID:DB04721 | PubChem CID:5326978 | N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE"
+BMGC_DG11656,BMG_DG158345,"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA | PubChem CID:5326979 | DrugBank ID:DB06971"
+BMGC_DG11657,BMG_DG158346,"Sulfamethazine | CAS RN:57-68-1 | PubChem CID:5327 | 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide | SULFAMETHAZINE | DrugBank ID:DB01582 | PubChem SID:175268866 | UNII:48U51W007F"
+BMGC_DG11658,BMG_DG158349,"DrugBank ID:DB04754 | GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE | PubChem CID:5327012"
+BMGC_DG11659,BMG_DG158350,"DrugBank ID:DB04753 | PubChem CID:5327013 | 9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE"
+BMGC_DG11660,BMG_DG158351,"PubChem CID:5327014 | DrugBank ID:DB04757 | GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE"
+BMGC_DG11661,BMG_DG158356,"DrugBank ID:DB07298 | PubChem CID:5327045 | 3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID"
+BMGC_DG11662,BMG_DG158357,"DrugBank ID:DB07606 | PubChem CID:5327057 | 6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE"
+BMGC_DG11663,BMG_DG158358,DrugBank ID:DB08423 | [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE | PubChem CID:5327066
+BMGC_DG11664,BMG_DG158359,"PubChem CID:5327067 | [5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE | DrugBank ID:DB08424"
+BMGC_DG11665,BMG_DG158360,Cyclohexyl-pentyl-maltoside | DrugBank ID:DB04664 | PubChem CID:5327073
+BMGC_DG11666,BMG_DG158364,PubChem CID:5327091 | CCT-018159 | DrugBank ID:DB07594
+BMGC_DG11667,BMG_DG158365,"PubChem CID:5327092 | DrugBank ID:DB08045 | 4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL"
+BMGC_DG11668,BMG_DG158366,"PubChem CID:5327095 | DrugBank ID:DB07495 | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE"
+BMGC_DG11669,BMG_DG158367,N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide | DrugBank ID:DB08677 | PubChem CID:5327096
+BMGC_DG11670,BMG_DG158368,"PubChem CID:5327097 | DrugBank ID:DB08673 | 4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE"
+BMGC_DG11671,BMG_DG158370,"PubChem CID:5327103 | N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE | DrugBank ID:DB06956"
+BMGC_DG11672,BMG_DG158371,"PubChem CID:5327104 | N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE | DrugBank ID:DB04588"
+BMGC_DG11673,BMG_DG158372,PubChem CID:5327109 | ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE | DrugBank ID:DB07947
+BMGC_DG11674,BMG_DG158373,"DrugBank ID:DB07583 | (4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE | PubChem CID:5327110"
+BMGC_DG11675,BMG_DG158376,PubChem CID:5327122 | 4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL | DrugBank ID:DB07336
+BMGC_DG11676,BMG_DG158377,PubChem CID:5327123 | 3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE | DrugBank ID:DB07959
+BMGC_DG11677,BMG_DG158378,"DrugBank ID:DB07595 | (5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE | PubChem CID:5327130"
+BMGC_DG11678,BMG_DG158379,DrugBank ID:DB04669 | TRIAZOLOPYRIMIDINE | PubChem CID:5327131
+BMGC_DG11679,BMG_DG158380,PubChem CID:5327150 | DrugBank ID:DB04768 | Pyrithiamine Pyrophosphate
+BMGC_DG11680,BMG_DG158381,"[(3S)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid | DrugBank ID:DB06887 | PubChem CID:5327152"
+BMGC_DG11681,BMG_DG158382,"DrugBank ID:DB08549 | (3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER | PubChem CID:5327153"
+BMGC_DG11682,BMG_DG158383,1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID | PubChem CID:5327154 | DrugBank ID:DB04800
+BMGC_DG11683,BMG_DG158384,"DrugBank ID:DB07719 | PubChem CID:5327155 | [(3R)-3-(Methylcarbamoyl)-2-{[(2-methyl-2-propanyl)oxy]carbonyl}-1,2,3,4-tetrahydro-7-isoquinolinyl]sulfamic acid"
+BMGC_DG11684,BMG_DG158388,CAS RN:1198579-27-9 | CAS RN:56995-20-1 | PubChem SID:198976803 | ethyl N-[2-amino-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate | FLUPIRTINE | Flupirtine | PubChem CID:53276 | DrugBank ID:DB06623 | UNII:MOH3ET196H
+BMGC_DG11685,BMG_DG158390,"CAS RN:125313-92-0 | PubChem SID:198944951 | UNII:DNZ11VPY7Q | MKC-1 | 1H-pyrrole-2,5-dione, 3-(1-methyl-1h-indol-3-yl)-4-(1-methyl-6-nitro-1h-indol-3-yl)- | DrugBank ID:DB05608 | PubChem CID:5327686 | 3-(1-methylindol-3-yl)-4-(1-methyl-6-nitroindol-3-yl)pyrrole-2,5-dione"
+BMGC_DG11686,BMG_DG158394,"Sulfamethizole | CAS RN:144-82-1 | PubChem CID:5328 | UNII:25W8454H16 | DrugBank ID:DB00576 | SULFAMETHIZOLE | 4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)benzenesulfonamide | PubChem SID:175267840"
+BMGC_DG11687,BMG_DG158395,"PubChem SID:485663534 | UNII:FGF5J7YB3H | N4-(3-BROMOPHENYL)QUINAZOLINE-4,6-DIAMINE | PubChem CID:5328042 | N4-(3-Bromophenyl)quinazoline-4,6-diamine | CAS RN:169205-78-1"
+BMGC_DG11688,BMG_DG158396,"PubChem CID:5328077 | PubChem SID:485663592 | 4-N-benzylpyrido[4,3-d]pyrimidine-4,7-diamine | CAS RN:171178-89-5 | UNII:QQ47LMT2NG | 4-N-BENZYLPYRIDO(4,3-D)PYRIMIDINE-4,7-DIAMINE"
+BMGC_DG11689,BMG_DG158397,"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine | DrugBank ID:DB08144 | PubChem CID:5328120"
+BMGC_DG11690,BMG_DG158398,"CAS RN:192705-79-6 | 1-[2-amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea | PubChem CID:5328127 | PD-166866 | UNII:NA856793UT | PubChem SID:198956848 | Urea, N-[2-amino-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl]-N'-(1,1-dimethylethyl)-"
+BMGC_DG11691,BMG_DG158399,"N-(3-bromophenyl)-6,7-dimethoxy-N-methylquinazolin-4-amine | CAS RN:229476-53-3 | Ebe-A22 | PubChem CID:5328227"
+BMGC_DG11692,BMG_DG158400,CAS RN:38205-85-5 | UNII:YLR9G9G6E8 | PubChem SID:459055920 | 5-METHOXY-1-PHENYL-1H-BENZIMIDAZOLE | PubChem CID:5328466
+BMGC_DG11693,BMG_DG158401,"CAS RN:100827-28-9 | N-[(E)-2-(2,5-dihydroxyphenyl)ethenyl]formamide | Erbstatin | UNII:WDH83K6T5P | ERBSTATIN | PubChem SID:198941015 | PubChem CID:5328552"
+BMGC_DG11694,BMG_DG158402,UNII:85GA4ESY8J | PubChem CID:5328733 | PD-173952 | PubChem SID:472421831 | CAS RN:305820-75-1
+BMGC_DG11695,BMG_DG158403,CAS RN:133550-18-2 | PubChem CID:5328760 | TYRPHOSTIN AG-538 | PubChem SID:472421962 | UNII:974K3CXM9B
+BMGC_DG11696,BMG_DG158404,PubChem CID:5328768 | TYRPHOSTIN A46 | PubChem SID:381132502 | UNII:ARL2OF9022 | CAS RN:122520-85-8
+BMGC_DG11697,BMG_DG158405,"PubChem SID:485660888 | PubChem CID:5328779 | AG-490 | CAS RN:133550-30-8 | Tyrphostin B42 | CAS RN:134036-52-5 | (E)-N-benzyl-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide | UNII:C4UD8F8XJY"
+BMGC_DG11698,BMG_DG158406,CAS RN:90947-89-0 | PubChem CID:5328785 | 2-[(4-hydroxy-3-nitrophenyl)methylidene]propanedinitrile | 2-[(4-Hydroxy-3-nitrophenyl)methylidene]propanedinitrile
+BMGC_DG11699,BMG_DG158407,alpha-Cyano-4-hydroxycinnamic acid | (E)-2-cyano-3-(4-hydroxyphenyl)prop-2-enoic acid | CAS RN:122520-77-8 | CAS RN:28166-41-8 | PubChem CID:5328791
+BMGC_DG11700,BMG_DG158409,"PubChem SID:175267629 | UNII:5018V4AEZ0 | CAS RN:380843-75-4 | BOSUTINIB | PubChem CID:5328940 | Bosutinib | DrugBank ID:DB06616 | 4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile"
+BMGC_DG11701,BMG_DG158411,PubChem CID:5328969 | (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide | DrugBank ID:DB08564
+BMGC_DG11702,BMG_DG158412,"NDC:62135-898 | NDC:50090-5682 | NDC:66993-727 | NDC:68071-4710 | NDC:50090-4848 | NDC:50090-5786 | NDC:50090-2479 | NDC:67296-0387 | NDC:62135-897 | NDC:80425-0003 | NDC:61971-115 | NDC:50090-5679 | CAS RN:723-46-6 | NDC:57237-233 | 4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide | NDC:67296-1916 | NDC:68788-7622 | NDC:67296-1612 | NDC:71205-810 | NDC:53489-145 | NDC:54348-625 | NDC:72789-018 | NDC:70069-363 | NDC:68788-7122 | NDC:53489-146 | NDC:55700-611 | NDC:50090-7008 | NDC:60687-442 | NDC:63187-782 | NDC:50090-5680 | NDC:69043-010 | NDC:62135-749 | NDC:63187-008 | NDC:42291-759 | NDC:67296-1657 | NDC:68788-8607 | NDC:50090-2201 | NDC:66267-816 | NDC:70934-544 | NDC:65862-419 | NDC:76420-064 | NDC:50090-0525 | NDC:65862-496 | NDC:67296-1502 | NDC:50090-2199 | NDC:50090-7393 | NDC:63629-1765 | NDC:67457-922 | NDC:60687-614 | NDC:42708-053 | NDC:60760-541 | Sulfamethoxazole | NDC:0121-0853 | NDC:65862-420 | NDC:70518-3432 | NDC:70954-258 | CAS RN:129378-89-8 | NDC:67457-779 | NDC:67296-1129 | NDC:68071-3579 | NDC:53746-271 | NDC:51655-307 | NDC:63187-695 | CAS RN:144930-01-8 | NDC:50090-2198 | NDC:51655-188 | NDC:0615-8121 | NDC:60429-259 | PubChem CID:5329 | NDC:50090-7399 | NDC:65162-271 | NDC:68788-7345 | NDC:70069-361 | NDC:60760-069 | NDC:70069-362 | NDC:70518-2604 | NDC:68071-4948 | NDC:67296-0724 | NDC:55154-7895 | NDC:67296-1904 | NDC:66267-196 | NDC:0703-9526 | NDC:67296-1327 | NDC:50090-4850 | NDC:53746-272 | NDC:50090-6901 | UNII:JE42381TNV | NDC:67457-921 | NDC:50090-4847 | DrugBank ID:DB01015 | NDC:42291-758 | NDC:62135-873 | NDC:50090-6902 | NDC:70518-2838 | NDC:0703-9514 | NDC:61971-120 | NDC:67457-778 | NDC:49708-145 | NDC:70518-3454 | NDC:57237-232 | NDC:60687-603 | NDC:80425-0001 | NDC:69043-011 | NDC:17856-0496 | NDC:67296-2085 | NDC:50268-728 | NDC:61919-645 | NDC:70518-0863 | NDC:70518-4043 | NDC:72789-064 | NDC:80425-0002 | SULFAMETHOXAZOLE | NDC:50090-2200 | NDC:0703-9503 | NDC:67046-1070 | NDC:0904-2725 | PubChem SID:175266891 | NDC:0121-0854 | NDC:82982-044 | NDC:49708-146 | NDC:71335-0762 | NDC:65162-272"
+BMGC_DG11703,BMG_DG158413,"CAS RN:153437-78-6 | UNII:W5C8Y7UK26 | PubChem CID:5329009 | N-(3-CHLORO-4-FLUOROPHENYL)-6,7-DIMETHOXY-4-QUINAZOLINAMINE"
+BMGC_DG11704,BMG_DG158414,N-DESMETHYL VANDETANIB | UNII:K4I43R5TNP | CAS RN:338992-12-4 | PubChem CID:5329048 | N-Desmethyl vandetanib | PubChem SID:313182925 | N-(4-bromo-2-fluorophenyl)-6-methoxy-7-(piperidin-4-ylmethoxy)quinazolin-4-amine
+BMGC_DG11705,BMG_DG158415,"PubChem SID:198984189 | SEMAXANIB | CAS RN:194413-58-6 | Semaxanib | (3Z)-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylidene]-1H-indol-2-one | DrugBank ID:DB06436 | PubChem CID:5329098 | UNII:71IA9S35AJ | CAS RN:204005-46-9"
+BMGC_DG11706,BMG_DG158416,"DrugBank ID:DB12072 | CAS RN:1044712-39-1 | CAS RN:210644-62-5 | CAS RN:252916-29-3 | PubChem SID:198939270 | CAS RN:245036-27-5 | UNII:9RL37ZZ665 | 3-[2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid | ORANTINIB | PubChem CID:5329099 | Orantinib"
+BMGC_DG11707,BMG_DG158418,"Sunitinib | SUNITINIB | PubChem CID:5329102 | DrugBank ID:DB01268 | UNII:V99T50803M | CAS RN:557795-19-4 | PubChem SID:198957003 | N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide"
+BMGC_DG11708,BMG_DG158419,PubChem SID:322058581 | CAS RN:326914-10-7 | SU-11652 | PubChem CID:5329103 | UNII:1C7AZL970U | DrugBank ID:DB08009
+BMGC_DG11709,BMG_DG158420,"PubChem CID:5329106 | TOCERANIB | PubChem SID:175266805 | 5-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-2,4-dimethyl-N-(2-pyrrolidin-1-ylethyl)-1H-pyrrole-3-carboxamide | Toceranib | UNII:59L7Y0530C | CAS RN:356068-94-5"
+BMGC_DG11710,BMG_DG158421,PubChem SID:318691887 | PubChem CID:5329155 | UNII:9NPC24K8FA | VEGFR 2 KINASE INHIBITOR II | CAS RN:288144-20-7
+BMGC_DG11711,BMG_DG158422,"PubChem SID:472422233 | PubChem CID:5329404 | N,5-DIPHENYL-2-OXAZOLAMINE | UNII:HNL2M9TQX2 | CAS RN:135307-33-4"
+BMGC_DG11712,BMG_DG158423,"CAS RN:216661-57-3 | 6-(4-METHOXYPHENYL)-3-(3-THIENYL)-PYRAZOLO(1,5-A)PYRIMIDINE | PubChem CID:5329468 | UNII:FHX0K077F6 | PubChem SID:198950801"
+BMGC_DG11713,BMG_DG158443,"PubChem CID:53297448 | CAS RN:161596-64-1 | Aflatoxin-M1-8,9-epoxide | (3S,4R,6S,8S)-3-hydroxy-12-methoxy-5,7,9,20-tetraoxahexacyclo[11.7.0.02,10.03,8.04,6.014,18]icosa-1,10,12,14(18)-tetraene-17,19-dione"
+BMGC_DG11714,BMG_DG158444,"CAS RN:141899-13-0 | PubChem CID:53297449 | Aflatoxin B1 endo-8,9-epoxide | (3R,4S,6R,8S)-12-methoxy-5,7,9,20-tetraoxahexacyclo[11.7.0.02,10.03,8.04,6.014,18]icosa-1,10,12,14(18)-tetraene-17,19-dione"
+BMGC_DG11715,BMG_DG158457,CAS RN:582315-72-8 | PubChem SID:198962506 | BMS-265246 | PubChem CID:5329775 | UNII:4GF4A623RF
+BMGC_DG11716,BMG_DG158458,CAS RN:681002-56-2 | 3-[(5-Phenyl-2-oxazolyl)amino]benzenemethanol | 3-((5-PHENYL-2-OXAZOLYL)AMINO)BENZENEMETHANOL | UNII:GP3GV5CL4P | PubChem CID:5329847 | PubChem SID:475550258
+BMGC_DG11717,BMG_DG158463,PubChem CID:533 | UNII:V91P54KPAM | Hydrogen selenide | CAS RN:7783-07-5 | selane | PubChem SID:198959730 | HYDROGEN SELENIDE
+BMGC_DG11718,BMG_DG158464,Sulfamethoxypyridazine | CAS RN:80-35-3 | PubChem CID:5330 | PubChem SID:198977604 | SULFAMETHOXYPYRIDAZINE | UNII:T034E4NS2Z | 4-amino-N-(6-methoxypyridazin-3-yl)benzenesulfonamide | DrugBank ID:DB13773
+BMGC_DG11719,BMG_DG158465,CAS RN:476159-98-5 | UNII:0361Z8214O | PubChem SID:198936162 | PubChem CID:5330175 | M-475271
+BMGC_DG11720,BMG_DG158466,"PubChem CID:5330197 | N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine | DrugBank ID:DB07249"
+BMGC_DG11721,BMG_DG158470,6-DESACETYL PALBOCICLIB | CAS RN:571190-22-2 | UNII:9M89JRK55G | PubChem SID:441583970 | PubChem CID:5330281
+BMGC_DG11722,BMG_DG158471,CAS RN:851067-56-6 | PubChem SID:441584105 | UNII:MGB9JX8TMP | 6-DESACETYL-6-BROMO PALBOCICLIB | PubChem CID:5330284
+BMGC_DG11723,BMG_DG158472,"PubChem SID:198975276 | CAS RN:571190-30-2 | NDC:63539-688 | DrugBank ID:DB09073 | NDC:0069-0688 | NDC:63539-189 | 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one | NDC:0069-0189 | NDC:63539-187 | PubChem CID:5330286 | NDC:0069-0187 | NDC:63539-486 | NDC:63539-188 | NDC:63539-284 | Palbociclib | NDC:0069-0284 | UNII:G9ZF61LE7G | PALBOCICLIB | NDC:0069-0188 | NDC:0069-0486"
+BMGC_DG11724,BMG_DG158473,N-METHYL PALBOCICLIB | PubChem CID:5330298 | PubChem SID:485664699 | N-Methyl Palbociclib | UNII:SYT54F7Y9L | CAS RN:571189-51-0
+BMGC_DG11725,BMG_DG158476,"CAS RN:202475-54-5 | 6,7-DIMETHOXY-N-(3,4,5-TRIMETHOXYPHENYL)-4-QUINAZOLINAMINE | 6,7-Dimethoxy-N-(3,4,5-trimethoxyphenyl)-4-quinazolinamine | PubChem SID:478838421 | PubChem CID:5330462 | UNII:8N6RCM55JJ"
+BMGC_DG11726,BMG_DG158477,UNII:YR2DP5GJ1Y | PubChem SID:198980814 | PubChem CID:5330524 | CAS RN:305820-76-2 | PD-173956
+BMGC_DG11727,BMG_DG158478,"PubChem SID:445500647 | CAS RN:97978-07-9 | PubChem CID:5330534 | METHANONE, BIS(BENZO(B)THIEN-2-YL)- | UNII:3U9B73C27C"
+BMGC_DG11728,BMG_DG158479,UNII:KCV65FK2NQ | PubChem CID:5330535 | PubChem SID:472422250 | (5-HYDROXY-1H-INDOL-2-YL)(1H-INDOL-2-YL)METHANONE | CAS RN:249762-62-7
+BMGC_DG11729,BMG_DG158480,"DrugBank ID:DB04607 | PubChem CID:5330608 | PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE"
+BMGC_DG11730,BMG_DG158487,JNJ-7706621 | CAS RN:443797-96-4 | PubChem CID:5330790 | UNII:74GK72DON8 | PubChem SID:198980347
+BMGC_DG11731,BMG_DG158488,K-00024 | PubChem CID:5330797 | UNII:XZ73ATU8W7 | CAS RN:546102-60-7 | PubChem SID:459055288
+BMGC_DG11732,BMG_DG158489,PubChem CID:5330812 | K-00546 | CAS RN:443798-47-8 | DrugBank ID:DB07664 | PubChem SID:319892195 | UNII:LFR1253W75
+BMGC_DG11733,BMG_DG158491,"3-(3,5-Dimethyl-1,2-Oxazol-4-Yl)-5-Ethoxybenzoic Acid | PubChem CID:53308655 | 3-(3,5-dimethyl-1,2-oxazol-4-yl)-5-ethoxybenzoic acid"
+BMGC_DG11734,BMG_DG158493,PubChem CID:53308743 | UNII:3334NG9XPB | CAS RN:1279038-40-2 | SAR-164653
+BMGC_DG11735,BMG_DG158495,"UNII:4ECQ44LZ2E | PubChem SID:459055260 | CAS RN:437982-90-6 | PubChem CID:5330948 | PHA-533533, (R)-"
+BMGC_DG11736,BMG_DG158496,PHA-533533 | PubChem SID:459055802 | PubChem CID:5330949 | UNII:G8GDE33ZUU | CAS RN:437982-89-3
+BMGC_DG11737,BMG_DG158498,"DrugBank ID:DB08527 | 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE | PubChem CID:5331010"
+BMGC_DG11738,BMG_DG158500,PubChem SID:316916281 | UNII:68UX3YT8DK | IMIGLIPTIN | CAS RN:1314944-07-4 | PubChem CID:53311070
+BMGC_DG11739,BMG_DG158502,"CAS RN:1314883-11-8 | 5-(4-(Methylsulfonyl)phenyl)-6'-(trifluoromethyl)-3,3'-bipyridine-2-amine | UNII:0Z5T00JJ10 | PubChem SID:333495414 | PubChem CID:53311393 | 5-(4-methylsulfonylphenyl)-3-[6-(trifluoromethyl)pyridin-3-yl]pyridin-2-amine | MMV-048"
+BMGC_DG11740,BMG_DG158504,"(4-Cyclopropyl-3,4-dihydro-2H-quinoxalin-1-yl)[4-(2,5-dichloro-phenoxy)-pyridin-3-yl]-methanone | PubChem CID:53311869 | (4-cyclopropyl-2,3-dihydroquinoxalin-1-yl)-[4-(2,5-dichlorophenoxy)pyridin-3-yl]methanone"
+BMGC_DG11741,BMG_DG158508,PubChem SID:377309208 | N-3-PYRIDINYL-9-ACRIDINAMINE | UNII:BE44S4YP6M | PubChem CID:53313 | CAS RN:75775-64-3
+BMGC_DG11742,BMG_DG158512,"CAS RN:19356-17-3 | PubChem CID:53315608 | (1S,3Z)-3-[(2E)-2-[(3aS,7aR)-1-[(2R)-6-hydroxy-7,7,7-tritritio-6-(tritritiomethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol"
+BMGC_DG11743,BMG_DG158513,UNII:3DG5AHY932 | PubChem SID:472425193 | CAS RN:1481677-78-4 | UNC-0642 | PubChem CID:53315878
+BMGC_DG11744,BMG_DG158514,UNII:Z5F4D95Y7J | PubChem CID:53315882 | CAS RN:1320288-17-2 | UNC-0646 | PubChem SID:482554717
+BMGC_DG11745,BMG_DG158518,"CAS RN:1004533-10-1 | CAS RN:849753-15-7 | PubChem CID:53316710 | PF-232798 | UNII:63P7W7886U | PubChem SID:198973400 | DrugBank ID:DB14813 | N-[(1S)-1-(3-fluorophenyl)-3-[(1R,5S)-3-[2-methyl-5-(2-methylpropanoyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridin-1-yl]-8-azabicyclo[3.2.1]octan-8-yl]propyl]acetamide"
+BMGC_DG11746,BMG_DG158521,UNII:QJ6GC7UX8D | PubChem SID:485665518 | PubChem CID:53318931 | AM-11542
+BMGC_DG11747,BMG_DG158532,"4-[(3R,3aR,6S,6aR)-3-(3,4-dihydroxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-6-yl]benzene-1,2-diol | PubChem CID:53321379"
+BMGC_DG11748,BMG_DG158536,PubChem SID:313184127 | PubChem CID:53322523 | CAS RN:62995-11-3 | UNII:816P6563TH | STELLATIN (C12)
+BMGC_DG11749,BMG_DG158545,UNII:GY6276ICQJ | PubChem SID:198943029 | CAS RN:1009821-06-0 | CX-5011 FREE ACID | PubChem CID:53326156
+BMGC_DG11750,BMG_DG158546,UNII:YV53AV45DS | ESTRONE CYANATE | PubChem SID:474492855 | PubChem CID:53326333 | CAS RN:23623-36-1
+BMGC_DG11751,BMG_DG158549,CAS RN:1337-39-9 | Sulfanilamide | DrugBank ID:DB00259 | SULFANILAMIDE | PubChem SID:175267100 | UNII:21240MF57M | 4-aminobenzenesulfonamide | CAS RN:63-74-1 | PubChem CID:5333
+BMGC_DG11752,BMG_DG158550,"PubChem CID:53330936 | DrugBank ID:DB12495 | (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-10-(4-amino-4-oxobutyl)-7-(2-amino-2-oxoethyl)-16-benzyl-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-1-oxo-5-(propan-2-ylamino)pentan-2-yl]pyrrolidine-2-carboxamide | Selepressin | UNII:8P2T76M0SJ | CAS RN:876296-47-8 | PubChem SID:198947962 | SELEPRESSIN"
+BMGC_DG11753,BMG_DG158554,PubChem CID:5334 | CAS RN:122-16-7 | SULFANITRAN | PubChem SID:198950934 | UNII:QT35T5T35Q
+BMGC_DG11754,BMG_DG158555,CAS RN:1316215-12-9 | Citarinostat | DrugBank ID:DB15449 | CITARINOSTAT | UNII:441P620G3P | 2-(N-(2-chlorophenyl)anilino)-N-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide | PubChem SID:316912324 | PubChem CID:53340426
+BMGC_DG11755,BMG_DG158558,DrugBank ID:DB12376 | RICOLINOSTAT | PubChem SID:198988199 | PubChem CID:53340666 | N-[7-(hydroxyamino)-7-oxoheptyl]-2-(N-phenylanilino)pyrimidine-5-carboxamide | Ricolinostat | CAS RN:1316214-52-4 | UNII:WKT909C62B
+BMGC_DG11756,BMG_DG158559,"CAS RN:1320346-97-1 | UNII:43A5P87Z4T | DrugBank ID:DB12297 | (2S)-3-[[2,5-dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]-2-[(4-methoxyphenyl)sulfonylamino]propanoic acid | Glpg-0187 | GLPG-0187 | PubChem CID:53340771 | PubChem SID:310825440"
+BMGC_DG11757,BMG_DG158562,PubChem SID:443625125 | CAS RN:1207745-58-1 | PubChem CID:53341130 | UNII:77GX6MU9ZL | MK-4409
+BMGC_DG11758,BMG_DG158570,DrugBank ID:DB06729 | PubChem CID:5335 | CAS RN:1420043-53-3 | SULFAPHENAZOLE | UNII:0J8L4V3F81 | PubChem SID:198948281 | 4-amino-N-(2-phenylpyrazol-3-yl)benzenesulfonamide | CAS RN:526-08-9 | Sulfaphenazole
+BMGC_DG11759,BMG_DG158577,"DrugBank ID:DB12675 | CAS RN:1331782-27-4 | Pf-04995274 | PubChem CID:53354764 | 4-[[4-[[4-[(3R)-oxolan-3-yl]oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-yl]methyl]oxan-4-ol | PubChem SID:198969007 | UNII:XI179PG9LV | PF-04995274"
+BMGC_DG11760,BMG_DG158578,PubChem CID:53354771 | UNII:ZSA4DW7LDJ | CAS RN:1332328-01-4 | DEBIO-1142 | PubChem SID:459055654
+BMGC_DG11761,BMG_DG158579,GSK-2485852 | UNII:6G04C5ZNQJ | PubChem CID:53354790 | Gsk-2485852 | [4-[[[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl]-methylsulfonylamino]methyl]-2-fluorophenyl]boronic acid | PubChem SID:317229773 | CAS RN:1331942-30-3
+BMGC_DG11762,BMG_DG158581,"PubChem CID:53356659 | CAS RN:14875-96-8 | 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,23-diid-2-yl]propanoic acid;iron | Ferroheme b"
+BMGC_DG11763,BMG_DG158594,"PubChem SID:461434222 | Tak-960 | TAK-960 | 4-[(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-8H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamide | CAS RN:1137868-52-0 | UNII:3831VFM1ZB | PubChem CID:53357478"
+BMGC_DG11764,BMG_DG158598,"DrugBank ID:DB12325 | UNII:QSQ883V35U | PubChem SID:198954526 | Idasanutlin | PubChem CID:53358942 | 4-[[(2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid | CAS RN:1229705-06-9 | IDASANUTLIN"
+BMGC_DG11765,BMG_DG158599,CAS RN:82964-04-3 | TOLRESTAT | PubChem SID:198944001 | PubChem CID:53359 | UNII:0T93LG5NMK | DrugBank ID:DB02383 | 2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methylamino]acetic acid | Tolrestat
+BMGC_DG11766,BMG_DG158602,CAS RN:144-83-2 | UNII:Y5V2N1KE8U | DrugBank ID:DB00891 | PubChem CID:5336 | SULFAPYRIDINE | PubChem SID:175268438 | Sulfapyridine | 4-amino-N-pyridin-2-ylbenzenesulfonamide
+BMGC_DG11767,BMG_DG158603,"PubChem SID:317229457 | UNII:0151W500HP | (3r,3as,6ar)-Hexahydrofuro[2,3-B]furan-3-Yl {(2s,3r)-4-[({2-[(1-Cyclopentylpiperidin-4-Yl)amino]-1,3-Benzothiazol-6-Yl}sulfonyl)(2-Methylpropyl)amino]-3-Hydroxy-1-Phenylbutan-2-Yl}carbamate | TMC-310911 | [(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[[2-[(1-cyclopentylpiperidin-4-yl)amino]-1,3-benzothiazol-6-yl]sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate | PubChem CID:53361968 | DrugBank ID:DB15623 | CAS RN:1000287-05-7"
+BMGC_DG11768,BMG_DG158610,UNII:9J4QL2SP4U | CAS RN:1312603-77-2 | Pacritinib Metabolite M1 | PubChem SID:474494806 | PubChem CID:53363151 | PACRITINIB METABOLITE M1
+BMGC_DG11769,BMG_DG158613,PubChem SID:475550888 | Pacritinib Metabolite M2 | PACRITINIB METABOLITE M2 | CAS RN:1312603-69-2 | UNII:UD78C37Y28 | PubChem CID:53364338
+BMGC_DG11770,BMG_DG158625,"Fosifloxuridine Nafalbenamide | CAS RN:1332837-31-6 | PubChem SID:346541145 | benzyl (2S)-2-[[[(2R,3S,5R)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-naphthalen-1-yloxyphosphoryl]amino]propanoate | PubChem CID:53373585 | DrugBank ID:DB14859 | fosifloxuridine nafalbenamide | FOSIFLOXURIDINE NAFALBENAMIDE | UNII:4YO6QT3SZ9"
+BMGC_DG11771,BMG_DG158627,Upacicalcet | UNII:5C1222PBE2 | CAS RN:1333218-50-0 | (2S)-2-amino-3-[(3-chloro-2-methyl-5-sulfophenyl)carbamoylamino]propanoic acid | PubChem CID:53374467 | PubChem SID:363909384 | UPACICALCET
+BMGC_DG11772,BMG_DG158644,DrugBank ID:DB13855 | CAS RN:965-52-6 | PubChem SID:198955358 | UNII:PM5LI0P38J | Nifuroxazide | 4-hydroxy-N-[(E)-(5-nitrofuran-2-yl)methylideneamino]benzamide | NIFUROXAZIDE | PubChem CID:5337997
+BMGC_DG11773,BMG_DG158645,PubChem CID:5338 | CAS RN:59-40-5 | UNII:WNW8115TM9 | 4-amino-N-quinoxalin-2-ylbenzenesulfonamide | SULFAQUINOXALINE | PubChem SID:175265511 | Sulfaquinoxaline | DrugBank ID:DB11464
+BMGC_DG11774,BMG_DG158647,"CAS RN:1651228-00-0 | PubChem CID:53380437 | ITACITINIB | 2-[1-[1-[3-fluoro-2-(trifluoromethyl)pyridine-4-carbonyl]piperidin-4-yl]-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile | CAS RN:1334298-90-6 | PubChem SID:252165310 | Itacitinib | DrugBank ID:DB12154 | UNII:19J3781LPM"
+BMGC_DG11775,BMG_DG158648,PF-4840154 | UNII:BR82CU5AC9 | PubChem CID:53380803 | CAS RN:1332708-14-1 | PubChem SID:474493521
+BMGC_DG11776,BMG_DG158670,UNII:6UZY4BZ33H | PubChem SID:318164634 | 3-BENZYL-4-METHYLUMBELLIFERONE | CAS RN:86-44-2 | PubChem CID:5338538
+BMGC_DG11777,BMG_DG158678,Pradigastat | UNII:2U23G6VNUZ | PubChem CID:53387035 | PubChem SID:198975565 | DrugBank ID:DB12866 | PRADIGASTAT | CAS RN:956136-95-1 | 2-[4-[4-[5-[[6-(trifluoromethyl)pyridin-3-yl]amino]pyridin-2-yl]phenyl]cyclohexyl]acetic acid
+BMGC_DG11778,BMG_DG158682,"Rimcazole | CAS RN:75859-04-0 | PubChem CID:53389 | 9-[3-[(3S,5R)-3,5-dimethylpiperazin-1-yl]propyl]carbazole | UNII:C3N1PS8CX1 | PubChem SID:198963611 | RIMCAZOLE"
+BMGC_DG11779,BMG_DG158685,NDC:0013-0102 | PubChem CID:5339 | SULFASALAZINE | CAS RN:599-79-1 | NDC:63629-9715 | DrugBank ID:DB00795 | NDC:71610-577 | NDC:71610-706 | NDC:70518-1829 | NDC:62135-960 | UNII:3XC8GUZ6CB | NDC:0013-0101 | NDC:0093-3234 | NDC:50090-6936 | PubChem SID:175267319 | NDC:59762-0104 | Sulfasalazine | 2-hydroxy-5-[[4-(pyridin-2-ylsulfamoyl)phenyl]diazenyl]benzoic acid | CAS RN:737754-28-8 | NDC:59762-5000 | NDC:50090-0086
+BMGC_DG11780,BMG_DG158687,4-BROMOPHENETHYLAMINE | PubChem SID:485661487 | 4-Bromophenethylamine | CAS RN:73918-56-6 | UNII:649Z5J48K2 | PubChem CID:533915
+BMGC_DG11781,BMG_DG158751,"4-amino-N-(1,3-thiazol-2-yl)benzenesulfonamide | SULFATHIAZOLE | Sulfathiazole | PubChem CID:5340 | CAS RN:72-14-0 | PubChem SID:175267882 | DrugBank ID:DB06147 | UNII:Y7FKS2XWQH"
+BMGC_DG11782,BMG_DG158772,"PubChem CID:5342 | PubChem SID:175271694 | DrugBank ID:DB01138 | UNII:V6OFU47K3W | 4-[2-(benzenesulfinyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione | Sulfinpyrazone | SULFINPYRAZONE | CAS RN:57-96-5"
+BMGC_DG11783,BMG_DG158793,"2-Nitro-7-methoxynaphtho(2-1b)furan | CAS RN:75965-74-1 | 7-METHOXY-2-NITRONAPHTHO(2,1-B)FURAN | UNII:JC755LAD2M | 7-methoxy-2-nitrobenzo[e][1]benzofuran | PubChem CID:53424"
+BMGC_DG11784,BMG_DG158810,"SULFISOMIDINE | PubChem CID:5343 | 4-amino-N-(2,6-dimethylpyrimidin-4-yl)benzenesulfonamide | Sulfisomidine | PubChem SID:198973150 | CAS RN:515-64-0 | UNII:W03L3ODK6E | DrugBank ID:DB13283"
+BMGC_DG11785,BMG_DG158840,PubChem SID:472423104 | PubChem CID:53439651 | CAS RN:70677-47-3 | CANNIPRENE | UNII:95QD8NF292
+BMGC_DG11786,BMG_DG158842,"DrugBank ID:DB00263 | CAS RN:127-69-5 | Sulfisoxazole | UNII:740T4C525W | 4-amino-N-(3,4-dimethyl-1,2-oxazol-5-yl)benzenesulfonamide | PubChem CID:5344 | PubChem SID:175266102 | SULFISOXAZOLE"
+BMGC_DG11787,BMG_DG158867,"PubChem CID:5345 | UNII:0C2P5QKL36 | PubChem SID:198941657 | Sulfobromophthalein | SULFOBROMOPHTHALEIN | 2-hydroxy-5-[4,5,6,7-tetrabromo-1-(4-hydroxy-3-sulfophenyl)-3-oxo-2-benzofuran-1-yl]benzenesulfonic acid | DrugBank ID:DB13215 | CAS RN:297-83-6"
+BMGC_DG11788,BMG_DG158871,"PubChem CID:5346086 | PubChem SID:461433586 | 1-(4-FLUOROPHENYL)-3-(3,4,5-TRIMETHOXYPHENYL)PROP-2-EN-1-ONE, (2E)- | CAS RN:478688-47-0 | UNII:40038O0ZWY"
+BMGC_DG11789,BMG_DG158875,"DrugBank ID:DB01346 | Quinidine barbiturate | (5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione | PubChem CID:53461739"
+BMGC_DG11790,BMG_DG158920,"PubChem SID:440794157 | UNII:73WY698HZ7 | UNII:09ERP08I3W | Lesinurad | CAS RN:878672-00-5 | UNII:Q59CAT99RS | LESINURAD, (4R)- | DrugBank ID:DB11560 | LESINURAD, (4S)- | PubChem SID:440793838 | 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid | PubChem CID:53465279 | CAS RN:1890222-26-0 | LESINURAD | CAS RN:1890222-25-9 | PubChem SID:198964591"
+BMGC_DG11791,BMG_DG158927,"5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine | PubChem SID:433968232 | CAS RN:1337962-47-6 | PubChem CID:53466958 | UNII:84I5UEP321 | 5-bromo-2,6-di(pyrazol-1-yl)pyrimidin-4-amine | TAMINADENANT"
+BMGC_DG11792,BMG_DG158933,GSK-2606414 | UNII:DPP2K6EFW8 | PubChem CID:53469448 | CAS RN:1337531-36-8 | PubChem SID:474492778
+BMGC_DG11793,BMG_DG158949,PubChem CID:53472153 | CAS RN:1188296-52-7 | UNII:GEE72DRC63 | PF-4800567 | PubChem SID:474492820
+BMGC_DG11794,BMG_DG158951,CAS RN:1337918-83-8 | PubChem SID:376072091 | Zavegepant | UNII:ODU3ZAZ94J | ZAVEGEPANT | N-[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1H-quinolin-3-yl)piperidine-1-carboxamide | PubChem CID:53472683
+BMGC_DG11795,BMG_DG158956,"PubChem CID:53476877 | UNII:8570LZ3RCA | SAR-405838 | (2'R,3R,3'S,5'S)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-(4-hydroxycyclohexyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide | DrugBank ID:DB12541 | CAS RN:1303607-60-4 | PubChem SID:249817577 | (2'S,3R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro(indole-3,3'-pyrrolidine)-5'-carboxamide"
+BMGC_DG11796,BMG_DG158957,PubChem SID:310825891 | 5-chloro-4-[1-(5-chloropyrimidin-2-yl)piperidin-4-yl]oxy-1-(2-fluoro-4-methylsulfonylphenyl)pyridin-2-one | CAS RN:1339944-47-6 | BMS-903452 | DrugBank ID:DB11773 | UNII:49731B9ULN | Bms-903452 | PubChem CID:53477157
+BMGC_DG11797,BMG_DG159004,CAS RN:9050-30-0 | UNII:47959853R5 | HEPARAN SULFATE (PORCINE 5500 MW) | PubChem SID:472388985 | PubChem CID:53477714
+BMGC_DG11798,BMG_DG161768,"11'-Carboxy-alpha-tocotrienol | PubChem CID:53481452 | (4E,8E)-11-[(2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl]-4,8-dimethylundeca-4,8-dienoic acid"
+BMGC_DG11799,BMG_DG161780,"13'-Carboxy-gamma-tocotrienol | PubChem CID:53481464 | (2E,6E,10E)-13-[(2R)-6-hydroxy-2,7,8-trimethyl-3,4-dihydrochromen-2-yl]-2,6,10-trimethyltrideca-2,6,10-trienoic acid"
+BMGC_DG11800,BMG_DG162075,"Linerixibat | DrugBank ID:DB11729 | LINERIXIBAT | UNII:386012Z45S | CAS RN:1345982-69-5 | 3-[[(3R,5R)-3-butyl-3-ethyl-7-methoxy-1,1-dioxo-5-phenyl-4,5-dihydro-2H-1lambda6,4-benzothiazepin-8-yl]methylamino]pentanedioic acid | PubChem SID:198981637 | PubChem CID:53492727"
+BMGC_DG11801,BMG_DG162078,CAS RN:1240348-39-3 | UNII:X763K4W3AA | PubChem CID:53494953 | PubChem SID:459055967 | FIBT F-18
+BMGC_DG11802,BMG_DG162082,PubChem CID:53495160 | PubChem SID:475550435 | UNII:9YPZ428KB4 | CAS RN:1346653-91-5 | GS-5759
+BMGC_DG11803,BMG_DG162084,"SLX-4090 | CAS RN:913541-47-6 | Slx-4090 | DrugBank ID:DB05678 | PubChem SID:346541491 | phenyl 6-[[3-methoxy-2-[4-(trifluoromethyl)phenyl]benzoyl]amino]-3,4-dihydro-1H-isoquinoline-2-carboxylate | UNII:F84YQX13FV | PubChem CID:53497429"
+BMGC_DG11804,BMG_DG162086,PubChem SID:198957602 | 1-aminocyclopropane-1-carboxylic acid | 1-Aminocyclopropanecarboxylic Acid | UNII:3K9EJ633GL | 1-AMINOCYCLOPROPANECARBOXYLIC ACID | PubChem CID:535 | DrugBank ID:DB02085 | 1-Aminocyclopropanecarboxylic acid | CAS RN:22059-21-8
+BMGC_DG11805,BMG_DG162087,"SULFORAPHANE, (+/-)- | PubChem CID:5350 | SULFORAPHANE, (±)- | PubChem SID:175271718 | CAS RN:4478-93-7 | 1-isothiocyanato-4-methylsulfinylbutane | UNII:41684WL1GL | Sulforaphane"
+BMGC_DG11806,BMG_DG162088,"BORONOPHENYLALANINE, DL- | 2-amino-3-(4-boronophenyl)propanoic acid | p-Boronophenylalanine | CAS RN:90580-64-6 | UNII:UID84303EL | PubChem SID:198978391 | PubChem CID:53503"
+BMGC_DG11807,BMG_DG162090,Sulfoxone | PubChem CID:5351 | CAS RN:144-76-3 | SULFOXONE | DrugBank ID:DB01145 | PubChem SID:198967158 | [4-[4-(sulfinomethylamino)phenyl]sulfonylanilino]methanesulfinic acid | UNII:0G3C18OH4D
+BMGC_DG11808,BMG_DG162095,CAS RN:459-86-9 | Mitoguazone | PubChem SID:198951210 | PubChem CID:5351154 | DrugBank ID:DB12967 | MITOGUAZONE | UNII:OD5Q0L447W | 2-[(E)-[(1E)-1-(diaminomethylidenehydrazinylidene)propan-2-ylidene]amino]guanidine | CAS RN:163955-22-4
+BMGC_DG11809,BMG_DG162096,PubChem CID:5351166 | Dacarbazine | DrugBank ID:DB00851
+BMGC_DG11810,BMG_DG162100,"PubChem SID:461433985 | 6-methyl-8H-pyrimido[5,4-e][1,2,4]triazine-5,7-dione | CAS RN:5016-18-2 | UNII:N94S395MFA | PubChem CID:5351216 | REUMYCIN | Reumycin"
+BMGC_DG11811,BMG_DG162101,PubChem CID:5351222 | LOMOFUNGIN | PubChem SID:198984582 | CAS RN:26786-84-5 | UNII:Z6Z18X1Y4D
+BMGC_DG11812,BMG_DG162102,"UNII:3FHI2X224O | PubChem CID:5351234 | CAS RN:4712-12-3 | PubChem SID:375579419 | KAMPFEROL-3,4'-DIMETHYL ETHER"
+BMGC_DG11813,BMG_DG162109,"BISANTRENE | N-[(E)-[10-[(E)-(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine | Bisantrene | PubChem CID:5351322 | CAS RN:78186-34-2 | UNII:39C34M111K | PubChem SID:198985406"
+BMGC_DG11814,BMG_DG162110,"PubChem CID:5351344 | CAS RN:117048-59-6 | Combretastatin A4 | DrugBank ID:DB14680 | UNII:16U6OP69RQ | PubChem SID:198974740 | 2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol | COMBRESTATIN A4"
+BMGC_DG11815,BMG_DG162111,DrugBank ID:DB12549 | PubChem CID:5351360 | Pyrazoloacridine
+BMGC_DG11816,BMG_DG162112,"PubChem SID:198936304 | Fosbretabulin | DrugBank ID:DB12577 | FOSBRETABULIN | UNII:I5590ES2QZ | PubChem CID:5351387 | CAS RN:222030-63-9 | [2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] dihydrogen phosphate"
+BMGC_DG11817,BMG_DG162143,CAS RN:501444-04-8 | 3-(3-(DIHYDROXYOXIDOSTIBINO)PHENYL)-2-PROPENOIC ACID | PubChem CID:5351653 | UNII:X1J63F333E | PubChem SID:313183976
+BMGC_DG11818,BMG_DG162152,"5,7-dihydroxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one | Myricetin 3-rhamnoside | PubChem CID:5352000"
+BMGC_DG11819,BMG_DG162153,"5,7-dihydroxy-3-methoxy-2-(4-methoxyphenyl)chromen-4-one | ERMANIN | Ermanin | CAS RN:20869-95-8 | PubChem CID:5352001 | UNII:850D90YJN3 | PubChem SID:198965666"
+BMGC_DG11820,BMG_DG162154,"RETUSIN | CAS RN:1245-15-4 | 2-(3,4-dimethoxyphenyl)-5-hydroxy-3,7-dimethoxychromen-4-one | Retusin | PubChem CID:5352005 | PubChem SID:198975614 | UNII:M8591903SD"
+BMGC_DG11821,BMG_DG162160,"Debromoaplysiatoxin | (1S,3R,4S,5S,9R,13S,14R)-13-hydroxy-9-[(1R)-1-hydroxyethyl]-3-[(2S,5S)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione | PubChem CID:5352033 | CAS RN:52423-28-6"
+BMGC_DG11822,BMG_DG162162,"UNII:CX3T89XQBK | (1S,4S,7Z,10S,16E,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone | CAS RN:128517-07-7 | NDC:0703-4004 | ROMIDEPSIN | DrugBank ID:DB06176 | PubChem CID:5352062 | Romidepsin | PubChem SID:175266198"
+BMGC_DG11823,BMG_DG162168,"DrugBank ID:DB00958 | PubChem CID:5352133 | azane;cyclobutane-1,1-dicarboxylic acid;platinum(2+) | cis-Diammine(1,1-cyclobutanedicarboxylato)platinum"
+BMGC_DG11824,BMG_DG162196,"1,3,8-trichlorodibenzofuran | PubChem CID:53524 | CAS RN:76621-12-0 | UNII:OUY5A8MFCG | PubChem SID:198949836 | 1,3,8-Trichlorodibenzofuran | 1,3,8-TRICHLORODIBENZOFURAN"
+BMGC_DG11825,BMG_DG162198,NDC:37662-1387 | NDC:48951-6045 | PubChem CID:5352425 | NDC:0220-4111 | NDC:0220-4108 | NDC:37662-1384 | UNII:7Y62STE4M2 | NDC:37662-1380 | NDC:48951-6046 | NDC:48951-8051 | NDC:0220-4115 | NDC:48951-8421 | NDC:48951-8053 | CAS RN:15158-12-0 | NDC:15631-0353 | NDC:53645-1251 | NDC:37662-1385 | NDC:0220-4107 | LEAD | Lead | NDC:0220-4112 | NDC:48951-6047 | PubChem SID:252165181 | NDC:15631-2904 | CAS RN:54076-28-7 | NDC:0220-4116 | LEAD CATION PB4+ | NDC:37662-1383 | CAS RN:7439-92-1 | NDC:37662-1382 | NDC:53645-1250 | lead | NDC:48951-8321 | NDC:37662-1386 | NDC:48951-8341 | UNII:2P299V784P | NDC:0220-4122 | NDC:48951-6090 | NDC:48951-8052 | NDC:61096-2023 | NDC:37662-1381
+BMGC_DG11826,BMG_DG162223,"2-ETHYLIDENE-1,5-DIMETHYL-3,3-DIPHENYLPYRROLIDINE | PubChem SID:241179134 | PubChem CID:5352621 | UNII:Z3LC48U94I | CAS RN:30223-73-5"
+BMGC_DG11827,BMG_DG162224,PubChem SID:198948328 | CAS RN:49627-27-2 | SULINDAC SULFIDE | CAS RN:32004-67-4 | PubChem CID:5352624 | 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfanylphenyl)methylidene]inden-1-yl]acetic acid | UNII:6UVA8S2DEY | Sulindac Sulfide
+BMGC_DG11828,BMG_DG162280,"CAS RN:73384-60-8 | SULMAZOLE | PubChem CID:5353 | Sulmazole | 2-(2-methoxy-4-methylsulfinylphenyl)-1H-imidazo[4,5-b]pyridine | PubChem SID:198963871 | UNII:HK56EH9K44"
+BMGC_DG11829,BMG_DG162294,"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID | DrugBank ID:DB07177 | PubChem CID:5353288"
+BMGC_DG11830,BMG_DG162295,2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine | PubChem CID:5353303 | DrugBank ID:DB01905
+BMGC_DG11831,BMG_DG162296,"PubChem CID:5353305 | 2-{2-hydroxy-[1,1'-biphenyl]-3-yl}-1H-1,3-benzodiazole-5-carboximidamide | DrugBank ID:DB01725"
+BMGC_DG11832,BMG_DG162297,PubChem CID:5353306 | 2-(2-hydroxy-phenyl)-3H-benzoimidazole-5-carboxamidine | DrugBank ID:DB02287
+BMGC_DG11833,BMG_DG162298,CRA_1144 | PubChem CID:5353307 | DrugBank ID:DB03643
+BMGC_DG11834,BMG_DG162301,"6,7-DIHYDROXYFLAVONE | UNII:P6R86H59XS | 6,7-dihydroxy-2-phenylchromen-4-one | 6,7-Dihydroxyflavone | PubChem SID:472422255 | PubChem CID:5353357 | CAS RN:38183-04-9"
+BMGC_DG11835,BMG_DG162303,(E)-octadec-9-enamide | DrugBank ID:DB03784 | CAS RN:4303-70-2 | PubChem CID:5353370 | ELAIDAMIDE | UNII:GOU8K597IT | PubChem SID:198960964 | Elaidamide
+BMGC_DG11836,BMG_DG162304,N-(P-AMYLCINNAMOYL)ANTHRANILIC ACID | PubChem CID:5353376 | PubChem SID:472423091 | CAS RN:99196-74-4 | UNII:LCJ9M6AJ5F
+BMGC_DG11837,BMG_DG162309,"3-[(2Z,5E)-2-[[3-(2-carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid | PubChem CID:5353439 | CAS RN:123316-14-3 | CAS RN:114-25-0 | Biliverdine"
+BMGC_DG11838,BMG_DG162313,N-hydroxy-3-[(E)-3-(hydroxyamino)-3-oxoprop-1-enyl]benzamide | Carboxycinnamic Acid Bishydroxamide | CAS RN:174664-65-4 | PubChem CID:5353484
+BMGC_DG11839,BMG_DG162321,"7-Nitro-2,3-Dioxo-2,3-Dihydroquinoxaline-6-Carbonitrile | PubChem CID:5353536"
+BMGC_DG11840,BMG_DG162328,DMBI | CAS RN:5812-07-7 | UNII:QTW8MQ534B | PubChem CID:5353593 | PubChem SID:472408656
+BMGC_DG11841,BMG_DG162330,CAS RN:99631-11-5 | CID 5353607 | CAS RN:73121-56-9 | PubChem CID:5353607 | CAS RN:105368-47-6
+BMGC_DG11842,BMG_DG162331,"PubChem SID:485660938 | CAS RN:63177-57-1 | UNII:6LF2DGK4XM | CAS RN:123064-80-2 | methyl (E)-3-(2,5-dihydroxyphenyl)prop-2-enoate | PubChem CID:5353609 | Methyl 2,5-dihydroxycinnamate | METHYL 2,5-DIHYDROXYCINNAMATE"
+BMGC_DG11843,BMG_DG162335,"PubChem CID:5353622 | CAS RN:76824-35-6 | 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide | Mylanta AR"
+BMGC_DG11844,BMG_DG162343,"(7E,9E,11E,13E)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid | PubChem CID:5353725"
+BMGC_DG11845,BMG_DG162348,CAS RN:414872-01-8 | PubChem CID:5353770 | PX-117794 | PubChem SID:459275390 | UNII:NJ65YJM5PE
+BMGC_DG11846,BMG_DG162349,"[6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-14-phenyl-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-17-yl] (2E,4E)-5-phenylpenta-2,4-dienoate | CAS RN:34807-41-5 | PubChem CID:5353772"
+BMGC_DG11847,BMG_DG162350,MOLSIDOMINE | PubChem CID:5353788 | DrugBank ID:DB09282 | PubChem SID:198958909 | UNII:D46583G77X | CAS RN:25717-80-0 | Molsidomine | (1E)-1-ethoxy-N-(3-morpholin-4-yloxadiazol-3-ium-5-yl)methanimidate
+BMGC_DG11848,BMG_DG162360,"(Z)-1-(2,4-dichlorophenyl)-N-[(2,4-dichlorophenyl)methoxy]-2-imidazol-1-ylethanimine | DrugBank ID:DB00239 | UNII:C668Q9I33J | CAS RN:64211-45-6 | PubChem SID:175267699 | CAS RN:76472-50-9 | Oxiconazole | OXICONAZOLE | PubChem CID:5353853"
+BMGC_DG11849,BMG_DG162365,DrugBank ID:DB00733 | Pralidoxime | PubChem CID:5353894
+BMGC_DG11850,BMG_DG162368,PubChem SID:198947199 | PubChem CID:5353911 | PSI-TECTORIGENIN | UNII:8HXB4THX7F | CAS RN:13111-57-4
+BMGC_DG11851,BMG_DG162370,UNII:S69D6672SX | PubChem CID:5353919 | PubChem SID:377308093 | GW-5074 (E)- | CAS RN:1044712-42-6
+BMGC_DG11852,BMG_DG162379,1-(4-Isopropylthiophenyl)-2-n-octylaminopropanol | CAS RN:54063-56-8 | PubChem CID:5354 | 2-(octylamino)-1-(4-propan-2-ylsulfanylphenyl)propan-1-ol
+BMGC_DG11853,BMG_DG162380,"2,3',4,5'-Tetramethoxystilbene | 1-[(E)-2-(2,4-dimethoxyphenyl)ethenyl]-3,5-dimethoxybenzene | CAS RN:24144-92-1 | PubChem CID:5354004 | CAS RN:20578-92-1"
+BMGC_DG11854,BMG_DG162405,PubChem SID:198949965 | PubChem CID:5354238 | VANILLYLIDENE ACETONE | UNII:8CJX5I27B7 | CAS RN:22214-42-2
+BMGC_DG11855,BMG_DG162412,"PubChem CID:5354284 | PubChem SID:198975545 | UNII:VP62D4346M | CAS RN:2107-76-8 | 5,7-DIHYDROXY-4-METHYLCOUMARIN"
+BMGC_DG11856,BMG_DG162437,PubChem CID:5354590 | CAS RN:5429-85-6 | PubChem SID:472388018 | UNII:6J8G54ZUQ5 | OLEANILIDE
+BMGC_DG11857,BMG_DG162459,PubChem SID:377307787 | PubChem CID:5354970 | MERADINE | CAS RN:7390-62-7 | UNII:V1VHB7IV58
+BMGC_DG11858,BMG_DG162464,DrugBank ID:DB00391 | N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide | UNII:7MNE9M8287 | PubChem SID:198974076 | CAS RN:15676-16-1 | PubChem CID:5355 | Sulpiride | SULPIRIDE
+BMGC_DG11859,BMG_DG162471,"6-amino-7,9-dihydropurin-8-one | PubChem CID:5355054 | CAS RN:21149-26-8 | 8-Hydroxyadenine"
+BMGC_DG11860,BMG_DG162473,PubChem CID:5355079 | CAS RN:6174-86-3 | 3-CHLORO-4-METHYL-7-HYDROXYCOUMARIN | UNII:EVI89HA9V3 | PubChem SID:198959495
+BMGC_DG11861,BMG_DG162475,PubChem SID:175271373 | DrugBank ID:DB09496 | CAS RN:5466-77-3 | UNII:4Y5P7MUD51 | OCTINOXATE | Octinoxate | 2-ethylhexyl (E)-3-(4-methoxyphenyl)prop-2-enoate | CAS RN:83834-59-7 | PubChem CID:5355130
+BMGC_DG11862,BMG_DG162491,"FLAVOKAWAIN A | PubChem SID:459055720 | CAS RN:3420-72-2 | UNII:8OM2XZ2ZM3 | CAS RN:37951-13-6 | PubChem CID:5355469 | (E)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one | Flavokawain A | CAS RN:64680-84-8"
+BMGC_DG11863,BMG_DG162492,3-[3-(imidazol-1-ylmethyl)-2-methylindol-1-yl]propanoic acid | PubChem SID:198974188 | CAS RN:76894-77-4 | UNII:31340R8PVU | PubChem CID:53555 | Dazmegrel | DAZMEGREL
+BMGC_DG11864,BMG_DG162493,CINNAMOYLHYDROXAMIC ACID | UNII:434STJ4H11 | CAS RN:29900-75-2 | PubChem SID:198980042 | PubChem CID:5355635
+BMGC_DG11865,BMG_DG162498,"PubChem CID:5355836 | 7,8-Dihydroxy-4-methylcoumarin | CAS RN:2107-77-9 | UNII:5Z87S33XES | 7,8-DIHYDROXY-4-METHYLCOUMARIN | PubChem SID:485662526"
+BMGC_DG11866,BMG_DG162509,"PubChem SID:198967283 | PubChem CID:5356 | DrugBank ID:DB08329 | Sulthiame | SULTHIAME | 4-(1,1-dioxothiazinan-2-yl)benzenesulfonamide | UNII:I00Q766CZ2 | CAS RN:61-56-3"
+BMGC_DG11867,BMG_DG162557,PubChem SID:198990184 | SULTOPRIDE | N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide | PubChem CID:5357 | Sultopride | DrugBank ID:DB13273 | UNII:AA0G3TW31W | CAS RN:53583-79-2
+BMGC_DG11868,BMG_DG162588,UNII:L0487H6Q0H | PubChem SID:313184121 | 7-HYDROXY-4-PHENYLCOUMARIN | PubChem CID:5357479 | CAS RN:2555-30-8
+BMGC_DG11869,BMG_DG162590,"PubChem CID:5357488 | 4,4'-DIMETHOXY-2'-HYDROXYCHALCONE | UNII:SJ29S3K2UX | CAS RN:62881-44-1"
+BMGC_DG11870,BMG_DG162605,NDC:69097-644 | NDC:45802-598 | DrugBank ID:DB00669 | PubChem SID:175265694 | PubChem CID:5358 | NDC:66993-082 | Sumatriptan | NDC:0173-0524 | CAS RN:103628-46-2 | NDC:0527-1859 | NDC:63629-8703 | NDC:67296-1420 | NDC:71921-170 | NDC:63629-8701 | NDC:70792-812 | NDC:66993-081 | 1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide | NDC:45802-619 | NDC:0245-0812 | NDC:0527-1818 | SUMATRIPTAN | UNII:8R78F6L9VO
+BMGC_DG11871,BMG_DG162618,"1,3,6,7-Tetrahydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one | 1,3,6,7-tetrahydroxy-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]xanthen-9-one | PubChem CID:5358385"
+BMGC_DG11872,BMG_DG162624,"5-((4-HYDROXYPHENYL)METHYLENE)-1,3-DIMETHYL-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE | PubChem SID:496141988 | CAS RN:57270-80-1 | 5-[(4-Hydroxyphenyl)methylene]-1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione | PubChem CID:5358573 | UNII:2F37W5U7WP"
+BMGC_DG11873,BMG_DG162631,Ethyl Fumarate | ETHYL FUMARATE | CAS RN:2459-05-4 | (E)-4-ethoxy-4-oxobut-2-enoic acid | UNII:Y3W849NG2N | CAS RN:3249-53-4 | PubChem SID:198957541 | PubChem CID:5358902
+BMGC_DG11874,BMG_DG162636,PubChem CID:5359 | SUPROFEN | DrugBank ID:DB00870 | UNII:988GU2F9PE | PubChem SID:175271925 | CAS RN:40828-46-4 | 2-[4-(thiophene-2-carbonyl)phenyl]propanoic acid | Suprofen
+BMGC_DG11875,BMG_DG162646,CAS RN:67-07-2 | 2-[methyl-[(Z)-N'-phosphonocarbamimidoyl]amino]acetic acid | CID 5359254 | PubChem CID:5359254
+BMGC_DG11876,BMG_DG162647,NDC:62106-1102 | NDC:43857-0632 | NDC:62106-1117 | NDC:62106-1120 | CAS RN:12011-61-9 | NDC:62185-0034 | Aluminum | NDC:44911-0650 | NDC:37662-2701 | NDC:62106-1119 | NDC:64578-0072 | CAS RN:7429-90-5 | NDC:62185-0062 | aluminum | NDC:62106-1118 | NDC:61657-0955 | NDC:58264-0121 | NDC:43857-0617 | NDC:43742-1312 | NDC:43857-0496 | NDC:55146-007 | NDC:43857-0485 | NDC:62106-1123 | NDC:62106-1127 | NDC:62106-1132 | NDC:37662-2694 | NDC:0220-0213 | ALUMINUM | NDC:37662-2695 | NDC:43857-0596 | NDC:37662-2699 | NDC:62106-1142 | NDC:43742-2221 | NDC:62106-1137 | NDC:43742-1951 | NDC:37662-2696 | UNII:CPD4NFA903 | NDC:43857-0369 | DrugBank ID:DB01370 | NDC:37662-2698 | NDC:37662-2700 | NDC:0220-0229 | Aluminium | NDC:37662-2697 | NDC:71742-0008 | NDC:43857-0615 | PubChem CID:5359268
+BMGC_DG11877,BMG_DG162648,"Ethylmorphine | UNII:RWO67D87EU | PubChem CID:5359271 | ETHYLMORPHINE | CAS RN:76-58-4 | PubChem SID:198959733 | DrugBank ID:DB01466 | (4R,4aR,7S,7aR,12bS)-9-ethoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol"
+BMGC_DG11878,BMG_DG162649,"UNII:V7R79HN3XD | Levorphanol | LEVORPHANOL | CAS RN:77-07-6 | CAS RN:297-90-5 | PubChem SID:175266678 | PubChem SID:198937437 | RACEMORPHAN | (1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol | DrugBank ID:DB00854 | PubChem CID:5359272 | UNII:27618J1N2X"
+BMGC_DG11879,BMG_DG162650,UNII:OH8700156W | 6-chloro-7H-purine | CAS RN:87-42-3 | CAS RN:111055-92-6 | PubChem CID:5359277 | 6-CHLOROPURINE | 6-Chloropurine | PubChem SID:198937279 | CAS RN:133762-83-1
+BMGC_DG11880,BMG_DG162656,BISMUTH | NDC:0220-0851 | bismuth | PubChem CID:5359367 | UNII:U015TT5I8H | CAS RN:7440-69-9 | NDC:83059-0026 | NDC:0220-0856 | Bismuth
+BMGC_DG11881,BMG_DG162657,"DrugBank ID:DB00504 | PubChem CID:5359371 | (1R,9R,10R)-17-prop-2-enyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol | UNII:353613BU4U | PubChem SID:198941341 | Levallorphan | CAS RN:152-02-3 | LEVALLORPHAN"
+BMGC_DG11882,BMG_DG162662,Indirubin | CAS RN:906748-38-7 | INDIRUBIN | DrugBank ID:DB12379 | PubChem CID:5359405 | PubChem SID:198990797 | UNII:V86L8P74GI
+BMGC_DG11883,BMG_DG162664,"DIHYDROMORPHINE | (4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol | Dihydromorphine | PubChem SID:198978460 | CAS RN:509-60-4 | DrugBank ID:DB01565 | PubChem CID:5359421 | UNII:C3S5FRP6JW"
+BMGC_DG11884,BMG_DG162669,Sulfasalazine | PubChem CID:5359476 | DrugBank ID:DB00795
+BMGC_DG11885,BMG_DG162671,"3,7,9-trihydroxy-1-methylbenzo[c]chromen-6-one | Alternariol | ALTERNARIOL | CAS RN:641-38-3 | PubChem CID:5359485 | UNII:KN9L4260JW | PubChem SID:198949856"
+BMGC_DG11886,BMG_DG162677,NDC:63545-229 | ARSENIC | CAS RN:7440-38-2 | PubChem CID:5359596 | NDC:63545-222 | NDC:0220-0540 | NDC:63545-223 | NDC:0220-0590 | Arsenic | NDC:63545-221 | NDC:63545-226 | NDC:63545-228 | NDC:63545-224 | NDC:53645-1350 | NDC:63545-227 | arsenic | UNII:N712M78A8G
+BMGC_DG11887,BMG_DG162678,PubChem CID:5359597 | CAS RN:11062-77-4 | Superoxides
+BMGC_DG11888,BMG_DG162687,CAS RN:4163-15-9 | UNII:U6Z73N36V0 | CYCLORPHAN | PubChem SID:198942051 | PubChem CID:5359966
+BMGC_DG11889,BMG_DG162691,2-Imidazol-1-yl-1-(4-nitrophenyl)ethanone | PubChem SID:485663572 | 2-IMIDAZOL-1-YL-1-(4-NITROPHENYL)ETHANONE | PubChem CID:53600 | CAS RN:37910-79-5 | UNII:S2C8JHS8JX
+BMGC_DG11890,BMG_DG162698,Magnesium Chloride | UNII:59XN63C8VM | PubChem SID:175265411 | DrugBank ID:DB09407 | MAGNESIUM CHLORIDE ANHYDROUS | Magnesium chloride | CAS RN:56491-84-0 | magnesium;dichloride | CAS RN:7786-30-3 | PubChem CID:5360315 | CAS RN:17638-61-8
+BMGC_DG11891,BMG_DG162700,UNII:83V03P835E | 2-Amino-6-chloropurine | CAS RN:10310-21-1 | PubChem CID:5360349 | 6-chloro-7H-purin-2-amine | PubChem SID:198974305 | CAS RN:133762-81-9 | 2-AMINO-6-CHLOROPURINE
+BMGC_DG11892,BMG_DG162704,"PubChem CID:5360373 | Bleomycin | 3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[3-[4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium | DrugBank ID:DB00290 | CAS RN:11056-06-7"
+BMGC_DG11893,BMG_DG162713,"DrugBank ID:DB00704 | CAS RN:16590-41-3 | PubChem CID:5360515 | UNII:5S6W795CQM | Naltrexone | NALTREXONE | PubChem SID:175267606 | (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one"
+BMGC_DG11894,BMG_DG162723,"Morphine-6-glucuronide | (2S,3S,4S,5R,6R)-6-[[(4R,4aR,7S,7aR,12bS)-9-hydroxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | PubChem CID:5360621 | MORPHINE-6-GLUCURONIDE | CAS RN:20290-10-2 | PubChem SID:198990027 | UNII:64Y9KYM60R | DrugBank ID:DB06409"
+BMGC_DG11895,BMG_DG162726,"UNII:7355X3ROTS | PubChem CID:5360696 | (1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene | PubChem SID:175267045 | CAS RN:125-71-3 | Dextromethorphan | DrugBank ID:DB00514 | DEXTROMETHORPHAN"
+BMGC_DG11896,BMG_DG162727,"CAS RN:125-73-5 | UNII:04B7QNO9WS | DrugBank ID:DB14682 | PubChem SID:198971521 | DEXTRORPHAN | (1S,9S,10S)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol | PubChem CID:5360697 | Dextrorphan"
+BMGC_DG11897,BMG_DG162729,"PubChem SID:272993800 | 3,7-dihydroxy-9-methoxy-1-methylbenzo[c]chromen-6-one | CAS RN:26894-49-5 | ALTERNARIOL MONOMETHYL ETHER | PubChem CID:5360741 | Alternariol monomethyl ether | CAS RN:23452-05-3 | UNII:Y79STA800H"
+BMGC_DG11898,BMG_DG162735,"CAS RN:25999-20-6 | 6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoic acid | UNII:W7V2ZZ2FWB | CAS RN:25999-31-9 | PubChem SID:175266084 | Lasalocid | LASALOCID | PubChem CID:5360807 | DrugBank ID:DB11423"
+BMGC_DG11899,BMG_DG162742,"CAS RN:145-63-1 | PubChem SID:198939788 | UNII:6032D45BEM | Suramin | PubChem CID:5361 | SURAMIN | 8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid | DrugBank ID:DB04786"
+BMGC_DG11900,BMG_DG162746,"PubChem CID:5361092 | Butorphanol | UNII:QV897JC36D | CAS RN:42408-82-2 | PubChem SID:175265477 | BUTORPHANOL | (1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol | CAS RN:58115-67-6"
+BMGC_DG11901,BMG_DG162749,"trans-Cefuroxime | (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2E)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem SID:443623859 | TRANS-CEFUROXIME | UNII:Z5PTJ86MTY | PubChem CID:5361202 | CAS RN:55268-75-2 | CAS RN:97232-97-8"
+BMGC_DG11902,BMG_DG162755,DrugBank ID:DB00837 | Progabide | PubChem CID:5361323
+BMGC_DG11903,BMG_DG162766,"CEFODIZIME | Cefodizime | CAS RN:69739-16-8 | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[[5-(carboxymethyl)-4-methyl-1,3-thiazol-2-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem CID:5361871 | CAS RN:97180-26-2 | UNII:Z31298J4HQ | DrugBank ID:DB13470 | PubChem SID:175266853"
+BMGC_DG11904,BMG_DG162773,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide | Relistor | PubChem CID:5361917 | CAS RN:73232-52-7"
+BMGC_DG11905,BMG_DG162774,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one | CAS RN:83387-25-1 | Methylnaltrexone | PubChem CID:5361918"
+BMGC_DG11906,BMG_DG162779,"DrugBank ID:DB13232 | PubChem SID:198973456 | CAS RN:27470-51-5 | PubChem CID:5362 | 4-[(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methoxy]-4-oxobutanoic acid | SUXIBUZONE | Suxibuzone | UNII:86TDZ5WP2B"
+BMGC_DG11907,BMG_DG162781,"Ceftazidime Pentahydrate(Contain 1 equivalent of Na2CO3 as stabilizer) | (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;pentahydrate | CAS RN:78439-06-2 | PubChem CID:5362051"
+BMGC_DG11908,BMG_DG162782,"UNII:XZ7BG04GJX | PubChem CID:5362065 | PubChem SID:175265490 | CAS RN:79350-37-1 | CEFIXIME ANHYDROUS | DrugBank ID:DB00671 | Cefixime | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid"
+BMGC_DG11909,BMG_DG162786,"UNII:W77UAL9THI | DrugBank ID:DB13312 | DELAPRIL | CAS RN:83435-66-9 | Delapril | PubChem SID:198935554 | 2-[2,3-dihydro-1H-inden-2-yl-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]amino]acetic acid | PubChem CID:5362116"
+BMGC_DG11910,BMG_DG162787,NDC:31722-178 | NDC:0591-0409 | NDC:0591-0407 | NDC:43063-815 | NDC:43353-662 | NDC:67046-2091 | NDC:68788-8351 | NDC:71610-726 | NDC:63187-780 | NDC:82868-009 | NDC:0591-0408 | NDC:63629-5247 | NDC:63629-8736 | NDC:23155-877 | NDC:24979-239 | NDC:43353-297 | NDC:68071-5098 | NDC:0615-8252 | NDC:43353-009 | NDC:43353-298 | NDC:43547-419 | NDC:63629-8823 | NDC:63187-257 | NDC:50090-7221 | NDC:43063-786 | NDC:24979-240 | NDC:43547-414 | NDC:42708-031 | NDC:50090-3765 | NDC:62135-643 | NDC:23155-879 | NDC:55154-8096 | NDC:60760-358 | NDC:51655-999 | NDC:65862-042 | NDC:68645-593 | NDC:68788-8562 | NDC:62135-644 | NDC:76282-420 | NDC:60687-656 | NDC:0615-8253 | NDC:51655-146 | NDC:82009-063 | NDC:50090-6303 | NDC:68645-553 | NDC:76282-730 | NDC:63187-722 | NDC:82009-064 | NDC:71610-588 | NDC:68788-7666 | NDC:52652-3001 | NDC:71610-727 | NDC:42708-033 | NDC:68001-336 | NDC:69844-121 | NDC:68645-554 | NDC:23155-880 | NDC:31722-176 | NDC:68180-516 | NDC:72865-212 | NDC:65862-041 | NDC:82009-062 | NDC:43063-810 | NDC:51655-994 | NDC:70518-3166 | NDC:71610-733 | NDC:51655-335 | NDC:68788-6920 | NDC:71335-0015 | NDC:76282-733 | NDC:70882-110 | NDC:76282-732 | NDC:43063-074 | NDC:67296-1839 | NDC:68071-5143 | NDC:70518-1316 | NDC:55154-2329 | NDC:71610-612 | NDC:55154-8078 | NDC:42708-154 | NDC:68071-3122 | NDC:42708-032 | NDC:68645-552 | NDC:31722-172 | NDC:70518-1156 | NDC:50090-5120 | NDC:55700-479 | NDC:68001-332 | NDC:0615-8254 | NDC:63187-775 | NDC:72789-101 | NDC:24979-238 | LISINOPRIL | NDC:43353-643 | Lisinopril dihydrate | NDC:63187-098 | NDC:52427-443 | NDC:70518-1152 | NDC:82009-065 | NDC:50090-7074 | NDC:68645-608 | NDC:24979-241 | NDC:71205-071 | NDC:51655-232 | NDC:0591-0406 | NDC:50090-4725 | NDC:60687-325 | NDC:68001-335 | NDC:68071-3123 | NDC:71335-0354 | NDC:63187-821 | NDC:50090-6860 | NDC:68180-980 | NDC:62135-642 | NDC:69844-120 | NDC:70882-103 | NDC:52427-441 | NDC:60760-359 | NDC:43547-415 | NDC:65862-037 | NDC:71205-742 | NDC:72865-213 | NDC:76282-418 | NDC:52427-439 | NDC:43547-418 | NDC:50090-2988 | NDC:68645-611 | NDC:69844-119 | NDC:70518-2561 | NDC:71610-741 | NDC:0904-6799 | NDC:43547-351 | NDC:60760-360 | NDC:51655-729 | NDC:71205-180 | NDC:71205-471 | NDC:68001-333 | NDC:76282-417 | NDC:68180-514 | NDC:68645-587 | NDC:71610-748 | NDC:43547-353 | NDC:24979-242 | NDC:68001-486 | NDC:68071-4660 | NDC:43547-417 | NDC:68180-513 | NDC:68071-1894 | PubChem SID:175267638 | NDC:43063-814 | NDC:42708-094 | NDC:72865-210 | NDC:43547-352 | NDC:60687-667 | NDC:43353-113 | NDC:68645-612 | NDC:31722-180 | NDC:55700-547 | NDC:60760-357 | NDC:68645-532 | UNII:E7199S1YWR | NDC:42708-176 | NDC:31722-179 | NDC:67296-1202 | NDC:76282-731 | NDC:43353-270 | NDC:68645-550 | NDC:68180-981 | NDC:68071-5089 | NDC:51655-995 | NDC:65862-040 | NDC:50090-3763 | NDC:68071-3220 | NDC:0904-7200 | NDC:71610-624 | NDC:23155-881 | NDC:52427-438 | NDC:82982-066 | NDC:43547-355 | NDC:50090-3175 | NDC:68001-334 | NDC:0591-0885 | NDC:76282-419 | NDC:43547-356 | NDC:50090-7022 | NDC:68071-1775 | NDC:70518-0530 | NDC:68180-517 | NDC:63187-534 | NDC:63187-099 | NDC:68180-515 | NDC:76282-422 | NDC:67046-1045 | NDC:71610-638 | NDC:52427-442 | NDC:68645-551 | NDC:62135-645 | NDC:43353-993 | NDC:76282-729 | NDC:71610-406 | NDC:0615-8548 | NDC:71335-0176 | NDC:68180-982 | NDC:82009-066 | NDC:42708-142 | NDC:71610-766 | NDC:50090-2228 | NDC:60687-333 | NDC:0615-8255 | NDC:72789-093 | NDC:68071-3064 | NDC:63629-1761 | NDC:23155-878 | NDC:43547-416 | NDC:68645-609 | NDC:55154-2128 | NDC:68180-979 | (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;dihydrate | NDC:42708-165 | NDC:71335-0498 | NDC:72865-208 | NDC:76282-728 | NDC:43353-301 | NDC:63187-442 | NDC:68788-8310 | NDC:50090-3774 | NDC:69844-122 | NDC:0904-6798 | CAS RN:83915-83-7 | NDC:68071-5046 | NDC:68645-613 | NDC:60760-438 | NDC:76282-421 | NDC:43063-811 | NDC:68071-1672 | NDC:0904-6797 | NDC:63187-237 | NDC:68788-7012 | NDC:68645-610 | NDC:67046-1011 | NDC:51655-486 | NDC:31722-177 | NDC:67296-1452 | NDC:70518-0544 | NDC:71335-0536 | NDC:68071-3043 | NDC:51655-411 | NDC:71610-536 | NDC:43063-800 | NDC:68071-5036 | NDC:68071-3178 | NDC:62135-640 | NDC:23155-876 | NDC:42708-096 | NDC:63187-825 | NDC:0591-0405 | NDC:68071-2224 | NDC:71335-0075 | NDC:67296-1249 | NDC:50090-4885 | NDC:43353-793 | NDC:50090-0808 | NDC:24979-243 | NDC:43063-769 | NDC:70518-0468 | NDC:43353-271 | NDC:50090-2934 | NDC:55700-480 | NDC:43063-812 | NDC:50090-2989 | NDC:50090-6912 | NDC:60687-678 | PubChem CID:5362118 | NDC:70882-104 | NDC:43063-813 | NDC:50090-5121 | NDC:71335-1380 | NDC:65862-038 | NDC:68180-512 | NDC:71610-731 | NDC:50090-4887 | NDC:51655-399 | NDC:68071-4858 | NDC:67046-1041 | NDC:0615-8405 | NDC:68788-6820 | NDC:65862-039 | NDC:71205-626 | NDC:69844-123 | NDC:72865-211 | NDC:72865-209 | NDC:55289-884 | NDC:62135-641 | NDC:70518-1906 | NDC:68788-6407 | NDC:50090-2431 | NDC:43547-354 | NDC:52427-440 | NDC:69844-118
+BMGC_DG11911,BMG_DG162788,Lisinopril | (2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid | CAS RN:77726-95-5 | UNII:7Q3P4BS2FD | DrugBank ID:DB00722 | CAS RN:76547-98-3 | LISINOPRIL ANHYDROUS | PubChem SID:175267222 | PubChem CID:5362119 | CAS RN:83915-83-7
+BMGC_DG11912,BMG_DG162789,"NDC:65862-116 | NDC:72189-110 | NDC:60760-351 | NDC:55154-4343 | NDC:51655-755 | NDC:71335-0457 | NDC:0185-0211 | CAS RN:88372-38-7 | NDC:53746-752 | NDC:72162-1816 | NDC:65162-751 | NDC:51655-065 | NDC:68071-5130 | NDC:68788-9327 | NDC:68071-1969 | NDC:71335-0267 | NDC:23155-752 | NDC:50090-5750 | NDC:65162-752 | NDC:43547-336 | NDC:68071-3057 | NDC:68071-3324 | NDC:50268-110 | NDC:0185-0325 | NDC:50090-5751 | NDC:63187-906 | NDC:68462-576 | NDC:62559-416 | NDC:23155-749 | NDC:72162-2328 | CAS RN:866541-74-4 | NDC:43547-338 | NDC:50090-3243 | NDC:43547-337 | NDC:60760-352 | NDC:71205-244 | NDC:70771-1149 | NDC:43063-679 | 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid;hydrochloride | NDC:63187-393 | NDC:72888-222 | Benazepril Hydrochloride | NDC:0185-0236 | NDC:51655-617 | NDC:68462-577 | NDC:51407-464 | NDC:70771-1148 | NDC:65162-754 | PubChem SID:175268724 | NDC:63187-500 | NDC:0574-0227 | NDC:0574-0228 | NDC:68788-6957 | NDC:63187-499 | NDC:23155-751 | NDC:68788-9313 | NDC:72888-220 | NDC:70771-1151 | NDC:51655-202 | NDC:51407-465 | NDC:51655-066 | CAS RN:86541-74-4 | NDC:68788-6889 | NDC:68071-4722 | NDC:53746-751 | NDC:0574-0229 | NDC:51407-463 | NDC:62135-721 | NDC:43063-677 | NDC:68462-579 | NDC:23155-750 | UNII:N1SN99T69T | NDC:51655-388 | NDC:65862-118 | NDC:68071-5129 | NDC:70518-1640 | NDC:50268-109 | NDC:71335-0854 | NDC:55154-4344 | NDC:68071-1769 | NDC:71335-1365 | NDC:70771-1150 | PubChem CID:5362123 | NDC:62559-414 | NDC:43063-748 | NDC:50090-3359 | NDC:71335-1086 | NDC:62559-417 | NDC:0185-0277 | NDC:50268-111 | NDC:53746-754 | NDC:53746-753 | NDC:71335-0078 | NDC:62135-720 | NDC:72888-221 | NDC:68071-5028 | NDC:68462-578 | NDC:50268-112 | NDC:70518-2125 | BENAZEPRIL HYDROCHLORIDE | NDC:51407-462 | NDC:43547-335 | NDC:62135-719 | NDC:71205-320 | NDC:65162-753 | NDC:68788-7845 | NDC:62559-415 | NDC:62135-722 | NDC:65862-117"
+BMGC_DG11913,BMG_DG162790,"UNII:PX47FSF9B3 | PubChem SID:175268822 | Benazepril | CAS RN:109010-10-8 | DrugBank ID:DB00542 | 2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid | CAS RN:86541-75-5 | BENAZEPRIL, (±)- | PubChem SID:198937963 | PubChem CID:5362124 | BENAZEPRIL | BENAZEPRIL, (+/-)- | CAS RN:86499-21-0 | UNII:UDM7Q7QWP8"
+BMGC_DG11914,BMG_DG162791,"NDC:63187-644 | NDC:68001-431 | NDC:50090-1120 | NDC:57237-225 | NDC:76282-672 | NDC:62135-274 | NDC:65841-656 | NDC:63187-277 | NDC:68382-144 | PubChem CID:5362129 | NDC:0054-0106 | NDC:70518-3038 | NDC:50090-5673 | NDC:50090-6829 | NDC:63187-816 | NDC:51655-144 | NDC:0054-0107 | NDC:57237-223 | NDC:68001-429 | NDC:57237-224 | NDC:68382-376 | NDC:76282-670 | NDC:50090-1118 | NDC:65841-699 | NDC:65862-474 | NDC:51655-347 | NDC:62135-271 | NDC:51655-346 | NDC:63187-915 | NDC:68180-589 | NDC:60760-571 | NDC:76282-671 | NDC:68382-374 | NDC:68382-147 | NDC:68382-145 | RAMIPRIL | NDC:65841-657 | NDC:68382-146 | NDC:50090-3059 | NDC:65862-475 | NDC:68001-430 | NDC:50090-3873 | NDC:65841-658 | DrugBank ID:DB00178 | NDC:71205-080 | NDC:51655-975 | NDC:68382-377 | Ramipril | NDC:68382-375 | NDC:72789-415 | NDC:51655-904 | NDC:51655-406 | NDC:71335-9645 | NDC:57237-222 | NDC:65841-655 | NDC:68180-590 | NDC:65862-477 | NDC:62135-273 | NDC:61570-120 | CAS RN:1028843-43-7 | (2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid | NDC:68001-428 | NDC:63629-1254 | NDC:63187-073 | NDC:0054-0108 | NDC:65841-700 | NDC:71335-0894 | NDC:61570-111 | NDC:71335-1057 | NDC:71205-029 | NDC:68180-591 | NDC:68180-588 | NDC:65841-702 | UNII:L35JN3I7SJ | NDC:71335-1056 | PubChem SID:175267179 | NDC:50090-5730 | CAS RN:87333-19-5 | NDC:60760-481 | NDC:65841-701 | NDC:76282-673 | NDC:62135-272 | NDC:51655-296 | NDC:0054-0109 | NDC:65862-476 | NDC:63187-854"
+BMGC_DG11915,BMG_DG162793,MEDORINONE | PubChem CID:5362132 | PubChem SID:198990556 | UNII:80X61Y4X0B | CAS RN:88296-61-1
+BMGC_DG11916,BMG_DG162794,"Elsamitrucin | PubChem CID:5362259 | DrugBank ID:DB05129 | UNII:ZTV0FOB6NU | ELSAMITRUCIN | CAS RN:97068-30-9 | PubChem SID:198976991 | 3-[(2S,3R,4S,5S,6R)-3-[(2R,3R,4R,5S,6R)-3-amino-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-8-hydroxy-15-methyl-11,18-dioxapentacyclo[10.6.2.02,7.09,19.016,20]icosa-1(19),2(7),3,5,8,12(20),13,15-octaene-10,17-dione"
+BMGC_DG11917,BMG_DG162799,PubChem CID:5362391 | 5-[(E)-[pyridin-3-yl-[3-(trifluoromethyl)phenyl]methylidene]amino]oxypentanoic acid | PubChem SID:198969038 | CAS RN:110140-89-1 | RIDOGREL | UNII:QTS5QOO42O | DrugBank ID:DB01207 | Ridogrel
+BMGC_DG11918,BMG_DG162800,CAS RN:111555-57-8 | PubChem CID:5362396 | PubChem SID:198944943 | N-METHYLNALTRINDOLE | UNII:M993BKL35V
+BMGC_DG11919,BMG_DG162802,PubChem CID:5362399 | BEMORADAN | PubChem SID:198939084 | CAS RN:112018-01-6 | UNII:G2S2V1ETBQ
+BMGC_DG11920,BMG_DG162803,"UNII:ACP75508EE | CANDOXATRIL | Candoxatril | PubChem SID:198962046 | DrugBank ID:DB00616 | 4-[[1-[(2S)-3-(2,3-dihydro-1H-inden-5-yloxy)-2-(2-methoxyethoxymethyl)-3-oxopropyl]cyclopentanecarbonyl]amino]cyclohexane-1-carboxylic acid | CAS RN:123122-55-4 | PubChem CID:5362417"
+BMGC_DG11921,BMG_DG162804,"CL-315555 | DrugBank ID:DB00460 | PubChem SID:198953299 | CAS RN:133513-12-9 | UNII:WU713D62N9 | Verteporfin | Visudyne | 3-[(23S,24R)-14-ethenyl-22,23-bis(methoxycarbonyl)-5-(3-methoxy-3-oxopropyl)-4,10,15,24-tetramethyl-25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1,3,5,7,9,11(27),12,14,16,18(25),19,21-dodecaen-9-yl]propanoic acid | PubChem CID:5362420"
+BMGC_DG11922,BMG_DG162805,"Batimastat | BATIMASTAT | UNII:BK349F52C9 | CAS RN:130370-60-4 | PubChem CID:5362422 | (2S,3R)-N-hydroxy-N'-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-(thiophen-2-ylsulfanylmethyl)butanediamide | DrugBank ID:DB03880 | PubChem SID:198990112"
+BMGC_DG11923,BMG_DG162806,Tegaserod | PubChem CID:5362436 | DrugBank ID:DB01079
+BMGC_DG11924,BMG_DG162807,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide | INDINAVIR ANHYDROUS | UNII:9MG78X43ZT | DrugBank ID:DB00224 | Indinavir | CAS RN:150378-17-9 | PubChem CID:5362440 | PubChem SID:175268656"
+BMGC_DG11925,BMG_DG162812,"PubChem CID:5362456 | (4R,4aR,7aS,12bS)-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol | UNII:7OP86J5E33 | Desomorphine | DESOMORPHINE | PubChem SID:198968898 | DrugBank ID:DB01531 | CAS RN:427-00-9"
+BMGC_DG11926,BMG_DG162816,"CAS RN:639-48-5 | [(4R,4aR,7S,7aR,12bS)-3-methyl-9-(pyridine-3-carbonyloxy)-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] pyridine-3-carboxylate | Nicomorphine | PubChem CID:5362460 | DrugBank ID:DB13454 | NICOMORPHINE | PubChem SID:198989626 | UNII:Y95FRL95FW"
+BMGC_DG11927,BMG_DG162821,sulfur | CAS RN:9035-99-8 | CAS RN:56996-94-2 | PubChem CID:5362487 | CAS RN:7704-34-9 | Sulfur
+BMGC_DG11928,BMG_DG162864,"CAS RN:428493-97-4 | PubChem SID:313183442 | 3-(2-DODECEN-1-YL)DIHYDRO-2,5-FURANDIONE, (2E)- | PubChem CID:5362708 | UNII:S63TTA7G5P"
+BMGC_DG11929,BMG_DG162900,"(3E,11E)-2,15-dihydroxy-7-methyl-6-oxabicyclo[11.3.0]hexadeca-3,11-dien-5-one | (2E,10E)-12,15-dihydroxy-7-methyl-8-oxabicyclo[11.3.0]hexadeca-2,10-dien-9-one | PubChem CID:5362868 | CAS RN:20350-15-6"
+BMGC_DG11930,BMG_DG162906,"Tas-114 | PubChem CID:53630253 | N-[(1R)-1-(3-cyclopentyloxyphenyl)ethyl]-3-[(2,4-dioxopyrimidin-1-yl)methoxy]propane-1-sulfonamide | CAS RN:1198221-21-4"
+BMGC_DG11931,BMG_DG163095,"ZIMELDINE | UNII:3J928617DW | DrugBank ID:DB04832 | Zimeldine | PubChem SID:198949441 | PubChem CID:5365247 | CAS RN:56775-88-3 | (Z)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-3-ylprop-2-en-1-amine"
+BMGC_DG11932,BMG_DG163217,2-Hydroxychalcone | (E)-3-(2-hydroxyphenyl)-1-phenylprop-2-en-1-one | CAS RN:644-78-0 | PubChem CID:5367146 | CAS RN:42224-53-3
+BMGC_DG11933,BMG_DG163301,PubChem CID:5369 | UNII:GNI5R14CFD | PubChem SID:287446553 | CAS RN:212500-02-2 | T-1032 FREE BASE
+BMGC_DG11934,BMG_DG163318,MONOMETHYL FUMARATE | Monomethyl Fumarate | PubChem CID:5369209 | (E)-4-methoxy-4-oxobut-2-enoic acid | CAS RN:2756-87-8 | PubChem SID:175267099 | UNII:45IUB1PX8R | DrugBank ID:DB14219 | CAS RN:44836-34-2
+BMGC_DG11935,BMG_DG163327,UNII:EY056ZZ9MG | Phenethyl cinnamate | PHENETHYL CINNAMATE | 2-phenylethyl (E)-3-phenylprop-2-enoate | PubChem SID:198974511 | CAS RN:103-53-7 | CAS RN:63238-64-2 | PubChem CID:5369459
+BMGC_DG11936,BMG_DG163360,CAS RN:136-72-1 | PubChem SID:198976859 | PubChem CID:5370536 | PIPERIC ACID | UNII:GFG3FLA9UR
+BMGC_DG11937,BMG_DG163370,"PubChem SID:198983581 | PubChem CID:53708 | DrugBank ID:DB04880 | 4-methyl-5-(4-methylsulfanylbenzoyl)-1,3-dihydroimidazol-2-one | ENOXIMONE | CAS RN:77671-31-9 | UNII:C7Z4ITI7L7 | Enoximone"
+BMGC_DG11938,BMG_DG163411,"CAS RN:54794-74-0 | (2E,4E,10E)-11-(1,3-benzodioxol-5-yl)-N-(2-methylpropyl)undeca-2,4,10-trienamide | Pipercide | PubChem CID:5372162"
+BMGC_DG11939,BMG_DG163418,"PubChem SID:482553956 | 5-methyl-2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzene-1,3-diol | PubChem CID:5372312 | Grifolin | GRIFOLIN | UNII:5P6UA2GF78 | CAS RN:6903-07-7"
+BMGC_DG11940,BMG_DG163426,"PubChem CID:5372683 | CAS RN:982-24-1 | CLOPENTHIXOL, TRANS | PubChem SID:198971891 | 2-[4-[(3E)-3-(2-chlorothioxanthen-9-ylidene)propyl]piperazin-1-yl]ethanol | UNII:FLE878A8ZI | Clopenthixol | CAS RN:53772-84-2"
+BMGC_DG11941,BMG_DG163428,PubChem SID:377307794 | ISOALLOXAZINE | CAS RN:490-59-5 | UNII:880W3VF9YW | PubChem CID:5372720
+BMGC_DG11942,BMG_DG163446,"PubChem CID:5373676 | 7-Methyl-1,8-naphthyridin-4(1H)-one | CAS RN:49655-73-4 | PubChem SID:485662564 | 7-METHYL-1,8-NAPHTHYRIDIN-4(1H)-ONE | UNII:J5KBM6XZV2"
+BMGC_DG11943,BMG_DG163459,"6-prop-2-enyl-4,5,7,8-tetrahydro-[1,3]thiazolo[4,5-d]azepin-2-amine | PubChem CID:5374 | Talipexole | PubChem SID:198978938 | UNII:7AM2J46Z1Y | CAS RN:101626-70-4 | TALIPEXOLE"
+BMGC_DG11944,BMG_DG163502,7-hydroxy-4-(trifluoromethyl)chromen-2-one | 7-Hydroxy-4-(trifluoromethyl)coumarin | PubChem CID:5375667 | CAS RN:575-03-1
+BMGC_DG11945,BMG_DG163504,PubChem CID:5375785 | DrugBank ID:DB13846 | CAS RN:91-82-7 | 1-[(Z)-4-(4-chlorophenyl)-3-phenylbut-2-enyl]pyrrolidine | 1-(4-(4-Chlorophenyl)-3-phenylbut-2-enyl)pyrrolidine
+BMGC_DG11946,BMG_DG163510,UNII:48GQI7H930 | 6-METHOXYHARMAN | CAS RN:3589-72-8 | PubChem SID:375579207 | PubChem CID:5376026
+BMGC_DG11947,BMG_DG163517,"PubChem CID:5376215 | CAS RN:14348-23-3 | 7H-Furo(3,2-g)(1)benzopyran-7-one, 4,9-dihydroxy- | 4,9-dihydroxyfuro[3,2-g]chromen-7-one"
+BMGC_DG11948,BMG_DG163529,PubChem CID:5376617 | 2-[(E)-2-(3-nitrophenyl)vinyl]quinoline | CAS RN:7251-91-4 | 2-[(E)-2-(3-nitrophenyl)ethenyl]quinoline | CAS RN:38101-92-7
+BMGC_DG11949,BMG_DG163531,2-Benzylidene-1-tetralone | 2-BENZYLIDENE-1-TETRALONE | CAS RN:57558-64-2 | PubChem SID:474491564 | PubChem CID:5376779 | UNII:5H84JJT89A
+BMGC_DG11950,BMG_DG163533,7-Hydroxyisoflavone | CAS RN:13057-72-2 | PubChem CID:5376891 | 7-hydroxy-3-phenylchromen-4-one
+BMGC_DG11951,BMG_DG163544,PubChem SID:198978148 | CAS RN:1222-98-6 | UNII:YT67D88ODY | 4-NITROCHALCONE | PubChem CID:5377323
+BMGC_DG11952,BMG_DG163564,"3,5,7-trihydroxy-2-(4-hydroxyphenyl)-6-methoxychromen-4-one | 6-Methoxykaempferol | PubChem CID:5377945 | CAS RN:32520-55-1"
+BMGC_DG11953,BMG_DG163566,"(2Z)-2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine | (2Z)-2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine | CAS RN:30223-73-5 | PubChem CID:5378015"
+BMGC_DG11954,BMG_DG163567,UNII:151J9IY8BY | PubChem CID:5378081 | PubChem SID:198967995 | 2-(P-DIMETHYLAMINOSTYRYL)BENZOTHIAZOLE | CAS RN:1628-58-6
+BMGC_DG11955,BMG_DG163581,PubChem SID:377308044 | UNII:54E45U4Q3N | CAS RN:27067-70-5 | PubChem CID:5378702 | 5-HYDROXYNORACRONYCIN
+BMGC_DG11956,BMG_DG163594,UNII:81485Y3A9A | CAS RN:160738-57-8 | Gatifloxacin | DrugBank ID:DB01044 | GATIFLOXACIN ANHYDROUS | CAS RN:112811-59-3 | PubChem CID:5379 | 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid | PubChem SID:175271628
+BMGC_DG11957,BMG_DG163599,"PubChem CID:5379096 | UNII:5U4Y68G678 | CAS RN:18085-97-7 | JACEOSIDIN | 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-6-methoxychromen-4-one | PubChem SID:472424484 | Jaceosidin"
+BMGC_DG11958,BMG_DG163608,PubChem SID:198936341 | PubChem CID:5380 | UNII:T0248823H1 | CAS RN:82989-25-1 | TAZANOLAST
+BMGC_DG11959,BMG_DG163625,"NDC:16110-833 | ethyl 6-[2-(4,4-dimethyl-2,3-dihydrothiochromen-6-yl)ethynyl]pyridine-3-carboxylate | NDC:16110-042 | NDC:45802-442 | UNII:81BDR9Y8PS | NDC:0023-0042 | NDC:16110-916 | NDC:73473-310 | NDC:72162-2202 | NDC:51862-295 | NDC:60758-561 | NDC:16110-915 | NDC:73473-309 | NDC:51672-1374 | NDC:45802-436 | NDC:73503-007 | NDC:68308-685 | PubChem CID:5381 | NDC:0023-8335 | PubChem SID:175265975 | NDC:0713-0805 | NDC:0713-0804 | NDC:73503-011 | Tazarotene | TAZAROTENE | CAS RN:1246815-76-8 | NDC:0187-2098 | NDC:0713-0670 | NDC:72162-2420 | CAS RN:118292-40-3 | DrugBank ID:DB00799 | NDC:45802-706 | NDC:51672-1373 | NDC:68308-745"
+BMGC_DG11960,BMG_DG163629,PubChem CID:5381226 | Rifampin | DrugBank ID:DB01045
+BMGC_DG11961,BMG_DG163644,"PubChem SID:474489686 | UNII:P4R368GDD7 | 1,4-BIS(2-(3,5-DICHLOROPYRIDYLOXY))BENZENE | PubChem CID:5382 | CAS RN:76150-91-9 | 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene"
+BMGC_DG11962,BMG_DG163690,"7H-PYRROLO(3,2-F)QUINAZOLINE-1,3-DIAMINE | CAS RN:65795-37-1 | UNII:DMA7VBB8RW | PubChem SID:348481077 | PubChem CID:5384532"
+BMGC_DG11963,BMG_DG163694,"(1R,3R,5Z)-5-{2-[(1R,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-hexahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol | PubChem CID:53846425 | CAS RN:32222-06-3 | (1R,3R)-5-[2-[(1R,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol"
+BMGC_DG11964,BMG_DG163695,"PubChem CID:5384684 | UNII:CB7ZJH3JT8 | PubChem SID:474491566 | (NE,Z)-N'-((2,4-DINITROPHENYL)AMINO)-N-(PHENYLIMINO)-1H-1,3-BENZODIAZOLE-2-CARBOXIMIDAMIDE | CAS RN:77200-72-7 | (NE,Z)-N'-[(2,4-dinitrophenyl)amino]-N-(phenylimino)-1H-1,3-benzodiazole-2-carboximidamide"
+BMGC_DG11965,BMG_DG163718,"PubChem CID:5385086 | 3'-HYDROXY-3,5,4'-TRIMETHOXYSTILBENE, (E)- | 3'-Hydroxy-3,5,4'-trimethoxystilbene, (E)- | PubChem SID:474491230 | CAS RN:108957-73-9 | UNII:KPM93CW8F2"
+BMGC_DG11966,BMG_DG163739,"CAS RN:17902-23-7 | TEGAFUR | Tegafur | PubChem SID:198944417 | DrugBank ID:DB09256 | UNII:1548R74NSZ | CAS RN:82294-77-7 | 5-fluoro-1-(oxolan-2-yl)pyrimidine-2,4-dione | PubChem CID:5386"
+BMGC_DG11967,BMG_DG163740,"PubChem CID:5386092 | CAS RN:1397-89-3 | Amphotericin B (VAN8C | (1R,3S,5R,6R,9R,11R,15S,16R,17R,18S,19E,21E,23E,25E,27E,29E,31E,33R,35S,36R,37S)-33-(4-amino-3,5-dihydroxy-6-methyloxan-2-yl)oxy-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,23,25,27,29,31-heptaene-36-carboxylic acid"
+BMGC_DG11968,BMG_DG163746,"PubChem SID:472426453 | PubChem CID:5386397 | CAS RN:117048-62-1 | UNII:ND4BUQ9WHL | 2-methoxy-5-[(E)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenol | COMBRETASTATIN A4, TRANS- | E-Combretastatin A-4 | Combretastatin A4, trans-"
+BMGC_DG11969,BMG_DG163750,"Ajoene | AJOENE, (E)- | CAS RN:92284-99-6 | UNII:W36UK64JYA | PubChem CID:5386591 | (E)-1-(prop-2-enyldisulfanyl)-3-prop-2-enylsulfinylprop-1-ene | CAS RN:92285-01-3 | PubChem SID:198983609"
+BMGC_DG11970,BMG_DG163783,"CAS RN:843663-66-1 | CAS RN:654653-93-7 | Bedaquiline | PubChem CID:5388906 | BEDAQUILINE | (1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol | DrugBank ID:DB08903 | UNII:78846I289Y | PubChem SID:175268499"
+BMGC_DG11971,BMG_DG163784,PubChem CID:5388909 | DrugBank ID:DB06832 | Prinaberel
+BMGC_DG11972,BMG_DG163785,"CAS RN:187148-13-6 | (3S,6S,9R,10R,11S,12S,13E,15E,18S,21S)-18-[(2E,4E,8S,9S)-10-[(2S,3R,4S,5S,6R,9S,11S)-9-ethyl-4-hydroxy-3,5,11-trimethyl-8-oxo-1-oxa-7-azaspiro[5.5]undecan-2-yl]-9-hydroxy-8-methyldeca-2,4-dien-2-yl]-10,12-dihydroxy-3-[(3-hydroxyphenyl)methyl]-11-methyl-9-(3-oxobutyl)-6-propan-2-yl-19-oxa-1,4,7,25-tetrazabicyclo[19.3.1]pentacosa-13,15-diene-2,5,8,20-tetrone | PubChem CID:5388925 | Sanglifehrin A | DrugBank ID:DB03393"
+BMGC_DG11973,BMG_DG163787,"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE | DrugBank ID:DB04612 | PubChem CID:5388929"
+BMGC_DG11974,BMG_DG163788,PubChem SID:198962252 | PubChem CID:5388936 | DrugBank ID:DB04805 | Virginiamycin S1 | VIRGINIAMYCIN S1 | UNII:J91D5GN5AT | CAS RN:23152-29-6
+BMGC_DG11975,BMG_DG163789,"N-[(3S,6S,12R,15S,16R,19S,22S,25R)-25-[[(3S)-1-azabicyclo[2.2.2]octan-3-yl]sulfanylmethyl]-3-[[4-(dimethylamino)phenyl]methyl]-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide | CAS RN:120138-50-3 | PubChem SID:175267844 | UNII:23OW28RS7P | QUINUPRISTIN | Quinupristin | PubChem CID:5388937 | DrugBank ID:DB01369"
+BMGC_DG11976,BMG_DG163792,NDC:60760-688 | NDC:72789-329 | NDC:0187-0146 | NDC:62135-591 | NDC:60429-186 | NDC:71335-1141 | NDC:50090-7302 | NDC:50090-6881 | NDC:55111-134 | NDC:51672-4245 | NDC:68788-8096 | NDC:50090-0689 | NDC:70518-1339 | NDC:23155-773 | NDC:68788-7671 | NDC:68645-606 | NDC:70518-3853 | NDC:50090-3275 | NDC:50090-7222 | NDC:71205-074 | NDC:16714-442 | NDC:71335-9604 | PubChem SID:175268306 | NDC:70518-4210 | NDC:0187-0140 | NDC:60760-575 | NDC:70518-3715 | NDC:68645-607 | NDC:23155-705 | NDC:62135-590 | NDC:72789-318 | NDC:51672-4045 | NDC:68645-456 | NDC:60429-184 | NDC:71335-1910 | NDC:16714-445 | NDC:51407-828 | NDC:23155-772 | NDC:60429-185 | NDC:70518-4011 | NDC:63629-1526 | NDC:51672-4046 | NDC:50090-0692 | NDC:70518-4256 | NDC:50090-6490 | NDC:52536-401 | NDC:68788-8284 | NDC:50090-4560 | NDC:68645-457 | NDC:52652-4001 | NDC:69452-237 | NDC:63629-1522 | NDC:68788-8385 | NDC:67877-712 | NDC:60429-183 | NDC:68645-455 | NDC:71205-075 | NDC:50090-3378 | NDC:50090-6437 | NDC:63187-397 | NDC:68788-8320 | NDC:51655-058 | NDC:51672-4038 | NDC:69238-2141 | NDC:71335-1854 | NDC:50090-6712 | NDC:55111-133 | NDC:70518-2621 | PubChem CID:5388961 | NDC:51655-207 | NDC:68682-710 | NDC:72603-247 | NDC:43547-547 | NDC:70518-4153 | NDC:71335-9698 | NDC:59651-529 | NDC:68071-3408 | NDC:70518-4197 | CAS RN:76095-16-4 | NDC:69238-1729 | NDC:63629-1525 | NDC:70518-1664 | NDC:0187-0143 | NDC:43547-546 | NDC:68788-7967 | NDC:70518-3874 | NDC:71335-2382 | Enalapril maleate | NDC:51655-006 | NDC:23155-704 | NDC:68071-2670 | NDC:63187-977 | ENALAPRIL MALEATE | NDC:60760-226 | NDC:68682-713 | NDC:0187-0141 | NDC:68788-8437 | NDC:16714-444 | UNII:9O25354EPJ | NDC:51672-4037 | NDC:63629-7895 | NDC:0187-0142 | NDC:72189-282 | NDC:51672-4040 | NDC:68645-605 | NDC:43547-545 | NDC:71335-9649 | NDC:51672-4039 | NDC:60760-587 | NDC:62135-589 | NDC:70518-3813 | NDC:62135-592 | NDC:68682-711 | NDC:71335-2252 | NDC:16714-443 | NDC:31722-020 | NDC:43547-548 | (Z)-but-2-enedioic acid;(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid | NDC:68788-8061 | NDC:51655-341 | NDC:51655-110 | NDC:68682-712
+BMGC_DG11977,BMG_DG163793,DrugBank ID:DB00584 | PubChem CID:5388962 | UNII:69PN84IO1A | (2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid | Enalapril | CAS RN:75847-73-3 | CAS RN:76095-16-4 | PubChem SID:175267182 | ENALAPRIL
+BMGC_DG11978,BMG_DG163799,"CAS RN:57-22-7 | PubChem SID:175268624 | DrugBank ID:DB00541 | VINCRISTINE | CAS RN:132142-73-5 | UNII:5J49Q6B70F | PubChem CID:5388993 | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | Citomid"
+BMGC_DG11979,BMG_DG163815,"NDC:0904-6436 | NDC:35356-664 | NDC:63629-8606 | NDC:68788-8493 | NDC:0406-9959 | NDC:71610-004 | NDC:50268-779 | NDC:43547-611 | NDC:71610-101 | NDC:62332-381 | NDC:51407-507 | NDC:63629-1619 | NDC:63629-8602 | NDC:65162-584 | DrugBank ID:DB00231 | NDC:63629-8605 | PubChem CID:5391 | NDC:50090-0285 | NDC:71335-2043 | NDC:70518-4106 | Temazepam | NDC:68788-8139 | NDC:46708-381 | NDC:72162-1824 | NDC:62332-382 | NDC:65162-556 | NDC:67877-148 | NDC:67877-146 | NDC:55289-660 | NDC:0406-9916 | NDC:50268-780 | NDC:0228-2077 | NDC:62332-379 | NDC:66267-321 | UNII:CHB1QD2QSS | NDC:43547-613 | NDC:63187-718 | NDC:46708-379 | NDC:68788-8081 | NDC:43547-612 | NDC:46708-382 | NDC:63629-8603 | NDC:71335-9741 | NDC:72789-449 | NDC:0406-9915 | NDC:55289-196 | NDC:68071-4083 | CAS RN:846-50-4 | NDC:51407-508 | NDC:71610-625 | NDC:63629-1621 | NDC:43353-260 | NDC:72162-1827 | NDC:53746-556 | NDC:67877-149 | NDC:67877-147 | NDC:0228-2076 | NDC:71335-2302 | NDC:43353-312 | NDC:0406-9917 | NDC:71610-086 | NDC:53746-557 | PubChem SID:175271449 | NDC:62332-380 | NDC:63739-003 | NDC:0406-9962 | NDC:17856-0148 | NDC:68084-549 | NDC:71335-0315 | NDC:71610-626 | NDC:71610-089 | NDC:0406-9914 | NDC:65162-583 | NDC:72162-1825 | NDC:60429-506 | NDC:0406-9961 | NDC:65162-557 | NDC:0406-9960 | NDC:71205-914 | NDC:71205-915 | NDC:60429-507 | NDC:63629-1057 | NDC:67544-136 | 7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one | NDC:80425-0191 | TEMAZEPAM | NDC:63629-8604 | NDC:43547-614 | NDC:46708-380 | NDC:63187-497 | NDC:50090-0186 | NDC:80425-0295 | NDC:63629-8601 | NDC:63187-132 | NDC:43353-152 | NDC:70518-0647 | NDC:71335-1901 | NDC:72162-1826"
+BMGC_DG11980,BMG_DG163829,PubChem CID:5392 | [4-(4-dimethoxyphosphinothioyloxyphenyl)sulfanylphenoxy]-dimethoxy-sulfanylidene-lambda5-phosphane | CAS RN:3383-96-8 | PubChem SID:198966024 | Temephos | TEMEFOS | Temefos | UNII:ONP3ME32DL | DrugBank ID:DB12231
+BMGC_DG11981,BMG_DG163830,PubChem CID:5392139 | 3-ACETYL-7-HYDROXY-2H-1-BENZOPYRAN-2-ONE | PubChem SID:482553862 | CAS RN:10441-27-7 | 3-Acetyl-7-hydroxy-2H-1-benzopyran-2-one | UNII:BLX779DF5D
+BMGC_DG11982,BMG_DG163837,"3,5-dihydroxy-2-phenylchromen-4-one | PubChem CID:5393151 | CAS RN:6665-69-6 | 3,5-Dihydroxyflavone"
+BMGC_DG11983,BMG_DG163838,"PubChem CID:5393152 | UNII:O948D0K9BQ | 3,7-dihydroxy-2-phenylchromen-4-one | CAS RN:492-00-2 | 3,7-DIHYDROXYFLAVONE | PubChem SID:318164764 | 3,7-Dihydroxyflavone"
+BMGC_DG11984,BMG_DG163842,PubChem CID:5393173 | 7-hydroxy-2-oxochromene-3-carbonitrile | 3-Cyano-7-hydroxycoumarin | CAS RN:19088-73-4
+BMGC_DG11985,BMG_DG163846,"3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide | NDC:65162-803 | NDC:16729-048 | NDC:31722-415 | NDC:16571-821 | NDC:67877-538 | NDC:75834-142 | NDC:0085-1430 | PubChem CID:5394 | NDC:0085-3004 | NDC:75834-145 | NDC:65162-806 | NDC:67877-541 | NDC:31722-412 | NDC:75834-146 | NDC:70771-1096 | DrugBank ID:DB00853 | NDC:50268-762 | NDC:31722-413 | NDC:59923-706 | NDC:65162-804 | NDC:0085-1519 | NDC:16571-816 | NDC:47335-890 | NDC:75834-144 | NDC:59923-708 | NDC:0085-1381 | NDC:59923-709 | NDC:59923-710 | NDC:70771-1097 | NDC:47335-930 | UNII:YF1K15M17Y | NDC:59923-707 | NDC:70771-1093 | NDC:70771-1095 | NDC:47335-892 | NDC:68382-754 | NDC:59923-705 | NDC:70771-1094 | NDC:16571-817 | NDC:50268-761 | NDC:65162-805 | NDC:59923-712 | NDC:16729-049 | NDC:16729-129 | NDC:16729-050 | NDC:67877-540 | NDC:16571-819 | NDC:16729-051 | NDC:59923-711 | NDC:70771-1092 | NDC:65162-802 | NDC:68382-753 | NDC:31722-414 | NDC:31722-411 | NDC:47335-891 | NDC:59923-713 | NDC:0085-1417 | NDC:68382-755 | NDC:59923-704 | NDC:68382-752 | NDC:16571-818 | NDC:67877-539 | NDC:16571-820 | NDC:75834-143 | PubChem SID:175268769 | CAS RN:85622-93-1 | NDC:67877-542 | NDC:75834-132 | NDC:68382-751 | Temozolomide | NDC:59923-703 | NDC:0085-1425 | NDC:67877-537 | NDC:47335-893 | TEMOZOLOMIDE | NDC:68382-756 | NDC:31722-416 | NDC:47335-929 | NDC:16729-130 | NDC:0085-1366 | NDC:65162-801"
+BMGC_DG11986,BMG_DG163858,"Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) | 5-[(7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one | PubChem CID:5396 | CAS RN:125851-00-5"
+BMGC_DG11987,BMG_DG163899,"UNII:8L5014XET7 | PubChem SID:175271751 | TERAZOSIN | [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone | CAS RN:141269-44-5 | PubChem CID:5401 | Terazosin | DrugBank ID:DB01162 | CAS RN:63590-64-7 | CAS RN:141269-45-6"
+BMGC_DG11988,BMG_DG163912,"Terbutaline | PubChem CID:5403 | PubChem SID:175271679 | UNII:N8ONU3L3PG | 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diol | TERBUTALINE | CAS RN:1164563-86-3 | DrugBank ID:DB00871 | CAS RN:23031-25-6"
+BMGC_DG11989,BMG_DG163916,DrugBank ID:DB08065 | 2-(1H-pyrazol-3-yl)-1H-benzimidazole | PubChem CID:5403336
+BMGC_DG11990,BMG_DG163917,"PubChem CID:5403427 | 4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol | DrugBank ID:DB08356"
+BMGC_DG11991,BMG_DG163931,Terfenadine | PubChem SID:472386189 | 1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol | CAS RN:50679-08-8 | PubChem CID:5405 | TERFENADINE | UNII:7BA5G9Y06Q | DrugBank ID:DB00342
+BMGC_DG11992,BMG_DG163945,"PubChem CID:5408233 | PubChem SID:198949290 | UNII:7X10PRH74D | CAS RN:1936-18-1 | Salutaridine | (1S,9R)-3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,10,13-pentaen-12-one | SALUTARIDINE"
+BMGC_DG11993,BMG_DG163965,CAS RN:100311-22-6 | NDC:67194-020 | Tetracaine | PubChem CID:5411 | CAS RN:94-24-6 | NDC:54723-017 | UNII:0619F35CGV | NDC:70372-729 | DrugBank ID:DB09085 | TETRACAINE | PubChem SID:175268100 | 2-(dimethylamino)ethyl 4-(butylamino)benzoate
+BMGC_DG11994,BMG_DG163967,CAS RN:6748-68-1 | PubChem CID:5411574 | 8-ACETYL-7-HYDROXYCOUMARIN | UNII:QD6QWL7EQR | PubChem SID:478838408
+BMGC_DG11995,BMG_DG163972,STEPRONIN | Stepronin | PubChem SID:198940882 | PubChem CID:54120 | DrugBank ID:DB01423 | CAS RN:72324-18-6 | 2-[2-(thiophene-2-carbonylsulfanyl)propanoylamino]acetic acid | UNII:0NOY894QRB
+BMGC_DG11996,BMG_DG163976,Tetraethylammonium | CAS RN:66-40-0 | TETRAETHYLAMMONIUM | PubChem CID:5413 | DrugBank ID:DB08837 | PubChem SID:198988799 | UNII:5AV7G7EIEE | tetraethylazanium
+BMGC_DG11997,BMG_DG163977,"DrugBank ID:DB08049 | 7,8-dihydroxy-4-phenyl-2H-chromen-2-one | PubChem CID:5413034"
+BMGC_DG11998,BMG_DG163983,"DrugBank ID:DB04233 | PubChem CID:5414 | (Hydroxyethyloxy)Tri(Ethyloxy)Octane | 3,6,9,12-TETRAOXAEICOSAN-1-OL | CAS RN:19327-39-0 | UNII:KE5RN26WTE"
+BMGC_DG11999,BMG_DG163993,"Mebrofenin | PubChem SID:175268654 | NDC:45567-0455 | CAS RN:78266-06-5 | 2-[[2-(3-bromo-2,4,6-trimethylanilino)-2-oxoethyl]-(carboxymethyl)amino]acetic acid | NDC:0270-0083 | MEBROFENIN | UNII:7PV0B6ED98 | PubChem CID:54158"
+BMGC_DG12000,BMG_DG163995,667-COUMARIN | UNII:X563HX34EA | CAS RN:83688-44-2 | PubChem CID:5415867 | PubChem SID:440794026
+BMGC_DG12001,BMG_DG164003,"PubChem SID:316909710 | PubChem CID:5417 | TETRAHYDROPALMATINE, (±)- | CAS RN:10097-84-4 | 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline | 6H-Dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy- | CAS RN:2934-97-6 | TETRAHYDROPALMATINE, (+/-)- | UNII:78F8583LNQ"
+BMGC_DG12002,BMG_DG164013,"2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole | PubChem CID:5419 | UNII:S9U025Y077 | PubChem SID:175271430 | PubChem SID:440088817 | Tetrahydrozoline | TETRAHYDROZOLINE | Tetryzoline | UNII:P7M4KML3S8 | CAS RN:84-22-0 | TETRAHYDROZOLINE, (-)- | DrugBank ID:DB06764 | CAS RN:67731-53-7"
+BMGC_DG12003,BMG_DG164023,N-[bis(propan-2-ylamino)phosphoryloxy-(propan-2-ylamino)phosphoryl]propan-2-amine | CAS RN:513-00-8 | Tetraisopropylpyrophosphamide | PubChem CID:5420
+BMGC_DG12004,BMG_DG164030,PubChem CID:542051 | UNII:L3P287BI9W | DOPR | CAS RN:63779-88-4 | PubChem SID:316911349
+BMGC_DG12005,BMG_DG164035,"CAS RN:2351146-82-0 | 4,5-alpha-Epoxy-6-beta-hydroxygermacra-1(10),11(13)-dien-12-oic acid gamma-lactone | UNII:2RDB26I5ZB | PubChem CID:5420805 | PubChem SID:175265569 | PARTHENOLIDE | (1S,2S,4R,7Z,11S)-4,8-dimethyl-12-methylidene-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one | CAS RN:20554-84-1"
+BMGC_DG12006,BMG_DG164036,"PubChem CID:54210200 | CAS RN:216657-60-2 | 5-[[5-(6,13-dimethyl-2-tricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaenyl)-2-oxo-4-sulfanylidenepyrimidin-1-yl]methyl]-N-(2H-tetrazol-5-yl)furan-2-carboxamide | AR-C118925XX"
+BMGC_DG12007,BMG_DG164060,"CAS RN:106614-68-0 | NDC:84534-002 | (2S,6R)-2,6-dimethyl-4-[2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine;hydrochloride | AMOROLFINE HYDROCHLORIDE | PubChem CID:54259 | PubChem SID:198972017 | CAS RN:78613-38-4 | UNII:741YH7379H | Amorolfine Hydrochloride"
+BMGC_DG12008,BMG_DG164063,"PubChem SID:175271940 | UNII:4Z8R6ORS6L | NDC:59572-205 | NDC:59572-220 | CAS RN:50-35-1 | PubChem CID:5426 | 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione | CAS RN:1012310-87-0 | NDC:59572-210 | NDC:59572-215 | THALIDOMIDE | Thalidomide | DrugBank ID:DB01041"
+BMGC_DG12009,BMG_DG164064,"PubChem CID:54260 | (2R,6S)-2,6-dimethyl-4-[2-methyl-3-[4-(2-methylbutan-2-yl)phenyl]propyl]morpholine | Amorolfine | DrugBank ID:DB09056 | CAS RN:78613-35-1"
+BMGC_DG12010,BMG_DG164095,"CAS RN:519-41-5 | PubChem SID:175266883 | 3,7-dimethylpurine-2,6-dione | DrugBank ID:DB01412 | THEOBROMINE | CAS RN:83-67-0 | PubChem CID:5429 | Theobromine | UNII:OBD445WZ5P"
+BMGC_DG12011,BMG_DG164102,"DrugBank ID:DB00730 | THIABENDAZOLE | PubChem CID:5430 | Thiabendazole | CAS RN:148-79-8 | UNII:N1Q45E87DT | PubChem SID:175267884 | 4-(1H-benzimidazol-2-yl)-1,3-thiazole"
+BMGC_DG12012,BMG_DG164106,"Cocarboxylase | [2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethoxy-hydroxyphosphoryl] hydrogen phosphate | PubChem CID:5431 | CAS RN:136-09-4 | Thiamin Diphosphate | DrugBank ID:DB01987"
+BMGC_DG12013,BMG_DG164108,"N-PROPYLAMPHETAMINE, (R)- | N-Propylamphetamine, (R)- | CAS RN:37577-16-5 | UNII:9HPQ833LFJ | PubChem CID:54315083 | PubChem SID:474494167"
+BMGC_DG12014,BMG_DG164120,"NDC:50090-6130 | NDC:69097-579 | [1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azanium;hydroxy-[(2R,3S)-3-methyloxiran-2-yl]phosphinate | FOSFOMYCIN TROMETHAMINE | NDC:67877-749 | NDC:70700-268 | PubChem SID:175265896 | PubChem CID:54331 | Monuril | NDC:50090-5826 | NDC:60219-3955 | UNII:7FXW6U30GY | CAS RN:78964-85-9"
+BMGC_DG12015,BMG_DG164135,"CAS RN:2602-86-0 | UNII:JEK9DQ4CNW | PubChem CID:54348149 | (17.BETA.)-ANDROSTA-3,5-DIEN-17-OL"
+BMGC_DG12016,BMG_DG164136,DrugBank ID:DB08171 | PubChem CID:543502 | 11-MERCAPTOUNDECANOIC ACID
+BMGC_DG12017,BMG_DG164152,"(6R,7R)-7-[[2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | (6R,7R)-7-[[2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem CID:54362 | CAS RN:79350-37-1"
+BMGC_DG12018,BMG_DG164160,"Piritrexim | UNII:MK2A783ZUT | CAS RN:72732-56-0 | 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine | PIRITREXIM | DrugBank ID:DB03695 | PubChem CID:54369 | PubChem SID:198977797"
+BMGC_DG12019,BMG_DG164162,"2,4-Thiazolidinedione | CAS RN:2295-31-0 | DrugBank ID:DB11898 | 2,4-thiazolidinedione | 2,4-THIAZOLIDINEDIONE | 1,3-thiazolidine-2,4-dione | PubChem CID:5437 | PubChem SID:316914745 | UNII:AA68LXK93C"
+BMGC_DG12020,BMG_DG164165,"PubChem CID:54373 | CAS RN:79517-01-4 | acetic acid;10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | H-DL-Phe-DL-Cys(1)-DL-Phe-DL-Trp-DL-Lys-DL-xiThr-DL-Cys(1)-Thr-ol.2CH3CO2H"
+BMGC_DG12021,BMG_DG164173,"DrugBank ID:DB03876 | PubChem CID:5438 | Thieno[2,3-B]Pyridine-2-Carboxamidine"
+BMGC_DG12022,BMG_DG164176,"UNII:124XMA6YEI | PubChem SID:175267780 | PubChem CID:54384 | (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid;hydrochloride | LEVOCABASTINE HYDROCHLORIDE | Levocabastine hydrochloride | CAS RN:79547-78-7"
+BMGC_DG12023,BMG_DG164178,"Levocabastine | LEVOCABASTINE | CAS RN:79449-98-2 | CAS RN:105452-51-5 | PubChem SID:198974743 | CABASTINE | CAS RN:79516-68-0 | PubChem CID:54385 | PubChem SID:175265815 | UNII:COU3RRH769 | (3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid | DrugBank ID:DB01106 | UNII:H68BP06S81"
+BMGC_DG12024,BMG_DG164188,CAS RN:15502-74-6 | UNII:N5509X556J | ARSENITE ION | PubChem CID:544 | PubChem SID:175265929 | arsorite | Arsenite ion
+BMGC_DG12025,BMG_DG164189,Thiethylperazine | CAS RN:1179-69-7 | UNII:8ETK1WAF6R | 2-ethylsulfanyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine | CAS RN:1420-55-9 | DrugBank ID:DB00372 | PubChem CID:5440 | PubChem SID:198985013 | THIETHYLPERAZINE
+BMGC_DG12026,BMG_DG164213,PubChem SID:441659787 | O-DESMETHYL-BRINZOLAMIDE | CAS RN:186377-56-0 | PubChem CID:54444800 | UNII:6MHY973FEJ
+BMGC_DG12027,BMG_DG164214,"(1S,6S,7R,8R,8aR)-1,2,3,5,6,7,8,8a-octahydroindolizine-1,6,7,8-tetrol | CAS RN:79831-76-8 | DrugBank ID:DB01816 | PubChem SID:175268340 | CASTANOSPERMINE | PubChem CID:54445 | UNII:Q0I3184XM7 | Castanospermine"
+BMGC_DG12028,BMG_DG164217,"NDC:78206-180 | NDC:24658-502 | NDC:71335-9642 | NDC:63629-3392 | NDC:65841-066 | NDC:50090-6459 | NDC:65862-052 | NDC:68788-9429 | NDC:71335-1891 | DrugBank ID:DB00641 | NDC:68645-470 | NDC:55111-198 | NDC:70518-3648 | NDC:70518-3630 | NDC:50090-1000 | NDC:68071-4998 | NDC:31722-513 | NDC:55154-8136 | NDC:55111-199 | Simvastatin | NDC:68788-8342 | NDC:50090-6236 | NDC:50090-7088 | NDC:71205-070 | NDC:0615-7993 | NDC:60760-580 | NDC:71335-1905 | NDC:63739-571 | NDC:78206-181 | NDC:71610-611 | NDC:67046-1259 | UNII:AGG2FN16EV | SIMVASTATIN | NDC:16729-004 | NDC:43063-080 | NDC:71335-9717 | NDC:68180-480 | NDC:71205-780 | NDC:31722-512 | NDC:82009-014 | NDC:68788-8406 | NDC:71335-1906 | NDC:16714-683 | NDC:24658-501 | NDC:71610-622 | NDC:43063-727 | NDC:68084-512 | NDC:71610-623 | NDC:50090-6306 | NDC:50090-6421 | NDC:16729-006 | NDC:42708-148 | NDC:43063-726 | NDC:43063-733 | NDC:82009-013 | NDC:60760-579 | NDC:68084-511 | NDC:68071-1646 | NDC:50090-6420 | NDC:71205-192 | NDC:70377-005 | NDC:72189-452 | NDC:71205-798 | NDC:63739-570 | NDC:71335-9630 | NDC:63629-7421 | NDC:50090-4897 | NDC:63629-1198 | NDC:72789-320 | NDC:51655-448 | NDC:71335-9636 | NDC:68788-9868 | NDC:29273-401 | NDC:42571-040 | NDC:63739-572 | NDC:68788-9747 | NDC:51655-643 | NDC:63629-3385 | NDC:24658-503 | NDC:72189-421 | PubChem SID:175267777 | NDC:24658-504 | NDC:42571-020 | NDC:60760-006 | NDC:31722-511 | NDC:63187-191 | NDC:51655-459 | NDC:70518-3678 | NDC:51655-113 | NDC:68788-8369 | NDC:71610-615 | NDC:65862-050 | NDC:68071-1711 | NDC:42708-168 | NDC:65862-054 | NDC:50090-6922 | NDC:68382-066 | NDC:55111-268 | NDC:50090-4901 | NDC:50090-0999 | NDC:71610-610 | NDC:68071-3391 | NDC:16714-685 | NDC:55111-197 | NDC:68071-4996 | NDC:78206-182 | NDC:50090-4736 | NDC:63629-3408 | NDC:63629-3393 | NDC:68382-069 | NDC:68382-068 | NDC:16714-681 | NDC:65841-068 | NDC:68180-464 | NDC:65862-051 | NDC:68180-465 | NDC:65841-067 | NDC:68180-479 | NDC:63187-075 | NDC:71610-250 | NDC:60760-019 | NDC:16714-684 | NDC:63739-573 | CAS RN:79902-63-9 | NDC:68788-8379 | NDC:70377-003 | NDC:50090-4801 | NDC:68788-9869 | NDC:50090-5788 | NDC:71610-609 | NDC:68180-482 | NDC:31722-510 | NDC:31722-514 | NDC:55154-4782 | NDC:72789-316 | NDC:82009-012 | [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate | NDC:50090-6424 | NDC:51655-387 | NDC:16729-007 | NDC:51655-598 | NDC:16729-156 | NDC:43063-162 | PubChem CID:54454 | NDC:68645-527 | NDC:71205-809 | NDC:24658-500 | NDC:50090-5019 | NDC:72189-427 | NDC:60687-210 | NDC:0615-7992 | NDC:68180-481 | NDC:70377-004 | NDC:71610-050 | NDC:51655-841 | NDC:16714-682 | NDC:0615-8056 | NDC:29273-402 | NDC:82009-015 | NDC:63187-449 | NDC:68180-478 | NDC:70377-001 | NDC:68382-067 | NDC:65841-069 | NDC:42708-169 | NDC:82009-016 | NDC:65862-053 | NDC:55111-200 | NDC:65841-065 | NDC:70518-4102 | NDC:72789-304 | NDC:60760-005 | NDC:71335-2262 | NDC:16729-005 | NDC:42571-010 | NDC:60760-585 | NDC:50090-6389 | NDC:70377-002 | NDC:42571-080 | NDC:70518-3349 | NDC:42571-005 | NDC:68382-065"
+BMGC_DG12029,BMG_DG164220,"PubChem SID:198945015 | SALSOLINOL, (+/-)- | UNII:51619CO22Q | CAS RN:525-72-4 | SALSOLINOL, (±)- | PubChem CID:54456"
+BMGC_DG12030,BMG_DG164223,"2-(2,3-dihydro-1,4-benzodioxin-3-yl)-4,5-dihydro-1H-imidazole | PubChem CID:54459 | UNII:Y310PA316B | IDAZOXAN | PubChem SID:198980405 | DrugBank ID:DB12551 | Idazoxan | CAS RN:79944-58-4"
+BMGC_DG12031,BMG_DG164234,Nitrofurazone | NITROFURAZONE | CAS RN:1217220-85-3 | PubChem SID:175267166 | UNII:X8XI70B5Z6 | Nitrofural | PubChem CID:5447130 | [(E)-(5-nitrofuran-2-yl)methylideneamino]urea | CAS RN:112574-44-4 | DrugBank ID:DB00336 | CAS RN:59-87-0 | CAS RN:1958113-24-0
+BMGC_DG12032,BMG_DG164238,"CAS RN:80125-14-0 | DrugBank ID:DB00409 | CAS RN:78810-02-3 | UNII:0223RD59PE | REMOXIPRIDE | PubChem SID:198968595 | 3-bromo-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2,6-dimethoxybenzamide | Remoxipride | PubChem CID:54477"
+BMGC_DG12033,BMG_DG164251,PubChem SID:198961275 | Arsenous acid | ARSENOUS ACID | DrugBank ID:DB04456 | CAS RN:13464-58-9 | arsorous acid | PubChem CID:545 | UNII:935XD1L5K2
+BMGC_DG12034,BMG_DG164262,CAS RN:107388-89-6 | CAS RN:50-52-2 | PubChem CID:5452 | 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine | Thioridazine | THIORIDAZINE | PubChem SID:175271767 | DrugBank ID:DB00679 | UNII:N3D6TG58NI
+BMGC_DG12035,BMG_DG164271,NDC:25021-246 | CAS RN:52-24-4 | NDC:0143-9292 | NDC:72205-045 | NDC:0143-9565 | THIOTEPA | NDC:81927-105 | NDC:0143-9309 | PubChem SID:175265296 | UNII:905Z5W3GKH | DrugBank ID:DB04572 | PubChem CID:5453 | NDC:65219-029 | NDC:70121-1631 | NDC:70121-1630 | CAS RN:1631739-26-8 | Thiotepa | NDC:71288-157 | NDC:43598-650 | NDC:71288-156 | NDC:43598-171 | tris(aziridin-1-yl)-sulfanylidene-lambda5-phosphane | NDC:72205-046 | NDC:68083-503 | NDC:68083-446
+BMGC_DG12036,BMG_DG164279,"PubChem CID:5455 | UNII:0D771IS0FH | Thiram | DrugBank ID:DB13245 | CAS RN:137-26-8 | THIRAM | PubChem SID:175266833 | dimethylcarbamothioylsulfanyl N,N-dimethylcarbamodithioate"
+BMGC_DG12037,BMG_DG164291,"Zabofloxacin | PubChem CID:54556623 | 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diazaspiro[3.4]octan-6-yl)-4-oxo-1,8-naphthyridine-3-carboxylic acid | CAS RN:219680-11-2"
+BMGC_DG12038,BMG_DG164297,Thonzonium | PubChem CID:5456 | THONZONIUM | hexadecyl-[2-[(4-methoxyphenyl)methyl-pyrimidin-2-ylamino]ethyl]-dimethylazanium | PubChem SID:175267309 | CAS RN:25466-36-8 | DrugBank ID:DB09552 | UNII:Z05ZE98FV8
+BMGC_DG12039,BMG_DG164302,"CAS RN:85760-74-3 | Quinpirole | QUINPIROLE | UNII:20OP60125T | CAS RN:74196-92-2 | (4aR,8aR)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline | PubChem CID:54562 | CAS RN:80373-22-4 | PubChem SID:198983085"
+BMGC_DG12040,BMG_DG164314,"UNII:R79646H5Z8 | Thonzylamine | CAS RN:91-85-0 | THONZYLAMINE | PubChem CID:5457 | N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyrimidin-2-ylethane-1,2-diamine | PubChem SID:175266656 | DrugBank ID:DB11235"
+BMGC_DG12041,BMG_DG164317,UNII:J6388YJ4YR | Da-6886 | 4-amino-5-chloro-2-methoxy-N-[[1-[3-(triazol-1-yl)propyl]piperidin-4-yl]methyl]benzamide | DrugBank ID:DB12853 | PubChem SID:313183891 | PubChem CID:54575171 | CAS RN:1342815-16-0 | DA-6886
+BMGC_DG12042,BMG_DG164321,"PubChem SID:249493247 | DrugBank ID:DB11891 | CAS RN:1339928-25-4 | N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide | Fimepinostat | PubChem CID:54575456 | FIMEPINOSTAT | UNII:3S9RX35S5X"
+BMGC_DG12043,BMG_DG164322,PubChem CID:54576073 | PubChem SID:249817485 | Tt-301 | UNII:CY416F5NSK | 6-phenyl-4-pyridin-4-yl-3-(4-pyrimidin-2-ylpiperazin-1-yl)pyridazine | DrugBank ID:DB12899 | TT-301 | CAS RN:886208-76-0
+BMGC_DG12044,BMG_DG164323,"Altiratinib | PubChem SID:316914780 | ALTIRATINIB | 1-N'-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide | CAS RN:1345847-93-9 | PubChem CID:54576299 | UNII:T678746713"
+BMGC_DG12045,BMG_DG164325,"UNII:AH2E5UQ11Y | CAS RN:1346528-50-4 | PubChem SID:376072651 | DrugBank ID:DB15173 | N-(4-chloropyridin-3-yl)-4-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]piperazine-1-carboxamide | Jnj-42165279 | PubChem CID:54576693 | JNJ-42165279"
+BMGC_DG12046,BMG_DG164327,CAS RN:2128698-24-6 | UNII:QXD8ZW7UVZ | BI-847325 | PubChem SID:445499173 | PubChem CID:54577344
+BMGC_DG12047,BMG_DG164347,"CAS RN:2468-21-5 | methyl (1R,15R,18R)-17-ethyl-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8,16-pentaene-1-carboxylate | Catharanthine | PubChem SID:198965945 | PubChem CID:5458190 | CATHARANTHINE | UNII:WT0YJV846J"
+BMGC_DG12048,BMG_DG164368,"Artocarpin | 2-(2,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-6-[(E)-3-methylbut-1-enyl]-3-(3-methylbut-2-enyl)chromen-4-one | CAS RN:7608-44-8 | PubChem CID:5458461"
+BMGC_DG12049,BMG_DG164372,BALSALAZIDE | DrugBank ID:DB01014 | CAS RN:80573-04-2 | Balsalazide | PubChem SID:175266453 | 5-[[4-(2-carboxyethylcarbamoyl)phenyl]diazenyl]-2-hydroxybenzoic acid | PubChem CID:54585 | CAS RN:399030-81-0 | UNII:P80AL8J7ZP
+BMGC_DG12050,BMG_DG164390,KAURENOIC ACID | PubChem SID:474491886 | PubChem CID:5458765 | CAS RN:6730-83-2 | UNII:D572D9R2TZ | Kaurenoic acid
+BMGC_DG12051,BMG_DG164416,"Methscopolamine bromide | NDC:72319-030 | METHSCOPOLAMINE BROMIDE | NDC:51991-191 | NDC:76385-100 | PubChem CID:5459110 | CAS RN:155-41-9 | [(1S,2S,4R,5R)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;bromide | NDC:43063-740 | NDC:76385-101 | PubChem SID:175267641 | UNII:RTN51LK7WL | NDC:51991-192 | NDC:72319-029 | NDC:43063-741"
+BMGC_DG12052,BMG_DG164433,"PubChem CID:5459308 | (1R,9S,10S)-3-hydroxy-4,12-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,11-tetraen-13-one | SINOMENINE | CAS RN:115-53-7 | Sinomenine | UNII:63LT81K70N | PubChem SID:198971068"
+BMGC_DG12053,BMG_DG164435,"PubChem CID:5459319 | DrugBank ID:DB01669 | Virginiamycin M1 | CAS RN:21411-53-0 | VIRGINIAMYCIN M1 | (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone | UNII:8W4UOL59AZ | Streptogramin A | PubChem SID:198972490"
+BMGC_DG12054,BMG_DG164442,PubChem SID:482553837 | UNII:LH5A9ZGN2U | DrugBank ID:DB04661 | PubChem CID:5459361 | CAS RN:151057-28-2 | cis-tetracosenoyl sulfatide | N-((1S)-2R-HYDROXY-1-(((3-O-SULFO-.BETA.-D-GALACTOPYRANOSYL)OXY)METHYL)-3E-HEPTADECEN-1-YL)-15Z-TETRACOSENAMIDE | N-[(1S)-2R-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3E-heptadecen-1-yl]-15Z-tetracosenamide
+BMGC_DG12055,BMG_DG164445,DrugBank ID:DB04715 | PubChem CID:5459373 | IMIDAZOPYRIDAZIN 1
+BMGC_DG12056,BMG_DG164446,PubChem CID:5459374 | (2S)-2-cyano-1-(4-phenyl-L-phenylalanyl)pyrrolidine | DrugBank ID:DB08024
+BMGC_DG12057,BMG_DG164463,DrugBank ID:DB04072 | Alpha-Methylisocitric Acid | PubChem CID:5459784
+BMGC_DG12058,BMG_DG164466,(2S)-2-hydroxybutanedioate | PubChem CID:5459792 | (S)-malate(2-)
+BMGC_DG12059,BMG_DG164472,"1-[3-(2,6-dimethylphenoxy)propyl]-4-(2-methoxyphenyl)piperazine;hydrochloride | PubChem CID:54598062 | 1-[(2,6-Dimethylphenoxy)propyl]-4-(2-methoxyphenyl)piperazine hydrochloride"
+BMGC_DG12060,BMG_DG164477,"DrugBank ID:DB04351 | (Z)-prop-1-ene-1,2,3-tricarboxylate | Aconitate Ion | PubChem CID:5459816"
+BMGC_DG12061,BMG_DG164482,"CAS RN:651-54-7 | 5alpha-Cholesta-7,24-dien-3beta-ol | PubChem CID:5459827 | (3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"
+BMGC_DG12062,BMG_DG164487,"UNII:779A7KPL0Y | PubChem SID:198985276 | CAS RN:5289-74-7 | PubChem CID:5459840 | 20-HYDROXYECDYSONE | (2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6-one | 20-Hydroxyecdysone"
+BMGC_DG12063,BMG_DG164488,Anthranilate | CAS RN:9031-59-8 | PubChem CID:5459842 | 2-aminobenzoate
+BMGC_DG12064,BMG_DG164497,"PubChem CID:5459861 | .ALPHA.-GLYCEROPHOSPHORYLETHANOLAMINE, (S)- | 2-aminoethyl [(2S)-2,3-dihydroxypropyl] hydrogen phosphate | DrugBank ID:DB03484 | PubChem SID:255509324 | UNII:966T5WN0AC | sn-glycero-3-phosphoethanolamine | Phosphoric acid, MONO(2-aminoethyl) mono((2S)-2,3-dihydroxypropyl) ester | CAS RN:59734-15-5"
+BMGC_DG12065,BMG_DG164502,"(3S,4R,5R,6R)-1,3,4,5,6,7-hexahydroxyheptan-2-one | D-SEDOHEPTULOSE | UNII:40A0W1XJ6X | Sedoheptulose | PubChem SID:363909821 | CAS RN:3019-74-7 | CAS RN:470-46-2 | PubChem CID:5459879"
+BMGC_DG12066,BMG_DG164515,"DrugBank ID:DB02236 | N(1)-(5-Phospho-D-ribosyl)glycinamide | PubChem CID:5459918 | Glycinamide Ribonucleotide | [(2R,3S,4R)-5-[(2-aminoacetyl)amino]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate"
+BMGC_DG12067,BMG_DG164541,PHOSPHONOACETIC ACID | CAS RN:7230-09-3 | UNII:N919E46723 | CAS RN:4408-78-0 | Phosphonoacetic Acid | PubChem CID:546 | DrugBank ID:DB02823 | CAS RN:36983-81-0 | 2-phosphonoacetic acid | Phosphonoacetic acid | PubChem SID:198983392
+BMGC_DG12068,BMG_DG164542,"PubChem SID:198991200 | PubChem CID:5460005 | CAS RN:533-67-5 | 2-DEOXYRIBOSE, D- | UNII:LSW4H01241"
+BMGC_DG12069,BMG_DG164546,PubChem CID:5460022 | CAS RN:499-40-1 | ISOMALTOSE | UNII:67I334IX2M | PubChem SID:198947122
+BMGC_DG12070,BMG_DG164548,CAS RN:585-99-9 | UNII:9B1VBE526I | PubChem CID:5460027 | PubChem SID:198954685 | MELIBIOSE
+BMGC_DG12071,BMG_DG164556,"ISOMALTOTRIOSE | PubChem CID:5460037 | CAS RN:3371-50-4 | PubChem SID:461434876 | (2R,3S,4R,5R)-2,3,4,5-tetrahydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal | UNII:L3L3XYP7MP | O-alpha-D-Glucopyranosyl-(1.6)-O-alpha-D-glucopyranosyl-(1.6)-D-glucose"
+BMGC_DG12072,BMG_DG164563,trans-Urocanate | CAS RN:104-98-3 | (E)-3-(1H-imidazol-5-yl)prop-2-enoate | PubChem CID:5460052
+BMGC_DG12073,BMG_DG164602,"PubChem SID:315658383 | (2S)-2-hydroxypropanoate | L-lactate | LACTATE ION, L- | PubChem CID:5460161 | CAS RN:72-08-2 | UNII:435SSH7H89"
+BMGC_DG12074,BMG_DG164604,"PubChem CID:5460172 | 1-hydroxypropane-1,2,3-tricarboxylate | 1-Hydroxypropane-1,2,3-tricarboxylate"
+BMGC_DG12075,BMG_DG164610,"CAS RN:13408-78-1 | Cob(II)alamin | CAS RN:18534-66-2 | PubChem CID:5460183 | CAS RN:14463-33-3 | cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate"
+BMGC_DG12076,BMG_DG164625,(Z)-octadec-9-enoate | PubChem CID:5460221 | CAS RN:115-06-0 | Oleate
+BMGC_DG12077,BMG_DG164647,"ARABINOSE, L- | PubChem SID:198971480 | (2R,3S,4S)-2,3,4,5-tetrahydroxypentanal | UNII:B40ROO395Z | CAS RN:147-81-9 | PubChem CID:5460291 | CAS RN:5328-37-0"
+BMGC_DG12078,BMG_DG164659,"PubChem CID:5460316 | N-(3alpha,7alpha,12alpha-trihydroxy-5beta-cholan-24-oyl)glycinate | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetate | DrugBank ID:DB02691 | Glycocholic acid"
+BMGC_DG12079,BMG_DG164664,"PubChem CID:5460332 | Linoleate | (9Z,12Z)-octadeca-9,12-dienoate | CAS RN:1509-85-9"
+BMGC_DG12080,BMG_DG164667,Calcium | NDC:55259-0001 | NDC:55259-1112 | DrugBank ID:DB01373 | PubChem CID:5460341 | UNII:SY7Q814VUP | NDC:55259-1113 | calcium | NDC:55259-0007 | NDC:55259-1116 | NDC:55259-1161 | CAS RN:7440-70-2 | CALCIUM
+BMGC_DG12081,BMG_DG164678,D-alanyl-D-alanine | D-ALANYL-D-ALANINE | PubChem CID:5460362 | UNII:1BVK9QMW8G | CAS RN:923-16-0 | PubChem SID:318691674 | (2R)-2-[[(2R)-2-aminopropanoyl]amino]propanoic acid
+BMGC_DG12082,BMG_DG164695,"L-threonic acid | CAS RN:7306-96-9 | PubChem SID:198964502 | THREONIC ACID, L- | UNII:75B0PMW2JF | (2R,3S)-2,3,4-trihydroxybutanoic acid | DrugBank ID:DB11192 | PubChem CID:5460407"
+BMGC_DG12083,BMG_DG164697,"(6S)-5,6,7,8-tetrahydrofolic acid | PubChem CID:5460413 | DrugBank ID:DB02031"
+BMGC_DG12084,BMG_DG164734,"CAS RN:68-19-9 | Rubramin | PubChem CID:54605677 | cobalt(2+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl hydrogen phosphate;cyanide"
+BMGC_DG12085,BMG_DG164775,"[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]methyl phosphate | CAS RN:488-69-7 | PubChem CID:5460765 | Fructose 1,6-bisphosphate"
+BMGC_DG12086,BMG_DG164782,"2-amino-5-[[1-(carboxymethylamino)-3-[[(4R,5S)-4-hydroxy-11-methoxy-16,18-dioxo-6,8,19-trioxapentacyclo[10.7.0.02,9.03,7.013,17]nonadeca-1,9,11,13(17)-tetraen-5-yl]sulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | CAS RN:68385-50-2 | PubChem CID:5460816 | Aflatoxin B1exo-8,9-epoxide-GSH"
+BMGC_DG12087,BMG_DG164811,"PubChem CID:5461005 | alpha-Linolenate | (9Z,12Z,15Z)-octadeca-9,12,15-trienoate"
+BMGC_DG12088,BMG_DG164813,Petroselinate | PubChem CID:5461010 | (Z)-octadec-6-enoate
+BMGC_DG12089,BMG_DG164821,MANNINOTRIOSE | CAS RN:13382-86-0 | UNII:2UTE2T5KRE | PubChem SID:461432964 | PubChem CID:5461026
+BMGC_DG12090,BMG_DG164828,PubChem CID:5461071 | (E)-octadec-9-enoate | Elaidate
+BMGC_DG12091,BMG_DG164834,"PubChem CID:5461108 | [[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate"
+BMGC_DG12092,BMG_DG164866,PubChem SID:445498908 | PubChem CID:5462194 | CAS RN:6778-30-9 | CROTONOBETAINE | (E)-4-(trimethylazaniumyl)but-2-enoate | CAS RN:927-89-9 | UNII:ZJ9SA2P3K7 | (E)-4-(trimethylammonio)but-2-enoate
+BMGC_DG12093,BMG_DG164871,NDC:37662-1523 | MAGNESIUM | DrugBank ID:DB14513 | UNII:I38ZP9992A | PubChem CID:5462224 | NDC:13411-868 | NDC:37662-1528 | NDC:37662-1527 | NDC:37662-1521 | NDC:37662-1522 | CAS RN:7439-95-4 | Magnesium | magnesium | NDC:37662-1525 | NDC:37662-1524 | NDC:37662-1526
+BMGC_DG12094,BMG_DG164885,"PubChem CID:5462328 | CAS RN:561-27-3 | [(4R,4aR,7S,7aR,12bS)-9-acetyloxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] acetate | Diamorphine | PubChem SID:175268259 | Heroin | UNII:70D95007SX | DIAMORPHINE | DrugBank ID:DB01452"
+BMGC_DG12095,BMG_DG164901,"PubChem SID:478838668 | CAS RN:103548-82-9 | DrugBank ID:DB03348 | PubChem CID:5462442 | UNII:DC3Z5425Y5 | Huperzine B | Huperzine B, (-)- | (1R,9R,10R)-16-methyl-6,14-diazatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,16-trien-5-one | HUPERZINE B, (-)- | CAS RN:195964-68-2"
+BMGC_DG12096,BMG_DG164906,UNII:2YM5VT3MNR | Damgo | CAS RN:950492-85-0 | DAMGO | PubChem SID:482554176 | PubChem CID:5462471 | (2S)-2-amino-N-[(2R)-1-[[2-[[(2S)-1-(2-hydroxyethylamino)-1-oxo-3-phenylpropan-2-yl]-methylamino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide | CAS RN:78123-71-4
+BMGC_DG12097,BMG_DG164907,CAS RN:76420-72-9 | Enalaprilat | PubChem SID:175266379 | PubChem CID:5462501 | ENALAPRILAT ANHYDROUS | DrugBank ID:DB09477 | UNII:Q508Q118JM | (2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
+BMGC_DG12098,BMG_DG164909,PubChem SID:316918043 | PubChem CID:5462505 | HETEROCODEINE | CAS RN:639-47-4 | UNII:SBO5K94K8L
+BMGC_DG12099,BMG_DG164925,AZODICARBONAMIDE | Azodicarbonamide | PubChem SID:198956996 | (E)-carbamoyliminourea | UNII:56Z28B9C8O | PubChem CID:5462814 | CAS RN:123-77-3
+BMGC_DG12100,BMG_DG164943,"2,3-bis[[(Z)-docos-13-enoyl]oxy]propyl (Z)-docos-13-enoate | DrugBank ID:DB12528 | Trierucin | UNII:I0IDQ0M20R | CAS RN:2752-99-0 | PubChem CID:5463075 | Glyceryl Trierucate | GLYCERYL TRIERUCATE | PubChem SID:198961166"
+BMGC_DG12101,BMG_DG164961,"PubChem SID:459055623 | PubChem CID:5463294 | UNII:RK70V910L8 | BENZENESULFONIC ACID, 2,2'-((E)-1,2-ETHENEDIYL)BIS(5-((E)-(2-AMINO-1-NAPHTHALENYL)AZO)- | CAS RN:5437-12-7"
+BMGC_DG12102,BMG_DG164986,"Norlevorphanol | MORPHINAN-3-OL, (+/-)- | PubChem SID:445500342 | UNII:E4S6LA88PG | MORPHINAN-3-OL, (±)- | NORLEVORPHANOL | PubChem SID:198981360 | CAS RN:39131-41-4 | CAS RN:1531-12-0 | UNII:IL94262N7K | PubChem CID:5463854 | (1R,9R,10R)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol"
+BMGC_DG12103,BMG_DG165020,"UNII:JRM708L703 | DrugBank ID:DB14125 | PubChem CID:5463984 | BENAZEPRILAT | PubChem SID:175266785 | (2S)-2-[[(3S)-1-(carboxymethyl)-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]amino]-4-phenylbutanoic acid | CAS RN:86541-78-8 | CAS RN:89747-91-1 | Benazeprilat"
+BMGC_DG12104,BMG_DG165026,"UNII:G7HS6P8ZEC | .GAMMA.-MANGOSTIN | gamma-Mangostin | PubChem CID:5464078 | PubChem SID:441331799 | CAS RN:31271-07-5 | 1,3,6,7-tetrahydroxy-2,8-bis(3-methylbut-2-enyl)xanthen-9-one"
+BMGC_DG12105,BMG_DG165031,"UNII:6N5U4QFC3G | CAS RN:87269-97-4 | DrugBank ID:DB14208 | RAMIPRILAT | PubChem CID:5464096 | Ramiprilat | (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid | PubChem SID:175266555"
+BMGC_DG12106,BMG_DG165032,"PubChem SID:175266851 | PubChem CID:5464097 | UNII:RR6866VL0O | TRANDOLAPRILAT | DrugBank ID:DB14209 | Trandolaprilat | (2S,3aR,7aS)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid | CAS RN:87679-71-8"
+BMGC_DG12107,BMG_DG165060,"tert-butyl (2S)-2-[[(2S)-1-[[(2S)-1-[[(4S,5S,7S)-5-hydroxy-2,8-dimethyl-7-[[(2S,3S)-3-methyl-1-oxo-1-(pyridin-2-ylmethylamino)pentan-2-yl]carbamoyl]nonan-4-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-methylamino]-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidine-1-carboxylate | PubChem SID:198963697 | UNII:5355S3W1IS | DITEKIREN | Ditekiren | CAS RN:103336-05-6 | PubChem CID:5464201"
+BMGC_DG12108,BMG_DG165078,PubChem SID:198977171 | PubChem CID:5464343 | Imidapril | (4S)-3-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid | DrugBank ID:DB11783 | IMIDAPRIL | CAS RN:89371-37-9 | UNII:BW7H1TJS22
+BMGC_DG12109,BMG_DG165079,IMIDAPRILAT | CAS RN:89371-44-8 | UNII:WUU07Y30IA | PubChem CID:5464344 | PubChem SID:198985989 | Imidaprilat | (4S)-3-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-1-methyl-2-oxoimidazolidine-4-carboxylic acid
+BMGC_DG12110,BMG_DG165083,UNII:CT1Q4E0I0W | Velutin | PubChem CID:5464381 | CAS RN:25739-41-7 | 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-methoxychromen-4-one | PubChem SID:241177446 | VELUTIN
+BMGC_DG12111,BMG_DG165114,"CAS RN:156306-84-2 | 6,8-BIS(4-(DIMETHYLAMINO)BENZYL)-1,4-DIHYDROXY-7H-BENZO(A)CYCLOHEPTEN-7-ONE | PubChem CID:5466111 | PubChem SID:377309177 | UNII:N8DHY7XG29"
+BMGC_DG12112,BMG_DG165116,"PubChem CID:5466139 | 8-Hydroxydaidzein | CAS RN:75187-63-2 | 7,8-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one | UNII:7KW44TB2DE | 4',7,8-TRIHYDROXYISOFLAVONE | PubChem SID:459055877"
+BMGC_DG12113,BMG_DG165123,UNII:LAH70H9JPH | PubChem CID:5467 | Tiapride | PubChem SID:198958497 | CAS RN:51012-32-9 | TIAPRIDE | DrugBank ID:DB13025 | N-[2-(diethylamino)ethyl]-2-methoxy-5-methylsulfonylbenzamide
+BMGC_DG12114,BMG_DG165124,"NDC:84785-0053 | NDC:84423-045 | NDC:83872-094 | NDC:84785-0054 | NDC:84025-143 | PubChem SID:175266339 | NDC:84186-006 | (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-5-one | NDC:84423-017 | NDC:84509-018 | NDC:63044-632 | NDC:84423-031 | NDC:84025-261 | NDC:84660-024 | NDC:83872-473 | NDC:84423-018 | NDC:83872-145 | NDC:83872-081 | NDC:84858-1010 | NDC:83872-457 | NDC:83872-029 | NDC:10542-012 | NDC:63044-633 | NDC:83872-447 | NDC:84785-0004 | NDC:84025-071 | NDC:84423-042 | NDC:10542-010 | NDC:84423-061 | NDC:83872-068 | NDC:72162-1659 | NDC:58264-0214 | NDC:84350-022 | NDC:52747-711 | NDC:59088-237 | CAS RN:53262-66-1 | NDC:84509-017 | NDC:84660-029 | NDC:58657-323 | NDC:74458-333 | NDC:83325-007 | NDC:17089-416 | NDC:83566-122 | NDC:52747-712 | NDC:84785-0003 | NDC:75854-320 | NDC:83566-234 | NDC:84025-163 | NDC:84423-060 | NDC:84423-040 | NDC:83872-144 | UNII:PQ6CK8PD0R | NDC:83872-093 | NDC:83566-288 | NDC:84025-299 | NDC:83872-165 | NDC:83872-077 | NDC:63629-1141 | NDC:83872-463 | NDC:52747-620 | NDC:67157-101 | NDC:84020-0001 | Ascorbic acid | NDC:83872-355 | NDC:83872-296 | NDC:83018-0003 | NDC:83872-461 | NDC:58657-324 | NDC:84867-008 | NDC:84423-055 | NDC:74458-100 | NDC:84732-039 | NDC:83566-199 | NDC:84732-016 | NDC:0178-0089 | NDC:43857-0454 | NDC:63044-635 | NDC:83021-686 | NDC:83872-074 | NDC:83872-080 | NDC:83872-143 | CAS RN:50-81-7 | NDC:63044-631 | NDC:84732-062 | NDC:84509-016 | Ascorbic Acid | NDC:43857-0513 | NDC:84423-062 | DrugBank ID:DB00126 | NDC:83872-298 | NDC:43857-0555 | NDC:83872-297 | NDC:83872-203 | CAS RN:6730-29-6 | NDC:84423-021 | NDC:84660-018 | NDC:74458-199 | NDC:83872-166 | NDC:83872-294 | NDC:84712-008 | NDC:83872-079 | NDC:52747-621 | NDC:59088-236 | NDC:83566-601 | NDC:84025-154 | NDC:83872-142 | ASCORBIC ACID | NDC:83872-096 | NDC:84509-019 | NDC:83872-095 | NDC:74458-268 | NDC:75854-344 | NDC:83872-119 | NDC:84025-189 | NDC:83872-082 | NDC:84025-162 | NDC:84660-030 | NDC:83872-070 | NDC:83872-078 | NDC:83872-299 | NDC:83872-073 | NDC:13411-848 | NDC:83872-528 | NDC:84423-056 | NDC:83872-295 | PubChem CID:54670067"
+BMGC_DG12115,BMG_DG165126,"PubChem CID:54671008 | N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide | RALTEGRAVIR | UNII:22VKV8053U | DrugBank ID:DB06817 | CAS RN:518048-05-0 | PubChem SID:175267085 | Raltegravir"
+BMGC_DG12116,BMG_DG165127,"CAS RN:7164-70-7 | CAS RN:564-25-0 | UNII:334895S862 | NDC:70436-032 | Doxycycline | PubChem CID:54671203 | DOXYCYCLINE ANHYDROUS | PubChem SID:175268616 | CAS RN:24390-14-5 | DrugBank ID:DB00254 | (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | NDC:70436-201"
+BMGC_DG12117,BMG_DG165143,"DrugBank ID:DB15456 | NDC:0006-5029 | Vericiguat | UNII:LV66ADM269 | CAS RN:1350653-20-1 | NDC:0006-5028 | NDC:0006-5030 | PubChem CID:54674461 | VERICIGUAT | PubChem SID:198984636 | methyl N-[4,6-diamino-2-[5-fluoro-1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]carbamate"
+BMGC_DG12118,BMG_DG165144,"PubChem SID:198964026 | PubChem CID:5467477 | 4,4'-DIHYDROXYCHALCONE, (E)- | UNII:CKY3J88Z94 | CAS RN:108997-30-4"
+BMGC_DG12119,BMG_DG165150,UNII:S1S883S4EE | 4-Hydroxy-6-methyl-2-pyrone | CAS RN:675-10-5 | 4-hydroxy-6-methylpyran-2-one | CAS RN:70254-61-4 | PubChem CID:54675757 | 4-HYDROXY-6-METHYL-2-PYRONE | PubChem SID:198939461
+BMGC_DG12120,BMG_DG165154,"CAS RN:1476-53-5 | [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate | UNII:17EC19951N | PubChem CID:54675769 | Novobiocin | CAS RN:303-81-1 | DrugBank ID:DB01051 | NOVOBIOCIN | PubChem SID:198987311"
+BMGC_DG12121,BMG_DG165156,"Tetracycline | UNII:F8VB5M810T | (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide | CAS RN:60-54-8 | PubChem CID:54675776 | TETRACYCLINE | DrugBank ID:DB00759 | PubChem SID:175266305"
+BMGC_DG12122,BMG_DG165157,"Chlortetracycline | DrugBank ID:DB09093 | (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide | UNII:WCK1KIQ23Q | PubChem SID:175267136 | PubChem CID:54675777 | CAS RN:57-62-5 | CHLORTETRACYCLINE"
+BMGC_DG12123,BMG_DG165158,"DrugBank ID:DB00595 | OXYTETRACYCLINE ANHYDROUS | CAS RN:79-57-2 | PubChem SID:175267151 | (4S,4aR,5S,5aR,6S,12aR)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide | UNII:SLF0D9077S | Oxytetracycline | PubChem CID:54675779"
+BMGC_DG12124,BMG_DG165159,"PubChem CID:54675783 | PubChem SID:175266028 | (4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | MINOCYCLINE | UNII:FYY3R43WGO | CAS RN:10118-90-8 | Minocycline | DrugBank ID:DB01017"
+BMGC_DG12125,BMG_DG165160,"UNII:IR235I7C5P | CAS RN:914-00-1 | DrugBank ID:DB00931 | PubChem CID:54675785 | (4S,4aR,5S,5aR,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide | PubChem SID:198940342 | METHACYCLINE | Methacycline | Metacycline"
+BMGC_DG12126,BMG_DG165172,P-HYDROXYBENZOATE ANION | 4-Hydroxybenzoate | 4-carboxyphenolate | DrugBank ID:DB04242 | UNII:8MJB9HSC8Q | PubChem SID:459275497 | CAS RN:456-23-5 | PubChem CID:54675830
+BMGC_DG12127,BMG_DG165188,CAS RN:63-36-5 | PubChem CID:54675850 | 2-carboxyphenolate | Salicylate
+BMGC_DG12128,BMG_DG165195,Vanillic acid | Vanillate | 4-carboxy-2-methoxyphenolate | PubChem CID:54675858 | DrugBank ID:DB02130
+BMGC_DG12129,BMG_DG165202,"PubChem CID:54675866 | DrugBank ID:DB03946 | 3,4-Dihydroxybenzoate | 4-carboxy-2-hydroxyphenolate"
+BMGC_DG12130,BMG_DG165214,PubChem CID:54676038 | PubChem SID:198984501 | Dicumarol | UNII:7QID3E7BG7 | Dicoumarol | CAS RN:66-76-2 | DrugBank ID:DB00266 | DICUMAROL | 4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one
+BMGC_DG12131,BMG_DG165217,"NDC:72789-211 | NDC:42571-176 | NDC:0093-0757 | NDC:70771-1430 | PubChem CID:54676228 | NDC:64380-843 | NDC:29300-256 | PIROXICAM | NDC:42291-953 | NDC:59762-0140 | NDC:70771-1429 | NDC:42571-177 | NDC:72162-1291 | DrugBank ID:DB00554 | NDC:71335-1999 | CAS RN:36322-90-4 | NDC:71335-2067 | PubChem SID:175266799 | NDC:72789-210 | NDC:29033-013 | NDC:71205-203 | CAS RN:1044566-76-8 | NDC:63187-972 | NDC:0093-0756 | NDC:63629-9149 | NDC:42291-677 | 4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-yl-1lambda6,2-benzothiazine-3-carboxamide | NDC:72162-1290 | NDC:29033-012 | NDC:71205-032 | NDC:29300-255 | NDC:64380-842 | Piroxicam | NDC:42291-954 | NDC:63629-9150 | NDC:72189-350 | NDC:63629-9148 | UNII:13T4O6VMAM | NDC:71335-9622 | NDC:42291-674"
+BMGC_DG12132,BMG_DG165221,"UNII:372T2944C0 | CAS RN:84088-42-6 | ROQUINIMEX | 4-hydroxy-N,1-dimethyl-2-oxo-N-phenylquinoline-3-carboxamide | Roquinimex | PubChem CID:54676478 | DrugBank ID:DB11366 | PubChem SID:198947673"
+BMGC_DG12133,BMG_DG165224,PubChem CID:54676537 | CAS RN:152-72-7 | ACENOCOUMAROL | Acenocoumarol | PubChem SID:175271626 | 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]chromen-2-one | DrugBank ID:DB01418 | UNII:I6WP63U32H
+BMGC_DG12134,BMG_DG165226,"(4S,4aR,5S,5aR,12aR)-7-chloro-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide | CAS RN:2013-58-3 | PubChem SID:198972460 | MECLOCYCLINE | DrugBank ID:DB13092 | Meclocycline | UNII:23Q8M2HE6S | PubChem CID:54676539"
+BMGC_DG12135,BMG_DG165230,"DrugBank ID:DB03064 | PubChem CID:54676715 | 3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline"
+BMGC_DG12136,BMG_DG165247,"NDC:70518-0200 | NDC:42708-007 | NDC:68382-051 | NDC:50090-6803 | NDC:60760-419 | NDC:68462-141 | NDC:68071-1994 | NDC:82804-029 | NDC:69097-158 | NDC:72865-137 | NDC:60760-448 | NDC:82009-130 | NDC:80425-0043 | NDC:68180-502 | NDC:71610-542 | NDC:31722-227 | NDC:71610-544 | NDC:29300-124 | NDC:76420-043 | NDC:50090-5339 | NDC:71610-580 | NDC:71610-872 | NDC:72789-403 | NDC:68071-1993 | PubChem CID:54677470 | NDC:49999-869 | NDC:63187-082 | NDC:70518-2631 | NDC:35356-808 | NDC:71205-924 | NDC:71205-923 | NDC:82009-129 | NDC:63629-2019 | NDC:80425-0041 | NDC:50268-526 | NDC:70518-3023 | NDC:76282-152 | NDC:70954-077 | NDC:67296-1460 | NDC:64380-716 | NDC:76420-039 | NDC:70518-1630 | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide | NDC:43063-395 | NDC:51655-177 | NDC:76282-153 | NDC:68788-8801 | NDC:68788-7904 | NDC:43602-623 | DrugBank ID:DB00814 | NDC:68071-3030 | NDC:0615-8040 | NDC:43063-396 | NDC:60760-653 | NDC:72919-124 | NDC:80425-0042 | NDC:68180-189 | NDC:16571-777 | NDC:61442-127 | NDC:63629-3328 | NDC:50090-6832 | NDC:60760-404 | MELOXICAM | NDC:11788-098 | NDC:11788-099 | NDC:55289-272 | NDC:60687-199 | NDC:43602-624 | NDC:68788-8758 | NDC:68788-7726 | NDC:70518-0039 | CAS RN:71125-38-7 | NDC:71610-657 | Meloxicam | NDC:72162-1738 | NDC:67046-1323 | NDC:71740-339 | NDC:65862-098 | NDC:68071-2184 | NDC:65841-051 | NDC:65862-097 | NDC:42708-093 | NDC:80425-0083 | NDC:50090-6672 | NDC:61442-126 | NDC:72789-446 | NDC:51655-731 | NDC:80425-0045 | NDC:69097-159 | NDC:0615-8124 | NDC:67296-0823 | NDC:71610-516 | NDC:71335-1888 | NDC:31722-226 | UNII:VG2QF83CGL | CAS RN:133687-22-6 | NDC:51655-571 | NDC:71610-583 | NDC:71335-0406 | NDC:71335-2080 | NDC:68462-140 | PubChem SID:175265774 | NDC:43063-401 | NDC:67296-0583 | NDC:72789-402 | NDC:70518-1828 | NDC:68180-188 | NDC:51407-610 | NDC:65841-050 | NDC:51407-611 | NDC:43353-979 | NDC:51655-577 | NDC:64380-715 | NDC:72789-447 | NDC:50090-5340 | NDC:62135-716 | NDC:29300-125 | NDC:62135-715 | NDC:63187-083 | NDC:71335-1956 | NDC:50090-6671 | NDC:63629-3248 | NDC:68180-501 | NDC:50090-5861 | NDC:72865-138 | NDC:67296-1817 | NDC:80425-0044 | NDC:50268-525 | NDC:70954-076 | NDC:71335-2327 | NDC:68382-050 | NDC:16571-776"
+BMGC_DG12137,BMG_DG165248,"PubChem CID:54677674 | 4-hydroxy-6-oxo-N-(3-piperidin-1-ylpropyl)-7-propan-2-ylthieno[2,3-b]pyridine-5-carboxamide | PubChem SID:198947109 | CAS RN:869493-21-0 | UNII:7QGN8QXG7I | 4-Hydroxy-7-isopropyl-6-oxo-n-(3-(1-piperidinyl)propyl)-6,7-dihydrothieno(2,3-b)pyridine-5-carboxamide | PRX-03140 | DrugBank ID:DB05596"
+BMGC_DG12138,BMG_DG165251,"PubChem CID:54677846 | 3,4-Dihydroxy-1,2-dihydroquinolin-2-one | 3,4-DIHYDROXY-1,2-DIHYDROQUINOLIN-2-ONE | PubChem SID:474492267 | CAS RN:219858-36-3 | UNII:Y2MM5BD5JP"
+BMGC_DG12139,BMG_DG165253,PubChem SID:198987470 | PubChem CID:54677946 | DrugBank ID:DB06685 | CAS RN:248281-84-7 | UNII:908SY76S4G | 5-chloro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenylquinoline-3-carboxamide | LAQUINIMOD | Laquinimod
+BMGC_DG12140,BMG_DG165254,"4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide | PubChem SID:175268475 | CAS RN:59804-37-4 | PubChem CID:54677971 | DrugBank ID:DB00469 | Tenoxicam | UNII:Z1R9N0A399 | TENOXICAM"
+BMGC_DG12141,BMG_DG165255,"UNII:8XU734C4NG | PubChem CID:54677972 | DrugBank ID:DB08942 | ISOXICAM | Isoxicam | 4-hydroxy-2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide | PubChem SID:198968917 | CAS RN:34552-84-6"
+BMGC_DG12142,BMG_DG165270,Warfarin | UNII:5Q7ZVV76EI | PubChem SID:175271416 | CAS RN:81-81-2 | CAS RN:5543-58-8 | DrugBank ID:DB00682 | PubChem CID:54678486 | 4-hydroxy-3-(3-oxo-1-phenylbutyl)chromen-2-one | WARFARIN | CAS RN:951658-59-6
+BMGC_DG12143,BMG_DG165274,UNII:2997C5EZ2N | CAS RN:1516773-58-2 | PubChem SID:474491909 | 3-[(4-chlorophenyl)-(4-hydroxy-2-oxochromen-3-yl)methyl]-4-hydroxychromen-2-one | 3-((4-CHLOROPHENYL)-(4-HYDROXY-2-OXOCHROMEN-3-YL)METHYL)-4-HYDROXYCHROMEN-2-ONE | PubChem CID:54678493
+BMGC_DG12144,BMG_DG165281,"Metastat | CAS RN:15866-90-7 | UNII:21G64WZQ4I | PubChem SID:198948649 | Incyclinide | DrugBank ID:DB11647 | (4aS,5aR,12aR)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | INCYCLINIDE | PubChem CID:54678924"
+BMGC_DG12145,BMG_DG165282,PubChem CID:54678950 | 6-heptyl-4-hydroxypyran-2-one | CAS RN:90632-45-4 | 6-heptyl-4-hydroxy-2H-pyran-2-one
+BMGC_DG12146,BMG_DG165286,"PubChem CID:54679182 | 4-Des-dimethylaminotetracycline | CAS RN:2444-65-7 | (4aS,5aS,6S,12aR)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide"
+BMGC_DG12147,BMG_DG165289,CAS RN:1349387-07-0 | CAS RN:103766-25-2 | 5-chloro-4-hydroxy-1H-pyridin-2-one | PubChem CID:54679224 | DrugBank ID:DB09257 | GIMERACIL | PubChem SID:198988990 | Gimeracil | UNII:UA8SE1325T
+BMGC_DG12148,BMG_DG165295,"PubChem SID:198938486 | CAS RN:24683-26-9 | UNII:EAD64Z1YS1 | PubChem CID:54679348 | 4-HYDROXY-2-METHYL-2H-1,2-BENZOTHIAZINE-3-CARBOXYLIC ACID ETHYLESTER 1,1-DIOXIDE"
+BMGC_DG12149,BMG_DG165301,PubChem CID:5468 | DrugBank ID:DB01600 | TIAPROFENIC ACID | UNII:1LS1T6R34C | PubChem SID:198977282 | Tiaprofenic acid | 2-(5-benzoylthiophen-2-yl)propanoic acid | Tiaprofenic Acid | CAS RN:33005-95-7
+BMGC_DG12150,BMG_DG165309,"Ascorbyl palmitate | ASCORBYL PALMITATE | [(2S)-2-[(2R)-3,4-dihydroxy-5-oxo-2H-furan-2-yl]-2-hydroxyethyl] hexadecanoate | UNII:QN83US2B0N | PubChem CID:54680660 | CAS RN:137-66-6 | PubChem SID:175268952"
+BMGC_DG12151,BMG_DG165310,"UNII:YP0241BU76 | PubChem SID:198938825 | (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-N-(hydroxymethyl)-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide | CAS RN:1181-54-0 | CLOMOCYCLINE | Clomocycline | PubChem CID:54680675 | DrugBank ID:DB00453"
+BMGC_DG12152,BMG_DG165311,"PubChem SID:198955109 | PubChem CID:54680676 | CAS RN:80449-88-3 | CAS RN:56073-10-0 | BRODIFACOUM | UNII:A25P3CP5S7 | Brodifacoum | 3-[3-[4-(4-bromophenyl)phenyl]-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxychromen-2-one"
+BMGC_DG12153,BMG_DG165312,"CAS RN:127-33-3 | UNII:5R5W9ICI6O | (4S,4aS,5aS,6S,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | CAS RN:1165453-98-4 | DrugBank ID:DB00618 | PubChem SID:175266411 | DEMECLOCYCLINE | PubChem CID:54680690 | Demeclocycline"
+BMGC_DG12154,BMG_DG165314,PubChem CID:54680692 | Phenprocoumon | CAS RN:5999-41-7 | PubChem SID:198989619 | 4-hydroxy-3-(1-phenylpropyl)chromen-2-one | CAS RN:435-97-2 | UNII:Q08SIO485D | PHENPROCOUMON | DrugBank ID:DB00946 | CAS RN:70206-44-9
+BMGC_DG12155,BMG_DG165329,PubChem CID:5468154 | UNII:S2SS9GB3XE | CAS RN:1053056-95-3 | UBISTATIN A | PubChem SID:440090086
+BMGC_DG12156,BMG_DG165332,"4-hydroxy-3-[(1R)-1-phenylpropyl]chromen-2-one | PHENPROCOUMON, (R)- | UNII:Y513Q74WCG | CAS RN:5999-27-9 | CAS RN:599-27-9 | PubChem CID:54681545 | (R)-Phenprocoumon | PubChem SID:310825995"
+BMGC_DG12157,BMG_DG165333,"PubChem SID:198940295 | (4S,4aS,5aR,12aR)-4-(dimethylamino)-1,10,11,12a-tetrahydroxy-7-[[methoxy(methyl)amino]methyl]-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | PubChem CID:54681908 | UNII:94O110CX2E | DrugBank ID:DB12035 | Sarecycline | SARECYCLINE | CAS RN:1035654-66-0"
+BMGC_DG12158,BMG_DG165335,CAS RN:64425-90-7 | CHOLINE MAGNESIUM TRISALICYLATE | UNII:DJJ95FJP1H | PubChem SID:175267443 | Choline Magnesium Trisalicylate | DrugBank ID:DB01401 | PubChem CID:54682045 | Choline magnesium trisalicylate | magnesium;2-carboxyphenolate;2-hydroxyethyl(trimethyl)azanium
+BMGC_DG12159,BMG_DG165344,UNII:ZZT404XD09 | Tipranavir | TIPRANAVIR | DrugBank ID:DB00932 | NDC:0597-0003 | PubChem CID:54682461 | N-[3-[(1R)-1-[(2R)-4-hydroxy-6-oxo-2-(2-phenylethyl)-2-propyl-3H-pyran-5-yl]propyl]phenyl]-5-(trifluoromethyl)pyridine-2-sulfonamide | PubChem SID:175267371 | CAS RN:174484-41-4
+BMGC_DG12160,BMG_DG165346,"CAS RN:18172-33-3 | PubChem CID:54682463 | DrugBank ID:DB07604 | UNII:X9TLY4580Z | CYCLOPIAZONIC ACID | (6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE | PubChem SID:198943370"
+BMGC_DG12161,BMG_DG165356,"CAS RN:15431-40-0 | MAGNESIUM ASCORBATE | PubChem SID:175267679 | DrugBank ID:DB14484 | magnesium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2H-furan-4-olate | UNII:0N1G678593 | PubChem CID:54682511 | Magnesium Ascorbate"
+BMGC_DG12162,BMG_DG165365,"UNII:756U07KN1R | PubChem CID:54682876 | TASQUINIMOD | DrugBank ID:DB05861 | CAS RN:254964-60-8 | Tasquinimod | 4-hydroxy-5-methoxy-N,1-dimethyl-2-oxo-N-[4-(trifluoromethyl)phenyl]quinoline-3-carboxamide | PubChem SID:198954177"
+BMGC_DG12163,BMG_DG165366,4-hydroxychromen-2-one | DrugBank ID:DB03410 | 4-Hydroxycoumarins | CAS RN:22105-09-5 | PubChem SID:198981001 | 4-hydroxycoumarin | CAS RN:1076-38-6 | PubChem CID:54682930 | 4-HYDROXYCOUMARIN | UNII:X954ZLL2RD
+BMGC_DG12164,BMG_DG165368,"Rolitetracycline | CAS RN:68060-64-0 | ROLITETRACYCLINE | (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-N-(pyrrolidin-1-ylmethyl)-4,4a,5,5a-tetrahydrotetracene-2-carboxamide | PubChem CID:54682938 | CAS RN:751-97-3 | PubChem SID:198938789 | UNII:GH9IW85221 | DrugBank ID:DB01301"
+BMGC_DG12165,BMG_DG165383,PubChem CID:54684141 | NDC:69539-032 | NDC:43598-281 | NDC:31722-246 | NDC:0378-0627 | NDC:0480-3156 | NDC:60505-4477 | NDC:69025-129 | NDC:59651-055 | NDC:0378-0628 | NDC:46708-313 | NDC:62332-314 | NDC:70377-018 | PubChem SID:175266318 | NDC:69238-1304 | NDC:69539-033 | NDC:68462-424 | NDC:60505-4478 | NDC:70512-851 | NDC:69339-170 | NDC:0781-5747 | NDC:42291-830 | NDC:42291-831 | NDC:46708-314 | NDC:16729-399 | NDC:70771-1011 | NDC:70710-1115 | DrugBank ID:DB08880 | NDC:69339-169 | Teriflunomide | NDC:70710-1114 | CAS RN:163451-81-8 | NDC:31722-247 | NDC:69539-315 | NDC:70377-017 | NDC:69025-130 | NDC:70771-1010 | TERIFLUNOMIDE | NDC:58468-0210 | NDC:16729-400 | NDC:0781-5755 | NDC:58468-0211 | NDC:69238-1303 | NDC:0480-3157 | CAS RN:108605-62-5 | NDC:62332-313 | NDC:68462-423 | NDC:69539-316 | NDC:70512-850 | UNII:1C058IKG3B | NDC:59651-054 | (Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
+BMGC_DG12166,BMG_DG165393,magnesium;2-carboxyphenolate | Magnesium Salicylate | MAGNESIUM SALICYLATE ANHYDROUS | CAS RN:551-37-1 | UNII:JQ69D454N1 | PubChem CID:54684589 | Magnesium salicylate | CAS RN:18917-89-0 | DrugBank ID:DB01397 | PubChem SID:198987833
+BMGC_DG12167,BMG_DG165394,"PubChem SID:251965917 | WARFARIN, (R)- | 4-hydroxy-3-[(1R)-3-oxo-1-phenylbutyl]chromen-2-one | PubChem CID:54684598 | CAS RN:5543-58-8 | UNII:09CC5J5C8A | DrugBank ID:DB08496 | (R)-Warfarin"
+BMGC_DG12168,BMG_DG165398,"UNII:HB76GLG27V | PAQUINIMOD | PubChem SID:198971492 | Paquinimod | N,5-diethyl-4-hydroxy-1-methyl-2-oxo-N-phenylquinoline-3-carboxamide | PubChem CID:54684617 | CAS RN:248282-01-1 | DrugBank ID:DB13118"
+BMGC_DG12169,BMG_DG165407,"4-[(1E,3S)-3-ethenyl-3,7-dimethylocta-1,6-dienyl]phenol | CAS RN:2197131-28-3 | Bakuchiol | CAS RN:10309-37-2 | PubChem CID:5468522 | UNII:OT12HJU3AR | BAKUCHIOL | PubChem SID:175266580"
+BMGC_DG12170,BMG_DG165410,"PubChem SID:198958140 | CAS RN:548-00-5 | DrugBank ID:DB08794 | Ethyl biscoumacetate | ethyl 2,2-bis(4-hydroxy-2-oxochromen-3-yl)acetate | ETHYL BISCOUMACETATE | UNII:08KL644731 | Ethyl Biscoumacetate | PubChem CID:54685524"
+BMGC_DG12171,BMG_DG165415,"PubChem SID:175267354 | UNII:4182Z6T2ET | DOXYCYCLINE HYDROCHLORIDE | CAS RN:10592-13-9 | Doxycycline hydrochloride | PubChem CID:54685920 | (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;hydrochloride"
+BMGC_DG12172,BMG_DG165420,CAS RN:15074-18-7 | PubChem CID:54686112 | 4-HYDROXY-3-BENZYLCOUMARIN | PubChem SID:459056194 | UNII:KV6AJ39594
+BMGC_DG12173,BMG_DG165422,"NDC:43547-325 | NDC:68999-626 | NDC:62135-985 | NDC:60505-4382 | NDC:55154-8079 | NDC:62332-352 | NDC:51862-560 | NDC:70518-1627 | NDC:42806-362 | NDC:72789-319 | NDC:71335-1768 | NDC:46708-499 | NDC:68999-984 | NDC:63187-942 | NDC:62332-499 | NDC:67296-1801 | NDC:72189-127 | NDC:71205-697 | NDC:50268-277 | NDC:72143-211 | NDC:42806-646 | NDC:51862-558 | NDC:62332-353 | NDC:71335-2526 | NDC:16110-601 | NDC:68382-910 | NDC:27241-154 | NDC:71205-653 | NDC:70518-3706 | NDC:70771-1358 | NDC:72162-2256 | NDC:71335-2179 | NDC:50090-6134 | NDC:76420-814 | NDC:46708-353 | NDC:27241-140 | NDC:0591-4575 | NDC:60219-1100 | NDC:70771-1589 | NDC:40032-794 | NDC:45865-203 | NDC:67296-1456 | NDC:72789-309 | NDC:68999-625 | NDC:72789-369 | NDC:68071-3466 | NDC:23155-611 | NDC:51862-571 | NDC:68382-710 | NDC:50090-0023 | NDC:50090-6133 | NDC:68788-8588 | NDC:70771-1104 | NDC:43063-999 | NDC:50090-7411 | NDC:27241-141 | NDC:60505-4384 | NDC:62135-625 | NDC:62332-484 | NDC:46708-483 | NDC:53489-118 | NDC:72578-001 | NDC:70518-3039 | NDC:71288-030 | NDC:71335-2100 | NDC:50090-6212 | NDC:66794-237 | NDC:70518-3213 | NDC:70748-338 | NDC:70518-1248 | NDC:50090-5380 | NDC:67296-0329 | NDC:68071-5265 | NDC:23155-143 | NDC:67296-1743 | NDC:50090-7410 | NDC:70771-1587 | NDC:71335-2113 | UNII:19XTS3T51U | NDC:42192-501 | NDC:42806-312 | NDC:46708-388 | NDC:55289-866 | NDC:82804-070 | NDC:68047-714 | Doxycycline hyclate | NDC:51407-298 | NDC:80425-0280 | NDC:82804-173 | NDC:72162-2186 | NDC:0591-4550 | NDC:24658-311 | NDC:80425-0211 | NDC:70771-1122 | NDC:69668-515 | NDC:70771-1121 | NDC:46708-484 | NDC:68788-7638 | NDC:70934-987 | NDC:55289-502 | NDC:72189-006 | NDC:27808-233 | NDC:62135-596 | NDC:62332-363 | NDC:0615-8529 | NDC:67457-437 | NDC:62584-693 | NDC:71335-1686 | NDC:72162-2402 | NDC:72789-277 | NDC:63323-130 | NDC:50268-278 | NDC:50090-5825 | NDC:24658-312 | NDC:62332-482 | NDC:68071-4883 | NDC:62332-387 | DOXYCYCLINE HYCLATE | NDC:51662-1402 | NDC:71205-554 | NDC:70771-1588 | NDC:42023-244 | NDC:69489-111 | NDC:0143-2112 | NDC:68382-911 | NDC:43063-988 | NDC:0143-9381 | NDC:62332-388 | NDC:68083-481 | (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride | NDC:80425-0114 | NDC:71335-0861 | NDC:71335-9718 | NDC:0143-9802 | NDC:67296-1762 | NDC:71335-1549 | NDC:83112-985 | NDC:72789-298 | NDC:46708-363 | NDC:68071-4836 | NDC:63187-818 | NDC:43547-324 | NDC:83112-233 | NDC:50268-279 | NDC:68180-653 | NDC:68788-8217 | NDC:71205-385 | NDC:50090-4981 | NDC:68071-5232 | NDC:70121-1616 | NDC:72578-055 | NDC:76420-813 | NDC:43386-794 | NDC:46708-481 | NDC:55154-7128 | NDC:68071-3564 | NDC:0904-0428 | NDC:68999-985 | NDC:0143-9803 | NDC:53489-647 | NDC:68071-5259 | NDC:23155-142 | NDC:60760-723 | NDC:71335-1464 | NDC:68071-4950 | NDC:59115-123 | NDC:62332-483 | NDC:71205-518 | NDC:71335-2086 | NDC:68308-716 | NDC:82804-179 | NDC:60760-626 | NDC:70518-4150 | NDC:69238-1100 | NDC:43547-462 | NDC:50090-5588 | NDC:55700-732 | NDC:27241-153 | NDC:60760-651 | NDC:49999-126 | NDC:42806-645 | NDC:67296-0264 | NDC:27808-234 | CAS RN:24390-14-5 | NDC:68788-8464 | NDC:62332-481 | NDC:72789-276 | NDC:46708-387 | NDC:53489-119 | NDC:72189-603 | NDC:72189-559 | NDC:23155-141 | NDC:72266-237 | NDC:70518-3869 | NDC:67296-1431 | NDC:67296-2066 | NDC:51655-998 | NDC:0904-0430 | NDC:46708-352 | NDC:68071-2761 | NDC:51655-478 | NDC:72789-419 | NDC:50090-5560 | NDC:82804-046 | NDC:62135-626 | NDC:62332-362 | NDC:60429-069 | NDC:53489-120 | NDC:68180-654 | NDC:76420-044 | NDC:67296-2075 | NDC:46708-362 | NDC:71205-156 | NDC:76420-562 | NDC:0404-9855 | NDC:60219-2132 | NDC:60760-721 | NDC:63187-845 | NDC:70771-1359 | NDC:82982-048 | NDC:0378-0167 | NDC:16714-644 | NDC:68382-708 | NDC:46708-482 | NDC:0591-5553 | NDC:62135-984 | NDC:60687-513 | NDC:42708-173 | NDC:62135-623 | NDC:70518-3488 | NDC:71610-117 | NDC:72578-054 | PubChem SID:175268315 | NDC:68382-709 | PubChem CID:54686183"
+BMGC_DG12174,BMG_DG165424,"Penimepicycline | CAS RN:4599-60-4 | PENIMEPICYCLINE | DrugBank ID:DB13264 | UNII:3RGQ4B6E87 | (4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-N-[[4-(2-hydroxyethyl)piperazin-1-yl]methyl]-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem SID:198956013 | PubChem CID:54686187"
+BMGC_DG12175,BMG_DG165432,NDC:58809-217 | PubChem CID:54686350 | CAS RN:2016-36-6 | NDC:58809-218 | UNII:KD510K1IQW | 2-carboxyphenolate;2-hydroxyethyl(trimethyl)azanium | DrugBank ID:DB14006 | Choline salicylate | CHOLINE SALICYLATE | PubChem SID:175265961
+BMGC_DG12176,BMG_DG165444,4-Hydroxy-6-pentylpyran-2-one | CAS RN:81017-02-9 | 4-hydroxy-6-pentylpyran-2-one | PubChem CID:54686804
+BMGC_DG12177,BMG_DG165446,Manitimus | PubChem SID:198984543 | (Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]hept-2-en-6-ynamide | UNII:4B135RK2KL | CAS RN:202057-76-9 | DrugBank ID:DB06481 | PubChem CID:54686843 | MANITIMUS | CAS RN:185915-33-7
+BMGC_DG12178,BMG_DG165450,"(4S,4aS,5aR,12aR)-9-[[2-(tert-butylamino)acetyl]amino]-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | Tigecycline | NDC:0781-3481 | NDC:55150-228 | NDC:70121-1647 | PubChem SID:175268074 | UNII:70JE2N95KR | CAS RN:220620-09-7 | NDC:60505-6098 | NDC:0008-4994 | DrugBank ID:DB00560 | NDC:63323-960 | TIGECYCLINE | NDC:71288-019 | PubChem CID:54686904 | NDC:0008-4990"
+BMGC_DG12179,BMG_DG165452,"(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid | Pravastatin | DrugBank ID:DB00175 | PubChem SID:175266850 | CAS RN:81093-37-0 | PubChem CID:54687 | UNII:KXO2KT9N0G | PRAVASTATIN"
+BMGC_DG12180,BMG_DG165481,PubChem CID:54688679 | Aurodox | DrugBank ID:DB04124
+BMGC_DG12181,BMG_DG165507,"CAS RN:70374-39-9 | UNII:ER09126G7A | DrugBank ID:DB06725 | Lornoxicam | LORNOXICAM | PubChem CID:54690031 | CAS RN:70374-27-5 | 6-chloro-4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide | PubChem SID:198975421"
+BMGC_DG12182,BMG_DG165573,"UNII:3DDC6976TQ | PubChem SID:475550269 | 5-(1-Hydroxyethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione | 5-(1-HYDROXYETHYLIDENE)-2,2-DIMETHYL-1,3-DIOXANE-4,6-DIONE | PubChem CID:54693142"
+BMGC_DG12183,BMG_DG165574,"CAS RN:162520-00-5 | SALIRASIB | 2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylbenzoic acid | PubChem SID:198947135 | DrugBank ID:DB12681 | PubChem CID:5469318 | Salirasib | UNII:MZH0OM550M"
+BMGC_DG12184,BMG_DG165588,"5-hydroxy-2,4-dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one | UNII:2KUZ32F7NT | ENOLTASOSARTAN | Enoltasosartan | PubChem CID:54693559 | CAS RN:159237-67-9 | PubChem SID:485666150"
+BMGC_DG12185,BMG_DG165589,CAS RN:81017-03-0 | PubChem CID:54693753 | 4-hydroxy-6-undecylpyran-2-one | 4-hydroxy-6-undecyl-2H-pyran-2-one
+BMGC_DG12186,BMG_DG165593,"PubChem CID:5469424 | UNII:W2F8059T80 | CAS RN:33171-16-3 | CAS RN:22608-11-3 | CAS RN:91884-87-6 | PubChem SID:198958479 | Demethoxycurcumin | CAS RN:24939-17-1 | (1E,6E)-1-(4-hydroxy-3-methoxyphenyl)-7-(4-hydroxyphenyl)hepta-1,6-diene-3,5-dione | DEMETHOXYCURCUMIN"
+BMGC_DG12187,BMG_DG165594,"CAS RN:60831-46-1 | BIS(3,4-DIHYDROXY-TRANS-CINNAMOYL)METHANE | PubChem CID:5469425 | UNII:V9WSK3JJL2 | PubChem SID:472409090 | Bis(3,4-Dihydroxy-trans-cinnamoyl)methane"
+BMGC_DG12188,BMG_DG165610,"3,4-DIHYDROXY-N-METHYLCARBOSTYRIL | DrugBank ID:DB01754 | PubChem CID:54695768 | CAS RN:41878-54-0 | UNII:3LH3M77BN6 | PubChem SID:443624510 | 3,4-Dihydroxy-1-Methylquinolin-2(1h)-One"
+BMGC_DG12189,BMG_DG165612,PubChem CID:5469634 | CAS RN:111047-30-4 | 2-(10-Heptadecenyl)-6-hydroxybenzoic acid | 2-[(Z)-heptadec-10-enyl]-6-hydroxybenzoic acid
+BMGC_DG12190,BMG_DG165616,"(4S,4aS,5aR,12aR)-4,7-bis(dimethylamino)-9-[(2,2-dimethylpropylamino)methyl]-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | NDC:71715-001 | CAS RN:389139-89-3 | Omadacycline | NDC:71715-002 | PubChem CID:54697325 | PubChem SID:198961283 | DrugBank ID:DB12455 | UNII:090IP5RV8F | OMADACYCLINE"
+BMGC_DG12191,BMG_DG165622,Coumermycin A1 | PubChem CID:54697785 | DrugBank ID:DB13912
+BMGC_DG12192,BMG_DG165634,"PubChem CID:547 | 2-(3,4-dihydroxyphenyl)acetic acid | 3,4-Dihydroxyphenylacetic acid | PubChem SID:252319626 | CAS RN:102-32-9 | 3,4-DIHYDROXYPHENYLACETIC ACID | UNII:KEX5N0R4N5 | DrugBank ID:DB01702 | 2-(3,4-Dihydroxyphenyl)Acetic Acid"
+BMGC_DG12193,BMG_DG165635,"PubChem CID:5470187 | CAS RN:471-05-6 | Zerumbone | (2E,6E,10E)-2,6,9,9-tetramethylcycloundeca-2,6,10-trien-1-one"
+BMGC_DG12194,BMG_DG165658,Clorobiocin | PubChem CID:54706138 | DrugBank ID:DB03966
+BMGC_DG12195,BMG_DG165666,"PubChem SID:198978908 | CAS RN:992-21-2 | PubChem CID:54707177 | DrugBank ID:DB00256 | (2S)-6-[[[(4S,4aS,5aS,6S,12aR)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carbonyl]amino]methylamino]-2-aminohexanoic acid | LYMECYCLINE | UNII:7D6EM3S13P | Lymecycline"
+BMGC_DG12196,BMG_DG165675,"CAS RN:7249-34-5 | PubChem CID:5470829 | 2,5-Bis(4-hydroxy-3-methoxybenzylidene)cyclopentanone | (2E,5E)-2,5-bis[(4-hydroxy-3-methoxyphenyl)methylidene]cyclopentan-1-one"
+BMGC_DG12197,BMG_DG165676,UNII:E5B7C16LFK | DrugBank ID:DB13451 | 3-[3-(4-chlorophenyl)-1-(5-chlorothiophen-2-yl)-3-hydroxypropyl]-4-hydroxychromen-2-one | TIOCLOMAROL | CAS RN:22619-35-8 | PubChem SID:198935214 | Tioclomarol | PubChem CID:54708299
+BMGC_DG12198,BMG_DG165678,A-769662 | CAS RN:844499-71-4 | PubChem SID:198936256 | UNII:P68477CD2C | PubChem CID:54708532
+BMGC_DG12199,BMG_DG165681,PubChem CID:54708735 | Chlortetracycline | DrugBank ID:DB09093
+BMGC_DG12200,BMG_DG165686,"PubChem SID:198972477 | CAS RN:7229-50-7 | UNII:6MON4029Q8 | Streptolydigin | STREPTOLYDIGIN | DrugBank ID:DB04785 | (2S)-2-[(2S,4E)-4-[(2E,4E,6R)-6-[(1R,3R,4S,5R,8R)-1,4-dimethylspiro[2,9-dioxabicyclo[3.3.1]non-6-ene-8,2'-oxirane]-3-yl]-1-hydroxy-4-methylhepta-2,4-dienylidene]-1-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]-3,5-dioxopyrrolidin-2-yl]-N-methylpropanamide | PubChem CID:54708748"
+BMGC_DG12201,BMG_DG165698,DrugBank ID:DB14490 | PubChem CID:54710214 | Ferrous ascorbate
+BMGC_DG12202,BMG_DG165723,CAS RN:7380-40-7 | PubChem CID:5471349 | UNII:JMU611YFRB | BERGAMOTTIN | PubChem SID:198958756
+BMGC_DG12203,BMG_DG165725,"(3R,6S)-N-[(2,4-difluorophenyl)methyl]-10-hydroxy-6-methyl-8,11-dioxo-4-oxa-1,7-diazatricyclo[7.4.0.03,7]trideca-9,12-diene-12-carboxamide | PubChem CID:54713659 | PubChem SID:198940204 | DrugBank ID:DB11751 | UNII:HMH0132Z1Q | CAS RN:1264720-72-0 | CAS RN:1051375-10-0 | Cabotegravir | CABOTEGRAVIR"
+BMGC_DG12204,BMG_DG165751,"PubChem SID:198970353 | TECARFARIN | CAS RN:867257-26-9 | UNII:WN1479YT50 | (1,1,1,3,3,3-hexafluoro-2-methylpropan-2-yl) 4-[(4-hydroxy-2-oxochromen-3-yl)methyl]benzoate | PubChem CID:54718618 | DrugBank ID:DB12823 | Tecarfarin"
+BMGC_DG12205,BMG_DG165756,CAS RN:135211-15-3 | PubChem SID:472423002 | PubChem CID:5471948 | LR132 | UNII:K7C7XKK3P3
+BMGC_DG12206,BMG_DG165759,"CAS RN:55142-85-3 | DrugBank ID:DB00208 | UNII:OM90ZUW7M1 | PubChem SID:175267089 | 5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine | PubChem CID:5472 | TICLOPIDINE | Ticlopidine"
+BMGC_DG12207,BMG_DG165767,PubChem CID:54723327 | (2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide | DrugBank ID:DB08169
+BMGC_DG12208,BMG_DG165768,"DrugBank ID:DB08736 | S,R-Warfarin alcohol | WARFARIN ALCOHOL, (S,R)- | PubChem CID:54723704 | CAS RN:40281-79-6 | PubChem SID:251965450 | UNII:62GD2Z2LXM"
+BMGC_DG12209,BMG_DG165771,"CAS RN:40281-89-8 | CAS RN:76496-88-3 | WARFARIN ALCOHOL, (±)-(R,R)- | WARFARIN ALCOHOL, (+/-)-(R,R)- | PubChem SID:251966157 | WARFARIN ALCOHOL, (R,R)- | UNII:4D7D987PGU | PubChem CID:54723890 | PubChem SID:251965876 | UNII:8T2RF5K626"
+BMGC_DG12210,BMG_DG165780,CAS RN:59864-04-9 | DrugBank ID:DB06246 | EXISULIND | PubChem CID:5472495 | UNII:K619IIG2R9 | 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfonylphenyl)methylidene]inden-1-yl]acetic acid | CAS RN:59973-80-7 | Exisulind | PubChem SID:198988487
+BMGC_DG12211,BMG_DG165785,"Dolutegravir | UNII:DKO1W9H7M1 | (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide | PubChem CID:54726191 | DrugBank ID:DB08930 | PubChem SID:198935766 | DOLUTEGRAVIR | CAS RN:1051375-16-6"
+BMGC_DG12212,BMG_DG165786,"Eravacycline | PubChem CID:54726192 | DrugBank ID:DB12329 | (4S,4aS,5aR,12aR)-4-(dimethylamino)-7-fluoro-1,10,11,12a-tetrahydroxy-3,12-dioxo-9-[(2-pyrrolidin-1-ylacetyl)amino]-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide | PubChem SID:198981036 | CAS RN:1207283-85-9 | UNII:07896928ZC | ERAVACYCLINE"
+BMGC_DG12213,BMG_DG165797,PubChem SID:441097587 | CAS RN:133740-20-2 | PAEPALANTINE | PubChem CID:5472703 | UNII:X4745NYK8U
+BMGC_DG12214,BMG_DG165798,(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide | PubChem CID:54727972 | DrugBank ID:DB07443
+BMGC_DG12215,BMG_DG165799,PubChem CID:54727975 | (2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide | DrugBank ID:DB08172
+BMGC_DG12216,BMG_DG165800,"DrugBank ID:DB07559 | PubChem CID:54727980 | (2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide"
+BMGC_DG12217,BMG_DG165801,DrugBank ID:DB07561 | (2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide | PubChem CID:54727985
+BMGC_DG12218,BMG_DG165818,"PubChem SID:472423233 | 3-Methoxy-4',5-dihydroxy-trans-stilbene | 3-[(E)-2-(4-hydroxyphenyl)ethenyl]-5-methoxyphenol | PubChem CID:5473050 | PINOSTILBENE | CAS RN:42438-89-1 | UNII:4PAK325BEM"
+BMGC_DG12219,BMG_DG165828,"PubChem SID:198941634 | Naldemedine | PubChem CID:54732242 | CAS RN:916072-89-4 | UNII:03KSI6WLXH | DrugBank ID:DB11691 | NALDEMEDINE | (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,7,9-trihydroxy-N-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)propan-2-yl]-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-6-carboxamide"
+BMGC_DG12220,BMG_DG165830,CAS RN:147666-81-7 | UNII:D2866L3MW5 | PubChem SID:472422854 | PubChem CID:5473310 | THUNBERGINOL B
+BMGC_DG12221,BMG_DG165841,"PubChem SID:251965953 | DrugBank ID:DB08735 | WARFARIN ALCOHOL, (±)-(R,S)- | PubChem CID:54736486 | WARFARIN ALCOHOL, (R,S)- | PubChem SID:251965059 | CAS RN:37571-78-1 | UNII:7FF8Z7G342 | WARFARIN ALCOHOL, (+/-)-(R,S)- | UNII:36J71T6R7X | CAS RN:76496-89-4 | R,S-Warfarin alcohol"
+BMGC_DG12222,BMG_DG165849,"PubChem CID:5473758 | (2Z)-3-ethyl-2-[(2E,4E)-5-(3-ethyl-1,3-benzothiazol-3-ium-2-yl)penta-2,4-dienylidene]-1,3-benzothiazole | Dithiazanine | CAS RN:7187-55-5"
+BMGC_DG12223,BMG_DG165860,CAS RN:85136-71-6 | PubChem SID:198937735 | TILISOLOL | UNII:QUF41MF56G | Tilisolol | 4-[3-(tert-butylamino)-2-hydroxypropoxy]-2-methylisoquinolin-1-one | PubChem CID:5474
+BMGC_DG12224,BMG_DG165881,"calcium;(2R)-2-[(1S)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2H-furan-4-olate | UNII:J96U0ZD4Y6 | DrugBank ID:DB14483 | PubChem SID:175266620 | Ascorbic acid calcium salt | PubChem CID:54740489 | CALCIUM ASCORBATE ANHYDROUS | CAS RN:5743-27-1"
+BMGC_DG12225,BMG_DG165901,"NDC:70512-860 | PubChem SID:175267048 | UNII:LL60K9J05T | NDC:50090-5834 | (6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | CABERGOLINE | NDC:0093-5420 | NDC:59762-1005 | NDC:69238-2693 | NDC:50090-6596 | Cabergoline | NDC:70069-824 | NDC:23155-823 | DrugBank ID:DB00248 | NDC:83085-003 | PubChem CID:54746 | NDC:50090-3157 | CAS RN:81409-90-7 | NDC:50742-118"
+BMGC_DG12226,BMG_DG165928,"TILORONE | CAS RN:27591-97-5 | 2,7-bis[2-(diethylamino)ethoxy]fluoren-9-one | UNII:O6W7VEW6KS | PubChem CID:5475 | PubChem SID:198948377 | Tilorone"
+BMGC_DG12227,BMG_DG165942,Cinanserin | (E)-N-[2-[3-(dimethylamino)propylsulfanyl]phenyl]-3-phenylprop-2-enamide | CAS RN:33464-86-7 | UNII:KI6J9OY7A3 | CAS RN:1166-34-3 | CINANSERIN | PubChem CID:5475158 | PubChem SID:198949847
+BMGC_DG12228,BMG_DG165945,UNII:XB7DL3H8SX | NAPHTHYLVINYLPYRIDINE | CAS RN:16375-78-3 | PubChem SID:472423156 | PubChem CID:5475238
+BMGC_DG12229,BMG_DG165951,CAS RN:16062-88-7 | PubChem SID:198987987 | MONOBUTYL FUMARATE | PubChem CID:5475335 | UNII:2T4KZW2ORV
+BMGC_DG12230,BMG_DG165956,6-amino-9-[(3R)-1-but-2-ynoylpyrrolidin-3-yl]-7-(4-phenoxyphenyl)purin-8-one | DrugBank ID:DB15227 | Tirabrutinib | PubChem CID:54755438 | PubChem SID:317230014 | UNII:LXG44NDL2T | TIRABRUTINIB | CAS RN:1351636-18-4
+BMGC_DG12231,BMG_DG165960,"OLMUTINIB | DrugBank ID:DB13164 | PubChem SID:310825938 | CAS RN:1802181-20-9 | CAS RN:1353550-13-6 | N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide | Olmutinib | PubChem CID:54758501 | UNII:CHL9B67L95"
+BMGC_DG12232,BMG_DG166002,"DrugBank ID:DB13850 | PubChem CID:5476 | TIMEPIDIUM | UNII:C1WS2XH3K4 | CAS RN:97094-64-9 | Timepidium | PubChem SID:198969930 | 3-(dithiophen-2-ylmethylidene)-5-methoxy-1,1-dimethylpiperidin-1-ium"
+BMGC_DG12233,BMG_DG166005,"Ruserontinib | PubChem SID:474493631 | UNII:AQ3TTU8UM7 | 2-N-[4-(4-methylpiperazin-1-yl)phenyl]-9-propan-2-yl-8-N-pyridin-3-ylpurine-2,8-diamine | PubChem CID:54760385 | RUSERONTINIB | CAS RN:1350544-93-2"
+BMGC_DG12234,BMG_DG166007,"CAS RN:1352226-88-0 | imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane | PubChem CID:54761306"
+BMGC_DG12235,BMG_DG166018,UNII:VAZ0AHM3I2 | N-DEACETYL-N-HYDROXYACETYL APREMILAST | PubChem CID:54764856 | CAS RN:1384814-94-1 | PubChem SID:252164019
+BMGC_DG12236,BMG_DG166023,2-Methoxy-6-{(E)-[(4-methylphenyl)imino]methyl}phenol | PubChem CID:5476587 | DrugBank ID:DB13869
+BMGC_DG12237,BMG_DG166024,"CAS RN:1353546-86-7 | PubChem SID:375083238 | ORISMILAST | PubChem CID:54765967 | 2-(3,5-dichloro-1-oxidopyridin-1-ium-4-yl)-1-[7-(difluoromethoxy)-1',1'-dioxospiro[1,3-benzodioxole-2,4'-thiane]-4-yl]ethanone | UNII:JH1CX8SG5V | Orismilast"
+BMGC_DG12238,BMG_DG166025,"DrugBank ID:DB01408 | [3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate | BAMBUTEROL | PubChem CID:54766 | UNII:Y1850G1OVC | PubChem SID:175271876 | Bambuterol | CAS RN:81732-65-2"
+BMGC_DG12239,BMG_DG166026,"Vactosertib | VACTOSERTIB | PubChem SID:346536839 | 2-fluoro-N-[[5-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]aniline | CAS RN:1352608-82-2 | PubChem CID:54766013 | DrugBank ID:DB15310 | UNII:6T4O391P5Y"
+BMGC_DG12240,BMG_DG166031,2-[3-(4-cyanonaphthalen-1-yl)pyridin-4-yl]sulfanyl-2-methylpropanoic acid | VERINURAD | DrugBank ID:DB11873 | PubChem CID:54767229 | CAS RN:1352792-74-5 | PubChem SID:316917565 | Verinurad | UNII:12WJ62D047
+BMGC_DG12241,BMG_DG166033,"PubChem SID:198965827 | CAS RN:1258226-87-7 | methyl N-[(2S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate | UNII:2302768XJ8 | DrugBank ID:DB09296 | OMBITASVIR | PubChem CID:54767916 | Ombitasvir"
+BMGC_DG12242,BMG_DG166046,CAS RN:78441-84-6 | PubChem SID:363907799 | PubChem CID:5477889 | UNII:G7PO7WW9U2 | BL-6341
+BMGC_DG12243,BMG_DG166052,"1-(Tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol | CAS RN:29023-48-1 | 1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol | PubChem CID:5478"
+BMGC_DG12244,BMG_DG166056,"PubChem CID:5478838 | PL-265 active metabolite | UNII:227MQ6QL9D | PubChem SID:485665129 | PL-265 ACTIVE METABOLITE | N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine | CAS RN:216097-44-8 | DrugBank ID:DB02062"
+BMGC_DG12245,BMG_DG166058,PubChem CID:5478860 | DrugBank ID:DB03442 | Acid yellow 54 free acid
+BMGC_DG12246,BMG_DG166059,N-1-methylheptylformamide | DrugBank ID:DB02131 | PubChem CID:5478865
+BMGC_DG12247,BMG_DG166060,"CAS RN:39324-30-6 | CAS RN:26305-03-3 | PubChem SID:198983600 | PubChem CID:5478883 | Pepstatin | PEPSTATIN | UNII:V6Y2T27Q1U | (3S,4S)-3-hydroxy-4-[[(2S)-2-[[(3S,4S)-3-hydroxy-6-methyl-4-[[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(3-methylbutanoylamino)butanoyl]amino]butanoyl]amino]heptanoyl]amino]propanoyl]amino]-6-methylheptanoic acid"
+BMGC_DG12248,BMG_DG166066,1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole | NDC:42799-208 | CAS RN:19387-91-8 | NDC:0178-8250 | TINIDAZOLE | PubChem SID:175265541 | NDC:64980-427 | NDC:62135-834 | PubChem CID:5479 | NDC:43386-550 | DrugBank ID:DB00911 | Tinidazole | NDC:42799-207 | NDC:70518-4172 | UNII:033KF7V46H | NDC:64980-426 | CAS RN:148159-84-6 | NDC:0178-8500 | NDC:62135-835 | NDC:43386-551 | NDC:67296-1836
+BMGC_DG12249,BMG_DG166074,"PubChem CID:5479527 | CAS RN:63527-52-6 | CAS RN:63527-53-7 | UNII:5KTC59K32X | CAS RN:1056874-43-1 | Claforan | CEFOTAXIME, E- | PubChem SID:198989911 | (6R,7R)-3-(acetyloxymethyl)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid"
+BMGC_DG12250,BMG_DG166075,"(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CEFUROXIME | DrugBank ID:DB01112 | Cefuroxime | PubChem CID:5479529 | CAS RN:55268-75-2 | UNII:O1R9FJ93ED | PubChem SID:175266075"
+BMGC_DG12251,BMG_DG166076,"UNII:75J73V1629 | PubChem CID:5479530 | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-5,6-dioxo-1H-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CAS RN:74578-69-1 | DrugBank ID:DB01212 | PubChem SID:175265409 | CAS RN:73384-59-5 | CEFTRIAXONE | Ceftriaxone"
+BMGC_DG12252,BMG_DG166077,"CEFEPIME | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | Cefepime | PubChem SID:175268534 | DrugBank ID:DB01413 | CAS RN:88040-23-7 | PubChem CID:5479537 | UNII:807PW4VQE3"
+BMGC_DG12253,BMG_DG166078,"PubChem CID:5479539 | PubChem SID:175266155 | Cefpirome | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(6,7-dihydro-5H-cyclopenta[b]pyridin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | CAS RN:84957-29-9 | DrugBank ID:DB13682 | UNII:S72Q2F09HY | CEFPIROME"
+BMGC_DG12254,BMG_DG166079,"tert-butyl N-[(2S,3R,5R)-6-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-benzyl-3-hydroxy-6-oxo-1-phenylhexan-2-yl]carbamate | L 685458 | CAS RN:292632-98-5 | PubChem CID:5479543"
+BMGC_DG12255,BMG_DG166085,"Tinoridine | TINORIDINE | PubChem SID:198948596 | ethyl 2-amino-6-benzyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylate | PubChem CID:5480 | DrugBank ID:DB13001 | CAS RN:24237-54-5 | UNII:C9Z9ICZ7YR"
+BMGC_DG12256,BMG_DG166087,Pafuramidine | PubChem SID:198989257 | UNII:H1VG379J2X | DrugBank ID:DB06532 | PAFURAMIDINE | N'-methoxy-4-[5-[4-[(Z)-N'-methoxycarbamimidoyl]phenyl]furan-2-yl]benzenecarboximidamide | CAS RN:186953-56-0 | PubChem CID:5480200
+BMGC_DG12257,BMG_DG166090,"PubChem CID:5480230 | (1S,2S,7S,8S,12R,20R,24R,32R)-11,33-bis(cyclopropylmethyl)-19,25-dioxa-11,22,33-triazaundecacyclo[24.9.1.18,14.01,24.02,32.04,23.05,21.07,12.08,20.030,36.018,37]heptatriaconta-4(23),5(21),14(37),15,17,26,28,30(36)-octaene-2,7,17,27-tetrol | Norbinaltorphimine | NORBINALTORPHIMINE | UNII:36OOQ86QM1 | CAS RN:105618-26-6 | PubChem SID:316914211"
+BMGC_DG12258,BMG_DG166091,"PubChem SID:485663553 | CAS RN:14686-65-8 | 1,5-Dihydroxyxanthone | PubChem CID:5480299 | 1,5-DIHYDROXYXANTHONE | 1,5-dihydroxyxanthen-9-one | UNII:2945MQ2UXP"
+BMGC_DG12259,BMG_DG166095,"(3R,4S,5S,6R,7R,9R,10Z,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one | (Z)-roxithromycin | CAS RN:134931-00-3 | CAS RN:80214-83-1 | PubChem SID:313182863 | PubChem CID:5480431 | UNII:7LG42MZ5GK | ROXITHROMYCIN, (Z)-"
+BMGC_DG12260,BMG_DG166100,"PubChem CID:5480817 | 5,21-dichloro-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione | Dichloroarcyriaflavin A | CAS RN:118458-56-3"
+BMGC_DG12261,BMG_DG166102,"CEFTAZIDIME ANHYDROUS | PubChem SID:175268371 | Ceftazidime | UNII:DZR1ENT301 | CAS RN:72558-82-8 | DrugBank ID:DB00438 | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | PubChem CID:5481173"
+BMGC_DG12262,BMG_DG166107,PubChem CID:5481350 | CAS RN:201341-05-1 | PubChem SID:198945572 | [[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate | Tenofovir Disoproxil | UNII:F4YU4LON7I | TENOFOVIR DISOPROXIL | Tenofovir disoproxil | DrugBank ID:DB00300
+BMGC_DG12263,BMG_DG166115,"Mulberrin | 2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3,8-bis(3-methylbut-2-enyl)chromen-4-one | PubChem CID:5481958 | CAS RN:62949-79-5"
+BMGC_DG12264,BMG_DG166120,"UNII:IA6I4SG21V | PubChem SID:438788456 | CAS RN:62949-93-3 | 2-(2,4-dihydroxyphenyl)-5-hydroxy-3-(3-hydroxy-3-methylbutyl)-8,8-dimethylpyrano[2,3-h]chromen-4-one | OXYDIHYDROMORUSI | Morusinol | PubChem CID:5481968"
+BMGC_DG12265,BMG_DG166121,"CAS RN:62596-34-3 | 11,19-dihydroxy-7,7-dimethyl-15-(2-methylprop-1-enyl)-2,8,16-trioxapentacyclo[12.8.0.03,12.04,9.017,22]docosa-1(14),3(12),4(9),5,10,17(22),18,20-octaen-13-one | PubChem CID:5481969 | Cyclomorusin"
+BMGC_DG12266,BMG_DG166122,"PubChem SID:474492513 | 2-(2,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one | NORARTOCARPETIN | Norartocarpetin | CAS RN:520-30-9 | UNII:L2Y5RSY4BM | PubChem CID:5481970"
+BMGC_DG12267,BMG_DG166124,"NDC:21130-060 | UNII:S57Y5X1117 | NDC:41250-426 | CAS RN:65899-73-2 | NDC:49348-508 | NDC:11822-0426 | NDC:70000-0357 | Tioconazole | NDC:0363-0426 | NDC:37808-426 | NDC:11673-426 | NDC:49035-426 | NDC:36800-426 | NDC:63736-413 | 1-[2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole | NDC:11509-0426 | NDC:59779-718 | NDC:41520-426 | NDC:70677-1224 | TIOCONAZOLE | PubChem SID:175272121 | NDC:55910-731 | PubChem CID:5482 | NDC:0113-0426 | DrugBank ID:DB01007 | NDC:72288-426 | NDC:41163-032"
+BMGC_DG12268,BMG_DG166126,"3,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)chromen-4-one | PubChem CID:5482101 | PubChem SID:438787658 | Geraldol | GERALDOL | CAS RN:21511-25-1 | UNII:2KR35TI2XV"
+BMGC_DG12269,BMG_DG166131,NDC:0480-9227 | NDC:0178-0901 | NDC:0480-7824 | NDC:0178-0900 | Tiopronin | NDC:0254-3035 | NDC:0254-3034 | UNII:C5W04GO61S | NDC:13668-691 | NDC:13668-692 | NDC:0093-7909 | CAS RN:1939-02-2 | TIOPRONIN | PubChem SID:175271837 | 2-(2-sulfanylpropanoylamino)acetic acid | CAS RN:2254742-22-6 | CAS RN:1953-02-2 | NDC:0178-0902 | DrugBank ID:DB06823 | NDC:60219-2009 | NDC:44523-055 | CAS RN:2254742-23-7 | PubChem CID:5483 | NDC:70709-123 | NDC:44523-054 | NDC:70709-121
+BMGC_DG12270,BMG_DG166155,NDC:64980-376 | NDC:60687-567 | PubChem CID:54840 | NDC:35573-417 | NDC:42291-069 | NDC:65841-605 | NDC:31722-716 | NDC:0093-3545 | NDC:50090-7462 | CAS RN:82248-59-7 | NDC:50090-7397 | NDC:60505-2832 | NDC:51407-106 | NDC:31722-719 | NDC:68462-267 | UNII:57WVB6I2W0 | NDC:64980-378 | NDC:71335-9702 | NDC:31722-714 | NDC:50090-6511 | NDC:60687-326 | NDC:60505-2836 | NDC:51407-103 | NDC:68382-215 | NDC:0002-3251 | NDC:0093-3542 | NDC:35573-420 | NDC:50090-6127 | NDC:50090-6143 | NDC:55111-564 | NDC:0093-3546 | NDC:64980-374 | NDC:63629-9427 | NDC:60505-2834 | NDC:50268-057 | NDC:65841-611 | NDC:65841-608 | NDC:51407-104 | NDC:42291-065 | NDC:35573-416 | NDC:16714-759 | Atomoxetine Hydrochloride | NDC:55111-521 | NDC:64980-373 | NDC:65841-607 | NDC:65862-239 | NDC:42291-070 | NDC:71335-2162 | NDC:55111-563 | NDC:35573-419 | NDC:0093-3548 | NDC:55111-528 | NDC:65841-606 | NDC:42291-068 | NDC:50090-6513 | NDC:35573-418 | NDC:50090-6289 | NDC:31722-717 | NDC:68462-266 | NDC:64980-375 | NDC:42291-066 | NDC:0093-3543 | NDC:50090-6444 | NDC:64980-377 | NDC:68382-216 | NDC:51407-102 | NDC:35573-421 | NDC:65862-238 | NDC:50090-6254 | NDC:68382-220 | NDC:71335-2361 | NDC:16714-756 | NDC:65862-240 | NDC:31722-715 | NDC:55111-522 | NDC:50090-4236 | NDC:50090-6703 | NDC:50090-6144 | NDC:31722-718 | NDC:63629-9428 | NDC:0002-3228 | NDC:16714-761 | NDC:64980-379 | NDC:65841-609 | NDC:0002-3239 | NDC:68382-219 | NDC:65862-241 | NDC:60505-2835 | NDC:50090-6512 | NDC:16714-757 | ATOMOXETINE HYDROCHLORIDE | NDC:0002-3250 | NDC:60505-2831 | NDC:42291-067 | NDC:65862-244 | NDC:35573-415 | NDC:16714-755 | NDC:16714-758 | NDC:68462-270 | NDC:68462-268 | NDC:68462-269 | NDC:55111-520 | NDC:51407-105 | NDC:68382-218 | NDC:68382-217 | NDC:51407-100 | (3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine;hydrochloride | NDC:51407-101 | NDC:50268-058 | NDC:50090-7463 | NDC:68462-265 | NDC:50090-7342 | NDC:0093-3544 | NDC:16714-760 | NDC:65841-610 | NDC:68382-223 | NDC:50090-4237 | NDC:0002-3227 | NDC:0002-3238 | NDC:0904-6908 | PubChem SID:175266827 | NDC:42291-064 | NDC:0002-3229 | NDC:65862-242 | NDC:55111-519 | NDC:31722-720 | NDC:65862-243 | NDC:60505-2830 | NDC:0093-3547 | NDC:68462-271 | NDC:60505-2833
+BMGC_DG12271,BMG_DG166156,"PubChem CID:5484006 | CAS RN:21637-25-2 | ISOQUERCITRIN | PubChem SID:198958706 | UNII:0YX10VRV6J | 3-[(2S,3R,4R,5R)-5-[(1R)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one | Isoquercitrin"
+BMGC_DG12272,BMG_DG166159,(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine | CAS RN:83015-26-3 | PubChem SID:175265837 | CAS RN:1027094-45-6 | DrugBank ID:DB00289 | ATOMOXETINE | PubChem CID:54841 | UNII:ASW034S0B8 | Atomoxetine
+BMGC_DG12273,BMG_DG166171,PubChem SID:198958327 | PubChem CID:5484286 | CAS RN:1531-25-5 | 3-METHOXYMORPHINAN | UNII:497WV2EY4T
+BMGC_DG12274,BMG_DG166173,"UNII:37AOH3N58S | CAS RN:1644661-10-8 | D-ALANYL-D-ALANINE, (±)- | PubChem CID:5484352 | UNII:MY4X7L3WAM | PubChem SID:318691684 | D-ALANYL-D-ALANINE, (+/-)- | DIALANINE | PubChem SID:316916354 | CAS RN:1948-31-8"
+BMGC_DG12275,BMG_DG166193,"CAS RN:72795-20-1 | CAS RN:72795-26-7 | PubChem CID:5484725 | (2R,3S)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)butan-2-ol | CAS RN:72795-19-8"
+BMGC_DG12276,BMG_DG166194,"(2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid | NDC:42806-053 | NDC:68462-295 | NDC:68462-294 | NDC:68180-566 | NDC:65862-166 | UNII:1T0N3G9CRC | NDC:71335-1431 | PubChem CID:5484727 | NDC:68180-568 | PubChem SID:175266111 | NDC:57237-089 | NDC:42806-054 | NDC:65862-164 | NDC:57237-090 | TRANDOLAPRIL | NDC:68180-567 | Trandolapril | NDC:68462-296 | NDC:68462-329 | NDC:57237-091 | CAS RN:87679-37-6 | NDC:65862-165 | DrugBank ID:DB00519 | NDC:42806-052"
+BMGC_DG12277,BMG_DG166196,"CAS RN:20290-09-9 | MORPHINE-3-GLUCURONIDE | Morphine-3-glucuronide | PubChem SID:198985611 | UNII:O27Z9CH39A | (2S,3S,4S,5R,6S)-6-[[(4R,4aR,7S,7aR,12bS)-7-hydroxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | PubChem CID:5484731"
+BMGC_DG12278,BMG_DG166207,PubChem CID:5485198 | DrugBank ID:DB12975 | Pyronaridine
+BMGC_DG12279,BMG_DG166208,PubChem CID:5485199 | Dermorphin | PubChem SID:198959384 | (2S)-N-[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]-1-[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxamide | CAS RN:77614-16-5 | DERMORPHIN | UNII:2SEC01B703
+BMGC_DG12280,BMG_DG166236,CAS RN:73232-50-5 | PubChem CID:5486183 | Methylnaloxonium | PubChem SID:482554129 | UNII:R4755TU8QX | METHYLNALOXONIUM
+BMGC_DG12281,BMG_DG166248,"PubChem SID:198990983 | PubChem CID:5486546 | CAS RN:183720-02-7 | UNII:52H8DB0TKX | CL-316243 FREE DIACID | Cl-316243 Free diacid | 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylic acid"
+BMGC_DG12282,BMG_DG166253,"UNII:J0W963M37T | PubChem SID:316910990 | (4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol | 6beta-Naltrexol | 6.BETA.-NALTREXOL | PubChem CID:5486554 | CAS RN:49625-89-0"
+BMGC_DG12283,BMG_DG166263,DrugBank ID:DB12177 | PubChem CID:5486684 | Eplivanserin
+BMGC_DG12284,BMG_DG166267,"DrugBank ID:DB13124 | PubChem SID:175268267 | PubChem CID:5486699 | TROXERUTIN | 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | UNII:7Y4N11PXO8 | Troxerutin | CAS RN:55965-63-4 | CAS RN:7085-55-4"
+BMGC_DG12285,BMG_DG166283,"DrugBank ID:DB11812 | PubChem CID:5486799 | UNII:P4ROX5ELT2 | (2S)-2-[[2-[(2S,3S)-7-carboxy-3-(2-carboxyethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioic acid | PubChem SID:198935553 | Monoaspartyl chlorin e6 | Talaporfin | CAS RN:110230-98-3 | TALAPORFIN"
+BMGC_DG12286,BMG_DG166289,"CAS RN:111555-58-9 | Naltriben | PubChem SID:440088615 | PubChem CID:5486827 | UNII:RXG719F189 | (1S,2S,13R,21R)-22-(cyclopropylmethyl)-11,14-dioxa-22-azaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5,7,9,15,17,19(25)-heptaene-2,16-diol | NALTRIBEN"
+BMGC_DG12287,BMG_DG166295,NDC:50228-357 | NDC:60219-1315 | NDC:62135-447 | NDC:82804-184 | NDC:63629-8195 | NDC:80425-0124 | NDC:76420-662 | NDC:76420-121 | NDC:50228-462 | NDC:70518-3597 | NDC:14445-124 | NDC:62135-445 | NDC:80425-0027 | CAS RN:1414928-41-8 | NDC:59762-1364 | NDC:69238-1310 | NDC:71209-035 | NDC:72205-014 | NDC:70518-3346 | NDC:71610-313 | NDC:76420-221 | NDC:69238-1313 | NDC:69097-957 | NDC:82619-122 | NDC:72205-011 | NDC:71610-799 | NDC:70518-3345 | NDC:71205-694 | NDC:68788-8472 | NDC:60760-205 | NDC:69367-326 | NDC:70518-3974 | NDC:65862-765 | NDC:31722-617 | NDC:75834-296 | NDC:63629-8196 | NDC:71335-1791 | NDC:43353-414 | NDC:71610-719 | NDC:62332-126 | NDC:71205-298 | PubChem SID:175267702 | NDC:0071-1018 | NDC:71610-791 | NDC:69097-956 | NDC:71335-1505 | NDC:71610-317 | NDC:55154-8097 | NDC:50228-355 | NDC:69238-1314 | NDC:72162-2025 | NDC:69097-958 | NDC:55700-904 | NDC:82619-124 | NDC:70518-2948 | NDC:71610-318 | NDC:71335-1476 | NDC:71610-316 | NDC:60219-1317 | NDC:60505-3800 | NDC:72162-2115 | NDC:64980-415 | NDC:60760-768 | NDC:68788-8360 | NDC:50090-6504 | NDC:69097-961 | NDC:46708-122 | NDC:43598-295 | NDC:69367-329 | NDC:0904-7002 | Pregabalin | NDC:71610-071 | NDC:75834-298 | NDC:72162-2024 | NDC:71335-2339 | NDC:64980-414 | NDC:67877-462 | NDC:43598-292 | NDC:80425-0026 | NDC:51407-580 | NDC:75834-302 | NDC:69367-324 | NDC:71205-639 | NDC:69539-018 | NDC:71610-729 | NDC:55154-8098 | NDC:80425-0147 | NDC:71610-619 | NDC:46708-123 | PREGABALIN | NDC:25000-185 | NDC:69367-331 | NDC:72162-1542 | NDC:82619-128 | NDC:80425-0417 | NDC:76282-572 | NDC:43353-876 | NDC:69367-330 | NDC:69097-954 | NDC:64980-411 | NDC:65862-762 | NDC:59762-1344 | NDC:0071-1012 | NDC:62332-121 | NDC:60505-3795 | NDC:43547-508 | NDC:69097-679 | NDC:43598-296 | (3S)-3-(aminomethyl)-5-methylhexanoic acid | NDC:62332-124 | NDC:43353-675 | NDC:71205-871 | NDC:71335-1300 | NDC:59762-1342 | NDC:71610-792 | NDC:72189-251 | NDC:76420-100 | NDC:72162-1548 | NDC:71209-039 | NDC:70518-3647 | NDC:71610-760 | NDC:76420-123 | NDC:31722-616 | NDC:60219-1316 | NDC:72205-078 | NDC:80425-0178 | NDC:70518-4024 | NDC:64980-416 | NDC:80425-0030 | NDC:14445-126 | NDC:0071-1014 | NDC:59762-1354 | NDC:71610-677 | NDC:69539-129 | NDC:69238-1311 | NDC:31722-611 | NDC:27808-237 | NDC:72162-2022 | NDC:70518-2762 | NDC:25000-182 | NDC:72162-2027 | NDC:69238-1315 | NDC:68788-7521 | NDC:80425-0152 | NDC:25000-181 | NDC:0071-1026 | NDC:0071-1020 | NDC:27808-235 | NDC:43547-510 | NDC:70518-2745 | NDC:69539-012 | NDC:0904-7004 | NDC:72888-051 | NDC:76420-660 | NDC:58151-246 | NDC:67877-466 | NDC:80425-0116 | NDC:43353-263 | NDC:63629-8208 | NDC:76282-575 | NDC:31722-610 | NDC:63304-047 | NDC:80425-0177 | NDC:71335-1789 | NDC:76420-124 | NDC:80425-0160 | NDC:58151-237 | NDC:60760-591 | NDC:43547-511 | NDC:80425-0025 | NDC:72658-0814 | NDC:62332-125 | NDC:46708-119 | NDC:31722-615 | NDC:80425-0185 | NDC:68788-7527 | NDC:69097-962 | NDC:45865-108 | NDC:72205-016 | NDC:82619-127 | NDC:76282-573 | NDC:70518-2571 | NDC:14445-125 | NDC:76420-247 | NDC:65862-758 | NDC:58151-247 | NDC:71205-816 | NDC:72162-1547 | NDC:72189-269 | NDC:43547-513 | NDC:47335-689 | NDC:60687-473 | NDC:68788-8391 | NDC:51407-576 | NDC:60687-484 | NDC:67877-465 | NDC:63629-8239 | NDC:71610-845 | NDC:82619-126 | NDC:63304-049 | NDC:46708-124 | NDC:70518-2525 | NDC:63304-048 | NDC:71205-677 | PubChem CID:5486971 | NDC:71209-032 | NDC:71610-871 | NDC:71209-034 | NDC:71610-755 | NDC:71335-9671 | NDC:71205-338 | NDC:60760-507 | NDC:72162-2028 | NDC:60505-3797 | NDC:62135-444 | NDC:62135-446 | NDC:72205-077 | NDC:46708-121 | NDC:68788-7523 | NDC:0071-1027 | NDC:72658-0812 | NDC:25000-184 | NDC:80425-0399 | NDC:72162-1545 | NDC:71610-618 | NDC:43547-506 | NDC:50228-463 | NDC:72205-079 | NDC:43598-291 | NDC:55700-827 | NDC:47335-686 | NDC:58151-245 | NDC:71335-9699 | NDC:71205-873 | NDC:45865-126 | NDC:71209-037 | NDC:50090-6503 | NDC:31722-612 | NDC:0904-6992 | NDC:70518-3643 | NDC:72658-0810 | NDC:58151-240 | NDC:0904-7001 | NDC:71209-033 | NDC:0071-1019 | NDC:71335-9740 | NDC:65862-759 | NDC:71335-1475 | NDC:72189-115 | NDC:72162-2304 | NDC:72189-241 | NDC:60505-3799 | NDC:67877-457 | NDC:69238-1316 | NDC:80425-0397 | NDC:43353-264 | NDC:69097-678 | NDC:71335-1740 | NDC:58151-241 | NDC:50090-6793 | NDC:60219-1313 | NDC:31722-613 | NDC:45865-107 | NDC:46708-126 | NDC:59762-1348 | CAS RN:148553-50-8 | NDC:71205-875 | NDC:25000-186 | NDC:55700-775 | NDC:14445-173 | NDC:71610-314 | NDC:0071-1017 | NDC:71610-315 | NDC:47335-690 | NDC:0071-1013 | NDC:71205-556 | NDC:62332-123 | NDC:27808-236 | NDC:76420-249 | NDC:68788-7522 | NDC:82804-049 | NDC:76420-117 | NDC:51407-577 | NDC:47335-688 | NDC:0228-2863 | NDC:58151-242 | NDC:82804-170 | NDC:0904-7000 | NDC:46708-120 | NDC:69238-1317 | NDC:60760-485 | NDC:71205-874 | NDC:76282-568 | NDC:76420-095 | NDC:72162-2023 | NDC:69367-327 | NDC:63629-8199 | NDC:72888-050 | NDC:62332-120 | NDC:76420-120 | NDC:0904-7003 | NDC:0904-7005 | NDC:71205-872 | NDC:51407-579 | NDC:80425-0308 | NDC:71205-304 | NDC:43598-298 | NDC:47335-691 | NDC:71205-396 | NDC:72205-018 | NDC:51407-574 | NDC:76282-569 | NDC:70518-2568 | NDC:71610-759 | NDC:67877-468 | NDC:72162-2026 | NDC:69539-128 | NDC:64980-417 | NDC:69539-127 | NDC:72162-1544 | NDC:64980-413 | NDC:80425-0028 | NDC:72888-049 | NDC:80425-0166 | NDC:72658-0808 | NDC:55700-891 | NDC:76420-122 | NDC:51407-575 | NDC:70518-2978 | NDC:60760-509 | NDC:71335-1751 | NDC:43598-293 | NDC:55700-774 | NDC:14445-123 | NDC:76420-656 | NDC:71335-1758 | NDC:76420-102 | NDC:76282-574 | NDC:62332-122 | NDC:58151-239 | NDC:69097-682 | NDC:68788-7524 | NDC:43598-297 | NDC:72205-017 | NDC:76420-101 | NDC:71610-758 | NDC:14445-174 | NDC:43547-507 | NDC:69367-328 | NDC:71205-621 | NDC:72189-033 | NDC:71335-1788 | NDC:65862-760 | NDC:71335-9691 | NDC:71610-754 | NDC:71209-036 | NDC:58151-244 | NDC:69367-325 | NDC:71205-323 | NDC:72658-0849 | NDC:47335-693 | NDC:55700-804 | NDC:71610-800 | NDC:50228-350 | NDC:69539-014 | NDC:69539-016 | NDC:69539-013 | NDC:67877-467 | NDC:60505-3793 | NDC:82619-123 | NDC:14445-128 | NDC:80425-0123 | NDC:72189-045 | NDC:71335-1744 | NDC:76420-096 | NDC:55154-4308 | NDC:58151-243 | NDC:69097-683 | NDC:72205-013 | NDC:71335-1745 | NDC:71205-869 | NDC:50228-351 | NDC:27808-240 | NDC:75834-300 | NDC:65862-761 | NDC:67877-469 | UNII:55JG375S6M | NDC:51407-581 | NDC:71610-823 | NDC:69097-955 | NDC:71610-808 | NDC:72162-1543 | NDC:50090-5071 | NDC:25000-180 | NDC:70518-2980 | NDC:55700-773 | NDC:50228-352 | NDC:75834-297 | NDC:76420-657 | NDC:47335-692 | NDC:72205-012 | NDC:69539-011 | NDC:50090-6477 | NDC:71610-765 | NDC:64980-412 | NDC:0071-1016 | NDC:62332-119 | NDC:60505-3796 | NDC:72658-0809 | NDC:69097-685 | NDC:68788-8383 | NDC:60505-3794 | NDC:71205-608 | NDC:71209-038 | NDC:68788-8347 | NDC:14445-127 | NDC:60760-486 | NDC:69097-681 | NDC:31722-614 | NDC:71610-320 | NDC:0904-6991 | NDC:69097-684 | NDC:69539-017 | NDC:76420-098 | NDC:60219-1314 | NDC:0071-1015 | NDC:69097-959 | NDC:69238-1312 | NDC:76420-661 | NDC:75834-301 | NDC:80425-0129 | NDC:60219-1310 | NDC:63629-8248 | NDC:55700-805 | NDC:60219-1311 | NDC:65862-764 | NDC:43547-509 | NDC:68788-8667 | NDC:76420-658 | NDC:27808-239 | NDC:80425-0327 | NDC:50228-354 | NDC:50090-5038 | NDC:72189-019 | NDC:71205-696 | NDC:59762-1351 | NDC:50228-356 | NDC:71335-1792 | NDC:76420-099 | NDC:76420-119 | NDC:80425-0277 | NDC:25000-179 | NDC:69539-015 | NDC:72205-015 | NDC:76282-570 | NDC:60687-517 | NDC:50228-353 | NDC:67877-464 | NDC:80425-0421 | NDC:70518-3636 | NDC:45865-106 | NDC:71610-820 | NDC:71335-1762 | NDC:80425-0170 | NDC:60219-1312 | NDC:69097-677 | NDC:39328-090 | NDC:70518-2763 | NDC:60687-495 | NDC:71205-870 | NDC:71335-1822 | NDC:76420-583 | NDC:82619-129 | NDC:50228-464 | NDC:72658-0811 | NDC:68788-7656 | NDC:71335-2343 | NDC:55700-964 | NDC:43598-294 | NDC:75834-303 | NDC:72189-328 | DrugBank ID:DB00230 | NDC:58151-236 | NDC:59762-1576 | NDC:71335-1555 | NDC:80425-0433 | NDC:76420-248 | NDC:27808-238 | NDC:67877-463 | NDC:43353-413 | NDC:46708-125 | NDC:70518-3646 | NDC:76282-571 | NDC:71335-1790 | NDC:72162-1546 | NDC:65862-763 | NDC:43547-512 | NDC:71335-1459 | NDC:60505-3798 | NDC:76420-659 | NDC:80425-0029 | NDC:64980-410 | NDC:71205-733 | NDC:72162-1541 | NDC:59762-1346 | NDC:71610-319 | NDC:72189-021 | NDC:82619-125 | NDC:72658-0813 | NDC:25000-183 | NDC:58151-238 | NDC:63629-8198 | NDC:47335-687 | NDC:75834-299 | NDC:68788-7520 | NDC:27808-241 | NDC:63629-8197 | NDC:72189-164 | NDC:51407-578 | NDC:60687-506 | NDC:71205-876 | NDC:43353-840 | NDC:76420-118 | NDC:76420-097 | NDC:80425-0307
+BMGC_DG12288,BMG_DG166298,"Tizanidine | PubChem CID:5487 | CAS RN:51322-75-9 | TIZANIDINE | PubChem SID:175265727 | UNII:6AI06C00GW | DrugBank ID:DB00697 | 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2,1,3-benzothiadiazol-4-amine"
+BMGC_DG12289,BMG_DG166304,CAS RN:124886-01-7 | UNII:ALR3F45M10 | BMY-20844 | PubChem CID:5487281 | PubChem SID:363909354
+BMGC_DG12290,BMG_DG166307,DrugBank ID:DB08482 | [[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER | PubChem CID:5487313
+BMGC_DG12291,BMG_DG166311,"Tiotropium bromide | PubChem SID:175268305 | NDC:0597-0100 | NDC:0597-0160 | [(1S,2S,4R,5R)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate;bromide | TIOTROPIUM BROMIDE ANHYDROUS | PubChem CID:5487426 | CAS RN:136310-93-5 | UNII:XX112XZP0J"
+BMGC_DG12292,BMG_DG166312,"[(1S,2S,4R,5R)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate | DrugBank ID:DB01409 | PubChem CID:5487427 | PubChem SID:175268858 | TIOTROPIUM | CAS RN:186691-13-4 | Tiotropium | UNII:0EB439235F"
+BMGC_DG12293,BMG_DG166319,Biphalin | CAS RN:83916-01-2 | PubChem CID:5487663 | (2S)-2-amino-N-[(2R)-1-[[2-[[(2S)-1-[2-[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]hydrazinyl]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]-3-(4-hydroxyphenyl)propanamide
+BMGC_DG12294,BMG_DG166326,"Citrusinine I | PubChem CID:5487772 | CAS RN:86680-32-2 | 1,5-dihydroxy-3,4-dimethoxy-10-methylacridin-9-one"
+BMGC_DG12295,BMG_DG166330,"PubChem CID:5487888 | PubChem SID:198938803 | UNII:4R5TV783X3 | CEFETAMET | CAS RN:65052-63-3 | Cefetamet | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | DrugBank ID:DB13504"
+BMGC_DG12296,BMG_DG166337,"Talaporfin sodium | CAS RN:220680-62-6 | PubChem CID:5488036 | tetrasodium;(2S)-2-[[2-[(2S,3S)-7-carboxylato-3-(2-carboxylatoethyl)-17-ethenyl-12-ethyl-2,8,13,18-tetramethyl-2,3,23,24-tetrahydroporphyrin-5-yl]acetyl]amino]butanedioate | PubChem SID:198981603 | CAS RN:220201-34-3 | UNII:L63605PZ70 | TALAPORFIN SODIUM"
+BMGC_DG12297,BMG_DG166382,"NDC:0254-3012 | ALVIMOPAN | PubChem CID:5488547 | UNII:677C126AET | NDC:0591-2312 | 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid;dihydrate | NDC:0054-0668 | NDC:51407-870 | PubChem SID:175265313 | CAS RN:170098-38-1 | Alvimopan dihydrate"
+BMGC_DG12298,BMG_DG166383,"PubChem CID:5488548 | CAS RN:145590-44-9 | ALVIMOPAN ANHYDROUS | PubChem SID:175267928 | UNII:Q153V49P3Z | DrugBank ID:DB06274 | Alvimopan | 2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid | CAS RN:156053-89-3"
+BMGC_DG12299,BMG_DG166388,DrugBank ID:DB04342 | PubChem CID:5488645 | 7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid
+BMGC_DG12300,BMG_DG166392,CAS RN:83398-08-7 | PubChem SID:198983744 | PubChem CID:5488746 | DELAPRILAT | UNII:50A464U6E7
+BMGC_DG12301,BMG_DG166407,"CAS RN:21071-51-2 | UNII:DWL616XF1K | Oxyfedrine | CAS RN:15687-41-9 | OXYFEDRINE | 3-[[(1R,2S)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-(3-methoxyphenyl)propan-1-one | DrugBank ID:DB13398 | PubChem SID:198946224 | PubChem CID:5489013"
+BMGC_DG12302,BMG_DG166410,"UNII:E2M937KY47 | CAS RN:20736-11-2 | (2S,3S,4S,5R,6R)-6-[[(4R,4aR,7S,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | Codeine-6-glucuronide | CODEINE-6-GLUCURONIDE | PubChem CID:5489029 | PubChem SID:198971188 | CAS RN:219533-59-2"
+BMGC_DG12303,BMG_DG166413,"NDC:68180-559 | NDC:63187-425 | NDC:63629-8710 | NDC:71335-1134 | NDC:68180-557 | NDC:69097-843 | NDC:62135-486 | NDC:43547-410 | NDC:65862-620 | PubChem CID:54891 | NDC:43547-411 | NDC:68001-187 | NDC:68001-188 | NDC:0071-0535 | Quinapril Hydrochloride | (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;hydrochloride | NDC:68180-554 | NDC:68001-260 | NDC:51655-737 | NDC:65862-617 | NDC:68180-558 | QUINAPRIL HYDROCHLORIDE | NDC:69097-841 | NDC:71205-484 | NDC:71205-635 | NDC:63187-874 | PubChem SID:175268356 | NDC:69097-839 | NDC:65862-618 | NDC:0071-0530 | NDC:43547-413 | NDC:0071-0527 | NDC:62135-487 | NDC:62135-485 | NDC:62135-484 | NDC:69097-842 | NDC:0071-0532 | NDC:63629-7934 | NDC:71335-1707 | CAS RN:82586-55-8 | NDC:68001-189 | UNII:33067B3N2M | NDC:65862-619 | NDC:43547-412"
+BMGC_DG12304,BMG_DG166414,"UNII:95Q949779D | PubChem CID:5489120 | Noroxycodone | (4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-1,2,3,4,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one | CAS RN:57664-96-7 | NOROXYCODONE | PubChem SID:198954746"
+BMGC_DG12305,BMG_DG166415,"CAS RN:85441-61-8 | PubChem SID:175266171 | PubChem CID:54892 | (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid | Quinapril | QUINAPRIL | DrugBank ID:DB00881 | UNII:RJ84Y44811"
+BMGC_DG12306,BMG_DG166418,CAS RN:109351-36-2 | PubChem SID:472422883 | PubChem CID:5489400 | UNII:J5624PB437 | SINOCOCULINE
+BMGC_DG12307,BMG_DG166419,PubChem SID:441331478 | UNII:YFG7XE25DV | PubChem CID:5489408 | CAS RN:111581-85-2 | MDL-27088
+BMGC_DG12308,BMG_DG166426,"CAS RN:521-38-0 | PubChem CID:5489487 | 5,7-dihydroxy-8-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)-4-propylchromen-2-one | Mammea B/BA"
+BMGC_DG12309,BMG_DG166431,"DrugBank ID:DB12926 | (-)-Cafedrine | PubChem CID:5489638 | CAFEDRINE | CAS RN:58166-83-9 | UNII:0UYY5V4U2Q | Cafedrine | 7-[2-[[(1R,2S)-1-hydroxy-1-phenylpropan-2-yl]amino]ethyl]-1,3-dimethylpurine-2,6-dione | PubChem SID:198987113"
+BMGC_DG12310,BMG_DG166432,"CAS RN:82626-01-5 | UNII:I93SC245QZ | 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide | PubChem CID:54897 | PubChem SID:198946219 | ALPIDEM | Alpidem"
+BMGC_DG12311,BMG_DG166442,PubChem CID:5490139 | CAS RN:34086-50-5 | PubChem SID:198966398 | UNII:6Q33HOF94Z | ALPINUMISOFLAVONE
+BMGC_DG12312,BMG_DG166456,"PubChem SID:175271576 | DrugBank ID:DB12766 | UNII:CHG7QC509W | PubChem CID:54910 | CAS RN:89943-82-8 | Cicletanine | 3-(4-chlorophenyl)-6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol | CICLETANINE"
+BMGC_DG12313,BMG_DG166466,CAS RN:172927-65-0 | CAS RN:170094-62-9 | PubChem CID:5491394 | SIBRAFIBAN | UNII:YUE443B0NF | ethyl 2-[1-[(2S)-2-[[4-[(E)-N'-hydroxycarbamimidoyl]benzoyl]amino]propanoyl]piperidin-4-yl]oxyacetate | PubChem SID:198984085
+BMGC_DG12314,BMG_DG166486,"NALOXONE, (+)- | UNII:54MPN7YN98 | Naloxone, (+)- | PubChem SID:474492845 | PubChem CID:5491858 | CAS RN:65700-73-4"
+BMGC_DG12315,BMG_DG166487,CAS RN:111469-88-6 | Oxymorphindole | OXYMORPHINDOLE | PubChem SID:478838491 | UNII:B85P9S9T5L | PubChem CID:5491897
+BMGC_DG12316,BMG_DG166496,OCHNAFLAVONE | UNII:5B97Q9UZ5T | PubChem CID:5492110 | PubChem SID:474492499 | CAS RN:50276-96-5 | Ochnaflavone
+BMGC_DG12317,BMG_DG166503,CAS RN:112859-12-8 | PubChem CID:5492386 | PubChem SID:438789052 | UNII:ZC0V0RZ3CB | BMY-21638
+BMGC_DG12318,BMG_DG166504,DrugBank ID:DB08762 | O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID | PubChem CID:5492457
+BMGC_DG12319,BMG_DG166524,"UNII:0H851I3O9D | 5-BENZYLACYCLOURIDINE | PubChem CID:54929 | 5-Benzylacyclouridine | CAS RN:82857-69-0 | PubChem SID:198944204 | DrugBank ID:DB07437 | 5-benzyl-1-(2-hydroxyethoxymethyl)pyrimidine-2,4-dione"
+BMGC_DG12320,BMG_DG166531,PubChem SID:198976750 | UNII:LN3E1Q0SU2 | RAFABEGRON | PubChem CID:5493324 | CAS RN:244081-42-3
+BMGC_DG12321,BMG_DG166533,Deferasirox | PubChem CID:5493381 | DrugBank ID:DB01609
+BMGC_DG12322,BMG_DG166536,"Aliskiren | CAS RN:1327153-71-8 | ALISKIREN | PubChem SID:175268617 | UNII:502FWN4Q32 | PubChem CID:5493444 | CAS RN:173334-57-1 | (2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide | DrugBank ID:DB09026"
+BMGC_DG12323,BMG_DG166538,PubChem SID:198982054 | UNII:5797K23F95 | NM-3 | PubChem CID:5493470 | DrugBank ID:DB12818 | 2-(8-hydroxy-6-methoxy-1-oxoisochromen-3-yl)propanoic acid | CAS RN:181427-78-1 | 2-(8-Hydroxy-6-methoxy-1-oxoisochromen-3-yl)propanoic acid
+BMGC_DG12324,BMG_DG166547,"DrugBank ID:DB04578 | PubChem CID:5494385 | (S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide"
+BMGC_DG12325,BMG_DG166548,"DrugBank ID:DB04633 | N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine | PubChem CID:5494411"
+BMGC_DG12326,BMG_DG166549,OLOMOUCINE II | DrugBank ID:DB04662 | PubChem CID:5494414
+BMGC_DG12327,BMG_DG166551,DrugBank ID:DB07779 | PubChem CID:5494422 | N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE
+BMGC_DG12328,BMG_DG166552,"2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one | PubChem SID:319892563 | PubChem CID:5494425 | CAS RN:457081-03-7 | PYRIDONE-6 | UNII:LDX3F0CCST | DrugBank ID:DB04716"
+BMGC_DG12329,BMG_DG166555,DrugBank ID:DB04771 | 1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE | PubChem CID:5494439
+BMGC_DG12330,BMG_DG166556,DrugBank ID:DB04772 | PubChem CID:5494440 | 1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE
+BMGC_DG12331,BMG_DG166557,PubChem CID:5494443 | 4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN | DrugBank ID:DB08480
+BMGC_DG12332,BMG_DG166560,PubChem CID:5494449 | UNII:234335M86K | PubChem SID:198947178 | CAS RN:936915-58-1 | CAS RN:639089-54-6 | N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide | Tozasertib | TOZASERTIB
+BMGC_DG12333,BMG_DG166566,PubChem CID:5494868 | SOTETSUFLAVONE | UNII:AL6OQW24CT | CAS RN:2608-21-1 | PubChem SID:438787572
+BMGC_DG12334,BMG_DG166567,"PubChem SID:198987850 | CAS RN:82952-64-5 | PubChem CID:54949 | TRIMETREXATE GLUCURONATE | UNII:L137U4A79K | Trimetrexate Glucuronate | 5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine;(2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid"
+BMGC_DG12335,BMG_DG166570,PubChem CID:5495818 | PubChem SID:198946200 | UNII:IMN5E6PLUK | CAS RN:357263-13-9 | BMS-378806
+BMGC_DG12336,BMG_DG166572,"1,6-dihydroxy-3,7-dimethoxy-2,8-bis(3-methylbut-2-enyl)xanthen-9-one | CAS RN:20931-37-7 | PubChem CID:5495925 | Beta-Mangostin"
+BMGC_DG12337,BMG_DG166573,"Garcinone D | CAS RN:107390-08-9 | PubChem CID:5495926 | 1,3,6-trihydroxy-8-(3-hydroxy-3-methylbutyl)-7-methoxy-2-(3-methylbut-2-enyl)xanthen-9-one"
+BMGC_DG12338,BMG_DG166575,"5,9-dihydroxy-8-methoxy-2,2-dimethyl-7-(3-methylbut-2-enyl)pyrano[3,2-b]xanthen-6-one | PubChem CID:5495929 | 9-Hydroxycalabaxanthone | CAS RN:35349-68-9"
+BMGC_DG12339,BMG_DG166580,PubChem SID:485665444 | CAS RN:730-08-5 | L-Tyrosyl-L-alanine | L-TYROSYL-L-ALANINE | PubChem CID:5496455 | UNII:Y2DJ9AYE8Z
+BMGC_DG12340,BMG_DG166585,"PubChem CID:5496597 | (S)-oxalosuccinic acid | DrugBank ID:DB02190 | (2S)-1-oxopropane-1,2,3-tricarboxylic acid"
+BMGC_DG12341,BMG_DG166586,PubChem CID:5496599 | N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide | DrugBank ID:DB03596
+BMGC_DG12342,BMG_DG166592,PubChem CID:5496653 | N-[4-(4-nitrophenylphospho)butanoyl]-L-alanine | DrugBank ID:DB08411
+BMGC_DG12343,BMG_DG166593,"PubChem CID:5496659 | UNII:S173RED00L | CAS RN:193153-04-7 | PubChem SID:198988717 | Otamixaban | OTAMIXABAN | DrugBank ID:DB06635 | methyl (2R,3R)-2-[(3-carbamimidoylphenyl)methyl]-3-[[4-(1-oxidopyridin-1-ium-4-yl)benzoyl]amino]butanoate"
+BMGC_DG12344,BMG_DG166595,PubChem CID:5496715 | DrugBank ID:DB04278 | 2-[2-(2-Cyclohexyl-2-guanidino-acetylamino)-acetylamino]-N-(3-mercapto-propyl)-propionamide
+BMGC_DG12345,BMG_DG166599,6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID | DrugBank ID:DB06866 | PubChem CID:5496862
+BMGC_DG12346,BMG_DG166600,"DrugBank ID:DB03621 | L-709,587 | PubChem CID:5496872"
+BMGC_DG12347,BMG_DG166605,"N,N-diethylpyridine-3-carboxamide | CAS RN:59-26-7 | UNII:368IVD6M32 | PubChem SID:198977733 | Nikethamide | NIKETHAMIDE | PubChem CID:5497 | DrugBank ID:DB13655"
+BMGC_DG12348,BMG_DG166607,PubChem CID:5497045 | DrugBank ID:DB03757 | N-{[(2-Methyl-2-propanyl)oxy]carbonyl}-L-alanyl-L-alaninamide
+BMGC_DG12349,BMG_DG166608,RPR128515 | PubChem CID:5497056 | DrugBank ID:DB04424
+BMGC_DG12350,BMG_DG166614,"Arachidonyl-coa | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenethioate | PubChem CID:5497113 | CAS RN:17046-56-9"
+BMGC_DG12351,BMG_DG166616,CAS RN:95167-41-2 | GSK-9089 | PubChem SID:198967032 | PubChem CID:5497124 | UNII:5VWV92039E
+BMGC_DG12352,BMG_DG166618,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] (E)-but-2-enethioate | CAS RN:992-67-6 | PubChem CID:5497143 | CROTONYL COENZYME A | PubChem SID:441659751 | crotonoyl-CoA | UNII:Q959BSX9OA"
+BMGC_DG12353,BMG_DG166621,Lysophosphatidic acid | (2-hydroxy-3-phosphonooxypropyl) (Z)-octadec-9-enoate | UNII:PG6M3969SG | PubChem CID:5497152 | LYSOPHOSPHATIDIC ACID | CAS RN:22002-87-5 | PubChem SID:316909556
+BMGC_DG12354,BMG_DG166625,"DrugBank ID:DB13038 | UNII:O05EC62663 | 2,3-bis[[(Z)-octadec-9-enoyl]oxy]propyl (Z)-octadec-9-enoate | PubChem SID:175268362 | Glyceryl Trioleate | GLYCERYL TRIOLEATE | CAS RN:122-32-7 | PubChem CID:5497163"
+BMGC_DG12355,BMG_DG166628,PubChem CID:5497171 | DrugBank ID:DB07744 | Z-Val-Ala-Asp fluoromethyl ketone
+BMGC_DG12356,BMG_DG166631,"CAS RN:24880-45-3 | CLUPANODONIC ACID | Docosapentaenoic Acid | CAS RN:244880-45-3 | CAS RN:32839-34-2 | PubChem CID:5497182 | UNII:NS3OZT14QT | (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid | PubChem SID:198971597"
+BMGC_DG12357,BMG_DG166632,"PubChem SID:198943750 | PubChem CID:5497186 | NALTRINDOLE | CAS RN:111555-53-4 | Naltrindole | UNII:G167Z38QA4 | (1S,2S,13R,21R)-22-(cyclopropylmethyl)-14-oxa-11,22-diazaheptacyclo[13.9.1.01,13.02,21.04,12.05,10.019,25]pentacosa-4(12),5,7,9,15,17,19(25)-heptaene-2,16-diol"
+BMGC_DG12358,BMG_DG166648,"PubChem SID:198990074 | PubChem CID:5502 | TOFISOPAM | 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine | DrugBank ID:DB08811 | Tofisopam | CAS RN:22345-47-7 | UNII:UZC80HAU42"
+BMGC_DG12359,BMG_DG166651,CAS RN:1156-19-0 | 1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea | TOLAZAMIDE | DrugBank ID:DB00839 | Tolazamide | PubChem CID:5503 | PubChem SID:175267995 | UNII:9LT1BRO48Q
+BMGC_DG12360,BMG_DG166654,"CAS RN:59-98-3 | PubChem SID:175268077 | 2-benzyl-4,5-dihydro-1H-imidazole | PubChem CID:5504 | TOLAZOLINE | DrugBank ID:DB00797 | Tolazoline | UNII:CHH9H12AQ3"
+BMGC_DG12361,BMG_DG166656,TOLBUTAMIDE | PubChem SID:175268502 | PubChem CID:5505 | CAS RN:64-77-7 | Tolbutamide | DrugBank ID:DB01124 | UNII:982XCM1FOI | 1-butyl-3-(4-methylphenyl)sulfonylurea
+BMGC_DG12362,BMG_DG166666,PubChem CID:5509 | Tolmetin | UNII:D8K2JPN18B | CAS RN:26171-23-3 | TOLMETIN | 2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetic acid | DrugBank ID:DB00500 | PubChem SID:175267561
+BMGC_DG12363,BMG_DG166667,NDC:52000-418 | NDC:41250-563 | NDC:50090-6147 | NDC:59088-477 | NDC:84010-065 | NDC:84023-501 | NDC:84168-036 | NDC:55505-234 | NDC:55505-193 | NDC:81929-004 | NDC:55301-132 | NDC:11822-0051 | NDC:57896-199 | NDC:23667-809 | NDC:55301-131 | NDC:67091-051 | NDC:11673-586 | NDC:44577-001 | NDC:84168-042 | NDC:83767-003 | NDC:84010-049 | NDC:83364-008 | NDC:0904-0722 | NDC:85038-001 | NDC:23667-816 | NDC:83872-330 | NDC:36800-075 | NDC:79903-055 | NDC:56104-252 | NDC:63347-511 | NDC:65923-021 | NDC:56104-902 | NDC:84117-019 | DrugBank ID:DB00525 | NDC:83872-438 | NDC:63868-181 | NDC:79903-016 | NDC:84168-046 | NDC:0363-7998 | NDC:72839-510 | NDC:11523-1190 | NDC:70856-3581 | NDC:73469-0691 | NDC:84010-026 | NDC:84168-041 | NDC:63941-541 | NDC:84168-040 | NDC:72446-012 | NDC:84010-013 | NDC:36800-006 | NDC:63868-798 | NDC:83872-329 | NDC:50090-3358 | NDC:84168-022 | NDC:23667-803 | NDC:84222-002 | NDC:11822-0782 | NDC:84369-143 | TOLNAFTATE | NDC:70000-0680 | NDC:21130-213 | NDC:23667-818 | NDC:11527-051 | NDC:62858-101 | NDC:69842-274 | NDC:83364-013 | NDC:72446-011 | NDC:84010-002 | NDC:63736-819 | NDC:36800-877 | NDC:83675-030 | NDC:49348-155 | NDC:49873-056 | NDC:79481-0592 | NDC:51672-2020 | NDC:0536-1329 | NDC:84010-032 | NDC:10157-4645 | NDC:73046-124 | NDC:81522-077 | NDC:79481-0660 | NDC:24385-032 | NDC:49873-050 | NDC:55505-219 | NDC:68071-4245 | NDC:51316-981 | NDC:69729-610 | NDC:85038-002 | NDC:23667-815 | NDC:53943-007 | NDC:84117-014 | NDC:67091-276 | NDC:23667-814 | NDC:84168-035 | NDC:23667-810 | NDC:69983-026 | NDC:73352-561 | NDC:79903-256 | NDC:46063-810 | NDC:67234-032 | NDC:72839-507 | NDC:41250-499 | NDC:69070-305 | NDC:36800-399 | NDC:79903-015 | NDC:49035-499 | NDC:83004-012 | NDC:83872-328 | NDC:41250-386 | NDC:44577-128 | NDC:0363-0216 | NDC:79481-0622 | NDC:84614-002 | NDC:59779-511 | NDC:11673-091 | NDC:84168-049 | NDC:84117-022 | NDC:83767-701 | NDC:23667-807 | NDC:11523-4162 | Tolnaftate | NDC:43136-104 | NDC:11523-0138 | NDC:70000-0322 | NDC:11523-0137 | NDC:83364-006 | NDC:83872-327 | NDC:11523-0777 | NDC:71101-934 | NDC:83324-301 | NDC:84010-035 | O-naphthalen-2-yl N-methyl-N-(3-methylphenyl)carbamothioate | NDC:23667-805 | NDC:72446-013 | NDC:83809-021 | NDC:82739-018 | NDC:67091-390 | NDC:79481-0623 | NDC:23667-813 | NDC:69396-130 | NDC:83364-011 | NDC:29784-181 | NDC:83324-049 | NDC:36800-023 | NDC:73046-613 | NDC:30142-147 | NDC:83767-501 | NDC:11822-9600 | NDC:11523-0165 | UNII:06KB629TKV | NDC:23667-820 | NDC:63941-540 | NDC:63941-557 | NDC:84010-003 | NDC:68016-663 | NDC:83872-326 | NDC:44577-470 | NDC:36800-876 | NDC:68016-609 | NDC:70677-1001 | NDC:69256-034 | NDC:37808-521 | NDC:82442-020 | NDC:21130-215 | NDC:83592-480 | NDC:84369-074 | NDC:30142-841 | NDC:83767-801 | NDC:70000-0494 | NDC:0363-0155 | NDC:84844-016 | NDC:65112-300 | NDC:84117-025 | NDC:11523-0934 | NDC:79481-0607 | NDC:83837-002 | NDC:84369-070 | PubChem CID:5510 | NDC:52389-298 | PubChem SID:175265352 | NDC:69842-336 | NDC:84369-087 | NDC:84033-006 | NDC:29784-183 | NDC:16864-100 | NDC:76020-100 | NDC:70356-001 | NDC:44577-002 | NDC:69396-042 | CAS RN:2398-96-1 | NDC:55319-538 | NDC:23667-806 | NDC:54291-036 | NDC:30142-125 | NDC:69396-016 | NDC:83837-001 | NDC:23667-811 | NDC:79481-0625 | NDC:16864-110 | NDC:11523-0011 | NDC:67091-753 | NDC:11822-0780 | NDC:55505-177 | NDC:59088-640 | NDC:0363-0186 | NDC:79481-0591 | NDC:58593-286 | NDC:69882-726 | NDC:82739-022 | NDC:84010-029 | NDC:11523-0136 | NDC:11673-093 | NDC:11822-0781 | NDC:21130-887 | NDC:70000-0637 | NDC:37808-530 | NDC:59088-443 | NDC:80684-040 | NDC:85038-005 | NDC:51151-000 | NDC:56104-247 | NDC:55505-203 | NDC:56104-248 | NDC:81522-068 | NDC:0363-1298 | NDC:82442-956 | NDC:58593-800 | NDC:68016-653 | NDC:84168-048 | NDC:84844-017 | NDC:11523-0010 | NDC:55505-195 | NDC:11523-0139 | NDC:69842-512 | NDC:73352-560 | NDC:70000-0084 | NDC:51824-001 | NDC:81929-001 | NDC:84010-059 | NDC:0363-1746 | NDC:84117-001 | NDC:83872-263 | NDC:41520-086 | NDC:63941-564 | NDC:11523-0072 | NDC:67091-391 | NDC:58593-288 | NDC:69842-185 | NDC:81929-006 | NDC:83872-262 | NDC:73469-0549 | NDC:83872-442 | NDC:84033-003 | NDC:77338-934 | NDC:68016-152 | NDC:79481-0604 | NDC:55505-185 | NDC:37808-514 | NDC:68016-586 | NDC:58593-285 | NDC:51316-898 | NDC:71335-2249 | NDC:10742-0020 | NDC:49035-252 | NDC:0536-1315 | NDC:56104-900 | NDC:41250-635 | NDC:56104-242
+BMGC_DG12364,BMG_DG166669,"UNII:4UO44T09QM | PubChem SID:198970072 | 1,2,3,6-TETRACHLORODIBENZOFURAN | 1,2,3,6-tetrachlorodibenzofuran | CAS RN:83704-21-6 | PubChem CID:55103 | 1,2,3,6-Tetrachlorodibenzofuran"
+BMGC_DG12365,BMG_DG166670,"1,2,3,7-TETRACHLORODIBENZOFURAN | PubChem SID:198942767 | CAS RN:83704-22-7 | 1,2,3,7-tetrachlorodibenzofuran | UNII:27924P92AY | 1,2,3,7-Tetrachlorodibenzofuran | PubChem CID:55104"
+BMGC_DG12366,BMG_DG166678,UNII:F5EOM0LD8E | 2-methyl-1-(4-methylphenyl)-3-piperidin-1-ylpropan-1-one | TOLPERISONE | CAS RN:728-88-1 | PubChem CID:5511 | PubChem SID:198953950 | DrugBank ID:DB06264 | Tolperisone
+BMGC_DG12367,BMG_DG166680,"UNII:4Z881H17NW | 2,3,4,7-TETRACHLORODIBENZOFURAN | PubChem SID:198982472 | 2,3,4,7-tetrachlorodibenzofuran | CAS RN:83704-31-8 | PubChem CID:55111 | 2,3,4,7-Tetrachlorodibenzofuran"
+BMGC_DG12368,BMG_DG166681,"2,3,4,8-Tetrachlorodibenzofuran | 2,3,4,8-TETRACHLORODIBENZOFURAN | 2,3,4,8-tetrachlorodibenzofuran | PubChem CID:55112 | PubChem SID:198979335 | UNII:5YIF7JI7VA | CAS RN:83704-32-9"
+BMGC_DG12369,BMG_DG166688,"1,3,6-TRICHLORODIBENZOFURAN | UNII:I043FM5MR8 | 1,3,6-trichlorodibenzofuran | PubChem SID:198952064 | 1,3,6-Trichlorodibenzofuran | CAS RN:83704-39-6 | PubChem CID:55119"
+BMGC_DG12370,BMG_DG166695,"UNII:EY831QW1U5 | CAS RN:83704-45-4 | 2,6,7-trichlorodibenzofuran | PubChem SID:198958103 | 2,6,7-TRICHLORODIBENZOFURAN | 2,6,7-Trichlorodibenzofuran | PubChem CID:55125"
+BMGC_DG12371,BMG_DG166703,"PubChem CID:55130 | PubChem SID:198939122 | CAS RN:83704-50-1 | 1,2,4,6,7-PENTACHLORODIBENZOFURAN | UNII:MI8HUV9QAR | 1,2,4,6,7-Pentachlorodibenzofuran | 1,2,4,6,7-pentachlorodibenzofuran"
+BMGC_DG12372,BMG_DG166707,"CAS RN:83704-53-4 | 1,2,3,7,9-pentachlorodibenzofuran | PubChem CID:55133 | 1,2,3,7,9-Pentachlorodibenzofuran | UNII:97FAG97HI0 | PubChem SID:198953020 | 1,2,3,7,9-PENTACHLORODIBENZOFURAN"
+BMGC_DG12373,BMG_DG166725,2-BUTYL-5-CHLORO-1H-IMIDAZOLE-4-CARBALDEHYDE | CAS RN:83857-96-9 | PubChem SID:198986630 | UNII:7H170U0SWE | PubChem CID:55176
+BMGC_DG12374,BMG_DG166733,"PubChem CID:55191 | DrugBank ID:DB12184 | UNII:JW5Y7B8Z18 | Gepirone | 4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione | PubChem SID:175265394 | CAS RN:83928-76-1 | GEPIRONE"
+BMGC_DG12375,BMG_DG166741,CAS RN:182485-36-5 | PubChem CID:5521 | TPMPA | UNII:TR7I0800L2 | PubChem SID:241179637
+BMGC_DG12376,BMG_DG166744,TRACAZOLATE | PubChem CID:5522 | PubChem SID:198944829 | UNII:NH0HPL3U1T | CAS RN:41094-88-6
+BMGC_DG12377,BMG_DG166745,DrugBank ID:DB13027 | Tucaresol | PubChem SID:198948732 | UNII:JH368G5B9M | CAS RN:84290-27-7 | PubChem CID:55223 | 4-[(2-formyl-3-hydroxyphenoxy)methyl]benzoic acid | TUCARESOL
+BMGC_DG12378,BMG_DG166750,"PubChem SID:198984905 | N-(5,6,7,8-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine | TRAMAZOLINE | UNII:SLE31693IV | CAS RN:1082-57-1 | PubChem CID:5524 | Tramazoline | DrugBank ID:DB13064"
+BMGC_DG12379,BMG_DG166751,"CAS RN:84371-65-3 | (8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | NDC:76346-073 | NDC:76346-654 | Mifepristone | NDC:0591-4390 | UNII:320T6RNW1F | MIFEPRISTONE | PubChem CID:55245 | DrugBank ID:DB00834 | NDC:43393-001 | CAS RN:83203-42-3 | PubChem SID:175266638 | CAS RN:122742-25-0"
+BMGC_DG12380,BMG_DG166762,"NDC:25021-418 | NDC:69918-301 | NDC:63629-8838 | NDC:0517-0960 | NDC:71335-1957 | TRANEXAMIC ACID | 4-(aminomethyl)cyclohexane-1-carboxylic acid | NDC:43066-008 | NDC:72485-510 | NDC:70771-1085 | NDC:81284-612 | NDC:70860-407 | NDC:50268-772 | PubChem SID:198972323 | PubChem CID:5526 | NDC:70121-1398 | CAS RN:701-54-2 | NDC:23155-524 | NDC:51754-0108 | NDC:0013-1114 | NDC:69918-300 | NDC:14593-318 | CAS RN:1197-17-7 | NDC:70518-4089 | NDC:67850-041 | NDC:51662-1532 | NDC:67457-197 | NDC:68083-613 | NDC:72888-178 | NDC:25021-415 | NDC:23155-166 | NDC:59651-839 | NDC:65145-106 | NDC:60687-750 | NDC:81284-611 | Tranexamic acid | NDC:68083-160 | NDC:68382-891 | NDC:60505-6169 | UNII:37YD696II6 | NDC:72603-387 | NDC:65219-534 | NDC:66298-5340 | UNII:6T84R30KC1 | NDC:42571-189 | NDC:50090-5072 | NDC:63323-563 | NDC:67850-042 | NDC:42571-314 | NDC:55150-188 | NDC:72485-107 | NDC:14789-115 | CAS RN:1197-18-8 | NDC:83634-401 | DrugBank ID:DB00302 | PubChem SID:175267527 | NDC:23155-909 | TRANEXAMIC ACID, CIS- | NDC:63629-8599 | NDC:23155-910 | NDC:71335-1981 | NDC:0591-3720 | NDC:80830-2329 | NDC:39822-1000 | NDC:62559-265"
+BMGC_DG12381,BMG_DG166764,"CAS RN:84490-12-0 | UNII:2VSD0380YB | 4-ethyl-5-(pyridine-4-carbonyl)-1,3-dihydroimidazol-2-one | PubChem CID:55263 | PIROXIMONE | PubChem SID:198942554 | Piroximone"
+BMGC_DG12382,BMG_DG166780,"NDC:65162-087 | DrugBank ID:DB01167 | NDC:70518-2872 | NDC:31722-006 | NDC:69339-159 | NDC:60687-299 | PubChem SID:175271485 | CAS RN:84604-65-9 | NDC:70771-1208 | 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one | NDC:49884-239 | Itraconazole | NDC:50268-450 | ITRACONAZOLE | NDC:50458-290 | NDC:13668-463 | NDC:68382-697 | NDC:10147-1700 | NDC:16571-245 | NDC:16714-743 | PubChem CID:55283 | NDC:46708-204 | UNII:304NUG5GF4 | NDC:10147-0150 | NDC:67877-454 | CAS RN:84625-61-6 | NDC:65162-630 | NDC:50458-295 | NDC:62332-204 | CAS RN:873066-43-4 | NDC:51862-462"
+BMGC_DG12383,BMG_DG166781,"Dotarizine | UNII:IO7663S6D3 | CAS RN:84625-59-2 | PubChem SID:198942116 | DrugBank ID:DB06446 | 1-benzhydryl-4-[3-(2-phenyl-1,3-dioxolan-2-yl)propyl]piperazine | DOTARIZINE | PubChem CID:55285"
+BMGC_DG12384,BMG_DG166816,DrugBank ID:DB00752 | 2-phenylcyclopropan-1-amine | CAS RN:155-09-9 | Parnate | Tranylcypromine | PubChem CID:5530 | CAS RN:54-97-7
+BMGC_DG12385,BMG_DG166824,"PubChem SID:198941600 | PubChem CID:5531 | DrugBank ID:DB09283 | Trapidil | UNII:EYG5Y6355E | TRAPIDIL | N,N-diethyl-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine | CAS RN:15421-84-8"
+BMGC_DG12386,BMG_DG166830,"DrugBank ID:DB00656 | TRAZODONE | PubChem SID:175266392 | 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one | CAS RN:19794-93-5 | UNII:YBK48BXK30 | PubChem CID:5533 | Trazodone"
+BMGC_DG12387,BMG_DG166831,"UNII:H3753190JS | PubChem CID:55331 | CAS RN:103775-14-0 | PubChem SID:175265745 | Moexiprilat | MOEXIPRILAT | (3S)-2-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid | DrugBank ID:DB14210"
+BMGC_DG12388,BMG_DG166833,"PubChem CID:5536 | PubChem SID:198974912 | UNII:H1187LU49Q | DrugBank ID:DB13311 | TREPIBUTONE | 4-oxo-4-(2,4,5-triethoxyphenyl)butanoic acid | Trepibutone | CAS RN:41826-92-0"
+BMGC_DG12389,BMG_DG166835,PubChem SID:198937788 | DrugBank ID:DB12692 | CAS RN:104317-84-2 | CAS RN:98629-43-7 | PubChem CID:55362 | GUSPERIMUS | UNII:UJ0ZJ76DO9 | N-[2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide | Gusperimus
+BMGC_DG12390,BMG_DG166836,"PubChem SID:198965494 | UNII:739I2958C1 | TREQUINSIN | 9,10-dimethoxy-3-methyl-2-(2,4,6-trimethylphenyl)imino-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one | PubChem CID:5537 | CAS RN:79855-88-2 | Trequinsin"
+BMGC_DG12391,BMG_DG166837,Tretinoin | PubChem CID:5538 | DrugBank ID:DB00755
+BMGC_DG12392,BMG_DG166839,"PubChem CID:55390 | CAS RN:85691-74-3 | PubChem SID:198984879 | PIRMAGREL | Pirmagrel | 6-imidazo[1,5-a]pyridin-5-ylhexanoic acid | UNII:9J5H2VA91V"
+BMGC_DG12393,BMG_DG166853,"3-(1-propylpiperidin-3-yl)phenol | CAS RN:75240-91-4 | PubChem SID:474492658 | PubChem CID:55445 | 3-(1-Propyl-3-piperidinyl)phenol | UNII:ND3NDM2EHM | PRECLAMOL, (+/-)- | Preclamol, (±)-"
+BMGC_DG12394,BMG_DG166856,"PubChem CID:5546 | PubChem SID:175265419 | DrugBank ID:DB00384 | NDC:52817-365 | NDC:66993-832 | NDC:72162-2265 | UNII:WS821Z52LQ | 6-phenylpteridine-2,4,7-triamine | NDC:52817-364 | TRIAMTERENE | CAS RN:396-01-0 | NDC:59212-003 | NDC:59212-002 | Triamterene | NDC:66993-831"
+BMGC_DG12395,BMG_DG166859,"2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol | PubChem CID:55466 | GADOPENTETATE DIMEGLUMINE | Gadopentetic acid | Gadopentetate Dimeglumine | DrugBank ID:DB00789 | CAS RN:86050-77-3 | PubChem SID:175268608 | UNII:RH248G8V27"
+BMGC_DG12396,BMG_DG166861,"UNII:X16K5179V5 | PubChem CID:55473 | [1-methyl-5-[3-[3-(piperidin-1-ylmethyl)phenoxy]propylamino]-1,2,4-triazol-3-yl]methanol | DrugBank ID:DB12884 | CAS RN:76956-02-0 | PubChem SID:198973016 | LAVOLTIDINE | Lavoltidine"
+BMGC_DG12397,BMG_DG166863,"PubChem CID:55480 | [(1S,2R)-2-(diethylcarbamoyl)-2-phenylcyclopropyl]methylazanium;chloride | PubChem SID:175271685 | NDC:0456-1525 | NDC:0456-1550 | NDC:65162-094 | [(1S,2R)-2-(Diethylcarbamoyl)-2-phenylcyclopropyl]methylazanium;chloride | NDC:0456-1512 | NDC:55154-4626 | NDC:0456-1510 | NDC:65162-093 | NDC:65162-091 | UNII:RNZ43O5WW5 | CAS RN:175131-61-0 | CAS RN:101152-94-7 | NDC:65162-092 | MILNACIPRAN HYDROCHLORIDE"
+BMGC_DG12398,BMG_DG166864,Temelastine | 2-[4-(5-bromo-3-methylpyridin-2-yl)butylamino]-5-[(6-methylpyridin-3-yl)methyl]-1H-pyrimidin-6-one | CAS RN:86181-42-2 | PubChem SID:198955321 | PubChem CID:55482 | TEMELASTINE | UNII:BF6IGI53XH
+BMGC_DG12399,BMG_DG166865,"Dopexamine | 4-[2-[6-(2-phenylethylamino)hexylamino]ethyl]benzene-1,2-diol | UNII:398E7Z7JB5 | DrugBank ID:DB12313 | PubChem CID:55483 | DOPEXAMINE | CAS RN:86197-47-9 | PubChem SID:198975207"
+BMGC_DG12400,BMG_DG166870,"1-METHYL-2-NITRONAPHTHO(2,1-B)FURAN | PubChem SID:474491778 | UNII:YHG3HHW4JF | CAS RN:86539-67-5 | PubChem CID:55508 | 1-Methyl-2-nitronaphtho[2,1-b]furan"
+BMGC_DG12401,BMG_DG166875,"PubChem CID:5556 | UNII:1HM943223R | NDC:50742-645 | Triazolam | 8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | NDC:70710-1289 | DrugBank ID:DB00897 | PubChem SID:175268086 | NDC:71335-1876 | NDC:50742-646 | CAS RN:28911-01-5 | NDC:50090-6471 | NDC:72789-349 | NDC:59762-3718 | NDC:59762-3717 | TRIAZOLAM | NDC:70771-1576 | NDC:70710-1521 | NDC:0009-0017 | NDC:50090-4733 | NDC:70771-1162 | NDC:43353-451"
+BMGC_DG12402,BMG_DG166881,bromoform | CAS RN:4471-18-5 | CAS RN:75-25-2 | Bromoform | UNII:TUT9J99IMU | PubChem CID:5558 | DrugBank ID:DB03054 | PubChem SID:198959649 | BROMOFORM
+BMGC_DG12403,BMG_DG166883,3-[[2-[[6-amino-2-[[2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-4-[[1-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid | alpha-Neurokinin;Neuromedin L;Substance K | PubChem CID:55582
+BMGC_DG12404,BMG_DG166884,"L-Methioninamide, L-alpha-aspartyl-L-methionyl-L-histidyl-L-alpha-aspartyl-L-phenylalanyl-L-phenylalanyl-L-valylglycyl-L-leucyl- | PubChem CID:55583 | 3-amino-4-[[1-[[1-[[1-[[1-[[1-[[1-[[2-[[1-[(1-amino-4-methylsulfanyl-1-oxobutan-2-yl)amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid"
+BMGC_DG12405,BMG_DG166886,"PubChem CID:5560 | UNII:Q58C92TUN0 | PubChem SID:175271543 | TRICHLORMETHIAZIDE | Trichlormethiazide | CAS RN:133-67-5 | DrugBank ID:DB01021 | 6-chloro-3-(dichloromethyl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide"
+BMGC_DG12406,BMG_DG166889,"CAS RN:306-52-5 | UNII:J712EO9048 | 2,2,2-trichloroethyl dihydrogen phosphate | TRICLOFOS | PubChem SID:198987804 | DrugBank ID:DB06753 | Triclofos | PubChem CID:5563"
+BMGC_DG12407,BMG_DG166890,"NDC:47593-360 | DrugBank ID:DB08604 | UNII:4NM5039Y5X | NDC:57337-036 | NDC:57337-023 | NDC:47593-341 | NDC:47593-469 | PubChem SID:175265453 | PubChem CID:5564 | CAS RN:3380-34-5 | TRICLOSAN | NDC:47593-305 | 5-chloro-2-(2,4-dichlorophenoxy)phenol | NDC:57337-021 | NDC:57337-020 | CAS RN:88032-08-0 | NDC:57337-016 | NDC:58503-011 | Triclosan"
+BMGC_DG12408,BMG_DG166893,"DrugBank ID:DB06824 | TRIENTINE | PubChem SID:175268834 | CAS RN:105821-86-1 | Triethylenetetramine | PubChem CID:5565 | UNII:SJ76Y07H5F | Trientine | N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine | CAS RN:112-24-3"
+BMGC_DG12409,BMG_DG166896,"UNII:N18ZH0M4NP | CAS RN:87151-85-7 | PubChem CID:55652 | Spiradoline | DrugBank ID:DB12704 | PubChem SID:198962019 | SPIRADOLINE | 2-(3,4-dichlorophenyl)-N-methyl-N-[(5R,7S,8S)-7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl]acetamide"
+BMGC_DG12410,BMG_DG166897,DrugBank ID:DB00831 | UNII:214IZI85K3 | CAS RN:117-89-5 | TRIFLUOPERAZINE | Trifluoperazine | PubChem SID:175268377 | CAS RN:81498-90-0 | PubChem CID:5566 | 10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
+BMGC_DG12411,BMG_DG166899,DrugBank ID:DB13552 | PubChem CID:5567 | UNII:R8869Q7R8I | TRIFLUPERIDOL | Trifluperidol | CAS RN:749-13-3 | 1-(4-fluorophenyl)-4-[4-hydroxy-4-[3-(trifluoromethyl)phenyl]piperidin-1-yl]butan-1-one | PubChem SID:198966303
+BMGC_DG12412,BMG_DG166901,"TRIFLUPROMAZINE | CAS RN:146-54-3 | DrugBank ID:DB00508 | N,N-dimethyl-3-[2-(trifluoromethyl)phenothiazin-10-yl]propan-1-amine | Triflupromazine | UNII:RO16TQF95Y | PubChem SID:198974217 | PubChem CID:5568"
+BMGC_DG12413,BMG_DG166905,"Isomazole | 2-(2-methoxy-4-methylsulfinylphenyl)-3H-imidazo[4,5-c]pyridine | ISOMAZOLE | PubChem SID:198990671 | PubChem CID:55690 | CAS RN:86315-52-8 | UNII:L8O2GV23DC"
+BMGC_DG12414,BMG_DG166915,"CAS RN:41729-52-6 | 6-amino-1,5-dihydroimidazo[4,5-c]pyridin-4-one | Dezaguanine | UNII:9DRB973HUI | PubChem CID:55710 | DEZAGUANINE | PubChem SID:198965758"
+BMGC_DG12415,BMG_DG166917,"PubChem SID:198986559 | DrugBank ID:DB08726 | DISOXARIL | CAS RN:87495-31-6 | 5-(7-(4-(4,5-dihydro-2-oxazolyl)phenoxy)heptyl)-3-methyl isoxazole | UNII:FX8Q9PI4VP | PubChem CID:55717 | Disoxaril | 5-[7-[4-(4,5-dihydro-1,3-oxazol-2-yl)phenoxy]heptyl]-3-methyl-1,2-oxazole"
+BMGC_DG12416,BMG_DG166919,1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol | UNII:6RC5V8B7PO | Trihexyphenidyl | TRIHEXYPHENIDYL | PubChem SID:175272079 | DrugBank ID:DB00376 | CAS RN:144-11-6 | PubChem CID:5572
+BMGC_DG12417,BMG_DG166922,"Trimebutine | UNII:U4UUZ24TRB | TRIMEBUTINE | CAS RN:58997-90-3 | UNII:QZ1OJ92E5R | CAS RN:58997-89-0 | PubChem SID:440088279 | CAS RN:39133-31-8 | PubChem CID:5573 | TRIMEBUTINE, (-)- | PubChem SID:198948092 | UNII:9RKX7S7WFY | PubChem SID:440089666 | [2-(dimethylamino)-2-phenylbutyl] 3,4,5-trimethoxybenzoate | DrugBank ID:DB09089 | TRIMEBUTINE, (+)-"
+BMGC_DG12418,BMG_DG166924,"Trimeprazine | Alimemazine | DrugBank ID:DB01246 | PubChem SID:175271411 | UNII:76H78MJJ52 | TRIMEPRAZINE | PubChem CID:5574 | N,N,2-trimethyl-3-phenothiazin-10-ylpropan-1-amine | CAS RN:84-96-8"
+BMGC_DG12419,BMG_DG166933,PubChem CID:55752 | UNII:35C6UMO5SR | PubChem SID:198968527 | TIOSPIRONE | CAS RN:87691-91-6
+BMGC_DG12420,BMG_DG166937,"CAS RN:127-48-0 | PubChem CID:5576 | PubChem SID:175267874 | TRIMETHADIONE | Trimethadione | UNII:R7GV3H6FQ4 | DrugBank ID:DB00347 | 3,5,5-trimethyl-1,3-oxazolidine-2,4-dione"
+BMGC_DG12421,BMG_DG166939,"UNII:W2X096QY97 | PubChem SID:175266935 | PubChem CID:5577 | Trimethobenzamide | DrugBank ID:DB00662 | CAS RN:138-56-7 | N-[[4-[2-(dimethylamino)ethoxy]phenyl]methyl]-3,4,5-trimethoxybenzamide | TRIMETHOBENZAMIDE"
+BMGC_DG12422,BMG_DG166940,"CAS RN:738-70-5 | NDC:70954-541 | NDC:51862-486 | Trimethoprim | PubChem SID:175266261 | NDC:51407-738 | NDC:43386-330 | 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine | NDC:75907-043 | NDC:40032-330 | PubChem CID:5578 | UNII:AN164J8Y0X | DrugBank ID:DB00440 | TRIMETHOPRIM"
+BMGC_DG12423,BMG_DG166945,CAS RN:3715-10-4 | 5-(diaminomethylideneamino)-2-oxopentanoic acid | PubChem CID:558 | 2-Oxoarginine
+BMGC_DG12424,BMG_DG166946,"1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol | UNII:V1NS79K43I | Racemic-trimetoquinol | TRETOQUINOL, (+/-)- | PubChem CID:5581 | TRETOQUINOL, (±)- | PubChem SID:241181532 | CAS RN:21650-42-0"
+BMGC_DG12425,BMG_DG166950,"TRIMETREXATE | 5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine | CAS RN:72828-03-6 | CAS RN:52128-35-5 | Trimetrexate | UNII:UPN4ITI8T4 | PubChem SID:198941687 | PubChem CID:5583 | CAS RN:251301-18-5 | DrugBank ID:DB01157"
+BMGC_DG12426,BMG_DG166952,"PubChem SID:313182556 | CAS RN:739-71-9 | UNII:9K5931C1H5 | 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine | UNII:QJ9MUH57H8 | TRIMIPRAMINE, (+)- | Trimipramine | PubChem SID:175271686 | TRIMIPRAMINE | DrugBank ID:DB00726 | CAS RN:3564-75-8 | CAS RN:3564-66-7 | PubChem CID:5584 | UNII:6S082C9NDT | TRIMIPRAMINE, (-)- | PubChem SID:313183372"
+BMGC_DG12427,BMG_DG166957,"PubChem SID:198983668 | 2,5,9-trimethylfuro[3,2-g]chromen-7-one | TRIOXSALEN | Trioxsalen | DrugBank ID:DB04571 | PubChem CID:5585 | CAS RN:3902-71-4 | UNII:Y6UY8OV51T"
+BMGC_DG12428,BMG_DG166959,"Tripelennamine | N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine | DrugBank ID:DB00792 | CAS RN:91-81-6 | PubChem CID:5587 | PubChem SID:175267396 | TRIPELENNAMINE | UNII:3C5ORO99TY"
+BMGC_DG12429,BMG_DG166964,"Fosinopril | DrugBank ID:DB00492 | CAS RN:474519-28-3 | CAS RN:1217600-34-4 | (2S,4S)-4-CYCLOHEXYL-1-(((SR)-((1SR)-2-METHYL-1-(1-OXOPROPOXY)PROPOXY)(4-PHENYLBUTYL)PHOSPHORYL)ACETYL)PYRROLIDINE-2-CARBOXYLIC ACID | PubChem CID:55891 | (2S,4S)-4-cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | CAS RN:98048-97-6 | UNII:8B3FLG23GN | PubChem SID:472425607"
+BMGC_DG12430,BMG_DG166972,"TROGLITAZONE | DrugBank ID:DB00197 | Troglitazone | CAS RN:97322-87-7 | PubChem CID:5591 | UNII:I66ZZ0ZN0E | PubChem SID:198940229 | 5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione"
+BMGC_DG12431,BMG_DG166976,"PubChem SID:198970753 | CAS RN:84243-58-3 | IMAZODAN | PubChem CID:55918 | Imazodan | 3-(4-imidazol-1-ylphenyl)-4,5-dihydro-1H-pyridazin-6-one | UNII:6PVQ5VQW24"
+BMGC_DG12432,BMG_DG166977,PubChem SID:175271564 | NDC:0998-0355 | NDC:61314-354 | TROPICAMIDE | N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide | NDC:61314-355 | UNII:N0A3Z5XTC6 | NDC:70069-121 | DrugBank ID:DB00809 | NDC:24208-590 | NDC:24208-585 | Tropicamide | NDC:0065-0355 | PubChem CID:5593 | CAS RN:1508-75-4
+BMGC_DG12433,BMG_DG166982,"PubChem CID:5596 | spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl 2-hydroxy-2,2-diphenylacetate | CAS RN:10360-09-5 | Trosec"
+BMGC_DG12434,BMG_DG166985,"CAS RN:30751-05-4 | Troxipide | DrugBank ID:DB13419 | UNII:W6QJX1Q00Z | 3,4,5-trimethoxy-N-piperidin-3-ylbenzamide | TROXIPIDE | PubChem CID:5597 | PubChem SID:198968434"
+BMGC_DG12435,BMG_DG166987,Imino-Tryptophan | Imino-tryptophan | PubChem CID:5599 | DrugBank ID:DB02988 | 2-imino-3-(1H-indol-3-yl)propanoic acid
+BMGC_DG12436,BMG_DG166988,"UNII:KLC3B8H9LE | PubChem SID:472407953 | PubChem CID:55993 | CAS RN:89664-18-6 | NOMIFENSINE, (S)-"
+BMGC_DG12437,BMG_DG166993,"DrugBank ID:DB04795 | UNII:MYQ9MNW7NI | 2-Thenoyltrifluoroacetone | Thenoyltrifluoroacetone | PubChem CID:5601 | PubChem SID:198937794 | CAS RN:326-91-0 | THENOYLTRIFLUOROACETONE | 4,4,4-trifluoro-1-thiophen-2-ylbutane-1,3-dione | CAS RN:29463-74-9"
+BMGC_DG12438,BMG_DG166996,"PubChem CID:56012 | (2S,3S)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"
+BMGC_DG12439,BMG_DG166997,"DrugBank ID:DB13861 | 5-[acetyl-(2-hydroxy-3-methoxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide | IOPENTOL | PubChem CID:56016 | UNII:7D6XWX076T | PubChem SID:198943996 | Iopentol | CAS RN:89797-00-2"
+BMGC_DG12440,BMG_DG167002,PubChem CID:5603 | Tuaminoheptane | heptan-2-amine | PubChem SID:198959284 | UNII:Z0420GYD84 | DrugBank ID:DB13238 | TUAMINOHEPTANE | CAS RN:123-82-0
+BMGC_DG12441,BMG_DG167004,"PubChem SID:175265332 | DrugBank ID:DB11556 | PubChem CID:56032 | Detomidine | DETOMIDINE | CAS RN:76631-46-4 | 5-[(2,3-dimethylphenyl)methyl]-1H-imidazole | UNII:7N8K34P2XH"
+BMGC_DG12442,BMG_DG167007,CAS RN:97825-25-7 | RACTOPAMINE | PubChem SID:175271594 | DrugBank ID:DB11541 | UNII:57370OZ3P1 | 4-[3-[[2-hydroxy-2-(4-hydroxyphenyl)ethyl]amino]butyl]phenol | PubChem CID:56052 | Ractopamine
+BMGC_DG12443,BMG_DG167010,DrugBank ID:DB12248 | Tulobuterol | TULOBUTEROL | 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol | PubChem SID:175271518 | PubChem CID:5606 | CAS RN:1246820-75-6 | CAS RN:41570-61-0 | UNII:591I9SU0F7
+BMGC_DG12444,BMG_DG167012,"PubChem CID:56069 | BICALUTAMIDE, (R)- | UNII:Z9DL98I0AF | PubChem SID:319891820 | (R)-Bicalutamide | DrugBank ID:DB02932 | CAS RN:113299-40-4"
+BMGC_DG12445,BMG_DG167018,DrugBank ID:DB08841 | PubChem SID:175267384 | UNII:X8ZC7V0OX3 | CAS RN:51-67-2 | TYRAMINE | Tyramine | 4-(2-aminoethyl)phenol | PubChem CID:5610
+BMGC_DG12446,BMG_DG167021,"2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methyl]butanoic acid | CAS RN:27293-82-9 | UNII:4F05V145YR | PubChem SID:198935978 | Tyropanic acid | DrugBank ID:DB09340 | Tyropanoic acid | PubChem CID:5611 | TYROPANIC ACID"
+BMGC_DG12447,BMG_DG167025,"CAS RN:10537-47-0 | MALONOBEN | PubChem SID:198949514 | UNII:87TE8MRS65 | Malonoben | PubChem CID:5614 | 2-[(3,5-ditert-butyl-4-hydroxyphenyl)methylidene]propanedinitrile"
+BMGC_DG12448,BMG_DG167031,"2-(3,4-dichlorophenyl)-N-methyl-N-(2-pyrrolidin-1-ylcyclohexyl)acetamide | PubChem CID:5619 | CAS RN:149341-39-9 | 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzeneacetamide"
+BMGC_DG12449,BMG_DG167033,"PubChem CID:5620 | 2-(3,4-Dichlorophenyl)-N-methyl-N-[7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide | 2-(3,4-dichlorophenyl)-N-methyl-N-(7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl)acetamide"
+BMGC_DG12450,BMG_DG167035,Difloxacin | DIFLOXACIN | PubChem CID:56206 | UNII:5Z7OO9FNFD | CAS RN:98106-17-3 | 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid | PubChem SID:175268256 | DrugBank ID:DB11511
+BMGC_DG12451,BMG_DG167037,DrugBank ID:DB11491 | SARAFLOXACIN | 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid | UNII:RC3WJ907XY | Sarafloxacin | PubChem CID:56208 | PubChem SID:198942774 | CAS RN:98105-99-8
+BMGC_DG12452,BMG_DG167043,DELAVIRDINE | PubChem SID:175267271 | DrugBank ID:DB00705 | UNII:DOL5F9JD3E | Delavirdine | CAS RN:136817-59-9 | N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide | PubChem CID:5625
+BMGC_DG12453,BMG_DG167053,PubChem CID:563 | 3-methylsulfanylpropanoic acid | CAS RN:646-01-5 | UNII:F523ALI47D | 3-(Methylthio)propionic acid | 3-(METHYLTHIO)PROPIONIC ACID | PubChem SID:198958299
+BMGC_DG12454,BMG_DG167056,"UNII:19KW7PI29F | CAS RN:92077-78-6 | Justor | PubChem SID:198978900 | CILAZAPRIL | PubChem CID:56329 | (4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid;hydrate"
+BMGC_DG12455,BMG_DG167057,"Cilazapril | PubChem CID:56330 | DrugBank ID:DB01340 | (4S,7S)-7-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid | CAS RN:88768-40-5 | CILAZAPRIL ANHYDROUS | PubChem SID:198942039 | UNII:8Q9454114Q"
+BMGC_DG12456,BMG_DG167058,"NDC:0069-5474 | NDC:0641-6137 | NDC:63323-403 | PubChem SID:175267817 | UNII:7VLR55452Z | NDC:0143-9782 | NDC:0641-6136 | NDC:68083-460 | FOSPHENYTOIN SODIUM | NDC:68462-622 | NDC:70121-1390 | NDC:0069-6001 | NDC:68462-621 | NDC:0069-5471 | NDC:0143-9788 | NDC:70121-1381 | NDC:68083-461 | PubChem CID:56338 | NDC:25021-798 | Fosphenytoin Sodium | NDC:65162-999 | disodium;(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl phosphate | CAS RN:92134-98-0 | NDC:65162-998"
+BMGC_DG12457,BMG_DG167059,"(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)methyl dihydrogen phosphate | UNII:B4SF212641 | CAS RN:93390-81-9 | PubChem SID:175267433 | DrugBank ID:DB01320 | Fosphenytoin | PubChem CID:56339 | FOSPHENYTOIN"
+BMGC_DG12458,BMG_DG167060,CAS RN:1333-28-4 | PubChem CID:5634 | NDC:83691-002 | NDC:63347-601 | NDC:80569-084 | NDC:72222-224 | PubChem SID:175265819 | NDC:58593-826 | undec-10-enoic acid | NDC:83691-000 | CAS RN:112-38-9 | UNII:K3D86KJ24N | CAS RN:96451-28-4 | NDC:85150-002 | NDC:83910-004 | NDC:71356-156 | NDC:54312-125 | NDC:84180-471 | DrugBank ID:DB11117 | NDC:76973-071 | NDC:84896-111 | NDC:69842-718 | NDC:73352-555 | NDC:36800-754 | NDC:63347-600 | NDC:63347-800 | NDC:70947-025 | Undecylenic Acid | NDC:49283-025 | UNDECYLENIC ACID | NDC:68016-474 | NDC:84841-111 | NDC:69469-201 | NDC:65121-071 | NDC:58593-601 | NDC:73352-550
+BMGC_DG12459,BMG_DG167063,"PubChem CID:5639 | 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione | PubChem SID:198963788 | CAS RN:34661-75-1 | DrugBank ID:DB12661 | Urapidil | URAPIDIL | UNII:A78GF17HJS"
+BMGC_DG12460,BMG_DG167066,NDC:80005-130 | NDC:59651-573 | NDC:0517-9120 | UNII:U6F3787206 | CAS RN:60-32-2 | CAS RN:1319-82-0 | NDC:17478-768 | NDC:70377-103 | NDC:72205-049 | DrugBank ID:DB00513 | NDC:69680-114 | 6-aminohexanoic acid | NDC:0517-9191 | NDC:80005-129 | NDC:17478-447 | NDC:69238-1596 | NDC:0054-1110 | NDC:49411-051 | NDC:49411-052 | NDC:31722-035 | NDC:17478-769 | Aminocaproic acid | NDC:60687-739 | NDC:69238-1637 | NDC:70377-104 | NDC:24658-798 | NDC:0054-1100 | AMINOCAPROIC ACID | NDC:70377-102 | NDC:52817-815 | NDC:80005-128 | NDC:72572-015 | NDC:0904-7165 | NDC:49411-050 | PubChem CID:564 | NDC:69680-116 | NDC:0409-4346 | PubChem SID:175267499 | NDC:0404-9812 | NDC:62559-225 | NDC:24658-799 | NDC:71872-7319 | NDC:72205-286 | NDC:69680-115
+BMGC_DG12461,BMG_DG167067,"6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3,5-trimethylpyrimidine-2,4-dione | PubChem CID:5640 | PubChem SID:198946634 | UNII:1HLS600135 | 5-Methylurapidil | CAS RN:34661-85-3 | 5-METHYLURAPIDIL"
+BMGC_DG12462,BMG_DG167069,ethyl carbamate | UNII:3IN71E75Z5 | DrugBank ID:DB04827 | Urethane | PubChem SID:175268892 | CAS RN:51-79-6 | URETHANE | PubChem CID:5641
+BMGC_DG12463,BMG_DG167076,"Usnic acid | PubChem CID:5646 | 2,6-diacetyl-7,9-dihydroxy-8,9b-dimethyldibenzofuran-1,3-dione | CAS RN:125-46-2"
+BMGC_DG12464,BMG_DG167077,UNII:P3JW662TWA | CAS RN:92623-83-1 | PRAVADOLINE | PubChem CID:56463 | PubChem SID:198972884
+BMGC_DG12465,BMG_DG167080,diethyl-methyl-[2-(3-methyl-2-phenylpentanoyl)oxyethyl]azanium | Valethamate | DrugBank ID:DB13497 | VALETHAMATE | PubChem SID:198973831 | PubChem CID:5648 | CAS RN:16376-74-2 | UNII:D64S64QVX7
+BMGC_DG12466,BMG_DG167081,CAS RN:92788-10-8 | PubChem CID:56487 | ROGLETIMIDE | UNII:14P4QR28QF | PubChem SID:198954296
+BMGC_DG12467,BMG_DG167084,"(2S)-2-amino-3-(2-(18F)fluoranyl-4,5-dihydroxyphenyl)propanoic acid | NDC:13267-345 | NDC:13267-346 | PubChem CID:56494 | DrugBank ID:DB13848 | CAS RN:92812-82-3 | UNII:2C598205QX | PubChem SID:198960719 | Fluorodopa F-18 | FLUORODOPA F-18"
+BMGC_DG12468,BMG_DG167093,PubChem CID:5656 | UNII:GRZ5RCB1QG | DrugBank ID:DB00285 | CAS RN:540726-98-5 | VENLAFAXINE | Venlafaxine | CAS RN:93413-69-5 | PubChem SID:175272117 | 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol
+BMGC_DG12469,BMG_DG167101,"1-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl]benzimidazole-2-carboxamide;hydrochloride | Imarikiren hydrochloride | IMARIKIREN HYDROCHLORIDE | UNII:1NE31CW68S | PubChem SID:319892540 | CAS RN:1202269-24-6 | PubChem CID:56591871"
+BMGC_DG12470,BMG_DG167112,PubChem CID:56597771 | CAS RN:1342300-14-4 | PubChem SID:474493500 | UNII:7AX37Z58VV | SERINOLAMIDE A
+BMGC_DG12471,BMG_DG167118,PubChem SID:198945744 | Pilaralisib | PILARALISIB | DrugBank ID:DB11772 | 2-amino-N-[3-[[3-(2-chloro-5-methoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-2-methylpropanamide | PubChem CID:56599306 | CAS RN:934526-89-3 | UNII:60ES45KTMK
+BMGC_DG12472,BMG_DG167163,2-(4-Phenylpiperidin-1-yl)cyclohexan-1-ol | 2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol | CAS RN:22232-64-0 | PubChem CID:5662
+BMGC_DG12473,BMG_DG167167,"CAS RN:81840-15-5 | PubChem CID:5663 | VESNARINONE | PubChem SID:198943053 | Vesnarinone | DrugBank ID:DB12082 | 6-[4-(3,4-dimethoxybenzoyl)piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one | UNII:5COW40EV8M"
+BMGC_DG12474,BMG_DG167180,"CAS RN:1221573-79-0 | DASABUVIR | DrugBank ID:DB09183 | N-[6-[3-tert-butyl-5-(2,4-dioxopyrimidin-1-yl)-2-methoxyphenyl]naphthalen-2-yl]methanesulfonamide | PubChem CID:56640146 | UNII:DE54EQW8T1 | CAS RN:1132935-63-7 | PubChem SID:198938552 | Dasabuvir"
+BMGC_DG12475,BMG_DG167189,5-DIMETHYLAMINOBUTYRYL CITALOPRAM | PubChem SID:198978088 | CAS RN:1329745-98-3 | PubChem CID:56643874 | UNII:2QX66DW22E
+BMGC_DG12476,BMG_DG167191,"PubChem SID:317229754 | POSELTINIB | N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]furo[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide | PubChem CID:56644522 | Poseltinib | UNII:D01E4B1U35 | CAS RN:1353552-97-2"
+BMGC_DG12477,BMG_DG167198,"8-cyclopentyl-2-[4-(4-methylpiperazin-1-yl)anilino]-7-oxopyrido[2,3-d]pyrimidine-6-carbonitrile | UNII:QJ8RO3296G | PubChem CID:56649281 | Narazaciclib | NARAZACICLIB | CAS RN:1357470-29-1 | PubChem SID:252319261"
+BMGC_DG12478,BMG_DG167201,"CAS RN:1005168-10-4 | UNII:3VF7K7Z10B | Pac-14028 | PubChem CID:56649347 | ASIVATREP | PubChem SID:198964262 | PAC-14028 | DrugBank ID:DB12428 | (E)-N-[(1R)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide"
+BMGC_DG12479,BMG_DG167205,"CAS RN:1360622-01-0 | UNII:FN57BDR4DA | Vipoglanstat | PubChem CID:56649447 | PubChem SID:472425502 | VIPOGLANSTAT | 2-[2,6-dichloro-3-[(2,2-dimethylpropanoylamino)methyl]anilino]-6-(2,2-difluoroethoxy)-1-methyl-N-[4-(trifluoromethyl)cyclohexyl]benzimidazole-5-carboxamide"
+BMGC_DG12480,BMG_DG167206,"UNII:08W5N2C97Q | (2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide | NDC:0078-0701 | CAS RN:1217486-61-7 | PubChem CID:56649450 | NDC:0078-0708 | NDC:0078-1021 | PubChem SID:198967672 | ALPELISIB | NDC:0078-1028 | Alpelisib | DrugBank ID:DB12015 | NDC:0078-1175"
+BMGC_DG12481,BMG_DG167208,"CAS RN:1360457-46-0 | Vaborbactam | DrugBank ID:DB12107 | VABORBACTAM | PubChem SID:252164399 | UNII:1C75676F8V | CAS RN:1575712-03-6 | 2-[(3R,6S)-2-hydroxy-3-[(2-thiophen-2-ylacetyl)amino]oxaborinan-6-yl]acetic acid | PubChem CID:56649692"
+BMGC_DG12482,BMG_DG167209,NDC:0591-3955 | CAS RN:68506-86-5 | NDC:80789-003 | NDC:60219-1424 | NDC:67877-674 | NDC:43598-697 | NDC:67386-211 | NDC:0054-0652 | 4-aminohex-5-enoic acid | NDC:60219-1425 | NDC:67386-111 | NDC:0591-3851 | NDC:49884-358 | NDC:69238-1425 | NDC:59651-367 | NDC:31722-009 | NDC:72205-093 | DrugBank ID:DB01080 | NDC:42799-950 | NDC:80789-117 | NDC:69097-964 | Vigabatrin | NDC:70710-1287 | UNII:GR120KRT6K | PubChem CID:5665 | NDC:43598-651 | NDC:0245-0556 | NDC:0245-6001 | NDC:70771-1654 | NDC:59651-366 | VIGABATRIN | PubChem SID:175271898 | NDC:69238-1424 | CAS RN:60643-86-9
+BMGC_DG12483,BMG_DG167218,6-(4-methylpentyl)naphthalene-2-carboxylic acid | CAS RN:1357838-47-1 | 6-(4-Methylpentyl)naphthalene-2-carboxylic acid | PubChem CID:56654447
+BMGC_DG12484,BMG_DG167219,RG-2833 | PubChem SID:198946789 | UNII:17V14R89EU | CAS RN:1215493-56-3 | PubChem CID:56654642
+BMGC_DG12485,BMG_DG167224,PubChem CID:5666 | PubChem SID:198955520 | Viloxazine | CAS RN:46817-91-8 | UNII:5I5Y2789ZF | 2-[(2-ethoxyphenoxy)methyl]morpholine | DrugBank ID:DB09185 | VILOXAZINE
+BMGC_DG12486,BMG_DG167233,"UNII:4SF5Q86VXC | PubChem CID:56671814 | CAS RN:1374356-45-2 | CRIZOTINIB, (S)- | PubChem SID:496142551 | Crizotinib, (S)-"
+BMGC_DG12487,BMG_DG167238,[1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic acid | {[1-(4-Amino-2-oxopyrimidin-1-YL)-3-hydroxypropan-2-YL]oxy}methyl(3-(hexadecyloxy)propoxy)phosphinic acid | PubChem CID:56674991
+BMGC_DG12488,BMG_DG167285,CAS RN:132-64-9 | DIBENZOFURAN | PubChem SID:198944199 | dibenzofuran | PubChem CID:568 | Dibenzofuran | UNII:8U54U639VI
+BMGC_DG12489,BMG_DG167290,DrugBank ID:DB04513 | N-(6-aminohexyl)-5-chloronaphthalene-1-sulfonamide | PubChem CID:5681 | CAS RN:65595-90-6 | N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
+BMGC_DG12490,BMG_DG167297,"UNII:AEL0YED4SU | PubChem CID:56832906 | Remdesivir triphosphate | PubChem SID:461432582 | [[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | CAS RN:1355149-45-9 | GS-441524 TRIPHOSPHATE"
+BMGC_DG12491,BMG_DG167303,RO-5263397 | CAS RN:1357266-05-7 | PubChem CID:56835991 | UNII:Y2P4KD8GDR | PubChem SID:445500371
+BMGC_DG12492,BMG_DG167309,"1-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-phenylbutane-1,4-dione | CAS RN:1360540-81-3 | UNII:QX6T87A52I | PubChem CID:56837361 | PubChem SID:433968472 | DALOSIRVAT | Dalosirvat"
+BMGC_DG12493,BMG_DG167314,"4-[2-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]sulfanylethyl]benzenesulfonic acid | 4-(2-(6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-ylthio)ethyl)benzene sulfonic acid | PubChem CID:56838950"
+BMGC_DG12494,BMG_DG167315,"2-[[5-chloro-2-[4-[(4-methylpiperazin-1-yl)methyl]anilino]pyrimidin-4-yl]amino]-N,N-dimethylbenzenesulfonamide | DUBERMATINIB | PubChem SID:316912535 | PubChem CID:56839178 | CAS RN:1341200-45-0 | Dubermatinib | DrugBank ID:DB15187 | UNII:14D65TV20J"
+BMGC_DG12495,BMG_DG167316,"N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-pyridin-2-ylcyclohexanecarboxamide | PubChem SID:198938426 | CAS RN:634908-75-1 | UNII:71IH826FEG | CAS RN:162760-96-5 | PubChem CID:5684 | WAY-100635 | CAS RN:158238-18-7 | Cyclohexanecarboxamide, n-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-n-2-pyridinyl-"
+BMGC_DG12496,BMG_DG167333,UNII:23X1185WBO | Iobenguane Sulfate I-123 | 2-[(3-(123I)iodanylphenyl)methyl]guanidine;sulfuric acid | PubChem SID:175266238 | IOBENGUANE SULFATE I-123 | Iobenguane sulfate I-123 | DrugBank ID:DB09546 | PubChem CID:56840904 | CAS RN:139755-80-9
+BMGC_DG12497,BMG_DG167361,"[(6S,8S,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate;2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol | CAS RN:136112-01-1 | Seretide | PubChem CID:56841124"
+BMGC_DG12498,BMG_DG167387,"(1S,2S,5R,7S,9S,10S,14R,19S)-15-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-4,14-dimethyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione;(1S,2R,5S,7R,9R,10S,14R,19S)-15-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-19-ethyl-14-methyl-7-[(2R,3R,4R,5S,6S)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy-20-oxatetracyclo[10.10.0.02,10.05,9]docosa-3,11-diene-13,21-dione | PubChem CID:56841558 | Spinosad [ISO]"
+BMGC_DG12499,BMG_DG167459,"UNII:S33056JLS5 | FLUPEROLONE | DrugBank ID:DB13491 | PubChem CID:56841872 | Fluperolone | PubChem SID:198944873 | (8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-17-[(2S)-2-hydroxypropanoyl]-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | CAS RN:3841-11-0"
+BMGC_DG12500,BMG_DG167469,CAS RN:83139-29-1 | PubChem CID:56841901 | UNII:GKK29YSF88 | PubChem SID:375084620 | PARATHYROID HORMONE (1-34)AMIDE
+BMGC_DG12501,BMG_DG167507,CAS RN:403989-79-7 | Usistapide | methyl (2R)-2-phenyl-2-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]phenyl]piperidin-1-yl]acetate | UNII:73YSY3U094 | PubChem SID:198936000 | PubChem CID:56842069 | USISTAPIDE | DrugBank ID:DB12414
+BMGC_DG12502,BMG_DG167517,"PubChem SID:198952689 | Mk-0767 | CAS RN:934017-32-0 | PubChem CID:56842109 | DrugBank ID:DB12055 | 5-[(2,4-dioxo-1,3-oxazolidin-5-yl)methyl]-2-methoxy-N-[[4-(trifluoromethyl)phenyl]methyl]benzamide | UNII:Y180U02GSB | MK-0767"
+BMGC_DG12503,BMG_DG167543,"PubChem CID:56842239 | (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid;(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid;(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid"
+BMGC_DG12504,BMG_DG167577,"CAS RN:40281-80-9 | PubChem SID:251965936 | PubChem CID:56842683 | UNII:98LBL83E6T | WARFARIN ALCOHOL, (S,S)-"
+BMGC_DG12505,BMG_DG167618,"CAS RN:910463-68-2 | SEMAGLUTIDE | NDC:0169-4130 | NDC:0169-4804 | 18-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-5-carbamimidamido-1-(carboxymethylamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-18-oxooctadecanoic acid | NDC:0169-4303 | NDC:0169-4517 | NDC:0169-4505 | NDC:0169-4307 | NDC:0169-4524 | NDC:0169-4181 | PubChem CID:56843331 | NDC:0169-4772 | NDC:0169-4809 | NDC:0169-4501 | NDC:0169-4815 | PubChem SID:198977278 | Semaglutide | NDC:0169-4525 | UNII:53AXN4NNHX | NDC:50090-5824 | NDC:50090-5949 | NDC:0169-4132 | NDC:0169-4314 | NDC:50090-6051"
+BMGC_DG12506,BMG_DG167668,"AGERAFENIB | PubChem CID:56846693 | Agerafenib | UNII:78I4VEX88N | PubChem SID:198942057 | CAS RN:1188910-76-0 | DrugBank ID:DB15068 | 1-[3-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-3-[5-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-3-yl]urea"
+BMGC_DG12507,BMG_DG167673,"PubChem SID:485660805 | PubChem CID:56847486 | CAS RN:1361030-48-9 | N-(4-(6,7-DIMETHOXYQUINOLIN-4-YL)OXY-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUORO-2-METHYLPHENYL)PYRAZOLE-3-CARBOXAMIDE | N-[4-(6,7-dimethoxyquinolin-4-yl)oxy-3-fluorophenyl]-4-ethoxy-1-(4-fluoro-2-methylphenyl)pyrazole-3-carboxamide | UNII:DK8ACB2D8P"
+BMGC_DG12508,BMG_DG167675,"PubChem CID:56847587 | DNA-PK-IN-11 | 3-fluoro-4-[7-methoxy-3-methyl-8-(1-methylpyrazol-4-yl)-2-oxoimidazo[4,5-c]quinolin-1-yl]benzonitrile | CAS RN:1360628-91-6"
+BMGC_DG12509,BMG_DG167677,METHYLBENZYL METHYLBENZIMIDAZOLE PIPERIDINYLMETHANONE | CAS RN:1234208-67-3 | PubChem CID:56848967 | UNII:Z9T72Z578T | PubChem SID:175266855
+BMGC_DG12510,BMG_DG167679,"Neladenoson Bialanate | UNII:IV690462VZ | Neladenoson bialanate | PubChem SID:249492749 | NELADENOSON BIALANATE | CAS RN:1239309-58-0 | PubChem CID:56848985 | 2-[4-[2-[[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methylsulfanyl]-3,5-dicyano-6-pyrrolidin-1-ylpyridin-4-yl]phenoxy]ethyl (2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoate | DrugBank ID:DB13138"
+BMGC_DG12511,BMG_DG167683,"PubChem CID:5685 | CAS RN:613-67-2 | (2-(2',6'-Dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane | N-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine | PubChem SID:316914026 | UNII:E9H51OIT2B | WB-4101"
+BMGC_DG12512,BMG_DG167686,PubChem CID:56851583 | UNII:71PAL357HO | CAS RN:1346133-08-1 | LY-2795050 | PubChem SID:241179819
+BMGC_DG12513,BMG_DG167691,"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline | PubChem CID:5687 | DrugBank ID:DB03365"
+BMGC_DG12514,BMG_DG167696,"2-NITRONAPHTHO(2,1-B)FURAN-1-ETHANOL | CAS RN:95455-02-0 | UNII:WQG46C95NP | PubChem SID:440793870 | PubChem CID:56909"
+BMGC_DG12515,BMG_DG167711,PubChem CID:56927063 | 4-(Phenethylamino)quinazoline-6-carbonitrile | CAS RN:1366002-50-7 | 4-(2-phenylethylamino)quinazoline-6-carbonitrile
+BMGC_DG12516,BMG_DG167713,Sodium stibogluconate | DrugBank ID:DB05630 | PubChem CID:56927674 | Myostibin
+BMGC_DG12517,BMG_DG167763,Histrelin Acetate | UNII:QMG7HLD1ZE | Histrelin | DrugBank ID:DB06788 | acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-3-(1-benzylimidazol-4-yl)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | HISTRELIN ACETATE | PubChem SID:313183274 | NDC:67979-002 | PubChem CID:56927879 | CAS RN:220810-26-4
+BMGC_DG12518,BMG_DG167829,DrugBank ID:DB08869 | Tesamorelin | PubChem CID:56928011
+BMGC_DG12519,BMG_DG167834,"CAS RN:31282-04-9 | HYGROMYCIN B | Hygromycin B | PubChem SID:175265401 | (3'R,3aS,4S,4'S,5'R,6R,6'R,7S,7aS)-4-[(1R,2S,3R,5S,6R)-3-amino-2,6-dihydroxy-5-(methylamino)cyclohexyl]oxy-6'-[(1S)-1-amino-2-hydroxyethyl]-6-(hydroxymethyl)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,2'-oxane]-3',4',5',7-tetrol | DrugBank ID:DB11520 | PubChem CID:56928061 | UNII:3XQ2233B0B"
+BMGC_DG12520,BMG_DG167847,"PubChem SID:249492988 | CAS RN:1362850-20-1 | Seletalisib | N-[(1R)-1-[8-chloro-2-(1-oxidopyridin-1-ium-3-yl)quinolin-3-yl]-2,2,2-trifluoroethyl]pyrido[3,2-d]pyrimidin-4-amine | UNII:64CW205BDD | PubChem CID:56928390 | SELETALISIB | DrugBank ID:DB12706"
+BMGC_DG12521,BMG_DG167849,"UNII:DW2NWI3TFN | methyl N-[6-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamate | Methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)carbamate | CAS RN:870603-16-0 | CAS RN:1029873-02-6 | DrugBank ID:DB12854 | PubChem CID:56931136 | PubChem SID:198988066 | BMS-908662"
+BMGC_DG12522,BMG_DG167855,UNII:M8R6ETA52F | PubChem SID:387065313 | N-(4-(3-CHLORO-4-FLUOROPHENYLAMINO)-7-((7-METHYL-7-AZASPIRO(3.5)NONAN-2-YL)METHOXY)QUINAZOLIN-6-YL)ACRYLAMIDE | CAS RN:1363358-86-4 | N-[4-(3-chloro-4-fluoroanilino)-7-[(7-methyl-7-azaspiro[3.5]nonan-2-yl)methoxy]quinazolin-6-yl]prop-2-enamide | Unii-M8R6eta52F | PubChem CID:56933206
+BMGC_DG12523,BMG_DG167859,"(8S,10R)-19-cyclohexyl-N-(dimethylsulfamoyl)-5-methoxy-10-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl]-12-azapentacyclo[10.7.0.02,7.08,10.013,18]nonadeca-1(19),2(7),3,5,13(18),14,16-heptaene-15-carboxamide | Beclabuvir | CAS RN:958002-33-0 | PubChem CID:56934415 | UNII:MYW1X5CO9S | BECLABUVIR | PubChem SID:198941303 | DrugBank ID:DB12225"
+BMGC_DG12524,BMG_DG167861,"TAFETINIB | PubChem CID:56935577 | CAS RN:1032265-57-8 | Tafetinib | UNII:H4X2M2NN5N | PubChem SID:317228939 | (7Z)-N-[2-(diethylamino)ethyl]-7-(5-fluoro-2-oxo-1H-indol-3-ylidene)-2-methyl-1,4,5,6-tetrahydroindole-3-carboxamide"
+BMGC_DG12525,BMG_DG168043,"UNII:86C4MRT55A | PIRINIXIC ACID | Pirinixic acid | 2-[4-chloro-6-(2,3-dimethylanilino)pyrimidin-2-yl]sulfanylacetic acid | PubChem SID:198965164 | PubChem CID:5694 | CAS RN:50892-23-4"
+BMGC_DG12526,BMG_DG168108,UNII:73Q4TVR90S | CAS RN:917896-43-6 | PubChem CID:56940925 | PubChem SID:198954900 | BHF-177
+BMGC_DG12527,BMG_DG168110,GDC-0810 | PubChem CID:56941241 | PubChem SID:313183294 | DrugBank ID:DB12253 | BRILANESTRANT | CAS RN:1365888-06-7 | (E)-3-[4-[(E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-enyl]phenyl]prop-2-enoic acid | Brilanestrant | UNII:9MM2R1A06R
+BMGC_DG12528,BMG_DG168120,"DrugBank ID:DB11951 | (1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide | PubChem CID:56944144 | NDC:62856-410 | CAS RN:1369764-02-2 | PubChem SID:198935999 | Lemborexant | NDC:62856-405 | LEMBOREXANT | UNII:0K5743G68X"
+BMGC_DG12529,BMG_DG168123,PALUPIPRANT | Palupiprant | PubChem CID:56944705 | 4-[(1S)-1-[[3-(difluoromethyl)-1-methyl-5-[3-(trifluoromethyl)phenoxy]pyrazole-4-carbonyl]amino]ethyl]benzoic acid | CAS RN:1369489-71-3 | PubChem SID:252164516 | UNII:YWY620GU8I
+BMGC_DG12530,BMG_DG168126,UNII:403N302X2Y | PubChem CID:56945146 | PubChem SID:252319272 | AZD-3161 | CAS RN:1369501-46-1
+BMGC_DG12531,BMG_DG168130,"PubChem SID:198956468 | PubChem CID:56947150 | [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate | CAS RN:35523-89-8 | UNII:Q0638E899B | SAXITOXIN | Saxitoxin"
+BMGC_DG12532,BMG_DG168136,CAS RN:494856-61-0 | Bilb-1941 | (E)-3-[4-[[1-[(3-cyclopentyl-1-methyl-2-pyridin-2-ylindole-6-carbonyl)amino]cyclobutanecarbonyl]amino]phenyl]prop-2-enoic acid | UNII:3WV68DY85W | BILB-1941 | PubChem CID:56949326 | PubChem SID:316918297
+BMGC_DG12533,BMG_DG168140,PubChem CID:56949517 | UNII:DW94IAT0LS | DrugBank ID:DB11795 | GSK-2636771 | CAS RN:1372540-25-4 | 2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylbenzimidazole-4-carboxylic acid | PubChem SID:198947436 | Gsk-2636771
+BMGC_DG12534,BMG_DG168142,"UNII:G2283XQ6VJ | PubChem SID:198938039 | 5-[3-(1-methylcyclopropyl)propyl]-1H-pyrano[2,3-d]pyrimidine-2,4,7-trione | SCH-900271 | DrugBank ID:DB12433 | 5-(3-(1-Methylcyclopropyl)propyl)-1H-pyrano(2,3-d)pyrimidine-2,4,7(3H)-trione | CAS RN:915210-50-3 | PubChem CID:56950369"
+BMGC_DG12535,BMG_DG168151,6-chloro-3-[3-[(4-chlorophenyl)methyl]-5-phenylimidazol-4-yl]-N-(2-morpholin-4-ylethyl)-1H-indole-2-carboxamide | 6-Chloro-3-[1-(4-Chlorobenzyl)-4-Phenyl-1h-Imidazol-5-Yl]-N-[2-(Morpholin-4-Yl)ethyl]-1h-Indole-2-Carboxamide | PubChem CID:56951871
+BMGC_DG12536,BMG_DG168161,Calcium carbimide | calcium;azanidylidenemethylideneazanide | PubChem CID:56955933 | DrugBank ID:DB09116
+BMGC_DG12537,BMG_DG168167,"NDC:42385-964 | NDC:69367-294 | NDC:70436-103 | RANOLAZINE | CAS RN:95635-55-5 | PubChem CID:56959 | UNII:A6IEZ5M406 | DrugBank ID:DB00243 | NDC:31722-669 | NDC:67877-525 | NDC:29300-297 | NDC:27241-125 | NDC:43353-880 | NDC:69844-024 | NDC:69844-025 | NDC:68462-320 | NDC:70756-704 | NDC:0904-7506 | NDC:71205-867 | NDC:45963-418 | NDC:50268-722 | NDC:68180-355 | NDC:31722-668 | NDC:59651-009 | NDC:65162-376 | NDC:71335-2556 | NDC:42385-963 | CAS RN:142387-99-3 | NDC:67877-526 | NDC:63304-017 | NDC:27241-126 | NDC:70625-206 | NDC:70756-703 | NDC:72578-064 | NDC:69367-293 | NDC:71205-868 | NDC:70625-207 | NDC:42291-773 | N-(2,6-dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide | NDC:70771-1500 | NDC:70436-104 | NDC:59651-010 | NDC:63629-4874 | NDC:82804-118 | NDC:42571-325 | NDC:42291-774 | NDC:70771-1499 | NDC:60687-549 | NDC:47335-625 | NDC:65162-379 | NDC:50228-423 | Ranolazine | NDC:45963-419 | NDC:68462-319 | NDC:72319-022 | NDC:42571-324 | CAS RN:1080496-58-7 | PubChem SID:175271357 | NDC:47335-624 | NDC:71610-518 | NDC:63304-018 | NDC:29300-296 | NDC:72578-065 | NDC:63739-229 | NDC:72319-021 | NDC:50228-424 | NDC:50268-723 | NDC:68180-354"
+BMGC_DG12538,BMG_DG168169,"CAS RN:854601-70-0 | PubChem SID:198945150 | DrugBank ID:DB09049 | PubChem CID:56959087 | UNII:44T7335BKE | (4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol | NALOXEGOL | Naloxegol"
+BMGC_DG12539,BMG_DG168173,"CAS RN:1370651-20-9 | ENSARTINIB | DrugBank ID:DB14860 | 6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-[(3R,5S)-3,5-dimethylpiperazine-1-carbonyl]phenyl]pyridazine-3-carboxamide | PubChem SID:316915436 | UNII:SMA5ZS5B22 | Ensartinib | PubChem CID:56960363"
+BMGC_DG12540,BMG_DG168174,"(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide | PubChem CID:56960447 | X-376 | UNII:7DR7JMB8BH | DrugBank ID:DB13104 | X-396 | 6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-N-[4-(4-methylpiperazine-1-carbonyl)phenyl]pyridazine-3-carboxamide | PubChem SID:198965485 | CAS RN:1365267-27-1"
+BMGC_DG12541,BMG_DG168177,"CAS RN:1369412-66-7 | Cyclohexanecarboxamide, 4-(3-(hydroxymethyl)phenoxy)-N-methyl-N-(3-methyl-4-(((3S)-3-methyl-1-piperazinyl)methyl)phenyl)-, trans- | PubChem SID:346537495 | 4-[3-(hydroxymethyl)phenoxy]-N-methyl-N-[3-methyl-4-[[(3S)-3-methylpiperazin-1-yl]methyl]phenyl]cyclohexane-1-carboxamide | PubChem CID:56960876 | DS-3801A | UNII:5H2DV04I6O"
+BMGC_DG12542,BMG_DG168181,"PubChem SID:333495649 | Usl-311 | USL-311 | PubChem CID:56961879 | DrugBank ID:DB15265 | 6-[4-(1-propan-2-ylpiperidin-4-yl)-1,4-diazepan-1-yl]-N-pyridin-4-ylpyridine-2-carboxamide | CAS RN:1373268-67-7 | UNII:2BTG5MX2Q2"
+BMGC_DG12543,BMG_DG168185,"[3-[[4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]phenyl] N,N-dimethylcarbamate | CAS RN:1192189-69-7 | LX-7101 | PubChem CID:56962369 | Lx-7101 | PubChem SID:346536738 | UNII:74B3C4ZT96"
+BMGC_DG12544,BMG_DG168189,"PubChem CID:56963011 | 1-[3-[4-(3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]-4,4,4-trifluorobutan-1-one | PubChem SID:198952633 | XL-418 | 1-Butanone, 1-(3-(4-(3-bromo-1H-pyrazolo(3,4-d)pyrimidin-4-yl)-1-piperazinyl)-4-methyl-5-((2-(1-pyrrolidinyl)ethyl)amino)phenyl)-4,4,4-trifluoro- | UNII:OLJ18SRI8A | CAS RN:871343-09-8"
+BMGC_DG12545,BMG_DG168198,"PubChem CID:56965901 | CAS RN:1338247-35-0 | N-(5-(1-(2,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyramide | N-[5-[2-(2,6-dichlorophenyl)-5-(difluoromethyl)pyrazol-3-yl]-1,3-thiazol-2-yl]-2-methylpropanamide"
+BMGC_DG12546,BMG_DG168202,"Ipsapirone | PubChem SID:198972236 | 1,1-dioxo-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2-benzothiazol-3-one | PubChem CID:56971 | UNII:6J9B11MN0K | IPSAPIRONE | CAS RN:95847-70-4"
+BMGC_DG12547,BMG_DG168230,XANTHURENIC ACID | 8-hydroxy-4-oxo-1H-quinoline-2-carboxylic acid | CAS RN:67283-71-0 | CAS RN:59-00-7 | PubChem SID:198955185 | PubChem CID:5699 | Xanthurenic acid | UNII:58LAB1BG8J
+BMGC_DG12548,BMG_DG168258,"GUANABENZ | Guanabenz | CAS RN:5051-62-7 | PubChem SID:175266630 | 2-[(E)-(2,6-dichlorophenyl)methylideneamino]guanidine | UNII:GGD30112WC | CAS RN:60329-05-7 | PubChem CID:5702063 | CAS RN:60329-03-5"
+BMGC_DG12549,BMG_DG168283,"NDC:69842-063 | NDC:49035-589 | NDC:43386-500 | PubChem CID:5702160 | NDC:0832-6045 | NDC:65862-860 | NDC:55111-119 | NDC:70756-051 | NDC:11673-697 | NDC:16837-889 | NDC:72789-331 | NDC:68001-398 | NDC:70518-3829 | NDC:58602-859 | NDC:70518-3831 | NDC:50090-7196 | NDC:67296-1795 | NDC:69238-2090 | NDC:83008-091 | NDC:72189-543 | NDC:68788-7922 | NDC:67877-775 | NDC:49884-366 | NDC:68788-8518 | NDC:71335-2190 | NDC:0113-0194 | NDC:25021-753 | NDC:71335-0370 | NDC:71335-1950 | NDC:83059-0005 | NDC:58602-706 | NDC:71335-9615 | NDC:71205-257 | NDC:56062-194 | NDC:68645-594 | NDC:21130-022 | NDC:80425-0422 | NDC:59779-141 | NDC:70000-0048 | NDC:80005-119 | NDC:50594-002 | NDC:69306-266 | NDC:69844-096 | NDC:50268-299 | NDC:71821-012 | NDC:70748-312 | NDC:36800-141 | NDC:72789-027 | NDC:71335-0409 | NDC:0172-5729 | NDC:68016-800 | NDC:67457-457 | NDC:68071-2306 | NDC:83008-089 | NDC:62332-002 | NDC:73581-108 | NDC:0363-4400 | NDC:37808-301 | NDC:68391-300 | NDC:69844-095 | NDC:21130-023 | NDC:72205-146 | NDC:72657-113 | NDC:0113-0141 | NDC:70518-0461 | NDC:69168-445 | NDC:60760-843 | CAS RN:76824-35-6 | NDC:31722-315 | NDC:50090-3888 | NDC:55910-194 | NDC:0187-4440 | NDC:46708-293 | NDC:70860-751 | NDC:83324-003 | NDC:70771-1703 | NDC:43063-086 | NDC:36800-194 | NDC:76420-712 | NDC:68094-054 | NDC:55154-4313 | NDC:49035-396 | NDC:63941-011 | NDC:50090-7180 | NDC:60760-736 | NDC:71335-2442 | NDC:67296-1859 | NDC:43602-602 | NDC:71335-9748 | NDC:72036-026 | NDC:0574-0147 | NDC:11673-031 | NDC:70710-1783 | NDC:50090-6932 | NDC:67296-1121 | NDC:71872-7235 | NDC:62332-001 | NDC:46122-735 | NDC:69367-400 | NDC:55111-120 | NDC:63868-583 | NDC:69842-924 | NDC:71821-010 | NDC:68001-397 | NDC:55315-435 | NDC:51662-1375 | FAMOTIDINE | NDC:63323-739 | NDC:63629-2015 | NDC:70677-1101 | NDC:50090-1044 | NDC:68001-494 | NDC:50090-7178 | NDC:63739-645 | NDC:63941-009 | NDC:0172-5728 | NDC:57896-319 | NDC:11822-0141 | NDC:50090-6916 | NDC:72476-150 | NDC:68071-4197 | NDC:69256-002 | NDC:70710-1782 | NDC:60429-721 | NDC:69842-267 | NDC:57896-317 | NDC:49035-507 | NDC:76420-891 | NDC:63323-738 | NDC:50090-1432 | NDC:30142-141 | NDC:72603-171 | NDC:37808-042 | NDC:69842-659 | NDC:71610-470 | NDC:46122-737 | NDC:64980-623 | NDC:0363-1899 | NDC:67457-448 | NDC:61442-121 | NDC:67046-1427 | NDC:0536-1298 | NDC:70771-1702 | NDC:63629-8891 | NDC:72789-453 | NDC:43063-533 | NDC:72288-194 | NDC:0363-9607 | NDC:55319-427 | NDC:71335-9724 | NDC:51407-684 | NDC:76162-300 | NDC:69230-327 | NDC:70860-753 | NDC:71205-276 | NDC:72162-1737 | NDC:11822-6123 | NDC:68071-3420 | NDC:43598-824 | NDC:55111-118 | NDC:69842-266 | NDC:72189-207 | NDC:53943-100 | NDC:66715-6458 | NDC:11822-1014 | NDC:11822-1194 | NDC:58602-828 | NDC:63187-908 | NDC:16837-872 | NDC:41163-001 | NDC:10267-5689 | NDC:63629-7013 | NDC:70518-1415 | NDC:25000-086 | NDC:46708-294 | NDC:43598-960 | NDC:70377-113 | NDC:43063-695 | NDC:68788-8269 | NDC:68475-400 | NDC:72559-032 | NDC:31722-017 | NDC:50090-6582 | NDC:43602-501 | NDC:69842-928 | NDC:62135-807 | NDC:59779-194 | NDC:58602-829 | NDC:0338-5197 | NDC:61442-122 | NDC:68071-3584 | NDC:70710-1683 | NDC:55910-141 | NDC:55154-2628 | NDC:16837-855 | NDC:49348-817 | NDC:56062-141 | NDC:70710-1784 | NDC:83324-116 | NDC:25000-087 | NDC:63629-2782 | NDC:68645-140 | NDC:67046-1224 | NDC:0641-6022 | NDC:63981-194 | NDC:55111-396 | NDC:49035-118 | NDC:70000-0710 | NDC:67877-889 | NDC:73581-109 | NDC:41520-901 | NDC:66715-9748 | NDC:68788-8733 | NDC:41167-0360 | NDC:62135-808 | NDC:70756-052 | NDC:68788-7853 | NDC:68788-8285 | NDC:67296-1383 | NDC:0641-6023 | NDC:41167-0361 | NDC:21130-033 | NDC:49348-128 | NDC:68788-8485 | NDC:21130-249 | NDC:71872-7220 | NDC:60760-327 | NDC:72865-214 | NDC:24385-385 | NDC:50090-5241 | NDC:11673-061 | NDC:10267-5690 | NDC:21130-777 | NDC:79903-115 | NDC:55910-814 | NDC:67457-433 | NDC:0363-0141 | NDC:70518-0163 | NDC:67296-1776 | NDC:43063-696 | NDC:55319-426 | NDC:43602-544 | NDC:69842-087 | NDC:59640-023 | NDC:81522-141 | NDC:49035-505 | NDC:63187-129 | NDC:41226-719 | NDC:43602-502 | NDC:70677-1102 | NDC:80425-0329 | NDC:63187-723 | NDC:55681-342 | NDC:25021-754 | NDC:70518-1877 | NDC:72288-329 | NDC:68016-801 | NDC:49483-720 | NDC:69168-443 | NDC:67296-1523 | NDC:69230-326 | NDC:50269-156 | NDC:63629-2014 | NDC:58602-705 | NDC:11673-414 | NDC:21130-039 | NDC:80267-501 | NDC:80425-0384 | NDC:72288-151 | NDC:41163-313 | NDC:50268-304 | NDC:75987-010 | NDC:72476-299 | NDC:72789-345 | NDC:83324-008 | NDC:31722-018 | NDC:60219-2090 | NDC:72288-141 | NDC:63187-999 | UNII:5QZO15J2Z8 | NDC:45865-881 | NDC:0904-5529 | NDC:67296-0963 | NDC:60687-595 | NDC:72789-427 | NDC:71335-2527 | NDC:63868-584 | NDC:71205-637 | NDC:67046-1473 | NDC:0615-8301 | NDC:53943-101 | NDC:65862-859 | NDC:70771-1847 | NDC:67877-626 | PubChem SID:175266759 | NDC:41167-0364 | NDC:46122-394 | NDC:55681-341 | NDC:0904-7193 | NDC:42571-433 | NDC:76420-713 | NDC:30142-194 | NDC:0187-4420 | NDC:31722-063 | NDC:69844-098 | NDC:67751-214 | NDC:0641-6021 | NDC:72205-145 | NDC:64980-624 | NDC:68382-444 | NDC:70000-0049 | NDC:43602-511 | NDC:68196-121 | NDC:69844-097 | 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide | NDC:49035-650 | NDC:72288-363 | NDC:50090-1045 | NDC:0363-1203 | NDC:43598-572 | NDC:41520-707 | NDC:69367-401 | NDC:59640-001 | NDC:66715-9758 | NDC:70954-316 | NDC:72865-215 | NDC:51407-452 | NDC:54257-802 | NDC:70000-0654 | NDC:72189-141 | NDC:67296-1892 | NDC:71205-535 | NDC:0363-5300 | NDC:41250-493 | NDC:51655-312 | NDC:68788-6859 | NDC:51655-233 | NDC:71335-0231 | NDC:11822-6141 | NDC:72657-112 | NDC:0363-0701 | NDC:70710-1684 | NDC:70860-752 | NDC:71205-634 | NDC:71335-1520 | NDC:80267-194 | NDC:27241-249 | NDC:55154-6843 | NDC:68071-3201 | NDC:51407-683 | NDC:72657-132 | NDC:71610-399 | NDC:50269-155 | NDC:71205-781 | NDC:55910-665 | NDC:51655-102 | NDC:70518-4084 | NDC:41250-712 | NDC:21130-191 | NDC:68788-7191 | NDC:71205-663 | NDC:0615-4582 | NDC:67877-843 | NDC:70771-1846 | NDC:67877-842 | NDC:50383-913 | NDC:68180-150 | NDC:70771-1845 | NDC:50090-6790 | Famotidine | NDC:21130-027 | NDC:83059-0031 | NDC:54257-180 | NDC:0904-5780"
+BMGC_DG12550,BMG_DG168290,azane;dichloroplatinum | CAS RN:14913-33-8 | PubChem CID:5702198
+BMGC_DG12551,BMG_DG168316,"CAS RN:57444-62-9 | RESINIFERATOXIN | PubChem SID:198952604 | [(1R,2R,6R,10S,11R,13S,15R,17R)-13-benzyl-6-hydroxy-4,17-dimethyl-5-oxo-15-prop-1-en-2-yl-12,14,18-trioxapentacyclo[11.4.1.01,10.02,6.011,15]octadeca-3,8-dien-8-yl]methyl 2-(4-hydroxy-3-methoxyphenyl)acetate | DrugBank ID:DB06515 | PubChem CID:5702546 | Resiniferatoxin | UNII:A5O6P1UL4I"
+BMGC_DG12552,BMG_DG168350,"2-(pyridin-2-ylmethylidene)-3,4-dihydronaphthalen-1-one, (2E)- | PubChem CID:5702960 | CAS RN:160488-11-9 | 2-(PYRIDIN-2-YLMETHYLIDENE)-3,4-DIHYDRONAPHTHALEN-1-ONE, (2E)- | UNII:7ZV7HN2CKA | PubChem SID:475550134"
+BMGC_DG12553,BMG_DG168351,Brequinar | BREQUINAR | PubChem SID:198976397 | CAS RN:96187-53-0 | UNII:5XL19F49H6 | PubChem CID:57030 | DrugBank ID:DB03523 | 6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid
+BMGC_DG12554,BMG_DG168361,"UNII:62GA3K28B6 | DrugBank ID:DB12194 | Atamestane | ATAMESTANE | CAS RN:96301-34-7 | PubChem SID:198977589 | (8R,9S,10S,13S,14S)-1,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione | PubChem CID:57050"
+BMGC_DG12555,BMG_DG168368,CAS RN:6835-55-8 | PubChem SID:472421978 | 6-acetyl-7-hydroxychromen-2-one | UNII:59LFP758NA | 6-ACETYL-7-HYDROXYCHROMEN-2-ONE | PubChem CID:5705744
+BMGC_DG12556,BMG_DG168385,"PubChem CID:5707 | UNII:2KFG9TP5V8 | Xylazine | DrugBank ID:DB11477 | XYLAZINE | N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine | PubChem SID:175267653 | CAS RN:7361-61-7"
+BMGC_DG12557,BMG_DG168390,"PubChem CID:5708 | CAS RN:85539-83-9 | 1,4-PHENYLENEBIS(METHYLENE)SELENOCYANATE | 1,4-Phenylenebis(methylene)selenocyanate | UNII:Q22S9Y993E | PubChem SID:381608359 | [4-(selenocyanatomethyl)phenyl]methyl selenocyanate"
+BMGC_DG12558,BMG_DG168402,PubChem SID:346538832 | CAS RN:152809-69-3 | PubChem CID:5708903 | (E)-1-(4'-CHLOROPHENYL)-3-(4-HYDROXY-3-METHOXYPHENYL)PROP-2-EN-1-ONE | UNII:RIK7LYIOUJ
+BMGC_DG12559,BMG_DG168403,"2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole | UNII:WPY40FTH8K | CAS RN:526-36-3 | PubChem SID:175267941 | Xylometazoline | PubChem CID:5709 | XYLOMETAZOLINE | DrugBank ID:DB06694"
+BMGC_DG12560,BMG_DG168408,"PubChem SID:317228877 | UNII:K2054N324R | CAS RN:6272-43-1 | PubChem CID:5709318 | 2',3,4-TRIHYDROXYCHALCONE"
+BMGC_DG12561,BMG_DG168415,ABLUKAST | CAS RN:96566-25-5 | UNII:000TKM5BBQ | PubChem CID:57109 | PubChem SID:198966578
+BMGC_DG12562,BMG_DG168417,DrugBank ID:DB12448 | PubChem SID:198989744 | UNII:6KWX9X0Q5K | Lifibrol | 4-[4-(4-tert-butylphenyl)-2-hydroxybutoxy]benzoic acid | CAS RN:96609-16-4 | PubChem CID:57112 | LIFIBROL
+BMGC_DG12563,BMG_DG168423,PubChem SID:198947115 | LIFICIGUAT | UNII:515CC1WPTE | PubChem CID:5712 | CAS RN:170632-47-0 | [5-(1-benzylindazol-3-yl)furan-2-yl]methanol | CAS RN:154453-18-6 | Lificiguat
+BMGC_DG12564,BMG_DG168425,"Virodhamine | 2-aminoethyl (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate | PubChem CID:5712057 | CAS RN:287937-12-6"
+BMGC_DG12565,BMG_DG168430,2-[(2-hydroxyphenyl)methylidene]-3H-inden-1-one | UNII:8T49Q2KKW6 | PubChem CID:5713138 | CAS RN:1801659-02-8 | PubChem SID:474492928 | 2-((2-HYDROXYPHENYL)METHYLIDENE)-3H-INDEN-1-ONE
+BMGC_DG12566,BMG_DG168439,"6-Ethyl-5-{3-[2-Methoxy-5-(Pyridin-4-Yl)phenyl]prop-1-Yn-1-Yl}pyrimidine-2,4-Diamine | 6-ethyl-5-[3-(2-methoxy-5-pyridin-4-ylphenyl)prop-1-ynyl]pyrimidine-2,4-diamine | PubChem CID:57149549"
+BMGC_DG12567,BMG_DG168440,"6-ethyl-5-[3-(3-methoxy-5-pyridin-4-ylphenyl)prop-1-ynyl]pyrimidine-2,4-diamine | PubChem CID:57149550 | 6-Ethyl-5-{3-[3-Methoxy-5-(Pyridin-4-Yl)phenyl]prop-1-Yn-1-Yl}pyrimidine-2,4-Diamine"
+BMGC_DG12568,BMG_DG168449,"N-[1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]benzamide | UNII:V25F9362OP | DrugBank ID:DB11618 | PubChem CID:57164040 | Zorubicin | PubChem SID:198961487 | CAS RN:54083-22-6 | ZORUBICIN"
+BMGC_DG12569,BMG_DG168450,PubChem CID:57166 | BIS-1-(8-(1-HYDROXYETHYL)DEUTEROPORPHYRIN-3-YL)ETHYL ETHER | UNII:625J2HS54G | CAS RN:97067-70-4 | PubChem SID:249492807
+BMGC_DG12570,BMG_DG168454,cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate | ZAFIRLUKAST | PubChem CID:5717 | NDC:64380-187 | NDC:42291-970 | PubChem SID:175267789 | NDC:64380-188 | DrugBank ID:DB00549 | NDC:64380-178 | NDC:59651-291 | Zafirlukast | NDC:55111-625 | NDC:31722-008 | NDC:31722-007 | CAS RN:107753-78-6 | NDC:55111-626 | NDC:68084-059 | NDC:72162-2362 | NDC:72162-2361 | NDC:64380-177 | NDC:59651-292 | UNII:XZ629S5L50 | NDC:42291-971
+BMGC_DG12571,BMG_DG168459,PubChem CID:57174031 | Lopac-T-104 | [(5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate
+BMGC_DG12572,BMG_DG168470,"NDC:71335-0236 | NDC:69452-364 | NDC:69452-365 | ZALEPLON | NDC:65862-215 | UNII:S62U433RMH | CAS RN:151319-34-5 | NDC:57237-239 | N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide | PubChem SID:175265396 | NDC:71335-1054 | Zaleplon | NDC:29300-132 | NDC:57237-240 | NDC:65862-214 | NDC:71335-2468 | NDC:43063-783 | PubChem CID:5719 | NDC:50090-1564 | NDC:0054-0085 | NDC:68788-7208 | NDC:43063-912 | NDC:63629-3405 | DrugBank ID:DB00962 | CAS RN:1007130-22-4 | NDC:0054-0084 | NDC:68788-8725 | NDC:43063-505 | NDC:29300-131"
+BMGC_DG12573,BMG_DG168474,UNII:5829E3D9I9 | CAS RN:66508-53-0 | FOSMIDOMYCIN | Fosmidomycin | 3-[formyl(hydroxy)amino]propylphosphonic acid | DrugBank ID:DB02948 | PubChem CID:572 | PubChem SID:198962774
+BMGC_DG12574,BMG_DG168475,DrugBank ID:DB06737 | CAS RN:74711-43-6 | ZALTOPROFEN | CAS RN:89482-00-8 | CAS RN:1166864-09-0 | Zaltoprofen | PubChem CID:5720 | UNII:H8635NG3PY | PubChem SID:198940738 | 2-(6-oxo-5H-benzo[b][1]benzothiepin-3-yl)propanoic acid
+BMGC_DG12575,BMG_DG168482,"PubChem SID:478837530 | PubChem CID:5721990 | N,N-DIMETHYL-4-(2-(QUINOLIN-2-YL)ETHENYL)ANILINE | UNII:E73KE2V2AV | CAS RN:48189-64-6 | N,N-dimethyl-4-[2-(quinolin-2-yl)ethenyl]aniline"
+BMGC_DG12576,BMG_DG168486,CAS RN:101975-10-4 | PubChem SID:198978497 | Zardaverine | PubChem CID:5723 | ZARDAVERINE | DrugBank ID:DB02918 | 3-[4-(difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-one | UNII:TQ358GWH6Y
+BMGC_DG12577,BMG_DG168489,"PubChem CID:5724 | UNII:180C9PJ8JT | DrugBank ID:DB02132 | PubChem SID:198947648 | ZENARESTAT | CAS RN:112733-06-9 | 2-[3-[(4-bromo-2-fluorophenyl)methyl]-7-chloro-2,4-dioxoquinazolin-1-yl]acetic acid | Zenarestat"
+BMGC_DG12578,BMG_DG168491,"QUINELORANE | (5aR,9aR)-6-propyl-5a,7,8,9,9a,10-hexahydro-5H-pyrido[2,3-g]quinazolin-2-amine | CAS RN:97466-90-5 | Quinelorane | CAS RN:97430-52-9 | UNII:Z0X4VT3Y1Q | PubChem CID:57242 | PubChem SID:198951792"
+BMGC_DG12579,BMG_DG168502,ETICLOPRIDE | PubChem SID:198968683 | Eticlopride | UNII:J8M468HBH4 | DrugBank ID:DB15492 | CAS RN:84226-12-0 | 5-chloro-3-ethyl-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide | PubChem CID:57267
+BMGC_DG12580,BMG_DG168503,DrugBank ID:DB07838 | PubChem CID:5726921 | (Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE
+BMGC_DG12581,BMG_DG168505,UNII:86Q357L16B | PubChem SID:175266535 | dichlorozinc | ZINC CHLORIDE | CAS RN:7646-85-7 | PubChem CID:5727 | Zinc Chloride | Zinc chloride
+BMGC_DG12582,BMG_DG168516,"4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]furan-2-Yl}benzenesulfonamide | DrugBank ID:DB07534 | PubChem CID:5729339"
+BMGC_DG12583,BMG_DG168527,"PubChem SID:175266082 | CAS RN:82626-48-0 | Zolpidem | DrugBank ID:DB00425 | N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide | UNII:7K383OQI23 | ZOLPIDEM | PubChem CID:5732"
+BMGC_DG12584,BMG_DG168535,"PubChem CID:57327016 | DrugBank ID:DB12674 | CAS RN:497871-47-3 | Lurbinectedin | UNII:2CN60TN6ZS | LURBINECTEDIN | PubChem SID:198985210 | NDC:68727-712 | [(1R,2R,3R,11S,12S,14R,26R)-5,12-dihydroxy-6,6'-dimethoxy-7,21,30-trimethyl-27-oxospiro[17,19,28-trioxa-24-thia-13,30-diazaheptacyclo[12.9.6.13,11.02,13.04,9.015,23.016,20]triaconta-4(9),5,7,15,20,22-hexaene-26,1'-2,3,4,9-tetrahydropyrido[3,4-b]indole]-22-yl] acetate"
+BMGC_DG12585,BMG_DG168537,"UNII:822G987U9J | Zomepirac | ZOMEPIRAC | CAS RN:33369-31-2 | PubChem SID:198952030 | DrugBank ID:DB04828 | 2-[5-(4-chlorobenzoyl)-1,4-dimethylpyrrol-2-yl]acetic acid | PubChem CID:5733"
+BMGC_DG12586,BMG_DG168546,"2-[4-(cyclohexylmethyl)piperazin-1-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one | DrugBank ID:DB14821 | CAS RN:1377239-83-2 | PubChem SID:363909932 | UNII:A3M1353L40 | PubChem CID:57331386 | Macozinone | MACOZINONE"
+BMGC_DG12587,BMG_DG168547,PubChem SID:313368803 | PubChem CID:57331749 | CAS RN:885496-53-7 | 1-[[6-ethyl-1-[(4-fluorophenyl)methyl]-5-methyl-2-oxopyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid | UNII:88NI79737I | S-777469
+BMGC_DG12588,BMG_DG168555,PubChem SID:198953918 | DrugBank ID:DB11907 | Rociletinib | PubChem CID:57335384 | UNII:72AH61702G | CAS RN:1374640-70-6 | N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide | ROCILETINIB
+BMGC_DG12589,BMG_DG168557,"CAS RN:1646183-13-2 | DrugBank ID:DB11877 | UNII:788PET5SUA | Basmisanil | (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone | BASMISANIL | CAS RN:1159600-41-5 | PubChem SID:198976187 | PubChem CID:57336276"
+BMGC_DG12590,BMG_DG168561,"(2S)-1-[4-[2-[6-amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]purin-9-yl]ethyl]piperidin-1-yl]-2-hydroxypropan-1-one | CAS RN:958025-66-6 | UNII:9UMA2EEO9Q | PubChem SID:198945308 | Mpc-3100 | PubChem CID:57336747 | MPC-3100"
+BMGC_DG12591,BMG_DG168562,PubChem SID:377308813 | GSK-2647544 | PubChem CID:57336782 | 2-[2-[4-[4-chloro-3-(trifluoromethyl)phenoxy]phenyl]ethoxy]-5-(pyrimidin-5-ylmethyl)-1H-pyrimidin-6-one | UNII:GKK5LY2UEI | CAS RN:1380426-95-8 | Gsk-2647544
+BMGC_DG12592,BMG_DG168563,CAS RN:1257704-57-6 | PubChem CID:57336812 | PubChem SID:485665513 | CEP-33779 | UNII:TE2YU6E6YP
+BMGC_DG12593,BMG_DG168565,Delmopinol | PubChem SID:198958526 | 2-[3-(4-propylheptyl)morpholin-4-yl]ethanol | DELMOPINOL | UNII:DT67WL708F | CAS RN:79874-76-3 | PubChem CID:57337
+BMGC_DG12594,BMG_DG168622,PubChem CID:57339412 | N-Hydroxy-1-[(2-Phenylethyl)sulfonyl]-D-Prolinamide | (2R)-N-hydroxy-1-(2-phenylethylsulfonyl)pyrrolidine-2-carboxamide
+BMGC_DG12595,BMG_DG168623,"1-[3-[(3,5-dichlorophenyl)methylamino]propyl]-3-phenylurea | PubChem CID:57339424 | 1-{3-[(3,5-Dichlorobenzyl)amino]propyl}-3-Phenylurea"
+BMGC_DG12596,BMG_DG168628,"UNII:0JD3P48M9V | GSK-2336805 | PubChem CID:57339460 | PubChem SID:316913462 | CAS RN:1256390-53-0 | methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(8S)-7-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-1,4-dioxa-7-azaspiro[4.4]nonan-8-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate | Gsk2336805"
+BMGC_DG12597,BMG_DG168631,"NDC:62756-258 | NDC:68001-242 | NDC:61919-917 | NDC:59651-378 | NDC:60687-230 | NDC:68001-243 | PubChem SID:175268290 | NDC:63187-583 | NDC:68788-7438 | NDC:80425-0392 | NDC:50268-816 | NDC:71205-727 | NDC:69097-861 | NDC:70518-3224 | PubChem CID:5734 | NDC:80425-0370 | NDC:76282-226 | NDC:59212-681 | NDC:0615-8266 | NDC:70771-1143 | NDC:70518-3903 | NDC:72578-042 | NDC:72189-374 | DrugBank ID:DB00909 | NDC:29300-428 | Zonisamide | NDC:72578-040 | NDC:72578-041 | NDC:76282-228 | NDC:59651-380 | NDC:70771-1144 | NDC:68462-130 | NDC:71335-0486 | NDC:68462-128 | NDC:70771-1142 | NDC:68462-129 | NDC:63629-3293 | NDC:76282-227 | NDC:70518-3180 | NDC:71335-9679 | NDC:62756-259 | NDC:68001-244 | NDC:59212-680 | CAS RN:68291-97-4 | NDC:29300-430 | NDC:52652-8001 | NDC:59651-379 | NDC:63187-897 | NDC:29300-429 | NDC:62756-260 | 1,2-benzoxazol-3-ylmethanesulfonamide | ZONISAMIDE | UNII:459384H98V"
+BMGC_DG12598,BMG_DG168632,CAS RN:1644498-56-5 | PubChem CID:57340686 | 3-[[(E)-4-(dimethylamino)but-2-enoyl]amino]-N-[3-methyl-4-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | CAS RN:1410880-22-6 | Jnk-IN-8
+BMGC_DG12599,BMG_DG168641,"UNII:F66X4M38G5 | PubChem SID:249492175 | CAS RN:1380288-88-9 | DrugBank ID:DB12920 | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[[3-[2-(6-tert-butyl-1H-benzimidazol-2-yl)ethyl]cyclobutyl]-propan-2-ylamino]methyl]oxolane-3,4-diol | PubChem CID:57345410 | CAS RN:1380288-87-8 | UNII:8V9YR09EF3 | PubChem SID:198943327 | PINOMETOSTAT | Pinometostat | PINOMETOSTAT, TRANS-"
+BMGC_DG12600,BMG_DG168651,PubChem SID:252164067 | Belizatinib | UNII:Z8A6022P3J | 4-fluoro-N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]benzimidazol-2-yl]benzamide | CAS RN:1357920-84-3 | PubChem CID:57345941 | BELIZATINIB
+BMGC_DG12601,BMG_DG168685,"PubChem CID:5735 | ZOPICLONE | CAS RN:1169825-88-0 | CAS RN:43200-80-2 | [6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate | PubChem SID:175272137 | UNII:03A5ORL08Q | Zopiclone | DrugBank ID:DB01198"
+BMGC_DG12602,BMG_DG168747,"2-(3-chlorobenzo[b][1]benzothiepin-5-yl)oxy-N,N-dimethylethanamine | PubChem SID:198951716 | Zotepine | UNII:U29O83JAZW | CAS RN:26615-21-4 | ZOTEPINE | DrugBank ID:DB09225 | PubChem CID:5736 | CAS RN:1200591-33-8"
+BMGC_DG12603,BMG_DG168750,"NDC:68645-541 | NDC:67877-455 | PubChem SID:175267476 | NDC:47335-714 | NDC:84539-001 | NDC:57237-061 | NDC:76282-412 | NDC:68788-6976 | NDC:68788-8275 | NDC:76420-151 | NDC:68382-074 | NDC:68788-6875 | NDC:68788-8377 | NDC:67877-288 | NDC:65862-927 | NDC:68071-3417 | NDC:69097-112 | NDC:70518-1704 | NDC:76420-074 | NDC:68788-8433 | NDC:31722-525 | CAS RN:140375-21-9 | NDC:70518-2287 | NDC:35573-400 | NDC:76420-154 | NDC:84539-002 | NDC:68071-3354 | NDC:16729-089 | NDC:68071-3785 | NDC:68071-3744 | NDC:71335-1304 | NDC:47335-715 | NDC:67296-2056 | NDC:50090-7086 | NDC:50090-1936 | CAS RN:98319-26-7 | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide | FINASTERIDE | NDC:70518-3182 | NDC:50090-4697 | NDC:43598-303 | NDC:68071-3380 | NDC:50090-6941 | NDC:68788-8749 | NDC:70518-0397 | Finasteride | NDC:68071-3094 | NDC:50090-7228 | NDC:43598-390 | NDC:63187-265 | NDC:78206-153 | NDC:55111-171 | NDC:71335-1898 | NDC:63187-863 | NDC:68071-4808 | NDC:50090-4648 | NDC:71335-0433 | NDC:82009-061 | NDC:50090-6940 | UNII:57GNO57U7G | NDC:50268-314 | NDC:70771-1152 | NDC:55154-8083 | NDC:71610-515 | NDC:72189-542 | NDC:71335-1530 | NDC:71335-1634 | NDC:71610-520 | NDC:71713-099 | NDC:70518-3600 | NDC:16729-090 | NDC:55111-172 | NDC:31722-526 | NDC:65862-149 | NDC:70518-3616 | NDC:78206-152 | PubChem CID:57363 | NDC:57237-062 | NDC:0904-6830 | NDC:60687-428 | NDC:0093-7355 | DrugBank ID:DB01216 | NDC:71205-790 | NDC:71205-767"
+BMGC_DG12604,BMG_DG168808,"PubChem SID:198981892 | DrugBank ID:DB09063 | CERITINIB | CAS RN:1032900-25-6 | UNII:K418KG2GET | PubChem CID:57379345 | NDC:0078-0694 | Ceritinib | 5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine"
+BMGC_DG12605,BMG_DG168813,"LY-3031207 | PubChem CID:57382526 | CAS RN:1381846-21-4 | UNII:NQ7VQ61PBC | Ly-3031207 | 2-chloro-5-[(2,2-dimethylpropanoylamino)methyl]-N-(1H-imidazol-2-yl)benzamide | PubChem SID:405055292"
+BMGC_DG12606,BMG_DG168822,"UNII:P5DKZ70636 | 5-(6,6-dimethyl-4-morpholin-4-yl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyrimidin-2-amine | CAS RN:1382979-44-3 | DrugBank ID:DB15186 | Gdc-0084 | PAXALISIB | PubChem CID:57384863 | PubChem SID:363909043"
+BMGC_DG12607,BMG_DG168823,"3-(2-(1-(CYCLOHEXYLMETHYL)-2-OXO-1H,2H,5H,6H,7H,8H,9H,10H-CYCLOOCTA(B)PYRIDINE-3-AMIDO)-1,3-THIAZOL-4-YL)PROPANOIC ACID | CAS RN:885490-15-3 | PubChem CID:57387465 | UNII:NVJ8QDQ4QW | PubChem SID:459055280"
+BMGC_DG12608,BMG_DG168828,"PubChem CID:57389999 | PubChem SID:346539482 | CAS RN:1380087-89-7 | UNII:U4017GUQ06 | PELABRESIB ANHYDROUS | CPI-0610 anhydrous | 2-[(4S)-6-(4-chlorophenyl)-1-methyl-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide"
+BMGC_DG12609,BMG_DG168829,"5-Chloro-N2-(4-(4-(dimethylamino)-1-piperidinyl)-2-methoxyphenyl)-N4-(2-(dimethylphosphinyl)phenyl)-2,4-pyrimidinediamine | UNII:3DGD69C6PV | 5-CHLORO-N2-(4-(4-(DIMETHYLAMINO)-1-PIPERIDINYL)-2-METHOXYPHENYL)-N4-(2-(DIMETHYLPHOSPHINYL)PHENYL)-2,4-PYRIMIDINEDIAMINE | 5-chloro-2-N-[4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl]-4-N-(2-dimethylphosphorylphenyl)pyrimidine-2,4-diamine | CAS RN:1197958-12-5 | PubChem CID:57390074 | PubChem SID:241177982"
+BMGC_DG12610,BMG_DG168831,PubChem SID:474492606 | AZ-11713908 | CAS RN:1309682-69-6 | PubChem CID:57390958 | UNII:MN7RR3VQL7
+BMGC_DG12611,BMG_DG168832,"methyl (1R,2S,5S,7R,10S,11S,13R,15S)-7,15-dihydroxy-2,6,6,10,13,15-hexamethyl-17-methylidene-14,16-dioxotetracyclo[11.3.1.02,11.05,10]heptadecane-1-carboxylate | PubChem CID:57391090 | Berkeleyone A"
+BMGC_DG12612,BMG_DG168836,"PubChem CID:57393422 | ethyl (4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-4-(dimethylamino)-3-hydroxy-5-[(2S,4R,5S,6S)-4-hydroxy-4,6-dimethyl-5-propanoyloxyoxan-2-yl]oxy-6-methyloxan-2-yl]oxy-10-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-diene-4-carboxylate"
+BMGC_DG12613,BMG_DG168837,PubChem SID:316917130 | SR-9009 | PubChem CID:57394020 | UNII:X5DCA09N30 | CAS RN:1379686-30-2
+BMGC_DG12614,BMG_DG168838,PubChem CID:57394021 | UNII:VYI79FLZ6W | CAS RN:1379686-29-9 | PubChem SID:316914106 | SR-9011
+BMGC_DG12615,BMG_DG168839,"Eliglustat (1S,2R) diastereomer | UNII:B7LMG26P79 | ELIGLUSTAT (1S,2R) DIASTEREOMER | PubChem CID:57394510 | CAS RN:1092472-65-5 | PubChem SID:485664201"
+BMGC_DG12616,BMG_DG168841,PubChem CID:57396865 | CAS RN:938435-69-9 | PubChem SID:198939476 | FLORBETAPIR | 4-[(E)-2-[6-[2-[2-(2-fluoroethoxy)ethoxy]ethoxy]pyridin-3-yl]ethenyl]-N-methylaniline | UNII:6867Q6IKOD | Florbetapir
+BMGC_DG12617,BMG_DG168844,"PubChem CID:57398141 | methyl (1R,2S,5S,10S,11S,13R,15S)-15-hydroxy-2,6,6,10,13,15-hexamethyl-17-methylidene-7,14,16-trioxotetracyclo[11.3.1.02,11.05,10]heptadecane-1-carboxylate | Preaustinoid A"
+BMGC_DG12618,BMG_DG168845,"Berkeleyone B | PubChem CID:57398142 | CAS RN:1334495-42-9 | methyl (1R,2S,11S,12S,14R,16S)-16-hydroxy-2,6,6,11,14,16-hexamethyl-18-methylidene-8,15,17-trioxo-7-oxatetracyclo[12.3.1.02,12.05,11]octadec-4-ene-1-carboxylate"
+BMGC_DG12619,BMG_DG168847,"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol | DrugBank ID:DB02848 | PubChem CID:5740"
+BMGC_DG12620,BMG_DG168856,AB-001 (cannabinoid) | PubChem CID:57404070 | PubChem SID:312524936 | CAS RN:1345973-49-0 | AB-001 (CANNABINOID) | UNII:H657DIA015
+BMGC_DG12621,BMG_DG168857,LY-2428703 | PubChem SID:198964604 | CAS RN:1050393-23-1 | UNII:QYE7R5ALMM | PubChem CID:57404255
+BMGC_DG12622,BMG_DG168858,(+/-)-Lanabecestat | PubChem CID:57404290
+BMGC_DG12623,BMG_DG168862,"DrugBank ID:DB14793 | UNII:Q8MI0X869M | PubChem CID:57406853 | CAS RN:939981-39-2 | RO-5045337 | PubChem SID:198966294 | Ro-5045337 | [(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone"
+BMGC_DG12624,BMG_DG168872,PubChem SID:313183790 | PubChem CID:57413968 | UNII:2HB46A9CNM | DTP-348 | DrugBank ID:DB12741 | CAS RN:1383370-92-0 | Dtp-348 | 2-methyl-5-nitro-1-[2-(sulfamoylamino)ethyl]imidazole
+BMGC_DG12625,BMG_DG168908,"Sitogluside | UNII:U45VN859W3 | PubChem CID:5742590 | PubChem SID:198945483 | SITOGLUSIDE | (2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | CAS RN:474-58-8"
+BMGC_DG12626,BMG_DG168911,"CAS RN:63527-52-6 | PubChem CID:5742673 | UNII:N2GI8B1GK7 | (6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Cefotaxime | PubChem SID:175268581 | CEFOTAXIME | CAS RN:60846-21-1 | DrugBank ID:DB00493"
+BMGC_DG12627,BMG_DG168912,"CAS RN:78110-38-0 | NDC:0409-0830 | Aztreonam | UNII:G2B4VE5GH8 | NDC:0003-2570 | 2-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid | PubChem SID:175267569 | PubChem CID:5742832 | NDC:0409-0829 | NDC:63323-401 | NDC:50090-7494 | NDC:63323-402 | CAS RN:149496-40-2 | AZTREONAM | NDC:0003-2560"
+BMGC_DG12628,BMG_DG168914,"NDC:68788-8467 | NDC:72578-167 | NDC:72893-015 | NDC:0904-7266 | NDC:63187-561 | NDC:63629-9570 | NDC:55289-582 | NDC:63629-7850 | NDC:0054-4182 | NDC:69452-276 | NDC:68071-3359 | NDC:68071-3588 | NDC:0078-0876 | NDC:55289-903 | NDC:70771-1707 | NDC:82667-100 | (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | NDC:55700-961 | NDC:50090-7267 | NDC:60505-6249 | NDC:72578-172 | NDC:70771-1699 | NDC:70771-1706 | NDC:60219-2056 | NDC:60505-6250 | NDC:63629-9572 | NDC:50090-1893 | NDC:70954-399 | NDC:51407-361 | NDC:0054-4183 | NDC:71335-2500 | NDC:68788-9702 | NDC:70771-1704 | NDC:63187-395 | NDC:67296-1413 | NDC:72578-168 | NDC:68071-4375 | NDC:0054-4179 | NDC:0054-3177 | NDC:69306-111 | NDC:63629-9571 | NDC:68788-8765 | NDC:0574-4031 | NDC:55154-4914 | NDC:69238-1373 | NDC:60219-2044 | NDC:69238-1374 | NDC:67296-0665 | NDC:68788-7267 | NDC:47781-914 | NDC:72189-320 | NDC:0078-0953 | NDC:61314-630 | NDC:24208-795 | NDC:72189-572 | NDC:72578-171 | NDC:68071-3603 | NDC:0054-3176 | NDC:72578-169 | NDC:70868-920 | NDC:67296-0827 | NDC:55154-4901 | NDC:71335-2108 | NDC:68071-4203 | NDC:64980-509 | NDC:0054-8180 | NDC:0054-4186 | NDC:69306-114 | NDC:71776-035 | NDC:0904-7267 | NDC:80425-0346 | CAS RN:50-02-2 | NDC:72189-523 | UNII:7S5I7G3JQL | NDC:70518-1534 | NDC:80425-0229 | NDC:0054-8175 | NDC:80425-0328 | NDC:60505-6251 | NDC:50090-6152 | NDC:60505-6254 | NDC:71335-2405 | DrugBank ID:DB01234 | NDC:61314-631 | PubChem CID:5743 | NDC:80425-0260 | NDC:72603-188 | NDC:60687-729 | NDC:70518-3994 | NDC:71205-012 | NDC:63187-669 | NDC:67296-0326 | NDC:68788-8763 | NDC:72603-212 | NDC:50090-0570 | NDC:67296-0435 | NDC:67296-1496 | NDC:72189-511 | NDC:71205-330 | NDC:82111-955 | NDC:82804-157 | NDC:0904-7444 | NDC:69238-1375 | NDC:50090-1914 | NDC:62135-114 | NDC:71205-703 | NDC:72162-1128 | NDC:82804-059 | NDC:80425-0366 | NDC:72578-170 | NDC:68788-8293 | NDC:0574-4160 | NDC:70382-204 | NDC:51655-012 | NDC:68788-8223 | NDC:63629-7806 | NDC:72578-166 | NDC:60505-6253 | NDC:66993-730 | NDC:24208-830 | NDC:50090-1136 | CAS RN:23495-06-9 | NDC:69306-112 | NDC:50090-4435 | NDC:24208-295 | NDC:68788-8748 | NDC:70954-404 | NDC:63629-4129 | NDC:50090-0088 | NDC:68071-5281 | NDC:72189-254 | NDC:0023-3348 | NDC:68047-702 | NDC:0054-4181 | DEXAMETHASONE | NDC:67296-1837 | NDC:71335-2227 | NDC:69452-277 | NDC:42291-155 | NDC:71205-013 | NDC:72189-383 | NDC:47781-916 | NDC:0054-8181 | NDC:50090-6181 | NDC:63187-383 | NDC:72603-187 | NDC:63629-3742 | NDC:82804-132 | NDC:60505-6255 | NDC:72603-189 | NDC:72603-213 | NDC:0054-8176 | Dexamethasone | NDC:0078-0771 | NDC:70771-1705 | NDC:55154-4315 | NDC:0054-8174 | NDC:69452-278 | NDC:72189-532 | NDC:70771-1700 | NDC:72189-468 | NDC:60687-773 | NDC:63187-498 | NDC:72603-190 | NDC:60687-718 | NDC:43063-266 | NDC:61314-647 | PubChem SID:175268703 | NDC:70954-402 | NDC:60219-2043 | NDC:60505-6252 | NDC:70954-398 | NDC:70954-401 | NDC:0054-4184 | NDC:0054-8183 | NDC:50090-1135 | NDC:76986-004 | NDC:50090-6151 | NDC:70771-1701 | NDC:0054-8179 | NDC:0054-4180 | NDC:66758-070 | NDC:70954-403"
+BMGC_DG12629,BMG_DG168917,UNII:4RC4WS4FSA | 3-PYRAZOLECARBOXYLIC ACID | PubChem SID:485661495 | CAS RN:1621-91-6 | PubChem CID:574310 | 3-Pyrazolecarboxylic acid
+BMGC_DG12630,BMG_DG168956,"NDC:45334-327 | NDC:47682-923 | CAS RN:53187-58-9 | NDC:63629-8670 | NDC:0713-0493 | NDC:72162-1394 | NDC:39328-129 | NDC:54766-726 | NDC:69367-397 | UNII:3X7931PO74 | NDC:0037-6830 | NDC:13925-164 | NDC:50332-0042 | Hydrocortisone Acetate | NDC:16477-201 | NDC:54766-760 | NDC:59088-819 | NDC:24689-102 | NDC:59088-305 | NDC:0574-7093 | NDC:42961-220 | NDC:70752-169 | NDC:63629-2530 | NDC:11822-2069 | NDC:75834-147 | NDC:63629-8674 | NDC:75834-197 | Hydrocortisone acetate | NDC:16477-202 | NDC:51407-665 | CAS RN:42016-02-4 | NDC:73408-981 | NDC:54766-778 | NDC:10135-751 | NDC:68071-2259 | NDC:49873-703 | NDC:47682-980 | PubChem CID:5744 | NDC:59088-430 | NDC:52187-551 | NDC:69367-243 | NDC:54766-763 | NDC:72162-1399 | DrugBank ID:DB14539 | NDC:45802-124 | NDC:0924-5632 | NDC:59898-800 | NDC:59088-317 | NDC:50268-411 | NDC:51824-050 | NDC:68001-526 | NDC:0363-0972 | NDC:24689-103 | NDC:79903-211 | NDC:45802-144 | NDC:0574-7090 | NDC:72162-1411 | CAS RN:50-03-3 | NDC:79503-103 | NDC:54766-799 | NDC:0037-6822 | NDC:71927-015 | NDC:57893-302 | NDC:13925-165 | NDC:63629-2531 | NDC:0713-0503 | NDC:13925-160 | NDC:59088-302 | NDC:47682-398 | NDC:13925-163 | NDC:42494-342 | NDC:0904-7340 | NDC:54766-729 | NDC:45802-472 | NDC:65649-411 | NDC:63629-8673 | NDC:52817-817 | NDC:0037-6824 | NDC:69367-260 | NDC:70000-0489 | NDC:47832-205 | NDC:63629-8669 | HYDROCORTISONE ACETATE | NDC:24470-965 | NDC:65649-511 | NDC:44118-704 | NDC:71205-976 | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | NDC:59088-432 | NDC:54766-716 | NDC:82637-9455 | NDC:52410-3050 | NDC:63629-8671 | NDC:63629-8672 | PubChem SID:175265353 | NDC:0363-0357 | NDC:73598-1014 | NDC:54766-829 | NDC:77338-305 | NDC:47682-981 | NDC:55681-224 | NDC:67777-003 | NDC:39328-029 | NDC:54766-777 | NDC:59088-319 | NDC:11509-5101 | NDC:50090-6331 | NDC:24470-964 | NDC:16571-676 | NDC:47682-207"
+BMGC_DG12631,BMG_DG168970,"CAS RN:923-27-3 | PubChem SID:198959602 | CAS RN:26853-89-4 | D-Lysine | D-LYSINE | PubChem CID:57449 | DrugBank ID:DB03252 | UNII:3HQ6U6424Q | (2R)-2,6-diaminohexanoic acid"
+BMGC_DG12632,BMG_DG168973,"CAS RN:50-04-4 | UNII:883WKN7W8X | NDC:0220-1550 | NDC:0220-1554 | Cortisone acetate | NDC:62135-173 | PubChem CID:5745 | NDC:0220-1553 | PubChem SID:175265746 | DrugBank ID:DB01380 | CORTISONE ACETATE | [2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | Cortisone Acetate"
+BMGC_DG12633,BMG_DG168977,"PubChem SID:198946096 | CAS RN:177469-96-4 | Implitapide | UNII:Q70OH404HR | (2S)-2-cyclopentyl-2-[3-[(2,4-dimethylpyrido[2,3-b]indol-9-yl)methyl]phenyl]-N-[(1R)-2-hydroxy-1-phenylethyl]acetamide | DrugBank ID:DB04852 | PubChem CID:5745206 | IMPLITAPIDE"
+BMGC_DG12634,BMG_DG168978,UNII:3LPF0S0GVV | (2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide | DrugBank ID:DB06649 | PRIRALFINAMIDE | Priralfinamide | PubChem SID:198939625 | PubChem CID:5745207 | CAS RN:133865-88-0
+BMGC_DG12635,BMG_DG168980,"UNII:9SGW2H1K8P | N,N'-bis[3,5-bis[(E)-N-(diaminomethylideneamino)-C-methylcarbonimidoyl]phenyl]decanediamide | Semapimod | PubChem CID:5745214 | DrugBank ID:DB12094 | CAS RN:352513-83-8 | SEMAPIMOD | PubChem SID:198968504"
+BMGC_DG12636,BMG_DG168998,1-Pentyl-3-(4-chloro-1-naphthoyl)indole | CAS RN:1292765-18-4 | (4-chloronaphthalen-1-yl)-(1-pentylindol-3-yl)methanone | UNII:RX0E95S90H | PubChem CID:57458928 | JWH-398 | PubChem SID:252319700
+BMGC_DG12637,BMG_DG169001,UNII:O4Q3AIP6BJ | JWH-424 | PubChem CID:57458937 | CAS RN:1366068-04-3 | PubChem SID:313183277
+BMGC_DG12638,BMG_DG169009,"[(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate | NDC:69448-001 | NDC:71288-137 | MITOMYCIN | NDC:55150-452 | NDC:0143-9280 | NDC:0143-9136 | NDC:65219-564 | NDC:71288-139 | NDC:0143-9135 | NDC:72819-152 | CAS RN:50-07-7 | NDC:16729-116 | NDC:25021-250 | NDC:0143-9279 | NDC:72819-154 | NDC:65219-568 | NDC:25021-251 | NDC:16729-115 | Mitomycin | PubChem SID:175268326 | NDC:68083-502 | UNII:50SG953SK6 | NDC:68083-484 | NDC:25021-252 | NDC:68083-483 | NDC:68001-390 | NDC:71288-138 | NDC:69448-002 | NDC:55150-450 | NDC:68001-616 | NDC:72819-153 | NDC:69448-003 | NDC:68001-617 | NDC:68001-391 | DrugBank ID:DB00305 | NDC:55150-451 | PubChem CID:5746 | CAS RN:1404-00-8 | NDC:68001-615 | NDC:65219-566 | NDC:68001-389"
+BMGC_DG12639,BMG_DG169040,"1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine | NDC:0093-3133 | DrugBank ID:DB00724 | NDC:72162-2332 | PubChem CID:57469 | NDC:99207-271 | UNII:P1QW714R7M | NDC:99207-270 | NDC:68682-272 | NDC:99207-276 | NDC:68462-536 | NDC:72189-084 | NDC:51672-4174 | CAS RN:99011-02-6 | IMIQUIMOD | PubChem SID:175267039 | Imiquimod | NDC:45802-368 | NDC:63629-8818 | NDC:51672-4145 | CAS RN:9050-31-1"
+BMGC_DG12640,BMG_DG169067,"CAS RN:150208-28-9 | 1-(2-(3,4-DICHLOROPHENYL)ETHYL)-4-METHYLPIPERAZINE | UNII:5X4CA32SG5 | PubChem CID:574780"
+BMGC_DG12641,BMG_DG169082,CAS RN:118111-54-9 | Cyprodime | PubChem CID:5748293 | CYPRODIME | PubChem SID:474489896 | UNII:2C6F5L8S8X
+BMGC_DG12642,BMG_DG169109,"CAS RN:478-67-1 | 5,7-dihydroxy-6-(3-methylbutanoyl)-8-(3-methylbut-2-enyl)-4-propylchromen-2-one | Isomammein | PubChem CID:5748528"
+BMGC_DG12643,BMG_DG169112,"Mammea A/BA | 5,7-dihydroxy-8-(3-methylbutanoyl)-6-(3-methylbut-2-enyl)-4-phenylchromen-2-one | CAS RN:5224-54-4 | PubChem CID:5748555"
+BMGC_DG12644,BMG_DG169119,"3-(3,4-dimethoxyphenyl)-7-hydroxy-4H-chromen-4-one | PubChem CID:5748605 | CAS RN:24160-14-3 | 3-(3,4-dimethoxyphenyl)-7-hydroxychromen-4-one"
+BMGC_DG12645,BMG_DG169130,CAS RN:63198-97-0 | PubChem CID:5748733 | PubChem SID:198941730 | UNII:133013L556 | Enviroxime | CAS RN:72301-79-2 | (NE)-N-[(2-amino-3-propan-2-ylsulfonylbenzimidazol-5-yl)-phenylmethylidene]hydroxylamine | ENVIROXIME
+BMGC_DG12646,BMG_DG169141,"CAS RN:116313-85-0 | PubChem CID:5748957 | UNII:34J6743XV2 | 3,4-DIHYDROXY-5-NITROBENZALDEHYDE | PubChem SID:198941913"
+BMGC_DG12647,BMG_DG169143,OXYPHENONIUM | PubChem SID:198959118 | PubChem CID:5749 | DrugBank ID:DB00219 | CAS RN:14214-84-7 | UNII:D2G5508Y7I | CAS RN:1407-05-2 | 2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium | Oxyphenonium
+BMGC_DG12648,BMG_DG169155,"UNII:L22772Z9CP | Leniolisib | 1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one | PubChem SID:310825618 | CAS RN:1354690-24-6 | LENIOLISIB | PubChem CID:57495353"
+BMGC_DG12649,BMG_DG169157,"Clesacostat | PubChem CID:57496611 | UNII:752DF9PPPI | CAS RN:2248008-98-0 | CAS RN:1370448-25-1 | 4-[6-methoxy-4-(7-oxo-1-propan-2-ylspiro[4,6-dihydroindazole-5,4'-piperidine]-1'-carbonyl)pyridin-2-yl]benzoic acid | PubChem SID:434369911 | CLESACOSTAT"
+BMGC_DG12650,BMG_DG169191,CAS RN:1345966-63-3 | PubChem SID:252823651 | RCS-2-BUTYL | UNII:RK29946319 | PubChem CID:57507910
+BMGC_DG12651,BMG_DG169192,RCS-2 | CAS RN:1345966-76-8 | PubChem CID:57507911 | PubChem SID:252823816 | UNII:KSN77ZL0GD
+BMGC_DG12652,BMG_DG169220,"CAS RN:128517-07-7 | Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (3-->5)-disulfide | PubChem CID:57515973 | (1S,4S,7Z,10S,16Z,21R)-7-ethylidene-4,21-di(propan-2-yl)-2-oxa-12,13-dithia-5,8,20,23-tetrazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone | DrugBank ID:DB06176 | Romidepsin"
+BMGC_DG12653,BMG_DG169236,"PubChem CID:57519748 | PubChem SID:252165019 | 8-[5-(2-hydroxypropan-2-yl)pyridin-3-yl]-1-[(2S)-2-methoxypropyl]-3-methylimidazo[4,5-c]quinolin-2-one | UNII:C88817F47Y | Samotolisib | LY-3023414 | SAMOTOLISIB | CAS RN:1386874-06-1 | DrugBank ID:DB12167"
+BMGC_DG12654,BMG_DG169240,UNII:X7REK61AIS | 4-[[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid | Glpg-0974 | PubChem SID:377308749 | CAS RN:1391076-61-1 | PubChem CID:57520598 | GLPG-0974 | DrugBank ID:DB15406
+BMGC_DG12655,BMG_DG169259,"PubChem CID:57525501 | Nicotinamide adenine dinucleotide phosphate | DrugBank ID:DB03461 | NADP | [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphate"
+BMGC_DG12656,BMG_DG169264,"Corticosterone | UNII:W980KJ009P | DrugBank ID:DB04652 | CORTICOSTERONE | PubChem SID:198974553 | (8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | PubChem CID:5753 | CAS RN:50-22-6"
+BMGC_DG12657,BMG_DG169266,"PubChem SID:198965376 | (4aR,10bR)-4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol | CAS RN:88058-88-2 | UNII:22Z7E0X6OF | CAS RN:88058-85-9 | Naxagolide | PubChem CID:57533 | NAXAGOLIDE"
+BMGC_DG12658,BMG_DG169268,"NDC:59651-415 | NDC:63629-8667 | NDC:50090-2365 | NDC:50090-6526 | NDC:11822-2685 | NDC:0168-0080 | NDC:0316-0186 | NDC:0096-0732 | NDC:24208-631 | NDC:72162-1763 | NDC:68071-2233 | NDC:82804-135 | NDC:63736-339 | NDC:63187-568 | NDC:68001-476 | NDC:67296-1004 | NDC:13709-326 | NDC:73352-650 | NDC:82942-1003 | NDC:37012-018 | NDC:24385-276 | NDC:70518-0864 | NDC:0363-0791 | NDC:43473-311 | NDC:69473-017 | NDC:69842-155 | NDC:69396-017 | NDC:0113-1369 | NDC:68016-063 | NDC:59088-264 | NDC:63629-1951 | NDC:10631-407 | NDC:24286-1578 | NDC:13709-316 | NDC:70677-1216 | NDC:10237-774 | NDC:59428-403 | NDC:63187-575 | NDC:44577-623 | NDC:51824-098 | NDC:62135-020 | NDC:64380-972 | NDC:0472-0321 | NDC:58228-2045 | NDC:51326-108 | NDC:67777-004 | NDC:63629-8666 | NDC:71863-109 | NDC:30142-973 | CAS RN:50-23-7 | NDC:59088-279 | NDC:42543-971 | NDC:61314-641 | NDC:63629-9416 | NDC:51822-021 | NDC:47682-933 | NDC:59088-209 | NDC:59762-0075 | NDC:62559-430 | NDC:42543-972 | NDC:71516-342 | NDC:47682-211 | NDC:55910-225 | NDC:63629-8668 | NDC:11673-842 | NDC:84387-005 | NDC:73408-937 | NDC:51824-097 | NDC:68071-2735 | NDC:13709-310 | NDC:45802-004 | NDC:10356-120 | NDC:71399-0180 | NDC:83324-047 | NDC:65923-925 | NDC:21130-369 | NDC:0363-0237 | NDC:64380-971 | NDC:0363-0230 | NDC:58228-6245 | NDC:43749-620 | NDC:69968-0888 | NDC:68788-7091 | NDC:63736-029 | NDC:41167-0109 | NDC:72162-2284 | NDC:49035-973 | NDC:41167-0105 | NDC:73352-455 | NDC:51672-3004 | NDC:55910-319 | NDC:11673-398 | NDC:0178-0455 | NDC:61040-129 | NDC:0536-1277 | NDC:69396-096 | NDC:41167-0022 | UNII:WI4X0X7BPJ | NDC:68016-909 | NDC:71335-1989 | NDC:36800-051 | NDC:72189-554 | NDC:76420-028 | NDC:80489-001 | NDC:63629-8847 | NDC:41167-0339 | NDC:41167-0028 | NDC:68016-099 | NDC:72162-1764 | NDC:71399-0120 | NDC:69729-269 | NDC:0363-0363 | NDC:13709-239 | NDC:41520-319 | NDC:41167-0331 | NDC:63629-1952 | NDC:50090-0431 | NDC:63187-270 | NDC:68016-529 | NDC:62135-551 | NDC:62559-431 | NDC:76314-003 | NDC:0924-1133 | NDC:11673-399 | NDC:24385-190 | NDC:41250-290 | NDC:21130-993 | NDC:63868-955 | NDC:0168-0015 | NDC:24208-635 | NDC:41163-369 | NDC:79481-0471 | NDC:69396-028 | NDC:60687-582 | NDC:41167-0036 | NDC:59256-004 | NDC:51143-059 | NDC:76420-104 | NDC:50090-0433 | NDC:21130-278 | NDC:41167-0021 | NDC:0394-0859 | NDC:71863-110 | NDC:68196-973 | NDC:80489-088 | NDC:44911-0275 | NDC:41415-047 | NDC:69396-057 | NDC:0573-2830 | NDC:41163-973 | NDC:67296-0615 | NDC:61010-5800 | NDC:73408-933 | NDC:37808-471 | NDC:72288-973 | NDC:69842-630 | NDC:64980-448 | NDC:62135-552 | NDC:84269-4506 | NDC:84010-008 | NDC:84722-3031 | NDC:36800-059 | NDC:79903-091 | NDC:50268-406 | NDC:36800-981 | NDC:63629-2527 | NDC:37808-319 | NDC:64380-970 | NDC:72789-229 | NDC:11383-268 | NDC:62559-138 | NDC:43742-1275 | NDC:72789-228 | NDC:70000-0543 | NDC:0363-1973 | NDC:71205-571 | NDC:45802-276 | NDC:0363-0638 | NDC:72162-1441 | NDC:0363-0670 | NDC:41167-0330 | NDC:76314-002 | NDC:42961-237 | NDC:71863-111 | NDC:69396-081 | NDC:21130-395 | NDC:50090-2452 | NDC:72162-2165 | NDC:43473-054 | NDC:82280-478 | NDC:72162-1383 | NDC:68071-4229 | NDC:68788-8078 | NDC:41167-0039 | NDC:41167-0338 | NDC:68071-4511 | NDC:41167-0335 | NDC:61314-645 | NDC:43473-049 | NDC:63629-2529 | NDC:59651-413 | NDC:68788-8130 | NDC:55910-541 | NDC:45802-014 | NDC:76314-004 | NDC:42543-970 | NDC:69396-050 | NDC:0316-0193 | NDC:61387-252 | NDC:30142-369 | NDC:0113-0541 | NDC:24385-274 | NDC:41167-0344 | NDC:68016-009 | NDC:41167-0035 | NDC:43136-103 | NDC:43749-250 | NDC:55910-504 | NDC:11383-292 | NDC:45802-438 | NDC:13709-317 | NDC:59651-414 | NDC:68016-149 | NDC:11822-2099 | NDC:41163-319 | NDC:50090-7255 | NDC:59779-878 | (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | NDC:37012-059 | NDC:68788-7787 | NDC:64980-324 | NDC:61314-646 | NDC:50090-0527 | NDC:67091-419 | NDC:72288-369 | NDC:70199-011 | NDC:51672-2018 | NDC:51316-230 | NDC:50090-5999 | NDC:50090-0244 | NDC:68071-5205 | NDC:72162-1805 | NDC:76420-110 | NDC:71297-010 | NDC:11822-3130 | NDC:36800-524 | HYDROCORTISONE | NDC:67296-1737 | NDC:49348-441 | NDC:53943-269 | NDC:0115-1697 | NDC:36800-471 | NDC:69396-003 | NDC:65923-494 | NDC:71101-211 | NDC:72162-1382 | NDC:41520-033 | NDC:21130-449 | NDC:0472-0337 | DrugBank ID:DB00741 | NDC:30142-541 | NDC:69396-149 | NDC:76420-031 | NDC:70677-1215 | NDC:10107-429 | NDC:63629-8844 | NDC:59088-208 | NDC:62135-186 | NDC:65649-401 | NDC:0316-0126 | NDC:0316-0128 | NDC:59762-0074 | NDC:59779-099 | NDC:37808-369 | NDC:55315-181 | NDC:65923-035 | NDC:41167-0027 | NDC:79481-0618 | NDC:67296-0833 | NDC:41250-369 | NDC:68788-8455 | NDC:69842-192 | NDC:0363-0358 | NDC:51672-3003 | NDC:50090-7428 | NDC:41163-471 | PubChem CID:5754 | NDC:0009-0044 | NDC:49348-522 | NDC:49035-011 | NDC:57896-146 | NDC:69729-301 | NDC:0009-0012 | NDC:37808-973 | NDC:70000-0662 | NDC:69396-147 | NDC:79903-213 | NDC:56104-250 | NDC:63824-851 | NDC:45802-937 | NDC:63629-2528 | NDC:71863-112 | NDC:62011-0095 | NDC:58228-2896 | NDC:62011-0096 | NDC:0904-7188 | NDC:68726-504 | NDC:80489-103 | NDC:70518-3078 | NDC:0363-9068 | NDC:69396-129 | NDC:70288-173 | NDC:76436-501 | NDC:43136-203 | NDC:51672-2010 | NDC:0113-0471 | NDC:36800-939 | NDC:63187-480 | NDC:68788-8583 | NDC:41167-0341 | NDC:0168-0146 | NDC:70288-714 | NDC:11822-0113 | NDC:68788-8302 | NDC:79481-0319 | NDC:68788-9922 | NDC:69842-292 | NDC:51672-2013 | NDC:77052-010 | NDC:49967-108 | NDC:55301-201 | NDC:69968-0511 | NDC:0115-1696 | NDC:79481-0973 | NDC:0168-0020 | NDC:55621-001 | NDC:67234-010 | NDC:69842-259 | NDC:65649-501 | NDC:59088-328 | NDC:24286-1560 | NDC:11673-392 | NDC:50268-405 | NDC:67091-055 | NDC:50090-6336 | NDC:21130-433 | NDC:71335-2044 | NDC:55758-420 | NDC:29784-142 | NDC:72162-2018 | NDC:72162-2283 | NDC:41167-0343 | NDC:68788-9924 | NDC:49348-521 | NDC:49035-732 | NDC:69842-485 | NDC:63981-973 | NDC:70000-0485 | NDC:72663-155 | NDC:67091-197 | NDC:41167-0032 | NDC:79903-092 | NDC:0363-9981 | NDC:69315-312 | NDC:68788-8353 | NDC:59779-729 | NDC:63187-308 | NDC:0536-1407 | NDC:11527-052 | NDC:79503-202 | NDC:63187-504 | NDC:83324-046 | NDC:62559-111 | NDC:51672-2063 | NDC:50268-407 | NDC:71101-800 | NDC:68071-4174 | NDC:70403-922 | NDC:36800-099 | NDC:11822-2090 | NDC:11383-313 | NDC:0924-5633 | NDC:82804-084 | NDC:63187-567 | NDC:11822-2215 | NDC:47682-397 | NDC:62742-4077 | NDC:51316-227 | NDC:0363-0620 | NDC:63187-648 | NDC:70518-0763 | NDC:50090-5470 | NDC:55505-222 | NDC:72789-227 | NDC:68391-100 | NDC:63629-9057 | PubChem SID:175265925 | NDC:69396-005 | NDC:55621-018 | NDC:69396-055 | NDC:72288-878 | NDC:11822-0499 | NDC:80684-038 | NDC:36800-018 | NDC:55315-182 | NDC:66267-967 | NDC:11673-890 | Hydrocortisone | NDC:52000-022 | NDC:51316-165 | NDC:30142-411 | NDC:52187-532 | NDC:71101-220 | NDC:41167-0033 | NDC:63629-2396 | NDC:63187-543 | NDC:79481-9967 | NDC:69683-202 | NDC:0115-1700 | NDC:84010-021 | NDC:69571-009 | NDC:69396-118 | NDC:55621-008 | NDC:82895-716 | NDC:0009-0031 | NDC:83838-415 | NDC:0904-7623 | NDC:68462-464 | NDC:55910-646 | NDC:67296-2051 | NDC:53329-091 | NDC:70677-1214 | NDC:59762-0073 | NDC:81929-005 | NDC:69729-103 | NDC:0573-0552 | NDC:63629-8817 | NDC:70403-923 | NDC:24385-021 | NDC:41415-048 | NDC:50090-0350 | NDC:51316-068 | NDC:69367-286 | NDC:0404-0166 | NDC:60541-1900 | NDC:72189-209"
+BMGC_DG12659,BMG_DG169271,"NDC:0527-5406 | PREDNISOLONE | NDC:63187-466 | NDC:42658-160 | NDC:59651-491 | NDC:60722-5011 | NDC:62135-250 | PubChem CID:5755 | NDC:0121-0885 | NDC:62135-437 | NDC:67296-1656 | PubChem SID:175267940 | CAS RN:50-24-8 | DrugBank ID:DB00860 | Prednisolone | CAS RN:8056-11-9 | UNII:9PHQ9Y1OLM | (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | NDC:50090-7115"
+BMGC_DG12660,BMG_DG169278,"CAS RN:1306-04-3 | ESTRIOL | UNII:FB33469R8E | CAS RN:50-27-1 | PubChem CID:5756 | PubChem SID:175267744 | (8R,9S,13S,14S,16R,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol | DrugBank ID:DB04573 | Estriol"
+BMGC_DG12661,BMG_DG169285,"NDC:69238-1610 | NDC:70771-1403 | NDC:59651-424 | NDC:0555-0887 | NDC:70771-1400 | NDC:50090-2321 | NDC:42291-426 | NDC:0378-4620 | NDC:45802-310 | NDC:13811-091 | NDC:50419-456 | NDC:69238-2452 | NDC:70771-1566 | NDC:70771-1563 | NDC:70954-533 | NDC:72162-2292 | CAS RN:50-28-2 | NDC:68308-748 | NDC:0078-0343 | NDC:68025-065 | NDC:69238-1251 | NDC:79929-012 | NDC:0378-4640 | NDC:0078-0346 | NDC:70518-3922 | NDC:69238-1630 | NDC:68025-067 | NDC:72162-2034 | NDC:65162-150 | NDC:50261-104 | NDC:70518-3910 | NDC:76420-021 | NDC:68382-323 | NDC:68788-8626 | CAS RN:17916-67-5 | NDC:70954-531 | NDC:50090-6811 | NDC:0430-0722 | NDC:0781-7122 | NDC:50419-452 | NDC:24658-703 | NDC:69238-1629 | NDC:51655-229 | NDC:68968-3475 | NDC:71335-1973 | NDC:63629-8803 | NDC:65162-995 | NDC:68968-3437 | NDC:0378-8770 | NDC:0781-7133 | NDC:50090-6363 | NDC:50419-455 | NDC:68071-3394 | NDC:68382-328 | NDC:70771-1404 | NDC:45802-452 | PubChem CID:5757 | NDC:70954-565 | NDC:0078-0345 | NDC:63629-8654 | NDC:0093-3223 | NDC:0781-7104 | NDC:68788-8481 | NDC:70700-195 | NDC:65162-149 | NDC:71335-1719 | NDC:71335-2477 | NDC:50090-7480 | NDC:70954-564 | NDC:50090-1882 | NDC:60846-231 | (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol | NDC:0378-7295 | NDC:63187-741 | NDC:0378-4621 | NDC:69238-1632 | NDC:70710-1194 | NDC:51991-474 | NDC:65162-228 | NDC:68968-3425 | NDC:70710-1195 | NDC:72603-273 | NDC:65162-997 | NDC:51655-227 | ESTRADIOL | NDC:50090-1876 | NDC:68462-711 | NDC:70518-0920 | NDC:72603-244 | NDC:69238-2449 | NDC:72603-245 | NDC:65162-989 | NDC:45802-202 | NDC:70518-0834 | NDC:68968-0514 | NDC:72789-360 | NDC:50090-6847 | NDC:70518-3818 | NDC:0378-3350 | NDC:70954-534 | NDC:13811-090 | NDC:68788-8570 | NDC:0378-4623 | NDC:68788-8566 | NDC:70700-143 | NDC:70771-1406 | NDC:0781-7167 | NDC:69238-2450 | NDC:0378-4619 | NDC:13811-094 | NDC:68025-086 | NDC:70771-1401 | NDC:70771-1402 | NDC:0430-0720 | NDC:13811-093 | NDC:66758-145 | NDC:68382-325 | NDC:68382-326 | NDC:70518-2829 | NDC:68788-7332 | NDC:0781-7119 | DrugBank ID:DB00783 | NDC:68025-066 | NDC:0378-4643 | NDC:69238-1295 | NDC:0378-3349 | NDC:50742-658 | NDC:68308-750 | NDC:71335-0430 | NDC:70771-1567 | NDC:69238-1633 | NDC:0093-3541 | NDC:54348-702 | NDC:68071-3629 | NDC:44911-0655 | NDC:0555-0886 | NDC:24658-704 | NDC:68968-6637 | NDC:69238-1294 | NDC:42806-087 | NDC:44911-0199 | NDC:68382-329 | NDC:69238-1296 | NDC:0378-3361 | NDC:69238-1631 | NDC:71335-2387 | NDC:83027-0075 | NDC:0430-3754 | NDC:71335-0201 | NDC:72162-2032 | NDC:72162-2290 | NDC:73473-308 | NDC:0378-3360 | NDC:42806-088 | NDC:70710-1192 | NDC:70954-646 | NDC:50090-1704 | NDC:72603-275 | NDC:24658-702 | NDC:69238-2451 | NDC:0378-3352 | NDC:70954-532 | NDC:72162-1389 | NDC:82868-026 | NDC:50419-453 | NDC:72162-2036 | NDC:50090-6359 | NDC:50090-5494 | NDC:72162-2033 | NDC:54348-701 | NDC:50419-459 | NDC:50261-110 | NDC:0037-4801 | NDC:0378-4642 | NDC:70954-530 | NDC:45802-573 | NDC:50090-7266 | NDC:69238-1293 | NDC:0378-4622 | NDC:68382-327 | NDC:0781-7134 | NDC:0078-0365 | NDC:69238-1690 | NDC:70771-1564 | UNII:4TI98Z838E | NDC:50742-657 | NDC:0169-5176 | NDC:72162-2291 | NDC:82868-038 | NDC:0781-7136 | NDC:66758-147 | NDC:0013-1042 | NDC:72189-502 | NDC:65162-126 | NDC:42806-089 | NDC:50419-491 | NDC:69238-1609 | NDC:70771-1565 | NDC:53746-226 | NDC:68308-751 | NDC:66758-149 | NDC:71335-0226 | NDC:70710-1193 | NDC:66758-146 | NDC:0781-7156 | NDC:72189-508 | NDC:0378-7294 | NDC:0781-7129 | NDC:42291-962 | NDC:70700-144 | NDC:72603-242 | NDC:65162-226 | NDC:68968-6650 | NDC:51991-623 | NDC:65162-148 | NDC:70954-566 | NDC:72603-274 | NDC:0781-7144 | NDC:72603-241 | NDC:65162-992 | NDC:0378-4644 | NDC:45802-134 | NDC:60846-232 | NDC:68788-7102 | NDC:0093-5455 | NDC:50090-3327 | NDC:68968-6625 | NDC:71335-0445 | Estradiol | NDC:45802-097 | NDC:68025-083 | NDC:13811-092 | NDC:69238-2448 | NDC:68968-0525 | NDC:50261-251 | NDC:63629-8804 | NDC:17139-617 | NDC:68071-3689 | NDC:72603-243 | NDC:60429-834 | PubChem SID:175266563 | NDC:0378-4641 | NDC:43857-0033 | NDC:70710-1191 | NDC:68968-3450 | NDC:68308-747 | NDC:69238-1447 | NDC:70700-194 | NDC:76420-023 | NDC:68382-324 | NDC:65162-993 | NDC:0574-2067 | NDC:50419-454 | NDC:72162-2293 | NDC:66993-002 | NDC:0555-0899 | NDC:0378-3351 | NDC:50090-7481 | NDC:68968-6610 | NDC:66758-148 | NDC:69238-1252 | NDC:0430-0721 | NDC:72162-2035 | NDC:71335-0797 | NDC:50419-451 | NDC:0078-0344 | NDC:51655-860 | NDC:68071-4485 | NDC:70771-1405 | NDC:0781-7138 | NDC:59651-425 | NDC:50261-211 | CAS RN:141290-02-0 | NDC:50090-7452 | NDC:76420-022 | NDC:72789-299 | NDC:68968-6675 | NDC:63629-8802 | NDC:68968-3410 | NDC:70700-145"
+BMGC_DG12662,BMG_DG169286,PubChem CID:57570497 | CAS RN:1418145-21-7 | PubChem SID:485665538 | UNII:4HM9QLK75N | N-[[4-[(1E)-1-[[[4-Cyclohexyl-3-(trifluoromethyl)phenyl]methoxy]imino]ethyl]-2-methylphenyl]methyl]-β-alanine | N-((4-((1E)-1-(((4-CYCLOHEXYL-3-(TRIFLUOROMETHYL)PHENYL)METHOXY)IMINO)ETHYL)-2-METHYLPHENYL)METHYL)-.BETA.-ALANINE
+BMGC_DG12663,BMG_DG169295,DrugBank ID:DB12468 | PubChem CID:57582353 | CAS RN:1079400-07-9 | PF-04531083 | Pf-04531083 | PubChem SID:312524859 | UNII:40497CY7Y3 | N-[6-amino-5-(2-chloro-5-methoxyphenyl)pyridin-2-yl]-2-methylpyrazole-3-carboxamide
+BMGC_DG12664,BMG_DG169311,"PubChem CID:5761 | LYSERGIDE | Lysergide | DrugBank ID:DB04829 | PubChem SID:198974017 | (6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | UNII:8NA5SWF92O | Lysergic acid diethylamide | CAS RN:50-37-3"
+BMGC_DG12665,BMG_DG169321,CAS RN:75755-07-6 | PIRIDRONIC ACID | PubChem SID:198949788 | PubChem CID:57637 | UNII:ADD4H8T3K9
+BMGC_DG12666,BMG_DG169340,"PubChem CID:5768 | (S)-[(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;sulfuric acid | CAS RN:11034-22-3 | CID 5768"
+BMGC_DG12667,BMG_DG169342,"PubChem CID:57682490 | [6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl phosphate | [6-[[5-Fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl phosphate"
+BMGC_DG12668,BMG_DG169346,"CETP inhibitor | PubChem CID:57686716 | 4-[(2S,6R)-4-[[3,5-bis(trifluoromethyl)phenyl]methyl-[5-(1-methylpyrazol-4-yl)pyrimidin-2-yl]amino]-2,6-diethylpiperidine-1-carbonyl]oxycyclohexane-1-carboxylic acid"
+BMGC_DG12669,BMG_DG169356,"UNII:2C09NV773M | PubChem SID:175268367 | PubChem CID:57697 | DrugBank ID:DB00885 | PEMIROLAST | 9-methyl-3-(2H-tetrazol-5-yl)pyrido[1,2-a]pyrimidin-4-one | CAS RN:69372-19-6 | Pemirolast"
+BMGC_DG12670,BMG_DG169357,"CAS RN:50-55-5 | PubChem SID:175266981 | PubChem CID:5770 | RESERPINE | DrugBank ID:DB00206 | UNII:8B1QWR724A | methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate | Reserpine"
+BMGC_DG12671,BMG_DG169382,"Cefaloridine | CAS RN:50-59-9 | PubChem SID:198939966 | CEPHALORIDINE | (6R,7R)-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | DrugBank ID:DB09008 | UNII:LVZ1VC61HB | PubChem CID:5773 | Cephaloridine"
+BMGC_DG12672,BMG_DG169394,"CAS RN:1149705-71-4 | 2-[[(2R)-butan-2-yl]amino]-4-N-[8-[5-(cyclopropanecarbonyl)pyridin-2-yl]-8-azabicyclo[3.2.1]octan-3-yl]-5-methylbenzene-1,4-dicarboxamide | PubChem CID:57748689 | XL888"
+BMGC_DG12673,BMG_DG169395,"PHENTOLAMINE | 3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol | CAS RN:50-60-2 | DrugBank ID:DB00692 | Phentolamine | UNII:Z468598HBV | PubChem CID:5775 | PubChem SID:175266547"
+BMGC_DG12674,BMG_DG169409,"HEXOBENDINE | PubChem SID:198952503 | DrugBank ID:DB13265 | PubChem CID:5777 | CAS RN:54-03-5 | 3-[methyl-[2-[methyl-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]amino]ethyl]amino]propyl 3,4,5-trimethoxybenzoate | UNII:B6X4SYR93B | Hexobendine"
+BMGC_DG12675,BMG_DG169410,"UNII:TBJ73RQT8F | Unii-tbj73rqt8F | PubChem CID:57770545 | V-116517 | CAS RN:1073616-61-1 | 4-[3-chloro-5-[(1S)-1,2-dihydroxyethyl]pyridin-2-yl]-N-[5-(trifluoromethyl)pyridin-2-yl]-3,6-dihydro-2H-pyridine-1-carboxamide | PubChem SID:405055702"
+BMGC_DG12676,BMG_DG169418,PubChem CID:5778 | 6-Methylmercaptopurine | CAS RN:50-66-8 | PubChem SID:198962371 | 6-methylsulfanyl-7H-purine | UNII:6V404DV25O | CAS RN:133762-85-3 | 6-METHYLMERCAPTOPURINE
+BMGC_DG12677,BMG_DG169419,CAS RN:1000334-38-2 | PubChem CID:57781216 | NEDEMELTEON | UNII:CW62HV1TTF
+BMGC_DG12678,BMG_DG169426,"CAS RN:50-70-4 | Sorbitol | UNII:506T60A25R | SORBITOL | NDC:0338-0295 | DrugBank ID:DB01638 | NDC:84025-252 | PubChem SID:175266625 | CAS RN:26566-34-7 | NDC:84025-161 | (2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol | NDC:84025-176 | NDC:57896-758 | PubChem CID:5780 | NDC:84372-048"
+BMGC_DG12679,BMG_DG169431,"1-(((4-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)PHENYL)AMINO)CARBONYL)CYCLOPROPANECARBOXYLIC ACID | PubChem SID:405055657 | PubChem CID:57810164 | CAS RN:849217-77-2 | UNII:QWG9YXZ229"
+BMGC_DG12680,BMG_DG169438,PubChem SID:445499820 | PubChem CID:57822053 | CAS RN:916070-62-7 | NALDEMEDINE-CARBOXYLIC ACID | UNII:MQS88P23Q4
+BMGC_DG12681,BMG_DG169460,"CAS RN:1388651-30-6 | Elenbecestat | ELENBECESTAT | N-[3-[(4aS,5R,7aS)-2-amino-5-methyl-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-(difluoromethyl)pyrazine-2-carboxamide | DrugBank ID:DB15391 | UNII:RXJ96XL94H | PubChem CID:57827330 | PubChem SID:381132400"
+BMGC_DG12682,BMG_DG169471,"PubChem CID:57855696 | PubChem SID:346538925 | DIFAMILAST | N-[[2-[4-(difluoromethoxy)-3-propan-2-yloxyphenyl]-1,3-oxazol-4-yl]methyl]-2-ethoxybenzamide | CAS RN:937782-05-3 | DrugBank ID:DB14987 | Difamilast | UNII:T3U32GLJ0F"
+BMGC_DG12683,BMG_DG169496,"CAS RN:50-89-5 | CAS RN:50-88-4 | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | PubChem SID:175267071 | PubChem CID:5789 | CAS RN:1211376-53-2 | CAS RN:146183-25-7 | DOXRIBTIMINE | Thymidine | Doxribtimine | DrugBank ID:DB04485 | UNII:VC2W18DGKR | CAS RN:157049-40-6 | CAS RN:157049-39-3"
+BMGC_DG12684,BMG_DG169502,PubChem CID:57899889 | BMS-863233 | DrugBank ID:DB12357
+BMGC_DG12685,BMG_DG169503,"NDC:0143-9270 | DrugBank ID:DB00322 | NDC:63323-145 | CAS RN:136353-77-0 | UNII:039LU44I5M | FLOXURIDINE | PubChem CID:5790 | 5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione | NDC:81643-9270 | Floxuridine | CAS RN:50-91-9 | PubChem SID:175268889"
+BMGC_DG12686,BMG_DG169511,"Acetamide, N-((3-endo)-8-((4-(thiazolo(4,5-b)pyridin-2-yloxy)phenyl)methyl)-8-azabicyclo(3.2.1)oct-3-yl)- | CAS RN:1191044-42-4 | N-[(1R,5S)-8-[[4-([1,3]thiazolo[4,5-b]pyridin-2-yloxy)phenyl]methyl]-8-azabicyclo[3.2.1]octan-3-yl]acetamide | JNJ-40929837 | PubChem SID:375083296 | UNII:R5CDF0LNV3 | PubChem CID:57910975"
+BMGC_DG12687,BMG_DG169520,"3H-pyrazolo[4,3-d]pyrimidin-7-ol | PubChem CID:5791881 | DrugBank ID:DB03153"
+BMGC_DG12688,BMG_DG169522,"(2S)-2-[3-(2-chlorophenoxy)-5-oxo-2H-pyrrol-1-yl]-N-[1-[(2R)-2,3-dihydroxypropyl]pyrazol-3-yl]-4-methylpentanamide | CAS RN:1191995-00-2 | DrugBank ID:DB15123 | Dorzagliatin | PubChem SID:333495582 | PubChem CID:57920094 | UNII:X59W6980E8 | DORZAGLIATIN"
+BMGC_DG12689,BMG_DG169524,"Peficitinib | PubChem SID:249492918 | UNII:HPH1166CKX | PEFICITINIB | DrugBank ID:DB11708 | CAS RN:944118-01-8 | PubChem CID:57928403 | 4-[[(1R,3S)-5-hydroxy-2-adamantyl]amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide | CAS RN:944134-74-1"
+BMGC_DG12690,BMG_DG169525,"CAS RN:944118-01-8 | PubChem CID:57928435 | 4-[(5-Hydroxyadamantan-2-yl)amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide | 4-[(5-hydroxy-2-adamantyl)amino]-1H-pyrrolo[2,3-b]pyridine-5-carboxamide"
+BMGC_DG12691,BMG_DG169527,"(3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol | CAS RN:2280-44-6 | D-Glucose | CAS RN:54-17-1 | PubChem CID:5793"
+BMGC_DG12692,BMG_DG169533,"(2Z)-2-[(3,4-dihydroxyphenyl)methylidene]-1-benzofuran-3-one | CAS RN:927429-51-4 | PubChem CID:5793932 | CAS RN:24418-86-8"
+BMGC_DG12693,BMG_DG169535,"NDC:0904-2528 | NDC:58809-650 | NDC:69842-250 | UNII:LWK91TU9AH | NDC:11383-312 | PubChem SID:175266290 | NDC:53943-253 | NDC:50804-253 | NDC:79481-2530 | NDC:63187-557 | NDC:0113-0866 | NDC:48201-006 | NDC:11383-253 | NDC:46122-759 | NDC:0904-7349 | NDC:83324-269 | NDC:11383-310 | 5-[2-(2-butoxyethoxy)ethoxymethyl]-6-propyl-1,3-benzodioxole | Piperonyl butoxide | NDC:55758-253 | NDC:55910-705 | NDC:11822-6616 | PubChem CID:5794 | NDC:59970-253 | NDC:24286-1253 | NDC:70677-1184 | NDC:55319-253 | NDC:76162-253 | NDC:75940-192 | NDC:53247-124 | NDC:63941-253 | NDC:30142-253 | NDC:68016-253 | NDC:75940-171 | NDC:49035-866 | NDC:70000-0633 | Piperonyl Butoxide | NDC:61715-253 | DrugBank ID:DB09350 | PIPERONYL BUTOXIDE | NDC:82392-100 | NDC:24286-0253 | NDC:49348-443 | NDC:36800-866 | NDC:0363-1253 | CAS RN:51-03-6"
+BMGC_DG12694,BMG_DG169543,"DrugBank ID:DB07802 | 3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE | PubChem CID:5795340"
+BMGC_DG12695,BMG_DG169565,1H-benzimidazole | BENZIMIDAZOLE | DrugBank ID:DB02962 | CAS RN:26985-65-9 | PubChem CID:5798 | PubChem SID:175266808 | Benzimidazole | CAS RN:51-17-2 | UNII:E24GX49LD8
+BMGC_DG12696,BMG_DG169568,PubChem CID:57987388 | CAS RN:884600-68-4 | UNII:RY5QK2J15V | GSM-1 | PubChem SID:249492785
+BMGC_DG12697,BMG_DG169571,"2,4,6-tris(aziridin-1-yl)-1,3,5-triazine | PubChem CID:5799 | CAS RN:51-18-3 | UNII:F7IY6HZG9D | DrugBank ID:DB14031 | TRIETHYLENEMELAMINE | PubChem SID:198966006 | Triethylenemelamine"
+BMGC_DG12698,BMG_DG169584,2-oxobutanoic acid | .ALPHA.-KETOBUTYRIC ACID | UNII:B92RB6HY1A | PubChem CID:58 | PubChem SID:198947026 | 2-Oxobutanoic acid | 2-Oxobutanoic Acid | DrugBank ID:DB04553 | CAS RN:600-18-0
+BMGC_DG12699,BMG_DG169606,"PubChem SID:198934755 | 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid | TIRATRICOL | DrugBank ID:DB03604 | PubChem CID:5803 | CAS RN:51-24-1 | UNII:29OQ9EU4R1 | Tiratricol"
+BMGC_DG12700,BMG_DG169608,"UNII:2WU922TK3L | methyl N-[(2S,3R)-1-[(2S)-2-[6-[(2R,5R)-1-[3,5-difluoro-4-[4-(4-fluorophenyl)piperidin-1-yl]phenyl]-5-[6-fluoro-2-[(2S)-1-[(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methoxy-1-oxobutan-2-yl]carbamate | PIBRENTASVIR | CAS RN:1353900-92-1 | Pibrentasvir | PubChem CID:58031952 | PubChem SID:333495524 | DrugBank ID:DB13878"
+BMGC_DG12701,BMG_DG169616,UNII:OK7481S22O | THYROPROPIC ACID | PubChem CID:5804 | PubChem SID:198960047 | CAS RN:51-26-3
+BMGC_DG12702,BMG_DG169623,UNII:8B5ED610XJ | PubChem CID:58059361 | CAS RN:1246453-56-4 | PubChem SID:241180781 | FLUTRICICLAMIDE
+BMGC_DG12703,BMG_DG169625,"DrugBank ID:DB12803 | 1-(3,4-dichlorophenyl)-2-(propan-2-ylamino)ethanol | PubChem SID:316910880 | Dichloroisoproterenol | CAS RN:59-61-0 | DICHLOROISOPROTERENOL | PubChem CID:5806 | UNII:U7NOE2K4M2"
+BMGC_DG12704,BMG_DG169641,"CAS RN:2743429-93-6 | DrugBank ID:DB12825 | [(1S,2R,3S,4S,6R,7R,8R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[(1R,2R,4R)-4-amino-2-hydroxycyclohexyl]sulfanylacetate | PubChem SID:198977804 | Lefamulin | UNII:21904A5386 | LEFAMULIN | PubChem CID:58076382 | CAS RN:1061337-51-6"
+BMGC_DG12705,BMG_DG169646,"UNII:70D2X5QMKK | ISOPROTERENOL, (+)- | CAS RN:2964-04-7 | PubChem SID:198957037 | PubChem CID:5808"
+BMGC_DG12706,BMG_DG169653,"CAS RN:147028-80-6 | CAS RN:6912-67-0 | (2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid | PubChem SID:175268850 | DrugBank ID:DB08847 | HYDROXYPROLINE | Hydroxyproline | CAS RN:618-28-0 | UNII:RMB44WO89X | CAS RN:51-35-4 | PubChem CID:5810"
+BMGC_DG12707,BMG_DG169655,PubChem CID:5810067 | DERRUBONE | UNII:EVN8G9T8C6 | PubChem SID:472423140 | CAS RN:22044-58-2
+BMGC_DG12708,BMG_DG169659,"PubChem SID:317229838 | DEZAPELISIB | PubChem CID:58111426 | 6-(3-fluorophenyl)-3-methyl-7-[(1S)-1-(7H-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one | Dezapelisib | CAS RN:1262440-25-4 | UNII:2K59L7G59M"
+BMGC_DG12709,BMG_DG169667,UNII:I7PZF0KTFK | PubChem CID:58124325 | AB-Fubinaca | CAS RN:1185282-01-2 | PubChem SID:252319872 | AB-FUBINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide
+BMGC_DG12710,BMG_DG169677,"DrugBank ID:DB12593 | APAZIQUONE | CAS RN:114560-48-4 | UNII:H464ZO600O | Apaziquone | PubChem CID:5813717 | PubChem SID:198951675 | 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(E)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione | CAS RN:141304-51-0"
+BMGC_DG12711,BMG_DG169688,"PubChem CID:5815 | NDC:70518-4152 | NDC:50227-1030 | NDC:0404-9977 | NDC:42756-1030 | CAS RN:51-42-3 | NDC:0404-6500 | NDC:0404-9975 | NDC:51662-1505 | NDC:51662-1405 | NDC:63323-487 | NDC:0362-0262 | NDC:50227-1020 | NDC:51662-1506 | NDC:66312-580 | NDC:66975-415 | NDC:63323-488 | NDC:51662-1622 | NDC:0404-6512 | NDC:63323-481 | NDC:51662-1550 | NDC:66467-9730 | NDC:0264-9378 | NDC:66467-9710 | UNII:30Q7KI53AK | NDC:50090-6851 | NDC:66312-176 | CAS RN:24351-82-4 | NDC:0404-9976 | (2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol | NDC:66312-181 | EPINEPHRINE BITARTRATE | NDC:51662-1412 | NDC:0362-1096 | NDC:63323-483 | CAS RN:16536-89-3 | NDC:63323-482 | NDC:66975-425 | NDC:0362-1095 | NDC:0362-0898 | NDC:71347-210 | PubChem SID:175268050 | Epinephrine Bitartrate | NDC:43128-105 | NDC:0404-9972 | NDC:63323-489 | NDC:67239-0240"
+BMGC_DG12712,BMG_DG169697,"NDC:76420-188 | NDC:54288-152 | NDC:0220-0078 | NDC:51662-1224 | NDC:76329-3318 | NDC:70385-2024 | NDC:0404-9896 | NDC:0404-9810 | NDC:51662-1223 | NDC:50090-4543 | NDC:51662-1232 | NDC:51662-1321 | NDC:51662-1531 | NDC:80069-015 | NDC:0517-1171 | NDC:70518-3816 | DrugBank ID:DB00668 | NDC:0093-5985 | NDC:76420-835 | NDC:0409-3178 | NDC:71872-7223 | NDC:51662-1504 | NDC:0220-0076 | NDC:51662-1629 | CAS RN:51-43-4 | NDC:76329-9060 | NDC:54288-117 | NDC:54288-120 | NDC:55154-0132 | NDC:0409-3183 | NDC:42023-159 | NDC:17270-5530 | NDC:51662-1290 | NDC:54288-119 | NDC:43742-1243 | NDC:70518-1215 | NDC:51662-1307 | PubChem SID:175266569 | NDC:50090-7037 | NDC:70518-2048 | NDC:49502-101 | UNII:YKH834O4BH | NDC:0093-5986 | NDC:70385-2022 | NDC:0404-9886 | NDC:51662-1395 | NDC:0409-4933 | NDC:0409-1209 | CAS RN:104655-05-2 | NDC:60842-021 | NDC:63629-8801 | NDC:51662-1503 | NDC:43406-0686 | NDC:60842-022 | NDC:50090-3039 | PubChem CID:5816 | NDC:0409-3181 | NDC:0115-1695 | NDC:51662-1476 | NDC:70385-2019 | NDC:71872-7040 | NDC:49502-102 | NDC:51662-1661 | NDC:76420-834 | NDC:82580-020 | NDC:71872-7172 | NDC:76420-584 | NDC:80425-0264 | NDC:0409-3182 | NDC:51662-1222 | NDC:0404-9891 | NDC:51662-1221 | NDC:51662-1419 | NDC:70385-2038 | NDC:49502-500 | NDC:0404-9806 | NDC:51662-1225 | NDC:54288-103 | NDC:71872-7134 | NDC:63323-696 | NDC:51662-1663 | NDC:42023-168 | NDC:70518-3173 | NDC:50090-3155 | NDC:60842-023 | NDC:0409-3177 | NDC:71872-7304 | NDC:71872-7173 | NDC:0517-3030 | NDC:71872-7250 | 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol | NDC:0404-9857 | Epinephrine | NDC:70385-2020 | NDC:70518-1342 | EPINEPHRINE | NDC:71872-7329 | NDC:0409-0007 | NDC:71872-7117 | NDC:70518-4156 | NDC:51662-1381 | NDC:0115-1694 | NDC:66096-778 | NDC:51662-1320 | NDC:49502-501 | NDC:42023-315 | NDC:51662-1662 | NDC:71872-7135 | NDC:0409-0147 | NDC:71872-7333 | NDC:50090-5254"
+BMGC_DG12713,BMG_DG169703,TETRAHYDROPIPERINE | PubChem CID:581676 | PubChem SID:198956176 | UNII:8904DO502T | CAS RN:23434-88-0
+BMGC_DG12714,BMG_DG169704,"3,4-DICHLOROBENZOIC ACID | CAS RN:51-44-5 | PubChem CID:5817 | UNII:YS4ZR9BXWX | PubChem SID:198944127"
+BMGC_DG12715,BMG_DG169711,UNII:M5MT8C9JP7 | PubChem CID:581853 | 3-CHLORO-4-PYRIDINAMINE | CAS RN:19798-77-7
+BMGC_DG12716,BMG_DG169715,"UNII:Q51BO43MG4 | NDC:42192-327 | NDC:63629-4556 | NDC:43742-0955 | NDC:76420-570 | NDC:68071-3691 | NDC:24338-032 | NDC:42192-329 | NDC:50090-5216 | NDC:24338-097 | NDC:24338-065 | NDC:24338-005 | NDC:24338-113 | NDC:50090-4376 | NDC:42192-331 | NDC:76420-568 | (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid | NDC:72189-218 | Levothyroxine | NDC:71335-0414 | NDC:42192-328 | NDC:24338-016 | NDC:76420-566 | PubChem SID:175266090 | NDC:24338-007 | DrugBank ID:DB00451 | CAS RN:51-48-9 | NDC:24338-009 | NDC:72189-202 | NDC:76420-569 | NDC:68071-3690 | NDC:44911-0373 | NDC:24338-006 | NDC:24338-008 | NDC:50090-5229 | PubChem CID:5819 | LEVOTHYROXINE | NDC:63629-8265 | NDC:76420-567 | NDC:51655-132 | NDC:42192-330"
+BMGC_DG12717,BMG_DG169727,"UNII:R34ID086Z6 | 6-[(4S)-2-methyl-4-naphthalen-2-yl-3,4-dihydro-1H-isoquinolin-7-yl]pyridazin-3-amine | PubChem CID:58212050 | Liafensine | PubChem SID:198957397 | DrugBank ID:DB14878 | LIAFENSINE | CAS RN:1198790-53-2"
+BMGC_DG12718,BMG_DG169754,PubChem SID:198967632 | CAS RN:778527-06-3 | STILONIUM | PubChem CID:5824382 | UNII:4L5V8Z34JM
+BMGC_DG12719,BMG_DG169755,NDC:24338-853 | CAS RN:51-63-8 | NDC:52536-510 | NDC:24338-854 | NDC:24338-856 | PubChem SID:175266696 | NDC:72162-2350 | NDC:0406-8959 | NDC:43386-871 | NDC:52536-500 | NDC:75826-123 | NDC:11534-188 | NDC:0115-9927 | DEXTROAMPHETAMINE SULFATE | (2S)-1-phenylpropan-2-amine;sulfuric acid | NDC:27808-089 | NDC:64896-675 | NDC:75826-125 | NDC:45963-303 | NDC:75826-126 | PubChem CID:5825 | NDC:64896-673 | NDC:0555-0953 | UNII:JJ768O327N | NDC:27808-090 | Dextroamphetamine Sulfate | NDC:0406-8960 | NDC:43386-870 | NDC:64896-674 | NDC:75826-121 | NDC:10702-065 | NDC:0406-8961 | NDC:63629-2375 | NDC:72162-1233 | NDC:13107-036 | NDC:63629-2374 | NDC:72162-2352 | NDC:75826-124 | NDC:24338-850 | NDC:24338-855 | NDC:72162-2353 | NDC:0406-8962 | NDC:75826-122 | NDC:72162-1234 | NDC:21724-701 | NDC:13107-035 | NDC:72162-2351 | NDC:24338-852 | NDC:10702-066 | NDC:0115-9928 | NDC:45963-304 | NDC:52536-515 | NDC:52536-530 | NDC:45963-305 | NDC:72162-2349 | NDC:0115-9929 | NDC:24338-851 | NDC:11534-189 | NDC:66993-359 | NDC:0406-8958 | NDC:72162-2043 | NDC:0555-0952 | NDC:52536-520 | NDC:75826-120 | NDC:27808-085
+BMGC_DG12720,BMG_DG169757,"Rufloxacin | RUFLOXACIN | CAS RN:101363-10-4 | UNII:Y521XM2900 | 7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid | PubChem SID:198936086 | DrugBank ID:DB13772 | PubChem CID:58258"
+BMGC_DG12721,BMG_DG169758,NDC:68968-0220 | UNII:TZ47U051FI | (2S)-1-phenylpropan-2-amine | NDC:68968-0205 | DEXTROAMPHETAMINE | NDC:68968-0210 | Dextroamphetamine | PubChem SID:175266841 | PubChem CID:5826 | NDC:68968-0215 | CAS RN:51-64-9 | DrugBank ID:DB01576
+BMGC_DG12722,BMG_DG169760,PubChem CID:58265877 | Bms-820132 | CAS RN:1001419-18-6 | 3-[5-(azetidine-1-carbonyl)pyrazin-2-yl]oxy-N-[1-(diethoxyphosphorylmethyl)pyrazol-3-yl]-5-propan-2-yloxybenzamide
+BMGC_DG12723,BMG_DG169761,"CAS RN:1627539-18-7 | PubChem CID:58266779 | GDC-0425 | DrugBank ID:DB14791 | PubChem SID:346538847 | UNII:4N173XZ7SX | 3-(1-ethylpiperidin-4-yl)oxy-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile | CAS RN:1200129-48-1 | Gdc-0425"
+BMGC_DG12724,BMG_DG169766,"PubChem CID:5828196 | 4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE | DrugBank ID:DB07531"
+BMGC_DG12725,BMG_DG169767,"PubChem CID:58282870 | Mk-8353 | (3S)-3-methylsulfanyl-1-[2-[4-[4-(1-methyl-1,2,4-triazol-3-yl)phenyl]-3,6-dihydro-2H-pyridin-1-yl]-2-oxoethyl]-N-[3-(6-propan-2-yloxypyridin-3-yl)-1H-indazol-5-yl]pyrrolidine-3-carboxamide | CAS RN:1184173-73-6"
+BMGC_DG12726,BMG_DG169770,"PubChem CID:58298316 | UNII:I8RA3543SY | DrugBank ID:DB12570 | CAS RN:1228013-30-6 | ONATASERTIB | CAS RN:1402453-64-8 | Onatasertib | PubChem SID:313182701 | 3-[6-(2-hydroxypropan-2-yl)pyridin-3-yl]-5-(4-methoxycyclohexyl)-7,8-dihydropyrazino[2,3-b]pyrazin-6-one | CC 223"
+BMGC_DG12727,BMG_DG169771,"CC-115 | PubChem CID:58298318 | UNII:FII75TFH5L | PubChem SID:313184234 | DrugBank ID:DB12740 | CAS RN:1228013-15-7 | 5-ethyl-3-[2-methyl-6-(1H-1,2,4-triazol-5-yl)pyridin-3-yl]-7,8-dihydropyrazino[2,3-b]pyrazin-6-one | Cc-115"
+BMGC_DG12728,BMG_DG169774,"Albanin F | 8-[6-(2,4-dihydroxybenzoyl)-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one | PubChem CID:5830135"
+BMGC_DG12729,BMG_DG169776,DrugBank ID:DB00411 | PubChem SID:175268000 | 2-carbamoyloxyethyl(trimethyl)azanium;chloride | Carbachol | CARBACHOL | CAS RN:51-83-2 | NDC:0065-0023 | UNII:8Y164V895Y | PubChem CID:5831 | Carbamoylcholine
+BMGC_DG12730,BMG_DG169782,"NDC:42291-650 | CAS RN:51-98-9 | NDC:51407-599 | NDC:70700-326 | NDC:0378-7291 | NDC:68462-304 | PubChem CID:5832 | UNII:9S44LIC7OJ | NORETHINDRONE ACETATE | NDC:65162-475 | NDC:0555-0211 | NDC:50742-267 | Norethindrone Acetate | [(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate | PubChem SID:175268488"
+BMGC_DG12731,BMG_DG169787,"NDC:68788-8452 | NDC:70518-1314 | NDC:63629-1063 | NDC:51655-153 | NDC:72789-292 | NDC:50090-6908 | NDC:69584-853 | NDC:60687-487 | NDC:59746-218 | NDC:63629-8539 | PubChem CID:5833 | NDC:72189-496 | NDC:70518-2385 | NDC:71205-147 | NDC:70518-3625 | NDC:71205-148 | NDC:16729-226 | NDC:51655-861 | NDC:72789-290 | NDC:63629-2438 | NDC:71205-146 | NDC:71610-287 | NDC:65162-515 | NDC:42708-126 | NDC:67296-1100 | NDC:63629-1062 | NDC:63629-5341 | NDC:68071-3375 | NDC:17856-1133 | NDC:63629-1830 | NDC:70518-3721 | NDC:54348-340 | NDC:50090-6601 | NDC:51655-636 | PubChem SID:175268911 | NDC:68788-7297 | NDC:70771-1029 | NDC:0615-8451 | NDC:63629-1064 | NDC:72162-1693 | NDC:70518-0455 | NDC:0378-0437 | NDC:72603-134 | NDC:63629-1067 | NDC:68382-661 | NDC:71335-2203 | NDC:63739-545 | NDC:50090-6909 | NDC:59651-428 | UNII:27O7W4T232 | NDC:63629-1094 | NDC:69584-852 | NDC:70518-3655 | NDC:70771-1028 | NDC:68788-8381 | NDC:55154-5517 | NDC:63187-634 | NDC:76420-558 | NDC:72162-1626 | NDC:50090-6408 | SPIRONOLACTONE | NDC:59746-217 | NDC:17856-2028 | NDC:63187-861 | NDC:72162-1694 | NDC:72789-291 | NDC:70518-3118 | NDC:72189-495 | NDC:55154-1495 | NDC:0378-2146 | NDC:0904-6927 | NDC:53489-328 | Spironolactone | NDC:71610-742 | NDC:16729-225 | NDC:69238-2027 | NDC:63739-544 | NDC:67544-310 | NDC:0574-1133 | NDC:71335-2207 | NDC:63629-1065 | NDC:71335-0053 | NDC:68788-7019 | NDC:51079-979 | NDC:70771-1027 | NDC:76420-062 | NDC:55154-3556 | NDC:53489-143 | NDC:0378-0243 | DrugBank ID:DB00421 | NDC:50090-6432 | NDC:68382-662 | NDC:70518-2585 | NDC:50090-6458 | NDC:76420-557 | NDC:68788-7051 | NDC:72189-497 | NDC:46287-020 | NDC:68788-8545 | NDC:70518-1742 | NDC:63629-1061 | NDC:50090-6369 | NDC:70518-2589 | NDC:71335-2366 | NDC:0025-1031 | NDC:43063-832 | NDC:60687-465 | NDC:71335-0304 | NDC:71335-0966 | NDC:51079-980 | NDC:63629-1095 | NDC:0615-8452 | NDC:53746-514 | NDC:50090-0136 | CAS RN:52-01-7 | NDC:70518-2384 | NDC:53489-329 | NDC:71205-772 | NDC:53746-515 | NDC:50090-7083 | NDC:63629-1066 | NDC:51079-103 | NDC:59651-427 | NDC:63629-1092 | NDC:60687-476 | NDC:69584-854 | NDC:50090-6600 | NDC:70518-2588 | NDC:76420-556 | NDC:16729-227 | NDC:63629-2437 | NDC:50090-3916 | NDC:50090-7082 | NDC:43063-974 | NDC:71335-2217 | NDC:59651-426 | NDC:71335-0401 | NDC:42708-101 | NDC:71335-2301 | NDC:50090-6539 | NDC:71335-2205 | S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate | NDC:71205-830 | NDC:63187-841 | NDC:63629-4094 | NDC:72162-2150 | NDC:65162-511 | NDC:71335-2204 | NDC:70518-0563 | NDC:50090-3580 | NDC:63629-1093 | NDC:67046-1117 | NDC:76420-063 | NDC:71610-288 | NDC:50090-3747 | NDC:0025-1001 | NDC:16714-086 | NDC:51655-344 | NDC:72603-135 | NDC:72603-136 | NDC:72162-1627 | NDC:43063-835 | NDC:50090-1292 | NDC:16714-085 | NDC:53746-511 | NDC:65162-514 | NDC:68071-4374 | NDC:71610-102 | NDC:59746-216 | NDC:72162-1624 | NDC:17856-0120 | NDC:0025-1041 | NDC:16714-084 | NDC:68382-660"
+BMGC_DG12732,BMG_DG169789,"DrugBank ID:DB15566 | NDC:67296-0775 | NDC:60758-119 | NDC:11980-174 | NDC:50090-1912 | NDC:61314-637 | CAS RN:52-21-1 | NDC:67296-0872 | NDC:68071-2222 | NDC:50090-0559 | NDC:76420-204 | NDC:50090-5275 | NDC:70748-332 | Prednisolone acetate | PubChem CID:5834 | PubChem SID:175265680 | NDC:11980-180 | UNII:8B2807733D | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | Prednisolone Acetate | PREDNISOLONE ACETATE | NDC:70518-4006"
+BMGC_DG12733,BMG_DG169805,"(10Z)-6-[4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one | (10Z)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one | CAS RN:80214-83-1 | PubChem CID:5837004"
+BMGC_DG12734,BMG_DG169809,"UNII:0M8A98AD9H | CYCLOBARBITAL | 5-(cyclohexen-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione | CAS RN:52-31-3 | Cyclobarbital | PubChem CID:5838 | DrugBank ID:DB13737 | PubChem SID:198976235"
+BMGC_DG12735,BMG_DG169815,"Aldosterone | PubChem SID:175268093 | CAS RN:52-39-1 | NDC:43742-1514 | UNII:4964P6T9RB | (8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde | PubChem CID:5839 | DrugBank ID:DB04630 | ALDOSTERONE"
+BMGC_DG12736,BMG_DG169831,"5,5-bis(prop-2-enyl)-1,3-diazinane-2,4,6-trione | PubChem SID:198951440 | PubChem CID:5842 | ALLOBARBITAL | Allobarbital | UNII:8NT43GG2HA | CAS RN:52-43-7 | DrugBank ID:DB13577"
+BMGC_DG12737,BMG_DG169836,"Azd1208 | PubChem SID:198990838 | (5Z)-5-[[2-[(3R)-3-aminopiperidin-1-yl]-3-phenylphenyl]methylidene]-1,3-thiazolidine-2,4-dione | CAS RN:1204144-28-4 | PubChem CID:58423153 | UNII:S98NFM1378 | AZD-1208"
+BMGC_DG12738,BMG_DG169847,"PubChem CID:58438464 | DrugBank ID:DB14870 | UNII:FF33NL9U5G | CAS RN:1334782-79-4 | PubChem SID:346537603 | Pf-5190457 | 2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-[2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone | PF-5190457"
+BMGC_DG12739,BMG_DG169848,"PubChem SID:472422776 | UNII:K8W82KUS7B | PubChem CID:5844100 | CAS RN:95522-37-5 | 3,4'-DIAMINOSTILBENE"
+BMGC_DG12740,BMG_DG169857,"Doravirine | UNII:913P6LK81M | NDC:0006-5007 | NDC:50090-6268 | PubChem SID:198985579 | PubChem CID:58460047 | DrugBank ID:DB12301 | NDC:0006-3069 | CAS RN:1338225-97-0 | 3-chloro-5-[1-[(4-methyl-5-oxo-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)pyridin-3-yl]oxybenzonitrile | DORAVIRINE"
+BMGC_DG12741,BMG_DG169877,"Setanaxib | PubChem CID:58496428 | CAS RN:1218942-37-0 | PubChem SID:198983370 | SETANAXIB | 2-(2-chlorophenyl)-4-[3-(dimethylamino)phenyl]-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6-dione | UNII:45II35329V"
+BMGC_DG12742,BMG_DG169878,1-methyl-1-[5-(1-methylpyrrolidin-1-ium-1-yl)pentyl]pyrrolidin-1-ium | PubChem CID:5850 | PubChem SID:198953613 | Pentolinium | CAS RN:144-44-5 | DrugBank ID:DB01090 | PENTOLINIUM | UNII:ULL76WPU5X
+BMGC_DG12743,BMG_DG169881,UNII:0NHB13IN3R | PubChem SID:198952506 | PubChem CID:58505 | CAS RN:101526-83-4 | Sematilide | SEMATILIDE | N-[2-(diethylamino)ethyl]-4-(methanesulfonamido)benzamide
+BMGC_DG12744,BMG_DG169883,"Bimiralisib | CAS RN:1225037-39-7 | PubChem SID:329589308 | UNII:6Z3QHB00LB | DrugBank ID:DB14846 | 5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine | BIMIRALISIB | PubChem CID:58507717"
+BMGC_DG12745,BMG_DG169886,PubChem CID:58511957 | CAS RN:1350296-21-7 | UNII:FRD9G40U5B | PubChem SID:329589128 | FTC-146
+BMGC_DG12746,BMG_DG169894,NDC:49884-146 | PubChem SID:175268684 | NDC:68682-020 | NDC:71205-916 | NDC:43598-634 | NDC:51991-974 | NDC:68475-201 | NDC:60505-4696 | Penicillamine | DrugBank ID:DB00859 | PENICILLAMINE | (2S)-2-amino-3-methyl-3-sulfanylbutanoic acid | NDC:72162-2112 | UNII:GNN1DV99GX | CAS RN:52-67-5 | NDC:70010-907 | NDC:25010-705 | NDC:0037-4401 | NDC:70748-153 | NDC:62559-970 | NDC:0254-2000 | PubChem CID:5852 | NDC:0591-4171
+BMGC_DG12747,BMG_DG169897,"PubChem SID:329904280 | Trichlorfon | PubChem CID:5853 | CAS RN:56042-27-4 | UNII:37VCQ9C0OG | METRIFONATE | PubChem SID:329903600 | UNII:1MVY4KU98F | UNII:DBF2DG4G2K | 2,2,2-trichloro-1-dimethoxyphosphorylethanol | METRIFONATE, (+)- | PubChem SID:175271905 | DrugBank ID:DB11473 | CAS RN:52-68-6 | CAS RN:26373-97-7 | CAS RN:56042-26-3 | METRIFONATE, (-)-"
+BMGC_DG12748,BMG_DG169909,"PubChem CID:58557659 | UPADACITINIB | CAS RN:1310726-60-3 | PubChem SID:346540590 | CAS RN:1831899-72-9 | UNII:4RA0KN46E0 | (3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide | NDC:0074-2310 | Upadacitinib | NDC:0074-2320 | NDC:0074-1043 | NDC:0074-2306 | DrugBank ID:DB15091"
+BMGC_DG12749,BMG_DG169911,"2,6-dichloro-N-[1,5-dimethyl-3-(2-methylpropyl)pyrazol-4-yl]-4-(2-piperazin-1-ylpyridin-4-yl)benzenesulfonamide | ZELENIRSTAT | PubChem CID:58561243 | UNII:5HY8BYC3Q6 | 2,6-Dichloro-4-(2-Piperazin-1-Ylpyridin-4-Yl)-N-(1,5-Dimethyl,3-Isobutyl-1h-Pyrazol-4-Yl)benzenesulfonamide | CAS RN:1215011-08-7 | Zelenirstat | PubChem SID:474494268"
+BMGC_DG12750,BMG_DG169914,"(8R,9S,10R,13S,14S,17R)-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol | Lynestrenol | PubChem CID:5857 | PubChem SID:198985273 | DrugBank ID:DB12474 | CAS RN:52-76-6 | LYNESTRENOL | UNII:N2Z8ALG4U5"
+BMGC_DG12751,BMG_DG169915,"PubChem SID:346539073 | NAVTEMADLIN | 2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[(2S)-3-methyl-1-propan-2-ylsulfonylbutan-2-yl]-2-oxopiperidin-3-yl]acetic acid | UNII:7R7G6EH5UL | Navtemadlin | DrugBank ID:DB15299 | CAS RN:1352066-68-2 | PubChem CID:58573469"
+BMGC_DG12752,BMG_DG169916,BEMARINONE | UNII:29J330V3XV | PubChem CID:58575 | CAS RN:92210-43-0 | PubChem SID:198940768
+BMGC_DG12753,BMG_DG169924,"4-dimethoxyphosphinothioyloxy-N,N-dimethylbenzenesulfonamide | CAS RN:52-85-7 | PubChem SID:198937869 | DrugBank ID:DB11408 | PubChem CID:5859 | Famphur | FAMPHUR | UNII:02UOP4Z0O0"
+BMGC_DG12754,BMG_DG169931,CAS RN:1093737-19-9 | CREATINE | DrugBank ID:DB00148 | CAS RN:57-00-1 | UNII:MU72812GK0 | PubChem CID:586 | 2-[carbamimidoyl(methyl)amino]acetic acid | Creatine | PubChem SID:175268800
+BMGC_DG12755,BMG_DG169943,DrugBank ID:DB00151 | CAS RN:4371-52-2 | PubChem SID:175268443 | UNII:K848JZ4886 | Cysteine | CYSTEINE | PubChem CID:5862 | CAS RN:52-90-4 | (2R)-2-amino-3-sulfanylpropanoic acid
+BMGC_DG12756,BMG_DG169950,"TETRAHYDROCORTISOL | UNII:7P2O6MFN8O | PubChem SID:198947299 | CAS RN:53-02-1 | 2-hydroxy-1-[(3R,5R,8S,9S,10S,11S,13S,14S,17R)-3,11,17-trihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone | PubChem CID:5864 | Tetrahydrocortisol"
+BMGC_DG12757,BMG_DG169956,"NDC:60760-715 | NDC:76420-069 | NDC:80425-0193 | NDC:55154-4310 | NDC:72789-235 | NDC:70518-3555 | NDC:0054-9828 | NDC:0054-3722 | NDC:0603-5335 | NDC:50090-7219 | NDC:70518-3401 | NDC:71335-1516 | NDC:63629-2264 | NDC:72189-593 | NDC:10135-777 | NDC:60687-122 | NDC:0054-8724 | NDC:63187-300 | NDC:10135-778 | NDC:50090-6122 | NDC:55700-203 | NDC:59651-485 | (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione | NDC:50090-6623 | NDC:51655-988 | NDC:42291-727 | DrugBank ID:DB00635 | NDC:51655-765 | NDC:67046-1280 | NDC:72189-489 | NDC:71335-2273 | NDC:70518-0242 | NDC:43063-968 | NDC:72162-1170 | NDC:71335-1926 | NDC:63629-2260 | NDC:0054-9818 | NDC:63629-1605 | NDC:70518-0948 | NDC:63629-2261 | NDC:51655-726 | NDC:50090-6621 | NDC:68071-3637 | NDC:63561-0122 | NDC:60687-145 | NDC:50090-3335 | NDC:72162-2149 | NDC:72789-393 | NDC:66267-812 | NDC:67296-1183 | NDC:59746-172 | NDC:50090-6376 | NDC:51407-921 | NDC:67296-2081 | NDC:63187-807 | NDC:70518-4243 | NDC:72162-1691 | NDC:71205-407 | NDC:45865-884 | NDC:59746-171 | NDC:50090-7371 | NDC:71335-9715 | NDC:59651-484 | NDC:0603-5339 | NDC:50090-6259 | NDC:71335-1737 | NDC:70518-4038 | NDC:64380-784 | NDC:71335-2079 | NDC:66267-860 | NDC:71335-2122 | NDC:62135-553 | NDC:0054-4741 | NDC:50090-7441 | NDC:63629-2257 | NDC:59746-173 | NDC:0054-3721 | NDC:42708-166 | NDC:43063-703 | NDC:51655-355 | NDC:51655-359 | NDC:64380-949 | NDC:50090-6123 | NDC:50090-1001 | NDC:67296-1194 | NDC:10135-774 | NDC:60760-796 | NDC:0054-0017 | NDC:60760-797 | NDC:68071-4685 | NDC:68788-8166 | PREDNISONE | NDC:51407-356 | NDC:71205-537 | NDC:66267-172 | NDC:59746-783 | NDC:0904-6923 | NDC:0054-0018 | NDC:68071-3617 | NDC:0603-5338 | NDC:60219-1707 | NDC:71335-0623 | NDC:71335-2389 | NDC:71205-729 | NDC:76420-068 | NDC:67296-1444 | NDC:68788-8663 | NDC:50090-1002 | NDC:42708-167 | NDC:55154-4950 | NDC:70954-061 | NDC:10135-775 | NDC:85000-0011 | NDC:42708-136 | NDC:62135-470 | NDC:0054-4742 | NDC:70518-3142 | NDC:68071-3746 | NDC:70954-056 | NDC:71610-721 | NDC:50090-5202 | NDC:51407-922 | NDC:71335-1780 | NDC:64380-785 | NDC:67296-0140 | NDC:60760-790 | NDC:70954-057 | NDC:51407-923 | NDC:70954-060 | NDC:71335-2356 | NDC:68071-3581 | NDC:63629-2254 | NDC:71610-641 | NDC:71335-2153 | NDC:43063-866 | NDC:75987-020 | NDC:63187-037 | NDC:67296-1083 | NDC:51655-541 | NDC:71205-239 | NDC:51655-242 | NDC:71335-2088 | NDC:71335-2069 | NDC:71335-2149 | NDC:71335-2051 | NDC:54348-506 | NDC:72789-413 | NDC:68788-8184 | NDC:68788-6440 | NDC:64380-783 | NDC:60219-1708 | NDC:55154-3564 | NDC:59651-489 | NDC:63187-243 | NDC:51655-939 | NDC:70518-0307 | NDC:63187-066 | NDC:51407-360 | NDC:63629-7917 | NDC:50090-6619 | NDC:0591-5442 | NDC:51407-358 | NDC:60219-1706 | NDC:0615-8438 | NDC:50090-3354 | NDC:50090-7369 | NDC:68788-8267 | NDC:71335-0508 | NDC:0054-8739 | NDC:50090-3137 | NDC:60687-134 | NDC:51407-357 | NDC:70518-4191 | NDC:82982-042 | NDC:68788-8579 | NDC:51655-972 | NDC:42708-045 | NDC:50090-7235 | NDC:67046-1019 | NDC:50090-2786 | NDC:72189-589 | NDC:67296-0138 | PubChem SID:175265838 | NDC:67296-1065 | NDC:51655-349 | NDC:42708-105 | NDC:68788-8212 | NDC:68788-8819 | NDC:66267-171 | NDC:71205-089 | NDC:10135-779 | UNII:VB0R961HZT | NDC:0054-8740 | NDC:43063-911 | NDC:68071-2661 | NDC:51655-410 | NDC:70518-0632 | NDC:70954-059 | NDC:50090-7024 | NDC:67296-1455 | NDC:55154-4946 | NDC:67296-1446 | NDC:50090-3336 | NDC:71335-2134 | NDC:71335-1524 | NDC:64380-835 | NDC:70518-3540 | NDC:71205-665 | NDC:42291-783 | NDC:59651-488 | Prednisone | NDC:0378-0641 | NDC:68071-3742 | NDC:62135-471 | NDC:63561-0121 | NDC:67296-1203 | NDC:70954-058 | NDC:67296-1331 | NDC:50090-7025 | NDC:60760-179 | NDC:51655-701 | NDC:0054-4728 | NDC:67296-0247 | NDC:60687-854 | NDC:50090-7023 | NDC:50090-5814 | NDC:72789-474 | NDC:51655-493 | NDC:71335-1525 | NDC:67544-399 | NDC:80425-0069 | NDC:71205-797 | NDC:71205-460 | NDC:76420-067 | NDC:0615-8441 | NDC:68071-3738 | NDC:10135-776 | NDC:60760-932 | NDC:80425-0068 | NDC:75987-022 | NDC:70882-117 | NDC:0904-7127 | NDC:72789-426 | NDC:68071-3729 | NDC:0603-5337 | NDC:50090-7124 | NDC:50090-7218 | NDC:42708-186 | NDC:60760-255 | NDC:0615-8439 | NDC:63187-020 | NDC:0378-0640 | NDC:42708-114 | NDC:59746-782 | NDC:71205-421 | NDC:72189-430 | NDC:68788-9551 | NDC:63187-085 | NDC:60219-1705 | NDC:59651-487 | NDC:63561-0120 | NDC:71205-755 | PubChem CID:5865 | NDC:75987-021 | NDC:55700-209 | NDC:67296-1419 | NDC:55154-4938 | NDC:42708-115 | NDC:60760-615 | NDC:59746-175 | NDC:68071-3143 | NDC:51655-068 | NDC:50090-6225 | NDC:51407-359 | NDC:0591-5052 | NDC:72789-448 | NDC:0603-5336 | NDC:64380-782 | NDC:72789-401 | NDC:70518-2486 | NDC:0591-5443 | NDC:70518-3537 | NDC:71610-834 | NDC:82982-041 | NDC:55700-208 | NDC:71205-741 | CAS RN:53-03-2 | NDC:51655-763 | NDC:51655-208 | NDC:67296-1457 | NDC:51655-935 | NDC:50090-1455 | NDC:68788-7372 | NDC:55289-330 | NDC:59651-486 | NDC:63739-588 | NDC:50090-0439 | NDC:63187-997 | NDC:71205-818 | NDC:50090-3361 | NDC:0615-8440 | NDC:80425-0106 | NDC:71205-362 | NDC:0054-9817 | NDC:51655-416 | NDC:71335-2160 | NDC:80425-0105 | NDC:0378-0642 | NDC:0054-0019 | NDC:68071-3641 | NDC:51655-197 | NDC:71335-0335 | NDC:70518-3476 | NDC:70518-3539 | NDC:68071-3721"
+BMGC_DG12758,BMG_DG169966,"PubChem SID:198960597 | Tetrahydrocortisone | PubChem CID:5866 | (3R,5R,8S,9S,10S,13S,14S,17R)-3,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-11-one | TETRAHYDROCORTISONE | UNII:5HF9TM2D15 | CAS RN:53-05-4"
+BMGC_DG12759,BMG_DG169985,CAS RN:38488-19-6 | PubChem CID:586971 | PubChem SID:478838327 | 1-(4-Chlorophenyl)-2-(phenylsulfonyl)ethanone | UNII:V3S6WW4VL8 | 1-(4-CHLOROPHENYL)-2-(PHENYLSULFONYL)ETHANONE
+BMGC_DG12760,BMG_DG169988,CAS RN:922-32-7 | PHOSPHOCREATINE | UNII:020IUV4N33 | 2-[methyl-(N'-phosphonocarbamimidoyl)amino]acetic acid | N-methyl-N-(N-phosphonocarbamimidoyl)glycine | PubChem CID:587 | PubChem SID:198938141 | CAS RN:67-07-2
+BMGC_DG12761,BMG_DG169989,"CAS RN:19973-76-3 | Estrone | NDC:43857-0036 | ESTRONE, (+/-)- | PubChem SID:316917049 | NDC:0220-9081 | (8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one | NDC:0220-2129 | DrugBank ID:DB00655 | UNII:2DI9HA706A | NDC:0220-2133 | ESTRONE | CAS RN:53-16-7 | NDC:43742-0066 | ESTRONE, (±)- | NDC:43857-0150 | NDC:0220-2117 | PubChem CID:5870 | NDC:43857-0074 | PubChem SID:175267804 | NDC:0220-2124 | UNII:X9XKA379T9 | NDC:0220-2116 | NDC:43857-0180"
+BMGC_DG12762,BMG_DG170019,"Paramethasone | UNII:VFC6ZX3584 | PubChem SID:198940543 | CAS RN:53-33-8 | PARAMETHASONE | DrugBank ID:DB01384 | PubChem CID:5875 | (6S,8S,9S,10R,11S,13S,14S,16R,17R)-6-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one"
+BMGC_DG12763,BMG_DG170022,"CAS RN:520505-01-5 | (2E)-2-(5-hydroxy-5,7,8,9-tetrahydrobenzo[7]annulen-6-ylidene)acetic acid | PubChem CID:5875451 | PubChem SID:459275998 | CAS RN:326809-98-7 | NCS-382 | UNII:8WW2CD9KK4"
+BMGC_DG12764,BMG_DG170026,"PubChem CID:5876 | UNII:9H05937G3X | FLUPREDNISOLONE | Fluprednisolone | PubChem SID:198983022 | CAS RN:53-34-9 | (6S,8S,9S,10R,11S,13S,14S,17R)-6-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | DrugBank ID:DB09378"
+BMGC_DG12765,BMG_DG170030,"NDC:70121-1573 | NDC:50090-0556 | NDC:70121-1552 | CAS RN:53-36-1 | NDC:0009-3475 | NDC:42023-238 | METHYLPREDNISOLONE ACETATE | NDC:70518-4045 | NDC:0009-0280 | NDC:0009-0274 | NDC:0009-3073 | UNII:43502P7F0P | NDC:50090-5894 | NDC:50090-6024 | NDC:76420-260 | PubChem SID:175268817 | NDC:60219-1573 | NDC:76420-262 | NDC:25021-820 | NDC:50090-1823 | NDC:25021-821 | NDC:63187-474 | Methylprednisolone Acetate | NDC:55150-313 | NDC:50090-0436 | NDC:70121-1574 | NDC:0781-3516 | NDC:76420-081 | NDC:50090-2098 | NDC:42023-239 | NDC:42023-240 | PubChem CID:5877 | NDC:0009-0306 | NDC:0781-3522 | NDC:70121-1610 | NDC:55150-314 | NDC:60219-1574 | [2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | NDC:70121-1609"
+BMGC_DG12766,BMG_DG170034,"PubChem CID:5878 | NDC:49884-302 | CAS RN:53-39-4 | (1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one | UNII:7H6TM3CT4L | DrugBank ID:DB00621 | Oxandrolone | NDC:49884-301 | PubChem SID:175266129 | OXANDROLONE"
+BMGC_DG12767,BMG_DG170044,"(3R,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one | Androsterone | PubChem SID:175267853 | ANDROSTERONE | CAS RN:53-41-8 | UNII:C24W7J5D5R | PubChem CID:5879"
+BMGC_DG12768,BMG_DG170050,creatinine | PubChem SID:175265839 | 2-amino-3-methyl-4H-imidazol-5-one | CREATININE | PubChem CID:588 | CAS RN:60-27-5 | DrugBank ID:DB11846 | CAS RN:62708-52-5 | UNII:AYI8EX34EU | Creatinine
+BMGC_DG12769,BMG_DG170051,"Aetiocholanolone | PubChem CID:5880 | UNII:97CGB1M48I | ETIOCHOLANOLONE | PubChem SID:198978902 | (3R,5R,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one | DrugBank ID:DB02854 | CAS RN:53-42-9 | Etiocholanolone"
+BMGC_DG12770,BMG_DG170053,N-FLUOROBENZENESULFONIMIDE | CAS RN:133745-75-2 | UNII:38TGL3A00I | PubChem CID:588007 | PubChem SID:241179084
+BMGC_DG12771,BMG_DG170060,"CAS RN:105597-37-3 | (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one | NDC:43857-0284 | PRASTERONE | CAS RN:53-43-0 | NDC:43857-0052 | PubChem CID:5881 | NDC:72495-501 | NDC:72495-401 | PubChem SID:175267676 | UNII:459AG36T1B | NDC:43742-0564 | DrugBank ID:DB01708 | Prasterone"
+BMGC_DG12772,BMG_DG170076,"PubChem SID:198981220 | UNII:381Q4X082D | PubChem CID:5884 | DrugBank ID:DB02338 | NADPH | CAS RN:53-57-6 | Nadph | CAS RN:2646-71-1 | NICOTINAMIDE-ADENINE DINUCLEOTIDE PHOSPHATE, REDUCED | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate"
+BMGC_DG12773,BMG_DG170081,"CAS RN:53-59-8 | DrugBank ID:DB03461 | PubChem SID:198968087 | NADIDE PHOSPHATE | UNII:BY8P107XEP | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate | PubChem CID:5885 | Triphosphopyridine nucleotide"
+BMGC_DG12774,BMG_DG170087,UNII:W96L2O9I1E | N-MONODESMETHYL BEDAQUILINE | CAS RN:861709-47-9 | PubChem SID:198972409 | PubChem CID:58853307
+BMGC_DG12775,BMG_DG170091,"CAS RN:12751-04-1 | CAS RN:112429-07-9 | CAS RN:141442-04-8 | NADP nicotinamide-adenine-dinucleotide phosphate | CAS RN:53-59-8 | CAS RN:122985-21-1 | PubChem CID:5886 | CAS RN:604-79-5 | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate | CAS RN:144906-21-8"
+BMGC_DG12776,BMG_DG170098,UNII:73A01W88SP | PubChem CID:5888 | PubChem SID:313182415 | 17-DEOXYESTRADIOL | CAS RN:53-63-4
+BMGC_DG12777,BMG_DG170102,"PubChem SID:198951439 | CAS RN:53-70-3 | naphtho[1,2-b]phenanthrene | Dibenz[a,h]anthracene | UNII:T30ELH3D5X | DIBENZ(A,H)ANTHRACENE | PubChem CID:5889"
+BMGC_DG12778,BMG_DG170103,4-HYDROXYLONCHOCARPIN | CAS RN:56083-03-5 | PubChem SID:402404380 | UNII:D6S8A779IY | PubChem CID:5889042
+BMGC_DG12779,BMG_DG170104,CAS RN:477589-41-6 | PubChem SID:333495592 | PubChem CID:58890996 | ZK-304709 | UNII:29713BMI56
+BMGC_DG12780,BMG_DG170107,N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide | PubChem SID:440794004 | UNII:82XC8RSD8V | CAS RN:442632-72-6 | PubChem CID:588963 | N-(2-(2-METHYLINDOL-3-YL)ETHYL)-2-THIENYLCARBOXAMIDE | DrugBank ID:DB08235
+BMGC_DG12781,BMG_DG170109,6-Isoquinolinamine | CAS RN:23687-26-5 | UNII:BP6NQZ58UP | PubChem SID:474493697 | 6-ISOQUINOLINAMINE | PubChem CID:588991
+BMGC_DG12782,BMG_DG170120,"CAS RN:53-84-9 | NADIDE | DrugBank ID:DB14128 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate | UNII:0U46U6E8UK | PubChem CID:5892 | PubChem SID:175267183 | CAS RN:64417-72-7 | Nadide"
+BMGC_DG12783,BMG_DG170130,"(2R,3R,4S,5R)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol | PubChem SID:333495870 | CAS RN:53-85-0 | Dichlororibofuranosylbenzimidazole | PubChem CID:5894 | UNII:8153319T3Q | DrugBank ID:DB08473 | 5,6-DICHLORORIBOFURANOSYLBENZIMIDAZOLE"
+BMGC_DG12784,BMG_DG170171,"UNII:7BVB29RCPR | PubChem SID:198986343 | 6-AZAURIDINE | PubChem CID:5901 | CAS RN:39455-15-7 | 2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazine-3,5-dione | CAS RN:54-25-1 | 6-Azauridine"
+BMGC_DG12785,BMG_DG170182,UNII:340B6Q764V | CAMYLOFIN | CAS RN:54-30-8 | PubChem CID:5902 | DrugBank ID:DB13738 | Camylofin | PubChem SID:198990804 | 3-methylbutyl 2-[2-(diethylamino)ethylamino]-2-phenylacetate
+BMGC_DG12786,BMG_DG170193,"DrugBank ID:DB09320 | PubChem SID:198966717 | Procaine benzylpenicillin | Penicillin G Procaine | CAS RN:54-35-3 | UNII:1LW5K9CIR1 | 2-(diethylamino)ethyl 4-aminobenzoate;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PENICILLIN G PROCAINE ANHYDROUS | PubChem CID:5903"
+BMGC_DG12787,BMG_DG170197,"(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Benzylpenicillin | CAS RN:61-33-6 | PubChem CID:5904 | PENICILLIN G | UNII:Q42T66VG0C | DrugBank ID:DB01053 | PubChem SID:175267090 | Penicillin G"
+BMGC_DG12788,BMG_DG170204,"Idoxuridine | PubChem CID:5905 | CAS RN:54-42-2 | UNII:LGP81V5245 | DrugBank ID:DB00249 | PubChem SID:175266852 | IDOXURIDINE | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione"
+BMGC_DG12789,BMG_DG170213,"3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol | METARAMINOL | PubChem SID:198942357 | UNII:818U2PZ2EH | DrugBank ID:DB00610 | Metaraminol | CAS RN:54-49-9 | PubChem CID:5906"
+BMGC_DG12790,BMG_DG170225,Methallenestril | DrugBank ID:DB13143 | PubChem CID:59084697
+BMGC_DG12791,BMG_DG170230,"PILOCARPINE HYDROCHLORIDE | NDC:0074-7098 | PubChem SID:175266840 | NDC:69292-265 | NDC:59651-224 | NDC:16714-121 | NDC:83661-018 | NDC:70069-201 | CAS RN:54-71-7 | NDC:71335-2120 | NDC:61314-206 | NDC:63629-8351 | NDC:0527-1407 | NDC:72162-1078 | Pilocarpine Hydrochloride | NDC:0574-0792 | NDC:0228-2801 | NDC:50268-652 | NDC:63629-8439 | UNII:0WW6D218XJ | NDC:59212-775 | NDC:69238-1745 | NDC:69238-1747 | NDC:61314-204 | NDC:70069-181 | NDC:69238-1746 | NDC:70069-191 | NDC:0527-1313 | NDC:59651-225 | NDC:68084-928 | NDC:16714-122 | NDC:61314-203 | NDC:60219-5922 | NDC:59212-705 | (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one;hydrochloride | NDC:0228-2837 | PubChem CID:5909 | NDC:63629-2099"
+BMGC_DG12792,BMG_DG170236,"UNII:01MI4Q9DI3 | (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one | CAS RN:92-13-7 | PILOCARPINE | PubChem CID:5910 | PubChem SID:175268441 | Pilocarpine | DrugBank ID:DB01085 | CAS RN:102282-25-7"
+BMGC_DG12793,BMG_DG170238,UNII:4V8564T36O | PubChem SID:198958672 | PubChem CID:5910161 | NIFURATRONE | CAS RN:19561-70-7
+BMGC_DG12794,BMG_DG170241,PubChem SID:198957770 | GEIPARVARIN | PubChem CID:5910585 | CAS RN:36413-91-9 | UNII:O0M5JB2L95
+BMGC_DG12795,BMG_DG170281,"UNII:WM5Z385K7T | 6,7,8,9-tetrahydro-5H-tetrazolo[1,5-a]azepine | PubChem SID:198972866 | PENTETRAZOL | CAS RN:20192-24-9 | DrugBank ID:DB13415 | Pentetrazol | PubChem CID:5917 | CAS RN:54-95-5"
+BMGC_DG12796,BMG_DG170286,DrugBank ID:DB11764 | UNII:DRU6NG543J | PubChem CID:59174488 | CAS RN:1202757-89-8 | Spebrutinib | SPEBRUTINIB | PubChem SID:198939026 | N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide
+BMGC_DG12797,BMG_DG170290,"pyridine-3,4-diamine | PubChem SID:175265903 | DrugBank ID:DB11640 | CAS RN:54-96-6 | AMIFAMPRIDINE | UNII:RU4S6E2G0J | Amifampridine | PubChem CID:5918"
+BMGC_DG12798,BMG_DG170302,CAS RN:199433-55-1 | PubChem CID:59198239 | Y-30141 | PubChem SID:485665312 | UNII:Y5SX5UDW77
+BMGC_DG12799,BMG_DG170303,2-(2-(1H-INDOL-3-YL)VINYL)QUINOLINE | PubChem SID:482553685 | CAS RN:1155810-01-7 | UNII:JWV4WQ68ES | PubChem CID:5919990 | 2-(2-(1H-Indol-3-yl)vinyl)quinoline
+BMGC_DG12800,BMG_DG170304,"LIOTHYRONINE | CAS RN:6893-02-3 | DrugBank ID:DB00279 | (2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid | PubChem CID:5920 | UNII:06LU7C9H1V | PubChem SID:175265733 | Liothyronine"
+BMGC_DG12801,BMG_DG170314,PubChem CID:5922 | CAS RN:55-22-1 | PubChem SID:198947898 | pyridine-4-carboxylic acid | ISONICOTINIC ACID | CAS RN:163751-04-0 | Isonicotinic acid | UNII:Y8SYN761TQ
+BMGC_DG12802,BMG_DG170317,PubChem SID:198958010 | CAS RN:125572-93-2 | PubChem CID:59226 | ROTIGOTINE HYDROCHLORIDE | UNII:6Q1W9573L2
+BMGC_DG12803,BMG_DG170318,"PubChem CID:59227 | (6S)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol | NDC:50474-801 | NDC:50474-803 | NDC:50474-804 | NDC:50474-802 | ROTIGOTINE | NDC:50474-805 | UNII:87T4T8BO2E | CAS RN:99755-59-6 | NDC:50474-806 | DrugBank ID:DB05271 | PubChem SID:175268915 | Rotigotine"
+BMGC_DG12804,BMG_DG170326,"PubChem CID:59239114 | CAS RN:1207358-59-5 | mTOR-IN-1 | 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-7-pyrimidin-2-yl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea"
+BMGC_DG12805,BMG_DG170327,"PubChem SID:198981498 | Gdc-0349 | DrugBank ID:DB13072 | 1-ethyl-3-[4-[4-[(3S)-3-methylmorpholin-4-yl]-7-(oxetan-3-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea | UNII:579255I6O9 | CAS RN:1207360-89-1 | GDC-0349 | PubChem CID:59239165"
+BMGC_DG12806,BMG_DG170330,"PubChem SID:377307906 | GW-5074, (Z)- | CAS RN:1233748-60-1 | UNII:B7W8RS1GG2 | PubChem CID:5924208"
+BMGC_DG12807,BMG_DG170334,CAS RN:918348-67-1 | UNII:FB7ZTJ8M8A | PubChem SID:441331830 | 2-[2-[2-(2-chlorophenyl)propan-2-yl]-1-[4-(3-methylsulfonylphenyl)phenyl]imidazol-4-yl]propan-2-ol | BMS-779788 | Bms-779788 | PubChem CID:59251511
+BMGC_DG12808,BMG_DG170369,"PubChem CID:59286554 | Bms-933043 | (3R)-N-(6-imidazol-1-ylpyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine | CAS RN:1221973-93-8"
+BMGC_DG12809,BMG_DG170371,DrugBank ID:DB09250 | Pheniprazine | CAS RN:55-52-7 | 1-phenylpropan-2-ylhydrazine | PubChem SID:198973747 | PHENIPRAZINE | UNII:37VKD7067M | PubChem CID:5929
+BMGC_DG12810,BMG_DG170387,"PubChem SID:312524973 | Glpg-0492 | UNII:8O59X1ACZT | PubChem CID:59317190 | CAS RN:1215085-92-9 | 4-[(4S)-4-(hydroxymethyl)-3-methyl-2,5-dioxo-4-phenylimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile | DrugBank ID:DB12461 | GLPG-0492"
+BMGC_DG12811,BMG_DG170397,"N,N-Dimethyl-4-[2-(3-methylphenyl)diazenyl]benzenamine | 4-(DIMETHYLAMINO)-3'-METHYLAZOBENZENE | UNII:SXK3ZE3U4Q | CAS RN:1081821-70-6 | PubChem CID:5934 | PubChem SID:198968131 | N,N-dimethyl-4-[(3-methylphenyl)diazenyl]aniline | CAS RN:55-80-1"
+BMGC_DG12812,BMG_DG170404,PubChem SID:313182695 | CAS RN:1227067-61-9 | PubChem CID:59351313 | 1-[4-[3-[4-(1H-benzimidazole-2-carbonyl)phenoxy]pyrazin-2-yl]piperidin-1-yl]ethanone | 4-(3-(1-Acetylpiperidine-4-yl)pyrazine-2-yloxy)phenyl(1H-benzoimidazole-2-yl)methanone | UNII:XW8D2TV27D | AMG-579
+BMGC_DG12813,BMG_DG170407,UNII:12UHW9R67N | Isoflurophate | CAS RN:55-91-4 | PubChem SID:198978488 | PubChem CID:5936 | ISOFLUROPHATE | 2-[fluoro(propan-2-yloxy)phosphoryl]oxypropane | DrugBank ID:DB00677
+BMGC_DG12814,BMG_DG170409,PubChem CID:59361866 | 3-(4-((1H-INDAZOL-5-YL)AMINO)QUINAZOLIN-2-YL)PHENYL ACETATE | UNII:F8E3B2GS9Y | CAS RN:911419-33-5
+BMGC_DG12815,BMG_DG170412,CAS RN:911417-89-5 | UNII:8NTY8K3WER | 2-(3-(4-((1H-INDAZOL-5-YL)AMINO)QUINAZOLIN-2-YL)PHENOXY)ACETAMIDE | PubChem SID:459055672 | PubChem CID:59361939
+BMGC_DG12816,BMG_DG170414,"CAS RN:145435-72-9 | UNII:ZE856183S0 | PubChem SID:175265532 | (2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-7-propyl-1-oxa-7-azacyclopentadecan-15-one | GAMITHROMYCIN | Gamithromycin | DrugBank ID:DB11416 | PubChem CID:59364992"
+BMGC_DG12817,BMG_DG170423,UNII:FB4Q52I9K2 | PubChem CID:5939 | CAS RN:56-03-1 | PubChem SID:198969807 | BIGUANIDE | 1-(diaminomethylidene)guanidine | Biguanide | CAS RN:4911-98-2 | DrugBank ID:DB13100
+BMGC_DG12818,BMG_DG170424,"CAS RN:1233332-14-3 | (2S)-2-[[4-[3-[[(1R)-1-(4-chloro-3-methylphenyl)ethyl]amino]phenyl]-2,6-dimethylbenzoyl]amino]propanoic acid | PubChem CID:59393720 | Nibr-0213"
+BMGC_DG12819,BMG_DG170425,ACRIZANIB | 5-[6-(methylaminomethyl)pyrimidin-4-yl]oxy-N-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]indole-1-carboxamide | CAS RN:1229453-99-9 | PubChem CID:59394698 | Acrizanib | PubChem SID:329589353 | UNII:F2CB8801I3
+BMGC_DG12820,BMG_DG170428,"PubChem CID:594 | DL-Cysteine | PubChem SID:175271622 | CAS RN:3374-22-9 | 2-amino-3-sulfanylpropanoic acid | CAS RN:84012-74-8 | CYSTEINE, DL- | CAS RN:150146-94-4 | UNII:5CM45Q5YAF | CAS RN:204523-09-1"
+BMGC_DG12821,BMG_DG170431,PubChem CID:5940264 | CAS RN:88070-98-8 | (6E)-6-(bromomethylidene)-3-naphthalen-1-yloxan-2-one | Bromoenol Lactone
+BMGC_DG12822,BMG_DG170436,Cystamine Dihydrochloride | CYSTAMINE DIHYDROCHLORIDE | UNII:I90T518457 | PubChem SID:198981006 | 2-(2-aminoethyldisulfanyl)ethanamine;dihydrochloride | PubChem CID:5941 | CAS RN:56-17-7
+BMGC_DG12823,BMG_DG170439,"PubChem SID:461432332 | CAS RN:1051463-82-1 | COBICISTAT, (R,R,R)- | UNII:LIQ3C1D1H4 | PubChem CID:59414201"
+BMGC_DG12824,BMG_DG170443,PubChem SID:198942827 | (E)-2-cyano-3-[3-ethoxy-4-hydroxy-5-(phenylsulfanylmethyl)phenyl]prop-2-enamide | 2-Cyano-3-(3-ethoxy-4-hydroxy-5-((phenylthio)methyl)phenyl)-2-propenamide | UNII:6X89Y2007R | ST-638 | PubChem CID:5941457 | CAS RN:107761-24-0
+BMGC_DG12825,BMG_DG170450,UNII:DD8K9FL3YS | CAS RN:1029713-99-2 | CNJ-294 | PubChem SID:433968560 | PubChem CID:59420946
+BMGC_DG12826,BMG_DG170451,"UNII:MZK2GP0RHK | (2R)-2-methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-N-(2,2,2-trifluoroethyl)butanamide | DECERNOTINIB | PubChem SID:198940921 | DrugBank ID:DB12566 | CAS RN:944842-54-0 | PubChem CID:59422203 | Decernotinib"
+BMGC_DG12827,BMG_DG170456,CARBON TETRACHLORIDE | Carbon Tetrachloride | Carbon tetrachloride | PubChem CID:5943 | tetrachloromethane | CAS RN:56-23-5 | UNII:CL2T97X0V0 | PubChem SID:198936420
+BMGC_DG12828,BMG_DG170464,"PubChem SID:175268572 | CAS RN:56-25-7 | DrugBank ID:DB12328 | PubChem CID:5944 | UNII:IGL471WQ8P | CANTHARIDIN | Cantharidin | (1R,2S,6R,7S)-2,6-dimethyl-4,10-dioxatricyclo[5.2.1.02,6]decane-3,5-dione"
+BMGC_DG12829,BMG_DG170472,CAS RN:31932-13-5 | UNII:YG5ED5JUB3 | CANNABIDIVARINIC ACID | PubChem CID:59444387 | PubChem SID:441331628
+BMGC_DG12830,BMG_DG170482,PubChem SID:440793703 | CAS RN:60113-11-3 | UNII:SSJ25E98QV | CANNABIDIBUTOL | PubChem CID:59444413
+BMGC_DG12831,BMG_DG170483,UNII:BL4R2AT3FE | CAS RN:39986-26-0 | PubChem SID:441332133 | TETRAHYDROCANNABIVARINIC ACID | PubChem CID:59444416
+BMGC_DG12832,BMG_DG170501,"Berzosertib | PubChem CID:59472121 | BERZOSERTIB | DrugBank ID:DB11794 | CAS RN:1232416-25-9 | UNII:L423PRV3V3 | 3-[3-[4-(methylaminomethyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine | PubChem SID:252164095"
+BMGC_DG12833,BMG_DG170502,"CAS RN:1229208-44-9 | DrugBank ID:DB12121 | PubChem CID:59473233 | 6-(1H-indazol-6-yl)-N-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyrazin-8-amine | ENTOSPLETINIB | UNII:6I3O3W6O3B | PubChem SID:198989653 | Entospletinib"
+BMGC_DG12834,BMG_DG170508,"CAS RN:19638-58-5 | PubChem SID:375084710 | PubChem CID:594809 | SCLERONE, (±)- | UNII:2FC112VQK2 | SCLERONE, (+/-)-"
+BMGC_DG12835,BMG_DG170516,2-amino-3-[(2-amino-2-carboxyethyl)disulfanyl]propanoic acid | PubChem CID:595 | CAS RN:923-32-0 | DL-Cystine
+BMGC_DG12836,BMG_DG170517,(2S)-2-aminopropanoic acid | CAS RN:77160-91-9 | NDC:0338-7022 | NDC:0338-7034 | NDC:0338-1133 | NDC:63323-712 | NDC:0338-7032 | NDC:0338-7020 | CAS RN:130380-93-7 | NDC:0338-0198 | UNII:OF5P57N2ZX | NDC:0338-1113 | NDC:0338-0210 | NDC:0338-0214 | CAS RN:26336-61-8 | NDC:0338-7007 | NDC:0338-7011 | CAS RN:115967-49-2 | NDC:0338-7036 | NDC:0338-0644 | DrugBank ID:DB00160 | NDC:0338-1145 | Alanine | NDC:0338-7015 | CAS RN:25191-17-7 | NDC:0338-7003 | NDC:0338-0194 | NDC:0338-1144 | NDC:0338-1148 | NDC:0338-1138 | CAS RN:56-41-7 | NDC:0338-1130 | NDC:0338-1137 | NDC:0338-7030 | NDC:0338-1099 | NDC:0338-1101 | NDC:0338-1089 | NDC:0338-1125 | NDC:0338-1134 | CAS RN:6898-94-8 | NDC:0338-7009 | NDC:0338-7028 | NDC:0338-0202 | NDC:0338-1091 | NDC:50845-0221 | NDC:63323-714 | NDC:0990-4178 | NDC:0338-1115 | NDC:0338-1142 | NDC:0338-7013 | ALANINE | NDC:0338-0180 | NDC:0338-0188 | NDC:0338-0184 | NDC:0338-0502 | NDC:0338-7005 | PubChem CID:5950 | PubChem SID:175266525 | NDC:0338-0499 | NDC:0990-4179 | NDC:0338-7026 | NDC:50845-0278 | NDC:0264-4500 | NDC:0338-7024 | NDC:0338-0206 | NDC:0338-7001 | NDC:0338-1123 | NDC:0338-1147
+BMGC_DG12837,BMG_DG170519,"UNII:Z65JAF632T | PubChem SID:472422375 | CAS RN:54107-70-9 | PubChem CID:595027 | 6-Amino-5-chloro-2,4(1H,3H)-pyrimidinedione | 6-AMINO-5-CHLORO-2,4(1H,3H)-PYRIMIDINEDIONE"
+BMGC_DG12838,BMG_DG170523,"DrugBank ID:DB11825 | PubChem CID:59509752 | Mirogabalin | 2-[(1R,5S,6S)-6-(aminomethyl)-3-ethyl-6-bicyclo[3.2.0]hept-3-enyl]acetic acid | MIROGABALIN | UNII:S7LK2KDM5U | PubChem SID:198970060 | CAS RN:1138245-13-2"
+BMGC_DG12839,BMG_DG170524,CAS RN:6898-95-9 | UNII:452VLY9402 | PubChem SID:175268492 | (2S)-2-amino-3-hydroxypropanoic acid | Serine | DrugBank ID:DB00133 | CAS RN:56-45-1 | PubChem CID:5951 | SERINE
+BMGC_DG12840,BMG_DG170533,"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID | DrugBank ID:DB07539 | PubChem CID:5951796"
+BMGC_DG12841,BMG_DG170537,"DrugBank ID:DB06780 | [2-[(8S,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | CAS RN:56-47-3 | UNII:6E0A168OB8 | DESOXYCORTICOSTERONE ACETATE | PubChem CID:5952 | Desoxycorticosterone Acetate | PubChem SID:198942316"
+BMGC_DG12842,BMG_DG170543,"PubChem CID:5953 | (S)-[(2R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol | Quinaglute | CAS RN:1234784-40-7"
+BMGC_DG12843,BMG_DG170550,[(2R)-3-(4-butoxycarbonylpiperazin-1-yl)-2-[[6-[(3S)-3-methoxypyrrolidin-1-yl]-2-phenylpyrimidine-4-carbonyl]amino]-3-oxopropyl]phosphonic acid | Selatogrel | PubChem CID:59534142 | CAS RN:1159500-34-1 | PubChem SID:375578857 | UNII:6DPK7O4PR7 | SELATOGREL | DrugBank ID:DB15163
+BMGC_DG12844,BMG_DG170551,"UNII:R0T9LLR4TN | CAS RN:1251528-23-0 | PubChem SID:375086197 | PubChem CID:59534386 | LAZUCIRNON | Lazucirnon | DrugBank ID:DB15269 | 2-[[(2R)-1-[1-[(4-chloro-3-methylphenyl)methyl]piperidin-4-yl]-5-oxopyrrolidine-2-carbonyl]amino]-N,N,6-trimethylpyridine-4-carboxamide"
+BMGC_DG12845,BMG_DG170554,"Petesicatib | (2S,4R)-N-(1-cyanocyclopropyl)-4-[4-(1-methylpyrazol-4-yl)-2-(trifluoromethyl)phenyl]sulfonyl-1-[1-(trifluoromethyl)cyclopropanecarbonyl]pyrrolidine-2-carboxamide | UNII:A26QO95U37 | PubChem SID:346541246 | PETESICATIB | PubChem CID:59543597 | CAS RN:1252637-35-6 | DrugBank ID:DB15297"
+BMGC_DG12846,BMG_DG170568,UNII:M371870BYL | PubChem CID:59568713 | 5-[(1R)-1-hydroxy-2-[4-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3H-2-benzofuran-1-one | MK-7145 | CAS RN:1255204-84-2 | PubChem SID:198971076 | Mk-7145 | DrugBank ID:DB11968
+BMGC_DG12847,BMG_DG170569,"NDC:63479-0712 | NDC:63479-1818 | NDC:63479-0705 | CAS RN:126339-06-8 | NDC:63479-1820 | NDC:63479-0714 | NDC:63479-2508 | NDC:43406-0592 | NDC:63479-1811 | NDC:81825-0001 | NDC:63479-2503 | PubChem CID:5957 | NDC:63479-2506 | NDC:63479-1804 | NDC:63479-1809 | NDC:63479-0710 | UNII:8L70Q75FXE | NDC:63479-2505 | CAS RN:56-65-5 | CAS RN:119439-06-4 | NDC:63479-1823 | NDC:63479-1801 | NDC:63479-1816 | NDC:43406-0715 | NDC:43406-0697 | NDC:63479-2511 | Adenosine-5'-triphosphate | DrugBank ID:DB00171 | ATP | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | NDC:63479-0716 | PubChem SID:175267267 | NDC:63479-1808 | NDC:63479-2516 | NDC:63479-0709 | NDC:63479-1803 | NDC:43406-0696 | NDC:63479-1806 | NDC:43406-0716 | NDC:63479-1827 | NDC:43406-0124 | NDC:63479-0711 | NDC:63479-0703 | NDC:63479-2509 | ADENOSINE TRIPHOSPHATE"
+BMGC_DG12848,BMG_DG170575,"CAS RN:56-75-7 | CHLORAMPHENICOL | DrugBank ID:DB00446 | CAS RN:125440-98-4 | Chloramphenicol | PubChem CID:5959 | PubChem SID:175267184 | 2,2-dichloro-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide | UNII:66974FR9Q1 | CAS RN:2787-09-9"
+BMGC_DG12849,BMG_DG170583,DrugBank ID:DB00128 | Aspartic acid | UNII:30KYC7MIAI | PubChem SID:175268925 | CAS RN:6899-03-2 | NDC:84660-054 | CAS RN:39162-75-9 | PubChem CID:5960 | ASPARTIC ACID | (2S)-2-aminobutanedioic acid | CAS RN:56-84-8 | CAS RN:55443-54-4 | Aspartic Acid
+BMGC_DG12850,BMG_DG170585,CAS RN:1375799-61-3 | Molidustat | PubChem CID:59603622 | MOLIDUSTAT | CAS RN:1154028-82-6 | UNII:9JH486CZ13 | 2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(triazol-1-yl)-1H-pyrazol-3-one | PubChem SID:198949511
+BMGC_DG12851,BMG_DG170586,XL-388 | PubChem SID:441097310 | UNII:B7I5G3Z7XR | PubChem CID:59604787 | CAS RN:1251156-08-7
+BMGC_DG12852,BMG_DG170588,"PubChem CID:5961 | CAS RN:26700-71-0 | NDC:70954-417 | CAS RN:184161-19-1 | Glutamine | L-Glutamine | (2S)-2,5-diamino-5-oxopentanoic acid | DrugBank ID:DB00130 | PubChem SID:175265821 | GLUTAMINE | UNII:0RH81L854J | CAS RN:56-85-9 | NDC:42457-420"
+BMGC_DG12853,BMG_DG170591,"LYSINE | (2S)-2,6-diaminohexanoic acid | CAS RN:12798-06-0 | UNII:K3Z4F929H6 | CAS RN:56-87-1 | PubChem CID:5962 | Lysine | CAS RN:25104-18-1 | CAS RN:20166-34-1 | PubChem SID:175268795 | DrugBank ID:DB00123"
+BMGC_DG12854,BMG_DG170596,Mitapivat | CAS RN:1260075-17-9 | N-[4-[4-(cyclopropylmethyl)piperazine-1-carbonyl]phenyl]quinoline-8-sulfonamide | PubChem CID:59634741 | UNII:2WTV10SIKH | MITAPIVAT | NDC:71334-210 | PubChem SID:329904402 | NDC:71334-220 | NDC:71334-205 | NDC:71334-215
+BMGC_DG12855,BMG_DG170617,DEMECARIUM | Demecarium | PubChem SID:175268051 | PubChem CID:5966 | DrugBank ID:DB00944 | UNII:ILP8XJ8R5K | trimethyl-[3-[methyl-[10-[methyl-[3-(trimethylazaniumyl)phenoxy]carbonylamino]decyl]carbamoyl]oxyphenyl]azanium | CAS RN:16505-84-3
+BMGC_DG12856,BMG_DG170625,PubChem SID:175266513 | NDC:83781-009 | NDC:84260-005 | NDC:84095-001 | acetic acid;2-[6-[[amino-[[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine | NDC:84291-003 | NDC:84291-002 | CHLORHEXIDINE ACETATE | NDC:84095-003 | NDC:84095-004 | NDC:84336-002 | NDC:84642-001 | Chlorhexidine acetate | UNII:5908ZUF22Y | CAS RN:56-95-1 | NDC:84260-002 | PubChem CID:5967
+BMGC_DG12857,BMG_DG170642,"Fadrozole | FADROZOLE | PubChem SID:198947343 | PubChem CID:59693 | CAS RN:102676-47-1 | UNII:H3988M64PU | 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile"
+BMGC_DG12858,BMG_DG170651,PubChem SID:198939543 | UNII:230447L0GL | PubChem CID:59708 | DrugBank ID:DB11868 | ETIRACETAM | CAS RN:33996-58-6 | Etiracetam | 2-(2-oxopyrrolidin-1-yl)butanamide
+BMGC_DG12859,BMG_DG170653,CAS RN:57-06-7 | PubChem CID:5971 | Allyl isothiocyanate | UNII:BN34FX42G3 | ALLYL ISOTHIOCYANATE | PubChem SID:198960922 | 3-isothiocyanatoprop-1-ene
+BMGC_DG12860,BMG_DG170677,PubChem CID:5974189 | CAS RN:67469-43-6 | GBR-12879 | UNII:VNS6D6QMEP | PubChem SID:255509213
+BMGC_DG12861,BMG_DG170684,PubChem CID:59749702 | PubChem SID:445499513 | N-(5-(CYCLOPROPYLCARBAMOYL)-2-METHYLPHENYL)-5-METHYL-1-(3-(TRIFLUOROMETHYL)PYRIDIN-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE | UNII:HF5XSJ9K57 | CAS RN:796069-97-1
+BMGC_DG12862,BMG_DG170685,cyanide | PubChem CID:5975 | CAS RN:57-12-5 | CYANIDE ANION | UNII:OXN4E7L11K | Cyanide ion | PubChem SID:312525004
+BMGC_DG12863,BMG_DG170693,UNII:TZ4OX61974 | 3-[5-(4-chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-methylpropanamide | PubChem CID:59757 | Tepoxalin | DrugBank ID:DB11466 | CAS RN:103475-41-8 | PubChem SID:198976094 | TEPOXALIN
+BMGC_DG12864,BMG_DG170694,"PubChem SID:198990045 | CAS RN:898280-07-4 | CAS RN:952306-27-3 | UNII:33M2XSK003 | XL-228 | PubChem CID:59757974 | 4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-N-[(3-propan-2-yl-1,2-oxazol-5-yl)methyl]pyrimidine-2,4-diamine"
+BMGC_DG12865,BMG_DG170699,CAS RN:81147-92-4 | UNII:MDY902UXSR | Esmolol | DrugBank ID:DB00187 | PubChem CID:59768 | methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate | ESMOLOL | CAS RN:103598-03-4 | PubChem SID:175271596
+BMGC_DG12866,BMG_DG170701,"PubChem CID:5977 | CHLOROBUTANOL | UNII:HM4YQM8WRC | CAS RN:57-15-8 | CAS RN:28471-22-9 | DrugBank ID:DB11386 | Chlorobutanol | PubChem SID:175266177 | 1,1,1-trichloro-2-methylpropan-2-ol"
+BMGC_DG12867,BMG_DG170715,"CAS RN:57-22-7 | DrugBank ID:DB00541 | CAS RN:1217704-92-1 | PubChem CID:5978 | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | Vincristine"
+BMGC_DG12868,BMG_DG170726,PubChem CID:598 | UNII:VHD28S0H7F | 2-Mercaptoethanesulfonic acid | DrugBank ID:DB09110 | Coenzyme M | PubChem SID:175268477 | 2-MERCAPTOETHANESULFONIC ACID | 2-sulfanylethanesulfonic acid | CAS RN:3375-50-6
+BMGC_DG12869,BMG_DG170737,"PHYSOSTIGMINE | [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate | CAS RN:57-47-6 | Physostigmine | PubChem CID:5983 | PubChem SID:175267711 | DrugBank ID:DB00981 | UNII:9U1VM840SP"
+BMGC_DG12870,BMG_DG170741,"D-(-)-Fructose | PubChem CID:5984 | CAS RN:57-48-7 | UNII:6YSS42VSEV | PubChem SID:440793311 | FRUCTOSE, DL- | UNII:02T79V874P | FRUCTOSE | PubChem SID:241178187 | CAS RN:30237-26-4 | CAS RN:25702-76-5 | (3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one"
+BMGC_DG12871,BMG_DG170752,UNII:M8RT9CVU2Q | CAS RN:960119-75-9 | PubChem SID:478838709 | 1-ETHYL-5-METHYL-2-PHENYL-1H-BENZIMIDAZOLE | PubChem CID:59847970 | 1-Ethyl-5-methyl-2-phenyl-1H-benzimidazole
+BMGC_DG12872,BMG_DG170757,"(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine | PubChem CID:59868 | DEXPRAMIPEXOLE | PubChem SID:198971391 | CAS RN:104632-28-2 | Dexpramipexole | DrugBank ID:DB15130 | UNII:WI638GUS96"
+BMGC_DG12873,BMG_DG170758,UNII:9NFU33906Q | PubChem SID:198937746 | PubChem CID:5987 | Sulfamic acid | CAS RN:5329-14-6 | SULFAMIC ACID | sulfamic acid
+BMGC_DG12874,BMG_DG170766,"Sucrose | CAS RN:85456-51-5 | PubChem SID:175265948 | DrugBank ID:DB02772 | CAS RN:57-50-1 | SUCROSE | CAS RN:87430-66-8 | PubChem CID:5988 | CAS RN:92004-84-7 | CAS RN:8030-20-4 | (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | CAS RN:8027-47-2 | CAS RN:86101-30-6 | UNII:C151H8M554"
+BMGC_DG12875,BMG_DG170784,"PubChem CID:5991 | NDC:0480-3472 | UNII:423D2T571U | NDC:0093-3122 | NDC:50090-1683 | NDC:50090-5959 | NDC:51285-127 | NDC:68462-504 | NDC:69238-1521 | NDC:70710-1190 | NDC:71671-100 | NDC:68462-656 | NDC:65162-469 | Ethinylestradiol | NDC:68308-752 | NDC:78206-146 | NDC:66993-605 | NDC:16714-029 | Ethinyl Estradiol | NDC:68180-827 | NDC:75834-129 | NDC:42291-930 | NDC:51862-148 | NDC:68180-828 | DrugBank ID:DB00977 | NDC:75834-130 | NDC:68462-637 | NDC:0555-9025 | NDC:0555-9009 | CAS RN:57-63-6 | NDC:51285-131 | PubChem SID:175266771 | NDC:65862-939 | NDC:70700-156 | NDC:72162-2220 | (8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol | NDC:67296-1159 | NDC:50090-6782 | NDC:0378-3340 | NDC:0093-7679 | NDC:42291-478 | NDC:0378-7274 | NDC:72189-215 | NDC:50261-313 | ETHINYL ESTRADIOL | NDC:65162-358 | NDC:65862-935 | NDC:68462-657 | NDC:50742-659 | NDC:70771-1777 | NDC:0378-7280 | NDC:75907-088 | NDC:68462-132 | NDC:0555-9027 | NDC:82804-172 | NDC:50090-5611"
+BMGC_DG12876,BMG_DG170800,"Progesterone | CAS RN:57-83-0 | CAS RN:753497-20-0 | CAS RN:137940-28-4 | PROGESTERONE | PubChem SID:175265744 | UNII:4G7DS2Q64Y | DrugBank ID:DB00396 | (8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | PubChem CID:5994"
+BMGC_DG12877,BMG_DG170802,"CAS RN:57-85-2 | Testosterone propionate | UNII:WI93Z9138A | Testosterone Propionate | TESTOSTERONE PROPIONATE | PubChem CID:5995 | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate | PubChem SID:175266744 | DrugBank ID:DB01420"
+BMGC_DG12878,BMG_DG170813,"NDC:62106-1162 | NDC:0220-1335 | NDC:62106-1207 | NDC:43742-1272 | DrugBank ID:DB04540 | NDC:43742-1414 | CAS RN:22243-67-0 | CAS RN:129111-15-5 | CAS RN:80356-14-5 | NDC:62106-1196 | CHOLESTEROL | NDC:0220-1339 | NDC:0220-1341 | Cholesterol | PubChem SID:175268672 | UNII:97C5T2UQ7J | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | CAS RN:57-88-5 | NDC:58264-0146 | NDC:0220-1334 | PubChem CID:5997"
+BMGC_DG12879,BMG_DG170821,"PubChem SID:198976175 | 1-chloro-2,4-dinitrobenzene | 2,4-DINITROCHLOROBENZENE | UNII:GE3IBT7BMN | Dinitrochlorobenzene | CAS RN:347840-12-4 | CAS RN:97-00-7 | PubChem CID:6 | DrugBank ID:DB11831"
+BMGC_DG12880,BMG_DG170822,"TUBOCURARINE | PubChem CID:6000 | CAS RN:57-95-4 | UNII:W9YXS298BM | (1S,16R)-10,25-dimethoxy-15,15,30-trimethyl-7,23-dioxa-30-aza-15-azoniaheptacyclo[22.6.2.23,6.18,12.118,22.027,31.016,34]hexatriaconta-3(36),4,6(35),8(34),9,11,18(33),19,21,24,26,31-dodecaene-9,21-diol | PubChem SID:198991050 | Tubocurarine | DrugBank ID:DB01199"
+BMGC_DG12881,BMG_DG170826,"PubChem CID:6001 | 7,12-dimethylbenzo[a]anthracene | UNII:F05B6S0395 | CAS RN:57-97-6 | PubChem SID:198979332 | 7,12-DIMETHYLBENZANTHRACENE | 7,12-Dimethylbenz[a]anthracene"
+BMGC_DG12882,BMG_DG170832,"TEMAFLOXACIN | PubChem SID:198935529 | CAS RN:108319-06-8 | PubChem CID:60021 | DrugBank ID:DB01405 | Temafloxacin | 1-(2,4-difluorophenyl)-6-fluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid | UNII:1WZ12GTT67"
+BMGC_DG12883,BMG_DG170835,PubChem SID:445499171 | L-NATEGLINIDE | PubChem CID:60026 | CAS RN:105816-05-5 | UNII:E9V3S85RHY
+BMGC_DG12884,BMG_DG170836,PubChem CID:6003770 | DrugBank ID:DB01250 | Olsalazine
+BMGC_DG12885,BMG_DG170844,"PubChem CID:6005 | Apomorphine | APOMORPHINE | CAS RN:58-00-4 | PubChem SID:175266202 | (6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol | UNII:N21FAR7B4S | DrugBank ID:DB00714"
+BMGC_DG12886,BMG_DG170847,Leucovorin | DrugBank ID:DB00650 | PubChem CID:6006
+BMGC_DG12887,BMG_DG170849,DrugBank ID:DB08302 | 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid | PubChem CID:6006216
+BMGC_DG12888,BMG_DG170851,UNII:8N86XTF9QD | PubChem SID:198938966 | PubChem CID:60063 | CAS RN:105956-97-6 | CLINAFLOXACIN | Clinafloxacin | DrugBank ID:DB14025 | 7-(3-aminopyrrolidin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid
+BMGC_DG12889,BMG_DG170863,"UNII:01704YP3MO | 4-(dimethylamino)-1,5-dimethyl-2-phenylpyrazol-3-one | AMINOPHENAZONE | PubChem CID:6009 | CAS RN:58-15-1 | Aminopyrine | Aminophenazone | PubChem SID:198940877 | DrugBank ID:DB01424"
+BMGC_DG12890,BMG_DG170868,"METHYLTESTOSTERONE | PubChem SID:175266857 | UNII:V9EFU16ZIF | PubChem CID:6010 | (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | NDC:0115-7037 | NDC:70954-255 | DrugBank ID:DB06710 | Methyltestosterone | CAS RN:58-18-4"
+BMGC_DG12891,BMG_DG170871,"PubChem CID:6011 | UNII:7DR7H00HDT | DrugBank ID:DB00858 | CAS RN:58-19-5 | DROMOSTANOLONE | (2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | Drostanolone | PubChem SID:198944990"
+BMGC_DG12892,BMG_DG170881,"NDC:0591-3217 | NDC:63629-2125 | NDC:0591-2925 | NDC:63629-9310 | NDC:68180-941 | NDC:0832-1121 | NDC:62332-488 | NDC:17139-562 | UNII:3XMK78S47O | DrugBank ID:DB00624 | NDC:62332-552 | NDC:0051-8462 | CAS RN:1050678-68-6 | NDC:0591-2363 | NDC:42667-5511 | NDC:24979-078 | NDC:0591-3216 | NDC:44117-0002 | NDC:16714-967 | NDC:72603-265 | NDC:16714-968 | NDC:0832-1120 | NDC:69238-1013 | PubChem CID:6013 | NDC:68180-943 | NDC:64380-151 | NDC:70700-112 | NDC:45802-610 | NDC:66887-004 | NDC:63629-8455 | NDC:72162-1426 | NDC:0591-2921 | CAS RN:58-22-0 | NDC:45802-366 | NDC:0245-0871 | NDC:16714-969 | NDC:64380-152 | NDC:0591-2926 | NDC:0245-0872 | Testosterone | PubChem SID:175267779 | NDC:24979-130 | NDC:0591-2924 | NDC:66887-001 | NDC:0591-3524 | NDC:21922-030 | NDC:69097-363 | TESTOSTERONE | NDC:72162-1421 | NDC:43742-1242 | NDC:45802-281 | NDC:45802-754 | NDC:72162-1962 | (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | NDC:0591-2114 | NDC:43598-304 | NDC:21922-019 | NDC:63629-2352"
+BMGC_DG12893,BMG_DG170885,UNII:F8GZ6C9MKZ | RKI-1447 | CAS RN:1342278-01-6 | PubChem CID:60138149 | PubChem SID:472410528
+BMGC_DG12894,BMG_DG170886,"Trans-4-{[4-(5-Methyl-3-Phenyl-1,2-Oxazol-4-Yl)pyrimidin-2-Yl]amino}cyclohexanol | 4-[[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)pyrimidin-2-yl]amino]cyclohexan-1-ol | PubChem CID:60138177"
+BMGC_DG12895,BMG_DG170889,NDC:69488-017 | CAS RN:1366302-52-4 | GOZETOTIDE | PubChem CID:60143283 | Gozetotide | PubChem SID:318164051 | (2S)-2-[[(1S)-1-carboxy-5-[6-[3-[3-[[2-[[5-(2-carboxyethyl)-2-hydroxyphenyl]methyl-(carboxymethyl)amino]ethyl-(carboxymethyl)amino]methyl]-4-hydroxyphenyl]propanoylamino]hexanoylamino]pentyl]carbamoylamino]pentanedioic acid | UNII:9AG41L3AOQ
+BMGC_DG12896,BMG_DG170906,"PubChem CID:60148401 | CAS RN:13870-90-1 | (3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(3S,4R)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(5Z,10Z,15Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl phosphate"
+BMGC_DG12897,BMG_DG170917,"CAS RN:1962178-27-3 | PubChem CID:60148521 | 5-(3-chloro-4-methoxyphenyl)-N-[3-(1,2,4-triazol-1-yl)propyl]-1,3-oxazole-4-carboxamide | 5-(3-Chloranyl-4-Methoxy-Phenyl)-~{n}-[3-(1,2,4-Triazol-1-Yl)propyl]-1,3-Oxazole-4-Carboxamide"
+BMGC_DG12898,BMG_DG170918,Sertindole | SERTINDOLE | CAS RN:106516-24-9 | PubChem SID:175268585 | UNII:GVV4Z879SP | DrugBank ID:DB06144 | 1-[2-[4-[5-chloro-1-(4-fluorophenyl)indol-3-yl]piperidin-1-yl]ethyl]imidazolidin-2-one | PubChem CID:60149
+BMGC_DG12899,BMG_DG170923,"PubChem CID:60150535 | CAS RN:1050477-31-0 | NDC:50419-540 | UNII:DE2O63YV8R | NDC:50419-541 | Finerenone | PubChem SID:198965471 | FINERENONE | (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide"
+BMGC_DG12900,BMG_DG170926,PubChem CID:60151476 | SUVN-G3031 DIHYDROCHLORIDE | PubChem SID:333495580 | UNII:6FZD7VS9EE | CAS RN:1394808-20-8 | N-[4-(1-cyclobutylpiperidin-4-yl)oxyphenyl]-2-morpholin-4-ylacetamide;dihydrochloride | SUVN-G3031 dihydrochloride
+BMGC_DG12901,BMG_DG170927,CAS RN:1394808-82-2 | PubChem SID:333495417 | DrugBank ID:DB14835 | Suvn-g3031 | SAMELISANT | UNII:65V47O9NOP | N-[4-(1-cyclobutylpiperidin-4-yl)oxyphenyl]-2-morpholin-4-ylacetamide | PubChem CID:60151477
+BMGC_DG12902,BMG_DG170928,PubChem CID:60151560 | Saroglitazar | DrugBank ID:DB13115 | (2S)-2-ethoxy-3-[4-[2-[2-methyl-5-(4-methylsulfanylphenyl)pyrrol-1-yl]ethoxy]phenyl]propanoic acid | CAS RN:495399-09-2 | UNII:E0YMX3S4JD | SAROGLITAZAR | PubChem SID:198938741
+BMGC_DG12903,BMG_DG170929,"PubChem SID:346537702 | Pf-06291874 | PubChem CID:60151939 | CAS RN:1393124-08-7 | DrugBank ID:DB15065 | PF-06291874 | UNII:CGY4I8F278 | 3-[[4-[(1S)-1-[3,5-dimethyl-4-[4-(trifluoromethyl)pyrazol-1-yl]phenoxy]butyl]benzoyl]amino]propanoic acid"
+BMGC_DG12904,BMG_DG170932,"PubChem SID:472424131 | PubChem CID:60152613 | N-[3-[5-[(1-ethylpiperidin-4-yl)-methylamino]-3-pyrimidin-5-ylpyrrolo[3,2-b]pyridin-1-yl]-2,4-difluorophenyl]propane-1-sulfonamide | pan-RAF Inhibitor XP-102 | XP-102 | UNII:V32TR55QP9 | CAS RN:1392429-79-6"
+BMGC_DG12905,BMG_DG170943,Thiazinamium | PubChem SID:198935698 | UNII:666W2P28N2 | CAS RN:2338-21-8 | trimethyl(1-phenothiazin-10-ylpropan-2-yl)azanium | PubChem CID:6016 | DrugBank ID:DB13420 | THIAZINAMIUM
+BMGC_DG12906,BMG_DG170950,NDC:45802-453 | NDC:0472-0126 | NDC:72162-1430 | NDC:51672-2150 | NDC:72657-158 | NDC:0536-1412 | NDC:70000-0666 | DrugBank ID:DB00210 | NDC:0316-0143 | NDC:72162-2295 | NDC:68462-301 | NDC:72162-1432 | NDC:72162-1048 | NDC:0299-5906 | NDC:49908-118 | NDC:49967-354 | NDC:73715-003 | NDC:51672-1364 | NDC:62332-549 | NDC:82429-012 | NDC:80861-115 | 6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid | NDC:63629-8607 | NDC:0299-4910 | NDC:51672-1377 | NDC:69968-0826 | NDC:0480-3154 | NDC:21922-051 | NDC:49967-591 | NDC:36800-088 | NDC:59726-888 | NDC:63629-8791 | PubChem SID:175268583 | NDC:80861-114 | NDC:11822-0062 | NDC:82429-313 | NDC:72657-102 | NDC:84893-001 | NDC:79481-1140 | NDC:46122-768 | NDC:71297-410 | Adapalene | NDC:11410-958 | NDC:51672-1384 | NDC:51316-114 | NDC:45802-853 | NDC:45802-846 | NDC:21130-754 | NDC:82442-105 | NDC:70000-0043 | NDC:70771-1716 | NDC:73581-214 | PubChem CID:60164 | NDC:0187-0006 | NDC:62332-662 | NDC:72162-2296 | NDC:0363-0888 | NDC:59726-114 | NDC:0363-1401 | NDC:68308-666 | UNII:1L4806J2QF | NDC:21922-052 | NDC:66993-869 | ADAPALENE | NDC:69842-088 | NDC:0299-5912 | NDC:0299-5918 | NDC:30142-725 | NDC:76162-114 | NDC:21130-708 | NDC:63629-9322 | NDC:72559-015 | NDC:0299-5908 | NDC:72578-119 | NDC:41250-288 | NDC:55910-880 | NDC:0168-0424 | NDC:0299-5915 | NDC:68308-662 | CAS RN:106685-40-9
+BMGC_DG12907,BMG_DG170952,"1H-Cyclopropa(4,5)cyclopenta(1,2-c)pyrazole-3-carboxamide, 4,4a,5,5a-tetrahydro-N-((1S)-1-(hydroxymethyl)-2,2-dimethylpropyl)-1-(4-oxido-2-pyrazinyl)-, (4aS,5aS)- | DrugBank ID:DB14998 | PubChem SID:363909773 | PubChem CID:60164925 | UNII:581F7DFA9B | CAS RN:1268881-20-4 | (2S,4S)-N-[(2S)-1-hydroxy-3,3-dimethylbutan-2-yl]-9-(4-oxidopyrazin-4-ium-2-yl)-8,9-diazatricyclo[4.3.0.02,4]nona-1(6),7-diene-7-carboxamide | OLORINAB"
+BMGC_DG12908,BMG_DG170954,"UNII:PW3Q92Z6A4 | NINGETINIB | PubChem CID:60165029 | N-[3-fluoro-4-[7-(2-hydroxy-2-methylpropoxy)quinolin-4-yl]oxyphenyl]-1,5-dimethyl-3-oxo-2-phenylpyrazole-4-carboxamide | CAS RN:1394820-69-9 | PubChem SID:381132152 | Ningetinib"
+BMGC_DG12909,BMG_DG170957,Auglurant | CAS RN:1396337-04-4 | PubChem CID:60168069 | AUGLURANT | N-(5-fluoropyridin-2-yl)-6-methyl-4-pyrimidin-5-yloxypyridine-2-carboxamide | UNII:GRN8X62ZW2 | PubChem SID:440088991
+BMGC_DG12910,BMG_DG170958,"Doxacurium | DrugBank ID:DB01135 | CAS RN:106791-39-3 | bis[3-[6,7,8-trimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propyl] butanedioate | PubChem CID:60169"
+BMGC_DG12911,BMG_DG170963,ADEFOVIR | DrugBank ID:DB13868 | UNII:6GQP90I798 | CAS RN:106941-25-7 | 2-(6-aminopurin-9-yl)ethoxymethylphosphonic acid | PubChem CID:60172 | Adefovir | PubChem SID:175267397
+BMGC_DG12912,BMG_DG170965,"CAS RN:1381929-92-5 | DrugBank ID:DB04844 | 9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one | PubChem CID:6018 | Tetrabenazine | CAS RN:58-46-8 | CAS RN:718635-93-9"
+BMGC_DG12913,BMG_DG170966,"UNII:77MPX3N42I | 4-[(3,4-dichlorobenzoyl)amino]-5-[3-methoxypropyl(pentyl)amino]-5-oxopentanoic acid | Loxiglumide | LOXIGLUMIDE | PubChem CID:60182 | PubChem SID:198939699 | CAS RN:107097-80-3"
+BMGC_DG12914,BMG_DG170967,PubChem SID:485664832 | UNII:YCS7VPH4WA | CAS RN:1443118-73-7 | PubChem CID:60182318 | N-Methyl-2-[[3-[2-(2-pyridinyl)ethyl]-1H-indazol-6-yl]thio]benzamide | N-METHYL-2-((3-(2-(2-PYRIDINYL)ETHYL)-1H-INDAZOL-6-YL)THIO)BENZAMIDE
+BMGC_DG12915,BMG_DG170968,"CAS RN:145513-37-7 | PubChem CID:60184 | 2'-EPI-PERINDOPRIL, (±)- | 2'-EPI-PERINDOPRIL, (2'R)- | UNII:LUF968K225 | UNII:FSH2P05QJT | PubChem SID:198936725 | 2'-EPI-PERINDOPRIL, (+/-)- | PubChem SID:198965016"
+BMGC_DG12916,BMG_DG170974,"UNII:WF9CA8UL2V | PubChem SID:387065531 | 7-[2-methoxy-6-[(4-methylpyridin-2-yl)methoxy]phenyl]-2,3,4,5-tetrahydro-1H-3-benzazepine | CAS RN:1398695-47-0 | GSK-2646264 | PubChem CID:60194098 | Gsk2646264"
+BMGC_DG12917,BMG_DG170979,UNII:F2B10OFV7Y | 3-[[[(1R)-1-(4-fluorophenyl)ethyl]-(quinoline-3-carbonyl)amino]methyl]benzoic acid | PF-05105679 | Pf-05105679 | DrugBank ID:DB15450 | PubChem CID:60195662 | PubChem SID:381132552 | CAS RN:1398583-31-7
+BMGC_DG12918,BMG_DG171015,"Methylcobalamin | CAS RN:13422-55-4 | PubChem CID:60196341 | carbanide;cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate"
+BMGC_DG12919,BMG_DG171037,"NDC:44278-025 | EXEMESTANE | NDC:59651-516 | NDC:71921-190 | NDC:72603-329 | NDC:68382-383 | PubChem SID:175266604 | NDC:59762-2858 | PubChem CID:60198 | UNII:NY22HMQ4BX | NDC:69097-316 | NDC:63629-2056 | NDC:70771-1374 | (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione | CAS RN:107868-30-4 | NDC:0009-7663 | NDC:0832-0595 | DrugBank ID:DB00990 | Exemestane | NDC:51991-005 | NDC:0054-0080 | NDC:65162-240"
+BMGC_DG12920,BMG_DG171044,"PubChem SID:249491953 | PubChem CID:60199242 | VENGLUSTAT | [(3S)-1-azabicyclo[2.2.2]octan-3-yl] N-[2-[2-(4-fluorophenyl)-1,3-thiazol-4-yl]propan-2-yl]carbamate | Venglustat | DrugBank ID:DB14966 | CAS RN:1401090-53-6 | UNII:BLP1XA3FZA"
+BMGC_DG12921,BMG_DG171051,"BOSUTINIB 3,5-DICHLORO-4-METHOXY ISOMER | UNII:SJH9PU93QM | PubChem CID:60202320 | CAS RN:1391063-17-4 | PubChem SID:474494597 | Bosutinib 3,5-dichloro-4-methoxy isomer"
+BMGC_DG12922,BMG_DG171052,"PubChem CID:60202647 | PubChem SID:251966036 | CAS RN:1401033-86-0 | AMG-925 | 2-hydroxy-1-[2-[[8-(4-methylcyclohexyl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-yl]amino]-7,8-dihydro-5H-1,6-naphthyridin-6-yl]ethanone | Ethanone, 1-(7,8-dihydro-2-((9-(trans-4-methylcyclohexyl)-9H-pyrido(4',3':4,5)pyrrolo(2,3-d)pyrimidin-2-yl)amino)-1,6-naphthyridin-6(5H)-yl)-2-hydroxy- | UNII:RB6Y814V4I"
+BMGC_DG12923,BMG_DG171053,PubChem SID:438788651 | PubChem CID:60202715 | UNII:UI9AT88BS7 | E-NORENDOXIFEN | CAS RN:1394929-55-5
+BMGC_DG12924,BMG_DG171056,"UNII:66Q80IL7CW | 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine | CAS RN:108030-77-9 | Penclomedine | PubChem SID:198947327 | PENCLOMEDINE | DrugBank ID:DB12987 | PubChem CID:60203"
+BMGC_DG12925,BMG_DG171059,"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine | DrugBank ID:DB06993 | PubChem CID:60206636"
+BMGC_DG12926,BMG_DG171068,"CAS RN:24127-35-3 | 7H-DIBENZ(B,D)AZEPIN-7-ONE, 5,6-DIHYDRO-5-((4-METHYLPHENYL)SULFONYL)- | 7H-Dibenz[b,d]azepin-7-one, 5,6-dihydro-5-[(4-methylphenyl)sulfonyl]- | UNII:33J9EB3UFZ | PubChem CID:602095 | PubChem SID:482554100"
+BMGC_DG12927,BMG_DG171073,PubChem CID:6021 | Inosine | DrugBank ID:DB04335
+BMGC_DG12928,BMG_DG171080,"CAS RN:104746-05-6 | ADENOSINE DIPHOSPHATE | CAS RN:11062-03-6 | PubChem SID:198940740 | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate | CAS RN:58-64-0 | CAS RN:112360-08-4 | CAS RN:20398-34-9 | CAS RN:17791-27-4 | PubChem CID:6022 | Adenosine-5'-diphosphate | CAS RN:110123-09-6 | UNII:61D2G4IYVH"
+BMGC_DG12929,BMG_DG171088,"UNII:R72LW146E6 | CAS RN:51098-29-4 | PubChem CID:6024 | PubChem SID:175265377 | Cefalotin | CAS RN:153-61-7 | CEPHALOTHIN | Cephalothin | (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | DrugBank ID:DB00456"
+BMGC_DG12930,BMG_DG171097,"Alpha-d-xylopyranose | DrugBank ID:DB03389 | (2S,3R,4S,5R)-oxane-2,3,4,5-tetrol | .ALPHA.-D-XYLOPYRANOSE | PubChem CID:6027 | alpha-D-Xylopyranose | CAS RN:130550-15-1 | PubChem SID:198961058 | UNII:C791ZE5K1W | CAS RN:6763-34-4"
+BMGC_DG12931,BMG_DG171099,UNII:8GK4W39WDT | PubChem SID:440088820 | PubChem CID:602761 | 1-(P-CHLOROPHENYL)CYCLOBUTANECARBOXYLIC ACID | CAS RN:50921-39-6
+BMGC_DG12932,BMG_DG171106,"1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione | PubChem SID:198951936 | UNII:WHI7HQ7H85 | Uridine | URIDINE | DrugBank ID:DB02745 | CAS RN:69-75-0 | CAS RN:92487-68-8 | PubChem CID:6029 | CAS RN:58-96-8"
+BMGC_DG12933,BMG_DG171108,"DrugBank ID:DB03685 | Uridine monophosphate | PubChem CID:6030 | CAS RN:27416-86-0 | Uridine Monophosphate | UNII:E2OU15WN0N | CAS RN:58-97-9 | PubChem SID:198949226 | URIDINE MONOPHOSPHATE | [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate"
+BMGC_DG12934,BMG_DG171112,"Uridine-5'-Diphosphate | PubChem SID:198966583 | CAS RN:27821-45-0 | DrugBank ID:DB03435 | UNII:5G0F599A1Y | [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate | URIDINE 5'-DIPHOSPHATE | PubChem CID:6031 | CAS RN:58-98-0 | Uridine-5'-diphosphate"
+BMGC_DG12935,BMG_DG171113,"DrugBank ID:DB01172 | UNII:EQK9Q303C5 | CAS RN:59-01-8 | PubChem CID:6032 | Kanamycin | CAS RN:8063-07-8 | (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol | PubChem SID:198962588 | KANAMYCIN A | CAS RN:1174286-24-8"
+BMGC_DG12936,BMG_DG171121,"BROXURIDINE | CAS RN:59-14-3 | DrugBank ID:DB12028 | PubChem CID:6035 | UNII:G34N38R2N1 | 5-bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione | 5-Bromo-2'-deoxyuridine | Broxuridine | PubChem SID:198958850"
+BMGC_DG12937,BMG_DG171126,"PubChem CID:6036 | D-Galactose | CAS RN:40825-89-6 | CAS RN:10257-28-0 | (3R,4S,5R,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol"
+BMGC_DG12938,BMG_DG171128,FOLIC ACID | DrugBank ID:DB00158 | CAS RN:59-30-3 | (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid | UNII:935E97BOY8 | PubChem SID:175267888 | PubChem CID:6037 | Folic acid
+BMGC_DG12939,BMG_DG171131,1H-quinolin-2-one | 2-Hydroxyquinoline | CAS RN:1321-40-0 | CAS RN:59-31-4 | PubChem CID:6038 | PubChem SID:198983802 | CAS RN:104534-80-7 | CAS RN:70254-42-1 | UNII:803BHY7QWU | Quinolones | CARBOSTYRIL | DrugBank ID:DB04745
+BMGC_DG12940,BMG_DG171140,3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol | CAS RN:59-42-7 | PubChem CID:6041 | PHENYLEPHRINE | DrugBank ID:DB00388 | Phenylephrine | PubChem SID:175267235 | UNII:1WS297W6MV | CAS RN:1228015-39-1
+BMGC_DG12941,BMG_DG171147,"UNII:3X996Q809V | 2-Benzoxazolinone | 3H-1,3-benzoxazol-2-one | CAS RN:69564-68-7 | CAS RN:59-49-4 | PubChem SID:198954242 | BENZOXAZOLONE | PubChem CID:6043"
+BMGC_DG12942,BMG_DG171154,"UNII:CV71VTP0VN | PubChem SID:198980923 | PubChem CID:604519 | IPIDACRINE | Ipidacrine | CAS RN:62732-44-9 | DrugBank ID:DB13668 | 2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]quinolin-9-amine"
+BMGC_DG12943,BMG_DG171157,PubChem SID:472422010 | PubChem CID:604575 | 7-TRIFLUOROMETHYLISATIN | CAS RN:391-12-8 | UNII:RLA848X4KR
+BMGC_DG12944,BMG_DG171159,"CAS RN:111542-93-9 | Sparfloxacin | DrugBank ID:DB01208 | UNII:Q90AGA787L | PubChem CID:60464 | CAS RN:110871-86-8 | PubChem SID:198934945 | SPARFLOXACIN | 5-amino-1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-6,8-difluoro-4-oxoquinoline-3-carboxylic acid"
+BMGC_DG12945,BMG_DG171163,"Levodopa | DrugBank ID:DB01235 | NDC:43857-0265 | CAS RN:59-92-7 | PubChem SID:175266688 | NDC:43742-1307 | UNII:46627O600J | (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | NDC:10144-342 | LEVODOPA | CAS RN:65170-01-6 | NDC:43857-0226 | PubChem CID:6047 | CAS RN:122769-74-8 | NDC:44911-0035"
+BMGC_DG12946,BMG_DG171169,Edetic Acid | CAS RN:139-33-3 | Edetic acid | EDETIC ACID | CAS RN:688-55-1 | PubChem SID:175265369 | PubChem CID:6049 | CAS RN:124949-23-1 | DrugBank ID:DB00974 | UNII:9G34HU7RV0 | CAS RN:60-00-4 | 2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid | CAS RN:53632-26-1 | CAS RN:470462-56-7
+BMGC_DG12947,BMG_DG171170,NDC:31722-044 | NDC:72603-246 | 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea | ZILEUTON | PubChem SID:175271412 | CAS RN:111406-87-2 | DrugBank ID:DB00744 | UNII:V1L22WVE2S | NDC:10122-901 | NDC:51407-741 | NDC:64980-206 | NDC:64380-189 | Zileuton | PubChem CID:60490
+BMGC_DG12948,BMG_DG171174,"NDC:67877-198 | NDC:63187-783 | NDC:50090-5389 | NDC:68788-9345 | NDC:68382-122 | NDC:68462-567 | NDC:68180-233 | NDC:70518-0297 | NDC:70518-1928 | NDC:65862-585 | NDC:0069-7476 | NDC:70518-1971 | NDC:66993-267 | NDC:42291-026 | NDC:33342-191 | NDC:64380-200 | NDC:68180-719 | NDC:65862-103 | NDC:64380-201 | NDC:0615-8430 | NDC:69097-128 | NDC:0904-6370 | NDC:42291-004 | NDC:71335-2507 | NDC:68180-463 | NDC:70518-3592 | NDC:0078-0406 | NDC:63629-1024 | NDC:46708-213 | NDC:62332-208 | NDC:65597-113 | NDC:71093-146 | NDC:65862-584 | NDC:70771-1460 | NDC:68788-8313 | NDC:71335-0945 | NDC:82982-020 | NDC:76282-509 | NDC:65862-740 | NDC:83008-039 | NDC:42291-025 | AMLODIPINE BESYLATE | NDC:60760-614 | NDC:71335-1946 | NDC:55700-541 | NDC:50090-6876 | NDC:70771-1188 | NDC:70518-2140 | NDC:46708-461 | NDC:27241-083 | NDC:68071-4251 | NDC:0713-0874 | NDC:0078-0405 | NDC:29300-398 | NDC:0378-4519 | NDC:68180-459 | NDC:68180-721 | NDC:51407-671 | NDC:0078-0488 | NDC:71093-148 | NDC:71610-722 | NDC:71610-539 | NDC:68180-751 | NDC:50090-3357 | NDC:50090-6185 | NDC:68645-516 | NDC:43063-041 | NDC:68180-771 | NDC:68462-569 | NDC:67877-502 | NDC:68001-135 | NDC:43386-083 | NDC:33342-286 | NDC:63187-198 | NDC:69097-127 | NDC:68180-759 | NDC:76282-239 | NDC:65862-856 | NDC:71610-687 | NDC:67877-197 | UNII:864V2Q084H | NDC:71093-147 | NDC:65162-007 | NDC:55111-339 | NDC:0069-1520 | NDC:0378-1078 | NDC:49884-788 | NDC:63187-914 | NDC:50090-4284 | NDC:72189-162 | NDC:43598-320 | NDC:66993-272 | NDC:65862-739 | NDC:0078-0364 | NDC:68788-8543 | NDC:64380-197 | NDC:68645-580 | NDC:63187-508 | NDC:0480-7167 | NDC:68180-720 | NDC:0713-0875 | NDC:65862-838 | NDC:68180-766 | NDC:55154-6892 | NDC:49884-790 | NDC:65862-586 | NDC:60505-3484 | NDC:0378-4515 | NDC:49884-789 | NDC:66993-269 | NDC:50090-2581 | NDC:46708-184 | NDC:46708-214 | NDC:65162-006 | NDC:0615-8431 | NDC:64380-198 | NDC:70518-2632 | NDC:71205-506 | NDC:65862-857 | NDC:0093-5003 | NDC:62332-214 | NDC:68788-6386 | NDC:70771-1467 | NDC:68382-428 | NDC:63629-2241 | NDC:60505-3489 | NDC:65162-008 | NDC:27241-085 | NDC:58151-353 | NDC:82804-164 | NDC:68180-765 | NDC:50090-5354 | NDC:43598-322 | NDC:72789-285 | NDC:50228-365 | NDC:0069-2260 | NDC:63629-2239 | NDC:46708-187 | NDC:55111-586 | NDC:70771-1462 | NDC:0069-6747 | NDC:42571-238 | NDC:43353-684 | NDC:72789-260 | NDC:0069-1530 | NDC:57237-144 | NDC:43598-319 | NDC:62332-205 | NDC:50228-366 | NDC:68180-774 | NDC:68382-426 | NDC:60505-3492 | NDC:63629-7535 | NDC:50090-6809 | NDC:0093-5002 | NDC:46708-215 | NDC:71335-2359 | PubChem CID:60496 | NDC:72162-2092 | NDC:42291-015 | NDC:51407-860 | NDC:0378-4513 | NDC:49884-787 | NDC:0378-1724 | NDC:71205-122 | NDC:65862-101 | NDC:50090-6877 | NDC:51655-869 | NDC:71335-1887 | NDC:71205-599 | NDC:0069-6565 | NDC:42806-056 | NDC:57237-146 | NDC:50090-6770 | NDC:68382-928 | NDC:33342-279 | NDC:68071-5151 | NDC:71335-0843 | NDC:65862-582 | NDC:0713-0878 | NDC:70771-1461 | NDC:66993-266 | NDC:52605-043 | NDC:51407-672 | NDC:42291-002 | NDC:68788-8454 | NDC:55154-6875 | NDC:0378-1077 | NDC:68382-433 | NDC:72789-082 | NDC:50090-6808 | NDC:42806-057 | NDC:42571-237 | NDC:76282-238 | NDC:83008-035 | NDC:0078-0379 | NDC:67877-501 | NDC:70771-1186 | NDC:70771-1457 | NDC:60505-3493 | NDC:43598-317 | NDC:43598-314 | NDC:50090-2720 | NDC:0480-0083 | NDC:68180-764 | NDC:63629-2238 | NDC:50228-367 | NDC:70771-1458 | NDC:46708-459 | NDC:64380-199 | NDC:72162-2091 | NDC:62332-212 | NDC:72162-1516 | NDC:71610-830 | NDC:50090-5059 | NDC:0078-0489 | NDC:0069-7810 | NDC:51407-669 | NDC:67877-500 | NDC:43598-316 | NDC:65862-583 | NDC:33342-282 | NDC:0093-5004 | NDC:46708-460 | NDC:50090-1627 | NDC:62332-215 | NDC:0378-1076 | NDC:68001-132 | NDC:42291-014 | NDC:70518-4165 | NDC:51655-291 | NDC:72162-2090 | NDC:57237-145 | NDC:68382-424 | NDC:0078-0563 | NDC:43598-313 | NDC:58151-355 | NDC:68180-756 | NDC:60687-488 | NDC:72162-1515 | NDC:55111-338 | NDC:60505-3483 | NDC:66993-271 | NDC:71610-802 | NDC:0378-1721 | NDC:27241-084 | NDC:62332-207 | NDC:43063-764 | NDC:71610-691 | NDC:63629-2240 | NDC:68462-568 | NDC:51407-858 | NDC:71610-469 | Amlodipine Besylate | NDC:76282-237 | NDC:57237-147 | NDC:67877-199 | NDC:55700-543 | NDC:67046-1227 | NDC:68180-772 | NDC:0069-7654 | NDC:68180-775 | NDC:72162-2093 | NDC:42291-027 | NDC:67046-0328 | NDC:59762-2010 | NDC:27241-086 | NDC:71335-0833 | NDC:0078-0561 | NDC:68180-472 | NDC:67296-1876 | NDC:65841-621 | NDC:68788-8627 | NDC:68382-927 | NDC:50090-1039 | NDC:60505-3488 | NDC:60687-496 | NDC:0069-6323 | NDC:46708-458 | NDC:55154-8093 | NDC:50090-6853 | NDC:46708-212 | NDC:29300-397 | NDC:50090-1418 | NDC:63629-1023 | NDC:42291-011 | NDC:68645-515 | NDC:43353-989 | NDC:52605-041 | NDC:0713-0876 | NDC:72162-1514 | NDC:72789-261 | NDC:33342-281 | NDC:72162-2360 | NDC:0069-7232 | NDC:68180-758 | NDC:70771-1459 | NDC:68382-123 | NDC:68788-7985 | PubChem SID:175271756 | NDC:71335-1278 | NDC:68071-3453 | NDC:50090-5357 | NDC:68788-8263 | NDC:65862-854 | NDC:0093-5006 | NDC:43386-081 | NDC:57237-143 | NDC:69238-2676 | NDC:0904-6371 | NDC:43386-082 | NDC:69238-2674 | NDC:72789-262 | NDC:69097-837 | NDC:68071-2520 | NDC:55111-587 | NDC:72162-2089 | NDC:72789-412 | NDC:72162-2094 | NDC:65862-836 | NDC:68180-760 | NDC:55111-340 | NDC:71335-0890 | NDC:65841-622 | NDC:68001-133 | NDC:69584-022 | NDC:50228-368 | NDC:0713-0871 | NDC:42806-055 | NDC:67877-499 | NDC:33342-284 | NDC:69097-836 | NDC:68788-8451 | NDC:68180-773 | NDC:33342-193 | NDC:68180-455 | NDC:0904-6369 | NDC:67046-1428 | NDC:68001-134 | NDC:76282-507 | NDC:68382-427 | NDC:59762-2135 | NDC:50090-1042 | NDC:42291-013 | NDC:82009-026 | NDC:69238-2673 | NDC:68180-196 | NDC:42708-066 | NDC:65862-855 | NDC:29300-396 | NDC:68382-930 | NDC:43598-315 | NDC:42571-235 | NDC:68382-431 | NDC:65862-834 | NDC:70771-1466 | NDC:68382-432 | NDC:69584-023 | NDC:42291-003 | NDC:52605-042 | NDC:49884-786 | NDC:70518-4073 | NDC:43353-691 | NDC:0480-7168 | NDC:57237-142 | CAS RN:111470-99-6 | NDC:50090-6427 | NDC:68180-757 | NDC:65841-620 | NDC:43598-321 | NDC:0378-1723 | NDC:46708-186 | NDC:70771-1465 | NDC:0615-8429 | NDC:68382-929 | NDC:72789-432 | NDC:71610-620 | NDC:33342-285 | NDC:68180-197 | NDC:0078-0559 | NDC:71205-596 | NDC:50090-5550 | NDC:68382-121 | NDC:33342-280 | NDC:43598-318 | NDC:51407-859 | NDC:65862-835 | NDC:68382-425 | NDC:70771-1463 | NDC:33342-287 | NDC:69584-021 | NDC:0713-0870 | NDC:66993-264 | NDC:66993-265 | NDC:55111-341 | NDC:43386-080 | NDC:68071-2305 | NDC:0713-0872 | NDC:50090-4903 | NDC:63187-326 | NDC:69097-126 | NDC:68180-755 | NDC:72162-2379 | NDC:68001-130 | NDC:0078-0562 | NDC:0069-6180 | NDC:70771-1464 | NDC:68180-767 | NDC:42571-236 | NDC:0378-1722 | NDC:72189-260 | NDC:60505-3479 | NDC:51655-213 | NDC:33342-190 | NDC:70934-075 | NDC:0078-0491 | NDC:43598-323 | NDC:68001-131 | NDC:69097-838 | NDC:0378-4520 | NDC:0078-0560 | NDC:60760-445 | NDC:66993-270 | NDC:70518-2981 | NDC:68071-3698 | NDC:82009-028 | NDC:67296-1648 | NDC:72189-520 | NDC:0713-0873 | NDC:60505-3478 | NDC:72189-529 | NDC:66993-273 | NDC:70771-1189 | NDC:33342-283 | NDC:68382-434 | NDC:42291-012 | NDC:0378-4516 | NDC:51655-586 | NDC:50090-7361 | NDC:71610-732 | NDC:42291-001 | NDC:65862-587 | NDC:0713-0877 | NDC:59762-2242 | NDC:71335-0953 | NDC:46708-185 | NDC:65862-738 | NDC:76282-508 | NDC:50090-5355 | NDC:43063-564 | NDC:82868-041 | NDC:68180-473 | NDC:0378-4518 | NDC:82868-031 | NDC:66993-268 | NDC:58151-354 | NDC:0078-0490 | NDC:65862-102 | NDC:0378-4517 | NDC:33342-192 | NDC:82009-027 | NDC:63187-197 | NDC:65862-737 | NDC:62332-213 | NDC:0093-5005 | NDC:65862-837 | NDC:0378-4514 | NDC:68382-429 | NDC:51407-668 | NDC:70771-1187 | NDC:68462-566 | NDC:71205-488 | NDC:71335-1865 | NDC:50090-2524 | NDC:51407-857 | NDC:51655-201 | NDC:62332-206 | NDC:51655-044 | NDC:70518-0367 | NDC:68382-430 | NDC:0069-1540 | NDC:66993-263 | NDC:0378-1075 | NDC:69238-2675 | NDC:51407-670 | benzenesulfonic acid;3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate"
+BMGC_DG12949,BMG_DG171178,"2,3-di(butanoyloxy)propyl butanoate | UNII:S05LZ624MF | CAS RN:60-01-5 | PubChem SID:198990251 | TRIBUTYRIN | Tributyrin | PubChem CID:6050 | DrugBank ID:DB12709"
+BMGC_DG12950,BMG_DG171182,"2-amino-N-(1,2-diphenylpropan-2-yl)acetamide | UNII:Y65K7HQ8FU | UNII:EH6763C1IC | PubChem CID:60511 | DrugBank ID:DB06458 | REMACEMIDE | CAS RN:118754-14-6 | CAS RN:118754-12-4 | REMACEMIDE, (-)- | PubChem SID:440793460 | Remacemide | PubChem SID:198976546 | UNII:SVE7VVM49X | PubChem SID:440793867 | REMACEMIDE, (+)- | CAS RN:135252-01-6 | CAS RN:128298-28-2"
+BMGC_DG12951,BMG_DG171189,UNII:0E8R4GDE2Q | PubChem CID:60539 | RITOLUKAST | CAS RN:111974-60-8 | PubChem SID:198940335
+BMGC_DG12952,BMG_DG171190,CAS RN:60-12-8 | PHENYLETHYL ALCOHOL | CAS RN:19601-20-8 | UNII:ML9LGA7468 | PubChem SID:175265366 | 2-phenylethanol | Phenylethyl Alcohol | PubChem CID:6054 | DrugBank ID:DB02192 | Phenylethyl alcohol | CAS RN:1321-27-3
+BMGC_DG12953,BMG_DG171191,"PubChem CID:60542 | 1-(3,5-ditert-butyl-4-hydroxyphenyl)hex-5-yn-1-one | Tebufelone | PubChem SID:198963087 | CAS RN:112018-00-5 | UNII:O048K9ZFHO | TEBUFELONE"
+BMGC_DG12954,BMG_DG171202,CAS RN:1189756-47-5 | DrugBank ID:DB00135 | UNII:42HK56048U | CAS RN:60-18-4 | (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid | Tyrosine | PubChem CID:6057 | CAS RN:25619-78-7 | TYROSINE | PubChem SID:175265436 | CAS RN:55520-40-6
+BMGC_DG12955,BMG_DG171209,"PubChem CID:6057891 | PubChem SID:496143637 | CAS RN:7529-87-5 | 4-ISOPROPOXY-4-OXOBUT-2-ENOIC ACID, (E)- | UNII:MF7U4U5XNP | 4-Isopropoxy-4-oxobut-2-enoic acid, (E)-"
+BMGC_DG12956,BMG_DG171210,2-aminoethanethiol | CAS RN:60-23-1 | CYSTEAMINE | Cysteamine | UNII:5UX2SD1KE2 | PubChem SID:175266613 | PubChem CID:6058 | DrugBank ID:DB00847
+BMGC_DG12957,BMG_DG171211,PubChem CID:60582 | PubChem SID:198972037 | SULFASUCCINAMIDE | UNII:8286I9062N | CAS RN:3563-14-2
+BMGC_DG12958,BMG_DG171214,"UNII:0U7YZ42Z47 | DrugBank ID:DB03395 | 3-amino-N-[(2S)-1-[[(2S)-1-[[(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6-methylheptan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-(4-methoxyphenyl)-1-oxopropan-2-yl]-3-methylbutanamide | PubChem SID:198935177 | CAS RN:113082-98-7 | ENALKIREN | PubChem CID:60594 | Enalkiren"
+BMGC_DG12959,BMG_DG171217,"Niguldipine | PubChem CID:60602 | NIGULDIPINE | 5-O-[3-(4,4-diphenylpiperidin-1-yl)propyl] 3-O-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | UNII:Z81N45O25Z | CAS RN:113165-32-5 | DrugBank ID:DB09239 | PubChem SID:198971262 | S(+)-Niguldipine hydrochloride"
+BMGC_DG12960,BMG_DG171218,"ORBIFLOXACIN | DrugBank ID:DB11443 | 1-cyclopropyl-7-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid | Orbifloxacin | UNII:660932TPY6 | CAS RN:113617-63-3 | PubChem SID:175265787 | PubChem CID:60605"
+BMGC_DG12961,BMG_DG171219,"DrugBank ID:DB00758 | PubChem CID:60606 | UNII:A74586SNO7 | PubChem SID:175267531 | NDC:31722-759 | NDC:31722-758 | CLOPIDOGREL | Clopidogrel | methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate | CAS RN:113665-84-2"
+BMGC_DG12962,BMG_DG171222,"LEVOMEDETOMIDINE | Levomedetomidine | CAS RN:119717-21-4 | UNII:K66HW308K4 | 5-[(1R)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole | PubChem SID:287445846 | PubChem CID:60612"
+BMGC_DG12963,BMG_DG171223,UNII:768M1V522C | PubChem SID:175268249 | DrugBank ID:DB00369 | Cidofovir | CAS RN:113852-37-2 | [(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid | PubChem CID:60613 | CIDOFOVIR ANHYDROUS
+BMGC_DG12964,BMG_DG171229,CAS RN:18493-30-6 | METOCHALCONE | UNII:1754ZE4075 | PubChem CID:6063342 | PubChem SID:198990387
+BMGC_DG12965,BMG_DG171238,"DrugBank ID:DB00906 | CAS RN:115103-54-3 | TIAGABINE | (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid | PubChem SID:175268881 | Tiagabine | PubChem CID:60648 | UNII:Z80I64HMNP | CAS RN:1006863-69-9"
+BMGC_DG12966,BMG_DG171240,"MARBOFLOXACIN | PubChem SID:175265386 | 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid | DrugBank ID:DB11426 | PubChem CID:60651 | UNII:8X09WU898T | Marbofloxacin | CAS RN:115550-35-1"
+BMGC_DG12967,BMG_DG171241,"PubChem SID:346540539 | UNII:090Y06W08H | CAS RN:172282-43-8 | PubChem SID:346538432 | Liarozole | DrugBank ID:DB13066 | 6-[(3-chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole | LIAROZOLE | CAS RN:171849-18-6 | UNII:17NYD2210B | UNII:K0Q29TGV9Y | LIAROZOLE, (+)- | CAS RN:115575-11-6 | PubChem SID:198944160 | LIAROZOLE, (-)- | PubChem CID:60652"
+BMGC_DG12968,BMG_DG171245,LEVOBETAXOLOL HYDROCHLORIDE | (2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride | UNII:8MR4W4O06J | PubChem CID:60656 | Levobetaxolol Hydrochloride | CAS RN:116209-55-3 | PubChem SID:198952791
+BMGC_DG12969,BMG_DG171246,DrugBank ID:DB09351 | PubChem SID:198967634 | UNII:75O9XHA4TU | LEVOBETAXOLOL | (2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol | CAS RN:93221-48-8 | Levobetaxolol | PubChem CID:60657
+BMGC_DG12970,BMG_DG171249,"DrugBank ID:DB01388 | PubChem SID:198963086 | UNII:27B90X776A | Mibefradil | [(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate | CAS RN:116644-53-2 | PubChem CID:60663 | MIBEFRADIL"
+BMGC_DG12971,BMG_DG171252,"CAS RN:117091-64-2 | Etopophos | PubChem CID:60668 | [4-[(5S,5aR,8aR,9R)-5-[(7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy]-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-9-yl]-2,6-dimethoxyphenyl] dihydrogen phosphate"
+BMGC_DG12972,BMG_DG171254,Penthienate | PubChem SID:198987041 | UNII:6LCT38OJV9 | PubChem CID:6067 | 2-(2-cyclopentyl-2-hydroxy-2-thiophen-2-ylacetyl)oxyethyl-diethyl-methylazanium | DrugBank ID:DB13695 | CAS RN:22064-27-3 | PENTHIENATE
+BMGC_DG12973,BMG_DG171263,CAS RN:117796-52-8 | UNII:GA60WRR45J | SCH-37370 | PubChem SID:198952725 | PubChem CID:60680
+BMGC_DG12974,BMG_DG171269,BESIPIRDINE | PubChem CID:60691 | PubChem SID:198969282 | CAS RN:119257-34-0 | UNII:95PY16J933
+BMGC_DG12975,BMG_DG171271,"SEZOLAMIDE | Sezolamide | PubChem SID:198958989 | (4S)-4-(2-methylpropylamino)-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide | PubChem CID:60693 | UNII:FC9C0XB7D4 | CAS RN:123308-22-5"
+BMGC_DG12976,BMG_DG171275,"NDC:0078-0674 | NDC:16729-151 | NDC:66758-101 | NDC:63323-762 | UNII:956S425ZCY | NDC:45963-615 | NDC:0078-0673 | TOPOTECAN HYDROCHLORIDE | Topotecan Hydrochloride | CAS RN:119413-54-6 | PubChem CID:60699 | PubChem SID:175266672 | NDC:0078-0672 | NDC:0409-0302 | NDC:66758-102 | (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione;hydrochloride"
+BMGC_DG12977,BMG_DG171277,"VERATRAMINE | UNII:RK363YG315 | CAS RN:60-70-8 | PubChem SID:198989723 | PubChem CID:6070 | (2S,3R,5S)-2-[(1S)-1-[(3S,6aR,11aS,11bR)-3-hydroxy-10,11b-dimethyl-1,2,3,4,6,6a,11,11a-octahydrobenzo[a]fluoren-9-yl]ethyl]-5-methylpiperidin-3-ol | Veratramine"
+BMGC_DG12978,BMG_DG171278,"DrugBank ID:DB01030 | CAS RN:123948-87-8 | TOPOTECAN | UNII:7M7YKX2N15 | PubChem CID:60700 | Topotecan | PubChem SID:175266050 | (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione | NDC:16729-243"
+BMGC_DG12979,BMG_DG171281,Eliprodil | CAS RN:119431-25-3 | PubChem SID:472422564 | 1-(4-chlorophenyl)-2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]ethanol | UNII:YW62A6TW29 | ELIPRODIL | DrugBank ID:DB12869 | PubChem CID:60703
+BMGC_DG12980,BMG_DG171282,5-chloro-2-hydroxy-3-(thiophene-2-carbonyl)indole-1-carboxamide | UNII:9K7CJ74ONH | DrugBank ID:DB13481 | PubChem SID:198938260 | TENIDAP | CAS RN:120210-48-2 | Tenidap | PubChem CID:60712
+BMGC_DG12981,BMG_DG171284,"NDC:0270-1111 | PubChem CID:60714 | DrugBank ID:DB00597 | PubChem SID:175267769 | CAS RN:120066-54-8 | GADOTERIDOL | 2-[4,7-bis(carboxylatomethyl)-10-(2-hydroxypropyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+) | Gadoteridol | UNII:0199MV609F"
+BMGC_DG12982,BMG_DG171287,CAS RN:24683-20-3 | SACCHARIN N-(2-ACETIC ACID ETHYL ESTER) | PubChem CID:607195 | PubChem SID:198967540 | UNII:KN712V27AV
+BMGC_DG12983,BMG_DG171288,"Phlorizin | CAS RN:60-81-1 | CAS RN:112318-65-7 | PHLORIZIN | NDC:44911-0509 | PubChem SID:175267865 | 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one | UNII:CU9S17279X | PubChem CID:6072"
+BMGC_DG12984,BMG_DG171290,CAS RN:91714-94-2 | PubChem SID:175268177 | UNII:864P0921DW | 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid | Bromfenac | BROMFENAC | PubChem CID:60726 | DrugBank ID:DB00963
+BMGC_DG12985,BMG_DG171293,CAS RN:120656-74-8 | PubChem SID:198955926 | Trefentanil | TREFENTANIL | DrugBank ID:DB09181 | PubChem CID:60728 | UNII:36QM58LVGU
+BMGC_DG12986,BMG_DG171297,"Celgosivir | PubChem CID:60734 | DrugBank ID:DB06580 | PubChem SID:198952779 | CELGOSIVIR | UNII:895VG117HN | [(1S,6S,7S,8R,8aR)-1,7,8-trihydroxy-1,2,3,5,6,7,8,8a-octahydroindolizin-6-yl] butanoate | CAS RN:121104-96-9"
+BMGC_DG12987,BMG_DG171305,"PubChem CID:60748 | Pivanex | CAS RN:37380-45-3 | UNII:55VNK5440P | butanoyloxymethyl 2,2-dimethylpropanoate | PubChem SID:198968196 | CAS RN:122110-53-6 | AN-9 | DrugBank ID:DB05103"
+BMGC_DG12988,BMG_DG171306,"PubChem SID:175266584 | NDC:0409-0183 | NDC:63323-102 | NDC:71288-114 | NDC:71288-117 | NDC:67457-618 | NDC:67457-617 | GEMCITABINE HYDROCHLORIDE | PubChem CID:60749 | NDC:50742-496 | NDC:0409-0181 | NDC:50742-498 | NDC:82511-009 | NDC:16729-423 | NDC:82511-008 | 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride | NDC:68001-359 | UNII:U347PV74IL | NDC:68083-148 | NDC:16729-426 | NDC:63323-126 | NDC:50742-497 | NDC:55111-687 | NDC:0409-0187 | NDC:72485-222 | NDC:67457-616 | NDC:72485-221 | NDC:63323-125 | NDC:16729-391 | NDC:68083-149 | NDC:68001-342 | NDC:16714-930 | Gemcitabine Hydrochloride | NDC:0409-0182 | NDC:55111-686 | CAS RN:122111-03-9 | NDC:72485-223 | NDC:0409-0186 | NDC:16714-909 | NDC:16729-419 | NDC:25021-234 | NDC:25021-235 | NDC:68001-348 | NDC:71288-113 | NDC:0409-0185"
+BMGC_DG12989,BMG_DG171307,PECAZINE | PubChem SID:198951727 | PubChem CID:6075 | UNII:PH34873A38 | CAS RN:60-89-9
+BMGC_DG12990,BMG_DG171308,"GEMCITABINE | Gemcitabine | PubChem CID:60750 | CAS RN:103882-84-4 | PubChem SID:175265804 | DrugBank ID:DB00441 | NDC:0143-9394 | NDC:0143-9395 | 4-amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | UNII:B76N6SBZ8R | CAS RN:95058-81-4"
+BMGC_DG12991,BMG_DG171309,"UNII:FU21S769PF | TEMOPORFIN | Temoporfin | 3-[10,15,20-tris(3-hydroxyphenyl)-2,3,22,24-tetrahydroporphyrin-5-yl]phenol | CAS RN:122341-38-2 | DrugBank ID:DB11630 | PubChem SID:198976280 | PubChem CID:60751"
+BMGC_DG12992,BMG_DG171310,IBUTILIDE | N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide | PubChem CID:60753 | CAS RN:122647-31-8 | CAS RN:100632-81-3 | DrugBank ID:DB00308 | PubChem SID:175271390 | CAS RN:130350-52-6 | Ibutilide | UNII:2436VX1U9B
+BMGC_DG12993,BMG_DG171311,2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate;gadolinium(3+);hydrate | Gadodiamide hydrate | CAS RN:122795-43-1 | PubChem CID:60754
+BMGC_DG12994,BMG_DG171315,"NDC:17089-233 | NDC:57955-3721 | ADENOSINE CYCLIC PHOSPHATE | NDC:57955-2808 | NDC:57955-2714 | NDC:43742-2203 | NDC:43742-0756 | NDC:64578-0179 | NDC:17089-501 | PubChem SID:175265303 | CAS RN:60-92-4 | (4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol | NDC:17089-231 | NDC:64578-0099 | NDC:43742-1262 | UNII:E0399OZS9N | CAS RN:114697-05-1 | NDC:43857-0023 | DrugBank ID:DB02527 | NDC:43742-1625 | NDC:57955-2806 | NDC:57955-2807 | NDC:78892-0001 | NDC:57955-2712 | NDC:57955-2810 | NDC:57955-2722 | NDC:75053-0008 | Cyclic adenosine monophosphate | NDC:57955-0756 | NDC:64578-0090 | NDC:64578-0155 | NDC:57955-0762 | PubChem CID:6076 | NDC:64578-0172 | NDC:64578-0173 | Adenosine cyclic phosphate | NDC:17089-502 | NDC:43742-2220 | NDC:57955-3720 | NDC:43742-1948 | NDC:64578-0177 | NDC:57955-2813 | NDC:64578-0175 | NDC:43742-1201 | NDC:57955-3724 | NDC:64578-0146"
+BMGC_DG12995,BMG_DG171319,"PubChem SID:198935044 | ENADOLINE | UNII:KJL283326C | CAS RN:124378-77-4 | 2-(1-benzofuran-4-yl)-N-methyl-N-[(5R,7S,8S)-7-pyrrolidin-1-yl-1-oxaspiro[4.5]decan-8-yl]acetamide | PubChem CID:60768 | Enadoline"
+BMGC_DG12996,BMG_DG171323,PubChem CID:6077 | PubChem SID:175267811 | 1-[10-[3-(dimethylamino)propyl]phenothiazin-2-yl]ethanone | UNII:54EJ303F0R | DrugBank ID:DB01614 | CAS RN:61-00-7 | ACEPROMAZINE | Acepromazine
+BMGC_DG12997,BMG_DG171326,Valaciclovir | PubChem CID:60773 | DrugBank ID:DB00577
+BMGC_DG12998,BMG_DG171327,PubChem SID:441659616 | CAS RN:124937-53-7 | (S)-TOLTERODINE | (S)-Tolterodine | UNII:UWD7V7S6JT | PubChem CID:60774 | 2-[(1S)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
+BMGC_DG12999,BMG_DG171328,UNII:I2MJ13SOFO | PubChem SID:346538368 | PubChem CID:60775 | RO-244736 | CAS RN:125030-71-9
+BMGC_DG13000,BMG_DG171331,"Navelbine (TN) | (2R,3R)-2,3-dihydroxybutanedioic acid;methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(12S)-16-ethyl-12-methoxycarbonyl-1,10-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8,15-pentaen-12-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | CAS RN:125317-39-7 | PubChem CID:60779"
+BMGC_DG13001,BMG_DG171338,"Fananserin | 3-[3-[4-(4-fluorophenyl)piperazin-1-yl]propyl]-2lambda6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4,6,8(12),9-pentaene 2,2-dioxide | UNII:38QJ762ET6 | PubChem CID:60785 | PubChem SID:198976575 | FANANSERIN | CAS RN:127625-29-0"
+BMGC_DG13002,BMG_DG171339,PubChem CID:60786 | Lobucavir | DrugBank ID:DB12531
+BMGC_DG13003,BMG_DG171342,"PubChem CID:60789 | ARBUTAMINE | Arbutamine | 4-[(1R)-1-hydroxy-2-[4-(4-hydroxyphenyl)butylamino]ethyl]benzene-1,2-diol | UNII:B07L15YAEV | CAS RN:128470-16-6 | PubChem SID:198953325 | DrugBank ID:DB01102"
+BMGC_DG13004,BMG_DG171348,"DrugBank ID:DB12352 | BIZELESIN | CAS RN:129655-21-6 | Bizelesin | 1,3-bis[2-[(8S)-8-(chloromethyl)-4-hydroxy-1-methyl-7,8-dihydro-3H-pyrrolo[3,2-e]indole-6-carbonyl]-1H-indol-5-yl]urea | UNII:L0O9OBI87E | PubChem CID:60794 | PubChem SID:198938512"
+BMGC_DG13005,BMG_DG171350,"NDC:70771-1451 | NDC:31722-921 | CAS RN:24-29-3 | PubChem SID:175268557 | NDC:46708-261 | NDC:60687-179 | NDC:31722-830 | NDC:33342-126 | NDC:43598-555 | NDC:50268-089 | NDC:60687-168 | NDC:65162-896 | NDC:16729-281 | NDC:72578-107 | NDC:43547-304 | NDC:50228-325 | NDC:76483-101 | NDC:31722-920 | NDC:16714-141 | ARIPIPRAZOLE | NDC:67877-435 | PubChem CID:60795 | NDC:60505-2673 | NDC:72865-154 | NDC:71205-392 | NDC:15370-401 | NDC:82009-088 | NDC:50090-6063 | NDC:50090-7125 | NDC:71335-1893 | NDC:17856-0570 | NDC:27241-055 | NDC:29300-175 | NDC:16714-145 | NDC:50268-087 | NDC:62332-098 | NDC:70518-0970 | NDC:16729-280 | NDC:50090-6563 | NDC:50228-324 | NDC:65162-899 | NDC:43547-888 | NDC:43547-884 | NDC:50090-4936 | NDC:50268-088 | NDC:72189-456 | CAS RN:1026778-41-5 | NDC:76483-100 | NDC:59148-008 | NDC:0904-7368 | NDC:62332-100 | NDC:43598-968 | NDC:50090-4665 | NDC:70518-2820 | NDC:62332-102 | NDC:13668-219 | NDC:71335-1980 | NDC:65162-898 | NDC:43598-966 | NDC:60687-213 | NDC:70771-1453 | NDC:15370-403 | DrugBank ID:DB01238 | NDC:0904-7369 | NDC:43547-886 | NDC:63629-7774 | UNII:82VFR53I78 | NDC:50090-7105 | NDC:60505-2675 | NDC:68788-7063 | NDC:67877-433 | NDC:43547-306 | NDC:43547-885 | NDC:70518-2806 | NDC:46708-255 | NDC:13668-217 | NDC:50228-328 | NDC:71335-0412 | NDC:29300-180 | NDC:71335-1513 | NDC:72789-462 | NDC:60687-202 | NDC:31722-919 | NDC:0615-8525 | NDC:0904-7371 | NDC:43547-887 | NDC:50228-477 | NDC:70518-3090 | NDC:50090-6403 | NDC:71205-480 | NDC:72189-466 | NDC:76282-044 | NDC:43547-307 | NDC:13668-221 | NDC:65162-893 | NDC:68788-8502 | NDC:65862-665 | NDC:27241-056 | NDC:43598-557 | NDC:50228-331 | NDC:46708-257 | NDC:72578-106 | NDC:0904-6510 | NDC:50268-092 | NDC:43547-303 | NDC:63739-069 | NDC:13668-220 | NDC:68382-086 | NDC:71335-1682 | Aripiprazole | NDC:63629-7003 | NDC:59148-034 | NDC:31722-827 | NDC:59148-011 | NDC:16714-144 | NDC:63739-070 | NDC:33342-125 | NDC:70518-2163 | NDC:68788-8089 | NDC:71335-1935 | NDC:70518-0896 | NDC:82009-091 | NDC:82804-023 | NDC:71335-1687 | NDC:29300-176 | NDC:50228-476 | NDC:27241-053 | NDC:63187-965 | NDC:50268-090 | NDC:59148-030 | NDC:67877-431 | NDC:43598-559 | NDC:65162-897 | NDC:60687-157 | NDC:68382-082 | NDC:27241-051 | NDC:16714-142 | NDC:59148-009 | NDC:72189-455 | NDC:50228-480 | NDC:0904-6512 | NDC:50228-478 | NDC:43547-302 | NDC:46708-256 | NDC:71335-1515 | NDC:59148-114 | NDC:62332-101 | NDC:68788-7733 | NDC:29300-179 | NDC:16729-282 | NDC:17856-0100 | NDC:43598-554 | NDC:62332-097 | NDC:0904-6511 | NDC:27241-054 | NDC:68788-7749 | NDC:43598-733 | NDC:69452-339 | NDC:65862-662 | NDC:76483-103 | NDC:65862-666 | NDC:67877-434 | NDC:59148-007 | NDC:72865-182 | NDC:82009-089 | NDC:65162-902 | NDC:70771-1456 | NDC:31722-684 | NDC:68382-085 | NDC:29300-178 | NDC:29300-177 | NDC:43598-558 | NDC:0904-7366 | NDC:70518-2897 | NDC:76282-045 | NDC:43598-967 | NDC:50228-475 | NDC:59651-110 | NDC:68382-439 | NDC:59148-010 | NDC:72865-155 | NDC:50090-7485 | NDC:43547-305 | NDC:72865-185 | NDC:50228-479 | NDC:16729-279 | NDC:60687-191 | NDC:70771-1452 | NDC:50268-091 | 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one | NDC:76282-046 | NDC:72603-445 | NDC:59148-031 | NDC:76282-049 | NDC:0904-6656 | NDC:71335-1892 | NDC:33342-122 | NDC:63629-7108 | NDC:68382-083 | NDC:59148-006 | NDC:70518-2869 | NDC:65862-664 | NDC:31722-829 | NDC:68382-084 | NDC:13668-218 | NDC:72865-158 | NDC:63739-078 | NDC:31722-922 | NDC:46708-259 | NDC:50228-330 | NDC:43598-970 | NDC:46708-254 | NDC:43598-969 | NDC:66689-735 | NDC:72865-183 | NDC:31722-819 | NDC:43547-889 | NDC:72865-153 | NDC:70518-2974 | NDC:72189-476 | NDC:72865-156 | NDC:31722-828 | NDC:62332-103 | NDC:70518-4107 | NDC:59148-029 | NDC:63739-074 | NDC:71335-1903 | NDC:72865-180 | NDC:16714-146 | NDC:46708-258 | NDC:50228-326 | CAS RN:129722-12-9 | NDC:31722-924 | NDC:67877-432 | NDC:0615-8524 | NDC:60505-0404 | NDC:50228-327 | NDC:76282-047 | NDC:31722-923 | NDC:59148-102 | NDC:68788-7808 | NDC:0904-7367 | NDC:16729-278 | NDC:43598-556 | NDC:33342-127 | NDC:65162-901 | NDC:50090-4863 | NDC:33342-123 | NDC:67877-430 | NDC:43598-965 | NDC:69452-338 | NDC:72865-184 | NDC:70518-2580 | NDC:72888-100 | NDC:72162-2369 | NDC:67046-2050 | NDC:72865-157 | NDC:27241-052 | NDC:60505-2674 | NDC:0615-8375 | NDC:68071-3725 | NDC:13668-216 | NDC:16714-143 | NDC:43598-734 | NDC:15370-402 | NDC:50090-6409 | NDC:59148-032 | NDC:50228-329 | NDC:0904-7370 | NDC:16729-283 | NDC:33342-124 | NDC:62332-099 | NDC:65862-663 | NDC:71335-1364 | NDC:76483-102 | NDC:54838-570 | NDC:72865-181 | NDC:82009-090 | NDC:70771-1455 | NDC:65862-661 | NDC:70518-2536 | NDC:70771-1454 | NDC:46708-260 | NDC:59148-033 | NDC:76282-048 | NDC:62332-104 | NDC:71335-1832 | NDC:31722-820 | NDC:67046-1190"
+BMGC_DG13006,BMG_DG171351,"PubChem CID:60796 | (+)-Vorozole | VOROZOLE, (±)- | CAS RN:118949-22-7 | VOROZOLE, (+/-)- | UNII:7331QX0ML8 | 6-[(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole | PubChem SID:198945952"
+BMGC_DG13007,BMG_DG171359,"CAS RN:131262-82-3 | PubChem SID:198978728 | [(2R,3R,4R,5S)-3,4,5-tri(butanoyloxy)-1-butylpiperidin-2-yl]methyl butanoate | UNII:QXJ91425UL | Glycovir | PubChem CID:60807 | GLYCOVIR | DrugBank ID:DB13106"
+BMGC_DG13008,BMG_DG171360,"PubChem SID:198936656 | Xanomeline | DrugBank ID:DB15357 | PubChem CID:60809 | CAS RN:1018845-70-9 | UNII:9ORI6L73CJ | XANOMELINE | 3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole | CAS RN:131986-45-3"
+BMGC_DG13009,BMG_DG171364,CAS RN:132236-18-1 | ZIFROSILONE | PubChem CID:60811 | UNII:6275788O83 | PubChem SID:198966611
+BMGC_DG13010,BMG_DG171367,UNII:H1CGM4755H | 2-[4-[4-(4-chloropyrazol-1-yl)butyl]piperazin-1-yl]pyrimidine | LESOPITRON | DrugBank ID:DB04970 | CAS RN:132449-46-8 | PubChem CID:60813 | PubChem SID:198940297 | Lesopitron
+BMGC_DG13011,BMG_DG171368,methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate;hydrochloride | REMIFENTANIL HYDROCHLORIDE | NDC:63323-725 | NDC:72078-034 | UNII:5V444H5WIC | NDC:75834-230 | CAS RN:132539-07-2 | NDC:75834-232 | NDC:0143-9391 | NDC:72078-035 | PubChem SID:175268928 | Remifentanil Hydrochloride | PubChem CID:60814 | NDC:0143-9393 | NDC:63323-723 | NDC:63323-724 | NDC:75834-231 | NDC:67457-912 | NDC:67457-913 | NDC:67457-914 | NDC:0143-9392 | NDC:72078-036
+BMGC_DG13012,BMG_DG171370,DrugBank ID:DB00899 | PubChem SID:175267741 | PubChem CID:60815 | Remifentanil | REMIFENTANIL | methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate | CAS RN:132875-61-7 | UNII:P10582JYYK
+BMGC_DG13013,BMG_DG171372,DrugBank ID:DB02568 | Peldesine | PubChem CID:60817
+BMGC_DG13014,BMG_DG171375,"2-amino-1-(2,5-dimethoxyphenyl)propan-1-ol | PubChem CID:6082 | DrugBank ID:DB00723 | Methoxamine | CAS RN:390-28-3"
+BMGC_DG13015,BMG_DG171376,MAZAPERTINE | CAS RN:134208-17-6 | PubChem SID:198990810 | UNII:N0X1XW704P | PubChem CID:60820
+BMGC_DG13016,BMG_DG171377,"calcium;(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate | Tahor | CAS RN:134523-03-8 | CAS RN:363599-71-7 | PubChem SID:175267412 | PubChem CID:60822 | NDC:81016-0007 | UNII:C0GEJ5QCSO | CAS RN:1316891-47-0 | NDC:81016-0008 | ATORVASTATIN CALCIUM ANHYDROUS"
+BMGC_DG13017,BMG_DG171379,"NDC:50090-6333 | NDC:68788-8416 | CAS RN:134523-03-8 | Atorvastatin | (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid | NDC:75834-255 | ATORVASTATIN | NDC:68788-8298 | NDC:75834-257 | UNII:A0JWA85V8F | NDC:68071-2967 | NDC:50090-6334 | NDC:71335-9646 | CAS RN:134523-00-5 | DrugBank ID:DB01076 | CAS RN:110862-48-1 | NDC:75834-256 | NDC:70518-3791 | NDC:72189-531 | NDC:71335-2213 | PubChem SID:175267885 | NDC:82804-056 | PubChem CID:60823 | NDC:68788-8656 | NDC:72189-291 | NDC:75834-258 | NDC:70518-3783 | NDC:70518-3848"
+BMGC_DG13018,BMG_DG171381,"NDC:31722-753 | NDC:65862-036 | DrugBank ID:DB00709 | NDC:68180-602 | NDC:0904-6583 | NDC:65862-026 | NDC:33342-002 | NDC:43063-900 | NDC:60429-353 | NDC:31722-754 | NDC:49502-450 | NDC:71335-0639 | NDC:50742-624 | NDC:62135-706 | NDC:31722-001 | PubChem SID:175266982 | NDC:31722-506 | NDC:60505-3252 | NDC:72865-144 | NDC:57237-274 | 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one | NDC:69097-167 | NDC:70518-2070 | UNII:2T8Q726O95 | NDC:65862-055 | NDC:69097-166 | NDC:60505-3250 | NDC:31722-739 | Lamivudine | NDC:60687-720 | NDC:49702-202 | NDC:70518-3267 | NDC:49702-205 | NDC:31722-752 | CAS RN:134678-17-4 | NDC:60429-354 | NDC:71335-0141 | LAMIVUDINE | CAS RN:1117764-41-6 | NDC:66993-478 | NDC:65862-025 | PubChem CID:60825 | NDC:33342-001 | NDC:71335-1916 | NDC:0173-0662 | NDC:50742-623 | NDC:33342-003 | NDC:60505-3251 | NDC:76282-115 | CAS RN:136891-12-8 | NDC:49702-203 | NDC:49702-204"
+BMGC_DG13019,BMG_DG171390,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | CAS RN:67583-85-1 | ADENOSINE PHOSPHATE | CAS RN:136920-07-5 | PubChem SID:175265298 | DrugBank ID:DB00131 | UNII:415SHH325A | CAS RN:61-19-8 | CAS RN:122768-03-0 | Adenosine phosphate | Adenosine Phosphate | PubChem CID:6083 | CAS RN:53624-78-5"
+BMGC_DG13020,BMG_DG171391,"(9,9-Dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-hydroxy-2,2-dithiophen-2-ylacetate;bromide | PubChem CID:60830 | (9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-hydroxy-2,2-dithiophen-2-ylacetate;bromide | CAS RN:1352567-52-2"
+BMGC_DG13021,BMG_DG171393,NDC:68071-2711 | NDC:46708-278 | NDC:68382-387 | NDC:65841-801 | NDC:47335-617 | NDC:80425-0389 | NDC:60429-164 | NDC:57237-017 | NDC:82804-024 | Duloxetine Hydrochloride | NDC:70710-1537 | NDC:68001-596 | NDC:13668-110 | NDC:63187-457 | NDC:55700-727 | NDC:55700-628 | NDC:71205-005 | NDC:72162-1598 | NDC:51991-746 | NDC:47335-383 | NDC:50090-6406 | NDC:63187-702 | NDC:71610-401 | NDC:49252-007 | NDC:67877-265 | NDC:60429-165 | NDC:46708-280 | NDC:50090-6900 | NDC:76420-623 | NDC:63187-172 | NDC:68001-595 | NDC:80425-0119 | NDC:31722-169 | NDC:82009-032 | NDC:0228-2891 | NDC:51407-818 | NDC:51991-750 | NDC:50090-5940 | NDC:76420-633 | NDC:68788-8782 | NDC:68001-570 | NDC:76420-634 | NDC:60429-166 | NDC:67877-263 | NDC:59651-282 | NDC:33342-161 | NDC:59651-280 | NDC:82009-031 | NDC:70710-1539 | CAS RN:136434-34-9 | NDC:71335-0402 | NDC:80425-0013 | NDC:80425-0012 | NDC:60687-734 | NDC:68071-3766 | NDC:70518-1765 | NDC:43063-877 | NDC:55154-2341 | NDC:82009-029 | NDC:25000-608 | NDC:0002-3235 | NDC:47335-381 | NDC:63187-612 | NDC:0904-7043 | NDC:65841-800 | NDC:47335-616 | DULOXETINE HYDROCHLORIDE | NDC:33342-162 | NDC:0615-8496 | NDC:63187-720 | NDC:71610-403 | NDC:72789-338 | NDC:71205-525 | NDC:0615-8494 | NDC:67046-1253 | NDC:71610-739 | NDC:70247-013 | NDC:43353-960 | NDC:50090-6281 | NDC:47335-619 | NDC:71610-743 | NDC:47335-382 | NDC:68788-8362 | NDC:71335-1672 | NDC:71335-0509 | NDC:68001-415 | NDC:51991-748 | NDC:27241-097 | NDC:51655-237 | NDC:68382-385 | NDC:63629-1992 | UNII:9044SC542W | NDC:72162-1597 | NDC:68180-295 | NDC:43063-878 | NDC:71205-602 | NDC:71335-1445 | NDC:50090-6889 | NDC:80425-0086 | NDC:0904-7045 | NDC:49252-008 | NDC:68788-9301 | NDC:68001-368 | NDC:71335-0392 | NDC:60760-559 | NDC:68382-386 | NDC:71335-2537 | NDC:55154-2579 | NDC:68071-3775 | NDC:13668-111 | NDC:50771-203 | NDC:71205-358 | NDC:76420-236 | NDC:70247-012 | NDC:70518-1011 | NDC:80425-0146 | NDC:51991-747 | NDC:80425-0014 | NDC:46708-279 | NDC:67046-1250 | NDC:70518-1139 | NDC:0904-7044 | NDC:49252-009 | NDC:65841-799 | NDC:70247-014 | NDC:50771-201 | NDC:71205-445 | PubChem CID:60834 | NDC:0228-2892 | NDC:68788-7672 | NDC:27241-098 | NDC:50090-3205 | NDC:82009-030 | NDC:50090-2226 | NDC:83008-046 | NDC:71335-2017 | NDC:25000-610 | NDC:63629-1991 | NDC:70518-0122 | NDC:43547-379 | NDC:60687-745 | NDC:27241-099 | NDC:55154-2342 | NDC:57237-018 | NDC:51407-817 | NDC:25000-609 | NDC:63187-666 | NDC:68788-8608 | NDC:51407-819 | NDC:0002-3270 | NDC:68001-413 | NDC:63629-1990 | NDC:31722-170 | NDC:43547-380 | NDC:71335-1964 | NDC:68180-297 | NDC:50090-4708 | NDC:68001-414 | NDC:83008-040 | (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine;hydrochloride | NDC:71610-736 | NDC:72162-1600 | NDC:50090-6899 | NDC:63187-716 | NDC:68788-7935 | NDC:70518-0937 | NDC:70518-1054 | NDC:70710-1538 | NDC:71610-218 | NDC:63629-8748 | NDC:67877-264 | NDC:59651-279 | NDC:0002-3240 | NDC:60760-461 | NDC:60687-723 | NDC:68001-594 | PubChem SID:175267242 | NDC:0615-8495 | NDC:68180-294 | NDC:63187-735 | NDC:70518-3287 | NDC:71335-0165 | NDC:50771-202 | NDC:80425-0441 | NDC:13668-109 | NDC:70771-1345 | NDC:31722-168 | NDC:70771-1346 | NDC:43547-381 | NDC:55700-605 | NDC:57237-019 | NDC:80425-0311 | NDC:68180-296 | NDC:0228-2890 | NDC:63187-181 | NDC:72189-608 | NDC:72162-1599 | NDC:70771-1344 | NDC:63629-2063 | NDC:50090-6775 | NDC:43353-025 | NDC:68788-7897 | NDC:63629-9187 | NDC:43353-106 | NDC:50090-6893 | NDC:27241-164 | NDC:71610-402 | NDC:47335-618 | NDC:72162-1058 | NDC:76420-636 | NDC:33342-160 | NDC:68788-8623 | NDC:60760-951
+BMGC_DG13022,BMG_DG171394,PubChem CID:60835 | DULOXETINE | (3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine | UNII:O5TNM5N07U | CAS RN:116539-59-4 | DrugBank ID:DB00476 | Duloxetine | PubChem SID:175266131
+BMGC_DG13023,BMG_DG171396,"NDC:0143-9701 | NDC:55150-353 | NDC:16714-027 | NDC:72485-213 | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;trihydrate;hydrochloride | NDC:50742-402 | NDC:63323-193 | NDC:70700-170 | NDC:67184-0513 | NDC:70700-169 | NDC:25021-230 | NDC:55150-354 | NDC:0009-0082 | NDC:60505-6128 | NDC:0009-7529 | PubChem SID:175267792 | NDC:68001-480 | NDC:50742-401 | NDC:0009-0112 | NDC:55150-355 | NDC:45963-614 | NDC:0143-9583 | NDC:67184-0511 | NDC:16714-131 | NDC:68083-381 | NDC:67184-0512 | NDC:72485-212 | NDC:61703-349 | PubChem CID:60837 | CAS RN:136572-09-3 | IRINOTECAN HYDROCHLORIDE | NDC:55150-352 | NDC:68083-382 | NDC:72485-211 | NDC:0143-9702 | NDC:60505-6272 | Irinotecan Hydrochloride Hydrate | UNII:042LAQ1IIS | NDC:15054-0043"
+BMGC_DG13024,BMG_DG171397,"CAS RN:97682-44-5 | PubChem CID:60838 | IRINOTECAN | DrugBank ID:DB00762 | PubChem SID:175267352 | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate | Irinotecan | UNII:7673326042"
+BMGC_DG13025,BMG_DG171400,PubChem SID:198951900 | CAS RN:137159-92-3 | Aptiganel | APTIGANEL | UNII:46475LV84I | 1-(3-ethylphenyl)-1-methyl-2-naphthalen-1-ylguanidine | PubChem CID:60840
+BMGC_DG13026,BMG_DG171402,"(2S,3R)-3-(2-carboxyethylsulfanyl)-2-hydroxy-3-[2-(8-phenyloctyl)phenyl]propanoic acid | UNII:R2N8IH71HC | PubChem CID:60842 | CAS RN:107023-41-6 | POBILUKAST | PubChem SID:198969838 | Pobilukast"
+BMGC_DG13027,BMG_DG171403,NDC:67877-415 | NDC:71205-301 | NDC:76483-024 | NDC:46708-047 | NDC:55111-732 | NDC:50268-749 | NDC:0378-5814 | NDC:59746-360 | Valsartan | NDC:71335-0475 | NDC:71335-0567 | NDC:50268-747 | NDC:55111-731 | NDC:72336-910 | NDC:46708-044 | NDC:72819-183 | NDC:82868-010 | UNII:80M03YXJ7I | NDC:0078-0359 | NDC:43547-369 | NDC:82868-011 | NDC:31722-747 | NDC:67046-1142 | NDC:59746-361 | NDC:42291-859 | NDC:70771-1885 | NDC:60687-634 | NDC:51655-244 | NDC:31722-151 | NDC:72578-131 | NDC:70771-1883 | NDC:43547-367 | NDC:50228-132 | NDC:42291-857 | NDC:51660-143 | NDC:72189-550 | NDC:50090-2424 | NDC:31722-748 | NDC:72819-184 | NDC:65862-573 | NDC:51660-142 | NDC:65862-570 | NDC:53746-839 | DrugBank ID:DB00177 | NDC:33342-064 | NDC:71335-2152 | NDC:50090-6348 | NDC:60687-623 | NDC:0078-0358 | NDC:59746-362 | NDC:76483-025 | CAS RN:137863-60-6 | NDC:62332-046 | NDC:67877-417 | NDC:62332-047 | NDC:51660-140 | NDC:46708-046 | NDC:43353-067 | NDC:29300-234 | NDC:31722-745 | NDC:43353-066 | NDC:71335-2155 | NDC:51655-834 | NDC:71335-2154 | NDC:31722-746 | NDC:53746-838 | NDC:51655-653 | NDC:42291-856 | NDC:63187-655 | NDC:71335-2248 | NDC:50228-134 | CAS RN:137862-53-4 | NDC:72578-133 | NDC:51655-456 | NDC:65162-838 | NDC:70954-310 | NDC:50268-746 | PubChem CID:60846 | NDC:50090-5191 | NDC:51655-695 | NDC:50090-3108 | NDC:65162-840 | NDC:50228-135 | NDC:68180-276 | NDC:0078-0360 | NDC:65162-839 | NDC:0078-0423 | NDC:72819-181 | NDC:82804-154 | NDC:0378-5815 | NDC:31722-153 | NDC:50090-7312 | NDC:29300-233 | NDC:43547-370 | NDC:50090-6346 | NDC:72819-182 | NDC:53746-840 | NDC:50090-6347 | NDC:50090-2433 | NDC:62332-045 | NDC:76483-023 | NDC:33342-065 | NDC:29300-235 | NDC:43353-059 | NDC:76483-026 | NDC:65162-837 | NDC:72789-281 | NDC:0378-5807 | NDC:65862-571 | NDC:29300-232 | NDC:42291-858 | NDC:67877-418 | NDC:72578-132 | NDC:31722-152 | NDC:46708-045 | NDC:31722-154 | NDC:50090-5192 | NDC:43547-368 | NDC:71335-2151 | NDC:51660-141 | PubChem SID:175268476 | NDC:62332-044 | VALSARTAN | (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid | NDC:59746-363 | NDC:53746-837 | NDC:72578-134 | NDC:33342-063 | NDC:55111-733 | NDC:55111-734 | NDC:65862-572 | NDC:67877-416 | NDC:50090-5190 | NDC:50268-748 | NDC:70771-1884 | NDC:70771-1882 | NDC:60687-612 | NDC:33342-062 | NDC:50228-133 | NDC:71335-2308 | NDC:0378-5813
+BMGC_DG13028,BMG_DG171405,DrugBank ID:DB12264 | CAS RN:136816-75-6 | ATEVIRDINE | [4-[3-(ethylamino)pyridin-2-yl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone | PubChem SID:198954901 | UNII:N24015WC6D | PubChem CID:60848 | Atevirdine
+BMGC_DG13029,BMG_DG171409,DrugBank ID:DB00710 | Ibandronate | PubChem SID:175267950 | UNII:UMD7G2653W | Ibandronic Acid | [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid | PubChem CID:60852 | CAS RN:114084-78-5 | IBANDRONIC ACID
+BMGC_DG13030,BMG_DG171410,"NDC:0904-6270 | NDC:63739-005 | NDC:67046-1038 | NDC:67046-2031 | NDC:71335-0585 | NDC:63629-3331 | NDC:68071-3563 | NDC:59762-1006 | NDC:70518-2374 | NDC:55111-256 | NDC:60505-2531 | NDC:0781-2168 | NDC:33342-145 | NDC:65862-702 | NDC:16714-835 | NDC:70518-0782 | NDC:60505-2529 | UNII:216X081ORU | PubChem CID:60853 | NDC:33342-147 | NDC:60429-768 | NDC:16714-837 | NDC:55111-257 | NDC:16714-838 | NDC:70518-0787 | NDC:68001-451 | NDC:60429-765 | NDC:60429-767 | NDC:62135-991 | NDC:70518-1586 | NDC:59762-1012 | NDC:68084-104 | NDC:68001-453 | NDC:0049-0056 | 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride | NDC:63187-448 | NDC:70518-0757 | NDC:70771-1182 | NDC:65862-705 | NDC:0781-2167 | NDC:63187-168 | NDC:70518-1835 | NDC:16714-836 | NDC:33342-144 | NDC:68084-105 | NDC:0781-2166 | NDC:68001-452 | NDC:60505-2530 | NDC:71335-2236 | NDC:70771-1181 | NDC:60505-2528 | NDC:0904-6271 | NDC:0904-6272 | NDC:70518-2367 | ZIPRASIDONE HYDROCHLORIDE | NDC:50268-812 | NDC:59762-1008 | NDC:70518-2294 | NDC:70518-1604 | NDC:70518-0743 | NDC:70771-1179 | NDC:33342-146 | NDC:68001-450 | NDC:72578-128 | NDC:63629-6916 | NDC:62135-994 | NDC:63187-431 | NDC:0781-2164 | PubChem SID:175268099 | NDC:72578-125 | NDC:65862-704 | NDC:50268-811 | NDC:62135-993 | NDC:50090-5420 | Ziprasidone hydrochloride monohydrate | NDC:0049-0058 | NDC:59762-1014 | NDC:0904-6269 | NDC:65862-703 | NDC:68084-106 | NDC:63739-666 | CAS RN:138982-67-9 | NDC:72578-127 | NDC:68084-103 | NDC:55111-259 | NDC:70771-1180 | NDC:60429-766 | NDC:71335-9761 | NDC:63739-508 | NDC:72578-126 | NDC:50268-814 | NDC:62135-992 | NDC:63739-988 | NDC:50268-813 | NDC:63629-8150 | NDC:63187-578 | NDC:55111-258"
+BMGC_DG13031,BMG_DG171411,"NDC:0049-0356 | Ziprasidone | ZIPRASIDONE | PubChem CID:60854 | PubChem SID:175266373 | UNII:6UKA5VEJ6X | NDC:0049-0352 | DrugBank ID:DB00246 | NDC:0049-0354 | 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one | CAS RN:146939-27-7 | NDC:0049-0358"
+BMGC_DG13032,BMG_DG171412,"NDC:0173-0681 | UNII:L6O3XI777I | PubChem SID:175267628 | Zanamivir | CAS RN:139110-80-8 | DrugBank ID:DB00558 | (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid | PubChem CID:60855 | CAS RN:551942-41-7 | ZANAMIVIR"
+BMGC_DG13033,BMG_DG171413,"NDC:68462-500 | NDC:65862-914 | NDC:69097-864 | NDC:63629-9575 | CAS RN:139264-17-8 | NDC:62332-463 | NDC:64896-084 | NDC:68001-250 | NDC:45802-711 | NDC:68382-714 | NDC:68462-498 | NDC:60846-133 | NDC:64896-083 | NDC:62332-462 | NDC:69238-2352 | NDC:69238-2351 | NDC:72189-434 | PubChem CID:60857 | NDC:46708-463 | NDC:65841-766 | NDC:65841-765 | NDC:63548-0101 | CAS RN:139264-25-8 | NDC:65841-768 | NDC:59746-461 | (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]-1,3-oxazolidin-2-one | NDC:62332-182 | NDC:16571-803 | NDC:46708-182 | NDC:68462-499 | NDC:64896-681 | NDC:60846-130 | NDC:68462-497 | NDC:62332-181 | NDC:71626-101 | NDC:59746-462 | NDC:72189-435 | PubChem SID:175268483 | NDC:69097-863 | NDC:68382-712 | NDC:46708-462 | NDC:65862-915 | NDC:68001-249 | NDC:27241-022 | Zolmitriptan | NDC:46708-181 | DrugBank ID:DB00315 | NDC:16571-804 | NDC:65841-767 | NDC:71626-102 | NDC:68382-717 | ZOLMITRIPTAN | UNII:2FS66TH3YW | NDC:68382-715 | NDC:27241-021 | NDC:63548-0102 | NDC:55700-944"
+BMGC_DG13034,BMG_DG171414,2-[(3-iodophenyl)methyl]guanidine | DrugBank ID:DB06704 | Iobenguane | IOBENGUANE | 3-Iodobenzylguanidine | CAS RN:139755-80-9 | CAS RN:80663-95-2 | PubChem CID:60860 | PubChem SID:198981681 | UNII:35MRW7B4AD
+BMGC_DG13035,BMG_DG171416,"PubChem SID:198945533 | PubChem CID:60867 | 2-[[4-(4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl)phenyl]hydrazinylidene]propanedinitrile | CAS RN:131741-08-7 | SIMENDAN | UNII:349552KRHK | DrugBank ID:DB12286 | Simendan"
+BMGC_DG13036,BMG_DG171417,"Meticillin | PubChem SID:198935870 | (2S,5R,6R)-6-[(2,6-dimethoxybenzoyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | CAS RN:61-32-5 | UNII:Q91FH1328A | PubChem CID:6087 | DrugBank ID:DB01603 | METHICILLIN | Methicillin"
+BMGC_DG13037,BMG_DG171419,"PubChem SID:175268238 | NDC:60505-3947 | PubChem CID:60871 | CAS RN:142340-99-6 | Adefovir Dipivoxil | NDC:42794-003 | Adefovir dipivoxil | [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate | ADEFOVIR DIPIVOXIL | UNII:U6Q8Z01514 | DrugBank ID:DB00718"
+BMGC_DG13038,BMG_DG171423,PubChem CID:60876 | CAS RN:143393-27-5 | PubChem SID:198953867 | UNII:2NL79NI1WS | AZALANSTAT
+BMGC_DG13039,BMG_DG171424,"UNII:ULS8902U4O | NDC:59651-166 | NDC:69238-2093 | CAS RN:145213-48-5 | NDC:61958-0701 | NDC:67296-1433 | NDC:72189-403 | NDC:67296-1237 | NDC:70710-1365 | Emtricitabine | NDC:42291-439 | NDC:70771-1620 | PubChem SID:198935702 | NDC:70771-1622 | NDC:31722-560 | CAS RN:143491-57-0 | NDC:50090-6494 | NDC:42385-953 | PubChem SID:175265875 | NDC:60687-719 | NDC:70710-1364 | NDC:61958-0704 | NDC:69097-642 | NDC:64380-719 | DrugBank ID:DB00879 | NDC:70710-1367 | NDC:65862-354 | EMTRICITABINE | NDC:0378-1930 | NDC:67296-1895 | NDC:0093-7704 | NDC:68180-287 | PubChem CID:60877 | NDC:72189-312 | NDC:69097-741 | NDC:70518-3696 | NDC:69097-209 | NDC:69238-2092 | EMTRICITABINE, (+/-)- | NDC:67296-1830 | NDC:70518-0230 | NDC:67296-1459 | NDC:61958-1101 | NDC:16714-534 | NDC:61958-0703 | NDC:69238-2094 | EMTRICITABINE, (±)- | UNII:G70B4ETF4S | NDC:51407-112 | 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one | CAS RN:143491-54-7 | NDC:61958-0705 | NDC:71205-776 | NDC:60219-2095 | NDC:70771-1709 | NDC:42543-719 | NDC:68071-2112 | NDC:33342-106 | NDC:69238-2095 | NDC:70771-1621 | NDC:0904-7172 | NDC:76282-677 | NDC:82009-109 | NDC:59651-165 | NDC:59651-167 | NDC:67296-1440 | NDC:65862-301 | NDC:68071-3695 | NDC:70710-1366"
+BMGC_DG13040,BMG_DG171425,UNII:6FRL4L3Z7V | 2-(1H-indol-3-yl)-N-methylethanamine | CAS RN:61-49-4 | PubChem SID:312525005 | N-Methyltryptamine | PubChem CID:6088 | N-METHYLTRYPTAMINE
+BMGC_DG13041,BMG_DG171428,"DrugBank ID:DB01488 | 2-(1H-indol-3-yl)-N,N-dimethylethanamine | DIMETHYLTRYPTAMINE | PubChem CID:6089 | UNII:WUB601BHAA | CAS RN:61-50-7 | Dimethyltryptamine | PubChem SID:198948879"
+BMGC_DG13042,BMG_DG171434,"CAS RN:61-51-8 | DrugBank ID:DB01460 | N,N-DIETHYLTRYPTAMINE | PubChem SID:198956647 | N,N-diethyl-2-(1H-indol-3-yl)ethanamine | UNII:916E8V4S2V | PubChem CID:6090 | N,N-Diethyltryptamine | Diethyltryptamine"
+BMGC_DG13043,BMG_DG171439,PubChem CID:60910 | MIFOBATE | UNII:ZKA4OVV12E | CAS RN:76541-72-5 | PubChem SID:198941894
+BMGC_DG13044,BMG_DG171445,"DrugBank ID:DB01349 | 2,4-dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[2,3-d]pyrimidin-7-one | UNII:48G92V856H | TASOSARTAN | PubChem CID:60919 | Tasosartan | PubChem SID:198987382 | CAS RN:145733-36-4"
+BMGC_DG13045,BMG_DG171447,CAS RN:146623-69-0 | SAPRISARTAN | Saprisartan | UNII:HS64NG1G69 | DrugBank ID:DB01347 | PubChem CID:60921 | 3-[[3-bromo-2-[2-(trifluoromethylsulfonylamino)phenyl]-1-benzofuran-5-yl]methyl]-5-cyclopropyl-2-ethylimidazole-4-carboxamide | PubChem SID:198974632
+BMGC_DG13046,BMG_DG171448,"CAS RN:136668-42-3 | PubChem CID:60923 | Quiflapon | UNII:9295C885I4 | QUIFLAPON | 3-[3-tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-(quinolin-2-ylmethoxy)indol-2-yl]-2,2-dimethylpropanoic acid | PubChem SID:198977215"
+BMGC_DG13047,BMG_DG171451,"1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one | Niridazole | UNII:N116U8Y5QQ | DrugBank ID:DB13661 | PubChem SID:198960452 | PubChem CID:6093 | CAS RN:61-57-4 | NIRIDAZOLE"
+BMGC_DG13048,BMG_DG171454,CAS RN:62-33-9 | PubChem SID:175267981 | Edetate calcium disodium | DrugBank ID:DB14598 | CAS RN:23411-34-9 | EDETATE CALCIUM DISODIUM ANHYDROUS | UNII:8U5D034955 | calcium;disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate | PubChem CID:6093170
+BMGC_DG13049,BMG_DG171461,DrugBank ID:DB03227 | Nicotinamide Mononucleotide | PubChem CID:6093202
+BMGC_DG13050,BMG_DG171487,"SAQUINAVIR MESYLATE | (2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide;methanesulfonic acid | UNII:UHB9Z3841A | CAS RN:149845-06-7 | PubChem CID:60934 | Saquinavir Mesylate | PubChem SID:175267786"
+BMGC_DG13051,BMG_DG171491,disodium;[(4-chlorophenyl)sulfanyl-[hydroxy(oxido)phosphoryl]methyl]-hydroxyphosphinate | PubChem SID:175268442 | CAS RN:149845-07-8 | PubChem CID:60936 | TILUDRONATE DISODIUM | Tiludronate Disodium | UNII:BH6M93CIA0
+BMGC_DG13052,BMG_DG171493,PubChem SID:175265863 | PubChem CID:60937 | CAS RN:89987-06-4 | Tiludronic acid | [(4-chlorophenyl)sulfanyl-phosphonomethyl]phosphonic acid | DrugBank ID:DB01133 | UNII:6PNS59HP4Y | Tiludronic Acid | TILUDRONIC ACID
+BMGC_DG13053,BMG_DG171498,"UNII:C1GL8G6G0O | Relcovaptan | DrugBank ID:DB13929 | (2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2H-indole-2-carbonyl]pyrrolidine-2-carboxamide | RELCOVAPTAN | PubChem SID:198968262 | PubChem CID:60943 | CAS RN:150375-75-0"
+BMGC_DG13054,BMG_DG171500,NDC:25208-902 | PubChem CID:60946 | CAS RN:142373-60-2 | CAS RN:150915-40-5 | PubChem SID:175266327 | (2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid;hydrate;hydrochloride | NDC:25208-002 | NDC:55150-429 | NDC:68083-145 | NDC:25208-001 | Tirofiban Hydrochloride | NDC:14789-101 | NDC:25021-417 | NDC:55150-430 | UNII:6H925F8O5J | NDC:25208-901 | NDC:14789-102 | TIROFIBAN HYDROCHLORIDE
+BMGC_DG13055,BMG_DG171501,Tirofiban | TIROFIBAN | (2S)-2-(butylsulfonylamino)-3-[4-(4-piperidin-4-ylbutoxy)phenyl]propanoic acid | PubChem SID:175268199 | PubChem CID:60947 | UNII:GGX234SI5H | CAS RN:144494-65-5 | DrugBank ID:DB00775
+BMGC_DG13056,BMG_DG171503,"2-[2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-4,4-dimethylisoquinoline-1,3-dione | PubChem CID:609483 | UNII:M7H349ZZ5T | PubChem SID:198957878 | AR-C-239 | AR-C239 | CAS RN:67339-62-2"
+BMGC_DG13057,BMG_DG171507,"NDC:67877-459 | NDC:67877-458 | NDC:72485-204 | NDC:83774-101 | PubChem CID:60953 | UNII:6804DJ8Z9U | NDC:72205-006 | NDC:0093-7474 | NDC:72606-555 | NDC:62135-783 | NDC:82511-002 | NDC:68001-487 | NDC:70756-816 | NDC:31722-774 | NDC:62756-238 | NDC:72603-303 | NDC:68001-488 | NDC:0004-1100 | NDC:61269-475 | DrugBank ID:DB01101 | NDC:82009-112 | NDC:62756-239 | NDC:59923-721 | NDC:0004-1101 | NDC:16729-072 | CAPECITABINE | NDC:72485-205 | NDC:62135-784 | NDC:59651-205 | NDC:70756-815 | NDC:55111-496 | NDC:69539-020 | pentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate | NDC:82511-001 | NDC:83774-100 | NDC:16714-467 | NDC:69097-949 | Capecitabine | NDC:72606-554 | PubChem SID:175266338 | NDC:69539-019 | NDC:0093-7473 | NDC:59651-204 | NDC:61269-470 | NDC:69097-948 | CAS RN:154361-50-9 | NDC:51407-639 | NDC:51407-640 | NDC:72205-007 | NDC:55111-497 | NDC:16714-468 | NDC:31722-775 | NDC:60687-149 | NDC:16729-073"
+BMGC_DG13058,BMG_DG171510,"Lurtotecan | DrugBank ID:DB12222 | CAS RN:149882-10-0 | LURTOTECAN | PubChem SID:198982376 | UNII:4J1L80T08I | PubChem CID:60956 | (18S)-18-ethyl-18-hydroxy-2-[(4-methylpiperazin-1-yl)methyl]-6,9,20-trioxa-13,24-diazahexacyclo[12.11.0.03,12.05,10.015,24.017,22]pentacosa-1,3,5(10),11,13,15,17(22)-heptaene-19,23-dione"
+BMGC_DG13059,BMG_DG171514,"NDC:23155-258 | NDC:73590-0072 | NDC:73590-0048 | NDC:82160-719 | NDC:84037-0086 | NDC:84037-0030 | NDC:82083-0007 | NDC:73590-0054 | NDC:73590-0053 | NDC:82083-0010 | NDC:71217-0060 | NDC:84037-0025 | NDC:73590-0040 | NDC:84037-0048 | NDC:82083-0002 | NDC:68083-156 | NDC:73590-0081 | NDC:82083-0005 | NDC:82083-0013 | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | NDC:16714-556 | NDC:73509-040 | NDC:73590-0061 | NDC:70518-4207 | NDC:84037-0082 | NDC:82083-0026 | NDC:71217-0050 | NDC:83071-120 | NDC:84037-0031 | NDC:82083-0016 | NDC:73590-0022 | NDC:84037-0061 | NDC:84037-0072 | NDC:84037-0021 | NDC:72211-004 | NDC:63323-651 | NDC:68083-157 | PubChem SID:175267213 | NDC:55150-192 | NDC:73590-0033 | NDC:25021-301 | NDC:73590-0071 | NDC:73590-0049 | NDC:51662-1511 | NDC:82083-0018 | NDC:16714-997 | NDC:71217-0061 | NDC:73590-0073 | NDC:82083-0025 | NDC:51662-1631 | NDC:77964-003 | NDC:82083-0008 | NDC:84037-0034 | NDC:73590-0080 | NDC:82083-0014 | NDC:82083-0020 | NDC:42491-1100 | NDC:67457-854 | NDC:84037-0007 | NDC:84037-0024 | NDC:73509-010 | NDC:73590-0047 | NDC:83071-100 | NDC:67457-858 | NDC:73590-0034 | CAS RN:58-61-7 | NDC:82083-0012 | NDC:73590-0046 | NDC:82083-0004 | NDC:73590-0052 | NDC:67457-857 | NDC:51662-1201 | UNII:K72T3FS567 | NDC:73590-0037 | NDC:73590-0035 | NDC:77964-004 | NDC:51662-1450 | DrugBank ID:DB00640 | NDC:73590-0038 | Adenosine | NDC:83071-150 | NDC:84037-0022 | NDC:73590-0036 | NDC:77964-002 | NDC:73590-0078 | CAS RN:142796-17-6 | NDC:84037-0084 | NDC:73590-0077 | NDC:73590-0051 | NDC:73590-0039 | NDC:84037-0044 | CAS RN:133248-01-8 | NDC:84037-0049 | NDC:67457-856 | NDC:73590-0082 | NDC:83071-130 | NDC:67457-859 | NDC:73509-090 | NDC:73590-0074 | NDC:82083-0011 | NDC:0404-9993 | NDC:82083-0006 | NDC:82083-0009 | ADENOSINE | NDC:72078-033 | NDC:73590-0076 | NDC:73590-0023 | NDC:73590-0045 | PubChem CID:60961 | NDC:55150-193 | NDC:73590-0070 | NDC:82083-0001 | NDC:77964-006 | NDC:25021-318 | CAS RN:41547-82-4 | NDC:84037-0033 | NDC:73590-0031 | NDC:71872-7209 | CAS RN:109767-06-8 | NDC:51662-1643 | NDC:73509-020 | NDC:42491-1200 | NDC:67457-855 | NDC:82083-0022 | NDC:84037-0032 | NDC:51662-1632 | NDC:68083-101 | NDC:82083-0019 | NDC:51662-1345 | NDC:73590-0024 | NDC:84037-0042 | NDC:73590-0032 | NDC:71872-7335 | NDC:84037-0092 | NDC:73590-0079"
+BMGC_DG13060,BMG_DG171524,"N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE | DrugBank ID:DB06877 | PubChem CID:6096886"
+BMGC_DG13061,BMG_DG171535,"3-hydroxy-1,3-dihydroindol-2-one | 3-Hydroxyindolin-2-one | CAS RN:61-71-2 | PubChem CID:6097"
+BMGC_DG13062,BMG_DG171549,1-(-2-PHENETHYL)-4-PHENYL-4-ACETOXYPIPERIDINE | CAS RN:64-52-8 | PubChem CID:60977 | [4-phenyl-1-(2-phenylethyl)piperidin-4-yl] acetate | UNII:T6LN72I828 | PubChem SID:252320016 | 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine | DrugBank ID:DB01562
+BMGC_DG13063,BMG_DG171551,"DrugBank ID:DB01147 | PubChem SID:175266641 | CAS RN:61-72-3 | UNII:O6X5QGC2VB | Cloxacillin | CLOXACILLIN | (2S,5R,6R)-6-[[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem CID:6098"
+BMGC_DG13064,BMG_DG171554,Aroxybutynin | 4-(diethylamino)but-2-ynyl (2R)-2-cyclohexyl-2-hydroxy-2-phenylacetate | AROXYBUTYNIN | PubChem SID:252164925 | UNII:5BRQ29UUB7 | CAS RN:119618-21-2 | PubChem CID:6098167
+BMGC_DG13065,BMG_DG171558,"heptane-2,3-dione | PubChem SID:198949831 | PubChem CID:60983 | CAS RN:96-04-8 | 2,3-HEPTANEDIONE | UNII:DK55DDE86P | 2,3-Heptanedione"
+BMGC_DG13066,BMG_DG171568,CAS RN:152071-32-4 | METHYLENE BLUE ANHYDROUS | Methylene blue | Methylene Blue | CAS RN:61-73-4 | PubChem CID:6099 | CAS RN:12262-49-6 | DrugBank ID:DB09241 | CAS RN:97130-83-1 | PubChem SID:198936555 | [7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium;chloride | CAS RN:105504-42-5 | UNII:8NAP7826UB | NDC:42494-419
+BMGC_DG13067,BMG_DG171586,"NDC:11822-4330 | NDC:55910-961 | NDC:70000-0659 | NDC:51316-880 | NDC:63868-935 | NDC:21130-709 | NDC:67860-166 | NDC:68071-5018 | NDC:55319-666 | NDC:83324-169 | PubChem CID:6099959 | NDC:0869-0162 | NDC:83872-132 | NDC:36800-626 | NDC:49035-592 | NDC:83324-170 | NDC:41250-769 | MAGNESIUM CITRATE | Magnesium citrate | NDC:83986-164 | NDC:37808-673 | NDC:72476-001 | NDC:82645-310 | NDC:69842-763 | NDC:0363-0415 | NDC:71399-0051 | NDC:49035-329 | NDC:50804-164 | NDC:50804-166 | NDC:11822-4303 | NDC:0904-6787 | NDC:83872-135 | NDC:41250-708 | PubChem SID:175268887 | NDC:0904-7418 | NDC:41163-769 | NDC:63941-533 | NDC:49035-506 | NDC:55910-615 | NDC:70677-0053 | NDC:41163-709 | NDC:56062-264 | NDC:71399-0053 | NDC:46122-741 | NDC:69842-983 | NDC:56062-266 | UNII:RHO26O1T9V | NDC:0869-0166 | NDC:63868-929 | NDC:0363-7162 | NDC:11344-164 | NDC:0363-8164 | NDC:69842-647 | NDC:79481-0032 | NDC:70000-0661 | CAS RN:7779-25-1 | NDC:0363-0427 | NDC:36800-329 | NDC:72476-002 | NDC:53943-166 | NDC:82645-312 | NDC:21130-165 | NDC:0363-8166 | NDC:51316-882 | NDC:55301-166 | NDC:72036-002 | NDC:63941-162 | NDC:83986-162 | NDC:30142-164 | NDC:68016-696 | NDC:69256-311 | NDC:69452-389 | NDC:83986-166 | trimagnesium;2-hydroxypropane-1,2,3-tricarboxylate | NDC:63868-934 | NDC:68016-701 | NDC:11344-162 | NDC:70000-0660 | NDC:11344-166 | NDC:70677-1111 | NDC:49035-028 | NDC:30142-806 | NDC:70677-0051 | NDC:69452-391 | NDC:46122-740 | NDC:30142-899 | NDC:11673-708 | NDC:55319-126 | NDC:63941-516 | NDC:36800-709 | DrugBank ID:DB11110 | NDC:55319-029 | NDC:51316-881 | NDC:63868-018 | NDC:79481-0033 | NDC:55319-164 | NDC:37808-769 | NDC:36800-164 | Magnesium Citrate | NDC:49035-593 | NDC:76470-025 | NDC:69452-390 | CAS RN:3344-18-1 | NDC:0869-0164 | NDC:0363-0416 | NDC:79481-0034 | NDC:70677-1112 | NDC:55910-183 | NDC:37808-695 | NDC:82645-311"
+BMGC_DG13068,BMG_DG171590,UNII:1LR2578324 | PubChem CID:61002 | CAS RN:103-03-7 | PHENICARBAZIDE | PubChem SID:198945545
+BMGC_DG13069,BMG_DG171598,"Ajmaline | (1R,9R,10S,12R,13S,14R,16S,17S,18R)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol | PubChem CID:6100671 | PubChem SID:198939051 | CAS RN:4360-12-7 | UNII:1PON08459R | AJMALINE"
+BMGC_DG13070,BMG_DG171604,PubChem SID:198966749 | CAS RN:104-15-4 | p-Toluenesulfonic acid | DrugBank ID:DB03120 | CAS RN:25231-46-3 | PubChem CID:6101 | 4-methylbenzenesulfonic acid | 4-TOLUENESULFONIC ACID | UNII:QGV5ZG5741
+BMGC_DG13071,BMG_DG171618,"[(2R,3R,4S,5S)-2,3,4,5-tetrahydroxy-6-oxohexyl] dihydrogen phosphate | UNII:U2S53JF879 | DrugBank ID:DB11848 | aldehydo-D-mannose 6-phosphate | PubChem SID:198934968 | Mannose 6-phosphate | MANNOSE 6-PHOSPHATE | PubChem CID:6101690 | CAS RN:3672-15-9"
+BMGC_DG13072,BMG_DG171624,"PubChem CID:6101829 | PubChem SID:329903770 | CITALOPRAM, (R)- | UNII:1TH2C9NJHL | CAS RN:128196-02-1"
+BMGC_DG13073,BMG_DG171643,6-fluoro-2-(2-hydroxy-3-isobutoxy-phenyl)-1H-benzoimidazole-5-carboxamidine | DrugBank ID:DB06855 | PubChem CID:6102526
+BMGC_DG13074,BMG_DG171644,CRA_10762 | PubChem CID:6102594 | DrugBank ID:DB02366
+BMGC_DG13075,BMG_DG171646,DrugBank ID:DB07313 | 5-Methyl-2-[(phenylsulfonyl)amino]benzoic acid | 5-METHYL-2-((PHENYLSULFONYL)AMINO)BENZOIC ACID | PubChem SID:485663623 | CAS RN:138964-56-4 | 5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID | PubChem CID:6102684 | UNII:BQ6W7H7DKV
+BMGC_DG13076,BMG_DG171647,"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID | PubChem CID:6102685 | DrugBank ID:DB07322"
+BMGC_DG13077,BMG_DG171648,"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID | PubChem CID:6102686 | DrugBank ID:DB07323"
+BMGC_DG13078,BMG_DG171650,1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL | PubChem CID:6102690 | DrugBank ID:DB07119
+BMGC_DG13079,BMG_DG171651,DrugBank ID:DB06875 | CAS RN:550997-55-2 | PubChem CID:6102691 | ERB-196 | PubChem SID:348481091 | UNII:470CL5L4AC
+BMGC_DG13080,BMG_DG171653,"PubChem CID:6102708 | 4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE | DrugBank ID:DB07121"
+BMGC_DG13081,BMG_DG171655,"DrugBank ID:DB08608 | PubChem CID:6102761 | 4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE"
+BMGC_DG13082,BMG_DG171656,"PubChem CID:6102762 | (N-{4-[(Ethylanilino)sulfonyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide | (2R)-N-{4-[Ethyl(phenyl)sulfamoyl]-2-methylphenyl}-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide | DrugBank ID:DB08609 | (2R)-N-[4-[ethyl(phenyl)sulfamoyl]-2-methylphenyl]-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide"
+BMGC_DG13083,BMG_DG171657,PubChem CID:6102763 | N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE | DrugBank ID:DB08610
+BMGC_DG13084,BMG_DG171659,PubChem CID:6102781 | DrugBank ID:DB06928 | (2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID
+BMGC_DG13085,BMG_DG171660,"PubChem CID:6102788 | DrugBank ID:DB06958 | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE"
+BMGC_DG13086,BMG_DG171664,BIOTINOL-5-AMP | DrugBank ID:DB04651 | PubChem CID:6102809
+BMGC_DG13087,BMG_DG171666,5-[3-[(6-Benzoyl-1-propyl-2-naphthalenyl)oxy]propoxy]-1H-indole-1-acetic acid | 5-(3-((6-BENZOYL-1-PROPYL-2-NAPHTHALENYL)OXY)PROPOXY)-1H-INDOLE-1-ACETIC ACID | CAS RN:853652-40-1 | PubChem SID:485665700 | PubChem CID:6102812 | 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID | DrugBank ID:DB04689 | UNII:ZYD7UQ32SY
+BMGC_DG13088,BMG_DG171667,"DrugBank ID:DB07312 | 2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE | PubChem CID:6102820"
+BMGC_DG13089,BMG_DG171668,"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE | PubChem CID:6102821 | DrugBank ID:DB07321"
+BMGC_DG13090,BMG_DG171669,"PubChem CID:6102822 | N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE | DrugBank ID:DB07270"
+BMGC_DG13091,BMG_DG171670,"DrugBank ID:DB08244 | (1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE | PubChem CID:6102824"
+BMGC_DG13092,BMG_DG171672,"UNII:9DOW362Q29 | PubChem CID:6103 | Zoxazolamine | CAS RN:61-80-3 | ZOXAZOLAMINE | 5-chloro-1,3-benzoxazol-2-amine | PubChem SID:198963689"
+BMGC_DG13093,BMG_DG171683,"PubChem CID:6104 | CAS RN:12192-57-3 | Aurothioglucose | gold(1+);(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxane-2-thiolate | UNII:2P2V9Q0E78 | DrugBank ID:DB09121 | AUROTHIOGLUCOSE | PubChem SID:198982149"
+BMGC_DG13094,BMG_DG171690,"2,6-dimethylbenzenethiol | 2,6-Dimethylbenzenethiol | 2,6-DIMETHYLTHIOPHENOL | PubChem CID:61045 | UNII:3A223G78P4 | CAS RN:118-72-9 | PubChem SID:198947566"
+BMGC_DG13095,BMG_DG171692,2-(3-chloro-2-methylanilino)benzoic acid | PubChem CID:610479 | PubChem SID:198978934 | Tolfenamic acid | CAS RN:13710-19-5 | TOLFENAMIC ACID | DrugBank ID:DB09216 | UNII:3G943U18KM
+BMGC_DG13096,BMG_DG171700,"CAS RN:286411-09-4 | 7-CHLORO-2-PHENYL-1,8-NAPHTHYRIDIN-4-OL | 7-Chloro-2-phenyl-1,8-naphthyridin-4-ol | 7-chloro-2-phenyl-1H-1,8-naphthyridin-4-one | 7-Chloro-4-hydroxy-2-phenyl-1,8-naphthyridine | UNII:PS7TVL32LN | PubChem SID:485663626 | PubChem CID:6105572"
+BMGC_DG13097,BMG_DG171702,DrugBank ID:DB01897 | 2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride | PubChem CID:6105620
+BMGC_DG13098,BMG_DG171707,PubChem CID:6106 | Leucine | (2S)-2-amino-4-methylpentanoic acid | CAS RN:61-90-5 | UNII:GMW67QNF9C | CAS RN:71000-80-1 | PubChem SID:175268061 | LEUCINE | DrugBank ID:DB00149
+BMGC_DG13099,BMG_DG171712,UNII:NMZ23S4WRW | PubChem CID:610682 | CAS RN:22126-67-6 | PubChem SID:445500284 | .BETA.-NAPHAZOLINE
+BMGC_DG13100,BMG_DG171729,CAS RN:62-33-9 | PubChem SID:175267981 | PubChem CID:6109 | DrugBank ID:DB14598 | EDETATE CALCIUM DISODIUM ANHYDROUS | UNII:8U5D034955 | Edetate calcium disodium anhydrous | calcium;disodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate | Calcium disodium ethylenediaminetetraacetate
+BMGC_DG13101,BMG_DG171740,"CAS RN:25513-46-6 | 2-aminopentanedioic acid | DL-Glutamic acid | CAS RN:617-65-2 | CAS RN:53931-70-7 | PubChem SID:198965576 | CAS RN:49717-32-0 | GLUTAMIC ACID, DL- | UNII:61LJO5I15S | PubChem CID:611"
+BMGC_DG13102,BMG_DG171744,DrugBank ID:DB03650 | (3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One | PubChem CID:611002
+BMGC_DG13103,BMG_DG171757,DrugBank ID:DB00166 | 5-[(3R)-dithiolan-3-yl]pentanoic acid | CAS RN:1200-22-2 | PubChem SID:175265887 | PubChem CID:6112 | ARLIPOIC ACID | Lipoic acid | Arlipoic acid | UNII:VLL71EBS9Z
+BMGC_DG13104,BMG_DG171766,PubChem CID:61127 | CAS RN:488-47-1 | TETRABROMOCATECHOL | UNII:N642CPH23M | PubChem SID:198961556
+BMGC_DG13105,BMG_DG171779,4-Hydroxyxanthone | PubChem CID:611428 | CAS RN:14686-63-6 | 4-OXIDANYLXANTHEN-9-ONE | UNII:3DU8IL6F8E | PubChem SID:459055421 | 4-hydroxyxanthen-9-one
+BMGC_DG13106,BMG_DG171790,PubChem SID:198943504 | aniline | ANILINE | CAS RN:62-53-3 | UNII:SIR7XX2F1K | Aniline | PubChem CID:6115 | DrugBank ID:DB06728 | CAS RN:136260-71-4
+BMGC_DG13107,BMG_DG171802,CAS RN:62-54-4 | Calcium acetate | DrugBank ID:DB00258 | PubChem CID:6116 | UNII:Y882YXF34X | Calcium Acetate | PubChem SID:175268402 | calcium;diacetate | CALCIUM ACETATE
+BMGC_DG13108,BMG_DG171803,UNII:LY5IL94D3K | 2-MORPHOLINOETHANOL | 2-morpholin-4-ylethanol | PubChem CID:61163 | PubChem SID:272993979 | CAS RN:622-40-2 | 2-Morpholinoethanol | CAS RN:1320-96-3
+BMGC_DG13109,BMG_DG171822,CAS RN:765258-64-8 | CAS RN:62-57-7 | CAS RN:857402-27-8 | PubChem CID:6119 | DrugBank ID:DB02952 | 2-amino-2-methylpropanoic acid | CAS RN:65503-84-6 | 2-Aminoisobutyric acid | 2-aminoisobutyric acid | PubChem SID:198970878 | .ALPHA.-AMINOISOBUTYRIC ACID | UNII:1E7ZW41IQU
+BMGC_DG13110,BMG_DG171823,DrugBank ID:DB02526 | PubChem CID:6119062 | CRA_10655
+BMGC_DG13111,BMG_DG171824,CRA_10656 | PubChem CID:6119063 | DrugBank ID:DB04470
+BMGC_DG13112,BMG_DG171830,"PubChem SID:175271832 | CAS RN:849585-22-4 | CAS RN:26811-96-1 | NDC:37662-1060 | NDC:37662-1055 | CAS RN:50-21-5 | NDC:59469-024 | DrugBank ID:DB04398 | CAS RN:152-36-3 | Lactic Acid | NDC:37662-1057 | 2-hydroxypropanoic acid | NDC:37662-1053 | NDC:37662-1058 | PubChem CID:612 | CAS RN:598-82-3 | NDC:37662-1059 | NDC:58264-0017 | Lactic acid | NDC:0220-3034 | LACTIC ACID, DL- | NDC:37662-1056 | NDC:37662-1054 | UNII:3B8D35Y7S4 | NDC:0220-3037"
+BMGC_DG13113,BMG_DG171836,tert-Butyl formate | UNII:J5BC8DA85J | Tert-Butyloxycarbonyl Group | PubChem CID:61207 | DrugBank ID:DB02768 | tert-butyl formate | CAS RN:762-75-4 | Tert-butyl formate | TERT-BUTYL FORMATE | PubChem SID:474489491
+BMGC_DG13114,BMG_DG171853,UNII:873YNA60FY | Vanillin acetate | (4-formyl-2-methoxyphenyl) acetate | PubChem SID:198961312 | PubChem CID:61229 | CAS RN:881-68-5 | VANILLIN ACETATE | CAS RN:4736-37-2
+BMGC_DG13115,BMG_DG171875,"1,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-4,5-dihydroxycyclohexane-1-carboxylic acid | Cynarin | PubChem CID:6124212 | CAS RN:1884-24-8"
+BMGC_DG13116,BMG_DG171890,"UNII:079IIA2811 | octyl 3,4,5-trihydroxybenzoate | PubChem CID:61253 | CAS RN:1034-01-1 | Octyl Gallate | OCTYL GALLATE | PubChem SID:198964361"
+BMGC_DG13117,BMG_DG171906,"DrugBank ID:DB13720 | PubChem CID:6127 | 4-benzhydrylidene-1,1-dimethylpiperidin-1-ium | CAS RN:15394-62-4 | Diphemanil | DIPHEMANIL | UNII:Q26TX1UD0W | PubChem SID:175267463"
+BMGC_DG13118,BMG_DG171916,"UNII:409J2J96VR | CAS RN:117598-81-9 | Androstenedione | ANDROSTENEDIONE | DrugBank ID:DB01536 | PubChem CID:6128 | CAS RN:63-05-8 | (8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | PubChem SID:175268097"
+BMGC_DG13119,BMG_DG171929,PubChem SID:198958384 | CAS RN:63-25-2 | naphthalen-1-yl N-methylcarbamate | CAS RN:27636-33-5 | CAS RN:3197-92-0 | PubChem CID:6129 | Carbaryl | UNII:R890C8J3N1 | CARBARIL
+BMGC_DG13120,BMG_DG171940,"CAS RN:28633-45-6 | FERRIC CITRATE ANHYDROUS | PubChem SID:175267497 | 2-hydroxypropane-1,2,3-tricarboxylate;iron(3+) | CAS RN:3522-50-7 | CAS RN:6043-74-9 | DrugBank ID:DB09162 | CAS RN:2338-05-8 | UNII:63G354M39Z | PubChem CID:61300 | Ferric citrate"
+BMGC_DG13121,BMG_DG171949,"Cytidine-5'-Monophosphate | PubChem CID:6131 | [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | 5'-CYTIDYLIC ACID | PubChem SID:198948917 | 5'-Cytidylic acid | UNII:F469818O25 | CAS RN:63-37-6 | DrugBank ID:DB03403"
+BMGC_DG13122,BMG_DG171951,"UNII:1ZH821MXU5 | Cytidine Diphosphate | PubChem SID:313390166 | Cytidine-5'-Diphosphate | [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate | CAS RN:63-38-7 | PubChem CID:6132 | DrugBank ID:DB04555 | CAS RN:54394-90-0 | CAS RN:102601-46-7 | CYTIDINE 5'-DIPHOSPHATE"
+BMGC_DG13123,BMG_DG171958,"CAS RN:63-39-8 | UNII:UT0S826Z60 | PubChem CID:6133 | URIDINE 5'-TRIPHOSPHATE | CAS RN:108321-53-5 | Uridine 5'-triphosphate | PubChem SID:198964628 | DrugBank ID:DB04005 | [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate"
+BMGC_DG13124,BMG_DG171969,"(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol | PubChem CID:6134 | beta-Lactose | PubChem SID:198975889 | CAS RN:5965-66-2 | .BETA.-LACTOSE | UNII:13Q3A43E0S"
+BMGC_DG13125,BMG_DG171970,2-Benzofurancarboxaldehyde | UNII:DGQ01SIT6T | PubChem SID:198968741 | 1-benzofuran-2-carbaldehyde | CAS RN:4265-16-1 | PubChem CID:61341 | 2-FORMYLBENZOFURAN
+BMGC_DG13126,BMG_DG171975,UNII:C7JXC99E8F | CAS RN:4316-42-1 | PubChem SID:472410503 | 1-BUTYLIMIDAZOLE | PubChem CID:61347
+BMGC_DG13127,BMG_DG171984,3-butyl-3H-2-benzofuran-1-one | PubChem SID:198941360 | PubChem CID:61361 | CAS RN:6066-49-5 | DrugBank ID:DB12749 | BUTYLPHTHALIDE | UNII:822Q956KGM | Butylphthalide
+BMGC_DG13128,BMG_DG171988,CAS RN:63-68-3 | CAS RN:1006386-95-3 | CAS RN:3654-96-4 | PubChem CID:6137 | Methionine | PubChem SID:175265880 | DrugBank ID:DB00134 | METHIONINE | UNII:AE28F7PNPL | (2S)-2-amino-4-methylsulfanylbutanoic acid | CAS RN:58576-49-1
+BMGC_DG13129,BMG_DG171996,"Moracenin a | PubChem CID:6138419 | 8-[6-[2,4-dihydroxy-3-(3-methylbut-2-enyl)benzoyl]-5-(2,4-dihydroxyphenyl)-3-methylcyclohex-2-en-1-yl]-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one"
+BMGC_DG13130,BMG_DG172008,DrugBank ID:DB00120 | CAS RN:63-91-2 | PHENYLALANINE | CAS RN:30394-07-1 | UNII:47E5O17Y3R | NDC:43857-0439 | NDC:44911-0412 | Phenylalanine | (2S)-2-amino-3-phenylpropanoic acid | PubChem SID:175265565 | PubChem CID:6140
+BMGC_DG13131,BMG_DG172032,PubChem SID:318691973 | PubChem CID:6142670 | CAS RN:159651-91-9 | UNII:CI98RA0M97 | 8-HYDROXY-PIPAT
+BMGC_DG13132,BMG_DG172040,PubChem CID:6144 | CAS RN:64-02-8 | CAS RN:8013-51-2 | CAS RN:7379-28-4 | Edetate Sodium | tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate | NDC:84434-006 | EDETATE SODIUM | DrugBank ID:DB13404 | PubChem SID:175266430 | CAS RN:67401-50-7 | UNII:MP1J8420LU
+BMGC_DG13133,BMG_DG172042,TETRACHLOROPLATINATE(2-) | PubChem CID:61441 | CAS RN:13965-91-8 | UNII:Q9BRS9C9G3
+BMGC_DG13134,BMG_DG172072,"PubChem CID:61475 | PubChem SID:175266062 | Thiosulfuric acid, disodium salt, pentahydrate | NDC:60267-705 | NDC:73077-010 | UNII:HX1032V43M | disodium;dioxido-oxo-sulfanylidene-lambda6-sulfane;pentahydrate | CAS RN:10102-17-7 | SODIUM THIOSULFATE"
+BMGC_DG13135,BMG_DG172097,"LACTIC ACID, D- | PubChem SID:198956500 | CAS RN:10326-41-7 | DrugBank ID:DB03066 | (2R)-2-hydroxypropanoic acid | UNII:3Q6M5SET7W | PubChem CID:61503 | D-Lactic acid"
+BMGC_DG13136,BMG_DG172101,"MEBUTAMATE | [2-(carbamoyloxymethyl)-2,3-dimethylpentyl] carbamate | PubChem CID:6151 | PubChem SID:198958314 | UNII:5H8F175RER | Mebutamate | DrugBank ID:DB06797 | CAS RN:64-55-1"
+BMGC_DG13137,BMG_DG172172,"6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine | PubChem CID:616267 | PubChem SID:198978783 | UNII:1X8JI3451K | 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine | 1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)PIPERAZINE | CAS RN:60547-97-9"
+BMGC_DG13138,BMG_DG172184,PubChem SID:198935959 | NDC:37662-3314 | NDC:37662-3311 | NDC:37662-3317 | NDC:37662-3316 | NDC:37662-3318 | NDC:37662-3315 | gallium;trinitrate | NDC:37662-3313 | Gallium nitrate | NDC:37662-3312 | PubChem CID:61635 | CAS RN:13494-90-1 | UNII:Y2V2R4W9TQ | GALLIUM NITRATE ANHYDROUS | DrugBank ID:DB05260
+BMGC_DG13139,BMG_DG172203,N-(PHENYLMETHYL)-4-QUINAZOLINAMINE | UNII:Z1Q67P7111 | CAS RN:100818-54-0 | PubChem SID:459276143 | PubChem CID:616573
+BMGC_DG13140,BMG_DG172206,"UNII:40GP35YQ49 | (8S,9S,10R,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | CAS RN:64-85-7 | DESOXYCORTONE | PubChem SID:175267837 | Desoxycortone | PubChem CID:6166"
+BMGC_DG13141,BMG_DG172215,UNII:LL8JLO3GTI | PubChem CID:616651 | CAS RN:32003-14-8 | PubChem SID:459055285 | 4-(PHENYLMETHYL)-2H-PHTHALAZIN-1-ONE
+BMGC_DG13142,BMG_DG172217,"PubChem CID:6167 | PubChem SID:175265451 | UNII:SML2Y3J35T | UNII:7JX9WZ3SJ5 | N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide | Colchicine | CAS RN:64-86-8 | COLCHICINE CONFORMATIONAL ISOMER | CAS RN:30512-31-3 | PubChem SID:482554543 | Colchicine conformational isomer | DrugBank ID:DB08117 | COLCHICINE"
+BMGC_DG13143,BMG_DG172229,Chromous sulfate | PubChem CID:61686 | chromium(2+);sulfate | UNII:TR64E2WM7Z | CAS RN:13825-86-0 | CHROMOUS SULFATE | DrugBank ID:DB14530 | PubChem SID:198975979
+BMGC_DG13144,BMG_DG172230,"Yohimbine Hydrochloride | YOHIMBINE HYDROCHLORIDE | methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride | CAS RN:65-19-0 | UNII:NB2E1YP49F | PubChem CID:6169 | PubChem SID:175265991"
+BMGC_DG13145,BMG_DG172249,"Gallamine Triethiodide | DrugBank ID:DB00483 | 2-[2,3-bis[2-(triethylazaniumyl)ethoxy]phenoxy]ethyl-triethylazanium;triiodide | PubChem CID:6172 | Gallamine triethiodide | PubChem SID:198964775 | UNII:Q3254X40X2 | CAS RN:65-29-2 | GALLAMINE TRIETHIODIDE"
+BMGC_DG13146,BMG_DG172276,"PubChem CID:6175 | PubChem SID:198957111 | CYTIDINE | 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | CAS RN:65-46-3 | Cytidine | DrugBank ID:DB02097 | UNII:5CSZ8459RP"
+BMGC_DG13147,BMG_DG172280,"CAS RN:131016-01-8 | [[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | PubChem SID:241178456 | DrugBank ID:DB02431 | CAS RN:147258-10-4 | CYTIDINE TRIPHOSPHATE | Cytidine-5'-Triphosphate | CAS RN:65-47-4 | CAS RN:123334-07-6 | PubChem CID:6176 | UNII:K0118UX80T | CAS RN:81012-87-5 | Cytidine-5'-triphosphate"
+BMGC_DG13148,BMG_DG172298,PubChem SID:175267378 | DrugBank ID:DB01131 | Proguanil | CAS RN:500-92-5 | PROGUANIL | UNII:S61K3P7B2V | PubChem CID:6178111 | (1E)-1-[amino-(4-chloroanilino)methylidene]-2-propan-2-ylguanidine
+BMGC_DG13149,BMG_DG172308,CAS RN:29248-55-3 | 1-phenylethylhydrazine | Mebanazine | DrugBank ID:DB09248 | PubChem CID:6179 | CAS RN:65-64-5 | MEBANAZINE | PubChem SID:198985625 | UNII:Z5R55CJ4CG | CAS RN:30681-37-9
+BMGC_DG13150,BMG_DG172309,"DrugBank ID:DB01459 | PubChem CID:61791 | PubChem SID:198981446 | UNII:3KXW0Y310I | Bezitramide | 4-[4-(2-oxo-3-propanoylbenzimidazol-1-yl)piperidin-1-yl]-2,2-diphenylbutanenitrile | CAS RN:15301-48-1 | BEZITRAMIDE"
+BMGC_DG13151,BMG_DG172320,"PubChem CID:6181 | UNII:ST90Q60YF3 | PubChem SID:198951254 | CAS RN:66-02-4 | DIIODOTYROSINE, DL-"
+BMGC_DG13152,BMG_DG172321,PubChem CID:61810 | PubChem SID:198984697 | FENPROPOREX | CAS RN:16397-28-7 | DrugBank ID:DB01550 | UNII:W0194S5FOA | CAS RN:15686-61-0 | 3-(1-phenylpropan-2-ylamino)propanenitrile | Fenproporex
+BMGC_DG13153,BMG_DG172331,CAS RN:15469-97-3 | UNII:35J4FD3HV2 | PubChem SID:459275376 | DECHLOROCLOTRIMAZOLE | PubChem CID:618231
+BMGC_DG13154,BMG_DG172352,PubChem SID:198982095 | UNII:W5O632DN33 | CAS RN:66-28-4 | PubChem CID:6185 | STROPHANTHIDIN
+BMGC_DG13155,BMG_DG172373,UNII:RGS87T004B | 2-CHLOROTHIOXANTHONE | PubChem CID:618848 | PubChem SID:252164424 | CAS RN:86-39-5
+BMGC_DG13156,BMG_DG172376,"PubChem SID:461434304 | CAS RN:40230-24-8 | PubChem CID:619024 | 4,6-DIPHENYLPYRIMIDIN-2-AMINE | UNII:CD4YQ121L6"
+BMGC_DG13157,BMG_DG172402,"5-[bis(2-chloroethyl)amino]-1H-pyrimidine-2,4-dione | DrugBank ID:DB00791 | PubChem SID:198965829 | UNII:W7KQ46GJ8U | URACIL MUSTARD | PubChem CID:6194 | CAS RN:66-75-1 | Uracil mustard | Uracil Mustard"
+BMGC_DG13158,BMG_DG172407,CAS RN:66-77-3 | 1-Naphthaldehyde | CAS RN:30678-61-6 | PubChem SID:375579863 | 1-NAPHTHALDEHYDE | naphthalene-1-carbaldehyde | PubChem CID:6195 | UNII:H3I0B5F8SX
+BMGC_DG13159,BMG_DG172414,"(2S,5R,6R)-3,3-dimethyl-6-[(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem SID:175266996 | DrugBank ID:DB00713 | CAS RN:66-79-5 | Oxacillin | UNII:UH95VD7V76 | OXACILLIN | PubChem CID:6196 | CAS RN:1173-88-2"
+BMGC_DG13160,BMG_DG172415,"4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione | PubChem SID:198988774 | PubChem CID:6197 | UNII:98600C0908 | CAS RN:4630-75-5 | CAS RN:66-81-9 | CAS RN:1154-57-0 | Cycloheximide | CYCLOHEXIMIDE"
+BMGC_DG13161,BMG_DG172435,"PSORALEN | PubChem CID:6199 | Psoralen | PubChem SID:198985332 | furo[3,2-g]chromen-7-one | UNII:KTZ7ZCN2EX | CAS RN:66-97-7"
+BMGC_DG13162,BMG_DG172440,3-METHYLFENTANYL | UNII:QVU94XE61A | CAS RN:42045-86-3 | 3-Methylfentanyl | DrugBank ID:DB01571 | PubChem CID:61996 | PubChem SID:316909103 | N-[3-methyl-1-(2-phenylethyl)piperidin-4-yl]-N-phenylpropanamide
+BMGC_DG13163,BMG_DG172471,"UNII:67WJC4Y2QY | PubChem SID:198935017 | Brolamfetamine | 1-(4-bromo-2,5-dimethoxyphenyl)propan-2-amine | CAS RN:32156-26-6 | 4-Bromo-2,5-dimethoxyamphetamine | PubChem CID:62065 | DrugBank ID:DB01484 | CAS RN:64638-07-9 | BROLAMFETAMINE"
+BMGC_DG13164,BMG_DG172507,"DrugBank ID:DB09173 | Butyrfentanyl | UNII:07V1H7R6ZN | PubChem CID:621174 | PubChem SID:312525117 | Butanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]- | BUTYRFENTANYL | CAS RN:1169-70-6 | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide"
+BMGC_DG13165,BMG_DG172510,NDC:37662-0261 | chloroform | NDC:37662-0260 | NDC:37662-0263 | DrugBank ID:DB11387 | PubChem SID:175266878 | Chloroform | NDC:37662-0262 | NDC:37662-0265 | PubChem CID:6212 | CAS RN:67-66-3 | CHLOROFORM | UNII:7V31YC746X | NDC:37662-0259 | NDC:37662-0264
+BMGC_DG13166,BMG_DG172531,"NDC:51672-1356 | NDC:72162-2321 | NDC:13925-508 | NDC:63629-8656 | (1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | NDC:0713-0709 | CAS RN:67-73-2 | NDC:71428-002 | NDC:68611-180 | NDC:62559-288 | NDC:43386-069 | NDC:68791-102 | NDC:0713-0223 | NDC:0591-2990 | NDC:45802-485 | NDC:43538-900 | NDC:64980-330 | NDC:62559-289 | NDC:68462-591 | NDC:62559-299 | NDC:68611-190 | NDC:0299-5950 | NDC:43538-910 | NDC:68791-103 | Fluocinolone Acetonide | Fluocinolone acetonide | NDC:0168-0064 | NDC:72162-1412 | NDC:50090-6780 | NDC:65162-702 | NDC:72162-2319 | FLUOCINOLONE ACETONIDE | NDC:70752-159 | NDC:64980-329 | NDC:68462-185 | NDC:24208-416 | NDC:71879-136 | NDC:68462-590 | NDC:13925-507 | NDC:64980-331 | NDC:51672-1357 | NDC:65162-703 | PubChem SID:175266910 | NDC:51672-1365 | NDC:0713-0224 | NDC:63629-8655 | NDC:43538-940 | NDC:45802-887 | NDC:65162-704 | NDC:72162-2320 | NDC:63629-9584 | NDC:68791-101 | NDC:72162-1434 | NDC:21922-003 | PubChem CID:6215 | NDC:70752-156 | NDC:72162-1271 | NDC:70752-158 | UNII:0CD5FD6S2M | NDC:39328-079 | NDC:45802-009 | NDC:0168-0059 | DrugBank ID:DB00591"
+BMGC_DG13167,BMG_DG172535,CARFENTANIL | CAS RN:59708-52-0 | Carfentanil | PubChem SID:198942200 | UNII:LA9DTA2L8F | DrugBank ID:DB01535 | methyl 1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate | PubChem CID:62156
+BMGC_DG13168,BMG_DG172540,"TRIAMCINOLONE DIACETATE | UNII:A73MM2Q32P | CAS RN:67-78-7 | PubChem CID:6216 | [2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetyloxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | Triamcinolone Diacetate | PubChem SID:175265652"
+BMGC_DG13169,BMG_DG172564,"CAS RN:15091-04-0 | DrugBank ID:DB07073 | 5,5-DIMETHYL-2-MORPHOLIN-4-YL-4,6-DIHYDRO-1,3-BENZOTHIAZOL-7-ONE | PubChem SID:459055200 | PubChem CID:622262 | 5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one | UNII:QDN0FW2IO9"
+BMGC_DG13170,BMG_DG172566,"PubChem CID:6223 | Gliotoxin | CAS RN:67-99-2 | (1R,7S,8S,11R)-7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.01,9.03,8]pentadeca-3,5-diene-10,14-dione | UNII:5L648PH06K | GLIOTOXIN | PubChem SID:241180530"
+BMGC_DG13171,BMG_DG172572,"DrugBank ID:DB09154 | ANHYDROUS TRISODIUM CITRATE | CAS RN:994-36-5 | Sodium citrate | CAS RN:8055-55-8 | CAS RN:68-04-2 | PubChem CID:6224 | trisodium;2-hydroxypropane-1,2,3-tricarboxylate | PubChem SID:175266136 | Sodium Citrate | UNII:RS7A450LGA"
+BMGC_DG13172,BMG_DG172580,CANNABIVARIN | CAS RN:33745-21-0 | PubChem SID:438788914 | UNII:MHH8UW410N | PubChem CID:622545
+BMGC_DG13173,BMG_DG172583,CAS RN:71031-15-7 | (2S)-2-amino-1-phenylpropan-1-one | DrugBank ID:DB01560 | CATHINONE | Cathinone | UNII:540EI4406J | PubChem SID:198952971 | PubChem CID:62258
+BMGC_DG13174,BMG_DG172587,2-Bromoacetyl Group | UNII:2B3HS32431 | BROMOACETIC ACID | CAS RN:79-08-3 | 2-bromoacetic acid | Bromoacetic acid | DrugBank ID:DB02198 | PubChem SID:198973503 | PubChem CID:6227
+BMGC_DG13175,BMG_DG172597,"N,N-dimethylformamide | CAS RN:68-12-2 | DrugBank ID:DB01844 | N,N-Dimethylformamide | UNII:8696NH0Y2X | PubChem CID:6228 | N,N-DIMETHYLFORMAMIDE | PubChem SID:198970582"
+BMGC_DG13176,BMG_DG172598,alpha-Methylfentanyl | DrugBank ID:DB01557 | N-phenyl-N-[1-(1-phenylpropan-2-yl)piperidin-4-yl]propanamide | PubChem CID:62281 | .ALPHA.-METHYLFENTANYL | CAS RN:79704-88-4 | UNII:8FU589W85C | PubChem SID:472385925 | α-Methylfentanyl
+BMGC_DG13177,BMG_DG172603,DrugBank ID:DB01439 | PubChem CID:62296 | 3-METHYLTHIOFENTANYL | N-[3-methyl-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide | CAS RN:86052-04-2 | UNII:C9C204973M | PubChem SID:316915598 | 3-Methylthiofentanyl
+BMGC_DG13178,BMG_DG172605,"(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | NORETHINDRONE | NDC:50090-6161 | NDC:68180-876 | NDC:68180-877 | NDC:65862-925 | NDC:59651-136 | NDC:68462-305 | NDC:72789-439 | UNII:T18F433X4S | NDC:51862-884 | PubChem SID:175265282 | NDC:52544-629 | NDC:75907-075 | NDC:0480-3475 | NDC:0378-7292 | PubChem CID:6230 | Norethindrone | NDC:70518-4211 | DrugBank ID:DB00717 | NDC:51862-886 | NDC:71205-526 | NDC:63187-748 | NDC:79929-015 | NDC:75907-074 | NDC:50102-300 | NDC:0378-7272 | NDC:68462-303 | CAS RN:68-22-4 | Norethisterone"
+BMGC_DG13179,BMG_DG172606,P-FLUOROFENTANYL | p-Fluorofentanyl | N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | PubChem CID:62300 | DrugBank ID:DB09177 | UNII:I45R05QM0Z | 4-Fluorofentanyl | CAS RN:90736-23-5 | CAS RN:2747915-21-3 | PubChem SID:252319329
+BMGC_DG13180,BMG_DG172612,"PubChem SID:198978969 | UNII:88181ACA0M | DrugBank ID:DB09371 | NORETHYNODREL | (8R,9S,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,4,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | PubChem CID:6231 | CAS RN:68-23-5 | Norethynodrel"
+BMGC_DG13181,BMG_DG172643,"CYCLOSERINE | Cycloserine | (4R)-4-amino-1,2-oxazolidin-3-one | CAS RN:68-41-7 | PubChem CID:6234 | NDC:43598-235 | DrugBank ID:DB00260 | UNII:95IK5KI84Z | PubChem SID:175268034"
+BMGC_DG13182,BMG_DG172647,"PubChem CID:62344 | 3-N,3-N,6-N,6-N-tetramethylacridine-3,6-diamine | UNII:F30N4O6XVV | Acridine orange | CAS RN:494-38-2 | ACRIDINE ORANGE | PubChem SID:198946757"
+BMGC_DG13183,BMG_DG172649,Vanillyl alcohol | PubChem SID:198962955 | CAS RN:498-00-0 | DrugBank ID:DB12087 | UNII:X7EA1JUA6M | PubChem CID:62348 | 4-(hydroxymethyl)-2-methoxyphenol | VANILLYL ALCOHOL
+BMGC_DG13184,BMG_DG172651,"2,3,5-tris(aziridin-1-yl)cyclohexa-2,5-diene-1,4-dione | CAS RN:68-76-8 | PubChem CID:6235 | Triaziquone | TRIAZIQUONE | PubChem SID:198967392 | UNII:F3D5D9P25I | DrugBank ID:DB13304"
+BMGC_DG13185,BMG_DG172657,PubChem CID:62358 | DrugBank ID:DB06768 | azanium;2-hydroxypropanoate | AMMONIUM LACTATE | CAS RN:52003-58-4 | CAS RN:515-98-0 | PubChem SID:175271870 | Ammonium Lactate | Ammonium lactate | UNII:67M901L9NQ
+BMGC_DG13186,BMG_DG172665,"Benziodarone | PubChem SID:198980332 | (2-ethyl-1-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone | PubChem CID:6237 | CAS RN:68-90-6 | DrugBank ID:DB13277 | BENZIODARONE | UNII:75CL65GTYR"
+BMGC_DG13187,BMG_DG172675,"UNII:21807M87J2 | (8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | PubChem CID:6238 | DrugBank ID:DB14570 | HYDROXYPROGESTERONE | CAS RN:110850-01-6 | CAS RN:604-09-1 | PubChem SID:175266077 | Hydroxyprogesterone | CAS RN:68-96-2"
+BMGC_DG13188,BMG_DG172681,PubChem CID:62389 | N-benzyl-7H-purin-6-amine | UNII:KXG6A989PS | 6-Benzylaminopurine | N6-BENZYLADENINE | CAS RN:1214-39-7 | PubChem SID:198990966
+BMGC_DG13189,BMG_DG172721,ROLICYCLIDINE | CAS RN:2201-39-0 | Rolicyclidine | PubChem CID:62436 | UNII:183O9O9JE3 | 1-(1-phenylcyclohexyl)pyrrolidine | DrugBank ID:DB01549 | PubChem SID:198968994
+BMGC_DG13190,BMG_DG172725,"UNII:JD3M24F66I | Chlorisondamine | trimethyl-[2-(4,5,6,7-tetrachloro-2-methyl-1,3-dihydroisoindol-2-ium-2-yl)ethyl]azanium | CAS RN:7701-62-4 | PubChem CID:6244 | PubChem SID:198936648 | CHLORISONDAMINE"
+BMGC_DG13191,BMG_DG172733,"Tubercidin | PubChem SID:198982412 | DrugBank ID:DB03172 | CAS RN:69-33-0 | UNII:M351LCX45Y | (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol | TUBERCIDIN | PubChem CID:6245"
+BMGC_DG13192,BMG_DG172736,DrugBank ID:DB02613 | UNII:G387VUT5EZ | PubChem CID:62452 | DECYLAMINE OXIDE | Capric dimethyl amine oxide | CAS RN:2605-79-0 | PubChem SID:198959583
+BMGC_DG13193,BMG_DG172756,PubChem SID:198979824 | VINYLSULFONIC ACID | DrugBank ID:DB04359 | Vinylsulfonic acid | PubChem CID:62474 | CAS RN:1184-84-5 | UNII:GJ6489R1WE
+BMGC_DG13194,BMG_DG172766,"CAS RN:69-53-4 | (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | DrugBank ID:DB00415 | PubChem CID:6249 | UNII:7C782967RD | Ampicillin | AMPICILLIN | PubChem SID:175268919"
+BMGC_DG13195,BMG_DG172780,"NDC:0404-9905 | NDC:84639-212 | MANNITOL | NDC:63323-024 | NDC:0338-0357 | NDC:10122-212 | NDC:0409-4031 | Mannitol | PubChem CID:6251 | NDC:73180-075 | CAS RN:133-43-7 | CAS RN:87-78-5 | NDC:0338-0355 | NDC:0990-7981 | NDC:0338-0353 | DrugBank ID:DB00742 | NDC:51662-1468 | NDC:0990-7715 | CAS RN:69-65-8 | CAS RN:85085-15-0 | NDC:0264-7578 | NDC:73180-005 | UNII:3OWL53L36A | PubChem SID:175267056 | (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol"
+BMGC_DG13196,BMG_DG172783,UNII:EL4L2474TY | PubChem CID:62513 | 1-methyl-4-phenylpiperidine-4-carbonitrile | 1-Methyl-4-phenylpiperidine-4-carbonitrile | PubChem SID:252320011 | CAS RN:3627-62-1 | 1-METHYL-4-PHENYLPIPERIDINE-4-CARBONITRILE
+BMGC_DG13197,BMG_DG172789,"CAS RN:29363-79-9 | PubChem SID:198960586 | 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride | Cytarabine hydrochloride | CAS RN:69-74-9 | PubChem CID:6252 | CYTARABINE HYDROCHLORIDE | UNII:33K3DB6591"
+BMGC_DG13198,BMG_DG172798,"NDC:25021-229 | NDC:71288-109 | NDC:61703-319 | UNII:04079A1RDZ | NDC:71288-169 | NDC:63323-120 | NDC:68083-343 | NDC:25021-223 | NDC:71288-168 | PubChem SID:175268461 | CAS RN:147-94-4 | CYTARABINE | NDC:68727-745 | NDC:61703-304 | Cytarabine | CAS RN:69-74-9 | NDC:68083-337 | PubChem CID:6253 | DrugBank ID:DB00987 | NDC:71288-108 | NDC:61703-303 | 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | NDC:61703-305"
+BMGC_DG13199,BMG_DG172801,MONODECYL PHOSPHATE | UNII:JS9NP12Y1Y | PubChem SID:252163744 | CAS RN:3921-30-0 | PubChem CID:62532
+BMGC_DG13200,BMG_DG172806,"PubChem SID:198935541 | hexane-3,4-dione | PubChem CID:62539 | CAS RN:4437-51-8 | 3,4-Hexanedione | 3,4-HEXANEDIONE | UNII:4M4NPR5VGD"
+BMGC_DG13201,BMG_DG172807,"CAS RN:69-78-3 | UNII:9BZQ3U62JX | 5,5'-Dithiobis(2-nitrobenzoic acid) | PubChem CID:6254 | PubChem SID:198959662 | 5,5'-DITHIOBIS(2-NITROBENZOIC ACID) | 5-[(3-carboxy-4-nitrophenyl)disulfanyl]-2-nitrobenzoic acid"
+BMGC_DG13202,BMG_DG172815,Chromium picolinate | DrugBank ID:DB11255 | Picolinic Acid Chromium(III) Salt | chromium;pyridine-2-carboxylic acid | PubChem CID:625469
+BMGC_DG13203,BMG_DG172818,"CAS RN:120022-04-0 | beta-Maltose | UNII:R4B6462NGR | .BETA.-MALTOSE | PubChem SID:198956087 | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol | CAS RN:69-79-4 | CAS RN:133-99-3 | PubChem CID:6255"
+BMGC_DG13204,BMG_DG172824,PubChem CID:6255462 | 4-METHOXYRESVERATROL | PubChem SID:472422896 | CAS RN:33626-08-3 | UNII:RU7RRY3RUW
+BMGC_DG13205,BMG_DG172829,"Trifluridine | PubChem CID:6256 | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione | PubChem SID:175266936 | UNII:RMW9V5RW38 | TRIFLURIDINE | NDC:61314-044 | DrugBank ID:DB00432 | CAS RN:70-00-8"
+BMGC_DG13206,BMG_DG172834,"5-[(2-methoxyphenoxy)methyl]-1,3-oxazolidin-2-one | Mephenoxalone | CAS RN:70-07-5 | MEPHENOXALONE | UNII:CZ87T54W8W | PubChem CID:6257 | DrugBank ID:DB13754 | PubChem SID:198989722"
+BMGC_DG13207,BMG_DG172853,PHENACYL BROMIDE | 2-Bromoacetophenone | UNII:754Y0U325I | 2-BROMOACETOPHENONE | 2-bromo-1-phenylethanone | PubChem SID:198955002 | PubChem CID:6259 | CAS RN:70-11-1
+BMGC_DG13208,BMG_DG172876,"L-ornithine | CAS RN:25104-12-5 | PubChem SID:175265701 | ORNITHINE | DrugBank ID:DB00129 | PubChem CID:6262 | CAS RN:70-26-8 | UNII:E524N2IXA3 | Ornithine | (2S)-2,5-diaminopentanoic acid"
+BMGC_DG13209,BMG_DG172906,"UNII:16D59922JU | CAS RN:7778-53-2 | tripotassium;phosphate | PubChem SID:198978494 | PubChem CID:62657 | Potassium phosphate | POTASSIUM PHOSPHATE, TRIBASIC"
+BMGC_DG13210,BMG_DG172909,PubChem SID:175266890 | NDC:37662-0850 | iron(2+);sulfate;heptahydrate | Ferrous sulfate anhydrous | NDC:0220-2111 | FERROUS SULFATE | NDC:48951-4174 | NDC:37662-0847 | NDC:37662-0849 | PubChem CID:62662 | NDC:37662-0843 | NDC:37662-0846 | NDC:37662-0848 | DrugBank ID:DB13257 | UNII:39R4TAN1VT | CAS RN:7782-63-0 | Ferrous sulfate heptahydrate | CAS RN:15491-23-3 | NDC:37662-0844 | NDC:37662-0845 | NDC:54738-963
+BMGC_DG13211,BMG_DG172914,"6,7,8,14-Tetradehydro-4,5-epoxy-6-methoxy-17-methylmorphinan-3-ol | 7-methoxy-3-methyl-2,4,7a,13-tetrahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-ol | PubChem CID:626667"
+BMGC_DG13212,BMG_DG172920,"ASPARAGINE | DrugBank ID:DB00174 | CAS RN:70-47-3 | (2S)-2,4-diamino-4-oxobutanoic acid | PubChem CID:6267 | Asparagine | UNII:5Z33R5TKO7 | PubChem SID:472404908"
+BMGC_DG13213,BMG_DG172940,P-Toluenesulfonamide | 4-methylbenzenesulfonamide | PubChem SID:198959281 | PubChem CID:6269 | CAS RN:70-55-3 | CAS RN:12552-95-3 | P-TOLUENESULFONAMIDE | UNII:I8266RI90M
+BMGC_DG13214,BMG_DG172943,"CAS RN:9004-53-9 | Dextrin | PubChem CID:62698 | (3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2R,3S,4R,5R,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol"
+BMGC_DG13215,BMG_DG172945,CAS RN:70-69-9 | 1-(4-aminophenyl)propan-1-one | PubChem SID:198948929 | PubChem CID:6270 | 4'-Aminopropiophenone | UNII:79GF917W6U | P-AMINOPROPIOPHENONE
+BMGC_DG13216,BMG_DG172951,PAROXYPROPIONE | PubChem CID:6271 | PubChem SID:198952049 | UNII:X9952001TG | CAS RN:70-70-2
+BMGC_DG13217,BMG_DG172973,CAS RN:7006-35-1 | Histidine | PubChem SID:175268515 | (2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid | UNII:4QD397987E | DrugBank ID:DB00117 | HISTIDINE | CAS RN:71-00-1 | PubChem CID:6274
+BMGC_DG13218,BMG_DG172984,1-(1-thiophen-2-ylcyclohexyl)piperidine | Tenocyclidine | PubChem CID:62751 | DrugBank ID:DB01520 | PubChem SID:198948198 | UNII:8BQ45Q6VCL | TENOCYCLIDINE | CAS RN:21500-98-1
+BMGC_DG13219,BMG_DG173007,"DrugBank ID:DB01465 | 1-(2,5-dimethoxyphenyl)propan-2-amine | 2,5-Dimethoxyamphetamine | 2,5-DMA | PubChem SID:198977772 | PubChem CID:62787 | UNII:OIM1536TQQ | CAS RN:2801-68-5"
+BMGC_DG13220,BMG_DG173011,"NDC:70518-3913 | [(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate | CAS RN:71-58-9 | NDC:0009-0287 | NDC:24201-150 | NDC:71205-118 | NDC:62756-090 | NDC:50090-0166 | NDC:50090-5747 | NDC:59762-0058 | NDC:59762-0055 | NDC:66993-371 | MEDROXYPROGESTERONE ACETATE | NDC:0555-0873 | NDC:0009-7376 | NDC:63187-382 | NDC:0548-5701 | NDC:0555-0872 | NDC:0548-5711 | NDC:63629-2612 | NDC:68788-9899 | PubChem SID:175266599 | NDC:69097-539 | NDC:70121-1467 | NDC:55150-329 | NDC:0548-5400 | NDC:50090-5925 | NDC:55150-330 | NDC:72789-043 | PubChem CID:6279 | NDC:63629-8826 | NDC:67457-887 | NDC:67296-0396 | NDC:50090-0491 | NDC:60687-105 | NDC:68788-8112 | UNII:C2QI4IOI2G | NDC:0009-4709 | NDC:63629-8824 | NDC:55289-160 | DrugBank ID:DB00603 | NDC:0009-0746 | NDC:0548-5410 | NDC:50090-3328 | NDC:54348-805 | NDC:51655-520 | NDC:0009-0065 | NDC:62756-091 | NDC:0009-0051 | NDC:50090-5619 | NDC:68071-4132 | NDC:59762-0056 | NDC:70121-1480 | NDC:70700-315 | Medroxyprogesterone acetate | NDC:63629-8825 | NDC:66993-370 | NDC:50090-0490 | NDC:0555-0779 | NDC:63629-8744"
+BMGC_DG13221,BMG_DG173018,"UNII:P0GZ1ICS6X | CAS RN:26148-68-5 | PubChem CID:62805 | PubChem SID:198946774 | 9H-pyrido[2,3-b]indol-2-amine | 2-AMINO-9H-PYRIDO(2,3-B)INDOLE | 2-Amino-9H-pyrido[2,3-b]indole"
+BMGC_DG13222,BMG_DG173025,"Alseroxylon | COLESTIPOL | N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine;2-(chloromethyl)oxirane | CAS RN:90366-83-9 | PubChem SID:472415922 | PubChem CID:62816 | CAS RN:8001-95-4 | DrugBank ID:DB00375 | CAS RN:50925-79-6 | Colestipol | UNII:K50N755924 | CAS RN:26658-42-4"
+BMGC_DG13223,BMG_DG173027,"1-[19-amino-7-(2-amino-2-oxoethyl)-13-butan-2-yl-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide | CAS RN:146479-72-3 | Follicle-stimulating hormone | CAS RN:26995-91-5 | PubChem CID:62819 | CAS RN:97048-13-0"
+BMGC_DG13224,BMG_DG173029,"CAS RN:58409-70-4 | CALCIUM 2-GLYCEROPHOSPHATE | Calcium beta-glycerophosphate | PubChem SID:198966551 | UNII:Y56W30YB7O | PubChem CID:62820 | calcium;1,3-dihydroxypropan-2-yl phosphate | DrugBank ID:DB11264"
+BMGC_DG13225,BMG_DG173066,"PubChem CID:628577 | 7,9-dimethoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline | 6-O-Methylcodeine"
+BMGC_DG13226,BMG_DG173067,"PubChem SID:198982831 | 2-azido-N-[(1R,2R)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide | PubChem CID:62858 | UNII:40257685LM | AZIDAMFENICOL | DrugBank ID:DB13294 | Azidamfenicol | CAS RN:13838-08-9"
+BMGC_DG13227,BMG_DG173068,"DrugBank ID:DB00326 | calcium;(3R,4S,5R,6R)-2,3,4,5,6,7-hexahydroxyheptanoate | Calcium Gluceptate | PubChem CID:62859 | CAS RN:29039-00-7 | Calcium glucoheptonate"
+BMGC_DG13228,BMG_DG173069,CAS RN:2095-24-1 | UNII:J205NZ30N2 | PubChem SID:198950629 | PubChem CID:62861 | CHLORPHENETHAZINE
+BMGC_DG13229,BMG_DG173072,CAS RN:3546-03-0 | PubChem CID:62865 | Cyamemazine | DrugBank ID:DB09000 | PubChem SID:175271811 | CYAMEMAZINE | 10-[3-(dimethylamino)-2-methylpropyl]phenothiazine-2-carbonitrile | UNII:A2JGV5CNU4
+BMGC_DG13230,BMG_DG173073,"DrugBank ID:DB01621 | PIPOTIAZINE | CAS RN:39860-99-6 | PubChem CID:62867 | PubChem SID:198935938 | Pipotiazine | 10-[3-[4-(2-hydroxyethyl)piperidin-1-yl]propyl]-N,N-dimethylphenothiazine-2-sulfonamide | UNII:L903J9JPYV"
+BMGC_DG13231,BMG_DG173075,CAS RN:72-18-4 | VALINE | UNII:HG18B9YRS7 | DrugBank ID:DB00161 | PubChem CID:6287 | CAS RN:7004-03-7 | (2S)-2-amino-3-methylbutanoic acid | PubChem SID:175265382 | Valine
+BMGC_DG13232,BMG_DG173080,PubChem CID:62875 | PubChem SID:198946727 | UNII:O1G7LW1I5H | CAS RN:1225-64-5 | 3-(2-chlorophenothiazin-10-yl)-N-methylpropan-1-amine | Norchlorpromazine | DEMETHYLCHLORPROMAZINE
+BMGC_DG13233,BMG_DG173085,"THREONINE | CAS RN:80-68-2 | UNII:2ZD004190S | CAS RN:7013-32-3 | THREONINE, DL- | DrugBank ID:DB00156 | PubChem SID:198941201 | PubChem CID:6288 | CAS RN:72-19-5 | PubChem SID:175265289 | (2S,3R)-2-amino-3-hydroxybutanoic acid | Threonine | UNII:TFM6DU5S6A"
+BMGC_DG13234,BMG_DG173094,"NDC:72785-0009 | NDC:70710-1532 | Cisatracurium | NDC:70069-161 | ATRACURIUM BESYLATE, (1R,1'R,2R,2'R)-(+/-)- | PubChem CID:62886 | NDC:65145-136 | NDC:70710-1533 | NDC:66794-246 | NDC:72785-0011 | NDC:63323-418 | NDC:63323-417 | NDC:0781-3153 | NDC:0703-2045 | ATRACURIUM BESYLATE, (1R,1'R,2R,2'R)-(±)- | NDC:72785-0008 | NDC:0409-5547 | NDC:0143-9396 | CISATRACURIUM BESYLATE | NDC:0143-9397 | NDC:70436-112 | PubChem SID:175266594 | NDC:71288-712 | NDC:0781-3152 | NDC:70436-114 | benzenesulfonate;5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate | NDC:71288-714 | NDC:55150-286 | NDC:71288-720 | NDC:70069-151 | NDC:70436-113 | DrugBank ID:DB00565 | NDC:70069-141 | NDC:0409-1098 | NDC:0703-2033 | NDC:72572-067 | PubChem SID:198957789 | NDC:24584-1112 | NDC:24584-1111 | NDC:70710-1534 | NDC:0409-7083 | NDC:0703-2056 | UNII:80YS8O1MBS | UNII:Y78PS7MEDE | NDC:0781-3150 | NDC:65145-135 | NDC:0409-1208 | NDC:71288-713 | Cisatracurium Besylate | NDC:65145-137 | NDC:0409-1103 | CAS RN:96946-42-8 | NDC:55150-284 | NDC:66794-245 | NDC:63323-416 | NDC:0409-3670"
+BMGC_DG13235,BMG_DG173095,"CAS RN:96946-41-7 | PubChem SID:198943613 | DrugBank ID:DB13450 | DrugBank ID:DB00565 | PubChem SID:175266713 | PubChem CID:62887 | Cisatracurium | 5-[3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[(1R,2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate | ATRACURIUM, (1R,1'R,2R,2'R)-(+/-)- | ATRACURIUM, (1R,1'R,2R,2'R)-(±)- | UNII:QX62KLI41N | CISATRACURIUM | UNII:SKE79AOA7L"
+BMGC_DG13236,BMG_DG173111,"Mestranol | PubChem SID:175267512 | (8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol | DrugBank ID:DB01357 | MESTRANOL | UNII:B2V233XGE7 | CAS RN:72-33-3 | PubChem CID:6291"
+BMGC_DG13237,BMG_DG173115,METHAQUALONE | 2-methyl-3-(2-methylphenyl)quinazolin-4-one | PubChem SID:198967332 | UNII:7ZKH8MQW6T | Methaqualone | CAS RN:1184966-71-9 | PubChem CID:6292 | DrugBank ID:DB04833 | CAS RN:72-44-6
+BMGC_DG13238,BMG_DG173124,"Alizarin | CAS RN:72-48-0 | 1,2-dihydroxyanthracene-9,10-dione | PubChem SID:198953068 | CAS RN:1322-60-7 | PubChem CID:6293 | UNII:60MEW57T9G | ALIZARIN"
+BMGC_DG13239,BMG_DG173125,"CAS RN:53016-31-2 | (8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol | UNII:R0TAY3X631 | DrugBank ID:DB06713 | Norelgestromin | NORELGESTROMIN | PubChem CID:62930 | PubChem SID:175268029"
+BMGC_DG13240,BMG_DG173142,"PubChem SID:175268009 | CAS RN:95399-71-6 | Fosinoprilat | (2S,4S)-4-cyclohexyl-1-[2-[hydroxy(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | UNII:S312EY6ZT8 | FOSINOPRILAT | PubChem CID:62956 | DrugBank ID:DB14207"
+BMGC_DG13241,BMG_DG173145,"Trovafloxacin | CAS RN:147059-72-1 | UNII:9F388J00UK | TROVAFLOXACIN | 7-[(1S,5R)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid | PubChem CID:62959 | DrugBank ID:DB00685 | PubChem SID:175265560"
+BMGC_DG13242,BMG_DG173146,"tetrasodium;5-amino-3-[[4-[4-[(8-amino-1-hydroxy-3,6-disulfonatonaphthalen-2-yl)diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]-4-hydroxynaphthalene-2,7-disulfonate | PubChem CID:6296 | NDC:68803-612 | Trypan blue | PubChem SID:175265769 | CAS RN:72-57-1 | UNII:I2ZWO3LS3M | TRYPAN BLUE"
+BMGC_DG13243,BMG_DG173151,UNII:5BGA9FD55H | BECLOMETHASONE 17-MONOPROPIONATE | CAS RN:5534-18-9 | PubChem CID:62965 | PubChem SID:175266378
+BMGC_DG13244,BMG_DG173156,"PubChem SID:198954200 | PubChem CID:6297 | DrugBank ID:DB09158 | 5-amino-3-[[4-[4-[(8-amino-1-hydroxy-3,6-disulfonaphthalen-2-yl)diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]-4-hydroxynaphthalene-2,7-disulfonic acid | Trypan Blue free acid | CAS RN:2538-83-2 | TRYPAN BLUE FREE ACID | UNII:768N7QO4KH"
+BMGC_DG13245,BMG_DG173172,"ZAPOTIN | Zapotin | 2-(2,6-dimethoxyphenyl)-5,6-dimethoxychromen-4-one | CAS RN:14813-19-5 | PubChem CID:629965 | UNII:Z7CW4S27SB | PubChem SID:472422321"
+BMGC_DG13246,BMG_DG173177,"Methandrostenolone | METHANDROSTENOLONE | CAS RN:72-63-9 | DrugBank ID:DB13586 | PubChem SID:198959312 | UNII:COZ1R7EOCC | PubChem CID:6300 | (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one"
+BMGC_DG13247,BMG_DG173183,"NDC:55700-948 | NDC:43063-033 | NDC:80425-0310 | NDC:50090-6917 | NDC:0049-4960 | UNII:UTI8907Y6X | NDC:60687-242 | NDC:65841-044 | NDC:71093-130 | NDC:71335-1078 | NDC:71205-205 | NDC:71335-0403 | NDC:63187-478 | NDC:59762-0067 | NDC:50228-468 | NDC:43353-447 | NDC:52427-672 | NDC:0615-8486 | NDC:55154-4692 | PubChem CID:63009 | NDC:71610-818 | NDC:16714-613 | NDC:76282-212 | NDC:76420-786 | NDC:70010-205 | NDC:76420-779 | NDC:71093-129 | NDC:52427-664 | NDC:72789-092 | NDC:69097-833 | NDC:50268-769 | NDC:31722-145 | NDC:65862-013 | NDC:71205-047 | NDC:71093-143 | NDC:63187-859 | NDC:82982-043 | NDC:71205-028 | NDC:70518-1290 | NDC:50090-2080 | NDC:67046-0559 | NDC:43602-979 | NDC:72865-206 | NDC:16714-611 | NDC:43063-855 | NDC:72789-088 | NDC:70010-203 | NDC:68788-6437 | NDC:68071-4993 | NDC:68788-7928 | NDC:71335-2300 | NDC:23155-757 | NDC:68645-523 | NDC:50090-6614 | NDC:72789-013 | NDC:42708-092 | NDC:0049-0050 | Sertraline Hydrochloride | NDC:42708-124 | NDC:58151-601 | NDC:60760-612 | NDC:50090-0989 | NDC:50228-469 | NDC:65841-045 | NDC:0049-4910 | NDC:68071-4973 | NDC:65862-012 | NDC:71335-0510 | PubChem SID:175266331 | NDC:31722-146 | NDC:71093-131 | NDC:71205-455 | NDC:72865-205 | NDC:68645-521 | NDC:72162-2411 | NDC:68788-8109 | NDC:16729-217 | NDC:72865-207 | NDC:51655-345 | NDC:70518-1748 | NDC:43353-970 | NDC:50090-0991 | NDC:70518-3145 | NDC:68071-4462 | (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride | NDC:71335-0328 | CAS RN:79896-32-5 | NDC:50090-7295 | NDC:68788-6429 | NDC:71610-651 | NDC:55700-910 | NDC:82009-050 | NDC:68788-8689 | NDC:71335-0415 | NDC:70518-4157 | NDC:0049-4900 | NDC:68788-8669 | NDC:43602-980 | NDC:63187-795 | NDC:72789-346 | NDC:60687-231 | NDC:76420-781 | NDC:51655-173 | NDC:60760-737 | NDC:71335-0896 | NDC:64980-409 | NDC:50090-3203 | NDC:0615-8487 | NDC:63187-055 | NDC:65841-043 | NDC:43602-981 | NDC:68071-4494 | NDC:68180-352 | NDC:72789-273 | NDC:55154-4687 | CAS RN:79559-97-0 | SERTRALINE HYDROCHLORIDE | NDC:50090-6379 | NDC:68788-6835 | NDC:68788-8732 | NDC:71610-433 | NDC:72189-551 | NDC:16714-612 | NDC:50090-6861 | NDC:55154-3570 | NDC:68071-4658 | NDC:63187-767 | NDC:0904-6926 | NDC:23155-759 | NDC:55700-362 | NDC:69097-834 | NDC:71610-435 | NDC:60760-738 | NDC:50090-7395 | NDC:71610-769 | NDC:58151-575 | NDC:65862-224 | NDC:51655-265 | NDC:55700-225 | NDC:72189-122 | NDC:71205-343 | NDC:82009-049 | NDC:70518-2812 | NDC:50090-5848 | NDC:58151-576 | CAS RN:79617-95-1 | NDC:68788-8612 | NDC:55154-3569 | NDC:43063-754 | NDC:69097-835 | NDC:68788-8210 | NDC:50268-770 | NDC:23155-758 | NDC:68180-353 | NDC:72162-2407 | NDC:63187-212 | NDC:16729-215 | NDC:60760-988 | NDC:31722-147 | NDC:50268-768 | NDC:68180-351 | NDC:70010-204 | NDC:16729-216 | NDC:60687-253 | NDC:50090-7396 | NDC:50228-467 | NDC:0904-6924 | NDC:16714-601 | NDC:68645-522 | NDC:70518-2448 | NDC:71335-0210 | NDC:68071-3626 | NDC:80425-0200 | NDC:60760-091 | NDC:0904-6925 | NDC:76282-213 | NDC:72162-2370 | NDC:76282-214 | NDC:71335-9714 | NDC:65862-011 | NDC:70518-4171 | NDC:50090-7230 | NDC:63629-8774 | NDC:50090-2071 | NDC:70518-1617 | NDC:71335-0808 | NDC:0615-8485 | NDC:58151-574"
+BMGC_DG13248,BMG_DG173184,"PubChem CID:6301 | Chlorquinaldol | CHLORQUINALDOL | DrugBank ID:DB13306 | CAS RN:72-80-0 | PubChem SID:175267963 | UNII:D6VHC87LLS | 5,7-dichloro-2-methylquinolin-8-ol"
+BMGC_DG13249,BMG_DG173194,"[(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-11-hydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl] propanoate | CAS RN:86401-95-8 | Methylprednisolone Aceponate | DrugBank ID:DB14643 | METHYLPREDNISOLONE ACEPONATE | UNII:ET54W9J4U2 | PubChem SID:198963194 | PubChem CID:63019"
+BMGC_DG13250,BMG_DG173197,"PubChem CID:63021 | [(8R,9S,10R,13S,14S,17S)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate | 17-(Acetyloxy)-19-norpregn-4-en-20-yn-3-one | CAS RN:38673-38-0"
+BMGC_DG13251,BMG_DG173201,"CORDYCEPIN | DrugBank ID:DB12156 | PubChem CID:6303 | CAS RN:73-03-0 | (2R,3R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol | Cordycepin | UNII:GZ8VF4M2J8 | PubChem SID:198965660"
+BMGC_DG13252,BMG_DG173217,PubChem CID:6305 | TRYPTOPHAN | CAS RN:80206-30-0 | NDC:43857-0416 | DrugBank ID:DB00150 | Tryptophan | UNII:8DUH1N11BX | NDC:43742-0770 | (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid | CAS RN:202406-50-6 | NDC:43857-0232 | CAS RN:73-22-3 | PubChem SID:175265677
+BMGC_DG13253,BMG_DG173221,CAS RN:148216-78-8 | PubChem SID:318164525 | PubChem CID:6305587 | UNII:N7GRI8K5R7 | 7-HYDROXY-PIPAT
+BMGC_DG13254,BMG_DG173222,"PubChem CID:63059 | CAS RN:91221-46-4 | UNII:K46GRM9275 | PubChem SID:485663708 | 1,1-Bis(4-hydroxyphenyl)-2-phenyl-1-butene | 1,1-BIS(4-HYDROXYPHENYL)-2-PHENYL-1-BUTENE"
+BMGC_DG13255,BMG_DG173223,"(2S,3S)-2-amino-3-methylpentanoic acid | ISOLEUCINE, DL- | PubChem CID:6306 | NDC:72951-150 | DrugBank ID:DB00167 | NDC:72951-140 | CAS RN:443-79-8 | PubChem SID:175267206 | UNII:5HX0BYT4E3 | UNII:04Y7590D77 | l-Isoleucine | Isoleucine | PubChem SID:198964246 | ISOLEUCINE | CAS RN:73-32-5 | CAS RN:1160211-67-5"
+BMGC_DG13256,BMG_DG173224,PubChem CID:63062 | CAS RN:68392-35-8 | 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol | 4-[1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol
+BMGC_DG13257,BMG_DG173225,"DrugBank ID:DB01325 | 7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide | PubChem SID:198988413 | PubChem CID:6307 | CAS RN:73-49-4 | QUINETHAZONE | Quinethazone | UNII:455E0S048W"
+BMGC_DG13258,BMG_DG173234,"UNII:783L7GB6V2 | 2,3',4,4',5',6-Hexachlorobiphenyl | PubChem CID:63078 | 1,2,3-trichloro-5-(2,4,6-trichlorophenyl)benzene | PubChem SID:198974918 | CAS RN:59291-65-5 | 2,3',4,4',5',6-HEXACHLOROBIPHENYL"
+BMGC_DG13259,BMG_DG173248,"3,3',4,4',5-Pentachlorobiphenyl | 3,3',4,4',5-PENTACHLOROBIPHENYL | PubChem CID:63090 | UNII:TSH69IA9XF | 1,2,3-trichloro-5-(3,4-dichlorophenyl)benzene | PubChem SID:198943469 | CAS RN:57465-28-8"
+BMGC_DG13260,BMG_DG173270,"3,5,7-trimethoxy-2-(4-methoxyphenyl)chromen-4-one | PubChem CID:631095 | TETRAMETHYLKAEMPFEROL | CAS RN:16692-52-7 | PubChem SID:313183655 | UNII:960ZC9V914 | Tetramethylkaempferol"
+BMGC_DG13261,BMG_DG173273,UNII:MK6JUA2E4J | CAS RN:17093-86-6 | TETRA-O-METHYLFISETIN | PubChem CID:631171 | PubChem SID:381132276
+BMGC_DG13262,BMG_DG173280,UNII:PF75E92XKM | PubChem SID:241177943 | OROIDIN | PubChem CID:6312649 | CAS RN:34649-22-4
+BMGC_DG13263,BMG_DG173285,"Motretinide | DrugBank ID:DB13368 | UNII:W786807KL1 | CAS RN:56281-36-8 | MOTRETINIDE | PubChem SID:198942143 | PubChem CID:6314185 | CAS RN:54757-59-4 | (2E,4E,6E,8E)-N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenamide"
+BMGC_DG13264,BMG_DG173300,"PubChem CID:6321 | 2,3-bis(sulfanyl)propane-1-sulfonic acid | 2,3-Dimercapto-1-propanesulfonic acid | UNII:086L82361J | 2,3-DIMERCAPTO-1-PROPANESULFONIC ACID | PubChem SID:198965072 | CAS RN:74-61-3"
+BMGC_DG13265,BMG_DG173313,"Isosinensetin | ISOSINENSETIN | UNII:63Z99S38LE | 2-(3,4-dimethoxyphenyl)-5,7,8-trimethoxychromen-4-one | PubChem CID:632135 | PubChem SID:198967316 | CAS RN:17290-70-9"
+BMGC_DG13266,BMG_DG173314,METHANANDAMIDE | CAS RN:157182-49-5 | PubChem SID:440090123 | UNII:F4U8EF3PBH | PubChem CID:6321351
+BMGC_DG13267,BMG_DG173337,"PubChem CID:6321408 | Buprenorphine + naloxone | (1S,2S,6R,14R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol"
+BMGC_DG13268,BMG_DG173338,"UNII:U7RWT9J78O | CAS RN:97164-56-2 | CAS RN:79350-37-1 | Cefixime anhydrous, (E)- | (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CEFIXIME ANHYDROUS, (E)- | PubChem CID:6321411 | PubChem SID:198963675"
+BMGC_DG13269,BMG_DG173342,"NDC:57237-058 | NDC:67046-1307 | NDC:68180-302 | NDC:65862-700 | NDC:63629-9448 | NDC:70518-3215 | NDC:72789-035 | NDC:63629-9447 | Cefuroxime Axetil | NDC:57297-302 | NDC:65862-698 | NDC:50090-7095 | NDC:67877-215 | NDC:50090-2157 | NDC:43063-656 | NDC:51407-333 | NDC:68071-1637 | NDC:65862-699 | NDC:63629-9446 | NDC:67046-1081 | NDC:67296-0747 | NDC:51407-334 | NDC:16714-400 | NDC:63629-9449 | NDC:67877-216 | NDC:43063-657 | UNII:Z49QDT0J8Z | NDC:57237-059 | 1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | NDC:67296-2079 | NDC:60687-272 | CAS RN:64544-07-6 | NDC:50090-6999 | PubChem SID:175272014 | NDC:50090-2158 | NDC:43063-584 | NDC:63187-991 | CEFUROXIME AXETIL | NDC:67296-2088 | NDC:50090-2159 | NDC:68071-4947 | NDC:60687-283 | NDC:43063-623 | NDC:16714-401 | PubChem CID:6321416 | NDC:67296-0939"
+BMGC_DG13270,BMG_DG173344,"UNII:8WV5538LFK | FAZADINIUM BROMIDE | CAS RN:49564-56-9 | Fazadinium Bromide | PubChem SID:198934885 | (E)-bis(3-methyl-2-phenylimidazo[1,2-a]pyridin-4-ium-1-yl)diazene;dibromide | PubChem CID:6321422 | DrugBank ID:DB13745"
+BMGC_DG13271,BMG_DG173345,"CAS RN:71827-03-7 | PubChem CID:6321424 | CAS RN:70288-86-7 | UNII:91Y2202OUW | CAS RN:70161-11-4 | PubChem SID:198958549 | IVERMECTIN B1A | (1R,4S,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-[(2S)-butan-2-yl]-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one | Ivermectin B1a"
+BMGC_DG13272,BMG_DG173351,NDC:83872-218 | NDC:61657-0974 | ARGININE | NDC:58264-0215 | NDC:83872-224 | NDC:83872-217 | NDC:43742-1554 | NDC:43857-0460 | NDC:43857-0650 | NDC:83872-219 | NDC:83872-216 | Arginine | NDC:50845-0261 | NDC:50845-0257 | NDC:44911-0542 | NDC:84660-012 | DrugBank ID:DB00125 | NDC:83872-226 | CAS RN:74-79-3 | CAS RN:4455-52-1 | NDC:43742-2082 | NDC:83018-0001 | PubChem CID:6322 | NDC:58264-0222 | NDC:58264-0093 | NDC:83872-221 | (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid | NDC:83872-222 | NDC:83027-0084 | PubChem SID:175268310 | NDC:83872-228 | NDC:83872-229 | NDC:83872-225 | NDC:83872-223 | UNII:94ZLA3W45F
+BMGC_DG13273,BMG_DG173356,6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE | DrugBank ID:DB06861 | PubChem CID:6323178
+BMGC_DG13274,BMG_DG173357,"PubChem CID:6323182 | DrugBank ID:DB03417 | (2S,3R)-2-[[4-(Tert-butylcarbamoyl)piperazine-1-carbonyl]amino]-6-(diaminomethylideneamino)-3-formylhexanoic acid"
+BMGC_DG13275,BMG_DG173360,DrugBank ID:DB03890 | PubChem CID:6323197 | N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide
+BMGC_DG13276,BMG_DG173365,"PubChem CID:6323220 | 5,6-Cyclic-Tetrahydropteridine | DrugBank ID:DB03332"
+BMGC_DG13277,BMG_DG173367,"PubChem CID:6323235 | 6S-5,6,7,8-Tetrahydrobiopterin | DrugBank ID:DB03918"
+BMGC_DG13278,BMG_DG173368,DrugBank ID:DB07542 | PubChem CID:6323244 | 5-Amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid
+BMGC_DG13279,BMG_DG173369,"DrugBank ID:DB07549 | 2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE | PubChem CID:6323250"
+BMGC_DG13280,BMG_DG173370,"DrugBank ID:DB09343 | Tipiracil | UNII:NGO10K751P | DrugBank ID:DB02631 | PubChem SID:198964886 | TIPIRACIL | 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione | PubChem CID:6323266 | CAS RN:183204-74-2"
+BMGC_DG13281,BMG_DG173371,"PubChem CID:6323289 | (6R,7S,10R,11R,12E,17E,19E,21S)-6-[2-(diethylamino)ethylsulfonyl]-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14,23-tetrone | CAS RN:112362-50-2 | Dalfopristin | PubChem SID:175267051 | DrugBank ID:DB01764 | DALFOPRISTIN | UNII:R9M4FJE48E"
+BMGC_DG13282,BMG_DG173373,"DrugBank ID:DB07888 | 3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER | PubChem CID:6323362"
+BMGC_DG13283,BMG_DG173374,DrugBank ID:DB02326 | PubChem CID:6323374 | 1-Hydroxyamine-2-Isobutylmalonic Acid
+BMGC_DG13284,BMG_DG173375,"PubChem CID:6323375 | DrugBank ID:DB02472 | 7,8-dihydroinosine"
+BMGC_DG13285,BMG_DG173380,"N-[4-([(2-Amino-4-oxo-1,4-dihydropyrido[3,2-d]pyrimidin-6-yl)methyl]{(2E)-3-[4-carbamoyl-1-(5-O-phosphono-beta-D-ribofuranosyl)-1H-imidazol-5-yl]-2-propenoyl}amino)benzoyl]-L-glutamic acid | PubChem CID:6323417 | DrugBank ID:DB04057"
+BMGC_DG13286,BMG_DG173382,PubChem CID:6323452 | DrugBank ID:DB04509 | N-Methylnaloxonium
+BMGC_DG13287,BMG_DG173386,DrugBank ID:DB00144 | PubChem CID:6323481 | Phosphatidyl serine | (2S)-2-amino-3-[[(2R)-2-butanoyloxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
+BMGC_DG13288,BMG_DG173388,DrugBank ID:DB00615 | PubChem SID:175267510 | UNII:1W306TDA6S | NDC:59762-1350 | CAS RN:72559-06-9 | NDC:70954-041 | RIFABUTIN | PubChem CID:6323490 | NDC:0013-5301 | NDC:70518-4254 | NDC:10135-738 | Rifabutin
+BMGC_DG13289,BMG_DG173389,"CAS RN:12772-57-5 | (4R,6R,8R,9Z,11E)-16-chloro-17,19-dihydroxy-4-methyl-3,7-dioxatricyclo[13.4.0.06,8]nonadeca-1(15),9,11,16,18-pentaene-2,13-dione | PubChem CID:6323491 | Radicicol | MONORDEN | UNII:I60EH8GECX | PubChem SID:241179499 | DrugBank ID:DB03758"
+BMGC_DG13290,BMG_DG173390,PubChem CID:6323497 | Rifapentine | DrugBank ID:DB01201
+BMGC_DG13291,BMG_DG173392,PubChem CID:6323515 | Triglu-5-formyl-tetrahydrofolate | DrugBank ID:DB02067
+BMGC_DG13292,BMG_DG173393,"5-hydroxymethyl-5,6-dihydrofolic acid | PubChem CID:6323516 | DrugBank ID:DB02800"
+BMGC_DG13293,BMG_DG173395,"(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID | PubChem CID:6323526 | DrugBank ID:DB08640"
+BMGC_DG13294,BMG_DG173396,"DrugBank ID:DB08641 | PubChem CID:6323527 | (2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID"
+BMGC_DG13295,BMG_DG173399,5-monophosphate-9-beta-D-ribofuranosyl xanthine | PubChem CID:6323540 | DrugBank ID:DB02309
+BMGC_DG13296,BMG_DG173401,PubChem CID:6324595 | 3-[(1R)-1-[[(2S)-3-[5-[(4-azido-2-hydroxy-5-iodobenzoyl)amino]pentyl-hydroxyphosphoryl]-2-hydroxypropyl]amino]ethyl]benzoic acid | CAS RN:200402-51-3 | Cgp 71872
+BMGC_DG13297,BMG_DG173402,"Brilliant Blue G | PubChem CID:6324599 | DrugBank ID:DB15594 | CAS RN:6104-58-1 | sodium;3-[[4-[(E)-[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfonatophenyl)methyl]azaniumylidene]-2-methylcyclohexa-2,5-dien-1-ylidene]methyl]-N-ethyl-3-methylanilino]methyl]benzenesulfonate"
+BMGC_DG13298,BMG_DG173405,"PubChem CID:6324613 | (1S,9R,13S)-10-(cyclopropylmethyl)-1-ethyl-4-hydroxy-13-methyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-8-one | CAS RN:36292-66-7 | Rel-Ethylketazocine"
+BMGC_DG13299,BMG_DG173406,"PubChem SID:175266627 | Rifamycin | CAS RN:15105-92-7 | PubChem CID:6324616 | CAS RN:6998-60-3 | UNII:DU69T8ZZPA | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate | DrugBank ID:DB11753 | RIFAMYCIN"
+BMGC_DG13300,BMG_DG173407,"CAS RN:15291-77-7 | DrugBank ID:DB06744 | ginkgolide-B | PubChem CID:6324617 | (1R,3R,6R,7S,8S,10R,11R,12R,13S,16S,17R)-8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione"
+BMGC_DG13301,BMG_DG173409,"CAS RN:174393-13-6 | PubChem SID:474492624 | PubChem CID:6324634 | LY-307,452 | UNII:ZU8PFA9K8G"
+BMGC_DG13302,BMG_DG173410,"LY-339434 | (2S,4R)-2-amino-4-[(E)-3-naphthalen-2-ylprop-2-enyl]pentanedioic acid | PubChem CID:6324635 | CAS RN:219566-62-8 | UNII:2L779V9YMY | PubChem SID:445499458"
+BMGC_DG13303,BMG_DG173413,(2S)-2-[[[(2S)-6-amino-2-(methanesulfonamido)hexanoyl]amino]methyl]-3-[1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl]cyclopentyl]propanoic acid | UNII:V7O29949TG | CAS RN:129981-36-8 | Sampatrilat | SAMPATRILAT | PubChem SID:198936782 | PubChem CID:6324648
+BMGC_DG13304,BMG_DG173414,"Remikiren | UNII:LC7FBL96A4 | PubChem SID:198960503 | PubChem CID:6324659 | REMIKIREN | CAS RN:126222-34-2 | (2S)-2-benzyl-3-tert-butylsulfonyl-N-[(2S)-1-[[(2S,3R,4S)-1-cyclohexyl-4-cyclopropyl-3,4-dihydroxybutan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]propanamide | CAS RN:135669-48-6 | DrugBank ID:DB00212"
+BMGC_DG13305,BMG_DG173416,PubChem CID:6324663 | CAS RN:60173-70-8 | DrugBank ID:DB06763 | CAS RN:34273-10-4 | Saralasin | (2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid
+BMGC_DG13306,BMG_DG173418,"PubChem CID:6324671 | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-8-formyl-10-hydroxy-5-methoxy-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate"
+BMGC_DG13307,BMG_DG173452,PubChem CID:6326970 | NDC:0220-4622 | NDC:37662-1249 | NDC:0220-4639 | NDC:0220-4628 | SELENIUM | NDC:37662-1250 | NDC:0220-4632 | CAS RN:7782-49-2 | CAS RN:7783-07-5 | NDC:0517-6560 | NDC:37662-1247 | Selenium | PubChem SID:198959730 | UNII:H6241UJ22B | NDC:37662-1252 | NDC:0517-6502 | NDC:37662-1253 | NDC:81279-106 | NDC:0220-4631 | NDC:37662-1251 | NDC:37662-1248 | NDC:0220-4640 | UNII:V91P54KPAM | NDC:37662-1254 | selenium | DrugBank ID:DB11135 | NDC:54288-174 | HYDROGEN SELENIDE
+BMGC_DG13308,BMG_DG173453,PubChem CID:6326972 | L-selenocysteine | CAS RN:10236-58-5 | CAS RN:3614-08-2
+BMGC_DG13309,BMG_DG173454,SELENOCYSTEINE | Selenocysteine | DrugBank ID:DB02345 | UNII:0CH9049VIS | PubChem CID:6326983 | CAS RN:10236-58-5 | PubChem SID:198945063
+BMGC_DG13310,BMG_DG173475,PubChem SID:438787938 | UNII:676G4RQ6ND | DrugBank ID:DB04491 | CAS RN:1809-20-7 | DIISOPROPYL PHOSPHONATE | Diisopropylphosphono Group | PubChem CID:6327350
+BMGC_DG13311,BMG_DG173492,CAS RN:645-96-5 | PubChem CID:6327608 | Benzeneselenol
+BMGC_DG13312,BMG_DG173498,PubChem CID:6327654 | DrugBank ID:DB02811 | PubChem SID:198983572 | CAS RN:762-04-9 | DIETHYL PHOSPHITE | Diethyl phosphonate | UNII:U9X9YBA22W
+BMGC_DG13313,BMG_DG173518,UNII:W90AYD6R3Q | Radium | CAS RN:7440-14-4 | PubChem CID:6328144 | RADIUM | radium
+BMGC_DG13314,BMG_DG173557,"UNII:83JL932I1C | PubChem SID:175267152 | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(furan-2-carbonylsulfanylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem CID:6328657 | DrugBank ID:DB11485 | CEFTIOFUR | CAS RN:80370-57-6 | Ceftiofur"
+BMGC_DG13315,BMG_DG173558,Aluminum;trihydroxide;hydrate | PubChem CID:6328660
+BMGC_DG13316,BMG_DG173565,UNII:BSF23SJ79E | PubChem SID:198953248 | PubChem CID:6329 | CAS RN:3767-37-1 | Methylamine | CAS RN:74-89-5 | DrugBank ID:DB01828 | methanamine | METHYLAMINE
+BMGC_DG13317,BMG_DG173571,DrugBank ID:DB02690 | NU1025 | PubChem CID:63306
+BMGC_DG13318,BMG_DG173599,DrugBank ID:DB01014 | PubChem CID:6335412 | Balsalazide
+BMGC_DG13319,BMG_DG173621,PubChem SID:198951141 | 2-[(E)-[1-(4-chlorophenyl)-5-methoxypentylidene]amino]oxyethanamine | UNII:7I22J7RY2A | CAS RN:54739-19-4 | CAS RN:1185246-59-6 | Clovoxamine | PubChem CID:6335903 | CLOVOXAMINE
+BMGC_DG13320,BMG_DG173622,UNII:QMT5SS3QRE | 3-aminopropyl-hydroxy-oxophosphanium | 3-AMINOPROPYLPHOSPHINIC ACID | PubChem CID:6335948 | 3-Aminopropylphosphinic acid | CAS RN:103680-47-3 | PubChem SID:472388019
+BMGC_DG13321,BMG_DG173623,"Cefpodoxime | CAS RN:80210-62-4 | CEFPODOXIME | UNII:7R4F94TVGY | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem CID:6335986 | DrugBank ID:DB01416 | PubChem SID:175268415"
+BMGC_DG13322,BMG_DG173631,"PubChem CID:6336338 | UNII:Y33Z4ABP6N | PubChem SID:198975993 | MCN-5652, (-)- | CAS RN:103729-13-1"
+BMGC_DG13323,BMG_DG173658,PubChem CID:6337 | Ethyl chloride | UNII:46U771ERWK | ETHYL CHLORIDE | CAS RN:75-00-3 | chloroethane | Ethyl Chloride | PubChem SID:198988063 | DrugBank ID:DB13259 | CAS RN:25052-55-5
+BMGC_DG13324,BMG_DG173681,"DrugBank ID:DB00377 | PALONOSETRON | PubChem CID:6337614 | UNII:5D06587D6R | Palonosetron | CAS RN:1021481-16-2 | (3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one | CAS RN:135729-61-2 | PubChem SID:175268166"
+BMGC_DG13325,BMG_DG173686,PubChem CID:6337677 | Selenoinosine | DrugBank ID:DB02753
+BMGC_DG13326,BMG_DG173695,PubChem CID:6338045 | CAS RN:33125-97-2 | CAS RN:56649-47-9 | 3-[(1S)-1-phenylethyl]-4-imidazolecarboxylic acid ethyl ester | ethyl 3-[(1S)-1-phenylethyl]imidazole-4-carboxylate
+BMGC_DG13327,BMG_DG173709,UNII:M5J17BI02D | PubChem SID:319891872 | HEXA-O-METHYLMYRICITIN | CAS RN:14813-27-5 | PubChem CID:634113
+BMGC_DG13328,BMG_DG173730,CYCLOPROPANE | UNII:99TB643425 | Cyclopropane | PubChem CID:6351 | CAS RN:75-19-4 | DrugBank ID:DB13984 | cyclopropane | PubChem SID:198964131
+BMGC_DG13329,BMG_DG173733,ETHYLENE OXIDE | UNII:JJH7GNN18P | PubChem SID:175266814 | Ethylene Oxide | CAS RN:75-21-8 | oxirane | PubChem CID:6354
+BMGC_DG13330,BMG_DG173752,"PubChem SID:175268699 | NDC:68462-299 | PubChem CID:636374 | NDC:51672-1306 | ALCLOMETASONE DIPROPIONATE | NDC:51672-1316 | NDC:0168-0263 | [2-[(7R,8S,9S,10R,11S,13S,14S,16R,17R)-7-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate | UNII:S56PQL4N1V | Alclometasone Dipropionate | CAS RN:66734-13-2"
+BMGC_DG13331,BMG_DG173755,"FONDAPARINUX SODIUM | decasodium;(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-6-[(2R,3S,4S,5R,6R)-2-carboxylato-4-hydroxy-6-[(2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-5-sulfonatooxyoxan-3-yl]oxy-5-(sulfonatoamino)-4-sulfonatooxy-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3-[(2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfonatoamino)-6-(sulfonatooxymethyl)oxan-2-yl]oxy-4,5-dihydroxyoxane-2-carboxylate | NDC:67457-593 | NDC:43598-606 | NDC:67457-584 | NDC:0781-3454 | NDC:70710-1516 | NDC:55111-678 | NDC:11797-157 | NDC:11797-154 | Fondaparinux Sodium | NDC:55111-679 | NDC:55150-232 | UNII:X0Q6N9USOZ | NDC:11797-155 | NDC:55150-230 | NDC:55111-681 | NDC:67457-582 | NDC:43598-609 | CAS RN:114870-03-0 | NDC:11797-156 | NDC:43598-607 | NDC:55150-233 | NDC:67457-583 | NDC:0781-3443 | NDC:67457-592 | NDC:70710-1515 | NDC:70710-1514 | NDC:0781-3476 | NDC:70710-1517 | NDC:55111-680 | NDC:67457-594 | NDC:67457-595 | NDC:0781-3465 | NDC:55150-231 | PubChem SID:175268930 | NDC:43598-608 | NDC:67457-585 | PubChem CID:636380"
+BMGC_DG13332,BMG_DG173765,"PubChem CID:636398 | DrugBank ID:DB14543 | UNII:O6550D6K3A | Hydrocortisone probutate | CAS RN:72590-77-3 | NDC:62559-325 | HYDROCORTISONE PROBUTATE | [(8S,9S,10R,11S,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3-oxo-17-(2-propanoyloxyacetyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] butanoate | PubChem SID:175268103 | Hydrocortisone Probutate"
+BMGC_DG13333,BMG_DG173770,"CAS RN:5697-56-3 | DrugBank ID:DB02329 | PubChem CID:636403 | (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid | Carbenoxolone | UNII:MM6384NG73 | CARBENOXOLONE | PubChem SID:198987908"
+BMGC_DG13334,BMG_DG173771,"PubChem CID:636405 | UNII:P936YA152N | PubChem SID:198966674 | DrugBank ID:DB00430 | CEFPIRAMIDE | (6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Cefpiramide | CAS RN:70797-11-4"
+BMGC_DG13335,BMG_DG173774,"CAS RN:113712-98-4 | UNII:RE0689TX2K | PubChem SID:198985744 | TENATOPRAZOLE | Tenatoprazole | 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-imidazo[4,5-b]pyridine | PubChem CID:636411"
+BMGC_DG13336,BMG_DG173818,"3,5-DIMETHYL-4-HYDROXYSTILBENE | PubChem CID:6365297 | CAS RN:122917-30-0 | DrugBank ID:DB08100 | UNII:1JVW0GEF1L | PubChem SID:440089697 | 2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol"
+BMGC_DG13337,BMG_DG173850,"PubChem SID:198965925 | PubChem CID:6366 | Vinylidene chloride | CAS RN:75-35-4 | UNII:21SK105J9D | 1,1-DICHLOROETHYLENE | 1,1-dichloroethene"
+BMGC_DG13338,BMG_DG173867,INDRALIN | PubChem SID:376231587 | UNII:ACF4F9H44I | CAS RN:156691-86-0 | PubChem CID:6366726
+BMGC_DG13339,BMG_DG173881,"Spongiadioxin C | PubChem CID:636835 | CAS RN:460092-06-2 | UNII:6S3WHR89VH | PubChem SID:472422670 | SPONGIADIOXIN C | 3,6,8-tribromodibenzo-p-dioxin-1-ol"
+BMGC_DG13340,BMG_DG173887,PubChem CID:6369389 | Methylphosphinate | DrugBank ID:DB02825
+BMGC_DG13341,BMG_DG173888,Methylphosphinic Acid | PubChem CID:6369390 | DrugBank ID:DB02845
+BMGC_DG13342,BMG_DG173892,PubChem CID:637026 | DESFORMYLFLUSTRABROMINE | PubChem SID:474492680 | UNII:24C2SY7KUV | CAS RN:474657-72-2
+BMGC_DG13343,BMG_DG173895,CROTONIC ACID | DrugBank ID:DB02074 | CAS RN:3724-65-0 | (E)-but-2-enoic acid | Crotonic acid | PubChem SID:198938967 | Butenoic Acid | CAS RN:107-93-7 | UNII:YW5WZZ4O5Q | PubChem CID:637090
+BMGC_DG13344,BMG_DG173903,"CAS RN:10236-16-5 | UNII:5YJX2M386O | PHYTYL ACETATE, (E)- | PubChem SID:198966150 | PubChem CID:637195"
+BMGC_DG13345,BMG_DG173911,CAS RN:84873-15-4 | 2-(4-hydroxyphenyl)ethyl (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate | PubChem CID:637308 | p-Hydroxyphenethyl trans-ferulate
+BMGC_DG13346,BMG_DG173914,CAS RN:41137-87-5 | HIRSUTENONE | PubChem CID:637394 | UNII:VQ04K2MMM5 | PubChem SID:433968523
+BMGC_DG13347,BMG_DG173916,IODOFORM | PubChem CID:6374 | DrugBank ID:DB13813 | CAS RN:75-47-8 | Iodoform | UNII:KXI2J76489 | PubChem SID:175266071 | iodoform
+BMGC_DG13348,BMG_DG173921,(E)-3-phenylprop-2-enal | CINNAMALDEHYDE | CAS RN:14371-10-9 | UNII:SR60A3XG0F | PubChem CID:637511 | DrugBank ID:DB14184 | PubChem SID:175265874 | CAS RN:104-55-2 | Cinnamaldehyde
+BMGC_DG13349,BMG_DG173924,CAS RN:112-79-8 | Oleic Acid | PubChem CID:637517 | UNII:4837010H8C | PubChem SID:198971545 | Elaidic Acid | ELAIDIC ACID | (E)-octadec-9-enoic acid | DrugBank ID:DB04224
+BMGC_DG13350,BMG_DG173928,"PubChem SID:198984070 | 2-HYDROXYCINNAMIC ACID, (2E)- | PubChem CID:637540 | (E)-3-(2-hydroxyphenyl)prop-2-enoic acid | trans-2-hydroxycinnamic acid | CAS RN:614-60-8 | DrugBank ID:DB01650 | 2-Hydroxycinnamic acid, (2E)- | UNII:23AU5FZB9C | CAS RN:583-17-5"
+BMGC_DG13351,BMG_DG173929,CAS RN:14755-02-3 | 3'-Hydroxycinnamic acid | UNII:KWJ2DDJ34H | PubChem SID:198988008 | 3'-HYDROXYCINNAMIC ACID | PubChem CID:637541 | CAS RN:588-30-7 | (E)-3-(3-hydroxyphenyl)prop-2-enoic acid
+BMGC_DG13352,BMG_DG173930,UNII:IBS9D1EU3J | CAS RN:50940-26-6 | (E)-3-(4-hydroxyphenyl)prop-2-enoic acid | CAS RN:7400-08-0 | DrugBank ID:DB04066 | p-Coumaric acid | CAS RN:501-98-4 | PubChem CID:637542 | P-COUMARIC ACID | PubChem SID:198988950
+BMGC_DG13353,BMG_DG173936,"CAS RN:106-24-1 | CAS RN:624-15-7 | GERANIOL | (2E)-3,7-dimethylocta-2,6-dien-1-ol | DrugBank ID:DB14183 | PubChem CID:637566 | Geraniol | UNII:L837108USY | PubChem SID:175267252"
+BMGC_DG13354,BMG_DG173937,NDC:70771-1531 | NDC:16729-416 | NDC:69097-322 | NDC:70512-852 | NDC:43598-429 | NDC:43598-430 | NDC:70512-853 | NDC:67877-555 | CAS RN:23055-10-9 | NDC:70771-1530 | NDC:70710-1204 | CAS RN:624-49-7 | NDC:24979-128 | NDC:51407-442 | PubChem SID:175267198 | UNII:FO2303MNI2 | NDC:69238-1318 | NDC:70710-1205 | NDC:43547-025 | dimethyl (E)-but-2-enedioate | NDC:68462-307 | NDC:67877-556 | NDC:0378-0396 | NDC:69097-323 | NDC:69238-1319 | NDC:33342-350 | NDC:50090-6722 | DIMETHYL FUMARATE | PubChem CID:637568 | NDC:33342-349 | NDC:64406-006 | Dimethyl fumarate | Dimethyl Fumarate | NDC:31722-658 | NDC:82009-138 | NDC:16729-417 | NDC:51407-441 | NDC:69539-042 | NDC:43547-024 | DrugBank ID:DB08908 | NDC:24979-127 | NDC:59651-083 | NDC:59651-084 | NDC:64406-005 | NDC:69539-043 | NDC:50090-5288 | NDC:0378-0399 | CAS RN:12287-98-8 | NDC:31722-657 | NDC:68462-308
+BMGC_DG13355,BMG_DG173941,UNII:1I92X32F6H | PubChem CID:637578 | PubChem SID:198977523 | TROPACOCAINE | CAS RN:537-26-8
+BMGC_DG13356,BMG_DG173943,EPIPINORESINOL | CAS RN:24404-50-0 | PubChem CID:637584 | PubChem SID:363908862 | UNII:6YKG9JJC1S
+BMGC_DG13357,BMG_DG173956,ETHYL CINNAMATE | PubChem SID:198982893 | CAS RN:103-36-6 | PubChem CID:637758 | UNII:C023P3M5JJ
+BMGC_DG13358,BMG_DG173958,"PubChem SID:198954074 | PubChem CID:637760 | CAS RN:94-41-7 | Chalcone | (E)-1,3-diphenylprop-2-en-1-one | CAS RN:614-47-1 | CHALCONE | UNII:5S5A2Q39HX"
+BMGC_DG13359,BMG_DG173959,"SINAPIC ACID, (E)- | CAS RN:530-59-6 | UNII:P0I60993EC | Sinapinic acid | PubChem CID:637775 | (E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoic acid | PubChem SID:198954527 | DrugBank ID:DB08587 | Sinapic acid | CAS RN:7362-37-0"
+BMGC_DG13360,BMG_DG173964,CAS RN:940-62-5 | 4-Chlorocinnamic acid | PubChem SID:496142330 | UNII:6J7K3LQS3P | PubChem CID:637797 | 4-CHLOROCINNAMIC ACID
+BMGC_DG13361,BMG_DG173966,PubChem SID:472388444 | 2-METHYL-3-PHENYL-2-PROPENOIC ACID | PubChem CID:637817 | UNII:52D2H37MVU | CAS RN:1895-97-2 | 2-Methyl-3-phenyl-2-propenoic acid
+BMGC_DG13362,BMG_DG173969,"N-DESMETHYLTAMOXIFEN | UNII:OOJ759O35C | CAS RN:31750-48-8 | 2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N-methylethanamine | PubChem CID:6378383 | N-Desmethyltamoxifen | PubChem SID:198967858"
+BMGC_DG13363,BMG_DG173971,"1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one | UNII:SGD66V4SVJ | CAS RN:20069-09-4 | PIPERLONGUMINE | PubChem CID:637858 | Piperlongumine | PubChem SID:198981200"
+BMGC_DG13364,BMG_DG173993,Tetramethylammonium | TETRAMETHYLAMMONIUM | PubChem CID:6380 | PubChem SID:313183296 | CAS RN:19269-48-8 | CAS RN:51-92-3 | DrugBank ID:DB03095 | tetramethylazanium | UNII:H0W55235FC
+BMGC_DG13365,BMG_DG173994,"PubChem CID:638011 | CAS RN:5392-40-5 | GERANIAL | (2E)-3,7-dimethylocta-2,6-dienal | PubChem SID:198990573 | CAS RN:141-27-5 | Citral | UNII:758ZMW724E"
+BMGC_DG13366,BMG_DG173996,"UNII:A7NRR1HLH6 | .BETA.-IONONE | CAS RN:14901-07-6 | beta-Ionone | PubChem SID:198978890 | CAS RN:79-77-6 | (E)-4-(2,6,6-trimethylcyclohexen-1-yl)but-3-en-2-one | PubChem CID:638014 | CAS RN:85949-43-5"
+BMGC_DG13367,BMG_DG173997,"RETINAL, ALL-TRANS | PubChem SID:175265990 | UNII:RR725D715M | Retinal | (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenal | PubChem CID:638015 | CAS RN:472-86-6 | CAS RN:116-31-4"
+BMGC_DG13368,BMG_DG174000,"Piperine | CAS RN:7780-20-3 | (2E,4E)-5-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylpenta-2,4-dien-1-one | PubChem CID:638024 | PIPERINE | UNII:U71XL721QK | CAS RN:147030-08-8 | DrugBank ID:DB12582 | PubChem SID:175266285 | CAS RN:94-62-2"
+BMGC_DG13369,BMG_DG174001,"UNII:B49D0HH807 | CAS RN:5957-75-5 | Delta-8-Tetrahydrocannabinol | PubChem SID:198979868 | (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol | PubChem CID:638026 | DELTA8-Tetrahydrocannabinol | DELTA-8-TETRAHYDROCANNABINOL"
+BMGC_DG13370,BMG_DG174013,"PubChem SID:175265318 | CAS RN:111-02-4 | SQUALENE | CAS RN:7683-64-9 | Squalene | UNII:7QWM220FJH | (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene | PubChem CID:638072 | DrugBank ID:DB11460 | CAS RN:11051-27-7"
+BMGC_DG13371,BMG_DG174023,trans-3-Chloroacrylic acid | (E)-3-chloroprop-2-enoic acid | CAS RN:2345-61-1 | PubChem CID:638124 | CAS RN:625-40-1 | CAS RN:26952-44-3
+BMGC_DG13372,BMG_DG174044,(E)-1-(2-hydroxyphenyl)-3-phenylprop-2-en-1-one | 2'-HYDROXYCHALCONE | PubChem CID:638276 | UNII:VY06DZ94OC | 2'-Hydroxychalcone | CAS RN:1214-47-7 | CAS RN:888-12-0 | PubChem SID:313389966
+BMGC_DG13373,BMG_DG174045,"PubChem SID:198990840 | Trihydroxychalcone | (E)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one | CAS RN:961-29-5 | TRIHYDROXYCHALCONE | CAS RN:1060-19-1 | CAS RN:13745-20-5 | DrugBank ID:DB03285 | UNII:B9CTI9GB8F | PubChem CID:638278 | Isoliquiritigenin"
+BMGC_DG13374,BMG_DG174061,PubChem CID:638437 | UNII:8DRL9H2PWA | CAS RN:22568-49-6 | 4-(2-Nitrovinyl)phenol | 4-(2-NITROVINYL)PHENOL | PubChem SID:478838203
+BMGC_DG13375,BMG_DG174069,tert-butanol | tert-Butyl alcohol | PubChem CID:6386 | DrugBank ID:DB03900 | 2-methylpropan-2-ol | Tert-Butyl Alcohol | TERT-BUTYL ALCOHOL | CAS RN:25-65-0 | PubChem SID:175267301 | CAS RN:75-65-0 | UNII:MD83SFE959
+BMGC_DG13376,BMG_DG174075,PROTIRELIN | PubChem SID:175267539 | CAS RN:117217-40-0 | CAS RN:24305-27-9 | Protirelin | UNII:5Y5F15120W | (2S)-N-[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | DrugBank ID:DB09421 | PubChem CID:638678
+BMGC_DG13377,BMG_DG174079,CAS RN:53170-93-7 | 3-Hydroxy-1-(4-hydroxyphenyl)propan-1-one | 3-HYDROXY-1-(4-HYDROXYPHENYL)-1-PROPANONE | PubChem CID:638759 | PubChem SID:482553902 | 3-hydroxy-1-(4-hydroxyphenyl)propan-1-one | UNII:LA5SG75SZB | 3-Hydroxy-1-(4-hydroxyphenyl)-1-propanone
+BMGC_DG13378,BMG_DG174081,PubChem CID:638793 | GONADORELIN | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | CAS RN:33515-09-2 | PubChem SID:375084993 | CAS RN:9034-40-6 | CAS RN:71447-49-9 | UNII:9O7312W37G | Gonadorelin
+BMGC_DG13379,BMG_DG174089,PubChem CID:639097 | DrugBank ID:DB07291 | 5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile
+BMGC_DG13380,BMG_DG174108,UNII:9810NUL4D1 | 8-hydroxy-5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino]ethyl]-1H-quinolin-2-one | CARMOTEROL | PubChem SID:198970364 | PubChem CID:63952 | Carmoterol | CAS RN:147568-66-9
+BMGC_DG13381,BMG_DG174119,"PubChem SID:198960343 | DrugBank ID:DB15359 | (E)-1-[2,4-dihydroxy-6-methoxy-3-(3-methylbut-2-enyl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one | CAS RN:6754-58-1 | UNII:T4467YT1NT | Xanthohumol | PubChem CID:639665 | CAS RN:569-83-5 | XANTHOHUMOL"
+BMGC_DG13382,BMG_DG174134,"CAS RN:103909-75-7 | PubChem CID:6398761 | Maxacalcitol | PubChem SID:198941399 | UNII:N2UJM5NBF6 | (1R,3S,5Z)-5-[(2E)-2-[(1S,3aS,7aS)-1-[(1S)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | MAXACALCITOL"
+BMGC_DG13383,BMG_DG174138,PubChem SID:485663441 | UNII:55K5464ZGS | CAS RN:269390-77-4 | 2-((4-PYRIDINYLMETHYL)AMINO)-N-(3-(TRIFLUOROMETHYL)PHENYL)BENZAMIDE | PubChem CID:6398883 | 2-[(4-Pyridinylmethyl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide
+BMGC_DG13384,BMG_DG174150,ISONITROSOACETONE | PubChem SID:198952270 | CAS RN:17280-41-0 | PubChem CID:6399095 | UNII:U32V8CLT4W
+BMGC_DG13385,BMG_DG174171,7-TACA | UNII:THX5266WJ5 | CAS RN:37539-03-0 | PubChem CID:6400459 | PubChem SID:441658927
+BMGC_DG13386,BMG_DG174177,"PubChem CID:640091 | UNII:L5GD8LDG49 | PROLINOL, (S)- | CAS RN:23356-96-9 | PubChem SID:441584137"
+BMGC_DG13387,BMG_DG174181,DIBENZALACETONE | UNII:9QXO7BCY9L | PubChem SID:198990590 | PubChem CID:640180 | CAS RN:35225-79-7
+BMGC_DG13388,BMG_DG174186,"CAS RN:39325-01-4 | OK-432 | Picibanil | UNII:2F42BH7X2L | PubChem SID:472400988 | PubChem CID:640429 | (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate"
+BMGC_DG13389,BMG_DG174187,"1H-quinazoline-2,4-dione | Benzoyleneurea | CAS RN:86-96-4 | 2,4-DIHYDROXYQUINAZOLINE | PubChem CID:64048 | PubChem SID:317229976 | CAS RN:1094158-39-0 | UNII:18K00A531C"
+BMGC_DG13390,BMG_DG174195,DrugBank ID:DB02203 | Acetone cyanohydrin | ACETONE CYANOHYDRIN | CAS RN:75-86-5 | Acetone Cyanohydrin | 2-hydroxy-2-methylpropanenitrile | UNII:CO1YOV1KFI | PubChem SID:198936363 | PubChem CID:6406
+BMGC_DG13391,BMG_DG174199,"CHLORAL | Chloral | UNII:FLI06WS32H | CAS RN:75-87-6 | 2,2,2-trichloroacetaldehyde | Trichloroacetaldehyde | PubChem CID:6407 | DrugBank ID:DB02650 | PubChem SID:175267268 | CAS RN:25154-92-1"
+BMGC_DG13392,BMG_DG174201,"Trifluoroethanol | 2,2,2-TRIFLUOROETHANOL | PubChem CID:6409 | PubChem SID:198972360 | DrugBank ID:DB03226 | UNII:8T8I76KYF1 | CAS RN:75-89-8"
+BMGC_DG13393,BMG_DG174203,"(3E)-3-hydroxyiminobutan-2-one | 2,3-Butanedione monoxime | UNII:19SQ93LM6H | PubChem CID:6409633 | CAS RN:110828-81-4 | CAS RN:57-71-6 | DIACETYL MONOXIME | PubChem SID:198972886 | CAS RN:17019-25-9"
+BMGC_DG13394,BMG_DG174217,"CEFATRIZINE | UNII:8P4W949T8K | Cefatrizine | PubChem SID:198981785 | (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(2H-triazol-4-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem CID:6410758 | CAS RN:51627-14-6 | DrugBank ID:DB13266"
+BMGC_DG13395,BMG_DG174223,PubChem CID:641115 | CAS RN:82857-82-7 | ILEPCIMIDE | UNII:5ML58O200F | PubChem SID:198988383
+BMGC_DG13396,BMG_DG174246,PubChem SID:472423230 | PubChem CID:641296 | CAS RN:15638-14-9 | PHOTOANETHOLE | UNII:AME9HMB99F
+BMGC_DG13397,BMG_DG174248,"(E)-3-(2-methoxyphenyl)prop-2-enal | PubChem CID:641298 | O-Methoxycinnamaldehyde, (E)- | UNII:3GG2B2MUHB | PubChem SID:198972717 | CAS RN:1504-74-1 | O-METHOXYCINNAMALDEHYDE, (E)- | CAS RN:60125-24-8"
+BMGC_DG13398,BMG_DG174256,"5-[6-hydroxy-5-(3-methylbut-2-enyl)-1-benzofuran-2-yl]benzene-1,3-diol | CAS RN:135248-05-4 | moracin N | PubChem CID:641376"
+BMGC_DG13399,BMG_DG174257,"Moracin D | PubChem CID:641378 | 7-(6-hydroxy-1-benzofuran-2-yl)-2,2-dimethylchromen-5-ol | CAS RN:69120-07-6"
+BMGC_DG13400,BMG_DG174258,"NDC:69097-301 | CAS RN:154598-52-4 | NDC:42385-915 | (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one | UNII:JE6H2O27P8 | DrugBank ID:DB00625 | EFAVIRENZ | NDC:0093-5234 | NDC:42385-929 | NDC:49502-475 | NDC:65862-106 | NDC:31722-504 | NDC:33342-138 | NDC:31722-736 | NDC:65862-105 | NDC:33342-013 | Efavirenz | PubChem SID:175265546 | NDC:64380-889 | PubChem CID:64139 | NDC:42385-928 | NDC:51407-382 | NDC:72865-172 | NDC:49502-425 | NDC:65862-497 | NDC:42543-889 | NDC:65862-049 | NDC:69097-210 | NDC:65862-104 | NDC:15584-0101"
+BMGC_DG13401,BMG_DG174260,"CAS RN:159989-65-8 | NELFINAVIR MESYLATE | NDC:63010-010 | (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;methanesulfonic acid | Nelfinavir Mesylate | UNII:98D603VP8V | NDC:63010-027 | PubChem CID:64142 | PubChem SID:175265295"
+BMGC_DG13402,BMG_DG174262,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide | NELFINAVIR | Nelfinavir | PubChem SID:175268605 | DrugBank ID:DB00220 | UNII:HO3OGH5D7I | PubChem CID:64143 | CAS RN:159989-64-7"
+BMGC_DG13403,BMG_DG174267,PubChem CID:64147 | DrugBank ID:DB01610 | Valganciclovir
+BMGC_DG13404,BMG_DG174297,PubChem SID:175265533 | PubChem CID:641785 | CAS RN:19309-14-9 | UNII:H8KP1OJ8JX | DIHYDROXYMETHOXYCHALCONE
+BMGC_DG13405,BMG_DG174301,CAS RN:22966-19-4 | (E)-1-(4-methoxyphenyl)-3-phenylprop-2-en-1-one | UNII:BM45N45FIZ | 4'-METHOXYCHALCONE | CAS RN:959-23-9 | PubChem CID:641818 | PubChem SID:198944785 | 4'-Methoxychalcone
+BMGC_DG13406,BMG_DG174315,PubChem CID:6419701 | UNII:DJA0CXH1MJ | [(2R)-2-hydroxy-3-phosphonooxypropyl] hexadecanoate | CAS RN:7220-34-0 | (2R)-2-hydroxy-3-(phosphonooxy)propyl hexadecanoate | 1-PALMITOYL-SN-GLYCEROL 3-PHOSPHATE | PubChem SID:434369785
+BMGC_DG13407,BMG_DG174325,PubChem SID:198951274 | N-(benzo[b][1]benzoxepin-5-ylmethyl)-N-methylprop-2-yn-1-amine | PubChem CID:6419718 | DrugBank ID:DB12879 | OMIGAPIL | CAS RN:181296-84-4 | CAS RN:634202-78-1 | Omigapil | UNII:5V14HD0N4Q
+BMGC_DG13408,BMG_DG174333,PubChem CID:6419739 | ML-3403 | UNII:VW1528F5YP | CAS RN:549505-65-9 | PubChem SID:319892341
+BMGC_DG13409,BMG_DG174334,PubChem CID:6419747 | OXSI-2 | UNII:5YZ3QBQ97C | CAS RN:1956296-96-0 | PubChem SID:441097154
+BMGC_DG13410,BMG_DG174336,PubChem SID:472410449 | UNII:E54BTB52GP | PubChem CID:6419755 | PKC.BETA. INHIBITOR | CAS RN:257879-35-9
+BMGC_DG13411,BMG_DG174338,PubChem CID:6419766 | N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE | DrugBank ID:DB08454
+BMGC_DG13412,BMG_DG174339,"DrugBank ID:DB07698 | 3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine | PubChem CID:6419789"
+BMGC_DG13413,BMG_DG174340,UNII:U07H877HUF | CAS RN:15966-93-5 | VEGFR 2 KINASE INHIBITOR I | PubChem SID:318691943 | PubChem CID:6419834
+BMGC_DG13414,BMG_DG174341,"[(2S,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | CATECHIN GALLATE, (-)- | (-)-Catechin gallate | PubChem SID:198961376 | CAS RN:130405-40-2 | UNII:0KT1FO6VO6 | PubChem CID:6419835"
+BMGC_DG13415,BMG_DG174365,"CAS RN:1217463-38-1 | CAS RN:3810-74-0 | PubChem CID:6419957 | Streptomycini sulfas | 2-[(1S,2S,3R,4S,5S,6R)-3-(diaminomethylideneamino)-4-[(2R,3R,4R,5S)-3-[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid"
+BMGC_DG13416,BMG_DG174389,"PubChem CID:6420024 | (S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester | [(1S,3R,7S,8S,8aR)-8-[2-[(4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate"
+BMGC_DG13417,BMG_DG174406,UNII:U63F8E95J1 | DrugBank ID:DB07187 | CP-744809 | PubChem CID:6420118 | PubChem SID:198947223 | CAS RN:463976-07-0
+BMGC_DG13418,BMG_DG174407,PubChem CID:6420119 | PubChem SID:478838378 | 4-(Cyclohexylcarbamoylamino)butanoic acid | 4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID | 4-(CYCLOHEXYLCARBAMOYLAMINO)BUTANOIC ACID | UNII:N2N8NLK6Q8 | DrugBank ID:DB08257 | CAS RN:511552-46-8
+BMGC_DG13419,BMG_DG174408,CAS RN:479413-50-8 | 6-(CYCLOHEXYLCARBAMOYLAMINO)HEXANOIC ACID | PubChem SID:461433130 | DrugBank ID:DB08258 | UNII:BCV85A2H3R | PubChem CID:6420120 | 6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID
+BMGC_DG13420,BMG_DG174409,PubChem CID:6420121 | 7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID | DrugBank ID:DB08259
+BMGC_DG13421,BMG_DG174411,"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL | DrugBank ID:DB07597 | PubChem CID:6420129"
+BMGC_DG13422,BMG_DG174412,"TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL | PubChem CID:6420130 | DrugBank ID:DB08654"
+BMGC_DG13423,BMG_DG174413,"CYC-116 | PubChem CID:6420138 | UNII:YAX4981K2D | PubChem SID:461435053 | CAS RN:693228-63-6 | 4-Methyl-5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)thiazol-2-amine | 4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine"
+BMGC_DG13424,BMG_DG174414,DrugBank ID:DB08060 | PubChem CID:6420149 | PubChem SID:459275901 | 2-AMINO-.GAMMA.-OXOBENZENEBUTANOIC ACID | CAS RN:35402-55-2 | 4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID | UNII:YU3DZ8UH2S
+BMGC_DG13425,BMG_DG174415,"PubChem CID:6420152 | DrugBank ID:DB08326 | 2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE"
+BMGC_DG13426,BMG_DG174417,"N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE | PubChem CID:6420159 | DrugBank ID:DB07839"
+BMGC_DG13427,BMG_DG174418,UBP-302 | PubChem SID:474492542 | PubChem CID:6420161 | CAS RN:745055-91-8 | UNII:FZ8AP4UA5Y
+BMGC_DG13428,BMG_DG174419,DrugBank ID:DB07207 | PubChem CID:6420178 | 2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE
+BMGC_DG13429,BMG_DG174432,"Trichloroacetic Acid | CAS RN:76-03-9 | PubChem CID:6421 | UNII:5V2JDO056X | 2,2,2-trichloroacetic acid | Trichloroacetic acid | PubChem SID:175267310 | TRICHLOROACETIC ACID"
+BMGC_DG13430,BMG_DG174439,PubChem SID:474492772 | Proxyfan | 5-(3-phenylmethoxypropyl)-1H-imidazole | PubChem CID:6421522 | CAS RN:177708-09-7 | UNII:2F2S8PT5HN | PROXYFAN
+BMGC_DG13431,BMG_DG174444,"PubChem SID:441331166 | CAS RN:934838-71-8 | IROXANADINE, (+/-)- | PubChem CID:6421776 | UNII:934VN4WJM3 | IROXANADINE, (±)- | CAS RN:203805-20-3 | Iroxanadine | CAS RN:276690-58-5 | IROXANADINE | PubChem SID:198984989 | UNII:3JD92A4CWW | DrugBank ID:DB05444 | IROXANADINE, (+)- | UNII:6K69EJ1DL1 | PubChem SID:441096785 | 5-(piperidin-1-ylmethyl)-3-pyridin-3-yl-5,6-dihydro-2H-1,2,4-oxadiazine"
+BMGC_DG13432,BMG_DG174448,PubChem SID:198972741 | UNII:5EVQ7IRG99 | PubChem CID:6422124 | CIPROXIFAN | cyclopropyl-[4-[3-(1H-imidazol-5-yl)propoxy]phenyl]methanone | Ciproxifan | CAS RN:184025-18-1
+BMGC_DG13433,BMG_DG174462,Leucine - Reduced Carbonyl | DrugBank ID:DB02107 | PubChem CID:642324
+BMGC_DG13434,BMG_DG174464,"PubChem CID:642376 | PubChem SID:312524926 | UNII:6GM611H175 | 3-BUTYLIDENEPHTHALIDE, (Z)- | CAS RN:72917-31-8"
+BMGC_DG13435,BMG_DG174493,PubChem SID:485665238 | CAS RN:170569-87-6 | UNII:228KL4J7NY | DESMETHYL CELECOXIB | Desmethyl Celecoxib | PubChem CID:6426663
+BMGC_DG13436,BMG_DG174495,GLYCYLARGININE | UNII:P56Q695EWK | CAS RN:18635-55-7 | PubChem SID:441583971 | PubChem CID:6426706
+BMGC_DG13437,BMG_DG174496,PROLYLGLYCINE | CAS RN:2578-57-6 | PubChem CID:6426709 | PubChem SID:198949506 | UNII:42521I3FYC
+BMGC_DG13438,BMG_DG174509,"3-[3-[4-[2-(3-Fluorophenyl)ethyl]-1-piperazinyl]propyl]-5-(4H-1,2,4-triazol-4-yl)-1H-indole | CAS RN:188400-51-3 | PubChem SID:485663728 | 1-(3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine | PubChem CID:6426760 | UNII:HY4LUL3MKS | 3-(3-(4-(2-(3-FLUOROPHENYL)ETHYL)-1-PIPERAZINYL)PROPYL)-5-(4H-1,2,4-TRIAZOL-4-YL)-1H-INDOLE | 3-[3-[4-[2-(3-fluorophenyl)ethyl]piperazin-1-yl]propyl]-5-(1,2,4-triazol-4-yl)-1H-indole"
+BMGC_DG13439,BMG_DG174510,"CAS RN:25999-20-6 | PubChem SID:175268661 | Lasalocid Sodium | PubChem CID:6426773 | LASALOCID SODIUM | UNII:W2S5C71Y3G | sodium;6-[(3R,4S,5S,7R)-7-[(2S,3S,5S)-5-ethyl-5-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-3-methyloxolan-2-yl]-4-hydroxy-3,5-dimethyl-6-oxononyl]-2-hydroxy-3-methylbenzoate"
+BMGC_DG13440,BMG_DG174528,Aspartyllysine | (2S)-6-amino-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]hexanoic acid | PubChem CID:6427003 | CAS RN:5891-51-0
+BMGC_DG13441,BMG_DG174641,"CAS RN:87-44-5 | PubChem CID:6429274 | (E)-2-epi-beta-caryophyllene | (1R,4E,9R)-4,11,11-trimethyl-8-methylidenebicyclo[7.2.0]undec-4-ene"
+BMGC_DG13442,BMG_DG174719,PubChem CID:643159 | UNII:UKC5X33HR6 | 2-Cyano-3-phenylacrylic acid | PubChem SID:482554925 | 2-CYANO-3-PHENYLACRYLIC ACID | CAS RN:1011-92-3
+BMGC_DG13443,BMG_DG174729,"UNII:V022ZK8GZ5 | CAS RN:3886-69-9 | PubChem SID:198962826 | 1-PHENETHYLAMINE, (+)- | PubChem CID:643189"
+BMGC_DG13444,BMG_DG174732,"PERFLUTREN | PubChem SID:175265364 | NDC:11994-011 | DrugBank ID:DB00556 | 1,1,1,2,2,3,3,3-octafluoropropane | CAS RN:76-19-7 | Perflutren | UNII:CK0N3WH0SR | PubChem CID:6432 | NDC:11994-017"
+BMGC_DG13445,BMG_DG174738,PubChem SID:472386015 | DrugBank ID:DB06215 | UNII:G6N3J05W84 | Ferumoxides | PubChem SID:175268252 | NDC:59338-775 | UNII:CLH5FT6412 | CAS RN:119683-68-0 | PubChem CID:6432052 | FERUMOXIDES NON-STOICHIOMETRIC MAGNETITE | CAS RN:1317-61-9 | PubChem SID:472385866 | FERROSOFERRIC OXIDE | UNII:XM0M87F357 | NDC:0781-3154 | FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE | iron(2+);iron(3+);oxygen(2-)
+BMGC_DG13446,BMG_DG174812,DrugBank ID:DB06231 | CALDARET | 5-methyl-2-piperazin-1-ylbenzenesulfonic acid | CAS RN:133804-44-1 | PubChem CID:6433076 | PubChem SID:198975042 | Caldaret | UNII:9L3Y3IJ2HI
+BMGC_DG13447,BMG_DG174814,Hexaminolevulinate Hydrochloride | PubChem SID:175268509 | UNII:D4F329SL1O | PubChem CID:6433082 | HEXAMINOLEVULINATE HYDROCHLORIDE | hexyl 5-amino-4-oxopentanoate;hydrochloride | CAS RN:140898-91-5
+BMGC_DG13448,BMG_DG174815,UNII:G7H20TKI67 | Hexaminolevulinate | hexyl 5-amino-4-oxopentanoate | CAS RN:140898-97-1 | DrugBank ID:DB06261 | HEXAMINOLEVULINATE | PubChem CID:6433083 | PubChem SID:175268833
+BMGC_DG13449,BMG_DG174817,"4-(2-methylimidazol-1-yl)-2,2-diphenylbutanamide | UNII:XJR8Y07LJO | IMIDAFENACIN | CAS RN:170105-16-5 | DrugBank ID:DB09262 | PubChem SID:198963787 | PubChem CID:6433090 | Imidafenacin"
+BMGC_DG13450,BMG_DG174818,PubChem SID:198970971 | CAS RN:176644-21-6 | PubChem CID:6433092 | ENIPORIDE | UNII:7IGF9182QU
+BMGC_DG13451,BMG_DG174819,PubChem CID:6433095 | PubChem SID:198989492 | DrugBank ID:DB06677 | UNII:3DRR0X4728 | N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methylpyridine-2-sulfonamide | CLAZOSENTAN | Clazosentan | CAS RN:180384-56-9
+BMGC_DG13452,BMG_DG174822,PubChem SID:198976423 | Pipendoxifene | PubChem CID:6433099 | UNII:TPC5Q8496G | PIPENDOXIFENE | 2-(4-hydroxyphenyl)-3-methyl-1-[[4-(2-piperidin-1-ylethoxy)phenyl]methyl]indol-5-ol | CAS RN:198480-55-6 | DrugBank ID:DB05414
+BMGC_DG13453,BMG_DG174826,"PubChem CID:6433106 | UNII:856DX0KJ84 | Neramexane | 1,3,3,5,5-pentamethylcyclohexan-1-amine | CAS RN:219810-59-0 | NERAMEXANE | PubChem SID:175266348 | DrugBank ID:DB04926"
+BMGC_DG13454,BMG_DG174827,"ROBENACOXIB | 2-[5-ethyl-2-(2,3,5,6-tetrafluoroanilino)phenyl]acetic acid | UNII:Z588009C7C | DrugBank ID:DB11455 | CAS RN:220991-32-2 | Robenacoxib | PubChem CID:6433107 | PubChem SID:175266573"
+BMGC_DG13455,BMG_DG174828,EMAPUNIL | DrugBank ID:DB12666 | Emapunil | UNII:OG837L732J | PubChem SID:198977567 | CAS RN:226954-04-7 | N-benzyl-N-ethyl-2-(7-methyl-8-oxo-2-phenylpurin-9-yl)acetamide | PubChem CID:6433109
+BMGC_DG13456,BMG_DG174829,PubChem SID:198940048 | PubChem CID:6433110 | 5-cyclopropyl-N-(diaminomethylidene)-1-quinolin-5-ylpyrazole-4-carboxamide | CAS RN:241800-98-6 | ZONIPORIDE | Zoniporide | UNII:8841R2UJPG
+BMGC_DG13457,BMG_DG174830,UNII:VR034VW8OG | DrugBank ID:DB13032 | Enecadin | PubChem SID:198960017 | PubChem CID:6433114 | CAS RN:259525-01-4 | ENECADIN | 4-(4-fluorophenyl)-2-methyl-6-(5-piperidin-1-ylpentoxy)pyrimidine
+BMGC_DG13458,BMG_DG174835,PubChem CID:6433122 | PubChem SID:198935204 | UNII:UL09X1D9EM | DrugBank ID:DB13094 | CAS RN:443144-26-1 | PRUVANSERIN | Pruvanserin | 7-[4-[2-(4-fluorophenyl)ethyl]piperazine-1-carbonyl]-1H-indole-3-carbonitrile
+BMGC_DG13459,BMG_DG174845,PubChem SID:175266545 | DrugBank ID:DB14491 | PubChem CID:6433164 | FERROUS FUMARATE | UNII:R5L488RY0Q | CAS RN:7705-12-6 | (E)-but-2-enedioate;iron(2+) | Ferrous Fumarate | CAS RN:141-01-5 | Ferrous fumarate
+BMGC_DG13460,BMG_DG174872,"PubChem CID:6433272 | Mycostatin | CAS RN:1400-61-9 | DrugBank ID:DB00646 | (1S,15S,16R,17R,18S,19E,21E,25E,27E,29E,31E)-33-[(2S,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-1,3,4,7,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicyclo[33.3.1]nonatriaconta-19,21,25,27,29,31-hexaene-36-carboxylic acid"
+BMGC_DG13461,BMG_DG174880,"PubChem SID:198943587 | DrugBank ID:DB04436 | PubChem CID:643330 | CAS RN:139-26-4 | CAS RN:7423-96-3 | (2S)-2-amino-3-(3-fluoro-4-hydroxyphenyl)propanoic acid | 3-FLUOROTYROSINE, L- | UNII:174NRG3M2X | 3-Fluoro-L-tyrosine"
+BMGC_DG13462,BMG_DG174884,"NDC:50991-783 | CAS RN:2391-03-9 | (3S)-3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine;(Z)-but-2-enedioic acid | DEXBROMPHENIRAMINE MALEATE | NDC:54859-803 | NDC:54859-812 | NDC:69367-353 | PubChem CID:6433334 | NDC:45737-210 | NDC:63102-108 | NDC:45737-239 | NDC:12830-816 | NDC:71321-700 | NDC:63102-401 | NDC:50991-788 | UNII:BPA9UT29BS | Dexbrompheniramine Maleate | NDC:54859-802 | NDC:10702-005 | NDC:54859-702 | PubChem SID:175268218"
+BMGC_DG13463,BMG_DG174897,"CAS RN:3709-43-1 | PubChem SID:272993841 | UNII:4U494VHI4D | PubChem CID:6433384 | DISODIUM 4,4'-DINITRO-2,2'-STILBENEDISULFONATE"
+BMGC_DG13464,BMG_DG174902,"PubChem SID:198951709 | 5-(methylsulfanylmethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one | DrugBank ID:DB13724 | NIFURATEL | UNII:U60U6P08SP | PubChem CID:6433427 | Nifuratel | CAS RN:4936-47-4"
+BMGC_DG13465,BMG_DG174917,dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane | CAS RN:8050-81-5 | DrugBank ID:DB09512 | PubChem CID:6433516 | Simethicone
+BMGC_DG13466,BMG_DG174920,"Bambermycin | DrugBank ID:DB11377 | PubChem CID:6433554 | (2S,3S,4R,5R,6R)-5-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-methyl-5-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-[(2-hydroxy-5-oxocyclopenten-1-yl)carbamoyl]oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-4-carbamoyloxy-3-hydroxy-6-[hydroxy-[(2R)-2-hydroxy-3-oxo-3-[(3E,7E,14E)-4,9,9,15,19-pentamethyl-12-methylideneicosa-3,7,14,18-tetraenoxy]propoxy]phosphoryl]oxy-3-methyloxane-2-carboxylic acid"
+BMGC_DG13467,BMG_DG174926,"CAS RN:13422-51-0 | cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate | PubChem CID:6433575"
+BMGC_DG13468,BMG_DG174968,PubChem SID:198945781 | UNII:M2U24OA3UJ | CAS RN:15690-24-1 | PubChem CID:643402 | 2-FURANACRYLIC ACID
+BMGC_DG13469,BMG_DG174979,"DrugBank ID:DB11219 | PubChem CID:6434217 | CAS RN:36861-47-9 | CAS RN:1782069-81-1 | CAS RN:38102-62-4 | (3E)-1,7,7-trimethyl-3-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-2-one | Enzacamene"
+BMGC_DG13470,BMG_DG174982,"Ascofuranone | ASCOFURANONE | UNII:I31EFB9515 | 5-chloro-3-[(2E,6E)-7-[(2S)-5,5-dimethyl-4-oxooxolan-2-yl]-3-methylocta-2,6-dienyl]-2,4-dihydroxy-6-methylbenzaldehyde | CAS RN:38462-04-3 | PubChem CID:6434242 | PubChem SID:319891850"
+BMGC_DG13471,BMG_DG174986,Auroglaucin | CAS RN:41451-81-4 | PubChem CID:6434324 | AUROGLAUCIN | PubChem SID:482553116 | UNII:F5EUT2L56J
+BMGC_DG13472,BMG_DG175012,"PubChem SID:198963463 | UNII:4109R0VM5R | PubChem CID:643497 | CAS RN:23756-79-8 | SULPIRIDE, (R)-"
+BMGC_DG13473,BMG_DG175020,"(1R,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-6'-butan-2-yl-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one;(1R,5'S,6R,6'R,8R,10E,12S,13S,14E,16E,20R,21R,24S)-21,24-dihydroxy-12-[(2R,4S,5S,6S)-5-[(4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethyl-6'-propan-2-ylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one | Mectizan | PubChem CID:6435110"
+BMGC_DG13474,BMG_DG175032,"(5E)-5-[(3aS,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-3,3a,4,5,6,6a-hexahydro-1H-pentalen-2-ylidene]pentanoic acid | PubChem CID:6435378 | CAS RN:78919-13-8"
+BMGC_DG13475,BMG_DG175041,"CAS RN:82009-34-5 | CILASTATIN | PubChem SID:175267016 | CAS RN:81129-83-1 | NDC:0006-3856 | DrugBank ID:DB01597 | (Z)-7-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoic acid | UNII:141A6AMN38 | PubChem CID:6435415 | Cilastatin"
+BMGC_DG13476,BMG_DG175062,"DrugBank ID:DB06433 | Tezacitabine | CAS RN:130306-02-4 | CAS RN:171233-40-2 | 4-amino-1-[(2R,3E,4S,5R)-3-(fluoromethylidene)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one | PubChem SID:198957981 | TEZACITABINE ANHYDROUS | UNII:7607Y95N9S | PubChem CID:6435808"
+BMGC_DG13477,BMG_DG175068,UNII:4TWC061LPM | CAS RN:150399-22-7 | PubChem SID:346538743 | SB-201993 | PubChem CID:6435820
+BMGC_DG13478,BMG_DG175103,"PubChem CID:6435901 | CAS RN:3999-01-7 | Linoleamide | (9Z,12Z)-octadeca-9,12-dienamide | UNII:5340S2UXSP | PubChem SID:198956932 | LINOLEAMIDE"
+BMGC_DG13479,BMG_DG175117,"NDC:45802-055 | NDC:70121-1049 | NDC:0168-0005 | NDC:36800-621 | NDC:45802-054 | NDC:0363-0811 | NDC:70121-1654 | NDC:70752-140 | NDC:70000-0702 | NDC:41163-443 | NDC:71205-627 | NDC:33342-328 | NDC:72162-1387 | NDC:68071-4286 | NDC:70518-3689 | NDC:50090-2542 | NDC:33342-332 | Triamcinolone Acetonide | (1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | NDC:0713-0655 | NDC:50090-0819 | NDC:0703-0245 | NDC:68071-2361 | NDC:71205-009 | NDC:72603-319 | NDC:21922-063 | NDC:0168-0002 | NDC:0713-0229 | NDC:71205-033 | NDC:16714-150 | NDC:50090-1444 | NDC:70121-1652 | NDC:0316-0170 | NDC:63629-8780 | NDC:68071-2362 | NDC:46122-385 | NDC:50090-2106 | NDC:50090-0295 | NDC:50090-6547 | NDC:72162-1806 | NDC:45802-109 | NDC:45802-063 | NDC:45802-817 | NDC:50090-0228 | NDC:68788-8457 | NDC:11822-0443 | NDC:70518-0136 | NDC:50090-2244 | NDC:70752-129 | NDC:70752-130 | NDC:72162-2289 | NDC:68462-798 | NDC:82804-145 | NDC:63187-495 | NDC:50090-3802 | NDC:72162-2334 | NDC:0713-0676 | NDC:45802-065 | NDC:67877-317 | NDC:76420-222 | NDC:16714-986 | NDC:63187-661 | PubChem SID:175266974 | NDC:63629-8782 | NDC:70121-1169 | NDC:72288-443 | NDC:30142-813 | NDC:72189-330 | NDC:71205-038 | NDC:81298-5783 | NDC:82667-800 | NDC:63629-8708 | NDC:68071-4945 | NDC:82804-019 | NDC:41167-5800 | NDC:50090-2658 | NDC:59779-746 | NDC:81298-5781 | NDC:11673-717 | NDC:67296-0764 | NDC:24208-040 | NDC:70518-1094 | NDC:0703-0241 | NDC:63629-8778 | NDC:50090-6211 | NDC:71205-108 | NDC:72162-1835 | NDC:0168-0006 | NDC:16714-140 | NDC:63187-053 | NDC:51672-1267 | NDC:70518-4205 | NDC:16714-130 | NDC:63629-8781 | NDC:63629-9574 | NDC:67296-2116 | NDC:0316-0175 | NDC:0003-0494 | NDC:82804-071 | NDC:0113-0443 | NDC:50090-6533 | NDC:55150-385 | NDC:35573-404 | NDC:33342-331 | NDC:45802-064 | NDC:50090-6566 | NDC:55910-280 | NDC:72162-2318 | NDC:70121-1651 | NDC:72189-571 | NDC:63629-8785 | NDC:67296-1364 | NDC:67457-623 | NDC:50090-0163 | NDC:50090-5980 | PubChem CID:6436 | NDC:63629-9573 | NDC:76420-085 | NDC:50090-4761 | NDC:63187-214 | NDC:51672-1282 | NDC:51672-1335 | NDC:0713-0228 | NDC:67296-1796 | NDC:51862-290 | NDC:64980-320 | NDC:68462-131 | NDC:81298-5785 | NDC:0316-0165 | NDC:72162-2069 | NDC:68462-797 | NDC:72189-039 | NDC:70677-1023 | NDC:21130-443 | NDC:67877-251 | NDC:0168-0003 | NDC:70000-0204 | NDC:33342-333 | NDC:37808-443 | NDC:21922-062 | NDC:55150-384 | NDC:63629-2406 | NDC:72162-1836 | NDC:46287-010 | NDC:0003-0293 | NDC:16714-985 | NDC:50090-0162 | NDC:63187-025 | NDC:68071-4391 | NDC:0713-0226 | NDC:33342-327 | NDC:72189-277 | NDC:68788-7814 | NDC:60505-6275 | NDC:68071-4383 | NDC:72162-2335 | NDC:33342-329 | NDC:76420-203 | NDC:51672-1284 | NDC:67457-621 | NDC:68071-2736 | NDC:49035-443 | NDC:67296-0873 | NDC:68788-8350 | NDC:0078-0897 | NDC:63629-8779 | NDC:72162-1386 | NDC:80425-0262 | NDC:82682-001 | NDC:42571-385 | NDC:70518-2285 | NDC:50090-0293 | NDC:70121-1653 | CAS RN:76-25-5 | NDC:68788-8515 | NDC:72162-2070 | NDC:33342-334 | NDC:83008-088 | NDC:0003-0315 | NDC:71205-124 | NDC:72162-1429 | NDC:70518-2938 | NDC:68788-8753 | NDC:52817-811 | NDC:63629-8841 | NDC:0713-0225 | NDC:45802-049 | UNII:F446C597KA | NDC:50090-1445 | NDC:0703-0243 | NDC:67457-622 | NDC:68788-8386 | NDC:70121-1657 | NDC:67877-318 | NDC:68071-2294 | NDC:68071-4397 | TRIAMCINOLONE ACETONIDE | NDC:45802-045 | NDC:0168-0004 | NDC:70121-1168 | NDC:16714-987 | NDC:41250-443 | NDC:50090-6978 | NDC:68788-8356 | NDC:70518-2963 | NDC:50090-0256 | NDC:63629-8707 | NDC:71656-040 | NDC:0536-1441 | NDC:71656-042 | NDC:63187-870 | NDC:70121-1655 | NDC:16714-268 | NDC:67296-1879 | NDC:68071-1872 | NDC:72162-1832 | NDC:21922-024 | NDC:71205-451 | NDC:24470-922 | NDC:72162-2336 | NDC:76420-220 | NDC:82804-079 | NDC:64380-901 | NDC:50090-3508 | NDC:63629-8784 | NDC:68071-3666 | NDC:63629-2407 | NDC:16714-267 | NDC:68788-7797 | NDC:71335-2211 | NDC:41520-443 | NDC:67296-1619"
+BMGC_DG13480,BMG_DG175123,"Mdl 73811 | UNII:7GI49JB39O | MDL-73811 | CAS RN:123642-27-3 | (2R,3S,4R,5R)-2-[[[(Z)-4-aminobut-2-enyl]-methylamino]methyl]-5-(6-aminopurin-9-yl)oxolane-3,4-diol | PubChem CID:6436013 | PubChem SID:198987950"
+BMGC_DG13481,BMG_DG175128,Prostalene | DrugBank ID:DB11454 | PROSTALENE | UNII:O02SWY8981 | CAS RN:54120-61-5 | PubChem CID:6436031 | PubChem SID:198987889
+BMGC_DG13482,BMG_DG175135,"UNII:104621892X | Vitamin A2 | PubChem SID:198962310 | (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)nona-2,4,6,8-tetraen-1-ol | 3-DEHYDRORETINOL | CAS RN:79-80-1 | PubChem CID:6436043"
+BMGC_DG13483,BMG_DG175141,UNII:668QM8QJFS | TAGORIZINE | PubChem SID:198944618 | CAS RN:118420-47-6 | PubChem CID:6436051
+BMGC_DG13484,BMG_DG175142,SAMIXOGREL | PubChem SID:198957180 | PubChem CID:6436053 | CAS RN:133276-80-9 | UNII:5MB73H1ADH
+BMGC_DG13485,BMG_DG175143,"CEFCAPENE | (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino]-3-(carbamoyloxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CAS RN:135889-00-8 | Cefcapene | UNII:4D5D3422MW | DrugBank ID:DB13461 | PubChem CID:6436055 | PubChem SID:198979368"
+BMGC_DG13486,BMG_DG175146,".ALPHA.-YOHIMBINE | PubChem SID:198947573 | CAS RN:131-03-3 | methyl (1S,15S,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate | CAS RN:112350-93-3 | PubChem CID:643606 | Rauwolscine | UNII:T4LJ7LU45W"
+BMGC_DG13487,BMG_DG175185,"CAS RN:112965-21-6 | PubChem CID:6436131 | (1R,3S,5Z)-5-[(2E)-2-[(1R,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol"
+BMGC_DG13488,BMG_DG175188,"4-[3-[(E)-2-(4-cyclobutyl-1,3-thiazol-2-yl)ethenyl]anilino]-2,2-diethyl-4-oxobutanoic acid | CAS RN:128312-51-6 | CINALUKAST | UNII:5E1O433QAI | Cinalukast | DrugBank ID:DB00587 | PubChem CID:6436135 | PubChem SID:198975891"
+BMGC_DG13489,BMG_DG175191,"Cobamamide | (2S,3S,4R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate | CAS RN:13870-90-1 | PubChem CID:6436143"
+BMGC_DG13490,BMG_DG175201,"CAS RN:80621-81-4 | PubChem SID:175267664 | PubChem CID:6436173 | RIFAXIMIN | DrugBank ID:DB01220 | CAS RN:88747-56-2 | [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,36-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22,30-octamethyl-6,23-dioxo-8,37-dioxa-24,27,33-triazahexacyclo[23.10.1.14,7.05,35.026,34.027,32]heptatriaconta-1(35),2,4,9,19,21,25(36),26(34),28,30,32-undecaen-13-yl] acetate | UNII:L36O5T016N | Rifaximin"
+BMGC_DG13491,BMG_DG175208,LATRUNCULIN B | PubChem SID:198977474 | CAS RN:76343-94-7 | Latrunculin B | DrugBank ID:DB08080 | PubChem CID:6436219 | UNII:LW7U308U7U
+BMGC_DG13492,BMG_DG175209,"DrugBank ID:DB06733 | CAS RN:88899-55-2 | (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16-[(2S,3R,4S)-4-[(2R,4R,5S,6R)-2,4-dihydroxy-5-methyl-6-propan-2-yloxan-2-yl]-3-hydroxypentan-2-yl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one | Bafilomycin A1 | PubChem CID:6436223"
+BMGC_DG13493,BMG_DG175210,"carbanide;cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate | Cobinamide, Co-methyl-, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole, stereoisomer | CAS RN:13422-55-4 | PubChem CID:6436232"
+BMGC_DG13494,BMG_DG175217,"PubChem CID:6436265 | UNII:M17C7V122D | Himbacine | (3S,3aR,4R,4aS,8aR,9aS)-4-[(E)-2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl]-3-methyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3H-benzo[f][2]benzofuran-1-one | PubChem SID:198956190 | HIMBACINE | CAS RN:6879-74-9"
+BMGC_DG13495,BMG_DG175219,AVIGLYCINE | UNII:OW5H814Y1I | CAS RN:49669-74-1 | PubChem CID:6436272 | PubChem SID:198962653
+BMGC_DG13496,BMG_DG175252,MISOPROSTOL ACID | UNII:12Z0SU967A | CAS RN:66792-31-2 | PubChem CID:6436406 | PubChem SID:329903780
+BMGC_DG13497,BMG_DG175348,"DrugBank ID:DB02955 | PubChem CID:643684 | Ricinoleic acid | RICINOLEIC ACID | (Z,12R)-12-hydroxyoctadec-9-enoic acid | CAS RN:141-22-0 | UNII:I2D0F69854 | PubChem SID:175265779"
+BMGC_DG13498,BMG_DG175365,2-[[(Z)-octadec-9-enoyl]amino]acetic acid | CAS RN:2601-90-3 | PubChem CID:6436908 | N-oleoylglycine
+BMGC_DG13499,BMG_DG175388,"PubChem CID:6437075 | Ticarcillin-clavulanic acid | CAS RN:86482-18-0 | (2S,5R,6R)-6-[[(2R)-2-carboxy-2-thiophen-3-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"
+BMGC_DG13500,BMG_DG175423,"Beta-Zearalenol | (4S,8S,12E)-8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraen-2-one | .BETA.-ZEARALENOL | PubChem CID:6437352 | PubChem SID:198958395 | CAS RN:71030-11-0 | UNII:35E809PP7O"
+BMGC_DG13501,BMG_DG175431,"Manoalide | PubChem SID:198946873 | MANOALIDE | UNII:E1DK0157K9 | CAS RN:75088-80-1 | (2R)-2-hydroxy-3-[(2R,6R)-6-hydroxy-5-[(E)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hex-3-enyl]-3,6-dihydro-2H-pyran-2-yl]-2H-furan-5-one | PubChem CID:6437368"
+BMGC_DG13502,BMG_DG175438,Latrunculin A | PubChem CID:6437378 | DrugBank ID:DB02621
+BMGC_DG13503,BMG_DG175440,"LUMEFANTRINE, (-)- | 2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol | PubChem SID:255509217 | LUMEFANTRINE | CAS RN:204133-10-8 | CAS RN:82186-77-4 | CAS RN:120583-71-3 | UNII:F38R0JR742 | DrugBank ID:DB06708 | CAS RN:120583-70-2 | PubChem SID:175271974 | LUMEFANTRINE, (+)- | Lumefantrine | UNII:01NP22J3SV | UNII:ZUV4B00D9P | PubChem CID:6437380 | PubChem SID:255509325"
+BMGC_DG13504,BMG_DG175441,"Microcystin-LA | PubChem CID:6437382 | (5R,8S,11R,12S,15S,18S,19S,22R)-18-[(1E,3E,5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,5,12,15,19-pentamethyl-2-methylidene-8-(2-methylpropyl)-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid | UNII:3E7C54U3SY | PubChem SID:318691980 | CAS RN:96180-79-9 | CYANOGINOSIN LA"
+BMGC_DG13505,BMG_DG175465,"NDC:43742-1507 | Aconitic Acid | UNII:OF5471ZHRR | NDC:43742-1371 | NDC:44911-0539 | CAS RN:499-12-7 | (Z)-prop-1-ene-1,2,3-tricarboxylic acid | NDC:44911-0294 | NDC:44911-0703 | PubChem CID:643757 | ACONITIC ACID, (Z)- | PubChem SID:175265402 | CAS RN:585-84-2"
+BMGC_DG13506,BMG_DG175504,"CAS RN:33631-47-9 | PubChem CID:6437840 | UNII:ZBJ8HC23XW | PubChem SID:482552991 | HYDROXYETHYL)RETINAMIDE, ALL-TRANS-4-N-(2-"
+BMGC_DG13507,BMG_DG175509,UNII:FE9XN4NVW4 | 4-[2-[4-[3-(4-Chlorophenyl)-2-propen-1-yl]-1-piperazinyl]ethyl]benzoic acid | 4-(2-(1-(4-Chlorocinnamyl)piperazin-4-yl)ethyl)benzoic acid | PubChem SID:485660943 | 4-(2-(4-(3-(4-CHLOROPHENYL)-2-PROPEN-1-YL)-1-PIPERAZINYL)ETHYL)BENZOIC ACID | PubChem CID:6437849 | 4-[2-[4-[(E)-3-(4-chlorophenyl)prop-2-enyl]piperazin-1-yl]ethyl]benzoic acid | CAS RN:86621-92-3
+BMGC_DG13508,BMG_DG175511,(2E)-2-(fluoromethylidene)-4-(4-fluorophenyl)butan-1-amine | PubChem SID:198940870 | Mofegiline | PubChem CID:6437850 | UNII:1FMJ6D8Y1B | CAS RN:119386-96-8 | MOFEGILINE
+BMGC_DG13509,BMG_DG175520,"CAS RN:117467-28-4 | Cefditoren Pivoxil | PubChem CID:6437877 | CAS RN:1448435-17-3 | CEFDITOREN PIVOXIL | UNII:78THA212DH | 2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | PubChem SID:175265676"
+BMGC_DG13510,BMG_DG175524,(Z)-3-chloroprop-2-enoic acid | PubChem CID:643794 | CAS RN:1609-93-4 | cis-3-Chloroacrylic acid
+BMGC_DG13511,BMG_DG175525,Citraconic acid | UNII:0RQ6CXO9KD | CAS RN:28259-97-4 | PubChem CID:643798 | DrugBank ID:DB04734 | PubChem SID:198971059 | CAS RN:498-23-7 | CITRACONIC ACID | (Z)-2-methylbut-2-enedioic acid | CAS RN:7407-59-2
+BMGC_DG13512,BMG_DG175549,UNII:PAU7YA7FF9 | PubChem SID:474489594 | Dehydrocurvularin | CAS RN:21178-57-4 | PubChem CID:6438143 | DEHYDROCURVULARIN
+BMGC_DG13513,BMG_DG175554,"DrugBank ID:DB14062 | CAS RN:98932-70-8 | Concanamycin A | PubChem CID:6438151 | [(2R,3S,4R,6R)-6-[(2R,4R,5S,6R)-2-[(2S,3R,4S)-4-[(2R,3S,4E,6E,9R,10S,11S,12R,13R,14E,16Z)-11-ethyl-10,12-dihydroxy-3,17-dimethoxy-7,9,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6,14,16-tetraen-2-yl]-3-hydroxypentan-2-yl]-2-hydroxy-5-methyl-6-[(E)-prop-1-enyl]oxan-4-yl]oxy-4-hydroxy-2-methyloxan-3-yl] carbamate | CAS RN:80890-47-7"
+BMGC_DG13514,BMG_DG175566,"UNII:38G5P53250 | (2Z)-3,7-dimethylocta-2,6-dien-1-ol | CAS RN:106-25-2 | NEROL | PubChem CID:643820 | PubChem SID:198969305 | Nerol"
+BMGC_DG13515,BMG_DG175587,"METHANANDAMIDE, (±)- | PubChem CID:6438332 | METHANANDAMIDE, (+/-)- | UNII:63WDT9CZ3Y | CAS RN:150314-39-9 | PubChem SID:440088385"
+BMGC_DG13516,BMG_DG175598,"(4R,4aS,6Z,7aR,12bS)-6-benzylidene-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,7a,13-hexahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one | Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-7-(phenylmethylene)-, (5alpha)- | PubChem CID:6438353 | CAS RN:129468-28-6"
+BMGC_DG13517,BMG_DG175599,UNII:ZK4N9HRN7L | CAS RN:112504-68-4 | N-(3-phenoxycinnamyl)acetohydroxamic acid | N-(3-PHENOXYCINNAMYL)ACETOHYDROXAMIC ACID | PubChem CID:6438354 | N-hydroxy-N-[(E)-3-(3-phenoxyphenyl)prop-2-enyl]acetamide | CAS RN:106328-57-8 | PubChem SID:482552982 | N-(3-Phenoxycinnamyl)acetohydroxamic acid
+BMGC_DG13518,BMG_DG175600,"PubChem CID:6438355 | UNII:1117HVX02L | CAS RN:144541-82-2 | (1S,3S,4S,5R,6R,7R)-1-[(4S,5R)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-6-[(E,4S,6S)-4,6-dimethyloct-2-enoyl]oxy-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid | ZARAGOZIC ACID A | PubChem SID:198947077 | CAS RN:138682-84-5 | Zaragozic Acid A | CAS RN:142561-96-4"
+BMGC_DG13519,BMG_DG175602,5-[2-(2-carboxyethyl)-3-[(E)-6-(4-methoxyphenyl)hex-5-enoxy]phenoxy]pentanoic acid | 5-(2-(2-Carboxyethyl)-3-(6-(4-methoxyphenyl)-5E-hexenyl)oxyphenoxy)valeric acid | CAS RN:134578-96-4 | PubChem CID:6438358
+BMGC_DG13520,BMG_DG175610,"S-farnesylcysteine | PubChem SID:434369686 | CAS RN:68000-92-0 | UNII:59S52SU9NV | (2R)-2-amino-3-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylpropanoic acid | S-FARNESYL CYSTEINE | PubChem CID:6438372"
+BMGC_DG13521,BMG_DG175612,"(E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S,5S)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]hept-2-enoic acid | UNII:L02U804092 | CAS RN:74397-12-9 | LIMAPROST | PubChem CID:6438378 | DrugBank ID:DB09211 | Limaprost | PubChem SID:198960262 | CAS RN:85679-52-3"
+BMGC_DG13522,BMG_DG175618,"CAS RN:35891-70-4 | MYRIOCIN | PubChem CID:6438394 | (E,2S,3R,4R)-2-amino-3,4-dihydroxy-2-(hydroxymethyl)-14-oxoicos-6-enoic acid | UNII:YRM4E8R9ST | PubChem SID:198960138 | Myriocin"
+BMGC_DG13523,BMG_DG175634,4-HYDROXYDERRICIN | CAS RN:55912-03-3 | PubChem SID:384158349 | PubChem CID:6438503 | UNII:PF5YY4IV2O
+BMGC_DG13524,BMG_DG175639,DrugBank ID:DB08455 | RO 12-7310 | CAS RN:65316-65-6 | PubChem SID:434370078 | Ro 12-7310 | PubChem CID:6438583 | UNII:G2CPU7AI1D
+BMGC_DG13525,BMG_DG175644,CAS RN:68676-88-0 | UNII:8K9Y0C8YN4 | TRICHOSTATIN C | PubChem SID:198981818 | PubChem CID:6438637
+BMGC_DG13526,BMG_DG175650,MANOALOGUE | PubChem CID:6438691 | CAS RN:136440-42-1 | UNII:9Y87O3147P | PubChem SID:316917973
+BMGC_DG13527,BMG_DG175662,UNII:8991DSI89V | CAS RN:99217-68-2 | BROUSSOCHALCONE A | PubChem SID:198949757 | PubChem CID:6438825
+BMGC_DG13528,BMG_DG175669,"PubChem SID:198947559 | CAS RN:188181-42-2 | UNII:TA7WJG93AR | [(2R,3S,4S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl (E)-octadec-9-enoate | DrugBank ID:DB05494 | CAS RN:101235-34-1 | PubChem CID:6438895 | ELACYTARABINE | Elacytarabine"
+BMGC_DG13529,BMG_DG175678,PubChem SID:376072269 | PubChem CID:6439060 | UNII:7G3UI0W9Y5 | RO-24-238 | CAS RN:120555-31-9
+BMGC_DG13530,BMG_DG175679,CAS RN:107019-95-4 | PubChem CID:6439099 | UNII:3P6464ZQCD | PubChem SID:241179195 | HYMENIDIN
+BMGC_DG13531,BMG_DG175694,PubChem CID:6439222 | CAS RN:127035-60-3 | PubChem SID:198964671 | ENOFELAST | UNII:3T93TS0430
+BMGC_DG13532,BMG_DG175701,UNII:9K6U3I1UR0 | DrugBank ID:DB05792 | PubChem CID:6439330 | SR-31747 | N-[(Z)-3-(3-chloro-4-cyclohexylphenyl)prop-2-enyl]-N-ethylcyclohexanamine;hydrochloride | CAS RN:132173-07-0 | PubChem SID:198970214 | Arylacenamide | N-Cyclohexyl-N-ethyl-3-(3-chloro-4-cyclohexylphenyl)propen-2-ylamine hydrochloride
+BMGC_DG13533,BMG_DG175703,"PubChem CID:6439397 | (2E)-2-[(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methylidene]undecanoic acid | PubChem SID:384648148 | APX-3330 | CAS RN:136164-66-4 | UNII:11267UI968"
+BMGC_DG13534,BMG_DG175717,"PubChem SID:198940070 | NDC:81672-5051 | 5-[(E)-2-phenylethenyl]-2-propan-2-ylbenzene-1,3-diol | PubChem CID:6439522 | UNII:84HW7D0V04 | CAS RN:115781-08-3 | TAPINAROF | DrugBank ID:DB06083 | CAS RN:79338-84-4 | Tapinarof"
+BMGC_DG13535,BMG_DG175738,"PubChem CID:643975 | DrugBank ID:DB03147 | UNII:ZC44YTI8KK | PubChem SID:175266471 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate | CAS RN:146-14-5 | Flavin adenine dinucleotide | Flavin-Adenine Dinucleotide | FLAVIN ADENINE DINUCLEOTIDE"
+BMGC_DG13536,BMG_DG175740,"PubChem CID:643976 | DrugBank ID:DB03247 | UNII:7N464URE7E | PubChem SID:198979376 | CAS RN:146-17-8 | RIBOFLAVIN 5'-PHOSPHATE | Flavin mononucleotide | [(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate"
+BMGC_DG13537,BMG_DG175747,"PubChem CID:6439848 | Eicosadienoic acid | (11Z,14Z)-icosa-11,14-dienoic acid | CAS RN:5598-38-9"
+BMGC_DG13538,BMG_DG175755,PubChem CID:643990 | SIALYL LEWIS X | CAS RN:98603-84-0 | PubChem SID:377308274 | UNII:0PS35WG8U3
+BMGC_DG13539,BMG_DG175758,"PubChem CID:6439929 | UNII:9B259YE66O | GUGGULSTERONE, (E)- | PubChem SID:198979541 | CAS RN:39025-24-6"
+BMGC_DG13540,BMG_DG175762,"(2E,4E,8E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnona-2,4,8-trien-1-one | Dehydropipernonaline | PubChem CID:6439947 | CAS RN:107584-38-3"
+BMGC_DG13541,BMG_DG175769,4-HYDROXY-DEXTROAMPHETAMINE | CAS RN:1693-66-9 | UNII:7UDF5TX27X | PubChem CID:644000 | PubChem SID:251966001
+BMGC_DG13542,BMG_DG175779,PubChem CID:644013 | 3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER | DrugBank ID:DB08618
+BMGC_DG13543,BMG_DG175781,"Fenretinide, (13Z)- | PubChem SID:472426352 | CAS RN:75686-07-6 | FENRETINIDE, (13Z)- | UNII:FC9HY55FGK | PubChem CID:6440160"
+BMGC_DG13544,BMG_DG175784,"CAS RN:75747-14-7 | PubChem CID:6440175 | [(4E,6E,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate"
+BMGC_DG13545,BMG_DG175785,"Krn-5500 | CAS RN:151276-95-8 | PubChem SID:322058775 | (2E,4E)-N-[2-[[(2R,3R,4R,5R,6S)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxy-6-(7H-purin-6-ylamino)oxan-3-yl]amino]-2-oxoethyl]tetradeca-2,4-dienamide | KRN-5500 | DrugBank ID:DB15215 | PubChem CID:6440176 | UNII:8VH13L5K20"
+BMGC_DG13546,BMG_DG175788,"UNII:1Q4092099O | PubChem CID:6440180 | PubChem SID:198984345 | DrugBank ID:DB04947 | ALTROPANE | Altropane | CAS RN:180468-34-2 | methyl (1R,2S,3S,5S)-3-(4-fluorophenyl)-8-[(E)-3-iodoprop-2-enyl]-8-azabicyclo[3.2.1]octane-2-carboxylate"
+BMGC_DG13547,BMG_DG175791,"2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol | CAS RN:3556-78-3 | UNII:19GBJ60SN5 | PubChem CID:644019 | CAS RN:13956-29-1 | CANNABIDIOL | PubChem SID:198983043 | DrugBank ID:DB09061 | NDC:70127-100 | Cannabidiol"
+BMGC_DG13548,BMG_DG175792,"UNII:298897D62S | Sparteine | SPARTEINE | CAS RN:90-39-1 | (1S,2R,9S,10S)-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadecane | PubChem SID:198956153 | DrugBank ID:DB06727 | PubChem CID:644020"
+BMGC_DG13549,BMG_DG175802,"CAS RN:223537-30-2 | Rupintrivir | PubChem SID:198938695 | PubChem CID:6440352 | RUPINTRIVIR | ethyl (E,4S)-4-[[(2R,5S)-2-[(4-fluorophenyl)methyl]-6-methyl-5-[(5-methyl-1,2-oxazole-3-carbonyl)amino]-4-oxoheptanoyl]amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate | DrugBank ID:DB05102 | UNII:RGE5K1Q5QW"
+BMGC_DG13550,BMG_DG175804,PubChem CID:6440365 | PubChem SID:485665924 | YAKUCHINONE B | CAS RN:81840-57-5 | UNII:J8L7BX8M7S | Yakuchinone B
+BMGC_DG13551,BMG_DG175809,"PubChem CID:6440422 | 4-[(2E)-3,7-dimethylocta-2,6-dienoxy]-9-methoxyfuro[3,2-g]chromen-7-one | 9-Hydroxy-4-(3,7-dimethyl-2,6-octadienyloxy)-psoralen | CAS RN:69239-53-8"
+BMGC_DG13552,BMG_DG175825,"DODECATETRAENOIC ACID ISOBUTYLAMIDE, (2E,4E,8Z,10E)- | PubChem CID:6440539 | UNII:NXV62B426A | PubChem SID:316909116 | CAS RN:75917-90-7"
+BMGC_DG13553,BMG_DG175841,"S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-hydroxybutanethioate | DrugBank ID:DB03612 | 3-hydroxybutanoyl-CoA | 3-Hydroxybutyryl-Coenzyme A | CAS RN:2871-66-1 | CAS RN:1259998-21-4 | PubChem CID:644065"
+BMGC_DG13554,BMG_DG175844,"DrugBank ID:DB04524 | CAS RN:524-14-1 | Malonyl coenzyme A | PubChem SID:474494185 | MALONYL COENZYME A | 3-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-3-oxopropanoic acid | malonyl-CoA | PubChem CID:644066 | UNII:LNB9YCJ9F9 | Malonyl-CoA"
+BMGC_DG13555,BMG_DG175850,"CAS RN:24916-50-5 | DrugBank ID:DB06145 | Spiramycin A | CAS RN:8025-81-8 | PubChem CID:6440717 | Spiramycin | 2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde"
+BMGC_DG13556,BMG_DG175854,"NDC:58284-208 | DrugBank ID:DB00921 | NDC:69238-1205 | NDC:47781-407 | NDC:69238-1202 | NDC:50742-374 | NDC:58284-228 | CAS RN:52485-79-7 | NDC:12496-0300 | NDC:69238-1204 | NDC:59011-751 | NDC:42858-586 | NDC:58284-296 | NDC:59011-757 | NDC:47781-408 | NDC:42858-493 | NDC:59011-758 | NDC:58284-232 | NDC:62175-458 | NDC:47781-406 | UNII:40D3SCR4GZ | PubChem CID:644073 | NDC:50742-372 | NDC:50742-376 | NDC:0093-3239 | NDC:62175-452 | NDC:69238-1505 | Buprenorphine | NDC:42858-750 | NDC:59011-750 | NDC:12496-0100 | (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol | NDC:0093-3659 | NDC:71335-1296 | NDC:0093-3656 | NDC:0093-3657 | NDC:59011-752 | NDC:58284-216 | NDC:42858-353 | NDC:58284-264 | NDC:71335-1378 | NDC:50742-375 | BUPRENORPHINE | NDC:0093-3658 | NDC:58064-408 | NDC:50742-373 | NDC:47781-419 | PubChem SID:175268731 | NDC:42858-839 | NDC:58284-224 | NDC:69238-1203"
+BMGC_DG13557,BMG_DG175859,"CAS RN:50-57-7 | (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide | LYPRESSIN | Lypressin | DrugBank ID:DB14642 | PubChem SID:375086200 | UNII:7CZF3L922Y | PubChem CID:644076"
+BMGC_DG13558,BMG_DG175861,"CAS RN:232925-18-7 | PubChem SID:198969576 | PubChem CID:6440764 | DrugBank ID:DB05116 | UNII:2ZRZ4TSW3F | Thymectacin | THYMECTACIN | methyl (2S)-2-[[[(2R,3S,5R)-5-[5-[(E)-2-bromoethenyl]-2,4-dioxopyrimidin-1-yl]-3-hydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate"
+BMGC_DG13559,BMG_DG175862,"Argipressin | CAS RN:113-79-1 | Vasopressin | VASOPRESSIN | PubChem CID:644077 | UNII:Y4907O6MFD | PubChem SID:375084243 | (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide"
+BMGC_DG13560,BMG_DG175889,"PubChem CID:6440940 | PubChem SID:198936993 | VALERENIC ACID | (E)-3-[(4S,7R,7aR)-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enoic acid | UNII:34NDB285PM | Valerenic acid | CAS RN:3569-10-6"
+BMGC_DG13561,BMG_DG175906,PYROPHOSPHATE | PubChem SID:312524799 | UNII:X3SSV2V6L3 | PubChem CID:644102 | phosphonato phosphate | CAS RN:14000-31-8 | Diphosphate
+BMGC_DG13562,BMG_DG175918,"CAS RN:1763-10-6 | Palmitoyl Coenzyme A | PubChem CID:644109 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] hexadecanethioate"
+BMGC_DG13563,BMG_DG175919,"CAS RN:63409-12-1 | PubChem CID:6441094 | [(2S,3S,4R,6S)-6-[(2R,3S,4R,5R,6R)-6-[[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-4-acetyloxy-16-ethyl-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-7-(2-oxoethyl)-1-oxacyclohexadeca-11,13-dien-6-yl]oxy]-4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2,4-dimethyloxan-3-yl] 3-methylbutanoate | DrugBank ID:DB11554 | PubChem SID:175268645 | Tylvalosin | UNII:9T02S42WQO | TYLVALOSIN"
+BMGC_DG13564,BMG_DG175941,MAREIN | CAS RN:535-96-6 | PubChem CID:6441269 | UNII:CY787E65J4 | PubChem SID:472422886
+BMGC_DG13565,BMG_DG175969,PubChem CID:6441498 | UNII:100IP83JAC | PubChem SID:241179490 | CAS RN:28831-65-4 | LITHOSPERMIC ACID
+BMGC_DG13566,BMG_DG175980,"XYLOSE | DrugBank ID:DB09419 | CAS RN:58-86-6 | DL-Xylose | CAS RN:25702-75-4 | (2R,3S,4R)-2,3,4,5-tetrahydroxypentanal | CAS RN:41247-05-6 | UNII:A1TA934AKO | PubChem CID:644160 | PubChem SID:175267280 | CAS RN:25990-60-7 | Xylose"
+BMGC_DG13567,BMG_DG175984,PubChem CID:6441619 | PubChem SID:198971071 | CAS RN:154413-61-3 | TICOLUBANT | UNII:C1FRU4800P
+BMGC_DG13568,BMG_DG175991,LATANOPROST ACID | CAS RN:41639-83-2 | PubChem SID:198989236 | PubChem CID:6441636 | UNII:EJ85341990
+BMGC_DG13569,BMG_DG176002,"PubChem SID:198951611 | CAS RN:67110-79-6 | Luprostiol | UNII:HWR60H5GZB | PubChem CID:6441712 | DrugBank ID:DB11425 | LUPROSTIOL | (Z)-7-[(1R,2S,3S,5R)-2-[(2R)-3-(3-chlorophenoxy)-2-hydroxypropyl]sulfanyl-3,5-dihydroxycyclopentyl]hept-5-enoic acid"
+BMGC_DG13570,BMG_DG176017,PubChem CID:6441913 | CAS RN:63644-62-2 | CONIFERYL FERULATE | PubChem SID:249493523 | UNII:3SK9G87Y9Q
+BMGC_DG13571,BMG_DG176030,"(1R,2S,6R,14R,15R,19R)-19-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol | PubChem CID:644209 | ETORPHINE | UNII:42M2Y6NU9O | PubChem SID:198970803 | CAS RN:14521-96-1 | Etorphine"
+BMGC_DG13572,BMG_DG176031,"UNII:QH25YS93HX | PubChem SID:441097341 | (2S)-2-[[(2S)-2-[[(3S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoic acid | PubChem CID:644210 | Tyrosyl-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-phenylalanyl-phenylalanine | CAS RN:146369-65-5 | TYR-TIC-PHE-PHE"
+BMGC_DG13573,BMG_DG176033,PubChem CID:644213 | DrugBank ID:DB07863 | 2-CHLORO-5-NITRO-N-PHENYLBENZAMIDE | CAS RN:22978-25-2 | 2-chloro-5-nitro-N-phenylbenzamide | PubChem SID:440088629 | UNII:UM18UZV2YD
+BMGC_DG13574,BMG_DG176034,PubChem SID:198938067 | CAS RN:164658-13-3 | CGP-60474 | PubChem CID:644215 | UNII:16IP6G5MLC
+BMGC_DG13575,BMG_DG176037,"CAS RN:159351-69-6 | PubChem CID:6442177 | Everolimus | UNII:9HW64Q8G6G | DrugBank ID:DB01590 | (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone | PubChem SID:175265707 | EVEROLIMUS"
+BMGC_DG13576,BMG_DG176047,"PubChem CID:6442269 | E 5531 | PubChem SID:348481187 | DrugBank ID:DB06447 | CAS RN:162679-36-9 | UNII:4468VT5E70 | [(3R)-1-[(2R,3R,4R,5S,6R)-2-[[(2R,3S,4R,5R,6R)-3-hydroxy-4-[(3R)-3-hydroxydecoxy]-5-(3-oxotetradecanoylamino)-6-phosphonooxyoxan-2-yl]methoxy]-6-(methoxymethyl)-3-(3-oxotetradecanoylamino)-5-phosphonooxyoxan-4-yl]oxydecan-3-yl] (Z)-dodec-5-enoate | E-5531"
+BMGC_DG13577,BMG_DG176058,GUINEESINE | PubChem CID:6442405 | PubChem SID:440088664 | UNII:7DK8DMU9JX | CAS RN:55038-30-7
+BMGC_DG13578,BMG_DG176059,NDC:24338-155 | CAS RN:641571-10-0 | PubChem CID:644241 | PubChem SID:175266747 | NDC:24338-154 | CAS RN:1353151-22-0 | NILOTINIB | Nilotinib | UNII:F41401512X | 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide | DrugBank ID:DB04868
+BMGC_DG13579,BMG_DG176070,"Sphinganine 1-phosphate | [(2S,3R)-2-amino-3-hydroxyoctadecyl] dihydrogen phosphate | CAS RN:19794-97-9 | CAS RN:108126-32-5 | PubChem CID:644260 | CAS RN:28508-07-8"
+BMGC_DG13580,BMG_DG176073,"PubChem CID:6442618 | PubChem SID:472424003 | UNII:6EHK92QE99 | CAS RN:38489-67-7 | 2,5-DIHYDROXYCINNAMIC ACID"
+BMGC_DG13581,BMG_DG176080,CAS RN:34221-41-5 | Echinatin | UNII:3816S4UA9R | PubChem CID:6442675 | ECHINATIN | PubChem SID:198990221 | (E)-3-(4-hydroxy-2-methoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one
+BMGC_DG13582,BMG_DG176092,UNII:8NZ4Y08T96 | PubChem SID:198938367 | REVERSE TRIIODOTHYRONINE | CAS RN:5817-39-0 | PubChem CID:644280
+BMGC_DG13583,BMG_DG176096,"Cobinamide, isocyanide, dihydrogen phosphate (eater), inner salt, 3'-ester with 5,6-dimethyl-1-alpha-D-ribofuranosyl-1H-benzimidazole | cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(4Z,9Z,14Z)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;cyanide | CAS RN:68-19-9 | PubChem CID:6442967 | CAS RN:89138-85-2"
+BMGC_DG13584,BMG_DG176098,"UNII:5F4WO3BVS9 | CAS RN:24738-51-0 | DODECATETRAENOIC ACID ISOBUTYLAMIDE, (2E,4E)- | PubChem SID:252164500 | PubChem CID:6443006"
+BMGC_DG13585,BMG_DG176099,"PubChem SID:441097380 | UNII:53CYY2A5PM | CORIOLIC ACID, (±)- | CAS RN:18104-45-5 | (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid | CORIOLIC ACID, (+/-)- | CORIOLIC ACID, (+)- | CAS RN:29623-28-7 | CAS RN:10219-69-9 | PubChem CID:6443013 | DrugBank ID:DB06926 | UNII:U2DA27TT5J | PubChem SID:441097651"
+BMGC_DG13586,BMG_DG176127,PubChem CID:644345 | (4S)-4-[[(2S)-2-acetamido-3-carboxypropanoyl]amino]-5-[[(2S)-1-[[(2S)-1-carboxy-3-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoic acid | CAS RN:169332-60-9 | CAS RN:184179-08-6 | Ac-DEVD-CHO
+BMGC_DG13587,BMG_DG176203,LY-223982 | PubChem SID:348481366 | CAS RN:117423-74-2 | PubChem CID:6444688 | UNII:XG52JC545T
+BMGC_DG13588,BMG_DG176204,"MUBRITINIB | PubChem SID:198947389 | Mubritinib | UNII:V734AZP9BR | CAS RN:366017-09-6 | PubChem CID:6444692 | 4-[[4-[4-(triazol-1-yl)butyl]phenoxy]methyl]-2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazole | DrugBank ID:DB12682"
+BMGC_DG13589,BMG_DG176208,PubChem SID:198959370 | DARBUFELONE | CAS RN:139226-28-1 | UNII:72H8H6K34C | PubChem CID:6444826
+BMGC_DG13590,BMG_DG176217,ethyl 3-(2-((4-(N-(hexyloxycarbonyl)carbamimidoyl)phenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate | DrugBank ID:DB06695 | ethyl 3-[[2-[[4-[(Z)-N'-hexoxycarbonylcarbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate | Dabigatran etexilate | PubChem CID:6445226
+BMGC_DG13591,BMG_DG176220,"DrugBank ID:DB13471 | CAS RN:152657-84-6 | PubChem CID:6445230 | Nalfurafine | PubChem SID:198970049 | (E)-N-[(4R,4aS,7R,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide | NALFURAFINE | UNII:XC41AVD567"
+BMGC_DG13592,BMG_DG176224,PubChem CID:6445533 | PubChem SID:198961127 | UNII:V10P524501 | DACINOSTAT | CAS RN:404951-53-7
+BMGC_DG13593,BMG_DG176227,CAS RN:951155-17-2 | IFERANSERIN | CAS RN:58754-46-4 | Iferanserin | PubChem CID:6445539 | DrugBank ID:DB11686 | (E)-N-[2-[2-[(2S)-1-methylpiperidin-2-yl]ethyl]phenyl]-3-phenylprop-2-enamide | PubChem SID:198986049 | UNII:NWR3BEB8PA
+BMGC_DG13594,BMG_DG176228,"UNII:K27005NP0A | IXABEPILONE | PubChem CID:6445540 | DrugBank ID:DB04845 | CAS RN:219989-84-1 | PubChem SID:175267394 | Ixabepilone | (1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione"
+BMGC_DG13595,BMG_DG176229,(E)-N-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide | PubChem SID:198957925 | DrugBank ID:DB05524 | CAS RN:257933-82-7 | Pelitinib | CAS RN:326894-84-2 | UNII:X5DWL380Z6 | PubChem CID:6445562 | PELITINIB
+BMGC_DG13596,BMG_DG176241,"CAS RN:76-43-7 | PubChem CID:6446 | PubChem SID:175265297 | DrugBank ID:DB01185 | FLUOXYMESTERONE | Fluoxymesterone | UNII:9JU12S4YFY | (8S,9R,10S,11S,13S,14S,17S)-9-fluoro-11,17-dihydroxy-10,13,17-trimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG13597,BMG_DG176243,"UNII:YFK4Y7J5WQ | CAS RN:54739-30-9 | (9Z,11E)-13-oxooctadeca-9,11-dienoic acid | PubChem CID:6446027 | 13-keto-9Z,11E-octadecadienoic acid | 13-OXO-9Z,11E-OCTADECADIENOIC ACID"
+BMGC_DG13598,BMG_DG176261,UNII:F0O89MB7QE | PubChem CID:6446788 | PROPENIDAZOLE | PubChem SID:198945611 | ethyl (2E)-2-[(1-methyl-5-nitroimidazol-2-yl)methylidene]-3-oxobutanoate | CAS RN:76448-31-2 | DrugBank ID:DB13319 | Propenidazole
+BMGC_DG13599,BMG_DG176284,"CAS RN:113866-89-0 | CAS RN:118026-33-8 | 1-(2,4-dihydroxyphenyl)-3-[2-[(2E)-3,7-dimethylocta-2,6-dienyl]-3,4-dihydroxyphenyl]propan-1-one | PubChem CID:6449829 | 2-Geranyl-2',3,4,4'-tetrahydroxydihydrochalcone"
+BMGC_DG13600,BMG_DG176287,DrugBank ID:DB12204 | CAS RN:149979-74-8 | (E)-6-[3-[(N'-tert-butyl-N-cyanocarbamimidoyl)amino]phenyl]-6-pyridin-3-ylhex-5-enoic acid | UNII:5Z4KWQ5OGN | PubChem CID:6449876 | TERBOGREL | PubChem SID:198978038 | Terbogrel
+BMGC_DG13601,BMG_DG176298,CANNABIGEROLIC ACID | CAS RN:25555-57-1 | PubChem CID:6449999 | UNII:80I4ZM847Y | PubChem SID:198942968
+BMGC_DG13602,BMG_DG176306,DrugBank ID:DB04506 | PubChem CID:6450186 | Chlorophyll B
+BMGC_DG13603,BMG_DG176323,"PubChem CID:6450278 | Guggulsterone | CAS RN:95975-55-6 | CAS RN:39025-23-5 | PubChem SID:198967326 | UNII:6CST3U34GN | (8R,9S,10R,13S,14S,17Z)-17-ethylidene-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15-decahydrocyclopenta[a]phenanthrene-3,16-dione | GUGGULSTERONE, (Z)-"
+BMGC_DG13604,BMG_DG176339,(Z)-7-phenyl-7-pyridin-4-ylhept-6-enoic acid | PubChem CID:6450501 | CAS RN:93943-87-4 | 7-Phenyl-7-(3-pyridinyl)-6-heptenoic acid
+BMGC_DG13605,BMG_DG176341,"N-[(2S,3R,4R,6S)-6-[(2S,3R,4S,6R)-6-[(1'R,2R,3S,4'S,6S,8'R,10'Z,12'S,13'S,14'Z,16'Z,20'R,21'R,24'S)-21',24'-dihydroxy-3,11',13',22'-tetramethyl-2'-oxo-2-propan-2-ylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-12'-yl]oxy-4-methoxy-2-methyloxan-3-yl]oxy-4-methoxy-2-methyloxan-3-yl]acetamide | DrugBank ID:DB11405 | Avermectin B1, 4''-(acetylamino)-4''-deoxy-, (4''R)- | PubChem CID:6450531"
+BMGC_DG13606,BMG_DG176343,"UNII:318X4QY113 | GAVESTINEL | DrugBank ID:DB06741 | 3-[(E)-3-anilino-3-oxoprop-1-enyl]-4,6-dichloro-1H-indole-2-carboxylic acid | PubChem CID:6450546 | CAS RN:153436-22-7 | PubChem SID:198982944 | Gavestinel"
+BMGC_DG13607,BMG_DG176346,NDC:63539-044 | N-methyl-2-[[3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide | NDC:0069-0145 | CAS RN:319460-85-0 | NDC:63539-026 | CAS RN:1528729-60-3 | AXITINIB | UNII:C9LVQ0YUXG | DrugBank ID:DB06626 | PubChem CID:6450551 | PubChem SID:175266320 | NDC:0069-0151 | Axitinib
+BMGC_DG13608,BMG_DG176350,"UNII:K3FRN4DDOY | PubChem SID:198946213 | Laniquidar | methyl 11-[1-[2-[4-(quinolin-2-ylmethoxy)phenyl]ethyl]piperidin-4-ylidene]-5,6-dihydroimidazo[2,1-b][3]benzazepine-3-carboxylate | PubChem CID:6450806 | DrugBank ID:DB12799 | LANIQUIDAR | CAS RN:197509-46-9"
+BMGC_DG13609,BMG_DG176354,"CAS RN:1001083-37-9 | DrugBank ID:DB12590 | UNII:8BT63DA42E | PubChem SID:198954185 | CAS RN:325715-02-4 | PubChem CID:6450813 | INDIPLON | N-methyl-N-[3-[3-(thiophene-2-carbonyl)pyrazolo[1,5-a]pyrimidin-7-yl]phenyl]acetamide | Indiplon"
+BMGC_DG13610,BMG_DG176355,UNII:RSH7NDI7MI | PubChem SID:198949472 | CAS RN:290296-68-3 | BEFETUPITANT | PubChem CID:6450815
+BMGC_DG13611,BMG_DG176358,UNII:L396QIB983 | CAS RN:393105-53-8 | TIPLASININ | PubChem CID:6450819 | PubChem SID:198955747
+BMGC_DG13612,BMG_DG176360,Pelitrexol | PubChem CID:6450821 | DrugBank ID:DB12757
+BMGC_DG13613,BMG_DG176362,"5-[(1R,2R)-2-(5,5-dimethylhex-1-ynyl)cyclopropyl]-1H-imidazole | PubChem CID:6450823 | UNII:309713XSKW | Cipralisant | CIPRALISANT | PubChem SID:198977663 | CAS RN:213027-19-1"
+BMGC_DG13614,BMG_DG176375,"UNII:8YGN0Y942M | Bromocresol green | BROMOCRESOL GREEN | CAS RN:76-60-8 | PubChem SID:198953331 | 2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxy-2-methylphenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]-3-methylphenol | PubChem CID:6451"
+BMGC_DG13615,BMG_DG176380,SALVIANOLIC ACID B | CAS RN:121521-90-2 | UNII:C1GQ844199 | PubChem CID:6451084 | PubChem SID:241180381
+BMGC_DG13616,BMG_DG176394,CX614 | CAS RN:191744-13-5 | PubChem CID:6451148 | PubChem SID:198961718 | UNII:87V631480W
+BMGC_DG13617,BMG_DG176395,"Netupitant | NETUPITANT | DrugBank ID:DB09048 | PubChem SID:198988386 | PubChem CID:6451149 | NDC:69639-101 | 2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridin-3-yl]propanamide | UNII:7732P08TIR | CAS RN:290297-26-6"
+BMGC_DG13618,BMG_DG176401,"UNII:FI96A8X663 | CAS RN:500287-72-9 | PubChem CID:6451164 | RILPIVIRINE | DrugBank ID:DB08864 | 4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile | PubChem SID:175268205 | Rilpivirine"
+BMGC_DG13619,BMG_DG176445,"PubChem SID:472423402 | PubChem CID:6451493 | 5alpha-Dihydrodeoxycorticosterone | DIHYDRODEOXYCORTICOSTERONE | UNII:J7LXT59G72 | (5S,8R,9S,10S,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | CAS RN:298-36-2"
+BMGC_DG13620,BMG_DG176479,"UNII:23298I791N | Trilobatin | TRILOBATIN | PubChem CID:6451798 | 1-[2,6-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one | CAS RN:4192-90-9 | PubChem SID:198954899"
+BMGC_DG13621,BMG_DG176544,CAS RN:39345-92-1 | UNII:Z310X5O5RP | chromium(3+);trichloride | Chromium chloride | PubChem SID:175265807 | Chromic chloride | PubChem CID:6452300 | DrugBank ID:DB09129 | CAS RN:10025-73-7 | CHROMIC CHLORIDE ANHYDROUS
+BMGC_DG13622,BMG_DG176585,DrugBank ID:DB09165 | Pirfotekh | PubChem CID:6452753 | CAS RN:52997-54-3 | phosphonato phosphate;technetium-99(4+) | Technetium Tc-99m pyrophosphate
+BMGC_DG13623,BMG_DG176616,UNII:WTK87HN3LG | TETRAHYDROCANNABIPHOROL | Tetrahydrocannabiphorol | PubChem SID:482554564 | PubChem CID:6453074 | CAS RN:54763-99-4
+BMGC_DG13624,BMG_DG176644,"CAS RN:57072-40-9 | CAS RN:685853-81-0 | UNII:LQC76G8WUE | chromium(3+);2-hydroxypropane-1,2,3-tricarboxylate | PubChem CID:6453431 | PubChem SID:198957110 | DrugBank ID:DB14526 | CHROMIC CITRATE | chromium(III) citrate"
+BMGC_DG13625,BMG_DG176655,PubChem CID:6453585 | DrugBank ID:DB04451 | 4-Methylpiperazin-1-Yl Carbonyl Group
+BMGC_DG13626,BMG_DG176674,PubChem CID:6453837 | GUANOSINE-5'-DIPHOSPHATE | CAS RN:146-91-8 | UNII:HLJ737P865 | PubChem SID:472424205
+BMGC_DG13627,BMG_DG176676,"CAS RN:596-94-1 | PubChem CID:6453841 | (20R,22R)-20,22-Dihydroxycholesterol | (2R,3R)-2-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylheptane-2,3-diol"
+BMGC_DG13628,BMG_DG176678,PubChem SID:252320403 | 3-BUTYL-.DELTA.9-TETRAHYDROCANNABINOL | UNII:LIC9QAS59U | PubChem CID:6453891 | CAS RN:60008-00-6
+BMGC_DG13629,BMG_DG176701,CAS RN:61430-12-4 | PubChem CID:6454191 | UNII:X5CGA70XLT | PubChem SID:318164677 | 1-D-ALANYL-L-PROLINE
+BMGC_DG13630,BMG_DG176742,Allolactose | PubChem CID:6454902 | DrugBank ID:DB04116
+BMGC_DG13631,BMG_DG176801,CHLOROTRIPHENYLMETHANE | Chlorotriphenylmethane | CAS RN:76-83-5 | PubChem SID:198965098 | PubChem CID:6456 | UNII:1D9GZ8QQXN
+BMGC_DG13632,BMG_DG176802,"BELOTECAN | UNII:27Z82M2G1N | (19S)-19-ethyl-19-hydroxy-10-[2-(propan-2-ylamino)ethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione | DrugBank ID:DB12459 | Belotecan | PubChem SID:198962242 | CAS RN:256411-32-2 | PubChem CID:6456014"
+BMGC_DG13633,BMG_DG176805,TRIPHENYLCARBINOL | UNII:U97Q0OU9KB | PubChem SID:198989699 | PubChem CID:6457 | CAS RN:76-84-6
+BMGC_DG13634,BMG_DG176812,PubChem SID:405055119 | NBUMP | UNII:G184WXO36J | PubChem CID:64622 | CAS RN:134390-72-0
+BMGC_DG13635,BMG_DG176813,"CAS RN:136199-02-5 | Rolofylline | PubChem CID:64627 | 1,3-dipropyl-8-(3-tricyclo[3.3.1.03,7]nonanyl)-7H-purine-2,6-dione"
+BMGC_DG13636,BMG_DG176814,"PubChem SID:175267086 | UNII:8F6J993XXR | CAS RN:76-93-7 | Benzilic acid | 2-hydroxy-2,2-diphenylacetic acid | PubChem CID:6463 | BENZILIC ACID"
+BMGC_DG13637,BMG_DG176817,"DrugBank ID:DB01352 | APROBARBITAL | CAS RN:77-02-1 | Aprobarbital | 5-propan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | PubChem CID:6464 | UNII:Q0YKG9L6RF | PubChem SID:198986708"
+BMGC_DG13638,BMG_DG176823,aluminum;phosphate | CAS RN:98499-64-0 | NDC:37662-3577 | UNII:F92V3S521O | CAS RN:7784-30-7 | CAS RN:56574-68-6 | NDC:37662-3576 | ALUMINUM PHOSPHATE | NDC:37662-3580 | NDC:37662-3581 | NDC:37662-3583 | Aluminum Phosphate | NDC:37662-3578 | PubChem SID:175265505 | DrugBank ID:DB14517 | NDC:37662-3579 | PubChem CID:64655 | NDC:37662-3582
+BMGC_DG13639,BMG_DG176824,"UNII:BU0A7MWB6L | GIBBERELLIC ACID | DrugBank ID:DB07814 | PubChem SID:198981819 | CAS RN:77-06-5 | Gibberellic acid | PubChem CID:6466 | (1R,2R,5S,8S,9S,10R,11S,12S)-5,12-dihydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylic acid"
+BMGC_DG13640,BMG_DG176833,CAS RN:77-10-1 | 1-(1-phenylcyclohexyl)piperidine | PHENCYCLIDINE | Phencyclidine | DrugBank ID:DB03575 | UNII:J1DOI7UV76 | PubChem SID:198957747 | PubChem CID:6468 | CAS RN:101887-87-0
+BMGC_DG13641,BMG_DG176837,"2',3'-DIDEHYDRO-2',3'-DIDEOXYCYTIDINE | PubChem SID:198945094 | PubChem CID:64683 | CAS RN:7481-88-1 | UNII:CI9X00489L"
+BMGC_DG13642,BMG_DG176840,"CAS RN:10385-78-1 | CAS RN:124-76-5 | CAS RN:507-70-0 | CAS RN:6627-72-1 | PubChem CID:64685 | 1,7,7-Trimethylbicyclo[2.2.1]heptan-2-ol | DrugBank ID:DB11288 | 1,7,7-trimethylbicyclo[2.2.1]heptan-2-ol"
+BMGC_DG13643,BMG_DG176842,"DrugBank ID:DB02379 | Beta-D-Glucose | CAS RN:9001-37-0 | PubChem CID:64689 | PubChem SID:175268089 | Glucosides | CAS RN:50986-29-3 | CAS RN:492-61-5 | CAS RN:136760-05-9 | UNII:J4R00M814D | CAS RN:28905-12-6 | (2R,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol | CAS RN:128009-02-9 | .BETA.-D-GLUCOPYRANOSE"
+BMGC_DG13644,BMG_DG176843,PubChem CID:6469 | ETHOHEPTAZINE | ethyl 1-methyl-4-phenylazepane-4-carboxylate | PubChem SID:198942220 | DrugBank ID:DB08988 | CAS RN:77-15-6 | Ethoheptazine | UNII:3A4G3A848U
+BMGC_DG13645,BMG_DG176848,CAS RN:358-72-5 | DrugBank ID:DB01785 | Dimethylallyl Diphosphate | PubChem CID:647 | 3-methylbut-2-enyl phosphono hydrogen phosphate | Dimethylallyl diphosphate
+BMGC_DG13646,BMG_DG176853,"Prodine | CAS RN:77-20-3 | PubChem CID:6471 | (1,3-dimethyl-4-phenylpiperidin-4-yl) propanoate"
+BMGC_DG13647,BMG_DG176854,"Lincocin | CAS RN:859-18-7 | PubChem SID:198946820 | LINCOMYCIN HYDROCHLORIDE ANHYDROUS | UNII:GCW8Y9936L | PubChem CID:64710 | (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;hydrochloride"
+BMGC_DG13648,BMG_DG176856,"PubChem CID:64715 | [(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate | CAS RN:73573-88-3 | DrugBank ID:DB06693 | UNII:1UQM1K0W9X | MEVASTATIN | Mevastatin | PubChem SID:198989583"
+BMGC_DG13649,BMG_DG176858,CARAMIPHEN | PubChem CID:6472 | UNII:97J7NP0XJY | PubChem SID:198984617 | CAS RN:77-22-5
+BMGC_DG13650,BMG_DG176862,"5-butyl-5-ethyl-1,3-diazinane-2,4,6-trione | DrugBank ID:DB01353 | CAS RN:77-28-1 | PubChem CID:6473 | Butobarbital | Butethal | BUTETHAL | UNII:OHZ8QAW6YC | PubChem SID:198977275"
+BMGC_DG13651,BMG_DG176863,"2-hydroxypropane-1,2,3-tricarboxylic acid;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal | CAS RN:13838-07-8 | CAS RN:8013-89-6 | Acid Citrate Dextrose | PubChem CID:64730"
+BMGC_DG13652,BMG_DG176865,UNII:04M8624OXV | trichlorolanthanum | PubChem SID:198975699 | LANTHANUM CHLORIDE | Lanthanum chloride | PubChem CID:64735 | CAS RN:10099-58-8
+BMGC_DG13653,BMG_DG176877,"PubChem CID:6473866 | (1R,9S,12S,13R,14S,17R,18Z,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone | CAS RN:104987-11-3"
+BMGC_DG13654,BMG_DG176878,"PubChem CID:6473876 | 9-(N-methyl-L-isoleucine)-cyclosporin A | (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-24-[(2S)-butan-2-yl]-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | (Melle-4)cyclosporin | DrugBank ID:DB13068 | 9-(N-METHYL-L-ISOLEUCINE)-CYCLOSPORIN A | PubChem SID:198958513 | CAS RN:143205-42-9 | UNII:96262S4I14"
+BMGC_DG13655,BMG_DG176879,"Parthenolide | DrugBank ID:DB13063 | (1S,2S,4R,7E,11S)-4,8-dimethyl-12-methylidene-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one | PubChem CID:6473881 | (1aR,7aS,10aS,10bS)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one | CAS RN:503551-53-9 | CAS RN:20554-84-1"
+BMGC_DG13656,BMG_DG176881,"Dirithromycin | CAS RN:62013-04-1 | (1R,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,10-dihydroxy-7-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-15-(2-methoxyethoxymethyl)-2,6,8,10,12,17-hexamethyl-4,16-dioxa-14-azabicyclo[11.3.1]heptadecan-5-one | UNII:1801D76STL | DIRITHROMYCIN | DrugBank ID:DB00954 | PubChem SID:198981601 | PubChem CID:6473883"
+BMGC_DG13657,BMG_DG176894,"CAS RN:57378-72-0 | 3,4-Dicaffeoylquinic acid | CAS RN:89886-30-6 | PubChem SID:255509277 | UNII:E57A0DKE0B | (1R,3R,4S,5R)-3,4-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1,5-dihydroxycyclohexane-1-carboxylic acid | PubChem CID:6474309 | 3,4-DICAFFEOYLQUINIC ACID"
+BMGC_DG13658,BMG_DG176895,"PubChem CID:6474310 | CAS RN:89919-62-0 | PubChem SID:255509387 | CAS RN:2450-53-5 | UNII:ND94C5E75K | (3R,5R)-3,5-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-1,4-dihydroxycyclohexane-1-carboxylic acid | CAS RN:879305-14-3 | Isochlorogenic acid A | 3,5-DI-O-CAFFEOYLQUINIC ACID"
+BMGC_DG13659,BMG_DG176896,"CAS RN:68-19-9 | Mecobalamin | cobalt(3+);[(2R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;cyanide | PubChem CID:6474318"
+BMGC_DG13660,BMG_DG176897,"cobalt(2+);[(2R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate;hydrate | PubChem CID:6474319 | Axion | CAS RN:13422-51-0"
+BMGC_DG13661,BMG_DG176898,"CAS RN:13870-90-1 | (2S,3S,4R,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | PubChem CID:6474320 | Vitamin B12 coenzyme"
+BMGC_DG13662,BMG_DG176899,"PubChem CID:6474321 | Methylcobal | carbanide;cobalt(3+);[(2R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[(2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate | CAS RN:13422-55-4"
+BMGC_DG13663,BMG_DG176907,"(1S,3R,4R,5R)-1,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-4,5-dihydroxycyclohexane-1-carboxylic acid | 1,3-Dicaffeoylquinic acid | PubChem CID:6474640 | CAS RN:251320-66-8 | CAS RN:19870-46-3"
+BMGC_DG13664,BMG_DG176914,"2-[1-(4-chlorophenyl)-1-phenylethoxy]-N,N-dimethylethanamine | PubChem SID:198935948 | DrugBank ID:DB09007 | CAS RN:77-38-3 | Chlorphenoxamine | CHLORPHENOXAMINE | PubChem CID:6475 | UNII:3UVD77BP8R"
+BMGC_DG13665,BMG_DG176920,"PubChem CID:6475296 | Geclosporin | (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-30-propyl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | PubChem SID:198944452 | GECLOSPORIN | UNII:UA3JNW70T9 | CAS RN:74436-00-3"
+BMGC_DG13666,BMG_DG176921,"UNII:2C4Y86R2AX | PubChem CID:6475492 | (Z)-N,N'-bis[3-(ethylamino)propyl]but-2-ene-1,4-diamine | CGC-11047 FREE BASE | CGC-11047 free base | CAS RN:308145-19-9 | PubChem SID:316917517"
+BMGC_DG13667,BMG_DG176931,"UNII:0G76K8X6C0 | Methsuximide | 1,3-dimethyl-3-phenylpyrrolidine-2,5-dione | DrugBank ID:DB05246 | METHSUXIMIDE | NDC:70954-228 | NDC:0071-0525 | CAS RN:77-41-8 | PubChem CID:6476 | PubChem SID:175272093"
+BMGC_DG13668,BMG_DG176938,PubChem SID:255509047 | PubChem CID:6476139 | METHYL CHLOROGENATE | CAS RN:123483-19-2 | UNII:E6GC3KV7JK
+BMGC_DG13669,BMG_DG176941,CAS RN:61303-13-7 | UNII:588LJK42AP | ISOACTEOSIDE | PubChem CID:6476333 | PubChem SID:198975757
+BMGC_DG13670,BMG_DG176947,"PubChem SID:198970707 | CILAZAPRILAT | (4S,7S)-7-[[(1S)-1-carboxy-3-phenylpropyl]amino]-6-oxo-1,2,3,4,7,8,9,10-octahydropyridazino[1,2-a]diazepine-4-carboxylic acid | DrugBank ID:DB15565 | CAS RN:90139-06-3 | UNII:WBL76FH528 | Cilazaprilat | PubChem CID:64766"
+BMGC_DG13671,BMG_DG176956,"PubChem CID:6477182 | CAS RN:52328-98-0 | CAS RN:115851-85-9 | CAS RN:917813-54-8 | Dimethylcurcumin | (1E,4Z,6E)-1,7-bis(3,4-dimethoxyphenyl)-5-hydroxyhepta-1,4,6-trien-3-one | DrugBank ID:DB06133"
+BMGC_DG13672,BMG_DG176966,CAS RN:543700-68-1 | PubChem CID:6478034 | PubChem SID:198952119 | BMS-433771 | UNII:G2427554NW
+BMGC_DG13673,BMG_DG176969,"METHYLEPHEDRINE, (+/-)- | PubChem CID:64782 | PubChem SID:198936057 | (1R,2S)-2-(dimethylamino)-1-phenylpropan-1-ol | DrugBank ID:DB11278 | UNII:60VH42A1KJ | CAS RN:552-79-4 | Methylephedrine | UNII:SHS9PGQ2LS | METHYLEPHEDRINE | CAS RN:1201-56-5 | PubChem SID:175271354 | METHYLEPHEDRINE, (±)-"
+BMGC_DG13674,BMG_DG176975,PubChem CID:6478685 | METHYL MYCOPHENOLATE | PubChem SID:198984666 | UNII:0B5C0EG8E8 | CAS RN:31858-66-9
+BMGC_DG13675,BMG_DG176977,CAS RN:22094-62-8 | UNII:8X8M8255WF | PubChem CID:64789 | PubChem SID:472388398 | 6-AMINOSACCHARIN
+BMGC_DG13676,BMG_DG176980,XANTHOANGELOL F | PubChem SID:405055105 | CAS RN:265652-71-9 | UNII:KA6UD18T8H | PubChem CID:6479088
+BMGC_DG13677,BMG_DG176983,"DrugBank ID:DB12451 | SCY-635 | UNII:WSU5343074 | (3S,6S,9S,12R,15S,18S,21S,24S,27R,30S,33S)-27-[2-(dimethylamino)ethylsulfanyl]-30-ethyl-33-[(E,1R,2R)-1-hydroxy-2-methylhex-4-enyl]-24-(2-hydroxy-2-methylpropyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18-tris(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | PubChem CID:6479267 | Scy-635 | CAS RN:210759-10-7 | PubChem SID:198957191"
+BMGC_DG13678,BMG_DG176987,"Azlocillin | PubChem CID:6479523 | CAS RN:37091-66-0 | UNII:HUM6H389W0 | DrugBank ID:DB01061 | PubChem SID:198934724 | AZLOCILLIN | CAS RN:37091-65-9 | (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"
+BMGC_DG13679,BMG_DG176988,UNII:2CKG6TX32F | PubChem SID:198941032 | CAS RN:553-03-7 | PubChem CID:64796 | HYDROCARBOSTYRIL
+BMGC_DG13680,BMG_DG176996,"PubChem CID:6479915 | Methyl Rosmarinate | methyl (2R)-3-(3,4-dihydroxyphenyl)-2-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxypropanoate | CAS RN:99353-00-1"
+BMGC_DG13681,BMG_DG177003,"(2R)-2-methyl-6-nitro-2-[[4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]phenoxy]methyl]-3H-imidazo[2,1-b][1,3]oxazole | UNII:8OOT6M1PC7 | DELAMANID | PubChem SID:198947264 | DrugBank ID:DB11637 | CAS RN:681492-22-8 | PubChem CID:6480466 | Delamanid"
+BMGC_DG13682,BMG_DG177007,"PubChem CID:64809 | 3,4-DIHYDRO-6-HYDROXYCOUMARIN | CAS RN:2669-94-5 | UNII:N7HV736HNQ | PubChem SID:472410021"
+BMGC_DG13683,BMG_DG177017,3-(Imidazo-1-ylmethyl)aniline | CAS RN:120107-85-9 | PubChem CID:6481821 | PubChem SID:485663454 | UNII:5GT9TR5Z4F | 3-(IMIDAZO-1-YLMETHYL)ANILINE
+BMGC_DG13684,BMG_DG177024,"CAS RN:222723-55-9 | UNII:0D295FLV8W | PubChem CID:6483057 | HU-310 | Noladin ether | 2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoxy]propane-1,3-diol | PubChem SID:198983380"
+BMGC_DG13685,BMG_DG177042,Carbromal | UNII:0Y299JY9V3 | 2-bromo-N-carbamoyl-2-ethylbutanamide | PubChem CID:6488 | CAS RN:77-65-6 | PubChem SID:198945148 | DrugBank ID:DB13817 | CARBROMAL
+BMGC_DG13686,BMG_DG177045,"CAS RN:504-07-4 | PubChem CID:649 | UNII:016FR52RU5 | DrugBank ID:DB01849 | DIHYDROURACIL | 1,3-diazinane-2,4-dione | PubChem SID:198969291 | Dihydrouracil"
+BMGC_DG13687,BMG_DG177047,C-16 | UNII:C9Q75QZK84 | CAS RN:1159885-47-8 | PubChem SID:445500651 | PubChem CID:6490494
+BMGC_DG13688,BMG_DG177048,"5,5-DIMETHYLHYDANTOIN | PubChem CID:6491 | PubChem SID:198991220 | 5,5-Dimethylhydantoin | UNII:34032MQ9RO | 5,5-dimethylimidazolidine-2,4-dione | CAS RN:77-71-4"
+BMGC_DG13689,BMG_DG177051,CAS RN:119625-78-4 | TERLAKIREN | PubChem CID:64922 | PubChem SID:198973715 | UNII:E5H9IP637W
+BMGC_DG13690,BMG_DG177053,PubChem SID:198939499 | CLOFOP | CAS RN:26129-32-8 | Clofop | 2-[4-(4-chlorophenoxy)phenoxy]propanoic acid | PubChem CID:64928 | UNII:KIH4IO8Q8Z
+BMGC_DG13691,BMG_DG177054,PubChem SID:175265316 | NDC:69844-023 | NDC:42385-945 | NDC:0115-1324 | NDC:0074-3162 | UNII:BGF9MN2HU1 | 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid | Fenofibric acid | NDC:0115-1554 | PubChem CID:64929 | NDC:0074-3161 | NDC:0115-1555 | NDC:46708-244 | NDC:69844-022 | CAS RN:42017-89-0 | NDC:42385-944 | NDC:69315-282 | DrugBank ID:DB13873 | NDC:69315-281 | Fenofibric Acid | NDC:42571-347 | NDC:62332-244 | NDC:62332-245 | NDC:59651-217 | FENOFIBRIC ACID | NDC:42571-348 | NDC:46708-245 | NDC:0115-1325 | NDC:59651-216
+BMGC_DG13692,BMG_DG177061,MEPARFYNOL | 3-methylpent-1-yn-3-ol | UNII:B017BC5B1N | DrugBank ID:DB13733 | CAS RN:77-75-8 | PubChem SID:198988623 | 3-Methyl-1-pentyn-3-ol | PubChem CID:6494
+BMGC_DG13693,BMG_DG177064,"Ursolic Acid | UNII:P3M2575F3F | URSOLIC ACID | DrugBank ID:DB15588 | (1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid | PubChem SID:175267525 | CAS RN:77-52-1 | PubChem CID:64945"
+BMGC_DG13694,BMG_DG177065,PubChem CID:64947 | PubChem SID:198943342 | UNII:QCF122NF3R | CAS RN:97-30-3 | METHYL GLUCOSE
+BMGC_DG13695,BMG_DG177067,PubChem SID:198940252 | UNII:G20G12V769 | Propamidine | PubChem CID:64949 | 4-[3-(4-carbamimidoylphenoxy)propoxy]benzenecarboximidamide | CAS RN:6275-69-0 | PROPAMIDINE | DrugBank ID:DB13296 | CAS RN:104-32-5
+BMGC_DG13696,BMG_DG177069,DrugBank ID:DB08840 | N-Methylnicotinamide | N-methylpyridine-3-carboxamide | PubChem SID:198969033 | CAS RN:114-33-0 | PubChem CID:64950 | NICOTINYL METHYLAMIDE | UNII:X3I82S5L8I
+BMGC_DG13697,BMG_DG177072,"UNII:75G4TW236W | PubChem SID:198968974 | DrugBank ID:DB13732 | PubChem CID:64953 | CAS RN:133-51-7 | hydroxy(dioxo)-lambda5-stibane;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol | Meglumine Antimoniate | MEGLUMINE ANTIMONIATE"
+BMGC_DG13698,BMG_DG177075,"9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-2,6-dione | CAS RN:146-80-5 | PubChem SID:198949883 | Xanthosine | XANTHOSINE | PubChem CID:64959 | UNII:BM66HT53C3"
+BMGC_DG13699,BMG_DG177078,"CAS RN:244-66-6 | 9H-pyrido[3,4-b]indole | 9H-Pyrido[3,4-B]indole | PubChem SID:198969760 | NORHARMAN | UNII:94HMA1I78O | CAS RN:244-63-3 | PubChem CID:64961"
+BMGC_DG13700,BMG_DG177084,"[hydroxy-[[(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate | PubChem SID:198981582 | PubChem CID:64968 | Thymidine-5'-triphosphate | DrugBank ID:DB02452 | UNII:QOP4K539MU | Thymidine 5'-triphosphate | THYMIDINE TRIPHOSPHATE | CAS RN:365-08-2"
+BMGC_DG13701,BMG_DG177085,PubChem CID:64969 | UNII:MEH8O8Y0H0 | (2S)-2-amino-3-(3-methylimidazol-4-yl)propanoic acid | PubChem SID:374388676 | 3-METHYLHISTIDINE | 3-Methyl-L-histidine | CAS RN:368-16-1
+BMGC_DG13702,BMG_DG177088,"Betulinic Acid | CAS RN:472-15-1 | (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid | BETULINIC ACID | PubChem CID:64971 | PubChem SID:198986654 | DrugBank ID:DB12480 | UNII:4G6A18707N"
+BMGC_DG13703,BMG_DG177089,"PubChem CID:64972 | DrugBank ID:DB04886 | CALANOLIDE A | PubChem SID:198946006 | UNII:S5A9TQN46W | (16R,17S,18S)-18-hydroxy-10,10,16,17-tetramethyl-6-propyl-3,9,15-trioxatetracyclo[12.4.0.02,7.08,13]octadeca-1(14),2(7),5,8(13),11-pentaen-4-one | Calanolide A | CAS RN:142632-32-4"
+BMGC_DG13704,BMG_DG177090,"UNII:KU8SPJ271W | CAS RN:134379-77-4 | DEXELVUCITABINE | PubChem SID:198974231 | Dexelvucitabine | DrugBank ID:DB12470 | PubChem CID:64973 | 4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2-one"
+BMGC_DG13705,BMG_DG177094,"ARCTIGENIN, (±)- | ARCTIGENIN | UNII:2FD8L150E7 | PubChem SID:198954941 | (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one | CAS RN:7770-78-7 | PubChem SID:198943265 | CAS RN:144901-91-7 | PubChem CID:64981 | Arctigenin | UNII:U76MR9VS6M | ARCTIGENIN, (+/-)-"
+BMGC_DG13706,BMG_DG177095,"Baicalin | BAICALIN | CAS RN:31564-28-0 | UNII:347Q89U4M5 | PubChem CID:64982 | PubChem SID:198939141 | CAS RN:21967-41-9 | (2S,3S,4S,5R,6S)-6-(5,6-dihydroxy-4-oxo-2-phenylchromen-7-yl)oxy-3,4,5-trihydroxyoxane-2-carboxylic acid"
+BMGC_DG13707,BMG_DG177101,"DrugBank ID:DB08843 | 2-(2,6-diaminopurin-9-yl)ethoxymethylphosphonic acid | CAS RN:113852-41-8 | PubChem CID:64988 | 9-(2-Phosphonylmethoxyethyl)-2,6-diaminopurine | PubChem SID:198987793 | GS 0573 | UNII:5EX1YUR4DH"
+BMGC_DG13708,BMG_DG177103,"1-(2-hydroxyethoxymethyl)-5-methyl-6-phenylsulfanylpyrimidine-2,4-dione | 1-(2-Hydroxyethyloxymethyl)-6-phenyl thiothymine | 1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE | CAS RN:123027-56-5 | DrugBank ID:DB07892 | PubChem CID:64993"
+BMGC_DG13709,BMG_DG177106,"PubChem CID:650 | DIACETYL | butane-2,3-dione | CAS RN:431-03-8 | Diacetyl | PubChem SID:198984685 | UNII:K324J5K4HM"
+BMGC_DG13710,BMG_DG177107,[dimethylamino(ethoxy)phosphoryl]formonitrile | TABUN | UNII:S45M750QSH | PubChem SID:198940697 | Tabun | CAS RN:77-81-6 | PubChem CID:6500
+BMGC_DG13711,BMG_DG177111,"Emivirine | DrugBank ID:DB08188 | 6-benzyl-1-(ethoxymethyl)-5-propan-2-ylpyrimidine-2,4-dione | EMIVIRINE | UNII:X87G8IX72O | PubChem CID:65013 | CAS RN:149950-60-7 | PubChem SID:198948441"
+BMGC_DG13712,BMG_DG177112,"PubChem CID:65014 | PLERIXAFOR OCTAHYDROCHLORIDE | PubChem SID:198944040 | Plerixafor Octahydrochloride | 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane;octahydrochloride | UNII:OD49913540 | CAS RN:155148-31-5"
+BMGC_DG13713,BMG_DG177113,"NDC:70121-1694 | Plerixafor | NDC:25021-416 | NDC:65219-284 | NDC:70710-1208 | NDC:68083-155 | PubChem SID:175268835 | NDC:43598-308 | NDC:0024-5862 | PLERIXAFOR | 1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane | NDC:70771-1776 | NDC:0480-4320 | NDC:55150-356 | DrugBank ID:DB06809 | NDC:71288-155 | PubChem CID:65015 | UNII:S915P5499N | CAS RN:110078-46-1 | NDC:72205-249"
+BMGC_DG13714,BMG_DG177114,"[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate | UNII:5S0W860XNR | CAS RN:161814-49-9 | AMPRENAVIR | Amprenavir | PubChem SID:175267240 | DrugBank ID:DB00701 | PubChem CID:65016"
+BMGC_DG13715,BMG_DG177118,"UNII:20O93L6F9H | OSELTAMIVIR | DrugBank ID:DB00198 | PubChem SID:175267600 | PubChem CID:65028 | CAS RN:182367-47-1 | ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate | CAS RN:196618-13-0 | Oseltamivir"
+BMGC_DG13716,BMG_DG177120,"TROMETHAMINE | PubChem SID:175268742 | CAS RN:126850-08-6 | CAS RN:126850-06-4 | CAS RN:77-86-1 | NDC:0409-1593 | CAS RN:136760-04-8 | UNII:023C2WHX2V | NDC:71357-001 | CAS RN:126850-03-1 | CAS RN:83147-39-1 | CAS RN:79261-03-3 | PubChem CID:6503 | 2-amino-2-(hydroxymethyl)propane-1,3-diol | DrugBank ID:DB03754 | Tromethamine | CAS RN:126850-05-3"
+BMGC_DG13717,BMG_DG177124,UNII:3C39BY17Y6 | PubChem CID:65036 | CAS RN:539-86-6 | PubChem SID:198967869 | ALLICIN | 3-prop-2-enylsulfinylsulfanylprop-1-ene | Allicin | DrugBank ID:DB11780
+BMGC_DG13718,BMG_DG177125,"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine | DrugBank ID:DB07697 | PubChem CID:650361"
+BMGC_DG13719,BMG_DG177129,"CAS RN:6556-12-3 | GLUCURONIC ACID | UNII:8A5D83Q4RW | CAS RN:576-37-4 | PubChem CID:65041 | PubChem SID:175265987 | (2S,3S,4S,5R)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid"
+BMGC_DG13720,BMG_DG177138,UNII:YL39R93PRE | PubChem SID:315658449 | CAS RN:596-09-8 | DIACETYLFLUORESCEIN | PubChem CID:65047
+BMGC_DG13721,BMG_DG177140,UNII:7X05537I17 | PubChem CID:65048 | PubChem SID:198976608 | MEDICAGENIC ACID | CAS RN:599-07-5
+BMGC_DG13722,BMG_DG177143,"THYMINE ARABINOSIDE | CAS RN:605-23-2 | PubChem CID:65049 | Spongothymidine | UNII:NS9U4BEG7Y | 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | PubChem SID:249492287"
+BMGC_DG13723,BMG_DG177145,"CAS RN:611-53-0 | IBACITABINE | DrugBank ID:DB13776 | Ibacitabine | PubChem CID:65050 | UNII:3EK8532DZV | 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one | PubChem SID:198983169"
+BMGC_DG13724,BMG_DG177146,PubChem CID:65051 | UNII:IA883WYU21 | 3'-DEOXYTHYMIDINE 5'-TRIPHOSPHATE | CAS RN:611-60-9 | PubChem SID:198975624
+BMGC_DG13725,BMG_DG177154,"CAS RN:863-03-6 | [(2S,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | PubChem CID:65056 | Epicatechin-3-gallate"
+BMGC_DG13726,BMG_DG177156,"PubChem CID:65057 | DIPHENCYPRONE | 2,3-diphenylcycloprop-2-en-1-one | CAS RN:886-38-4 | Diphencyprone | Diphenylcyclopropenone | UNII:I7G14NW5EC | PubChem SID:198962527 | DrugBank ID:DB12173 | CAS RN:40736-43-4"
+BMGC_DG13727,BMG_DG177157,"UNII:03DEY1684B | N-(2,3-DIHYDROXYPROPYL)RETINAMIDE | PubChem SID:316914537 | CAS RN:75664-72-1 | PubChem CID:6505795"
+BMGC_DG13728,BMG_DG177158,PubChem CID:65058 | DrugBank ID:DB02380 | Deoxyinosine
+BMGC_DG13729,BMG_DG177159,"PubChem SID:198944265 | UNII:4GY0AVT3L4 | TANESPIMYCIN | [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate | PubChem CID:6505803 | DrugBank ID:DB05134 | Tanespimycin | CAS RN:75747-14-7"
+BMGC_DG13730,BMG_DG177160,2'-Deoxyguanosine-5'-Monophosphate | PubChem CID:65059 | DrugBank ID:DB04457
+BMGC_DG13731,BMG_DG177172,"[(2R,3S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate | 2'-DEOXYURIDYLIC ACID | DrugBank ID:DB03800 | PubChem CID:65063 | PubChem SID:433968556 | Deoxyuridine monophosphate | CAS RN:964-26-1 | UNII:N9J10KFG94 | 2'-Deoxyuridine 5'-monophosphate"
+BMGC_DG13732,BMG_DG177174,"25-Hydroxycholecalciferol, 5-trans- | UNII:SN331791VY | PubChem CID:6506392 | CAS RN:36149-00-5 | CAS RN:1233749-00-2 | CAS RN:19356-17-3 | 25-HYDROXYCHOLECALCIFEROL, 5-TRANS- | PubChem SID:198971246 | (1S,3E)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol"
+BMGC_DG13733,BMG_DG177176,"Epigallocatechin Gallate | UNII:BQM438CTEL | Epigallocatechin gallate | PubChem CID:65064 | EPIGALLOCATECHIN GALLATE | DrugBank ID:DB12116 | CAS RN:989-51-5 | PubChem SID:175267892 | [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate | CAS RN:2041570-28-7"
+BMGC_DG13734,BMG_DG177179,N-Acetyl-L-aspartic acid | (2S)-2-acetamidobutanedioic acid | CAS RN:997-55-7 | ACETYL ASPARTIC ACID | UNII:445Y04YIWR | PubChem SID:198939575 | PubChem CID:65065
+BMGC_DG13735,BMG_DG177189,CAS RN:53755-02-5 | UNII:973626KV9L | PubChem SID:241177709 | TRANS-CLOVAMIDE | PubChem CID:6506968
+BMGC_DG13736,BMG_DG177191,"Deoxyuridine triphosphate | Deoxyuridine-5'-Triphosphate | DrugBank ID:DB02333 | CAS RN:91918-34-2 | [[(2R,3S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | PubChem CID:65070 | CAS RN:1173-82-6 | CAS RN:102814-08-4"
+BMGC_DG13737,BMG_DG177196,"DrugBank ID:DB04425 | PubChem CID:65074 | 7,8-Dihydroneopterin"
+BMGC_DG13738,BMG_DG177197,"CAS RN:1256-86-6 | [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate | Cholesterol sulfate | UNII:KU576NT9O9 | PubChem SID:198979584 | CHOLESTERYL SULFATE | DrugBank ID:DB01990 | PubChem CID:65076"
+BMGC_DG13739,BMG_DG177198,Dansylamide | PubChem CID:65077 | 5-(dimethylamino)naphthalene-1-sulfonamide | DrugBank ID:DB02866 | PubChem SID:438788771 | DANSYLAMIDE | UNII:ZUZ5S5875E | CAS RN:1431-39-6
+BMGC_DG13740,BMG_DG177199,"OFTASCEINE | PubChem CID:65079 | Oftasceine | PubChem SID:175266806 | 2-[[7'-[[bis(carboxymethyl)amino]methyl]-3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-2'-yl]methyl-(carboxymethyl)amino]acetic acid | UNII:V0YM2B16TS | CAS RN:1461-15-0 | DrugBank ID:DB11184"
+BMGC_DG13741,BMG_DG177202,"Quinic acid | CAS RN:77-95-2 | PubChem CID:6508 | Quinic Acid | PubChem SID:175268187 | UNII:058C04BGYI | QUINIC ACID | (3R,5R)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid"
+BMGC_DG13742,BMG_DG177208,"PubChem SID:198938376 | UNII:HEJ6575V1X | CAS RN:970-73-0 | CAS RN:1617-55-6 | (2R,3S)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol | PubChem CID:65084 | Gallocatechin | GALLOCATECHIN"
+BMGC_DG13743,BMG_DG177213,"CAS RN:1899-48-5 | UNII:R3UB0T78EL | 2,4-DIAMINOQUINAZOLINE | PubChem CID:65087 | PubChem SID:375578832"
+BMGC_DG13744,BMG_DG177216,PubChem CID:6508725 | PubChem SID:198987935 | CAS RN:774154-52-8 | UNII:IJ810D9J9O | FM1-43 CATION
+BMGC_DG13745,BMG_DG177219,"PubChem SID:472388484 | 9-hydroxyfuro[3,2-g]chromen-7-one | CAS RN:2009-24-7 | UNII:8RL486L8A5 | PubChem CID:65090 | XANTHOTOXOL | Xanthotoxol"
+BMGC_DG13746,BMG_DG177220,"[[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | 2'-Deoxycytidine 5'-Triphosphate | PubChem CID:65091 | CAS RN:2056-98-6 | CAS RN:102783-51-7 | 2'-Deoxycytidine 5'-triphosphate | DrugBank ID:DB03258"
+BMGC_DG13747,BMG_DG177221,"2,2'-Dithiodipyridine | PubChem SID:198979793 | CAS RN:2127-03-9 | UNII:L6X912UPBU | 2,2'-PYRIDINE DISULFIDE | 2-(pyridin-2-yldisulfanyl)pyridine | PubChem CID:65093"
+BMGC_DG13748,BMG_DG177222,"UNII:767JTD2N31 | 25-HYDROXYCHOLESTEROL | DrugBank ID:DB04705 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-6-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | PubChem CID:65094 | 25-Hydroxycholesterol | PubChem SID:198989052 | CAS RN:2140-46-7"
+BMGC_DG13749,BMG_DG177225,Norvaline | PubChem SID:198955715 | PubChem CID:65098 | CAS RN:6600-40-4 | UNII:A70UKS48FE | DrugBank ID:DB04185 | NORVALINE
+BMGC_DG13750,BMG_DG177230,Verlukast | PubChem CID:6509849 | VERLUKAST | CAS RN:120443-16-5 | 3-[(R)-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-[3-(dimethylamino)-3-oxopropyl]sulfanylmethyl]sulfanylpropanoic acid | PubChem SID:198966715 | UNII:5Q9O54P0H7
+BMGC_DG13751,BMG_DG177234,"NDC:0187-5100 | NDC:68462-609 | NDC:0187-5101 | DrugBank ID:DB00337 | NDC:68682-111 | NDC:68682-110 | UNII:7KYV510875 | CAS RN:137071-32-0 | NDC:72162-1889 | NDC:0187-5103 | PubChem CID:6509979 | NDC:72162-1891 | NDC:72162-1890 | NDC:0591-2944 | PubChem SID:175266451 | PIMECROLIMUS | Pimecrolimus | NDC:0187-5102 | (1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(E)-1-[(1R,3R,4S)-4-chloro-3-methoxycyclohexyl]prop-1-en-2-yl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone | NDC:68682-112"
+BMGC_DG13752,BMG_DG177240,PubChem CID:65103 | 2'-Deoxyguanosine-5'-Triphosphate | DrugBank ID:DB02181
+BMGC_DG13753,BMG_DG177248,"AICAR | AICA ribonucleotide | [(2R,3S,4R,5R)-5-(5-amino-4-carbamoylimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | PubChem CID:65110 | UNII:F0X88YW0YK | DrugBank ID:DB01700 | PubChem SID:198970084 | CAS RN:3031-94-5"
+BMGC_DG13754,BMG_DG177255,DrugBank ID:DB03867 | CAS RN:621-44-3 | 3-nitro-L-tyrosine | PubChem SID:198939004 | UNII:7COY1HA6HK | PubChem CID:65124 | 3-NITRO-L-TYROSINE | (2S)-2-amino-3-(4-hydroxy-3-nitrophenyl)propanoic acid
+BMGC_DG13755,BMG_DG177257,"PubChem SID:198974931 | PubChem CID:65126 | CAS RN:3650-09-7 | (4aR,10aS)-5,6-dihydroxy-1,1-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-4a-carboxylic acid | CARNOSIC ACID | CAS RN:139236-75-2 | UNII:LI791SXT24 | Carnosic acid"
+BMGC_DG13756,BMG_DG177260,4-[6-(4-carbamimidoylphenoxy)hexoxy]benzenecarboximidamide | UNII:3483C2H13H | DrugBank ID:DB03808 | HEXAMIDINE | Hexamidine | PubChem SID:198959195 | PubChem CID:65130 | CAS RN:3811-75-4
+BMGC_DG13757,BMG_DG177268,"DrugBank ID:DB02043 | DIPALMITOYLPHOSPHATIDYLGLYCEROL, DL- | PubChem CID:65144 | PubChem SID:175271605 | UNII:VA9U6BR3SB | CAS RN:4537-77-3 | 1,2-Dipalmitoyl-Phosphatidyl-Glycerole"
+BMGC_DG13758,BMG_DG177273,"N-ACETYLMANNOSAMINE | N-acetylmannosamine | DrugBank ID:DB12536 | N-[(2S,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide | PubChem SID:198956974 | CAS RN:3615-17-6 | N-((2S,3R,4S,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl)acetamide | PubChem CID:65150 | UNII:X80PR7P73R"
+BMGC_DG13759,BMG_DG177276,"UNII:H16A5VCT9C | NDC:67979-511 | CAS RN:5949-44-0 | NDC:69087-237 | Testosterone Undecanoate | NDC:73352-105 | DrugBank ID:DB13946 | PubChem CID:65157 | TESTOSTERONE UNDECANOATE | NDC:54436-112 | NDC:80603-105 | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] undecanoate | NDC:80603-101 | NDC:80603-103 | NDC:69087-158 | PubChem SID:175268717 | NDC:69087-198 | NDC:74676-0112"
+BMGC_DG13760,BMG_DG177285,"PENTAERYTHRITOL TETRANITRATE | UNII:10L39TRG1Z | CAS RN:78-11-5 | PubChem CID:6518 | [3-nitrooxy-2,2-bis(nitrooxymethyl)propyl] nitrate | Pentaerythritol tetranitrate | PubChem SID:198939420 | DrugBank ID:DB06154"
+BMGC_DG13761,BMG_DG177287,"CAS RN:7240-90-6 | PubChem SID:198935021 | PubChem CID:65181 | 5-Bromo-4-chloro-3-indolyl beta-galactoside | UNII:V595OG374W | 5-BROMO-4-CHLOROINDOL-3-YL .BETA.-D-GALACTOPYRANOSIDE | (2S,3R,4S,5R,6R)-2-[(5-bromo-4-chloro-1H-indol-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol"
+BMGC_DG13762,BMG_DG177290,CAS RN:196808-24-9 | GW-1929 | UNII:X8S066WKF4 | PubChem SID:198943189 | PubChem CID:6518171
+BMGC_DG13763,BMG_DG177293,NILE RED | 9-(diethylamino)benzo[a]phenoxazin-5-one | PubChem SID:198970001 | PubChem CID:65182 | UNII:P476F1L81G | Nile Red | CAS RN:7385-67-3
+BMGC_DG13764,BMG_DG177297,UNII:3N789LD38N | XANTHYLETIN | PubChem SID:198975514 | PubChem CID:65188 | CAS RN:553-19-5
+BMGC_DG13765,BMG_DG177313,"CAS RN:484-11-7 | UNII:8E7D2SH3BV | NEOCUPROINE | 2,9-dimethyl-1,10-phenanthroline | Neocuproine | PubChem CID:65237 | PubChem SID:198953266"
+BMGC_DG13766,BMG_DG177314,"UNII:3UI3K8W93I | PubChem CID:65238 | PENTAGALLOYLGLUCOSE | Pentagalloylglucose | CAS RN:14937-32-7 | [(2R,3R,4S,5R,6S)-3,4,5,6-tetrakis[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate | DrugBank ID:DB03208 | PubChem SID:241178383"
+BMGC_DG13767,BMG_DG177316,PubChem SID:175268831 | PubChem CID:65241 | fluoro-dioxido-oxo-lambda5-phosphane | UNII:4964UZ79MI | MONOFLUOROPHOSPHATE ION | Monofluorophosphate ion | CAS RN:15181-43-8 | DrugBank ID:DB02348
+BMGC_DG13768,BMG_DG177319,UNII:J82727ADC8 | PubChem SID:474492439 | FRUCTOSE 1-PHOSPHATE | PubChem CID:65246 | CAS RN:15978-08-2 | Fructose 1-phosphate
+BMGC_DG13769,BMG_DG177322,CAS RN:16354-58-8 | DrugBank ID:DB02340 | UNII:W98518XGZ3 | (2S)-2-acetamido-3-hydroxypropanoic acid | N-ACETYLSERINE | N-Acetylserine | PubChem CID:65249 | N-Acetyl-Serine | PubChem SID:198990849
+BMGC_DG13770,BMG_DG177324,"Obtusifoliol | UNII:3RH57E39ER | OBTUSIFOLIOL | CAS RN:16910-32-0 | PubChem CID:65252 | PubChem SID:198937127 | (3S,4S,5S,10S,13R,14R,17R)-4,10,13,14-tetramethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-1,2,3,4,5,6,7,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol"
+BMGC_DG13771,BMG_DG177327,Para-Mercury-Benzenesulfonic Acid | DrugBank ID:DB02983 | PubChem CID:65258
+BMGC_DG13772,BMG_DG177329,UNII:KCJ747D3R4 | PubChem SID:198968014 | EMYLCAMATE | 3-methylpentan-3-yl carbamate | DrugBank ID:DB13572 | Emylcamate | PubChem CID:6526 | CAS RN:78-28-4
+BMGC_DG13773,BMG_DG177331,"NDC:64980-403 | NDC:64980-402 | NDC:65862-096 | NDC:69043-006 | NDC:68071-3616 | NDC:69292-512 | NDC:67877-878 | NDC:65862-095 | NDC:67877-560 | NDC:67877-879 | NDC:16714-394 | NDC:16714-395 | PubChem CID:6526396 | NDC:0781-5438 | NDC:69043-007 | NDC:16714-403 | CEFPODOXIME PROXETIL | NDC:65862-141 | NDC:16714-402 | NDC:69292-510 | Cefpodoxime Proxetil | CAS RN:87239-81-4 | NDC:0781-5439 | NDC:51407-084 | 1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | NDC:69292-516 | NDC:65862-140 | NDC:51407-083 | UNII:2TB00A1Z7N | NDC:55289-393 | PubChem SID:175271846 | NDC:69292-514 | NDC:67877-559"
+BMGC_DG13774,BMG_DG177336,UNII:9B710FV2AE | 6-METHOXYGUANINE | PubChem SID:249493001 | PubChem CID:65275 | CAS RN:20535-83-5
+BMGC_DG13775,BMG_DG177340,"PubChem CID:65281 | Baciguent | CAS RN:22601-59-8 | 4-[[2-[[2-(1-amino-2-methylbutyl)-4,5-dihydro-1,3-thiazole-4-carbonyl]amino]-4-methylpentanoyl]amino]-5-[[1-[[3-(2-amino-2-oxoethyl)-18-(3-aminopropyl)-12-benzyl-15-butan-2-yl-6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclopentacos-21-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid"
+BMGC_DG13776,BMG_DG177350,DrugBank ID:DB01666 | PubChem CID:65302 | D-Myo-Inositol-Hexasulphate
+BMGC_DG13777,BMG_DG177351,PubChem CID:65303 | UNII:D9R89W89CJ | DISALICYLOHYDRAZIDE | CAS RN:23647-78-1 | PubChem SID:474490657 | Disalicylohydrazide
+BMGC_DG13778,BMG_DG177352,"[[(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | UNII:9MCI2H1EJ6 | DrugBank ID:DB02189 | PubChem CID:65304 | 2',3'-Dideoxyadenosine triphosphate | PubChem SID:198988734 | CAS RN:24027-80-3 | DIDEOXYADENOSINE 5'-TRIPHOSPHATE"
+BMGC_DG13779,BMG_DG177353,"OMACETAXINE | PubChem CID:65305 | (2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-ol | PubChem SID:175265588 | Omacetaxine | UNII:84MI6OYN4Z | CAS RN:24316-19-6"
+BMGC_DG13780,BMG_DG177356,"CAS RN:24967-27-9 | PubChem CID:65309 | UNII:QR7675ZK8X | 2-deoxy-2,3-dehydro-N-acetylneuraminic acid | (2R,3R,4S)-3-acetamido-4-hydroxy-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid | PubChem SID:440793713 | 2-DEOXY-2,3-DEHYDRO-N-ACETYLNEURAMINIC ACID | 2-Deoxy-2,3-dehydro-n-acetyl-neuraminic acid | DrugBank ID:DB03991"
+BMGC_DG13781,BMG_DG177375,"UNII:C43C467DPE | CAS RN:68403-31-6 | PubChem CID:6533629 | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CAS RN:68401-81-0 | PubChem SID:175268604 | CEFTIZOXIME | Ceftizoxime | DrugBank ID:DB01332"
+BMGC_DG13782,BMG_DG177385,Triethyl phosphate | CAS RN:78-40-0 | triethyl phosphate | PubChem CID:6535 | PubChem SID:198959120 | UNII:QIH4K96K7J | TRIETHYL PHOSPHATE | DrugBank ID:DB03347
+BMGC_DG13783,BMG_DG177389,CAS RN:26194-89-8 | PubChem SID:318164642 | Stavudine triphosphate | UNII:1ZP0VJ751G | STAVUDINE TRIPHOSPHATE | PubChem CID:65355 | DrugBank ID:DB02887
+BMGC_DG13784,BMG_DG177391,CAS RN:27025-41-8 | DrugBank ID:DB03310 | UNII:ULW86O013H | Oxiglutatione | PubChem CID:65359 | (2S)-2-amino-5-[[(2R)-3-[[(2R)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]disulfanyl]-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | Glutathione disulfide | PubChem SID:175268458 | OXIGLUTATIONE
+BMGC_DG13785,BMG_DG177392,CAS RN:78-41-1 | TRIPARANOL | PubChem CID:6536 | UNII:63S8C3RXGS | Triparanol | 2-(4-chlorophenyl)-1-[4-[2-(diethylamino)ethoxy]phenyl]-1-(4-methylphenyl)ethanol | PubChem SID:198974413
+BMGC_DG13786,BMG_DG177398,PubChem SID:175271350 | MAGNESIUM LACTATE | Magnesium lactate | UNII:MT6QI8324A | CAS RN:18917-93-6 | PubChem CID:6536825 | magnesium;2-hydroxypropanoate
+BMGC_DG13787,BMG_DG177410,"CID 65370 | UNII:U782C039QP | GLATIRAMER | PubChem CID:65370 | (2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2S)-2-aminopentanedioic acid;(2S)-2-aminopropanoic acid;(2S)-2,6-diaminohexanoic acid | CAS RN:28704-27-0 | PubChem SID:472407069"
+BMGC_DG13788,BMG_DG177419,"PubChem CID:65373 | DrugBank ID:DB12179 | CAS RN:29388-59-8 | SECOISOLARICIRESINOL | UNII:M8QRJ7JEJH | (2R,3R)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol | Secoisolariciresinol | PubChem SID:198953414"
+BMGC_DG13789,BMG_DG177421,ZIDOVUDINE MONOPHOSPHATE | PubChem SID:198976154 | PubChem CID:65374 | DrugBank ID:DB03666 | CAS RN:29706-85-2 | Zidovudine monophosphate | UNII:97YMU05VPJ
+BMGC_DG13790,BMG_DG177422,"PubChem CID:6537425 | CAS RN:42504-84-7 | PubChem SID:404859729 | BISULEPIN, (Z)- | UNII:2J9S539DHX"
+BMGC_DG13791,BMG_DG177465,DrugBank ID:DB01963 | Phenylethane Boronic Acid | PubChem CID:65389
+BMGC_DG13792,BMG_DG177466,PubChem CID:6538959 | CAS RN:302356-18-9 | CB-403 | UNII:4V9Q0C88UK | PubChem SID:198946534
+BMGC_DG13793,BMG_DG177468,"N-[(2S)-1-[[(2S,3S)-5-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-[(4-bromophenyl)methoxy]-3-hydroxy-5-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]pyridine-2-carboxamide | PubChem CID:6539221 | N-((3S,4S)-5-[(4-Bromobenzyl)oxy]-3-hydroxy-4-{[N-(pyridin-2-ylcarbonyl)-L-valyl]amino}pentanoyl)-L-alanyl-L-leucinamide"
+BMGC_DG13794,BMG_DG177469,"PubChem CID:6539361 | N-(3-Methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-yl-2-pyrimidinamine | PubChem SID:482553890 | N-(3-METHOXYPHENYL)-4-PYRAZOLO(1,5-B)PYRIDAZIN-3-YL-2-PYRIMIDINAMINE | CAS RN:551920-54-8 | UNII:LB2TD227R6"
+BMGC_DG13795,BMG_DG177474,"PubChem SID:475550272 | UNII:ZPB349KCU5 | 3-(1-METHYL-3,4-DIHYDRONAPHTHALIN-2-YL)PYRIDINE | PubChem CID:6540050 | 3-(1-Methyl-3,4-dihydronaphthalin-2-yl)pyridine | CAS RN:3614-50-4"
+BMGC_DG13796,BMG_DG177477,"DrugBank ID:DB07444 | 6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE | PubChem CID:6540255"
+BMGC_DG13797,BMG_DG177478,"DrugBank ID:DB07713 | PubChem CID:6540261 | (1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid"
+BMGC_DG13798,BMG_DG177479,N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE | DrugBank ID:DB07973 | PubChem CID:6540267
+BMGC_DG13799,BMG_DG177480,PubChem CID:6540268 | DrugBank ID:DB07974 | 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE
+BMGC_DG13800,BMG_DG177481,DrugBank ID:DB07037 | PubChem CID:6540273 | (2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL
+BMGC_DG13801,BMG_DG177482,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE | DrugBank ID:DB07917 | PubChem CID:6540277
+BMGC_DG13802,BMG_DG177483,"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DrugBank ID:DB07218 | PubChem CID:6540289"
+BMGC_DG13803,BMG_DG177484,"DrugBank ID:DB08095 | PubChem CID:6540299 | 3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA"
+BMGC_DG13804,BMG_DG177490,"Deseril | PubChem CID:6540428 | CAS RN:220756-57-0 | Methysergide | (6aR,9R)-N-(1-hydroxybutan-2-yl)-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide | DrugBank ID:DB00247"
+BMGC_DG13805,BMG_DG177495,"CAS RN:20799-27-3 | Norgestimate | CAS RN:107382-52-5 | PubChem SID:459055274 | CAS RN:35189-28-7 | NORGESTIMATE, E- | PubChem CID:6540478 | DrugBank ID:DB00957 | UNII:NKX8DN6TY9 | [(3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate"
+BMGC_DG13806,BMG_DG177500,Rifalazil | DrugBank ID:DB04934 | PubChem CID:6540558
+BMGC_DG13807,BMG_DG177501,"(E)-N-[(4R,4aS,7aR,12bR)-3-(cyclopropylmethyl)-9-hydroxy-7-oxo-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-4a-yl]-3-(4-chlorophenyl)prop-2-enamide | Clocinnamox | PubChem CID:6540640"
+BMGC_DG13808,BMG_DG177504,"4-Nitrobenzylthioinosine | CAS RN:38048-32-7 | (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[(4-nitrophenyl)methylsulfanyl]purin-9-yl]oxolane-3,4-diol | PubChem SID:336286754 | PubChem CID:65407 | UNII:GV1L2DZM2Z | 4-NITROBENZYLTHIOINOSINE"
+BMGC_DG13809,BMG_DG177538,"DrugBank ID:DB07628 | PubChem CID:654376 | 6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one"
+BMGC_DG13810,BMG_DG177550,"PubChem SID:175265625 | DrugBank ID:DB11432 | PubChem CID:65452 | CAS RN:55134-13-9 | UNII:DZY9VU539P | (2R)-2-[(2R,3S,5S,6R)-6-[(2S,3S,4S,6R)-6-[(3S,5S,7R,9S,10S,12R,15R)-3-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-3,10,12-trimethyl-4,6,8-trioxadispiro[4.1.57.35]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-3,5-dimethyloxan-2-yl]butanoic acid | NARASIN | Narasin"
+BMGC_DG13811,BMG_DG177554,PubChem CID:65457 | Bropirimine | DrugBank ID:DB04168
+BMGC_DG13812,BMG_DG177576,"UNII:W2U467CIIL | CAS RN:58944-73-3 | SINEFUNGIN | Sinefungin | PubChem CID:65482 | (2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid | DrugBank ID:DB01910 | PubChem SID:198951903"
+BMGC_DG13813,BMG_DG177581,"PubChem CID:6549 | CAS RN:22564-99-4 | 3,7-dimethylocta-1,6-dien-3-ol | CAS RN:78-70-6 | LINALOOL, (±)- | UNII:D81QY6I88E | Linalool, (+/-)- | LINALOOL, (+/-)- | PubChem SID:175271943"
+BMGC_DG13814,BMG_DG177582,UNII:65Q28TV0ZY | CAS RN:59831-65-1 | PubChem CID:65490 | HALOPEMIDE | PubChem SID:198986775
+BMGC_DG13815,BMG_DG177584,"NDC:0270-1316 | NDC:0270-1411 | NDC:0270-1314 | NDC:70436-211 | NDC:70436-219 | PubChem CID:65492 | NDC:0270-1315 | CAS RN:60166-93-0 | NDC:70436-125 | DrugBank ID:DB08947 | NDC:70436-126 | Iopamidol | NDC:0270-1412 | 1-N,3-N-bis(1,3-dihydroxypropan-2-yl)-5-[[(2S)-2-hydroxypropanoyl]amino]-2,4,6-triiodobenzene-1,3-dicarboxamide | NDC:70436-124 | NDC:70436-127 | UNII:JR13W81H44 | IOPAMIDOL | PubChem SID:175266066 | NDC:0270-1317"
+BMGC_DG13816,BMG_DG177591,"CAS RN:2465-65-8 | O,O-DIETHYL HYDROGEN THIOPHOSPHATE | O,O-DIETHYL PHOSPHOROTHIOATE | O,O-Diethyl hydrogen thiophosphate | PubChem CID:655 | DrugBank ID:DB07674 | diethoxy-hydroxy-sulfanylidene-lambda5-phosphane | UNII:FND2ADQ374 | PubChem SID:405218141"
+BMGC_DG13817,BMG_DG177594,"CAS RN:129885-19-4 | CAS RN:68252-19-7 | CAS RN:129885-18-3 | Pirmenol | 4-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-1-phenyl-1-pyridin-2-ylbutan-1-ol | PubChem CID:65502"
+BMGC_DG13818,BMG_DG177600,"CAS RN:53-00-9 | UNII:CL15H93XTM | (3S,7S,8R,9S,10R,13S,14S)-3,7-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one | PubChem CID:65517 | 7.ALPHA.-HYDROXYDEHYDROEPIANDROSTERONE | PubChem SID:287445766 | 7alpha-Hydroxydehydroepiandrosterone"
+BMGC_DG13819,BMG_DG177605,"CAS RN:56-19-9 | N'-(3-aminopropyl)pentane-1,5-diamine | PubChem CID:65523 | Aminopropylcadaverine"
+BMGC_DG13820,BMG_DG177606,4-(Aminomethyl)benzoic acid | PubChem SID:198958286 | CAS RN:56-91-7 | DrugBank ID:DB13244 | AMINOMETHYLBENZOIC ACID | PubChem CID:65526 | 4-(aminomethyl)benzoic acid | UNII:68WG9JKC7L
+BMGC_DG13821,BMG_DG177609,"[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] dihydrogen phosphate | .ALPHA.-GLUCOSE-1-PHOSPHATE | PubChem SID:198962816 | alpha-D-glucose-1-phosphate | UNII:CIX3U01VAU | DrugBank ID:DB02843 | CAS RN:59-56-3 | PubChem CID:65533"
+BMGC_DG13822,BMG_DG177611,"DrugBank ID:DB03313 | PubChem CID:65536 | PubChem SID:198983234 | UNII:3XIY7HJT5L | CAS RN:39879-21-5 | (6R,7R)-3-(acetyloxymethyl)-7-[[(5R)-5-amino-5-carboxypentanoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CEPHALOSPORIN C | cephalosporin C | CAS RN:61-24-5 | Cephalosporin C | CAS RN:59143-60-1"
+BMGC_DG13823,BMG_DG177620,"UNII:2GJX0P354Z | PubChem SID:346538510 | 6beta-Hydroxytestosterone | CAS RN:62-99-7 | 6.BETA.-HYDROXYTESTOSTERONE | (6R,8R,9S,10R,13S,14S,17S)-6,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | PubChem CID:65543"
+BMGC_DG13824,BMG_DG177621,"6.BETA.-HYDROXYANDROSTENEDIONE | PubChem CID:65544 | 6beta-Hydroxyandrostenedione | PubChem SID:287445800 | (6R,8R,9S,10R,13S,14S)-6-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | CAS RN:63-00-3 | UNII:7E9225W0A9"
+BMGC_DG13825,BMG_DG177622,"16.ALPHA.-HYDROXYTESTOSTERONE | (8R,9S,10R,13S,14S,16R,17R)-16,17-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | CAS RN:63-01-4 | 16alpha-Hydroxytestosterone | PubChem CID:65545 | UNII:76E963P1A9 | PubChem SID:318164089"
+BMGC_DG13826,BMG_DG177627,"3,3',5,5'-TETRAIODOTHYROACETIC ACID | Tetraiodothyroacetic acid | PubChem SID:198969498 | PubChem CID:65552 | UNII:PA7UX1FFYQ | DrugBank ID:DB01751 | CAS RN:67-30-1"
+BMGC_DG13827,BMG_DG177628,"CAS RN:68-42-8 | UNII:PUW84K2LEC | PubChem SID:441583841 | 1-[(3R,5R,8S,9S,10S,11S,13S,14S,17S)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone | TETRAHYDROCORTICOSTERONE | PubChem CID:65553 | Tetrahydrocorticosterone"
+BMGC_DG13828,BMG_DG177629,"PubChem CID:65554 | 4,5beta-Dihydrocortisone | DIHYDROCORTISONE, (5.BETA.)- | UNII:6F8SZ90823 | (5R,8S,9S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,11-dione | CAS RN:68-54-2 | PubChem SID:315658397"
+BMGC_DG13829,BMG_DG177632,"CAS RN:70-09-7 | PubChem CID:65558 | PubChem SID:322058868 | 4',4''-BIS(2-IMIDAZOLIN-2-YL)-2-CHLOROTEREPHTHALANILIDE | UNII:WDG983W63E"
+BMGC_DG13830,BMG_DG177636,PubChem SID:198977878 | PubChem CID:65562 | CORDYCEPIN TRIPHOSPHATE | UNII:59P84ZU54H | DrugBank ID:DB01860 | Cordycepin Triphosphate | CAS RN:73-04-1
+BMGC_DG13831,BMG_DG177639,PubChem CID:65565 | CAS RN:76-61-9 | THYMOL BLUE | PubChem SID:198954431 | UNII:8YB4804L4M
+BMGC_DG13832,BMG_DG177642,TETRABROMOPHENOLPHTHALEIN | UNII:YZ4HT20I0V | CAS RN:76-62-0 | PubChem SID:198953797 | PubChem CID:65569
+BMGC_DG13833,BMG_DG177658,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine oxide | PubChem SID:198945291 | Imipraminoxide | PubChem CID:65589 | CAS RN:6829-98-7 | IMIPRAMINOXIDE | UNII:8MKS280XJW | DrugBank ID:DB13782"
+BMGC_DG13834,BMG_DG177664,"Iprazochrome | (3,6-dihydroxy-1-propan-2-yl-2,3-dihydroindol-5-yl)iminourea | CAS RN:7248-21-7 | UNII:903A9K181P | IPRAZOCHROME | PubChem CID:65594 | PubChem SID:198949548 | DrugBank ID:DB13541"
+BMGC_DG13835,BMG_DG177665,PubChem SID:198958475 | UNII:US65H9WBNH | TIPINDOLE | PubChem CID:65595 | CAS RN:7489-66-9
+BMGC_DG13836,BMG_DG177669,PubChem SID:175267682 | ISOBUTYL ALCOHOL | CAS RN:78-83-1 | PubChem CID:6560 | 2-methylpropan-1-ol | UNII:56F9Z98TEM | Isobutanol
+BMGC_DG13837,BMG_DG177670,Quifenadine | CAS RN:10447-39-9 | PubChem CID:65600 | DrugBank ID:DB13713 | 1-azabicyclo[2.2.2]octan-3-yl(diphenyl)methanol | UNII:W9A18RJ49B | PubChem SID:198985518 | QUIFENADINE
+BMGC_DG13838,BMG_DG177691,FORMETOREX | UNII:30555LM9SQ | CAS RN:15302-18-8 | PubChem CID:65614 | PubChem SID:198984690
+BMGC_DG13839,BMG_DG177702,CAS RN:16188-61-7 | PubChem CID:65624 | DrugBank ID:DB13349 | PubChem SID:198956637 | Talastine | TALASTINE | 4-benzyl-2-[2-(dimethylamino)ethyl]phthalazin-1-one | UNII:49AB2PA48B
+BMGC_DG13840,BMG_DG177706,PubChem CID:65628 | PubChem SID:175267866 | DrugBank ID:DB06769 | CAS RN:16506-27-7 | UNII:9266D9P3PQ | Bendamustine | BENDAMUSTINE | 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoic acid
+BMGC_DG13841,BMG_DG177711,ERDOSTEINE | PubChem SID:175271849 | PubChem CID:65632 | CAS RN:84611-23-4 | CAS RN:105426-14-0 | UNII:76J0853EKA | 2-[2-oxo-2-[(2-oxothiolan-3-yl)amino]ethyl]sulfanylacetic acid | Erdosteine | DrugBank ID:DB05057
+BMGC_DG13842,BMG_DG177715,"CAS RN:85175-67-3 | ZATEBRADINE | Zatebradine | PubChem SID:198966287 | UNII:TV27RY5876 | 3-[3-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one | PubChem CID:65637 | CAS RN:125846-52-8"
+BMGC_DG13843,BMG_DG177716,UNII:BP76593251 | RONIPAMIL | CAS RN:85247-77-4 | PubChem SID:198966010 | PubChem CID:65638
+BMGC_DG13844,BMG_DG177736,"PubChem CID:656495 | (2R)-2-phenyl-2-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | CAS RN:29883-15-6"
+BMGC_DG13845,BMG_DG177739,PubChem SID:198968520 | 4-(naphthalen-2-ylmethoxy)piperidine | PubChem CID:65650 | DrugBank ID:DB15038 | UNII:9980ST005G | CAS RN:86811-09-8 | LITOXETINE | Litoxetine
+BMGC_DG13846,BMG_DG177746,"Mezlocillin | CAS RN:59798-30-0 | PubChem CID:656511 | CAS RN:51481-65-3 | (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | MEZLOCILLIN | UNII:OH2O403D1G | DrugBank ID:DB00948 | PubChem SID:198944248"
+BMGC_DG13847,BMG_DG177748,"PubChem CID:656516 | Amygdalin | (2R)-2-phenyl-2-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | UNII:214UUQ9N0H | AMYGDALIN | PubChem SID:175267093 | CAS RN:29883-15-6"
+BMGC_DG13848,BMG_DG177765,"CAS RN:62587-73-9 | (6R,7R)-3-[(4-carbamoylpyridin-1-ium-1-yl)methyl]-8-oxo-7-[[(2R)-2-phenyl-2-sulfoacetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | CEFSULODIN | PubChem CID:656575 | DrugBank ID:DB13499 | Cefsulodin | PubChem SID:198937242 | UNII:OV42LHE42B"
+BMGC_DG13849,BMG_DG177767,"CAS RN:3544-94-3 | UNII:ZCX619U9A1 | 4-[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propoxy]-4-oxobutanoic acid | PubChem SID:198957612 | Chloramphenicol succinate | DrugBank ID:DB07565 | CHLORAMPHENICOL SUCCINATE | PubChem CID:656580"
+BMGC_DG13850,BMG_DG177768,"Saccharin sodium | PubChem SID:175267154 | CAS RN:128-44-9 | PubChem CID:656582 | sodium;1,1-dioxo-1,2-benzothiazol-2-id-3-one | UNII:I4807BK602 | SACCHARIN SODIUM ANHYDROUS | CAS RN:6155-57-3"
+BMGC_DG13851,BMG_DG177769,"TRILOSTANE | PubChem CID:656583 | CAS RN:13647-35-3 | Trilostane | (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile | UNII:L0FPV48Q5R | DrugBank ID:DB01108 | PubChem SID:175265964"
+BMGC_DG13852,BMG_DG177771,UNII:URX5F7RDER | PubChem CID:65659 | EPROBEMIDE | PubChem SID:198935754 | CAS RN:87940-60-1
+BMGC_DG13853,BMG_DG177774,UNII:7WSK03KXXW | CAS RN:107080-63-7 | BUTROPIUM | PubChem SID:198940876 | PubChem CID:656593
+BMGC_DG13854,BMG_DG177787,PubChem CID:656604 | DrugBank ID:DB12160 | CAS RN:65002-17-7 | BUCILLAMINE | (2R)-2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic acid | UNII:R80LRA5WTF | Bucillamine | PubChem SID:198956432
+BMGC_DG13855,BMG_DG177794,"PubChem SID:198947917 | UNII:87UG89VA9K | PubChem CID:656615 | CAS RN:4138-96-9 | Canrenoic acid | CAS RN:2181-04-6 | 3-[(8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid | CANRENOIC ACID | Canrenoic Acid | DrugBank ID:DB09015"
+BMGC_DG13856,BMG_DG177796,"OMAPATRILAT | PubChem SID:198936670 | CAS RN:167305-00-2 | (4S,7S,10aS)-5-oxo-4-[[(2S)-3-phenyl-2-sulfanylpropanoyl]amino]-2,3,4,7,8,9,10,10a-octahydropyrido[2,1-b][1,3]thiazepine-7-carboxylic acid | Omapatrilat | CAS RN:159317-63-2 | DrugBank ID:DB00886 | PubChem CID:656629 | UNII:36NLI90E7T"
+BMGC_DG13857,BMG_DG177797,"CAS RN:88321-09-9 | PubChem CID:65663 | ethyl (2S,3S)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate | Aloxistatin | UNII:L5W337AOUR | ALOXISTATIN | PubChem SID:198950560"
+BMGC_DG13858,BMG_DG177798,"LANATOSIDE C | DrugBank ID:DB13467 | lanatoside C | PubChem CID:656630 | UNII:5RR3JFZ771 | PubChem SID:198973713 | [(2R,3R,4S,6S)-6-[(2R,3S,4S,6S)-6-[(2R,3S,4S,6R)-6-[[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-12,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-4-hydroxy-2-methyloxan-3-yl]oxy-4-hydroxy-2-methyloxan-3-yl]oxy-2-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl] acetate | CAS RN:17575-22-3"
+BMGC_DG13859,BMG_DG177800,"PubChem SID:198943314 | (1S)-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol;hydrochloride | PubChem CID:656634 | Trimethoquinol | UNII:298SP836N4 | TRETOQUINOL HYDROCHLORIDE ANHYDROUS | CAS RN:18559-59-6"
+BMGC_DG13860,BMG_DG177804,DrugBank ID:DB06811 | Polidocanol | CAS RN:3055-99-0 | 2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol | CAS RN:9043-30-5 | PubChem CID:656641
+BMGC_DG13861,BMG_DG177812,"1,3-dimethyl-2-oxopurin-6-olate;2-hydroxyethyl(trimethyl)azanium | CAS RN:146-71-4 | PubChem SID:198974919 | Oxtriphylline | OXTRIPHYLLINE | CAS RN:4499-40-5 | UNII:3K045XR58X | PubChem CID:656652 | DrugBank ID:DB01303"
+BMGC_DG13862,BMG_DG177814,"Mitobronitol | DrugBank ID:DB13543 | PubChem CID:656655 | PubChem SID:198956746 | CAS RN:488-41-5 | MITOBRONITOL | UNII:5UP30YED7N | (2S,3S,4S,5S)-1,6-dibromohexane-2,3,4,5-tetrol"
+BMGC_DG13863,BMG_DG177820,"Tropisetron | PubChem SID:198945704 | CAS RN:89565-86-6 | DrugBank ID:DB11699 | CAS RN:89565-68-4 | TROPISETRON | PubChem CID:656665 | CAS RN:105826-92-4 | UNII:6I819NIK1W | [(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 1H-indole-3-carboxylate"
+BMGC_DG13864,BMG_DG177823,"DrugBank ID:DB09231 | Benidipine | CAS RN:119065-60-0 | PubChem SID:198964233 | PubChem CID:656668 | 5-O-[(3R)-1-benzylpiperidin-3-yl] 3-O-methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | UNII:4G9T91JS7E | CAS RN:105979-17-7 | BENIDIPINE"
+BMGC_DG13865,BMG_DG177824,"UNII:5M64643B5U | (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-[(2R)-butan-2-yl]-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | Epicriptine | CAS RN:88660-47-3 | EPICRIPTINE | PubChem SID:175267149 | DrugBank ID:DB11275 | PubChem CID:65667"
+BMGC_DG13866,BMG_DG177841,LY-395153 | CAS RN:211313-51-8 | UNII:U9AF5D17SA | PubChem SID:198988682 | PubChem CID:656707
+BMGC_DG13867,BMG_DG177844,"PubChem SID:198957316 | 1-AMINO-4-((4-((4-CHLORO-6-((3-SULFOPHENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-3-SULFOPHENYL)AMINO)-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENESULFONIC ACID | CAS RN:79241-87-5 | UNII:J0A052J6QF | 1-amino-4-[4-[[4-chloro-6-(3-sulfoanilino)-1,3,5-triazin-2-yl]amino]-3-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid | Reactive Blue 2 | PubChem CID:656725"
+BMGC_DG13868,BMG_DG177845,"5,8-Diethoxypsoralen | PubChem CID:656729 | 4,9-diethoxyfuro[3,2-g]chromen-7-one"
+BMGC_DG13869,BMG_DG177846,IMIRESTAT | PubChem CID:65673 | PubChem SID:198934720 | CAS RN:89391-50-4 | UNII:0PM69S95UQ
+BMGC_DG13870,BMG_DG177848,1-((2-CHLOROPHENYL)DIPHENYLMETHYL)PYRAZOLE | PubChem CID:656734 | CAS RN:289905-88-0 | 1-[(2-Chlorophenyl)diphenylmethyl]pyrazole | UNII:X3BGE57NBF | PubChem SID:485663379
+BMGC_DG13871,BMG_DG177858,UNII:UMV604ENM8 | PubChem SID:363908090 | PubChem CID:656771 | BRL-32872 FREE BASE | CAS RN:113241-09-1
+BMGC_DG13872,BMG_DG177864,"Droxicam | UNII:F24ADO1E2D | PubChem SID:198962764 | PubChem CID:65679 | CAS RN:90101-16-9 | DROXICAM | DrugBank ID:DB09215 | 5-methyl-6,6-dioxo-3-pyridin-2-yl-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4-dione"
+BMGC_DG13873,BMG_DG177867,"4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid | Prednisolone hemisuccinate | PubChem CID:656804 | PubChem SID:175266342 | CAS RN:2920-86-7 | PREDNISOLONE HEMISUCCINATE | UNII:G7080T74ON | DrugBank ID:DB14633"
+BMGC_DG13874,BMG_DG177908,PubChem CID:656902 | PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE | DrugBank ID:DB08430
+BMGC_DG13875,BMG_DG177909,"DrugBank ID:DB08558 | CAS RN:85618-21-9 | (2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-octylsulfanyloxane-3,4,5-triol | 2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL | PubChem CID:656909 | octyl 1-thio-beta-D-glucopyranoside"
+BMGC_DG13876,BMG_DG177910,PubChem CID:65691 | BERLAFENONE | CAS RN:18965-97-4 | PubChem SID:198983759 | UNII:4MYE3XA3GV
+BMGC_DG13877,BMG_DG177911,"PubChem CID:656910 | L-N(omega)-Nitroarginine-2,4-L-diaminobutyric amide | DrugBank ID:DB01821"
+BMGC_DG13878,BMG_DG177912,DrugBank ID:DB02027 | N-{(4S)-4-Amino-5-[(2-aminoethyl)amino]pentyl}-N'-nitroguanidine | PubChem CID:656911
+BMGC_DG13879,BMG_DG177913,PubChem CID:656912 | L-N(omega)-nitroarginine-(4R)-amino-L-proline amide | DrugBank ID:DB02077
+BMGC_DG13880,BMG_DG177914,"PubChem CID:656913 | DrugBank ID:DB07550 | 2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE"
+BMGC_DG13881,BMG_DG177915,DrugBank ID:DB04450 | Heptyl 1-Thiohexopyranoside | PubChem CID:656917
+BMGC_DG13882,BMG_DG177919,2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid | DrugBank ID:DB04016 | PubChem CID:656932
+BMGC_DG13883,BMG_DG177920,PubChem CID:656936 | DrugBank ID:DB07032 | 2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL
+BMGC_DG13884,BMG_DG177923,"PubChem CID:656949 | N-[(3Z)-5-Tert-butyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-ylidene]-N'-(4-chlorophenyl)urea | DrugBank ID:DB01807"
+BMGC_DG13885,BMG_DG177925,DrugBank ID:DB07198 | PubChem CID:656952 | 5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE
+BMGC_DG13886,BMG_DG177926,[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE | UNII:7B877S86BL | DrugBank ID:DB06927 | CAS RN:551001-11-7 | PubChem CID:656953 | 2-(5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL)ACETONITRILE | PubChem SID:443624036
+BMGC_DG13887,BMG_DG177927,"UNII:A9C8MNF7CA | 7-ethenyl-2-(3-fluoro-4-hydroxyphenyl)-1,3-benzoxazol-5-ol | PubChem CID:656954 | Prinaberel | CAS RN:524684-52-4 | DrugBank ID:DB06832 | PRINABEREL | PubChem SID:198977575"
+BMGC_DG13888,BMG_DG177928,Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside | PubChem CID:656957 | DrugBank ID:DB02422
+BMGC_DG13889,BMG_DG177929,"PubChem SID:175266804 | DrugBank ID:DB11468 | TIAMULIN | Tiamulin | CAS RN:55297-95-5 | [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-(diethylamino)ethylsulfanyl]acetate | UNII:E38WZ4U54R | PubChem CID:656958"
+BMGC_DG13890,BMG_DG177930,"PubChem CID:656959 | (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester | DrugBank ID:DB03392"
+BMGC_DG13891,BMG_DG177932,"CAS RN:849416-70-2 | UNII:Z9UH9VQ8ZK | DrugBank ID:DB04469 | ETHYL 1-(4-METHOXYPHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLATE | 1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester | PubChem SID:485663484 | Ethyl 1-(4-methoxyphenyl)-3,5-dimethyl-1H-pyrazole-4-carboxylate | PubChem CID:656965"
+BMGC_DG13892,BMG_DG177933,"PubChem CID:656966 | UNII:T6MC6N4LS7 | DrugBank ID:DB03183 | 1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester | ETHYL 1-(4-AMINOPHENYL)-3,5-DIMETHYL-PYRAZOLE-4-CARBOXYLATE | PubChem SID:472422605 | CAS RN:257863-04-0"
+BMGC_DG13893,BMG_DG177935,"PubChem CID:656968 | DrugBank ID:DB03807 | 1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester"
+BMGC_DG13894,BMG_DG177936,"ETHYL 3,5-DIMETHYL-1-(3-NITROPHENYL)PYRAZOLE-4-CARBOXYLATE | PubChem CID:656969 | 3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester | UNII:JT7Z77NV2G | DrugBank ID:DB01959 | CAS RN:346440-86-6"
+BMGC_DG13895,BMG_DG177938,"PubChem CID:656970 | (3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL | DrugBank ID:DB08606"
+BMGC_DG13896,BMG_DG177940,DrugBank ID:DB02368 | N-Acetyl-L-citrulline | N-Acetyl-L-Citrulline | CAS RN:33965-42-3 | (2S)-2-acetamido-5-(carbamoylamino)pentanoic acid | PubChem CID:656979
+BMGC_DG13897,BMG_DG177941,TACRINE(8)-4-AMINOQUINOLINE | PubChem CID:656986 | DrugBank ID:DB04616
+BMGC_DG13898,BMG_DG177942,DrugBank ID:DB02555 | PubChem CID:656989 | SP4160
+BMGC_DG13899,BMG_DG177947,"PubChem CID:657004 | DrugBank ID:DB03240 | (S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid"
+BMGC_DG13900,BMG_DG177949,N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE | DrugBank ID:DB06859 | PubChem CID:657007
+BMGC_DG13901,BMG_DG177952,"PubChem SID:198965081 | CAS RN:72282-85-0 | N,N,3-tris(2-chloroethyl)-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine | Trofosfamide | CAS RN:72282-84-9 | PubChem CID:65702 | DrugBank ID:DB12902 | CAS RN:22089-22-1 | UNII:H64JRU6GJ0 | TROFOSFAMIDE"
+BMGC_DG13902,BMG_DG177961,DrugBank ID:DB03509 | UNII:EK3YT5P3LA | PubChem CID:657038 | PARP INHIBITOR XII | CAS RN:489457-67-2 | 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
+BMGC_DG13903,BMG_DG177963,PubChem CID:657041 | Farnesyl thiopyrophosphate | DrugBank ID:DB04695
+BMGC_DG13904,BMG_DG177964,"PubChem CID:657043 | 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole | DrugBank ID:DB03354"
+BMGC_DG13905,BMG_DG177967,"PubChem CID:657061 | DrugBank ID:DB08388 | 5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE"
+BMGC_DG13906,BMG_DG177970,CAS RN:3986-98-9 | PubChem SID:482553297 | PubChem CID:657073 | Thiocoumarin | UNII:CM773J3THB | DrugBank ID:DB02462 | THIOCOUMARIN
+BMGC_DG13907,BMG_DG177971,PubChem CID:657077 | [4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE | DrugBank ID:DB04764
+BMGC_DG13908,BMG_DG177972,PROCODAZOLE | CAS RN:23249-97-0 | PubChem CID:65708 | PubChem SID:198972515 | UNII:SG5IU7FD3R
+BMGC_DG13909,BMG_DG177973,"PubChem CID:657081 | 2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide | DrugBank ID:DB01827"
+BMGC_DG13910,BMG_DG177974,DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID | PubChem CID:657085 | DrugBank ID:DB04585
+BMGC_DG13911,BMG_DG177975,DrugBank ID:DB02499 | Dinor-N(Omega)-Hydroxy-L-Arginine | PubChem CID:657087
+BMGC_DG13912,BMG_DG177976,CAS RN:23465-76-1 | 1-[2-(diethylamino)ethyl]-3-[(4-methoxyphenyl)methyl]quinoxalin-2-one | PubChem CID:65709 | DrugBank ID:DB13835 | Caroverine | PubChem SID:198970174 | CAROVERINE | UNII:XJ73B0K6KB
+BMGC_DG13913,BMG_DG177977,"(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-4-methylsulfanylbutanoyl]amino]-3-carboxypropanoyl]amino]-5-oxopentanoyl]amino]-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylbutanoic acid | DISOMOTIDE | UNII:8028PPX4PM | PubChem CID:657090 | Disomotide | PubChem SID:375085957 | CAS RN:181477-43-0"
+BMGC_DG13914,BMG_DG177978,"DrugBank ID:DB04463 | 3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol | PubChem CID:657095"
+BMGC_DG13915,BMG_DG177979,"PubChem CID:657096 | 2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400 | DrugBank ID:DB03556"
+BMGC_DG13916,BMG_DG177980,"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid | DrugBank ID:DB03276 | PubChem CID:657098"
+BMGC_DG13917,BMG_DG177982,METRIFUDIL | UNII:7K4GKQ4XSE | CAS RN:23707-33-7 | PubChem SID:198950982 | PubChem CID:65710
+BMGC_DG13918,BMG_DG177990,BX-320 | PubChem CID:657138 | PubChem SID:198936818 | UNII:B504GXS5SM | CAS RN:702676-93-5
+BMGC_DG13919,BMG_DG177991,CAS RN:24527-27-3 | PubChem CID:65714 | SPICLOMAZINE | PubChem SID:198956392 | UNII:G2V8248111
+BMGC_DG13920,BMG_DG177992,DrugBank ID:DB04044 | 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid | PubChem CID:657140
+BMGC_DG13921,BMG_DG177993,"PubChem CID:657141 | DrugBank ID:DB03067 | 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid"
+BMGC_DG13922,BMG_DG177994,3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid | DrugBank ID:DB01935 | PubChem CID:657144
+BMGC_DG13923,BMG_DG177995,N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl) | DrugBank ID:DB02505 | PubChem CID:657149
+BMGC_DG13924,BMG_DG177998,CAS RN:53714-56-0 | UNII:37JNS02E7V | NDC:62935-163 | PubChem SID:175266813 | acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | CAS RN:74381-53-6 | LEUPROLIDE ACETATE | PubChem CID:657180 | NDC:62935-227 | NDC:62935-306 | NDC:62935-461 | Leuprolide Acetate | NDC:62935-756
+BMGC_DG13925,BMG_DG177999,PubChem CID:657181 | CAS RN:53714-56-0 | Leuprolide | (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide | PubChem SID:175266671 | LEUPROLIDE | UNII:EFY6W0M8TG | DrugBank ID:DB00007
+BMGC_DG13926,BMG_DG178000,PubChem SID:198961636 | PubChem CID:65719 | ESERIDINE | UNII:LW9S78L4M8 | CAS RN:25573-43-7
+BMGC_DG13927,BMG_DG178003,"[(1R,5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] 2-propylpentanoate;bromide | PubChem CID:657201 | PubChem SID:198974990 | Anisotropine methylbromide | UNII:62M960DHIL | ANISOTROPINE METHYLBROMIDE | CAS RN:80-50-2"
+BMGC_DG13928,BMG_DG178008,Diethylstilbestrol Dipropionate | DIETHYLSTILBESTROL DIPROPIONATE | UNII:Y98CK3J0OL | [4-[(E)-4-(4-propanoyloxyphenyl)hex-3-en-3-yl]phenyl] propanoate | PubChem SID:198961797 | CAS RN:37221-14-0 | PubChem CID:657220 | CAS RN:130-80-3
+BMGC_DG13929,BMG_DG178010,"CAS RN:21679-14-1 | Fludarabine | UNII:P2K93U8740 | (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | FLUDARABINE | PubChem SID:175265538 | PubChem CID:657237 | DrugBank ID:DB01073"
+BMGC_DG13930,BMG_DG178015,"(1S,2R)-2-(octylamino)-1-(4-propan-2-ylsulfanylphenyl)propan-1-ol | PubChem CID:657255 | (1S,2R)-2-(octylamino)-1-[4-(propan-2-ylthio)phenyl]-1-propanol | CAS RN:54767-75-8"
+BMGC_DG13931,BMG_DG178020,"PubChem SID:198989336 | CHOLINE ALFOSCERATE | Choline alfoscerate | DrugBank ID:DB04660 | UNII:60M22SGW66 | CAS RN:28319-77-9 | PubChem CID:657272 | Choline Alfoscerate | [(2R)-2,3-dihydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate"
+BMGC_DG13932,BMG_DG178022,"Lathosterol | (3S,5S,9R,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | PubChem CID:65728 | CAS RN:80-99-9"
+BMGC_DG13933,BMG_DG178025,"PubChem SID:175266182 | [(1S,2S,4R,5R)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;nitrate | Scopolamine methyl nitrate | PubChem CID:657297 | METHSCOPOLAMINE NITRATE | UNII:K0813KQM3V | CAS RN:6106-46-3"
+BMGC_DG13934,BMG_DG178026,PROPYLTHIOURACIL | CAS RN:51-52-5 | NDC:0228-2348 | CAS RN:500-50-5 | 6-propyl-2-sulfanylidene-1H-pyrimidin-4-one | PubChem SID:175267902 | NDC:0480-9242 | NDC:33342-314 | NDC:72162-2072 | Propylthiouracil | NDC:67253-651 | DrugBank ID:DB00550 | PubChem CID:657298 | NDC:68084-964 | NDC:70752-171 | UNII:721M9407IY | NDC:62135-606
+BMGC_DG13935,BMG_DG178031,"PubChem SID:472388417 | [(1R,5S)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;bromide | IPRATROPIUM BROMIDE ANHYDROUS | CAS RN:60251-88-9 | IPRATROPIUM BROMIDE, EXO- | CAS RN:22254-24-6 | UNII:3FR83WLC6J | PubChem CID:657308 | Ipratropium | CAS RN:24358-20-1 | Ipratropium bromide | DrugBank ID:DB00332 | UNII:VJV4X1P2Z1"
+BMGC_DG13936,BMG_DG178032,"[(1S,5R)-8-methyl-8-propan-2-yl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate | PubChem CID:657309 | Ipratropium | DrugBank ID:DB00332 | CAS RN:60205-81-4"
+BMGC_DG13937,BMG_DG178039,PubChem SID:198966803 | .BETA.-DIETHYLAMINOETHYL PHENOTHIAZINE-N-CARBOXYLATE | UNII:DOV7Z6J44Z | PubChem CID:65735 | CAS RN:82-00-8
+BMGC_DG13938,BMG_DG178043,"UNII:7LG47VG1ID | PubChem CID:657378 | CAS RN:41552-82-3 | PubChem SID:377308117 | (2R,3R,4S,5R)-2-[6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol | N-CYCLOPENTYLADENOSINE | N6-Cyclopentyladenosine"
+BMGC_DG13939,BMG_DG178054,"PubChem SID:198953834 | PubChem CID:6575 | UNII:290YE8AR51 | Trichloroethylene | 1,1,2-trichloroethene | CAS RN:79-01-6 | TRICHLOROETHYLENE | DrugBank ID:DB13323 | CAS RN:123919-09-5"
+BMGC_DG13940,BMG_DG178055,"PubChem SID:198944666 | PubChem CID:65750 | Chlorproethazine | CAS RN:84-01-5 | CHLORPROETHAZINE | 3-(2-chlorophenothiazin-10-yl)-N,N-diethylpropan-1-amine | DrugBank ID:DB13382 | UNII:960NX27Z07"
+BMGC_DG13941,BMG_DG178058,CAS RN:84-24-2 | PubChem CID:65751 | PubChem SID:198943205 | PHYSODIC ACID | UNII:X901BNT6BF
+BMGC_DG13942,BMG_DG178059,"3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one | CAS RN:84-26-4 | UNII:8XZV289PRY | RUTECARPINE | Rutaecarpine | PubChem SID:198956955 | PubChem CID:65752"
+BMGC_DG13943,BMG_DG178062,"PubChem SID:249817669 | PubChem CID:6575389 | UNII:2635N2PS4Q | NIPECOTIC ACID, S- | CAS RN:59045-82-8"
+BMGC_DG13944,BMG_DG178064,"CAS RN:26973-24-0 | DrugBank ID:DB13821 | UNII:2Z86SYP11W | CEFTEZOLE | (6R,7R)-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-3-(1,3,4-thiadiazol-2-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem SID:198946844 | PubChem CID:65755 | Ceftezole"
+BMGC_DG13945,BMG_DG178069,"PubChem SID:198960288 | Dichloroacetaldehyde | 2,2-dichloroacetaldehyde | UNII:9GT3DHH725 | PubChem CID:6576 | CAS RN:79-02-7 | DICHLOROACETALDEHYDE"
+BMGC_DG13946,BMG_DG178074,PubChem SID:198985616 | PubChem CID:65764 | UNII:36YG4ZMR69 | MOTRAZEPAM | CAS RN:29442-58-8
+BMGC_DG13947,BMG_DG178078,2-chloroacetyl chloride | CHLOROACETYL CHLORIDE | CAS RN:79-04-9 | PubChem SID:198961649 | UNII:K5UML06YUO | Chloroacetyl chloride | PubChem CID:6577
+BMGC_DG13948,BMG_DG178081,"PubChem CID:65772 | CAS RN:30418-38-3 | UNII:JIO3275WGI | DrugBank ID:DB13692 | PubChem SID:198961074 | (1S)-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol | TRETOQUINOL | Tretoquinol"
+BMGC_DG13949,BMG_DG178086,ETOFIBRATE | 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl pyridine-3-carboxylate | CAS RN:31637-97-5 | PubChem SID:198945221 | UNII:23TF67G79M | Etofibrate | PubChem CID:65777 | DrugBank ID:DB08983
+BMGC_DG13950,BMG_DG178091,"ECABET | (1R,4aS,10aR)-1,4a-dimethyl-7-propan-2-yl-6-sulfo-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid | PubChem SID:198948317 | PubChem CID:65781 | DrugBank ID:DB05265 | CAS RN:33159-27-2 | UNII:2K02669KWP | Ecabet"
+BMGC_DG13951,BMG_DG178093,"Oxaceprol | OXACEPROL | (2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid | CAS RN:2235464-65-8 | UNII:Q0XV76B96L | PubChem SID:198980089 | DrugBank ID:DB13363 | CAS RN:33996-33-7 | PubChem CID:65784"
+BMGC_DG13952,BMG_DG178109,PubChem CID:65801 | PubChem SID:198986465 | CAS RN:37577-24-5 | LEVOFENFLURAMINE | UNII:953A94Y45B
+BMGC_DG13953,BMG_DG178115,"(2R)-2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile | CAS RN:38321-02-7 | PubChem CID:65808 | DrugBank ID:DB14063 | DEXVERAPAMIL | Dexverapamil | UNII:QR5PYD126V | PubChem SID:198948998"
+BMGC_DG13954,BMG_DG178117,CAS RN:9063-87-0 | prop-2-enoic acid | CAS RN:79-10-7 | CAS RN:55927-87-2 | PubChem CID:6581 | NDC:84660-015 | PubChem SID:175267339 | Acrylic acid | ACRYLIC ACID | Acrylic Acid | UNII:J94PBK7X8S | DrugBank ID:DB02579
+BMGC_DG13955,BMG_DG178122,"DrugBank ID:DB13508 | PubChem SID:198976709 | CAS RN:39563-28-5 | CLORANOLOL | Cloranolol | 1-(tert-butylamino)-3-(2,5-dichlorophenoxy)propan-2-ol | PubChem CID:65814 | UNII:Q3U058H86V"
+BMGC_DG13956,BMG_DG178131,"PubChem CID:65825 | Tedisamil | UNII:A5VAY2U3R8 | TEDISAMIL | DrugBank ID:DB06200 | CAS RN:90961-53-8 | PubChem SID:198959186 | 3,7-bis(cyclopropylmethyl)spiro[3,7-diazabicyclo[3.3.1]nonane-9,1'-cyclopentane]"
+BMGC_DG13957,BMG_DG178138,"CAS RN:96847-55-1 | Milnacipran | UNII:G56VK1HF36 | PubChem CID:65833 | PubChem SID:252164630 | UNII:ES1O38J3C4 | PubChem SID:175272145 | DEXTROMILNACIPRAN | (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide | MILNACIPRAN | DrugBank ID:DB04896 | CAS RN:92623-85-3"
+BMGC_DG13958,BMG_DG178142,UNII:90K2YE9FTO | CAS RN:94149-41-4 | PubChem CID:65837 | PubChem SID:198975062 | MIDESTEINE
+BMGC_DG13959,BMG_DG178146,UNII:VSI302RYSR | Colestilan | PubChem CID:65840 | 2-(chloromethyl)oxirane;2-methyl-1H-imidazole | CAS RN:95522-45-5 | COLESTILAN CHLORIDE | PubChem SID:472400699
+BMGC_DG13960,BMG_DG178152,PubChem SID:198982311 | DrugBank ID:DB14556 | Peracetic Acid | UNII:I6KPI2E1HD | PERACETIC ACID | CAS RN:79-21-0 | PubChem CID:6585 | NDC:81803-050 | NDC:81803-020 | ethaneperoxoic acid
+BMGC_DG13961,BMG_DG178155,"UNII:510M006KO6 | DrugBank ID:DB12883 | 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine | CAS RN:98224-03-4 | ELTOPRAZINE | PubChem SID:198943134 | Eltoprazine | PubChem CID:65853"
+BMGC_DG13962,BMG_DG178157,CAS RN:98819-76-2 | Esreboxetine | (2S)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine | UNII:L8S50ZY490 | DrugBank ID:DB12395 | PubChem SID:198973023 | ESREBOXETINE | PubChem CID:65856
+BMGC_DG13963,BMG_DG178158,PubChem CID:65858 | UNII:17VM9WN49U | CAS RN:99287-30-6 | PubChem SID:198981035 | EGUALEN
+BMGC_DG13964,BMG_DG178163,"UNII:72W71I16EG | SERTACONAZOLE | PubChem CID:65863 | DrugBank ID:DB01153 | 1-[2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole | Sertaconazole | CAS RN:99592-32-2 | PubChem SID:175271806"
+BMGC_DG13965,BMG_DG178164,"UNII:V9E5U5XF42 | Flomoxef | (6R,7R)-7-[[2-(difluoromethylsulfanyl)acetyl]amino]-3-[[1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem SID:198985671 | FLOMOXEF | DrugBank ID:DB11935 | CAS RN:99665-00-6 | PubChem CID:65864"
+BMGC_DG13966,BMG_DG178168,"UNII:V7XTJ4R0BH | DrugBank ID:DB00528 | LERCANIDIPINE | PubChem SID:175272116 | PubChem CID:65866 | CAS RN:100427-26-7 | Lercanidipine | 5-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate"
+BMGC_DG13967,BMG_DG178171,"PubChem SID:198971390 | UNII:TMZ3IBW2OW | N-(4-bromophenyl)sulfonyl-N'-[2-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]methanimidamide | EBROTIDINE | Ebrotidine | PubChem CID:65869 | CAS RN:100981-43-9"
+BMGC_DG13968,BMG_DG178175,"UNII:6PZZ52D76Q | Eptastigmine | PubChem SID:198937784 | [(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-heptylcarbamate | PubChem CID:65872 | EPTASTIGMINE | CAS RN:101246-68-8"
+BMGC_DG13969,BMG_DG178190,"UNII:J613NI05SV | 3-[7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-4-yl]-1-morpholin-4-ylpropan-1-one | PubChem SID:198957763 | APAFANT | Apafant | CAS RN:105219-56-5 | PubChem CID:65889"
+BMGC_DG13970,BMG_DG178194,"UNII:F52Y83BGH3 | CAS RN:106560-14-9 | Faropenem | DrugBank ID:DB12190 | PubChem SID:198979214 | CAS RN:122547-49-3 | PubChem CID:65894 | (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid | FAROPENEM"
+BMGC_DG13971,BMG_DG178195,CAS RN:106669-71-0 | PubChem CID:65895 | ARPROMIDINE | PubChem SID:198957951 | UNII:85713MT0EH
+BMGC_DG13972,BMG_DG178201,Isobutyric Acid | 2-methylpropanoic acid | ISOBUTYRIC ACID | PubChem SID:198966866 | UNII:8LL210O1U0 | DrugBank ID:DB02531 | PubChem CID:6590 | Isobutyric acid | CAS RN:79-31-2
+BMGC_DG13973,BMG_DG178206,2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one | PubChem SID:198970044 | PubChem CID:65906 | DrugBank ID:DB12523 | UNII:244O1F90NA | MIZOLASTINE | CAS RN:108612-45-9 | Mizolastine
+BMGC_DG13974,BMG_DG178207,"PubChem SID:198958529 | NEMORUBICIN | (7S,9S)-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-7-[(2R,4S,5S,6S)-5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyloxan-2-yl]oxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione | PubChem CID:65907 | UNII:7618O47BQM | CAS RN:108852-90-0 | Nemorubicin"
+BMGC_DG13975,BMG_DG178215,"PubChem CID:65914 | CAS RN:111841-85-1 | PubChem SID:198973744 | Abecarnil | propan-2-yl 4-(methoxymethyl)-6-phenylmethoxy-9H-pyrido[3,4-b]indole-3-carboxylate | ABECARNIL | UNII:IZM1PNJ3JL"
+BMGC_DG13976,BMG_DG178223,PubChem CID:65922 | IMITRODAST | PubChem SID:198984027 | UNII:JCQ5G1KFHN | CAS RN:114686-12-3
+BMGC_DG13977,BMG_DG178225,N-[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-[[4-[bis(2-chloroethyl)amino]benzoyl]amino]-1-methylpyrrole-2-carboxamide | Tallimustine | PubChem CID:65924 | UNII:71193OXG6S | DrugBank ID:DB15466 | CAS RN:115308-98-0 | PubChem SID:198941611 | TALLIMUSTINE
+BMGC_DG13978,BMG_DG178232,PubChem SID:198990625 | PubChem CID:65934 | CAS RN:119322-27-9 | MERIBENDAN | UNII:4WYD7I9GF4
+BMGC_DG13979,BMG_DG178235,"CAS RN:119817-90-2 | DEXLOXIGLUMIDE | PubChem CID:65937 | PubChem SID:198940007 | DrugBank ID:DB04856 | (4R)-4-[(3,4-dichlorobenzoyl)amino]-5-[3-methoxypropyl(pentyl)amino]-5-oxopentanoic acid | UNII:69DY40RH9B | Dexloxiglumide"
+BMGC_DG13980,BMG_DG178240,"CAS RN:121277-96-1 | Terikalant | TERIKALANT | PubChem SID:198969630 | 1-[2-[(4S)-3,4-dihydro-2H-chromen-4-yl]ethyl]-4-(3,4-dimethoxyphenyl)piperidine | UNII:G8ZMP77RGJ | PubChem CID:65941 | CAS RN:132338-79-5"
+BMGC_DG13981,BMG_DG178243,"PIDOTIMOD | CAS RN:121808-62-6 | Pidotimod | DrugBank ID:DB11364 | PubChem SID:198954620 | PubChem CID:65944 | UNII:785363R681 | (4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid"
+BMGC_DG13982,BMG_DG178246,"CAS RN:123447-63-2 | CAS RN:123447-62-1 | Prulifloxacin | UNII:J42298IESW | DrugBank ID:DB11892 | PRULIFLOXACIN | PubChem CID:65947 | 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid | PubChem SID:198968769"
+BMGC_DG13983,BMG_DG178247,"UNII:PV23P19YUG | 3-O-(1-benzhydrylazetidin-3-yl) 5-O-propan-2-yl 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | PubChem SID:198976749 | Azelnidipine | AZELNIDIPINE | PubChem CID:65948 | CAS RN:123524-52-7 | DrugBank ID:DB09230"
+BMGC_DG13984,BMG_DG178252,"INTOPLICINE | UNII:FB2CIN6HMI | Intoplicine | 16-[3-(dimethylamino)propylamino]-13-methyl-11,15-diazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(10),2(7),3,5,8,12(17),13,15-octaen-5-ol | PubChem SID:198949422 | CAS RN:125974-72-3 | DrugBank ID:DB12868 | PubChem CID:65954"
+BMGC_DG13985,BMG_DG178254,"UNII:4CZ1R38NDI | CAS RN:127046-18-8 | CAS RN:127045-41-4 | Pazufloxacin | PubChem CID:65957 | (2S)-6-(1-aminocyclopropyl)-7-fluoro-2-methyl-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid | PubChem SID:198941671 | PAZUFLOXACIN | DrugBank ID:DB11774"
+BMGC_DG13986,BMG_DG178264,"Dichloroacetic Acid | 2,2-dichloroacetic acid | Dichloroacetic acid | PubChem SID:198990518 | UNII:9LSH52S3LQ | PubChem CID:6597 | DrugBank ID:DB08809 | CAS RN:79-43-6 | DICHLOROACETIC ACID"
+BMGC_DG13987,BMG_DG178270,"INDANAZOLINE | PubChem SID:198940963 | UNII:L0U38EHD86 | Indanazoline | PubChem CID:65979 | DrugBank ID:DB13827 | N-(2,3-dihydro-1H-inden-4-yl)-4,5-dihydro-1H-imidazol-2-amine | CAS RN:40507-78-6"
+BMGC_DG13988,BMG_DG178272,NDC:33342-249 | CAS RN:135062-02-1 | NDC:63629-8448 | UNII:668Z8C33LU | NDC:65862-670 | NDC:57664-745 | NDC:63629-8447 | NDC:60687-560 | 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid | NDC:33342-248 | NDC:71335-2554 | DrugBank ID:DB00912 | NDC:0574-0241 | NDC:57237-159 | NDC:65862-672 | NDC:57237-158 | NDC:72162-1112 | NDC:65862-671 | NDC:57237-157 | NDC:33342-250 | PubChem CID:65981 | PubChem SID:175267049 | NDC:72162-1113 | NDC:63629-4866 | NDC:57664-747 | REPAGLINIDE | Repaglinide
+BMGC_DG13989,BMG_DG178275,"Vesamicol | (1R,2R)-2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol | VESAMICOL, (+/-)- | PubChem SID:249817595 | VESAMICOL, (-)- | VESAMICOL, (±)- | UNII:3D416V0FLM | CAS RN:115362-28-2 | CAS RN:112709-59-8 | PubChem CID:659840 | PubChem SID:472407349 | UNII:I1A877466V"
+BMGC_DG13990,BMG_DG178276,"1-N,3-N-bis(2,3-dihydroxypropyl)-5-[[3-hydroxy-2-(hydroxymethyl)propanoyl]amino]-2,4,6-triiodo-1-N,3-N-dimethylbenzene-1,3-dicarboxamide | DrugBank ID:DB12407 | PubChem CID:65985 | UNII:182ECH14UH | IOBITRIDOL | CAS RN:136949-58-1 | Iobitridol | PubChem SID:198957053"
+BMGC_DG13991,BMG_DG178277,"TUROSTERIDE | PubChem SID:198966762 | CAS RN:137099-09-3 | PubChem CID:65986 | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-6,9a,11a-trimethyl-7-oxo-N-propan-2-yl-N-(propan-2-ylcarbamoyl)-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinoline-1-carboxamide | Turosteride | UNII:LU1LTK666W"
+BMGC_DG13992,BMG_DG178278,PubChem SID:198968017 | SPIROGLUMIDE | CAS RN:137795-35-8 | PubChem CID:65987 | UNII:EZS5V8UN4Y
+BMGC_DG13993,BMG_DG178284,SAMERIDINE | UNII:NQP2Y50Y6B | PubChem CID:65996 | CAS RN:143257-97-0 | PubChem SID:198954488
+BMGC_DG13994,BMG_DG178285,1-benzyl-2-piperazin-1-ylbenzimidazole | LERISETRON | Lerisetron | PubChem SID:198990772 | UNII:Q36R82SXRG | DrugBank ID:DB12964 | CAS RN:143257-98-1 | PubChem CID:65997
+BMGC_DG13995,BMG_DG178287,NDC:67877-482 | NDC:42291-791 | NDC:43547-283 | NDC:42291-790 | NDC:70756-314 | NDC:0597-0041 | NDC:70756-313 | NDC:70518-3556 | NDC:62332-088 | NDC:62332-087 | NDC:71335-2173 | NDC:59746-440 | NDC:68382-472 | NDC:65162-292 | NDC:65162-293 | NDC:53746-291 | NDC:53746-292 | NDC:62135-535 | NDC:42291-792 | NDC:63187-951 | NDC:70756-312 | NDC:65862-867 | NDC:72241-015 | PubChem SID:175268456 | NDC:67877-484 | Telmisartan | NDC:43547-285 | NDC:42571-227 | NDC:50090-7450 | NDC:68382-471 | NDC:0378-2921 | NDC:46708-609 | NDC:42571-226 | NDC:72162-2439 | NDC:65841-805 | NDC:71335-1428 | UNII:U5SYW473RQ | NDC:59746-439 | NDC:42571-228 | NDC:72241-016 | NDC:67877-483 | NDC:65841-806 | NDC:68071-5178 | NDC:63629-5682 | PubChem CID:65999 | NDC:68382-473 | NDC:65862-869 | NDC:71335-1723 | NDC:71209-049 | DrugBank ID:DB00966 | NDC:50090-5492 | NDC:65862-868 | NDC:68462-201 | NDC:71209-051 | NDC:71335-2191 | TELMISARTAN | NDC:62332-089 | NDC:68462-200 | 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid | NDC:68788-8441 | NDC:0597-0039 | NDC:59746-441 | NDC:0378-2922 | NDC:53746-293 | NDC:65162-291 | NDC:62135-536 | NDC:43547-284 | NDC:68788-8440 | NDC:62135-537 | NDC:72162-2440 | NDC:71209-050 | NDC:46708-608 | NDC:65841-804 | NDC:68788-8665 | NDC:50090-5490 | NDC:0378-2920 | NDC:72162-2438 | NDC:72789-371 | CAS RN:144701-48-4 | NDC:68462-199 | NDC:68788-8718 | NDC:0597-0040 | NDC:46708-610 | NDC:72241-017
+BMGC_DG13996,BMG_DG178290,"DrugBank ID:DB06472 | PubChem SID:198948455 | UNII:DQ0H2B8YKN | PubChem CID:66000 | 2-[(3S,5S)-5-[[4-(4-carbamimidoylphenyl)phenoxy]methyl]-2-oxopyrrolidin-3-yl]acetic acid | FRADAFIBAN | Fradafiban | CAS RN:148396-36-5"
+BMGC_DG13997,BMG_DG178294,UNII:B57Z82EOGE | CAS RN:152317-89-0 | PubChem CID:66004 | PubChem SID:198978671 | ALNIDITAN
+BMGC_DG13998,BMG_DG178324,"(2R,3R,4S,5S,6R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol | Stigmasterol glucoside | CAS RN:19716-26-8 | PubChem CID:6602508"
+BMGC_DG13999,BMG_DG178335,"UNII:N5I18JI9D6 | PubChem SID:198944529 | Pempidine | CAS RN:79-55-0 | PubChem CID:6603 | 1,2,2,6,6-pentamethylpiperidine | PEMPIDINE"
+BMGC_DG14000,BMG_DG178339,"5-[3-(4-fluorophenyl)-1-phenylpyrazol-4-yl]imidazolidine-2,4-dione | CAS RN:484049-04-9 | 5-(3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)imidazolidine-2,4-dione | PubChem CID:660311"
+BMGC_DG14001,BMG_DG178347,PubChem CID:66035 | 4-METHYLBENZYLAMINE | UNII:F9B6VRU8WP | 4-Methylbenzylamine | PubChem SID:485662258 | CAS RN:104-84-7
+BMGC_DG14002,BMG_DG178349,4-Chlorobenzylamine | PubChem SID:482553366 | 4-CHLOROBENZYLAMINE | CAS RN:104-86-9 | PubChem CID:66036 | UNII:V67JZR9DMP
+BMGC_DG14003,BMG_DG178352,PubChem CID:6603697 | CAS RN:55199-25-2 | UNII:2B75NX3MA8 | 4-AMINOISOCROTONIC ACID | PubChem SID:459275586
+BMGC_DG14004,BMG_DG178353,"CAS RN:778546-51-3 | A-77636 | 1H-2-Benzopyran-5,6-diol, 1-(aminomethyl)-3,4-dihydro-3-tricyclo(3.3.1.13,7)dec-1-yl-, (1R,3S)- | (1R,3S)-3-(1-adamantyl)-1-(aminomethyl)-3,4-dihydro-1H-isochromene-5,6-diol | PubChem CID:6603703 | CAS RN:145307-34-2 | PubChem SID:318164394 | UNII:8PDA66H6ZI"
+BMGC_DG14005,BMG_DG178356,PubChem CID:6603746 | (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one | DrugBank ID:DB06842
+BMGC_DG14006,BMG_DG178358,"UNII:Z7YP8B158Q | PubChem SID:375085380 | CGP-12177, (S)- | 2H-Benzimidazol-2-one, 4-((2S)-3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,3-dihydro- | PubChem CID:6603756 | 4-[(2S)-3-(tert-butylamino)-2-hydroxypropoxy]-1,3-dihydrobenzimidazol-2-one | CAS RN:95840-76-9"
+BMGC_DG14007,BMG_DG178359,"UNII:RIH052ANA4 | PubChem SID:363908613 | CYCLAZOCINE, (+)- | CAS RN:7313-87-3 | PubChem CID:6603759"
+BMGC_DG14008,BMG_DG178361,CAS RN:205934-46-9 | N-[(2S)-butan-2-yl]-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide | PubChem CID:6603767
+BMGC_DG14009,BMG_DG178370,"(6aR,12bS)-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine-10,11-diol | DIHYDREXIDINE, (+)- | UNII:Q3PJ4B4D0X | PubChem SID:377308501 | CAS RN:174691-84-0 | PubChem CID:6603820 | CAS RN:123039-93-0"
+BMGC_DG14010,BMG_DG178378,PubChem SID:312524917 | UNII:860VEX6583 | CAS RN:126766-42-5 | GR-103545 | PubChem CID:6603856
+BMGC_DG14011,BMG_DG178379,"CAS RN:80300-09-0 | PubChem SID:313183144 | UNII:6417Y85XND | PubChem CID:6603866 | 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN, (+)-"
+BMGC_DG14012,BMG_DG178384,PubChem CID:6603901 | PubChem SID:472388032 | L-165041 | {4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid | CAS RN:79558-09-1 | UNII:7RV682Z3FQ | DrugBank ID:DB08078
+BMGC_DG14013,BMG_DG178385,PubChem CID:6603904 | PubChem SID:474492646 | UNII:CR7JLF2GBM | L-765314 | CAS RN:189349-50-6
+BMGC_DG14014,BMG_DG178389,CAS RN:155204-26-5 | UNII:81KHI46E5L | 4-FLUORO-N-(2-(4-(2-METHOXYPHENYL)-1-PIPERAZINYL)ETHYL)-N-2-PYRIDINYLBENZAMIDE | PubChem SID:287446477 | PubChem CID:6603915
+BMGC_DG14015,BMG_DG178391,PubChem SID:443624236 | MRS-1754 | CAS RN:264622-58-4 | UNII:7E435V2DAH | PubChem CID:6603931
+BMGC_DG14016,BMG_DG178396,"CLOROTEPINE, (R)- | PubChem SID:329904012 | PubChem CID:6603950 | UNII:04F30EG8C0 | CAS RN:41931-05-9"
+BMGC_DG14017,BMG_DG178398,PD-404182 | UNII:3PYK7K517E | CAS RN:72596-74-8 | PubChem SID:198958536 | PubChem CID:6603967
+BMGC_DG14018,BMG_DG178400,PSORA-4 | PubChem CID:6603977 | UNII:QDY3FLF2DY | CAS RN:724709-68-6 | Psora-4 | PubChem SID:482555244
+BMGC_DG14019,BMG_DG178401,"PubChem CID:6603989 | SELICICLIB, (S)- | PubChem SID:198972078 | UNII:8C43G94891 | CAS RN:186692-45-5"
+BMGC_DG14020,BMG_DG178406,3-[[(2S)-2-[2-(4-Methyl-1-piperidinyl)ethyl]-1-pyrrolidinyl]sulfonyl]phenol | UNII:V9ZSJ3MNH7 | CAS RN:2182241-63-8 | 3-(((2S)-2-(2-(4-METHYL-1-PIPERIDINYL)ETHYL)-1-PYRROLIDINYL)SULFONYL)PHENOL | PubChem SID:474494375 | PubChem CID:6604010
+BMGC_DG14021,BMG_DG178408,PubChem SID:474492436 | PubChem CID:6604042 | VER-3323 | UNII:6V95Z2V9WG | CAS RN:259857-99-3
+BMGC_DG14022,BMG_DG178409,"PubChem CID:6604049 | PubChem SID:329903812 | CAS RN:1229516-19-1 | XAMOTEROL, (R)- | UNII:M4489SH71S"
+BMGC_DG14023,BMG_DG178414,PubChem SID:198948894 | UNII:28F0G1E0VF | CAS RN:14663-23-1 | DANTROLENE SODIUM ANHYDROUS | CAS RN:24868-20-0 | PubChem CID:6604100 | Dantrolene Sodium | sodium;3-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-2-oxo-4H-imidazol-5-olate
+BMGC_DG14024,BMG_DG178417,"PubChem CID:6604117 | CAS RN:74991-36-9 | IFENPRODIL, ERYTHRO- | UNII:T8N3S4QE90 | PubChem SID:472423581"
+BMGC_DG14025,BMG_DG178426,UNII:DWH62Y9TCA | PubChem SID:375579814 | 4-formylbenzonitrile | PubChem CID:66042 | 4-Cyanobenzaldehyde | TEREPHTHALALDEHYDONITRILE | CAS RN:105-07-7
+BMGC_DG14026,BMG_DG178427,"NDC:70771-1171 | NDC:59651-753 | NDC:42571-393 | NDC:67296-2105 | NDC:71335-1069 | NDC:68071-4428 | NDC:82868-015 | NDC:60687-839 | NDC:70518-3717 | 1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione | NDC:68071-3569 | NDC:0115-1643 | NDC:52427-285 | NDC:63187-995 | NDC:70756-412 | NDC:72162-1262 | NDC:70756-410 | NDC:42708-178 | NDC:63187-245 | CAS RN:67-20-9 | NDC:50090-3737 | NDC:71205-023 | NDC:71335-2254 | NDC:43386-450 | DrugBank ID:DB00698 | NDC:40032-450 | NDC:83008-032 | NDC:52427-286 | NDC:71335-0024 | NDC:61919-842 | NDC:68001-423 | NDC:70954-496 | NDC:46708-391 | NDC:68382-559 | NDC:70518-4026 | NDC:72603-196 | NDC:52427-287 | NDC:70199-036 | NDC:63629-1748 | NDC:70518-3827 | NDC:46708-390 | NDC:68001-384 | NDC:60760-853 | NDC:68001-606 | NDC:0115-1645 | NDC:71205-297 | NDC:65162-689 | NDC:60760-194 | NDC:63629-2464 | NDC:72189-179 | NDC:70518-4244 | NDC:50090-3856 | NDC:71335-2320 | NDC:71205-370 | NDC:72603-182 | NDC:50090-6769 | NDC:71205-852 | NDC:51655-948 | NDC:50090-6748 | NDC:13811-719 | NDC:69238-2512 | NDC:68001-605 | NDC:57664-231 | NDC:57664-233 | NDC:57664-232 | NDC:59651-942 | NDC:70518-1087 | NDC:71205-365 | NDC:50268-625 | NDC:60687-472 | NDC:68071-4367 | NDC:51655-611 | NDC:47781-303 | NDC:59651-795 | NDC:82804-115 | NDC:71335-2074 | NDC:62332-389 | NDC:50090-0865 | NDC:68382-560 | NDC:71335-2255 | NDC:68071-3593 | PubChem SID:175265734 | NDC:16571-740 | CAS RN:178170-37-1 | NDC:72162-1815 | NDC:16571-888 | NDC:72789-270 | NDC:50268-623 | NDC:70756-404 | NDC:0121-1996 | NDC:82982-017 | NDC:68001-603 | NDC:72603-184 | NDC:68001-385 | NDC:0904-7026 | NDC:76420-884 | NDC:43386-641 | NDC:71205-546 | NDC:42708-184 | NDC:72189-395 | NDC:52427-288 | NDC:0904-7137 | NDC:65162-478 | NDC:68001-604 | NDC:71335-2212 | NDC:72789-386 | NDC:50090-7308 | NDC:68001-386 | NDC:47781-307 | NDC:72789-234 | NDC:54348-849 | NDC:68071-2363 | NDC:71335-0863 | NDC:60687-850 | NDC:65862-929 | NDC:70771-1170 | NDC:46708-389 | NDC:50090-0866 | NDC:67296-1442 | NDC:68788-8258 | NDC:60687-633 | NDC:72789-242 | NDC:50268-624 | NDC:70408-239 | NDC:82868-065 | CAS RN:1516934-90-9 | PubChem CID:6604200 | NDC:0185-0122 | NDC:60687-483 | NDC:82804-131 | NDC:72789-340 | NDC:68788-8571 | UNII:927AH8112L | NDC:50090-6750 | NDC:43386-642 | NDC:71205-171 | NDC:70518-0265 | NDC:59746-762 | NDC:50090-6664 | NDC:72603-176 | NDC:70756-411 | NDC:82868-021 | NDC:72603-183 | NDC:70377-118 | NDC:47781-308 | NDC:62332-390 | NDC:50090-7217 | NDC:0615-8531 | Nitrofurantoin | NDC:70518-0103 | NDC:70518-2531 | NDC:47781-306 | NDC:63187-263 | NDC:71335-1135 | NDC:62332-391 | NDC:16714-439 | NDC:50090-5693 | NDC:72789-387 | NDC:70518-2602 | NDC:76420-195 | NDC:82982-052 | NDC:70199-006 | NDC:82868-012 | NDC:71335-2377 | NITROFURANTOIN"
+BMGC_DG14027,BMG_DG178431,"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE | DrugBank ID:DB08645 | PubChem CID:6604229"
+BMGC_DG14028,BMG_DG178456,"ECONAZOLE, (R)- | PubChem CID:6604378 | CAS RN:73094-39-0 | UNII:H18Z54707C | PubChem SID:329904342"
+BMGC_DG14029,BMG_DG178462,"SULOCTIDIL | UNII:XV1N1XY17K | PubChem SID:198979019 | (1R,2S)-2-(octylamino)-1-(4-propan-2-ylsulfanylphenyl)propan-1-ol | Suloctidil | CAS RN:54767-75-8 | PubChem CID:6604413 | DrugBank ID:DB13340"
+BMGC_DG14030,BMG_DG178472,"PubChem SID:198940131 | UNII:A4JPI6XU9A | CAS RN:120279-90-5 | DORZOLAMIDE, (CIS)-(±)- | PubChem CID:6604453 | DORZOLAMIDE, (CIS)-(+/-)-"
+BMGC_DG14031,BMG_DG178473,"PubChem SID:441659713 | CAS RN:154127-19-2 | BRINZOLAMIDE, (S)- | UNII:YXQ6TKU98F | PubChem CID:6604454"
+BMGC_DG14032,BMG_DG178492,"PubChem SID:198987577 | PubChem CID:6604707 | CAS RN:83654-13-1 | UNII:F45TJ02EL1 | AMPA, D-"
+BMGC_DG14033,BMG_DG178499,"UH 232 | (1S,2R)-5-methoxy-1-methyl-N,N-dipropyl-1,2,3,4-tetrahydronaphthalen-2-amine | PubChem SID:346540513 | UNII:QQYOR9S587 | CAS RN:95999-12-5 | PubChem CID:6604756 | UH-232"
+BMGC_DG14034,BMG_DG178508,UNII:XVJ94H0U21 | AM-404 | CAS RN:183718-77-6 | PubChem CID:6604822 | PubChem SID:198944239
+BMGC_DG14035,BMG_DG178511,"UNII:41H5Y15VA0 | PubChem CID:6604866 | CAS RN:121367-05-3 | PubChem SID:329904296 | DIMETINDENE, (S)-"
+BMGC_DG14036,BMG_DG178520,PubChem SID:474492498 | PubChem CID:6604889 | CAS RN:201038-74-6 | SB-269970 | UNII:KC8KP5XU6F
+BMGC_DG14037,BMG_DG178522,DrugBank ID:DB03719 | PubChem CID:6604901 | N-Ethyl-5'-Carboxamido Adenosine
+BMGC_DG14038,BMG_DG178526,PubChem SID:472421944 | CAS RN:39069-52-8 | PubChem CID:6604928 | UNII:HD3T22A5DM | GS-39783
+BMGC_DG14039,BMG_DG178527,PubChem SID:472425819 | WAY-629 | PubChem CID:6604933 | CAS RN:57756-45-3 | UNII:V59TZ3ACG6
+BMGC_DG14040,BMG_DG178533,CAS RN:905973-89-9 | PubChem CID:6605258 | DIPHENYL ACETAMIDOTRICHLOROETHYL FLUORONITROPHENYL THIOUREA | UNII:L3DGZ99QYM | PubChem SID:316911367
+BMGC_DG14041,BMG_DG178538,"CAS RN:46699-50-7 | PubChem CID:660572 | 4,4'-VINYLIDENEDIPHENOL | PubChem SID:313184060 | UNII:95VKC4M375"
+BMGC_DG14042,BMG_DG178546,PubChem SID:198983208 | CAS RN:477-90-7 | PubChem CID:66065 | UNII:L84RBE4IDC | BERGENIN
+BMGC_DG14043,BMG_DG178574,"N-[(1R,2R)-1-hydroxy-3-morpholin-4-yl-1-phenylpropan-2-yl]decanamide | PubChem CID:6610216 | CAS RN:109836-82-0"
+BMGC_DG14044,BMG_DG178580,PubChem SID:472421751 | CAS RN:331770-21-9 | PubChem CID:6610278 | AURORA KINASE INHIBITOR II | UNII:57YX8GY957
+BMGC_DG14045,BMG_DG178582,"Lactacystin | PubChem CID:6610292 | CAS RN:133343-34-7 | (2R)-2-acetamido-3-[(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-2-methylpropyl]-4-methyl-5-oxopyrrolidine-2-carbonyl]sulfanylpropanoic acid"
+BMGC_DG14046,BMG_DG178585,DrugBank ID:DB07223 | CA-074 methyl ester | PubChem CID:6610318
+BMGC_DG14047,BMG_DG178595,"Protheobromine | 1-(2-hydroxypropyl)-3,7-dimethylpurine-2,6-dione | CAS RN:50-39-5 | UNII:8067S1388X | PROTHEOBROMINE | PubChem CID:66120 | PubChem SID:198972010"
+BMGC_DG14048,BMG_DG178603,"CAS RN:79-83-4 | 3-[[(2R)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoic acid | DrugBank ID:DB01783 | Pantothenic Acid | PubChem SID:175268433 | PubChem CID:6613 | PANTOTHENIC ACID | UNII:19F5HK2737"
+BMGC_DG14049,BMG_DG178604,UNII:R8FS8HV4RL | PubChem CID:66130 | 2-ETHYLIMIDAZOLE | PubChem SID:472405748 | CAS RN:1072-62-4
+BMGC_DG14050,BMG_DG178613,N-Acetylproline | PubChem CID:66141 | CAS RN:68-95-1 | DrugBank ID:DB03360 | ACETYL PROLINE | PubChem SID:198976606 | UNII:CC8XZ138VZ
+BMGC_DG14051,BMG_DG178626,"CAMPHENE | PubChem CID:6616 | UNII:G3VG94Z26E | PubChem SID:316914608 | CAS RN:79-92-5 | 2,2-dimethyl-3-methylidenebicyclo[2.2.1]heptane | Camphene"
+BMGC_DG14052,BMG_DG178627,PubChem CID:66160 | UNII:GFR227X6YY | PHENYLMETHYLBARBITURIC ACID | CAS RN:76-94-8 | PubChem SID:198981719
+BMGC_DG14053,BMG_DG178633,UNII:R28U7T7UPL | PubChem SID:441659265 | CAS RN:77-55-4 | PubChem CID:66167 | 1-PHENYLCYCLOPENTANECARBOXYLIC ACID
+BMGC_DG14054,BMG_DG178638,UNII:ODY9ION63A | N-VINYLIMIDAZOLE | PubChem CID:66171 | CAS RN:1072-63-5 | PubChem SID:198972659
+BMGC_DG14055,BMG_DG178644,"Tetrabromobisphenol A | PubChem CID:6618 | 2,6-dibromo-4-[2-(3,5-dibromo-4-hydroxyphenyl)propan-2-yl]phenol | PubChem SID:198958602 | CAS RN:79-94-7 | UNII:FQI02RFC3A | TETRABROMOBISPHENOL A"
+BMGC_DG14056,BMG_DG178648,CAS RN:1088-56-8 | LUMIFLAVINE | DrugBank ID:DB04726 | Lumiflavin | UNII:4M2669414M | PubChem CID:66184 | PubChem SID:198973963
+BMGC_DG14057,BMG_DG178682,MAGNESIUM ORTHOSILICATE | UNII:33JD0Q1Q6P | CAS RN:10034-94-3 | PubChem CID:66225 | PubChem SID:198961436
+BMGC_DG14058,BMG_DG178686,CAS RN:102438-62-0 | PubChem CID:6623 | Bisphenol A | PubChem SID:198989399 | UNII:MLT3645I99 | BISPHENOL A | 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol | DrugBank ID:DB06973 | CAS RN:80-05-7 | CAS RN:25766-59-0
+BMGC_DG14059,BMG_DG178700,"PubChem SID:198939786 | BENZILONIUM | Benzilone | UNII:GY56LQX77B | CAS RN:16175-92-1 | PubChem CID:66248 | DrugBank ID:DB13369 | (1,1-diethylpyrrolidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate"
+BMGC_DG14060,BMG_DG178701,"CORTIVAZOL | DrugBank ID:DB13003 | [2-[(1S,2R,13S,14S,16R,17R,18S,20S)-17,20-dihydroxy-2,11,16,18-tetramethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5,9,11-tetraen-17-yl]-2-oxoethyl] acetate | PubChem CID:66249 | UNII:YM183K0H63 | PubChem SID:198981339 | CAS RN:1110-40-3 | Cortivazol"
+BMGC_DG14061,BMG_DG178707,Selenomethionine Se-75 | DrugBank ID:DB09400 | SELENOMETHIONINE SE-75 | (2S)-2-amino-4-methyl(75Se)selanylbutanoic acid | PubChem CID:66254 | CAS RN:1187-56-0 | PubChem SID:175267364 | UNII:P6708E7555
+BMGC_DG14062,BMG_DG178714,"PubChem CID:66261 | CAS RN:2921-92-8 | 2,2-bis(nitrooxymethyl)butyl nitrate | Propatyl Nitrate | DrugBank ID:DB13255 | UNII:AJT2YN495R | PROPATYL NITRATE | PubChem SID:198988537"
+BMGC_DG14063,BMG_DG178718,UNII:E35R3G56OV | (2S)-N-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine | DEXFENFLURAMINE | Dexfenfluramine | PubChem SID:198956174 | PubChem CID:66265 | DrugBank ID:DB01191 | CAS RN:3239-44-9
+BMGC_DG14064,BMG_DG178723,"UNII:4D70V7R51N | DIOXADROL | PubChem CID:66270 | CAS RN:6495-46-1 | 2-(2,2-diphenyl-1,3-dioxolan-4-yl)piperidine | Dioxadrol | CAS RN:4741-41-7 | CAS RN:4792-18-1 | PubChem SID:198961109"
+BMGC_DG14065,BMG_DG178748,"PubChem SID:198990159 | PubChem SID:198973888 | PubChem CID:66308 | UNII:F0W6ETZ4E5 | UNII:509X20752R | (2S,3R,4R)-2,3,4,5-tetrahydroxypentanal | CAS RN:147-81-9 | ARABINOSE, DL- | ARABINOSE, D- | CAS RN:10323-20-3"
+BMGC_DG14066,BMG_DG178750,"6-CYCLOHEXYL-3-(2-FURANYL)-1,2,4-TRIAZOLO(3,4-B)(1,3,4)THIADIAZOLE | PubChem SID:459056230 | PubChem CID:663145 | CAS RN:577696-37-8 | UNII:698D5VCY7H"
+BMGC_DG14067,BMG_DG178753,PubChem SID:459055985 | PubChem CID:66319 | UNII:42L29D4UCP | N-BENZOYLIMIDAZOLE | CAS RN:10364-94-0
+BMGC_DG14068,BMG_DG178768,4-amino-N-(6-chloropyridazin-3-yl)benzenesulfonamide | UNII:P78D9P90C0 | SULFACHLORPYRIDAZINE | PubChem SID:198958903 | CAS RN:80-32-0 | Sulfachlorpyridazine | DrugBank ID:DB11461 | PubChem CID:6634
+BMGC_DG14069,BMG_DG178773,Octasulfur | DrugBank ID:DB09353 | octathiocane | Cyclooctasulfur | CAS RN:10544-50-0 | Sulfur | CAS RN:1326-66-5 | UNII:70FD1KFU70 | SULFUR | PubChem CID:66348
+BMGC_DG14070,BMG_DG178775,(4-chlorophenyl) 4-chlorobenzenesulfonate | CHLORFENSON | PubChem CID:6635 | Chlorfenson | CAS RN:80-33-1 | PubChem SID:198938003 | DrugBank ID:DB05377 | UNII:LW65NJ3YWV
+BMGC_DG14071,BMG_DG178789,"UNII:4L3WC4P6GF | (2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;hydrate | CAS RN:14431-43-7 | PubChem SID:198959779 | .ALPHA.-D-GLUCOPYRANOSE MONOHYDRATE | alpha-D-Glucose monohydrate | PubChem CID:66370"
+BMGC_DG14072,BMG_DG178795,"Edoxudine | 5-ethyl-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione | EDOXUDINE | PubChem CID:66377 | CAS RN:15176-29-1 | UNII:15ZQM81Y3R | DrugBank ID:DB13421 | PubChem SID:198974380"
+BMGC_DG14073,BMG_DG178802,PubChem SID:198934695 | CETIEDIL | 2-(azepan-1-yl)ethyl 2-cyclohexyl-2-thiophen-3-ylacetate | UNII:621RT200TO | Cetiedil | PubChem CID:66384 | CAS RN:14176-10-4 | DrugBank ID:DB13753
+BMGC_DG14074,BMG_DG178813,PubChem CID:66413 | METHYLESTRADIOL | UNII:08IS5358PS | CAS RN:302-76-1 | PubChem SID:198988598
+BMGC_DG14075,BMG_DG178814,"DrugBank ID:DB02342 | UNII:6I2QW73SR5 | CAS RN:362-07-2 | 2-METHOXYESTRADIOL | PubChem SID:175265450 | PubChem CID:66414 | 2-Methoxyestradiol | (8R,9S,13S,14S,17S)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol"
+BMGC_DG14076,BMG_DG178823,CAS RN:2553-34-6 | 17.ALPHA.-ETHYLESTRADIOL | PubChem SID:472406064 | UNII:JL3XDL8DYL | PubChem CID:66428 | 17α-Ethylestradiol
+BMGC_DG14077,BMG_DG178828,ESTRADIOL 17-PHOSPHATE | PubChem SID:198936175 | PubChem CID:66435 | CAS RN:4995-43-1 | UNII:SKL7PDP588
+BMGC_DG14078,BMG_DG178842,PubChem CID:66457 | UNII:V7JP5963WT | P-TOLUENESULFONO-O-TOLUIDIDE | p-Toluenesulfono-o-toluidide | PubChem SID:474490556 | CAS RN:80-28-4
+BMGC_DG14079,BMG_DG178844,"DrugBank ID:DB00725 | Methylhomatropine bromide | Homatropine methylbromide | (8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl) 2-hydroxy-2-phenylacetate;bromide | PubChem CID:6646 | CAS RN:80-49-9"
+BMGC_DG14080,BMG_DG178862,UNII:GI0TV19GBN | CAS RN:81-83-4 | PubChem SID:251965539 | NAPHTHALIMIDE | PubChem CID:66491
+BMGC_DG14081,BMG_DG178877,"(2R)-2-phenyl-2-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyacetonitrile | CAS RN:29883-15-6 | CAS RN:1630795-88-8 | PubChem CID:66509032"
+BMGC_DG14082,BMG_DG178907,2-Hydroxy-3-carboxybenzo[a]carbazole | PubChem CID:66531 | PubChem SID:474490096 | UNII:76KBX76TT4 | CAS RN:84-43-5 | 2-HYDROXY-3-CARBOXYBENZO(A)CARBAZOLE
+BMGC_DG14083,BMG_DG178908,2-tert-Butylanthraquinone | 2-TERT-BUTYLANTHRAQUINONE | CAS RN:84-47-9 | PubChem SID:475549950 | UNII:6D4HUF2LSS | PubChem CID:66532
+BMGC_DG14084,BMG_DG178911,"Cytidine 3'-monophosphate | DrugBank ID:DB01961 | CAS RN:84-52-6 | PubChem SID:198970897 | UNII:6DZL5I6D4D | [(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] dihydrogen phosphate | PubChem CID:66535 | 3'-CYTIDYLIC ACID"
+BMGC_DG14085,BMG_DG178918,"TOXOFLAVIN | Toxoflavin | CAS RN:84-82-2 | UNII:5N5YI4IP1P | PubChem CID:66541 | PubChem SID:198970968 | 1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione"
+BMGC_DG14086,BMG_DG178928,"3-[2-(4-Amino-2-methylphenyl)diazenyl]-1,5-naphthalenedisulfonic acid | 3-(2-(4-AMINO-2-METHYLPHENYL)DIAZENYL)-1,5-NAPHTHALENEDISULFONIC ACID | PubChem SID:478837439 | PubChem CID:66546 | CAS RN:84-94-6 | UNII:MH3QME85AJ"
+BMGC_DG14087,BMG_DG178931,"CAS RN:84-99-1 | UNII:69MPX4M5VD | Xanthoxyletin | 5-methoxy-2,2-dimethylpyrano[3,2-g]chromen-8-one | XANTHOXYLETIN | PubChem SID:198945957 | PubChem CID:66548"
+BMGC_DG14088,BMG_DG178936,"PubChem CID:665493 | Glyceryl lactopalmitate | PubChem SID:485663449 | GLYCERYL LACTOPALMITATE | CAS RN:850229-73-1 | UNII:QYX7VQ8FJJ | 6-(2,6-dimethoxyphenyl)-3-(3-phenyl-1H-pyrazol-5-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole"
+BMGC_DG14089,BMG_DG178940,PubChem SID:198935138 | ELUXADOLINE DIHYDROCHLORIDE | PubChem CID:66550842 | CAS RN:864825-13-8 | UNII:7U4JQA48TT
+BMGC_DG14090,BMG_DG178945,NDC:71308-011 | PubChem SID:333495819 | N-[(3-methoxythiophen-2-yl)methyl]-2-[(9R)-9-pyridin-2-yl-6-oxaspiro[4.5]decan-9-yl]ethanamine | OLICERIDINE | CAS RN:1401028-24-7 | Oliceridine | PubChem CID:66553195 | UNII:MCN858TCP0 | DrugBank ID:DB14881 | NDC:71308-021
+BMGC_DG14091,BMG_DG178946,PubChem SID:363908585 | CAS RN:1392116-14-1 | PubChem CID:66553204 | JD-5037 | UNII:ENZ75DG2Z6
+BMGC_DG14092,BMG_DG178955,PubChem SID:252319691 | UNII:NR9ZYH80Z8 | [5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone | Zoligratinib | PubChem CID:66555680 | DrugBank ID:DB12903 | DEBIO-1347 | CAS RN:1265229-25-1 | ZOLIGRATINIB
+BMGC_DG14093,BMG_DG178961,"PubChem CID:66558664 | CAS RN:1403254-99-8 | DrugBank ID:DB12887 | TAZEMETOSTAT | PubChem SID:249492962 | Tazemetostat | N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide | UNII:Q40W93WPE1"
+BMGC_DG14094,BMG_DG178965,"UNII:LN5VY52MRQ | PubChem SID:485663557 | PubChem CID:66559939 | 8-Bromo-3,4-dihydro-6-(3-pyridinyl)-2(1H)-quinolinone | 8-BROMO-3,4-DIHYDRO-6-(3-PYRIDINYL)-2(1H)-QUINOLINONE"
+BMGC_DG14095,BMG_DG178969,PubChem SID:459275414 | UNII:2C52X44WTF | CYM-9484 | PubChem CID:66561564 | CAS RN:1383478-94-1
+BMGC_DG14096,BMG_DG178970,"CAS RN:1155419-89-8 | (2S)-2-[2-methyl-4-(2-oxa-8-azatricyclo[7.3.1.05,13]trideca-1(13),5,7,9,11-pentaen-10-yl)quinolin-3-yl]-2-[(2-methylpropan-2-yl)oxy]acetic acid | PubChem SID:198934897 | 3-Quinolineacetic acid, 4-(2,3-dihydropyrano(4,3,2-de)quinolin-7-yl)-alpha-(1,1-dimethylethoxy)-2-methyl-, (alphaS,4R)- | PubChem CID:66561902 | BI-224436 | UNII:99A996378Y"
+BMGC_DG14097,BMG_DG178973,PubChem SID:198951046 | CAS RN:85-55-2 | PubChem CID:66563 | 2-(P-TOLUOYL)BENZOIC ACID | UNII:4DN9G70PQF
+BMGC_DG14098,BMG_DG178975,"3-(2-{3-[(2,4-Diamino-6-Ethylpyrimidin-5-Yl)oxy]propoxy}phenyl)propanoic Acid | PubChem CID:66563688 | 3-[2-[3-(2,4-diamino-6-ethylpyrimidin-5-yl)oxypropoxy]phenyl]propanoic acid | CAS RN:1142407-81-5"
+BMGC_DG14099,BMG_DG178977,PubChem CID:66564 | CAS RN:85-56-3 | 2-(4'-CHLOROBENZOYL)BENZOIC ACID | PubChem SID:317229495 | UNII:3U7W4YOY3R
+BMGC_DG14100,BMG_DG178996,"PF-06273340 | DrugBank ID:DB12269 | PubChem CID:66571548 | N-[5-[2-amino-7-(1-hydroxy-2-methylpropan-2-yl)pyrrolo[2,3-d]pyrimidine-5-carbonyl]pyridin-3-yl]-2-(5-chloropyridin-2-yl)acetamide | CAS RN:1402438-74-7 | PubChem SID:312524731 | UNII:I136775ABW | Pf-06273340"
+BMGC_DG14101,BMG_DG178997,"CAS RN:1401966-63-9 | UNII:GT77Z6Y09Z | CAS RN:1401966-69-5 | PubChem SID:251965496 | GSK-2879552 | Gsk2879552 | PubChem CID:66571643 | 4-[[4-[[[(1R,2S)-2-phenylcyclopropyl]amino]methyl]piperidin-1-yl]methyl]benzoic acid"
+BMGC_DG14102,BMG_DG179020,CAS RN:1415562-82-1 | PF-543 | [(2R)-1-[[4-[[3-(benzenesulfonylmethyl)-5-methylphenoxy]methyl]phenyl]methyl]pyrrolidin-2-yl]methanol | PubChem CID:66577038
+BMGC_DG14103,BMG_DG179037,"UNII:6K8FC2TF54 | Msc-2360844 | Roginolisib | CAS RN:1305267-37-1 | PubChem CID:66580799 | [6-fluoro-1-[4-(morpholin-4-ylmethyl)phenyl]-5,5-dioxo-4H-thiochromeno[4,3-c]pyrazol-3-yl]-morpholin-4-ylmethanone | PubChem SID:472423805 | ROGINOLISIB"
+BMGC_DG14104,BMG_DG179071,CHLOROXOQUINOLINE | PubChem CID:66593 | CAS RN:23833-97-8 | PubChem SID:377308434 | UNII:23FWH4CH0U
+BMGC_DG14105,BMG_DG179080,"2-((1r,4r)-4-((3-(3-(Trifluoromethyl)phenyl)imidazo[1,2-b]pyridazin-6-yl)amino)cyclohexyl)propan-2-ol | Nuvisertib | PubChem SID:381132241 | UNII:EOB0N7BOY4 | PubChem CID:66598080 | 2-[4-[[3-[3-(trifluoromethyl)phenyl]imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol | CAS RN:1361951-15-6 | NUVISERTIB"
+BMGC_DG14106,BMG_DG179085,"PubChem SID:252165369 | [4-[(2S)-3-amino-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl]phenyl]methyl 2,4-dimethylbenzoate | UNII:W6I5QDT7QI | Netarsudil | CAS RN:1254032-66-0 | NETARSUDIL | DrugBank ID:DB13931 | PubChem CID:66599893"
+BMGC_DG14107,BMG_DG179092,"CAS RN:1161921-82-9 | (4S)-4-(4-cyano-2-methylsulfonylphenyl)-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-4H-pyrimidine-5-carbonitrile | UNII:U9DE68P1CA | BAY-85-8501 | PubChem CID:66601502 | Bay 85-8501 | PubChem SID:461434211"
+BMGC_DG14108,BMG_DG179134,"SULFISOXAZOLE ACETYL | PubChem SID:175266213 | UNII:WBT5QH3KED | Sulfisoxazole Acetyl | CAS RN:80-74-0 | DrugBank ID:DB14033 | PubChem CID:6662 | Acetyl sulfisoxazole | N-(4-aminophenyl)sulfonyl-N-(3,4-dimethyl-1,2-oxazol-5-yl)acetamide"
+BMGC_DG14109,BMG_DG179156,"PubChem CID:66634 | UNII:23GE66VPA5 | CAS RN:89-29-2 | M-(4,5-DIHYDRO-3-METHYL-5-OXO-1H-PYRAZOL-1-YL)BENZENESULFONAMIDE | PubChem SID:459055252"
+BMGC_DG14110,BMG_DG179161,"3,5-Dihydroxy-2-naphthoic acid | CAS RN:89-35-0 | PubChem CID:66637 | UNII:RCB7DWP5NB | 3,5-DIHYDROXY-2-NAPHTHOIC ACID | PubChem SID:474490256"
+BMGC_DG14111,BMG_DG179167,PubChem CID:666418 | Prothionamide | PROTIONAMIDE | DrugBank ID:DB12667 | Protionamide | PubChem SID:198962089 | UNII:76YOO33643 | CAS RN:14222-60-7 | 2-propylpyridine-4-carbothioamide
+BMGC_DG14112,BMG_DG179171,"SALICYLHYDROXAMIC ACID | PubChem SID:198971408 | CAS RN:89-73-6 | N,2-dihydroxybenzamide | UNII:8Q07182D0T | PubChem CID:66644 | Salicylhydroxamic acid | Salicylhydroxamic Acid | DrugBank ID:DB03819"
+BMGC_DG14113,BMG_DG179173,"UNII:160DHE331M | [4-[(1E,6E)-7-(4-hydroxy-3-methoxyphenyl)-3,5-dioxohepta-1,6-dienyl]-2-methoxyphenyl] hydrogen sulfate | CAS RN:339286-19-0 | DrugBank ID:DB14635 | PubChem CID:66645351 | PubChem SID:241180946 | CURCUMIN SULFATE | Curcumin sulfate"
+BMGC_DG14114,BMG_DG179178,2-CHLOROBENZYLAMINE | UNII:L790J4Y7A3 | PubChem SID:198979948 | CAS RN:89-97-4 | PubChem CID:66648
+BMGC_DG14115,BMG_DG179196,"3,5-Dichlorosalicylaldehyde | 3,5-DICHLOROSALICYLALDEHYDE | PubChem SID:474490514 | UNII:9K38C4J9W8 | CAS RN:90-60-8 | PubChem CID:66660"
+BMGC_DG14116,BMG_DG179203,"PubChem SID:474489669 | CAS RN:869974-19-6 | INCB-13739 | PubChem CID:66662059 | Incb13739 | N-methyl-5-[4-[1-[(1R)-3-oxospiro[2-benzofuran-1,3'-pyrrolidine]-1'-carbonyl]cyclopropyl]phenyl]pyridine-2-carboxamide | UNII:160R8ZBH0X"
+BMGC_DG14117,BMG_DG179212,UNII:9YU7B7YH38 | CAS RN:91-30-5 | PubChem SID:474490783 | 6-ANILINOMETANILIC ACID | PubChem CID:66671 | 6-Anilinometanilic acid
+BMGC_DG14118,BMG_DG179276,"VAFIDEMSTAT | 5-[[[(1R,2S)-2-(4-phenylmethoxyphenyl)cyclopropyl]amino]methyl]-1,3,4-oxadiazol-2-amine | PubChem CID:66714983 | PubChem SID:375579719 | Vafidemstat | CAS RN:1357362-02-7 | UNII:LZ82JLT4UP"
+BMGC_DG14119,BMG_DG179284,A-953227 | PubChem CID:66720197 | CAS RN:1037826-77-9 | PubChem SID:461433894 | UNII:454US66B1N
+BMGC_DG14120,BMG_DG179285,PubChem CID:66721 | 3-HYDROXY-4'-METHOXY-2-NAPHTHANILIDE | CAS RN:92-79-5 | PubChem SID:313182982 | UNII:T0MUF32GX6
+BMGC_DG14121,BMG_DG179288,3-HYDROXY-N-(2-HYDROXYETHYL)-2-NAPHTHOAMIDE | UNII:R909LHN7LQ | PubChem SID:374388682 | PubChem CID:66722 | CAS RN:92-80-8
+BMGC_DG14122,BMG_DG179291,CAS RN:92-92-2 | 4-BIPHENYLCARBOXYLIC ACID | UNII:36J7VPO67K | PubChem CID:66724 | PubChem SID:317229461
+BMGC_DG14123,BMG_DG179314,"Dehydrocholic acid | DrugBank ID:DB11622 | (4R)-4-[(5S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid | PubChem SID:175265558 | UNII:NH5000009I | DEHYDROCHOLIC ACID | CAS RN:81-23-2 | PubChem CID:6674"
+BMGC_DG14124,BMG_DG179336,"PubChem CID:667458 | PubChem SID:474493772 | (2R)-1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine | UNII:3947754WXW | (-)-Methylenedioxymethamphetamine | MIDOMAFETAMINE, (R)- | CAS RN:81262-70-6"
+BMGC_DG14125,BMG_DG179339,"(3E)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine | CAS RN:4695-61-8 | CHLORPROTHIXENE, (E)- | DrugBank ID:DB01239 | Chlorprothixene | PubChem CID:667466 | (3E)-3-(2-chloro-9H-thioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine | UNII:73V29V2M54 | Chlorprothixene, (E)- | PubChem SID:485664191 | CAS RN:4546-35-4"
+BMGC_DG14126,BMG_DG179340,"PubChem CID:667467 | (3Z)-3-(2-chlorothioxanthen-9-ylidene)-N,N-dimethylpropan-1-amine | DrugBank ID:DB01239 | Chlorprothixene | CHLORPROTHIXENE | PubChem SID:198936237 | CAS RN:113-59-7 | UNII:9S7OD60EWP"
+BMGC_DG14127,BMG_DG179341,"(3Z)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine | PubChem SID:198978955 | CAS RN:1668-19-5 | CAS RN:3607-18-9 | CIDOXEPIN | DrugBank ID:DB14750 | UNII:F96TTB8728 | PubChem CID:667468 | DrugBank ID:DB01142 | Cidoxepin | Doxepin"
+BMGC_DG14128,BMG_DG179343,"PubChem SID:198985780 | DIENESTROL | Dienestrol | CAS RN:84-17-3 | 4-[(2E,4E)-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol | PubChem CID:667476 | UNII:RRW32X4U1F | CAS RN:13029-44-2 | DrugBank ID:DB00890"
+BMGC_DG14129,BMG_DG179344,"CAS RN:1668-19-5 | DOXEPIN, (E)- | PubChem CID:667477 | UNII:851NLB57HQ | CAS RN:3607-34-9 | PubChem SID:198960370 | Doxepin | (3E)-3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine"
+BMGC_DG14130,BMG_DG179348,NDC:72572-161 | NDC:72572-160 | NDC:67457-903 | NDC:0143-9311 | ETOMIDATE | UNII:Z22628B598 | DrugBank ID:DB00292 | NDC:55150-221 | CAS RN:33125-97-2 | NDC:51662-1542 | NDC:72485-509 | NDC:65841-818 | NDC:0143-9506 | Etomidate | NDC:55150-222 | NDC:68083-234 | NDC:65219-445 | NDC:0409-6695 | NDC:68083-235 | NDC:51662-1485 | NDC:72266-146 | NDC:0143-9507 | NDC:51662-1459 | NDC:0404-9811 | NDC:51662-1634 | NDC:65145-128 | NDC:65219-447 | NDC:72266-147 | NDC:68382-545 | PubChem CID:667484 | NDC:0143-9310 | NDC:65145-127 | PubChem SID:175268838 | NDC:67457-902 | ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate | NDC:72485-508
+BMGC_DG14131,BMG_DG179349,PubChem CID:66749 | PubChem SID:474490841 | 3-(Diethylamino)-1-phenylpropan-1-one | 3-(DIETHYLAMINO)-1-PHENYLPROPAN-1-ONE | UNII:8SBE3AMK5D | CAS RN:94-38-2
+BMGC_DG14132,BMG_DG179350,"DrugBank ID:DB01033 | PubChem SID:175265536 | UNII:PKK6MUZ20G | CAS RN:157930-11-5 | CAS RN:1194-62-3 | MERCAPTOPURINE ANHYDROUS | PubChem CID:667490 | CAS RN:50-44-2 | Mercaptopurine | 3,7-dihydropurine-6-thione"
+BMGC_DG14133,BMG_DG179352,PubChem CID:667492 | UNII:K3QML4J07E | (2-hydroxy-1-methylindol-3-yl)iminothiourea | METHISAZONE | CAS RN:1910-68-5 | Methisazone | CAS RN:26153-15-1 | DrugBank ID:DB13641 | PubChem SID:198953536
+BMGC_DG14134,BMG_DG179353,CAS RN:91795-77-6 | CAS RN:56-04-2 | Methylthiouracil | PubChem SID:198965415 | UNII:QW24888U5F | CAS RN:1123-10-0 | 6-methyl-2-sulfanylidene-1H-pyrimidin-4-one | METHYLTHIOURACIL | PubChem CID:667493 | DrugBank ID:DB13644
+BMGC_DG14135,BMG_DG179355,PubChem SID:198955166 | PubChem CID:667496 | UNII:6C2ZBI733P | VASICINE | CAS RN:6159-55-3
+BMGC_DG14136,BMG_DG179357,"CAS RN:81-24-3 | Taurocholic acid | PubChem CID:6675 | PubChem SID:198948969 | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | DrugBank ID:DB04348 | TAUROCHOLIC ACID | UNII:5E090O0G3Z"
+BMGC_DG14137,BMG_DG179372,"2-[(1R)-1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl]acetic acid | (R)-Etodolac | CAS RN:87226-41-3 | ETODOLAC, (R)- | CAS RN:848873-99-4 | UNII:Y1RAH31T6K | PubChem CID:667528 | PubChem SID:198968609"
+BMGC_DG14138,BMG_DG179378,"UNII:8KTH918W9P | PubChem CID:667538 | CAS RN:99614-60-5 | PubChem SID:198984408 | ONDANSETRON, (3R)-"
+BMGC_DG14139,BMG_DG179384,(2S)-2-(3-benzoylphenyl)propanoic acid | DrugBank ID:DB09214 | PubChem SID:198949513 | UNII:6KD9E78X68 | PubChem CID:667550 | Dexketoprofen | DEXKETOPROFEN | CAS RN:22161-81-5
+BMGC_DG14140,BMG_DG179386,PubChem SID:459275906 | CAS RN:157862-79-8 | N-BENZYL-2-(3-PYRIDINYL)-4-QUINAZOLINAMINE | UNII:76HY3LWB8V | PubChem CID:667555
+BMGC_DG14141,BMG_DG179393,"UNII:02C2G1D30D | CAS RN:537049-40-4 | CAS RN:1350555-93-9 | PubChem SID:198964011 | N-[4-[(2R,4R,6S)-4-[(4,5-diphenyl-1,3-oxazol-2-yl)sulfanylmethyl]-6-[4-(hydroxymethyl)phenyl]-1,3-dioxan-2-yl]phenyl]-N'-hydroxyoctanediamide | Tubacin | TUBACIN | PubChem CID:6675804"
+BMGC_DG14142,BMG_DG179396,SB-366791 | PubChem CID:667594 | CAS RN:1649486-65-6 | UNII:E8EY4M2N4H | PubChem SID:472407930
+BMGC_DG14143,BMG_DG179397,CAS RN:94-97-3 | PubChem SID:317229644 | UNII:8C7O46G78K | 5-CHLOROBENZOTRIAZOLE | PubChem CID:66760
+BMGC_DG14144,BMG_DG179405,"CAS RN:4339-71-3 | DrugBank ID:DB08399 | Piceatannol | 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol | CAS RN:10083-24-6 | UNII:6KS3LS0D4F | PICEATANNOL | PubChem SID:252164598 | PubChem CID:667639"
+BMGC_DG14145,BMG_DG179412,PubChem SID:472421754 | CAS RN:69445-45-0 | UNII:8J6DU66ARH | PubChem CID:667662 | 1-PHENYLBENZIMIDAZOL-5-OL
+BMGC_DG14146,BMG_DG179425,"6-METHYL-2-(4-METHYLPHENYL)IMIDAZO(1,2-A)PYRIDINE | CAS RN:88965-00-8 | PubChem CID:667720 | UNII:45KG7MQ2D7"
+BMGC_DG14147,BMG_DG179456,DrugBank ID:DB04326 | DIHYDROXYACETONE PHOSPHATE | (3-hydroxy-2-oxopropyl) dihydrogen phosphate | PubChem CID:668 | UNII:T7KF2T6W95 | CAS RN:57-04-5 | PubChem SID:313368824 | Dihydroxyacetone Phosphate | Dihydroxyacetone phosphate
+BMGC_DG14148,BMG_DG179459,"PubChem CID:66802 | 4,4'-THIODIRESORCINOL | UNII:U2M09JWG5R | PubChem SID:316909224 | CAS RN:97-29-0"
+BMGC_DG14149,BMG_DG179470,PubChem CID:66808 | 5-NITROSALICYLALDEHYDE | PubChem SID:474489584 | UNII:ZJ6GGT3K66 | CAS RN:97-51-8
+BMGC_DG14150,BMG_DG179475,"CAS RN:4604-06-2 | PubChem SID:445499542 | 2-AMINO-3-CYANO-4,6-DIPHENYLPYRIDINE | PubChem CID:668105 | UNII:7T5BBV4MQ2"
+BMGC_DG14151,BMG_DG179482,PubChem SID:313184284 | CAS RN:98-32-8 | PubChem CID:66814 | 4-HYDROXYMETANILAMIDE | UNII:S18Z30538J
+BMGC_DG14152,BMG_DG179494,CAS RN:98-64-6 | 4-Chlorobenzenesulfonamide | PubChem CID:66824 | 4-chlorobenzenesulfonamide
+BMGC_DG14153,BMG_DG179497,PubChem CID:66826 | NITARSONE | PubChem SID:175266224 | DrugBank ID:DB11437 | CAS RN:98-72-6 | Nitarsone | (4-nitrophenyl)arsonic acid | UNII:JP2EN8WORU
+BMGC_DG14154,BMG_DG179500,Phenylboronic acid | PubChem SID:198943043 | PubChem CID:66827 | UNII:L12H7B02G5 | CAS RN:98-80-6 | phenylboronic acid | BENZENEBORONIC ACID | DrugBank ID:DB01795
+BMGC_DG14155,BMG_DG179503,"UNII:K6BUU8J72P | PubChem CID:66828839 | (1R,14E,18R,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-13,13-difluoro-24,27-dioxo-2,17,23-trioxa-4,11,25,28-tetrazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3,5,7,9,11,14-hexaene-29-carboxamide | NDC:0074-2600 | Glecaprevir | PubChem SID:333495653 | CAS RN:1365970-03-1 | NDC:0074-2625 | DrugBank ID:DB13879 | GLECAPREVIR"
+BMGC_DG14156,BMG_DG179506,"PubChem SID:198978450 | PURPURIN | CAS RN:81-54-9 | 1,2,4-trihydroxyanthracene-9,10-dione | Purpurin | UNII:L1GT81LS6N | PubChem CID:6683"
+BMGC_DG14157,BMG_DG179516,UNII:FN6949L56Q | CAS RN:99-40-1 | PubChem CID:66834 | 4-(CHLOROACETYL)CATECHOL | PubChem SID:198952433
+BMGC_DG14158,BMG_DG179527,2-Bromo-4'-nitroacetophenone | CAS RN:99-81-0 | PubChem CID:66840 | UNII:8NDY44R4NW | PubChem SID:474490373 | 2-BROMO-4'-NITROACETOPHENONE
+BMGC_DG14159,BMG_DG179564,"UNII:604BGD9J5B | PubChem SID:198956684 | CAS RN:101-60-0 | 21,22-dihydroporphyrin | PubChem CID:66868 | PORPHINE | Porphyrin"
+BMGC_DG14160,BMG_DG179565,N-(P-METHOXYPHENYL)-P-PHENYLENEDIAMINE | PubChem CID:66869 | PubChem SID:198937801 | UNII:X817863RG1 | CAS RN:101-64-4
+BMGC_DG14161,BMG_DG179572,PubChem CID:668712 | UNII:LEG3NVF47Q | PubChem SID:478838432 | 4-Methoxy-N-(4-phenyl-2-thiazolyl)benzamide | CAS RN:15850-34-7 | 4-METHOXY-N-(4-PHENYL-2-THIAZOLYL)BENZAMIDE
+BMGC_DG14162,BMG_DG179585,"CAS RN:81-64-1 | Quinizarin | QUINIZARIN | UNII:8S496ZV3CS | PubChem SID:198984390 | PubChem CID:6688 | CAS RN:103220-12-8 | 1,4-dihydroxyanthracene-9,10-dione"
+BMGC_DG14163,BMG_DG179601,CAS RN:103-47-9 | DrugBank ID:DB03309 | PubChem CID:66898 | N-cyclohexyltaurine | 2-(CYCLOHEXYLAMINO)ETHANESULFONIC ACID | PubChem SID:198968688 | UNII:71X53V3RZ1
+BMGC_DG14164,BMG_DG179606,UNII:JVK4XP2V8T | 2-((4-AMINOPHENYL)AMINO)-2-OXOACETIC ACID | PubChem SID:376230931 | CAS RN:103-92-4 | PubChem CID:66900
+BMGC_DG14165,BMG_DG179612,2-(dimethylamino)-N-(1-oxo-2H-isoquinolin-6-yl)-2-thiophen-3-ylacetamide | VEROSUDIL | Verosudil | PubChem CID:66906051 | CAS RN:1414854-42-4 | PubChem SID:241180803 | UNII:MAF34143WM
+BMGC_DG14166,BMG_DG179639,PubChem SID:198946632 | CAS RN:81-84-5 | NAPHTHALIC ANHYDRIDE | UNII:32RS852X55 | PubChem CID:6693
+BMGC_DG14167,BMG_DG179718,"CAS RN:96-26-4 | UNII:O10DDW6JOO | NDC:74458-555 | NDC:74458-095 | 1,3-dihydroxypropan-2-one | Dihydroxyacetone | DrugBank ID:DB01775 | PubChem CID:670 | NDC:74458-551 | PubChem SID:175267961 | DIHYDROXYACETONE"
+BMGC_DG14168,BMG_DG179722,CAS RN:116-34-7 | 2-Amino-N-ethyl-5-nitrobenzenesulfonanilide | UNII:4LD64U6WHP | PubChem CID:67001 | PubChem SID:485666910 | 2-AMINO-N-ETHYL-5-NITROBENZENESULFONANILIDE
+BMGC_DG14169,BMG_DG179729,UNII:413N4ED0PF | 1-AMINOANTHRAQUINONE-2-CARBOXYLIC ACID | CAS RN:82-24-6 | PubChem SID:198984174 | PubChem CID:6701
+BMGC_DG14170,BMG_DG179733,PubChem CID:670143 | PubChem SID:485663685 | N-(4-(AMINOSULFONYL)PHENYL)-2-THIOPHENEACETAMIDE | CAS RN:349432-97-9 | UNII:5CR9Q3S2Y2 | N-[4-(Aminosulfonyl)phenyl]-2-thiopheneacetamide
+BMGC_DG14171,BMG_DG179739,UNII:RHN157F30Q | PubChem SID:198965908 | CAS RN:82-28-0 | PubChem CID:6702 | DISPERSE ORANGE 11
+BMGC_DG14172,BMG_DG179751,TEDALINAB | PubChem CID:67029278 | UNII:5R7X34Y6Q1 | PubChem SID:198983898 | CAS RN:916591-01-0
+BMGC_DG14173,BMG_DG179752,UNII:3WS64LL78M | CAS RN:117-78-2 | PubChem SID:474490124 | 2-Anthraquinonecarboxylic acid | PubChem CID:67030 | 2-ANTHRAQUINONECARBOXYLIC ACID
+BMGC_DG14174,BMG_DG179766,"CAS RN:1196509-60-0 | 3-[5-[(1R,2S)-2-(2,2-difluoropropanoylamino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy]indazol-1-yl]-N-[(3R)-oxolan-3-yl]benzamide | CID 67041274 | PubChem CID:67041274"
+BMGC_DG14175,BMG_DG179793,PubChem SID:474490537 | UNII:N7X5HXL2JG | 6-ANILINO-4-HYDROXYNAPHTHALENE-2-SULFONIC ACID | CAS RN:119-19-7 | PubChem CID:67062 | 6-Anilino-4-hydroxynaphthalene-2-sulfonic acid
+BMGC_DG14176,BMG_DG179804,UNII:7B2AG5D9PQ | 5-Amino-2-[(4-aminophenyl)amino]benzenesulfonic acid | CAS RN:119-70-0 | PubChem CID:67070 | PubChem SID:472408762 | 5-AMINO-2-(4-AMINOANILINO)BENZENESULFONIC ACID
+BMGC_DG14177,BMG_DG179806,7-(4-AMINOBENZAMIDO)-4-HYDROXYNAPHTHALENE-2-SULFONIC ACID | PubChem SID:459275255 | CAS RN:119-77-7 | PubChem CID:67074 | UNII:4B2M4HX3E2
+BMGC_DG14178,BMG_DG179817,"(2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | CAS RN:845958-55-6 | PubChem CID:6708482 | CAS RN:98048-97-6 | (2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphoryl]-1-oxoethyl]-2-pyrrolidinecarboxylic acid"
+BMGC_DG14179,BMG_DG179835,"PubChem CID:67095330 | PubChem SID:346537786 | ALICAPISTAT | CAS RN:1254698-46-8 | UNII:BWF3F50KF8 | (2R)-1-benzyl-N-[4-(cyclopropylamino)-3,4-dioxo-1-phenylbutan-2-yl]-5-oxopyrrolidine-2-carboxamide | Alicapistat"
+BMGC_DG14180,BMG_DG179840,CAS RN:82-45-1 | PubChem CID:6710 | 1-AMINOANTHRAQUINONE | PubChem SID:198944261 | UNII:N5YYY1NEUI
+BMGC_DG14181,BMG_DG179864,"CAS RN:865-21-4 | PubChem CID:6710780 | methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate | Vinblastin sulfate"
+BMGC_DG14182,BMG_DG179870,"Cgp53353 | PubChem CID:6711154 | 5,6-bis(4-fluoroanilino)isoindole-1,3-dione | CAS RN:145915-60-2"
+BMGC_DG14183,BMG_DG179881,"PubChem SID:272993954 | CAS RN:120-21-8 | UNII:S640XWL10H | PubChem CID:67114 | 4-(N,N-DIETHYLAMINO)BENZALDEHYDE"
+BMGC_DG14184,BMG_DG179890,"CAS RN:1293281-49-8 | PubChem CID:67116280 | (5-(4,6-Dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)(2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)methanone | [2-(4,6-dimethylpyrimidin-2-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-[2-fluoro-6-(triazol-2-yl)phenyl]methanone"
+BMGC_DG14185,BMG_DG179917,"CAS RN:220913-32-6 | DrugBank ID:DB12384 | PubChem CID:6712744 | (19S)-10-[tert-butyl(dimethyl)silyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione | Silatecan | Ar-67 | UNII:3YEA04NV6H | AR-67 | PubChem SID:198968600"
+BMGC_DG14186,BMG_DG179919,CAS RN:872726-44-8 | PubChem CID:6712941 | GW-610 | UNII:X3XWA9LQ3Q | PubChem SID:198938425
+BMGC_DG14187,BMG_DG179930,PubChem SID:485661649 | PubChem CID:67133 | N-(4-AMINO-2-CHLORO-5-METHYLPHENYL)BENZAMIDE | N-(4-Amino-2-chloro-5-methylphenyl)benzamide | CAS RN:121-22-2 | UNII:WF943S8VL7
+BMGC_DG14188,BMG_DG179933,5-Chloro-2-(4-chlorophenoxy)aniline | PubChem SID:475549849 | 5-CHLORO-2-(4-CHLOROPHENOXY)ANILINE | PubChem CID:67135 | UNII:LK5QE26HRU | CAS RN:121-27-7
+BMGC_DG14189,BMG_DG179935,"4-amino-6-chlorobenzene-1,3-disulfonamide | CAS RN:1184995-49-0 | CHLORAMINOPHENAMIDE | PubChem CID:67136 | PubChem SID:198990225 | 4-Amino-6-chloro-1,3-benzenedisulfonamide | UNII:3A52O8YREJ | CAS RN:121-30-2"
+BMGC_DG14190,BMG_DG179943,"UNII:G0H6U7VSTK | CAS RN:6489-97-0 | PubChem SID:198966007 | METAMPICILLIN | (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-(methylideneamino)-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Metampicillin | PubChem CID:6713928 | DrugBank ID:DB13836"
+BMGC_DG14191,BMG_DG179956,"[2-[(8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate | Prednicarbate | DrugBank ID:DB01130 | PubChem CID:6714002 | CAS RN:73771-04-7 | PREDNICARBATE | UNII:V901LV1K7D | PubChem SID:175267150"
+BMGC_DG14192,BMG_DG179962,"UNII:2KF4FVV76N | PubChem SID:198962591 | CAS RN:122-25-8 | 5,5'-METHYLENEDISALICYCLIC ACID | PubChem CID:67145"
+BMGC_DG14193,BMG_DG179968,"UNII:C6Y51501JB | PubChem SID:374388726 | PubChem CID:67150 | CAS RN:122-95-2 | 1,4-DIETHOXYBENZENE"
+BMGC_DG14194,BMG_DG179981,CAS RN:1184300-63-7 | PubChem CID:67155200 | 5-Chlorothiophene-2-carboxylic acid N-[(S)-2-[[[2-methyl-3-(2-oxopyrrolidin-1-yl)phenyl]sulfonyl]amino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide | SEGATROXABAN | PubChem SID:496143986 | Segatroxaban | UNII:53FM6EUY9U | 5-chloro-N-[(2S)-2-[[2-methyl-3-(2-oxopyrrolidin-1-yl)phenyl]sulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]thiophene-2-carboxamide
+BMGC_DG14195,BMG_DG179984,"DrugBank ID:DB12013 | Axelopran | AXELOPRAN | PubChem SID:198956709 | TD-1211 | CAS RN:949904-48-7 | UNII:85U7ROB149 | 3-[(1R,5S)-8-[2-[cyclohexylmethyl-[(2S)-2,3-dihydroxypropanoyl]amino]ethyl]-8-azabicyclo[3.2.1]octan-3-yl]benzamide | PubChem CID:67156338"
+BMGC_DG14196,BMG_DG179986,CAS RN:949904-50-1 | PubChem SID:198958692 | AXELOPRAN SULFATE | UNII:8OJM0A31U9 | PubChem CID:67157108
+BMGC_DG14197,BMG_DG179990,VISNAGIN | PubChem CID:6716 | CAS RN:82-57-5 | PubChem SID:198988905 | UNII:P64438MLBW
+BMGC_DG14198,BMG_DG179995,UNII:3A8R61G6QV | PubChem SID:198952275 | THIOMORPHOLINE | CAS RN:123-90-0 | PubChem CID:67164
+BMGC_DG14199,BMG_DG179997,"Bemesetron | BEMESETRON | UNII:O98T3677PA | PubChem CID:671690 | PubChem SID:198968859 | CAS RN:40796-97-2 | [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3,5-dichlorobenzoate"
+BMGC_DG14200,BMG_DG180005,N-[(2S)-1-[3-(3-chloro-4-cyanophenyl)pyrazol-1-yl]propan-2-yl]-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide | PubChem SID:316911393 | CAS RN:1297538-32-9 | PubChem CID:67171867 | DrugBank ID:DB12941 | DAROLUTAMIDE | UNII:X05U0N2RCO | Darolutamide | NDC:50419-395
+BMGC_DG14201,BMG_DG180026,"CAS RN:128-38-1 | PubChem CID:67185 | PubChem SID:198973537 | 4,4'-BIS(2,6-DI-TERT-BUTYLPHENOL) | UNII:D85N5VOL1N"
+BMGC_DG14202,BMG_DG180030,"PubChem CID:6719 | 2-(2,2-diphenylacetyl)indene-1,3-dione | CAS RN:82-66-6 | DIPHENADIONE | PubChem SID:198935868 | Diphacinone | UNII:54CA01C6JX | DrugBank ID:DB13347"
+BMGC_DG14203,BMG_DG180061,"Bi-187004 | PubChem SID:440794202 | CAS RN:1303515-32-3 | UNII:280XKM6Z2K | PubChem CID:67223373 | (4aR,9aS)-1-(3H-benzimidazole-5-carbonyl)-2,3,4,4a,9,9a-hexahydroindeno[2,1-b]pyridine-6-carbonitrile | BI-187004"
+BMGC_DG14204,BMG_DG180067,PubChem CID:67228 | PubChem SID:241179433 | RESERPILINE | UNII:C0N6EP99UK | CAS RN:131-02-2
+BMGC_DG14205,BMG_DG180070,PubChem CID:6723 | Pyridoxic Acid | PubChem SID:198938136 | 4-PYRIDOXIC ACID | CAS RN:82-82-6 | 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carboxylic acid | UNII:5K18793O8D
+BMGC_DG14206,BMG_DG180073,PubChem SID:459055353 | PubChem CID:67232 | 1-(O-ETHYLPHENYL)-3-METHYL-2-PYRAZOLIN-5-ONE | CAS RN:131-65-7 | UNII:YA9FDN3EYB
+BMGC_DG14207,BMG_DG180086,"acenaphthylene-1,2-dione | ACENAPHTHENEQUINONE | PubChem CID:6724 | CAS RN:82-86-0 | Acenaphthenequinone | PubChem SID:198968597 | UNII:3950D6UEIQ"
+BMGC_DG14208,BMG_DG180105,J UREA ACID | UNII:2QJN9485J7 | PubChem CID:67254 | PubChem SID:474492159 | J Urea Acid | CAS RN:134-47-4
+BMGC_DG14209,BMG_DG180110,PubChem SID:175268281 | Cyclizine | PubChem CID:6726 | CAS RN:82-92-8 | 1-benzhydryl-4-methylpiperazine | DrugBank ID:DB01176 | UNII:QRW9FCR9P2 | CYCLIZINE
+BMGC_DG14210,BMG_DG180120,"2,2'-DIBENZOYLAMINODIPHENYL DISULFIDE | PubChem SID:198989529 | UNII:10X28GH3DL | CAS RN:135-57-9 | PubChem CID:67271"
+BMGC_DG14211,BMG_DG180124,"PubChem CID:67275 | 2-NAPHTHALENECARBOXAMIDE, N-(5-CHLORO-2-METHYLPHENYL)-3-HYDROXY- | CAS RN:135-63-7 | 2-Naphthalenecarboxamide, N-(5-chloro-2-methylphenyl)-3-hydroxy- | UNII:QU4S9LKB9E | PubChem SID:485661446"
+BMGC_DG14212,BMG_DG180126,PubChem CID:67277 | UNII:8K775B2J7E | PubChem SID:198985032 | CAS RN:135-65-9 | 3-HYDROXY-3'-NITRO-2-NAPHTHANILIDE
+BMGC_DG14213,BMG_DG180127,PubChem SID:198969823 | PHENOXAZINE | CAS RN:135-67-1 | PubChem CID:67278 | UNII:C2ZWT499SG
+BMGC_DG14214,BMG_DG180133,PubChem CID:67282 | PubChem SID:472405828 | 4-PHENYLPHENACYL BROMIDE | UNII:XRZ97JC5PS | CAS RN:135-73-9
+BMGC_DG14215,BMG_DG180134,"UNII:3KU3WD07SS | 1,2,4-TRIMETHOXYBENZENE | CAS RN:135-77-3 | PubChem CID:67284 | PubChem SID:198954984"
+BMGC_DG14216,BMG_DG180136,"PIMODIVIR | CAS RN:1259366-34-1 | PubChem CID:67286591 | Pimodivir | (2S,3S)-3-[[5-fluoro-2-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]bicyclo[2.2.2]octane-2-carboxylic acid | PubChem SID:317229958 | UNII:DFC121MXC3 | CAS RN:1629869-44-8 | DrugBank ID:DB14974"
+BMGC_DG14217,BMG_DG180141,"CAS RN:82-95-1 | PubChem SID:317229565 | UNII:UFN4445AF2 | UNII:0C94V6X681 | PubChem SID:317229634 | Buclizine | PubChem SID:198959968 | UNII:1178B2VD9B | PubChem CID:6729 | CAS RN:163837-51-2 | BUCLIZINE | DrugBank ID:DB00354 | CAS RN:163837-52-3 | 1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine | BUCLIZINE, (-)- | BUCLIZINE, (+)-"
+BMGC_DG14218,BMG_DG180150,"PubChem SID:175266464 | CAS RN:1118-68-9 | CAS RN:780741-89-1 | N,N-dimethylglycine | 2-(dimethylamino)acetic acid | PubChem CID:673 | DrugBank ID:DB02083 | UNII:7797M4CPPA | N,N-DIMETHYLGLYCINE | N,N-Dimethylglycine"
+BMGC_DG14219,BMG_DG180152,"PubChem SID:474490796 | CAS RN:137-47-3 | 4-CHLORO-N,N-DIMETHYL-3-NITROBENZENESULFONAMIDE | UNII:Y4SEF4NTW3 | PubChem CID:67300 | 4-Chloro-N,N-dimethyl-3-nitrobenzenesulfonamide"
+BMGC_DG14220,BMG_DG180155,"Miransertib HCl | 3-[3-[4-(1-aminocyclobutyl)phenyl]-5-phenylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine;hydrochloride | PubChem CID:67305743 | CAS RN:1313883-00-9"
+BMGC_DG14221,BMG_DG180159,"D&C YELLOW NO. 11 | 2-quinolin-2-ylindene-1,3-dione | UNII:44F3HYL954 | Quinoline Yellow | CAS RN:83-08-9 | PubChem SID:175266249 | CAS RN:8003-22-3 | PubChem CID:6731"
+BMGC_DG14222,BMG_DG180164,MK-1496 | PubChem CID:67313626 | (1S)-1-[4-[(1S)-1-aminoethyl]phenyl]-2-(tert-butylamino)ethanol | CAS RN:1037254-47-9 | UNII:CS17H9370C | DrugBank ID:DB12763 | Mk-1496 | PubChem SID:313183137
+BMGC_DG14223,BMG_DG180181,PubChem SID:496141452 | 4-FLUOROBENZYLAMINE | CAS RN:140-75-0 | 4-Fluorobenzylamine | PubChem CID:67326 | UNII:P5W29VUB78
+BMGC_DG14224,BMG_DG180185,"PubChem CID:67328148 | N-[4-chloro-3-[2-[4-(methylcarbamoyl)anilino]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl]phenyl]-4-(trifluoromethyl)pyridine-2-carboxamide | Debio 0617B | CAS RN:1332329-27-7"
+BMGC_DG14225,BMG_DG180197,"(3S)-3-[7-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione | IBERDOMIDE | PubChem SID:313182619 | Iberdomide | UNII:8V66F27X44 | CAS RN:1323403-33-3 | DrugBank ID:DB12101 | PubChem CID:67335295"
+BMGC_DG14226,BMG_DG180229,CAS RN:148-61-8 | PubChem SID:175265648 | Ethylmercurithiosalicylic acid | PubChem CID:67361 | ETHYLMERCURITHIOSALICYLIC ACID | UNII:4071N4J64W | DrugBank ID:DB02731
+BMGC_DG14227,BMG_DG180235,PubChem CID:67364 | PubChem SID:252164891 | 4-(DIETHYLAMINO)-2-METHYLANILINE | CAS RN:148-71-0 | UNII:A640ZQ81DV
+BMGC_DG14228,BMG_DG180250,CAS RN:83-40-9 | 2-hydroxy-3-methylbenzoic acid | PubChem SID:198963580 | PubChem CID:6738 | UNII:ZH3HEY032H | 3-Methylsalicylic acid | HYDROXYTOLUIC ACID | CAS RN:45848-87-1
+BMGC_DG14229,BMG_DG180266,"DrugBank ID:DB15157 | PubChem CID:67409219 | Voruciclib | PubChem SID:198969207 | 2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]chromen-4-one | UNII:W66XP666AM | CAS RN:1000023-04-0 | VORUCICLIB"
+BMGC_DG14230,BMG_DG180267,"NDC:42806-400 | NDC:67296-1765 | Methylprednisolone | NDC:50090-3094 | NDC:62135-763 | NDC:68382-917 | NDC:55289-649 | CAS RN:83-43-2 | NDC:68001-005 | NDC:0009-0073 | NDC:68071-2370 | NDC:62135-760 | NDC:69306-004 | NDC:68788-4593 | NDC:59762-0051 | NDC:65162-982 | NDC:80425-0230 | NDC:70771-1349 | NDC:0009-0020 | NDC:62135-761 | NDC:62135-762 | NDC:59762-0049 | NDC:67296-1713 | METHYLPREDNISOLONE | NDC:59762-0050 | NDC:65162-984 | NDC:68001-560 | NDC:67296-1759 | NDC:76420-193 | NDC:63187-160 | NDC:67296-1821 | NDC:72162-1161 | NDC:76420-041 | NDC:70771-1351 | NDC:59746-003 | NDC:63629-2226 | NDC:68382-919 | NDC:57582-101 | NDC:68382-916 | NDC:0904-6914 | NDC:59746-002 | NDC:71205-054 | NDC:65162-871 | NDC:62135-759 | DrugBank ID:DB00959 | NDC:68071-5221 | NDC:65162-980 | NDC:70518-2864 | NDC:49999-153 | NDC:0009-0022 | PubChem SID:175266101 | NDC:68788-7833 | NDC:68382-918 | NDC:70518-2982 | NDC:68788-8276 | NDC:82804-007 | NDC:70518-4213 | PubChem CID:6741 | NDC:71205-453 | NDC:60760-961 | NDC:80425-0255 | NDC:67296-0420 | NDC:0009-0056 | NDC:72162-1689 | NDC:68084-149 | UNII:X4W7ZR7023 | NDC:63187-802 | NDC:63629-2433 | NDC:68001-557 | NDC:59746-015 | NDC:63629-2218 | NDC:59762-4440 | NDC:50090-3811 | NDC:69306-400 | NDC:59746-001 | NDC:70771-1350 | NDC:68001-559 | NDC:70771-1348 | NDC:68001-558 | NDC:0603-4593 | NDC:80425-0231 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one | NDC:83008-061"
+BMGC_DG14231,BMG_DG180283,"CAS RN:153-76-4 | GALLAMINE | 2-[2,3-bis[2-(diethylamino)ethoxy]phenoxy]-N,N-diethylethanamine | DrugBank ID:DB13584 | PubChem SID:198959046 | UNII:1146X1WTNM | PubChem CID:67425 | Gallamine"
+BMGC_DG14232,BMG_DG180287,DrugBank ID:DB01985 | UNII:TQ7DL04CAE | PubChem CID:67427 | N-Acetyl-L-arginine | ACETYL ARGININE | N-acetyl-L-arginine | PubChem SID:198954275 | CAS RN:155-84-0 | (2S)-2-acetamido-5-(diaminomethylideneamino)pentanoic acid
+BMGC_DG14233,BMG_DG180293,"2,4-DIAMINOPYRIMIDINE | UNII:L5ZY0JJP5J | PubChem SID:376072248 | PubChem CID:67431 | CAS RN:156-81-0"
+BMGC_DG14234,BMG_DG180294,"CAS RN:156-83-2 | PubChem SID:441583526 | 2,4-DIAMINO-6-CHLOROPYRIMIDINE | PubChem CID:67432 | UNII:83NU5F7ZAS"
+BMGC_DG14235,BMG_DG180319,PubChem SID:363908317 | DrugBank ID:DB15256 | RELDESEMTIV | CAS RN:1345410-31-2 | Ck-2127107 | PubChem CID:67454400 | 1-[2-[[3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methylamino]pyrimidin-5-yl]pyrrole-3-carboxamide | UNII:4S0HBYW6QE
+BMGC_DG14236,BMG_DG180323,"Erdafitinib | N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine | NDC:59676-050 | CAS RN:1346242-81-6 | PubChem SID:252163629 | ERDAFITINIB | UNII:890E37NHMV | NDC:59676-030 | PubChem CID:67462786 | NDC:59676-040 | DrugBank ID:DB12147"
+BMGC_DG14237,BMG_DG180334,"UNII:1210T8CX6K | PubChem SID:317229085 | N-((3R,4S)-3,4-Dihydro-3-(((methylamino)carbonyl)oxy)-6-(4-(3-oxetanyl)-1-piperazinyl)-2H-1-benzopyran-4-yl)-4-fluorobenzamide | LY-3000328 | [(3R,4S)-4-[(4-fluorobenzoyl)amino]-6-[4-(oxetan-3-yl)piperazin-1-yl]-3,4-dihydro-2H-chromen-3-yl] N-methylcarbamate | CAS RN:1373215-15-6 | PubChem CID:67475270"
+BMGC_DG14238,BMG_DG180338,CAS RN:1257705-09-1 | UNII:XHF94L8HXD | PubChem CID:67479440 | GS-829845 | PubChem SID:475550905
+BMGC_DG14239,BMG_DG180361,"UNII:553XI1DS20 | CAS RN:582-60-5 | DrugBank ID:DB02591 | 5,6-DIMETHYLBENZIMIDAZOLE | 5,6-dimethyl-1H-benzimidazole | PubChem CID:675 | PubChem SID:198978875 | 5,6-Dimethylbenzimidazole"
+BMGC_DG14240,BMG_DG180364,"Tas-116 | CAS RN:1260533-36-5 | 3-ethyl-4-[4-[4-(1-methylpyrazol-4-yl)imidazol-1-yl]-3-propan-2-ylpyrazolo[3,4-b]pyridin-1-yl]benzamide | PubChem SID:319892003 | UNII:PLO044MUDZ | PubChem CID:67501411 | DrugBank ID:DB14876 | PIMITESPIB"
+BMGC_DG14241,BMG_DG180365,"2,1,3-BENZOTHIADIAZOLE | PubChem SID:472410808 | UNII:8FTH8AJA9H | PubChem CID:67502 | CAS RN:273-13-2"
+BMGC_DG14242,BMG_DG180368,"NDC:61958-1804 | LEDIPASVIR | UNII:013TE6E4WV | PubChem CID:67505836 | methyl N-[(2S)-1-[(6S)-6-[5-[9,9-difluoro-7-[2-[(1R,3S,4S)-2-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2-azabicyclo[2.2.1]heptan-3-yl]-3H-benzimidazol-5-yl]fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptan-5-yl]-3-methyl-1-oxobutan-2-yl]carbamate | CAS RN:1256388-51-8 | DrugBank ID:DB09027 | Ledipasvir | NDC:61958-1801 | NDC:61958-1803 | NDC:72626-2601 | NDC:61958-1805 | PubChem SID:175265983"
+BMGC_DG14243,BMG_DG180387,UNII:W5H9TE2BNY | PubChem CID:67528638 | NE-40 | CAS RN:1192134-09-0
+BMGC_DG14244,BMG_DG180390,"3,5-Dibromo-L-tyrosine | Dibromotyrosine | DIBROMOTYROSINE | PubChem CID:67532 | PubChem SID:198960623 | (2S)-2-amino-3-(3,5-dibromo-4-hydroxyphenyl)propanoic acid | UNII:QD49LEP46E | DrugBank ID:DB07637 | CAS RN:300-38-9"
+BMGC_DG14245,BMG_DG180411,"CAS RN:27699-93-0 | PubChem SID:198939973 | DrugBank ID:DB04744 | Lawsone | 4-hydroxynaphthalene-1,2-dione | PubChem CID:6755 | LAWSONE | CAS RN:83-72-7 | 2-Hydroxy-1,4-naphthoquinone | UNII:TLH4A6LV1W"
+BMGC_DG14246,BMG_DG180432,"CAS RN:83-79-4 | PubChem SID:175268505 | DrugBank ID:DB11457 | Rotenone | (1S,6R,13S)-16,17-dimethoxy-6-prop-1-en-2-yl-2,7,20-trioxapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-3(11),4(8),9,14,16,18-hexaen-12-one | UNII:03L9OT429T | PubChem CID:6758 | ROTENONE"
+BMGC_DG14247,BMG_DG180438,UNII:68N62L9HM6 | 5-Phenylsalicylic acid | PubChem SID:474490369 | 5-PHENYLSALICYLIC ACID | CAS RN:323-87-5 | PubChem CID:67584
+BMGC_DG14248,BMG_DG180452,PubChem CID:6760 | CAS RN:83-95-4 | UNII:4E1KLC380B | PubChem SID:198940166 | SKIMMIANINE
+BMGC_DG14249,BMG_DG180459,CAS RN:84-04-8 | UNII:653552FH1N | PubChem CID:6761 | PIPAMAZINE | PubChem SID:198986962
+BMGC_DG14250,BMG_DG180464,"INDOLE-3-LACTIC ACID, (S)- | 3-(INDOL-3-YL) LACTATE | DrugBank ID:DB07060 | UNII:DJ9KH2U67F | PubChem SID:441097654 | (2S)-2-Hydroxy-3-(1H-indol-3-YL)propanoic acid | (2S)-2-hydroxy-3-(1H-indol-3-yl)propanoic acid | CAS RN:7417-65-4 | PubChem CID:676157"
+BMGC_DG14251,BMG_DG180466,N-1-Methyl-L-tryptophan | PubChem SID:363908895 | N-1-METHYL-L-TRYPTOPHAN | PubChem CID:676159 | CAS RN:21339-55-9 | UNII:XD0FY1J13B
+BMGC_DG14252,BMG_DG180470,THIOPROPAZATE | Thiopropazate | 2-[4-[3-(2-chlorophenothiazin-10-yl)propyl]piperazin-1-yl]ethyl acetate | DrugBank ID:DB13557 | UNII:0JFY081Q2X | CAS RN:84-06-0 | PubChem CID:6762 | PubChem SID:198965938
+BMGC_DG14253,BMG_DG180478,"PubChem CID:6763 | UNII:42L7BZ8H74 | 9,10-Phenanthrenequinone | CAS RN:84-11-7 | 9,10-PHENANTHRENEDIONE | phenanthrene-9,10-dione | PubChem SID:198988449"
+BMGC_DG14254,BMG_DG180481,"CAS RN:137502-84-2 | UNII:F67B8S3MH9 | PubChem CID:676310 | 7,8,3'-TRIHYDROXYFLAVONE | PubChem SID:445499271"
+BMGC_DG14255,BMG_DG180499,"PubChem SID:252164886 | (5R)-Dihydrothymine | PubChem CID:676415 | (5R)-5-methyl-1,3-diazinane-2,4-dione | DIHYDROTHYMINE, (5R)- | CAS RN:86387-01-1 | UNII:774RV8NHN3"
+BMGC_DG14256,BMG_DG180508,PubChem SID:198958274 | UNII:6F82C6Q54C | DrugBank ID:DB03694 | PubChem CID:676454 | CAS RN:103-85-5 | phenylthiourea | N-phenylthiourea | Phenylthiourea | PHENYLTHIOUREA
+BMGC_DG14257,BMG_DG180509,CAS RN:76424-47-0 | PubChem CID:676464 | 3-PROPYL-1H-PYRAZOLE-5-CARBOXYLIC ACID | UNII:RB4C9X44RN | PubChem SID:482554049 | 3-Propyl-1H-pyrazole-5-carboxylic acid
+BMGC_DG14258,BMG_DG180522,UNII:GDQ70COQ4K | CAS RN:345-16-4 | 2-HYDROXY-5-FLUOROBENZOIC ACID | PubChem SID:384647897 | PubChem CID:67658
+BMGC_DG14259,BMG_DG180539,Cystine | PubChem CID:67678 | PubChem SID:175266095 | CAS RN:2079930-29-1 | UNII:48TCX9A1VT | (2R)-2-amino-3-[[(2R)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid | CAS RN:56-89-3 | CYSTINE | CAS RN:24645-67-8 | DrugBank ID:DB00138
+BMGC_DG14260,BMG_DG180544,"methyl N-[(1R)-2-[(2S,4S)-2-[5-[6-[(2S,5S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate | DrugBank ID:DB11613 | PubChem SID:198948024 | UNII:KCU0C7RS7Z | CAS RN:1377049-84-7 | VELPATASVIR | Velpatasvir | PubChem CID:67683363"
+BMGC_DG14261,BMG_DG180546,"SULBENTINE | Sulbentine | CAS RN:350-12-9 | PubChem SID:198935322 | DrugBank ID:DB13671 | UNII:D0NR12WK9J | 3,5-dibenzyl-1,3,5-thiadiazinane-2-thione | PubChem CID:67686"
+BMGC_DG14262,BMG_DG180549,SYROSINGOPINE | PubChem CID:6769 | UNII:PPG46JF0EG | CAS RN:84-36-6 | PubChem SID:198953614
+BMGC_DG14263,BMG_DG180561,3-(diaminomethylideneamino)propanoic acid | 3-Guanidinopropionic acid | PubChem SID:252164777 | PubChem CID:67701 | Ompenaclid | UNII:UL1984YRKA | OMPENACLID | CAS RN:353-09-3
+BMGC_DG14264,BMG_DG180583,UNII:Q9P233HWAJ | PubChem SID:198937212 | PubChem CID:6773 | CAS RN:84-54-8 | 2-METHYLANTHRAQUINONE
+BMGC_DG14265,BMG_DG180646,"CAS RN:71730-08-0 | PubChem SID:198966170 | anthracene-9,10-dione | Anthraquinone | CAS RN:84-65-1 | PubChem CID:6780 | ANTHRAQUINONE | UNII:030MS0JBDO"
+BMGC_DG14266,BMG_DG180704,PubChem CID:67861 | UNII:ZL8W3FGT5K | PubChem SID:440088742 | 5-FLUOROINDOLE | CAS RN:399-52-0
+BMGC_DG14267,BMG_DG180715,DrugBank ID:DB03610 | CAS RN:402-45-9 | 4-(Trifluoromethyl)phenol | 4-TRIFLUOROMETHYLPHENOL | UNII:G8PMO13PO4 | PubChem CID:67874 | PubChem SID:438788907 | CAS RN:73073-69-5 | 4-(trifluoromethyl)phenol
+BMGC_DG14268,BMG_DG180732,DrugBank ID:DB01093 | DIMETHYL SULFOXIDE | UNII:YOW8V9698H | CAS RN:8070-53-9 | Dimethyl sulfoxide | PubChem CID:679 | CAS RN:67-68-5 | PubChem SID:175266734 | Dimethyl Sulfoxide | methylsulfinylmethane
+BMGC_DG14269,BMG_DG180746,8-HYDROXY-5-QUINOLINESULFONIC ACID | PubChem SID:198990976 | CAS RN:84-88-8 | UNII:E8Z193G3L2 | PubChem CID:6792
+BMGC_DG14270,BMG_DG180769,UNII:YFD4HT23V4 | CAS RN:433-17-0 | 2-BENZOTHIAZOLESULFONAMIDE | 2-Benzothiazolesulfonamide | PubChem CID:67944 | PubChem SID:482554012
+BMGC_DG14271,BMG_DG180802,CAS RN:451-82-1 | PubChem SID:474490506 | UNII:X2W3C5ER3N | 2-FLUOROPHENYLACETIC ACID | 2-Fluorophenylacetic acid | PubChem CID:67979
+BMGC_DG14272,BMG_DG180803,PubChem CID:67979346 | CAS RN:1383982-64-6 | CAS RN:1383984-21-1 | LANABECESTAT | DrugBank ID:DB14814 | PubChem SID:317229306 | Lanabecestat | UNII:X8SPJ492VF
+BMGC_DG14273,BMG_DG180848,Guanosine | PubChem CID:6802 | DrugBank ID:DB02857
+BMGC_DG14274,BMG_DG180858,"(3R,4S)-3,4-bis(4-hydroxyphenyl)-8-methyl-3,4-dihydro-2H-chromen-7-ol | DrugBank ID:DB13062 | PubChem SID:198940385 | Me-344 | CAS RN:1374524-68-1 | ME-344 | UNII:843G0TDV51 | PubChem CID:68026984"
+BMGC_DG14275,BMG_DG180861,"PubChem CID:68029831 | UNII:U6072DO9XG | 4-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one | DrugBank ID:DB15442 | CAS RN:1374743-00-6 | Trilaciclib | TRILACICLIB | PubChem SID:329589124"
+BMGC_DG14276,BMG_DG180862,"UNII:TA9UOF49CY | PENTAFLUOROPROPANE | Pentafluoropropane | PubChem CID:68030 | PubChem SID:198979261 | CAS RN:460-73-1 | 1,1,1,3,3-Pentafluoropropane | DrugBank ID:DB13117 | 1,1,1,3,3-pentafluoropropane"
+BMGC_DG14277,BMG_DG180867,NORENDOXIFEN | UNII:51GJD354B5 | CAS RN:1308808-22-1 | CAS RN:1217237-98-3 | PubChem SID:438789022 | Norendoxifen | PubChem CID:68037237 | 4-[(Z)-1-[4-(2-aminoethoxy)phenyl]-2-phenylbut-1-enyl]phenol
+BMGC_DG14278,BMG_DG180870,DrugBank ID:DB01972 | PubChem CID:6804 | Guanosine-5'-Monophosphate
+BMGC_DG14279,BMG_DG180878,PubChem CID:680502 | PubChem SID:198981904 | AMG-9810 | CAS RN:545395-94-6 | UNII:182HIJ2D7F
+BMGC_DG14280,BMG_DG180890,"Atranorin | PubChem CID:68066 | PubChem SID:198962563 | UNII:450U2VJ2VG | CAS RN:479-20-9 | ATRANORIN | (3-hydroxy-4-methoxycarbonyl-2,5-dimethylphenyl) 3-formyl-2,4-dihydroxy-6-methylbenzoate"
+BMGC_DG14281,BMG_DG180895,"PubChem CID:68071 | CAS RN:480-39-7 | (2S)-5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one | Pinocembrin | UNII:8T7C8CH791 | PINOCEMBRIN | PubChem SID:313184483"
+BMGC_DG14282,BMG_DG180896,PubChem SID:198959509 | UNII:11XLA0494B | CAS RN:480-64-8 | ORSELLINIC ACID | PubChem CID:68072
+BMGC_DG14283,BMG_DG180897,"PHLOROACETOPHENONE | CAS RN:480-66-0 | UNII:8L7XD8830T | 2',4',6'-Trihydroxyacetophenone | PubChem SID:198976959 | PubChem CID:68073 | 1-(2,4,6-trihydroxyphenyl)ethanone"
+BMGC_DG14284,BMG_DG180900,"CAS RN:481-53-8 | UNII:I4TLA1DLX6 | TANGERETIN | PubChem CID:68077 | 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one | PubChem SID:198987028 | Tangeretin"
+BMGC_DG14285,BMG_DG180902,"CAS RN:482-27-9 | UNII:20GCF755G6 | PubChem SID:198955806 | Isopimpinellin | 4,9-dimethoxyfuro[3,2-g]chromen-7-one | ISOPIMPINELLIN | PubChem CID:68079"
+BMGC_DG14286,BMG_DG180904,"PubChem CID:68081 | ISOIMPERATORIN | Isoimperatorin | CAS RN:482-45-1 | UNII:0ZMV066080 | 4-(3-methylbut-2-enoxy)furo[3,2-g]chromen-7-one | PubChem SID:198974409"
+BMGC_DG14287,BMG_DG180909,UNII:VJ1360YWR9 | CAS RN:484-51-5 | KHELLINONE | PubChem SID:375086050 | PubChem CID:68086
+BMGC_DG14288,BMG_DG180913,PubChem SID:198942657 | UNII:539M941Y9O | PubChem CID:68089 | CAS RN:485-34-7 | NEOCINCHOPHEN
+BMGC_DG14289,BMG_DG180914,"UNII:1J6PQ7YI80 | PHTHALIMIDE | CAS RN:85-41-6 | Phthalimide | PubChem CID:6809 | isoindole-1,3-dione | PubChem SID:198945076 | CAS RN:223537-84-6 | CAS RN:136918-14-4"
+BMGC_DG14290,BMG_DG180916,CAS RN:2400-99-9 | 2-Mercapto-3-phenyl-3H-quinazolin-4-one | PubChem CID:680914 | CAS RN:18741-24-7 | 3-phenyl-2-sulfanylidene-1H-quinazolin-4-one
+BMGC_DG14291,BMG_DG180919,N-PHENYL-1H-PYRAZOLE-3-CARBOXAMIDE | PubChem CID:680935 | UNII:LB4UGM0L6N | DrugBank ID:DB08135 | N-phenyl-1H-pyrazole-3-carboxamide | PubChem SID:438788021 | CAS RN:124828-46-2
+BMGC_DG14292,BMG_DG180920,"CAS RN:487-03-6 | UNII:7PQ075MCA6 | PubChem SID:363908119 | HARMOL | 1-methyl-2,9-dihydropyrido[3,4-b]indol-7-one | PubChem CID:68094 | Harmol"
+BMGC_DG14293,BMG_DG180925,"DOPAMINE | DrugBank ID:DB00988 | CAS RN:51-61-6 | CAS RN:50444-17-2 | Dopamine | UNII:VTD58H1Z2X | 4-(2-aminoethyl)benzene-1,2-diol | PubChem CID:681 | CAS RN:86389-83-5 | PubChem SID:175268815"
+BMGC_DG14294,BMG_DG180932,PubChem CID:68107965 | GSK-2578215A | PubChem SID:198984633 | UNII:Q641JSF42X | CAS RN:1285515-21-0
+BMGC_DG14295,BMG_DG180936,CAS RN:1387633-03-5 | 1-[5-chloro-6-(2-methylpropoxy)pyridin-3-yl]-3-methyl-N-methylsulfonylindazole-5-carboxamide | DrugBank ID:DB15124 | UNII:8RAL5N48VT | Pf-05241328 | PF-05241328 | PubChem SID:317229080 | PubChem CID:68109743
+BMGC_DG14296,BMG_DG180939,5-hydroxy-2-phenylchromen-4-one | 5-HYDROXYFLAVONE | PubChem SID:375578998 | 5-Hydroxyflavone | CAS RN:491-78-1 | UNII:378AE9MHL3 | PubChem CID:68112
+BMGC_DG14297,BMG_DG180941,"2,2′-Pyridil | UNII:83Z989L39X | PubChem CID:68115 | PubChem SID:485661800 | 2,2'-PYRIDIL | CAS RN:492-73-9"
+BMGC_DG14298,BMG_DG180945,.ALPHA.-FURIL | PubChem SID:198953025 | CAS RN:492-94-4 | PubChem CID:68119 | UNII:3AFE4C3P1F
+BMGC_DG14299,BMG_DG180949,N-benzyl-N-(2-pyrrolidin-1-ylethyl)aniline | HISTAPYRRODINE | UNII:0FYM61NG4D | Histapyrrodine | PubChem SID:198962064 | PubChem CID:68122 | CAS RN:493-80-1 | DrugBank ID:DB13479
+BMGC_DG14300,BMG_DG180951,NICOTELLINE | UNII:7AO144V8IZ | PubChem CID:68123 | CAS RN:494-04-2 | PubChem SID:241179427
+BMGC_DG14301,BMG_DG180955,PubChem CID:68126 | UNII:349X0G2SSF | CAS RN:494-99-5 | 4-METHYLVERATROLE | PubChem SID:198956511
+BMGC_DG14302,BMG_DG180956,PubChem SID:198942148 | CAS RN:496-63-9 | 3-HYDROXY-4H-PYRAN-4-ONE | PubChem CID:68129 | UNII:8J0G2X46R7
+BMGC_DG14303,BMG_DG180957,PubChem SID:198988116 | 2-BENZOYLBENZOIC ACID | UNII:1N20Y812XW | CAS RN:85-52-9 | PubChem CID:6813
+BMGC_DG14304,BMG_DG180989,PubChem SID:198959656 | UNII:C4ZF6XLD2X | 3-Hydroxypropionic acid | 3-hydroxypropanoic acid | PubChem CID:68152 | CAS RN:503-66-2 | DrugBank ID:DB03688 | Hydracrylic acid | HYDRACRYLIC ACID
+BMGC_DG14305,BMG_DG180991,PubChem SID:198974309 | PubChem CID:68154 | 2H-PYRAN-2-ONE | CAS RN:504-31-4 | UNII:8WW45I202V
+BMGC_DG14306,BMG_DG180997,"CAS RN:85-61-0 | CAS RN:900498-43-3 | PubChem CID:6816 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate"
+BMGC_DG14307,BMG_DG181004,"NDC:63020-090 | CAS RN:1197953-54-0 | Brigatinib | PubChem SID:316914554 | NDC:63020-113 | DrugBank ID:DB12267 | PubChem CID:68165256 | 5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine | NDC:63020-180 | BRIGATINIB | UNII:HYW8DB273J"
+BMGC_DG14308,BMG_DG181031,PubChem SID:198970375 | UNII:471LF4O004 | SPIRAMIDE | PubChem CID:68186 | CAS RN:510-74-7
+BMGC_DG14309,BMG_DG181040,"PubChem CID:68194743 | (3S)-3-[4-[[5-(spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylmethyl)thiophen-2-yl]methoxy]phenyl]hex-4-ynoic acid | CAS RN:1309435-78-6"
+BMGC_DG14310,BMG_DG181047,"DOPAQUINONE, (±)- | CAS RN:4430-97-1 | UNII:5P7FHT9NL7 | PubChem CID:682 | alpha-Amino-3,4-dioxo-1,5-cyclohexadiene-1-propanoic acid | 2-amino-3-(3,4-dioxocyclohexa-1,5-dien-1-yl)propanoic acid | PubChem SID:441097123 | DOPAQUINONE, (+/-)-"
+BMGC_DG14311,BMG_DG181051,DrugBank ID:DB07764 | PubChem CID:68205 | PubChem SID:249493192 | Fluorescin | FLUORESCIN | CAS RN:518-44-5 | UNII:ES5WQ31089
+BMGC_DG14312,BMG_DG181061,"1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide | PubChem SID:317229431 | GSK-2816126 | PubChem CID:68210102 | UNII:W4OGW9QZ97 | (S)-1-(sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide | CAS RN:1346574-57-9"
+BMGC_DG14313,BMG_DG181064,CAS RN:1350549-36-8 | PubChem CID:68212798 | PubChem SID:241180030 | UNII:T7755XP5Y6 | UNC-1062
+BMGC_DG14314,BMG_DG181068,"2-PHENYL-1,3-ISOINDOLINEDIONE | UNII:LA29QA196M | PubChem CID:68215 | PubChem SID:375579079 | CAS RN:520-03-6"
+BMGC_DG14315,BMG_DG181074,"CAS RN:522-24-7 | FENETHAZINE | Fenethazine | UNII:8J97CUZ4HX | PubChem CID:68223 | PubChem SID:198961374 | N,N-dimethyl-2-phenothiazin-10-ylethanamine"
+BMGC_DG14316,BMG_DG181077,"PubChem CID:68229 | 8,8-dimethylpyrano[2,3-f]chromen-2-one | Seselin | CAS RN:523-59-1 | UNII:5634E8957P | PubChem SID:251965792 | SESELIN"
+BMGC_DG14317,BMG_DG181078,"CAS RN:9050-36-6 | (3S,6R)-2-(hydroxymethyl)-6-[(3S,6S)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol | PubChem CID:68229136"
+BMGC_DG14318,BMG_DG181085,"Telacebec | TELACEBEC | UNII:55G92WGH3X | PubChem SID:249493488 | CAS RN:1334719-95-7 | PubChem CID:68234908 | 6-chloro-2-ethyl-N-[[4-[4-[4-(trifluoromethoxy)phenyl]piperidin-1-yl]phenyl]methyl]imidazo[1,2-a]pyridine-3-carboxamide"
+BMGC_DG14319,BMG_DG181087,CAS RN:525-76-8 | PubChem SID:198951944 | ACETANTHRANIL | PubChem CID:68236 | UNII:Y938TMX1D8
+BMGC_DG14320,BMG_DG181091,DrugBank ID:DB01927 | PubChem CID:68238 | DUROQUINONE | Duroquinone | PubChem SID:198983932 | UNII:X0Q8791R69 | CAS RN:527-17-3
+BMGC_DG14321,BMG_DG181099,"UNII:EM6MD4AEHE | DELPHINIDIN CHLORIDE | CAS RN:528-53-0 | PubChem SID:198989577 | PubChem CID:68245 | 2-(3,4,5-trihydroxyphenyl)chromenylium-3,5,7-triol;chloride | Delphinidin"
+BMGC_DG14322,BMG_DG181100,SOVESUDIL | propyl 3-[2-(aminomethyl)-5-[(3-fluoropyridin-4-yl)carbamoyl]phenyl]benzoate | Sovesudil | UNII:C23O3R93BM | PubChem SID:404859783 | CAS RN:1333400-14-8 | PubChem CID:68245749
+BMGC_DG14323,BMG_DG181101,CAS RN:528-58-5 | UNII:2G4283G96U | CYANIDIN CHLORIDE | PubChem CID:68247 | PubChem SID:198983464
+BMGC_DG14324,BMG_DG181109,"N-[3-[(4S)-2-amino-4-methyl-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide | PubChem CID:68254185 | ATABECESTAT | DrugBank ID:DB15307 | CAS RN:1200493-78-2 | Atabecestat | UNII:2834W8D6GK | PubChem SID:346540593"
+BMGC_DG14325,BMG_DG181116,UNII:1R7B5I98HV | 5-HYDROXYTETRALIN | PubChem CID:68258 | PubChem SID:198956682 | CAS RN:529-35-1
+BMGC_DG14326,BMG_DG181120,"(4R,6R)-5-acetamido-2,4-dihydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid | CAS RN:131-48-6 | CID 68260278 | PubChem CID:68260278"
+BMGC_DG14327,BMG_DG181121,"PubChem SID:198951450 | 2,6-Dimethoxyquinone | PubChem CID:68262 | UNII:1Z701W789S | CAS RN:26547-64-8 | CAS RN:530-55-2 | 2,6-DIMETHOXYQUINONE | 2,6-dimethoxycyclohexa-2,5-diene-1,4-dione"
+BMGC_DG14328,BMG_DG181122,"N,N'-CARBONYLDIIMIDAZOLE | PubChem SID:198971414 | UNII:63A10X1FSP | PubChem CID:68263 | CAS RN:530-62-1"
+BMGC_DG14329,BMG_DG181126,"PubChem CID:68266 | 1,2,3,4-Tetrahydro-2-naphthalenone | CAS RN:530-93-8 | PubChem SID:472410853 | UNII:K46ZZ833BH | 1,2,3,4-TETRAHYDRO-2-NAPHTHALENONE"
+BMGC_DG14330,BMG_DG181130,Coproporphyrin I | UNII:BW4SWA9YWC | DrugBank ID:DB03727 | COPROPORPHYRIN I | CAS RN:531-14-6 | PubChem SID:475549794 | PubChem CID:68271
+BMGC_DG14331,BMG_DG181137,"PubChem SID:198941800 | 1,3-DI-6-QUINOLYLUREA | UNII:OS8SLN7588 | CAS RN:532-05-8 | PubChem CID:68281"
+BMGC_DG14332,BMG_DG181147,"UNII:2A2DA6857R | DrugBank ID:DB12048 | SAVOLITINIB | PubChem CID:68289010 | Savolitinib | 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine | PubChem SID:316913792 | CAS RN:1313725-88-0"
+BMGC_DG14333,BMG_DG181163,"phosphono 2-hydroxy-3-phosphonooxypropanoate | PubChem CID:683 | Glyceric acid 1,3-biphosphate | CAS RN:1981-49-3"
+BMGC_DG14334,BMG_DG181164,PubChem CID:6830 | Guanosine-5'-Triphosphate | DrugBank ID:DB04137
+BMGC_DG14335,BMG_DG181167,PubChem CID:68303 | UNII:2R0V40DI4R | PubChem SID:198975788 | P-CHLOROPHENACYL BROMIDE | CAS RN:536-38-9
+BMGC_DG14336,BMG_DG181173,UNII:DA8G610ZO5 | (2S)-2-acetamido-3-(4-hydroxyphenyl)propanoic acid | ACETYL L-TYROSINE | N-acetyltyrosine | NDC:0990-7172 | PubChem SID:175267308 | NDC:0264-1933 | DrugBank ID:DB11102 | N-Acetyl-L-tyrosine | CAS RN:537-55-3 | NDC:0990-7171 | PubChem CID:68310
+BMGC_DG14337,BMG_DG181183,"Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)amino)-2-pyrimidinyl)amino)-2-methyl- | GSK-1071306 | UNII:Z51V93OIDV | PubChem SID:198988453 | PubChem CID:68319455 | CAS RN:1252927-47-1 | 5-[[4-[(2,3-dimethylindazol-6-yl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide"
+BMGC_DG14338,BMG_DG181204,"UNII:H57G17P2FN | 3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine | CAS RN:156428-33-0 | PubChem SID:175271787 | BROMPHENIRAMINE | PubChem CID:6834 | Brompheniramine | DrugBank ID:DB00835 | CAS RN:86-22-6"
+BMGC_DG14339,BMG_DG181210,PubChem SID:198948227 | CAS RN:46124-27-0 | UNII:3EJT87W36D | P-CHLOROBENZYLPSEUDOTHIURONIUM | PubChem CID:68343
+BMGC_DG14340,BMG_DG181217,PubChem SID:198976137 | UNII:HKA2A1D99J | PubChem CID:68351 | CAS RN:547-52-4 | N4-SULFANILYLSULFANILAMIDE
+BMGC_DG14341,BMG_DG181231,"CAS RN:550-33-4 | UNII:B8B604PS4P | NEBULARINE | (2R,3S,4R,5R)-2-(hydroxymethyl)-5-purin-9-yloxolane-3,4-diol | PubChem SID:198988142 | PubChem CID:68368 | Purine Nucleosides | DrugBank ID:DB04440 | Nebularine"
+BMGC_DG14342,BMG_DG181236,"7-METHYLXANTHINE | 7-methyl-3H-purine-2,6-dione | PubChem SID:198936492 | PubChem CID:68374 | UNII:E9M81NJM6G | CAS RN:552-62-5 | 7-Methylxanthine"
+BMGC_DG14343,BMG_DG181242,PubChem SID:313389908 | ISOPHTHALIDE | CAS RN:553-86-6 | PubChem CID:68382 | UNII:4K47Z4Q1E7
+BMGC_DG14344,BMG_DG181250,"Phensuximide | CAS RN:34367-67-4 | CAS RN:86-34-0 | 1-methyl-3-phenylpyrrolidine-2,5-dione | DrugBank ID:DB00832 | PubChem CID:6839 | UNII:6WVL9C355G | PubChem SID:198963783 | PHENSUXIMIDE"
+BMGC_DG14345,BMG_DG181264,PubChem CID:68406 | CAS RN:557-61-9 | PubChem SID:175267567 | octacosan-1-ol | CAS RN:68580-63-2 | UNII:81I2215OVK | 1-Octacosanol | DrugBank ID:DB11220 | 1-OCTACOSANOL | Octacosanol
+BMGC_DG14346,BMG_DG181282,"CAS RN:23256-30-6 | UNII:M84I3K7C2O | Nifurtimox | NDC:50419-751 | CAS RN:39072-16-7 | NIFURTIMOX | PubChem SID:198951492 | DrugBank ID:DB11820 | (E)-N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitrofuran-2-yl)methanimine | NDC:50419-750 | PubChem CID:6842999 | CAS RN:39072-15-6"
+BMGC_DG14347,BMG_DG181283,PubChem CID:6843 | UNII:EPD1EH7F53 | 2-(diethylamino)ethyl 4-amino-2-propoxybenzoate | PubChem SID:198975218 | Propoxycaine | PROPOXYCAINE | CAS RN:86-43-1 | DrugBank ID:DB09342
+BMGC_DG14348,BMG_DG181290,CAS RN:86-48-6 | PubChem CID:6844 | 1-HYDROXY-2-NAPHTHOIC ACID | UNII:U8LZ3R07L8 | PubChem SID:198936272
+BMGC_DG14349,BMG_DG181320,PubChem SID:198975273 | naphthalene-1-carboxylic acid | CAS RN:1320-04-3 | CAS RN:86-55-5 | 1-Naphthoic acid | PubChem CID:6847 | 1-NAPHTHOIC ACID | UNII:2NIV4O66BH
+BMGC_DG14350,BMG_DG181321,"Ns-2359 | (1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-2-(methoxymethyl)-8-methyl-8-azabicyclo[3.2.1]octane | NS-2359 | DrugBank ID:DB05805 | CAS RN:195875-68-4 | PubChem SID:198977329 | UNII:76H76554PA | PubChem CID:68470595"
+BMGC_DG14351,BMG_DG181331,PubChem SID:198952699 | CAS RN:579-93-1 | UNII:6085493379 | PubChem CID:68482 | 2-benzamidobenzoic acid | N-BENZOYLANTHRANILIC ACID | N-benzoylanthranilic acid
+BMGC_DG14352,BMG_DG181335,"PubChem SID:198946626 | 3,3'-BIPYRIDINE | PubChem CID:68487 | CAS RN:581-46-4 | UNII:7B4E4PPN49"
+BMGC_DG14353,BMG_DG181338,"PubChem SID:310825767 | 4-[[(1S,4S)-5-[[4-[4-(1,3-oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]benzoic acid | PubChem CID:68488178 | CAS RN:943764-99-6 | ACEBILUSTAT | UNII:J64RI4D29U | DrugBank ID:DB15385 | Acebilustat"
+BMGC_DG14354,BMG_DG181341,PubChem SID:198937668 | CAS RN:86-57-7 | PubChem CID:6849 | 1-Nitronaphthalene | 1-nitronaphthalene | CAS RN:27254-36-0 | UNII:A51NP1DL2T | 1-NITRONAPHTHALENE
+BMGC_DG14355,BMG_DG181354,PubChem CID:68498031 | DrugBank ID:DB09297 | Paritaprevir
+BMGC_DG14356,BMG_DG181367,CAS RN:1309-48-4 | PubChem CID:6850729 | UNII:3A3U0GI71G | magnesium;oxygen(2-) | Magnesium oxide | Magnesiumoxide | DrugBank ID:DB01377 | MAGNESIUM OXIDE | PubChem SID:175266286
+BMGC_DG14357,BMG_DG181383,"N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine | PubChem CID:6850813 | UNII:7XUS3ZJ4WB | CAS RN:63940-51-2 | ATOMOXETINE, (+/-)- | Tomoxetine"
+BMGC_DG14358,BMG_DG181410,PubChem SID:198979359 | DrugBank ID:DB06188 | Ispinesib | UNII:BKT5F9C2NI | CAS RN:336113-53-2 | ISPINESIB | N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxoquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide | PubChem CID:6851740
+BMGC_DG14359,BMG_DG181411,SALFLUVERINE | PubChem SID:198985598 | UNII:GAK955D9Q5 | CAS RN:587-49-5 | PubChem CID:68519
+BMGC_DG14360,BMG_DG181413,PubChem CID:6851947 | DrugBank ID:DB13048 | PAC-1
+BMGC_DG14361,BMG_DG181419,"1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE | PubChem CID:6852124 | DrugBank ID:DB08576"
+BMGC_DG14362,BMG_DG181422,DrugBank ID:DB08301 | N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE | PubChem CID:6852128
+BMGC_DG14363,BMG_DG181423,"PubChem CID:6852129 | 6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE | DrugBank ID:DB08765"
+BMGC_DG14364,BMG_DG181424,N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE | DrugBank ID:DB07212 | PubChem CID:6852140
+BMGC_DG14365,BMG_DG181425,PubChem CID:6852141 | DrugBank ID:DB07074 | 6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER
+BMGC_DG14366,BMG_DG181426,"DrugBank ID:DB07772 | PubChem CID:6852147 | (1R)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid"
+BMGC_DG14367,BMG_DG181427,"PubChem CID:6852154 | DrugBank ID:DB07086 | 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL"
+BMGC_DG14368,BMG_DG181428,DrugBank ID:DB06831 | PubChem CID:6852165 | 2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE
+BMGC_DG14369,BMG_DG181429,"N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide | N-[5-[4-Chloro-3-[[(2-hydroxyethyl)amino]sulfonyl]phenyl]-4-methyl-2-thiazolyl]acetamide | PubChem CID:6852167 | DrugBank ID:DB06836 | CAS RN:593960-11-3 | PubChem SID:482553892 | N-(5-(4-CHLORO-3-(((2-HYDROXYETHYL)AMINO)SULFONYL)PHENYL)-4-METHYL-2-THIAZOLYL)ACETAMIDE | UNII:QS3XFL5JRX"
+BMGC_DG14370,BMG_DG181430,PubChem CID:6852168 | 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE | DrugBank ID:DB07847
+BMGC_DG14371,BMG_DG181432,"DrugBank ID:DB07733 | PubChem CID:6852193 | 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE"
+BMGC_DG14372,BMG_DG181435,3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL | DrugBank ID:DB08309 | PubChem CID:6852201
+BMGC_DG14373,BMG_DG181436,"DrugBank ID:DB07272 | N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE | PubChem CID:6852206"
+BMGC_DG14374,BMG_DG181437,"PubChem CID:6852209 | DrugBank ID:DB08096 | 8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM"
+BMGC_DG14375,BMG_DG181438,DrugBank ID:DB04590 | (2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID | PubChem CID:6852220
+BMGC_DG14376,BMG_DG181441,PubChem SID:198990670 | 4-BROMOPHENETOLE | PubChem CID:68523 | UNII:T0L17BX1WR | CAS RN:588-96-5
+BMGC_DG14377,BMG_DG181442,CAS RN:312317-26-3 | (2-METHYLPHENYL)-PYRAZOL-1-YL-METHANONE | UNII:2F2NEA57NT | PubChem SID:461434471 | PubChem CID:685230
+BMGC_DG14378,BMG_DG181446,"PubChem CID:6852376 | CAS RN:62751-59-1 | UNII:YZC2Y51NHJ | SKF-38393, (R)- | PubChem SID:363908346"
+BMGC_DG14379,BMG_DG181450,"UNII:0GH9JX37C8 | PubChem CID:6852391 | Scopolamine butylbromide | CAS RN:150521-07-6 | [(1S,2S,4R,5R)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;bromide | DrugBank ID:DB09300 | CAS RN:149-64-4 | Butylscopolamine | BUTYLSCOPOLAMINE BROMIDE | PubChem SID:175272125"
+BMGC_DG14380,BMG_DG181452,2-[[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-1-[[5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamoylamino]-3-phenylpropanoic acid | CAS RN:37691-11-5 | PubChem CID:6852398
+BMGC_DG14381,BMG_DG181478,CARBAZOLE | CAS RN:51555-21-6 | PubChem SID:198939958 | CAS RN:86-74-8 | Carbazole | DrugBank ID:DB07301 | 9H-carbazole | PubChem CID:6854 | UNII:0P2197HHHN
+BMGC_DG14382,BMG_DG181480,CAS RN:77201-64-0 | PubChem SID:249492111 | N-COUMAROYL-3-HYDROXYTYROSINE | UNII:48U8WX77YJ | PubChem CID:68540305
+BMGC_DG14383,BMG_DG181491,"UNII:LJ1U13R8IK | DrugBank ID:DB13708 | PubChem SID:198937582 | PubChem CID:68548 | 7-chloro-4-oxo-2-phenyl-2,3-dihydro-1H-quinazoline-6-sulfonamide | Fenquizone | CAS RN:20287-37-0 | FENQUIZONE"
+BMGC_DG14384,BMG_DG181493,PubChem CID:6855 | PubChem SID:198946362 | CAS RN:86-75-9 | UNII:GRE0P19C3Z | BENZOXIQUINE
+BMGC_DG14385,BMG_DG181496,"PubChem SID:198988941 | CAS RN:21535-47-7 | UNII:2X03TN217S | Mianserin hydrochloride | MIANSERIN HYDROCHLORIDE | CAS RN:78644-54-9 | PubChem CID:68551 | 5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene;hydrochloride"
+BMGC_DG14386,BMG_DG181500,PubChem SID:175268346 | [4-[2-(methylamino)ethyl]-2-(2-methylpropanoyloxy)phenyl] 2-methylpropanoate | Ibopamine | IBOPAMINE | DrugBank ID:DB13316 | PubChem CID:68555 | UNII:8ZCA2I2L11 | CAS RN:66195-31-1
+BMGC_DG14387,BMG_DG181504,"4-AMINO-3-PHENYLBUTYRIC ACID, (R)- | UNII:5P4YG4PU0Z | PubChem SID:198948145 | CAS RN:35568-36-6 | PubChem CID:685622"
+BMGC_DG14388,BMG_DG181511,"2-(3-butylisoquinolin-1-yl)oxy-N,N-dimethylethanamine | DIMETHISOQUIN | DrugBank ID:DB13683 | UNII:772EN3BH6I | PubChem SID:198984890 | CAS RN:86-80-6 | Dimethisoquin | PubChem CID:6857"
+BMGC_DG14389,BMG_DG181543,"PubChem CID:6857417 | UNII:0IK55ZPI0I | DrugBank ID:DB04304 | CAS RN:526-97-6 | L-Gluconic Acid | GULONIC ACID, L- | PubChem SID:241179927"
+BMGC_DG14390,BMG_DG181554,"L-Fuconate | CAS RN:26372-13-4 | (2S,3R,4R,5S)-2,3,4,5-tetrahydroxyhexanoate | PubChem CID:6857452"
+BMGC_DG14391,BMG_DG181564,CAS RN:80529-93-7 | PubChem CID:6857474 | DrugBank ID:DB00789 | Gadopentetate | 2-[bis[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]acetate;gadolinium(3+)
+BMGC_DG14392,BMG_DG181565,"PubChem SID:198953204 | UNII:KBX06MQJ5Y | CAS RN:4680-24-4 | DrugBank ID:DB02924 | PubChem CID:6857487 | LIMONENE OXIDE, CIS-(+)- | (4R)-limonene 1α,2α-epoxide"
+BMGC_DG14393,BMG_DG181576,"CAS RN:349-46-2 | UNII:06681CV9GH | PubChem CID:6857538 | PubChem SID:198984204 | UNII:KX1RHN0Y0B | CYSTINE, DL- | D-Cystine | PubChem SID:198972229 | CAS RN:923-32-0 | CYSTINE, D- | (2S)-2-amino-3-[[(2S)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid"
+BMGC_DG14394,BMG_DG181586,"(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+) | DrugBank ID:DB00526 | PubChem CID:6857599 | Oxaliplatin"
+BMGC_DG14395,BMG_DG181592,".BETA.-SANTALOL | UNII:1JL7K2LW6L | PubChem CID:6857681 | PubChem SID:198938355 | CAS RN:77-42-9 | Beta-Santalol | (Z)-2-methyl-5-[(1S,2R,4R)-2-methyl-3-methylidene-2-bicyclo[2.2.1]heptanyl]pent-2-en-1-ol"
+BMGC_DG14396,BMG_DG181593,"TETRAHYDROGESTRINONE | DrugBank ID:DB06870 | UNII:643MR6L9LB | PubChem SID:249492051 | Tetrahydrogestrinone | (8S,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | CAS RN:618903-56-3 | PubChem CID:6857686"
+BMGC_DG14397,BMG_DG181594,"(1R)-2-[(Diaminomethylene)amino]-1-{4-[(4R)-4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl]phenyl}ethyl nicotinate | PubChem CID:6857688 | DrugBank ID:DB07023"
+BMGC_DG14398,BMG_DG181595,"DrugBank ID:DB07064 | (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE | PubChem CID:6857690"
+BMGC_DG14399,BMG_DG181596,"DrugBank ID:DB07071 | (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenethyl)guanidine | PubChem CID:6857691"
+BMGC_DG14400,BMG_DG181597,"DrugBank ID:DB07077 | PubChem CID:6857692 | (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-dioxaborolan-2-YL)phenyl)guanidine"
+BMGC_DG14401,BMG_DG181598,"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL | DrugBank ID:DB07195 | PubChem CID:6857699"
+BMGC_DG14402,BMG_DG181600,4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE | PubChem CID:6857702 | DrugBank ID:DB07299
+BMGC_DG14403,BMG_DG181602,(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE | DrugBank ID:DB07627 | PubChem CID:6857711
+BMGC_DG14404,BMG_DG181603,SNJ-1945 | UNII:8Y4UQW4KYC | PubChem CID:6857712 | CAS RN:854402-59-8
+BMGC_DG14405,BMG_DG181604,"DrugBank ID:DB07887 | (R)-1-(4-(4-(hydroxymethyl)-1,3,2-dioxaborolan-2-yl)benzyl)guanidine | PubChem CID:6857719"
+BMGC_DG14406,BMG_DG181606,"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE | PubChem CID:6857727 | DrugBank ID:DB08751"
+BMGC_DG14407,BMG_DG181614,"PubChem SID:474492402 | 4-Methoxyestradiol | (8R,9S,13S,14S,17S)-4-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol | CAS RN:26788-23-8 | 4-METHOXYESTRADIOL | UNII:R6YV5Q2LKS | PubChem CID:68578"
+BMGC_DG14408,BMG_DG181629,UNII:PZ35LUM333 | DrugBank ID:DB13804 | BENZYLTHIOURACIL | PubChem CID:685814 | CAS RN:6336-50-1 | PubChem SID:198964891 | 6-benzyl-2-sulfanylidene-1H-pyrimidin-4-one | Benzylthiouracil
+BMGC_DG14409,BMG_DG181633,DrugBank ID:DB04389 | PubChem CID:6858209 | Ado-P-Ch2-P-Ps-Ado
+BMGC_DG14410,BMG_DG181634,"(4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-hydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol | (Rp)-cAMPS | PubChem CID:6858240 | CAS RN:73208-40-9 | CAS RN:23645-17-2 | Adenosine-3',5'-cyclic phosphorothioate | DrugBank ID:DB01790 | CAS RN:71774-13-5"
+BMGC_DG14411,BMG_DG181647,"MADURAMICIN | Cygro | CAS RN:79356-08-4 | CAS RN:84878-61-5 | PubChem CID:68595 | UNII:5U912U22T2 | azane;2-[(2R,3S,4S,5R,6S)-6-[(1R)-1-[(2S,5R,7S,8R,9S)-2-[(2R,5S)-5-[(2R,3S,5R)-3-[(2R,4S,5S,6S)-4,5-dimethoxy-6-methyloxan-2-yl]oxy-5-[(2S,3S,5R,6S)-6-hydroxy-3,5,6-trimethyloxan-2-yl]oxolan-2-yl]-5-methyloxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]ethyl]-2-hydroxy-4,5-dimethoxy-3-methyloxan-2-yl]acetic acid | DrugBank ID:DB11525 | PubChem SID:198935326 | CAS RN:61991-54-6"
+BMGC_DG14412,BMG_DG181657,"Medetomidine | 5-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole | PubChem SID:175271770 | PubChem CID:68602 | MEDETOMIDINE | DrugBank ID:DB11428 | UNII:MR15E85MQM | CAS RN:6918-06-5 | CAS RN:86347-14-0"
+BMGC_DG14413,BMG_DG181671,"PubChem CID:68613 | CAS RN:90779-69-4 | 1-({(4r,7s,13s,16r)-7-(2-Amino-2-oxoethyl)-13-[(2s)-butan-2-yl]-16-(4-ethoxybenzyl)-10-[(1r)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl}carbonyl)-l-prolyl-l-ornithylglycinamide | (2S)-N-[(2S)-5-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxopentan-2-yl]-1-[(4R,7S,13S,16R)-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-16-[(4-ethoxyphenyl)methyl]-10-[(1R)-1-hydroxyethyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide"
+BMGC_DG14414,BMG_DG181672,"NDC:65857-150 | UNII:0Z5B2CJX4D | NDC:73410-003 | NDC:40028-511 | FLUDEOXYGLUCOSE F-18 | NDC:69587-001 | NDC:16129-001 | CAS RN:63503-12-8 | NDC:60055-334 | NDC:76318-334 | NDC:24562-003 | NDC:62072-008 | (2R,3S,4R,5R)-2-(18F)fluoranyl-3,4,5,6-tetrahydroxyhexanal | NDC:24275-0185 | NDC:69864-001 | NDC:13267-234 | NDC:49609-101 | DrugBank ID:DB09502 | NDC:24417-001 | NDC:52670-551 | NDC:24562-001 | NDC:75913-647 | NDC:76326-001 | NDC:52768-001 | PubChem CID:68614 | NDC:67939-010 | NDC:29998-001 | NDC:24450-647 | NDC:40098-101 | PubChem SID:175268525 | NDC:78714-001 | Fludeoxyglucose (18F) | Fludeoxyglucose F-18 | NDC:76376-618"
+BMGC_DG14415,BMG_DG181676,PubChem CID:6861503 | 4-DIMETHYLAMINOBENZALDEHYDE ISONICOTINOYL HYDRAZONE | CAS RN:13059-77-3 | PubChem SID:485663123 | 4-Dimethylaminobenzaldehyde isonicotinoyl hydrazone | UNII:JE76YCT42J
+BMGC_DG14416,BMG_DG181678,"PubChem CID:6861557 | CAS RN:6971-97-7 | (E)-1-(3-chlorophenyl)-N-[(E)-(3-chlorophenyl)methylideneamino]methanimine | Benzaldehyde, 3-chloro-, [(3-chlorophenyl)methylene]hydrazone"
+BMGC_DG14417,BMG_DG181679,PubChem SID:472388031 | U-50488 | PubChem CID:68616 | CAS RN:67198-13-4 | UNII:39K8JHE8XN
+BMGC_DG14418,BMG_DG181680,"CAS RN:79617-95-1 | CAS RN:219736-80-8 | PubChem CID:68617 | PubChem SID:175268312 | Sertraline | SERTRALINE | (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | CAS RN:79617-96-2 | DrugBank ID:DB01104 | UNII:QUC7NX6WMB"
+BMGC_DG14419,BMG_DG181683,CAS RN:26445-01-2 | DrugBank ID:DB01750 | 1-naphthaleneacetic acid | PubChem CID:6862 | 1-Naphthaleneacetic acid | UNII:33T7G7757C | PubChem SID:198961531 | 1-NAPHTHALENEACETIC ACID | CAS RN:86-87-3 | 2-naphthalen-1-ylacetic acid
+BMGC_DG14420,BMG_DG181695,OXIPEROMIDE | PubChem CID:68634 | PubChem SID:198955424 | UNII:WRO75M6RW2 | CAS RN:5322-53-2
+BMGC_DG14421,BMG_DG181709,5-AMINO-2-NAPHTHOL | CAS RN:86-97-5 | UNII:C8NZH84CBM | PubChem CID:6865 | PubChem SID:459055990
+BMGC_DG14422,BMG_DG181722,BIRIPERONE | UNII:5776HBV7UD | PubChem CID:68663 | CAS RN:41510-23-0 | PubChem SID:198979771
+BMGC_DG14423,BMG_DG181735,DrugBank ID:DB13460 | RONIFIBRATE | PubChem SID:198958492 | UNII:W86I18X716 | Ronifibrate | CAS RN:42597-57-9 | 3-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxypropyl pyridine-3-carboxylate | PubChem CID:68671
+BMGC_DG14424,BMG_DG181741,PubChem CID:68677 | CAS RN:50270-33-2 | UNII:7K6U6T1360 | ISOFEZOLAC | PubChem SID:198958519
+BMGC_DG14425,BMG_DG181742,"CAS RN:927961-18-0 | LANIFIBRANOR | 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloroindol-2-yl]butanoic acid | PubChem SID:317229038 | UNII:28Q8AG0PYL | Lanifibranor | PubChem CID:68677842 | DrugBank ID:DB14801"
+BMGC_DG14426,BMG_DG181743,PubChem SID:198948378 | CAS RN:50335-55-2 | UNII:V243ORA40X | PubChem CID:68678 | MEZILAMINE
+BMGC_DG14427,BMG_DG181745,UNII:9A1IU1C93L | PubChem SID:317229321 | 1-HYDROXY-6-AMINO-3-NAPHTHALENESULFONIC ACID | PubChem CID:6868 | CAS RN:87-02-5
+BMGC_DG14428,BMG_DG181748,"UNII:G7V6SLI20L | CAS RN:51025-85-5 | ARBEKACIN | (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide | PubChem SID:198976904 | Arbekacin | PubChem CID:68682 | DrugBank ID:DB06696"
+BMGC_DG14429,BMG_DG181752,CAS RN:51527-19-6 | UNII:P0T3ZRK3XV | TIANAFAC | PubChem CID:68686 | PubChem SID:198963816
+BMGC_DG14430,BMG_DG181756,"PubChem SID:175266462 | UNII:Z61I075U2W | PENICILLIN V | DrugBank ID:DB00417 | PubChem CID:6869 | (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | CAS RN:87-08-1 | Phenoxymethylpenicillin | Penicillin V"
+BMGC_DG14431,BMG_DG181770,PubChem SID:198966535 | N-hydroxy-2-[4-(2-methylpropyl)phenyl]propanamide | Ibuproxam | IBUPROXAM | UNII:O3LD16O96Z | DrugBank ID:DB08955 | PubChem CID:68704 | CAS RN:53648-05-8
+BMGC_DG14432,BMG_DG181772,PubChem SID:198970827 | UNII:13097143QI | LONAZOLAC | PubChem CID:68706 | Lonazolac | DrugBank ID:DB13432 | 2-[3-(4-chlorophenyl)-1-phenylpyrazol-4-yl]acetic acid | CAS RN:53808-88-1
+BMGC_DG14433,BMG_DG181773,"PubChem CID:6870646 | UNII:K2R4N34Y9I | DrugBank ID:DB13475 | 1-[(E)-[(E)-3-(5-nitrofuran-2-yl)prop-2-enylidene]amino]imidazolidine-2,4-dione | FURAZIDINE | Furagin | PubChem SID:198942003 | CAS RN:1672-88-4"
+BMGC_DG14434,BMG_DG181781,"PubChem SID:198990056 | N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine | RILMENIDINE | CAS RN:54187-04-1 | UNII:P67IM25ID8 | Rilmenidine | PubChem CID:68712 | DrugBank ID:DB11738"
+BMGC_DG14435,BMG_DG181799,PubChem CID:68723 | CAS RN:55300-29-3 | 2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl 2-[[7-(trifluoromethyl)quinolin-4-yl]amino]benzoate | UNII:21FS93Y6OE | DrugBank ID:DB01419 | ANTRAFENINE | Antrafenine | PubChem SID:198952505
+BMGC_DG14436,BMG_DG181819,CAS RN:118072-93-8 | ZOLEDRONIC ACID ANHYDROUS | Zoledronic acid | UNII:70HZ18PH24 | (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid | PubChem SID:175268122 | Zoledronate | DrugBank ID:DB00399 | PubChem CID:68740
+BMGC_DG14437,BMG_DG181821,"CAS RN:119169-78-7 | PubChem SID:198943395 | Epristeride | (8S,9S,10R,13S,14S,17S)-17-(tert-butylcarbamoyl)-10,13-dimethyl-2,7,8,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthrene-3-carboxylic acid | PubChem CID:68741 | EPRISTERIDE | UNII:39517A04PS"
+BMGC_DG14438,BMG_DG181822,"N-BENZYL-(9Z,12Z,15Z)-OCTADECATRIENAMIDE | PubChem CID:68741582 | UNII:60D4QDV5QG | PubChem SID:241179559 | CAS RN:883715-18-2"
+BMGC_DG14439,BMG_DG181824,PubChem SID:241177619 | UNII:5P4OF5ZU43 | PubChem CID:68742556 | N-BENZYL-LINOLEAMIDE | CAS RN:18286-71-0
+BMGC_DG14440,BMG_DG181831,"NDC:0023-6498 | NDC:0023-6501 | PubChem SID:198940024 | DrugBank ID:DB15328 | Ubrogepant | UNII:AD0O8X2QJR | (3S)-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[b]pyridine]-3'-carboxamide | UBROGEPANT | CAS RN:1374248-77-7 | PubChem CID:68748835"
+BMGC_DG14441,BMG_DG181832,(2-methoxyphenyl) 2-acetyloxybenzoate | Guacetisal | PubChem CID:68749 | UNII:T6EKB9V2O2 | DrugBank ID:DB13538 | GUACETISAL | PubChem SID:198957850 | CAS RN:55482-89-8
+BMGC_DG14442,BMG_DG181841,MIROPROFEN | PubChem CID:68752 | CAS RN:55843-86-2 | UNII:S00I5XG484 | PubChem SID:198982066
+BMGC_DG14443,BMG_DG181854,CAS RN:56488-60-9 | (2S)-2-amino-5-oxo-5-(2-sulfoethylamino)pentanoic acid | PubChem CID:68759 | PubChem SID:198947965 | UNII:B5T2Z06Y9N | Glutaurine | GLUTAURINE
+BMGC_DG14444,BMG_DG181856,"PubChem CID:68760 | DrugBank ID:DB13795 | BRODIMOPRIM | Brodimoprim | UNII:V1YC7T6LLI | PubChem SID:198938846 | CAS RN:56518-41-3 | 5-[(4-bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine"
+BMGC_DG14445,BMG_DG181861,UNII:1YF1KXP4QF | CAS RN:56739-21-0 | PubChem SID:198966592 | PubChem CID:68765 | NITRAQUAZONE
+BMGC_DG14446,BMG_DG181869,1-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-3-cyclohexylurea | CAS RN:38649-73-9 | UNII:3S82268BKG | PubChem SID:198984819 | TALINOLOL | DrugBank ID:DB11770 | CAS RN:57460-41-0 | PubChem CID:68770 | Talinolol
+BMGC_DG14447,BMG_DG181876,"BUDIPINE | UNII:L9026OPI2Z | DrugBank ID:DB13502 | Budipine | 1-tert-butyl-4,4-diphenylpiperidine | PubChem CID:68778 | CAS RN:57982-78-2 | PubChem SID:198966081"
+BMGC_DG14448,BMG_DG181882,"PubChem CID:68783 | Nomegestrol | DrugBank ID:DB11636 | (8S,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,13-dimethyl-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | UNII:10F89177CO | NOMEGESTROL | PubChem SID:175267479 | CAS RN:58691-88-6"
+BMGC_DG14449,BMG_DG181887,CAS RN:59032-40-5 | PubChem SID:198989719 | DISULERGINE | PubChem CID:68788 | UNII:1Q3CYC1YR6
+BMGC_DG14450,BMG_DG181891,"Imexon | UNII:8F63U28T2V | PubChem CID:68791 | DrugBank ID:DB05003 | CAS RN:59643-91-3 | 4-amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one | IMEXON | PubChem SID:198974619"
+BMGC_DG14451,BMG_DG181892,1-methyl-2-[(4-methylsulfanylphenoxy)methyl]-5-nitroimidazole | PubChem SID:198952623 | CAS RN:59729-37-2 | DrugBank ID:DB12265 | UNII:306ERL82IR | NDC:0024-4512 | PubChem CID:68792 | FEXINIDAZOLE | Fexinidazole
+BMGC_DG14452,BMG_DG181899,PubChem SID:175266994 | PubChem CID:6880 | DrugBank ID:DB11323 | 2-hydroxyethyl 2-hydroxybenzoate | UNII:3I1VBB7AXH | CAS RN:87-28-5 | 2-Hydroxyethyl salicylate | Glycol salicylate | GLYCOL SALICYLATE
+BMGC_DG14453,BMG_DG181902,PubChem CID:68801 | PubChem SID:198943369 | PIKETOPROFEN | UNII:362QBC4NL0 | CAS RN:60576-13-8 | 2-(3-benzoylphenyl)-N-(4-methylpyridin-2-yl)propanamide | Piketoprofen
+BMGC_DG14454,BMG_DG181904,"CAS RN:145165-49-7 | PIRLINDOLE | UNII:V39YPH45FZ | 12-methyl-1,4-diazatetracyclo[7.6.1.05,16.010,15]hexadeca-9(16),10(15),11,13-tetraene | PubChem CID:68802 | DrugBank ID:DB09244 | CAS RN:60762-57-4 | Pirlindole | PubChem SID:198960332"
+BMGC_DG14455,BMG_DG181905,"CAS RN:124236-29-9 | 2-Butenamide, N-ethyl-N-(2-methylphenyl)- | CROTAMITON, (E)- | (E)-N-ethyl-N-(2-methylphenyl)but-2-enamide | UNII:2EEH27851Y | CAS RN:483-63-6 | PubChem SID:198949193 | PubChem CID:688020"
+BMGC_DG14456,BMG_DG181941,CAS RN:58473-74-8 | CINROMIDE | PubChem CID:688145 | UNII:M197KE7A5N | PubChem SID:198968223
+BMGC_DG14457,BMG_DG181962,UNII:PPW0ENH1HA | EPICAPTOPRIL | Epicaptopril | (2S)-1-[(2R)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid | PubChem SID:198991157 | CAS RN:63250-36-2 | DrugBank ID:DB02032 | PubChem CID:688267
+BMGC_DG14458,BMG_DG181963,"(1R,4S,5R,8S,9R,12S,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-one | PubChem CID:68827 | UNII:9RMU91N5K2 | ARTEMISININ | CAS RN:63968-64-9 | PubChem SID:198960942 | CAS RN:119241-68-8 | NDC:83278-001 | DrugBank ID:DB13132 | Artemisinin"
+BMGC_DG14459,BMG_DG181964,Levosulpiride | UNII:JTG7R315LK | N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide | PubChem CID:688272 | CAS RN:23672-07-3 | LEVOSULPIRIDE | PubChem SID:175267072
+BMGC_DG14460,BMG_DG181966,"NDC:63739-367 | ISOSORBIDE DINITRATE | NDC:68084-083 | NDC:70710-1149 | [(3S,3aS,6R,6aS)-3-nitrooxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl] nitrate | NDC:0187-0152 | NDC:68682-193 | CAS RN:54650-95-2 | NDC:55154-7990 | NDC:0615-8463 | NDC:49884-021 | Isosorbide dinitrate | NDC:0781-1556 | NDC:51407-147 | NDC:16714-007 | NDC:0143-1769 | NDC:49884-009 | NDC:50268-447 | NDC:63739-569 | NDC:68001-374 | NDC:68001-375 | NDC:70710-1152 | NDC:70710-1148 | PubChem SID:175266423 | NDC:49884-020 | NDC:0904-6619 | PubChem CID:6883 | NDC:72888-084 | Isosorbide Dinitrate | CAS RN:1246815-45-1 | NDC:42291-350 | NDC:70710-1150 | NDC:16714-008 | NDC:16714-010 | NDC:70771-1504 | NDC:70771-1505 | NDC:72888-082 | DrugBank ID:DB00883 | NDC:70771-1503 | NDC:68084-082 | NDC:72888-081 | NDC:0143-1771 | NDC:55154-7991 | UNII:IA7306519N | NDC:49884-022 | NDC:43353-141 | NDC:0615-8464 | NDC:68001-373 | NDC:70771-1501 | NDC:72888-083 | NDC:0143-1772 | NDC:82804-108 | NDC:0781-1695 | NDC:70518-3637 | NDC:0187-0192 | NDC:49884-556 | NDC:51407-149 | NDC:68001-562 | NDC:63629-9593 | NDC:16714-009 | NDC:50268-449 | NDC:0615-8465 | NDC:0904-6620 | NDC:43353-139 | NDC:72888-085 | NDC:51407-148 | NDC:50268-448 | NDC:70710-1151 | NDC:70771-1502 | NDC:0781-1635 | CAS RN:87-33-2 | NDC:82804-117 | NDC:68682-192"
+BMGC_DG14461,BMG_DG181979,UNII:38QSU0IB5L | PubChem SID:198963209 | ESAPRAZOLE | CAS RN:64204-55-3 | PubChem CID:68835
+BMGC_DG14462,BMG_DG181983,5-fluorotryptophan | DrugBank ID:DB03314 | PubChem SID:287446267 | PubChem CID:688357 | 5-FLUOROTRYPTOPHAN | UNII:17H03VO4KZ | CAS RN:16626-02-1
+BMGC_DG14463,BMG_DG181996,CAS RN:407-41-0 | Phosphoserine | DrugBank ID:DB04522 | PubChem CID:68841 | Dexfosfoserine | CAS RN:7331-08-0 | PubChem SID:198965490 | (2S)-2-amino-3-phosphonooxypropanoic acid | DEXFOSFOSERINE | UNII:VI4F0K069V
+BMGC_DG14464,BMG_DG182001,"CHLORTALIDONE, (S)- | PubChem CID:688424 | UNII:0953RA202M | DrugBank ID:DB08046 | CAS RN:1441368-51-9 | 2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide | PubChem SID:329903905"
+BMGC_DG14465,BMG_DG182007,"NDC:0574-4012 | NDC:63629-8793 | DrugBank ID:DB01194 | NDC:66758-085 | NDC:72162-2201 | Brinzolamide | (4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide | NDC:68682-464 | BRINZOLAMIDE | NDC:0781-6014 | NDC:24208-464 | NDC:0078-0722 | CAS RN:138890-62-7 | PubChem CID:68844 | CAS RN:138890-50-3 | NDC:0591-2127 | PubChem SID:175267145 | UNII:9451Z89515"
+BMGC_DG14466,BMG_DG182008,UNII:0PE6UXH3WG | PubChem CID:688441 | PubChem SID:198959302 | LEVDOBUTAMINE | CAS RN:61661-06-1
+BMGC_DG14467,BMG_DG182014,"FENOTEROL, R,R'- | PubChem SID:287446345 | R,R-Fenoterol | UNII:5Z64M7W0JM | UNII:22M9P70OQ9 | 5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol | CAS RN:69421-37-0 | PubChem SID:175266687 | PubChem CID:688468 | CAS RN:130156-24-0 | FENOTEROL"
+BMGC_DG14468,BMG_DG182017,"UNII:SML95FK06I | Mesulergine | PubChem SID:198945608 | CAS RN:64795-35-3 | MESULERGINE | (6aR,9S,10aR)-9-(dimethylsulfamoylamino)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline | PubChem CID:68848"
+BMGC_DG14469,BMG_DG182035,"DrugBank ID:DB01366 | CAS RN:72332-33-3 | Procaterol | CAS RN:2675401-90-6 | 8-hydroxy-5-[(1R,2S)-1-hydroxy-2-(propan-2-ylamino)butyl]-1H-quinolin-2-one | 8-hydroxy-5-[(1R,2S)-1-hydroxy-2-[(propan-2-yl)amino]butyl]-1,2-dihydroquinolin-2-one | PubChem CID:688561"
+BMGC_DG14470,BMG_DG182041,"4-[2-[[(1S,2R)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol | RITODRINE | PubChem CID:688570 | PubChem SID:198973442 | Ritodrina | UNII:I0Q6O6740J | CAS RN:26652-09-5"
+BMGC_DG14471,BMG_DG182056,"UNII:46M3EV8HHE | DrugBank ID:DB09123 | PubChem SID:175265834 | Dienogest | CAS RN:65928-58-7 | 2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile | PubChem CID:68861 | DIENOGEST"
+BMGC_DG14472,BMG_DG182063,DrugBank ID:DB09288 | PubChem SID:198955359 | CAS RN:66532-85-2 | PROPACETAMOL | Propacetamol | (4-acetamidophenyl) 2-(diethylamino)acetate | UNII:5CHW4JMR82 | PubChem CID:68865
+BMGC_DG14473,BMG_DG182066,"3,6-dihydroxy-2-phenylchromen-4-one | 3,6-Dihydroxyflavone | PubChem CID:688659 | CAS RN:108238-41-1"
+BMGC_DG14474,BMG_DG182068,DrugBank ID:DB08810 | UNII:R8I97I2L24 | CAS RN:66564-14-5 | PubChem CID:68867 | CINITAPRIDE | 4-amino-N-[1-(cyclohex-3-en-1-ylmethyl)piperidin-4-yl]-2-ethoxy-5-nitrobenzamide | Cinitapride | PubChem SID:472423568
+BMGC_DG14475,BMG_DG182072,"FLUNOXAPROFEN | DrugBank ID:DB13317 | Flunoxaprofen | PubChem CID:68869 | PubChem SID:198942197 | UNII:UKU5U19W9M | (2S)-2-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]propanoic acid | CAS RN:66934-18-7"
+BMGC_DG14476,BMG_DG182074,"UNII:0T493YFU8O | CAS RN:66981-73-5 | CAS RN:191172-75-5 | Tianeptine | TIANEPTINE | DrugBank ID:DB09289 | PubChem CID:68870 | PubChem SID:313183131 | UNII:XV6773012I | TIANEPTINE, (-)- | TIANEPTINE, (+)- | CAS RN:72797-41-2 | UNII:AKU7QFL9ZT | CAS RN:169293-31-6 | PubChem SID:198985939 | PubChem SID:313182394 | 7-[(3-chloro-6-methyl-5,5-dioxo-11H-benzo[c][2,1]benzothiazepin-11-yl)amino]heptanoic acid"
+BMGC_DG14477,BMG_DG182075,CAS RN:67165-56-4 | PubChem CID:68871 | DICLOFENSINE | UNII:09HKW863J6 | PubChem SID:198955471
+BMGC_DG14478,BMG_DG182079,"(1R,2R,4R,10R,11S,14S,15S,16S,18S,19S)-10,14-dimethylspiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadec-5-ene-15,5'-oxolane]-2',7-dione | NDC:50419-483 | PubChem CID:68873 | CAS RN:67392-87-4 | Drospirenone | DrugBank ID:DB01395 | NDC:50419-482 | UNII:N295J34A25 | DROSPIRENONE | PubChem SID:175267473"
+BMGC_DG14479,BMG_DG182081,DrugBank ID:DB13367 | Cloricromen | PubChem CID:68876 | CLORICROMEN | CAS RN:68206-94-0 | PubChem SID:198944644 | UNII:B9454PE93C | ethyl 2-[8-chloro-3-[2-(diethylamino)ethyl]-4-methyl-2-oxochromen-7-yl]oxyacetate
+BMGC_DG14480,BMG_DG182085,"7,8,3',4'-TETRAHYDROXYFLAVONE | CAS RN:3440-24-2 | PubChem CID:688798 | UNII:SE9ZF942CK"
+BMGC_DG14481,BMG_DG182094,"PubChem CID:688857 | CAS RN:2545-13-3 | DrugBank ID:DB04274 | 7-HYDROXYFLAVANONE, (S)- | (2S)-7-hydroxyflavanone | PubChem SID:313390160 | (2S)-7-hydroxy-2-phenyl-2,3-dihydrochromen-4-one | CAS RN:41680-08-4 | UNII:MF98742K2H"
+BMGC_DG14482,BMG_DG182096,DrugBank ID:DB04429 | PubChem CID:688859 | 4'-Hydroxyflavanone
+BMGC_DG14483,BMG_DG182100,"Pivagabine | PubChem CID:68888 | UNII:C53SV0WO4V | PIVAGABINE | PubChem SID:198941652 | 4-(2,2-dimethylpropanoylamino)butanoic acid | CAS RN:69542-93-4 | DrugBank ID:DB12951"
+BMGC_DG14484,BMG_DG182127,"NDC:43742-0764 | CAS RN:331-89-5 | CAFFEIC ACID | CAS RN:501-16-6 | CAS RN:331-39-5 | PubChem SID:175268546 | PubChem CID:689043 | Caffeic Acid | 3,4-Dihydroxycinnamic Acid | (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid | CAS RN:71693-97-5 | UNII:U2S3A33KVM | DrugBank ID:DB01880"
+BMGC_DG14485,BMG_DG182133,CAS RN:3843-74-1 | CAFFEIC ACID METHYL ESTER | PubChem CID:689075 | PubChem SID:198944275 | UNII:N79173B9HF
+BMGC_DG14486,BMG_DG182136,"PubChem SID:198958616 | RIODIPINE | CAS RN:71653-63-9 | PubChem CID:68909 | dimethyl 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | Riodipine | UNII:W12VDB26LB"
+BMGC_DG14487,BMG_DG182144,"DrugBank ID:DB06697 | NDC:0078-0568 | CAS RN:71963-77-4 | (1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane | ARTEMETHER | PubChem SID:472385910 | UNII:C7D6T3H22J | Artemether | PubChem CID:68911"
+BMGC_DG14488,BMG_DG182151,UNII:4NRP32S46E | PubChem SID:474492728 | PubChem CID:6891506 | DMEOB | CAS RN:41097-48-7
+BMGC_DG14489,BMG_DG182153,CAS RN:73090-70-7 | UNII:9G69D95443 | EPIROPRIM | PubChem CID:68916 | PubChem SID:198976410
+BMGC_DG14490,BMG_DG182159,"PubChem CID:68921 | Hydrocortisone Aceponate | PubChem SID:175268317 | HYDROCORTISONE ACEPONATE | DrugBank ID:DB14538 | UNII:2340UP1L2G | [(8S,9S,10R,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-11-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] propanoate | CAS RN:74050-20-7"
+BMGC_DG14491,BMG_DG182164,PubChem SID:198959599 | PubChem CID:68928 | UNII:CNG7995Y4B | CAS RN:525-61-1 | QUINOCIDE
+BMGC_DG14492,BMG_DG182166,"PubChem CID:68929 | EPIESTRIOL | Epiestriol | CAS RN:547-81-9 | (8R,9S,13S,14S,16S,17R)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,16,17-triol | UNII:8XZ32LI44K | PubChem SID:198944583"
+BMGC_DG14493,BMG_DG182170,SULFAPERIN | PubChem SID:198939820 | Sulfaperin | 4-amino-N-(5-methylpyrimidin-2-yl)benzenesulfonamide | CAS RN:599-88-2 | PubChem CID:68933 | UNII:W5E840UV9P | DrugBank ID:DB13320
+BMGC_DG14494,BMG_DG182178,UNII:6PL3DO2B30 | PubChem CID:68939 | BITHIONOLOXIDE | CAS RN:844-26-8 | PubChem SID:198973600
+BMGC_DG14495,BMG_DG182182,"2-(4-fluorophenyl)indene-1,3-dione | Fluindione | PubChem SID:198963904 | CAS RN:1246820-41-6 | CAS RN:957-56-2 | UNII:EQ35YMS20Q | PubChem CID:68942 | FLUINDIONE | DrugBank ID:DB13136"
+BMGC_DG14496,BMG_DG182188,CAS RN:1093-58-9 | PubChem CID:68947 | PubChem SID:198944686 | Clostebol | DrugBank ID:DB01521 | UNII:Z7D4G976SH | CLOSTEBOL
+BMGC_DG14497,BMG_DG182192,PubChem CID:68950 | UNII:NEZ417265P | CAS RN:1157-87-5 | PubChem SID:198941592 | ETOLOXAMINE
+BMGC_DG14498,BMG_DG182193,PubChem SID:198936081 | METIPRENALINE | CAS RN:1212-03-9 | PubChem CID:68951 | UNII:1WBF92D66N
+BMGC_DG14499,BMG_DG182194,"DrugBank ID:DB13185 | Oxabolone cipionate | OXABOLONE CIPIONATE | UNII:5RXY50Q01N | PubChem SID:198985009 | CAS RN:1254-35-9 | [(8R,9S,10R,13S,14S,17S)-4-hydroxy-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate | PubChem CID:68952"
+BMGC_DG14500,BMG_DG182195,"5-bromo-2-phenylindene-1,3-dione | PubChem CID:68953 | UNII:J1J87P409K | PubChem SID:198964036 | ISOBROMINDIONE | Isobromindione | DrugBank ID:DB13545 | CAS RN:1470-35-5"
+BMGC_DG14501,BMG_DG182200,4-AMINOPYRIMIDINE | PubChem SID:472415668 | PubChem CID:68958 | CAS RN:591-54-8 | UNII:BU3262X8CZ
+BMGC_DG14502,BMG_DG182223,UNII:O27JHO40J8 | TRITHIOCARBONIC ACID | CAS RN:594-08-1 | PubChem SID:198942734 | PubChem CID:68982
+BMGC_DG14503,BMG_DG182224,CAS RN:122794-99-4 | ETHYL 6-BROMO-4-HYDROXYQUINOLINE -3-CARBOXYLATE | UNII:9H26696PMU | PubChem CID:689824
+BMGC_DG14504,BMG_DG182233,PubChem SID:445499501 | PubChem CID:68992 | TRIPHENYLACETIC ACID | UNII:AMG3VF7EBL | CAS RN:595-91-5
+BMGC_DG14505,BMG_DG182266,PubChem SID:198991011 | UNII:4JDT453NWO | DrugBank ID:DB03636 | CAS RN:598-41-4 | PubChem CID:69020 | GLYCINAMIDE | Glycinamide
+BMGC_DG14506,BMG_DG182275,UNII:C64L4UMH19 | CAS RN:599-71-3 | PubChem SID:198949262 | N-HYDROXYBENZENESULFONAMIDE | PubChem CID:69033
+BMGC_DG14507,BMG_DG182284,DrugBank ID:DB14232 | Deacetylbisacodyl | DEACETYLBISACODYL | 4-[(4-hydroxyphenyl)-pyridin-2-ylmethyl]phenol | PubChem SID:198944927 | PubChem CID:69046 | UNII:R09078E41Y | CAS RN:603-41-8
+BMGC_DG14508,BMG_DG182319,"BMS-984923 | PubChem CID:69084898 | Bms-984923 | CAS RN:1375752-78-5 | (4R,5R)-5-(2-chlorophenyl)-4-[5-(2-phenylethynyl)pyridin-3-yl]-1,3-oxazolidin-2-one | UNII:3I1803DK5Z | PubChem SID:438788696"
+BMGC_DG14509,BMG_DG182323,PubChem CID:69088 | 4-methyl-1H-quinolin-2-one | CAS RN:607-66-9 | CAS RN:84909-43-3 | 4-Methylquinolin-2-ol
+BMGC_DG14510,BMG_DG182329,2-methyl-2-[3-methyl-4-[[4-(methylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]pyrazol-1-yl]propanenitrile | PubChem CID:69093374 | Gne-0877 | DNL-201 | CAS RN:1374828-69-9 | PubChem SID:346539311 | UNII:ANGHS285FG
+BMGC_DG14511,BMG_DG182362,"Ribitol | UNII:VCQ006KQ1E | (2S,4R)-pentane-1,2,3,4,5-pentol | PubChem SID:175266511 | DrugBank ID:DB11195 | PubChem CID:6912 | UNII:353ZQ9TVDA | Xylitol | DrugBank ID:DB01904 | CAS RN:16277-71-7 | PubChem SID:198954201 | CAS RN:488-81-3 | CAS RN:87-99-0 | XYLITOL | CAS RN:87849-01-2 | DrugBank ID:DB14704 | RIBITOL"
+BMGC_DG14512,BMG_DG182371,"DrugBank ID:DB04933 | PubChem SID:198973902 | CAS RN:185955-34-4 | [(2R,3R,4R,5S,6R)-4-decoxy-5-hydroxy-6-[[(2R,3R,4R,5S,6R)-4-[(3R)-3-methoxydecoxy]-6-(methoxymethyl)-3-[[(Z)-octadec-11-enoyl]amino]-5-phosphonooxyoxan-2-yl]oxymethyl]-3-(3-oxotetradecanoylamino)oxan-2-yl] dihydrogen phosphate | ERITORAN | UNII:551541VI0Y | PubChem CID:6912404 | Eritoran"
+BMGC_DG14513,BMG_DG182397,CAS RN:4627-61-6 | OLEOYL GLUTAMIC ACID | UNII:I0RBS4L0IJ | PubChem SID:198936245 | PubChem CID:6913738
+BMGC_DG14514,BMG_DG182400,"FOSTRIECIN | CAS RN:87810-56-8 | [(1E,3R,4R,6R,7Z,9Z,11E)-3,6,13-trihydroxy-3-methyl-1-[(2R)-6-oxo-2,3-dihydropyran-2-yl]trideca-1,7,9,11-tetraen-4-yl] dihydrogen phosphate | Fostriecin | PubChem SID:198936909 | UNII:ZO1648L551 | PubChem CID:6913994 | CAS RN:87860-39-7"
+BMGC_DG14515,BMG_DG182404,"UNII:M1O131WXFO | PubChem SID:198966016 | 4-Hydroxyquinoline | PubChem CID:69141 | 4-HYDROXYQUINOLINE | 1,4-DIHYDRO-4-QUINOLINONE | 1H-quinolin-4-one | CAS RN:611-36-9 | CAS RN:529-37-3"
+BMGC_DG14516,BMG_DG182409,"PubChem SID:175268146 | 1-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]imidazolidine-2,4-dione | CAS RN:833480-90-3 | Dantrolene | CAS RN:7261-97-4 | CAS RN:1185234-99-4 | DrugBank ID:DB01219 | PubChem CID:6914273 | UNII:F64QU97QCR | CAS RN:85008-71-5 | DANTROLENE"
+BMGC_DG14517,BMG_DG182423,"PubChem CID:6914564 | DrugBank ID:DB07877 | 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE"
+BMGC_DG14518,BMG_DG182424,"PubChem CID:6914568 | N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE | DrugBank ID:DB06876"
+BMGC_DG14519,BMG_DG182425,DrugBank ID:DB07544 | PubChem CID:6914573 | N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE
+BMGC_DG14520,BMG_DG182428,"(3,4-Dihydroxy-2-nitrophenyl)(phenyl)methanone | DrugBank ID:DB07462 | PubChem CID:6914595 | (3,4-dihydroxy-2-nitrophenyl)-phenylmethanone | (3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE"
+BMGC_DG14521,BMG_DG182429,UNII:I4XJ07373M | PubChem SID:198949090 | 4-METHOXYBENZOPHENONE | CAS RN:611-94-9 | PubChem CID:69146
+BMGC_DG14522,BMG_DG182432,DrugBank ID:DB07379 | PubChem CID:6914609 | (2S)-2-({6-[(3-Amino-5-chlorophenyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-3-methyl-1-butanol
+BMGC_DG14523,BMG_DG182433,"PubChem CID:6914612 | (1R,2R,3R,4S,5R)-4-(Benzylamino)-5-(methylthio)cyclopentane-1,2,3-triol | DrugBank ID:DB06984"
+BMGC_DG14524,BMG_DG182434,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE | PubChem CID:6914613 | DrugBank ID:DB07107
+BMGC_DG14525,BMG_DG182435,"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE | PubChem CID:6914614 | DrugBank ID:DB07204"
+BMGC_DG14526,BMG_DG182436,(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE | PubChem CID:6914621 | DrugBank ID:DB07145
+BMGC_DG14527,BMG_DG182437,"1-(3-amino-1,2-benzoxazol-5-yl)-6-[4-[2-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]phenyl]phenyl]-3-(trifluoromethyl)-4,5-dihydropyrazolo[3,4-c]pyridin-7-one | BMS-740808 | UNII:LDD74E663F | 1-(3-Amino-1,2-benzisoxazol-5-YL)-6-(2'-{[(3R)-3-hydroxypyrrolidin-1-YL]methyl}biphenyl-4-YL)-3-(trifluoromethyl)-1,4,5,6-tetrahydro-7H-pyrazolo[3,4-C]pyridin-7-one | CAS RN:280118-23-2 | PubChem CID:6914623 | PubChem SID:198972006"
+BMGC_DG14528,BMG_DG182438,DrugBank ID:DB07112 | N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE | PubChem CID:6914624
+BMGC_DG14529,BMG_DG182439,"DrugBank ID:DB06899 | PubChem CID:6914625 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE"
+BMGC_DG14530,BMG_DG182440,"DrugBank ID:DB06967 | PubChem CID:6914626 | 6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE"
+BMGC_DG14531,BMG_DG182441,"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE | PubChem CID:6914627 | DrugBank ID:DB07059"
+BMGC_DG14532,BMG_DG182442,"PubChem CID:6914629 | DrugBank ID:DB07174 | 6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE"
+BMGC_DG14533,BMG_DG182443,"PubChem CID:6914633 | DrugBank ID:DB07244 | 5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE"
+BMGC_DG14534,BMG_DG182444,"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE | DrugBank ID:DB08743 | PubChem CID:6914643"
+BMGC_DG14535,BMG_DG182445,DrugBank ID:DB07273 | PubChem CID:6914644 | 1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE
+BMGC_DG14536,BMG_DG182448,CAS RN:201034-75-5 | UNII:V71TF6V9M7 | CAS RN:658084-64-1 | DAPORINAD | Daporinad | CAS RN:1198425-96-5 | PubChem CID:6914657 | (E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-pyridin-3-ylprop-2-enamide | CAS RN:658084-94-7 | PubChem SID:198977556 | DrugBank ID:DB12731
+BMGC_DG14537,BMG_DG182449,{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID | DrugBank ID:DB06989 | PubChem CID:6914659
+BMGC_DG14538,BMG_DG182450,"(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID | PubChem CID:6914660 | DrugBank ID:DB07068"
+BMGC_DG14539,BMG_DG182451,"DrugBank ID:DB07127 | PubChem CID:6914661 | {4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID"
+BMGC_DG14540,BMG_DG182453,N-[(1-Chloro-4-hydroxyisoquinolin-3-YL)carbonyl]glycine | PubChem CID:6914666 | UNII:RU921DS4Z5 | 2-[(1-chloro-4-hydroxyisoquinoline-3-carbonyl)amino]acetic acid | FG-2216 | CAS RN:223387-75-5 | DrugBank ID:DB08687 | PubChem SID:249492436
+BMGC_DG14541,BMG_DG182454,4-Benzoylbenzoic acid | CAS RN:611-95-0 | PubChem CID:69147 | PubChem SID:485662480 | 4-BENZOYLBENZOIC ACID | UNII:GWF8XRR32J
+BMGC_DG14542,BMG_DG182471,"ROXITHROMYCIN | (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one | DrugBank ID:DB00778 | UNII:21KOF230FA | PubChem CID:6915744 | CAS RN:80214-83-1 | Roxithromycin | PubChem SID:175265634"
+BMGC_DG14543,BMG_DG182473,"CAS RN:163217-09-2 | DrugBank ID:DB04796 | PubChem CID:6915835 | (1R,3R)-5-[(2E)-2-[(1R,3aR,7aR)-1-[(2R)-6-hydroxy-6-methylhept-4-yn-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol | UNII:05FZV98342 | Inecalcitol | INECALCITOL | PubChem SID:198981087"
+BMGC_DG14544,BMG_DG182474,DrugBank ID:DB02805 | PubChem CID:6915836 | Arabinouridine 3'-phosphate
+BMGC_DG14545,BMG_DG182479,"NDC:68788-8115 | NDC:50090-1033 | NDC:67296-0526 | NDC:68071-2503 | NDC:65862-218 | NDC:67046-1298 | NDC:50090-6171 | NDC:70518-4169 | NDC:68071-4970 | NDC:43063-959 | NDC:71205-405 | NDC:68788-8062 | NDC:71205-380 | NDC:68071-5145 | PubChem SID:175267126 | NDC:50090-6041 | NDC:50090-6417 | NDC:68788-7987 | NDC:71205-224 | DrugBank ID:DB00535 | NDC:72189-308 | NDC:63629-8968 | UNII:CI0FAO63WC | NDC:70518-1880 | NDC:65862-219 | NDC:67877-543 | NDC:57237-099 | NDC:63187-835 | NDC:67877-547 | NDC:50090-2735 | NDC:68180-723 | NDC:63187-989 | NDC:0093-3160 | NDC:50090-5811 | NDC:68071-3609 | NDC:70518-2537 | NDC:71205-183 | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | NDC:67296-1448 | NDC:72189-043 | NDC:50090-2719 | NDC:50090-6042 | NDC:65862-177 | NDC:68071-4946 | NDC:68180-722 | NDC:72189-185 | NDC:60687-699 | PubChem CID:6915944 | NDC:72189-259 | NDC:43063-964 | NDC:68788-8323 | NDC:72189-423 | NDC:68071-4007 | NDC:42291-043 | CEFDINIR | NDC:67296-1216 | NDC:71205-576 | NDC:67296-0868 | NDC:68788-8404 | NDC:72789-054 | Cefdinir | NDC:82982-071 | NDC:68001-362 | NDC:0781-2176 | NDC:67296-0469 | NDC:72789-061 | CAS RN:91832-40-5 | NDC:68180-711 | NDC:82868-059 | NDC:50090-3723 | NDC:72189-186 | NDC:68788-7844 | NDC:67877-548 | NDC:68788-7339 | NDC:68071-5106"
+BMGC_DG14546,BMG_DG182482,"CAS RN:612-37-3 | 7-Methyluric acid | UNII:0040741VCN | PubChem SID:252163855 | PubChem CID:69160 | 7-methyl-3,9-dihydropurine-2,6,8-trione | 7-METHYLURIC ACID"
+BMGC_DG14547,BMG_DG182495,"DrugBank ID:DB00611 | PubChem CID:6916249 | (1R,9S,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol | Butorphanol"
+BMGC_DG14548,BMG_DG182498,Drotebanol | DrugBank ID:DB01547 | PubChem CID:6916258
+BMGC_DG14549,BMG_DG182513,CAS RN:25249-54-1 | UNII:76H9G81541 | N-Vinyl-2-pyrrolidone | CAS RN:88-12-0 | 1-ethenylpyrrolidin-2-one | N-VINYLPYRROLIDINONE | PubChem SID:175267616 | PubChem CID:6917
+BMGC_DG14550,BMG_DG182525,PubChem SID:252163803 | CAS RN:21525-08-6 | PF-1543 | UNII:3098LU3I5P | PubChem CID:69175940
+BMGC_DG14551,BMG_DG182527,"PubChem CID:6917653 | CAS RN:73671-86-0 | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N,N-diethyl-6,9a,11a-trimethyl-7-oxo-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydro-1H-indeno[5,4-f]quinoline-1-carboxamide | 17-N,N-Diethylcarbamoyl-4-methyl-4-azaandrostane-3-one"
+BMGC_DG14552,BMG_DG182528,"DrugBank ID:DB02640 | PubChem SID:198977418 | FUMAGILLIN | (2E,4E,6E,8E)-10-[[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl]oxy]-10-oxodeca-2,4,6,8-tetraenoic acid | UNII:7OW73204U1 | PubChem CID:6917655 | CAS RN:127913-45-5 | CAS RN:23110-15-8 | Fumagillin"
+BMGC_DG14553,BMG_DG182543,"4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide | CAS RN:86718-70-9 | Cisapride | DrugBank ID:DB00604 | CAS RN:104860-66-4 | PubChem SID:175271454 | CAS RN:81098-60-4 | UNII:UVL329170W | CISAPRIDE | PubChem CID:6917698"
+BMGC_DG14554,BMG_DG182545,PubChem CID:6917707 | UNII:CQK2YXW6EZ | PubChem SID:485665835 | DADLE | CAS RN:63631-40-3
+BMGC_DG14555,BMG_DG182550,"DrugBank ID:DB00294 | NDC:78206-145 | PubChem CID:6917715 | PubChem SID:175268832 | UNII:304GTH6RNH | (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | ETONOGESTREL | CAS RN:54048-10-1 | Etonogestrel"
+BMGC_DG14556,BMG_DG182576,"NDC:65162-960 | UNII:371U2ZK31U | NDC:0456-2240 | (1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide;hydrochloride | CAS RN:175131-60-9 | NDC:0456-2280 | NDC:0456-2212 | Levomilnacipran Hydrochloride | LEVOMILNACIPRAN HYDROCHLORIDE | NDC:65162-411 | PubChem CID:6917778 | NDC:0456-2220 | NDC:65162-437 | NDC:65162-455 | CAS RN:101152-94-7 | PubChem SID:198937142"
+BMGC_DG14557,BMG_DG182577,"LEVOMILNACIPRAN | CAS RN:96847-55-1 | CAS RN:96847-54-0 | DrugBank ID:DB08918 | UNII:UGM0326TXX | PubChem CID:6917779 | Levomilnacipran | (1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide | PubChem SID:198967714"
+BMGC_DG14558,BMG_DG182592,"(2R,3R,4S,5R)-2-(6-amino-2-anilinopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | UNII:K40I59G1EF | 2-PHENYLAMINOADENOSINE | PubChem CID:6917803 | 2-Phenylaminoadenosine | PubChem SID:198962798 | CAS RN:53296-10-9"
+BMGC_DG14559,BMG_DG182616,"UNII:60W3249T9M | PubChem CID:6917864 | Artesunate | CAS RN:88495-63-0 | ARTESUNATE | 4-oxo-4-[[(1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl]oxy]butanoic acid | DrugBank ID:DB09274 | PubChem SID:175268539"
+BMGC_DG14560,BMG_DG182618,"CAS RN:99571-64-9 | Oxitropium | PubChem SID:198938559 | DrugBank ID:DB12086 | PubChem CID:6917866 | UNII:8G15T83E6I | [(1S,2S,4R,5R)-9-ethyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate | OXITROPIUM"
+BMGC_DG14561,BMG_DG182636,"PubChem CID:6917907 | CAS RN:87081-35-4 | LEPTOMYCIN B | UNII:Y031I2N1EO | PubChem SID:198967401 | (2E,5S,6R,7S,9R,10E,12E,15R,16Z,18E)-17-ethyl-6-hydroxy-3,5,7,9,11,15-hexamethyl-19-[(2S,3S)-3-methyl-6-oxo-2,3-dihydropyran-2-yl]-8-oxononadeca-2,10,12,16,18-pentaenoic acid | Leptomycin B"
+BMGC_DG14562,BMG_DG182637,"Edatrexate | CAS RN:80576-83-6 | PubChem SID:198977387 | UNII:JT4X6Z1HRR | (2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)butan-2-yl]benzoyl]amino]pentanedioic acid | PubChem CID:6917908 | EDATREXATE"
+BMGC_DG14563,BMG_DG182646,"UNII:35E3NJJ4O6 | BERAPROST | PubChem CID:6917951 | Beraprost | CAS RN:88430-50-6 | CAS RN:218432-32-7 | 4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoic acid | PubChem SID:198978287"
+BMGC_DG14564,BMG_DG182655,"STEPHOLIDINE | PubChem SID:317229387 | (13aS)-3,9-dimethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline-2,10-diol | Stepholidine | PubChem CID:6917970 | UNII:0UPX3E69W8 | CAS RN:16562-13-3"
+BMGC_DG14565,BMG_DG182659,"(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | UNII:N219O0L31C | CAS RN:11021-13-9 | Ginsenoside C | DrugBank ID:DB06748 | GINSENOSIDE C | PubChem SID:198942017 | PubChem CID:6917976"
+BMGC_DG14566,BMG_DG182671,PubChem CID:6918 | 3-THIOPHENECARBOXYLIC ACID | PubChem SID:198940137 | CAS RN:88-13-1 | UNII:6V3012Q6BE
+BMGC_DG14567,BMG_DG182676,"acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | CAS RN:2378114-72-6 | PubChem CID:6918010 | Somatuline"
+BMGC_DG14568,BMG_DG182677,"(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | PubChem SID:375084565 | CAS RN:118992-92-0 | Lanreotide | CAS RN:108736-35-2 | UNII:0G3DE8943Y | LANREOTIDE | PubChem CID:6918011"
+BMGC_DG14569,BMG_DG182682,"Vapreotide | PubChem SID:316918699 | VAPREOTIDE | DrugBank ID:DB04894 | (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | CAS RN:103222-11-3 | UNII:2PK59M9GFF | PubChem CID:6918026"
+BMGC_DG14570,BMG_DG182691,POLAPREZINC | PubChem SID:198971579 | CAS RN:107667-60-7 | Promac | UNII:0WA1B15A1Z | Polaprezinc | DrugBank ID:DB09221 | zinc;(2S)-2-[(3-amino-1-oxidopropylidene)amino]-3-(1H-imidazol-5-yl)propanoate | PubChem CID:6918055
+BMGC_DG14571,BMG_DG182702,"Etoposide Phosphate | CAS RN:117091-64-2 | ETOPOSIDE PHOSPHATE | PubChem CID:6918092 | PubChem SID:175267936 | UNII:528XYJ8L1N | [4-[(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-9-yl]-2,6-dimethoxyphenyl] dihydrogen phosphate"
+BMGC_DG14572,BMG_DG182705,"PubChem CID:6918097 | UNII:N9DG6ZTC43 | 5-O-[3-(4,4-diphenylpiperidin-1-yl)propyl] 3-O-methyl (4R)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | DrugBank ID:DB14068 | DEXNIGULDIPINE | Dexniguldipine | CAS RN:120054-86-6 | PubChem SID:198939748"
+BMGC_DG14573,BMG_DG182711,"(12R)-12-[(2-methylimidazol-1-yl)methyl]-1-azatetracyclo[7.6.1.05,16.010,15]hexadeca-5(16),6,8,10(15)-tetraen-11-one | PubChem CID:6918107 | DrugBank ID:DB04885 | PubChem SID:198944242 | CAS RN:120635-74-7 | Cilansetron | UNII:2J6DQ1U5B5 | CILANSETRON"
+BMGC_DG14574,BMG_DG182720,"NDC:62332-516 | NDC:66302-632 | PubChem SID:175265596 | NDC:66302-111 | NDC:62332-515 | NDC:43598-649 | NDC:0781-3430 | NDC:66302-300 | DrugBank ID:DB00374 | NDC:0703-0686 | Treprostinil | TREPROSTINIL | NDC:66302-102 | NDC:66302-206 | PubChem CID:6918140 | NDC:42023-207 | NDC:66302-664 | NDC:66302-302 | NDC:0781-3420 | NDC:66302-780 | NDC:0703-0696 | CAS RN:81846-19-7 | NDC:43598-648 | NDC:66302-105 | NDC:66302-310 | NDC:66302-732 | NDC:66302-112 | NDC:66302-648 | NDC:66302-110 | NDC:43598-646 | UNII:RUM6K67ESG | NDC:43598-647 | 2-[[(1R,2R,3aS,9aS)-2-hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[g]naphthalen-5-yl]oxy]acetic acid | NDC:0703-0666 | NDC:66302-120 | NDC:0781-3425 | NDC:66302-350 | NDC:0703-0676 | NDC:66302-748 | NDC:42023-209 | NDC:66302-101 | NDC:66302-764 | NDC:42023-208 | NDC:66302-114 | NDC:0781-3427 | NDC:66302-680 | NDC:66302-716 | NDC:66302-616 | NDC:62332-517 | NDC:42023-206 | NDC:62332-514 | NDC:66302-325"
+BMGC_DG14575,BMG_DG182721,"PubChem CID:6918141 | DrugBank ID:DB05295 | CAS RN:104121-92-8 | ELDECALCITOL | UNII:I2JP8UE90H | Eldecalcitol | PubChem SID:198969988 | (1R,2R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-(3-hydroxypropoxy)-4-methylidenecyclohexane-1,3-diol"
+BMGC_DG14576,BMG_DG182723,"CAS RN:109229-58-5 | UNII:ZQW5577C3O | ENGLITAZONE | PubChem CID:6918151 | DrugBank ID:DB14035 | 5-[[(2R)-2-benzyl-3,4-dihydro-2H-chromen-6-yl]methyl]-1,3-thiazolidine-2,4-dione | Englitazone | PubChem SID:198963306"
+BMGC_DG14577,BMG_DG182726,"PubChem SID:175266964 | NDC:70515-711 | DrugBank ID:DB01410 | [2-[(1S,2S,4R,6R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] 2-methylpropanoate | NDC:70515-701 | CAS RN:126544-47-6 | CICLESONIDE | NDC:70515-712 | PubChem CID:6918155 | CAS RN:141845-82-1 | Ciclesonide | UNII:S59502J185 | NDC:70515-737"
+BMGC_DG14578,BMG_DG182734,"CAS RN:138614-30-9 | NDC:72162-2106 | NDC:54092-702 | NDC:62332-654 | (2S)-2-[[(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid;acetic acid | NDC:0093-3066 | NDC:24201-207 | Icatibant Acetate | NDC:60505-6214 | PubChem SID:175268094 | NDC:55150-351 | NDC:69097-664 | ICATIBANT ACETATE | UNII:325O8467XK | NDC:70709-013 | NDC:63323-574 | PubChem CID:6918172"
+BMGC_DG14579,BMG_DG182735,"ICATIBANT | DrugBank ID:DB06196 | CAS RN:130308-48-4 | PubChem CID:6918173 | (2S)-2-[[(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid | UNII:7PG89G35Q7 | PubChem SID:175266670 | Icatibant"
+BMGC_DG14580,BMG_DG182739,"CAS RN:66852-54-8 | NDC:63629-8665 | UNII:91A0K1TY3Z | NDC:0187-0653 | PubChem CID:6918178 | NDC:45802-129 | NDC:51672-1322 | PubChem SID:175267181 | NDC:70752-119 | NDC:0713-0640 | NDC:68308-769 | NDC:0713-0339 | NDC:0187-0002 | NDC:72162-2331 | NDC:63629-8664 | HALOBETASOL PROPIONATE | NDC:72162-2258 | NDC:51672-1321 | [(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | NDC:72162-2067 | NDC:45802-131 | NDC:72162-1396 | NDC:63629-8735 | Halobetasol Propionate | NDC:0168-0355"
+BMGC_DG14581,BMG_DG182740,PubChem CID:6918182 | Strontium ranelate | Strontium Ranelate | UNII:04NQ160FRU | PubChem SID:198949129 | DrugBank ID:DB09267 | CAS RN:135459-87-9 | STRONTIUM RANELATE | distrontium;5-[bis(carboxylatomethyl)amino]-3-(carboxylatomethyl)-4-cyanothiophene-2-carboxylate
+BMGC_DG14582,BMG_DG182744,"Vorozole | UNII:1E2S9YXV2A | PubChem CID:6918191 | PubChem SID:198952603 | 6-[(S)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole | CAS RN:129731-10-8 | DrugBank ID:DB13767 | VOROZOLE"
+BMGC_DG14583,BMG_DG182745,MnDPDP | PubChem CID:6918193 | trisodium;2-[2-[carboxylatomethyl-[[3-hydroxy-2-methyl-5-(phosphonatooxymethyl)pyridin-1-ium-4-yl]methyl]amino]ethyl-[[3-hydroxy-5-[[hydroxy(oxido)phosphoryl]oxymethyl]-2-methylpyridin-1-ium-4-yl]methyl]amino]acetate;manganese
+BMGC_DG14584,BMG_DG182746,"DrugBank ID:DB05642 | DDP-225 | 4-(2-fluorophenyl)-6-methyl-2-piperazin-1-ylthieno[2,3-d]pyrimidine;hydrate;hydrochloride | PubChem SID:198962841 | Ddp-225 | CAS RN:476148-82-0 | PubChem CID:6918194 | UNII:SZU399KT7Q"
+BMGC_DG14585,BMG_DG182750,"2-[2-[carboxylatomethyl-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl]amino]ethyl-(carboxymethyl)amino]-3-phenylmethoxypropanoate;gadolinium(3+);(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol | PubChem CID:6918204 | Gadobenate Dimeglumine | CAS RN:127000-20-8"
+BMGC_DG14586,BMG_DG182755,"Faropenem Medoxomil | UNII:5OK523O4FU | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate | CAS RN:141702-36-5 | Faropenem medoxomil | PubChem CID:6918218 | PubChem SID:198976273 | DrugBank ID:DB05659 | FAROPENEM MEDOXOMIL"
+BMGC_DG14587,BMG_DG182769,Pralmorelin | PRALMORELIN | PubChem CID:6918245 | CAS RN:158861-67-7 | UNII:E6S6E1F19M | PubChem SID:175268741 | (2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
+BMGC_DG14588,BMG_DG182771,FLIBANSERIN | NDC:58604-214 | PubChem CID:6918248 | PubChem SID:198977406 | UNII:37JK4STR6Z | CAS RN:167933-07-5 | 3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one | Flibanserin | DrugBank ID:DB04908
+BMGC_DG14589,BMG_DG182781,"UNII:49D4Q4254Z | Tt-232 | CAS RN:147159-51-1 | PubChem SID:198967127 | TT-232 | DrugBank ID:DB12088 | PubChem CID:6918265 | (4R,7S,10R,13S,16R)-7-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-16-[[(2R)-2-amino-3-phenylpropanoyl]amino]-13-[(4-hydroxyphenyl)methyl]-10-(1H-indol-3-ylmethyl)-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide"
+BMGC_DG14590,BMG_DG182783,"MITEMCINAL | Mitemcinal | (2S,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-11-[(2S,3R,4S,6R)-3-hydroxy-6-methyl-4-[methyl(propan-2-yl)amino]oxan-2-yl]oxy-4-methoxy-2,4,8,10,12,14-hexamethyl-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-ene-3,7-dione | DrugBank ID:DB06587 | PubChem CID:6918267 | UNII:6X5NRJ664L | PubChem SID:198970460 | CAS RN:154738-42-8"
+BMGC_DG14591,BMG_DG182784,"PubChem CID:6918268 | 3-[[2-[2-(4-chlorophenyl)sulfanylethoxy]-3-methoxy-5-[(2S,5S)-5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]methyl]-1-hydroxy-1-methylurea | CAS RN:205654-37-1"
+BMGC_DG14592,BMG_DG182788,UNII:8DL7FH77SF | DES-CICLESONIDE | PubChem CID:6918281 | CAS RN:161115-59-9 | PubChem SID:346539252
+BMGC_DG14593,BMG_DG182790,"LABRADIMIL | DrugBank ID:DB06549 | (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-methoxyphenyl)propyl]amino]-5-(diaminomethylideneamino)pentanoic acid | PubChem SID:316916866 | UNII:2MK663C346 | Labradimil | PubChem CID:6918284 | CAS RN:159768-75-9"
+BMGC_DG14594,BMG_DG182792,"PubChem CID:6918289 | Temsirolimus | PubChem SID:175265620 | CAS RN:162635-04-3 | TEMSIROLIMUS | [(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl] 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate | UNII:624KN6GM2T"
+BMGC_DG14595,BMG_DG182796,"DUTASTERIDE | NDC:59651-021 | NDC:63629-1223 | NDC:70771-1347 | PubChem CID:6918296 | NDC:80725-712 | NDC:71205-039 | NDC:68071-3732 | NDC:68071-3757 | NDC:72578-019 | NDC:72865-140 | NDC:59651-063 | DrugBank ID:DB01126 | NDC:63629-1222 | NDC:72162-1296 | NDC:80725-809 | NDC:10370-280 | NDC:70771-1356 | NDC:63629-8207 | NDC:68382-640 | NDC:31722-131 | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide | NDC:25000-011 | UNII:O0J6XJN02I | NDC:50090-4010 | NDC:42806-549 | CAS RN:164656-23-9 | NDC:51407-157 | Dutasteride | NDC:50090-7305 | NDC:71205-278 | NDC:65162-750 | NDC:68071-4821 | PubChem SID:175265390 | NDC:42291-031"
+BMGC_DG14596,BMG_DG182797,EXAMORELIN | PubChem CID:6918297 | CAS RN:140703-51-1 | PubChem SID:198988677 | UNII:09QF37C617
+BMGC_DG14597,BMG_DG182800,"DrugBank ID:DB05087 | Ganaxolone | PubChem CID:6918305 | 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone | NDC:81583-100 | PubChem SID:198957182 | GANAXOLONE | CAS RN:38398-32-2 | UNII:98WI44OHIQ"
+BMGC_DG14598,BMG_DG182805,NDC:82804-128 | PubChem SID:175266390 | 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide;hydrochloride | NDC:72205-261 | NDC:42291-949 | NDC:69097-979 | NDC:62332-232 | NDC:0456-1110 | NDC:46708-234 | NDC:68788-8734 | NDC:0480-2044 | NDC:72603-815 | VILAZODONE HYDROCHLORIDE | NDC:72603-814 | NDC:0456-1140 | NDC:68788-8735 | NDC:69097-982 | NDC:76282-544 | NDC:60505-4372 | NDC:16729-354 | NDC:72603-127 | NDC:46708-232 | NDC:42291-948 | NDC:60505-4773 | NDC:76282-545 | NDC:60505-4374 | NDC:60505-4373 | NDC:16729-352 | NDC:72205-262 | NDC:62332-233 | UNII:U8HTX2GK8J | NDC:72205-260 | CAS RN:163521-08-2 | NDC:16729-353 | NDC:42291-950 | NDC:60505-4772 | NDC:62332-234 | NDC:69097-981 | NDC:76282-546 | PubChem CID:6918313 | NDC:0456-1120 | Vilazodone Hydrochloride | NDC:46708-233 | NDC:72603-813 | NDC:60505-4774 | NDC:0480-2043 | NDC:0480-2045
+BMGC_DG14599,BMG_DG182806,5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide | Vilazodone | VILAZODONE | CAS RN:163521-12-8 | PubChem SID:175268384 | DrugBank ID:DB06684 | UNII:S239O2OOV3 | PubChem CID:6918314
+BMGC_DG14600,BMG_DG182807,"PubChem CID:6918315 | DrugBank ID:DB12677 | SOBLIDOTIN | (2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-(2-phenylethylamino)propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide | Soblidotin | CAS RN:149606-27-9 | PubChem SID:198946540 | UNII:DQC51A0WQH"
+BMGC_DG14601,BMG_DG182811,"CAS RN:175013-84-0 | PubChem CID:6918324 | UNII:2XD9773ZMN | PubChem SID:198957547 | TONABERSAT | N-[(3S,4S)-6-acetyl-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-3-chloro-4-fluorobenzamide | DrugBank ID:DB06578 | Tonabersat"
+BMGC_DG14602,BMG_DG182812,"PubChem CID:6918328 | (3S,6S,9S,12R)-3-[(2S)-butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone | Apicidin"
+BMGC_DG14603,BMG_DG182814,"CAS RN:168266-90-8 | UNII:K08BK043YS | Vofopitant | PubChem SID:198960924 | VOFOPITANT | PubChem CID:6918331 | (2S,3S)-N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine | DrugBank ID:DB12436"
+BMGC_DG14604,BMG_DG182817,TANOMASTAT | PubChem CID:6918336 | UNII:AM1ZX94EXH | Tanomastat | (2S)-4-[4-(4-chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic acid | CAS RN:179545-77-8 | PubChem SID:198936655 | DrugBank ID:DB06276
+BMGC_DG14605,BMG_DG182818,"[(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] sulfamate | DrugBank ID:DB06597 | PubChem CID:6918339 | ESTRADIOL SULFAMATE | UNII:WO55ODW08Z | PubChem SID:375083582 | CAS RN:172377-52-5 | Estradiol sulfamate"
+BMGC_DG14606,BMG_DG182825,PubChem CID:6918365 | DrugBank ID:DB00673 | Aprepitant
+BMGC_DG14607,BMG_DG182827,"DrugBank ID:DB04870 | PubChem CID:6918373 | Oleoyl-estrone | CAS RN:180003-17-2 | OLEOYLESTRONE | PubChem SID:313183222 | [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] (Z)-octadec-9-enoate | UNII:64R56KMG1Z"
+BMGC_DG14608,BMG_DG182832,UNII:T5490K8I7S | CAS RN:199986-75-9 | PubChem CID:6918386 | PubChem SID:198941207 | CVT-313
+BMGC_DG14609,BMG_DG182834,"PubChem CID:6918388 | UNII:467LU0UCUW | PubChem SID:198975374 | Sarizotan | 1-[(2R)-3,4-dihydro-2H-chromen-2-yl]-N-[[5-(4-fluorophenyl)pyridin-3-yl]methyl]methanamine | DrugBank ID:DB06454 | CAS RN:351862-32-3 | SARIZOTAN"
+BMGC_DG14610,BMG_DG182839,"Pki166 | CAS RN:1350639-79-0 | 4-[4-[[(1R)-1-phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol | UNII:9RIE5HW38P | PubChem SID:322058659 | PubChem CID:6918403 | CAS RN:187724-61-4 | PKI-166"
+BMGC_DG14611,BMG_DG182845,CAS RN:193359-26-1 | UNII:Q85IYK36S4 | PubChem SID:198938244 | CO-101244 | PubChem CID:6918409
+BMGC_DG14612,BMG_DG182847,"UNII:8H61Y4E29N | PubChem SID:198938892 | DrugBank ID:DB11669 | PubChem CID:6918412 | CAS RN:186348-23-2 | Ortataxel | [(1S,2S,3R,4S,7R,9S,10S,12R,15R,16S)-4,12-diacetyloxy-9-hydroxy-15-[(2R,3S)-2-hydroxy-5-methyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoyl]oxy-10,14,20,20-tetramethyl-11,18-dioxo-6,17,19-trioxapentacyclo[11.6.1.01,16.03,10.04,7]icos-13-en-2-yl] benzoate | ORTATAXEL"
+BMGC_DG14613,BMG_DG182852,"4-(7-(((1R)-1-((3-CHLORO-2-THIENYL)METHYL)PROPYL)AMINO)-3H-IMIDAZO(4,5-B)PYRIDIN-3-YL)-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE, (1S,2R,3S,4R)- | CAS RN:143395-98-6 | UNII:85CCL08543 | PubChem SID:375083305 | PubChem CID:6918429"
+BMGC_DG14614,BMG_DG182854,UNII:F5OSA8VL97 | PubChem SID:252319581 | PubChem CID:6918439 | T-1095A | CAS RN:209746-56-5
+BMGC_DG14615,BMG_DG182856,DrugBank ID:DB05695 | 2-chloro-6-[(2R)-2-hydroxy-3-[(2-methyl-1-naphthalen-2-ylpropan-2-yl)amino]propoxy]benzonitrile | UNII:Z25PJ77W7V | NPS-2143 | Nps-2143 | CAS RN:284035-33-2 | PubChem SID:198959006 | PubChem CID:6918446
+BMGC_DG14616,BMG_DG182858,PubChem SID:198936893 | UNII:1M7NI1A92L | CAS RN:215874-86-5 | L-822179 | PubChem CID:6918451
+BMGC_DG14617,BMG_DG182860,"UNII:3H04W2810V | NDC:54766-093 | PubChem SID:175266130 | CAS RN:34031-32-8 | AURANOFIN | PubChem CID:6918453 | gold(1+);(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphane | Ridauran"
+BMGC_DG14618,BMG_DG182861,"UNII:R3K9Y00J04 | DrugBank ID:DB12429 | PubChem CID:6918454 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | CAS RN:212631-79-3 | CI-1040 | 2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide | PubChem SID:198947819"
+BMGC_DG14619,BMG_DG182863,"CAS RN:150322-43-3 | [5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-6,7-dihydro-4H-thieno[3,2-c]pyridin-2-yl] acetate | UNII:34K66TBT99 | PRASUGREL | PubChem SID:175272000 | Prasugrel | DrugBank ID:DB06209 | PubChem CID:6918456"
+BMGC_DG14620,BMG_DG182864,UNII:SA7S7H5D4B | PubChem CID:6918458 | PubChem SID:445499576 | FTI-2153 | CAS RN:344900-92-1
+BMGC_DG14621,BMG_DG182866,"DrugBank ID:DB01256 | UNII:4MG6O8991R | [(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl]acetate | CAS RN:224452-66-8 | PubChem SID:175268370 | Retapamulin | RETAPAMULIN | PubChem CID:6918462"
+BMGC_DG14622,BMG_DG182867,P-32/98 | PubChem CID:6918465 | UNII:SDH8E9EM4L | PubChem SID:375084648 | CAS RN:136259-20-6
+BMGC_DG14623,BMG_DG182868,CAS RN:219639-75-5 | UNII:FBK4LNR4Q7 | PMX-53 | PubChem CID:6918468
+BMGC_DG14624,BMG_DG182869,PubChem SID:313183564 | CAS RN:31186-12-6 | ALTENUSIN | PubChem CID:6918469 | UNII:WM31322YA1
+BMGC_DG14625,BMG_DG182870,"PubChem CID:6918473 | DHA-paclitaxel | PubChem SID:198953999 | UNII:OJE5810C4F | CAS RN:199796-52-6 | PACLITAXEL DOCOSAHEXAENOIC ACID | Paclitaxel docosahexaenoic acid | DrugBank ID:DB05297 | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate"
+BMGC_DG14626,BMG_DG182871,PubChem CID:6918474 | Carisbamate | [(2S)-2-(2-chlorophenyl)-2-hydroxyethyl] carbamate | UNII:P7725I9V3Z | CAS RN:194085-75-1 | CARISBAMATE | DrugBank ID:DB12338 | PubChem SID:198974092
+BMGC_DG14627,BMG_DG182874,"CAS RN:131175-87-6 | DrugBank ID:DB11638 | CAS RN:71939-50-9 | (1R,4S,5R,8S,9R,12R,13R)-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol | PubChem CID:6918483 | Cotecxin"
+BMGC_DG14628,BMG_DG182876,"ISAVUCONAZOLE | 4-[2-[(2R,3R)-3-(2,5-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]-1,3-thiazol-4-yl]benzonitrile | CAS RN:1286730-05-9 | DrugBank ID:DB11633 | UNII:60UTO373KE | PubChem SID:198957657 | CAS RN:241479-67-4 | Isavuconazole | PubChem CID:6918485"
+BMGC_DG14629,BMG_DG182877,"UNII:2PN063X6B1 | (3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhepta-4,6-dienyl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone | NDC:75626-001 | CAS RN:515814-01-4 | Voclosporin | CAS RN:515814-00-3 | PubChem SID:198979642 | VOCLOSPORIN | PubChem CID:6918486 | DrugBank ID:DB11693"
+BMGC_DG14630,BMG_DG182880,"NDC:82009-141 | NDC:42794-051 | NDC:59651-494 | NDC:0591-2405 | NDC:70710-1180 | NDC:60505-4553 | Ambrisentan | NDC:69097-386 | NDC:70710-1179 | NDC:42794-052 | NDC:59651-495 | CAS RN:177036-94-1 | PubChem SID:175267375 | NDC:47335-237 | NDC:70771-1364 | NDC:47335-236 | DrugBank ID:DB06403 | PubChem CID:6918493 | NDC:70771-1363 | (2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid | NDC:0378-4271 | AMBRISENTAN | NDC:69097-387 | UNII:HW6NV07QEC | NDC:82009-142 | NDC:0591-2406 | NDC:60505-4552 | NDC:0378-4270"
+BMGC_DG14631,BMG_DG182882,"UNII:HD099HOT7H | CAS RN:202796-41-6 | PubChem SID:198983356 | PubChem CID:6918496 | PubChem SID:198937895 | CAS RN:202796-42-7 | J-113863, TRANS- | UNII:H942HGF14D | J-113863, CIS-"
+BMGC_DG14632,BMG_DG182883,"J-113863 CATION, CIS- | J-113863 CATION, TRANS- | PubChem SID:198978101 | PubChem CID:6918497 | UNII:Y99524800Z | CAS RN:716313-11-0 | PubChem SID:198945411 | CAS RN:765882-14-2 | UNII:E449119QPL"
+BMGC_DG14633,BMG_DG182885,"CAS RN:609845-93-4 | Beloranib | DrugBank ID:DB12671 | UNII:FI471K8BU6 | PubChem CID:6918502 | [(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] (E)-3-[4-[2-(dimethylamino)ethoxy]phenyl]prop-2-enoate | CAS RN:251111-30-5 | BELORANIB | PubChem SID:198950332"
+BMGC_DG14634,BMG_DG182886,UNII:TDG8048RDA | JWH-133 | CAS RN:259869-55-1 | PubChem SID:375085803 | PubChem CID:6918505
+BMGC_DG14635,BMG_DG182887,"PubChem CID:6918508 | UNII:0MU316797D | Falnidamol | CAS RN:196612-93-8 | 4-N-(3-chloro-4-fluorophenyl)-6-N-(1-methylpiperidin-4-yl)pyrimido[5,4-d]pyrimidine-4,6-diamine | DrugBank ID:DB12966 | PubChem SID:198975662 | FALNIDAMOL"
+BMGC_DG14636,BMG_DG182888,"PubChem CID:6918509 | OLCEGEPANT | CAS RN:204697-65-4 | PubChem SID:198977553 | UNII:WOA5J8TX6M | N-[(2R)-1-[[(2S)-6-amino-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)hexan-2-yl]amino]-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropan-2-yl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide | Olcegepant | DrugBank ID:DB04869"
+BMGC_DG14637,BMG_DG182889,"PubChem CID:6918513 | PubChem SID:474492515 | 2-Ethyl-5-methoxy-N,N-dimethyltryptamine | EMDT | CAS RN:263744-72-5 | 2-(2-ethyl-5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine | UNII:GWM65988LJ"
+BMGC_DG14638,BMG_DG182890,CAS RN:17375-63-2 | BGC-20-761 | PubChem CID:6918515 | UNII:6G5F6ESV5I | PubChem SID:198970627
+BMGC_DG14639,BMG_DG182891,PubChem CID:6918520 | CAS RN:263262-73-3 | CP-800569 | PubChem SID:459055825 | UNII:WRB543XRA8
+BMGC_DG14640,BMG_DG182893,Udenafil | DrugBank ID:DB06267 | PubChem CID:6918523
+BMGC_DG14641,BMG_DG182895,"CAS RN:269718-84-5 | Pardoprunox | PubChem CID:6918525 | PubChem SID:198983334 | PARDOPRUNOX | DrugBank ID:DB12061 | UNII:5R72CHP32S | 7-(4-methylpiperazin-1-yl)-3H-1,3-benzoxazol-2-one"
+BMGC_DG14642,BMG_DG182897,NCX 701 | PubChem CID:6918532 | DrugBank ID:DB05409 | CAS RN:326850-30-0 | NITROPARACETAMOL | Nitroparacetamol | (4-acetamidophenyl) 4-nitrooxybutanoate | PubChem SID:348481392 | UNII:F8Y1ZV5V9P
+BMGC_DG14643,BMG_DG182898,UNII:I6B4B2U96P | PubChem CID:6918537 | VILDAGLIPTIN | (2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile | DrugBank ID:DB04876 | PubChem SID:175266579 | CAS RN:274901-16-5 | Vildagliptin
+BMGC_DG14644,BMG_DG182899,S-[2-[[1-(2-ethylbutyl)cyclohexanecarbonyl]amino]phenyl] 2-methylpropanethioate | CAS RN:211513-37-0 | UNII:3D050LIQ3H | DALCETRAPIB | PubChem SID:198984686 | PubChem CID:6918540 | DrugBank ID:DB12181 | Dalcetrapib
+BMGC_DG14645,BMG_DG182900,MS-245 | PubChem CID:6918542 | UNII:L7TKH887Y7 | PubChem SID:461432614 | CAS RN:263384-65-2
+BMGC_DG14646,BMG_DG182903,"PubChem SID:198967416 | Oxi-4503 | DrugBank ID:DB05143 | UNII:JH6Z94GLUD | [3-methoxy-2-phosphonooxy-6-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl] dihydrogen phosphate | COMBRETASTATIN A-1 PHOSPHATE | Combretastatin A-1 phosphate | OXI-4503 | PubChem CID:6918546 | CAS RN:288847-35-8"
+BMGC_DG14647,BMG_DG182905,"LONAPRISAN | (8S,11R,13S,14S,17S)-11-(4-acetylphenyl)-17-hydroxy-13-methyl-17-(1,1,2,2,2-pentafluoroethyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | UNII:F5Z5EL4D26 | PubChem SID:198954485 | CAS RN:211254-73-8 | Lonaprisan | PubChem CID:6918548"
+BMGC_DG14648,BMG_DG182906,"CAS RN:312753-06-3 | INDACATEROL | PubChem CID:6918554 | DrugBank ID:DB05039 | 5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one | UNII:8OR09251MQ | CAS RN:753498-25-8 | PubChem SID:175266645 | Indacaterol"
+BMGC_DG14649,BMG_DG182907,PubChem SID:175268192 | Fesoterodine | FESOTERODINE | UNII:621G617227 | CAS RN:286930-02-7 | DrugBank ID:DB06702 | PubChem CID:6918558 | [2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate
+BMGC_DG14650,BMG_DG182909,"ABT-510 | PubChem CID:6918562 | CAS RN:251579-55-2 | (2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R,3S)-2-[[(2S)-2-[[2-[[2-[acetyl(methyl)amino]acetyl]amino]acetyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]pentanoyl]amino]-3-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-ethylpyrrolidine-2-carboxamide | UNII:CRR8E37XOB | Abt-510 | DrugBank ID:DB05434 | PubChem SID:198967138"
+BMGC_DG14651,BMG_DG182910,TALABOSTAT | UNII:KZ1O2SH88Z | DrugBank ID:DB06182 | [(2R)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid | PubChem CID:6918572 | Talabostat | PubChem SID:198962076 | CAS RN:149682-77-9
+BMGC_DG14652,BMG_DG182914,PubChem SID:472423327 | UNII:TXZ4DVJ9MF | PubChem CID:6918583 | CAS RN:342652-67-9 | MRK-016
+BMGC_DG14653,BMG_DG182915,"Sugammadex Sodium | NDC:71872-7187 | NDC:0006-5425 | SUGAMMADEX SODIUM | octasodium;3-[[(1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36S,38S,40S,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R,54R,55R,56R)-10,15,20,25,30,35,40-heptakis(2-carboxylatoethylsulfanylmethyl)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-hexadecahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontan-5-yl]methylsulfanyl]propanoate | NDC:0006-5423 | UNII:ERJ6X2MXV7 | PubChem SID:198943949 | PubChem CID:6918584 | CAS RN:343306-79-6"
+BMGC_DG14654,BMG_DG182916,"3-[[(1S,3S,5S,6S,8S,10S,11S,13S,15S,16S,18S,20S,21S,23S,25S,26S,28S,30S,31S,33S,35S,36S,38S,40S,41R,42R,43R,44R,45R,46R,47R,48R,49R,50R,51R,52R,53R,54R,55R,56R)-10,15,20,25,30,35,40-heptakis(2-carboxyethylsulfanylmethyl)-41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56-hexadecahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34,37,39-hexadecaoxanonacyclo[36.2.2.23,6.28,11.213,16.218,21.223,26.228,31.233,36]hexapentacontan-5-yl]methylsulfanyl]propanoic acid | CAS RN:343306-71-8 | Sugammadex | DrugBank ID:DB06206 | SUGAMMADEX | UNII:361LPM2T56 | PubChem SID:198986519 | PubChem CID:6918585"
+BMGC_DG14655,BMG_DG182918,"DrugBank ID:DB12334 | Milataxel | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-15-[(2R,3R)-3-(furan-2-yl)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoyl]oxy-1,12-dihydroxy-10,14,17,17-tetramethyl-11-oxo-9-propanoyloxy-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate | CAS RN:352425-37-7 | UNII:J41Q4S20GS | MILATAXEL | CAS RN:393101-41-2 | PubChem SID:198935981 | PubChem CID:6918589"
+BMGC_DG14656,BMG_DG182920,"RELACATIB | PubChem SID:198988740 | PubChem CID:6918602 | UNII:BL51M8CB8R | DrugBank ID:DB06367 | N-[(2S)-4-methyl-1-[[(4S,7R)-7-methyl-3-oxo-1-pyridin-2-ylsulfonylazepan-4-yl]amino]-1-oxopentan-2-yl]-1-benzofuran-2-carboxamide | CAS RN:362505-84-8 | Relacatib"
+BMGC_DG14657,BMG_DG182922,"CAS RN:742049-41-8 | PubChem CID:6918606 | Isavuconazonium | UNII:VH2L779W8Q | DrugBank ID:DB06636 | [2-[1-[1-[(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,5-difluorophenyl)-2-hydroxybutyl]-1,2,4-triazol-4-ium-4-yl]ethoxycarbonyl-methylamino]pyridin-3-yl]methyl 2-(methylamino)acetate | ISAVUCONAZONIUM | PubChem SID:198979317"
+BMGC_DG14658,BMG_DG182923,"CAS RN:55869-99-3 | DrugBank ID:DB11785 | PubChem SID:198961524 | UNII:01343Q8EL8 | PubChem CID:6918612 | Anisodamine | UNII:U5AC4ZPQ36 | CAS RN:85760-60-7 | RACEANISODAMINE | PubChem SID:472424248 | ANISODAMINE | [(1R,3S,5R,6S)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate"
+BMGC_DG14659,BMG_DG182927,"3-(2-hydroxyethylsulfanyl)-6,6-dimethyl-1-(1,3-thiazol-2-yl)-5,7-dihydro-2-benzothiophen-4-one | CAS RN:207306-50-1 | PubChem SID:474492857 | TB-21007 | 6,7-Dihydro-3-[(2-hydroxyethyl)thio]-6,6-dimethyl-1-(2-thiazolyl)-benzo[C]thiophen-4(5H)-one | PubChem CID:6918633 | UNII:VL2NQQ83RN"
+BMGC_DG14660,BMG_DG182929,"CAS RN:444667-96-3 | PubChem SID:496143524 | BGC-20-1259 | (S)-4-(1-(methylamino)-3-(4-nitrophenoxy)propyl)phenyl dimethylcarbamate | PubChem CID:6918635 | [4-[(1S)-1-(methylamino)-3-(4-nitrophenoxy)propyl]phenyl] N,N-dimethylcarbamate | UNII:Y73947J3R5"
+BMGC_DG14661,BMG_DG182930,UNII:J6D6912BXS | TALTOBULIN | PubChem CID:6918637 | CAS RN:228266-40-8 | PubChem SID:198991141
+BMGC_DG14662,BMG_DG182931,NDC:72893-002 | CAS RN:414864-00-9 | (E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide | CAS RN:866323-14-0 | PubChem CID:6918638 | PubChem SID:198958714 | DrugBank ID:DB05015 | Belinostat | UNII:F4H96P17NZ | BELINOSTAT
+BMGC_DG14663,BMG_DG182933,UNII:5BH7TN3FWY | PubChem SID:474493147 | SB-399885 | CAS RN:402713-80-8 | PubChem CID:6918649
+BMGC_DG14664,BMG_DG182934,BVT-2733 | PubChem SID:198974595 | PubChem CID:6918651 | CAS RN:376640-41-4 | UNII:2EGD70329U
+BMGC_DG14665,BMG_DG182935,"UNII:NA0Y2SRR29 | Metapro | CAS RN:431077-35-9 | DrugBank ID:DB05864 | PPI-2458 | PubChem SID:198954902 | [(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] N-[(2R)-1-amino-3-methyl-1-oxobutan-2-yl]carbamate | PubChem CID:6918653"
+BMGC_DG14666,BMG_DG182937,"PubChem CID:6918662 | ethyl 5-amino-2-methyl-4-phenyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate | Ethyl 5-amino-2-methyl-4-phenyl-6,7,8,9-tetrahydrobenzo[b][1,8]naphthyridine-3-carboxylate"
+BMGC_DG14667,BMG_DG182941,"Ingenol mebutate | UNII:7686S50JAH | CAS RN:75567-37-2 | Ingenol Mebutate | DrugBank ID:DB05013 | PubChem CID:6918670 | [(1S,4S,5S,6R,9S,10R,12R,14R)-5,6-dihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxo-4-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl] (Z)-2-methylbut-2-enoate | PubChem SID:175267125 | INGENOL MEBUTATE"
+BMGC_DG14668,BMG_DG182945,PubChem CID:6918688 | PubChem SID:459056059 | CAS RN:768357-45-5 | MCL-0129 | UNII:8D47339CYL
+BMGC_DG14669,BMG_DG182949,"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine | PubChem CID:6918710 | DrugBank ID:DB07164"
+BMGC_DG14670,BMG_DG182952,"UNII:67DOW7F9GL | Rigosertib | CAS RN:592542-59-1 | DrugBank ID:DB12146 | 2-[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetic acid | PubChem SID:198958366 | PubChem CID:6918736 | RIGOSERTIB"
+BMGC_DG14671,BMG_DG182954,JCF-177 FREE BASE | PubChem CID:6918748 | CAS RN:697758-03-5 | UNII:KE3M008KFU | PubChem SID:198983716
+BMGC_DG14672,BMG_DG182956,PubChem SID:198944705 | PubChem CID:6918774 | UNII:AMX2I57A98 | COROSOLIC ACID | CAS RN:4547-24-4
+BMGC_DG14673,BMG_DG182957,UNII:D29UW59350 | BN-82270 | PubChem CID:6918776 | PubChem SID:198947855 | CAS RN:742104-24-1
+BMGC_DG14674,BMG_DG182958,UNII:A4CE428LGJ | PubChem SID:472423608 | PubChem CID:6918788 | CAS RN:796844-24-1 | XCT-790
+BMGC_DG14675,BMG_DG182961,CAS RN:211513-21-2 | 1-(2-Ethylbutyl)-N-(2-mercaptophenyl)cyclohexanecarboxamide | 1-(2-ETHYLBUTYL)-N-(2-MERCAPTOPHENYL)CYCLOHEXANECARBOXAMIDE | PubChem SID:478839011 | UNII:PEW5P6H57S | PubChem CID:6918816
+BMGC_DG14676,BMG_DG182964,2-[5-(3-methylphenyl)-1-octylindol-3-yl]acetamide | CAS RN:851636-83-4 | Cysmethynil | UNII:R5MT8HFQ9E | CYSMETHYNIL | PubChem SID:472423221 | PubChem CID:6918831
+BMGC_DG14677,BMG_DG182965,PubChem CID:6918834 | AG-24322 | DrugBank ID:DB13035
+BMGC_DG14678,BMG_DG182966,"(4S,7R,8S,9S,10E,13Z,16S)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(E)-1-(2-methyl-1,3-thiazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadeca-10,13-diene-2,6-dione | Kos-1584 | UNII:82481G197K | PubChem SID:252164437 | CAS RN:350493-61-7 | KOS-1584 | DrugBank ID:DB05903 | PubChem CID:6918835"
+BMGC_DG14679,BMG_DG182967,E-6837 | CAS RN:528859-61-2 | PubChem CID:6918836 | UNII:4AXX8P95BU | PubChem SID:459055593
+BMGC_DG14680,BMG_DG182968,Panobinostat | PubChem CID:6918837 | CAS RN:404950-80-7 | DrugBank ID:DB06603 | PANOBINOSTAT | (E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide | UNII:9647FM7Y3Z | PubChem SID:198980468
+BMGC_DG14681,BMG_DG182971,AR-42 | (S)-N-Hydroxy-4-(3-methyl-2-phenylbutanamido)benzamide | REC-2282 | N-hydroxy-4-[[(2S)-3-methyl-2-phenylbutanoyl]amino]benzamide | UNII:E0GG29V0AQ | DrugBank ID:DB12707 | PubChem SID:198970418 | CAS RN:935881-37-1 | PubChem CID:6918848
+BMGC_DG14682,BMG_DG182972,"DrugBank ID:DB08094 | UNII:T61871RKRI | PubChem CID:6918852 | CAS RN:741713-40-6 | RO-4584820 | [4-amino-2-[(1-methylsulfonylpiperidin-4-yl)amino]pyrimidin-5-yl]-(2,3-difluoro-6-methoxyphenyl)methanone | (4-Amino-2-((1-(methylsulfonyl)piperidin-4-yl)amino)pyrimidin-5-yl)(2,3-difluoro-6-methoxyphenyl)methanone | R-547 | PubChem SID:198942799"
+BMGC_DG14683,BMG_DG182974,4-Acetamidobenzoate | 4-acetamidobenzoate | PubChem CID:6918889
+BMGC_DG14684,BMG_DG183001,"5-BENZYL-1,3-THIAZOL-2-AMINE | PubChem SID:438788077 | CAS RN:121952-97-4 | DrugBank ID:DB08114 | PubChem CID:691952 | 5-benzyl-1,3-thiazol-2-amine | UNII:80LHQ4O8WW"
+BMGC_DG14685,BMG_DG183056,CAS RN:616-76-2 | 5-FORMYLSALICYLIC ACID | PubChem SID:441096643 | PubChem CID:69226 | UNII:23V3W745T8
+BMGC_DG14686,BMG_DG183063,"PubChem CID:6922965 | [(1R,2S)-1-hydroxy-1-phenylpropan-2-yl]-methylazanium | (-)-Ephedrinium"
+BMGC_DG14687,BMG_DG183098,CAS RN:1004551-40-9 | BMS-593214 | PubChem SID:198952840 | UNII:XD269G3O31 | PubChem CID:69249482
+BMGC_DG14688,BMG_DG183108,(2S)-2-(6-methoxynaphthalen-2-yl)propanoate | Anaprox | PubChem CID:6925666
+BMGC_DG14689,BMG_DG183128,2-Bromo-4'-methylacetophenone | 2-BROMO-4'-METHYLACETOPHENONE | PubChem SID:474490562 | PubChem CID:69272 | CAS RN:619-41-0 | UNII:7DX9QRY7DP
+BMGC_DG14690,BMG_DG183138,"UNII:RZW97F6CTS | PubChem SID:198944193 | CAS RN:88-24-4 | PubChem CID:6928 | 2,2'-METHYLENEBIS(4-ETHYL-6-TERT-BUTYLPHENOL)"
+BMGC_DG14691,BMG_DG183141,PubChem SID:474490821 | PubChem CID:69282 | UNII:S2BPD52X4F | Dibenzyl sulfone | CAS RN:620-32-6 | DIBENZYL SULFONE | benzylsulfonylmethylbenzene
+BMGC_DG14692,BMG_DG183150,"PubChem SID:175266435 | CAS RN:620-67-7 | DrugBank ID:DB11677 | UNII:2P6O7CFW5K | TRIHEPTANOIN | Triheptanoin | 2,3-di(heptanoyloxy)propyl heptanoate | PubChem CID:69286"
+BMGC_DG14693,BMG_DG183154,Oxanilide | UNII:AN528D9TLC | PubChem SID:474490492 | PubChem CID:69288 | OXANILIDE | CAS RN:620-81-5
+BMGC_DG14694,BMG_DG183181,"PubChem CID:69307211 | PubChem SID:198967418 | CAS RN:95720-01-7 | .DELTA.3-TETRAHYDROCANNABINOL, (R)- | UNII:EZP9408TXD"
+BMGC_DG14695,BMG_DG183192,"meso-1,2-Diphenylethylenediamine | PubChem SID:472422209 | CAS RN:951-87-1 | PubChem CID:6931234 | MESO-1,2-DIPHENYLETHYLENEDIAMINE | UNII:SLY76BC5ZF"
+BMGC_DG14696,BMG_DG183212,UNII:A03IJ8ROOP | 2-tert-Butyl-4-hydroxyanisole | PubChem SID:198945594 | PubChem CID:6932 | 3-tert-butyl-4-methoxyphenol | 2-TERT-BUTYL-4-HYDROXYANISOLE | CAS RN:88-32-4
+BMGC_DG14697,BMG_DG183240,CAS RN:4949-88-6 | PubChem CID:693365 | UNII:B54Y4CVZ2U | N-BENZOYL-N'-(O-TOLYL)THIOUREA | PubChem SID:377308703
+BMGC_DG14698,BMG_DG183241,RO-0506997 ACID | PubChem CID:69337579 | UNII:CH9Z955RV6 | CAS RN:343850-71-5
+BMGC_DG14699,BMG_DG183331,2-Aminobenzamide | 2-aminobenzamide | CAS RN:28144-70-9 | PubChem SID:198974403 | PubChem CID:6942 | UNII:Q1M2WEK6VA | CAS RN:88-68-6 | 2-AMINOBENZAMIDE
+BMGC_DG14700,BMG_DG183344,CAS RN:88-69-7 | PubChem SID:198983250 | 2-propan-2-ylphenol | CAS RN:25168-06-3 | 2-Isopropylphenol | 2-ISOPROPYLPHENOL | PubChem CID:6943 | UNII:B2899Z0Q2U
+BMGC_DG14701,BMG_DG183355,2-Nitrotoluene | UNII:6Q9N88YIAY | PubChem SID:198966309 | CAS RN:1321-12-6 | CAS RN:88-72-2 | PubChem CID:6944 | 1-methyl-2-nitrobenzene | O-NITROTOLUENE
+BMGC_DG14702,BMG_DG183364,N-1-NAPHTHYLBENZAMIDE | N-1-Naphthylbenzamide | PubChem SID:474490566 | PubChem CID:69448 | CAS RN:634-42-4 | UNII:FX8F4FZ8RG
+BMGC_DG14703,BMG_DG183378,7-hydroxyphenoxazin-3-one | RESORUFIN | PubChem CID:69462 | PubChem SID:474492126 | Resorufin | CAS RN:635-78-9 | UNII:A3NUS7K96S
+BMGC_DG14704,BMG_DG183394,"1-(4-FLUOROPHENYL)-4-((6BS,10AR)-2,3,6B,9,10,10A-HEXAHYDRO-3-METHYL-1H-PYRIDO(3',4':4,5)PYRROLO(1,2,3-DE)QUINOXALIN-8(7H)-YL)-1-BUTANONE | CAS RN:313368-92-2 | 1-(4-Fluorophenyl)-4-[(6bS,10aR)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-1-butanone | UNII:FR8MDN3MMB | PubChem SID:496143409 | PubChem CID:69471377"
+BMGC_DG14705,BMG_DG183485,CAS RN:587-33-7 | PubChem CID:6950578 | 3-Tyrosine | L-META-TYROSINE | UNII:D5YF57V4QW | PubChem SID:198956603 | DrugBank ID:DB03552
+BMGC_DG14706,BMG_DG183490,"PubChem SID:198954512 | DrugBank ID:DB04493 | PubChem CID:69507 | UNII:2012QM764Y | Fructose-6-phosphate | [(2R,3R,4S)-2,3,4,6-tetrahydroxy-5-oxohexyl] dihydrogen phosphate | CAS RN:6814-87-5 | CAS RN:643-13-0 | FRUCTOSE 6-PHOSPHATE"
+BMGC_DG14707,BMG_DG183517,"PubChem CID:6951123 | CAS RN:31321-74-1 | PubChem SID:363907776 | N-METHYLLEUCINE, D- | DrugBank ID:DB04487 | UNII:RS2PMV5S1P | N-Methylleucine"
+BMGC_DG14708,BMG_DG183531,PubChem SID:198944559 | MALVIDIN CHLORIDE | CAS RN:643-84-5 | PubChem CID:69512 | UNII:GL5KGZ4D8U
+BMGC_DG14709,BMG_DG183556,PubChem CID:69519 | PubChem SID:472411118 | UNII:TJ4YXB9N7P | O-TOLYLACETIC ACID | CAS RN:644-36-0
+BMGC_DG14710,BMG_DG183557,3-METHYLHISTAMINE | PubChem SID:474492378 | CAS RN:644-42-8 | UNII:XAF2U6Z4G7 | 3-Methylhistamine | 2-(3-methylimidazol-4-yl)ethanamine | PubChem CID:69520
+BMGC_DG14711,BMG_DG183563,UNII:KHD3D6L8XQ | LAURIC ANHYDRIDE | CAS RN:645-66-9 | PubChem SID:461433925 | PubChem CID:69527
+BMGC_DG14712,BMG_DG183574,"PICRIC ACID | DrugBank ID:DB03651 | NDC:37662-2362 | NDC:37662-2357 | Picric acid | NDC:0220-4030 | PubChem CID:6954 | NDC:37662-2360 | NDC:37662-2363 | NDC:37662-2356 | PubChem SID:175265550 | UNII:A49OS0F91S | Picric Acid | NDC:0220-4056 | 2,4,6-trinitrophenol | NDC:0220-4055 | NDC:37662-2361 | CAS RN:88-89-1 | NDC:37662-2359 | NDC:37662-2358"
+BMGC_DG14713,BMG_DG183582,"CAS RN:652-37-9 | 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid | Acefylline | PubChem SID:198958511 | UNII:M494UE2YEP | ACEFYLLINE | PubChem CID:69550 | DrugBank ID:DB13573"
+BMGC_DG14714,BMG_DG183596,"UNII:YBN90877RI | PubChem CID:69561 | 2,4-DISULFAMOYL-5-TRIFLUOROMETHYLANILINE | CAS RN:654-62-6 | PubChem SID:287446461"
+BMGC_DG14715,BMG_DG183618,UNII:239IF5W61J | PubChem CID:6957673 | 4-[[(2S)-2-benzamido-3-(4-hydroxyphenyl)propanoyl]amino]benzoic acid | CAS RN:37106-97-1 | DrugBank ID:DB00522 | BENTIROMIDE | PubChem SID:198942185 | Bentiromide
+BMGC_DG14716,BMG_DG183628,PubChem SID:198965695 | UNII:398688L26Z | CAS RN:668-94-0 | PubChem CID:69588 | DIPHENYLIMIDAZOLE
+BMGC_DG14717,BMG_DG183631,4-PHENYLIMIDAZOLE | PubChem SID:478837956 | PubChem CID:69590 | UNII:8VQ67XR7XY | DrugBank ID:DB03254 | 4-Phenyl-1h-Imidazole | CAS RN:670-95-1 | 4-Phenylimidazole
+BMGC_DG14718,BMG_DG183632,"DrugBank ID:DB07616 | PubChem CID:695906 | 4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid"
+BMGC_DG14719,BMG_DG183633,PubChem CID:69591 | 2-PHENYLIMIDAZOLE | UNII:7R2590HM4L | PubChem SID:198954382 | CAS RN:670-96-2
+BMGC_DG14720,BMG_DG183635,"UNII:582ILN204B | DrugBank ID:DB13663 | Clofenamide | 4-chlorobenzene-1,3-disulfonamide | PubChem SID:198934906 | PubChem CID:69594 | CLOFENAMIDE | CAS RN:671-95-4"
+BMGC_DG14721,BMG_DG183642,CAS RN:673-22-3 | PubChem CID:69600 | PubChem SID:198963268 | UNII:2N395P88LW | 4-METHOXYSALICYLALDEHYDE
+BMGC_DG14722,BMG_DG183644,UNII:E65S46EBQ6 | PubChem CID:69602 | ACETYLHISTAMINE | CAS RN:673-49-4 | N-acetylhistamine | PubChem SID:377308979 | DrugBank ID:DB04622
+BMGC_DG14723,BMG_DG183646,PubChem CID:69604735 | PubChem SID:198952456 | CP-601932 | UNII:8EQZ26LUCA | CAS RN:357425-68-4
+BMGC_DG14724,BMG_DG183652,PubChem SID:198984756 | DrugBank ID:DB02749 | UNII:D9UXG2U6ZU | PYROMELLITIC ACID | PubChem CID:6961 | Pyromellitic Acid | CAS RN:89-05-4
+BMGC_DG14725,BMG_DG183691,"(S)-glaucine | (6aS)-1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinolin-6-ium | PubChem CID:6963957"
+BMGC_DG14726,BMG_DG183693,PubChem SID:198949569 | Leucinamide | CAS RN:687-51-4 | PubChem CID:69640 | (2S)-2-amino-4-methylpentanamide | LEUCINAMIDE | UNII:RP28A6538M
+BMGC_DG14727,BMG_DG183729,5-Iodouracil | DrugBank ID:DB03554 | 5-IODOURACIL | UNII:H59BRK500M | PubChem SID:249493222 | PubChem CID:69672 | CAS RN:696-07-1
+BMGC_DG14728,BMG_DG183740,"1-(2,6-dihydroxyphenyl)ethanone | PubChem SID:198987111 | 2',6'-DIHYDROXYACETOPHENONE | PubChem CID:69687 | CAS RN:699-83-2 | UNII:88BO51G3Y2 | 2',6'-Dihydroxyacetophenone"
+BMGC_DG14729,BMG_DG183746,PubChem CID:69696 | 4-BROMOBENZENESULFONAMIDE | 4-Bromobenzenesulfonamide | PubChem SID:485662995 | UNII:JX6HE2F2XX | CAS RN:701-34-8
+BMGC_DG14730,BMG_DG183748,"CAS RN:701-44-0 | PubChem SID:249492176 | PubChem CID:69698 | 1-Methyl-6-oxo-1,6-dihydropyridine-3-carboxamide | 1-methyl-6-oxopyridine-3-carboxamide | NUDIFLORAMIDE | UNII:68139USC7W"
+BMGC_DG14731,BMG_DG183807,PubChem CID:69711 | 5-FLUOROOROTIC ACID | PubChem SID:198987512 | UNII:7IA9OUC93E | CAS RN:703-95-7
+BMGC_DG14732,BMG_DG183816,"(S)-(+)-1-Indanol | PubChem CID:6971242 | CAS RN:25501-32-0 | (1S)-2,3-dihydro-1H-inden-1-ol"
+BMGC_DG14733,BMG_DG183839,"CAS RN:7013-05-0 | PubChem CID:6971281 | .GAMMA.-AMINO-.BETA.-HYDROXYBUTYRIC ACID, (+)- | UNII:CM46XGM78M | PubChem SID:198944530"
+BMGC_DG14734,BMG_DG183854,"CAS RN:369397-92-2 | N2-BENZYL-N4-CYCLOHEXYL-6-METHYLPYRIMIDINE-2,4-DIAMINE | PubChem SID:485663412 | N2-benzyl-N4-cyclohexyl-6-methylpyrimidine-2,4-diamine | UNII:MDB747R6NC | PubChem CID:697226"
+BMGC_DG14735,BMG_DG183855,"PubChem CID:69725 | UNII:8AQ22EXM7G | CAS RN:708-76-9 | PubChem SID:443623938 | 4,6-DIMETHOXYSALICYLALDEHYDE"
+BMGC_DG14736,BMG_DG183856,"CAS RN:708-79-2 | PubChem CID:69726 | UNII:2WS4HQ639J | 1-Methyluric acid | 1-methyl-7,9-dihydro-3H-purine-2,6,8-trione | 1-METHYLURIC ACID | CAS RN:1173022-91-7 | PubChem SID:198960208"
+BMGC_DG14737,BMG_DG183857,UNII:6GAI2MTV5V | PubChem SID:198946709 | CAS RN:89-56-5 | P-CRESOTIC ACID | PubChem CID:6973
+BMGC_DG14738,BMG_DG183866,DrugBank ID:DB03197 | PubChem CID:69736 | 6-Hydroxymethylpterin
+BMGC_DG14739,BMG_DG183900,"UNII:R4V8VYQ7XL | PubChem SID:445499876 | PubChem CID:69765 | 2,6-DI-TERT-BUTYL-4-NITROPHENOL | CAS RN:728-40-5"
+BMGC_DG14740,BMG_DG183905,UNII:J9ZZ3TP9ZJ | 4'-Nitro-p-toluenesulfonanilide | CAS RN:734-25-8 | 4'-NITRO-P-TOLUENESULFONANILIDE | PubChem SID:472414524 | PubChem CID:69772
+BMGC_DG14741,BMG_DG183935,4-Carboxycinnamic Acid | DrugBank ID:DB02126 | PubChem CID:697959
+BMGC_DG14742,BMG_DG183939,"UNII:5RLR54Z22K | 2-MERCAPTOBENZOTHIAZOLE | CAS RN:118090-09-8 | PubChem CID:697993 | DrugBank ID:DB11496 | 3H-1,3-benzothiazole-2-thione | CAS RN:149-30-4 | PubChem SID:175267380 | CAS RN:155-04-4 | 2-Mercaptobenzothiazole"
+BMGC_DG14743,BMG_DG184013,PubChem SID:374388293 | PubChem CID:69873 | CAS RN:771-99-3 | UNII:8V8IM567WT | 4-PHENYLPIPERIDINE
+BMGC_DG14744,BMG_DG184034,CAS RN:89-83-8 | 5-methyl-2-propan-2-ylphenol | PubChem CID:6989 | PubChem SID:175268347 | UNII:3J50XA376E | THYMOL | DrugBank ID:DB02513 | Thymol
+BMGC_DG14745,BMG_DG184042,CAS RN:776-86-3 | 6-hydroxy-7-methoxychromen-2-one | PubChem CID:69894 | Isoscopoletin
+BMGC_DG14746,BMG_DG184048,"PubChem CID:6990 | PubChem SID:198935024 | CAS RN:89-84-9 | RESACETOPHENONE | 1-(2,4-dihydroxyphenyl)ethanone | Resacetophenone | UNII:UC3V356VZC"
+BMGC_DG14747,BMG_DG184105,"PubChem SID:313368789 | EFLORNITHINE, (S)- | UNII:C780YUS9YI | CAS RN:66640-93-5 | PubChem CID:6992039 | L-Eflornithine | DrugBank ID:DB03856"
+BMGC_DG14748,BMG_DG184127,PubChem CID:6992101 | 5-azaniumylpentanoate | 5-Aminopentanoate
+BMGC_DG14749,BMG_DG184138,UNII:637C487Y09 | PubChem SID:198980301 | GOLOTIMOD | Golotimod | CAS RN:229305-39-9 | DrugBank ID:DB05475 | PubChem CID:6992140 | (2R)-2-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid
+BMGC_DG14750,BMG_DG184151,CAS RN:721-90-4 | 2-[[(2S)-2-amino-3-phenylpropanoyl]amino]acetic acid | PubChem CID:6992304 | Phenylalanylglycine
+BMGC_DG14751,BMG_DG184152,UNII:3P49EB3X2W | CAS RN:5156-22-9 | L-Leucyl-L-tryptophan | PubChem SID:474492496 | PubChem CID:6992319 | L-LEUCYL-L-TRYPTOPHAN
+BMGC_DG14752,BMG_DG184153,LYSYLVALINE | CAS RN:20556-11-0 | PubChem CID:6992341 | PubChem SID:198983366 | UNII:ZB4A1U383X
+BMGC_DG14753,BMG_DG184154,(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-phenylpropanoic acid | CAS RN:14492-14-9 | PubChem CID:6992350 | Met-phe
+BMGC_DG14754,BMG_DG184164,CAS RN:791-31-1 | TRIPHENYLSILANOL | PubChem SID:252165555 | UNII:AZC8O4TTX4 | PubChem CID:69925
+BMGC_DG14755,BMG_DG184183,CAS RN:2650-65-9 | PubChem SID:472406493 | UNII:XWG2S6LG7H | PubChem CID:6992691 | N-L-GLUTAMINYLGLYCINE
+BMGC_DG14756,BMG_DG184187,"PubChem CID:6992713 | UNII:2252QEF2PL | CAS RN:23235-03-2 | PubChem SID:198938119 | PROPARGYLGLYCINE, D-"
+BMGC_DG14757,BMG_DG184203,L-METHIONYLGLYCINE | CAS RN:14486-03-4 | PubChem SID:313183692 | UNII:T872MM2E20 | PubChem CID:6992930
+BMGC_DG14758,BMG_DG184212,PubChem CID:6993090 | (2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoic acid | H-Phe-phe-OH | CAS RN:2577-40-4
+BMGC_DG14759,BMG_DG184217,UNII:7RCA4Q6HYZ | CAS RN:1332826-08-0 | PubChem SID:377308623 | PubChem CID:69932178 | IMA-107
+BMGC_DG14760,BMG_DG184271,CAS RN:943-89-5 | CAS RN:830-09-1 | UNII:6G4ML8401A | CAS RN:30-09-1 | trans-4-Methoxycinnamic acid | PubChem SID:198985275 | PubChem CID:699414 | (E)-3-(4-methoxyphenyl)prop-2-enoic acid | 4-METHOXYCINNAMIC ACID
+BMGC_DG14761,BMG_DG184309,PubChem CID:699486 | LEVOGLUCOSENONE | PubChem SID:241181372 | UNII:B7N23SN1LB | CAS RN:37112-31-5
+BMGC_DG14762,BMG_DG184322,(2S)-2-HYDROXYOCTANOIC ACID | PubChem CID:6995013 | DrugBank ID:DB07907
+BMGC_DG14763,BMG_DG184367,HYDROXYPYRIDINONE | PubChem SID:198960028 | PubChem CID:69975 | CAS RN:822-89-9 | UNII:YO3915897S
+BMGC_DG14764,BMG_DG184376,SALICYLALDEHYDE | PubChem SID:198960918 | PubChem CID:6998 | CAS RN:90-02-8 | 2-hydroxybenzaldehyde | CAS RN:27761-48-4 | Salicylaldehyde | UNII:17K64GZH20
+BMGC_DG14765,BMG_DG184379,"ALANYLGLYCINE, L- | PubChem SID:472406714 | CAS RN:687-69-4 | PubChem CID:6998029 | UNII:QXQ6Y9X6ZS"
+BMGC_DG14766,BMG_DG184380,PubChem CID:69982 | (4-FLUOROPHENYL)HYDRAZINE | UNII:H9HH4MGZ2V | (4-Fluorophenyl)hydrazine | PubChem SID:485662661 | CAS RN:371-14-2
+BMGC_DG14767,BMG_DG184450,.ALPHA.-KETOISOCAPROIC ACID | 4-methyl-2-oxopentanoic acid | alpha-Ketoisocaproic acid | 4-Methyl-2-oxopentanoic acid | CAS RN:816-66-0 | PubChem SID:198979362 | UNII:4GUJ8AH400 | PubChem CID:70 | DrugBank ID:DB03229
+BMGC_DG14768,BMG_DG184451,DrugBank ID:DB03994 | 2-aminoethanol | 2-Aminoethanol | PubChem SID:175266121 | CAS RN:141-43-5 | UNII:5KV86114PT | 2-AMINOETHANOL | PubChem CID:700 | CAS RN:12220-07-4 | CAS RN:12220-09-6 | Ethanolamine | Monoethanolamine
+BMGC_DG14769,BMG_DG184483,"PubChem SID:376072986 | 5-PHENYL-1,2-DITHIOL-3-ONE | UNII:IVT9U4E26Z | PubChem CID:70011 | CAS RN:827-42-9"
+BMGC_DG14770,BMG_DG184490,CAS RN:90-12-0 | 1-methylnaphthalene | CAS RN:1321-94-4 | UNII:E7SK1Y1311 | 1-Methylnaphthalene | 1-METHYLNAPHTHALENE | PubChem SID:198940276 | PubChem CID:7002
+BMGC_DG14771,BMG_DG184497,CAS RN:25586-43-0 | CAS RN:90-13-1 | PubChem SID:198938343 | 1-CHLORONAPHTHALENE | 1-Chloronaphthalene | PubChem CID:7003 | UNII:K4OIF2EC56 | 1-chloronaphthalene
+BMGC_DG14772,BMG_DG184524,PubChem SID:198985969 | PubChem CID:7005 | 1-NAPHTHOL | UNII:2A71EAQ389 | naphthalen-1-ol | CAS RN:1321-67-1 | CAS RN:50356-21-3 | CAS RN:90-15-3 | 1-Naphthol
+BMGC_DG14773,BMG_DG184539,"CAS RN:91-48-5 | UNII:0PKH62904B | PubChem SID:198972452 | .ALPHA.-PHENYLCINNAMIC ACID, (E)- | PubChem CID:700620"
+BMGC_DG14774,BMG_DG184584,(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoic acid | Tyrosylphenylalanine | PubChem CID:7009600 | CAS RN:17355-11-2
+BMGC_DG14775,BMG_DG184594,2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]acetic acid | Ser-gly | CAS RN:687-63-8 | PubChem CID:7009644
+BMGC_DG14776,BMG_DG184620,"UNII:H34V7IM5ML | PubChem SID:198949095 | Lysylglutamic acid | CAS RN:45234-02-4 | (2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]pentanedioic acid | PubChem CID:7010502 | LYSYLGLUTAMIC ACID"
+BMGC_DG14777,BMG_DG184650,PubChem CID:70119 | Para-Bromobenzyl Alcohol | DrugBank ID:DB02822
+BMGC_DG14778,BMG_DG184651,2-PHENYLBUTYRIC ACID | 2-phenylbutanoic acid | UNII:S7S079H2C2 | PubChem SID:316910574 | PubChem CID:7012 | 2-Phenylbutyric acid | CAS RN:90-27-7
+BMGC_DG14779,BMG_DG184652,"PubChem SID:474490437 | CAS RN:874-14-6 | 1,3-DIMETHYLURACIL | UNII:BN3V9WZ8FN | 1,3-Dimethyluracil | PubChem CID:70122 | 1,3-dimethylpyrimidine-2,4-dione"
+BMGC_DG14780,BMG_DG184657,UNII:5I112077IN | N-Phenyl-1-naphthylamine | N-PHENYL-1-NAPTHYLAMINE | N-phenylnaphthalen-1-amine | PubChem CID:7013 | CAS RN:90-30-2 | PubChem SID:198983134
+BMGC_DG14781,BMG_DG184660,"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID | DrugBank ID:DB07663 | PubChem CID:7013169"
+BMGC_DG14782,BMG_DG184661,UNII:8K85H86ZED | PubChem SID:440090106 | PubChem CID:70133 | CAS RN:875-59-2 | 4-HYDROXY-2-METHYLACETOPHENONE
+BMGC_DG14783,BMG_DG184703,(2S)-6-amino-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]hexanoic acid | Glu-lys | PubChem CID:7015704 | CAS RN:5891-53-2
+BMGC_DG14784,BMG_DG184725,PubChem CID:70164 | METHYL SYRINGATE | DrugBank ID:DB08589 | PubChem SID:438789014 | CAS RN:884-35-5 | UNII:W5A196MP8A | SYRINGATE
+BMGC_DG14785,BMG_DG184734,PubChem SID:175265789 | 2-phenylphenol | PubChem CID:7017 | CAS RN:90-43-7 | 2-Phenylphenol | UNII:D343Z75HT8 | 2-PHENYLPHENOL | CAS RN:73829-47-7
+BMGC_DG14786,BMG_DG184740,PubChem CID:70177 | 4-amino-3-chloro-N-[2-(diethylamino)ethyl]benzamide | CAS RN:891-60-1 | Declopramide | DECLOPRAMIDE | UNII:916GJF577D | PubChem SID:198968591 | DrugBank ID:DB06421
+BMGC_DG14787,BMG_DG184766,acridin-9-amine | PubChem SID:198946738 | AMINACRINE | CAS RN:110166-26-2 | Aminacrine | PubChem CID:7019 | UNII:78OY3Z0P7Z | DrugBank ID:DB11561 | CAS RN:65944-23-2 | CAS RN:90-45-9
+BMGC_DG14788,BMG_DG184780,PubChem CID:7019085 | UNII:AY4YUP87RZ | CAS RN:13589-06-5 | L-ISOLEUCYL-L-TRYPTOPHAN | PubChem SID:441583235
+BMGC_DG14789,BMG_DG184782,H-Ser-ser-OH | (2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-3-hydroxypropanoic acid | PubChem CID:7019105 | CAS RN:6620-95-7
+BMGC_DG14790,BMG_DG184785,"CAS RN:95342-41-9 | ENZACAMENE | DrugBank ID:DB11219 | PubChem CID:7019255 | UNII:8I3XWY40L9 | ENZACAMENE, (+)- | PubChem SID:175271970 | CAS RN:36861-47-9 | PubChem SID:252823930 | UNII:7576E1028E | Enzacamene"
+BMGC_DG14791,BMG_DG184787,PubChem SID:375085990 | CAS RN:770-39-8 | 1-(4-HYDROXYPHENYL)-2-PROPANONE | PubChem CID:7019274 | UNII:7K79N2OO7F
+BMGC_DG14792,BMG_DG184802,NDC:11673-780 | NDC:54860-423 | NDC:80684-063 | NDC:64942-2033 | NDC:0363-0859 | NDC:74177-006 | NDC:70412-192 | NDC:80684-118 | NDC:75262-011 | NDC:11673-075 | NDC:70445-601 | NDC:77129-000 | NDC:69842-207 | NDC:62670-6565 | NDC:21749-717 | NDC:74934-003 | NDC:71611-095 | NDC:82311-0118 | NDC:68599-1120 | NDC:64987-0322 | NDC:41366-015 | NDC:63148-522 | NDC:75981-370 | NDC:62670-6671 | NDC:71073-302 | NDC:59779-219 | NDC:74934-050 | NDC:77725-003 | NDC:63533-645 | NDC:63148-526 | NDC:47593-638 | NDC:11673-768 | NDC:42681-0041 | NDC:60637-143 | NDC:77939-000 | NDC:67777-320 | NDC:49351-105 | NDC:47593-490 | NDC:62670-6651 | NDC:63148-725 | NDC:62670-6727 | NDC:63354-270 | NDC:62670-6646 | NDC:71734-201 | NDC:77678-003 | NDC:63868-882 | NDC:54622-309 | NDC:76891-135 | NDC:70445-608 | NDC:82825-001 | NDC:62670-6636 | NDC:62670-6668 | ethanol | NDC:74934-052 | NDC:39892-0412 | NDC:82140-432 | NDC:76309-451 | NDC:50814-050 | NDC:41167-0751 | NDC:63533-221 | NDC:35418-402 | NDC:60742-011 | NDC:74177-010 | NDC:81793-187 | NDC:82442-002 | NDC:84219-003 | NDC:74177-024 | NDC:76924-000 | NDC:67091-107 | NDC:75990-783 | NDC:11673-862 | NDC:62670-6778 | NDC:54748-403 | NDC:62169-203 | NDC:74139-444 | NDC:78304-005 | NDC:62670-6662 | NDC:60637-191 | NDC:11673-076 | NDC:63148-530 | NDC:71270-203 | NDC:83021-402 | NDC:81319-112 | NDC:62670-6755 | NDC:80139-182 | NDC:64536-8068 | NDC:80684-080 | NDC:41366-052 | NDC:74246-103 | NDC:62654-139 | NDC:64536-1726 | NDC:0363-0046 | NDC:62670-6789 | NDC:52854-600 | NDC:74246-102 | NDC:78016-102 | NDC:76309-301 | NDC:47593-498 | NDC:62670-6761 | NDC:80684-005 | NDC:11383-309 | NDC:79903-283 | NDC:82355-020 | NDC:80684-004 | NDC:62670-6552 | NDC:56062-370 | NDC:76402-422 | NDC:74934-054 | NDC:62670-6762 | NDC:77462-010 | NDC:62670-6752 | NDC:65585-374 | NDC:62832-370 | NDC:79396-000 | NDC:47593-480 | NDC:41366-055 | NDC:15751-3050 | NDC:69366-310 | NDC:80684-081 | NDC:67751-200 | NDC:74047-001 | NDC:74177-034 | NDC:81670-000 | NDC:71270-201 | NDC:62670-6748 | NDC:51531-8735 | NDC:41163-870 | NDC:72288-826 | NDC:11673-860 | NDC:73881-338 | NDC:62670-6654 | NDC:62670-6699 | NDC:63148-524 | NDC:71160-110 | NDC:67326-006 | NDC:75214-504 | NDC:75990-605 | NDC:80335-103 | NDC:63533-693 | NDC:37808-907 | NDC:50536-077 | NDC:72033-142 | NDC:80684-104 | NDC:0924-0450 | NDC:11291-070 | NDC:83986-456 | NDC:75742-029 | NDC:70006-500 | NDC:62670-6684 | NDC:62670-6733 | NDC:62670-6754 | NDC:76906-007 | NDC:62670-6585 | NDC:81428-072 | NDC:11084-034 | NDC:84732-071 | NDC:70677-0056 | NDC:53125-801 | NDC:62670-6797 | NDC:47593-473 | NDC:54748-304 | NDC:75248-000 | NDC:53943-022 | NDC:62670-6785 | NDC:79468-001 | NDC:10819-3916 | NDC:72487-013 | NDC:11084-006 | NDC:63710-003 | NDC:64942-1745 | NDC:80684-034 | NDC:83986-652 | NDC:62670-6618 | NDC:52915-074 | NDC:73453-143 | NDC:62670-6729 | NDC:49351-301 | NDC:82645-911 | NDC:60637-121 | NDC:68599-5322 | NDC:80335-114 | NDC:21749-029 | NDC:73796-112 | NDC:83021-740 | NDC:70335-010 | NDC:62670-6598 | NDC:76370-0004 | NDC:76806-018 | NDC:55301-876 | NDC:80954-000 | NDC:62670-6568 | NDC:54860-428 | NDC:17518-051 | NDC:56136-022 | PubChem SID:175266802 | NDC:57337-017 | NDC:60637-219 | NDC:76378-011 | NDC:74177-036 | NDC:65626-206 | NDC:76906-001 | NDC:83986-028 | NDC:60637-230 | NDC:62670-6664 | NDC:71611-096 | NDC:30142-956 | NDC:55319-777 | NDC:56136-730 | NDC:75742-028 | NDC:62670-6555 | NDC:82311-0102 | NDC:57362-465 | NDC:30142-000 | NDC:78828-222 | NDC:62670-6792 | NDC:69771-007 | NDC:71270-202 | NDC:62670-6772 | NDC:80684-000 | NDC:71734-206 | NDC:62670-6718 | NDC:65692-2055 | NDC:71763-201 | NDC:80711-002 | NDC:50021-020 | NDC:79481-0826 | NDC:54748-101 | NDC:54748-501 | NDC:62670-6623 | NDC:69790-801 | NDC:62670-6675 | NDC:65517-1020 | NDC:61649-513 | NDC:70412-134 | NDC:65585-375 | NDC:63868-330 | NDC:80335-109 | NDC:62670-6629 | NDC:75262-002 | NDC:62670-6721 | NDC:72033-104 | NDC:70793-008 | NDC:62011-0116 | NDC:80684-095 | NDC:59900-121 | NDC:62712-783 | NDC:11673-864 | NDC:23667-104 | NDC:37662-0688 | NDC:80237-001 | NDC:73928-006 | NDC:42681-6809 | NDC:47593-489 | NDC:68196-602 | NDC:72033-106 | NDC:80714-034 | NDC:67751-071 | NDC:51628-4441 | NDC:56194-107 | NDC:75742-027 | NDC:59860-002 | NDC:70335-306 | NDC:84853-0001 | Ethanol | NDC:15127-009 | NDC:73369-0010 | NDC:63148-100 | NDC:54748-702 | NDC:67858-693 | NDC:79747-008 | NDC:60637-144 | NDC:50814-051 | NDC:82953-007 | NDC:62670-6634 | NDC:70108-101 | NDC:51326-900 | NDC:21749-854 | NDC:62670-6673 | NDC:82127-000 | NDC:80684-100 | NDC:49035-418 | NDC:77556-580 | NDC:83019-102 | NDC:62670-6672 | NDC:71611-091 | NDC:72033-114 | NDC:11673-782 | NDC:61649-813 | NDC:74934-091 | NDC:81079-002 | NDC:64233-221 | NDC:62670-6720 | NDC:77573-005 | NDC:80661-002 | NDC:73978-003 | NDC:67751-188 | NDC:43473-011 | NDC:56136-444 | NDC:72866-005 | NDC:73796-114 | NDC:81670-003 | NDC:62670-6562 | NDC:64987-6323 | NDC:54748-305 | NDC:65692-2079 | NDC:72288-849 | NDC:57337-044 | NDC:65585-379 | NDC:62670-6621 | NDC:83779-002 | NDC:41190-370 | NDC:80237-003 | NDC:54748-701 | NDC:54622-121 | NDC:53125-803 | NDC:37808-307 | NDC:55814-101 | NDC:60913-415 | NDC:63941-439 | NDC:62670-6747 | NDC:68400-498 | NDC:81551-802 | NDC:50241-223 | NDC:42961-123 | NDC:62670-6726 | NDC:78641-001 | NDC:71896-701 | NDC:82061-006 | NDC:54860-429 | NDC:69842-760 | NDC:65692-2083 | NDC:81755-003 | NDC:76906-006 | NDC:70412-131 | NDC:76557-000 | NDC:75786-336 | NDC:21749-027 | NDC:62670-6650 | NDC:83318-605 | NDC:80684-113 | NDC:34645-0003 | NDC:65692-2075 | NDC:62670-6576 | NDC:54622-701 | NDC:65692-1003 | NDC:62670-6724 | NDC:24385-213 | NDC:63148-726 | NDC:67326-005 | NDC:81339-101 | NDC:39892-0401 | NDC:49035-343 | NDC:11084-813 | NDC:71788-011 | NDC:69771-001 | NDC:62670-6719 | NDC:62257-007 | NDC:60637-123 | NDC:50980-056 | NDC:10819-3918 | NDC:54622-311 | NDC:54860-430 | NDC:79016-102 | NDC:21749-806 | NDC:80684-062 | NDC:63868-331 | NDC:58228-2362 | NDC:79091-014 | NDC:43473-051 | NDC:61649-713 | NDC:63998-364 | NDC:66715-7012 | NDC:43742-2191 | NDC:70741-003 | NDC:11429-1004 | NDC:21749-127 | NDC:79985-200 | NDC:49035-417 | NDC:74177-005 | NDC:72866-007 | NDC:72033-120 | NDC:80684-006 | NDC:55550-611 | NDC:24385-034 | NDC:74934-029 | NDC:21749-706 | NDC:72033-217 | NDC:82488-693 | NDC:60637-140 | NDC:36800-960 | NDC:72288-876 | NDC:51628-4436 | NDC:47993-364 | NDC:82953-021 | NDC:0363-0370 | NDC:52489-001 | NDC:77725-004 | NDC:83038-693 | NDC:83021-501 | NDC:83986-899 | NDC:50814-080 | NDC:81385-002 | NDC:80684-064 | NDC:57915-020 | NDC:65692-2081 | NDC:76891-140 | NDC:11701-025 | NDC:81404-002 | NDC:49348-133 | NDC:10819-3917 | NDC:70108-085 | NDC:77446-000 | NDC:64942-1830 | NDC:62670-6588 | NDC:74979-001 | NDC:54748-504 | NDC:62670-6655 | NDC:0404-0122 | NDC:84219-005 | NDC:64646-380 | NDC:74934-088 | NDC:72036-370 | NDC:80948-013 | NDC:70335-011 | NDC:82645-926 | NDC:53329-998 | NDC:11673-863 | NDC:77371-124 | NDC:84853-0002 | NDC:62670-6732 | NDC:69335-002 | NDC:77573-001 | NDC:72793-300 | NDC:62670-6639 | NDC:62257-122 | NDC:65585-580 | NDC:74641-000 | NDC:50865-688 | NDC:42681-0009 | NDC:82127-007 | NDC:57337-012 | NDC:55550-201 | NDC:60637-231 | NDC:73769-054 | NDC:62670-6777 | NDC:81438-693 | NDC:73833-004 | NDC:68400-487 | NDC:49035-720 | NDC:55550-271 | NDC:0519-6257 | NDC:67777-010 | NDC:73928-007 | NDC:0395-1213 | NDC:67777-340 | NDC:81428-074 | NDC:21749-702 | NDC:47993-365 | NDC:79091-006 | NDC:53329-840 | NDC:81630-003 | NDC:53943-439 | NDC:50254-693 | NDC:62670-6592 | NDC:71584-0109 | NDC:50021-009 | NDC:54748-303 | NDC:62011-0353 | NDC:72033-140 | NDC:57915-009 | NDC:74934-002 | NDC:68599-5202 | NDC:80684-105 | NDC:62670-6679 | NDC:56194-503 | NDC:80684-096 | NDC:81761-112 | NDC:67777-330 | NDC:74177-025 | NDC:52915-066 | NDC:75262-013 | NDC:65753-201 | NDC:72288-196 | NDC:53329-003 | NDC:54288-105 | NDC:78016-103 | NDC:70412-112 | NDC:62670-6606 | NDC:78740-004 | NDC:70983-025 | NDC:75990-968 | NDC:47593-612 | NDC:62670-6577 | NDC:62670-6617 | NDC:80684-035 | NDC:60637-122 | NDC:72866-006 | NDC:42681-0042 | NDC:79316-057 | NDC:41366-019 | NDC:62670-6644 | NDC:62670-6550 | NDC:23667-103 | NDC:72033-107 | NDC:50814-063 | NDC:73928-004 | NDC:62670-6791 | NDC:80948-001 | NDC:52667-011 | NDC:51811-400 | NDC:60637-120 | NDC:72866-010 | NDC:77678-004 | NDC:80016-003 | NDC:47593-487 | NDC:39892-0400 | NDC:54622-120 | NDC:67326-400 | NDC:64942-1839 | NDC:62670-6735 | NDC:70204-100 | NDC:74047-005 | NDC:71101-051 | NDC:81628-693 | NDC:71087-001 | NDC:77665-104 | NDC:11084-803 | NDC:59985-113 | NDC:57362-469 | NDC:77462-011 | NDC:63941-008 | NDC:80588-021 | NDC:78016-105 | NDC:80328-409 | NDC:83021-617 | NDC:81792-003 | NDC:62257-658 | NDC:60637-142 | NDC:65692-2062 | NDC:75115-467 | NDC:80684-106 | NDC:70108-098 | NDC:68776-1001 | NDC:0363-0876 | NDC:65692-1002 | NDC:62670-6567 | NDC:73796-111 | NDC:62670-6696 | NDC:79401-000 | NDC:59900-123 | NDC:66949-137 | NDC:36800-370 | NDC:62670-6734 | NDC:43473-056 | NDC:72976-016 | NDC:66353-117 | NDC:62670-6753 | NDC:63148-160 | NDC:62670-6751 | NDC:59900-351 | NDC:50536-103 | NDC:80684-112 | NDC:55319-116 | NDC:77446-001 | NDC:62670-6660 | NDC:80016-001 | NDC:71212-100 | NDC:62670-6637 | NDC:11673-865 | NDC:72866-014 | NDC:21749-713 | NDC:62670-6631 | NDC:51042-002 | NDC:65692-2060 | NDC:11673-607 | NDC:69771-005 | NDC:63146-112 | NDC:84853-0004 | NDC:80684-036 | NDC:83165-003 | NDC:72033-216 | NDC:41366-050 | NDC:70170-0020 | NDC:82131-252 | NDC:42961-017 | NDC:64646-043 | NDC:56136-447 | NDC:64942-1837 | NDC:64942-2041 | NDC:74934-025 | NDC:62670-6615 | NDC:83165-000 | NDC:66949-119 | NDC:64942-2036 | NDC:30142-185 | NDC:74177-033 | NDC:54860-404 | NDC:80237-002 | NDC:62670-6784 | NDC:81471-693 | NDC:43493-0000 | NDC:70412-132 | NDC:57915-021 | NDC:60637-195 | NDC:81670-002 | NDC:64942-2034 | NDC:11084-303 | NDC:62670-6730 | NDC:65616-011 | NDC:51316-849 | NDC:37662-0689 | NDC:63148-540 | NDC:81442-693 | NDC:50332-0040 | NDC:80335-117 | NDC:72866-008 | NDC:21749-875 | NDC:82127-008 | NDC:69366-317 | NDC:59503-2605 | NDC:62670-6587 | NDC:57337-058 | NDC:62670-6697 | NDC:21749-802 | NDC:54340-136 | NDC:15127-007 | NDC:49035-690 | NDC:59900-125 | NDC:72172-001 | NDC:80228-2001 | NDC:50814-040 | NDC:62670-6570 | NDC:57337-148 | NDC:69139-201 | NDC:82442-003 | NDC:61010-4111 | NDC:69366-316 | NDC:75376-004 | NDC:68400-486 | NDC:74934-056 | NDC:68599-5207 | NDC:30805-013 | NDC:58228-8691 | NDC:46122-329 | NDC:80684-125 | NDC:72119-002 | NDC:83986-370 | NDC:80335-112 | NDC:11673-869 | NDC:63940-439 | NDC:80524-000 | NDC:71788-013 | NDC:84456-746 | NDC:65692-2078 | NDC:54622-015 | NDC:73898-003 | NDC:60637-228 | NDC:76315-2020 | NDC:62654-140 | NDC:51628-4437 | NDC:64646-420 | NDC:64942-1829 | NDC:41366-053 | NDC:77008-3194 | NDC:62670-6578 | NDC:62670-6758 | NDC:59051-7100 | NDC:62670-6746 | NDC:21749-367 | NDC:52915-076 | NDC:71611-093 | NDC:47593-502 | NDC:76370-0010 | NDC:21749-908 | NDC:67623-002 | NDC:66949-906 | NDC:74177-031 | NDC:43473-057 | NDC:62670-6783 | NDC:55758-374 | NDC:60913-416 | NDC:50814-065 | NDC:76891-142 | NDC:76892-001 | NDC:62670-6736 | NDC:58593-780 | NDC:73978-001 | NDC:11673-079 | NDC:41190-849 | NDC:57337-014 | NDC:67777-308 | NDC:21749-022 | NDC:72036-439 | NDC:74934-055 | NDC:59900-126 | NDC:53942-370 | NDC:21749-716 | NDC:76635-003 | NDC:57243-370 | NDC:54748-602 | NDC:30805-001 | NDC:81286-102 | NDC:41366-016 | NDC:75376-000 | NDC:62670-6622 | NDC:57337-059 | NDC:73796-119 | NDC:62670-6548 | NDC:63900-002 | NDC:34645-0004 | NDC:62670-6760 | NDC:57362-466 | NDC:57362-523 | NDC:77595-004 | NDC:67751-086 | NDC:75214-503 | NDC:50536-203 | NDC:55118-704 | NDC:60637-194 | NDC:65692-2074 | NDC:75742-026 | NDC:65585-525 | NDC:70677-1202 | NDC:54748-601 | NDC:62670-6596 | NDC:55415-002 | NDC:62670-6630 | NDC:68196-370 | NDC:77133-001 | NDC:81385-000 | NDC:78434-110 | NDC:54622-122 | NDC:81404-001 | NDC:62670-6669 | NDC:64942-2035 | NDC:80684-031 | NDC:70445-609 | NDC:72852-585 | NDC:62670-6683 | NDC:66715-6400 | NDC:62670-6602 | NDC:54748-505 | NDC:49348-477 | NDC:79444-005 | NDC:69366-312 | NDC:62670-6695 | NDC:80661-001 | NDC:79446-028 | NDC:11084-035 | NDC:73928-001 | NDC:81417-008 | NDC:48324-693 | NDC:82127-001 | NDC:54622-486 | NDC:62670-6659 | NDC:53329-202 | NDC:42681-0010 | NDC:72866-003 | NDC:11673-439 | NDC:37808-826 | NDC:65616-008 | NDC:64942-1844 | NDC:61649-893 | NDC:60637-193 | NDC:64942-1842 | NDC:70793-011 | NDC:73881-337 | NDC:62670-6657 | NDC:62670-6702 | NDC:64987-6322 | NDC:66902-443 | NDC:77707-006 | NDC:74177-007 | NDC:80335-116 | NDC:78016-107 | NDC:80684-003 | NDC:74545-002 | NDC:54748-301 | NDC:80684-115 | NDC:60637-301 | NDC:62670-6717 | NDC:63146-318 | NDC:61139-701 | NDC:66975-101 | NDC:76402-402 | NDC:71611-092 | NDC:73145-007 | NDC:11673-078 | NDC:30142-834 | NDC:73145-004 | NDC:70412-119 | NDC:74810-725 | NDC:11673-826 | NDC:72922-011 | NDC:64709-177 | NDC:72033-105 | NDC:42681-6808 | NDC:21749-718 | NDC:21749-128 | NDC:77573-003 | NDC:62670-6725 | NDC:72663-111 | NDC:58345-103 | NDC:65585-372 | NDC:64942-1832 | NDC:83584-225 | NDC:82953-012 | NDC:47593-472 | NDC:73943-945 | NDC:49035-420 | NDC:60637-227 | NDC:62670-6600 | NDC:66902-549 | NDC:53329-121 | NDC:54748-103 | NDC:63146-310 | NDC:62670-6564 | NDC:74553-000 | NDC:74934-041 | NDC:73088-205 | NDC:56136-021 | NDC:62670-6716 | NDC:66715-6300 | NDC:81670-001 | NDC:61010-7111 | NDC:72866-009 | NDC:21130-439 | NDC:54860-399 | NDC:50241-465 | NDC:71160-188 | NDC:72496-2469 | NDC:72033-113 | NDC:70445-602 | NDC:21749-827 | NDC:62670-6601 | NDC:73796-110 | NDC:70741-007 | NDC:82041-693 | NDC:41366-017 | NDC:71160-189 | NDC:82953-001 | NDC:79524-000 | NDC:80684-082 | NDC:63148-403 | NDC:71441-180 | NDC:55346-3302 | NDC:77133-002 | NDC:63146-303 | NDC:43742-2066 | NDC:62670-6767 | NDC:83165-001 | NDC:70170-0021 | NDC:68814-010 | NDC:37662-0691 | NDC:70793-012 | NDC:79396-001 | NDC:82355-021 | NDC:80773-001 | NDC:76585-009 | NDC:64536-7295 | NDC:73898-007 | NDC:81339-100 | NDC:55550-106 | NDC:80588-012 | NDC:54748-506 | NDC:74177-022 | NDC:66949-118 | NDC:80236-001 | NDC:72033-109 | NDC:36800-849 | NDC:42681-0035 | NDC:73928-002 | NDC:71788-014 | NDC:75376-006 | NDC:60933-220 | NDC:76370-0005 | NDC:83807-001 | NDC:62670-6793 | NDC:51811-300 | NDC:54622-308 | NDC:76138-114 | NDC:76402-410 | NDC:62670-6766 | NDC:73369-0009 | NDC:62670-6566 | NDC:62670-6571 | NDC:11084-802 | NDC:34645-0007 | NDC:62670-6742 | NDC:79091-010 | NDC:31507-024 | NDC:78405-001 | NDC:72033-102 | NDC:62670-6665 | NDC:47993-363 | NDC:74934-035 | NDC:62670-6642 | NDC:69884-700 | NDC:72197-011 | NDC:72449-100 | NDC:69842-213 | NDC:80684-091 | NDC:41163-439 | NDC:81792-001 | NDC:77661-001 | NDC:62670-6647 | NDC:62670-6563 | NDC:74810-726 | NDC:62670-6614 | NDC:77008-0870 | NDC:62670-6579 | NDC:81379-001 | NDC:37808-334 | NDC:41250-370 | NDC:70793-009 | NDC:74934-087 | NDC:64009-660 | NDC:80684-102 | NDC:72033-103 | NDC:62670-6769 | NDC:70412-191 | NDC:53942-439 | NDC:62670-6627 | NDC:81551-693 | NDC:59900-350 | NDC:62670-6641 | NDC:47593-466 | NDC:83584-024 | NDC:54340-130 | NDC:81751-001 | NDC:50536-101 | NDC:64942-1838 | NDC:76891-136 | NDC:53329-203 | NDC:62670-6616 | NDC:70445-607 | NDC:63742-040 | NDC:62670-6670 | NDC:64536-6618 | NDC:62670-6677 | NDC:79401-001 | NDC:63148-632 | NDC:49035-694 | NDC:55319-117 | NDC:80016-005 | NDC:24286-1529 | NDC:80684-099 | NDC:73928-003 | NDC:41366-018 | NDC:56131-800 | NDC:80689-000 | NDC:83029-201 | NDC:84559-001 | NDC:63148-626 | NDC:74177-021 | NDC:59900-352 | NDC:61649-390 | NDC:71087-004 | NDC:72496-2471 | NDC:68599-5205 | NDC:74177-023 | NDC:76891-141 | NDC:68306-106 | NDC:65692-2054 | DrugBank ID:DB00898 | NDC:11673-606 | NDC:76138-113 | NDC:73466-0006 | NDC:64024-849 | NDC:44224-3621 | NDC:62670-6744 | NDC:70412-114 | NDC:70445-603 | NDC:67326-010 | NDC:54748-502 | NDC:81633-001 | NDC:54748-604 | NDC:30805-012 | NDC:62670-6599 | NDC:73898-006 | NDC:55814-102 | NDC:42681-6893 | NDC:72202-026 | NDC:71763-101 | NDC:37000-603 | NDC:66902-943 | NDC:77371-023 | NDC:82355-012 | NDC:62670-6680 | NDC:62670-6557 | NDC:83986-439 | NDC:68306-116 | NDC:80953-894 | NDC:74934-080 | NDC:76370-0003 | NDC:82127-002 | NDC:62670-6572 | NDC:74047-010 | NDC:62670-6776 | NDC:62936-0370 | NDC:62670-6547 | NDC:71489-007 | NDC:82127-003 | NDC:54340-171 | NDC:21749-826 | NDC:11928-004 | NDC:64942-2032 | NDC:11673-867 | NDC:47682-350 | NDC:77955-003 | NDC:82311-0101 | NDC:21749-906 | NDC:63710-005 | NDC:50814-078 | NDC:60637-232 | NDC:62670-6560 | NDC:42681-0003 | NDC:69674-100 | NDC:70000-0020 | NDC:79258-802 | NDC:63148-402 | NDC:70412-133 | NDC:41190-439 | NDC:62670-6693 | NDC:76567-0215 | NDC:79903-144 | NDC:76309-351 | NDC:83986-100 | NDC:62670-6722 | NDC:83130-101 | NDC:64942-1827 | NDC:65601-801 | NDC:21749-992 | NDC:64942-1840 | NDC:72033-108 | NDC:62670-6604 | NDC:77462-012 | NDC:70108-096 | NDC:79091-007 | NDC:11673-784 | NDC:71897-456 | NDC:64709-256 | NDC:0404-5988 | NDC:62670-6756 | NDC:84973-0075 | NDC:21749-801 | NDC:74640-010 | NDC:80684-083 | NDC:62670-6546 | NDC:71338-124 | NDC:64942-1996 | NDC:52862-612 | NDC:79913-101 | NDC:17518-050 | NDC:60637-240 | NDC:47593-491 | NDC:79091-015 | NDC:83638-001 | NDC:65585-498 | NDC:62670-6574 | NDC:74934-044 | NDC:82771-950 | NDC:61333-213 | NDC:54748-302 | NDC:63710-002 | NDC:76585-006 | NDC:78156-007 | NDC:43473-052 | NDC:69662-111 | NDC:80045-313 | NDC:72866-002 | NDC:69204-025 | NDC:83986-199 | NDC:43473-041 | NDC:63146-309 | NDC:63146-312 | NDC:62670-6794 | NDC:80614-005 | NDC:56136-445 | NDC:71513-105 | NDC:62670-6740 | NDC:62670-6645 | NDC:57337-140 | NDC:59898-420 | NDC:72476-370 | NDC:61010-2017 | NDC:47682-511 | NDC:66077-693 | NDC:78713-000 | NDC:42681-7162 | NDC:50021-014 | NDC:62670-6643 | NDC:62670-6694 | NDC:74934-009 | NDC:70412-135 | NDC:42681-0002 | NDC:80016-004 | NDC:62670-6681 | NDC:0924-0255 | NDC:70108-086 | NDC:74934-049 | NDC:77243-103 | NDC:62670-6796 | NDC:80586-801 | NDC:75541-015 | NDC:57337-147 | NDC:80684-032 | NDC:75262-008 | NDC:41163-975 | NDC:74757-002 | NDC:71087-003 | NDC:74979-002 | NDC:79913-201 | NDC:77573-006 | NDC:64942-1833 | NDC:66902-548 | NDC:77693-010 | NDC:41366-054 | NDC:59448-004 | NDC:74934-001 | NDC:11084-026 | NDC:54748-401 | NDC:56136-443 | NDC:62670-6626 | NDC:73418-200 | NDC:62670-6780 | NDC:47593-508 | NDC:50241-326 | NDC:54622-708 | NDC:62670-6701 | NDC:21749-625 | NDC:74712-000 | NDC:10565-075 | NDC:69790-770 | NDC:76585-002 | NDC:74548-016 | NDC:62670-6551 | NDC:63148-502 | NDC:53329-009 | NDC:63148-727 | NDC:65616-009 | NDC:65585-522 | NDC:55118-546 | NDC:65585-378 | NDC:64307-001 | NDC:65353-8442 | NDC:57915-005 | NDC:76138-120 | NDC:51628-4435 | NDC:67091-439 | NDC:82539-211 | NDC:37662-0690 | NDC:74876-656 | NDC:78229-005 | NDC:50862-1310 | NDC:64987-0323 | NDC:50814-060 | NDC:71875-800 | NDC:63146-311 | NDC:70108-097 | NDC:75262-201 | NDC:75214-502 | NDC:66902-547 | NDC:83046-101 | NDC:0395-0040 | NDC:62670-6624 | NDC:69886-111 | NDC:47593-637 | NDC:71513-309 | NDC:74177-035 | NDC:74934-033 | NDC:50865-710 | NDC:72033-112 | NDC:73145-012 | NDC:68599-5808 | NDC:79481-0080 | NDC:11084-704 | NDC:47593-406 | NDC:70445-600 | NDC:0404-5991 | NDC:54860-422 | NDC:49035-696 | NDC:62670-6581 | NDC:62672-608 | NDC:77573-002 | NDC:61010-5111 | NDC:72033-408 | NDC:71734-348 | NDC:62670-6619 | NDC:21749-751 | NDC:65692-2076 | NDC:50814-008 | NDC:71734-204 | NDC:11429-1003 | NDC:79401-002 | NDC:83986-996 | NDC:82355-022 | NDC:54860-425 | NDC:64942-1834 | NDC:62670-6666 | NDC:11383-308 | NDC:49514-472 | NDC:65517-1023 | NDC:76891-139 | NDC:62670-6635 | NDC:50021-008 | NDC:21749-700 | NDC:70393-415 | NDC:10056-532 | NDC:10565-072 | NDC:62670-6605 | NDC:71611-094 | NDC:65692-2077 | NDC:83021-300 | NDC:62670-6798 | NDC:80684-001 | NDC:52305-225 | NDC:49348-711 | NDC:52915-075 | NDC:62670-6663 | NDC:74934-034 | NDC:81428-070 | NDC:65692-2061 | NDC:82716-000 | NDC:76370-0008 | NDC:77975-015 | NDC:62670-6700 | NDC:50522-221 | NDC:77720-033 | NDC:21749-811 | NDC:62440-370 | NDC:80335-105 | NDC:71489-009 | NDC:62670-6628 | NDC:42961-600 | NDC:72866-004 | NDC:80588-022 | NDC:64646-082 | NDC:62670-6582 | NDC:68306-109 | NDC:84853-0003 | NDC:63148-114 | NDC:78768-003 | NDC:62670-6795 | NDC:72033-100 | NDC:47593-500 | NDC:66949-133 | NDC:83986-529 | NDC:11673-783 | NDC:63998-693 | NDC:59448-001 | NDC:51628-4438 | NDC:65585-358 | NDC:81385-003 | NDC:47593-636 | NDC:73898-001 | NDC:59958-500 | NDC:80684-119 | NDC:14051-221 | NDC:75742-031 | NDC:62670-6790 | NDC:21749-530 | NDC:75262-006 | NDC:49035-322 | NDC:67224-693 | NDC:80016-002 | NDC:62670-6799 | NDC:72866-001 | NDC:83814-005 | NDC:84456-493 | NDC:62670-6658 | NDC:64942-1835 | NDC:77129-001 | NDC:62670-6625 | NDC:65133-110 | NDC:62428-701 | NDC:63710-004 | NDC:55715-004 | NDC:65626-470 | NDC:53329-209 | NDC:51811-100 | NDC:75712-849 | NDC:82996-005 | NDC:73769-050 | NDC:61369-401 | NDC:54748-203 | NDC:79035-002 | NDC:83986-721 | NDC:72476-439 | NDC:54748-703 | NDC:74979-003 | NDC:80684-123 | NDC:50536-039 | NDC:11673-868 | NDC:74934-019 | NDC:75742-036 | CAS RN:42845-45-4 | NDC:69366-311 | NDC:78768-002 | NDC:66715-5756 | NDC:80588-010 | NDC:21749-905 | NDC:62257-606 | NDC:75742-032 | NDC:81524-111 | NDC:49543-783 | NDC:70000-0399 | NDC:59779-070 | NDC:81755-002 | NDC:50536-078 | NDC:57337-146 | NDC:56136-023 | NDC:62670-6723 | NDC:70000-0579 | NDC:53950-6010 | NDC:83021-401 | NDC:65692-2056 | NDC:11673-870 | NDC:63621-356 | NDC:11822-0023 | NDC:69221-501 | NDC:80588-020 | NDC:81079-003 | NDC:65321-024 | NDC:58228-0691 | NDC:62670-6739 | NDC:78768-001 | NDC:54748-102 | NDC:62670-6771 | NDC:73833-000 | NDC:68016-370 | NDC:62670-6589 | NDC:59450-471 | NDC:51801-366 | NDC:82901-002 | NDC:82953-015 | NDC:80684-092 | NDC:65585-524 | NDC:62670-6715 | NDC:76138-116 | NDC:21749-364 | NDC:62670-6667 | NDC:79631-000 | NDC:36800-898 | NDC:78768-004 | NDC:62654-143 | NDC:70108-084 | NDC:80684-117 | NDC:73145-010 | NDC:85062-001 | NDC:70797-160 | NDC:76370-0022 | NDC:11673-605 | NDC:73833-001 | NDC:70445-605 | NDC:64233-693 | NDC:80684-116 | NDC:62670-6620 | NDC:51628-4434 | NDC:62670-6661 | NDC:65133-120 | NDC:71564-008 | NDC:73408-512 | NDC:0363-5721 | NDC:30142-842 | NDC:53329-133 | NDC:82645-909 | NDC:10565-076 | NDC:73145-003 | NDC:62670-6698 | NDC:42681-6894 | NDC:62670-6757 | NDC:76585-001 | NDC:59088-299 | NDC:70079-101 | NDC:62670-6549 | NDC:62654-151 | NDC:71788-015 | NDC:68599-5201 | NDC:81761-111 | NDC:72033-144 | NDC:62670-6569 | NDC:10819-3914 | NDC:71569-370 | NDC:80434-280 | NDC:69366-313 | NDC:47593-509 | NDC:80684-124 | NDC:60637-229 | NDC:75765-040 | NDC:73386-147 | NDC:72866-012 | NDC:61010-1111 | NDC:79016-101 | NDC:53863-002 | NDC:25113-444 | NDC:79740-005 | NDC:30805-014 | NDC:62670-6763 | NDC:11673-074 | NDC:80684-114 | NDC:21749-807 | NDC:62670-6775 | NDC:72866-016 | NDC:65585-489 | NDC:42681-6810 | NDC:65692-2058 | NDC:43116-035 | NDC:0363-0898 | NDC:36800-207 | NDC:82953-022 | NDC:76138-112 | NDC:11822-3700 | NDC:70741-012 | PubChem CID:702 | NDC:72197-032 | NDC:37662-0692 | NDC:83986-969 | NDC:74213-381 | NDC:62670-6682 | NDC:62670-6653 | NDC:15127-008 | NDC:72976-007 | NDC:11673-781 | NDC:65321-011 | NDC:83986-826 | NDC:50804-876 | NDC:59088-413 | NDC:81385-001 | NDC:80684-061 | NDC:50814-041 | NDC:62670-6765 | NDC:70412-190 | NDC:80335-118 | NDC:75376-002 | NDC:56136-446 | NDC:11928-005 | NDC:53329-214 | NDC:55319-118 | NDC:64121-693 | NDC:62670-6656 | NDC:79052-023 | NDC:77955-002 | NDC:42681-0033 | NDC:0395-1207 | NDC:82127-006 | NDC:65585-380 | NDC:21749-363 | NDC:73928-005 | NDC:42681-0007 | NDC:80684-033 | NDC:70412-110 | NDC:71630-383 | NDC:63146-314 | NDC:79481-0849 | NDC:75742-034 | NDC:75742-035 | NDC:76891-138 | NDC:83259-693 | NDC:82996-003 | NDC:79671-797 | NDC:65321-036 | NDC:62670-6764 | NDC:82355-011 | NDC:81630-001 | NDC:83986-849 | NDC:11344-849 | NDC:65321-041 | NDC:76138-117 | NDC:63354-099 | NDC:62670-6782 | NDC:55118-530 | NDC:62670-6590 | NDC:43742-1177 | NDC:80773-003 | UNII:3K9958V90M | NDC:62670-6575 | NDC:70412-111 | NDC:62670-6648 | NDC:62670-6788 | NDC:65585-359 | NDC:70445-604 | NDC:72033-111 | NDC:69790-456 | NDC:83986-815 | NDC:55118-531 | NDC:68599-5803 | NDC:51824-110 | NDC:71630-098 | NDC:81434-693 | NDC:62670-6703 | NDC:31507-585 | NDC:62670-6674 | NDC:11344-876 | NDC:57337-015 | NDC:80684-002 | NDC:10819-6008 | NDC:62670-6573 | NDC:50814-004 | NDC:63146-301 | NDC:54860-427 | NDC:69842-557 | NDC:77971-016 | NDC:71160-180 | NDC:51824-020 | NDC:41163-876 | NDC:63148-660 | NDC:55910-889 | NDC:60913-026 | NDC:53943-207 | NDC:64942-1841 | NDC:44911-0182 | NDC:65616-007 | NDC:61924-106 | NDC:60637-300 | NDC:68642-693 | NDC:65585-376 | NDC:62670-6770 | NDC:62440-439 | NDC:69256-213 | NDC:62670-6787 | NDC:63146-313 | NDC:68998-370 | NDC:61010-5200 | NDC:76378-015 | NDC:71087-002 | NDC:11822-0015 | NDC:62670-6745 | NDC:53943-213 | NDC:50865-056 | NDC:10819-6007 | NDC:62670-6750 | NDC:83502-002 | NDC:11344-370 | NDC:60637-141 | NDC:62670-6586 | NDC:61010-8700 | NDC:80684-060 | NDC:82127-005 | NDC:72033-101 | NDC:75269-013 | NDC:60637-117 | NDC:62832-447 | NDC:77050-016 | NDC:69540-0037 | NDC:64942-2030 | NDC:68534-002 | NDC:70108-087 | NDC:30805-003 | NDC:62670-6676 | NDC:74934-053 | NDC:42681-0006 | NDC:77955-001 | NDC:76567-0230 | NDC:76585-010 | NDC:80860-001 | NDC:83021-624 | NDC:74642-000 | NDC:43473-013 | NDC:41250-439 | NDC:11822-0876 | NDC:21749-907 | NDC:47593-488 | NDC:79805-001 | NDC:57362-568 | NDC:17518-055 | NDC:61010-3111 | ALCOHOL | NDC:77725-005 | NDC:82127-004 | NDC:21749-028 | NDC:60637-302 | NDC:64709-157 | NDC:60637-124 | NDC:81755-001 | NDC:21749-704 | NDC:73898-002 | NDC:50241-464 | NDC:80139-102 | NDC:30805-020 | NDC:79903-143 | NDC:41163-826 | NDC:62670-6786 | NDC:52380-0540 | NDC:54860-426 | NDC:65616-006 | NDC:59779-059 | NDC:69138-693 | NDC:41366-051 | NDC:50814-056 | NDC:74934-013 | NDC:43473-307 | NDC:61649-293 | NDC:82953-016 | NDC:62832-437 | NDC:73898-005 | NDC:62670-6591 | NDC:71141-849 | NDC:62257-061 | NDC:63710-001 | NDC:81755-004 | NDC:30142-849 | NDC:69396-137 | NDC:72866-000 | NDC:54860-424 | NDC:70108-099 | NDC:70677-1220 | NDC:59448-008 | NDC:74246-104 | NDC:64987-0321 | NDC:57337-043 | NDC:74934-024 | NDC:64942-1826 | NDC:75214-900 | NDC:30142-439 | NDC:62670-6759 | NDC:55319-776 | NDC:57337-013 | NDC:62670-6559 | NDC:62670-6743 | NDC:37662-0693 | NDC:61924-107 | NDC:64942-1746 | NDC:62670-6632 | NDC:30142-596 | NDC:59900-117 | NDC:72496-1130 | NDC:59779-164 | NDC:69060-6930 | NDC:60637-118 | NDC:74934-073 | NDC:62670-6714 | NDC:80016-006 | NDC:66902-482 | NDC:48878-0231 | NDC:57337-018 | NDC:80524-001 | NDC:55443-0400 | NDC:21130-145 | NDC:63940-876 | NDC:72033-110 | NDC:70741-006 | NDC:84231-001 | NDC:62670-6580 | NDC:80710-213 | NDC:77267-004 | NDC:77267-002 | NDC:83986-447 | NDC:62476-005 | NDC:82355-010 | NDC:73833-003 | NDC:80860-000 | NDC:72033-141 | NDC:61805-110 | NDC:62670-6597 | NDC:80684-107 | NDC:75214-501 | NDC:80684-065 | NDC:42681-0043 | NDC:62654-149 | NDC:74177-003 | NDC:62670-6741 | NDC:62670-6649 | NDC:47593-611 | NDC:62670-6583 | NDC:80684-103 | NDC:47593-563 | NDC:66715-7172 | NDC:71788-012 | NDC:62670-6768 | NDC:67858-645 | NDC:57915-008 | NDC:64942-1747 | NDC:71734-202 | NDC:21749-851 | NDC:49687-0015 | NDC:62670-6781 | NDC:82953-008 | NDC:76184-1000 | NDC:62670-6638 | NDC:70412-194 | NDC:78434-100 | NDC:78573-002 | NDC:54748-603 | NDC:74177-026 | NDC:79091-009 | NDC:0363-1233 | NDC:80684-090 | NDC:64942-1740 | NDC:80588-011 | NDC:51801-437 | NDC:84032-001 | NDC:79091-008 | NDC:62670-6652 | NDC:74707-010 | NDC:62670-6678 | NDC:59900-124 | NDC:68534-001 | NDC:21749-837 | NDC:59900-129 | NDC:56136-448 | NDC:54748-201 | NDC:66949-117 | NDC:55319-778 | NDC:77678-002 | NDC:59900-757 | NDC:66715-5863 | NDC:57362-524 | NDC:11673-988 | NDC:79835-701 | NDC:69790-849 | NDC:64942-1828 | NDC:66949-405 | NDC:52489-004 | NDC:62670-6640 | NDC:62257-830 | NDC:75262-012 | NDC:82345-858 | NDC:47593-264 | NDC:65601-802 | NDC:62670-6774 | NDC:62670-6749 | NDC:75742-033 | NDC:11673-785 | NDC:62670-6738 | NDC:50814-062 | NDC:62712-221 | NDC:11673-861 | NDC:62011-0117 | NDC:70793-013 | NDC:21749-856 | NDC:74177-032 | NDC:81504-693 | NDC:72119-003 | NDC:37662-0694 | NDC:0869-0876 | NDC:58345-106 | NDC:81126-020 | NDC:80237-004 | NDC:24286-1528 | CAS RN:64-17-5 | NDC:56136-449 | NDC:74177-004 | NDC:80684-030 | NDC:30805-009 | NDC:64942-1831 | NDC:11822-6450 | NDC:69842-455 | NDC:71788-010 | NDC:64709-185 | NDC:50804-088 | NDC:10819-6006 | NDC:80328-123 | NDC:81073-000 | NDC:62670-6594 | NDC:73928-040 | NDC:74545-001 | NDC:51801-779 | NDC:72866-015 | NDC:62670-6561 | NDC:77573-004 | NDC:75742-030 | NDC:42681-0034 | NDC:62670-6603 | NDC:73769-051 | NDC:62670-6705 | NDC:64942-2042 | NDC:77908-005 | NDC:0363-0952 | NDC:55301-439 | NDC:11084-702 | NDC:81286-101 | NDC:78824-615 | NDC:61010-1112 | NDC:50814-061 | NDC:75742-038 | NDC:60637-119 | NDC:73408-513 | NDC:74934-017 | NDC:23667-102 | NDC:60933-062 | NDC:62670-6737 | NDC:80823-693 | NDC:82645-207 | NDC:80434-230 | NDC:47593-656 | NDC:54748-402 | NDC:65692-2053 | NDC:80335-115 | NDC:62670-6633 | NDC:62670-6704 | NDC:75541-014 | NDC:60637-192 | NDC:54860-431 | NDC:62670-6731 | NDC:68400-489 | NDC:47593-507 | NDC:57362-525 | NDC:62670-6728 | NDC:77373-001 | NDC:56131-701
+BMGC_DG14793,BMG_DG184803,CAS RN:90-47-1 | UNII:9749WEV0CA | XANTHONE | PubChem SID:198947039 | PubChem CID:7020
+BMGC_DG14794,BMG_DG184804,L-GLUTAMINYL-L-GLUTAMIC ACID | CAS RN:88830-90-4 | UNII:EK6VPV7VWH | PubChem CID:7020029
+BMGC_DG14795,BMG_DG184810,PubChem SID:375579241 | P-BENZOYL-L-PHENYLALANINE | p-Benzoyl-L-phenylalanine | CAS RN:104504-45-2 | (2S)-2-amino-3-(4-benzoylphenyl)propanoic acid | DrugBank ID:DB08371 | UNII:9RU6KQ9WYD | PubChem CID:7020128
+BMGC_DG14796,BMG_DG184811,PubChem CID:7020333 | PubChem SID:198948230 | Dipeptide-3 | UNII:6KRO2N7539 | CAS RN:40968-45-4 | DIPEPTIDE-3
+BMGC_DG14797,BMG_DG184821,PubChem CID:7020642 | CAS RN:7669-65-0 | Phe-Pro | (2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid
+BMGC_DG14798,BMG_DG184849,CAS RN:58971-11-2 | UNII:T535ZL7726 | PubChem SID:287446355 | PubChem CID:7021736 | 3-BROMOPHENETHYLAMINE
+BMGC_DG14799,BMG_DG184855,UNII:QJH0S8U69Z | PubChem SID:440089507 | 2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetic acid | CAS RN:673-08-5 | Tyr-Gly | PubChem CID:7021854 | L-TYROSYLGLYCINE
+BMGC_DG14800,BMG_DG184870,PubChem SID:381608362 | 6-METHOXY-8-QUINOLINAMINE | UNII:35HXP99PXF | CAS RN:90-52-8 | PubChem CID:7023
+BMGC_DG14801,BMG_DG184871,PubChem CID:7023019 | PubChem SID:485663394 | (4-FLUOROPHENYL)-4-PYRIDINYLMETHANONE | CAS RN:41538-36-7 | UNII:J88AAY34QE | (4-fluorophenyl)(pyridin-4-yl)methanone | (4-Fluorophenyl)-4-pyridinylmethanone | DrugBank ID:DB06917
+BMGC_DG14802,BMG_DG184881,"PubChem CID:7024 | CAS RN:90-59-5 | PubChem SID:198949966 | 3,5-DIBROMOSALICYLALDEHYDE | UNII:7A260PBI3A"
+BMGC_DG14803,BMG_DG184897,UNII:P0TFZ8R21Y | PubChem SID:198958182 | CAS RN:930-88-1 | N-METHYLMALEIMIDE | PubChem CID:70261
+BMGC_DG14804,BMG_DG184898,"CAS RN:931-36-2 | PubChem SID:198949508 | PubChem CID:70262 | UNII:5K8XI641G3 | 1H-IMIDAZOLE, 2-ETHYL-5-METHYL-"
+BMGC_DG14805,BMG_DG184906,"PubChem CID:7027 | UNII:WQ29KQ9POT | CAS RN:135820-79-0 | DrugBank ID:DB04564 | CAS RN:4253-68-3 | Gluconolactone | CAS RN:90-80-2 | GLUCONOLACTONE | CAS RN:1335-57-5 | (3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-one | PubChem SID:175268570"
+BMGC_DG14806,BMG_DG184915,"PubChem SID:175267598 | CAS RN:90-82-4 | PubChem CID:7028 | Pseudoephedrine | PSEUDOEPHEDRINE | DrugBank ID:DB00852 | UNII:7CUC9DDI9F | (1S,2S)-2-(methylamino)-1-phenylpropan-1-ol"
+BMGC_DG14807,BMG_DG184923,DrugBank ID:DB00937 | 2-(diethylamino)-1-phenylpropan-1-one | CAS RN:90-84-6 | PubChem CID:7029 | PubChem SID:175271878 | DIETHYLPROPION | UNII:Q94YYU22B8 | Diethylpropion
+BMGC_DG14808,BMG_DG184931,"2,4'-DICHLOROACETOPHENONE | PubChem CID:70298 | CAS RN:937-20-2 | PubChem SID:441659236 | UNII:ZXE9VA3E38"
+BMGC_DG14809,BMG_DG184961,PubChem CID:70335 | CAS RN:19735-89-8 | CAS RN:942-32-5 | 3-Methyl-1-phenyl-1H-pyrazol-5-ol | 5-methyl-2-phenyl-1H-pyrazol-3-one
+BMGC_DG14810,BMG_DG184980,PubChem SID:474491049 | 1-(4-Morpholinyl)-2-phenylethanethione | 1-(4-MORPHOLINYL)-2-PHENYLETHANETHIONE | UNII:U6HQ4JDB4M | CAS RN:949-01-9 | PubChem CID:70362
+BMGC_DG14811,BMG_DG184999,PubChem SID:198948462 | N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide | UNII:8CFL28PA3W | PubChem CID:70374 | MORINAMIDE | Morinamide | DrugBank ID:DB13417 | CAS RN:952-54-5
+BMGC_DG14812,BMG_DG185015,"2,5-Diphenylfuran | PubChem CID:70387 | CAS RN:955-83-9 | PubChem SID:252164268 | 2,5-DIPHENYLFURAN | 2,5-diphenylfuran | UNII:2FGD8BE3PZ"
+BMGC_DG14813,BMG_DG185039,"2,6-DIMETHOXYPHENOL | PubChem CID:7041 | UNII:4UQT464H8K | 2,6-dimethoxyphenol | CAS RN:91-10-1 | PubChem SID:198987932 | CAS RN:33-51-2 | 2,6-Dimethoxyphenol | CAS RN:25511-61-9"
+BMGC_DG14814,BMG_DG185050,UNII:73861AE9L7 | PHENYLFLUORONE | PubChem SID:198953072 | PubChem CID:70420 | CAS RN:975-17-7
+BMGC_DG14815,BMG_DG185055,PubChem SID:461434273 | CAS RN:81225-61-8 | N-TERT-BUTYLPHENOTHIAZINE-10-CARBOXAMIDE | PubChem CID:704261 | UNII:985ZCD8PRY
+BMGC_DG14816,BMG_DG185058,"1,2-dimethoxybenzene | PubChem CID:7043 | CAS RN:91-16-7 | UNII:61WJZ2Q41I | VERATROLE | 1,2-Dimethoxybenzene | PubChem SID:198977582"
+BMGC_DG14817,BMG_DG185098,(3R)-3-acetyloxy-4-(trimethylazaniumyl)butanoate | UNII:6DH1W9VH8Q | DrugBank ID:DB08842 | Acetylcarnitine | ACETYLCARNITINE | PubChem SID:175268954 | Acetyl-L-Carnitine | PubChem CID:7045767 | CAS RN:3040-38-8
+BMGC_DG14818,BMG_DG185103,UNII:56W89FBX3E | PubChem SID:198952108 | TETRAHYDROISOQUINOLINE | PubChem CID:7046 | CAS RN:91-21-4
+BMGC_DG14819,BMG_DG185141,"Keflin | PubChem CID:7048634 | (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate"
+BMGC_DG14820,BMG_DG185151,"CAS RN:126830-75-9 | PubChem CID:7048803 | UNII:6NH2EV93XU | PubChem SID:440793924 | TERFENADINE, (R)-"
+BMGC_DG14821,BMG_DG185164,CAS RN:91-44-1 | DIETHYLAMINOMETHYLCOUMARIN | PubChem CID:7050 | UNII:1SFJ7F6R2C | PubChem SID:198989504
+BMGC_DG14822,BMG_DG185172,"PubChem SID:249492299 | 2,6-DIETHYLPHENOL | CAS RN:1006-59-3 | PubChem CID:70507 | UNII:FXC69FTD6U"
+BMGC_DG14823,BMG_DG185177,UNII:7TUM3QV83F | DIHYDRO-4-PHENYLFURAN-2(3H)-ONE | PubChem SID:474492651 | PubChem CID:70515 | Dihydro-4-phenylfuran-2(3H)-one | CAS RN:1008-73-7
+BMGC_DG14824,BMG_DG185185,"PubChem CID:7053 | UNII:TFW7O9HWZK | PubChem SID:317229580 | 2,3-DIMETHYLINDOLE | CAS RN:91-55-4"
+BMGC_DG14825,BMG_DG185195,"Isatin | CAS RN:91-56-5 | DrugBank ID:DB02095 | 1H-indole-2,3-dione | PubChem CID:7054 | UNII:82X95S7M06 | CAS RN:84788-92-1 | CAS RN:1186480-61-4 | PubChem SID:198955860 | ISATIN"
+BMGC_DG14826,BMG_DG185200,CAS RN:1016-47-3 | CAS RN:374572-55-1 | N-Acetyltryptamine | PubChem CID:70547 | N-[2-(1H-indol-3-yl)ethyl]acetamide
+BMGC_DG14827,BMG_DG185202,CAS RN:7419-61-6 | CAS RN:91-57-6 | 2-METHYLNAPHTHALENE | UNII:S8MCX3C16H | 2-Methylnaphthalene | PubChem CID:7055 | 2-methylnaphthalene | PubChem SID:198949338
+BMGC_DG14828,BMG_DG185210,CAS RN:91-58-7 | 2-CHLORONAPHTHALENE | CAS RN:51569-12-1 | PubChem CID:7056 | 2-Chloronaphthalene | UNII:49O81U3ITI | PubChem SID:198987682 | 2-chloronaphthalene
+BMGC_DG14829,BMG_DG185218,"1-hexyl-3,7-dimethylpurine-2,6-dione | PubChem SID:198943781 | PubChem CID:70569 | CAS RN:1028-33-7 | DrugBank ID:DB13634 | PENTIFYLLINE | UNII:MBM1C4K26S | Pentifylline"
+BMGC_DG14830,BMG_DG185222,N-[(4-methoxyphenyl)sulfonyl]-D-alanine | PubChem CID:705712 | DrugBank ID:DB08599
+BMGC_DG14831,BMG_DG185226,10-(4-MORPHOLINYLCARBONYL)-10H-PHENOTHIAZINE | PubChem CID:705776 | PubChem SID:485663726 | UNII:H9ZNB3FQE9 | CAS RN:176092-23-2 | 10-(4-morpholinylcarbonyl)-10H-phenothiazine
+BMGC_DG14832,BMG_DG185228,Homoserine Lactone | PubChem CID:7057884 | DrugBank ID:DB02624
+BMGC_DG14833,BMG_DG185246,"(R)-(-)-1,2,3,4-Tetrahydro-1-naphthol | (1R)-1,2,3,4-tetrahydronaphthalen-1-ol | CAS RN:5929-35-1 | CAS RN:23357-45-1 | PubChem CID:7058028"
+BMGC_DG14834,BMG_DG185247,"PubChem CID:7058029 | UNII:50MT77537D | CAS RN:53732-47-1 | 1-TETRALOL, (S)- | PubChem SID:313390033"
+BMGC_DG14835,BMG_DG185287,"3',5'-cyclic AMP(1-) | (4aR,6R,7R,7aS)-6-(6-aminopurin-9-yl)-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol | PubChem CID:7059571 | CAS RN:62906-31-4"
+BMGC_DG14836,BMG_DG185295,CAS RN:27601-00-9 | PubChem CID:7060 | 2-methylquinoline | 2-Methylquinoline | QUINALDINE | UNII:DVG30M0M87 | CAS RN:91-63-4 | PubChem SID:198962224
+BMGC_DG14837,BMG_DG185302,N-METHYL-N-(2-THIEN-2-YLBENZYL)AMINE | UNII:JXK7BCF78O | CAS RN:852180-66-6 | N-methyl-1-(2-thiophen-2-ylphenyl)methanamine | PubChem CID:7060565 | PubChem SID:438788218 | DrugBank ID:DB07196
+BMGC_DG14838,BMG_DG185335,"3-methyl-7H-purine-2,6-dione | UNII:WS6X982OEC | CAS RN:1076-22-8 | 3-METHYLXANTHINE | 3-Methylxanthine | PubChem CID:70639 | PubChem SID:198948713"
+BMGC_DG14839,BMG_DG185337,"CAS RN:91-76-9 | UNII:B9E2Q3VTUB | PubChem SID:198960875 | 6-phenyl-1,3,5-triazine-2,4-diamine | 6-Phenyl-1,3,5-triazine-2,4-diamine | PubChem CID:7064 | BENZOGUANAMINE"
+BMGC_DG14840,BMG_DG185338,PubChem SID:375579504 | PubChem CID:70641 | 3-PHENYL-5-ISOXAZOLONE | CAS RN:1076-59-1 | UNII:VHX8DF99G7
+BMGC_DG14841,BMG_DG185357,"PubChem SID:312524908 | PubChem CID:70662473 | DrugBank ID:DB12800 | CHF-6001 | CAS RN:1239278-59-1 | TRANIMILAST | [(1S)-1-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-(3,5-dichloro-1-oxidopyridin-1-ium-4-yl)ethyl] 3-(cyclopropylmethoxy)-4-(methanesulfonamido)benzoate | UNII:0984EU6E2F | Chf-6001"
+BMGC_DG14842,BMG_DG185373,PubChem SID:346538968 | LAS-191954 | CAS RN:1403947-26-1 | PubChem CID:70675172 | UNII:1MK0TQ597B
+BMGC_DG14843,BMG_DG185386,UNII:429P6KRK5A | PubChem CID:70677953 | PSB-SB-1202 | CAS RN:1399049-60-5 | PubChem SID:474492773
+BMGC_DG14844,BMG_DG185394,"Adenosylcobalamin | DrugBank ID:DB11191 | CAS RN:13870-90-1 | PubChem CID:70678541 | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate"
+BMGC_DG14845,BMG_DG185395,"Hydroxocobalamin | CAS RN:13422-51-0 | DrugBank ID:DB00200 | cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate | PubChem CID:70678542 | Axlon"
+BMGC_DG14846,BMG_DG185414,"cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide | CAS RN:68-19-9 | DrugBank ID:DB00115 | Crystamine | Cyanocobalamin | PubChem CID:70678590"
+BMGC_DG14847,BMG_DG185479,"Fidaxomicin | DrugBank ID:DB08874 | Lipiarmycin | CAS RN:873857-62-6 | PubChem CID:70678896 | [(2R,3S,4S,5S,6R)-6-[[(3E,5E,8S,9E,11S,12R,13E,15E)-12-[(2R,3S,4R,5S)-3,4-dihydroxy-6,6-dimethyl-5-(2-methylpropanoyloxy)oxan-2-yl]oxy-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxo-1-oxacyclooctadeca-3,5,9,13,15-pentaen-3-yl]methoxy]-4-hydroxy-5-methoxy-2-methyloxan-3-yl] 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate"
+BMGC_DG14848,BMG_DG185499,"CAS RN:770691-21-9 | PubChem CID:70678987 | Gadolinium-DO3A-butriol | 2-[4,10-bis(carboxylatomethyl)-7-[(2S,3R)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+) | DrugBank ID:DB06703 | Gadobutrol"
+BMGC_DG14849,BMG_DG185570,"(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S,3R)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-carboxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-methylpentanoyl]amino]-4-oxobutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]butanedioic acid | CID 70683012 | PubChem CID:70683012"
+BMGC_DG14850,BMG_DG185573,"(2R,4S,5R,6R)-2-[[(2R,3R,4R,5R,6S)-5-acetamido-6-[(1S,2R)-1-amino-1-carboxypropan-2-yl]oxy-3,4-dihydroxyoxan-2-yl]methoxy]-4-hydroxy-5-[[2-(2-methoxyethoxycarbonylamino)acetyl]amino]-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid | PubChem CID:70683024"
+BMGC_DG14851,BMG_DG185587,CAS RN:741693-84-5 | PubChem CID:70685727 | N-DESMETHYLDULOXETINE-5-.BETA.-D-GLUCOPYRANOSIDURONIC ACID | UNII:XE7RH9J8MC | PubChem SID:445499818
+BMGC_DG14852,BMG_DG185597,"3-(diethylamino)propyl (1S,4R)-2-phenylbicyclo[2.2.1]heptane-2-carboxylate | CAS RN:20448-86-6 | BORNAPRINE | DrugBank ID:DB13619 | Bornaprine | UNII:9M363FGA7J | PubChem SID:198980789 | PubChem CID:70687267"
+BMGC_DG14853,BMG_DG185604,PubChem SID:198936991 | CCG-203778 | UNII:9EGB3J3KI5 | CAS RN:1292321-15-3 | PubChem CID:70688193
+BMGC_DG14854,BMG_DG185608,"cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate | CAS RN:13422-51-0 | PubChem CID:70689311"
+BMGC_DG14855,BMG_DG185626,Naxifylline | DrugBank ID:DB06471 | PubChem CID:70691449
+BMGC_DG14856,BMG_DG185634,"PubChem CID:70693500 | DrugBank ID:DB13170 | UNII:7IK8Z952OK | (2S)-2-[[(1R,4S,7S,10S,13S,16R,19S,22S,25R,32S,38R)-10-(2-amino-2-oxoethyl)-25-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]propanoyl]amino]butanoyl]amino]-22-(2-carboxyethyl)-32-[(1R)-1-hydroxyethyl]-4-methyl-19-(2-methylpropyl)-3,6,9,12,15,18,21,24,30,33,36-undecaoxo-7,13-di(propan-2-yl)-27,28,40,41-tetrathia-2,5,8,11,14,17,20,23,31,34,37-undecazabicyclo[14.13.13]dotetracontane-38-carbonyl]amino]-4-methylpentanoic acid | PubChem SID:375086123 | NDC:65649-003 | PLECANATIDE | Plecanatide | CAS RN:467426-54-6"
+BMGC_DG14857,BMG_DG185648,PubChem CID:70693563 | 2-[(S)-[4-(cyclopropylmethoxy)pyridin-2-yl]methylsulfinyl]-6-fluoro-1H-benzimidazole
+BMGC_DG14858,BMG_DG185657,PubChem CID:70695640 | [4-[3-(4-ethylphenyl)butyl]phenyl]-trimethylazanium;chloride | Colestyramine
+BMGC_DG14859,BMG_DG185671,"methyl (1R,2S,3S,5R)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate | PubChem CID:70697274"
+BMGC_DG14860,BMG_DG185736,"VLX-1005 | PubChem SID:440090058 | N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxyphenyl)methylamino]benzenesulfonamide | CAS RN:1532593-30-8 | UNII:JKU4XCC48Y | PubChem CID:70701426 | Vlx-1005"
+BMGC_DG14861,BMG_DG185745,"PubChem SID:472425869 | PubChem CID:707029 | UNII:MUD9R3TJV3 | CAS RN:848193-68-0 | SELISISTAT, (S)-"
+BMGC_DG14862,BMG_DG185747,"SELISISTAT, (R)- | CAS RN:848193-69-1 | UNII:N4L745VB64 | PubChem CID:707032 | PubChem SID:472407719"
+BMGC_DG14863,BMG_DG185748,PubChem CID:707035 | CAS RN:583-39-1 | 2-BENZIMIDAZOLETHIOL | UNII:619CVM6HOK | PubChem SID:198968746
+BMGC_DG14864,BMG_DG185750,"5-(Phenylamino)-1,3,4-thiadiazole-2(3H)-thione | CAS RN:10253-83-5 | PubChem SID:485662575 | UNII:CM2NE3A8UG | 5-(PHENYLAMINO)-1,3,4-THIADIAZOLE-2(3H)-THIONE | PubChem CID:707055"
+BMGC_DG14865,BMG_DG185785,"PubChem SID:434370141 | (3S,8aS)-3-(2-methylpropyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | UNII:KQV8MY059B | (3S,8aS)-3-Isobutylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione | PubChem CID:7074739 | CAS RN:2873-36-1 | GANCIDIN W"
+BMGC_DG14866,BMG_DG185787,"CAS RN:10184-70-0 | (8S,10S,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one | PubChem SID:198937789 | Anecortave | PubChem CID:7074810 | ANECORTAVE | UNII:R5Y8O51589 | DrugBank ID:DB12081"
+BMGC_DG14867,BMG_DG185802,"4-Ethylcatechol | 4-ETHYLCATECHOL | PubChem CID:70761 | PubChem SID:198936560 | 4-ethylbenzene-1,2-diol | UNII:574JV8BYR2 | CAS RN:1124-39-6"
+BMGC_DG14868,BMG_DG185810,PubChem CID:70766 | 5-Aminoisoquinoline | 5-AMINOISOQUINOLINE | CAS RN:1125-60-6 | PubChem SID:438788427 | UNII:LDJ0JLN1Y7 | DrugBank ID:DB04605
+BMGC_DG14869,BMG_DG185813,1-PHENYLPYRAZOLE | PubChem SID:474491040 | UNII:SD5GA7KV5R | CAS RN:1126-00-7 | 1-Phenylpyrazole | PubChem CID:70769
+BMGC_DG14870,BMG_DG185814,"2-(2-benzylphenoxy)-N,N-dimethylethanamine | CAS RN:92-12-6 | PubChem SID:175268024 | PubChem CID:7077 | PHENYLTOLOXAMINE | DrugBank ID:DB11160 | UNII:K65LB6598J | Phenyltoloxamine"
+BMGC_DG14871,BMG_DG185818,"UNII:FG58C4J9BR | CAS RN:1126-61-0 | HYDROXYCHAVICOL | PubChem CID:70775 | 4-Allylbenzene-1,2-diol | 4-prop-2-enylbenzene-1,2-diol | PubChem SID:459055496"
+BMGC_DG14872,BMG_DG185827,"Ridaura | PubChem CID:70788951 | DrugBank ID:DB00995 | Auranofin | gold;(2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate;triethylphosphanium"
+BMGC_DG14873,BMG_DG185831,"PASIREOTIDE DIASPARTATE | PubChem SID:198942379 | CAS RN:820232-50-6 | (2S)-2-aminobutanedioic acid;[(3S,6S,9S,12R,15S,18S,20R)-9-(4-aminobutyl)-3-benzyl-12-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-6-[(4-phenylmethoxyphenyl)methyl]-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl] N-(2-aminoethyl)carbamate | PubChem CID:70788982 | Pasireotide Diaspartate | UNII:I4P76SY3N4"
+BMGC_DG14874,BMG_DG185839,PubChem CID:70789197 | DrugBank ID:DB00364 | Sucralfate
+BMGC_DG14875,BMG_DG185842,"[2-[17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate | Colistimethate | PubChem CID:70789202 | [2-[17-(1-Hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfonatomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfonatomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-11,14-bis[2-(sulfonatomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonate | DrugBank ID:DB01111"
+BMGC_DG14876,BMG_DG185846,"1-[(2s,4s)-4-[4-(4-Fluorophenyl)-1,2,3-Triazol-1-Yl]-2-Pyrrolidin-1-Ylcarbonyl-Pyrrolidin-1-Yl]-4-Phenyl-Butan-1-One | PubChem CID:70789754 | 1-[(2S,4S)-4-[4-(4-fluorophenyl)triazol-1-yl]-2-(pyrrolidine-1-carbonyl)pyrrolidin-1-yl]-4-phenylbutan-1-one"
+BMGC_DG14877,BMG_DG185857,"PubChem CID:70798655 | UNII:43J9Q56T3W | Serabelisib | DrugBank ID:DB14935 | CAS RN:1268454-23-4 | SERABELISIB | [6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone | CAS RN:1428967-74-1 | PubChem SID:346540434"
+BMGC_DG14878,BMG_DG185868,PubChem SID:198962560 | 3-(N-MORPHOLINO)PROPANESULFONIC ACID | CAS RN:1132-61-2 | 3-(N-morpholino)propanesulfonic acid | 3[N-Morpholino]propane sulfonic acid | UNII:273BP63NV3 | 3-morpholin-4-ylpropane-1-sulfonic acid | PubChem CID:70807 | DrugBank ID:DB03434
+BMGC_DG14879,BMG_DG185870,"2,7-Dimethyl-3,6-acridinediamine | PubChem CID:7081 | PubChem SID:485666824 | 2,7-Dimethylacridine-3,6-diamine | CAS RN:92-26-2 | UNII:8FFU4K83E9 | 2,7-DIMETHYL-3,6-ACRIDINEDIAMINE | 2,7-dimethylacridine-3,6-diamine"
+BMGC_DG14880,BMG_DG185876,3-(cyclohexylamino)propane-1-sulfonic acid | PubChem CID:70815 | 3-Cyclohexyl-1-propylsulfonic acid | 3-(cyclohexylamino)propanesulfonic acid | DrugBank ID:DB02219 | CAS RN:1135-40-6 | PubChem SID:198972474 | 3-(CYCLOHEXYLAMINO)PROPANESULFONIC ACID | UNII:4W981O1LXP
+BMGC_DG14881,BMG_DG185880,"CAS RN:1402608-02-9 | Bay-1125976 | BAY-1125976 | PubChem SID:377308562 | UNII:ZL7A1UM87X | 2-[4-(1-aminocyclobutyl)phenyl]-3-phenylimidazo[1,2-b]pyridazine-6-carboxamide | PubChem CID:70817911"
+BMGC_DG14882,BMG_DG185882,UNII:877S053KX3 | PubChem CID:7082 | PubChem SID:317229744 | 2-TRIFLUOROMETHYLPHENOTHIAZINE | CAS RN:92-30-8
+BMGC_DG14883,BMG_DG185883,PubChem SID:475550290 | PubChem CID:708205 | UNII:MN234D98U6 | 2-METHYLBUT-3-YN-2-YL 4-METHOXYBENZOATE | 2-Methylbut-3-yn-2-yl 4-methoxybenzoate | CAS RN:294619-87-7
+BMGC_DG14884,BMG_DG185886,"3,5-DI-TERT-BUTYLPHENOL | PubChem CID:70825 | UNII:F4SMH8G9W7 | PubChem SID:198945373 | CAS RN:1138-52-9"
+BMGC_DG14885,BMG_DG185892,"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE | PubChem CID:708346 | DrugBank ID:DB07158"
+BMGC_DG14886,BMG_DG185893,PubChem SID:198978518 | CAS RN:1143-30-2 | UNII:AMU665LKFR | PubChem CID:70835 | 1-BUTYLTHEOBROMINE
+BMGC_DG14887,BMG_DG185895,"5H-DIBENZ(B,E)AZEPINE-6,11-DIONE | PubChem CID:70836 | PubChem SID:376230954 | UNII:T0WI39HQ1R | CAS RN:1143-50-6"
+BMGC_DG14888,BMG_DG185896,PubChem CID:70837 | UNII:8FBX2Q800V | CAS RN:1143-72-2 | ALIZARIN YELLOW A | PubChem SID:198966915
+BMGC_DG14889,BMG_DG185902,Tolonium | (7-amino-8-methylphenothiazin-3-ylidene)-dimethylazanium | TOLONIUM | PubChem CID:7084 | UNII:P3Y6XJA2D1 | CAS RN:56109-24-1 | PubChem SID:198960014
+BMGC_DG14890,BMG_DG185906,"CAS RN:1146-99-2 | UNII:541C7WS64R | PubChem SID:198957016 | CLORINDIONE | 2-(4-chlorophenyl)indene-1,3-dione | Clorindione | DrugBank ID:DB13275 | PubChem CID:70846"
+BMGC_DG14891,BMG_DG185908,"CAS RN:1148-79-4 | 2,2':6',2''-TERPYRIDINE | PubChem CID:70848 | UNII:G5E357ISH5 | PubChem SID:198951039"
+BMGC_DG14892,BMG_DG185924,PubChem CID:7087 | UNII:69UN466K3Z | PubChem SID:252164390 | CAS RN:92-36-4 | DEHYDROTHIO-P-TOLUIDINE
+BMGC_DG14893,BMG_DG185934,PubChem CID:7088 | UNII:95H3AO2301 | CAS RN:92-39-7 | 2-CHLOROPHENOTHIAZINE | PubChem SID:198953469
+BMGC_DG14894,BMG_DG185936,"Moxaverine | PubChem SID:198962557 | DrugBank ID:DB12251 | UNII:P3P08Y1XJ4 | CAS RN:10539-19-2 | 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline | MOXAVERINE | PubChem CID:70882"
+BMGC_DG14895,BMG_DG185938,"CAS RN:15686-83-6 | PubChem SID:175267632 | 1-methyl-2-[(E)-2-thiophen-2-ylethenyl]-5,6-dihydro-4H-pyrimidine | PYRANTEL | UNII:4QIH0N49E7 | Pyrantel | NDC:84177-4125 | PubChem CID:708857 | DrugBank ID:DB11156 | CAS RN:5686-02-2"
+BMGC_DG14896,BMG_DG185939,CAS RN:22876-19-3 | UNII:2D3DP73PWF | PubChem CID:708870 | PubChem SID:485663055 | 5-CHLORO-2-MERCAPTOBENZOXAZOLE | 5-Chloro-2-mercaptobenzoxazole
+BMGC_DG14897,BMG_DG185942,"UNII:1T16F5401Q | CAS RN:1172-02-7 | PubChem CID:70894 | 9-DICYANOMETHYLENE-2,4,7-TRINITROFLUORENE | PubChem SID:198966511"
+BMGC_DG14898,BMG_DG185949,UNII:H0U5612P6K | CAS RN:92-43-3 | PubChem SID:198957322 | 1-PHENYL-3-PYRAZOLIDINONE | 1-phenylpyrazolidin-3-one | PubChem CID:7090 | Phenidone | CAS RN:14776-33-1
+BMGC_DG14899,BMG_DG185955,CAS RN:1187-50-4 | UNII:A2642S87E9 | L-LEUCYLGLYCYLGLYCINE | PubChem CID:70910
+BMGC_DG14900,BMG_DG185959,PubChem SID:198976644 | DrugBank ID:DB04075 | UNII:MA61H539YZ | N-Acetyl-L-glutamic acid | (2S)-2-acetamidopentanedioic acid | PubChem CID:70914 | N-Acetyl-L-Glutamate | CAS RN:1188-37-0 | ACETYL GLUTAMIC ACID
+BMGC_DG14901,BMG_DG185960,"CAS RN:1402837-78-8 | UNII:926SHL95NC | Navoximod | PubChem CID:70914230 | PubChem SID:317229623 | 4-[(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl]cyclohexan-1-ol | DrugBank ID:DB15439 | NAVOXIMOD"
+BMGC_DG14902,BMG_DG185978,DrugBank ID:DB02580 | PubChem CID:70931 | Pentaglyme
+BMGC_DG14903,BMG_DG186000,"PubChem CID:7095 | 1,1'-biphenyl | Biphenyl | BIPHENYL | PubChem SID:198973438 | CAS RN:26008-28-6 | UNII:2L9GJK6MGN | CAS RN:4819-98-1 | CAS RN:92-52-4"
+BMGC_DG14904,BMG_DG186007,"UNII:T1JP1KYU9O | DrugBank ID:DB14914 | Flortaucipir F-18 | 7-(6-(18F)fluoranylpyridin-3-yl)-5H-pyrido[4,3-b]indole | NDC:0002-1220 | FLORTAUCIPIR F-18 | CAS RN:1522051-90-6 | PubChem CID:70957463 | PubChem SID:198989045"
+BMGC_DG14905,BMG_DG186011,CAS RN:92-54-6 | 1-PHENYLPIPERAZINE | UNII:J9225CBI7D | PubChem CID:7096 | 1-phenylpiperazine | Phenylpiperazine | PubChem SID:198949254
+BMGC_DG14906,BMG_DG186063,"UNII:CY3RNB3K4T | CAS RN:92-62-6 | Proflavine | PROFLAVINE | CAS RN:1811-28-5 | PubChem CID:7099 | DrugBank ID:DB01123 | PubChem SID:198973750 | acridine-3,6-diamine"
+BMGC_DG14907,BMG_DG186075,2-oxohexanedioic acid | CAS RN:3184-35-8 | PubChem CID:71 | 2-Oxoadipic acid | UNII:BB72FKL1M2 | 2-OXOADIPIC ACID | PubChem SID:198943551
+BMGC_DG14908,BMG_DG186087,CAS RN:1207-71-2 | UNII:8SVJ4R3Y3D | Phenothiazine 5-oxide | PubChem CID:71014 | PubChem SID:474489538 | PHENOTHIAZINE 5-OXIDE
+BMGC_DG14909,BMG_DG186097,"PHENOTHIAZINE 5,5-DIOXIDE | CAS RN:1209-66-1 | UNII:2A1OL5D4U2 | PubChem SID:198935003 | PubChem CID:71024"
+BMGC_DG14910,BMG_DG186100,UNII:U18P8J9O2I | CAS RN:1210-56-6 | PubChem CID:71028 | PubChem SID:198961698 | ADRENOGLOMERULOTROPIN
+BMGC_DG14911,BMG_DG186102,PubChem CID:7103 | PubChem SID:198975777 | 4-Phenylphenol | 4-BIPHENYLOL | 4-phenylphenol | CAS RN:1322-20-9 | CAS RN:92-69-3 | CAS RN:446276-69-3 | UNII:50LH4BZ6MD
+BMGC_DG14912,BMG_DG186105,2-methoxyxanthen-9-one | CAS RN:1214-20-6 | 2-Methoxy-9H-xanthen-9-one | PubChem CID:71034
+BMGC_DG14913,BMG_DG186107,HYDROXYNAPHTHOIC ACID | CAS RN:92-70-6 | UNII:C7S9D784HX | PubChem CID:7104 | 3-hydroxynaphthalene-2-carboxylic acid | 3-Hydroxy-2-naphthoic acid | PubChem SID:198943546
+BMGC_DG14914,BMG_DG186108,"CAS RN:1414455-21-2 | PubChem SID:482554576 | AUM-302 | PubChem CID:71041971 | 18-Fluoro-25-methoxy-31-methyl-22,22-dioxo-3,22lambda6,30-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,12,17,19,21(29),24,26-dodecaen-16-one | 18-fluoro-25-methoxy-31-methyl-22,22-dioxo-3,22lambda6,30-trithia-6,8,15,23,26-pentazahexacyclo[22.3.1.12,5.110,13.117,21.04,9]hentriaconta-1(28),2(31),4,6,8,10,12,17,19,21(29),24,26-dodecaen-16-one | UNII:F7WQK85U32"
+BMGC_DG14915,BMG_DG186109,Anisil | PubChem CID:71043 | ANISIL | PubChem SID:474493860 | UNII:98DR7869CR | CAS RN:1226-42-2
+BMGC_DG14916,BMG_DG186122,CAS RN:1415089-24-5 | 2-(Difluoromethyl)-5-{[(2-Methylpropanoyl)amino]methyl}-N-{5-Methyl-4-[4-(Trifluoromethyl)phenyl]-1h-Imidazol-2-Yl}pyridine-3-Carboxamide | PubChem CID:71059525 | 2-(difluoromethyl)-5-[(2-methylpropanoylamino)methyl]-N-[5-methyl-4-[4-(trifluoromethyl)phenyl]-1H-imidazol-2-yl]pyridine-3-carboxamide
+BMGC_DG14917,BMG_DG186123,"CAS RN:1415379-56-4 | PubChem CID:71059746 | UNII:J09QS3Z3WB | PubChem SID:198938555 | 7-(6-fluoropyridin-3-yl)-5H-pyrido[4,3-b]indole | Flortaucipir | FLORTAUCIPIR | DrugBank ID:DB15033"
+BMGC_DG14918,BMG_DG186125,PubChem SID:474490421 | Naphthol AS-BI | CAS RN:1237-75-8 | PubChem CID:71060 | UNII:V2TG9VZA3M | NAPHTHOL AS-BI
+BMGC_DG14919,BMG_DG186129,"PubChem SID:198935757 | CAS RN:157-06-2 | D-Arginine | D-arginine | UNII:R54Z304Z7C | DrugBank ID:DB04027 | CAS RN:61155-84-8 | PubChem CID:71070 | (2R)-2-amino-5-(diaminomethylideneamino)pentanoic acid | ARGININE, D-"
+BMGC_DG14920,BMG_DG186135,"UNII:1K77H2Z9B1 | PubChem SID:198971450 | D-serine | CAS RN:13095-79-9 | DrugBank ID:DB03929 | SERINE, D- | CAS RN:312-84-5 | PubChem CID:71077 | D-Serine | (2R)-2-amino-3-hydroxypropanoic acid"
+BMGC_DG14921,BMG_DG186136,Phenothiazine | UNII:GS9EX7QNU6 | PubChem CID:7108 | PubChem SID:198940313 | PHENOTHIAZINE | 10H-phenothiazine | CAS RN:92-84-2 | DrugBank ID:DB11447 | CAS RN:75788-67-9
+BMGC_DG14922,BMG_DG186137,"DrugBank ID:DB01786 | PubChem SID:198942283 | UNII:E3UDS4613U | (2R)-2-aminopropanoic acid | PubChem CID:71080 | CAS RN:338-69-2 | D-Alanine | ALANINE, D-"
+BMGC_DG14923,BMG_DG186139,UNII:PQ7QG47K6T | CAS RN:338-70-5 | PubChem SID:440793634 | Oxalate ion | OXALATE ION | PubChem CID:71081 | oxalate
+BMGC_DG14924,BMG_DG186140,"PubChem CID:71082 | (2R)-2,5-diaminopentanoic acid | PubChem SID:198949229 | ORNITHINE, D- | CAS RN:348-66-3 | UNII:2H368YCK0U | D-Ornithine"
+BMGC_DG14925,BMG_DG186149,PubChem CID:71098 | UNII:WQ5G9JQ7GC | D-TYROSINE | D-Tyrosine | DrugBank ID:DB03839 | CAS RN:556-02-5 | PubChem SID:438787805
+BMGC_DG14926,BMG_DG186153,CAS RN:29520-22-7 | Menadiol disulfate | MENADIOL DISULFATE | (2-methyl-4-sulfooxynaphthalen-1-yl) hydrogen sulfate | PubChem CID:71103 | UNII:4TGB4HYC3M | PubChem SID:198943671
+BMGC_DG14927,BMG_DG186164,2-propylpentanamide | DrugBank ID:DB04165 | PubChem CID:71113 | VALPROMIDE | UNII:RUA6CWU76G | CAS RN:2430-27-5 | Valpromide | PubChem SID:198962590
+BMGC_DG14928,BMG_DG186173,"4,4'-BIPHENYLDIOL | PubChem SID:198956963 | CAS RN:92-88-6 | UNII:R8994A0904 | PubChem CID:7112"
+BMGC_DG14929,BMG_DG186181,"Aprofene | 2-(diethylamino)ethyl 2,2-diphenylpropanoate | PubChem CID:71128 | CAS RN:3563-01-7 | UNII:PL791XXJ7B | PubChem SID:198989935 | APROFENE"
+BMGC_DG14930,BMG_DG186196,"PubChem CID:71141 | UNII:PW08Y13465 | DrugBank ID:DB09062 | Cefminox | CEFMINOX | CAS RN:84305-41-9 | CAS RN:75481-73-1 | PubChem SID:316914434 | (6R,7S)-7-[[2-[(2S)-2-amino-2-carboxyethyl]sulfanylacetyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid"
+BMGC_DG14931,BMG_DG186200,CAS RN:1416799-28-4 | Amg 333 | 6-[[(S)-(3-fluoropyridin-2-yl)-[3-fluoro-4-(trifluoromethoxy)phenyl]methyl]carbamoyl]pyridine-3-carboxylic acid | PubChem CID:71144018
+BMGC_DG14932,BMG_DG186206,"PubChem SID:198973787 | 1-(3-bromo-1,2-oxazol-5-yl)-2-(tert-butylamino)ethanol | BROXATEROL | Broxaterol | UNII:ZE4IRB4DUC | CAS RN:76596-57-1 | PubChem CID:71149"
+BMGC_DG14933,BMG_DG186207,"UNII:GWP218ZY6F | PubChem SID:198963520 | CAS RN:92-94-4 | P-TERPHENYL | PubChem CID:7115 | 1,4-diphenylbenzene | p-Terphenyl"
+BMGC_DG14934,BMG_DG186212,"DrugBank ID:DB13082 | UNII:1JK12GX30N | Nefiracetam | CAS RN:77191-36-7 | N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide | PubChem SID:198978344 | NEFIRACETAM | PubChem CID:71157"
+BMGC_DG14935,BMG_DG186214,PubChem CID:71158 | CAS RN:77337-76-9 | ACAMPROSATE | UNII:N4K14YGM3J | 3-acetamidopropane-1-sulfonic acid | DrugBank ID:DB00659 | Acamprosate | PubChem SID:175267284
+BMGC_DG14936,BMG_DG186225,PubChem CID:71166 | UNII:08T7936572 | Aminoquinuride | CAS RN:3811-56-1 | AMINOQUINURIDE | PubChem SID:198937380 | DrugBank ID:DB04452
+BMGC_DG14937,BMG_DG186238,PubChem CID:71180 | disodium;hydroxy-dioxido-oxo-(32P)lambda5-phosphane | SODIUM PHOSPHATE P-32 | UNII:O181101B5G | PubChem SID:175265851 | Sodium Phosphate P-32 | CAS RN:7635-46-3 | DrugBank ID:DB09370
+BMGC_DG14938,BMG_DG186242,"PubChem CID:71183 | [(1R,2R,4S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate | CAS RN:13265-10-6 | METHSCOPOLAMINE | PubChem SID:175267545 | Methscopolamine | DrugBank ID:DB11315 | UNII:VDR09VTQ8U"
+BMGC_DG14939,BMG_DG186243,"PubChem SID:249493462 | PubChem CID:71183216 | DrugBank ID:DB12394 | CAS RN:1443211-72-0 | ELECLAZINE | 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one | UNII:PUY08529FK | Eleclazine"
+BMGC_DG14940,BMG_DG186244,CAS RN:77679-27-7 | PubChem SID:175266151 | IOBENGUANE I-131 | 2-[(3-(131I)iodanylphenyl)methyl]guanidine | UNII:Q461L7AK4R | Iobenguane I-131 | PubChem CID:71184
+BMGC_DG14941,BMG_DG186245,CAS RN:1417691-95-2 | PubChem CID:71185716 | PubChem SID:496141436 | KVD-001 | UNII:0LN50R4A7P
+BMGC_DG14942,BMG_DG186247,"4-[1-[[6-[[4-(trifluoromethyl)phenyl]methyl]-6-azaspiro[2.5]octane-7-carbonyl]amino]cyclopropyl]benzoic acid | UNII:TNK4EB6VB5 | CAS RN:1417742-86-9 | PubChem CID:71186236 | PubChem SID:496143701 | VORBIPIPRANT, (+/-)- | Cr-6086 | Vorbipiprant, (+/-)-"
+BMGC_DG14943,BMG_DG186249,ENROFLOXACIN | PubChem CID:71188 | CAS RN:93106-60-6 | Enrofloxacin | 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid | DrugBank ID:DB11404 | UNII:3DX3XEK1BN | PubChem SID:175268843
+BMGC_DG14944,BMG_DG186250,UNII:VX2T1Z50C4 | PubChem SID:198962445 | CAS RN:93-04-9 | PubChem CID:7119 | 2-Methoxynaphthalene | CAS RN:68251-84-3 | CAS RN:68251-83-2 | 2-METHOXYNAPHTHALENE | 2-methoxynaphthalene
+BMGC_DG14945,BMG_DG186254,"BARBEXACLONE | (2S)-1-cyclohexyl-N-methylpropan-2-amine;5-ethyl-5-phenyl-1,3-diazinane-2,4,6-trione | CAS RN:4388-82-3 | PubChem SID:198965589 | PubChem CID:71196 | DrugBank ID:DB09001 | UNII:291GX1YB65 | Barbexaclone"
+BMGC_DG14946,BMG_DG186259,Formaldehyde | CAS RN:30525-89-4 | CAS RN:50-00-0 | FORMALDEHYDE | PubChem CID:712 | formaldehyde | PubChem SID:175265462 | UNII:1HG84L3525 | CAS RN:8013-13-6 | CAS RN:53026-80-5 | DrugBank ID:DB03843
+BMGC_DG14947,BMG_DG186262,"VINBURNINE, (±)- | VINBURNINE, (+/-)- | CAS RN:2580-88-3 | (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-one | DrugBank ID:DB13793 | CAS RN:4880-88-0 | PubChem SID:198974824 | VINBURNINE | UNII:64UB2942IE | PubChem CID:71203 | Vinburnine | UNII:G54D0HMY25 | PubChem SID:198972993"
+BMGC_DG14948,BMG_DG186272,"UNII:1YY04E7RR4 | 3,4-Dimethoxybenzoic acid | PubChem SID:198969247 | 3,4-dimethoxybenzoic acid | VERATRIC ACID | PubChem CID:7121 | CAS RN:93-07-2"
+BMGC_DG14949,BMG_DG186274,UNII:Z3H2D4MF7A | NICOXAMAT | CAS RN:5657-61-4 | PubChem SID:198946190 | PubChem CID:71211
+BMGC_DG14950,BMG_DG186275,"PubChem SID:198975807 | CAS RN:5714-08-9 | Detrothyronine | DETROTHYRONINE | (2R)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid | CAS RN:327-86-6 | UNII:46XII7C16X | PubChem CID:71212"
+BMGC_DG14951,BMG_DG186287,Emopamil | 5-[methyl(2-phenylethyl)amino]-2-phenyl-2-propan-2-ylpentanenitrile | PubChem SID:198984994 | CAS RN:78370-13-5 | UNII:M514041RF7 | DrugBank ID:DB14064 | EMOPAMIL | PubChem CID:71225
+BMGC_DG14952,BMG_DG186290,"PubChem SID:252165158 | ACALABRUTINIB | Acalabrutinib | PubChem CID:71226662 | DrugBank ID:DB11703 | 4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide | NDC:0310-3512 | CAS RN:1420477-60-6 | NDC:0310-0512 | UNII:I42748ELQW"
+BMGC_DG14953,BMG_DG186294,"PubChem SID:363909430 | CAS RN:2163097-55-8 | CAS RN:1418274-28-8 | CILOFEXOR | UNII:YUN2306954 | 2-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic acid | Cilofexor | PubChem CID:71228883 | DrugBank ID:DB15168"
+BMGC_DG14954,BMG_DG186307,"NICARAVEN, (+)- | DrugBank ID:DB06397 | PubChem SID:198943457 | UNII:K13EV3J70Q | CAS RN:79455-30-4 | NICARAVEN | PubChem SID:310826017 | CAS RN:409303-59-9 | Nicaraven | NICARAVEN, (-)- | PubChem SID:310825792 | PubChem CID:71234 | UNII:UD8PEV6JBD | CAS RN:160888-15-3 | UNII:457KF8A3QQ | N-[2-(pyridine-3-carbonylamino)propyl]pyridine-3-carboxamide"
+BMGC_DG14955,BMG_DG186314,"4,4,4-trifluoro-N-[(2S)-1-[[(7S)-5-(2-hydroxyethyl)-6-oxo-7H-pyrido[2,3-d][3]benzazepin-7-yl]amino]-1-oxopropan-2-yl]butanamide | Crenigacestat | DrugBank ID:DB12050 | CRENIGACESTAT | PubChem SID:252163760 | PubChem CID:71236992 | CAS RN:1421438-81-4 | UNII:923X28214S | LY-3039478"
+BMGC_DG14956,BMG_DG186315,Neridronic acid | NERIDRONIC ACID | PubChem CID:71237 | (6-amino-1-hydroxy-1-phosphonohexyl)phosphonic acid | PubChem SID:198934666 | CAS RN:79778-41-9 | DrugBank ID:DB11620 | UNII:8U27U3RIN4 | Neridronic Acid
+BMGC_DG14957,BMG_DG186317,"CC-90001 | 2-(tert-butylamino)-4-[[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino]pyrimidine-5-carboxamide | PubChem SID:472425319 | CAS RN:1403859-14-2 | Cc-90001 | UNII:JD5ZWE631K | PubChem CID:71237511"
+BMGC_DG14958,BMG_DG186318,PubChem CID:712377 | UNII:7PFU48RAFX | BENZOXAZOLE-2-THIONE | CAS RN:2382-96-9 | PubChem SID:198969862
+BMGC_DG14959,BMG_DG186320,DrugBank ID:DB02428 | QUINALDIC ACID | Quinoline-2-carboxylic acid | PubChem CID:7124 | UNII:P90NWT719R | quinoline-2-carboxylic acid | CAS RN:26469-60-3 | CAS RN:93-10-7 | CAS RN:1199266-78-8 | Quinaldic Acid | PubChem SID:198960289
+BMGC_DG14960,BMG_DG186323,"DrugBank ID:DB02884 | 3-CYCLOHEXYLALANINE, L- | 3-Cyclohexyl-L-alanine | PubChem CID:712421 | UNII:GYR4SF0FVQ | PubChem SID:376072219 | CAS RN:27527-05-5"
+BMGC_DG14961,BMG_DG186324,CAS RN:870964-67-3 | PubChem CID:71242808 | EVOCALCET | DrugBank ID:DB12388 | PubChem SID:252165373 | UNII:E58MLH082P | 2-[4-[(3S)-3-[[(1R)-1-naphthalen-1-ylethyl]amino]pyrrolidin-1-yl]phenyl]acetic acid | Evocalcet
+BMGC_DG14962,BMG_DG186327,"PubChem CID:71244 | PubChem SID:198991163 | UNII:D0TAM1017B | Rentiapril | CAS RN:80830-42-8 | (2R,4R)-2-(2-hydroxyphenyl)-3-(3-sulfanylpropanoyl)-1,3-thiazolidine-4-carboxylic acid | RENTIAPRIL"
+BMGC_DG14963,BMG_DG186332,"5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl]benzamide | Selonsertib | DrugBank ID:DB14916 | PubChem SID:252164726 | SELONSERTIB | PubChem CID:71245288 | CAS RN:1448428-04-3 | UNII:NS3988A2TC"
+BMGC_DG14964,BMG_DG186333,"Flosulide | PubChem SID:198984626 | UNII:GVR41S4ZHJ | CAS RN:80937-31-1 | N-[6-(2,4-difluorophenoxy)-1-oxo-2,3-dihydroinden-5-yl]methanesulfonamide | PubChem CID:71246 | FLOSULIDE"
+BMGC_DG14965,BMG_DG186336,PubChem CID:71249 | PubChem SID:198974533 | 1-[2-[2-hydroxy-3-(2-methylbutan-2-ylamino)propoxy]phenyl]-3-phenylpropan-1-one | CAS RN:85414-47-7 | DIPRAFENONE | UNII:1P35MD5C1F | Diprafenone | CAS RN:81447-80-5
+BMGC_DG14966,BMG_DG186349,"(3S)-3-[4-[[5-[(8-methoxy-3,4-dihydro-2H-quinolin-1-yl)methyl]thiophen-2-yl]methoxy]phenyl]hex-4-ynoic acid | PubChem CID:71257551 | (S)-3-(4-((5-((8-Methoxy-3,4-dihydroquinolin-1(2H)-yl)methyl)thiophen-2-yl)methoxy)phenyl)hex-4-ynoic acid | CAS RN:1423018-12-5"
+BMGC_DG14967,BMG_DG186353,PubChem CID:71258526 | GSK-2983559 ACTIVE METABOLITE | CAS RN:1423186-80-4 | UNII:2893X36L7K
+BMGC_DG14968,BMG_DG186356,"FLURITHROMYCIN | UNII:56C9DTE69V | PubChem SID:198970737 | DrugBank ID:DB13338 | CAS RN:82664-20-8 | (3R,4S,5S,6R,7R,9S,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-9-fluoro-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione | Flurithromycin | PubChem CID:71260"
+BMGC_DG14969,BMG_DG186361,"PubChem CID:71261649 | CAS RN:53447-14-6 | UNII:2D7L80A51V | ISOCORYPALMINE, (+)- | PubChem SID:198960862"
+BMGC_DG14970,BMG_DG186366,MIFENTIDINE | PubChem SID:198954947 | UNII:2F70KF5S0K | PubChem CID:71263 | N-[4-(1H-imidazol-5-yl)phenyl]-N'-propan-2-ylmethanimidamide | CAS RN:83184-43-4 | Mifentidine
+BMGC_DG14971,BMG_DG186368,"ethyl N-[11-[2-(dimethylamino)acetyl]-5,6-dihydrobenzo[b][1]benzazepin-2-yl]carbamate | UNII:9UUO2T61K7 | PubChem SID:198953631 | Tiracizine | DrugBank ID:DB13635 | TIRACIZINE | PubChem CID:71264 | CAS RN:83275-56-3"
+BMGC_DG14972,BMG_DG186375,"PubChem SID:377308784 | UNII:DW78HM3N4L | CAS RN:5275-11-6 | 3-AMINO-5,6,7,8-TETRAHYDRO-1-THIOXO-1H-2-BENZOTHIOPYRAN-4-CARBONITRILE | PubChem CID:712660"
+BMGC_DG14973,BMG_DG186377,FRILUGLANSTAT | UNII:L65P4UM6KV | PubChem CID:71267445 | PubChem SID:485666571 | CAS RN:1422203-86-8 | Friluglanstat
+BMGC_DG14974,BMG_DG186380,"PubChem CID:71269142 | UNII:4801QYW816 | 2-[1-[4-[4-(4-hydroxypiperidin-1-yl)anilino]-5-oxo-6H-pyrimido[4,5-d]pyridazin-2-yl]piperidin-4-yl]acetonitrile | GUSACITINIB | CAS RN:1425381-60-7 | PubChem SID:387065288 | Gusacitinib"
+BMGC_DG14975,BMG_DG186381,"Methyleugenol | METHYL EUGENOL | UNII:29T9VA6R7M | PubChem SID:175266368 | PubChem CID:7127 | 1,2-dimethoxy-4-prop-2-enylbenzene | CAS RN:93-15-2"
+BMGC_DG14976,BMG_DG186383,"Luvadaxistat | UNII:76IC00YRVR | PubChem CID:71270546 | PubChem SID:404859390 | 6-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2-dihydropyridazine-3,4-dione | CAS RN:1425511-32-5 | LUVADAXISTAT"
+BMGC_DG14977,BMG_DG186384,"UNII:7M430JI73B | PubChem CID:71271414 | MK-8189 | 2-Methyl-6-{[(1S,2S)-2-(5-methylpyridin-2-yl)cyclopropyl]methoxy}-N-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]pyrimidin-4-amine | PubChem SID:475549776 | CAS RN:1424371-93-6 | 2-methyl-6-[[(1S,2S)-2-(5-methylpyridin-2-yl)cyclopropyl]methoxy]-N-[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]pyrimidin-4-amine"
+BMGC_DG14978,BMG_DG186465,"1beta,25-Dihydroxyvitamin-D3;1-Epicalcitriol | CAS RN:73837-24-8 | CAS RN:32222-06-3 | 5-[2-[(7aR)-1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | PubChem CID:71296883"
+BMGC_DG14979,BMG_DG186545,Depatuxizumab mafodotin | DrugBank ID:DB11731 | PubChem CID:71300933
+BMGC_DG14980,BMG_DG186550,"CAS RN:118457-14-0 | DrugBank ID:DB04861 | CAS RN:9920-09-6 | CAS RN:99200-09-6 | 1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-[[2-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)-2-hydroxyethyl]amino]ethanol | Nebivolol | PubChem CID:71301"
+BMGC_DG14981,BMG_DG186567,"Orm-12741 | (1S,12bS)-1-(methoxymethyl)-1-methyl-2,3,4,6,7,12b-hexahydro-[1]benzofuro[2,3-a]quinolizine | UNII:C5D3YG7ZR8 | ORM-12741 | ORM-10921 | PubChem CID:71301276 | PubChem SID:474494580 | DrugBank ID:DB12057 | CAS RN:610782-82-6"
+BMGC_DG14982,BMG_DG186575,CAS RN:1445752-09-9 | UNII:6J3KC3S2PA | PubChem SID:346540599 | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-pentylindazole-3-carboxamide | AB-Pinaca | PubChem CID:71301472 | AB-PINACA
+BMGC_DG14983,BMG_DG186581,UNII:KP6G2WBA2G | CAS RN:138774-94-4 | PubChem SID:478839191 | (αR)-α-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-naphthalenepropanoic acid | (.ALPHA.R)-.ALPHA.-(((9H-FLUOREN-9-YLMETHOXY)CARBONYL)AMINO)-2-NAPHTHALENEPROPANOIC ACID | PubChem CID:7130590
+BMGC_DG14984,BMG_DG186582,"H-DL-Phe-DL-Cys(1)-DL-Tyr-DL-Trp-DL-Lys-DL-Val-DL-Cys(1)-DL-Trp-NH2 | CAS RN:103222-11-3 | PubChem CID:71306 | 10-(4-aminobutyl)-N-[1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-19-[(2-amino-3-phenylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide"
+BMGC_DG14985,BMG_DG186583,"PubChem CID:71306319 | MeCbl | carbanide;cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | Mecobalamin | CAS RN:13422-55-4 | DrugBank ID:DB03614"
+BMGC_DG14986,BMG_DG186603,"PubChem CID:71306410 | 1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide | CAS RN:1110563-69-3 | Azarga"
+BMGC_DG14987,BMG_DG186618,"PubChem CID:71306834 | CAS RN:98530-12-2 | PubChem SID:472397824 | INTERFERON ALFA-2B | sodium;diiodomethanesulfonate;N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide | UNII:43K1W2T1M6"
+BMGC_DG14988,BMG_DG186621,"(4S)-5-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[2-[[(2S)-1-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoic acid | Secretin(human) | PubChem CID:71306891"
+BMGC_DG14989,BMG_DG186654,PubChem CID:71308155 | PubChem SID:272993949 | APICA | UNII:HKU510FH74 | CAS RN:1345973-50-3
+BMGC_DG14990,BMG_DG186672,CAS RN:501926-82-5 | PubChem CID:71308243 | PubChem SID:312524954 | UNII:8WXU5YRE25 | MN-25
+BMGC_DG14991,BMG_DG186712,"CAS RN:104054-27-5 | ATIPAMEZOLE | DrugBank ID:DB11481 | PubChem SID:175266036 | CAS RN:308081-08-5 | 5-(2-ethyl-1,3-dihydroinden-2-yl)-1H-imidazole | Atipamezole | PubChem CID:71310 | UNII:03N9U5JAF6"
+BMGC_DG14992,BMG_DG186715,"[(1S)-2-methyl-4-oxo-3-[(2E)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate;[2-methyl-4-oxo-3-[(2E)-penta-2,4-dienyl]cyclopent-2-en-1-yl] (1R)-3-[(E)-3-methoxy-2-methyl-3-oxoprop-1-enyl]-2,2-dimethylcyclopropane-1-carboxylate | CAS RN:1217499-99-4 | PubChem CID:71310221 | Pyrethrins | CAS RN:8003-34-7"
+BMGC_DG14993,BMG_DG186868,"CAS RN:1390637-82-7 | PubChem SID:404859878 | PubChem CID:71315139 | CYP3cide | PF-04981517 | UNII:ZRD2TT3Y1T | 1-methyl-3-[1-methyl-5-(4-methylphenyl)pyrazol-4-yl]-4-[(3S)-3-piperidin-1-ylpyrrolidin-1-yl]pyrazolo[3,4-d]pyrimidine"
+BMGC_DG14994,BMG_DG186891,4-(4-(4-CHLOROPHENYL)-4-HYDROXYPIPERIDIN-1-YL)-1-(2-FLUOROPHENYL)BUTAN-1-ONE | PubChem SID:198960947 | CAS RN:1391052-53-1 | UNII:6ZQO8KXL92 | PubChem CID:71315272
+BMGC_DG14995,BMG_DG187072,"CAS RN:109214-55-3 | PubChem CID:71320 | UNII:QD8496WWYK | (2S)-6-amino-2-[[(3S)-1-(carboxymethyl)-2-oxo-4,5-dihydro-3H-1-benzazepin-3-yl]amino]hexanoic acid | Libenzapril | PubChem SID:198965292 | LIBENZAPRIL"
+BMGC_DG14996,BMG_DG187073,PubChem SID:198969939 | PubChem CID:71321 | ROMAZARIT | UNII:CN68E94R2X | CAS RN:109543-76-2
+BMGC_DG14997,BMG_DG187096,NDC:42794-045 | NDC:84280-5125 | NDC:51862-025 | NDC:84280-5500 | NDC:0904-7523 | NDC:72205-039 | NDC:0069-5800 | NDC:0069-5820 | NDC:0069-5810 | NDC:59651-120 | NDC:16729-492 | NDC:47335-061 | UNII:R4Z9X1N2ND | N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide | NDC:47335-063 | NDC:70010-025 | NDC:76282-757 | NDC:84280-5250 | DOFETILIDE | NDC:69452-133 | NDC:59651-119 | NDC:0904-6682 | NDC:16729-490 | NDC:59651-118 | Dofetilide | NDC:69452-131 | NDC:70010-026 | NDC:72664-231 | NDC:75907-056 | PubChem CID:71329 | NDC:51862-125 | NDC:72205-040 | NDC:72603-130 | NDC:0904-7524 | NDC:70010-024 | NDC:76282-755 | NDC:42794-044 | NDC:69452-132 | NDC:0904-6681 | NDC:72603-132 | NDC:0904-7522 | NDC:76282-756 | NDC:72664-229 | NDC:75907-054 | NDC:75907-055 | NDC:42794-046 | NDC:16729-491 | NDC:51862-005 | CAS RN:115256-11-6 | NDC:72205-041 | NDC:0904-6683 | NDC:72664-230 | PubChem SID:175267357 | NDC:47335-062 | NDC:72603-131 | DrugBank ID:DB00204
+BMGC_DG14998,BMG_DG187116,"(4R,5S,6S)-3-(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazol-4-ium-6-ylsulfanyl)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate | CAS RN:120410-24-4 | BIAPENEM | UNII:YR5U3L9ZH1 | PubChem CID:71339 | Biapenem | PubChem SID:198957223 | DrugBank ID:DB13028"
+BMGC_DG14999,BMG_DG187138,"PubChem CID:71349 | 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-[(2-amino-3-naphthalen-2-ylpropanoyl)amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | Lanreotide | CAS RN:108736-35-2 | DrugBank ID:DB06791 | CAS RN:127984-74-1"
+BMGC_DG15000,BMG_DG187145,"3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2,9-dimethylpyrido[1,2-a]pyrimidin-4-one | UNII:26HUS7139V | OCAPERIDONE | CAS RN:129029-23-8 | Ocaperidone | PubChem CID:71351 | PubChem SID:198981439 | DrugBank ID:DB06229"
+BMGC_DG15001,BMG_DG187154,"Dapoxetine | PubChem CID:71353 | UNII:GB2433A4M3 | DrugBank ID:DB04884 | DAPOXETINE | PubChem SID:198971449 | CAS RN:119356-77-3 | (1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine"
+BMGC_DG15002,BMG_DG187157,UNII:JQ11LH711M | BINDARIT | PubChem SID:198934664 | PubChem CID:71354 | DrugBank ID:DB12739 | 2-[(1-benzylindazol-3-yl)methoxy]-2-methylpropanoic acid | CAS RN:130641-38-2 | Bindarit
+BMGC_DG15003,BMG_DG187165,CAS RN:132210-43-6 | CIPAMFYLLINE | UNII:AFP56R140L | PubChem CID:71356 | PubChem SID:198946942
+BMGC_DG15004,BMG_DG187186,"NDC:43068-108 | NDC:0378-0633 | NDC:43068-110 | NDC:0378-0632 | NDC:43068-901 | PubChem CID:71360 | NDC:51672-4178 | NDC:51672-4182 | NDC:51672-4181 | 1-[4-[3-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]propoxy]-3-methoxyphenyl]ethanone | NDC:0378-0635 | UNII:VPO7KJ050N | Iloperidone | NDC:0378-0631 | NDC:43068-104 | NDC:43068-106 | PubChem SID:175266551 | NDC:51672-4183 | NDC:43068-102 | NDC:43068-101 | NDC:51672-4180 | NDC:0378-0630 | NDC:43068-904 | NDC:0378-0636 | CAS RN:133454-47-4 | DrugBank ID:DB04946 | NDC:43068-905 | NDC:43068-902 | NDC:51672-4179 | NDC:0378-0634 | ILOPERIDONE | NDC:43068-112 | NDC:51672-4184"
+BMGC_DG15005,BMG_DG187205,"(2S)-2-[[(3aS,7aS)-1-[2-[(2S)-2-[[(2S)-2-[[2-[[(4R)-1-[1-[2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxy-pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-yl-propan | (2S)-2-[[(3aS,7aS)-1-[2-[(2S)-2-[[(2S)-2-[[2-[[(4R)-1-[1-[2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid | PubChem CID:71364 | DrugBank ID:DB06196 | Icatibant"
+BMGC_DG15006,BMG_DG187210,PubChem CID:71367 | UNII:Y8B7PF4062 | PubChem SID:198957786 | CAS RN:7681-80-3 | PENTAPIPERIUM METHYLSULFATE
+BMGC_DG15007,BMG_DG187214,Sodium Iodide I-131 | sodium;iodine-131(1-) | NDC:65174-880 | PubChem SID:175267300 | UNII:29VCO8ACHH | CAS RN:7790-26-3 | PubChem CID:71368 | NDC:65174-461 | SODIUM IODIDE I-131
+BMGC_DG15008,BMG_DG187222,"Liotrix | DrugBank ID:DB01583 | PubChem CID:71371 | CAS RN:8065-29-0 | disodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate;(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoate"
+BMGC_DG15009,BMG_DG187240,"UNII:7K9YKG6MZP | CAS RN:93-37-8 | 2,7-DIMETHYLQUINOLINE | PubChem CID:7138 | PubChem SID:474490588 | 2,7-Dimethylquinoline"
+BMGC_DG15010,BMG_DG187247,"4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione | CAS RN:24584-09-6 | PubChem SID:175266611 | PubChem CID:71384 | Dexrazoxane | DrugBank ID:DB00380 | DEXRAZOXANE | UNII:048L81261F"
+BMGC_DG15011,BMG_DG187249,"CLOBETASONE BUTYRATE | PubChem CID:71386 | PubChem SID:198941443 | UNII:8U0H6XI6EO | Clobetasone butyrate | [(8S,9R,10S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-10,13,16-trimethyl-3,11-dioxo-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-17-yl] butanoate | CAS RN:25122-57-0"
+BMGC_DG15012,BMG_DG187250,"PubChem SID:198950297 | UNII:LT69WY1J6D | DrugBank ID:DB13158 | Clobetasone | (8S,9R,10S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-17-hydroxy-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthrene-3,11-dione | CLOBETASONE | CAS RN:54063-32-0 | PubChem CID:71387"
+BMGC_DG15013,BMG_DG187251,"CAS RN:25301-02-4 | PubChem CID:71388 | Macrocyclon | formaldehyde;oxirane;4-(2,4,4-trimethylpentan-2-yl)phenol"
+BMGC_DG15014,BMG_DG187258,"CAS RN:61914-52-1 | PubChem CID:71391212 | 1-(3,4-Dimethoxyphenyl)-5-hydroxydecan-3-one | 1-(3,4-dimethoxyphenyl)-5-hydroxydecan-3-one"
+BMGC_DG15015,BMG_DG187261,"DrugBank ID:DB13300 | UNII:3LU1L73C8Y | EPICILLIN | PubChem SID:198965348 | CAS RN:26774-90-3 | (2S,5R,6R)-6-[[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Epicillin | PubChem CID:71392"
+BMGC_DG15016,BMG_DG187272,"PubChem CID:71398 | PubChem SID:175268494 | UNII:7BO8G1BYQU | DrugBank ID:DB00179 | 4-[(2S,3R)-4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol | CAS RN:27686-84-6 | CAS RN:1050512-02-1 | Masoprocol | MASOPROCOL"
+BMGC_DG15017,BMG_DG187301,"1-O-(2-hydroxyethyl) 4-O-[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydrochromen-6-yl] butanedioate | Tocophersolan | PubChem CID:71406 | CAS RN:30999-06-5 | CAS RN:1217678-66-4"
+BMGC_DG15018,BMG_DG187302,PubChem SID:198957964 | CAS RN:31478-45-2 | UNII:4X7Y0185J3 | BAMNIDAZOLE | PubChem CID:71407
+BMGC_DG15019,BMG_DG187317,"NDC:71800-009 | [2-[(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-acetyloxy-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | Diflorasone Diacetate | NDC:51672-1296 | UNII:7W2J09SCWX | NDC:51672-5292 | DIFLORASONE DIACETATE | NDC:64980-124 | CAS RN:33564-31-7 | PubChem SID:175268136 | NDC:72919-549 | NDC:51672-1295 | PubChem CID:71414"
+BMGC_DG15020,BMG_DG187319,"DIFLORASONE | (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | PubChem CID:71415 | Diflorasone | DrugBank ID:DB00223 | PubChem SID:175268551 | CAS RN:2557-49-5 | UNII:T2DHJ9645W"
+BMGC_DG15021,BMG_DG187321,"UNII:K4DX5DYD7Y | PubChem CID:7141654 | CAS RN:1039033-93-6 | 2-(5-METHYL-2-FURANYL)PYRROLIDINE, (2S)-"
+BMGC_DG15022,BMG_DG187322,"PubChem CID:7141656 | 2-(5-METHYL-2-FURANYL)PYRROLIDINE, (2R)- | CAS RN:1039033-95-8 | UNII:XJR2T9WGF2"
+BMGC_DG15023,BMG_DG187326,PubChem SID:461434560 | PubChem CID:7141881 | UNII:NPA5DYB93P | CAS RN:67268-37-5 | SEP-227900
+BMGC_DG15024,BMG_DG187378,UNII:ZJ7UBW7579 | CAS RN:20873-58-9 | PubChem SID:485663438 | 5-(Methylthio)-2-thiophenecarboxylic acid | 5-(METHYLTHIO)-2-THIOPHENECARBOXYLIC ACID | PubChem CID:714372
+BMGC_DG15025,BMG_DG187418,"CAS RN:47747-56-8 | TALAMPICILLIN | PubChem SID:198942585 | UNII:29OJI73DPC | Talampicillin | (3-oxo-1H-2-benzofuran-1-yl) (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate | PubChem CID:71447 | DrugBank ID:DB13814"
+BMGC_DG15026,BMG_DG187453,FECNT | PubChem CID:71454201 | PubChem SID:312524801 | UNII:5A2M010H3O | CAS RN:281667-94-5
+BMGC_DG15027,BMG_DG187454,CAS RN:1366067-59-5 | PubChem SID:441331399 | UNII:9FJY4287ZP | JWH-387 | PubChem CID:71454233
+BMGC_DG15028,BMG_DG187455,JWH-412 | PubChem CID:71454236 | UNII:PCX2678XVD | CAS RN:1364933-59-4 | PubChem SID:441332137
+BMGC_DG15029,BMG_DG187456,"PubChem SID:459275958 | MOBINITINIB | UNII:ZE94SP78UG | PubChem CID:71454279 | 6-chloro-7-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-2-(1,3-dimethylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine | EP-0042 | CAS RN:1402709-93-6"
+BMGC_DG15030,BMG_DG187457,"CAS RN:25518-51-8 | DECANOYLCARNITINE, (+)- | PubChem CID:71454369 | PubChem SID:313183869 | UNII:3W7M177KTK"
+BMGC_DG15031,BMG_DG187459,CAS RN:143383-65-7 | UNII:UOM2HMO524 | PubChem SID:198964894 | PREMAFLOXACIN | PubChem CID:71455
+BMGC_DG15032,BMG_DG187470,"2-Chloro-N,N-diethyl-5-[[4-[2-[4-[[(methylamino)carbonyl]amino]phenyl]-4-pyridinyl]-2-pyrimidinyl]amino]benzenesulfonamide | PubChem SID:485664316 | PubChem CID:71458575 | 2-CHLORO-N,N-DIETHYL-5-((4-(2-(4-(((METHYLAMINO)CARBONYL)AMINO)PHENYL)-4-PYRIDINYL)-2-PYRIMIDINYL)AMINO)BENZENESULFONAMIDE | UNII:X245Q9ZA3J | CAS RN:1402452-15-6"
+BMGC_DG15033,BMG_DG187474,"PubChem CID:71460148 | PubChem SID:496141865 | UNII:H8U6Z2QCB3 | CAS RN:1404559-15-4 | (2S,4R)-Teneligliptin | (2S,4R)-TENELIGLIPTIN"
+BMGC_DG15034,BMG_DG187475,"PubChem SID:496141866 | UNII:VW67FXM7KT | (2R,4R)-TENELIGLIPTIN | PubChem CID:71460149 | (2R,4R)-Teneligliptin | CAS RN:1404559-17-6"
+BMGC_DG15035,BMG_DG187480,"JNJ-42491293 | 8-chloro-3-(cyclopropylmethyl)-7-[4-(3,6-difluoro-2-methoxyphenyl)piperidin-1-yl]-[1,2,4]triazolo[4,3-a]pyridine | CAS RN:1376334-37-0 | Jnj-42491293 | PubChem CID:71461395 | PubChem SID:440089210 | UNII:L3EZ379BGB"
+BMGC_DG15036,BMG_DG187524,"ACORAMIDIS | CAS RN:1446711-81-4 | PubChem CID:71464713 | Acoramidis | UNII:T12B44A1OE | 3-[3-(3,5-dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoic acid | PubChem SID:348480895"
+BMGC_DG15037,BMG_DG187537,Phenoxypropazine | UNII:8E92V52324 | FENOXYPROPAZINE | 1-phenoxypropan-2-ylhydrazine | PubChem CID:71467 | PubChem SID:198986108 | DrugBank ID:DB09251 | CAS RN:3818-37-9
+BMGC_DG15038,BMG_DG187541,"5-cyclopropyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide | CAS RN:1408234-79-6 | PubChem CID:71468161 | Bisthianostat"
+BMGC_DG15039,BMG_DG187542,UNII:56QS71SWUJ | PubChem SID:472405970 | BAY-1143269 | PubChem CID:71468412 | CAS RN:1426928-20-2
+BMGC_DG15040,BMG_DG187545,"NDC:68083-513 | CAS RN:3847-29-8 | CAS RN:1334-39-0 | PubChem SID:175265939 | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;(2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoic acid | UNII:33H58I7GLQ | NDC:14789-116 | Erythromycin Lactobionate | NDC:0409-6476 | ERYTHROMYCIN LACTOBIONATE | PubChem CID:71469 | NDC:0409-6482"
+BMGC_DG15041,BMG_DG187547,UNII:0F897O3O4M | PubChem SID:175271963 | PubChem CID:7147 | 1-Phenyl-1-propanol | 1-phenylpropan-1-ol | CAS RN:93-54-9 | PHENYLPROPANOL
+BMGC_DG15042,BMG_DG187555,"Trisodium Citrate Dihydrate | NDC:76297-006 | CAS RN:6132-04-3 | NDC:69842-423 | NDC:0942-9505 | NDC:0942-9504 | NDC:0942-9506 | NDC:23731-6030 | PubChem CID:71474 | NDC:65197-204 | trisodium;2-hydroxypropane-1,2,3-tricarboxylate;dihydrate | NDC:81839-782 | NDC:52389-242 | TRISODIUM CITRATE DIHYDRATE | UNII:B22547B95K | NDC:14537-881 | NDC:65197-203 | NDC:0338-9669 | NDC:65197-420 | PubChem SID:175267167 | NDC:65197-410"
+BMGC_DG15043,BMG_DG187558,"DrugBank ID:DB13041 | methyl N-[(2S)-1-[(2S,3aS,7aS)-2-[6-[11-[2-[(2S,3aS,7aS)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-2,3,3a,4,5,6,7,7a-octahydroindol-2-yl]-3H-benzimidazol-5-yl]-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]-2,3,3a,4,5,6,7,7a-octahydroindol-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate | PubChem SID:198944505 | CAS RN:1415119-52-6 | UNII:OVR52K7BDW | PubChem CID:71474517 | Odalasvir | ODALASVIR"
+BMGC_DG15044,BMG_DG187562,"4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-([1,2,4]triazolo[4,3-a]pyridin-3-yl)ethynyl]benzamide | CAS RN:1416241-23-0 | VAMOTINIB | PubChem CID:71475839 | DrugBank ID:DB15396 | PubChem SID:375085831 | Pf-114 | UNII:I8C3R768IZ | Vamotinib"
+BMGC_DG15045,BMG_DG187571,Evobrutinib | 1-[4-[[[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino]methyl]piperidin-1-yl]prop-2-en-1-one | PubChem SID:316909689 | UNII:ZA45457L1K | PubChem CID:71479709 | EVOBRUTINIB | DrugBank ID:DB15170 | CAS RN:1415823-73-2
+BMGC_DG15046,BMG_DG187574,"Selinexor | NDC:72237-102 | NDC:72237-103 | CAS RN:1621865-82-4 | NDC:72237-101 | NDC:72237-104 | PubChem CID:71481097 | UNII:31TZ62FO8F | CAS RN:1393477-72-9 | (Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyrazin-2-ylprop-2-enehydrazide | SELINEXOR | PubChem SID:198946299 | DrugBank ID:DB11942"
+BMGC_DG15047,BMG_DG187576,CAS RN:1417031-79-8 | (2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonic acid | PubChem CID:71481120 | GC-376 FREE ACID | UNII:O9H5KY11SV | PubChem SID:405054938 | GC-376 free acid
+BMGC_DG15048,BMG_DG187585,"SUCRALOSE | CAS RN:56038-13-2 | (2R,3R,4R,5R,6R)-2-[(2R,3S,4S,5S)-2,5-bis(chloromethyl)-3,4-dihydroxyoxolan-2-yl]oxy-5-chloro-6-(hydroxymethyl)oxane-3,4-diol | Sucralose | UNII:96K6UQ3ZD4 | PubChem SID:175268904 | PubChem CID:71485"
+BMGC_DG15049,BMG_DG187590,UNII:9NN2OZ1YX4 | PubChem CID:71488522 | CAS RN:1392502-82-7 | PubChem SID:438788606 | MEFUPARIB
+BMGC_DG15050,BMG_DG187595,"PubChem SID:198938220 | CAS RN:258329-46-3 | UNII:KP2L8LC73B | DrugBank ID:DB13759 | Fenpiverinium | PubChem CID:71490 | 4-(1-methylpiperidin-1-ium-1-yl)-2,2-diphenylbutanamide | FENPIVERINIUM"
+BMGC_DG15051,BMG_DG187608,"Roniciclib | PubChem CID:71494949 | DrugBank ID:DB12974 | (2R,3R)-3-[2-[4-(cyclopropylsulfonimidoyl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]oxybutan-2-ol | CAS RN:1456621-53-6 | CAS RN:1223498-69-8 | PubChem SID:198961684 | RONICICLIB | UNII:0W9Q8U337A"
+BMGC_DG15052,BMG_DG187614,PubChem CID:71496458 | N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide | CAS RN:1421373-65-0 | PubChem SID:198967282 | DrugBank ID:DB09330 | UNII:3C06JJ0Z2O | NDC:0310-1349 | NDC:0310-1350 | OSIMERTINIB | Osimertinib
+BMGC_DG15053,BMG_DG187615,PubChem SID:405055698 | PubChem CID:71496459 | CAS RN:1421373-99-0 | UNII:NI2ZUZ6F4O | AZ-7550
+BMGC_DG15054,BMG_DG187616,UNII:2DWZ6SE1E1 | PubChem SID:405054996 | N-[2-[2-(dimethylamino)ethyl-methylamino]-5-[[4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxyphenyl]prop-2-enamide | AZ5104 | AZ-5104 | PubChem CID:71496460 | CAS RN:1421373-98-9
+BMGC_DG15055,BMG_DG187625,CAS RN:1407150-85-9 | 2-AMINOTHIAZOLOBENZAZEPINE | UNII:U3Q7MK2GQ8 | PubChem CID:71500036 | PubChem SID:434369839
+BMGC_DG15056,BMG_DG187640,"CAS RN:1428862-32-1 | PubChem CID:71508291 | PubChem SID:333495869 | UNII:GNQ25KYD72 | USMARAPRIDE | Suvn-d4010 | 2-[1-(3-methoxypropyl)piperidin-4-yl]-5-(1-propan-2-ylindazol-3-yl)-1,3,4-oxadiazole"
+BMGC_DG15057,BMG_DG187643,"Pri-724 | UNII:43Y934BBZ6 | PubChem SID:461432375 | [4-[[(6S,9S,9aS)-1-(benzylcarbamoyl)-2,9-dimethyl-4,7-dioxo-8-(quinolin-8-ylmethyl)-3,6,9,9a-tetrahydropyrazino[2,1-c][1,2,4]triazin-6-yl]methyl]phenyl] dihydrogen phosphate | CAS RN:1422253-38-0 | DrugBank ID:DB15034 | PubChem CID:71509318 | FOSCENVIVINT | CAS RN:1198780-38-9"
+BMGC_DG15058,BMG_DG187645,methyl pyridine-3-carboxylate | METHYL NICOTINATE | DrugBank ID:DB13882 | CAS RN:93-60-7 | PubChem CID:7151 | UNII:7B1AVU9DJN | Methyl Nicotinate | Methyl nicotinate | PubChem SID:175266364
+BMGC_DG15059,BMG_DG187656,PubChem SID:198962899 | CAS RN:1262780-97-1 | DrugBank ID:DB12865 | UNII:60ME133FJB | PubChem CID:71511839 | ETELCALCETIDE | (2R)-3-[[(2S)-2-acetamido-3-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-[[(2R)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-oxopropyl]disulfanyl]-2-aminopropanoic acid | Etelcalcetide
+BMGC_DG15060,BMG_DG187679,"PubChem CID:71520717 | CAS RN:1418033-25-6 | N-((6-(hydroxyamino)-6-oxohexyl)oxy)-3,5-dimethylbenzamide | N-[6-(hydroxyamino)-6-oxohexoxy]-3,5-dimethylbenzamide"
+BMGC_DG15061,BMG_DG187683,"Vlx1570 | PubChem CID:71523377 | CAS RN:1956378-23-6 | PubChem SID:333495728 | CAS RN:1431280-51-1 | (3E,5E)-3,5-bis[(4-fluoro-3-nitrophenyl)methylidene]-1-prop-2-enoylazepan-4-one | UNII:K6067N5M6N | VLX-1570"
+BMGC_DG15062,BMG_DG187686,"CAS RN:6808-56-6 | PubChem SID:198947647 | UNII:VY8C9191MJ | PubChem CID:71524613 | NANDININE, (-)-"
+BMGC_DG15063,BMG_DG187688,"6-ethyl-5-[3-(3-methoxy-5-pyridin-4-ylphenyl)but-1-ynyl]pyrimidine-2,4-diamine | PubChem CID:71525312 | 6-Ethyl-5-[3-(3-methoxy-5-pyridin-4-ylphenyl)but-1-ynyl]pyrimidine-2,4-diamine"
+BMGC_DG15064,BMG_DG187700,"UNII:55MOB566V7 | PubChem CID:71528768 | LASCUFLOXACIN | 7-[(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidin-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxoquinoline-3-carboxylic acid | Lascufloxacin | PubChem SID:249492198 | CAS RN:848416-07-9"
+BMGC_DG15065,BMG_DG187705,MECOPROP | CAS RN:7085-19-0 | PubChem SID:198939398 | UNII:74N8TKR9P8 | Mecoprop | CAS RN:93-65-2 | 2-(4-chloro-2-methylphenoxy)propanoic acid | PubChem CID:7153
+BMGC_DG15066,BMG_DG187709,PubChem CID:71532123 | PIFLUFOLASTAT | (2S)-2-[[(1S)-1-carboxy-5-[(6-fluoropyridine-3-carbonyl)amino]pentyl]carbamoylamino]pentanedioic acid | UNII:82VH67YON8 | CAS RN:1423758-00-2 | PubChem SID:198989876 | Dcfpyl
+BMGC_DG15067,BMG_DG187714,"Decoglurant | DECOGLURANT | 5-[2-[7-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]ethynyl]pyridin-2-amine | CAS RN:911115-16-7 | UNII:5VX4P0JKC5 | PubChem CID:71533696 | DrugBank ID:DB11923 | PubChem SID:198990157"
+BMGC_DG15068,BMG_DG187716,"1-[(3R,4R)-3-[[5-chloro-2-[(1-methylpyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxymethyl]-4-methoxypyrrolidin-1-yl]prop-2-en-1-one | Pf-06459988 | UNII:5IE92SK9EB | DrugBank ID:DB14768 | CAS RN:1428774-45-1 | PubChem SID:346539026 | PubChem CID:71535003 | PF-06459988"
+BMGC_DG15069,BMG_DG187718,"N-[(8R)-4-(1-methyl-2-oxo-3,4-dihydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl]propanamide | UNII:NF3P9Z8J5Y | CAS RN:1428652-17-8 | Baxdrostat | PubChem SID:461434929 | BAXDROSTAT | PubChem CID:71535962"
+BMGC_DG15070,BMG_DG187730,"UNII:IZ2GRM2YZB | BAY-1128688 | 3-[[(8S,9S,13S,14S)-17-(5-fluoropyridin-3-yl)-13-methyl-6,7,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthrene-3-carbonyl]-methylamino]propanoic acid | CAS RN:1428988-21-9 | beta-Alanine, N-((17-(5-fluoro-3-pyridinyl)estra-1,3,5(10),16-tetraen-3-yl)carbonyl)-N-methyl- | PubChem SID:375083858 | PubChem CID:71542153"
+BMGC_DG15071,BMG_DG187731,PubChem SID:485665916 | CAS RN:1357471-57-8 | UNII:6M5CL626MU | PubChem CID:71542350 | TJ-M2010-5
+BMGC_DG15072,BMG_DG187732,"PubChem SID:252823697 | ISOBUTYLAMIDO THIAZOLYL RESORCINOL | Isobutylamido thiazolyl resorcinol | UNII:OH3UOW0EHH | CAS RN:1428450-95-6 | N-[4-(2,4-dihydroxyphenyl)-1,3-thiazol-2-yl]-2-methylpropanamide | PubChem CID:71543007"
+BMGC_DG15073,BMG_DG187733,"UNII:54T74394F8 | PubChem SID:433968918 | IADADEMSTAT | 4-N-[(1R,2S)-2-phenylcyclopropyl]cyclohexane-1,4-diamine | CAS RN:1431304-21-0 | Iadademstat | PubChem CID:71543365"
+BMGC_DG15074,BMG_DG187737,"PubChem CID:71544786 | UNII:T672P80L2S | NDC:69639-102 | DrugBank ID:DB14019 | CAS RN:1703748-89-3 | FOSNETUPITANT | [4-[5-[[2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoyl]-methylamino]-4-(2-methylphenyl)pyridin-2-yl]-1-methylpiperazin-1-ium-1-yl]methyl hydrogen phosphate | PubChem SID:252164971 | Fosnetupitant | NDC:69639-105 | NDC:69639-106"
+BMGC_DG15075,BMG_DG187740,IZUFORANT | Izuforant | CAS RN:1429374-83-3 | PubChem SID:474492332 | PubChem CID:71547284 | UNII:IZ2A6R2JAL
+BMGC_DG15076,BMG_DG187741,"CAS RN:1379397-83-7 | UNII:5T8Q3Q8478 | N-(3-(1,1-DIMETHYLETHYL)-1-(4-METHYLPHENYL)-1H-PYRAZOL-5-YL)-N'-(4-((2-(PHENYLAMINO)-4-PYRIMIDINYL)OXY)-1-NAPHTHALENYL)UREA | PubChem CID:71547929"
+BMGC_DG15077,BMG_DG187744,"UNII:VWJ4VVZ3OU | Bms-962212 | PubChem CID:71548883 | PubChem SID:377308940 | BMS-962212 | CAS RN:1430114-34-3 | 4-[[(1S)-2-[(E)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1H-isoquinoline-1-carbonyl]amino]benzoic acid"
+BMGC_DG15078,BMG_DG187752,PubChem SID:441097467 | PubChem CID:71552369 | CAS RN:1433497-19-8 | LY-2955303 | UNII:EGR6ZG7M0Z
+BMGC_DG15079,BMG_DG187758,"UNII:Y7HJ4D4CRT | ODM-203 | Odm-203 | CAS RN:1814961-19-7 | PubChem SID:461434881 | N-[3-(2,4-difluorophenyl)-5-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]cyclopropanesulfonamide | CAS RN:1430723-35-5 | PubChem CID:71554322"
+BMGC_DG15080,BMG_DG187765,"UNII:U29GY32XJ4 | PubChem SID:375084011 | [4-[3-[5-[[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]methyl]benzotriazol-1-yl]propyl-methylamino]cyclohexyl] 2-hydroxy-2,2-dithiophen-2-ylacetate | Azd8871 | CAS RN:1435519-06-4 | PubChem CID:71558565 | NAVAFENTEROL"
+BMGC_DG15081,BMG_DG187769,"PubChem CID:71560291 | 5-[3-(3-methoxy-5-pyridin-4-ylphenyl)but-1-ynyl]-6-methylpyrimidine-2,4-diamine | 5-[3-(3-Methoxy-5-pyridin-4-ylphenyl)but-1-ynyl]-6-methylpyrimidine-2,4-diamine"
+BMGC_DG15082,BMG_DG187771,"Asnuciclib | ASNUCICLIB | 3-[[5-fluoro-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide | PubChem CID:71561915 | PubChem SID:474493993 | UNII:235XBY3N9F | CAS RN:1421693-22-2"
+BMGC_DG15083,BMG_DG187772,"VALINE, D- | UNII:Y14I1443UR | PubChem CID:71563 | PubChem SID:198952449 | CAS RN:640-68-6"
+BMGC_DG15084,BMG_DG187773,"(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,6R)-7-(1-adamantyl)-6-hydroxyhept-4-yn-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-methylidenecyclohexane-1,3-diol | PubChem CID:71563370 | (1r,3r,7e,17beta)-17-{(2r,6r)-6-Hydroxy-7-[(3s,5s,7s)-Tricyclo[3.3.1.1~3,7~]dec-1-Yl]hept-4-Yn-2-Yl}-2-Methylidene-9,10-Secoestra-5,7-Diene-1,3-Diol"
+BMGC_DG15085,BMG_DG187779,UNII:0N15II81VX | Nivasorexant | PubChem SID:445498773 | NIVASOREXANT | [4-methyl-2-(triazol-2-yl)phenyl]-[(3R)-3-[[3-(triazol-2-yl)phenyl]methyl]morpholin-4-yl]methanone | PubChem CID:71566267 | CAS RN:1435480-40-2
+BMGC_DG15086,BMG_DG187781,"PubChem CID:71566778 | Opiranserin | OPIRANSERIN | PubChem SID:346538452 | UNII:AP031EC2NI | CAS RN:1441000-45-8 | 4-butoxy-N-[[4-(dimethylamino)oxan-4-yl]methyl]-3,5-dimethoxybenzamide"
+BMGC_DG15087,BMG_DG187782,"PubChem CID:71567 | CAS RN:673-06-3 | PubChem SID:198948584 | DrugBank ID:DB02556 | UNII:032K16VRCU | PHENYLALANINE, D- | D-Phenylalanine"
+BMGC_DG15088,BMG_DG187794,PubChem SID:312524813 | PF-06282999 | PubChem CID:71571306 | DrugBank ID:DB11683 | CAS RN:1435467-37-0 | UNII:YO3O4Q2NC8 | Pf-06282999 | 2-[6-(5-chloro-2-methoxyphenyl)-4-oxo-2-sulfanylidenepyrimidin-1-yl]acetamide
+BMGC_DG15089,BMG_DG187797,UNII:U374135N48 | Tirabrutinib Hydrochloride | CAS RN:1439901-97-9 | TIRABRUTINIB HYDROCHLORIDE | PubChem CID:71571562 | 6-amino-9-[(3R)-1-but-2-ynoylpyrrolidin-3-yl]-7-(4-phenoxyphenyl)purin-8-one;hydrochloride | PubChem SID:317229762
+BMGC_DG15090,BMG_DG187799,PubChem CID:71572 | PubChem SID:198974683 | UNII:YB79F3XB1G | CAS RN:824-75-9 | 4-FLUOROBENZAMIDE
+BMGC_DG15091,BMG_DG187823,"PubChem CID:71577426 | PubChem SID:348481525 | TELAGLENASTAT | DrugBank ID:DB15232 | N-[6-[4-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide | CAS RN:1439399-58-2 | UNII:U6CL98GLP4 | Telaglenastat"
+BMGC_DG15092,BMG_DG187954,"CAS RN:1441057-15-3 | BMS-963272 | PubChem CID:71582672 | UNII:0V8WFB28CB | PubChem SID:485661318 | (2S)-4-(4-methylphenyl)-5-(2H-tetrazol-5-yl)-2-[4-(4,4,4-trifluorobutoxy)phenyl]-2-(trifluoromethyl)-1,3-dihydropyridin-6-one"
+BMGC_DG15093,BMG_DG187957,CAS RN:37951-12-5 | UNII:C1T5NW58W3 | PubChem CID:715840 | BIS(4-METHOXYBENZYLIDENE)ACETONE | PubChem SID:441659028
+BMGC_DG15094,BMG_DG187959,"DrugBank ID:DB14840 | NDC:73207-101 | Ripretinib | 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea | PubChem CID:71584930 | UNII:9XW757O13D | PubChem SID:381132311 | RIPRETINIB | CAS RN:1442472-39-0"
+BMGC_DG15095,BMG_DG187986,UNII:A585MN1H2L | CAS RN:110070-78-5 | MONTMORILLONITE | UNII:A3N5ZCN45C | BENTONITE | CAS RN:1318-93-0 | PubChem CID:71586775 | Bentonite | CAS RN:1302-78-9 | dialuminum;dioxosilane;oxygen(2-);hydrate | PubChem SID:175266572 | DrugBank ID:DB13654 | PubChem SID:383470503 | Montmorillonite
+BMGC_DG15096,BMG_DG188118,UNII:6QT214X4XU | PubChem SID:198952306 | dialuminum;2-acetyloxybenzoic acid;oxygen(2-) | CAS RN:9014-67-9 | DrugBank ID:DB13509 | ALOXIPRIN | Aloxiprin | PubChem CID:71586929
+BMGC_DG15097,BMG_DG188130,Aluminum chlorohydrate | PubChem CID:71586946 | DrugBank ID:DB11573
+BMGC_DG15098,BMG_DG188194,"CAS RN:17427-14-4 | 2-acetamidoacetic acid;2,2,2-trichloroethane-1,1-diol | Acetylglycinamide chloral hydrate | ACETYLGLYCINAMIDE CHLORAL HYDRATE | UNII:6WZ3595RLZ | PubChem SID:198935748 | DrugBank ID:DB13402 | PubChem CID:71587019"
+BMGC_DG15099,BMG_DG188280,"chromium(3+);(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate | PubChem CID:71587119 | CHROMIUM GLUCONATE | DrugBank ID:DB14528 | UNII:V236ZVR3RL | CAS RN:33661-40-4 | PubChem SID:175266773 | Chromium gluconate"
+BMGC_DG15100,BMG_DG188356,"magnesium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate;dihydrate | Magnesium D-gluconate (1:2) hydrate | CAS RN:59625-89-7 | MAGNESIUM GLUCONATE | PubChem SID:175266659 | DrugBank ID:DB13749 | Magnesium gluconate | PubChem CID:71587201 | UNII:T42NAD2KHC"
+BMGC_DG15101,BMG_DG188501,"PubChem SID:198974066 | UNII:PYI73UAY3K | CAS RN:95720-02-8 | .DELTA.3-TETRAHYDROCANNABINOL, (S)- | PubChem CID:71587360"
+BMGC_DG15102,BMG_DG188752,PubChem CID:71587645 | UNII:LXI28K87U3 | PubChem SID:198951139 | CAS RN:219920-81-7 | BISNORCYMSERINE
+BMGC_DG15103,BMG_DG188855,EC-17 | DrugBank ID:DB12559 | PubChem CID:71587764
+BMGC_DG15104,BMG_DG188863,"UNII:P3LKY4ZL5O | MK-0812 | PubChem SID:198941604 | (3S,4S)-3-methoxy-N-[(1R,3S)-3-propan-2-yl-3-[[3-(trifluoromethyl)-7,8-dihydro-5H-1,6-naphthyridin-6-yl]methyl]cyclopentyl]oxan-4-amine | DrugBank ID:DB11990 | CAS RN:624733-88-6 | D-Erythro-pentitol, 1,5-anhydro-2,3-dideoxy-3-(((1R,3S)-3-((7,8-dihydro-3-(trifluoromethyl)-1,6-naphthyridin-6(5H)-yl)carbonyl)-3-(1-methylethyl)cyclopentyl)amino)-4-o-methyl- | PubChem CID:71587773"
+BMGC_DG15105,BMG_DG188898,PubChem CID:71587812 | DrugBank ID:DB11863 | Alvelestat
+BMGC_DG15106,BMG_DG188951,DrugBank ID:DB11918 | PubChem CID:71587872 | Guadecitabine
+BMGC_DG15107,BMG_DG188977,"(3R)-3-[[4-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1,1-diethoxypentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoyl]amino]-4-(trimethylazaniumyl)butanoate | PubChem CID:71587904 | PubChem SID:198975987 | C-101 | L-Aminocarnityl-succinyl-leucyl-argininal-diethylacetal | DrugBank ID:DB06124 | CAS RN:1006685-44-4 | UNII:BK727F83NO"
+BMGC_DG15108,BMG_DG189018,"PubChem CID:71587953 | UNII:WYD79216A6 | TENAPANOR | PubChem SID:198966338 | CAS RN:1234423-95-0 | 1-[2-[2-[2-[[3-[(4S)-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylamino]ethoxy]ethoxy]ethyl]-3-[4-[2-[2-[2-[[3-[(4S)-6,8-dichloro-2-methyl-3,4-dihydro-1H-isoquinolin-4-yl]phenyl]sulfonylamino]ethoxy]ethoxy]ethylcarbamoylamino]butyl]urea | DrugBank ID:DB11761 | Tenapanor"
+BMGC_DG15109,BMG_DG189077,"(2R)-2-(4-fluorophenyl)-N-[4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]propanamide | UNII:02Y3Z2756M | CAS RN:1443763-60-7 | PubChem SID:329589157 | PubChem CID:71599640 | Empesertib | CAS RN:1443764-31-5 | EMPESERTIB"
+BMGC_DG15110,BMG_DG189081,"UPROLESELAN | PubChem CID:71600085 | CAS RN:1983970-12-2 | Uproleselan | UNII:PE952ANF83 | (2S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2-[(1R,2R,3S,5R)-3-ethyl-5-[2-[3-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]propanoylamino]ethylcarbamoyl]-2-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3-cyclohexylpropanoic acid | PubChem SID:346538460 | DrugBank ID:DB14829"
+BMGC_DG15111,BMG_DG189082,"Mivebresib | MIVEBRESIB | PubChem CID:71600087 | N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide | UNII:VR86R11J7J | CAS RN:1445993-26-9 | PubChem SID:346540190"
+BMGC_DG15112,BMG_DG189085,CAS RN:1078-38-2 | Acetylisoniazid | PubChem CID:71602 | ACETYLISONIAZID | N'-acetylpyridine-4-carbohydrazide | PubChem SID:198969169 | UNII:J42942UVUN
+BMGC_DG15113,BMG_DG189086,2-hydroxy-6-[[2-(2-propan-2-ylpyrazol-3-yl)pyridin-3-yl]methoxy]benzaldehyde | CAS RN:1446321-46-5 | NDC:72786-102 | PubChem CID:71602803 | Voxelotor | DrugBank ID:DB14975 | NDC:72786-101 | VOXELOTOR | PubChem SID:329903743 | UNII:3ZO554A4Q8 | NDC:72786-111
+BMGC_DG15114,BMG_DG189109,"4-[[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl]piperazin-2-one | CAS RN:1443530-05-9 | UNII:98BSN6N516 | PubChem CID:71611869 | Rogaratinib | PubChem SID:317228941 | ROGARATINIB | DrugBank ID:DB15078"
+BMGC_DG15115,BMG_DG189111,"LEO-39652 | PubChem CID:71611998 | 2-methylpropyl 1-[8-methoxy-5-(1-oxo-3H-2-benzofuran-5-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropane-1-carboxylate | UNII:MUY3M35C3Q | CAS RN:1445656-91-6 | PubChem SID:485665184"
+BMGC_DG15116,BMG_DG189114,"PubChem SID:198946923 | (3S,5S,8R,9S,10S,13S,14S,16R)-16-bromo-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one | CAS RN:28507-02-0 | UNII:9735KA370S | 16alpha-Bromoepiandrosterone | 16-Bromoepiandrosterone | DrugBank ID:DB05107 | PubChem CID:71613 | 16.ALPHA.-BROMOEPIANDROSTERONE"
+BMGC_DG15117,BMG_DG189118,"NDC:39822-1077 | NDC:70436-230 | NDC:27241-063 | PubChem SID:198945259 | NDC:59762-0936 | NDC:63629-8734 | NDC:65219-190 | NDC:70710-1247 | NDC:60687-273 | NDC:16714-198 | CAS RN:137234-62-9 | NDC:65162-913 | NDC:68462-572 | CAS RN:188416-29-7 | NDC:55150-321 | NDC:59762-0934 | NDC:71288-027 | NDC:27241-062 | NDC:0378-1626 | NDC:0781-5668 | NDC:63739-008 | VORICONAZOLE, (+/-)- | NDC:65862-891 | DrugBank ID:DB00582 | NDC:0904-7024 | NDC:14335-220 | NDC:0378-1640 | NDC:70594-067 | NDC:16714-199 | Voriconazole | NDC:65841-830 | NDC:0904-6596 | PubChem CID:71616 | NDC:68083-321 | NDC:70771-1413 | (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1,2,4-triazol-1-yl)butan-2-ol | NDC:43547-378 | NDC:72578-062 | NDC:72266-131 | NDC:72843-441 | NDC:70436-029 | NDC:0781-3416 | NDC:59762-0935 | NDC:40032-038 | NDC:68462-573 | CAS RN:173967-54-9 | NDC:43386-088 | NDC:31722-224 | NDC:65862-892 | NDC:0049-3180 | NDC:0049-4190 | NDC:72578-063 | UNII:USG4B1CD29 | UNII:JFU09I87TR | VORICONAZOLE, (±)- | NDC:72572-875 | PubChem SID:175268219 | VORICONAZOLE | NDC:47781-466 | NDC:50268-803 | NDC:43386-038 | NDC:43386-089 | NDC:0049-3170 | NDC:0049-3160 | NDC:43547-377 | NDC:65841-831 | NDC:60687-294 | NDC:0049-3190 | NDC:0781-5667"
+BMGC_DG15118,BMG_DG189119,"PubChem SID:376231572 | CAS RN:1445847-37-9 | PubChem CID:71616860 | 9-(2-cyclopropylethynyl)-2-[[(2S)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one | UNII:K9WR6LRA5D | GLPG-1205 | Glpg-1205 | DrugBank ID:DB15346"
+BMGC_DG15119,BMG_DG189130,"FUTIBATINIB | CAS RN:1814961-20-0 | 1-[(3S)-3-[4-amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one | UNII:4B93MGE4AL | PubChem SID:346536891 | PubChem CID:71621331 | DrugBank ID:DB15149 | NDC:64842-0120 | Futibatinib | CAS RN:1448169-71-8"
+BMGC_DG15120,BMG_DG189134,"Ivarmacitinib | UNII:K6K4B9Z5TV | IVARMACITINIB | (3aS,6aR)-N-(3-methoxy-1,2,4-thiadiazol-5-yl)-5-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2-carboxamide | PubChem CID:71622431 | CAS RN:1445987-21-2 | PubChem SID:459055329"
+BMGC_DG15121,BMG_DG189137,"(2R)-2-[3-chloro-4-(2,2,2-trifluoroethoxy)-5-[4-(trifluoromethyl)phenyl]phenyl]-3-cyclobutylpropanoic acid | (r)-2-(5-Chloro-6-(2,2,2-trifluoroethoxy)-4'-(trifluoromethyl)biphenyl-3-yl)-3-cyclobutylpropanoic acid | PubChem CID:71623049 | CAS RN:1447811-26-8"
+BMGC_DG15122,BMG_DG189212,CAS RN:522-18-9 | PubChem CID:71636 | UNII:N52918SLYN | 1-[2-[(2-chlorophenyl)-phenylmethoxy]ethyl]-4-[(2-methylphenyl)methyl]piperazine | Chlorbenzoxamine | CHLORBENZOXAMINE | PubChem SID:198977114 | DrugBank ID:DB13788
+BMGC_DG15123,BMG_DG189219,ETHYL BENZOATE | PubChem SID:198952955 | ethyl benzoate | CAS RN:93-89-0 | Ethyl benzoate | UNII:J115BRJ15H | PubChem CID:7165
+BMGC_DG15124,BMG_DG189223,PubChem CID:71651 | CAS RN:3440-28-6 | UNII:3W0M245736 | BETAMIPRON | PubChem SID:198954096 | Betamipron | 3-benzamidopropanoic acid
+BMGC_DG15125,BMG_DG189225,"6-chloro-3-(3-methylpentan-2-yl)-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | PubChem CID:71652 | MEBUTIZIDE | DrugBank ID:DB13430 | Mebutizide | UNII:7738AS8324 | CAS RN:3568-00-1 | PubChem SID:198982857"
+BMGC_DG15126,BMG_DG189228,UNII:6CTK2FB9QM | PubChem SID:198950312 | HYDRACARBAZINE | PubChem CID:71653 | Hydracarbazine | CAS RN:3614-47-9 | DrugBank ID:DB09243 | 6-hydrazinylpyridazine-3-carboxamide
+BMGC_DG15127,BMG_DG189231,"S-55746 | UNII:W93257I68I | PubChem SID:461433802 | PubChem CID:71654876 | CAS RN:1448584-12-0 | N-(4-hydroxyphenyl)-3-[6-[(3S)-3-(morpholin-4-ylmethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]-1,3-benzodioxol-5-yl]-N-phenyl-5,6,7,8-tetrahydroindolizine-1-carboxamide"
+BMGC_DG15128,BMG_DG189232,DrugBank ID:DB13597 | PubChem CID:71655 | CAS RN:3731-59-7 | PubChem SID:198975342 | Moroxydine | N-(diaminomethylidene)morpholine-4-carboximidamide | UNII:O611591WAH | MOROXYDINE
+BMGC_DG15129,BMG_DG189236,"PubChem SID:310825786 | Ivosidenib | IVOSIDENIB | CAS RN:1448347-49-6 | NDC:72694-617 | DrugBank ID:DB14568 | PubChem CID:71657455 | UNII:Q2PCN8MAM6 | (2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide"
+BMGC_DG15130,BMG_DG189237,"Abx-1431 | PubChem SID:402404524 | CAS RN:1446817-84-0 | UNII:FB39E94UXK | 1,1,1,3,3,3-hexafluoropropan-2-yl 4-[[2-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate | PubChem CID:71657619 | ELCUBRAGISTAT"
+BMGC_DG15131,BMG_DG189245,"UNII:Y68179SY2L | PubChem SID:251965767 | PubChem CID:71661158 | CAS RN:2101630-92-4 | CAS RN:459831-08-4 | 2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gallium-68(3+) | EDOTREOTIDE GALLIUM GA-68 | Edotreotide Gallium Ga-68 | NDC:24417-681"
+BMGC_DG15132,BMG_DG189248,"Elbasvir | PubChem SID:198948863 | ELBASVIR | PubChem CID:71661251 | methyl N-[(2S)-1-[(2S)-2-[5-[(6S)-3-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6-phenyl-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate | CAS RN:1370468-36-2 | NDC:0006-3074 | DrugBank ID:DB11574 | UNII:632L571YDK"
+BMGC_DG15133,BMG_DG189249,4-[2-[6-(4-methylpiperazine-1-carbonyl)naphthalen-2-yl]ethylamino]quinazoline-6-carbonitrile | SENEXIN B | PubChem SID:434370069 | CAS RN:1449228-40-3 | PubChem CID:71661259 | UNII:E2X758P2BZ | Senexin B
+BMGC_DG15134,BMG_DG189250,PubChem CID:71661716 | PubChem SID:346540238 | AM-4054 | UNII:EB2LY5BFGL | CAS RN:1434124-99-8
+BMGC_DG15135,BMG_DG189254,"CAS RN:1431326-61-2 | PubChem CID:71664305 | UNII:G02YXY861Q | PubChem SID:461432521 | 4-N-[(1R,2S)-2-phenylcyclopropyl]cyclohexane-1,4-diamine;dihydrochloride | CAS RN:1431303-72-8 | Iadademstat dihydrochloride | IADADEMSTAT DIHYDROCHLORIDE"
+BMGC_DG15136,BMG_DG189262,"UNII:G5Y3F1X9MU | DrugBank ID:DB12106 | Pf-06305591 | PubChem SID:312524759 | PF-06305591 | PubChem CID:71666749 | CAS RN:1449473-97-5 | (2R,3S)-3-amino-3-(6-tert-butyl-1H-benzimidazol-2-yl)-2-methylpropanamide"
+BMGC_DG15137,BMG_DG189264,6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide | NAQUOTINIB | Naquotinib | PubChem CID:71667668 | CAS RN:1448232-80-1 | PubChem SID:310825772 | DrugBank ID:DB12036 | UNII:47DD4548PB
+BMGC_DG15138,BMG_DG189297,DrugBank ID:DB09246 | UNII:XC9FY2SGBG | Benmoxin | PubChem CID:71671 | CAS RN:7654-03-7 | PubChem SID:198985850 | N'-(1-phenylethyl)benzohydrazide | BENMOXIN
+BMGC_DG15139,BMG_DG189300,"[(2R,3S,4R,6S)-6-[(2'R,3'S,3aR,4R,4'R,6S,7aR)-6-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4S,5S,6S)-6-[(2R,3aS,3'aR,6'R,7R,7'S,7aR,7'aR)-7'-acetyl-7'-hydroxy-6'-methyl-7-(2-methylpropanoyloxy)spiro[4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-2,4'-6,7a-dihydro-3aH-[1,3]dioxolo[4,5-c]pyran]-6-yl]oxy-4-hydroxy-5-methoxy-2-(methoxymethyl)oxan-3-yl]oxy-3-hydroxy-5-methoxy-6-methyloxan-4-yl]oxy-4'-hydroxy-2',4,7a-trimethylspiro[3a,4,6,7-tetrahydro-[1,3]dioxolo[4,5-c]pyran-2,6'-oxane]-3'-yl]oxy-4-hydroxy-2-methyloxan-3-yl] 3,5-dichloro-4-hydroxy-2-methoxy-6-methylbenzoate | CAS RN:69787-79-7 | CAS RN:11051-71-1 | Avilamycin | PubChem CID:71674 | DrugBank ID:DB11375"
+BMGC_DG15140,BMG_DG189307,"Siremadlin | PubChem SID:346540402 | PubChem CID:71678098 | CAS RN:1448867-41-1 | SIREMADLIN | (4S)-5-(5-chloro-1-methyl-2-oxopyridin-3-yl)-4-(4-chlorophenyl)-2-(2,4-dimethoxypyrimidin-5-yl)-3-propan-2-yl-4H-pyrrolo[3,4-d]imidazol-6-one | UNII:0282IF4JC8"
+BMGC_DG15141,BMG_DG189311,"MELADRAZINE | PubChem CID:71679 | 2-N,2-N,4-N,4-N-tetraethyl-6-hydrazinyl-1,3,5-triazine-2,4-diamine | UNII:2V6Z0JG2X0 | CAS RN:13957-36-3 | DrugBank ID:DB13272 | Meladrazine | PubChem SID:198989292"
+BMGC_DG15142,BMG_DG189315,CAS RN:24332-98-7 | Methyl beta-L-fucopyranoside | METHYL .BETA.-L-FUCOPYRANOSIDE | PubChem CID:7167925 | PubChem SID:375579549 | DrugBank ID:DB03194 | UNII:WW71PB1NF3
+BMGC_DG15143,BMG_DG189327,CAS RN:1438280-73-9 | PubChem CID:71682591 | PubChem SID:461434903 | UNII:YS8VEM6ZWU | 1Z-105
+BMGC_DG15144,BMG_DG189343,"PubChem SID:485662426 | 5-Furyl-1,2-dihydro-3H-1,2,4-triazole-3-thione | CAS RN:35771-65-4 | 5-FURYL-1,2-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE | PubChem CID:716904 | UNII:PFG8W7G8XG"
+BMGC_DG15145,BMG_DG189355,PubChem SID:198984066 | CAS RN:22494-47-9 | UNII:W3D7B06505 | PubChem CID:71697 | CLOBUZARIT
+BMGC_DG15146,BMG_DG189357,UNII:00Q31ER368 | DrugBank ID:DB13530 | MEPINDOLOL | PubChem CID:71698 | 1-[(2-methyl-1H-indol-4-yl)oxy]-3-(propan-2-ylamino)propan-2-ol | CAS RN:23694-81-7 | PubChem SID:198979934 | Mepindolol
+BMGC_DG15147,BMG_DG189359,"(1R,3S,5E)-5-[(2E)-2-[(1R,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | PubChem CID:71699993 | CAS RN:32222-06-3"
+BMGC_DG15148,BMG_DG189373,"DS-1971 | PubChem CID:71711862 | PubChem SID:310825739 | CAS RN:1450595-86-4 | 5-chloro-2-fluoro-4-[(1S,2R)-2-(2-methylpyrazol-3-yl)cyclohexyl]oxy-N-pyrimidin-4-ylbenzenesulfonamide | DS-1971a | UNII:EHV5F71MBF"
+BMGC_DG15149,BMG_DG189374,PubChem SID:433968566 | UCT-943 | UNII:393V9PB5QE | PubChem CID:71711915
+BMGC_DG15150,BMG_DG189383,"PubChem CID:71715374 | CAS RN:1450833-55-2 | Tak-243 | [(1R,2R,3S,4R)-2,3-dihydroxy-4-[[2-[3-(trifluoromethylsulfanyl)phenyl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]cyclopentyl]methyl sulfamate | UNII:V9GGV0YCDI | DrugBank ID:DB15013 | PubChem SID:317229403 | TAK-243"
+BMGC_DG15151,BMG_DG189395,PubChem CID:7172 | PubChem SID:198973577 | OXEDRINE | CAS RN:94-07-5 | Synephrine | 4-[1-hydroxy-2-(methylamino)ethyl]phenol | DrugBank ID:DB09203 | UNII:PEG5DP7434
+BMGC_DG15152,BMG_DG189405,"PubChem SID:249817407 | UNII:1GDT36RARO | CAS RN:1454682-72-4 | PubChem CID:71721540 | 1-(3,3-dimethylbutyl)-3-[2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl]urea | LY3009120 | LY-3009120"
+BMGC_DG15153,BMG_DG189408,"CAS RN:1391712-60-9 | CEP-37440 | PubChem CID:71721648 | UNII:O3MNS8782H | DrugBank ID:DB13060 | PubChem SID:255509545 | CAS RN:1609103-92-5 | Cep-37440 | 2-[[5-chloro-2-[[(6S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide"
+BMGC_DG15154,BMG_DG189424,PubChem CID:71727581 | RAVOXERTINIB | DrugBank ID:DB15281 | UNII:R6AXV96CRH | PubChem SID:317229250 | Ravoxertinib | CAS RN:1453848-26-4 | 1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]pyridin-2-one
+BMGC_DG15155,BMG_DG189475,"LORLATINIB | NDC:63539-927 | CAS RN:1454846-35-5 | NDC:0069-0227 | PubChem CID:71731823 | NDC:0069-0231 | Lorlatinib | DrugBank ID:DB12130 | (16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile | PubChem SID:252165152 | UNII:OSP71S83EU"
+BMGC_DG15156,BMG_DG189478,CAS RN:57704-15-1 | PubChem CID:71733 | Bufuralol | PubChem SID:198940798 | UNII:891H89GFT4 | BUFURALOL | DrugBank ID:DB06726 | CAS RN:54340-62-4 | 2-(tert-butylamino)-1-(7-ethyl-1-benzofuran-2-yl)ethanol
+BMGC_DG15157,BMG_DG189484,"UNII:7Y86X0D799 | CAS RN:56187-47-4 | (6R,7R)-7-[[2-(3,5-dichloro-4-oxopyridin-1-yl)acetyl]amino]-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem CID:71736 | Cefazedone | CEFAZEDONE | PubChem SID:198990124 | DrugBank ID:DB13778"
+BMGC_DG15158,BMG_DG189486,"Asp5878 | PubChem CID:71736582 | 2-[4-[[5-[(2,6-difluoro-3,5-dimethoxyphenyl)methoxy]pyrimidin-2-yl]amino]pyrazol-1-yl]ethanol | PubChem SID:346540992 | UNII:C0Z095LL72 | CAS RN:1453208-66-6 | ASP-5878 | CAS RN:1814961-17-5"
+BMGC_DG15159,BMG_DG189500,1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol | Carazolol | PubChem SID:198974536 | UNII:29PW75S82A | PubChem CID:71739 | CARAZOLOL | CAS RN:57775-29-8
+BMGC_DG15160,BMG_DG189503,"PubChem SID:198938652 | 1-(2-chloroethyl)-1-nitroso-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl]urea | Ranimustine | CAS RN:58994-96-0 | UNII:RYH2T97J77 | PubChem CID:71741 | DrugBank ID:DB13832 | RANIMUSTINE"
+BMGC_DG15161,BMG_DG189507,"UNII:O1ZB1046R1 | PubChem CID:71743 | QUINFAMIDE | Quinfamide | [1-(2,2-dichloroacetyl)-3,4-dihydro-2H-quinolin-6-yl] furan-2-carboxylate | CAS RN:62265-68-3 | DrugBank ID:DB12780 | PubChem SID:198945587"
+BMGC_DG15162,BMG_DG189517,6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic acid | PubChem CID:71748255 | PubChem SID:472423937 | PF-06409577 | UNII:A89WAM8FBH | CAS RN:1467057-23-3 | PF-6409577
+BMGC_DG15163,BMG_DG189518,PubChem CID:71748268 | Cabamiquine | PubChem SID:433968998 | 6-fluoro-2-[4-(morpholin-4-ylmethyl)phenyl]-N-(2-pyrrolidin-1-ylethyl)quinoline-4-carboxamide | CAS RN:1469439-69-7 | UNII:E3OC1CU1F4 | CABAMIQUINE
+BMGC_DG15164,BMG_DG189528,"6-(Hydroxymethyl)androsta-1,4,6-triene-3,17-dione | PubChem CID:71748876 | (8R,9S,10R,13S,14S)-6-(hydroxymethyl)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthrene-3,17-dione | CAS RN:152764-26-6"
+BMGC_DG15165,BMG_DG189600,PROPYLPARABEN | CAS RN:94-13-3 | propyl 4-hydroxybenzoate | PubChem SID:175268039 | DrugBank ID:DB14177 | Propylparaben | UNII:Z8IX2SC1OH | PubChem CID:7175 | CAS RN:85403-59-4
+BMGC_DG15166,BMG_DG189601,"DANIQUIDONE | UNII:E780TX33D2 | PubChem SID:198964136 | Daniquidone | 8-amino-10H-isoindolo[1,2-b]quinazolin-12-one | DrugBank ID:DB12804 | CAS RN:67199-66-0 | PubChem CID:71750"
+BMGC_DG15167,BMG_DG189618,PubChem SID:496141899 | CAS RN:1346601-52-2 | UNII:ZC8GRP8M2B | 4-METHYL ERLOTINIB | PubChem CID:71750333 | 4-Methyl erlotinib
+BMGC_DG15168,BMG_DG189662,PRIFELONE | PubChem SID:198969876 | CAS RN:69425-13-4 | PubChem CID:71751 | UNII:0414BW860U
+BMGC_DG15169,BMG_DG189761,"PubChem SID:198957683 | CAS RN:2316-26-9 | PubChem CID:717531 | 3,4-DIMETHOXYCINNAMIC ACID, (E)- | (E)-3-(3,4-dimethoxyphenyl)prop-2-enoic acid | CAS RN:14737-89-4 | CAS RN:1185241-38-6 | 3,4-Dimethoxycinnamic acid | UNII:BVZ841PVJL"
+BMGC_DG15170,BMG_DG189783,"4-(6-(4-(Morpholine-4-carbonyl)phenyl)imidazo[1,2-a]pyridin-3-yl)benzonitrile | UNII:MND3WX2R7I | CAS RN:1464151-33-4 | PubChem CID:71766360 | TINODASERTIB | 4-[6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile | PubChem SID:472418978 | Tinodasertib"
+BMGC_DG15171,BMG_DG189799,"Buparvaquone | CAS RN:88426-33-9 | PubChem SID:175266939 | UNII:0354RT7LG4 | BUPARVAQUONE | PubChem CID:71768 | 3-[(4-tert-butylcyclohexyl)methyl]-4-hydroxynaphthalene-1,2-dione"
+BMGC_DG15172,BMG_DG189801,DrugBank ID:DB09068 | Vortioxetine | PubChem CID:71768094
+BMGC_DG15173,BMG_DG189845,"PubChem CID:71771 | 2-[2-[2-(2,6-dichloroanilino)phenyl]acetyl]oxyacetic acid | PubChem SID:175266371 | CAS RN:89796-99-6 | Aceclofenac | DrugBank ID:DB06736 | UNII:RPK779R03H | ACECLOFENAC"
+BMGC_DG15174,BMG_DG189880,"CAS RN:130841-26-8 | CAS RN:103055-07-8 | UNII:9CR45YMS74 | PubChem SID:318691838 | LUFENURON | Lufenuron | N-[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl]-2,6-difluorobenzamide | UNII:1R754M4918 | PubChem SID:318691266 | PubChem CID:71777 | LUFENURON, (-)- | UNII:4629851K7Q | PubChem SID:175271772 | DrugBank ID:DB11424 | LUFENURON, (+)- | CAS RN:130841-22-4"
+BMGC_DG15175,BMG_DG189894,GLEMANSERIN | PubChem SID:198943639 | UNII:X96LS7MC5Z | PubChem CID:71781 | CAS RN:132553-86-7
+BMGC_DG15176,BMG_DG189899,PubChem SID:198956535 | DrugBank ID:DB12287 | CAS RN:147025-53-4 | Talsaclidine | TALSACLIDINE | UNII:1O8VSL798T | (3R)-3-prop-2-ynoxy-1-azabicyclo[2.2.2]octane | PubChem CID:71792
+BMGC_DG15177,BMG_DG189904,"PubChem CID:71798 | methyl (1R,15S,17R,18R,19S,20S)-7,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate | PubChem SID:198947576 | UNII:8F8C1JQH53 | DrugBank ID:DB13631 | Methoserpidine | CAS RN:865-04-3 | METHOSERPIDINE"
+BMGC_DG15178,BMG_DG189905,"CAS RN:34693-23-7 | Fructose 1,6-diphosphate | [2,3,4-trihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]methyl dihydrogen phosphate | CAS RN:488-69-7 | PubChem CID:718"
+BMGC_DG15179,BMG_DG189911,"CLOMETOCILLIN | (2S,5R,6R)-6-[[2-(3,4-dichlorophenyl)-2-methoxyacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | CAS RN:1926-49-4 | Clometocillin | PubChem SID:198957643 | UNII:YI8LL014GF | DrugBank ID:DB13686 | PubChem CID:71807"
+BMGC_DG15180,BMG_DG189914,SULFAETHIDOLE | PubChem CID:7181 | PubChem SID:198941941 | CAS RN:94-19-9 | UNII:R77Q4O5ZMD
+BMGC_DG15181,BMG_DG189919,"PubChem CID:71811910 | PubChem SID:252164747 | DrugBank ID:DB12513 | N-[(4aS,6aR,6bS,8aR,12aS,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,3,4,5,6,7,8,8a,14a,14b-decahydropicen-4a-yl]-2,2-difluoropropanamide | UNII:G69Z98951Q | Omaveloxolone | OMAVELOXOLONE | NDC:64406-250 | NDC:73179-250 | CAS RN:1474034-05-3"
+BMGC_DG15182,BMG_DG189923,CAS RN:1477492-01-5 | PubChem SID:377308327 | UNII:DBIUB0EGPU | SF-0034 | PubChem CID:71812240
+BMGC_DG15183,BMG_DG189925,PXS-4728A FREE BASE | 4-[(E)-2-(aminomethyl)-3-fluoroprop-2-enoxy]-N-tert-butylbenzamide | Pxs-4728 | PubChem SID:252823889 | CAS RN:1478364-40-7 | PubChem CID:71812247 | UNII:MFI2XG2PVK
+BMGC_DG15184,BMG_DG189933,NDC:27437-051 | DrugBank ID:DB12834 | Secnidazole | CAS RN:3366-95-8 | 1-(2-methyl-5-nitroimidazol-1-yl)propan-2-ol | PubChem CID:71815 | PubChem SID:175271597 | UNII:R3459K699K | SECNIDAZOLE
+BMGC_DG15185,BMG_DG189946,1-(3-methylbenzoyl)indazole-3-carbonitrile | PubChem CID:71818549 | CAS RN:1448314-31-5 | 1-(3-Methylbenzoyl)-1H-indazole-3-carbonitrile
+BMGC_DG15186,BMG_DG189948,CAS RN:1998197-39-9 | UNII:TT8WUB7KTF | 6-METHYL-3-(2-NITRO-1-(2-THIENYL)ETHYL)-2-PHENYL-1H-INDOLE | PubChem CID:71819307
+BMGC_DG15187,BMG_DG189951,PubChem SID:198944065 | UNII:8IKK64FJVX | DrugBank ID:DB13611 | Chlormidazole | CAS RN:3689-76-7 | 1-[(4-chlorophenyl)methyl]-2-methylbenzimidazole | PubChem CID:71821 | CHLORMIDAZOLE
+BMGC_DG15188,BMG_DG189953,CAS RN:523-54-6 | UNII:861J4K81C7 | ETYMEMAZINE | PubChem SID:198953421 | PubChem CID:71823
+BMGC_DG15189,BMG_DG189963,"UNII:M4HBT852YO | GUANOCLOR | Guanoclor | DrugBank ID:DB13779 | CAS RN:551-48-4 | PubChem SID:198941664 | PubChem CID:71835 | 2-[2-(2,6-dichlorophenoxy)ethylamino]guanidine | CAS RN:5001-32-1"
+BMGC_DG15190,BMG_DG189967,butyl 4-hydroxybenzoate | DrugBank ID:DB14084 | PubChem CID:7184 | PubChem SID:175268955 | BUTYLPARABEN | CAS RN:94-26-8 | Butylparaben | UNII:3QPI1U3FV8
+BMGC_DG15191,BMG_DG189977,"Chitosan | CAS RN:9012-76-4 | methyl N-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-5-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-[(2R,3S,4R,5R,6S)-5-amino-6-[(2R,3S,4R,5R,6R)-5-amino-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-3-yl]carbamate | PubChem CID:71853"
+BMGC_DG15192,BMG_DG189981,"7-[2-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]ethyl]-1,3-dimethylpurine-2,6-dione | CAS RN:13460-98-5 | Theodrenaline | PubChem CID:71857 | DrugBank ID:DB12927 | PubChem SID:198952243 | THEODRENALINE | UNII:RW8PD99T8G"
+BMGC_DG15193,BMG_DG189984,(2-hydroxy-2-phenylethyl) carbamate | PubChem SID:198953784 | STYRAMATE | UNII:CBK7Y28SP3 | CAS RN:94-35-9 | CAS RN:807334-25-4 | Styramate | PubChem CID:7186 | DrugBank ID:DB13357
+BMGC_DG15194,BMG_DG189992,Benzoyl Peroxide | BENZOYL PEROXIDE | PubChem CID:7187 | Benzoyl peroxide | CAS RN:94-36-0 | DrugBank ID:DB09096 | UNII:W9WZN9A0GM | PubChem SID:175266480 | benzoyl benzenecarboperoxoate | CAS RN:2685-64-5
+BMGC_DG15195,BMG_DG189998,DrugBank ID:DB14174 | CAS RN:94-37-1 | UNII:CR113982E5 | Dipentamethylenethiuram disulfide | DIPENTAMETHYLENETHIURAM DISULFIDE | piperidine-1-carbothioylsulfanyl piperidine-1-carbodithioate | PubChem SID:175267703 | PubChem CID:7188
+BMGC_DG15196,BMG_DG190011,"DrugBank ID:DB13736 | PubChem CID:71899 | 2-[(2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole | CAS RN:4846-91-7 | FENOXAZOLINE | PubChem SID:198934830 | UNII:97JJW1W1R3 | Fenoxazoline"
+BMGC_DG15197,BMG_DG190014,N-(2-hydroxyethyl)-3-methyl-4-oxido-1-oxoquinoxalin-1-ium-2-carboxamide | PubChem SID:198974331 | CAS RN:23696-28-8 | PubChem CID:71905 | OLAQUINDOX | UNII:G3LAW9U88T | Olaquindox
+BMGC_DG15198,BMG_DG190028,"PubChem SID:310825687 | UNII:R2H3YN6E3L | UNII:1346Q758L9 | UNII:5QKW305N9F | DrugBank ID:DB13687 | PubChem SID:198935581 | Niaprazine | CAS RN:27367-90-4 | NIAPRAZINE, (-)- | N-[4-[4-(4-fluorophenyl)piperazin-1-yl]butan-2-yl]pyridine-3-carboxamide | PubChem CID:71919 | NIAPRAZINE, (+)- | CAS RN:119328-74-4 | PubChem SID:310825943 | CAS RN:119306-37-5 | NIAPRAZINE"
+BMGC_DG15199,BMG_DG190072,5-NITROBENZIMIDAZOLE | PubChem SID:198937480 | 5-Nitrobenzimidazole | CAS RN:94-52-0 | 6-nitro-1H-benzimidazole | PubChem CID:7195 | UNII:A7V95AYT2T
+BMGC_DG15200,BMG_DG190081,PubChem CID:71955 | DrugBank ID:DB08952 | Indenolol | CAS RN:106656-86-4 | 1-(1H-inden-4-yloxy)-3-(propan-2-ylamino)propan-2-ol | 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)INDENE | PubChem SID:198980291 | CAS RN:60607-68-3 | UNII:8GU15N96I8
+BMGC_DG15201,BMG_DG190093,"ASPOXICILLIN | UNII:0745KNO26J | PubChem CID:71961 | Aspoxicillin | CAS RN:63358-49-6 | DrugBank ID:DB13816 | (2S,5R,6R)-6-[[(2R)-2-[[(2R)-2-amino-4-(methylamino)-4-oxobutanoyl]amino]-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem SID:198957836"
+BMGC_DG15202,BMG_DG190102,"UNII:876351L05K | PubChem CID:71969 | PubChem SID:175265458 | CAS RN:65896-16-4 | ROMIFIDINE | N-(2-bromo-6-fluorophenyl)-4,5-dihydro-1H-imidazol-2-amine | Romifidine | DrugBank ID:DB11543"
+BMGC_DG15203,BMG_DG190111,PubChem SID:485663376 | UNII:R23B6XSF3K | PubChem CID:719761 | CAS RN:425372-86-7 | 2-(4-BROMO-2-(TERT-BUTYL)PHENOXY)ACETIC ACID | 2-[4-Bromo-2-(tert-butyl)phenoxy]acetic acid
+BMGC_DG15204,BMG_DG190122,(2S)-2-[[(2S)-1-[(2S)-3-acetylsulfanyl-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoic acid | PubChem SID:198968997 | PubChem CID:71992 | ALACEPRIL | UNII:X39TL7JDPF | CAS RN:219554-02-6 | CAS RN:74258-86-9 | Alacepril
+BMGC_DG15205,BMG_DG190126,"CAS RN:1225528-47-1 | 3,4-DIHYDROXYBENZOIC ACID | PubChem CID:72 | DrugBank ID:DB03946 | 3,4-Dihydroxybenzoic Acid | 3,4-Dihydroxybenzoic acid | 3,4-dihydroxybenzoic acid | CAS RN:99-50-3 | PubChem SID:198940749 | UNII:36R5QJ8L4B"
+BMGC_DG15206,BMG_DG190139,UNII:9KGC55KP6A | CAS RN:86880-51-5 | Epanolol | PubChem CID:72014 | EPANOLOL | PubChem SID:198942268 | DrugBank ID:DB13757 | N-[2-[[3-(2-cyanophenoxy)-2-hydroxypropyl]amino]ethyl]-2-(4-hydroxyphenyl)acetamide
+BMGC_DG15207,BMG_DG190144,"PubChem SID:175267306 | PubChem CID:72022 | Perindoprilat | CAS RN:95153-31-4 | (2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-carboxybutyl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid | PERINDOPRILAT | DrugBank ID:DB14213 | UNII:2UV6ZNQ92K"
+BMGC_DG15208,BMG_DG190151,PubChem SID:198955168 | UNII:TDE8767O88 | PubChem CID:72027 | LEVEMOPAMIL | (2S)-5-[methyl(2-phenylethyl)amino]-2-phenyl-2-propan-2-ylpentanenitrile | Levemopamil | CAS RN:101238-51-1
+BMGC_DG15209,BMG_DG190162,MCPA | 2-(4-chloro-2-methylphenoxy)acetic acid | 2-Methyl-4-chlorophenoxyacetic Acid | PubChem SID:198987713 | UNII:D888C394VO | CAS RN:94-74-6 | PubChem CID:7204
+BMGC_DG15210,BMG_DG190166,DrugBank ID:DB11164 | ethyl (2R)-2-[2-[[(2R)-1-ethoxy-1-oxo-3-sulfanylpropan-2-yl]amino]ethylamino]-3-sulfanylpropanoate | BICISATE | PubChem SID:175267998 | CAS RN:121251-02-3 | UNII:3JXF0Z0XOI | Bicisate | PubChem CID:72048
+BMGC_DG15211,BMG_DG190170,"PubChem SID:198953428 | CAS RN:128326-82-9 | UNII:V7O1U41C9B | 1-(4,6-dichloro-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenyl)imidazole | EBERCONAZOLE | Eberconazole | PubChem CID:72051 | DrugBank ID:DB13656"
+BMGC_DG15212,BMG_DG190173,PubChem SID:198938450 | CAS RN:141579-54-6 | UNII:LG64454O6I | PubChem CID:72059 | FENLEUTON
+BMGC_DG15213,BMG_DG190175,PubChem SID:198984280 | CAS RN:6192-36-5 | CAS RN:67865-68-3 | Pheneturide | CAS RN:6509-31-5 | N-carbamoyl-2-phenylbutanamide | CAS RN:6509-32-6 | DrugBank ID:DB13362 | PHENETURIDE | UNII:878CEJ4HGX | CAS RN:90-49-3 | PubChem CID:72060
+BMGC_DG15214,BMG_DG190176,"CAS RN:145-12-0 | (8R,9S,10R,13S,14S,17S)-4,17-dihydroxy-10,13,17-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | UNII:4R73K9MRMX | Oxymesterone | PubChem SID:198967594 | PubChem CID:72061 | OXYMESTERONE"
+BMGC_DG15215,BMG_DG190179,PubChem CID:72064 | CAS RN:479-81-2 | UNII:4MGI916O6Y | BIETAMIVERINE | PubChem SID:198973917
+BMGC_DG15216,BMG_DG190190,Bamipine | CAS RN:4945-47-5 | BAMIPINE | PubChem SID:198951780 | N-benzyl-1-methyl-N-phenylpiperidin-4-amine | UNII:Y6BHZ28O92 | PubChem CID:72075 | DrugBank ID:DB13489
+BMGC_DG15217,BMG_DG190193,"DrugBank ID:DB14631 | UNII:752SY38R6C | PREDNISOLONE 21-PHOSPHATE | PubChem SID:175268829 | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate | CAS RN:302-25-0 | Prednisolone phosphate | PubChem CID:72078 | CAS RN:125-02-0"
+BMGC_DG15218,BMG_DG190197,"Terlipressin | CAS RN:914453-96-6 | UNII:7Z5X49W53P | CAS RN:14636-12-5 | DrugBank ID:DB02638 | PubChem SID:375083624 | (2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide | PubChem CID:72081 | NDC:43825-200 | TERLIPRESSIN"
+BMGC_DG15219,BMG_DG190208,Otilonium | PubChem SID:198960033 | diethyl-methyl-[2-[4-[(2-octoxybenzoyl)amino]benzoyl]oxyethyl]azanium | DrugBank ID:DB13500 | OTILONIUM | CAS RN:105360-89-2 | PubChem CID:72093 | UNII:6330179ARU
+BMGC_DG15220,BMG_DG190212,"CAS RN:37561-27-6 | UNII:N274ZQ6PZJ | 2-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-1-phenothiazin-10-ylethanone | PubChem CID:72098 | PubChem SID:198989941 | FENOVERINE | Fenoverine | DrugBank ID:DB13042"
+BMGC_DG15221,BMG_DG190213,Esflurbiprofen | CAS RN:51543-39-6 | ESFLURBIPROFEN | PubChem CID:72099 | PubChem SID:198971914 | (2S)-2-(3-fluoro-4-phenylphenyl)propanoic acid | UNII:J5ZZK9P7MX
+BMGC_DG15222,BMG_DG190218,PubChem CID:72103 | BUFROLIN | PubChem SID:198968230 | UNII:46C1PX266N | CAS RN:54867-56-0
+BMGC_DG15223,BMG_DG190220,PubChem CID:72106 | Morniflumate | CAS RN:65847-85-0 | DrugBank ID:DB09285 | UNII:R133MWH7X1 | PubChem SID:198976983 | MORNIFLUMATE | 2-morpholin-4-ylethyl 2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylate
+BMGC_DG15224,BMG_DG190228,CAS RN:94011-82-2 | PubChem SID:198961950 | PubChem CID:72119 | UNII:NU8Y4C529J | BAZINAPRINE
+BMGC_DG15225,BMG_DG190243,"CAS RN:2430-49-1 | PubChem SID:198966362 | UNII:3J2D3OVU7O | PubChem CID:72135 | Vinylbital | CAS RN:5821-16-9 | DrugBank ID:DB13770 | UNII:KI0U0LRM1V | UNII:3W58ITX06Q | VINYLBITAL, (-)- | 5-ethenyl-5-pentan-2-yl-1,3-diazinane-2,4,6-trione | PubChem SID:313184244 | CAS RN:5767-33-9 | PubChem SID:313182980 | VINYLBITAL, (+)- | VINYLBITAL"
+BMGC_DG15226,BMG_DG190247,"PubChem CID:72138 | UNII:I4O795Q03O | DrugBank ID:DB13429 | CAS RN:4201-22-3 | Tolonidine | TOLONIDINE | PubChem SID:198945701 | N-(2-chloro-4-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine"
+BMGC_DG15227,BMG_DG190248,"6-hydroxy-1,3-benzoxathiol-2-one | UNII:S0FAJ1R9CD | PubChem CID:72139 | Tioxolone | TIOXOLONE | PubChem SID:198982798 | CAS RN:4991-65-5 | DrugBank ID:DB13343"
+BMGC_DG15228,BMG_DG190249,"TOLPROPAMINE | UNII:TBZ8909KFS | PubChem CID:72141 | CAS RN:5632-44-0 | PubChem SID:198958325 | DrugBank ID:DB13305 | N,N-dimethyl-3-(4-methylphenyl)-3-phenylpropan-1-amine | Tolpropamine"
+BMGC_DG15229,BMG_DG190250,3-(4-methylmorpholin-4-ium-4-yl)-1-phenyl-1-thiophen-2-ylpropan-1-ol;iodide | PubChem CID:72142 | PubChem SID:198973838 | Tiemonium iodide | CAS RN:144-12-7 | UNII:FZ2LZ7U304 | DrugBank ID:DB13666 | TIEMONIUM IODIDE
+BMGC_DG15230,BMG_DG190253,"PubChem SID:198970648 | UNII:F4MW5166YH | PubChem CID:72145 | CAS RN:14504-73-5 | 7-amino-4,5,6-triethoxy-3-(4-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-3H-2-benzofuran-1-one | Tritoqualine | TRITOQUALINE | DrugBank ID:DB13711"
+BMGC_DG15231,BMG_DG190257,SULFIRAM | CAS RN:95-05-6 | PubChem SID:198946743 | UNII:1XHL4Q8P7Y | PubChem CID:7215
+BMGC_DG15232,BMG_DG190276,UNII:L1F3R18W77 | PubChem CID:72165228 | DrugBank ID:DB12597 | PubChem SID:313184368 | N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide | CAS RN:1492952-76-7 | Asciminib | ASCIMINIB
+BMGC_DG15233,BMG_DG190277,UNII:QB6LNL4NF6 | PubChem SID:459055835 | CAS RN:1489389-18-5 | SRA-737 | 5-[[4-[[(2R)-morpholin-2-yl]methylamino]-5-(trifluoromethyl)pyridin-2-yl]amino]pyrazine-2-carbonitrile | PubChem CID:72165232 | (R)-5-((4-((morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile
+BMGC_DG15234,BMG_DG190283,PubChem CID:72170 | PubChem SID:175266366 | UNII:3I8Y076A0E | CAS RN:55172-29-7 | NDC:69945-120 | THALLOUS CHLORIDE TL-201
+BMGC_DG15235,BMG_DG190284,Timoprazole | 2-(pyridin-2-ylmethylsulfinyl)-1H-benzimidazole | PubChem SID:198962501 | TIMOPRAZOLE | CAS RN:57237-97-5 | UNII:95H6S1X9CC | PubChem CID:72171
+BMGC_DG15236,BMG_DG190285,"(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid | PubChem SID:316910706 | Ubenimex | PubChem CID:72172 | UNII:I0J33N5627 | DrugBank ID:DB03424 | UBENIMEX | CAS RN:58970-76-6"
+BMGC_DG15237,BMG_DG190291,"PubChem CID:72185 | UNII:KZX416VN2B | PubChem SID:198945549 | Avarol | CAS RN:55303-98-5 | 2-[[(1R,2S,4aS,8aS)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl]benzene-1,4-diol | AVAROL"
+BMGC_DG15238,BMG_DG190295,"PubChem CID:72187 | PubChem SID:198981204 | CAS RN:106060-92-8 | [[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | Zidovudine triphosphate | ZIDOVUDINE TRIPHOSPHATE | UNII:6RGF96R053 | CAS RN:92586-35-1"
+BMGC_DG15239,BMG_DG190297,UNII:IYT6MP4NS9 | DrugBank ID:DB11839 | CAS RN:371131-16-7 | PubChem SID:198939967 | N-[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]hexadecanamide | PubChem CID:72187679 | Pz-128 | PZ-128
+BMGC_DG15240,BMG_DG190305,"PubChem SID:375085891 | BMS-986141 | DrugBank ID:DB14942 | PubChem CID:72188743 | Bms-986141 | CAS RN:1478711-48-6 | 4-[4-[[6-methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)-1-benzofuran-4-yl]oxymethyl]-1,3-thiazol-2-yl]-N,N-dimethylbenzamide | UNII:W530IRZ40G"
+BMGC_DG15241,BMG_DG190308,"CAS RN:1478712-37-6 | PubChem CID:72190270 | UNII:WDT28B7071 | BMS-986120 | 4-[4-[[6-methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)-1-benzofuran-4-yl]oxymethyl]-5-methyl-1,3-thiazol-2-yl]morpholine | Bms-986120 | PubChem SID:441097554"
+BMGC_DG15242,BMG_DG190309,"N-[(1S)-1-[3-fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl]-7-methoxy-2-oxo-1,3-dihydropyrido[2,3-b]pyrazine-4-carboxamide | TAK-915 | PubChem SID:346536802 | CAS RN:1476727-50-0 | UNII:0M4DME62Y9 | Tak-915 | PubChem CID:72190879"
+BMGC_DG15243,BMG_DG190314,"CAS RN:1496508-34-9 | UNII:HR4RD5RBJ6 | PubChem SID:443624378 | [(4aR)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinolin-4a-yl]-pyridin-2-ylmethanone | Dazucorilant | DAZUCORILANT | PubChem CID:72192163"
+BMGC_DG15244,BMG_DG190390,PubChem CID:72194 | DrugBank ID:DB02103 | 2-Chlorodideoxyadenosine
+BMGC_DG15245,BMG_DG190392,"N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1H-pyrazole-5-carboxamide | PubChem SID:461433163 | Fn-1501 | FN-1501 | PubChem CID:72195175 | UNII:6MC966B505 | CAS RN:1429515-59-2"
+BMGC_DG15246,BMG_DG190393,PubChem CID:72195461 | CAS RN:1436462-69-9 | PubChem SID:346541444 | N-HYDROXY-5-(1-(4-MORPHOLINOBENZYL)-1H-PYRAZOL-3-YL)PENTANAMIDE | UNII:3B8AWZC8NY
+BMGC_DG15247,BMG_DG190394,PubChem SID:346541247 | UNII:DLDATMQVL6 | N-HYDROXY-5-(1-(4-NITROBENZYL)-1H-PYRAZOL-3-YL)PENTANAMIDE | CAS RN:1436462-60-0 | PubChem CID:72195597
+BMGC_DG15248,BMG_DG190395,PubChem CID:72195598 | 5-(1-(4-BROMOBENZYL)-1H-PYRAZOL-3-YL)-NHYDROXYPENTANAMIDE | PubChem SID:346537716 | UNII:D2H3D0I22Y | CAS RN:1436462-59-7
+BMGC_DG15249,BMG_DG190402,CAS RN:95-14-7 | PubChem CID:7220 | 1H-Benzotriazole | 2H-benzotriazole | BENZOTRIAZOLE | CAS RN:273-02-9 | UNII:86110UXM5Y | CAS RN:27556-51-0 | PubChem SID:198967554
+BMGC_DG15250,BMG_DG190414,"CAS RN:1489389-23-2 | PubChem CID:72202596 | SRA-737, (S)- | UNII:LCR5PKK3H6 | PubChem SID:459055816"
+BMGC_DG15251,BMG_DG190427,"Benzothiazole | 1,3-benzothiazole | UNII:G5BW2593EP | PubChem SID:198955763 | PubChem CID:7222 | BENZOTHIAZOLE | CAS RN:95-16-9"
+BMGC_DG15252,BMG_DG190428,"2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-10,13-dimethyl-3-sulfooxy-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid | SULFOLITHOCHOLYLGLYCINE | CAS RN:64936-82-9 | PubChem SID:445500186 | CAS RN:15324-64-8 | UNII:ZH5HPJ9WHW | PubChem CID:72222 | Sulfoglycolithocholic acid"
+BMGC_DG15253,BMG_DG190431,DrugBank ID:DB04860 | Isatoribine | PubChem CID:72231
+BMGC_DG15254,BMG_DG190438,"DrugBank ID:DB03955 | 1-Deoxymannojirimycin | PubChem CID:72258 | CAS RN:84444-90-6 | (2R,3R,4R,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol | 1-deoxymannojirimycin"
+BMGC_DG15255,BMG_DG190439,"(2R,3R,4R)-2-(hydroxymethyl)piperidine-3,4-diol | PubChem SID:198961263 | UNII:1M10C1P4SM | D-Fagomine | CAS RN:53185-12-9 | D-FAGOMINE | Fagomine | PubChem CID:72259"
+BMGC_DG15256,BMG_DG190443,"PubChem SID:198960442 | (2S,3R,4R,6R,18R)-18-hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one | CAS RN:112953-11-4 | PubChem CID:72271 | DrugBank ID:DB01933 | 7-Hydroxystaurosporine | 7-HYDROXYSTAUROSPORINE | UNII:7BU5H4V94A"
+BMGC_DG15257,BMG_DG190444,"EPICATECHIN | UNII:34PHS7TU43 | PubChem SID:198956689 | (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol | DrugBank ID:DB12039 | PubChem CID:72276 | Epicatechin | CAS RN:490-46-0"
+BMGC_DG15258,BMG_DG190445,"UNII:7Z197MG6QL | CAS RN:970-74-1 | (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol | Epigallocatechin | CAS RN:188819-07-0 | PubChem SID:198941081 | PubChem CID:72277 | CAS RN:124107-38-6 | DrugBank ID:DB03823 | EPIGALLOCATECHIN"
+BMGC_DG15259,BMG_DG190449,6-hydroxy-2-phenylchromen-4-one | CAS RN:6665-83-4 | PubChem CID:72279 | 6-HYDROXYFLAVONE | UNII:148S6Z78H6 | 6-Hydroxyflavone | PubChem SID:198949116
+BMGC_DG15260,BMG_DG190451,"CAS RN:41001-90-5 | PubChem SID:175267165 | Hesperetin | HESPERETIN | CAS RN:520-33-2 | (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one | PubChem CID:72281 | UNII:Q9Q3D557F1 | DrugBank ID:DB01094"
+BMGC_DG15261,BMG_DG190455,"PubChem CID:72287 | LEVOMEPROMAZINE | CAS RN:7104-38-3 | UNII:9G0LAW7ATQ | CAS RN:60-99-1 | (2R)-3-(2-methoxyphenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine | Levomepromazine | PubChem SID:198940264 | Methotrimeprazine | DrugBank ID:DB01403"
+BMGC_DG15262,BMG_DG190461,PubChem SID:198936894 | MAGNOLOL | PubChem CID:72300 | Magnolol | CAS RN:528-43-8 | 2-(2-hydroxy-5-prop-2-enylphenyl)-4-prop-2-enylphenol | UNII:001E35HGVF
+BMGC_DG15263,BMG_DG190462,"(13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline | CAS RN:483-14-7 | UNII:3X69CO5I79 | DrugBank ID:DB12093 | PubChem SID:198989528 | PubChem CID:72301 | TETRAHYDROPALMATINE | Tetrahydropalmatine"
+BMGC_DG15264,BMG_DG190463,HONOKIOL | CAS RN:35354-74-6 | 2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol | PubChem SID:198952428 | UNII:11513CCO0N | Honokiol | PubChem CID:72303
+BMGC_DG15265,BMG_DG190464,UNII:OVO2KUW8H8 | Isoflavone | PubChem SID:198962777 | DrugBank ID:DB12007 | ISOFLAVONE | CAS RN:574-12-9 | 3-phenylchromen-4-one | PubChem CID:72304
+BMGC_DG15266,BMG_DG190467,"CAS RN:3621-36-1 | UNII:7T4808FEJW | COLUMBAMINE | 3,9,10-trimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-7-ium-2-ol | PubChem SID:198984929 | PubChem CID:72310 | Columbamine"
+BMGC_DG15267,BMG_DG190470,PubChem CID:72313 | UNII:TP250R6K5B | PubChem SID:346537586 | PUBESCINE | CAS RN:482-96-2
+BMGC_DG15268,BMG_DG190475,"5,7,17,19-tetraoxa-13-azoniahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaene | PubChem CID:72322 | COPTISINE | PubChem SID:198974993 | UNII:0GCL71VN14 | CAS RN:1198398-71-8 | CAS RN:3486-66-6 | Coptisine"
+BMGC_DG15269,BMG_DG190476,PubChem CID:72323 | UNII:091S1F8V5Q | JATRORRHIZINE | PubChem SID:198979095 | CAS RN:3621-38-3
+BMGC_DG15270,BMG_DG190478,"UNII:6W70HN7X7O | (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-ol | CAS RN:7372-31-8 | PubChem CID:72326 | PubChem SID:198968352 | Betulin | BETULIN | CAS RN:473-98-3"
+BMGC_DG15271,BMG_DG190479,"1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | UNII:37F7D05ANB | 2'-Fluoro-5-methylarabinosyluracil | CAS RN:69256-17-3 | PubChem CID:72327 | 5-METHYL-2'-FLUOROARAURACIL | PubChem SID:319891873"
+BMGC_DG15272,BMG_DG190486,CAS RN:6681-13-6 | PubChem CID:72343 | PubChem SID:474492827 | HERNANDEZINE | UNII:HPH24MXX7G
+BMGC_DG15273,BMG_DG190487,"NOBILETIN | 2-(3,4-dimethoxyphenyl)-5,6,7,8-tetramethoxychromen-4-one | PubChem CID:72344 | Nobiletin | PubChem SID:198944930 | CAS RN:478-01-3 | UNII:D65ILJ7WLY"
+BMGC_DG15274,BMG_DG190497,"CAS RN:95-47-6 | O-XYLENE | PubChem SID:175267989 | PubChem CID:7237 | 1,2-xylene | UNII:Z2474E14QP | O-Xylene"
+BMGC_DG15275,BMG_DG190505,"CAS RN:476-28-8 | (1S,17S,18S,19S)-5,7-dioxa-12-azapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-2,4(8),9,15-tetraene-17,18-diol | Lycorine | UNII:I9Q105R5BU | LYCORINE | PubChem CID:72378 | PubChem SID:198955393"
+BMGC_DG15276,BMG_DG190508,CAS RN:26571-11-9 | CAS RN:14409-72-4 | Nonaethylene glycol nonylphenyl ether | PubChem CID:72385 | DrugBank ID:DB06804 | Nonoxynol-9 | 2-[2-[2-[2-[2-[2-[2-[2-[2-(4-nonylphenoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol
+BMGC_DG15277,BMG_DG190513,"CAS RN:19771-63-2 | UNII:X7063P804E | Procysteine | (4R)-2-oxo-1,3-thiazolidine-4-carboxylic acid | OXOTHIAZOLIDINECARBOXYLIC ACID | DrugBank ID:DB12224 | PubChem SID:198966507 | Oxothiazolidinecarboxylic acid | PubChem CID:72390"
+BMGC_DG15278,BMG_DG190515,CAS RN:3947-65-7 | UNII:5981U00LY0 | NEAMINE | Neamine | DrugBank ID:DB04808 | PubChem SID:198955287 | PubChem CID:72392
+BMGC_DG15279,BMG_DG190517,DrugBank ID:DB04728 | UNII:A606AJ494W | CAS RN:36441-41-5 | LIVIDOMYCIN | PubChem SID:198991203 | Lividomycin A | PubChem CID:72394
+BMGC_DG15280,BMG_DG190518,"CAS RN:877009-84-2 | CAS RN:25876-10-2 | Gentamicin C1 | GENTAMICIN C1 | PubChem SID:198940544 | (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[(1R)-1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol | UNII:I904Y9FPPV | PubChem CID:72395"
+BMGC_DG15281,BMG_DG190519,UNII:AV4A72IATD | GENTAMICIN C1A | Gentamicin C1a | PubChem CID:72396 | PubChem SID:198975543 | CAS RN:26098-04-4 | DrugBank ID:DB04729
+BMGC_DG15282,BMG_DG190526,"PubChem CID:72402 | PubChem SID:198973567 | 9-aminocamptothecin | UNII:5MB77ICE2Q | (19S)-8-amino-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione | CAS RN:91421-43-1 | DrugBank ID:DB12515 | 9-Aminocamptothecin | 9-AMINOCAMPTOTHECIN"
+BMGC_DG15283,BMG_DG190529,PubChem CID:7241 | CAS RN:95-52-3 | O-FLUOROTOLUENE | PubChem SID:198982902 | UNII:L55XKB3K7H
+BMGC_DG15284,BMG_DG190536,"TELEOCIDIN B4 | UNII:633532Z10M | (6S,9S,14R,17R)-17-ethenyl-6-(hydroxymethyl)-10,14,17-trimethyl-9,14-di(propan-2-yl)-2,7,10-triazatetracyclo[9.7.1.04,19.013,18]nonadeca-1(18),3,11(19),12-tetraen-8-one | PubChem CID:72425 | CAS RN:11032-05-6 | Teleocidin B4 | PubChem SID:198935345 | CAS RN:78474-55-2"
+BMGC_DG15285,BMG_DG190537,UNII:J97339NR3V | Leupeptin | CAS RN:103476-89-7 | CAS RN:55123-66-5 | PubChem SID:175267735 | LEUPEPTIN | CAS RN:24365-47-7 | PubChem CID:72429 | (2S)-2-acetamido-N-[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide
+BMGC_DG15286,BMG_DG190539,PubChem SID:198957324 | MDL-28170 | benzyl N-[(2S)-3-methyl-1-oxo-1-[[(2S)-1-oxo-3-phenylpropan-2-yl]amino]butan-2-yl]carbamate | CAS RN:756485-04-8 | UNII:WCJ9LQ197S | PubChem CID:72430 | CAS RN:88191-84-8 | Calpain Inhibitor III
+BMGC_DG15287,BMG_DG190541,"DrugBank ID:DB12802 | UNII:0F35AOI227 | PubChem CID:72435 | CAS RN:477-47-4 | (5R,5aR,8aS,9R)-5-hydroxy-9-(3,4,5-trimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[5,6-f][1,3]benzodioxol-8-one | CAS RN:17434-18-3 | CAS RN:118627-04-6 | CAS RN:1352873-82-5 | PubChem SID:198986487 | Picropodophyllin | PICROPODOPHYLLIN"
+BMGC_DG15288,BMG_DG190544,DrugBank ID:DB04586 | 2-Bromophenol | CAS RN:95-56-7 | 2-bromophenol | PubChem SID:198987183 | PubChem CID:7244 | CAS RN:32762-51-9 | O-BROMOPHENOL | o-Bromophenol | UNII:A0UB206YF0
+BMGC_DG15289,BMG_DG190551,2-Chlorophenol | UNII:K9KAV4K6BN | 2-CHLOROPHENOL | PubChem SID:198980204 | CAS RN:95-57-8 | CAS RN:25167-80-0 | PubChem CID:7245 | 2-chlorophenol | DrugBank ID:DB03110
+BMGC_DG15290,BMG_DG190552,Isometamidium | 3-[2-(3-amino-5-ethyl-6-phenylphenanthridin-5-ium-8-yl)iminohydrazinyl]benzenecarboximidamide | PubChem SID:198981722 | CAS RN:20438-03-3 | UNII:S9HA0WUW3H | ISOMETAMIDIUM | PubChem CID:72452
+BMGC_DG15291,BMG_DG190556,UNII:UDN7ZE867Z | TOPSENTIN | PubChem CID:72457 | CAS RN:112515-43-2 | Topsentin | PubChem SID:485661125
+BMGC_DG15292,BMG_DG190558,CHLORSULFAQUINOXALINE | 4-amino-N-(5-chloroquinoxalin-2-yl)benzenesulfonamide | UNII:O0408QB48D | Chlorsulfaquinoxaline | PubChem CID:72462 | PubChem SID:198961426 | DrugBank ID:DB12921 | CAS RN:97919-22-7
+BMGC_DG15293,BMG_DG190559,"3-[[2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium;hydrogen sulfate | PubChem CID:72466 | Bleomycin, sulfate (salt) | CAS RN:9041-93-4"
+BMGC_DG15294,BMG_DG190561,PubChem CID:72474 | DrugBank ID:DB00365 | 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid | CAS RN:119914-60-2 | PubChem SID:198971708 | GREPAFLOXACIN | Grepafloxacin | UNII:L1M1U2HC31 | CAS RN:146863-02-7
+BMGC_DG15295,BMG_DG190567,"UNII:4L479F5JU6 | 3,4-XYLENOL | DrugBank ID:DB04052 | CAS RN:95-65-8 | 3,4-Xylenol | PubChem SID:198978007 | 3,4-dimethylphenol | 3,4-Dimethylphenol | PubChem CID:7249"
+BMGC_DG15296,BMG_DG190571,"PubChem CID:72493 | PubChem SID:198949114 | OLEANDOMYCIN | UNII:P8ZQ646136 | (3R,5S,6S,7R,8S,9R,12R,13R,14S,15R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-8-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-1,11-dioxaspiro[2.13]hexadecane-10,16-dione | CAS RN:3922-90-5 | Oleandomycin | DrugBank ID:DB11442"
+BMGC_DG15297,BMG_DG190573,"DrugBank ID:DB06461 | CAS RN:148717-90-2 | [(3R,6R)-6-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-(4-aminobutylamino)propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] hydrogen sulfate | SQUALAMINE | UNII:F8PO54Z4V7 | PubChem CID:72495 | Squalamine | PubChem SID:198980718"
+BMGC_DG15298,BMG_DG190577,"PubChem CID:72501 | 3-Deazaaristeromycin | CAS RN:58316-88-4 | (1R,2S,3R,5R)-3-(4-aminoimidazo[4,5-c]pyridin-1-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol"
+BMGC_DG15299,BMG_DG190579,"Tadeonal | POLYGODIAL | CAS RN:33118-34-2 | PubChem SID:241180866 | PubChem SID:241179997 | UNII:A00RAV0W57 | POLYGODIAL, (±)- | UNII:5FAF7T66M7 | PubChem CID:72503 | (1R,4aS,8aS)-5,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalene-1,2-dicarbaldehyde | CAS RN:6754-20-7 | POLYGODIAL, (+/-)-"
+BMGC_DG15300,BMG_DG190590,"Parthenolide | UNII:2RDB26I5ZB | PubChem SID:175265569 | PARTHENOLIDE | (1S,2R,4R,7E,11S)-4,8-dimethyl-12-methylidene-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one | PubChem CID:7251185 | CAS RN:20554-84-1"
+BMGC_DG15301,BMG_DG190591,PubChem SID:241177464 | 9-METHOXYELLIPTICINE | UNII:U0924292N9 | CAS RN:10371-86-5 | PubChem CID:72512
+BMGC_DG15302,BMG_DG190607,"CAS RN:1510829-06-7 | PubChem SID:346540263 | Vecabrutinib | VECABRUTINIB | (3R,4S)-1-(6-amino-5-fluoropyrimidin-4-yl)-3-[(3R)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxopiperidin-1-yl]piperidine-4-carboxamide | UNII:PQ7O0OB5GU | PubChem CID:72547837"
+BMGC_DG15303,BMG_DG190610,"UNII:2UG29YVL56 | GURETOLIMOD | PubChem CID:72548788 | CAS RN:1488364-57-3 | 2-[[4-[[2-amino-4-[[(3S)-1-hydroxyhexan-3-yl]amino]-6-methylpyrimidin-5-yl]methyl]-3-methoxyphenyl]methyl-(2,2,2-trifluoroethyl)amino]acetic acid | Guretolimod | PubChem SID:461433981"
+BMGC_DG15304,BMG_DG190617,"PubChem SID:405218098 | Risovalisib | RISOVALISIB | methyl N-[5-[6-[(4-methylsulfonylpiperazin-1-yl)methyl]-4-morpholin-4-ylpyrrolo[2,1-f][1,2,4]triazin-2-yl]-4-(trifluoromethyl)pyridin-2-yl]carbamate | CAS RN:1494684-28-4 | PubChem CID:72550012 | UNII:RCA38L4HB5"
+BMGC_DG15305,BMG_DG190693,UNII:I2YT97EQE9 | CAS RN:16652-64-5 | O-BENZYL-L-TYROSINE | PubChem SID:376230915 | PubChem CID:725701
+BMGC_DG15306,BMG_DG190695,"PubChem SID:376072814 | 2,2'-((3,3'-DIMETHOXY(1,1'-BIPHENYL)-4,4'-DIYL)DIIMINO)BIS-BENZOIC ACID | UNII:Q0VK2156M5 | PubChem CID:72571 | CAS RN:52962-95-5"
+BMGC_DG15307,BMG_DG190696,7-OXO-7H-BENZO(E)PERIMIDINE-4-CARBOXYLIC ACID | PubChem SID:363909605 | PubChem CID:72574 | UNII:B1A8BPF5U8 | CAS RN:65359-16-2
+BMGC_DG15308,BMG_DG190722,"VASICINE, (+/-)- | PubChem CID:72610 | UNII:0VFV53RMC2 | VASICINE, (±)- | PubChem SID:198953724 | CAS RN:6159-56-4"
+BMGC_DG15309,BMG_DG190743,COUMARIN 153 | PubChem CID:72652 | Coumarin 153 | UNII:BC3BHZ527V | CAS RN:53518-18-6 | PubChem SID:474490597
+BMGC_DG15310,BMG_DG190790,PubChem CID:72698550 | OSI-027 | DrugBank ID:DB12387
+BMGC_DG15311,BMG_DG190793,PubChem SID:474490646 | CAS RN:5341-58-2 | 3-Hydroxy-2-naphthohydrazide | 3-HYDROXY-2-NAPHTHOHYDRAZIDE | UNII:XF75J6Z7L4 | PubChem CID:72699
+BMGC_DG15312,BMG_DG190795,"PubChem SID:329589259 | PubChem SID:175266929 | .ALPHA.-HEXACHLORCYCLOHEXANE | UNII:5477B350EK | PubChem SID:198949839 | CAS RN:58-89-9 | PubChem SID:441659549 | .EPSILON.-1,2,3,4,5,6-HEXACHLOROCYCLOHEXANE | CAS RN:6108-10-7 | DrugBank ID:DB00431 | CAS RN:319-85-7 | PubChem SID:198968400 | PubChem CID:727 | .DELTA.-HEXACHLOROCYCLOHEXANE | Lindane | UNII:59NEE7PCAB | UNII:88RHN9KHN8 | Hexachlorocyclohexane | LINDANE | CAS RN:119911-69-2 | CAS RN:319-86-8 | HEXACHLORCYCLOHEXANE (MIXED ISOMERS) | PubChem SID:198962917 | 1,2,3,4,5,6-hexachlorocyclohexane | CAS RN:319-84-6 | UNII:YM80ODM9PD | .BETA.-HEXACHLOROCYCLOHEXANE | UNII:YV2D256Z3N | UNII:IVM9A2N49K | CAS RN:608-73-1"
+BMGC_DG15313,BMG_DG190805,"CAS RN:1456878-22-0 | PubChem CID:72703256 | PubChem SID:310825517 | UNII:8Z8X7Q6RTZ | 4-(6-FLUORO-5,5-DIOXIDO-3-DIBENZOTHIENYL)-1,4-DIAZABICYCLO(3.2.2)NONANE"
+BMGC_DG15314,BMG_DG190806,CAS RN:1456878-32-2 | UNII:PAQ54LXG95 | PubChem SID:485665366 | DBT-10 | PubChem CID:72703471
+BMGC_DG15315,BMG_DG190809,NAZARTINIB | Nazartinib | CAS RN:1508250-71-2 | PubChem CID:72703790 | PubChem SID:310825834 | UNII:KE7K32EME8 | N-[7-chloro-1-[(3R)-1-[(E)-4-(dimethylamino)but-2-enoyl]azepan-3-yl]benzimidazol-2-yl]-2-methylpyridine-4-carboxamide
+BMGC_DG15316,BMG_DG190823,PF-06439015 | PubChem SID:404859279 | UNII:76PND635L1 | CAS RN:1549629-82-4 | PubChem CID:72710568
+BMGC_DG15317,BMG_DG190977,UNII:FQK825B5DX | PubChem SID:363909399 | CAS RN:1538604-68-0 | BLU-9931 | PubChem CID:72710839
+BMGC_DG15318,BMG_DG191046,CAS RN:5407-46-5 | UNII:KQC69H1NAG | METHYL FLUORONE BLACK | PubChem SID:363909756 | PubChem CID:72721
+BMGC_DG15319,BMG_DG191049,"(1s,2s,3s)-1-Fluoranyl-2-[4-(5-Fluoranylpyrimidin-2-Yl)phenyl]-N-Oxidanyl-3-Phenyl-Cyclopropane-1-Carboxamide | PubChem CID:72722126 | (1S,2S,3S)-1-fluoro-2-[4-(5-fluoropyrimidin-2-yl)phenyl]-N-hydroxy-3-phenylcyclopropane-1-carboxamide"
+BMGC_DG15320,BMG_DG191056,CAS RN:1916-59-2 | PubChem CID:72725 | PubChem SID:474491862 | 2-aminophenoxazin-3-one | Questiomycin A | QUESTIOMYCIN A | UNII:J4CM69VF7H
+BMGC_DG15321,BMG_DG191066,"PubChem CID:72732 | PubChem SID:255508945 | alpha-Lapachone | .ALPHA.-LAPACHONE | CAS RN:4707-33-9 | UNII:VPE3AOX9QV | 2,2-dimethyl-3,4-dihydrobenzo[g]chromene-5,10-dione"
+BMGC_DG15322,BMG_DG191068,UNII:305WY61CUF | CAS RN:15297-92-4 | PubChem CID:72734 | PubChem SID:375579316 | XYLOIDONE
+BMGC_DG15323,BMG_DG191074,"Bis(sitafloxacin) trihydrate | PubChem SID:198944226 | SITAFLOXACIN | UNII:9TD681796G | 7-[(7S)-7-amino-5-azaspiro[2.4]heptan-5-yl]-8-chloro-6-fluoro-1-[(1R,2S)-2-fluorocyclopropyl]-4-oxoquinoline-3-carboxylic acid;trihydrate | PubChem CID:72734323 | CAS RN:163253-35-8 | DrugBank ID:DB13261"
+BMGC_DG15324,BMG_DG191076,FENPROSTALENE | CAS RN:69381-94-8 | PubChem CID:72734332 | PubChem SID:472386195 | UNII:X8I39OJF4P | DrugBank ID:DB11411 | Fenprostalene
+BMGC_DG15325,BMG_DG191078,"H-Gly-Gly-Gly-Cys(1)-Tyr-Phe-Gln-Asn-Cys(1)-Pro-Lys-Gly-NH2.CH3CO2H | CAS RN:914453-96-6 | PubChem CID:72734347 | acetic acid;(2S)-1-[(4R,7S,10S,13S,16S,19R)-19-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]pyrrolidine-2-carboxamide | CAS RN:68560-61-2"
+BMGC_DG15326,BMG_DG191086,"PubChem CID:72734520 | ABIVERTINIB | N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide | Abivertinib | CAS RN:1557267-42-1 | DrugBank ID:DB15327 | UNII:CER0OPG92L | PubChem SID:461432952"
+BMGC_DG15327,BMG_DG191088,PubChem CID:72735 | 4-DESMETHYLLUCANTHONE | PubChem SID:375579739 | UNII:U5C16CI3HW | CAS RN:32484-50-7
+BMGC_DG15328,BMG_DG191098,JUNCUSOL | PubChem SID:375579481 | UNII:6T481HU7OI | PubChem CID:72740 | CAS RN:62023-90-9
+BMGC_DG15329,BMG_DG191101,5-Cinnamylidenebarbituric acid | UNII:44AUD6T6MG | PubChem CID:727420 | CAS RN:212375-00-3 | PubChem SID:482553655 | 5-CINNAMYLIDENEBARBITURIC ACID
+BMGC_DG15330,BMG_DG191104,"PubChem CID:727443 | 4,5-DIMETHYLAMINOBENZYLIDENE-2-THIOBARBITURIC ACID | UNII:RTU8Z2WNX3 | CAS RN:27430-15-5 | PubChem SID:377308084"
+BMGC_DG15331,BMG_DG191112,"CAS RN:3736-24-1 | 4-Amino-9,10-dihydro-1,3-dihydroxy-9,10-dioxo-2-anthracenesulfonic acid | UNII:HES3AT9TQL | PubChem SID:474493819 | PubChem CID:72752 | 4-AMINO-9,10-DIHYDRO-1,3-DIHYDROXY-9,10-DIOXO-2-ANTHRACENESULFONIC ACID"
+BMGC_DG15332,BMG_DG191147,"PubChem CID:72784645 | carbanide;cobalt(3+);[5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] 1-[3-[2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl phosphate | CAS RN:13422-55-4"
+BMGC_DG15333,BMG_DG191152,"4,7-Dimethyl-[1,10]Phenanthroline | DrugBank ID:DB02586 | 4,7-DIMETHYL-1,10-PHENANTHROLINE | CAS RN:3248-05-3 | PubChem CID:72792 | UNII:P3YJ54Z8ZO | PubChem SID:438787981"
+BMGC_DG15334,BMG_DG191157,"PubChem CID:72792692 | TBA-7371 | N-(2-hydroxyethyl)-1-[(6-methoxy-5-methylpyrimidin-4-yl)methyl]-6-methylpyrrolo[3,2-b]pyridine-3-carboxamide | Tba-7371 | PubChem SID:404859863 | CAS RN:1494675-86-3 | UNII:R3T98GBE3C"
+BMGC_DG15335,BMG_DG191183,CAS RN:27318-90-7 | PHENDIONE | PubChem CID:72810 | UNII:8JD7KXA2W0 | PubChem SID:377308144
+BMGC_DG15336,BMG_DG191187,"CAS RN:1698-53-9 | UNII:N78AH78WRV | PubChem SID:472409285 | 2-Phenyl-4,5-dichloro-3-pyridazinone | PubChem CID:72813 | 2-PHENYL-4,5-DICHLORO-3-PYRIDAZINONE"
+BMGC_DG15337,BMG_DG191189,PubChem SID:376073094 | UNII:UAE2W88H3G | CAS RN:4921-82-8 | PubChem CID:728148 | N'-PHENYL-N-BENZOYLTHIOUREA
+BMGC_DG15338,BMG_DG191191,"CAS RN:14318-37-7 | TETRAHYDRO-3,5-BIS(2-PHENYLETHYL)-2H-1,3,5-THIADIAZINE-2-THIONE | PubChem SID:377309015 | PubChem CID:72816 | UNII:IS23UN1ZSO"
+BMGC_DG15339,BMG_DG191203,PubChem SID:198973538 | SW-6 | UNII:ZOE3WN5620 | CAS RN:16140-27-5 | PubChem CID:72827
+BMGC_DG15340,BMG_DG191222,UNII:V6RH8QUN6U | PubChem CID:728520 | CAS RN:24416-78-2 | 7-BENZYLOXY-4-METHYLCOUMARIN
+BMGC_DG15341,BMG_DG191229,"UNII:SFJ7GO22AF | PubChem SID:375579018 | P-TERPHENYL-2',5'-DIOL | PubChem CID:72859 | CAS RN:5422-91-3"
+BMGC_DG15342,BMG_DG191231,PubChem SID:198955694 | 5-BROMOSALICYLALDEHYDE | UNII:0Z65A0A8CE | CAS RN:1761-61-1 | PubChem CID:72863
+BMGC_DG15343,BMG_DG191239,UNII:UV05GZ4D9Z | CAS RN:2051-95-8 | PubChem CID:72871 | PubChem SID:461433770 | 3-BENZOYLPROPIONIC ACID
+BMGC_DG15344,BMG_DG191247,CAS RN:3144-09-0 | PubChem SID:404859308 | PubChem CID:72879 | METHANESULFONAMIDE | Methanesulfonamide | UNII:98YB2P6NHR
+BMGC_DG15345,BMG_DG191249,thiophene-2-sulfonamide | 2-THIOPHENESULFONAMIDE | PubChem SID:445499404 | PubChem CID:72881 | CAS RN:6339-87-3 | UNII:P6Q26TS6AU | 2-Thiophenesulfonamide
+BMGC_DG15346,BMG_DG191251,"PubChem CID:72884 | UNII:YMR3ZF0Q4M | N'-acetylacetohydrazide | PubChem SID:198947360 | N,N'-Diacetylhydrazine | CAS RN:3148-73-0 | 1,2-DIACETYLHYDRAZINE"
+BMGC_DG15347,BMG_DG191252,"L-cysteic acid | L-Cysteic acid | CYSTEIC ACID, L- | DrugBank ID:DB03661 | CAS RN:498-40-8 | PubChem SID:198936633 | PubChem CID:72886 | UNII:M6W2DJ6N5K | (2R)-2-amino-3-sulfopropanoic acid"
+BMGC_DG15348,BMG_DG191260,UNII:YME8QXY8ED | PubChem SID:474490370 | CAS RN:3306-62-5 | 2-AMINOBENZENESULFONAMIDE | 2-Aminobenzenesulfonamide | PubChem CID:72894
+BMGC_DG15349,BMG_DG191271,"4-AMINO-1,2-NAPHTHOQUINONE | UNII:R2URY17RR2 | PubChem SID:346539335 | CAS RN:5460-35-5 | PubChem CID:72908"
+BMGC_DG15350,BMG_DG191293,PubChem CID:72930 | 2-Aminonicotinic acid | UNII:S29G45VTQ6 | 2-AMINONICOTINIC ACID | CAS RN:5345-47-1 | PubChem SID:482554600
+BMGC_DG15351,BMG_DG191296,"Sophoraflavanone G | PubChem CID:72936 | (2S)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2R)-5-methyl-2-prop-1-en-2-ylhex-4-enyl]-2,3-dihydrochromen-4-one | CAS RN:97938-30-2"
+BMGC_DG15352,BMG_DG191308,Magnesium Silicate | magnesium;oxygen(2-);silicon(4+) | PubChem SID:472386766 | MAGNESIUM SILICATE | PubChem CID:72941442 | DrugBank ID:DB13249 | CAS RN:1343-88-0 | UNII:9B9691B2N9
+BMGC_DG15353,BMG_DG191799,5-[3-(difluoromethyl)-4-fluorophenyl]-3-[(2-methylimidazol-1-yl)methyl]pyridazine;dihydrochloride | DrugBank ID:DB05956 | PubChem SID:198963632 | UNII:B55T45AA8F | EVT-101 | PubChem CID:72941990 | CAS RN:1189088-41-2 | Evt-101
+BMGC_DG15354,BMG_DG191854,ethyl N-[4-oxo-4-(2-phenylethylamino)butyl]carbamate | CAS RN:1477949-42-0 | PubChem CID:72946782 | Santacruzamate A
+BMGC_DG15355,BMG_DG191858,"1-(1-Methyl-6-oxo-1,6-dihydropyridazin-3-yl)piperidin-4-yl 4-cyclobutylpiperazine-1-carboxylate | CAS RN:1542135-76-1 | LML-134 | UNII:UM4TJY3PCY | PubChem CID:72948400 | PubChem SID:485663306 | [1-(1-methyl-6-oxopyridazin-3-yl)piperidin-4-yl] 4-cyclobutylpiperazine-1-carboxylate"
+BMGC_DG15356,BMG_DG191862,"PubChem CID:72950407 | UNII:T4SR539YKF | Zed1227 | methyl (E,6S)-7-[[1-[2-(2-ethylbutylamino)-2-oxoethyl]-2-oxopyridin-3-yl]amino]-6-[(3-methylimidazole-4-carbonyl)amino]-7-oxohept-2-enoate | ZED-1227 | CAS RN:1542132-88-6 | PubChem SID:459055132"
+BMGC_DG15357,BMG_DG191863,"Umbralisib | CAS RN:1532533-67-7 | 2-[(1S)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one | PubChem SID:333495515 | DrugBank ID:DB14989 | UMBRALISIB | PubChem CID:72950888 | UNII:38073MQB2A"
+BMGC_DG15358,BMG_DG191873,"Neplanocin A | (1S,2R,5R)-5-(6-aminopurin-9-yl)-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol | PubChem CID:72968 | CAS RN:72877-50-0"
+BMGC_DG15359,BMG_DG191892,UNII:PJ9MD2UR9C | 2-PHENYL-N-(4-SULFAMOYLPHENYL)ACETAMIDE | PubChem SID:485663653 | 2-Phenyl-N-(4-sulfamoylphenyl)acetamide | PubChem CID:729977 | CAS RN:331274-56-7
+BMGC_DG15360,BMG_DG191903,LJH-685 | UNII:27CZQ807C1 | CAS RN:1627710-50-2 | PubChem CID:73010393 | PubChem SID:329589088
+BMGC_DG15361,BMG_DG191920,PubChem CID:7302 | oxolan-2-one | DrugBank ID:DB04699 | PubChem SID:198960514 | UNII:OL659KIY4X | CAS RN:96-48-0 | BUTYROLACTONE | gamma-Butyrolactone | CAS RN:31213-03-3
+BMGC_DG15362,BMG_DG191925,PubChem CID:73024 | UNII:Y3G6PD8NRB | CAS RN:2516-05-4 | METHYLENE VIOLET | PubChem SID:198966248
+BMGC_DG15363,BMG_DG191945,PubChem CID:73046 | UNII:88RBJ4ZE9R | CAS RN:2480-28-6 | PubChem SID:336286736 | N2-METHYL-L-ARGININE
+BMGC_DG15364,BMG_DG191951,"MS 325; Vasovist | DrugBank ID:DB06705 | PubChem CID:73049652 | Gadofosveset trisodium | CAS RN:193901-90-5 | trisodium;2-[[2-[bis(carboxylatomethyl)amino]-3-[(4,4-diphenylcyclohexyl)oxy-oxidophosphoryl]oxypropyl]-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;gadolinium(3+)"
+BMGC_DG15365,BMG_DG191961,"CB-5083 | CAS RN:1542705-92-9 | PubChem SID:322058570 | 1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methylindole-4-carboxamide | UNII:591IV6UL6J | PubChem CID:73051434 | Cb-5083"
+BMGC_DG15366,BMG_DG191962,"PubChem SID:346540152 | PubChem CID:73051463 | RELACORILANT | Relacorilant | CAS RN:1496510-51-0 | DrugBank ID:DB14976 | [(4aR)-1-(4-fluorophenyl)-6-(1-methylpyrazol-4-yl)sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinolin-4a-yl]-[4-(trifluoromethyl)pyridin-2-yl]methanone | UNII:2158753C7E"
+BMGC_DG15367,BMG_DG191964,"2-[[1-[[6-(4-chlorophenoxy)pyridin-3-yl]methyl]-4-hydroxy-6-oxo-2,3-dihydropyridine-5-carbonyl]amino]acetic acid | 2-(1-((6-(4-Chlorophenoxy)pyridin-3-yl)methyl)-4-hydroxy-2-oxo-1,2,5,6-tetrahydropyridine-3-carboxamido)acetic acid | PubChem CID:73052863 | UNII:V65GPE6NTB | PubChem SID:459055561 | CAS RN:1558021-37-6 | TP-0463518"
+BMGC_DG15368,BMG_DG191992,"(1S,14S)-9,20,21,25-tetramethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.18,12.114,18.027,31.022,33]hexatriaconta-3(36),4,6(35),8,10,12(34),18,20,22(33),24,26,31-dodecaene | UNII:VS4W77H3SD | TETRANDRINE, (+/-)- | CAS RN:916770-74-6 | DrugBank ID:DB14066 | CAS RN:518-34-3 | UNII:29EX23D5AJ | Tetrandrine | TETRANDRINE, (+)- | PubChem CID:73078 | PubChem SID:441096677 | PubChem SID:175265345 | TETRANDRINE, (±)- | CAS RN:23495-89-8"
+BMGC_DG15369,BMG_DG192002,PubChem CID:73087 | UNII:544SH4020S | CAS RN:102052-95-9 | 3-DEAZANEPLANOCIN | PubChem SID:249492591
+BMGC_DG15370,BMG_DG192021,DrugBank ID:DB08603 | Tosyl-L-lysine chloromethyl ketone | N-[(3S)-7-amino-1-chloro-2-oxoheptan-3-yl]-4-methylbenzenesulfonamide | PubChem CID:73094 | N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide | CAS RN:2364-87-6
+BMGC_DG15371,BMG_DG192048,"UNII:FOB94G6HZT | CAS RN:96-76-4 | PubChem SID:272993798 | 2,4-ditert-butylphenol | 2,4-DI-TERT-BUTYLPHENOL | PubChem CID:7311 | 2,4-Di-tert-butylphenol"
+BMGC_DG15372,BMG_DG192049,"DrugBank ID:DB14729 | CAS RN:93908-02-2 | PubChem SID:348481712 | Rebeccamycin | 5,21-dichloro-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione | PubChem CID:73110 | REBECCAMYCIN | UNII:Y96MQM21V9"
+BMGC_DG15373,BMG_DG192051,"PubChem CID:73111 | SENNOSIDE A | PubChem SID:198982903 | CAS RN:8013-11-4 | Senna | CAS RN:85085-71-8 | CAS RN:81-27-6 | (9R)-9-[(9R)-2-carboxy-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid | UNII:2F1O30GVXH"
+BMGC_DG15374,BMG_DG192052,"Clevudine | CLEVUDINE | DrugBank ID:DB06683 | 1-[(2S,3R,4S,5S)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | CAS RN:163252-36-6 | UNII:IN51MVP5F1 | PubChem CID:73115 | CAS RN:1027764-72-2 | PubChem SID:198949300"
+BMGC_DG15375,BMG_DG192075,"PubChem CID:73124 | CAS RN:54262-83-8 | (2S)-3-(6-aminopurin-9-yl)propane-1,2-diol | (S)-9-(2,3-Dihydroxypropyl)adenine"
+BMGC_DG15376,BMG_DG192092,".BETA.-AMYRIN | PubChem CID:73145 | UNII:KM8353IPSO | (3S,4aR,6aR,6bS,8aR,12aR,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-ol | Beta-Amyrin | CAS RN:559-70-6 | PubChem SID:198967553"
+BMGC_DG15377,BMG_DG192142,"PubChem CID:73160 | CAS RN:18829-70-4 | PubChem SID:198946245 | CIANIDANOL, (-)- | UNII:FHB0GX3D44"
+BMGC_DG15378,BMG_DG192151,(2S)-2-amino-3-(1H-indol-3-yl)-N-[1-[(5-methyl-1H-indol-3-yl)methyl]piperidin-4-yl]propanamide | N-{1-[(5-Methyl-1h-Indol-3-Yl)methyl]piperidin-4-Yl}-L-Tryptophanamide | PubChem CID:73167574
+BMGC_DG15379,BMG_DG192154,".ALPHA.-AMYRIN | alpha-Amyrin | PubChem SID:198934949 | CAS RN:638-95-9 | PubChem CID:73170 | UNII:30ZAG40J8N | (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol"
+BMGC_DG15380,BMG_DG192156,2-CYANOPYRAZINE | UNII:74CP756B49 | PubChem CID:73172 | CAS RN:19847-12-2 | PubChem SID:375579403
+BMGC_DG15381,BMG_DG192161,"CAS RN:79886-50-3 | [(2R,3R,4S,5R,6S)-3-hydroxy-4,5,6-tris[(3,4,5-trihydroxybenzoyl)oxy]oxan-2-yl]methyl 3,4,5-trihydroxybenzoate | PubChem SID:241179951 | PubChem CID:73178 | NP-003686 | CAS RN:84297-48-3 | UNII:4648S0G699"
+BMGC_DG15382,BMG_DG192170,NODAKENIN | CAS RN:495-31-8 | PubChem CID:73191 | PubChem SID:249493292 | UNII:S2KTH28M3N
+BMGC_DG15383,BMG_DG192172,PubChem CID:73193 | CAS RN:13850-16-3 | TORMENTIC ACID | PubChem SID:472425566 | UNII:9WL8LH7U78
+BMGC_DG15384,BMG_DG192182,CAS RN:480-37-5 | UNII:SZD9LZS694 | PINOSTROBIN | PubChem CID:73201 | PubChem SID:317229610
+BMGC_DG15385,BMG_DG192183,"PubChem SID:363908651 | PINOBANKSIN | (2R,3R)-3,5,7-trihydroxy-2-phenyl-2,3-dihydrochromen-4-one | Pinobanksin | PubChem CID:73202 | UNII:BK3ABR33DT | CAS RN:548-82-3"
+BMGC_DG15386,BMG_DG192188,"PubChem SID:198989061 | UNII:3IN82Y8CAA | PubChem CID:73207 | XANTHOMICROL | CAS RN:16545-23-6 | Xanthomicrol | 5-hydroxy-2-(4-hydroxyphenyl)-6,7,8-trimethoxychromen-4-one"
+BMGC_DG15387,BMG_DG192193,BI-1181181 | PubChem SID:485665557 | UNII:R9Y5R8LRV9 | PubChem CID:73211794
+BMGC_DG15388,BMG_DG192201,"UNII:C460ZSU1OW | EPEREZOLID | CAS RN:165800-04-4 | N-[[(5S)-3-[3-fluoro-4-[4-(2-hydroxyacetyl)piperazin-1-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide | PubChem CID:73214 | Eperezolid | PubChem SID:198971801"
+BMGC_DG15389,BMG_DG192206,PubChem CID:7322 | 2-Hydroxy-5-sulfobenzoic acid | SULFOSALICYLIC ACID | CAS RN:97-05-2 | UNII:L8XED79U3U | PubChem SID:198941927 | 2-hydroxy-5-sulfobenzoic acid
+BMGC_DG15390,BMG_DG192223,CAS RN:97-09-6 | PubChem CID:7324 | 4-CHLORO-3-NITROBENZENESULFONAMIDE | PubChem SID:198951370 | UNII:2O1T5ZXF22
+BMGC_DG15391,BMG_DG192237,UNII:QN2NZL16NG | CAS RN:2435-53-2 | O-CHLORANIL | PubChem SID:198965804 | PubChem CID:73252
+BMGC_DG15392,BMG_DG192249,UNII:EF762EX2DY | PubChem SID:472424034 | URACIL-4-ACETIC ACID | 6-Carboxymethyluracil | PubChem CID:73271 | CAS RN:4628-39-1 | DrugBank ID:DB03048
+BMGC_DG15393,BMG_DG192260,PubChem SID:198948392 | PubChem CID:7329 | 4-chloro-2-(5-chloro-2-hydroxyphenyl)sulfanylphenol | CAS RN:97-24-5 | FENTICLOR | UNII:D61659OVD0 | Fenticlor
+BMGC_DG15394,BMG_DG192268,PubChem CID:73297271 | PubChem SID:441097336 | CAS RN:1883711-97-4 | AM-0902 | UNII:3E4SQ96PCJ
+BMGC_DG15395,BMG_DG192269,DrugBank ID:DB15257 | UNII:R3I80TLN7S | PubChem SID:317229820 | MILADEMETAN | Milademetan | PubChem CID:73297272 | CAS RN:1398568-47-2
+BMGC_DG15396,BMG_DG192270,HEDERAGENIN | PubChem SID:198979796 | PubChem CID:73299 | CAS RN:465-99-6 | UNII:RQF57J8212
+BMGC_DG15397,BMG_DG192273,"DrugBank ID:DB06211 | PubChem SID:175266776 | DORIPENEM | UNII:BHV525JOBH | CAS RN:148016-81-3 | Doripenem | (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoylamino)methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid | PubChem CID:73303"
+BMGC_DG15398,BMG_DG192279,UNII:L4DUW10YOF | ECHINOCYSTIC ACID | CAS RN:510-30-5 | PubChem SID:198938657 | PubChem CID:73309
+BMGC_DG15399,BMG_DG192283,DrugBank ID:DB02502 | 8-hydroxy-2'-deoxyguanosine | PubChem CID:73318
+BMGC_DG15400,BMG_DG192284,"[(2R,3S,4R,5R)-5-(2,6-dioxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate | CAS RN:523-98-8 | PubChem CID:73323 | XANTHOSINE 5'-MONOPHOSPHATE | PubChem SID:472423603 | UNII:Y29K672ETF | Xanthosine-5'-monophosphate"
+BMGC_DG15401,BMG_DG192288,"PubChem CID:7333 | 1,3-Di-o-tolylguanidine | CAS RN:97-39-2 | PubChem SID:198988707 | 1,2-bis(2-methylphenyl)guanidine | UNII:LL2P01I17O | 1,3-DI-O-TOLYLGUANIDINE"
+BMGC_DG15402,BMG_DG192290,"DIROXIMEL FUMARATE | UNII:K0N0Z40J3W | 4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate | Diroximel Fumarate | CAS RN:1577222-14-0 | PubChem CID:73330464 | DrugBank ID:DB14783 | NDC:64406-020 | PubChem SID:316912332"
+BMGC_DG15403,BMG_DG192292,PBB-3 | UNII:F09FXO5I7I | PubChem CID:73330716 | PubChem SID:251965421 | CAS RN:1565796-97-5
+BMGC_DG15404,BMG_DG192295,"PubChem CID:73333 | 4-[4,4-bis(4-fluorophenyl)butyl]-N-ethylpiperazine-1-carboxamide | CAS RN:75558-90-6 | AMPEROZIDE | CAS RN:75529-73-6 | Amperozide | PubChem SID:198969592 | DrugBank ID:DB08927 | UNII:0M2W3TAG39"
+BMGC_DG15405,BMG_DG192304,Naftifine | PubChem CID:73342 | N-methyl-N-(1-naphthalenylmethyl)-3-phenyl-2-propen-1-amine | DrugBank ID:DB00735 | N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine | CAS RN:134274-83-2
+BMGC_DG15406,BMG_DG192312,UNII:GH7ZNH3JMF | CAS RN:1174223-49-4 | RB-64 | PubChem CID:73347341 | PubChem SID:472424216
+BMGC_DG15407,BMG_DG192315,PYRIPYROPENE B | PubChem SID:496143402 | UNII:3MVX5CJ3K4 | PubChem CID:73348800 | CAS RN:151519-44-7 | Pyripyropene B
+BMGC_DG15408,BMG_DG192326,"N-((3-METHOXYPHENYL)METHYL)OCTADECA-9,12,15-TRIENAMIDE, (9Z,12Z,15Z)- | UNII:FZ9FWW7N2Q | PubChem CID:73353637 | PubChem SID:459275311 | CAS RN:883715-23-9"
+BMGC_DG15409,BMG_DG192334,VS-105 | UNII:W3DX0X37FV | PubChem CID:73357083 | CAS RN:1469985-12-3 | PubChem SID:310825973
+BMGC_DG15410,BMG_DG192345,benzyl N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxohexan-2-yl]amino]pentan-2-yl]carbamate | PubChem CID:73364 | CALPEPTIN | UNII:18X9FR245W | PubChem SID:198967385 | CAS RN:117591-20-5 | Calpeptin
+BMGC_DG15411,BMG_DG192350,PubChem SID:312525081 | UNII:QMH3V8VSPB | Ctt-1057 | DrugBank ID:DB14965 | CTT-1057 | (2S)-2-[[[(4S)-4-carboxy-4-[[(4S)-4-carboxy-4-[6-[(4-fluorobenzoyl)amino]hexanoylamino]butanoyl]amino]butoxy]-hydroxyphosphoryl]amino]pentanedioic acid | PubChem CID:73386645 | CAS RN:1628717-55-4
+BMGC_DG15412,BMG_DG192354,"DrugBank ID:DB15498 | UNII:85Z2L2FYT7 | CAS RN:1578245-44-9 | BOS-172722 | PubChem SID:496143946 | PubChem CID:73386890 | 8-N-(2,2-dimethylpropyl)-2-N-[2-ethoxy-4-(4-methyl-1,2,4-triazol-3-yl)phenyl]-6-methylpyrido[3,4-d]pyrimidine-2,8-diamine | Bos172722"
+BMGC_DG15413,BMG_DG192358,"(E)-2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile | UNII:5G1WE425BI | CAS RN:1575591-66-0 | CAS RN:2416219-30-0 | CAS RN:1575596-29-0 | PubChem CID:73388818 | PubChem SID:387065231 | Rilzabrutinib | RILZABRUTINIB, (E)-"
+BMGC_DG15414,BMG_DG192359,"CAS RN:1575596-77-8 | UNII:8968AMP7ZM | RILZABRUTINIB, (.ALPHA.E,3S)- | PubChem CID:73388819"
+BMGC_DG15415,BMG_DG192361,"CAS RN:7540-64-9 | Phosphoribosyl pyrophosphate | UNII:W5555R4ERG | PubChem SID:472422828 | 5-O-phosphono-alpha-D-ribofuranosyl diphosphate | PHOSPHORIBOSYL PYROPHOSPHATE | DrugBank ID:DB01632 | PubChem CID:7339 | [(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl] phosphono hydrogen phosphate"
+BMGC_DG15416,BMG_DG192363,"Serpentine | CAS RN:18786-24-8 | PubChem CID:73391 | methyl (15R,16S,20S)-16-methyl-17-oxa-3-aza-13-azoniapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4,6,8,11,18-heptaene-19-carboxylate"
+BMGC_DG15417,BMG_DG192367,"18α-Glycyrrhetic acid | UNII:X6NYL2CP2E | (2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bS)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid | PubChem SID:475550722 | PubChem CID:73398 | 18Alpha-Glycyrrhetinic Acid | 18.ALPHA.-GLYCYRRHETIC ACID | CAS RN:1449-05-4"
+BMGC_DG15418,BMG_DG192370,"PubChem CID:73400 | DAURICINE | 4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]-2-[4-[[(1R)-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-1-yl]methyl]phenoxy]phenol | Dauricine | UNII:8QTO90G5W5 | CAS RN:524-17-4 | PubChem SID:198952767"
+BMGC_DG15419,BMG_DG192377,"CAS RN:18449-41-7 | DrugBank ID:DB14037 | MADECASSIC ACID | UNII:M7O1N24J82 | PubChem SID:198977710 | PubChem CID:73412 | Madecassic Acid | (1S,2R,4aS,6aR,6aS,6bR,8R,8aR,9R,10R,11R,12aR,14bS)-8,10,11-trihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid"
+BMGC_DG15420,BMG_DG192385,CAS RN:1304-85-4 | UNII:H19J064BA5 | NDC:63545-493 | NDC:63545-498 | NDC:0220-0859 | CAS RN:1327-35-1 | NDC:63545-492 | NDC:37662-2737 | NDC:37662-2735 | pentabismuth;oxygen(2-);nonahydroxide;tetranitrate | NDC:63545-491 | NDC:37662-2734 | NDC:37662-2740 | NDC:37662-2738 | NDC:37662-2739 | NDC:37662-2741 | NDC:63545-494 | NDC:63545-495 | Bismuth Subnitrate | NDC:63545-497 | DrugBank ID:DB13209 | BISMUTH SUBNITRATE | PubChem SID:175265709 | PubChem CID:73415757 | NDC:63545-496 | NDC:37662-2736
+BMGC_DG15421,BMG_DG192406,NDC:70436-205 | NDC:70121-1189 | NDC:70436-206 | NDC:67457-839 | NDC:70069-261 | CAS RN:13755-38-9 | NDC:51754-1029 | SODIUM NITROPRUSSIDE | NDC:14789-012 | NDC:14335-131 | NDC:43598-587 | NDC:51754-1006 | NDC:67457-999 | NDC:69097-532 | NDC:71839-120 | UNII:EAO03PE1TC | NDC:72485-105 | NDC:55150-320 | NDC:70436-028 | NDC:70436-207 | NDC:14335-134 | disodium;azanylidyneoxidanium;iron(2+);pentacyanide;dihydrate | NDC:71288-202 | PubChem CID:73415791 | NDC:14335-133 | PubChem SID:175267197 | Sodium Nitroprusside | NDC:14335-132
+BMGC_DG15422,BMG_DG192412,"carbanide;cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | CAS RN:13422-55-4 | METHYLCOBALAMIN | PubChem CID:73415798 | UNII:BR1SN1JS2W | PubChem SID:175267548 | Methycobal"
+BMGC_DG15423,BMG_DG192428,"CAS RN:13408-78-1 | Cobalamin [vandf] | UNII:8406EY2OQA | COBALAMIN | cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | DrugBank ID:DB14098 | PubChem SID:175268664 | NDC:64661-793 | PubChem CID:73415824"
+BMGC_DG15424,BMG_DG192517,DrugBank ID:DB04952 | Ramoplanin | PubChem CID:73425378
+BMGC_DG15425,BMG_DG192519,DrugBank ID:DB08871 | PubChem CID:73425383 | Eribulin
+BMGC_DG15426,BMG_DG192671,CAS RN:1429505-03-2 | SOTICLESTAT | (4-benzyl-4-hydroxypiperidin-1-yl)-(2-pyridin-4-ylpyridin-3-yl)methanone | PubChem SID:375579529 | Soticlestat | UNII:1766MU795L | PubChem CID:73437845
+BMGC_DG15427,BMG_DG192672,"PubChem CID:73438222 | PubChem SID:443625161 | ATUZABRUTINIB | (E)-2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile | Atuzabrutinib | CAS RN:1581714-49-9 | UNII:YZ68ZB8LWA"
+BMGC_DG15428,BMG_DG192684,"PubChem CID:73441910 | 2-[(1S)-1-[(2S,5R)-5-[4-chloro-5-fluoro-2-(trifluoromethyl)phenyl]oxolan-2-yl]ethyl]-7-(4-methylimidazol-1-yl)-3,4-dihydropyrido[1,2-a]pyrazine-1,6-dione | CAS RN:1587727-31-8"
+BMGC_DG15429,BMG_DG192688,"DrugBank ID:DB12161 | NDC:68546-474 | PubChem CID:73442840 | NDC:68546-171 | (3S,11bS)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one | UNII:P341G6W9NB | Deutetrabenazine | NDC:68546-476 | DEUTETRABENAZINE | NDC:68546-473 | NDC:68546-170 | NDC:68546-470 | NDC:68546-472 | CAS RN:1392826-25-3 | NDC:68546-471 | NDC:68546-479 | NDC:68546-172 | PubChem SID:316909729 | NDC:68546-475"
+BMGC_DG15430,BMG_DG192700,CAS RN:564-36-3 | Ergocornine | ERGOCORNINE | PubChem CID:73453 | PubChem SID:198951899 | UNII:7W36B25464
+BMGC_DG15431,BMG_DG192715,"DrugBank ID:DB14178 | PubChem SID:175267316 | dimethylcarbamothioyl N,N-dimethylcarbamodithioate | Tetramethylthiuram monosulfide | UNII:01W430XXSQ | PubChem CID:7347 | CAS RN:97-74-5 | TETRAMETHYLTHIURAM MONOSULFIDE"
+BMGC_DG15432,BMG_DG192722,"disodium;[(2R,3S)-3-methyloxiran-2-yl]-dioxido-oxo-lambda5-phosphane | FOSFOMYCIN SODIUM | PubChem SID:198983816 | CAS RN:25030-61-9 | CAS RN:25162-71-4 | CAS RN:26016-99-9 | UNII:97MMO19FNO | Fosfomycin sodium | PubChem CID:73491"
+BMGC_DG15433,BMG_DG192723,PANAXADIOL | PubChem CID:73498 | CAS RN:19666-76-3 | PubChem SID:472387996 | UNII:F84BLM3L74
+BMGC_DG15434,BMG_DG192726,"CAS RN:1571903-56-4 | Vabametkib | PubChem SID:478838508 | VABAMETKIB | (2S)-4-[5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrimidin-2-yl]-2-[[5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazin-3-yl]methyl]morpholine | UNII:XT5T3BT4QP | PubChem CID:73504719"
+BMGC_DG15435,BMG_DG192746,CAS RN:13220-57-0 | UNII:4Y6E3F2U66 | Tryptanthrine | PubChem SID:440793807 | TRYPTANTHRINE | PubChem CID:73549
+BMGC_DG15436,BMG_DG192775,CAS RN:923-06-8 | PubChem SID:198937888 | BROMOSUCCINIC ACID | UNII:O3K54IBV7F | PubChem CID:73557
+BMGC_DG15437,BMG_DG192782,"PubChem CID:73565 | 5-BENZYLHYDANTOIN, DL- | UNII:MG67DQ24RF | CAS RN:3530-82-3"
+BMGC_DG15438,BMG_DG192783,"CAS RN:23094-69-1 | Corilagin | [(1S,19R,21S,22R,23R)-6,7,8,11,12,13,22,23-octahydroxy-3,16-dioxo-2,17,20-trioxatetracyclo[17.3.1.04,9.010,15]tricosa-4,6,8,10,12,14-hexaen-21-yl] 3,4,5-trihydroxybenzoate | PubChem CID:73568 | CAS RN:2088321-44-0"
+BMGC_DG15439,BMG_DG192785,"Sakuranetin | (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydrochromen-4-one | DrugBank ID:DB08517 | PubChem CID:73571 | CAS RN:2957-21-3 | SAKURANETIN | UNII:3O38P61299 | PubChem SID:198955160"
+BMGC_DG15440,BMG_DG192787,"UNII:C9096D920O | PubChem SID:315658481 | PubChem CID:735755 | CAS RN:20329-98-0 | 3,4,5-TRIMETHOXYCINNAMIC ACID"
+BMGC_DG15441,BMG_DG192797,2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE | PubChem CID:735838 | DrugBank ID:DB08359
+BMGC_DG15442,BMG_DG192802,PubChem CID:73587 | PREZATIDE | (2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid | DrugBank ID:DB11296 | NDC:76986-003 | Glycyl-l-histidyl-l-lysine | CAS RN:1227510-36-2 | CAS RN:49557-75-7 | UNII:39TG2H631E | Prezatide | PubChem SID:316908751
+BMGC_DG15443,BMG_DG192803,PubChem SID:241179943 | CAS RN:19026-31-4 | PubChem CID:73588 | TAXODIONE | UNII:W96G420HJX
+BMGC_DG15444,BMG_DG192814,"2-THIOPHENEACRYLIC ACID, (E)- | CAS RN:15690-25-2 | PubChem CID:735981 | UNII:INO5ATY68D | PubChem SID:198982130"
+BMGC_DG15445,BMG_DG192827,CAS RN:1428569-85-0 | PubChem CID:73603034 | PubChem SID:381132337 | GDC-0339 | UNII:2PRJ7DX38T
+BMGC_DG15446,BMG_DG192835,"PubChem SID:376231447 | PubChem CID:736083 | UNII:LH812IV7LI | APOMORPHINE, S- | CAS RN:39478-62-1"
+BMGC_DG15447,BMG_DG192838,Furfuryl alcohol | UNII:D582054MUH | PubChem CID:7361 | CAS RN:93793-62-5 | FURFURYL ALCOHOL | PubChem SID:198967036 | CAS RN:98-00-0 | furan-2-ylmethanol
+BMGC_DG15448,BMG_DG192844,"UNII:VO1XSY74EW | PubChem CID:736140 | PubChem SID:438789012 | CAS RN:35853-41-9 | 2,8-BIS(TRIFLUOROMETHYL)QUINOLIN-4-OL"
+BMGC_DG15449,BMG_DG192850,PubChem CID:736186 | ISOFERULIC ACID | UNII:XSQ2K2G7MC | PubChem SID:198987528 | (E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid | Isoferulic acid | CAS RN:537-73-5 | DrugBank ID:DB07109 | CAS RN:25522-33-2
+BMGC_DG15450,BMG_DG192857,methyl L-phenylalaninate | PubChem CID:736234 | METHYL L-PHENYLALANINATE | DrugBank ID:DB06838 | CAS RN:2577-90-4 | PubChem SID:287446051 | UNII:10AT497I17 | Methyl L-phenylalaninate
+BMGC_DG15451,BMG_DG192862,"L-lobeline free base | PubChem CID:736282 | 2-[(2S,6R)-6-[(2S)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanone"
+BMGC_DG15452,BMG_DG192865,"PIPECOLIC ACID, (+)- | (R)-Piperidine-2-carboxylic acid | PubChem CID:736316 | (2R)-piperidine-2-carboxylic acid | PubChem SID:241178905 | CAS RN:1723-00-8 | UNII:XPO6784Z20"
+BMGC_DG15453,BMG_DG192871,"CAS RN:446-71-9 | PubChem CID:73635 | PubChem SID:198987809 | Homoeriodictyol | UNII:EHE7H3705C | HOMOERIODICTYOL | (2S)-5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-2,3-dihydrochromen-4-one"
+BMGC_DG15454,BMG_DG192875,PubChem CID:7364 | PubChem SID:377308989 | CAS RN:98-03-3 | UNII:IW05BB9XBM | Thiophene-2-carbaldehyde | thiophene-2-carbaldehyde | THIOPHENE-2-CARBOXALDEHYDE
+BMGC_DG15455,BMG_DG192876,(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE | DrugBank ID:DB08186 | PubChem CID:736407
+BMGC_DG15456,BMG_DG192877,ARJUNOLIC ACID | UNII:8N8Q74HVN3 | CAS RN:465-00-9 | PubChem CID:73641
+BMGC_DG15457,BMG_DG192881,UNII:57F9KU116M | PubChem SID:198977859 | phenylarsonic acid | CAS RN:98-05-5 | PubChem CID:7365 | BENZENEARSONIC ACID | Benzenearsonic acid
+BMGC_DG15458,BMG_DG192904,"(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid | UNII:E233J88OHQ | PubChem SID:198980151 | CAS RN:4373-41-5 | PubChem CID:73659 | Maslinic Acid | MASLINIC ACID"
+BMGC_DG15459,BMG_DG192910,"PubChem SID:198938508 | UNII:99SFL01YCL | PubChem CID:73665 | N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamide | PROCHLORAZ | Prochloraz | CAS RN:67747-09-5"
+BMGC_DG15460,BMG_DG192922,CAS RN:104-98-3 | trans-urocanic acid | UNII:G8D26XJJ3B | PubChem SID:198949402 | DrugBank ID:DB01971 | CAS RN:3465-72-3 | (E)-3-(1H-imidazol-5-yl)prop-2-enoic acid | UROCANIC ACID | PubChem CID:736715 | Urocanic acid
+BMGC_DG15461,BMG_DG192932,"Oxycodegol | OXYCODEGOL | (4R,4aS,7S,7aR,12bS)-9-methoxy-7-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-methyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-4a-ol | PubChem CID:73673720 | DrugBank ID:DB14146 | PubChem SID:346540964 | CAS RN:1211231-76-3 | UNII:J2WIV0JMML"
+BMGC_DG15462,BMG_DG192936,Stictic acid | UNII:NZR6AX77LP | STICTIC ACID | PubChem CID:73677 | CAS RN:549-06-4 | PubChem SID:474489722
+BMGC_DG15463,BMG_DG192939,"Thiazole-4-carboxamide adenine dinucleotide | CAS RN:83285-83-0 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(4-carbamoyl-1,3-thiazol-2-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate | PubChem CID:73680"
+BMGC_DG15464,BMG_DG192940,CAS RN:67686-01-5 | PubChem SID:496142325 | (1-BENZYLPIPERIDIN-4-YL)METHANOL | UNII:DF3NB7LV3J | (1-Benzylpiperidin-4-yl)methanol | PubChem CID:736802
+BMGC_DG15465,BMG_DG192958,PubChem CID:7370 | benzenesulfonamide | Benzenesulfonamide | CAS RN:98-10-2
+BMGC_DG15466,BMG_DG192998,CAS RN:1530-88-7 | UNII:DVF8MV7L37 | PubChem SID:475549948 | 1-PYRROLIDINECARBONITRILE | PubChem CID:73737 | 1-Pyrrolidinecarbonitrile
+BMGC_DG15467,BMG_DG193005,CAS RN:1532-84-9 | UNII:QUG12T52WZ | PubChem SID:198944025 | PubChem CID:73742 | 1-AMINOISOQUINOLINE
+BMGC_DG15468,BMG_DG193070,"PubChem SID:474490660 | Aminobenzenesulfonamide, 3- | CAS RN:98-18-0 | PubChem CID:7377 | AMINOBENZENESULFONAMIDE, 3- | UNII:DW73A2TD9A"
+BMGC_DG15469,BMG_DG193074,"DrugBank ID:DB12895 | Olitigaltin | OLITIGALTIN | (2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-2-[(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,5-diol | UNII:60Y0GUO72B | PubChem SID:249817579 | CAS RN:1450824-22-2 | PubChem CID:73774610"
+BMGC_DG15470,BMG_DG193079,UNII:6LGR0RYY5Q | PubChem SID:383470575 | PubChem CID:73776233 | SEL120-34A FREE BASE | CAS RN:1609522-33-9
+BMGC_DG15471,BMG_DG193082,"DrugBank ID:DB14844 | CAS RN:1616632-77-9 | 11-benzyl-7-[(2-methylphenyl)methyl]-2,5,7,11-tetrazatricyclo[7.4.0.02,6]trideca-1(9),5-dien-8-one | PubChem CID:73777259 | 7-Benzyl-4-(2-methylbenzyl)-1,2,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5(4H)-one | PubChem SID:317229123 | Dordaviprone | UNII:9U35A31JAI | DORDAVIPRONE | CAS RN:1342897-86-2"
+BMGC_DG15472,BMG_DG193224,"UNII:SGC97J8AST | CAS RN:1456-22-0 | PubChem CID:73819 | 3-PHENYL-4,5-DIHYDRO-1,2,4-OXADIAZOL-5-ONE | PubChem SID:441658417"
+BMGC_DG15473,BMG_DG193279,PubChem SID:459055955 | PubChem CID:73836 | 3-AMINOPICOLINIC ACID | UNII:KRX7SG6NCS | CAS RN:1462-86-8
+BMGC_DG15474,BMG_DG193280,UNII:9JZN0X101D | 7-CHLORO-4-(PIPERAZIN-1-YL)QUINOLINE | PubChem CID:738389 | PubChem SID:376072659 | CAS RN:837-52-5
+BMGC_DG15475,BMG_DG193287,CAS RN:1467-70-5 | PubChem SID:440089929 | PubChem CID:73846 | 2-FURYLGLYOXYLIC ACID | UNII:MQ4GX46XFF
+BMGC_DG15476,BMG_DG193293,"CAS RN:1470-79-7 | PubChem SID:252164939 | PubChem CID:73852 | 2,4,4'-TRIHYDROXYBENZOPHENONE | UNII:QP9121IG2S"
+BMGC_DG15477,BMG_DG193303,CAS RN:1477-49-2 | PubChem SID:441583632 | PubChem CID:73863 | INDOLE-3-GLYOXALIC ACID | UNII:34U8W7RF8Q
+BMGC_DG15478,BMG_DG193310,PubChem SID:472423902 | MDPEA | PubChem CID:73874 | CAS RN:1484-85-1 | UNII:F2J2U8J2G5
+BMGC_DG15479,BMG_DG193316,PubChem CID:73880 | CAS RN:1486-51-7 | UNII:4K45H4G7KP | PubChem SID:459275312 | 4-BENZYLOXYBENZOIC ACID
+BMGC_DG15480,BMG_DG193325,ARSANILIC ACID | UNII:UDX9AKS7GM | PubChem SID:198966685 | (4-aminophenyl)arsonic acid | CAS RN:98-50-0 | PubChem CID:7389 | Arsanilic acid | DrugBank ID:DB03006
+BMGC_DG15481,BMG_DG193330,Lexacalcitol | PubChem CID:73896915 | DrugBank ID:DB03451
+BMGC_DG15482,BMG_DG193332,"PubChem CID:73897258 | Colistimethatesodium | CAS RN:30387-39-4 | [2-[11-(2-aminoethyl)-17-(1-hydroxyethyl)-22-[[2-[[3-hydroxy-2-[[2-(6-methyloctanoylamino)-4-(sulfomethylamino)butanoyl]amino]butanoyl]amino]-4-(sulfomethylamino)butanoyl]amino]-5,8-bis(2-methylpropyl)-3,6,9,12,15,18,23-heptaoxo-14-[2-(sulfomethylamino)ethyl]-1,4,7,10,13,16,19-heptazacyclotricos-2-yl]ethylamino]methanesulfonic acid"
+BMGC_DG15483,BMG_DG193356,4-tert-butylphenol | PubChem CID:7393 | CAS RN:98-54-4 | UNII:O81VMW36CV | 4-TERT-BUTYLPHENOL | 4-tert-Butylphenol | PubChem SID:198952435
+BMGC_DG15484,BMG_DG193360,"PubChem CID:739358 | N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE | DrugBank ID:DB08776"
+BMGC_DG15485,BMG_DG193362,"CAS RN:58905-16-1 | 1-(2,4-Dichlorophenyl)-2-(1h-1,2,4-triazol-1-yl)ethanone | PubChem CID:739374 | 1-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)ethanone"
+BMGC_DG15486,BMG_DG193370,2-Nitro-N-(quinolin-8-yl)benzenesulfonamide | PubChem CID:739449 | 2-NITRO-N-(QUINOLIN-8-YL)BENZENESULFONAMIDE | PubChem SID:482554036 | UNII:QX533D5WV7 | CAS RN:21868-77-9
+BMGC_DG15487,BMG_DG193415,Magnesium Hydroxide | DrugBank ID:DB09104 | UNII:NBZ3QY004S | magnesium;dihydroxide | PubChem CID:73981 | Magnesium hydroxide | MAGNESIUM HYDROXIDE | CAS RN:1309-42-8 | PubChem SID:175267175 | CAS RN:1909-42-8
+BMGC_DG15488,BMG_DG193439,"UNII:D6H647726W | PubChem CID:739884 | 3,6-DICHLORO-1-BENZOTHIOPHENE-2-CARBOXYLIC ACID | PubChem SID:404859455"
+BMGC_DG15489,BMG_DG193453,PubChem CID:7400 | PubChem SID:198966122 | UNII:5CN6B87IK2 | P-CHLOROBENZENESULFONIC ACID | CAS RN:98-66-8
+BMGC_DG15490,BMG_DG193495,UNII:43Z7T3VN0R | PubChem SID:198971170 | 4-TERT-BUTYLBENZOIC ACID | 4-tert-Butylbenzoic acid | CAS RN:98-73-7 | 4-tert-butylbenzoic acid | PubChem CID:7403
+BMGC_DG15491,BMG_DG193514,Pidolic acid | CAS RN:98-79-3 | UNII:SZB83O1W42 | DrugBank ID:DB03088 | PubChem CID:7405 | PubChem SID:175267668 | L-Pyroglutamic acid | PIDOLIC ACID | (2S)-5-oxopyrrolidine-2-carboxylic acid
+BMGC_DG15492,BMG_DG193535,"(3,4,8b-Trimethyl-3-oxido-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-3-ium-7-yl) N-(2-ethylphenyl)carbamate | DrugBank ID:DB07846 | PubChem CID:74077203"
+BMGC_DG15493,BMG_DG193537,8-Hydroxyquinaldinic acid | PubChem CID:74079 | 8-HYDROXYQUINALDINIC ACID | PubChem SID:478836854 | CAS RN:1571-30-8 | UNII:EBM66FCM33
+BMGC_DG15494,BMG_DG193539,PubChem CID:7408 | UNII:HZ9DM6B2MT | PubChem SID:198941366 | CAS RN:618-36-0 | 1-PHENETHYLAMINE | 1-phenylethanamine | 1-Phenylethylamine | CAS RN:98-84-0
+BMGC_DG15495,BMG_DG193582,CAS RN:1576-43-8 | UNII:1IIT7R7VPJ | PubChem CID:74093 | PubChem SID:198981595 | P-HYDROXYBENZENESULFONAMIDE
+BMGC_DG15496,BMG_DG193591,PubChem SID:198957771 | UNII:RK493WHV10 | ACETOPHENONE | DrugBank ID:DB04619 | 1-phenylethanone | CAS RN:98-86-2 | Acetophenone | PubChem CID:7410
+BMGC_DG15497,BMG_DG193619,PubChem SID:198955019 | THIOBENZOIC ACID | UNII:GBG5RLO56N | PubChem CID:7414 | CAS RN:98-91-9
+BMGC_DG15498,BMG_DG193621,2-AMINO-4-METHYLTHIAZOLE | PubChem SID:198982968 | PubChem CID:74143 | CAS RN:1603-91-4 | UNII:R95713542R
+BMGC_DG15499,BMG_DG193637,CAS RN:99-03-6 | PubChem SID:482553107 | PubChem CID:7417 | UNII:H366ULD45X | 3'-AMINOACETOPHENONE | 3'-Aminoacetophenone
+BMGC_DG15500,BMG_DG193645,UNII:1UA7K8EEXT | CAS RN:99-04-7 | PubChem CID:7418 | PubChem SID:198966455 | M-TOLUIC ACID
+BMGC_DG15501,BMG_DG193646,"PubChem CID:74181 | CAS RN:1620-68-4 | 2,6-BIS((2-HYDROXY-5-METHYLPHENYL)METHYL)-4-METHYLPHENOL | UNII:H9F7SG62G8 | PubChem SID:363908051"
+BMGC_DG15502,BMG_DG193651,DrugBank ID:DB02054 | CAS RN:99-05-8 | M-AMINOBENZOIC ACID | Gabaculine | UNII:G2X3B3O37U | m-AMINOBENZOIC ACID | PubChem CID:7419 | PubChem SID:198983033
+BMGC_DG15503,BMG_DG193652,PubChem CID:74190 | Ethyl dihydrogen phosphate | PubChem SID:198952915 | CAS RN:1623-14-9 | UNII:BMH1WT204A | DrugBank ID:DB03822 | MONOETHYL PHOSPHATE
+BMGC_DG15504,BMG_DG193662,3-Hydroxybenzoic acid | CAS RN:99-06-9 | UNII:2ZFW40OJ7U | 3-hydroxybenzoic acid | 3-HYDROXYBENZOIC ACID | PubChem SID:198964511 | PubChem CID:7420 | CAS RN:25302-76-5
+BMGC_DG15505,BMG_DG193663,CAS RN:1628-29-1 | UNII:P2H6XAV83R | 10-ACETYLPHENOTHIAZINE | PubChem CID:74200 | PubChem SID:441583515
+BMGC_DG15506,BMG_DG193667,PubChem SID:472411115 | N-BENZYLMALEIMIDE | UNII:UPL94A7TQH | PubChem CID:74204 | CAS RN:1631-26-1 | N-Benzylmaleimide
+BMGC_DG15507,BMG_DG193681,CAS RN:36-37-3 | PubChem SID:198987263 | 3-Nitrotoluene | UNII:29A9W826KQ | PubChem CID:7422 | CAS RN:99-08-1 | 1-methyl-3-nitrobenzene | M-NITROTOLUENE
+BMGC_DG15508,BMG_DG193688,PubChem SID:346538422 | PubChem CID:74223604 | LY-3130481 | CAS RN:1610802-47-5 | UNII:YIQTLNB50N
+BMGC_DG15509,BMG_DG193698,"UNII:2WC5LMO6L1 | PubChem CID:7424 | 3,5-DIHYDROXYBENZOIC ACID | PubChem SID:198986737 | CAS RN:99-10-5"
+BMGC_DG15510,BMG_DG193714,"PubChem CID:7427 | Trehalose | TREHALOSE | DrugBank ID:DB12310 | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol | PubChem SID:175266461 | CAS RN:99-20-7 | NDC:84372-046 | UNII:B8WCK70T7I | NDC:84372-047"
+BMGC_DG15511,BMG_DG193720,UNII:623D3XG80C | METHYL GALLATE | PubChem SID:198988876 | PubChem CID:7428 | CAS RN:99-24-1
+BMGC_DG15512,BMG_DG193732,CAS RN:1678-25-7 | PubChem SID:474493108 | BENZENESULFONANILIDE | PubChem CID:74296 | UNII:W8ZF9FCZ3K | Benzenesulfonanilide
+BMGC_DG15513,BMG_DG193735,PubChem CID:74299 | PubChem SID:459055667 | UNII:AB2T8N4T4C | 4-CHLOROPHENYLBORONIC ACID | CAS RN:1679-18-1
+BMGC_DG15514,BMG_DG193736,CAS RN:110-94-1 | Glutaric acid | GLUTARIC ACID | DrugBank ID:DB03553 | PubChem SID:198955754 | Glutaric Acid | pentanedioic acid | UNII:H849F7N00B | PubChem CID:743
+BMGC_DG15515,BMG_DG193742,"CAS RN:1684-14-6 | PubChem SID:441659245 | PubChem CID:74311 | 2,3-DIPHENYLQUINOXALINE | UNII:5MJ74FC4Q6"
+BMGC_DG15516,BMG_DG193746,PubChem CID:74318 | PubChem SID:198949555 | UNII:BV0Q72R613 | 9H-fluoren-9-ol | 9H-Fluoren-9-ol | 9-HYDROXYFLUORENE | CAS RN:1689-64-1
+BMGC_DG15517,BMG_DG193759,"PubChem CID:7433 | PubChem SID:198979634 | UNII:4V3F9Q018P | 3,5-DINITROBENZOIC ACID | CAS RN:99-34-3"
+BMGC_DG15518,BMG_DG193768,UNII:5DZD8Z9XMT | PubChem SID:485664421 | CAS RN:1161002-05-6 | PubChem CID:7433743 | G-15
+BMGC_DG15519,BMG_DG193790,"Adrenalone | PubChem CID:7436 | DrugBank ID:DB13394 | UNII:EGU41QL329 | 1-(3,4-dihydroxyphenyl)-2-(methylamino)ethanone | CAS RN:99-45-6 | ADRENALONE | PubChem SID:198985654"
+BMGC_DG15520,BMG_DG193907,"PubChem SID:198973789 | PubChem CID:7450 | 1,3-di(propan-2-yl)benzene | 1,3-DIISOPROPYLBENZENE | 1,3-Diisopropylbenzene | CAS RN:99-62-7 | UNII:482VXW192E"
+BMGC_DG15521,BMG_DG193919,"PubChem CID:7452 | DrugBank ID:DB02680 | UNII:DK8B627BU0 | M-DINITROBENZENE | 1,3-Dinitrobenzene | 1,3-dinitrobenzene | CAS RN:99-65-0 | PubChem SID:198978400"
+BMGC_DG15522,BMG_DG193932,"P-BROMOPHENACYL BROMIDE | UNII:PN0FRW1G4Z | CAS RN:132309-76-3 | 2-bromo-1-(4-bromophenyl)ethanone | CAS RN:99-73-0 | 2,4'-Dibromoacetophenone | PubChem CID:7454 | PubChem SID:198969763"
+BMGC_DG15523,BMG_DG193947,PubChem SID:175267581 | PubChem CID:7456 | METHYLPARABEN | CAS RN:99-76-3 | methyl 4-hydroxybenzoate | DrugBank ID:DB14212 | UNII:A2I8C7HI9T | Methylparaben
+BMGC_DG15524,BMG_DG193969,PubChem SID:440088973 | PubChem CID:74592 | 1-ETHYLBENZ(CD)INDOL-2(1H)-ONE | CAS RN:1830-56-4 | UNII:PR88TZB3LN
+BMGC_DG15525,BMG_DG193975,PubChem CID:745994 | UNII:SL3TT94T4C | CAS RN:41472-49-5 | PubChem SID:478838561 | N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE | DrugBank ID:DB08155 | N-(2-(4-(AMINOSULFONYL)PHENYL)ETHYL)ACETAMIDE | N-[2-[4-(Aminosulfonyl)phenyl]ethyl]acetamide
+BMGC_DG15526,BMG_DG194003,PubChem CID:74626 | Phenyl formate | UNII:V4EL38P3VW | PubChem SID:472411617 | CAS RN:1864-94-4 | PHENYL FORMATE
+BMGC_DG15527,BMG_DG194012,DrugBank ID:DB02114 | PubChem SID:198950347 | 4-Isopropylaniline | Cumidine | PubChem CID:7464 | CAS RN:99-88-7 | CUMIDINE | 4-propan-2-ylaniline | UNII:0D54T7V7XL
+BMGC_DG15528,BMG_DG194035,PubChem CID:7467 | 1-(4-chlorophenyl)ethanone | UNII:ZV4A71K303 | P-Chloroacetophenone | CAS RN:238399-91-2 | CAS RN:99-91-2 | PubChem SID:198951949 | CAS RN:1174565-85-5 | P-CHLOROACETOPHENONE
+BMGC_DG15529,BMG_DG194044,UNII:G1L3HT4CMH | 1-(4-hydroxyphenyl)ethanone | CAS RN:261172-42-3 | 4'-Hydroxyacetophenone | PubChem SID:198988712 | HYDROXYACETOPHENONE | CAS RN:99-93-4 | PubChem CID:7469
+BMGC_DG15530,BMG_DG194059,PubChem CID:74708 | 2-hydroxyxanthen-9-one | CAS RN:1915-98-6 | 2-Hydroxyxanthone
+BMGC_DG15531,BMG_DG194060,"5-HYDROXYVERATRIC ACID | UNII:J6FH4N7RMW | PubChem SID:375578867 | 3-hydroxy-4,5-dimethoxybenzoic acid | 3-Hydroxy-4,5-dimethoxybenzoic acid | PubChem CID:74709 | CAS RN:1916-08-1"
+BMGC_DG15532,BMG_DG194064,PubChem SID:441658823 | CAS RN:1918-79-2 | PubChem CID:74713 | UNII:5SX6CX4FJB | 5-METHYLTHIOPHENE-2-CARBOXYLIC ACID
+BMGC_DG15533,BMG_DG194075,CAS RN:99-99-0 | 4-Nitrotoluene | 1-methyl-4-nitrobenzene | P-NITROTOLUENE | PubChem SID:198941815 | PubChem CID:7473 | UNII:E88IMG14EX
+BMGC_DG15534,BMG_DG194093,"1-Propanesulfinothioic acid, S-propyl ester | 1-propylsulfinylsulfanylpropane | CAS RN:1948-52-3 | PubChem CID:74761"
+BMGC_DG15535,BMG_DG194106,"Zalsenertant Tetraxetan | CAS RN:1613265-38-5 | ZALSENERTANT TETRAXETAN | PubChem CID:74766516 | 2-[[5-(2,6-dimethoxyphenyl)-1-[4-[methyl-[3-[methyl-[3-[methyl-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]propyl]amino]propyl]carbamoyl]-2-propan-2-ylphenyl]pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid | PubChem SID:433968074 | UNII:XF82V61Y8U"
+BMGC_DG15536,BMG_DG194108,CAS RN:1610358-59-2 | CAS RN:1610408-96-2 | PubChem CID:74767009 | CAS RN:1610358-56-9 | 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-[4-[(methylsulfonimidoyl)methyl]pyridin-2-yl]pyridin-2-amine | (Inverted exclamation markA)-BAY-1251152 | CAS RN:1610358-53-6
+BMGC_DG15537,BMG_DG194119,P-ANISIC ACID | CAS RN:100-09-4 | P-Anisic Acid | DrugBank ID:DB02795 | PubChem SID:175267501 | PubChem CID:7478 | UNII:4SB6Y7DMM3
+BMGC_DG15538,BMG_DG194122,UNII:T7NXE620EK | PubChem SID:377308939 | CAS RN:1969-74-0 | PHENYLISATOGEN | PubChem CID:74787
+BMGC_DG15539,BMG_DG194127,4-(dimethylamino)benzaldehyde | P-DIMETHYLAMINOBENZALDEHYDE | PubChem SID:198934890 | 4-(Dimethylamino)Benzaldehyde | CAS RN:100-10-7 | PubChem CID:7479 | UNII:V7E88PR1YB
+BMGC_DG15540,BMG_DG194201,PubChem CID:74865 | o-Tyramine | UNII:D2TTC59FQW | CAS RN:2039-66-9 | PubChem SID:485661476 | O-TYRAMINE
+BMGC_DG15541,BMG_DG194202,3-METHOXYPHENYLETHYLAMINE | PubChem SID:313184085 | PubChem CID:74866 | UNII:7WX5W6GM6F | CAS RN:2039-67-0
+BMGC_DG15542,BMG_DG194221,IBRITUMOMAB TIUXETAN | PubChem SID:472398729 | PubChem CID:74890578 | UNII:4Q52C550XK | CAS RN:206181-63-7
+BMGC_DG15543,BMG_DG194227,CAS RN:2045-79-6 | PubChem SID:472407965 | 2-METHOXYPHENETHYLAMINE | UNII:A87YWS9XM3 | PubChem CID:74896
+BMGC_DG15544,BMG_DG194255,UNII:4K1KGR926X | PubChem CID:7493 | PubChem SID:198977750 | CAS RN:100-26-5 | ISOCINCHOMERONIC ACID
+BMGC_DG15545,BMG_DG194473,"NDC:0173-0675 | NDC:68462-421 | CAS RN:137732-39-9 | CAS RN:94015-53-9 | NDC:51407-869 | 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione | NDC:69452-252 | NDC:65162-693 | NDC:43063-393 | NDC:63187-879 | NDC:72603-248 | NDC:0378-4162 | NDC:63739-203 | CAS RN:95233-18-4 | Atovaquone | NDC:17856-0631 | NDC:73141-104 | NDC:0173-0676 | ATOVAQUONE | NDC:62135-528 | UNII:F1W7QUV0KI | PubChem SID:175268629 | NDC:10702-223 | NDC:68462-404 | NDC:68001-245 | DrugBank ID:DB01117 | NDC:70748-299 | NDC:51407-642 | PubChem SID:434369695 | NDC:0173-0665 | PubChem CID:74989 | NDC:16714-900 | NDC:66993-060 | NDC:0121-1016 | NDC:68462-402 | 1,4-NAPHTHALENEDIONE, 2-(CIS-4-(4-CHLOROPHENYL)CYCLOHEXYL)-3-HYDROXY- | NDC:50268-086 | NDC:0173-0547 | UNII:Y883P1Z2LT | NDC:60687-534 | NDC:31722-629 | NDC:0904-7459 | NDC:81033-104 | NDC:0904-7064 | NDC:0121-1796 | NDC:50090-1302 | NDC:50090-2980 | NDC:0378-4160"
+BMGC_DG15546,BMG_DG194479,PubChem CID:750 | CAS RN:25718-94-9 | GLYCINE | 2-aminoacetic acid | UNII:TE7660XO1C | Glycine | DrugBank ID:DB00145 | PubChem SID:175266246 | CAS RN:56-40-6 | CAS RN:18875-39-3
+BMGC_DG15547,BMG_DG194484,"5,6,9,13,17,23,24,27,31,35-decamethyl-10,28-dioctyl-2,20-diazanonacyclo[19.15.0.03,19.05,17.06,14.09,13.023,35.024,32.027,31]hexatriaconta-1(21),2,19-triene | 5,6,9,13,17,23,24,27,31,35-Decamethyl-10,28-dioctyl-2,20-diazanonacyclo[19.15.0.03,19.05,17.06,14.09,13.023,35.024,32.027,31]hexatriaconta-1(21),2,19-triene | PubChem CID:75007581"
+BMGC_DG15548,BMG_DG194493,"UNII:F805RZI8GO | PubChem SID:198989108 | 5,6-DIMETHOXY-1-INDANONE | PubChem CID:75018 | CAS RN:2107-69-9"
+BMGC_DG15549,BMG_DG194504,"1,3-PROPANEDIYL DISALICYLATE | CAS RN:84370-82-1 | PubChem SID:472424618 | PubChem CID:7503587 | UNII:S599NXL75W"
+BMGC_DG15550,BMG_DG194510,DrugBank ID:DB02464 | phenylmethanamine | Benzylamine | CAS RN:100-46-9 | CAS RN:89551-24-6 | PubChem SID:198972950 | PubChem CID:7504 | BENZYLAMINE | UNII:A1O31ROR09
+BMGC_DG15551,BMG_DG194544,"CAS RN:2138-49-0 | 3,5-Diisopropylpyrocatechol | 3,5-DIISOPROPYLPYROCATECHOL | PubChem CID:75058 | UNII:G7Z5WUX63N | PubChem SID:482554971"
+BMGC_DG15552,BMG_DG194545,PubChem SID:198935945 | CAS RN:2142-01-0 | BENZYLPHTHALIMIDE | PubChem CID:75059 | UNII:3G2A77460J
+BMGC_DG15553,BMG_DG194583,"UNII:41U1BRD8AX | PubChem SID:375579063 | CAS RN:2150-44-9 | PubChem CID:75076 | METHYL 3,5-HYDROXYBENZOATE"
+BMGC_DG15554,BMG_DG194584,UNII:LS28B004KM | PubChem CID:75077 | METHYL DIHYDROXYBENZOATE | PubChem SID:198960993 | CAS RN:2150-46-1
+BMGC_DG15555,BMG_DG194598,UNII:OS34A21OBZ | CAS RN:16528-58-8 | PubChem SID:198974053 | Benzyl mercaptan | BENZYL MERCAPTAN | phenylmethanethiol | CAS RN:100-53-8 | PubChem CID:7509
+BMGC_DG15556,BMG_DG194606,"CAS RN:367-47-5 | Glyceraldehyde | PubChem CID:751 | 2,3-dihydroxypropanal | PubChem SID:198934998 | UNII:DI19XSG16H | CAS RN:56-82-6 | GLYCERALDEHYDE, DL- | CAS RN:478529-62-3"
+BMGC_DG15557,BMG_DG194607,3-Pyridinemethanol | DrugBank ID:DB04145 | CAS RN:100-55-0 | PubChem CID:7510 | Nicotinyl alcohol | NICOTINYL ALCOHOL | PubChem SID:198980785 | pyridin-3-ylmethanol | UNII:9TF312056Y
+BMGC_DG15558,BMG_DG194614,"3,3,3-TRIS(4-CHLOROPHENYL)PROPANOIC ACID | CAS RN:2168-06-1 | PubChem CID:75107 | PubChem SID:441583280 | UNII:LD3SB44ZHS"
+BMGC_DG15559,BMG_DG194618,UNII:Y455KS1U7Q | PubChem SID:329589015 | PubChem CID:75110 | CAS RN:2170-03-8 | ITACONIC ANHYDRIDE
+BMGC_DG15560,BMG_DG194641,CAS RN:2182-38-9 | UNII:VX3T76J4TH | PubChem CID:75128 | PubChem SID:472410901 | 2-ANILINO-2-METHYLPROPIONONITRILE
+BMGC_DG15561,BMG_DG194644,1-(3-Chlorophenyl)-3-cyclohexylurea | CAS RN:72802-45-0 | PubChem CID:751320 | UNII:5D829P4VH6 | PubChem SID:485663444 | 1-(3-CHLOROPHENYL)-3-CYCLOHEXYLUREA
+BMGC_DG15562,BMG_DG194679,PubChem SID:198961002 | PubChem CID:7516 | CAS RN:125687-18-5 | Phenylhydrazine | phenylhydrazine | PHENYLHYDRAZINE | CAS RN:100-63-0 | UNII:064F424C9K
+BMGC_DG15563,BMG_DG194695,N-Phenylhydroxylamine | UNII:282MU82Z9A | N-phenylhydroxylamine | PubChem SID:198986028 | CAS RN:100-65-2 | PubChem CID:7518 | PHENYLHYDROXYLAMINE
+BMGC_DG15564,BMG_DG194696,1-Benzyl-1H-indazol-3-ol | PubChem SID:474492254 | CAS RN:2215-63-6 | 1-BENZYL-1H-INDAZOL-3-OL | PubChem CID:75181 | UNII:YL5ZXN63Q6
+BMGC_DG15565,BMG_DG194702,ANISOLE | PubChem SID:198989810 | anisole | PubChem CID:7519 | Anisole | CAS RN:100-66-3 | UNII:B3W693GAZH
+BMGC_DG15566,BMG_DG194709,PubChem SID:198991132 | GLYCERIC ACID | CAS RN:473-81-4 | UNII:70KH64UX7G | PubChem CID:752
+BMGC_DG15567,BMG_DG194748,3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER | DrugBank ID:DB07639 | PubChem CID:75243795
+BMGC_DG15568,BMG_DG194756,"UNII:XM6NV2GYM9 | 4-(Thiazol-2-yldiazenyl)benzene-1,3-diol | PubChem CID:75253 | PubChem SID:482553684 | 4-(THIAZOL-2-YLDIAZENYL)BENZENE-1,3-DIOL | CAS RN:96627-60-0"
+BMGC_DG15569,BMG_DG194765,PubChem SID:198944849 | CAS RN:2253-73-8 | ISOPROPYL ISOTHIOCYANATE | PubChem CID:75263 | UNII:46561PKP9T
+BMGC_DG15570,BMG_DG194785,CAS RN:2284-30-2 | PubChem CID:75294 | PubChem SID:478839070 | 4-Benzylresorcinol | UNII:RXH9P8G3D7 | 4-BENZYLRESORCINOL
+BMGC_DG15571,BMG_DG194792,"Glycerin | CAS RN:144086-03-3 | PubChem SID:175265561 | PubChem CID:753 | CAS RN:153050-05-6 | CAS RN:11003-00-2 | CAS RN:107283-02-3 | propane-1,2,3-triol | CAS RN:56-81-5 | UNII:PDC6A3C0OX | CAS RN:8013-25-0 | GLYCERIN | DrugBank ID:DB09462 | CAS RN:101662-08-2"
+BMGC_DG15572,BMG_DG194793,PubChem SID:249492131 | PubChem CID:7530 | UNII:UI9I3Y6WTZ | CAS RN:100-84-5 | 1-METHOXY-3-METHYLBENZENE
+BMGC_DG15573,BMG_DG194812,PubChem CID:7532 | phenylmethanesulfonic acid | Benzylsulfonic acid | BENZYLSULFONIC ACID | PubChem SID:198951537 | DrugBank ID:DB03297 | UNII:5BRP81V98H | CAS RN:57267-76-2 | CAS RN:100-87-8
+BMGC_DG15574,BMG_DG194816,"PubChem SID:478838461 | UNII:UQN36XF25Z | 6-(4-METHYL-1-PIPERAZINYL)-2,4-PYRIMIDINEDIAMINE | PubChem CID:753256 | 6-(4-Methyl-1-piperazinyl)-2,4-pyrimidinediamine | CAS RN:4940-96-9"
+BMGC_DG15575,BMG_DG194818,UNII:HN3OFO5036 | PubChem CID:7533 | Cyclamic acid | cyclohexylsulfamic acid | CAS RN:100-88-9 | CYCLAMIC ACID | PubChem SID:198956042
+BMGC_DG15576,BMG_DG194846,"UNII:BPS74SKX8K | 4-(1H-1,2,4-TRIAZOL-1-YLMETHYL)BENZONITRILE | 4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile | PubChem CID:7537616 | CAS RN:112809-25-3 | PubChem SID:485664697"
+BMGC_DG15577,BMG_DG194858,UNII:9NTI6P3O4X | GLYCERYL 1-PHOSPHATE | CAS RN:57-03-4 | PubChem CID:754 | PubChem SID:198975845
+BMGC_DG15578,BMG_DG194873,"PubChem CID:75412604 | CAS RN:934760-90-4 | DrugBank ID:DB05188 | Kd3010 | 4-[(2R,6S)-2,6-dimethyl-4-[4-(trifluoromethoxy)phenyl]piperazin-1-yl]sulfonyl-2,3-dihydro-1H-indene-2-carboxylic acid;4-methylbenzenesulfonic acid"
+BMGC_DG15579,BMG_DG194878,"CAS RN:64834-00-0 | PubChem CID:75420 | PubChem SID:315658382 | CAS RN:2380-63-4 | 1H-pyrazolo(3,4-d)pyrimidin-4-amine | 1H-pyrazolo[3,4-d]pyrimidin-4-amine | UNII:0356MAT9LX | 8-AZA-7-DEAZAADENINE"
+BMGC_DG15580,BMG_DG194879,UNII:1W4VD9085V | CAS RN:2380-94-1 | PubChem SID:198960702 | PubChem CID:75421 | 4-HYDROXYINDOLE
+BMGC_DG15581,BMG_DG194886,"PubChem CID:75436 | CAS RN:2387-48-6 | UNII:NK9MZ6M6HG | 2,6-DIAMINO-5-NITROSO-4(3H)-PYRIMIDINONE"
+BMGC_DG15582,BMG_DG194895,UNII:2M6QLM4NWE | 4-METHOXYBENZYLAMINE | CAS RN:2393-23-9 | PubChem SID:461434071 | PubChem CID:75452
+BMGC_DG15583,BMG_DG194909,"Triclocarban | DrugBank ID:DB11155 | PubChem SID:175267689 | TRICLOCARBAN | PubChem CID:7547 | 1-(4-chlorophenyl)-3-(3,4-dichlorophenyl)urea | UNII:BGG1Y1ED0Y | CAS RN:101-20-2"
+BMGC_DG15584,BMG_DG194913,UNII:HFB27SS2KM | PubChem CID:75473 | 3-PHENYLTHIOPHENE | CAS RN:2404-87-7 | PubChem SID:441096998
+BMGC_DG15585,BMG_DG194928,"3,3′,5,5′-Tetramethyl[1,1′-biphenyl]-4,4′-diol | CAS RN:2417-04-1 | PubChem CID:75490 | PubChem SID:474492535 | 3,3',5,5'-TETRAMETHYL(1,1'-BIPHENYL)-4,4'-DIOL | UNII:KV93XB4DEU"
+BMGC_DG15586,BMG_DG194944,4-METHYLBENZIL | CAS RN:2431-00-7 | UNII:J463KL3E8Q | PubChem CID:75511
+BMGC_DG15587,BMG_DG194990,UNII:DH59VKG9S4 | 4-PYRROLIDINOPYRIDINE | PubChem CID:75567 | PubChem SID:472409637 | CAS RN:2456-81-7
+BMGC_DG15588,BMG_DG194996,"PubChem SID:198946283 | UNII:04D0A23747 | CAS RN:2467-02-9 | 2,2'-BISPHENOL F | PubChem CID:75575"
+BMGC_DG15589,BMG_DG194998,1-cyclohexyl-N-methylpropan-2-amine | DrugBank ID:DB06714 | PROPYLHEXEDRINE | PubChem CID:7558 | CAS RN:3595-11-7 | NDC:0225-0611 | PubChem SID:198988147 | CAS RN:101-40-6 | Propylhexedrine | UNII:LQU92IU8LL | NDC:0225-0610
+BMGC_DG15590,BMG_DG195048,"PubChem CID:75629 | PubChem SID:375084652 | 5-METHYL-(1,2,4)TRIAZOLO(1,5-A)PYRIMIDIN-7(1H)-ONE | UNII:J13JT2L1BY | CAS RN:35523-67-2"
+BMGC_DG15591,BMG_DG195060,"4-N-phenylbenzene-1,4-diamine | UNII:007X4XXS71 | N-PHENYL-P-PHENYLENEDIAMINE | PubChem CID:7564 | 4-Aminodiphenylamine | CAS RN:101-54-2 | PubChem SID:198956807"
+BMGC_DG15592,BMG_DG195097,CAS RN:2540-09-2 | UNII:1658899LQL | PubChem SID:348481810 | 7-CHLORO-4-METHYLCARBOSTYRIL | PubChem CID:75680
+BMGC_DG15593,BMG_DG195113,DrugBank ID:DB03085 | UNII:0WT12SX38S | Glycolic acid | PubChem CID:757 | 2-hydroxyacetic acid | Glycolic Acid | GLYCOLIC ACID | CAS RN:79-14-1 | PubChem SID:175268575
+BMGC_DG15594,BMG_DG195133,CAS RN:2566-34-9 | PubChem SID:461433941 | 2-(METHYLAMINO)ISOBUTYRIC ACID | PubChem CID:75725 | UNII:26F96C8MBJ
+BMGC_DG15595,BMG_DG195159,CAS RN:2589-71-1 | PubChem CID:75766 | UNII:RFV916NJJ6 | PubChem SID:376072421 | 4-VALERYLPHENOL
+BMGC_DG15596,BMG_DG195160,UNII:E2E77Z6DUK | PubChem SID:348480988 | CAS RN:2589-73-3 | 4-OCTANOYLPHENOL | PubChem CID:75767
+BMGC_DG15597,BMG_DG195179,UNII:92EX195E1G | RU78191 | PubChem SID:438788639 | DrugBank ID:DB04080 | CAS RN:2613-89-0 | PubChem CID:75791 | PHENYLMALONIC ACID
+BMGC_DG15598,BMG_DG195192,PubChem CID:75810 | UNII:EKP351892F | PubChem SID:198940078 | 2-(1-methylimidazol-4-yl)acetic acid | N-METHYLIMIDAZOLEACETIC ACID | 2-(1-methyl-1H-imidazol-4-yl)acetic acid | CAS RN:2625-49-2
+BMGC_DG15599,BMG_DG195195,UNII:1S20IA5GGO | 3-isothiocyanatopropylbenzene | CAS RN:2627-27-2 | PubChem CID:75815 | 3-Phenylpropyl isothiocyanate | 3-PHENYLPROPYL ISOTHIOCYANATE | PubChem SID:198935142
+BMGC_DG15600,BMG_DG195197,PubChem SID:198980713 | UNII:0K08L8GE2H | LAURYL PHOSPHATE | CAS RN:2627-35-2 | PubChem CID:75816
+BMGC_DG15601,BMG_DG195199,"PubChem CID:75818 | CAS RN:2627-86-3 | 1-PHENETHYLAMINE, (-)- | PubChem SID:198946588 | UNII:05780F90V3"
+BMGC_DG15602,BMG_DG195201,DICYCLOHEXYLAMINE | CAS RN:101-83-7 | Dicyclohexylamine | N-cyclohexylcyclohexanamine | PubChem SID:198949418 | UNII:1A93RJW924 | PubChem CID:7582
+BMGC_DG15603,BMG_DG195208,"3,5-Diiodosalicylaldehyde | CAS RN:2631-77-8 | PubChem SID:474490314 | PubChem CID:75829 | UNII:WDZ9NS6YPP | 3,5-DIIODOSALICYLALDEHYDE"
+BMGC_DG15604,BMG_DG195215,"DrugBank ID:DB07623 | 4,4'-DIPYRIDYL DISULFIDE | PubChem SID:438788127 | CAS RN:2645-22-9 | PubChem CID:75846 | UNII:EI4LXL5JH8"
+BMGC_DG15605,BMG_DG195236,"3,3',4,4'-TETRAAMINODIPHENYL ETHER | UNII:A8NR6PP85T | PubChem SID:472409307 | CAS RN:2676-59-7 | PubChem CID:75887"
+BMGC_DG15606,BMG_DG195245,2-PHENOXYANILINE | UNII:T96D49XD9H | CAS RN:2688-84-8 | PubChem CID:75899 | PubChem SID:472408345
+BMGC_DG15607,BMG_DG195267,2-(2-Aminoethyl)pyridine | UNII:ATW1AH7OJ5 | 2-PYRIDINEETHANAMINE | CAS RN:2706-56-1 | PubChem CID:75919 | PubChem SID:198950915 | 2-pyridin-2-ylethanamine
+BMGC_DG15608,BMG_DG195275,"PubChem CID:75928 | CAS RN:2713-34-0 | UNII:JN34ZXS9X7 | 3,5-DIFLUOROPHENOL"
+BMGC_DG15609,BMG_DG195277,9-BUTYL-9H-PURIN-6-AMINE | PubChem CID:75929 | UNII:YUB5RM7D27 | CAS RN:2715-70-0
+BMGC_DG15610,BMG_DG195284,"PubChem CID:7594 | PubChem SID:175266108 | CAS RN:102-06-7 | 1,3-Diphenylguanidine | UNII:6MRZ85RNHQ | DrugBank ID:DB14191 | DIPHENYLGUANIDINE | 1,2-diphenylguanidine"
+BMGC_DG15611,BMG_DG195285,N-(2-Aminophenyl)benzamide | CAS RN:721-47-1 | N-(2-AMINOPHENYL)BENZAMIDE | UNII:3ZR595YS57 | PubChem CID:759408 | PubChem SID:485665610
+BMGC_DG15612,BMG_DG195292,"1,3-diphenylurea | PubChem SID:198983443 | CAS RN:102-07-8 | UNII:94YD8RMX5B | 1,3-DIPHENYLUREA | DrugBank ID:DB07496 | 1,3-Diphenylurea | PubChem CID:7595"
+BMGC_DG15613,BMG_DG195325,UNII:3UG152ZU0E | CAS RN:2759-28-6 | PubChem CID:75994 | PubChem SID:198969966 | BENZYLPIPERAZINE | CAS RN:860027-50-5 | 1-benzylpiperazine | CAS RN:2759-17-3 | 1-Benzylpiperazine
+BMGC_DG15614,BMG_DG195329,PubChem SID:198945782 | GLYOXYLIC ACID | oxaldehydic acid | PubChem CID:760 | DrugBank ID:DB04343 | Glyoxylic acid | UNII:JQ39C92HH6 | CAS RN:298-12-4
+BMGC_DG15615,BMG_DG195339,UNII:2T7Q0CK9IF | CAS RN:2769-64-4 | N-Butyl Isocyanide | PubChem CID:76008 | DrugBank ID:DB01826 | BUTYL ISOCYANIDE | PubChem SID:438788843
+BMGC_DG15616,BMG_DG195343,7-(3-Chloropropyl)theophylline | CAS RN:2770-66-3 | PubChem CID:76011 | PubChem SID:472410264 | UNII:2C2KFZ8SFT | 7-(3-CHLOROPROPYL)THEOPHYLLINE
+BMGC_DG15617,BMG_DG195400,UNII:JE4R4NBV2R | PubChem CID:76052 | CAS RN:2810-04-0 | PubChem SID:472410635 | ETHYL 2-THENOATE
+BMGC_DG15618,BMG_DG195416,"CAS RN:1612755-71-1 | 6-[(4R)-4-methyl-1,1-dioxo-1,2,6-thiadiazinan-2-yl]isoquinoline-1-carbonitrile | UNII:3I487UHH95 | DrugBank ID:DB15221 | Pf-06260414 | PubChem CID:76071881 | PubChem SID:346539258 | PF-06260414"
+BMGC_DG15619,BMG_DG195426,UNII:WB9Q6M8O60 | Cyclopentamine | 1-cyclopentyl-N-methylpropan-2-amine | PubChem CID:7608 | DrugBank ID:DB08999 | CYCLOPENTAMINE | PubChem SID:198966130 | CAS RN:102-45-4
+BMGC_DG15620,BMG_DG195428,UNII:CS8D10SY5L | 5-AMINO-2-HYDROXYTOLUENE | CAS RN:2835-96-3 | PubChem CID:76081 | PubChem SID:198936270
+BMGC_DG15621,BMG_DG195437,4-(1H-PURIN-6-YL)MORPHOLINE | PubChem SID:474490032 | CAS RN:2846-96-0 | DrugBank ID:DB08780 | UNII:89VN5RQ48X | 6-MORPHOLIN-4-YL-9H-PURINE | PubChem CID:76098 | 4-(1H-Purin-6-yl)morpholine
+BMGC_DG15622,BMG_DG195454,"CAS RN:102-56-7 | PubChem SID:198979318 | 2,5-DIMETHOXYANILINE | PubChem CID:7613 | UNII:V3Z5U3FL10"
+BMGC_DG15623,BMG_DG195458,PubChem SID:376072208 | 1-METHOXYPHENAZINE | UNII:YB0SBX4FRJ | PubChem CID:76137 | CAS RN:2876-17-7
+BMGC_DG15624,BMG_DG195467,DE(CHLOROBENZOYL)INDOMETHACIN | 5-Methoxy-2-methyl-3-indoleacetic acid | De(chlorobenzoyl)indomethacin | UNII:KY9AD0AQM0 | CAS RN:2882-15-7 | PubChem CID:76151 | 2-(5-methoxy-2-methyl-1H-indol-3-yl)acetic acid | PubChem SID:384436199
+BMGC_DG15625,BMG_DG195492,PubChem SID:438789066 | UNII:4JHQ7M3460 | CAS RN:2898-08-0 | PubChem CID:76175 | RO-05-2921
+BMGC_DG15626,BMG_DG195494,TROLAMINE | UNII:9O3K93S3TK | Trolamine | PubChem CID:7618 | Triethanolamine | PubChem SID:175265715 | CAS RN:102-71-6 | DrugBank ID:DB13747 | 2-[bis(2-hydroxyethyl)amino]ethanol
+BMGC_DG15627,BMG_DG195565,UNII:R57ZHV85D4 | PubChem SID:175266726 | CAS RN:11113-50-1 | CAS RN:10043-35-3 | BORIC ACID | DrugBank ID:DB11326 | boric acid | NDC:52747-155 | NDC:83819-102 | Boric Acid | PubChem CID:7628 | NDC:52747-255 | Boric acid
+BMGC_DG15628,BMG_DG195568,"PubChem SID:319891956 | Pco-371 | UNII:TE53TU0WSQ | PubChem CID:76283707 | CAS RN:1613373-33-3 | DrugBank ID:DB14946 | 1-[3,5-dimethyl-4-[2-[[4-oxo-2-[4-(trifluoromethoxy)phenyl]-1,3,8-triazaspiro[4.5]dec-1-en-8-yl]sulfonyl]ethyl]phenyl]-5,5-dimethylimidazolidine-2,4-dione | PCO-371"
+BMGC_DG15629,BMG_DG195580,"PubChem CID:76287260 | Darigabat | CAS RN:1614245-70-3 | DARIGABAT | 7-ethyl-4-[3-(4-ethylsulfonyl-2-methoxyphenyl)-4-fluorophenyl]imidazo[4,5-c]pyridazine | PubChem SID:461434947 | UNII:O9BP19HZ3Q"
+BMGC_DG15630,BMG_DG195588,Glycocyamine | DrugBank ID:DB02751 | GLYCOCYAMINE | UNII:GO52O1A04E | 2-(diaminomethylideneamino)acetic acid | PubChem CID:763 | PubChem SID:198988119 | CAS RN:352-97-6
+BMGC_DG15631,BMG_DG195599,PubChem CID:76310822 | ALISOL F | PubChem SID:459275953 | UNII:YQC8D2QG5Y | CAS RN:155521-45-2
+BMGC_DG15632,BMG_DG195603,"[(4R,4aS,7aR,12bS)-9-methoxy-3-methyl-2,4,4a,5,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-yl] benzoate | DrugBank ID:DB15465 | PubChem CID:76314940"
+BMGC_DG15633,BMG_DG195613,"(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid;(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid;(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid;(6Z,9Z,12Z,15Z,18Z)-henicosa-6,9,12,15,18-pentaenoic acid;(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid;(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoic acid;(9Z,12Z)-octadeca-9,12-dienoic acid;(6Z,9Z,12Z)-octadeca-6,9,12-trienoic acid;(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid | Omega-3 carboxylic acid | PubChem CID:76322221"
+BMGC_DG15634,BMG_DG195617,"2-[(4R,5S,6S,7R,9R,10R,11E,13E,16S)-6-[(2S,3R,4R,5S,6R)-5-[(2R,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6S)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde | PubChem CID:76324338"
+BMGC_DG15635,BMG_DG195626,PubChem SID:443624160 | UNII:DGR6SF48KT | MICONAZOLE BENZYL ANALOG | PubChem CID:76334268 | CAS RN:181931-30-6
+BMGC_DG15636,BMG_DG195655,Monobenzone | CAS RN:103-16-2 | PubChem SID:175265338 | PubChem CID:7638 | DrugBank ID:DB00600 | 4-phenylmethoxyphenol | UNII:9L2KA76MG5 | MONOBENZONE
+BMGC_DG15637,BMG_DG195669,DrugBank ID:DB02377 | PubChem CID:764 | Guanine
+BMGC_DG15638,BMG_DG195682,UNII:MBY1SL921L | PubChem CID:7641 | CAS RN:70147-21-6 | CAS RN:2072051-04-6 | Bis(2-ethylhexyl) adipate | bis(2-ethylhexyl) hexanedioate | PubChem SID:175271589 | CAS RN:103-23-1 | DIETHYLHEXYL ADIPATE
+BMGC_DG15639,BMG_DG195702,UNII:DWG32KT6XA | PubChem CID:76428 | PubChem SID:441659144 | CAS RN:3034-50-2 | 1H-IMIDAZOLE-4-CARBALDEHYDE
+BMGC_DG15640,BMG_DG195732,PubChem CID:76470 | UNII:CCB3DC6HV9 | CAS RN:3064-73-1 | PubChem SID:485661771 | Bis(diisobutylthiocarbamoyl) disulfide | BIS(DIISOBUTYLTHIOCARBAMOYL) DISULFIDE
+BMGC_DG15641,BMG_DG195738,"4,4'-DITHIODIMORPHOLINE | PubChem CID:7648 | UNII:M786P489YF | CAS RN:103-34-4 | PubChem SID:198948383"
+BMGC_DG15642,BMG_DG195758,PubChem CID:76509 | UNII:0OAF7T9SCQ | HEXAMETHYLTRIETHYLENETETRAMINE | CAS RN:3083-10-1 | PubChem SID:375579089
+BMGC_DG15643,BMG_DG195806,UNII:33EH6K4PRB | BENZYL PHENYL SULFONE | PubChem SID:474490351 | CAS RN:3112-88-7 | PubChem CID:76561 | Benzyl phenyl sulfone
+BMGC_DG15644,BMG_DG195839,"PubChem SID:198979791 | 5-PENTADECYLRESORCINOL | CAS RN:3158-56-3 | UNII:U1FU33YCG0 | PubChem CID:76617 | 5-pentadecylbenzene-1,3-diol | 5-Pentadecylresorcinol"
+BMGC_DG15645,BMG_DG195846,PubChem SID:441584088 | CAS RN:3166-00-5 | UNII:VJW2DLQ5TY | PubChem CID:76630 | N-(AMINOIMINOMETHYL)BENZAMIDE
+BMGC_DG15646,BMG_DG195848,"UNII:9A8XF4GA0X | CAS RN:3600-86-0 | PubChem SID:198944762 | PubChem CID:76632 | 2-(2,5-dimethoxyphenyl)ethanamine | 2,5-Dimethoxyphenethylamine | 2C-H"
+BMGC_DG15647,BMG_DG195866,"CAS RN:3187-58-4 | METHYL 2,4-DIHYDROXY-6-METHYLBENZOATE | PubChem SID:485661333 | UNII:B2WMD7B62Y | Methyl 2,4-dihydroxy-6-methylbenzoate | PubChem CID:76658"
+BMGC_DG15648,BMG_DG195892,"PubChem CID:76685059 | CAS RN:1620576-64-8 | 1-[4-[5-[5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl]-1-ethyl-1,2,4-triazol-3-yl]piperidin-1-yl]-3-hydroxypropan-1-one | AZD-8835 | Azd8835 | UNII:8B97A88D35 | PubChem SID:346537589"
+BMGC_DG15649,BMG_DG195900,"PubChem SID:485663417 | UNII:2FGB7C97EL | CAS RN:304884-83-1 | DrugBank ID:DB07217 | PubChem CID:766948 | N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thien-2-yl)-2-fluorobenzamide | N-(3-CYANO-4,5,6,7-TETRAHYDROBENZO(B)THIEN-2-YL)-2-FLUOROBENZAMIDE | N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide"
+BMGC_DG15650,BMG_DG195904,CAS RN:22719-67-1 | CAS RN:463-79-6 | carbonic acid | Carbonic Acid | PubChem CID:767
+BMGC_DG15651,BMG_DG195926,PHENYL ISOTHIOCYANATE | NDC:44911-0423 | Phenyl Isothiocyanate | UNII:0D58F84LSU | PubChem CID:7673 | PubChem SID:175267445 | isothiocyanatobenzene | CAS RN:103-72-0
+BMGC_DG15652,BMG_DG195941,PubChem CID:76751 | UNII:2APY7DEB6E | PubChem SID:474489989 | CAS RN:3261-62-9 | P-METHYLPHENETHYLAMINE
+BMGC_DG15653,BMG_DG195959,"CAS RN:3278-31-7 | UNII:BEC7P1E6J1 | N,N'-1,4-Phenylenedimaleimide | PubChem CID:76765 | PubChem SID:198938855 | 1-[4-(2,5-dioxopyrrol-1-yl)phenyl]pyrrole-2,5-dione | N,N'-4-PHENYLENEDIMALEIMIDE"
+BMGC_DG15654,BMG_DG195975,PubChem CID:76784 | CAS RN:3288-99-1 | PubChem SID:376072776 | UNII:JJV56A2CNJ | (4-TERT-BUTYLPHENYL)ACETONITRILE
+BMGC_DG15655,BMG_DG195979,UNII:33BK77102I | 4-METHOXYBENZHYDRAZIDE | CAS RN:3290-99-1 | PubChem SID:241178943 | PubChem CID:76792
+BMGC_DG15656,BMG_DG195987,PubChem CID:768 | formonitrile | NDC:0220-2523 | PubChem SID:175265312 | UNII:2WTB3V159F | CAS RN:74-90-8 | HYDROGEN CYANIDE | CAS RN:143334-20-7 | NDC:0220-2530 | Hydrogen Cyanide
+BMGC_DG15657,BMG_DG195991,(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoic acid | Leu-Leu | CAS RN:3303-31-9 | PubChem CID:76807
+BMGC_DG15658,BMG_DG196047,"PubChem CID:76899969 | Unii-49958O183Z | PubChem SID:387065499 | Nesvategrast | (3S)-3-[6-(difluoromethoxy)pyridin-3-yl]-3-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]imidazolidin-1-yl]propanoic acid | UNII:49958O183Z | NESVATEGRAST | CAS RN:1621332-91-9"
+BMGC_DG15659,BMG_DG196048,"3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[4-methoxy-6-[(2S)-2-methylpiperazin-1-yl]pyridin-3-yl]pyridin-2-amine | UNII:QB7KTQ7VW9 | ENVONALKIB | CAS RN:1621519-26-3 | PubChem CID:76899983 | PubChem SID:461434661 | Envonalkib"
+BMGC_DG15660,BMG_DG196049,BICARBONATE ION | PubChem SID:175266123 | Bicarbonate Ion | hydrogen carbonate | PubChem CID:769 | CAS RN:71-52-3 | UNII:HN1ZRA3Q20
+BMGC_DG15661,BMG_DG196054,PubChem SID:404859925 | Pelcitoclax | PELCITOCLAX | PubChem CID:76900653 | CAS RN:1619923-36-2 | 3-[1-[(3R)-3-[4-[[4-[4-[3-[2-(4-chlorophenyl)-5-methyl-4-methylsulfonyl-1-propan-2-ylpyrrol-3-yl]-5-fluorophenyl]piperazin-1-yl]phenyl]sulfamoyl]-2-(trifluoromethylsulfonyl)anilino]-4-phenylsulfanylbutyl]piperidine-4-carbonyl]oxypropylphosphonic acid | UNII:317UBD60ML
+BMGC_DG15662,BMG_DG196076,"Methyl alpha-D-galactopyranoside | METHYL-.ALPHA.-D-GALACTOSE | Methyl alpha-galactoside | (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol | PubChem CID:76935 | CAS RN:3396-99-4 | Methyl-α-D-galactose | DrugBank ID:DB02100 | PubChem SID:472423014 | UNII:ESJ6UY55QN"
+BMGC_DG15663,BMG_DG196081,"PubChem SID:375084653 | CID 76943386 | NDC:70539-001 | UNII:AVK0I6HY2U | PubChem CID:76943386 | ABALOPARATIDE | CAS RN:247062-33-5 | (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]acetyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-amino-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid"
+BMGC_DG15664,BMG_DG196090,"CAS RN:1621164-74-6 | CAMLIPIXANT | PubChem CID:76955630 | methyl (2S)-2-[[2-[2,6-difluoro-4-(methylcarbamoyl)phenyl]-7-methylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine-4-carboxylate | PubChem SID:461432492 | Camlipixant | UNII:TB7D2H7MZZ | Blu-5937"
+BMGC_DG15665,BMG_DG196091,N-hexylsulfonyl-4-[(4-phenylphenyl)methylsulfanylmethyl]benzamide | PubChem CID:76955652 | CAS RN:1621673-53-7
+BMGC_DG15666,BMG_DG196324,"PubChem CID:76957773 | PubChem SID:198940839 | [(1R,9R,10S,12R,13S,14R,16S,17S,18R)-13-ethyl-14-hydroxy-8-methyl-8,15-diazahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-trien-18-yl] 2-chloroacetate | CAS RN:47562-08-3 | LORAJMINE | DrugBank ID:DB13651 | Lorajmine | UNII:F96VX65849"
+BMGC_DG15667,BMG_DG196412,"PubChem CID:76958517 | DrugBank ID:DB08976 | UNII:9YH7975LEF | Floctafenine | PubChem SID:329904432 | FLOCTAFENINE, (R)-"
+BMGC_DG15668,BMG_DG196458,PubChem SID:198938236 | 4-METHOXYBENZAMIDE | CAS RN:3424-93-9 | PubChem CID:76959 | UNII:Z85FX3977E
+BMGC_DG15669,BMG_DG196503,"PubChem SID:198945340 | NDC:81942-125 | UNII:HEH4938D7K | LOTILANER | PubChem CID:76959255 | CAS RN:1369852-71-0 | Lotilaner | 3-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-5-[(5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]thiophene-2-carboxamide"
+BMGC_DG15670,BMG_DG196549,"PubChem CID:76959818 | Prajmaline | PRAJMALIUM | PubChem SID:198949292 | (1R,9R,10S,12R,13S,14R,15R,16S,17S,18R)-13-ethyl-8-methyl-15-propyl-8-aza-15-azoniahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol | DrugBank ID:DB13555 | UNII:75934UD4GJ | CAS RN:35080-11-6"
+BMGC_DG15671,BMG_DG196670,selenocyanate | Selenocyanate | PubChem CID:76961 | CAS RN:5749-48-4
+BMGC_DG15672,BMG_DG196729,"PubChem CID:76961489 | (7R,8R,12Z,17S,18S)-18-(2-carboxyethyl)-7-ethyl-20-(2-methoxy-2-oxoethyl)-3,8,13,17-tetramethyl-12-(1-oxidoethylidene)-N-(2-sulfoethyl)-8,17,18,22-tetrahydro-7H-porphyrin-2-carboximidate;palladium(2+) | UNII:EEO29FZT86 | PADELIPORFIN | DrugBank ID:DB15575 | PubChem SID:198952027 | Padeliporfin | CAS RN:759457-82-4"
+BMGC_DG15673,BMG_DG196852,"UNII:036B9W83KK | PubChem SID:198955512 | DrugBank ID:DB13856 | CAS RN:3693-38-7 | Fluclorolone | PubChem CID:76962649 | FLUCLOROLONE | (6S,8S,9R,10S,11S,13S,14S,16R,17S)-9,11-dichloro-6-fluoro-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG15674,BMG_DG196861,PubChem SID:198955716 | DrugBank ID:DB05273 | Samarium Sm 153 lexidronam | PubChem CID:76962714 | UNII:745X144DZY | SAMARIUM SM-153 LEXIDRONAM | Samarium (153Sm) lexidronam | [2-[bis[[hydroxy(oxido)phosphoryl]methyl]amino]ethyl-(phosphonomethyl)amino]methyl-hydroxyphosphinate;samarium-153(3+) | CAS RN:122575-21-7
+BMGC_DG15675,BMG_DG196913,"PubChem CID:76963096 | CAS RN:987-78-0 | [[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(trimethylazaniumyl)ethyl phosphate;hydron | Nicholin | PubChem SID:198957061 | CITICOLINE | UNII:536BQ2JVC7"
+BMGC_DG15676,BMG_DG197174,"PubChem SID:198971554 | (1S,3S,4R)-4-[(3aS,4R,5S,7aS)-4-(aminomethyl)-7a-methyl-1-methylidene-3,3a,4,5,6,7-hexahydro-2H-inden-5-yl]-3-(hydroxymethyl)-4-methylcyclohexan-1-ol | CAS RN:782487-28-9 | Rosiptor | ROSIPTOR | DrugBank ID:DB13012 | PubChem CID:76965484 | UNII:6R5034F862 | AQX-1125"
+BMGC_DG15677,BMG_DG197298,"CALCIUM PANGAMATE | UNII:492G10Q871 | DrugBank ID:DB13590 | Calcium pangamate | PubChem SID:198968327 | PubChem CID:76966485 | CAS RN:20310-61-6 | calcium;(2R,3S,4R,5R)-6-[2-(dimethylamino)acetyl]oxy-2,3,4,5-tetrahydroxyhexanoate"
+BMGC_DG15678,BMG_DG197343,"NDC:69488-003 | DrugBank ID:DB13985 | Lutetium Lu 177 Dotatate | LUTETIUM OXODOTREOTIDE LU-177 | CAS RN:437608-50-9 | PubChem SID:198969747 | 2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;lutetium-177(3+) | PubChem CID:76966897 | UNII:AE221IM3BB"
+BMGC_DG15679,BMG_DG197531,"PubChem CID:76968449 | CAS RN:3475-65-8 | PubChem SID:198975255 | THIAMINE TRIPHOSPHORATE | 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-1,3-thiazol-3-ium-5-yl]ethyl [hydroxy(phosphonooxy)phosphoryl] phosphate | UNII:464M6AQ7IV | Thiamine triphosphoric acid ester"
+BMGC_DG15680,BMG_DG197567,"PubChem SID:198976589 | UNII:5970HH9923 | MAFOSFAMIDE | 2-[[(2S,4S)-2-[bis(2-chloroethyl)amino]-2-oxo-1,3,2lambda5-oxazaphosphinan-4-yl]sulfanyl]ethanesulfonic acid | DrugBank ID:DB12083 | CAS RN:88859-04-5 | Mafosfamide | PubChem CID:76968809"
+BMGC_DG15681,BMG_DG197573,"CAS RN:34089-81-1 | NDC:0143-9570 | NDC:0143-9298 | NDC:0024-2794 | Sodium Ferric Gluconate Complex | Sodium ferric gluconate complex | DrugBank ID:DB09517 | NDC:0024-2792 | sodium;(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;iron(3+);oxygen(2-);(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate | SODIUM FERRIC GLUCONATE COMPLEX | PubChem SID:198976678 | UNII:CC9149U2QX | PubChem CID:76968835"
+BMGC_DG15682,BMG_DG197611,CAS RN:7712-50-7 | PubChem CID:76969111 | UNII:9902116282 | MYRTECAINE | PubChem SID:198977550
+BMGC_DG15683,BMG_DG197707,"UNII:I670DAL4SZ | DrugBank ID:DB00856 | PubChem CID:7697 | Chlorphenesin | PubChem SID:175271991 | CAS RN:104-29-0 | CHLORPHENESIN | 3-(4-chlorophenoxy)propane-1,2-diol"
+BMGC_DG15684,BMG_DG198014,"DrugBank ID:DB05607 | Prx-08066 | PubChem CID:76972919 | UNII:92E9B7675Y | PubChem SID:198991161 | (E)-but-2-enedioic acid;5-[[4-[(6-chlorothieno[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]methyl]-2-fluorobenzonitrile | PRX-08066"
+BMGC_DG15685,BMG_DG198042,NDC:43063-980 | NDC:67296-1768 | NDC:72865-118 | NDC:50090-6850 | NDC:51655-776 | NDC:68071-1395 | NDC:23155-899 | NDC:83008-023 | NDC:67296-1475 | NDC:65162-537 | NDC:50090-6294 | NDC:63187-016 | NDC:67296-1782 | NDC:71205-643 | NDC:68084-214 | NDC:51224-001 | NDC:67296-1454 | NDC:72162-1914 | NDC:83008-041 | NDC:62332-427 | NDC:71335-0031 | NDC:23155-898 | NDC:67877-575 | NDC:63629-9189 | NDC:72162-1561 | NDC:71335-2486 | NDC:51655-754 | NDC:68788-7607 | NDC:43063-979 | NDC:65841-614 | NDC:72789-025 | NDC:71205-037 | NDC:71205-885 | NDC:55154-3372 | NDC:63187-185 | NDC:71205-972 | NDC:82982-031 | DrugBank ID:DB00868 | NDC:63187-928 | NDC:50090-5986 | NDC:72789-232 | NDC:51655-762 | NDC:71335-1329 | NDC:42806-714 | NDC:63187-606 | NDC:70518-2873 | PubChem CID:7699 | NDC:42291-092 | NDC:68382-247 | NDC:71205-067 | NDC:31722-956 | NDC:62135-440 | NDC:68788-8405 | NDC:72189-606 | NDC:50090-6205 | NDC:67296-1833 | NDC:63629-2475 | NDC:71335-0688 | NDC:72162-1316 | NDC:50090-4969 | NDC:63629-2473 | NDC:64380-713 | NDC:72189-192 | NDC:67296-1450 | NDC:71205-659 | NDC:72789-014 | NDC:69452-143 | NDC:71335-1544 | NDC:71335-0725 | NDC:50090-6387 | NDC:67296-1464 | NDC:69452-144 | NDC:50090-6080 | NDC:71610-692 | NDC:72789-231 | NDC:42806-715 | NDC:60429-927 | NDC:63187-799 | NDC:63629-1229 | NDC:64980-634 | NDC:68094-798 | NDC:50090-5409 | NDC:70518-3542 | NDC:71335-2021 | NDC:42291-091 | NDC:72162-1913 | NDC:60760-700 | NDC:71205-662 | NDC:82982-064 | NDC:71335-1880 | NDC:0615-8403 | NDC:76420-803 | NDC:68071-5105 | NDC:68094-901 | NDC:31722-957 | NDC:71335-1968 | NDC:67296-1751 | PubChem SID:472405873 | NDC:68382-091 | NDC:0904-6564 | NDC:0904-7153 | NDC:71205-886 | NDC:71205-853 | NDC:82982-023 | NDC:71205-699 | Benzonatate | NDC:50090-4968 | NDC:70518-4182 | NDC:67296-1566 | NDC:67296-1583 | NDC:68788-8336 | NDC:67877-573 | CAS RN:32760-16-0 | NDC:64980-635 | UNII:5P4DHS6ENR | NDC:31722-958 | NDC:71205-971 | NDC:62332-426 | NDC:68071-2562 | NDC:72189-194 | NDC:68788-8329 | NDC:71335-1927 | NDC:51224-010 | NDC:72865-117 | NDC:60429-914 | NDC:68071-5223 | NDC:64380-712 | NDC:72865-119 | NDC:50090-6228 | NDC:68071-5083 | NDC:63187-076 | NDC:67296-1576 | BENZONATATE | NDC:72789-230 | NDC:63629-2476 | NDC:72162-1560 | NDC:67296-1549 | NDC:71205-605 | NDC:71205-632 | NDC:65162-536 | NDC:71205-887 | NDC:42708-082 | NDC:62135-441 | NDC:63629-2474 | NDC:76420-804 | NDC:71335-1553 | NDC:68071-5156 | CAS RN:104-31-4 | NDC:70518-2491 | NDC:42708-171 | NDC:65841-843 | NDC:71205-673 | 2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate
+BMGC_DG15686,BMG_DG198046,"CAS RN:3457-48-5 | PubChem SID:474490909 | UNII:4HZ2Y7K8GZ | 4,4'-Dimethylbenzil | 4,4'-DIMETHYLBENZIL | PubChem CID:76996"
+BMGC_DG15687,BMG_DG198068,DrugBank ID:DB02721 | 4-Iodopyrazole | UNII:F33UJD465Q | PubChem SID:440089511 | CAS RN:3469-69-0 | PubChem CID:77022 | 4-IODOPYRAZOLE
+BMGC_DG15688,BMG_DG198074,CAS RN:3483-82-7 | UNII:J2P4C4RJ59 | BENZOYLTYROSINE ETHYL ESTER | PubChem CID:77033 | PubChem SID:461434015
+BMGC_DG15689,BMG_DG198077,3-(DIMETHYLAMINO)PROPIOPHENONE | CAS RN:3506-36-3 | UNII:844YA6J34K | PubChem SID:322058954 | PubChem CID:77042
+BMGC_DG15690,BMG_DG198084,BUTYLBENZENE | Butylbenzene | CAS RN:104-51-8 | butylbenzene | PubChem CID:7705 | PubChem SID:198985090 | UNII:S8XZ2901RZ
+BMGC_DG15691,BMG_DG198086,"Bms-986104 | CAS RN:1622180-31-7 | [(1R,3S)-1-amino-3-[(6R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl]cyclopentyl]methanol | UNII:KJ9D084FO4 | DrugBank ID:DB15214 | PubChem SID:346539433 | PubChem CID:77050638 | BMS-986104"
+BMGC_DG15692,BMG_DG198088,"CAS RN:1340593-59-0 | OTESECONAZOLE | NDC:74695-823 | DrugBank ID:DB13055 | PubChem CID:77050711 | (2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl]propan-2-ol | PubChem SID:255509491 | UNII:VHH774W97N | Oteseconazole"
+BMGC_DG15693,BMG_DG198090,PubChem CID:77052 | CAS RN:3516-95-8 | 2'-HYDROXY-3-PHENYLPROPIOPHENONE | PubChem SID:198959270 | UNII:0VE7O0Z9NZ
+BMGC_DG15694,BMG_DG198113,BENZYL FORMATE | UNII:79GJF97O0Y | PubChem CID:7708 | PubChem SID:198964105 | DrugBank ID:DB04569 | benzyl formate | CAS RN:104-57-4 | Benzyl formate
+BMGC_DG15695,BMG_DG198124,PubChem CID:7710 | CAS RN:57084-16-9 | PubChem SID:198960235 | .GAMMA.-NONALACTONE | UNII:I1XGH66S8P | Gamma-nonalactone | CAS RN:104-61-0 | 5-pentyloxolan-2-one | CAS RN:82373-92-0
+BMGC_DG15696,BMG_DG198126,"CAS RN:1620909-95-6 | 5-bromo-4-N-prop-2-ynyl-2-(1,2,4-triazol-1-yl)pyrimidine-4,6-diamine | PBF-999 | UNII:DY6W3NQA36 | Pbf-999 | PubChem CID:77107498 | PubChem SID:459276091"
+BMGC_DG15697,BMG_DG198129,"PubChem CID:77108121 | CAS RN:1622848-92-3 | GSK-2982772 | PubChem SID:346537585 | 5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide | (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-3-carboxamide | UNII:T5W3M0VO9B"
+BMGC_DG15698,BMG_DG198141,PubChem SID:198983140 | CHLORFENAZOLE | UNII:RT668W2SVP | CAS RN:3574-96-7 | PubChem CID:77123
+BMGC_DG15699,BMG_DG198153,CAS RN:57084-17-0 | PubChem CID:7714 | 5-heptyloxolan-2-one | UNII:QB1T0AG2YL | CAS RN:104-67-6 | .GAMMA.-UNDECALACTONE | PubChem SID:175271438 | Gamma-undecalactone
+BMGC_DG15700,BMG_DG198161,"CAS RN:3608-67-1 | UNII:QWK86805EB | PubChem SID:198949994 | Enpiperate | (1-methylpiperidin-4-yl) 2-hydroxy-2,2-diphenylacetate | 1-METHYL-4-PIPERIDYL BENZILATE | PubChem CID:77157"
+BMGC_DG15701,BMG_DG198191,"NDC:25021-411 | Lovenox | NDC:63323-564 | NDC:0955-1010 | NDC:68001-638 | NDC:71288-438 | NDC:71839-116 | NDC:55154-3540 | NDC:0781-3510 | NDC:72603-205 | NDC:63323-533 | NDC:68083-638 | NDC:72603-195 | NDC:11797-757 | NDC:71288-433 | NDC:68083-637 | NDC:63323-655 | NDC:16714-016 | NDC:70710-1760 | NDC:71839-109 | NDC:68001-637 | NDC:70710-1761 | NDC:0955-1015 | NDC:63323-531 | NDC:68001-462 | NDC:0781-3238 | NDC:68083-636 | NDC:71839-115 | NDC:0781-3513 | NDC:16714-066 | NDC:68001-461 | NDC:68001-634 | PubChem SID:472418658 | NDC:0955-1008 | NDC:81952-124 | NDC:55154-3543 | NDC:68001-457 | NDC:0781-3505 | NDC:63323-539 | NDC:63323-566 | NDC:68001-636 | NDC:11797-763 | NDC:0955-1006 | NDC:72603-165 | NDC:71839-113 | NDC:0781-3460 | NDC:16714-026 | NDC:0781-3262 | NDC:72603-215 | NDC:0075-8014 | NDC:0548-5606 | NDC:55154-3544 | NDC:0075-8016 | NDC:11797-761 | NDC:63323-584 | NDC:0548-5604 | NDC:16714-006 | NDC:11797-760 | NDC:0548-5602 | NDC:0075-8030 | CAS RN:679809-58-6 | NDC:71839-112 | NDC:81952-135 | NDC:71288-437 | NDC:16714-056 | NDC:0548-5607 | NDC:81952-132 | NDC:0075-8025 | NDC:63323-589 | NDC:63323-605 | NDC:0781-3268 | CAS RN:91449-79-5 | NDC:11797-758 | NDC:68001-463 | NDC:0075-8022 | NDC:63323-609 | NDC:71288-410 | NDC:68083-639 | NDC:68001-464 | NDC:55154-4028 | NDC:16714-036 | NDC:71839-110 | ENOXAPARIN SODIUM | NDC:0781-3488 | NDC:55154-9586 | NDC:70710-1757 | NDC:72603-225 | NDC:81952-130 | NDC:68083-634 | NDC:68001-635 | NDC:72603-185 | NDC:70710-1762 | NDC:81952-123 | NDC:25021-410 | NDC:71839-111 | NDC:0781-3482 | NDC:68001-458 | NDC:63323-537 | NDC:0075-8018 | NDC:0955-1004 | NDC:63323-535 | NDC:71288-411 | NDC:68083-640 | NDC:68001-459 | NDC:55154-3542 | NDC:0781-3256 | PubChem CID:772 | NDC:0548-5601 | NDC:68083-635 | NDC:70710-1759 | NDC:0075-8013 | NDC:70710-1758 | NDC:0955-1016 | NDC:0548-5608 | NDC:71288-432 | NDC:71288-435 | NDC:0781-3502 | NDC:63323-559 | NDC:81952-126 | NDC:0548-5603 | NDC:68001-460 | NDC:0781-3246 | NDC:0548-5605 | NDC:63323-586 | NDC:81952-128 | NDC:11797-759 | NDC:63323-607 | NDC:71288-426 | NDC:68001-639 | NDC:11797-762 | NDC:71288-434 | NDC:72603-175 | 6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid | NDC:0075-8020 | UNII:8NZ41MIK1O | NDC:0955-1003 | NDC:0781-3298 | NDC:68001-633 | NDC:71288-436 | NDC:55154-3541 | NDC:0781-3299 | NDC:16714-046 | NDC:0955-1012 | NDC:70710-1763"
+BMGC_DG15702,BMG_DG198216,CAS RN:104-85-8 | PubChem SID:198964358 | P-TOLUNITRILE | PubChem CID:7724 | UNII:H20555V8NO
+BMGC_DG15703,BMG_DG198219,CAS RN:104-87-0 | 4-Methylbenzaldehyde | 4-methylbenzaldehyde | PubChem CID:7725 | PubChem SID:198937866 | P-TOLUALDEHYDE | UNII:GAX22QZ28Q
+BMGC_DG15704,BMG_DG198220,PubChem SID:472410904 | 2-BENZHYDRYLPYRIDINE | CAS RN:3678-70-4 | UNII:SZE5F94WJH | PubChem CID:77250
+BMGC_DG15705,BMG_DG198221,PubChem SID:482553390 | 3-Benzhydrylpyridine | UNII:L7GLC7F3XR | CAS RN:3678-71-5 | 3-BENZHYDRYLPYRIDINE | PubChem CID:77251
+BMGC_DG15706,BMG_DG198222,4-(DIPHENYLMETHYL)PYRIDINE | PubChem CID:77252 | 4-(Diphenylmethyl)pyridine | CAS RN:3678-72-6 | UNII:BH8XS6N9JA | PubChem SID:482553505
+BMGC_DG15707,BMG_DG198243,TRIPHENYLMETHANETHIOL | CAS RN:3695-77-0 | UNII:T7AQN86QSJ | Triphenylmethanethiol | PubChem SID:472410579 | PubChem CID:77281
+BMGC_DG15708,BMG_DG198261,3-METHOXYXANTHONE | PubChem CID:77309 | CAS RN:3722-52-9 | UNII:WW24PSE3QM | PubChem SID:375579771
+BMGC_DG15709,BMG_DG198262,1-Methoxy-4-methylbenzene | PubChem SID:175268013 | PubChem CID:7731 | UNII:10FAI0OR9W | P-METHYL ANISOLE | 1-methoxy-4-methylbenzene | CAS RN:104-93-8
+BMGC_DG15710,BMG_DG198298,PubChem CID:77372 | CAS RN:3760-54-1 | PROLINAL | UNII:LO74GWE7WD | pyrrolidine-1-carbaldehyde | PubChem SID:249492147 | Prolinal
+BMGC_DG15711,BMG_DG198301,PubChem SID:478839042 | PubChem CID:77379 | UNII:9V4S232P62 | 5-Chlorotryptamine | CAS RN:3764-94-1 | 5-CHLOROTRYPTAMINE
+BMGC_DG15712,BMG_DG198309,"PubChem CID:77390 | PubChem SID:485661654 | Benzenamine, 4-[(6-methoxy-2-benzothiazolyl)azo]-N,N-dimethyl- | UNII:D39S8AXY82 | BENZENAMINE, 4-((6-METHOXY-2-BENZOTHIAZOLYL)AZO)-N,N-DIMETHYL- | CAS RN:3771-31-1"
+BMGC_DG15713,BMG_DG198313,CAS RN:65592-96-3 | PubChem SID:175266575 | UNII:820484N8I3 | NDC:65044-9998 | CAS RN:51-45-6 | HISTAMINE | 2-(1H-imidazol-5-yl)ethanamine | PubChem CID:774 | CAS RN:117932-92-0 | Histamine | DrugBank ID:DB05381
+BMGC_DG15714,BMG_DG198320,"UNII:ZE8WE76SKK | 4',5'-DIHYDRO-8-METHOXYPSORALEN | PubChem CID:77409 | CAS RN:3779-03-1 | PubChem SID:375579295"
+BMGC_DG15715,BMG_DG198321,BETAZOLE | UNII:1C065P542O | CAS RN:1121-45-5 | PubChem CID:7741 | DrugBank ID:DB00272 | Betazole | 2-(1H-pyrazol-5-yl)ethanamine | PubChem SID:198968267 | CAS RN:105-20-4
+BMGC_DG15716,BMG_DG198328,PubChem CID:7742 | PubChem SID:198935342 | UNII:U4XIN3U7DH | 5-propyloxolan-2-one | CAS RN:105-21-5 | .GAMMA.-HEPTALACTONE | gamma-Heptalactone | CAS RN:57129-71-2
+BMGC_DG15717,BMG_DG198333,PubChem CID:774282 | DrugBank ID:DB02215 | Furoyl-Leucine
+BMGC_DG15718,BMG_DG198351,"3-methyl-6-[4-(2-methylphenyl)phenyl]benzotriazole-4-carboxylic acid | 1-methyl-5-(2'-methyl-[1,1'-biphenyl]-4-yl)-1H-benzo[d][1,2,3]triazole-7-carboxylic acid | PubChem CID:77461001 | CAS RN:1623416-31-8"
+BMGC_DG15719,BMG_DG198355,PubChem CID:77461273 | CAS RN:1351185-54-0 | UNII:JFG7JWH6YL | ONC1-13B | PubChem SID:459055605
+BMGC_DG15720,BMG_DG198410,PubChem CID:77547 | UNII:4YGJ96WTBG | CAS RN:3943-89-3 | ETHYL PROTOCATECHUATE | PubChem SID:198960764
+BMGC_DG15721,BMG_DG198411,"CAS RN:3943-91-7 | PubChem CID:77548 | PubChem SID:485661524 | ETHYL 2,5-DIHYDROXYBENZOATE | UNII:LYS94A6JYL | Ethyl 2,5-dihydroxybenzoate"
+BMGC_DG15722,BMG_DG198416,CAS RN:3949-36-8 | 3-ACETYLCOUMARIN | PubChem SID:374388545 | PubChem CID:77553 | UNII:ID71XJ0D40
+BMGC_DG15723,BMG_DG198428,"PubChem CID:77575 | UNII:9XQD7X5YXD | PubChem SID:472409605 | 2,2-DIPHENYLETHYLAMINE | CAS RN:3963-62-0"
+BMGC_DG15724,BMG_DG198439,2-METHOXYETHOXYMETHYL CHLORIDE | CAS RN:3970-21-6 | PubChem CID:77590 | PubChem SID:459276174 | UNII:A5RRM67QUG
+BMGC_DG15725,BMG_DG198464,PubChem CID:776315 | DrugBank ID:DB07407 | 5-(2-METHOXYPHENYL)-2-FUROIC ACID
+BMGC_DG15726,BMG_DG198492,"4-Chloro-1,8-naphthalic anhydride | PubChem SID:478838609 | PubChem CID:77672 | CAS RN:4053-08-1 | 4-CHLORO-1,8-NAPHTHALIC ANHYDRIDE | UNII:3TK8N66ETU"
+BMGC_DG15727,BMG_DG198507,2-THIOPHENEGLYOXYLIC ACID | PubChem SID:252164514 | UNII:723A77PV2M | CAS RN:4075-59-6 | PubChem CID:77694
+BMGC_DG15728,BMG_DG198511,DrugBank ID:DB02022 | UNII:G62V17J09J | PubChem CID:777 | CAS RN:73-67-6 | 4-Amino-5-Hydroxymethyl-2-Methylpyrimidine | PubChem SID:198974171 | TOXOPYRIMIDINE | (4-amino-2-methylpyrimidin-5-yl)methanol
+BMGC_DG15729,BMG_DG198573,"UNII:S7IJP4A89K | DL-Homocysteine | CAS RN:454-29-5 | PubChem SID:198969779 | HOMOCYSTEINE, DL- | PubChem CID:778 | 2-amino-4-sulfanylbutanoic acid | CAS RN:454-28-4"
+BMGC_DG15730,BMG_DG198580,2-(4-Methoxybenzoyl)thiophene | PubChem CID:77812 | 2-(4-METHOXYBENZOYL)THIOPHENE | CAS RN:4160-63-8 | PubChem SID:474493821 | UNII:4QQ887QUG7
+BMGC_DG15731,BMG_DG198599,"CEFIDEROCOL | UNII:SZ34OMG6E8 | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-3-[[1-[2-[(2-chloro-3,4-dihydroxybenzoyl)amino]ethyl]pyrrolidin-1-ium-1-yl]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | PubChem CID:77843966 | CAS RN:2009350-93-8 | Cefiderocol | PubChem SID:310825754 | DrugBank ID:DB14879 | CAS RN:1225208-94-5"
+BMGC_DG15732,BMG_DG198652,"PubChem CID:77910626 | 2-[[5-acetamido-6-(1-amino-1-carboxypropan-2-yl)oxy-3,4-dihydroxyoxan-2-yl]methoxy]-4-hydroxy-5-[[2-(2-methoxyethoxycarbonylamino)acetyl]amino]-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid | Lipegfilgrastim"
+BMGC_DG15733,BMG_DG198660,PubChem CID:77918 | 1-BENZYLIMIDAZOLE | 1-Benzylimidazole | 1-benzylimidazole | PubChem SID:387065126 | CAS RN:4238-71-5 | UNII:W4C9Z5BCV7 | DrugBank ID:DB04581
+BMGC_DG15734,BMG_DG198683,"CAS RN:4273-92-1 | PubChem SID:485662032 | 2-Naphthalenecarboxamide, N-(4-chloro-2,5-dimethoxyphenyl)-3-hydroxy- | PubChem CID:77955 | UNII:8KEU3457L4 | 2-NAPHTHALENECARBOXAMIDE, N-(4-CHLORO-2,5-DIMETHOXYPHENYL)-3-HYDROXY-"
+BMGC_DG15735,BMG_DG198684,CAS RN:4273-98-7 | PubChem SID:198955642 | 2-(PHENYLSULFONYL)ANILINE | UNII:6VU39ID7LU | PubChem CID:77956
+BMGC_DG15736,BMG_DG198685,"PubChem SID:377308094 | 1,3-DIPHENYL-2-AMINOPROPANE | CAS RN:4275-43-8 | UNII:MDE5MS815A | PubChem CID:77960"
+BMGC_DG15737,BMG_DG198693,PubChem CID:77980 | METHYL L-TRYPTOPHANATE | UNII:ZP5C4VEH76 | CAS RN:4299-70-1 | Methyl L-tryptophanate | PubChem SID:485666123
+BMGC_DG15738,BMG_DG198695,"DrugBank ID:DB02053 | Ribose-5-phosphate | UNII:4B2428FLTO | PubChem SID:198974600 | PubChem CID:77982 | RIBOSE 5-PHOSPHATE | CAS RN:4300-28-1 | CAS RN:3615-55-2 | [(2R,3R,4R)-2,3,4-trihydroxy-5-oxopentyl] dihydrogen phosphate"
+BMGC_DG15739,BMG_DG198699,"(2S,3S)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate | PubChem CID:77990"
+BMGC_DG15740,BMG_DG198700,NDC:0781-7304 | NDC:16714-117 | NDC:70710-1196 | NDC:63629-2065 | NDC:0378-9072 | NDC:72162-1608 | NDC:0781-7313 | NDC:0078-0501 | NDC:63629-2066 | NDC:63629-8846 | CAS RN:123441-03-2 | NDC:16714-116 | NDC:70710-1198 | NDC:51956-0003 | NDC:65162-825 | NDC:51991-898 | NDC:63629-8807 | NDC:51956-0001 | Rivastigmine | NDC:63629-2064 | NDC:72162-1609 | UNII:PKI06M3IW0 | NDC:0078-0502 | NDC:0078-0503 | NDC:65162-749 | PubChem CID:77991 | NDC:0378-9070 | PubChem SID:175268589 | NDC:51991-897 | [3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate | NDC:72162-1610 | NDC:0781-7309 | NDC:51991-899 | NDC:0378-9071 | DrugBank ID:DB00989 | RIVASTIGMINE | NDC:65162-826 | NDC:70710-1197 | NDC:51956-0002 | NDC:16714-115
+BMGC_DG15741,BMG_DG198701,"CAS RN:158747-02-5 | PubChem CID:77992 | Frovatriptan | UNII:H82Q2D5WA7 | DrugBank ID:DB00998 | FROVATRIPTAN | PubChem SID:175265638 | (6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide"
+BMGC_DG15742,BMG_DG198703,CAS RN:143322-58-1 | Eletriptan | PubChem CID:77993 | DrugBank ID:DB00216 | ELETRIPTAN | UNII:22QOO9B8KI | PubChem SID:175265777 | 5-[2-(benzenesulfonyl)ethyl]-3-[[(2R)-1-methylpyrrolidin-2-yl]methyl]-1H-indole
+BMGC_DG15743,BMG_DG198706,"benzoic acid;N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethanamine | NDC:71205-398 | NDC:51407-681 | NDC:55700-942 | NDC:68462-467 | NDC:71335-2536 | NDC:63187-563 | NDC:67877-261 | NDC:68071-3568 | NDC:82619-112 | CAS RN:145202-66-0 | NDC:35781-0600 | NDC:69452-157 | RIZATRIPTAN BENZOATE | NDC:33342-087 | NDC:29300-269 | NDC:65862-626 | NDC:68462-465 | UNII:WR978S7QHH | NDC:65862-600 | NDC:65862-625 | Rizatriptan Benzoate | NDC:71205-644 | NDC:71335-1819 | NDC:51407-679 | NDC:82619-111 | NDC:57237-085 | NDC:57237-086 | NDC:72189-341 | NDC:43817-135 | NDC:51407-680 | NDC:71335-1149 | NDC:51991-362 | NDC:69097-866 | NDC:29300-317 | NDC:0378-1403 | NDC:33342-093 | NDC:72189-609 | NDC:0093-7472 | NDC:0093-7471 | NDC:69452-156 | NDC:72189-447 | NDC:50090-3367 | NDC:33342-088 | NDC:65862-599 | NDC:71205-557 | PubChem CID:77997 | NDC:78206-143 | NDC:71335-2031 | NDC:29300-268 | NDC:72189-126 | NDC:72189-512 | NDC:69097-865 | NDC:57237-087 | NDC:71335-1912 | NDC:51407-682 | PubChem SID:175268653 | NDC:68462-468 | NDC:72189-316 | NDC:67877-262 | NDC:43817-133 | NDC:50090-3343 | NDC:68462-466 | NDC:71335-1352 | NDC:57237-088 | NDC:78206-142 | NDC:33342-094 | NDC:51991-363 | NDC:72189-258 | NDC:29300-316 | NDC:0378-1404"
+BMGC_DG15744,BMG_DG198707,"PubChem CID:77999 | PubChem SID:175271369 | ROSIGLITAZONE | 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | UNII:05V02F2KDG | Rosiglitazone | DrugBank ID:DB00412 | CAS RN:122320-73-4 | CAS RN:1217260-35-9"
+BMGC_DG15745,BMG_DG198708,"PubChem CID:780 | CAS RN:71694-00-3 | UNII:NP8UE6VF08 | Homogentisic acid | CAS RN:451-13-8 | PubChem SID:198964200 | 2-(2,5-dihydroxyphenyl)acetic acid | DrugBank ID:DB08327 | HOMOGENTISIC ACID"
+BMGC_DG15746,BMG_DG198721,"3,5-dihydroxy-4-methoxybenzoic acid | UNII:0XW32QVU6J | 3,5-Dihydroxy-4-methoxybenzoic acid | PubChem CID:78016 | 3,5-DIHYDROXY-4-METHOXYBENZOIC ACID | CAS RN:4319-02-2 | PubChem SID:198987725"
+BMGC_DG15747,BMG_DG198729,"PubChem SID:198959285 | UNII:9991W3M5HZ | CAS RN:27815-07-2 | 1,4-dibromobenzene | CAS RN:106-37-6 | P-DIBROMOBENZENE | 1,4-Dibromobenzene | PubChem CID:7804"
+BMGC_DG15748,BMG_DG198737,"UNII:XO8API468S | 3,6,9,12,15-PENTAOXAHEPTADECANE | PubChem CID:78057 | PubChem SID:440089002 | 3,6,9,12,15-Pentaoxaheptadecane | DrugBank ID:DB02343 | CAS RN:4353-28-0"
+BMGC_DG15749,BMG_DG198738,"DrugBank ID:DB07344 | UNII:AV4Y6WN88C | PubChem SID:440089639 | CAS RN:4353-29-1 | 3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL | PubChem CID:78058"
+BMGC_DG15750,BMG_DG198746,PubChem CID:78063 | PubChem SID:485663459 | CAS RN:946-50-9 | (4-NITROPHENYL)METHYL CARBAMIMIDOTHIOATE | UNII:AR4R6VK6F2 | (4-Nitrophenyl)methyl carbamimidothioate
+BMGC_DG15751,BMG_DG198750,PubChem SID:198980425 | CAS RN:106-40-1 | PubChem CID:7807 | 4-Bromoaniline | UNII:0RR61TC330 | 4-bromoaniline | P-BROMOANILINE
+BMGC_DG15752,BMG_DG198762,PubChem CID:7808 | 4-bromophenol | CAS RN:106-41-2 | 4-BROMOPHENOL | 4-Bromophenol | PubChem SID:198957381 | UNII:LAO4J0183I
+BMGC_DG15753,BMG_DG198771,"CAS RN:136777-61-2 | PubChem SID:198947706 | UNII:6WAC1O477V | P-XYLENE | P-Xylene | 1,4-xylene | PubChem CID:7809 | CAS RN:106-42-3"
+BMGC_DG15754,BMG_DG198774,"3-Isochromanone | PubChem CID:78092 | 3-ISOCHROMANONE | CAS RN:4385-35-7 | UNII:4J87XDF6HE | PubChem SID:475550039 | 1,4-dihydroisochromen-3-one"
+BMGC_DG15755,BMG_DG198781,PubChem SID:198981267 | THIOCYANIC ACID | PubChem CID:781 | UNII:A5KWW7N91V | CAS RN:463-56-9 | thiocyanic acid | Thiocyanic Acid
+BMGC_DG15756,BMG_DG198788,PubChem CID:78105 | P-HYDRAZINOBENZENESULFONAMIDE | p-Hydrazinobenzenesulfonamide | CAS RN:4392-54-5 | UNII:642KHM22TW | PubChem SID:474490334
+BMGC_DG15757,BMG_DG198799,4-Chloroaniline | PubChem CID:7812 | 4-chloroaniline | 4-CHLOROANILINE | UNII:Z553SGH315 | PubChem SID:198980111 | CAS RN:106-47-8
+BMGC_DG15758,BMG_DG198811,PubChem SID:198991008 | CAS RN:106-49-0 | CAS RN:26915-12-8 | PubChem CID:7813 | UNII:I1D0KL7I4U | 4-methylaniline | 4-METHYLBENZENAMINE | CAS RN:12221-03-3 | p-Toluidine
+BMGC_DG15759,BMG_DG198826,PubChem CID:7815 | CAS RN:106-54-7 | UNII:1O71UA6O72 | PubChem SID:198958518 | P-CHLOROTHIOPHENOL
+BMGC_DG15760,BMG_DG198828,PubChem SID:198958250 | 2-BUTYL ISOTHIOCYANATE | CAS RN:4426-79-3 | PubChem CID:78151 | UNII:126JI237AW
+BMGC_DG15761,BMG_DG198924,"CAS RN:1626387-80-1 | PubChem CID:78209992 | PubChem SID:319891984 | DrugBank ID:DB14795 | Azd-3759 | [4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl] (2R)-2,4-dimethylpiperazine-1-carboxylate | UNII:67SX9H68W2 | ZORIFERTINIB"
+BMGC_DG15762,BMG_DG198929,"N-[3-[(4aR,7aS)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide | LY3202626 | 1L8QUK35RX | LY-3202626 | PubChem SID:461434295 | CAS RN:1628690-73-2 | PubChem CID:78210254 | UNII:1L8QUK35RX"
+BMGC_DG15763,BMG_DG198933,CAS RN:490-20-0 | PubChem SID:198984084 | COCAIC ACID | UNII:821BB4R21V | PubChem CID:78213
+BMGC_DG15764,BMG_DG198959,PubChem SID:441583947 | ETHYL 1H-INDAZOLE-3-CARBOXYLATE | UNII:NVS5MS5YGC | CAS RN:4498-68-4 | PubChem CID:78251
+BMGC_DG15765,BMG_DG198960,UNII:YRF4LCH7A3 | PubChem CID:78252 | (4-Methylphenyl)methanethiol | PubChem SID:485662772 | (4-METHYLPHENYL)METHANETHIOL | CAS RN:4498-99-1
+BMGC_DG15766,BMG_DG198968,"5,6-DIPHENYL-1,2,4-TRIAZIN-3-AMINE | UNII:APY3XH5WU9 | CAS RN:4511-99-3 | PubChem SID:376231216 | PubChem CID:78268"
+BMGC_DG15767,BMG_DG198986,N-(4-(AMINOSULFONYL)PHENYL)-3-OXOBUTYRAMIDE | PubChem SID:485662359 | PubChem CID:78297 | CAS RN:4542-32-9 | UNII:6EM8D59PE8 | N-(4-(Aminosulfonyl)phenyl)-3-oxobutyramide
+BMGC_DG15768,BMG_DG199007,PubChem CID:78318 | UNII:23VQ7K2YL2 | CAS RN:4563-33-1 | PubChem SID:441583652 | BENZENEMETHANESULFONAMIDE
+BMGC_DG15769,BMG_DG199009,"CAS RN:1631754-41-0 | CID 78318119 | 2-[[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[4-(4-pentoxyphenyl)phenyl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-21-yl]oxy]ethyl-trimethylazanium | CAS RN:1396640-59-7 | UNII:G013B5478J | NDC:70842-240 | PubChem CID:78318119 | PubChem SID:313182375 | REZAFUNGIN"
+BMGC_DG15770,BMG_DG199011,"LIRAMETOSTAT | PubChem SID:346539102 | N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide | DrugBank ID:DB14581 | CAS RN:1621862-70-1 | PubChem CID:78320408 | UNII:455J2479FY | Cpi-1205"
+BMGC_DG15771,BMG_DG199012,"PubChem SID:346538754 | PubChem CID:78320750 | Bay-1217389 | UNII:M964LB1114 | BAY-1217389 | N-cyclopropyl-4-[6-(2,3-difluoro-4-methoxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide | CAS RN:1554458-53-5"
+BMGC_DG15772,BMG_DG199017,Tasurgratinib | TASURGRATINIB | UNII:TN7CUD1NGA | CAS RN:1622204-21-0 | 5-[2-[[4-[1-(2-hydroxyethyl)piperidin-4-yl]benzoyl]amino]pyridin-4-yl]oxy-6-(2-methoxyethoxy)-N-methylindole-1-carboxamide | PubChem SID:317229432 | PubChem CID:78323434
+BMGC_DG15773,BMG_DG199018,"PubChem CID:78323835 | CAS RN:1622902-68-4 | UNII:73SM5SF3OR | NDC:63539-336 | NDC:0069-0435 | NDC:0069-0235 | NDC:0069-0335 | ABROCITINIB | NDC:63539-236 | DrugBank ID:DB14973 | NDC:63539-436 | PubChem SID:346538485 | N-[3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide | Abrocitinib"
+BMGC_DG15774,BMG_DG199022,"PubChem SID:405055618 | PubChem CID:78325042 | N-(4-((6,7-DIMETHOXY-1-OXIDO-4-QUINOLINYL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE | CAS RN:1621681-63-7 | UNII:LKX6L2LD4X"
+BMGC_DG15775,BMG_DG199031,5-PYRIMIDINECARBOXYLIC ACID | CAS RN:4595-61-3 | PubChem CID:78346 | UNII:R9AW3LRY8R | PubChem SID:478837337 | 5-Pyrimidinecarboxylic acid
+BMGC_DG15776,BMG_DG199044,"CAS RN:1610537-15-9 | PubChem SID:249817801 | SEVITERONEL | DrugBank ID:DB12275 | Seviteronel | PubChem CID:78357816 | UNII:8S5OIN36X4 | (1S)-1-[6,7-bis(difluoromethoxy)naphthalen-2-yl]-2-methyl-1-(2H-triazol-4-yl)propan-1-ol"
+BMGC_DG15777,BMG_DG199136,"UNII:1N41638RNO | 1,2-dibromoethane | PubChem SID:198969624 | CAS RN:106-93-4 | 1,2-Dibromoethane | Ethylene dibromide | PubChem CID:7839 | ETHYLENE DIBROMIDE"
+BMGC_DG15778,BMG_DG199144,Hydrogen peroxide | DrugBank ID:DB11091 | CAS RN:8007-30-5 | UNII:BBX060AN9V | CAS RN:7722-84-1 | Hydrogen Peroxide | PubChem SID:175267825 | HYDROGEN PEROXIDE | hydrogen peroxide | PubChem CID:784
+BMGC_DG15779,BMG_DG199147,PubChem CID:78401 | CAS RN:4671-75-4 | TETRADECYLPHOSPHONIC ACID | UNII:TU4EHR9XDW
+BMGC_DG15780,BMG_DG199193,UNII:ED3VQI55T0 | PubChem SID:376072582 | PubChem CID:78443 | CAS RN:4711-68-6 | 4'-ETHOXY-3-HYDROXY-2-NAPHTHANILIDE
+BMGC_DG15781,BMG_DG199204,PubChem SID:443624568 | PubChem CID:784625 | DrugBank ID:DB02909 | CAS RN:41019-43-6 | UNII:L5RCO4YA70 | 5-(2-CHLOROPHENYL)-2-FUROIC ACID | 5-(2-Chlorophenyl)Furan-2-Carboxylic Acid
+BMGC_DG15782,BMG_DG199207,prop-2-enal | PubChem CID:7847 | ACROLEIN | PubChem SID:198940134 | CAS RN:107-02-8 | CAS RN:81788-96-7 | UNII:7864XYD3JJ | Acrolein
+BMGC_DG15783,BMG_DG199215,"PubChem SID:198987648 | CAS RN:4741-99-5 | PubChem CID:78479 | 1,4,8,11-TETRAAZAUNDECANE | UNII:3J941O9333"
+BMGC_DG15784,BMG_DG199229,"CAS RN:123-31-9 | CAS RN:3225-30-7 | DrugBank ID:DB09526 | benzene-1,4-diol | UNII:XV74C1N1AE | Hydroquinone | PubChem SID:175265689 | HYDROQUINONE | PubChem CID:785"
+BMGC_DG15785,BMG_DG199243,CAS RN:103517-57-3 | PubChem CID:785232 | N-(2-AMINOPHENYL)-4-METHOXYBENZAMIDE | PubChem SID:441658315 | UNII:N26VF3Q659
+BMGC_DG15786,BMG_DG199255,"2,6-DICYCLOHEXYLPHENOL | 2,6-Dicyclohexylphenol | UNII:N3TJ3CW4DU | CAS RN:4821-19-6 | PubChem CID:78540 | PubChem SID:482553530"
+BMGC_DG15787,BMG_DG199290,PubChem SID:478837826 | 5-Methoxy-1H-benzimidazole | 5-Methoxybenzimidazole | DrugBank ID:DB04130 | 6-methoxy-1H-benzimidazole | UNII:Y9FY4BD73M | 5-METHOXY-1H-BENZIMIDAZOLE | PubChem CID:78598 | CAS RN:4887-80-3
+BMGC_DG15788,BMG_DG199295,PubChem SID:478837126 | UNII:U749PF8VJ4 | 2-(2-PHENYLETHYL)BENZOIC ACID | 2-(2-Phenylethyl)benzoic acid | PubChem CID:78603 | CAS RN:4890-85-1
+BMGC_DG15789,BMG_DG199297,PubChem CID:78607 | UNII:WBP6BM27HP | 4-PIPERIDINO-PIPERIDINE | CAS RN:4897-50-1 | 4-Piperidino-Piperidine | PubChem SID:472409042 | DrugBank ID:DB03056
+BMGC_DG15790,BMG_DG199314,CAS RN:4928-02-3 | UNII:1A49O337AZ | PubChem SID:241179886 | 7-AMINONITRAZEPAM | PubChem CID:78641
+BMGC_DG15791,BMG_DG199349,2-[fluoro(methyl)phosphoryl]oxypropane | PubChem SID:198934735 | UNII:B4XG72QGFM | Sarin | PubChem CID:7871 | SARIN | CAS RN:107-44-8
+BMGC_DG15792,BMG_DG199355,2-(1-NAPHTHOYL)BENZOIC ACID | 2-(1-Naphthoyl)benzoic acid | UNII:Z9UWM9S7B3 | PubChem CID:78723 | CAS RN:5018-87-1 | PubChem SID:482553507
+BMGC_DG15793,BMG_DG199362,UNII:QN37N4JU4V | PubChem SID:482553741 | 1-(3-AMINOPROPYL)IMIDAZOLE | CAS RN:5036-48-6 | PubChem CID:78736 | 1-(3-Aminopropyl)imidazole
+BMGC_DG15794,BMG_DG199371,PubChem CID:78747 | PubChem SID:472425029 | CAS RN:5049-61-6 | PYRAZINAMINE | UNII:ES73FRK6MY
+BMGC_DG15795,BMG_DG199403,PubChem CID:788 | Hydroxymethylbilane | CAS RN:71861-60-4 | 3-[5-[[3-(2-carboxyethyl)-5-[[3-(2-carboxyethyl)-5-[[3-(2-carboxyethyl)-4-(carboxymethyl)-5-(hydroxymethyl)-1H-pyrrol-2-yl]methyl]-4-(carboxymethyl)-1H-pyrrol-2-yl]methyl]-4-(carboxymethyl)-1H-pyrrol-2-yl]methyl]-4-(carboxymethyl)-1H-pyrrol-3-yl]propanoic acid
+BMGC_DG15796,BMG_DG199406,"CAS RN:1728-95-6 | 2-(4-METHOXYPHENYL)-4,5-DIPHENYL-1H-IMIDAZOLE | PubChem CID:788012 | PubChem SID:482553120 | 2-(4-Methoxyphenyl)-4,5-diphenyl-1H-imidazole | UNII:Q8N5AKL42B"
+BMGC_DG15797,BMG_DG199438,UNII:96AN057F7A | PHOSPHORYLCHOLINE CHLORIDE | PubChem CID:7886 | CAS RN:107-73-3 | PubChem SID:198985294
+BMGC_DG15798,BMG_DG199442,PubChem CID:78867 | CAS RN:5192-03-0 | UNII:Q732PG0Y16 | 5-AMINOINDOLE | PubChem SID:198940997
+BMGC_DG15799,BMG_DG199451,"UNII:8SQ0VA4YUR | PubChem CID:7888 | PubChem SID:175272055 | HYDROXYCITRONELLAL | 7-hydroxy-3,7-dimethyloctanal | DrugBank ID:DB14187 | CAS RN:107-75-5 | Hydroxycitronellal"
+BMGC_DG15800,BMG_DG199453,N-((4-(AMINOSULFONYL)PHENYL)METHYL)-4-FLUOROBENZENESULFONAMIDE | PubChem SID:472422281 | CAS RN:333442-92-5 | PubChem CID:788811 | UNII:QHE6EV4DS9
+BMGC_DG15801,BMG_DG199468,"1,8-Naphtholactone | CAS RN:5247-85-8 | UNII:RMP9G8FBJ8 | 1,8-NAPHTHOLACTONE | PubChem SID:485662283 | PubChem CID:78907"
+BMGC_DG15802,BMG_DG199478,"PubChem CID:78926 | PubChem SID:478838047 | 1,1-DIPHENYLETHYLBENZENE | 1,1-Diphenylethylbenzene | UNII:JL2TCT4BQ9 | CAS RN:5271-39-6"
+BMGC_DG15803,BMG_DG199482,3-methylbutan-1-amine | PubChem CID:7894 | ISOAMYLAMINE | CAS RN:107-85-7 | PubChem SID:198967065 | UNII:LPO0L33SHY | Isoamylamine
+BMGC_DG15804,BMG_DG199502,CYANOACETAMIDE | 2-cyanoacetamide | PubChem CID:7898 | PubChem SID:198952357 | CAS RN:107-91-5 | Cyanoacetamide | UNII:YBK38G2YXH
+BMGC_DG15805,BMG_DG199511,3-Cyanopyridine | PubChem SID:198949081 | NICOTINONITRILE | UNII:X64V0K6260 | CAS RN:100-54-9 | pyridine-3-carbonitrile | PubChem CID:79 | Nicotinonitrile
+BMGC_DG15806,BMG_DG199512,"PubChem SID:198935612 | PubChem CID:790 | Hypoxanthine | 3,7-dihydropurin-6-one | CID 790 | CAS RN:68-94-0 | DrugBank ID:DB04076 | UNII:2TN51YD919 | HYPOXANTHINE"
+BMGC_DG15807,BMG_DG199521,"DrugBank ID:DB02536 | GLYCERALDEHYDE, D- | PubChem SID:198986667 | UNII:41A680M0WB | D-glyceraldehyde | (2R)-2,3-dihydroxypropanal | CAS RN:453-17-8 | PubChem CID:79014"
+BMGC_DG15808,BMG_DG199525,DrugBank ID:DB13352 | DEANOL | Deanol | UNII:2N6K9DRA24 | PubChem SID:175267413 | CAS RN:108-01-0 | 2-(dimethylamino)ethanol | PubChem CID:7902
+BMGC_DG15809,BMG_DG199526,UNII:5QME6N6BKP | CAS RN:487-51-4 | PubChem CID:79020 | 4-CARBETHOXY-3-METHYL-2-CYCLOHEXEN-1-ONE | PubChem SID:441583234
+BMGC_DG15810,BMG_DG199529,"UNII:5J5I9EB41E | alpha-D-Glucopyranose | .ALPHA.-D-GLUCOPYRANOSE | PubChem SID:198971393 | CAS RN:27707-45-5 | CAS RN:492-62-6 | (2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol | PubChem CID:79025"
+BMGC_DG15811,BMG_DG199533,12-Hydroxydodecanoic acid | UNII:SUH3LR2K9D | 12-hydroxydodecanoic acid | PubChem SID:440089811 | CAS RN:505-95-3 | CAS RN:27925-01-5 | DrugBank ID:DB03704 | PubChem CID:79034 | 12-Hydroxydodecanoic Acid | 12-HYDROXYDODECANOIC ACID
+BMGC_DG15812,BMG_DG199566,N-PROPYL ISOCYANIDE | PubChem SID:438788748 | UNII:5E1K8OTJ0C | CAS RN:627-36-1 | DrugBank ID:DB04050 | PubChem CID:79084 | N-Propyl Isocyanide
+BMGC_DG15813,BMG_DG199588,PubChem SID:438788234 | Nitrosoethane | NITROSOETHANE | UNII:EV3G0P128S | DrugBank ID:DB02646 | PubChem CID:79124 | CAS RN:925-91-7
+BMGC_DG15814,BMG_DG199626,.GAMMA.-VALEROLACTONE | gamma-Valerolactone | CAS RN:108-29-2 | PubChem CID:7921 | UNII:O7056XK37X | 5-methyloxolan-2-one | CAS RN:57129-69-8 | CAS RN:219630-19-0 | PubChem SID:198978048
+BMGC_DG15815,BMG_DG199677,"m-Xylene | UNII:O9XS864HTE | PubChem SID:198953201 | CAS RN:108-38-3 | M-XYLENE | PubChem CID:7929 | 1,3-xylene"
+BMGC_DG15816,BMG_DG199717,"PubChem CID:79351 | 6-Bromo-3,4-dimethoxybenzaldehyde | CAS RN:5392-10-9 | 6-BROMO-3,4-DIMETHOXYBENZALDEHYDE | PubChem SID:474490873 | UNII:DX8K9VA6TF"
+BMGC_DG15817,BMG_DG199718,PubChem CID:79352 | CAS RN:5392-12-1 | 2-METHOXY-1-NAPHTHALDEHYDE | PubChem SID:198978343 | UNII:7Q7TX7TB9E
+BMGC_DG15818,BMG_DG199720,"PubChem SID:198966449 | PubChem CID:7936 | 2,4-Dimethylpyridine | UNII:83903UJ0WW | 2,4-LUTIDINE | CAS RN:108-47-4 | 2,4-dimethylpyridine"
+BMGC_DG15819,BMG_DG199770,PubChem SID:348481592 | CAS RN:5409-54-1 | UNII:BQB4H6KVM4 | N-(4-HYDROXYBIPHENYL-3-YL)ACETAMIDE | PubChem CID:79419
+BMGC_DG15820,BMG_DG199786,"UNII:6BSM97YZ8G | PubChem CID:794323 | (S)-Monastrol | CAS RN:254753-54-3 | ethyl (4S)-4-(3-hydroxyphenyl)-6-methyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate | MONASTROL | DrugBank ID:DB04331 | Monastrol | PubChem SID:241180165"
+BMGC_DG15821,BMG_DG199838,PubChem CID:795 | Imidazole | PubChem SID:198989967 | 1H-imidazole | CAS RN:227760-40-9 | DrugBank ID:DB03366 | UNII:7GBN705NH1 | CAS RN:288-32-4 | IMIDAZOLE
+BMGC_DG15822,BMG_DG199860,"10,10-DIMETHYLANTHRACEN-9-ONE | PubChem SID:472424917 | PubChem CID:79529 | CAS RN:5447-86-9 | UNII:E3A9WP7V4R"
+BMGC_DG15823,BMG_DG199873,"CAS RN:108-78-1 | MELAMINE | 1,3,5-triazine-2,4,6-triamine | PubChem CID:7955 | UNII:N3GP2YSD88 | PubChem SID:198937335 | CAS RN:5432-64-4 | Melamine"
+BMGC_DG15824,BMG_DG199925,CAS RN:5470-75-7 | UNII:5EBB5KL32K | 6-Chloro-8-aminoquinoline | 6-CHLORO-8-AMINOQUINOLINE | PubChem CID:79618 | PubChem SID:474491483
+BMGC_DG15825,BMG_DG199932,"2,5-Dihydroxy-1,4-benzenediacetic acid | PubChem SID:485662269 | CAS RN:5488-16-4 | 2,5-DIHYDROXY-1,4-BENZENEDIACETIC ACID | PubChem CID:79628 | UNII:SRN4T854L5"
+BMGC_DG15826,BMG_DG199940,PubChem CID:79639 | DrugBank ID:DB02489 | 9-Methylguanine
+BMGC_DG15827,BMG_DG199952,PubChem CID:7966 | PubChem SID:198976994 | CYCLOHEXANOL | Cyclohexanol | DrugBank ID:DB03703 | CAS RN:108-93-0 | UNII:8E7S519M3P | cyclohexanol
+BMGC_DG15828,BMG_DG199960,cyclohexanone | UNII:5QOR3YM052 | DrugBank ID:DB02060 | CYCLOHEXANONE | Cyclohexanone | PubChem SID:198936972 | PubChem CID:7967 | CAS RN:108-94-1 | CAS RN:9075-99-4
+BMGC_DG15829,BMG_DG199978,"CAS RN:5586-73-2 | PubChem SID:287445816 | 3,3-DIPHENYLPROPYLAMINE | PubChem CID:79698 | UNII:C31E561S64"
+BMGC_DG15830,BMG_DG199980,beta-PICOLINE | CAS RN:108-99-6 | 3-Methylpyridine | PubChem CID:7970 | DrugBank ID:DB01996 | PubChem SID:198947643 | .BETA.-PICOLINE | UNII:B083J4KF7F | 3-methylpyridine
+BMGC_DG15831,BMG_DG199983,UNII:4KBE4P5B6S | PubChem SID:198963612 | PubChem CID:7971 | 3-PYRIDINOL | CAS RN:80618-81-1 | CAS RN:109-00-2 | pyridin-3-ol | 3-Hydroxypyridine
+BMGC_DG15832,BMG_DG199986,DrugBank ID:DB03394 | PubChem CID:79718 | Heptaethylene glycol
+BMGC_DG15833,BMG_DG200025,pyrimidin-2-amine | 2-AMINOPYRIMIDINE | CAS RN:109-12-6 | CAS RN:176773-05-0 | PubChem CID:7978 | CAS RN:27043-39-6 | UNII:OB8I17P2G4 | 2-Aminopyrimidine | PubChem SID:363909880 | CAS RN:551920-04-8 | CAS RN:153824-54-5 | CAS RN:176773-04-9
+BMGC_DG15834,BMG_DG200034,P-TOLUENEBORONIC ACID | UNII:YJM4GM7K66 | PubChem CID:79799 | CAS RN:5720-05-8 | PubChem SID:315658477
+BMGC_DG15835,BMG_DG200035,DrugBank ID:DB04532 | CAS RN:82451-55-6 | PubChem CID:798 | PubChem SID:175265717 | 1H-indole | INDOLE | CAS RN:120-72-9 | UNII:8724FJW4M5 | Indole
+BMGC_DG15836,BMG_DG200072,"CAS RN:5792-36-9 | 2',4'-DIHYDROXYPROPIOPHENONE | PubChem SID:475549870 | UNII:UXV5BK8TF2 | 2′,4′-Dihydroxypropiophenone | PubChem CID:79856"
+BMGC_DG15837,BMG_DG200085,"UNII:713NZ1A32D | CAS RN:5807-30-7 | 3,4-DICHLOROPHENYLACETIC ACID | PubChem CID:79874 | PubChem SID:384647799"
+BMGC_DG15838,BMG_DG200105,DrugBank ID:DB02406 | pentanoic acid | Valeric acid | CAS RN:109-52-4 | N-Valeric Acid | PubChem SID:175266735 | UNII:GZK92PJM7B | VALERIC ACID | PubChem CID:7991 | CAS RN:67291-18-3
+BMGC_DG15839,BMG_DG200124,CAS RN:109-60-4 | PubChem SID:198957303 | PROPYL ACETATE | Propyl acetate | DrugBank ID:DB01670 | PubChem CID:7997 | propyl acetate | UNII:4AWM8C91G6
+BMGC_DG15840,BMG_DG200138,CAS RN:2591-98-2 | 2-(1H-indol-3-yl)acetaldehyde | Indole-3-acetaldehyde | PubChem CID:800 | PubChem SID:472387789 | INDOLE-3-ACETALDEHYDE | UNII:A346H8E8WU
+BMGC_DG15841,BMG_DG200141,CAS RN:5900-58-3 | METHYL 2-AMINO-4-CHLOROBENZOATE | PubChem CID:80001 | PubChem SID:474492257 | UNII:BWN3H69QRA | Methyl 2-amino-4-chlorobenzoate
+BMGC_DG15842,BMG_DG200172,N-butyl Chloride | DrugBank ID:DB11534 | CAS RN:109-69-3 | 1-chlorobutane | PubChem SID:198979288 | BUTYL CHLORIDE | UNII:ZP7R667SGD | PubChem CID:8005 | CAS RN:25154-42-1
+BMGC_DG15843,BMG_DG200179,PubChem SID:443624863 | CAS RN:5961-55-7 | 4-METHOXY-1-NAPHTHONITRILE | UNII:42Q2XWA3AE | PubChem CID:80063
+BMGC_DG15844,BMG_DG200184,CAS RN:109-73-9 | UNII:N2QV60B4WR | Butylamine | DrugBank ID:DB03659 | BUTYLAMINE | PubChem CID:8007 | PubChem SID:198948926 | butan-1-amine
+BMGC_DG15845,BMG_DG200193,PubChem CID:80084 | EMETONIUM IODIDE | PubChem SID:198983565 | 2-benzhydryloxyethyl-diethyl-methylazanium;iodide | UNII:CW3OT0Y51W | DrugBank ID:DB13769 | Ethylbenzhydramine methyl iodide | CAS RN:5982-52-5
+BMGC_DG15846,BMG_DG200201,CAS RN:5995-27-7 | PubChem CID:80094 | UNII:PR8HV42XTW | ((PROPYLIMINO)BIS(METHYLENE))DIPHOSPHONIC ACID | ((Propylimino)bis(methylene))diphosphonic acid | PubChem SID:485666143
+BMGC_DG15847,BMG_DG200240,((ISOPROPYLIMINO)DIMETHYLENE)BISPHOSPHONIC ACID | UNII:THU3BK98DW | CAS RN:6056-52-6 | PubChem CID:80161
+BMGC_DG15848,BMG_DG200256,2-methoxyethanol | ETHYLENE GLYCOL MONOMETHYL ETHER | UNII:EK1L6XWI56 | PubChem SID:198963487 | CAS RN:109-86-4 | CAS RN:32718-54-0 | DrugBank ID:DB02806 | PubChem CID:8019 | CAS RN:138667-25-1 | 2-Methoxyethanol
+BMGC_DG15849,BMG_DG200264,Indoleacetic acid | UNII:6U1S09C61L | DrugBank ID:DB07950 | PubChem CID:802 | PubChem SID:198960344 | INDOLEACETIC ACID | 2-(1H-indol-3-yl)acetic acid | Indole-3-acetic acid | CAS RN:87-51-4
+BMGC_DG15850,BMG_DG200276,"1-METHYLXANTHINE | 1-Methylxanthine | CAS RN:6136-37-4 | PubChem CID:80220 | 1-methyl-3,7-dihydropurine-2,6-dione | PubChem SID:198952723 | UNII:7EE8WCA32U"
+BMGC_DG15851,BMG_DG200289,VINYL ETHER | ethenoxyethene | PubChem SID:198988798 | PubChem CID:8024 | DrugBank ID:DB13690 | Vinyl ether | UNII:2H2T044E11 | CAS RN:109-93-3
+BMGC_DG15852,BMG_DG200313,"PubChem SID:198934626 | CAS RN:1492-24-6 | L-2-Aminobutyric acid | .ALPHA.-AMINOBUTYRIC ACID, L- | PubChem CID:80283 | (2S)-2-aminobutanoic acid | UNII:0QAJ5KN9IM"
+BMGC_DG15853,BMG_DG200315,CAS RN:1518-84-9 | 2-CYCLOPENTYLPHENOL | UNII:J8GB7MQJ8S | PubChem SID:474490584 | PubChem CID:80285
+BMGC_DG15854,BMG_DG200321,α-Thujaplicin | .ALPHA.-THUJAPLICIN | CAS RN:1946-74-3 | PubChem SID:474489606 | UNII:6TU33PGY8A | PubChem CID:80297
+BMGC_DG15855,BMG_DG200324,CAS RN:392-12-1 | 3-(1H-indol-3-yl)-2-oxopropanoic acid | UNII:4QM0LT13A8 | Indole-3-pyruvic acid | PubChem CID:803 | PubChem SID:241180252 | INDOLE-3-PYRUVIC ACID
+BMGC_DG15856,BMG_DG200334,"PubChem CID:80311 | N'-[(4-chlorophenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine;hydrochloride | Chloropyramine hydrochloride | CHLOROPYRAMINE HYDROCHLORIDE | PubChem SID:198952090 | UNII:FWA92Z14NN | CAS RN:6170-42-9"
+BMGC_DG15857,BMG_DG200383,4-METHOXY-ALPHA-TOLUENETHIOL | PubChem CID:80407 | UNII:9FTY888ZTV | CAS RN:6258-60-2 | PubChem SID:472411072
+BMGC_DG15858,BMG_DG200408,"5,5'-METHYLENEDIANTHRANILIC ACID | PubChem CID:80444 | UNII:WAN82A3TCL | CAS RN:7330-46-3 | PubChem SID:441659321"
+BMGC_DG15859,BMG_DG200410,PubChem SID:474492723 | UNII:SE8XST987K | PubChem CID:80447 | 1-(4-NITROPHENYL)PIPERAZINE | CAS RN:6269-89-2 | 1-(4-Nitrophenyl)piperazine
+BMGC_DG15860,BMG_DG200420,"PubChem SID:363907862 | 6,7-DIHYDROXYCOUMARANONE | CAS RN:6272-27-1 | PubChem CID:80458 | UNII:YK1BM25U2J"
+BMGC_DG15861,BMG_DG200441,5-METHYL-2-AMINOBENZIMIDAZOLE | UNII:44V7C5WTS8 | CAS RN:6285-68-3 | PubChem SID:440794204 | PubChem CID:80495
+BMGC_DG15862,BMG_DG200473,UNII:S75GE4B24J | CAS RN:6299-39-4 | PubChem CID:80533 | 4-NITRO-1H-BENZOTRIAZOLE | PubChem SID:440089156
+BMGC_DG15863,BMG_DG200491,UNII:QZ8C8FWQ3L | CAS RN:6306-24-7 | PubChem SID:474490931 | 4-Sulfamoylbenzamide | 4-SULFAMOYLBENZAMIDE | PubChem CID:80563
+BMGC_DG15864,BMG_DG200502,CAS RN:6312-73-8 | UNII:HCS8T22JQZ | 6-AMINO-5-BROMOURACIL | PubChem SID:387065325 | PubChem CID:80578
+BMGC_DG15865,BMG_DG200522,PubChem CID:8060 | CAS RN:110-58-7 | UNII:E05QM3V8EF | Amylamine | PENTYLAMINE | PubChem SID:175267261 | DrugBank ID:DB02045
+BMGC_DG15866,BMG_DG200536,PubChem CID:80622 | PubChem SID:474489952 | UNII:5AE9HP6RPU | 2-CYANO-N-METHYLACETAMIDE | 2-Cyano-N-methylacetamide | CAS RN:6330-25-2
+BMGC_DG15867,BMG_DG200538,CAS RN:110-62-3 | PubChem SID:198989623 | Valeraldehyde | PubChem CID:8063 | UNII:B975S3014W | Pentanal | VALERALDEHYDE | DrugBank ID:DB01919 | pentanal
+BMGC_DG15868,BMG_DG200544,"PubChem CID:8064 | DrugBank ID:DB01955 | butane-1,4-diol | UNII:7XOO2LE6G3 | PubChem SID:198952504 | CAS RN:110-63-4 | 1,4-BUTANEDIOL | CAS RN:732189-03-6 | 1,4-Butanediol"
+BMGC_DG15869,BMG_DG200555,UNII:L363D92ELK | CAS RN:6343-54-0 | N-BENZYLFORMAMIDE | N-benzylformamide | PubChem CID:80654 | PubChem SID:249492139 | DrugBank ID:DB02481 | N-Benzylformamide
+BMGC_DG15870,BMG_DG200576,PubChem SID:198962273 | A-425619 | CAS RN:581809-67-8 | UNII:N2NOA4CE04 | PubChem CID:8068410
+BMGC_DG15871,BMG_DG200582,Iodine | CAS RN:8031-47-8 | CAS RN:7553-56-2 | UNII:9679TC07X4 | PubChem CID:807 | molecular iodine | IODINE | CAS RN:12190-71-5 | DrugBank ID:DB05382
+BMGC_DG15872,BMG_DG200588,"DrugBank ID:DB01749 | PubChem CID:8071 | PubChem SID:198981172 | 1,2-DIMETHOXYETHANE | UNII:GXS24JF5IW | CAS RN:110-71-4 | 1,2-Dimethoxyethane"
+BMGC_DG15873,BMG_DG200612,CAS RN:110-80-5 | UNII:IDK7C2HS09 | 2-ethoxyethanol | ETHYLENE GLYCOL MONOETHYL ETHER | PubChem CID:8076 | DrugBank ID:DB02249 | 2-Ethoxyethanol | PubChem SID:175265923
+BMGC_DG15874,BMG_DG200636,"UNII:25MI3KZ1HF | TRIBROMOBISPHENOL A | Tribromobisphenol A | CAS RN:6386-73-8 | PubChem CID:80801 | 2,6-dibromo-4-[2-(3-bromo-4-hydroxyphenyl)propan-2-yl]phenol | PubChem SID:198982959"
+BMGC_DG15875,BMG_DG200649,CAS RN:6403-35-6 | (2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidine-2-carboxylic acid | Leucylproline | PubChem CID:80817
+BMGC_DG15876,BMG_DG200650,CAS RN:52167-54-1 | piperidine | UNII:67I85E138Y | PIPERIDINE | Piperidine | CAS RN:110-89-4 | PubChem SID:198937234 | PubChem CID:8082 | CAS RN:89014-30-2
+BMGC_DG15877,BMG_DG200653,Morpholine | CAS RN:110-91-8 | DrugBank ID:DB13669 | morpholine | PubChem SID:175267041 | CAS RN:138048-80-3 | PubChem CID:8083 | UNII:8B2ZCK305O | MORPHOLINE
+BMGC_DG15878,BMG_DG200681,"NDC:84350-004 | NDC:84025-138 | NDC:84350-002 | NDC:84350-003 | NDC:84025-140 | CAS RN:111-01-3 | NDC:84025-036 | NDC:84025-142 | NDC:84350-008 | NDC:84025-137 | NDC:84350-006 | NDC:84025-141 | NDC:84025-136 | UNII:GW89575KF9 | NDC:84350-077 | NDC:84350-005 | SQUALANE | NDC:84350-009 | PubChem CID:8089 | NDC:84423-037 | NDC:84025-034 | Squalane | NDC:83566-168 | NDC:84350-017 | PubChem SID:175272038 | DrugBank ID:DB11420 | 2,6,10,15,19,23-hexamethyltetracosane | NDC:84350-066 | NDC:84025-038 | NDC:84025-139"
+BMGC_DG15879,BMG_DG200694,"PubChem CID:80922 | 3,4,5-TRIMETHOXYTOLUENE | CAS RN:6443-69-2 | UNII:DZV7MLT5SB | 3,4,5-Trimethoxytoluene | PubChem SID:482553200"
+BMGC_DG15880,BMG_DG200704,CAS RN:352431-36-8 | Heptanoic Acid | Heptanoic acid | CAS RN:1219802-86-4 | PubChem SID:175268046 | heptanoic acid | UNII:THE3YNP39D | DrugBank ID:DB02938 | CAS RN:101488-09-9 | PubChem CID:8094 | CAS RN:111-14-8 | HEPTANOIC ACID
+BMGC_DG15881,BMG_DG200758,"PubChem CID:81049 | CAS RN:6574-15-8 | UNII:FRZ5EYH8V6 | PubChem SID:441583568 | PIPERIDINE, 1-(4-NITROPHENYL)-"
+BMGC_DG15882,BMG_DG200768,"PubChem CID:81058 | PubChem SID:241180702 | UNII:K8G025CX8W | 2,6-DICHLOROPHENYLACETIC ACID | CAS RN:6575-24-2"
+BMGC_DG15883,BMG_DG200769,1-HEXANETHIOL | 1-Hexanethiol | CAS RN:111-31-9 | UNII:1KH2129A0Q | hexane-1-thiol | PubChem SID:198944968 | PubChem CID:8106
+BMGC_DG15884,BMG_DG200771,"PubChem SID:474490385 | PubChem CID:81062 | UNII:WN6H8S4VKP | CAS RN:6583-06-8 | 4-NITROBENZO(C)(1,2,5)THIADIAZOLE | 4-Nitrobenzo[c][1,2,5]thiadiazole"
+BMGC_DG15885,BMG_DG200791,CAS RN:25119-64-6 | ITACONIC ACID | 2-methylidenebutanedioic acid | PubChem SID:198963586 | UNII:Q4516562YH | PubChem CID:811 | Itaconic acid | CAS RN:97-65-4
+BMGC_DG15886,BMG_DG200800,"Diethylenetriamine | N'-(2-aminoethyl)ethane-1,2-diamine | UNII:03K6SX4V2J | PubChem SID:198989865 | CAS RN:111-40-0 | DIETHYLENETRIAMINE | PubChem CID:8111"
+BMGC_DG15887,BMG_DG200820,Methyl phenothiazin-2-yl ketone | UNII:8DEE7H3XAB | PubChem CID:81131 | METHYL PHENOTHIAZIN-2-YL KETONE | PubChem SID:474490574 | CAS RN:6631-94-3
+BMGC_DG15888,BMG_DG200821,1-(10-ACETYLPHENOTHIAZIN-2-YL)ETHANONE | PubChem SID:472409943 | UNII:6N8956723X | CAS RN:6632-11-7 | PubChem CID:81132
+BMGC_DG15889,BMG_DG200839,PubChem SID:441659012 | UNII:QC9YQ3S9RU | PubChem CID:81146 | CAS RN:6640-09-1 | 5-(PHENYLMETHOXY)-1H-INDOLE-2-CARBOXYLIC ACID
+BMGC_DG15890,BMG_DG200855,"PubChem SID:198958130 | PubChem CID:81184 | CAS RN:6674-22-2 | UNII:H1ILJ6IBUX | 1,8-DIAZABICYCLO(5.4.0)UNDEC-7-ENE"
+BMGC_DG15891,BMG_DG200921,DrugBank ID:DB01345 | UNII:295O53K152 | potassium(1+) | CAS RN:24203-36-9 | NDC:35484-204 | PubChem SID:175266884 | POTASSIUM CATION | Potassium Cation | CAS RN:138363-30-1 | CAS RN:125352-08-1 | PubChem CID:813
+BMGC_DG15892,BMG_DG200999,6-AMINOINDAZOLE | PubChem SID:375579558 | CAS RN:6967-12-0 | UNII:KN72RH56SR | PubChem CID:81423
+BMGC_DG15893,BMG_DG201004,PubChem CID:81430 | CAS RN:16015-71-7 | UNII:6LCP52962G | PubChem SID:312525187 | N-(3-METHOXYPHENYL)PIPERAZINE
+BMGC_DG15894,BMG_DG201034,ETHYL 5-AMINO-1H-PYRAZOLE-4-CARBOXYLATE | Ethyl 5-amino-1H-pyrazole-4-carboxylate | CAS RN:6994-25-8 | UNII:9GY5HA1GAA | PubChem CID:81472 | PubChem SID:198986144
+BMGC_DG15895,BMG_DG201048,CAS RN:111-96-6 | Diglyme | 1-methoxy-2-(2-methoxyethoxy)ethane | DIETHYLENE GLYCOL DIMETHYLETHER | UNII:M4BH3X0MVZ | PubChem CID:8150 | DrugBank ID:DB02935 | PubChem SID:198971694
+BMGC_DG15896,BMG_DG201061,DrugBank ID:DB02779 | UNII:GT3793XV5S | dodecyl(trimethyl)azanium | LAURTRIMONIUM | CAS RN:10182-91-9 | PubChem CID:8153 | PubChem SID:198951079 | Dodecyltrimethylammonium
+BMGC_DG15897,BMG_DG201078,"PubChem SID:433968857 | UNII:DJ0M4HZY00 | CAS RN:15461-40-2 | N,N,N-TRIMETHYLOCTADECAN-1-AMINIUM | PubChem CID:8156"
+BMGC_DG15898,BMG_DG201122,CAS RN:112-12-9 | PubChem CID:8163 | 2-Undecanone | PubChem SID:198964226 | undecan-2-one | CAS RN:53452-70-3 | DrugBank ID:DB08688 | 2-UNDECANONE | UNII:YV5DSO8CY9
+BMGC_DG15899,BMG_DG201152,PubChem CID:8168 | UNII:6V2OM30I1Z | CAS RN:112-18-5 | DIMETHYL LAURAMINE | PubChem SID:175267331
+BMGC_DG15900,BMG_DG201156,UNII:R228S06SOH | PubChem CID:81689736 | PubChem SID:375083362 | CAS RN:1463913-43-0 | AB-22
+BMGC_DG15901,BMG_DG201157,UNII:19ZTZ9YC4O | DrugBank ID:DB14839 | PubChem SID:375085804 | PubChem CID:81689783 | 3-[[4-[4-[[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]carbamoylamino]naphthalen-1-yl]oxypyrimidin-2-yl]amino]-5-ethynyl-N-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]benzamide | CAS RN:1630202-02-6 | TOP-1288 | Top-1288
+BMGC_DG15902,BMG_DG201176,PubChem CID:8172 | PubChem SID:175267148 | CAS RN:112-27-6 | Triethylene Glycol | CAS RN:122784-99-0 | DrugBank ID:DB02327 | 2-[2-(2-hydroxyethoxy)ethoxy]ethanol | CAS RN:137800-98-7 | UNII:3P5SU53360 | CAS RN:119438-10-7 | Triethylene glycol | CAS RN:103734-98-1 | CAS RN:145112-98-7 | TRIETHYLENE GLYCOL
+BMGC_DG15903,BMG_DG201178,UNII:M5Z5KX9GYZ | PubChem SID:474489679 | LEUCYLALANINE | CAS RN:7298-84-2 | PubChem CID:81721
+BMGC_DG15904,BMG_DG201184,"UNII:GX66DA3FXR | PubChem CID:81734 | PubChem SID:482554791 | 1-(4-HYDROXYPHENYL)-1H-PYRROLE-2,5-DIONE | 1-(4-Hydroxyphenyl)-1H-pyrrole-2,5-dione | CAS RN:7300-91-6"
+BMGC_DG15905,BMG_DG201190,PubChem SID:472411406 | UNII:V6R37R6AU3 | PubChem CID:81744 | 2-HYDROXY-5-METHYLISOPHTHALALDEHYDE | CAS RN:7310-95-4
+BMGC_DG15906,BMG_DG201191,N-METHYLDODECYLAMINE | PubChem CID:81746 | UNII:88NN43I94S | CAS RN:7311-30-0 | PubChem SID:198981153
+BMGC_DG15907,BMG_DG201219,Diethylene glycol diethyl ether | DIETHYLENE GLYCOL DIETHYL ETHER | UNII:ZH086O935Z | CAS RN:112-36-7 | DrugBank ID:DB08357 | PubChem CID:8179 | PubChem SID:198943164
+BMGC_DG15908,BMG_DG201238,PubChem CID:81829 | 3-INDAZOLINONE | PubChem SID:198987175 | UNII:8E254S9S1R | CAS RN:7364-25-2
+BMGC_DG15909,BMG_DG201240,"CAS RN:7365-44-8 | PubChem SID:316909476 | DrugBank ID:DB02371 | UNII:L173DK6289 | PubChem CID:81831 | 2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid | N-TRIS(HYDROXYMETHYL)METHYL-2-AMINOETHANESULFONIC ACID"
+BMGC_DG15910,BMG_DG201253,PubChem CID:8186 | CAS RN:112-44-7 | PubChem SID:198968975 | UNII:B6P0A9PSHN | undecanal | DrugBank ID:DB04093 | UNDECANAL | Undecanal
+BMGC_DG15911,BMG_DG201274,CAS RN:112-49-2 | TRIGLYME | Triglyme | DrugBank ID:DB02078 | PubChem CID:8189 | UNII:32YXG88KK0 | PubChem SID:198947818
+BMGC_DG15912,BMG_DG201280,"5,6-DIAMINOINDAZOLE | PubChem SID:363908413 | PubChem CID:81900 | CAS RN:7404-68-4 | UNII:60SN334A6B"
+BMGC_DG15913,BMG_DG201289,PubChem SID:241177981 | 5-METHYL-2-PHENYLBENZOXAZOLE | CAS RN:7420-86-2 | UNII:51X3IK0GBZ | PubChem CID:81919
+BMGC_DG15914,BMG_DG201296,PubChem CID:8193 | CAS RN:27342-88-7 | 1-Dodecanol | CAS RN:112-53-8 | UNII:178A96NLP2 | DrugBank ID:DB06894 | NDC:84372-057 | Lauryl Alcohol | PubChem SID:175265416 | dodecan-1-ol | LAURYL ALCOHOL
+BMGC_DG15915,BMG_DG201328,"PubChem CID:8197 | CAS RN:27233-92-7 | Tetraethylenepentamine | PubChem SID:198938166 | UNII:YZD1C9KQ28 | CAS RN:26913-06-4 | N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine | TETRAETHYLENEPENTAMINE | CAS RN:112-57-2"
+BMGC_DG15916,BMG_DG201391,"PubChem SID:252164158 | CAS RN:7575-35-1 | 2,2'-((4-AMINOPHENYL)IMINO)BISETHANOL | PubChem CID:82057 | UNII:O0618TXU5S"
+BMGC_DG15917,BMG_DG201401,"PubChem SID:474490554 | UNII:KS6N6SP2MG | DIETHYL (2,2-DIETHOXYETHYL)PHOSPHONATE | CAS RN:7598-61-0 | PubChem CID:82071"
+BMGC_DG15918,BMG_DG201403,"PubChem CID:82073 | 1H-INDOLE-3-CARBOXYLIC ACID, 5-HYDROXY-2-METHYL-, ETHYL ESTER | CAS RN:7598-91-6 | UNII:NV7P3AB9BM | PubChem SID:441583838"
+BMGC_DG15919,BMG_DG201407,UNII:SCI2054E4F | CAS RN:53348-92-8 | 4-AMINOCOUMARIN | PubChem SID:329589003 | PubChem CID:820807
+BMGC_DG15920,BMG_DG201464,"PubChem CID:82143 | 5-methylindolo[3,2-b]quinoline | CAS RN:480-26-2 | UNII:OF1UIT4RDH | PubChem SID:433968543 | Cryptolepine | CRYPTOLEPINE"
+BMGC_DG15921,BMG_DG201465,PubChem SID:472393786 | PubChem CID:821449 | CNIDILIN | UNII:GGS6U48RG7 | CAS RN:14348-22-2
+BMGC_DG15922,BMG_DG201467,"PubChem SID:175268663 | BEXAROTENE | PubChem CID:82146 | NDC:42291-072 | Bexarotene | NDC:0187-5526 | NDC:73190-999 | CAS RN:153559-49-0 | 4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid | CAS RN:166175-31-1 | DrugBank ID:DB00307 | NDC:69238-1250 | NDC:0832-0285 | UNII:A61RXM4375 | NDC:0378-6955 | NDC:0187-5525 | NDC:43975-315 | NDC:0591-2832 | NDC:43602-176 | NDC:69238-2088"
+BMGC_DG15923,BMG_DG201468,PubChem CID:82148 | PubChem SID:198943892 | CAS RN:138112-76-2 | Agomelatine | AGOMELATINE | N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide | UNII:137R1N49AD | DrugBank ID:DB06594
+BMGC_DG15924,BMG_DG201471,Behenic Acid | PubChem CID:8215 | docosanoic acid | CAS RN:112-85-6 | BEHENIC ACID | UNII:H390488X0A | PubChem SID:175267444 | Behenic acid
+BMGC_DG15925,BMG_DG201473,"UNII:78M02AA8KF | CAS RN:3385-03-3 | DrugBank ID:DB00180 | PubChem SID:175265631 | (1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | CAS RN:77326-96-6 | FLUNISOLIDE ANHYDROUS | PubChem CID:82153 | Flunisolide"
+BMGC_DG15926,BMG_DG201496,N-(4-METHOXYPHENYL)ACRYLAMIDE | UNII:WFM3C9437Z | PubChem CID:82197 | PubChem SID:485661700 | N-(4-Methoxyphenyl)acrylamide | CAS RN:7766-37-2
+BMGC_DG15927,BMG_DG201497,PubChem CID:821974 | 3-AMINOBENZO(B)THIOPHENE-2-CARBOXAMIDE | CAS RN:37839-59-1 | PubChem SID:485663391 | UNII:C5KAY95V3L | 3-Aminobenzo[b]thiophene-2-carboxamide
+BMGC_DG15928,BMG_DG201524,"Ergotamine | CAS RN:113-15-5 | CAS RN:1080650-16-3 | CAS RN:379-79-3 | (6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide | PubChem SID:175265544 | PubChem CID:8223 | ERGOTAMINE | UNII:PR834Q503T | DrugBank ID:DB00696"
+BMGC_DG15929,BMG_DG201548,"DrugBank ID:DB00353 | PubChem CID:8226 | PubChem SID:175268799 | Methylergonovine | Methylergometrine | CAS RN:113-42-8 | UNII:W53L6FE61V | METHYLERGONOVINE | (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide"
+BMGC_DG15930,BMG_DG201552,NAPHTHALHYDROXAMIC ACID | PubChem SID:348481826 | CAS RN:7797-81-1 | PubChem CID:82263 | UNII:DZG9AVW5V2
+BMGC_DG15931,BMG_DG201554,CAS RN:7803-58-9 | PubChem CID:82267 | SULFAMIDE | UNII:VS7TZW634V | PubChem SID:198977585
+BMGC_DG15932,BMG_DG201569,"Argipressin tannate | PubChem CID:8230 | CAS RN:113-79-1 | 1-[19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pyrrolidine-2-carboxamide"
+BMGC_DG15933,BMG_DG201580,"DrugBank ID:DB03740 | PubChem SID:198976875 | UNII:T13TI5GH3D | N-ACETYL-.ALPHA.-D-GLUCOSAMINE | PubChem CID:82313 | CAS RN:10036-64-3 | N-acetyl-alpha-D-glucosamine | 2-Acetamido-2-deoxy-alpha-D-glucopyranose | N-[(2S,3R,4R,5S,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide"
+BMGC_DG15934,BMG_DG201581,PubChem CID:82315 | DrugBank ID:DB08214 | 4-(1H-IMIDAZOL-1-YL)PHENOL
+BMGC_DG15935,BMG_DG201582,PubChem CID:82316 | CAS RN:10041-06-2 | UNII:KQU6ES7DSS | RO 22-3581 | PubChem SID:461435034
+BMGC_DG15936,BMG_DG201585,1-Ethyl-2-benzimidazolinone | 3-ethyl-1H-benzimidazol-2-one | CAS RN:10045-45-1 | UNII:M82W79SS4W | PubChem CID:82320 | PubChem SID:198949015 | 1-ETHYL-2-BENZIMIDAZOLINONE
+BMGC_DG15937,BMG_DG201586,PubChem SID:252320495 | PubChem CID:823206 | CAS RN:212707-61-4 | UNII:XY7RW8O14Q | CINNAMOYL TRYPTAMINE
+BMGC_DG15938,BMG_DG201611,PubChem SID:198945284 | UNII:19C742D53K | OXOBENZOXAZINYL NAPHTHALENE SULFOANILIDE | PubChem CID:82379 | CAS RN:10128-55-9
+BMGC_DG15939,BMG_DG201615,N-(4-bromo-2-methylphenyl)naphthalene-2-carboxamide | N-(4-BROMO-2-METHYLPHENYL)NAPHTHALENE-2-CARBOXAMIDE | CAS RN:429627-41-8 | PubChem SID:472422282 | UNII:3W4NVD97ZD | PubChem CID:823850
+BMGC_DG15940,BMG_DG201622,"Alpha-D-Glucose 1,6-Bisphosphate | GLUCOSE 1,6-BISPHOSPHATE | DrugBank ID:DB02835 | PubChem CID:82400 | alpha-D-Glucose 1,6-bisphosphate | [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(phosphonooxymethyl)oxan-2-yl] dihydrogen phosphate | CAS RN:10139-18-1 | PubChem SID:363907903 | UNII:DRX17R6AM2"
+BMGC_DG15941,BMG_DG201651,1-Acetyl-2-phenylhydrazine | ACETYLPHENYLHYDRAZINE | PubChem SID:198973145 | UNII:C818L19FMP | N'-phenylacetohydrazide | PubChem CID:8247 | CAS RN:114-83-0
+BMGC_DG15942,BMG_DG201661,CAS RN:114-86-3 | PubChem SID:198942069 | DrugBank ID:DB00914 | Phenformin | PHENFORMIN | 1-(diaminomethylidene)-2-(2-phenylethyl)guanidine | PubChem CID:8249 | UNII:DD5K7529CE
+BMGC_DG15943,BMG_DG201687,UNII:AM13FS69BX | PubChem SID:175267607 | PubChem CID:8254 | CAS RN:115-10-6 | methoxymethane | CAS RN:157621-61-9 | DIMETHYL ETHER | Dimethyl Ether
+BMGC_DG15944,BMG_DG201716,"PubChem CID:8259 | CAS RN:115-20-8 | 2,2,2-Trichloroethanol | 2,2,2-trichloroethanol | 2,2,2-TRICHLOROETHANOL | UNII:AW835AJ62N | PubChem SID:198934843"
+BMGC_DG15945,BMG_DG201721,"PubChem CID:826073 | UNII:94P4B8V4G4 | CAS RN:15272-24-9 | PubChem SID:482553939 | 4,8-dimethoxyquinolin-2-ol | 4,8-DIMETHOXYQUINOLIN-2-OL"
+BMGC_DG15946,BMG_DG201773,OXYPHENISATIN ACETATE | PubChem SID:198984351 | CAS RN:115-33-3 | PubChem CID:8269 | Oxyphenisatin acetate | UNII:U0Y1YAL65X | DrugBank ID:DB14627 | [4-[3-(4-acetyloxyphenyl)-2-oxo-1H-indol-3-yl]phenyl] acetate
+BMGC_DG15947,BMG_DG201774,5-CHLOROINDOLE-2-CARBOXYLIC ACID | PubChem SID:485661824 | UNII:HZ63WGR8YY | 5-Chloroindole-2-carboxylic acid | CAS RN:10517-21-2 | PubChem CID:82693
+BMGC_DG15948,BMG_DG201778,PubChem CID:82700 | CAS RN:10525-37-8 | PubChem SID:198943696 | UNII:594M3CY45Q | 1-EICOSANAMINE
+BMGC_DG15949,BMG_DG201783,"MEPHOBARBITAL | UNII:5NC67NU76B | PubChem SID:175271417 | Methylphenobarbital | PubChem CID:8271 | 5-ethyl-1-methyl-5-phenyl-1,3-diazinane-2,4,6-trione | Mephobarbital | DrugBank ID:DB00849 | CAS RN:115-38-8"
+BMGC_DG15950,BMG_DG201787,"Bromophenol Blue | BROMOPHENOL BLUE | PubChem SID:198971857 | CAS RN:115-39-9 | UNII:0R2969YC90 | 2,6-dibromo-4-[3-(3,5-dibromo-4-hydroxyphenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]phenol | PubChem CID:8272"
+BMGC_DG15951,BMG_DG201810,"N,N'-Dimethyldiphenylthiuram disulfide | PubChem SID:485665259 | PubChem CID:82747 | UNII:QC4LB75RUZ | N,N'-DIMETHYLDIPHENYLTHIURAM DISULFIDE | CAS RN:10591-84-1"
+BMGC_DG15952,BMG_DG201813,"PubChem CID:8275 | TALBUTAL | 5-butan-2-yl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | CAS RN:115-44-6 | UNII:4YIR8202AX | PubChem SID:198946209 | DrugBank ID:DB00306 | Talbutal"
+BMGC_DG15953,BMG_DG201816,"HYDROXYTYROSOL | DrugBank ID:DB12771 | UNII:QEU0NE4O90 | Hydroxytyrosol | PubChem SID:175267358 | PubChem CID:82755 | CAS RN:10597-60-1 | 4-(2-hydroxyethyl)benzene-1,2-diol"
+BMGC_DG15954,BMG_DG201829,PubChem CID:828 | Argininosuccinate | 2-[[N'-(4-amino-4-carboxybutyl)carbamimidoyl]amino]butanedioic acid | CAS RN:92008-07-6 | CAS RN:2387-71-5
+BMGC_DG15955,BMG_DG201830,"PubChem SID:198942808 | Paramethadione | DrugBank ID:DB00617 | CAS RN:115-67-3 | 5-ethyl-3,5-dimethyl-1,3-oxazolidine-2,4-dione | UNII:Z615FRW64N | PubChem CID:8280 | PARAMETHADIONE"
+BMGC_DG15956,BMG_DG201831,UNII:7WZ5EG263C | PubChem CID:8281 | SULFADICRAMIDE | N-(4-aminophenyl)sulfonyl-3-methylbut-2-enamide | PubChem SID:198985261 | CAS RN:115-68-4 | Sulfadicramide | DrugBank ID:DB13214
+BMGC_DG15957,BMG_DG201835,CAS RN:115-76-4 | PRENDEROL | PubChem SID:198991246 | PubChem CID:8284 | UNII:A40PF8120T
+BMGC_DG15958,BMG_DG201837,"DrugBank ID:DB13526 | CAS RN:334974-06-0 | CAS RN:115-77-5 | 2,2-bis(hydroxymethyl)propane-1,3-diol | PubChem SID:175265945 | UNII:SU420W1S6N | CAS RN:88201-29-0 | CAS RN:1632063-92-3 | PubChem CID:8285 | PENTAERYTHRITOL | Pentaerythritol"
+BMGC_DG15959,BMG_DG201876,CAS RN:126595-07-1 | 3-[[2-carboxyethyl(oxo)germyl]oxy-oxogermyl]propanoic acid | Bis (2-Carboxyethylgermanium)sesquioxide | PubChem CID:83030 | CAS RN:12758-40-6
+BMGC_DG15960,BMG_DG201880,UNII:W37EF2CKB8 | CAS RN:270584-99-1 | N-8-QUINOLINYL-2-THIOPHENESULFONAMIDE | PubChem CID:830459 | PubChem SID:459055276
+BMGC_DG15961,BMG_DG201884,UNII:O6874J5528 | CAS RN:13020-57-0 | 3-HYDROXYBENZOPHENONE | PubChem SID:198957299 | PubChem CID:83050
+BMGC_DG15962,BMG_DG201887,CAS RN:13021-71-1 | 2-Benzylamino-4-methylpyridine | PubChem SID:485666636 | UNII:ZLT6LG39XT | PubChem CID:83053 | 2-BENZYLAMINO-4-METHYLPYRIDINE
+BMGC_DG15963,BMG_DG201915,CAS RN:41186-03-2 | 1-(3-Methylphenyl)piperazine | UNII:FYS4L9BW6G | 1-(3-METHYLPHENYL)PIPERAZINE | PubChem SID:441658694 | PubChem CID:83111
+BMGC_DG15964,BMG_DG201918,O-CHLOROPHENETHYLAMINE | CAS RN:13078-80-3 | PubChem SID:472408325 | PubChem CID:83117 | UNII:HS4BM7QJE4
+BMGC_DG15965,BMG_DG201922,"PubChem SID:198946475 | 3,7-Dimethyluric acid | PubChem CID:83126 | 3,7-DIMETHYLURIC ACID | 3,7-dimethyl-9H-purine-2,6,8-trione | CAS RN:13087-49-5 | UNII:LR195N9E9A"
+BMGC_DG15966,BMG_DG201939,"PubChem SID:198964359 | PubChem CID:83156 | N,N'-2-PHENYLENEDIMALEIMIDE | UNII:W46FEU5446 | N,N'-2-Phenylenedimaleimide | 1-[2-(2,5-dioxopyrrol-1-yl)phenyl]pyrrole-2,5-dione | CAS RN:13118-04-2"
+BMGC_DG15967,BMG_DG201942,"DrugBank ID:DB07573 | (2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol | PubChem CID:831616"
+BMGC_DG15968,BMG_DG201959,PubChem SID:374388737 | CAS RN:116-83-6 | PubChem CID:8321 | UNII:BCH9T82ZKZ | 4-METHOXY-1-ANTHRAQUINONYLAMINE
+BMGC_DG15969,BMG_DG201967,UNII:15FG1M8OP9 | PubChem SID:374388708 | DISPERSE RED 15 | CAS RN:116-85-8 | PubChem CID:8323
+BMGC_DG15970,BMG_DG201973,4-PHENYLBUTYLAMINE | 4-phenylbutan-1-amine | DrugBank ID:DB04311 | UNII:UG8K2LT79Y | PubChem CID:83242 | CAS RN:13214-66-9 | 4-Phenylbutylamine | PubChem SID:459055965
+BMGC_DG15971,BMG_DG201992,PubChem CID:83278 | PubChem SID:441659581 | CAS RN:13262-48-1 | UNII:8BQB9TX88Z | BIPHENYL-4-YLUREA
+BMGC_DG15972,BMG_DG202001,CAS RN:13278-36-9 | N-(M-CHLOROPHENYL)ANTHRANILIC ACID | PubChem SID:377308618 | PubChem CID:83293 | UNII:LW9LF7L96X
+BMGC_DG15973,BMG_DG202016,DIPHENYLACETIC ACID | CAS RN:117-34-0 | Diphenylacetic acid | PubChem SID:198980106 | DrugBank ID:DB03588 | UNII:658NCZ0NKO | PubChem CID:8333
+BMGC_DG15974,BMG_DG202044,Guanosine 3'-monophosphate | DrugBank ID:DB03315 | PubChem CID:8339
+BMGC_DG15975,BMG_DG202049,"(1S,2S)-2-(4-phenylpiperidin-1-yl)cyclohexan-1-ol | CAS RN:112709-60-1 | 2-(4-Phenylpiperidino)cyclohexanol | PubChem CID:833992"
+BMGC_DG15976,BMG_DG202063,"PubChem CID:8342 | Dichlone | DICHLONE | CAS RN:117-80-6 | UNII:C28BKZ2J9A | PubChem SID:198980844 | 2,3-dichloronaphthalene-1,4-dione"
+BMGC_DG15977,BMG_DG202068,"CAS RN:117-81-7 | bis(2-ethylhexyl) benzene-1,2-dicarboxylate | PubChem SID:198945058 | CAS RN:8033-53-2 | DIETHYLHEXYL PHTHALATE | PubChem CID:8343 | CAS RN:352431-42-6 | CAS RN:15495-94-0 | CAS RN:82208-43-3 | CAS RN:50885-87-5 | Bis(2-ethylhexyl) phthalate | UNII:C42K0PH13C"
+BMGC_DG15978,BMG_DG202095,"Eriocitrin | CAS RN:13463-28-0 | PubChem CID:83489 | UNII:AS293HR5XQ | PubChem SID:198955116 | ERIOCITRIN | (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one"
+BMGC_DG15979,BMG_DG202117,PubChem SID:434370074 | PubChem CID:83525 | ALANYLPROLINE | CAS RN:13485-59-1 | UNII:C6G5K79L0O
+BMGC_DG15980,BMG_DG202145,"ISATOIC ANHYDRIDE | CAS RN:118-48-9 | Isatoic anhydride | DrugBank ID:DB11593 | UNII:R8TFA74Y4U | PubChem SID:198976106 | PubChem CID:8359 | 1H-3,1-benzoxazine-2,4-dione"
+BMGC_DG15981,BMG_DG202151,"DOPA, DL- | UNII:QI9C343R60 | CAS RN:63-84-3 | DL-Dopa | 2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | PubChem SID:198970293 | PubChem CID:836"
+BMGC_DG15982,BMG_DG202155,Phenyl salicylate | CAS RN:118-55-8 | PHENYL SALICYLATE | DrugBank ID:DB11071 | UNII:28A37T47QO | PubChem CID:8361 | phenyl 2-hydroxybenzoate | PubChem SID:175267918
+BMGC_DG15983,BMG_DG202164,"NDC:76354-512 | NDC:84281-477 | NDC:76354-779 | NDC:82109-142 | NDC:72220-001 | NDC:82109-145 | NDC:76354-781 | NDC:68577-148 | NDC:82109-141 | NDC:76354-796 | NDC:54997-056 | NDC:52257-1450 | NDC:59735-918 | NDC:60232-1022 | NDC:71070-868 | NDC:82442-013 | NDC:76354-770 | NDC:68828-805 | NDC:76354-514 | NDC:44717-084 | NDC:68577-123 | NDC:76354-524 | NDC:76354-789 | NDC:79625-001 | NDC:82109-109 | NDC:70060-1901 | NDC:59735-911 | NDC:68577-149 | NDC:76354-534 | NDC:68577-146 | NDC:76354-515 | NDC:68577-132 | NDC:73928-010 | NDC:0311-0741 | NDC:68577-147 | NDC:72085-308 | NDC:76354-798 | NDC:76354-523 | NDC:63940-062 | NDC:76354-520 | NDC:83872-014 | NDC:76354-511 | (3,3,5-trimethylcyclohexyl) 2-hydroxybenzoate | NDC:63354-264 | NDC:0096-0688 | NDC:82109-146 | NDC:84662-020 | NDC:51531-6620 | NDC:82109-104 | NDC:76354-533 | NDC:82109-138 | NDC:76354-778 | NDC:82109-101 | NDC:82109-117 | NDC:51316-722 | NDC:82109-106 | NDC:82109-139 | NDC:74690-030 | NDC:59735-910 | NDC:58668-2951 | NDC:82109-113 | NDC:69259-5968 | NDC:76354-530 | NDC:82109-122 | NDC:59735-915 | NDC:49035-962 | NDC:76354-773 | NDC:82109-116 | NDC:0311-0740 | NDC:52456-025 | UNII:V06SV4M95S | NDC:53675-150 | NDC:69259-5908 | NDC:53675-154 | NDC:59735-916 | NDC:82109-110 | NDC:82109-127 | NDC:76354-538 | NDC:82109-114 | DrugBank ID:DB11064 | NDC:68577-125 | NDC:76354-775 | NDC:62742-4253 | NDC:82109-111 | NDC:60232-1026 | NDC:61010-6103 | NDC:68577-127 | CAS RN:52253-93-7 | NDC:81159-258 | NDC:71883-050 | NDC:49967-356 | NDC:44717-083 | NDC:68577-133 | NDC:68828-803 | NDC:36800-513 | NDC:76354-528 | NDC:76354-788 | NDC:68577-134 | NDC:82109-118 | NDC:49967-015 | NDC:82109-121 | NDC:58668-1618 | NDC:84259-475 | NDC:76354-522 | NDC:76354-786 | NDC:84270-001 | NDC:42221-127 | NDC:68577-144 | NDC:49967-451 | NDC:59735-908 | NDC:76354-780 | NDC:76354-797 | NDC:84425-105 | NDC:52257-1410 | NDC:72085-311 | NDC:0311-0738 | NDC:75779-006 | NDC:68577-122 | NDC:76354-525 | NDC:76354-539 | NDC:84281-476 | NDC:76354-535 | NDC:83872-541 | NDC:76354-532 | NDC:59735-914 | NDC:62742-4255 | NDC:13733-500 | NDC:60232-0036 | NDC:68577-138 | NDC:72085-307 | NDC:76354-777 | NDC:82109-112 | NDC:84462-456 | NDC:59735-919 | NDC:82109-130 | NDC:82109-143 | NDC:68577-130 | NDC:82109-124 | NDC:62217-071 | NDC:82109-147 | NDC:84204-0002 | NDC:76354-791 | NDC:82109-125 | NDC:82109-107 | NDC:51531-2823 | NDC:54181-006 | NDC:79481-0227 | NDC:82109-119 | NDC:51531-2825 | NDC:83872-542 | NDC:76354-790 | NDC:0311-0739 | NDC:68828-802 | NDC:84662-040 | NDC:53675-152 | NDC:49967-940 | NDC:76354-776 | PubChem CID:8362 | NDC:49967-992 | NDC:82109-105 | NDC:63354-323 | NDC:68828-806 | NDC:76354-526 | NDC:76354-799 | NDC:79356-203 | NDC:65008-007 | NDC:76354-527 | NDC:76354-516 | NDC:67777-177 | Homosalate | NDC:63354-682 | NDC:68577-135 | NDC:82109-131 | NDC:82109-144 | NDC:76354-793 | NDC:84754-051 | NDC:76354-782 | NDC:81746-183 | NDC:69968-0609 | NDC:76354-513 | NDC:79356-202 | NDC:84164-460 | NDC:79903-058 | NDC:52554-9051 | NDC:72085-309 | NDC:68828-807 | CAS RN:118-56-9 | NDC:76354-772 | NDC:82109-120 | NDC:84662-050 | NDC:49967-263 | NDC:0311-0723 | NDC:59735-909 | NDC:63354-261 | NDC:59735-907 | NDC:82109-129 | NDC:52554-9052 | NDC:82109-133 | NDC:52257-1420 | NDC:68577-124 | NDC:82109-136 | NDC:60232-0035 | NDC:68577-128 | NDC:68828-809 | NDC:76354-529 | NDC:82109-134 | NDC:63354-502 | NDC:58668-1621 | NDC:49967-832 | NDC:76354-521 | NDC:76354-774 | NDC:76354-794 | NDC:44717-082 | NDC:57627-170 | NDC:84462-458 | NDC:59735-912 | NDC:82109-115 | NDC:68577-143 | NDC:82109-132 | NDC:82109-123 | NDC:52257-1460 | NDC:68577-131 | NDC:84326-001 | NDC:68828-808 | NDC:68577-139 | NDC:82109-135 | NDC:82109-137 | NDC:76354-783 | NDC:58668-1619 | NDC:84326-002 | NDC:82109-140 | NDC:0363-0187 | NDC:76354-537 | NDC:62217-043 | NDC:51531-2824 | NDC:68577-137 | NDC:68828-804 | NDC:62742-4223 | NDC:76354-510 | NDC:76354-531 | PubChem SID:175271482 | NDC:51531-2822 | NDC:51316-042 | NDC:68577-142 | NDC:76354-795 | NDC:68577-141 | NDC:68577-145 | NDC:71501-1902 | NDC:0311-0737 | NDC:49967-346 | NDC:76354-785 | NDC:52854-945 | NDC:82109-126 | NDC:49967-964 | NDC:63354-542 | NDC:68577-129 | NDC:68828-800 | NDC:61477-215 | NDC:76354-784 | NDC:82109-103 | NDC:82109-108 | NDC:83566-218 | NDC:76354-787 | NDC:54473-403 | NDC:55550-102 | NDC:68577-140 | NDC:74690-020 | NDC:68577-126 | NDC:76354-519 | HOMOSALATE | NDC:76354-517 | NDC:84562-509 | NDC:84203-003 | NDC:76354-536 | NDC:79481-0000 | NDC:69968-0607 | NDC:59735-906 | NDC:11673-239 | NDC:61477-225 | NDC:76354-518 | NDC:49967-942 | NDC:61369-202 | NDC:76354-771 | NDC:76354-792 | NDC:68828-801 | NDC:59735-917 | NDC:68577-136 | NDC:77365-005 | NDC:10967-663 | NDC:82109-100 | NDC:59735-913 | NDC:82109-102 | NDC:84164-461 | NDC:82109-128"
+BMGC_DG15984,BMG_DG202172,"PubChem SID:255509328 | UNII:MXF0417QII | PubChem CID:83632 | N,N-DIMETHYL-2,2-DIPHENYLETHYLAMINE | CAS RN:7647-54-3"
+BMGC_DG15985,BMG_DG202182,"N,N'-BISMALEIMIDO-4,4'-DIPHENYLMETHANE | CAS RN:13676-54-5 | PubChem CID:83648 | UNII:I67AL345KM | PubChem SID:198969969"
+BMGC_DG15986,BMG_DG202219,CAS RN:13750-62-4 | 2-Methyl-1-(phenylmethyl)-1H-imidazole | PubChem SID:485662883 | UNII:5V6JMQ38AM | PubChem CID:83699 | 2-METHYL-1-(PHENYLMETHYL)-1H-IMIDAZOLE
+BMGC_DG15987,BMG_DG202220,"HEXACHLOROBENZENE | PubChem SID:198985827 | Hexachlorobenzene | CAS RN:118-74-1 | UNII:4Z87H0LKUY | PubChem CID:8370 | 1,2,3,4,5,6-hexachlorobenzene"
+BMGC_DG15988,BMG_DG202228,"PubChem SID:198971392 | CAS RN:118-75-2 | UNII:01W5X7N5XV | 2,3,5,6-tetrachlorocyclohexa-2,5-diene-1,4-dione | PubChem CID:8371 | CHLORANIL | Chloranil"
+BMGC_DG15989,BMG_DG202256,"DrugBank ID:DB01676 | UNII:H43RF5TRM5 | CAS RN:131612-90-3 | CAS RN:118-96-7 | 2-methyl-1,3,5-trinitrobenzene | Trinitrotoluene | PubChem SID:198935486 | PubChem CID:8376 | 2,4,6-TRINITROTOLUENE"
+BMGC_DG15990,BMG_DG202259,UNII:YMD9TFB2PG | CAS RN:13831-30-6 | PubChem CID:83766 | ACETOXYACETIC ACID | PubChem SID:198958531
+BMGC_DG15991,BMG_DG202264,CAS RN:13852-81-8 | PubChem SID:474490447 | 4-CHLORO-2-NITROBENZENESULFONAMIDE | UNII:W8M2G6K5SV | 4-Chloro-2-nitrobenzenesulfonamide | PubChem CID:83773
+BMGC_DG15992,BMG_DG202268,"CAS RN:11004-65-2 | FRAMYCETIN | Framycetin | PubChem SID:198945812 | CAS RN:119-04-0 | CAS RN:1404-04-2 | DrugBank ID:DB00452 | (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol | PubChem CID:8378 | UNII:4BOC774388"
+BMGC_DG15993,BMG_DG202277,"PubChem CID:838 | CAS RN:329-65-7 | UNII:GR0L9S3J0F | CAS RN:104655-05-2 | RACEPINEPHRINE | 4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol | PubChem SID:175271570 | Racepinephrine"
+BMGC_DG15994,BMG_DG202288,"PubChem SID:198990096 | BIOCYTIN | (2S)-6-[5-[(3aS,4S,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-2-aminohexanoic acid | Biocytin | PubChem CID:83814 | UNII:G6D6147J22 | CAS RN:576-19-2"
+BMGC_DG15995,BMG_DG202311,CAS RN:119-28-8 | UNII:21QEG50798 | 1-NAPHTHYLAMINE-7-SULFONIC ACID | PubChem SID:198977296 | PubChem CID:8386
+BMGC_DG15996,BMG_DG202321,"CAS RN:1783-96-6 | DrugBank ID:DB02655 | UNII:4SR0Q8YD1X | PubChem CID:83887 | D-Aspartic Acid | ASPARTIC ACID, D- | CAS RN:27881-01-2 | (2R)-2-aminobutanedioic acid | PubChem SID:198976585"
+BMGC_DG15997,BMG_DG202324,"CAS RN:1035535-90-0 | PubChem CID:83898 | Cevimeline | CAS RN:107233-08-9 | (2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane]"
+BMGC_DG15998,BMG_DG202327,2-NITRO-P-CRESOL | 2-Nitro-4-cresol | CAS RN:68137-08-6 | CAS RN:119-33-5 | UNII:P92KPK2NL3 | PubChem SID:198974404 | DrugBank ID:DB04110 | 4-methyl-2-nitrophenol | CAS RN:12167-20-3 | PubChem CID:8391 | 4-Methyl-2-nitrophenol
+BMGC_DG15999,BMG_DG202341,CAS RN:26116-56-3 | UNII:YX9KV1OMA4 | PubChem CID:83952 | PubChem SID:348481276 | 9(S)-ERYTHROMYCYLAMINE
+BMGC_DG16000,BMG_DG202342,"UNII:32B40I7V7B | (2R,3R,4S,5R,8R,9S,10S,11R,12R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-5-ethyl-3,4-dihydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-7-one | PubChem SID:198990321 | Erythromycin A enol ether | ERYTHROMYCIN A ENOL ETHER | PubChem CID:83954 | CAS RN:33396-29-1"
+BMGC_DG16001,BMG_DG202349,CAS RN:122063-20-1 | methyl N-(6-propylsulfinyl-1H-benzimidazol-2-yl)carbamate | PubChem CID:83969 | PubChem SID:198970389 | CAS RN:54029-12-8 | UNII:J39B52TV34 | DrugBank ID:DB13871 | CAS RN:122063-21-2 | Albendazole oxide | ALBENDAZOLE OXIDE
+BMGC_DG16002,BMG_DG202351,"(1,3-dioxo-4,5,6,7-tetrahydroisoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropane-1-carboxylate | DrugBank ID:DB13752 | CAS RN:66525-27-7 | UNII:Z72930Q46K | PubChem SID:198950103 | CAS RN:7696-12-0 | Tetramethrin | TETRAMETHRIN | PubChem CID:83975"
+BMGC_DG16003,BMG_DG202352,UNII:KVM0X4X57B | METHYLENE DI-T-BUTYLCRESOL | PubChem SID:198945432 | PubChem CID:8398 | CAS RN:119-47-1
+BMGC_DG16004,BMG_DG202357,"DrugBank ID:DB14020 | PubChem CID:8400 | BENZOIN, (+/-)- | CAS RN:119-53-9 | BENZOIN, (±)- | UNII:L7J6A1NE81 | Benzoin | PubChem SID:175271519 | 2-hydroxy-1,2-diphenylethanone | CAS RN:579-44-2"
+BMGC_DG16005,BMG_DG202359,"NDC:50090-7453 | NDC:62135-811 | NDC:72572-354 | NDC:76420-032 | NDC:65145-140 | NDC:70512-842 | NDC:70771-1747 | NDC:47335-220 | NDC:67296-1489 | NDC:63187-128 | NDC:65145-139 | NDC:76045-104 | NDC:76420-250 | UNII:4EVE5946BQ | NDC:76045-105 | NDC:0023-9277 | NDC:69344-144 | NDC:60505-1003 | NDC:68071-3684 | NDC:60760-668 | NDC:68788-8504 | NDC:50090-6265 | NDC:71205-116 | NDC:76045-107 | NDC:80425-0267 | NDC:43598-139 | NDC:76420-272 | NDC:82449-215 | NDC:63629-2974 | NDC:35573-450 | NDC:65145-138 | NDC:51662-1292 | NDC:65862-770 | NDC:43063-904 | NDC:70512-790 | NDC:51662-1594 | NDC:55150-341 | NDC:31722-307 | NDC:0378-1134 | NDC:71872-7185 | NDC:0023-2181 | NDC:50090-6807 | NDC:31722-306 | NDC:60760-314 | NDC:71205-594 | NDC:31722-686 | NDC:82449-216 | KETOROLAC TROMETHAMINE | NDC:69315-260 | NDC:47335-221 | NDC:68788-8149 | NDC:70518-0048 | NDC:71335-2136 | NDC:68083-132 | NDC:65145-145 | NDC:72189-371 | NDC:70512-844 | NDC:50090-4635 | CAS RN:74103-07-4 | Ketorolac Tromethamine | NDC:70518-3912 | NDC:72572-355 | NDC:67296-1412 | NDC:50090-2746 | NDC:69784-601 | NDC:61314-126 | NDC:62332-599 | NDC:63323-161 | NDC:0641-6042 | NDC:76420-184 | NDC:66267-418 | NDC:68788-8549 | NDC:25021-700 | NDC:50090-5013 | NDC:72684-006 | NDC:0338-0069 | NDC:71872-7212 | NDC:71205-296 | NDC:0487-6232 | NDC:70518-2927 | NDC:70710-1710 | NDC:70518-3800 | NDC:80425-0139 | NDC:71872-7287 | NDC:82449-219 | NDC:65862-775 | NDC:69452-275 | NDC:80425-0455 | NDC:68071-2252 | NDC:72162-2384 | NDC:0023-3507 | NDC:51407-677 | NDC:65145-147 | NDC:50090-7265 | NDC:0409-3793 | NDC:70518-4255 | NDC:71205-582 | NDC:71872-7327 | NDC:76420-252 | NDC:55154-9368 | NDC:55150-339 | NDC:62332-600 | NDC:76045-209 | NDC:71872-7234 | NDC:50090-5428 | NDC:60758-773 | NDC:70518-4161 | NDC:68462-757 | NDC:68788-8701 | NDC:55150-340 | NDC:72266-118 | NDC:50090-6772 | 2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid | NDC:72603-153 | NDC:72189-555 | NDC:82449-218 | NDC:82449-217 | NDC:25021-701 | NDC:68462-755 | NDC:0409-3795 | NDC:55154-0120 | NDC:68462-756 | NDC:63187-777 | NDC:60687-104 | NDC:63187-628 | NDC:0404-9996 | NDC:47335-935 | NDC:47335-219 | NDC:72603-161 | NDC:0641-6043 | NDC:31722-305 | NDC:50090-5609 | NDC:51655-170 | NDC:55154-6960 | NDC:67296-2070 | NDC:68083-133 | NDC:0641-6041 | NDC:51662-1295 | NDC:0338-0076 | NDC:63323-162 | NDC:67296-1881 | NDC:0093-0314 | NDC:71335-2444 | NDC:70518-4253 | NDC:69315-322 | NDC:70512-843 | NDC:66267-832 | NDC:47335-933 | NDC:50090-1328 | NDC:72611-719 | NDC:42571-137 | NDC:0338-0072 | NDC:0904-7303 | NDC:67296-1569 | NDC:83008-005 | NDC:71872-7288 | NDC:72266-234 | PubChem CID:84003 | NDC:71872-7213 | NDC:72266-119 | NDC:0404-9998 | NDC:65145-146 | NDC:68788-8400 | NDC:71872-7328 | PubChem SID:175271797 | NDC:70518-3369 | NDC:47335-934 | NDC:71335-9639 | NDC:67296-0614 | NDC:55154-9398 | NDC:0409-3796 | NDC:50090-3550 | NDC:72789-437 | NDC:55154-9366 | NDC:72603-172 | NDC:82449-220 | NDC:82868-020 | NDC:0404-9997 | NDC:68071-3591 | NDC:72189-583 | NDC:68083-134 | NDC:62332-601 | NDC:72189-335"
+BMGC_DG16006,BMG_DG202366,"NDC:68071-3116 | NDC:68788-7933 | NDC:50090-1830 | NDC:62135-883 | NDC:72189-299 | NDC:64380-905 | NDC:64380-906 | NDC:71335-0017 | DrugBank ID:DB01211 | NDC:67296-1360 | NDC:70518-0204 | NDC:50090-0994 | PubChem SID:175268147 | NDC:0781-6022 | NDC:50268-178 | NDC:50090-0927 | NDC:67296-0464 | NDC:62135-616 | NDC:43063-752 | NDC:82804-141 | NDC:60687-435 | NDC:71335-1493 | NDC:50268-179 | NDC:0527-1932 | NDC:57237-044 | NDC:0781-1961 | NDC:65862-226 | NDC:0527-1931 | CAS RN:116836-41-0 | NDC:57237-045 | NDC:43063-823 | NDC:62332-344 | NDC:0527-1930 | NDC:82804-069 | NDC:0781-6023 | NDC:51655-668 | NDC:65862-225 | NDC:43063-530 | NDC:68788-8480 | NDC:50090-5282 | UNII:H1250JIK0A | PubChem CID:84029 | NDC:62135-615 | NDC:0591-2805 | NDC:27241-065 | NDC:27241-064 | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione | NDC:43063-942 | NDC:63187-376 | NDC:76420-051 | CLARITHROMYCIN | CAS RN:81103-11-9 | NDC:63187-625 | Clarithromycin | NDC:62332-345 | NDC:46708-345 | NDC:0781-1962 | NDC:46708-344 | NDC:0904-6872"
+BMGC_DG16007,BMG_DG202371,CAS RN:5841-63-4 | PubChem SID:316917604 | 5-PHENYLOXAZOLIDINEDIONE | PubChem CID:84042 | UNII:R4IZ4GP09U
+BMGC_DG16008,BMG_DG202375,CAS RN:2241982-85-2 | isoquinoline | Isoquinoline | DrugBank ID:DB04329 | CAS RN:119-65-3 | UNII:JGX76Y85M6 | ISOQUINOLINE | PubChem CID:8405 | PubChem SID:198962746
+BMGC_DG16009,BMG_DG202381,PubChem SID:198968020 | UNII:18LC87Z10L | PubChem CID:84076 | CAS RN:87424-25-7 | 3-DESMETHYLTHIOCOLCHICINE
+BMGC_DG16010,BMG_DG202382,1-NAPHTHYLAMINE-6-SULFONIC ACID | 5-aminonaphthalene-2-sulfonic acid | DrugBank ID:DB08238 | UNII:59G56TB11B | PubChem CID:8408 | PubChem SID:198947528 | CAS RN:119-79-9
+BMGC_DG16011,BMG_DG202383,"PubChem CID:84088 | CAS RN:76-47-1 | [2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2-(diethylamino)acetate | UNII:Y3N00BK5WK | PubChem SID:198961523 | DrugBank ID:DB00769 | HYDROCORTAMATE | Hydrocortamate"
+BMGC_DG16012,BMG_DG202387,"DrugBank ID:DB12938 | UNII:0T9R0O0EYT | (5-cyclopropyl-1,2-oxazol-4-yl)-[2-methylsulfonyl-4-(trifluoromethyl)phenyl]methanone | CAS RN:141112-29-0 | ISOXAFLUTOLE | PubChem CID:84098 | PubChem SID:175266976 | Isoxaflutole"
+BMGC_DG16013,BMG_DG202420,"CAS RN:120-08-1 | UNII:H5841PDT4Y | PubChem SID:198950985 | SCOPARONE | Scoparone | 6,7-dimethoxychromen-2-one | PubChem CID:8417"
+BMGC_DG16014,BMG_DG202432,UNII:O9S4K2S25E | CAS RN:120-18-3 | 2-NAPHTHALENESULFONIC ACID | PubChem CID:8420 | DrugBank ID:DB08254 | 2-Naphthalenesulfonic acid | PubChem SID:198990507
+BMGC_DG16015,BMG_DG202439,UNII:717GVR334R | 2-naphthalen-2-yloxyacetic acid | CAS RN:120-23-0 | PubChem SID:198936503 | PubChem CID:8422 | 2-Naphthoxyacetic acid | (2-NAPHTHYLOXY)ACETIC ACID
+BMGC_DG16016,BMG_DG202446,PubChem SID:485662824 | UNII:NP52UM3ECS | HYDRAZINOACETIC ACID | PubChem CID:84227 | Hydrazinoacetic acid | CAS RN:14150-64-2
+BMGC_DG16017,BMG_DG202462,".ALPHA.-N-ACETYL-D-GALACTOSAMINE | PubChem CID:84265 | CAS RN:31022-50-1 | CAS RN:14215-68-0 | UNII:00C01APN10 | alpha-N-Acetyl-D-galactosamine | 2-acetamido-2-deoxy-alpha-D-galactopyranose | DrugBank ID:DB03567 | N-[(2S,3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | PubChem SID:313183563"
+BMGC_DG16018,BMG_DG202490,"Dibenzoylmethane | PubChem CID:8433 | DIBENZOYLMETHANE | 1,3-diphenylpropane-1,3-dione | UNII:ANS7ME8OKC | NDC:61805-118 | CAS RN:120-46-7 | PubChem SID:198964733"
+BMGC_DG16019,BMG_DG202494,ethyl 4-hydroxybenzoate | Ethylparaben | PubChem SID:175268902 | PubChem CID:8434 | DrugBank ID:DB13628 | CAS RN:120-47-8 | UNII:14255EXE39 | ETHYLPARABEN | CAS RN:9001-05-2
+BMGC_DG16020,BMG_DG202548,"2,2'-Dithiobisbenzothiazole | 2-(1,3-benzothiazol-2-yldisulfanyl)-1,3-benzothiazole | UNII:6OK753033Z | PubChem SID:175268596 | DrugBank ID:DB14201 | 2,2'-DITHIOBISBENZOTHIAZOLE | PubChem CID:8447 | CAS RN:120-78-5"
+BMGC_DG16021,BMG_DG202622,Magnesium Glycinate | CAS RN:14783-68-7 | PubChem CID:84645 | PubChem SID:175268523 | UNII:IFN18A4Y6B | magnesium;2-aminoacetate | DrugBank ID:DB11189 | Magnesium glycinate | MAGNESIUM GLYCINATE
+BMGC_DG16022,BMG_DG202624,PubChem CID:8465 | ISOPROTERENONE | CAS RN:121-28-8 | UNII:299T6A9WRP | PubChem SID:377308848
+BMGC_DG16023,BMG_DG202641,PubChem SID:198990257 | Vanillic Acid | PubChem CID:8468 | CAS RN:121-34-6 | 4-hydroxy-3-methoxybenzoic acid | VANILLIC ACID | UNII:GM8Q3JM2Y8
+BMGC_DG16024,BMG_DG202652,"METHIONINE SULFOXIDE, DL- | CAS RN:454-41-1 | PubChem SID:198961757 | CAS RN:62697-73-8 | PubChem CID:847 | 2-amino-4-methylsulfinylbutanoic acid | UNII:O74B4F6OYL | Methionine sulfoxide | CAS RN:4241-59-2"
+BMGC_DG16025,BMG_DG202658,"PubChem CID:84704 | DrugBank ID:DB02643 | N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate"
+BMGC_DG16026,BMG_DG202665,UNII:F687N81LIZ | PubChem SID:198983783 | CAS RN:14949-00-9 | DESACETYL ACETAZOLAMIDE | PubChem CID:84724
+BMGC_DG16027,BMG_DG202687,N-(4-sulfamoylphenyl)propanamide | CAS RN:4708-37-6 | N-(4-SULFAMOYLPHENYL)PROPANAMIDE | UNII:6Q424VDF6Z | PubChem SID:482554055 | PubChem CID:847760
+BMGC_DG16028,BMG_DG202691,"NDC:68605-1040 | NDC:16864-660 | NDC:69740-492 | Benzethonium Chloride | NDC:77573-015 | NDC:60762-151 | NDC:36800-382 | NDC:72797-005 | NDC:11673-629 | NDC:67777-403 | NDC:53247-135 | NDC:66977-032 | NDC:11822-5074 | NDC:46122-525 | NDC:59779-385 | NDC:83829-042 | NDC:79903-485 | NDC:68599-5501 | NDC:53247-136 | NDC:53247-137 | NDC:47682-487 | NDC:69842-084 | NDC:42829-002 | NDC:72446-005 | NDC:83829-052 | NDC:41250-132 | NDC:57362-467 | NDC:72797-004 | NDC:42961-223 | NDC:11822-0779 | NDC:72797-006 | NDC:42961-031 | NDC:83829-012 | NDC:72797-009 | NDC:69740-490 | NDC:50332-0217 | NDC:74810-728 | NDC:53329-073 | NDC:50332-0218 | NDC:69903-002 | CAS RN:121-54-0 | NDC:51879-211 | NDC:70936-111 | NDC:47682-300 | NDC:69740-309 | NDC:61924-102 | NDC:16864-670 | UNII:PH41D05744 | NDC:70936-112 | NDC:56104-502 | NDC:63941-546 | NDC:16864-440 | NDC:60762-112 | NDC:63868-045 | NDC:72797-001 | NDC:53247-138 | NDC:16864-450 | NDC:47682-450 | NDC:30142-150 | NDC:69842-327 | NDC:83829-022 | NDC:60762-113 | NDC:37945-902 | NDC:0363-1507 | NDC:83829-032 | NDC:68599-5502 | NDC:71734-203 | benzyl-dimethyl-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]azanium;chloride | NDC:72797-002 | NDC:0363-0210 | NDC:68605-7171 | NDC:41520-089 | NDC:77573-010 | NDC:11822-0128 | NDC:77573-009 | BENZETHONIUM CHLORIDE | NDC:72797-007 | CAS RN:1313-08-2 | NDC:62654-232 | NDC:68016-615 | NDC:74810-727 | NDC:56104-246 | NDC:10237-700 | NDC:67091-751 | NDC:37808-512 | NDC:79481-0606 | PubChem SID:175266794 | NDC:72797-008 | NDC:82061-007 | NDC:72797-003 | NDC:72146-037 | NDC:43116-036 | NDC:63824-810 | NDC:69256-037 | NDC:77573-007 | NDC:47682-226 | PubChem CID:8478 | NDC:71029-390"
+BMGC_DG16029,BMG_DG202701,PubChem CID:8480 | CARBARSONE | Carbarsone | DrugBank ID:DB11382 | CAS RN:121-59-5 | PubChem SID:198963934 | UNII:8PK70TXE1T | [4-(carbamoylamino)phenyl]arsonic acid
+BMGC_DG16030,BMG_DG202702,PRIMIN | PubChem CID:84800 | UNII:580KA9SG8W | PubChem SID:252164965 | CAS RN:15121-94-5
+BMGC_DG16031,BMG_DG202710,"(2R)-2-amino-4-methylsulfanylbutanoic acid | CAS RN:348-67-4 | UNII:868496F25R | PubChem CID:84815 | DrugBank ID:DB02893 | PubChem SID:198961239 | D-Methionine | METHIONINE, D-"
+BMGC_DG16032,BMG_DG202713,N4-ACETYLSULFANILAMIDE | UNII:340484WZ3L | 4-Acetamidobenzenesulfonamide | PubChem CID:8482 | CAS RN:121-61-9 | N-(4-sulfamoylphenyl)acetamide | PubChem SID:198980469
+BMGC_DG16033,BMG_DG202735,"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE | DrugBank ID:DB07653 | PubChem CID:848641"
+BMGC_DG16034,BMG_DG202744,PubChem CID:848780 | CAS RN:220001-53-6 | 7-Benzyloxy-4-trifluoromethylcoumarin | 7-phenylmethoxy-4-(trifluoromethyl)chromen-2-one
+BMGC_DG16035,BMG_DG202772,IODATE ION | CAS RN:15454-31-6 | PubChem SID:175268569 | PubChem CID:84927 | UNII:877S7T6EXV
+BMGC_DG16036,BMG_DG202781,"[(2R,3R,4S)-2,3,4-trihydroxy-5-oxo-6-phosphonooxyhexyl] dihydrogen phosphate | CAS RN:488-69-7 | CAS RN:4937-84-2 | PubChem SID:198956582 | PubChem CID:84951 | FOSFRUCTOSE | DrugBank ID:DB13863 | 1,6-di-O-phosphono-D-fructose | UNII:M7522JYX1H"
+BMGC_DG16037,BMG_DG202797,METHYL ANISATE | UNII:2MFL7873W9 | CAS RN:121-98-2 | Methyl 4-methoxybenzoate | PubChem SID:198963127 | methyl 4-methoxybenzoate | PubChem CID:8499
+BMGC_DG16038,BMG_DG202809,PubChem CID:850202 | UNII:7673MX9MVW | PubChem SID:478838457 | 6-ACETYL-7-METHOXYCOUMARIN | 6-Acetyl-7-methoxycoumarin | CAS RN:16850-94-5
+BMGC_DG16039,BMG_DG202844,"UNII:6JWL4MZ5HH | 3,6-DIACETAMIDOACRIDINE | CAS RN:15724-70-6 | PubChem SID:348481389 | PubChem CID:85070"
+BMGC_DG16040,BMG_DG202955,UNII:1TW30Y2766 | PYRAZOLANTHRONE | Pyrazolanthrone | CAS RN:129-56-6 | DrugBank ID:DB01782 | PubChem SID:313390027 | PubChem CID:8515
+BMGC_DG16041,BMG_DG202987,UNII:MQ5FV9R7B9 | Phenylalanylphenylalanylamide | CAS RN:15893-46-6 | PubChem SID:478838440 | PHENYLALANYLPHENYLALANYLAMIDE | PubChem CID:85169
+BMGC_DG16042,BMG_DG203006,"1-(2,3-Dichlorophenyl)piperazine | PubChem SID:198944185 | 1-(2,3-DICHLOROPHENYL)PIPERAZINE | PubChem CID:851833 | UNII:891W3EV0B1 | CAS RN:41202-77-1 | 1-(2,3-dichlorophenyl)piperazine"
+BMGC_DG16043,BMG_DG203202,UNII:LE6NFT66MY | PubChem CID:85277 | 3-Methyl-4-(pyrrolidin-1-yl)aniline | PubChem SID:485660833 | CAS RN:16089-43-3 | 3-METHYL-4-(PYRROLIDIN-1-YL)ANILINE
+BMGC_DG16044,BMG_DG203228,"THYROXINE, DL- | PubChem CID:853 | PubChem SID:198967171 | UNII:QR0BV3BRIA | CAS RN:300-30-1"
+BMGC_DG16045,BMG_DG203229,"1,4-Naphthoquinone | UNII:RBF5ZU7R7K | CAS RN:130-15-4 | NDC:44911-0419 | PubChem SID:198951548 | 1,4-NAPHTHOQUINONE | naphthalene-1,4-dione | NDC:70321-0003 | PubChem CID:8530"
+BMGC_DG16046,BMG_DG203275,"ISOEUGENOL, (E)- | PubChem SID:198941920 | PubChem CID:853433 | DrugBank ID:DB14188 | CAS RN:5932-68-3 | CAS RN:97-54-1 | Isoeugenol | 2-methoxy-4-[(E)-prop-1-enyl]phenol | UNII:28FSR1NAY4"
+BMGC_DG16047,BMG_DG203280,Methyl D-phenylalaninate | PubChem SID:485665566 | UNII:HY9FCC3QDX | PubChem CID:853474 | CAS RN:21685-51-8 | METHYL D-PHENYLALANINATE
+BMGC_DG16048,BMG_DG203294,"PubChem CID:853608 | 9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE | DrugBank ID:DB08655"
+BMGC_DG16049,BMG_DG203331,"2,3,4,5-tetrahydroxypentanal | CAS RN:58-86-6 | CAS RN:20235-19-2 | CAS RN:1114-34-7 | CAS RN:41247-05-6 | CAS RN:53106-52-8 | CAS RN:147-81-9 | PubChem CID:854 | CAS RN:25990-60-7 | CAS RN:1949-78-6 | CAS RN:9000-69-5 | DL-Arabinose"
+BMGC_DG16050,BMG_DG203334,UNII:K5161X06LL | CAS RN:486-56-6 | PubChem CID:854019 | Cotinine | COTININE | (5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one | PubChem SID:198948857
+BMGC_DG16051,BMG_DG203335,"EPIBATIDINE | (1R,2R,4S)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane | PubChem CID:854023 | CAS RN:140111-52-0 | PubChem SID:316917058 | Epibatidine | DrugBank ID:DB07720 | (1R,2R,4S)-2-(6-Chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane | UNII:M6K314F1XX"
+BMGC_DG16052,BMG_DG203337,"HUPERZINE A | PubChem CID:854026 | CAS RN:102518-79-6 | Huperzine A | DrugBank ID:DB04864 | (1R,9R,13E)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one | CAS RN:1369-64-8 | CAS RN:120786-18-7 | UNII:0111871I23 | PubChem SID:198957907"
+BMGC_DG16053,BMG_DG203341,"UNII:9B6GK297FN | PubChem CID:854031 | CAS RN:66142-89-0 | MIDOMAFETAMINE, (S)- | PubChem SID:474493657"
+BMGC_DG16054,BMG_DG203342,"3-BROMO-4,5-DIHYDROXYBENZALDEHYDE | PubChem SID:461433501 | UNII:KC2J6HXJ8S | CAS RN:16414-34-9 | PubChem CID:85405"
+BMGC_DG16055,BMG_DG203345,"PubChem CID:854067 | OXEDRINE, (-)- | UNII:Y276ILP9M0 | CAS RN:614-35-7 | PubChem SID:198939113"
+BMGC_DG16056,BMG_DG203371,"SOBREROL, TRANS-, (±)- | DrugBank ID:DB13315 | SOBREROL, TRANS-, (+/-)- | (1S,5R)-5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-en-1-ol | CAS RN:42370-41-2 | UNII:AI0NX02O35 | UNII:7WJQ6A6U4W | PubChem SID:198956427 | PubChem SID:198958436 | trans-Sobrerol | PubChem CID:854498 | SOBREROL, TRANS-(-)- | CAS RN:71697-84-2"
+BMGC_DG16057,BMG_DG203378,CAS RN:130-85-8 | UNII:7RRQ8QZ38N | PAMOIC ACID | PubChem SID:198945068 | PubChem CID:8546
+BMGC_DG16058,BMG_DG203379,"UNII:58SUQ7J26N | CAS RN:16517-70-7 | 1,4-DIAMINO-5,8-DIHYDROXY-ANTHRAQUINONE | PubChem CID:85466 | DrugBank ID:DB03924 | PubChem SID:438788139 | 5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone"
+BMGC_DG16059,BMG_DG203384,"PubChem CID:85469632 | PubChem SID:459275621 | (2S)-N-[[3-chloro-5-(trifluoromethyl)pyridin-2-yl]methyl]-2-cyclopropyl-1-(4-fluorophenyl)sulfonyl-1',1'-dioxospiro[2H-indole-3,4'-thiane]-5-carboxamide | Bay-784 | CAS RN:1631164-24-3 | UNII:66VRX9TN9T | BAY-1214784"
+BMGC_DG16060,BMG_DG203402,"(R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol | PubChem CID:8549"
+BMGC_DG16061,BMG_DG203405,Brompyrogallol Red | UNII:A6NS5EJ2GF | BROMPYROGALLOL RED | PubChem SID:472411241 | CAS RN:16574-43-9 | PubChem CID:85495
+BMGC_DG16062,BMG_DG203407,2-METHYLBENZOTRIAZOLE | CAS RN:16584-00-2 | PubChem SID:482554343 | UNII:CVC67ET4QX | PubChem CID:85498
+BMGC_DG16063,BMG_DG203409,"Deserpidine | PubChem SID:175266731 | DrugBank ID:DB01089 | PubChem CID:8550 | UNII:9016E3VB47 | methyl (1R,15S,17R,18R,19S,20S)-18-methoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate | DESERPIDINE | CAS RN:131-01-1"
+BMGC_DG16064,BMG_DG203412,UNII:389H8733F1 | PubChem SID:252164816 | PubChem CID:85505 | 4-CHLORO-3-NITROBENZALDEHYDE | CAS RN:16588-34-4
+BMGC_DG16065,BMG_DG203441,"UNII:08X7F5UDJM | Dimethyl Phthalate | PubChem SID:198951483 | DrugBank ID:DB13336 | DIMETHYL PHTHALATE | PubChem CID:8554 | dimethyl benzene-1,2-dicarboxylate | CAS RN:131-11-3"
+BMGC_DG16066,BMG_DG203443,UNII:8TF6P2NUB5 | PubChem CID:85542 | 4-(2-(5-CHLORO-2-METHOXYBENZAMIDO)ETHYL)PHENYLSULFONAMIDE | CAS RN:16673-34-0 | PubChem SID:404859610
+BMGC_DG16067,BMG_DG203452,PubChem SID:198951570 | DrugBank ID:DB09332 | Kappadione | UNII:R2L46WE615 | CAS RN:131-13-5 | PubChem CID:8555 | MENADIOL SODIUM DIPHOSPHATE ANHYDROUS | tetrasodium;(2-methyl-4-phosphonatooxynaphthalen-1-yl) phosphate
+BMGC_DG16068,BMG_DG203488,"UNII:9Q765ZIF8L | DrugBank ID:DB12919 | (2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophen-3-yl)(4-chlorophenyl)methanone | (2-amino-4,5,6,7-tetrahydro-1-benzothiophen-3-yl)-(4-chlorophenyl)methanone | CAS RN:40312-34-3 | T-62 | PubChem CID:855908 | PubChem SID:198972600"
+BMGC_DG16069,BMG_DG203551,"Erbitux | PubChem CID:85668777 | 6-(3,3-dimethyl-2-methylideneindol-1-yl)hexanoic acid"
+BMGC_DG16070,BMG_DG203564,PubChem CID:8569 | (2-hydroxy-4-methoxyphenyl)-(2-hydroxyphenyl)methanone | PubChem SID:175266270 | DrugBank ID:DB11221 | Dioxybenzone | CAS RN:131-53-3 | DIOXYBENZONE | UNII:B762XZ551X
+BMGC_DG16071,BMG_DG203585,"2,4-Dihydroxybenzophenone | (2,4-dihydroxyphenyl)-phenylmethanone | CAS RN:131-56-6 | CAS RN:92092-63-2 | BENZORESORCINOL | PubChem CID:8572 | UNII:LJ54R4Z029 | PubChem SID:175268491"
+BMGC_DG16072,BMG_DG203648,"2-(3,4-dihydroxyphenyl)-2-hydroxyacetic acid | UNII:WDP6VCX5T6 | PubChem SID:472423951 | 3,4-Dihydroxymandelic acid | CAS RN:775-01-9 | 3,4-DIHYDROXYMANDELIC ACID | CAS RN:14883-87-5 | PubChem CID:85782"
+BMGC_DG16073,BMG_DG203692,Inosinic Acid | PubChem CID:8582 | DrugBank ID:DB04566
+BMGC_DG16074,BMG_DG203737,"CAS RN:15588-95-1 | 1-(2,5-dimethoxy-4-methylphenyl)propan-2-amine | PubChem SID:198945966 | PubChem CID:85875 | 4-Methyl-2,5-dimethoxyamphetamine | DrugBank ID:DB01528 | DOM | 2,5-Dimethoxy-4-methylamphetamine | UNII:UKI9MLD5OI"
+BMGC_DG16075,BMG_DG203779,PubChem SID:198945521 | 2-phenylquinoline-4-carboxylic acid | CINCHOPHEN | CAS RN:132-60-5 | UNII:39Y533Z02M | PubChem CID:8593 | DrugBank ID:DB13551 | Cinchophen
+BMGC_DG16076,BMG_DG203783,CAS RN:132-66-1 | 2-(naphthalen-1-ylcarbamoyl)benzoic acid | PubChem SID:198981500 | PubChem CID:8594 | NAPTALAM | Naptalam | UNII:306R88V86P
+BMGC_DG16077,BMG_DG203824,UNII:1UQB1BT4OT | PubChem SID:198935501 | CAS RN:548-93-6 | 3-hydroxyanthranilic acid | DrugBank ID:DB03644 | 3-Hydroxyanthranilic Acid | 2-amino-3-hydroxybenzoic acid | 2-AMINO-3-HYDROXYBENZOIC ACID | PubChem CID:86
+BMGC_DG16078,BMG_DG203831,PubChem CID:8601 | CAS RN:132-86-5 | PubChem SID:198969543 | UNII:5X457YEW8Y | NAPHTHORESORCINOL
+BMGC_DG16079,BMG_DG203836,PubChem SID:198986341 | PubChem CID:8602 | UNII:KA0B657LV3 | CAS RN:132-89-8 | CHLORTHENOXAZINE
+BMGC_DG16080,BMG_DG203876,DrugBank ID:DB06807 | PubChem CID:8609 | PHENYL AMINOSALICYLATE | Phenyl Aminosalicylate | phenyl 4-amino-2-hydroxybenzoate | CAS RN:133-11-9 | PubChem SID:198974146 | UNII:52936SIP7V
+BMGC_DG16081,BMG_DG203879,UNII:O48UO55HR0 | PubChem CID:861 | CAS RN:3130-96-9 | PubChem SID:198952983 | RATHYRONINE
+BMGC_DG16082,BMG_DG203881,"N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-5-iodo-2,3-dimethoxybenzamide | PubChem CID:86101 | Epidepride | CAS RN:107188-87-4"
+BMGC_DG16083,BMG_DG203894,Chloroprocaine | PubChem SID:175265449 | 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate | CAS RN:133-16-4 | CHLOROPROCAINE | UNII:5YVB0POT2H | PubChem CID:8612 | DrugBank ID:DB01161
+BMGC_DG16084,BMG_DG203932,DrugBank ID:DB15445 | IODOHIPPURIC ACID | CAS RN:147-58-0 | UNII:3Y68K91A3M | 2-[(2-iodobenzoyl)amino]acetic acid | 2-Iodohippuric acid | PubChem SID:198961690 | PubChem CID:8614
+BMGC_DG16085,BMG_DG203947,DrugBank ID:DB02740 | INDOLEBUTYRIC ACID | 3-Indolebutyric Acid | PubChem CID:8617 | CAS RN:933-32-4 | PubChem SID:198939220 | CAS RN:133-32-4 | Indole-3-butyric acid | UNII:061SKE27JP | 4-(1H-indol-3-yl)butanoic acid
+BMGC_DG16086,BMG_DG204118,CAS RN:1628606-05-2 | UNII:PX9FTM69BF | PubChem SID:433968595 | PubChem CID:86267612 | 3-methyl-5-[6-methyl-5-[2-(1-methylpyrazol-4-yl)pyridin-4-yl]oxypyridin-2-yl]-2-(propan-2-ylamino)pyrimidin-4-one | VIMSELTINIB | Vimseltinib
+BMGC_DG16087,BMG_DG204122,"CAS RN:1628139-03-6 | UNII:V929QJ7NQ8 | PubChem SID:461433458 | RV6153 | 2-[[4-amino-3-(3-fluoro-5-hydroxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-5-[3-[2-(2-methoxyethoxy)ethoxy]prop-1-ynyl]-3-[[2-(trifluoromethyl)phenyl]methyl]quinazolin-4-one | RV-6153 | PubChem CID:86268622"
+BMGC_DG16088,BMG_DG204123,"UNII:WBH8AY6ENB | 4-[[5-(4-propan-2-ylpiperazin-1-yl)pyridin-2-yl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one | Lerociclib | PubChem CID:86269224 | CAS RN:1628256-23-4 | LEROCICLIB | PubChem SID:375579522"
+BMGC_DG16089,BMG_DG204125,"PubChem CID:86269463 | N-(4-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)PHENYL)-N'-(4-FLUORO-2-HYDROXYPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE | UNII:XU28OQ19RG | PubChem SID:405055047 | CAS RN:1628530-38-0"
+BMGC_DG16090,BMG_DG204130,"PubChem SID:405055658 | UNII:XGZ892JZ1E | PubChem CID:86269671 | CAS RN:1628530-47-1 | N-(4-FLUOROPHENYL)-N'-(4-((6-HYDROXY-7-METHOXY-4-QUINOLINYL)OXY)PHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE"
+BMGC_DG16091,BMG_DG204134,CAS RN:1628502-91-9 | MW-150 | 6-(4-methylpiperazin-1-yl)-3-naphthalen-2-yl-4-pyridin-4-ylpyridazine | PubChem CID:86270361 | PubChem SID:381608404 | 6-(4-Methylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)pyridazine | UNII:EPZ68T461K
+BMGC_DG16092,BMG_DG204137,PubChem CID:86272865 | UNII:L6EE7H64YF | GSK-3008348 FREE BASE | CAS RN:1629249-33-7 | PubChem SID:496143091
+BMGC_DG16093,BMG_DG204143,PubChem SID:384648039 | 5F-CUMYL-PINACA | UNII:E827UUV3S9 | CAS RN:1400742-16-6 | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide | PubChem CID:86274158 | 5F-Cumyl-PINACA
+BMGC_DG16094,BMG_DG204196,"NDC:0517-0650 | CID 86278165 | PubChem CID:86278165 | UNII:6897GXD6OE | NDC:0517-0602 | NDC:0517-0620 | PubChem SID:472418110 | CAS RN:1461680-64-7 | (2S,3S,4S,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoate;iron(3+);oxygen(2-);hydroxide;hydrate | FERRIC CARBOXYMALTOSE"
+BMGC_DG16095,BMG_DG204328,PEGNIVACOGIN | UNII:AYC3D1NPYB | CAS RN:959716-28-0 | PubChem SID:472406396 | Pegnivacogin | PubChem CID:86278323 | CAS RN:2509153-97-1 | DrugBank ID:DB06293 | 2-methoxyethyl N-[6-(2-methoxyethoxycarbonylamino)-1-oxo-1-(6-phosphonooxyhexylamino)hexan-2-yl]carbamate
+BMGC_DG16096,BMG_DG204348,"UNII:981TME683S | ROPEGINTERFERON ALFA-2B | CID 86278347 | NDC:73536-500 | CAS RN:1335098-50-4 | PubChem CID:86278347 | PubChem SID:472408143 | (2S)-1-[3,7-bis(2-methoxyethoxycarbonylamino)heptyl]pyrrolidine-2-carboxylic acid"
+BMGC_DG16097,BMG_DG204349,"NDC:73594-9310 | CAS RN:1345510-43-1 | UNII:AHU547PI9H | NDC:73594-9301 | PubChem CID:86278348 | DrugBank ID:DB15617 | CID 86278348 | iron(3+);(2S,3R,4R,5R)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexane-1,2,3,4,5-pentol | PubChem SID:472405837 | FERRIC DERISOMALTOSE | NDC:73594-9305"
+BMGC_DG16098,BMG_DG204359,"SELTOREXANT | PubChem SID:241181378 | UNII:AIS8N3O50B | Seltorexant | CAS RN:1452539-75-1 | PubChem CID:86278359 | DrugBank ID:DB14961 | [(3aS,6aR)-2-(4,6-dimethylpyrimidin-2-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-[2-fluoro-6-(triazol-2-yl)phenyl]methanone"
+BMGC_DG16099,BMG_DG204362,PubChem CID:86278362 | Pegvaliase | (2S)-2-amino-6-[6-(2-methoxyethoxy)hexanoylamino]hexanoic acid | CAS RN:1585984-95-7 | DrugBank ID:DB12839 | CAS RN:2714339-04-3
+BMGC_DG16100,BMG_DG204372,PubChem SID:346540553 | [(2S)-2-acetyloxy-3-[4-[2-[4-[(2S)-2-acetyloxy-3-chloropropoxy]phenyl]propan-2-yl]phenoxy]propyl] acetate | UNII:L10K286T2H | Ralaniten Acetate | PubChem CID:86278934 | RALANITEN ACETATE | CAS RN:1637573-04-6
+BMGC_DG16101,BMG_DG204405,PubChem CID:86287518 | CAS RN:138261-41-3 | DrugBank ID:DB11421 | Imidacloprid | (NE)-N-[1-[(6-chloropyridin-3-yl)methyl]imidazolidin-2-ylidene]nitramide
+BMGC_DG16102,BMG_DG204414,"AZD-9496 | PubChem SID:317229646 | UNII:DA9P7LN909 | Azd-9496 | DrugBank ID:DB15138 | PubChem CID:86287635 | (E)-3-[3,5-difluoro-4-[(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1,3,4,9-tetrahydropyrido[3,4-b]indol-1-yl]phenyl]prop-2-enoic acid | CAS RN:1639042-08-2"
+BMGC_DG16103,BMG_DG204754,"UNII:V50K1D7P4Y | [[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate | URIDINE DIPHOSPHATE GLUCOSE | PubChem SID:198984201 | PubChem CID:8629 | Uridine Diphosphate Glucose | DrugBank ID:DB01861 | Uridine diphosphate glucose | CAS RN:133-89-1"
+BMGC_DG16104,BMG_DG204831,"PubChem SID:438788380 | UNII:4A3702A96F | MEVIDALEN | CAS RN:1638667-79-4 | Mevidalen | 2-(2,6-dichlorophenyl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]ethanone | PubChem CID:86290953"
+BMGC_DG16105,BMG_DG204833,CAS RN:1639417-53-0 | Tenalisib | TENALISIB | UNII:2261HH611H | 3-(3-fluorophenyl)-2-[(1S)-1-(7H-purin-6-ylamino)propyl]chromen-4-one | DrugBank ID:DB15295 | PubChem SID:310825826 | PubChem CID:86291103 | CAS RN:1693773-94-2
+BMGC_DG16106,BMG_DG204834,"3-chloro-4-[(3,5-difluoropyridin-2-yl)methoxy]-1-[2-[2-(2-hydroxypropan-2-yl)pyrimidin-4-yl]-5-methylpyridin-4-yl]-6-methylpyridin-2-one | ZUNSEMETINIB | PubChem CID:86291496 | PubChem SID:443623500 | CAS RN:1640282-42-3 | CAS RN:1640282-44-5 | UNII:AX2VWG0ZCR | CAS RN:1639791-42-6 | Zunsemetinib"
+BMGC_DG16107,BMG_DG204840,PEPOSERTIB | PubChem SID:363907697 | UNII:GN429E725A | CAS RN:1637542-33-6 | (S)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol | PubChem CID:86292849 | Peposertib
+BMGC_DG16108,BMG_DG204843,"(1R,5S,6R)-N-{2-methyl-1-[(3-methylpyridin-2-yl)oxy]propan-2-yl}-3-azabicyclo[3.1.0]hexane-6-carboxamide | (1S,5R)-N-[2-methyl-1-(3-methylpyridin-2-yl)oxypropan-2-yl]-3-azabicyclo[3.1.0]hexane-6-carboxamide | PubChem CID:86294067 | CAS RN:1638588-92-7"
+BMGC_DG16109,BMG_DG204844,"1-[2-[(3R,5R,8R,9R,10S,13S,14S,17S)-3-hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl]pyrazole-4-carbonitrile | Zuranolone | DrugBank ID:DB15490 | NDC:64406-030 | NDC:64406-031 | UNII:7ZW49N180B | PubChem SID:405055394 | PubChem CID:86294073 | ZURANOLONE | CAS RN:1632051-40-1 | NDC:64406-029"
+BMGC_DG16110,BMG_DG204845,CAS RN:1638327-48-6 | RUZINURAD | UNII:UP8J9CA76I | Ruzinurad | PubChem CID:86294127 | PubChem SID:434369788 | 1-(6-bromoquinolin-4-yl)sulfanylcyclobutane-1-carboxylic acid
+BMGC_DG16111,BMG_DG204857,PubChem SID:474493714 | CAS RN:1628718-05-7 | UNII:A4F7XWQ48V | CTT-1298 | PubChem CID:86297087
+BMGC_DG16112,BMG_DG204861,"UNII:4N6KQ7D685 | PubChem SID:461432867 | PubChem CID:86298636 | CAS RN:1637394-01-4 | Gdc-0134 | 3-(difluoromethoxy)-5-[2-(3,3-difluoropyrrolidin-1-yl)-6-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrimidin-4-yl]pyridin-2-amine | GDC-0134"
+BMGC_DG16113,BMG_DG204869,CAS RN:1628106-94-4 | [(3R)-1-(2-ethoxy-2-oxoethyl)-1-methylpyrrolidin-1-ium-3-yl] (2R)-2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide | SOFPIRONIUM BROMIDE | PubChem SID:316913960 | NDC:83723-010 | UNII:7B2Y1932XU | PubChem CID:86301316 | Sofpironium bromide
+BMGC_DG16114,BMG_DG204871,Cipepofol | CAS RN:1637741-58-2 | PubChem SID:383470461 | PubChem CID:86301664 | CIPEPOFOL | UNII:M3WGS532VY | 2-[(1R)-1-cyclopropylethyl]-6-propan-2-ylphenol
+BMGC_DG16115,BMG_DG204873,"UNII:4SP7R879Y5 | Dalmelitinib | PubChem CID:86302574 | 9-[[8-fluoro-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]-4-methyl-[1,4]oxazino[3,2-c]quinolin-3-one | CAS RN:1637658-98-0 | DALMELITINIB | PubChem SID:474493947"
+BMGC_DG16116,BMG_DG204878,"CAS RN:1629853-48-0 | UNII:8ENS5K3JW8 | PubChem CID:86305217 | DALZANEMDOR | (3S,8S,9S,10R,13R,14S,17R)-3,10,13-trimethyl-17-[(2R,5S)-6,6,6-trifluoro-5-hydroxy-5-methylhexan-2-yl]-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ol | PubChem SID:474493485 | Dalzanemdor"
+BMGC_DG16117,BMG_DG204887,EPOXY EXEMESTANE (6-BETA ISOMER) | UNII:T56UME7SVS | CAS RN:152764-31-3 | PubChem CID:86307678 | PubChem SID:485664788 | Epoxy Exemestane (6-Beta Isomer)
+BMGC_DG16118,BMG_DG204906,"2-HYDROXY-3,5-DIIODOBENZOIC ACID | PubChem SID:198970768 | CAS RN:133-91-5 | PubChem CID:8631 | DrugBank ID:DB04674 | 3,5-DIIODOSALICYLIC ACID | UNII:1496OH15B6"
+BMGC_DG16119,BMG_DG204941,"CAS RN:1613225-53-8 | Teixobactin | PubChem CID:86341926 | UNII:LC730GUE72 | (2R)-N-[(2R,3S)-1-[[(2S,3S)-1-[[(2S)-1-[[(3S,6S,9S,12R,13S)-6-[[(5S)-2-amino-4,5-dihydro-1H-imidazol-5-yl]methyl]-3-[(2S)-butan-2-yl]-9,13-dimethyl-2,5,8,11-tetraoxo-1-oxa-4,7,10-triazacyclotridec-12-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-2-[[(2S)-3-hydroxy-2-[[(2S,3S)-3-methyl-2-[[(2R)-2-(methylamino)-3-phenylpropanoyl]amino]pentanoyl]amino]propanoyl]amino]pentanediamide | TEIXOBACTIN | PubChem SID:241180627"
+BMGC_DG16120,BMG_DG204944,"CAS RN:118024-67-2 | 1-METHYL-3-PROPYL-7H-PURINE-2,6-DIONE | PubChem SID:461434937 | UNII:DWZ57272FA | PubChem CID:86344"
+BMGC_DG16121,BMG_DG204951,PubChem SID:319891952 | UNII:6OQJ5L847C | PubChem CID:86346639 | KDM5-C49 | CAS RN:1596348-16-1
+BMGC_DG16122,BMG_DG204961,"CAS RN:122836-35-5 | Sulfentrazone | PubChem SID:198957825 | UNII:7TY7WT1599 | N-[2,4-dichloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]phenyl]methanesulfonamide | PubChem CID:86369 | SULFENTRAZONE"
+BMGC_DG16123,BMG_DG204976,NDC:80814-0002 | NDC:43742-1971 | NDC:51885-9489 | UNII:73Y7P0K73Y | NDC:73399-002 | PubChem CID:864 | NDC:43742-2207 | NDC:62795-9489 | NDC:80814-0001 | CAS RN:62-46-4 | ALPHA LIPOIC ACID | NDC:43742-1326 | NDC:43742-1665 | PubChem SID:175271419 | NDC:43742-2177 | NDC:74550-0001 | Thioctic Acid | CAS RN:1077-28-7 | 5-(dithiolan-3-yl)pentanoic acid
+BMGC_DG16124,BMG_DG204977,naphthalen-1-amine | CAS RN:25168-10-9 | 1-Naphthylamine | PubChem SID:198935031 | CAS RN:134-32-7 | 1-NAPHTHYLAMINE | PubChem CID:8640 | UNII:9753I242R5
+BMGC_DG16125,BMG_DG204983,"UNII:3BN7M937V8 | N-[1-[(6-chloropyridin-3-yl)methyl]-4,5-dihydroimidazol-2-yl]nitramide | PubChem CID:86418 | CAS RN:138261-41-3 | Imidacloprid | DrugBank ID:DB11421 | IMIDACLOPRID | PubChem SID:175268391 | N-[1-[(6-chloro-3-pyridinyl)methyl]-4,5-dihydroimidazol-2-yl]nitramide | CAS RN:105827-78-9"
+BMGC_DG16126,BMG_DG204984,"CAS RN:134-46-3 | 5-fluoro-2'-deoxyuridine-5'-monophosphate | PubChem SID:346537799 | DrugBank ID:DB03761 | UNII:7CJ707H131 | CAS RN:88410-68-8 | FOSIFLOXURIDINE | PubChem CID:8642 | Fluorodeoxyuridylate | [(2R,3S,5R)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate"
+BMGC_DG16127,BMG_DG204994,8-azaguanine | PubChem CID:8646 | DrugBank ID:DB01667
+BMGC_DG16128,BMG_DG204999,"UNII:A7E6112E4N | CAS RN:58-95-7 | NDC:81279-103 | PubChem SID:175268667 | NDC:81279-102 | Alpha-Tocopherol Acetate | PubChem CID:86472 | DrugBank ID:DB14002 | NDC:84460-903 | [(2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] acetate | .ALPHA.-TOCOPHEROL ACETATE, D- | NDC:59088-660 | NDC:15370-250 | CAS RN:52225-20-4 | NDC:59088-659 | CAS RN:54-22-8"
+BMGC_DG16129,BMG_DG205002,"PubChem SID:252165471 | PubChem CID:86488 | CAS RN:55511-44-9 | AMINOGLUTETHIMIDE, (R)- | UNII:LUC985IS6T"
+BMGC_DG16130,BMG_DG205004,"1,2-diphenylethane-1,2-dione | UNII:S85X61172J | CAS RN:134-81-6 | PubChem SID:198960195 | BENZIL | Benzil | PubChem CID:8651 | CAS RN:103852-36-4"
+BMGC_DG16131,BMG_DG205020,Avoralstat | CAS RN:918407-35-9 | DrugBank ID:DB12120 | 3-[2-[(4-carbamimidoylphenyl)carbamoyl]-4-ethenyl-5-methoxyphenyl]-6-(cyclopropylmethylcarbamoyl)pyridine-2-carboxylic acid | UNII:UX17773O15 | PubChem CID:86566678 | PubChem SID:249492059 | AVORALSTAT
+BMGC_DG16132,BMG_DG205024,"10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one | FENEBRUTINIB | Fenebrutinib | DrugBank ID:DB14785 | CAS RN:1434048-34-6 | UNII:E9L2885WUL | PubChem CID:86567195 | PubChem SID:346540690"
+BMGC_DG16133,BMG_DG205043,"(7S)-3-fluoro-4-[3-(8-fluoro-1-methyl-2,4-dioxoquinazolin-3-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-6,7,8,9-tetrahydro-5H-carbazole-1-carboxamide | Bms-986142 | PubChem SID:329903975 | PubChem CID:86582336 | DrugBank ID:DB15291 | CAS RN:1643368-58-4 | UNII:PJX9GH268R | BMS-986142"
+BMGC_DG16134,BMG_DG205142,2-Naphthol | PubChem CID:8663 | naphthalen-2-ol | BETANAPHTHOL | CAS RN:135-19-3 | UNII:P2Z71CIK5H | PubChem SID:198953959 | CAS RN:26716-78-9
+BMGC_DG16135,BMG_DG205158,"CAS RN:1352226-88-0 | 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-(S-methylsulfonimidoyl)cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b]pyridine | PubChem CID:86660217 | imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane"
+BMGC_DG16136,BMG_DG205161,CAS RN:1357576-48-7 | AZD-4320 | PubChem SID:443625100 | UNII:LH1ZTY91OR | PubChem CID:86661883
+BMGC_DG16137,BMG_DG205166,METHAPYRILENE HYDROCHLORIDE | Methapyrilene | PubChem SID:198947367 | UNII:00S42N58OM | DrugBank ID:DB04819 | PubChem CID:8667 | CAS RN:135-23-9
+BMGC_DG16138,BMG_DG205172,"6-(2-chloro-6-methylpyridin-4-yl)-5-(4-fluorophenyl)-1,2,4-triazin-3-amine | IMARADENANT | PubChem SID:404859292 | PubChem CID:86676119 | UNII:770140J08A | CAS RN:1321514-06-0 | Imaradenant"
+BMGC_DG16139,BMG_DG205175,"PubChem CID:86677874 | (4R)-4-[3-[(1S)-1-(4-amino-3-methylpyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl]pyrrolidin-2-one | Parsaclisib | PubChem SID:346540321 | PARSACLISIB | DrugBank ID:DB14867 | UNII:OS7097575K | CAS RN:1426698-88-5"
+BMGC_DG16140,BMG_DG205205,PubChem SID:198939341 | DrugBank ID:DB02175 | CAS RN:87205-08-1 | CAS RN:141-82-2 | MALONIC ACID | PubChem CID:867 | CAS RN:63524-05-0 | Malonic acid | propanedioic acid | UNII:9KX7ZMG0MK
+BMGC_DG16141,BMG_DG205210,"PubChem CID:86705695 | PEMIGATINIB | DrugBank ID:DB15102 | CAS RN:1513857-77-6 | PubChem SID:363908392 | 11-(2,6-difluoro-3,5-dimethoxyphenyl)-13-ethyl-4-(morpholin-4-ylmethyl)-5,7,11,13-tetrazatricyclo[7.4.0.02,6]trideca-1,3,6,8-tetraen-12-one | Pemigatinib | NDC:50881-026 | UNII:Y6BX7BL23K | NDC:50881-027 | NDC:50881-028"
+BMGC_DG16142,BMG_DG205213,PubChem SID:346540374 | GSK-2881078 | 1-[(2R)-1-methylsulfonylpropan-2-yl]-4-(trifluoromethyl)indole-5-carbonitrile | PubChem CID:86709174 | UNII:47M5ZXU844 | Gsk2881078 | CAS RN:1539314-06-1
+BMGC_DG16143,BMG_DG205227,PubChem CID:86721856 | CAS RN:1415823-49-2 | 1-(4-(((6-Amino-5-(4-phenoxyphenyl)pyrimidin-4-yl)amino)methyl)-4-fluoropiperidin-1-yl)prop-2-en-1-one | 1-[4-[[[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino]methyl]-4-fluoropiperidin-1-yl]prop-2-en-1-one
+BMGC_DG16144,BMG_DG205257,"PubChem SID:348481362 | Gs-9901 | 2,4-diamino-6-[[(S)-(5-chloro-8-fluoro-4-oxo-3-pyridin-3-ylquinazolin-2-yl)-cyclopropylmethyl]amino]pyrimidine-5-carbonitrile | CAS RN:1640247-87-5 | GS-9901 | PubChem CID:86763204 | UNII:U09Q76B8VK"
+BMGC_DG16145,BMG_DG205301,DIAZOAMINOBENZENE | CAS RN:136-35-6 | PubChem SID:198991168 | UNII:5T4EEW75HJ | PubChem CID:8689
+BMGC_DG16146,BMG_DG205313,"4-(2,5-dioxopyrrol-1-yl)benzoic acid | PubChem CID:86925 | PubChem SID:474490761 | 4-(2,5-DIOXOPYRROL-1-YL)BENZOIC ACID | CAS RN:17057-04-4 | UNII:79D4NT6S3E"
+BMGC_DG16147,BMG_DG205325,2-OXOHEPTANEDIOIC ACID | CAS RN:17126-90-8 | PubChem CID:86962 | PubChem SID:461434928 | UNII:C9WK7H3LKX
+BMGC_DG16148,BMG_DG205337,4-HYDROXYBENZENEACETAMIDE | PubChem SID:241177599 | PubChem CID:86986 | UNII:0HY0N4ITN4 | CAS RN:17194-82-0
+BMGC_DG16149,BMG_DG205355,DrugBank ID:DB08132 | PubChem SID:438787863 | PubChem CID:87031 | 5-HYDROXYNAPHTHALENE-1-SULFONAMIDE | 5-hydroxynaphthalene-1-sulfonamide | UNII:5MS1N9V1FR | CAS RN:17286-26-9
+BMGC_DG16150,BMG_DG205364,"PubChem CID:87052 | PubChem SID:485663114 | UNII:JW87Q22JDK | CAS RN:17328-16-4 | SULFONE, BIS((4-CHLOROACETYLAMINO)PHENYL) | Sulfone, bis((4-chloroacetylamino)phenyl)"
+BMGC_DG16151,BMG_DG205365,(2S)-2-[4-[2-[3-(fluoromethyl)azetidin-1-yl]ethoxy]phenyl]-3-(3-hydroxyphenyl)-4-methyl-2H-chromen-6-ol | PubChem SID:461433625 | CAS RN:2100830-77-9 | CAS RN:1642297-01-5 | DrugBank ID:DB14934 | UNII:ST9B0EMC0H | Gdc-0927 | PubChem CID:87055263 | GDC-0927
+BMGC_DG16152,BMG_DG205367,"2-[3-[4-amino-6-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]-2-(hydroxymethyl)phenyl]-6-cyclopropyl-8-fluoroisoquinolin-1-one | CAS RN:1646608-10-7 | PubChem SID:478838850 | PubChem CID:87056204 | UNII:PZP2D7F6L5 | Sofnobrutinib | SOFNOBRUTINIB"
+BMGC_DG16153,BMG_DG205373,"1,3-benzothiazol-2-amine | CAS RN:102337-98-4 | CAS RN:84293-42-5 | CAS RN:136-95-8 | PubChem CID:8706 | 2-Aminobenzothiazole | UNII:08K5TLY3EQ | PubChem SID:198953902 | 2-AMINOBENZOTHIAZOLE"
+BMGC_DG16154,BMG_DG205421,UNII:FMJ30GB9J6 | CAS RN:17422-32-1 | PubChem SID:377308323 | 5-CHLOROINDOLE | PubChem CID:87110
+BMGC_DG16155,BMG_DG205423,UNII:M4E7MR63DA | 6-CHLOROINDOLE | 6-Chloroindole | CAS RN:17422-33-2 | PubChem SID:474490181 | PubChem CID:87111
+BMGC_DG16156,BMG_DG205424,CHROMONE-3-CARBOXALDEHYDE | PubChem SID:474490813 | PubChem CID:87112 | CAS RN:17422-74-1 | UNII:BLA42VBH65 | Chromone-3-carboxaldehyde
+BMGC_DG16157,BMG_DG205456,PubChem CID:87152 | 6-(Methylsulfonyl)-2-benzothiazolamine | UNII:JVA34UM59P | CAS RN:17557-67-4 | 6-(METHYLSULFONYL)-2-BENZOTHIAZOLAMINE | PubChem SID:485662606
+BMGC_DG16158,BMG_DG205491,"CAS RN:499-40-1 | 6-[[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol | 6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol | CAS RN:28447-39-4 | CAS RN:6614-35-3 | PubChem CID:872 | CAS RN:71184-87-7"
+BMGC_DG16159,BMG_DG205564,"PubChem SID:198952429 | Dextrothyroxine | DrugBank ID:DB00509 | CAS RN:51-49-0 | PubChem CID:8730 | (2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid | UNII:4W9K63FION | DEXTROTHYROXINE"
+BMGC_DG16160,BMG_DG205617,"2,3,4,9-TETRAHYDRO-6-METHOXY-1H-PYRIDO(3,4-B)INDOL-1-ONE | UNII:39TAX3LQ5V | CAS RN:17952-87-3 | PubChem SID:485661623 | 2,3,4,9-Tetrahydro-6-methoxy-1H-pyrido[3,4-b]indol-1-one | PubChem CID:87372"
+BMGC_DG16161,BMG_DG205630,CARZENIDE | UNII:30Z5HQB5A4 | CAS RN:138-41-0 | PubChem SID:198966106 | PubChem CID:8739
+BMGC_DG16162,BMG_DG205647,"5-(3-(Dimethylamino)propyl)-5H-dibenzo(a,d)cyclohepten-5-ol | PubChem SID:461432625 | 5-(3-(DIMETHYLAMINO)PROPYL)-5H-DIBENZO(A,D)CYCLOHEPTEN-5-OL | UNII:T0G51SY89M | CAS RN:18029-54-4 | PubChem CID:87418"
+BMGC_DG16163,BMG_DG205653,UNII:L66K25GN4V | PubChem CID:87425 | 5-PHENYL-1H-TETRAZOLE | PubChem SID:198935200 | CAS RN:18039-42-4
+BMGC_DG16164,BMG_DG205655,PubChem SID:377309174 | CAS RN:138-60-3 | PubChem CID:8743 | CHELIDAMIC ACID | UNII:1A59BH8SXE
+BMGC_DG16165,BMG_DG205677,"(4S)-4-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]hexanoyl]amino]-5-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[1-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-2-methyl-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-oxopentanoic acid | PubChem CID:87453228 | DrugBank ID:DB14027 | CAS RN:275371-94-3 | CID 87453228"
+BMGC_DG16166,BMG_DG205692,PubChem CID:8747 | DrugBank ID:DB03975 | Mercuribenzoic Acid
+BMGC_DG16167,BMG_DG205713,UNII:7JCD6XG3XY | PubChem SID:363907857 | HEXYL ANTHRANILATE | PubChem CID:87500 | CAS RN:18189-05-4
+BMGC_DG16168,BMG_DG205722,PubChem SID:438787589 | CAS RN:18228-17-6 | N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE | PubChem CID:87517 | DrugBank ID:DB08240 | NAPHTHOLAS-EPHOSPHATE | UNII:H6R6B93QFC
+BMGC_DG16169,BMG_DG205734,PubChem CID:8754 | PubChem SID:198954699 | benzyl-dodecyl-dimethylazanium | BENZODODECINIUM ION | DrugBank ID:DB13282 | Benzododecinium | CAS RN:5459-84-7 | CAS RN:1340-95-0 | UNII:N0BN0O8CSL | CAS RN:10328-35-5
+BMGC_DG16170,BMG_DG205747,CAS RN:16287-71-1 | DrugBank ID:DB13774 | PubChem CID:8756 | benzyl-dimethyl-tetradecylazanium | CAS RN:5285-67-6 | Benzyldimethyltetradecylammonium | PubChem SID:198947184 | UNII:I5M8YK41GK | MYRISTALKONIUM ION
+BMGC_DG16171,BMG_DG205748,DrugBank ID:DB14518 | Aluminum acetate | Aluminum Acetate | UNII:80EHD8I43D | CAS RN:139-12-8 | PubChem CID:8757 | PubChem SID:175266583 | aluminum;triacetate | ALUMINUM ACETATE
+BMGC_DG16172,BMG_DG205752,UNII:KA90006V9D | PubChem SID:198937433 | Nitrilotriacetic acid | DrugBank ID:DB03040 | 2-[bis(carboxymethyl)amino]acetic acid | CAS RN:139-13-9 | NITRILOTRIACETIC ACID | PubChem CID:8758 | CAS RN:80751-51-5 | CAS RN:49784-42-1
+BMGC_DG16173,BMG_DG205757,CAS RN:139-33-3 | PubChem SID:175268341 | Edetate disodium anhydrous | EDETATE DISODIUM ANHYDROUS | UNII:8NLQ36F6MM | CAS RN:69772-70-9 | disodium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate | PubChem CID:8759 | DrugBank ID:DB14600 | Ethylenediaminetetraacetic acid disodium salt
+BMGC_DG16174,BMG_DG205763,PubChem SID:175271549 | CAS RN:7005-18-7 | CAS RN:26062-47-5 | Racemethionine | CAS RN:33807-07-7 | RACEMETHIONINE | PubChem CID:876 | DrugBank ID:DB13972 | 2-amino-4-methylsulfanylbutanoic acid | CAS RN:59-51-8 | UNII:73JWT2K6T3
+BMGC_DG16175,BMG_DG205770,"PubChem SID:445499785 | UNII:84KQ4M4N8B | CAS RN:775274-06-1 | Azd-9684 | (2S,3R)-2-[(6-aminopyridin-3-yl)methyl]-3-sulfanylbutanoic acid | AZD-9684 | PubChem CID:87609775"
+BMGC_DG16176,BMG_DG205771,UNII:1J484QFI1O | DrugBank ID:DB03709 | 2-[bis(2-hydroxyethyl)amino]acetic acid | CAS RN:150-25-4 | PubChem SID:198940799 | PubChem CID:8761 | Bicine | BICINE
+BMGC_DG16177,BMG_DG205793,"CAS RN:85-61-0 | CAS RN:143180-18-1 | Coenzyme A | PubChem SID:175267886 | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate | UNII:SAA04E81UX | COENZYME A | DrugBank ID:DB01992 | PubChem CID:87642"
+BMGC_DG16178,BMG_DG205802,"2-(1,3-thiazol-2-yl)ethanamine | CAS RN:18453-07-1 | 2-(2-Aminoethyl)thiazole | CAS RN:56933-57-4 | PubChem CID:87653"
+BMGC_DG16179,BMG_DG205816,"CAS RN:139-85-5 | PubChem SID:175266037 | UNII:4PVP2HCH4T | PROTOCATECHUALDEHYDE | DrugBank ID:DB11268 | 3,4-dihydroxybenzaldehyde | PubChem CID:8768 | Protocatechualdehyde"
+BMGC_DG16180,BMG_DG205839,PubChem SID:175271957 | UNII:6326W0DRHY | PubChem CID:8771 | (7-ethyl-2-methylundecan-4-yl) hydrogen sulfate | NDC:67457-162 | CAS RN:300-52-7 | TETRADECYL HYDROGEN SULFATE (ESTER) | DrugBank ID:DB11328 | NDC:51662-1562 | Tetradecyl hydrogen sulfate (ester) | NDC:67457-163 | NDC:51662-1563
+BMGC_DG16181,BMG_DG205851,CAS RN:18625-22-4 | PubChem CID:87731 | D-LEUCYLGLYCYLGLYCINE | UNII:MU2CH7XB2S
+BMGC_DG16182,BMG_DG205855,"UNII:MK8G23M5G6 | PubChem SID:485666257 | PubChem CID:87739 | 2-NAPHTHALENECARBOXAMIDE, N-(4-(2,4-BIS(1,1-DIMETHYLPROPYL)PHENOXY)BUTYL)-1-HYDROXY-4-(4-NITROPHENOXY)- | CAS RN:18643-47-5 | 2-Naphthalenecarboxamide, N-[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]butyl]-1-hydroxy-4-(4-nitrophenoxy)-"
+BMGC_DG16183,BMG_DG205866,PubChem CID:87754 | 2-Bromophenylacetic acid | UNII:ET8T4B2RZF | PubChem SID:485662125 | CAS RN:18698-97-0 | 2-BROMOPHENYLACETIC ACID
+BMGC_DG16184,BMG_DG205883,PubChem SID:175266232 | PubChem CID:8778 | LAURYL SULFATE | Dodecyl sulfate | DrugBank ID:DB03967 | Lauryl sulfate | UNII:DIQ16UC154 | dodecyl hydrogen sulfate | CAS RN:151-41-7
+BMGC_DG16185,BMG_DG205893,Methanethiol | CAS RN:74-93-1 | UNII:2X8406WW9I | methanethiol | PubChem CID:878 | METHYL MERCAPTAN | CAS RN:17719-48-1 | PubChem SID:175266948
+BMGC_DG16186,BMG_DG205929,CAS RN:2986-22-3 | PubChem SID:474491972 | Butyl carbamimidothioate | PubChem CID:87862 | UNII:BTH3PUH3B2 | BUTYL CARBAMIMIDOTHIOATE
+BMGC_DG16187,BMG_DG205930,magnesium;(2S)-2-aminobutanedioate;hydron | UNII:082H981FMA | PubChem SID:198976639 | Magnesium L-aspartate | PubChem CID:87869 | CAS RN:18962-61-3 | MAGNESIUM ASPARTATE ANHYDROUS
+BMGC_DG16188,BMG_DG205933,CAS RN:103-40-2 | MONOBENZYL SUCCINATE | PubChem SID:198936261 | UNII:R1X1431M4O | PubChem CID:8788
+BMGC_DG16189,BMG_DG205948,CAS RN:19012-03-4 | 1-METHYL-1H-INDOLE-3-CARBALDEHYDE | PubChem CID:87894 | PubChem SID:461432815 | UNII:Z612E3VMZ5
+BMGC_DG16190,BMG_DG205953,"PubChem CID:87901 | 2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone | DrugBank ID:DB02813 | 2-ACETAMIDO-2-DEOXY-D-GLUCONO-1,5-LACTONE | CAS RN:19026-22-3 | UNII:09ICI1V6AX | PubChem SID:440089174"
+BMGC_DG16191,BMG_DG205964,UNII:CY3Y2W2RLN | N4-ACETYLSULFAGUANIDINE | PubChem CID:87925 | CAS RN:19077-97-5 | PubChem SID:374388088
+BMGC_DG16192,BMG_DG206020,PubChem SID:175268117 | UNII:722KLD7415 | 2-oxopropanal | DrugBank ID:DB03587 | PubChem CID:880 | CAS RN:51252-84-7 | PYRUVALDEHYDE | Pyruvaldehyde | CAS RN:78-98-8
+BMGC_DG16193,BMG_DG206027,CAS RN:19335-11-6 | PubChem SID:376072401 | 5-AMINOINDAZOLE | UNII:A5B06TDT72 | PubChem CID:88012
+BMGC_DG16194,BMG_DG206046,CAS RN:19427-28-2 | N-Formyl-L-aspartic acid | PubChem CID:88052 | (2S)-2-formamidobutanedioic acid
+BMGC_DG16195,BMG_DG206052,(2S)-2-acetamidopropanoic acid | PubChem SID:198948893 | CAS RN:110294-55-8 | CAS RN:97-69-8 | N-Acetyl-L-alanine | PubChem CID:88064 | DrugBank ID:DB02518 | N-Acetylalanine | UNII:26C4VY6Z0M | N-ACETYLALANINE
+BMGC_DG16196,BMG_DG206060,"PubChem CID:88079 | (2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoic acid | CAS RN:19461-38-2 | N-Glycyl-L-isoleucine"
+BMGC_DG16197,BMG_DG206088,"4-tert-Octylphenol | PubChem SID:198953991 | 4-TERT-OCTYLPHENOL | 4-(2,4,4-trimethylpentan-2-yl)phenol | CAS RN:140-66-9 | UNII:IOY9FVU3J3 | PubChem CID:8814"
+BMGC_DG16198,BMG_DG206089,"CAS RN:6281-57-8 | UNII:CBT5NEC8SY | PubChem CID:881405 | 1-BENZOYL-3-(2,5-DICHLORO-PHENYL)-THIOUREA | PubChem SID:384647824"
+BMGC_DG16199,BMG_DG206171,PubChem CID:8830 | DrugBank ID:DB13332 | DIBUTYL SUCCINATE | CAS RN:141-03-7 | PubChem SID:198942526 | Dibutyl succinate | UNII:Q050512U41 | dibutyl butanedioate
+BMGC_DG16200,BMG_DG206195,"1,2,4-Benzotriazin-3-amine | UNII:R9N3TLB6WH | PubChem CID:88336 | PubChem SID:475550373 | CAS RN:20028-80-2 | 1,2,4-BENZOTRIAZIN-3-AMINE"
+BMGC_DG16201,BMG_DG206256,"beta-CITRONELLOL, (+/-)- | PubChem SID:175271762 | .BETA.-CITRONELLOL, (±)- | PubChem CID:8842 | CAS RN:26489-01-0 | CAS RN:106-22-9 | UNII:565OK72VNF | .BETA.-CITRONELLOL, (+/-)- | 3,7-dimethyloct-6-en-1-ol"
+BMGC_DG16202,BMG_DG206277,PubChem CID:88450 | 3-DIBENZOFURANOL | CAS RN:20279-16-7 | 3-Dibenzofuranol | PubChem SID:485662231 | UNII:C9JQ848XHS
+BMGC_DG16203,BMG_DG206295,PubChem CID:88505 | UNII:3V2SVJ99E2 | CAS RN:20357-25-9 | 6-NITROVERATRALDEHYDE | 6-Nitroveratraldehyde | PubChem SID:474490882
+BMGC_DG16204,BMG_DG206333,UNII:76845O8NMZ | ETHYL ACETATE | CAS RN:141-78-6 | Ethyl acetate | PubChem SID:175267363 | ethyl acetate | Ethyl Acetate | PubChem CID:8857
+BMGC_DG16205,BMG_DG206343,PubChem SID:478837472 | UNII:8NX73KU7CZ | 7-Diethylaminocoumarin | PubChem CID:88598 | 7-DIETHYLAMINOCOUMARIN | CAS RN:20571-42-0
+BMGC_DG16206,BMG_DG206346,"CAS RN:1387560-01-1 | PubChem CID:88602735 | UNII:4612B80545 | N-[6-[(3R,6R)-5-amino-3,6-dimethyl-6-(trifluoromethyl)-2H-1,4-oxazin-3-yl]-5-fluoropyridin-2-yl]-3-chloro-5-(trifluoromethyl)pyridine-2-carboxamide | UMIBECESTAT | PubChem SID:375579425 | Umibecestat"
+BMGC_DG16207,BMG_DG206400,"BIS(2,4-DIMETHOXYBENZYL)AMINE | Bis(2,4-dimethoxybenzyl)amine | PubChem CID:88696 | PubChem SID:485661943 | CAS RN:20781-23-1 | UNII:KL52CY83PM"
+BMGC_DG16208,BMG_DG206402,PubChem SID:175266492 | PubChem CID:887 | methanol | CAS RN:170082-17-4 | UNII:Y4S76JWI15 | CAS RN:67-56-1 | Methanol | Methyl Alcohol | METHYL ALCOHOL
+BMGC_DG16209,BMG_DG206409,CAS RN:20826-04-4 | PubChem SID:472407813 | PubChem CID:88707 | UNII:ZDB972TSH7 | 5-BROMONICOTINIC ACID | 5-Bromonicotinic acid
+BMGC_DG16210,BMG_DG206414,2-PYRIDONE | 2-Hydroxypyridine | CAS RN:72762-00-6 | CAS RN:142-08-5 | CAS RN:66396-89-2 | 1H-pyridin-2-one | UNII:6770O3A2I5 | PubChem CID:8871 | PubChem SID:198972677 | CAS RN:930-70-1
+BMGC_DG16211,BMG_DG206434,CAS RN:20980-22-7 | 2-(1-Piperazinyl)pyrimidine | 1-(2-PYRIMIDINYL)PIPERAZINE | UNII:H3B5B38F56 | 2-piperazin-1-ylpyrimidine | CAS RN:125523-53-7 | PubChem SID:198935137 | PubChem CID:88747
+BMGC_DG16212,BMG_DG206463,PubChem CID:888 | NDC:48951-6044 | CAS RN:22537-22-0 | Magnesium cation | CAS RN:133361-35-0 | MAGNESIUM CATION | PubChem SID:175267495 | NDC:48951-5145 | DrugBank ID:DB01378 | UNII:T6V3LHY838 | Magnesium Cation | CAS RN:102781-35-1 | magnesium(2+)
+BMGC_DG16213,BMG_DG206471,"CAS RN:19356-17-3 | (1S,3Z)-3-[2-[(1R,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol | 25-OH-Vitamin D3 | PubChem CID:88810851"
+BMGC_DG16214,BMG_DG206492,"PubChem SID:375579223 | CAS RN:21316-30-3 | UNII:Z6QS1AG93Q | PubChem CID:88868 | 2,4-Diamino-5,6-dihydro-6,6-dimethyl-5-(4'-methoxyphenyl)-s-triazine | 2,4-DIAMINO-5,6-DIHYDRO-6,6-DIMETHYL-5-(4'-METHOXYPHENYL)-S-TRIAZINE | 1-(4-methoxyphenyl)-6,6-dimethyl-1,3,5-triazine-2,4-diamine"
+BMGC_DG16215,BMG_DG206498,"PubChem CID:8888 | 3,7,11-trimethyldodeca-1,6,10-trien-3-ol | Nerolidol"
+BMGC_DG16216,BMG_DG206499,"5,7-Dimethoxyflavone | 5,7-DIMETHOXYFLAVONE | PubChem SID:472388697 | 5,7-dimethoxy-2-phenylchromen-4-one | PubChem CID:88881 | UNII:J8HQQ4R4F2 | CAS RN:21392-57-4"
+BMGC_DG16217,BMG_DG206537,Tetrahydropyran | TETRAHYDROPYRAN | PubChem SID:198955097 | DrugBank ID:DB02412 | PubChem CID:8894 | UNII:V06I3ILG6B | CAS RN:142-68-7
+BMGC_DG16218,BMG_DG206552,CAS RN:21598-06-1 | PubChem SID:472411435 | PubChem CID:88958 | UNII:5XP5R85YFD | 5-HYDROXYINDOLE-2-CARBOXYLIC ACID
+BMGC_DG16219,BMG_DG206554,PubChem CID:8896 | DrugBank ID:DB13996 | PubChem SID:175266717 | UNII:0E95JZY48K | magnesium;diacetate | CAS RN:142-72-3 | MAGNESIUM ACETATE | Magnesium acetate
+BMGC_DG16220,BMG_DG206581,"FYTIC ACID | CAS RN:83-86-3 | PubChem CID:890 | CAS RN:33705-24-7 | DrugBank ID:DB14981 | Phytic acid | UNII:7IGF0S7R8I | (2,3,4,5,6-pentaphosphonooxycyclohexyl) dihydrogen phosphate | PubChem SID:175266647"
+BMGC_DG16221,BMG_DG206635,"PubChem SID:198947440 | 5-(aziridin-1-yl)-2,4-dinitrobenzamide | CAS RN:21919-05-1 | UNII:7865D5D01M | Tretazicar | DrugBank ID:DB04253 | PubChem CID:89105 | TRETAZICAR"
+BMGC_DG16222,BMG_DG206638,PYRAZOLONE T | PubChem CID:89113 | UNII:2A9HS5E9L7 | CAS RN:118-47-8 | PubChem SID:375083909
+BMGC_DG16223,BMG_DG206646,CAS RN:143-08-8 | NONYL ALCOHOL | Nonan-1-Ol | PubChem SID:198971898 | PubChem CID:8914 | 1-Nonanol | UNII:NGK73Q6XMC | DrugBank ID:DB03143 | nonan-1-ol | CAS RN:28473-21-4
+BMGC_DG16224,BMG_DG206658,CAS RN:2016-57-1 | DECYLAMINE | PubChem CID:8916 | PubChem SID:198988081 | UNII:M9KKQ6ZZG9
+BMGC_DG16225,BMG_DG206661,UNII:A2H8YRB236 | PubChem SID:474489715 | DECYL MERCAPTAN | DECANE-1-THIOL | PubChem CID:8917 | CAS RN:143-10-2 | Decyl mercaptan | DrugBank ID:DB07611
+BMGC_DG16226,BMG_DG206665,4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE | PubChem CID:891831 | DrugBank ID:DB08202
+BMGC_DG16227,BMG_DG206670,"INOSITOL | CHIRO-INOSITOL, (-)- | CAS RN:488-59-5 | PubChem SID:313390004 | PubChem SID:313389895 | UNII:M94176HJ2F | UNII:9O6Y5O4P9W | CAS RN:488-58-4 | CAS RN:41546-34-3 | CAS RN:551-72-4 | PubChem SID:175266780 | PubChem SID:198941980 | SCYLLO-INOSITOL | PubChem SID:316911160 | PubChem SID:313390029 | EPI-INOSITOL | Inositol | ALLO-INOSITOL | PubChem SID:313389858 | UNII:6R79WV4R10 | DrugBank ID:DB15350 | CAS RN:488-54-0 | CAS RN:87-89-8 | CAS RN:643-10-7 | CAS RN:576-63-6 | UNII:R1Y9F3N15A | UNII:63GQX5QW03 | NEO-INOSITOL | UNII:4L6452S749 | CIS-INOSITOL | scyllo-inositol | CHIRO-INOSITOL, (+)- | UNII:8LQ63P85IC | PubChem SID:313389869 | CAS RN:643-12-9 | UNII:587A93P465 | PubChem SID:313390089 | UNII:1VS4X81277 | PubChem SID:313390132 | DrugBank ID:DB13178 | DrugBank ID:DB03106 | UNII:4661D3JP8D | CHIRO-INOSITOL | CAS RN:488-55-1 | CAS RN:38876-99-2 | MUCO-INOSITOL | CAS RN:6917-35-7 | cyclohexane-1,2,3,4,5,6-hexol | PubChem CID:892"
+BMGC_DG16228,BMG_DG206718,tetraphenylboranuide | CAS RN:4358-26-3 | Tetraphenylborate | UNII:8TYC18K6NX | TETRAPHENYLBORATE | CAS RN:163709-59-9 | PubChem CID:8934 | PubChem SID:198976557
+BMGC_DG16229,BMG_DG206739,"PubChem CID:89420683 | 4-[3-[(1S)-1-(4-amino-3-methylpyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl]pyrrolidin-2-one"
+BMGC_DG16230,BMG_DG206752,UNII:71Q1A3O279 | ethyl 1-[2-(4-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate | ANILERIDINE | PubChem SID:198938328 | Anileridine | CAS RN:144-14-9 | PubChem CID:8944 | DrugBank ID:DB00913
+BMGC_DG16231,BMG_DG206766,PubChem SID:198939451 | METHYLARSONIC ACID | Methylarsonic acid | UNII:J37VJ5709S | CAS RN:124-58-3 | PubChem CID:8948 | CAS RN:4950-59-8 | methylarsonic acid
+BMGC_DG16232,BMG_DG206773,"CAS RN:1429882-07-4 | UNII:2MT30EHI63 | PubChem CID:89495685 | PubChem SID:441097637 | MRX-2843 | 2MT30Ehi63 | 4-[2-(2-cyclopropylethylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol"
+BMGC_DG16233,BMG_DG206790,"PubChem SID:440793445 | CAS RN:1310426-33-5 | PubChem CID:89532783 | 1-[(7S)-5,7-dihydro-4H-thieno[2,3-c]pyran-7-yl]-N-methylmethanamine | Ulotaront | ULOTARONT | UNII:3K6270MG59 | Sep-363856"
+BMGC_DG16234,BMG_DG206794,MKC-8866 | PubChem CID:89542346 | UNII:1NZ0YBP9HB | CAS RN:1338934-59-0 | PubChem SID:381608563
+BMGC_DG16235,BMG_DG206797,CAS RN:1432729-22-0 | UNII:WGY5L2V9GM | MK-8768 | PubChem CID:89545222 | PubChem SID:485665419
+BMGC_DG16236,BMG_DG206800,"PREGNENOLONE | Pregnenolone | PubChem CID:8955 | PubChem SID:175266432 | DrugBank ID:DB02789 | CAS RN:145-13-1 | 1-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone | UNII:73R90F7MQ8"
+BMGC_DG16237,BMG_DG206802,MK-8056 | PubChem CID:89554892 | PubChem SID:485666030 | UNII:CSA5N4ZW6B | CAS RN:1432731-00-4
+BMGC_DG16238,BMG_DG206808,"20.ALPHA.-HYDROXYPROGESTERONE | PubChem CID:8956 | (8S,9S,10R,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | CAS RN:145-14-2 | UNII:45630A64AC | 20-alpha-Dihydroprogesterone | PubChem SID:198988469"
+BMGC_DG16239,BMG_DG206820,UNII:A83P5GDE4Q | 5-BENZYLOXYTRYPTAMINE | PubChem CID:89576 | PubChem SID:474492468 | CAS RN:20776-45-8 | 5-Benzyloxytryptamine
+BMGC_DG16240,BMG_DG206831,NDC:79481-0223 | NDC:70677-0170 | NDC:68196-082 | NDC:49035-442 | NDC:0363-0734 | NDC:56062-873 | NDC:37808-820 | NDC:72288-170 | NDC:0363-0919 | NDC:49035-170 | NDC:68196-029 | NDC:53329-191 | NDC:0363-9250 | NDC:17856-1241 | NDC:49035-873 | NDC:46122-732 | NDC:30142-029 | NDC:70677-0090 | NDC:72288-509 | NDC:72288-077 | NDC:0113-0206 | NDC:43598-487 | NDC:50090-1697 | NDC:30142-309 | NDC:82442-000 | NDC:57237-320 | NDC:59726-935 | NDC:49348-787 | PubChem CID:89594 | NDC:50090-7063 | NDC:41250-529 | NDC:69842-858 | NDC:69842-026 | NDC:56062-504 | NDC:82442-755 | NDC:11822-4973 | NDC:49035-190 | NDC:60505-7066 | NDC:0363-1609 | NDC:0363-0424 | NDC:46122-731 | NDC:50090-1152 | NDC:43598-448 | NDC:11822-1720 | NDC:46122-725 | NDC:11673-727 | NDC:63548-0264 | NDC:70677-0088 | NDC:59779-397 | NDC:0363-0365 | NDC:56062-608 | NDC:69842-430 | NDC:49035-702 | NDC:58602-723 | NDC:68196-194 | NDC:0363-9620 | NDC:49035-365 | NDC:50090-3560 | NDC:11822-0699 | NDC:46122-720 | NDC:49035-854 | NDC:68016-289 | NDC:11822-3622 | NDC:68391-023 | NDC:46122-449 | NDC:58602-854 | NDC:70677-1193 | NDC:82442-029 | NDC:70000-0348 | NDC:84720-456 | NDC:11673-365 | NDC:45802-651 | NDC:49035-957 | NDC:59726-929 | NDC:49035-532 | NDC:72162-2267 | NDC:0363-9260 | NDC:69842-428 | NDC:49348-573 | NDC:72288-292 | NDC:83364-015 | NDC:37808-658 | NDC:82442-500 | NDC:36800-967 | NDC:11822-0903 | NDC:0135-0635 | NDC:11822-0424 | NDC:41250-190 | NDC:69842-587 | NDC:37808-533 | NDC:82442-957 | NDC:63868-848 | NDC:29485-5270 | NDC:69842-564 | NDC:46122-354 | NDC:68016-280 | NDC:0135-0466 | NDC:82966-269 | NDC:63868-732 | NDC:72288-352 | NDC:84720-933 | NDC:37808-461 | NDC:11822-3314 | NDC:0363-7269 | NDC:68016-284 | NDC:72288-532 | NDC:68016-293 | NDC:0363-1608 | NDC:11822-0201 | NDC:59726-262 | NDC:68391-170 | NDC:69842-608 | NDC:49035-194 | NDC:0536-3113 | NDC:49035-415 | NDC:55301-503 | NDC:70000-0343 | NDC:0135-0229 | NDC:70677-1175 | NDC:11822-0755 | NDC:11822-0971 | NDC:68016-087 | NDC:36800-375 | NDC:70677-1266 | NDC:0363-0455 | NDC:36800-170 | NDC:69842-609 | NDC:59450-001 | NDC:36800-032 | NDC:36800-863 | NDC:59450-003 | NDC:68391-029 | NDC:69842-216 | NDC:82442-023 | CAS RN:104062-50-2 | NDC:11673-873 | NDC:11673-532 | NDC:70000-0341 | NDC:11822-0269 | NDC:63868-733 | NDC:43598-982 | NDC:0363-1243 | NDC:49348-853 | NDC:60429-445 | NDC:55301-873 | NDC:82442-741 | NDC:50090-6695 | NDC:30142-797 | NDC:46122-177 | NDC:63981-170 | NDC:0536-1362 | CAS RN:54-11-5 | NDC:63548-0262 | NDC:59779-443 | NDC:41520-792 | NDC:0009-5400 | NDC:37808-863 | NDC:0363-2309 | NDC:60505-7065 | NDC:41250-700 | NDC:46122-718 | NDC:70677-1179 | NDC:41250-587 | NDC:0536-3112 | NDC:63739-368 | NDC:72288-577 | NDC:0363-9580 | NDC:41520-711 | NDC:41520-873 | NDC:17856-1362 | NDC:68016-560 | NDC:0135-0510 | NDC:0113-0734 | NDC:46122-173 | NDC:11673-196 | NDC:68016-286 | NDC:79481-1123 | NDC:70677-1264 | NDC:70677-1265 | NDC:11822-0365 | NDC:49035-493 | NDC:72288-223 | NDC:0363-4049 | NDC:70677-0169 | NDC:11673-424 | NDC:55910-933 | NDC:70000-0347 | NDC:41250-854 | NDC:46122-254 | NDC:11822-0905 | NDC:79481-0301 | NDC:79903-182 | NDC:0363-9590 | NDC:70000-0512 | NDC:0363-0457 | NDC:69842-024 | NDC:49035-791 | NDC:72288-003 | NDC:43598-447 | NDC:55319-966 | NDC:56062-344 | NDC:0363-9290 | NDC:0363-9570 | NDC:72288-029 | NDC:11822-0344 | NDC:21130-522 | NDC:68196-012 | NDC:0363-7103 | NDC:70000-0510 | NDC:0536-3405 | NDC:46122-174 | NDC:0135-2800 | NDC:68391-873 | NDC:0536-1337 | NDC:41250-422 | NDC:0113-2502 | NDC:0536-1107 | NDC:0113-1190 | NDC:68196-957 | NDC:11822-3317 | NDC:41250-206 | NDC:41520-843 | NDC:0536-3029 | NDC:50090-1694 | NDC:45802-957 | UNII:6M3C89ZY6R | NDC:82966-012 | NDC:36800-460 | NDC:0363-1012 | NDC:0135-0195 | NDC:41250-689 | NDC:0135-0475 | NDC:30142-696 | NDC:55910-606 | NDC:70677-0030 | NDC:0363-0451 | NDC:0363-9780 | NDC:36800-344 | NDC:68196-971 | NDC:0363-5770 | NDC:82442-456 | NDC:0135-0636 | NDC:76162-700 | NDC:11822-3326 | NDC:55910-122 | NDC:51316-190 | NDC:83253-262 | NDC:11673-456 | NDC:11822-0854 | NDC:68196-365 | NDC:36800-456 | NDC:0536-1372 | NDC:37808-911 | NDC:11673-953 | NDC:11822-3322 | NDC:66715-8124 | NDC:55741-448 | NDC:11822-0456 | NDC:59779-873 | NDC:37808-682 | NDC:30142-848 | NDC:59726-913 | Nicotine | NDC:43598-486 | NDC:0363-9330 | NDC:56062-503 | NDC:70000-0345 | NDC:37808-821 | NDC:59779-448 | NDC:70677-0089 | NDC:82966-971 | NDC:79903-104 | NDC:30142-344 | NDC:55910-918 | NDC:70677-0031 | NDC:58602-855 | NDC:46122-724 | NDC:0536-1338 | NDC:69842-957 | NDC:0363-1245 | NDC:0009-5401 | NDC:30142-749 | NDC:0135-0158 | NDC:36800-029 | NDC:46122-176 | NDC:0363-0411 | NDC:66715-8123 | NDC:55910-313 | NDC:70677-0085 | NDC:36800-539 | NDC:45802-344 | NDC:82442-124 | NDC:84720-532 | NDC:69842-932 | NDC:70677-1170 | NDC:41250-029 | NDC:11822-3316 | NDC:30142-170 | NDC:79481-0052 | NDC:82442-802 | NDC:41520-734 | NDC:43598-986 | NDC:0135-0474 | NDC:43598-488 | NDC:21130-185 | NDC:0363-3290 | NDC:41250-532 | NICOTINE | NDC:79481-0054 | NDC:0135-0467 | NDC:55910-957 | NDC:55910-796 | NDC:11822-3337 | NDC:36800-038 | NDC:46122-715 | NDC:0363-0262 | NDC:72288-957 | NDC:59779-344 | NDC:11822-0734 | NDC:72162-2288 | NDC:53329-193 | NDC:46122-568 | NDC:41250-424 | NDC:11673-879 | NDC:72162-2266 | NDC:68001-434 | NDC:69842-828 | NDC:0135-0241 | NDC:30142-209 | NDC:0135-0194 | NDC:0363-1420 | NDC:11822-0352 | NDC:55741-447 | NDC:68196-269 | NDC:76162-403 | NDC:11673-971 | NDC:21130-173 | NDC:68391-800 | NDC:0113-0170 | NDC:59779-734 | NDC:62011-0199 | NDC:37808-460 | NDC:46122-352 | NDC:0135-0625 | NDC:45802-089 | NDC:63868-849 | NDC:72288-811 | NDC:46122-734 | NDC:11673-881 | NDC:69842-662 | NDC:49035-352 | NDC:59779-445 | NDC:63868-845 | NDC:72288-442 | NDC:11673-029 | NDC:0363-0979 | NDC:11673-269 | NDC:70000-0342 | NDC:11673-344 | NDC:0363-3911 | NDC:21130-389 | NDC:11822-2128 | NDC:70677-1174 | NDC:0363-0456 | NDC:55301-617 | NDC:83364-016 | NDC:46122-717 | NDC:11822-4974 | NDC:72162-2287 | NDC:37808-909 | NDC:41520-891 | NDC:68016-086 | NDC:68391-309 | NDC:68391-957 | NDC:21130-269 | NDC:56062-429 | NDC:0113-0532 | NDC:0363-1421 | NDC:0363-5760 | NDC:69842-769 | NDC:82649-927 | NDC:82966-002 | NDC:11673-309 | NDC:29485-5271 | NDC:58602-722 | NDC:41250-170 | NDC:46122-353 | NDC:72888-187 | NDC:70000-0346 | NDC:0113-0873 | NDC:11673-206 | NDC:0363-9270 | NDC:41250-734 | NDC:68001-432 | NDC:68016-290 | NDC:55301-504 | NDC:0135-1500 | NDC:37808-753 | NDC:30142-859 | NDC:43598-985 | NDC:70000-0562 | NDC:84720-927 | NDC:55741-446 | NDC:11822-3325 | NDC:0363-7050 | NDC:11673-124 | NDC:55301-428 | NDC:37808-674 | NDC:70677-0086 | NDC:0135-0511 | NDC:0536-5895 | NDC:59726-428 | NDC:63981-190 | NDC:72288-623 | NDC:46122-172 | NDC:0536-5896 | NDC:72288-266 | NDC:37808-707 | NDC:46122-286 | NDC:11822-0904 | NDC:82442-873 | NDC:37808-383 | NDC:72288-206 | NDC:11673-170 | NDC:59726-499 | NDC:0113-1125 | NDC:11673-190 | NDC:49035-029 | NDC:70677-0032 | NDC:46122-284 | NDC:70000-0561 | NDC:11822-3319 | NDC:0135-0196 | NDC:69842-976 | NDC:37808-611 | NDC:70000-0350 | NDC:36800-734 | NDC:21130-229 | NDC:46122-666 | NDC:70000-0511 | NDC:0113-0456 | NDC:36800-650 | NDC:79481-0103 | NDC:0135-0626 | NDC:46122-665 | NDC:49035-195 | NDC:36800-957 | NDC:11822-3990 | NDC:70677-1180 | NDC:43598-485 | NDC:68016-292 | NDC:46122-664 | NDC:69842-217 | NDC:63981-012 | NDC:63868-734 | NDC:79903-127 | NDC:82966-001 | NDC:82442-344 | NDC:57237-322 | NDC:70677-1164 | NDC:69842-025 | NDC:43598-484 | NDC:49348-788 | NDC:36800-532 | NDC:59726-264 | NDC:37808-563 | NDC:70677-1176 | NDC:37808-900 | NDC:72224-870 | NDC:0135-0533 | NDC:0363-7044 | NDC:30142-124 | NDC:30142-873 | NDC:45802-827 | NDC:0536-3387 | NDC:46122-171 | NDC:49035-201 | NDC:60429-444 | NDC:69842-605 | NDC:70677-1165 | NDC:56062-428 | NDC:24385-598 | NDC:0363-7971 | NDC:37808-711 | NDC:72288-190 | NDC:0363-0124 | PubChem SID:175266437 | NDC:68196-873 | NDC:0135-0157 | NDC:49035-456 | NDC:62011-0200 | NDC:82442-170 | NDC:0113-8100 | NDC:72288-808 | NDC:30142-060 | NDC:68016-559 | NDC:72288-344 | NDC:0113-8600 | NDC:69842-964 | NDC:83804-107 | NDC:56062-609 | NDC:0363-1244 | NDC:70000-0117 | NDC:50090-7060 | NDC:70677-0087 | NDC:59726-592 | NDC:21130-700 | NDC:57237-321 | NDC:11822-3379 | NDC:37808-739 | NDC:59779-957 | NDC:70677-1192 | NDC:41520-701 | NDC:68196-811 | NDC:0536-1108 | NDC:70000-0121 | NDC:46122-663 | NDC:63443-5057 | NDC:55301-429 | NDC:11673-195 | NDC:11822-0873 | NDC:46122-719 | NDC:63868-168 | NDC:72288-734 | NDC:41250-873 | NDC:49348-852 | NDC:30142-671 | NDC:41250-637 | NDC:49348-572 | NDC:82442-532 | NDC:57237-323 | NDC:72288-693 | NDC:82442-190 | NDC:37808-948 | NDC:0135-0508 | NDC:0135-0355 | NDC:0536-1241 | NDC:58602-904 | NDC:60505-7088 | NDC:63868-844 | NDC:0113-0344 | NDC:11822-3313 | NDC:63981-309 | NDC:21130-211 | NDC:37808-781 | NDC:11673-957 | NDC:82442-399 | NDC:41520-957 | NDC:82442-490 | NDC:0536-1106 | NDC:60505-7090 | NDC:68016-281 | NDC:66715-8125 | NDC:79481-0053 | NDC:69842-028 | NDC:63739-370 | NDC:0363-0201 | NDC:0363-6011 | NDC:84318-001 | NDC:68196-442 | NDC:30142-208 | NDC:58602-903 | NDC:41250-201 | NDC:11822-3328 | NDC:0113-0854 | DrugBank ID:DB00184 | NDC:0113-0957 | NDC:0363-9610 | NDC:82442-723 | NDC:68016-287 | NDC:11822-0009 | NDC:37808-849 | NDC:0363-7051 | NDC:70677-1167 | NDC:0135-0242 | NDC:41520-352 | NDC:84720-000 | NDC:72288-492 | NDC:82442-971 | NDC:49035-422 | NDC:50090-1154 | NDC:55301-957 | NDC:0113-1352 | NDC:0113-5023 | NDC:79481-1100 | NDC:11673-858 | NDC:49035-900 | NDC:11673-442 | NDC:58602-835 | NDC:41250-957 | NDC:36800-034 | NDC:50090-1148 | NDC:0536-5894 | NDC:55301-734 | NDC:11822-9902 | NDC:21130-820 | NDC:82442-269 | NDC:11822-3323 | NDC:72288-642 | NDC:79481-0100 | NDC:59450-002 | NDC:36800-206 | NDC:82442-123 | NDC:68391-734 | NDC:60429-443 | NDC:70677-1181 | NDC:72288-124 | NDC:49035-124 | NDC:41250-510 | NDC:63868-843 | NDC:0363-9350 | NDC:49035-196 | NDC:72888-186 | NDC:11822-1103 | NDC:70677-1177 | NDC:63739-371 | NDC:50090-7061 | NDC:0536-3386 | NDC:45802-873 | NDC:0363-0873 | NDC:72288-690 | NDC:58602-905 | NDC:0135-0532 | NDC:41250-209 | NDC:63868-167 | NDC:11673-411 | NDC:11822-3315 | NDC:49035-206 | NDC:11822-0170 | NDC:55910-662 | NDC:11822-0957 | NDC:11673-194 | NDC:63739-369 | NDC:0363-0960 | NDC:63981-124 | NDC:46122-716 | 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine | NDC:11822-0029 | NDC:68196-734 | NDC:49035-734 | NDC:50090-6674 | NDC:11822-0124 | NDC:79481-0601 | NDC:49348-691 | NDC:37808-683 | NDC:60505-7064 | NDC:68016-285 | NDC:70000-0344 | NDC:68196-170 | NDC:0113-0029 | NDC:68391-012 | NDC:83253-264 | NDC:11822-2331 | NDC:72288-873 | NDC:11822-1007 | NDC:83364-017 | NDC:63868-735 | NDC:11822-0309 | NDC:43598-983 | NDC:68016-288 | NDC:72288-456 | NDC:0135-0230 | NDC:84720-352 | NDC:49035-309 | NDC:70000-0560 | NDC:11673-734 | NDC:36800-269 | NDC:72224-000 | NDC:53329-192 | NDC:79481-0957 | NDC:63981-344 | NDC:68001-433 | NDC:21130-172 | NDC:60505-7089 | NDC:68196-309 | NDC:70677-1178 | NDC:0220-3657 | NDC:41250-456 | NDC:0363-9240 | NDC:37808-617 | NDC:0363-1130 | NDC:79903-160 | NDC:17856-3030 | NDC:58602-836 | NDC:79903-128 | NDC:46122-733 | NDC:0363-0957 | NDC:79481-0755 | NDC:82442-800 | NDC:43598-446 | NDC:0536-3030 | NDC:46122-448 | NDC:72288-694 | NDC:0363-9310 | NDC:70677-1182 | NDC:70677-1173 | NDC:0536-3404 | NDC:30142-190 | NDC:0536-1239 | NDC:41520-854 | NDC:70677-1166 | NDC:84720-007 | NDC:50090-6383 | NDC:79903-101 | NDC:72288-422 | NDC:63981-873 | NDC:0113-0422 | NDC:46122-255 | NDC:50090-6240 | NDC:55910-532 | NDC:70000-0559 | NDC:43598-984 | NDC:59779-201 | NDC:43598-987 | NDC:0113-0053 | NDC:0363-4190 | NDC:0363-2640 | NDC:11822-4975 | NDC:41250-344 | NDC:63981-029 | NDC:69842-919 | NDC:70677-1172 | NDC:82442-734 | NDC:63868-842 | NDC:0363-0709 | NDC:11822-1649 | NDC:58602-906 | NDC:43598-489 | NDC:11673-422 | NDC:82442-103 | NDC:69842-934 | NDC:84720-854 | NDC:68196-084 | NDC:0363-1825 | NDC:21130-186 | NDC:69842-595 | NDC:68391-344 | NDC:17856-1239 | NDC:36800-873 | NDC:70677-1171
+BMGC_DG16241,BMG_DG206834,NDC:43857-0511 | PubChem SID:175267062 | NDC:44911-0247 | UNII:JL5DK93RCL | DrugBank ID:DB01065 | CAS RN:73-31-4 | NDC:43857-0086 | CAS RN:8041-44-9 | Melatonin | NDC:43742-0771 | PubChem CID:896 | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide | MELATONIN | NDC:44911-0194
+BMGC_DG16242,BMG_DG206840,"PubChem CID:89607 | CAS RN:22134-75-4 | UNII:LBV8HX7GMM | 3,5-Dichlorosulfanilamide | 3,5-DICHLOROSULFANILAMIDE | PubChem SID:485662174"
+BMGC_DG16243,BMG_DG206845,"1-[5-tert-butyl-2-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]pyrazol-3-yl]-3-[(1S,4R)-4-[[3-[(2S)-2-methylpiperidin-1-yl]-[1,2,4]triazolo[4,3-a]pyridin-6-yl]oxy]-1,2,3,4-tetrahydronaphthalen-1-yl]urea | UNII:AM9K4SZ3XK | CAS RN:1443242-46-3 | Urea, N-(1'-(2-(dimethylamino)ethyl)-3-(1,1-dimethylethyl)(1,4'-bi-1H-pyrazol)-5-yl)-N'-((1S,4R)-1,2,3,4-tetrahydro-4-((3-((2S)-2-methyl-1-piperidinyl)-1,2,4-triazolo(4,3-a)pyridin-6-yl)oxy)-1-naphthalenyl)- | PubChem CID:89612265 | PubChem SID:376231404 | CHF-6297"
+BMGC_DG16244,BMG_DG206852,PubChem SID:459055398 | UNII:6GS37SZ47Q | CAS RN:22190-12-1 | 2-(PHENYLTHIO)QUINOLINE | PubChem CID:89621
+BMGC_DG16245,BMG_DG206862,PubChem SID:474489596 | UNII:ZS3LU23BE3 | CAS RN:22268-16-2 | PubChem CID:89644 | ALTERSOLANOL A
+BMGC_DG16246,BMG_DG206874,"4-amino-N-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide | Belvarafenib | UNII:31M3WLJ3KG | PubChem CID:89655386 | CAS RN:1446113-23-0 | PubChem SID:363908760 | BELVARAFENIB"
+BMGC_DG16247,BMG_DG206879,"DrugBank ID:DB13727 | UNII:9TTR0UA2KC | Azapetine | AZAPETINE | PubChem CID:8966 | 6-prop-2-enyl-5,7-dihydrobenzo[d][2]benzazepine | CAS RN:146-36-1 | PubChem SID:198987436"
+BMGC_DG16248,BMG_DG206887,"PubChem CID:89670174 | CAS RN:1446090-79-4 | PubChem SID:317229219 | DrugBank ID:DB14773 | 5-[[(1R,1aS,6bR)-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1a,6b-dihydro-1H-cyclopropa[b][1]benzofuran-5-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one | UNII:8762XZS5ZF | LIFIRAFENIB | Beigene-283 | CAS RN:1446090-77-2"
+BMGC_DG16249,BMG_DG206894,"UNII:3T1SS4E7AG | PubChem CID:89683805 | CAS RN:1802003-09-3 | DrugBank ID:DB13874 | ENASIDENIB | Enasidenib | 2-methyl-1-[[4-[6-(trifluoromethyl)pyridin-2-yl]-6-[[2-(trifluoromethyl)pyridin-4-yl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol | PubChem SID:252164253 | CAS RN:1446502-11-9"
+BMGC_DG16250,BMG_DG206896,"methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate | Yohimbine | CAS RN:103834-06-6 | PubChem CID:8969 | CAS RN:146-48-5 | YOHIMBINE | UNII:2Y49VWD90Q | DrugBank ID:DB01392 | PubChem SID:175266927"
+BMGC_DG16251,BMG_DG206943,UNII:7W7ZUG45G8 | PubChem SID:198958465 | PubChem CID:8974 | 2-CHLOROADENOSINE | CAS RN:146-77-0
+BMGC_DG16252,BMG_DG206946,"PubChem CID:89741565 | RG7800 | CAS RN:1449598-06-4 | 2-(4-ethyl-6-methylpyrazolo[1,5-a]pyrazin-2-yl)-9-methyl-7-(1-methylpiperidin-4-yl)pyrido[1,2-a]pyrimidin-4-one"
+BMGC_DG16253,BMG_DG206950,PubChem SID:198966998 | 2-FLUOROADENOSINE | CAS RN:146-78-1 | PubChem CID:8975 | 2-Fluoroadenosine | UNII:0S67290CRJ | DrugBank ID:DB04441
+BMGC_DG16254,BMG_DG206968,"UNII:9844OS3B0J | Niludipine | CAS RN:22609-73-0 | DrugBank ID:DB09240 | PubChem CID:89767 | NILUDIPINE | bis(2-propoxyethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | PubChem SID:198938675"
+BMGC_DG16255,BMG_DG206970,Guanosine-5'-Diphosphate | DrugBank ID:DB04315 | PubChem CID:8977
+BMGC_DG16256,BMG_DG206987,DESMETHYL TRILACICLIB | PubChem CID:89798202 | UNII:7FEL7S9EY5 | CAS RN:1374743-01-7
+BMGC_DG16257,BMG_DG206989,PubChem SID:461433987 | UNII:NX93J5ZDB7 | PubChem CID:89801 | CAS RN:22711-23-5 | (P-CHLOROPHENYL)PHENYLETHANEDIONE
+BMGC_DG16258,BMG_DG206996,DrugBank ID:DB15431 | CAS RN:1379545-95-5 | UNII:0DXG50I4WD | RUPITASERTIB | 4-[[(1S)-2-(azetidin-1-yl)-1-[4-chloro-3-(trifluoromethyl)phenyl]ethyl]amino]quinazoline-8-carboxamide | Rupitasertib | PubChem SID:377308585 | PubChem CID:89808643 | M-2698
+BMGC_DG16259,BMG_DG207008,"Nafcillin | PubChem SID:175268322 | NAFCILLIN | DrugBank ID:DB00607 | CAS RN:147-52-4 | PubChem CID:8982 | (2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | UNII:4CNZ27M7RV"
+BMGC_DG16260,BMG_DG207036,"PubChem SID:375579360 | DURLOBACTAM | CAS RN:1467829-71-5 | [(2S,5R)-2-carbamoyl-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-en-6-yl] hydrogen sulfate | Durlobactam | UNII:PSA33KO9WA | PubChem CID:89851852"
+BMGC_DG16261,BMG_DG207042,"UNII:URX2UMQ8XV | Conteltinib | CAS RN:1384860-29-0 | 2-[[2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-N-propan-2-ylbenzenesulfonamide | CONTELTINIB | PubChem CID:89860551 | PubChem SID:363908000"
+BMGC_DG16262,BMG_DG207048,PubChem SID:198957017 | Ditiocarb | PubChem CID:8987 | DrugBank ID:DB02520 | DITIOCARB | CAS RN:147-84-2 | diethylcarbamodithioic acid | UNII:99Z2744345
+BMGC_DG16263,BMG_DG207052,PubChem CID:89875987 | PubChem SID:329904191 | Gsk2981278 | UNII:L49V5G013I | GSK-2981278 | N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-(oxan-4-ylmethoxy)benzenesulfonamide | CAS RN:1474110-21-8
+BMGC_DG16264,BMG_DG207055,DrugBank ID:DB02853 | CAS RN:1331908-17-8 | D-Proline | D-proline | PubChem CID:8988 | UNII:L01Q4LGZ5L | (2R)-pyrrolidine-2-carboxylic acid | CAS RN:344-25-2 | D-PROLINE | PubChem SID:438787648
+BMGC_DG16265,BMG_DG207060,UNII:N8Q12KU2SW | 2-chloro-6-methyl-N'-[4-methyl-3-(2-quinolin-3-ylethynyl)benzoyl]benzohydrazide | Vodobatinib | VODOBATINIB | PubChem SID:433968155 | PubChem CID:89884852 | CAS RN:1388803-90-4
+BMGC_DG16266,BMG_DG207076,CAS RN:148-53-8 | UNII:008LR748FI | PubChem SID:317229988 | PubChem CID:8991 | 2-HYDROXY-3-METHOXYBENZALDEHYDE
+BMGC_DG16267,BMG_DG207082,"CAS RN:1527475-61-1 | PubChem CID:89915073 | 1-methyl-4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)pyrrole-2-carbonitrile"
+BMGC_DG16268,BMG_DG207083,"PubChem CID:8992 | CAS RN:148-56-1 | Flumethiazide | FLUMETHIAZIDE | UNII:3PA0CDS0M5 | 1,1-dioxo-6-(trifluoromethyl)-4H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | PubChem SID:198972036"
+BMGC_DG16269,BMG_DG207084,"Voxilaprevir | PubChem CID:89921642 | UNII:0570F37359 | (1R,18R,20R,24S,27S,28S)-24-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-[(1-methylcyclopropyl)sulfonylcarbamoyl]cyclopropyl]-28-ethyl-13,13-difluoro-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide | PubChem SID:252164867 | VOXILAPREVIR | DrugBank ID:DB12026 | CAS RN:1535212-07-7"
+BMGC_DG16270,BMG_DG207093,"4-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol | CAS RN:22972-55-0 | UNII:T4WF2D7YPH | PubChem CID:89949 | PubChem SID:472425871 | 4-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)-5-PENTYL-1,3-BENZENEDIOL"
+BMGC_DG16271,BMG_DG207095,Uridylyl-2'-5'-phospho-guanosine | DrugBank ID:DB04514 | PubChem CID:89950
+BMGC_DG16272,BMG_DG207130,"(3S)-4-[[(4R)-4-(2-chloro-4-fluorophenyl)-5-methoxycarbonyl-2-(1,3-thiazol-2-yl)-1,4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid | CAS RN:1578153-27-1 | PubChem CID:89996234"
+BMGC_DG16273,BMG_DG207162,UNII:K5IZ54DF9G | PubChem CID:90044055 | PubChem SID:319891959 | CAS RN:1575818-46-0 | PRN-694
+BMGC_DG16274,BMG_DG207170,"PubChem CID:90055716 | CAS RN:1496551-77-9 | DrugBank ID:DB15206 | Uprifosbuvir | propan-2-yl (2R)-2-[[[(2R,3R,4R,5R)-4-chloro-5-(2,4-dioxopyrimidin-1-yl)-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate | UNII:JW31KPS26S | UPRIFOSBUVIR | PubChem SID:316911319"
+BMGC_DG16275,BMG_DG207192,CAS RN:1596348-32-1 | PubChem CID:90094283 | KDM5-C70 | UNII:4288BE400F | PubChem SID:333495677
+BMGC_DG16276,BMG_DG207204,PubChem SID:387065409 | 2-[4-[[2-(3-chlorophenyl)-6-(trifluoromethyl)pyridin-4-yl]methyl]phenyl]acetic acid | ZATOLMILAST | CAS RN:1606974-33-7 | UNII:G786V328X6 | Zatolmilast | PubChem CID:90111638
+BMGC_DG16277,BMG_DG207226,DrugBank ID:DB09516 | MEQUINOL | UNII:6HT8U7K3AM | Mequinol | PubChem SID:175266667 | PubChem CID:9015 | 4-methoxyphenol | CAS RN:150-76-5
+BMGC_DG16278,BMG_DG207230,"CAS RN:150-78-7 | 1,4-DIMETHOXYBENZENE | 1,4-Dimethoxybenzene | PubChem CID:9016 | UNII:24WC6T6X0G | CAS RN:42500-66-3 | PubChem SID:198971424 | 1,4-dimethoxybenzene"
+BMGC_DG16279,BMG_DG207235,"UNII:IZ420RT3OY | PubChem SID:198964198 | Citronellyl acetate | CITRONELLYL ACETATE | PubChem CID:9017 | 3,7-dimethyloct-6-enyl acetate | CAS RN:67650-82-2 | CAS RN:150-84-5"
+BMGC_DG16280,BMG_DG207247,4-[(Phenylmethyl)thio]-3-pyridinesulfonamide | UNII:CK3LQ5P7ZA | 4-((PHENYLMETHYL)THIO)-3-PYRIDINESULFONAMIDE | PubChem CID:901953 | PubChem SID:485663647 | CAS RN:353278-70-3
+BMGC_DG16281,BMG_DG207250,4-[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo-1H-quinolin-5-yl)ethyl]amino]butyl 5-[[3-[(S)-[[(3R)-1-azabicyclo[2.2.2]octan-3-yl]oxycarbonylamino]-phenylmethyl]phenoxy]methyl]-1-methylpyrazole-3-carboxylate | CAS RN:1615208-41-7 | PubChem CID:90200922
+BMGC_DG16282,BMG_DG207251,HEXYL NICOTINATE | PubChem CID:90202 | PubChem SID:198942459 | CAS RN:23597-82-2 | UNII:BN07PB44IV
+BMGC_DG16283,BMG_DG207258,"3,6,9,12,15,18-HEXAOXAEICOSANE | PubChem CID:90206 | PubChem SID:472406998 | CAS RN:23601-39-0 | DrugBank ID:DB06867 | UNII:72DU7F2YXZ | 3,6,9,12,15,18-HEXAOXAICOSANE"
+BMGC_DG16284,BMG_DG207297,2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol | DrugBank ID:DB04332 | PubChem CID:90263
+BMGC_DG16285,BMG_DG207314,"UZANSERTIB | N-[(7R)-4-[(3R,4R,5S)-3-amino-4-hydroxy-5-methylpiperidin-1-yl]-7-hydroxy-6,7-dihydro-5H-cyclopenta[b]pyridin-3-yl]-6-(2,6-difluorophenyl)-5-fluoropyridine-2-carboxamide | CAS RN:1620012-39-6 | PubChem SID:404859518 | Uzansertib | PubChem CID:90279868 | UNII:0237X8153Q"
+BMGC_DG16286,BMG_DG207325,PubChem CID:90295 | 6-Amino-1-naphthol | 6-aminonaphthalen-1-ol | CAS RN:23894-12-4
+BMGC_DG16287,BMG_DG207328,UNII:P4TO3C82WV | N-ACETYLSEROTONIN | PubChem SID:198975531 | PubChem CID:903 | N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide | N-Acetyl-5-hydroxytryptamine | CAS RN:1210-83-9 | DrugBank ID:DB04275 | N-acetylserotonin
+BMGC_DG16288,BMG_DG207332,"CAS RN:1611493-60-7 | PubChem SID:252163723 | Bictegravir | BICTEGRAVIR | DrugBank ID:DB11799 | (1S,11R,13R)-5-hydroxy-3,6-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-12-oxa-2,9-diazatetracyclo[11.2.1.02,11.04,9]hexadeca-4,7-diene-7-carboxamide | PubChem CID:90311989 | UNII:8GB79LOJ07"
+BMGC_DG16289,BMG_DG207341,"CAS RN:1616340-12-5 | UNII:45CN2ZAS2D | (2S,5R,13AS)-2,3,4,5,7,9,13,13A-OCTAHYDRO-8-HYDROXY-7,9-DIOXO-N-((2,4,6-TRIFLUOROPHENYL)METHYL)-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXAMIDE | PubChem CID:90328411"
+BMGC_DG16290,BMG_DG207346,CAS RN:1621999-82-3 | N-[2-[[2-[(2-methoxy-5-methylpyridin-4-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]-5-methylphenyl]prop-2-enamide | PubChem CID:90331177
+BMGC_DG16291,BMG_DG207348,CAS RN:24016-03-3 | 2-AMINO-3-BENZYLOXYPYRIDINE | PubChem SID:440088953 | UNII:IYW7T7718Z | PubChem CID:90334 | DrugBank ID:DB02352 | 3-(Benzyloxy)Pyridin-2-Amine
+BMGC_DG16292,BMG_DG207351,"CAS RN:18652-93-2 | 5-hex-3-yn-2-yl-1-methyl-5-prop-2-enyl-1,3-diazinane-2,4,6-trione | UNII:E5B8ND5IPE | Methohexital | PubChem SID:198982552 | PubChem CID:9034 | DrugBank ID:DB00474 | CAS RN:151-83-7 | METHOHEXITAL"
+BMGC_DG16293,BMG_DG207382,UNII:SP86R356CC | N-phenylacetamide | PubChem CID:904 | ACETANILIDE | Acetanilide | PubChem SID:198973896 | CAS RN:103-84-4
+BMGC_DG16294,BMG_DG207387,"PubChem CID:90408860 | [(6S)-1-(5-fluoropyrimidin-2-yl)-6-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridin-5-yl]-[3-fluoro-2-(trifluoromethyl)pyridin-4-yl]methanone | (S)-(3-fluoro-2-(trifluoromethyl)pyridin-4-yl)(1-(5-fluoropyrimidin-2-yl)-6-methyl-6,7-dihydro-1H-[1,2,3]triazolo[4,5-c]pyridin-5(4H)-yl)methanone | JNJ-55308942 | PubChem SID:482554242 | ZANVIPIXANT | CAS RN:2166558-11-6 | UNII:B7YN3CQ7S7"
+BMGC_DG16295,BMG_DG207388,"Jnj-54175446 | [2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridin-5-yl]methanone | UNII:32524GLF40 | DrugBank ID:DB15358 | CAS RN:1627902-21-9 | PubChem CID:90409366 | PubChem SID:319891821 | JNJ-54175446"
+BMGC_DG16296,BMG_DG207396,"CAS RN:1628260-79-6 | DrugBank ID:DB15403 | PubChem SID:319892323 | PubChem CID:90420193 | ZIRITAXESTAT | Ziritaxestat | UNII:I02418V13W | 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile"
+BMGC_DG16297,BMG_DG207403,"CAS RN:1628530-41-5 | N-(4-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)PHENYL)-N'-(4-FLUORO-3-HYDROXYPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE | UNII:F5HE6AB5AL | PubChem CID:90435554 | PubChem SID:405055220"
+BMGC_DG16298,BMG_DG207419,PubChem CID:90456533 | NAPORAFENIB | N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide | CAS RN:1800398-38-2 | PubChem SID:433968801 | UNII:15JL80DG6H | Naporafenib
+BMGC_DG16299,BMG_DG207425,"PubChem SID:198952033 | PubChem CID:9046 | DrugBank ID:DB04575 | UNII:JR0N7XD5GZ | (8R,9S,13S,14S,17R)-3-cyclopentyloxy-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol | Quinestrol | CAS RN:152-43-2 | QUINESTROL"
+BMGC_DG16300,BMG_DG207454,CAS RN:152-47-6 | Sulfametopyrazine | CAS RN:5175-55-3 | UNII:T6BL4ZC15G | DrugBank ID:DB00664 | 4-amino-N-(3-methoxypyrazin-2-yl)benzenesulfonamide | PubChem SID:198945916 | Sulfalene | PubChem CID:9047 | SULFALENE
+BMGC_DG16301,BMG_DG207456,NDC:66658-234 | ANAKINRA | PubChem SID:472398157 | UNII:9013DUQ28K | PubChem CID:90470007 | CAS RN:143090-92-0
+BMGC_DG16302,BMG_DG207458,"Trigallic Acid | PubChem CID:90470472 | 3-[3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]oxy-4,5-dihydroxybenzoic acid | Trigallic acid | CAS RN:2131-66-0 | PubChem SID:478838464 | UNII:6HV67CW76G | TRIGALLIC ACID"
+BMGC_DG16303,BMG_DG207477,"PubChem CID:90472060 | (4S)-5-[[2-[[(2S,3R)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-2-oxoethyl]amino]-4-[[2-[[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]amino]acetyl]amino]-5-oxopentanoic acid | CAS RN:320367-13-3 | Lixisenatide"
+BMGC_DG16304,BMG_DG207584,SULFARSIDE | CAS RN:1134-98-1 | UNII:69RJM6V8ZJ | PubChem SID:241177777 | PubChem CID:90478480
+BMGC_DG16305,BMG_DG207586,"(2S)-1-[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S,3S)-2-amino-3-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-3-(1H-indol-3-yl)propanoyl]-N-[(2R)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide | PubChem CID:90478486 | UNII:073SBV429N | Indolicidin | INDOLICIDIN | PubChem SID:241177794 | CAS RN:140896-21-5"
+BMGC_DG16306,BMG_DG207654,"Tetraferric Tricitrate Decahydrate | TETRAFERRIC TRICITRATE DECAHYDRATE | iron(3+);2-oxidopropane-1,2,3-tricarboxylate;decahydrate | NDC:59922-631 | UNII:Q91187K011 | DrugBank ID:DB14520 | PubChem SID:198981199 | PubChem CID:90478690"
+BMGC_DG16307,BMG_DG207897,PubChem SID:241180378 | UNII:8JJC99KHGL | MARTINOSTAT | PubChem CID:90479372 | CAS RN:1629052-58-9
+BMGC_DG16308,BMG_DG208046,"DrugBank ID:DB05724 | CAS RN:740980-24-9 | CAS RN:467428-30-4 | 3-[(1R,6R,9S,12S,15S,21S,24S,27S,30S,33R,36S,39S,45S,48S,53R)-53-[(2-aminoacetyl)amino]-30-(2-amino-2-oxoethyl)-9-[(2S)-butan-2-yl]-36-(3-carbamimidamidopropyl)-6-carbamoyl-24,45-bis(carboxymethyl)-48-(hydroxymethyl)-27-[(4-hydroxyphenyl)methyl]-21-(1H-imidazol-4-ylmethyl)-8,11,14,20,23,26,29,32,35,38,44,47,50,52-tetradecaoxo-3,4,55,56-tetrathia-7,10,13,19,22,25,28,31,34,37,43,46,49,51-tetradecazatetracyclo[31.17.7.015,19.039,43]heptapentacontan-12-yl]propanoic acid | UNII:5U5J1KR8NU | alpha-Conotoxin VC 1.1 | .ALPHA.-CONOTOXIN VC 1.1 | PubChem CID:90488812 | PubChem SID:375085133"
+BMGC_DG16309,BMG_DG208056,UNII:32CN2DQE3Q | 25CN-NBOH | PubChem SID:461434286 | CAS RN:1391489-32-9 | PubChem CID:90489020
+BMGC_DG16310,BMG_DG208060,"DrugBank ID:DB14763 | PubChem SID:198941333 | Cycloguanil | PubChem CID:9049 | 1-(4-chlorophenyl)-6,6-dimethyl-1,3,5-triazine-2,4-diamine | CAS RN:516-21-2 | CYCLOGUANIL | UNII:26RM326WVN"
+BMGC_DG16311,BMG_DG208072,"PubChem CID:9051 | (8S,9R,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one | DrugBank ID:DB00378 | CAS RN:152-62-5 | UNII:90I02KLE8K | PubChem SID:198986003 | DYDROGESTERONE | Dydrogesterone"
+BMGC_DG16312,BMG_DG208081,"(6S,8S,9S,10R,11S,13S,14S,16R,17S)-6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one | DrugBank ID:DB08971 | CAS RN:152-97-6 | PubChem CID:9053 | Fluocortolone | FLUOCORTOLONE | UNII:65VXC1MH0J | PubChem SID:198968660"
+BMGC_DG16313,BMG_DG208103,CAS RN:24650-42-8 | UNII:1DK0094V28 | PHENYLDIMETHOXYACETOPHENONE | PubChem SID:198986558 | PubChem CID:90571
+BMGC_DG16314,BMG_DG208104,"PubChem SID:363908618 | CAS RN:24677-78-9 | 2,3-DIHYDROXYBENZALDEHYDE | PubChem CID:90579 | UNII:GP9HDE43LE"
+BMGC_DG16315,BMG_DG208115,"CAS RN:131-48-6 | PubChem CID:906 | Neuraminic acid, N-acetyl- | CAS RN:6918-20-3 | CAS RN:489-46-3 | 5-acetamido-2,4-dihydroxy-6-(1,2,3-trihydroxypropyl)oxane-2-carboxylic acid"
+BMGC_DG16316,BMG_DG208116,"UNII:7NS97N9H1G | CAS RN:153-94-6 | PubChem CID:9060 | PubChem SID:198968885 | D-Tryptophan | DrugBank ID:DB03225 | TRYPTOPHAN, D-"
+BMGC_DG16317,BMG_DG208119,Hydroxytryptophol | UNII:52MNE52QA1 | PubChem SID:376072955 | CAS RN:154-02-9 | PubChem CID:9061 | 5-HYDROXYTRYPTOPHOL | 3-(2-hydroxyethyl)-1H-indol-5-ol
+BMGC_DG16318,BMG_DG208129,4-HYDROXY-3-NITROBENZENESULFONAMIDE | UNII:XQ57JP789V | PubChem CID:90631 | CAS RN:24855-58-1
+BMGC_DG16319,BMG_DG208133,"(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol | CAS RN:100786-01-4 | UNII:8R1V1STN48 | CAS RN:7295-85-4 | Cianidanol | CAS RN:88191-48-4 | UNII:5J4Y243W61 | DrugBank ID:DB14086 | PubChem CID:9064 | CAS RN:154-23-4 | CAS RN:321-01-7 | PubChem SID:198941571 | CIANIDANOL | PubChem SID:175265379 | CIANIDANOL, (+/-)- | CIANIDANOL, (±)-"
+BMGC_DG16320,BMG_DG208140,UNII:73HBY5P486 | PubChem SID:441097135 | PubChem CID:90644511 | CAS RN:1065110-43-1 | PF-04479745
+BMGC_DG16321,BMG_DG208152,DELTOIN | PubChem SID:313183962 | UNII:H7ID2E493F | PubChem CID:906525 | CAS RN:19662-71-6
+BMGC_DG16322,BMG_DG208154,"PubChem SID:485665893 | 4-[(6bR,10aS)-2,3,6b,9,10,10a-Hexahydro-3-methyl-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-1-phenyl-1-butanone | UNII:JCA888U9RN | 4-((6BR,10AS)-2,3,6B,9,10,10A-HEXAHYDRO-3-METHYL-1H-PYRIDO(3',4':4,5)PYRROLO(1,2,3-DE)QUINOXALIN-8(7H)-YL)-1-PHENYL-1-BUTANONE | PubChem CID:90655115 | CAS RN:1576239-82-1"
+BMGC_DG16323,BMG_DG208956,CAS RN:1668565-74-9 | 1-[2-[bis(2-methylpropyl)amino]-5-[2-(2H-tetrazol-5-yl)phenyl]phenyl]-3-(4-methylphenyl)urea | PubChem CID:90718185
+BMGC_DG16324,BMG_DG208996,PubChem CID:9084 | UNII:4N2NU7R76L | Malonate Ion | propanedioate | PROPANEDIOATE | CAS RN:156-80-9 | Malonate | DrugBank ID:DB02201 | PubChem SID:438788901
+BMGC_DG16325,BMG_DG209001,"PubChem SID:316914188 | PubChem CID:9085 | Homoarginine | L-homoarginine | HOMOARGININE, L- | (2S)-2-amino-6-(diaminomethylideneamino)hexanoic acid | CAS RN:156-86-5 | CAS RN:13094-78-5 | DrugBank ID:DB03974 | UNII:JF751CK38I"
+BMGC_DG16326,BMG_DG209046,"PubChem CID:910 | 2-amino-4-(2-formamidophenyl)-4-oxobutanoic acid | FORMYLKYNURENINE, (+/-)- | PubChem SID:363908792 | N'-formylkynurenine | UNII:N3FFD7AJC9 | FORMYLKYNURENINE, (±)- | CAS RN:1022-31-7"
+BMGC_DG16327,BMG_DG209094,UNII:Y7QR253130 | PubChem CID:912 | N.ALPHA.-METHYLHISTAMINE | CAS RN:673-50-7 | PubChem SID:198969008
+BMGC_DG16328,BMG_DG209121,"CAS RN:103775-10-6 | PubChem CID:91270 | (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid | MOEXIPRIL | PubChem SID:175266162 | CAS RN:109715-88-0 | UNII:WT87C52TJZ | DrugBank ID:DB00691 | Moexipril"
+BMGC_DG16329,BMG_DG209123,PubChem CID:91272 | Deoxyspergualin | N-[(1S)-2-[4-(3-aminopropylamino)butylamino]-1-hydroxy-2-oxoethyl]-7-(diaminomethylideneamino)heptanamide | DrugBank ID:DB12991 | (-)-Gusperimus | DEOXYSPERGUALIN | CAS RN:89149-10-0 | UNII:57F9XM233R | PubChem SID:198970005
+BMGC_DG16330,BMG_DG209124,"PubChem SID:198973269 | (1R,2S,6R,7S)-4-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione | TANDOSPIRONE | DrugBank ID:DB12833 | CAS RN:87760-53-0 | PubChem CID:91273 | Tandospirone | UNII:190230I669"
+BMGC_DG16331,BMG_DG209126,CAS RN:78273-80-0 | ROXATIDINE | PubChem SID:198950459 | UNII:IV9VHT3YUM | Roxatidine | 2-hydroxy-N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]acetamide | PubChem CID:91276
+BMGC_DG16332,BMG_DG209148,1-HYDROXY-.ALPHA.-PHENYLCYCLOPENTYLACETIC ACID | UNII:C1GZ2XU3YM | PubChem CID:91332 | PubChem SID:198960311 | CAS RN:25209-52-3
+BMGC_DG16333,BMG_DG209195,QUININE DIHYDROCHLORIDE | CAS RN:60-93-5 | PubChem CID:91429 | UNII:8C3EMH7D9X | PubChem SID:198973857
+BMGC_DG16334,BMG_DG209196,UNII:67VX8ZHF8G | CAS RN:6093-72-7 | ETHYL 7-METHOXY-2-OXO-2H-1-BENZOPYRAN-3-CARBOXYLATE | PubChem CID:914298 | PubChem SID:482554626 | Ethyl 7-methoxy-2-oxo-2H-1-benzopyran-3-carboxylate
+BMGC_DG16335,BMG_DG209201,"CAS RN:113-21-3 | PubChem CID:91435 | PubChem SID:316917101 | Lactate | LACTATE ION, DL- | 2-hydroxypropanoate | UNII:13GMT0VU0O"
+BMGC_DG16336,BMG_DG209203,"PREDNISONE ACETATE | [2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate | DrugBank ID:DB14646 | CAS RN:125-10-0 | Prednisone acetate | UNII:OU93QEL83U | PubChem SID:175268558 | PubChem CID:91438"
+BMGC_DG16337,BMG_DG209207,"SENNOSIDE B | CAS RN:128-57-4 | Sennoside B | PubChem SID:198965440 | PubChem CID:91440 | (9S)-9-[(9R)-2-carboxy-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracen-9-yl]-4-hydroxy-10-oxo-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9H-anthracene-2-carboxylic acid | UNII:F887D1637W"
+BMGC_DG16338,BMG_DG209210,Tetrahydrofolic acid | PubChem CID:91443 | DrugBank ID:DB00116
+BMGC_DG16339,BMG_DG209215,"PubChem SID:316910679 | PubChem CID:91451 | 17-Alpha-Hydroxypregnenolone | CAS RN:85179-30-2 | 1-[(3S,8R,9S,10R,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone | CAS RN:19454-90-1 | CAS RN:387-79-1 | UNII:77ME40334S | 17-HYDROXYPREGNENOLONE"
+BMGC_DG16340,BMG_DG209218,PubChem SID:198966920 | STACHYOSE | UNII:25VX64653N | CAS RN:470-55-3 | PubChem CID:91455
+BMGC_DG16341,BMG_DG209223,"ECGONINE, (+/-)- | CAS RN:876657-17-9 | PubChem CID:91460 | (1R,2R,3S,5S)-3-hydroxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid | UNII:342I22959I | CAS RN:54808-87-6 | DrugBank ID:DB01525 | CAS RN:481-37-8 | ECGONINE | UNII:DX2E9E17AV | PubChem SID:198975623 | PubChem SID:198936484 | Ecgonine | ECGONINE, (±)-"
+BMGC_DG16342,BMG_DG209225,PubChem SID:198939681 | NORNICOTINE | CAS RN:494-97-3 | PubChem CID:91462 | 3-[(2S)-pyrrolidin-2-yl]pyridine | UNII:83H6L5QD8Z
+BMGC_DG16343,BMG_DG209226,Sobrerol | CAS RN:42370-41-2 | CAS RN:498-71-5 | PubChem CID:91463 | 5-(2-hydroxypropan-2-yl)-2-methylcyclohex-2-en-1-ol
+BMGC_DG16344,BMG_DG209228,"PubChem SID:241179885 | UNII:N390W430AC | (1R,2R,9S,17S)-7,13-diazatetracyclo[7.7.1.02,7.013,17]heptadecan-6-one | MATRINE | Matrine | CAS RN:519-02-8 | PubChem CID:91466"
+BMGC_DG16345,BMG_DG209230,"PubChem CID:91469 | DrugBank ID:DB11674 | PubChem SID:198937940 | Equol | UNII:2T6D2HPX7Q | CAS RN:531-95-3 | EQUOL | (3S)-3-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-7-ol"
+BMGC_DG16346,BMG_DG209233,"FRIEDELIN | PubChem CID:91472 | UNII:AK21264UAD | Friedelin | (4R,4aS,6aS,6aS,6bR,8aR,12aR,14aS,14bS)-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1H-picen-3-one | PubChem SID:241181284 | CAS RN:559-74-0"
+BMGC_DG16347,BMG_DG209235,"PubChem SID:198938118 | 7-OXOCHOLESTEROL | UNII:O7676FE78M | 7-Ketocholesterol | (3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-7-one | CAS RN:566-28-9 | PubChem CID:91474"
+BMGC_DG16348,BMG_DG209242,"(2S,3R)-2-aminooctadecane-1,3-diol | SPHINGANINE | UNII:YT0ZSD64HM | PubChem SID:198973899 | Sphinganine | CAS RN:3102-56-5 | CAS RN:764-22-7 | PubChem CID:91486"
+BMGC_DG16349,BMG_DG209244,"FLUOCINOLONE | PubChem CID:91488 | UNII:CT1IX58L9S | (6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-difluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | CAS RN:807-38-5 | PubChem SID:175266068 | DrugBank ID:DB12553 | Fluocinolone"
+BMGC_DG16350,BMG_DG209248,"UNII:W31WK7B8U0 | 6-Phosphogluconic acid | 6-PHOSPHOGLUCONIC ACID | (2R,3S,4R,5R)-2,3,4,5-tetrahydroxy-6-phosphonooxyhexanoic acid | DrugBank ID:DB02076 | PubChem CID:91493 | CAS RN:921-62-0 | PubChem SID:198945453 | 6-phospho-D-gluconic acid"
+BMGC_DG16351,BMG_DG209252,"UNII:5XAB8PH90A | PubChem CID:91498 | PubChem SID:198962756 | CAS RN:1253-84-5 | 3.BETA.,5.ALPHA.,6.BETA.-TRIHYDROXYCHOLESTANE | (3S,5R,6R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,5,6-triol | 3beta,5alpha,6beta-Trihydroxycholestane"
+BMGC_DG16352,BMG_DG209258,"PubChem CID:91503 | Hydroquinidine | CAS RN:1435-55-8 | HYDROQUINIDINE | DrugBank ID:DB15300 | (S)-[(2R,4S,5R)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol | UNII:8P68XPY4HG | PubChem SID:198936500"
+BMGC_DG16353,BMG_DG209261,"CAS RN:1553-55-5 | 3-Hydroxy-3-methylglutaryl-CoA | 5-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-3-hydroxy-3-methyl-5-oxopentanoic acid | PubChem CID:91506"
+BMGC_DG16354,BMG_DG209278,"3,4-DIHYDROXYPHENYLGLYCOL, (±)- | 3,4-Dihydroxyphenylglycol | 3,4-DIHYDROXYPHENYLGLYCOL, (+/-)- | UNII:UEH9K539KJ | 4-(1,2-dihydroxyethyl)benzene-1,2-diol | PubChem CID:91528 | CAS RN:3343-19-9 | CAS RN:28822-73-3 | PubChem SID:377308484"
+BMGC_DG16355,BMG_DG209281,"PubChem CID:91532 | DrugBank ID:DB03909 | Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate"
+BMGC_DG16356,BMG_DG209282,PubChem CID:91536 | PubChem SID:198942530 | UNII:74MLR03FLC | LEVOPROPRANOLOL | CAS RN:4199-09-1
+BMGC_DG16357,BMG_DG209290,(R)-warfarin | DrugBank ID:DB08496 | PubChem CID:91546
+BMGC_DG16358,BMG_DG209293,UNII:0LVT1QZ0BA | PubChem CID:91552 | HOMOCYSTEINE | DrugBank ID:DB04422 | CAS RN:6027-13-0 | Homocysteine | PubChem SID:198986143 | (2S)-2-amino-4-sulfanylbutanoic acid | L-Homocysteine
+BMGC_DG16359,BMG_DG209298,"(.ALPHA.,.BETA.-METHYLENE)ADENOSINE 5'-TRIPHOSPHATE | CAS RN:7292-42-4 | DrugBank ID:DB02596 | Diphosphomethylphosphonic acid adenosyl ester | alpha,beta-Methyleneadenosine 5'-triphosphate | PubChem CID:91557 | [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-[[hydroxy(phosphonooxy)phosphoryl]methyl]phosphinic acid | UNII:NYX13NT29D | PubChem SID:252320400"
+BMGC_DG16360,BMG_DG209301,"CEPHACETRILE | (6R,7R)-3-(acetyloxymethyl)-7-[(2-cyanoacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem SID:198954909 | UNII:FDM21QQ344 | Cefacetrile | DrugBank ID:DB01414 | PubChem CID:91562 | CAS RN:10206-21-0 | Cephacetrile"
+BMGC_DG16361,BMG_DG209315,trimethylselanium | UNII:SL67TG557G | PubChem CID:91580 | TRIMETHYLSELENONIUM | CAS RN:25930-79-4 | Trimethylselenonium | PubChem SID:198958566
+BMGC_DG16362,BMG_DG209320,"UNII:9ILS801M65 | PubChem CID:91588 | (1S)-1-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol | CAS RN:27740-96-1 | PubChem SID:175267612 | SALSOLINOL | Salsolinol"
+BMGC_DG16363,BMG_DG209344,"CAS RN:33342-05-1 | PubChem SID:198956380 | GLIQUIDONE | UNII:C7C2QDD75P | CAS RN:62783-47-5 | DrugBank ID:DB01251 | PubChem CID:91610 | Gliquidone | 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea"
+BMGC_DG16364,BMG_DG209346,"UNII:Z633Z7KAJU | 1,7-DIMETHYLURIC ACID | 1,7-dimethyl-3,9-dihydropurine-2,6,8-trione | PubChem SID:198943826 | PubChem CID:91611 | CAS RN:33868-03-0 | 1,7-Dimethyluric acid"
+BMGC_DG16365,BMG_DG209348,CAS RN:34392-54-6 | PubChem SID:198963460 | UNII:H5DHG2WBHM | PubChem CID:91613 | 2-METHYLHISTAMINE
+BMGC_DG16366,BMG_DG209399,"2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid | DAPRODUSTAT | CAS RN:960539-70-2 | Daprodustat | PubChem CID:91617630 | DrugBank ID:DB11682 | PubChem SID:249492203 | UNII:JVR38ZM64B"
+BMGC_DG16367,BMG_DG209595,"(4aR,6R,7R,7aS)-6-[6-amino-8-(4-chlorophenyl)sulfanylpurin-9-yl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol | PubChem CID:91636 | CAS RN:41941-66-6 | 8-((4-chlorophenyl)thio)cyclic-3',5'-AMP"
+BMGC_DG16368,BMG_DG209600,"PubChem CID:91643 | CAS RN:51131-85-2 | UNII:9G4A3ET6XG | PubChem SID:241179627 | 9-Hydroxyellipticine | 9-HYDROXYELLIPTICINE | 5,11-dimethyl-6H-pyrido[4,3-b]carbazol-9-ol"
+BMGC_DG16369,BMG_DG209606,2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide | PubChem CID:91649 | HYDROXYFLUTAMIDE | Hydroxyflutamide | CAS RN:52806-53-8 | PubChem SID:198961962 | UNII:31D90UKP5Y
+BMGC_DG16370,BMG_DG209630,"NDC:49230-534 | UNII:FZ7NYF5N8L | PubChem SID:472417534 | Iron sucrose | disodium;(2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;iron(3+);oxygen(2-);hydroxide;trihydrate | NDC:0517-2325 | NDC:0517-2310 | CAS RN:8047-67-4 | NDC:49230-530 | NDC:0517-2340 | PubChem CID:91663255 | Sucroferric oxyhydroxide | IRON SUCROSE | DrugBank ID:DB09146 | NDC:51662-1568"
+BMGC_DG16371,BMG_DG209646,"(4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-[[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2-aminopropanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-4-carboxybutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-5-oxopentanoic acid | PubChem CID:91663466 | PYY-(3-36) (pig)"
+BMGC_DG16372,BMG_DG209653,"DrugBank ID:DB02756 | CAS RN:57369-32-1 | Pyroquilon | 1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-11-one | PYROQUILON | PubChem CID:91665 | UNII:WS195Z0WJH | PubChem SID:198966247"
+BMGC_DG16373,BMG_DG209716,PubChem SID:404859640 | 2-(4-phenoxyphenyl)-6-(1-prop-2-enoylpiperidin-4-yl)pyridine-3-carboxamide | UNII:WJA5UO9E10 | Orelabrutinib | CAS RN:1655504-04-3 | ORELABRUTINIB | PubChem CID:91667513
+BMGC_DG16374,BMG_DG209762,"DrugBank ID:DB09275 | bismuth;pentapotassium;2-oxidopropane-1,2,3-tricarboxylate | BISMUTH SUBCITRATE POTASSIUM ANHYDROUS | PubChem SID:198935182 | PubChem CID:91667825 | CAS RN:880149-29-1 | Bismuth subcitrate potassium anhydrous | UNII:BQE6KE1T4H"
+BMGC_DG16375,BMG_DG209763,"CAS RN:331242-75-2 | zinc;(2R)-2-[(1S)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2H-furan-4-olate | CAS RN:134343-96-7 | PubChem SID:198938909 | PubChem CID:91667835 | ZINC ASCORBATE | UNII:9TI35313XW | Zinc Ascorbate | DrugBank ID:DB14485"
+BMGC_DG16376,BMG_DG209805,"PubChem SID:175267383 | Nomegestrol acetate | CAS RN:58652-20-3 | [(8S,9S,10R,13S,14S,17R)-17-acetyl-6,13-dimethyl-3-oxo-1,2,8,9,10,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate | NOMEGESTROL ACETATE | PubChem CID:91668 | UNII:83J78V5W05 | DrugBank ID:DB13981"
+BMGC_DG16377,BMG_DG209836,"PubChem CID:91668184 | PubChem SID:472406400 | LABETUZUMAB GOVITECAN | UNII:8E3HI6QQ9J | DrugBank ID:DB12331 | Labetuzumab govitecan | (2R)-2-amino-3-[1-[[4-[[1-[2-[2-[2-[2-[2-[2-[2-[2-[2-[[2-[2-[[(2S)-5-amino-1-[4-[[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl]oxycarbonyloxymethyl]anilino]-1-oxopentan-2-yl]amino]-2-oxoethoxy]acetyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methylcarbamoyl]cyclohexyl]methyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid | CAS RN:1469876-18-3"
+BMGC_DG16378,BMG_DG209838,"GOVITECAN CYSTEINYL CONJUGATE | Satralizumab linker | (2R)-2-amino-3-[1-[[4-[[1-[2-[2-[2-[2-[2-[2-[2-[2-[2-[[2-[2-[[(2S)-6-amino-1-[4-[[(19S)-10,19-diethyl-7-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-19-yl]oxycarbonyloxymethyl]anilino]-1-oxohexan-2-yl]amino]-2-oxoethoxy]acetyl]amino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]triazol-4-yl]methylcarbamoyl]cyclohexyl]methyl]-2,5-dioxopyrrolidin-3-yl]sulfanylpropanoic acid | UNII:DA64T2C2IO | CAS RN:1491917-83-9 | CAS RN:1535963-91-7 | CAS RN:1796566-95-4 | PubChem SID:384158365 | PubChem CID:91668186"
+BMGC_DG16379,BMG_DG209842,"MAVELERTINIB | Mavelertinib | PubChem SID:319892002 | N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide | UNII:YXX2180047 | CAS RN:1776112-90-3 | PubChem CID:91668194"
+BMGC_DG16380,BMG_DG209851,"PubChem CID:91673 | Etaconazole | ETACONAZOLE | UNII:3MT15AE9VG | CAS RN:60207-93-4 | PubChem SID:198987188 | 1-[[2-(2,4-dichlorophenyl)-4-ethyl-1,3-dioxolan-2-yl]methyl]-1,2,4-triazole"
+BMGC_DG16381,BMG_DG209879,CAS RN:67306-00-7 | PubChem CID:91694 | UNII:845XW54F31 | DrugBank ID:DB12728 | FENPROPIDIN | 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine | PubChem SID:316916617 | Fenpropidin
+BMGC_DG16382,BMG_DG209918,"(10S,13S)-5-[(3R)-3,7-dimethylocta-1,6-dien-3-yl]-13-(hydroxymethyl)-9-methyl-10-propan-2-yl-3,9,12-triazatricyclo[6.6.1.04,15]pentadeca-1,4,6,8(15)-tetraen-11-one | CAS RN:70497-14-2 | TELEOCIDIN A1 | UNII:SE69L721CS | PubChem SID:198958364 | PubChem CID:91706 | Lyngbyatoxin a"
+BMGC_DG16383,BMG_DG209924,CAS RN:65777-08-4 | PubChem SID:198934917 | Chrysene | PubChem CID:9171 | UNII:084HCM49PT | CAS RN:218-01-9 | chrysene | CHRYSENE
+BMGC_DG16384,BMG_DG210033,PubChem SID:198976473 | 2-tert-butyl-5-[(4-tert-butylphenyl)methylsulfanyl]-4-chloropyridazin-3-one | CAS RN:96489-71-3 | PYRIDABEN | PubChem CID:91754 | UNII:2E4JBA5272 | Pyridaben
+BMGC_DG16385,BMG_DG210036,"PubChem CID:91754477 | cyclopropyl-[5-[[4-[4-[[(4S)-4-hydroxy-1,2-oxazolidin-2-yl]methyl]-3-methylpyrazol-1-yl]pyrimidin-2-yl]amino]-1-methylindol-3-yl]methanone | UNII:3N3H8BX897 | PubChem SID:363909693 | Cevidoplenib | CEVIDOPLENIB | CAS RN:1703788-21-9"
+BMGC_DG16386,BMG_DG210037,"CAS RN:1268244-85-4 | PubChem CID:91754483 | rel-(+)-4-((1R,2R)-2-(2-Chloro-4-((5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl)methoxy)phenyl)cyclopropyl)benzoic acid | 4-[(1R,2R)-2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid | CAS RN:1268244-87-6"
+BMGC_DG16387,BMG_DG210038,"CAS RN:1672665-49-4 | PubChem CID:91754484 | UNII:6O16716DXP | PT2385 | 3-[[(1S)-2,2-difluoro-1-hydroxy-7-methylsulfonyl-1,3-dihydroinden-4-yl]oxy]-5-fluorobenzonitrile | PubChem SID:346541364 | PT-2385"
+BMGC_DG16388,BMG_DG210039,UNII:05HYK3CV9N | PubChem SID:377308734 | LINPERLISIB | Linperlisib | PubChem CID:91754520 | CAS RN:1702816-75-8 | N-[5-[6-fluoro-8-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-2-morpholin-4-ylquinazolin-4-yl]-2-methoxypyridin-3-yl]methanesulfonamide
+BMGC_DG16389,BMG_DG210057,"FULACIMSTAT | DrugBank ID:DB15085 | UNII:VIR72PP4ZU | CAS RN:1488354-15-9 | Fulacimstat | 1-(3-methyl-2-oxo-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)-4-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]pyrimidine-5-carboxylic acid | PubChem CID:91758792 | PubChem SID:348481452"
+BMGC_DG16390,BMG_DG210176,Daridorexant | NDC:80491-7850 | [(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone | NDC:80491-7825 | UNII:LMQ24G57E9 | PubChem CID:91801202 | CAS RN:1505484-82-1 | PubChem SID:346540711 | DARIDOREXANT | DrugBank ID:DB15031
+BMGC_DG16391,BMG_DG210185,LY-3104607 | UNII:2OH4RUC1V4 | CAS RN:1795232-22-2 | PubChem SID:381132512 | PubChem CID:91809187
+BMGC_DG16392,BMG_DG210187,"PubChem CID:91809202 | Cudetaxestat | CAS RN:1782070-21-6 | CUDETAXESTAT | 3-[2,6-dichloro-7-fluoro-1-(1-propylpyrazol-4-yl)indol-3-yl]sulfanyl-2-fluorobenzoic acid | PubChem SID:443624215 | UNII:6B7TYB2MJX"
+BMGC_DG16393,BMG_DG210191,4-(1-adamantylmethoxy)-N-(azetidin-1-ylsulfonyl)-5-cyclopropyl-2-fluorobenzamide | PubChem SID:485661465 | UNII:05ZYW7RU5V | PubChem CID:91809347 | GDC-0276 | CAS RN:1494581-70-2
+BMGC_DG16394,BMG_DG210322,"CIBINETIDE | UNII:9W5677JKDA | PubChem CID:91810664 | (4S)-5-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(1S)-1-carboxy-2-hydroxyethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-oxo-4-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoic acid | Cibinetide | PubChem SID:252164704 | DrugBank ID:DB13006 | CAS RN:1208243-50-8"
+BMGC_DG16395,BMG_DG210352,"CAS RN:1453084-37-1 | 1-amino-4-[[5-[[(2S)-1-[[(1S,2R,3S,5S,6S,16E,18E,20R,21S)-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl]oxy]-1-oxopropan-2-yl]-methylamino]-2-methyl-5-oxopentan-2-yl]disulfanyl]-1-oxobutane-2-sulfonic acid | Mirvetuximab-soravtansine | MIRVETUXIMAB SORAVTANSINE | PubChem CID:91810695 | Mirvetuximab Soravtansine | PubChem SID:472407177 | UNII:98DE7VN88D"
+BMGC_DG16396,BMG_DG210530,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt;[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2S)-1-[3-[(1R,2R,3S,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | Calomide | CAS RN:13870-90-1 | PubChem CID:91820207"
+BMGC_DG16397,BMG_DG210660,"CAS RN:9001-54-1 | Hyaluronoglucosaminidase | PubChem CID:91820602 | 6-(3,3-dimethyl-2-methylideneindol-1-yl)hexanoic acid;hydrobromide | CAS RN:37326-33-3"
+BMGC_DG16398,BMG_DG210669,CID 91824176 | CAS RN:1801379-22-5 | (2S)-N-[(2S)-3-(4-fluorophenyl)-1-(naphthalen-1-ylmethylamino)-1-oxopropan-2-yl]-N'-[(2-methylpropan-2-yl)oxy]-2-(3-phenylpropanoylamino)butanediamide | PubChem CID:91824176
+BMGC_DG16399,BMG_DG210675,"Murepavadin | UNII:0D02GRY87Z | CAS RN:944252-63-5 | DrugBank ID:DB14777 | PubChem CID:91824766 | MUREPAVADIN | PubChem SID:252320101 | (3R,9S,12S,15S,18S,21S,24S,27R,30S,33S,36S,39S,42S,45S)-15,18,24,27,33-pentakis(2-aminoethyl)-30-(3-aminopropyl)-36-[(2S)-butan-2-yl]-42-[(1R)-1-hydroxyethyl]-9-(hydroxymethyl)-21,39-bis(1H-indol-3-ylmethyl)-12-methyl-1,7,10,13,16,19,22,25,28,31,34,37,40,43-tetradecazatricyclo[43.3.0.03,7]octatetracontane-2,8,11,14,17,20,23,26,29,32,35,38,41,44-tetradecone"
+BMGC_DG16400,BMG_DG210678,DrugBank ID:DB13381 | PubChem CID:91825573 | sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate;iron | Sodium ferric EDTA
+BMGC_DG16401,BMG_DG210743,CAS RN:256373-96-3 | PubChem SID:433968531 | UNII:66BL55B687 | MCC-950 SODIUM | PubChem CID:91826093
+BMGC_DG16402,BMG_DG210811,DrugBank ID:DB11717 | PubChem CID:91826917 | Epacadostat
+BMGC_DG16403,BMG_DG210943,"CAS RN:1263871-36-8 | UNII:9W144SV55B | BMS-932481 | PubChem CID:91844660 | Bms-932481 | (7S)-7-(4-fluorophenyl)-2-N-[3-methoxy-4-(3-methyl-1,2,4-triazol-1-yl)phenyl]-4-N-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidine-2,4-diamine | PubChem SID:346536704"
+BMGC_DG16404,BMG_DG210944,NP-G2-044 | CAS RN:1807454-59-6 | PubChem CID:91844684 | 2-methyl-N-[1-[[4-(trifluoromethyl)phenyl]methyl]indazol-3-yl]furan-3-carboxamide | UNII:1ER2O3UZ4W | Np-g2-044 | PubChem SID:376072639 | DrugBank ID:DB14995
+BMGC_DG16405,BMG_DG210946,"PubChem CID:91844733 | SAMURACICLIB | PubChem SID:381608424 | UNII:46D4HS9ODA | (3R,4R)-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol | Samuraciclib | CAS RN:1805833-75-3"
+BMGC_DG16406,BMG_DG211078,"CAS RN:19356-17-3 | PubChem CID:91864756 | (1R)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol"
+BMGC_DG16407,BMG_DG211102,"Motixafortide | UNII:DA9G065962 | MOTIXAFORTIDE | DrugBank ID:DB14939 | (3S,6S,9S,12S,15R,20R,23S,26S,29S,32S)-3,6-bis(4-aminobutyl)-N-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]-15-[[(2S)-2-[[(2S)-5-carbamimidamido-2-[[(2S)-5-carbamimidamido-2-[(4-fluorobenzoyl)amino]pentanoyl]amino]pentanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-26-(3-carbamimidamidopropyl)-9,23-bis[3-(carbamoylamino)propyl]-12,29-bis[(4-hydroxyphenyl)methyl]-2,5,8,11,14,22,25,28,31-nonaoxo-17,18-dithia-1,4,7,10,13,21,24,27,30-nonazabicyclo[30.3.0]pentatriacontane-20-carboxamide | PubChem CID:91865076 | PubChem SID:252320077 | CAS RN:664334-36-5"
+BMGC_DG16408,BMG_DG211122,"2,4-DIFLUOROBENZYL ALCOHOL | PubChem SID:440090084 | DrugBank ID:DB04448 | UNII:SVX5XQB2MB | PubChem CID:91867 | CAS RN:56456-47-4 | 2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene"
+BMGC_DG16409,BMG_DG211143,"(1R,3S,5Z)-5-[2-[(1R,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | PubChem CID:91884755 | CAS RN:32222-06-3"
+BMGC_DG16410,BMG_DG211153,"OLOROFIM | 2-(1,5-dimethyl-3-phenylpyrrol-2-yl)-N-[4-[4-(5-fluoropyrimidin-2-yl)piperazin-1-yl]phenyl]-2-oxoacetamide | DrugBank ID:DB15245 | CAS RN:1928707-56-5 | Olorofim | UNII:T34SH2H9HI | PubChem CID:91885568 | PubChem SID:317229195"
+BMGC_DG16411,BMG_DG211154,"UNII:5Q7R99CKV2 | PubChem SID:433968569 | N-[(3S,4S)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino]oxan-4-yl]prop-2-enamide | Fisogatinib | PubChem CID:91885617 | CAS RN:1707289-21-1 | FISOGATINIB"
+BMGC_DG16412,BMG_DG211158,QUILSECONAZOLE | CAS RN:1340593-70-5 | PubChem CID:91886002 | UNII:7WJ1XH4Z6A | PubChem SID:322058720
+BMGC_DG16413,BMG_DG211182,"PubChem CID:91898871 | [(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,4Z,7S,9Z,12S,13S,14Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate | Hydroxoc-obalamin"
+BMGC_DG16414,BMG_DG211190,"CAS RN:501-96-2 | RHODODENDROL, (-)- | UNII:97PTR2F3Z8 | PubChem SID:198980840 | PubChem CID:919205"
+BMGC_DG16415,BMG_DG211196,"Endothelin 1, ET-1 | PubChem CID:91928636 | (3S)-3-[[(2S)-2-[[(2S)-2-[[(1S,4S,7S,10R,13S,16R,19S,22R,25R,28R,31S,36R,39S,42R,45S)-31-amino-7-(4-aminobutyl)-39-benzyl-4-(2-carboxyethyl)-10-(carboxymethyl)-19,22,28-tris(hydroxymethyl)-42-[(4-hydroxyphenyl)methyl]-16-(2-methylpropyl)-13-(2-methylsulfanylethyl)-3,6,9,12,15,18,21,24,27,30,38,41,44,47-tetradecaoxo-45-propan-2-yl-33,34,49,50-tetrathia-2,5,8,11,14,17,20,23,26,29,37,40,43,46-tetradecazabicyclo[23.22.4]henpentacontane-36-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-4-[[(2S,3S)-1-[[(2S,3S)-1-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-oxobutanoic acid"
+BMGC_DG16416,BMG_DG211197,"PubChem CID:91929988 | [(2R,3R,4S,5S,6R)-6-[(2R,3S,4S,5R,6R)-2-[(2R,3S,4S,5R,6R)-2-[(2R,3R,4S,5S,6R)-3,5-disulfonatooxy-2-(sulfonatooxymethyl)-6-[(2R,3S,4R,5R,6R)-2,4,5-trisulfonatooxy-6-(sulfonatooxymethyl)oxan-3-yl]oxyoxan-4-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)oxan-4-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)oxan-4-yl]oxy-3,4,5-trisulfonatooxyoxan-2-yl]methyl phosphate"
+BMGC_DG16417,BMG_DG211203,EC-5026 | EC5026 | PubChem CID:91933845 | PubChem SID:459275712 | 1-[3-fluoro-4-(trifluoromethoxy)phenyl]-3-[1-[(2S)-2-methylbutanoyl]piperidin-4-yl]urea | CAS RN:1809885-32-2 | UNII:D5X8A5HWL0
+BMGC_DG16418,BMG_DG211204,"ADOMEGLIVANT | PubChem CID:91933867 | UNII:74Z5ZL2KVG | 3-[[4-[(1S)-1-[4-(4-tert-butylphenyl)-3,5-dimethylphenoxy]-4,4,4-trifluorobutyl]benzoyl]amino]propanoic acid | CAS RN:872260-20-3 | CAS RN:1488363-78-5 | PubChem SID:252823986 | DrugBank ID:DB11704 | Adomeglivant"
+BMGC_DG16419,BMG_DG211205,"2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide | PubChem CID:91933883 | Eganelisib | PubChem SID:381132669 | EGANELISIB | UNII:FOF5155FMZ | CAS RN:1693758-51-8"
+BMGC_DG16420,BMG_DG211206,"Pacap27 | (3S)-4-[[2-[[(2S,3S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoic acid | PubChem CID:91935802"
+BMGC_DG16421,BMG_DG211207,"PubChem CID:91935803 | (3S)-4-[[2-[[(2S,3S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-4-amino-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoic acid | Pacap-38"
+BMGC_DG16422,BMG_DG211228,"DrugBank ID:DB11713 | RUZASVIR | methyl N-[(2S)-1-[(2S)-2-[5-[(6S)-6-(2-cyclopropyl-1,3-thiazol-5-yl)-1-fluoro-3-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6H-indolo[1,2-c][1,3]benzoxazin-10-yl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate | Ruzasvir | PubChem SID:252823720 | PubChem CID:91936863 | UNII:LX752BD95Y | CAS RN:1613081-64-3"
+BMGC_DG16423,BMG_DG211259,5-Fluoro-AB-PINACA | CAS RN:1800101-60-3 | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)indazole-3-carboxamide | 5-FLUORO-AB-PINACA | PubChem SID:252823919 | PubChem CID:91936927 | UNII:3L83B2298V
+BMGC_DG16424,BMG_DG211281,UNII:3Y3SPE26QX | PubChem SID:198946428 | PubChem CID:9196 | BENZO(A)CARBAZOLE | CAS RN:239-01-0
+BMGC_DG16425,BMG_DG211284,2-MEPP | CAS RN:39512-51-1 | UNII:6P26KQQ7V5 | PubChem CID:91965 | PubChem SID:441331712
+BMGC_DG16426,BMG_DG211303,PubChem SID:346539435 | ALRIZOMADLIN | Alrizomadlin | UNII:15QAU0SI9J | PubChem CID:91972012 | CAS RN:1818393-16-6
+BMGC_DG16427,BMG_DG211339,"PubChem SID:496141396 | 2,3,4,4′-Tetrahydroxybenzophenone | CAS RN:31127-54-5 | 2,3,4,4'-TETRAHYDROXYBENZOPHENONE | PubChem CID:919792 | UNII:4LA53WCH2Y"
+BMGC_DG16428,BMG_DG211404,DrugBank ID:DB01575 | NDC:37662-3516 | dialuminum;trioxido(trioxidosilyloxy)silane;dihydrate | NDC:0220-0226 | NDC:37662-3518 | CAS RN:1332-58-7 | KAOLIN | NDC:37662-3515 | NDC:37662-3512 | PubChem CID:92024769 | NDC:37662-3513 | NDC:84753-018 | Kaolin | NDC:69842-955 | NDC:82083-0027 | NDC:37662-3517 | NDC:0220-0209 | UNII:24H4NWX5CO | NDC:42669-231 | PubChem SID:175268372 | NDC:37662-3519 | NDC:37662-3514
+BMGC_DG16429,BMG_DG211455,"decasodium;3-methoxy-6-[2-(6-methoxy-4,5-disulfonatooxyoxan-3-yl)oxy-5-[5-(5-methoxy-3,4-disulfonatooxyoxan-2-yl)oxy-3,4-disulfonatooxyoxan-2-yl]oxy-4-sulfonatooxyoxan-3-yl]oxy-4,5-disulfonatooxyoxane-2-carboxylate | PubChem CID:92043424 | Pentosan | CAS RN:37319-17-8 | CAS RN:140207-93-8"
+BMGC_DG16430,BMG_DG211464,"(4R,5S,6S,7R,9R,10R,11E,13E,16R)-10-[(2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-6-[(2S,3R,4R,5S,6R)-5-[(2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-7-(2-hydroxyethyl)-5-methoxy-9,16-dimethyl-1-oxacyclohexadeca-11,13-dien-2-one | PubChem CID:92043599 | CAS RN:113427-24-0 | rhEPO"
+BMGC_DG16431,BMG_DG211476,"Sodium;6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid | PubChem CID:92044406 | sodium;6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid"
+BMGC_DG16432,BMG_DG211484,"PubChem SID:363909070 | TINLAREBANT | 1-[3-[4-[3,4-difluoro-2-(trifluoromethyl)phenyl]piperidine-1-carbonyl]-1,4,5,7-tetrahydropyrazolo[3,4-c]pyridin-6-yl]ethanone | UNII:63WI9S8P1M | PubChem CID:92044505 | Tinlarebant | CAS RN:1821327-95-0"
+BMGC_DG16433,BMG_DG211485,"Sutidiazine | PubChem SID:461434465 | CAS RN:1821293-40-6 | UNII:VL8W9427Y4 | 2-N-(4-cyclopropyl-5-fluoro-6-methylpyridin-2-yl)-5-[(3R)-3,4-dimethylpiperazin-1-yl]-4-N-(1,5-dimethylpyrazol-3-yl)pyrimidine-2,4-diamine | SUTIDIAZINE | PubChem CID:92045019"
+BMGC_DG16434,BMG_DG211505,"PubChem CID:92087 | UNII:55O5C6I73D | CAS RN:120279-95-0 | PubChem SID:198966401 | DORZOLAMIDE, (TRANS)-(+)-"
+BMGC_DG16435,BMG_DG211508,"PubChem CID:92092 | Tagatose | PubChem SID:198946251 | (3S,4S,5R)-1,3,4,5,6-pentahydroxyhexan-2-one | CAS RN:87-81-0 | UNII:T7A20Y888Y | CAS RN:17598-81-1 | TAGATOSE | DrugBank ID:DB04936"
+BMGC_DG16436,BMG_DG211511,"PubChem SID:198943559 | CAS RN:126-19-2 | Sarsasapogenin | SARSAGENIN | (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S,16S,18R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-ol | PubChem CID:92095 | UNII:CFS802C28F"
+BMGC_DG16437,BMG_DG211515,PubChem CID:9210 | CAS RN:253-82-7 | PubChem SID:198952489 | QUINAZOLINE | UNII:UB9QUR18NL
+BMGC_DG16438,BMG_DG211518,1-Methylhistidine | CAS RN:332-80-9 | UNII:583O01BJ32 | PubChem SID:198944579 | 1-Methyl-L-histidine | 1-METHYLHISTIDINE | PubChem CID:92105 | (2S)-2-amino-3-(1-methylimidazol-4-yl)propanoic acid | DrugBank ID:DB04151
+BMGC_DG16439,BMG_DG211521,"Gibberellin A4 | PubChem SID:318164541 | UNII:1360M56KLC | DrugBank ID:DB07815 | CAS RN:468-44-0 | (1R,2R,5R,8R,9S,10R,11S,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylic acid | GIBBERELLIN A4 | PubChem CID:92109"
+BMGC_DG16440,BMG_DG211525,"PubChem CID:92113 | CAS RN:474-63-5 | 24-METHYLENECHOLESTEROL | (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | PubChem SID:198942329 | UNII:SJ0718OYKX | 24-Methylenecholesterol"
+BMGC_DG16441,BMG_DG211527,PubChem CID:92117 | DL-HOMOCYSTEIC ACID | CAS RN:504-33-6 | UNII:HYA2G5T79L | PubChem SID:318691339
+BMGC_DG16442,BMG_DG211560,"CAS RN:13422-51-0 | PubChem CID:92132748 | Hydroxocobalamin (~90%) | cobalt(2+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,7S,12S,13S,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-21-id-3-yl]propanoylamino]propan-2-yl] phosphate;hydrate"
+BMGC_DG16443,BMG_DG211562,"PubChem SID:438788880 | SUCCINYL COENZYME A | 4-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethylsulfanyl]-4-oxobutanoic acid | PubChem CID:92133 | Succinyl-coenzyme A | UNII:BSI27HW5EQ | Succinyl-Coenzyme A | CAS RN:604-98-8 | DrugBank ID:DB03699"
+BMGC_DG16444,BMG_DG211563,"PubChem SID:198950869 | 3-HYDROXYBUTANOIC ACID, (R)- | (R)-3-Hydroxybutyric acid | (3R)-3-hydroxybutanoic acid | UNII:148ULJ1DF4 | PubChem CID:92135 | CAS RN:625-72-9"
+BMGC_DG16445,BMG_DG211584,UNII:ZI5ZER54A9 | PR-924 | PubChem CID:92135659 | CAS RN:1416709-79-9 | PubChem SID:255508957
+BMGC_DG16446,BMG_DG211684,"UNII:90YLS47BRX | CAS RN:1825302-42-8 | DrugBank ID:DB14017 | H3B-8800 | PubChem CID:92135969 | PubChem SID:461434171 | [(2S,3S,4E,6S,7R,10R)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-[(2E,4E,6R)-6-pyridin-2-ylhepta-2,4-dien-2-yl]-1-oxacyclododec-4-en-6-yl] 4-methylpiperazine-1-carboxylate"
+BMGC_DG16447,BMG_DG211685,"(2S)-2-aminohexanedioic acid | PubChem CID:92136 | L-2-Aminoadipic acid | PubChem SID:198941047 | CAS RN:1118-90-7 | 2-AMINOADIPIC ACID, L- | UNII:88ZH74L7SR"
+BMGC_DG16448,BMG_DG211730,CAS RN:6324-01-2 | 4-Hydroxyphenylglycine | PubChem SID:198988330 | 2-amino-2-(4-hydroxyphenyl)acetic acid | CAS RN:938-97-6 | 4-HYDROXYPHENYLGLYCINE | DrugBank ID:DB02601 | PubChem CID:92143 | CAS RN:37784-25-1 | UNII:7UYG7X0F53
+BMGC_DG16449,BMG_DG211742,UNII:42NI1P5Q1X | PubChem SID:198963249 | Acridine | acridine | PubChem CID:9215 | ACRIDINE | CAS RN:260-94-6
+BMGC_DG16450,BMG_DG211745,"CAS RN:1420-36-6 | PubChem CID:92153 | DrugBank ID:DB03059 | Acetoacetyl-CoA | acetoacetyl-CoA | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] 3-oxobutanethioate"
+BMGC_DG16451,BMG_DG211762,PubChem CID:92164 | PubChem SID:313183154 | N-ACETYL-D-GALACTOSAMINE | CAS RN:1811-31-0 | UNII:833755V695
+BMGC_DG16452,BMG_DG211796,PubChem SID:249817767 | N(6)-dimethylallyladenine | DrugBank ID:DB08768 | ENADENINE | PubChem CID:92180 | UNII:V500BB256Z | CAS RN:2365-40-4 | N-(3-Methylbut-2-EN-1-YL)-9H-purin-6-amine | N-(3-methylbut-2-enyl)-7H-purin-6-amine
+BMGC_DG16453,BMG_DG211797,UNII:35BKX0QF16 | CAS RN:2390-74-1 | PubChem SID:198971119 | GLYCYLTRYPTOPHAN | PubChem CID:92181
+BMGC_DG16454,BMG_DG211806,"DrugBank ID:DB01447 | CAS RN:3568-94-3 | PubChem SID:319891939 | 4-METHYLAMINOREX | UNII:7PK6VC94OU | 4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine | PubChem CID:92196 | 4-Methylaminorex"
+BMGC_DG16455,BMG_DG211809,"PubChem CID:92199 | DrugBank ID:DB03148 | PubChem SID:252319262 | UNII:0T2A5439OE | .ALPHA.,.BETA.-METHYLENE ADENOSINE 5'-DIPHOSPHATE | Adenosine 5'-methylenediphosphate | Phosphomethylphosphonic acid adenosyl ester | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid | CAS RN:3768-14-7 | CAS RN:104835-70-3"
+BMGC_DG16456,BMG_DG211811,"Columbianetin | UNII:2AUQ7TG6K2 | PubChem CID:92201 | COLUMBIANETIN | CAS RN:3804-70-4 | (8S)-8-(2-hydroxypropan-2-yl)-8,9-dihydrofuro[2,3-h]chromen-2-one"
+BMGC_DG16457,BMG_DG211822,N6-BENZYLADENOSINE | PubChem SID:241179973 | CAS RN:4294-16-0 | PubChem CID:92208 | UNII:0M6S0FAH3T
+BMGC_DG16458,BMG_DG211828,CAS RN:271-44-3 | PubChem CID:9221 | PubChem SID:198947598 | UNII:7C4VQE5C03 | INDAZOLE
+BMGC_DG16459,BMG_DG211842,"1,7-DIAZAINDENE | PubChem SID:249492616 | UNII:QX4465NR9T | PubChem CID:9222 | CAS RN:271-63-6"
+BMGC_DG16460,BMG_DG211844,"DOPA, D- | CAS RN:5796-17-8 | PubChem SID:198948118 | D-Dopa | PubChem CID:92222 | (2R)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | UNII:8T862R29FY"
+BMGC_DG16461,BMG_DG211845,(5S)-5-pyridin-3-ylpyrrolidin-2-one | CAS RN:5980-06-3 | Demethylcotinine | DEMETHYLCOTININE | PubChem SID:198970128 | PubChem CID:92223 | UNII:8QA8709E9J
+BMGC_DG16462,BMG_DG211853,PubChem SID:318164307 | UNII:766N8850JA | CAS RN:6734-33-4 | PubChem CID:92229 | 4-METHYLUMBELLIFERYL .BETA.-D-XYLOPYRANOSIDE
+BMGC_DG16463,BMG_DG211854,DrugBank ID:DB04179 | UNII:LK6946W774 | CAS RN:271-89-6 | PubChem SID:198971698 | PubChem CID:9223 | 1-benzofuran | BENZOFURAN | Benzofuran
+BMGC_DG16464,BMG_DG211868,7-amino-4-methylchromen-2-one | PubChem SID:252319577 | DrugBank ID:DB08168 | PubChem CID:92249 | 7-AMINO-4-METHYLCOUMARIN | 7-Amino-4-methylcoumarin | Coumarin 120 | UNII:OCY3JCT44X | CAS RN:26093-31-2
+BMGC_DG16465,BMG_DG211872,"CAS RN:41148-30-5 | (2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide | LEVOBUPIVACAINE | PubChem SID:198980870 | PubChem CID:92253 | CAS RN:27262-47-1 | Levobupivacaine | UNII:A5H73K9U3W | DrugBank ID:DB01002"
+BMGC_DG16466,BMG_DG211879,"2,6-DIISOPROPYLPHENYL ISOCYANATE | PubChem SID:445500253 | UNII:9F3446A37P | PubChem CID:92259 | CAS RN:28178-42-9"
+BMGC_DG16467,BMG_DG211888,CAS RN:30270-60-1 | PubChem CID:92267 | UNII:G7C424U3DJ | MONOCERIN | PubChem SID:318691899
+BMGC_DG16468,BMG_DG211889,"CAS RN:30377-37-8 | PubChem SID:474491289 | UNII:MYE4YC3VKU | CAS RN:1022140-21-1 | 2,8-DIHYDROXYADENINE | 2,8-Dihydroxyadenine | 6-amino-7,9-dihydro-1H-purine-2,8-dione | PubChem CID:92268"
+BMGC_DG16469,BMG_DG211891,DrugBank ID:DB01896 | M-Aminophenylboronic Acid | CAS RN:30418-59-8 | PubChem SID:438787564 | 3-AMINOPHENYLBORONIC ACID | PubChem CID:92269 | UNII:44U8ADR772
+BMGC_DG16470,BMG_DG211908,DrugBank ID:DB02635 | N-[O-Phosphono-Pyridoxyl]-Isoleucine | PubChem CID:92282619
+BMGC_DG16471,BMG_DG211909,"PubChem SID:198951489 | PubChem CID:92283 | UNII:XE4Y3016M9 | (2R)-2-[(2S,3R,4S)-3,4-dihydroxy-5-oxooxolan-2-yl]-2-hydroxyacetaldehyde | GLUCUROLACTONE | CAS RN:6814-06-8 | CAS RN:32449-92-6 | Glucuronolactone"
+BMGC_DG16472,BMG_DG211932,"1,2-(METHYLENEDIOXY)BENZENE | UNII:F0XLL582B8 | PubChem CID:9229 | CAS RN:274-09-9 | PubChem SID:198968103"
+BMGC_DG16473,BMG_DG211937,"UNII:7T03QW0G7C | PubChem SID:241179417 | 7-Aminoflunitrazepam | CAS RN:34084-50-9 | 7-AMINOFLUNITRAZEPAM | 7-amino-5-(2-fluorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one | PubChem CID:92294"
+BMGC_DG16474,BMG_DG211944,UNII:LYR4M0NH37 | DrugBank ID:DB14516 | CAS RN:17341-25-2 | Sodium Cation | PubChem SID:175268931 | sodium(1+) | PubChem CID:923 | CAS RN:124224-04-0 | SODIUM CATION
+BMGC_DG16475,BMG_DG211945,PubChem CID:9230 | CAS RN:274-40-8 | INDOLIZINE | PubChem SID:472423998 | UNII:B48FMH8YFQ
+BMGC_DG16476,BMG_DG211950,"VERAPAMIL, (-)- | PubChem SID:198954752 | CAS RN:36622-29-4 | UNII:9P7619E627 | PubChem CID:92305"
+BMGC_DG16477,BMG_DG211969,PubChem SID:175267390 | Tarenflurbil | DrugBank ID:DB05289 | CAS RN:51543-40-9 | UNII:501W00OOWA | PubChem CID:92337 | TARENFLURBIL | (2R)-2-(3-fluoro-4-phenylphenyl)propanoic acid
+BMGC_DG16478,BMG_DG211994,"PubChem SID:198958443 | (2R,3R,4R,5S)-2-(hydroxymethyl)-1-methylpiperidine-3,4,5-triol | N-METHYLDEOXYNOJIRIMYCIN | CAS RN:69567-10-8 | PubChem CID:92381 | N-Methyl-1-Deoxynojirimycin | UNII:YZS8607G9Z"
+BMGC_DG16479,BMG_DG212006,"ZOFENOPRIL | CAS RN:81872-10-8 | DrugBank ID:DB13166 | PubChem CID:92400 | (2S,4S)-1-[(2S)-3-benzoylsulfanyl-2-methylpropanoyl]-4-phenylsulfanylpyrrolidine-2-carboxylic acid | UNII:290ZY759PI | PubChem SID:175267683 | Zofenopril"
+BMGC_DG16480,BMG_DG212012,"CAS RN:85375-85-5 | N-(4,4-Diphenyl-3-butenyl)nipecotic acid | PubChem CID:92409 | 1-(4,4-diphenylbut-3-enyl)piperidine-3-carboxylic acid"
+BMGC_DG16481,BMG_DG212013,"1,3-DIPROPYL-8-(2-AMINO-4-CHLOROPHENYL)XANTHINE | CAS RN:85872-51-1 | 8-(2-amino-4-chlorophenyl)-1,3-dipropyl-7H-purine-2,6-dione | PubChem CID:92411 | PubChem SID:198990668 | 1,3-Dipropyl-8-(2-amino-4-chlorophenyl)xanthine | UNII:ET7OKC2MCY"
+BMGC_DG16482,BMG_DG212049,CYCLOPROPYL ISOTHIOCYANATE | Cyclopropyl isothiocyanate | PubChem CID:92463 | PubChem SID:485661692 | CAS RN:56601-42-4 | UNII:RCK2DWK2N7
+BMGC_DG16483,BMG_DG212067,CAS RN:56718-71-9 | PubChem CID:92516 | 4-(2-METHOXYETHYL)PHENOL | UNII:PY1W0AKW8I | PubChem SID:198953339
+BMGC_DG16484,BMG_DG212076,Methoxy arachidonyl fluorophosphonate | DrugBank ID:DB02465 | PubChem CID:92536013
+BMGC_DG16485,BMG_DG212088,"CAS RN:288-88-0 | PubChem SID:198985566 | PubChem CID:9257 | 1,2,4-Triazole | DrugBank ID:DB03594 | CAS RN:63598-71-0 | UNII:10MS0Y1RDI | CAS RN:736917-78-5 | 1H-1,2,4-TRIAZOLE | 1H-1,2,4-triazole"
+BMGC_DG16486,BMG_DG212127,"Ethynodiol diacetate | CAS RN:297-76-7 | [(3S,8R,9S,10R,13S,14S,17R)-17-acetyloxy-17-ethynyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate | ETHYNODIOL DIACETATE | DrugBank ID:DB00823 | UNII:62H10A1236 | PubChem SID:175267492 | PubChem CID:9270"
+BMGC_DG16487,BMG_DG212130,"NDC:63323-526 | NDC:0143-9674 | (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid;hydrate | PubChem CID:92721 | NDC:0143-9377 | NDC:16729-430 | NDC:0409-1140 | NDC:65145-126 | ARGATROBAN | Argatroban monohydrate | NDC:42023-182 | PubChem SID:175271853 | CAS RN:141396-28-3 | NDC:55150-241 | UNII:IY90U61Z3S | NDC:25021-414 | NDC:65219-429 | NDC:68083-141 | NDC:70121-1037 | NDC:0143-9559 | NDC:0143-9288 | NDC:68083-568 | NDC:67457-212"
+BMGC_DG16488,BMG_DG212131,"PubChem SID:198954390 | CAS RN:74863-84-6 | CAS RN:121785-71-5 | UNII:OCY3U280Y3 | (2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid | PubChem CID:92722 | ARGATROBAN ANHYDROUS | DrugBank ID:DB00278 | Argatroban"
+BMGC_DG16489,BMG_DG212133,"NDC:0074-4014 | NDC:0074-3956 | NDC:42385-933 | CAS RN:192725-17-0 | Lopinavir | NDC:33342-164 | NDC:31722-556 | NDC:31722-603 | NDC:0527-1947 | (2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide | LOPINAVIR | NDC:42385-934 | PubChem CID:92727 | PubChem SID:175267272 | NDC:0074-6799 | NDC:0074-0522 | UNII:2494G1JF75 | NDC:0074-3008 | NDC:33342-163 | DrugBank ID:DB01601"
+BMGC_DG16490,BMG_DG212134,"(2R)-2,7,8-trimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol | CAS RN:54-28-4 | UNII:8EF1Z1238F | DrugBank ID:DB15394 | PubChem SID:198944245 | gamma-Tocopherol | .GAMMA.-TOCOPHEROL | PubChem CID:92729"
+BMGC_DG16491,BMG_DG212136,"PubChem SID:474492598 | 11alpha-Hydroxyprogesterone | (8S,9S,10R,11R,13S,14S,17S)-17-acetyl-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one | UNII:D8X4JXL4VM | 11.ALPHA.-HYDROXYPROGESTERONE | PubChem CID:92730 | CAS RN:80-75-1"
+BMGC_DG16492,BMG_DG212146,"3,20-Pregnanedione | PubChem CID:92745 | CAS RN:128-23-4 | UNII:105J2Q45A0 | PubChem SID:198971312 | DrugBank ID:DB07557 | 3,20-PREGNANEDIONE | (5R,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | 5beta-Pregnane-3,20-dione"
+BMGC_DG16493,BMG_DG212147,"Zymosterol | (3S,5S,10S,13R,14R,17R)-10,13-dimethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,4,5,6,7,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | ZYMOSTEROL | PubChem CID:92746 | UNII:PU2755PT4O | CAS RN:128-33-6 | PubChem SID:198938365"
+BMGC_DG16494,BMG_DG212148,"(20R)-20-Hydroxypregn-4-en-3-one | CAS RN:145-15-3 | PubChem SID:443625271 | 20.BETA.-HYDROXYPROGESTERONE | UNII:67N4JZ6CHL | PubChem CID:92747 | (8S,9S,10R,13S,14S,17S)-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG16495,BMG_DG212153,"CAS RN:317-66-8 | UNII:H7HQA57V5H | propionyl-CoA | DrugBank ID:DB02912 | PubChem CID:92753 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] propanethioate | PROPIONYL COENZYME A | PubChem SID:316913739 | Propanoyl-CoA"
+BMGC_DG16496,BMG_DG212165,"Cryptopleurine | CRYPTOPLEURINE | PubChem CID:92765 | PubChem SID:252164577 | (14aR)-2,3,6-trimethoxy-11,12,13,14,14a,15-hexahydro-9H-phenanthro[9,10-b]quinolizine | CAS RN:482-22-4 | UNII:3JZK58H75B"
+BMGC_DG16497,BMG_DG212166,"methyl (1S,15R,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate | PubChem SID:198982129 | PubChem CID:92766 | Corynanthine | CORYNANTHINE | CAS RN:483-10-3 | UNII:F5Z7C9RK8U"
+BMGC_DG16498,BMG_DG212171,PubChem SID:374388086 | N-METHYLANABASINE | PubChem CID:927709 | UNII:6F89FI7JTI | CAS RN:24380-92-5
+BMGC_DG16499,BMG_DG212173,"Butin | UNII:S23T8BI9DD | PubChem SID:404859447 | CAS RN:492-14-8 | PubChem CID:92775 | (2S)-2-(3,4-dihydroxyphenyl)-7-hydroxy-2,3-dihydrochromen-4-one | BUTIN"
+BMGC_DG16500,BMG_DG212185,"BREXANOLONE | 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone | UNII:S39XZ5QV8Y | PubChem CID:92786 | Allopregnanolone | DrugBank ID:DB11859 | CAS RN:516-54-1 | PubChem SID:198958618 | Brexanolone"
+BMGC_DG16501,BMG_DG212186,"DrugBank ID:DB12972 | CAS RN:516-55-2 | UNII:3P8Z6V53MU | PubChem SID:198982203 | PubChem CID:92787 | Isopregnanolone | Sepranolone | 1-[(3S,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone | SEPRANOLONE"
+BMGC_DG16502,BMG_DG212191,"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one | PubChem SID:472390552 | PRUNIN | CAS RN:529-55-5 | UNII:LSB8HDX4E5 | PubChem CID:92794 | Prunin"
+BMGC_DG16503,BMG_DG212197,"Uvaol | PubChem SID:198969402 | PubChem CID:92802 | UNII:W599R31ROT | (3S,4aR,6aR,6bS,8aS,11R,12S,12aS,14aR,14bR)-8a-(hydroxymethyl)-4,4,6a,6b,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol | UVAOL | CAS RN:545-46-0"
+BMGC_DG16504,BMG_DG212198,"CHOLANIC ACID, (5.BETA.)- | UNII:970EKW2JTO | PubChem CID:92803 | CAS RN:546-18-9 | PubChem SID:198984680"
+BMGC_DG16505,BMG_DG212204,"CAS RN:566-65-4 | PubChem SID:198980388 | (5S,8R,9S,10S,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one | UNII:98G4S1OH0Z | PubChem CID:92810 | 3,20-ALLOPREGNANEDIONE | 5alpha-Pregnane-3,20-dione"
+BMGC_DG16506,BMG_DG212210,7-Acetoxycoumarin | UNII:S8L7MG576C | PubChem CID:928228 | 7-ACETOXYCOUMARIN | PubChem SID:482554034
+BMGC_DG16507,BMG_DG212211,"UNII:P750Y95K96 | MALIC ACID, D- | PubChem CID:92824 | PubChem SID:198977308 | D-Malic acid | DrugBank ID:DB03499 | (2R)-2-hydroxybutanedioic acid | CAS RN:636-61-3 | D-malate"
+BMGC_DG16508,BMG_DG212214,"21-DEOXYCORTISOL | 21-Deoxycortisol | (8S,9S,10R,11S,13S,14S,17R)-17-acetyl-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one | CAS RN:641-77-0 | PubChem CID:92827 | UNII:XZ1JYU14MZ | PubChem SID:404859732"
+BMGC_DG16509,BMG_DG212215,UNII:A226496H4O | GLYCYL-TYROSINE | PubChem CID:92829 | PubChem SID:198938809 | CAS RN:658-79-7
+BMGC_DG16510,BMG_DG212220,"CAS RN:734-32-7 | PubChem SID:198982265 | 19-Norandrostenedione | 19-NORANDROSTENEDIONE | (8R,9S,10R,13S,14S)-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,17-dione | PubChem CID:92834 | UNII:U90987PVU5 | 19-norandrostenedione | DrugBank ID:DB01434"
+BMGC_DG16511,BMG_DG212226,(2S)-2-[(2-aminoacetyl)amino]-4-methylpentanoic acid | PubChem SID:198954436 | Glycyl-L-leucine | PubChem CID:92843 | CAS RN:869-19-2 | GLYCYLLEUCINE | UNII:8L97V505GU
+BMGC_DG16512,BMG_DG212227,"O-METHYLAEGELENIN | PubChem CID:928446 | PubChem SID:461433321 | Pyridine, 3-(5-(p-methoxyphenyl)-2-oxazolyl)- | UNII:ECU9KW6SW3 | 5-(4-methoxyphenyl)-2-pyridin-3-yl-1,3-oxazole | CAS RN:33864-03-8"
+BMGC_DG16513,BMG_DG212230,PubChem CID:92846 | PubChem SID:198967029 | UNII:4L6USG266B | ESTRONE ACETATE | CAS RN:901-93-9
+BMGC_DG16514,BMG_DG212236,PubChem SID:316913661 | D-Cysteine | DrugBank ID:DB03201 | (2S)-2-amino-3-sulfanylpropanoic acid | D-cysteine | CAS RN:921-01-7 | PubChem CID:92851 | UNII:IU8WN3PPI2 | D-CYSTEINE
+BMGC_DG16515,BMG_DG212243,PREGNADIENOLONE ACETATE | PubChem CID:92855 | CAS RN:979-02-2 | UNII:832VMW7ZGC | PubChem SID:461432914
+BMGC_DG16516,BMG_DG212246,"3,5-DIIODOTHYRONINE, L- | CAS RN:1041-01-6 | PubChem CID:92859 | UNII:CAL3MRM51F | PubChem SID:198964725"
+BMGC_DG16517,BMG_DG212255,PubChem CID:9287 | INDOPAN | 1-(1H-indol-3-yl)propan-2-amine | PubChem SID:198987509 | UNII:BIK35ACJ0Q | CAS RN:299-26-3 | CAS RN:304-54-1 | alpha-Methyltryptamine | Indopan | DrugBank ID:DB01446
+BMGC_DG16518,BMG_DG212261,"PROPICILLIN | (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenoxybutanoylamino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | PubChem CID:92879 | CAS RN:551-27-9 | UNII:8X1R260V33 | Propicillin | PubChem SID:198969111 | DrugBank ID:DB13660"
+BMGC_DG16519,BMG_DG212264,"PubChem CID:92886 | PubChem SID:443624225 | 1,2-CYCLOHEXANEDIOL, TRANS- | 1,2-CYCLOHEXANEDIOL, (1R-TRANS)- | CAS RN:1072-86-2 | (1R,2R)-cyclohexane-1,2-diol | PubChem SID:316917601 | CAS RN:1460-57-7 | UNII:8W5CKZ32GP | trans-1,2-Cyclohexanediol | UNII:89G7G95Z1Y"
+BMGC_DG16520,BMG_DG212271,"PubChem SID:316914531 | ESTRONE METHYL ETHER, (+/-)- | UNII:59359RSB8X | ESTRONE METHYL ETHER, (±)- | PubChem CID:92895 | PubChem SID:198950876 | ESTRONE 3-METHYL ETHER | CAS RN:1091-94-7 | CAS RN:1624-62-0 | UNII:4SMZ4A51IJ"
+BMGC_DG16521,BMG_DG212276,"DrugBank ID:DB11126 | Calcium Gluconate | PubChem SID:175266723 | calcium;(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate | Calcium gluconate | PubChem CID:9290 | CALCIUM GLUCONATE | UNII:SQE6VB453K | NDC:74458-065 | CAS RN:299-28-5"
+BMGC_DG16522,BMG_DG212277,"CAS RN:1792-81-0 | UNII:G9FB3QY86K | 1,2-CYCLOHEXANEDIOL, CIS- | PubChem CID:92903 | PubChem SID:443623492"
+BMGC_DG16523,BMG_DG212278,UNII:5SW11R7M7M | CAS RN:832-97-3 | 2-hydroxy-3-(1H-indol-3-yl)propanoic acid | CAS RN:1821-52-9 | PubChem CID:92904 | Indole-3-lactic acid | PubChem SID:316909376 | INDOLE-3-LACTIC ACID
+BMGC_DG16524,BMG_DG212283,DrugBank ID:DB14488 | PubChem CID:9291 | Ferrous gluconate
+BMGC_DG16525,BMG_DG212284,PubChem SID:198948766 | MELANOCYTE-STIMULATING HORMONE RELEASE-INHIBITING FACTOR-1 | Melanostatin | (2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide | PubChem CID:92910 | UNII:3KY24B4Q62 | CAS RN:2002-44-0
+BMGC_DG16526,BMG_DG212288,"PubChem SID:241178151 | CAS RN:2140-61-6 | UNII:TL9PB228DC | 5-Methylcytidine | PubChem CID:92918 | 5-METHYLCYTIDINE | 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one"
+BMGC_DG16527,BMG_DG212292,"PubChem SID:175271391 | GLYCERYL 1-CAPRATE | UNII:197M6VFC1W | GLYCERYL CAPRATE | CAS RN:69070-60-6 | CAS RN:2277-23-8 | 2,3-Dihydroxypropyl decanoate | 2,3-dihydroxypropyl decanoate | PubChem CID:92926 | CAS RN:11139-88-1 | CAS RN:26402-22-2"
+BMGC_DG16528,BMG_DG212293,UNII:37W4O0O6E6 | SCLAREOLIDE | PubChem CID:929262 | PubChem SID:175267669 | CAS RN:564-20-5
+BMGC_DG16529,BMG_DG212304,"CAS RN:299-42-3 | DrugBank ID:DB01364 | Ephedrine | UNII:GN83C131XS | (1R,2S)-2-(methylamino)-1-phenylpropan-1-ol | PubChem SID:175265573 | PubChem CID:9294 | EPHEDRINE"
+BMGC_DG16530,BMG_DG212307,"(3S)-3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-ylbutan-1-one | CAS RN:357-56-2 | DrugBank ID:DB01529 | PubChem SID:198943891 | PubChem CID:92943 | Dextromoramide | UNII:9S4S6CIY83 | DEXTROMORAMIDE"
+BMGC_DG16531,BMG_DG212312,UNII:7U35X863XK | PubChem CID:92953 | PubChem SID:441659027 | CAS RN:3321-03-7 | GLYCYL-L-PHENYLALANINE
+BMGC_DG16532,BMG_DG212320,PubChem SID:376072970 | 4-HYDROXYBENZYLIDENEMALONONITRILE | UNII:UKI2IW0CAY | CAS RN:3785-90-8 | PubChem CID:92970
+BMGC_DG16533,BMG_DG212326,"NDC:72205-072 | NDC:67877-705 | NDC:69539-146 | NDC:27241-201 | NDC:59651-376 | NDC:0832-0720 | CAS RN:23651-95-8 | NDC:67877-706 | NDC:69452-257 | NDC:50228-430 | PubChem CID:92974 | NDC:51407-766 | THREO-DIHYDROXYPHENYLSERINE | DrugBank ID:DB06262 | NDC:0904-7392 | NDC:27241-199 | NDC:31722-010 | NDC:50228-431 | NDC:68180-988 | NDC:68180-987 | Droxidopa | NDC:70436-140 | NDC:27241-200 | NDC:31722-014 | NDC:51407-767 | (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid | NDC:70710-1390 | NDC:0832-0722 | NDC:31722-015 | DROXIDOPA | NDC:67877-704 | NDC:51407-765 | NDC:68180-989 | NDC:70436-141 | CAS RN:1260173-94-1 | NDC:72205-074 | NDC:69539-089 | NDC:70771-1611 | NDC:70771-1610 | NDC:69452-256 | NDC:63304-112 | NDC:69452-258 | UNII:J7A92W69L7 | UNII:24A0V01WKS | NDC:63304-104 | NDC:50228-429 | NDC:69539-088 | NDC:0904-7394 | CAS RN:3916-18-5 | NDC:0832-0721 | NDC:59651-375 | NDC:67386-820 | PubChem SID:198948648 | NDC:70436-142 | NDC:67386-822 | NDC:59651-377 | NDC:70710-1389 | NDC:70710-1391 | NDC:63304-086 | NDC:72205-073 | PubChem SID:249492216 | NDC:67386-821 | NDC:0904-7393 | NDC:70771-1609"
+BMGC_DG16534,BMG_DG212372,UNII:7KD7K3964H | CAS RN:6736-85-2 | CATALPOSIDE | PubChem CID:93039 | PubChem SID:198986011
+BMGC_DG16535,BMG_DG212377,"(2S)-2-amino-3-(4-hydroxy-3,5-diiodophenyl)propanoic acid | 3,5-Diiodotyrosine | 3,5-Diiodo-L-tyrosine | UNII:6L57Q44ZWW | CAS RN:300-39-0 | PubChem CID:9305 | DIIODOTYROSINE | PubChem SID:198989724 | DrugBank ID:DB03374"
+BMGC_DG16536,BMG_DG212381,"Demegestone | DrugBank ID:DB13857 | DEMEGESTONE | CAS RN:10116-22-0 | UNII:6E89AM91SZ | PubChem SID:198941623 | (8S,13S,14S,17S)-17-acetyl-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | PubChem CID:93057"
+BMGC_DG16537,BMG_DG212385,DrugBank ID:DB04252 | (2S)-2-(carbamoylamino)butanedioic acid | CAS RN:13184-27-5 | N-carbamoyl-L-aspartate | N-Carbamoylaspartic acid | PubChem SID:198964345 | UNII:R2521024DK | N-CARBAMOYLASPARTIC ACID | PubChem CID:93072
+BMGC_DG16538,BMG_DG212391,"PubChem CID:9308 | MUSCARINE | CAS RN:300-54-9 | PubChem SID:198939053 | UNII:7T101UWZ5W | Muscarine | [(2S,4R,5S)-4-hydroxy-5-methyloxolan-2-yl]methyl-trimethylazanium"
+BMGC_DG16539,BMG_DG212393,PubChem CID:93082 | 5'-Guanylylmethylenebisphosphonate | DrugBank ID:DB03725
+BMGC_DG16540,BMG_DG212402,PubChem CID:931 | naphthalene | UNII:2166IN72UN | NDC:0220-3553 | PubChem SID:175268864 | CAS RN:91-20-3 | NDC:0220-3554 | CAS RN:31807-65-5 | CAS RN:287399-39-7 | Naphthalene | NAPHTHALENE
+BMGC_DG16541,BMG_DG212412,"2,4-Diamino-5-phenyl-6-ethylpyrimidine | DIAMINO-5-PHENYL-6-ETHYLPYRIMIDINE, 2,4- | PubChem CID:93114 | PubChem SID:198972696 | CAS RN:27653-49-2 | UNII:KMJ59LN22F | DrugBank ID:DB07577"
+BMGC_DG16542,BMG_DG212419,"2-Amino-5,6-dimethylbenzimidazole | CAS RN:29096-75-1 | 2-AMINO-5,6-DIMETHYLBENZIMIDAZOLE | PubChem SID:478837736 | UNII:UNN55GA2W2 | PubChem CID:93125"
+BMGC_DG16543,BMG_DG212423,UNII:2JE8SG6VDT | CAS RN:29816-01-1 | PubChem CID:93131 | PubChem SID:377308363 | GLYCYLSARCOSINE
+BMGC_DG16544,BMG_DG212431,2-ISOBUTYLPHENOL | PubChem SID:363908655 | CAS RN:4167-75-3 | PubChem CID:93144 | UNII:WG4PCJ3E5M
+BMGC_DG16545,BMG_DG212433,"UNII:I5YE3I47D8 | TETRAHYDROCANNABIVARIN | (6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol | PubChem SID:198957879 | DrugBank ID:DB11755 | CAS RN:31262-37-0 | Tetrahydrocannabivarin | PubChem CID:93147"
+BMGC_DG16546,BMG_DG212436,"11-(1-azabicyclo[2.2.2]octan-3-yl)-5,6-dihydrobenzo[b][1]benzazepine | CAS RN:31721-17-2 | QUINUPRAMINE | Quinupramine | PubChem CID:93154 | PubChem SID:198941326 | UNII:29O61HFF4L | DrugBank ID:DB13246"
+BMGC_DG16547,BMG_DG212442,"PubChem CID:93168 | UNII:L49D7PR96D | PubChem SID:198955730 | 2-(3,4-dimethoxyphenyl)-5-(methylamino)-2-propan-2-ylpentanenitrile | D-617 | 3-(3,4-Dimethoxyphenyl)-2-methyl-6-methylaminohexane-3-carbonitrile | CAS RN:34245-14-2"
+BMGC_DG16548,BMG_DG212446,"(4R)-1,3-thiazolidine-4-carboxylic acid | DrugBank ID:DB02846 | UNII:KL096K0KXL | L-thioproline | L-Thioproline | TIMONACIC, (R)- | CAS RN:34592-47-7 | PubChem CID:93176 | PubChem SID:198972647"
+BMGC_DG16549,BMG_DG212447,CAS RN:34846-64-5 | PubChem SID:475549894 | 3-Quinolinecarbonitrile | UNII:6GHZ8PDL63 | 3-QUINOLINECARBONITRILE | PubChem CID:93177
+BMGC_DG16550,BMG_DG212452,"DrugBank ID:DB09319 | PubChem CID:93184 | CAS RN:35531-88-5 | CARBENICILLIN INDANYL | PubChem SID:198988490 | (2S,5R,6R)-6-[[3-(2,3-dihydro-1H-inden-5-yloxy)-3-oxo-2-phenylpropanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | Carbenicillin indanyl | UNII:5V278481KE"
+BMGC_DG16551,BMG_DG212464,"5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one | CAS RN:67604-48-2 | PubChem CID:932 | CAS RN:93602-28-9 | 5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one"
+BMGC_DG16552,BMG_DG212469,CAS RN:302-01-2 | Hydrazine | hydrazine | CAS RN:119775-10-9 | UNII:27RFH0GB4R | HYDRAZINE | PubChem SID:198985064 | PubChem CID:9321
+BMGC_DG16553,BMG_DG212472,1-ETHYLTHEOBROMINE | PubChem CID:93219 | UNII:9T24XXI18T | CAS RN:39832-36-5 | PubChem SID:198966245
+BMGC_DG16554,BMG_DG212473,Thiocyanate | PubChem CID:9322 | CAS RN:302-04-5 | CAS RN:71048-69-6 | THIOCYANATE ION | UNII:O748SU14OM | thiocyanate | PubChem SID:363909140
+BMGC_DG16555,BMG_DG212495,"PubChem CID:93250 | 2-OXOQUAZEPAM | PubChem SID:252164471 | CAS RN:49606-44-2 | 2-Oxoquazepam | 7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-2-one | UNII:8T62S796K7"
+BMGC_DG16556,BMG_DG212515,"Benactyzine | BENACTYZINE | CAS RN:302-40-9 | PubChem CID:9330 | DrugBank ID:DB09023 | UNII:595EG71R3F | 2-(diethylamino)ethyl 2-hydroxy-2,2-diphenylacetate | PubChem SID:198987026"
+BMGC_DG16557,BMG_DG212522,"PIRITRAMIDE | PubChem SID:198960917 | PubChem CID:9331 | DrugBank ID:DB12492 | CAS RN:302-41-0 | UNII:4RP92LYZ2F | 1-(3-cyano-3,3-diphenylpropyl)-4-piperidin-1-ylpiperidine-4-carboxamide | Piritramide"
+BMGC_DG16558,BMG_DG212561,"PubChem SID:472406102 | CAS RN:67564-91-4 | (2R,6S)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine | PubChem CID:93365 | Fenpropimorph | UNII:4548UM725F | FENPROPIMORPH"
+BMGC_DG16559,BMG_DG212566,"UNII:RSA5G6VRPV | PubChem CID:9338 | 2,6-dihydroxybenzoic acid | PubChem SID:198953362 | CAS RN:303-07-1 | 2,6-DIHYDROXYBENZOIC ACID | 2,6-Dihydroxybenzoic acid"
+BMGC_DG16560,BMG_DG212571,DrugBank ID:DB14204 | UNII:OIS2CXW7AM | Nickel cation | CAS RN:14701-22-5 | PubChem SID:175267289 | NICKEL CATION | PubChem CID:934 | nickel(2+)
+BMGC_DG16561,BMG_DG212574,PubChem CID:934131 | UNII:WT24YMB3D6 | CAS RN:432510-15-1 | N-(4-METHYLPHENYL)PHENOTHIAZINE-10-CARBOXAMIDE | PubChem SID:461433903
+BMGC_DG16562,BMG_DG212587,PubChem SID:198962380 | UNII:H2S3M5M720 | CAS RN:303-75-3 | PubChem CID:9345 | RO-4-1284
+BMGC_DG16563,BMG_DG212602,PubChem CID:9348 | 3-PHENYLSALICYLIC ACID | UNII:3327W9W36P | PubChem SID:329904003 | CAS RN:304-06-3
+BMGC_DG16564,BMG_DG212623,"CROMAKALIM | UNII:RW7PN4BLDJ | CAS RN:94535-50-9 | PubChem SID:198959342 | CAS RN:94470-67-4 | PubChem CID:93504 | PubChem SID:198975025 | Levcromakalim | UNII:0G4X367WA3 | LEVCROMAKALIM | (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)-3,4-dihydrochromene-6-carbonitrile"
+BMGC_DG16565,BMG_DG212624,UNII:MR69RTSOVN | PubChem SID:346538478 | PubChem CID:93505 | 6-AMINO-2-BENZOTHIAZOLESULFONAMIDE | CAS RN:94641-11-9
+BMGC_DG16566,BMG_DG212640,"DrugBank ID:DB14089 | PubChem CID:9354 | 2,3-bis(sulfanyl)butanedioic acid | Dimercaptosuccinic Acid | CAS RN:2418-14-6"
+BMGC_DG16567,BMG_DG212659,"CAS RN:6160-78-7 | 4-Methylumbelliferyl-galactopyranoside | 4-methyl-7-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one | PubChem CID:93577"
+BMGC_DG16568,BMG_DG212667,NDC:84712-038 | NDC:83872-408 | Nicotinamide | NDC:84037-0098 | NDC:84037-0029 | NDC:83872-409 | NDC:84025-282 | NDC:84037-0005 | NDC:84372-018 | NDC:84037-0103 | NDC:73466-0008 | NDC:84716-112 | NDC:83872-031 | NDC:73590-0029 | PubChem SID:175266673 | NDC:84372-049 | NDC:83872-034 | NDC:73590-0041 | NDC:83872-378 | NDC:83872-032 | NDC:84037-0008 | NDC:84372-056 | NDC:84019-025 | NDC:84025-262 | NDC:82083-0028 | NDC:82160-771 | pyridine-3-carboxamide | NDC:74458-234 | NDC:84558-004 | NDC:83872-385 | NDC:73590-0025 | NDC:83071-140 | NDC:84423-010 | CAS RN:98-92-0 | UNII:25X51I8RD4 | NDC:84037-0026 | NDC:84763-002 | CAS RN:11032-50-1 | NDC:82160-757 | NDC:73590-0027 | NDC:84028-112 | NDC:83872-212 | NDC:84037-0106 | NDC:84037-0099 | PubChem CID:936 | NDC:83872-211 | NDC:83872-272 | NDC:73590-0026 | NDC:84037-0028 | NDC:82237-0006 | NDC:73590-0050 | NDC:82083-0003 | NDC:73590-0075 | NDC:84673-012 | NDC:82083-0029 | NDC:82083-0023 | NDC:83071-110 | NDC:84673-004 | NDC:82237-0008 | NDC:84010-051 | NDC:73590-0028 | NDC:84673-011 | NDC:84778-025 | NDC:84712-042 | NDC:84673-006 | NDC:82237-0007 | DrugBank ID:DB02701 | Niacinamide | NDC:84037-0018 | NDC:82237-0005 | NDC:84673-013 | NDC:84037-0027 | NDC:73509-030 | NIACINAMIDE | NDC:74458-165 | NDC:84372-044 | NDC:84844-005 | NDC:83872-444
+BMGC_DG16569,BMG_DG212669,"PubChem SID:475549982 | UNII:W3Z3JV25J5 | PubChem CID:93617 | 5-((4-(DIMETHYLAMINO)PHENYL)METHYLENE)-1,3-DIMETHYLBARBITURIC ACID | CAS RN:57270-81-2"
+BMGC_DG16570,BMG_DG212672,"Ethamivan | UNII:M44O63YPV9 | DrugBank ID:DB08989 | CAS RN:304-84-7 | Etamivan | ETHAMIVAN | PubChem CID:9363 | PubChem SID:198936076 | N,N-diethyl-4-hydroxy-3-methoxybenzamide"
+BMGC_DG16571,BMG_DG212692,PubChem CID:937 | Nicotinate | pyridine-3-carboxylate
+BMGC_DG16572,BMG_DG212705,"DrugBank ID:DB09252 | PIVHYDRAZINE | UNII:TK1T520ASG | PubChem SID:198970863 | Pivhydrazine | N'-benzyl-2,2-dimethylpropanehydrazide | PubChem CID:9375 | CAS RN:306-19-4"
+BMGC_DG16573,BMG_DG212717,DrugBank ID:DB00627 | NDC:50268-584 | NDC:84712-001 | NDC:62175-322 | NDC:65162-322 | NDC:47335-614 | NDC:59651-018 | NDC:33342-187 | NDC:47335-539 | NDC:68180-222 | NDC:65162-321 | NDC:59651-020 | NDC:47335-613 | UNII:2679MF687A | NDC:33342-189 | CAS RN:101113-41-1 | NIACIN | Niacin | pyridine-3-carboxylic acid | NDC:71740-001 | NDC:62175-320 | NDC:59651-019 | NDC:62135-497 | NDC:51407-267 | NDC:62135-498 | NDC:72919-420 | NDC:65162-323 | PubChem SID:175268797 | PubChem CID:938 | Nicotinic acid | NDC:51407-268 | NDC:71741-020 | CAS RN:59-67-6
+BMGC_DG16574,BMG_DG212768,DrugBank ID:DB13495 | UNII:Q9CX8P80JW | diethyl (4-nitrophenyl) phosphate | PARAOXON | Paraoxon | PubChem SID:198985639 | CAS RN:311-45-5 | PubChem CID:9395
+BMGC_DG16575,BMG_DG212778,PubChem SID:441658634 | CAS RN:312-30-1 | UNII:DBR958H7K9 | DIFLUORODINITROBENZENE SULFONE | PubChem CID:9398
+BMGC_DG16576,BMG_DG212789,"PubChem SID:175267692 | UNII:2BP70L44PR | PubChem CID:9400 | DEXAMETHASONE PHOSPHATE | [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate | Dexamethasone phosphate | CAS RN:312-93-6"
+BMGC_DG16577,BMG_DG212801,"NDC:0009-0271 | Estradiol Cypionate | PubChem SID:175267496 | PubChem CID:9403 | Estradiol cypionate | UNII:7E1DV054LO | [(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] 3-cyclopentylpropanoate | DrugBank ID:DB13954 | CAS RN:313-06-4 | ESTRADIOL CYPIONATE"
+BMGC_DG16578,BMG_DG212815,"Evans blue | PubChem CID:9409 | CAS RN:314-13-6 | PubChem SID:198968784 | tetrasodium;4-amino-6-[[4-[4-[(8-amino-1-hydroxy-5,7-disulfonatonaphthalen-2-yl)diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]-5-hydroxynaphthalene-1,3-disulfonate | UNII:45PG892GO1 | EVANS BLUE"
+BMGC_DG16579,BMG_DG212831,CAS RN:130-49-4 | ADENOSINE 2'-MONOPHOSPHATE | PubChem CID:94136 | PubChem SID:249817389 | UNII:W907528R6O
+BMGC_DG16580,BMG_DG212832,FLUNARIZINE | CAS RN:52468-60-7 | PubChem CID:941361 | DrugBank ID:DB04841 | CAS RN:40218-96-0 | Flunarizine | PubChem SID:175266809 | 1-[bis(4-fluorophenyl)methyl]-4-[(E)-3-phenylprop-2-enyl]piperazine | UNII:R7PLA2DM0J
+BMGC_DG16581,BMG_DG212836,"stearoyl-CoA | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] octadecanethioate | UNII:OBC49BV194 | PubChem SID:316914110 | STEARYL COENZYME A | PubChem CID:94140 | CAS RN:362-66-3"
+BMGC_DG16582,BMG_DG212837,"UNII:41G81C896T | CAS RN:382-44-5 | PubChem SID:198968799 | PubChem CID:94141 | (8S,9S,10R,11S,13S,14S)-11-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | 11beta-Hydroxyandrostenedione | 11.BETA.-HYDROXYANDROSTENEDIONE"
+BMGC_DG16583,BMG_DG212850,"NDC:0143-9750 | PubChem CID:9416 | [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] heptanoate | NDC:54436-275 | CAS RN:315-37-7 | Testosterone Enanthate | NDC:55150-336 | PubChem SID:175267236 | DrugBank ID:DB13944 | NDC:54436-200 | UNII:7Z6522T8N9 | TESTOSTERONE ENANTHATE | NDC:54436-250"
+BMGC_DG16584,BMG_DG212855,"(9E)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide | CAS RN:3313-27-7 | PubChem CID:941650 | CAS RN:5591-45-7 | UNII:7UE42HF37R | trans-Thiothixene | PubChem SID:241179858 | THIOTHIXENE, (E)-"
+BMGC_DG16585,BMG_DG212856,"NDC:70954-016 | PubChem CID:941651 | (9Z)-N,N-dimethyl-9-[3-(4-methylpiperazin-1-yl)propylidene]thioxanthene-2-sulfonamide | NDC:60219-1675 | CAS RN:5591-45-7 | CAS RN:3313-26-6 | NDC:60219-1673 | NDC:51407-276 | NDC:51407-277 | NDC:70954-017 | NDC:60219-1674 | DrugBank ID:DB01623 | Thiothixene | THIOTHIXENE | NDC:51407-275 | PubChem SID:175268220 | UNII:7318FJ13YJ | NDC:51407-278 | NDC:70954-015 | NDC:70954-014 | NDC:60219-1676"
+BMGC_DG16586,BMG_DG212861,2-[4-(3-benzo[b][1]benzazepin-11-ylpropyl)piperazin-1-yl]ethanol | CAS RN:315-72-0 | OPIPRAMOL | PubChem SID:175266219 | Opipramol | PubChem CID:9417 | DrugBank ID:DB12930 | UNII:D23ZXO613C
+BMGC_DG16587,BMG_DG212875,"PubChem SID:198954605 | CAS RN:4498-32-2 | DrugBank ID:DB13225 | PubChem CID:9419 | UNII:510SJZ1Y6L | 5-[2-(dimethylamino)ethyl]-11-methylbenzo[b][1,4]benzodiazepin-6-one | Dibenzepin | DIBENZEPIN"
+BMGC_DG16588,BMG_DG212877,Di-Stearoyl-3-Sn-Phosphatidylcholine | DrugBank ID:DB04178 | PubChem CID:94191
+BMGC_DG16589,BMG_DG212879,"Pregnenediol | (3S,8S,9S,10R,13S,14S,17S)-17-[(1S)-1-hydroxyethyl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol | UNII:3Z565YJO1O | PubChem SID:198960930 | PREGNENEDIOL | CAS RN:901-56-4 | PubChem CID:94194"
+BMGC_DG16590,BMG_DG212882,"PubChem CID:94199 | 1-[(1R,2S,4R,6S,7S,10S,11R,14S)-14-hydroxy-7,11-dimethyl-5-oxapentacyclo[8.8.0.02,7.04,6.011,16]octadec-16-en-6-yl]ethanone | 16-alpha,17-alpha-Epoxy-3-beta-hydroxypregn-5-en-20-one | CAS RN:974-23-2"
+BMGC_DG16591,BMG_DG212883,CAS RN:22083-74-5 | 3-(1-Methylpyrrolidin-2-yl)pyridine | PubChem CID:942 | CAS RN:75202-10-7 | 3-(1-methylpyrrolidin-2-yl)pyridine
+BMGC_DG16592,BMG_DG212890,"CAS RN:1824-94-8 | (2R,3R,4S,5R,6R)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol | PubChem SID:198965337 | METHYL .BETA.-D-GALACTOPYRANOSIDE | Methyl beta-galactoside | Methyl galactoside | DrugBank ID:DB04046 | PubChem CID:94214 | UNII:64RYD088RJ"
+BMGC_DG16593,BMG_DG212910,"DrugBank ID:DB01629 | CAS RN:316-46-1 | UNII:4K0M952561 | 5-FLUOROURIDINE | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoropyrimidine-2,4-dione | CAS RN:18814-21-6 | PubChem SID:198982484 | 5-fluorouridine | 5-Fluorouridine | PubChem CID:9427"
+BMGC_DG16594,BMG_DG212915,"PubChem CID:94280 | DIMETACRINE | UNII:O341NY501N | DrugBank ID:DB08996 | CAS RN:4757-55-5 | PubChem SID:198955695 | Dimetacrine | 3-(9,9-dimethylacridin-10-yl)-N,N-dimethylpropan-1-amine"
+BMGC_DG16595,BMG_DG212917,"(5Z)-7-{(1R,4S,5R,6R)-6-[(1E)-1-Octen-1-yl]-2,3-diazabicyclo[2.2.1]hept-2-en-5-yl}-5-heptenoic acid | DrugBank ID:DB08675 | PubChem CID:94286438"
+BMGC_DG16596,BMG_DG212920,"N,N-dimethyl-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine-2-sulfonamide | UNII:YJ050AQ56X | Thioproperazine | PubChem SID:198978662 | THIOPROPERAZINE | CAS RN:316-81-4 | PubChem CID:9429 | DrugBank ID:DB01622"
+BMGC_DG16597,BMG_DG212926,PubChem CID:943 | PubChem SID:175266067 | Nitrate | DrugBank ID:DB14049 | NITRATE ION | CAS RN:14797-55-8 | UNII:T93E9Y2844 | nitrate
+BMGC_DG16598,BMG_DG212933,"PubChem SID:316917390 | UNII:0D5FR359JO | PubChem CID:94312 | DIHYDROURIDINE | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4-dione | CAS RN:5627-05-4 | 5,6-Dihydrouridine"
+BMGC_DG16599,BMG_DG212939,"(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-acetyloxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid | PubChem SID:198946865 | UNII:CWW961Q19K | Acetoxolone | PubChem CID:94320 | ACETOXOLONE | DrugBank ID:DB13640 | CAS RN:6277-14-1"
+BMGC_DG16600,BMG_DG212944,"DrugBank ID:DB01223 | Aminophylline | CAS RN:95646-60-9 | CAS RN:317-34-0 | PubChem SID:175268503 | PubChem CID:9433 | 1,3-dimethyl-7H-purine-2,6-dione;ethane-1,2-diamine | UNII:27Y3KJK423 | AMINOPHYLLINE"
+BMGC_DG16601,BMG_DG212964,PubChem SID:198961973 | UNII:BO24ID7E9U | 1-(4-hydroxy-3-methoxyphenyl)decan-3-one | Paradol | PubChem CID:94378 | CAS RN:27113-22-0 | 1-(4-HYDROXY-3-METHOXYPHENYL)-DECAN-3-ONE
+BMGC_DG16602,BMG_DG212965,COUMARIN 7 | Coumarin 7 | PubChem SID:475549783 | UNII:VX3Q255SG5 | PubChem CID:94381 | CAS RN:27425-55-4
+BMGC_DG16603,BMG_DG212973,CAS RN:309963-65-3 | PubChem CID:944 | nitric acid | PubChem SID:175267980 | CAS RN:12033-49-7 | CAS RN:122392-03-4 | NITRIC ACID | UNII:411VRN1TV4 | CAS RN:78989-43-2 | Nitric acid | CAS RN:7697-37-2 | Nitric Acid
+BMGC_DG16604,BMG_DG212995,"CAS RN:32638-88-3 | PubChem CID:94437 | CAS RN:85531-30-2 | CAS RN:3172-49-4 | Pyrogallol Red | 1,1-dioxospiro[2,1lambda6-benzoxathiole-3,9'-xanthene]-3',4',5',6'-tetrol"
+BMGC_DG16605,BMG_DG212996,"PubChem SID:175266189 | AZACITIDINE | CAS RN:320-67-2 | CAS RN:1401238-97-8 | PubChem CID:9444 | 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one | UNII:M801H13NRU | DrugBank ID:DB00928 | Azacitidine"
+BMGC_DG16606,BMG_DG212997,Dansyl hydrazine | CAS RN:33008-06-9 | PubChem CID:94442 | 5-(dimethylamino)naphthalene-1-sulfonohydrazide
+BMGC_DG16607,BMG_DG213001,"PubChem SID:198976765 | 3,5-DICHLOROSALICYLIC ACID | CAS RN:320-72-9 | PubChem CID:9445 | UNII:O6PXR32G3V"
+BMGC_DG16608,BMG_DG213005,UNII:5IO1HZP7ZN | 1-(2-PYRIDINYL)PIPERAZINE | PubChem CID:94459 | PubChem SID:375579456 | CAS RN:34803-66-2
+BMGC_DG16609,BMG_DG213007,UNII:4QT7M9V35S | PubChem SID:485661274 | CAS RN:35203-91-9 | 8-Quinolinesulfonamide | 8-QUINOLINESULFONAMIDE | PubChem CID:94464
+BMGC_DG16610,BMG_DG213009,5-Chlorosalicylic Acid | PubChem SID:198953120 | 5-CHLOROSALICYLIC ACID | UNII:J2YFG68VCZ | 5-chloro-2-hydroxybenzoic acid | CAS RN:321-14-2 | PubChem CID:9447
+BMGC_DG16611,BMG_DG213010,"3-(SALICYLOYLAMINO)-1,2,4-TRIAZOLE | PubChem SID:474489489 | PubChem CID:94473 | CAS RN:36411-52-6 | UNII:ZFV6FN7NKV"
+BMGC_DG16612,BMG_DG213018,"UNII:P7Q15MLX1X | CAS RN:71276-50-1 | PubChem SID:198977566 | PubChem SID:198951056 | CAS RN:38976-17-9 | .ALPHA.-TOCOPHEROL PHOSPHATE, DL- | PubChem CID:94493 | UNII:V7EZ83SETP | .ALPHA.-TOCOPHEROL PHOSPHATE, D-"
+BMGC_DG16613,BMG_DG213044,"UNII:2Y6VQU63E8 | ETAFEDRINE | (1R,2S)-2-[ethyl(methyl)amino]-1-phenylpropan-1-ol | CAS RN:48141-64-6 | PubChem SID:198974510 | (1r,2s)-2-[Ethyl(methyl)amino]-1-phenylpropan-1-ol | PubChem CID:94532 | DrugBank ID:DB11587"
+BMGC_DG16614,BMG_DG213045,PubChem CID:9454 | Haloxon | bis(2-chloroethyl) (3-chloro-4-methyl-2-oxochromen-7-yl) phosphate | DrugBank ID:DB11419 | HALOXON | UNII:T8KXA37068 | PubChem SID:198980182 | CAS RN:321-55-1
+BMGC_DG16615,BMG_DG213055,"UNII:UDY8JGH6TS | PubChem SID:474490939 | p-(3,3-Dimethyl-1-triazeno)benzenesulfonamide | PubChem CID:94575 | P-(3,3-DIMETHYL-1-TRIAZENO)BENZENESULFONAMIDE | CAS RN:55469-64-2"
+BMGC_DG16616,BMG_DG213059,CAS RN:322-79-2 | Triflusal | PubChem SID:198951020 | 2-acetyloxy-4-(trifluoromethyl)benzoic acid | PubChem CID:9458 | UNII:1Z0YFI05OO | TRIFLUSAL | DrugBank ID:DB08814
+BMGC_DG16617,BMG_DG213064,"[3-(Dodecanoylamino)propyl](hydroxy)dimethylammonium | UNII:I6KX160QTV | 3-(dodecanoylamino)-N,N-dimethylpropan-1-amine oxide | DrugBank ID:DB01736 | CAS RN:61792-31-2 | PubChem SID:175265406 | PubChem CID:94599 | [3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium | LAURAMIDOPROPYLAMINE OXIDE"
+BMGC_DG16618,BMG_DG213065,UNII:J39976L608 | Nitrite Ion | CAS RN:14797-65-0 | NITRITE ION | PubChem SID:175266456 | Nitrite | DrugBank ID:DB12529 | PubChem CID:946 | nitrite
+BMGC_DG16619,BMG_DG213093,UNII:N762921K75 | molecular nitrogen | DrugBank ID:DB09152 | PubChem CID:947 | Nitrogen | CAS RN:7727-37-9 | NITROGEN
+BMGC_DG16620,BMG_DG213094,CAS RN:553-69-5 | PubChem CID:9470 | Fenyramidol | UNII:R3V02WL7O3 | DrugBank ID:DB13414 | PHENYRAMIDOL | 1-phenyl-2-(pyridin-2-ylamino)ethanol | PubChem SID:198956877
+BMGC_DG16621,BMG_DG213095,"(2S,3S)-2-[[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-methylpentanoic acid | PubChem CID:94701 | CAS RN:90614-48-5 | Diprotin A"
+BMGC_DG16622,BMG_DG213098,CAS RN:1198-40-9 | 7-CHLORO-4-AMINOQUINOLINE | UNII:2SJ6Y866TU | PubChem CID:94711 | PubChem SID:440088291
+BMGC_DG16623,BMG_DG213107,"UNII:G6D9CL80W9 | PubChem CID:94727 | PubChem SID:376071992 | CAS RN:5333-03-9 | 2,5-BIS(4-METHOXYPHENYL)-2,5-CYCLOHEXADIENE-1,4-DIONE"
+BMGC_DG16624,BMG_DG213130,"PubChem CID:947740 | 2-PYRIDIN-2-YL-3H-IMIDAZO(4,5-C)PYRIDINE | PubChem SID:478838342 | 2-Pyridin-2-yl-3H-imidazo(4,5-c)pyridine | UNII:L7ZH585NW9 | CAS RN:14060-62-9"
+BMGC_DG16625,BMG_DG213147,Nitrous Oxide | NDC:42751-1075 | NDC:46123-006 | DrugBank ID:DB06690 | NDC:43621-003 | NDC:48273-002 | UNII:K50XQU1029 | NDC:52085-003 | NDC:54218-800 | NDC:67477-002 | NDC:33335-003 | PubChem SID:175268716 | NDC:44076-012 | NDC:53440-003 | PubChem CID:948 | CAS RN:10024-97-2 | NDC:18482-002 | NDC:24312-003 | NDC:10014-003 | NDC:50554-005 | NDC:34057-010 | NDC:54260-001 | CAS RN:100240-04-8 | NDC:72343-001 | NDC:63978-201 | NDC:62273-005 | NDC:46362-003 | NDC:55404-002 | NDC:20703-003 | NDC:46123-007 | NDC:59579-004 | NDC:12121-002 | NDC:51486-007 | NDC:10167-200 | NDC:12213-593 | NDC:17575-011 | NDC:22557-003 | NDC:52568-002 | NDC:55037-301 | NITROUS OXIDE | Nitrous oxide | NDC:53511-003 | NDC:67525-400 | NDC:21220-122 | NDC:11054-007 | NDC:72276-002 | NDC:52086-015 | nitrous oxide | NDC:55050-0018 | NDC:42602-003 | NDC:62097-0004 | NDC:84120-003 | NDC:44517-020 | NDC:70151-004 | NDC:49575-003
+BMGC_DG16626,BMG_DG213197,UNII:SW12CAS9T7 | PubChem SID:377308771 | PubChem CID:94880 | 2-AMINONAPHTHIAZOLE | CAS RN:40172-65-4
+BMGC_DG16627,BMG_DG213209,UNII:A05OL9V6OM | PubChem CID:94904 | CAS RN:1839-18-5 | PubChem SID:461434943 | 2-CHLOROADENINE
+BMGC_DG16628,BMG_DG213211,"1,1'-BINAPHTHYL-8,8'-DICARBOXYLIC ACID | PubChem CID:94908 | 1,1'-Binaphthyl-8,8'-dicarboxylic acid | UNII:9TV2DT592L | PubChem SID:474490251 | CAS RN:29878-91-9"
+BMGC_DG16629,BMG_DG213236,"PubChem CID:94952 | PubChem SID:472421830 | 2,5-Difluorophenol | 2,5-DIFLUOROPHENOL | UNII:53EYY8S7LA | CAS RN:2713-31-7"
+BMGC_DG16630,BMG_DG213243,PubChem CID:94960 | UNII:X2NM84QRZ0 | 6-METHYL-2-PYRIDONE-3-CARBOXYLIC ACID | CAS RN:38116-61-9 | PubChem SID:441331948
+BMGC_DG16631,BMG_DG213276,"Isoluminol | ISOLUMINOL | PubChem CID:95014 | CAS RN:3682-14-2 | 6-amino-2,3-dihydrophthalazine-1,4-dione | DrugBank ID:DB02041 | PubChem SID:438788122 | UNII:5ID1912ANA"
+BMGC_DG16632,BMG_DG213289,UNII:WC4T5K5JUC | CAS RN:1807-85-8 | 7-BENZYLTHEOPHYLLINE | PubChem CID:95028
+BMGC_DG16633,BMG_DG213304,CAS RN:24065-33-6 | PubChem CID:95048 | PubChem SID:441658563 | 5-CHLORO-2-THIOPHENECARBOXYLIC ACID | UNII:XV5SRC3PJ3
+BMGC_DG16634,BMG_DG213306,PubChem CID:95054 | DrugBank ID:DB04196 | Pteroic acid
+BMGC_DG16635,BMG_DG213308,"Phenol, p-(1,2,3,6-tetrahydro-1-methyl-4-pyridyl)- | PubChem SID:474493221 | 4-(1,2,3,6-Tetrahydro-1-methyl-4-pyridinyl)phenol | 4-(1,2,3,6-TETRAHYDRO-1-METHYL-4-PYRIDINYL)PHENOL | CAS RN:5233-54-5 | PubChem CID:95056 | 4-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)phenol | UNII:UQ66U8BXY4"
+BMGC_DG16636,BMG_DG213341,"PubChem SID:198948011 | 4-(2-amino-1-hydroxyethyl)benzene-1,2-diol | PubChem CID:951 | CAS RN:586-17-4 | CAS RN:104655-07-4 | NORADRENALINE, (±)- | 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)- | NORADRENALINE, (+/-)- | UNII:K294OAI79V | CAS RN:138-65-8"
+BMGC_DG16637,BMG_DG213352,PubChem CID:95121 | 9-CYCLOHEXYLADENINE | UNII:KJ42775NZE | CAS RN:4235-94-3
+BMGC_DG16638,BMG_DG213356,PubChem SID:474490663 | 1-(2-PHENYLETHYL)PIPERIDINE | 1-(2-Phenylethyl)piperidine | UNII:5TY7C52M7F | CAS RN:332-14-9 | PubChem CID:9513
+BMGC_DG16639,BMG_DG213366,PubChem SID:441658715 | 4-NITROPHENETHYLAMINE | CAS RN:24954-67-4 | PubChem CID:95153 | UNII:SAS3H3GQM9
+BMGC_DG16640,BMG_DG213386,PubChem SID:198978124 | CAS RN:482-53-1 | OSAJIN | PubChem CID:95168 | UNII:83R5N9X74B
+BMGC_DG16641,BMG_DG213388,"CAS RN:5436-43-1 | 2,2',4,4'-Tetrabromodiphenyl ether | PubChem SID:198989640 | 2,4-dibromo-1-(2,4-dibromophenoxy)benzene | PubChem CID:95170 | UNII:0N97R5X10X | 2,2',4,4'-TETRABROMODIPHENYL ETHER"
+BMGC_DG16642,BMG_DG213391,2-Amino-3-(4-aminophenyl)propanoic acid | PubChem CID:95174 | 2-amino-3-(4-aminophenyl)propanoic acid | CAS RN:2922-41-0
+BMGC_DG16643,BMG_DG213429,N-2-NAPHTHYLANTHRANILIC ACID | CAS RN:4800-34-4 | UNII:QC2JBA8UJT | PubChem SID:440793721 | PubChem CID:95272
+BMGC_DG16644,BMG_DG213433,"FLUROTHYL | PubChem SID:198944547 | PubChem CID:9528 | 1,1,1-trifluoro-2-(2,2,2-trifluoroethoxy)ethane | Flurothyl | CAS RN:333-36-8 | DrugBank ID:DB08969 | UNII:9Z467FG2YK"
+BMGC_DG16645,BMG_DG213480,ANISOIN | Anisoin | CAS RN:119-52-8 | UNII:KUY567Z2QL | PubChem SID:485663020 | PubChem CID:95415
+BMGC_DG16646,BMG_DG213499,"PubChem CID:9543026 | S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] prop-2-enethioate | CAS RN:5776-58-9 | ACRYLOYL-COA | Acryloyl-coa | PubChem SID:472425974 | UNII:PV7BP6Q8B6"
+BMGC_DG16647,BMG_DG213704,PubChem CID:9543420 | DrugBank ID:DB08507 | N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID
+BMGC_DG16648,BMG_DG213705,DrugBank ID:DB02895 | PubChem CID:9543424 | 3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol
+BMGC_DG16649,BMG_DG213708,Methyl Methylsulfinylmethyl Sulfide | PubChem CID:9543427 | DrugBank ID:DB02311
+BMGC_DG16650,BMG_DG213710,PubChem CID:9543437 | 4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE | DrugBank ID:DB07607
+BMGC_DG16651,BMG_DG213712,"PubChem CID:9543443 | DrugBank ID:DB04222 | SPARSOMYCIN | (E)-N-[(2S)-1-hydroxy-3-[(R)-methylsulfanylmethylsulfinyl]propan-2-yl]-3-(6-methyl-2,4-dioxo-1H-pyrimidin-5-yl)prop-2-enamide | PubChem SID:198937057 | UNII:6C940P63E7 | Sparsomycin | CAS RN:1404-64-4"
+BMGC_DG16652,BMG_DG213715,"DrugBank ID:DB07522 | N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE | PubChem CID:9543486"
+BMGC_DG16653,BMG_DG213716,"DrugBank ID:DB07527 | N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE | PubChem CID:9543487"
+BMGC_DG16654,BMG_DG213721,"(4R)-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one | 1-(3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-YL)-4-hydroxy-tetrahydro-pyrimidin-2-one | PubChem CID:9543506"
+BMGC_DG16655,BMG_DG213722,"PubChem CID:9543517 | DrugBank ID:DB08097 | 2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE"
+BMGC_DG16656,BMG_DG213723,"DrugBank ID:DB07276 | PubChem CID:9543521 | 5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE"
+BMGC_DG16657,BMG_DG213724,DrugBank ID:DB02871 | PubChem CID:9543528 | 3-Butylthiolane 1-Oxide
+BMGC_DG16658,BMG_DG213729,N1-(2-Aminophenyl)-N7-phenylheptanediamide | PubChem CID:9543539 | CAS RN:537034-15-4 | N'-(2-aminophenyl)-N-phenylheptanediamide
+BMGC_DG16659,BMG_DG213730,CAS RN:537034-17-6 | N'-(2-aminophenyl)-N-phenyloctanediamide | PubChem CID:9543540 | Bml-210
+BMGC_DG16660,BMG_DG213755,"PubChem SID:198952077 | UNII:0B6KAM5VNK | GLYCERYL 1,2-DIOLEATE, (S)- | 1,2-Dioleoyl-Sn-Glycerol | [(2S)-3-hydroxy-2-[(Z)-octadec-9-enoyl]oxypropyl] (Z)-octadec-9-enoate | PubChem CID:9543716 | CAS RN:24529-88-2"
+BMGC_DG16661,BMG_DG214343,1-(9Z-octadecenoyl)-sn-glycero-3-phosphoserine | PubChem CID:9547099 | (2S)-2-amino-3-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid
+BMGC_DG16662,BMG_DG214356,1-Myristoyl-sn-glycerol 3-phosphate | CAS RN:65446-07-3 | [(2R)-2-hydroxy-3-phosphonooxypropyl] tetradecanoate | PubChem CID:9547180
+BMGC_DG16663,BMG_DG214360,"Bufalin | UNII:U549S98QLW | PubChem CID:9547215 | 5-[(3S,5R,8R,9S,10S,13R,14S,17R)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one | CAS RN:465-21-4 | BUFALIN | PubChem SID:241180814"
+BMGC_DG16664,BMG_DG214370,"(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-5-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | DrugBank ID:DB06117 | 1.ALPHA.,24S-DIHYDROXYVITAMIN D2 | PubChem CID:9547261 | UNII:2900I92Z36 | CAS RN:156316-85-7 | 1alpha,24S-Dihydroxyvitamin D2 | PubChem SID:198976202"
+BMGC_DG16665,BMG_DG214371,"(3R)-3-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]butanoic acid | PubChem SID:198974668 | CAS RN:71204-89-2 | UNII:F7KIE52YT0 | CALCITROIC ACID | PubChem CID:9547273 | Calcitroic acid"
+BMGC_DG16666,BMG_DG214373,"PubChem CID:9547326 | 19-NOR-1.ALPHA.,25-DIHYDROXYVITAMIN D3 | PubChem SID:346536861 | CAS RN:130447-37-9 | UNII:K5ZM856PSA"
+BMGC_DG16667,BMG_DG214387,"N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide | DrugBank ID:DB04101 | PubChem CID:9547884"
+BMGC_DG16668,BMG_DG214388,PubChem CID:9547890 | 6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE | DrugBank ID:DB08247
+BMGC_DG16669,BMG_DG214389,DrugBank ID:DB07053 | 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID | PubChem CID:9547900
+BMGC_DG16670,BMG_DG214390,DrugBank ID:DB07968 | N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA | PubChem CID:9547901
+BMGC_DG16671,BMG_DG214391,"DrugBank ID:DB07216 | PubChem CID:9547909 | (11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE"
+BMGC_DG16672,BMG_DG214392,PubChem CID:9547915 | ISOTHIAZOLIDINONE ANALOG | DrugBank ID:DB08003
+BMGC_DG16673,BMG_DG214393,PubChem CID:9547919 | N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE | DrugBank ID:DB07651
+BMGC_DG16674,BMG_DG214394,"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE | DrugBank ID:DB07605 | PubChem CID:9547923"
+BMGC_DG16675,BMG_DG214395,"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE | DrugBank ID:DB07763 | PubChem CID:9547935"
+BMGC_DG16676,BMG_DG214397,PubChem CID:9547939 | DrugBank ID:DB06923 | 2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE
+BMGC_DG16677,BMG_DG214398,PubChem CID:9547940 | 2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE | DrugBank ID:DB06918
+BMGC_DG16678,BMG_DG214399,(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE | DrugBank ID:DB08195 | PubChem CID:9547943
+BMGC_DG16679,BMG_DG214400,PubChem CID:9547945 | DrugBank ID:DB08184 | 2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE
+BMGC_DG16680,BMG_DG214401,PubChem CID:9547958 | DrugBank ID:DB07197 | 4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID
+BMGC_DG16681,BMG_DG214402,PubChem CID:9547959 | 4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID | DrugBank ID:DB07130
+BMGC_DG16682,BMG_DG214406,DrugBank ID:DB08678 | PubChem CID:9547998 | (4-ETHYLPHENYL)SULFAMIC ACID
+BMGC_DG16683,BMG_DG214413,"2-[[(4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate | 2-[(3alpha-Hydroxy-24-oxo-5beta-cholan-24-yl)amino]ethanesulfonate | PubChem CID:9548567"
+BMGC_DG16684,BMG_DG214422,"CAS RN:474-25-9 | (4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate | Chenodeoxycholate anion | PubChem CID:9548590"
+BMGC_DG16685,BMG_DG214429,DrugBank ID:DB13191 | PHOSPHOCREATINE | UNII:020IUV4N33 | 2-[methyl-[(E)-N'-phosphonocarbamimidoyl]amino]acetic acid | PubChem CID:9548602 | Phosphocreatine | PubChem SID:198938141 | CAS RN:67-07-2
+BMGC_DG16686,BMG_DG214450,"Deoxycholate | PubChem CID:9548661 | (4R)-4-[(3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate"
+BMGC_DG16687,BMG_DG214482,"PubChem CID:9548794 | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonate | Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-"
+BMGC_DG16688,BMG_DG214501,"(Glycolato-O,O')diammineplatinum(II) | PubChem CID:9548889 | CAS RN:95734-82-0 | azane;2-hydroxyacetic acid;platinum(2+) | Nedaplatin | DrugBank ID:DB13145"
+BMGC_DG16689,BMG_DG214516,"CAS RN:20562-02-1 | (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-[[(1S,2S,7S,10R,11S,14S,15R,16S,17R,20S,23S)-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.02,11.05,10.015,23.017,22]tetracos-4-en-7-yl]oxy]-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol | PubChem CID:9549171 | CAS RN:51938-42-2 | Solanin"
+BMGC_DG16690,BMG_DG214519,CAS RN:1011733-40-6 | UNII:ZP488KVU9Q | DrugBank ID:DB06871 | PubChem CID:9549180 | 17-METHYL-17-ALPHA-DIHYDROEQUILENIN | 17.BETA.-METHYL-17.ALPHA.-DIHYDROEQUILENIN | PubChem SID:441097558
+BMGC_DG16691,BMG_DG214520,PubChem CID:9549184 | CAS RN:869748-10-7 | PubChem SID:198991030 | UNII:U9855G2ZPR | A-770041
+BMGC_DG16692,BMG_DG214522,"UNII:06IVK87M04 | Pu-h71 | Zelavespib | CAS RN:873436-91-0 | DrugBank ID:DB12638 | 8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine | PubChem SID:198944362 | PubChem CID:9549213 | ZELAVESPIB"
+BMGC_DG16693,BMG_DG214523,"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE | DrugBank ID:DB07747 | PubChem CID:9549217"
+BMGC_DG16694,BMG_DG214524,PubChem CID:9549223 | 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE | DrugBank ID:DB06884
+BMGC_DG16695,BMG_DG214525,"PubChem CID:9549225 | (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID | DrugBank ID:DB06908"
+BMGC_DG16696,BMG_DG214526,PubChem CID:9549257 | 5-Chloro-N-{(3S)-1-[(2S)-1-(4-morpholinyl)-1-oxo-2-propanyl]-2-oxo-3-pyrrolidinyl}-1H-indole-2-sulfonamide | DrugBank ID:DB07848
+BMGC_DG16697,BMG_DG214527,DrugBank ID:DB07844 | 6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE | PubChem CID:9549258
+BMGC_DG16698,BMG_DG214528,5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE | PubChem CID:9549259 | DrugBank ID:DB07843
+BMGC_DG16699,BMG_DG214532,KRN-633 | UNII:E1V875I8DX | PubChem SID:318691663 | CAS RN:286370-15-8 | PubChem CID:9549295
+BMGC_DG16700,BMG_DG214533,Syk Inhibitor II | PubChem SID:472410702 | SYK INHIBITOR II | UNII:DHY3UC4XFH | PubChem CID:9549296 | CAS RN:726695-51-8
+BMGC_DG16701,BMG_DG214534,N-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide | PubChem CID:9549299 | CAS RN:879127-07-8 | EGFR inhibitor
+BMGC_DG16702,BMG_DG214535,C-1368 | PubChem CID:9549303 | PubChem SID:441096911 | N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE | CAS RN:879127-16-9 | UNII:E9Q3ZU9CRL | DrugBank ID:DB07545
+BMGC_DG16703,BMG_DG214536,PubChem CID:9549305 | PQ-401 | UNII:2N3LV83S8J | PubChem SID:198936454 | CAS RN:196868-63-0
+BMGC_DG16704,BMG_DG214546,O-SUCCINYLBENZOATE | PubChem SID:438788182 | CAS RN:27415-09-4 | UNII:XX4Y7I0FTT | DrugBank ID:DB02251 | O-Succinylbenzoate | PubChem CID:955
+BMGC_DG16705,BMG_DG214557,CHLORHEXIDINE | NDC:84509-012 | CAS RN:55-56-1 | NDC:84509-041 | CAS RN:1246816-96-5 | PubChem SID:175266234 | NDC:84288-005 | PubChem CID:9552079 | UNII:R4KO0DY52L | NDC:84288-001 | Chlorhexidine | DrugBank ID:DB00878 | (1E)-2-[6-[[amino-[(E)-[amino-(4-chloroanilino)methylidene]amino]methylidene]amino]hexyl]-1-[amino-(4-chloroanilino)methylidene]guanidine
+BMGC_DG16706,BMG_DG214562,"Furaltadone | UNII:5X4V82ZN30 | CAS RN:3795-88-8 | PubChem SID:198941205 | 5-(morpholin-4-ylmethyl)-3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one | CAS RN:139-91-3 | FURALTADONE | PubChem CID:9553856"
+BMGC_DG16707,BMG_DG214585,UNII:2DZZ7LKL6G | CAS RN:2366254-89-7 | ((5-AMINOISOQUINOLIN-1-YL)METHYLIDENEAMINO)THIOUREA | [(5-Aminoisoquinolin-1-yl)methylideneamino]thiourea | PubChem SID:478838126 | PubChem CID:9554793
+BMGC_DG16708,BMG_DG214616,"CAS RN:64165-64-6 | CAS RN:50428-03-0 | PubChem CID:95575 | PubChem SID:198955757 | UNII:FU67PLJ48R | PROPARGYLGLYCINE, DL- | 2-aminopent-4-ynoic acid | DL-Propargylglycine"
+BMGC_DG16709,BMG_DG214644,PubChem CID:9562061 | Trypan blue free acid | DrugBank ID:DB09158
+BMGC_DG16710,BMG_DG214656,DrugBank ID:DB13406 | Carbutamide | UNII:E3K8P4869P | CARBUTAMIDE | PubChem SID:198979799 | PubChem CID:9564 | CAS RN:339-43-5 | 1-(4-aminophenyl)sulfonyl-3-butylurea
+BMGC_DG16711,BMG_DG214659,PubChem CID:9565 | Glymidine | CAS RN:339-44-6 | PubChem SID:198954932 | DrugBank ID:DB01382 | N-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzenesulfonamide | UNII:4C5I4BQZ8F | GLYMIDINE
+BMGC_DG16712,BMG_DG214671,UNII:W2BST3D58N | PubChem SID:198969099 | CAS RN:14934-27-1 | PubChem CID:9566592 | 1-(4-HYDROXYPHENYLAZO)-2-NAPHTHOL
+BMGC_DG16713,BMG_DG214675,"(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one | (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-[4-(Dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-(5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-oxacyclotetradecan-2-one | CAS RN:80214-83-1 | PubChem CID:9567573"
+BMGC_DG16714,BMG_DG214679,"GUANOXABENZ | PubChem SID:198973437 | CAS RN:24047-25-4 | UNII:P9HIK5V7WK | PubChem CID:9567831 | Guanoxabenz | 2-[(E)-(2,6-dichlorophenyl)methylideneamino]-1-hydroxyguanidine | DrugBank ID:DB13410"
+BMGC_DG16715,BMG_DG214693,CAS RN:104-06-3 | PubChem SID:198948892 | Amithiozone | CAS RN:910379-02-1 | AMITHIOZONE | DrugBank ID:DB12829 | PubChem CID:9568512 | UNII:MMG78X7SSR | Thioacetazone | N-[4-[(E)-(carbamothioylhydrazinylidene)methyl]phenyl]acetamide
+BMGC_DG16716,BMG_DG214694,"PubChem SID:198986677 | magnesium;5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide | UNII:925R0D7W1O | CAS RN:1198768-91-0 | CAS RN:161973-10-0 | PubChem CID:9568613 | ESOMEPRAZOLE MAGNESIUM ANHYDROUS | Esomeprazole Magnesium"
+BMGC_DG16717,BMG_DG214695,"NDC:30142-273 | NDC:33342-306 | ESOMEPRAZOLE | NDC:11673-898 | NDC:70677-1099 | NDC:21130-714 | NDC:41250-900 | NDC:46122-648 | DrugBank ID:DB00736 | NDC:0363-1699 | NDC:79481-0411 | NDC:64239-112 | UNII:N3PA6559FT | NDC:33342-307 | NDC:70677-0016 | NDC:72288-898 | NDC:0113-2022 | NDC:68391-898 | NDC:37808-719 | NDC:11822-0898 | Esomeprazole | 6-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole | NDC:55301-898 | NDC:0363-1898 | NDC:55910-250 | PubChem SID:175267781 | NDC:41163-539 | NDC:21130-088 | NDC:0113-0898 | PubChem CID:9568614 | NDC:0113-0651 | NDC:68196-898 | NDC:62011-0332 | NDC:55910-640 | NDC:46122-641 | NDC:0363-7223 | NDC:72288-700 | NDC:41520-727 | NDC:50594-029 | NDC:55910-593 | NDC:36800-636 | NDC:69842-898 | CAS RN:119141-88-7 | NDC:11822-0024 | NDC:51316-220 | NDC:11822-4011 | NDC:63981-898"
+BMGC_DG16718,BMG_DG214696,Aztreonam | PubChem CID:9568617 | DrugBank ID:DB00355
+BMGC_DG16719,BMG_DG214699,"CAS RN:53016-31-2 | UNII:UM2XKY25DH | CAS RN:74183-55-4 | PubChem SID:459055976 | Ortho Evra | (3E,8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-ol | NORELGESTROMIN, (E)- | PubChem CID:9568628"
+BMGC_DG16720,BMG_DG214712,2-HYDROXY-5-METHOXYBENZALDEHYDE | 2-Hydroxy-5-methoxybenzaldehyde | UNII:GYT2Q9UR3W | PubChem SID:472411063 | CAS RN:672-13-9 | PubChem CID:95695
+BMGC_DG16721,BMG_DG214715,"PubChem CID:95699 | PubChem SID:375579656 | 2,5-BIS((DIMETHYLAMINO)METHYL)HYDROQUINONE | UNII:7B4L97Q8XI | CAS RN:6339-48-6"
+BMGC_DG16722,BMG_DG214716,UNII:NV1779205D | DrugBank ID:DB12452 | Caprylic alcohol | PubChem SID:198965196 | PubChem CID:957 | CAS RN:220713-26-8 | octan-1-ol | CAPRYLIC ALCOHOL | CAS RN:111-87-5 | 1-Octanol
+BMGC_DG16723,BMG_DG214717,PubChem CID:9570 | UNII:Y5G39SHR0V | Methylthioinosine | DrugBank ID:DB02896 | CAS RN:342-69-8 | PubChem SID:198965995 | METHYLTHIOINOSINE
+BMGC_DG16724,BMG_DG214719,CAS RN:116-06-3 | PubChem CID:9570071 | [(E)-(2-methyl-2-methylsulfanylpropylidene)amino] N-methylcarbamate | (1E)-2-methyl-2-(methylthio)propanal O-[(methylamino)carbonyl]oxime
+BMGC_DG16725,BMG_DG214739,UNII:DS7YB3SNX0 | PubChem SID:363908778 | PubChem CID:9570364 | WR-81844 | CAS RN:21062-28-2
+BMGC_DG16726,BMG_DG214751,PubChem SID:478838152 | UNII:HU4C6L6R6L | PubChem CID:95706 | CAS RN:7251-00-5 | 2-NITRO-10H-ACRIDIN-9-ONE | 2-Nitro-10H-acridin-9-one
+BMGC_DG16727,BMG_DG214757,"PubChem SID:198946928 | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | CEFMENOXIME | CAS RN:65085-01-0 | PubChem CID:9570757 | Cefmenoxime | DrugBank ID:DB00267 | UNII:KBZ4844CXN"
+BMGC_DG16728,BMG_DG214765,PubChem SID:198957021 | UNII:R9X77R42FN | MILAMELINE | PubChem CID:9571002 | CAS RN:139886-32-1
+BMGC_DG16729,BMG_DG214766,"Azimilide Dihydrochloride | UNII:6E6VJP68KR | PubChem SID:198943505 | 1-[(E)-[5-(4-chlorophenyl)furan-2-yl]methylideneamino]-3-[4-(4-methylpiperazin-1-yl)butyl]imidazolidine-2,4-dione;dihydrochloride | CAS RN:149888-94-8 | AZIMILIDE DIHYDROCHLORIDE | CAS RN:1384448-07-0 | PubChem CID:9571003"
+BMGC_DG16730,BMG_DG214767,"CAS RN:1294552-65-0 | PubChem SID:198966924 | AZIMILIDE | CAS RN:149908-53-2 | UNII:74QU6P2934 | DrugBank ID:DB04957 | 1-[(E)-[5-(4-chlorophenyl)furan-2-yl]methylideneamino]-3-[4-(4-methylpiperazin-1-yl)butyl]imidazolidine-2,4-dione | Azimilide | PubChem CID:9571004"
+BMGC_DG16731,BMG_DG214776,"DrugBank ID:DB12314 | UNII:8O3249M729 | (1E)-1-[amino-(3,4-dichloroanilino)methylidene]-2-propan-2-ylguanidine | Chlorproguanil | PubChem SID:198944550 | CHLORPROGUANIL | PubChem CID:9571037 | CAS RN:537-21-3"
+BMGC_DG16732,BMG_DG214786,"PubChem SID:198958507 | PubChem CID:9571062 | CAS RN:1088-92-2 | NIFURTOINOL | UNII:980688H13O | DrugBank ID:DB13730 | 3-(hydroxymethyl)-1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione | Nifurtoinol"
+BMGC_DG16733,BMG_DG214793,"PubChem SID:198964023 | CEFOZOPRAN | DrugBank ID:DB13667 | UNII:1LG87K28LW | PubChem CID:9571080 | (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | CAS RN:113359-04-9 | Cefozopran"
+BMGC_DG16734,BMG_DG214800,"DrugBank ID:DB01155 | Gemifloxacin | CAS RN:204519-64-2 | PubChem SID:175271960 | UNII:OKR68Y0E4T | GEMIFLOXACIN | 7-[(4Z)-3-(aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid | PubChem CID:9571107 | CAS RN:1073254-49-5 | CAS RN:210353-54-1 | CAS RN:175463-14-6"
+BMGC_DG16735,BMG_DG214816,CAS RN:236392-56-6 | CAS RN:200933-27-3 | OCX-0191 | PubChem SID:198986376 | Triapine | [(E)-(3-aminopyridin-2-yl)methylideneamino]thiourea | PubChem CID:9571836 | CAS RN:143621-35-6 | UNII:U4XIL4091C | DrugBank ID:DB11940
+BMGC_DG16736,BMG_DG214837,PubChem CID:9574101 | CAS RN:192939-46-1 | Ximelagatran | Exanta | ethyl 2-[[(1R)-1-cyclohexyl-2-[(2S)-2-[[4-[(Z)-N'-hydroxycarbamimidoyl]phenyl]methylcarbamoyl]azetidin-1-yl]-2-oxoethyl]amino]acetate | CAS RN:1243838-77-8 | DrugBank ID:DB04898
+BMGC_DG16737,BMG_DG214843,DrugBank ID:DB09299 | CAS RN:379270-37-8 | TENOFOVIR ALAFENAMIDE | Tenofovir Alafenamide | PubChem CID:9574768 | UNII:EL9943AG5J | PubChem SID:198972072 | propan-2-yl (2S)-2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphoryl]amino]propanoate | Tenofovir alafenamide | CAS RN:383365-04-6
+BMGC_DG16738,BMG_DG214881,PubChem CID:9576413 | Naloxonazine | CAS RN:82824-01-9 | NALOXONAZINE | UNII:BW5W4K4S7Z | PubChem SID:474491681
+BMGC_DG16739,BMG_DG214901,CAS RN:132489-69-1 | PubChem CID:9576811 | PubChem SID:440793282 | UNII:AWZ7VE64B6 | PUGNAC
+BMGC_DG16740,BMG_DG214907,PubChem CID:9576891 | BIMOCLOMOL | DrugBank ID:DB06258 | Bimoclomol | (3Z)-N-(2-hydroxy-3-piperidin-1-ylpropoxy)pyridine-3-carboximidoyl chloride | UNII:9IYF14814M | CAS RN:130493-03-7 | PubChem SID:198981454
+BMGC_DG16741,BMG_DG214909,"CAS RN:144348-08-3 | PubChem CID:9576912 | UNII:LJA4M1L5LG | PubChem SID:198986563 | BINODENOSON | DrugBank ID:DB04853 | Binodenoson | (2R,3R,4S,5R)-2-[6-amino-2-[(2E)-2-(cyclohexylmethylidene)hydrazinyl]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol"
+BMGC_DG16742,BMG_DG214910,"DrugBank ID:DB04863 | PubChem CID:9576916 | Lefradafiban | methyl 2-[(3S,5S)-5-[[4-[4-[(Z)-N'-methoxycarbonylcarbamimidoyl]phenyl]phenoxy]methyl]-2-oxopyrrolidin-3-yl]acetate"
+BMGC_DG16743,BMG_DG214918,"CAS RN:292620-90-7 | CAS RN:292618-32-7 | Gimatecan | (19S)-19-ethyl-19-hydroxy-10-[(E)-(2-methylpropan-2-yl)oxyiminomethyl]-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione | GIMATECAN | UNII:7KKS9R192F | PubChem CID:9577124 | DrugBank ID:DB06721 | PubChem SID:198967695"
+BMGC_DG16744,BMG_DG214922,"CAS RN:199396-76-4 | UNII:72W09924WP | ASOPRISNIL | Asoprisnil | PubChem SID:198964838 | PubChem CID:9577221 | DrugBank ID:DB06680 | (8S,11R,13S,14S,17S)-11-[4-[(E)-hydroxyiminomethyl]phenyl]-17-methoxy-17-(methoxymethyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG16745,BMG_DG214931,PubChem SID:198969252 | SULFORAPHANE | L-Sulforaphane | UNII:GA49J4310U | DrugBank ID:DB12422 | CAS RN:142825-10-3 | Sulforaphane | 1-isothiocyanato-4-[(R)-methylsulfinyl]butane | PubChem CID:9577379
+BMGC_DG16746,BMG_DG214945,"PubChem CID:95778 | PubChem SID:376072174 | 5-PHENYL-4H-1,2,4-TRIAZOL-3-AMINE | CAS RN:4922-98-9 | UNII:QA2L2ED2R9"
+BMGC_DG16747,BMG_DG214951,UNII:P8P92V596C | SABCOMELINE | PubChem SID:198959063 | PubChem CID:9577995 | CAS RN:159912-53-5
+BMGC_DG16748,BMG_DG214953,"NDC:50090-7451 | NDC:70518-3693 | UNII:UYE4T5I70X | NDC:24979-703 | NDC:51407-746 | NDC:72162-2214 | NDC:50090-5944 | PubChem CID:9578005 | PubChem SID:175265917 | Dexlansoprazole | NDC:24979-001 | NDC:51407-747 | CAS RN:138530-94-6 | NDC:72162-2244 | NDC:55154-5154 | NDC:64764-175 | DrugBank ID:DB05351 | 2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole | NDC:72162-2239 | DEXLANSOPRAZOLE | NDC:24979-704 | NDC:49884-147 | NDC:24979-002 | NDC:50090-6514 | NDC:49884-148 | NDC:64764-171"
+BMGC_DG16749,BMG_DG214964,CAS RN:141184-34-1 | UNII:CDD69JC61J | Filaminast | DrugBank ID:DB02660 | FILAMINAST | PubChem SID:198943947 | PubChem CID:9578243
+BMGC_DG16750,BMG_DG214966,"3,3',4,4'-TETRACHLOROCARBANILIDE | UNII:W5A83C0L6P | 1,3-bis(3,4-dichlorophenyl)urea | CAS RN:4300-43-0 | PubChem SID:198945526 | 3,3',4,4'-Tetrachlorocarbanilide | PubChem CID:95783"
+BMGC_DG16751,BMG_DG214975,"PubChem SID:175267225 | CAS RN:165108-07-6 | (1R,4S,5'S,6R,6'S,8R,10E,12S,13S,14E,16E,20R,21Z,24S)-6'-cyclohexyl-24-hydroxy-21-hydroxyimino-12-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-5',11,13,22-tetramethylspiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one | SELAMECTIN | DrugBank ID:DB11459 | CAS RN:220119-17-5 | UNII:A2669OWX9N | PubChem CID:9578507 | Selamectin"
+BMGC_DG16752,BMG_DG214978,ethyl 3-[[2-[[4-[(E)-N'-hexoxycarbonylcarbamimidoyl]anilino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoate | ethyl N-[(2-{[(4-{N'-[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-beta-alaninate | PubChem CID:9578572
+BMGC_DG16753,BMG_DG214990,"6-methoxy-2-[(R)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole | PubChem CID:9579578 | UNII:S51HU491WJ | (+)-Omeprazole | CAS RN:119141-88-7 | PubChem SID:287445852 | OMEPRAZOLE, (R)- | CAS RN:119141-89-8"
+BMGC_DG16754,BMG_DG214995,PubChem SID:377308372 | UNII:45T1754HHH | CAS RN:51866-19-4 | 6-ETHYLGUANINE | PubChem CID:95805
+BMGC_DG16755,BMG_DG215020,"PubChem CID:95840 | CAS RN:41335-56-2 | 2-Allyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide | 2-ALLYL-1,2-BENZISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE | PubChem SID:474492123 | UNII:24Z9TR39CM"
+BMGC_DG16756,BMG_DG215021,"PubChem SID:474490950 | 1,2-Benzisothiazolin-3-one, 2-benzyl-, 1,1-dioxide | 1,2-BENZISOTHIAZOLIN-3-ONE, 2-BENZYL-, 1,1-DIOXIDE | UNII:V7GV6HG8MA | CAS RN:3416-59-9 | PubChem CID:95841"
+BMGC_DG16757,BMG_DG215033,"3-AMINO-1,2-DIHYDROXYANTHRAQUINONE | 3-Amino-1,2-dihydroxyanthraquinone | CAS RN:3963-78-8 | PubChem SID:474491742 | UNII:A8Q5T7UZ9F | PubChem CID:95861"
+BMGC_DG16758,BMG_DG215035,"PubChem SID:474492533 | 4-METHYL-N-(4-OXIDANYLIDENE-3-(1H-1,2,4-TRIAZOL-5-YLSULFANYL)NAPHTHALEN-1-YLIDENE)BENZENESULFONAMIDE | UNII:3J648T8SMJ | CAS RN:1242148-56-6 | PubChem CID:9586239"
+BMGC_DG16759,BMG_DG215037,THIONAPHTHENE-2-CARBOXYLIC ACID | PubChem CID:95864 | UNII:HLR49221FQ | PubChem SID:249817233 | CAS RN:6314-28-9
+BMGC_DG16760,BMG_DG215044,"N,N,N',N'-TETRAISOPROPYLTHIURAM DISULFIDE | CAS RN:4136-91-8 | PubChem SID:376231325 | UNII:V3H0EJ3KXW | PubChem CID:95876"
+BMGC_DG16761,BMG_DG215053,"4-METHYL-DL-GLUTAMIC ACID, ERYTHRO- | UNII:6B8Q87JVZ7 | PubChem CID:95883 | UNII:PQ76GL74VZ | 4-methyl-DL-Glutamic acid, erythro- | 4-methyl-L-Glutamic acid, (4R)- | PubChem SID:474494610 | CAS RN:31137-74-3 | CAS RN:77842-39-8 | PubChem SID:474493902 | 4-METHYL-L-GLUTAMIC ACID, (4R)-"
+BMGC_DG16762,BMG_DG215056,PubChem SID:318691423 | UNII:7ECX3219Y7 | N4-ACETYLSULFAQUINOXALINE | PubChem CID:95887 | CAS RN:6632-67-3
+BMGC_DG16763,BMG_DG215063,PubChem CID:95894 | PubChem SID:440089159 | UNII:UYV55A79UH | 3-CHLORO-1H-INDAZOLE | CAS RN:29110-74-5
+BMGC_DG16764,BMG_DG215091,"DrugBank ID:DB11618 | CID 9595290 | N-[(E)-1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]benzamide | Zorubicin | CAS RN:54083-22-6 | PubChem CID:9595290"
+BMGC_DG16765,BMG_DG215118,ACETOACETIC ACID | DrugBank ID:DB01762 | 3-oxobutanoic acid | PubChem CID:96 | UNII:4ZI204Y1MC | PubChem SID:198938007 | CAS RN:4387-93-3 | Acetoacetic acid | CAS RN:541-50-4
+BMGC_DG16766,BMG_DG215123,"PubChem CID:9600408 | DrugBank ID:DB04659 | (1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE"
+BMGC_DG16767,BMG_DG215124,"PubChem CID:9600409 | 6-(4-CHLOROPHENYL)IMIDAZO(2,1-B)(1,3)THIAZOLE-5-CARBALDEHYDE O-(3,4-DICHLOROBENZYL)OXIME | CAS RN:338404-52-7 | PubChem SID:198935661 | UNII:D77H8321PB"
+BMGC_DG16768,BMG_DG215129,DrugBank ID:DB04779 | ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE | PubChem CID:9600421
+BMGC_DG16769,BMG_DG215130,[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester | PubChem CID:9600423 | DrugBank ID:DB04107
+BMGC_DG16770,BMG_DG215143,(2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide | PubChem CID:9601217 | DrugBank ID:DB07137
+BMGC_DG16771,BMG_DG215146,"PubChem SID:175267858 | DrugBank ID:DB00492 | PubChem CID:9601226 | UNII:R43D2573WO | (2S,4S)-4-cyclohexyl-1-[2-[[(1S)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid | CAS RN:98048-97-6 | Fozitec | FOSINOPRIL"
+BMGC_DG16772,BMG_DG215161,PubChem SID:474489592 | CAS RN:491-33-8 | 8-QUINOLINETHIOL | PubChem CID:96028 | UNII:F77S9F93J4
+BMGC_DG16773,BMG_DG215162,CAS RN:352-32-9 | PubChem CID:9603 | UNII:NUD6WZ1B8F | PubChem SID:198987965 | P-FLUOROTOLUENE
+BMGC_DG16774,BMG_DG215182,"PubChem CID:9604653 | Pradefovir Mesylate | CAS RN:625095-61-6 | 9-[2-[[(2R,4S)-4-(3-chlorophenyl)-2-oxo-1,3,2lambda5-dioxaphosphinan-2-yl]methoxy]ethyl]purin-6-amine;methanesulfonic acid | PubChem SID:198958995 | Pradefovir mesylate | UNII:0D5204ZSIX | PRADEFOVIR MESYLATE | DrugBank ID:DB05478"
+BMGC_DG16775,BMG_DG215184,CAS RN:6344-05-4 | UNII:U0NSS4B19Q | PubChem CID:96047 | 4-CHLOROISATIN | PubChem SID:405218185
+BMGC_DG16776,BMG_DG215185,6-(4-NITROBENZYLTHIO)GUANOSINE | UNII:G25563DF3W | CAS RN:13153-27-0 | PubChem CID:96048
+BMGC_DG16777,BMG_DG215190,UNII:F72W445DQ0 | CAS RN:352-70-5 | PubChem SID:198972508 | PubChem CID:9606 | M-FLUOROTOLUENE
+BMGC_DG16778,BMG_DG215196,CAS RN:5069-69-2 | PubChem CID:96074 | UNII:L7AV5Z4CBS | 6-(((3-CHLOROPHENYL)METHYL)THIO)-9H-PURINE
+BMGC_DG16779,BMG_DG215208,Hydroxide | PubChem SID:175266676 | UNII:9159UV381P | hydroxide | NDC:70970-007 | CAS RN:14280-30-9 | NDC:70970-006 | PubChem CID:961 | HYDROXIDE ION | CAS RN:14337-01-0 | DrugBank ID:DB14522
+BMGC_DG16780,BMG_DG215215,"TETRAMETHYLSCUTELLAREIN | CAS RN:1168-42-9 | UNII:DWN851IYG6 | PubChem SID:377308779 | 5,6,7-trimethoxy-2-(4-methoxyphenyl)chromen-4-one | PubChem CID:96118 | Tetramethylscutellarein"
+BMGC_DG16781,BMG_DG215217,UNII:B9S8CMG5AD | PubChem SID:472425237 | PubChem CID:96125 | 5-BROMOIMIDAZOLE | CAS RN:2302-25-2 | 5-Bromoimidazole
+BMGC_DG16782,BMG_DG215228,PubChem CID:96145 | UNII:03706BK74M | CAS RN:6947-81-5 | .BETA.-(P-CUMOYL)PROPIONIC ACID | PubChem SID:376073057
+BMGC_DG16783,BMG_DG215229,"CAS RN:171655-91-7 | BRASOFENSINE | PubChem SID:198959758 | UNII:1YP2S94RVH | PubChem CID:9614919 | Brasofensine | (E)-1-[(1R,2R,3S,5S)-3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octan-2-yl]-N-methoxymethanimine | DrugBank ID:DB04857"
+BMGC_DG16784,BMG_DG215244,"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL | DrugBank ID:DB07061 | PubChem CID:961704"
+BMGC_DG16785,BMG_DG215258,NDC:73408-198 | NDC:0498-0100 | NDC:11822-9860 | NDC:70000-0018 | NDC:58264-0272 | NDC:0517-3010 | NDC:65785-162 | NDC:72598-095 | NDC:84939-001 | NDC:30142-010 | PubChem SID:175268772 | NDC:0264-7385 | NDC:51662-1266 | NDC:66302-150 | NDC:47682-936 | NDC:65785-169 | NDC:0409-3977 | NDC:72745-100 | NDC:0169-2001 | NDC:73408-936 | NDC:65785-160 | NDC:84732-018 | NDC:0924-0158 | NDC:59276-416 | WATER | NDC:0990-8139 | NDC:0990-7139 | NDC:84219-007 | NDC:84732-009 | PubChem CID:962 | NDC:24208-005 | NDC:43598-126 | NDC:65219-499 | NDC:0338-9782 | NDC:68599-1981 | NDC:72745-101 | NDC:0924-0160 | NDC:65785-164 | NDC:62135-833 | NDC:0006-4175 | NDC:0498-0630 | NDC:50814-010 | NDC:0264-2101 | NDC:71584-0107 | NDC:72572-747 | NDC:0404-9970 | NDC:55154-0127 | NDC:0338-0013 | NDC:0498-0601 | NDC:0143-9339 | NDC:0990-7973 | NDC:0338-0004 | NDC:0990-7118 | NDC:0641-6147 | NDC:55651-555 | NDC:47682-198 | NDC:50332-0201 | NDC:0404-9971 | NDC:59779-337 | NDC:57687-226 | NDC:72598-022 | NDC:0338-0003 | NDC:76420-082 | NDC:57349-220 | NDC:0924-0162 | NDC:55154-9588 | NDC:0065-0530 | NDC:67691-770 | NDC:49873-020 | NDC:84990-0001 | NDC:0264-7386 | NDC:0498-0101 | NDC:71872-7290 | NDC:0990-6139 | NDC:65219-187 | NDC:84732-010 | NDC:0536-1224 | NDC:71872-7041 | NDC:0363-0700 | NDC:83291-230 | NDC:0002-0800 | NDC:0498-0631 | NDC:69666-187 | NDC:0990-7990 | NDC:0498-0640 | NDC:84762-016 | UNII:059QF0KO0R | NDC:0173-0857 | NDC:50090-7440 | CAS RN:7732-18-5 | NDC:64253-020 | NDC:17271-750 | NDC:84732-017 | NDC:64108-313 | NDC:42961-231 | NDC:0006-4309 | NDC:0404-9959 | NDC:0487-6105 | NDC:84732-011 | NDC:63323-185 | NDC:47682-197 | oxidane | NDC:72924-001 | NDC:71338-119 | NDC:57687-276 | NDC:71872-7129 | NDC:65785-166 | NDC:70290-310 | NDC:0409-4887 | NDC:0517-3020 | NDC:51662-1473 | NDC:82996-007 | NDC:47682-412 | NDC:51662-1474 | NDC:51662-1329 | NDC:81238-6708 | NDC:47682-410 | NDC:83324-192 | NDC:84732-058 | NDC:69790-010 | NDC:43857-0220 | NDC:51662-1265 | NDC:0781-6021 | NDC:52584-887 | NDC:78641-786 | NDC:63323-178 | NDC:82001-001 | NDC:0498-0620 | NDC:0264-7850 | Water | DrugBank ID:DB09145 | NDC:49687-0010 | NDC:81016-0005 | NDC:84732-006
+BMGC_DG16786,BMG_DG215267,"UNII:TNH9CR5Y5H | CAS RN:49623-71-4 | 2,4,6-Triisopropylbenzoic acid | PubChem CID:96214 | PubChem SID:485663188 | 2,4,6-TRIISOPROPYLBENZOIC ACID"
+BMGC_DG16787,BMG_DG215268,UNII:IGZ30Z24EJ | CAS RN:645-65-8 | PubChem SID:198941508 | IMIDAZOLEACETIC ACID | Imidazoleacetic acid | 2-(1H-imidazol-5-yl)acetic acid | PubChem CID:96215
+BMGC_DG16788,BMG_DG215320,"UNII:CU38B5F52J | PubChem SID:485663102 | PubChem CID:96324 | 2-Methylthio-1,4-naphthoquinone | 2-METHYLTHIO-1,4-NAPHTHOQUINONE | CAS RN:26037-60-5"
+BMGC_DG16789,BMG_DG215366,"PubChem CID:9638 | Perflubutane | 1,1,1,2,2,3,3,4,4,4-decafluorobutane | PERFLUBUTANE | CAS RN:355-25-9 | DrugBank ID:DB12821 | UNII:SE4TWR0K2C | PubChem SID:198949451"
+BMGC_DG16790,BMG_DG215372,UNII:R5N9CD7DLM | CAS RN:19005-93-7 | 2-FORMYLINDOLE | PubChem CID:96389 | PubChem SID:348481566
+BMGC_DG16791,BMG_DG215373,"DrugBank ID:DB09531 | Perflexane | 1,1,1,2,2,3,3,4,4,5,5,6,6,6-tetradecafluorohexane | CAS RN:355-42-0 | UNII:FX3WJ41CMX | PERFLEXANE | PubChem CID:9639 | PubChem SID:198944250"
+BMGC_DG16792,BMG_DG215380,3-Hydroxypyruvic Acid | Hydroxypyruvic acid | 3-hydroxy-2-oxopropanoic acid | PubChem CID:964 | HYDROXYPYRUVIC ACID | CAS RN:1113-60-6 | DrugBank ID:DB02951 | PubChem SID:198973086 | UNII:934B2KHY0S | CAS RN:131000-16-3
+BMGC_DG16793,BMG_DG215396,"NDC:69238-1271 | NDC:71085-006 | NDC:51672-1279 | NDC:70771-1375 | NDC:72603-703 | NDC:51672-1353 | NDC:76420-509 | NDC:0093-0262 | NDC:50090-6309 | NDC:63629-2509 | NDC:76420-530 | NDC:63187-033 | NDC:68788-8593 | NDC:63629-2508 | NDC:33342-320 | NDC:63629-2337 | NDC:51672-1254 | NDC:51672-1386 | NDC:72578-087 | NDC:70700-146 | CAS RN:356-12-7 | NDC:50090-2419 | NDC:71085-005 | NDC:72162-2006 | NDC:50090-3277 | [2-[(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-6,6,9,13-tetramethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] acetate | NDC:43386-026 | NDC:63629-2339 | NDC:63629-2510 | NDC:40032-026 | NDC:51672-1253 | NDC:72162-2146 | NDC:70771-1393 | NDC:99207-525 | NDC:72162-1270 | NDC:69238-1534 | NDC:0713-0664 | NDC:0093-0264 | UNII:2W4A77YPAN | NDC:51672-1264 | PubChem SID:175268733 | DrugBank ID:DB01047 | NDC:71085-004 | NDC:0168-0134 | NDC:50090-1784 | NDC:67296-1407 | NDC:71205-092 | NDC:72162-1972 | NDC:0093-0263 | NDC:63629-2338 | NDC:66267-973 | NDC:68071-4921 | NDC:0713-0663 | NDC:63629-9583 | NDC:21922-001 | NDC:68071-2202 | NDC:51672-1273 | NDC:68462-505 | NDC:68071-4219 | NDC:68788-8554 | NDC:70710-1284 | Fluocinonide | NDC:45802-151 | PubChem CID:9642 | NDC:68788-8105 | FLUOCINONIDE"
+BMGC_DG16794,BMG_DG215402,"CAS RN:35578-47-3 | PubChem CID:96430 | 4,4'-DIBROMOBENZIL | PubChem SID:198963688 | UNII:O4TXV8A656"
+BMGC_DG16795,BMG_DG215449,"UNII:LMG443BS12 | CAS RN:577-26-4 | PubChem CID:96506 | PubChem SID:377308382 | 5,6,7,8,4'-PENTAHYDROXYFLAVONE"
+BMGC_DG16796,BMG_DG215452,"PubChem SID:175266724 | CAS RN:1008759-59-8 | PubChem SID:316916259 | GALANTAMINE | CAS RN:357-70-0 | CAS RN:23173-12-8 | GALANTAMINE, (±)- | (1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol | DrugBank ID:DB00674 | PubChem CID:9651 | UNII:1T835Z585R | Galantamine | UNII:0D3Q044KCA | GALANTAMINE, (+/-)-"
+BMGC_DG16797,BMG_DG215473,CAS RN:4730-77-2 | PubChem SID:485663037 | UNII:KTU83W5H88 | PubChem CID:96536 | (1-Naphthalenylmethyl)phosphonic acid | (1-NAPHTHALENYLMETHYL)PHOSPHONIC ACID
+BMGC_DG16798,BMG_DG215476,"CAS RN:2798-20-1 | PubChem CID:96539 | UNII:313E89KN5E | Gardenin B | 5-hydroxy-6,7,8-trimethoxy-2-(4-methoxyphenyl)chromen-4-one | PubChem SID:198981431 | GARDENIN B"
+BMGC_DG16799,BMG_DG215495,"6-Amino-7-chloro-5,8-quinolinedione | 6-AMINO-7-CHLORO-5,8-QUINOLINEDIONE | UNII:2Q2DY57FQM | PubChem SID:474491465 | PubChem CID:96583 | CAS RN:18892-39-2"
+BMGC_DG16800,BMG_DG215505,PubChem CID:966005 | 3-METHYL-N-(6-METHYL-2-PYRIDINYL)BENZAMIDE | CAS RN:346720-66-9 | UNII:3F7946H6D8 | PubChem SID:459055804
+BMGC_DG16801,BMG_DG215514,UNII:0J9RN2PRJ7 | HEXAPROPYMATE | PubChem SID:198988127 | Hexapropymate | CAS RN:358-52-1 | (1-prop-2-ynylcyclohexyl) carbamate | PubChem CID:9661 | DrugBank ID:DB13662
+BMGC_DG16802,BMG_DG215549,(2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone | (2-BUTYLBENZOFURAN-3-YL)(4-HYDROXYPHENYL)METHANONE | UNII:7PK1H9HDST | CAS RN:52490-15-0 | PubChem CID:96670 | PubChem SID:198991058
+BMGC_DG16803,BMG_DG215560,"UNII:61H4T033E5 | Orotic Acid | DrugBank ID:DB02262 | PubChem CID:967 | Orotic acid | OROTIC ACID | PubChem SID:175267468 | CAS RN:65-86-1 | CAS RN:15184-25-5 | 2,4-dioxo-1H-pyrimidine-6-carboxylic acid"
+BMGC_DG16804,BMG_DG215566,CAS RN:13395-02-3 | UNII:3G8CFM4T9A | ARISTOLOLACTUM | PubChem SID:472407482 | PubChem CID:96710
+BMGC_DG16805,BMG_DG215590,UNII:N3PVV2GVQ8 | 2-Bromo-1-(4-fluorophenyl)ethanone | PubChem SID:474490897 | 2-BROMO-1-(4-FLUOROPHENYL)ETHANONE | PubChem CID:96749 | CAS RN:403-29-2
+BMGC_DG16806,BMG_DG215597,PubChem SID:198935475 | PubChem CID:9676 | CAS RN:360-66-7 | UNII:6WRG30P3CG | ANDROISOXAZOLE
+BMGC_DG16807,BMG_DG215600,"UNII:H45187T098 | [(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl] decanoate | NANDROLONE DECANOATE | PubChem CID:9677 | PubChem SID:175267201 | DrugBank ID:DB08804 | Nandrolone decanoate | Nandrolone Decanoate | CAS RN:360-70-3"
+BMGC_DG16808,BMG_DG215607,CAS RN:21299-72-9 | UNII:3V0Y2PDE6K | PubChem SID:198975359 | 4-AMINO-5-IMIDAZOLE CARBOXAMIDE | 4-amino-1H-imidazole-5-carboxamide | 5-Aminoimidazole-4-carboxamide | PubChem CID:9679 | CAS RN:360-97-4
+BMGC_DG16809,BMG_DG215609,PubChem CID:96796 | UNII:A8235021UP | CAS RN:3695-80-5 | ALANYL-D-ALANINE | PubChem SID:318691835
+BMGC_DG16810,BMG_DG215613,"UNII:XZA9HY6Z98 | PubChem SID:175266387 | CAS RN:361-37-5 | Methysergide | METHYSERGIDE | PubChem CID:9681 | (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide"
+BMGC_DG16811,BMG_DG215637,"PubChem SID:374388118 | PubChem CID:96869 | CAS RN:27505-78-8 | UNII:B4TH2M5RNW | 2,3,7-TRIMETHYLINDOLE"
+BMGC_DG16812,BMG_DG215640,"UNII:63X7MBT2LQ | [(4aR,6R,7R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate | PubChem SID:198970011 | Bucladesine | DrugBank ID:DB13242 | CAS RN:362-74-3 | PubChem CID:9687 | BUCLADESINE"
+BMGC_DG16813,BMG_DG215642,PubChem SID:438788028 | DrugBank ID:DB08165 | PubChem CID:96876 | INDANE-5-SULFONAMIDE | UNII:XJL3C99615 | CAS RN:35203-93-1 | indane-5-sulfonamide
+BMGC_DG16814,BMG_DG215645,"UNII:KNB6553J7R | 2-phenylcyclohexa-2,5-diene-1,4-dione | CAS RN:363-03-1 | PubChem SID:317228921 | PubChem CID:9688 | Phenyl-p-benzoquinone | 2-PHENYL-1,4-BENZOQUINONE"
+BMGC_DG16815,BMG_DG215650,2-(4-BROMO-2-FORMYLPHENOXY)ACETIC ACID | CAS RN:24589-89-7 | PubChem CID:968879 | PubChem SID:478838386 | UNII:N6SU7T9RR6 | 2-(4-Bromo-2-formylphenoxy)acetic acid
+BMGC_DG16816,BMG_DG215656,PubChem CID:96894 | UNII:E1D0M0NA1C | 1-(DICYANOMETHYLENE)ACENAPHTHEN-2-ONE | CAS RN:14619-86-4 | PubChem SID:376072617
+BMGC_DG16817,BMG_DG215657,"5,12-DIAZANAPHTHACENE | UNII:YA98B1BS6A | PubChem CID:96896 | CAS RN:257-97-6 | PubChem SID:376072583"
+BMGC_DG16818,BMG_DG215665,NDC:0093-3092 | NDC:69339-178 | NDC:0093-3090 | DrugBank ID:DB06413 | NDC:68788-7593 | NDC:0781-8029 | CAS RN:112111-43-0 | NDC:0378-3433 | NDC:0378-3432 | NDC:65862-998 | NDC:0093-3094 | PubChem CID:9690109 | NDC:65862-807 | NDC:65862-805 | NDC:63459-220 | NDC:71335-1308 | NDC:69339-179 | NDC:72189-464 | NDC:72189-353 | UNII:V63XWA605I | NDC:63459-205 | NDC:69339-180 | NDC:0093-3093 | NDC:71335-1193 | PubChem SID:175267253 | NDC:71335-1857 | NDC:72189-261 | NDC:63459-225 | Armodafinil | NDC:68788-7880 | NDC:0378-3431 | NDC:68788-7826 | 2-[(R)-benzhydrylsulfinyl]acetamide | NDC:55700-510 | NDC:63459-215 | NDC:0781-8045 | NDC:72189-133 | NDC:0781-8037 | NDC:69339-177 | NDC:65862-806 | NDC:0781-8053 | NDC:71335-1842 | ARMODAFINIL
+BMGC_DG16819,BMG_DG215683,4-CHLORO-2-NITROBENZONITRILE | PubChem CID:96924 | PubChem SID:474490049 | CAS RN:34662-32-3 | 4-Chloro-2-nitrobenzonitrile | UNII:SA5YV6UQF5
+BMGC_DG16820,BMG_DG215687,"PubChem SID:198982241 | (6,7-dimethoxyisoquinolin-1-yl)-(3,4-dimethoxyphenyl)methanone | UNII:L8825LX0F5 | CAS RN:522-57-6 | PAPAVERALDINE | Papaveraldine | PubChem CID:96932"
+BMGC_DG16821,BMG_DG215691,"UNII:WH639V7QSF | Girinimbine | GIRINIMBINE | PubChem CID:96943 | PubChem SID:474491700 | 3,3,5-trimethyl-11H-pyrano[3,2-a]carbazole | CAS RN:23095-44-5"
+BMGC_DG16822,BMG_DG215693,"NDC:68462-382 | NDC:0378-5271 | NDC:33342-299 | NDC:60429-633 | NDC:82804-076 | NDC:69452-348 | NDC:71335-0598 | NDC:55111-629 | NDC:71610-409 | NDC:43353-097 | UNII:UZX80K71OE | NDC:71335-2002 | NDC:63402-193 | NDC:76420-027 | NDC:63402-191 | NDC:80425-0098 | CAS RN:138729-47-2 | NDC:68180-322 | [(7S)-6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate | NDC:80425-0064 | NDC:31722-855 | NDC:80425-0407 | NDC:65862-968 | NDC:55111-617 | NDC:65862-969 | NDC:68462-383 | NDC:0093-5538 | NDC:60429-634 | NDC:60760-526 | NDC:80425-0062 | NDC:63187-665 | NDC:43063-795 | NDC:68788-7029 | NDC:68462-384 | PubChem CID:969472 | NDC:55700-581 | NDC:50090-3514 | NDC:68788-8387 | NDC:71335-0089 | NDC:71335-0574 | NDC:55111-619 | NDC:70518-3576 | NDC:72789-067 | NDC:68071-3376 | NDC:69452-349 | Eszopiclone | NDC:33342-300 | NDC:68180-323 | NDC:70518-1310 | NDC:60429-632 | NDC:82804-159 | NDC:47335-586 | NDC:76420-024 | NDC:68788-8077 | NDC:71205-633 | NDC:80425-0115 | NDC:31722-857 | NDC:0378-5270 | NDC:55700-583 | NDC:31722-856 | NDC:76420-026 | NDC:71205-236 | NDC:80725-012 | NDC:71335-0512 | NDC:80425-0067 | NDC:68788-7169 | NDC:68788-7667 | NDC:71335-0148 | NDC:71205-513 | NDC:55700-610 | NDC:43353-101 | NDC:80725-010 | NDC:71205-384 | NDC:72189-099 | NDC:69452-347 | NDC:0093-5539 | NDC:80425-0168 | NDC:63402-190 | NDC:71205-581 | NDC:80425-0066 | NDC:63187-817 | NDC:80425-0065 | DrugBank ID:DB00402 | NDC:63187-579 | ESZOPICLONE | NDC:80725-011 | NDC:71335-0116 | NDC:0093-5537 | NDC:55700-621 | PubChem SID:175265884 | NDC:71335-9659 | NDC:68180-324 | NDC:80425-0063 | NDC:33342-301 | NDC:65862-967 | NDC:0378-5272 | CAS RN:1140433-81-3 | NDC:63187-970 | NDC:47335-588 | NDC:63187-843 | NDC:47335-587"
+BMGC_DG16823,BMG_DG215703,"1-[(2S)-2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole | PubChem CID:969503 | UNII:45V2100TWW | MICONAZOLE, (S)- | PubChem SID:255508968 | CAS RN:47447-52-9 | (S)-Miconazole"
+BMGC_DG16824,BMG_DG215706,"NDC:84025-196 | PubChem SID:175265433 | Curcumin | NDC:84025-208 | (1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione | CAS RN:458-37-7 | DrugBank ID:DB11672 | PubChem CID:969516 | CAS RN:94875-80-6 | CURCUMIN | UNII:IT942ZTH98 | NDC:84025-253"
+BMGC_DG16825,BMG_DG215725,UNII:2F399MM81J | PubChem SID:198948853 | PubChem CID:970 | OXALOACETIC ACID | CAS RN:7619-04-7 | Oxalacetic acid | CAS RN:328-42-7 | 2-oxobutanedioic acid
+BMGC_DG16826,BMG_DG215726,"PubChem CID:9700 | THYMIDINE 5'-MONOPHOSPHATE | CAS RN:365-07-1 | Thymidine Monophosphate | [(2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl dihydrogen phosphate | PubChem SID:198989976 | UNII:43W3021X6C | Thymidine monophosphate | DrugBank ID:DB01643"
+BMGC_DG16827,BMG_DG215740,CAS RN:366-70-1 | 4-[(2-methylhydrazinyl)methyl]-N-propan-2-ylbenzamide;hydrochloride | NDC:54482-054 | PubChem SID:175265848 | UNII:XH0NPH5ZX8 | PubChem CID:9703 | PROCARBAZINE HYDROCHLORIDE | Procarbazine Hydrochloride
+BMGC_DG16828,BMG_DG215744,"PubChem CID:97032 | UNII:OHS8K6J04I | 3,3',5,5'-TETRACHLORO-4,4'-BIPHENYLDIOL | CAS RN:13049-13-3 | 3,3',5,5'-tetrachlorobiphenyl-4,4'-diol | PubChem SID:198986052 | DrugBank ID:DB03346"
+BMGC_DG16829,BMG_DG215772,UNII:GLE75A3004 | CAS RN:7360-09-0 | PubChem CID:97054 | TRYPTOPHYLGLYCINE | PubChem SID:198979604
+BMGC_DG16830,BMG_DG215780,CAS RN:4005-49-6 | UNII:7BQB2WI1II | PubChem SID:374388078 | 6-BENZAMIDOPURINE | PubChem CID:97075
+BMGC_DG16831,BMG_DG215792,UNII:9E7R5L6H31 | Oxalic Acid | OXALIC ACID | DrugBank ID:DB03902 | oxalic acid | PubChem CID:971 | PubChem SID:175268918 | CAS RN:144-62-7
+BMGC_DG16832,BMG_DG215844,"CAS RN:1948-82-9 | UNII:DFK99PW32K | OXALOSUCCINIC ACID | 1-oxopropane-1,2,3-tricarboxylic acid | PubChem SID:198947510 | Oxalosuccinic acid | PubChem CID:972"
+BMGC_DG16833,BMG_DG215849,"CAS RN:855-96-9 | 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxychromen-4-one | EUPATORIN | UNII:3J474AV6MY | PubChem CID:97214 | PubChem SID:198972857 | Eupatorin"
+BMGC_DG16834,BMG_DG215852,"PubChem SID:198959698 | DrugBank ID:DB12385 | PubChem CID:97226 | UNII:9Z01632KRV | 10-Hydroxycamptothecin | 10-HYDROXYCAMPTOTHECIN | (19S)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione | CAS RN:19685-09-7 | 10-hydroxycamptothecin"
+BMGC_DG16835,BMG_DG215860,"1,4-DIMETHYL-2-QUINOLONE | UNII:6WT6AG3ZQJ | PubChem SID:348481299 | PubChem CID:97252 | CAS RN:2584-47-6"
+BMGC_DG16836,BMG_DG215869,PubChem CID:9727 | N-METHYLTYRAMINE | UNII:G3S4E2F7TA | PubChem SID:198955428 | CAS RN:370-98-9
+BMGC_DG16837,BMG_DG215877,PubChem SID:478837426 | 4-((4-METHOXYPHENYL)METHYLIDENEAMINO)PHENOL | UNII:CY6TQC6XHV | CAS RN:67097-24-9 | PubChem CID:97286 | 4-[(4-methoxyphenyl)methylideneamino]phenol
+BMGC_DG16838,BMG_DG215889,"CAS RN:24386-93-4 | (2R,3R,4S,5R)-2-(4-amino-5-iodopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol | 5-Iodotubercidin | PubChem CID:97297 | 5-iodotubercidin | DrugBank ID:DB04604"
+BMGC_DG16839,BMG_DG215890,"UNII:H1C37ZB0P3 | CAS RN:27693-67-0 | 2,3'-IMINODI-BENZOIC ACID | PubChem CID:97298 | PubChem SID:377308337"
+BMGC_DG16840,BMG_DG215901,UNII:60HI1G076Z | 4-Fluoroaniline | PubChem CID:9731 | PubChem SID:198965638 | 4-fluoroaniline | 4-FLUOROANILINE | CAS RN:371-40-4
+BMGC_DG16841,BMG_DG215912,"PubChem CID:97332 | CAS RN:1247-97-8 | Quercetin pentamethyl ether | UNII:V6J41K636O | 2-(3,4-dimethoxyphenyl)-3,5,7-trimethoxychromen-4-one | PubChem SID:387065129 | PENTAMETHYLQUERCETIN"
+BMGC_DG16842,BMG_DG215932,GLYCYL-L-ASPARTIC ACID | UNII:SBX24TG7PB | PubChem CID:97363 | CAS RN:4685-12-5
+BMGC_DG16843,BMG_DG215933,2-[[(2S)-2-amino-4-methylpentanoyl]amino]acetic acid | PubChem CID:97364 | Leu-Gly | CAS RN:686-50-0
+BMGC_DG16844,BMG_DG215946,PubChem SID:441658845 | CAS RN:55698-67-4 | UNII:LG29EB6D6Q | PubChem CID:97394 | 8-HYDROXYCINCHONINIC ACID
+BMGC_DG16845,BMG_DG215947,"6-(2-Chlorophenyl)-1,3,5-triazine-2,4-diamine | UNII:DFZ9452WV2 | CAS RN:29366-77-6 | PubChem SID:474490243 | 6-(2-CHLOROPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE | PubChem CID:97399"
+BMGC_DG16846,BMG_DG215948,PubChem SID:198976056 | PubChem CID:974 | Oxamic acid | CAS RN:66257-53-2 | CAS RN:471-47-6 | OXAMIC ACID | Oxamic Acid | DrugBank ID:DB03940 | UNII:QU60N5OPLG | oxamic acid
+BMGC_DG16847,BMG_DG215970,UNII:5GKC25PU4B | PubChem CID:97463 | PubChem SID:440088798 | CAS RN:31225-17-9 | DICHLORPHENYLOXYUREA
+BMGC_DG16848,BMG_DG215974,4-HYDROXYBENZYLAMINE | PubChem SID:198948690 | UNII:7J7F85B7BI | PubChem CID:97472 | 4-(aminomethyl)phenol | 4-Hydroxybenzylamine | CAS RN:696-60-6
+BMGC_DG16849,BMG_DG215976,CAS RN:38212-33-8 | 1-(4-Chlorophenyl)piperazine | UNII:FMD47JE5C3 | 1-(4-CHLOROPHENYL)PIPERAZINE | PubChem CID:97478 | PubChem SID:441332044
+BMGC_DG16850,BMG_DG215979,"8-methoxy-3,3,5-trimethyl-11H-pyrano[3,2-a]carbazole | Koenimbine | PubChem CID:97487 | CAS RN:21087-98-9"
+BMGC_DG16851,BMG_DG215981,PubChem SID:175266866 | CITRULLINE | DrugBank ID:DB00155 | (2S)-2-amino-5-(carbamoylamino)pentanoic acid | CAS RN:372-75-8 | PubChem CID:9750 | UNII:29VT07BGDA | Citrulline
+BMGC_DG16852,BMG_DG215995,"UNII:SVV7S48NBR | PubChem CID:97525 | CAS RN:22906-75-8 | 3,5-DIMETHYLPYRAZOLE-1-CARBOXAMIDINE | PubChem SID:377308300"
+BMGC_DG16853,BMG_DG215996,"PubChem CID:97529 | UNII:CVS5KHM2SL | PubChem SID:440089133 | CAS RN:69844-34-4 | 2-CHLORO-3-((2-HYDROXYETHYL)AMINO)-1,4-NAPHTHOQUINONE"
+BMGC_DG16854,BMG_DG216001,"CAS RN:26289-39-4 | UNII:HL4G8D2C8T | PubChem SID:441097513 | PubChem CID:97535 | S-(2,4-DINITROPHENYL)GLUTATHIONE | S-(2,4-Dinitrophenyl)glutathione | S-(2,4-dinitrophenyl)glutathione | DrugBank ID:DB02458 | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(2,4-dinitrophenyl)sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid"
+BMGC_DG16855,BMG_DG216002,PubChem CID:97536 | CAS RN:24425-56-7 | HEXYLGLUTATHIONE | PubChem SID:198976845 | s-Hexylglutathione | S-Hexylglutathione | UNII:M73SNN908F | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-hexylsulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid | DrugBank ID:DB04132
+BMGC_DG16856,BMG_DG216003,CAS RN:6803-19-6 | DrugBank ID:DB03686 | S-(4-Nitrobenzyl)glutathione | S-(4-nitrobenzyl)glutathione | PubChem CID:97538 | (2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(4-nitrophenyl)methylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
+BMGC_DG16857,BMG_DG216007,"UNII:EHP230YST8 | PubChem SID:377308981 | PubChem CID:97548 | CAS RN:14756-22-0 | 4'-METHOXY-7,8-BENZOFLAVONE"
+BMGC_DG16858,BMG_DG216024,"DrugBank ID:DB02916 | PubChem CID:97576 | [(2r,3s,4r,5r)-5-(6-Amino-9h-Purin-9-Yl)-3,4-Dihydroxytetrahydro-2-Furanyl]Methyl Sulfamate"
+BMGC_DG16859,BMG_DG216032,PubChem SID:474491503 | PubChem CID:97589 | UNII:CM2FB2FDJ3 | P-((DICYANOMETHYL)AZO)BENZENESULFONAMIDE | p-((Dicyanomethyl)azo)benzenesulfonamide | CAS RN:90323-46-9
+BMGC_DG16860,BMG_DG216054,LANUGINOSINE | PubChem SID:249493186 | PubChem CID:97622 | UNII:L7DSM4NF0P | CAS RN:23740-25-2
+BMGC_DG16861,BMG_DG216073,PubChem CID:97663 | L-Aspartic acid beta-hydroxamate | CAS RN:1955-68-6 | (2S)-2-amino-4-(hydroxyamino)-4-oxobutanoic acid
+BMGC_DG16862,BMG_DG216081,BIS-A-TDA | CAS RN:26907-37-9 | PubChem CID:97676 | PubChem SID:472387294 | UNII:QP76P89NYJ
+BMGC_DG16863,BMG_DG216089,"1,3-DIMETHOXY-9(10H)-ACRIDINONE | PubChem CID:97696 | PubChem SID:376072683 | CAS RN:27221-40-5 | UNII:IIS0LYM7Z3"
+BMGC_DG16864,BMG_DG216091,DrugBank ID:DB09140 | CAS RN:7782-44-7 | PubChem CID:977 | molecular oxygen | OXYGEN | Oxygen | UNII:S88TT14065
+BMGC_DG16865,BMG_DG216095,PubChem CID:97709 | CAS RN:6323-97-3 | 1-AMINOETHYLPHOSPHONIC ACID | UNII:W5P74040W1 | PubChem SID:316909553
+BMGC_DG16866,BMG_DG216128,PubChem SID:175268170 | UNII:TL2TJE8QTX | CAS RN:150-13-0 | 4-aminobenzoic acid | PubChem CID:978 | AMINOBENZOIC ACID | NDC:83027-0122 | 4-Aminobenzoic Acid | Aminobenzoic acid | DrugBank ID:DB02362
+BMGC_DG16867,BMG_DG216131,"DrugBank ID:DB00443 | PubChem CID:9782 | CAS RN:378-44-9 | (8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | BETAMETHASONE | Betamethasone | PubChem SID:175267436 | UNII:9842X06Q6M"
+BMGC_DG16868,BMG_DG216139,CAS RN:86123-10-6 | PubChem SID:485664189 | FMOC-D-PHENYLALANINE | UNII:S98AJ2BS3A | PubChem CID:978332 | Fmoc-D-phenylalanine
+BMGC_DG16869,BMG_DG216148,UNII:6CS44YN4Y5 | 6-METHOXYFLAVANONE | CAS RN:3034-04-6 | PubChem CID:97860
+BMGC_DG16870,BMG_DG216158,DrugBank ID:DB07718 | UNII:0YP1694WNQ | 3-(4-hydroxyphenyl)-2-oxopropanoic acid | PubChem SID:198949106 | 4-Hydroxyphenylpyruvic acid | 3-(4-HYDROXYPHENYL)PYRUVIC ACID | PubChem CID:979 | 4-Hydroxyphenylpyruvic Acid | CAS RN:156-39-8
+BMGC_DG16871,BMG_DG216164,"PubChem CID:9793 | (9R,16R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,14,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3-one | Desoxymetasone"
+BMGC_DG16872,BMG_DG216170,UNII:87PZU03K0K | CAS RN:20344-49-4 | NDC:49230-645 | PubChem CID:9793696 | FERRIC OXYHYDROXIDE | PubChem SID:198957315 | Iron hydroxide oxide | iron(3+);oxygen(2-);hydroxide | DrugBank ID:DB14695
+BMGC_DG16873,BMG_DG216173,"PubChem CID:9793728 | 3,4,5,6-TETRAHYDRO-2H-AZEPIN-7-AMINE | PubChem SID:441659353 | UNII:WNA2UR4ULZ | CAS RN:2214-67-7"
+BMGC_DG16874,BMG_DG216191,PubChem CID:9793868 | PubChem SID:472424032 | CAS RN:34973-91-6 | UNII:88JSL4TQ76 | IMPENTAMINE
+BMGC_DG16875,BMG_DG216208,CAS RN:364344-56-9 | PubChem SID:445500602 | UNII:UVL6VJD7YC | PubChem CID:9794092 | PNU-181731
+BMGC_DG16876,BMG_DG216209,(Z)-2-cyano-3-(4-hydroxyphenyl)prop-2-enoic acid | CID 9794103 | CAS RN:28166-41-8 | PubChem CID:9794103
+BMGC_DG16877,BMG_DG216212,PubChem CID:9794141 | CAS RN:161416-43-9 | A-84543 | UNII:WSK2XM6RPF | PubChem SID:474492661
+BMGC_DG16878,BMG_DG216214,DrugBank ID:DB11889 | CAS RN:153322-05-5 | (1S)-1-phenyl-2-pyridin-2-ylethanamine | PubChem CID:9794203 | PubChem SID:198938400 | LANICEMINE | UNII:9TMU325RK3 | Lanicemine
+BMGC_DG16879,BMG_DG216215,MTEP | UNII:XDA7P9K5S6 | PubChem CID:9794218 | CAS RN:329205-68-7 | PubChem SID:474492563
+BMGC_DG16880,BMG_DG216223,"AZD-0328 | CAS RN:220099-91-2 | DrugBank ID:DB12145 | PubChem CID:9794392 | UNII:2B218X5QIY | Spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine], (2'R)- | (3R)-spiro[1-azabicyclo[2.2.2]octane-3,2'-3H-furo[2,3-b]pyridine] | PubChem SID:198960366"
+BMGC_DG16881,BMG_DG216226,"CAS RN:121742-46-9 | PubChem CID:9794431 | ROGLETIMIDE, (R)- | PubChem SID:310825936 | UNII:MN5U7K1K5P"
+BMGC_DG16882,BMG_DG216230,CAS RN:547770-05-8 | PF-219061 | PubChem SID:445500556 | PubChem CID:9794475 | UNII:ZK5ZP8L5S2
+BMGC_DG16883,BMG_DG216231,"DrugBank ID:DB12032 | CAS RN:223445-75-8 | ATAGABALIN | PubChem CID:9794485 | 2-[(3S,4S)-1-(aminomethyl)-3,4-dimethylcyclopentyl]acetic acid | Atagabalin | PubChem SID:198940289 | UNII:JT7957Q2FB"
+BMGC_DG16884,BMG_DG216239,CAS RN:436083-07-7 | PubChem SID:474493530 | ORG-37684 Free Base | PubChem CID:9794656 | UNII:48QQ8ZTE6C | ORG-37684 FREE BASE
+BMGC_DG16885,BMG_DG216241,UNII:ECZ29UKI0W | PubChem SID:198943413 | L-158507 | 5-(4'-METHYL-2-BIPHENYL)TETRAZOLE | CAS RN:120568-11-8 | PubChem CID:9794697
+BMGC_DG16886,BMG_DG216246,"PubChem CID:9794806 | (1S,9R,13E)-1-amino-13-ethylidene-11-methyl-6-azatricyclo[7.3.1.02,7]trideca-2(7),3,10-trien-5-one | Selagine"
+BMGC_DG16887,BMG_DG216254,"PubChem CID:9795056 | CAS RN:192374-14-4 | (2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethylmorpholin-2-ol | RADAFAXINE | Radafaxine | UNII:Q47741214K | DrugBank ID:DB11790 | PubChem SID:198965716 | CAS RN:233600-52-7"
+BMGC_DG16888,BMG_DG216258,PubChem CID:9795278 | UNII:27M563MU5U | CAS RN:711085-63-1 | PNU-282987 FREE BASE | PubChem SID:198963660
+BMGC_DG16889,BMG_DG216261,"PubChem SID:445499938 | UNII:W5RZ9PP66Q | 10-CHLORO-6-HYDROXY-11LAMBDA5-PYRIDO(1,2-A)QUINOLIN-11-YLIUM | PubChem CID:9795308 | CAS RN:586349-01-1"
+BMGC_DG16890,BMG_DG216269,"PubChem CID:9795623 | PubChem SID:329903897 | UNII:B33212715Z | VENLAFAXINE, (R)- | CAS RN:93413-46-8"
+BMGC_DG16891,BMG_DG216273,DrugBank ID:DB11947 | CAS RN:346688-38-8 | PubChem CID:9795739 | PRIDOPIDINE | PubChem SID:198943799 | Pridopidine | 4-(3-methylsulfonylphenyl)-1-propylpiperidine | UNII:HD4TW8S2VK
+BMGC_DG16892,BMG_DG216274,OSU-6162 | UNII:0D21EQAQQA | PubChem CID:9795741 | (3S)-3-(3-methylsulfonylphenyl)-1-propylpiperidine | CAS RN:146798-66-5 | PubChem SID:346538695 | Osu 6162
+BMGC_DG16893,BMG_DG216281,DrugBank ID:DB13877 | UNII:2ZWI7KHK8F | PubChem CID:9796068 | INIPARIB | CAS RN:160003-66-7 | 4-iodo-3-nitrobenzamide | Iniparib | PubChem SID:198977422
+BMGC_DG16894,BMG_DG216286,"PubChem CID:9796161 | DrugBank ID:DB07100 | 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL"
+BMGC_DG16895,BMG_DG216294,UNII:HCX5M1YIOM | 6-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl]amino]ethylamino]pyridine-3-carbonitrile | PubChem SID:346536792 | Nvp-dpp728 | NVP-DPP-728 | CAS RN:247016-69-9 | PubChem CID:9796290
+BMGC_DG16896,BMG_DG216296,CAS RN:150208-42-7 | PubChem SID:474492682 | BD1018 | PubChem CID:9796317 | UNII:G9DYE9JU44
+BMGC_DG16897,BMG_DG216302,PubChem CID:9796408 | CAS RN:132834-56-1 | ORG-12962 | PubChem SID:474492632 | UNII:TUK9RFW5YL
+BMGC_DG16898,BMG_DG216306,"PubChem SID:198943196 | CAS RN:566939-85-3 | PubChem CID:9796590 | ORTERONEL | Orteronel | UNII:UE5K2FNS92 | DrugBank ID:DB12066 | 6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide"
+BMGC_DG16899,BMG_DG216309,CP-226269 | CAS RN:220941-93-5 | PubChem CID:9796720 | PubChem SID:472425902 | UNII:WX4CVT9DYH
+BMGC_DG16900,BMG_DG216314,UNII:B735YEI65V | CAS RN:138356-12-4 | PubChem SID:198954322 | BD-1067 | PubChem CID:9796923
+BMGC_DG16901,BMG_DG216317,"CAS RN:210354-22-6 | DrugBank ID:DB12237 | L-Homocysteine, S-(2-((1-iminoethyl)amino)ethyl)- | PubChem CID:9797017 | GW-274150 | (2S)-2-amino-4-[2-(1-aminoethylideneamino)ethylsulfanyl]butanoic acid | UNII:0ZZF1V8G63 | PubChem SID:198942494"
+BMGC_DG16902,BMG_DG216321,SB-235699 | UNII:NP7J08ZRYY | PubChem CID:9797240 | PubChem SID:461432626 | CAS RN:180869-32-3
+BMGC_DG16903,BMG_DG216324,"PubChem CID:9797360 | PubChem SID:252164786 | SSR-180711 | (4-bromophenyl) 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate | UNII:QF4P1U1666 | CAS RN:298198-52-4 | Ssr180711"
+BMGC_DG16904,BMG_DG216325,"CAS RN:627512-69-0 | N-(3-fluorophenyl)-6,7-dimethoxy-1,4-dihydroindeno[1,2-c]pyrazol-3-amine | PubChem CID:9797370 | CAS RN:627518-40-5"
+BMGC_DG16905,BMG_DG216327,PubChem SID:474492677 | BD1052 | CAS RN:138356-16-8 | UNII:9SWF79BC2H | PubChem CID:9797436
+BMGC_DG16906,BMG_DG216328,RTI-111 FREE BASE | CAS RN:143965-99-5 | PubChem CID:9797476 | PubChem SID:441331886 | UNII:AX9YHD42FT
+BMGC_DG16907,BMG_DG216332,"NORFLUOXETINE, (R)- | PubChem SID:241180796 | UNII:05UQ1299DN | CAS RN:130194-43-3 | (3R)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | PubChem CID:9797657 | (R)-Norfluoxetine"
+BMGC_DG16908,BMG_DG216333,PubChem SID:198973162 | PubChem CID:9797661 | MK-0916 | UNII:BXI2C3DERP | CAS RN:633317-53-0
+BMGC_DG16909,BMG_DG216335,PubChem CID:9797857 | DrugBank ID:DB07002 | 4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile
+BMGC_DG16910,BMG_DG216336,N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide | PubChem CID:9797919 | DrugBank ID:DB07288
+BMGC_DG16911,BMG_DG216348,PubChem CID:9798392 | PubChem SID:459055389 | CAS RN:212126-32-4 | UNII:PVD44GF6Y4 | L-776967
+BMGC_DG16912,BMG_DG216351,CAS RN:757183-18-9 | UNII:63G6TLD54V | NNC-38-1049 | PubChem CID:9798429 | PubChem SID:472423151
+BMGC_DG16913,BMG_DG216356,"GSK-189254 | CAS RN:854485-15-7 | 6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide | PubChem SID:198968915 | CAS RN:720690-73-3 | PubChem CID:9798547 | UNII:5T4TX6CO53 | 6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide | GSK-189254A"
+BMGC_DG16914,BMG_DG216360,PubChem CID:9798659 | CAS RN:344457-87-0 | PubChem SID:459055788 | UNII:WX9Y9W9AAY | EO-1606
+BMGC_DG16915,BMG_DG216361,CAS RN:87099-73-8 | CRYPTOCHLOROGENIC ACID | UNII:F23DJ84IZ9 | PubChem CID:9798666 | PubChem SID:241179701
+BMGC_DG16916,BMG_DG216365,"PubChem SID:478838356 | 2-(2-FURANYL)-7-(3-PHENYLPROPYL)-7H-PYRAZOLO(4,3-E)(1,2,4)TRIAZOLO(1,5-C)PYRIMIDIN-5-AMINE | CAS RN:174648-45-4 | 2-(2-Furanyl)-7-(3-phenylpropyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine | UNII:QU4DJW5LLR | PubChem CID:9798914"
+BMGC_DG16917,BMG_DG216368,PubChem CID:9798973 | BAY-41-2272 | CAS RN:256376-24-6 | PubChem SID:198966688 | UNII:34A162J6WB
+BMGC_DG16918,BMG_DG216369,TP-13 | PubChem CID:9799023 | UNII:DKP4YGH6WN | PubChem SID:441096960 | CAS RN:202930-12-9
+BMGC_DG16919,BMG_DG216376,DrugBank ID:DB13080 | 2-[[1-[2-(4-fluorophenyl)-2-oxoethyl]piperidin-4-yl]methyl]-3H-isoindol-1-one | ROLUPERIDONE | PubChem CID:9799284 | Roluperidone | CAS RN:359625-79-9 | UNII:4P31I0M3BF | PubChem SID:198940144
+BMGC_DG16920,BMG_DG216377,UNII:H0EVX3PS4B | PubChem SID:198938972 | 2-(4-methoxyphenyl)-N-[(4-methylphenyl)methyl]-N-(1-methylpiperidin-4-yl)acetamide | CAS RN:359878-17-4 | PubChem CID:9799308 | AC-90179
+BMGC_DG16921,BMG_DG216381,PubChem SID:287445981 | naphthalen-1-yl-(4-pentoxynaphthalen-1-yl)methanone | CB-13 | UNII:9XRJ6055XT | CAS RN:432047-72-8 | 1-Naphthalenyl[4-(pentyloxy)-1-naphthalenyl]methanone | PubChem CID:9799417
+BMGC_DG16922,BMG_DG216382,"N-[6-(2,4-difluorophenyl)sulfanyl-1-oxo-2,3-dihydroinden-5-yl]methanesulfonamide | L 745337 | CAS RN:158205-05-1 | PubChem CID:9799453"
+BMGC_DG16923,BMG_DG216384,"Rimeporide | UNII:QH6B4V5743 | PubChem CID:9799487 | N-(diaminomethylidene)-2-methyl-4,5-bis(methylsulfonyl)benzamide | PubChem SID:198972980 | CAS RN:187870-78-6 | DrugBank ID:DB12861 | RIMEPORIDE"
+BMGC_DG16924,BMG_DG216388,ER-27319 FREE BASE | PubChem CID:9799509 | UNII:5308DT8060 | CAS RN:175281-16-0 | PubChem SID:198937846
+BMGC_DG16925,BMG_DG216392,"N-[4-[2-ethyl-1-(1,2,4-triazol-1-yl)butyl]phenyl]-1,3-benzothiazol-2-amine | CAS RN:201410-66-4 | PubChem SID:198943220 | TALAROZOLE | PubChem CID:9799888 | CAS RN:201410-67-5 | DrugBank ID:DB13083 | Talarozole | UNII:XKD9N5CJ6W | CAS RN:201410-53-9"
+BMGC_DG16926,BMG_DG216393,UNII:2K9WS7SUR3 | AM-411 | PubChem SID:440089797 | CAS RN:212835-02-4 | PubChem CID:9799945
+BMGC_DG16927,BMG_DG216395,2-oxo-3-sulfanylpropanoic acid | PubChem CID:98 | 3-MERCAPTOPYRUVIC ACID | CAS RN:2464-23-5 | UNII:5Z1F5OW4YB | PubChem SID:198969866 | 3-Mercaptopyruvic acid
+BMGC_DG16928,BMG_DG216396,PubChem CID:980 | 4-Nitrophenol | DrugBank ID:DB04417 | P-Nitrophenol | P-NITROPHENOL | CAS RN:100-02-7 | PubChem SID:198967680 | 4-nitrophenol | UNII:Y92ZL45L4R
+BMGC_DG16929,BMG_DG216406,"N-Acetyl-D-lactosamine | PubChem CID:9800166 | CAS RN:32181-59-2 | N-[(3R,4R,5S,6R)-2,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide"
+BMGC_DG16930,BMG_DG216414,N-(2-AMINO-5-FLUOROPHENYL)-4-(((1-OXO-3-(3-PYRIDINYL)-2-PROPEN-1-YL)AMINO)METHYL)BENZAMIDE | UNII:462284YV3M | PubChem SID:346538444 | CAS RN:743420-02-2 | N-(2-amino-5-fluorophenyl)-4-[[[(E)-3-pyridin-3-ylprop-2-enoyl]amino]methyl]benzamide | CAS RN:1883690-47-8 | PubChem CID:9800555 | N-(2-Amino-5-fluorophenyl)-4-[[[1-oxo-3-(3-pyridinyl)-2-propen-1-yl]amino]methyl]benzamide
+BMGC_DG16931,BMG_DG216417,UNII:4U96TT078E | PD-171729 | CAS RN:202579-59-7 | PubChem CID:9800614 | PubChem SID:198951840
+BMGC_DG16932,BMG_DG216422,"PubChem CID:9800765 | DrugBank ID:DB12571 | CAS RN:215174-50-8 | RIMACALIB | UNII:BZ76J3N815 | PubChem SID:198953065 | Rimacalib | N'-[3-[(1S)-1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-5-yl]morpholine-4-carboximidamide"
+BMGC_DG16933,BMG_DG216438,PubChem SID:363909839 | CAS RN:124150-27-2 | CP-80798 | UNII:09G7N40OS3 | PubChem CID:9800998
+BMGC_DG16934,BMG_DG216439,"DrugBank ID:DB04825 | PubChem SID:198966522 | PubChem CID:9801 | 3,3-diphenyl-N-(1-phenylpropan-2-yl)propan-1-amine | UNII:K2OH82Z000 | CAS RN:390-64-7 | Prenylamine | PRENYLAMINE"
+BMGC_DG16935,BMG_DG216441,"10-(2-chloro-4-methoxyphenyl)-11-methyl-N-pentan-3-yl-1,8,12-triazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraen-2-amine | PubChem CID:9801039 | PubChem SID:312525249 | CAS RN:441060-02-2 | 5H-Cyclopenta(d)pyrazolo(1,5-a)pyrimidin-8-amine, 3-(2-chloro-4-methoxyphenyl)-N-(1-ethylpropyl)-6,7-dihydro-2-methyl- | UNII:T989JBG788 | ONO-2333"
+BMGC_DG16936,BMG_DG216457,"Piclozotan | PICLOZOTAN | UNII:FQE44HS7AH | 3-chloro-4-[4-(4-pyridin-2-yl-3,6-dihydro-2H-pyridin-1-yl)butyl]-1,4-benzoxazepin-5-one | DrugBank ID:DB12361 | PubChem CID:9801640 | CAS RN:182415-09-4 | PubChem SID:198966192"
+BMGC_DG16937,BMG_DG216460,"CALCIPOTRIOL, (5E)- | UNII:QRA3492A7Q | PubChem CID:9801803 | CAS RN:113082-99-8 | PubChem SID:198938554 | (1R,3S,5E)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-5-cyclopropyl-5-hydroxypent-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | CAS RN:910133-70-9 | CAS RN:112965-21-6 | (5E)-Calcipotriol"
+BMGC_DG16938,BMG_DG216462,"CAS RN:51529-11-4 | PubChem CID:9801811 | Beta-Sitosterone | (8S,9S,10R,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one"
+BMGC_DG16939,BMG_DG216465,EO-1428 | PubChem CID:9801969 | CAS RN:321351-00-2 | PubChem SID:198977616 | UNII:MV2RHJ680O
+BMGC_DG16940,BMG_DG216476,PubChem SID:198951416 | PubChem CID:9802488 | BMS-262084 | CAS RN:253174-92-4 | UNII:I0IR71971G
+BMGC_DG16941,BMG_DG216480,Unii-ywx923E9LD | 2-(HYDROXYMETHYL)-4-(5-(4-METHOXYPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)BENZENE-1-SULFONAMIDE | UNII:YWX923E9LD | 2-(hydroxymethyl)-4-[5-(4-methoxyphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide | PubChem SID:459055160 | PubChem CID:9802596 | CAS RN:304647-55-0
+BMGC_DG16942,BMG_DG216487,N-hydroxy-4-(4-phenylsulfanylphenyl)sulfonyl-1-prop-2-ynylpiperidine-4-carboxamide | CAS RN:226393-68-6 | CID 9802768 | PubChem CID:9802768
+BMGC_DG16943,BMG_DG216491,CAS RN:444659-43-2 | SCH-351591 | UNII:G6EF7V146S | PubChem CID:9802841 | PubChem SID:313184320
+BMGC_DG16944,BMG_DG216501,"MK-0752 | 3-[4-(4-chlorophenyl)sulfonyl-4-(2,5-difluorophenyl)cyclohexyl]propanoic acid | PubChem CID:9803433 | CAS RN:952578-68-6 | CAS RN:471905-41-6 | DrugBank ID:DB12852 | UNII:9JD9B4S53T | PubChem SID:249492837"
+BMGC_DG16945,BMG_DG216503,PubChem CID:9803475 | UNII:73663SY1DT | PubChem SID:198953314 | NNC-63-0532 | CAS RN:250685-44-0
+BMGC_DG16946,BMG_DG216515,"GW-501516 | 2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid | CAS RN:317318-70-0 | PubChem SID:198963667 | PubChem CID:9803963 | Cardarine | DrugBank ID:DB05416 | UNII:7I2HA1NU22 | Endurobol"
+BMGC_DG16947,BMG_DG216522,CAS RN:153707-88-1 | BMS-180492 | PubChem CID:9804174 | PubChem SID:249493064 | UNII:3508097W2U
+BMGC_DG16948,BMG_DG216529,"PubChem CID:9804302 | (9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE | DrugBank ID:DB08416 | PubChem SID:474492543 | UNII:S57SQE6LE5 | CAS RN:401600-86-0 | STX-140"
+BMGC_DG16949,BMG_DG216534,MCL-101 FREE BASE | PubChem SID:445498734 | UNII:6KS5448QQJ | CAS RN:4163-26-2 | PubChem CID:9804450
+BMGC_DG16950,BMG_DG216540,EFLUCIMIBE | PubChem CID:9804740 | UNII:3DK1X2C37M | PubChem SID:198989049 | CAS RN:202340-45-2
+BMGC_DG16951,BMG_DG216541,SM-130686 FREE BASE | CAS RN:259666-71-2 | UNII:1GH34I6261 | PubChem SID:312525165 | PubChem CID:9804743
+BMGC_DG16952,BMG_DG216543,"EPIGALLOCATECHIN 3-O-(3-O-METHYL)GALLATE | PubChem CID:9804842 | CAS RN:83104-87-4 | [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4-dihydroxy-5-methoxybenzoate | UNII:O97U9TPY8V | PubChem SID:198963643 | Epigallocatechin 3-O-(3-O-methyl)gallate"
+BMGC_DG16953,BMG_DG216547,Macimorelin | UNII:8680B21W73 | PubChem CID:9804938 | MACIMORELIN | DrugBank ID:DB13074 | CAS RN:381231-18-1 | NDC:0169-1401 | PubChem SID:198981091 | 2-amino-N-[(2R)-1-[[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide
+BMGC_DG16954,BMG_DG216549,UNII:RC2V4W0EYC | PubChem CID:9804984 | butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | CAS RN:477775-14-7 | PubChem SID:377309165 | BULOXIBUTID | Buloxibutid | butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate
+BMGC_DG16955,BMG_DG216551,PubChem SID:198975202 | UNII:5P60F84FBH | CAS RN:497833-27-9 | Givinostat | [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate | PubChem CID:9804992 | DrugBank ID:DB12645 | GIVINOSTAT
+BMGC_DG16956,BMG_DG216553,ZK-216348 | PubChem CID:9805004 | PubChem SID:472408765 | CAS RN:669073-68-1 | UNII:8BY7XK862L
+BMGC_DG16957,BMG_DG216563,"PubChem SID:198952972 | UNII:BTS1Y6777M | methyl 4-[3-[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]prop-2-ynyl]cyclohexane-1-carboxylate | Apadenoson | PubChem CID:9805430 | CAS RN:250386-15-3 | APADENOSON | DrugBank ID:DB05009"
+BMGC_DG16958,BMG_DG216574,PubChem SID:198978062 | UNII:8163770L8P | CAPESEROD | PubChem CID:9805719 | CAS RN:769901-96-4
+BMGC_DG16959,BMG_DG216576,PubChem SID:346537800 | PD-154075 | CAS RN:158991-23-2 | PubChem CID:9805809 | UNII:QK6IAJLA0M
+BMGC_DG16960,BMG_DG216579,"N-desmethyl loperamide | CAS RN:66164-07-6 | DESMETHYLLOPERAMIDE | UNII:0R07BFN7L3 | 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N-methyl-2,2-diphenylbutanamide | PubChem CID:9805944 | PubChem SID:333495408"
+BMGC_DG16961,BMG_DG216589,"PubChem SID:198967928 | [(8S,11R,13S,14S,17R)-11-[4-(dimethylamino)phenyl]-17-(2-methoxyacetyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate | TELAPRISTONE ACETATE | Telapristone Acetate | PubChem CID:9806190 | UNII:1K9EYK92PQ | CAS RN:198414-31-2 | DrugBank ID:DB05253"
+BMGC_DG16962,BMG_DG216591,AV-412 free base | PubChem SID:198977625 | UNII:41OXH4FE7B | N-[4-(3-chloro-4-fluoroanilino)-7-[3-methyl-3-(4-methylpiperazin-1-yl)but-1-ynyl]quinazolin-6-yl]prop-2-enamide | CAS RN:451492-95-8 | AV-412 FREE BASE | PubChem CID:9806229
+BMGC_DG16963,BMG_DG216610,PubChem SID:433968365 | UNII:UHG8ON73DX | PubChem CID:9806910 | RO-0505376 | CAS RN:343981-29-3
+BMGC_DG16964,BMG_DG216617,UNII:K9GJ38KJ9F | YM-466 free base | {[(7-Carbamimidoylnaphthalen-2-Yl)methyl][4-({1-[(1e)-Ethanimidoyl]piperidin-4-Yl}oxy)phenyl]sulfamoyl}acetic Acid | PubChem SID:485665798 | PubChem CID:9807238 | 2-[(7-carbamimidoylnaphthalen-2-yl)methyl-[4-(1-ethanimidoylpiperidin-4-yl)oxyphenyl]sulfamoyl]acetic acid | CAS RN:179755-65-8 | YM-466 FREE BASE | CAS RN:201933-41-7
+BMGC_DG16965,BMG_DG216622,UNII:V7M68E8XRC | PubChem CID:9807403 | CAS RN:178309-91-6 | UK-224671
+BMGC_DG16966,BMG_DG216625,CAS RN:291778-77-3 | AE-3763 | PubChem SID:443625185 | PubChem CID:9807572 | UNII:F7YC3C4YFS
+BMGC_DG16967,BMG_DG216627,CAS RN:197650-99-0 | PubChem SID:363908352 | PubChem CID:9807597 | L-739943 FREE BASE | UNII:FHV8MGN2OE
+BMGC_DG16968,BMG_DG216636,"PubChem SID:485665848 | (3R)-3-[[(2S)-1-[[(1S)-2-methoxy-1-phenylethyl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamoyl]-6-(3-methyl-4-phenylphenyl)hexanoic acid | UNII:W2WJ6ME4K7 | (R)-3-((S)-1-((S)-2-methoxy-1-phenylethylamino)-3,3-dimethyl-1-oxobutan-2-ylcarbamoyl)-6-(2-methyl biphenyl-4-yl)hexanoic acid | CAS RN:230961-21-4 | UK-370106 | PubChem CID:9808181"
+BMGC_DG16969,BMG_DG216640,"UNII:NMG938VJ6T | TAVILERMIDE | DrugBank ID:DB12441 | PubChem CID:9808372 | 3-[(5S,8S,11S)-8-(4-aminobutyl)-5-(carboxymethylcarbamoyl)-16-nitro-7,10,13-trioxo-2-oxa-6,9,12-triazabicyclo[12.4.0]octadeca-1(14),15,17-trien-11-yl]propanoic acid | CAS RN:263251-78-1 | Tavilermide | PubChem SID:198934813"
+BMGC_DG16970,BMG_DG216642,PubChem SID:387065194 | IMNOPITANT | PubChem CID:9808518 | UNII:F1516R3E77 | CAS RN:290297-57-3
+BMGC_DG16971,BMG_DG216645,"(2R)-2-[[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]methyl]-2,5,7,8-tetramethyl-3,4-dihydrochromen-6-ol | PubChem CID:9808655 | (2R)-[[4-(2,6-di-1-Pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl]methyl]-3,4-dihydro-2,5,7,8-tetramethyl-2H-1-benzopyran-6-ol"
+BMGC_DG16972,BMG_DG216646,PubChem CID:9808666 | UNII:Z7C5CD91WI | CAS RN:351351-75-2 | Braco-19 | PubChem SID:198975352 | N-[9-[4-(dimethylamino)anilino]-6-(3-pyrrolidin-1-ylpropanoylamino)acridin-3-yl]-3-pyrrolidin-1-ylpropanamide | BRACO-19
+BMGC_DG16973,BMG_DG216649,"TELATINIB | CAS RN:332012-40-5 | 4-[[4-(4-chloroanilino)furo[2,3-d]pyridazin-7-yl]oxymethyl]-N-methylpyridine-2-carboxamide | PubChem CID:9808844 | DrugBank ID:DB15393 | Telatinib | PubChem SID:198939231 | UNII:18P7197Q7J"
+BMGC_DG16974,BMG_DG216650,UNII:X4EDB9177R | CAS RN:208840-22-6 | CE-2072 | PubChem CID:9808874 | PubChem SID:198953829
+BMGC_DG16975,BMG_DG216654,"Edotecarin | UNII:1V8X590XDP | PubChem CID:9808998 | PubChem SID:198943502 | CAS RN:174402-32-5 | EDOTECARIN | 13-(1,3-dihydroxypropan-2-ylamino)-6,20-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione | DrugBank ID:DB04882"
+BMGC_DG16976,BMG_DG216661,UNII:8DA56TKF53 | PubChem CID:9809280 | PubChem SID:472408594 | CAS RN:144628-52-4 | FONSARTAN FREE ACID
+BMGC_DG16977,BMG_DG216664,"1-(3-PHENYLPROPYL)-4-(3-PYRIDINYL)BUTYL (2S)-1-(2,2-DIFLUORO-2-(3,4,5-TRIMETHOXYPHENYL)ACETYL)-2-PIPERIDINECARBOXYLATE | PubChem CID:9809312 | UNII:DD7HFH26Q8 | CAS RN:391669-34-4"
+BMGC_DG16978,BMG_DG216672,PubChem SID:375579256 | GW-559090 | (2S)-3-[4-(4-carbamoylpiperidine-1-carbonyl)oxyphenyl]-2-[[(2S)-4-methyl-2-[[2-(2-methylphenoxy)acetyl]amino]pentanoyl]amino]propanoic acid | PubChem CID:9809516 | UNII:H9W4YH429K | CAS RN:278598-52-0 | DrugBank ID:DB06508
+BMGC_DG16979,BMG_DG216679,CAS RN:656247-17-5 | PubChem CID:9809715 | PubChem SID:198986794 | Nintedanib | UNII:G6HRD2P839 | NINTEDANIB | DrugBank ID:DB09079
+BMGC_DG16980,BMG_DG216687,CAS RN:193079-69-5 | UNII:L51CBE03KF | PubChem CID:9810101 | PubChem SID:198954121 | TABIMORELIN
+BMGC_DG16981,BMG_DG216693,"FR167344 | CAS RN:215258-13-2 | PubChem CID:9810391 | 4-[(E)-3-[[2-[3-[(3-bromo-2-methylimidazo[1,2-a]pyridin-8-yl)oxymethyl]-2,4-dichloro-N-methylanilino]-2-oxoethyl]amino]-3-oxoprop-1-enyl]-N,N-dimethylbenzamide"
+BMGC_DG16982,BMG_DG216695,PubChem SID:375084242 | LARAZOTIDE | PubChem CID:9810532 | DrugBank ID:DB05645 | Larazotide | CAS RN:258818-34-7 | UNII:ZN3R5560ZV | 2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]acetic acid
+BMGC_DG16983,BMG_DG216701,"UNII:C28MV4IM0B | PubChem SID:198977542 | Aldoxorubicin | CAS RN:151038-96-9 | PubChem CID:9810709 | DrugBank ID:DB06013 | CAS RN:1361644-26-9 | N-[(E)-[1-[(2S,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-hydroxyethylidene]amino]-6-(2,5-dioxopyrrol-1-yl)hexanamide | ALDOXORUBICIN"
+BMGC_DG16984,BMG_DG216704,PubChem CID:9810884 | UNII:00ALI1GAY2 | CAS RN:199433-58-4 | PubChem SID:198972273 | Y-33075
+BMGC_DG16985,BMG_DG216706,"PubChem CID:9810927 | PubChem SID:313183074 | DrugBank ID:DB12760 | UNII:93OG0JL22O | Gw-493838 | (2S,3S,4R,5R)-2-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-[6-(4-chloro-2-fluoroanilino)purin-9-yl]oxolane-3,4-diol | CAS RN:253124-46-8 | GW-493838"
+BMGC_DG16986,BMG_DG216707,"(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide | DrugBank ID:DB12730 | PubChem SID:198977109 | DOLASTATIN 10 | CAS RN:110417-88-4 | Dolastatin 10 | PubChem CID:9810929 | UNII:EI946JT51X"
+BMGC_DG16987,BMG_DG216715,"UNII:4V9C6FBZ7M | PubChem CID:9811100 | CAS RN:321344-57-4 | 7-(5-(4-FLUOROPHENYL)-4-(PYRIDIN-4-YL)-1H-PYRROL-3-YL)-1,2,3,5,6,8A-HEXAHYDROINDOLIZINE, (8AS)- | PubChem SID:445500558"
+BMGC_DG16988,BMG_DG216721,"PubChem CID:9811353 | UNII:97B5KCW80W | 2-[3-[5-[6-[3-[3-(carboxymethyl)phenyl]-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]hexyl]-2-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]phenyl]acetic acid | PubChem SID:198935960 | BIMOSIAMOSE | DrugBank ID:DB06197 | Bimosiamose | CAS RN:187269-40-5"
+BMGC_DG16989,BMG_DG216722,AVE-0118 | UNII:Q1B712V03A | CAS RN:498577-53-0 | PubChem CID:9811357 | PubChem SID:198939311
+BMGC_DG16990,BMG_DG216723,PubChem SID:198961373 | CAS RN:246146-55-4 | PubChem CID:9811493 | UNII:N3Z657H81X | BIIE-0246
+BMGC_DG16991,BMG_DG216727,"PubChem SID:375084253 | Aclerastide | CAS RN:227803-63-6 | UNII:YYD6UT8T47 | (2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid | DrugBank ID:DB12631 | PubChem CID:9811551 | ACLERASTIDE"
+BMGC_DG16992,BMG_DG216730,"UNII:W1B375O5M2 | 3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-(4-pyrrolidin-1-ylbutylcarbamoylamino)-1,2-thiazole-4-carboxamide | 3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide | PubChem SID:198984058 | CP-547632 | DrugBank ID:DB12962 | CAS RN:252003-65-9 | PubChem CID:9811611"
+BMGC_DG16993,BMG_DG216734,"DrugBank ID:DB12761 | UNII:U141W322WZ | Timcodar | TIMCODAR | PubChem SID:198970849 | (2S)-N-benzyl-3-(4-chlorophenyl)-N-(1,5-dipyridin-4-ylpentan-3-yl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]amino]propanamide | PubChem CID:9811664 | CAS RN:179033-51-3"
+BMGC_DG16994,BMG_DG216736,"PubChem SID:175271612 | NDC:71335-9725 | NDC:72789-133 | NDC:64380-760 | NDC:71205-854 | NDC:0054-0142 | NDC:0054-0141 | NDC:23155-149 | NDC:23155-148 | NDC:72789-132 | NDC:43353-951 | NDC:64380-759 | DrugBank ID:DB00284 | NDC:62135-454 | NDC:71205-856 | NDC:62135-453 | NDC:23155-147 | NDC:71205-855 | NDC:62135-455 | NDC:72789-131 | NDC:64380-758 | NDC:0054-0140 | (2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanal | Acarbose | NDC:71335-1583 | PubChem CID:9811704 | UNII:T58MSI464G | NDC:63629-5698 | CAS RN:56180-94-0 | ACARBOSE"
+BMGC_DG16995,BMG_DG216746,"NDC:46708-556 | NDC:0078-9777 | NDC:42385-932 | NDC:0078-1238 | PubChem SID:198938523 | NDC:42385-931 | NDC:73190-007 | NDC:72205-280 | NDC:46708-558 | NDC:72205-281 | NDC:13668-635 | NDC:71610-806 | NDC:62332-558 | NDC:46708-557 | NDC:72205-282 | NDC:0078-9659 | NDC:13668-636 | UNII:17ERJ0MKGI | CAS RN:149709-62-6 | NDC:0078-0696 | NDC:62332-557 | NDC:67877-707 | NDC:73190-006 | NDC:0078-1231 | 4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid | NDC:67877-708 | PubChem CID:9811834 | Sacubitril | SACUBITRIL | NDC:62332-556 | NDC:13668-634 | NDC:73190-005 | DrugBank ID:DB09292 | NDC:67877-709 | NDC:71610-807 | NDC:42385-930 | NDC:71610-810 | NDC:0078-0777 | NDC:0078-0659"
+BMGC_DG16996,BMG_DG216747,"DrugBank ID:DB05518 | Managlinat Dialanetil | UNII:3W93F83K7S | PubChem CID:9811837 | MANAGLINAT DIALANETIL | PubChem SID:198986474 | ethyl (2S)-2-[[[5-[2-amino-5-(2-methylpropyl)-1,3-thiazol-4-yl]furan-2-yl]-[[(2S)-1-ethoxy-1-oxopropan-2-yl]amino]phosphoryl]amino]propanoate | CAS RN:280782-97-0"
+BMGC_DG16997,BMG_DG216755,"PubChem CID:9812534 | CAS RN:137219-37-5 | (2S)-N-[(2R)-1-[[(3S,6S,8S,12S,13R,16S,17R,20S,23S)-13-[(2S)-butan-2-yl]-12-hydroxy-20-[(4-methoxyphenyl)methyl]-6,17,21-trimethyl-3-(2-methylpropyl)-2,5,7,10,15,19,22-heptaoxo-8-propan-2-yl-9,18-dioxa-1,4,14,21-tetrazabicyclo[21.3.0]hexacosan-16-yl]amino]-4-methyl-1-oxopentan-2-yl]-N-methyl-1-(2-oxopropanoyl)pyrrolidine-2-carboxamide | PubChem SID:316912158 | DrugBank ID:DB04977 | PLITIDEPSIN | Plitidepsin | UNII:Y76ID234HW"
+BMGC_DG16998,BMG_DG216772,"6,7-DICHLORO-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE | UNII:XK5GKR75E3 | CAS RN:180160-89-8 | PubChem SID:472422445 | PubChem CID:9813197"
+BMGC_DG16999,BMG_DG216776,"4-(2-Thiazolyl)thieno[3,2-d]pyrimidin-2-amine | CAS RN:443148-62-7 | UNII:4U5BZA9NL4 | 4-(2-THIAZOLYL)THIENO(3,2-D)PYRIMIDIN-2-AMINE | PubChem SID:485664818 | PubChem CID:9813424"
+BMGC_DG17000,BMG_DG216780,PubChem CID:9813758 | CAS RN:445430-58-0 | PubChem SID:198982142 | BMS-345541 FREE BASE | UNII:26SU0NEF5F
+BMGC_DG17001,BMG_DG216794,UNII:JL0R030ML5 | PubChem CID:9814674 | CAS RN:460748-95-2 | PubChem SID:198990893 | A-688057
+BMGC_DG17002,BMG_DG216812,"PubChem SID:478838362 | CAS RN:133240-06-9 | 2-Ethyl-5,7-dimethyl-1H-imidazo[4,5-b]pyridine | UNII:B8NB2AA6HQ | 2-ETHYL-5,7-DIMETHYL-1H-IMIDAZO(4,5-B)PYRIDINE | PubChem CID:9815374"
+BMGC_DG17003,BMG_DG216825,PubChem CID:9815539 | UNII:AEX7433VC9 | CAS RN:214478-65-6 | ONO-1714 FREE BASE | PubChem SID:459055746
+BMGC_DG17004,BMG_DG216828,STREPTOKINASE | PubChem SID:472399232 | UNII:8X1OXL3SNU | CAS RN:9002-01-1 | PubChem CID:9815560
+BMGC_DG17005,BMG_DG216834,PubChem SID:313184299 | PubChem CID:9815618 | CAS RN:19036-73-8 | NORDEXFENFLURAMINE | UNII:CLX07A6ZIY | (S)-Norfenfluramine | (2S)-1-[3-(trifluoromethyl)phenyl]propan-2-amine
+BMGC_DG17006,BMG_DG216835,HESPERIN | PubChem CID:9815648 | CAS RN:4430-35-7 | 6-Methylsulfinylhexyl isothiocyanate | 1-isothiocyanato-6-methylsulfinylhexane | UNII:8RUP6Q3JBB | PubChem SID:441096854
+BMGC_DG17007,BMG_DG216848,"4-[(5r)-5,6,7,8-Tetrahydroimidazo[1,5-A]pyridin-5-Yl]benzonitrile | 4-[(5R)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl]benzonitrile | UNII:IC1B8751F6 | DEXFADROSTAT | CAS RN:102676-87-9 | PubChem SID:329903904 | PubChem CID:9815923"
+BMGC_DG17008,BMG_DG216866,"OR-1896 | UNII:IKC90B19NV | PubChem CID:9816296 | (R)-N-Acetyl-6-(4-aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone | CAS RN:220246-81-1 | N-[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]acetamide | PubChem SID:433968846"
+BMGC_DG17009,BMG_DG216868,PubChem SID:445499142 | PubChem CID:9816455 | DINAPSOLINE | UNII:GZ9XC6C5P9 | CAS RN:679433-68-2
+BMGC_DG17010,BMG_DG216869,UNII:K8F7E2OVP2 | GW-505524B | CAS RN:305809-45-4 | PubChem CID:9816461 | PubChem SID:198952095
+BMGC_DG17011,BMG_DG216875,PubChem CID:9816527 | TS-011 | CAS RN:339071-18-0 | PubChem SID:404859742 | UNII:FP24MFJ1RM
+BMGC_DG17012,BMG_DG216888,4-HYDROXYATOMOXETINE | 3-methyl-4-[(1R)-3-(methylamino)-1-phenylpropoxy]phenol | PubChem CID:9816910 | CAS RN:435293-66-6 | UNII:6T2XYC0A9R | PubChem SID:198977537 | 4-Hydroxyatomoxetine
+BMGC_DG17013,BMG_DG216890,CAS RN:173458-56-5 | UNII:YP9UZR062O | PubChem CID:9816954 | CGP-59326 | PubChem SID:198989539
+BMGC_DG17014,BMG_DG216895,AGL-2043 | PubChem SID:198983575 | UNII:8OO2SLF34L | PubChem CID:9817165 | CAS RN:226717-28-8
+BMGC_DG17015,BMG_DG216896,PD-144418 | CAS RN:154130-99-1 | UNII:FV9595VZB7 | PubChem SID:474492753 | PubChem CID:9817231
+BMGC_DG17016,BMG_DG216904,"PubChem CID:9817381 | (1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol | DrugBank ID:DB08321"
+BMGC_DG17017,BMG_DG216909,PubChem CID:9817550 | DrugBank ID:DB08694 | Variolin B
+BMGC_DG17018,BMG_DG216932,(2S)-1-[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid | PubChem SID:198974906 | PubChem CID:9818200 | UNII:2U1R84870F | Val-Pro-Pro | CAS RN:58872-39-2 | VAL-PRO-PRO
+BMGC_DG17019,BMG_DG216937,"Estradiol Acetate | ESTRADIOL ACETATE | DrugBank ID:DB13952 | Estradiol acetate | NDC:72495-202 | PubChem SID:175268112 | NDC:72495-201 | PubChem CID:9818306 | UNII:5R97F5H93P | CAS RN:4245-41-4 | [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] acetate"
+BMGC_DG17020,BMG_DG216943,"DrugBank ID:DB06477 | CAS RN:179386-43-7 | PubChem SID:198967559 | SUMANIROLE | Sumanirole | PubChem CID:9818479 | (10R)-10-(methylamino)-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-2-one | UNII:3E93IV1U45"
+BMGC_DG17021,BMG_DG216947,"PubChem CID:9818682 | CAS RN:348622-88-8 | 5-[(3R)-6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl]-1,2,4-oxadiazole-3-carboxamide | (R)-5-(6-cyclohexyl-1-(hydroxyamino)-1-oxohexan-3-yl)-1,2,4-oxadiazole-3-carboxamide"
+BMGC_DG17022,BMG_DG216952,"PubChem SID:363908468 | 3,6-dimethyl-4-pentan-3-yloxy-2-(2,4,6-trimethylphenoxy)pyridine | CP-316311 | PubChem CID:9818802 | CAS RN:175139-41-0 | Pyridine, 4-(1-ethylpropoxy)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)- | UNII:GNW87JO5PF"
+BMGC_DG17023,BMG_DG216955,"CAS RN:181695-81-8 | 4-[5-(hydroxymethyl)-3-phenyl-1,2-oxazol-4-yl]benzenesulfonamide | 1-HYDROXYVALDECOXIB | UNII:T5Q8Y8772I | PubChem CID:9818888 | 1-Hydroxyvaldecoxib | PubChem SID:198943569"
+BMGC_DG17024,BMG_DG216956,UNII:86H6B395PI | CAS RN:460746-46-7 | 4-[2-[2-[(2R)-2-methylpyrrolidin-1-yl]ethyl]-1-benzofuran-5-yl]benzonitrile | ABT-239 | (R)-4-(2-(2-(2-methylpyrrolidin-1-yl)ethyl)benzofuran-5-yl)benzonitrile | PubChem SID:198964492 | PubChem CID:9818903
+BMGC_DG17025,BMG_DG216967,"PubChem CID:9819350 | ((4-(7-HYDROXY-2,3-DIHYDRO-1H-INDEN-4-YL)OXY)-3,5-DIMETHYLPHENYL)AMINO)OXO)ACETIC ACID | CAS RN:290352-28-2 | ((4-(7-Hydroxy-2,3-dihydro-1H-inden-4-yl)oxy)-3,5-dimethylphenyl)amino)oxo)acetic acid | PubChem SID:475549750 | UNII:ZVX2HK95PX"
+BMGC_DG17026,BMG_DG216968,UNII:JV44YT58G6 | CAS RN:159925-31-2 | 8-(3-Nitrophenyl)-6-(4-pyridinylmethyl)quinoline | 8-(3-NITROPHENYL)-6-(4-PYRIDINYLMETHYL)QUINOLINE | PubChem SID:482553929 | PubChem CID:9819356
+BMGC_DG17027,BMG_DG216969,2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenol | PubChem CID:9819382 | DrugBank ID:DB15578 | DESFESOTERODINE | CAS RN:207679-81-0 | Desfesoterodine | PubChem SID:249493334 | UNII:YU871O78GR
+BMGC_DG17028,BMG_DG216974,403U76 FREE BASE | PubChem SID:363909360 | PubChem CID:9819496 | CAS RN:133884-20-5 | UNII:06KJP8A4M6
+BMGC_DG17029,BMG_DG216975,"UNII:38126EQF7A | PubChem SID:375083307 | PubChem CID:9819593 | ZACOPRIDE, (R)- | CAS RN:123441-85-0"
+BMGC_DG17030,BMG_DG216977,"DrugBank ID:DB07358 | 2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide | PubChem CID:9819610"
+BMGC_DG17031,BMG_DG216984,CAS RN:223774-67-2 | PubChem CID:9819926 | UNII:KK74JH2JTT | GR-242468 | PubChem SID:445500007
+BMGC_DG17032,BMG_DG216985,"2-[(1s,2s)-2-Carboxycyclopropyl]-3-(9h-Xanthen-9-Yl)-D-Alanine | CAS RN:201943-63-7 | UNII:AQ73SP6QSF | PubChem SID:474492858 | (1S,2S)-2-[(1S)-1-amino-1-carboxy-2-(9H-xanthen-9-yl)ethyl]cyclopropane-1-carboxylic acid | LY-341495 | PubChem CID:9819927"
+BMGC_DG17033,BMG_DG216988,2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid | CAS RN:717824-30-1 | PubChem CID:9820008 | UNII:8Y1PJ3VG81 | Vidofludimus | PubChem SID:198966034 | VIDOFLUDIMUS | DrugBank ID:DB15446
+BMGC_DG17034,BMG_DG216989,N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE | PubChem CID:9820034 | DrugBank ID:DB07279
+BMGC_DG17035,BMG_DG216990,CAS RN:197904-84-0 | PubChem SID:198941609 | APRICOXIB | UNII:5X5HB3VZ3Z | DrugBank ID:DB12378 | PubChem CID:9820073 | Apricoxib | 4-[2-(4-ethoxyphenyl)-4-methylpyrrol-1-yl]benzenesulfonamide
+BMGC_DG17036,BMG_DG216991,"CP-293019 | (7R,9aS)-7-[(4-fluorophenoxy)methyl]-2-(5-fluoropyrimidin-2-yl)-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine | PubChem CID:9820261 | CAS RN:179089-90-8"
+BMGC_DG17037,BMG_DG216994,AS-602868 | UNII:Y1FZ8P93E0 | CAS RN:219773-55-4 | PubChem SID:377308418 | PubChem CID:9820526
+BMGC_DG17038,BMG_DG216996,CAS RN:305822-63-3 | UNII:227D9ED2SI | PubChem CID:9820558 | CP-394531 | PubChem SID:198941831
+BMGC_DG17039,BMG_DG216999,PubChem SID:198975257 | UNII:YV0E1W422C | PD-160678 | PubChem CID:9820644 | CAS RN:198959-83-0
+BMGC_DG17040,BMG_DG217002,PubChem CID:9820766 | CAS RN:181468-88-2 | 6-((2-(1-METHYLETHYL)PHENYL)SULFONYL)-5-NITRO-8-QUINOLINAMINE | 6-[[2-(1-Methylethyl)phenyl]sulfonyl]-5-nitro-8-quinolinamine | PubChem SID:478838323 | UNII:GQ34MN6NT8
+BMGC_DG17041,BMG_DG217007,"PubChem SID:198982920 | 2-[4-[2-[[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]-2,5-dimethylphenoxy]acetic acid | PubChem CID:9820882 | UNII:LD86RKR53M | DrugBank ID:DB12080 | RITOBEGRON | Ritobegron | CAS RN:255734-04-4"
+BMGC_DG17042,BMG_DG217010,PubChem CID:9820916 | KF-26777 | UNII:N33070GI64 | CAS RN:206129-88-6 | PubChem SID:198952782
+BMGC_DG17043,BMG_DG217017,"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide | DrugBank ID:DB06909 | PubChem CID:9821178"
+BMGC_DG17044,BMG_DG217019,"DrugBank ID:DB05421 | CP-122721 | (2S,3S)-N-[[2-methoxy-5-(trifluoromethoxy)phenyl]methyl]-2-phenylpiperidin-3-amine | CAS RN:145742-28-5 | PubChem SID:198985924 | UNII:R7OYP6N58F | (2S,3S)-N-(2-methoxy-5-(trifluoromethoxy)benzyl)-2-phenylpiperidin-3-amine | PubChem CID:9821217"
+BMGC_DG17045,BMG_DG217020,CAS RN:195055-03-9 | PubChem SID:198989082 | PubChem CID:9821250 | NBI-30775 | UNII:G82N555U1N
+BMGC_DG17046,BMG_DG217024,"PubChem CID:9821383 | CAS RN:134448-10-5 | (2S)-1-[(2S,3S)-3-methyl-2-[[(2S,3S)-3-(propylcarbamoyl)oxirane-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carboxylic acid | Cathepsin B Inhibitor III"
+BMGC_DG17047,BMG_DG217027,"CAS RN:112830-95-2 | PubChem SID:198962833 | UNII:191042422P | PubChem CID:9821569 | HU-210 | (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol"
+BMGC_DG17048,BMG_DG217033,"NDC:72162-2151 | NDC:43598-358 | NDC:60219-1754 | NDC:57894-100 | NDC:0143-9597 | [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate | NDC:82009-140 | NDC:72603-110 | NDC:0591-4365 | NDC:82249-010 | NDC:82009-139 | NDC:72205-285 | NDC:68462-135 | NDC:69238-1754 | NDC:72205-284 | NDC:0378-6921 | NDC:69539-319 | NDC:71921-177 | NDC:72789-213 | NDC:0093-1125 | NDC:71921-178 | NDC:64980-418 | NDC:60505-4764 | NDC:60219-1165 | NDC:72606-566 | NDC:69539-318 | NDC:57894-050 | PubChem CID:9821849 | CAS RN:154229-18-2 | NDC:69238-1165 | NDC:60687-455 | UNII:EM5OCB9YJ6 | ABIRATERONE ACETATE | NDC:16714-963 | NDC:82249-011 | NDC:60505-4327 | NDC:43598-468 | NDC:82293-002 | NDC:72205-030 | NDC:47335-401 | NDC:57894-150 | NDC:69539-049 | NDC:68001-489 | NDC:0378-6920 | NDC:72606-573 | PubChem SID:175267140 | NDC:0904-6948 | NDC:82293-001 | NDC:57894-195 | NDC:68462-882 | NDC:42291-024 | NDC:72603-111 | NDC:60687-790 | Abiraterone Acetate"
+BMGC_DG17049,BMG_DG217034,CAS RN:161313-73-1 | (2R)-2-[benzyl-(4-methoxyphenyl)sulfonylamino]-N-hydroxy-3-methylbutanamide | (R)-2-(N-Benzyl-4-methoxyphenylsulfonamido)-N-hydroxy-3-methylbutanamide | PubChem CID:9821883
+BMGC_DG17050,BMG_DG217037,CAS RN:179420-17-8 | PubChem CID:9821945 | CJ-13610 | PubChem SID:198958713 | UNII:5275PJ1C59
+BMGC_DG17051,BMG_DG217042,5-METHYLPYRAZOLE-3-CARBOXYLIC ACID | UNII:U71778T48T | PubChem SID:198968148 | CAS RN:402-61-9 | PubChem CID:9822
+BMGC_DG17052,BMG_DG217057,"DrugBank ID:DB08519 | PubChem CID:9822610 | N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine"
+BMGC_DG17053,BMG_DG217060,PubChem CID:9822722 | O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-N-PROPYL-L-TYROSINE | CAS RN:185679-16-7 | PubChem SID:459055777 | UNII:W6E59KDD9D
+BMGC_DG17054,BMG_DG217061,PubChem SID:198966663 | UNII:414MEG73VU | PubChem CID:9822724 | SOLIMASTAT | CAS RN:226072-63-5
+BMGC_DG17055,BMG_DG217063,"Levamlodipine | UNII:0P6NLP6806 | PubChem CID:9822750 | 3-O-ethyl 5-O-methyl (4S)-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | DrugBank ID:DB09237 | PubChem SID:198945165 | LEVAMLODIPINE | CAS RN:103129-82-4"
+BMGC_DG17056,BMG_DG217079,"[(4aS,9aS)-2,4a,9-trimethyl-4,9a-dihydro-3H-oxazino[6,5-b]indol-6-yl] N-(2-ethylphenyl)carbamate | PubChem CID:9823294 | UNII:QRR9SV89XI | Ganstigmine | CAS RN:457075-21-7 | PubChem SID:198941475 | GANSTIGMINE | DrugBank ID:DB06525"
+BMGC_DG17057,BMG_DG217081,"UNII:U85LDX3HM8 | N-(2-(2H-1,3-BENZODIOXOL-5-YL)ETHYL)-1-(2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL)PYRROLIDINE-2-CARBOXAMIDE, (2S)- | PubChem CID:9823449 | CAS RN:212636-42-5"
+BMGC_DG17058,BMG_DG217082,(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide | PubChem CID:9823454 | DrugBank ID:DB07861
+BMGC_DG17059,BMG_DG217090,4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide | NDC:62856-710 | UNII:EE083865G2 | CAS RN:417716-92-8 | PubChem CID:9823820 | NDC:62856-708 | PubChem SID:198978519 | Lenvatinib | NDC:62856-704 | LENVATINIB | NDC:62856-712 | NDC:62856-720 | DrugBank ID:DB09078
+BMGC_DG17060,BMG_DG217092,"PubChem CID:9823886 | UNII:YB1F0V77MK | CAS RN:204981-48-6 | PubChem SID:198986544 | DrugBank ID:DB13053 | Cp-195543 | CP-195543 | 2-[(3S,4R)-3-benzyl-4-hydroxy-3,4-dihydro-2H-chromen-7-yl]-4-(trifluoromethyl)benzoic acid"
+BMGC_DG17061,BMG_DG217097,"Ilepatril | ILEPATRIL | CAS RN:473289-62-2 | (4S,7S,12bR)-7-[[(2S)-2-acetylsulfanyl-3-methylbutanoyl]amino]-6-oxo-2,3,4,7,8,12b-hexahydro-1H-pyrido[2,1-a][2]benzazepine-4-carboxylic acid | PubChem CID:9824131 | PubChem SID:198942986 | DrugBank ID:DB06604 | UNII:5N1YAP5FCM"
+BMGC_DG17062,BMG_DG217100,"CAS RN:252870-53-4 | PubChem SID:198975498 | Ispronicline | PubChem CID:9824145 | UNII:3E05NBH9V5 | ISPRONICLINE | (E,2S)-N-methyl-5-(5-propan-2-yloxypyridin-3-yl)pent-4-en-2-amine"
+BMGC_DG17063,BMG_DG217103,"UNII:02HQ4TYQ60 | PubChem SID:198968231 | PubChem CID:9824350 | Cipemastat | CAS RN:190648-49-8 | (2R,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-piperidin-1-yl-2-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]butanamide | CIPEMASTAT"
+BMGC_DG17064,BMG_DG217104,PubChem CID:9824353 | UNII:T7XW73LKW4 | RIVENPROST FREE ACID | PubChem SID:478838837 | CAS RN:256382-23-7 | Rivenprost free acid
+BMGC_DG17065,BMG_DG217106,PubChem CID:9824562 | UNII:7UT2HAH49H | CAS RN:401900-40-1 | PubChem SID:198981980 | DrugBank ID:DB07423 | ANDARINE | Andarine
+BMGC_DG17066,BMG_DG217108,"TROGLITAZONE, (2R,5R)-(±)- | TROGLITAZONE, (2R,5R)-(+/-)- | PubChem SID:198942256 | (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE | UNII:1A70L3TM4P | PubChem CID:9824580 | DrugBank ID:DB08607 | CAS RN:640275-14-5"
+BMGC_DG17067,BMG_DG217115,CAS RN:311770-26-0 | KRP-101 | UNII:V123C0BB32 | PubChem SID:313183079 | PubChem CID:9825046
+BMGC_DG17068,BMG_DG217118,ADW-742 | CAS RN:475488-23-4 | UNII:MXS2N5862L | PubChem CID:9825149 | PubChem SID:252823856
+BMGC_DG17069,BMG_DG217122,5-methyltetrahydrofolic acid | PubChem CID:9825434 | DrugBank ID:DB04789
+BMGC_DG17070,BMG_DG217124,"EDAGLITAZONE, (+)- | DrugBank ID:DB06519 | EDAGLITAZONE | UNII:59LQZ96XUU | UNII:QP6GWW0LZD | PubChem SID:198951853 | EDAGLITAZONE, (-)- | PubChem SID:441583750 | CAS RN:213411-83-7 | PubChem SID:440089759 | UNII:8GKF7V499B | 5-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophen-7-yl]methyl]-1,3-thiazolidine-2,4-dione | CAS RN:892128-36-8 | CAS RN:892128-35-7 | PubChem CID:9825701 | Edaglitazone"
+BMGC_DG17071,BMG_DG217126,CAS RN:282728-65-8 | UNII:3B98TP8EKJ | INDOMETHACIN N-OCTYL AMIDE | PubChem CID:9825900
+BMGC_DG17072,BMG_DG217131,TANOGITRAN | PubChem CID:9826322 | UNII:X5QRR6Z56Q | PubChem SID:198949843 | CAS RN:637328-69-9
+BMGC_DG17073,BMG_DG217134,"5-[[4-[2-[[6-(4-methoxyphenoxy)pyrimidin-4-yl]-methylamino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | DrugBank ID:DB09198 | PubChem SID:198969705 | CAS RN:607723-33-1 | Lobeglitazone | LOBEGLITAZONE | PubChem CID:9826451 | UNII:MY89F08K5D"
+BMGC_DG17074,BMG_DG217136,PubChem CID:9826520 | CAS RN:515141-51-2 | PubChem SID:198972475 | GW-803430 | UNII:4R0136W1PR
+BMGC_DG17075,BMG_DG217138,"Mirdametinib | N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide | PubChem CID:9826528 | N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide | PubChem SID:198974803 | CAS RN:391209-97-5 | DrugBank ID:DB07101 | CAS RN:391210-10-9 | UNII:86K0J5AK6M | MIRDAMETINIB"
+BMGC_DG17076,BMG_DG217141,"PubChem CID:9826744 | IBIPINABANT | Ibipinabant | UNII:O5CSC6WH1T | PubChem SID:198935703 | DrugBank ID:DB12649 | (4S)-5-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide | CAS RN:464213-10-3"
+BMGC_DG17077,BMG_DG217143,PubChem SID:198983159 | CAS RN:182417-73-8 | PubChem CID:9826770 | UNII:R3UO4Y068S | DPI-3290
+BMGC_DG17078,BMG_DG217151,PubChem CID:9827497 | CAS RN:286845-00-9 | ABT-518 | PubChem SID:198974841 | UNII:7S00622N3Z
+BMGC_DG17079,BMG_DG217156,CAS RN:260270-56-2 | PubChem CID:9827846 | UNII:06MZZ28P7W | GW-4459 | PubChem SID:198959969
+BMGC_DG17080,BMG_DG217157,CAS RN:801312-28-7 | UNII:2D6GK059SR | PubChem CID:9827968 | CAS RN:13122-87-7 | DrugBank ID:DB12137 | CAS RN:801315-14-0 | GSK-256066 | PubChem SID:198983498 | Gsk-256066 | 6-[3-(dimethylcarbamoyl)phenyl]sulfonyl-4-(3-methoxyanilino)-8-methylquinoline-3-carboxamide
+BMGC_DG17081,BMG_DG217164,CAS RN:379692-00-9 | UNII:W1AEF8025F | CP-664511 | PubChem SID:198950942 | PubChem CID:9828124
+BMGC_DG17082,BMG_DG217168,BMS-210285 | PubChem SID:198970923 | PubChem CID:9828292 | CAS RN:344607-69-8 | UNII:WS7S13Q9RH
+BMGC_DG17083,BMG_DG217170,"PubChem SID:198968521 | DrugBank ID:DB12564 | [(2R,3R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4,4-difluoro-3-hydroxyoxolan-2-yl]methyl (E)-octadec-9-enoate | GEMCITABINE ELAIDATE | CAS RN:210829-30-4 | PubChem CID:9828310 | UNII:231C73W7LG | Gemcitabine elaidate"
+BMGC_DG17084,BMG_DG217174,UNII:A1LB8I4247 | PubChem SID:255509319 | CAS RN:331727-55-0 | CP-608039 | PubChem CID:9828356
+BMGC_DG17085,BMG_DG217179,"PubChem SID:363909156 | PubChem CID:9828471 | ethyl 2-(2-hydroxyethylcarbamoyloxymethyl)-5,7-dimethyl-3-[2-(methylsulfamoyl)phenyl]-4-oxoquinazoline-6-carboxylate | Sad-448 | UNII:951G84HQ4I | CAS RN:581106-09-4 | SAD-448"
+BMGC_DG17086,BMG_DG217183,"PubChem CID:9828617 | CAS RN:264262-71-7 | 3-(5-methyl-1,2,4-oxadiazol-3-yl)-N-[4-[2-(7-methylsulfonyl-1,2,4,5-tetrahydro-3-benzazepin-3-yl)ethyl]cyclohexyl]benzamide | N-{4-[2-(7-Methanesulfonyl-1,2,4,5-tetrahydro-benzo[d]azepin-3-yl)-ethyl]-cyclohexyl}-3-(5-methyl-[1,2,4]oxadiazol-3-yl)-benzamide"
+BMGC_DG17087,BMG_DG217185,PubChem SID:346539248 | FR-135313 | PubChem CID:9828788 | CAS RN:390745-19-4 | UNII:4MQ5UQAIB8
+BMGC_DG17088,BMG_DG217189,Anamorelin | ANAMORELIN | CAS RN:249921-19-5 | PubChem CID:9828911 | DrugBank ID:DB06645 | UNII:DD5RBA1NKF | PubChem SID:175267765 | 2-amino-N-[(2R)-1-[(3R)-3-benzyl-3-[dimethylamino(methyl)carbamoyl]piperidin-1-yl]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide
+BMGC_DG17089,BMG_DG217199,PubChem SID:445500296 | UNII:8Q53S9RF4H | CAS RN:216988-52-2 | PubChem CID:9829239 | O-1057 FREE BASE
+BMGC_DG17090,BMG_DG217200,"CAS RN:651729-53-2 | DrugBank ID:DB13135 | AGN-201904 | Agn-201904 | 2-[4-[5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-yl]sulfonylphenoxy]acetic acid | UNII:G0835O03ZM | PubChem SID:198944750 | PubChem CID:9829253"
+BMGC_DG17091,BMG_DG217202,A-317491 | UNII:H327N08IPV | PubChem CID:9829395 | CAS RN:475205-49-3 | PubChem SID:198984213
+BMGC_DG17092,BMG_DG217204,"UNII:1S9VO1DQG5 | PubChem CID:9829419 | 13-DEOXYDOXORUBICIN | 13-Deoxydoxorubicin | CAS RN:628290-43-7 | (7S,9R)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione | PubChem SID:313183039 | DrugBank ID:DB05706"
+BMGC_DG17093,BMG_DG217207,"DrugBank ID:DB06595 | MIDOSTAURIN | Midostaurin | PubChem CID:9829523 | PubChem SID:198965438 | CAS RN:120685-11-2 | NDC:0078-0698 | UNII:ID912S5VON | N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide"
+BMGC_DG17094,BMG_DG217208,"PubChem CID:9829526 | PubChem SID:198956815 | CAS RN:147817-50-3 | UNII:3IX8CWR24V | 1'-[4-[1-(4-fluorophenyl)indol-3-yl]butyl]spiro[1H-2-benzofuran-3,4'-piperidine] | Siramesine | SIRAMESINE | DrugBank ID:DB06555"
+BMGC_DG17095,BMG_DG217215,PubChem SID:198946117 | CP-195494 | PubChem CID:9829784 | UNII:1D055URF6U | CAS RN:158103-57-2
+BMGC_DG17096,BMG_DG217219,L-755507 | CAS RN:159182-43-1 | PubChem CID:9829836 | PubChem SID:482554109 | UNII:H3HB4MCV7G
+BMGC_DG17097,BMG_DG217221,PubChem CID:983 | TRIPHOSPHORIC ACID | CAS RN:10380-08-2 | Triphosphoric acid | PubChem SID:198965483 | diphosphono hydrogen phosphate | UNII:NU43IAG5BC | DrugBank ID:DB03896
+BMGC_DG17098,BMG_DG217234,"UPAMOSTAT | ethyl 4-[(2S)-3-[3-[(Z)-N'-hydroxycarbamimidoyl]phenyl]-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperazine-1-carboxylate | PubChem CID:9830667 | PubChem SID:198962363 | CAS RN:590368-25-5 | CAS RN:1191101-18-4 | UNII:S5M7KW6U17 | WX-671/Mesupron"
+BMGC_DG17099,BMG_DG217237,CAS RN:442548-99-4 | UNII:GR7FP8T3TF | AZD-1134 | PubChem CID:9830790 | PubChem SID:443624834
+BMGC_DG17100,BMG_DG217240,HEXYL GALLATE | CAS RN:1087-26-9 | PubChem CID:9831030 | UNII:P2FVT76J5V | PubChem SID:485661074 | Hexyl gallate
+BMGC_DG17101,BMG_DG217245,"NDC:62135-780 | CAS RN:861006-80-6 | NDC:0904-6706 | CAS RN:308081-97-2 | NDC:50090-5800 | NDC:0615-8550 | NDC:60505-4462 | NDC:24658-350 | NDC:42291-657 | NDC:63629-1918 | ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate;ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate | NDC:60505-3170 | NDC:51407-763 | OMEGA-3-ACID ETHYL ESTERS | NDC:49264-4274 | NDC:69784-420 | NDC:71335-2024 | NDC:65162-034 | NDC:0904-7495 | PubChem CID:9831414 | NDC:72162-1310 | NDC:69452-175 | UNII:D87YGH4Z0Q | Lovaza | NDC:50090-5799 | NDC:72998-851 | NDC:70518-3040 | NDC:63629-2448 | PubChem SID:175271352 | NDC:70756-423 | NDC:60687-127 | NDC:72865-139 | NDC:50090-6691 | NDC:31722-936 | NDC:72162-2111 | NDC:64380-761 | NDC:50090-6692 | NDC:42806-552 | NDC:50090-6822 | NDC:0254-3010"
+BMGC_DG17102,BMG_DG217246,"NDC:0054-0508 | DrugBank ID:DB08887 | NDC:52937-101 | ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate | NDC:31722-298 | NDC:70710-1592 | NDC:72162-1000 | CAS RN:86227-47-6 | NDC:60505-4033 | CAS RN:73310-10-8 | UNII:6GC8A4PAYH | NDC:43602-291 | NDC:70710-1738 | NDC:52937-001 | NDC:43598-746 | NDC:72603-129 | NDC:69238-2597 | Icosapent Ethyl | ICOSAPENT ETHYL | NDC:31722-299 | NDC:42806-560 | NDC:72865-290 | NDC:35916-0958 | NDC:60687-764 | NDC:63629-9311 | NDC:0480-0126 | NDC:72865-289 | NDC:52937-003 | NDC:0480-0127 | NDC:42291-032 | NDC:63629-8247 | Icosapent ethyl | NDC:43602-547 | NDC:69238-2598 | NDC:0054-0621 | NDC:43598-267 | PubChem SID:175266496 | PubChem CID:9831415 | NDC:42806-559 | NDC:42291-046 | NDC:63629-9312"
+BMGC_DG17103,BMG_DG217259,"(4R,5R)-5-[4-[[4-(4-aza-1-azoniabicyclo[2.2.2]octan-1-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2H-1lambda6-benzothiepin-4-ol | MARALIXIBAT | UNII:UYB6UOF69L | CAS RN:716313-53-0 | Maralixibat | PubChem SID:316910834 | PubChem CID:9831643"
+BMGC_DG17104,BMG_DG217260,"ANATIBANT | (2S)-N-[3-[(4-carbamimidoylbenzoyl)amino]propyl]-1-[2,4-dichloro-3-[(2,4-dimethylquinolin-8-yl)oxymethyl]phenyl]sulfonylpyrrolidine-2-carboxamide | UNII:CLO4JRD21F | PubChem SID:198974674 | PubChem CID:9831652 | Anatibant | DrugBank ID:DB05038 | CAS RN:209733-45-9"
+BMGC_DG17105,BMG_DG217261,CAS RN:170851-70-4 | (2S)-6-amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide | PubChem CID:9831659 | PubChem SID:175267329 | IPAMORELIN | UNII:Y9M3S784Z6 | Ipamorelin | DrugBank ID:DB12370
+BMGC_DG17106,BMG_DG217265,"2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one;6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide | PubChem CID:9831761 | CAS RN:448264-66-2 | Karvezide"
+BMGC_DG17107,BMG_DG217267,"(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid;(E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide;(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid | PubChem CID:9831783 | CAS RN:745835-09-0 | Stalevo"
+BMGC_DG17108,BMG_DG217268,"EM-523 | (2R,3R,4S,5R,8R,9S,10S,11R,12R)-5-Ethyl-11-[(2S,3R,4S,6R)-4-[ethyl(methyl)amino]-3-hydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-7-one | CAS RN:110205-60-2 | UNII:BW08A9O7OH | PubChem CID:9831800 | PubChem SID:472390377 | (2R,3R,4S,5R,8R,9S,10S,11R,12R)-5-ethyl-11-[(2S,3R,4S,6R)-4-[ethyl(methyl)amino]-3-hydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-7-one"
+BMGC_DG17109,BMG_DG217285,"TULATHROMYCIN A | (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-3,4,10-trihydroxy-13-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-5-(propylaminomethyl)oxan-2-yl]oxy-3,5,8,10,12,14-hexamethyl-1-oxa-6-azacyclopentadecan-15-one | PubChem SID:198965128 | CAS RN:217500-96-4 | PubChem CID:9832301 | UNII:897A3KN7AP | Tulathromycin | DrugBank ID:DB11474"
+BMGC_DG17110,BMG_DG217287,"PubChem SID:198958680 | Vestipitant | UNII:S052TOI9BI | PubChem CID:9832383 | (2S)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperazine-1-carboxamide | VESTIPITANT | DrugBank ID:DB11949 | CAS RN:334476-46-9"
+BMGC_DG17111,BMG_DG217290,"UNII:UX33I93GLS | PubChem SID:198982184 | (4S,7S,10S,13S,16R)-N-[(2S)-5-amino-1-hydroxypentan-2-yl]-7-(2-amino-2-oxoethyl)-13-[(2S)-butan-2-yl]-10-[(2R)-butan-2-yl]-16-(1H-indol-3-ylmethyl)-N-methyl-6,9,12,15,18-pentaoxo-1-thia-5,8,11,14,17-pentazacycloicosane-4-carboxamide | CAS RN:285571-64-4 | PubChem CID:9832431 | BARUSIBAN | Barusiban | DrugBank ID:DB12292"
+BMGC_DG17112,BMG_DG217291,"PubChem CID:9832447 | DrugBank ID:DB11894 | Inolitazone | 5-[[4-[[6-(4-amino-3,5-dimethylphenoxy)-1-methylbenzimidazol-2-yl]methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | CAS RN:223132-37-4 | EFATUTAZONE | Efatutazone | UNII:M17ILL71MC | PubChem SID:198977873"
+BMGC_DG17113,BMG_DG217295,"PubChem CID:9832687 | 2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]pyrazolo[1,5-b]pyridazine | PubChem SID:198966530 | UNII:5Y869C2THE | DrugBank ID:DB12009 | GW-406381 | 2-(4-ethoxyphenyl)-3-(4-methylsulfonylphenyl)pyrazolo[1,5-b]pyridazine | CAS RN:537697-89-5 | CAS RN:221148-46-5"
+BMGC_DG17114,BMG_DG217298,"Doramectin | DORAMECTIN | UNII:KGD7A54H5P | CAS RN:117704-25-3 | PubChem SID:175266263 | PubChem CID:9832750 | (1'R,2R,3S,4'S,6S,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-2-cyclohexyl-21',24'-dihydroxy-12'-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-3,11',13',22'-tetramethylspiro[2,3-dihydropyran-6,6'-3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene]-2'-one | DrugBank ID:DB11400"
+BMGC_DG17115,BMG_DG217303,"CAS RN:119718-45-5 | CAS RN:113507-06-5 | PubChem CID:9832912 | Moxidectin | PubChem SID:175266540 | MOXIDECTIN | (1R,4S,4'E,5'S,6R,6'S,8R,10E,13R,14E,16E,20R,21R,24S)-21,24-dihydroxy-4'-methoxyimino-5',11,13,22-tetramethyl-6'-[(E)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2'-oxane]-2-one | NDC:71705-050 | UNII:NGU5H31YO9 | DrugBank ID:DB11431"
+BMGC_DG17116,BMG_DG217309,UNII:K82NW38NLW | PubChem CID:9833312 | PubChem SID:472386213 | CAS RN:313272-12-7 | CS-526
+BMGC_DG17117,BMG_DG217312,"acetic acid;(2S)-N-[(2R)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide | UNII:1K12647SFC | PubChem SID:198976540 | PubChem CID:9833407 | DESMOPRESSIN ACETATE ANHYDROUS | Desmopressin Acetate | CAS RN:16679-58-6 | CAS RN:62288-83-9"
+BMGC_DG17118,BMG_DG217314,DrugBank ID:DB09142 | NDC:70511-131 | SINCALIDE | NDC:63323-579 | CAS RN:25126-32-3 | PubChem SID:316911856 | NDC:72266-248 | (3S)-3-amino-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-1-oxo-3-(4-sulfooxyphenyl)propan-2-yl]amino]-4-oxobutanoic acid | PubChem CID:9833444 | Sincalide | UNII:M03GIQ7Z6P | NDC:0270-0556
+BMGC_DG17119,BMG_DG217318,"CAS RN:380221-63-6 | DrugBank ID:DB12691 | UNII:8L3OAJ1R5A | 6-(2,2-Diphenylethylamino)-9-[(2r,3r,4s,5s)-5-(Ethylcarbamoyl)-3,4-Dihydroxy-Oxolan-2-Yl]-N-[2-[(1-Pyridin-2-Ylpiperidin-4-Yl)carbamoylamino]ethyl]purine-2-Carboxamide | 6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide | UK-432097 | PubChem SID:198983573 | PubChem CID:9833519"
+BMGC_DG17120,BMG_DG217320,PubChem SID:461433449 | BIM-23190 | CAS RN:182153-96-4 | PubChem CID:9833535 | UNII:V55PUY46VR
+BMGC_DG17121,BMG_DG217331,PubChem SID:198937103 | PubChem CID:9833984 | UNII:4D6Q6HGC7Z | CAS RN:344413-67-8 | LESOGABERAN | DrugBank ID:DB11920 | Lesogaberan | [(2R)-3-amino-2-fluoropropyl]-hydroxy-oxophosphanium
+BMGC_DG17122,BMG_DG217342,"DIHYDROTHIOCTIC ACID, (R)- | PubChem CID:9834298 | UNII:00K1YL9Q69 | CAS RN:119365-69-4 | DrugBank ID:DB03760 | PubChem SID:472407227 | Dihydrolipoic Acid"
+BMGC_DG17123,BMG_DG217347,UNII:531QUG7P9E | PubChem CID:9834591 | PubChem SID:198943115 | CAS RN:635318-11-5 | POMAGLUMETAD
+BMGC_DG17124,BMG_DG217355,"2-Ethyl-4-(2-thiazolyl)thieno[3,2-d]pyrimidine | PubChem SID:485663644 | 2-ETHYL-4-(2-THIAZOLYL)THIENO(3,2-D)PYRIMIDINE | CAS RN:443148-33-2 | UNII:E5MR2A42KY | PubChem CID:9834769"
+BMGC_DG17125,BMG_DG217360,"DrugBank ID:DB09060 | PubChem SID:198988951 | AVIBACTAM, (±)- | UNII:7352665165 | UNII:06MFO7817I | AVIBACTAM, (+/-)- | [(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate | Avibactam | CAS RN:1416134-69-4 | CAS RN:1192500-31-4 | CAS RN:794508-22-8 | PubChem CID:9835049 | CAS RN:396731-14-9 | AVIBACTAM | PubChem SID:198983147"
+BMGC_DG17126,BMG_DG217361,PubChem CID:9835167 | 6-METHOXY-2-(4-METHYLAMINOPHENYL)BENZOTHIAZOLE | UNII:6NRE5K4JBL | 6-Methoxy-2-(4-methylaminophenyl)benzothiazole | PubChem SID:485663548
+BMGC_DG17127,BMG_DG217365,PubChem SID:198959515 | BOLANDIOL | Bolandiol | UNII:49SD6G16U5 | CAS RN:19793-20-5 | DrugBank ID:DB01554 | PubChem CID:9835303
+BMGC_DG17128,BMG_DG217377,"(3S,5R,7S,8R,9S,10S,13S,14S)-3,7-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one | DrugBank ID:DB06622 | 7-beta-Hydroxyepiandrosterone | UNII:OCP3E5KD08 | CAS RN:25848-69-5 | 7.BETA.-HYDROXY-EPI-ANDROSTERONE | PubChem SID:317229284 | PubChem CID:9836181"
+BMGC_DG17129,BMG_DG217379,PubChem CID:9836383 | CAS RN:756473-59-3 | PubChem SID:441097646 | UNII:7FA6XAN9CH | 2-BUTYL-3-(4-CHLOROPHENYL)-1-AZABICYCLO(2.2.2)OCT-2-ENE
+BMGC_DG17130,BMG_DG217391,2-aminoacetate;iron(2+) | UNII:SFW1D987QV | PubChem CID:9837124 | Ferrous bisglycinate | CAS RN:34369-82-9 | CAS RN:20150-34-9 | FERROUS BISGLYCINATE | DrugBank ID:DB11210 | PubChem SID:175268413
+BMGC_DG17131,BMG_DG217402,NDC:50474-470 | BRIVARACETAM | Brivaracetam | NDC:50474-970 | NDC:50474-370 | (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide | DrugBank ID:DB05541 | CAS RN:357336-20-0 | PubChem CID:9837243 | NDC:50474-770 | UNII:U863JGG2IA | PubChem SID:198941312 | NDC:50474-570 | NDC:50474-670 | NDC:50474-870
+BMGC_DG17132,BMG_DG217405,MGS-0028 | UNII:YMS878LR7I | PubChem CID:9837317 | CAS RN:321963-33-1 | PubChem SID:198967495
+BMGC_DG17133,BMG_DG217411,"CAS RN:848859-43-8 | Gpi-1485 | (2S)-1-(3,3-dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylic acid | CAS RN:186268-78-0 | GPI-1485 | PubChem SID:198982474 | DrugBank ID:DB05814 | PubChem CID:9837656 | UNII:0709BVY57W"
+BMGC_DG17134,BMG_DG217418,"CAS RN:214335-23-6 | 4-(4-CHLOROPHENYL)-1-METHYL-3-PROPYLPIPERIDINE, (3S,4S)- | 4-(4-Chlorophenyl)-1-methyl-3-propylpiperidine, (3S,4S)- | PubChem CID:9837874 | PubChem SID:474492729 | UNII:PJ74S72YHZ"
+BMGC_DG17135,BMG_DG217422,"NDC:24510-058 | NDC:24510-291 | Tapentadol Hydrochloride | CAS RN:175591-09-0 | NDC:24510-232 | NDC:24510-100 | NDC:24510-050 | NDC:24510-075 | 3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol;hydrochloride | UNII:71204KII53 | NDC:24510-116 | NDC:24510-174 | PubChem CID:9838021 | TAPENTADOL HYDROCHLORIDE | PubChem SID:175267395"
+BMGC_DG17136,BMG_DG217423,"3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol | DrugBank ID:DB06204 | PubChem SID:175267498 | UNII:H8A007M585 | TAPENTADOL | CAS RN:175591-23-8 | Tapentadol | PubChem CID:9838022"
+BMGC_DG17137,BMG_DG217431,CAS RN:258526-74-8 | PubChem SID:198973290 | ABT-866 | UNII:P7JGJ12E1W | PubChem CID:9838192
+BMGC_DG17138,BMG_DG217439,"UNII:NM2KXJ990T | DrugBank ID:DB14849 | 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethanone | CAS RN:274925-86-9 | PubChem CID:9838389 | PubChem SID:198940728 | NEBICAPONE | Nebicapone"
+BMGC_DG17139,BMG_DG217440,"Norgalanthamine | UNII:2BPQ4IVQ21 | PubChem SID:198955243 | (1S,12S,14R)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol | PubChem CID:9838394 | N-DESMETHYLGALANTAMINE | CAS RN:41303-74-6"
+BMGC_DG17140,BMG_DG217442,QH-II-66 | CAS RN:183239-39-6 | PubChem CID:9838431 | PubChem SID:459275648 | UNII:PKW6UCK55B
+BMGC_DG17141,BMG_DG217449,(2R)-2-[4-(2-methylpropyl)phenyl]-N-methylsulfonylpropanamide | UNII:U604E1NB3K | PubChem CID:9838712 | DrugBank ID:DB12614 | Reparixin | PubChem SID:198955457 | CAS RN:266359-83-5 | REPARIXIN
+BMGC_DG17142,BMG_DG217451,CAS RN:327056-26-8 | UNII:54SQ9B412I | PubChem SID:322058603 | AZD-9272 | PubChem CID:9838729
+BMGC_DG17143,BMG_DG217453,UNII:D62L7OV01X | PubChem CID:9838763 | PubChem SID:198988480 | GAROMEFRINE | CAS RN:137431-02-8
+BMGC_DG17144,BMG_DG217455,"CAS RN:80456-81-1 | 3-[(1R,2R)-2-[(dimethylamino)methyl]-1-hydroxycyclohexyl]phenol | UNII:9W28LW2ET5 | DESMETRAMADOL | O-Desmethyltramadol | PubChem SID:198977045 | CAS RN:144830-14-8 | UNII:2WA8F50C3F | DESMETRAMADOL, CIS-(+)- | PubChem CID:9838803 | PubChem SID:384436515"
+BMGC_DG17145,BMG_DG217459,"DrugBank ID:DB05830 | PubChem SID:198952896 | PubChem CID:9838899 | (7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one | CAS RN:3764-87-2 | Trestolone | UNII:40P3287I94 | TRESTOLONE"
+BMGC_DG17146,BMG_DG217463,"CAS RN:219986-94-4 | BROMO-DRAGONFLY, (±)- | PubChem CID:9839057 | BROMO-DRAGONFLY, (+/-)- | PubChem SID:316915319 | UNII:U9Q905Y70C"
+BMGC_DG17147,BMG_DG217467,"UNII:242F29CP76 | 6-ethyl-4-(trifluoromethyl)-1H,2H,6H,7H,8H,9H-pyrido[3,2-g]quinolin-2-one | LG-121071 | 6-ethyl-4-(trifluoromethyl)-6,7,8,9-tetrahydro-1H-pyrido[3,2-g]quinolin-2-one | PubChem CID:9839132 | PubChem SID:474492852 | CAS RN:179897-70-2"
+BMGC_DG17148,BMG_DG217471,"PubChem SID:445498974 | UNII:QUV7HRB5DN | 17-Hydroxy-19-norpregn-4-en-20-yn-3-one | (8R,9S,10R,13S,14S,17S)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one | CAS RN:38673-36-8 | PubChem CID:9839243 | 18-METHYLLEVONORGESTREL"
+BMGC_DG17149,BMG_DG217472,UNII:TP7TB1SSZD | PubChem CID:9839311 | A-205804 | CAS RN:251992-66-2 | PubChem SID:198946365
+BMGC_DG17150,BMG_DG217480,"5-(AZEPAN-1-YLSULFONYL)-1H-INDOLE-2,3-DIONE | UNII:FZJ9W3Z6PZ | CAS RN:220510-14-5 | PubChem SID:443624251 | PubChem CID:9839586"
+BMGC_DG17151,BMG_DG217490,PubChem CID:9839975 | 5-cyclohexyl-1-[4-(1H-imidazol-5-yl)piperidin-1-yl]pentan-1-one | CAS RN:152241-24-2 | 1-(4-(1H-Imidazol-5-yl)piperidin-1-yl)-5-cyclohexylpentan-1-one
+BMGC_DG17152,BMG_DG217491,hexadecanal | Hexadecanal | DrugBank ID:DB03381 | PubChem CID:984 | CAS RN:629-80-1 | HEXADECANAL | PubChem SID:198945681 | UNII:WQD27655QE
+BMGC_DG17153,BMG_DG217493,PubChem SID:198960971 | CAS RN:328543-09-5 | AG-14361 | UNII:48N0U0K50I | PubChem CID:9840076
+BMGC_DG17154,BMG_DG217494,"UNII:D6E55XML6H | CAS RN:82864-06-0 | PubChem SID:474494590 | DOI, (R)- | PubChem CID:9840090"
+BMGC_DG17155,BMG_DG217495,"PubChem CID:9840237 | UNII:F2R32BF2CH | CAS RN:189954-66-3 | 5,5-DIMETHYL-3-(1-METHYLETHOXY)-4-(4-(METHYLSULFONYL)PHENYL)-2(5H)-FURANONE | PubChem SID:348481738"
+BMGC_DG17156,BMG_DG217510,PubChem CID:9840687 | UNII:D474W0A165 | CGS-26582 | CAS RN:186376-96-5 | PubChem SID:198943834
+BMGC_DG17157,BMG_DG217516,PubChem SID:198949483 | CAS RN:144506-14-9 | UNII:P1H7W3812O | LICOCHALCONE C | PubChem CID:9840805
+BMGC_DG17158,BMG_DG217517,CAS RN:189806-34-6 | N-(3-(2-(DIMETHYLAMINO)ETHYL)-2-METHYL-1H-INDOL-5-YL)-4-FLUOROBENZAMIDE | PubChem CID:9840850 | PubChem SID:445499540 | UNII:FC7LVP85JZ
+BMGC_DG17159,BMG_DG217518,UNII:CG8692ZN14 | CAS RN:55-68-5 | PHENYLMERCURIC NITRATE | PubChem CID:9840857 | PubChem SID:175268387
+BMGC_DG17160,BMG_DG217526,PBR-28 | CAS RN:253307-65-2 | UNII:4XS5FDP2HY | PubChem SID:485666027 | PubChem CID:9841240
+BMGC_DG17161,BMG_DG217531,CAS RN:171961-95-8 | UNII:S3ZIH99X6E | A-86929 | PubChem CID:9841398 | PubChem SID:348481295
+BMGC_DG17162,BMG_DG217536,NE-100 FREE BASE | PubChem SID:434369942 | N-(4-methoxy-3-phenethoxyphenethyl)-N-propylpropan-1-amine | CAS RN:149860-29-7 | N-[2-[4-methoxy-3-(2-phenylethoxy)phenyl]ethyl]-N-propylpropan-1-amine | PubChem CID:9841596 | UNII:RN9I7K5RVN
+BMGC_DG17163,BMG_DG217539,PubChem CID:9841667 | SB-265610 | PubChem SID:198956636 | CAS RN:211096-49-0 | UNII:9P785F0579
+BMGC_DG17164,BMG_DG217545,"CAS RN:203737-93-3 | PubChem SID:405055415 | PubChem CID:9841834 | DrugBank ID:DB06157 | ISTAROXIME, (E)- | Istaroxime | UNII:W40687GO3S | (3E,5S,8R,9S,10R,13S,14S)-3-(2-aminoethoxyimino)-10,13-dimethyl-1,2,4,5,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-6,17-dione | CAS RN:203738-46-9"
+BMGC_DG17165,BMG_DG217546,"PubChem SID:198988454 | Polmacoxib | PubChem CID:9841854 | CAS RN:1427301-99-2 | CAS RN:301692-76-2 | POLMACOXIB | DrugBank ID:DB12399 | 4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxofuran-2-yl]benzenesulfonamide | UNII:IJ34D6YPAO"
+BMGC_DG17166,BMG_DG217547,"DJ7ZL6Xvm7 | S-33138 | N-[4-[2-[(3aS,9bR)-8-cyano-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]ethyl]phenyl]acetamide | PubChem CID:9841864 | UNII:DJ7ZL6XVM7 | CAS RN:245514-32-3 | PubChem SID:445499560"
+BMGC_DG17167,BMG_DG217550,SB-206606 | PubChem SID:198982360 | CAS RN:116049-78-6 | PubChem SID:249817747 | 2-[4-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]phenoxy]acetic acid | CAS RN:114333-71-0 | BRL-37344 | Brl 37344 | UNII:5DZZ1926YW | PubChem CID:9841972 | UNII:42FZ27IZLV
+BMGC_DG17168,BMG_DG217553,"Quingestanol | PubChem SID:198957682 | DrugBank ID:DB13685 | PubChem CID:9842127 | CAS RN:10592-65-1 | (8R,9S,10R,13S,14S,17R)-3-cyclopentyloxy-17-ethynyl-13-methyl-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-ol | UNII:1A635076CE | QUINGESTANOL"
+BMGC_DG17169,BMG_DG217563,"VAPITADINE | DrugBank ID:DB05738 | PubChem CID:9842252 | PubChem SID:198954171 | Vapitadine | UNII:Z5014VUX83 | CAS RN:793655-64-8 | spiro[5,6-dihydroimidazo[2,1-b][3]benzazepine-11,4'-piperidine]-3-carboxamide"
+BMGC_DG17170,BMG_DG217570,PubChem SID:472424582 | RS-25344 | PubChem CID:9842556 | UNII:7KKH9V6X32 | CAS RN:152814-89-6
+BMGC_DG17171,BMG_DG217573,"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE | PubChem CID:9842606 | DrugBank ID:DB07173"
+BMGC_DG17172,BMG_DG217578,GW-0791 | PubChem CID:9842758 | PubChem SID:198971202 | UNII:YJA4D2G471 | CAS RN:936713-53-0
+BMGC_DG17173,BMG_DG217585,Mavacoxib | MAVACOXIB | 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide | PubChem SID:198937653 | UNII:YFT7X7SR77 | CAS RN:170569-88-7 | PubChem CID:9843089
+BMGC_DG17174,BMG_DG217587,CAS RN:201608-41-5 | PubChem SID:316911477 | PubChem CID:9843179 | UNII:27CN8PNO4K | DR-4004
+BMGC_DG17175,BMG_DG217590,"PubChem SID:445499884 | CAS RN:197799-44-3 | PubChem CID:9843355 | UNII:XQ7C2A24G4 | N-(2-CHLORO-4,6-DIMETHYLPHENYL)-1-(2-METHOXY-1-(METHOXYMETHYL)ETHYL)-6-METHYL-1H-1,2,3-TRIAZOLO(4,5-C)PYRIDIN-4-AMINE"
+BMGC_DG17176,BMG_DG217595,"Bms-193884 | UNII:7ON53PV45J | CAS RN:176960-47-7 | N-(3,4-dimethyl-1,2-oxazol-5-yl)-2-[4-(1,3-oxazol-2-yl)phenyl]benzenesulfonamide | PubChem CID:9843631 | BMS-193884 | PubChem SID:198969257"
+BMGC_DG17177,BMG_DG217599,"PubChem SID:255509286 | PubChem CID:9843744 | UNII:O4T475XIIY | N-[(11R)-6-amino-12-oxo-9-phenyl-1,10-diazatricyclo[6.4.1.04,13]trideca-4(13),5,7,9-tetraen-11-yl]pyridine-3-carboxamide | CI-1044 | CAS RN:197894-84-1"
+BMGC_DG17178,BMG_DG217601,"DrugBank ID:DB12463 | UNII:3YN0602W4W | Semagacestat | CAS RN:425386-60-3 | SEMAGACESTAT | PubChem CID:9843750 | (2S)-2-hydroxy-3-methyl-N-[(2S)-1-[[(5S)-3-methyl-4-oxo-2,5-dihydro-1H-3-benzazepin-5-yl]amino]-1-oxopropan-2-yl]butanamide | PubChem SID:198989769 | CAS RN:866488-53-1"
+BMGC_DG17179,BMG_DG217605,2-(MORPHOLIN-4-YL)-6-(4-(NAPHTHALEN-1-YL)PHENYL)-4H-THIOPYRAN-4-ONE | CAS RN:500169-73-3 | UNII:UKT5M3GU4F | PubChem CID:9843885 | PubChem SID:459055615
+BMGC_DG17180,BMG_DG217606,PubChem SID:198940124 | TEGLICAR | UNII:8V3VQ6HMII | CAS RN:250694-07-6 | PubChem CID:9843897
+BMGC_DG17181,BMG_DG217607,CAS RN:186392-40-5 | PubChem SID:198959648 | CP-91149 | UNII:O8EV00W45A | PubChem CID:9843900
+BMGC_DG17182,BMG_DG217611,"PubChem CID:9844011 | DrugBank ID:DB07320 | 4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID"
+BMGC_DG17183,BMG_DG217612,"CAS RN:280783-56-4 | PubChem CID:9844019 | PubChem SID:474492735 | RO64-6198 | 8-[(1S,3aS)-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | UNII:HKN6H9XXS6"
+BMGC_DG17184,BMG_DG217619,UNII:GW6VPL3JLU | PubChem SID:445498678 | PubChem CID:9844204 | LY-367366 | CAS RN:209332-61-6
+BMGC_DG17185,BMG_DG217622,UNII:8FX9DP2Y1W | PubChem CID:9844320 | BMS-279700 | PubChem SID:198940807 | CAS RN:240814-54-4
+BMGC_DG17186,BMG_DG217625,"4-[(2-carbamimidoyl-3,4-dihydro-1H-isoquinolin-7-yl)oxymethyl]-1-pyridin-4-ylpiperidine-4-carboxylic acid | JTV-803 FREE BASE | JTV-803 free base | PubChem CID:9844392 | UNII:P7Z08VK9XO | CAS RN:247131-06-2 | PubChem SID:198936199"
+BMGC_DG17187,BMG_DG217627,PubChem CID:9844410 | DAA-1097 | UNII:TE4VJ6U6XS | CAS RN:220551-79-1 | PubChem SID:474492479
+BMGC_DG17188,BMG_DG217631,"Onternabez | [(1R,4S,5R)-4-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-2-bicyclo[3.1.1]hept-2-enyl]methanol | PubChem CID:9844711"
+BMGC_DG17189,BMG_DG217633,"PubChem CID:9844749 | 2H-1-Benzopyran-2-one, 6,7-dimethoxy-3-(4-((methyl(phenylmethyl)amino)methyl)phenyl)- | PubChem SID:198961132 | AP-2238 | UNII:545225E0BC | CAS RN:553681-56-4 | 3-[4-[[benzyl(methyl)amino]methyl]phenyl]-6,7-dimethoxychromen-2-one"
+BMGC_DG17190,BMG_DG217639,CAS RN:18108-22-0 | UNII:AWN2XCG43R | PubChem CID:98449 | (AMINO(PHENYL)METHYL)PHOSPHONIC ACID
+BMGC_DG17191,BMG_DG217646,"DrugBank ID:DB08220 | PubChem CID:9845059 | (8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid"
+BMGC_DG17192,BMG_DG217648,PNU-142633 | CAS RN:187665-65-2 | PubChem CID:9845148 | UNII:B54P1BQ73L | PubChem SID:198951678
+BMGC_DG17193,BMG_DG217651,SB-237376 FREE BASE | UNII:JED8M29NSU | CAS RN:179258-59-4 | PubChem SID:313390064 | PubChem CID:9845214
+BMGC_DG17194,BMG_DG217663,"1-Butanesulfonic acid, 4,4,4-trifluoro-, 3-(((2R)-2,3-dihydro-2-(hydroxymethyl)-1H-inden-4-yl)oxy)phenyl ester | PubChem SID:198988002 | PubChem CID:9845561 | KN-387271 | UNII:SRX4T6TMUS | CAS RN:212188-60-8 | [3-[[(2R)-2-(hydroxymethyl)-2,3-dihydro-1H-inden-4-yl]oxy]phenyl] 4,4,4-trifluorobutane-1-sulfonate"
+BMGC_DG17195,BMG_DG217678,Eltrombopag | PubChem CID:9846180 | DrugBank ID:DB06210
+BMGC_DG17196,BMG_DG217683,MK-0969 | UNII:I98T8BS72C | PubChem SID:333495796 | PubChem CID:9846311 | CAS RN:203321-88-4
+BMGC_DG17197,BMG_DG217685,"Halometasone | DrugBank ID:DB13728 | CAS RN:50629-82-8 | PubChem CID:9846332 | (6S,8S,9R,10S,11S,13S,14S,16R,17R)-2-chloro-6,9-difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | HALOMETASONE | PubChem SID:198967590 | UNII:J69Z9UU41Z"
+BMGC_DG17198,BMG_DG217686,CAS RN:108560-70-9 | UNII:17LEI49C2G | Gallium maltolate | PubChem SID:252320449 | GALLIUM MALTOLATE | Gallium Maltolate | gallium;2-methyl-4-oxopyran-3-olate | DrugBank ID:DB05420 | PubChem CID:9846339
+BMGC_DG17199,BMG_DG217698,UNII:5I8WFS075A | PubChem CID:9846729 | CAS RN:280749-17-9 | A-286982 | PubChem SID:198987132
+BMGC_DG17200,BMG_DG217702,"1-benzyl-1,2,3,4-tetrahydroisoquinoline | 1-Benzyl-1,2,3,4-tetrahydroisoquinoline | CAS RN:19716-56-4 | UNII:X4S06GK4KN | 1,2,3,4-TETRAHYDRO-1-(PHENYLMETHYL)ISOQUINOLINE | PubChem SID:316916560 | PubChem CID:98468"
+BMGC_DG17201,BMG_DG217714,"(2R)-2-(4-fluorophenyl)-2-[[1-[3-[5-(1,2,4-triazol-4-yl)-1H-indol-3-yl]propyl]piperidin-4-yl]amino]ethanol | PubChem CID:9847194 | L-772,405 | CAS RN:177947-03-4"
+BMGC_DG17202,BMG_DG217720,GPI-1511 | PubChem CID:9847345 | CAS RN:252770-39-1 | PubChem SID:459055487 | UNII:MGA8LX553F
+BMGC_DG17203,BMG_DG217722,"PubChem CID:9847548 | 11-KETO-.BETA.-BOSWELLIC ACID | 11-KETO-beta-BOSWELLIC ACID | (3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bS)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid | PubChem SID:198954624 | UNII:0S3BIF6H0Q | CAS RN:17019-92-0"
+BMGC_DG17204,BMG_DG217723,CAS RN:252916-76-0 | PubChem SID:198945692 | UNII:CMQ1L0E91Y | PubChem CID:9847557 | CHIR-98023
+BMGC_DG17205,BMG_DG217724,"UNII:E026V904RL | (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-2-hydroxy-1-methoxy-3-octanoyloxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid | Laninamivir octanoate | PubChem SID:198960282 | DrugBank ID:DB11888 | CAS RN:203120-46-1 | LANINAMIVIR OCTANOATE | PubChem CID:9847629"
+BMGC_DG17206,BMG_DG217738,PubChem CID:9848628 | CAS RN:192756-07-3 | VRT-18858 | UNII:WV88DU3MUX | PubChem SID:459056287
+BMGC_DG17207,BMG_DG217740,3-Methoxybenzamide | PubChem CID:98487 | DrugBank ID:DB03073 | CAS RN:5813-86-5 | UNII:M8502TLK98 | PubChem SID:252320442 | 3-METHOXYBENZAMIDE | 3-methoxybenzamide
+BMGC_DG17208,BMG_DG217743,"2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | CAS RN:14605-22-2 | Tauroursodeoxycholic acid | TAURURSODIOL | PubChem SID:198951671 | PubChem CID:9848818 | DrugBank ID:DB08834 | UNII:60EUX8MN5X"
+BMGC_DG17209,BMG_DG217750,"(1S,2S,6R,14R,15S,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol | PubChem CID:9848990"
+BMGC_DG17210,BMG_DG217766,"5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-piperidin-1-ylpyrazole-3-carboxamide | UNII:SF8R9VCB0X | SURINABANT | PubChem SID:198935559 | PubChem CID:9849616 | DrugBank ID:DB13070 | Surinabant | CAS RN:288104-79-0"
+BMGC_DG17211,BMG_DG217768,PubChem CID:9849699 | Ly-377604 | CAS RN:204592-94-9 | DrugBank ID:DB12858 | PubChem SID:198941837 | 6-[4-[2-[[(2S)-3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]amino]-2-methylpropyl]phenoxy]pyridine-3-carboxamide | LY-377604 | UNII:OCC6TB3P6K
+BMGC_DG17212,BMG_DG217770,"Sonolisib | PubChem SID:198939430 | CAS RN:502632-66-8 | [(3aR,6E,9S,9aR,10R,11aS)-6-[[bis(prop-2-enyl)amino]methylidene]-5-hydroxy-9-(methoxymethyl)-9a,11a-dimethyl-1,4,7-trioxo-2,3,3a,9,10,11-hexahydroindeno[4,5-h]isochromen-10-yl] acetate | PubChem CID:9849735 | UNII:987796874T | SONOLISIB | DrugBank ID:DB12601"
+BMGC_DG17213,BMG_DG217772,NDC:65162-369 | PubChem CID:9849808 | NDC:63539-242 | FESOTERODINE FUMARATE | CAS RN:286930-03-8 | Fesoterodine Fumarate | UNII:EOS72165S7 | NDC:63539-183 | NDC:0069-0244 | NDC:68382-479 | NDC:51407-662 | NDC:31722-033 | NDC:46708-175 | NDC:62332-175 | NDC:72603-414 | NDC:70771-1168 | NDC:67877-068 | NDC:43598-248 | NDC:67877-064 | (E)-but-2-enedioic acid;[2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate | NDC:62332-176 | NDC:68382-480 | NDC:72603-413 | NDC:65162-370 | NDC:43598-247 | NDC:70771-1169 | NDC:31722-034 | NDC:65862-767 | NDC:65862-766 | NDC:0069-0242 | PubChem SID:175266591 | NDC:51407-661 | NDC:46708-176
+BMGC_DG17214,BMG_DG217775,PubChem SID:198982699 | PubChem CID:9849983 | CAS RN:190670-74-7 | UNII:49YWY1424G | EGIS-9933
+BMGC_DG17215,BMG_DG217778,PubChem CID:985 | CAS RN:57-10-3 | UNII:2V16EO95H1 | CAS RN:1219802-61-5 | NDC:83872-382 | hexadecanoic acid | DrugBank ID:DB03796 | PubChem SID:175266140 | PALMITIC ACID | Palmitic Acid | NDC:83872-383
+BMGC_DG17216,BMG_DG217784,KI-23057 | UNII:5ZH5NA7ZMF | PubChem SID:459056002 | CAS RN:516523-31-2 | PubChem CID:9850161
+BMGC_DG17217,BMG_DG217795,CAS RN:170567-08-5 | N-[(R)-1-{[Acetyl-(2-methoxy-benzyl)-amino]-methyl}-2-(1H-indol-3-yl)-ethyl]-2-(4-cyclohexyl-piperazin-1-yl)-acetamide | PubChem CID:9850771 | N-[(2R)-1-[acetyl-[(2-methoxyphenyl)methyl]amino]-3-(1H-indol-3-yl)propan-2-yl]-2-(4-cyclohexylpiperazin-1-yl)acetamide
+BMGC_DG17218,BMG_DG217801,"UNII:320A4L58IZ | CAS RN:233277-99-1 | PubChem CID:9851116 | PubChem SID:198947910 | N-[(2S)-1-[[(E,3S)-1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide | 1-Piperazinecarboxamide, 4-methyl-N-((1S)-2-oxo-2-(((1S)-1-(2-phenylethyl)-3-(phenylsulfonyl)-2-propenyl)amino)-1-(phenylmethyl)ethyl)- | CAS RN:502960-90-9 | APC-3316"
+BMGC_DG17219,BMG_DG217802,"5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | Isorhoifolin | UNII:0B66T65281 | PubChem CID:9851181 | CAS RN:36790-49-5 | CAS RN:552-57-8 | PubChem SID:252320003 | ISORHOIFOLIN"
+BMGC_DG17220,BMG_DG217803,"CAS RN:180046-99-5 | (2S)-2-N-[(2S)-1-[benzyl(methyl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-1-N-(2-nitrophenyl)pyrrolidine-1,2-dicarboxamide | PubChem CID:9851211 | Sdz nkt 343"
+BMGC_DG17221,BMG_DG217804,PubChem CID:9851233 | PubChem SID:198975112 | UNII:V1MT8X7850 | FE-200041 | CAS RN:212710-26-4
+BMGC_DG17222,BMG_DG217806,"PubChem CID:9851337 | PubChem SID:348481171 | UNII:GD2VR8TE0W | N-(3-HYDROXY-5-((1,4,5,6-TETRAHYDRO-5-HYDROXY-2-PYRIMIDINYL)AMINO)BENZOYL)GLYCYL-3-(3-BROMO-5-CHLORO-2-HYDROXYPHENYL)-.BETA.-ALANINE, (3S)- | CAS RN:243135-72-0"
+BMGC_DG17223,BMG_DG217808,"L 768673 | 2-[2,4-bis(trifluoromethyl)phenyl]-N-[(3R)-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3H-1,4-benzodiazepin-3-yl]acetamide | PubChem CID:9851380 | CAS RN:177954-68-6"
+BMGC_DG17224,BMG_DG217825,"UNII:IIU6V0W3JD | Orvepitant | DrugBank ID:DB12427 | (2R,4S)-4-[(8aS)-6-oxo-1,3,4,7,8,8a-hexahydropyrrolo[1,2-a]pyrazin-2-yl]-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide | CAS RN:579475-18-6 | ORVEPITANT | PubChem SID:198941755 | PubChem CID:9852175"
+BMGC_DG17225,BMG_DG217827,PubChem CID:9852185 | PubChem SID:198970210 | UNII:8N585K83U2 | GAMBOGIC ACID | CAS RN:2752-65-0
+BMGC_DG17226,BMG_DG217828,"PubChem CID:9852188 | CAS RN:56575-23-6 | Cannabinoids | (6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol;2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol | DrugBank ID:DB14011"
+BMGC_DG17227,BMG_DG217830,"UPAMOSTAT | ethyl 4-[(2S)-3-[3-[(E)-N'-hydroxycarbamimidoyl]phenyl]-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperazine-1-carboxylate | PubChem SID:198962363 | PubChem CID:9852201 | CAS RN:590368-25-5 | Upamostat | CAS RN:1191101-18-4 | DrugBank ID:DB13052 | UNII:S5M7KW6U17"
+BMGC_DG17228,BMG_DG217832,"UNII:EJ6CZV0K5Y | PubChem SID:198967558 | CAS RN:23978-85-0 | .DELTA.9-TETRAHYDROCANNABINOLIC ACID | (6aR,10aR)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-2-carboxylic acid | delta9-Tetrahydrocannabinolic acid | PubChem CID:98523"
+BMGC_DG17229,BMG_DG217834,CAS RN:169679-53-2 | N-[6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-5-(4-methylphenyl)pyrimidin-4-yl]-4-(1-hydroxy-2-methylpropan-2-yl)benzenesulfonamide | PubChem CID:9852318
+BMGC_DG17230,BMG_DG217835,PubChem CID:9852384 | PubChem SID:433968252 | L-163491 | CAS RN:170969-73-0 | UNII:ZF8TN281W9
+BMGC_DG17231,BMG_DG217836,"UNII:3H8GSZ4SQL | CAS RN:570406-98-3 | DrugBank ID:DB11995 | Avatrombopag | 1-[3-chloro-5-[[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)-1,3-thiazol-2-yl]carbamoyl]pyridin-2-yl]piperidine-4-carboxylic acid | AVATROMBOPAG | PubChem SID:198963167 | PubChem CID:9852519"
+BMGC_DG17232,BMG_DG217842,"2-(3,4-dihydroxyphenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | PubChem SID:198972204 | Monoxerutin | PubChem CID:9852585 | UNII:EKF7043SBU | CAS RN:23869-24-1 | MONOXERUTIN | DrugBank ID:DB13764"
+BMGC_DG17233,BMG_DG217845,"2C-B | PubChem CID:98527 | 4-Bromo-2,5-dimethoxyphenethylamine | CAS RN:66142-81-2 | 2,5-Dimethoxy-4-bromophenethylamine | DrugBank ID:DB01537 | 2-(4-bromo-2,5-dimethoxyphenyl)ethanamine | PubChem SID:198989059 | UNII:V77772N32H"
+BMGC_DG17234,BMG_DG217846,"NDC:72526-110 | NDC:50458-563 | [3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-9-yl] hexadecanoate | NDC:50458-606 | NDC:72526-105 | NDC:50458-564 | NDC:72526-107 | UNII:R8P8USM8FR | NDC:72526-108 | NDC:50458-562 | NDC:50458-612 | NDC:50458-560 | NDC:50458-561 | PubChem SID:472385885 | NDC:50458-609 | NDC:72526-106 | NDC:72526-109 | NDC:50458-608 | NDC:50458-611 | NDC:50458-607 | Paliperidone Palmitate | PubChem CID:9852746 | PALIPERIDONE PALMITATE | CAS RN:199739-10-1"
+BMGC_DG17235,BMG_DG217853,"Ceftaroline fosamil | DrugBank ID:DB06590 | (6R,7R)-7-[[(2Z)-2-ethoxyimino-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl]amino]-3-[[4-(1-methylpyridin-1-ium-4-yl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | PubChem CID:9852981 | NDC:0456-0400 | Ceftaroline Fosamil | CAS RN:229016-73-3 | PubChem SID:175268204 | UNII:7P6FQA5D21 | CEFTAROLINE FOSAMIL | NDC:0456-0600"
+BMGC_DG17236,BMG_DG217856,"DrugBank ID:DB08827 | PubChem CID:9853053 | PubChem SID:175266823 | N-(2,2,2-trifluoroethyl)-9-[4-[4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]piperidin-1-yl]butyl]fluorene-9-carboxamide | UNII:82KUB0583F | CAS RN:182431-12-5 | Lomitapide | LOMITAPIDE"
+BMGC_DG17237,BMG_DG217861,"tert-butyl N-[2-[4-[[1-[2-bromo-5-(pentanoylamino)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | PubChem CID:9853391"
+BMGC_DG17238,BMG_DG217862,UNII:D27Z1V25BZ | CAS RN:144337-18-8 | PubChem SID:316917632 | YM-26734 | PubChem CID:9853400
+BMGC_DG17239,BMG_DG217865,"PubChem SID:198967207 | 3-methyl-5-[(E)-1-(4-methylsulfonylphenyl)-2-[3-[6-(2-methylsulfonylpropan-2-yl)quinolin-8-yl]phenyl]ethenyl]-1,2,4-oxadiazole | MK-0359 | CAS RN:346629-30-9 | PubChem CID:9853498 | UNII:G6GSO9SDNJ"
+BMGC_DG17240,BMG_DG217866,PubChem CID:9853499 | UNII:S97YUG2A91 | CAS RN:381683-94-9 | PubChem SID:198977939 | EFIPLADIB
+BMGC_DG17241,BMG_DG217868,"(3S)-3-(6-methoxypyridin-3-yl)-3-[2-oxo-3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]imidazolidin-1-yl]propanoic acid | UNII:1JL033A2D0 | MK-0429 | CAS RN:227963-15-7 | PubChem CID:9853559 | PubChem SID:313183517"
+BMGC_DG17242,BMG_DG217869,PubChem CID:9853566 | CAS RN:194213-64-4 | PubChem SID:198963836 | UNII:0Z473OO6GB | BMS-212122
+BMGC_DG17243,BMG_DG217875,PubChem SID:316909573 | PENTAGASTRIN | CAS RN:5534-95-2 | Pentagastrin | (3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoylamino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoic acid | PubChem CID:9853654 | UNII:EF0NX91490 | DrugBank ID:DB00183
+BMGC_DG17244,BMG_DG217880,"Cangrelor | PubChem SID:198960207 | CANGRELOR | NDC:10122-620 | UNII:6AQ1Y404U7 | [dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid | DrugBank ID:DB06441 | CAS RN:163706-06-7 | PubChem CID:9854012"
+BMGC_DG17245,BMG_DG217881,"CABAZITAXEL | PubChem CID:9854073 | PubChem SID:175267969 | UNII:51F690397J | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate | Cabazitaxel | CAS RN:183133-96-2 | DrugBank ID:DB06772"
+BMGC_DG17246,BMG_DG217892,"Fluticasone Furoate | NDC:0173-0887 | NDC:0135-0616 | NDC:0173-0893 | NDC:50090-6075 | DrugBank ID:DB08906 | NDC:0173-0876 | NDC:66993-135 | UNII:JS86977WNV | NDC:0173-0916 | CAS RN:397864-44-7 | NDC:0135-0615 | PubChem CID:9854489 | NDC:66993-136 | NDC:0173-0859 | FLUTICASONE FUROATE | NDC:0173-0882 | NDC:0173-0888 | PubChem SID:175266839 | Fluticasone furoate | NDC:50090-5967 | NDC:0173-0874 | [(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate"
+BMGC_DG17247,BMG_DG217898,(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]pentanediamide | PubChem CID:9854861 | CAS RN:99566-27-5 | Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe amide
+BMGC_DG17248,BMG_DG217917,PubChem SID:175265629 | PubChem CID:9855541 | CAS RN:12258-53-6 | BORATE ION | UNII:44OAE30D22
+BMGC_DG17249,BMG_DG217953,CAS RN:441765-98-6 | TALAGLUMETAD | UNII:2OXQ1Z504M | PubChem CID:9857256 | PubChem SID:198943028
+BMGC_DG17250,BMG_DG217959,PubChem CID:9858195 | PubChem SID:198976432 | CAS RN:397276-53-8 | UNII:Y1NLI5M7J6 | 4-(4-((1-ISOPROPYLPIPERIDIN-4-YL)OXY)BENZYL)MORPHOLINE
+BMGC_DG17251,BMG_DG217967,CAS RN:215122-74-0 | PubChem CID:9858913 | UNII:C8D42HX4WH | TIGEMOCOXIB
+BMGC_DG17252,BMG_DG217982,PubChem SID:198978199 | DrugBank ID:DB07731 | CAS RN:140651-18-9 | CAN-508 | UNII:ZG0O47K626 | PubChem CID:9859248
+BMGC_DG17253,BMG_DG217987,PubChem SID:445500709 | PubChem CID:9859407 | UNII:M7FHF24Q22 | CAS RN:141474-59-1 | SDZ SER-082
+BMGC_DG17254,BMG_DG217990,SINBAGLUSTAT | PubChem SID:387065258 | CAS RN:441061-33-2 | PubChem CID:9859470 | UNII:T5Y7NB5M2U
+BMGC_DG17255,BMG_DG218002,"CAS RN:252021-89-9 | UNII:UR97LQ3DH9 | 11,13-DIMETHYL-12-THIA-3,4-DIAZATRICYCLO(8.3.0.0(2,6))TRIDECA-1(13),2,5,10-TETRAENE | PubChem CID:9859861 | PubChem SID:445499523"
+BMGC_DG17256,BMG_DG218003,PubChem SID:443624412 | COUMATE | CAS RN:136167-05-0 | PubChem CID:9859866 | UNII:BY0SSJ2SU0
+BMGC_DG17257,BMG_DG218012,"PubChem CID:9860102 | DrugBank ID:DB07807 | (3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL"
+BMGC_DG17258,BMG_DG218018,PubChem SID:474492446 | UNII:NTK8WWM73W | ST-1535 | CAS RN:496955-42-1 | PubChem CID:9860294 | 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine
+BMGC_DG17259,BMG_DG218030,UNII:DJ7RQT66H6 | NU-7026 | PubChem SID:440088296 | CAS RN:154447-35-5 | PubChem CID:9860529
+BMGC_DG17260,BMG_DG218032,ALX-0646 | PubChem SID:333495813 | PubChem CID:9860595 | UNII:U5B6O9B4RJ | CAS RN:208464-67-9
+BMGC_DG17261,BMG_DG218041,UNII:M7UP6XJ2AA | PubChem CID:98608 | PHELLOPTERIN | CAS RN:2543-94-4 | PubChem SID:474489522
+BMGC_DG17262,BMG_DG218044,4-AMINO-3-IODOBENZENESULFONAMIDE | UNII:DK6Y4LDV97 | CAS RN:60154-06-5 | PubChem CID:9861037
+BMGC_DG17263,BMG_DG218049,"CAS RN:289716-94-5 | PubChem SID:316909207 | UNII:I98GXM21LM | PubChem CID:9861124 | 1-(2-(3,4-DICHLOROPHENOXY)-5-FLUOROPHENYL)-N-METHYLMETHANAMINE"
+BMGC_DG17264,BMG_DG218052,Alcophosphamide | 3-[amino-[bis(2-chloroethyl)amino]phosphoryl]oxypropan-1-ol | PubChem CID:98612 | CAS RN:52336-54-6 | ALCOPHOSPHAMIDE | PubChem SID:472411577 | UNII:X3CP3B98PL
+BMGC_DG17265,BMG_DG218057,"DrugBank ID:DB08777 | 5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE | PubChem SID:485663835 | 5,6,7,8-TETRAHYDRO(1)BENZOTHIENO(2,3-D)PYRIMIDIN-4(1H)-ONE | 5,6,7,8-Tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(1H)-one | CAS RN:14346-24-8 | UNII:2QH62B6VZS | PubChem CID:98614"
+BMGC_DG17266,BMG_DG218064,(3S)-1-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}pyrrolidine-3-thiol | PubChem CID:9861547 | DrugBank ID:DB06943
+BMGC_DG17267,BMG_DG218068,CAS RN:177365-18-3 | PubChem CID:9861661 | UNII:LP3ZF53ZSQ | PGV-20229 | PubChem SID:441659042
+BMGC_DG17268,BMG_DG218084,"PubChem CID:9862248 | 2-[4-[(4-hydroxy-3-propan-2-ylphenyl)methyl]-3,5-dimethylphenoxy]acetic acid | Sobetirome | DrugBank ID:DB07425 | SOBETIROME | UNII:XQ31741E9Q | PubChem SID:198942875 | CAS RN:211110-63-3"
+BMGC_DG17269,BMG_DG218086,5-Chloro-1-(4-fluorophenyl)-3-(piperidin-4-yl)-1H-indole | PubChem CID:9862272 | 5-chloro-1-(4-fluorophenyl)-3-piperidin-4-ylindole | CAS RN:138900-27-3
+BMGC_DG17270,BMG_DG218096,"UNII:KRR4CUV7BP | (E)-1-[2,4-dihydroxy-3-(3-methylbut-2-enyl)phenyl]-3-(2,4-dihydroxyphenyl)prop-2-en-1-one | MORACHALCONE A | Morachalcone A | CAS RN:76472-88-3 | PubChem SID:482553968 | PubChem CID:9862769"
+BMGC_DG17271,BMG_DG218099,"(6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoic acid | 5-HETE, (±)- | 5-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid | CAS RN:73307-52-5 | 5-HETE, (+/-)- | PubChem SID:461432701 | UNII:92JQY74TBX | PubChem CID:9862886 | CAS RN:71030-39-2"
+BMGC_DG17272,BMG_DG218102,UNII:0F8K1X115C | 4-[2-[(6-ethoxy-1H-benzimidazol-2-yl)sulfanyl]ethyl]morpholine | PubChem CID:9862937 | FABOMOTIZOLE | DrugBank ID:DB13623 | CAS RN:173352-21-1 | Fabomotizole | PubChem SID:198978642
+BMGC_DG17273,BMG_DG218113,"VTP-194204 | PubChem CID:9863341 | DrugBank ID:DB11806 | CAS RN:220619-73-8 | (2E,4E)-3-methyl-5-[(1S,2S)-2-methyl-2-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)cyclopropyl]penta-2,4-dienoic acid | 2,4-Pentadienoic acid, 3-methyl-5-((1S,2S)-2-methyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)cyclopropyl)-, (2E,4E)- | PubChem SID:198977254 | UNII:877M97Z38Y"
+BMGC_DG17274,BMG_DG218116,PubChem CID:9863447 | CAS RN:219691-94-8 | PubChem SID:198965161 | DrugBank ID:DB03176 | KB-141 | UNII:M5P363AFVC
+BMGC_DG17275,BMG_DG218117,NS-2710 | PubChem SID:198944380 | PubChem CID:9863520 | CAS RN:184220-36-8 | UNII:J0WHC91NJO
+BMGC_DG17276,BMG_DG218118,PubChem CID:9863540 | PubChem SID:198988122 | UNII:3F15HDF3VV | PD-89211 | CAS RN:444725-49-9
+BMGC_DG17277,BMG_DG218125,"RIPASUDIL | CAS RN:223645-67-8 | PubChem CID:9863672 | UNII:11978226XX | DrugBank ID:DB13165 | 4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline | PubChem SID:198941309 | Ripasudil"
+BMGC_DG17278,BMG_DG218128,"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid | DrugBank ID:DB07945 | PubChem CID:9863791"
+BMGC_DG17279,BMG_DG218130,OZENOXACIN | UNII:V0LH498RFO | 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)pyridin-3-yl]-4-oxoquinoline-3-carboxylic acid | Ozenoxacin | CAS RN:245765-41-7 | PubChem SID:198983313 | DrugBank ID:DB12924 | PubChem CID:9863827
+BMGC_DG17280,BMG_DG218136,CYANAMIDE | CAS RN:2669-76-3 | UNII:21CP7826LC | PubChem CID:9864 | CAS RN:156-62-7 | PubChem SID:198989639 | cyanamide | DrugBank ID:DB02679 | CAS RN:420-04-2 | Cyanamide
+BMGC_DG17281,BMG_DG218143,"PubChem CID:9864291 | Ar-H047108 free base | CAS RN:248281-68-7 | UNII:D7RA6Q7F69 | 8-[(2-ethyl-6-methylphenyl)methylamino]-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide | PubChem SID:348481415 | AR-H047108 FREE BASE"
+BMGC_DG17282,BMG_DG218147,PubChem SID:198944506 | PubChem CID:9864378 | UNII:W6SU73VG8H | ADAROTENE | CAS RN:496868-77-0
+BMGC_DG17283,BMG_DG218160,"DrugBank ID:DB05187 | CAS RN:923978-27-2 | NDC:15054-0080 | Elafibranor | PubChem CID:9864881 | CAS RN:824932-88-9 | UNII:2J3H5C81A5 | PubChem SID:249492598 | ELAFIBRANOR | 2-[2,6-dimethyl-4-[(E)-3-(4-methylsulfanylphenyl)-3-oxoprop-1-enyl]phenoxy]-2-methylpropanoic acid"
+BMGC_DG17284,BMG_DG218171,PubChem CID:9865233 | CAS RN:425377-76-0 | TPA-023B | UNII:GMY695BP6Q | PubChem SID:363907850
+BMGC_DG17285,BMG_DG218176,"UNII:2O43FXG9IG | (3S,5S)-5-(3-(Cyclopentyloxy)-4-methoxyphenyl)-3-(3-methylbenzyl)piperidin-2-one | HT-0712 | (3S,5S)-5-(3-cyclopentyloxy-4-methoxyphenyl)-3-[(3-methylphenyl)methyl]piperidin-2-one | CAS RN:617720-02-2 | PubChem SID:198984162 | PubChem CID:9865375 | DrugBank ID:DB11650"
+BMGC_DG17286,BMG_DG218178,PubChem CID:9865384 | UNII:RAT9OHA1YH | PubChem SID:198970996 | Befiradol | CAS RN:208110-64-9 | (3-chloro-4-fluorophenyl)-[4-fluoro-4-[[(5-methylpyridin-2-yl)methylamino]methyl]piperidin-1-yl]methanone | BEFIRADOL
+BMGC_DG17287,BMG_DG218180,4-(BROMOACETYL)BENZONITRILE | PubChem SID:443623535 | UNII:E6T2NP32GC | CAS RN:20099-89-2 | PubChem CID:98654
+BMGC_DG17288,BMG_DG218181,PubChem SID:381132692 | T-863 | UNII:OF68Z8HK6V | PubChem CID:9865421 | CAS RN:701232-20-4
+BMGC_DG17289,BMG_DG218182,"CAS RN:129260-79-3 | Loteprednol | DrugBank ID:DB00873 | DrugBank ID:DB14596 | PubChem SID:175266954 | chloromethyl (8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate | LOTEPREDNOL | PubChem CID:9865442 | UNII:Z8CBU6KR16 | Loteprednol etabonate"
+BMGC_DG17290,BMG_DG218186,PubChem CID:9865514 | PubChem SID:272993826 | CAS RN:179024-48-7 | UNII:Y4O6325SYW | PD-168787
+BMGC_DG17291,BMG_DG218187,PubChem CID:9865515 | PubChem SID:198936135 | CAS RN:726169-73-9 | CAS RN:9003-99-0 | MOCETINOSTAT | DrugBank ID:DB11830 | N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide | Mocetinostat | UNII:A6GWB8T96J
+BMGC_DG17292,BMG_DG218188,"NDC:0469-2602 | NDC:70771-1753 | MIRABEGRON | 2-(2-amino-1,3-thiazol-4-yl)-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]acetamide | CAS RN:223673-61-8 | NDC:70710-1159 | NDC:68180-151 | PubChem SID:175267526 | NDC:55154-8712 | DrugBank ID:DB08893 | NDC:55154-8713 | NDC:70710-1160 | NDC:68180-152 | Mirabegron | UNII:MVR3JL3B2V | NDC:70518-2435 | NDC:0469-2601 | PubChem CID:9865528 | NDC:70771-1752 | NDC:0469-5020"
+BMGC_DG17293,BMG_DG218189,"2-hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobuten-1-yl]amino]benzamide | (R)-2-Hydroxy-N,N-dimethyl-3-((2-((1-(5-methylfuran-2-yl)propyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)benzamide | PubChem SID:198954316 | UNII:4GMU5HUX5I | CAS RN:473727-83-2 | PubChem CID:9865554 | NAVARIXIN ANHYDROUS"
+BMGC_DG17294,BMG_DG218190,PubChem CID:9865575 | NBI-27155 | CAS RN:186342-55-2 | UNII:XUG7ZGW4UN | PubChem SID:459055235
+BMGC_DG17295,BMG_DG218191,PubChem SID:348481406 | RS-97078 FREE BASE | CAS RN:723731-91-7 | PubChem CID:9865577 | UNII:2L5SGH4CVS
+BMGC_DG17296,BMG_DG218192,UNII:C57VF8YO91 | PubChem SID:377308362 | PubChem CID:9865587 | SD-0006 | CAS RN:271576-80-8 | DrugBank ID:DB07943
+BMGC_DG17297,BMG_DG218194,CAS RN:195054-99-0 | PubChem CID:9865624 | PubChem SID:316918811 | UNII:XBY7Y3DR1J | NBI-30545
+BMGC_DG17298,BMG_DG218195,PubChem SID:198955460 | CAS RN:431058-65-0 | UNII:H012AL9PN0 | PubChem CID:9865774 | DX-619
+BMGC_DG17299,BMG_DG218198,PubChem CID:9865801 | UNII:BF4A3Q806B | CAS RN:171277-06-8 | PubChem SID:313184494 | JTH-601 FREE BASE
+BMGC_DG17300,BMG_DG218200,4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | PubChem SID:381132499 | DrugBank ID:DB14059 | CAS RN:170569-86-5 | UNII:9HGW1H8S2M | PubChem CID:9865808 | 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide | SC-236
+BMGC_DG17301,BMG_DG218210,4-[[4-(4-fluorophenoxy)phenyl]sulfonylamino]-N-hydroxyoxane-4-carboxamide | PubChem CID:9866250 | PubChem SID:255509574 | UNII:516DO4KL5R | CP-544439 | CAS RN:230954-09-3
+BMGC_DG17302,BMG_DG218217,"PubChem CID:9866696 | Aloin | CAS RN:8015-61-0 | DrugBank ID:DB15477 | CAS RN:452311-56-7 | 1,8-dihydroxy-3-(hydroxymethyl)-10-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-10H-anthracen-9-one"
+BMGC_DG17303,BMG_DG218229,"UNII:Z7354TW4BM | CAS RN:158081-99-3 | PubChem SID:255509199 | 1-[(3S,4R)-4-hydroxy-3-[(4-phenylphenyl)methyl]-3,4-dihydro-2H-chromen-7-yl]cyclopentane-1-carboxylic acid | PubChem CID:9867257 | CP-105696 | 1-(3-(4-Phenylbenzyl)-4-hydroxychroman-7-yl)cyclopentane-1-carboxylic acid"
+BMGC_DG17304,BMG_DG218231,"UNII:17VAN37K4Y | PubChem SID:198967829 | CAS RN:189035-07-2 | PubChem CID:9867361 | (8S,11R,13S,14S,17S)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one | ORG-34517 | Org-34517 | DrugBank ID:DB05423"
+BMGC_DG17305,BMG_DG218239,"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide | DrugBank ID:DB07665 | PubChem CID:9867609"
+BMGC_DG17306,BMG_DG218240,"Laropiprant | PubChem CID:9867642 | LAROPIPRANT | 2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid | PubChem SID:175266118 | DrugBank ID:DB11629 | CAS RN:571170-77-9 | UNII:G7N11T8O78 | CAS RN:572874-50-1"
+BMGC_DG17307,BMG_DG218242,"CAS RN:367273-07-2 | Irx-5183 | PubChem SID:312524935 | PubChem CID:9867758 | IRX-5183 | 4-[(4-chloro-3-hydroxy-5,5,8,8-tetramethyl-6,7-dihydronaphthalene-2-carbonyl)amino]-2,6-difluorobenzoic acid | DrugBank ID:DB05653 | UNII:RC87L028HU"
+BMGC_DG17308,BMG_DG218243,CAS RN:282089-49-0 | UNII:DAV3Q7SNOL | PubChem SID:198972805 | JTE-907 | PubChem CID:9867770
+BMGC_DG17309,BMG_DG218246,"UNII:7V4A8U16MB | methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate | CAS RN:308242-62-8 | PubChem SID:198959215 | PubChem CID:9867812 | REMIMAZOLAM | Remimazolam | DrugBank ID:DB12404"
+BMGC_DG17310,BMG_DG218249,PubChem SID:198977407 | PubChem CID:9867949 | CAS RN:209268-36-0 | S-5751 | UNII:GA0E7U1R52
+BMGC_DG17311,BMG_DG218253,PubChem CID:9868037 | UNII:G1PEG5Q9Y2 | OSI-930 | Osi-930 | CAS RN:728033-96-3 | 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide | DrugBank ID:DB05913 | PubChem SID:198968760
+BMGC_DG17312,BMG_DG218256,PubChem SID:198957840 | SABIPORIDE | PubChem CID:9868115 | UNII:U52APA00X7 | CAS RN:324758-66-9
+BMGC_DG17313,BMG_DG218262,O-1269 | UNII:ZK4MED9M94 | PubChem SID:474493124 | CAS RN:336615-64-6 | PubChem CID:9868408
+BMGC_DG17314,BMG_DG218263,CAS RN:205678-31-5 | UNII:HG7MY8V9AA | PubChem CID:9868426 | SB-273005 | PubChem SID:348481802
+BMGC_DG17315,BMG_DG218265,"PubChem SID:175268334 | PubChem CID:9868491 | UNII:1O6WQ6T7G3 | CAS RN:209860-87-7 | DrugBank ID:DB08819 | Tafluprost | propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate | TAFLUPROST"
+BMGC_DG17316,BMG_DG218266,CAS RN:459836-30-7 | PubChem SID:445500406 | PEAQX | PubChem CID:9868551 | UNII:LE8K7M4APN
+BMGC_DG17317,BMG_DG218279,"1,3,10-trihydroxy-5-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-11H-benzo[b][1,4]benzodiazepin-6-one | DrugBank ID:DB12420 | CAS RN:733035-26-2 | UNII:YPH994Y0RF | Diazepinomicin | PubChem CID:9868980 | DIAZEPINOMICIN | PubChem SID:198979381 | CAS RN:179981-40-9"
+BMGC_DG17318,BMG_DG218280,CP-671906 | UNII:GLZ1WA47Q8 | PubChem SID:198978116 | PubChem CID:9869041 | CAS RN:332178-44-6
+BMGC_DG17319,BMG_DG218284,"PubChem CID:9869229 | UNII:V5Q32BZX79 | DrugBank ID:DB12557 | FK-614 | 3-[(2,4-dichlorophenyl)methyl]-2-methyl-N-pentylsulfonylbenzimidazole-5-carboxamide | CAS RN:193012-35-0 | PubChem SID:198943152"
+BMGC_DG17320,BMG_DG218289,"(2S)-5-carbamimidamido-2-(2,2-diphenylacetamido)-N-[(4-hydroxyphenyl)methyl]pentanamide | BIBP-3435 | (2S)-5-(diaminomethylideneamino)-2-[(2,2-diphenylacetyl)amino]-N-[(4-hydroxyphenyl)methyl]pentanamide | UNII:62WN57Y66D | PubChem CID:9869458 | CAS RN:170969-75-2 | PubChem SID:474494803"
+BMGC_DG17321,BMG_DG218291,2-(3-CARBAMIMIDOYL)-5-(METHYL-N-(4-(2-SULFAMOYLPHENYL)PHENYL)PYRAZOLE-3-CARBOXAMIDE | UNII:3UG7N37FYU | PubChem CID:9869498 | PubChem SID:485663508 | 2-(3-Carbamimidoyl)-5-(methyl-N-(4-(2-sulfamoylphenyl)phenyl)pyrazole-3-carboxamide | CAS RN:209954-52-9
+BMGC_DG17322,BMG_DG218292,SB-203220 | PubChem CID:9869504 | UNII:A9T9WVAH03 | CAS RN:144143-97-5 | PubChem SID:346539269
+BMGC_DG17323,BMG_DG218297,CAS RN:404844-02-6 | CGP-74588 | PubChem CID:9869737 | PubChem SID:198937399 | UNII:6GOH0N63QD | N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]-4-(piperazin-1-ylmethyl)benzamide | N-Desmethyl Imatinib
+BMGC_DG17324,BMG_DG218298,"(E,3R,5S)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate | Rosuvastatin(1-) | PubChem CID:9869776"
+BMGC_DG17325,BMG_DG218299,UNII:T4W68CAT3P | KI-20227 | PubChem SID:459056088 | PubChem CID:9869779 | CAS RN:623142-96-1
+BMGC_DG17326,BMG_DG218302,CAS RN:220614-50-6 | UNII:I8NWP25THF | PubChem SID:198962284 | PubChem CID:9869811 | ABT-770
+BMGC_DG17327,BMG_DG218303,"UNII:DJF621DE4F | PubChem SID:313183687 | (2R,3R,4S,5R)-2-[6-amino-2-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-5-(2-ethyltetrazol-5-yl)oxolane-3,4-diol | GW-328267 | CAS RN:210237-78-8 | PubChem CID:9869857 | Gw-328267"
+BMGC_DG17328,BMG_DG218306,4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide | AVANAFIL | NDC:31722-441 | DrugBank ID:DB06237 | NDC:72384-752 | Avanafil | NDC:72384-753 | NDC:31722-442 | NDC:72384-751 | NDC:31722-440 | CAS RN:330784-47-9 | PubChem CID:9869929 | PubChem SID:175267514 | UNII:DR5S136IVO
+BMGC_DG17329,BMG_DG218307,PubChem SID:198941413 | JNJ-10397049 | UNII:1B419P24AV | CAS RN:708275-58-5 | PubChem CID:9869934
+BMGC_DG17330,BMG_DG218316,"PubChem SID:198948829 | (2R)-3-(1H-indol-3-yl)-2-[[4-(2-phenyltetrazol-5-yl)phenyl]sulfonylamino]propanoic acid | CAS RN:193809-84-6 | UNII:CDL03A411T | PubChem CID:9870100 | D-Tryptophan, N-((4-(2-phenyl-2H-tetrazol-5-yl)phenyl)sulfonyl)- | MMI-166"
+BMGC_DG17331,BMG_DG218321,PubChem SID:198966764 | UNII:FM0D5L3W03 | PubChem CID:9870286 | BMS-196085 | CAS RN:170686-10-9
+BMGC_DG17332,BMG_DG218323,GW-9578 | UNII:H32ABL87X4 | PubChem SID:198953743 | PubChem CID:9870304 | CAS RN:247923-29-1
+BMGC_DG17333,BMG_DG218325,CAS RN:483987-38-8 | UNII:C52WZ2Q5T4 | KR-61639 | PubChem SID:445500009 | PubChem CID:9870334
+BMGC_DG17334,BMG_DG218329,"PubChem SID:198944735 | 1-[(3R)-1-(3,3-dimethyl-2-oxobutyl)-2-oxo-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-3-[3-(methylamino)phenyl]urea | CAS RN:155488-25-8 | NETAZEPIDE | PubChem CID:9870520 | Netazepide | UNII:HOU4I0G29C | DrugBank ID:DB12355"
+BMGC_DG17335,BMG_DG218333,UNII:23Y783RURX | CAS RN:196809-22-0 | PubChem CID:9870584 | PubChem SID:317229299 | GW-7845
+BMGC_DG17336,BMG_DG218334,"PubChem SID:198981809 | PubChem CID:9870652 | Fimasartan | 2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-5-yl]-N,N-dimethylethanethioamide | FIMASARTAN | CAS RN:247257-48-3 | DrugBank ID:DB09279 | UNII:P58222188P"
+BMGC_DG17337,BMG_DG218341,"CEFDITOREN | DrugBank ID:DB01066 | CAS RN:104145-95-1 | Cefditoren | UNII:81QS09V3YW | (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | PubChem SID:175267477 | PubChem CID:9870843"
+BMGC_DG17338,BMG_DG218344,"CAS RN:309913-83-5 | PubChem CID:9871074 | 2-[6-chloro-5-[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl]-1-methylindol-3-yl]-N,N-dimethyl-2-oxoacetamide | DrugBank ID:DB05412 | CAS RN:309915-13-7 | Talmapimod | UNII:B1E00KQ6NT | TALMAPIMOD | PubChem SID:198945302"
+BMGC_DG17339,BMG_DG218351,CAS RN:530084-87-8 | PubChem SID:445499485 | TD-5471 | PubChem CID:9871386 | UNII:M37E3NE7QB
+BMGC_DG17340,BMG_DG218354,"Ticagrelor | TICAGRELOR | NDC:69238-1134 | NDC:0186-0776 | NDC:42658-115 | NDC:55154-9618 | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol | NDC:71610-815 | NDC:0186-0777 | CAS RN:274693-27-5 | PubChem SID:175267325 | NDC:69238-1507 | DrugBank ID:DB08816 | UNII:GLH0314RVC | PubChem CID:9871419"
+BMGC_DG17341,BMG_DG218355,"ethyl [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[5-methyl-1-propan-2-yl-4-[(4-propan-2-yloxyphenyl)methyl]pyrazol-3-yl]oxyoxan-2-yl]methyl carbonate | UNII:TR0QT6QSUL | DrugBank ID:DB12935 | CAS RN:442201-24-3 | Remogliflozin etabonate | PubChem SID:198937387 | REMOGLIFLOZIN ETABONATE | PubChem CID:9871420"
+BMGC_DG17342,BMG_DG218361,CAS RN:871576-03-3 | Flovagatran | [(1R)-4-methoxy-1-[[(2S)-1-[(2R)-3-phenyl-2-(phenylmethoxycarbonylamino)propanoyl]pyrrolidine-2-carbonyl]amino]butyl]boronic acid | PubChem SID:198935434 | DrugBank ID:DB05714 | UNII:2WA50NUH6H | FLOVAGATRAN | PubChem CID:9871747
+BMGC_DG17343,BMG_DG218363,PubChem SID:376231609 | LB-30870 | CAS RN:280780-95-2 | PubChem CID:9871765 | UNII:FS64O4K98A
+BMGC_DG17344,BMG_DG218365,CAS RN:308824-37-5 | CID 9871883 | 1-cyclopropyl-N-hydroxy-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylpiperidine-4-carboxamide | PubChem CID:9871883
+BMGC_DG17345,BMG_DG218372,CAS RN:170686-12-1 | PubChem SID:198942079 | BMS-194449 | UNII:93ZDV2P17I | PubChem CID:9872113
+BMGC_DG17346,BMG_DG218375,CAS RN:147030-48-6 | KB-130015 | PubChem SID:198981193 | UNII:9YA9HD8JR2 | PubChem CID:9872203
+BMGC_DG17347,BMG_DG218379,"4,5-DIHYDRO-N-(2-METHOXY-6-METHYLPHENYL)-2-OXAZOLAMINE | PubChem CID:98724 | PubChem SID:375579838 | UNII:XUM4W4GH4I | CAS RN:21561-18-2"
+BMGC_DG17348,BMG_DG218385,CAS RN:186386-21-0 | RS-100975 | UNII:3AK2RKG763 | PubChem SID:363908652 | PubChem CID:9872515
+BMGC_DG17349,BMG_DG218387,"PubChem CID:9872620 | [[(2R,3S,4R,5R)-5-(5-bromo-2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate | 5-Bromo-utp"
+BMGC_DG17350,BMG_DG218392,"PubChem CID:9872780 | UNII:OYK17DYO9M | CAROTEGRAST METHYL | PubChem SID:198981744 | Carotegrast Methyl | CAS RN:401905-67-7 | methyl (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[6-(dimethylamino)-1-methyl-2,4-dioxoquinazolin-3-yl]phenyl]propanoate"
+BMGC_DG17351,BMG_DG218397,"(1R,5R,6S,13S,21R)-5,13-bis(3,4-dihydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.02,11.03,8.015,20]henicosa-2(11),3(8),9,15,17,19-hexaene-6,9,17,19,21-pentol | CAS RN:12798-56-0 | CAS RN:103883-03-0 | UNII:LX492GRN5W | PubChem CID:9872976 | Proanthocyanidin A1 | PubChem SID:482554188 | PROCYANIDIN A1"
+BMGC_DG17352,BMG_DG218401,CAS RN:378233-39-7 | PubChem CID:9873094 | PubChem SID:198945945 | UNII:1JWR9M39YC | A-320436
+BMGC_DG17353,BMG_DG218408,PubChem CID:9873257 | CAS RN:173901-95-6 | UNII:5DZ9YI6UZ5 | L-770644 | PubChem SID:348481833
+BMGC_DG17354,BMG_DG218437,"Lapaquistat acetate | CAS RN:189060-13-7 | LAPAQUISTAT ACETATE | PubChem CID:9874248 | PubChem SID:198960777 | 2-[1-[2-[(3R,5S)-1-(3-acetyloxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-5H-4,1-benzoxazepin-3-yl]acetyl]piperidin-4-yl]acetic acid | UNII:IUH3AY74O3"
+BMGC_DG17355,BMG_DG218442,"NEOGRIFOLIN | Neogrifolin | UNII:2SLA8PNR99 | 5-methyl-4-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]benzene-1,3-diol | CAS RN:23665-96-5 | PubChem SID:482554028 | PubChem CID:9874426"
+BMGC_DG17356,BMG_DG218452,"CAS RN:229634-98-4 | PubChem SID:252320419 | DrugBank ID:DB05966 | TAS-108 | (7R,8S,9S,13R,14S,17R)-17-[2-[4-(diethylaminomethyl)-2-methoxyphenoxy]ethyl]-7,13-dimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-ol;2-hydroxypropane-1,2,3-tricarboxylic acid | UNII:9B29N23K7E | PubChem CID:9874874 | Tas-108"
+BMGC_DG17357,BMG_DG218454,PubChem CID:9874913 | PubChem SID:198937309 | 2-methoxy-N-[(E)-3-[4-[3-methyl-4-(6-methylpyridin-3-yl)oxyanilino]quinazolin-6-yl]prop-2-enyl]acetamide | CAS RN:845680-17-3 | DrugBank ID:DB12302 | CAS RN:383432-38-0 | 2-Methoxy-N-[(2E)-3-[4-[[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]phenyl]amino]-6-quinazolinyl]-2-propen-1-yl]acetamide | CP-724714 | CAS RN:916496-82-7 | UNII:I05QZ0S4V3
+BMGC_DG17358,BMG_DG218455,"UNII:IW9MH6LGKH | PubChem SID:346540561 | PubChem CID:9874983 | CAS RN:200050-59-5 | L-771688 | methyl (4S)-4-(3,4-difluorophenyl)-6-(methoxymethyl)-2-oxo-3-[3-(4-pyridin-2-ylpiperidin-1-yl)propylcarbamoyl]-1,4-dihydropyrimidine-5-carboxylate"
+BMGC_DG17359,BMG_DG218460,Anacardic acid triene | CAS RN:103904-73-0 | PubChem SID:474490273 | ANACARDIC ACID TRIENE | PubChem CID:9875131 | UNII:F5X3PZ4LDA
+BMGC_DG17360,BMG_DG218463,PubChem CID:9875205 | UNII:SPWHS19WTL | PubChem SID:346539283 | CE-1037 FREE ACID | CAS RN:150493-09-7
+BMGC_DG17361,BMG_DG218467,"DrugBank ID:DB06228 | NDC:50090-4469 | CAS RN:366789-02-8 | NDC:50458-580 | NDC:55154-1422 | NDC:50090-3625 | UNII:9NDF7JZ4M3 | NDC:50090-4468 | NDC:50090-3639 | NDC:50458-575 | NDC:50458-578 | NDC:71610-690 | NDC:50458-579 | CAS RN:1429742-50-6 | PubChem CID:9875401 | NDC:55154-1424 | NDC:55154-1423 | NDC:50458-577 | PubChem SID:175266472 | 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide | Rivaroxaban | RIVAROXABAN"
+BMGC_DG17362,BMG_DG218468,UNII:M531IV9E0V | BMS-453 | PubChem SID:198951742 | CAS RN:166977-43-1 | PubChem CID:9875424
+BMGC_DG17363,BMG_DG218472,"DrugBank ID:DB04983 | PubChem SID:198961532 | PubChem CID:9875516 | UNII:5PC250KSSH | CAS RN:211448-85-0 | DENUFOSOL | [[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate | Denufosol"
+BMGC_DG17364,BMG_DG218489,PubChem CID:9876378 | UNII:H4GXR80IZE | CAS RN:221877-54-9 | ZOTAROLIMUS | PubChem SID:175265510
+BMGC_DG17365,BMG_DG218490,"PubChem CID:9876393 | UNII:YOG0PR3Q8J | CAS RN:582332-31-8 | UK-500001 | CAS RN:857900-47-1 | 2-(3,4-difluorophenoxy)-5-fluoro-N-[4-[(2-hydroxy-5-methylbenzoyl)amino]cyclohexyl]pyridine-3-carboxamide | DrugBank ID:DB12837 | 2-(3,4-Difluorophenoxy)-5-fluoro-N-(cis-4-((2-hydroxy-5-methylbenzoyl)amino)cyclohexyl)nicotinamide | PubChem SID:287445718"
+BMGC_DG17366,BMG_DG218494,UNII:E40O9G0MM3 | CP-464709 | PubChem SID:198980853 | CAS RN:193272-70-7 | PubChem CID:9876514
+BMGC_DG17367,BMG_DG218516,"UNII:8452E71EO7 | PubChem CID:9877482 | PubChem SID:316915925 | NORCANTHARIDIN | 4,7-Epoxyisobenzofuran-1,3-dione, hexahydro-, (3aR,4S,7R,7aS)-rel- | (1R,2S,6R,7S)-4,10-dioxatricyclo[5.2.1.02,6]decane-3,5-dione | CAS RN:29745-04-8"
+BMGC_DG17368,BMG_DG218520,(2R)-2-amino-3-(2-boronoethylsulfanyl)propanoic acid | CAS RN:63107-40-4 | PubChem CID:9877608 | S-(2-boronoethyl)-L-cysteine
+BMGC_DG17369,BMG_DG218524,"PubChem CID:9877796 | CAS RN:496955-70-5 | 9-Methyl-8-(1,2,3-triazol-2-yl)purin-6-amine | UNII:SUH3FF5GYJ | 9-METHYL-8-(1,2,3-TRIAZOL-2-YL)PURIN-6-AMINE | PubChem SID:485663402"
+BMGC_DG17370,BMG_DG218528,"NDC:60219-1586 | PubChem CID:9878 | Fluorometholone | NDC:60219-1585 | CAS RN:426-13-1 | (6S,8S,9R,10S,11S,13S,14S,17R)-17-acetyl-9-fluoro-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one | NDC:60758-880 | DrugBank ID:DB00324 | PubChem SID:175268774 | UNII:SV0CSG527L | NDC:11980-211 | FLUOROMETHOLONE | NDC:11980-228"
+BMGC_DG17371,BMG_DG218532,"DrugBank ID:DB14930 | 1-[(2R,4S,5R)-4-(18F)fluoranyl-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione | UNII:2X1K91UT6N | PubChem CID:9878109 | CAS RN:287114-80-1 | PubChem SID:198985950 | Fluorothymidine F-18 | ALOVUDINE F-18"
+BMGC_DG17372,BMG_DG218537,"3,5,4'-TRIMETHOXYSTILBENE, (Z)- | PubChem CID:9878556 | UNII:V36C3MR96B | CAS RN:94608-23-8"
+BMGC_DG17373,BMG_DG218542,PubChem CID:9878913 | PubChem SID:198949367 | Tedatioxetine | 4-[2-(4-methylphenyl)sulfanylphenyl]piperidine | UNII:5H681S8O3S | CAS RN:508233-95-2 | DrugBank ID:DB12641 | TEDATIOXETINE
+BMGC_DG17374,BMG_DG218547,Dihydrofolic Acid | DrugBank ID:DB02015 | PubChem CID:98792
+BMGC_DG17375,BMG_DG218549,"PubChem CID:9879308 | CAS RN:478488-83-4 | PubChem SID:459056158 | 5-CHLORO-2-(5-(3-CHLOROTHIOPHEN-2-YL)-1,2,4-OXADIAZOL-3-YL)PYRIDINE | UNII:5VTC25AJ7C"
+BMGC_DG17376,BMG_DG218557,"3-[(2,4-dihydroxy-3,3-dimethylbutanoyl)amino]propanoic acid | PANTOTHENIC ACID, (±)- | Pantothenic acid | PubChem CID:988 | DrugBank ID:DB01783 | CAS RN:1113-70-8 | DL-Pantothenic acid | UNII:66Y94D1203 | CAS RN:599-54-2 | PANTOTHENIC ACID, (+/-)- | PubChem SID:198979899"
+BMGC_DG17377,BMG_DG218558,"UNII:4KM2BN5JHF | CAS RN:427-51-0 | Cyproterone Acetate | CYPROTERONE ACETATE | PubChem SID:175266652 | DrugBank ID:DB04839 | PubChem CID:9880 | Cyproterone acetate | [(1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate"
+BMGC_DG17378,BMG_DG218569,"PubChem CID:9881148 | (Z)-1-(prop-2-enyldisulfanyl)-3-prop-2-enylsulfinylprop-1-ene | UNII:J9XLK7547H | CAS RN:92285-00-2 | AJOENE, (Z)- | (Z)-Ajoene | PubChem SID:198950446"
+BMGC_DG17379,BMG_DG218574,UNII:OLT4M28U3Z | PubChem SID:198937191 | CAS RN:146780-09-8 | ((3-TRIFLUOROMETHYL)PHENYL)METHYL-PHOSPHONIC ACID | PubChem CID:9881235
+BMGC_DG17380,BMG_DG218577,CAS RN:143321-57-7 | PubChem CID:9881324 | 5-MEO-MPMI | PubChem SID:441097561 | UNII:N29TFW7VRV
+BMGC_DG17381,BMG_DG218584,"CAS RN:104746-04-5 | PubChem SID:175266523 | (5S)-5-hydroxy-5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide | Eslicarbazepine | ESLICARBAZEPINE | UNII:S5VXA428R4 | PubChem CID:9881504 | DrugBank ID:DB14575"
+BMGC_DG17382,BMG_DG218585,"PubChem SID:445499598 | UNII:XZS3S55BTX | PubChem CID:9881505 | 2-AMINO-6-((1-IMINOETHYL)AMINO)-N-2H-TETRAZOL-5-YLHEXANAMIDE, (2S)- | CAS RN:179337-79-2"
+BMGC_DG17383,BMG_DG218587,PubChem CID:9881526 | PubChem SID:445498898 | CAS RN:154594-22-6 | UNII:9IL3UOX666 | L-741604
+BMGC_DG17384,BMG_DG218606,PubChem CID:9882067 | CAS RN:221109-26-8 | PubChem SID:443623536 | 2-PHENYL-3-(4-PIPERIDINYL)INDOLE | UNII:C8QVX49UNW
+BMGC_DG17385,BMG_DG218609,"PubChem CID:9882105 | CAS RN:299-75-2 | CAS RN:21106-06-9 | UNII:CO61ER3EPI | [(2S,3S)-2,3-dihydroxy-4-methylsulfonyloxybutyl] methanesulfonate | DrugBank ID:DB11678 | PubChem SID:198962999 | Treosulfan | TREOSULFAN"
+BMGC_DG17386,BMG_DG218610,"PubChem SID:198974037 | 1-(2,2-diphenyloxolan-3-yl)-N,N-dimethylmethanamine | PubChem CID:9882189 | DrugBank ID:DB05592 | Blarcamesine | UNII:9T210MMZ3F | BLARCAMESINE | CAS RN:195615-83-9"
+BMGC_DG17387,BMG_DG218624,"PubChem CID:9882812 | DrugBank ID:DB07553 | 9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE"
+BMGC_DG17388,BMG_DG218628,CAS RN:34441-14-0 | PubChem SID:363909543 | Nicotianamine | UNII:2OGX6YHQ1F | NICOTIANAMINE | (2S)-1-[(3S)-3-[[(3S)-3-amino-3-carboxypropyl]amino]-3-carboxypropyl]azetidine-2-carboxylic acid | PubChem CID:9882882
+BMGC_DG17389,BMG_DG218629,"CAS RN:169255-48-5 | UNII:6WD5JT8TB8 | PubChem SID:474492443 | PubChem CID:9882905 | 4-Iodo-2,6-bis(isopropyl)phenol | 4-IODO-2,6-BIS(ISOPROPYL)PHENOL"
+BMGC_DG17390,BMG_DG218631,DrugBank ID:DB07286 | BMS-564929 | UNII:9BLW27W4X7 | PubChem SID:252823630 | PubChem CID:9882972 | CAS RN:627530-84-1
+BMGC_DG17391,BMG_DG218632,"UNII:ZUY6SFU8RX | UNII:4N6S45X78A | CAS RN:79951-46-5 | SERTRALINE, TRANS-(±)- | SERTRALINE, TRANS-(+/-)- | CAS RN:79836-45-6 | PubChem SID:198942991 | SERTRALINE, (1R,4S)- | PubChem CID:9882979"
+BMGC_DG17392,BMG_DG218636,"6-(7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl)-N-methylnaphthalene-2-carboxamide | PubChem CID:9883029 | CAS RN:426219-18-3 | 6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide | CAS RN:426219-32-1 | CAS RN:426219-23-0"
+BMGC_DG17393,BMG_DG218661,OCAROCOXIB | PubChem SID:438787669 | PubChem CID:9883880 | UNII:96RH6Z678D | CAS RN:215122-22-8
+BMGC_DG17394,BMG_DG218664,2-[1-[[1-(2-methylpropanoyloxy)ethoxycarbonylamino]methyl]cyclohexyl]acetic acid | Gabapentin Enacarbil | NDC:53451-0101 | DrugBank ID:DB08872 | GABAPENTIN ENACARBIL | CAS RN:478296-72-9 | UNII:75OCL1SPBQ | NDC:53451-0103 | Gabapentin enacarbil | PubChem CID:9883933 | PubChem SID:175271730
+BMGC_DG17395,BMG_DG218665,PubChem CID:9883980 | 4-[2-[2-(2-methylpyrrolidin-1-yl)ethyl]-1-benzofuran-5-yl]benzonitrile | (R)-4-(2-(2-(2-Methylpyrrolidin-1-yl)-ethyl)benzofuran-5-yl)benzonitrile
+BMGC_DG17396,BMG_DG218674,"CAS RN:308368-85-6 | Topopyrone C | PubChem CID:9884262 | 5,9,11-trihydroxy-2-methylnaphtho[3,2-h]chromene-4,7,12-trione"
+BMGC_DG17397,BMG_DG218675,PubChem CID:9884318 | DrugBank ID:DB07167 | 5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE
+BMGC_DG17398,BMG_DG218676,"PubChem CID:9884349 | 2-Amino-4-(1,3-benzodioxol-5-yl)-6-(2-hydroxyethyl)sulfanyl-3,5-pyridinedicarbonitrile | 2-amino-4-(1,3-benzodioxol-5-yl)-6-(2-hydroxyethylsulfanyl)pyridine-3,5-dicarbonitrile"
+BMGC_DG17399,BMG_DG218677,"PubChem CID:9884366 | UNII:LF1VBG4ZUK | PubChem SID:198985503 | N-[(2R)-butan-2-yl]-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine | PEXACERFONT | DrugBank ID:DB12572 | Pexacerfont | CAS RN:459856-18-9"
+BMGC_DG17400,BMG_DG218683,"PubChem SID:440088280 | CAS RN:181644-49-5 | UNII:07H40AH4NA | PubChem CID:9884538 | 3-HYDROXY-4,3',4',5'-TETRAMETHOXYCHALCONE"
+BMGC_DG17401,BMG_DG218689,CAS RN:163133-43-5 | PubChem CID:9884642 | UNII:V24GR4LI3I | 4-nitrooxybutyl (2S)-2-(6-methoxynaphthalen-2-yl)propanoate | DrugBank ID:DB06682 | NAPROXCINOD | PubChem SID:198935880 | Naproxcinod
+BMGC_DG17402,BMG_DG218691,CAS RN:371935-74-9 | PI-103 | UNII:YQX02F616F | PubChem CID:9884685 | PubChem SID:198977080
+BMGC_DG17403,BMG_DG218693,PubChem CID:9884746 | UNII:45WZM2FLYQ | PubChem SID:198956291 | A-331440 | CAS RN:392338-13-5
+BMGC_DG17404,BMG_DG218694,"PubChem CID:9884781 | CID 9884781 | 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(2,3-dihydro-1H-inden-2-ylmethyl)piperazine"
+BMGC_DG17405,BMG_DG218697,"CAS RN:124555-18-6 | PubChem CID:9884817 | UNII:Q4H682B2VZ | (2R,3R,4S,5R)-2-[6-[[(1S,2S)-2-hydroxycyclopentyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol | N-((1S,trans)-2-hydroxycyclopentyl)adenosine | PubChem SID:251966032 | GR-79236"
+BMGC_DG17406,BMG_DG218698,CAS RN:364321-71-1 | UNII:W26I0D1D6J | PubChem CID:9884876 | CAS RN:934301-71-0 | 3-[(dimethylamino)methyl]-4-(4-methylsulfanylphenoxy)benzenesulfonamide | Uk-390957 | UK-390957 | PubChem SID:198946938 | DrugBank ID:DB11719
+BMGC_DG17407,BMG_DG218703,"UNII:G7FMS28PYD | PubChem SID:384647895 | CAS RN:200195-01-3 | 7-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-4H-1,4-benzoxazin-3-one | PD-172760 | 7-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-4H-1,4-benzoxazin-3-one | PubChem CID:9885114"
+BMGC_DG17408,BMG_DG218704,PubChem CID:9885167 | CAS RN:223671-94-1 | UK-356202 | PubChem SID:485665213 | UNII:P8NB948DQJ
+BMGC_DG17409,BMG_DG218719,DrugBank ID:DB12312 | PubChem SID:312525127 | ORG-25435 | PubChem CID:9885653 | CAS RN:256456-73-2 | UNII:VCW1NHW3OV
+BMGC_DG17410,BMG_DG218721,UNII:O5YT36MST0 | PubChem CID:9885748 | CAS RN:917813-75-3 | EF-24 | PubChem SID:434369667
+BMGC_DG17411,BMG_DG218722,UNII:YG7YTU4JQJ | PubChem SID:459055475 | PGE-9262932 | PubChem CID:9885754 | CAS RN:221221-18-7
+BMGC_DG17412,BMG_DG218729,L-167307 | PubChem CID:9885993 | PubChem SID:316915910 | CAS RN:188352-45-6 | UNII:E8LOH7143R
+BMGC_DG17413,BMG_DG218730,PubChem SID:198974939 | UNII:8JV86J4A30 | CAS RN:16919-18-9 | PubChem CID:9886 | HEXAFLUOROPHOSPHATE ION
+BMGC_DG17414,BMG_DG218731,MGS-0039 | PubChem CID:9886034 | CAS RN:569686-87-9 | PubChem SID:404859324 | UNII:M8KC1PQ31A
+BMGC_DG17415,BMG_DG218735,"Crobenetine | (1S,9R)-1,13,13-trimethyl-10-[(2S)-2-phenylmethoxypropyl]-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-6-ol | PubChem CID:9886143 | CAS RN:221019-25-6 | PubChem SID:198969332 | UNII:Q72DWI2G4C | CROBENETINE"
+BMGC_DG17416,BMG_DG218737,"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE | PubChem CID:9886249 | DrugBank ID:DB07405"
+BMGC_DG17417,BMG_DG218739,"(11R,16S)-misoprostol | UNII:55DV34K57L | CAS RN:59122-49-5 | Misoprostol, S-isomer | methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E,4S)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate | PubChem SID:485666097 | MISOPROSTOL, S-ISOMER | PubChem CID:9886273"
+BMGC_DG17418,BMG_DG218753,CAS RN:521064-34-6 | PubChem CID:9886720 | UNII:5TT4A4MBLR | PubChem SID:198965849 | CT-32228
+BMGC_DG17419,BMG_DG218754,PubChem CID:9886917 | methyl 2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetate | CAS RN:172733-08-3 | Varespladib methyl | PubChem SID:198962998 | VARESPLADIB METHYL | DrugBank ID:DB05737 | UNII:0NB98NBX3D
+BMGC_DG17420,BMG_DG218755,CAS RN:205807-59-6 | PubChem CID:9886977 | PubChem SID:445500370 | PKF-242-484 | UNII:Q4Y6E79VUH
+BMGC_DG17421,BMG_DG218757,"PubChem CID:9887053 | Oxalato(trans-l-1,2-cyclohexanediamine)platinum(II) | [(1R,2R)-2-azanidylcyclohexyl]azanide;oxalic acid;platinum(2+)"
+BMGC_DG17422,BMG_DG218765,SR11254 | DrugBank ID:DB02258 | PubChem CID:9887303
+BMGC_DG17423,BMG_DG218768,UNII:M7IAS8PR23 | RWJ-38063 | PubChem CID:9887378 | CAS RN:216252-56-1 | PubChem SID:384647780
+BMGC_DG17424,BMG_DG218769,ORG-41841 | UNII:5J2KL52JYJ | PubChem CID:9887381 | PubChem SID:443624725 | CAS RN:301847-37-0
+BMGC_DG17425,BMG_DG218774,PubChem SID:198988441 | PubChem CID:9887537 | ADOPRAZINE | UNII:7SNB18Q89D | CAS RN:222551-17-9
+BMGC_DG17426,BMG_DG218775,PubChem CID:9887557 | DrugBank ID:DB08752 | N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
+BMGC_DG17427,BMG_DG218776,"Emindole Sb | PubChem CID:9887568 | (1S,12S,15R,16S,17S,20S)-1,16,20-trimethyl-16-(4-methylpent-3-enyl)-3-azapentacyclo[10.8.0.02,10.04,9.015,20]icosa-2(10),4,6,8-tetraen-17-ol"
+BMGC_DG17428,BMG_DG218780,"(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol | DrugBank ID:DB06292 | UNII:1ULL0QJ8UC | PubChem CID:9887712 | DAPAGLIFLOZIN | Dapagliflozin | PubChem SID:198934677 | CAS RN:461432-26-8"
+BMGC_DG17429,BMG_DG218783,PubChem SID:313182767 | UNII:5HLP8UVL8M | SB-332235 | PubChem CID:9887803 | CAS RN:276702-15-9
+BMGC_DG17430,BMG_DG218784,UNII:55P6YH9O6N | Solabegron | 3-[3-[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethylamino]phenyl]benzoic acid | CAS RN:252920-94-8 | PubChem CID:9887812 | DrugBank ID:DB06190 | PubChem SID:198945674 | SOLABEGRON
+BMGC_DG17431,BMG_DG218785,PubChem CID:9887834 | CAS RN:223749-46-0 | UNII:4IF4R31066 | PubChem SID:316915316 | HMR-1556
+BMGC_DG17432,BMG_DG218786,UNII:OT7W70P7E1 | CAS RN:174956-43-5 | PubChem SID:198941537 | FLUVASTATIN ANTI-ISOMER | PubChem CID:9887837
+BMGC_DG17433,BMG_DG218787,ZD-6888 | PubChem CID:9887844 | PubChem SID:363908856 | UNII:V85UF0B9WX | CAS RN:138620-04-9
+BMGC_DG17434,BMG_DG218789,"PD-166793 | (S)-2-(4'-Bromo-[1,1'-biphenyl]-4-ylsulfonamido)-3-methylbutanoic acid | CAS RN:199850-67-4 | PubChem CID:9887870 | PubChem SID:198944520 | (2S)-2-[[4-(4-bromophenyl)phenyl]sulfonylamino]-3-methylbutanoic acid | UNII:U855L3SOXD"
+BMGC_DG17435,BMG_DG218790,PubChem CID:9887884 | PubChem SID:348481680 | DMP-543 | UNII:DYD4418J7V | CAS RN:160588-45-4
+BMGC_DG17436,BMG_DG218799,UNII:874OEY3JEJ | NBI-34041 | PubChem SID:313183377 | PubChem CID:9888194 | CAS RN:268545-87-5
+BMGC_DG17437,BMG_DG218800,4-PENTYLCYCLOHEXYLCARBOXYLIC ACID | UNII:S86CWG6K6Q | CAS RN:38289-29-1 | PubChem SID:376072751 | PubChem CID:98882
+BMGC_DG17438,BMG_DG218801,UNII:69GK99VB9C | PubChem CID:9888211 | PubChem SID:313182355 | SLV-310 | CAS RN:264869-71-8
+BMGC_DG17439,BMG_DG218805,NAVEGLITAZAR | PubChem CID:9888484 | CAS RN:476436-68-7 | Naveglitazar | UNII:Y995M7GM0G | PubChem SID:198952880 | (2S)-2-methoxy-3-[4-[3-(4-phenoxyphenoxy)propoxy]phenyl]propanoic acid | DrugBank ID:DB12662
+BMGC_DG17440,BMG_DG218806,PubChem CID:9888555 | N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]-1-benzothiophene-2-carboxamide | N-(4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl)benzo[b]thiophene-2-carboxamide | CAS RN:474432-65-0
+BMGC_DG17441,BMG_DG218807,PubChem SID:459055466 | PubChem CID:9888568 | 4-(((3-CHLORO-4-METHOXYPHENYL)METHYL)AMINO)-1-(4-HYDROXYPIPERIDIN-1-YL)PHTHALAZINE-6-CARBONITRILE | CAS RN:178308-65-1 | UNII:YZE9GCM2BB
+BMGC_DG17442,BMG_DG218810,PubChem SID:443624821 | PubChem CID:9888695 | EF-6265 | CAS RN:683247-35-0 | UNII:3E96CZP3FE
+BMGC_DG17443,BMG_DG218813,"N-(2-aminoethyl)-1-aziridineethanamine | UNII:K93WMR7E2S | PubChem SID:348480725 | PubChem CID:98888 | N'-[2-(aziridin-1-yl)ethyl]ethane-1,2-diamine | CAS RN:23435-23-6 | N-(2-AMINOETHYL)-1-AZIRIDINEETHANAMINE"
+BMGC_DG17444,BMG_DG218814,SB-247853 | UNII:JBJ4VCT98Y | CAS RN:200711-10-0 | PubChem SID:445500672 | PubChem CID:9888804
+BMGC_DG17445,BMG_DG218826,PubChem SID:198955711 | CAS RN:197890-44-1 | UNII:171SKM32U6 | GW-311616A | PubChem CID:9889108
+BMGC_DG17446,BMG_DG218830,"UNII:4M1609828O | 5-[[4-[(3-methyl-4-oxoquinazolin-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione | CAS RN:199113-98-9 | DrugBank ID:DB12781 | BALAGLITAZONE | Balaglitazone | PubChem SID:198976234 | PubChem CID:9889200"
+BMGC_DG17447,BMG_DG218832,CAS RN:375345-95-2 | MIBAMPATOR | DrugBank ID:DB12717 | UNII:A9V5BW73UU | N-[(2R)-2-[4-[4-[2-(methanesulfonamido)ethyl]phenyl]phenyl]propyl]propane-2-sulfonamide | PubChem CID:9889366 | Mibampator | PubChem SID:198965140
+BMGC_DG17448,BMG_DG218837,HX-630 | PubChem CID:9889522 | CAS RN:188844-52-2 | UNII:N564S742U1 | PubChem SID:198979537
+BMGC_DG17449,BMG_DG218842,PubChem CID:9889867 | IM-491 | PubChem SID:198975012 | CAS RN:252918-63-1 | UNII:UG82Y9C069
+BMGC_DG17450,BMG_DG218865,DrugBank ID:DB12022 | Evatanepag | PubChem CID:9890801 | EVATANEPAG | UNII:L266R6E31E | CAS RN:223488-57-1 | 2-[3-[[(4-tert-butylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid | PubChem SID:198982832
+BMGC_DG17451,BMG_DG218867,"IMIGLITAZAR | CAS RN:250601-04-8 | DrugBank ID:DB12511 | UNII:7244710F59 | Imiglitazar | (4E)-4-[[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]methoxyimino]-4-phenylbutanoic acid | PubChem SID:198988781 | PubChem CID:9890879"
+BMGC_DG17452,BMG_DG218883,PubChem SID:317229968 | UNII:U5Z444BP5F | CAS RN:452339-68-3 | PubChem CID:9891927 | GW-597901
+BMGC_DG17453,BMG_DG218884,PubChem CID:9891946 | L-796449 | UNII:O937X0Z5EM | PubChem SID:198940099 | CAS RN:194608-80-5
+BMGC_DG17454,BMG_DG218888,PubChem CID:9892106 | CAS RN:218297-83-7 | 2-(1-aminoisoquinolin-7-yl)-5-methyl-N-[4-(2-sulfamoylphenyl)phenyl]pyrazole-3-carboxamide | 1-(1-aminoisoquinolin-7-yl)-3-methyl-N-[4-(2-sulfamoylphenyl)phenyl]-1H-pyrazole-5-carboxamide
+BMGC_DG17455,BMG_DG218889,CAS RN:270902-51-7 | PubChem CID:9892113 | PubChem SID:445500179 | LAF-389 | UNII:XAE4WV436T
+BMGC_DG17456,BMG_DG218891,PubChem CID:9892148 | PubChem SID:459055682 | CAS RN:171964-73-1 | UNII:KXL5BC5A6F | ZD-0892
+BMGC_DG17457,BMG_DG218894,"PubChem CID:9892288 | 2-[4-[2-(1H-benzimidazol-2-ylsulfanyl)ethyl]piperazin-1-yl]-N-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]acetamide | CAS RN:561023-90-3"
+BMGC_DG17458,BMG_DG218897,CAS RN:652990-07-3 | UNII:LGY1VQ9622 | PubChem SID:198962950 | Milveterol | MILVETEROL | PubChem CID:9892481 | N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[2-[4-[[(2R)-2-hydroxy-2-phenylethyl]amino]phenyl]ethylamino]ethyl]phenyl]formamide
+BMGC_DG17459,BMG_DG218899,"UNII:1981OTB4DS | PubChem SID:363909204 | 1-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-methoxy-3,4-dihydroquinolin-2-one | OPC-14523 | DrugBank ID:DB05422 | Opc-14523 | CAS RN:145969-30-8 | PubChem CID:9892540"
+BMGC_DG17460,BMG_DG218904,PubChem CID:9892815 | CAS RN:226396-25-4 | N-hydroxy-1-(2-methoxyethyl)-4-[4-[4-(trifluoromethoxy)phenoxy]phenyl]sulfonylpiperidine-4-carboxamide
+BMGC_DG17461,BMG_DG218905,Gisadenafil | DrugBank ID:DB11902 | PubChem CID:9892860
+BMGC_DG17462,BMG_DG218912,PubChem CID:9893228 | 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenyl)sulfanylpropoxy]-2-propylphenoxy]butanoic acid | Tipelukast | UNII:08379P260O | TIPELUKAST | DrugBank ID:DB12435 | PubChem SID:198985765 | CAS RN:125961-82-2
+BMGC_DG17463,BMG_DG218921,UNII:SR225WUZ0H | CAS RN:278779-30-9 | PubChem CID:9893571 | GW-4064 | PubChem SID:198952869
+BMGC_DG17464,BMG_DG218922,"PubChem CID:9893658 | Ipi-493 | UNII:SLQ1AJG3VB | IPI-493 | DrugBank ID:DB13023 | PubChem SID:198945567 | CAS RN:64202-81-9 | [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-19-amino-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl] carbamate"
+BMGC_DG17465,BMG_DG218925,"CAS RN:204267-34-5 | PubChem SID:198949712 | (2S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2-(4,6-dimethylpyrimidin-2-yl)oxy-3,3-diphenylpropanoic acid | UNII:6RW6H4951Z | PubChem CID:9893800 | Feloprentan | CAS RN:204267-33-4 | FELOPRENTAN"
+BMGC_DG17466,BMG_DG218927,UNII:9X9D329ZX2 | PubChem CID:9893924 | NNC-26-9100 | PubChem SID:459055206 | CAS RN:199522-35-5
+BMGC_DG17467,BMG_DG218931,PubChem SID:348481753 | UNII:61GSP3D46U | CAS RN:331765-50-5 | SCH-211803 | PubChem CID:9894173
+BMGC_DG17468,BMG_DG218935,"PubChem SID:363909907 | UNII:5S3JHR3VC1 | PubChem CID:9894291 | 1-(1-(3-ETHOXYPHENYL)-4-METHYLCYCLOHEXYL)-4-PHENYL-PIPERAZINE, CIS- | CAS RN:179172-85-1"
+BMGC_DG17469,BMG_DG218938,TAK-637 | UNII:QRT7W0TL6X | PubChem CID:9894349 | CAS RN:183549-93-1 | PubChem SID:363908513
+BMGC_DG17470,BMG_DG218945,"Ezetimibe Phenoxy Glucuronide | UNII:V7FA38E13K | CAS RN:190448-57-8 | PubChem SID:405055541 | EZETIMIBE GLUCURONIDE | (2S,3S,4S,5R,6S)-6-[4-[(2S,3R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-2-yl]phenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid | PubChem CID:9894653"
+BMGC_DG17471,BMG_DG218946,UNII:V02XH3498Z | CAS RN:262596-45-2 | PubChem CID:9894720 | FR-233074 | PubChem SID:198960838
+BMGC_DG17472,BMG_DG218952,"UNII:00LOF6890B | PubChem CID:9895193 | ethyl 4-[(2S)-3-(3-carbamimidoylphenyl)-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperazine-1-carboxylate | CAS RN:220355-63-5 | Wx-uk1 free base | WX-UK1 FREE BASE | PubChem SID:198952750"
+BMGC_DG17473,BMG_DG218954,"COMBRETASTATIN | DrugBank ID:DB12596 | UNII:7O62J06F18 | PubChem SID:198971513 | 5-[(2R)-2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol | CAS RN:82855-09-2 | PubChem CID:9895264 | Combretastatin"
+BMGC_DG17474,BMG_DG218956,"CAS RN:439687-69-1 | (2S,4R)-1-[(3R)-5-chloro-1-(2,4-dimethoxyphenyl)sulfonyl-3-(2-methoxyphenyl)-2-oxoindol-3-yl]-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide | DrugBank ID:DB12643 | PubChem SID:198949574 | Nelivaptan | CAS RN:352276-92-7 | NELIVAPTAN | PubChem CID:9895468 | UNII:3TY57MQ4OA"
+BMGC_DG17475,BMG_DG218957,PubChem CID:9895503 | UNII:21BKD6T22E | PubChem SID:443623784 | KNI-10006 | CAS RN:461444-55-3
+BMGC_DG17476,BMG_DG218961,2-[3-(aminomethyl)phenyl]-N-[2-fluoro-4-(2-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide | DPC-423 FREE BASE | PubChem CID:9895762 | PubChem SID:445499509 | 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide | UNII:XXQ8EQ9VMM | CAS RN:209957-47-1
+BMGC_DG17477,BMG_DG218965,UNII:KM3Y5FBP4V | PubChem SID:346539249 | BMS-201620 | CAS RN:197643-49-5 | PubChem CID:9895810
+BMGC_DG17478,BMG_DG218968,BMS-248360 | PubChem CID:9895957 | CAS RN:254737-87-6 | PubChem SID:198974616 | UNII:EEP77N970Y
+BMGC_DG17479,BMG_DG218974,"PubChem SID:198951336 | PubChem CID:9896267 | UNII:5D7022962A | TOFIMILAST | Tofimilast | DrugBank ID:DB11681 | 12-cyclopentyl-10-ethyl-5-thiophen-2-yl-3,4,6,11,12-pentazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,10-tetraene | CAS RN:185954-27-2"
+BMGC_DG17480,BMG_DG218978,"DrugBank ID:DB08561 | BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE | PubChem CID:9896504"
+BMGC_DG17481,BMG_DG218985,CAS RN:122224-84-4 | UNII:4DEV5X6A19 | PubChem CID:9896827 | A-65317 | PubChem SID:317229720
+BMGC_DG17482,BMG_DG218990,"CAS RN:874310-50-6 | (2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3S)-2-[[2-[[(2S,3S)-2-[[2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoyl]amino]acetyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoic acid | PubChem CID:9897305 | MART-1 (27-35) (human)"
+BMGC_DG17483,BMG_DG218998,"PubChem CID:9897771 | (2S,4aS,6aR,6aS,6bR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid | 18b-Glycyrrhetic acid"
+BMGC_DG17484,BMG_DG219009,"PubChem SID:252319307 | DrugBank ID:DB06749 | (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-3-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | UNII:7413S0WMH6 | Ginsenoside Rb1 | CAS RN:41753-43-9 | PubChem CID:9898279 | GINSENOSIDE RB1"
+BMGC_DG17485,BMG_DG219014,"PubChem SID:198941255 | Depreotide | CAS RN:161982-62-3 | DEPREOTIDE | UNII:NDP0H8E844 | (2S)-6-amino-2-[[(2R)-2-[[(2S)-6-amino-2-[[(2S)-2-amino-3-[[2-[2-[(2S,5S,8S,11R,14S,17S)-14-(4-aminobutyl)-5-benzyl-8-[(4-hydroxyphenyl)methyl]-11-(1H-indol-3-ylmethyl)-4-methyl-3,6,9,12,15,18-hexaoxo-17-propan-2-yl-1,4,7,10,13,16-hexazacyclooctadec-2-yl]ethylsulfanyl]acetyl]amino]propanoyl]amino]hexanoyl]amino]-3-sulfanylpropanoyl]amino]hexanamide | DrugBank ID:DB11628 | PubChem CID:9898619"
+BMGC_DG17486,BMG_DG219039,"19-Nor-5-androstenediol | PubChem CID:9900246 | CAS RN:25975-59-1 | UNII:5N0V272KSA | DrugBank ID:DB01455 | (3S,8R,9S,10R,13S,14S,17S)-13-methyl-1,2,3,4,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol | 19-NOR-5-ANDROSTENEDIOL | PubChem SID:252319902"
+BMGC_DG17487,BMG_DG219048,PubChem SID:198976199 | UNII:A2EXW95647 | CAS RN:479683-64-2 | CP-809101 | PubChem CID:9901086
+BMGC_DG17488,BMG_DG219054,CAS RN:519187-23-6 | 1-[3-[2-(1-benzothiophen-5-yl)ethoxy]propyl]azetidin-3-ol | DrugBank ID:DB05938 | PubChem SID:313183707 | UNII:QY49O94S2W | EDONERPIC | PubChem CID:9901946 | Edonerpic
+BMGC_DG17489,BMG_DG219055,CAS RN:501667-77-2 | 5-[[9-methyl-8-[methyl(propan-2-yl)amino]purin-6-yl]amino]bicyclo[2.2.1]heptan-2-ol | PubChem CID:9902054 | 5-[[9-Methyl-8-[methyl(propan-2-yl)amino]purin-6-yl]amino]bicyclo[2.2.1]heptan-2-ol
+BMGC_DG17490,BMG_DG219062,"Lithocholic Acid | LITHOCHOLIC ACID | CAS RN:434-13-9 | (4R)-4-[(3R,5R,8R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid | PubChem CID:9903 | UNII:5QU0I8393U | PubChem SID:198959149"
+BMGC_DG17491,BMG_DG219070,PubChem SID:496141966 | PubChem CID:9903343 | 1-(3-(3-PHENYLPROPOXY)PROPYL)PIPERIDINE | UNII:DC323PGJ2N | CAS RN:362665-54-1 | 1-[3-(3-Phenylpropoxy)propyl]piperidine
+BMGC_DG17492,BMG_DG219074,"PubChem SID:472422396 | PubChem CID:9903426 | CAS RN:220510-08-7 | UNII:YY5RXG2CM5 | 5-(1-AZETIDINYLSULFONYL)-1H-INDOLE-2,3-DIONE"
+BMGC_DG17493,BMG_DG219076,PubChem CID:9903497 | UNII:VU7278D853 | PubChem SID:198953729 | ICA-27243 | CAS RN:325457-89-4
+BMGC_DG17494,BMG_DG219077,CAS RN:146535-06-0 | UNII:568TMU9H2K | PubChem SID:472422251 | RPR-101511 | PubChem CID:9903563
+BMGC_DG17495,BMG_DG219081,UNII:9M632G86CC | 2-(carbamoylamino)-5-(4-fluorophenyl)thiophene-3-carboxamide | CAS RN:507475-17-4 | TPCA-1 | PubChem SID:329904133 | Tpca-1 | PubChem CID:9903786
+BMGC_DG17496,BMG_DG219085,"CAS RN:65576-45-6 | 5-Chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo(2,3:6,7)oxepino(4,5-c)pyrrole | 9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene | CAS RN:65621-78-5 | PubChem CID:9903970 | CAS RN:158018-50-9"
+BMGC_DG17497,BMG_DG219086,"PubChem CID:9904 | NANDROLONE | DrugBank ID:DB13169 | Nandrolone | UNII:6PG9VR430D | CAS RN:434-22-0 | (8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one | PubChem SID:175266503"
+BMGC_DG17498,BMG_DG219091,UNII:BT2QU919S1 | CAS RN:254885-67-1 | PubChem SID:198971595 | GMC-1111 FREE BASE | PubChem CID:9904074
+BMGC_DG17499,BMG_DG219093,"DrugBank ID:DB12316 | UAB-30 | CAS RN:205252-57-9 | PubChem SID:198962553 | 9CUAB30 | 9cUAB30 | (2E,4E,6Z,8E)-8-(3,4-dihydro-2H-naphthalen-1-ylidene)-3,7-dimethylocta-2,4,6-trienoic acid | UNII:PFP09575EX | PubChem CID:9904203"
+BMGC_DG17500,BMG_DG219095,"NORKETOTIFEN | PubChem CID:9904236 | CAS RN:34580-20-6 | PubChem SID:381132656 | UNII:Z24BD2IFB3 | 2-piperidin-4-ylidene-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one | Norketotifen"
+BMGC_DG17501,BMG_DG219096,CAS RN:136924-88-4 | UNII:9JQ994EAB3 | U-92016A | PubChem CID:9904242 | PubChem SID:474494166
+BMGC_DG17502,BMG_DG219099,"2-Amino-5,6-dichloro-3,4-dihydroquinazoline | UNII:BD898EX8IE | 5,6-dichloro-1,4-dihydroquinazolin-2-amine | PubChem SID:402404492 | CAS RN:444904-63-6 | RL-603 | PubChem CID:9904281"
+BMGC_DG17503,BMG_DG219108,DrugBank ID:DB11175 | PubChem CID:9904746 | Zinc picolinate | PubChem SID:175268042 | UNII:ALO92O31SE | CAS RN:17949-65-4 | zinc;pyridine-2-carboxylate | ZINC PICOLINATE | Zinc Picolinate
+BMGC_DG17504,BMG_DG219110,"(8R,9S,10S,13S,14S)-13-methyl-10-prop-2-ynyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione | UNII:FL3VS913TW | Plomestane | PubChem SID:198982343 | PubChem CID:9904788 | CAS RN:77016-85-4 | PLOMESTANE"
+BMGC_DG17505,BMG_DG219113,PubChem CID:9904854 | PubChem SID:443623569 | CAS RN:575474-82-7 | R-112 | 3-[[5-fluoro-2-(3-hydroxyanilino)pyrimidin-4-yl]amino]phenol | UNII:Y7W5AL9KHB
+BMGC_DG17506,BMG_DG219127,"PubChem CID:9905233 | MLN-977 | DrugBank ID:DB05431 | CAS RN:175212-04-1 | Mln-977 | UNII:VNR0T3Q498 | PubChem SID:333495549 | 1-[4-[(2S,5S)-5-[(4-fluorophenoxy)methyl]oxolan-2-yl]but-3-ynyl]-1-hydroxyurea"
+BMGC_DG17507,BMG_DG219132,UNII:1O88C1NAS7 | SR-14150 | PubChem CID:9905428 | CAS RN:709024-69-1 | PubChem SID:445499132
+BMGC_DG17508,BMG_DG219153,PubChem SID:198937848 | CAS RN:460747-37-9 | UNII:81I6NQ807P | PubChem CID:9906447 | A-431404
+BMGC_DG17509,BMG_DG219154,"UNII:BX98J4T6JU | DrugBank ID:DB11529 | Melengestrol | MELENGESTROL | (8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-16-methylidene-1,2,8,9,11,12,14,15-octahydrocyclopenta[a]phenanthren-3-one | PubChem SID:198944592 | CAS RN:5633-18-1 | PubChem CID:9906614"
+BMGC_DG17510,BMG_DG219155,"BENZO(B)THIOPHENE-4-ACETAMIDE, N-METHYL-N-((1S,2S)-2-(1-PYRROLIDINYL)CYCLOHEXYL)- | PubChem CID:9906722 | PubChem SID:198945831 | UNII:8S8RZB3SIM | CAS RN:114419-76-0"
+BMGC_DG17511,BMG_DG219159,PubChem SID:310825456 | UNII:65JK8810RM | 2-[(R)-[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole | PubChem CID:9906855 | DrugBank ID:DB13762 | DEXRABEPRAZOLE | Dexrabeprazole | CAS RN:177795-60-7
+BMGC_DG17512,BMG_DG219160,"(2R)-2-amino-1-[4-[3-[4-(cyclopropanecarbonyl)phenoxy]propyl]piperazin-1-yl]propan-1-one | UNII:1039LG569Y | A-304121 | PubChem CID:9906860 | CAS RN:360551-71-9 | Piperazine, 1-((2R)-2-amino-1-oxopropyl)-4-(3-(4-(cyclopropylcarbonyl)phenoxy)propyl)- | PubChem SID:198934803"
+BMGC_DG17513,BMG_DG219164,PubChem SID:198947060 | TGX-221 | UNII:6L28AW98TH | PubChem CID:9907093 | CAS RN:663619-89-4
+BMGC_DG17514,BMG_DG219170,PubChem SID:198938732 | CAS RN:210755-45-6 | PubChem CID:9907286 | CP-471474 | UNII:96U47H947L
+BMGC_DG17515,BMG_DG219171,"CAS RN:97846-21-4 | PubChem SID:198987913 | 1,3-bis(methoxymethyl)-5,5-diphenyl-1,3-diazinane-2,4,6-trione | T-2000 | PubChem CID:9907289 | DrugBank ID:DB11654 | UNII:QW2J7VST60"
+BMGC_DG17516,BMG_DG219172,"CAS RN:165377-43-5 | CUTAMESINE | PubChem SID:198967210 | 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine | DrugBank ID:DB06618 | PubChem CID:9907323 | Cutamesine | UNII:9J7A4144BX"
+BMGC_DG17517,BMG_DG219178,"5-bromo-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2,3-dimethoxybenzamide | ISOREMOXIPRIDE | UNII:GH32HX9WCX | Flb 457 | PubChem CID:9907436 | PubChem SID:363908592 | CAS RN:107188-74-9"
+BMGC_DG17518,BMG_DG219181,PubChem CID:9907650 | CAS RN:187400-18-6 | UNII:6G5214L6K9 | ER-34617 | PubChem SID:198976422
+BMGC_DG17519,BMG_DG219186,PubChem SID:440088766 | CYMSERINE | PubChem CID:9907847 | UNII:EOI96371PZ | CAS RN:145209-39-8
+BMGC_DG17520,BMG_DG219188,CAS RN:140196-34-5 | PubChem CID:9907994 | benzyl N-[3-methyl-1-oxo-1-[(1-oxo-3-phenylpropan-2-yl)amino]butan-2-yl]carbamate | Carbobenzoxy-valinyl-phenylalaninal | CAS RN:88191-84-8
+BMGC_DG17521,BMG_DG219199,"CID 9908389 | (2S,3R)-N-hydroxy-N'-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-prop-2-enylbutanediamide | PubChem CID:9908389"
+BMGC_DG17522,BMG_DG219201,"PubChem SID:198960601 | PubChem CID:9908684 | CAS RN:252977-51-8 | DrugBank ID:DB12238 | MK-0777 | 7-tert-butyl-6-[(2-ethyl-1,2,4-triazol-3-yl)methoxy]-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine | 7-(tert-Butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine | UNII:1FI3KTC550"
+BMGC_DG17523,BMG_DG219204,CAS RN:170571-00-3 | 4-[5-[4-(hydroxymethyl)phenyl]-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide | UNII:1DIW8DT7Q3 | PubChem SID:198969941 | 4'-HYDROXYCELECOXIB | 4'-Hydroxycelecoxib | PubChem CID:9908776
+BMGC_DG17524,BMG_DG219205,CAS RN:371242-69-2 | UNII:9HC746B1KF | PubChem SID:198973439 | IC-87114 | PubChem CID:9908783
+BMGC_DG17525,BMG_DG219208,"PubChem SID:198949996 | CAS RN:286456-42-6 | L-838417 | 7-tert-butyl-3-(2,5-difluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine | UNII:8CZO0970G3 | PubChem CID:9908880 | 7-(tert-Butyl)-3-(2,5-difluorophenyl)-6-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine"
+BMGC_DG17526,BMG_DG219217,CAS RN:15291-75-5 | PubChem SID:198955028 | DrugBank ID:DB06743 | Ginkgolide A | GINKGOLIDE A | UNII:TAZ2DPR77B | PubChem CID:9909368
+BMGC_DG17527,BMG_DG219220,DrugBank ID:DB12988 | PubChem CID:9909438 | LY-518674
+BMGC_DG17528,BMG_DG219221,PubChem CID:9909448 | CAS RN:187665-60-7 | PNU-109291 | UNII:6E4LJL8K38 | PubChem SID:459055433
+BMGC_DG17529,BMG_DG219222,DMP-696 | PubChem SID:459055695 | PubChem CID:9909468 | CAS RN:202578-52-7 | UNII:WCA5SCC429
+BMGC_DG17530,BMG_DG219227,UNII:115755X1L7 | CAS RN:155990-20-8 | WIN-71425 | PubChem SID:198965413 | PubChem CID:9909677
+BMGC_DG17531,BMG_DG219233,chromium(3+);pyridine-3-carboxylate | CHROMIUM NICOTINATE | PubChem SID:175265861 | CAS RN:64452-96-6 | DrugBank ID:DB14529 | UNII:A150AY412V | Chromium nicotinate | PubChem CID:9909912
+BMGC_DG17532,BMG_DG219234,PubChem SID:198949526 | CAS RN:210484-07-4 | UNII:6Q34G5PLNL | A-177430 | PubChem CID:9909994
+BMGC_DG17533,BMG_DG219237,"PubChem SID:198971862 | PubChem CID:9910098 | (2R,3R,4S,5R)-2-[6-amino-2-[2-(4-chlorophenyl)ethoxy]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol | SONEDENOSON | UNII:2OT4KAG5JL | DrugBank ID:DB12443 | CAS RN:131865-88-8 | Sonedenoson"
+BMGC_DG17534,BMG_DG219238,PubChem SID:348481069 | UNII:T7FIA2S66D | CAS RN:182073-77-4 | PubChem CID:9910174 | ZD-8321
+BMGC_DG17535,BMG_DG219241,PubChem CID:9910220 | RTI-229 | CAS RN:160948-17-4 | PubChem SID:474492786 | UNII:4XC2A2NPZ2
+BMGC_DG17536,BMG_DG219242,"UNII:8054MM4902 | DrugBank ID:DB06629 | CAS RN:186497-07-4 | PubChem CID:9910224 | ZIBOTENTAN | Zibotentan | N-(3-methoxy-5-methylpyrazin-2-yl)-2-[4-(1,3,4-oxadiazol-2-yl)phenyl]pyridine-3-sulfonamide | PubChem SID:198974084"
+BMGC_DG17537,BMG_DG219246,"PubChem CID:9910352 | N-[4-[2-(7-cyano-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]cyclohexyl]-1H-indole-2-carboxamide | CAS RN:215802-15-6"
+BMGC_DG17538,BMG_DG219247,PubChem SID:433968068 | PubChem CID:9910393 | CAS RN:210826-40-7 | UNII:6RS86E2BWQ | MCC-950
+BMGC_DG17539,BMG_DG219249,CAS RN:501951-42-4 | UNII:T74V9O0Y2W | 1-(2-bromophenyl)-3-[(3R)-1-[5-(trifluoromethyl)pyridin-2-yl]pyrrolidin-3-yl]urea | Sb-705498 | SB-705498 | PubChem SID:198989585 | DrugBank ID:DB11883 | PubChem CID:9910486
+BMGC_DG17540,BMG_DG219263,CID 9911332 | 3-tert-butyl-1-propyl-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrazole-4-carboxylic acid | PubChem CID:9911332
+BMGC_DG17541,BMG_DG219265,PubChem SID:316916610 | CAS RN:180002-83-9 | PubChem CID:9911463 | L-768242 | UNII:85K154W99L
+BMGC_DG17542,BMG_DG219266,"2-[[(6R)-6-(diphenylcarbamoyloxymethyl)-6-hydroxy-7,8-dihydro-5H-naphthalen-1-yl]oxy]acetic acid | UNII:LSJ4493RPW | FK-788 | CAS RN:227951-89-5 | PubChem CID:9911469 | PubChem SID:198949947"
+BMGC_DG17543,BMG_DG219268,UNII:1Y3JD5PEMS | (E)-2-(5-chlorothiophen-2-yl)-N-[(3S)-1-[(2S)-1-morpholin-4-yl-1-oxopropan-2-yl]-2-oxopyrrolidin-3-yl]ethenesulfonamide | PubChem SID:346537714 | CAS RN:478644-12-1 | DrugBank ID:DB07278 | PubChem CID:9911502 | 2-(5-Chloro-2-Thienyl)-N-{(3s)-1-[(1s)-1-Methyl-2-Morpholin-4-Yl-2-Oxoethyl]-2-Oxopyrrolidin-3-Yl}ethenesulfonamide | GW-813893
+BMGC_DG17544,BMG_DG219275,"CAS RN:475108-18-0 | TIVOZANIB | PubChem SID:198967758 | 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea | Tivozanib | UNII:172030934T | DrugBank ID:DB11800 | PubChem CID:9911830"
+BMGC_DG17545,BMG_DG219276,CAS RN:402942-54-5 | DR-4485 Free Base | DR-4485 FREE BASE | PubChem CID:9911844 | PubChem SID:474492756 | UNII:4UZ647AQV9
+BMGC_DG17546,BMG_DG219279,PubChem SID:198953785 | UNII:NUG7541QVZ | PubChem CID:9912035 | A-292949 | CAS RN:280750-31-4
+BMGC_DG17547,BMG_DG219281,CAS RN:284045-56-3 | PubChem SID:459055591 | PubChem CID:9912111 | UNII:C38U4WZ67T | KW-2581
+BMGC_DG17548,BMG_DG219285,"CAS RN:377727-26-9 | 10-[2-[4-(2,4-difluorophenyl)piperazin-1-yl]ethyl]-4-(furan-2-yl)-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine | PubChem CID:9912318 | CID 9912318"
+BMGC_DG17549,BMG_DG219286,"methyl (15S,16S,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylate | K-252A(Epi) | PubChem CID:9912410"
+BMGC_DG17550,BMG_DG219289,"(4as,4br,10bs,12as)-12a-Methyl-1,3-Dioxo-2-(Pyridin-3-Ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-Dodecahydronaphtho[2,1-F]isoquinolin-8-Yl Sulfamate | (4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate | DrugBank ID:DB08418 | PubChem CID:9912519 | [(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-4,4a,4b,5,6,10b,11,12-octahydronaphtho[2,1-f]isoquinolin-8-yl] sulfamate"
+BMGC_DG17551,BMG_DG219298,"CAS RN:232271-19-1 | PubChem CID:9912743 | PubChem SID:459055130 | UNII:UW585PBD7S | (S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid | TR-14035 | (2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-(2,6-dimethoxyphenyl)phenyl]propanoic acid"
+BMGC_DG17552,BMG_DG219299,"Darexaban | DAREXABAN | PubChem SID:198966689 | N-[2-hydroxy-6-[(4-methoxybenzoyl)amino]phenyl]-4-(4-methyl-1,4-diazepan-1-yl)benzamide | CAS RN:365462-23-3 | DrugBank ID:DB12289 | UNII:KF322K101S | PubChem CID:9912771"
+BMGC_DG17553,BMG_DG219300,PubChem CID:99128 | 2-Phenyl-3-indolone | CAS RN:2989-63-1 | UNII:WW775YE4JA | PubChem SID:474491461 | 2-PHENYL-3-INDOLONE
+BMGC_DG17554,BMG_DG219303,AVOSENTAN | PubChem SID:198969826 | CAS RN:290815-26-8 | N-[6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]-5-methylpyridine-2-sulfonamide | UNII:L94KSX715K | Avosentan | PubChem CID:9912992
+BMGC_DG17555,BMG_DG219304,"PubChem CID:9913 | Xanthinol | PubChem SID:198971110 | DrugBank ID:DB09092 | UNII:TN1B5910V2 | CAS RN:2530-97-4 | 7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione | XANTHINOL"
+BMGC_DG17556,BMG_DG219306,CAS RN:603139-12-4 | PubChem SID:198980961 | L-873724 | UNII:29250PP3ON | PubChem CID:9913088
+BMGC_DG17557,BMG_DG219311,PubChem CID:9913339 | UNII:9688E11ZQ0 | BMS-566419 | CAS RN:566161-24-8 | PubChem SID:198979199
+BMGC_DG17558,BMG_DG219315,CAS RN:173842-04-1 | L-017608 | UNII:RG6V2LL3J2 | PubChem CID:9913449 | PubChem SID:443624080
+BMGC_DG17559,BMG_DG219317,CAS RN:184770-78-3 | PubChem SID:363908787 | PubChem CID:9913629 | UNII:IF979JQU3S | LB-30057 FREE BASE
+BMGC_DG17560,BMG_DG219320,"UNII:5EXC0E384L | CAS RN:475086-01-2 | 2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide | PubChem CID:9913767 | SELEXIPAG | DrugBank ID:DB11362 | Selexipag | PubChem SID:198953024"
+BMGC_DG17561,BMG_DG219322,"(2S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-4-methyl-2-[[(2S)-2-sulfanyl-4-(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)butanoyl]amino]pentanamide | DrugBank ID:DB06573 | PubChem CID:9913881 | UNII:1B47R6ZX4K | Rebimastat | PubChem SID:198942458 | REBIMASTAT | CAS RN:259188-38-0"
+BMGC_DG17562,BMG_DG219329,ZM-447439 | PubChem CID:9914412 | CAS RN:331771-20-1 | PubChem SID:198957226 | UNII:RSN3P9776R
+BMGC_DG17563,BMG_DG219333,"Atromentin | 2,5-dihydroxy-3,6-bis(4-hydroxyphenyl)cyclohexa-2,5-diene-1,4-dione | ATROMENTIN | PubChem CID:99148 | CAS RN:519-67-5 | PubChem SID:318164617 | UNII:59557692U6"
+BMGC_DG17564,BMG_DG219334,"FIGOPITANT | PubChem SID:198970113 | Figopitant | (2S)-N-[2-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-[4-(cyclopropylmethyl)piperazin-1-yl]-N-methyl-2-phenylacetamide | PubChem CID:9914857 | DrugBank ID:DB12122 | UNII:23X73B9O6Q | CAS RN:502422-74-4"
+BMGC_DG17565,BMG_DG219339,UNII:PN03VLW8WV | PubChem CID:9915028 | A-216546 FREE BASE | CAS RN:212481-66-8 | PubChem SID:198961924
+BMGC_DG17566,BMG_DG219340,PubChem SID:459055430 | Dpc 602 | 2-[2-(aminomethyl)phenyl]-N-[2-fluoro-4-(2-sulfamoylphenyl)phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide | UNII:F6NYW6W9FS | PubChem CID:9915041 | DPC-602 | CAS RN:228258-45-5
+BMGC_DG17567,BMG_DG219345,CAS RN:173901-42-3 | PubChem SID:459056350 | 3-HEXYL-1-(4-((4-(2-(((2R)-2-HYDROXY-2-(PYRIDIN-3-YL)ETHYL)AMINO)ETHYL)PHENYL)SULFAMOYL)PHENYL)UREA | PubChem CID:9915238 | UNII:4R8Y22FMW2
+BMGC_DG17568,BMG_DG219349,UNII:RVW8CZ26BK | PubChem SID:443624720 | CAS RN:188754-67-8 | PubChem CID:9915313 | PNU-157706
+BMGC_DG17569,BMG_DG219358,Neratinib | (E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide | DrugBank ID:DB11828 | PubChem SID:198962615 | NERATINIB | UNII:JJH94R3PWB | CAS RN:698387-09-6 | PubChem CID:9915743
+BMGC_DG17570,BMG_DG219365,"N-[(7S)-1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide | Thiocolchicoside | DrugBank ID:DB11582 | CAS RN:602-41-5 | PubChem CID:9915886 | PubChem SID:198956399 | THIOCOLCHICOSIDE | UNII:T1X8S697GT"
+BMGC_DG17571,BMG_DG219376,PubChem CID:9916104 | PubChem SID:198965645 | ABT-925 anhydrous free base | ABT-925 ANHYDROUS FREE BASE | 2-[3-[4-[2-tert-butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl]propylsulfanyl]-1H-pyrimidin-6-one | CAS RN:220519-06-2 | UNII:E6CKI5C54O
+BMGC_DG17572,BMG_DG219377,PubChem CID:9916195 | SR-144190 | PubChem SID:459055805 | UNII:Y2646FAP82 | CAS RN:201152-86-5
+BMGC_DG17573,BMG_DG219384,PubChem CID:9916428 | MEN-10930 | N-[1-[[(2S)-1-[benzyl(methyl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]carbamoyl]cyclohexyl]-1H-indole-3-carboxamide | UNII:66D5QL5G2S | CAS RN:171272-39-2 | Unii-66D5QL5G2S | PubChem SID:445499537
+BMGC_DG17574,BMG_DG219386,PubChem CID:9916436 | CAS RN:491869-01-3 | L-826141 | UNII:2JN104XMOK | PubChem SID:198944405
+BMGC_DG17575,BMG_DG219387,"DrugBank ID:DB12580 | UNII:NY0COC51FI | Tradipitant | PubChem CID:9916461 | PubChem SID:198955967 | TRADIPITANT | [2-[1-[[3,5-bis(trifluoromethyl)phenyl]methyl]-5-pyridin-4-yltriazol-4-yl]pyridin-3-yl]-(2-chlorophenyl)methanone | CAS RN:622370-35-8"
+BMGC_DG17576,BMG_DG219391,"CAS RN:188723-25-3 | 2-((1,4'-BIPIPERIDIN)-1'-YL)-1-(2-((4-CHLOROPHENOXY)METHYL)-1-(3-((3S)-PIPERIDIN-3-YL)PROPYL)-1H-INDOL-3-YL)ETHAN-1-ONE | PubChem SID:445500649 | PubChem CID:9916525 | UNII:Z5M5FX29YG"
+BMGC_DG17577,BMG_DG219400,"PubChem SID:445498702 | 2-((6-(BIS(2-HYDROXYETHYL)AMINO)-4,8-BIS((((4-METHOXYPHENYL)METHYL)AMINO))-(1,3)DIAZINO(5,4-D)PYRIMIDIN-2-YL)(2-HYDROXYETHYL)AMINO)ETHAN-1-OL | PubChem CID:9916871 | CAS RN:213839-95-3 | UNII:9NR6JP5JPE"
+BMGC_DG17578,BMG_DG219403,"Cep-1347 | PubChem CID:9917013 | methyl (15S,16R,18R)-10,23-bis(ethylsulfanylmethyl)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-16-carboxylate | CEP-1347 | PubChem SID:318691289 | CAS RN:156177-65-0 | UNII:200HA2LIMK"
+BMGC_DG17579,BMG_DG219404,PubChem SID:485660785 | DW-908 | CAS RN:793669-59-7 | UNII:L4L3Q7THK4 | PubChem CID:9917020
+BMGC_DG17580,BMG_DG219405,"Casopitant | (2R,4S)-4-(4-acetylpiperazin-1-yl)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide | CAS RN:852393-14-7 | CASOPITANT | CAS RN:414910-27-3 | PubChem SID:198941397 | PubChem CID:9917021 | UNII:3B03KPM27L | DrugBank ID:DB06634"
+BMGC_DG17581,BMG_DG219408,"N-[(2R,4S)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-[(4-chlorophenyl)methyl]piperidin-4-yl]quinoline-4-carboxamide | 4-Quinolinecarboxamide, N-(1-(3,5-bis(trifluoromethyl)benzoyl)-2-((4-chlorophenyl)methyl)-4-piperidinyl)-, (2R-trans)- | CAS RN:177707-12-9 | PubChem SID:333495837 | PubChem CID:9917079 | UNII:987K1SBI71 | AV-608"
+BMGC_DG17582,BMG_DG219428,PubChem SID:198952706 | Dirlotapide | DIRLOTAPIDE | PubChem CID:9917862 | CAS RN:481658-94-0 | DrugBank ID:DB11399 | UNII:578H0RMP25 | N-[(1S)-2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]-1-methyl-5-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]indole-2-carboxamide
+BMGC_DG17583,BMG_DG219432,"PubChem CID:9917944 | 2-[1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)morpholin-2-yl]ethyl]piperidin-4-yl]-2-methylpropanamide | CID 9917944"
+BMGC_DG17584,BMG_DG219433,"Trodusquemine | TRODUSQUEMINE | DrugBank ID:DB06333 | PubChem SID:198972692 | PubChem CID:9917968 | UNII:KKC12PIF16 | [(3R,6R)-6-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] hydrogen sulfate | CAS RN:186139-09-3"
+BMGC_DG17585,BMG_DG219436,"ALEMCINAL | CAS RN:150785-53-8 | (2R,3S,4R,5R,8R,9S,10S,11R,12R)-5-ethyl-11-[(2S,3R,4S,6R)-4-[ethyl(methyl)amino]-3-hydroxy-6-methyloxan-2-yl]oxy-3-hydroxy-9-[(2S,4S,6S)-4-methoxy-4,6-dimethyloxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6,15-dioxabicyclo[10.2.1]pentadec-1(14)-en-7-one | UNII:5DS173ODI4 | Alemcinal | PubChem SID:198957659 | PubChem CID:9918079"
+BMGC_DG17586,BMG_DG219440,"CAS RN:527-75-3 | (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione | UNII:AN686JJ1YI | BERYTHROMYCIN | PubChem SID:198965272 | PubChem CID:9918244 | Erythromycin B"
+BMGC_DG17587,BMG_DG219444,"RILAPLADIB | DrugBank ID:DB05119 | Rilapladib | PubChem SID:198952399 | CAS RN:412950-08-4 | PubChem CID:9918381 | UNII:O14CWE893Z | 2-[2-[(2,3-difluorophenyl)methylsulfanyl]-4-oxoquinolin-1-yl]-N-[1-(2-methoxyethyl)piperidin-4-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide"
+BMGC_DG17588,BMG_DG219477,UNII:4H7N4I6X6A | PubChem SID:198985295 | HEXAPEPTIDE-2 | CAS RN:87616-84-0 | Hexapeptide-2 | PubChem CID:9919153
+BMGC_DG17589,BMG_DG219483,"PubChem CID:9919490 | Ovemotide | CAS RN:181477-91-8 | (4S)-4-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-5-[(2S)-2-[[2-[(2S)-2-[[(2S)-1-[[(2S,3R)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]carbamoyl]pyrrolidin-1-yl]-5-oxopentanoic acid"
+BMGC_DG17590,BMG_DG219485,"CAS RN:500355-52-2 | MK-0873 | N-cyclopropyl-1-[3-[2-(1-oxidopyridin-1-ium-3-yl)ethynyl]phenyl]-4-oxo-1,8-naphthyridine-3-carboxamide | PubChem SID:198935086 | UNII:K4KAC9XCCO | Mk-0873 | PubChem CID:9919680 | DrugBank ID:DB13029"
+BMGC_DG17591,BMG_DG219494,"Antrin | PubChem SID:198963169 | UNII:0V38NF6N89 | MOTEXAFIN LUTETIUM ANHYDROUS | CAS RN:246252-04-0 | DrugBank ID:DB05296 | 3-[4,5-diethyl-24-(3-hydroxypropyl)-16,17-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-10,23-dimethyl-13,20,25,26-tetraza-27-azanidapentacyclo[20.2.1.13,6.18,11.014,19]heptacosa-1(25),2,4,6,8(26),9,11,13,15,17,19,21,23-tridecaen-9-yl]propan-1-ol;lutetium(3+);diacetate | PubChem CID:9919942"
+BMGC_DG17592,BMG_DG219526,PubChem SID:445499816 | CAS RN:1210-81-7 | UNII:4R5ZNV2CHC | ST-1936 | PubChem CID:9921064
+BMGC_DG17593,BMG_DG219528,"7-Ethyl-α-methyl-1H-furo[2,3-g]indazole-1-ethanamine | CAS RN:1557165-96-4 | 7-ETHYL-.ALPHA.-METHYL-1H-FURO(2,3-G)INDAZOLE-1-ETHANAMINE | PubChem CID:9921157 | UNII:3UR6ZZV2LA | PubChem SID:474494771"
+BMGC_DG17594,BMG_DG219549,ASP-6537 | UNII:LN4A42V962 | PubChem SID:459276158 | PubChem CID:9922739 | CAS RN:524699-72-7
+BMGC_DG17595,BMG_DG219552,"DrugBank ID:DB01711 | 2,3,4,5,6-Pentafluorobenzyl Alcohol | PubChem SID:440088708 | PubChem CID:9923 | CAS RN:440-60-8 | UNII:FYY8AJK1SP | 2,3,4,5,6-PENTAFLUOROBENZYL ALCOHOL"
+BMGC_DG17596,BMG_DG219566,UNII:H821664NPK | PubChem CID:9924495 | DrugBank ID:DB08883 | PubChem SID:175268698 | CAS RN:1174302-51-2 | NDC:62856-278 | NDC:69616-272 | NDC:62856-290 | Perampanel | NDC:69616-278 | NDC:69616-282 | NDC:62856-274 | NDC:69616-280 | NDC:62856-276 | NDC:62856-282 | NDC:69616-290 | NDC:69616-276 | 2-(2-oxo-1-phenyl-5-pyridin-2-ylpyridin-3-yl)benzonitrile | CAS RN:380917-97-5 | NDC:69616-274 | PERAMPANEL | NDC:62856-280 | NDC:62856-272
+BMGC_DG17597,BMG_DG219568,"PubChem SID:472423780 | 4-(8-(3-FLUOROPHENYL)(1,7)NAPHTHYRIDIN6-YL)-TRANS-CYCLOHEXANECARBOXYLIC ACID | CAS RN:880466-44-4 | UNII:ZL6XTZ7R7K | PubChem CID:9924539"
+BMGC_DG17598,BMG_DG219583,PubChem CID:9925502 | CAS RN:230640-88-7 | BMS-284640 | UNII:XP87V064PV | PubChem SID:198978260
+BMGC_DG17599,BMG_DG219596,"CAS RN:467-15-2 | PubChem CID:9925873 | PubChem SID:198977576 | (4R,4aR,7S,7aR,12bS)-9-methoxy-1,2,3,4,4a,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol | Norcodeine | NORCODEINE | UNII:32W9P3T4ML"
+BMGC_DG17600,BMG_DG219601,PubChem CID:9925908 | PubChem SID:198958993 | UNII:01FPW436S6 | A-620223 | DrugBank ID:DB07330 | CAS RN:272769-49-0
+BMGC_DG17601,BMG_DG219604,"PubChem SID:441097418 | PubChem SID:441097283 | PubChem CID:9925999 | UNII:S8XT6RJ44E | 1-(7-((DIMETHYLAMINO)METHYL)-4-METHOXYBICYCLO(4.2.0)OCTA-1,3,5-TRIEN-7-YL)CYCLOHEXANOL, (+)- | UNII:UK5SE4YR5N | S-33005 | CAS RN:242473-60-5 | CAS RN:242473-59-2 | UNII:C53PYU3EBT | 1-(7-((DIMETHYLAMINO)METHYL)-4-METHOXYBICYCLO(4.2.0)OCTA-1,3,5-TRIEN-7-YL)CYCLOHEXANOL | PubChem SID:441097185 | CAS RN:700802-13-7"
+BMGC_DG17602,BMG_DG219622,PubChem CID:9926623 | UNII:CC3Q66M53N | CAS RN:27608-12-4 | 1-(9-Phenylfluoren-9-yl)imidazole | PubChem SID:475550294 | 1-(9-PHENYLFLUOREN-9-YL)IMIDAZOLE
+BMGC_DG17603,BMG_DG219627,"3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile | UNII:87LA6FU830 | DrugBank ID:DB08895 | Tofacitinib | CAS RN:477600-75-2 | PubChem SID:175266281 | CAS RN:1259404-17-5 | TOFACITINIB | PubChem CID:9926791"
+BMGC_DG17604,BMG_DG219630,"DrugBank ID:DB13004 | MAVOGLURANT | CAS RN:543906-09-8 | UNII:GT0I9SV4F6 | Mavoglurant | methyl (3aR,4S,7aR)-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-3,3a,5,6,7,7a-hexahydro-2H-indole-1-carboxylate | CAS RN:1636881-61-2 | PubChem CID:9926832 | PubChem SID:198936767"
+BMGC_DG17605,BMG_DG219632,PubChem CID:9926933 | DrugBank ID:DB08133 | N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide
+BMGC_DG17606,BMG_DG219646,"DrugBank ID:DB08020 | PubChem CID:9927355 | (3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL"
+BMGC_DG17607,BMG_DG219647,CAS RN:651767-99-6 | PubChem CID:9927379 | 6-((2-BROMOACETYL)AMINO)-N-PHENYLHEXANAMIDE | PubChem SID:485663410 | UNII:Y72W23RAT2 | 6-[(2-Bromoacetyl)amino]-N-phenylhexanamide
+BMGC_DG17608,BMG_DG219663,PubChem CID:9928016 | UNII:75W6I8W6OU | PubChem SID:198942072 | LY-404187 | CAS RN:211311-95-4
+BMGC_DG17609,BMG_DG219666,PubChem SID:316913668 | CP-99433 | PubChem CID:9928085 | UNII:GF5588CN9T | CAS RN:147059-71-0
+BMGC_DG17610,BMG_DG219671,AC-260584 | UNII:M4PN46N313 | PubChem CID:9928284 | PubChem SID:198983125 | CAS RN:560083-42-3
+BMGC_DG17611,BMG_DG219678,"PubChem SID:387065485 | BE-13793C | UNII:RW5116NX9T | 5,21-dihydroxy-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione | 1,11-Dihydroxy-12,13-dihydro-5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione | CAS RN:133805-03-5 | PubChem CID:9928668"
+BMGC_DG17612,BMG_DG219679,"DrugBank ID:DB01739 | PubChem SID:198934864 | UNII:05T3WT3PJ1 | CAS RN:1509-34-8 | CAS RN:3107-04-8 | PubChem SID:198969258 | L-Alloisoleucine | ALLOISOLEUCINE, L- | UNII:6RNR8XN7S2 | ALLOISOLEUCINE, DL- | PubChem CID:99288 | L-alloisoleucine | (2S,3R)-2-amino-3-methylpentanoic acid"
+BMGC_DG17613,BMG_DG219689,PubChem SID:445500660 | ML-120B | PubChem CID:9929127 | UNII:GD8S432HM5 | CAS RN:783348-36-7
+BMGC_DG17614,BMG_DG219690,UNII:D213B92S1Y | PubChem CID:9929138 | CAS RN:63208-82-2 | PIFITHRIN-.ALPHA. | PubChem SID:198957710
+BMGC_DG17615,BMG_DG219691,CAS RN:461045-07-8 | PubChem CID:9929160 | UNII:2AAE1WI5J3 | PubChem SID:198944714 | A-417022
+BMGC_DG17616,BMG_DG219702,UNII:6W6AEG3W3E | CAS RN:159730-07-1 | LY-272015 FREE BASE | PubChem CID:9929424 | PubChem SID:474494710
+BMGC_DG17617,BMG_DG219703,BCTC | CAS RN:393514-24-4 | PubChem SID:485663415 | UNII:3HW474Y8YZ | PubChem CID:9929425
+BMGC_DG17618,BMG_DG219707,Hypothemycin | PubChem CID:9929643 | DrugBank ID:DB07905
+BMGC_DG17619,BMG_DG219715,"CAS RN:171864-80-5 | (3S,8aS)-3-[[6-methoxy-2-(3-methylbut-2-enyl)-1H-indol-3-yl]methyl]-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione | Tryprostatin A | PubChem CID:9929833"
+BMGC_DG17620,BMG_DG219717,"(R)-3,4-Dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2H-1-benzopyran-6-ol | TOCOTRIENOL | DrugBank ID:DB12647 | Tocotrienol | CAS RN:6829-55-6 | UNII:0867I0N41V | 2-methyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl]-3,4-dihydrochromen-6-ol | CAS RN:97530-73-9 | PubChem SID:316917380 | PubChem CID:9929901"
+BMGC_DG17621,BMG_DG219722,"PubChem SID:198957046 | CAS RN:748810-28-8 | Vernakalant Hydrochloride | CAS RN:605683-48-5 | (3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol;hydrochloride | PubChem CID:9930048 | VERNAKALANT HYDROCHLORIDE | UNII:7G4J1ZD9UQ"
+BMGC_DG17622,BMG_DG219723,"PubChem SID:198977082 | CAS RN:794466-70-9 | VERNAKALANT | PubChem CID:9930049 | UNII:9G468C8B13 | DrugBank ID:DB06217 | (3R)-1-[(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl]pyrrolidin-3-ol | Vernakalant"
+BMGC_DG17623,BMG_DG219726,CAS RN:478149-53-0 | PHA-543613 | UNII:R36R9KVD6Y | PubChem SID:241179216 | PubChem CID:9930121
+BMGC_DG17624,BMG_DG219734,5-VINYLURACIL | PubChem CID:99305 | PubChem SID:377308051 | CAS RN:37107-81-6 | UNII:FZA8N5LEF2
+BMGC_DG17625,BMG_DG219735,"2-(7-chloro-5-methyl-4-oxo-3-phenylpyridazino[4,5-b]indol-1-yl)-N,N-dimethylacetamide | PubChem CID:9930560 | CAS RN:220448-02-2 | UNII:4K8W47WK2L | 2-(7-Chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-3H-pyridazino[4,5-b]indol-1-yl)-N,N-dimethylacetamide | PubChem SID:346540714 | SSR-180575"
+BMGC_DG17626,BMG_DG219741,L-818571 | UNII:3Q4QR6LA4J | CAS RN:213763-92-9 | PubChem CID:9930747 | PubChem SID:459275740
+BMGC_DG17627,BMG_DG219752,"PubChem SID:478838088 | CAS RN:21332-96-7 | 6-(4-Butylanilino)-1H-pyrimidine-2,4-dione | 6-(4-BUTYLANILINO)-1H-PYRIMIDINE-2,4-DIONE | PubChem CID:99310 | UNII:RH3FMS7MDA"
+BMGC_DG17628,BMG_DG219761,"8-{2-[4-(2,4,5-Trifluoro-phenyl)-piperazin-1-yl]-ethyl}-8-aza-spiro[4.5]decane-7,9-dione | PubChem CID:9931327 | 8-[2-[4-(2,4,5-trifluorophenyl)piperazin-1-yl]ethyl]-8-azaspiro[4.5]decane-7,9-dione"
+BMGC_DG17629,BMG_DG219762,"PubChem CID:9931329 | 4-[3-fluoro-5-[[4-(2-methylimidazol-1-yl)phenyl]methoxy]phenyl]oxane-4-carboxamide | UNII:L3R3V6CK0F | PubChem SID:198973375 | CJ-13454 | CAS RN:179420-14-5 | 2H-Pyran-4-carboxamide, 4-(3-fluoro-5-((4-(2-methyl-1H-imidazol-1-yl)phenyl)methoxy)phenyl)tetrahydro-"
+BMGC_DG17630,BMG_DG219770,"PubChem SID:319891987 | [4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]acetic acid | CAS RN:475085-57-5 | PubChem CID:9931891 | UNII:E9PC7N0DID | LASELIPAG"
+BMGC_DG17631,BMG_DG219772,"6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one | PubChem CID:9931954 | DrugBank ID:DB12332 | UNII:8237F3U7EH | RUCAPARIB | Rucaparib | CAS RN:283173-50-2 | PubChem SID:198980201"
+BMGC_DG17632,BMG_DG219773,PubChem SID:346538364 | UNII:C9IF5SIJ2I | PubChem CID:9932000 | CAS RN:527680-56-4 | PHA-568487
+BMGC_DG17633,BMG_DG219786,PubChem CID:99327 | UNII:83P935XGB5 | N-((4-METHYLPHENYL)SULFONYL)-L-PHENYLALANINE | N-[(4-Methylphenyl)sulfonyl]-L-phenylalanine | CAS RN:13505-32-3 | PubChem SID:485665600
+BMGC_DG17634,BMG_DG219790,"CAS RN:189954-65-2 | UNII:2Y89BQT8CV | 3-((5-BROMO-2-PYRIDINYL)OXY)-5,5-DIMETHYL-4-(4-(METHYLSULFONYL)PHENYL)-2(5H)-FURANONE | PubChem SID:459055791 | PubChem CID:9932828"
+BMGC_DG17635,BMG_DG219796,"Glycopyrronium | PubChem SID:316910091 | GLYCOPYRRONIUM, (2R,3'S)- | [(3S)-1,1-dimethylpyrrolidin-1-ium-3-yl] (2R)-2-cyclopentyl-2-hydroxy-2-phenylacetate | CAS RN:740028-90-4 | CAS RN:746600-85-1 | PubChem CID:9933193 | UNII:A14FB57V1D | UNII:HTB34557V4 | GLYCOPYRRONIUM | Glycopyrronium, (2R,3'S)- | PubChem SID:175271997 | DrugBank ID:DB00986"
+BMGC_DG17636,BMG_DG219797,PubChem CID:9933197 | CAS RN:226395-57-9 | N-hydroxy-4-[4-[4-(trifluoromethyl)phenoxy]phenyl]sulfonyloxane-4-carboxamide | DrugBank ID:DB06945 | N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide | N-hydroxy-4-((4-(4-(trifluoromethyl)phenoxy)phenyl)sulfonyl)tetrahydro-2H-pyran-4-carboxamide
+BMGC_DG17637,BMG_DG219802,UNII:NQU9IPY4K9 | CEDIRANIB | CAS RN:288383-20-0 | Cediranib | 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline | PubChem CID:9933475 | PubChem SID:198958766 | DrugBank ID:DB04849
+BMGC_DG17638,BMG_DG219810,"PubChem CID:9933928 | N-[3-Amino-4-(2-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino}-ethoxy)-phenyl]-methanesulfonamide | N-[3-amino-4-[2-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]ethoxy]phenyl]methanesulfonamide"
+BMGC_DG17639,BMG_DG219814,"Timonacic | TIMONACIC | UNII:E5913T3IBL | PubChem CID:9934 | DrugBank ID:DB12856 | PubChem SID:198962510 | 1,3-thiazolidine-4-carboxylic acid | CAS RN:444-27-9"
+BMGC_DG17640,BMG_DG219816,PubChem SID:198950482 | PubChem CID:9934033 | CAS RN:509118-03-0 | UNII:539503G9M0 | ATC-0175 FREE BASE
+BMGC_DG17641,BMG_DG219821,PubChem CID:9934142 | QUERCETIN 3'-GLUCOSIDE | CAS RN:19254-30-9 | UNII:ZX8DUW9DKD
+BMGC_DG17642,BMG_DG219826,"UNII:8NWU765OLC | CAS RN:150481-98-4 | CAS RN:161799-18-4 | PubChem SID:433968374 | MK-499 FREE BASE | PubChem CID:9934294 | MK-499 FREE BASE, (+/-)- | PubChem SID:384647989 | MK-499 FREE BASE, (±)- | UNII:OM3KJ27ATS"
+BMGC_DG17643,BMG_DG219829,PubChem CID:9934347 | DrugBank ID:DB07460 | 2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE
+BMGC_DG17644,BMG_DG219831,CP-432 | PubChem CID:9934368 | CAS RN:431990-08-8 | UNII:XO355X0D3B | PubChem SID:198978461
+BMGC_DG17645,BMG_DG219833,PubChem CID:9934458 | UNII:4PZK9FJC4Z | PubChem SID:461432972 | CAS RN:317318-84-6 | GW-0742
+BMGC_DG17646,BMG_DG219838,UNII:HEJ6QDU4PA | PubChem CID:9934643 | PubChem SID:472426286 | CAS RN:845895-51-4 | AP-23464
+BMGC_DG17647,BMG_DG219842,FR-181877 | PubChem SID:198937043 | UNII:1H463450OS | CAS RN:172936-99-1 | PubChem CID:9934864
+BMGC_DG17648,BMG_DG219843,1-(3-CHLOROPHENYL)-1H-IMIDAZOLE | CAS RN:51581-52-3 | PubChem SID:374388725 | UNII:HPC0JIU29O | PubChem CID:99349
+BMGC_DG17649,BMG_DG219847,PubChem CID:9935062 | CP-865569 | PubChem SID:348481408 | UNII:YZ7Z6YGG69 | CAS RN:478833-25-9
+BMGC_DG17650,BMG_DG219848,"UNII:332VLD554F | CAS RN:199331-40-3 | PubChem SID:198990189 | ETIPREDNOL DICLOACETATE | Etiprednol dicloacetate | PubChem CID:9935073 | ethyl (8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dichloroacetyl)oxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate | DrugBank ID:DB05442"
+BMGC_DG17651,BMG_DG219858,CAS RN:380449-51-4 | PubChem CID:9935639 | UNII:F70C5K4786 | MELPHALAN FLUFENAMIDE | PubChem SID:198940780 | Melphalan flufenamide | ethyl (2S)-2-[[(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoyl]amino]-3-(4-fluorophenyl)propanoate
+BMGC_DG17652,BMG_DG219859,CAS RN:317844-33-0 | PubChem CID:9935648 | UNII:O46A5T721G | PubChem SID:251965974 | LY-466195
+BMGC_DG17653,BMG_DG219867,UNII:540N75454L | PubChem SID:198961256 | CKD-731 | PubChem CID:9935823 | CAS RN:251111-15-6
+BMGC_DG17654,BMG_DG219872,"N-(3,4-DIMETHYL-2,5-DIOXO-2,5-DIHYDRO-1H-PYRROL-1-YL)-2-(4-(2,6-DIOXO-1,3-DIPROPYL-2,3,6,9-TETRAHYDRO-1H-PURIN-8-YL)PHENOXY)ACETAMIDE | PubChem SID:459055449 | UNII:4DRK8YR3E6 | PubChem CID:9936058 | CAS RN:249926-37-2"
+BMGC_DG17655,BMG_DG219876,UNII:19L3G9YL39 | PubChem CID:9936145 | PubChem SID:198945562 | A-292438 | CAS RN:380180-51-8
+BMGC_DG17656,BMG_DG219877,CAS RN:374670-24-3 | PHA-927F FREE BASE | UNII:MFX52L2G4C | PubChem SID:445499079 | PubChem CID:9936190
+BMGC_DG17657,BMG_DG219881,Sb-743921 | PubChem SID:346537648 | N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxochromen-2-yl)-2-methylpropyl]-4-methylbenzamide | PubChem CID:9936388 | CAS RN:1067881-56-4 | CAS RN:618430-39-0 | UNII:24DSZ1VN92 | SB-743921
+BMGC_DG17658,BMG_DG219882,"PubChem SID:198937614 | CAS RN:544417-40-5 | UNII:O519NVW73R | 2-amino-6-[[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methylsulfanyl]-4-[4-(2-hydroxyethoxy)phenyl]pyridine-3,5-dicarbonitrile | CAPADENOSON | Capadenoson | PubChem CID:9936489"
+BMGC_DG17659,BMG_DG219886,PubChem SID:348480805 | CEP-7055 | PubChem CID:9936664 | UNII:AD6CBG7OXO | CAS RN:402857-58-3
+BMGC_DG17660,BMG_DG219890,"DrugBank ID:DB15189 | 2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]-N-(4-hydroxyphenyl)acetamide | UNII:X40LKS49S3 | BIRABRESIB | CAS RN:202590-98-5 | PubChem CID:9936746 | Birabresib | PubChem SID:316910042"
+BMGC_DG17661,BMG_DG219899,"CAS RN:1316755-17-5 | (3S)-2-(2,2-diphenylacetyl)-6-methoxy-5-phenylmethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid | CAS RN:1316755-16-4 | UNII:P0FN522VTO | OLODANRIGAN | Olodanrigan | PubChem SID:329903606 | PubChem CID:9937291"
+BMGC_DG17662,BMG_DG219924,CAS RN:289715-28-2 | UNII:55I8ETE76Y | CB-300919 | PubChem SID:198937067 | PubChem CID:9938280
+BMGC_DG17663,BMG_DG219926,PubChem SID:445499810 | CAS RN:225938-38-5 | PubChem CID:9938283 | UNII:XH72H96MUZ | GGTI-2151 FREE BASE
+BMGC_DG17664,BMG_DG219928,PubChem SID:474490998 | UNII:WPC8RDS67E | PubChem CID:99383 | 9-Methoxyacridine | CAS RN:10228-90-7 | 9-METHOXYACRIDINE
+BMGC_DG17665,BMG_DG219929,UNII:EP8475W580 | PubChem SID:198976081 | PubChem CID:9938311 | SMP-797 ANHYDROUS FREE BASE | CAS RN:437763-85-4
+BMGC_DG17666,BMG_DG219940,"CAS RN:55297-96-6 | (E)-but-2-enedioic acid;[(1S,2R,3S,4S,6R,7R,8R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[2-(diethylamino)ethylsulfanyl]acetate | PubChem CID:9938794"
+BMGC_DG17667,BMG_DG219948,"N-[(E,2R)-1-(3,4-dichlorophenyl)-5-oxo-5-[[(3R)-2-oxoazepan-3-yl]amino]pent-3-en-2-yl]-N-methyl-3,5-bis(trifluoromethyl)benzamide | Dnk 333 | PubChem CID:9939040 | DNK-333 | PubChem SID:198978318 | CAS RN:398507-81-8 | UNII:G9BL4978MZ"
+BMGC_DG17668,BMG_DG219955,"PubChem CID:9939191 | N-[2-[4-[[3-butyl-5-oxo-1-[2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]phenyl]phenyl]sulfonylbenzamide"
+BMGC_DG17669,BMG_DG219958,"PubChem CID:9939426 | PubChem SID:198953379 | WX-UK1 | CAS RN:255374-84-6 | UNII:UJ925Q0P3B | DrugBank ID:DB05476 | ethyl 4-[(2S)-3-(3-carbamimidoylphenyl)-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperazine-1-carboxylate;hydrochloride"
+BMGC_DG17670,BMG_DG219963,"DARAPLADIB | DrugBank ID:DB06311 | N-[2-(diethylamino)ethyl]-2-[2-[(4-fluorophenyl)methylsulfanyl]-4-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-1-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide | PubChem CID:9939609 | PubChem SID:198984335 | Darapladib | UNII:UI1U1MYH09 | CAS RN:356057-34-6"
+BMGC_DG17671,BMG_DG219968,"CAS RN:313489-71-3 | DrugBank ID:DB05713 | N-[(1R)-2-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-2-oxo-1-phenylethyl]-1H-indole-6-carboxamide | UNII:TSA990HP1K | 1H-Indole-6-carboxamide, N-((1R)-2-(4-(1-methyl-4-piperidinyl)-1-piperazinyl)-2-oxo-1-phenylethyl)- | LY-517717 | PubChem CID:9939865 | PubChem SID:251965680"
+BMGC_DG17672,BMG_DG219969,"2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1lambda6,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic acid | ELOBIXIBAT | Elobixibat | PubChem CID:9939892 | CAS RN:439087-18-0 | UNII:865UEK4EJC | PubChem SID:198947212 | DrugBank ID:DB12486"
+BMGC_DG17673,BMG_DG219994,"PubChem CID:9940864 | Olmetec Plus | 6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide;(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate | CAS RN:760190-74-7"
+BMGC_DG17674,BMG_DG220007,"Nelipepimut-S | CAS RN:160212-35-1 | UNII:7M0A29CD8B | PubChem CID:9941306 | NELIPEPIMUT-S | (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid | PubChem SID:198938364"
+BMGC_DG17675,BMG_DG220008,"UNII:6Y24O4F92S | (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid | Bremelanotide | BREMELANOTIDE | PubChem CID:9941379 | CAS RN:189691-06-3 | DrugBank ID:DB11653 | PubChem SID:316911242"
+BMGC_DG17676,BMG_DG220010,"CAS RN:396091-73-9 | PubChem SID:175268286 | PubChem CID:9941444 | NDC:55292-133 | NDC:55292-131 | DrugBank ID:DB06663 | Pasireotide | [(3S,6S,9S,12R,15S,18S,20R)-9-(4-aminobutyl)-3-benzyl-12-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-15-phenyl-6-[(4-phenylmethoxyphenyl)methyl]-1,4,7,10,13,16-hexazabicyclo[16.3.0]henicosan-20-yl] N-(2-aminoethyl)carbamate | UNII:98H1T17066 | NDC:55292-132 | PASIREOTIDE"
+BMGC_DG17677,BMG_DG220031,"4-(1H-1,2,3-TRIAZOL-5-YL)PYRIDINE | CAS RN:369363-76-8 | PubChem CID:9942176 | 4-(1H-1,2,3-Triazol-5-yl)pyridine | PubChem SID:482554040 | UNII:FU5BWG3QNH"
+BMGC_DG17678,BMG_DG220048,CAS RN:219694-63-0 | INGAVIRIN | Ingavirin | UNII:3CM03MUJ69 | 5-[2-(1H-imidazol-5-yl)ethylamino]-5-oxopentanoic acid | PubChem CID:9942657 | DrugBank ID:DB11944 | PubChem SID:255509371
+BMGC_DG17679,BMG_DG220049,"DrugBank ID:DB05885 | SELETRACETAM | (2S)-2-[(4S)-4-(2,2-difluoroethenyl)-2-oxopyrrolidin-1-yl]butanamide | Seletracetam | PubChem CID:9942725 | UNII:RFR2CH3QZK | CAS RN:357336-74-4 | PubChem SID:198964485"
+BMGC_DG17680,BMG_DG220073,"PubChem CID:9944398 | DrugBank ID:DB08087 | 4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE"
+BMGC_DG17681,BMG_DG220078,CAS RN:544707-19-9 | UNII:JD270971QC | JNJ-10181457 | PubChem CID:9944610 | PubChem SID:198940454
+BMGC_DG17682,BMG_DG220097,"26-Hydroxycholesterol | PubChem CID:99470 | CAS RN:13095-61-9 | (3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol"
+BMGC_DG17683,BMG_DG220103,6-HYDROXYCOUMARIN | CAS RN:6093-68-1 | PubChem SID:474489614 | PubChem CID:99477 | UNII:7FS6H939K6
+BMGC_DG17684,BMG_DG220104,PubChem SID:316915184 | CAS RN:25248-96-8 | UNII:G05L7T7ZEQ | O-ACETYLSERINE | O-acetyl-L-serine | PubChem CID:99478 | DrugBank ID:DB01837 | (2S)-3-acetyloxy-2-aminopropanoic acid | CAS RN:5147-00-2
+BMGC_DG17685,BMG_DG220107,"PubChem SID:459056280 | PubChem CID:9947841 | (3Z)-1,3-DIHYDRO-5-(3-PYRIDINYL)-3-(1H-PYRROL-2-YLMETHYLENE)-2H-INDOL-2-ONE | UNII:5KU2EZ77LX | CAS RN:623175-13-3"
+BMGC_DG17686,BMG_DG220108,4-ANDROSTEN-3.BETA.-OL-17-ONE | CAS RN:571-44-8 | PubChem SID:310825610 | UNII:8U3PGO66GQ | PubChem CID:9947889
+BMGC_DG17687,BMG_DG220109,"CHROMANOL | Chromanol | PubChem SID:198973166 | DrugBank ID:DB13111 | 2,2,5,7,8-Pentamethyl-6-chromanol | PubChem CID:99479 | 2,2,5,7,8-pentamethyl-3,4-dihydrochromen-6-ol | UNII:7G73627R36 | CAS RN:950-99-2"
+BMGC_DG17688,BMG_DG220111,"PubChem SID:198945819 | UNII:4D28EY0L5T | CAS RN:675126-05-3 | PubChem CID:9947999 | DASOTRALINE | DrugBank ID:DB12305 | (1R,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine | Dasotraline"
+BMGC_DG17689,BMG_DG220115,UNII:4BC83L4PIY | PubChem CID:9948102 | PubChem SID:198942557 | DrugBank ID:DB11642 | CAS RN:362665-56-3 | Pitolisant | 1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine | PITOLISANT
+BMGC_DG17690,BMG_DG220118,"PubChem SID:198940860 | UNII:5007H57E2L | CAS RN:129075-73-6 | 3,4-Dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinone | 3,4-DIHYDRO-5-(4-(1-PIPERIDINYL)BUTOXY)-1(2H)-ISOQUINOLINONE | 5-(4-piperidin-1-ylbutoxy)-3,4-dihydro-2H-isoquinolin-1-one | PubChem CID:9948349"
+BMGC_DG17691,BMG_DG220128,"CAS RN:649735-41-1 | PubChem CID:9948660 | 4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol | 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol"
+BMGC_DG17692,BMG_DG220134,CAS RN:431898-65-6 | PubChem SID:433968479 | PS-1145 | UNII:12GL090NZZ | PubChem CID:9949093
+BMGC_DG17693,BMG_DG220143,METAGLIDASEN | CAS RN:4687-08-5 | UNII:V02QWF9PMI | PubChem CID:9949411 | PubChem SID:381132294
+BMGC_DG17694,BMG_DG220146,"(3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione | Plinabulin | DrugBank ID:DB05992 | PubChem CID:9949641 | UNII:986FY7F8XR | PLINABULIN | CAS RN:714272-27-2 | PubChem SID:198973468"
+BMGC_DG17695,BMG_DG220147,PubChem SID:198948848 | 7-[4-(4-cyanophenyl)phenoxy]-N-hydroxyheptanamide | A-161906 | CAS RN:191228-04-3 | PubChem CID:9949740 | UNII:R198471H35
+BMGC_DG17696,BMG_DG220148,UK-414495 | PubChem CID:9949799 | CAS RN:388630-36-2 | UNII:JV29CG9MQ2 | PubChem SID:445498863
+BMGC_DG17697,BMG_DG220151,PubChem SID:313183082 | PubChem CID:9949821 | UNII:FG7DYB4F07 | CAS RN:668981-02-0 | CP-863187
+BMGC_DG17698,BMG_DG220152,"DrugBank ID:DB09124 | (8R,9S,10R,13S,14S,17S)-17-acetyl-6,10,13,17-tetramethyl-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-3-one | CAS RN:977-79-7 | UNII:077DN93G5B | Medrogestone | MEDROGESTONE | PubChem CID:9949848 | PubChem SID:198953211"
+BMGC_DG17699,BMG_DG220155,PHENANTHRENE | UNII:448J8E5BST | PubChem SID:198940526 | Phenanthrene | phenanthrene | CAS RN:85-01-8 | PubChem CID:995
+BMGC_DG17700,BMG_DG220157,"3-[(4aS,12aR)-2-methyl-1,3,4,5,12,12a-hexahydropyrido[3,4-b]acridin-4a-yl]phenol | TAN-67 | PubChem CID:9950038 | CAS RN:148545-09-9 | PubChem SID:474493074 | UNII:UY7TB22PB7"
+BMGC_DG17701,BMG_DG220172,PubChem CID:9950486 | PubChem SID:198967873 | UNII:E3OY6PCU04 | AM-1714 | CAS RN:335371-37-4
+BMGC_DG17702,BMG_DG220173,3-IODOTHYRONAMINE | UNII:VMM45J7F4L | PubChem SID:474492485 | PubChem CID:9950514 | CAS RN:712349-95-6 | 4-[4-(2-aminoethyl)-2-iodophenoxy]phenol | 3-Iodothyronamine
+BMGC_DG17703,BMG_DG220184,UNII:STV44CBK1W | PubChem CID:9950925 | PubChem SID:198955110 | ENMD-1068 | CAS RN:789488-77-3
+BMGC_DG17704,BMG_DG220188,"CAS RN:847574-05-4 | CAS RN:248919-64-4 | LINAPRAZAN | 8-[(2,6-dimethylphenyl)methylamino]-N-(2-hydroxyethyl)-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxamide | Linaprazan | UNII:E0OU4SC8DP | PubChem SID:198944582 | PubChem CID:9951066"
+BMGC_DG17705,BMG_DG220189,CAS RN:195055-01-7 | PubChem SID:459056385 | UNII:8S7XY8R7HP | PubChem CID:9951076 | R-121920
+BMGC_DG17706,BMG_DG220191,PubChem SID:251965641 | PubChem CID:9951118 | CAS RN:156130-41-5 | ADL-08-0011 | UNII:3I1G16537O
+BMGC_DG17707,BMG_DG220200,"Isosteviol | UNII:091QB7QO95 | (1R,4S,5R,9S,10R,13S)-5,9,13-trimethyl-14-oxotetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid | CAS RN:27975-19-5 | PubChem CID:99514 | PubChem SID:198953971 | ISOSTEVIOL"
+BMGC_DG17708,BMG_DG220206,CAS RN:1229665-91-1 | PubChem CID:9951641 | UNII:532R2SRL4B | CGP-79807 | PubChem SID:198957877
+BMGC_DG17709,BMG_DG220212,PubChem SID:333495786 | PubChem CID:9951995 | BMS-223131 | CAS RN:275375-69-4 | UNII:889F719S7K
+BMGC_DG17710,BMG_DG220214,"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE | PubChem CID:9952008 | DrugBank ID:DB08441"
+BMGC_DG17711,BMG_DG220218,"PubChem SID:198972276 | UNII:U96J5LG435 | CAS RN:203191-10-0 | DrugBank ID:DB12058 | PubChem CID:9952125 | RECOFLAVONE | 2-[2-(3,4-dimethoxyphenyl)-5-methoxy-4-oxochromen-7-yl]oxyacetic acid | Recoflavone"
+BMGC_DG17712,BMG_DG220220,"PubChem CID:9952220 | N-[(2S,3S)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide | (2S,3S)-nemonapride"
+BMGC_DG17713,BMG_DG220227,"TAK-715 | CAS RN:303162-79-0 | N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]pyridin-2-yl]benzamide | UNII:WE92U03C5Z | Tak-715 | PubChem SID:198936078 | PubChem CID:9952773"
+BMGC_DG17714,BMG_DG220231,"PubChem CID:9952843 | 3-epi-25-Hydroxy Vitamin D3 | CAS RN:73809-05-9 | CAS RN:19356-17-3 | (1R,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol"
+BMGC_DG17715,BMG_DG220232,"Zabofloxacin | PubChem CID:9952872 | DrugBank ID:DB12479 | 1-cyclopropyl-6-fluoro-7-[(8E)-8-methoxyimino-2,6-diazaspiro[3.4]octan-6-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid | CAS RN:219680-11-2 | (E)-1-cyclopropyl-6-fluoro-7-(8-(methoxyimino)-2,6-diazaspiro[3.4]octan-6-yl)-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid"
+BMGC_DG17716,BMG_DG220234,"UNII:K6A90IIZ19 | PubChem CID:9952884 | 7-[(3S,4S)-3-methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,8-naphthyridine-3-carboxylic acid | Vosaroxin | PubChem SID:198984748 | DrugBank ID:DB11999 | VOSAROXIN | CAS RN:960398-99-6 | CAS RN:174726-60-4 | CAS RN:175414-77-4"
+BMGC_DG17717,BMG_DG220236,"DrugBank ID:DB06586 | 2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one | Cetilistat | CETILISTAT | PubChem CID:9952916 | CAS RN:282526-98-1 | UNII:LC5G1JUA39 | PubChem SID:198943777"
+BMGC_DG17718,BMG_DG220237,PubChem CID:9953 | CAS RN:451-71-8 | GLYHEXAMIDE | PubChem SID:198944497 | UNII:WW7NA7WQD2
+BMGC_DG17719,BMG_DG220240,"DrugBank ID:DB12446 | PubChem CID:9953065 | PubChem SID:198975483 | Derenofylline | DERENOFYLLINE | UNII:O1Q96UZ63W | CAS RN:251945-92-3 | CAS RN:1990532-34-7 | 4-[(2-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexan-1-ol"
+BMGC_DG17720,BMG_DG220244,PubChem CID:9953185 | LY-266097 | PubChem SID:441096661 | UNII:2Z9TC7YMY4 | CAS RN:208591-60-0
+BMGC_DG17721,BMG_DG220247,"PubChem CID:9953358 | PubChem SID:198954979 | UNII:UAG0ANS9HZ | DARUSENTAN, (±)- | CAS RN:178306-46-2 | DARUSENTAN, (+/-)-"
+BMGC_DG17722,BMG_DG220254,BIBM-1015 | UNII:260BQD3PS6 | PubChem CID:9953722 | PubChem SID:198935879 | CAS RN:253431-20-8
+BMGC_DG17723,BMG_DG220263,"CAS RN:327026-93-7 | (2R)-8-[4-[3-(5-fluoro-1H-indol-3-yl)propyl]piperazin-1-yl]-2-methyl-4H-1,4-benzoxazin-3-one | PubChem SID:198941299 | PubChem CID:9954003 | LENSIPRAZINE | Lensiprazine | UNII:N47MW76OGX"
+BMGC_DG17724,BMG_DG220264,CAS RN:372513-99-0 | A-349821 FREE BASE | PubChem SID:198976651 | PubChem CID:9954017 | UNII:67WL275ISI
+BMGC_DG17725,BMG_DG220267,PubChem CID:9954083 | 3.BETA.-(2-(DIETHYLAMINO)ETHOXY)ANDROST-5-EN-17-ONE | PubChem SID:310825729 | CAS RN:2855-62-1 | UNII:539DN9NA2P
+BMGC_DG17726,BMG_DG220287,"DrugBank ID:DB08174 | PubChem CID:9954980 | 5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE"
+BMGC_DG17727,BMG_DG220288,2-Aminopurine | 2-AMINOPURINE | PubChem SID:198939155 | 7H-purin-2-amine | UNII:O14B3U97FW | PubChem CID:9955 | CAS RN:61655-24-1 | CAS RN:191236-69-8 | CAS RN:452-06-2
+BMGC_DG17728,BMG_DG220292,PubChem SID:445498626 | UNII:EB3GE9ZR8T | NAS-181 FREE BASE | CAS RN:205242-61-1 | PubChem CID:9955015
+BMGC_DG17729,BMG_DG220294,"2-[[4-[2-[dimethyl(oxido)azaniumyl]ethylamino]-5,8-dihydroxy-9,10-dioxoanthracen-1-yl]amino]-N,N-dimethylethanamine oxide | BANOXANTRONE | CAS RN:136470-65-0 | UNII:W5H7E45YT3 | DrugBank ID:DB04975 | PubChem SID:198958257 | Banoxantrone | PubChem CID:9955116"
+BMGC_DG17730,BMG_DG220304,PubChem SID:461432921 | PubChem CID:9955461 | SB-267268 | CAS RN:205678-26-8 | UNII:N7AXG87WLD
+BMGC_DG17731,BMG_DG220305,GPI-1234 | CAS RN:205388-30-3 | PubChem CID:9955490 | UNII:V8NT8N7MKR | PubChem SID:443624351
+BMGC_DG17732,BMG_DG220307,"PubChem SID:434369702 | UNII:S6MPG81Y84 | DPOC-4088 | Dpoc-4088 | 2-[6-chloro-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-oxopyrazin-1-yl]-N-[(3-fluoropyridin-2-yl)methyl]acetamide | CAS RN:312904-62-4 | PubChem CID:9955534"
+BMGC_DG17733,BMG_DG220308,PubChem CID:9955578 | CAS RN:445295-04-5 | UNII:9LH034R9R9 | CP-671305 | PubChem SID:255509446
+BMGC_DG17734,BMG_DG220310,PubChem SID:198950929 | PubChem CID:9955657 | CAS RN:146978-48-5 | MOXILUBANT | UNII:2F3QKD3W17
+BMGC_DG17735,BMG_DG220316,S-(2-AMINOETHYL)CYSTEINE | CAS RN:2936-69-8 | PubChem SID:384648125 | UNII:OS2H9OH0GT | (2R)-2-amino-3-(2-aminoethylsulfanyl)propanoic acid | PubChem CID:99558 | S-(2-Aminoethyl)-L-cysteine
+BMGC_DG17736,BMG_DG220317,PubChem SID:313368851 | CAS RN:225919-29-9 | PubChem CID:9955864 | CT-2450 | UNII:LK7K48H683
+BMGC_DG17737,BMG_DG220326,"6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile | UNII:234CMT4GK4 | PubChem SID:198978381 | 6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile | CAS RN:252917-06-9 | PubChem CID:9956119 | LADUVIGLUSIB"
+BMGC_DG17738,BMG_DG220327,PubChem SID:198951121 | PubChem CID:9956127 | CAS RN:134002-60-1 | UNII:CU98Q2IL7P | CP-85958
+BMGC_DG17739,BMG_DG220328,"PubChem SID:441331255 | JDTIC | PubChem CID:9956146 | CAS RN:361444-66-8 | (3R)-7-hydroxy-N-[(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide | Jdtic | UNII:3C6FZ6UXC8"
+BMGC_DG17740,BMG_DG220331,"3,7-dimethyl-1-prop-2-ynylpurine-2,6-dione | 3,7-DIMETHYL-1-PROPARGYLXANTHINE | PubChem CID:99562 | 3,7-Dimethyl-1-propargylxanthine | UNII:5YFR5SPS6T | CAS RN:14114-46-6 | PubChem SID:198952091"
+BMGC_DG17741,BMG_DG220341,"2-Methyl-2-(4-((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazole-5-carboxamido)methyl)phenoxy)propanoic acid | 2-methyl-2-[4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carbonyl]amino]methyl]phenoxy]propanoic acid | PubChem SID:198951157 | CAS RN:622402-22-6 | PubChem CID:9956726 | UNII:QKY617BBX5 | GW-590735 | CAS RN:343321-96-0 | DrugBank ID:DB07215"
+BMGC_DG17742,BMG_DG220344,"PubChem SID:496142039 | PubChem CID:9956774 | 3-METHYL 5-(2-(METHYL(PHENYLMETHYL)AMINO)ETHYL) 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE | UNII:UG95QZ3YWA | 3-Methyl 5-[2-[methyl(phenylmethyl)amino]ethyl] 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate | CAS RN:71784-26-4"
+BMGC_DG17743,BMG_DG220348,CAS RN:187162-97-6 | PubChem SID:445499522 | PubChem CID:9956947 | L-375052 | UNII:7WVZ3C3PMQ
+BMGC_DG17744,BMG_DG220352,"DrugBank ID:DB04020 | 4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol | PubChem CID:9957008"
+BMGC_DG17745,BMG_DG220353,"PubChem SID:198969202 | PubChem CID:9957090 | 4-Thiazolecarboxamide, N-(2-(bis(1-methylethyl)amino)ethyl)-2-((2-hydroxy-4,5-dimethoxybenzoyl)amino)-, monohydrochloride | UNII:510791NN30 | ACOTIAMIDE HYDROCHLORIDE ANHYDROUS | CAS RN:185104-11-4 | N-[2-[di(propan-2-yl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxamide;hydrochloride"
+BMGC_DG17746,BMG_DG220357,CAS RN:144337-28-0 | UNII:5S62FD4P9Z | Didodecanoylphloroglucinol | DIDODECANOYLPHLOROGLUCINOL | PubChem CID:9957245 | PubChem SID:485663666
+BMGC_DG17747,BMG_DG220359,UNII:MET7ZRB8Y7 | CAS RN:357400-14-7 | NNC-55-0396 FREE BASE | PubChem SID:198963255 | PubChem CID:9957280
+BMGC_DG17748,BMG_DG220373,"PubChem CID:9958 | 4-METHYLCATECHOL | PubChem SID:198942058 | 4-Methylcatechol | 4-methylbenzene-1,2-diol | DrugBank ID:DB04120 | CAS RN:83719-41-9 | CAS RN:452-86-8 | UNII:12GLI7JGB3 | 4-Methyl-1,2-Benzenediol"
+BMGC_DG17749,BMG_DG220377,PubChem SID:443624896 | UNII:JXZ8FN7FU5 | CAS RN:673485-33-1 | LK-732 | PubChem CID:9958168
+BMGC_DG17750,BMG_DG220381,I-AB-MECA | CAS RN:152918-27-9 | PubChem SID:198986754 | PubChem CID:9958472 | UNII:9WR19428J3
+BMGC_DG17751,BMG_DG220411,PubChem SID:316917532 | PubChem CID:9959777 | UNII:81DP93CF8M | J-115814 | CAS RN:329716-61-2
+BMGC_DG17752,BMG_DG220417,PubChem CID:996 | DrugBank ID:DB03255 | Phenol | PubChem SID:175268139 | PHENOL | CAS RN:108-95-2 | CAS RN:17442-59-0 | CAS RN:27073-41-2 | phenol | CAS RN:63496-48-0 | UNII:339NCG44TV | CAS RN:73607-76-8
+BMGC_DG17753,BMG_DG220419,"PubChem SID:474490145 | 3,4-Dihydro-6-(isopropyl)-3-(4-(isopropyl)phenyl)quinazoline | PubChem CID:99600 | CAS RN:71412-21-0 | UNII:TJ7EA689VP | 3,4-DIHYDRO-6-(ISOPROPYL)-3-(4-(ISOPROPYL)PHENYL)QUINAZOLINE"
+BMGC_DG17754,BMG_DG220429,"2-[1-[2-[(3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-5H-4,1-benzoxazepin-3-yl]acetyl]piperidin-4-yl]acetic acid | LAPAQUISTAT | Lapaquistat | UNII:PEZ79BV72X | CAS RN:189059-71-0 | PubChem SID:198982652 | PubChem CID:9960389"
+BMGC_DG17755,BMG_DG220435,"tert-butyl (4S)-5-[[(2S)-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-[[(2S,3S)-3-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-5-oxopentanoate | PubChem CID:9960660 | CAS RN:158442-41-2 | Z-Ile-Glu(O-t-butyl)-Ala-Leucinal"
+BMGC_DG17756,BMG_DG220436,"Nuvaring | (8S,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy-11-methylidene-2,6,7,8,9,10,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one;(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol | CAS RN:131562-74-8 | PubChem CID:9960701"
+BMGC_DG17757,BMG_DG220445,ATECEGATRAN METOXIL | Atecegatran Metoxil | UNII:4GU1D587JV | (2S)-1-[(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyacetyl]-N-[[4-[(Z)-N'-methoxycarbamimidoyl]phenyl]methyl]azetidine-2-carboxamide | PubChem SID:198956701 | PubChem CID:9961205 | CAS RN:433937-93-0 | Atecegatran metoxil | DrugBank ID:DB12507
+BMGC_DG17758,BMG_DG220453,"PubChem CID:9961741 | Itraconazole, (R)-(-)- | PubChem SID:472424101 | ITRACONAZOLE, (R)-(-)- | CAS RN:154003-19-7 | UNII:6B8556A65Q"
+BMGC_DG17759,BMG_DG220454,UNII:61G4E2353I | BIO-1211 | PubChem SID:198945992 | PubChem CID:9961766 | CAS RN:187735-94-0
+BMGC_DG17760,BMG_DG220458,7-(2-Aminoethyl)theophylline | UNII:A8WQD8A7TZ | 7-(2-AMINOETHYL)THEOPHYLLINE | PubChem CID:99619 | PubChem SID:474490609 | CAS RN:35206-02-1
+BMGC_DG17761,BMG_DG220469,PubChem SID:198964964 | CGH-1484A FREE BASE | UNII:620VW8H64Y | PubChem CID:9962561 | CAS RN:202468-90-4
+BMGC_DG17762,BMG_DG220473,"CAS RN:341973-06-6 | Pyrrophenone | N-[[(2S,4R)-1-[2-(2,4-difluorobenzoyl)benzoyl]-4-tritylsulfanylpyrrolidin-2-yl]methyl]-4-[(E)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]benzamide | PubChem CID:9962675"
+BMGC_DG17763,BMG_DG220475,"PubChem CID:9962735 | DrugBank ID:DB11340 | Ubiquinol | 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylbenzene-1,4-diol | CAS RN:992-78-9 | UBIQUINOL | UNII:M9NL0C577Y | PubChem SID:175266755"
+BMGC_DG17764,BMG_DG220487,"PubChem CID:9963057 | CAS RN:194785-19-8 | DrugBank ID:DB05590 | 2-[[(7S)-7-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]-N,N-dimethylacetamide | BEDORADRINE | Bedoradrine | PubChem SID:198947335 | UNII:4EAR229231"
+BMGC_DG17765,BMG_DG220491,"UNII:9WQP0L619L | BIRICODAR DICITRATE | DrugBank ID:DB04851 | 1,7-dipyridin-3-ylheptan-4-yl (2S)-1-[2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl]piperidine-2-carboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid | CAS RN:174254-13-8 | Biricodar | PubChem SID:198949425 | PubChem CID:9963148 | Biricodar Dicitrate"
+BMGC_DG17766,BMG_DG220503,"PubChem CID:9963516 | CAS RN:73837-24-8 | (1R,3S,5Z)-5-[(2E)-2-[(1R,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol | CAS RN:32222-06-3 | (1R,3S,Z)-5-((E)-2-((1R,7AR)-1-((R)-6-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol"
+BMGC_DG17767,BMG_DG220525,"PubChem CID:9964493 | 4-(2-FURANYL)THIENO(3,2-D)PYRIMIDIN-2-AMINE | UNII:RH93KQ6L2N | PubChem SID:459276199 | CAS RN:443148-30-9"
+BMGC_DG17768,BMG_DG220557,IMATINIB AMINE | UNII:JR9RZF7KDS | PubChem SID:434370110 | CAS RN:152460-10-1 | PubChem CID:9965429
+BMGC_DG17769,BMG_DG220568,"1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine | DrugBank ID:DB09068 | CAS RN:508233-74-7 | UNII:3O2K1S3WQV | Vortioxetine | PubChem CID:9966051 | VORTIOXETINE | PubChem SID:175266271"
+BMGC_DG17770,BMG_DG220571,"EPITOFACITINIB, (3S,4R)- | CAS RN:1092578-48-7 | UNII:D2E2X7QH4A | PubChem CID:9966538 | PubChem SID:441583537"
+BMGC_DG17771,BMG_DG220586,"PubChem CID:9968046 | (3S,3aR,4S,4aR,8aR,9aS)-4-[(E)-2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl]-3-methyl-3a,4,4a,5,6,7,8,8a,9,9a-decahydro-3H-benzo[f][2]benzofuran-1-one"
+BMGC_DG17772,BMG_DG220596,"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide | DrugBank ID:DB06834 | PubChem CID:9968957"
+BMGC_DG17773,BMG_DG220602,"DrugBank ID:DB07008 | PubChem CID:9969613 | 4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE"
+BMGC_DG17774,BMG_DG220604,2-oxo-3-phenylpropanoic acid | PubChem SID:198966542 | CAS RN:156-06-9 | UNII:X7CO62M413 | PubChem CID:997 | DrugBank ID:DB03884 | PHENYLPYRUVIC ACID | Phenylpyruvic acid
+BMGC_DG17775,BMG_DG220605,PubChem CID:9970357 | CAS RN:677306-35-3 | FACINICLINE | UNII:6A6FX0J03K | N-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-1H-indazole-3-carboxamide | Facinicline | DrugBank ID:DB05586 | PubChem SID:198981912
+BMGC_DG17776,BMG_DG220606,"PubChem SID:478837440 | PubChem CID:9970501 | (2,3-dichloro-4-hydroxyphenyl)-thiophen-2-ylmethanone | 2,3-DICHLORO-4-HYDROXYPHENYL 2-THIENYL KETONE | 2,3-Dichloro-4-hydroxyphenyl 2-thienyl ketone | UNII:W3A25L8HC2 | CAS RN:40180-03-8"
+BMGC_DG17777,BMG_DG220614,NAPHTHALEN-1-YL(1-PENTYL-1H-PYRROL-3-YL)METHANONE | CAS RN:162934-73-8 | PubChem SID:346540970 | UNII:D3WWBII0GZ | PubChem CID:9971539
+BMGC_DG17778,BMG_DG220615,UNII:9D3DS54YCD | PubChem CID:9971547 | CAS RN:164025-33-6 | PWZ-029 | PubChem SID:459275636
+BMGC_DG17779,BMG_DG220626,RTI-112 | CAS RN:143982-09-6 | PubChem CID:9972515 | PubChem SID:441096787 | UNII:TDD7WP3S39
+BMGC_DG17780,BMG_DG220629,CAS RN:752958-88-6 | RTI-150 | PubChem SID:441583988 | UNII:Y8KCN7S6KE | PubChem CID:9972881
+BMGC_DG17781,BMG_DG220637,"PubChem SID:241180353 | 4-Hydroxycyclophosphamide | 4-HYDROXYCYCLOPHOSPHAMIDE | CAS RN:40277-05-2 | 2-[bis(2-chloroethyl)amino]-2-oxo-1,3,2lambda5-oxazaphosphinan-4-ol | CAS RN:61903-30-8 | UNII:1XBF4E50HS | PubChem CID:99735"
+BMGC_DG17782,BMG_DG220642,PubChem CID:9973893 | 2-hydroxy-3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one | UNII:8DJV9U9K61 | CAS RN:185147-17-5 | PubChem SID:316914898 | 5-HYDROXYROFECOXIB | 5-Hydroxyrofecoxib
+BMGC_DG17783,BMG_DG220652,"Pipernonaline | (2E,8E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnona-2,8-dien-1-one | PubChem CID:9974595 | CAS RN:88660-10-0"
+BMGC_DG17784,BMG_DG220661,HALOPERIDOL PYRIDINIUM | 4-[4-(4-chlorophenyl)pyridin-1-ium-1-yl]-1-(4-fluorophenyl)butan-1-one | UNII:47Z7A2W953 | PubChem SID:198938780 | Haloperidol pyridinium | PubChem CID:9975463 | CAS RN:125785-69-5
+BMGC_DG17785,BMG_DG220666,CAS RN:49665-58-9 | PubChem SID:376072768 | PubChem CID:99760 | N-CYCLOHEXYL-N'-2-PYRIDINYLUREA | UNII:JBC8B0W1J5
+BMGC_DG17786,BMG_DG220675,"UNII:4I7U5C459M | PubChem SID:333495840 | CAS RN:720691-69-0 | DrugBank ID:DB15120 | 1-(6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[D]azepin-7-YL)oxy)pyridin-3-YL)pyrrolidin-2-one | 1-[6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]pyridin-3-yl]pyrrolidin-2-one | PubChem CID:9976892 | GSK-239512"
+BMGC_DG17787,BMG_DG220684,PubChem CID:9977819 | Dovitinib | DrugBank ID:DB05928
+BMGC_DG17788,BMG_DG220685,"PubChem CID:9978312 | 3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID | DrugBank ID:DB07265"
+BMGC_DG17789,BMG_DG220686,PubChem CID:9978336 | UNII:J4IP5Z9DAU | Enprostil | CAS RN:73121-56-9 | PubChem SID:472387109 | ENPROSTIL | DrugBank ID:DB13824
+BMGC_DG17790,BMG_DG220699,Phenylacetaldehyde | PHENYLACETALDEHYDE | DrugBank ID:DB02178 | CAS RN:122-78-1 | PubChem SID:175266769 | PubChem CID:998 | 2-phenylacetaldehyde | UNII:U8J5PLW9MR
+BMGC_DG17791,BMG_DG220700,"PubChem SID:198963526 | FLUPREDNIDENE ACETATE | Fluprednidene acetate | UNII:GE65DV564S | CAS RN:1255-35-2 | PubChem CID:9980241 | DrugBank ID:DB14634 | [2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-16-methylidene-3-oxo-7,8,11,12,14,15-hexahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate"
+BMGC_DG17792,BMG_DG220708,"CAS RN:99570-78-2 | 9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylicacid, 2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-, (9S,10R,12R)- | PubChem CID:9981344 | (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylic acid"
+BMGC_DG17793,BMG_DG220709,"(15R,16S,18S)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylic acid | CAS RN:99570-78-2 | PubChem CID:9981346 | (9r,10s,12s)-2,3,9,10,11,12-Hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1h-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid"
+BMGC_DG17794,BMG_DG220710,EMPA | PubChem SID:461434420 | UNII:VT87V86D7W | Empa | N-ethyl-2-[(6-methoxypyridin-3-yl)-(2-methylphenyl)sulfonylamino]-N-(pyridin-3-ylmethyl)acetamide | PubChem CID:9981404 | CAS RN:680590-49-2
+BMGC_DG17795,BMG_DG220713,UNII:45PK2NS4NQ | PubChem SID:474492948 | HIPPURISTANOL | PubChem CID:9981822 | CAS RN:80442-78-0
+BMGC_DG17796,BMG_DG220716,CAS RN:457-87-4 | ETILAMFETAMINE | DrugBank ID:DB13285 | UNII:022YON1XMX | PubChem SID:198955218 | PubChem CID:9982 | N-ethyl-1-phenylpropan-2-amine | Etilamfetamine
+BMGC_DG17797,BMG_DG220752,"PubChem SID:443624249 | 3,4,5,6-TETRABROMO-2-(2',4'-DIBROMO-PHENOXY)-PHENOL | PubChem CID:9986835 | UNII:8K0A2EQF1O | CAS RN:111863-67-3"
+BMGC_DG17798,BMG_DG220773,CAS RN:12737-16-5 | NDC:48951-2058 | NDC:81488-002 | NDC:43742-1451 | NDC:0220-0195 | NDC:37662-3549 | NDC:48951-2059 | NDC:0220-0182 | NDC:58264-0103 | NDC:61727-304 | PubChem SID:175265470 | NDC:81488-003 | NDC:82969-2210 | ALUMINUM OXIDE | NDC:0220-0199 | NDC:43853-0041 | NDC:44911-0411 | NDC:44911-0633 | NDC:64578-0144 | NDC:37662-3546 | NDC:37662-3547 | CAS RN:12522-88-2 | NDC:48951-3191 | NDC:0220-0194 | NDC:37662-3551 | NDC:0220-0205 | CAS RN:1344-28-1 | NDC:37662-3545 | NDC:0220-0183 | NDC:37662-3548 | UNII:LMI26O6933 | NDC:0220-0215 | NDC:37662-3550 | NDC:43742-1628 | NDC:48951-2077 | NDC:57955-2817 | NDC:43406-0641 | NDC:61626-0103 | dialuminum;oxygen(2-) | NDC:64578-0143 | NDC:0220-0211 | DrugBank ID:DB11342 | NDC:0220-0198 | NDC:37662-3544 | NDC:81825-0005 | NDC:43742-2182 | NDC:53645-1380 | NDC:81488-008 | NDC:48951-2078 | NDC:58264-0037 | Aluminum oxide | NDC:64578-0174 | Aluminum Oxide | NDC:43406-0689 | PubChem CID:9989226 | NDC:15631-0022 | NDC:43406-0057 | NDC:15631-2573 | NDC:44911-0350 | NDC:58264-0109 | NDC:59985-310 | NDC:44911-0540
+BMGC_DG17799,BMG_DG220775,UNII:F8ZT2IBM1X | PubChem CID:9989505 | CAS RN:87976-03-2 | IMMETHRIDINE | PubChem SID:381132485
+BMGC_DG17800,BMG_DG220782,PHENYLACETIC ACID | Phenylacetic Acid | CAS RN:17303-65-0 | CAS RN:103-82-2 | DrugBank ID:DB09269 | PubChem CID:999 | Phenylacetic acid | UNII:ER5I1W795A | 2-phenylacetic acid | PubChem SID:175267987 | CAS RN:51146-16-8
+BMGC_DG17801,BMG_DG220784,PubChem CID:9990388 | PubChem SID:459275387 | CAS RN:184023-52-7 | FUB-349 | UNII:A9UP25GJ6E
+BMGC_DG17802,BMG_DG220796,"PubChem CID:9991833 | 3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine | DrugBank ID:DB08533"
+BMGC_DG17803,BMG_DG220812,PubChem SID:478839178 | DrugBank ID:DB08134 | 4-((6-CHLORO-2-PYRAZINYL)AMINO)BENZENESULFONAMIDE | PubChem CID:9994066 | UNII:RMT3PKK7NW | 4-[(6-Chloro-2-pyrazinyl)amino]benzenesulfonamide | CAS RN:642459-21-0 | 4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide
+BMGC_DG17804,BMG_DG220816,PubChem SID:459056110 | UNII:78XZC39FR5 | PubChem CID:9994754 | NE-21650 | CAS RN:427899-21-6
+BMGC_DG17805,BMG_DG220817,CAS RN:656261-24-4 | PubChem SID:482554066 | N-[4-[(Hydroxyamino)carbonyl]phenyl]benzenebutanamide | PubChem CID:9994848 | UNII:AF79XX2F6M | N-(4-((HYDROXYAMINO)CARBONYL)PHENYL)BENZENEBUTANAMIDE
+BMGC_DG17806,BMG_DG220818,"PubChem CID:9994897 | N-Caffeoyltyramine | DrugBank ID:DB08754 | PubChem SID:249492057 | (E)-3-(3,4-dihydroxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide | N-CAFFEOYLTYRAMINE | CAS RN:103188-48-3 | UNII:3LZ974DQ9J"
+BMGC_DG17807,BMG_DG220827,CAS RN:313972-96-2 | PubChem CID:9995904 | UNII:YRL8JC6D3Z | PubChem SID:198956305 | FAUC-299
+BMGC_DG17808,BMG_DG220830,"1-(3',4'-Dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid | UNII:C35RF1MWQZ | PubChem CID:9996409 | CAS RN:749269-83-8 | ITANAPRACED | 1-[4-(3,4-dichlorophenyl)-3-fluorophenyl]cyclopropane-1-carboxylic acid | PubChem SID:198986527"
+BMGC_DG17809,BMG_DG220840,DrugBank ID:DB08450 | N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine | PubChem CID:9998128
+BMGC_DG17810,BMG_DG220843,2-(4-PYRIDYL)THIAZOLIDINE-4-CARBOXYLIC ACID | UNII:JZU7FHG252 | CAS RN:51226-84-7 | PubChem CID:99985
+BMGC_DG17811,BMG_DG220850,"CAS RN:207279-23-0 | UNII:ISK95MWA33 | PubChem SID:443623900 | PubChem CID:9999276 | DrugBank ID:DB08299 | 4-(8-(3-NITROPHENYL)-1,7-NAPHTHYRIDIN-6-YL)BENZOIC ACID | 4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid"
+BMGC_DG17812,BMG_DG220851,PubChem CID:9999342 | CP-944629 | CAS RN:668990-94-1 | PubChem SID:472423235 | UNII:KB2ZD36HED
+BMGC_DG17813,BMG_DG220869,CAS RN:1405-87-4 | UNII:58H6RWO52I | BACITRACIN | Bacitracin | PubChem SID:175271370
+BMGC_DG17814,BMG_DG221035,DrugBank ID:DB05488 | Technetium Tc-99m ciprofloxacin | PubChem SID:175427018
+BMGC_DG17815,BMG_DG221036,PubChem SID:175427071 | DrugBank ID:DB06439 | Tyloxapol
+BMGC_DG17816,BMG_DG221037,PubChem SID:175427138 | DrugBank ID:DB08894 | Peginesatide
+BMGC_DG17817,BMG_DG221038,DrugBank ID:DB08913 | Radium Ra 223 dichloride | PubChem SID:175427151
+BMGC_DG17818,BMG_DG221788,PHYTONADIONE EPOXIDE | UNII:QK3W0KB88K | CAS RN:25486-55-9 | PubChem SID:241180364
+BMGC_DG17819,BMG_DG221945,"PubChem SID:310265216 | DrugBank ID:DB09341 | Dextrose, unspecified form"
+BMGC_DG17820,BMG_DG222063,"UNII:5Z16Y5VG9Y | BENZO(A)PYRENE-7,8-DIHYDRODIOL 9,10-EPOXIDE | CAS RN:55097-80-8 | PubChem SID:316911845"
+BMGC_DG17821,BMG_DG222252,NDC:73238-001 | CAS RN:11103-57-4 | PubChem SID:346538724 | UNII:81G40H8B0T | NDC:84558-002 | NDC:84558-003 | VITAMIN A | NDC:52000-026
+BMGC_DG17822,BMG_DG222289,PubChem SID:347827873 | DrugBank ID:DB09532 | Secretin human
+BMGC_DG17823,BMG_DG222290,DrugBank ID:DB11707 | PubChem SID:347828072 | Olaptesed Pegol
+BMGC_DG17824,BMG_DG222292,DrugBank ID:DB12578 | Lexaptepid pegol | PubChem SID:347828800
+BMGC_DG17825,BMG_DG222293,DrugBank ID:DB13178 | Inositol | PubChem SID:347829280
+BMGC_DG17826,BMG_DG222295,AZD3409 | PubChem SID:347909841 | DrugBank ID:DB04893
+BMGC_DG17827,BMG_DG222296,PubChem SID:347909842 | Lucinactant | DrugBank ID:DB04897
+BMGC_DG17828,BMG_DG222297,DrugBank ID:DB04901 | Galiximab | PubChem SID:347909843
+BMGC_DG17829,BMG_DG222299,DrugBank ID:DB04907 | PubChem SID:347909845 | Sitimagene ceradenovec
+BMGC_DG17830,BMG_DG222300,DrugBank ID:DB04914 | G17DT Immunogen | PubChem SID:347909846
+BMGC_DG17831,BMG_DG222301,Alfimeprase | DrugBank ID:DB04919 | PubChem SID:347909847
+BMGC_DG17832,BMG_DG222303,DrugBank ID:DB04925 | PubChem SID:347909849 | Desmoteplase
+BMGC_DG17833,BMG_DG222305,DrugBank ID:DB04929 | PubChem SID:347909852 | DG031
+BMGC_DG17834,BMG_DG222306,DrugBank ID:DB04941 | PubChem SID:347909853 | Crofelemer
+BMGC_DG17835,BMG_DG222308,PubChem SID:347909855 | DrugBank ID:DB04949 | Pexelizumab
+BMGC_DG17836,BMG_DG222309,PubChem SID:347909856 | DrugBank ID:DB04950 | Ranpirnase
+BMGC_DG17837,BMG_DG222311,Afelimomab | PubChem SID:347909858 | DrugBank ID:DB04956
+BMGC_DG17838,BMG_DG222312,PubChem SID:347909859 | Epratuzumab | DrugBank ID:DB04958
+BMGC_DG17839,BMG_DG222313,DrugBank ID:DB04959 | Verpasep caltespen | PubChem SID:347909860
+BMGC_DG17840,BMG_DG222314,DrugBank ID:DB04962 | PubChem SID:347909861 | Bectumomab
+BMGC_DG17841,BMG_DG222316,Oregovomab | PubChem SID:347909863 | DrugBank ID:DB04964
+BMGC_DG17842,BMG_DG222319,Reglitazar | PubChem SID:347909866 | DrugBank ID:DB04971
+BMGC_DG17843,BMG_DG222320,PubChem SID:347909867 | LErafAON | DrugBank ID:DB04973
+BMGC_DG17844,BMG_DG222321,DrugBank ID:DB04974 | Rimiducid | PubChem SID:347909868
+BMGC_DG17845,BMG_DG222323,DrugBank ID:DB04978 | SP1049C | PubChem SID:347909870
+BMGC_DG17846,BMG_DG222327,Tigapotide | DrugBank ID:DB04985 | PubChem SID:347909874
+BMGC_DG17847,BMG_DG222330,IGN311 | DrugBank ID:DB04988 | PubChem SID:347909877
+BMGC_DG17848,BMG_DG222332,PubChem SID:347909879 | DrugBank ID:DB04991 | XL784
+BMGC_DG17849,BMG_DG222335,DrugBank ID:DB04997 | PubChem SID:347909882 | ATL1102
+BMGC_DG17850,BMG_DG222336,PubChem SID:347909883 | DrugBank ID:DB04998 | AGRO100
+BMGC_DG17851,BMG_DG222339,PubChem SID:347909886 | DrugBank ID:DB05001 | PSN9301
+BMGC_DG17852,BMG_DG222340,Peptide YY (3-36) | PubChem SID:347909887 | DrugBank ID:DB05004
+BMGC_DG17853,BMG_DG222341,PubChem SID:347909889 | Adecatumumab | DrugBank ID:DB05006
+BMGC_DG17854,BMG_DG222343,XEN-2174 | DrugBank ID:DB05012 | PubChem SID:347909891
+BMGC_DG17855,BMG_DG222344,DrugBank ID:DB05014 | XL999 | PubChem SID:347909892
+BMGC_DG17856,BMG_DG222345,DrugBank ID:DB05017 | YSIL6 | PubChem SID:347909893
+BMGC_DG17857,BMG_DG222349,ATL1101 | DrugBank ID:DB05023 | PubChem SID:347909897
+BMGC_DG17858,BMG_DG222350,DrugBank ID:DB05024 | CTA018 | PubChem SID:347909898
+BMGC_DG17859,BMG_DG222353,REV131 | DrugBank ID:DB05032 | PubChem SID:347909902
+BMGC_DG17860,BMG_DG222354,DrugBank ID:DB05033 | PubChem SID:347909903 | INCB7839
+BMGC_DG17861,BMG_DG222355,PubChem SID:347909904 | Grn163l | DrugBank ID:DB05036
+BMGC_DG17862,BMG_DG222357,DrugBank ID:DB05042 | PubChem SID:347909908 | SGS518
+BMGC_DG17863,BMG_DG222359,DrugBank ID:DB05044 | PubChem SID:347909910 | PSN357
+BMGC_DG17864,BMG_DG222360,DrugBank ID:DB05046 | V1003 | PubChem SID:347909911
+BMGC_DG17865,BMG_DG222361,PubChem SID:347909912 | CX-717 | DrugBank ID:DB05047
+BMGC_DG17866,BMG_DG222362,DDP733 | PubChem SID:347909913 | DrugBank ID:DB05049
+BMGC_DG17867,BMG_DG222363,ADL5859 | DrugBank ID:DB05050 | PubChem SID:347909914
+BMGC_DG17868,BMG_DG222365,MF101 | DrugBank ID:DB05052 | PubChem SID:347909916
+BMGC_DG17869,BMG_DG222373,PubChem SID:347909924 | INCB13739 | DrugBank ID:DB05064
+BMGC_DG17870,BMG_DG222375,DrugBank ID:DB05069 | PubChem SID:347909926 | ATG003
+BMGC_DG17871,BMG_DG222376,DrugBank ID:DB05070 | ADX10059 | PubChem SID:347909927
+BMGC_DG17872,BMG_DG222378,PubChem SID:347909929 | AV608 | DrugBank ID:DB05072
+BMGC_DG17873,BMG_DG222379,DrugBank ID:DB05077 | PubChem SID:347909931 | SLV319
+BMGC_DG17874,BMG_DG222380,AER001 | DrugBank ID:DB05078 | PubChem SID:347909932
+BMGC_DG17875,BMG_DG222381,HY10275 | DrugBank ID:DB05079 | PubChem SID:347909933
+BMGC_DG17876,BMG_DG222382,PubChem SID:347909934 | OBE101 | DrugBank ID:DB05080
+BMGC_DG17877,BMG_DG222385,Abaloparatide | PubChem SID:347909937 | DrugBank ID:DB05084
+BMGC_DG17878,BMG_DG222388,M0002 | PubChem SID:347909940 | DrugBank ID:DB05091
+BMGC_DG17879,BMG_DG222389,DrugBank ID:DB05092 | CDP323 | PubChem SID:347909941
+BMGC_DG17880,BMG_DG222391,PubChem SID:347909943 | DrugBank ID:DB05096 | LY2140023
+BMGC_DG17881,BMG_DG222392,Labetuzumab | DrugBank ID:DB05097 | PubChem SID:347909944
+BMGC_DG17882,BMG_DG222393,PubChem SID:347909945 | Leptin | DrugBank ID:DB05098
+BMGC_DG17883,BMG_DG222394,Ancrod | DrugBank ID:DB05099 | PubChem SID:347909946
+BMGC_DG17884,BMG_DG222395,Matuzumab | DrugBank ID:DB05101 | PubChem SID:347909947
+BMGC_DG17885,BMG_DG222398,DrugBank ID:DB05110 | PubChem SID:347909950 | VIR201
+BMGC_DG17886,BMG_DG222399,Fontolizumab | DrugBank ID:DB05111 | PubChem SID:347909951
+BMGC_DG17887,BMG_DG222403,DrugBank ID:DB05115 | NN344 | PubChem SID:347909955
+BMGC_DG17888,BMG_DG222406,PubChem SID:347909958 | AT1391 | DrugBank ID:DB05120
+BMGC_DG17889,BMG_DG222407,DrugBank ID:DB05121 | 1D09C3 | PubChem SID:347909959
+BMGC_DG17890,BMG_DG222408,PubChem SID:347909960 | DrugBank ID:DB05122 | R1295
+BMGC_DG17891,BMG_DG222410,DrugBank ID:DB05125 | SC12267 | PubChem SID:347909962
+BMGC_DG17892,BMG_DG222412,DrugBank ID:DB05127 | ANA971 | PubChem SID:347909964
+BMGC_DG17893,BMG_DG222413,PubChem SID:347909965 | DrugBank ID:DB05130 | INCB3284
+BMGC_DG17894,BMG_DG222414,DrugBank ID:DB05131 | PubChem SID:347909966 | TTP889
+BMGC_DG17895,BMG_DG222416,PubChem SID:347909968 | DrugBank ID:DB05133 | VP025
+BMGC_DG17896,BMG_DG222418,DrugBank ID:DB05136 | Bavituximab | PubChem SID:347909970
+BMGC_DG17897,BMG_DG222420,DrugBank ID:DB05139 | CR002 | PubChem SID:347909972
+BMGC_DG17898,BMG_DG222422,PubChem SID:347909974 | LY2181308 | DrugBank ID:DB05141
+BMGC_DG17899,BMG_DG222423,ND7001 | PubChem SID:347909975 | DrugBank ID:DB05142
+BMGC_DG17900,BMG_DG222424,PubChem SID:347909976 | DrugBank ID:DB05144 | PEV3A
+BMGC_DG17901,BMG_DG222426,XL820 | DrugBank ID:DB05146 | PubChem SID:347909978
+BMGC_DG17902,BMG_DG222427,CYT997 | DrugBank ID:DB05147 | PubChem SID:347909979
+BMGC_DG17903,BMG_DG222429,PubChem SID:347909981 | XL844 | DrugBank ID:DB05149
+BMGC_DG17904,BMG_DG222430,DrugBank ID:DB05150 | CAD106 | PubChem SID:347909982
+BMGC_DG17905,BMG_DG222432,PubChem SID:347909984 | DrugBank ID:DB05152 | NGX267
+BMGC_DG17906,BMG_DG222434,KC706 | DrugBank ID:DB05157 | PubChem SID:347909986
+BMGC_DG17907,BMG_DG222436,PubChem SID:347909988 | DrugBank ID:DB05159 | CCX915
+BMGC_DG17908,BMG_DG222438,PubChem SID:347909990 | DrugBank ID:DB05161 | Elafin
+BMGC_DG17909,BMG_DG222441,LY2275796 | PubChem SID:347909993 | DrugBank ID:DB05165
+BMGC_DG17910,BMG_DG222442,DrugBank ID:DB05166 | PubChem SID:347909994 | APD668
+BMGC_DG17911,BMG_DG222444,DrugBank ID:DB05169 | AT9283 | PubChem SID:347909996
+BMGC_DG17912,BMG_DG222449,DrugBank ID:DB05177 | PubChem SID:347910001 | DG051
+BMGC_DG17913,BMG_DG222455,MLN0415 | DrugBank ID:DB05183 | PubChem SID:347910007
+BMGC_DG17914,BMG_DG222456,DrugBank ID:DB05184 | PubChem SID:347910008 | XL228
+BMGC_DG17915,BMG_DG222458,KD3010 | PubChem SID:347910010 | DrugBank ID:DB05188
+BMGC_DG17916,BMG_DG222460,XL281 | DrugBank ID:DB05190 | PubChem SID:347910012
+BMGC_DG17917,BMG_DG222461,DrugBank ID:DB05191 | PubChem SID:347910013 | Atl146e
+BMGC_DG17918,BMG_DG222462,DrugBank ID:DB05192 | MB07811 | PubChem SID:347910014
+BMGC_DG17919,BMG_DG222463,DrugBank ID:DB05194 | KB002 | PubChem SID:347910015
+BMGC_DG17920,BMG_DG222466,CYC116 | PubChem SID:347910018 | DrugBank ID:DB05198
+BMGC_DG17921,BMG_DG222467,LX1031 | PubChem SID:347910019 | DrugBank ID:DB05199
+BMGC_DG17922,BMG_DG222468,DrugBank ID:DB05200 | PubChem SID:347910020 | AT2220
+BMGC_DG17923,BMG_DG222469,PubChem SID:347910021 | DrugBank ID:DB05201 | V24343
+BMGC_DG17924,BMG_DG222470,Egaptivon pegol | DrugBank ID:DB05202 | PubChem SID:347910022
+BMGC_DG17925,BMG_DG222471,SPP1148 | DrugBank ID:DB05203 | PubChem SID:347910023
+BMGC_DG17926,BMG_DG222472,DrugBank ID:DB05204 | PubChem SID:347910024 | XL418
+BMGC_DG17927,BMG_DG222473,PubChem SID:347910025 | DrugBank ID:DB05205 | CX157
+BMGC_DG17928,BMG_DG222474,DrugBank ID:DB05207 | SD118 | PubChem SID:347910026
+BMGC_DG17929,BMG_DG222475,DrugBank ID:DB05209 | Rozrolimupab | PubChem SID:347910027
+BMGC_DG17930,BMG_DG222476,DrugBank ID:DB05210 | SF1126 | PubChem SID:347910028
+BMGC_DG17931,BMG_DG222478,PubChem SID:347910030 | DrugBank ID:DB05214 | KD7040
+BMGC_DG17932,BMG_DG222479,DrugBank ID:DB05217 | GMX1777 | PubChem SID:347910031
+BMGC_DG17933,BMG_DG222480,PN0621 | PubChem SID:347910032 | DrugBank ID:DB05218
+BMGC_DG17934,BMG_DG222483,PubChem SID:347910035 | AM103 | DrugBank ID:DB05225
+BMGC_DG17935,BMG_DG222485,APD791 | DrugBank ID:DB05227 | PubChem SID:347910037
+BMGC_DG17936,BMG_DG222488,DrugBank ID:DB05233 | AP1081 | PubChem SID:347910040
+BMGC_DG17937,BMG_DG222489,NRP409 | PubChem SID:347910041 | DrugBank ID:DB05235
+BMGC_DG17938,BMG_DG222492,DrugBank ID:DB05241 | PubChem SID:347910044 | XL765
+BMGC_DG17939,BMG_DG222494,PubChem SID:347910046 | XL019 | DrugBank ID:DB05243
+BMGC_DG17940,BMG_DG222496,FavId | DrugBank ID:DB05249 | PubChem SID:347910048
+BMGC_DG17941,BMG_DG222497,PubChem SID:347910049 | DrugBank ID:DB05253 | Telapristone acetate
+BMGC_DG17942,BMG_DG222498,PubChem SID:347910050 | Fibrinolysin | DrugBank ID:DB05254
+BMGC_DG17943,BMG_DG222500,Interferon alfa | DrugBank ID:DB05258 | PubChem SID:347910052
+BMGC_DG17944,BMG_DG222501,NPI 32101 | PubChem SID:347910053 | DrugBank ID:DB05264
+BMGC_DG17945,BMG_DG222502,PubChem SID:347910054 | DrugBank ID:DB05268 | iCo-007
+BMGC_DG17946,BMG_DG222503,Hepatitis B immune globulin | DrugBank ID:DB05276 | PubChem SID:347910055
+BMGC_DG17947,BMG_DG222504,MCC | PubChem SID:347910057 | DrugBank ID:DB05282
+BMGC_DG17948,BMG_DG222506,SPP 301 | DrugBank ID:DB05290 | PubChem SID:347910059
+BMGC_DG17949,BMG_DG222509,Keyhole limpet hemocyanin | DrugBank ID:DB05299 | PubChem SID:347910062
+BMGC_DG17950,BMG_DG222511,LAX-101 | DrugBank ID:DB05301 | PubChem SID:347910064
+BMGC_DG17951,BMG_DG222512,DrugBank ID:DB05303 | PubChem SID:347910065 | OMS-103HP
+BMGC_DG17952,BMG_DG222513,DrugBank ID:DB05304 | Girentuximab | PubChem SID:347910066
+BMGC_DG17953,BMG_DG222514,Cintredekin besudotox | PubChem SID:347910067 | DrugBank ID:DB05305
+BMGC_DG17954,BMG_DG222515,PubChem SID:347910068 | Alferminogene tadenovec | DrugBank ID:DB05306
+BMGC_DG17955,BMG_DG222516,DrugBank ID:DB05308 | PubChem SID:347910070 | ANX-510
+BMGC_DG17956,BMG_DG222517,PubChem SID:347910071 | DrugBank ID:DB05309 | TP-508
+BMGC_DG17957,BMG_DG222519,DrugBank ID:DB05311 | PubChem SID:347910073 | Ecallantide
+BMGC_DG17958,BMG_DG222523,DrugBank ID:DB05317 | PubChem SID:347910077 | TAK-475
+BMGC_DG17959,BMG_DG222524,Oportuzumab monatox | PubChem SID:347910078 | DrugBank ID:DB05319
+BMGC_DG17960,BMG_DG222526,PubChem SID:347910080 | DrugBank ID:DB05321 | PEG-uricase
+BMGC_DG17961,BMG_DG222528,PubChem SID:347910082 | DrugBank ID:DB05325 | INGN 225
+BMGC_DG17962,BMG_DG222533,PubChem SID:347910087 | DrugBank ID:DB05332 | Romiplostim
+BMGC_DG17963,BMG_DG222535,PubChem SID:347910089 | DrugBank ID:DB05336 | Obiltoxaximab
+BMGC_DG17964,BMG_DG222536,SOT-107 | PubChem SID:347910090 | DrugBank ID:DB05337
+BMGC_DG17965,BMG_DG222538,PubChem SID:347910093 | DrugBank ID:DB05345 | SO-101
+BMGC_DG17966,BMG_DG222540,PubChem SID:347910096 | Fx-1006A | DrugBank ID:DB05352
+BMGC_DG17967,BMG_DG222542,SR-123781A | DrugBank ID:DB05361 | PubChem SID:347910098
+BMGC_DG17968,BMG_DG222543,SSR-126517E | PubChem SID:347910099 | DrugBank ID:DB05362
+BMGC_DG17969,BMG_DG222545,ROX-888 | DrugBank ID:DB05364 | PubChem SID:347910101
+BMGC_DG17970,BMG_DG222546,Actelion-1 | DrugBank ID:DB05367 | PubChem SID:347910103
+BMGC_DG17971,BMG_DG222548,DrugBank ID:DB05369 | PubChem SID:347910105 | HZT-501
+BMGC_DG17972,BMG_DG222550,DrugBank ID:DB05374 | PubChem SID:347910109 | Rindopepimut
+BMGC_DG17973,BMG_DG222552,Regramostim | PubChem SID:347910111 | DrugBank ID:DB05386
+BMGC_DG17974,BMG_DG222553,PubChem SID:347910112 | Neovastat | DrugBank ID:DB05387
+BMGC_DG17975,BMG_DG222554,PubChem SID:347910113 | DrugBank ID:DB05390 | INS 316
+BMGC_DG17976,BMG_DG222555,PubChem SID:347910114 | DrugBank ID:DB05391 | Liposomal prostaglandin E1
+BMGC_DG17977,BMG_DG222558,DrugBank ID:DB05396 | Albinterferon Alfa-2B | PubChem SID:347910117
+BMGC_DG17978,BMG_DG222560,AZD 3355 | PubChem SID:347910120 | DrugBank ID:DB05404
+BMGC_DG17979,BMG_DG222561,PubChem SID:347910121 | DrugBank ID:DB05405 | XTL-001
+BMGC_DG17980,BMG_DG222563,TBC-3711 | PubChem SID:347910123 | DrugBank ID:DB05407
+BMGC_DG17981,BMG_DG222566,DrugBank ID:DB05415 | OSI-461 | PubChem SID:347910126
+BMGC_DG17982,BMG_DG222567,PubChem SID:347910127 | DrugBank ID:DB05417 | GW 468816
+BMGC_DG17983,BMG_DG222568,PubChem SID:347910128 | DrugBank ID:DB05418 | GW 597599
+BMGC_DG17984,BMG_DG222569,ADX-10061 | DrugBank ID:DB05419 | PubChem SID:347910129
+BMGC_DG17985,BMG_DG222570,OPC-14523 | PubChem SID:347910130 | DrugBank ID:DB05422
+BMGC_DG17986,BMG_DG222572,DrugBank ID:DB05429 | PubChem SID:347910132 | Bertilimumab
+BMGC_DG17987,BMG_DG222574,DrugBank ID:DB05431 | PubChem SID:347910134 | MLN-977
+BMGC_DG17988,BMG_DG222575,PubChem SID:347910135 | DrugBank ID:DB05432 | DAS-431 IV
+BMGC_DG17989,BMG_DG222577,DrugBank ID:DB05437 | NAV 1800 | PubChem SID:347910137
+BMGC_DG17990,BMG_DG222580,PubChem SID:347910140 | SRP 299 | DrugBank ID:DB05440
+BMGC_DG17991,BMG_DG222582,DrugBank ID:DB05443 | PubChem SID:347910142 | ADL 10-0101
+BMGC_DG17992,BMG_DG222584,PubChem SID:347910144 | AVI-4557 | DrugBank ID:DB05447
+BMGC_DG17993,BMG_DG222585,FM-VP4 | PubChem SID:347910145 | DrugBank ID:DB05449
+BMGC_DG17994,BMG_DG222587,DrugBank ID:DB05451 | PubChem SID:347910147 | P54
+BMGC_DG17995,BMG_DG222588,DrugBank ID:DB05452 | PubChem SID:347910148 | PH-284
+BMGC_DG17996,BMG_DG222589,DrugBank ID:DB05455 | PubChem SID:347910149 | SR 121463
+BMGC_DG17997,BMG_DG222590,OSI-7904L | PubChem SID:347910150 | DrugBank ID:DB05457
+BMGC_DG17998,BMG_DG222591,PubChem SID:347910151 | DrugBank ID:DB05459 | Briakinumab
+BMGC_DG17999,BMG_DG222592,ISS-1018 | DrugBank ID:DB05463 | PubChem SID:347910152
+BMGC_DG18000,BMG_DG222593,PubChem SID:347910153 | NOX-700 | DrugBank ID:DB05464
+BMGC_DG18001,BMG_DG222594,PubChem SID:347910154 | R673 | DrugBank ID:DB05466
+BMGC_DG18002,BMG_DG222595,DrugBank ID:DB05468 | PubChem SID:347910156 | R411
+BMGC_DG18003,BMG_DG222596,R450 | PubChem SID:347910157 | DrugBank ID:DB05469
+BMGC_DG18004,BMG_DG222597,DrugBank ID:DB05471 | PubChem SID:347910158 | SGN-30
+BMGC_DG18005,BMG_DG222598,PubChem SID:347910159 | Human interferon omega-1 | DrugBank ID:DB05472
+BMGC_DG18006,BMG_DG222603,PubChem SID:347910164 | Recombinant alpha 1-antitrypsin | DrugBank ID:DB05481
+BMGC_DG18007,BMG_DG222604,DrugBank ID:DB05483 | PubChem SID:347910165 | Picolinic acid
+BMGC_DG18008,BMG_DG222605,PubChem SID:347910166 | DrugBank ID:DB05484 | MDX-018
+BMGC_DG18009,BMG_DG222607,Custirsen | PubChem SID:347910168 | DrugBank ID:DB05487
+BMGC_DG18010,BMG_DG222611,PubChem SID:347910172 | PG-530742 | DrugBank ID:DB05495
+BMGC_DG18011,BMG_DG222612,DrugBank ID:DB05496 | PubChem SID:347910173 | Otelixizumab
+BMGC_DG18012,BMG_DG222616,PubChem SID:347910177 | DrugBank ID:DB05505 | NM-702
+BMGC_DG18013,BMG_DG222617,PubChem SID:347910178 | DrugBank ID:DB05506 | ISIS 113715
+BMGC_DG18014,BMG_DG222618,VX-765 | DrugBank ID:DB05507 | PubChem SID:347910179
+BMGC_DG18015,BMG_DG222619,PubChem SID:347910180 | DrugBank ID:DB05509 | LI-301
+BMGC_DG18016,BMG_DG222621,PubChem SID:347910183 | Ramucirumab | DrugBank ID:DB05578
+BMGC_DG18017,BMG_DG222622,Farletuzumab | PubChem SID:347910184 | DrugBank ID:DB05595
+BMGC_DG18018,BMG_DG222625,DrugBank ID:DB05662 | PubChem SID:347910187 | NP-50301
+BMGC_DG18019,BMG_DG222627,DrugBank ID:DB05675 | EP-2104R | PubChem SID:347910189
+BMGC_DG18020,BMG_DG222628,DrugBank ID:DB05679 | Ustekinumab | PubChem SID:347910190
+BMGC_DG18021,BMG_DG222629,FX06 | DrugBank ID:DB05685 | PubChem SID:347910191
+BMGC_DG18022,BMG_DG222630,PubChem SID:347910192 | BL-1020 | DrugBank ID:DB05687
+BMGC_DG18023,BMG_DG222631,CRx-119 | DrugBank ID:DB05688 | PubChem SID:347910193
+BMGC_DG18024,BMG_DG222633,PubChem SID:347910195 | DrugBank ID:DB05712 | AZD-9684
+BMGC_DG18025,BMG_DG222634,PubChem SID:347910196 | DrugBank ID:DB05718 | Maxy-G34
+BMGC_DG18026,BMG_DG222639,DrugBank ID:DB05736 | MIV-701 | PubChem SID:347910201
+BMGC_DG18027,BMG_DG222640,CYT006-AngQb | PubChem SID:347910202 | DrugBank ID:DB05739
+BMGC_DG18028,BMG_DG222641,RPI-78M | PubChem SID:347910203 | DrugBank ID:DB05740
+BMGC_DG18029,BMG_DG222644,PubChem SID:347910206 | CRx-139 | DrugBank ID:DB05744
+BMGC_DG18030,BMG_DG222647,MPI-674 | PubChem SID:347910209 | DrugBank ID:DB05749
+BMGC_DG18031,BMG_DG222648,DrugBank ID:DB05750 | Drinabant | PubChem SID:347910210
+BMGC_DG18032,BMG_DG222650,PubChem SID:347910212 | ALKS 27 | DrugBank ID:DB05752
+BMGC_DG18033,BMG_DG222656,CYT007-TNFQb | PubChem SID:347910218 | DrugBank ID:DB05758
+BMGC_DG18034,BMG_DG222658,DrugBank ID:DB05766 | PubChem SID:347910220 | Norclozapine
+BMGC_DG18035,BMG_DG222659,PubChem SID:347910221 | DrugBank ID:DB05768 | Alkaline Phosphatase
+BMGC_DG18036,BMG_DG222661,PubChem SID:347910223 | LLL-3348 | DrugBank ID:DB05771
+BMGC_DG18037,BMG_DG222662,DrugBank ID:DB05773 | Trastuzumab emtansine | PubChem SID:347910224
+BMGC_DG18038,BMG_DG222665,DrugBank ID:DB05777 | Thrombomodulin Alfa | PubChem SID:347910227
+BMGC_DG18039,BMG_DG222668,DrugBank ID:DB05785 | LGD-1550 | PubChem SID:347910230
+BMGC_DG18040,BMG_DG222669,PubChem SID:347910231 | DrugBank ID:DB05787 | LM-609
+BMGC_DG18041,BMG_DG222671,PRO-542 | DrugBank ID:DB05793 | PubChem SID:347910233
+BMGC_DG18042,BMG_DG222673,TNX-901 | DrugBank ID:DB05797 | PubChem SID:347910236
+BMGC_DG18043,BMG_DG222674,PubChem SID:347910237 | GEM-231 | DrugBank ID:DB05798
+BMGC_DG18044,BMG_DG222676,GTI 2040 | PubChem SID:347910239 | DrugBank ID:DB05801
+BMGC_DG18045,BMG_DG222692,DrugBank ID:DB05829 | Parathyroid hormone | PubChem SID:347910255
+BMGC_DG18046,BMG_DG222693,DrugBank ID:DB05831 | PubChem SID:347910256 | ING-1
+BMGC_DG18047,BMG_DG222702,DrugBank ID:DB05846 | Mito-4509 | PubChem SID:347910266
+BMGC_DG18048,BMG_DG222703,DrugBank ID:DB05848 | PubChem SID:347910267 | humanized SMART Anti-IL-12 Antibody
+BMGC_DG18049,BMG_DG222704,DrugBank ID:DB05849 | NCX 950 | PubChem SID:347910268
+BMGC_DG18050,BMG_DG222707,PubChem SID:347910271 | CLX-0921 | DrugBank ID:DB05854
+BMGC_DG18051,BMG_DG222712,DrugBank ID:DB05860 | PubChem SID:347910276 | Peginterferon alfacon-1
+BMGC_DG18052,BMG_DG222716,99mTc-14 F7 Mab | DrugBank ID:DB05867 | PubChem SID:347910280
+BMGC_DG18053,BMG_DG222719,PubChem SID:347910284 | AEOL-10150 | DrugBank ID:DB05874
+BMGC_DG18054,BMG_DG222720,"PubChem SID:347910285 | Sar9, Met (O2)11-Substance P | DrugBank ID:DB05875"
+BMGC_DG18055,BMG_DG222721,DrugBank ID:DB05879 | AME-527 | PubChem SID:347910288
+BMGC_DG18056,BMG_DG222724,DrugBank ID:DB05882 | PubChem SID:347910291 | CHF 4227
+BMGC_DG18057,BMG_DG222725,PubChem SID:347910292 | ABX-PTH | DrugBank ID:DB05883
+BMGC_DG18058,BMG_DG222729,Inotuzumab ozogamicin | DrugBank ID:DB05889 | PubChem SID:347910296
+BMGC_DG18059,BMG_DG222730,PubChem SID:347910297 | Veglin | DrugBank ID:DB05890
+BMGC_DG18060,BMG_DG222731,RI 624 | PubChem SID:347910298 | DrugBank ID:DB05892
+BMGC_DG18061,BMG_DG222733,DrugBank ID:DB05895 | PubChem SID:347910300 | HGS-TR2J
+BMGC_DG18062,BMG_DG222735,DrugBank ID:DB05897 | PubChem SID:347910302 | rhIGFBP-3
+BMGC_DG18063,BMG_DG222739,PubChem SID:347910306 | DrugBank ID:DB05905 | TD-2749
+BMGC_DG18064,BMG_DG222740,CCR5 mAb | DrugBank ID:DB05906 | PubChem SID:347910307
+BMGC_DG18065,BMG_DG222743,Stamulumab | DrugBank ID:DB05915 | PubChem SID:347910311
+BMGC_DG18066,BMG_DG222744,CT-011 | PubChem SID:347910312 | DrugBank ID:DB05916
+BMGC_DG18067,BMG_DG222747,RTA 744 | PubChem SID:347910315 | DrugBank ID:DB05920
+BMGC_DG18068,BMG_DG222750,DrugBank ID:DB05930 | PubChem SID:347910318 | SB-559448
+BMGC_DG18069,BMG_DG222751,DrugBank ID:DB06014 | Eteplirsen | PubChem SID:347910319
+BMGC_DG18070,BMG_DG222753,DrugBank ID:DB06042 | PubChem SID:347910321 | ZEN-012
+BMGC_DG18071,BMG_DG222754,PubChem SID:347910322 | Olaratumab | DrugBank ID:DB06043
+BMGC_DG18072,BMG_DG222757,PubChem SID:347910325 | KAI-1455 | DrugBank ID:DB06064
+BMGC_DG18073,BMG_DG222758,DrugBank ID:DB06069 | PubChem SID:347910326 | XMT-1001
+BMGC_DG18074,BMG_DG222760,CTS-21166 | DrugBank ID:DB06073 | PubChem SID:347910328
+BMGC_DG18075,BMG_DG222761,PubChem SID:347910329 | DrugBank ID:DB06080 | Linifanib
+BMGC_DG18076,BMG_DG222762,PubChem SID:347910330 | DrugBank ID:DB06089 | ICA-105665
+BMGC_DG18077,BMG_DG222764,NXN-188 | PubChem SID:347910332 | DrugBank ID:DB06096
+BMGC_DG18078,BMG_DG222765,GSK-923295 | DrugBank ID:DB06097 | PubChem SID:347910333
+BMGC_DG18079,BMG_DG222766,DrugBank ID:DB06098 | PubChem SID:347910334 | PRLX 93936
+BMGC_DG18080,BMG_DG222767,PubChem SID:347910335 | IMC-1C11 | DrugBank ID:DB06101
+BMGC_DG18081,BMG_DG222768,VX-148 | DrugBank ID:DB06103 | PubChem SID:347910336
+BMGC_DG18082,BMG_DG222769,Bisegliptin | PubChem SID:347910337 | DrugBank ID:DB06127
+BMGC_DG18083,BMG_DG222772,DrugBank ID:DB06168 | Canakinumab | PubChem SID:347910340
+BMGC_DG18084,BMG_DG222773,DrugBank ID:DB06186 | PubChem SID:347910341 | Ipilimumab
+BMGC_DG18085,BMG_DG222774,Hyaluronidase (human recombinant) | PubChem SID:347910342 | DrugBank ID:DB06205
+BMGC_DG18086,BMG_DG222775,Sulodexide | DrugBank ID:DB06271 | PubChem SID:347910343
+BMGC_DG18087,BMG_DG222776,PubChem SID:347910344 | Tocilizumab | DrugBank ID:DB06273
+BMGC_DG18088,BMG_DG222777,PubChem SID:347910345 | Ziconotide | DrugBank ID:DB06283
+BMGC_DG18089,BMG_DG222778,Teriparatide | DrugBank ID:DB06285 | PubChem SID:347910346
+BMGC_DG18090,BMG_DG222779,DrugBank ID:DB06317 | PubChem SID:347910347 | Elotuzumab
+BMGC_DG18091,BMG_DG222780,PubChem SID:347910348 | Pertuzumab | DrugBank ID:DB06366
+BMGC_DG18092,BMG_DG222781,DrugBank ID:DB06372 | PubChem SID:347910349 | Rilonacept
+BMGC_DG18093,BMG_DG222782,DrugBank ID:DB06404 | Human C1-esterase inhibitor | PubChem SID:347910350
+BMGC_DG18094,BMG_DG222783,Calfactant | PubChem SID:347910351 | DrugBank ID:DB06415
+BMGC_DG18095,BMG_DG222784,PubChem SID:347910352 | Reslizumab | DrugBank ID:DB06602
+BMGC_DG18096,BMG_DG222785,DrugBank ID:DB06612 | Mepolizumab | PubChem SID:347910353
+BMGC_DG18097,BMG_DG222786,PubChem SID:347910354 | Denosumab | DrugBank ID:DB06643
+BMGC_DG18098,BMG_DG222787,PubChem SID:347910355 | DrugBank ID:DB06650 | Ofatumumab
+BMGC_DG18099,BMG_DG222788,PubChem SID:347910356 | Liraglutide | DrugBank ID:DB06655
+BMGC_DG18100,BMG_DG222789,DrugBank ID:DB06674 | Golimumab | PubChem SID:347910358
+BMGC_DG18101,BMG_DG222790,PubChem SID:347910359 | DrugBank ID:DB06681 | Belatacept
+BMGC_DG18102,BMG_DG222791,Sipuleucel-T | PubChem SID:347910360 | DrugBank ID:DB06688
+BMGC_DG18103,BMG_DG222792,Aprotinin | PubChem SID:347910361 | DrugBank ID:DB06692
+BMGC_DG18104,BMG_DG222793,DrugBank ID:DB06719 | Buserelin | PubChem SID:347910362
+BMGC_DG18105,BMG_DG222794,PubChem SID:347910363 | DrugBank ID:DB06720 | Velaglucerase alfa
+BMGC_DG18106,BMG_DG222795,PubChem SID:347910364 | Bafilomycin B1 | DrugBank ID:DB06734
+BMGC_DG18107,BMG_DG222796,DrugBank ID:DB06752 | Chymopapain | PubChem SID:347910365
+BMGC_DG18108,BMG_DG222797,PubChem SID:347910366 | DrugBank ID:DB06754 | Danaparoid
+BMGC_DG18109,BMG_DG222798,PubChem SID:347910367 | DrugBank ID:DB06759 | Fomivirsen
+BMGC_DG18110,BMG_DG222799,Sacrosidase | DrugBank ID:DB06760 | PubChem SID:347910368
+BMGC_DG18111,BMG_DG222800,DrugBank ID:DB06761 | Beractant | PubChem SID:347910369
+BMGC_DG18112,BMG_DG222801,DrugBank ID:DB06773 | Human calcitonin | PubChem SID:347910370
+BMGC_DG18113,BMG_DG222802,DrugBank ID:DB06779 | PubChem SID:347910371 | Dalteparin
+BMGC_DG18114,BMG_DG222803,PubChem SID:347910372 | DrugBank ID:DB06812 | Povidone-iodine
+BMGC_DG18115,BMG_DG222804,Tinzaparin | PubChem SID:347910373 | DrugBank ID:DB06822
+BMGC_DG18116,BMG_DG222805,DrugBank ID:DB08813 | Nadroparin | PubChem SID:347910374
+BMGC_DG18117,BMG_DG222806,Cholecystokinin | PubChem SID:347910375 | DrugBank ID:DB08862
+BMGC_DG18118,BMG_DG222807,Brentuximab vedotin | PubChem SID:347910376 | DrugBank ID:DB08870
+BMGC_DG18119,BMG_DG222808,Taliglucerase alfa | PubChem SID:347910377 | DrugBank ID:DB08876
+BMGC_DG18120,BMG_DG222809,Belimumab | DrugBank ID:DB08879 | PubChem SID:347910378
+BMGC_DG18121,BMG_DG222810,Aflibercept | PubChem SID:347910379 | DrugBank ID:DB08885
+BMGC_DG18122,BMG_DG222811,PubChem SID:347910380 | DrugBank ID:DB08886 | Asparaginase Erwinia chrysanthemi
+BMGC_DG18123,BMG_DG222812,PubChem SID:347910381 | DrugBank ID:DB08888 | Ocriplasmin
+BMGC_DG18124,BMG_DG222813,Glucarpidase | PubChem SID:347910382 | DrugBank ID:DB08898
+BMGC_DG18125,BMG_DG222814,DrugBank ID:DB08900 | Teduglutide | PubChem SID:347910383
+BMGC_DG18126,BMG_DG222815,DrugBank ID:DB08902 | Raxibacumab | PubChem SID:347910384
+BMGC_DG18127,BMG_DG222816,Certolizumab pegol | PubChem SID:347910385 | DrugBank ID:DB08904
+BMGC_DG18128,BMG_DG222817,PubChem SID:347910386 | DrugBank ID:DB08917 | Ferric carboxymaltose
+BMGC_DG18129,BMG_DG222818,Adrafinil | DrugBank ID:DB08925 | PubChem SID:347910387
+BMGC_DG18130,BMG_DG222819,PubChem SID:347910388 | DrugBank ID:DB08935 | Obinutuzumab
+BMGC_DG18131,BMG_DG222821,DrugBank ID:DB09029 | Secukinumab | PubChem SID:347910391
+BMGC_DG18132,BMG_DG222822,DrugBank ID:DB09033 | Vedolizumab | PubChem SID:347910392
+BMGC_DG18133,BMG_DG222823,PubChem SID:347910393 | Nivolumab | DrugBank ID:DB09035
+BMGC_DG18134,BMG_DG222824,PubChem SID:347910394 | Siltuximab | DrugBank ID:DB09036
+BMGC_DG18135,BMG_DG222825,Pembrolizumab | DrugBank ID:DB09037 | PubChem SID:347910395
+BMGC_DG18136,BMG_DG222826,Albiglutide | DrugBank ID:DB09043 | PubChem SID:347910396
+BMGC_DG18137,BMG_DG222827,DrugBank ID:DB09045 | Dulaglutide | PubChem SID:347910397
+BMGC_DG18138,BMG_DG222828,PubChem SID:347910398 | DrugBank ID:DB09046 | Metreleptin
+BMGC_DG18139,BMG_DG222829,PubChem SID:347910399 | DrugBank ID:DB09051 | Elosulfase alfa
+BMGC_DG18140,BMG_DG222830,PubChem SID:347910400 | Blinatumomab | DrugBank ID:DB09052
+BMGC_DG18141,BMG_DG222831,DrugBank ID:DB09057 | Anthrax immune globulin human | PubChem SID:347910401
+BMGC_DG18142,BMG_DG222832,Dinutuximab | DrugBank ID:DB09077 | PubChem SID:347910402
+BMGC_DG18143,BMG_DG222833,DrugBank ID:DB09098 | Somatrem | PubChem SID:347910403
+BMGC_DG18144,BMG_DG222834,"Thyroid, porcine | DrugBank ID:DB09100 | PubChem SID:347910404"
+BMGC_DG18145,BMG_DG222835,Ancestim | DrugBank ID:DB09103 | PubChem SID:347910405
+BMGC_DG18146,BMG_DG222836,Asfotase alfa | DrugBank ID:DB09105 | PubChem SID:347910406
+BMGC_DG18147,BMG_DG222837,Hydroxyethyl Starch | PubChem SID:347910407 | DrugBank ID:DB09106
+BMGC_DG18148,BMG_DG222838,Methoxy polyethylene glycol-epoetin beta | PubChem SID:347910408 | DrugBank ID:DB09107
+BMGC_DG18149,BMG_DG222839,DrugBank ID:DB09108 | Simoctocog alfa | PubChem SID:347910409
+BMGC_DG18150,BMG_DG222840,DrugBank ID:DB09109 | Turoctocog alfa | PubChem SID:347910410
+BMGC_DG18151,BMG_DG222841,Pentastarch | PubChem SID:347910411 | DrugBank ID:DB09111
+BMGC_DG18152,BMG_DG222842,Poractant alfa | PubChem SID:347910412 | DrugBank ID:DB09113
+BMGC_DG18153,BMG_DG222843,DrugBank ID:DB09122 | PubChem SID:347910413 | Peginterferon beta-1a
+BMGC_DG18154,BMG_DG222844,DrugBank ID:DB09126 | Chorionic Gonadotropin (Human) | PubChem SID:347910414
+BMGC_DG18155,BMG_DG222845,DrugBank ID:DB09141 | Protamine sulfate | PubChem SID:347910415
+BMGC_DG18156,BMG_DG222846,Technetium Tc-99m exametazime | PubChem SID:347910416 | DrugBank ID:DB09163
+BMGC_DG18157,BMG_DG222847,Pegloticase | PubChem SID:347910417 | DrugBank ID:DB09208
+BMGC_DG18158,BMG_DG222848,PubChem SID:347910418 | DrugBank ID:DB09222 | Fibrinogen human
+BMGC_DG18159,BMG_DG222849,DrugBank ID:DB09226 | Brilaroxazine | PubChem SID:347910419
+BMGC_DG18160,BMG_DG222850,DrugBank ID:DB09228 | Conestat alfa | PubChem SID:347910420
+BMGC_DG18161,BMG_DG222851,Dextran | DrugBank ID:DB09255 | PubChem SID:347910421
+BMGC_DG18162,BMG_DG222852,PubChem SID:347910422 | Bemiparin | DrugBank ID:DB09258
+BMGC_DG18163,BMG_DG222853,Reviparin | PubChem SID:347910423 | DrugBank ID:DB09259
+BMGC_DG18164,BMG_DG222854,Parnaparin | DrugBank ID:DB09260 | PubChem SID:347910424
+BMGC_DG18165,BMG_DG222855,DrugBank ID:DB09261 | PubChem SID:347910425 | Certoparin
+BMGC_DG18166,BMG_DG222856,DrugBank ID:DB09263 | PubChem SID:347910426 | Patiromer
+BMGC_DG18167,BMG_DG222857,DrugBank ID:DB09264 | Idarucizumab | PubChem SID:347910427
+BMGC_DG18168,BMG_DG222858,PubChem SID:347910428 | DrugBank ID:DB09266 | Technetium Tc-99m tilmanocept
+BMGC_DG18169,BMG_DG222859,DrugBank ID:DB09287 | PubChem SID:347910429 | Polyethylene glycol
+BMGC_DG18170,BMG_DG222860,PubChem SID:347910430 | DrugBank ID:DB09301 | Chondroitin sulfate
+BMGC_DG18171,BMG_DG222861,DrugBank ID:DB09302 | PubChem SID:347910431 | Alirocumab
+BMGC_DG18172,BMG_DG222862,DrugBank ID:DB09303 | Evolocumab | PubChem SID:347910432
+BMGC_DG18173,BMG_DG222863,Oxaprotiline | PubChem SID:347910433 | DrugBank ID:DB09307
+BMGC_DG18174,BMG_DG222864,DrugBank ID:DB09310 | Catridecacog | PubChem SID:347910434
+BMGC_DG18175,BMG_DG222865,PubChem SID:347910435 | DrugBank ID:DB09311 | Polycarbophil
+BMGC_DG18176,BMG_DG222866,Antilymphocyte immunoglobulin (horse) | DrugBank ID:DB09312 | PubChem SID:347910436
+BMGC_DG18177,BMG_DG222867,"DrugBank ID:DB09317 | Synthetic Conjugated Estrogens, A | PubChem SID:347910437"
+BMGC_DG18178,BMG_DG222868,"Synthetic Conjugated Estrogens, B | PubChem SID:347910438 | DrugBank ID:DB09318"
+BMGC_DG18179,BMG_DG222869,PubChem SID:347910439 | Vayarin | DrugBank ID:DB09328
+BMGC_DG18180,BMG_DG222870,"PubChem SID:347910440 | DrugBank ID:DB09329 | Antihemophilic factor (recombinant), PEGylated"
+BMGC_DG18181,BMG_DG222871,DrugBank ID:DB09331 | PubChem SID:347910441 | Daratumumab
+BMGC_DG18182,BMG_DG222872,Technetium Tc-99m nofetumomab merpentan | DrugBank ID:DB09336 | PubChem SID:347910442
+BMGC_DG18183,BMG_DG222875,PubChem SID:347910445 | DrugBank ID:DB09344 | Invert sugar
+BMGC_DG18184,BMG_DG222877,DrugBank ID:DB09363 | Rauwolfia serpentina root | PubChem SID:347910447
+BMGC_DG18185,BMG_DG222878,PubChem SID:347910448 | DrugBank ID:DB09372 | Tannic acid
+BMGC_DG18186,BMG_DG222879,DrugBank ID:DB09375 | PubChem SID:347910449 | Chymotrypsin
+BMGC_DG18187,BMG_DG222881,Esterified estrogens | PubChem SID:347910451 | DrugBank ID:DB09381
+BMGC_DG18188,BMG_DG222882,DrugBank ID:DB09422 | PubChem SID:347910452 | Soybean oil
+BMGC_DG18189,BMG_DG222883,PubChem SID:347910453 | Insulin beef | DrugBank ID:DB09456
+BMGC_DG18190,BMG_DG222884,DrugBank ID:DB09484 | PubChem SID:347910454 | Sodium fluorophosphate
+BMGC_DG18191,BMG_DG222886,Talc | DrugBank ID:DB09511 | PubChem SID:347910456
+BMGC_DG18192,BMG_DG222887,DrugBank ID:DB09512 | Simethicone | PubChem SID:347910457
+BMGC_DG18193,BMG_DG222888,PubChem SID:347910458 | DrugBank ID:DB09535 | Octocrylene
+BMGC_DG18194,BMG_DG222890,DrugBank ID:DB09539 | PubChem SID:347910460 | Omega-3-acid ethyl esters
+BMGC_DG18195,BMG_DG222891,PubChem SID:347910461 | DrugBank ID:DB09551 | Desoxyribonuclease
+BMGC_DG18196,BMG_DG222892,DrugBank ID:DB09559 | Necitumumab | PubChem SID:347910462
+BMGC_DG18197,BMG_DG222893,PubChem SID:347910463 | Insulin degludec | DrugBank ID:DB09564
+BMGC_DG18198,BMG_DG222894,Olive oil | DrugBank ID:DB09567 | PubChem SID:347910464
+BMGC_DG18199,BMG_DG222895,DrugBank ID:DB09568 | PubChem SID:347910465 | Omega-3-carboxylic acids
+BMGC_DG18200,BMG_DG222898,Rotavirus vaccine | PubChem SID:347910468 | DrugBank ID:DB10276
+BMGC_DG18201,BMG_DG222899,"Rabies virus inactivated antigen, A | DrugBank ID:DB10283 | PubChem SID:347910469"
+BMGC_DG18202,BMG_DG222924,DrugBank ID:DB10315 | Measles virus vaccine live attenuated | PubChem SID:347910494
+BMGC_DG18203,BMG_DG222925,Mumps virus strain B level jeryl lynn live antigen | PubChem SID:347910495 | DrugBank ID:DB10316
+BMGC_DG18204,BMG_DG222926,Rubella virus vaccine | PubChem SID:347910496 | DrugBank ID:DB10317
+BMGC_DG18205,BMG_DG222927,Varicella zoster vaccine (live/attenuated) | DrugBank ID:DB10318 | PubChem SID:347910497
+BMGC_DG18206,BMG_DG222952,PubChem SID:347910522 | Bacillus calmette-guerin substrain tice live antigen | DrugBank ID:DB10343
+BMGC_DG18207,BMG_DG222957,Paspalum notatum pollen | PubChem SID:347910527 | DrugBank ID:DB10349
+BMGC_DG18208,BMG_DG222959,Cynodon dactylon pollen | DrugBank ID:DB10351 | PubChem SID:347910529
+BMGC_DG18209,BMG_DG222961,DrugBank ID:DB10353 | Poa annua pollen | PubChem SID:347910531
+BMGC_DG18210,BMG_DG222972,PubChem SID:347910542 | Sorghum halepense pollen | DrugBank ID:DB10365
+BMGC_DG18211,BMG_DG222973,Poa pratensis pollen | DrugBank ID:DB10366 | PubChem SID:347910543
+BMGC_DG18212,BMG_DG222976,Festuca pratensis pollen | PubChem SID:347910546 | DrugBank ID:DB10370
+BMGC_DG18213,BMG_DG222985,PubChem SID:347910555 | DrugBank ID:DB10379 | Dactylis glomerata pollen
+BMGC_DG18214,BMG_DG222994,Lolium perenne pollen | DrugBank ID:DB10389 | PubChem SID:347910564
+BMGC_DG18215,BMG_DG222999,Phleum pratense pollen | PubChem SID:347910569 | DrugBank ID:DB10394
+BMGC_DG18216,BMG_DG223000,Holcus lanatus pollen | DrugBank ID:DB10395 | PubChem SID:347910570
+BMGC_DG18217,BMG_DG223007,Agrostis gigantea pollen | PubChem SID:347910577 | DrugBank ID:DB10403
+BMGC_DG18218,BMG_DG223008,DrugBank ID:DB10404 | Anthoxanthum odoratum pollen | PubChem SID:347910578
+BMGC_DG18219,BMG_DG223085,DrugBank ID:DB10489 | PubChem SID:347910655 | Elymus repens pollen
+BMGC_DG18220,BMG_DG223089,PubChem SID:347910659 | Distichlis spicata pollen | DrugBank ID:DB10494
+BMGC_DG18221,BMG_DG223122,DrugBank ID:DB10532 | PubChem SID:347910692 | Garlic
+BMGC_DG18222,BMG_DG223124,PubChem SID:347910694 | Grapefruit | DrugBank ID:DB10534
+BMGC_DG18223,BMG_DG223128,DrugBank ID:DB10538 | PubChem SID:347910698 | Lemon
+BMGC_DG18224,BMG_DG223172,DrugBank ID:DB10583 | PubChem SID:347910742 | Clostridium tetani toxoid antigen (formaldehyde inactivated)
+BMGC_DG18225,BMG_DG223249,DrugBank ID:DB10685 | Wheat bran | PubChem SID:347910819
+BMGC_DG18226,BMG_DG223273,PubChem SID:347910843 | DrugBank ID:DB10713 | Poa compressa pollen
+BMGC_DG18227,BMG_DG223274,DrugBank ID:DB10714 | Phalaris arundinacea pollen | PubChem SID:347910844
+BMGC_DG18228,BMG_DG223275,Bouteloua gracilis pollen | DrugBank ID:DB10715 | PubChem SID:347910845
+BMGC_DG18229,BMG_DG223276,Urochloa mutica pollen | DrugBank ID:DB10716 | PubChem SID:347910846
+BMGC_DG18230,BMG_DG223277,DrugBank ID:DB10717 | Secale cereale pollen | PubChem SID:347910847
+BMGC_DG18231,BMG_DG223279,PubChem SID:347910849 | DrugBank ID:DB10719 | Pascopyrum smithii pollen
+BMGC_DG18232,BMG_DG223339,PubChem SID:347910909 | DrugBank ID:DB10803 | Typhoid Vi polysaccharide vaccine
+BMGC_DG18233,BMG_DG223340,DrugBank ID:DB10804 | Bacillus calmette-guerin substrain connaught live antigen | PubChem SID:347910910
+BMGC_DG18234,BMG_DG223341,DrugBank ID:DB10805 | Yellow fever vaccine | PubChem SID:347910911
+BMGC_DG18235,BMG_DG223371,Bromus secalinus pollen | DrugBank ID:DB10836 | PubChem SID:347910941
+BMGC_DG18236,BMG_DG223410,DrugBank ID:DB10879 | Arrhenatherum elatius pollen | PubChem SID:347910980
+BMGC_DG18237,BMG_DG223470,DrugBank ID:DB10949 | PubChem SID:347911040 | Koeleria macrantha pollen
+BMGC_DG18238,BMG_DG223481,Agrostis stolonifera pollen | PubChem SID:347911051 | DrugBank ID:DB10962
+BMGC_DG18239,BMG_DG223482,DrugBank ID:DB10963 | PubChem SID:347911052 | Phalaris minor pollen
+BMGC_DG18240,BMG_DG223483,PubChem SID:347911053 | DrugBank ID:DB10964 | Lolium perenne subsp. multiflorum pollen
+BMGC_DG18241,BMG_DG223485,DrugBank ID:DB10966 | Sorghum bicolor subsp. drummondii pollen | PubChem SID:347911055
+BMGC_DG18242,BMG_DG223501,PubChem SID:347911071 | DrugBank ID:DB10989 | Hepatitis A Vaccine
+BMGC_DG18243,BMG_DG223502,DrugBank ID:DB10990 | PubChem SID:347911072 | Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen
+BMGC_DG18244,BMG_DG223503,"PubChem SID:347911073 | DrugBank ID:DB10991 | Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)"
+BMGC_DG18245,BMG_DG223505,Anthrax vaccine | PubChem SID:347911075 | DrugBank ID:DB11003
+BMGC_DG18246,BMG_DG223523,Typhoid Vaccine Live | PubChem SID:347911093 | DrugBank ID:DB11050
+BMGC_DG18247,BMG_DG223524,DrugBank ID:DB11051 | PubChem SID:347911094 | Azficel-T
+BMGC_DG18248,BMG_DG223526,Mineral oil | PubChem SID:347911096 | DrugBank ID:DB11057
+BMGC_DG18249,BMG_DG223528,Carboxymethylcellulose | DrugBank ID:DB11059 | PubChem SID:347911098
+BMGC_DG18250,BMG_DG223529,DrugBank ID:DB11060 | Polyvinyl alcohol | PubChem SID:347911099
+BMGC_DG18251,BMG_DG223530,PubChem SID:347911100 | DrugBank ID:DB11061 | Povidone
+BMGC_DG18252,BMG_DG223532,DrugBank ID:DB11063 | Polysorbate 80 | PubChem SID:347911102
+BMGC_DG18253,BMG_DG223533,DrugBank ID:DB11064 | Homosalate | PubChem SID:347911103
+BMGC_DG18254,BMG_DG223534,DrugBank ID:DB11074 | Dimethicone | PubChem SID:347911104
+BMGC_DG18255,BMG_DG223535,Hypromellose | DrugBank ID:DB11075 | PubChem SID:347911105
+BMGC_DG18256,BMG_DG223536,Polyethylene glycol 400 | PubChem SID:347911107 | DrugBank ID:DB11077
+BMGC_DG18257,BMG_DG223539,PubChem SID:347911110 | Pyrethrum extract | DrugBank ID:DB11087
+BMGC_DG18258,BMG_DG223541,PubChem SID:347911112 | DrugBank ID:DB11089 | Docusate
+BMGC_DG18259,BMG_DG223542,PubChem SID:347911113 | DrugBank ID:DB11094 | Vitamin D
+BMGC_DG18260,BMG_DG223543,DrugBank ID:DB11095 | Desirudin | PubChem SID:347911114
+BMGC_DG18261,BMG_DG223544,DrugBank ID:DB11097 | PubChem SID:347911115 | Plantago seed
+BMGC_DG18262,BMG_DG223545,PubChem SID:347911116 | DrugBank ID:DB11100 | Allantoin
+BMGC_DG18263,BMG_DG223546,PubChem SID:347911117 | DrugBank ID:DB11105 | Benzalkonium
+BMGC_DG18264,BMG_DG223547,PubChem SID:347911118 | DrugBank ID:DB11108 | Aluminum sesquichlorohydrate
+BMGC_DG18265,BMG_DG223550,PubChem SID:347911121 | Castor oil | DrugBank ID:DB11113
+BMGC_DG18266,BMG_DG223551,DrugBank ID:DB11114 | Eucalyptus oil | PubChem SID:347911122
+BMGC_DG18267,BMG_DG223553,Undecylenic acid | DrugBank ID:DB11117 | PubChem SID:347911124
+BMGC_DG18268,BMG_DG223554,PubChem SID:347911125 | Ammonia | DrugBank ID:DB11118
+BMGC_DG18269,BMG_DG223555,DrugBank ID:DB11120 | Turpentine | PubChem SID:347911126
+BMGC_DG18270,BMG_DG223556,DrugBank ID:DB11124 | PubChem SID:347911128 | Racepinephrine
+BMGC_DG18271,BMG_DG223557,PubChem SID:347911129 | Opium | DrugBank ID:DB11130
+BMGC_DG18272,BMG_DG223558,Capsicum oleoresin | PubChem SID:347911130 | DrugBank ID:DB11131
+BMGC_DG18273,BMG_DG223559,PubChem SID:347911131 | Omega-3 fatty acids | DrugBank ID:DB11133
+BMGC_DG18274,BMG_DG223561,DrugBank ID:DB11143 | PubChem SID:347911133 | Cresol
+BMGC_DG18275,BMG_DG223566,DrugBank ID:DB11161 | PubChem SID:347911138 | Polyethylene glycol 300
+BMGC_DG18276,BMG_DG223568,DrugBank ID:DB11166 | Antithrombin Alfa | PubChem SID:347911141
+BMGC_DG18277,BMG_DG223573,Homatropine | DrugBank ID:DB11181 | PubChem SID:347911146
+BMGC_DG18278,BMG_DG223574,PubChem SID:347911147 | DrugBank ID:DB11182 | Rose bengal
+BMGC_DG18279,BMG_DG223575,PubChem SID:347911148 | DrugBank ID:DB11191 | Cobamamide
+BMGC_DG18280,BMG_DG223576,DrugBank ID:DB11193 | Papain | PubChem SID:347911149
+BMGC_DG18281,BMG_DG223577,DrugBank ID:DB11195 | Xylitol | PubChem SID:347911150
+BMGC_DG18282,BMG_DG223578,Peppermint oil | DrugBank ID:DB11198 | PubChem SID:347911151
+BMGC_DG18283,BMG_DG223579,Sage oil | DrugBank ID:DB11199 | PubChem SID:347911152
+BMGC_DG18284,BMG_DG223583,DrugBank ID:DB11218 | PubChem SID:347911156 | Tea tree oil
+BMGC_DG18285,BMG_DG223585,PubChem SID:347911158 | Methylcellulose | DrugBank ID:DB11228
+BMGC_DG18286,BMG_DG223586,PubChem SID:347911159 | Poliglusam | DrugBank ID:DB11234
+BMGC_DG18287,BMG_DG223587,DrugBank ID:DB11237 | PubChem SID:347911160 | Trypsin
+BMGC_DG18288,BMG_DG223588,DrugBank ID:DB11238 | PubChem SID:347911161 | Borage oil
+BMGC_DG18289,BMG_DG223591,DrugBank ID:DB11251 | Tocopherol | PubChem SID:347911165
+BMGC_DG18290,BMG_DG223595,DrugBank ID:DB11264 | PubChem SID:347911170 | Calcium glycerophosphate
+BMGC_DG18291,BMG_DG223602,PubChem SID:347911178 | Coccidioides immitis spherule | DrugBank ID:DB11294
+BMGC_DG18292,BMG_DG223605,PubChem SID:347911181 | DrugBank ID:DB11300 | Thrombin
+BMGC_DG18293,BMG_DG223608,PubChem SID:347911184 | DrugBank ID:DB11311 | Prothrombin
+BMGC_DG18294,BMG_DG223609,DrugBank ID:DB11312 | PubChem SID:347911185 | Protein C
+BMGC_DG18295,BMG_DG223612,Factor IX Complex (Human) | DrugBank ID:DB11330 | PubChem SID:347911188
+BMGC_DG18296,BMG_DG223614,PubChem SID:347911190 | DrugBank ID:DB11338 | Clove oil
+BMGC_DG18297,BMG_DG223618,PubChem SID:347911194 | Ascorbyl phosphate | DrugBank ID:DB11352
+BMGC_DG18298,BMG_DG223622,PubChem SID:347911198 | Evening primrose oil | DrugBank ID:DB11358
+BMGC_DG18299,BMG_DG223624,PubChem SID:347911200 | Sennosides | DrugBank ID:DB11365
+BMGC_DG18300,BMG_DG223626,DrugBank ID:DB11563 | Sebelipase alfa | PubChem SID:347911202
+BMGC_DG18301,BMG_DG223627,Ixekizumab | DrugBank ID:DB11569 | PubChem SID:347911203
+BMGC_DG18302,BMG_DG223628,DrugBank ID:DB11571 | PubChem SID:347911204 | Human thrombin
+BMGC_DG18303,BMG_DG223629,Thrombin alfa | DrugBank ID:DB11572 | PubChem SID:347911205
+BMGC_DG18304,BMG_DG223631,DrugBank ID:DB11595 | PubChem SID:347911207 | Atezolizumab
+BMGC_DG18305,BMG_DG223632,DrugBank ID:DB11597 | PubChem SID:347911208 | Human Rho(D) immune globulin
+BMGC_DG18306,BMG_DG223633,DrugBank ID:DB11598 | Antithrombin III human | PubChem SID:347911209
+BMGC_DG18307,BMG_DG223636,Tuberculin purified protein derivative | PubChem SID:347911212 | DrugBank ID:DB11601
+BMGC_DG18308,BMG_DG223637,"DrugBank ID:DB11603 | Rabies immune globulin, human | PubChem SID:347911213"
+BMGC_DG18309,BMG_DG223638,"DrugBank ID:DB11604 | PubChem SID:347911214 | Tetanus immune globulin, human"
+BMGC_DG18310,BMG_DG223639,Myrrh | PubChem SID:347911215 | DrugBank ID:DB11605
+BMGC_DG18311,BMG_DG223640,DrugBank ID:DB11606 | PubChem SID:347911216 | Susoctocog alfa
+BMGC_DG18312,BMG_DG223641,Efmoroctocog alfa | PubChem SID:347911217 | DrugBank ID:DB11607
+BMGC_DG18313,BMG_DG223642,PubChem SID:347911218 | Eftrenonacog alfa | DrugBank ID:DB11608
+BMGC_DG18314,BMG_DG223643,Human varicella-zoster immune globulin | PubChem SID:347911219 | DrugBank ID:DB11621
+BMGC_DG18315,BMG_DG223644,Hepatitis B Vaccine (Recombinant) | PubChem SID:347911220 | DrugBank ID:DB11627
+BMGC_DG18316,BMG_DG223645,Tocofersolan | DrugBank ID:DB11635 | PubChem SID:347911221
+BMGC_DG18317,BMG_DG223646,PubChem SID:347911222 | DrugBank ID:DB11646 | Conatumumab
+BMGC_DG18318,BMG_DG223647,Tabalumab | DrugBank ID:DB11657 | PubChem SID:347911223
+BMGC_DG18319,BMG_DG223648,DrugBank ID:DB11661 | PubChem SID:347911224 | Eptacog alfa pegol (activated)
+BMGC_DG18320,BMG_DG223649,DrugBank ID:DB11668 | PubChem SID:347911225 | Rusalatide acetate
+BMGC_DG18321,BMG_DG223650,DrugBank ID:DB11680 | Ficlatuzumab | PubChem SID:347911226
+BMGC_DG18322,BMG_DG223651,PubChem SID:347911227 | DrugBank ID:DB11685 | Figitumumab
+BMGC_DG18323,BMG_DG223653,Durvalumab | DrugBank ID:DB11714 | PubChem SID:347911229
+BMGC_DG18324,BMG_DG223654,DrugBank ID:DB11715 | Bapineuzumab | PubChem SID:347911230
+BMGC_DG18325,BMG_DG223655,Bombesin | PubChem SID:347911231 | DrugBank ID:DB11724
+BMGC_DG18326,BMG_DG223656,PubChem SID:347911232 | Endostar | DrugBank ID:DB11727
+BMGC_DG18327,BMG_DG223657,Onartuzumab | DrugBank ID:DB11746 | PubChem SID:347911234
+BMGC_DG18328,BMG_DG223658,PubChem SID:347911235 | Rifamycin | DrugBank ID:DB11753
+BMGC_DG18329,BMG_DG223660,PubChem SID:347911237 | Solanezumab | DrugBank ID:DB11756
+BMGC_DG18330,BMG_DG223661,Sarilumab | DrugBank ID:DB11767 | PubChem SID:347911238
+BMGC_DG18331,BMG_DG223662,Tremelimumab | DrugBank ID:DB11771 | PubChem SID:347911239
+BMGC_DG18332,BMG_DG223663,DrugBank ID:DB11776 | PubChem SID:347911240 | Brodalumab
+BMGC_DG18333,BMG_DG223666,PubChem SID:347911243 | DrugBank ID:DB11803 | Sirukumab
+BMGC_DG18334,BMG_DG223667,PubChem SID:347911244 | Lampalizumab | DrugBank ID:DB11826
+BMGC_DG18335,BMG_DG223668,Guselkumab | DrugBank ID:DB11834 | PubChem SID:347911245
+BMGC_DG18336,BMG_DG223669,DrugBank ID:DB11840 | PubChem SID:347911246 | Dalotuzumab
+BMGC_DG18337,BMG_DG223670,Emibetuzumab | DrugBank ID:DB11849 | PubChem SID:347911247
+BMGC_DG18338,BMG_DG223671,Ublituximab | DrugBank ID:DB11850 | PubChem SID:347911248
+BMGC_DG18339,BMG_DG223673,DrugBank ID:DB11856 | Ligelizumab | PubChem SID:347911250
+BMGC_DG18340,BMG_DG223674,PubChem SID:347911251 | Seribantumab | DrugBank ID:DB11857
+BMGC_DG18341,BMG_DG223675,Landogrozumab | PubChem SID:347911252 | DrugBank ID:DB11862
+BMGC_DG18342,BMG_DG223676,DrugBank ID:DB11866 | Romosozumab | PubChem SID:347911253
+BMGC_DG18343,BMG_DG223677,DrugBank ID:DB11884 | PubChem SID:347911254 | Vadastuximab talirine
+BMGC_DG18344,BMG_DG223679,PubChem SID:347911256 | DrugBank ID:DB11914 | Lebrikizumab
+BMGC_DG18345,BMG_DG223681,PubChem SID:347911258 | Vosoritide | DrugBank ID:DB11928
+BMGC_DG18346,BMG_DG223682,DrugBank ID:DB11930 | PubChem SID:347911259 | Varlilumab
+BMGC_DG18347,BMG_DG223683,Avelumab | DrugBank ID:DB11945 | PubChem SID:347911260
+BMGC_DG18348,BMG_DG223685,PubChem SID:347911262 | Crenezumab | DrugBank ID:DB11959
+BMGC_DG18349,BMG_DG223686,PubChem SID:347911263 | DrugBank ID:DB11972 | Rilotumumab
+BMGC_DG18350,BMG_DG223687,DrugBank ID:DB11976 | Anifrolumab | PubChem SID:347911264
+BMGC_DG18351,BMG_DG223689,DrugBank ID:DB11988 | PubChem SID:347911266 | Ocrelizumab
+BMGC_DG18352,BMG_DG223692,PubChem SID:347911269 | DrugBank ID:DB12014 | Ozoralizumab
+BMGC_DG18353,BMG_DG223693,DrugBank ID:DB12018 | Ulocuplumab | PubChem SID:347911270
+BMGC_DG18354,BMG_DG223694,Benralizumab | DrugBank ID:DB12023 | PubChem SID:347911271
+BMGC_DG18355,BMG_DG223696,Gantenerumab | PubChem SID:347911273 | DrugBank ID:DB12034
+BMGC_DG18356,BMG_DG223698,DrugBank ID:DB12053 | PubChem SID:347911275 | Visilizumab
+BMGC_DG18357,BMG_DG223699,DrugBank ID:DB12056 | Trebananib | PubChem SID:347911276
+BMGC_DG18358,BMG_DG223702,PubChem SID:347911279 | Urelumab | DrugBank ID:DB12077
+BMGC_DG18359,BMG_DG223703,DrugBank ID:DB12089 | PubChem SID:347911280 | Lorvotuzumab mertansine
+BMGC_DG18360,BMG_DG223704,Patritumab | PubChem SID:347911281 | DrugBank ID:DB12090
+BMGC_DG18361,BMG_DG223705,Fulranumab | DrugBank ID:DB12102 | PubChem SID:347911282
+BMGC_DG18362,BMG_DG223706,Tarextumab | DrugBank ID:DB12104 | PubChem SID:347911283
+BMGC_DG18363,BMG_DG223707,Sotatercept | DrugBank ID:DB12118 | PubChem SID:347911284
+BMGC_DG18364,BMG_DG223708,Gevokizumab | PubChem SID:347911285 | DrugBank ID:DB12119
+BMGC_DG18365,BMG_DG223711,Duligotuzumab | DrugBank ID:DB12142 | PubChem SID:347911288
+BMGC_DG18366,BMG_DG223712,PubChem SID:347911289 | Simtuzumab | DrugBank ID:DB12152
+BMGC_DG18367,BMG_DG223713,PubChem SID:347911290 | Citicoline | DrugBank ID:DB12153
+BMGC_DG18368,BMG_DG223714,DrugBank ID:DB12157 | PubChem SID:347911291 | Fasinumab
+BMGC_DG18369,BMG_DG223715,Dupilumab | DrugBank ID:DB12159 | PubChem SID:347911292
+BMGC_DG18370,BMG_DG223716,Tralokinumab | PubChem SID:347911293 | DrugBank ID:DB12169
+BMGC_DG18371,BMG_DG223718,Binetrakin | DrugBank ID:DB12182 | PubChem SID:347911295
+BMGC_DG18372,BMG_DG223719,PubChem SID:347911296 | DrugBank ID:DB12189 | Etrolizumab
+BMGC_DG18373,BMG_DG223720,PubChem SID:347911297 | Zalutumumab | DrugBank ID:DB12202
+BMGC_DG18374,BMG_DG223721,DrugBank ID:DB12205 | Ganitumab | PubChem SID:347911298
+BMGC_DG18375,BMG_DG223722,PubChem SID:347911299 | DrugBank ID:DB12208 | Iron isomaltoside 1000
+BMGC_DG18376,BMG_DG223723,Etaracizumab | PubChem SID:347911300 | DrugBank ID:DB12213
+BMGC_DG18377,BMG_DG223724,Polatuzumab vedotin | PubChem SID:347911301 | DrugBank ID:DB12240
+BMGC_DG18378,BMG_DG223725,Inclacumab | PubChem SID:347911302 | DrugBank ID:DB12246
+BMGC_DG18379,BMG_DG223727,Cixutumumab | PubChem SID:347911304 | DrugBank ID:DB12250
+BMGC_DG18380,BMG_DG223729,PubChem SID:347911306 | Abicipar Pegol | DrugBank ID:DB12258
+BMGC_DG18381,BMG_DG223730,Ascrinvacumab | PubChem SID:347911307 | DrugBank ID:DB12261
+BMGC_DG18382,BMG_DG223731,DrugBank ID:DB12266 | Epofolate | PubChem SID:347911308
+BMGC_DG18383,BMG_DG223732,DrugBank ID:DB12274 | PubChem SID:347911309 | Aducanumab
+BMGC_DG18384,BMG_DG223734,DrugBank ID:DB12281 | PubChem SID:347911311 | Luspatercept
+BMGC_DG18385,BMG_DG223736,PubChem SID:347911313 | GS-5745 | DrugBank ID:DB12296
+BMGC_DG18386,BMG_DG223738,Vanucizumab | DrugBank ID:DB12317 | PubChem SID:347911315
+BMGC_DG18387,BMG_DG223741,DrugBank ID:DB12335 | PubChem SID:347911318 | Tanezumab
+BMGC_DG18388,BMG_DG223742,Ensituximab | DrugBank ID:DB12342 | PubChem SID:347911319
+BMGC_DG18389,BMG_DG223743,PubChem SID:347911320 | Fezakinumab | DrugBank ID:DB12344
+BMGC_DG18390,BMG_DG223748,PubChem SID:347911325 | DrugBank ID:DB12363 | Dusigitumab
+BMGC_DG18391,BMG_DG223749,DrugBank ID:DB12366 | PubChem SID:347911326 | Vestronidase alfa
+BMGC_DG18392,BMG_DG223751,Velmanase alfa | DrugBank ID:DB12374 | PubChem SID:347911328
+BMGC_DG18393,BMG_DG223752,PubChem SID:347911329 | Bacillus calmette-guerin substrain danish 1331 live antigen | DrugBank ID:DB12386
+BMGC_DG18394,BMG_DG223753,PubChem SID:347911330 | Fresolimumab | DrugBank ID:DB12396
+BMGC_DG18395,BMG_DG223754,DrugBank ID:DB12409 | PubChem SID:347911331 | Vatreptacog alfa
+BMGC_DG18396,BMG_DG223755,Indusatumab vedotin | DrugBank ID:DB12413 | PubChem SID:347911332
+BMGC_DG18397,BMG_DG223757,PubChem SID:347911334 | DrugBank ID:DB12431 | Muplestim
+BMGC_DG18398,BMG_DG223758,DrugBank ID:DB12456 | Bococizumab | PubChem SID:347911335
+BMGC_DG18399,BMG_DG223760,PubChem SID:347911337 | DrugBank ID:DB12487 | Promestriene
+BMGC_DG18400,BMG_DG223762,Mogamulizumab | PubChem SID:347911339 | DrugBank ID:DB12498
+BMGC_DG18401,BMG_DG223763,Plozalizumab | DrugBank ID:DB12520 | PubChem SID:347911340
+BMGC_DG18402,BMG_DG223764,PubChem SID:347911341 | Molgramostim | DrugBank ID:DB12525
+BMGC_DG18403,BMG_DG223765,PubChem SID:347911342 | Inebilizumab | DrugBank ID:DB12530
+BMGC_DG18404,BMG_DG223766,PubChem SID:347911343 | Mavrilimumab | DrugBank ID:DB12534
+BMGC_DG18405,BMG_DG223767,Blosozumab | DrugBank ID:DB12560 | PubChem SID:347911344
+BMGC_DG18406,BMG_DG223768,Tecemotide | DrugBank ID:DB12568 | PubChem SID:347911345
+BMGC_DG18407,BMG_DG223770,DrugBank ID:DB12584 | Bimagrumab | PubChem SID:347911347
+BMGC_DG18408,BMG_DG223771,PubChem SID:347911348 | DrugBank ID:DB12589 | Dacetuzumab
+BMGC_DG18409,BMG_DG223774,Tovetumab | PubChem SID:347911351 | DrugBank ID:DB12609
+BMGC_DG18410,BMG_DG223782,Somatorelin | PubChem SID:347911359 | DrugBank ID:DB12656
+BMGC_DG18411,BMG_DG223783,PubChem SID:347911360 | Lumretuzumab | DrugBank ID:DB12683
+BMGC_DG18412,BMG_DG223785,PubChem SID:347911362 | DrugBank ID:DB12688 | Moxetumomab pasudotox
+BMGC_DG18413,BMG_DG223786,PubChem SID:347911363 | Ibalizumab | DrugBank ID:DB12698
+BMGC_DG18414,BMG_DG223787,PubChem SID:347911364 | Balugrastim | DrugBank ID:DB12699
+BMGC_DG18415,BMG_DG223788,Intetumumab | PubChem SID:347911365 | DrugBank ID:DB12701
+BMGC_DG18416,BMG_DG223789,PubChem SID:347911366 | Carlumab | DrugBank ID:DB12718
+BMGC_DG18417,BMG_DG223791,DrugBank ID:DB12726 | Monteplase | PubChem SID:347911368
+BMGC_DG18418,BMG_DG223792,Demcizumab | DrugBank ID:DB12734 | PubChem SID:347911369
+BMGC_DG18419,BMG_DG223795,Tertomotide | DrugBank ID:DB12747 | PubChem SID:347911372
+BMGC_DG18420,BMG_DG223796,PubChem SID:347911373 | Racivir | DrugBank ID:DB12753
+BMGC_DG18421,BMG_DG223797,DrugBank ID:DB12755 | PubChem SID:347911374 | Zoptarelin doxorubicin
+BMGC_DG18422,BMG_DG223799,PubChem SID:347911376 | BCG vaccine | DrugBank ID:DB12768
+BMGC_DG18423,BMG_DG223800,DrugBank ID:DB12773 | PubChem SID:347911377 | Sifalimumab
+BMGC_DG18424,BMG_DG223801,DrugBank ID:DB12775 | PubChem SID:347911378 | Abituzumab
+BMGC_DG18425,BMG_DG223802,DrugBank ID:DB12778 | Rivipansel | PubChem SID:347911379
+BMGC_DG18426,BMG_DG223805,Condoliase | DrugBank ID:DB12793 | PubChem SID:347911382
+BMGC_DG18427,BMG_DG223806,DrugBank ID:DB12797 | PubChem SID:347911383 | Ecromeximab
+BMGC_DG18428,BMG_DG223807,Naptumomab estafenatox | PubChem SID:347911384 | DrugBank ID:DB12807
+BMGC_DG18429,BMG_DG223808,DrugBank ID:DB12814 | Cepeginterferon alfa-2B | PubChem SID:347911385
+BMGC_DG18430,BMG_DG223809,DrugBank ID:DB12815 | PubChem SID:347911386 | Crotedumab
+BMGC_DG18431,BMG_DG223810,Concizumab | DrugBank ID:DB12820 | PubChem SID:347911387
+BMGC_DG18432,BMG_DG223813,DrugBank ID:DB12826 | PubChem SID:347911390 | Depatuxizumab
+BMGC_DG18433,BMG_DG223814,Olipudase alfa | PubChem SID:347911391 | DrugBank ID:DB12835
+BMGC_DG18434,BMG_DG223816,Pegamotecan | DrugBank ID:DB12842 | PubChem SID:347911393
+BMGC_DG18435,BMG_DG223817,Rontalizumab | DrugBank ID:DB12844 | PubChem SID:347911394
+BMGC_DG18436,BMG_DG223818,DrugBank ID:DB12845 | PubChem SID:347911395 | Amatuximab
+BMGC_DG18437,BMG_DG223819,DrugBank ID:DB12849 | PubChem SID:347911396 | Clazakizumab
+BMGC_DG18438,BMG_DG223823,Vonicog alfa | PubChem SID:347911400 | DrugBank ID:DB12872
+BMGC_DG18439,BMG_DG223825,Ozanezumab | DrugBank ID:DB12891 | PubChem SID:347911402
+BMGC_DG18440,BMG_DG223826,DrugBank ID:DB12893 | Sacituzumab govitecan | PubChem SID:347911403
+BMGC_DG18441,BMG_DG223829,Factor XIII (human) | PubChem SID:347911406 | DrugBank ID:DB12909
+BMGC_DG18442,BMG_DG223831,PubChem SID:347911408 | DrugBank ID:DB12917 | Bimekizumab
+BMGC_DG18443,BMG_DG223832,Milatuzumab | DrugBank ID:DB12943 | PubChem SID:347911409
+BMGC_DG18444,BMG_DG223833,DrugBank ID:DB12950 | Albusomatropin | PubChem SID:347911410
+BMGC_DG18445,BMG_DG223834,PubChem SID:347911411 | DrugBank ID:DB12953 | Disitertide
+BMGC_DG18446,BMG_DG223836,PubChem SID:347911413 | Robatumumab | DrugBank ID:DB12976
+BMGC_DG18447,BMG_DG223838,Enfortumab vedotin | DrugBank ID:DB13007 | PubChem SID:347911415
+BMGC_DG18448,BMG_DG223839,Rovalpituzumab tesirine | DrugBank ID:DB13017 | PubChem SID:347911416
+BMGC_DG18449,BMG_DG223840,Urocortin-2 | PubChem SID:347911417 | DrugBank ID:DB13033
+BMGC_DG18450,BMG_DG223841,DrugBank ID:DB13037 | Namilumab | PubChem SID:347911418
+BMGC_DG18451,BMG_DG223842,Racotumomab | DrugBank ID:DB13045 | PubChem SID:347911419
+BMGC_DG18452,BMG_DG223845,Tregalizumab | DrugBank ID:DB13073 | PubChem SID:347911422
+BMGC_DG18453,BMG_DG223848,Olokizumab | PubChem SID:347911425 | DrugBank ID:DB13127
+BMGC_DG18454,BMG_DG223849,DrugBank ID:DB13128 | PubChem SID:347911426 | Sizofiran
+BMGC_DG18455,BMG_DG223851,DrugBank ID:DB13133 | PubChem SID:347911428 | Von Willebrand factor human
+BMGC_DG18456,BMG_DG223852,PubChem SID:347911429 | Bezlotoxumab | DrugBank ID:DB13140
+BMGC_DG18457,BMG_DG223853,PubChem SID:347911430 | DrugBank ID:DB13144 | Lenograstim
+BMGC_DG18458,BMG_DG223855,Coagulation factor X human | PubChem SID:347911432 | DrugBank ID:DB13148
+BMGC_DG18459,BMG_DG223856,PubChem SID:347911433 | DrugBank ID:DB13149 | Protein S human
+BMGC_DG18460,BMG_DG223857,PubChem SID:347911434 | DrugBank ID:DB13150 | Coagulation factor VII human
+BMGC_DG18461,BMG_DG223858,Anti-inhibitor coagulant complex | DrugBank ID:DB13151 | PubChem SID:347911435
+BMGC_DG18462,BMG_DG223859,DrugBank ID:DB13152 | PubChem SID:347911436 | Coagulation Factor IX Human
+BMGC_DG18463,BMG_DG223860,DrugBank ID:DB13161 | PubChem SID:347911437 | Nusinersen
+BMGC_DG18464,BMG_DG223862,PubChem SID:347911439 | DrugBank ID:DB13172 | Tunicamycin
+BMGC_DG18465,BMG_DG223863,Cerliponase alfa | DrugBank ID:DB13173 | PubChem SID:347911440
+BMGC_DG18466,BMG_DG223864,DrugBank ID:DB13192 | Antihemophilic factor human | PubChem SID:347911441
+BMGC_DG18467,BMG_DG223870,DrugBank ID:DB13293 | Ipecac | PubChem SID:347911447
+BMGC_DG18468,BMG_DG223871,Magnesium aspartate | DrugBank ID:DB13359 | PubChem SID:347911448
+BMGC_DG18469,BMG_DG223872,Potassium guaiacolsulfonate | PubChem SID:347911449 | DrugBank ID:DB13735
+BMGC_DG18470,BMG_DG223874,PubChem SID:347911451 | DrugBank ID:DB13881 | Tisagenlecleucel
+BMGC_DG18471,BMG_DG223876,Albutrepenonacog alfa | PubChem SID:347911453 | DrugBank ID:DB13884
+BMGC_DG18472,BMG_DG223878,Human cytomegalovirus immune globulin | PubChem SID:347911455 | DrugBank ID:DB13886
+BMGC_DG18473,BMG_DG223885,PubChem SID:347911462 | DrugBank ID:DB13893 | Crotalus adamanteus antivenin
+BMGC_DG18474,BMG_DG223886,Agkistrodon piscivorus antivenin | DrugBank ID:DB13894 | PubChem SID:347911463
+BMGC_DG18475,BMG_DG223888,Talimogene laherparepvec | PubChem SID:347911465 | DrugBank ID:DB13896
+BMGC_DG18476,BMG_DG223899,DrugBank ID:DB13915 | PubChem SID:347911476 | Axicabtagene ciloleucel
+BMGC_DG18477,BMG_DG223956,UNII:A52610600U | CAS RN:39382-08-6 | CEPHALINS (WHEAT GERM OIL) | PubChem SID:375083696
+BMGC_DG18478,BMG_DG224322,PubChem SID:383470502 | UNII:B04Z1JB2HS | C16G2
+BMGC_DG18479,BMG_DG224335,UNII:0S9K0E25FL | SUPEROXIDES | PubChem SID:384158413 | CAS RN:11062-77-4
+BMGC_DG18480,BMG_DG224644,Lyme disease vaccine (recombinant OspA) | PubChem SID:46504444 | DrugBank ID:DB00045
+BMGC_DG18481,BMG_DG224645,Insulin glulisine | DrugBank ID:DB01309 | PubChem SID:46504450
+BMGC_DG18482,BMG_DG224646,Interferon beta-1b | DrugBank ID:DB00068 | PubChem SID:46504458
+BMGC_DG18483,BMG_DG224647,PubChem SID:46504469 | Daclizumab | DrugBank ID:DB00111
+BMGC_DG18484,BMG_DG224648,Bevacizumab | DrugBank ID:DB00112 | PubChem SID:46504473
+BMGC_DG18485,BMG_DG224649,Darbepoetin alfa | DrugBank ID:DB00012 | PubChem SID:46504480
+BMGC_DG18486,BMG_DG224650,DrugBank ID:DB00029 | Anistreplase | PubChem SID:46504487
+BMGC_DG18487,BMG_DG224651,Rasburicase | PubChem SID:46504490 | DrugBank ID:DB00049
+BMGC_DG18488,BMG_DG224652,DrugBank ID:DB04895 | Pegaptanib | PubChem SID:46504497
+BMGC_DG18489,BMG_DG224653,Menotropins | PubChem SID:46504503 | DrugBank ID:DB00032
+BMGC_DG18490,BMG_DG224655,DrugBank ID:DB04900 | PubChem SID:46504578 | Thymalfasin
+BMGC_DG18491,BMG_DG224656,Adenosine-5'-ditungstate | PubChem SID:46504581 | DrugBank ID:DB02183
+BMGC_DG18492,BMG_DG224657,PubChem SID:46504595 | DrugBank ID:DB01272 | Alglucosidase alfa
+BMGC_DG18493,BMG_DG224658,Pancrelipase | DrugBank ID:DB00085 | PubChem SID:46504728
+BMGC_DG18494,BMG_DG224659,Glucagon | DrugBank ID:DB00040 | PubChem SID:46504732
+BMGC_DG18495,BMG_DG224660,Botulinum toxin type B | PubChem SID:46504750 | DrugBank ID:DB00042
+BMGC_DG18496,BMG_DG224661,DrugBank ID:DB03404 | Hemin | PubChem SID:46504761
+BMGC_DG18497,BMG_DG224662,DrugBank ID:DB01152 | PubChem SID:46504812 | Candicidin
+BMGC_DG18498,BMG_DG224663,Ephedra sinica root | PubChem SID:46504840 | DrugBank ID:DB01363
+BMGC_DG18499,BMG_DG224664,DrugBank ID:DB00008 | PubChem SID:46504860 | Peginterferon alfa-2a
+BMGC_DG18500,BMG_DG224665,Mecasermin | PubChem SID:46504889 | DrugBank ID:DB01277
+BMGC_DG18501,BMG_DG224666,PubChem SID:46504899 | DrugBank ID:DB00060 | Interferon beta-1a
+BMGC_DG18502,BMG_DG224667,PubChem SID:46504982 | DrugBank ID:DB00051 | Adalimumab
+BMGC_DG18503,BMG_DG224668,PubChem SID:46505063 | Panitumumab | DrugBank ID:DB01269
+BMGC_DG18504,BMG_DG224669,Hyaluronidase (ovine) | DrugBank ID:DB00070 | PubChem SID:46505087
+BMGC_DG18505,BMG_DG224670,Ethiodized oil | PubChem SID:46505147 | DrugBank ID:DB00965
+BMGC_DG18506,BMG_DG224671,DrugBank ID:DB00074 | PubChem SID:46505169 | Basiliximab
+BMGC_DG18507,BMG_DG224672,DrugBank ID:DB00407 | Ardeparin | PubChem SID:46505194
+BMGC_DG18508,BMG_DG224673,PubChem SID:46505252 | DrugBank ID:DB00095 | Efalizumab
+BMGC_DG18509,BMG_DG224674,DrugBank ID:DB05259 | Glatiramer | PubChem SID:46505299
+BMGC_DG18510,BMG_DG224675,DrugBank ID:DB00083 | PubChem SID:46505347 | Botulinum toxin type A
+BMGC_DG18511,BMG_DG224676,Pegaspargase | DrugBank ID:DB00059 | PubChem SID:46505366
+BMGC_DG18512,BMG_DG224677,Eculizumab | DrugBank ID:DB01257 | PubChem SID:46505429
+BMGC_DG18513,BMG_DG224678,DrugBank ID:DB00930 | Colesevelam | PubChem SID:46505437
+BMGC_DG18514,BMG_DG224679,DrugBank ID:DB00063 | Eptifibatide | PubChem SID:46505459
+BMGC_DG18515,BMG_DG224680,PubChem SID:46505507 | DrugBank ID:DB00082 | Pegvisomant
+BMGC_DG18516,BMG_DG224681,Neomycin | DrugBank ID:DB00994 | PubChem SID:46505525
+BMGC_DG18517,BMG_DG224682,Infliximab | PubChem SID:46505602 | DrugBank ID:DB00065
+BMGC_DG18518,BMG_DG224683,DrugBank ID:DB00090 | Laronidase | PubChem SID:46505612
+BMGC_DG18519,BMG_DG224684,DrugBank ID:DB00086 | PubChem SID:46505625 | Streptokinase
+BMGC_DG18520,BMG_DG224685,PubChem SID:46505655 | DrugBank ID:DB00055 | Drotrecogin alfa
+BMGC_DG18521,BMG_DG224686,DrugBank ID:DB00286 | Conjugated estrogens | PubChem SID:46505680
+BMGC_DG18522,BMG_DG224687,DrugBank ID:DB00024 | PubChem SID:46505696 | Thyrotropin alfa
+BMGC_DG18523,BMG_DG224688,PubChem SID:46505767 | Gemtuzumab ozogamicin | DrugBank ID:DB00056
+BMGC_DG18524,BMG_DG224689,PubChem SID:46505772 | Alefacept | DrugBank ID:DB00092
+BMGC_DG18525,BMG_DG224691,DrugBank ID:DB00073 | Rituximab | PubChem SID:46505820
+BMGC_DG18526,BMG_DG224693,DrugBank ID:DB00099 | PubChem SID:46505833 | Filgrastim
+BMGC_DG18527,BMG_DG224694,Natalizumab | DrugBank ID:DB00108 | PubChem SID:46505849
+BMGC_DG18528,BMG_DG224695,Pegfilgrastim | DrugBank ID:DB00019 | PubChem SID:46505853
+BMGC_DG18529,BMG_DG224696,Indium In-111 satumomab pendetide | DrugBank ID:DB00057 | PubChem SID:46505873
+BMGC_DG18530,BMG_DG224697,Abciximab | DrugBank ID:DB00054 | PubChem SID:46505910
+BMGC_DG18531,BMG_DG224698,DrugBank ID:DB00067 | PubChem SID:46505933 | Vasopressin
+BMGC_DG18532,BMG_DG224699,PubChem SID:46505963 | DrugBank ID:DB01049 | Ergoloid mesylate
+BMGC_DG18533,BMG_DG224700,PubChem SID:46505985 | DrugBank ID:DB00069 | Interferon alfacon-1
+BMGC_DG18534,BMG_DG224701,Somatotropin | PubChem SID:46506010 | DrugBank ID:DB00052
+BMGC_DG18535,BMG_DG224702,Salmon calcitonin | DrugBank ID:DB00017 | PubChem SID:46506061
+BMGC_DG18536,BMG_DG224703,DrugBank ID:DB00109 | PubChem SID:46506067 | Enfuvirtide
+BMGC_DG18537,BMG_DG224704,PubChem SID:46506092 | Reteplase | DrugBank ID:DB00015
+BMGC_DG18538,BMG_DG224705,DrugBank ID:DB00078 | Ibritumomab tiuxetan | PubChem SID:46506112
+BMGC_DG18539,BMG_DG224706,PubChem SID:46506136 | DrugBank ID:DB00893 | Iron Dextran
+BMGC_DG18540,BMG_DG224707,DrugBank ID:DB01266 | Sinecatechins | PubChem SID:46506183
+BMGC_DG18541,BMG_DG224708,"Antihemophilic factor, human recombinant | PubChem SID:46506209 | DrugBank ID:DB00025"
+BMGC_DG18542,BMG_DG224709,DrugBank ID:DB00011 | PubChem SID:46506227 | Interferon alfa-n1
+BMGC_DG18543,BMG_DG224710,PubChem SID:46506231 | DrugBank ID:DB00030 | Insulin human
+BMGC_DG18544,BMG_DG224711,Cholestyramine | PubChem SID:46506251 | DrugBank ID:DB01432
+BMGC_DG18545,BMG_DG224712,PubChem SID:46506263 | Capromab pendetide | DrugBank ID:DB00089
+BMGC_DG18546,BMG_DG224713,PubChem SID:46506299 | Urokinase | DrugBank ID:DB00013
+BMGC_DG18547,BMG_DG224714,DrugBank ID:DB01285 | Corticotropin | PubChem SID:46506307
+BMGC_DG18548,BMG_DG224715,DrugBank ID:DB00058 | PubChem SID:46506364 | Alpha-1-proteinase inhibitor
+BMGC_DG18549,BMG_DG224716,Digoxin Immune Fab (Ovine) | PubChem SID:46506432 | DrugBank ID:DB00076
+BMGC_DG18550,BMG_DG224717,Oprelvekin | DrugBank ID:DB00038 | PubChem SID:46506470
+BMGC_DG18551,BMG_DG224718,DrugBank ID:DB00048 | Collagenase clostridium histolyticum | PubChem SID:46506485
+BMGC_DG18552,BMG_DG224719,DrugBank ID:DB01572 | PubChem SID:46506576 | Methyl-1-testosterone
+BMGC_DG18553,BMG_DG224720,DrugBank ID:DB00110 | PubChem SID:46506637 | Palivizumab
+BMGC_DG18554,BMG_DG224721,Tositumomab | PubChem SID:46506662 | DrugBank ID:DB00081
+BMGC_DG18555,BMG_DG224722,Peginterferon alfa-2b | PubChem SID:46506669 | DrugBank ID:DB00022
+BMGC_DG18556,BMG_DG224723,DrugBank ID:DB00039 | PubChem SID:46506691 | Palifermin
+BMGC_DG18557,BMG_DG224724,DrugBank ID:DB00034 | PubChem SID:46506712 | Interferon alfa-2a
+BMGC_DG18558,BMG_DG224725,Etanercept | PubChem SID:46506732 | DrugBank ID:DB00005
+BMGC_DG18559,BMG_DG224726,Oxytocin | PubChem SID:46506775 | DrugBank ID:DB00107
+BMGC_DG18560,BMG_DG224727,PubChem SID:46506863 | Choriogonadotropin alfa | DrugBank ID:DB00097
+BMGC_DG18561,BMG_DG224728,DrugBank ID:DB00098 | Antithymocyte immunoglobulin (rabbit) | PubChem SID:46506920
+BMGC_DG18562,BMG_DG224729,PubChem SID:46506950 | Denileukin diftitox | DrugBank ID:DB00004
+BMGC_DG18563,BMG_DG224730,DrugBank ID:DB01270 | Ranibizumab | PubChem SID:46506960
+BMGC_DG18564,BMG_DG224731,PubChem SID:46507000 | DrugBank ID:DB00020 | Sargramostim
+BMGC_DG18565,BMG_DG224732,PubChem SID:46507002 | Omalizumab | DrugBank ID:DB00043
+BMGC_DG18566,BMG_DG224733,Lepirudin | PubChem SID:46507011 | DrugBank ID:DB00001
+BMGC_DG18567,BMG_DG224734,PubChem SID:46507035 | DrugBank ID:DB00009 | Alteplase
+BMGC_DG18568,BMG_DG224735,DrugBank ID:DB00002 | PubChem SID:46507042 | Cetuximab
+BMGC_DG18569,BMG_DG224736,Interferon alfa-2b | DrugBank ID:DB00105 | PubChem SID:46507075
+BMGC_DG18570,BMG_DG224738,PubChem SID:46507194 | Interferon gamma-1b | DrugBank ID:DB00033
+BMGC_DG18571,BMG_DG224739,PubChem SID:46507309 | Insulin aspart | DrugBank ID:DB01306
+BMGC_DG18572,BMG_DG224740,PubChem SID:46507347 | Idursulfase | DrugBank ID:DB01271
+BMGC_DG18573,BMG_DG224741,DrugBank ID:DB00087 | Alemtuzumab | PubChem SID:46507379
+BMGC_DG18574,BMG_DG224742,Urofollitropin | PubChem SID:46507385 | DrugBank ID:DB00094
+BMGC_DG18575,BMG_DG224743,Sermorelin | PubChem SID:46507399 | DrugBank ID:DB00010
+BMGC_DG18576,BMG_DG224744,PubChem SID:46507450 | DrugBank ID:DB01225 | Enoxaparin
+BMGC_DG18577,BMG_DG224745,PubChem SID:46507498 | DrugBank ID:DB00046 | Insulin lispro
+BMGC_DG18578,BMG_DG224746,DrugBank ID:DB00088 | Alglucerase | PubChem SID:46507500
+BMGC_DG18579,BMG_DG224747,Teicoplanin | PubChem SID:46507509 | DrugBank ID:DB06149
+BMGC_DG18580,BMG_DG224748,DrugBank ID:DB00072 | PubChem SID:46507516 | Trastuzumab
+BMGC_DG18581,BMG_DG224749,PubChem SID:46507544 | DrugBank ID:DB00036 | Coagulation factor VIIa Recombinant Human
+BMGC_DG18582,BMG_DG224750,DrugBank ID:DB01510 | Dehydrochloromethyltestosterone | PubChem SID:46507577
+BMGC_DG18583,BMG_DG224751,DrugBank ID:DB01109 | Heparin | PubChem SID:46507594
+BMGC_DG18584,BMG_DG224752,DrugBank ID:DB00044 | Lutropin alfa | PubChem SID:46507624
+BMGC_DG18585,BMG_DG224753,PubChem SID:46507633 | Asparaginase Escherichia coli | DrugBank ID:DB00023
+BMGC_DG18586,BMG_DG224754,PubChem SID:46507635 | DrugBank ID:DB00007 | Leuprolide
+BMGC_DG18587,BMG_DG224755,Technetium Tc-99m arcitumomab | DrugBank ID:DB00113 | PubChem SID:46507781
+BMGC_DG18588,BMG_DG224756,DrugBank ID:DB00003 | PubChem SID:46507792 | Dornase alfa
+BMGC_DG18589,BMG_DG224757,DrugBank ID:DB00785 | Cryptenamine | PubChem SID:46507822
+BMGC_DG18590,BMG_DG224758,DrugBank ID:DB01344 | Tolevamer | PubChem SID:46507832
+BMGC_DG18591,BMG_DG224760,PubChem SID:46507837 | DrugBank ID:DB00075 | Muromonab
+BMGC_DG18592,BMG_DG224761,PubChem SID:46507869 | St. John's Wort | DrugBank ID:DB01323
+BMGC_DG18593,BMG_DG224762,PubChem SID:46507930 | DrugBank ID:DB01341 | Dihydroquinidine barbiturate
+BMGC_DG18594,BMG_DG224763,Anakinra | PubChem SID:46507944 | DrugBank ID:DB00026
+BMGC_DG18595,BMG_DG224764,PubChem SID:46507981 | DrugBank ID:DB00047 | Insulin glargine
+BMGC_DG18596,BMG_DG224765,DrugBank ID:DB00041 | PubChem SID:46508054 | Aldesleukin
+BMGC_DG18597,BMG_DG224766,DrugBank ID:DB00516 | PubChem SID:46508055 | Bentoquatam
+BMGC_DG18598,BMG_DG224767,Erythropoietin | DrugBank ID:DB00016 | PubChem SID:46508122
+BMGC_DG18599,BMG_DG224768,Defibrotide | DrugBank ID:DB04932 | PubChem SID:46508192
+BMGC_DG18600,BMG_DG224769,PubChem SID:46508246 | DrugBank ID:DB00102 | Becaplermin
+BMGC_DG18601,BMG_DG224770,"2,8-bis[oxido(oxo)vanadio]-1,1,1,3,5,5,7,7,9,9,9-undecaoxopentavanadoxane-2,8-diium | DrugBank ID:DB02681 | PubChem SID:46508307"
+BMGC_DG18602,BMG_DG224772,Pegademase | PubChem SID:46508490 | DrugBank ID:DB00061
+BMGC_DG18603,BMG_DG224773,PubChem SID:46508506 | DrugBank ID:DB04899 | Nesiritide
+BMGC_DG18604,BMG_DG224774,Agalsidase beta | DrugBank ID:DB00103 | PubChem SID:46508538
+BMGC_DG18605,BMG_DG224776,DrugBank ID:DB00707 | Porfimer sodium | PubChem SID:46508600
+BMGC_DG18606,BMG_DG224777,Tenecteplase | DrugBank ID:DB00031 | PubChem SID:46508657
+BMGC_DG18607,BMG_DG224778,Imiglucerase | DrugBank ID:DB00053 | PubChem SID:46508744
+BMGC_DG18608,BMG_DG224779,PubChem SID:46508774 | DrugBank ID:DB00028 | Human immunoglobulin G
+BMGC_DG18609,BMG_DG224780,PubChem SID:46508818 | Follitropin | DrugBank ID:DB00066
+BMGC_DG18610,BMG_DG224781,DrugBank ID:DB01381 | Ginkgo biloba | PubChem SID:46508832
+BMGC_DG18611,BMG_DG224782,Coagulation Factor IX (Recombinant) | DrugBank ID:DB00100 | PubChem SID:46508858
+BMGC_DG18612,BMG_DG224783,PubChem SID:46508877 | DrugBank ID:DB01307 | Insulin detemir
+BMGC_DG18613,BMG_DG224784,PubChem SID:46508902 | Interferon alfa-n3 | DrugBank ID:DB00018
+BMGC_DG18614,BMG_DG224785,Insulin pork | DrugBank ID:DB00071 | PubChem SID:46508925
+BMGC_DG18615,BMG_DG224786,Ginseng | DrugBank ID:DB01404 | PubChem SID:46508934
+BMGC_DG18616,BMG_DG224787,PubChem SID:46509017 | Exenatide | DrugBank ID:DB01276
+BMGC_DG18617,BMG_DG224788,DrugBank ID:DB01278 | PubChem SID:46509048 | Pramlintide
+BMGC_DG18618,BMG_DG224790,PubChem SID:46509151 | Galsulfase | DrugBank ID:DB01279
+BMGC_DG18619,BMG_DG224791,PubChem SID:46509198 | Abatacept | DrugBank ID:DB01281
+BMGC_DG18620,BMG_DG227480,FIBRINOLYSIN | UNII:A4028U842W | PubChem SID:472388936 | CAS RN:9001-90-5
+BMGC_DG18621,BMG_DG235854,NDC:13411-856 | NDC:13411-858 | UNII:6IC1M3OG5Z | CHONDROITIN SULFATE (BOVINE) | CAS RN:9007-28-7 | PubChem SID:472397447
+BMGC_DG18622,BMG_DG236441,"PubChem SID:472406995 | PubChem SID:472398216 | NDC:63736-305 | NDC:83566-238 | STARCH, TAPIOCA | UNII:8I089SAH3T | STARCH, POTATO | UNII:79QS2MG2LP | PubChem SID:472404736 | UNII:4DGK8B7I3S | NDC:11523-0259 | STARCH, WHEAT | UNII:904CE6697V | NDC:0363-0911 | PubChem SID:472398065 | STARCH, RICE | PubChem SID:472398061 | STARCH, OAT | NDC:63736-306 | PubChem SID:472400638 | UNII:O8232NY3SJ | STARCH, PEA | UNII:YAQ9FOE480 | UNII:24SC3U704I | STARCH, CORN | PubChem SID:472388156 | CAS RN:9005-25-8 | NDC:11523-0012"
+BMGC_DG18623,BMG_DG236564,NDC:63713-461 | UNII:6K15ABL77G | PubChem SID:472398203 | HUMAN THROMBIN | CAS RN:9002-04-4
+BMGC_DG18624,BMG_DG239119,CAS RN:9002-05-5 | THROMBOPLASTIN | PubChem SID:472400922 | UNII:1U5PI2DLU1
+BMGC_DG18625,BMG_DG242246,UNII:DF35I47HCM | CAS RN:9007-12-9 | PubChem SID:472404595 | CALCITONIN
+BMGC_DG18626,BMG_DG244301,UNII:7CVR7L4A2D | CAS RN:9050-36-6 | PubChem SID:472407398 | MALTODEXTRIN
+BMGC_DG18627,BMG_DG253708,CHITIN | PubChem SID:472418722 | CAS RN:1398-61-4 | UNII:8SH93A7QWW
+BMGC_DG18628,BMG_DG254779,YEAST .BETA.-D-GLUCAN | NDC:84611-101 | CAS RN:9041-22-9 | PubChem SID:472419893 | UNII:44FQ49X6UN
+BMGC_DG18629,BMG_DG255060,NDC:84025-313 | NDC:83872-048 | NDC:83872-041 | NDC:83872-277 | NDC:84732-077 | UNII:B7SG5YV2SI | PubChem SID:472406838 | PubChem SID:472420199 | NDC:84025-305 | NDC:83872-276 | NDC:84660-041 | NDC:84025-315 | NDC:83872-044 | NDC:84732-078 | NDC:84019-023 | NDC:84732-096 | NDC:83872-039 | NDC:83872-121 | NDC:84732-013 | NDC:74458-200 | NDC:84025-310 | NDC:84775-063 | NDC:83872-042 | NDC:83872-055 | NDC:84025-295 | NDC:83872-140 | NDC:84025-318 | NDC:83872-040 | NDC:83872-049 | NDC:84025-316 | NDC:84732-012 | NDC:83872-019 | NDC:83872-036 | NDC:84372-052 | NDC:83872-037 | HYALURONIC ACID | NDC:83872-062 | NDC:83872-050 | NDC:83872-030 | NDC:83872-141 | NDC:83872-440 | NDC:83872-445 | NDC:83872-053 | NDC:83872-453 | NDC:84025-312 | NDC:85117-001 | CAS RN:9004-61-9 | NDC:77039-031 | NDC:83872-038 | NDC:83872-047 | NDC:83872-035 | NDC:83872-043 | NDC:83872-046 | NDC:84025-320 | UNII:S270N0TRQY | HYALURONIC ACID (NON-ANIMAL STABILIZED) | NDC:84372-051 | NDC:83872-052 | NDC:83872-033 | NDC:84025-107 | NDC:83872-118 | NDC:84025-317 | NDC:84025-309 | NDC:84025-304 | NDC:84025-319 | NDC:83872-054 | NDC:84785-0009 | NDC:84732-067 | NDC:83872-045 | NDC:84025-094 | NDC:84025-311
+BMGC_DG18630,BMG_DG255620,FIBRIN | PubChem SID:472420792 | CAS RN:9001-31-4 | UNII:AQ4K8I4R6F
+BMGC_DG18631,BMG_DG258417,UNII:7528N5H79B | CAS RN:64-17-5 | PubChem SID:472425664 | ALCOHOL 95%
+BMGC_DG18632,BMG_DG259758,CYTOCHROME C | UNII:Q5ED5J76AX | PubChem SID:482554369 | CAS RN:9007-43-6
+BMGC_DG18633,BMG_DG260880,DrugBank ID:DB08276 | trifluoro-[hydroxy-[hydroxy-[2-(N-methyl-2-nitro-anilino)ethoxy]phosphoryl]oxy-phosphoryl]oxy-beryllium(1-) | PubChem SID:99444747
+BMGC_DG18634,BMG_DG261549,"UNII:VAD2K35XAJ | CAS RN:9004-53-9 | DEXTRIN, CORN"
+BMGC_DG18635,BMG_DG262179,Desmopressin | DrugBank ID:DB00035
+BMGC_DG18636,BMG_DG262180,Polymyxin B | DrugBank ID:DB00781
+BMGC_DG18637,BMG_DG262181,Loteprednol | DrugBank ID:DB00873
+BMGC_DG18638,BMG_DG262183,DrugBank ID:DB05085 | TM30339
+BMGC_DG18639,BMG_DG262184,DrugBank ID:DB05467 | Palovarotene
+BMGC_DG18640,BMG_DG262185,DrugBank ID:DB05513 | Atiprimod
+BMGC_DG18641,BMG_DG262186,DrugBank ID:DB05514 | Cobiprostone
+BMGC_DG18642,BMG_DG262188,Managlinat dialanetil | DrugBank ID:DB05518
+BMGC_DG18643,BMG_DG262191,DrugBank ID:DB05524 | Pelitinib
+BMGC_DG18644,BMG_DG262193,DrugBank ID:DB05530 | CPG 10101
+BMGC_DG18645,BMG_DG262195,DrugBank ID:DB05532 | BMS-488043
+BMGC_DG18646,BMG_DG262196,QR-333 | DrugBank ID:DB05533
+BMGC_DG18647,BMG_DG262198,Naronapride | DrugBank ID:DB05542
+BMGC_DG18648,BMG_DG262199,DrugBank ID:DB05545 | AMG 108
+BMGC_DG18649,BMG_DG262203,DrugBank ID:DB05550 | Iratumumab
+BMGC_DG18650,BMG_DG262204,DrugBank ID:DB05552 | TG100-115
+BMGC_DG18651,BMG_DG262205,DrugBank ID:DB05553 | Regrelor
+BMGC_DG18652,BMG_DG262206,Enokizumab | DrugBank ID:DB05555
+BMGC_DG18653,BMG_DG262207,DrugBank ID:DB05559 | NF-kappaB Decoy
+BMGC_DG18654,BMG_DG262208,Delcasertib | DrugBank ID:DB05560
+BMGC_DG18655,BMG_DG262209,Naluzotan | DrugBank ID:DB05562
+BMGC_DG18656,BMG_DG262210,PBT-1033 | DrugBank ID:DB05565
+BMGC_DG18657,BMG_DG262212,Motesanib | DrugBank ID:DB05575
+BMGC_DG18658,BMG_DG262218,DrugBank ID:DB05586 | Facinicline
+BMGC_DG18659,BMG_DG262220,Bedoradrine | DrugBank ID:DB05590
+BMGC_DG18660,BMG_DG262221,Blarcamesine | DrugBank ID:DB05592
+BMGC_DG18661,BMG_DG262229,DrugBank ID:DB05607 | PRX-08066
+BMGC_DG18662,BMG_DG262230,DrugBank ID:DB05608 | MKC-1
+BMGC_DG18663,BMG_DG262231,DrugBank ID:DB05611 | Apilimod
+BMGC_DG18664,BMG_DG262236,Teverelix | DrugBank ID:DB05624
+BMGC_DG18665,BMG_DG262237,CTCE-9908 | DrugBank ID:DB05625
+BMGC_DG18666,BMG_DG262239,ALT-2074 | DrugBank ID:DB05631
+BMGC_DG18667,BMG_DG262244,DrugBank ID:DB05642 | DDP-225
+BMGC_DG18668,BMG_DG262247,DrugBank ID:DB05645 | Larazotide
+BMGC_DG18669,BMG_DG262248,DrugBank ID:DB05646 | VT-111
+BMGC_DG18670,BMG_DG262250,DrugBank ID:DB05653 | IRX-5183
+BMGC_DG18671,BMG_DG262251,DrugBank ID:DB05656 | Veltuzumab
+BMGC_DG18672,BMG_DG262252,D-JNKI-1 | DrugBank ID:DB05660
+BMGC_DG18673,BMG_DG262253,Levoketoconazole | DrugBank ID:DB05667
+BMGC_DG18674,BMG_DG262254,DrugBank ID:DB05668 | Palifosfamide
+BMGC_DG18675,BMG_DG262257,NV-52 | DrugBank ID:DB05673
+BMGC_DG18676,BMG_DG262258,DrugBank ID:DB05678 | SLx-4090
+BMGC_DG18677,BMG_DG262262,NPS-2143 | DrugBank ID:DB05695
+BMGC_DG18678,BMG_DG262263,Trabedersen | DrugBank ID:DB05697
+BMGC_DG18679,BMG_DG262265,13-deoxydoxorubicin | DrugBank ID:DB05706
+BMGC_DG18680,BMG_DG262266,Flovagatran | DrugBank ID:DB05714
+BMGC_DG18681,BMG_DG262268,EVT 201 | DrugBank ID:DB05721
+BMGC_DG18682,BMG_DG262269,alpha-Conotoxin VC 1.1 | DrugBank ID:DB05724
+BMGC_DG18683,BMG_DG262275,Pegdinetanib | DrugBank ID:DB05931
+BMGC_DG18684,BMG_DG262276,Denibulin | DrugBank ID:DB05932
+BMGC_DG18685,BMG_DG262277,DrugBank ID:DB05933 | MK-4721
+BMGC_DG18686,BMG_DG262278,CTCE-0214 | DrugBank ID:DB05934
+BMGC_DG18687,BMG_DG262280,CVT-6883 | DrugBank ID:DB05936
+BMGC_DG18688,BMG_DG262281,DrugBank ID:DB05938 | Edonerpic
+BMGC_DG18689,BMG_DG262282,MK-0354 | DrugBank ID:DB05939
+BMGC_DG18690,BMG_DG262283,Leronlimab | DrugBank ID:DB05941
+BMGC_DG18691,BMG_DG262284,DrugBank ID:DB05942 | GI-5005
+BMGC_DG18692,BMG_DG262285,DrugBank ID:DB05943 | Resatorvid
+BMGC_DG18693,BMG_DG262286,MDX-1303 | DrugBank ID:DB05945
+BMGC_DG18694,BMG_DG262287,DrugBank ID:DB05946 | KOS-2187
+BMGC_DG18695,BMG_DG262290,DrugBank ID:DB05950 | Contulakin-G
+BMGC_DG18696,BMG_DG262291,DrugBank ID:DB05951 | CRA-028129
+BMGC_DG18697,BMG_DG262293,DrugBank ID:DB05956 | EVT-101
+BMGC_DG18698,BMG_DG262295,DrugBank ID:DB05959 | ENMD-1198
+BMGC_DG18699,BMG_DG262296,DrugBank ID:DB05961 | PPL-100
+BMGC_DG18700,BMG_DG262297,DrugBank ID:DB05964 | Amitifadine
+BMGC_DG18701,BMG_DG262298,TAS-108 | DrugBank ID:DB05966
+BMGC_DG18702,BMG_DG262299,ANZ-100 | DrugBank ID:DB05967
+BMGC_DG18703,BMG_DG262300,DrugBank ID:DB05968 | PR-104
+BMGC_DG18704,BMG_DG262301,DrugBank ID:DB05969 | SNS-032
+BMGC_DG18705,BMG_DG262302,DrugBank ID:DB05970 | LY-2599506
+BMGC_DG18706,BMG_DG262303,Archexin | DrugBank ID:DB05971
+BMGC_DG18707,BMG_DG262305,DrugBank ID:DB05974 | Transcrocetinate
+BMGC_DG18708,BMG_DG262306,DrugBank ID:DB05981 | MN-246
+BMGC_DG18709,BMG_DG262307,DrugBank ID:DB05983 | Bardoxolone methyl
+BMGC_DG18710,BMG_DG262308,DrugBank ID:DB05984 | RAF-265
+BMGC_DG18711,BMG_DG262310,DrugBank ID:DB05992 | Plinabulin
+BMGC_DG18712,BMG_DG262311,DrugBank ID:DB05993 | PRX-07034
+BMGC_DG18713,BMG_DG262312,DrugBank ID:DB05996 | Glembatumumab vedotin
+BMGC_DG18714,BMG_DG262313,DrugBank ID:DB05998 | T-5224
+BMGC_DG18715,BMG_DG262317,ATHX-105 | DrugBank ID:DB06008
+BMGC_DG18716,BMG_DG262318,AMG-222 | DrugBank ID:DB06011
+BMGC_DG18717,BMG_DG262319,Aldoxorubicin | DrugBank ID:DB06013
+BMGC_DG18718,BMG_DG262320,DrugBank ID:DB06017 | C326
+BMGC_DG18719,BMG_DG262322,AV-412 | DrugBank ID:DB06021
+BMGC_DG18720,BMG_DG262323,DrugBank ID:DB06022 | GlycoPEG-GCSF
+BMGC_DG18721,BMG_DG262325,NGD-4715 | DrugBank ID:DB06027
+BMGC_DG18722,BMG_DG262326,DrugBank ID:DB06029 | BF-1
+BMGC_DG18723,BMG_DG262329,PR-15 | DrugBank ID:DB06037
+BMGC_DG18724,BMG_DG262330,Filanesib | DrugBank ID:DB06040
+BMGC_DG18725,BMG_DG262331,DrugBank ID:DB06044 | TC-2216
+BMGC_DG18726,BMG_DG262332,DrugBank ID:DB06045 | Trofinetide
+BMGC_DG18727,BMG_DG262333,DrugBank ID:DB06048 | RTP-801i
+BMGC_DG18728,BMG_DG262334,DrugBank ID:DB06049 | IPH 2101
+BMGC_DG18729,BMG_DG262335,DrugBank ID:DB06050 | TB-402
+BMGC_DG18730,BMG_DG262336,POT-4 | DrugBank ID:DB06056
+BMGC_DG18731,BMG_DG262337,DrugBank ID:DB06057 | EVT 302
+BMGC_DG18732,BMG_DG262339,DrugBank ID:DB06072 | Citatuzumab Bogatox
+BMGC_DG18733,BMG_DG262340,DrugBank ID:DB06075 | Linsitinib
+BMGC_DG18734,BMG_DG262341,DrugBank ID:DB06081 | Caplacizumab
+BMGC_DG18735,BMG_DG262342,PX-478 | DrugBank ID:DB06082
+BMGC_DG18736,BMG_DG262343,DrugBank ID:DB06083 | Tapinarof
+BMGC_DG18737,BMG_DG262344,DrugBank ID:DB06086 | Affitope AD01
+BMGC_DG18738,BMG_DG262347,DrugBank ID:DB06099 | ISIS 325568
+BMGC_DG18739,BMG_DG262350,YKP-1358 | DrugBank ID:DB06109
+BMGC_DG18740,BMG_DG262351,MDX-214 | DrugBank ID:DB06110
+BMGC_DG18741,BMG_DG262355,Eldelumab | DrugBank ID:DB06116
+BMGC_DG18742,BMG_DG262356,"1alpha,24S-Dihydroxyvitamin D2 | DrugBank ID:DB06117"
+BMGC_DG18743,BMG_DG262358,Cenobamate | DrugBank ID:DB06119
+BMGC_DG18744,BMG_DG262359,DrugBank ID:DB06121 | DPI-221
+BMGC_DG18745,BMG_DG262360,DrugBank ID:DB06124 | L-aminocarnityl-succinyl-leucyl-argininal-diethylacetal
+BMGC_DG18746,BMG_DG262361,Dimethylcurcumin | DrugBank ID:DB06133
+BMGC_DG18747,BMG_DG262362,DrugBank ID:DB06134 | SNS-314
+BMGC_DG18748,BMG_DG262363,DrugBank ID:DB06137 | Tirbanibulin
+BMGC_DG18749,BMG_DG262364,DrugBank ID:DB06138 | IRL-1620
+BMGC_DG18750,BMG_DG262366,SUVN-502 | DrugBank ID:DB06140
+BMGC_DG18751,BMG_DG262367,DrugBank ID:DB06143 | Aminoimidazole carboxamide
+BMGC_DG18752,BMG_DG262368,DrugBank ID:DB06156 | Tesofensine
+BMGC_DG18753,BMG_DG262369,DrugBank ID:DB06157 | Istaroxime
+BMGC_DG18754,BMG_DG262370,DrugBank ID:DB06160 | Garenoxacin
+BMGC_DG18755,BMG_DG262372,DrugBank ID:DB06162 | Lumiliximab
+BMGC_DG18756,BMG_DG262373,DrugBank ID:DB06163 | Plevitrexed
+BMGC_DG18757,BMG_DG262375,Indibulin | DrugBank ID:DB06169
+BMGC_DG18758,BMG_DG262376,Paclitaxel trevatide | DrugBank ID:DB06171
+BMGC_DG18759,BMG_DG262377,Noscapine | DrugBank ID:DB06174
+BMGC_DG18760,BMG_DG262380,Talotrexin | DrugBank ID:DB06178
+BMGC_DG18761,BMG_DG262381,DrugBank ID:DB06179 | Darinaparsin
+BMGC_DG18762,BMG_DG262383,EMD-1201081 | DrugBank ID:DB06181
+BMGC_DG18763,BMG_DG262384,Talabostat | DrugBank ID:DB06182
+BMGC_DG18764,BMG_DG262385,DrugBank ID:DB06184 | AEG35156
+BMGC_DG18765,BMG_DG262387,DrugBank ID:DB06188 | Ispinesib
+BMGC_DG18766,BMG_DG262388,Nimotuzumab | DrugBank ID:DB06192
+BMGC_DG18767,BMG_DG262389,DrugBank ID:DB06197 | Bimosiamose
+BMGC_DG18768,BMG_DG262390,DrugBank ID:DB06198 | Alovudine
+BMGC_DG18769,BMG_DG262392,Alicaforsen | DrugBank ID:DB06224
+BMGC_DG18770,BMG_DG262394,DrugBank ID:DB06226 | Nelipepimut-S
+BMGC_DG18771,BMG_DG262395,DrugBank ID:DB06229 | Ocaperidone
+BMGC_DG18772,BMG_DG262396,Nalmefene | DrugBank ID:DB06230
+BMGC_DG18773,BMG_DG262397,Caldaret | DrugBank ID:DB06231
+BMGC_DG18774,BMG_DG262398,DrugBank ID:DB06233 | Ridaforolimus
+BMGC_DG18775,BMG_DG262399,DrugBank ID:DB06234 | Maribavir
+BMGC_DG18776,BMG_DG262400,DrugBank ID:DB06236 | Elvucitabine
+BMGC_DG18777,BMG_DG262402,DrugBank ID:DB06240 | Tariquidar
+BMGC_DG18778,BMG_DG262403,DrugBank ID:DB06241 | Clenoliximab
+BMGC_DG18779,BMG_DG262404,Trafermin | DrugBank ID:DB06244
+BMGC_DG18780,BMG_DG262405,DrugBank ID:DB06245 | Lanoteplase
+BMGC_DG18781,BMG_DG262406,DrugBank ID:DB06246 | Exisulind
+BMGC_DG18782,BMG_DG262407,CX516 | DrugBank ID:DB06247
+BMGC_DG18783,BMG_DG262408,DrugBank ID:DB06248 | Amelubant
+BMGC_DG18784,BMG_DG262409,DrugBank ID:DB06249 | Arzoxifene
+BMGC_DG18785,BMG_DG262410,Fluasterone | DrugBank ID:DB06250
+BMGC_DG18786,BMG_DG262411,DrugBank ID:DB06251 | Dersalazine
+BMGC_DG18787,BMG_DG262412,DrugBank ID:DB06252 | R112
+BMGC_DG18788,BMG_DG262417,DrugBank ID:DB06264 | Tolperisone
+BMGC_DG18789,BMG_DG262419,DrugBank ID:DB06272 | Maxacalcitol
+BMGC_DG18790,BMG_DG262420,Tanomastat | DrugBank ID:DB06276
+BMGC_DG18791,BMG_DG262421,Senicapoc | DrugBank ID:DB06280
+BMGC_DG18792,BMG_DG262422,Pegnivacogin | DrugBank ID:DB06293
+BMGC_DG18793,BMG_DG262423,DrugBank ID:DB06294 | Semuloparin
+BMGC_DG18794,BMG_DG262425,DrugBank ID:DB06297 | LX-2931
+BMGC_DG18795,BMG_DG262427,Glesatinib | DrugBank ID:DB06302
+BMGC_DG18796,BMG_DG262429,DrugBank ID:DB06304 | BIIB015
+BMGC_DG18797,BMG_DG262430,DrugBank ID:DB06305 | Sonepcizumab
+BMGC_DG18798,BMG_DG262431,Onalespib | DrugBank ID:DB06306
+BMGC_DG18799,BMG_DG262432,Apoptone | DrugBank ID:DB06307
+BMGC_DG18800,BMG_DG262435,DrugBank ID:DB06310 | Motavizumab
+BMGC_DG18801,BMG_DG262436,DrugBank ID:DB06311 | Darapladib
+BMGC_DG18802,BMG_DG262438,DrugBank ID:DB06314 | SGX-523
+BMGC_DG18803,BMG_DG262439,DrugBank ID:DB06315 | ISF402
+BMGC_DG18804,BMG_DG262440,R343 | DrugBank ID:DB06316
+BMGC_DG18805,BMG_DG262441,AVE9633 | DrugBank ID:DB06318
+BMGC_DG18806,BMG_DG262442,DrugBank ID:DB06319 | XP21279
+BMGC_DG18807,BMG_DG262443,R-348 | DrugBank ID:DB06321
+BMGC_DG18808,BMG_DG262444,Carotuximab | DrugBank ID:DB06322
+BMGC_DG18809,BMG_DG262446,DrugBank ID:DB06324 | XmAb 2513
+BMGC_DG18810,BMG_DG262447,DrugBank ID:DB06325 | Pegpleranib
+BMGC_DG18811,BMG_DG262449,Methoxyamine | DrugBank ID:DB06328
+BMGC_DG18812,BMG_DG262450,RG-7795 | DrugBank ID:DB06329
+BMGC_DG18813,BMG_DG262452,Trodusquemine | DrugBank ID:DB06333
+BMGC_DG18814,BMG_DG262453,Tucidinostat | DrugBank ID:DB06334
+BMGC_DG18815,BMG_DG262456,DrugBank ID:DB06342 | Coltuximab ravtansine
+BMGC_DG18816,BMG_DG262457,DrugBank ID:DB06343 | Teprotumumab
+BMGC_DG18817,BMG_DG262458,DrugBank ID:DB06345 | AR-9281
+BMGC_DG18818,BMG_DG262459,Fiboflapon | DrugBank ID:DB06346
+BMGC_DG18819,BMG_DG262460,DrugBank ID:DB06347 | Cenisertib
+BMGC_DG18820,BMG_DG262462,DrugBank ID:DB06350 | Elinogrel
+BMGC_DG18821,BMG_DG262465,DrugBank ID:DB06354 | Tezampanel
+BMGC_DG18822,BMG_DG262467,DrugBank ID:DB06356 | TRC093
+BMGC_DG18823,BMG_DG262468,DrugBank ID:DB06358 | Iclaprim
+BMGC_DG18824,BMG_DG262469,DrugBank ID:DB06359 | G4460
+BMGC_DG18825,BMG_DG262470,DrugBank ID:DB06360 | Lucatumumab
+BMGC_DG18826,BMG_DG262472,Becatecarin | DrugBank ID:DB06362
+BMGC_DG18827,BMG_DG262474,XR5944 | DrugBank ID:DB06364
+BMGC_DG18828,BMG_DG262475,DrugBank ID:DB06365 | Sapacitabine
+BMGC_DG18829,BMG_DG262476,DrugBank ID:DB06367 | Relacatib
+BMGC_DG18830,BMG_DG262477,DrugBank ID:DB06371 | Siplizumab
+BMGC_DG18831,BMG_DG262478,DrugBank ID:DB06373 | ASI402
+BMGC_DG18832,BMG_DG262479,DrugBank ID:DB06374 | Elacestrant
+BMGC_DG18833,BMG_DG262481,CHGN111 | DrugBank ID:DB06376
+BMGC_DG18834,BMG_DG262482,Calcitonin gene-related peptide | DrugBank ID:DB06379
+BMGC_DG18835,BMG_DG262488,DrugBank ID:DB06391 | T611
+BMGC_DG18836,BMG_DG262489,Xaliproden | DrugBank ID:DB06393
+BMGC_DG18837,BMG_DG262491,DrugBank ID:DB06397 | Nicaraven
+BMGC_DG18838,BMG_DG262493,DrugBank ID:DB06400 | Vitespen
+BMGC_DG18839,BMG_DG262495,DrugBank ID:DB06406 | Idraparinux
+BMGC_DG18840,BMG_DG262496,Taribavirin | DrugBank ID:DB06408
+BMGC_DG18841,BMG_DG262497,DrugBank ID:DB06409 | Morphine glucuronide
+BMGC_DG18842,BMG_DG262498,Annamycin | DrugBank ID:DB06420
+BMGC_DG18843,BMG_DG262499,Declopramide | DrugBank ID:DB06421
+BMGC_DG18844,BMG_DG262500,Ticalopride | DrugBank ID:DB06422
+BMGC_DG18845,BMG_DG262501,DrugBank ID:DB06423 | Endostatin
+BMGC_DG18846,BMG_DG262506,Tarazepide | DrugBank ID:DB06435
+BMGC_DG18847,BMG_DG262508,Avasimibe | DrugBank ID:DB06442
+BMGC_DG18848,BMG_DG262509,DrugBank ID:DB06445 | Diethylnorspermine
+BMGC_DG18849,BMG_DG262510,E5531 | DrugBank ID:DB06447
+BMGC_DG18850,BMG_DG262513,Aprinocarsen | DrugBank ID:DB06451
+BMGC_DG18851,BMG_DG262515,Sarizotan | DrugBank ID:DB06454
+BMGC_DG18852,BMG_DG262516,DrugBank ID:DB06455 | Meclinertant
+BMGC_DG18853,BMG_DG262517,Tecastemizole | DrugBank ID:DB06457
+BMGC_DG18854,BMG_DG262518,DrugBank ID:DB06458 | Remacemide
+BMGC_DG18855,BMG_DG262519,Enrasentan | DrugBank ID:DB06460
+BMGC_DG18856,BMG_DG262520,DrugBank ID:DB06461 | Squalamine
+BMGC_DG18857,BMG_DG262525,DrugBank ID:DB06467 | Apolizumab
+BMGC_DG18858,BMG_DG262526,DrugBank ID:DB06468 | Cariporide
+BMGC_DG18859,BMG_DG262527,Lestaurtinib | DrugBank ID:DB06469
+BMGC_DG18860,BMG_DG262528,DrugBank ID:DB06472 | Fradafiban
+BMGC_DG18861,BMG_DG262529,Sibrotuzumab | DrugBank ID:DB06474
+BMGC_DG18862,BMG_DG262530,DrugBank ID:DB06475 | Ruplizumab
+BMGC_DG18863,BMG_DG262531,Sumanirole | DrugBank ID:DB06477
+BMGC_DG18864,BMG_DG262532,DrugBank ID:DB06478 | Porfiromycin
+BMGC_DG18865,BMG_DG262533,Propentofylline | DrugBank ID:DB06479
+BMGC_DG18866,BMG_DG262534,Manitimus | DrugBank ID:DB06481
+BMGC_DG18867,BMG_DG262536,PW2101 | DrugBank ID:DB06483
+BMGC_DG18868,BMG_DG262537,FK352B | DrugBank ID:DB06484
+BMGC_DG18869,BMG_DG262539,DrugBank ID:DB06486 | Enzastaurin
+BMGC_DG18870,BMG_DG262541,ANA975 | DrugBank ID:DB06490
+BMGC_DG18871,BMG_DG262542,Mirococept | DrugBank ID:DB06492
+BMGC_DG18872,BMG_DG262544,Sufugolix | DrugBank ID:DB06494
+BMGC_DG18873,BMG_DG262545,DrugBank ID:DB06495 | Onercept
+BMGC_DG18874,BMG_DG262547,Aplaviroc | DrugBank ID:DB06497
+BMGC_DG18875,BMG_DG262551,MLN2222 | DrugBank ID:DB06503
+BMGC_DG18876,BMG_DG262552,S-8510 | DrugBank ID:DB06504
+BMGC_DG18877,BMG_DG262553,DrugBank ID:DB06505 | MLN3897
+BMGC_DG18878,BMG_DG262554,Repinotan | DrugBank ID:DB06506
+BMGC_DG18879,BMG_DG262555,DrugBank ID:DB06508 | GW-559090
+BMGC_DG18880,BMG_DG262556,Muraglitazar | DrugBank ID:DB06510
+BMGC_DG18881,BMG_DG262557,AMGN-0007 | DrugBank ID:DB06511
+BMGC_DG18882,BMG_DG262559,DrugBank ID:DB06517 | MLN576
+BMGC_DG18883,BMG_DG262560,DrugBank ID:DB06518 | R-1487
+BMGC_DG18884,BMG_DG262561,DrugBank ID:DB06519 | Edaglitazone
+BMGC_DG18885,BMG_DG262562,DrugBank ID:DB06521 | Ertiprotafib
+BMGC_DG18886,BMG_DG262564,Ganstigmine | DrugBank ID:DB06525
+BMGC_DG18887,BMG_DG262565,DrugBank ID:DB06527 | Tramiprosate
+BMGC_DG18888,BMG_DG262566,DrugBank ID:DB06529 | Ocinaplon
+BMGC_DG18889,BMG_DG262567,DrugBank ID:DB06530 | Resiquimod
+BMGC_DG18890,BMG_DG262569,Pafuramidine | DrugBank ID:DB06532
+BMGC_DG18891,BMG_DG262570,Ragaglitazar | DrugBank ID:DB06533
+BMGC_DG18892,BMG_DG262571,Thrombopoietin | DrugBank ID:DB06534
+BMGC_DG18893,BMG_DG262572,Etilevodopa | DrugBank ID:DB06535
+BMGC_DG18894,BMG_DG262573,Robalzotan | DrugBank ID:DB06538
+BMGC_DG18895,BMG_DG262576,MG98 | DrugBank ID:DB06544
+BMGC_DG18896,BMG_DG262578,Atibuclimab | DrugBank ID:DB06546
+BMGC_DG18897,BMG_DG262579,Minodronic acid | DrugBank ID:DB06548
+BMGC_DG18898,BMG_DG262580,Labradimil | DrugBank ID:DB06549
+BMGC_DG18899,BMG_DG262581,DrugBank ID:DB06550 | Bivatuzumab
+BMGC_DG18900,BMG_DG262582,Anpocogin | DrugBank ID:DB06552
+BMGC_DG18901,BMG_DG262584,DrugBank ID:DB06555 | Siramesine
+BMGC_DG18902,BMG_DG262586,DrugBank ID:DB06557 | Lerdelimumab
+BMGC_DG18903,BMG_DG262588,Pascolizumab | DrugBank ID:DB06560
+BMGC_DG18904,BMG_DG262596,DrugBank ID:DB06575 | Valomaciclovir
+BMGC_DG18905,BMG_DG262598,DrugBank ID:DB06578 | Tonabersat
+BMGC_DG18906,BMG_DG262599,Celgosivir | DrugBank ID:DB06580
+BMGC_DG18907,BMG_DG262600,DrugBank ID:DB06582 | Dextofisopam
+BMGC_DG18908,BMG_DG262601,DrugBank ID:DB06584 | TG4010
+BMGC_DG18909,BMG_DG262603,Mitemcinal | DrugBank ID:DB06587
+BMGC_DG18910,BMG_DG262607,DrugBank ID:DB06597 | Estradiol sulfamate
+BMGC_DG18911,BMG_DG262609,DrugBank ID:DB06599 | Lexatumumab
+BMGC_DG18912,BMG_DG262610,DrugBank ID:DB06600 | Nemonoxacin
+BMGC_DG18913,BMG_DG262611,Ilepatril | DrugBank ID:DB06604
+BMGC_DG18914,BMG_DG262612,DrugBank ID:DB06606 | Teplizumab
+BMGC_DG18915,BMG_DG262613,DrugBank ID:DB06607 | Catumaxomab
+BMGC_DG18916,BMG_DG262614,DrugBank ID:DB06608 | Tafenoquine
+BMGC_DG18917,BMG_DG262615,DrugBank ID:DB06609 | Odiparcil
+BMGC_DG18918,BMG_DG262617,DrugBank ID:DB06611 | Pegsunercept
+BMGC_DG18919,BMG_DG262618,DrugBank ID:DB06618 | Cutamesine
+BMGC_DG18920,BMG_DG262620,Aplindore | DrugBank ID:DB06620
+BMGC_DG18921,BMG_DG262622,DrugBank ID:DB06622 | 7-beta-Hydroxyepiandrosterone
+BMGC_DG18922,BMG_DG262623,Taranabant | DrugBank ID:DB06624
+BMGC_DG18923,BMG_DG262624,Vipadenant | DrugBank ID:DB06625
+BMGC_DG18924,BMG_DG262626,DrugBank ID:DB06629 | Zibotentan
+BMGC_DG18925,BMG_DG262627,Anacetrapib | DrugBank ID:DB06630
+BMGC_DG18926,BMG_DG262629,Casopitant | DrugBank ID:DB06634
+BMGC_DG18927,BMG_DG262630,DrugBank ID:DB06638 | Quarfloxin
+BMGC_DG18928,BMG_DG262632,DrugBank ID:DB06641 | Perifosine
+BMGC_DG18929,BMG_DG262633,DrugBank ID:DB06642 | Bevasiranib
+BMGC_DG18930,BMG_DG262634,Anamorelin | DrugBank ID:DB06645
+BMGC_DG18931,BMG_DG262635,DrugBank ID:DB06647 | Volociximab
+BMGC_DG18932,BMG_DG262636,Priralfinamide | DrugBank ID:DB06649
+BMGC_DG18933,BMG_DG262637,DrugBank ID:DB06651 | DiaPep 277
+BMGC_DG18934,BMG_DG262638,Vicriviroc | DrugBank ID:DB06652
+BMGC_DG18935,BMG_DG262641,Rostaporfin | DrugBank ID:DB06659
+BMGC_DG18936,BMG_DG262642,DrugBank ID:DB06660 | Saredutant
+BMGC_DG18937,BMG_DG262644,Abetimus | DrugBank ID:DB06662
+BMGC_DG18938,BMG_DG262645,DrugBank ID:DB06666 | Lixivaptan
+BMGC_DG18939,BMG_DG262647,DrugBank ID:DB06673 | Almorexant
+BMGC_DG18940,BMG_DG262648,Clazosentan | DrugBank ID:DB06677
+BMGC_DG18941,BMG_DG262649,Amediplase | DrugBank ID:DB06679
+BMGC_DG18942,BMG_DG262650,Asoprisnil | DrugBank ID:DB06680
+BMGC_DG18943,BMG_DG262651,DrugBank ID:DB06682 | Naproxcinod
+BMGC_DG18944,BMG_DG262652,Clevudine | DrugBank ID:DB06683
+BMGC_DG18945,BMG_DG262653,DrugBank ID:DB06721 | Gimatecan
+BMGC_DG18946,BMG_DG262654,DrugBank ID:DB06753 | Triclofos
+BMGC_DG18947,BMG_DG262655,DrugBank ID:DB06762 | Pinacidil
+BMGC_DG18948,BMG_DG262656,DrugBank ID:DB06763 | Saralasin
+BMGC_DG18949,BMG_DG262658,DrugBank ID:DB06780 | Desoxycorticosterone acetate
+BMGC_DG18950,BMG_DG262659,Mebutamate | DrugBank ID:DB06797
+BMGC_DG18951,BMG_DG262661,Phenyl aminosalicylate | DrugBank ID:DB06807
+BMGC_DG18952,BMG_DG262662,Piperacetazine | DrugBank ID:DB06808
+BMGC_DG18953,BMG_DG262663,DrugBank ID:DB06814 | Protokylol
+BMGC_DG18954,BMG_DG262664,DrugBank ID:DB06821 | Sulfameter
+BMGC_DG18955,BMG_DG262665,DrugBank ID:DB08833 | Taurochenodeoxycholic acid
+BMGC_DG18956,BMG_DG262666,DrugBank ID:DB08839 | Serotonin
+BMGC_DG18957,BMG_DG262667,N-methylnicotinamide | DrugBank ID:DB08840
+BMGC_DG18958,BMG_DG262668,GS 0573 | DrugBank ID:DB08843
+BMGC_DG18959,BMG_DG262669,DrugBank ID:DB08845 | Oxogluric acid
+BMGC_DG18960,BMG_DG262670,DrugBank ID:DB08849 | Nipecotic acid
+BMGC_DG18961,BMG_DG262671,DrugBank ID:DB08855 | Leukotriene C4
+BMGC_DG18962,BMG_DG262672,DADLE | DrugBank ID:DB08856
+BMGC_DG18963,BMG_DG262673,Bamet-UD2 | DrugBank ID:DB08857
+BMGC_DG18964,BMG_DG262674,DrugBank ID:DB08858 | cis-Diamminechlorocholylglycinateplatinum(II)
+BMGC_DG18965,BMG_DG262675,DPDPE | DrugBank ID:DB08861
+BMGC_DG18966,BMG_DG262676,(4R)-limonene | DrugBank ID:DB08921
+BMGC_DG18967,BMG_DG262678,DrugBank ID:DB08963 | Glafenine
+BMGC_DG18968,BMG_DG262680,DrugBank ID:DB09056 | Amorolfine
+BMGC_DG18969,BMG_DG262681,DrugBank ID:DB09059 | Atosiban
+BMGC_DG18970,BMG_DG262682,DrugBank ID:DB09062 | Cefminox
+BMGC_DG18971,BMG_DG262683,DrugBank ID:DB09064 | Ciprofibrate
+BMGC_DG18972,BMG_DG262684,Corifollitropin alfa | DrugBank ID:DB09066
+BMGC_DG18973,BMG_DG262685,Olaparib | DrugBank ID:DB09074
+BMGC_DG18974,BMG_DG262686,Piracetam | DrugBank ID:DB09210
+BMGC_DG18975,BMG_DG262687,DrugBank ID:DB09319 | Carindacillin
+BMGC_DG18976,BMG_DG262688,Seractide acetate | DrugBank ID:DB09334
+BMGC_DG18977,BMG_DG262689,DrugBank ID:DB09355 | Sulfabenzamide
+BMGC_DG18978,BMG_DG262691,DrugBank ID:DB09361 | Evans blue
+BMGC_DG18979,BMG_DG262693,DrugBank ID:DB09366 | Propyliodone
+BMGC_DG18980,BMG_DG262694,DrugBank ID:DB09369 | Polyestradiol phosphate
+BMGC_DG18981,BMG_DG262695,Sodium phosphate P 32 | DrugBank ID:DB09370
+BMGC_DG18982,BMG_DG262696,DrugBank ID:DB09371 | Norethynodrel
+BMGC_DG18983,BMG_DG262699,DrugBank ID:DB09378 | Fluprednisolone
+BMGC_DG18984,BMG_DG262702,DrugBank ID:DB09383 | Meprednisone
+BMGC_DG18985,BMG_DG262707,DrugBank ID:DB09400 | Selenomethionine Se-75
+BMGC_DG18986,BMG_DG262708,DrugBank ID:DB09401 | Isosorbide
+BMGC_DG18987,BMG_DG262709,Iocetamic acid | DrugBank ID:DB09403
+BMGC_DG18988,BMG_DG262712,DrugBank ID:DB09415 | Meglumine
+BMGC_DG18989,BMG_DG262722,Iofetamine I-123 | DrugBank ID:DB09480
+BMGC_DG18990,BMG_DG262723,Potassium lactate | DrugBank ID:DB09483
+BMGC_DG18991,BMG_DG262725,DrugBank ID:DB09501 | Ferric ammonium citrate
+BMGC_DG18992,BMG_DG262726,Ferumoxsil | DrugBank ID:DB09507
+BMGC_DG18993,BMG_DG262727,Ferumoxides | DrugBank ID:DB09508
+BMGC_DG18994,BMG_DG262728,DrugBank ID:DB09527 | Secretin porcine
+BMGC_DG18995,BMG_DG262729,DrugBank ID:DB09531 | Perflexane
+BMGC_DG18996,BMG_DG262730,Tetracycline phosphate complex | DrugBank ID:DB09550
+BMGC_DG18997,BMG_DG262732,"DrugBank ID:DB10061 | Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine"
+BMGC_DG18998,BMG_DG262733,"DrugBank ID:DB10062 | Rabies virus inactivated antigen, B"
+BMGC_DG18999,BMG_DG262739,Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) | DrugBank ID:DB10584
+BMGC_DG19000,BMG_DG262744,Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (propiolactone inactivated) | DrugBank ID:DB10600
+BMGC_DG19001,BMG_DG262748,DrugBank ID:DB10769 | Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)
+BMGC_DG19002,BMG_DG262749,Foreskin fibroblast (neonatal) | DrugBank ID:DB10770
+BMGC_DG19003,BMG_DG262751,Foreskin keratinocyte (neonatal) | DrugBank ID:DB10772
+BMGC_DG19004,BMG_DG262770,DrugBank ID:DB10794 | Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated)
+BMGC_DG19005,BMG_DG262807,Influenza A virus A/Brisbane/59/2007(H1N1) hemagglutinin antigen (propiolactone inactivated) | DrugBank ID:DB11038
+BMGC_DG19006,BMG_DG262809,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated) | DrugBank ID:DB11040
+BMGC_DG19007,BMG_DG262810,DrugBank ID:DB11041 | Influenza A virus A/California/7/2009 X-181 (H1N1) hemagglutinin antigen (propiolactone inactivated)
+BMGC_DG19008,BMG_DG262813,DrugBank ID:DB11044 | Influenza B virus B/Brisbane/60/2008 antigen (propiolactone inactivated)
+BMGC_DG19009,BMG_DG262826,2-(l-menthoxy)ethanol | DrugBank ID:DB11174
+BMGC_DG19010,BMG_DG262829,DrugBank ID:DB11192 | L-threonic acid
+BMGC_DG19011,BMG_DG262831,DrugBank ID:DB11201 | Menthyl salicylate
+BMGC_DG19012,BMG_DG262838,Dioxybenzone | DrugBank ID:DB11221
+BMGC_DG19013,BMG_DG262845,Magnesium Aluminum Silicate | DrugBank ID:DB11230
+BMGC_DG19014,BMG_DG262856,DrugBank ID:DB11273 | Dihydroergocornine
+BMGC_DG19015,BMG_DG262857,DrugBank ID:DB11274 | Dihydro-alpha-ergocryptine
+BMGC_DG19016,BMG_DG262858,DrugBank ID:DB11275 | Epicriptine
+BMGC_DG19017,BMG_DG262859,DrugBank ID:DB11278 | DL-Methylephedrine
+BMGC_DG19018,BMG_DG262860,DrugBank ID:DB11281 | Bismuth subcarbonate
+BMGC_DG19019,BMG_DG262861,DrugBank ID:DB11282 | Diethyltoluamide
+BMGC_DG19020,BMG_DG262865,DrugBank ID:DB11288 | Borneol
+BMGC_DG19021,BMG_DG262871,Bentonite | DrugBank ID:DB11306
+BMGC_DG19022,BMG_DG262872,DrugBank ID:DB11309 | Sulfuric acid
+BMGC_DG19023,BMG_DG262875,DrugBank ID:DB11324 | Nonivamide
+BMGC_DG19024,BMG_DG262877,Dipyrithione | DrugBank ID:DB11327
+BMGC_DG19025,BMG_DG262878,DrugBank ID:DB11328 | Tetradecyl hydrogen sulfate (ester)
+BMGC_DG19026,BMG_DG262882,DrugBank ID:DB11337 | Zeatin
+BMGC_DG19027,BMG_DG262884,DrugBank ID:DB11345 | (S)-camphor
+BMGC_DG19028,BMG_DG262889,DrugBank ID:DB11369 | Afoxolaner
+BMGC_DG19029,BMG_DG262890,DrugBank ID:DB11372 | Altrenogest
+BMGC_DG19030,BMG_DG262891,DrugBank ID:DB11373 | Amitraz
+BMGC_DG19031,BMG_DG262893,Avilamycin | DrugBank ID:DB11375
+BMGC_DG19032,BMG_DG262894,Azaperone | DrugBank ID:DB11376
+BMGC_DG19033,BMG_DG262895,DrugBank ID:DB11377 | Bambermycins
+BMGC_DG19034,BMG_DG262898,Cambendazole | DrugBank ID:DB11380
+BMGC_DG19035,BMG_DG262899,DrugBank ID:DB11382 | Carbarsone
+BMGC_DG19036,BMG_DG262900,DrugBank ID:DB11383 | Carbomycin
+BMGC_DG19037,BMG_DG262901,Cefalonium | DrugBank ID:DB11385
+BMGC_DG19038,BMG_DG262902,Chloroform | DrugBank ID:DB11387
+BMGC_DG19039,BMG_DG262903,DrugBank ID:DB11389 | Clorsulon
+BMGC_DG19040,BMG_DG262904,DrugBank ID:DB11390 | Coumaphos
+BMGC_DG19041,BMG_DG262907,Decoquinate | DrugBank ID:DB11394
+BMGC_DG19042,BMG_DG262908,DrugBank ID:DB11395 | Deracoxib
+BMGC_DG19043,BMG_DG262909,Dichlorophen | DrugBank ID:DB11396
+BMGC_DG19044,BMG_DG262910,DrugBank ID:DB11397 | Dichlorvos
+BMGC_DG19045,BMG_DG262911,Diclazuril | DrugBank ID:DB11398
+BMGC_DG19046,BMG_DG262912,DrugBank ID:DB11399 | Dirlotapide
+BMGC_DG19047,BMG_DG262913,Doramectin | DrugBank ID:DB11400
+BMGC_DG19048,BMG_DG262914,Efrotomycin | DrugBank ID:DB11401
+BMGC_DG19049,BMG_DG262916,DrugBank ID:DB11404 | Enrofloxacin
+BMGC_DG19050,BMG_DG262917,Eprinomectin | DrugBank ID:DB11405
+BMGC_DG19051,BMG_DG262918,Famphur | DrugBank ID:DB11408
+BMGC_DG19052,BMG_DG262919,Febantel | DrugBank ID:DB11409
+BMGC_DG19053,BMG_DG262920,Fenbendazole | DrugBank ID:DB11410
+BMGC_DG19054,BMG_DG262921,DrugBank ID:DB11411 | Fenprostalene
+BMGC_DG19055,BMG_DG262922,DrugBank ID:DB11412 | Fenthion
+BMGC_DG19056,BMG_DG262923,Florfenicol | DrugBank ID:DB11413
+BMGC_DG19057,BMG_DG262924,Fluralaner | DrugBank ID:DB11414
+BMGC_DG19058,BMG_DG262925,Gamithromycin | DrugBank ID:DB11416
+BMGC_DG19059,BMG_DG262926,Gleptoferron | DrugBank ID:DB11417
+BMGC_DG19060,BMG_DG262927,DrugBank ID:DB11419 | Haloxon
+BMGC_DG19061,BMG_DG262928,Squalane | DrugBank ID:DB11420
+BMGC_DG19062,BMG_DG262929,DrugBank ID:DB11423 | Lasalocid
+BMGC_DG19063,BMG_DG262930,DrugBank ID:DB11424 | Lufenuron
+BMGC_DG19064,BMG_DG262931,Luprostiol | DrugBank ID:DB11425
+BMGC_DG19065,BMG_DG262932,Marbofloxacin | DrugBank ID:DB11426
+BMGC_DG19066,BMG_DG262934,Medetomidine | DrugBank ID:DB11428
+BMGC_DG19067,BMG_DG262935,Mibolerone | DrugBank ID:DB11429
+BMGC_DG19068,BMG_DG262937,Moxidectin | DrugBank ID:DB11431
+BMGC_DG19069,BMG_DG262938,DrugBank ID:DB11432 | Narasin
+BMGC_DG19070,BMG_DG262939,DrugBank ID:DB11433 | Nequinate
+BMGC_DG19071,BMG_DG262942,Nitarsone | DrugBank ID:DB11437
+BMGC_DG19072,BMG_DG262945,Oclacitinib | DrugBank ID:DB11441
+BMGC_DG19073,BMG_DG262946,Oleandomycin | DrugBank ID:DB11442
+BMGC_DG19074,BMG_DG262947,Orbifloxacin | DrugBank ID:DB11443
+BMGC_DG19075,BMG_DG262949,DrugBank ID:DB11446 | Oxfendazole
+BMGC_DG19076,BMG_DG262950,Phenothiazine | DrugBank ID:DB11447
+BMGC_DG19077,BMG_DG262951,Phosmet | DrugBank ID:DB11448
+BMGC_DG19078,BMG_DG262953,DrugBank ID:DB11450 | Pimobendan
+BMGC_DG19079,BMG_DG262957,Prostalene | DrugBank ID:DB11454
+BMGC_DG19080,BMG_DG262958,Robenacoxib | DrugBank ID:DB11455
+BMGC_DG19081,BMG_DG262960,Roxarsone | DrugBank ID:DB11458
+BMGC_DG19082,BMG_DG262961,DrugBank ID:DB11459 | Selamectin
+BMGC_DG19083,BMG_DG262962,Sulfachlorpyridazine | DrugBank ID:DB11461
+BMGC_DG19084,BMG_DG262963,DrugBank ID:DB11462 | Sulfaethoxypyridazine
+BMGC_DG19085,BMG_DG262964,DrugBank ID:DB11463 | Sulfanitran
+BMGC_DG19086,BMG_DG262965,Sulfaquinoxaline | DrugBank ID:DB11464
+BMGC_DG19087,BMG_DG262966,DrugBank ID:DB11466 | Tepoxalin
+BMGC_DG19088,BMG_DG262967,DrugBank ID:DB11467 | Thiostrepton
+BMGC_DG19089,BMG_DG262968,Tiamulin | DrugBank ID:DB11468
+BMGC_DG19090,BMG_DG262969,DrugBank ID:DB11470 | Tildipirosin
+BMGC_DG19091,BMG_DG262970,Tilmicosin | DrugBank ID:DB11471
+BMGC_DG19092,BMG_DG262972,DrugBank ID:DB11473 | Metrifonate
+BMGC_DG19093,BMG_DG262973,Tulathromycin A | DrugBank ID:DB11474
+BMGC_DG19094,BMG_DG262974,DrugBank ID:DB11475 | Tylosin
+BMGC_DG19095,BMG_DG262976,Xylazine | DrugBank ID:DB11477
+BMGC_DG19096,BMG_DG262977,DrugBank ID:DB11478 | Zeranol
+BMGC_DG19097,BMG_DG262979,DrugBank ID:DB11480 | Zoalene
+BMGC_DG19098,BMG_DG262980,Atipamezole | DrugBank ID:DB11481
+BMGC_DG19099,BMG_DG262981,DrugBank ID:DB11485 | Ceftiofur
+BMGC_DG19100,BMG_DG262982,DrugBank ID:DB11487 | Dexamethasone isonicotinate
+BMGC_DG19101,BMG_DG262983,DrugBank ID:DB11490 | Nalorphine
+BMGC_DG19102,BMG_DG262984,DrugBank ID:DB11493 | Sodium tripolyphosphate
+BMGC_DG19103,BMG_DG262986,DrugBank ID:DB11496 | 2-mercaptobenzothiazole
+BMGC_DG19104,BMG_DG262987,DrugBank ID:DB11497 | Sulfotep
+BMGC_DG19105,BMG_DG262990,DrugBank ID:DB11502 | Butacaine
+BMGC_DG19106,BMG_DG262991,Caramiphen | DrugBank ID:DB11504
+BMGC_DG19107,BMG_DG262993,DrugBank ID:DB11507 | Cloprostenol
+BMGC_DG19108,BMG_DG262995,Deslorelin | DrugBank ID:DB11510
+BMGC_DG19109,BMG_DG262996,Difloxacin | DrugBank ID:DB11511
+BMGC_DG19110,BMG_DG262997,Dihydrostreptomycin | DrugBank ID:DB11512
+BMGC_DG19111,BMG_DG263000,Etymemazine | DrugBank ID:DB11517
+BMGC_DG19112,BMG_DG263001,Flunixin | DrugBank ID:DB11518
+BMGC_DG19113,BMG_DG263002,Fluprostenol | DrugBank ID:DB11519
+BMGC_DG19114,BMG_DG263003,Hygromycin B | DrugBank ID:DB11520
+BMGC_DG19115,BMG_DG263004,Imidocarb | DrugBank ID:DB11521
+BMGC_DG19116,BMG_DG263005,DrugBank ID:DB11522 | Isoflupredone
+BMGC_DG19117,BMG_DG263006,DrugBank ID:DB11525 | Maduramicin
+BMGC_DG19118,BMG_DG263007,DrugBank ID:DB11526 | Masitinib
+BMGC_DG19119,BMG_DG263009,DrugBank ID:DB11529 | Melengestrol
+BMGC_DG19120,BMG_DG263012,Butyl chloride | DrugBank ID:DB11534
+BMGC_DG19121,BMG_DG263013,DrugBank ID:DB11537 | Pirlimycin
+BMGC_DG19122,BMG_DG263015,DrugBank ID:DB11540 | Propiopromazine
+BMGC_DG19123,BMG_DG263016,DrugBank ID:DB11541 | Ractopamine
+BMGC_DG19124,BMG_DG263018,Romifidine | DrugBank ID:DB11543
+BMGC_DG19125,BMG_DG263019,Salinomycin | DrugBank ID:DB11544
+BMGC_DG19126,BMG_DG263022,Tiletamine | DrugBank ID:DB11549
+BMGC_DG19127,BMG_DG263024,DrugBank ID:DB11552 | Tricaine
+BMGC_DG19128,BMG_DG263025,Tylvalosin | DrugBank ID:DB11554
+BMGC_DG19129,BMG_DG263026,DrugBank ID:DB11555 | Zolazepam
+BMGC_DG19130,BMG_DG263027,Detomidine | DrugBank ID:DB11556
+BMGC_DG19131,BMG_DG263028,DrugBank ID:DB11564 | Insulin argine
+BMGC_DG19132,BMG_DG263029,DrugBank ID:DB11567 | Insulin peglispro
+BMGC_DG19133,BMG_DG263030,Insulin tregopil | DrugBank ID:DB11568
+BMGC_DG19134,BMG_DG263031,DrugBank ID:DB11576 | Ferric oxide
+BMGC_DG19135,BMG_DG263033,Ravulizumab | DrugBank ID:DB11580
+BMGC_DG19136,BMG_DG263034,DrugBank ID:DB11584 | Pipradrol
+BMGC_DG19137,BMG_DG263036,DrugBank ID:DB11587 | Etafedrine
+BMGC_DG19138,BMG_DG263037,Epoetin delta | DrugBank ID:DB11624
+BMGC_DG19139,BMG_DG263038,Perflenapent | DrugBank ID:DB11625
+BMGC_DG19140,BMG_DG263039,Tasonermin | DrugBank ID:DB11626
+BMGC_DG19141,BMG_DG263041,Laropiprant | DrugBank ID:DB11629
+BMGC_DG19142,BMG_DG263042,Temoporfin | DrugBank ID:DB11630
+BMGC_DG19143,BMG_DG263044,DrugBank ID:DB11632 | Opicapone
+BMGC_DG19144,BMG_DG263045,Isavuconazole | DrugBank ID:DB11633
+BMGC_DG19145,BMG_DG263046,DrugBank ID:DB11634 | Colestilan chloride
+BMGC_DG19146,BMG_DG263047,DrugBank ID:DB11636 | Nomegestrol
+BMGC_DG19147,BMG_DG263048,Delamanid | DrugBank ID:DB11637
+BMGC_DG19148,BMG_DG263049,Artenimol | DrugBank ID:DB11638
+BMGC_DG19149,BMG_DG263050,Dibotermin alfa | DrugBank ID:DB11639
+BMGC_DG19150,BMG_DG263051,Amifampridine | DrugBank ID:DB11640
+BMGC_DG19151,BMG_DG263052,Vinflunine | DrugBank ID:DB11641
+BMGC_DG19152,BMG_DG263053,Pitolisant | DrugBank ID:DB11642
+BMGC_DG19153,BMG_DG263055,DrugBank ID:DB12070 | Letermovir
+BMGC_DG19154,BMG_DG263056,Macimorelin | DrugBank ID:DB13074
+BMGC_DG19155,BMG_DG263057,4-methylumbelliferyl beta-D-glucoside | DrugBank ID:DB13177
+BMGC_DG19156,BMG_DG263058,Daidzein | DrugBank ID:DB13182
+BMGC_DG19157,BMG_DG263059,DrugBank ID:DB13189 | Calcitonin porcine
+BMGC_DG19158,BMG_DG263060,Ethacridine | DrugBank ID:DB13190
+BMGC_DG19159,BMG_DG263062,DrugBank ID:DB13197 | Kallidinogenase
+BMGC_DG19160,BMG_DG263063,DrugBank ID:DB13199 | Brinase
+BMGC_DG19161,BMG_DG263064,DrugBank ID:DB13200 | Lipegfilgrastim
+BMGC_DG19162,BMG_DG263065,Trenonacog alfa | DrugBank ID:DB13201
+BMGC_DG19163,BMG_DG263067,DrugBank ID:DB13203 | Bamifylline
+BMGC_DG19164,BMG_DG263070,DrugBank ID:DB13206 | Bamethan
+BMGC_DG19165,BMG_DG263071,DrugBank ID:DB13207 | Arginine glutamate
+BMGC_DG19166,BMG_DG263072,DrugBank ID:DB13208 | Prednylidene
+BMGC_DG19167,BMG_DG263073,DrugBank ID:DB13209 | Bismuth subnitrate
+BMGC_DG19168,BMG_DG263074,Sodium chlorite | DrugBank ID:DB13210
+BMGC_DG19169,BMG_DG263075,DrugBank ID:DB13211 | Guanoxan
+BMGC_DG19170,BMG_DG263077,Butaperazine | DrugBank ID:DB13213
+BMGC_DG19171,BMG_DG263078,Sulfadicramide | DrugBank ID:DB13214
+BMGC_DG19172,BMG_DG263079,DrugBank ID:DB13215 | Sulfobromophthalein
+BMGC_DG19173,BMG_DG263081,DrugBank ID:DB13217 | Fentiazac
+BMGC_DG19174,BMG_DG263082,Mandelic acid | DrugBank ID:DB13218
+BMGC_DG19175,BMG_DG263083,Medifoxamine | DrugBank ID:DB13219
+BMGC_DG19176,BMG_DG263085,Apronalide | DrugBank ID:DB13221
+BMGC_DG19177,BMG_DG263087,DrugBank ID:DB13223 | Fluocortin
+BMGC_DG19178,BMG_DG263089,Dibenzepin | DrugBank ID:DB13225
+BMGC_DG19179,BMG_DG263090,DrugBank ID:DB13226 | Acetylleucine
+BMGC_DG19180,BMG_DG263092,DrugBank ID:DB13228 | Flosequinan
+BMGC_DG19181,BMG_DG263093,Enibomal | DrugBank ID:DB13229
+BMGC_DG19182,BMG_DG263094,Gestonorone | DrugBank ID:DB13230
+BMGC_DG19183,BMG_DG263095,DrugBank ID:DB13232 | Suxibuzone
+BMGC_DG19184,BMG_DG263096,Propanidid | DrugBank ID:DB13234
+BMGC_DG19185,BMG_DG263098,Stibophen | DrugBank ID:DB13236
+BMGC_DG19186,BMG_DG263099,DrugBank ID:DB13237 | Clofoctol
+BMGC_DG19187,BMG_DG263100,Tuaminoheptane | DrugBank ID:DB13238
+BMGC_DG19188,BMG_DG263101,DrugBank ID:DB13239 | Neltenexine
+BMGC_DG19189,BMG_DG263102,Cymarin | DrugBank ID:DB13240
+BMGC_DG19190,BMG_DG263103,Begelomab | DrugBank ID:DB13241
+BMGC_DG19191,BMG_DG263104,DrugBank ID:DB13242 | Bucladesine
+BMGC_DG19192,BMG_DG263105,Tiazofurine | DrugBank ID:DB13243
+BMGC_DG19193,BMG_DG263106,Aminomethylbenzoic acid | DrugBank ID:DB13244
+BMGC_DG19194,BMG_DG263107,DrugBank ID:DB13245 | Thiram
+BMGC_DG19195,BMG_DG263108,DrugBank ID:DB13246 | Quinupramine
+BMGC_DG19196,BMG_DG263109,Pramiracetam | DrugBank ID:DB13247
+BMGC_DG19197,BMG_DG263110,Phthalylsulfathiazole | DrugBank ID:DB13248
+BMGC_DG19198,BMG_DG263111,Magnesium silicate | DrugBank ID:DB13249
+BMGC_DG19199,BMG_DG263113,DrugBank ID:DB13251 | Octopamine
+BMGC_DG19200,BMG_DG263114,DrugBank ID:DB13252 | Tropatepine
+BMGC_DG19201,BMG_DG263115,DrugBank ID:DB13253 | Proxibarbal
+BMGC_DG19202,BMG_DG263116,DrugBank ID:DB13254 | Prifinium
+BMGC_DG19203,BMG_DG263117,DrugBank ID:DB13255 | Propatyl nitrate
+BMGC_DG19204,BMG_DG263118,DrugBank ID:DB13256 | Clothiapine
+BMGC_DG19205,BMG_DG263120,DrugBank ID:DB13260 | Lysozyme
+BMGC_DG19206,BMG_DG263121,Sitafloxacin | DrugBank ID:DB13261
+BMGC_DG19207,BMG_DG263122,Aceclidine | DrugBank ID:DB13262
+BMGC_DG19208,BMG_DG263124,Penimepicycline | DrugBank ID:DB13264
+BMGC_DG19209,BMG_DG263125,DrugBank ID:DB13265 | Hexobendine
+BMGC_DG19210,BMG_DG263126,DrugBank ID:DB13266 | Cefatrizine
+BMGC_DG19211,BMG_DG263128,DrugBank ID:DB13268 | Acetarsol
+BMGC_DG19212,BMG_DG263129,Dichlorobenzyl alcohol | DrugBank ID:DB13269
+BMGC_DG19213,BMG_DG263130,Dibekacin | DrugBank ID:DB13270
+BMGC_DG19214,BMG_DG263132,Meladrazine | DrugBank ID:DB13272
+BMGC_DG19215,BMG_DG263133,Sultopride | DrugBank ID:DB13273
+BMGC_DG19216,BMG_DG263134,DrugBank ID:DB13274 | Micronomicin
+BMGC_DG19217,BMG_DG263135,Clorindione | DrugBank ID:DB13275
+BMGC_DG19218,BMG_DG263137,Benziodarone | DrugBank ID:DB13277
+BMGC_DG19219,BMG_DG263139,DrugBank ID:DB13279 | Carbocromen
+BMGC_DG19220,BMG_DG263140,DrugBank ID:DB13280 | Aluminium acetoacetate
+BMGC_DG19221,BMG_DG263141,DrugBank ID:DB13282 | Benzododecinium
+BMGC_DG19222,BMG_DG263142,Sulfaisodimidine | DrugBank ID:DB13283
+BMGC_DG19223,BMG_DG263143,Meticrane | DrugBank ID:DB13284
+BMGC_DG19224,BMG_DG263144,Etilamfetamine | DrugBank ID:DB13285
+BMGC_DG19225,BMG_DG263145,Bumadizone | DrugBank ID:DB13286
+BMGC_DG19226,BMG_DG263146,DrugBank ID:DB13287 | Miocamycin
+BMGC_DG19227,BMG_DG263151,Pimethixene | DrugBank ID:DB13292
+BMGC_DG19228,BMG_DG263152,Azidamfenicol | DrugBank ID:DB13294
+BMGC_DG19229,BMG_DG263153,Atracurium | DrugBank ID:DB13295
+BMGC_DG19230,BMG_DG263154,Propamidine | DrugBank ID:DB13296
+BMGC_DG19231,BMG_DG263158,DrugBank ID:DB13300 | Epicillin
+BMGC_DG19232,BMG_DG263159,DrugBank ID:DB13302 | Hachimycin
+BMGC_DG19233,BMG_DG263160,DrugBank ID:DB13303 | Febarbamate
+BMGC_DG19234,BMG_DG263161,Triaziquone | DrugBank ID:DB13304
+BMGC_DG19235,BMG_DG263162,DrugBank ID:DB13305 | Tolpropamine
+BMGC_DG19236,BMG_DG263163,Chlorquinaldol | DrugBank ID:DB13306
+BMGC_DG19237,BMG_DG263164,Oxametacin | DrugBank ID:DB13308
+BMGC_DG19238,BMG_DG263166,DrugBank ID:DB13310 | Ormeloxifene
+BMGC_DG19239,BMG_DG263167,Trepibutone | DrugBank ID:DB13311
+BMGC_DG19240,BMG_DG263168,DrugBank ID:DB13312 | Delapril
+BMGC_DG19241,BMG_DG263169,Melevodopa | DrugBank ID:DB13313
+BMGC_DG19242,BMG_DG263170,Alminoprofen | DrugBank ID:DB13314
+BMGC_DG19243,BMG_DG263171,Sobrerol | DrugBank ID:DB13315
+BMGC_DG19244,BMG_DG263172,Ibopamine | DrugBank ID:DB13316
+BMGC_DG19245,BMG_DG263173,Flunoxaprofen | DrugBank ID:DB13317
+BMGC_DG19246,BMG_DG263174,DrugBank ID:DB13318 | Demecolcine
+BMGC_DG19247,BMG_DG263175,DrugBank ID:DB13319 | Propenidazole
+BMGC_DG19248,BMG_DG263176,Sulfaperin | DrugBank ID:DB13320
+BMGC_DG19249,BMG_DG263178,Hydrotalcite | DrugBank ID:DB13322
+BMGC_DG19250,BMG_DG263179,DrugBank ID:DB13323 | Trichloroethylene
+BMGC_DG19251,BMG_DG263180,Tetrazepam | DrugBank ID:DB13324
+BMGC_DG19252,BMG_DG263183,Picotamide | DrugBank ID:DB13327
+BMGC_DG19253,BMG_DG263184,DrugBank ID:DB13328 | Butanilicaine
+BMGC_DG19254,BMG_DG263185,DrugBank ID:DB13329 | Guaiazulen
+BMGC_DG19255,BMG_DG263187,DrugBank ID:DB13331 | Pyrithyldione
+BMGC_DG19256,BMG_DG263188,DrugBank ID:DB13332 | Dibutylsuccinate
+BMGC_DG19257,BMG_DG263190,Mannosulfan | DrugBank ID:DB13334
+BMGC_DG19258,BMG_DG263191,Pinazepam | DrugBank ID:DB13335
+BMGC_DG19259,BMG_DG263192,DrugBank ID:DB13336 | Dimethylphthalate
+BMGC_DG19260,BMG_DG263193,Pheneticillin | DrugBank ID:DB13337
+BMGC_DG19261,BMG_DG263194,DrugBank ID:DB13338 | Flurithromycin
+BMGC_DG19262,BMG_DG263195,DrugBank ID:DB13339 | Etoglucid
+BMGC_DG19263,BMG_DG263196,Suloctidil | DrugBank ID:DB13340
+BMGC_DG19264,BMG_DG263197,Fenozolone | DrugBank ID:DB13341
+BMGC_DG19265,BMG_DG263199,DrugBank ID:DB13343 | Tioxolone
+BMGC_DG19266,BMG_DG263201,Dihydroergocristine | DrugBank ID:DB13345
+BMGC_DG19267,BMG_DG263202,Diphenadione | DrugBank ID:DB13347
+BMGC_DG19268,BMG_DG263203,DrugBank ID:DB13348 | Tiadenol
+BMGC_DG19269,BMG_DG263204,DrugBank ID:DB13349 | Talastine
+BMGC_DG19270,BMG_DG263206,DrugBank ID:DB13351 | Piperidolate
+BMGC_DG19271,BMG_DG263208,Phenprobamate | DrugBank ID:DB13354
+BMGC_DG19272,BMG_DG263211,DrugBank ID:DB13357 | Styramate
+BMGC_DG19273,BMG_DG263212,Cibenzoline | DrugBank ID:DB13358
+BMGC_DG19274,BMG_DG263215,DrugBank ID:DB13362 | Pheneturide
+BMGC_DG19275,BMG_DG263216,DrugBank ID:DB13363 | Oxaceprol
+BMGC_DG19276,BMG_DG263217,Feprazone | DrugBank ID:DB13364
+BMGC_DG19277,BMG_DG263218,DrugBank ID:DB13365 | Calcium lactate gluconate
+BMGC_DG19278,BMG_DG263219,Hydrochloric acid | DrugBank ID:DB13366
+BMGC_DG19279,BMG_DG263220,DrugBank ID:DB13367 | Cloricromen
+BMGC_DG19280,BMG_DG263221,Motretinide | DrugBank ID:DB13368
+BMGC_DG19281,BMG_DG263222,Benzilone | DrugBank ID:DB13369
+BMGC_DG19282,BMG_DG263223,Bromisoval | DrugBank ID:DB13370
+BMGC_DG19283,BMG_DG263224,DrugBank ID:DB13371 | Difenpiramide
+BMGC_DG19284,BMG_DG263227,Edrecolomab | DrugBank ID:DB13375
+BMGC_DG19285,BMG_DG263228,DrugBank ID:DB13376 | Succinimide
+BMGC_DG19286,BMG_DG263229,DrugBank ID:DB13377 | Vinbarbital
+BMGC_DG19287,BMG_DG263230,Norfenefrine | DrugBank ID:DB13378
+BMGC_DG19288,BMG_DG263232,DrugBank ID:DB13380 | Difemerine
+BMGC_DG19289,BMG_DG263233,DrugBank ID:DB13381 | Sodium feredetate
+BMGC_DG19290,BMG_DG263234,Chlorproethazine | DrugBank ID:DB13382
+BMGC_DG19291,BMG_DG263236,DrugBank ID:DB13384 | Melitracen
+BMGC_DG19292,BMG_DG263237,Dihydroergocryptine | DrugBank ID:DB13385
+BMGC_DG19293,BMG_DG263238,Epimestrol | DrugBank ID:DB13386
+BMGC_DG19294,BMG_DG263239,Hematin | DrugBank ID:DB13387
+BMGC_DG19295,BMG_DG263240,Phenylmercuric nitrate | DrugBank ID:DB13388
+BMGC_DG19296,BMG_DG263243,Emetine | DrugBank ID:DB13393
+BMGC_DG19297,BMG_DG263244,Adrenalone | DrugBank ID:DB13394
+BMGC_DG19298,BMG_DG263246,Neocitrullamon | DrugBank ID:DB13396
+BMGC_DG19299,BMG_DG263248,DrugBank ID:DB13398 | Oxyfedrine
+BMGC_DG19300,BMG_DG263249,Terguride | DrugBank ID:DB13399
+BMGC_DG19301,BMG_DG263250,Linsidomine | DrugBank ID:DB13400
+BMGC_DG19302,BMG_DG263251,DrugBank ID:DB13401 | Metildigoxin
+BMGC_DG19303,BMG_DG263252,DrugBank ID:DB13402 | Acetylglycinamide chloral hydrate
+BMGC_DG19304,BMG_DG263253,DrugBank ID:DB13403 | Oxypertine
+BMGC_DG19305,BMG_DG263254,Edetate sodium | DrugBank ID:DB13404
+BMGC_DG19306,BMG_DG263255,Mefruside | DrugBank ID:DB13405
+BMGC_DG19307,BMG_DG263256,DrugBank ID:DB13406 | Carbutamide
+BMGC_DG19308,BMG_DG263257,DrugBank ID:DB13407 | Nifenazone
+BMGC_DG19309,BMG_DG263258,Methylpropylpropanediol dinitrate | DrugBank ID:DB13408
+BMGC_DG19310,BMG_DG263259,DrugBank ID:DB13409 | Rokitamycin
+BMGC_DG19311,BMG_DG263260,DrugBank ID:DB13410 | Guanoxabenz
+BMGC_DG19312,BMG_DG263261,DrugBank ID:DB13411 | Lofepramine
+BMGC_DG19313,BMG_DG263263,DrugBank ID:DB13413 | Phenglutarimide
+BMGC_DG19314,BMG_DG263264,DrugBank ID:DB13414 | Fenyramidol
+BMGC_DG19315,BMG_DG263265,Pentetrazol | DrugBank ID:DB13415
+BMGC_DG19316,BMG_DG263266,DrugBank ID:DB13417 | Morinamide
+BMGC_DG19317,BMG_DG263267,Moxestrol | DrugBank ID:DB13418
+BMGC_DG19318,BMG_DG263268,Troxipide | DrugBank ID:DB13419
+BMGC_DG19319,BMG_DG263269,Thiazinam | DrugBank ID:DB13420
+BMGC_DG19320,BMG_DG263270,DrugBank ID:DB13422 | Nicofuranose
+BMGC_DG19321,BMG_DG263271,Ferric hydroxide | DrugBank ID:DB13423
+BMGC_DG19322,BMG_DG263272,DrugBank ID:DB13424 | Clofenotane
+BMGC_DG19323,BMG_DG263273,Flutrimazole | DrugBank ID:DB13425
+BMGC_DG19324,BMG_DG263276,DrugBank ID:DB13429 | Tolonidine
+BMGC_DG19325,BMG_DG263277,Mebutizide | DrugBank ID:DB13430
+BMGC_DG19326,BMG_DG263278,DrugBank ID:DB13431 | Proglumide
+BMGC_DG19327,BMG_DG263279,DrugBank ID:DB13432 | Lonazolac
+BMGC_DG19328,BMG_DG263280,DrugBank ID:DB13433 | Simfibrate
+BMGC_DG19329,BMG_DG263281,DrugBank ID:DB13434 | Fenticonazole
+BMGC_DG19330,BMG_DG263282,DrugBank ID:DB13435 | Endralazine
+BMGC_DG19331,BMG_DG263284,Medazepam | DrugBank ID:DB13437
+BMGC_DG19332,BMG_DG263285,Prolintane | DrugBank ID:DB13438
+BMGC_DG19333,BMG_DG263287,Niceritrol | DrugBank ID:DB13441
+BMGC_DG19334,BMG_DG263288,DrugBank ID:DB13442 | Citiolone
+BMGC_DG19335,BMG_DG263289,Esatenolol | DrugBank ID:DB13443
+BMGC_DG19336,BMG_DG263290,Ioxitalamic acid | DrugBank ID:DB13444
+BMGC_DG19337,BMG_DG263291,DrugBank ID:DB13445 | Nepinalone
+BMGC_DG19338,BMG_DG263292,Guar gum | DrugBank ID:DB13446
+BMGC_DG19339,BMG_DG263294,Mazaticol | DrugBank ID:DB13448
+BMGC_DG19340,BMG_DG263295,DrugBank ID:DB13449 | Proxyphylline
+BMGC_DG19341,BMG_DG263296,DrugBank ID:DB13451 | Tioclomarol
+BMGC_DG19342,BMG_DG263297,Cadralazine | DrugBank ID:DB13452
+BMGC_DG19343,BMG_DG263298,Xenon | DrugBank ID:DB13453
+BMGC_DG19344,BMG_DG263299,Nicomorphine | DrugBank ID:DB13454
+BMGC_DG19345,BMG_DG263300,Phenibut | DrugBank ID:DB13455
+BMGC_DG19346,BMG_DG263301,Midecamycin | DrugBank ID:DB13456
+BMGC_DG19347,BMG_DG263302,DrugBank ID:DB13457 | Oxaflozane
+BMGC_DG19348,BMG_DG263304,DrugBank ID:DB13459 | Pecilocin
+BMGC_DG19349,BMG_DG263305,DrugBank ID:DB13460 | Ronifibrate
+BMGC_DG19350,BMG_DG263306,DrugBank ID:DB13461 | Cefcapene
+BMGC_DG19351,BMG_DG263308,Oxetorone | DrugBank ID:DB13463
+BMGC_DG19352,BMG_DG263309,DrugBank ID:DB13464 | Ornipressin
+BMGC_DG19353,BMG_DG263311,DrugBank ID:DB13466 | Deptropine
+BMGC_DG19354,BMG_DG263312,Lanatoside C | DrugBank ID:DB13467
+BMGC_DG19355,BMG_DG263313,DrugBank ID:DB13468 | Etybenzatropine
+BMGC_DG19356,BMG_DG263315,DrugBank ID:DB13470 | Cefodizime
+BMGC_DG19357,BMG_DG263316,Nalfurafine | DrugBank ID:DB13471
+BMGC_DG19358,BMG_DG263317,Cyclofenil | DrugBank ID:DB13472
+BMGC_DG19359,BMG_DG263320,DrugBank ID:DB13475 | Furazidin
+BMGC_DG19360,BMG_DG263323,Meptazinol | DrugBank ID:DB13478
+BMGC_DG19361,BMG_DG263324,Histapyrrodine | DrugBank ID:DB13479
+BMGC_DG19362,BMG_DG263325,DrugBank ID:DB13480 | Lentinan
+BMGC_DG19363,BMG_DG263326,Tenidap | DrugBank ID:DB13481
+BMGC_DG19364,BMG_DG263330,DrugBank ID:DB13485 | Sulfametomidine
+BMGC_DG19365,BMG_DG263331,Magnesium peroxide | DrugBank ID:DB13486
+BMGC_DG19366,BMG_DG263333,DrugBank ID:DB13488 | Bencyclane
+BMGC_DG19367,BMG_DG263334,DrugBank ID:DB13489 | Bamipine
+BMGC_DG19368,BMG_DG263336,DrugBank ID:DB13491 | Fluperolone
+BMGC_DG19369,BMG_DG263340,Paraoxon | DrugBank ID:DB13495
+BMGC_DG19370,BMG_DG263341,DrugBank ID:DB13496 | Iprindole
+BMGC_DG19371,BMG_DG263342,DrugBank ID:DB13497 | Valethamate
+BMGC_DG19372,BMG_DG263343,Cefsulodin | DrugBank ID:DB13499
+BMGC_DG19373,BMG_DG263344,Otilonium | DrugBank ID:DB13500
+BMGC_DG19374,BMG_DG263345,Bendazac | DrugBank ID:DB13501
+BMGC_DG19375,BMG_DG263346,DrugBank ID:DB13502 | Budipine
+BMGC_DG19376,BMG_DG263347,Tyrothricin | DrugBank ID:DB13503
+BMGC_DG19377,BMG_DG263348,Cefetamet | DrugBank ID:DB13504
+BMGC_DG19378,BMG_DG263349,Emepronium | DrugBank ID:DB13505
+BMGC_DG19379,BMG_DG263350,Carfecillin | DrugBank ID:DB13506
+BMGC_DG19380,BMG_DG263351,DrugBank ID:DB13507 | Poldine
+BMGC_DG19381,BMG_DG263352,Cloranolol | DrugBank ID:DB13508
+BMGC_DG19382,BMG_DG263353,DrugBank ID:DB13509 | Aloxiprin
+BMGC_DG19383,BMG_DG263354,Buflomedil | DrugBank ID:DB13510
+BMGC_DG19384,BMG_DG263355,DrugBank ID:DB13511 | Clebopride
+BMGC_DG19385,BMG_DG263358,DrugBank ID:DB13514 | Pranoprofen
+BMGC_DG19386,BMG_DG263359,Levomethadone | DrugBank ID:DB13515
+BMGC_DG19387,BMG_DG263361,DrugBank ID:DB13517 | Angiotensinamide
+BMGC_DG19388,BMG_DG263363,Alipogene tiparvovec | DrugBank ID:DB13521
+BMGC_DG19389,BMG_DG263364,DrugBank ID:DB13522 | Mebicar
+BMGC_DG19390,BMG_DG263365,DrugBank ID:DB13523 | Veralipride
+BMGC_DG19391,BMG_DG263366,Propyphenazone | DrugBank ID:DB13524
+BMGC_DG19392,BMG_DG263368,Pentaerithrityl | DrugBank ID:DB13526
+BMGC_DG19393,BMG_DG263369,Proglumetacin | DrugBank ID:DB13527
+BMGC_DG19394,BMG_DG263370,DrugBank ID:DB13528 | Chlormadinone
+BMGC_DG19395,BMG_DG263371,Dobesilic acid | DrugBank ID:DB13529
+BMGC_DG19396,BMG_DG263372,DrugBank ID:DB13530 | Mepindolol
+BMGC_DG19397,BMG_DG263374,DrugBank ID:DB13533 | Methylestrenolone
+BMGC_DG19398,BMG_DG263375,DrugBank ID:DB13534 | Gedocarnil
+BMGC_DG19399,BMG_DG263376,Nebacumab | DrugBank ID:DB13535
+BMGC_DG19400,BMG_DG263378,Gitoformate | DrugBank ID:DB13537
+BMGC_DG19401,BMG_DG263379,DrugBank ID:DB13538 | Guacetisal
+BMGC_DG19402,BMG_DG263380,DrugBank ID:DB13539 | Iodoxamic acid
+BMGC_DG19403,BMG_DG263381,Isepamicin | DrugBank ID:DB13540
+BMGC_DG19404,BMG_DG263382,Iprazochrome | DrugBank ID:DB13541
+BMGC_DG19405,BMG_DG263383,DrugBank ID:DB13542 | Bevonium
+BMGC_DG19406,BMG_DG263384,Mitobronitol | DrugBank ID:DB13543
+BMGC_DG19407,BMG_DG263385,DrugBank ID:DB13544 | Ethenzamide
+BMGC_DG19408,BMG_DG263386,Isobromindione | DrugBank ID:DB13545
+BMGC_DG19409,BMG_DG263387,Nizofenone | DrugBank ID:DB13546
+BMGC_DG19410,BMG_DG263388,DrugBank ID:DB13547 | Sulfatolamide
+BMGC_DG19411,BMG_DG263389,DrugBank ID:DB13548 | Dibrompropamidine
+BMGC_DG19412,BMG_DG263390,4-dimethylaminophenol | DrugBank ID:DB13549
+BMGC_DG19413,BMG_DG263391,Bifemelane | DrugBank ID:DB13550
+BMGC_DG19414,BMG_DG263392,DrugBank ID:DB13551 | Cinchophen
+BMGC_DG19415,BMG_DG263393,Trifluperidol | DrugBank ID:DB13552
+BMGC_DG19416,BMG_DG263395,Moperone | DrugBank ID:DB13554
+BMGC_DG19417,BMG_DG263396,DrugBank ID:DB13555 | Prajmaline
+BMGC_DG19418,BMG_DG263397,Sulfamazone | DrugBank ID:DB13556
+BMGC_DG19419,BMG_DG263398,DrugBank ID:DB13557 | Thiopropazate
+BMGC_DG19420,BMG_DG263400,DrugBank ID:DB13559 | Rimiterol
+BMGC_DG19421,BMG_DG263403,DrugBank ID:DB13563 | Norgestrienone
+BMGC_DG19422,BMG_DG263404,Zipeprol | DrugBank ID:DB13564
+BMGC_DG19423,BMG_DG263406,DrugBank ID:DB13566 | Sequifenadine
+BMGC_DG19424,BMG_DG263409,Ferrous chloride | DrugBank ID:DB13569
+BMGC_DG19425,BMG_DG263411,DrugBank ID:DB13571 | Pentamycin
+BMGC_DG19426,BMG_DG263412,DrugBank ID:DB13572 | Emylcamate
+BMGC_DG19427,BMG_DG263413,DrugBank ID:DB13573 | Acefylline
+BMGC_DG19428,BMG_DG263414,Heptaminol | DrugBank ID:DB13574
+BMGC_DG19429,BMG_DG263415,DrugBank ID:DB13575 | Bietaserpine
+BMGC_DG19430,BMG_DG263417,Allobarbital | DrugBank ID:DB13577
+BMGC_DG19431,BMG_DG263418,DrugBank ID:DB13578 | Metabutethamine
+BMGC_DG19432,BMG_DG263420,Succinylsulfathiazole | DrugBank ID:DB13580
+BMGC_DG19433,BMG_DG263421,DrugBank ID:DB13581 | Rociverine
+BMGC_DG19434,BMG_DG263423,DrugBank ID:DB13583 | Mephenesin
+BMGC_DG19435,BMG_DG263424,DrugBank ID:DB13584 | Gallamine
+BMGC_DG19436,BMG_DG263426,DrugBank ID:DB13586 | Metandienone
+BMGC_DG19437,BMG_DG263427,Naftidrofuryl | DrugBank ID:DB13588
+BMGC_DG19438,BMG_DG263428,DrugBank ID:DB13590 | Calcium pangamate
+BMGC_DG19439,BMG_DG263429,Metopimazine | DrugBank ID:DB13591
+BMGC_DG19440,BMG_DG263430,DrugBank ID:DB13592 | Etamiphylline
+BMGC_DG19441,BMG_DG263432,DrugBank ID:DB13596 | Oxycinchophen
+BMGC_DG19442,BMG_DG263433,DrugBank ID:DB13597 | Moroxydine
+BMGC_DG19443,BMG_DG263434,Diethyl ether | DrugBank ID:DB13598
+BMGC_DG19444,BMG_DG263436,Deltamethrin | DrugBank ID:DB13600
+BMGC_DG19445,BMG_DG263437,DrugBank ID:DB13601 | Oxiracetam
+BMGC_DG19446,BMG_DG263438,Promegestone | DrugBank ID:DB13602
+BMGC_DG19447,BMG_DG263439,Pyrrolnitrin | DrugBank ID:DB13603
+BMGC_DG19448,BMG_DG263440,DrugBank ID:DB13604 | Guanazodine
+BMGC_DG19449,BMG_DG263441,DrugBank ID:DB13605 | Phenoperidine
+BMGC_DG19450,BMG_DG263442,Phenazocine | DrugBank ID:DB13606
+BMGC_DG19451,BMG_DG263444,Tiocarlide | DrugBank ID:DB13608
+BMGC_DG19452,BMG_DG263445,DrugBank ID:DB13609 | Umifenovir
+BMGC_DG19453,BMG_DG263447,DrugBank ID:DB13611 | Chlormidazole
+BMGC_DG19454,BMG_DG263448,DrugBank ID:DB13612 | Carbaspirin calcium
+BMGC_DG19455,BMG_DG263450,DrugBank ID:DB13614 | Metizoline
+BMGC_DG19456,BMG_DG263451,DrugBank ID:DB13615 | Mifamurtide
+BMGC_DG19457,BMG_DG263452,DrugBank ID:DB13616 | Melagatran
+BMGC_DG19458,BMG_DG263453,Clorexolone | DrugBank ID:DB13617
+BMGC_DG19459,BMG_DG263454,DrugBank ID:DB13618 | Ipriflavone
+BMGC_DG19460,BMG_DG263455,DrugBank ID:DB13619 | Bornaprine
+BMGC_DG19461,BMG_DG263457,DrugBank ID:DB13622 | Selenium (75Se) norcholesterol
+BMGC_DG19462,BMG_DG263458,DrugBank ID:DB13623 | Fabomotizole
+BMGC_DG19463,BMG_DG263459,DrugBank ID:DB13624 | Methoxyphenamine
+BMGC_DG19464,BMG_DG263460,Carbuterol | DrugBank ID:DB13625
+BMGC_DG19465,BMG_DG263461,Aluminium glycinate | DrugBank ID:DB13626
+BMGC_DG19466,BMG_DG263462,Oxolinic acid | DrugBank ID:DB13627
+BMGC_DG19467,BMG_DG263463,Ethyl hydroxybenzoate | DrugBank ID:DB13628
+BMGC_DG19468,BMG_DG263464,DrugBank ID:DB13629 | Mofebutazone
+BMGC_DG19469,BMG_DG263466,Methoserpidine | DrugBank ID:DB13631
+BMGC_DG19470,BMG_DG263468,Mepartricin | DrugBank ID:DB13633
+BMGC_DG19471,BMG_DG263469,DrugBank ID:DB13634 | Pentifylline
+BMGC_DG19472,BMG_DG263470,Tiracizine | DrugBank ID:DB13635
+BMGC_DG19473,BMG_DG263471,Etanautine | DrugBank ID:DB13636
+BMGC_DG19474,BMG_DG263472,Tenitramine | DrugBank ID:DB13637
+BMGC_DG19475,BMG_DG263473,DrugBank ID:DB13638 | Cefbuperazone
+BMGC_DG19476,BMG_DG263475,DrugBank ID:DB13640 | Acetoxolone
+BMGC_DG19477,BMG_DG263476,Metisazone | DrugBank ID:DB13641
+BMGC_DG19478,BMG_DG263477,DrugBank ID:DB13642 | Pridinol
+BMGC_DG19479,BMG_DG263478,DrugBank ID:DB13644 | Methylthiouracil
+BMGC_DG19480,BMG_DG263479,DrugBank ID:DB13645 | Ethacizine
+BMGC_DG19481,BMG_DG263480,Saruplase | DrugBank ID:DB13646
+BMGC_DG19482,BMG_DG263481,DrugBank ID:DB13647 | Semustine
+BMGC_DG19483,BMG_DG263482,DrugBank ID:DB13648 | Alcuronium
+BMGC_DG19484,BMG_DG263483,DrugBank ID:DB13649 | Proquazone
+BMGC_DG19485,BMG_DG263484,DrugBank ID:DB13650 | Aloglutamol
+BMGC_DG19486,BMG_DG263485,Lorajmine | DrugBank ID:DB13651
+BMGC_DG19487,BMG_DG263486,DrugBank ID:DB13652 | Bunaftine
+BMGC_DG19488,BMG_DG263487,DrugBank ID:DB13653 | Lorcainide
+BMGC_DG19489,BMG_DG263488,Montmorillonite | DrugBank ID:DB13654
+BMGC_DG19490,BMG_DG263489,DrugBank ID:DB13655 | Nikethamide
+BMGC_DG19491,BMG_DG263490,Eberconazole | DrugBank ID:DB13656
+BMGC_DG19492,BMG_DG263491,Benorilate | DrugBank ID:DB13657
+BMGC_DG19493,BMG_DG263493,DrugBank ID:DB13659 | Tenonitrozole
+BMGC_DG19494,BMG_DG263494,DrugBank ID:DB13660 | Propicillin
+BMGC_DG19495,BMG_DG263495,DrugBank ID:DB13661 | Niridazole
+BMGC_DG19496,BMG_DG263496,Hexapropymate | DrugBank ID:DB13662
+BMGC_DG19497,BMG_DG263497,DrugBank ID:DB13663 | Clofenamide
+BMGC_DG19498,BMG_DG263498,Formocortal | DrugBank ID:DB13664
+BMGC_DG19499,BMG_DG263499,Fluanisone | DrugBank ID:DB13665
+BMGC_DG19500,BMG_DG263500,Tiemonium iodide | DrugBank ID:DB13666
+BMGC_DG19501,BMG_DG263501,Cefozopran | DrugBank ID:DB13667
+BMGC_DG19502,BMG_DG263502,DrugBank ID:DB13668 | Ipidacrine
+BMGC_DG19503,BMG_DG263503,Morpholine | DrugBank ID:DB13669
+BMGC_DG19504,BMG_DG263504,DrugBank ID:DB13670 | Oxantel
+BMGC_DG19505,BMG_DG263505,DrugBank ID:DB13671 | Sulbentine
+BMGC_DG19506,BMG_DG263507,DrugBank ID:DB13673 | Bekanamycin
+BMGC_DG19507,BMG_DG263508,DrugBank ID:DB13674 | Cridanimod
+BMGC_DG19508,BMG_DG263509,Metahexamide | DrugBank ID:DB13675
+BMGC_DG19509,BMG_DG263510,Mosapramine | DrugBank ID:DB13676
+BMGC_DG19510,BMG_DG263511,DrugBank ID:DB13677 | Carboquone
+BMGC_DG19511,BMG_DG263512,Dihexyverine | DrugBank ID:DB13678
+BMGC_DG19512,BMG_DG263514,Butalamine | DrugBank ID:DB13681
+BMGC_DG19513,BMG_DG263515,DrugBank ID:DB13682 | Cefpirome
+BMGC_DG19514,BMG_DG263516,Quinisocaine | DrugBank ID:DB13683
+BMGC_DG19515,BMG_DG263517,DrugBank ID:DB13684 | Omoconazole
+BMGC_DG19516,BMG_DG263518,Quingestanol | DrugBank ID:DB13685
+BMGC_DG19517,BMG_DG263519,DrugBank ID:DB13686 | Clometocillin
+BMGC_DG19518,BMG_DG263520,DrugBank ID:DB13687 | Niaprazine
+BMGC_DG19519,BMG_DG263521,Drisapersen | DrugBank ID:DB13688
+BMGC_DG19520,BMG_DG263522,Tacalcitol | DrugBank ID:DB13689
+BMGC_DG19521,BMG_DG263523,DrugBank ID:DB13690 | Vinyl ether
+BMGC_DG19522,BMG_DG263524,Acetyldigoxin | DrugBank ID:DB13691
+BMGC_DG19523,BMG_DG263525,Tretoquinol | DrugBank ID:DB13692
+BMGC_DG19524,BMG_DG263526,DrugBank ID:DB13693 | Sulbenicillin
+BMGC_DG19525,BMG_DG263527,Penthienate | DrugBank ID:DB13695
+BMGC_DG19526,BMG_DG263530,DrugBank ID:DB13698 | Ferrous carbonate
+BMGC_DG19527,BMG_DG263531,Sulfathiourea | DrugBank ID:DB13699
+BMGC_DG19528,BMG_DG263532,DrugBank ID:DB13700 | Protamine
+BMGC_DG19529,BMG_DG263535,Gepefrine | DrugBank ID:DB13703
+BMGC_DG19530,BMG_DG263536,DrugBank ID:DB13704 | Pristinamycin
+BMGC_DG19531,BMG_DG263537,Decamethoxine | DrugBank ID:DB13705
+BMGC_DG19532,BMG_DG263538,Eosin | DrugBank ID:DB13706
+BMGC_DG19533,BMG_DG263539,Fenquizone | DrugBank ID:DB13708
+BMGC_DG19534,BMG_DG263541,Metenolone | DrugBank ID:DB13710
+BMGC_DG19535,BMG_DG263542,Tritoqualine | DrugBank ID:DB13711
+BMGC_DG19536,BMG_DG263544,DrugBank ID:DB13713 | Quifenadine
+BMGC_DG19537,BMG_DG263546,DrugBank ID:DB13715 | Dilazep
+BMGC_DG19538,BMG_DG263547,DrugBank ID:DB13716 | Dibutylphthalate
+BMGC_DG19539,BMG_DG263548,Phenothrin | DrugBank ID:DB13717
+BMGC_DG19540,BMG_DG263549,Hydroquinine | DrugBank ID:DB13718
+BMGC_DG19541,BMG_DG263550,Trolnitrate | DrugBank ID:DB13719
+BMGC_DG19542,BMG_DG263551,DrugBank ID:DB13720 | Diphemanil
+BMGC_DG19543,BMG_DG263552,Cypermethrin | DrugBank ID:DB13721
+BMGC_DG19544,BMG_DG263553,Pirprofen | DrugBank ID:DB13722
+BMGC_DG19545,BMG_DG263554,DrugBank ID:DB13723 | Meldonium
+BMGC_DG19546,BMG_DG263555,DrugBank ID:DB13724 | Nifuratel
+BMGC_DG19547,BMG_DG263556,DrugBank ID:DB13725 | Terodiline
+BMGC_DG19548,BMG_DG263557,DrugBank ID:DB13726 | Sulfaguanidine
+BMGC_DG19549,BMG_DG263558,DrugBank ID:DB13727 | Azapetine
+BMGC_DG19550,BMG_DG263559,DrugBank ID:DB13728 | Halometasone
+BMGC_DG19551,BMG_DG263560,Camostat | DrugBank ID:DB13729
+BMGC_DG19552,BMG_DG263561,Nifurtoinol | DrugBank ID:DB13730
+BMGC_DG19553,BMG_DG263563,DrugBank ID:DB13732 | Meglumine antimoniate
+BMGC_DG19554,BMG_DG263564,Methylpentynol | DrugBank ID:DB13733
+BMGC_DG19555,BMG_DG263566,Fenoxazoline | DrugBank ID:DB13736
+BMGC_DG19556,BMG_DG263567,Cyclobarbital | DrugBank ID:DB13737
+BMGC_DG19557,BMG_DG263568,DrugBank ID:DB13738 | Camylofin
+BMGC_DG19558,BMG_DG263569,DrugBank ID:DB13739 | Penamecillin
+BMGC_DG19559,BMG_DG263570,Bemegride | DrugBank ID:DB13740
+BMGC_DG19560,BMG_DG263571,DrugBank ID:DB13741 | Ioglycamic acid
+BMGC_DG19561,BMG_DG263572,Elcatonin | DrugBank ID:DB13742
+BMGC_DG19562,BMG_DG263574,DrugBank ID:DB13744 | Piromidic acid
+BMGC_DG19563,BMG_DG263575,DrugBank ID:DB13745 | Fazadinium bromide
+BMGC_DG19564,BMG_DG263577,Obidoxime | DrugBank ID:DB13750
+BMGC_DG19565,BMG_DG263578,Glycyrrhizic acid | DrugBank ID:DB13751
+BMGC_DG19566,BMG_DG263579,Tetramethrin | DrugBank ID:DB13752
+BMGC_DG19567,BMG_DG263580,Cetiedil | DrugBank ID:DB13753
+BMGC_DG19568,BMG_DG263581,DrugBank ID:DB13754 | Mephenoxalone
+BMGC_DG19569,BMG_DG263582,DrugBank ID:DB13755 | Iocarmic acid
+BMGC_DG19570,BMG_DG263583,Peruvoside | DrugBank ID:DB13756
+BMGC_DG19571,BMG_DG263584,DrugBank ID:DB13757 | Epanolol
+BMGC_DG19572,BMG_DG263585,Meclofenoxate | DrugBank ID:DB13758
+BMGC_DG19573,BMG_DG263586,DrugBank ID:DB13759 | Fenpiverinium
+BMGC_DG19574,BMG_DG263587,DrugBank ID:DB13760 | Niperotidine
+BMGC_DG19575,BMG_DG263588,Dexrabeprazole | DrugBank ID:DB13762
+BMGC_DG19576,BMG_DG263590,DrugBank ID:DB13764 | Monoxerutin
+BMGC_DG19577,BMG_DG263592,Lidoflazine | DrugBank ID:DB13766
+BMGC_DG19578,BMG_DG263593,Vorozole | DrugBank ID:DB13767
+BMGC_DG19579,BMG_DG263595,Emetonium iodide | DrugBank ID:DB13769
+BMGC_DG19580,BMG_DG263596,Vinylbital | DrugBank ID:DB13770
+BMGC_DG19581,BMG_DG263598,Rufloxacin | DrugBank ID:DB13772
+BMGC_DG19582,BMG_DG263599,DrugBank ID:DB13773 | Sulfamethoxypyridazine
+BMGC_DG19583,BMG_DG263601,DrugBank ID:DB13775 | Tertatolol
+BMGC_DG19584,BMG_DG263602,DrugBank ID:DB13776 | Ibacitabine
+BMGC_DG19585,BMG_DG263603,DrugBank ID:DB13777 | Prenalterol
+BMGC_DG19586,BMG_DG263604,DrugBank ID:DB13778 | Cefazedone
+BMGC_DG19587,BMG_DG263605,Guanoclor | DrugBank ID:DB13779
+BMGC_DG19588,BMG_DG263606,Aluminium clofibrate | DrugBank ID:DB13780
+BMGC_DG19589,BMG_DG263607,DrugBank ID:DB13782 | Imipramine oxide
+BMGC_DG19590,BMG_DG263608,DrugBank ID:DB13784 | Dixyrazine
+BMGC_DG19591,BMG_DG263609,Dropropizine | DrugBank ID:DB13785
+BMGC_DG19592,BMG_DG263610,DrugBank ID:DB13787 | Tilidine
+BMGC_DG19593,BMG_DG263611,DrugBank ID:DB13788 | Chlorbenzoxamine
+BMGC_DG19594,BMG_DG263613,DrugBank ID:DB13790 | Fipexide
+BMGC_DG19595,BMG_DG263614,DrugBank ID:DB13791 | Penfluridol
+BMGC_DG19596,BMG_DG263615,DrugBank ID:DB13793 | Vinburnine
+BMGC_DG19597,BMG_DG263617,DrugBank ID:DB13795 | Brodimoprim
+BMGC_DG19598,BMG_DG263620,DrugBank ID:DB13798 | Demoxytocin
+BMGC_DG19599,BMG_DG263621,Ethadione | DrugBank ID:DB13799
+BMGC_DG19600,BMG_DG263622,Calcium levulinate | DrugBank ID:DB13800
+BMGC_DG19601,BMG_DG263623,DrugBank ID:DB13801 | Muzolimine
+BMGC_DG19602,BMG_DG263625,DrugBank ID:DB13803 | Xipamide
+BMGC_DG19603,BMG_DG263626,Benzylthiouracil | DrugBank ID:DB13804
+BMGC_DG19604,BMG_DG263627,DrugBank ID:DB13805 | Reposal
+BMGC_DG19605,BMG_DG263628,Linopirdine | DrugBank ID:DB13806
+BMGC_DG19606,BMG_DG263629,DrugBank ID:DB13807 | Tisopurine
+BMGC_DG19607,BMG_DG263630,Mebhydrolin | DrugBank ID:DB13808
+BMGC_DG19608,BMG_DG263631,DrugBank ID:DB13809 | Paclitaxel poliglumex
+BMGC_DG19609,BMG_DG263632,Dimemorfan | DrugBank ID:DB13810
+BMGC_DG19610,BMG_DG263633,DrugBank ID:DB13811 | Oblimersen
+BMGC_DG19611,BMG_DG263634,Bufylline | DrugBank ID:DB13812
+BMGC_DG19612,BMG_DG263635,DrugBank ID:DB13814 | Talampicillin
+BMGC_DG19613,BMG_DG263637,DrugBank ID:DB13816 | Aspoxicillin
+BMGC_DG19614,BMG_DG263638,Carbromal | DrugBank ID:DB13817
+BMGC_DG19615,BMG_DG263641,DrugBank ID:DB13820 | Oxomemazine
+BMGC_DG19616,BMG_DG263642,DrugBank ID:DB13821 | Ceftezole
+BMGC_DG19617,BMG_DG263644,DrugBank ID:DB13823 | Pipemidic acid
+BMGC_DG19618,BMG_DG263645,Enprostil | DrugBank ID:DB13824
+BMGC_DG19619,BMG_DG263648,DrugBank ID:DB13827 | Indanazoline
+BMGC_DG19620,BMG_DG263649,Cyfluthrin | DrugBank ID:DB13828
+BMGC_DG19621,BMG_DG263650,DrugBank ID:DB13829 | Calcium silicate
+BMGC_DG19622,BMG_DG263653,Ranimustine | DrugBank ID:DB13832
+BMGC_DG19623,BMG_DG263656,DrugBank ID:DB13835 | Caroverine
+BMGC_DG19624,BMG_DG263657,Metampicillin | DrugBank ID:DB13836
+BMGC_DG19625,BMG_DG263658,Doxefazepam | DrugBank ID:DB13837
+BMGC_DG19626,BMG_DG263659,Noxytiolin | DrugBank ID:DB13838
+BMGC_DG19627,BMG_DG263661,Hydroxyethylpromethazine | DrugBank ID:DB13840
+BMGC_DG19628,BMG_DG263662,Clopenthixol | DrugBank ID:DB13841
+BMGC_DG19629,BMG_DG263664,Cloprednol | DrugBank ID:DB13843
+BMGC_DG19630,BMG_DG263665,Pipenzolate | DrugBank ID:DB13844
+BMGC_DG19631,BMG_DG263666,DrugBank ID:DB13845 | Etafenone
+BMGC_DG19632,BMG_DG263667,DrugBank ID:DB13846 | Pyrrobutamine
+BMGC_DG19633,BMG_DG263669,DrugBank ID:DB13848 | Fluorodopa (18F)
+BMGC_DG19634,BMG_DG263670,Clofibride | DrugBank ID:DB13849
+BMGC_DG19635,BMG_DG263671,Timepidium | DrugBank ID:DB13850
+BMGC_DG19636,BMG_DG263672,DrugBank ID:DB13851 | Artemotil
+BMGC_DG19637,BMG_DG263673,DrugBank ID:DB13852 | Mefenorex
+BMGC_DG19638,BMG_DG263674,Gamolenic acid | DrugBank ID:DB13854
+BMGC_DG19639,BMG_DG263675,Nifuroxazide | DrugBank ID:DB13855
+BMGC_DG19640,BMG_DG263676,Fluclorolone | DrugBank ID:DB13856
+BMGC_DG19641,BMG_DG263677,DrugBank ID:DB13857 | Demegestone
+BMGC_DG19642,BMG_DG263679,DrugBank ID:DB13860 | Imidazole salicylate
+BMGC_DG19643,BMG_DG263680,DrugBank ID:DB13861 | Iopentol
+BMGC_DG19644,BMG_DG263681,DrugBank ID:DB13862 | Magnesium phosphate
+BMGC_DG19645,BMG_DG263682,DrugBank ID:DB13863 | Fosfructose
+BMGC_DG19646,BMG_DG263685,DrugBank ID:DB13867 | Fluticasone
+BMGC_DG19647,BMG_DG263686,DrugBank ID:DB13868 | Adefovir
+BMGC_DG19648,BMG_DG263687,DrugBank ID:DB13877 | Iniparib
+BMGC_DG19649,BMG_DG263689,Amylmetacresol | DrugBank ID:DB13908
+BMGC_DG19650,BMG_DG263690,Bismuth subgallate | DrugBank ID:DB13909
+BMGC_DG19651,BMG_DG263691,Valproate bismuth | DrugBank ID:DB13910
+BMGC_DG19652,BMG_DG263693,Belladonna | DrugBank ID:DB13913
+BMGC_DG19653,BMG_DG263694,DrugBank ID:DB13916 | Toyocamycin
+BMGC_DG19654,BMG_DG263695,DrugBank ID:DB13917 | Deoxyepinephrine
+BMGC_DG19655,BMG_DG263698,DrugBank ID:DB13923 | Emicizumab
+BMGC_DG19656,BMG_DG263699,DrugBank ID:DB13924 | Varicella zoster vaccine (recombinant)
+BMGC_DG19657,BMG_DG263700,Dotatate gallium Ga-68 | DrugBank ID:DB13925
+BMGC_DG19658,BMG_DG263701,Cenegermin | DrugBank ID:DB13926
+BMGC_DG19659,BMG_DG263703,DrugBank ID:DB13928 | Semaglutide
+BMGC_DG19660,BMG_DG263704,Relcovaptan | DrugBank ID:DB13929
+BMGC_DG19661,BMG_DG263705,DrugBank ID:DB13930 | Ulixertinib
+BMGC_DG19662,BMG_DG263706,Netarsudil | DrugBank ID:DB13931
+BMGC_DG19663,BMG_DG263707,DrugBank ID:DB13932 | Voretigene neparvovec
+BMGC_DG19664,BMG_DG263708,DrugBank ID:DB13933 | Nonacog beta pegol
+BMGC_DG19665,BMG_DG263709,DrugBank ID:DB13934 | Ligandrol
+BMGC_DG19666,BMG_DG263714,DrugBank ID:DB13939 | RAD-140
+BMGC_DG19667,BMG_DG263715,"2,5-Dimethoxy-4-ethylthioamphetamine | DrugBank ID:DB13940"
+BMGC_DG19668,BMG_DG263716,Piperaquine | DrugBank ID:DB13941
+BMGC_DG19669,BMG_DG263717,DrugBank ID:DB13943 | Testosterone cypionate
+BMGC_DG19670,BMG_DG263718,DrugBank ID:DB13944 | Testosterone enanthate
+BMGC_DG19671,BMG_DG263719,Testosterone undecanoate | DrugBank ID:DB13946
+BMGC_DG19672,BMG_DG263720,Testosterone enantate benzilic acid hydrazone | DrugBank ID:DB13947
+BMGC_DG19673,BMG_DG263721,"N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine | DrugBank ID:DB13948"
+BMGC_DG19674,BMG_DG263722,DrugBank ID:DB13949 | Ferric cation
+BMGC_DG19675,BMG_DG263723,DrugBank ID:DB13950 | WIN 55212-2
+BMGC_DG19676,BMG_DG263724,Stanolone acetate | DrugBank ID:DB13951
+BMGC_DG19677,BMG_DG263725,DrugBank ID:DB13955 | Estradiol dienanthate
+BMGC_DG19678,BMG_DG263727,Trestolone acetate | DrugBank ID:DB13958
+BMGC_DG19679,BMG_DG263729,Bronopol | DrugBank ID:DB13960
+BMGC_DG19680,BMG_DG263730,DrugBank ID:DB13961 | Fish oil
+BMGC_DG19681,BMG_DG263736,DrugBank ID:DB13967 | Patent Blue
+BMGC_DG19682,BMG_DG263744,DrugBank ID:DB13975 | Black cohosh
+BMGC_DG19683,BMG_DG263745,Sulesomab | DrugBank ID:DB13976
+BMGC_DG19684,BMG_DG263746,DrugBank ID:DB13977 | Potassium carbonate
+BMGC_DG19685,BMG_DG263747,Selisistat | DrugBank ID:DB13978
+BMGC_DG19686,BMG_DG263748,Besilesomab | DrugBank ID:DB13979
+BMGC_DG19687,BMG_DG263750,Nomegestrol acetate | DrugBank ID:DB13981
+BMGC_DG19688,BMG_DG263752,"5,7,2′-trihydroxy-6,8-dimethoxyflavone | DrugBank ID:DB13983"
+BMGC_DG19689,BMG_DG263753,Cyclopropane | DrugBank ID:DB13984
+BMGC_DG19690,BMG_DG263754,Lutetium Lu 177 dotatate | DrugBank ID:DB13985
+BMGC_DG19691,BMG_DG263755,Strontium chloride | DrugBank ID:DB13987
+BMGC_DG19692,BMG_DG263756,DrugBank ID:DB13988 | SB-269970
+BMGC_DG19693,BMG_DG263757,DrugBank ID:DB13989 | Epitizide
+BMGC_DG19694,BMG_DG263761,MRK-409 | DrugBank ID:DB13993
+BMGC_DG19695,BMG_DG263762,AZD-7325 | DrugBank ID:DB13994
+BMGC_DG19696,BMG_DG263763,Ferric pyrophosphate citrate | DrugBank ID:DB13995
+BMGC_DG19697,BMG_DG263764,Magnesium acetate | DrugBank ID:DB13996
+BMGC_DG19698,BMG_DG263765,Baloxavir marboxil | DrugBank ID:DB13997
+BMGC_DG19699,BMG_DG263766,Lonoctocog alfa | DrugBank ID:DB13998
+BMGC_DG19700,BMG_DG263767,Moroctocog alfa | DrugBank ID:DB13999
+BMGC_DG19701,BMG_DG263769,alpha-Tocopherol succinate | DrugBank ID:DB14001
+BMGC_DG19702,BMG_DG263770,DrugBank ID:DB14002 | D-alpha-Tocopherol acetate
+BMGC_DG19703,BMG_DG263771,DrugBank ID:DB14003 | alpha-Tocopherol acetate
+BMGC_DG19704,BMG_DG263772,DrugBank ID:DB14004 | Tildrakizumab
+BMGC_DG19705,BMG_DG263773,DrugBank ID:DB14005 | Dimethicone 410
+BMGC_DG19706,BMG_DG263774,Choline salicylate | DrugBank ID:DB14006
+BMGC_DG19707,BMG_DG263775,DrugBank ID:DB14007 | Pentetic acid
+BMGC_DG19708,BMG_DG263777,Medical Cannabis | DrugBank ID:DB14009
+BMGC_DG19709,BMG_DG263778,"DrugBank ID:DB14010 | 5-methoxy-N,N-dimethyltryptamine"
+BMGC_DG19710,BMG_DG263779,DrugBank ID:DB14011 | Nabiximols
+BMGC_DG19711,BMG_DG263780,Burosumab | DrugBank ID:DB14012
+BMGC_DG19712,BMG_DG263781,DrugBank ID:DB14013 | SR-9009
+BMGC_DG19713,BMG_DG263782,SR-9011 | DrugBank ID:DB14014
+BMGC_DG19714,BMG_DG263783,Sodium bisulfite | DrugBank ID:DB14015
+BMGC_DG19715,BMG_DG263784,DrugBank ID:DB14016 | Ox bile extract
+BMGC_DG19716,BMG_DG263785,DrugBank ID:DB14017 | H3B-8800
+BMGC_DG19717,BMG_DG263786,DrugBank ID:DB14018 | Bromotheophylline
+BMGC_DG19718,BMG_DG263787,DrugBank ID:DB14019 | Fosnetupitant
+BMGC_DG19719,BMG_DG263788,Benzoin | DrugBank ID:DB14020
+BMGC_DG19720,BMG_DG263789,Typhoid vaccine | DrugBank ID:DB14022
+BMGC_DG19721,BMG_DG263790,Clinafloxacin | DrugBank ID:DB14025
+BMGC_DG19722,BMG_DG263791,DrugBank ID:DB14026 | Thiosalicylic acid
+BMGC_DG19723,BMG_DG263792,DrugBank ID:DB14027 | Taspoglutide
+BMGC_DG19724,BMG_DG263793,DrugBank ID:DB14028 | Nordazepam
+BMGC_DG19725,BMG_DG263794,DrugBank ID:DB14029 | Furafylline
+BMGC_DG19726,BMG_DG263796,DrugBank ID:DB14031 | Tretamine
+BMGC_DG19727,BMG_DG263797,Darglitazone | DrugBank ID:DB14034
+BMGC_DG19728,BMG_DG263798,DrugBank ID:DB14035 | Englitazone
+BMGC_DG19729,BMG_DG263800,beta-Sitosterol | DrugBank ID:DB14038
+BMGC_DG19730,BMG_DG263801,DrugBank ID:DB14039 | Erenumab
+BMGC_DG19731,BMG_DG263802,Eptinezumab | DrugBank ID:DB14040
+BMGC_DG19732,BMG_DG263803,DrugBank ID:DB14041 | Fremanezumab
+BMGC_DG19733,BMG_DG263804,DrugBank ID:DB14042 | Galcanezumab
+BMGC_DG19734,BMG_DG263805,DrugBank ID:DB14043 | Palmidrol
+BMGC_DG19735,BMG_DG263809,DrugBank ID:DB14048 | Sodium zirconium cyclosilicate
+BMGC_DG19736,BMG_DG263810,Nitrate | DrugBank ID:DB14049
+BMGC_DG19737,BMG_DG263811,Cannabidivarin | DrugBank ID:DB14050
+BMGC_DG19738,BMG_DG263812,Malacidin A | DrugBank ID:DB14051
+BMGC_DG19739,BMG_DG263813,Malacidin B | DrugBank ID:DB14052
+BMGC_DG19740,BMG_DG263814,DrugBank ID:DB14054 | Asiatic acid
+BMGC_DG19741,BMG_DG263815,DrugBank ID:DB14055 | (S)-Warfarin
+BMGC_DG19742,BMG_DG263816,DrugBank ID:DB14056 | Nigericin
+BMGC_DG19743,BMG_DG263817,Valinomycin | DrugBank ID:DB14057
+BMGC_DG19744,BMG_DG263818,DrugBank ID:DB14058 | Basifungin
+BMGC_DG19745,BMG_DG263819,SC-236 | DrugBank ID:DB14059
+BMGC_DG19746,BMG_DG263820,NS-398 | DrugBank ID:DB14060
+BMGC_DG19747,BMG_DG263821,DrugBank ID:DB14061 | Hycanthone
+BMGC_DG19748,BMG_DG263822,DrugBank ID:DB14062 | Concanamycin A
+BMGC_DG19749,BMG_DG263823,DrugBank ID:DB14063 | Dexverapamil
+BMGC_DG19750,BMG_DG263824,Emopamil | DrugBank ID:DB14064
+BMGC_DG19751,BMG_DG263825,Lomerizine | DrugBank ID:DB14065
+BMGC_DG19752,BMG_DG263826,Tetrandrine | DrugBank ID:DB14066
+BMGC_DG19753,BMG_DG263827,Dofequidar | DrugBank ID:DB14067
+BMGC_DG19754,BMG_DG263828,Dexniguldipine | DrugBank ID:DB14068
+BMGC_DG19755,BMG_DG263829,ONT-093 | DrugBank ID:DB14069
+BMGC_DG19756,BMG_DG263830,HM-30181 | DrugBank ID:DB14070
+BMGC_DG19757,BMG_DG263831,Desmethylsertraline | DrugBank ID:DB14071
+BMGC_DG19758,BMG_DG263832,Reversin 121 | DrugBank ID:DB14072
+BMGC_DG19759,BMG_DG263834,Icaridin | DrugBank ID:DB14074
+BMGC_DG19760,BMG_DG263837,DrugBank ID:DB14077 | Magnesium stearate
+BMGC_DG19761,BMG_DG263843,DrugBank ID:DB14083 | Bisphenol A diglycidyl ether
+BMGC_DG19762,BMG_DG263846,Cianidanol | DrugBank ID:DB14086
+BMGC_DG19763,BMG_DG263853,"(1,2,6,7-3H)Testosterone | DrugBank ID:DB14093"
+BMGC_DG19764,BMG_DG263854,Tocopherylquinone | DrugBank ID:DB14094
+BMGC_DG19765,BMG_DG263857,Cobalamin | DrugBank ID:DB14098
+BMGC_DG19766,BMG_DG263863,DrugBank ID:DB14104 | Linoleic acid
+BMGC_DG19767,BMG_DG263868,DrugBank ID:DB14109 | alpha-Arbutin
+BMGC_DG19768,BMG_DG263881,Menthol | DrugBank ID:DB14123
+BMGC_DG19769,BMG_DG263883,DrugBank ID:DB14125 | Benazeprilat
+BMGC_DG19770,BMG_DG263884,Tenofovir | DrugBank ID:DB14126
+BMGC_DG19771,BMG_DG263885,DrugBank ID:DB14127 | Sacubitrilat
+BMGC_DG19772,BMG_DG263886,DrugBank ID:DB14128 | Nadide
+BMGC_DG19773,BMG_DG263889,Basic Fibroblast Growth Factor | DrugBank ID:DB14131
+BMGC_DG19774,BMG_DG263890,8-chlorotheophylline | DrugBank ID:DB14132
+BMGC_DG19775,BMG_DG263901,p-Aminophenol | DrugBank ID:DB14144
+BMGC_DG19776,BMG_DG263903,DrugBank ID:DB14146 | Loxicodegol
+BMGC_DG19777,BMG_DG263912,DrugBank ID:DB14156 | Synthetic camphor
+BMGC_DG19778,BMG_DG263930,Dipentamethylenethiuram disulfide | DrugBank ID:DB14174
+BMGC_DG19779,BMG_DG263939,Geraniol | DrugBank ID:DB14183
+BMGC_DG19780,BMG_DG263940,DrugBank ID:DB14184 | Cinnamaldehyde
+BMGC_DG19781,BMG_DG263941,Aripiprazole lauroxil | DrugBank ID:DB14185
+BMGC_DG19782,BMG_DG263942,Cinnamyl alcohol | DrugBank ID:DB14186
+BMGC_DG19783,BMG_DG263943,Hydroxycitronellal | DrugBank ID:DB14187
+BMGC_DG19784,BMG_DG263944,DrugBank ID:DB14188 | Isoeugenol
+BMGC_DG19785,BMG_DG263949,DrugBank ID:DB14193 | Ditiocarb zinc
+BMGC_DG19786,BMG_DG263950,DrugBank ID:DB14194 | Zinc dibutyldithiocarbamate
+BMGC_DG19787,BMG_DG263963,Fosinoprilat | DrugBank ID:DB14207
+BMGC_DG19788,BMG_DG263964,Ramiprilat | DrugBank ID:DB14208
+BMGC_DG19789,BMG_DG263965,DrugBank ID:DB14209 | Trandolaprilat
+BMGC_DG19790,BMG_DG263966,Moexiprilat | DrugBank ID:DB14210
+BMGC_DG19791,BMG_DG263967,DrugBank ID:DB14211 | Fanolesomab
+BMGC_DG19792,BMG_DG263968,DrugBank ID:DB14212 | Methylparaben
+BMGC_DG19793,BMG_DG263969,Perindoprilat | DrugBank ID:DB14213
+BMGC_DG19794,BMG_DG263971,Quinaprilat | DrugBank ID:DB14217
+BMGC_DG19795,BMG_DG263972,DrugBank ID:DB14218 | Telotristat
+BMGC_DG19796,BMG_DG263973,Monomethyl fumarate | DrugBank ID:DB14219
+BMGC_DG19797,BMG_DG263984,Quinoline Yellow WS | DrugBank ID:DB14231
+BMGC_DG19798,BMG_DG263985,DrugBank ID:DB14232 | Deacetylbisacodyl
+BMGC_DG19799,BMG_DG263993,Echinacea | DrugBank ID:DB14240
+BMGC_DG19800,BMG_DG264009,DrugBank ID:DB14256 | Centella asiatica
+BMGC_DG19801,BMG_DG264090,Salvia miltiorrhiza root | DrugBank ID:DB14337
+BMGC_DG19802,BMG_DG264124,Mangostin | DrugBank ID:DB14371
+BMGC_DG19803,BMG_DG264135,DrugBank ID:DB14384 | Influenza A virus A/Victoria/210/2009 X-187 (H3N2) hemagglutinin antigen (formaldehyde inactivated)
+BMGC_DG19804,BMG_DG264136,Influenza B virus B/Brisbane/60/2008 hemagglutinin antigen (formaldehyde inactivated) | DrugBank ID:DB14385
+BMGC_DG19805,BMG_DG264145,DrugBank ID:DB14394 | Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
+BMGC_DG19806,BMG_DG264160,Human adenovirus e serotype 4 strain cl-68578 antigen | DrugBank ID:DB14409
+BMGC_DG19807,BMG_DG264194,DrugBank ID:DB14443 | Vibrio cholerae CVD 103-HgR strain live antigen
+BMGC_DG19808,BMG_DG264196,Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) | DrugBank ID:DB14445
+BMGC_DG19809,BMG_DG264199,DrugBank ID:DB14449 | Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
+BMGC_DG19810,BMG_DG264223,Beroctocog alfa | DrugBank ID:DB14473
+BMGC_DG19811,BMG_DG264226,DrugBank ID:DB14476 | DL-alpha-Tocopherol
+BMGC_DG19812,BMG_DG264227,DrugBank ID:DB14477 | DL-alpha tocopheryl acetate
+BMGC_DG19813,BMG_DG264229,DrugBank ID:DB14479 | Acetylcysteine zinc
+BMGC_DG19814,BMG_DG264231,DrugBank ID:DB14481 | Calcium phosphate dihydrate
+BMGC_DG19815,BMG_DG264232,DrugBank ID:DB14482 | Sodium ascorbate
+BMGC_DG19816,BMG_DG264233,Calcium ascorbate | DrugBank ID:DB14483
+BMGC_DG19817,BMG_DG264234,DrugBank ID:DB14484 | Magnesium ascorbate
+BMGC_DG19818,BMG_DG264235,Zinc ascorbate | DrugBank ID:DB14485
+BMGC_DG19819,BMG_DG264236,Niacinamide ascorbate | DrugBank ID:DB14486
+BMGC_DG19820,BMG_DG264237,Zinc acetate | DrugBank ID:DB14487
+BMGC_DG19821,BMG_DG264238,DrugBank ID:DB14492 | Potassium triiodide
+BMGC_DG19822,BMG_DG264239,DrugBank ID:DB14493 | Zinc glycinate
+BMGC_DG19823,BMG_DG264240,Zinc carbonate | DrugBank ID:DB14494
+BMGC_DG19824,BMG_DG264244,Potassium acetate | DrugBank ID:DB14498
+BMGC_DG19825,BMG_DG264245,DrugBank ID:DB14499 | Potassium sulfate
+BMGC_DG19826,BMG_DG264246,DrugBank ID:DB14500 | Potassium
+BMGC_DG19827,BMG_DG264247,"Sodium phosphate, dibasic | DrugBank ID:DB14502"
+BMGC_DG19828,BMG_DG264248,"DrugBank ID:DB14503 | Sodium phosphate, monobasic, unspecified form"
+BMGC_DG19829,BMG_DG264249,"Sodium phosphate, dibasic, unspecified form | DrugBank ID:DB14504"
+BMGC_DG19830,BMG_DG264251,Lithium hydroxide | DrugBank ID:DB14506
+BMGC_DG19831,BMG_DG264252,DrugBank ID:DB14507 | Lithium citrate
+BMGC_DG19832,BMG_DG264253,Lithium succinate | DrugBank ID:DB14508
+BMGC_DG19833,BMG_DG264254,DrugBank ID:DB14509 | Lithium carbonate
+BMGC_DG19834,BMG_DG264256,Acetate | DrugBank ID:DB14511
+BMGC_DG19835,BMG_DG264257,DrugBank ID:DB14512 | Mometasone furoate
+BMGC_DG19836,BMG_DG264258,Magnesium | DrugBank ID:DB14513
+BMGC_DG19837,BMG_DG264259,Magnesium levulinate | DrugBank ID:DB14514
+BMGC_DG19838,BMG_DG264260,DrugBank ID:DB14515 | Magnesium lactate
+BMGC_DG19839,BMG_DG264261,DrugBank ID:DB14516 | Sodium cation
+BMGC_DG19840,BMG_DG264262,Aluminium phosphate | DrugBank ID:DB14517
+BMGC_DG19841,BMG_DG264263,Aluminum acetate | DrugBank ID:DB14518
+BMGC_DG19842,BMG_DG264264,DrugBank ID:DB14519 | Aluminum cation
+BMGC_DG19843,BMG_DG264265,DrugBank ID:DB14520 | Tetraferric tricitrate decahydrate
+BMGC_DG19844,BMG_DG264268,Phosphate ion | DrugBank ID:DB14523
+BMGC_DG19845,BMG_DG264269,Gallium cation | DrugBank ID:DB14524
+BMGC_DG19846,BMG_DG264271,DrugBank ID:DB14526 | Chromic citrate
+BMGC_DG19847,BMG_DG264272,Chromic nitrate | DrugBank ID:DB14527
+BMGC_DG19848,BMG_DG264273,DrugBank ID:DB14528 | Chromium gluconate
+BMGC_DG19849,BMG_DG264274,DrugBank ID:DB14529 | Chromium nicotinate
+BMGC_DG19850,BMG_DG264275,DrugBank ID:DB14530 | Chromous sulfate
+BMGC_DG19851,BMG_DG264277,DrugBank ID:DB14532 | Zinc cation
+BMGC_DG19852,BMG_DG264278,DrugBank ID:DB14533 | Zinc chloride
+BMGC_DG19853,BMG_DG264283,Hydrocortisone aceponate | DrugBank ID:DB14538
+BMGC_DG19854,BMG_DG264284,Hydrocortisone butyrate | DrugBank ID:DB14540
+BMGC_DG19855,BMG_DG264285,DrugBank ID:DB14541 | Hydrocortisone cypionate
+BMGC_DG19856,BMG_DG264286,Hydrocortisone phosphate | DrugBank ID:DB14542
+BMGC_DG19857,BMG_DG264287,DrugBank ID:DB14545 | Hydrocortisone succinate
+BMGC_DG19858,BMG_DG264288,Sulfate ion | DrugBank ID:DB14546
+BMGC_DG19859,BMG_DG264290,"Zinc sulfate, unspecified form | DrugBank ID:DB14548"
+BMGC_DG19860,BMG_DG264304,DrugBank ID:DB14562 | Andexanet alfa
+BMGC_DG19861,BMG_DG264310,DrugBank ID:DB14568 | Ivosidenib
+BMGC_DG19862,BMG_DG264311,Tedizolid | DrugBank ID:DB14569
+BMGC_DG19863,BMG_DG264312,DrugBank ID:DB14570 | Hydroxyprogesterone
+BMGC_DG19864,BMG_DG264317,Eslicarbazepine | DrugBank ID:DB14575
+BMGC_DG19865,BMG_DG264319,DrugBank ID:DB14577 | Calcium cation
+BMGC_DG19866,BMG_DG264321,DrugBank ID:DB14579 | Lanthanum III cation
+BMGC_DG19867,BMG_DG264322,Lecanemab | DrugBank ID:DB14580
+BMGC_DG19868,BMG_DG264323,DrugBank ID:DB14581 | CPI-1205
+BMGC_DG19869,BMG_DG264324,Patisiran | DrugBank ID:DB14582
+BMGC_DG19870,BMG_DG264325,Segesterone acetate | DrugBank ID:DB14583
+BMGC_DG19871,BMG_DG264327,Plantago ovata seed | DrugBank ID:DB14585
+BMGC_DG19872,BMG_DG264338,Lanadelumab | DrugBank ID:DB14597
+BMGC_DG19873,BMG_DG264358,DrugBank ID:DB14619 | Influenza A virus A/Uruguay/716/2007(H3N2) antigen (propiolactone inactivated)
+BMGC_DG19874,BMG_DG264359,DrugBank ID:DB14620 | Influenza A virus A/Brisbane/59/2007(H1N1) antigen (propiolactone inactivated)
+BMGC_DG19875,BMG_DG264365,DrugBank ID:DB14627 | Oxyphenisatin acetate
+BMGC_DG19876,BMG_DG264369,Prednisolone phosphate | DrugBank ID:DB14631
+BMGC_DG19877,BMG_DG264370,Prednisolone hemisuccinate | DrugBank ID:DB14633
+BMGC_DG19878,BMG_DG264371,Fluprednidene acetate | DrugBank ID:DB14634
+BMGC_DG19879,BMG_DG264372,DrugBank ID:DB14635 | Curcumin sulfate
+BMGC_DG19880,BMG_DG264373,Triciribine phosphate | DrugBank ID:DB14636
+BMGC_DG19881,BMG_DG264375,Diloxanide furoate | DrugBank ID:DB14638
+BMGC_DG19882,BMG_DG264376,Boldenone undecylenate | DrugBank ID:DB14639
+BMGC_DG19883,BMG_DG264377,Isoflupredone acetate | DrugBank ID:DB14640
+BMGC_DG19884,BMG_DG264378,DrugBank ID:DB14642 | Lypressin
+BMGC_DG19885,BMG_DG264379,Methylprednisolone aceponate | DrugBank ID:DB14643
+BMGC_DG19886,BMG_DG264380,DrugBank ID:DB14644 | Methylprednisolone hemisuccinate
+BMGC_DG19887,BMG_DG264382,Prednisone acetate | DrugBank ID:DB14646
+BMGC_DG19888,BMG_DG264385,DrugBank ID:DB14652 | Clocortolone acetate
+BMGC_DG19889,BMG_DG264388,Drostanolone propionate | DrugBank ID:DB14655
+BMGC_DG19890,BMG_DG264392,Melengestrol acetate | DrugBank ID:DB14659
+BMGC_DG19891,BMG_DG264402,Betamethasone phosphate | DrugBank ID:DB14669
+BMGC_DG19892,BMG_DG264405,Oxazepam acetate | DrugBank ID:DB14672
+BMGC_DG19893,BMG_DG264407,DrugBank ID:DB14674 | Estramustine phosphate
+BMGC_DG19894,BMG_DG264411,Norethindrone enanthate | DrugBank ID:DB14678
+BMGC_DG19895,BMG_DG264412,DrugBank ID:DB14679 | Quingestanol acetate
+BMGC_DG19896,BMG_DG264413,DrugBank ID:DB14680 | Combretastatin A4
+BMGC_DG19897,BMG_DG264414,Cortisone | DrugBank ID:DB14681
+BMGC_DG19898,BMG_DG264417,Calcium polycarbophil | DrugBank ID:DB14684
+BMGC_DG19899,BMG_DG264418,DrugBank ID:DB14685 | Adenovirus type 7 vaccine live
+BMGC_DG19900,BMG_DG264423,Ginger oil | DrugBank ID:DB14690
+BMGC_DG19901,BMG_DG264428,Ferric oxyhydroxide | DrugBank ID:DB14695
+BMGC_DG19902,BMG_DG264433,DrugBank ID:DB14700 | Damoctocog alfa pegol
+BMGC_DG19903,BMG_DG264440,Cemiplimab | DrugBank ID:DB14707
+BMGC_DG19904,BMG_DG264441,Tosylchloramide | DrugBank ID:DB14708
+BMGC_DG19905,BMG_DG264444,"Smallpox (Vaccinia) Vaccine, Live | DrugBank ID:DB14711"
+BMGC_DG19906,BMG_DG264445,DrugBank ID:DB14712 | Elapegademase
+BMGC_DG19907,BMG_DG264446,DrugBank ID:DB14713 | Inotersen
+BMGC_DG19908,BMG_DG264448,DrugBank ID:DB14715 | Cinazepam
+BMGC_DG19909,BMG_DG264451,DrugBank ID:DB14718 | Pyrazolam
+BMGC_DG19910,BMG_DG264452,DrugBank ID:DB14719 | Bentazepam
+BMGC_DG19911,BMG_DG264455,DrugBank ID:DB14722 | ADU-S100
+BMGC_DG19912,BMG_DG264456,DrugBank ID:DB14723 | Larotrectinib
+BMGC_DG19913,BMG_DG264457,Emapalumab | DrugBank ID:DB14724
+BMGC_DG19914,BMG_DG264458,DrugBank ID:DB14725 | Cefamandole nafate
+BMGC_DG19915,BMG_DG264459,Dabigatran | DrugBank ID:DB14726
+BMGC_DG19916,BMG_DG264463,DrugBank ID:DB14730 | Calaspargase pegol
+BMGC_DG19917,BMG_DG264464,DrugBank ID:DB14731 | Tagraxofusp
+BMGC_DG19918,BMG_DG264466,DrugBank ID:DB14733 | Ceftobiprole medocaril
+BMGC_DG19919,BMG_DG264470,Cannabinol | DrugBank ID:DB14737
+BMGC_DG19920,BMG_DG264471,DrugBank ID:DB14738 | Turoctocog alfa pegol
+BMGC_DG19921,BMG_DG264473,Hyaluronidase | DrugBank ID:DB14740
+BMGC_DG19922,BMG_DG264483,DrugBank ID:DB14751 | Mecasermin rinfabate
+BMGC_DG19923,BMG_DG264484,DrugBank ID:DB14752 | Racephedrine
+BMGC_DG19924,BMG_DG264486,Solriamfetol | DrugBank ID:DB14754
+BMGC_DG19925,BMG_DG264493,DrugBank ID:DB14761 | Remdesivir
+BMGC_DG19926,BMG_DG264494,Risankizumab | DrugBank ID:DB14762
+BMGC_DG19927,BMG_DG264495,Cycloguanil | DrugBank ID:DB14763
+BMGC_DG19928,BMG_DG264497,DrugBank ID:DB14765 | Rivoceranib
+BMGC_DG19929,BMG_DG264498,DrugBank ID:DB14766 | Etrasimod
+BMGC_DG19930,BMG_DG264502,Lanraplenib | DrugBank ID:DB14770
+BMGC_DG19931,BMG_DG264505,Lifirafenib | DrugBank ID:DB14773
+BMGC_DG19932,BMG_DG264506,DrugBank ID:DB14774 | Balipodect
+BMGC_DG19933,BMG_DG264508,Camrelizumab | DrugBank ID:DB14776
+BMGC_DG19934,BMG_DG264509,Murepavadin | DrugBank ID:DB14777
+BMGC_DG19935,BMG_DG264510,Setrusumab | DrugBank ID:DB14778
+BMGC_DG19936,BMG_DG264511,DrugBank ID:DB14779 | LGD-6972
+BMGC_DG19937,BMG_DG264514,Tofersen | DrugBank ID:DB14782
+BMGC_DG19938,BMG_DG264515,Diroximel fumarate | DrugBank ID:DB14783
+BMGC_DG19939,BMG_DG264516,Gancotamab | DrugBank ID:DB14784
+BMGC_DG19940,BMG_DG264517,DrugBank ID:DB14785 | Fenebrutinib
+BMGC_DG19941,BMG_DG264519,DrugBank ID:DB14787 | BMS-830216
+BMGC_DG19942,BMG_DG264522,Zatolmilast | DrugBank ID:DB14790
+BMGC_DG19943,BMG_DG264523,GDC-0425 | DrugBank ID:DB14791
+BMGC_DG19944,BMG_DG264524,DrugBank ID:DB14792 | AZD-5991
+BMGC_DG19945,BMG_DG264531,PF-06821497 | DrugBank ID:DB14799
+BMGC_DG19946,BMG_DG264533,DrugBank ID:DB14801 | Lanifibranor
+BMGC_DG19947,BMG_DG264534,ONO-2952 | DrugBank ID:DB14802
+BMGC_DG19948,BMG_DG264535,DrugBank ID:DB14803 | AMY-101
+BMGC_DG19949,BMG_DG264537,Piflufolastat F 18 | DrugBank ID:DB14805
+BMGC_DG19950,BMG_DG264538,DrugBank ID:DB14806 | Avexitide
+BMGC_DG19951,BMG_DG264541,DrugBank ID:DB14809 | Anetumab ravtansine
+BMGC_DG19952,BMG_DG264542,AZD-1656 | DrugBank ID:DB14810
+BMGC_DG19953,BMG_DG264543,Isatuximab | DrugBank ID:DB14811
+BMGC_DG19954,BMG_DG264545,DrugBank ID:DB14813 | PF-232798
+BMGC_DG19955,BMG_DG264554,DrugBank ID:DB14822 | SB-649868
+BMGC_DG19956,BMG_DG264555,Balovaptan | DrugBank ID:DB14823
+BMGC_DG19957,BMG_DG264556,DrugBank ID:DB14824 | Icrucumab
+BMGC_DG19958,BMG_DG264561,Uproleselan | DrugBank ID:DB14829
+BMGC_DG19959,BMG_DG264567,SUVN-G3031 | DrugBank ID:DB14835
+BMGC_DG19960,BMG_DG264571,DrugBank ID:DB14840 | Ripretinib
+BMGC_DG19961,BMG_DG264574,Codrituzumab | DrugBank ID:DB14843
+BMGC_DG19962,BMG_DG264575,Dordaviprone | DrugBank ID:DB14844
+BMGC_DG19963,BMG_DG264576,DrugBank ID:DB14845 | Filgotinib
+BMGC_DG19964,BMG_DG264577,DrugBank ID:DB14846 | Bimiralisib
+BMGC_DG19965,BMG_DG264580,DrugBank ID:DB14849 | Nebicapone
+BMGC_DG19966,BMG_DG264582,DrugBank ID:DB14851 | Relatlimab
+BMGC_DG19967,BMG_DG264584,DrugBank ID:DB14853 | Myrcludex B
+BMGC_DG19968,BMG_DG264585,DrugBank ID:DB14854 | TC-6987
+BMGC_DG19969,BMG_DG264587,DrugBank ID:DB14856 | PF-05089771
+BMGC_DG19970,BMG_DG264588,Avadomide | DrugBank ID:DB14857
+BMGC_DG19971,BMG_DG264590,DrugBank ID:DB14859 | Fosifloxuridine nafalbenamide
+BMGC_DG19972,BMG_DG264591,Ensartinib | DrugBank ID:DB14860
+BMGC_DG19973,BMG_DG264593,DrugBank ID:DB14864 | Brolucizumab
+BMGC_DG19974,BMG_DG264594,Human interleukin-2 | DrugBank ID:DB14865
+BMGC_DG19975,BMG_DG264595,DrugBank ID:DB14866 | Amcasertib
+BMGC_DG19976,BMG_DG264596,Parsaclisib | DrugBank ID:DB14867
+BMGC_DG19977,BMG_DG264597,DrugBank ID:DB14868 | AZD-8848
+BMGC_DG19978,BMG_DG264599,PF-5190457 | DrugBank ID:DB14870
+BMGC_DG19979,BMG_DG264600,DrugBank ID:DB14871 | Xentuzumab
+BMGC_DG19980,BMG_DG264604,DrugBank ID:DB14875 | AZD-4017
+BMGC_DG19981,BMG_DG264605,DrugBank ID:DB14876 | TAS-116
+BMGC_DG19982,BMG_DG264606,DrugBank ID:DB14877 | Lintuzumab
+BMGC_DG19983,BMG_DG264608,DrugBank ID:DB14879 | Cefiderocol
+BMGC_DG19984,BMG_DG264610,Oliceridine | DrugBank ID:DB14881
+BMGC_DG19985,BMG_DG264615,DrugBank ID:DB14886 | BIO-11006
+BMGC_DG19986,BMG_DG264616,PF-04620110 | DrugBank ID:DB14887
+BMGC_DG19987,BMG_DG264617,IQP-0528 | DrugBank ID:DB14888
+BMGC_DG19988,BMG_DG264618,DrugBank ID:DB14889 | Derazantinib
+BMGC_DG19989,BMG_DG264619,DrugBank ID:DB14890 | Obicetrapib
+BMGC_DG19990,BMG_DG264620,Vobarilizumab | DrugBank ID:DB14891
+BMGC_DG19991,BMG_DG264621,DrugBank ID:DB14892 | Spartalizumab
+BMGC_DG19992,BMG_DG264622,Galicaftor | DrugBank ID:DB14894
+BMGC_DG19993,BMG_DG264623,DrugBank ID:DB14895 | Vibegron
+BMGC_DG19994,BMG_DG264624,DrugBank ID:DB14896 | Selitrectinib
+BMGC_DG19995,BMG_DG264625,DrugBank ID:DB14897 | Parsatuzumab
+BMGC_DG19996,BMG_DG264626,Retagliptin | DrugBank ID:DB14898
+BMGC_DG19997,BMG_DG264628,DrugBank ID:DB14900 | ISO-1 F-18
+BMGC_DG19998,BMG_DG264629,DrugBank ID:DB14901 | Inclisiran
+BMGC_DG19999,BMG_DG264632,Pimasertib | DrugBank ID:DB14904
+BMGC_DG20000,BMG_DG264633,Emactuzumab | DrugBank ID:DB14905
+BMGC_DG20001,BMG_DG264634,Adafosbuvir | DrugBank ID:DB14906
+BMGC_DG20002,BMG_DG264635,Bevacizumab zirconium Zr-89 | DrugBank ID:DB14907
+BMGC_DG20003,BMG_DG264636,Refanezumab | DrugBank ID:DB14908
+BMGC_DG20004,BMG_DG264637,DrugBank ID:DB14909 | Imetelstat
+BMGC_DG20005,BMG_DG264638,Mirikizumab | DrugBank ID:DB14910
+BMGC_DG20006,BMG_DG264639,Risuteganib | DrugBank ID:DB14911
+BMGC_DG20007,BMG_DG264642,DrugBank ID:DB14914 | Flortaucipir F-18
+BMGC_DG20008,BMG_DG264644,DrugBank ID:DB14916 | Selonsertib
+BMGC_DG20009,BMG_DG264645,Ceralasertib | DrugBank ID:DB14917
+BMGC_DG20010,BMG_DG264646,DrugBank ID:DB14918 | Branaplam
+BMGC_DG20011,BMG_DG264647,Rozanolixizumab | DrugBank ID:DB14919
+BMGC_DG20012,BMG_DG264649,Mavacamten | DrugBank ID:DB14921
+BMGC_DG20013,BMG_DG264650,Tislelizumab | DrugBank ID:DB14922
+BMGC_DG20014,BMG_DG264651,Satavaptan | DrugBank ID:DB14923
+BMGC_DG20015,BMG_DG264652,Ritlecitinib | DrugBank ID:DB14924
+BMGC_DG20016,BMG_DG264658,DrugBank ID:DB14930 | Alovudine F-18
+BMGC_DG20017,BMG_DG264663,Serabelisib | DrugBank ID:DB14935
+BMGC_DG20018,BMG_DG264664,Menaquinone 6 | DrugBank ID:DB14936
+BMGC_DG20019,BMG_DG264666,Flurbiprofen axetil | DrugBank ID:DB14938
+BMGC_DG20020,BMG_DG264667,Motixafortide | DrugBank ID:DB14939
+BMGC_DG20021,BMG_DG264669,DrugBank ID:DB14941 | BMS-817399
+BMGC_DG20022,BMG_DG264670,DrugBank ID:DB14942 | BMS-986141
+BMGC_DG20023,BMG_DG264671,DrugBank ID:DB14943 | LGH-447
+BMGC_DG20024,BMG_DG264672,DrugBank ID:DB14944 | Tarloxotinib
+BMGC_DG20025,BMG_DG264674,DrugBank ID:DB14946 | PCO-371
+BMGC_DG20026,BMG_DG264675,DrugBank ID:DB14947 | Bermekimab
+BMGC_DG20027,BMG_DG264676,BMS-986020 | DrugBank ID:DB14948
+BMGC_DG20028,BMG_DG264679,Etirinotecan pegol | DrugBank ID:DB14951
+BMGC_DG20029,BMG_DG264680,DrugBank ID:DB14952 | Pamrevlumab
+BMGC_DG20030,BMG_DG264687,DrugBank ID:DB14959 | Opicinumab
+BMGC_DG20031,BMG_DG264688,Somatrogon | DrugBank ID:DB14960
+BMGC_DG20032,BMG_DG264690,Trastuzumab deruxtecan | DrugBank ID:DB14962
+BMGC_DG20033,BMG_DG264691,Konjac mannan | DrugBank ID:DB14963
+BMGC_DG20034,BMG_DG264694,Venglustat | DrugBank ID:DB14966
+BMGC_DG20035,BMG_DG264695,Margetuximab | DrugBank ID:DB14967
+BMGC_DG20036,BMG_DG264697,DrugBank ID:DB14969 | GTX-758
+BMGC_DG20037,BMG_DG264701,Abrocitinib | DrugBank ID:DB14973
+BMGC_DG20038,BMG_DG264703,Voxelotor | DrugBank ID:DB14975
+BMGC_DG20039,BMG_DG264704,DrugBank ID:DB14976 | Relacorilant
+BMGC_DG20040,BMG_DG264705,DrugBank ID:DB14977 | Padsevonil
+BMGC_DG20041,BMG_DG264707,Martinostat | DrugBank ID:DB14979
+BMGC_DG20042,BMG_DG264708,DrugBank ID:DB14980 | AZD-6482
+BMGC_DG20043,BMG_DG264709,DrugBank ID:DB14981 | Phytic acid
+BMGC_DG20044,BMG_DG264710,DrugBank ID:DB14982 | Miransertib
+BMGC_DG20045,BMG_DG264712,Casimersen | DrugBank ID:DB14984
+BMGC_DG20046,BMG_DG264713,DrugBank ID:DB14985 | Enarodustat
+BMGC_DG20047,BMG_DG264715,DrugBank ID:DB14987 | Difamilast
+BMGC_DG20048,BMG_DG264716,Dalantercept | DrugBank ID:DB14988
+BMGC_DG20049,BMG_DG264717,DrugBank ID:DB14989 | Umbralisib
+BMGC_DG20050,BMG_DG264720,DrugBank ID:DB14992 | Pegunigalsidase alfa
+BMGC_DG20051,BMG_DG264721,Pyrotinib | DrugBank ID:DB14993
+BMGC_DG20052,BMG_DG264722,NP-G2-044 | DrugBank ID:DB14995
+BMGC_DG20053,BMG_DG264723,DrugBank ID:DB14996 | Sutimlimab
+BMGC_DG20054,BMG_DG264724,Pateclizumab | DrugBank ID:DB14997
+BMGC_DG20055,BMG_DG264725,DrugBank ID:DB14998 | Olorinab
+BMGC_DG20056,BMG_DG264726,DrugBank ID:DB14999 | Human interferon beta
+BMGC_DG20057,BMG_DG264728,DrugBank ID:DB15001 | Eflapegrastim
+BMGC_DG20058,BMG_DG264730,DrugBank ID:DB15003 | PF-06700841
+BMGC_DG20059,BMG_DG264732,DrugBank ID:DB15005 | Viltolarsen
+BMGC_DG20060,BMG_DG264736,PF-04937319 | DrugBank ID:DB15009
+BMGC_DG20061,BMG_DG264737,DrugBank ID:DB15010 | Edasalonexent
+BMGC_DG20062,BMG_DG264738,Avacopan | DrugBank ID:DB15011
+BMGC_DG20063,BMG_DG264739,Farampator | DrugBank ID:DB15012
+BMGC_DG20064,BMG_DG264741,Gremubamab | DrugBank ID:DB15014
+BMGC_DG20065,BMG_DG264748,Leriglitazone | DrugBank ID:DB15021
+BMGC_DG20066,BMG_DG264749,Apomab | DrugBank ID:DB15022
+BMGC_DG20067,BMG_DG264754,DrugBank ID:DB15027 | Adriforant
+BMGC_DG20068,BMG_DG264756,AZD-8186 | DrugBank ID:DB15029
+BMGC_DG20069,BMG_DG264758,Daridorexant | DrugBank ID:DB15031
+BMGC_DG20070,BMG_DG264760,Flortaucipir | DrugBank ID:DB15033
+BMGC_DG20071,BMG_DG264761,PRI-724 | DrugBank ID:DB15034
+BMGC_DG20072,BMG_DG264762,DrugBank ID:DB15035 | Zanubrutinib
+BMGC_DG20073,BMG_DG264763,Sitravatinib | DrugBank ID:DB15036
+BMGC_DG20074,BMG_DG264765,Litoxetine | DrugBank ID:DB15038
+BMGC_DG20075,BMG_DG264770,DrugBank ID:DB15043 | Toripalimab
+BMGC_DG20076,BMG_DG264771,DrugBank ID:DB15044 | Tafasitamab
+BMGC_DG20077,BMG_DG264772,DrugBank ID:DB15045 | Ipafricept
+BMGC_DG20078,BMG_DG264773,DrugBank ID:DB15046 | LY-2881835
+BMGC_DG20079,BMG_DG264774,BMS-919373 | DrugBank ID:DB15047
+BMGC_DG20080,BMG_DG264775,DrugBank ID:DB15048 | Licogliflozin
+BMGC_DG20081,BMG_DG264778,DrugBank ID:DB15051 | Ethaselen
+BMGC_DG20082,BMG_DG264782,DrugBank ID:DB15055 | ABT-639
+BMGC_DG20083,BMG_DG264784,DrugBank ID:DB15057 | Fosgemcitabine palabenamide
+BMGC_DG20084,BMG_DG264786,Aprocitentan | DrugBank ID:DB15059
+BMGC_DG20085,BMG_DG264790,DrugBank ID:DB15063 | Inarigivir soproxil
+BMGC_DG20086,BMG_DG264792,DrugBank ID:DB15065 | PF-06291874
+BMGC_DG20087,BMG_DG264793,DrugBank ID:DB15066 | Givosiran
+BMGC_DG20088,BMG_DG264794,Volanesorsen | DrugBank ID:DB15067
+BMGC_DG20089,BMG_DG264795,DrugBank ID:DB15068 | Agerafenib
+BMGC_DG20090,BMG_DG264798,Omidenepag isopropyl | DrugBank ID:DB15071
+BMGC_DG20091,BMG_DG264803,DrugBank ID:DB15076 | Abrilumab
+BMGC_DG20092,BMG_DG264812,Fulacimstat | DrugBank ID:DB15085
+BMGC_DG20093,BMG_DG264816,DrugBank ID:DB15089 | Frovocimab
+BMGC_DG20094,BMG_DG264817,DrugBank ID:DB15090 | Tezepelumab
+BMGC_DG20095,BMG_DG264818,Upadacitinib | DrugBank ID:DB15091
+BMGC_DG20096,BMG_DG264819,LY-2624803 | DrugBank ID:DB15092
+BMGC_DG20097,BMG_DG264820,DrugBank ID:DB15093 | Somapacitan
+BMGC_DG20098,BMG_DG264822,DrugBank ID:DB15095 | Leridistim
+BMGC_DG20099,BMG_DG264823,18-methoxycoronaridine | DrugBank ID:DB15096
+BMGC_DG20100,BMG_DG264824,DrugBank ID:DB15097 | Gefapixant
+BMGC_DG20101,BMG_DG264827,DrugBank ID:DB15100 | Cusatuzumab
+BMGC_DG20102,BMG_DG264828,DrugBank ID:DB15101 | Tigatuzumab
+BMGC_DG20103,BMG_DG264829,DrugBank ID:DB15102 | Pemigatinib
+BMGC_DG20104,BMG_DG264831,Telisotuzumab vedotin | DrugBank ID:DB15104
+BMGC_DG20105,BMG_DG264833,DrugBank ID:DB15106 | Surufatinib
+BMGC_DG20106,BMG_DG264837,Onvansertib | DrugBank ID:DB15110
+BMGC_DG20107,BMG_DG264839,Somatropin pegol | DrugBank ID:DB15112
+BMGC_DG20108,BMG_DG264840,Utomilumab | DrugBank ID:DB15113
+BMGC_DG20109,BMG_DG264841,Vamorolone | DrugBank ID:DB15114
+BMGC_DG20110,BMG_DG264845,DrugBank ID:DB15118 | Zolbetuximab
+BMGC_DG20111,BMG_DG264846,Ropeginterferon alfa-2b | DrugBank ID:DB15119
+BMGC_DG20112,BMG_DG264847,GSK-239512 | DrugBank ID:DB15120
+BMGC_DG20113,BMG_DG264849,DrugBank ID:DB15122 | PCS-499
+BMGC_DG20114,BMG_DG264850,DrugBank ID:DB15123 | Dorzagliatin
+BMGC_DG20115,BMG_DG264851,PF-05241328 | DrugBank ID:DB15124
+BMGC_DG20116,BMG_DG264853,IMG-7289 | DrugBank ID:DB15126
+BMGC_DG20117,BMG_DG264857,Dexpramipexole | DrugBank ID:DB15130
+BMGC_DG20118,BMG_DG264858,DrugBank ID:DB15131 | Interferon alfa-2c
+BMGC_DG20119,BMG_DG264859,DrugBank ID:DB15132 | AZD-8165
+BMGC_DG20120,BMG_DG264860,Tepotinib | DrugBank ID:DB15133
+BMGC_DG20121,BMG_DG264862,Ponezumab | DrugBank ID:DB15135
+BMGC_DG20122,BMG_DG264864,VK-2809 | DrugBank ID:DB15137
+BMGC_DG20123,BMG_DG264865,AZD-9496 | DrugBank ID:DB15138
+BMGC_DG20124,BMG_DG264876,Futibatinib | DrugBank ID:DB15149
+BMGC_DG20125,BMG_DG264884,Voruciclib | DrugBank ID:DB15157
+BMGC_DG20126,BMG_DG264887,Asunercept | DrugBank ID:DB15160
+BMGC_DG20127,BMG_DG264890,Selatogrel | DrugBank ID:DB15163
+BMGC_DG20128,BMG_DG264891,DrugBank ID:DB15164 | Apadamtase alfa
+BMGC_DG20129,BMG_DG264892,Avacincaptad pegol | DrugBank ID:DB15165
+BMGC_DG20130,BMG_DG264894,DrugBank ID:DB15167 | Fallypride
+BMGC_DG20131,BMG_DG264895,Cilofexor | DrugBank ID:DB15168
+BMGC_DG20132,BMG_DG264896,DrugBank ID:DB15169 | H3B-6527
+BMGC_DG20133,BMG_DG264897,Evobrutinib | DrugBank ID:DB15170
+BMGC_DG20134,BMG_DG264898,DrugBank ID:DB15171 | Tirzepatide
+BMGC_DG20135,BMG_DG264899,Suvratoxumab | DrugBank ID:DB15172
+BMGC_DG20136,BMG_DG264900,DrugBank ID:DB15173 | JNJ-42165279
+BMGC_DG20137,BMG_DG264911,DrugBank ID:DB15186 | Paxalisib
+BMGC_DG20138,BMG_DG264912,DrugBank ID:DB15187 | Dubermatinib
+BMGC_DG20139,BMG_DG264914,Birabresib | DrugBank ID:DB15189
+BMGC_DG20140,BMG_DG264915,DrugBank ID:DB15190 | GLPG-0259
+BMGC_DG20141,BMG_DG264917,DrugBank ID:DB15192 | ABT-288
+BMGC_DG20142,BMG_DG264919,Cotadutide | DrugBank ID:DB15194
+BMGC_DG20143,BMG_DG264928,DrugBank ID:DB15203 | JNJ-26489112
+BMGC_DG20144,BMG_DG264930,Capromorelin | DrugBank ID:DB15205
+BMGC_DG20145,BMG_DG264931,DrugBank ID:DB15206 | Uprifosbuvir
+BMGC_DG20146,BMG_DG264932,DrugBank ID:DB15207 | Esaxerenone
+BMGC_DG20147,BMG_DG264937,DrugBank ID:DB15212 | Pemafibrate
+BMGC_DG20148,BMG_DG264938,25-desacetylrifapentine | DrugBank ID:DB15213
+BMGC_DG20149,BMG_DG264939,DrugBank ID:DB15214 | BMS-986104
+BMGC_DG20150,BMG_DG264940,KRN-5500 | DrugBank ID:DB15215
+BMGC_DG20151,BMG_DG264942,Gastric inhibitory polypeptide | DrugBank ID:DB15217
+BMGC_DG20152,BMG_DG264943,DrugBank ID:DB15218 | Pozelimab
+BMGC_DG20153,BMG_DG264944,Tomivosertib | DrugBank ID:DB15219
+BMGC_DG20154,BMG_DG264946,DrugBank ID:DB15221 | PF-06260414
+BMGC_DG20155,BMG_DG264950,Mitazalimab | DrugBank ID:DB15225
+BMGC_DG20156,BMG_DG264951,DrugBank ID:DB15226 | Dasiglucagon
+BMGC_DG20157,BMG_DG264952,DrugBank ID:DB15227 | Tirabrutinib
+BMGC_DG20158,BMG_DG264954,DrugBank ID:DB15229 | CNV-2197944
+BMGC_DG20159,BMG_DG264957,Telaglenastat | DrugBank ID:DB15232
+BMGC_DG20160,BMG_DG264958,DrugBank ID:DB15233 | Avapritinib
+BMGC_DG20161,BMG_DG264970,DrugBank ID:DB15245 | Olorofim
+BMGC_DG20162,BMG_DG264973,DrugBank ID:DB15248 | Bulevirtide
+BMGC_DG20163,BMG_DG264975,DrugBank ID:DB15250 | Vercirnon
+BMGC_DG20164,BMG_DG264977,Nemolizumab | DrugBank ID:DB15252
+BMGC_DG20165,BMG_DG264978,DrugBank ID:DB15253 | Bleselumab
+BMGC_DG20166,BMG_DG264979,Avutometinib | DrugBank ID:DB15254
+BMGC_DG20167,BMG_DG264980,DrugBank ID:DB15256 | Reldesemtiv
+BMGC_DG20168,BMG_DG264981,Milademetan | DrugBank ID:DB15257
+BMGC_DG20169,BMG_DG264982,DrugBank ID:DB15258 | Imlifidase
+BMGC_DG20170,BMG_DG264987,DrugBank ID:DB15263 | Thyrotropin
+BMGC_DG20171,BMG_DG264989,USL-311 | DrugBank ID:DB15265
+BMGC_DG20172,BMG_DG264990,DrugBank ID:DB15266 | Tovorafenib
+BMGC_DG20173,BMG_DG264994,DrugBank ID:DB15270 | Efgartigimod alfa
+BMGC_DG20174,BMG_DG264995,Crizanlizumab | DrugBank ID:DB15271
+BMGC_DG20175,BMG_DG264997,VS-4718 | DrugBank ID:DB15273
+BMGC_DG20176,BMG_DG264998,DrugBank ID:DB15274 | Pertussis vaccine
+BMGC_DG20177,BMG_DG264999,Inavolisib | DrugBank ID:DB15275
+BMGC_DG20178,BMG_DG265001,Gedivumab | DrugBank ID:DB15277
+BMGC_DG20179,BMG_DG265005,DrugBank ID:DB15281 | Ravoxertinib
+BMGC_DG20180,BMG_DG265007,DrugBank ID:DB15283 | Tebentafusp
+BMGC_DG20181,BMG_DG265012,Etamicastat | DrugBank ID:DB15288
+BMGC_DG20182,BMG_DG265013,DrugBank ID:DB15289 | Perillyl alcohol
+BMGC_DG20183,BMG_DG265014,DrugBank ID:DB15290 | Pegteograstim
+BMGC_DG20184,BMG_DG265015,DrugBank ID:DB15291 | BMS-986142
+BMGC_DG20185,BMG_DG265017,DrugBank ID:DB15293 | Epalrestat
+BMGC_DG20186,BMG_DG265018,SB-1578 | DrugBank ID:DB15294
+BMGC_DG20187,BMG_DG265019,Tenalisib | DrugBank ID:DB15295
+BMGC_DG20188,BMG_DG265021,Petesicatib | DrugBank ID:DB15297
+BMGC_DG20189,BMG_DG265023,Navtemadlin | DrugBank ID:DB15299
+BMGC_DG20190,BMG_DG265024,Hydroquinidine | DrugBank ID:DB15300
+BMGC_DG20191,BMG_DG265027,DrugBank ID:DB15303 | Faricimab
+BMGC_DG20192,BMG_DG265029,DrugBank ID:DB15305 | Risdiplam
+BMGC_DG20193,BMG_DG265034,Vactosertib | DrugBank ID:DB15310
+BMGC_DG20194,BMG_DG265041,Posiphen | DrugBank ID:DB15317
+BMGC_DG20195,BMG_DG265045,Tefinostat | DrugBank ID:DB15321
+BMGC_DG20196,BMG_DG265047,Trelagliptin | DrugBank ID:DB15323
+BMGC_DG20197,BMG_DG265051,DrugBank ID:DB15327 | Abivertinib
+BMGC_DG20198,BMG_DG265052,Ubrogepant | DrugBank ID:DB15328
+BMGC_DG20199,BMG_DG265056,DrugBank ID:DB15332 | Radavirsen
+BMGC_DG20200,BMG_DG265058,DrugBank ID:DB15334 | Biochanin A
+BMGC_DG20201,BMG_DG265059,Formononetin | DrugBank ID:DB15335
+BMGC_DG20202,BMG_DG265060,Valanafusp alfa | DrugBank ID:DB15336
+BMGC_DG20203,BMG_DG265070,DrugBank ID:DB15347 | Branebrutinib
+BMGC_DG20204,BMG_DG265071,DrugBank ID:DB15348 | Ampreloxetine
+BMGC_DG20205,BMG_DG265072,Sofituzumab vedotin | DrugBank ID:DB15349
+BMGC_DG20206,BMG_DG265074,Dihematoporphyrin ether | DrugBank ID:DB15351
+BMGC_DG20207,BMG_DG265077,DrugBank ID:DB15354 | Evinacumab
+BMGC_DG20208,BMG_DG265078,PL-3994 | DrugBank ID:DB15355
+BMGC_DG20209,BMG_DG265079,SLV-334 | DrugBank ID:DB15356
+BMGC_DG20210,BMG_DG265080,DrugBank ID:DB15357 | Xanomeline
+BMGC_DG20211,BMG_DG265081,DrugBank ID:DB15358 | JNJ-54175446
+BMGC_DG20212,BMG_DG265083,"Carfentanil, C-11 | DrugBank ID:DB15360"
+BMGC_DG20213,BMG_DG265086,Istiratumab | DrugBank ID:DB15363
+BMGC_DG20214,BMG_DG265089,SOR-C13 | DrugBank ID:DB15366
+BMGC_DG20215,BMG_DG265090,DrugBank ID:DB15367 | LY-2623091
+BMGC_DG20216,BMG_DG265105,SAR-125844 | DrugBank ID:DB15382
+BMGC_DG20217,BMG_DG265106,Pidilizumab | DrugBank ID:DB15383
+BMGC_DG20218,BMG_DG265108,DrugBank ID:DB15385 | Acebilustat
+BMGC_DG20219,BMG_DG265112,DrugBank ID:DB15389 | Teceleukin
+BMGC_DG20220,BMG_DG265114,Elenbecestat | DrugBank ID:DB15391
+BMGC_DG20221,BMG_DG265116,DrugBank ID:DB15393 | Telatinib
+BMGC_DG20222,BMG_DG265117,DrugBank ID:DB15394 | gamma-Tocopherol
+BMGC_DG20223,BMG_DG265118,DrugBank ID:DB15395 | Elranatamab
+BMGC_DG20224,BMG_DG265120,GMA-161 | DrugBank ID:DB15397
+BMGC_DG20225,BMG_DG265122,BMS-754807 | DrugBank ID:DB15399
+BMGC_DG20226,BMG_DG265124,DrugBank ID:DB15401 | Danicopan
+BMGC_DG20227,BMG_DG265129,GLPG-0974 | DrugBank ID:DB15406
+BMGC_DG20228,BMG_DG265130,DrugBank ID:DB15407 | Acalisib
+BMGC_DG20229,BMG_DG265131,DrugBank ID:DB15408 | Silmitasertib
+BMGC_DG20230,BMG_DG265132,DrugBank ID:DB15409 | Ladiratuzumab vedotin
+BMGC_DG20231,BMG_DG265136,DrugBank ID:DB15413 | Pafolacianine
+BMGC_DG20232,BMG_DG265138,DrugBank ID:DB15415 | Tomaralimab
+BMGC_DG20233,BMG_DG265139,PX-102 | DrugBank ID:DB15416
+BMGC_DG20234,BMG_DG265142,Nanatinostat | DrugBank ID:DB15419
+BMGC_DG20235,BMG_DG265148,CYC-065 | DrugBank ID:DB15425
+BMGC_DG20236,BMG_DG265150,DrugBank ID:DB15427 | Fialuridine
+BMGC_DG20237,BMG_DG265151,DrugBank ID:DB15428 | Vesencumab
+BMGC_DG20238,BMG_DG265154,DrugBank ID:DB15431 | M-2698
+BMGC_DG20239,BMG_DG265155,DrugBank ID:DB15432 | Pinatuzumab vedotin
+BMGC_DG20240,BMG_DG265157,Mosunetuzumab | DrugBank ID:DB15434
+BMGC_DG20241,BMG_DG265164,Lulizumab pegol | DrugBank ID:DB15441
+BMGC_DG20242,BMG_DG265165,Trilaciclib | DrugBank ID:DB15442
+BMGC_DG20243,BMG_DG265166,Lorukafusp alfa | DrugBank ID:DB15443
+BMGC_DG20244,BMG_DG265167,DrugBank ID:DB15444 | Elexacaftor
+BMGC_DG20245,BMG_DG265168,DrugBank ID:DB15445 | Iodohippuric acid
+BMGC_DG20246,BMG_DG265169,Vidofludimus | DrugBank ID:DB15446
+BMGC_DG20247,BMG_DG265170,DrugBank ID:DB15447 | Setogepram
+BMGC_DG20248,BMG_DG265172,Citarinostat | DrugBank ID:DB15449
+BMGC_DG20249,BMG_DG265173,PF-05105679 | DrugBank ID:DB15450
+BMGC_DG20250,BMG_DG265176,DrugBank ID:DB15453 | Naratuximab emtansine
+BMGC_DG20251,BMG_DG265179,DrugBank ID:DB15456 | Vericiguat
+BMGC_DG20252,BMG_DG265181,DrugBank ID:DB15458 | Norleucine
+BMGC_DG20253,BMG_DG265182,DrugBank ID:DB15460 | AGG-523
+BMGC_DG20254,BMG_DG265183,Yersinia pestis 195/p antigen (formaldehyde inactivated) | DrugBank ID:DB15461
+BMGC_DG20255,BMG_DG265184,DrugBank ID:DB15462 | Fucoxanthin
+BMGC_DG20256,BMG_DG265185,DrugBank ID:DB15463 | Belzutifan
+BMGC_DG20257,BMG_DG265187,Benzhydrocodone | DrugBank ID:DB15465
+BMGC_DG20258,BMG_DG265188,DrugBank ID:DB15466 | Tallimustine
+BMGC_DG20259,BMG_DG265193,DrugBank ID:DB15471 | Zanidatamab
+BMGC_DG20260,BMG_DG265199,Alloin | DrugBank ID:DB15477
+BMGC_DG20261,BMG_DG265200,Frangula purshiana bark | DrugBank ID:DB15478
+BMGC_DG20262,BMG_DG265205,DrugBank ID:DB15483 | Modified vaccinia ankara
+BMGC_DG20263,BMG_DG265210,Echinacoside | DrugBank ID:DB15488
+BMGC_DG20264,BMG_DG265211,DrugBank ID:DB15489 | Mexazolam
+BMGC_DG20265,BMG_DG265212,DrugBank ID:DB15490 | Zuranolone
+BMGC_DG20266,BMG_DG265214,DrugBank ID:DB15492 | Eticlopride
+BMGC_DG20267,BMG_DG265215,DrugBank ID:DB15493 | Cambinol
+BMGC_DG20268,BMG_DG265216,Edotreotide gallium Ga-68 | DrugBank ID:DB15494
+BMGC_DG20269,BMG_DG265217,Rocaglamide | DrugBank ID:DB15495
+BMGC_DG20270,BMG_DG265218,DrugBank ID:DB15496 | Didesmethylrocaglamide
+BMGC_DG20271,BMG_DG265220,DrugBank ID:DB15498 | BOS172722
+BMGC_DG20272,BMG_DG265221,Cerdulatinib | DrugBank ID:DB15499
+BMGC_DG20273,BMG_DG265250,DrugBank ID:DB15528 | Onasemnogene abeparvovec
+BMGC_DG20274,BMG_DG265256,DrugBank ID:DB15534 | Colchiceine
+BMGC_DG20275,BMG_DG265258,Ferric chloride | DrugBank ID:DB15536
+BMGC_DG20276,BMG_DG265281,Zenocutuzumab | DrugBank ID:DB15559
+BMGC_DG20277,BMG_DG265283,Valoctocogene roxaparvovec | DrugBank ID:DB15561
+BMGC_DG20278,BMG_DG265287,DrugBank ID:DB15565 | Cilazaprilat
+BMGC_DG20279,BMG_DG265289,DrugBank ID:DB15568 | Adagrasib
+BMGC_DG20280,BMG_DG265290,DrugBank ID:DB15569 | Sotorasib
+BMGC_DG20281,BMG_DG265291,FLX475 | DrugBank ID:DB15570
+BMGC_DG20282,BMG_DG265293,DrugBank ID:DB15572 | Exagamglogene autotemcel
+BMGC_DG20283,BMG_DG265294,alpha-Pinene | DrugBank ID:DB15573
+BMGC_DG20284,BMG_DG265295,DrugBank ID:DB15574 | beta-Pinene
+BMGC_DG20285,BMG_DG265296,Padeliporfin | DrugBank ID:DB15575
+BMGC_DG20286,BMG_DG265298,DrugBank ID:DB15578 | Desfesoterodine
+BMGC_DG20287,BMG_DG265300,Climbazole | DrugBank ID:DB15580
+BMGC_DG20288,BMG_DG265301,Chrysin | DrugBank ID:DB15581
+BMGC_DG20289,BMG_DG265304,Luteolin | DrugBank ID:DB15584
+BMGC_DG20290,BMG_DG265305,DrugBank ID:DB15585 | ORG-31710
+BMGC_DG20291,BMG_DG265306,DrugBank ID:DB15586 | Patulin
+BMGC_DG20292,BMG_DG265308,DrugBank ID:DB15588 | Ursolic acid
+BMGC_DG20293,BMG_DG265311,DrugBank ID:DB15591 | Atrial natriuretic peptide
+BMGC_DG20294,BMG_DG265313,DrugBank ID:DB15593 | Golodirsen
+BMGC_DG20295,BMG_DG265314,DrugBank ID:DB15594 | Brilliant blue G
+BMGC_DG20296,BMG_DG265315,"Ebola Zaire vaccine (live, attenuated) | DrugBank ID:DB15595"
+BMGC_DG20297,BMG_DG265318,DrugBank ID:DB15598 | Ferric maltol
+BMGC_DG20298,BMG_DG265319,MIV-711 | DrugBank ID:DB15599
+BMGC_DG20299,BMG_DG265333,Previtamin D(3) | DrugBank ID:DB15614
+BMGC_DG20300,BMG_DG265336,Ferric derisomaltose | DrugBank ID:DB15617
+BMGC_DG20301,BMG_DG265342,DrugBank ID:DB15623 | TMC-310911
+BMGC_DG20302,BMG_DG265343,DrugBank ID:DB15624 | Halicin
+BMGC_DG20303,BMG_DG265344,DrugBank ID:DB15626 | Spesolimab
+BMGC_DG20304,BMG_DG265345,DrugBank ID:DB15627 | Dostarlimab
+BMGC_DG20305,BMG_DG265346,DrugBank ID:DB15628 | Inolimomab
+BMGC_DG20306,BMG_DG265349,Edodekin alfa | DrugBank ID:DB15631
+BMGC_DG20307,BMG_DG265351,DrugBank ID:DB15633 | Pabinafusp alfa
+BMGC_DG20308,BMG_DG265353,DrugBank ID:DB15635 | Omburtamab
+BMGC_DG20309,BMG_DG265354,Zilucoplan | DrugBank ID:DB15636
+BMGC_DG20310,BMG_DG265355,Fluzoparib | DrugBank ID:DB15637
+BMGC_DG20311,BMG_DG265357,DrugBank ID:DB15639 | AMG-337
+BMGC_DG20312,BMG_DG265358,DrugBank ID:DB15640 | CDC-801
+BMGC_DG20313,BMG_DG265359,Droloxifene | DrugBank ID:DB15641
+BMGC_DG20314,BMG_DG265360,DrugBank ID:DB15642 | Molidustat
+BMGC_DG20315,BMG_DG265361,DrugBank ID:DB15643 | N-(2-Aminoethyl)-1-aziridineethanamine
+BMGC_DG20316,BMG_DG265364,DrugBank ID:DB15646 | Fasitibant
+BMGC_DG20317,BMG_DG265365,DrugBank ID:DB15647 | Ketodarolutamide
+BMGC_DG20318,BMG_DG265368,DrugBank ID:DB15650 | Efpeglenatide
+BMGC_DG20319,BMG_DG265372,DrugBank ID:DB15654 | Moderna COVID-19 Vaccine
+BMGC_DG20320,BMG_DG265374,AstraZeneca COVID-19 Vaccine | DrugBank ID:DB15656
+BMGC_DG20321,BMG_DG265375,Ala-geninthiocin | DrugBank ID:DB15657
+BMGC_DG20322,BMG_DG265378,N4-Hydroxycytidine | DrugBank ID:DB15660
+BMGC_DG20323,BMG_DG265379,Molnupiravir | DrugBank ID:DB15661
+BMGC_DG20324,BMG_DG265383,SEP-363856 | DrugBank ID:DB15665
+BMGC_DG20325,BMG_DG265387,DrugBank ID:DB15669 | Fezolinetant
+BMGC_DG20326,BMG_DG265388,DrugBank ID:DB15670 | Gusacitinib
+BMGC_DG20327,BMG_DG265391,DrugBank ID:DB15673 | Lenacapavir
+BMGC_DG20328,BMG_DG265393,Baloxavir | DrugBank ID:DB15675
+BMGC_DG20329,BMG_DG265403,DrugBank ID:DB15685 | Selpercatinib
+BMGC_DG20330,BMG_DG265404,DrugBank ID:DB15686 | GS-441524
+BMGC_DG20331,BMG_DG265406,Zavegepant | DrugBank ID:DB15688
+BMGC_DG20332,BMG_DG265408,DrugBank ID:DB15690 | Fluoroestradiol F-18
+BMGC_DG20333,BMG_DG265412,Cedazuridine | DrugBank ID:DB15694
+BMGC_DG20334,BMG_DG265417,DrugBank ID:DB15699 | Brexucabtagene autoleucel
+BMGC_DG20335,BMG_DG265436,Bamlanivimab | DrugBank ID:DB15718
+BMGC_DG20336,BMG_DG265437,Belantamab mafodotin | DrugBank ID:DB15719
+BMGC_DG20337,BMG_DG265467,DrugBank ID:DB15749 | Interferon Kappa
+BMGC_DG20338,BMG_DG265471,Interferon Gamma | DrugBank ID:DB15753
+BMGC_DG20339,BMG_DG265475,Metronidazole benzoate | DrugBank ID:DB15759
+BMGC_DG20340,BMG_DG265478,DrugBank ID:DB15762 | Satralizumab
+BMGC_DG20341,BMG_DG265479,DrugBank ID:DB15763 | Iron polymaltose
+BMGC_DG20342,BMG_DG265481,DrugBank ID:DB15765 | Sintilimab
+BMGC_DG20343,BMG_DG265482,Retifanlimab | DrugBank ID:DB15766
+BMGC_DG20344,BMG_DG265483,DrugBank ID:DB15767 | AMP-224
+BMGC_DG20345,BMG_DG265484,DrugBank ID:DB15768 | MEDI0680
+BMGC_DG20346,BMG_DG265485,DrugBank ID:DB15769 | Envafolimab
+BMGC_DG20347,BMG_DG265486,DrugBank ID:DB15770 | Cosibelimab
+BMGC_DG20348,BMG_DG265487,AUNP-12 | DrugBank ID:DB15771
+BMGC_DG20349,BMG_DG265488,DrugBank ID:DB15772 | CA-170
+BMGC_DG20350,BMG_DG265489,DrugBank ID:DB15773 | anti-OX40 antibody BMS 986178
+BMGC_DG20351,BMG_DG265491,DrugBank ID:DB15775 | Algestone acetophenide
+BMGC_DG20352,BMG_DG265493,DrugBank ID:DB15777 | Fluocortolone pivalate
+BMGC_DG20353,BMG_DG265500,DrugBank ID:DB15784 | Carmoterol
+BMGC_DG20354,BMG_DG265501,Myrtecaine | DrugBank ID:DB15785
+BMGC_DG20355,BMG_DG265502,DrugBank ID:DB15786 | Maritime pine extract
+BMGC_DG20356,BMG_DG265507,MK-0668 | DrugBank ID:DB15791
+BMGC_DG20357,BMG_DG265525,DrugBank ID:DB15810 | Nuvaxovid
+BMGC_DG20358,BMG_DG265536,DrugBank ID:DB15821 | Fluocortolone caproate
+BMGC_DG20359,BMG_DG265537,Pralsetinib | DrugBank ID:DB15822
+BMGC_DG20360,BMG_DG265540,DrugBank ID:DB15825 | Dihydroxyaluminum sodium carbonate
+BMGC_DG20361,BMG_DG265569,Janssen COVID-19 Vaccine | DrugBank ID:DB15857
+BMGC_DG20362,BMG_DG265573,Buthiazide | DrugBank ID:DB15861
+BMGC_DG20363,BMG_DG265577,Pentaglobin | DrugBank ID:DB15865
+BMGC_DG20364,BMG_DG265585,Copper oxodotreotide Cu-64 | DrugBank ID:DB15873
+BMGC_DG20365,BMG_DG265586,DrugBank ID:DB15874 | Agalsidase alfa
+BMGC_DG20366,BMG_DG265592,DrugBank ID:DB15880 | Dermatan sulfate
+BMGC_DG20367,BMG_DG265601,DrugBank ID:DB15889 | Senna leaf
+BMGC_DG20368,BMG_DG265608,DrugBank ID:DB15897 | Etesevimab
+BMGC_DG20369,BMG_DG265609,DrugBank ID:DB15898 | Atoltivimab
+BMGC_DG20370,BMG_DG265610,Maftivimab | DrugBank ID:DB15899
+BMGC_DG20371,BMG_DG265611,DrugBank ID:DB15900 | Odesivimab
+BMGC_DG20372,BMG_DG265614,Chlormadinone acetate | DrugBank ID:DB15903
+BMGC_DG20373,BMG_DG265622,Amfenac | DrugBank ID:DB15911
+BMGC_DG20374,BMG_DG265627,DrugBank ID:DB15917 | Camphene
+BMGC_DG20375,BMG_DG265629,Diquafosol | DrugBank ID:DB15919
+BMGC_DG20376,BMG_DG265640,DrugBank ID:DB15930 | Carbaryl
+BMGC_DG20377,BMG_DG265642,DrugBank ID:DB15932 | Clemizole
+BMGC_DG20378,BMG_DG265643,Cloxyquin | DrugBank ID:DB15933
+BMGC_DG20379,BMG_DG265645,DrugBank ID:DB15935 | Lumasiran
+BMGC_DG20380,BMG_DG265650,DrugBank ID:DB15940 | Imdevimab
+BMGC_DG20381,BMG_DG265651,DrugBank ID:DB15941 | Casirivimab
+BMGC_DG20382,BMG_DG265654,Menadione bisulfite | DrugBank ID:DB15944
+BMGC_DG20383,BMG_DG265659,DrugBank ID:DB15949 | Raubasine
+BMGC_DG20384,BMG_DG265664,Strychnine | DrugBank ID:DB15954
+BMGC_DG20385,BMG_DG265669,DrugBank ID:DB15959 | Tripamide
+BMGC_DG20386,BMG_DG265675,DrugBank ID:DB15965 | Naxitamab
+BMGC_DG20387,BMG_DG265678,DrugBank ID:DB15968 | Butropium
+BMGC_DG20388,BMG_DG265681,Clorotepine | DrugBank ID:DB15971
+BMGC_DG20389,BMG_DG265682,Desoxycortone | DrugBank ID:DB15972
+BMGC_DG20390,BMG_DG265685,Sulfametrole | DrugBank ID:DB15975
+BMGC_DG20391,BMG_DG265688,DrugBank ID:DB15978 | Parathiazine
+BMGC_DG20392,BMG_DG265692,DrugBank ID:DB15982 | Berotralstat
+BMGC_DG20393,BMG_DG265695,Gamma-amino-beta-hydroxybutyric acid | DrugBank ID:DB15985
+BMGC_DG20394,BMG_DG265696,DrugBank ID:DB15986 | Cinnamon oil
+BMGC_DG20395,BMG_DG265702,DrugBank ID:DB15992 | Sulfogaiacol
+BMGC_DG20396,BMG_DG265711,Testosterone decanoate | DrugBank ID:DB16001
+BMGC_DG20397,BMG_DG265712,Testosterone isocaproate | DrugBank ID:DB16002
+BMGC_DG20398,BMG_DG265713,Testosterone phenylpropionate | DrugBank ID:DB16003
+BMGC_DG20399,BMG_DG265714,DrugBank ID:DB16004 | Butedronic acid
+BMGC_DG20400,BMG_DG265717,DrugBank ID:DB16007 | Rurioctocog alfa pegol
+BMGC_DG20401,BMG_DG265718,Nifekalant | DrugBank ID:DB16008
+BMGC_DG20402,BMG_DG265723,SER-100 | DrugBank ID:DB16013
+BMGC_DG20403,BMG_DG265729,DrugBank ID:DB16019 | Gallium Ga-68 gozetotide
+BMGC_DG20404,BMG_DG265731,Levosulpiride | DrugBank ID:DB16021
+BMGC_DG20405,BMG_DG265738,Azemiglitazone | DrugBank ID:DB16028
+BMGC_DG20406,BMG_DG265746,ABX-1431 | DrugBank ID:DB16036
+BMGC_DG20407,BMG_DG265748,PLX8394 | DrugBank ID:DB16038
+BMGC_DG20408,BMG_DG265749,DrugBank ID:DB16039 | AN2898
+BMGC_DG20409,BMG_DG265750,DU125530 | DrugBank ID:DB16040
+BMGC_DG20410,BMG_DG265753,PF-06882961 | DrugBank ID:DB16043
+BMGC_DG20411,BMG_DG265755,DrugBank ID:DB16045 | TERN-101
+BMGC_DG20412,BMG_DG265757,DrugBank ID:DB16047 | Elraglusib
+BMGC_DG20413,BMG_DG265758,DrugBank ID:DB16048 | BTRX-246040
+BMGC_DG20414,BMG_DG265760,DrugBank ID:DB16050 | FF-10101-01
+BMGC_DG20415,BMG_DG265761,DrugBank ID:DB16051 | MOL-4239
+BMGC_DG20416,BMG_DG265763,ARRY-502 | DrugBank ID:DB16053
+BMGC_DG20417,BMG_DG265765,DrugBank ID:DB16055 | PT-2385
+BMGC_DG20418,BMG_DG265766,DrugBank ID:DB16056 | GZ-389988
+BMGC_DG20419,BMG_DG265771,DrugBank ID:DB16061 | Samuraciclib
+BMGC_DG20420,BMG_DG265773,2X-121 | DrugBank ID:DB16063
+BMGC_DG20421,BMG_DG265774,DrugBank ID:DB16064 | LY-3200882
+BMGC_DG20422,BMG_DG265776,Ilacirnon | DrugBank ID:DB16066
+BMGC_DG20423,BMG_DG265777,DrugBank ID:DB16067 | Luvadaxistat
+BMGC_DG20424,BMG_DG265778,DrugBank ID:DB16068 | BTRX-335140
+BMGC_DG20425,BMG_DG265781,DrugBank ID:DB16071 | 4'-Thio-fac
+BMGC_DG20426,BMG_DG265782,ORP-101 | DrugBank ID:DB16072
+BMGC_DG20427,BMG_DG265783,DrugBank ID:DB16073 | AZD8529
+BMGC_DG20428,BMG_DG265786,DrugBank ID:DB16076 | GSK2245035
+BMGC_DG20429,BMG_DG265787,DrugBank ID:DB16077 | Abagovomab
+BMGC_DG20430,BMG_DG265789,Aclimostat | DrugBank ID:DB16079
+BMGC_DG20431,BMG_DG265790,Acolbifene | DrugBank ID:DB16080
+BMGC_DG20432,BMG_DG265794,DrugBank ID:DB16084 | Iron (III) oxide adipate
+BMGC_DG20433,BMG_DG265799,Anivamersen | DrugBank ID:DB16089
+BMGC_DG20434,BMG_DG265805,DrugBank ID:DB16095 | APG-1387
+BMGC_DG20435,BMG_DG265808,DrugBank ID:DB16098 | Atogepant
+BMGC_DG20436,BMG_DG265809,Avalglucosidase alfa | DrugBank ID:DB16099
+BMGC_DG20437,BMG_DG265811,DrugBank ID:DB16101 | Baicalein
+BMGC_DG20438,BMG_DG265816,DrugBank ID:DB16106 | GSK2256098
+BMGC_DG20439,BMG_DG265817,BI 2536 | DrugBank ID:DB16107
+BMGC_DG20440,BMG_DG265819,GED-0507-34-Levo | DrugBank ID:DB16109
+BMGC_DG20441,BMG_DG265822,DrugBank ID:DB16112 | OT-730
+BMGC_DG20442,BMG_DG265828,DrugBank ID:DB16118 | Capadenoson
+BMGC_DG20443,BMG_DG265829,Carotegrast methyl | DrugBank ID:DB16119
+BMGC_DG20444,BMG_DG265833,DrugBank ID:DB16123 | Ceralifimod
+BMGC_DG20445,BMG_DG265835,DrugBank ID:DB16125 | Ciforadenant
+BMGC_DG20446,BMG_DG265836,DrugBank ID:DB16126 | Cinaciguat
+BMGC_DG20447,BMG_DG265838,DrugBank ID:DB16128 | Crovalimab
+BMGC_DG20448,BMG_DG265840,DrugBank ID:DB16130 | Dapansutrile
+BMGC_DG20449,BMG_DG265843,Delgocitinib | DrugBank ID:DB16133
+BMGC_DG20450,BMG_DG265844,Denagliptin | DrugBank ID:DB16134
+BMGC_DG20451,BMG_DG265847,DrugBank ID:DB16137 | Dezapelisib
+BMGC_DG20452,BMG_DG265848,DrugBank ID:DB16138 | Diflomotecan
+BMGC_DG20453,BMG_DG265855,Dotinurad | DrugBank ID:DB16145
+BMGC_DG20454,BMG_DG265856,DrugBank ID:DB16146 | Dynorphin
+BMGC_DG20455,BMG_DG265858,Ecraprost | DrugBank ID:DB16148
+BMGC_DG20456,BMG_DG265861,DrugBank ID:DB16151 | Efungumab
+BMGC_DG20457,BMG_DG265863,Eltanexor | DrugBank ID:DB16153
+BMGC_DG20458,BMG_DG265867,Ensifentrine | DrugBank ID:DB16157
+BMGC_DG20459,BMG_DG265869,Esflurbiprofen | DrugBank ID:DB16159
+BMGC_DG20460,BMG_DG265870,Tolinapant | DrugBank ID:DB16160
+BMGC_DG20461,BMG_DG265872,Exicorilant | DrugBank ID:DB16162
+BMGC_DG20462,BMG_DG265875,DrugBank ID:DB16165 | Finerenone
+BMGC_DG20463,BMG_DG265877,DrugBank ID:DB16167 | Fisogatinib
+BMGC_DG20464,BMG_DG265878,DrugBank ID:DB16168 | Fluorocyclopentenylcytosine
+BMGC_DG20465,BMG_DG265880,DrugBank ID:DB16170 | Foralumab
+BMGC_DG20466,BMG_DG265881,DrugBank ID:DB16171 | Foscarbidopa
+BMGC_DG20467,BMG_DG265893,Hemoporfin | DrugBank ID:DB16183
+BMGC_DG20468,BMG_DG265896,PEN-866 | DrugBank ID:DB16186
+BMGC_DG20469,BMG_DG265900,DrugBank ID:DB16190 | Idursulfase beta
+BMGC_DG20470,BMG_DG265901,DrugBank ID:DB16191 | Ifidancitinib
+BMGC_DG20471,BMG_DG265902,DrugBank ID:DB16192 | Imaradenant
+BMGC_DG20472,BMG_DG265903,DrugBank ID:DB16193 | Tovinontrine
+BMGC_DG20473,BMG_DG265905,Indatuximab ravtansine | DrugBank ID:DB16195
+BMGC_DG20474,BMG_DG265910,DrugBank ID:DB16200 | Iptacopan
+BMGC_DG20475,BMG_DG265915,Ispronicline | DrugBank ID:DB16205
+BMGC_DG20476,BMG_DG265920,DrugBank ID:DB16210 | Kisspeptin-10
+BMGC_DG20477,BMG_DG265923,Ladostigil | DrugBank ID:DB16213
+BMGC_DG20478,BMG_DG265924,Landipirdine | DrugBank ID:DB16214
+BMGC_DG20479,BMG_DG265926,DrugBank ID:DB16216 | Lazertinib
+BMGC_DG20480,BMG_DG265927,Leniolisib | DrugBank ID:DB16217
+BMGC_DG20481,BMG_DG265928,Lerociclib | DrugBank ID:DB16218
+BMGC_DG20482,BMG_DG265930,DrugBank ID:DB16220 | Lonapegsomatropin
+BMGC_DG20483,BMG_DG265931,DrugBank ID:DB16221 | Lonaprisan
+BMGC_DG20484,BMG_DG265932,Loncastuximab tesirine | DrugBank ID:DB16222
+BMGC_DG20485,BMG_DG265935,DrugBank ID:DB16225 | Magrolimab
+BMGC_DG20486,BMG_DG265936,Maralixibat | DrugBank ID:DB16226
+BMGC_DG20487,BMG_DG265937,DrugBank ID:DB16227 | Masilukast
+BMGC_DG20488,BMG_DG265942,DrugBank ID:DB16232 | Milciclib Maleate
+BMGC_DG20489,BMG_DG265943,DrugBank ID:DB16233 | Milvexian
+BMGC_DG20490,BMG_DG265946,Mitapivat | DrugBank ID:DB16236
+BMGC_DG20491,BMG_DG265949,DrugBank ID:DB16239 | Molibresib
+BMGC_DG20492,BMG_DG265950,DrugBank ID:DB16240 | BMS-813160
+BMGC_DG20493,BMG_DG265954,DrugBank ID:DB16244 | MK-0773
+BMGC_DG20494,BMG_DG265960,DrugBank ID:DB16250 | Nazartinib
+BMGC_DG20495,BMG_DG265962,Nedisertib | DrugBank ID:DB16252
+BMGC_DG20496,BMG_DG265964,DrugBank ID:DB16254 | Nevanimibe
+BMGC_DG20497,BMG_DG265965,DrugBank ID:DB16255 | Nidufexor
+BMGC_DG20498,BMG_DG265968,Nirsevimab | DrugBank ID:DB16258
+BMGC_DG20499,BMG_DG265971,DrugBank ID:DB16261 | Odevixibat
+BMGC_DG20500,BMG_DG265975,Olinvacimab | DrugBank ID:DB16265
+BMGC_DG20501,BMG_DG265976,DrugBank ID:DB16266 | Olodanrigan
+BMGC_DG20502,BMG_DG265977,Olutasidenib | DrugBank ID:DB16267
+BMGC_DG20503,BMG_DG265982,Orelabrutinib | DrugBank ID:DB16272
+BMGC_DG20504,BMG_DG265984,DrugBank ID:DB16274 | Osoresnontrine
+BMGC_DG20505,BMG_DG265985,DrugBank ID:DB16275 | Otlertuzumab
+BMGC_DG20506,BMG_DG265987,DrugBank ID:DB16277 | Paltusotine
+BMGC_DG20507,BMG_DG265989,Pecavaptan | DrugBank ID:DB16279
+BMGC_DG20508,BMG_DG265992,DrugBank ID:DB16282 | Pegylated Recombinant Human Arginase I
+BMGC_DG20509,BMG_DG265998,Peoniflorin | DrugBank ID:DB16288
+BMGC_DG20510,BMG_DG266004,DrugBank ID:DB16294 | Pexmetinib
+BMGC_DG20511,BMG_DG266006,IPI-549 | DrugBank ID:DB16296
+BMGC_DG20512,BMG_DG266009,Poseltinib | DrugBank ID:DB16299
+BMGC_DG20513,BMG_DG266010,Praliciguat | DrugBank ID:DB16300
+BMGC_DG20514,BMG_DG266015,Xevinapant | DrugBank ID:DB16305
+BMGC_DG20515,BMG_DG266018,Revaprazan | DrugBank ID:DB16308
+BMGC_DG20516,BMG_DG266019,Revusiran | DrugBank ID:DB16309
+BMGC_DG20517,BMG_DG266020,Rezafungin | DrugBank ID:DB16310
+BMGC_DG20518,BMG_DG266025,DrugBank ID:DB16315 | Rivenprost
+BMGC_DG20519,BMG_DG266028,DrugBank ID:DB16318 | Romilkimab
+BMGC_DG20520,BMG_DG266029,GSK-2981278 | DrugBank ID:DB16319
+BMGC_DG20521,BMG_DG266031,DrugBank ID:DB16321 | S-777469
+BMGC_DG20522,BMG_DG266034,DrugBank ID:DB16324 | Selgantolimod
+BMGC_DG20523,BMG_DG266035,Selodenoson | DrugBank ID:DB16325
+BMGC_DG20524,BMG_DG266040,DrugBank ID:DB16330 | Simurosertib
+BMGC_DG20525,BMG_DG266041,Siremadlin | DrugBank ID:DB16331
+BMGC_DG20526,BMG_DG266042,DrugBank ID:DB16332 | Sodelglitazar
+BMGC_DG20527,BMG_DG266045,DrugBank ID:DB16335 | Sulopenem etzadroxil
+BMGC_DG20528,BMG_DG266051,Tilsotolimod | DrugBank ID:DB16341
+BMGC_DG20529,BMG_DG266053,DrugBank ID:DB16343 | Tropifexor
+BMGC_DG20530,BMG_DG266056,DrugBank ID:DB16346 | Veliflapon
+BMGC_DG20531,BMG_DG266059,Vicagrel | DrugBank ID:DB16349
+BMGC_DG20532,BMG_DG266061,DrugBank ID:DB16351 | Volinanserin
+BMGC_DG20533,BMG_DG266063,Razuprotafib | DrugBank ID:DB16353
+BMGC_DG20534,BMG_DG266065,Sotrovimab | DrugBank ID:DB16355
+BMGC_DG20535,BMG_DG266080,DrugBank ID:DB16370 | Mezagitamab
+BMGC_DG20536,BMG_DG266081,DrugBank ID:DB16371 | Glofitamab
+BMGC_DG20537,BMG_DG266086,DrugBank ID:DB16376 | Actoxumab
+BMGC_DG20538,BMG_DG266089,DrugBank ID:DB16379 | Garetosmab
+BMGC_DG20539,BMG_DG266094,DrugBank ID:DB16385 | Ansuvimab
+BMGC_DG20540,BMG_DG266097,DrugBank ID:DB16388 | Axatilimab
+BMGC_DG20541,BMG_DG266099,Mobocertinib | DrugBank ID:DB16390
+BMGC_DG20542,BMG_DG266102,Cilgavimab | DrugBank ID:DB16393
+BMGC_DG20543,BMG_DG266103,DrugBank ID:DB16394 | Tixagevimab
+BMGC_DG20544,BMG_DG266113,DrugBank ID:DB16404 | Carvacrol
+BMGC_DG20545,BMG_DG266114,Regdanvimab | DrugBank ID:DB16405
+BMGC_DG20546,BMG_DG266116,DrugBank ID:DB16407 | Azvudine
+BMGC_DG20547,BMG_DG266120,Camidanlumab tesirine | DrugBank ID:DB16411
+BMGC_DG20548,BMG_DG266125,Vilobelimab | DrugBank ID:DB16416
+BMGC_DG20549,BMG_DG266126,Geptanolimab | DrugBank ID:DB16417
+BMGC_DG20550,BMG_DG266127,Narsoplimab | DrugBank ID:DB16418
+BMGC_DG20551,BMG_DG266130,Volagidemab | DrugBank ID:DB16421
+BMGC_DG20552,BMG_DG266155,DrugBank ID:DB16446 | Vafidemstat
+BMGC_DG20553,BMG_DG266156,Thymoquinone | DrugBank ID:DB16447
+BMGC_DG20554,BMG_DG266162,Efzofitimod | DrugBank ID:DB16453
+BMGC_DG20555,BMG_DG266163,DrugBank ID:DB16454 | XPro1595
+BMGC_DG20556,BMG_DG266164,DrugBank ID:DB16456 | Human Interleukin 8
+BMGC_DG20557,BMG_DG266179,DrugBank ID:DB16473 | MEDI3506
+BMGC_DG20558,BMG_DG266180,DrugBank ID:DB16474 | Pam2csk4
+BMGC_DG20559,BMG_DG266184,Inbakicept | DrugBank ID:DB16479
+BMGC_DG20560,BMG_DG266189,ODN M362 | DrugBank ID:DB16485
+BMGC_DG20561,BMG_DG266194,DrugBank ID:DB16492 | SAR443122
+BMGC_DG20562,BMG_DG266197,Oleic monoethanolamide | DrugBank ID:DB16495
+BMGC_DG20563,BMG_DG266204,DrugBank ID:DB16502 | Zunsemetinib
+BMGC_DG20564,BMG_DG266211,DrugBank ID:DB16511 | KAND567
+BMGC_DG20565,BMG_DG266214,DrugBank ID:DB16515 | PLN-74809
+BMGC_DG20566,BMG_DG266215,DrugBank ID:DB16516 | TM5614
+BMGC_DG20567,BMG_DG266231,DrugBank ID:DB16532 | LL-37
+BMGC_DG20568,BMG_DG266235,Birch bark extract | DrugBank ID:DB16536
+BMGC_DG20569,BMG_DG266246,Furvina | DrugBank ID:DB16547
+BMGC_DG20570,BMG_DG266253,DrugBank ID:DB16554 | Metadoxine
+BMGC_DG20571,BMG_DG266254,DrugBank ID:DB16555 | Lactoferrin
+BMGC_DG20572,BMG_DG266260,DrugBank ID:DB16561 | Tetramisole
+BMGC_DG20573,BMG_DG266266,Furaltadone | DrugBank ID:DB16567
+BMGC_DG20574,BMG_DG266279,Afimetoran | DrugBank ID:DB16580
+BMGC_DG20575,BMG_DG266281,DrugBank ID:DB16582 | Lisocabtagene maraleucel
+BMGC_DG20576,BMG_DG266301,Dihydroergotoxine | DrugBank ID:DB16602
+BMGC_DG20577,BMG_DG266306,DrugBank ID:DB16607 | Lithium chloride
+BMGC_DG20578,BMG_DG266310,"Tick-borne encephalitis vaccine (whole virus, inactivated) | DrugBank ID:DB16611"
+BMGC_DG20579,BMG_DG266322,DrugBank ID:DB16623 | Amidephrine
+BMGC_DG20580,BMG_DG266324,Prasterone enantate | DrugBank ID:DB16625
+BMGC_DG20581,BMG_DG266326,Melphalan flufenamide | DrugBank ID:DB16627
+BMGC_DG20582,BMG_DG266327,DrugBank ID:DB16628 | Fosdenopterin
+BMGC_DG20583,BMG_DG266328,Serdexmethylphenidate | DrugBank ID:DB16629
+BMGC_DG20584,BMG_DG266329,OPB-111077 | DrugBank ID:DB16630
+BMGC_DG20585,BMG_DG266336,DrugBank ID:DB16637 | KW-2450 free base
+BMGC_DG20586,BMG_DG266339,Almonertinib | DrugBank ID:DB16640
+BMGC_DG20587,BMG_DG266346,DrugBank ID:DB16647 | Donanemab
+BMGC_DG20588,BMG_DG266347,Bacillus calmette-guerin substrain russian BCG-I live antigen | DrugBank ID:DB16648
+BMGC_DG20589,BMG_DG266349,DrugBank ID:DB16650 | Deucravacitinib
+BMGC_DG20590,BMG_DG266351,Avotaciclib | DrugBank ID:DB16652
+BMGC_DG20591,BMG_DG266354,Teclistamab | DrugBank ID:DB16655
+BMGC_DG20592,BMG_DG266355,Zotiraciclib | DrugBank ID:DB16656
+BMGC_DG20593,BMG_DG266356,Vecabrutinib | DrugBank ID:DB16657
+BMGC_DG20594,BMG_DG266358,DrugBank ID:DB16659 | Bentracimab
+BMGC_DG20595,BMG_DG266361,DrugBank ID:DB16662 | Efanesoctocog alfa
+BMGC_DG20596,BMG_DG266364,Idecabtagene vicleucel | DrugBank ID:DB16665
+BMGC_DG20597,BMG_DG266367,DrugBank ID:DB16668 | Budigalimab
+BMGC_DG20598,BMG_DG266371,DrugBank ID:DB16672 | Epcoritamab
+BMGC_DG20599,BMG_DG266377,Talquetamab | DrugBank ID:DB16678
+BMGC_DG20600,BMG_DG266382,DrugBank ID:DB16683 | Foslevodopa
+BMGC_DG20601,BMG_DG266383,DrugBank ID:DB16684 | Odronextamab
+BMGC_DG20602,BMG_DG266389,Tegoprazan | DrugBank ID:DB16690
+BMGC_DG20603,BMG_DG266390,Nirmatrelvir | DrugBank ID:DB16691
+BMGC_DG20604,BMG_DG266392,Insulin icodec | DrugBank ID:DB16693
+BMGC_DG20605,BMG_DG266393,DrugBank ID:DB16694 | Pegcetacoplan
+BMGC_DG20606,BMG_DG266394,Amivantamab | DrugBank ID:DB16695
+BMGC_DG20607,BMG_DG266395,DrugBank ID:DB16697 | Glutazumab
+BMGC_DG20608,BMG_DG266396,DrugBank ID:DB16698 | Neihulizumab
+BMGC_DG20609,BMG_DG266397,Vutrisiran | DrugBank ID:DB16699
+BMGC_DG20610,BMG_DG266398,Runcaciguat | DrugBank ID:DB16700
+BMGC_DG20611,BMG_DG266400,DrugBank ID:DB16702 | Famprofazone
+BMGC_DG20612,BMG_DG266401,DrugBank ID:DB16703 | Belumosudil
+BMGC_DG20613,BMG_DG266402,Durlobactam | DrugBank ID:DB16704
+BMGC_DG20614,BMG_DG266405,Gavorestat | DrugBank ID:DB16707
+BMGC_DG20615,BMG_DG266406,Cipaglucosidase alfa | DrugBank ID:DB16708
+BMGC_DG20616,BMG_DG266407,Allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen | DrugBank ID:DB16709
+BMGC_DG20617,BMG_DG266430,Tisotumab vedotin | DrugBank ID:DB16732
+BMGC_DG20618,BMG_DG266431,DrugBank ID:DB16733 | Rimtuzalcap
+BMGC_DG20619,BMG_DG266434,Allogeneic processed thymus tissue | DrugBank ID:DB16736
+BMGC_DG20620,BMG_DG266435,MM3122 | DrugBank ID:DB16737
+BMGC_DG20621,BMG_DG266436,Ciltacabtagene autoleucel | DrugBank ID:DB16738
+BMGC_DG20622,BMG_DG266437,DrugBank ID:DB16739 | MK-886
+BMGC_DG20623,BMG_DG266438,Prolgolimab | DrugBank ID:DB16740
+BMGC_DG20624,BMG_DG266439,DrugBank ID:DB16741 | Bortezomib D-mannitol
+BMGC_DG20625,BMG_DG266440,RP-67580 | DrugBank ID:DB16742
+BMGC_DG20626,BMG_DG266442,CP-96345 | DrugBank ID:DB16744
+BMGC_DG20627,BMG_DG266444,Elivaldogene autotemcel | DrugBank ID:DB16746
+BMGC_DG20628,BMG_DG266451,DrugBank ID:DB16754 | TPMPA
+BMGC_DG20629,BMG_DG266452,DrugBank ID:DB16755 | Bebtelovimab
+BMGC_DG20630,BMG_DG266453,Ivarmacitinib | DrugBank ID:DB16756
+BMGC_DG20631,BMG_DG266464,Isorhamnetin | DrugBank ID:DB16767
+BMGC_DG20632,BMG_DG266465,Lavendustin A | DrugBank ID:DB16768
+BMGC_DG20633,BMG_DG266467,DrugBank ID:DB16770 | Morin
+BMGC_DG20634,BMG_DG266468,DrugBank ID:DB16771 | Phlorizin
+BMGC_DG20635,BMG_DG266474,Lutetium Lu-177 vipivotide tetraxetan | DrugBank ID:DB16778
+BMGC_DG20636,BMG_DG266476,Eladocagene exuparvovec | DrugBank ID:DB16780
+BMGC_DG20637,BMG_DG266487,Etranacogene dezaparvovec | DrugBank ID:DB16791
+BMGC_DG20638,BMG_DG266516,DrugBank ID:DB16820 | LetibotulinumtoxinA
+BMGC_DG20639,BMG_DG266518,DrugBank ID:DB16822 | AZD-5069
+BMGC_DG20640,BMG_DG266519,DrugBank ID:DB16823 | Vebreltinib
+BMGC_DG20641,BMG_DG266520,Cepharanthine | DrugBank ID:DB16824
+BMGC_DG20642,BMG_DG266521,DrugBank ID:DB16825 | Itanapraced
+BMGC_DG20643,BMG_DG266522,Repotrectinib | DrugBank ID:DB16826
+BMGC_DG20644,BMG_DG266524,DrugBank ID:DB16828 | MK-2206
+BMGC_DG20645,BMG_DG266528,Fadrozole | DrugBank ID:DB16832
+BMGC_DG20646,BMG_DG266529,DrugBank ID:DB16833 | Adenosine disphosphate
+BMGC_DG20647,BMG_DG266530,DrugBank ID:DB16834 | AZD-7648
+BMGC_DG20648,BMG_DG266532,DrugBank ID:DB16836 | Vitexin
+BMGC_DG20649,BMG_DG266533,Azasetron | DrugBank ID:DB16837
+BMGC_DG20650,BMG_DG266534,DrugBank ID:DB16838 | BLZ-945
+BMGC_DG20651,BMG_DG266540,BMS-833923 | DrugBank ID:DB16844
+BMGC_DG20652,BMG_DG266541,DrugBank ID:DB16845 | Roblitinib
+BMGC_DG20653,BMG_DG266543,DrugBank ID:DB16847 | Olprinone
+BMGC_DG20654,BMG_DG266545,Mivavotinib | DrugBank ID:DB16849
+BMGC_DG20655,BMG_DG266550,Caryophyllene | DrugBank ID:DB16854
+BMGC_DG20656,BMG_DG266551,DrugBank ID:DB16855 | Tyrosol
+BMGC_DG20657,BMG_DG266553,DrugBank ID:DB16857 | Undecanoic acid
+BMGC_DG20658,BMG_DG266555,Naringin | DrugBank ID:DB16859
+BMGC_DG20659,BMG_DG266558,DrugBank ID:DB16862 | Indigo
+BMGC_DG20660,BMG_DG266559,DrugBank ID:DB16863 | Butylated hydroxytoluene
+BMGC_DG20661,BMG_DG266561,DrugBank ID:DB16865 | Rosmarinic acid
+BMGC_DG20662,BMG_DG266565,DrugBank ID:DB16869 | Setanaxib
+BMGC_DG20663,BMG_DG266570,CB-5083 | DrugBank ID:DB16874
+BMGC_DG20664,BMG_DG266571,DrugBank ID:DB16875 | GSK-2982772
+BMGC_DG20665,BMG_DG266573,Ampiroxicam | DrugBank ID:DB16877
+BMGC_DG20666,BMG_DG266575,AMG-319 | DrugBank ID:DB16879
+BMGC_DG20667,BMG_DG266580,DrugBank ID:DB16884 | Isonicotinic acid
+BMGC_DG20668,BMG_DG266586,DrugBank ID:DB16890 | Betulin
+BMGC_DG20669,BMG_DG266587,DrugBank ID:DB16891 | ENMD-981693
+BMGC_DG20670,BMG_DG266589,DrugBank ID:DB16893 | S-38093
+BMGC_DG20671,BMG_DG266591,GSK-2879552 | DrugBank ID:DB16895
+BMGC_DG20672,BMG_DG266596,Betibeglogene autotemcel | DrugBank ID:DB16900
+BMGC_DG20673,BMG_DG266597,DrugBank ID:DB16901 | Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen
+BMGC_DG20674,BMG_DG266605,DrugBank ID:DB16909 | TIK-301
+BMGC_DG20675,BMG_DG266607,DrugBank ID:DB16911 | AF-710B
+BMGC_DG20676,BMG_DG266623,S-Apomorphine | DrugBank ID:DB16927
+BMGC_DG20677,BMG_DG266625,Sodium dichloroacetate | DrugBank ID:DB16929
+BMGC_DG20678,BMG_DG266632,DrugBank ID:DB16936 | F-15599
+BMGC_DG20679,BMG_DG266634,D-157495 | DrugBank ID:DB16938
+BMGC_DG20680,BMG_DG266639,DrugBank ID:DB16943 | STX-107
+BMGC_DG20681,BMG_DG266651,RG-2833 | DrugBank ID:DB16955
+BMGC_DG20682,BMG_DG266652,DrugBank ID:DB16956 | L-Acetylleucine
+BMGC_DG20683,BMG_DG266663,Enadoline | DrugBank ID:DB16967
+BMGC_DG20684,BMG_DG266664,DrugBank ID:DB16968 | SRX-246
+BMGC_DG20685,BMG_DG266683,DrugBank ID:DB16987 | Soticlestat
+BMGC_DG20686,BMG_DG266691,DrugBank ID:DB16995 | NP-51
+BMGC_DG20687,BMG_DG266714,DrugBank ID:DB17018 | AZD-5153
+BMGC_DG20688,BMG_DG266717,DrugBank ID:DB17021 | JQ1
+BMGC_DG20689,BMG_DG266718,DrugBank ID:DB17022 | Arachidonyltrifluoromethane
+BMGC_DG20690,BMG_DG266719,ABT-737 | DrugBank ID:DB17023
+BMGC_DG20691,BMG_DG266720,DrugBank ID:DB17024 | Chelerythrine
+BMGC_DG20692,BMG_DG266722,Ellipticine | DrugBank ID:DB17026
+BMGC_DG20693,BMG_DG266725,Go-6976 | DrugBank ID:DB17029
+BMGC_DG20694,BMG_DG266728,Indatraline | DrugBank ID:DB17032
+BMGC_DG20695,BMG_DG266729,JTC-801 free base | DrugBank ID:DB17033
+BMGC_DG20696,BMG_DG266730,DrugBank ID:DB17034 | Dacinostat
+BMGC_DG20697,BMG_DG266735,DrugBank ID:DB17039 | Nutlin-3
+BMGC_DG20698,BMG_DG266736,DrugBank ID:DB17040 | PD-169316
+BMGC_DG20699,BMG_DG266737,PD-173952 | DrugBank ID:DB17041
+BMGC_DG20700,BMG_DG266738,DrugBank ID:DB17042 | PD-98059
+BMGC_DG20701,BMG_DG266739,PHA-767491 | DrugBank ID:DB17043
+BMGC_DG20702,BMG_DG266741,Phorbol 12-myristate 13-acetate diester | DrugBank ID:DB17045
+BMGC_DG20703,BMG_DG266742,PI-103 | DrugBank ID:DB17046
+BMGC_DG20704,BMG_DG266743,DrugBank ID:DB17047 | PIK-75
+BMGC_DG20705,BMG_DG266744,Plumbagin | DrugBank ID:DB17048
+BMGC_DG20706,BMG_DG266747,DrugBank ID:DB17051 | SB-218078
+BMGC_DG20707,BMG_DG266748,DrugBank ID:DB17052 | SB 224289
+BMGC_DG20708,BMG_DG266749,DrugBank ID:DB17053 | Scriptaid
+BMGC_DG20709,BMG_DG266751,DrugBank ID:DB17055 | SNX-2112
+BMGC_DG20710,BMG_DG266752,DrugBank ID:DB17056 | Spiperone
+BMGC_DG20711,BMG_DG266755,TW-37 | DrugBank ID:DB17059
+BMGC_DG20712,BMG_DG266756,DrugBank ID:DB17060 | U-0126
+BMGC_DG20713,BMG_DG266757,DrugBank ID:DB17061 | VEGFR 2 Kinase inhibitor I
+BMGC_DG20714,BMG_DG266759,DrugBank ID:DB17063 | ZK-93423
+BMGC_DG20715,BMG_DG266760,DrugBank ID:DB17064 | ZM-39923
+BMGC_DG20716,BMG_DG266770,DrugBank ID:DB17074 | Amiselimod
+BMGC_DG20717,BMG_DG266776,KW-6356 | DrugBank ID:DB17080
+BMGC_DG20718,BMG_DG266779,DrugBank ID:DB17083 | Linzagolix
+BMGC_DG20719,BMG_DG266783,DrugBank ID:DB17087 | JNJ-17216498
+BMGC_DG20720,BMG_DG266784,DrugBank ID:DB17088 | Famtozinameran
+BMGC_DG20721,BMG_DG266793,Vorasidenib | DrugBank ID:DB17097
+BMGC_DG20722,BMG_DG266797,DrugBank ID:DB17101 | SC 41930
+BMGC_DG20723,BMG_DG266803,DrugBank ID:DB17107 | Lifileucel
+BMGC_DG20724,BMG_DG266808,DrugBank ID:DB17112 | SM-337
+BMGC_DG20725,BMG_DG266813,Seclidemstat | DrugBank ID:DB17117
+BMGC_DG20726,BMG_DG266825,DrugBank ID:DB17129 | Pelabresib anhydrous
+BMGC_DG20727,BMG_DG266827,JAB-3068 | DrugBank ID:DB17131
+BMGC_DG20728,BMG_DG266836,DrugBank ID:DB17140 | JNJ-28312141
+BMGC_DG20729,BMG_DG266839,DrugBank ID:DB17143 | APTO-253
+BMGC_DG20730,BMG_DG266845,DrugBank ID:DB17149 | Berubicin
+BMGC_DG20731,BMG_DG266848,DRF-1042 | DrugBank ID:DB17152
+BMGC_DG20732,BMG_DG266855,DrugBank ID:DB17159 | Denfivontinib
+BMGC_DG20733,BMG_DG266862,DrugBank ID:DB17166 | Tapotoclax
+BMGC_DG20734,BMG_DG266876,DrugBank ID:DB17180 | KX-2361
+BMGC_DG20735,BMG_DG266887,Altiratinib | DrugBank ID:DB17191
+BMGC_DG20736,BMG_DG266893,AMG-900 | DrugBank ID:DB17197
+BMGC_DG20737,BMG_DG266943,DrugBank ID:DB17247 | Bisantrene
+BMGC_DG20738,BMG_DG266952,DrugBank ID:DB17256 | Tarlatamab
+BMGC_DG20739,BMG_DG266973,DrugBank ID:DB17277 | CBP-501
+BMGC_DG20740,BMG_DG266979,Chrysoeriol | DrugBank ID:DB17283
+BMGC_DG20741,BMG_DG266985,L-arginine | DrugBank ID:DB17289
+BMGC_DG20742,BMG_DG266994,DrugBank ID:DB17298 | Disufenton
+BMGC_DG20743,BMG_DG266995,DrugBank ID:DB17299 | p-Toluenesulfonamide
+BMGC_DG20744,BMG_DG267005,DrugBank ID:DB17309 | Minnelide
+BMGC_DG20745,BMG_DG267079,FN-1501 | DrugBank ID:DB17383
+BMGC_DG20746,BMG_DG267081,DrugBank ID:DB17385 | Lipotecan
+BMGC_DG20747,BMG_DG267145,DrugBank ID:DB17449 | Anacaulase
+BMGC_DG20748,BMG_DG267168,DrugBank ID:DB17472 | Pirtobrutinib
+BMGC_DG20749,BMG_DG267186,DrugBank ID:DB17490 | NT-219
+BMGC_DG20750,BMG_DG267189,Bioymifi | DrugBank ID:DB17493
+BMGC_DG20751,BMG_DG267202,Etrumadenant | DrugBank ID:DB17506
+BMGC_DG20752,BMG_DG267203,DrugBank ID:DB17507 | COTI-2
+BMGC_DG20753,BMG_DG267216,DrugBank ID:DB17520 | Vimseltinib
+BMGC_DG20754,BMG_DG267221,Zanzalintinib | DrugBank ID:DB17525
+BMGC_DG20755,BMG_DG267234,DrugBank ID:DB17538 | Atidarsagene autotemcel
+BMGC_DG20756,BMG_DG267245,Alrizomadlin | DrugBank ID:DB17549
+BMGC_DG20757,BMG_DG267263,DrugBank ID:DB17568 | Belvarafenib
+BMGC_DG20758,BMG_DG267273,DrugBank ID:DB17578 | TTI-101
+BMGC_DG20759,BMG_DG267282,KIN-3248 | DrugBank ID:DB17587
+BMGC_DG20760,BMG_DG267284,Loxoribine | DrugBank ID:DB17589
+BMGC_DG20761,BMG_DG267297,Acecainide | DrugBank ID:DB17602
+BMGC_DG20762,BMG_DG267330,Nedosiran | DrugBank ID:DB17635
+BMGC_DG20763,BMG_DG267365,DrugBank ID:DB17670 | VK-0214
+BMGC_DG20764,BMG_DG267401,"DrugBank ID:DB17706 | 2,2-Dimethylbutyrate"
+BMGC_DG20765,BMG_DG267420,Marstacimab | DrugBank ID:DB17725
+BMGC_DG20766,BMG_DG267430,Ajoene | DrugBank ID:DB17735
+BMGC_DG20767,BMG_DG267438,Fecal microbiota | DrugBank ID:DB17743
+BMGC_DG20768,BMG_DG267444,AQ-13 | DrugBank ID:DB17749
+BMGC_DG20769,BMG_DG267453,Quilseconazole | DrugBank ID:DB17758
+BMGC_DG20770,BMG_DG267457,"DrugBank ID:DB17762 | Respiratory syncytial virus vaccine, adjuvanted"
+BMGC_DG20771,BMG_DG267527,Tinlarebant | DrugBank ID:DB17832
+BMGC_DG20772,BMG_DG267532,DrugBank ID:DB17837 | DS-1211
+BMGC_DG20773,BMG_DG267546,DrugBank ID:DB17851 | Flotufolastat F-18
+BMGC_DG20774,BMG_DG267551,DrugBank ID:DB17856 | Soraprazan
+BMGC_DG20775,BMG_DG267568,Depelestat | DrugBank ID:DB17873
+BMGC_DG20776,BMG_DG267577,DrugBank ID:DB17882 | Epitalon
+BMGC_DG20777,BMG_DG267587,TAK-603 | DrugBank ID:DB17892
+BMGC_DG20778,BMG_DG267614,CPP-115 free base | DrugBank ID:DB17919
+BMGC_DG20779,BMG_DG267624,DrugBank ID:DB17929 | DaxibotulinumtoxinA
+BMGC_DG20780,BMG_DG267671,Murizatoclax | DrugBank ID:DB17977
+BMGC_DG20781,BMG_DG267678,BQ-788 | DrugBank ID:DB17984
+BMGC_DG20782,BMG_DG267693,Acoramidis | DrugBank ID:DB17999
+BMGC_DG20783,BMG_DG267694,Algestone | DrugBank ID:DB18000
+BMGC_DG20784,BMG_DG267696,DrugBank ID:DB18002 | Lomifylline
+BMGC_DG20785,BMG_DG267701,Dersimelagon | DrugBank ID:DB18007
+BMGC_DG20786,BMG_DG267705,BMS-986278 | DrugBank ID:DB18011
+BMGC_DG20787,BMG_DG267706,Vemircopan | DrugBank ID:DB18012
+BMGC_DG20788,BMG_DG267713,DrugBank ID:DB18019 | Erbumine
+BMGC_DG20789,BMG_DG267732,DrugBank ID:DB18038 | Buloxibutid
+BMGC_DG20790,BMG_DG267735,DrugBank ID:DB18041 | Bezuclastinib
+BMGC_DG20791,BMG_DG267740,DrugBank ID:DB18046 | Docarpamine
+BMGC_DG20792,BMG_DG267748,DrugBank ID:DB18054 | Lisaftoclax
+BMGC_DG20793,BMG_DG267774,Unesbulin | DrugBank ID:DB18080
+BMGC_DG20794,BMG_DG267785,LNS-8801 | DrugBank ID:DB18091
+BMGC_DG20795,BMG_DG267790,DrugBank ID:DB18096 | Encaleret
+BMGC_DG20796,BMG_DG267798,TP-1287 | DrugBank ID:DB18104
+BMGC_DG20797,BMG_DG267801,DrugBank ID:DB18107 | SEL120-34A free base
+BMGC_DG20798,BMG_DG267816,PF-07059013 | DrugBank ID:DB18122
+BMGC_DG20799,BMG_DG267818,Fipaxalparant | DrugBank ID:DB18124
+BMGC_DG20800,BMG_DG267819,DrugBank ID:DB18125 | PTX-100
+BMGC_DG20801,BMG_DG267839,Aloxistatin | DrugBank ID:DB18145
+BMGC_DG20802,BMG_DG267897,Cudetaxestat | DrugBank ID:DB18203
+BMGC_DG20803,BMG_DG267907,DrugBank ID:DB18213 | Idroxioleic acid
+BMGC_DG20804,BMG_DG267908,DrugBank ID:DB18214 | Ibutamoren
+BMGC_DG20805,BMG_DG267930,DrugBank ID:DB18236 | (R)-9b
+BMGC_DG20806,BMG_DG267946,Pralmorelin | DrugBank ID:DB18252
+BMGC_DG20807,BMG_DG267961,DrugBank ID:DB18267 | Ferroheme
+BMGC_DG20808,BMG_DG267962,DrugBank ID:DB18268 | TAK-075 Free base
+BMGC_DG20809,BMG_DG267990,DrugBank ID:DB18296 | AB-22
+BMGC_DG20810,BMG_DG267992,DrugBank ID:DB18298 | PTI-110
+BMGC_DG20811,BMG_DG268001,DrugBank ID:DB18307 | VLX-1005
+BMGC_DG20812,BMG_DG268007,Cinnamic acid | DrugBank ID:DB18313
+BMGC_DG20813,BMG_DG268009,Zagociguat | DrugBank ID:DB18315
+BMGC_DG20814,BMG_DG268062,Tiprelestat | DrugBank ID:DB18368
+BMGC_DG20815,BMG_DG268087,EP-217609 | DrugBank ID:DB18393
+BMGC_DG20816,BMG_DG268099,DrugBank ID:DB18405 | Crisdesalazine
+BMGC_DG20817,BMG_DG268158,Esuberaprost | DrugBank ID:DB18464
+BMGC_DG20818,BMG_DG268173,Rodatristat ethyl | DrugBank ID:DB18479
+BMGC_DG20819,BMG_DG268182,DMP-777 | DrugBank ID:DB18488
+BMGC_DG20820,BMG_DG268184,Aficamten | DrugBank ID:DB18490
+BMGC_DG20821,BMG_DG268209,Revumenib | DrugBank ID:DB18515
+BMGC_DG20822,BMG_DG268212,DrugBank ID:DB18518 | Crinecerfont
+BMGC_DG20823,BMG_DG268326,"DrugBank ID:DB18632 | 1-(3-fluoro-4-(7-(5-methyl-1H-imidazol-2-yl)-1-oxo-2,3-dihydro-1H-isoindo-1-4-yl)-phenyl)-3-(3-trifluoromethyl-phenyl)-urea"
+BMGC_DG20824,BMG_DG268328,Vasoactive intestinal peptide | DrugBank ID:DB18634
+BMGC_DG20825,BMG_DG268355,Influenza A virus A/Norway/31694/2022 (H1N1) live (attenuated) antigen | DrugBank ID:DB18661
+BMGC_DG20826,BMG_DG268359,DrugBank ID:DB18665 | Psoralen
+BMGC_DG20827,BMG_DG268370,Palopegteriparatide | DrugBank ID:DB18676
+BMGC_DG20828,BMG_DG268395,"DrugBank ID:DB18701 | Chikungunya vaccine (live, attenuated)"
+BMGC_DG20829,BMG_DG268398,Efbemalenograstim alfa | DrugBank ID:DB18704
+BMGC_DG20830,BMG_DG268399,SARS-CoV-2 virus recombinant spike (S) protein receptor binding domain (RBD) fusion heterodimer (B.1.351-B.1.1.7 strains) | DrugBank ID:DB18705
+BMGC_DG20831,BMG_DG268401,AVL-3288 | DrugBank ID:DB18707
+BMGC_DG20832,BMG_DG268409,DrugBank ID:DB18715 | Tolebrutinib
+BMGC_DG20833,BMG_DG268410,DrugBank ID:DB18716 | Enmetazobactam
+BMGC_DG20834,BMG_DG268412,RVT-3101 | DrugBank ID:DB18718
+BMGC_DG20835,BMG_DG268413,Tulisokibart | DrugBank ID:DB18719
+BMGC_DG20836,BMG_DG268414,Pemivibart | DrugBank ID:DB18720
+BMGC_DG20837,BMG_DG268419,DrugBank ID:DB18725 | Cevidoplenib
+BMGC_DG20838,BMG_DG268430,Celastrol | DrugBank ID:DB18736
+BMGC_DG20839,BMG_DG268434,DrugBank ID:DB18740 | Nogapendekin alfa
+BMGC_DG20840,BMG_DG268445,Indotecan | DrugBank ID:DB18752
+BMGC_DG20841,BMG_DG268452,APD-209 | DrugBank ID:DB18759
+BMGC_DG20842,BMG_DG268454,Zotarolimus | DrugBank ID:DB18761
+BMGC_DG20843,BMG_DG268460,Zabedosertib | DrugBank ID:DB18767
+BMGC_DG20844,BMG_DG268466,DrugBank ID:DB18773 | Flurpiridaz F-18
+BMGC_DG20845,BMG_DG268475,DrugBank ID:DB18782 | Vonafexor
+BMGC_DG20846,BMG_DG268478,DrugBank ID:DB18785 | Varoglutamstat
+BMGC_DG20847,BMG_DG268479,DrugBank ID:DB18786 | APX-3330
+BMGC_DG20848,BMG_DG268481,Ulixacaltamide | DrugBank ID:DB18788
+BMGC_DG20849,BMG_DG268486,Trelanserin | DrugBank ID:DB18793
+BMGC_DG20850,BMG_DG268487,Trazpiroben | DrugBank ID:DB18794
+BMGC_DG20851,BMG_DG268488,Traxoprodil | DrugBank ID:DB18795
+BMGC_DG20852,BMG_DG268497,DrugBank ID:DB18804 | Tepilamide fumarate
+BMGC_DG20853,BMG_DG268499,DrugBank ID:DB18806 | Temuterkib
+BMGC_DG20854,BMG_DG268502,Rocatinlimab | DrugBank ID:DB18809
+BMGC_DG20855,BMG_DG268503,DrugBank ID:DB18810 | Tarafenacin
+BMGC_DG20856,BMG_DG268504,DrugBank ID:DB18811 | Taminadenant
+BMGC_DG20857,BMG_DG268510,DrugBank ID:DB18817 | Simufilam
+BMGC_DG20858,BMG_DG268516,DrugBank ID:DB18823 | Zemirciclib
+BMGC_DG20859,BMG_DG268533,Allitinib | DrugBank ID:DB18840
+BMGC_DG20860,BMG_DG268540,DrugBank ID:DB18847 | Deuruxolitinib
+BMGC_DG20861,BMG_DG268558,DrugBank ID:DB18865 | Naporafenib
+BMGC_DG20862,BMG_DG268559,Nemtabrutinib | DrugBank ID:DB18866
+BMGC_DG20863,BMG_DG268643,Caricotamide | DrugBank ID:DB18950
+BMGC_DG20864,BMG_DG268647,DrugBank ID:DB18954 | TAK-071
+BMGC_DG20865,BMG_DG268656,Mitiperstat | DrugBank ID:DB18963
+BMGC_DG20866,BMG_DG268657,Orforglipron | DrugBank ID:DB18964
+BMGC_DG20867,BMG_DG268661,DrugBank ID:DB18968 | Elinzanetant
+BMGC_DG20868,BMG_DG268703,Supinoxin | DrugBank ID:DB19010
+BMGC_DG20869,BMG_DG268716,DrugBank ID:DB19023 | Chiglitazar
+BMGC_DG20870,BMG_DG268721,Atamparib | DrugBank ID:DB19028
+BMGC_DG20871,BMG_DG268726,DrugBank ID:DB19033 | Befiradol
+BMGC_DG20872,BMG_DG268734,DrugBank ID:DB19041 | Elimusertib
+BMGC_DG20873,BMG_DG268736,Imlunestrant | DrugBank ID:DB19043
+BMGC_DG20874,BMG_DG268747,Deudextromethorphan | DrugBank ID:DB19054
+BMGC_DG20875,BMG_DG268751,Iclepertin | DrugBank ID:DB19058
+BMGC_DG20876,BMG_DG268776,DrugBank ID:DB19083 | Mescaline
+BMGC_DG20877,BMG_DG268778,DrugBank ID:DB19085 | Novolimus
+BMGC_DG20878,BMG_DG268781,DrugBank ID:DB19088 | Asundexian
+BMGC_DG20879,BMG_DG268783,Baxdrostat | DrugBank ID:DB19090
+BMGC_DG20880,BMG_DG268787,DrugBank ID:DB19094 | Dimepheptanol
+BMGC_DG20881,BMG_DG268816,DrugBank ID:DB19123 | Enzalutamide d3
+BMGC_DG20882,BMG_DG268818,Giredestrant | DrugBank ID:DB19125
+BMGC_DG20883,BMG_DG268822,DrugBank ID:DB19129 | Inupadenant
+BMGC_DG20884,BMG_DG268823,DrugBank ID:DB19130 | Relmapirazin
+BMGC_DG20885,BMG_DG268853,Quemliclustat | DrugBank ID:DB19160
+BMGC_DG20886,BMG_DG268861,Dexamethasone palmitate | DrugBank ID:DB19168
+BMGC_DG20887,BMG_DG268862,DrugBank ID:DB19169 | Pamapimod
+BMGC_DG20888,BMG_DG268863,Pemrametostat | DrugBank ID:DB19170
+BMGC_DG20889,BMG_DG268870,PXS-4728A free base | DrugBank ID:DB19177
+BMGC_DG20890,BMG_DG268884,Valiltramiprosate | DrugBank ID:DB19191
+BMGC_DG20891,BMG_DG268886,DrugBank ID:DB19193 | CFG-920
+BMGC_DG20892,BMG_DG268891,Substance P | DrugBank ID:DB19198
+BMGC_DG20893,BMG_DG268892,DrugBank ID:DB19199 | ABBV-744
+BMGC_DG20894,BMG_DG268894,DrugBank ID:DB19201 | Tamnorzatinib
+BMGC_DG20895,BMG_DG268895,DrugBank ID:DB19202 | Acoltremon
+BMGC_DG20896,BMG_DG268898,MAK-683 | DrugBank ID:DB19205
+BMGC_DG20897,BMG_DG268899,ONO-5334 | DrugBank ID:DB19206
+BMGC_DG20898,BMG_DG268902,DrugBank ID:DB19209 | Ruzinurad
+BMGC_DG20899,BMG_DG268903,DrugBank ID:DB19210 | SX-682
+BMGC_DG20900,BMG_DG268911,DrugBank ID:DB19218 | Camizestrant
+BMGC_DG20901,BMG_DG268936,Padnarsertib | DrugBank ID:DB19243
+BMGC_DG20902,BMG_DG268948,Gingerol | DrugBank ID:DB19255
+BMGC_DG20903,BMG_DG268950,DrugBank ID:DB19257 | Ginsenoside Rg3
+BMGC_DG20904,BMG_DG268970,DrugBank ID:DB19277 | Omilancor
+BMGC_DG20905,BMG_DG268974,DrugBank ID:DB19281 | Licochalcone A
+BMGC_DG20906,BMG_DG268976,DrugBank ID:DB19283 | Honokiol
+BMGC_DG20907,BMG_DG268999,DrugBank ID:DB19306 | XK-469 free acid
+BMGC_DG20908,BMG_DG269004,Farglitazar | DrugBank ID:DB19311
+BMGC_DG20909,BMG_DG269005,Sipoglitazar | DrugBank ID:DB19312
+BMGC_DG20910,BMG_DG269007,DrugBank ID:DB19314 | Nemonapride
+BMGC_DG20911,BMG_DG269018,DrugBank ID:DB19325 | Sofpironium
+BMGC_DG20912,BMG_DG269022,DrugBank ID:DB19329 | Azelaprag
+BMGC_DG20913,BMG_DG269046,Benzgalantamine | DrugBank ID:DB19353
+BMGC_DG20914,BMG_DG269064,Zoxazolamine | DrugBank ID:DB19372
+BMGC_DG20915,BMG_DG269070,Megestrol | DrugBank ID:DB19378
+BMGC_DG20916,BMG_DG269073,DrugBank ID:DB19381 | AZACYCLONOL
+BMGC_DG20917,BMG_DG269082,DrugBank ID:DB19397 | AZD8630
+BMGC_DG20918,BMG_DG269087,DrugBank ID:DB19413 | Influenza A Virus A/Thailand/8/2022 IVR-237 (H3N2) whole